*********** PTASSAMj00 ******** FILEIN user.vek ../../CSA/PIK_SPRITE/ ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 1 3 # 1 A 445 SER A 189 SER^? 11.75 MG MG A 302 A 524 ASP A 148 ASP^? 2.72 MG MG A 301s A 556 HIS A 147 HIS^? 9.20 MG MG A 302 coo 12.47 10.19 -6.98 12.48 12.40 -7.89 40.99 19.00 44.32 41.51 18.14 46.48 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 41.50 28.88 41.13 43.33 29.67 41.93 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 40.24 23.10 39.83 38.32 22.34 40.22 ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 2 3 # 2 A 445 SER B 189 SER^? 12.11 MG MG B 301 A 524 ASP B 148 ASP^? 2.58 MG MG B 302s A 556 HIS B 147 HIS^? 9.27 MG MG B 301 coo 12.47 10.19 -6.98 12.48 12.40 -7.89 43.10 20.95 -7.74 42.82 21.56 -10.02 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 46.73 18.97 -3.05 45.63 17.32 -3.73 ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 3 3 # 3 A 445 SER C 189 SER^? 12.09 MG MG C 301 A 524 ASP C 148 ASP^? 2.75 MG MG C 302s A 556 HIS C 147 HIS^? 9.44 MG MG C 301 coo 12.47 10.19 -6.98 12.48 12.40 -7.89 90.33 28.79 1.19 90.26 29.61 3.45 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 87.61 25.71 -3.59 89.22 24.50 -2.99 ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 4 3 # 4 A 445 SER D 189 SER^? 12.12 MG MG D 301 A 524 ASP D 148 ASP^? 2.35 MG MG D 302s A 556 HIS D 147 HIS^? 9.43 MG MG D 301 coo 12.47 10.19 -6.98 12.48 12.40 -7.89 91.62 28.58 -50.95 91.45 27.78 -53.25 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 90.95 32.51 -46.42 92.98 32.42 -46.93 ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 5 3 # 5 A 445 SER E 189 SER^? 11.91 MG MG E 301 A 524 ASP E 148 ASP^? 2.62 MG MG E 302s A 556 HIS E 147 HIS^? 9.22 MG MG E 301 coo 12.47 10.19 -6.98 12.48 12.40 -7.89 60.13 65.61 -43.87 59.01 65.34 -41.74 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 63.87 64.43 -48.39 64.18 66.45 -47.92 ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 6 3 # 6 A 445 SER F 189 SER^? 11.88 MG MG F 302 A 524 ASP F 148 ASP^? 2.72 MG MG F 301s A 556 HIS F 147 HIS^? 8.79 MG MG F 302 coo 12.47 10.19 -6.98 12.48 12.40 -7.89 59.91 63.90 -95.91 60.70 64.22 -98.13 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 56.63 61.66 -91.16 55.69 63.43 -91.80 3o4g_o00 source 3O4G ACYLAMINO-ACID-RELEASING ENZYME : 6 hits 3o4g_o00 naa= 3 ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 A 98 SER A 189 SER^? 11.75 MG MG A 302 A 123 HIS A 147 HIS^? 9.20 MG MG A 302 A 172 ASP A 148 ASP^? 2.72 MG MG A 301s coo 45.74 29.80 42.79 47.58 31.06 41.64 40.99 19.00 44.32 41.51 18.14 46.48 coo 44.17 25.61 37.60 45.21 25.56 35.81 40.24 23.10 39.83 38.32 22.34 40.22 coo 39.85 24.35 34.94 41.12 25.58 33.83 41.50 28.88 41.13 43.33 29.67 41.93 ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 A 98 SER B 189 SER^? 12.11 MG MG B 301 A 123 HIS B 147 HIS^? 9.27 MG MG B 301 A 172 ASP B 148 ASP^? 2.58 MG MG B 302s coo 45.74 29.80 42.79 47.58 31.06 41.64 43.10 20.95 -7.74 42.82 21.56 -10.02 coo 44.17 25.61 37.60 45.21 25.56 35.81 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 39.85 24.35 34.94 41.12 25.58 33.83 52.73 19.23 -3.77 53.81 20.99 -4.31 ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 3 3 # 3 A 98 SER C 189 SER^? 12.09 MG MG C 301 A 123 HIS C 147 HIS^? 9.44 MG MG C 301 A 172 ASP C 148 ASP^? 2.75 MG MG C 302s coo 45.74 29.80 42.79 47.58 31.06 41.64 90.33 28.79 1.19 90.26 29.61 3.45 coo 44.17 25.61 37.60 45.21 25.56 35.81 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 39.85 24.35 34.94 41.12 25.58 33.83 81.96 23.83 -2.68 80.24 25.11 -2.27 ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 4 3 # 4 A 98 SER D 189 SER^? 12.12 MG MG D 301 A 123 HIS D 147 HIS^? 9.43 MG MG D 301 A 172 ASP D 148 ASP^? 2.35 MG MG D 302s coo 45.74 29.80 42.79 47.58 31.06 41.64 91.62 28.58 -50.95 91.45 27.78 -53.25 coo 44.17 25.61 37.60 45.21 25.56 35.81 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 39.85 24.35 34.94 41.12 25.58 33.83 87.78 37.50 -47.56 85.79 37.49 -48.28 ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 5 3 # 5 A 98 SER E 189 SER^? 11.91 MG MG E 301 A 123 HIS E 147 HIS^? 9.22 MG MG E 301 A 172 ASP E 148 ASP^? 2.62 MG MG E 302s coo 45.74 29.80 42.79 47.58 31.06 41.64 60.13 65.61 -43.87 59.01 65.34 -41.74 coo 44.17 25.61 37.60 45.21 25.56 35.81 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 39.85 24.35 34.94 41.12 25.58 33.83 68.29 60.44 -47.29 68.03 58.42 -46.50 ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 6 3 # 6 A 98 SER F 189 SER^? 11.88 MG MG F 302 A 123 HIS F 147 HIS^? 8.79 MG MG F 302 A 172 ASP F 148 ASP^? 2.72 MG MG F 301s coo 45.74 29.80 42.79 47.58 31.06 41.64 59.91 63.90 -95.91 60.70 64.22 -98.13 coo 44.17 25.61 37.60 45.21 25.56 35.81 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 39.85 24.35 34.94 41.12 25.58 33.83 53.64 56.47 -91.98 54.61 54.68 -92.64 3qwd_o00 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 6 hits 3qwd_o00 naa= 3 ULMN 4 1aq0_c00 1,3-1,4-BETA-GLUCANASE user 1 4 # 1 A 232 GLU C 19 GLU^? 19.08 MG MG C 301 A 280 GLU C 33 GLU^? 22.71 MG MG C 302 A 283 LYS C 76 LYS^? 24.95 MG MG C 302 A 288 GLU C 75 GLU^? 16.14 MG MG B 301 coo 5.76 85.47 37.35 6.76 85.56 39.24 80.46 7.67 -6.81 81.43 5.97 -5.99 coo 4.25 95.66 42.75 4.18 93.57 42.69 78.39 11.67 -18.82 78.34 12.01 -20.91 coo 9.66 95.18 46.95 8.19 90.97 44.00 71.11 8.63 -16.76 75.44 5.17 -16.80 coo 13.49 92.75 43.16 12.39 91.15 42.33 69.49 12.18 -14.30 67.44 12.65 -13.83 1aq0_c00 source 1aq0 1,3-1,4-BETA-GLUCANASE : 1 hits 1aq0_c00 naa= 4 ULMN 4 1aq0_c01 1,3-1,4-BETA-GLUCANASE user 1 4 # 1 B 232 GLU C 19 GLU^? 19.08 MG MG C 301 B 280 GLU C 33 GLU^? 22.71 MG MG C 302 B 283 LYS C 76 LYS^? 24.95 MG MG C 302 B 288 GLU C 75 GLU^? 16.14 MG MG B 301 coo -0.96 61.87 2.24 -2.27 63.48 2.70 80.46 7.67 -6.81 81.43 5.97 -5.99 coo -4.32 67.50 -7.41 -4.63 66.46 -5.59 78.39 11.67 -18.82 78.34 12.01 -20.91 coo -6.22 73.35 -4.20 -4.99 69.00 -1.28 71.11 8.63 -16.76 75.44 5.17 -16.80 coo -1.91 73.68 -0.16 -1.91 71.74 0.71 69.49 12.18 -14.30 67.44 12.65 -13.83 1aq0_c01 source 1aq0 1,3-1,4-BETA-GLUCANASE : 1 hits 1aq0_c01 naa= 4 ULMN 4 1at1_c00 ASPARTATE CARBAMOYLTRANSFERASE (ASPAuser 1 4 # 1 A 54 ARG A 37 ARG^? 18.99 MG MG A 301 A 55 THR A 40 THR^? 24.69 MG MG A 301 A 105 ARG A 8 ARG^? 20.36 MG MG A 301 A 134 HIS A 42 HIS^? 28.45 MG MG A 301 coo 45.01 25.56 13.42 46.87 24.72 15.81 32.99 26.50 25.19 35.50 25.33 26.51 coo 46.66 31.81 11.47 45.07 33.00 12.28 32.64 20.47 25.22 32.40 21.22 23.20 coo 45.90 36.70 17.09 45.44 33.84 15.97 40.62 19.52 24.63 40.98 22.51 23.88 coo 39.84 34.19 14.29 41.49 33.14 13.80 34.62 18.32 19.57 34.29 16.25 19.41 ULMN 4 1at1_c00 ASPARTATE CARBAMOYLTRANSFERASE (ASPAuser 2 4 # 2 A 54 ARG B 37 ARG^? 19.17 MG MG B 302 A 55 THR B 40 THR^? 24.25 MG MG B 302 A 105 ARG B 8 ARG^? 20.39 MG MG B 302 A 134 HIS B 42 HIS^? 28.37 MG MG B 302 coo 45.01 25.56 13.42 46.87 24.72 15.81 47.41 10.20 11.40 46.99 12.91 10.22 coo 46.66 31.81 11.47 45.07 33.00 12.28 41.77 11.06 10.77 42.63 10.70 12.73 coo 45.90 36.70 17.09 45.44 33.84 15.97 41.99 18.82 11.83 44.91 18.76 12.93 coo 39.84 34.19 14.29 41.49 33.14 13.80 39.34 12.99 16.30 37.26 13.24 16.40 ULMN 4 1at1_c00 ASPARTATE CARBAMOYLTRANSFERASE (ASPAuser 3 4 # 3 A 54 ARG C 37 ARG^? 19.01 MG MG C 302 A 55 THR C 40 THR^? 24.02 MG MG C 302 A 105 ARG C 8 ARG^? 20.00 MG MG C 302 A 134 HIS C 42 HIS^? 28.09 MG MG C 302 coo 45.01 25.56 13.42 46.87 24.72 15.81 89.36 17.23 -17.57 89.29 20.20 -16.76 coo 46.66 31.81 11.47 45.07 33.00 12.28 94.40 20.37 -17.61 93.73 19.75 -19.59 coo 45.90 36.70 17.09 45.44 33.84 15.97 91.42 27.61 -18.53 88.82 26.28 -19.38 coo 39.84 34.19 14.29 41.49 33.14 13.80 95.93 22.96 -23.11 97.92 23.62 -23.02 ULMN 4 1at1_c00 ASPARTATE CARBAMOYLTRANSFERASE (ASPAuser 4 4 # 4 A 54 ARG D 37 ARG^? 18.81 MG MG D 302 A 55 THR D 40 THR^? 24.02 MG MG D 302 A 105 ARG D 8 ARG^? 20.22 MG MG D 302 A 134 HIS D 42 HIS^? 28.21 MG MG D 302 coo 45.01 25.56 13.42 46.87 24.72 15.81 96.81 38.21 -31.63 94.97 36.32 -33.06 coo 46.66 31.81 11.47 45.07 33.00 12.28 99.14 32.63 -32.12 99.04 33.58 -30.18 coo 45.90 36.70 17.09 45.44 33.84 15.97 92.22 28.83 -31.23 90.93 31.55 -30.54 coo 39.84 34.19 14.29 41.49 33.14 13.80 98.45 29.90 -26.44 99.32 28.02 -26.13 ULMN 4 1at1_c00 ASPARTATE CARBAMOYLTRANSFERASE (ASPAuser 5 4 # 5 A 54 ARG E 37 ARG^? 19.17 MG MG E 302 A 55 THR E 40 THR^? 24.66 MG MG E 302 A 105 ARG E 8 ARG^? 20.19 MG MG E 302 A 134 HIS E 42 HIS^? 28.20 MG MG E 302 coo 45.01 25.56 13.42 46.87 24.72 15.81 70.82 68.02 -63.63 68.17 67.46 -62.14 coo 46.66 31.81 11.47 45.07 33.00 12.28 65.26 72.42 -63.00 65.97 72.32 -65.06 coo 45.90 36.70 17.09 45.44 33.84 15.97 60.42 66.09 -63.48 62.84 64.38 -64.17 coo 39.84 34.19 14.29 41.49 33.14 13.80 62.33 71.93 -68.30 60.54 72.96 -68.64 ULMN 4 1at1_c00 ASPARTATE CARBAMOYLTRANSFERASE (ASPAuser 6 4 # 6 A 54 ARG F 37 ARG^? 19.14 MG MG F 301 A 55 THR F 40 THR^? 24.18 MG MG F 301 A 105 ARG F 8 ARG^? 20.20 MG MG F 301 A 134 HIS F 42 HIS^? 28.34 MG MG F 301 coo 45.01 25.56 13.42 46.87 24.72 15.81 48.80 64.46 -76.37 51.50 64.15 -77.79 coo 46.66 31.81 11.47 45.07 33.00 12.28 52.32 69.62 -77.21 51.38 69.00 -75.36 coo 45.90 36.70 17.09 45.44 33.84 15.97 58.98 65.22 -76.31 57.29 62.84 -75.38 coo 39.84 34.19 14.29 41.49 33.14 13.80 55.11 70.50 -71.64 56.29 72.22 -71.48 1at1_c00 source 1at1 ASPARTATE CARBAMOYLTRANSFERASE (ASPARTATE TRAN: 6 hits 1at1_c00 naa= 4 ULMN 4 1at1_c01 ASPARTATE CARBAMOYLTRANSFERASE (ASPAuser 1 4 # 1 C 54 ARG A 37 ARG^? 18.99 MG MG A 301 C 55 THR A 40 THR^? 24.69 MG MG A 301 C 105 ARG A 8 ARG^? 20.36 MG MG A 301 C 134 HIS A 42 HIS^? 28.45 MG MG A 301 coo 72.21 50.46 66.89 73.19 48.88 64.48 32.99 26.50 25.19 35.50 25.33 26.51 coo 66.13 49.41 68.53 64.87 51.09 67.81 32.64 20.47 25.22 32.40 21.22 23.20 coo 61.54 50.76 63.40 64.63 51.00 63.85 40.62 19.52 24.63 40.98 22.51 23.88 coo 64.44 56.54 65.92 65.14 54.67 66.30 34.62 18.32 19.57 34.29 16.25 19.41 ULMN 4 1at1_c01 ASPARTATE CARBAMOYLTRANSFERASE (ASPAuser 2 4 # 2 C 54 ARG B 37 ARG^? 19.17 MG MG B 302 C 55 THR B 40 THR^? 24.25 MG MG B 302 C 105 ARG B 8 ARG^? 20.39 MG MG B 302 C 134 HIS B 42 HIS^? 28.37 MG MG B 302 coo 72.21 50.46 66.89 73.19 48.88 64.48 47.41 10.20 11.40 46.99 12.91 10.22 coo 66.13 49.41 68.53 64.87 51.09 67.81 41.77 11.06 10.77 42.63 10.70 12.73 coo 61.54 50.76 63.40 64.63 51.00 63.85 41.99 18.82 11.83 44.91 18.76 12.93 coo 64.44 56.54 65.92 65.14 54.67 66.30 39.34 12.99 16.30 37.26 13.24 16.40 ULMN 4 1at1_c01 ASPARTATE CARBAMOYLTRANSFERASE (ASPAuser 3 4 # 3 C 54 ARG C 37 ARG^? 19.01 MG MG C 302 C 55 THR C 40 THR^? 24.02 MG MG C 302 C 105 ARG C 8 ARG^? 20.00 MG MG C 302 C 134 HIS C 42 HIS^? 28.09 MG MG C 302 coo 72.21 50.46 66.89 73.19 48.88 64.48 89.36 17.23 -17.57 89.29 20.20 -16.76 coo 66.13 49.41 68.53 64.87 51.09 67.81 94.40 20.37 -17.61 93.73 19.75 -19.59 coo 61.54 50.76 63.40 64.63 51.00 63.85 91.42 27.61 -18.53 88.82 26.28 -19.38 coo 64.44 56.54 65.92 65.14 54.67 66.30 95.93 22.96 -23.11 97.92 23.62 -23.02 ULMN 4 1at1_c01 ASPARTATE CARBAMOYLTRANSFERASE (ASPAuser 4 4 # 4 C 54 ARG D 37 ARG^? 18.81 MG MG D 302 C 55 THR D 40 THR^? 24.02 MG MG D 302 C 105 ARG D 8 ARG^? 20.22 MG MG D 302 C 134 HIS D 42 HIS^? 28.21 MG MG D 302 coo 72.21 50.46 66.89 73.19 48.88 64.48 96.81 38.21 -31.63 94.97 36.32 -33.06 coo 66.13 49.41 68.53 64.87 51.09 67.81 99.14 32.63 -32.12 99.04 33.58 -30.18 coo 61.54 50.76 63.40 64.63 51.00 63.85 92.22 28.83 -31.23 90.93 31.55 -30.54 coo 64.44 56.54 65.92 65.14 54.67 66.30 98.45 29.90 -26.44 99.32 28.02 -26.13 ULMN 4 1at1_c01 ASPARTATE CARBAMOYLTRANSFERASE (ASPAuser 5 4 # 5 C 54 ARG E 37 ARG^? 19.17 MG MG E 302 C 55 THR E 40 THR^? 24.66 MG MG E 302 C 105 ARG E 8 ARG^? 20.19 MG MG E 302 C 134 HIS E 42 HIS^? 28.20 MG MG E 302 coo 72.21 50.46 66.89 73.19 48.88 64.48 70.82 68.02 -63.63 68.17 67.46 -62.14 coo 66.13 49.41 68.53 64.87 51.09 67.81 65.26 72.42 -63.00 65.97 72.32 -65.06 coo 61.54 50.76 63.40 64.63 51.00 63.85 60.42 66.09 -63.48 62.84 64.38 -64.17 coo 64.44 56.54 65.92 65.14 54.67 66.30 62.33 71.93 -68.30 60.54 72.96 -68.64 ULMN 4 1at1_c01 ASPARTATE CARBAMOYLTRANSFERASE (ASPAuser 6 4 # 6 C 54 ARG F 37 ARG^? 19.14 MG MG F 301 C 55 THR F 40 THR^? 24.18 MG MG F 301 C 105 ARG F 8 ARG^? 20.20 MG MG F 301 C 134 HIS F 42 HIS^? 28.34 MG MG F 301 coo 72.21 50.46 66.89 73.19 48.88 64.48 48.80 64.46 -76.37 51.50 64.15 -77.79 coo 66.13 49.41 68.53 64.87 51.09 67.81 52.32 69.62 -77.21 51.38 69.00 -75.36 coo 61.54 50.76 63.40 64.63 51.00 63.85 58.98 65.22 -76.31 57.29 62.84 -75.38 coo 64.44 56.54 65.92 65.14 54.67 66.30 55.11 70.50 -71.64 56.29 72.22 -71.48 1at1_c01 source 1at1 ASPARTATE CARBAMOYLTRANSFERASE (ASPARTATE TRAN: 6 hits 1at1_c01 naa= 4 ULMN 4 1bvz_c07 ALPHA-AMYLASE II user 1 4 # 1 B 244 HIS B 170 HIS^? 10.51 MG MG B 301 B 325 ASP B 171 ASP^? 16.92 MG MG B 301 B 354 GLU B 38 GLU^? 21.75 MG MG B 301 B 421 ASP B 35 ASP^? 16.92 MG MG B 302 coo 18.86 7.90 56.29 20.11 7.10 54.89 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 25.90 8.19 53.87 25.36 6.97 52.29 45.30 8.50 -0.71 46.30 6.81 0.12 coo 27.87 10.66 47.95 27.82 8.60 48.27 44.79 4.95 7.12 46.66 4.47 6.21 coo 26.02 1.87 43.38 25.90 1.97 45.49 52.63 11.07 10.18 53.68 12.85 9.94 1bvz_c07 source 1bvz ALPHA-AMYLASE II : 1 hits 1bvz_c07 naa= 4 ULMN 4 1c17_c11 ATP SYNTHASE SUBUNIT C user 1 4 # 1 A 61 ASP B 138 ASP^? 33.32 MG MG B 302 M 206 SER A 10 SER^? 16.72 MG MG A 301 M 210 ARG A 8 ARG^? 20.36 MG MG A 301 M 214 ASN B 45 ASN^? 24.27 MG MG A 301 coo 2.15 -17.14 -6.89 2.91 -15.59 -8.10 23.42 29.01 6.78 24.36 28.48 4.94 coo -2.55 -23.32 19.81 -3.48 -21.59 18.38 40.39 23.85 29.26 38.85 24.86 27.67 coo 1.98 -17.11 17.69 1.79 -15.15 15.33 40.62 19.52 24.63 40.98 22.51 23.88 coo 8.13 -16.73 20.92 6.75 -15.93 19.51 47.87 19.20 19.75 47.40 21.26 19.77 ULMN 4 1c17_c11 ATP SYNTHASE SUBUNIT C user 2 4 # 2 A 61 ASP D 138 ASP^? 33.64 MG MG D 302 M 206 SER C 10 SER^? 16.50 MG MG C 302 M 210 ARG C 8 ARG^? 20.00 MG MG C 302 M 214 ASN D 45 ASN^? 24.33 MG MG C 302 coo 2.15 -17.14 -6.89 2.91 -15.59 -8.10 93.00 7.50 -35.79 93.88 8.48 -37.45 coo -2.55 -23.32 19.81 -3.48 -21.59 18.38 87.65 25.37 -14.15 87.84 23.42 -15.55 coo 1.98 -17.11 17.69 1.79 -15.15 15.33 91.42 27.61 -18.53 88.82 26.28 -19.38 coo 8.13 -16.73 20.92 6.75 -15.93 19.51 88.35 34.04 -23.87 86.82 32.62 -24.25 1c17_c11 source 1c17 ATP SYNTHASE SUBUNIT C : 2 hits 1c17_c11 naa= 4 ULMN 4 1dae_c00 DETHIOBIOTIN SYNTHETASE user 1 4 # 1 11 THR A 18 THR.? 15.77 MG MG A 301 15 LYS A 76 LYS^? 25.42 MG MG A 301 37 LYS B 61 LYS^? 22.03 MG MG A 301 41 SER A 36 SER^? 23.25 MG MG A 301 coo 0.09 24.25 7.43 -1.97 23.87 6.88 32.02 38.89 33.13 34.18 39.03 32.98 coo 7.11 25.15 11.60 2.05 27.82 12.68 34.45 46.53 27.28 28.88 44.93 27.25 coo 1.91 29.06 21.41 0.93 26.02 16.70 32.50 37.62 17.61 36.68 34.92 21.51 coo -6.12 22.99 17.90 -6.59 23.98 15.67 29.88 32.10 25.40 29.53 34.39 24.57 ULMN 4 1dae_c00 DETHIOBIOTIN SYNTHETASE user 2 4 # 2 11 THR B 73 THR^? 15.28 MG MG B 302 15 LYS B 86 LYS^? 26.44 MG MG B 302 37 LYS A 61 LYS^? 21.99 MG MG B 302 41 SER B 16 SER^? 23.97 MG MG B 302 coo 0.09 24.25 7.43 -1.97 23.87 6.88 61.79 16.15 11.00 62.15 17.08 9.05 coo 7.11 25.15 11.60 2.05 27.82 12.68 69.25 10.45 13.86 65.27 7.74 16.08 coo 1.91 29.06 21.41 0.93 26.02 16.70 57.78 7.35 19.60 56.77 12.20 15.61 coo -6.12 22.99 17.90 -6.59 23.98 15.67 56.70 5.18 9.63 55.76 3.58 11.01 ULMN 4 1dae_c00 DETHIOBIOTIN SYNTHETASE user 3 4 # 3 11 THR D 18 THR^? 15.54 MG MG D 302 15 LYS D 76 LYS^? 25.08 MG MG D 302 37 LYS C 61 LYS^? 21.91 MG MG D 302 41 SER D 36 SER^? 22.42 MG MG D 302 coo 0.09 24.25 7.43 -1.97 23.87 6.88 93.52 49.91 -39.68 91.41 49.57 -39.76 coo 7.11 25.15 11.60 2.05 27.82 12.68 88.18 56.35 -34.05 93.80 56.17 -32.93 coo 1.91 29.06 21.41 0.93 26.02 16.70 93.60 48.56 -24.05 90.39 44.71 -27.98 coo -6.12 22.99 17.90 -6.59 23.98 15.67 97.85 44.42 -32.20 96.60 46.20 -31.15 ULMN 4 1dae_c00 DETHIOBIOTIN SYNTHETASE user 4 4 # 4 11 THR D 73 THR^? 15.26 MG MG D 302 15 LYS D 76 LYS^? 25.08 MG MG D 302 37 LYS C 61 LYS^? 21.91 MG MG D 302 41 SER D 36 SER^? 22.42 MG MG D 302 coo 0.09 24.25 7.43 -1.97 23.87 6.88 84.65 47.16 -33.26 83.69 47.10 -35.24 coo 7.11 25.15 11.60 2.05 27.82 12.68 88.18 56.35 -34.05 93.80 56.17 -32.93 coo 1.91 29.06 21.41 0.93 26.02 16.70 93.60 48.56 -24.05 90.39 44.71 -27.98 coo -6.12 22.99 17.90 -6.59 23.98 15.67 97.85 44.42 -32.20 96.60 46.20 -31.15 ULMN 4 1dae_c00 DETHIOBIOTIN SYNTHETASE user 5 4 # 5 11 THR D 73 THR^? 15.26 MG MG D 302 15 LYS D 86 LYS^? 25.80 MG MG D 302 37 LYS C 61 LYS^? 21.91 MG MG D 302 41 SER D 16 SER^? 23.71 MG MG D 302 coo 0.09 24.25 7.43 -1.97 23.87 6.88 84.65 47.16 -33.26 83.69 47.10 -35.24 coo 7.11 25.15 11.60 2.05 27.82 12.68 85.54 56.79 -30.27 90.24 54.54 -28.62 coo 1.91 29.06 21.41 0.93 26.02 16.70 93.60 48.56 -24.05 90.39 44.71 -27.98 coo -6.12 22.99 17.90 -6.59 23.98 15.67 96.73 48.43 -33.75 98.58 48.68 -32.31 ULMN 4 1dae_c00 DETHIOBIOTIN SYNTHETASE user 6 4 # 6 11 THR E 18 THR^? 15.84 MG MG E 302 15 LYS E 76 LYS^? 25.68 MG MG E 302 37 LYS F 61 LYS^? 21.75 MG MG E 302 41 SER E 36 SER^? 22.92 MG MG E 302 coo 0.09 24.25 7.43 -1.97 23.87 6.88 81.45 64.25 -55.27 80.73 62.21 -55.24 coo 7.11 25.15 11.60 2.05 27.82 12.68 87.09 58.11 -60.91 88.65 63.65 -61.27 coo 1.91 29.06 21.41 0.93 26.02 16.70 80.24 64.12 -71.01 76.23 61.95 -66.39 coo -6.12 22.99 17.90 -6.59 23.98 15.67 76.63 69.18 -62.93 78.20 67.77 -64.11 ULMN 4 1dae_c00 DETHIOBIOTIN SYNTHETASE user 7 4 # 7 11 THR E 73 THR^? 15.13 MG MG E 302 15 LYS E 76 LYS^? 25.68 MG MG E 302 37 LYS F 61 LYS^? 21.75 MG MG E 302 41 SER E 36 SER^? 22.92 MG MG E 302 coo 0.09 24.25 7.43 -1.97 23.87 6.88 77.31 55.78 -61.57 77.11 55.21 -59.48 coo 7.11 25.15 11.60 2.05 27.82 12.68 87.09 58.11 -60.91 88.65 63.65 -61.27 coo 1.91 29.06 21.41 0.93 26.02 16.70 80.24 64.12 -71.01 76.23 61.95 -66.39 coo -6.12 22.99 17.90 -6.59 23.98 15.67 76.63 69.18 -62.93 78.20 67.77 -64.11 ULMN 4 1dae_c00 DETHIOBIOTIN SYNTHETASE user 8 4 # 8 11 THR E 73 THR^? 15.13 MG MG E 302 15 LYS E 86 LYS^? 26.73 MG MG D 301 37 LYS F 61 LYS^? 21.75 MG MG E 302 41 SER E 16 SER^? 24.21 MG MG E 302 coo 0.09 24.25 7.43 -1.97 23.87 6.88 77.31 55.78 -61.57 77.11 55.21 -59.48 coo 7.11 25.15 11.60 2.05 27.82 12.68 86.84 54.85 -64.43 87.07 60.83 -66.10 coo 1.91 29.06 21.41 0.93 26.02 16.70 80.24 64.12 -71.01 76.23 61.95 -66.39 coo -6.12 22.99 17.90 -6.59 23.98 15.67 80.65 67.65 -61.22 81.30 69.49 -62.59 1dae_c00 source 1dae DETHIOBIOTIN SYNTHETASE : 8 hits 1dae_c00 naa= 4 ULMN 4 1db3_c00 GDP-MANNOSE 4,6-DEHYDRATASE user 1 4 # 1 A 132 THR A 169 THR^? 18.45 MG MG A 302 A 134 GLU A 154 GLU^? 19.22 MG MG A 301 A 156 TYR A 156 TYR^? 21.80 MG MG A 301 A 160 LYS A 166 LYS^? 20.93 MG MG A 302 coo 10.50 56.87 17.73 11.24 57.93 19.43 34.64 19.08 35.13 33.08 18.40 33.78 coo 14.05 56.93 22.25 14.86 58.63 23.18 36.54 21.95 29.78 35.14 22.21 28.17 coo 11.64 63.07 23.95 11.76 62.47 21.20 37.50 16.28 27.75 35.30 17.94 28.08 coo 5.78 61.30 21.65 8.04 62.89 17.54 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 4 1db3_c00 GDP-MANNOSE 4,6-DEHYDRATASE user 2 4 # 2 A 132 THR B 40 THR^? 24.25 MG MG B 302 A 134 GLU B 154 GLU^? 19.05 MG MG B 302 A 156 TYR B 156 TYR^? 21.63 MG MG B 302 A 160 LYS B 166 LYS^? 22.75 MG MG B 301 coo 10.50 56.87 17.73 11.24 57.93 19.43 41.77 11.06 10.77 42.63 10.70 12.73 coo 14.05 56.93 22.25 14.86 58.63 23.18 44.04 15.11 6.74 44.19 13.59 8.30 coo 11.64 63.07 23.95 11.76 62.47 21.20 38.56 16.71 8.27 39.91 14.31 7.86 coo 5.78 61.30 21.65 8.04 62.89 17.54 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 4 1db3_c00 GDP-MANNOSE 4,6-DEHYDRATASE user 3 4 # 3 A 132 THR B 169 THR^? 18.43 MG MG B 301 A 134 GLU B 154 GLU^? 19.05 MG MG B 302 A 156 TYR B 156 TYR^? 21.63 MG MG B 302 A 160 LYS B 166 LYS^? 22.75 MG MG B 301 coo 10.50 56.87 17.73 11.24 57.93 19.43 41.38 13.97 0.97 40.27 12.43 2.02 coo 14.05 56.93 22.25 14.86 58.63 23.18 44.04 15.11 6.74 44.19 13.59 8.30 coo 11.64 63.07 23.95 11.76 62.47 21.20 38.56 16.71 8.27 39.91 14.31 7.86 coo 5.78 61.30 21.65 8.04 62.89 17.54 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 4 1db3_c00 GDP-MANNOSE 4,6-DEHYDRATASE user 4 4 # 4 A 132 THR C 169 THR^? 18.51 MG MG C 301 A 134 GLU C 154 GLU^? 18.91 MG MG C 302 A 156 TYR C 156 TYR^? 21.58 MG MG C 302 A 160 LYS C 166 LYS^? 22.53 MG MG C 301 coo 10.50 56.87 17.73 11.24 57.93 19.43 94.19 23.02 -7.83 95.56 21.86 -9.07 coo 14.05 56.93 22.25 14.86 58.63 23.18 91.15 23.27 -13.33 91.61 21.91 -14.95 coo 11.64 63.07 23.95 11.76 62.47 21.20 95.64 26.50 -15.14 95.25 23.76 -14.77 coo 5.78 61.30 21.65 8.04 62.89 17.54 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 4 1db3_c00 GDP-MANNOSE 4,6-DEHYDRATASE user 5 4 # 5 A 132 THR D 169 THR^? 18.47 MG MG D 301 A 134 GLU D 154 GLU^? 18.75 MG MG D 302 A 156 TYR D 156 TYR^? 21.34 MG MG D 302 A 160 LYS D 166 LYS^? 21.08 MG MG D 301 coo 10.50 56.87 17.73 11.24 57.93 19.43 97.62 30.68 -41.94 99.48 30.62 -40.85 coo 14.05 56.93 22.25 14.86 58.63 23.18 94.87 32.52 -36.42 96.07 33.39 -34.88 coo 11.64 63.07 23.95 11.76 62.47 21.20 96.25 27.10 -34.64 97.58 29.48 -35.03 coo 5.78 61.30 21.65 8.04 62.89 17.54 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 4 1db3_c00 GDP-MANNOSE 4,6-DEHYDRATASE user 6 4 # 6 A 132 THR F 40 THR^? 24.18 MG MG F 301 A 134 GLU F 154 GLU^? 18.97 MG MG F 301 A 156 TYR F 156 TYR^? 21.68 MG MG F 302 A 160 LYS F 166 LYS^? 20.76 MG MG F 302 coo 10.50 56.87 17.73 11.24 57.93 19.43 52.32 69.62 -77.21 51.38 69.00 -75.36 coo 14.05 56.93 22.25 14.86 58.63 23.18 54.57 65.67 -81.55 53.36 66.51 -80.09 coo 11.64 63.07 23.95 11.76 62.47 21.20 58.80 69.55 -79.65 56.09 69.80 -80.15 coo 5.78 61.30 21.65 8.04 62.89 17.54 59.28 73.05 -82.63 55.63 74.15 -86.94 ULMN 4 1db3_c00 GDP-MANNOSE 4,6-DEHYDRATASE user 7 4 # 7 A 132 THR F 169 THR^? 17.93 MG MG F 302 A 134 GLU F 154 GLU^? 18.97 MG MG F 301 A 156 TYR F 156 TYR^? 21.68 MG MG F 302 A 160 LYS F 166 LYS^? 20.76 MG MG F 302 coo 10.50 56.87 17.73 11.24 57.93 19.43 54.83 68.79 -86.99 54.09 70.44 -85.82 coo 14.05 56.93 22.25 14.86 58.63 23.18 54.57 65.67 -81.55 53.36 66.51 -80.09 coo 11.64 63.07 23.95 11.76 62.47 21.20 58.80 69.55 -79.65 56.09 69.80 -80.15 coo 5.78 61.30 21.65 8.04 62.89 17.54 59.28 73.05 -82.63 55.63 74.15 -86.94 1db3_c00 source 1db3 GDP-MANNOSE 4,6-DEHYDRATASE : 7 hits 1db3_c00 naa= 4 ULMN 4 1dd8_c00 BETA-KETOACYL [ACYL CARRIER PROTEIN]user 1 4 # 1 A 163 CYH A 152 CYH^? 15.18 MG MG A 302 A 298 HIS A 147 HIS^? 9.20 MG MG A 302 A 333 HIS A 170 HIS^? 10.56 MG MG A 302 A 392 PHE A 150 PHE^? 10.47 MG MG A 302 coo 35.40 69.19 64.32 37.60 70.93 64.10 34.81 26.51 34.70 32.10 26.95 34.06 coo 33.88 74.99 60.50 35.24 73.95 61.71 40.24 23.10 39.83 38.32 22.34 40.22 coo 35.99 74.82 67.51 35.98 73.21 66.18 34.91 23.57 39.32 34.35 24.95 40.81 coo 42.33 69.65 62.68 42.99 72.12 63.86 35.63 32.10 38.88 34.73 33.93 37.00 ULMN 4 1dd8_c00 BETA-KETOACYL [ACYL CARRIER PROTEIN]user 2 4 # 2 A 163 CYH A 152 CYH^? 15.18 MG MG A 302 A 298 HIS A 170 HIS^? 10.56 MG MG A 302 A 333 HIS A 147 HIS^? 9.20 MG MG A 302 A 392 PHE A 150 PHE^? 10.47 MG MG A 302 coo 35.40 69.19 64.32 37.60 70.93 64.10 34.81 26.51 34.70 32.10 26.95 34.06 coo 33.88 74.99 60.50 35.24 73.95 61.71 34.91 23.57 39.32 34.35 24.95 40.81 coo 35.99 74.82 67.51 35.98 73.21 66.18 40.24 23.10 39.83 38.32 22.34 40.22 coo 42.33 69.65 62.68 42.99 72.12 63.86 35.63 32.10 38.88 34.73 33.93 37.00 ULMN 4 1dd8_c00 BETA-KETOACYL [ACYL CARRIER PROTEIN]user 3 4 # 3 A 163 CYH E 152 CYH^? 14.64 MG MG E 301 A 298 HIS E 147 HIS^? 9.22 MG MG E 301 A 333 HIS E 170 HIS^? 10.33 MG MG E 301 A 392 PHE E 150 PHE^? 10.10 MG MG E 301 coo 35.40 69.19 64.32 37.60 70.93 64.10 69.49 67.27 -53.54 71.02 69.50 -54.03 coo 33.88 74.99 60.50 35.24 73.95 61.71 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 35.99 74.82 67.51 35.98 73.21 66.18 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 42.33 69.65 62.68 42.99 72.12 63.86 74.01 63.99 -49.53 76.06 63.87 -51.45 ULMN 4 1dd8_c00 BETA-KETOACYL [ACYL CARRIER PROTEIN]user 4 4 # 4 A 163 CYH E 152 CYH^? 14.64 MG MG E 301 A 298 HIS E 170 HIS^? 10.33 MG MG E 301 A 333 HIS E 147 HIS^? 9.22 MG MG E 301 A 392 PHE E 150 PHE^? 10.10 MG MG E 301 coo 35.40 69.19 64.32 37.60 70.93 64.10 69.49 67.27 -53.54 71.02 69.50 -54.03 coo 33.88 74.99 60.50 35.24 73.95 61.71 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 35.99 74.82 67.51 35.98 73.21 66.18 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 42.33 69.65 62.68 42.99 72.12 63.86 74.01 63.99 -49.53 76.06 63.87 -51.45 ULMN 4 1dd8_c00 BETA-KETOACYL [ACYL CARRIER PROTEIN]user 5 4 # 5 A 163 CYH F 152 CYH^? 14.14 MG MG F 302 A 298 HIS F 147 HIS^? 8.79 MG MG F 302 A 333 HIS F 170 HIS^? 9.84 MG MG F 302 A 392 PHE F 150 PHE^? 9.82 MG MG F 302 coo 35.40 69.19 64.32 37.60 70.93 64.10 50.28 62.76 -86.08 48.12 64.34 -85.77 coo 33.88 74.99 60.50 35.24 73.95 61.71 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 35.99 74.82 67.51 35.98 73.21 66.18 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 42.33 69.65 62.68 42.99 72.12 63.86 47.10 57.70 -89.94 45.06 57.27 -88.04 ULMN 4 1dd8_c00 BETA-KETOACYL [ACYL CARRIER PROTEIN]user 6 4 # 6 A 163 CYH F 152 CYH^? 14.14 MG MG F 302 A 298 HIS F 170 HIS^? 9.84 MG MG F 302 A 333 HIS F 147 HIS^? 8.79 MG MG F 302 A 392 PHE F 150 PHE^? 9.82 MG MG F 302 coo 35.40 69.19 64.32 37.60 70.93 64.10 50.28 62.76 -86.08 48.12 64.34 -85.77 coo 33.88 74.99 60.50 35.24 73.95 61.71 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 35.99 74.82 67.51 35.98 73.21 66.18 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 42.33 69.65 62.68 42.99 72.12 63.86 47.10 57.70 -89.94 45.06 57.27 -88.04 1dd8_c00 source 1dd8 BETA-KETOACYL [ACYL CARRIER PROTEIN] SYNTHASE : 6 hits 1dd8_c00 naa= 4 ULMN 4 1dd8_c01 BETA-KETOACYL [ACYL CARRIER PROTEIN]user 1 4 # 1 B 163 CYH A 152 CYH^? 15.18 MG MG A 302 B 298 HIS A 147 HIS^? 9.20 MG MG A 302 B 333 HIS A 170 HIS^? 10.56 MG MG A 302 B 392 PHE A 150 PHE^? 10.47 MG MG A 302 coo 36.35 45.34 70.21 36.57 44.22 72.81 34.81 26.51 34.70 32.10 26.95 34.06 coo 34.44 38.52 70.53 35.24 40.22 71.46 40.24 23.10 39.83 38.32 22.34 40.22 coo 41.02 41.23 72.17 39.27 42.32 71.79 34.91 23.57 39.32 34.35 24.95 40.81 coo 34.75 46.39 77.04 36.53 44.64 78.31 35.63 32.10 38.88 34.73 33.93 37.00 ULMN 4 1dd8_c01 BETA-KETOACYL [ACYL CARRIER PROTEIN]user 2 4 # 2 B 163 CYH A 152 CYH^? 15.18 MG MG A 302 B 298 HIS A 170 HIS^? 10.56 MG MG A 302 B 333 HIS A 147 HIS^? 9.20 MG MG A 302 B 392 PHE A 150 PHE^? 10.47 MG MG A 302 coo 36.35 45.34 70.21 36.57 44.22 72.81 34.81 26.51 34.70 32.10 26.95 34.06 coo 34.44 38.52 70.53 35.24 40.22 71.46 34.91 23.57 39.32 34.35 24.95 40.81 coo 41.02 41.23 72.17 39.27 42.32 71.79 40.24 23.10 39.83 38.32 22.34 40.22 coo 34.75 46.39 77.04 36.53 44.64 78.31 35.63 32.10 38.88 34.73 33.93 37.00 ULMN 4 1dd8_c01 BETA-KETOACYL [ACYL CARRIER PROTEIN]user 3 4 # 3 B 163 CYH E 152 CYH^? 14.64 MG MG E 301 B 298 HIS E 147 HIS^? 9.22 MG MG E 301 B 333 HIS E 170 HIS^? 10.33 MG MG E 301 B 392 PHE E 150 PHE^? 10.10 MG MG E 301 coo 36.35 45.34 70.21 36.57 44.22 72.81 69.49 67.27 -53.54 71.02 69.50 -54.03 coo 34.44 38.52 70.53 35.24 40.22 71.46 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 41.02 41.23 72.17 39.27 42.32 71.79 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 34.75 46.39 77.04 36.53 44.64 78.31 74.01 63.99 -49.53 76.06 63.87 -51.45 ULMN 4 1dd8_c01 BETA-KETOACYL [ACYL CARRIER PROTEIN]user 4 4 # 4 B 163 CYH E 152 CYH^? 14.64 MG MG E 301 B 298 HIS E 170 HIS^? 10.33 MG MG E 301 B 333 HIS E 147 HIS^? 9.22 MG MG E 301 B 392 PHE E 150 PHE^? 10.10 MG MG E 301 coo 36.35 45.34 70.21 36.57 44.22 72.81 69.49 67.27 -53.54 71.02 69.50 -54.03 coo 34.44 38.52 70.53 35.24 40.22 71.46 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 41.02 41.23 72.17 39.27 42.32 71.79 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 34.75 46.39 77.04 36.53 44.64 78.31 74.01 63.99 -49.53 76.06 63.87 -51.45 ULMN 4 1dd8_c01 BETA-KETOACYL [ACYL CARRIER PROTEIN]user 5 4 # 5 B 163 CYH F 152 CYH^? 14.14 MG MG F 302 B 298 HIS F 147 HIS^? 8.79 MG MG F 302 B 333 HIS F 170 HIS^? 9.84 MG MG F 302 B 392 PHE F 150 PHE^? 9.82 MG MG F 302 coo 36.35 45.34 70.21 36.57 44.22 72.81 50.28 62.76 -86.08 48.12 64.34 -85.77 coo 34.44 38.52 70.53 35.24 40.22 71.46 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 41.02 41.23 72.17 39.27 42.32 71.79 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 34.75 46.39 77.04 36.53 44.64 78.31 47.10 57.70 -89.94 45.06 57.27 -88.04 ULMN 4 1dd8_c01 BETA-KETOACYL [ACYL CARRIER PROTEIN]user 6 4 # 6 B 163 CYH F 152 CYH^? 14.14 MG MG F 302 B 298 HIS F 170 HIS^? 9.84 MG MG F 302 B 333 HIS F 147 HIS^? 8.79 MG MG F 302 B 392 PHE F 150 PHE^? 9.82 MG MG F 302 coo 36.35 45.34 70.21 36.57 44.22 72.81 50.28 62.76 -86.08 48.12 64.34 -85.77 coo 34.44 38.52 70.53 35.24 40.22 71.46 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 41.02 41.23 72.17 39.27 42.32 71.79 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 34.75 46.39 77.04 36.53 44.64 78.31 47.10 57.70 -89.94 45.06 57.27 -88.04 1dd8_c01 source 1dd8 BETA-KETOACYL [ACYL CARRIER PROTEIN] SYNTHASE : 6 hits 1dd8_c01 naa= 4 ULMN 4 1dd8_c02 BETA-KETOACYL [ACYL CARRIER PROTEIN]user 1 4 # 1 C 163 CYH A 152 CYH^? 15.18 MG MG A 302 C 298 HIS A 147 HIS^? 9.20 MG MG A 302 C 333 HIS A 170 HIS^? 10.56 MG MG A 302 C 392 PHE A 150 PHE^? 10.47 MG MG A 302 coo 56.26 66.80 120.15 56.49 64.08 119.30 34.81 26.51 34.70 32.10 26.95 34.06 coo 54.26 62.31 125.28 54.86 62.62 123.29 40.24 23.10 39.83 38.32 22.34 40.22 coo 51.27 62.90 118.61 53.04 63.84 119.22 34.91 23.57 39.32 34.35 24.95 40.81 coo 60.64 61.97 117.27 58.81 59.95 116.51 35.63 32.10 38.88 34.73 33.93 37.00 ULMN 4 1dd8_c02 BETA-KETOACYL [ACYL CARRIER PROTEIN]user 2 4 # 2 C 163 CYH A 152 CYH^? 15.18 MG MG A 302 C 298 HIS A 170 HIS^? 10.56 MG MG A 302 C 333 HIS A 147 HIS^? 9.20 MG MG A 302 C 392 PHE A 150 PHE^? 10.47 MG MG A 302 coo 56.26 66.80 120.15 56.49 64.08 119.30 34.81 26.51 34.70 32.10 26.95 34.06 coo 54.26 62.31 125.28 54.86 62.62 123.29 34.91 23.57 39.32 34.35 24.95 40.81 coo 51.27 62.90 118.61 53.04 63.84 119.22 40.24 23.10 39.83 38.32 22.34 40.22 coo 60.64 61.97 117.27 58.81 59.95 116.51 35.63 32.10 38.88 34.73 33.93 37.00 ULMN 4 1dd8_c02 BETA-KETOACYL [ACYL CARRIER PROTEIN]user 3 4 # 3 C 163 CYH E 152 CYH^? 14.64 MG MG E 301 C 298 HIS E 147 HIS^? 9.22 MG MG E 301 C 333 HIS E 170 HIS^? 10.33 MG MG E 301 C 392 PHE E 150 PHE^? 10.10 MG MG E 301 coo 56.26 66.80 120.15 56.49 64.08 119.30 69.49 67.27 -53.54 71.02 69.50 -54.03 coo 54.26 62.31 125.28 54.86 62.62 123.29 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 51.27 62.90 118.61 53.04 63.84 119.22 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 60.64 61.97 117.27 58.81 59.95 116.51 74.01 63.99 -49.53 76.06 63.87 -51.45 ULMN 4 1dd8_c02 BETA-KETOACYL [ACYL CARRIER PROTEIN]user 4 4 # 4 C 163 CYH E 152 CYH^? 14.64 MG MG E 301 C 298 HIS E 170 HIS^? 10.33 MG MG E 301 C 333 HIS E 147 HIS^? 9.22 MG MG E 301 C 392 PHE E 150 PHE^? 10.10 MG MG E 301 coo 56.26 66.80 120.15 56.49 64.08 119.30 69.49 67.27 -53.54 71.02 69.50 -54.03 coo 54.26 62.31 125.28 54.86 62.62 123.29 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 51.27 62.90 118.61 53.04 63.84 119.22 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 60.64 61.97 117.27 58.81 59.95 116.51 74.01 63.99 -49.53 76.06 63.87 -51.45 ULMN 4 1dd8_c02 BETA-KETOACYL [ACYL CARRIER PROTEIN]user 5 4 # 5 C 163 CYH F 152 CYH^? 14.14 MG MG F 302 C 298 HIS F 147 HIS^? 8.79 MG MG F 302 C 333 HIS F 170 HIS^? 9.84 MG MG F 302 C 392 PHE F 150 PHE^? 9.82 MG MG F 302 coo 56.26 66.80 120.15 56.49 64.08 119.30 50.28 62.76 -86.08 48.12 64.34 -85.77 coo 54.26 62.31 125.28 54.86 62.62 123.29 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 51.27 62.90 118.61 53.04 63.84 119.22 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 60.64 61.97 117.27 58.81 59.95 116.51 47.10 57.70 -89.94 45.06 57.27 -88.04 ULMN 4 1dd8_c02 BETA-KETOACYL [ACYL CARRIER PROTEIN]user 6 4 # 6 C 163 CYH F 152 CYH^? 14.14 MG MG F 302 C 298 HIS F 170 HIS^? 9.84 MG MG F 302 C 333 HIS F 147 HIS^? 8.79 MG MG F 302 C 392 PHE F 150 PHE^? 9.82 MG MG F 302 coo 56.26 66.80 120.15 56.49 64.08 119.30 50.28 62.76 -86.08 48.12 64.34 -85.77 coo 54.26 62.31 125.28 54.86 62.62 123.29 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 51.27 62.90 118.61 53.04 63.84 119.22 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 60.64 61.97 117.27 58.81 59.95 116.51 47.10 57.70 -89.94 45.06 57.27 -88.04 1dd8_c02 source 1dd8 BETA-KETOACYL [ACYL CARRIER PROTEIN] SYNTHASE : 6 hits 1dd8_c02 naa= 4 ULMN 4 1dd8_c03 BETA-KETOACYL [ACYL CARRIER PROTEIN]user 1 4 # 1 D 163 CYH A 152 CYH^? 15.18 MG MG A 302 D 298 HIS A 147 HIS^? 9.20 MG MG A 302 D 333 HIS A 170 HIS^? 10.56 MG MG A 302 D 392 PHE A 150 PHE^? 10.47 MG MG A 302 coo 67.34 86.01 109.78 66.48 87.39 107.43 34.81 26.51 34.70 32.10 26.95 34.06 coo 70.13 92.51 109.26 69.00 90.99 108.37 40.24 23.10 39.83 38.32 22.34 40.22 coo 71.07 86.98 104.57 69.72 87.07 106.17 34.91 23.57 39.32 34.35 24.95 40.81 coo 61.70 87.79 105.86 62.91 88.45 103.42 35.63 32.10 38.88 34.73 33.93 37.00 ULMN 4 1dd8_c03 BETA-KETOACYL [ACYL CARRIER PROTEIN]user 2 4 # 2 D 163 CYH A 152 CYH^? 15.18 MG MG A 302 D 298 HIS A 170 HIS^? 10.56 MG MG A 302 D 333 HIS A 147 HIS^? 9.20 MG MG A 302 D 392 PHE A 150 PHE^? 10.47 MG MG A 302 coo 67.34 86.01 109.78 66.48 87.39 107.43 34.81 26.51 34.70 32.10 26.95 34.06 coo 70.13 92.51 109.26 69.00 90.99 108.37 34.91 23.57 39.32 34.35 24.95 40.81 coo 71.07 86.98 104.57 69.72 87.07 106.17 40.24 23.10 39.83 38.32 22.34 40.22 coo 61.70 87.79 105.86 62.91 88.45 103.42 35.63 32.10 38.88 34.73 33.93 37.00 ULMN 4 1dd8_c03 BETA-KETOACYL [ACYL CARRIER PROTEIN]user 3 4 # 3 D 163 CYH E 152 CYH^? 14.64 MG MG E 301 D 298 HIS E 147 HIS^? 9.22 MG MG E 301 D 333 HIS E 170 HIS^? 10.33 MG MG E 301 D 392 PHE E 150 PHE^? 10.10 MG MG E 301 coo 67.34 86.01 109.78 66.48 87.39 107.43 69.49 67.27 -53.54 71.02 69.50 -54.03 coo 70.13 92.51 109.26 69.00 90.99 108.37 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 71.07 86.98 104.57 69.72 87.07 106.17 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 61.70 87.79 105.86 62.91 88.45 103.42 74.01 63.99 -49.53 76.06 63.87 -51.45 ULMN 4 1dd8_c03 BETA-KETOACYL [ACYL CARRIER PROTEIN]user 4 4 # 4 D 163 CYH E 152 CYH^? 14.64 MG MG E 301 D 298 HIS E 170 HIS^? 10.33 MG MG E 301 D 333 HIS E 147 HIS^? 9.22 MG MG E 301 D 392 PHE E 150 PHE^? 10.10 MG MG E 301 coo 67.34 86.01 109.78 66.48 87.39 107.43 69.49 67.27 -53.54 71.02 69.50 -54.03 coo 70.13 92.51 109.26 69.00 90.99 108.37 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 71.07 86.98 104.57 69.72 87.07 106.17 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 61.70 87.79 105.86 62.91 88.45 103.42 74.01 63.99 -49.53 76.06 63.87 -51.45 ULMN 4 1dd8_c03 BETA-KETOACYL [ACYL CARRIER PROTEIN]user 5 4 # 5 D 163 CYH F 152 CYH^? 14.14 MG MG F 302 D 298 HIS F 147 HIS^? 8.79 MG MG F 302 D 333 HIS F 170 HIS^? 9.84 MG MG F 302 D 392 PHE F 150 PHE^? 9.82 MG MG F 302 coo 67.34 86.01 109.78 66.48 87.39 107.43 50.28 62.76 -86.08 48.12 64.34 -85.77 coo 70.13 92.51 109.26 69.00 90.99 108.37 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 71.07 86.98 104.57 69.72 87.07 106.17 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 61.70 87.79 105.86 62.91 88.45 103.42 47.10 57.70 -89.94 45.06 57.27 -88.04 ULMN 4 1dd8_c03 BETA-KETOACYL [ACYL CARRIER PROTEIN]user 6 4 # 6 D 163 CYH F 152 CYH^? 14.14 MG MG F 302 D 298 HIS F 170 HIS^? 9.84 MG MG F 302 D 333 HIS F 147 HIS^? 8.79 MG MG F 302 D 392 PHE F 150 PHE^? 9.82 MG MG F 302 coo 67.34 86.01 109.78 66.48 87.39 107.43 50.28 62.76 -86.08 48.12 64.34 -85.77 coo 70.13 92.51 109.26 69.00 90.99 108.37 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 71.07 86.98 104.57 69.72 87.07 106.17 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 61.70 87.79 105.86 62.91 88.45 103.42 47.10 57.70 -89.94 45.06 57.27 -88.04 1dd8_c03 source 1dd8 BETA-KETOACYL [ACYL CARRIER PROTEIN] SYNTHASE : 6 hits 1dd8_c03 naa= 4 ULMN 4 1doo_c04 HEAT SHOCK LOCUS U user 1 4 # 1 A 1 THR B 70 THR^? 14.69 MG MG B 302 A 33 LYS B 90 LYS^? 18.68 MG MG B 302 A 45 GLY B 89 GLY^? 19.24 MG MG B 302 A 124 SER B 49 SER^? 17.51 MG MG B 302 coo 20.60 80.81 78.25 19.93 81.48 80.23 54.82 21.76 11.59 56.34 23.17 10.82 coo 24.21 79.63 86.31 23.19 81.94 80.55 61.66 21.61 12.88 56.74 22.88 14.81 coo 20.39 75.93 87.86 19.67 76.00 88.35 64.90 19.68 12.95 64.28 19.13 13.13 coo 15.73 80.26 75.45 17.95 80.97 75.03 51.67 15.70 10.57 49.37 16.19 11.15 ULMN 4 1doo_c04 HEAT SHOCK LOCUS U user 2 4 # 2 A 1 THR D 70 THR^? 14.99 MG MG D 302 A 33 LYS D 90 LYS^? 18.98 MG MG D 302 A 45 GLY D 89 GLY^? 19.56 MG MG D 302 A 124 SER D 49 SER^? 17.22 MG MG D 302 coo 20.60 80.81 78.25 19.93 81.48 80.23 83.38 38.35 -32.45 81.51 39.04 -33.23 coo 24.21 79.63 86.31 23.19 81.94 80.55 79.83 44.38 -31.44 80.32 39.55 -29.40 coo 20.39 75.93 87.86 19.67 76.00 88.35 79.91 48.18 -31.33 80.69 47.93 -31.18 coo 15.73 80.26 75.45 17.95 80.97 75.03 90.26 38.73 -32.99 91.21 36.48 -32.65 ULMN 4 1doo_c04 HEAT SHOCK LOCUS U user 3 4 # 3 A 1 THR E 70 THR^? 14.75 MG MG E 302 A 33 LYS E 90 LYS^? 19.16 MG MG E 302 A 45 GLY E 89 GLY^? 19.25 MG MG D 301 A 124 SER E 49 SER^? 17.46 MG MG E 302 coo 20.60 80.81 78.25 19.93 81.48 80.23 68.45 55.77 -62.07 68.75 53.75 -61.41 coo 24.21 79.63 86.31 23.19 81.94 80.55 73.81 51.50 -63.18 69.15 52.39 -65.65 coo 20.39 75.93 87.86 19.67 76.00 88.35 77.50 50.68 -63.25 77.41 51.57 -63.34 coo 15.73 80.26 75.45 17.95 80.97 75.03 69.86 62.56 -61.93 67.83 63.87 -62.36 ULMN 4 1doo_c04 HEAT SHOCK LOCUS U user 4 4 # 4 A 1 THR F 70 THR^? 14.73 MG MG F 301 A 33 LYS F 90 LYS^? 18.57 MG MG F 301 A 45 GLY F 89 GLY^? 19.22 MG MG F 301 A 124 SER F 49 SER^? 17.41 MG MG F 301 coo 20.60 80.81 78.25 19.93 81.48 80.23 55.11 52.83 -76.85 55.53 50.86 -77.56 coo 24.21 79.63 86.31 23.19 81.94 80.55 51.54 47.01 -75.58 55.05 50.31 -73.74 coo 20.39 75.93 87.86 19.67 76.00 88.35 48.22 45.17 -75.46 48.08 46.04 -75.34 coo 15.73 80.26 75.45 17.95 80.97 75.03 51.43 58.69 -77.53 52.81 60.66 -77.24 1doo_c04 source 1doo HEAT SHOCK LOCUS U : 4 hits 1doo_c04 naa= 4 ULMN 4 1doo_c05 HEAT SHOCK LOCUS U user 1 4 # 1 B 1 THR B 70 THR^? 14.69 MG MG B 302 B 33 LYS B 90 LYS^? 18.68 MG MG B 302 B 45 GLY B 89 GLY^? 19.24 MG MG B 302 B 124 SER B 49 SER^? 17.51 MG MG B 302 coo 26.69 108.13 78.57 25.70 107.69 80.43 54.82 21.76 11.59 56.34 23.17 10.82 coo 30.17 110.91 86.31 27.32 111.03 80.63 61.66 21.61 12.88 56.74 22.88 14.81 coo 31.73 106.00 88.02 31.34 105.46 88.62 64.90 19.68 12.95 64.28 19.13 13.13 coo 24.65 103.43 76.04 24.59 105.78 75.60 51.67 15.70 10.57 49.37 16.19 11.15 ULMN 4 1doo_c05 HEAT SHOCK LOCUS U user 2 4 # 2 B 1 THR D 70 THR^? 14.99 MG MG D 302 B 33 LYS D 90 LYS^? 18.98 MG MG D 302 B 45 GLY D 89 GLY^? 19.56 MG MG D 302 B 124 SER D 49 SER^? 17.22 MG MG D 302 coo 26.69 108.13 78.57 25.70 107.69 80.43 83.38 38.35 -32.45 81.51 39.04 -33.23 coo 30.17 110.91 86.31 27.32 111.03 80.63 79.83 44.38 -31.44 80.32 39.55 -29.40 coo 31.73 106.00 88.02 31.34 105.46 88.62 79.91 48.18 -31.33 80.69 47.93 -31.18 coo 24.65 103.43 76.04 24.59 105.78 75.60 90.26 38.73 -32.99 91.21 36.48 -32.65 ULMN 4 1doo_c05 HEAT SHOCK LOCUS U user 3 4 # 3 B 1 THR E 70 THR^? 14.75 MG MG E 302 B 33 LYS E 90 LYS^? 19.16 MG MG E 302 B 45 GLY E 89 GLY^? 19.25 MG MG D 301 B 124 SER E 49 SER^? 17.46 MG MG E 302 coo 26.69 108.13 78.57 25.70 107.69 80.43 68.45 55.77 -62.07 68.75 53.75 -61.41 coo 30.17 110.91 86.31 27.32 111.03 80.63 73.81 51.50 -63.18 69.15 52.39 -65.65 coo 31.73 106.00 88.02 31.34 105.46 88.62 77.50 50.68 -63.25 77.41 51.57 -63.34 coo 24.65 103.43 76.04 24.59 105.78 75.60 69.86 62.56 -61.93 67.83 63.87 -62.36 ULMN 4 1doo_c05 HEAT SHOCK LOCUS U user 4 4 # 4 B 1 THR F 70 THR^? 14.73 MG MG F 301 B 33 LYS F 90 LYS^? 18.57 MG MG F 301 B 45 GLY F 89 GLY^? 19.22 MG MG F 301 B 124 SER F 49 SER^? 17.41 MG MG F 301 coo 26.69 108.13 78.57 25.70 107.69 80.43 55.11 52.83 -76.85 55.53 50.86 -77.56 coo 30.17 110.91 86.31 27.32 111.03 80.63 51.54 47.01 -75.58 55.05 50.31 -73.74 coo 31.73 106.00 88.02 31.34 105.46 88.62 48.22 45.17 -75.46 48.08 46.04 -75.34 coo 24.65 103.43 76.04 24.59 105.78 75.60 51.43 58.69 -77.53 52.81 60.66 -77.24 1doo_c05 source 1doo HEAT SHOCK LOCUS U : 4 hits 1doo_c05 naa= 4 ULMN 4 1doo_c06 HEAT SHOCK LOCUS U user 1 4 # 1 C 1 THR A 70 THR^? 14.66 MG MG A 301 C 33 LYS A 90 LYS^? 18.58 MG MG A 301 C 45 GLY A 89 GLY^? 19.32 MG MG A 301 C 124 SER A 49 SER^? 17.63 MG MG A 301 coo -5.30 26.59 199.66 -4.98 26.05 197.57 45.68 31.52 26.25 47.33 32.60 27.12 coo -4.62 30.60 191.94 -3.32 28.83 197.07 46.62 38.29 25.46 47.51 33.29 23.22 coo -9.57 29.11 189.94 -9.84 28.44 189.46 45.26 41.83 25.16 44.62 41.32 24.97 coo -8.31 23.03 202.48 -6.18 24.15 202.80 38.68 29.52 26.48 39.52 27.49 25.41 ULMN 4 1doo_c06 HEAT SHOCK LOCUS U user 2 4 # 2 C 1 THR B 70 THR^? 14.69 MG MG B 302 C 33 LYS B 90 LYS^? 18.68 MG MG B 302 C 45 GLY B 89 GLY^? 19.24 MG MG B 302 C 124 SER B 49 SER^? 17.51 MG MG B 302 coo -5.30 26.59 199.66 -4.98 26.05 197.57 54.82 21.76 11.59 56.34 23.17 10.82 coo -4.62 30.60 191.94 -3.32 28.83 197.07 61.66 21.61 12.88 56.74 22.88 14.81 coo -9.57 29.11 189.94 -9.84 28.44 189.46 64.90 19.68 12.95 64.28 19.13 13.13 coo -8.31 23.03 202.48 -6.18 24.15 202.80 51.67 15.70 10.57 49.37 16.19 11.15 ULMN 4 1doo_c06 HEAT SHOCK LOCUS U user 3 4 # 3 C 1 THR C 70 THR^? 14.45 MG MG C 302 C 33 LYS C 90 LYS^? 18.24 MG MG C 302 C 45 GLY C 89 GLY^? 18.96 MG MG C 302 C 124 SER C 49 SER^? 17.53 MG MG C 302 coo -5.30 26.59 199.66 -4.98 26.05 197.57 78.63 25.77 -17.76 76.70 26.55 -17.21 coo -4.62 30.60 191.94 -3.32 28.83 197.07 72.37 23.25 -18.94 76.11 26.52 -20.97 coo -9.57 29.11 189.94 -9.84 28.44 189.46 69.98 20.32 -19.31 70.77 19.99 -19.37 coo -8.31 23.03 202.48 -6.18 24.15 202.80 83.83 21.24 -17.13 85.75 22.50 -18.00 ULMN 4 1doo_c06 HEAT SHOCK LOCUS U user 4 4 # 4 C 1 THR D 70 THR^? 14.99 MG MG D 302 C 33 LYS D 90 LYS^? 18.98 MG MG D 302 C 45 GLY D 89 GLY^? 19.56 MG MG D 302 C 124 SER D 49 SER^? 17.22 MG MG D 302 coo -5.30 26.59 199.66 -4.98 26.05 197.57 83.38 38.35 -32.45 81.51 39.04 -33.23 coo -4.62 30.60 191.94 -3.32 28.83 197.07 79.83 44.38 -31.44 80.32 39.55 -29.40 coo -9.57 29.11 189.94 -9.84 28.44 189.46 79.91 48.18 -31.33 80.69 47.93 -31.18 coo -8.31 23.03 202.48 -6.18 24.15 202.80 90.26 38.73 -32.99 91.21 36.48 -32.65 ULMN 4 1doo_c06 HEAT SHOCK LOCUS U user 5 4 # 5 C 1 THR E 70 THR^? 14.75 MG MG E 302 C 33 LYS E 90 LYS^? 19.16 MG MG E 302 C 45 GLY E 89 GLY^? 19.25 MG MG D 301 C 124 SER E 49 SER^? 17.46 MG MG E 302 coo -5.30 26.59 199.66 -4.98 26.05 197.57 68.45 55.77 -62.07 68.75 53.75 -61.41 coo -4.62 30.60 191.94 -3.32 28.83 197.07 73.81 51.50 -63.18 69.15 52.39 -65.65 coo -9.57 29.11 189.94 -9.84 28.44 189.46 77.50 50.68 -63.25 77.41 51.57 -63.34 coo -8.31 23.03 202.48 -6.18 24.15 202.80 69.86 62.56 -61.93 67.83 63.87 -62.36 ULMN 4 1doo_c06 HEAT SHOCK LOCUS U user 6 4 # 6 C 1 THR F 70 THR^? 14.73 MG MG F 301 C 33 LYS F 90 LYS^? 18.57 MG MG F 301 C 45 GLY F 89 GLY^? 19.22 MG MG F 301 C 124 SER F 49 SER^? 17.41 MG MG F 301 coo -5.30 26.59 199.66 -4.98 26.05 197.57 55.11 52.83 -76.85 55.53 50.86 -77.56 coo -4.62 30.60 191.94 -3.32 28.83 197.07 51.54 47.01 -75.58 55.05 50.31 -73.74 coo -9.57 29.11 189.94 -9.84 28.44 189.46 48.22 45.17 -75.46 48.08 46.04 -75.34 coo -8.31 23.03 202.48 -6.18 24.15 202.80 51.43 58.69 -77.53 52.81 60.66 -77.24 1doo_c06 source 1doo HEAT SHOCK LOCUS U : 6 hits 1doo_c06 naa= 4 ULMN 4 1doo_c07 HEAT SHOCK LOCUS U user 1 4 # 1 D 1 THR B 70 THR^? 14.69 MG MG B 302 D 33 LYS B 90 LYS^? 18.68 MG MG B 302 D 45 GLY B 89 GLY^? 19.24 MG MG B 302 D 124 SER B 49 SER^? 17.51 MG MG B 302 coo 21.09 18.28 199.42 20.72 17.74 197.38 54.82 21.76 11.59 56.34 23.17 10.82 coo 25.54 20.08 191.91 24.21 17.77 197.54 61.66 21.61 12.88 56.74 22.88 14.81 coo 21.95 23.77 189.96 21.30 23.70 189.39 64.90 19.68 12.95 64.28 19.13 13.13 coo 16.26 18.98 201.87 18.32 18.00 202.67 51.67 15.70 10.57 49.37 16.19 11.15 ULMN 4 1doo_c07 HEAT SHOCK LOCUS U user 2 4 # 2 D 1 THR D 70 THR^? 14.99 MG MG D 302 D 33 LYS D 90 LYS^? 18.98 MG MG D 302 D 45 GLY D 89 GLY^? 19.56 MG MG D 302 D 124 SER D 49 SER^? 17.22 MG MG D 302 coo 21.09 18.28 199.42 20.72 17.74 197.38 83.38 38.35 -32.45 81.51 39.04 -33.23 coo 25.54 20.08 191.91 24.21 17.77 197.54 79.83 44.38 -31.44 80.32 39.55 -29.40 coo 21.95 23.77 189.96 21.30 23.70 189.39 79.91 48.18 -31.33 80.69 47.93 -31.18 coo 16.26 18.98 201.87 18.32 18.00 202.67 90.26 38.73 -32.99 91.21 36.48 -32.65 ULMN 4 1doo_c07 HEAT SHOCK LOCUS U user 3 4 # 3 D 1 THR E 70 THR^? 14.75 MG MG E 302 D 33 LYS E 90 LYS^? 19.16 MG MG E 302 D 45 GLY E 89 GLY^? 19.25 MG MG D 301 D 124 SER E 49 SER^? 17.46 MG MG E 302 coo 21.09 18.28 199.42 20.72 17.74 197.38 68.45 55.77 -62.07 68.75 53.75 -61.41 coo 25.54 20.08 191.91 24.21 17.77 197.54 73.81 51.50 -63.18 69.15 52.39 -65.65 coo 21.95 23.77 189.96 21.30 23.70 189.39 77.50 50.68 -63.25 77.41 51.57 -63.34 coo 16.26 18.98 201.87 18.32 18.00 202.67 69.86 62.56 -61.93 67.83 63.87 -62.36 ULMN 4 1doo_c07 HEAT SHOCK LOCUS U user 4 4 # 4 D 1 THR F 70 THR^? 14.73 MG MG F 301 D 33 LYS F 90 LYS^? 18.57 MG MG F 301 D 45 GLY F 89 GLY^? 19.22 MG MG F 301 D 124 SER F 49 SER^? 17.41 MG MG F 301 coo 21.09 18.28 199.42 20.72 17.74 197.38 55.11 52.83 -76.85 55.53 50.86 -77.56 coo 25.54 20.08 191.91 24.21 17.77 197.54 51.54 47.01 -75.58 55.05 50.31 -73.74 coo 21.95 23.77 189.96 21.30 23.70 189.39 48.22 45.17 -75.46 48.08 46.04 -75.34 coo 16.26 18.98 201.87 18.32 18.00 202.67 51.43 58.69 -77.53 52.81 60.66 -77.24 1doo_c07 source 1doo HEAT SHOCK LOCUS U : 4 hits 1doo_c07 naa= 4 ULMN 4 1e6e_c01 ADRENODOXIN user 1 4 # 1 C 55 HIS E 170 HIS^? 10.33 MG MG E 301 C 159 ASP E 148 ASP^? 2.62 MG MG E 302s C 376 ILE E 13 ILE^? 14.83 MG MG E 302 C 377 THR E 18 THR^? 15.84 MG MG E 302 coo -29.07 40.56 142.27 -27.79 41.91 141.29 66.96 68.76 -48.87 68.36 68.54 -47.33 coo -23.44 38.39 138.46 -25.44 39.03 138.64 68.29 60.44 -47.29 68.03 58.42 -46.50 coo -37.08 37.01 134.95 -37.09 36.11 136.10 75.39 65.02 -56.97 76.29 64.19 -56.33 coo -39.65 39.67 132.35 -40.33 41.62 133.03 81.45 64.25 -55.27 80.73 62.21 -55.24 1e6e_c01 source 1e6e ADRENODOXIN : 1 hits 1e6e_c01 naa= 4 ULMN 4 1h7o_c00 5-AMINOLAEVULINIC ACID DEHYDRATASE user 1 4 # 1 A 131 ASP A 142 ASP^? 23.70 MG MG A 302 A 179 SER A 140 SER^? 30.67 MG MG A 302 A 210 LYS A 157 LYS^? 28.65 MG MG A 302 A 263 LYS A 6 LYS^? 25.88 MG MG A 301 coo 15.28 27.01 21.57 16.48 25.33 21.25 46.39 7.18 37.53 46.28 7.18 39.63 coo 16.21 20.65 20.59 17.61 22.54 21.18 44.28 3.90 31.34 44.69 1.94 32.71 coo 18.09 17.00 14.23 20.70 20.73 18.57 41.42 12.06 27.58 41.46 5.93 29.41 coo 17.39 20.36 11.09 19.81 23.46 16.09 46.20 12.82 24.71 44.50 16.64 20.52 ULMN 4 1h7o_c00 5-AMINOLAEVULINIC ACID DEHYDRATASE user 2 4 # 2 A 131 ASP C 142 ASP^? 23.76 MG MG C 301 A 179 SER C 140 SER^? 30.64 MG MG C 302 A 210 LYS C 157 LYS^? 28.15 MG MG C 302 A 263 LYS C 6 LYS^? 25.73 MG MG C 302 coo 15.28 27.01 21.57 16.48 25.33 21.25 97.94 39.27 -5.03 98.08 38.70 -2.97 coo 16.21 20.65 20.59 17.61 22.54 21.18 102.22 39.34 -11.26 103.20 41.01 -9.93 coo 18.09 17.00 14.23 20.70 20.73 18.57 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 17.39 20.36 11.09 19.81 23.46 16.09 94.42 35.68 -18.56 92.21 32.03 -23.05 ULMN 4 1h7o_c00 5-AMINOLAEVULINIC ACID DEHYDRATASE user 3 4 # 3 A 131 ASP E 138 ASP^? 33.31 MG MG E 302 A 179 SER E 140 SER^? 30.62 MG MG E 302 A 210 LYS E 157 LYS^? 28.40 MG MG E 302 A 263 LYS E 6 LYS^? 25.59 MG MG E 302 coo 15.28 27.01 21.57 16.48 25.33 21.25 39.58 70.77 -58.63 40.74 70.78 -56.80 coo 16.21 20.65 20.59 17.61 22.54 21.18 45.10 70.42 -56.56 43.21 70.47 -55.13 coo 18.09 17.00 14.23 20.70 20.73 18.57 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 17.39 20.36 11.09 19.81 23.46 16.09 51.95 64.70 -63.33 56.16 64.03 -67.52 ULMN 4 1h7o_c00 5-AMINOLAEVULINIC ACID DEHYDRATASE user 4 4 # 4 A 131 ASP E 142 ASP^? 23.66 MG MG E 301 A 179 SER E 140 SER^? 30.62 MG MG E 302 A 210 LYS E 157 LYS^? 28.40 MG MG E 302 A 263 LYS E 6 LYS^? 25.59 MG MG E 302 coo 15.28 27.01 21.57 16.48 25.33 21.25 47.19 67.15 -50.37 47.44 67.18 -48.23 coo 16.21 20.65 20.59 17.61 22.54 21.18 45.10 70.42 -56.56 43.21 70.47 -55.13 coo 18.09 17.00 14.23 20.70 20.73 18.57 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 17.39 20.36 11.09 19.81 23.46 16.09 51.95 64.70 -63.33 56.16 64.03 -67.52 1h7o_c00 source 1h7o 5-AMINOLAEVULINIC ACID DEHYDRATASE : 4 hits 1h7o_c00 naa= 4 ULMN 4 1kas_c00 BETA-KETOACYL ACP SYNTHASE II user 1 4 # 1 163 CYH A 152 CYH^? 15.18 MG MG A 302 303 HIS A 147 HIS^? 9.20 MG MG A 302 340 HIS A 170 HIS^? 10.56 MG MG A 302 400 PHE A 150 PHE^? 10.47 MG MG A 302 coo 16.75 23.75 11.48 16.42 25.83 13.36 34.81 26.51 34.70 32.10 26.95 34.06 coo 15.95 21.52 18.00 16.33 23.09 16.67 40.24 23.10 39.83 38.32 22.34 40.22 coo 21.34 25.20 15.45 19.58 24.66 14.44 34.91 23.57 39.32 34.35 24.95 40.81 coo 14.43 29.45 13.32 16.55 29.76 15.09 35.63 32.10 38.88 34.73 33.93 37.00 ULMN 4 1kas_c00 BETA-KETOACYL ACP SYNTHASE II user 2 4 # 2 163 CYH A 152 CYH^? 15.18 MG MG A 302 303 HIS A 147 HIS^? 9.20 MG MG A 302 340 HIS A 170 HIS^? 10.56 MG MG A 302 400 PHE A 172 PHE^? 13.28 MG MG A 302 coo 16.75 23.75 11.48 16.42 25.83 13.36 34.81 26.51 34.70 32.10 26.95 34.06 coo 15.95 21.52 18.00 16.33 23.09 16.67 40.24 23.10 39.83 38.32 22.34 40.22 coo 21.34 25.20 15.45 19.58 24.66 14.44 34.91 23.57 39.32 34.35 24.95 40.81 coo 14.43 29.45 13.32 16.55 29.76 15.09 31.82 29.57 38.19 30.91 31.55 36.40 ULMN 4 1kas_c00 BETA-KETOACYL ACP SYNTHASE II user 3 4 # 3 163 CYH B 152 CYH^? 14.66 MG MG B 301 303 HIS B 147 HIS^? 9.27 MG MG B 301 340 HIS B 170 HIS^? 10.51 MG MG B 301 400 PHE B 150 PHE^? 9.88 MG MG B 301 coo 16.75 23.75 11.48 16.42 25.83 13.36 48.74 12.82 1.93 48.51 10.17 2.19 coo 15.95 21.52 18.00 16.33 23.09 16.67 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 21.34 25.20 15.45 19.58 24.66 14.44 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 14.43 29.45 13.32 16.55 29.76 15.09 54.70 12.86 -1.84 56.31 11.50 0.05 ULMN 4 1kas_c00 BETA-KETOACYL ACP SYNTHASE II user 4 4 # 4 163 CYH B 152 CYH^? 14.66 MG MG B 301 303 HIS B 147 HIS^? 9.27 MG MG B 301 340 HIS B 170 HIS^? 10.51 MG MG B 301 400 PHE B 172 PHE^? 12.81 MG MG B 301 coo 16.75 23.75 11.48 16.42 25.83 13.36 48.74 12.82 1.93 48.51 10.17 2.19 coo 15.95 21.52 18.00 16.33 23.09 16.67 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 21.34 25.20 15.45 19.58 24.66 14.44 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 14.43 29.45 13.32 16.55 29.76 15.09 51.51 9.59 -1.64 53.03 8.15 0.22 ULMN 4 1kas_c00 BETA-KETOACYL ACP SYNTHASE II user 5 4 # 5 163 CYH B 152 CYH^? 14.66 MG MG B 301 303 HIS B 170 HIS^? 10.51 MG MG B 301 340 HIS B 147 HIS^? 9.27 MG MG B 301 400 PHE B 150 PHE^? 9.88 MG MG B 301 coo 16.75 23.75 11.48 16.42 25.83 13.36 48.74 12.82 1.93 48.51 10.17 2.19 coo 15.95 21.52 18.00 16.33 23.09 16.67 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 21.34 25.20 15.45 19.58 24.66 14.44 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 14.43 29.45 13.32 16.55 29.76 15.09 54.70 12.86 -1.84 56.31 11.50 0.05 ULMN 4 1kas_c00 BETA-KETOACYL ACP SYNTHASE II user 6 4 # 6 163 CYH C 152 CYH^? 14.61 MG MG C 301 303 HIS C 147 HIS^? 9.44 MG MG C 301 340 HIS C 170 HIS^? 10.68 MG MG C 301 400 PHE C 150 PHE^? 10.02 MG MG C 301 coo 16.75 23.75 11.48 16.42 25.83 13.36 87.66 19.43 -8.58 88.77 17.04 -8.78 coo 15.95 21.52 18.00 16.33 23.09 16.67 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 21.34 25.20 15.45 19.58 24.66 14.44 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 14.43 29.45 13.32 16.55 29.76 15.09 82.11 17.28 -4.80 81.16 15.47 -6.75 ULMN 4 1kas_c00 BETA-KETOACYL ACP SYNTHASE II user 7 4 # 7 163 CYH C 152 CYH^? 14.61 MG MG C 301 303 HIS C 147 HIS^? 9.44 MG MG C 301 340 HIS C 170 HIS^? 10.68 MG MG C 301 400 PHE C 172 PHE^? 13.00 MG MG C 301 coo 16.75 23.75 11.48 16.42 25.83 13.36 87.66 19.43 -8.58 88.77 17.04 -8.78 coo 15.95 21.52 18.00 16.33 23.09 16.67 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 21.34 25.20 15.45 19.58 24.66 14.44 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 14.43 29.45 13.32 16.55 29.76 15.09 86.45 15.28 -5.05 85.50 13.59 -7.08 ULMN 4 1kas_c00 BETA-KETOACYL ACP SYNTHASE II user 8 4 # 8 163 CYH C 152 CYH^? 14.61 MG MG C 301 303 HIS C 170 HIS^? 10.68 MG MG C 301 340 HIS C 147 HIS^? 9.44 MG MG C 301 400 PHE C 150 PHE^? 10.02 MG MG C 301 coo 16.75 23.75 11.48 16.42 25.83 13.36 87.66 19.43 -8.58 88.77 17.04 -8.78 coo 15.95 21.52 18.00 16.33 23.09 16.67 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 21.34 25.20 15.45 19.58 24.66 14.44 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 14.43 29.45 13.32 16.55 29.76 15.09 82.11 17.28 -4.80 81.16 15.47 -6.75 ULMN 4 1kas_c00 BETA-KETOACYL ACP SYNTHASE II user 9 4 # 9 163 CYH D 152 CYH^? 14.66 MG MG D 301 303 HIS D 147 HIS^? 9.43 MG MG D 301 340 HIS D 170 HIS^? 10.59 MG MG D 301 400 PHE D 150 PHE^? 10.21 MG MG D 301 coo 16.75 23.75 11.48 16.42 25.83 13.36 94.69 37.43 -41.36 96.92 38.83 -40.94 coo 15.95 21.52 18.00 16.33 23.09 16.67 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 21.34 25.20 15.45 19.58 24.66 14.44 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 14.43 29.45 13.32 16.55 29.76 15.09 91.92 42.74 -45.34 92.24 44.79 -43.44 ULMN 4 1kas_c00 BETA-KETOACYL ACP SYNTHASE II user 10 4 # 10 163 CYH D 152 CYH^? 14.66 MG MG D 301 303 HIS D 147 HIS^? 9.43 MG MG D 301 340 HIS D 170 HIS^? 10.59 MG MG D 301 400 PHE D 172 PHE^? 13.02 MG MG D 301 coo 16.75 23.75 11.48 16.42 25.83 13.36 94.69 37.43 -41.36 96.92 38.83 -40.94 coo 15.95 21.52 18.00 16.33 23.09 16.67 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 21.34 25.20 15.45 19.58 24.66 14.44 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 14.43 29.45 13.32 16.55 29.76 15.09 96.36 41.50 -44.84 96.77 43.66 -43.13 ULMN 4 1kas_c00 BETA-KETOACYL ACP SYNTHASE II user 11 4 # 11 163 CYH D 152 CYH^? 14.66 MG MG D 301 303 HIS D 170 HIS^? 10.59 MG MG D 301 340 HIS D 147 HIS^? 9.43 MG MG D 301 400 PHE D 150 PHE^? 10.21 MG MG D 301 coo 16.75 23.75 11.48 16.42 25.83 13.36 94.69 37.43 -41.36 96.92 38.83 -40.94 coo 15.95 21.52 18.00 16.33 23.09 16.67 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 21.34 25.20 15.45 19.58 24.66 14.44 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 14.43 29.45 13.32 16.55 29.76 15.09 91.92 42.74 -45.34 92.24 44.79 -43.44 ULMN 4 1kas_c00 BETA-KETOACYL ACP SYNTHASE II user 12 4 # 12 163 CYH E 152 CYH^? 14.64 MG MG E 301 303 HIS E 147 HIS^? 9.22 MG MG E 301 340 HIS E 170 HIS^? 10.33 MG MG E 301 400 PHE E 150 PHE^? 10.10 MG MG E 301 coo 16.75 23.75 11.48 16.42 25.83 13.36 69.49 67.27 -53.54 71.02 69.50 -54.03 coo 15.95 21.52 18.00 16.33 23.09 16.67 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 21.34 25.20 15.45 19.58 24.66 14.44 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 14.43 29.45 13.32 16.55 29.76 15.09 74.01 63.99 -49.53 76.06 63.87 -51.45 ULMN 4 1kas_c00 BETA-KETOACYL ACP SYNTHASE II user 13 4 # 13 163 CYH E 152 CYH^? 14.64 MG MG E 301 303 HIS E 147 HIS^? 9.22 MG MG E 301 340 HIS E 170 HIS^? 10.33 MG MG E 301 400 PHE E 172 PHE^? 12.71 MG MG E 301 coo 16.75 23.75 11.48 16.42 25.83 13.36 69.49 67.27 -53.54 71.02 69.50 -54.03 coo 15.95 21.52 18.00 16.33 23.09 16.67 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 21.34 25.20 15.45 19.58 24.66 14.44 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 14.43 29.45 13.32 16.55 29.76 15.09 73.54 68.41 -50.00 75.58 68.36 -51.87 ULMN 4 1kas_c00 BETA-KETOACYL ACP SYNTHASE II user 14 4 # 14 163 CYH E 152 CYH^? 14.64 MG MG E 301 303 HIS E 170 HIS^? 10.33 MG MG E 301 340 HIS E 147 HIS^? 9.22 MG MG E 301 400 PHE E 150 PHE^? 10.10 MG MG E 301 coo 16.75 23.75 11.48 16.42 25.83 13.36 69.49 67.27 -53.54 71.02 69.50 -54.03 coo 15.95 21.52 18.00 16.33 23.09 16.67 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 21.34 25.20 15.45 19.58 24.66 14.44 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 14.43 29.45 13.32 16.55 29.76 15.09 74.01 63.99 -49.53 76.06 63.87 -51.45 ULMN 4 1kas_c00 BETA-KETOACYL ACP SYNTHASE II user 15 4 # 15 163 CYH F 152 CYH^? 14.14 MG MG F 302 303 HIS F 147 HIS^? 8.79 MG MG F 302 340 HIS F 170 HIS^? 9.84 MG MG F 302 400 PHE F 150 PHE^? 9.82 MG MG F 302 coo 16.75 23.75 11.48 16.42 25.83 13.36 50.28 62.76 -86.08 48.12 64.34 -85.77 coo 15.95 21.52 18.00 16.33 23.09 16.67 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 21.34 25.20 15.45 19.58 24.66 14.44 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 14.43 29.45 13.32 16.55 29.76 15.09 47.10 57.70 -89.94 45.06 57.27 -88.04 ULMN 4 1kas_c00 BETA-KETOACYL ACP SYNTHASE II user 16 4 # 16 163 CYH F 152 CYH^? 14.14 MG MG F 302 303 HIS F 147 HIS^? 8.79 MG MG F 302 340 HIS F 170 HIS^? 9.84 MG MG F 302 400 PHE F 172 PHE^? 12.43 MG MG F 302 coo 16.75 23.75 11.48 16.42 25.83 13.36 50.28 62.76 -86.08 48.12 64.34 -85.77 coo 15.95 21.52 18.00 16.33 23.09 16.67 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 21.34 25.20 15.45 19.58 24.66 14.44 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 14.43 29.45 13.32 16.55 29.76 15.09 45.85 62.23 -89.68 43.95 61.55 -87.75 1kas_c00 source 1kas BETA-KETOACYL ACP SYNTHASE II : 16 hits 1kas_c00 naa= 4 ULMN 4 1ltq_c00 POLYNUCLEOTIDE KINASE user 1 4 # 1 A 15 LYS A 6 LYS^? 25.88 MG MG A 301 A 35 ASP A 160 ASP^? 31.61 MG MG B 302 A 126 ARG B 48 ARG^? 25.20 MG MG B 302 A 165 ASP B 100 ASP^? 19.41 MG MG B 302 coo 25.71 11.82 52.50 25.05 7.88 50.17 46.20 12.82 24.71 44.50 16.64 20.52 coo 23.50 1.36 54.56 23.86 1.61 52.50 44.21 5.00 19.54 46.02 3.84 19.76 coo 33.89 4.42 51.79 30.99 5.09 51.05 52.22 10.51 15.00 52.46 7.79 16.39 coo 42.34 11.15 22.32 43.58 12.11 23.75 42.99 37.37 0.88 44.84 37.85 0.06 ULMN 4 1ltq_c00 POLYNUCLEOTIDE KINASE user 2 4 # 2 A 15 LYS B 6 LYS^? 25.90 MG MG B 302 A 35 ASP B 160 ASP^? 31.65 MG MG A 301 A 126 ARG A 48 ARG^? 25.29 MG MG A 301 A 165 ASP A 100 ASP^? 19.37 MG MG A 301 coo 25.71 11.82 52.50 25.05 7.88 50.17 36.26 25.44 11.74 39.65 23.12 16.29 coo 23.50 1.36 54.56 23.86 1.61 52.50 28.01 24.83 16.38 27.44 26.81 15.80 coo 33.89 4.42 51.79 30.99 5.09 51.05 33.88 31.17 22.03 31.48 31.85 20.30 coo 42.34 11.15 22.32 43.58 12.11 23.75 57.94 16.31 36.90 58.41 17.97 38.14 ULMN 4 1ltq_c00 POLYNUCLEOTIDE KINASE user 3 4 # 3 A 15 LYS C 6 LYS^? 25.73 MG MG C 302 A 35 ASP C 160 ASP^? 31.63 MG MG D 302 A 126 ARG D 48 ARG^? 24.87 MG MG D 302 A 165 ASP D 100 ASP^? 19.59 MG MG D 302 coo 25.71 11.82 52.50 25.05 7.88 50.17 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 23.50 1.36 54.56 23.86 1.61 52.50 102.50 38.00 -23.28 102.43 39.97 -22.46 coo 33.89 4.42 51.79 30.99 5.09 51.05 94.06 41.76 -28.37 96.24 43.38 -26.96 coo 42.34 11.15 22.32 43.58 12.11 23.75 76.41 19.73 -43.25 75.56 21.48 -44.12 ULMN 4 1ltq_c00 POLYNUCLEOTIDE KINASE user 4 4 # 4 A 15 LYS D 6 LYS^? 25.98 MG MG D 302 A 35 ASP D 160 ASP^? 31.45 MG MG C 302 A 126 ARG C 48 ARG^? 25.02 MG MG C 302 A 165 ASP C 100 ASP^? 19.40 MG MG C 302 coo 25.71 11.82 52.50 25.05 7.88 50.17 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 23.50 1.36 54.56 23.86 1.61 52.50 94.15 13.98 -26.57 92.71 12.42 -26.99 coo 33.89 4.42 51.79 30.99 5.09 51.05 84.94 16.06 -21.53 85.81 13.55 -23.08 coo 42.34 11.15 22.32 43.58 12.11 23.75 84.40 44.48 -7.24 82.54 44.18 -6.18 ULMN 4 1ltq_c00 POLYNUCLEOTIDE KINASE user 5 4 # 5 A 15 LYS E 6 LYS^? 25.59 MG MG E 302 A 35 ASP E 160 ASP^? 31.54 MG MG F 301 A 126 ARG F 48 ARG^? 25.18 MG MG F 301 A 165 ASP F 100 ASP^? 19.36 MG MG F 301 coo 25.71 11.82 52.50 25.05 7.88 50.17 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 23.50 1.36 54.56 23.86 1.61 52.50 45.81 70.00 -68.45 44.10 68.87 -67.77 coo 33.89 4.42 51.79 30.99 5.09 51.05 46.82 60.90 -73.07 44.43 61.88 -71.46 coo 42.34 11.15 22.32 43.58 12.11 23.75 74.18 55.53 -87.58 73.63 53.79 -88.67 ULMN 4 1ltq_c00 POLYNUCLEOTIDE KINASE user 6 4 # 6 A 15 LYS F 6 LYS^? 26.09 MG MG F 301 A 35 ASP F 160 ASP^? 31.59 MG MG E 302 A 126 ARG E 48 ARG^? 25.02 MG MG E 302 A 165 ASP E 100 ASP^? 19.27 MG MG E 302 coo 25.71 11.82 52.50 25.05 7.88 50.17 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 23.50 1.36 54.56 23.86 1.61 52.50 71.27 74.59 -71.77 73.23 74.02 -72.37 coo 33.89 4.42 51.79 30.99 5.09 51.05 73.60 65.75 -66.57 75.51 67.67 -67.91 coo 42.34 11.15 22.32 43.58 12.11 23.75 49.30 52.58 -51.44 50.47 51.29 -50.20 1ltq_c00 source 1ltq POLYNUCLEOTIDE KINASE : 6 hits 1ltq_c00 naa= 4 ULMN 4 1mdr_c00 MANDELATE RACEMASE (E.C.5.1.2.2) user 1 4 # 1 166 LYS A 111 LYS^? 15.16 MG MG A 301 270 ASP A 148 ASP^? 2.72 MG MG A 301s 297 HIS A 147 HIS^? 9.20 MG MG A 302 317 GLU A 146 GLU^? 9.80 MG MG A 302 coo 27.27 1.43 25.09 29.18 5.25 22.89 52.67 17.19 35.90 54.65 19.90 40.50 coo 29.40 9.25 9.79 31.51 9.14 10.05 41.50 28.88 41.13 43.33 29.67 41.93 coo 29.05 8.65 14.00 30.25 7.04 14.30 40.24 23.10 39.83 38.32 22.34 40.22 coo 29.25 11.66 19.43 29.42 9.79 18.51 45.17 20.35 44.20 46.68 21.21 45.40 ULMN 4 1mdr_c00 MANDELATE RACEMASE (E.C.5.1.2.2) user 2 4 # 2 166 LYS A 192 LYS^? 22.83 MG MG A 302 270 ASP A 148 ASP^? 2.72 MG MG A 301s 297 HIS A 147 HIS^? 9.20 MG MG A 302 317 GLU A 146 GLU^? 9.80 MG MG A 302 coo 27.27 1.43 25.09 29.18 5.25 22.89 40.19 10.20 38.86 35.42 9.85 36.29 coo 29.40 9.25 9.79 31.51 9.14 10.05 41.50 28.88 41.13 43.33 29.67 41.93 coo 29.05 8.65 14.00 30.25 7.04 14.30 40.24 23.10 39.83 38.32 22.34 40.22 coo 29.25 11.66 19.43 29.42 9.79 18.51 45.17 20.35 44.20 46.68 21.21 45.40 ULMN 4 1mdr_c00 MANDELATE RACEMASE (E.C.5.1.2.2) user 3 4 # 3 166 LYS B 111 LYS^? 13.75 MG MG B 302 270 ASP B 148 ASP^? 2.58 MG MG B 302s 297 HIS B 147 HIS^? 9.27 MG MG B 301 317 GLU B 146 GLU^? 10.54 MG MG B 301 coo 27.27 1.43 25.09 29.18 5.25 22.89 42.84 32.14 1.80 46.84 32.68 -2.87 coo 29.40 9.25 9.79 31.51 9.14 10.05 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 29.05 8.65 14.00 30.25 7.04 14.30 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 29.25 11.66 19.43 29.42 9.79 18.51 45.13 24.51 -7.01 46.08 25.99 -8.13 ULMN 4 1mdr_c00 MANDELATE RACEMASE (E.C.5.1.2.2) user 4 4 # 4 166 LYS B 192 LYS^? 23.73 MG MG B 301 270 ASP B 148 ASP^? 2.58 MG MG B 302s 297 HIS B 147 HIS^? 9.27 MG MG B 301 317 GLU B 146 GLU^? 10.54 MG MG B 301 coo 27.27 1.43 25.09 29.18 5.25 22.89 33.83 21.17 -2.93 31.87 16.45 -0.74 coo 29.40 9.25 9.79 31.51 9.14 10.05 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 29.05 8.65 14.00 30.25 7.04 14.30 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 29.25 11.66 19.43 29.42 9.79 18.51 45.13 24.51 -7.01 46.08 25.99 -8.13 ULMN 4 1mdr_c00 MANDELATE RACEMASE (E.C.5.1.2.2) user 5 4 # 5 166 LYS C 111 LYS^? 16.56 MG MG C 302 270 ASP C 148 ASP^? 2.75 MG MG C 302s 297 HIS C 147 HIS^? 9.44 MG MG C 301 317 GLU C 146 GLU^? 10.46 MG MG C 301 coo 27.27 1.43 25.09 29.18 5.25 22.89 86.36 39.56 -8.06 84.36 40.84 -3.15 coo 29.40 9.25 9.79 31.51 9.14 10.05 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 29.05 8.65 14.00 30.25 7.04 14.30 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 29.25 11.66 19.43 29.42 9.79 18.51 87.01 31.93 0.25 85.57 32.56 1.72 ULMN 4 1mdr_c00 MANDELATE RACEMASE (E.C.5.1.2.2) user 6 4 # 6 166 LYS C 192 LYS^? 24.43 MG MG C 301 270 ASP C 148 ASP^? 2.75 MG MG C 302s 297 HIS C 147 HIS^? 9.44 MG MG C 301 317 GLU C 146 GLU^? 10.46 MG MG C 301 coo 27.27 1.43 25.09 29.18 5.25 22.89 98.71 32.33 -3.93 102.89 29.25 -5.78 coo 29.40 9.25 9.79 31.51 9.14 10.05 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 29.05 8.65 14.00 30.25 7.04 14.30 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 29.25 11.66 19.43 29.42 9.79 18.51 87.01 31.93 0.25 85.57 32.56 1.72 ULMN 4 1mdr_c00 MANDELATE RACEMASE (E.C.5.1.2.2) user 7 4 # 7 166 LYS D 111 LYS^? 15.85 MG MG D 302 270 ASP D 148 ASP^? 2.35 MG MG D 302s 297 HIS D 147 HIS^? 9.43 MG MG D 301 317 GLU D 146 GLU^? 10.62 MG MG D 301 coo 27.27 1.43 25.09 29.18 5.25 22.89 81.21 22.69 -42.10 78.68 23.89 -46.57 coo 29.40 9.25 9.79 31.51 9.14 10.05 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 29.05 8.65 14.00 30.25 7.04 14.30 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 29.25 11.66 19.43 29.42 9.79 18.51 87.24 28.82 -50.92 85.47 28.08 -51.67 ULMN 4 1mdr_c00 MANDELATE RACEMASE (E.C.5.1.2.2) user 8 4 # 8 166 LYS D 192 LYS^? 24.09 MG MG D 301 270 ASP D 148 ASP^? 2.35 MG MG D 302s 297 HIS D 147 HIS^? 9.43 MG MG D 301 317 GLU D 146 GLU^? 10.62 MG MG D 301 coo 27.27 1.43 25.09 29.18 5.25 22.89 95.35 20.28 -45.75 100.42 20.77 -43.05 coo 29.40 9.25 9.79 31.51 9.14 10.05 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 29.05 8.65 14.00 30.25 7.04 14.30 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 29.25 11.66 19.43 29.42 9.79 18.51 87.24 28.82 -50.92 85.47 28.08 -51.67 ULMN 4 1mdr_c00 MANDELATE RACEMASE (E.C.5.1.2.2) user 9 4 # 9 166 LYS E 111 LYS^? 14.52 MG MG E 302 270 ASP E 148 ASP^? 2.62 MG MG E 302s 297 HIS E 147 HIS^? 9.22 MG MG E 301 317 GLU E 146 GLU^? 10.15 MG MG E 301 coo 27.27 1.43 25.09 29.18 5.25 22.89 52.49 56.44 -52.43 54.52 53.78 -47.52 coo 29.40 9.25 9.79 31.51 9.14 10.05 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 29.05 8.65 14.00 30.25 7.04 14.30 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 29.25 11.66 19.43 29.42 9.79 18.51 58.72 60.89 -44.51 59.23 60.24 -42.54 ULMN 4 1mdr_c00 MANDELATE RACEMASE (E.C.5.1.2.2) user 10 4 # 10 166 LYS E 192 LYS^? 23.62 MG MG E 301 270 ASP E 148 ASP^? 2.62 MG MG E 302s 297 HIS E 147 HIS^? 9.22 MG MG E 301 317 GLU E 146 GLU^? 10.15 MG MG E 301 coo 27.27 1.43 25.09 29.18 5.25 22.89 52.64 70.58 -49.14 53.48 75.40 -50.95 coo 29.40 9.25 9.79 31.51 9.14 10.05 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 29.05 8.65 14.00 30.25 7.04 14.30 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 29.25 11.66 19.43 29.42 9.79 18.51 58.72 60.89 -44.51 59.23 60.24 -42.54 ULMN 4 1mdr_c00 MANDELATE RACEMASE (E.C.5.1.2.2) user 11 4 # 11 166 LYS F 111 LYS^? 15.21 MG MG F 301 270 ASP F 148 ASP^? 2.72 MG MG F 301s 297 HIS F 147 HIS^? 8.79 MG MG F 302 317 GLU F 146 GLU^? 10.36 MG MG F 302 coo 27.27 1.43 25.09 29.18 5.25 22.89 69.70 58.57 -86.86 69.67 53.74 -90.29 coo 29.40 9.25 9.79 31.51 9.14 10.05 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 29.05 8.65 14.00 30.25 7.04 14.30 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 29.25 11.66 19.43 29.42 9.79 18.51 61.95 60.17 -95.28 62.87 58.56 -96.19 ULMN 4 1mdr_c00 MANDELATE RACEMASE (E.C.5.1.2.2) user 12 4 # 12 166 LYS F 192 LYS^? 23.61 MG MG F 302 270 ASP F 148 ASP^? 2.72 MG MG F 301s 297 HIS F 147 HIS^? 8.79 MG MG F 302 317 GLU F 146 GLU^? 10.36 MG MG F 302 coo 27.27 1.43 25.09 29.18 5.25 22.89 64.82 71.59 -91.06 62.22 76.11 -88.75 coo 29.40 9.25 9.79 31.51 9.14 10.05 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 29.05 8.65 14.00 30.25 7.04 14.30 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 29.25 11.66 19.43 29.42 9.79 18.51 61.95 60.17 -95.28 62.87 58.56 -96.19 1mdr_c00 source 1mdr MANDELATE RACEMASE (E.C.5.1.2.2) : 12 hits 1mdr_c00 naa= 4 ULMN 4 1ohh_c03 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 1 4 # 1 A 373 ARG A 48 ARG^? 25.29 MG MG A 301 E 162 LYS B 6 LYS^? 25.90 MG MG B 302 E 188 GLU A 52 GLU^? 19.89 MG MG A 301 E 189 ARG A 37 ARG^? 18.99 MG MG A 301 coo 101.13 34.06 -17.55 103.52 32.17 -17.47 33.88 31.17 22.03 31.48 31.85 20.30 coo 99.70 45.17 -13.94 103.86 40.77 -11.97 36.26 25.44 11.74 39.65 23.12 16.29 coo 111.54 40.04 -16.26 109.58 40.74 -16.69 42.67 25.16 24.80 42.61 25.77 22.75 coo 107.06 33.49 -18.08 106.01 34.28 -15.30 32.99 26.50 25.19 35.50 25.33 26.51 ULMN 4 1ohh_c03 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 2 4 # 2 A 373 ARG E 48 ARG^? 25.02 MG MG E 302 E 162 LYS F 6 LYS^? 26.09 MG MG F 301 E 188 GLU E 52 GLU^? 19.96 MG MG E 302 E 189 ARG E 37 ARG^? 19.17 MG MG E 302 coo 101.13 34.06 -17.55 103.52 32.17 -17.47 73.60 65.75 -66.57 75.51 67.67 -67.91 coo 99.70 45.17 -13.94 103.86 40.77 -11.97 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 111.54 40.04 -16.26 109.58 40.74 -16.69 64.71 60.06 -63.78 64.69 61.36 -65.58 coo 107.06 33.49 -18.08 106.01 34.28 -15.30 70.82 68.02 -63.63 68.17 67.46 -62.14 ULMN 4 1ohh_c03 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 3 4 # 3 A 373 ARG F 48 ARG^? 25.18 MG MG F 301 E 162 LYS E 6 LYS^? 25.59 MG MG E 302 E 188 GLU F 52 GLU^? 20.13 MG MG F 301 E 189 ARG F 37 ARG^? 19.14 MG MG F 301 coo 101.13 34.06 -17.55 103.52 32.17 -17.47 46.82 60.90 -73.07 44.43 61.88 -71.46 coo 99.70 45.17 -13.94 103.86 40.77 -11.97 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 111.54 40.04 -16.26 109.58 40.74 -16.69 57.09 59.62 -75.76 56.76 59.40 -73.62 coo 107.06 33.49 -18.08 106.01 34.28 -15.30 48.80 64.46 -76.37 51.50 64.15 -77.79 1ohh_c03 source 1ohh ATP SYNTHASE ALPHA CHAIN HEART ISOFORM, MITOCH: 3 hits 1ohh_c03 naa= 4 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 1 4 # 1 A 151 VAL D 84 VAL^? 24.30 MG MG E 301 A 194 GLY D 82 GLY^? 26.13 MG MG E 301 A 417 ILE E 7 ILE^? 20.91 MG MG E 302 A 457 ALA E 9 ALA^? 15.19 MG MG E 302 coo 60.43 93.31 8.03 62.16 94.30 8.93 89.24 62.54 -31.31 91.02 61.37 -30.71 coo 59.34 89.99 13.88 59.24 89.18 13.73 92.26 67.62 -33.70 91.51 67.68 -33.55 coo 39.61 128.90 22.54 40.04 128.24 23.80 53.75 63.88 -58.98 53.36 64.78 -57.73 coo 43.27 124.32 20.47 43.79 125.29 21.53 60.74 63.76 -58.54 60.44 62.76 -57.48 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 2 4 # 2 A 151 VAL E 84 VAL^? 24.45 MG MG D 301 A 194 GLY E 82 GLY^? 26.59 MG MG D 301 A 417 ILE D 7 ILE^? 20.93 MG MG D 302 A 457 ALA D 9 ALA^? 15.02 MG MG D 302 coo 60.43 93.31 8.03 62.16 94.30 8.93 93.10 57.56 -63.54 92.42 59.40 -64.54 coo 59.34 89.99 13.88 59.24 89.18 13.73 98.75 59.89 -61.45 98.48 59.14 -61.39 coo 39.61 128.90 22.54 40.04 128.24 23.80 89.03 22.73 -35.87 89.94 22.01 -36.86 coo 43.27 124.32 20.47 43.79 125.29 21.53 89.67 29.50 -36.34 88.55 29.40 -37.31 1pix_c00 source 1pix GLUTACONYL-COA DECARBOXYLASE A SUBUNIT : 2 hits 1pix_c00 naa= 4 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 1 4 # 1 B 151 VAL C 84 VAL^? 25.39 MG MG B 301 B 194 GLY C 82 GLY^? 26.42 MG MG B 301 B 417 ILE B 7 ILE^? 21.00 MG MG B 302 B 457 ALA B 9 ALA^? 15.20 MG MG B 302 coo 52.95 126.71 13.21 51.34 125.24 13.19 67.88 3.44 -19.60 69.83 2.65 -20.37 coo 50.40 126.23 20.48 50.46 127.00 20.75 65.53 -2.15 -17.30 65.04 -1.60 -17.50 coo 68.38 85.45 19.33 67.41 85.52 20.41 38.55 25.14 7.56 37.66 24.77 6.38 coo 65.50 91.13 17.77 64.65 89.88 18.00 44.07 20.95 7.16 44.62 22.08 6.31 1pix_c01 source 1pix GLUTACONYL-COA DECARBOXYLASE A SUBUNIT : 1 hits 1pix_c01 naa= 4 ULMN 4 1pvd_c00 PYRUVATE DECARBOXYLASE (PDC) (E.C.4.user 1 4 # 1 A 28 ASP A 148 ASP^? 2.72 MG MG A 301s A 114 HIS A 170 HIS^? 10.56 MG MG A 302 A 115 HIS A 147 HIS^? 9.20 MG MG A 302 A 477 GLU B 33 GLU^? 22.65 MG MG B 302 coo -15.88 -12.55 22.80 -17.35 -11.37 23.73 41.50 28.88 41.13 43.33 29.67 41.93 coo -19.86 -7.63 20.42 -20.26 -6.94 22.43 34.91 23.57 39.32 34.35 24.95 40.81 coo -15.53 -7.10 20.34 -16.48 -7.70 22.11 40.24 23.10 39.83 38.32 22.34 40.22 coo 5.56 18.52 30.85 3.87 17.54 30.36 59.88 9.09 12.22 59.91 9.49 14.33 ULMN 4 1pvd_c00 PYRUVATE DECARBOXYLASE (PDC) (E.C.4.user 2 4 # 2 A 28 ASP B 148 ASP^? 2.58 MG MG B 302s A 114 HIS B 170 HIS^? 10.51 MG MG B 301 A 115 HIS B 147 HIS^? 9.27 MG MG B 301 A 477 GLU A 33 GLU^? 22.87 MG MG A 301 coo -15.88 -12.55 22.80 -17.35 -11.37 23.73 52.73 19.23 -3.77 53.81 20.99 -4.31 coo -19.86 -7.63 20.42 -20.26 -6.94 22.43 46.22 13.75 -2.72 47.53 13.11 -4.24 coo -15.53 -7.10 20.34 -16.48 -7.70 22.11 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 5.56 18.52 30.85 3.87 17.54 30.36 33.74 38.67 24.96 34.13 38.85 22.87 ULMN 4 1pvd_c00 PYRUVATE DECARBOXYLASE (PDC) (E.C.4.user 3 4 # 3 A 28 ASP C 148 ASP^? 2.75 MG MG C 302s A 114 HIS C 170 HIS^? 10.68 MG MG C 301 A 115 HIS C 147 HIS^? 9.44 MG MG C 301 A 477 GLU D 33 GLU^? 22.23 MG MG D 302 coo -15.88 -12.55 22.80 -17.35 -11.37 23.73 81.96 23.83 -2.68 80.24 25.11 -2.27 coo -19.86 -7.63 20.42 -20.26 -6.94 22.43 89.96 21.05 -3.85 88.74 19.88 -2.61 coo -15.53 -7.10 20.34 -16.48 -7.70 22.11 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 5.56 18.52 30.85 3.87 17.54 30.36 91.55 48.87 -31.66 91.12 48.92 -29.63 ULMN 4 1pvd_c00 PYRUVATE DECARBOXYLASE (PDC) (E.C.4.user 4 4 # 4 A 28 ASP D 148 ASP^? 2.35 MG MG D 302s A 114 HIS D 170 HIS^? 10.59 MG MG D 301 A 115 HIS D 147 HIS^? 9.43 MG MG D 301 A 477 GLU C 33 GLU^? 22.71 MG MG C 302 coo -15.88 -12.55 22.80 -17.35 -11.37 23.73 87.78 37.50 -47.56 85.79 37.49 -48.28 coo -19.86 -7.63 20.42 -20.26 -6.94 22.43 95.57 34.81 -46.05 95.59 36.24 -47.59 coo -15.53 -7.10 20.34 -16.48 -7.70 22.11 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 5.56 18.52 30.85 3.87 17.54 30.36 78.39 11.67 -18.82 78.34 12.01 -20.91 ULMN 4 1pvd_c00 PYRUVATE DECARBOXYLASE (PDC) (E.C.4.user 5 4 # 5 A 28 ASP E 148 ASP^? 2.62 MG MG E 302s A 114 HIS E 170 HIS^? 10.33 MG MG E 301 A 115 HIS E 147 HIS^? 9.22 MG MG E 301 A 477 GLU F 33 GLU^? 22.46 MG MG F 301 coo -15.88 -12.55 22.80 -17.35 -11.37 23.73 68.29 60.44 -47.29 68.03 58.42 -46.50 coo -19.86 -7.63 20.42 -20.26 -6.94 22.43 66.96 68.76 -48.87 68.36 68.54 -47.33 coo -15.53 -7.10 20.34 -16.48 -7.70 22.11 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 5.56 18.52 30.85 3.87 17.54 30.36 41.88 55.13 -75.91 42.06 54.64 -73.84 ULMN 4 1pvd_c00 PYRUVATE DECARBOXYLASE (PDC) (E.C.4.user 6 4 # 6 A 28 ASP F 148 ASP^? 2.72 MG MG F 301s A 114 HIS F 170 HIS^? 9.84 MG MG F 302 A 115 HIS F 147 HIS^? 8.79 MG MG F 302 A 477 GLU E 33 GLU^? 22.81 MG MG E 302 coo -15.88 -12.55 22.80 -17.35 -11.37 23.73 53.64 56.47 -91.98 54.61 54.68 -92.64 coo -19.86 -7.63 20.42 -20.26 -6.94 22.43 52.25 64.82 -90.91 50.95 63.88 -92.26 coo -15.53 -7.10 20.34 -16.48 -7.70 22.11 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 5.56 18.52 30.85 3.87 17.54 30.36 80.16 62.57 -63.35 80.54 62.13 -65.43 1pvd_c00 source 1pvd PYRUVATE DECARBOXYLASE (PDC) (E.C.4.1.1.1) : 6 hits 1pvd_c00 naa= 4 ULMN 4 1pvd_c01 PYRUVATE DECARBOXYLASE (PDC) (E.C.4.user 1 4 # 1 B 28 ASP A 148 ASP^? 2.72 MG MG A 301s B 114 HIS A 170 HIS^? 10.56 MG MG A 302 B 115 HIS A 147 HIS^? 9.20 MG MG A 302 B 477 GLU B 33 GLU^? 22.65 MG MG B 302 coo 7.54 16.02 24.50 8.40 15.18 26.23 41.50 28.88 41.13 43.33 29.67 41.93 coo 12.56 11.13 24.12 12.84 11.07 26.21 34.91 23.57 39.32 34.35 24.95 40.81 coo 8.02 10.56 23.37 8.23 11.43 25.26 40.24 23.10 39.83 38.32 22.34 40.22 coo -16.37 -13.88 29.96 -14.84 -12.68 29.83 59.88 9.09 12.22 59.91 9.49 14.33 ULMN 4 1pvd_c01 PYRUVATE DECARBOXYLASE (PDC) (E.C.4.user 2 4 # 2 B 28 ASP B 148 ASP^? 2.58 MG MG B 302s B 114 HIS B 170 HIS^? 10.51 MG MG B 301 B 115 HIS B 147 HIS^? 9.27 MG MG B 301 B 477 GLU A 33 GLU^? 22.87 MG MG A 301 coo 7.54 16.02 24.50 8.40 15.18 26.23 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 12.56 11.13 24.12 12.84 11.07 26.21 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 8.02 10.56 23.37 8.23 11.43 25.26 46.73 18.97 -3.05 45.63 17.32 -3.73 coo -16.37 -13.88 29.96 -14.84 -12.68 29.83 33.74 38.67 24.96 34.13 38.85 22.87 ULMN 4 1pvd_c01 PYRUVATE DECARBOXYLASE (PDC) (E.C.4.user 3 4 # 3 B 28 ASP C 148 ASP^? 2.75 MG MG C 302s B 114 HIS C 170 HIS^? 10.68 MG MG C 301 B 115 HIS C 147 HIS^? 9.44 MG MG C 301 B 477 GLU D 33 GLU^? 22.23 MG MG D 302 coo 7.54 16.02 24.50 8.40 15.18 26.23 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 12.56 11.13 24.12 12.84 11.07 26.21 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 8.02 10.56 23.37 8.23 11.43 25.26 87.61 25.71 -3.59 89.22 24.50 -2.99 coo -16.37 -13.88 29.96 -14.84 -12.68 29.83 91.55 48.87 -31.66 91.12 48.92 -29.63 ULMN 4 1pvd_c01 PYRUVATE DECARBOXYLASE (PDC) (E.C.4.user 4 4 # 4 B 28 ASP D 148 ASP^? 2.35 MG MG D 302s B 114 HIS D 170 HIS^? 10.59 MG MG D 301 B 115 HIS D 147 HIS^? 9.43 MG MG D 301 B 477 GLU C 33 GLU^? 22.71 MG MG C 302 coo 7.54 16.02 24.50 8.40 15.18 26.23 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 12.56 11.13 24.12 12.84 11.07 26.21 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 8.02 10.56 23.37 8.23 11.43 25.26 90.95 32.51 -46.42 92.98 32.42 -46.93 coo -16.37 -13.88 29.96 -14.84 -12.68 29.83 78.39 11.67 -18.82 78.34 12.01 -20.91 ULMN 4 1pvd_c01 PYRUVATE DECARBOXYLASE (PDC) (E.C.4.user 5 4 # 5 B 28 ASP E 148 ASP^? 2.62 MG MG E 302s B 114 HIS E 170 HIS^? 10.33 MG MG E 301 B 115 HIS E 147 HIS^? 9.22 MG MG E 301 B 477 GLU F 33 GLU^? 22.46 MG MG F 301 coo 7.54 16.02 24.50 8.40 15.18 26.23 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 12.56 11.13 24.12 12.84 11.07 26.21 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 8.02 10.56 23.37 8.23 11.43 25.26 63.87 64.43 -48.39 64.18 66.45 -47.92 coo -16.37 -13.88 29.96 -14.84 -12.68 29.83 41.88 55.13 -75.91 42.06 54.64 -73.84 ULMN 4 1pvd_c01 PYRUVATE DECARBOXYLASE (PDC) (E.C.4.user 6 4 # 6 B 28 ASP F 148 ASP^? 2.72 MG MG F 301s B 114 HIS F 170 HIS^? 9.84 MG MG F 302 B 115 HIS F 147 HIS^? 8.79 MG MG F 302 B 477 GLU E 33 GLU^? 22.81 MG MG E 302 coo 7.54 16.02 24.50 8.40 15.18 26.23 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 12.56 11.13 24.12 12.84 11.07 26.21 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 8.02 10.56 23.37 8.23 11.43 25.26 56.63 61.66 -91.16 55.69 63.43 -91.80 coo -16.37 -13.88 29.96 -14.84 -12.68 29.83 80.16 62.57 -63.35 80.54 62.13 -65.43 1pvd_c01 source 1pvd PYRUVATE DECARBOXYLASE (PDC) (E.C.4.1.1.1) : 6 hits 1pvd_c01 naa= 4 ULMN 4 1qrz_c04 PLASMINOGEN user 1 4 # 1 A 603 HIS A 147 HIS^? 9.20 MG MG A 302 A 646 ASP A 128 ASP^? -3.32 MG MG A 301s A 741 SER A 189 SER^? 11.75 MG MG A 302 A 742 GLY A 145 GLY^? 13.39 MG MG A 302 coo -20.72 2.99 34.37 -21.94 1.82 35.61 40.24 23.10 39.83 38.32 22.34 40.22 coo -18.83 7.68 26.86 -20.89 7.78 26.56 46.50 28.23 39.77 47.49 30.10 39.82 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 40.99 19.00 44.32 41.51 18.14 46.48 coo -13.41 0.94 31.30 -13.38 0.16 31.09 44.20 17.56 40.29 44.09 17.33 41.06 ULMN 4 1qrz_c04 PLASMINOGEN user 2 4 # 2 A 603 HIS B 147 HIS^? 9.27 MG MG B 301 A 646 ASP B 128 ASP^? -3.57 MG MG B 302s A 741 SER B 189 SER^? 12.11 MG MG B 301 A 742 GLY B 145 GLY^? 13.71 MG MG B 301 coo -20.72 2.99 34.37 -21.94 1.82 35.61 46.73 18.97 -3.05 45.63 17.32 -3.73 coo -18.83 7.68 26.86 -20.89 7.78 26.56 52.92 24.09 -2.19 54.73 25.14 -1.90 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 43.10 20.95 -7.74 42.82 21.56 -10.02 coo -13.41 0.94 31.30 -13.38 0.16 31.09 42.04 23.97 -3.40 41.83 23.90 -4.16 ULMN 4 1qrz_c04 PLASMINOGEN user 3 4 # 3 A 603 HIS C 147 HIS^? 9.44 MG MG C 301 A 646 ASP C 128 ASP^? -3.22 MG MG C 302s A 741 SER C 189 SER^? 12.09 MG MG C 301 A 742 GLY C 145 GLY^? 13.72 MG MG C 301 coo -20.72 2.99 34.37 -21.94 1.82 35.61 87.61 25.71 -3.59 89.22 24.50 -2.99 coo -18.83 7.68 26.86 -20.89 7.78 26.56 80.05 28.39 -4.25 77.97 28.60 -4.21 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 90.33 28.79 1.19 90.26 29.61 3.45 coo -13.41 0.94 31.30 -13.38 0.16 31.09 90.12 32.13 -3.16 90.38 32.11 -2.40 ULMN 4 1qrz_c04 PLASMINOGEN user 4 4 # 4 A 603 HIS D 147 HIS^? 9.43 MG MG D 301 A 646 ASP D 128 ASP^? -3.70 MG MG D 302s A 741 SER D 189 SER^? 12.12 MG MG D 301 A 742 GLY D 145 GLY^? 13.51 MG MG D 301 coo -20.72 2.99 34.37 -21.94 1.82 35.61 90.95 32.51 -46.42 92.98 32.42 -46.93 coo -18.83 7.68 26.86 -20.89 7.78 26.56 83.33 35.45 -46.13 81.57 36.63 -46.10 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 91.62 28.58 -50.95 91.45 27.78 -53.25 coo -13.41 0.94 31.30 -13.38 0.16 31.09 88.90 26.07 -46.90 89.21 25.93 -47.57 ULMN 4 1qrz_c04 PLASMINOGEN user 5 4 # 5 A 603 HIS E 147 HIS^? 9.22 MG MG E 301 A 646 ASP E 128 ASP^? -3.53 MG MG E 302s A 741 SER E 189 SER^? 11.91 MG MG E 301 A 742 GLY E 145 GLY^? 13.69 MG MG E 301 coo -20.72 2.99 34.37 -21.94 1.82 35.61 63.87 64.43 -48.39 64.18 66.45 -47.92 coo -18.83 7.68 26.86 -20.89 7.78 26.56 65.38 56.57 -48.58 66.15 54.57 -48.61 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 60.13 65.61 -43.87 59.01 65.34 -41.74 coo -13.41 0.94 31.30 -13.38 0.16 31.09 57.08 63.68 -47.92 56.95 63.88 -47.12 ULMN 4 1qrz_c04 PLASMINOGEN user 6 4 # 6 A 603 HIS F 147 HIS^? 8.79 MG MG F 302 A 646 ASP F 128 ASP^? -3.41 MG MG F 301s A 741 SER F 189 SER^? 11.88 MG MG F 302 A 742 GLY F 145 GLY^? 13.40 MG MG F 302 coo -20.72 2.99 34.37 -21.94 1.82 35.61 56.63 61.66 -91.16 55.69 63.43 -91.80 coo -18.83 7.68 26.86 -20.89 7.78 26.56 57.76 53.73 -90.50 57.46 51.64 -90.28 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 59.91 63.90 -95.91 60.70 64.22 -98.13 coo -13.41 0.94 31.30 -13.38 0.16 31.09 63.24 63.21 -91.82 63.24 63.42 -92.59 1qrz_c04 source 1qrz PLASMINOGEN : 6 hits 1qrz_c04 naa= 4 ULMN 4 1qrz_c05 PLASMINOGEN user 1 4 # 1 B 603 HIS A 147 HIS^? 9.20 MG MG A 302 B 646 ASP A 128 ASP^? -3.32 MG MG A 301s B 741 SER A 189 SER^? 11.75 MG MG A 302 B 742 GLY A 145 GLY^? 13.39 MG MG A 302 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 40.24 23.10 39.83 38.32 22.34 40.22 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 46.50 28.23 39.77 47.49 30.10 39.82 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 40.99 19.00 44.32 41.51 18.14 46.48 coo -41.03 0.89 -7.12 -41.01 0.10 -7.37 44.20 17.56 40.29 44.09 17.33 41.06 ULMN 4 1qrz_c05 PLASMINOGEN user 2 4 # 2 B 603 HIS B 147 HIS^? 9.27 MG MG B 301 B 646 ASP B 128 ASP^? -3.57 MG MG B 302s B 741 SER B 189 SER^? 12.11 MG MG B 301 B 742 GLY B 145 GLY^? 13.71 MG MG B 301 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 46.73 18.97 -3.05 45.63 17.32 -3.73 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 52.92 24.09 -2.19 54.73 25.14 -1.90 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 43.10 20.95 -7.74 42.82 21.56 -10.02 coo -41.03 0.89 -7.12 -41.01 0.10 -7.37 42.04 23.97 -3.40 41.83 23.90 -4.16 ULMN 4 1qrz_c05 PLASMINOGEN user 3 4 # 3 B 603 HIS C 147 HIS^? 9.44 MG MG C 301 B 646 ASP C 128 ASP^? -3.22 MG MG C 302s B 741 SER C 189 SER^? 12.09 MG MG C 301 B 742 GLY C 145 GLY^? 13.72 MG MG C 301 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 87.61 25.71 -3.59 89.22 24.50 -2.99 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 80.05 28.39 -4.25 77.97 28.60 -4.21 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 90.33 28.79 1.19 90.26 29.61 3.45 coo -41.03 0.89 -7.12 -41.01 0.10 -7.37 90.12 32.13 -3.16 90.38 32.11 -2.40 ULMN 4 1qrz_c05 PLASMINOGEN user 4 4 # 4 B 603 HIS D 147 HIS^? 9.43 MG MG D 301 B 646 ASP D 128 ASP^? -3.70 MG MG D 302s B 741 SER D 189 SER^? 12.12 MG MG D 301 B 742 GLY D 145 GLY^? 13.51 MG MG D 301 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 90.95 32.51 -46.42 92.98 32.42 -46.93 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 83.33 35.45 -46.13 81.57 36.63 -46.10 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 91.62 28.58 -50.95 91.45 27.78 -53.25 coo -41.03 0.89 -7.12 -41.01 0.10 -7.37 88.90 26.07 -46.90 89.21 25.93 -47.57 ULMN 4 1qrz_c05 PLASMINOGEN user 5 4 # 5 B 603 HIS E 147 HIS^? 9.22 MG MG E 301 B 646 ASP E 128 ASP^? -3.53 MG MG E 302s B 741 SER E 189 SER^? 11.91 MG MG E 301 B 742 GLY E 145 GLY^? 13.69 MG MG E 301 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 63.87 64.43 -48.39 64.18 66.45 -47.92 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 65.38 56.57 -48.58 66.15 54.57 -48.61 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 60.13 65.61 -43.87 59.01 65.34 -41.74 coo -41.03 0.89 -7.12 -41.01 0.10 -7.37 57.08 63.68 -47.92 56.95 63.88 -47.12 ULMN 4 1qrz_c05 PLASMINOGEN user 6 4 # 6 B 603 HIS F 147 HIS^? 8.79 MG MG F 302 B 646 ASP F 128 ASP^? -3.41 MG MG F 301s B 741 SER F 189 SER^? 11.88 MG MG F 302 B 742 GLY F 145 GLY^? 13.40 MG MG F 302 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 56.63 61.66 -91.16 55.69 63.43 -91.80 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 57.76 53.73 -90.50 57.46 51.64 -90.28 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 59.91 63.90 -95.91 60.70 64.22 -98.13 coo -41.03 0.89 -7.12 -41.01 0.10 -7.37 63.24 63.21 -91.82 63.24 63.42 -92.59 1qrz_c05 source 1qrz PLASMINOGEN : 6 hits 1qrz_c05 naa= 4 ULMN 4 1qrz_c06 PLASMINOGEN user 1 4 # 1 C 603 HIS A 147 HIS^? 9.20 MG MG A 302 C 646 ASP A 128 ASP^? -3.32 MG MG A 301s C 741 SER A 189 SER^? 11.75 MG MG A 302 C 742 GLY A 145 GLY^? 13.39 MG MG A 302 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 40.24 23.10 39.83 38.32 22.34 40.22 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 46.50 28.23 39.77 47.49 30.10 39.82 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 40.99 19.00 44.32 41.51 18.14 46.48 coo 6.69 -6.98 2.53 6.88 -6.20 2.57 44.20 17.56 40.29 44.09 17.33 41.06 ULMN 4 1qrz_c06 PLASMINOGEN user 2 4 # 2 C 603 HIS B 147 HIS^? 9.27 MG MG B 301 C 646 ASP B 128 ASP^? -3.57 MG MG B 302s C 741 SER B 189 SER^? 12.11 MG MG B 301 C 742 GLY B 145 GLY^? 13.71 MG MG B 301 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 52.92 24.09 -2.19 54.73 25.14 -1.90 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 43.10 20.95 -7.74 42.82 21.56 -10.02 coo 6.69 -6.98 2.53 6.88 -6.20 2.57 42.04 23.97 -3.40 41.83 23.90 -4.16 ULMN 4 1qrz_c06 PLASMINOGEN user 3 4 # 3 C 603 HIS C 147 HIS^? 9.44 MG MG C 301 C 646 ASP C 128 ASP^? -3.22 MG MG C 302s C 741 SER C 189 SER^? 12.09 MG MG C 301 C 742 GLY C 145 GLY^? 13.72 MG MG C 301 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 90.33 28.79 1.19 90.26 29.61 3.45 coo 6.69 -6.98 2.53 6.88 -6.20 2.57 90.12 32.13 -3.16 90.38 32.11 -2.40 ULMN 4 1qrz_c06 PLASMINOGEN user 4 4 # 4 C 603 HIS D 147 HIS^? 9.43 MG MG D 301 C 646 ASP D 128 ASP^? -3.70 MG MG D 302s C 741 SER D 189 SER^? 12.12 MG MG D 301 C 742 GLY D 145 GLY^? 13.51 MG MG D 301 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 83.33 35.45 -46.13 81.57 36.63 -46.10 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 91.62 28.58 -50.95 91.45 27.78 -53.25 coo 6.69 -6.98 2.53 6.88 -6.20 2.57 88.90 26.07 -46.90 89.21 25.93 -47.57 ULMN 4 1qrz_c06 PLASMINOGEN user 5 4 # 5 C 603 HIS E 147 HIS^? 9.22 MG MG E 301 C 646 ASP E 128 ASP^? -3.53 MG MG E 302s C 741 SER E 189 SER^? 11.91 MG MG E 301 C 742 GLY E 145 GLY^? 13.69 MG MG E 301 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 65.38 56.57 -48.58 66.15 54.57 -48.61 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 60.13 65.61 -43.87 59.01 65.34 -41.74 coo 6.69 -6.98 2.53 6.88 -6.20 2.57 57.08 63.68 -47.92 56.95 63.88 -47.12 ULMN 4 1qrz_c06 PLASMINOGEN user 6 4 # 6 C 603 HIS F 147 HIS^? 8.79 MG MG F 302 C 646 ASP F 128 ASP^? -3.41 MG MG F 301s C 741 SER F 189 SER^? 11.88 MG MG F 302 C 742 GLY F 145 GLY^? 13.40 MG MG F 302 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 57.76 53.73 -90.50 57.46 51.64 -90.28 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 59.91 63.90 -95.91 60.70 64.22 -98.13 coo 6.69 -6.98 2.53 6.88 -6.20 2.57 63.24 63.21 -91.82 63.24 63.42 -92.59 1qrz_c06 source 1qrz PLASMINOGEN : 6 hits 1qrz_c06 naa= 4 ULMN 4 1qrz_c07 PLASMINOGEN user 1 4 # 1 D 603 HIS A 147 HIS^? 9.20 MG MG A 302 D 646 ASP A 128 ASP^? -3.32 MG MG A 301s D 741 SER A 189 SER^? 11.75 MG MG A 302 D 742 GLY A 145 GLY^? 13.39 MG MG A 302 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 40.24 23.10 39.83 38.32 22.34 40.22 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 46.50 28.23 39.77 47.49 30.10 39.82 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 40.99 19.00 44.32 41.51 18.14 46.48 coo -47.33 -7.05 40.93 -47.11 -6.27 40.97 44.20 17.56 40.29 44.09 17.33 41.06 ULMN 4 1qrz_c07 PLASMINOGEN user 2 4 # 2 D 603 HIS B 147 HIS^? 9.27 MG MG B 301 D 646 ASP B 128 ASP^? -3.57 MG MG B 302s D 741 SER B 189 SER^? 12.11 MG MG B 301 D 742 GLY B 145 GLY^? 13.71 MG MG B 301 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 46.73 18.97 -3.05 45.63 17.32 -3.73 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 52.92 24.09 -2.19 54.73 25.14 -1.90 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 43.10 20.95 -7.74 42.82 21.56 -10.02 coo -47.33 -7.05 40.93 -47.11 -6.27 40.97 42.04 23.97 -3.40 41.83 23.90 -4.16 ULMN 4 1qrz_c07 PLASMINOGEN user 3 4 # 3 D 603 HIS C 147 HIS^? 9.44 MG MG C 301 D 646 ASP C 128 ASP^? -3.22 MG MG C 302s D 741 SER C 189 SER^? 12.09 MG MG C 301 D 742 GLY C 145 GLY^? 13.72 MG MG C 301 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 87.61 25.71 -3.59 89.22 24.50 -2.99 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 80.05 28.39 -4.25 77.97 28.60 -4.21 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 90.33 28.79 1.19 90.26 29.61 3.45 coo -47.33 -7.05 40.93 -47.11 -6.27 40.97 90.12 32.13 -3.16 90.38 32.11 -2.40 ULMN 4 1qrz_c07 PLASMINOGEN user 4 4 # 4 D 603 HIS D 147 HIS^? 9.43 MG MG D 301 D 646 ASP D 128 ASP^? -3.70 MG MG D 302s D 741 SER D 189 SER^? 12.12 MG MG D 301 D 742 GLY D 145 GLY^? 13.51 MG MG D 301 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 90.95 32.51 -46.42 92.98 32.42 -46.93 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 83.33 35.45 -46.13 81.57 36.63 -46.10 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 91.62 28.58 -50.95 91.45 27.78 -53.25 coo -47.33 -7.05 40.93 -47.11 -6.27 40.97 88.90 26.07 -46.90 89.21 25.93 -47.57 ULMN 4 1qrz_c07 PLASMINOGEN user 5 4 # 5 D 603 HIS E 147 HIS^? 9.22 MG MG E 301 D 646 ASP E 128 ASP^? -3.53 MG MG E 302s D 741 SER E 189 SER^? 11.91 MG MG E 301 D 742 GLY E 145 GLY^? 13.69 MG MG E 301 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 63.87 64.43 -48.39 64.18 66.45 -47.92 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 65.38 56.57 -48.58 66.15 54.57 -48.61 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 60.13 65.61 -43.87 59.01 65.34 -41.74 coo -47.33 -7.05 40.93 -47.11 -6.27 40.97 57.08 63.68 -47.92 56.95 63.88 -47.12 ULMN 4 1qrz_c07 PLASMINOGEN user 6 4 # 6 D 603 HIS F 147 HIS^? 8.79 MG MG F 302 D 646 ASP F 128 ASP^? -3.41 MG MG F 301s D 741 SER F 189 SER^? 11.88 MG MG F 302 D 742 GLY F 145 GLY^? 13.40 MG MG F 302 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 56.63 61.66 -91.16 55.69 63.43 -91.80 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 57.76 53.73 -90.50 57.46 51.64 -90.28 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 59.91 63.90 -95.91 60.70 64.22 -98.13 coo -47.33 -7.05 40.93 -47.11 -6.27 40.97 63.24 63.21 -91.82 63.24 63.42 -92.59 1qrz_c07 source 1qrz PLASMINOGEN : 6 hits 1qrz_c07 naa= 4 ULMN 4 1xtc_c00 CHOLERA TOXIN user 1 4 # 1 A 7 ARG A 37 ARG^? 18.99 MG MG A 301 A 61 SER A 49 SER^? 17.63 MG MG A 301 A 110 GLU A 54 GLU^? 22.98 MG MG A 301 A 112 GLU A 52 GLU^? 19.89 MG MG A 301 coo 40.84 -12.81 5.27 43.40 -12.96 7.11 32.99 26.50 25.19 35.50 25.33 26.51 coo 43.36 -8.81 2.69 45.06 -10.01 1.28 38.68 29.52 26.48 39.52 27.49 25.41 coo 50.78 -11.66 -4.90 52.36 -12.10 -6.21 45.06 19.97 24.02 44.05 19.39 22.19 coo 46.91 -7.83 -2.12 47.28 -9.79 -1.54 42.67 25.16 24.80 42.61 25.77 22.75 ULMN 4 1xtc_c00 CHOLERA TOXIN user 2 4 # 2 A 7 ARG A 48 ARG^? 25.29 MG MG A 301 A 61 SER A 49 SER^? 17.63 MG MG A 301 A 110 GLU A 54 GLU^? 22.98 MG MG A 301 A 112 GLU A 52 GLU^? 19.89 MG MG A 301 coo 40.84 -12.81 5.27 43.40 -12.96 7.11 33.88 31.17 22.03 31.48 31.85 20.30 coo 43.36 -8.81 2.69 45.06 -10.01 1.28 38.68 29.52 26.48 39.52 27.49 25.41 coo 50.78 -11.66 -4.90 52.36 -12.10 -6.21 45.06 19.97 24.02 44.05 19.39 22.19 coo 46.91 -7.83 -2.12 47.28 -9.79 -1.54 42.67 25.16 24.80 42.61 25.77 22.75 ULMN 4 1xtc_c00 CHOLERA TOXIN user 3 4 # 3 A 7 ARG A 50 ARG^? 15.98 MG MG A 301 A 61 SER A 49 SER^? 17.63 MG MG A 301 A 110 GLU A 54 GLU^? 22.98 MG MG A 301 A 112 GLU A 52 GLU^? 19.89 MG MG A 301 coo 40.84 -12.81 5.27 43.40 -12.96 7.11 38.44 33.02 29.31 39.55 34.58 26.90 coo 43.36 -8.81 2.69 45.06 -10.01 1.28 38.68 29.52 26.48 39.52 27.49 25.41 coo 50.78 -11.66 -4.90 52.36 -12.10 -6.21 45.06 19.97 24.02 44.05 19.39 22.19 coo 46.91 -7.83 -2.12 47.28 -9.79 -1.54 42.67 25.16 24.80 42.61 25.77 22.75 ULMN 4 1xtc_c00 CHOLERA TOXIN user 4 4 # 4 A 7 ARG B 37 ARG^? 19.17 MG MG B 302 A 61 SER B 49 SER^? 17.51 MG MG B 302 A 110 GLU B 54 GLU^? 22.94 MG MG B 302 A 112 GLU B 52 GLU^? 20.06 MG MG B 302 coo 40.84 -12.81 5.27 43.40 -12.96 7.11 47.41 10.20 11.40 46.99 12.91 10.22 coo 43.36 -8.81 2.69 45.06 -10.01 1.28 51.67 15.70 10.57 49.37 16.19 11.15 coo 50.78 -11.66 -4.90 52.36 -12.10 -6.21 43.18 23.27 12.99 42.40 22.23 14.68 coo 46.91 -7.83 -2.12 47.28 -9.79 -1.54 47.87 20.25 12.36 48.11 19.69 14.43 ULMN 4 1xtc_c00 CHOLERA TOXIN user 5 4 # 5 A 7 ARG B 48 ARG^? 25.20 MG MG B 302 A 61 SER B 49 SER^? 17.51 MG MG B 302 A 110 GLU B 54 GLU^? 22.94 MG MG B 302 A 112 GLU B 52 GLU^? 20.06 MG MG B 302 coo 40.84 -12.81 5.27 43.40 -12.96 7.11 52.22 10.51 15.00 52.46 7.79 16.39 coo 43.36 -8.81 2.69 45.06 -10.01 1.28 51.67 15.70 10.57 49.37 16.19 11.15 coo 50.78 -11.66 -4.90 52.36 -12.10 -6.21 43.18 23.27 12.99 42.40 22.23 14.68 coo 46.91 -7.83 -2.12 47.28 -9.79 -1.54 47.87 20.25 12.36 48.11 19.69 14.43 ULMN 4 1xtc_c00 CHOLERA TOXIN user 6 4 # 6 A 7 ARG B 50 ARG^? 16.38 MG MG B 302 A 61 SER B 49 SER^? 17.51 MG MG B 302 A 110 GLU B 54 GLU^? 22.94 MG MG B 302 A 112 GLU B 52 GLU^? 20.06 MG MG B 302 coo 40.84 -12.81 5.27 43.40 -12.96 7.11 55.38 14.91 7.80 56.60 14.73 10.62 coo 43.36 -8.81 2.69 45.06 -10.01 1.28 51.67 15.70 10.57 49.37 16.19 11.15 coo 50.78 -11.66 -4.90 52.36 -12.10 -6.21 43.18 23.27 12.99 42.40 22.23 14.68 coo 46.91 -7.83 -2.12 47.28 -9.79 -1.54 47.87 20.25 12.36 48.11 19.69 14.43 ULMN 4 1xtc_c00 CHOLERA TOXIN user 7 4 # 7 A 7 ARG C 37 ARG^? 19.01 MG MG C 302 A 61 SER C 49 SER^? 17.53 MG MG C 302 A 110 GLU C 54 GLU^? 22.77 MG MG C 302 A 112 GLU C 52 GLU^? 19.67 MG MG C 302 coo 40.84 -12.81 5.27 43.40 -12.96 7.11 89.36 17.23 -17.57 89.29 20.20 -16.76 coo 43.36 -8.81 2.69 45.06 -10.01 1.28 83.83 21.24 -17.13 85.75 22.50 -18.00 coo 50.78 -11.66 -4.90 52.36 -12.10 -6.21 88.91 31.25 -19.52 89.97 30.69 -21.29 coo 46.91 -7.83 -2.12 47.28 -9.79 -1.54 84.27 26.98 -19.19 85.21 26.16 -20.96 ULMN 4 1xtc_c00 CHOLERA TOXIN user 8 4 # 8 A 7 ARG C 48 ARG^? 25.02 MG MG C 302 A 61 SER C 49 SER^? 17.53 MG MG C 302 A 110 GLU C 54 GLU^? 22.77 MG MG C 302 A 112 GLU C 52 GLU^? 19.67 MG MG C 302 coo 40.84 -12.81 5.27 43.40 -12.96 7.11 84.94 16.06 -21.53 85.81 13.55 -23.08 coo 43.36 -8.81 2.69 45.06 -10.01 1.28 83.83 21.24 -17.13 85.75 22.50 -18.00 coo 50.78 -11.66 -4.90 52.36 -12.10 -6.21 88.91 31.25 -19.52 89.97 30.69 -21.29 coo 46.91 -7.83 -2.12 47.28 -9.79 -1.54 84.27 26.98 -19.19 85.21 26.16 -20.96 ULMN 4 1xtc_c00 CHOLERA TOXIN user 9 4 # 9 A 7 ARG C 50 ARG^? 16.05 MG MG C 302 A 61 SER C 49 SER^? 17.53 MG MG C 302 A 110 GLU C 54 GLU^? 22.77 MG MG C 302 A 112 GLU C 52 GLU^? 19.67 MG MG C 302 coo 40.84 -12.81 5.27 43.40 -12.96 7.11 80.61 19.03 -14.42 79.16 18.55 -17.10 coo 43.36 -8.81 2.69 45.06 -10.01 1.28 83.83 21.24 -17.13 85.75 22.50 -18.00 coo 50.78 -11.66 -4.90 52.36 -12.10 -6.21 88.91 31.25 -19.52 89.97 30.69 -21.29 coo 46.91 -7.83 -2.12 47.28 -9.79 -1.54 84.27 26.98 -19.19 85.21 26.16 -20.96 ULMN 4 1xtc_c00 CHOLERA TOXIN user 10 4 # 10 A 7 ARG D 37 ARG^? 18.81 MG MG D 302 A 61 SER D 49 SER^? 17.22 MG MG D 302 A 110 GLU D 54 GLU^? 22.96 MG MG D 302 A 112 GLU D 52 GLU^? 19.94 MG MG D 302 coo 40.84 -12.81 5.27 43.40 -12.96 7.11 96.81 38.21 -31.63 94.97 36.32 -33.06 coo 43.36 -8.81 2.69 45.06 -10.01 1.28 90.26 38.73 -32.99 91.21 36.48 -32.65 coo 50.78 -11.66 -4.90 52.36 -12.10 -6.21 87.96 27.60 -30.52 89.07 27.55 -28.72 coo 46.91 -7.83 -2.12 47.28 -9.79 -1.54 87.13 33.17 -30.97 88.40 33.70 -29.31 ULMN 4 1xtc_c00 CHOLERA TOXIN user 11 4 # 11 A 7 ARG D 48 ARG^? 24.87 MG MG D 302 A 61 SER D 49 SER^? 17.22 MG MG D 302 A 110 GLU D 54 GLU^? 22.96 MG MG D 302 A 112 GLU D 52 GLU^? 19.94 MG MG D 302 coo 40.84 -12.81 5.27 43.40 -12.96 7.11 94.06 41.76 -28.37 96.24 43.38 -26.96 coo 43.36 -8.81 2.69 45.06 -10.01 1.28 90.26 38.73 -32.99 91.21 36.48 -32.65 coo 50.78 -11.66 -4.90 52.36 -12.10 -6.21 87.96 27.60 -30.52 89.07 27.55 -28.72 coo 46.91 -7.83 -2.12 47.28 -9.79 -1.54 87.13 33.17 -30.97 88.40 33.70 -29.31 ULMN 4 1xtc_c00 CHOLERA TOXIN user 12 4 # 12 A 7 ARG E 37 ARG^? 19.17 MG MG E 302 A 61 SER E 49 SER^? 17.46 MG MG E 302 A 110 GLU E 54 GLU^? 22.83 MG MG E 302 A 112 GLU E 52 GLU^? 19.96 MG MG E 302 coo 40.84 -12.81 5.27 43.40 -12.96 7.11 70.82 68.02 -63.63 68.17 67.46 -62.14 coo 43.36 -8.81 2.69 45.06 -10.01 1.28 69.86 62.56 -61.93 67.83 63.87 -62.36 coo 50.78 -11.66 -4.90 52.36 -12.10 -6.21 58.39 62.16 -64.12 58.73 62.98 -66.04 coo 46.91 -7.83 -2.12 47.28 -9.79 -1.54 64.71 60.06 -63.78 64.69 61.36 -65.58 ULMN 4 1xtc_c00 CHOLERA TOXIN user 13 4 # 13 A 7 ARG E 48 ARG^? 25.02 MG MG E 302 A 61 SER E 49 SER^? 17.46 MG MG E 302 A 110 GLU E 54 GLU^? 22.83 MG MG E 302 A 112 GLU E 52 GLU^? 19.96 MG MG E 302 coo 40.84 -12.81 5.27 43.40 -12.96 7.11 73.60 65.75 -66.57 75.51 67.67 -67.91 coo 43.36 -8.81 2.69 45.06 -10.01 1.28 69.86 62.56 -61.93 67.83 63.87 -62.36 coo 50.78 -11.66 -4.90 52.36 -12.10 -6.21 58.39 62.16 -64.12 58.73 62.98 -66.04 coo 46.91 -7.83 -2.12 47.28 -9.79 -1.54 64.71 60.06 -63.78 64.69 61.36 -65.58 ULMN 4 1xtc_c00 CHOLERA TOXIN user 14 4 # 14 A 7 ARG F 37 ARG^? 19.14 MG MG F 301 A 61 SER F 49 SER^? 17.41 MG MG F 301 A 110 GLU F 54 GLU^? 22.98 MG MG F 301 A 112 GLU F 52 GLU^? 20.13 MG MG F 301 coo 40.84 -12.81 5.27 43.40 -12.96 7.11 48.80 64.46 -76.37 51.50 64.15 -77.79 coo 43.36 -8.81 2.69 45.06 -10.01 1.28 51.43 58.69 -77.53 52.81 60.66 -77.24 coo 50.78 -11.66 -4.90 52.36 -12.10 -6.21 62.26 62.27 -75.30 61.72 63.47 -73.60 coo 46.91 -7.83 -2.12 47.28 -9.79 -1.54 57.09 59.62 -75.76 56.76 59.40 -73.62 ULMN 4 1xtc_c00 CHOLERA TOXIN user 15 4 # 15 A 7 ARG F 48 ARG^? 25.18 MG MG F 301 A 61 SER F 49 SER^? 17.41 MG MG F 301 A 110 GLU F 54 GLU^? 22.98 MG MG F 301 A 112 GLU F 52 GLU^? 20.13 MG MG F 301 coo 40.84 -12.81 5.27 43.40 -12.96 7.11 46.82 60.90 -73.07 44.43 61.88 -71.46 coo 43.36 -8.81 2.69 45.06 -10.01 1.28 51.43 58.69 -77.53 52.81 60.66 -77.24 coo 50.78 -11.66 -4.90 52.36 -12.10 -6.21 62.26 62.27 -75.30 61.72 63.47 -73.60 coo 46.91 -7.83 -2.12 47.28 -9.79 -1.54 57.09 59.62 -75.76 56.76 59.40 -73.62 ULMN 4 1xtc_c00 CHOLERA TOXIN user 16 4 # 16 A 7 ARG F 50 ARG^? 16.24 MG MG F 301 A 61 SER F 49 SER^? 17.41 MG MG F 301 A 110 GLU F 54 GLU^? 22.98 MG MG F 301 A 112 GLU F 52 GLU^? 20.13 MG MG F 301 coo 40.84 -12.81 5.27 43.40 -12.96 7.11 48.85 56.05 -80.24 48.26 54.66 -77.55 coo 43.36 -8.81 2.69 45.06 -10.01 1.28 51.43 58.69 -77.53 52.81 60.66 -77.24 coo 50.78 -11.66 -4.90 52.36 -12.10 -6.21 62.26 62.27 -75.30 61.72 63.47 -73.60 coo 46.91 -7.83 -2.12 47.28 -9.79 -1.54 57.09 59.62 -75.76 56.76 59.40 -73.62 1xtc_c00 source 1xtc CHOLERA TOXIN : 16 hits 1xtc_c00 naa= 4 ULMN 4 2amg_c01 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 4 # 1 117 HIS A 170 HIS^? 10.56 MG MG A 302 193 ASP A 187 ASP^? -3.29 MG MG A 302s 219 GLU A 146 GLU^? 9.80 MG MG A 302 294 ASP A 128 ASP^? -3.32 MG MG A 301s coo 31.07 94.80 15.41 31.42 96.70 14.59 34.91 23.57 39.32 34.35 24.95 40.81 coo 27.89 102.52 14.98 29.35 101.92 13.57 39.43 26.57 46.78 39.37 27.83 45.03 coo 25.84 105.87 9.06 27.86 105.55 8.74 45.17 20.35 44.20 46.68 21.21 45.40 coo 33.16 106.80 7.72 33.34 104.87 6.92 46.50 28.23 39.77 47.49 30.10 39.82 2amg_c01 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 1 hits 2amg_c01 naa= 4 ULMN 4 2hgs_c00 GLUTATHIONE SYNTHETASE user 1 4 # 1 A 125 ARG B 37 ARG^? 19.17 MG MG B 302 A 151 SER B 49 SER^? 17.51 MG MG B 302 A 369 GLY B 34 GLY^? 18.20 MG MG B 302 A 450 ARG B 48 ARG^? 25.20 MG MG B 302 coo 48.89 -0.02 20.42 48.11 2.83 21.18 47.41 10.20 11.40 46.99 12.91 10.22 coo 43.71 3.15 18.25 42.31 5.11 18.82 51.67 15.70 10.57 49.37 16.19 11.15 coo 46.80 10.26 23.98 47.38 10.43 24.45 56.73 9.38 8.85 56.97 9.44 9.63 coo 51.72 4.74 17.91 51.63 5.04 21.04 52.22 10.51 15.00 52.46 7.79 16.39 ULMN 4 2hgs_c00 GLUTATHIONE SYNTHETASE user 2 4 # 2 A 125 ARG C 37 ARG^? 19.01 MG MG C 302 A 151 SER C 49 SER^? 17.53 MG MG C 302 A 369 GLY C 34 GLY^? 18.00 MG MG C 302 A 450 ARG C 48 ARG^? 25.02 MG MG C 302 coo 48.89 -0.02 20.42 48.11 2.83 21.18 89.36 17.23 -17.57 89.29 20.20 -16.76 coo 43.71 3.15 18.25 42.31 5.11 18.82 83.83 21.24 -17.13 85.75 22.50 -18.00 coo 46.80 10.26 23.98 47.38 10.43 24.45 81.22 13.31 -15.34 80.98 13.29 -16.15 coo 51.72 4.74 17.91 51.63 5.04 21.04 84.94 16.06 -21.53 85.81 13.55 -23.08 ULMN 4 2hgs_c00 GLUTATHIONE SYNTHETASE user 3 4 # 3 A 125 ARG D 37 ARG^? 18.81 MG MG D 302 A 151 SER D 49 SER^? 17.22 MG MG D 302 A 369 GLY D 34 GLY^? 17.73 MG MG D 302 A 450 ARG D 48 ARG^? 24.87 MG MG D 302 coo 48.89 -0.02 20.42 48.11 2.83 21.18 96.81 38.21 -31.63 94.97 36.32 -33.06 coo 43.71 3.15 18.25 42.31 5.11 18.82 90.26 38.73 -32.99 91.21 36.48 -32.65 coo 46.80 10.26 23.98 47.38 10.43 24.45 93.02 46.29 -34.84 92.89 46.52 -34.02 coo 51.72 4.74 17.91 51.63 5.04 21.04 94.06 41.76 -28.37 96.24 43.38 -26.96 ULMN 4 2hgs_c00 GLUTATHIONE SYNTHETASE user 4 4 # 4 A 125 ARG F 37 ARG^? 19.14 MG MG F 301 A 151 SER F 49 SER^? 17.41 MG MG F 301 A 369 GLY F 34 GLY^? 17.95 MG MG F 301 A 450 ARG F 48 ARG^? 25.18 MG MG F 301 coo 48.89 -0.02 20.42 48.11 2.83 21.18 48.80 64.46 -76.37 51.50 64.15 -77.79 coo 43.71 3.15 18.25 42.31 5.11 18.82 51.43 58.69 -77.53 52.81 60.66 -77.24 coo 46.80 10.26 23.98 47.38 10.43 24.45 43.60 57.46 -79.20 43.37 57.32 -78.41 coo 51.72 4.74 17.91 51.63 5.04 21.04 46.82 60.90 -73.07 44.43 61.88 -71.46 2hgs_c00 source 2hgs GLUTATHIONE SYNTHETASE : 4 hits 2hgs_c00 naa= 4 ULMN 4 2pda_c02 PYRUVATE-FERREDOXIN OXIDOREDUCTASE user 1 4 # 1 A 31 THR A 46 THR^? 24.24 MG MG A 301 A 64 GLU A 154 GLU^? 19.22 MG MG A 301 A 114 ARG A 48 ARG^? 25.29 MG MG A 301 A 996 ASN A 69 ASN^? 19.68 MG MG A 301 coo -31.93 -70.88 26.26 -31.36 -72.64 25.07 38.63 28.11 18.80 36.62 27.50 19.27 coo -28.83 -60.40 27.93 -28.59 -62.02 26.61 36.54 21.95 29.78 35.14 22.21 28.17 coo -28.60 -70.98 30.66 -27.00 -70.27 28.18 33.88 31.17 22.03 31.48 31.85 20.30 coo -27.31 -71.61 17.96 -26.98 -72.71 19.76 46.77 28.40 23.46 47.19 29.97 22.08 ULMN 4 2pda_c02 PYRUVATE-FERREDOXIN OXIDOREDUCTASE user 2 4 # 2 A 31 THR A 46 THR^? 24.24 MG MG A 301 A 64 GLU B 63 GLU^? 27.83 MG MG A 301 A 114 ARG A 48 ARG^? 25.29 MG MG A 301 A 996 ASN A 69 ASN^? 19.68 MG MG A 301 coo -31.93 -70.88 26.26 -31.36 -72.64 25.07 38.63 28.11 18.80 36.62 27.50 19.27 coo -28.83 -60.40 27.93 -28.59 -62.02 26.61 36.89 38.35 16.01 38.64 39.45 15.67 coo -28.60 -70.98 30.66 -27.00 -70.27 28.18 33.88 31.17 22.03 31.48 31.85 20.30 coo -27.31 -71.61 17.96 -26.98 -72.71 19.76 46.77 28.40 23.46 47.19 29.97 22.08 ULMN 4 2pda_c02 PYRUVATE-FERREDOXIN OXIDOREDUCTASE user 3 4 # 3 A 31 THR B 46 THR^? 23.88 MG MG B 302 A 64 GLU A 63 GLU^? 28.10 MG MG B 302 A 114 ARG B 48 ARG^? 25.20 MG MG B 302 A 996 ASN B 69 ASN^? 19.69 MG MG B 302 coo -31.93 -70.88 26.26 -31.36 -72.64 25.07 49.71 15.16 18.13 48.80 13.51 17.14 coo -28.83 -60.40 27.93 -28.59 -62.02 26.61 59.13 11.55 21.47 60.51 12.96 22.22 coo -28.60 -70.98 30.66 -27.00 -70.27 28.18 52.22 10.51 15.00 52.46 7.79 16.39 coo -27.31 -71.61 17.96 -26.98 -72.71 19.76 51.67 23.38 14.25 53.20 23.05 15.64 ULMN 4 2pda_c02 PYRUVATE-FERREDOXIN OXIDOREDUCTASE user 4 4 # 4 A 31 THR B 46 THR^? 23.88 MG MG B 302 A 64 GLU B 154 GLU^? 19.05 MG MG B 302 A 114 ARG B 48 ARG^? 25.20 MG MG B 302 A 996 ASN B 69 ASN^? 19.69 MG MG B 302 coo -31.93 -70.88 26.26 -31.36 -72.64 25.07 49.71 15.16 18.13 48.80 13.51 17.14 coo -28.83 -60.40 27.93 -28.59 -62.02 26.61 44.04 15.11 6.74 44.19 13.59 8.30 coo -28.60 -70.98 30.66 -27.00 -70.27 28.18 52.22 10.51 15.00 52.46 7.79 16.39 coo -27.31 -71.61 17.96 -26.98 -72.71 19.76 51.67 23.38 14.25 53.20 23.05 15.64 ULMN 4 2pda_c02 PYRUVATE-FERREDOXIN OXIDOREDUCTASE user 5 4 # 5 A 31 THR C 46 THR^? 24.02 MG MG C 302 A 64 GLU C 154 GLU^? 18.91 MG MG C 302 A 114 ARG C 48 ARG^? 25.02 MG MG C 302 A 996 ASN C 69 ASN^? 19.30 MG MG C 302 coo -31.93 -70.88 26.26 -31.36 -72.64 25.07 85.56 21.34 -24.69 87.12 20.00 -24.12 coo -28.83 -60.40 27.93 -28.59 -62.02 26.61 91.15 23.27 -13.33 91.61 21.91 -14.95 coo -28.60 -70.98 30.66 -27.00 -70.27 28.18 84.94 16.06 -21.53 85.81 13.55 -23.08 coo -27.31 -71.61 17.96 -26.98 -72.71 19.76 80.86 28.32 -20.51 79.46 27.66 -21.93 ULMN 4 2pda_c02 PYRUVATE-FERREDOXIN OXIDOREDUCTASE user 6 4 # 6 A 31 THR C 46 THR^? 24.02 MG MG C 302 A 64 GLU D 63 GLU^? 27.62 MG MG C 302 A 114 ARG C 48 ARG^? 25.02 MG MG C 302 A 996 ASN C 69 ASN^? 19.30 MG MG C 302 coo -31.93 -70.88 26.26 -31.36 -72.64 25.07 85.56 21.34 -24.69 87.12 20.00 -24.12 coo -28.83 -60.40 27.93 -28.59 -62.02 26.61 77.46 14.75 -28.07 75.93 16.12 -28.66 coo -28.60 -70.98 30.66 -27.00 -70.27 28.18 84.94 16.06 -21.53 85.81 13.55 -23.08 coo -27.31 -71.61 17.96 -26.98 -72.71 19.76 80.86 28.32 -20.51 79.46 27.66 -21.93 ULMN 4 2pda_c02 PYRUVATE-FERREDOXIN OXIDOREDUCTASE user 7 4 # 7 A 31 THR D 46 THR^? 23.86 MG MG D 302 A 64 GLU C 63 GLU^? 27.26 MG MG D 302 A 114 ARG D 48 ARG^? 24.87 MG MG D 302 A 996 ASN D 69 ASN^? 19.77 MG MG D 302 coo -31.93 -70.88 26.26 -31.36 -72.64 25.07 91.28 37.63 -25.27 93.05 36.72 -26.12 coo -28.83 -60.40 27.93 -28.59 -62.02 26.61 89.51 47.54 -22.35 87.55 48.20 -22.72 coo -28.60 -70.98 30.66 -27.00 -70.27 28.18 94.06 41.76 -28.37 96.24 43.38 -26.96 coo -27.31 -71.61 17.96 -26.98 -72.71 19.76 83.26 34.94 -29.76 82.66 36.44 -28.44 ULMN 4 2pda_c02 PYRUVATE-FERREDOXIN OXIDOREDUCTASE user 8 4 # 8 A 31 THR D 46 THR^? 23.86 MG MG D 302 A 64 GLU D 154 GLU^? 18.75 MG MG D 302 A 114 ARG D 48 ARG^? 24.87 MG MG D 302 A 996 ASN D 69 ASN^? 19.77 MG MG D 302 coo -31.93 -70.88 26.26 -31.36 -72.64 25.07 91.28 37.63 -25.27 93.05 36.72 -26.12 coo -28.83 -60.40 27.93 -28.59 -62.02 26.61 94.87 32.52 -36.42 96.07 33.39 -34.88 coo -28.60 -70.98 30.66 -27.00 -70.27 28.18 94.06 41.76 -28.37 96.24 43.38 -26.96 coo -27.31 -71.61 17.96 -26.98 -72.71 19.76 83.26 34.94 -29.76 82.66 36.44 -28.44 ULMN 4 2pda_c02 PYRUVATE-FERREDOXIN OXIDOREDUCTASE user 9 4 # 9 A 31 THR E 46 THR^? 24.08 MG MG E 302 A 64 GLU E 154 GLU^? 19.05 MG MG E 302 A 114 ARG E 48 ARG^? 25.02 MG MG E 302 A 996 ASN E 69 ASN^? 19.64 MG MG E 302 coo -31.93 -70.88 26.26 -31.36 -72.64 25.07 68.80 63.64 -69.48 69.18 65.66 -68.86 coo -28.83 -60.40 27.93 -28.59 -62.02 26.61 64.41 68.21 -58.47 65.40 69.20 -60.08 coo -28.60 -70.98 30.66 -27.00 -70.27 28.18 73.60 65.75 -66.57 75.51 67.67 -67.91 coo -27.31 -71.61 17.96 -26.98 -72.71 19.76 65.28 56.38 -64.89 66.38 55.27 -66.29 ULMN 4 2pda_c02 PYRUVATE-FERREDOXIN OXIDOREDUCTASE user 10 4 # 10 A 31 THR E 46 THR^? 24.08 MG MG E 302 A 64 GLU F 63 GLU^? 27.81 MG MG E 302 A 114 ARG E 48 ARG^? 25.02 MG MG E 302 A 996 ASN E 69 ASN^? 19.64 MG MG E 302 coo -31.93 -70.88 26.26 -31.36 -72.64 25.07 68.80 63.64 -69.48 69.18 65.66 -68.86 coo -28.83 -60.40 27.93 -28.59 -62.02 26.61 78.38 60.07 -72.34 78.48 58.04 -72.84 coo -28.60 -70.98 30.66 -27.00 -70.27 28.18 73.60 65.75 -66.57 75.51 67.67 -67.91 coo -27.31 -71.61 17.96 -26.98 -72.71 19.76 65.28 56.38 -64.89 66.38 55.27 -66.29 ULMN 4 2pda_c02 PYRUVATE-FERREDOXIN OXIDOREDUCTASE user 11 4 # 11 A 31 THR F 46 THR^? 24.16 MG MG F 301 A 64 GLU E 63 GLU^? 28.08 MG MG F 301 A 114 ARG F 48 ARG^? 25.18 MG MG F 301 A 996 ASN F 69 ASN^? 19.72 MG MG F 301 coo -31.93 -70.88 26.26 -31.36 -72.64 25.07 51.99 60.48 -70.07 50.88 62.21 -70.66 coo -28.83 -60.40 27.93 -28.59 -62.02 26.61 44.04 53.99 -66.79 43.77 51.93 -66.35 coo -28.60 -70.98 30.66 -27.00 -70.27 28.18 46.82 60.90 -73.07 44.43 61.88 -71.46 coo -27.31 -71.61 17.96 -26.98 -72.71 19.76 58.04 54.70 -74.12 56.99 53.50 -72.70 ULMN 4 2pda_c02 PYRUVATE-FERREDOXIN OXIDOREDUCTASE user 12 4 # 12 A 31 THR F 46 THR^? 24.16 MG MG F 301 A 64 GLU F 154 GLU^? 18.97 MG MG F 301 A 114 ARG F 48 ARG^? 25.18 MG MG F 301 A 996 ASN F 69 ASN^? 19.72 MG MG F 301 coo -31.93 -70.88 26.26 -31.36 -72.64 25.07 51.99 60.48 -70.07 50.88 62.21 -70.66 coo -28.83 -60.40 27.93 -28.59 -62.02 26.61 54.57 65.67 -81.55 53.36 66.51 -80.09 coo -28.60 -70.98 30.66 -27.00 -70.27 28.18 46.82 60.90 -73.07 44.43 61.88 -71.46 coo -27.31 -71.61 17.96 -26.98 -72.71 19.76 58.04 54.70 -74.12 56.99 53.50 -72.70 2pda_c02 source 2pda PYRUVATE-FERREDOXIN OXIDOREDUCTASE : 12 hits 2pda_c02 naa= 4 ULMN 4 2pda_c03 PYRUVATE-FERREDOXIN OXIDOREDUCTASE user 1 4 # 1 B 31 THR A 46 THR^? 24.24 MG MG A 301 B 64 GLU A 154 GLU^? 19.22 MG MG A 301 B 114 ARG A 48 ARG^? 25.29 MG MG A 301 B 996 ASN A 69 ASN^? 19.68 MG MG A 301 coo -13.02 -42.92 38.04 -13.54 -40.80 38.29 38.63 28.11 18.80 36.62 27.50 19.27 coo -15.92 -51.72 32.00 -16.09 -49.62 32.08 36.54 21.95 29.78 35.14 22.21 28.17 coo -16.73 -45.67 41.07 -18.08 -44.48 38.62 33.88 31.17 22.03 31.48 31.85 20.30 coo -16.90 -36.67 32.00 -17.42 -37.04 34.03 46.77 28.40 23.46 47.19 29.97 22.08 ULMN 4 2pda_c03 PYRUVATE-FERREDOXIN OXIDOREDUCTASE user 2 4 # 2 B 31 THR A 46 THR^? 24.24 MG MG A 301 B 64 GLU B 63 GLU^? 27.83 MG MG A 301 B 114 ARG A 48 ARG^? 25.29 MG MG A 301 B 996 ASN A 69 ASN^? 19.68 MG MG A 301 coo -13.02 -42.92 38.04 -13.54 -40.80 38.29 38.63 28.11 18.80 36.62 27.50 19.27 coo -15.92 -51.72 32.00 -16.09 -49.62 32.08 36.89 38.35 16.01 38.64 39.45 15.67 coo -16.73 -45.67 41.07 -18.08 -44.48 38.62 33.88 31.17 22.03 31.48 31.85 20.30 coo -16.90 -36.67 32.00 -17.42 -37.04 34.03 46.77 28.40 23.46 47.19 29.97 22.08 ULMN 4 2pda_c03 PYRUVATE-FERREDOXIN OXIDOREDUCTASE user 3 4 # 3 B 31 THR B 46 THR^? 23.88 MG MG B 302 B 64 GLU A 63 GLU^? 28.10 MG MG B 302 B 114 ARG B 48 ARG^? 25.20 MG MG B 302 B 996 ASN B 69 ASN^? 19.69 MG MG B 302 coo -13.02 -42.92 38.04 -13.54 -40.80 38.29 49.71 15.16 18.13 48.80 13.51 17.14 coo -15.92 -51.72 32.00 -16.09 -49.62 32.08 59.13 11.55 21.47 60.51 12.96 22.22 coo -16.73 -45.67 41.07 -18.08 -44.48 38.62 52.22 10.51 15.00 52.46 7.79 16.39 coo -16.90 -36.67 32.00 -17.42 -37.04 34.03 51.67 23.38 14.25 53.20 23.05 15.64 ULMN 4 2pda_c03 PYRUVATE-FERREDOXIN OXIDOREDUCTASE user 4 4 # 4 B 31 THR B 46 THR^? 23.88 MG MG B 302 B 64 GLU B 154 GLU^? 19.05 MG MG B 302 B 114 ARG B 48 ARG^? 25.20 MG MG B 302 B 996 ASN B 69 ASN^? 19.69 MG MG B 302 coo -13.02 -42.92 38.04 -13.54 -40.80 38.29 49.71 15.16 18.13 48.80 13.51 17.14 coo -15.92 -51.72 32.00 -16.09 -49.62 32.08 44.04 15.11 6.74 44.19 13.59 8.30 coo -16.73 -45.67 41.07 -18.08 -44.48 38.62 52.22 10.51 15.00 52.46 7.79 16.39 coo -16.90 -36.67 32.00 -17.42 -37.04 34.03 51.67 23.38 14.25 53.20 23.05 15.64 ULMN 4 2pda_c03 PYRUVATE-FERREDOXIN OXIDOREDUCTASE user 5 4 # 5 B 31 THR C 46 THR^? 24.02 MG MG C 302 B 64 GLU C 154 GLU^? 18.91 MG MG C 302 B 114 ARG C 48 ARG^? 25.02 MG MG C 302 B 996 ASN C 69 ASN^? 19.30 MG MG C 302 coo -13.02 -42.92 38.04 -13.54 -40.80 38.29 85.56 21.34 -24.69 87.12 20.00 -24.12 coo -15.92 -51.72 32.00 -16.09 -49.62 32.08 91.15 23.27 -13.33 91.61 21.91 -14.95 coo -16.73 -45.67 41.07 -18.08 -44.48 38.62 84.94 16.06 -21.53 85.81 13.55 -23.08 coo -16.90 -36.67 32.00 -17.42 -37.04 34.03 80.86 28.32 -20.51 79.46 27.66 -21.93 ULMN 4 2pda_c03 PYRUVATE-FERREDOXIN OXIDOREDUCTASE user 6 4 # 6 B 31 THR C 46 THR^? 24.02 MG MG C 302 B 64 GLU D 63 GLU^? 27.62 MG MG C 302 B 114 ARG C 48 ARG^? 25.02 MG MG C 302 B 996 ASN C 69 ASN^? 19.30 MG MG C 302 coo -13.02 -42.92 38.04 -13.54 -40.80 38.29 85.56 21.34 -24.69 87.12 20.00 -24.12 coo -15.92 -51.72 32.00 -16.09 -49.62 32.08 77.46 14.75 -28.07 75.93 16.12 -28.66 coo -16.73 -45.67 41.07 -18.08 -44.48 38.62 84.94 16.06 -21.53 85.81 13.55 -23.08 coo -16.90 -36.67 32.00 -17.42 -37.04 34.03 80.86 28.32 -20.51 79.46 27.66 -21.93 ULMN 4 2pda_c03 PYRUVATE-FERREDOXIN OXIDOREDUCTASE user 7 4 # 7 B 31 THR D 46 THR^? 23.86 MG MG D 302 B 64 GLU C 63 GLU^? 27.26 MG MG D 302 B 114 ARG D 48 ARG^? 24.87 MG MG D 302 B 996 ASN D 69 ASN^? 19.77 MG MG D 302 coo -13.02 -42.92 38.04 -13.54 -40.80 38.29 91.28 37.63 -25.27 93.05 36.72 -26.12 coo -15.92 -51.72 32.00 -16.09 -49.62 32.08 89.51 47.54 -22.35 87.55 48.20 -22.72 coo -16.73 -45.67 41.07 -18.08 -44.48 38.62 94.06 41.76 -28.37 96.24 43.38 -26.96 coo -16.90 -36.67 32.00 -17.42 -37.04 34.03 83.26 34.94 -29.76 82.66 36.44 -28.44 ULMN 4 2pda_c03 PYRUVATE-FERREDOXIN OXIDOREDUCTASE user 8 4 # 8 B 31 THR D 46 THR^? 23.86 MG MG D 302 B 64 GLU D 154 GLU^? 18.75 MG MG D 302 B 114 ARG D 48 ARG^? 24.87 MG MG D 302 B 996 ASN D 69 ASN^? 19.77 MG MG D 302 coo -13.02 -42.92 38.04 -13.54 -40.80 38.29 91.28 37.63 -25.27 93.05 36.72 -26.12 coo -15.92 -51.72 32.00 -16.09 -49.62 32.08 94.87 32.52 -36.42 96.07 33.39 -34.88 coo -16.73 -45.67 41.07 -18.08 -44.48 38.62 94.06 41.76 -28.37 96.24 43.38 -26.96 coo -16.90 -36.67 32.00 -17.42 -37.04 34.03 83.26 34.94 -29.76 82.66 36.44 -28.44 ULMN 4 2pda_c03 PYRUVATE-FERREDOXIN OXIDOREDUCTASE user 9 4 # 9 B 31 THR E 46 THR^? 24.08 MG MG E 302 B 64 GLU E 154 GLU^? 19.05 MG MG E 302 B 114 ARG E 48 ARG^? 25.02 MG MG E 302 B 996 ASN E 69 ASN^? 19.64 MG MG E 302 coo -13.02 -42.92 38.04 -13.54 -40.80 38.29 68.80 63.64 -69.48 69.18 65.66 -68.86 coo -15.92 -51.72 32.00 -16.09 -49.62 32.08 64.41 68.21 -58.47 65.40 69.20 -60.08 coo -16.73 -45.67 41.07 -18.08 -44.48 38.62 73.60 65.75 -66.57 75.51 67.67 -67.91 coo -16.90 -36.67 32.00 -17.42 -37.04 34.03 65.28 56.38 -64.89 66.38 55.27 -66.29 ULMN 4 2pda_c03 PYRUVATE-FERREDOXIN OXIDOREDUCTASE user 10 4 # 10 B 31 THR E 46 THR^? 24.08 MG MG E 302 B 64 GLU F 63 GLU^? 27.81 MG MG E 302 B 114 ARG E 48 ARG^? 25.02 MG MG E 302 B 996 ASN E 69 ASN^? 19.64 MG MG E 302 coo -13.02 -42.92 38.04 -13.54 -40.80 38.29 68.80 63.64 -69.48 69.18 65.66 -68.86 coo -15.92 -51.72 32.00 -16.09 -49.62 32.08 78.38 60.07 -72.34 78.48 58.04 -72.84 coo -16.73 -45.67 41.07 -18.08 -44.48 38.62 73.60 65.75 -66.57 75.51 67.67 -67.91 coo -16.90 -36.67 32.00 -17.42 -37.04 34.03 65.28 56.38 -64.89 66.38 55.27 -66.29 ULMN 4 2pda_c03 PYRUVATE-FERREDOXIN OXIDOREDUCTASE user 11 4 # 11 B 31 THR F 46 THR^? 24.16 MG MG F 301 B 64 GLU E 63 GLU^? 28.08 MG MG F 301 B 114 ARG F 48 ARG^? 25.18 MG MG F 301 B 996 ASN F 69 ASN^? 19.72 MG MG F 301 coo -13.02 -42.92 38.04 -13.54 -40.80 38.29 51.99 60.48 -70.07 50.88 62.21 -70.66 coo -15.92 -51.72 32.00 -16.09 -49.62 32.08 44.04 53.99 -66.79 43.77 51.93 -66.35 coo -16.73 -45.67 41.07 -18.08 -44.48 38.62 46.82 60.90 -73.07 44.43 61.88 -71.46 coo -16.90 -36.67 32.00 -17.42 -37.04 34.03 58.04 54.70 -74.12 56.99 53.50 -72.70 ULMN 4 2pda_c03 PYRUVATE-FERREDOXIN OXIDOREDUCTASE user 12 4 # 12 B 31 THR F 46 THR^? 24.16 MG MG F 301 B 64 GLU F 154 GLU^? 18.97 MG MG F 301 B 114 ARG F 48 ARG^? 25.18 MG MG F 301 B 996 ASN F 69 ASN^? 19.72 MG MG F 301 coo -13.02 -42.92 38.04 -13.54 -40.80 38.29 51.99 60.48 -70.07 50.88 62.21 -70.66 coo -15.92 -51.72 32.00 -16.09 -49.62 32.08 54.57 65.67 -81.55 53.36 66.51 -80.09 coo -16.73 -45.67 41.07 -18.08 -44.48 38.62 46.82 60.90 -73.07 44.43 61.88 -71.46 coo -16.90 -36.67 32.00 -17.42 -37.04 34.03 58.04 54.70 -74.12 56.99 53.50 -72.70 2pda_c03 source 2pda PYRUVATE-FERREDOXIN OXIDOREDUCTASE : 12 hits 2pda_c03 naa= 4 ULMN 4 2tpl_c02 TYROSINE PHENOL-LYASE user 1 4 # 1 A 71 TYR B 188 TYR^? 8.84 MG MG B 301 A 123 PHE B 59 PHE^? 31.31 MG MG B 302 A 214 ASP B 138 ASP^? 33.32 MG MG B 302 A 381 ARG A 48 ARG^? 25.29 MG MG A 301 coo -18.26 14.59 1.38 -20.32 13.94 3.12 46.41 16.35 -7.52 47.38 13.88 -8.38 coo -30.08 -12.81 5.71 -28.04 -12.05 7.46 29.63 33.55 11.36 30.42 32.81 8.75 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 23.42 29.01 6.78 24.36 28.48 4.94 coo -28.50 -18.89 13.52 -29.04 -16.11 14.56 33.88 31.17 22.03 31.48 31.85 20.30 ULMN 4 2tpl_c02 TYROSINE PHENOL-LYASE user 2 4 # 2 A 71 TYR D 188 TYR^? 8.87 MG MG D 301 A 123 PHE D 59 PHE^? 31.49 MG MG D 302 A 214 ASP D 138 ASP^? 33.64 MG MG D 302 A 381 ARG C 48 ARG^? 25.02 MG MG C 302 coo -18.26 14.59 1.38 -20.32 13.94 3.12 93.72 33.91 -50.86 95.36 36.03 -51.61 coo -30.08 -12.81 5.71 -28.04 -12.05 7.46 86.17 10.70 -31.86 86.41 11.56 -34.53 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 93.00 7.50 -35.79 93.88 8.48 -37.45 coo -28.50 -18.89 13.52 -29.04 -16.11 14.56 84.94 16.06 -21.53 85.81 13.55 -23.08 2tpl_c02 source 2tpl TYROSINE PHENOL-LYASE : 2 hits 2tpl_c02 naa= 4 ULMN 4 2tpl_c03 TYROSINE PHENOL-LYASE user 1 4 # 1 B 71 TYR D 188 TYR^? 8.87 MG MG D 301 B 123 PHE D 59 PHE^? 31.49 MG MG D 302 B 214 ASP D 138 ASP^? 33.64 MG MG D 302 B 381 ARG C 48 ARG^? 25.02 MG MG C 302 coo -20.85 -10.53 13.88 -22.65 -9.60 11.98 93.72 33.91 -50.86 95.36 36.03 -51.61 coo -26.81 18.98 9.83 -25.06 17.93 7.94 86.17 10.70 -31.86 86.41 11.56 -34.53 coo -26.88 17.61 16.89 -26.08 17.11 15.00 93.00 7.50 -35.79 93.88 8.48 -37.45 coo -23.89 24.28 2.03 -24.86 21.74 0.63 84.94 16.06 -21.53 85.81 13.55 -23.08 2tpl_c03 source 2tpl TYROSINE PHENOL-LYASE : 1 hits 2tpl_c03 naa= 4 ULMN 4 3csm_c00 CHORISMATE MUTASE user 1 4 # 1 A 16 ARG E 37 ARG^? 19.17 MG MG E 302 A 157 ARG E 50 ARG^? 15.97 MG MG E 302 A 168 LYS F 61 LYS^? 21.75 MG MG E 302 A 246 GLU E 33 GLU^? 22.81 MG MG E 302 coo 37.85 22.13 39.07 35.08 21.72 40.26 70.82 68.02 -63.63 68.17 67.46 -62.14 coo 42.53 17.43 30.59 39.80 18.74 31.20 73.62 60.83 -58.23 74.10 60.41 -61.24 coo 36.10 13.35 45.30 34.36 14.97 39.48 80.24 64.12 -71.01 76.23 61.95 -66.39 coo 36.95 11.32 36.89 36.00 13.20 36.97 80.16 62.57 -63.35 80.54 62.13 -65.43 3csm_c00 source 3csm CHORISMATE MUTASE : 1 hits 3csm_c00 naa= 4 ULMN 4 3csm_c01 CHORISMATE MUTASE user 1 4 # 1 B 16 ARG E 37 ARG^? 19.17 MG MG E 302 B 157 ARG E 50 ARG^? 15.97 MG MG E 302 B 168 LYS F 61 LYS^? 21.75 MG MG E 302 B 246 GLU E 33 GLU^? 22.81 MG MG E 302 coo 36.39 28.16 -15.11 39.30 27.67 -15.87 70.82 68.02 -63.63 68.17 67.46 -62.14 coo 30.58 24.11 -7.00 33.37 25.38 -7.33 73.62 60.83 -58.23 74.10 60.41 -61.24 coo 38.96 18.92 -20.31 39.88 21.02 -14.46 80.24 64.12 -71.01 76.23 61.95 -66.39 coo 36.95 17.56 -11.96 37.91 19.44 -12.06 80.16 62.57 -63.35 80.54 62.13 -65.43 3csm_c01 source 3csm CHORISMATE MUTASE : 1 hits 3csm_c01 naa= 4 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 1 3 # 1 A 140 TYR E 123 TYR^? 10.90 MG MG D 302 B 190 LYS D 21 LYS^? 14.47 MG MG D 302 B 222 ASP D 23 ASP^? 15.37 MG MG E 301 coo 7.17 16.59 41.26 8.01 19.20 40.73 82.15 50.70 -47.72 84.01 48.63 -47.87 coo 13.38 20.00 35.06 11.43 22.49 39.53 90.57 56.85 -44.52 87.39 52.68 -46.00 coo 9.76 26.58 38.10 11.63 25.78 38.76 85.70 62.10 -45.60 84.07 62.13 -46.93 1a05_c00 source 1a05 3-ISOPROPYLMALATE DEHYDROGENASE : 1 hits 1a05_c00 naa= 3 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 1 3 # 1 A 190 LYS D 21 LYS^? 14.47 MG MG D 302 A 222 ASP D 23 ASP^? 15.37 MG MG E 301 B 140 TYR E 123 TYR^? 10.90 MG MG D 302 coo -4.61 20.12 30.34 -2.74 22.65 25.95 90.57 56.85 -44.52 87.39 52.68 -46.00 coo -1.04 26.60 27.37 -2.94 25.93 26.69 85.70 62.10 -45.60 84.07 62.13 -46.93 coo 1.51 16.60 24.17 0.82 19.23 24.79 82.15 50.70 -47.72 84.01 48.63 -47.87 1a05_c01 source 1a05 3-ISOPROPYLMALATE DEHYDROGENASE : 1 hits 1a05_c01 naa= 3 ULMN 3 1a0j_c00 TRYPSIN user 1 3 # 1 A 57 HIS A 147 HIS^? 9.20 MG MG A 302 A 102 ASP A 148 ASP^? 2.72 MG MG A 301s A 195 SER A 189 SER^? 11.75 MG MG A 302 coo 25.57 41.22 61.68 24.18 39.98 62.50 40.24 23.10 39.83 38.32 22.34 40.22 coo 22.33 45.48 59.73 23.35 43.67 60.06 41.50 28.88 41.13 43.33 29.67 41.93 coo 20.90 36.72 61.65 22.18 37.53 63.52 40.99 19.00 44.32 41.51 18.14 46.48 ULMN 3 1a0j_c00 TRYPSIN user 2 3 # 2 A 57 HIS B 147 HIS^? 9.27 MG MG B 301 A 102 ASP B 148 ASP^? 2.58 MG MG B 302s A 195 SER B 189 SER^? 12.11 MG MG B 301 coo 25.57 41.22 61.68 24.18 39.98 62.50 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 22.33 45.48 59.73 23.35 43.67 60.06 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 20.90 36.72 61.65 22.18 37.53 63.52 43.10 20.95 -7.74 42.82 21.56 -10.02 ULMN 3 1a0j_c00 TRYPSIN user 3 3 # 3 A 57 HIS C 147 HIS^? 9.44 MG MG C 301 A 102 ASP C 148 ASP^? 2.75 MG MG C 302s A 195 SER C 189 SER^? 12.09 MG MG C 301 coo 25.57 41.22 61.68 24.18 39.98 62.50 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 22.33 45.48 59.73 23.35 43.67 60.06 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 20.90 36.72 61.65 22.18 37.53 63.52 90.33 28.79 1.19 90.26 29.61 3.45 ULMN 3 1a0j_c00 TRYPSIN user 4 3 # 4 A 57 HIS D 147 HIS^? 9.43 MG MG D 301 A 102 ASP D 148 ASP^? 2.35 MG MG D 302s A 195 SER D 189 SER^? 12.12 MG MG D 301 coo 25.57 41.22 61.68 24.18 39.98 62.50 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 22.33 45.48 59.73 23.35 43.67 60.06 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 20.90 36.72 61.65 22.18 37.53 63.52 91.62 28.58 -50.95 91.45 27.78 -53.25 ULMN 3 1a0j_c00 TRYPSIN user 5 3 # 5 A 57 HIS D 147 HIS^? 9.43 MG MG D 301 A 102 ASP D 187 ASP^? -2.95 MG MG D 301s A 195 SER D 189 SER^? 12.12 MG MG D 301 coo 25.57 41.22 61.68 24.18 39.98 62.50 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 22.33 45.48 59.73 23.35 43.67 60.06 90.40 36.34 -52.69 89.24 37.98 -51.99 coo 20.90 36.72 61.65 22.18 37.53 63.52 91.62 28.58 -50.95 91.45 27.78 -53.25 ULMN 3 1a0j_c00 TRYPSIN user 6 3 # 6 A 57 HIS E 147 HIS^? 9.22 MG MG E 301 A 102 ASP E 148 ASP^? 2.62 MG MG E 302s A 195 SER E 189 SER^? 11.91 MG MG E 301 coo 25.57 41.22 61.68 24.18 39.98 62.50 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 22.33 45.48 59.73 23.35 43.67 60.06 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 20.90 36.72 61.65 22.18 37.53 63.52 60.13 65.61 -43.87 59.01 65.34 -41.74 ULMN 3 1a0j_c00 TRYPSIN user 7 3 # 7 A 57 HIS E 147 HIS^? 9.22 MG MG E 301 A 102 ASP E 187 ASP^? -2.71 MG MG E 301s A 195 SER E 189 SER^? 11.91 MG MG E 301 coo 25.57 41.22 61.68 24.18 39.98 62.50 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 22.33 45.48 59.73 23.35 43.67 60.06 67.50 63.43 -41.69 68.97 62.26 -42.81 coo 20.90 36.72 61.65 22.18 37.53 63.52 60.13 65.61 -43.87 59.01 65.34 -41.74 ULMN 3 1a0j_c00 TRYPSIN user 8 3 # 8 A 57 HIS F 147 HIS^? 8.79 MG MG F 302 A 102 ASP F 148 ASP^? 2.72 MG MG F 301s A 195 SER F 189 SER^? 11.88 MG MG F 302 coo 25.57 41.22 61.68 24.18 39.98 62.50 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 22.33 45.48 59.73 23.35 43.67 60.06 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 20.90 36.72 61.65 22.18 37.53 63.52 59.91 63.90 -95.91 60.70 64.22 -98.13 1a0j_c00 source 1a0j TRYPSIN : 8 hits 1a0j_c00 naa= 3 ULMN 3 1a0j_c01 TRYPSIN user 1 3 # 1 B 57 HIS A 147 HIS^? 9.20 MG MG A 302 B 102 ASP A 148 ASP^? 2.72 MG MG A 301s B 195 SER A 189 SER^? 11.75 MG MG A 302 coo 44.08 45.58 52.81 45.86 46.55 52.85 40.24 23.10 39.83 38.32 22.34 40.22 coo 43.04 44.75 47.18 43.31 45.51 49.13 41.50 28.88 41.13 43.33 29.67 41.93 coo 48.11 50.52 52.24 48.62 48.46 53.13 40.99 19.00 44.32 41.51 18.14 46.48 ULMN 3 1a0j_c01 TRYPSIN user 2 3 # 2 B 57 HIS B 147 HIS^? 9.27 MG MG B 301 B 102 ASP B 148 ASP^? 2.58 MG MG B 302s B 195 SER B 189 SER^? 12.11 MG MG B 301 coo 44.08 45.58 52.81 45.86 46.55 52.85 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 43.04 44.75 47.18 43.31 45.51 49.13 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 48.11 50.52 52.24 48.62 48.46 53.13 43.10 20.95 -7.74 42.82 21.56 -10.02 ULMN 3 1a0j_c01 TRYPSIN user 3 3 # 3 B 57 HIS B 147 HIS^? 9.27 MG MG B 301 B 102 ASP B 187 ASP^? -3.44 MG MG B 301s B 195 SER B 189 SER^? 12.11 MG MG B 301 coo 44.08 45.58 52.81 45.86 46.55 52.85 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 43.04 44.75 47.18 43.31 45.51 49.13 50.64 18.14 -9.69 51.74 17.63 -7.86 coo 48.11 50.52 52.24 48.62 48.46 53.13 43.10 20.95 -7.74 42.82 21.56 -10.02 ULMN 3 1a0j_c01 TRYPSIN user 4 3 # 4 B 57 HIS C 147 HIS^? 9.44 MG MG C 301 B 102 ASP C 148 ASP^? 2.75 MG MG C 302s B 195 SER C 189 SER^? 12.09 MG MG C 301 coo 44.08 45.58 52.81 45.86 46.55 52.85 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 43.04 44.75 47.18 43.31 45.51 49.13 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 48.11 50.52 52.24 48.62 48.46 53.13 90.33 28.79 1.19 90.26 29.61 3.45 ULMN 3 1a0j_c01 TRYPSIN user 5 3 # 5 B 57 HIS D 147 HIS^? 9.43 MG MG D 301 B 102 ASP D 148 ASP^? 2.35 MG MG D 302s B 195 SER D 189 SER^? 12.12 MG MG D 301 coo 44.08 45.58 52.81 45.86 46.55 52.85 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 43.04 44.75 47.18 43.31 45.51 49.13 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 48.11 50.52 52.24 48.62 48.46 53.13 91.62 28.58 -50.95 91.45 27.78 -53.25 ULMN 3 1a0j_c01 TRYPSIN user 6 3 # 6 B 57 HIS D 147 HIS^? 9.43 MG MG D 301 B 102 ASP D 187 ASP^? -2.95 MG MG D 301s B 195 SER D 189 SER^? 12.12 MG MG D 301 coo 44.08 45.58 52.81 45.86 46.55 52.85 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 43.04 44.75 47.18 43.31 45.51 49.13 90.40 36.34 -52.69 89.24 37.98 -51.99 coo 48.11 50.52 52.24 48.62 48.46 53.13 91.62 28.58 -50.95 91.45 27.78 -53.25 ULMN 3 1a0j_c01 TRYPSIN user 7 3 # 7 B 57 HIS E 147 HIS^? 9.22 MG MG E 301 B 102 ASP E 148 ASP^? 2.62 MG MG E 302s B 195 SER E 189 SER^? 11.91 MG MG E 301 coo 44.08 45.58 52.81 45.86 46.55 52.85 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 43.04 44.75 47.18 43.31 45.51 49.13 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 48.11 50.52 52.24 48.62 48.46 53.13 60.13 65.61 -43.87 59.01 65.34 -41.74 ULMN 3 1a0j_c01 TRYPSIN user 8 3 # 8 B 57 HIS E 147 HIS^? 9.22 MG MG E 301 B 102 ASP E 187 ASP^? -2.71 MG MG E 301s B 195 SER E 189 SER^? 11.91 MG MG E 301 coo 44.08 45.58 52.81 45.86 46.55 52.85 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 43.04 44.75 47.18 43.31 45.51 49.13 67.50 63.43 -41.69 68.97 62.26 -42.81 coo 48.11 50.52 52.24 48.62 48.46 53.13 60.13 65.61 -43.87 59.01 65.34 -41.74 ULMN 3 1a0j_c01 TRYPSIN user 9 3 # 9 B 57 HIS F 147 HIS^? 8.79 MG MG F 302 B 102 ASP F 148 ASP^? 2.72 MG MG F 301s B 195 SER F 189 SER^? 11.88 MG MG F 302 coo 44.08 45.58 52.81 45.86 46.55 52.85 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 43.04 44.75 47.18 43.31 45.51 49.13 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 48.11 50.52 52.24 48.62 48.46 53.13 59.91 63.90 -95.91 60.70 64.22 -98.13 1a0j_c01 source 1a0j TRYPSIN : 9 hits 1a0j_c01 naa= 3 ULMN 3 1a0j_c02 TRYPSIN user 1 3 # 1 C 57 HIS A 147 HIS^? 9.20 MG MG A 302 C 102 ASP A 148 ASP^? 2.72 MG MG A 301s C 195 SER A 189 SER^? 11.75 MG MG A 302 coo 34.37 41.18 73.21 34.04 43.09 73.87 40.24 23.10 39.83 38.32 22.34 40.22 coo 34.89 38.34 78.12 35.11 39.59 76.42 41.50 28.88 41.13 43.33 29.67 41.93 coo 36.16 46.87 75.66 34.01 46.43 74.59 40.99 19.00 44.32 41.51 18.14 46.48 ULMN 3 1a0j_c02 TRYPSIN user 2 3 # 2 C 57 HIS B 147 HIS^? 9.27 MG MG B 301 C 102 ASP B 148 ASP^? 2.58 MG MG B 302s C 195 SER B 189 SER^? 12.11 MG MG B 301 coo 34.37 41.18 73.21 34.04 43.09 73.87 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 34.89 38.34 78.12 35.11 39.59 76.42 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 36.16 46.87 75.66 34.01 46.43 74.59 43.10 20.95 -7.74 42.82 21.56 -10.02 ULMN 3 1a0j_c02 TRYPSIN user 3 3 # 3 C 57 HIS C 147 HIS^? 9.44 MG MG C 301 C 102 ASP C 148 ASP^? 2.75 MG MG C 302s C 195 SER C 189 SER^? 12.09 MG MG C 301 coo 34.37 41.18 73.21 34.04 43.09 73.87 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 34.89 38.34 78.12 35.11 39.59 76.42 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 36.16 46.87 75.66 34.01 46.43 74.59 90.33 28.79 1.19 90.26 29.61 3.45 ULMN 3 1a0j_c02 TRYPSIN user 4 3 # 4 C 57 HIS D 147 HIS^? 9.43 MG MG D 301 C 102 ASP D 148 ASP^? 2.35 MG MG D 302s C 195 SER D 189 SER^? 12.12 MG MG D 301 coo 34.37 41.18 73.21 34.04 43.09 73.87 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 34.89 38.34 78.12 35.11 39.59 76.42 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 36.16 46.87 75.66 34.01 46.43 74.59 91.62 28.58 -50.95 91.45 27.78 -53.25 ULMN 3 1a0j_c02 TRYPSIN user 5 3 # 5 C 57 HIS D 147 HIS^? 9.43 MG MG D 301 C 102 ASP D 187 ASP^? -2.95 MG MG D 301s C 195 SER D 189 SER^? 12.12 MG MG D 301 coo 34.37 41.18 73.21 34.04 43.09 73.87 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 34.89 38.34 78.12 35.11 39.59 76.42 90.40 36.34 -52.69 89.24 37.98 -51.99 coo 36.16 46.87 75.66 34.01 46.43 74.59 91.62 28.58 -50.95 91.45 27.78 -53.25 ULMN 3 1a0j_c02 TRYPSIN user 6 3 # 6 C 57 HIS E 147 HIS^? 9.22 MG MG E 301 C 102 ASP E 148 ASP^? 2.62 MG MG E 302s C 195 SER E 189 SER^? 11.91 MG MG E 301 coo 34.37 41.18 73.21 34.04 43.09 73.87 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 34.89 38.34 78.12 35.11 39.59 76.42 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 36.16 46.87 75.66 34.01 46.43 74.59 60.13 65.61 -43.87 59.01 65.34 -41.74 ULMN 3 1a0j_c02 TRYPSIN user 7 3 # 7 C 57 HIS E 147 HIS^? 9.22 MG MG E 301 C 102 ASP E 187 ASP^? -2.71 MG MG E 301s C 195 SER E 189 SER^? 11.91 MG MG E 301 coo 34.37 41.18 73.21 34.04 43.09 73.87 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 34.89 38.34 78.12 35.11 39.59 76.42 67.50 63.43 -41.69 68.97 62.26 -42.81 coo 36.16 46.87 75.66 34.01 46.43 74.59 60.13 65.61 -43.87 59.01 65.34 -41.74 ULMN 3 1a0j_c02 TRYPSIN user 8 3 # 8 C 57 HIS F 147 HIS^? 8.79 MG MG F 302 C 102 ASP F 148 ASP^? 2.72 MG MG F 301s C 195 SER F 189 SER^? 11.88 MG MG F 302 coo 34.37 41.18 73.21 34.04 43.09 73.87 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 34.89 38.34 78.12 35.11 39.59 76.42 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 36.16 46.87 75.66 34.01 46.43 74.59 59.91 63.90 -95.91 60.70 64.22 -98.13 1a0j_c02 source 1a0j TRYPSIN : 8 hits 1a0j_c02 naa= 3 ULMN 3 1a0j_c03 TRYPSIN user 1 3 # 1 D 57 HIS A 147 HIS^? 9.20 MG MG A 302 D 102 ASP A 148 ASP^? 2.72 MG MG A 301s D 195 SER A 189 SER^? 11.75 MG MG A 302 coo 8.19 15.01 95.72 7.78 16.53 97.01 40.24 23.10 39.83 38.32 22.34 40.22 coo 13.53 16.28 93.98 11.45 16.21 94.40 41.50 28.88 41.13 43.33 29.67 41.93 coo 6.63 21.03 97.42 6.71 19.20 98.95 40.99 19.00 44.32 41.51 18.14 46.48 ULMN 3 1a0j_c03 TRYPSIN user 2 3 # 2 D 57 HIS B 147 HIS^? 9.27 MG MG B 301 D 102 ASP B 148 ASP^? 2.58 MG MG B 302s D 195 SER B 189 SER^? 12.11 MG MG B 301 coo 8.19 15.01 95.72 7.78 16.53 97.01 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 13.53 16.28 93.98 11.45 16.21 94.40 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 6.63 21.03 97.42 6.71 19.20 98.95 43.10 20.95 -7.74 42.82 21.56 -10.02 ULMN 3 1a0j_c03 TRYPSIN user 3 3 # 3 D 57 HIS B 147 HIS^? 9.27 MG MG B 301 D 102 ASP B 187 ASP^? -3.44 MG MG B 301s D 195 SER B 189 SER^? 12.11 MG MG B 301 coo 8.19 15.01 95.72 7.78 16.53 97.01 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 13.53 16.28 93.98 11.45 16.21 94.40 50.64 18.14 -9.69 51.74 17.63 -7.86 coo 6.63 21.03 97.42 6.71 19.20 98.95 43.10 20.95 -7.74 42.82 21.56 -10.02 ULMN 3 1a0j_c03 TRYPSIN user 4 3 # 4 D 57 HIS C 147 HIS^? 9.44 MG MG C 301 D 102 ASP C 148 ASP^? 2.75 MG MG C 302s D 195 SER C 189 SER^? 12.09 MG MG C 301 coo 8.19 15.01 95.72 7.78 16.53 97.01 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 13.53 16.28 93.98 11.45 16.21 94.40 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 6.63 21.03 97.42 6.71 19.20 98.95 90.33 28.79 1.19 90.26 29.61 3.45 ULMN 3 1a0j_c03 TRYPSIN user 5 3 # 5 D 57 HIS D 147 HIS^? 9.43 MG MG D 301 D 102 ASP D 148 ASP^? 2.35 MG MG D 302s D 195 SER D 189 SER^? 12.12 MG MG D 301 coo 8.19 15.01 95.72 7.78 16.53 97.01 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 13.53 16.28 93.98 11.45 16.21 94.40 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 6.63 21.03 97.42 6.71 19.20 98.95 91.62 28.58 -50.95 91.45 27.78 -53.25 ULMN 3 1a0j_c03 TRYPSIN user 6 3 # 6 D 57 HIS D 147 HIS^? 9.43 MG MG D 301 D 102 ASP D 187 ASP^? -2.95 MG MG D 301s D 195 SER D 189 SER^? 12.12 MG MG D 301 coo 8.19 15.01 95.72 7.78 16.53 97.01 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 13.53 16.28 93.98 11.45 16.21 94.40 90.40 36.34 -52.69 89.24 37.98 -51.99 coo 6.63 21.03 97.42 6.71 19.20 98.95 91.62 28.58 -50.95 91.45 27.78 -53.25 ULMN 3 1a0j_c03 TRYPSIN user 7 3 # 7 D 57 HIS E 147 HIS^? 9.22 MG MG E 301 D 102 ASP E 148 ASP^? 2.62 MG MG E 302s D 195 SER E 189 SER^? 11.91 MG MG E 301 coo 8.19 15.01 95.72 7.78 16.53 97.01 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 13.53 16.28 93.98 11.45 16.21 94.40 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 6.63 21.03 97.42 6.71 19.20 98.95 60.13 65.61 -43.87 59.01 65.34 -41.74 ULMN 3 1a0j_c03 TRYPSIN user 8 3 # 8 D 57 HIS E 147 HIS^? 9.22 MG MG E 301 D 102 ASP E 187 ASP^? -2.71 MG MG E 301s D 195 SER E 189 SER^? 11.91 MG MG E 301 coo 8.19 15.01 95.72 7.78 16.53 97.01 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 13.53 16.28 93.98 11.45 16.21 94.40 67.50 63.43 -41.69 68.97 62.26 -42.81 coo 6.63 21.03 97.42 6.71 19.20 98.95 60.13 65.61 -43.87 59.01 65.34 -41.74 ULMN 3 1a0j_c03 TRYPSIN user 9 3 # 9 D 57 HIS F 147 HIS^? 8.79 MG MG F 302 D 102 ASP F 148 ASP^? 2.72 MG MG F 301s D 195 SER F 189 SER^? 11.88 MG MG F 302 coo 8.19 15.01 95.72 7.78 16.53 97.01 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 13.53 16.28 93.98 11.45 16.21 94.40 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 6.63 21.03 97.42 6.71 19.20 98.95 59.91 63.90 -95.91 60.70 64.22 -98.13 1a0j_c03 source 1a0j TRYPSIN : 9 hits 1a0j_c03 naa= 3 ULMN 3 1a0j_c12 TRYPSIN user 1 3 # 1 A 57 HIS C 170 HIS^? 10.68 MG MG C 301 A 102 ASP C 171 ASP^? 17.08 MG MG C 301 A 193 GLY C 145 GLY^? 13.72 MG MG C 301 coo 25.57 41.22 61.68 24.18 39.98 62.50 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 22.33 45.48 59.73 23.35 43.67 60.06 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 22.57 32.23 64.13 21.98 32.82 64.22 90.12 32.13 -3.16 90.38 32.11 -2.40 1a0j_c12 source 1a0j TRYPSIN : 1 hits 1a0j_c12 naa= 3 ULMN 3 1a0j_c13 TRYPSIN user 1 3 # 1 B 57 HIS A 170 HIS^? 10.56 MG MG A 302 B 102 ASP A 171 ASP^? 17.17 MG MG A 302 B 193 GLY A 145 GLY^? 13.39 MG MG A 302 coo 44.08 45.58 52.81 45.86 46.55 52.85 34.91 23.57 39.32 34.35 24.95 40.81 coo 43.04 44.75 47.18 43.31 45.51 49.13 29.78 23.67 36.63 28.48 25.11 35.71 coo 50.46 51.91 56.90 50.65 51.62 56.14 44.20 17.56 40.29 44.09 17.33 41.06 ULMN 3 1a0j_c13 TRYPSIN user 2 3 # 2 B 57 HIS B 170 HIS^? 10.51 MG MG B 301 B 102 ASP B 171 ASP^? 16.92 MG MG B 301 B 193 GLY B 145 GLY^? 13.71 MG MG B 301 coo 44.08 45.58 52.81 45.86 46.55 52.85 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 43.04 44.75 47.18 43.31 45.51 49.13 45.30 8.50 -0.71 46.30 6.81 0.12 coo 50.46 51.91 56.90 50.65 51.62 56.14 42.04 23.97 -3.40 41.83 23.90 -4.16 ULMN 3 1a0j_c13 TRYPSIN user 3 3 # 3 B 57 HIS C 170 HIS^? 10.68 MG MG C 301 B 102 ASP C 171 ASP^? 17.08 MG MG C 301 B 193 GLY C 145 GLY^? 13.72 MG MG C 301 coo 44.08 45.58 52.81 45.86 46.55 52.85 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 43.04 44.75 47.18 43.31 45.51 49.13 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 50.46 51.91 56.90 50.65 51.62 56.14 90.12 32.13 -3.16 90.38 32.11 -2.40 ULMN 3 1a0j_c13 TRYPSIN user 4 3 # 4 B 57 HIS D 170 HIS^? 10.59 MG MG D 301 B 102 ASP D 171 ASP^? 16.95 MG MG D 301 B 193 GLY D 145 GLY^? 13.51 MG MG D 301 coo 44.08 45.58 52.81 45.86 46.55 52.85 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 43.04 44.75 47.18 43.31 45.51 49.13 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 50.46 51.91 56.90 50.65 51.62 56.14 88.90 26.07 -46.90 89.21 25.93 -47.57 ULMN 3 1a0j_c13 TRYPSIN user 5 3 # 5 B 57 HIS E 170 HIS^? 10.33 MG MG E 301 B 102 ASP E 171 ASP^? 16.73 MG MG E 301 B 193 GLY E 145 GLY^? 13.69 MG MG E 301 coo 44.08 45.58 52.81 45.86 46.55 52.85 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 43.04 44.75 47.18 43.31 45.51 49.13 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 50.46 51.91 56.90 50.65 51.62 56.14 57.08 63.68 -47.92 56.95 63.88 -47.12 ULMN 3 1a0j_c13 TRYPSIN user 6 3 # 6 B 57 HIS F 170 HIS^? 9.84 MG MG F 302 B 102 ASP F 171 ASP^? 16.35 MG MG F 302 B 193 GLY F 145 GLY^? 13.40 MG MG F 302 coo 44.08 45.58 52.81 45.86 46.55 52.85 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 43.04 44.75 47.18 43.31 45.51 49.13 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 50.46 51.91 56.90 50.65 51.62 56.14 63.24 63.21 -91.82 63.24 63.42 -92.59 1a0j_c13 source 1a0j TRYPSIN : 6 hits 1a0j_c13 naa= 3 ULMN 3 1a0j_c14 TRYPSIN user 1 3 # 1 C 57 HIS C 170 HIS^? 10.68 MG MG C 301 C 102 ASP C 171 ASP^? 17.08 MG MG C 301 C 193 GLY C 145 GLY^? 13.72 MG MG C 301 coo 34.37 41.18 73.21 34.04 43.09 73.87 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 34.89 38.34 78.12 35.11 39.59 76.42 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 35.43 51.03 72.12 35.20 50.72 72.87 90.12 32.13 -3.16 90.38 32.11 -2.40 1a0j_c14 source 1a0j TRYPSIN : 1 hits 1a0j_c14 naa= 3 ULMN 3 1a0j_c15 TRYPSIN user 1 3 # 1 D 57 HIS A 170 HIS^? 10.56 MG MG A 302 D 102 ASP A 171 ASP^? 17.17 MG MG A 302 D 193 GLY A 145 GLY^? 13.39 MG MG A 302 coo 8.19 15.01 95.72 7.78 16.53 97.01 34.91 23.57 39.32 34.35 24.95 40.81 coo 13.53 16.28 93.98 11.45 16.21 94.40 29.78 23.67 36.63 28.48 25.11 35.71 coo 1.80 21.25 100.04 2.61 21.42 100.18 44.20 17.56 40.29 44.09 17.33 41.06 ULMN 3 1a0j_c15 TRYPSIN user 2 3 # 2 D 57 HIS B 170 HIS^? 10.51 MG MG B 301 D 102 ASP B 171 ASP^? 16.92 MG MG B 301 D 193 GLY B 145 GLY^? 13.71 MG MG B 301 coo 8.19 15.01 95.72 7.78 16.53 97.01 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 13.53 16.28 93.98 11.45 16.21 94.40 45.30 8.50 -0.71 46.30 6.81 0.12 coo 1.80 21.25 100.04 2.61 21.42 100.18 42.04 23.97 -3.40 41.83 23.90 -4.16 ULMN 3 1a0j_c15 TRYPSIN user 3 3 # 3 D 57 HIS C 170 HIS^? 10.68 MG MG C 301 D 102 ASP C 171 ASP^? 17.08 MG MG C 301 D 193 GLY C 145 GLY^? 13.72 MG MG C 301 coo 8.19 15.01 95.72 7.78 16.53 97.01 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 13.53 16.28 93.98 11.45 16.21 94.40 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 1.80 21.25 100.04 2.61 21.42 100.18 90.12 32.13 -3.16 90.38 32.11 -2.40 ULMN 3 1a0j_c15 TRYPSIN user 4 3 # 4 D 57 HIS D 170 HIS^? 10.59 MG MG D 301 D 102 ASP D 171 ASP^? 16.95 MG MG D 301 D 193 GLY D 145 GLY^? 13.51 MG MG D 301 coo 8.19 15.01 95.72 7.78 16.53 97.01 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 13.53 16.28 93.98 11.45 16.21 94.40 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 1.80 21.25 100.04 2.61 21.42 100.18 88.90 26.07 -46.90 89.21 25.93 -47.57 1a0j_c15 source 1a0j TRYPSIN : 4 hits 1a0j_c15 naa= 3 ULMN 3 1a41_c01 TOPOISOMERASE I user 1 3 # 1 223 ARG A 37 ARG^? 18.99 MG MG A 301 265 HIS A 42 HIS^? 28.45 MG MG A 301 274 TYR A 67 TYR^? 21.33 MG MG A 301 coo -15.18 55.46 8.55 -14.82 52.98 10.38 32.99 26.50 25.19 35.50 25.33 26.51 coo -14.48 45.59 11.18 -14.02 47.49 10.42 34.62 18.32 19.57 34.29 16.25 19.41 coo 0.94 52.26 9.16 1.95 54.78 9.91 48.62 23.20 22.09 46.84 25.23 21.44 ULMN 3 1a41_c01 TOPOISOMERASE I user 2 3 # 2 223 ARG A 37 ARG^? 18.99 MG MG A 301 265 HIS A 42 HIS^? 28.45 MG MG A 301 274 TYR A 168 TYR^? 14.52 MG MG A 302 coo -15.18 55.46 8.55 -14.82 52.98 10.38 32.99 26.50 25.19 35.50 25.33 26.51 coo -14.48 45.59 11.18 -14.02 47.49 10.42 34.62 18.32 19.57 34.29 16.25 19.41 coo 0.94 52.26 9.16 1.95 54.78 9.91 37.31 16.98 37.59 36.65 18.86 39.55 ULMN 3 1a41_c01 TOPOISOMERASE I user 3 3 # 3 223 ARG A 37 ARG^? 18.99 MG MG A 301 265 HIS A 42 HIS^? 28.45 MG MG A 301 274 TYR B 67 TYR^? 21.41 MG MG B 302 coo -15.18 55.46 8.55 -14.82 52.98 10.38 32.99 26.50 25.19 35.50 25.33 26.51 coo -14.48 45.59 11.18 -14.02 47.49 10.42 34.62 18.32 19.57 34.29 16.25 19.41 coo 0.94 52.26 9.16 1.95 54.78 9.91 46.94 25.86 15.48 48.70 23.84 16.15 ULMN 3 1a41_c01 TOPOISOMERASE I user 4 3 # 4 223 ARG B 37 ARG^? 19.17 MG MG B 302 265 HIS B 42 HIS^? 28.37 MG MG B 302 274 TYR A 67 TYR^? 21.33 MG MG A 301 coo -15.18 55.46 8.55 -14.82 52.98 10.38 47.41 10.20 11.40 46.99 12.91 10.22 coo -14.48 45.59 11.18 -14.02 47.49 10.42 39.34 12.99 16.30 37.26 13.24 16.40 coo 0.94 52.26 9.16 1.95 54.78 9.91 48.62 23.20 22.09 46.84 25.23 21.44 ULMN 3 1a41_c01 TOPOISOMERASE I user 5 3 # 5 223 ARG B 37 ARG^? 19.17 MG MG B 302 265 HIS B 42 HIS^? 28.37 MG MG B 302 274 TYR B 67 TYR^? 21.41 MG MG B 302 coo -15.18 55.46 8.55 -14.82 52.98 10.38 47.41 10.20 11.40 46.99 12.91 10.22 coo -14.48 45.59 11.18 -14.02 47.49 10.42 39.34 12.99 16.30 37.26 13.24 16.40 coo 0.94 52.26 9.16 1.95 54.78 9.91 46.94 25.86 15.48 48.70 23.84 16.15 ULMN 3 1a41_c01 TOPOISOMERASE I user 6 3 # 6 223 ARG B 37 ARG^? 19.17 MG MG B 302 265 HIS B 42 HIS^? 28.37 MG MG B 302 274 TYR B 168 TYR^? 14.66 MG MG B 301 coo -15.18 55.46 8.55 -14.82 52.98 10.38 47.41 10.20 11.40 46.99 12.91 10.22 coo -14.48 45.59 11.18 -14.02 47.49 10.42 39.34 12.99 16.30 37.26 13.24 16.40 coo 0.94 52.26 9.16 1.95 54.78 9.91 40.03 17.20 -1.34 41.92 16.43 -3.19 ULMN 3 1a41_c01 TOPOISOMERASE I user 7 3 # 7 223 ARG C 37 ARG^? 19.01 MG MG C 302 265 HIS C 42 HIS^? 28.09 MG MG C 302 274 TYR C 67 TYR^? 21.03 MG MG C 302 coo -15.18 55.46 8.55 -14.82 52.98 10.38 89.36 17.23 -17.57 89.29 20.20 -16.76 coo -14.48 45.59 11.18 -14.02 47.49 10.42 95.93 22.96 -23.11 97.92 23.62 -23.02 coo 0.94 52.26 9.16 1.95 54.78 9.91 84.52 32.45 -21.76 83.69 29.84 -22.37 ULMN 3 1a41_c01 TOPOISOMERASE I user 8 3 # 8 223 ARG C 37 ARG^? 19.01 MG MG C 302 265 HIS C 42 HIS^? 28.09 MG MG C 302 274 TYR C 168 TYR^? 14.82 MG MG C 301 coo -15.18 55.46 8.55 -14.82 52.98 10.38 89.36 17.23 -17.57 89.29 20.20 -16.76 coo -14.48 45.59 11.18 -14.02 47.49 10.42 95.93 22.96 -23.11 97.92 23.62 -23.02 coo 0.94 52.26 9.16 1.95 54.78 9.91 94.44 26.43 -5.44 92.97 25.09 -3.55 ULMN 3 1a41_c01 TOPOISOMERASE I user 9 3 # 9 223 ARG C 37 ARG^? 19.01 MG MG C 302 265 HIS C 42 HIS^? 28.09 MG MG C 302 274 TYR D 67 TYR^? 21.42 MG MG D 302 coo -15.18 55.46 8.55 -14.82 52.98 10.38 89.36 17.23 -17.57 89.29 20.20 -16.76 coo -14.48 45.59 11.18 -14.02 47.49 10.42 95.93 22.96 -23.11 97.92 23.62 -23.02 coo 0.94 52.26 9.16 1.95 54.78 9.91 83.62 29.64 -28.35 84.67 32.17 -27.90 ULMN 3 1a41_c01 TOPOISOMERASE I user 10 3 # 10 223 ARG D 37 ARG^? 18.81 MG MG D 302 265 HIS D 42 HIS^? 28.21 MG MG D 302 274 TYR C 67 TYR^? 21.03 MG MG C 302 coo -15.18 55.46 8.55 -14.82 52.98 10.38 96.81 38.21 -31.63 94.97 36.32 -33.06 coo -14.48 45.59 11.18 -14.02 47.49 10.42 98.45 29.90 -26.44 99.32 28.02 -26.13 coo 0.94 52.26 9.16 1.95 54.78 9.91 84.52 32.45 -21.76 83.69 29.84 -22.37 ULMN 3 1a41_c01 TOPOISOMERASE I user 11 3 # 11 223 ARG D 37 ARG^? 18.81 MG MG D 302 265 HIS D 42 HIS^? 28.21 MG MG D 302 274 TYR D 67 TYR^? 21.42 MG MG D 302 coo -15.18 55.46 8.55 -14.82 52.98 10.38 96.81 38.21 -31.63 94.97 36.32 -33.06 coo -14.48 45.59 11.18 -14.02 47.49 10.42 98.45 29.90 -26.44 99.32 28.02 -26.13 coo 0.94 52.26 9.16 1.95 54.78 9.91 83.62 29.64 -28.35 84.67 32.17 -27.90 ULMN 3 1a41_c01 TOPOISOMERASE I user 12 3 # 12 223 ARG D 37 ARG^? 18.81 MG MG D 302 265 HIS D 42 HIS^? 28.21 MG MG D 302 274 TYR D 168 TYR^? 14.75 MG MG D 301 coo -15.18 55.46 8.55 -14.82 52.98 10.38 96.81 38.21 -31.63 94.97 36.32 -33.06 coo -14.48 45.59 11.18 -14.02 47.49 10.42 98.45 29.90 -26.44 99.32 28.02 -26.13 coo 0.94 52.26 9.16 1.95 54.78 9.91 95.79 27.80 -44.35 95.71 29.78 -46.32 ULMN 3 1a41_c01 TOPOISOMERASE I user 13 3 # 13 223 ARG E 37 ARG^? 19.17 MG MG E 302 265 HIS E 42 HIS^? 28.20 MG MG E 302 274 TYR E 168 TYR^? 14.43 MG MG E 301 coo -15.18 55.46 8.55 -14.82 52.98 10.38 70.82 68.02 -63.63 68.17 67.46 -62.14 coo -14.48 45.59 11.18 -14.02 47.49 10.42 62.33 71.93 -68.30 60.54 72.96 -68.64 coo 0.94 52.26 9.16 1.95 54.78 9.91 60.07 69.95 -50.54 61.99 69.37 -48.59 ULMN 3 1a41_c01 TOPOISOMERASE I user 14 3 # 14 223 ARG E 37 ARG^? 19.17 MG MG E 302 265 HIS E 42 HIS^? 28.20 MG MG E 302 274 TYR F 67 TYR^? 21.41 MG MG F 301 coo -15.18 55.46 8.55 -14.82 52.98 10.38 70.82 68.02 -63.63 68.17 67.46 -62.14 coo -14.48 45.59 11.18 -14.02 47.49 10.42 62.33 71.93 -68.30 60.54 72.96 -68.64 coo 0.94 52.26 9.16 1.95 54.78 9.91 62.63 57.65 -72.90 59.95 57.21 -72.29 ULMN 3 1a41_c01 TOPOISOMERASE I user 15 3 # 15 223 ARG F 37 ARG^? 19.14 MG MG F 301 265 HIS F 42 HIS^? 28.34 MG MG F 301 274 TYR F 67 TYR^? 21.41 MG MG F 301 coo -15.18 55.46 8.55 -14.82 52.98 10.38 48.80 64.46 -76.37 51.50 64.15 -77.79 coo -14.48 45.59 11.18 -14.02 47.49 10.42 55.11 70.50 -71.64 56.29 72.22 -71.48 coo 0.94 52.26 9.16 1.95 54.78 9.91 62.63 57.65 -72.90 59.95 57.21 -72.29 ULMN 3 1a41_c01 TOPOISOMERASE I user 16 3 # 16 223 ARG F 37 ARG^? 19.14 MG MG F 301 265 HIS F 42 HIS^? 28.34 MG MG F 301 274 TYR F 168 TYR^? 14.10 MG MG F 302 coo -15.18 55.46 8.55 -14.82 52.98 10.38 48.80 64.46 -76.37 51.50 64.15 -77.79 coo -14.48 45.59 11.18 -14.02 47.49 10.42 55.11 70.50 -71.64 56.29 72.22 -71.48 coo 0.94 52.26 9.16 1.95 54.78 9.91 58.29 68.32 -89.29 56.67 67.12 -91.21 1a41_c01 source 1a41 TOPOISOMERASE I : 16 hits 1a41_c01 naa= 3 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 1 3 # 1 B 13 HIS A 42 HIS^? 28.45 MG MG A 301 B 40 LYS A 166 LYS^? 20.93 MG MG A 302 B 114 HIS B 42 HIS^? 28.37 MG MG B 302 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 34.62 18.32 19.57 34.29 16.25 19.41 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 35.34 13.14 30.41 31.67 15.04 34.58 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 39.34 12.99 16.30 37.26 13.24 16.40 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 2 3 # 2 B 13 HIS A 42 HIS^? 28.45 MG MG A 301 B 40 LYS B 6 LYS^? 25.90 MG MG B 302 B 114 HIS B 42 HIS^? 28.37 MG MG B 302 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 34.62 18.32 19.57 34.29 16.25 19.41 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 36.26 25.44 11.74 39.65 23.12 16.29 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 39.34 12.99 16.30 37.26 13.24 16.40 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 3 3 # 3 B 13 HIS B 42 HIS^? 28.37 MG MG B 302 B 40 LYS A 6 LYS^? 25.88 MG MG A 301 B 114 HIS A 42 HIS^? 28.45 MG MG A 301 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 39.34 12.99 16.30 37.26 13.24 16.40 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 46.20 12.82 24.71 44.50 16.64 20.52 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 34.62 18.32 19.57 34.29 16.25 19.41 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 4 3 # 4 B 13 HIS B 42 HIS^? 28.37 MG MG B 302 B 40 LYS B 166 LYS^? 22.75 MG MG B 301 B 114 HIS A 42 HIS^? 28.45 MG MG A 301 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 39.34 12.99 16.30 37.26 13.24 16.40 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 35.27 15.38 5.31 37.27 9.81 3.93 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 34.62 18.32 19.57 34.29 16.25 19.41 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 5 3 # 5 B 13 HIS C 42 HIS^? 28.09 MG MG C 302 B 40 LYS C 166 LYS^? 22.53 MG MG C 301 B 114 HIS D 42 HIS^? 28.21 MG MG D 302 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 95.93 22.96 -23.11 97.92 23.62 -23.02 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 99.24 26.71 -12.25 100.23 21.90 -8.99 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 98.45 29.90 -26.44 99.32 28.02 -26.13 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 6 3 # 6 B 13 HIS C 42 HIS^? 28.09 MG MG C 302 B 40 LYS D 6 LYS^? 25.98 MG MG D 302 B 114 HIS D 42 HIS^? 28.21 MG MG D 302 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 95.93 22.96 -23.11 97.92 23.62 -23.02 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 89.78 20.68 -31.57 90.15 24.89 -27.02 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 98.45 29.90 -26.44 99.32 28.02 -26.13 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 7 3 # 7 B 13 HIS D 42 HIS^? 28.21 MG MG D 302 B 40 LYS C 6 LYS^? 25.73 MG MG C 302 B 114 HIS C 42 HIS^? 28.09 MG MG C 302 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 98.45 29.90 -26.44 99.32 28.02 -26.13 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 94.42 35.68 -18.56 92.21 32.03 -23.05 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 95.93 22.96 -23.11 97.92 23.62 -23.02 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 8 3 # 8 B 13 HIS D 42 HIS^? 28.21 MG MG D 302 B 40 LYS D 166 LYS^? 21.08 MG MG D 301 B 114 HIS C 42 HIS^? 28.09 MG MG C 302 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 98.45 29.90 -26.44 99.32 28.02 -26.13 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 99.23 24.85 -37.31 101.73 27.34 -42.07 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 95.93 22.96 -23.11 97.92 23.62 -23.02 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 9 3 # 9 B 13 HIS E 42 HIS^? 28.20 MG MG E 302 B 40 LYS E 166 LYS^? 21.46 MG MG E 301 B 114 HIS F 42 HIS^? 28.34 MG MG F 301 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 62.33 71.93 -68.30 60.54 72.96 -68.64 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 57.66 73.57 -57.60 60.27 76.17 -53.59 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 55.11 70.50 -71.64 56.29 72.22 -71.48 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 10 3 # 10 B 13 HIS E 42 HIS^? 28.20 MG MG E 302 B 40 LYS F 6 LYS^? 26.09 MG MG F 301 B 114 HIS F 42 HIS^? 28.34 MG MG F 301 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 62.33 71.93 -68.30 60.54 72.96 -68.64 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 67.53 67.03 -76.43 64.05 65.33 -71.86 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 55.11 70.50 -71.64 56.29 72.22 -71.48 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 11 3 # 11 B 13 HIS F 42 HIS^? 28.34 MG MG F 301 B 40 LYS E 6 LYS^? 25.59 MG MG E 302 B 114 HIS E 42 HIS^? 28.20 MG MG E 302 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 55.11 70.50 -71.64 56.29 72.22 -71.48 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 51.95 64.70 -63.33 56.16 64.03 -67.52 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 62.33 71.93 -68.30 60.54 72.96 -68.64 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 12 3 # 12 B 13 HIS F 42 HIS^? 28.34 MG MG F 301 B 40 LYS F 166 LYS^? 20.76 MG MG F 302 B 114 HIS E 42 HIS^? 28.20 MG MG E 302 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 55.11 70.50 -71.64 56.29 72.22 -71.48 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 59.28 73.05 -82.63 55.63 74.15 -86.94 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 62.33 71.93 -68.30 60.54 72.96 -68.64 1a4y_c00 source 1a4y RIBONUCLEASE INHIBITOR : 12 hits 1a4y_c00 naa= 3 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 1 3 # 1 E 13 HIS A 42 HIS^? 28.45 MG MG A 301 E 40 LYS A 166 LYS^? 20.93 MG MG A 302 E 114 HIS B 42 HIS^? 28.37 MG MG B 302 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 34.62 18.32 19.57 34.29 16.25 19.41 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 35.34 13.14 30.41 31.67 15.04 34.58 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 39.34 12.99 16.30 37.26 13.24 16.40 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 2 3 # 2 E 13 HIS A 42 HIS^? 28.45 MG MG A 301 E 40 LYS B 6 LYS^? 25.90 MG MG B 302 E 114 HIS B 42 HIS^? 28.37 MG MG B 302 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 34.62 18.32 19.57 34.29 16.25 19.41 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 36.26 25.44 11.74 39.65 23.12 16.29 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 39.34 12.99 16.30 37.26 13.24 16.40 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 3 3 # 3 E 13 HIS B 42 HIS^? 28.37 MG MG B 302 E 40 LYS A 6 LYS^? 25.88 MG MG A 301 E 114 HIS A 42 HIS^? 28.45 MG MG A 301 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 39.34 12.99 16.30 37.26 13.24 16.40 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 46.20 12.82 24.71 44.50 16.64 20.52 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 34.62 18.32 19.57 34.29 16.25 19.41 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 4 3 # 4 E 13 HIS B 42 HIS^? 28.37 MG MG B 302 E 40 LYS B 166 LYS^? 22.75 MG MG B 301 E 114 HIS A 42 HIS^? 28.45 MG MG A 301 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 39.34 12.99 16.30 37.26 13.24 16.40 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 35.27 15.38 5.31 37.27 9.81 3.93 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 34.62 18.32 19.57 34.29 16.25 19.41 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 5 3 # 5 E 13 HIS C 42 HIS^? 28.09 MG MG C 302 E 40 LYS C 166 LYS^? 22.53 MG MG C 301 E 114 HIS D 42 HIS^? 28.21 MG MG D 302 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 95.93 22.96 -23.11 97.92 23.62 -23.02 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 98.45 29.90 -26.44 99.32 28.02 -26.13 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 6 3 # 6 E 13 HIS C 42 HIS^? 28.09 MG MG C 302 E 40 LYS D 6 LYS^? 25.98 MG MG D 302 E 114 HIS D 42 HIS^? 28.21 MG MG D 302 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 95.93 22.96 -23.11 97.92 23.62 -23.02 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 98.45 29.90 -26.44 99.32 28.02 -26.13 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 7 3 # 7 E 13 HIS D 42 HIS^? 28.21 MG MG D 302 E 40 LYS C 6 LYS^? 25.73 MG MG C 302 E 114 HIS C 42 HIS^? 28.09 MG MG C 302 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 98.45 29.90 -26.44 99.32 28.02 -26.13 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 95.93 22.96 -23.11 97.92 23.62 -23.02 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 8 3 # 8 E 13 HIS D 42 HIS^? 28.21 MG MG D 302 E 40 LYS D 166 LYS^? 21.08 MG MG D 301 E 114 HIS C 42 HIS^? 28.09 MG MG C 302 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 98.45 29.90 -26.44 99.32 28.02 -26.13 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 95.93 22.96 -23.11 97.92 23.62 -23.02 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 9 3 # 9 E 13 HIS E 42 HIS^? 28.20 MG MG E 302 E 40 LYS E 166 LYS^? 21.46 MG MG E 301 E 114 HIS F 42 HIS^? 28.34 MG MG F 301 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 62.33 71.93 -68.30 60.54 72.96 -68.64 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 55.11 70.50 -71.64 56.29 72.22 -71.48 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 10 3 # 10 E 13 HIS E 42 HIS^? 28.20 MG MG E 302 E 40 LYS F 6 LYS^? 26.09 MG MG F 301 E 114 HIS F 42 HIS^? 28.34 MG MG F 301 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 62.33 71.93 -68.30 60.54 72.96 -68.64 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 55.11 70.50 -71.64 56.29 72.22 -71.48 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 11 3 # 11 E 13 HIS F 42 HIS^? 28.34 MG MG F 301 E 40 LYS E 6 LYS^? 25.59 MG MG E 302 E 114 HIS E 42 HIS^? 28.20 MG MG E 302 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 55.11 70.50 -71.64 56.29 72.22 -71.48 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 62.33 71.93 -68.30 60.54 72.96 -68.64 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 12 3 # 12 E 13 HIS F 42 HIS^? 28.34 MG MG F 301 E 40 LYS F 166 LYS^? 20.76 MG MG F 302 E 114 HIS E 42 HIS^? 28.20 MG MG E 302 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 55.11 70.50 -71.64 56.29 72.22 -71.48 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 62.33 71.93 -68.30 60.54 72.96 -68.64 1a4y_c01 source 1a4y RIBONUCLEASE INHIBITOR : 12 hits 1a4y_c01 naa= 3 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 1 3 # 1 A 49 GLU C 154 GLU^? 18.91 MG MG C 302 A 60 ASP C 148 ASP^? 2.75 MG MG C 302s A 175 TYR C 168 TYR^? 14.82 MG MG C 301 coo 46.10 28.27 19.27 45.48 26.99 20.84 91.15 23.27 -13.33 91.61 21.91 -14.95 coo 56.42 28.06 12.93 55.01 27.92 14.50 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 45.02 22.04 15.38 46.16 24.00 13.76 94.44 26.43 -5.44 92.97 25.09 -3.55 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 2 3 # 2 A 49 GLU E 54 GLU^? 22.83 MG MG E 302 A 60 ASP E 58 ASP^? 26.76 MG MG F 301 A 175 TYR E 67 TYR^? 21.41 MG MG E 302 coo 46.10 28.27 19.27 45.48 26.99 20.84 58.39 62.16 -64.12 58.73 62.98 -66.04 coo 56.42 28.06 12.93 55.01 27.92 14.50 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 45.02 22.04 15.38 46.16 24.00 13.76 59.76 57.41 -66.37 62.46 58.08 -67.03 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 3 3 # 3 A 49 GLU F 154 GLU^? 18.97 MG MG F 301 A 60 ASP F 148 ASP^? 2.72 MG MG F 301s A 175 TYR F 168 TYR^? 14.10 MG MG F 302 coo 46.10 28.27 19.27 45.48 26.99 20.84 54.57 65.67 -81.55 53.36 66.51 -80.09 coo 56.42 28.06 12.93 55.01 27.92 14.50 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 45.02 22.04 15.38 46.16 24.00 13.76 58.29 68.32 -89.29 56.67 67.12 -91.21 1a50_c03 source 1a50 TRYPTOPHAN SYNTHASE : 3 hits 1a50_c03 naa= 3 ULMN 3 1a65_c00 LACCASE user 1 3 # 1 A 451 HIS D 170 HIS^? 10.59 MG MG D 301 A 452 CYH D 152 CYH^? 14.66 MG MG D 301 A 453 HIS D 147 HIS^? 9.43 MG MG D 301 coo 3.92 41.70 29.28 5.16 41.54 27.59 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 2.17 37.54 30.39 0.70 35.33 29.69 94.69 37.43 -41.36 96.92 38.83 -40.94 coo 6.12 36.86 25.94 7.22 37.67 24.36 90.95 32.51 -46.42 92.98 32.42 -46.93 1a65_c00 source 1a65 LACCASE : 1 hits 1a65_c00 naa= 3 ULMN 3 1a7u_c02 CHLOROPEROXIDASE T user 1 3 # 1 A 98 SER A 189 SER^? 11.75 MG MG A 302 A 228 ASP A 148 ASP^? 2.72 MG MG A 301s A 257 HIS A 147 HIS^? 9.20 MG MG A 302 coo 9.47 41.64 34.15 9.10 39.28 33.93 40.99 19.00 44.32 41.51 18.14 46.48 coo 2.03 38.95 28.44 3.60 38.60 29.83 41.50 28.88 41.13 43.33 29.67 41.93 coo 6.85 37.62 29.99 7.50 38.47 31.78 40.24 23.10 39.83 38.32 22.34 40.22 ULMN 3 1a7u_c02 CHLOROPEROXIDASE T user 2 3 # 2 A 98 SER B 189 SER^? 12.11 MG MG B 301 A 228 ASP B 148 ASP^? 2.58 MG MG B 302s A 257 HIS B 147 HIS^? 9.27 MG MG B 301 coo 9.47 41.64 34.15 9.10 39.28 33.93 43.10 20.95 -7.74 42.82 21.56 -10.02 coo 2.03 38.95 28.44 3.60 38.60 29.83 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 6.85 37.62 29.99 7.50 38.47 31.78 46.73 18.97 -3.05 45.63 17.32 -3.73 ULMN 3 1a7u_c02 CHLOROPEROXIDASE T user 3 3 # 3 A 98 SER C 189 SER^? 12.09 MG MG C 301 A 228 ASP C 148 ASP^? 2.75 MG MG C 302s A 257 HIS C 147 HIS^? 9.44 MG MG C 301 coo 9.47 41.64 34.15 9.10 39.28 33.93 90.33 28.79 1.19 90.26 29.61 3.45 coo 2.03 38.95 28.44 3.60 38.60 29.83 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 6.85 37.62 29.99 7.50 38.47 31.78 87.61 25.71 -3.59 89.22 24.50 -2.99 ULMN 3 1a7u_c02 CHLOROPEROXIDASE T user 4 3 # 4 A 98 SER D 189 SER^? 12.12 MG MG D 301 A 228 ASP D 148 ASP^? 2.35 MG MG D 302s A 257 HIS D 147 HIS^? 9.43 MG MG D 301 coo 9.47 41.64 34.15 9.10 39.28 33.93 91.62 28.58 -50.95 91.45 27.78 -53.25 coo 2.03 38.95 28.44 3.60 38.60 29.83 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 6.85 37.62 29.99 7.50 38.47 31.78 90.95 32.51 -46.42 92.98 32.42 -46.93 ULMN 3 1a7u_c02 CHLOROPEROXIDASE T user 5 3 # 5 A 98 SER E 189 SER^? 11.91 MG MG E 301 A 228 ASP E 148 ASP^? 2.62 MG MG E 302s A 257 HIS E 147 HIS^? 9.22 MG MG E 301 coo 9.47 41.64 34.15 9.10 39.28 33.93 60.13 65.61 -43.87 59.01 65.34 -41.74 coo 2.03 38.95 28.44 3.60 38.60 29.83 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 6.85 37.62 29.99 7.50 38.47 31.78 63.87 64.43 -48.39 64.18 66.45 -47.92 ULMN 3 1a7u_c02 CHLOROPEROXIDASE T user 6 3 # 6 A 98 SER F 189 SER^? 11.88 MG MG F 302 A 228 ASP F 148 ASP^? 2.72 MG MG F 301s A 257 HIS F 147 HIS^? 8.79 MG MG F 302 coo 9.47 41.64 34.15 9.10 39.28 33.93 59.91 63.90 -95.91 60.70 64.22 -98.13 coo 2.03 38.95 28.44 3.60 38.60 29.83 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 6.85 37.62 29.99 7.50 38.47 31.78 56.63 61.66 -91.16 55.69 63.43 -91.80 1a7u_c02 source 1a7u CHLOROPEROXIDASE T : 6 hits 1a7u_c02 naa= 3 ULMN 3 1a7u_c03 CHLOROPEROXIDASE T user 1 3 # 1 B 98 SER A 189 SER^? 11.75 MG MG A 302 B 228 ASP A 148 ASP^? 2.72 MG MG A 301s B 257 HIS A 147 HIS^? 9.20 MG MG A 302 coo 28.35 71.07 3.94 30.08 69.46 4.49 40.99 19.00 44.32 41.51 18.14 46.48 coo 31.11 65.98 -3.92 31.07 66.41 -1.82 41.50 28.88 41.13 43.33 29.67 41.93 coo 32.76 68.02 0.70 31.21 68.44 2.05 40.24 23.10 39.83 38.32 22.34 40.22 ULMN 3 1a7u_c03 CHLOROPEROXIDASE T user 2 3 # 2 B 98 SER B 189 SER^? 12.11 MG MG B 301 B 228 ASP B 148 ASP^? 2.58 MG MG B 302s B 257 HIS B 147 HIS^? 9.27 MG MG B 301 coo 28.35 71.07 3.94 30.08 69.46 4.49 43.10 20.95 -7.74 42.82 21.56 -10.02 coo 31.11 65.98 -3.92 31.07 66.41 -1.82 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 32.76 68.02 0.70 31.21 68.44 2.05 46.73 18.97 -3.05 45.63 17.32 -3.73 ULMN 3 1a7u_c03 CHLOROPEROXIDASE T user 3 3 # 3 B 98 SER C 189 SER^? 12.09 MG MG C 301 B 228 ASP C 148 ASP^? 2.75 MG MG C 302s B 257 HIS C 147 HIS^? 9.44 MG MG C 301 coo 28.35 71.07 3.94 30.08 69.46 4.49 90.33 28.79 1.19 90.26 29.61 3.45 coo 31.11 65.98 -3.92 31.07 66.41 -1.82 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 32.76 68.02 0.70 31.21 68.44 2.05 87.61 25.71 -3.59 89.22 24.50 -2.99 ULMN 3 1a7u_c03 CHLOROPEROXIDASE T user 4 3 # 4 B 98 SER D 189 SER^? 12.12 MG MG D 301 B 228 ASP D 148 ASP^? 2.35 MG MG D 302s B 257 HIS D 147 HIS^? 9.43 MG MG D 301 coo 28.35 71.07 3.94 30.08 69.46 4.49 91.62 28.58 -50.95 91.45 27.78 -53.25 coo 31.11 65.98 -3.92 31.07 66.41 -1.82 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 32.76 68.02 0.70 31.21 68.44 2.05 90.95 32.51 -46.42 92.98 32.42 -46.93 ULMN 3 1a7u_c03 CHLOROPEROXIDASE T user 5 3 # 5 B 98 SER E 189 SER^? 11.91 MG MG E 301 B 228 ASP E 148 ASP^? 2.62 MG MG E 302s B 257 HIS E 147 HIS^? 9.22 MG MG E 301 coo 28.35 71.07 3.94 30.08 69.46 4.49 60.13 65.61 -43.87 59.01 65.34 -41.74 coo 31.11 65.98 -3.92 31.07 66.41 -1.82 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 32.76 68.02 0.70 31.21 68.44 2.05 63.87 64.43 -48.39 64.18 66.45 -47.92 ULMN 3 1a7u_c03 CHLOROPEROXIDASE T user 6 3 # 6 B 98 SER F 189 SER^? 11.88 MG MG F 302 B 228 ASP F 148 ASP^? 2.72 MG MG F 301s B 257 HIS F 147 HIS^? 8.79 MG MG F 302 coo 28.35 71.07 3.94 30.08 69.46 4.49 59.91 63.90 -95.91 60.70 64.22 -98.13 coo 31.11 65.98 -3.92 31.07 66.41 -1.82 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 32.76 68.02 0.70 31.21 68.44 2.05 56.63 61.66 -91.16 55.69 63.43 -91.80 1a7u_c03 source 1a7u CHLOROPEROXIDASE T : 6 hits 1a7u_c03 naa= 3 ULMN 3 1a8q_c00 BROMOPEROXIDASE A1 user 1 3 # 1 94 SER A 189 SER^? 11.75 MG MG A 302 223 ASP A 148 ASP^? 2.72 MG MG A 301s 252 HIS A 147 HIS^? 9.20 MG MG A 302 coo 40.95 0.07 3.20 39.54 1.39 4.66 40.99 19.00 44.32 41.51 18.14 46.48 coo 42.66 -2.61 12.07 41.85 -1.47 10.53 41.50 28.88 41.13 43.33 29.67 41.93 coo 41.54 1.64 9.09 40.82 1.05 7.19 40.24 23.10 39.83 38.32 22.34 40.22 ULMN 3 1a8q_c00 BROMOPEROXIDASE A1 user 2 3 # 2 94 SER B 189 SER^? 12.11 MG MG B 301 223 ASP B 148 ASP^? 2.58 MG MG B 302s 252 HIS B 147 HIS^? 9.27 MG MG B 301 coo 40.95 0.07 3.20 39.54 1.39 4.66 43.10 20.95 -7.74 42.82 21.56 -10.02 coo 42.66 -2.61 12.07 41.85 -1.47 10.53 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 41.54 1.64 9.09 40.82 1.05 7.19 46.73 18.97 -3.05 45.63 17.32 -3.73 ULMN 3 1a8q_c00 BROMOPEROXIDASE A1 user 3 3 # 3 94 SER C 189 SER^? 12.09 MG MG C 301 223 ASP C 148 ASP^? 2.75 MG MG C 302s 252 HIS C 147 HIS^? 9.44 MG MG C 301 coo 40.95 0.07 3.20 39.54 1.39 4.66 90.33 28.79 1.19 90.26 29.61 3.45 coo 42.66 -2.61 12.07 41.85 -1.47 10.53 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 41.54 1.64 9.09 40.82 1.05 7.19 87.61 25.71 -3.59 89.22 24.50 -2.99 ULMN 3 1a8q_c00 BROMOPEROXIDASE A1 user 4 3 # 4 94 SER D 189 SER^? 12.12 MG MG D 301 223 ASP D 148 ASP^? 2.35 MG MG D 302s 252 HIS D 147 HIS^? 9.43 MG MG D 301 coo 40.95 0.07 3.20 39.54 1.39 4.66 91.62 28.58 -50.95 91.45 27.78 -53.25 coo 42.66 -2.61 12.07 41.85 -1.47 10.53 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 41.54 1.64 9.09 40.82 1.05 7.19 90.95 32.51 -46.42 92.98 32.42 -46.93 ULMN 3 1a8q_c00 BROMOPEROXIDASE A1 user 5 3 # 5 94 SER E 189 SER^? 11.91 MG MG E 301 223 ASP E 148 ASP^? 2.62 MG MG E 302s 252 HIS E 147 HIS^? 9.22 MG MG E 301 coo 40.95 0.07 3.20 39.54 1.39 4.66 60.13 65.61 -43.87 59.01 65.34 -41.74 coo 42.66 -2.61 12.07 41.85 -1.47 10.53 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 41.54 1.64 9.09 40.82 1.05 7.19 63.87 64.43 -48.39 64.18 66.45 -47.92 ULMN 3 1a8q_c00 BROMOPEROXIDASE A1 user 6 3 # 6 94 SER F 189 SER^? 11.88 MG MG F 302 223 ASP F 148 ASP^? 2.72 MG MG F 301s 252 HIS F 147 HIS^? 8.79 MG MG F 302 coo 40.95 0.07 3.20 39.54 1.39 4.66 59.91 63.90 -95.91 60.70 64.22 -98.13 coo 42.66 -2.61 12.07 41.85 -1.47 10.53 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 41.54 1.64 9.09 40.82 1.05 7.19 56.63 61.66 -91.16 55.69 63.43 -91.80 1a8q_c00 source 1a8q BROMOPEROXIDASE A1 : 6 hits 1a8q_c00 naa= 3 ULMN 3 1a8s_c00 CHLOROPEROXIDASE F user 1 3 # 1 94 SER A 189 SER^? 11.75 MG MG A 302 224 ASP A 148 ASP^? 2.72 MG MG A 301s 253 HIS A 147 HIS^? 9.20 MG MG A 302 coo 16.00 80.13 58.60 16.16 82.12 59.96 40.99 19.00 44.32 41.51 18.14 46.48 coo 8.47 84.84 62.27 10.52 84.40 62.08 41.50 28.88 41.13 43.33 29.67 41.93 coo 13.14 83.03 63.68 14.37 82.62 62.02 40.24 23.10 39.83 38.32 22.34 40.22 ULMN 3 1a8s_c00 CHLOROPEROXIDASE F user 2 3 # 2 94 SER B 189 SER^? 12.11 MG MG B 301 224 ASP B 148 ASP^? 2.58 MG MG B 302s 253 HIS B 147 HIS^? 9.27 MG MG B 301 coo 16.00 80.13 58.60 16.16 82.12 59.96 43.10 20.95 -7.74 42.82 21.56 -10.02 coo 8.47 84.84 62.27 10.52 84.40 62.08 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 13.14 83.03 63.68 14.37 82.62 62.02 46.73 18.97 -3.05 45.63 17.32 -3.73 ULMN 3 1a8s_c00 CHLOROPEROXIDASE F user 3 3 # 3 94 SER C 189 SER^? 12.09 MG MG C 301 224 ASP C 148 ASP^? 2.75 MG MG C 302s 253 HIS C 147 HIS^? 9.44 MG MG C 301 coo 16.00 80.13 58.60 16.16 82.12 59.96 90.33 28.79 1.19 90.26 29.61 3.45 coo 8.47 84.84 62.27 10.52 84.40 62.08 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 13.14 83.03 63.68 14.37 82.62 62.02 87.61 25.71 -3.59 89.22 24.50 -2.99 ULMN 3 1a8s_c00 CHLOROPEROXIDASE F user 4 3 # 4 94 SER D 189 SER^? 12.12 MG MG D 301 224 ASP D 148 ASP^? 2.35 MG MG D 302s 253 HIS D 147 HIS^? 9.43 MG MG D 301 coo 16.00 80.13 58.60 16.16 82.12 59.96 91.62 28.58 -50.95 91.45 27.78 -53.25 coo 8.47 84.84 62.27 10.52 84.40 62.08 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 13.14 83.03 63.68 14.37 82.62 62.02 90.95 32.51 -46.42 92.98 32.42 -46.93 ULMN 3 1a8s_c00 CHLOROPEROXIDASE F user 5 3 # 5 94 SER E 189 SER^? 11.91 MG MG E 301 224 ASP E 148 ASP^? 2.62 MG MG E 302s 253 HIS E 147 HIS^? 9.22 MG MG E 301 coo 16.00 80.13 58.60 16.16 82.12 59.96 60.13 65.61 -43.87 59.01 65.34 -41.74 coo 8.47 84.84 62.27 10.52 84.40 62.08 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 13.14 83.03 63.68 14.37 82.62 62.02 63.87 64.43 -48.39 64.18 66.45 -47.92 ULMN 3 1a8s_c00 CHLOROPEROXIDASE F user 6 3 # 6 94 SER F 189 SER^? 11.88 MG MG F 302 224 ASP F 148 ASP^? 2.72 MG MG F 301s 253 HIS F 147 HIS^? 8.79 MG MG F 302 coo 16.00 80.13 58.60 16.16 82.12 59.96 59.91 63.90 -95.91 60.70 64.22 -98.13 coo 8.47 84.84 62.27 10.52 84.40 62.08 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 13.14 83.03 63.68 14.37 82.62 62.02 56.63 61.66 -91.16 55.69 63.43 -91.80 1a8s_c00 source 1a8s CHLOROPEROXIDASE F : 6 hits 1a8s_c00 naa= 3 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 1 3 # 1 142 TRP A 103 TRP^? 29.78 MG MG A 301 223 ASP A 58 ASP^? 26.75 MG MG B 302 258 LYS A 136 LYS^? 30.58 MG MG A 302 coo 127.19 33.46 26.14 126.78 36.79 28.15 59.99 9.32 29.49 57.09 7.83 27.30 coo 126.95 41.66 23.38 128.48 40.72 24.51 53.93 9.80 21.09 53.83 8.90 19.15 coo 138.83 37.95 25.17 133.50 36.37 26.52 50.14 3.36 31.42 51.28 2.21 35.89 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 2 3 # 2 142 TRP A 103 TRP^? 29.78 MG MG A 301 223 ASP A 58 ASP^? 26.75 MG MG B 302 258 LYS A 137 LYS^? 34.85 MG MG A 301 coo 127.19 33.46 26.14 126.78 36.79 28.15 59.99 9.32 29.49 57.09 7.83 27.30 coo 126.95 41.66 23.38 128.48 40.72 24.51 53.93 9.80 21.09 53.83 8.90 19.15 coo 138.83 37.95 25.17 133.50 36.37 26.52 50.97 1.58 28.14 56.13 1.49 28.03 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 3 3 # 3 142 TRP B 103 TRP^? 29.74 MG MG B 302 223 ASP B 58 ASP^? 26.73 MG MG A 301 258 LYS B 136 LYS^? 33.75 MG MG B 302 coo 127.19 33.46 26.14 126.78 36.79 28.15 35.60 40.22 7.93 33.65 37.37 9.82 coo 126.95 41.66 23.38 128.48 40.72 24.51 34.42 33.56 15.74 33.50 33.49 17.59 coo 138.83 37.95 25.17 133.50 36.37 26.52 28.47 31.35 4.78 24.04 31.81 1.99 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 4 3 # 4 142 TRP B 103 TRP^? 29.74 MG MG B 302 223 ASP B 58 ASP^? 26.73 MG MG A 301 258 LYS B 137 LYS^? 34.56 MG MG B 302 coo 127.19 33.46 26.14 126.78 36.79 28.15 35.60 40.22 7.93 33.65 37.37 9.82 coo 126.95 41.66 23.38 128.48 40.72 24.51 34.42 33.56 15.74 33.50 33.49 17.59 coo 138.83 37.95 25.17 133.50 36.37 26.52 26.56 32.46 7.93 27.87 37.71 9.31 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 5 3 # 5 142 TRP C 103 TRP^? 29.51 MG MG C 302 223 ASP C 58 ASP^? 26.67 MG MG D 302 258 LYS C 136 LYS^? 30.63 MG MG C 302 coo 127.19 33.46 26.14 126.78 36.79 28.15 90.16 49.24 -14.37 93.26 47.67 -16.22 coo 126.95 41.66 23.38 128.48 40.72 24.51 93.40 43.81 -22.27 94.18 44.45 -24.11 coo 138.83 37.95 25.17 133.50 36.37 26.52 99.75 44.04 -11.38 100.98 45.13 -6.77 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 6 3 # 6 142 TRP C 103 TRP^? 29.51 MG MG C 302 223 ASP C 58 ASP^? 26.67 MG MG D 302 258 LYS C 137 LYS^? 35.41 MG MG C 302 coo 127.19 33.46 26.14 126.78 36.79 28.15 90.16 49.24 -14.37 93.26 47.67 -16.22 coo 126.95 41.66 23.38 128.48 40.72 24.51 93.40 43.81 -22.27 94.18 44.45 -24.11 coo 138.83 37.95 25.17 133.50 36.37 26.52 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 7 3 # 7 142 TRP D 103 TRP^? 29.85 MG MG D 302 223 ASP D 58 ASP^? 26.59 MG MG C 302 258 LYS D 136 LYS^? 34.99 MG MG D 302 coo 127.19 33.46 26.14 126.78 36.79 28.15 77.64 12.56 -35.88 81.02 12.20 -33.92 coo 126.95 41.66 23.38 128.48 40.72 24.51 83.38 14.85 -27.71 84.09 14.12 -25.85 coo 138.83 37.95 25.17 133.50 36.37 26.52 88.96 10.62 -38.53 90.77 6.00 -38.00 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 8 3 # 8 142 TRP D 103 TRP^? 29.85 MG MG D 302 223 ASP D 58 ASP^? 26.59 MG MG C 302 258 LYS D 137 LYS^? 37.57 MG MG D 302 coo 127.19 33.46 26.14 126.78 36.79 28.15 77.64 12.56 -35.88 81.02 12.20 -33.92 coo 126.95 41.66 23.38 128.48 40.72 24.51 83.38 14.85 -27.71 84.09 14.12 -25.85 coo 138.83 37.95 25.17 133.50 36.37 26.52 88.48 8.58 -35.33 84.88 3.98 -33.96 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 9 3 # 9 142 TRP E 103 TRP^? 29.56 MG MG E 302 223 ASP E 58 ASP^? 26.76 MG MG F 301 258 LYS E 136 LYS^? 31.27 MG MG E 302 coo 127.19 33.46 26.14 126.78 36.79 28.15 42.03 54.00 -58.74 42.60 57.21 -60.89 coo 126.95 41.66 23.38 128.48 40.72 24.51 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 138.83 37.95 25.17 133.50 36.37 26.52 42.12 65.93 -56.52 39.36 65.07 -51.83 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 10 3 # 10 142 TRP E 103 TRP^? 29.56 MG MG E 302 223 ASP E 58 ASP^? 26.76 MG MG F 301 258 LYS E 137 LYS^? 35.26 MG MG E 302 coo 127.19 33.46 26.14 126.78 36.79 28.15 42.03 54.00 -58.74 42.60 57.21 -60.89 coo 126.95 41.66 23.38 128.48 40.72 24.51 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 138.83 37.95 25.17 133.50 36.37 26.52 40.01 66.05 -59.66 36.65 60.99 -60.28 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 11 3 # 11 142 TRP F 103 TRP^? 29.78 MG MG F 301 223 ASP F 58 ASP^? 26.87 MG MG E 302 258 LYS F 136 LYS^? 30.53 MG MG F 301 coo 127.19 33.46 26.14 126.78 36.79 28.15 80.05 60.24 -80.06 79.17 63.82 -78.73 coo 126.95 41.66 23.38 128.48 40.72 24.51 75.55 64.68 -72.56 76.21 65.63 -70.79 coo 138.83 37.95 25.17 133.50 36.37 26.52 76.49 71.19 -83.39 78.38 70.88 -88.47 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 12 3 # 12 142 TRP F 103 TRP^? 29.78 MG MG F 301 223 ASP F 58 ASP^? 26.87 MG MG E 302 258 LYS F 137 LYS^? 35.13 MG MG F 301 coo 127.19 33.46 26.14 126.78 36.79 28.15 80.05 60.24 -80.06 79.17 63.82 -78.73 coo 126.95 41.66 23.38 128.48 40.72 24.51 75.55 64.68 -72.56 76.21 65.63 -70.79 coo 138.83 37.95 25.17 133.50 36.37 26.52 78.53 72.20 -80.30 83.01 68.64 -79.79 1aam_c01 source 1aam ASPARTATE AMINOTRANSFERASE : 12 hits 1aam_c01 naa= 3 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 1 3 # 1 22 ASN A 45 ASN^? 24.62 MG MG B 302 63 ARG A 8 ARG^? 20.36 MG MG A 301 255 ARG B 8 ARG^? 20.39 MG MG B 302 coo 42.10 13.02 11.14 41.85 11.12 10.23 42.72 26.12 17.32 44.44 25.00 17.78 coo 44.36 11.24 3.39 41.81 12.78 4.00 40.62 19.52 24.63 40.98 22.51 23.88 coo 38.40 3.83 10.26 40.02 6.30 9.25 41.99 18.82 11.83 44.91 18.76 12.93 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 2 3 # 2 22 ASN A 45 ASN^? 24.62 MG MG B 302 63 ARG B 8 ARG^? 20.39 MG MG B 302 255 ARG A 8 ARG^? 20.36 MG MG A 301 coo 42.10 13.02 11.14 41.85 11.12 10.23 42.72 26.12 17.32 44.44 25.00 17.78 coo 44.36 11.24 3.39 41.81 12.78 4.00 41.99 18.82 11.83 44.91 18.76 12.93 coo 38.40 3.83 10.26 40.02 6.30 9.25 40.62 19.52 24.63 40.98 22.51 23.88 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 3 3 # 3 22 ASN B 45 ASN^? 24.27 MG MG A 301 63 ARG A 8 ARG^? 20.36 MG MG A 301 255 ARG B 8 ARG^? 20.39 MG MG B 302 coo 42.10 13.02 11.14 41.85 11.12 10.23 47.87 19.20 19.75 47.40 21.26 19.77 coo 44.36 11.24 3.39 41.81 12.78 4.00 40.62 19.52 24.63 40.98 22.51 23.88 coo 38.40 3.83 10.26 40.02 6.30 9.25 41.99 18.82 11.83 44.91 18.76 12.93 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 4 3 # 4 22 ASN B 45 ASN^? 24.27 MG MG A 301 63 ARG B 8 ARG^? 20.39 MG MG B 302 255 ARG A 8 ARG^? 20.36 MG MG A 301 coo 42.10 13.02 11.14 41.85 11.12 10.23 47.87 19.20 19.75 47.40 21.26 19.77 coo 44.36 11.24 3.39 41.81 12.78 4.00 41.99 18.82 11.83 44.91 18.76 12.93 coo 38.40 3.83 10.26 40.02 6.30 9.25 40.62 19.52 24.63 40.98 22.51 23.88 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 5 3 # 5 22 ASN B 45 ASN^? 24.27 MG MG A 301 63 ARG B 8 ARG^? 20.39 MG MG B 302 255 ARG B 48 ARG^? 25.20 MG MG B 302 coo 42.10 13.02 11.14 41.85 11.12 10.23 47.87 19.20 19.75 47.40 21.26 19.77 coo 44.36 11.24 3.39 41.81 12.78 4.00 41.99 18.82 11.83 44.91 18.76 12.93 coo 38.40 3.83 10.26 40.02 6.30 9.25 52.22 10.51 15.00 52.46 7.79 16.39 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 6 3 # 6 22 ASN C 45 ASN^? 24.54 MG MG C 302 63 ARG C 8 ARG^? 20.00 MG MG C 302 255 ARG C 48 ARG^? 25.02 MG MG C 302 coo 42.10 13.02 11.14 41.85 11.12 10.23 85.43 25.82 -26.31 85.43 27.91 -25.97 coo 44.36 11.24 3.39 41.81 12.78 4.00 91.42 27.61 -18.53 88.82 26.28 -19.38 coo 38.40 3.83 10.26 40.02 6.30 9.25 84.94 16.06 -21.53 85.81 13.55 -23.08 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 7 3 # 7 22 ASN C 45 ASN^? 24.54 MG MG C 302 63 ARG C 8 ARG^? 20.00 MG MG C 302 255 ARG D 8 ARG^? 20.22 MG MG D 302 coo 42.10 13.02 11.14 41.85 11.12 10.23 85.43 25.82 -26.31 85.43 27.91 -25.97 coo 44.36 11.24 3.39 41.81 12.78 4.00 91.42 27.61 -18.53 88.82 26.28 -19.38 coo 38.40 3.83 10.26 40.02 6.30 9.25 92.22 28.83 -31.23 90.93 31.55 -30.54 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 8 3 # 8 22 ASN C 45 ASN^? 24.54 MG MG C 302 63 ARG D 8 ARG^? 20.22 MG MG D 302 255 ARG C 8 ARG^? 20.00 MG MG C 302 coo 42.10 13.02 11.14 41.85 11.12 10.23 85.43 25.82 -26.31 85.43 27.91 -25.97 coo 44.36 11.24 3.39 41.81 12.78 4.00 92.22 28.83 -31.23 90.93 31.55 -30.54 coo 38.40 3.83 10.26 40.02 6.30 9.25 91.42 27.61 -18.53 88.82 26.28 -19.38 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 9 3 # 9 22 ASN D 45 ASN^? 24.33 MG MG C 302 63 ARG C 8 ARG^? 20.00 MG MG C 302 255 ARG D 8 ARG^? 20.22 MG MG D 302 coo 42.10 13.02 11.14 41.85 11.12 10.23 88.35 34.04 -23.87 86.82 32.62 -24.25 coo 44.36 11.24 3.39 41.81 12.78 4.00 91.42 27.61 -18.53 88.82 26.28 -19.38 coo 38.40 3.83 10.26 40.02 6.30 9.25 92.22 28.83 -31.23 90.93 31.55 -30.54 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 10 3 # 10 22 ASN D 45 ASN^? 24.33 MG MG C 302 63 ARG D 8 ARG^? 20.22 MG MG D 302 255 ARG C 8 ARG^? 20.00 MG MG C 302 coo 42.10 13.02 11.14 41.85 11.12 10.23 88.35 34.04 -23.87 86.82 32.62 -24.25 coo 44.36 11.24 3.39 41.81 12.78 4.00 92.22 28.83 -31.23 90.93 31.55 -30.54 coo 38.40 3.83 10.26 40.02 6.30 9.25 91.42 27.61 -18.53 88.82 26.28 -19.38 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 11 3 # 11 22 ASN D 45 ASN^? 24.33 MG MG C 302 63 ARG D 8 ARG^? 20.22 MG MG D 302 255 ARG D 48 ARG^? 24.87 MG MG D 302 coo 42.10 13.02 11.14 41.85 11.12 10.23 88.35 34.04 -23.87 86.82 32.62 -24.25 coo 44.36 11.24 3.39 41.81 12.78 4.00 92.22 28.83 -31.23 90.93 31.55 -30.54 coo 38.40 3.83 10.26 40.02 6.30 9.25 94.06 41.76 -28.37 96.24 43.38 -26.96 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 12 3 # 12 22 ASN E 45 ASN^? 24.46 MG MG F 301 63 ARG E 8 ARG^? 20.19 MG MG E 302 255 ARG E 37 ARG^? 19.17 MG MG E 302 coo 42.10 13.02 11.14 41.85 11.12 10.23 64.97 61.33 -71.05 63.29 60.06 -70.79 coo 44.36 11.24 3.39 41.81 12.78 4.00 60.42 66.09 -63.48 62.84 64.38 -64.17 coo 38.40 3.83 10.26 40.02 6.30 9.25 70.82 68.02 -63.63 68.17 67.46 -62.14 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 13 3 # 13 22 ASN E 45 ASN^? 24.46 MG MG F 301 63 ARG E 8 ARG^? 20.19 MG MG E 302 255 ARG E 48 ARG^? 25.02 MG MG E 302 coo 42.10 13.02 11.14 41.85 11.12 10.23 64.97 61.33 -71.05 63.29 60.06 -70.79 coo 44.36 11.24 3.39 41.81 12.78 4.00 60.42 66.09 -63.48 62.84 64.38 -64.17 coo 38.40 3.83 10.26 40.02 6.30 9.25 73.60 65.75 -66.57 75.51 67.67 -67.91 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 14 3 # 14 22 ASN E 45 ASN^? 24.46 MG MG F 301 63 ARG E 8 ARG^? 20.19 MG MG E 302 255 ARG F 8 ARG^? 20.20 MG MG F 301 coo 42.10 13.02 11.14 41.85 11.12 10.23 64.97 61.33 -71.05 63.29 60.06 -70.79 coo 44.36 11.24 3.39 41.81 12.78 4.00 60.42 66.09 -63.48 62.84 64.38 -64.17 coo 38.40 3.83 10.26 40.02 6.30 9.25 58.98 65.22 -76.31 57.29 62.84 -75.38 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 15 3 # 15 22 ASN E 45 ASN^? 24.46 MG MG F 301 63 ARG F 8 ARG^? 20.20 MG MG F 301 255 ARG E 8 ARG^? 20.19 MG MG E 302 coo 42.10 13.02 11.14 41.85 11.12 10.23 64.97 61.33 -71.05 63.29 60.06 -70.79 coo 44.36 11.24 3.39 41.81 12.78 4.00 58.98 65.22 -76.31 57.29 62.84 -75.38 coo 38.40 3.83 10.26 40.02 6.30 9.25 60.42 66.09 -63.48 62.84 64.38 -64.17 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 16 3 # 16 22 ASN F 45 ASN^? 24.43 MG MG E 302 63 ARG E 8 ARG^? 20.19 MG MG E 302 255 ARG F 8 ARG^? 20.20 MG MG F 301 coo 42.10 13.02 11.14 41.85 11.12 10.23 56.42 59.79 -68.43 58.48 59.32 -68.69 coo 44.36 11.24 3.39 41.81 12.78 4.00 60.42 66.09 -63.48 62.84 64.38 -64.17 coo 38.40 3.83 10.26 40.02 6.30 9.25 58.98 65.22 -76.31 57.29 62.84 -75.38 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 17 3 # 17 22 ASN F 45 ASN^? 24.43 MG MG E 302 63 ARG F 8 ARG^? 20.20 MG MG F 301 255 ARG E 8 ARG^? 20.19 MG MG E 302 coo 42.10 13.02 11.14 41.85 11.12 10.23 56.42 59.79 -68.43 58.48 59.32 -68.69 coo 44.36 11.24 3.39 41.81 12.78 4.00 58.98 65.22 -76.31 57.29 62.84 -75.38 coo 38.40 3.83 10.26 40.02 6.30 9.25 60.42 66.09 -63.48 62.84 64.38 -64.17 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 18 3 # 18 22 ASN F 45 ASN^? 24.43 MG MG E 302 63 ARG F 8 ARG^? 20.20 MG MG F 301 255 ARG F 37 ARG^? 19.14 MG MG F 301 coo 42.10 13.02 11.14 41.85 11.12 10.23 56.42 59.79 -68.43 58.48 59.32 -68.69 coo 44.36 11.24 3.39 41.81 12.78 4.00 58.98 65.22 -76.31 57.29 62.84 -75.38 coo 38.40 3.83 10.26 40.02 6.30 9.25 48.80 64.46 -76.37 51.50 64.15 -77.79 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 19 3 # 19 22 ASN F 45 ASN^? 24.43 MG MG E 302 63 ARG F 8 ARG^? 20.20 MG MG F 301 255 ARG F 48 ARG^? 25.18 MG MG F 301 coo 42.10 13.02 11.14 41.85 11.12 10.23 56.42 59.79 -68.43 58.48 59.32 -68.69 coo 44.36 11.24 3.39 41.81 12.78 4.00 58.98 65.22 -76.31 57.29 62.84 -75.38 coo 38.40 3.83 10.26 40.02 6.30 9.25 46.82 60.90 -73.07 44.43 61.88 -71.46 1aj0_c00 source 1aj0 DIHYDROPTEROATE SYNTHASE : 19 hits 1aj0_c00 naa= 3 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 1 3 # 1 252 THR A 18 THR.? 15.77 MG MG A 301 350 PHE A 150 PHE^? 10.47 MG MG A 302 357 CYH A 152 CYH^? 15.18 MG MG A 302 coo 17.85 20.47 14.62 16.85 19.84 12.80 32.02 38.89 33.13 34.18 39.03 32.98 coo 7.92 21.96 13.27 8.57 20.30 15.42 35.63 32.10 38.88 34.73 33.93 37.00 coo 8.82 20.77 7.90 10.59 19.75 9.80 34.81 26.51 34.70 32.10 26.95 34.06 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 2 3 # 2 252 THR A 18 THR.? 15.77 MG MG A 301 350 PHE A 172 PHE^? 13.28 MG MG A 302 357 CYH A 152 CYH^? 15.18 MG MG A 302 coo 17.85 20.47 14.62 16.85 19.84 12.80 32.02 38.89 33.13 34.18 39.03 32.98 coo 7.92 21.96 13.27 8.57 20.30 15.42 31.82 29.57 38.19 30.91 31.55 36.40 coo 8.82 20.77 7.90 10.59 19.75 9.80 34.81 26.51 34.70 32.10 26.95 34.06 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 3 3 # 3 252 THR A 40 THR^? 24.69 MG MG A 301 350 PHE A 12 PHE^? 17.15 MG MG A 301 357 CYH A 152 CYH^? 15.18 MG MG A 302 coo 17.85 20.47 14.62 16.85 19.84 12.80 32.64 20.47 25.22 32.40 21.22 23.20 coo 7.92 21.96 13.27 8.57 20.30 15.42 34.93 27.27 29.42 32.88 25.47 30.10 coo 8.82 20.77 7.90 10.59 19.75 9.80 34.81 26.51 34.70 32.10 26.95 34.06 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 4 3 # 4 252 THR A 175 THR^? 12.07 MG MG A 302 350 PHE A 150 PHE^? 10.47 MG MG A 302 357 CYH A 152 CYH^? 15.18 MG MG A 302 coo 17.85 20.47 14.62 16.85 19.84 12.80 29.08 25.19 42.91 31.22 24.90 42.83 coo 7.92 21.96 13.27 8.57 20.30 15.42 35.63 32.10 38.88 34.73 33.93 37.00 coo 8.82 20.77 7.90 10.59 19.75 9.80 34.81 26.51 34.70 32.10 26.95 34.06 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 5 3 # 5 252 THR A 175 THR^? 12.07 MG MG A 302 350 PHE A 153 PHE^? 9.64 MG MG A 301 357 CYH A 152 CYH^? 15.18 MG MG A 302 coo 17.85 20.47 14.62 16.85 19.84 12.80 29.08 25.19 42.91 31.22 24.90 42.83 coo 7.92 21.96 13.27 8.57 20.30 15.42 38.89 24.49 36.07 40.14 26.70 37.23 coo 8.82 20.77 7.90 10.59 19.75 9.80 34.81 26.51 34.70 32.10 26.95 34.06 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 6 3 # 6 252 THR B 18 THR^? 16.08 MG MG B 302 350 PHE B 150 PHE^? 9.88 MG MG B 301 357 CYH B 152 CYH^? 14.66 MG MG B 301 coo 17.85 20.47 14.62 16.85 19.84 12.80 60.02 7.32 3.97 60.86 9.29 4.05 coo 7.92 21.96 13.27 8.57 20.30 15.42 54.70 12.86 -1.84 56.31 11.50 0.05 coo 8.82 20.77 7.90 10.59 19.75 9.80 48.74 12.82 1.93 48.51 10.17 2.19 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 7 3 # 7 252 THR B 18 THR^? 16.08 MG MG B 302 350 PHE B 172 PHE^? 12.81 MG MG B 301 357 CYH B 152 CYH^? 14.66 MG MG B 301 coo 17.85 20.47 14.62 16.85 19.84 12.80 60.02 7.32 3.97 60.86 9.29 4.05 coo 7.92 21.96 13.27 8.57 20.30 15.42 51.51 9.59 -1.64 53.03 8.15 0.22 coo 8.82 20.77 7.90 10.59 19.75 9.80 48.74 12.82 1.93 48.51 10.17 2.19 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 8 3 # 8 252 THR B 40 THR^? 24.25 MG MG B 302 350 PHE B 12 PHE^? 17.13 MG MG B 302 357 CYH B 152 CYH^? 14.66 MG MG B 301 coo 17.85 20.47 14.62 16.85 19.84 12.80 41.77 11.06 10.77 42.63 10.70 12.73 coo 7.92 21.96 13.27 8.57 20.30 15.42 49.02 12.29 7.19 47.01 10.60 6.19 coo 8.82 20.77 7.90 10.59 19.75 9.80 48.74 12.82 1.93 48.51 10.17 2.19 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 9 3 # 9 252 THR B 175 THR^? 12.15 MG MG B 301 350 PHE B 150 PHE^? 9.88 MG MG B 301 357 CYH B 152 CYH^? 14.66 MG MG B 301 coo 17.85 20.47 14.62 16.85 19.84 12.80 46.88 7.94 -7.07 47.05 10.06 -6.52 coo 7.92 21.96 13.27 8.57 20.30 15.42 54.70 12.86 -1.84 56.31 11.50 0.05 coo 8.82 20.77 7.90 10.59 19.75 9.80 48.74 12.82 1.93 48.51 10.17 2.19 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 10 3 # 10 252 THR B 175 THR^? 12.15 MG MG B 301 350 PHE B 153 PHE^? 9.59 MG MG B 302 357 CYH B 152 CYH^? 14.66 MG MG B 301 coo 17.85 20.47 14.62 16.85 19.84 12.80 46.88 7.94 -7.07 47.05 10.06 -6.52 coo 7.92 21.96 13.27 8.57 20.30 15.42 47.54 17.09 0.77 50.03 17.91 -0.19 coo 8.82 20.77 7.90 10.59 19.75 9.80 48.74 12.82 1.93 48.51 10.17 2.19 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 11 3 # 11 252 THR C 18 THR^? 15.72 MG MG C 302 350 PHE C 150 PHE^? 10.02 MG MG C 301 357 CYH C 152 CYH^? 14.61 MG MG C 301 coo 17.85 20.47 14.62 16.85 19.84 12.80 79.00 10.43 -10.53 77.64 12.10 -10.65 coo 7.92 21.96 13.27 8.57 20.30 15.42 82.11 17.28 -4.80 81.16 15.47 -6.75 coo 8.82 20.77 7.90 10.59 19.75 9.80 87.66 19.43 -8.58 88.77 17.04 -8.78 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 12 3 # 12 252 THR C 18 THR^? 15.72 MG MG C 302 350 PHE C 172 PHE^? 13.00 MG MG C 301 357 CYH C 152 CYH^? 14.61 MG MG C 301 coo 17.85 20.47 14.62 16.85 19.84 12.80 79.00 10.43 -10.53 77.64 12.10 -10.65 coo 7.92 21.96 13.27 8.57 20.30 15.42 86.45 15.28 -5.05 85.50 13.59 -7.08 coo 8.82 20.77 7.90 10.59 19.75 9.80 87.66 19.43 -8.58 88.77 17.04 -8.78 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 13 3 # 13 252 THR C 175 THR^? 12.73 MG MG C 301 350 PHE C 150 PHE^? 10.02 MG MG C 301 357 CYH C 152 CYH^? 14.61 MG MG C 301 coo 17.85 20.47 14.62 16.85 19.84 12.80 91.24 15.45 0.47 90.99 17.39 -0.47 coo 7.92 21.96 13.27 8.57 20.30 15.42 82.11 17.28 -4.80 81.16 15.47 -6.75 coo 8.82 20.77 7.90 10.59 19.75 9.80 87.66 19.43 -8.58 88.77 17.04 -8.78 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 14 3 # 14 252 THR D 18 THR^? 15.54 MG MG D 302 350 PHE D 150 PHE^? 10.21 MG MG D 301 357 CYH D 152 CYH^? 14.66 MG MG D 301 coo 17.85 20.47 14.62 16.85 19.84 12.80 93.52 49.91 -39.68 91.41 49.57 -39.76 coo 7.92 21.96 13.27 8.57 20.30 15.42 91.92 42.74 -45.34 92.24 44.79 -43.44 coo 8.82 20.77 7.90 10.59 19.75 9.80 94.69 37.43 -41.36 96.92 38.83 -40.94 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 15 3 # 15 252 THR D 18 THR^? 15.54 MG MG D 302 350 PHE D 172 PHE^? 13.02 MG MG D 301 357 CYH D 152 CYH^? 14.66 MG MG D 301 coo 17.85 20.47 14.62 16.85 19.84 12.80 93.52 49.91 -39.68 91.41 49.57 -39.76 coo 7.92 21.96 13.27 8.57 20.30 15.42 96.36 41.50 -44.84 96.77 43.66 -43.13 coo 8.82 20.77 7.90 10.59 19.75 9.80 94.69 37.43 -41.36 96.92 38.83 -40.94 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 16 3 # 16 252 THR D 175 THR^? 12.60 MG MG D 301 350 PHE D 150 PHE^? 10.21 MG MG D 301 357 CYH D 152 CYH^? 14.66 MG MG D 301 coo 17.85 20.47 14.62 16.85 19.84 12.80 100.33 38.24 -50.15 98.81 36.95 -49.29 coo 7.92 21.96 13.27 8.57 20.30 15.42 91.92 42.74 -45.34 92.24 44.79 -43.44 coo 8.82 20.77 7.90 10.59 19.75 9.80 94.69 37.43 -41.36 96.92 38.83 -40.94 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 17 3 # 17 252 THR D 175 THR^? 12.60 MG MG D 301 350 PHE D 153 PHE^? 9.11 MG MG D 302 357 CYH D 152 CYH^? 14.66 MG MG D 301 coo 17.85 20.47 14.62 16.85 19.84 12.80 100.33 38.24 -50.15 98.81 36.95 -49.29 coo 7.92 21.96 13.27 8.57 20.30 15.42 91.67 34.35 -42.71 89.76 36.10 -43.73 coo 8.82 20.77 7.90 10.59 19.75 9.80 94.69 37.43 -41.36 96.92 38.83 -40.94 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 18 3 # 18 252 THR E 18 THR^? 15.84 MG MG E 302 350 PHE E 150 PHE^? 10.10 MG MG E 301 357 CYH E 152 CYH^? 14.64 MG MG E 301 coo 17.85 20.47 14.62 16.85 19.84 12.80 81.45 64.25 -55.27 80.73 62.21 -55.24 coo 7.92 21.96 13.27 8.57 20.30 15.42 74.01 63.99 -49.53 76.06 63.87 -51.45 coo 8.82 20.77 7.90 10.59 19.75 9.80 69.49 67.27 -53.54 71.02 69.50 -54.03 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 19 3 # 19 252 THR E 18 THR^? 15.84 MG MG E 302 350 PHE E 172 PHE^? 12.71 MG MG E 301 357 CYH E 152 CYH^? 14.64 MG MG E 301 coo 17.85 20.47 14.62 16.85 19.84 12.80 81.45 64.25 -55.27 80.73 62.21 -55.24 coo 7.92 21.96 13.27 8.57 20.30 15.42 73.54 68.41 -50.00 75.58 68.36 -51.87 coo 8.82 20.77 7.90 10.59 19.75 9.80 69.49 67.27 -53.54 71.02 69.50 -54.03 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 20 3 # 20 252 THR E 40 THR^? 24.66 MG MG E 302 350 PHE E 12 PHE^? 17.09 MG MG E 302 357 CYH E 152 CYH^? 14.64 MG MG E 301 coo 17.85 20.47 14.62 16.85 19.84 12.80 65.26 72.42 -63.00 65.97 72.32 -65.06 coo 7.92 21.96 13.27 8.57 20.30 15.42 70.06 67.18 -58.76 69.33 69.81 -58.07 coo 8.82 20.77 7.90 10.59 19.75 9.80 69.49 67.27 -53.54 71.02 69.50 -54.03 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 21 3 # 21 252 THR E 175 THR^? 12.38 MG MG E 301 350 PHE E 150 PHE^? 10.10 MG MG E 301 357 CYH E 152 CYH^? 14.64 MG MG E 301 coo 17.85 20.47 14.62 16.85 19.84 12.80 71.20 72.92 -44.89 69.57 71.76 -45.77 coo 7.92 21.96 13.27 8.57 20.30 15.42 74.01 63.99 -49.53 76.06 63.87 -51.45 coo 8.82 20.77 7.90 10.59 19.75 9.80 69.49 67.27 -53.54 71.02 69.50 -54.03 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 22 3 # 22 252 THR E 175 THR^? 12.38 MG MG E 301 350 PHE E 153 PHE^? 9.50 MG MG E 302 357 CYH E 152 CYH^? 14.64 MG MG E 301 coo 17.85 20.47 14.62 16.85 19.84 12.80 71.20 72.92 -44.89 69.57 71.76 -45.77 coo 7.92 21.96 13.27 8.57 20.30 15.42 65.86 64.95 -52.12 67.22 62.73 -51.09 coo 8.82 20.77 7.90 10.59 19.75 9.80 69.49 67.27 -53.54 71.02 69.50 -54.03 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 23 3 # 23 252 THR F 18 THR^? 15.93 MG MG F 301 350 PHE F 150 PHE^? 9.82 MG MG F 302 357 CYH F 152 CYH^? 14.14 MG MG F 302 coo 17.85 20.47 14.62 16.85 19.84 12.80 39.95 55.99 -83.96 41.26 54.27 -83.96 coo 7.92 21.96 13.27 8.57 20.30 15.42 47.10 57.70 -89.94 45.06 57.27 -88.04 coo 8.82 20.77 7.90 10.59 19.75 9.80 50.28 62.76 -86.08 48.12 64.34 -85.77 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 24 3 # 24 252 THR F 18 THR^? 15.93 MG MG F 301 350 PHE F 172 PHE^? 12.43 MG MG F 302 357 CYH F 152 CYH^? 14.14 MG MG F 302 coo 17.85 20.47 14.62 16.85 19.84 12.80 39.95 55.99 -83.96 41.26 54.27 -83.96 coo 7.92 21.96 13.27 8.57 20.30 15.42 45.85 62.23 -89.68 43.95 61.55 -87.75 coo 8.82 20.77 7.90 10.59 19.75 9.80 50.28 62.76 -86.08 48.12 64.34 -85.77 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 25 3 # 25 252 THR F 40 THR^? 24.18 MG MG F 301 350 PHE F 12 PHE^? 17.12 MG MG F 301 357 CYH F 152 CYH^? 14.14 MG MG F 302 coo 17.85 20.47 14.62 16.85 19.84 12.80 52.32 69.62 -77.21 51.38 69.00 -75.36 coo 7.92 21.96 13.27 8.57 20.30 15.42 49.70 62.79 -80.90 49.37 65.44 -81.67 coo 8.82 20.77 7.90 10.59 19.75 9.80 50.28 62.76 -86.08 48.12 64.34 -85.77 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 26 3 # 26 252 THR F 175 THR^? 11.83 MG MG F 302 350 PHE F 150 PHE^? 9.82 MG MG F 302 357 CYH F 152 CYH^? 14.14 MG MG F 302 coo 17.85 20.47 14.62 16.85 19.84 12.80 46.82 66.80 -95.29 48.97 66.65 -95.25 coo 7.92 21.96 13.27 8.57 20.30 15.42 47.10 57.70 -89.94 45.06 57.27 -88.04 coo 8.82 20.77 7.90 10.59 19.75 9.80 50.28 62.76 -86.08 48.12 64.34 -85.77 1akd_c01 source 1akd CYTOCHROME P450CAM : 26 hits 1akd_c01 naa= 3 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 1 3 # 1 33 ASP A 23 ASP^? 22.90 MG MG A 301 187 GLU A 75 GLU^? 20.23 MG MG A 301 229 LYS A 76 LYS^? 25.42 MG MG A 301 coo -52.57 56.60 47.75 -51.52 54.87 46.95 36.40 52.47 38.61 38.03 53.36 39.72 coo -45.08 48.37 46.81 -46.53 49.74 45.96 38.99 46.65 28.68 39.94 47.65 30.33 coo -47.40 44.36 48.48 -50.80 49.18 46.20 34.45 46.53 27.28 28.88 44.93 27.25 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 2 3 # 2 33 ASP B 23 ASP^? 15.67 MG MG C 301 187 GLU B 75 GLU^? 15.82 MG MG C 301 229 LYS B 76 LYS^? 25.77 MG MG B 302 coo -52.57 56.60 47.75 -51.52 54.87 46.95 74.31 7.55 -1.09 75.08 9.17 -2.23 coo -45.08 48.37 46.81 -46.53 49.74 45.96 68.81 12.14 8.61 69.95 13.49 7.45 coo -47.40 44.36 48.48 -50.80 49.18 46.20 67.82 8.19 10.14 64.96 3.09 10.62 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 3 3 # 3 33 ASP B 35 ASP^? 16.92 MG MG B 302 187 GLU A 63 GLU^? 28.10 MG MG B 302 229 LYS A 61 LYS^? 21.99 MG MG B 302 coo -52.57 56.60 47.75 -51.52 54.87 46.95 52.63 11.07 10.18 53.68 12.85 9.94 coo -45.08 48.37 46.81 -46.53 49.74 45.96 59.13 11.55 21.47 60.51 12.96 22.22 coo -47.40 44.36 48.48 -50.80 49.18 46.20 57.78 7.35 19.60 56.77 12.20 15.61 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 4 3 # 4 33 ASP C 23 ASP^? 15.39 MG MG B 301 187 GLU C 75 GLU^? 16.14 MG MG B 301 229 LYS C 76 LYS^? 24.95 MG MG C 302 coo -52.57 56.60 47.75 -51.52 54.87 46.95 65.24 6.82 -5.11 63.43 7.54 -4.15 coo -45.08 48.37 46.81 -46.53 49.74 45.96 69.49 12.18 -14.30 67.44 12.65 -13.83 coo -47.40 44.36 48.48 -50.80 49.18 46.20 71.11 8.63 -16.76 75.44 5.17 -16.80 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 5 3 # 5 33 ASP D 23 ASP^? 15.37 MG MG E 301 187 GLU D 75 GLU^? 15.53 MG MG E 301 229 LYS D 76 LYS^? 25.08 MG MG D 302 coo -52.57 56.60 47.75 -51.52 54.87 46.95 85.70 62.10 -45.60 84.07 62.13 -46.93 coo -45.08 48.37 46.81 -46.53 49.74 45.96 84.53 54.81 -36.40 82.75 56.01 -36.42 coo -47.40 44.36 48.48 -50.80 49.18 46.20 88.18 56.35 -34.05 93.80 56.17 -32.93 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 6 3 # 6 33 ASP E 23 ASP^? 15.43 MG MG D 301 187 GLU E 75 GLU^? 15.76 MG MG D 301 229 LYS E 76 LYS^? 25.68 MG MG E 302 coo -52.57 56.60 47.75 -51.52 54.87 46.95 91.98 54.64 -49.37 91.93 52.78 -48.33 coo -45.08 48.37 46.81 -46.53 49.74 45.96 84.65 53.96 -59.58 85.64 52.81 -58.05 coo -47.40 44.36 48.48 -50.80 49.18 46.20 87.09 58.11 -60.91 88.65 63.65 -61.27 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 7 3 # 7 33 ASP F 23 ASP^? 23.03 MG MG F 301 187 GLU F 75 GLU^? 19.96 MG MG F 301 229 LYS F 76 LYS^? 25.89 MG MG F 301 coo -52.57 56.60 47.75 -51.52 54.87 46.95 31.30 43.61 -89.40 33.44 43.69 -89.02 coo -45.08 48.37 46.81 -46.53 49.74 45.96 40.19 46.06 -80.81 40.09 43.94 -81.24 coo -47.40 44.36 48.48 -50.80 49.18 46.20 36.96 48.52 -78.06 33.74 53.37 -77.06 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 8 3 # 8 33 ASP F 35 ASP^? 16.93 MG MG F 301 187 GLU E 63 GLU^? 28.08 MG MG F 301 229 LYS E 61 LYS^? 22.16 MG MG F 301 coo -52.57 56.60 47.75 -51.52 54.87 46.95 46.82 60.47 -77.63 48.00 58.79 -78.23 coo -45.08 48.37 46.81 -46.53 49.74 45.96 44.04 53.99 -66.79 43.77 51.93 -66.35 coo -47.40 44.36 48.48 -50.80 49.18 46.20 40.99 56.84 -68.48 45.99 56.72 -72.39 1ald_c00 source 1ald ALDOLASE A (E.C.4.1.2.13) : 8 hits 1ald_c00 naa= 3 ULMN 3 1amo_c00 NADPH-CYTOCHROME P450 REDUCTASE user 1 3 # 1 A 457 SER A 140 SER^? 30.67 MG MG A 302 A 630 CYH A 134 CYH^? 26.26 MG MG A 301 A 675 ASP A 142 ASP^? 23.70 MG MG A 302 coo 2.70 -0.05 22.31 2.42 1.39 24.24 44.28 3.90 31.34 44.69 1.94 32.71 coo 0.87 7.55 27.28 1.82 5.91 25.24 50.20 8.98 35.26 50.67 6.53 36.33 coo 0.10 3.62 28.03 1.23 2.44 26.67 46.39 7.18 37.53 46.28 7.18 39.63 ULMN 3 1amo_c00 NADPH-CYTOCHROME P450 REDUCTASE user 2 3 # 2 A 457 SER B 140 SER^? 30.81 MG MG B 301 A 630 CYH B 134 CYH^? 26.11 MG MG B 302 A 675 ASP B 142 ASP^? 23.97 MG MG B 301 coo 2.70 -0.05 22.31 2.42 1.39 24.24 27.68 26.34 4.28 26.00 26.10 2.61 coo 0.87 7.55 27.28 1.82 5.91 25.24 34.20 30.90 1.45 31.94 31.91 0.17 coo 0.10 3.62 28.03 1.23 2.44 26.67 31.69 27.40 -1.31 32.10 27.37 -3.38 ULMN 3 1amo_c00 NADPH-CYTOCHROME P450 REDUCTASE user 3 3 # 3 A 457 SER C 140 SER^? 30.64 MG MG C 302 A 630 CYH C 134 CYH^? 26.29 MG MG C 302 A 675 ASP C 142 ASP^? 23.76 MG MG C 301 coo 2.70 -0.05 22.31 2.42 1.39 24.24 102.22 39.34 -11.26 103.20 41.01 -9.93 coo 0.87 7.55 27.28 1.82 5.91 25.24 94.82 41.56 -7.94 96.69 43.34 -6.91 coo 0.10 3.62 28.03 1.23 2.44 26.67 97.94 39.27 -5.03 98.08 38.70 -2.97 ULMN 3 1amo_c00 NADPH-CYTOCHROME P450 REDUCTASE user 4 3 # 4 A 457 SER D 140 SER^? 31.33 MG MG D 302 A 630 CYH D 134 CYH^? 26.15 MG MG D 302 A 675 ASP D 142 ASP^? 23.49 MG MG D 301 coo 2.70 -0.05 22.31 2.42 1.39 24.24 93.76 12.87 -38.46 94.82 10.83 -39.17 coo 0.87 7.55 27.28 1.82 5.91 25.24 86.76 15.73 -41.96 86.80 13.27 -43.24 coo 0.10 3.62 28.03 1.23 2.44 26.67 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 1amo_c00 NADPH-CYTOCHROME P450 REDUCTASE user 5 3 # 5 A 457 SER E 140 SER^? 30.62 MG MG E 302 A 630 CYH E 134 CYH^? 26.24 MG MG E 302 A 675 ASP E 142 ASP^? 23.66 MG MG E 301 coo 2.70 -0.05 22.31 2.42 1.39 24.24 45.10 70.42 -56.56 43.21 70.47 -55.13 coo 0.87 7.55 27.28 1.82 5.91 25.24 46.74 63.09 -52.79 44.18 63.32 -51.85 coo 0.10 3.62 28.03 1.23 2.44 26.67 47.19 67.15 -50.37 47.44 67.18 -48.23 ULMN 3 1amo_c00 NADPH-CYTOCHROME P450 REDUCTASE user 6 3 # 6 A 457 SER F 140 SER^? 31.01 MG MG F 302 A 630 CYH F 134 CYH^? 26.42 MG MG F 301 A 675 ASP F 142 ASP^? 23.43 MG MG F 302 coo 2.70 -0.05 22.31 2.42 1.39 24.24 72.45 74.17 -84.01 73.77 75.91 -85.04 coo 0.87 7.55 27.28 1.82 5.91 25.24 73.26 66.44 -86.89 75.26 68.05 -88.15 coo 0.10 3.62 28.03 1.23 2.44 26.67 71.46 69.88 -89.76 71.03 69.93 -91.81 1amo_c00 source 1amo NADPH-CYTOCHROME P450 REDUCTASE : 6 hits 1amo_c00 naa= 3 ULMN 3 1amo_c01 NADPH-CYTOCHROME P450 REDUCTASE user 1 3 # 1 B 457 SER A 140 SER^? 30.67 MG MG A 302 B 630 CYH A 134 CYH^? 26.26 MG MG A 301 B 675 ASP A 142 ASP^? 23.70 MG MG A 302 coo 48.68 26.05 22.04 49.09 24.42 23.79 44.28 3.90 31.34 44.69 1.94 32.71 coo 50.83 17.98 26.05 49.75 19.82 24.27 50.20 8.98 35.26 50.67 6.53 36.33 coo 51.67 21.81 27.15 50.44 23.13 26.00 46.39 7.18 37.53 46.28 7.18 39.63 ULMN 3 1amo_c01 NADPH-CYTOCHROME P450 REDUCTASE user 2 3 # 2 B 457 SER B 140 SER^? 30.81 MG MG B 301 B 630 CYH B 134 CYH^? 26.11 MG MG B 302 B 675 ASP B 142 ASP^? 23.97 MG MG B 301 coo 48.68 26.05 22.04 49.09 24.42 23.79 27.68 26.34 4.28 26.00 26.10 2.61 coo 50.83 17.98 26.05 49.75 19.82 24.27 34.20 30.90 1.45 31.94 31.91 0.17 coo 51.67 21.81 27.15 50.44 23.13 26.00 31.69 27.40 -1.31 32.10 27.37 -3.38 ULMN 3 1amo_c01 NADPH-CYTOCHROME P450 REDUCTASE user 3 3 # 3 B 457 SER C 140 SER^? 30.64 MG MG C 302 B 630 CYH C 134 CYH^? 26.29 MG MG C 302 B 675 ASP C 142 ASP^? 23.76 MG MG C 301 coo 48.68 26.05 22.04 49.09 24.42 23.79 102.22 39.34 -11.26 103.20 41.01 -9.93 coo 50.83 17.98 26.05 49.75 19.82 24.27 94.82 41.56 -7.94 96.69 43.34 -6.91 coo 51.67 21.81 27.15 50.44 23.13 26.00 97.94 39.27 -5.03 98.08 38.70 -2.97 ULMN 3 1amo_c01 NADPH-CYTOCHROME P450 REDUCTASE user 4 3 # 4 B 457 SER D 140 SER^? 31.33 MG MG D 302 B 630 CYH D 134 CYH^? 26.15 MG MG D 302 B 675 ASP D 142 ASP^? 23.49 MG MG D 301 coo 48.68 26.05 22.04 49.09 24.42 23.79 93.76 12.87 -38.46 94.82 10.83 -39.17 coo 50.83 17.98 26.05 49.75 19.82 24.27 86.76 15.73 -41.96 86.80 13.27 -43.24 coo 51.67 21.81 27.15 50.44 23.13 26.00 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 1amo_c01 NADPH-CYTOCHROME P450 REDUCTASE user 5 3 # 5 B 457 SER E 140 SER^? 30.62 MG MG E 302 B 630 CYH E 134 CYH^? 26.24 MG MG E 302 B 675 ASP E 142 ASP^? 23.66 MG MG E 301 coo 48.68 26.05 22.04 49.09 24.42 23.79 45.10 70.42 -56.56 43.21 70.47 -55.13 coo 50.83 17.98 26.05 49.75 19.82 24.27 46.74 63.09 -52.79 44.18 63.32 -51.85 coo 51.67 21.81 27.15 50.44 23.13 26.00 47.19 67.15 -50.37 47.44 67.18 -48.23 ULMN 3 1amo_c01 NADPH-CYTOCHROME P450 REDUCTASE user 6 3 # 6 B 457 SER F 140 SER^? 31.01 MG MG F 302 B 630 CYH F 134 CYH^? 26.42 MG MG F 301 B 675 ASP F 142 ASP^? 23.43 MG MG F 302 coo 48.68 26.05 22.04 49.09 24.42 23.79 72.45 74.17 -84.01 73.77 75.91 -85.04 coo 50.83 17.98 26.05 49.75 19.82 24.27 73.26 66.44 -86.89 75.26 68.05 -88.15 coo 51.67 21.81 27.15 50.44 23.13 26.00 71.46 69.88 -89.76 71.03 69.93 -91.81 1amo_c01 source 1amo NADPH-CYTOCHROME P450 REDUCTASE : 6 hits 1amo_c01 naa= 3 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 138 ASP^? 33.08 MG MG A 302 214 ASP A 171 ASP^? 17.17 MG MG A 302 289 ASP A 142 ASP^? 23.70 MG MG A 302 coo -0.62 65.95 29.97 0.31 67.47 31.05 47.10 -0.97 29.63 45.89 0.22 30.96 coo 26.86 59.76 46.36 25.42 58.23 45.92 29.78 23.67 36.63 28.48 25.11 35.71 coo 9.42 68.07 30.27 7.35 68.27 30.10 46.39 7.18 37.53 46.28 7.18 39.63 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP B 128 ASP^? -3.57 MG MG B 302s 214 ASP C 81 ASP^? 23.42 MG MG B 301 289 ASP B 187 ASP^? -3.44 MG MG B 301s coo -0.62 65.95 29.97 0.31 67.47 31.05 52.92 24.09 -2.19 54.73 25.14 -1.90 coo 26.86 59.76 46.36 25.42 58.23 45.92 60.68 -2.08 -16.91 61.02 -0.17 -17.89 coo 9.42 68.07 30.27 7.35 68.27 30.10 50.64 18.14 -9.69 51.74 17.63 -7.86 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP B 138 ASP^? 33.32 MG MG B 302 214 ASP A 160 ASP^? 31.61 MG MG B 302 289 ASP B 160 ASP^? 31.65 MG MG A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 23.42 29.01 6.78 24.36 28.48 4.94 coo 26.86 59.76 46.36 25.42 58.23 45.92 44.21 5.00 19.54 46.02 3.84 19.76 coo 9.42 68.07 30.27 7.35 68.27 30.10 28.01 24.83 16.38 27.44 26.81 15.80 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP B 138 ASP^? 33.32 MG MG B 302 214 ASP B 171 ASP^? 16.92 MG MG B 301 289 ASP B 142 ASP^? 23.97 MG MG B 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 23.42 29.01 6.78 24.36 28.48 4.94 coo 26.86 59.76 46.36 25.42 58.23 45.92 45.30 8.50 -0.71 46.30 6.81 0.12 coo 9.42 68.07 30.27 7.35 68.27 30.10 31.69 27.40 -1.31 32.10 27.37 -3.38 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP C 58 ASP^? 26.67 MG MG D 302 214 ASP D 23 ASP^? 15.37 MG MG E 301 289 ASP D 35 ASP^? 16.80 MG MG D 302 coo -0.62 65.95 29.97 0.31 67.47 31.05 93.40 43.81 -22.27 94.18 44.45 -24.11 coo 26.86 59.76 46.36 25.42 58.23 45.92 85.70 62.10 -45.60 84.07 62.13 -46.93 coo 9.42 68.07 30.27 7.35 68.27 30.10 93.83 42.00 -33.14 91.74 41.83 -33.51 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP C 128 ASP^? -3.22 MG MG C 302s 214 ASP B 81 ASP^? 24.85 MG MG C 301 289 ASP C 187 ASP^? -3.72 MG MG C 301s coo -0.62 65.95 29.97 0.31 67.47 31.05 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 26.86 59.76 46.36 25.42 58.23 45.92 79.93 -0.44 10.01 79.44 1.19 11.29 coo 9.42 68.07 30.27 7.35 68.27 30.10 84.01 23.73 3.39 83.47 22.54 1.59 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 7 3 # 7 179 ASP C 138 ASP^? 33.43 MG MG C 302 214 ASP C 171 ASP^? 17.08 MG MG C 301 289 ASP C 142 ASP^? 23.76 MG MG C 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 105.43 43.97 -13.30 104.85 43.08 -11.43 coo 26.86 59.76 46.36 25.42 58.23 45.92 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 9.42 68.07 30.27 7.35 68.27 30.10 97.94 39.27 -5.03 98.08 38.70 -2.97 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 8 3 # 8 179 ASP D 128 ASP^? -3.70 MG MG D 302s 214 ASP E 81 ASP^? 24.19 MG MG D 301 289 ASP D 187 ASP^? -2.95 MG MG D 301s coo -0.62 65.95 29.97 0.31 67.47 31.05 83.33 35.45 -46.13 81.57 36.63 -46.10 coo 26.86 59.76 46.36 25.42 58.23 45.92 101.61 56.30 -60.24 100.25 55.53 -61.72 coo 9.42 68.07 30.27 7.35 68.27 30.10 90.40 36.34 -52.69 89.24 37.98 -51.99 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 9 3 # 9 179 ASP D 138 ASP^? 33.64 MG MG D 302 214 ASP C 160 ASP^? 31.63 MG MG D 302 289 ASP D 160 ASP^? 31.45 MG MG C 302 coo -0.62 65.95 29.97 0.31 67.47 31.05 93.00 7.50 -35.79 93.88 8.48 -37.45 coo 26.86 59.76 46.36 25.42 58.23 45.92 102.50 38.00 -23.28 102.43 39.97 -22.46 coo 9.42 68.07 30.27 7.35 68.27 30.10 94.15 13.98 -26.57 92.71 12.42 -26.99 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 10 3 # 10 179 ASP D 138 ASP^? 33.64 MG MG D 302 214 ASP D 171 ASP^? 16.95 MG MG D 301 289 ASP D 142 ASP^? 23.49 MG MG D 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 93.00 7.50 -35.79 93.88 8.48 -37.45 coo 26.86 59.76 46.36 25.42 58.23 45.92 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 9.42 68.07 30.27 7.35 68.27 30.10 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 11 3 # 11 179 ASP E 58 ASP^? 26.76 MG MG F 301 214 ASP F 23 ASP^? 23.03 MG MG F 301 289 ASP F 35 ASP^? 16.93 MG MG F 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 26.86 59.76 46.36 25.42 58.23 45.92 31.30 43.61 -89.40 33.44 43.69 -89.02 coo 9.42 68.07 30.27 7.35 68.27 30.10 46.82 60.47 -77.63 48.00 58.79 -78.23 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 12 3 # 12 179 ASP E 128 ASP^? -3.53 MG MG E 302s 214 ASP D 81 ASP^? 23.25 MG MG E 301 289 ASP E 187 ASP^? -2.71 MG MG E 301s coo -0.62 65.95 29.97 0.31 67.47 31.05 65.38 56.57 -48.58 66.15 54.57 -48.61 coo 26.86 59.76 46.36 25.42 58.23 45.92 89.25 71.36 -34.47 87.72 70.06 -33.67 coo 9.42 68.07 30.27 7.35 68.27 30.10 67.50 63.43 -41.69 68.97 62.26 -42.81 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 13 3 # 13 179 ASP E 138 ASP^? 33.31 MG MG E 302 214 ASP E 171 ASP^? 16.73 MG MG E 301 289 ASP E 142 ASP^? 23.66 MG MG E 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 39.58 70.77 -58.63 40.74 70.78 -56.80 coo 26.86 59.76 46.36 25.42 58.23 45.92 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 9.42 68.07 30.27 7.35 68.27 30.10 47.19 67.15 -50.37 47.44 67.18 -48.23 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 14 3 # 14 179 ASP E 138 ASP^? 33.31 MG MG E 302 214 ASP F 160 ASP^? 31.59 MG MG E 302 289 ASP E 160 ASP^? 31.54 MG MG F 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 39.58 70.77 -58.63 40.74 70.78 -56.80 coo 26.86 59.76 46.36 25.42 58.23 45.92 71.27 74.59 -71.77 73.23 74.02 -72.37 coo 9.42 68.07 30.27 7.35 68.27 30.10 45.81 70.00 -68.45 44.10 68.87 -67.77 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 15 3 # 15 179 ASP F 138 ASP^? 33.51 MG MG F 302 214 ASP F 171 ASP^? 16.35 MG MG F 302 289 ASP F 142 ASP^? 23.43 MG MG F 302 coo -0.62 65.95 29.97 0.31 67.47 31.05 77.17 76.66 -81.48 76.14 76.33 -83.32 coo 26.86 59.76 46.36 25.42 58.23 45.92 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 9.42 68.07 30.27 7.35 68.27 30.10 71.46 69.88 -89.76 71.03 69.93 -91.81 1amy_c01 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 15 hits 1amy_c01 naa= 3 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP D 187 ASP^? -2.95 MG MG D 301s 204 GLU D 146 GLU^? 10.62 MG MG D 301 289 ASP D 128 ASP^? -3.70 MG MG D 302s coo -0.62 65.95 29.97 0.31 67.47 31.05 90.40 36.34 -52.69 89.24 37.98 -51.99 coo 4.34 62.44 32.05 4.22 64.48 32.53 87.24 28.82 -50.92 85.47 28.08 -51.67 coo 9.42 68.07 30.27 7.35 68.27 30.10 83.33 35.45 -46.13 81.57 36.63 -46.10 1amy_c05 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 1 hits 1amy_c05 naa= 3 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 35 ASP^? 16.92 MG MG A 301 227 GLU A 54 GLU^? 22.98 MG MG A 301 289 ASP B 58 ASP^? 26.73 MG MG A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 34.49 31.10 26.54 36.41 31.82 27.10 coo 3.96 55.76 41.24 4.83 57.69 41.17 45.06 19.97 24.02 44.05 19.39 22.19 coo 9.42 68.07 30.27 7.35 68.27 30.10 34.42 33.56 15.74 33.50 33.49 17.59 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 35 ASP^? 16.92 MG MG A 301 227 GLU A 75 GLU^? 20.23 MG MG A 301 289 ASP B 58 ASP^? 26.73 MG MG A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 34.49 31.10 26.54 36.41 31.82 27.10 coo 3.96 55.76 41.24 4.83 57.69 41.17 38.99 46.65 28.68 39.94 47.65 30.33 coo 9.42 68.07 30.27 7.35 68.27 30.10 34.42 33.56 15.74 33.50 33.49 17.59 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP A 58 ASP^? 26.75 MG MG B 302 227 GLU B 52 GLU^? 20.06 MG MG B 302 289 ASP A 160 ASP^? 31.61 MG MG B 302 coo -0.62 65.95 29.97 0.31 67.47 31.05 53.93 9.80 21.09 53.83 8.90 19.15 coo 3.96 55.76 41.24 4.83 57.69 41.17 47.87 20.25 12.36 48.11 19.69 14.43 coo 9.42 68.07 30.27 7.35 68.27 30.10 44.21 5.00 19.54 46.02 3.84 19.76 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP A 128 ASP^? -3.32 MG MG A 301s 227 GLU A 154 GLU^? 19.22 MG MG A 301 289 ASP A 187 ASP^? -3.29 MG MG A 302s coo -0.62 65.95 29.97 0.31 67.47 31.05 46.50 28.23 39.77 47.49 30.10 39.82 coo 3.96 55.76 41.24 4.83 57.69 41.17 36.54 21.95 29.78 35.14 22.21 28.17 coo 9.42 68.07 30.27 7.35 68.27 30.10 39.43 26.57 46.78 39.37 27.83 45.03 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP A 148 ASP^? 2.72 MG MG A 301s 227 GLU A 154 GLU^? 19.22 MG MG A 301 289 ASP A 177 ASP^? 8.44 MG MG A 302 coo -0.62 65.95 29.97 0.31 67.47 31.05 41.50 28.88 41.13 43.33 29.67 41.93 coo 3.96 55.76 41.24 4.83 57.69 41.17 36.54 21.95 29.78 35.14 22.21 28.17 coo 9.42 68.07 30.27 7.35 68.27 30.10 33.02 29.04 43.18 33.79 27.88 44.78 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP A 160 ASP^? 31.61 MG MG B 302 227 GLU A 63 GLU^? 28.10 MG MG B 302 289 ASP A 138 ASP^? 33.08 MG MG A 302 coo -0.62 65.95 29.97 0.31 67.47 31.05 44.21 5.00 19.54 46.02 3.84 19.76 coo 3.96 55.76 41.24 4.83 57.69 41.17 59.13 11.55 21.47 60.51 12.96 22.22 coo 9.42 68.07 30.27 7.35 68.27 30.10 47.10 -0.97 29.63 45.89 0.22 30.96 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 7 3 # 7 179 ASP A 160 ASP^? 31.61 MG MG B 302 227 GLU B 154 GLU^? 19.05 MG MG B 302 289 ASP A 58 ASP^? 26.75 MG MG B 302 coo -0.62 65.95 29.97 0.31 67.47 31.05 44.21 5.00 19.54 46.02 3.84 19.76 coo 3.96 55.76 41.24 4.83 57.69 41.17 44.04 15.11 6.74 44.19 13.59 8.30 coo 9.42 68.07 30.27 7.35 68.27 30.10 53.93 9.80 21.09 53.83 8.90 19.15 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 8 3 # 8 179 ASP A 177 ASP^? 8.44 MG MG A 302 227 GLU A 146 GLU^? 9.80 MG MG A 302 289 ASP A 171 ASP^? 17.17 MG MG A 302 coo -0.62 65.95 29.97 0.31 67.47 31.05 33.02 29.04 43.18 33.79 27.88 44.78 coo 3.96 55.76 41.24 4.83 57.69 41.17 45.17 20.35 44.20 46.68 21.21 45.40 coo 9.42 68.07 30.27 7.35 68.27 30.10 29.78 23.67 36.63 28.48 25.11 35.71 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 9 3 # 9 179 ASP A 187 ASP^? -3.29 MG MG A 302s 227 GLU A 154 GLU^? 19.22 MG MG A 301 289 ASP A 128 ASP^? -3.32 MG MG A 301s coo -0.62 65.95 29.97 0.31 67.47 31.05 39.43 26.57 46.78 39.37 27.83 45.03 coo 3.96 55.76 41.24 4.83 57.69 41.17 36.54 21.95 29.78 35.14 22.21 28.17 coo 9.42 68.07 30.27 7.35 68.27 30.10 46.50 28.23 39.77 47.49 30.10 39.82 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 10 3 # 10 179 ASP B 35 ASP^? 16.92 MG MG B 302 227 GLU B 54 GLU^? 22.94 MG MG B 302 289 ASP A 58 ASP^? 26.75 MG MG B 302 coo -0.62 65.95 29.97 0.31 67.47 31.05 52.63 11.07 10.18 53.68 12.85 9.94 coo 3.96 55.76 41.24 4.83 57.69 41.17 43.18 23.27 12.99 42.40 22.23 14.68 coo 9.42 68.07 30.27 7.35 68.27 30.10 53.93 9.80 21.09 53.83 8.90 19.15 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 11 3 # 11 179 ASP B 58 ASP^? 26.73 MG MG A 301 227 GLU A 52 GLU^? 19.89 MG MG A 301 289 ASP B 160 ASP^? 31.65 MG MG A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 34.42 33.56 15.74 33.50 33.49 17.59 coo 3.96 55.76 41.24 4.83 57.69 41.17 42.67 25.16 24.80 42.61 25.77 22.75 coo 9.42 68.07 30.27 7.35 68.27 30.10 28.01 24.83 16.38 27.44 26.81 15.80 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 12 3 # 12 179 ASP B 128 ASP^? -3.57 MG MG B 302s 227 GLU B 154 GLU^? 19.05 MG MG B 302 289 ASP B 187 ASP^? -3.44 MG MG B 301s coo -0.62 65.95 29.97 0.31 67.47 31.05 52.92 24.09 -2.19 54.73 25.14 -1.90 coo 3.96 55.76 41.24 4.83 57.69 41.17 44.04 15.11 6.74 44.19 13.59 8.30 coo 9.42 68.07 30.27 7.35 68.27 30.10 50.64 18.14 -9.69 51.74 17.63 -7.86 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 13 3 # 13 179 ASP B 148 ASP^? 2.58 MG MG B 302s 227 GLU B 154 GLU^? 19.05 MG MG B 302 289 ASP B 177 ASP^? 9.03 MG MG B 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 3.96 55.76 41.24 4.83 57.69 41.17 44.04 15.11 6.74 44.19 13.59 8.30 coo 9.42 68.07 30.27 7.35 68.27 30.10 51.97 11.04 -6.64 50.39 11.62 -7.94 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 14 3 # 14 179 ASP B 160 ASP^? 31.65 MG MG A 301 227 GLU A 154 GLU^? 19.22 MG MG A 301 289 ASP B 58 ASP^? 26.73 MG MG A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 28.01 24.83 16.38 27.44 26.81 15.80 coo 3.96 55.76 41.24 4.83 57.69 41.17 36.54 21.95 29.78 35.14 22.21 28.17 coo 9.42 68.07 30.27 7.35 68.27 30.10 34.42 33.56 15.74 33.50 33.49 17.59 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 15 3 # 15 179 ASP B 160 ASP^? 31.65 MG MG A 301 227 GLU B 63 GLU^? 27.83 MG MG A 301 289 ASP B 138 ASP^? 33.32 MG MG B 302 coo -0.62 65.95 29.97 0.31 67.47 31.05 28.01 24.83 16.38 27.44 26.81 15.80 coo 3.96 55.76 41.24 4.83 57.69 41.17 36.89 38.35 16.01 38.64 39.45 15.67 coo 9.42 68.07 30.27 7.35 68.27 30.10 23.42 29.01 6.78 24.36 28.48 4.94 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 16 3 # 16 179 ASP B 177 ASP^? 9.03 MG MG B 301 227 GLU B 146 GLU^? 10.54 MG MG B 301 289 ASP B 171 ASP^? 16.92 MG MG B 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 51.97 11.04 -6.64 50.39 11.62 -7.94 coo 3.96 55.76 41.24 4.83 57.69 41.17 45.13 24.51 -7.01 46.08 25.99 -8.13 coo 9.42 68.07 30.27 7.35 68.27 30.10 45.30 8.50 -0.71 46.30 6.81 0.12 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 17 3 # 17 179 ASP B 187 ASP^? -3.44 MG MG B 301s 227 GLU C 25 GLU^? 12.27 MG MG B 301 289 ASP B 128 ASP^? -3.57 MG MG B 302s coo -0.62 65.95 29.97 0.31 67.47 31.05 50.64 18.14 -9.69 51.74 17.63 -7.86 coo 3.96 55.76 41.24 4.83 57.69 41.17 58.50 6.48 -3.59 57.94 8.54 -3.41 coo 9.42 68.07 30.27 7.35 68.27 30.10 52.92 24.09 -2.19 54.73 25.14 -1.90 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 18 3 # 18 179 ASP C 35 ASP^? 16.42 MG MG C 302 227 GLU C 54 GLU^? 22.77 MG MG C 302 289 ASP D 58 ASP^? 26.59 MG MG C 302 coo -0.62 65.95 29.97 0.31 67.47 31.05 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 3.96 55.76 41.24 4.83 57.69 41.17 88.91 31.25 -19.52 89.97 30.69 -21.29 coo 9.42 68.07 30.27 7.35 68.27 30.10 83.38 14.85 -27.71 84.09 14.12 -25.85 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 19 3 # 19 179 ASP C 58 ASP^? 26.67 MG MG D 302 227 GLU D 52 GLU^? 19.94 MG MG D 302 289 ASP C 160 ASP^? 31.63 MG MG D 302 coo -0.62 65.95 29.97 0.31 67.47 31.05 93.40 43.81 -22.27 94.18 44.45 -24.11 coo 3.96 55.76 41.24 4.83 57.69 41.17 87.13 33.17 -30.97 88.40 33.70 -29.31 coo 9.42 68.07 30.27 7.35 68.27 30.10 102.50 38.00 -23.28 102.43 39.97 -22.46 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 20 3 # 20 179 ASP C 128 ASP^? -3.22 MG MG C 302s 227 GLU C 154 GLU^? 18.91 MG MG C 302 289 ASP C 187 ASP^? -3.72 MG MG C 301s coo -0.62 65.95 29.97 0.31 67.47 31.05 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 3.96 55.76 41.24 4.83 57.69 41.17 91.15 23.27 -13.33 91.61 21.91 -14.95 coo 9.42 68.07 30.27 7.35 68.27 30.10 84.01 23.73 3.39 83.47 22.54 1.59 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 21 3 # 21 179 ASP C 148 ASP^? 2.75 MG MG C 302s 227 GLU C 154 GLU^? 18.91 MG MG C 302 289 ASP C 177 ASP^? 8.84 MG MG C 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 3.96 55.76 41.24 4.83 57.69 41.17 91.15 23.27 -13.33 91.61 21.91 -14.95 coo 9.42 68.07 30.27 7.35 68.27 30.10 85.60 16.42 -0.31 86.51 17.71 1.09 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 22 3 # 22 179 ASP C 160 ASP^? 31.63 MG MG D 302 227 GLU C 63 GLU^? 27.26 MG MG D 302 289 ASP C 138 ASP^? 33.43 MG MG C 302 coo -0.62 65.95 29.97 0.31 67.47 31.05 102.50 38.00 -23.28 102.43 39.97 -22.46 coo 3.96 55.76 41.24 4.83 57.69 41.17 89.51 47.54 -22.35 87.55 48.20 -22.72 coo 9.42 68.07 30.27 7.35 68.27 30.10 105.43 43.97 -13.30 104.85 43.08 -11.43 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 23 3 # 23 179 ASP C 160 ASP^? 31.63 MG MG D 302 227 GLU D 154 GLU^? 18.75 MG MG D 302 289 ASP C 58 ASP^? 26.67 MG MG D 302 coo -0.62 65.95 29.97 0.31 67.47 31.05 102.50 38.00 -23.28 102.43 39.97 -22.46 coo 3.96 55.76 41.24 4.83 57.69 41.17 94.87 32.52 -36.42 96.07 33.39 -34.88 coo 9.42 68.07 30.27 7.35 68.27 30.10 93.40 43.81 -22.27 94.18 44.45 -24.11 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 24 3 # 24 179 ASP C 171 ASP^? 17.08 MG MG C 301 227 GLU C 146 GLU^? 10.46 MG MG C 301 289 ASP C 177 ASP^? 8.84 MG MG C 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 3.96 55.76 41.24 4.83 57.69 41.17 87.01 31.93 0.25 85.57 32.56 1.72 coo 9.42 68.07 30.27 7.35 68.27 30.10 85.60 16.42 -0.31 86.51 17.71 1.09 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 25 3 # 25 179 ASP C 177 ASP^? 8.84 MG MG C 301 227 GLU C 146 GLU^? 10.46 MG MG C 301 289 ASP C 171 ASP^? 17.08 MG MG C 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 85.60 16.42 -0.31 86.51 17.71 1.09 coo 3.96 55.76 41.24 4.83 57.69 41.17 87.01 31.93 0.25 85.57 32.56 1.72 coo 9.42 68.07 30.27 7.35 68.27 30.10 92.57 16.68 -6.24 92.24 14.74 -7.03 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 26 3 # 26 179 ASP C 177 ASP^? 8.84 MG MG C 301 227 GLU C 154 GLU^? 18.91 MG MG C 302 289 ASP C 187 ASP^? -3.72 MG MG C 301s coo -0.62 65.95 29.97 0.31 67.47 31.05 85.60 16.42 -0.31 86.51 17.71 1.09 coo 3.96 55.76 41.24 4.83 57.69 41.17 91.15 23.27 -13.33 91.61 21.91 -14.95 coo 9.42 68.07 30.27 7.35 68.27 30.10 84.01 23.73 3.39 83.47 22.54 1.59 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 27 3 # 27 179 ASP C 187 ASP^? -3.72 MG MG C 301s 227 GLU B 25 GLU^? 12.88 MG MG C 301 289 ASP C 128 ASP^? -3.22 MG MG C 302s coo -0.62 65.95 29.97 0.31 67.47 31.05 84.01 23.73 3.39 83.47 22.54 1.59 coo 3.96 55.76 41.24 4.83 57.69 41.17 79.57 9.59 -3.08 79.20 11.68 -3.64 coo 9.42 68.07 30.27 7.35 68.27 30.10 80.05 28.39 -4.25 77.97 28.60 -4.21 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 28 3 # 28 179 ASP D 35 ASP^? 16.80 MG MG D 302 227 GLU D 54 GLU^? 22.96 MG MG D 302 289 ASP C 58 ASP^? 26.67 MG MG D 302 coo -0.62 65.95 29.97 0.31 67.47 31.05 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 3.96 55.76 41.24 4.83 57.69 41.17 87.96 27.60 -30.52 89.07 27.55 -28.72 coo 9.42 68.07 30.27 7.35 68.27 30.10 93.40 43.81 -22.27 94.18 44.45 -24.11 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 29 3 # 29 179 ASP D 58 ASP^? 26.59 MG MG C 302 227 GLU C 52 GLU^? 19.67 MG MG C 302 289 ASP D 160 ASP^? 31.45 MG MG C 302 coo -0.62 65.95 29.97 0.31 67.47 31.05 83.38 14.85 -27.71 84.09 14.12 -25.85 coo 3.96 55.76 41.24 4.83 57.69 41.17 84.27 26.98 -19.19 85.21 26.16 -20.96 coo 9.42 68.07 30.27 7.35 68.27 30.10 94.15 13.98 -26.57 92.71 12.42 -26.99 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 30 3 # 30 179 ASP D 128 ASP^? -3.70 MG MG D 302s 227 GLU D 154 GLU^? 18.75 MG MG D 302 289 ASP D 187 ASP^? -2.95 MG MG D 301s coo -0.62 65.95 29.97 0.31 67.47 31.05 83.33 35.45 -46.13 81.57 36.63 -46.10 coo 3.96 55.76 41.24 4.83 57.69 41.17 94.87 32.52 -36.42 96.07 33.39 -34.88 coo 9.42 68.07 30.27 7.35 68.27 30.10 90.40 36.34 -52.69 89.24 37.98 -51.99 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 31 3 # 31 179 ASP D 148 ASP^? 2.35 MG MG D 302s 227 GLU D 154 GLU^? 18.75 MG MG D 302 289 ASP D 177 ASP^? 8.43 MG MG D 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 3.96 55.76 41.24 4.83 57.69 41.17 94.87 32.52 -36.42 96.07 33.39 -34.88 coo 9.42 68.07 30.27 7.35 68.27 30.10 95.74 41.01 -49.76 94.81 39.90 -51.24 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 32 3 # 32 179 ASP D 160 ASP^? 31.45 MG MG C 302 227 GLU C 154 GLU^? 18.91 MG MG C 302 289 ASP D 58 ASP^? 26.59 MG MG C 302 coo -0.62 65.95 29.97 0.31 67.47 31.05 94.15 13.98 -26.57 92.71 12.42 -26.99 coo 3.96 55.76 41.24 4.83 57.69 41.17 91.15 23.27 -13.33 91.61 21.91 -14.95 coo 9.42 68.07 30.27 7.35 68.27 30.10 83.38 14.85 -27.71 84.09 14.12 -25.85 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 33 3 # 33 179 ASP D 160 ASP^? 31.45 MG MG C 302 227 GLU D 63 GLU^? 27.62 MG MG C 302 289 ASP D 138 ASP^? 33.64 MG MG D 302 coo -0.62 65.95 29.97 0.31 67.47 31.05 94.15 13.98 -26.57 92.71 12.42 -26.99 coo 3.96 55.76 41.24 4.83 57.69 41.17 77.46 14.75 -28.07 75.93 16.12 -28.66 coo 9.42 68.07 30.27 7.35 68.27 30.10 93.00 7.50 -35.79 93.88 8.48 -37.45 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 34 3 # 34 179 ASP D 177 ASP^? 8.43 MG MG D 301 227 GLU D 146 GLU^? 10.62 MG MG D 301 289 ASP D 171 ASP^? 16.95 MG MG D 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 95.74 41.01 -49.76 94.81 39.90 -51.24 coo 3.96 55.76 41.24 4.83 57.69 41.17 87.24 28.82 -50.92 85.47 28.08 -51.67 coo 9.42 68.07 30.27 7.35 68.27 30.10 100.39 36.69 -43.49 101.13 38.51 -42.69 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 35 3 # 35 179 ASP D 187 ASP^? -2.95 MG MG D 301s 227 GLU E 25 GLU^? 12.55 MG MG D 301 289 ASP D 128 ASP^? -3.70 MG MG D 302s coo -0.62 65.95 29.97 0.31 67.47 31.05 90.40 36.34 -52.69 89.24 37.98 -51.99 coo 3.96 55.76 41.24 4.83 57.69 41.17 95.44 49.40 -47.17 93.82 48.00 -47.21 coo 9.42 68.07 30.27 7.35 68.27 30.10 83.33 35.45 -46.13 81.57 36.63 -46.10 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 36 3 # 36 179 ASP E 35 ASP^? 16.91 MG MG E 302 227 GLU E 54 GLU^? 22.83 MG MG E 302 289 ASP F 58 ASP^? 26.87 MG MG E 302 coo -0.62 65.95 29.97 0.31 67.47 31.05 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 3.96 55.76 41.24 4.83 57.69 41.17 58.39 62.16 -64.12 58.73 62.98 -66.04 coo 9.42 68.07 30.27 7.35 68.27 30.10 75.55 64.68 -72.56 76.21 65.63 -70.79 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 37 3 # 37 179 ASP E 35 ASP^? 16.91 MG MG E 302 227 GLU E 75 GLU^? 15.76 MG MG D 301 289 ASP F 58 ASP^? 26.87 MG MG E 302 coo -0.62 65.95 29.97 0.31 67.47 31.05 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 3.96 55.76 41.24 4.83 57.69 41.17 84.65 53.96 -59.58 85.64 52.81 -58.05 coo 9.42 68.07 30.27 7.35 68.27 30.10 75.55 64.68 -72.56 76.21 65.63 -70.79 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 38 3 # 38 179 ASP E 58 ASP^? 26.76 MG MG F 301 227 GLU F 52 GLU^? 20.13 MG MG F 301 289 ASP E 160 ASP^? 31.54 MG MG F 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 3.96 55.76 41.24 4.83 57.69 41.17 57.09 59.62 -75.76 56.76 59.40 -73.62 coo 9.42 68.07 30.27 7.35 68.27 30.10 45.81 70.00 -68.45 44.10 68.87 -67.77 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 39 3 # 39 179 ASP E 128 ASP^? -3.53 MG MG E 302s 227 GLU E 154 GLU^? 19.05 MG MG E 302 289 ASP E 187 ASP^? -2.71 MG MG E 301s coo -0.62 65.95 29.97 0.31 67.47 31.05 65.38 56.57 -48.58 66.15 54.57 -48.61 coo 3.96 55.76 41.24 4.83 57.69 41.17 64.41 68.21 -58.47 65.40 69.20 -60.08 coo 9.42 68.07 30.27 7.35 68.27 30.10 67.50 63.43 -41.69 68.97 62.26 -42.81 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 40 3 # 40 179 ASP E 148 ASP^? 2.62 MG MG E 302s 227 GLU E 154 GLU^? 19.05 MG MG E 302 289 ASP E 177 ASP^? 8.55 MG MG E 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 3.96 55.76 41.24 4.83 57.69 41.17 64.41 68.21 -58.47 65.40 69.20 -60.08 coo 9.42 68.07 30.27 7.35 68.27 30.10 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 41 3 # 41 179 ASP E 160 ASP^? 31.54 MG MG F 301 227 GLU E 63 GLU^? 28.08 MG MG F 301 289 ASP E 138 ASP^? 33.31 MG MG E 302 coo -0.62 65.95 29.97 0.31 67.47 31.05 45.81 70.00 -68.45 44.10 68.87 -67.77 coo 3.96 55.76 41.24 4.83 57.69 41.17 44.04 53.99 -66.79 43.77 51.93 -66.35 coo 9.42 68.07 30.27 7.35 68.27 30.10 39.58 70.77 -58.63 40.74 70.78 -56.80 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 42 3 # 42 179 ASP E 160 ASP^? 31.54 MG MG F 301 227 GLU F 154 GLU^? 18.97 MG MG F 301 289 ASP E 58 ASP^? 26.76 MG MG F 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 45.81 70.00 -68.45 44.10 68.87 -67.77 coo 3.96 55.76 41.24 4.83 57.69 41.17 54.57 65.67 -81.55 53.36 66.51 -80.09 coo 9.42 68.07 30.27 7.35 68.27 30.10 45.39 59.31 -66.83 44.62 59.88 -68.72 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 43 3 # 43 179 ASP E 171 ASP^? 16.73 MG MG E 301 227 GLU E 146 GLU^? 10.15 MG MG E 301 289 ASP E 177 ASP^? 8.55 MG MG E 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 3.96 55.76 41.24 4.83 57.69 41.17 58.72 60.89 -44.51 59.23 60.24 -42.54 coo 9.42 68.07 30.27 7.35 68.27 30.10 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 44 3 # 44 179 ASP E 177 ASP^? 8.55 MG MG E 301 227 GLU E 146 GLU^? 10.15 MG MG E 301 289 ASP E 171 ASP^? 16.73 MG MG E 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 72.81 67.32 -45.03 71.14 67.96 -43.95 coo 3.96 55.76 41.24 4.83 57.69 41.17 58.72 60.89 -44.51 59.23 60.24 -42.54 coo 9.42 68.07 30.27 7.35 68.27 30.10 69.61 73.12 -51.56 71.50 73.53 -52.39 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 45 3 # 45 179 ASP E 187 ASP^? -2.71 MG MG E 301s 227 GLU D 25 GLU^? 12.44 MG MG E 301 289 ASP E 128 ASP^? -3.53 MG MG E 302s coo -0.62 65.95 29.97 0.31 67.47 31.05 67.50 63.43 -41.69 68.97 62.26 -42.81 coo 3.96 55.76 41.24 4.83 57.69 41.17 81.26 66.22 -47.78 79.52 64.98 -48.06 coo 9.42 68.07 30.27 7.35 68.27 30.10 65.38 56.57 -48.58 66.15 54.57 -48.61 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 46 3 # 46 179 ASP F 35 ASP^? 16.93 MG MG F 301 227 GLU F 54 GLU^? 22.98 MG MG F 301 289 ASP E 58 ASP^? 26.76 MG MG F 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 46.82 60.47 -77.63 48.00 58.79 -78.23 coo 3.96 55.76 41.24 4.83 57.69 41.17 62.26 62.27 -75.30 61.72 63.47 -73.60 coo 9.42 68.07 30.27 7.35 68.27 30.10 45.39 59.31 -66.83 44.62 59.88 -68.72 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 47 3 # 47 179 ASP F 58 ASP^? 26.87 MG MG E 302 227 GLU E 52 GLU^? 19.96 MG MG E 302 289 ASP F 160 ASP^? 31.59 MG MG E 302 coo -0.62 65.95 29.97 0.31 67.47 31.05 75.55 64.68 -72.56 76.21 65.63 -70.79 coo 3.96 55.76 41.24 4.83 57.69 41.17 64.71 60.06 -63.78 64.69 61.36 -65.58 coo 9.42 68.07 30.27 7.35 68.27 30.10 71.27 74.59 -71.77 73.23 74.02 -72.37 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 48 3 # 48 179 ASP F 128 ASP^? -3.41 MG MG F 301s 227 GLU F 154 GLU^? 18.97 MG MG F 301 289 ASP F 187 ASP^? -3.27 MG MG F 302s coo -0.62 65.95 29.97 0.31 67.47 31.05 57.76 53.73 -90.50 57.46 51.64 -90.28 coo 3.96 55.76 41.24 4.83 57.69 41.17 54.57 65.67 -81.55 53.36 66.51 -80.09 coo 9.42 68.07 30.27 7.35 68.27 30.10 53.93 58.87 -98.14 52.45 58.62 -96.61 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 49 3 # 49 179 ASP F 148 ASP^? 2.72 MG MG F 301s 227 GLU F 154 GLU^? 18.97 MG MG F 301 289 ASP F 177 ASP^? 8.15 MG MG F 302 coo -0.62 65.95 29.97 0.31 67.47 31.05 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 3.96 55.76 41.24 4.83 57.69 41.17 54.57 65.67 -81.55 53.36 66.51 -80.09 coo 9.42 68.07 30.27 7.35 68.27 30.10 47.18 61.22 -94.50 48.48 62.32 -95.73 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 50 3 # 50 179 ASP F 160 ASP^? 31.59 MG MG E 302 227 GLU E 154 GLU^? 19.05 MG MG E 302 289 ASP F 58 ASP^? 26.87 MG MG E 302 coo -0.62 65.95 29.97 0.31 67.47 31.05 71.27 74.59 -71.77 73.23 74.02 -72.37 coo 3.96 55.76 41.24 4.83 57.69 41.17 64.41 68.21 -58.47 65.40 69.20 -60.08 coo 9.42 68.07 30.27 7.35 68.27 30.10 75.55 64.68 -72.56 76.21 65.63 -70.79 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 51 3 # 51 179 ASP F 160 ASP^? 31.59 MG MG E 302 227 GLU F 63 GLU^? 27.81 MG MG E 302 289 ASP F 138 ASP^? 33.51 MG MG F 302 coo -0.62 65.95 29.97 0.31 67.47 31.05 71.27 74.59 -71.77 73.23 74.02 -72.37 coo 3.96 55.76 41.24 4.83 57.69 41.17 78.38 60.07 -72.34 78.48 58.04 -72.84 coo 9.42 68.07 30.27 7.35 68.27 30.10 77.17 76.66 -81.48 76.14 76.33 -83.32 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 52 3 # 52 179 ASP F 177 ASP^? 8.15 MG MG F 302 227 GLU F 146 GLU^? 10.36 MG MG F 302 289 ASP F 171 ASP^? 16.35 MG MG F 302 coo -0.62 65.95 29.97 0.31 67.47 31.05 47.18 61.22 -94.50 48.48 62.32 -95.73 coo 3.96 55.76 41.24 4.83 57.69 41.17 61.95 60.17 -95.28 62.87 58.56 -96.19 coo 9.42 68.07 30.27 7.35 68.27 30.10 48.23 68.08 -88.47 46.26 68.02 -87.56 1amy_c06 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 52 hits 1amy_c06 naa= 3 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 1 3 # 1 232 HIS A 42 HIS^? 28.45 MG MG A 301 254 LYS B 6 LYS^? 25.90 MG MG B 302 333 ARG A 48 ARG^? 25.29 MG MG A 301 coo 28.11 -1.15 8.51 29.21 0.63 8.34 34.62 18.32 19.57 34.29 16.25 19.41 coo 26.09 4.87 14.60 27.89 3.33 10.26 36.26 25.44 11.74 39.65 23.12 16.29 coo 37.35 7.47 11.84 34.90 6.11 10.60 33.88 31.17 22.03 31.48 31.85 20.30 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 2 3 # 2 232 HIS C 42 HIS^? 28.09 MG MG C 302 254 LYS D 6 LYS^? 25.98 MG MG D 302 333 ARG C 48 ARG^? 25.02 MG MG C 302 coo 28.11 -1.15 8.51 29.21 0.63 8.34 95.93 22.96 -23.11 97.92 23.62 -23.02 coo 26.09 4.87 14.60 27.89 3.33 10.26 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 37.35 7.47 11.84 34.90 6.11 10.60 84.94 16.06 -21.53 85.81 13.55 -23.08 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 3 3 # 3 232 HIS D 42 HIS^? 28.21 MG MG D 302 254 LYS C 6 LYS^? 25.73 MG MG C 302 333 ARG D 48 ARG^? 24.87 MG MG D 302 coo 28.11 -1.15 8.51 29.21 0.63 8.34 98.45 29.90 -26.44 99.32 28.02 -26.13 coo 26.09 4.87 14.60 27.89 3.33 10.26 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 37.35 7.47 11.84 34.90 6.11 10.60 94.06 41.76 -28.37 96.24 43.38 -26.96 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 4 3 # 4 232 HIS F 42 HIS^? 28.34 MG MG F 301 254 LYS E 6 LYS^? 25.59 MG MG E 302 333 ARG F 48 ARG^? 25.18 MG MG F 301 coo 28.11 -1.15 8.51 29.21 0.63 8.34 55.11 70.50 -71.64 56.29 72.22 -71.48 coo 26.09 4.87 14.60 27.89 3.33 10.26 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 37.35 7.47 11.84 34.90 6.11 10.60 46.82 60.90 -73.07 44.43 61.88 -71.46 1aq2_c00 source 1aq2 PHOSPHOENOLPYRUVATE CARBOXYKINASE : 4 hits 1aq2_c00 naa= 3 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 A 194 SER A 36 SER^? 23.25 MG MG A 301 A 292 ASP B 138 ASP^? 33.32 MG MG B 302 A 322 HIS A 170 HIS^? 10.56 MG MG A 302 coo 36.34 32.23 39.60 36.43 34.62 39.93 29.88 32.10 25.40 29.53 34.39 24.57 coo 19.73 19.18 41.39 21.50 18.65 40.34 23.42 29.01 6.78 24.36 28.48 4.94 coo 41.69 45.14 46.60 41.78 47.19 46.18 34.91 23.57 39.32 34.35 24.95 40.81 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 A 194 SER B 36 SER^? 24.04 MG MG B 302 A 292 ASP A 138 ASP^? 33.08 MG MG A 302 A 322 HIS B 170 HIS^? 10.51 MG MG B 301 coo 36.34 32.23 39.60 36.43 34.62 39.93 52.58 6.45 11.01 53.61 4.84 12.41 coo 19.73 19.18 41.39 21.50 18.65 40.34 47.10 -0.97 29.63 45.89 0.22 30.96 coo 41.69 45.14 46.60 41.78 47.19 46.18 46.22 13.75 -2.72 47.53 13.11 -4.24 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 A 194 SER B 36 SER^? 24.04 MG MG B 302 A 292 ASP C 23 ASP^? 15.39 MG MG B 301 A 322 HIS B 42 HIS^? 28.37 MG MG B 302 coo 36.34 32.23 39.60 36.43 34.62 39.93 52.58 6.45 11.01 53.61 4.84 12.41 coo 19.73 19.18 41.39 21.50 18.65 40.34 65.24 6.82 -5.11 63.43 7.54 -4.15 coo 41.69 45.14 46.60 41.78 47.19 46.18 39.34 12.99 16.30 37.26 13.24 16.40 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 4 3 # 4 A 194 SER B 49 SER^? 17.51 MG MG B 302 A 292 ASP C 23 ASP^? 15.39 MG MG B 301 A 322 HIS B 42 HIS^? 28.37 MG MG B 302 coo 36.34 32.23 39.60 36.43 34.62 39.93 51.67 15.70 10.57 49.37 16.19 11.15 coo 19.73 19.18 41.39 21.50 18.65 40.34 65.24 6.82 -5.11 63.43 7.54 -4.15 coo 41.69 45.14 46.60 41.78 47.19 46.18 39.34 12.99 16.30 37.26 13.24 16.40 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 5 3 # 5 A 194 SER B 117 SER^? 9.14 MG MG B 302 A 292 ASP C 128 ASP^? -3.22 MG MG C 302s A 322 HIS B 147 HIS^? 9.27 MG MG B 301 coo 36.34 32.23 39.60 36.43 34.62 39.93 60.50 22.87 3.68 61.23 25.10 3.08 coo 19.73 19.18 41.39 21.50 18.65 40.34 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 41.69 45.14 46.60 41.78 47.19 46.18 46.73 18.97 -3.05 45.63 17.32 -3.73 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 6 3 # 6 A 194 SER B 117 SER^? 9.14 MG MG B 302 A 292 ASP C 148 ASP^? 2.75 MG MG C 302s A 322 HIS B 147 HIS^? 9.27 MG MG B 301 coo 36.34 32.23 39.60 36.43 34.62 39.93 60.50 22.87 3.68 61.23 25.10 3.08 coo 19.73 19.18 41.39 21.50 18.65 40.34 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 41.69 45.14 46.60 41.78 47.19 46.18 46.73 18.97 -3.05 45.63 17.32 -3.73 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 7 3 # 7 A 194 SER C 36 SER^? 23.69 MG MG C 302 A 292 ASP B 23 ASP^? 15.67 MG MG C 301 A 322 HIS C 42 HIS^? 28.09 MG MG C 302 coo 36.34 32.23 39.60 36.43 34.62 39.93 86.07 12.19 -17.80 85.34 10.22 -18.98 coo 19.73 19.18 41.39 21.50 18.65 40.34 74.31 7.55 -1.09 75.08 9.17 -2.23 coo 41.69 45.14 46.60 41.78 47.19 46.18 95.93 22.96 -23.11 97.92 23.62 -23.02 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 8 3 # 8 A 194 SER C 36 SER^? 23.69 MG MG C 302 A 292 ASP D 138 ASP^? 33.64 MG MG D 302 A 322 HIS C 170 HIS^? 10.68 MG MG C 301 coo 36.34 32.23 39.60 36.43 34.62 39.93 86.07 12.19 -17.80 85.34 10.22 -18.98 coo 19.73 19.18 41.39 21.50 18.65 40.34 93.00 7.50 -35.79 93.88 8.48 -37.45 coo 41.69 45.14 46.60 41.78 47.19 46.18 89.96 21.05 -3.85 88.74 19.88 -2.61 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 9 3 # 9 A 194 SER C 49 SER^? 17.53 MG MG C 302 A 292 ASP B 23 ASP^? 15.67 MG MG C 301 A 322 HIS C 42 HIS^? 28.09 MG MG C 302 coo 36.34 32.23 39.60 36.43 34.62 39.93 83.83 21.24 -17.13 85.75 22.50 -18.00 coo 19.73 19.18 41.39 21.50 18.65 40.34 74.31 7.55 -1.09 75.08 9.17 -2.23 coo 41.69 45.14 46.60 41.78 47.19 46.18 95.93 22.96 -23.11 97.92 23.62 -23.02 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 10 3 # 10 A 194 SER C 117 SER^? 8.92 MG MG C 302 A 292 ASP B 128 ASP^? -3.57 MG MG B 302s A 322 HIS C 147 HIS^? 9.44 MG MG C 301 coo 36.34 32.23 39.60 36.43 34.62 39.93 72.96 24.67 -9.95 71.40 26.26 -9.18 coo 19.73 19.18 41.39 21.50 18.65 40.34 52.92 24.09 -2.19 54.73 25.14 -1.90 coo 41.69 45.14 46.60 41.78 47.19 46.18 87.61 25.71 -3.59 89.22 24.50 -2.99 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 11 3 # 11 A 194 SER C 117 SER^? 8.92 MG MG C 302 A 292 ASP B 148 ASP^? 2.58 MG MG B 302s A 322 HIS C 147 HIS^? 9.44 MG MG C 301 coo 36.34 32.23 39.60 36.43 34.62 39.93 72.96 24.67 -9.95 71.40 26.26 -9.18 coo 19.73 19.18 41.39 21.50 18.65 40.34 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 41.69 45.14 46.60 41.78 47.19 46.18 87.61 25.71 -3.59 89.22 24.50 -2.99 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 12 3 # 12 A 194 SER D 36 SER^? 22.42 MG MG D 302 A 292 ASP C 138 ASP^? 33.43 MG MG C 302 A 322 HIS D 170 HIS^? 10.59 MG MG D 301 coo 36.34 32.23 39.60 36.43 34.62 39.93 97.85 44.42 -32.20 96.60 46.20 -31.15 coo 19.73 19.18 41.39 21.50 18.65 40.34 105.43 43.97 -13.30 104.85 43.08 -11.43 coo 41.69 45.14 46.60 41.78 47.19 46.18 95.57 34.81 -46.05 95.59 36.24 -47.59 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 13 3 # 13 A 194 SER D 36 SER^? 22.42 MG MG D 302 A 292 ASP E 23 ASP^? 15.43 MG MG D 301 A 322 HIS D 42 HIS^? 28.21 MG MG D 302 coo 36.34 32.23 39.60 36.43 34.62 39.93 97.85 44.42 -32.20 96.60 46.20 -31.15 coo 19.73 19.18 41.39 21.50 18.65 40.34 91.98 54.64 -49.37 91.93 52.78 -48.33 coo 41.69 45.14 46.60 41.78 47.19 46.18 98.45 29.90 -26.44 99.32 28.02 -26.13 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 14 3 # 14 A 194 SER D 49 SER^? 17.22 MG MG D 302 A 292 ASP E 23 ASP^? 15.43 MG MG D 301 A 322 HIS D 42 HIS^? 28.21 MG MG D 302 coo 36.34 32.23 39.60 36.43 34.62 39.93 90.26 38.73 -32.99 91.21 36.48 -32.65 coo 19.73 19.18 41.39 21.50 18.65 40.34 91.98 54.64 -49.37 91.93 52.78 -48.33 coo 41.69 45.14 46.60 41.78 47.19 46.18 98.45 29.90 -26.44 99.32 28.02 -26.13 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 15 3 # 15 A 194 SER D 117 SER^? 9.64 MG MG D 302 A 292 ASP E 128 ASP^? -3.53 MG MG E 302s A 322 HIS D 147 HIS^? 9.43 MG MG D 301 coo 36.34 32.23 39.60 36.43 34.62 39.93 79.93 42.54 -40.62 77.69 42.23 -41.47 coo 19.73 19.18 41.39 21.50 18.65 40.34 65.38 56.57 -48.58 66.15 54.57 -48.61 coo 41.69 45.14 46.60 41.78 47.19 46.18 90.95 32.51 -46.42 92.98 32.42 -46.93 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 16 3 # 16 A 194 SER D 117 SER^? 9.64 MG MG D 302 A 292 ASP E 148 ASP^? 2.62 MG MG E 302s A 322 HIS D 147 HIS^? 9.43 MG MG D 301 coo 36.34 32.23 39.60 36.43 34.62 39.93 79.93 42.54 -40.62 77.69 42.23 -41.47 coo 19.73 19.18 41.39 21.50 18.65 40.34 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 41.69 45.14 46.60 41.78 47.19 46.18 90.95 32.51 -46.42 92.98 32.42 -46.93 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 17 3 # 17 A 194 SER E 36 SER^? 22.92 MG MG E 302 A 292 ASP D 23 ASP^? 15.37 MG MG E 301 A 322 HIS E 42 HIS^? 28.20 MG MG E 302 coo 36.34 32.23 39.60 36.43 34.62 39.93 76.63 69.18 -62.93 78.20 67.77 -64.11 coo 19.73 19.18 41.39 21.50 18.65 40.34 85.70 62.10 -45.60 84.07 62.13 -46.93 coo 41.69 45.14 46.60 41.78 47.19 46.18 62.33 71.93 -68.30 60.54 72.96 -68.64 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 18 3 # 18 A 194 SER E 36 SER^? 22.92 MG MG E 302 A 292 ASP F 138 ASP^? 33.51 MG MG F 302 A 322 HIS E 170 HIS^? 10.33 MG MG E 301 coo 36.34 32.23 39.60 36.43 34.62 39.93 76.63 69.18 -62.93 78.20 67.77 -64.11 coo 19.73 19.18 41.39 21.50 18.65 40.34 77.17 76.66 -81.48 76.14 76.33 -83.32 coo 41.69 45.14 46.60 41.78 47.19 46.18 66.96 68.76 -48.87 68.36 68.54 -47.33 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 19 3 # 19 A 194 SER E 49 SER^? 17.46 MG MG E 302 A 292 ASP D 23 ASP^? 15.37 MG MG E 301 A 322 HIS E 42 HIS^? 28.20 MG MG E 302 coo 36.34 32.23 39.60 36.43 34.62 39.93 69.86 62.56 -61.93 67.83 63.87 -62.36 coo 19.73 19.18 41.39 21.50 18.65 40.34 85.70 62.10 -45.60 84.07 62.13 -46.93 coo 41.69 45.14 46.60 41.78 47.19 46.18 62.33 71.93 -68.30 60.54 72.96 -68.64 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 20 3 # 20 A 194 SER E 117 SER^? 9.12 MG MG E 302 A 292 ASP D 128 ASP^? -3.70 MG MG D 302s A 322 HIS E 147 HIS^? 9.22 MG MG E 301 coo 36.34 32.23 39.60 36.43 34.62 39.93 72.02 51.78 -53.96 71.28 49.71 -53.01 coo 19.73 19.18 41.39 21.50 18.65 40.34 83.33 35.45 -46.13 81.57 36.63 -46.10 coo 41.69 45.14 46.60 41.78 47.19 46.18 63.87 64.43 -48.39 64.18 66.45 -47.92 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 21 3 # 21 A 194 SER E 117 SER^? 9.12 MG MG E 302 A 292 ASP D 148 ASP^? 2.35 MG MG D 302s A 322 HIS E 147 HIS^? 9.22 MG MG E 301 coo 36.34 32.23 39.60 36.43 34.62 39.93 72.02 51.78 -53.96 71.28 49.71 -53.01 coo 19.73 19.18 41.39 21.50 18.65 40.34 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 41.69 45.14 46.60 41.78 47.19 46.18 63.87 64.43 -48.39 64.18 66.45 -47.92 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 22 3 # 22 A 194 SER F 36 SER^? 23.07 MG MG F 301 A 292 ASP E 138 ASP^? 33.31 MG MG E 302 A 322 HIS F 170 HIS^? 9.84 MG MG F 302 coo 36.34 32.23 39.60 36.43 34.62 39.93 42.79 62.77 -76.96 42.19 61.23 -75.17 coo 19.73 19.18 41.39 21.50 18.65 40.34 39.58 70.77 -58.63 40.74 70.78 -56.80 coo 41.69 45.14 46.60 41.78 47.19 46.18 52.25 64.82 -90.91 50.95 63.88 -92.26 1aql_c02 source 1aql BILE-SALT ACTIVATED LIPASE : 22 hits 1aql_c02 naa= 3 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 B 194 SER A 36 SER^? 23.25 MG MG A 301 B 292 ASP B 138 ASP^? 33.32 MG MG B 302 B 322 HIS A 170 HIS^? 10.56 MG MG A 302 coo 35.42 71.28 22.94 36.24 69.06 22.37 29.88 32.10 25.40 29.53 34.39 24.57 coo 24.74 78.07 5.59 24.32 79.03 7.46 23.42 29.01 6.78 24.36 28.48 4.94 coo 48.81 64.16 26.34 49.30 62.16 26.73 34.91 23.57 39.32 34.35 24.95 40.81 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 B 194 SER B 36 SER^? 24.04 MG MG B 302 B 292 ASP A 138 ASP^? 33.08 MG MG A 302 B 322 HIS B 170 HIS^? 10.51 MG MG B 301 coo 35.42 71.28 22.94 36.24 69.06 22.37 52.58 6.45 11.01 53.61 4.84 12.41 coo 24.74 78.07 5.59 24.32 79.03 7.46 47.10 -0.97 29.63 45.89 0.22 30.96 coo 48.81 64.16 26.34 49.30 62.16 26.73 46.22 13.75 -2.72 47.53 13.11 -4.24 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 B 194 SER B 36 SER^? 24.04 MG MG B 302 B 292 ASP C 23 ASP^? 15.39 MG MG B 301 B 322 HIS B 42 HIS^? 28.37 MG MG B 302 coo 35.42 71.28 22.94 36.24 69.06 22.37 52.58 6.45 11.01 53.61 4.84 12.41 coo 24.74 78.07 5.59 24.32 79.03 7.46 65.24 6.82 -5.11 63.43 7.54 -4.15 coo 48.81 64.16 26.34 49.30 62.16 26.73 39.34 12.99 16.30 37.26 13.24 16.40 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 4 3 # 4 B 194 SER B 49 SER^? 17.51 MG MG B 302 B 292 ASP C 23 ASP^? 15.39 MG MG B 301 B 322 HIS B 42 HIS^? 28.37 MG MG B 302 coo 35.42 71.28 22.94 36.24 69.06 22.37 51.67 15.70 10.57 49.37 16.19 11.15 coo 24.74 78.07 5.59 24.32 79.03 7.46 65.24 6.82 -5.11 63.43 7.54 -4.15 coo 48.81 64.16 26.34 49.30 62.16 26.73 39.34 12.99 16.30 37.26 13.24 16.40 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 5 3 # 5 B 194 SER B 117 SER^? 9.14 MG MG B 302 B 292 ASP C 128 ASP^? -3.22 MG MG C 302s B 322 HIS B 147 HIS^? 9.27 MG MG B 301 coo 35.42 71.28 22.94 36.24 69.06 22.37 60.50 22.87 3.68 61.23 25.10 3.08 coo 24.74 78.07 5.59 24.32 79.03 7.46 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 48.81 64.16 26.34 49.30 62.16 26.73 46.73 18.97 -3.05 45.63 17.32 -3.73 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 6 3 # 6 B 194 SER B 117 SER^? 9.14 MG MG B 302 B 292 ASP C 148 ASP^? 2.75 MG MG C 302s B 322 HIS B 147 HIS^? 9.27 MG MG B 301 coo 35.42 71.28 22.94 36.24 69.06 22.37 60.50 22.87 3.68 61.23 25.10 3.08 coo 24.74 78.07 5.59 24.32 79.03 7.46 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 48.81 64.16 26.34 49.30 62.16 26.73 46.73 18.97 -3.05 45.63 17.32 -3.73 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 7 3 # 7 B 194 SER C 36 SER^? 23.69 MG MG C 302 B 292 ASP B 23 ASP^? 15.67 MG MG C 301 B 322 HIS C 42 HIS^? 28.09 MG MG C 302 coo 35.42 71.28 22.94 36.24 69.06 22.37 86.07 12.19 -17.80 85.34 10.22 -18.98 coo 24.74 78.07 5.59 24.32 79.03 7.46 74.31 7.55 -1.09 75.08 9.17 -2.23 coo 48.81 64.16 26.34 49.30 62.16 26.73 95.93 22.96 -23.11 97.92 23.62 -23.02 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 8 3 # 8 B 194 SER C 36 SER^? 23.69 MG MG C 302 B 292 ASP D 138 ASP^? 33.64 MG MG D 302 B 322 HIS C 170 HIS^? 10.68 MG MG C 301 coo 35.42 71.28 22.94 36.24 69.06 22.37 86.07 12.19 -17.80 85.34 10.22 -18.98 coo 24.74 78.07 5.59 24.32 79.03 7.46 93.00 7.50 -35.79 93.88 8.48 -37.45 coo 48.81 64.16 26.34 49.30 62.16 26.73 89.96 21.05 -3.85 88.74 19.88 -2.61 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 9 3 # 9 B 194 SER C 49 SER^? 17.53 MG MG C 302 B 292 ASP B 23 ASP^? 15.67 MG MG C 301 B 322 HIS C 42 HIS^? 28.09 MG MG C 302 coo 35.42 71.28 22.94 36.24 69.06 22.37 83.83 21.24 -17.13 85.75 22.50 -18.00 coo 24.74 78.07 5.59 24.32 79.03 7.46 74.31 7.55 -1.09 75.08 9.17 -2.23 coo 48.81 64.16 26.34 49.30 62.16 26.73 95.93 22.96 -23.11 97.92 23.62 -23.02 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 10 3 # 10 B 194 SER C 117 SER^? 8.92 MG MG C 302 B 292 ASP B 128 ASP^? -3.57 MG MG B 302s B 322 HIS C 147 HIS^? 9.44 MG MG C 301 coo 35.42 71.28 22.94 36.24 69.06 22.37 72.96 24.67 -9.95 71.40 26.26 -9.18 coo 24.74 78.07 5.59 24.32 79.03 7.46 52.92 24.09 -2.19 54.73 25.14 -1.90 coo 48.81 64.16 26.34 49.30 62.16 26.73 87.61 25.71 -3.59 89.22 24.50 -2.99 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 11 3 # 11 B 194 SER C 117 SER^? 8.92 MG MG C 302 B 292 ASP B 148 ASP^? 2.58 MG MG B 302s B 322 HIS C 147 HIS^? 9.44 MG MG C 301 coo 35.42 71.28 22.94 36.24 69.06 22.37 72.96 24.67 -9.95 71.40 26.26 -9.18 coo 24.74 78.07 5.59 24.32 79.03 7.46 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 48.81 64.16 26.34 49.30 62.16 26.73 87.61 25.71 -3.59 89.22 24.50 -2.99 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 12 3 # 12 B 194 SER D 36 SER^? 22.42 MG MG D 302 B 292 ASP C 138 ASP^? 33.43 MG MG C 302 B 322 HIS D 170 HIS^? 10.59 MG MG D 301 coo 35.42 71.28 22.94 36.24 69.06 22.37 97.85 44.42 -32.20 96.60 46.20 -31.15 coo 24.74 78.07 5.59 24.32 79.03 7.46 105.43 43.97 -13.30 104.85 43.08 -11.43 coo 48.81 64.16 26.34 49.30 62.16 26.73 95.57 34.81 -46.05 95.59 36.24 -47.59 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 13 3 # 13 B 194 SER D 36 SER^? 22.42 MG MG D 302 B 292 ASP E 23 ASP^? 15.43 MG MG D 301 B 322 HIS D 42 HIS^? 28.21 MG MG D 302 coo 35.42 71.28 22.94 36.24 69.06 22.37 97.85 44.42 -32.20 96.60 46.20 -31.15 coo 24.74 78.07 5.59 24.32 79.03 7.46 91.98 54.64 -49.37 91.93 52.78 -48.33 coo 48.81 64.16 26.34 49.30 62.16 26.73 98.45 29.90 -26.44 99.32 28.02 -26.13 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 14 3 # 14 B 194 SER D 49 SER^? 17.22 MG MG D 302 B 292 ASP E 23 ASP^? 15.43 MG MG D 301 B 322 HIS D 42 HIS^? 28.21 MG MG D 302 coo 35.42 71.28 22.94 36.24 69.06 22.37 90.26 38.73 -32.99 91.21 36.48 -32.65 coo 24.74 78.07 5.59 24.32 79.03 7.46 91.98 54.64 -49.37 91.93 52.78 -48.33 coo 48.81 64.16 26.34 49.30 62.16 26.73 98.45 29.90 -26.44 99.32 28.02 -26.13 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 15 3 # 15 B 194 SER D 117 SER^? 9.64 MG MG D 302 B 292 ASP E 128 ASP^? -3.53 MG MG E 302s B 322 HIS D 147 HIS^? 9.43 MG MG D 301 coo 35.42 71.28 22.94 36.24 69.06 22.37 79.93 42.54 -40.62 77.69 42.23 -41.47 coo 24.74 78.07 5.59 24.32 79.03 7.46 65.38 56.57 -48.58 66.15 54.57 -48.61 coo 48.81 64.16 26.34 49.30 62.16 26.73 90.95 32.51 -46.42 92.98 32.42 -46.93 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 16 3 # 16 B 194 SER D 117 SER^? 9.64 MG MG D 302 B 292 ASP E 148 ASP^? 2.62 MG MG E 302s B 322 HIS D 147 HIS^? 9.43 MG MG D 301 coo 35.42 71.28 22.94 36.24 69.06 22.37 79.93 42.54 -40.62 77.69 42.23 -41.47 coo 24.74 78.07 5.59 24.32 79.03 7.46 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 48.81 64.16 26.34 49.30 62.16 26.73 90.95 32.51 -46.42 92.98 32.42 -46.93 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 17 3 # 17 B 194 SER E 36 SER^? 22.92 MG MG E 302 B 292 ASP D 23 ASP^? 15.37 MG MG E 301 B 322 HIS E 42 HIS^? 28.20 MG MG E 302 coo 35.42 71.28 22.94 36.24 69.06 22.37 76.63 69.18 -62.93 78.20 67.77 -64.11 coo 24.74 78.07 5.59 24.32 79.03 7.46 85.70 62.10 -45.60 84.07 62.13 -46.93 coo 48.81 64.16 26.34 49.30 62.16 26.73 62.33 71.93 -68.30 60.54 72.96 -68.64 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 18 3 # 18 B 194 SER E 36 SER^? 22.92 MG MG E 302 B 292 ASP F 138 ASP^? 33.51 MG MG F 302 B 322 HIS E 170 HIS^? 10.33 MG MG E 301 coo 35.42 71.28 22.94 36.24 69.06 22.37 76.63 69.18 -62.93 78.20 67.77 -64.11 coo 24.74 78.07 5.59 24.32 79.03 7.46 77.17 76.66 -81.48 76.14 76.33 -83.32 coo 48.81 64.16 26.34 49.30 62.16 26.73 66.96 68.76 -48.87 68.36 68.54 -47.33 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 19 3 # 19 B 194 SER E 49 SER^? 17.46 MG MG E 302 B 292 ASP D 23 ASP^? 15.37 MG MG E 301 B 322 HIS E 42 HIS^? 28.20 MG MG E 302 coo 35.42 71.28 22.94 36.24 69.06 22.37 69.86 62.56 -61.93 67.83 63.87 -62.36 coo 24.74 78.07 5.59 24.32 79.03 7.46 85.70 62.10 -45.60 84.07 62.13 -46.93 coo 48.81 64.16 26.34 49.30 62.16 26.73 62.33 71.93 -68.30 60.54 72.96 -68.64 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 20 3 # 20 B 194 SER E 117 SER^? 9.12 MG MG E 302 B 292 ASP D 128 ASP^? -3.70 MG MG D 302s B 322 HIS E 147 HIS^? 9.22 MG MG E 301 coo 35.42 71.28 22.94 36.24 69.06 22.37 72.02 51.78 -53.96 71.28 49.71 -53.01 coo 24.74 78.07 5.59 24.32 79.03 7.46 83.33 35.45 -46.13 81.57 36.63 -46.10 coo 48.81 64.16 26.34 49.30 62.16 26.73 63.87 64.43 -48.39 64.18 66.45 -47.92 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 21 3 # 21 B 194 SER E 117 SER^? 9.12 MG MG E 302 B 292 ASP D 148 ASP^? 2.35 MG MG D 302s B 322 HIS E 147 HIS^? 9.22 MG MG E 301 coo 35.42 71.28 22.94 36.24 69.06 22.37 72.02 51.78 -53.96 71.28 49.71 -53.01 coo 24.74 78.07 5.59 24.32 79.03 7.46 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 48.81 64.16 26.34 49.30 62.16 26.73 63.87 64.43 -48.39 64.18 66.45 -47.92 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 22 3 # 22 B 194 SER F 36 SER^? 23.07 MG MG F 301 B 292 ASP E 138 ASP^? 33.31 MG MG E 302 B 322 HIS F 170 HIS^? 9.84 MG MG F 302 coo 35.42 71.28 22.94 36.24 69.06 22.37 42.79 62.77 -76.96 42.19 61.23 -75.17 coo 24.74 78.07 5.59 24.32 79.03 7.46 39.58 70.77 -58.63 40.74 70.78 -56.80 coo 48.81 64.16 26.34 49.30 62.16 26.73 52.25 64.82 -90.91 50.95 63.88 -92.26 1aql_c03 source 1aql BILE-SALT ACTIVATED LIPASE : 22 hits 1aql_c03 naa= 3 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 B 325 ARG A 37 ARG^? 18.99 MG MG A 301 B 342 ASP A 171 ASP^? 17.17 MG MG A 302 B 531 ARG A 8 ARG^? 20.36 MG MG A 301 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 32.99 26.50 25.19 35.50 25.33 26.51 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 29.78 23.67 36.63 28.48 25.11 35.71 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 40.62 19.52 24.63 40.98 22.51 23.88 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 2 3 # 2 B 325 ARG A 37 ARG^? 18.99 MG MG A 301 B 342 ASP A 171 ASP^? 17.17 MG MG A 302 B 531 ARG A 50 ARG^? 15.98 MG MG A 301 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 32.99 26.50 25.19 35.50 25.33 26.51 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 29.78 23.67 36.63 28.48 25.11 35.71 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 38.44 33.02 29.31 39.55 34.58 26.90 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 3 3 # 3 B 325 ARG A 37 ARG^? 18.99 MG MG A 301 B 342 ASP B 58 ASP^? 26.73 MG MG A 301 B 531 ARG A 50 ARG^? 15.98 MG MG A 301 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 32.99 26.50 25.19 35.50 25.33 26.51 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 34.42 33.56 15.74 33.50 33.49 17.59 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 38.44 33.02 29.31 39.55 34.58 26.90 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 4 3 # 4 B 325 ARG A 37 ARG^? 18.99 MG MG A 301 B 342 ASP B 160 ASP^? 31.65 MG MG A 301 B 531 ARG A 8 ARG^? 20.36 MG MG A 301 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 32.99 26.50 25.19 35.50 25.33 26.51 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 28.01 24.83 16.38 27.44 26.81 15.80 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 40.62 19.52 24.63 40.98 22.51 23.88 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 5 3 # 5 B 325 ARG A 50 ARG^? 15.98 MG MG A 301 B 342 ASP A 148 ASP^? 2.72 MG MG A 301s B 531 ARG A 173 ARG^? 19.27 MG MG A 302 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 38.44 33.02 29.31 39.55 34.58 26.90 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 41.50 28.88 41.13 43.33 29.67 41.93 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 27.76 29.24 35.14 27.46 27.11 32.86 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 6 3 # 6 B 325 ARG B 37 ARG^? 19.17 MG MG B 302 B 342 ASP A 58 ASP^? 26.75 MG MG B 302 B 531 ARG B 50 ARG^? 16.38 MG MG B 302 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 47.41 10.20 11.40 46.99 12.91 10.22 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 53.93 9.80 21.09 53.83 8.90 19.15 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 55.38 14.91 7.80 56.60 14.73 10.62 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 7 3 # 7 B 325 ARG B 37 ARG^? 19.17 MG MG B 302 B 342 ASP A 160 ASP^? 31.61 MG MG B 302 B 531 ARG B 8 ARG^? 20.39 MG MG B 302 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 47.41 10.20 11.40 46.99 12.91 10.22 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 44.21 5.00 19.54 46.02 3.84 19.76 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 41.99 18.82 11.83 44.91 18.76 12.93 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 8 3 # 8 B 325 ARG B 37 ARG^? 19.17 MG MG B 302 B 342 ASP B 171 ASP^? 16.92 MG MG B 301 B 531 ARG B 8 ARG^? 20.39 MG MG B 302 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 47.41 10.20 11.40 46.99 12.91 10.22 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 45.30 8.50 -0.71 46.30 6.81 0.12 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 41.99 18.82 11.83 44.91 18.76 12.93 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 9 3 # 9 B 325 ARG B 37 ARG^? 19.17 MG MG B 302 B 342 ASP B 171 ASP^? 16.92 MG MG B 301 B 531 ARG B 50 ARG^? 16.38 MG MG B 302 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 47.41 10.20 11.40 46.99 12.91 10.22 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 45.30 8.50 -0.71 46.30 6.81 0.12 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 55.38 14.91 7.80 56.60 14.73 10.62 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 10 3 # 10 B 325 ARG B 50 ARG^? 16.38 MG MG B 302 B 342 ASP B 148 ASP^? 2.58 MG MG B 302s B 531 ARG B 173 ARG^? 18.75 MG MG B 301 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 55.38 14.91 7.80 56.60 14.73 10.62 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 49.83 5.55 0.39 48.19 5.30 3.03 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 11 3 # 11 B 325 ARG C 37 ARG^? 19.01 MG MG C 302 B 342 ASP C 171 ASP^? 17.08 MG MG C 301 B 531 ARG C 8 ARG^? 20.00 MG MG C 302 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 89.36 17.23 -17.57 89.29 20.20 -16.76 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 91.42 27.61 -18.53 88.82 26.28 -19.38 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 12 3 # 12 B 325 ARG C 37 ARG^? 19.01 MG MG C 302 B 342 ASP C 171 ASP^? 17.08 MG MG C 301 B 531 ARG C 50 ARG^? 16.05 MG MG C 302 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 89.36 17.23 -17.57 89.29 20.20 -16.76 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 80.61 19.03 -14.42 79.16 18.55 -17.10 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 13 3 # 13 B 325 ARG C 37 ARG^? 19.01 MG MG C 302 B 342 ASP D 58 ASP^? 26.59 MG MG C 302 B 531 ARG C 50 ARG^? 16.05 MG MG C 302 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 89.36 17.23 -17.57 89.29 20.20 -16.76 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 83.38 14.85 -27.71 84.09 14.12 -25.85 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 80.61 19.03 -14.42 79.16 18.55 -17.10 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 14 3 # 14 B 325 ARG C 37 ARG^? 19.01 MG MG C 302 B 342 ASP D 160 ASP^? 31.45 MG MG C 302 B 531 ARG C 8 ARG^? 20.00 MG MG C 302 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 89.36 17.23 -17.57 89.29 20.20 -16.76 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 94.15 13.98 -26.57 92.71 12.42 -26.99 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 91.42 27.61 -18.53 88.82 26.28 -19.38 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 15 3 # 15 B 325 ARG D 37 ARG^? 18.81 MG MG D 302 B 342 ASP C 58 ASP^? 26.67 MG MG D 302 B 531 ARG D 50 ARG^? 16.15 MG MG D 302 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 96.81 38.21 -31.63 94.97 36.32 -33.06 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 93.40 43.81 -22.27 94.18 44.45 -24.11 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 88.00 43.26 -36.30 88.86 43.23 -33.34 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 16 3 # 16 B 325 ARG D 37 ARG^? 18.81 MG MG D 302 B 342 ASP C 160 ASP^? 31.63 MG MG D 302 B 531 ARG D 8 ARG^? 20.22 MG MG D 302 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 96.81 38.21 -31.63 94.97 36.32 -33.06 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 102.50 38.00 -23.28 102.43 39.97 -22.46 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 92.22 28.83 -31.23 90.93 31.55 -30.54 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 17 3 # 17 B 325 ARG D 37 ARG^? 18.81 MG MG D 302 B 342 ASP D 171 ASP^? 16.95 MG MG D 301 B 531 ARG D 8 ARG^? 20.22 MG MG D 302 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 96.81 38.21 -31.63 94.97 36.32 -33.06 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 92.22 28.83 -31.23 90.93 31.55 -30.54 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 18 3 # 18 B 325 ARG D 37 ARG^? 18.81 MG MG D 302 B 342 ASP D 171 ASP^? 16.95 MG MG D 301 B 531 ARG D 50 ARG^? 16.15 MG MG D 302 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 96.81 38.21 -31.63 94.97 36.32 -33.06 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 88.00 43.26 -36.30 88.86 43.23 -33.34 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 19 3 # 19 B 325 ARG E 37 ARG^? 19.17 MG MG E 302 B 342 ASP E 171 ASP^? 16.73 MG MG E 301 B 531 ARG E 8 ARG^? 20.19 MG MG E 302 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 70.82 68.02 -63.63 68.17 67.46 -62.14 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 60.42 66.09 -63.48 62.84 64.38 -64.17 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 20 3 # 20 B 325 ARG E 37 ARG^? 19.17 MG MG E 302 B 342 ASP E 171 ASP^? 16.73 MG MG E 301 B 531 ARG E 50 ARG^? 15.97 MG MG E 302 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 70.82 68.02 -63.63 68.17 67.46 -62.14 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 73.62 60.83 -58.23 74.10 60.41 -61.24 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 21 3 # 21 B 325 ARG E 37 ARG^? 19.17 MG MG E 302 B 342 ASP F 58 ASP^? 26.87 MG MG E 302 B 531 ARG E 50 ARG^? 15.97 MG MG E 302 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 70.82 68.02 -63.63 68.17 67.46 -62.14 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 75.55 64.68 -72.56 76.21 65.63 -70.79 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 73.62 60.83 -58.23 74.10 60.41 -61.24 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 22 3 # 22 B 325 ARG E 37 ARG^? 19.17 MG MG E 302 B 342 ASP F 160 ASP^? 31.59 MG MG E 302 B 531 ARG E 8 ARG^? 20.19 MG MG E 302 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 70.82 68.02 -63.63 68.17 67.46 -62.14 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 71.27 74.59 -71.77 73.23 74.02 -72.37 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 60.42 66.09 -63.48 62.84 64.38 -64.17 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 23 3 # 23 B 325 ARG E 50 ARG^? 15.97 MG MG E 302 B 342 ASP E 148 ASP^? 2.62 MG MG E 302s B 531 ARG E 173 ARG^? 18.66 MG MG E 301 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 73.62 60.83 -58.23 74.10 60.41 -61.24 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 75.16 72.26 -52.56 73.67 73.54 -55.01 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 24 3 # 24 B 325 ARG F 37 ARG^? 19.14 MG MG F 301 B 342 ASP E 58 ASP^? 26.76 MG MG F 301 B 531 ARG F 50 ARG^? 16.24 MG MG F 301 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 48.80 64.46 -76.37 51.50 64.15 -77.79 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 48.85 56.05 -80.24 48.26 54.66 -77.55 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 25 3 # 25 B 325 ARG F 37 ARG^? 19.14 MG MG F 301 B 342 ASP E 160 ASP^? 31.54 MG MG F 301 B 531 ARG F 8 ARG^? 20.20 MG MG F 301 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 48.80 64.46 -76.37 51.50 64.15 -77.79 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 45.81 70.00 -68.45 44.10 68.87 -67.77 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 58.98 65.22 -76.31 57.29 62.84 -75.38 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 26 3 # 26 B 325 ARG F 37 ARG^? 19.14 MG MG F 301 B 342 ASP F 171 ASP^? 16.35 MG MG F 302 B 531 ARG F 8 ARG^? 20.20 MG MG F 301 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 48.80 64.46 -76.37 51.50 64.15 -77.79 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 58.98 65.22 -76.31 57.29 62.84 -75.38 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 27 3 # 27 B 325 ARG F 37 ARG^? 19.14 MG MG F 301 B 342 ASP F 171 ASP^? 16.35 MG MG F 302 B 531 ARG F 50 ARG^? 16.24 MG MG F 301 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 48.80 64.46 -76.37 51.50 64.15 -77.79 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 48.85 56.05 -80.24 48.26 54.66 -77.55 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 28 3 # 28 B 325 ARG F 50 ARG^? 16.24 MG MG F 301 B 342 ASP F 148 ASP^? 2.72 MG MG F 301s B 531 ARG F 173 ARG^? 18.61 MG MG F 302 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 48.85 56.05 -80.24 48.26 54.66 -77.55 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 43.18 65.58 -86.96 44.06 67.55 -84.65 1asy_c00 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 28 hits 1asy_c00 naa= 3 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 A 325 ARG A 37 ARG^? 18.99 MG MG A 301 A 342 ASP A 171 ASP^? 17.17 MG MG A 302 A 531 ARG A 8 ARG^? 20.36 MG MG A 301 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 32.99 26.50 25.19 35.50 25.33 26.51 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 29.78 23.67 36.63 28.48 25.11 35.71 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 40.62 19.52 24.63 40.98 22.51 23.88 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 2 3 # 2 A 325 ARG A 50 ARG^? 15.98 MG MG A 301 A 342 ASP A 148 ASP^? 2.72 MG MG A 301s A 531 ARG A 173 ARG^? 19.27 MG MG A 302 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 38.44 33.02 29.31 39.55 34.58 26.90 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 41.50 28.88 41.13 43.33 29.67 41.93 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 27.76 29.24 35.14 27.46 27.11 32.86 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 3 3 # 3 A 325 ARG A 173 ARG^? 19.27 MG MG A 302 A 342 ASP A 148 ASP^? 2.72 MG MG A 301s A 531 ARG A 50 ARG^? 15.98 MG MG A 301 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 27.76 29.24 35.14 27.46 27.11 32.86 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 41.50 28.88 41.13 43.33 29.67 41.93 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 38.44 33.02 29.31 39.55 34.58 26.90 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 4 3 # 4 A 325 ARG B 37 ARG^? 19.17 MG MG B 302 A 342 ASP A 58 ASP^? 26.75 MG MG B 302 A 531 ARG B 50 ARG^? 16.38 MG MG B 302 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 47.41 10.20 11.40 46.99 12.91 10.22 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 53.93 9.80 21.09 53.83 8.90 19.15 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 55.38 14.91 7.80 56.60 14.73 10.62 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 5 3 # 5 A 325 ARG B 37 ARG^? 19.17 MG MG B 302 A 342 ASP B 171 ASP^? 16.92 MG MG B 301 A 531 ARG B 8 ARG^? 20.39 MG MG B 302 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 47.41 10.20 11.40 46.99 12.91 10.22 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 45.30 8.50 -0.71 46.30 6.81 0.12 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 41.99 18.82 11.83 44.91 18.76 12.93 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 6 3 # 6 A 325 ARG B 37 ARG^? 19.17 MG MG B 302 A 342 ASP B 171 ASP^? 16.92 MG MG B 301 A 531 ARG B 50 ARG^? 16.38 MG MG B 302 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 47.41 10.20 11.40 46.99 12.91 10.22 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 45.30 8.50 -0.71 46.30 6.81 0.12 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 55.38 14.91 7.80 56.60 14.73 10.62 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 7 3 # 7 A 325 ARG B 50 ARG^? 16.38 MG MG B 302 A 342 ASP B 148 ASP^? 2.58 MG MG B 302s A 531 ARG B 173 ARG^? 18.75 MG MG B 301 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 55.38 14.91 7.80 56.60 14.73 10.62 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 49.83 5.55 0.39 48.19 5.30 3.03 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 8 3 # 8 A 325 ARG C 37 ARG^? 19.01 MG MG C 302 A 342 ASP C 171 ASP^? 17.08 MG MG C 301 A 531 ARG C 8 ARG^? 20.00 MG MG C 302 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 89.36 17.23 -17.57 89.29 20.20 -16.76 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 91.42 27.61 -18.53 88.82 26.28 -19.38 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 9 3 # 9 A 325 ARG C 50 ARG^? 16.05 MG MG C 302 A 342 ASP C 148 ASP^? 2.75 MG MG C 302s A 531 ARG C 173 ARG^? 18.96 MG MG C 301 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 80.61 19.03 -14.42 79.16 18.55 -17.10 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 89.11 11.40 -7.73 91.21 12.63 -9.73 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 10 3 # 10 A 325 ARG D 37 ARG^? 18.81 MG MG D 302 A 342 ASP C 58 ASP^? 26.67 MG MG D 302 A 531 ARG D 50 ARG^? 16.15 MG MG D 302 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 96.81 38.21 -31.63 94.97 36.32 -33.06 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 93.40 43.81 -22.27 94.18 44.45 -24.11 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 88.00 43.26 -36.30 88.86 43.23 -33.34 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 11 3 # 11 A 325 ARG D 37 ARG^? 18.81 MG MG D 302 A 342 ASP D 171 ASP^? 16.95 MG MG D 301 A 531 ARG D 8 ARG^? 20.22 MG MG D 302 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 96.81 38.21 -31.63 94.97 36.32 -33.06 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 92.22 28.83 -31.23 90.93 31.55 -30.54 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 12 3 # 12 A 325 ARG D 37 ARG^? 18.81 MG MG D 302 A 342 ASP D 171 ASP^? 16.95 MG MG D 301 A 531 ARG D 50 ARG^? 16.15 MG MG D 302 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 96.81 38.21 -31.63 94.97 36.32 -33.06 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 88.00 43.26 -36.30 88.86 43.23 -33.34 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 13 3 # 13 A 325 ARG E 37 ARG^? 19.17 MG MG E 302 A 342 ASP E 171 ASP^? 16.73 MG MG E 301 A 531 ARG E 8 ARG^? 20.19 MG MG E 302 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 70.82 68.02 -63.63 68.17 67.46 -62.14 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 60.42 66.09 -63.48 62.84 64.38 -64.17 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 14 3 # 14 A 325 ARG E 50 ARG^? 15.97 MG MG E 302 A 342 ASP E 148 ASP^? 2.62 MG MG E 302s A 531 ARG E 173 ARG^? 18.66 MG MG E 301 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 73.62 60.83 -58.23 74.10 60.41 -61.24 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 75.16 72.26 -52.56 73.67 73.54 -55.01 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 15 3 # 15 A 325 ARG F 37 ARG^? 19.14 MG MG F 301 A 342 ASP F 171 ASP^? 16.35 MG MG F 302 A 531 ARG F 8 ARG^? 20.20 MG MG F 301 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 48.80 64.46 -76.37 51.50 64.15 -77.79 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 58.98 65.22 -76.31 57.29 62.84 -75.38 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 16 3 # 16 A 325 ARG F 50 ARG^? 16.24 MG MG F 301 A 342 ASP F 148 ASP^? 2.72 MG MG F 301s A 531 ARG F 173 ARG^? 18.61 MG MG F 302 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 48.85 56.05 -80.24 48.26 54.66 -77.55 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 43.18 65.58 -86.96 44.06 67.55 -84.65 1asy_c01 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 16 hits 1asy_c01 naa= 3 ULMN 3 1ax4_c04 TRYPTOPHANASE user 1 3 # 1 A 130 PHE A 150 PHE^? 10.47 MG MG A 302 A 223 ASP A 35 ASP^? 16.92 MG MG A 301 A 265 LYS A 90 LYS^? 18.58 MG MG A 301 coo 39.74 52.86 65.74 41.15 55.14 66.52 35.63 32.10 38.88 34.73 33.93 37.00 coo 30.70 47.50 67.53 29.83 49.47 67.39 34.49 31.10 26.54 36.41 31.82 27.10 coo 19.99 54.53 64.11 20.55 58.78 68.33 46.62 38.29 25.46 47.51 33.29 23.22 ULMN 3 1ax4_c04 TRYPTOPHANASE user 2 3 # 2 A 130 PHE A 150 PHE^? 10.47 MG MG A 302 A 223 ASP A 171 ASP^? 17.17 MG MG A 302 A 265 LYS A 166 LYS^? 20.93 MG MG A 302 coo 39.74 52.86 65.74 41.15 55.14 66.52 35.63 32.10 38.88 34.73 33.93 37.00 coo 30.70 47.50 67.53 29.83 49.47 67.39 29.78 23.67 36.63 28.48 25.11 35.71 coo 19.99 54.53 64.11 20.55 58.78 68.33 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1ax4_c04 TRYPTOPHANASE user 3 3 # 3 A 130 PHE A 153 PHE^? 9.64 MG MG A 301 A 223 ASP A 35 ASP^? 16.92 MG MG A 301 A 265 LYS A 90 LYS^? 18.58 MG MG A 301 coo 39.74 52.86 65.74 41.15 55.14 66.52 38.89 24.49 36.07 40.14 26.70 37.23 coo 30.70 47.50 67.53 29.83 49.47 67.39 34.49 31.10 26.54 36.41 31.82 27.10 coo 19.99 54.53 64.11 20.55 58.78 68.33 46.62 38.29 25.46 47.51 33.29 23.22 ULMN 3 1ax4_c04 TRYPTOPHANASE user 4 3 # 4 A 130 PHE A 161 PHE^? 25.62 MG MG B 302 A 223 ASP B 35 ASP^? 16.92 MG MG B 302 A 265 LYS B 90 LYS^? 18.68 MG MG B 302 coo 39.74 52.86 65.74 41.15 55.14 66.52 44.24 9.29 16.03 46.90 9.95 15.56 coo 30.70 47.50 67.53 29.83 49.47 67.39 52.63 11.07 10.18 53.68 12.85 9.94 coo 19.99 54.53 64.11 20.55 58.78 68.33 61.66 21.61 12.88 56.74 22.88 14.81 ULMN 3 1ax4_c04 TRYPTOPHANASE user 5 3 # 5 A 130 PHE A 164 PHE^? 26.07 MG MG A 301 A 223 ASP A 160 ASP^? 31.61 MG MG B 302 A 265 LYS A 61 LYS^? 21.99 MG MG B 302 coo 39.74 52.86 65.74 41.15 55.14 66.52 37.51 14.27 23.18 39.37 15.97 21.97 coo 30.70 47.50 67.53 29.83 49.47 67.39 44.21 5.00 19.54 46.02 3.84 19.76 coo 19.99 54.53 64.11 20.55 58.78 68.33 57.78 7.35 19.60 56.77 12.20 15.61 ULMN 3 1ax4_c04 TRYPTOPHANASE user 6 3 # 6 A 130 PHE A 164 PHE^? 26.07 MG MG A 301 A 223 ASP A 160 ASP^? 31.61 MG MG B 302 A 265 LYS A 136 LYS^? 30.58 MG MG A 302 coo 39.74 52.86 65.74 41.15 55.14 66.52 37.51 14.27 23.18 39.37 15.97 21.97 coo 30.70 47.50 67.53 29.83 49.47 67.39 44.21 5.00 19.54 46.02 3.84 19.76 coo 19.99 54.53 64.11 20.55 58.78 68.33 50.14 3.36 31.42 51.28 2.21 35.89 ULMN 3 1ax4_c04 TRYPTOPHANASE user 7 3 # 7 A 130 PHE A 164 PHE^? 26.07 MG MG A 301 A 223 ASP A 160 ASP^? 31.61 MG MG B 302 A 265 LYS A 137 LYS^? 34.85 MG MG A 301 coo 39.74 52.86 65.74 41.15 55.14 66.52 37.51 14.27 23.18 39.37 15.97 21.97 coo 30.70 47.50 67.53 29.83 49.47 67.39 44.21 5.00 19.54 46.02 3.84 19.76 coo 19.99 54.53 64.11 20.55 58.78 68.33 50.97 1.58 28.14 56.13 1.49 28.03 ULMN 3 1ax4_c04 TRYPTOPHANASE user 8 3 # 8 A 130 PHE A 172 PHE^? 13.28 MG MG A 302 A 223 ASP A 35 ASP^? 16.92 MG MG A 301 A 265 LYS A 90 LYS^? 18.58 MG MG A 301 coo 39.74 52.86 65.74 41.15 55.14 66.52 31.82 29.57 38.19 30.91 31.55 36.40 coo 30.70 47.50 67.53 29.83 49.47 67.39 34.49 31.10 26.54 36.41 31.82 27.10 coo 19.99 54.53 64.11 20.55 58.78 68.33 46.62 38.29 25.46 47.51 33.29 23.22 ULMN 3 1ax4_c04 TRYPTOPHANASE user 9 3 # 9 A 130 PHE B 39 PHE^? 18.11 MG MG B 301 A 223 ASP B 35 ASP^? 16.92 MG MG B 302 A 265 LYS A 61 LYS^? 21.99 MG MG B 302 coo 39.74 52.86 65.74 41.15 55.14 66.52 43.21 9.88 5.15 44.59 10.44 2.80 coo 30.70 47.50 67.53 29.83 49.47 67.39 52.63 11.07 10.18 53.68 12.85 9.94 coo 19.99 54.53 64.11 20.55 58.78 68.33 57.78 7.35 19.60 56.77 12.20 15.61 ULMN 3 1ax4_c04 TRYPTOPHANASE user 10 3 # 10 A 130 PHE B 150 PHE^? 9.88 MG MG B 301 A 223 ASP B 35 ASP^? 16.92 MG MG B 302 A 265 LYS B 90 LYS^? 18.68 MG MG B 302 coo 39.74 52.86 65.74 41.15 55.14 66.52 54.70 12.86 -1.84 56.31 11.50 0.05 coo 30.70 47.50 67.53 29.83 49.47 67.39 52.63 11.07 10.18 53.68 12.85 9.94 coo 19.99 54.53 64.11 20.55 58.78 68.33 61.66 21.61 12.88 56.74 22.88 14.81 ULMN 3 1ax4_c04 TRYPTOPHANASE user 11 3 # 11 A 130 PHE B 150 PHE^? 9.88 MG MG B 301 A 223 ASP B 171 ASP^? 16.92 MG MG B 301 A 265 LYS B 166 LYS^? 22.75 MG MG B 301 coo 39.74 52.86 65.74 41.15 55.14 66.52 54.70 12.86 -1.84 56.31 11.50 0.05 coo 30.70 47.50 67.53 29.83 49.47 67.39 45.30 8.50 -0.71 46.30 6.81 0.12 coo 19.99 54.53 64.11 20.55 58.78 68.33 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1ax4_c04 TRYPTOPHANASE user 12 3 # 12 A 130 PHE B 153 PHE^? 9.59 MG MG B 302 A 223 ASP B 35 ASP^? 16.92 MG MG B 302 A 265 LYS B 90 LYS^? 18.68 MG MG B 302 coo 39.74 52.86 65.74 41.15 55.14 66.52 47.54 17.09 0.77 50.03 17.91 -0.19 coo 30.70 47.50 67.53 29.83 49.47 67.39 52.63 11.07 10.18 53.68 12.85 9.94 coo 19.99 54.53 64.11 20.55 58.78 68.33 61.66 21.61 12.88 56.74 22.88 14.81 ULMN 3 1ax4_c04 TRYPTOPHANASE user 13 3 # 13 A 130 PHE B 161 PHE^? 25.78 MG MG A 301 A 223 ASP A 35 ASP^? 16.92 MG MG A 301 A 265 LYS A 90 LYS^? 18.58 MG MG A 301 coo 39.74 52.86 65.74 41.15 55.14 66.52 31.87 23.58 19.99 32.61 26.21 20.65 coo 30.70 47.50 67.53 29.83 49.47 67.39 34.49 31.10 26.54 36.41 31.82 27.10 coo 19.99 54.53 64.11 20.55 58.78 68.33 46.62 38.29 25.46 47.51 33.29 23.22 ULMN 3 1ax4_c04 TRYPTOPHANASE user 14 3 # 14 A 130 PHE B 164 PHE^? 25.95 MG MG B 302 A 223 ASP B 160 ASP^? 31.65 MG MG A 301 A 265 LYS B 61 LYS^? 22.03 MG MG A 301 coo 39.74 52.86 65.74 41.15 55.14 66.52 36.16 16.77 12.72 38.04 18.41 13.99 coo 30.70 47.50 67.53 29.83 49.47 67.39 28.01 24.83 16.38 27.44 26.81 15.80 coo 19.99 54.53 64.11 20.55 58.78 68.33 32.50 37.62 17.61 36.68 34.92 21.51 ULMN 3 1ax4_c04 TRYPTOPHANASE user 15 3 # 15 A 130 PHE B 164 PHE^? 25.95 MG MG B 302 A 223 ASP B 160 ASP^? 31.65 MG MG A 301 A 265 LYS B 136 LYS^? 33.75 MG MG B 302 coo 39.74 52.86 65.74 41.15 55.14 66.52 36.16 16.77 12.72 38.04 18.41 13.99 coo 30.70 47.50 67.53 29.83 49.47 67.39 28.01 24.83 16.38 27.44 26.81 15.80 coo 19.99 54.53 64.11 20.55 58.78 68.33 28.47 31.35 4.78 24.04 31.81 1.99 ULMN 3 1ax4_c04 TRYPTOPHANASE user 16 3 # 16 A 130 PHE B 164 PHE^? 25.95 MG MG B 302 A 223 ASP B 160 ASP^? 31.65 MG MG A 301 A 265 LYS B 137 LYS^? 34.56 MG MG B 302 coo 39.74 52.86 65.74 41.15 55.14 66.52 36.16 16.77 12.72 38.04 18.41 13.99 coo 30.70 47.50 67.53 29.83 49.47 67.39 28.01 24.83 16.38 27.44 26.81 15.80 coo 19.99 54.53 64.11 20.55 58.78 68.33 26.56 32.46 7.93 27.87 37.71 9.31 ULMN 3 1ax4_c04 TRYPTOPHANASE user 17 3 # 17 A 130 PHE B 172 PHE^? 12.81 MG MG B 301 A 223 ASP B 35 ASP^? 16.92 MG MG B 302 A 265 LYS B 90 LYS^? 18.68 MG MG B 302 coo 39.74 52.86 65.74 41.15 55.14 66.52 51.51 9.59 -1.64 53.03 8.15 0.22 coo 30.70 47.50 67.53 29.83 49.47 67.39 52.63 11.07 10.18 53.68 12.85 9.94 coo 19.99 54.53 64.11 20.55 58.78 68.33 61.66 21.61 12.88 56.74 22.88 14.81 ULMN 3 1ax4_c04 TRYPTOPHANASE user 18 3 # 18 A 130 PHE B 190 PHE^? 14.80 MG MG B 301 A 223 ASP B 142 ASP^? 23.97 MG MG B 301 A 265 LYS B 137 LYS^? 34.56 MG MG B 302 coo 39.74 52.86 65.74 41.15 55.14 66.52 40.06 19.97 -3.89 40.77 21.13 -1.45 coo 30.70 47.50 67.53 29.83 49.47 67.39 31.69 27.40 -1.31 32.10 27.37 -3.38 coo 19.99 54.53 64.11 20.55 58.78 68.33 26.56 32.46 7.93 27.87 37.71 9.31 ULMN 3 1ax4_c04 TRYPTOPHANASE user 19 3 # 19 A 130 PHE C 39 PHE^? 18.26 MG MG C 301 A 223 ASP C 35 ASP^? 16.42 MG MG C 302 A 265 LYS D 61 LYS^? 21.93 MG MG C 302 coo 39.74 52.86 65.74 41.15 55.14 66.52 93.83 18.63 -11.96 92.54 18.49 -9.49 coo 30.70 47.50 67.53 29.83 49.47 67.39 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 19.99 54.53 64.11 20.55 58.78 68.33 80.64 11.23 -26.16 80.65 16.24 -22.36 ULMN 3 1ax4_c04 TRYPTOPHANASE user 20 3 # 20 A 130 PHE C 150 PHE^? 10.02 MG MG C 301 A 223 ASP C 35 ASP^? 16.42 MG MG C 302 A 265 LYS C 90 LYS^? 18.24 MG MG C 302 coo 39.74 52.86 65.74 41.15 55.14 66.52 82.11 17.28 -4.80 81.16 15.47 -6.75 coo 30.70 47.50 67.53 29.83 49.47 67.39 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 19.99 54.53 64.11 20.55 58.78 68.33 72.37 23.25 -18.94 76.11 26.52 -20.97 ULMN 3 1ax4_c04 TRYPTOPHANASE user 21 3 # 21 A 130 PHE C 150 PHE^? 10.02 MG MG C 301 A 223 ASP C 171 ASP^? 17.08 MG MG C 301 A 265 LYS C 166 LYS^? 22.53 MG MG C 301 coo 39.74 52.86 65.74 41.15 55.14 66.52 82.11 17.28 -4.80 81.16 15.47 -6.75 coo 30.70 47.50 67.53 29.83 49.47 67.39 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 19.99 54.53 64.11 20.55 58.78 68.33 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1ax4_c04 TRYPTOPHANASE user 22 3 # 22 A 130 PHE C 153 PHE^? 9.34 MG MG C 302 A 223 ASP C 35 ASP^? 16.42 MG MG C 302 A 265 LYS C 90 LYS^? 18.24 MG MG C 302 coo 39.74 52.86 65.74 41.15 55.14 66.52 87.15 23.83 -7.29 84.55 23.79 -6.26 coo 30.70 47.50 67.53 29.83 49.47 67.39 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 19.99 54.53 64.11 20.55 58.78 68.33 72.37 23.25 -18.94 76.11 26.52 -20.97 ULMN 3 1ax4_c04 TRYPTOPHANASE user 23 3 # 23 A 130 PHE C 161 PHE^? 25.47 MG MG D 302 A 223 ASP D 35 ASP^? 16.80 MG MG D 302 A 265 LYS D 90 LYS^? 18.98 MG MG D 302 coo 39.74 52.86 65.74 41.15 55.14 66.52 98.98 35.62 -26.76 97.40 37.84 -27.44 coo 30.70 47.50 67.53 29.83 49.47 67.39 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 19.99 54.53 64.11 20.55 58.78 68.33 79.83 44.38 -31.44 80.32 39.55 -29.40 ULMN 3 1ax4_c04 TRYPTOPHANASE user 24 3 # 24 A 130 PHE C 164 PHE^? 25.79 MG MG C 302 A 223 ASP C 160 ASP^? 31.63 MG MG D 302 A 265 LYS C 61 LYS^? 21.91 MG MG D 302 coo 39.74 52.86 65.74 41.15 55.14 66.52 97.62 27.66 -19.56 95.28 28.38 -20.99 coo 30.70 47.50 67.53 29.83 49.47 67.39 102.50 38.00 -23.28 102.43 39.97 -22.46 coo 19.99 54.53 64.11 20.55 58.78 68.33 93.60 48.56 -24.05 90.39 44.71 -27.98 ULMN 3 1ax4_c04 TRYPTOPHANASE user 25 3 # 25 A 130 PHE C 164 PHE^? 25.79 MG MG C 302 A 223 ASP C 160 ASP^? 31.63 MG MG D 302 A 265 LYS C 136 LYS^? 30.63 MG MG C 302 coo 39.74 52.86 65.74 41.15 55.14 66.52 97.62 27.66 -19.56 95.28 28.38 -20.99 coo 30.70 47.50 67.53 29.83 49.47 67.39 102.50 38.00 -23.28 102.43 39.97 -22.46 coo 19.99 54.53 64.11 20.55 58.78 68.33 99.75 44.04 -11.38 100.98 45.13 -6.77 ULMN 3 1ax4_c04 TRYPTOPHANASE user 26 3 # 26 A 130 PHE C 164 PHE^? 25.79 MG MG C 302 A 223 ASP C 160 ASP^? 31.63 MG MG D 302 A 265 LYS C 137 LYS^? 35.41 MG MG C 302 coo 39.74 52.86 65.74 41.15 55.14 66.52 97.62 27.66 -19.56 95.28 28.38 -20.99 coo 30.70 47.50 67.53 29.83 49.47 67.39 102.50 38.00 -23.28 102.43 39.97 -22.46 coo 19.99 54.53 64.11 20.55 58.78 68.33 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 1ax4_c04 TRYPTOPHANASE user 27 3 # 27 A 130 PHE C 172 PHE^? 13.00 MG MG C 301 A 223 ASP C 35 ASP^? 16.42 MG MG C 302 A 265 LYS C 90 LYS^? 18.24 MG MG C 302 coo 39.74 52.86 65.74 41.15 55.14 66.52 86.45 15.28 -5.05 85.50 13.59 -7.08 coo 30.70 47.50 67.53 29.83 49.47 67.39 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 19.99 54.53 64.11 20.55 58.78 68.33 72.37 23.25 -18.94 76.11 26.52 -20.97 ULMN 3 1ax4_c04 TRYPTOPHANASE user 28 3 # 28 A 130 PHE C 190 PHE^? 14.91 MG MG C 301 A 223 ASP C 142 ASP^? 23.76 MG MG C 301 A 265 LYS C 137 LYS^? 35.41 MG MG C 302 coo 39.74 52.86 65.74 41.15 55.14 66.52 93.44 29.01 -2.85 92.36 29.94 -5.20 coo 30.70 47.50 67.53 29.83 49.47 67.39 97.94 39.27 -5.03 98.08 38.70 -2.97 coo 19.99 54.53 64.11 20.55 58.78 68.33 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 1ax4_c04 TRYPTOPHANASE user 29 3 # 29 A 130 PHE D 150 PHE^? 10.21 MG MG D 301 A 223 ASP D 35 ASP^? 16.80 MG MG D 302 A 265 LYS D 90 LYS^? 18.98 MG MG D 302 coo 39.74 52.86 65.74 41.15 55.14 66.52 91.92 42.74 -45.34 92.24 44.79 -43.44 coo 30.70 47.50 67.53 29.83 49.47 67.39 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 19.99 54.53 64.11 20.55 58.78 68.33 79.83 44.38 -31.44 80.32 39.55 -29.40 ULMN 3 1ax4_c04 TRYPTOPHANASE user 30 3 # 30 A 130 PHE D 150 PHE^? 10.21 MG MG D 301 A 223 ASP D 171 ASP^? 16.95 MG MG D 301 A 265 LYS D 166 LYS^? 21.08 MG MG D 301 coo 39.74 52.86 65.74 41.15 55.14 66.52 91.92 42.74 -45.34 92.24 44.79 -43.44 coo 30.70 47.50 67.53 29.83 49.47 67.39 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 19.99 54.53 64.11 20.55 58.78 68.33 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1ax4_c04 TRYPTOPHANASE user 31 3 # 31 A 130 PHE D 153 PHE^? 9.11 MG MG D 302 A 223 ASP D 35 ASP^? 16.80 MG MG D 302 A 265 LYS D 90 LYS^? 18.98 MG MG D 302 coo 39.74 52.86 65.74 41.15 55.14 66.52 91.67 34.35 -42.71 89.76 36.10 -43.73 coo 30.70 47.50 67.53 29.83 49.47 67.39 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 19.99 54.53 64.11 20.55 58.78 68.33 79.83 44.38 -31.44 80.32 39.55 -29.40 ULMN 3 1ax4_c04 TRYPTOPHANASE user 32 3 # 32 A 130 PHE D 161 PHE^? 25.58 MG MG C 302 A 223 ASP C 35 ASP^? 16.42 MG MG C 302 A 265 LYS C 90 LYS^? 18.24 MG MG C 302 coo 39.74 52.86 65.74 41.15 55.14 66.52 92.97 17.97 -22.91 90.24 17.44 -22.45 coo 30.70 47.50 67.53 29.83 49.47 67.39 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 19.99 54.53 64.11 20.55 58.78 68.33 72.37 23.25 -18.94 76.11 26.52 -20.97 ULMN 3 1ax4_c04 TRYPTOPHANASE user 33 3 # 33 A 130 PHE D 164 PHE^? 25.90 MG MG D 302 A 223 ASP D 160 ASP^? 31.45 MG MG C 302 A 265 LYS D 61 LYS^? 21.93 MG MG C 302 coo 39.74 52.86 65.74 41.15 55.14 66.52 97.06 25.02 -29.96 94.69 25.91 -28.78 coo 30.70 47.50 67.53 29.83 49.47 67.39 94.15 13.98 -26.57 92.71 12.42 -26.99 coo 19.99 54.53 64.11 20.55 58.78 68.33 80.64 11.23 -26.16 80.65 16.24 -22.36 ULMN 3 1ax4_c04 TRYPTOPHANASE user 34 3 # 34 A 130 PHE D 164 PHE^? 25.90 MG MG D 302 A 223 ASP D 160 ASP^? 31.45 MG MG C 302 A 265 LYS D 136 LYS^? 34.99 MG MG D 302 coo 39.74 52.86 65.74 41.15 55.14 66.52 97.06 25.02 -29.96 94.69 25.91 -28.78 coo 30.70 47.50 67.53 29.83 49.47 67.39 94.15 13.98 -26.57 92.71 12.42 -26.99 coo 19.99 54.53 64.11 20.55 58.78 68.33 88.96 10.62 -38.53 90.77 6.00 -38.00 ULMN 3 1ax4_c04 TRYPTOPHANASE user 35 3 # 35 A 130 PHE D 164 PHE^? 25.90 MG MG D 302 A 223 ASP D 160 ASP^? 31.45 MG MG C 302 A 265 LYS D 137 LYS^? 37.57 MG MG D 302 coo 39.74 52.86 65.74 41.15 55.14 66.52 97.06 25.02 -29.96 94.69 25.91 -28.78 coo 30.70 47.50 67.53 29.83 49.47 67.39 94.15 13.98 -26.57 92.71 12.42 -26.99 coo 19.99 54.53 64.11 20.55 58.78 68.33 88.48 8.58 -35.33 84.88 3.98 -33.96 ULMN 3 1ax4_c04 TRYPTOPHANASE user 36 3 # 36 A 130 PHE D 172 PHE^? 13.02 MG MG D 301 A 223 ASP D 35 ASP^? 16.80 MG MG D 302 A 265 LYS D 90 LYS^? 18.98 MG MG D 302 coo 39.74 52.86 65.74 41.15 55.14 66.52 96.36 41.50 -44.84 96.77 43.66 -43.13 coo 30.70 47.50 67.53 29.83 49.47 67.39 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 19.99 54.53 64.11 20.55 58.78 68.33 79.83 44.38 -31.44 80.32 39.55 -29.40 ULMN 3 1ax4_c04 TRYPTOPHANASE user 37 3 # 37 A 130 PHE D 190 PHE^? 14.83 MG MG D 301 A 223 ASP D 142 ASP^? 23.49 MG MG D 301 A 265 LYS D 137 LYS^? 37.57 MG MG D 302 coo 39.74 52.86 65.74 41.15 55.14 66.52 93.52 26.32 -46.94 92.08 26.47 -44.56 coo 30.70 47.50 67.53 29.83 49.47 67.39 90.90 15.58 -44.76 91.35 16.09 -46.79 coo 19.99 54.53 64.11 20.55 58.78 68.33 88.48 8.58 -35.33 84.88 3.98 -33.96 ULMN 3 1ax4_c04 TRYPTOPHANASE user 38 3 # 38 A 130 PHE E 150 PHE^? 10.10 MG MG E 301 A 223 ASP E 35 ASP^? 16.91 MG MG E 302 A 265 LYS E 90 LYS^? 19.16 MG MG E 302 coo 39.74 52.86 65.74 41.15 55.14 66.52 74.01 63.99 -49.53 76.06 63.87 -51.45 coo 30.70 47.50 67.53 29.83 49.47 67.39 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 19.99 54.53 64.11 20.55 58.78 68.33 73.81 51.50 -63.18 69.15 52.39 -65.65 ULMN 3 1ax4_c04 TRYPTOPHANASE user 39 3 # 39 A 130 PHE E 150 PHE^? 10.10 MG MG E 301 A 223 ASP E 171 ASP^? 16.73 MG MG E 301 A 265 LYS E 166 LYS^? 21.46 MG MG E 301 coo 39.74 52.86 65.74 41.15 55.14 66.52 74.01 63.99 -49.53 76.06 63.87 -51.45 coo 30.70 47.50 67.53 29.83 49.47 67.39 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 19.99 54.53 64.11 20.55 58.78 68.33 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1ax4_c04 TRYPTOPHANASE user 40 3 # 40 A 130 PHE E 153 PHE^? 9.50 MG MG E 302 A 223 ASP E 35 ASP^? 16.91 MG MG E 302 A 265 LYS E 90 LYS^? 19.16 MG MG E 302 coo 39.74 52.86 65.74 41.15 55.14 66.52 65.86 64.95 -52.12 67.22 62.73 -51.09 coo 30.70 47.50 67.53 29.83 49.47 67.39 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 19.99 54.53 64.11 20.55 58.78 68.33 73.81 51.50 -63.18 69.15 52.39 -65.65 ULMN 3 1ax4_c04 TRYPTOPHANASE user 41 3 # 41 A 130 PHE E 161 PHE^? 25.51 MG MG F 301 A 223 ASP F 35 ASP^? 16.93 MG MG F 301 A 265 LYS F 90 LYS^? 18.57 MG MG F 301 coo 39.74 52.86 65.74 41.15 55.14 66.52 49.74 68.03 -71.94 48.60 65.47 -72.38 coo 30.70 47.50 67.53 29.83 49.47 67.39 46.82 60.47 -77.63 48.00 58.79 -78.23 coo 19.99 54.53 64.11 20.55 58.78 68.33 51.54 47.01 -75.58 55.05 50.31 -73.74 ULMN 3 1ax4_c04 TRYPTOPHANASE user 42 3 # 42 A 130 PHE E 164 PHE^? 25.87 MG MG E 302 A 223 ASP E 160 ASP^? 31.54 MG MG F 301 A 265 LYS E 136 LYS^? 31.27 MG MG E 302 coo 39.74 52.86 65.74 41.15 55.14 66.52 57.42 71.31 -64.81 57.98 68.84 -66.03 coo 30.70 47.50 67.53 29.83 49.47 67.39 45.81 70.00 -68.45 44.10 68.87 -67.77 coo 19.99 54.53 64.11 20.55 58.78 68.33 42.12 65.93 -56.52 39.36 65.07 -51.83 ULMN 3 1ax4_c04 TRYPTOPHANASE user 43 3 # 43 A 130 PHE E 172 PHE^? 12.71 MG MG E 301 A 223 ASP E 35 ASP^? 16.91 MG MG E 302 A 265 LYS E 90 LYS^? 19.16 MG MG E 302 coo 39.74 52.86 65.74 41.15 55.14 66.52 73.54 68.41 -50.00 75.58 68.36 -51.87 coo 30.70 47.50 67.53 29.83 49.47 67.39 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 19.99 54.53 64.11 20.55 58.78 68.33 73.81 51.50 -63.18 69.15 52.39 -65.65 ULMN 3 1ax4_c04 TRYPTOPHANASE user 44 3 # 44 A 130 PHE E 190 PHE^? 14.70 MG MG E 301 A 223 ASP E 142 ASP^? 23.66 MG MG E 301 A 265 LYS E 137 LYS^? 35.26 MG MG E 302 coo 39.74 52.86 65.74 41.15 55.14 66.52 58.27 67.97 -47.86 58.03 66.58 -50.23 coo 30.70 47.50 67.53 29.83 49.47 67.39 47.19 67.15 -50.37 47.44 67.18 -48.23 coo 19.99 54.53 64.11 20.55 58.78 68.33 40.01 66.05 -59.66 36.65 60.99 -60.28 ULMN 3 1ax4_c04 TRYPTOPHANASE user 45 3 # 45 A 130 PHE F 39 PHE^? 17.69 MG MG F 302 A 223 ASP F 35 ASP^? 16.93 MG MG F 301 A 265 LYS E 61 LYS^? 22.16 MG MG F 301 coo 39.74 52.86 65.74 41.15 55.14 66.52 50.42 69.23 -82.87 49.95 67.86 -85.25 coo 30.70 47.50 67.53 29.83 49.47 67.39 46.82 60.47 -77.63 48.00 58.79 -78.23 coo 19.99 54.53 64.11 20.55 58.78 68.33 40.99 56.84 -68.48 45.99 56.72 -72.39 ULMN 3 1ax4_c04 TRYPTOPHANASE user 46 3 # 46 A 130 PHE F 150 PHE^? 9.82 MG MG F 302 A 223 ASP F 35 ASP^? 16.93 MG MG F 301 A 265 LYS F 90 LYS^? 18.57 MG MG F 301 coo 39.74 52.86 65.74 41.15 55.14 66.52 47.10 57.70 -89.94 45.06 57.27 -88.04 coo 30.70 47.50 67.53 29.83 49.47 67.39 46.82 60.47 -77.63 48.00 58.79 -78.23 coo 19.99 54.53 64.11 20.55 58.78 68.33 51.54 47.01 -75.58 55.05 50.31 -73.74 ULMN 3 1ax4_c04 TRYPTOPHANASE user 47 3 # 47 A 130 PHE F 150 PHE^? 9.82 MG MG F 302 A 223 ASP F 171 ASP^? 16.35 MG MG F 302 A 265 LYS F 166 LYS^? 20.76 MG MG F 302 coo 39.74 52.86 65.74 41.15 55.14 66.52 47.10 57.70 -89.94 45.06 57.27 -88.04 coo 30.70 47.50 67.53 29.83 49.47 67.39 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 19.99 54.53 64.11 20.55 58.78 68.33 59.28 73.05 -82.63 55.63 74.15 -86.94 ULMN 3 1ax4_c04 TRYPTOPHANASE user 48 3 # 48 A 130 PHE F 153 PHE^? 9.26 MG MG F 302 A 223 ASP F 35 ASP^? 16.93 MG MG F 301 A 265 LYS F 90 LYS^? 18.57 MG MG F 301 coo 39.74 52.86 65.74 41.15 55.14 66.52 54.49 61.65 -87.43 53.89 59.08 -88.37 coo 30.70 47.50 67.53 29.83 49.47 67.39 46.82 60.47 -77.63 48.00 58.79 -78.23 coo 19.99 54.53 64.11 20.55 58.78 68.33 51.54 47.01 -75.58 55.05 50.31 -73.74 ULMN 3 1ax4_c04 TRYPTOPHANASE user 49 3 # 49 A 130 PHE F 161 PHE^? 25.66 MG MG E 302 A 223 ASP E 35 ASP^? 16.91 MG MG E 302 A 265 LYS E 90 LYS^? 19.16 MG MG E 302 coo 39.74 52.86 65.74 41.15 55.14 66.52 68.33 71.65 -68.19 70.12 69.57 -67.59 coo 30.70 47.50 67.53 29.83 49.47 67.39 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 19.99 54.53 64.11 20.55 58.78 68.33 73.81 51.50 -63.18 69.15 52.39 -65.65 ULMN 3 1ax4_c04 TRYPTOPHANASE user 50 3 # 50 A 130 PHE F 164 PHE^? 26.17 MG MG F 301 A 223 ASP F 160 ASP^? 31.59 MG MG E 302 A 265 LYS F 136 LYS^? 30.53 MG MG F 301 coo 39.74 52.86 65.74 41.15 55.14 66.52 60.03 71.53 -75.24 60.39 69.25 -73.67 coo 30.70 47.50 67.53 29.83 49.47 67.39 71.27 74.59 -71.77 73.23 74.02 -72.37 coo 19.99 54.53 64.11 20.55 58.78 68.33 76.49 71.19 -83.39 78.38 70.88 -88.47 ULMN 3 1ax4_c04 TRYPTOPHANASE user 51 3 # 51 A 130 PHE F 164 PHE^? 26.17 MG MG F 301 A 223 ASP F 160 ASP^? 31.59 MG MG E 302 A 265 LYS F 137 LYS^? 35.13 MG MG F 301 coo 39.74 52.86 65.74 41.15 55.14 66.52 60.03 71.53 -75.24 60.39 69.25 -73.67 coo 30.70 47.50 67.53 29.83 49.47 67.39 71.27 74.59 -71.77 73.23 74.02 -72.37 coo 19.99 54.53 64.11 20.55 58.78 68.33 78.53 72.20 -80.30 83.01 68.64 -79.79 ULMN 3 1ax4_c04 TRYPTOPHANASE user 52 3 # 52 A 130 PHE F 172 PHE^? 12.43 MG MG F 302 A 223 ASP F 35 ASP^? 16.93 MG MG F 301 A 265 LYS F 90 LYS^? 18.57 MG MG F 301 coo 39.74 52.86 65.74 41.15 55.14 66.52 45.85 62.23 -89.68 43.95 61.55 -87.75 coo 30.70 47.50 67.53 29.83 49.47 67.39 46.82 60.47 -77.63 48.00 58.79 -78.23 coo 19.99 54.53 64.11 20.55 58.78 68.33 51.54 47.01 -75.58 55.05 50.31 -73.74 1ax4_c04 source 1ax4 TRYPTOPHANASE : 52 hits 1ax4_c04 naa= 3 ULMN 3 1ax4_c05 TRYPTOPHANASE user 1 3 # 1 B 130 PHE A 150 PHE^? 10.47 MG MG A 302 B 223 ASP A 35 ASP^? 16.92 MG MG A 301 B 265 LYS A 90 LYS^? 18.58 MG MG A 301 coo 7.48 54.94 99.62 7.67 52.27 100.42 35.63 32.10 38.88 34.73 33.93 37.00 coo 10.43 61.66 91.81 9.80 60.04 90.61 34.49 31.10 26.54 36.41 31.82 27.10 coo 5.43 58.06 80.08 8.57 53.00 79.37 46.62 38.29 25.46 47.51 33.29 23.22 ULMN 3 1ax4_c05 TRYPTOPHANASE user 2 3 # 2 B 130 PHE A 150 PHE^? 10.47 MG MG A 302 B 223 ASP A 171 ASP^? 17.17 MG MG A 302 B 265 LYS A 166 LYS^? 20.93 MG MG A 302 coo 7.48 54.94 99.62 7.67 52.27 100.42 35.63 32.10 38.88 34.73 33.93 37.00 coo 10.43 61.66 91.81 9.80 60.04 90.61 29.78 23.67 36.63 28.48 25.11 35.71 coo 5.43 58.06 80.08 8.57 53.00 79.37 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1ax4_c05 TRYPTOPHANASE user 3 3 # 3 B 130 PHE A 153 PHE^? 9.64 MG MG A 301 B 223 ASP A 35 ASP^? 16.92 MG MG A 301 B 265 LYS A 90 LYS^? 18.58 MG MG A 301 coo 7.48 54.94 99.62 7.67 52.27 100.42 38.89 24.49 36.07 40.14 26.70 37.23 coo 10.43 61.66 91.81 9.80 60.04 90.61 34.49 31.10 26.54 36.41 31.82 27.10 coo 5.43 58.06 80.08 8.57 53.00 79.37 46.62 38.29 25.46 47.51 33.29 23.22 ULMN 3 1ax4_c05 TRYPTOPHANASE user 4 3 # 4 B 130 PHE A 161 PHE^? 25.62 MG MG B 302 B 223 ASP B 35 ASP^? 16.92 MG MG B 302 B 265 LYS B 90 LYS^? 18.68 MG MG B 302 coo 7.48 54.94 99.62 7.67 52.27 100.42 44.24 9.29 16.03 46.90 9.95 15.56 coo 10.43 61.66 91.81 9.80 60.04 90.61 52.63 11.07 10.18 53.68 12.85 9.94 coo 5.43 58.06 80.08 8.57 53.00 79.37 61.66 21.61 12.88 56.74 22.88 14.81 ULMN 3 1ax4_c05 TRYPTOPHANASE user 5 3 # 5 B 130 PHE A 164 PHE^? 26.07 MG MG A 301 B 223 ASP A 160 ASP^? 31.61 MG MG B 302 B 265 LYS A 61 LYS^? 21.99 MG MG B 302 coo 7.48 54.94 99.62 7.67 52.27 100.42 37.51 14.27 23.18 39.37 15.97 21.97 coo 10.43 61.66 91.81 9.80 60.04 90.61 44.21 5.00 19.54 46.02 3.84 19.76 coo 5.43 58.06 80.08 8.57 53.00 79.37 57.78 7.35 19.60 56.77 12.20 15.61 ULMN 3 1ax4_c05 TRYPTOPHANASE user 6 3 # 6 B 130 PHE A 164 PHE^? 26.07 MG MG A 301 B 223 ASP A 160 ASP^? 31.61 MG MG B 302 B 265 LYS A 136 LYS^? 30.58 MG MG A 302 coo 7.48 54.94 99.62 7.67 52.27 100.42 37.51 14.27 23.18 39.37 15.97 21.97 coo 10.43 61.66 91.81 9.80 60.04 90.61 44.21 5.00 19.54 46.02 3.84 19.76 coo 5.43 58.06 80.08 8.57 53.00 79.37 50.14 3.36 31.42 51.28 2.21 35.89 ULMN 3 1ax4_c05 TRYPTOPHANASE user 7 3 # 7 B 130 PHE A 164 PHE^? 26.07 MG MG A 301 B 223 ASP A 160 ASP^? 31.61 MG MG B 302 B 265 LYS A 137 LYS^? 34.85 MG MG A 301 coo 7.48 54.94 99.62 7.67 52.27 100.42 37.51 14.27 23.18 39.37 15.97 21.97 coo 10.43 61.66 91.81 9.80 60.04 90.61 44.21 5.00 19.54 46.02 3.84 19.76 coo 5.43 58.06 80.08 8.57 53.00 79.37 50.97 1.58 28.14 56.13 1.49 28.03 ULMN 3 1ax4_c05 TRYPTOPHANASE user 8 3 # 8 B 130 PHE A 172 PHE^? 13.28 MG MG A 302 B 223 ASP A 35 ASP^? 16.92 MG MG A 301 B 265 LYS A 90 LYS^? 18.58 MG MG A 301 coo 7.48 54.94 99.62 7.67 52.27 100.42 31.82 29.57 38.19 30.91 31.55 36.40 coo 10.43 61.66 91.81 9.80 60.04 90.61 34.49 31.10 26.54 36.41 31.82 27.10 coo 5.43 58.06 80.08 8.57 53.00 79.37 46.62 38.29 25.46 47.51 33.29 23.22 ULMN 3 1ax4_c05 TRYPTOPHANASE user 9 3 # 9 B 130 PHE B 39 PHE^? 18.11 MG MG B 301 B 223 ASP B 35 ASP^? 16.92 MG MG B 302 B 265 LYS A 61 LYS^? 21.99 MG MG B 302 coo 7.48 54.94 99.62 7.67 52.27 100.42 43.21 9.88 5.15 44.59 10.44 2.80 coo 10.43 61.66 91.81 9.80 60.04 90.61 52.63 11.07 10.18 53.68 12.85 9.94 coo 5.43 58.06 80.08 8.57 53.00 79.37 57.78 7.35 19.60 56.77 12.20 15.61 ULMN 3 1ax4_c05 TRYPTOPHANASE user 10 3 # 10 B 130 PHE B 150 PHE^? 9.88 MG MG B 301 B 223 ASP B 35 ASP^? 16.92 MG MG B 302 B 265 LYS B 90 LYS^? 18.68 MG MG B 302 coo 7.48 54.94 99.62 7.67 52.27 100.42 54.70 12.86 -1.84 56.31 11.50 0.05 coo 10.43 61.66 91.81 9.80 60.04 90.61 52.63 11.07 10.18 53.68 12.85 9.94 coo 5.43 58.06 80.08 8.57 53.00 79.37 61.66 21.61 12.88 56.74 22.88 14.81 ULMN 3 1ax4_c05 TRYPTOPHANASE user 11 3 # 11 B 130 PHE B 150 PHE^? 9.88 MG MG B 301 B 223 ASP B 171 ASP^? 16.92 MG MG B 301 B 265 LYS B 166 LYS^? 22.75 MG MG B 301 coo 7.48 54.94 99.62 7.67 52.27 100.42 54.70 12.86 -1.84 56.31 11.50 0.05 coo 10.43 61.66 91.81 9.80 60.04 90.61 45.30 8.50 -0.71 46.30 6.81 0.12 coo 5.43 58.06 80.08 8.57 53.00 79.37 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1ax4_c05 TRYPTOPHANASE user 12 3 # 12 B 130 PHE B 153 PHE^? 9.59 MG MG B 302 B 223 ASP B 35 ASP^? 16.92 MG MG B 302 B 265 LYS B 90 LYS^? 18.68 MG MG B 302 coo 7.48 54.94 99.62 7.67 52.27 100.42 47.54 17.09 0.77 50.03 17.91 -0.19 coo 10.43 61.66 91.81 9.80 60.04 90.61 52.63 11.07 10.18 53.68 12.85 9.94 coo 5.43 58.06 80.08 8.57 53.00 79.37 61.66 21.61 12.88 56.74 22.88 14.81 ULMN 3 1ax4_c05 TRYPTOPHANASE user 13 3 # 13 B 130 PHE B 161 PHE^? 25.78 MG MG A 301 B 223 ASP A 35 ASP^? 16.92 MG MG A 301 B 265 LYS A 90 LYS^? 18.58 MG MG A 301 coo 7.48 54.94 99.62 7.67 52.27 100.42 31.87 23.58 19.99 32.61 26.21 20.65 coo 10.43 61.66 91.81 9.80 60.04 90.61 34.49 31.10 26.54 36.41 31.82 27.10 coo 5.43 58.06 80.08 8.57 53.00 79.37 46.62 38.29 25.46 47.51 33.29 23.22 ULMN 3 1ax4_c05 TRYPTOPHANASE user 14 3 # 14 B 130 PHE B 164 PHE^? 25.95 MG MG B 302 B 223 ASP B 160 ASP^? 31.65 MG MG A 301 B 265 LYS B 61 LYS^? 22.03 MG MG A 301 coo 7.48 54.94 99.62 7.67 52.27 100.42 36.16 16.77 12.72 38.04 18.41 13.99 coo 10.43 61.66 91.81 9.80 60.04 90.61 28.01 24.83 16.38 27.44 26.81 15.80 coo 5.43 58.06 80.08 8.57 53.00 79.37 32.50 37.62 17.61 36.68 34.92 21.51 ULMN 3 1ax4_c05 TRYPTOPHANASE user 15 3 # 15 B 130 PHE B 164 PHE^? 25.95 MG MG B 302 B 223 ASP B 160 ASP^? 31.65 MG MG A 301 B 265 LYS B 136 LYS^? 33.75 MG MG B 302 coo 7.48 54.94 99.62 7.67 52.27 100.42 36.16 16.77 12.72 38.04 18.41 13.99 coo 10.43 61.66 91.81 9.80 60.04 90.61 28.01 24.83 16.38 27.44 26.81 15.80 coo 5.43 58.06 80.08 8.57 53.00 79.37 28.47 31.35 4.78 24.04 31.81 1.99 ULMN 3 1ax4_c05 TRYPTOPHANASE user 16 3 # 16 B 130 PHE B 164 PHE^? 25.95 MG MG B 302 B 223 ASP B 160 ASP^? 31.65 MG MG A 301 B 265 LYS B 137 LYS^? 34.56 MG MG B 302 coo 7.48 54.94 99.62 7.67 52.27 100.42 36.16 16.77 12.72 38.04 18.41 13.99 coo 10.43 61.66 91.81 9.80 60.04 90.61 28.01 24.83 16.38 27.44 26.81 15.80 coo 5.43 58.06 80.08 8.57 53.00 79.37 26.56 32.46 7.93 27.87 37.71 9.31 ULMN 3 1ax4_c05 TRYPTOPHANASE user 17 3 # 17 B 130 PHE B 172 PHE^? 12.81 MG MG B 301 B 223 ASP B 35 ASP^? 16.92 MG MG B 302 B 265 LYS B 90 LYS^? 18.68 MG MG B 302 coo 7.48 54.94 99.62 7.67 52.27 100.42 51.51 9.59 -1.64 53.03 8.15 0.22 coo 10.43 61.66 91.81 9.80 60.04 90.61 52.63 11.07 10.18 53.68 12.85 9.94 coo 5.43 58.06 80.08 8.57 53.00 79.37 61.66 21.61 12.88 56.74 22.88 14.81 ULMN 3 1ax4_c05 TRYPTOPHANASE user 18 3 # 18 B 130 PHE B 190 PHE^? 14.80 MG MG B 301 B 223 ASP B 142 ASP^? 23.97 MG MG B 301 B 265 LYS B 137 LYS^? 34.56 MG MG B 302 coo 7.48 54.94 99.62 7.67 52.27 100.42 40.06 19.97 -3.89 40.77 21.13 -1.45 coo 10.43 61.66 91.81 9.80 60.04 90.61 31.69 27.40 -1.31 32.10 27.37 -3.38 coo 5.43 58.06 80.08 8.57 53.00 79.37 26.56 32.46 7.93 27.87 37.71 9.31 ULMN 3 1ax4_c05 TRYPTOPHANASE user 19 3 # 19 B 130 PHE C 39 PHE^? 18.26 MG MG C 301 B 223 ASP C 35 ASP^? 16.42 MG MG C 302 B 265 LYS D 61 LYS^? 21.93 MG MG C 302 coo 7.48 54.94 99.62 7.67 52.27 100.42 93.83 18.63 -11.96 92.54 18.49 -9.49 coo 10.43 61.66 91.81 9.80 60.04 90.61 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 5.43 58.06 80.08 8.57 53.00 79.37 80.64 11.23 -26.16 80.65 16.24 -22.36 ULMN 3 1ax4_c05 TRYPTOPHANASE user 20 3 # 20 B 130 PHE C 150 PHE^? 10.02 MG MG C 301 B 223 ASP C 35 ASP^? 16.42 MG MG C 302 B 265 LYS C 90 LYS^? 18.24 MG MG C 302 coo 7.48 54.94 99.62 7.67 52.27 100.42 82.11 17.28 -4.80 81.16 15.47 -6.75 coo 10.43 61.66 91.81 9.80 60.04 90.61 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 5.43 58.06 80.08 8.57 53.00 79.37 72.37 23.25 -18.94 76.11 26.52 -20.97 ULMN 3 1ax4_c05 TRYPTOPHANASE user 21 3 # 21 B 130 PHE C 150 PHE^? 10.02 MG MG C 301 B 223 ASP C 171 ASP^? 17.08 MG MG C 301 B 265 LYS C 166 LYS^? 22.53 MG MG C 301 coo 7.48 54.94 99.62 7.67 52.27 100.42 82.11 17.28 -4.80 81.16 15.47 -6.75 coo 10.43 61.66 91.81 9.80 60.04 90.61 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 5.43 58.06 80.08 8.57 53.00 79.37 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1ax4_c05 TRYPTOPHANASE user 22 3 # 22 B 130 PHE C 153 PHE^? 9.34 MG MG C 302 B 223 ASP C 35 ASP^? 16.42 MG MG C 302 B 265 LYS C 90 LYS^? 18.24 MG MG C 302 coo 7.48 54.94 99.62 7.67 52.27 100.42 87.15 23.83 -7.29 84.55 23.79 -6.26 coo 10.43 61.66 91.81 9.80 60.04 90.61 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 5.43 58.06 80.08 8.57 53.00 79.37 72.37 23.25 -18.94 76.11 26.52 -20.97 ULMN 3 1ax4_c05 TRYPTOPHANASE user 23 3 # 23 B 130 PHE C 161 PHE^? 25.47 MG MG D 302 B 223 ASP D 35 ASP^? 16.80 MG MG D 302 B 265 LYS D 90 LYS^? 18.98 MG MG D 302 coo 7.48 54.94 99.62 7.67 52.27 100.42 98.98 35.62 -26.76 97.40 37.84 -27.44 coo 10.43 61.66 91.81 9.80 60.04 90.61 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 5.43 58.06 80.08 8.57 53.00 79.37 79.83 44.38 -31.44 80.32 39.55 -29.40 ULMN 3 1ax4_c05 TRYPTOPHANASE user 24 3 # 24 B 130 PHE C 164 PHE^? 25.79 MG MG C 302 B 223 ASP C 160 ASP^? 31.63 MG MG D 302 B 265 LYS C 61 LYS^? 21.91 MG MG D 302 coo 7.48 54.94 99.62 7.67 52.27 100.42 97.62 27.66 -19.56 95.28 28.38 -20.99 coo 10.43 61.66 91.81 9.80 60.04 90.61 102.50 38.00 -23.28 102.43 39.97 -22.46 coo 5.43 58.06 80.08 8.57 53.00 79.37 93.60 48.56 -24.05 90.39 44.71 -27.98 ULMN 3 1ax4_c05 TRYPTOPHANASE user 25 3 # 25 B 130 PHE C 164 PHE^? 25.79 MG MG C 302 B 223 ASP C 160 ASP^? 31.63 MG MG D 302 B 265 LYS C 136 LYS^? 30.63 MG MG C 302 coo 7.48 54.94 99.62 7.67 52.27 100.42 97.62 27.66 -19.56 95.28 28.38 -20.99 coo 10.43 61.66 91.81 9.80 60.04 90.61 102.50 38.00 -23.28 102.43 39.97 -22.46 coo 5.43 58.06 80.08 8.57 53.00 79.37 99.75 44.04 -11.38 100.98 45.13 -6.77 ULMN 3 1ax4_c05 TRYPTOPHANASE user 26 3 # 26 B 130 PHE C 164 PHE^? 25.79 MG MG C 302 B 223 ASP C 160 ASP^? 31.63 MG MG D 302 B 265 LYS C 137 LYS^? 35.41 MG MG C 302 coo 7.48 54.94 99.62 7.67 52.27 100.42 97.62 27.66 -19.56 95.28 28.38 -20.99 coo 10.43 61.66 91.81 9.80 60.04 90.61 102.50 38.00 -23.28 102.43 39.97 -22.46 coo 5.43 58.06 80.08 8.57 53.00 79.37 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 1ax4_c05 TRYPTOPHANASE user 27 3 # 27 B 130 PHE C 172 PHE^? 13.00 MG MG C 301 B 223 ASP C 35 ASP^? 16.42 MG MG C 302 B 265 LYS C 90 LYS^? 18.24 MG MG C 302 coo 7.48 54.94 99.62 7.67 52.27 100.42 86.45 15.28 -5.05 85.50 13.59 -7.08 coo 10.43 61.66 91.81 9.80 60.04 90.61 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 5.43 58.06 80.08 8.57 53.00 79.37 72.37 23.25 -18.94 76.11 26.52 -20.97 ULMN 3 1ax4_c05 TRYPTOPHANASE user 28 3 # 28 B 130 PHE C 190 PHE^? 14.91 MG MG C 301 B 223 ASP C 142 ASP^? 23.76 MG MG C 301 B 265 LYS C 137 LYS^? 35.41 MG MG C 302 coo 7.48 54.94 99.62 7.67 52.27 100.42 93.44 29.01 -2.85 92.36 29.94 -5.20 coo 10.43 61.66 91.81 9.80 60.04 90.61 97.94 39.27 -5.03 98.08 38.70 -2.97 coo 5.43 58.06 80.08 8.57 53.00 79.37 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 1ax4_c05 TRYPTOPHANASE user 29 3 # 29 B 130 PHE D 150 PHE^? 10.21 MG MG D 301 B 223 ASP D 35 ASP^? 16.80 MG MG D 302 B 265 LYS D 90 LYS^? 18.98 MG MG D 302 coo 7.48 54.94 99.62 7.67 52.27 100.42 91.92 42.74 -45.34 92.24 44.79 -43.44 coo 10.43 61.66 91.81 9.80 60.04 90.61 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 5.43 58.06 80.08 8.57 53.00 79.37 79.83 44.38 -31.44 80.32 39.55 -29.40 ULMN 3 1ax4_c05 TRYPTOPHANASE user 30 3 # 30 B 130 PHE D 150 PHE^? 10.21 MG MG D 301 B 223 ASP D 171 ASP^? 16.95 MG MG D 301 B 265 LYS D 166 LYS^? 21.08 MG MG D 301 coo 7.48 54.94 99.62 7.67 52.27 100.42 91.92 42.74 -45.34 92.24 44.79 -43.44 coo 10.43 61.66 91.81 9.80 60.04 90.61 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 5.43 58.06 80.08 8.57 53.00 79.37 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1ax4_c05 TRYPTOPHANASE user 31 3 # 31 B 130 PHE D 153 PHE^? 9.11 MG MG D 302 B 223 ASP D 35 ASP^? 16.80 MG MG D 302 B 265 LYS D 90 LYS^? 18.98 MG MG D 302 coo 7.48 54.94 99.62 7.67 52.27 100.42 91.67 34.35 -42.71 89.76 36.10 -43.73 coo 10.43 61.66 91.81 9.80 60.04 90.61 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 5.43 58.06 80.08 8.57 53.00 79.37 79.83 44.38 -31.44 80.32 39.55 -29.40 ULMN 3 1ax4_c05 TRYPTOPHANASE user 32 3 # 32 B 130 PHE D 161 PHE^? 25.58 MG MG C 302 B 223 ASP C 35 ASP^? 16.42 MG MG C 302 B 265 LYS C 90 LYS^? 18.24 MG MG C 302 coo 7.48 54.94 99.62 7.67 52.27 100.42 92.97 17.97 -22.91 90.24 17.44 -22.45 coo 10.43 61.66 91.81 9.80 60.04 90.61 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 5.43 58.06 80.08 8.57 53.00 79.37 72.37 23.25 -18.94 76.11 26.52 -20.97 ULMN 3 1ax4_c05 TRYPTOPHANASE user 33 3 # 33 B 130 PHE D 164 PHE^? 25.90 MG MG D 302 B 223 ASP D 160 ASP^? 31.45 MG MG C 302 B 265 LYS D 61 LYS^? 21.93 MG MG C 302 coo 7.48 54.94 99.62 7.67 52.27 100.42 97.06 25.02 -29.96 94.69 25.91 -28.78 coo 10.43 61.66 91.81 9.80 60.04 90.61 94.15 13.98 -26.57 92.71 12.42 -26.99 coo 5.43 58.06 80.08 8.57 53.00 79.37 80.64 11.23 -26.16 80.65 16.24 -22.36 ULMN 3 1ax4_c05 TRYPTOPHANASE user 34 3 # 34 B 130 PHE D 164 PHE^? 25.90 MG MG D 302 B 223 ASP D 160 ASP^? 31.45 MG MG C 302 B 265 LYS D 136 LYS^? 34.99 MG MG D 302 coo 7.48 54.94 99.62 7.67 52.27 100.42 97.06 25.02 -29.96 94.69 25.91 -28.78 coo 10.43 61.66 91.81 9.80 60.04 90.61 94.15 13.98 -26.57 92.71 12.42 -26.99 coo 5.43 58.06 80.08 8.57 53.00 79.37 88.96 10.62 -38.53 90.77 6.00 -38.00 ULMN 3 1ax4_c05 TRYPTOPHANASE user 35 3 # 35 B 130 PHE D 164 PHE^? 25.90 MG MG D 302 B 223 ASP D 160 ASP^? 31.45 MG MG C 302 B 265 LYS D 137 LYS^? 37.57 MG MG D 302 coo 7.48 54.94 99.62 7.67 52.27 100.42 97.06 25.02 -29.96 94.69 25.91 -28.78 coo 10.43 61.66 91.81 9.80 60.04 90.61 94.15 13.98 -26.57 92.71 12.42 -26.99 coo 5.43 58.06 80.08 8.57 53.00 79.37 88.48 8.58 -35.33 84.88 3.98 -33.96 ULMN 3 1ax4_c05 TRYPTOPHANASE user 36 3 # 36 B 130 PHE D 172 PHE^? 13.02 MG MG D 301 B 223 ASP D 35 ASP^? 16.80 MG MG D 302 B 265 LYS D 90 LYS^? 18.98 MG MG D 302 coo 7.48 54.94 99.62 7.67 52.27 100.42 96.36 41.50 -44.84 96.77 43.66 -43.13 coo 10.43 61.66 91.81 9.80 60.04 90.61 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 5.43 58.06 80.08 8.57 53.00 79.37 79.83 44.38 -31.44 80.32 39.55 -29.40 ULMN 3 1ax4_c05 TRYPTOPHANASE user 37 3 # 37 B 130 PHE D 190 PHE^? 14.83 MG MG D 301 B 223 ASP D 142 ASP^? 23.49 MG MG D 301 B 265 LYS D 137 LYS^? 37.57 MG MG D 302 coo 7.48 54.94 99.62 7.67 52.27 100.42 93.52 26.32 -46.94 92.08 26.47 -44.56 coo 10.43 61.66 91.81 9.80 60.04 90.61 90.90 15.58 -44.76 91.35 16.09 -46.79 coo 5.43 58.06 80.08 8.57 53.00 79.37 88.48 8.58 -35.33 84.88 3.98 -33.96 ULMN 3 1ax4_c05 TRYPTOPHANASE user 38 3 # 38 B 130 PHE E 150 PHE^? 10.10 MG MG E 301 B 223 ASP E 35 ASP^? 16.91 MG MG E 302 B 265 LYS E 90 LYS^? 19.16 MG MG E 302 coo 7.48 54.94 99.62 7.67 52.27 100.42 74.01 63.99 -49.53 76.06 63.87 -51.45 coo 10.43 61.66 91.81 9.80 60.04 90.61 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 5.43 58.06 80.08 8.57 53.00 79.37 73.81 51.50 -63.18 69.15 52.39 -65.65 ULMN 3 1ax4_c05 TRYPTOPHANASE user 39 3 # 39 B 130 PHE E 150 PHE^? 10.10 MG MG E 301 B 223 ASP E 171 ASP^? 16.73 MG MG E 301 B 265 LYS E 166 LYS^? 21.46 MG MG E 301 coo 7.48 54.94 99.62 7.67 52.27 100.42 74.01 63.99 -49.53 76.06 63.87 -51.45 coo 10.43 61.66 91.81 9.80 60.04 90.61 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 5.43 58.06 80.08 8.57 53.00 79.37 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1ax4_c05 TRYPTOPHANASE user 40 3 # 40 B 130 PHE E 153 PHE^? 9.50 MG MG E 302 B 223 ASP E 35 ASP^? 16.91 MG MG E 302 B 265 LYS E 90 LYS^? 19.16 MG MG E 302 coo 7.48 54.94 99.62 7.67 52.27 100.42 65.86 64.95 -52.12 67.22 62.73 -51.09 coo 10.43 61.66 91.81 9.80 60.04 90.61 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 5.43 58.06 80.08 8.57 53.00 79.37 73.81 51.50 -63.18 69.15 52.39 -65.65 ULMN 3 1ax4_c05 TRYPTOPHANASE user 41 3 # 41 B 130 PHE E 161 PHE^? 25.51 MG MG F 301 B 223 ASP F 35 ASP^? 16.93 MG MG F 301 B 265 LYS F 90 LYS^? 18.57 MG MG F 301 coo 7.48 54.94 99.62 7.67 52.27 100.42 49.74 68.03 -71.94 48.60 65.47 -72.38 coo 10.43 61.66 91.81 9.80 60.04 90.61 46.82 60.47 -77.63 48.00 58.79 -78.23 coo 5.43 58.06 80.08 8.57 53.00 79.37 51.54 47.01 -75.58 55.05 50.31 -73.74 ULMN 3 1ax4_c05 TRYPTOPHANASE user 42 3 # 42 B 130 PHE E 164 PHE^? 25.87 MG MG E 302 B 223 ASP E 160 ASP^? 31.54 MG MG F 301 B 265 LYS E 136 LYS^? 31.27 MG MG E 302 coo 7.48 54.94 99.62 7.67 52.27 100.42 57.42 71.31 -64.81 57.98 68.84 -66.03 coo 10.43 61.66 91.81 9.80 60.04 90.61 45.81 70.00 -68.45 44.10 68.87 -67.77 coo 5.43 58.06 80.08 8.57 53.00 79.37 42.12 65.93 -56.52 39.36 65.07 -51.83 ULMN 3 1ax4_c05 TRYPTOPHANASE user 43 3 # 43 B 130 PHE E 172 PHE^? 12.71 MG MG E 301 B 223 ASP E 35 ASP^? 16.91 MG MG E 302 B 265 LYS E 90 LYS^? 19.16 MG MG E 302 coo 7.48 54.94 99.62 7.67 52.27 100.42 73.54 68.41 -50.00 75.58 68.36 -51.87 coo 10.43 61.66 91.81 9.80 60.04 90.61 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 5.43 58.06 80.08 8.57 53.00 79.37 73.81 51.50 -63.18 69.15 52.39 -65.65 ULMN 3 1ax4_c05 TRYPTOPHANASE user 44 3 # 44 B 130 PHE E 190 PHE^? 14.70 MG MG E 301 B 223 ASP E 142 ASP^? 23.66 MG MG E 301 B 265 LYS E 137 LYS^? 35.26 MG MG E 302 coo 7.48 54.94 99.62 7.67 52.27 100.42 58.27 67.97 -47.86 58.03 66.58 -50.23 coo 10.43 61.66 91.81 9.80 60.04 90.61 47.19 67.15 -50.37 47.44 67.18 -48.23 coo 5.43 58.06 80.08 8.57 53.00 79.37 40.01 66.05 -59.66 36.65 60.99 -60.28 ULMN 3 1ax4_c05 TRYPTOPHANASE user 45 3 # 45 B 130 PHE F 39 PHE^? 17.69 MG MG F 302 B 223 ASP F 35 ASP^? 16.93 MG MG F 301 B 265 LYS E 61 LYS^? 22.16 MG MG F 301 coo 7.48 54.94 99.62 7.67 52.27 100.42 50.42 69.23 -82.87 49.95 67.86 -85.25 coo 10.43 61.66 91.81 9.80 60.04 90.61 46.82 60.47 -77.63 48.00 58.79 -78.23 coo 5.43 58.06 80.08 8.57 53.00 79.37 40.99 56.84 -68.48 45.99 56.72 -72.39 ULMN 3 1ax4_c05 TRYPTOPHANASE user 46 3 # 46 B 130 PHE F 150 PHE^? 9.82 MG MG F 302 B 223 ASP F 35 ASP^? 16.93 MG MG F 301 B 265 LYS F 90 LYS^? 18.57 MG MG F 301 coo 7.48 54.94 99.62 7.67 52.27 100.42 47.10 57.70 -89.94 45.06 57.27 -88.04 coo 10.43 61.66 91.81 9.80 60.04 90.61 46.82 60.47 -77.63 48.00 58.79 -78.23 coo 5.43 58.06 80.08 8.57 53.00 79.37 51.54 47.01 -75.58 55.05 50.31 -73.74 ULMN 3 1ax4_c05 TRYPTOPHANASE user 47 3 # 47 B 130 PHE F 150 PHE^? 9.82 MG MG F 302 B 223 ASP F 171 ASP^? 16.35 MG MG F 302 B 265 LYS F 166 LYS^? 20.76 MG MG F 302 coo 7.48 54.94 99.62 7.67 52.27 100.42 47.10 57.70 -89.94 45.06 57.27 -88.04 coo 10.43 61.66 91.81 9.80 60.04 90.61 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 5.43 58.06 80.08 8.57 53.00 79.37 59.28 73.05 -82.63 55.63 74.15 -86.94 ULMN 3 1ax4_c05 TRYPTOPHANASE user 48 3 # 48 B 130 PHE F 153 PHE^? 9.26 MG MG F 302 B 223 ASP F 35 ASP^? 16.93 MG MG F 301 B 265 LYS F 90 LYS^? 18.57 MG MG F 301 coo 7.48 54.94 99.62 7.67 52.27 100.42 54.49 61.65 -87.43 53.89 59.08 -88.37 coo 10.43 61.66 91.81 9.80 60.04 90.61 46.82 60.47 -77.63 48.00 58.79 -78.23 coo 5.43 58.06 80.08 8.57 53.00 79.37 51.54 47.01 -75.58 55.05 50.31 -73.74 ULMN 3 1ax4_c05 TRYPTOPHANASE user 49 3 # 49 B 130 PHE F 161 PHE^? 25.66 MG MG E 302 B 223 ASP E 35 ASP^? 16.91 MG MG E 302 B 265 LYS E 90 LYS^? 19.16 MG MG E 302 coo 7.48 54.94 99.62 7.67 52.27 100.42 68.33 71.65 -68.19 70.12 69.57 -67.59 coo 10.43 61.66 91.81 9.80 60.04 90.61 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 5.43 58.06 80.08 8.57 53.00 79.37 73.81 51.50 -63.18 69.15 52.39 -65.65 ULMN 3 1ax4_c05 TRYPTOPHANASE user 50 3 # 50 B 130 PHE F 164 PHE^? 26.17 MG MG F 301 B 223 ASP F 160 ASP^? 31.59 MG MG E 302 B 265 LYS F 136 LYS^? 30.53 MG MG F 301 coo 7.48 54.94 99.62 7.67 52.27 100.42 60.03 71.53 -75.24 60.39 69.25 -73.67 coo 10.43 61.66 91.81 9.80 60.04 90.61 71.27 74.59 -71.77 73.23 74.02 -72.37 coo 5.43 58.06 80.08 8.57 53.00 79.37 76.49 71.19 -83.39 78.38 70.88 -88.47 ULMN 3 1ax4_c05 TRYPTOPHANASE user 51 3 # 51 B 130 PHE F 164 PHE^? 26.17 MG MG F 301 B 223 ASP F 160 ASP^? 31.59 MG MG E 302 B 265 LYS F 137 LYS^? 35.13 MG MG F 301 coo 7.48 54.94 99.62 7.67 52.27 100.42 60.03 71.53 -75.24 60.39 69.25 -73.67 coo 10.43 61.66 91.81 9.80 60.04 90.61 71.27 74.59 -71.77 73.23 74.02 -72.37 coo 5.43 58.06 80.08 8.57 53.00 79.37 78.53 72.20 -80.30 83.01 68.64 -79.79 ULMN 3 1ax4_c05 TRYPTOPHANASE user 52 3 # 52 B 130 PHE F 172 PHE^? 12.43 MG MG F 302 B 223 ASP F 35 ASP^? 16.93 MG MG F 301 B 265 LYS F 90 LYS^? 18.57 MG MG F 301 coo 7.48 54.94 99.62 7.67 52.27 100.42 45.85 62.23 -89.68 43.95 61.55 -87.75 coo 10.43 61.66 91.81 9.80 60.04 90.61 46.82 60.47 -77.63 48.00 58.79 -78.23 coo 5.43 58.06 80.08 8.57 53.00 79.37 51.54 47.01 -75.58 55.05 50.31 -73.74 1ax4_c05 source 1ax4 TRYPTOPHANASE : 52 hits 1ax4_c05 naa= 3 ULMN 3 1ax4_c06 TRYPTOPHANASE user 1 3 # 1 C 130 PHE A 39 PHE^? 18.63 MG MG A 302 C 223 ASP A 35 ASP^? 16.92 MG MG A 301 C 265 LYS B 61 LYS^? 22.03 MG MG A 301 coo -6.55 73.45 23.60 -6.77 71.48 21.66 31.04 21.84 30.70 31.32 23.06 33.20 coo -9.52 75.74 33.62 -8.85 73.74 33.93 34.49 31.10 26.54 36.41 31.82 27.10 coo -4.44 67.20 42.32 -7.50 62.41 40.49 32.50 37.62 17.61 36.68 34.92 21.51 ULMN 3 1ax4_c06 TRYPTOPHANASE user 2 3 # 2 C 130 PHE A 110 PHE^? 21.60 MG MG A 301 C 223 ASP A 142 ASP^? 23.70 MG MG A 302 C 265 LYS A 166 LYS^? 20.93 MG MG A 302 coo -6.55 73.45 23.60 -6.77 71.48 21.66 53.06 14.15 32.16 50.69 13.44 30.81 coo -9.52 75.74 33.62 -8.85 73.74 33.93 46.39 7.18 37.53 46.28 7.18 39.63 coo -4.44 67.20 42.32 -7.50 62.41 40.49 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1ax4_c06 TRYPTOPHANASE user 3 3 # 3 C 130 PHE A 150 PHE^? 10.47 MG MG A 302 C 223 ASP A 35 ASP^? 16.92 MG MG A 301 C 265 LYS A 90 LYS^? 18.58 MG MG A 301 coo -6.55 73.45 23.60 -6.77 71.48 21.66 35.63 32.10 38.88 34.73 33.93 37.00 coo -9.52 75.74 33.62 -8.85 73.74 33.93 34.49 31.10 26.54 36.41 31.82 27.10 coo -4.44 67.20 42.32 -7.50 62.41 40.49 46.62 38.29 25.46 47.51 33.29 23.22 ULMN 3 1ax4_c06 TRYPTOPHANASE user 4 3 # 4 C 130 PHE A 150 PHE^? 10.47 MG MG A 302 C 223 ASP A 171 ASP^? 17.17 MG MG A 302 C 265 LYS A 166 LYS^? 20.93 MG MG A 302 coo -6.55 73.45 23.60 -6.77 71.48 21.66 35.63 32.10 38.88 34.73 33.93 37.00 coo -9.52 75.74 33.62 -8.85 73.74 33.93 29.78 23.67 36.63 28.48 25.11 35.71 coo -4.44 67.20 42.32 -7.50 62.41 40.49 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1ax4_c06 TRYPTOPHANASE user 5 3 # 5 C 130 PHE A 153 PHE^? 9.64 MG MG A 301 C 223 ASP A 35 ASP^? 16.92 MG MG A 301 C 265 LYS A 90 LYS^? 18.58 MG MG A 301 coo -6.55 73.45 23.60 -6.77 71.48 21.66 38.89 24.49 36.07 40.14 26.70 37.23 coo -9.52 75.74 33.62 -8.85 73.74 33.93 34.49 31.10 26.54 36.41 31.82 27.10 coo -4.44 67.20 42.32 -7.50 62.41 40.49 46.62 38.29 25.46 47.51 33.29 23.22 ULMN 3 1ax4_c06 TRYPTOPHANASE user 6 3 # 6 C 130 PHE A 161 PHE^? 25.62 MG MG B 302 C 223 ASP B 35 ASP^? 16.92 MG MG B 302 C 265 LYS B 90 LYS^? 18.68 MG MG B 302 coo -6.55 73.45 23.60 -6.77 71.48 21.66 44.24 9.29 16.03 46.90 9.95 15.56 coo -9.52 75.74 33.62 -8.85 73.74 33.93 52.63 11.07 10.18 53.68 12.85 9.94 coo -4.44 67.20 42.32 -7.50 62.41 40.49 61.66 21.61 12.88 56.74 22.88 14.81 ULMN 3 1ax4_c06 TRYPTOPHANASE user 7 3 # 7 C 130 PHE A 164 PHE^? 26.07 MG MG A 301 C 223 ASP A 160 ASP^? 31.61 MG MG B 302 C 265 LYS A 61 LYS^? 21.99 MG MG B 302 coo -6.55 73.45 23.60 -6.77 71.48 21.66 37.51 14.27 23.18 39.37 15.97 21.97 coo -9.52 75.74 33.62 -8.85 73.74 33.93 44.21 5.00 19.54 46.02 3.84 19.76 coo -4.44 67.20 42.32 -7.50 62.41 40.49 57.78 7.35 19.60 56.77 12.20 15.61 ULMN 3 1ax4_c06 TRYPTOPHANASE user 8 3 # 8 C 130 PHE A 164 PHE^? 26.07 MG MG A 301 C 223 ASP A 160 ASP^? 31.61 MG MG B 302 C 265 LYS A 136 LYS^? 30.58 MG MG A 302 coo -6.55 73.45 23.60 -6.77 71.48 21.66 37.51 14.27 23.18 39.37 15.97 21.97 coo -9.52 75.74 33.62 -8.85 73.74 33.93 44.21 5.00 19.54 46.02 3.84 19.76 coo -4.44 67.20 42.32 -7.50 62.41 40.49 50.14 3.36 31.42 51.28 2.21 35.89 ULMN 3 1ax4_c06 TRYPTOPHANASE user 9 3 # 9 C 130 PHE A 164 PHE^? 26.07 MG MG A 301 C 223 ASP A 160 ASP^? 31.61 MG MG B 302 C 265 LYS A 137 LYS^? 34.85 MG MG A 301 coo -6.55 73.45 23.60 -6.77 71.48 21.66 37.51 14.27 23.18 39.37 15.97 21.97 coo -9.52 75.74 33.62 -8.85 73.74 33.93 44.21 5.00 19.54 46.02 3.84 19.76 coo -4.44 67.20 42.32 -7.50 62.41 40.49 50.97 1.58 28.14 56.13 1.49 28.03 ULMN 3 1ax4_c06 TRYPTOPHANASE user 10 3 # 10 C 130 PHE A 172 PHE^? 13.28 MG MG A 302 C 223 ASP A 35 ASP^? 16.92 MG MG A 301 C 265 LYS A 90 LYS^? 18.58 MG MG A 301 coo -6.55 73.45 23.60 -6.77 71.48 21.66 31.82 29.57 38.19 30.91 31.55 36.40 coo -9.52 75.74 33.62 -8.85 73.74 33.93 34.49 31.10 26.54 36.41 31.82 27.10 coo -4.44 67.20 42.32 -7.50 62.41 40.49 46.62 38.29 25.46 47.51 33.29 23.22 ULMN 3 1ax4_c06 TRYPTOPHANASE user 11 3 # 11 C 130 PHE B 39 PHE^? 18.11 MG MG B 301 C 223 ASP B 35 ASP^? 16.92 MG MG B 302 C 265 LYS A 61 LYS^? 21.99 MG MG B 302 coo -6.55 73.45 23.60 -6.77 71.48 21.66 43.21 9.88 5.15 44.59 10.44 2.80 coo -9.52 75.74 33.62 -8.85 73.74 33.93 52.63 11.07 10.18 53.68 12.85 9.94 coo -4.44 67.20 42.32 -7.50 62.41 40.49 57.78 7.35 19.60 56.77 12.20 15.61 ULMN 3 1ax4_c06 TRYPTOPHANASE user 12 3 # 12 C 130 PHE B 150 PHE^? 9.88 MG MG B 301 C 223 ASP B 35 ASP^? 16.92 MG MG B 302 C 265 LYS B 90 LYS^? 18.68 MG MG B 302 coo -6.55 73.45 23.60 -6.77 71.48 21.66 54.70 12.86 -1.84 56.31 11.50 0.05 coo -9.52 75.74 33.62 -8.85 73.74 33.93 52.63 11.07 10.18 53.68 12.85 9.94 coo -4.44 67.20 42.32 -7.50 62.41 40.49 61.66 21.61 12.88 56.74 22.88 14.81 ULMN 3 1ax4_c06 TRYPTOPHANASE user 13 3 # 13 C 130 PHE B 150 PHE^? 9.88 MG MG B 301 C 223 ASP B 171 ASP^? 16.92 MG MG B 301 C 265 LYS B 166 LYS^? 22.75 MG MG B 301 coo -6.55 73.45 23.60 -6.77 71.48 21.66 54.70 12.86 -1.84 56.31 11.50 0.05 coo -9.52 75.74 33.62 -8.85 73.74 33.93 45.30 8.50 -0.71 46.30 6.81 0.12 coo -4.44 67.20 42.32 -7.50 62.41 40.49 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1ax4_c06 TRYPTOPHANASE user 14 3 # 14 C 130 PHE B 153 PHE^? 9.59 MG MG B 302 C 223 ASP B 35 ASP^? 16.92 MG MG B 302 C 265 LYS B 90 LYS^? 18.68 MG MG B 302 coo -6.55 73.45 23.60 -6.77 71.48 21.66 47.54 17.09 0.77 50.03 17.91 -0.19 coo -9.52 75.74 33.62 -8.85 73.74 33.93 52.63 11.07 10.18 53.68 12.85 9.94 coo -4.44 67.20 42.32 -7.50 62.41 40.49 61.66 21.61 12.88 56.74 22.88 14.81 ULMN 3 1ax4_c06 TRYPTOPHANASE user 15 3 # 15 C 130 PHE B 161 PHE^? 25.78 MG MG A 301 C 223 ASP A 35 ASP^? 16.92 MG MG A 301 C 265 LYS A 90 LYS^? 18.58 MG MG A 301 coo -6.55 73.45 23.60 -6.77 71.48 21.66 31.87 23.58 19.99 32.61 26.21 20.65 coo -9.52 75.74 33.62 -8.85 73.74 33.93 34.49 31.10 26.54 36.41 31.82 27.10 coo -4.44 67.20 42.32 -7.50 62.41 40.49 46.62 38.29 25.46 47.51 33.29 23.22 ULMN 3 1ax4_c06 TRYPTOPHANASE user 16 3 # 16 C 130 PHE B 164 PHE^? 25.95 MG MG B 302 C 223 ASP B 160 ASP^? 31.65 MG MG A 301 C 265 LYS B 61 LYS^? 22.03 MG MG A 301 coo -6.55 73.45 23.60 -6.77 71.48 21.66 36.16 16.77 12.72 38.04 18.41 13.99 coo -9.52 75.74 33.62 -8.85 73.74 33.93 28.01 24.83 16.38 27.44 26.81 15.80 coo -4.44 67.20 42.32 -7.50 62.41 40.49 32.50 37.62 17.61 36.68 34.92 21.51 ULMN 3 1ax4_c06 TRYPTOPHANASE user 17 3 # 17 C 130 PHE B 164 PHE^? 25.95 MG MG B 302 C 223 ASP B 160 ASP^? 31.65 MG MG A 301 C 265 LYS B 136 LYS^? 33.75 MG MG B 302 coo -6.55 73.45 23.60 -6.77 71.48 21.66 36.16 16.77 12.72 38.04 18.41 13.99 coo -9.52 75.74 33.62 -8.85 73.74 33.93 28.01 24.83 16.38 27.44 26.81 15.80 coo -4.44 67.20 42.32 -7.50 62.41 40.49 28.47 31.35 4.78 24.04 31.81 1.99 ULMN 3 1ax4_c06 TRYPTOPHANASE user 18 3 # 18 C 130 PHE B 164 PHE^? 25.95 MG MG B 302 C 223 ASP B 160 ASP^? 31.65 MG MG A 301 C 265 LYS B 137 LYS^? 34.56 MG MG B 302 coo -6.55 73.45 23.60 -6.77 71.48 21.66 36.16 16.77 12.72 38.04 18.41 13.99 coo -9.52 75.74 33.62 -8.85 73.74 33.93 28.01 24.83 16.38 27.44 26.81 15.80 coo -4.44 67.20 42.32 -7.50 62.41 40.49 26.56 32.46 7.93 27.87 37.71 9.31 ULMN 3 1ax4_c06 TRYPTOPHANASE user 19 3 # 19 C 130 PHE B 172 PHE^? 12.81 MG MG B 301 C 223 ASP B 35 ASP^? 16.92 MG MG B 302 C 265 LYS B 90 LYS^? 18.68 MG MG B 302 coo -6.55 73.45 23.60 -6.77 71.48 21.66 51.51 9.59 -1.64 53.03 8.15 0.22 coo -9.52 75.74 33.62 -8.85 73.74 33.93 52.63 11.07 10.18 53.68 12.85 9.94 coo -4.44 67.20 42.32 -7.50 62.41 40.49 61.66 21.61 12.88 56.74 22.88 14.81 ULMN 3 1ax4_c06 TRYPTOPHANASE user 20 3 # 20 C 130 PHE C 39 PHE^? 18.26 MG MG C 301 C 223 ASP C 35 ASP^? 16.42 MG MG C 302 C 265 LYS D 61 LYS^? 21.93 MG MG C 302 coo -6.55 73.45 23.60 -6.77 71.48 21.66 93.83 18.63 -11.96 92.54 18.49 -9.49 coo -9.52 75.74 33.62 -8.85 73.74 33.93 84.40 16.53 -16.68 82.83 17.91 -16.28 coo -4.44 67.20 42.32 -7.50 62.41 40.49 80.64 11.23 -26.16 80.65 16.24 -22.36 ULMN 3 1ax4_c06 TRYPTOPHANASE user 21 3 # 21 C 130 PHE C 110 PHE^? 21.25 MG MG C 302 C 223 ASP C 142 ASP^? 23.76 MG MG C 301 C 265 LYS C 166 LYS^? 22.53 MG MG C 301 coo -6.55 73.45 23.60 -6.77 71.48 21.66 89.08 41.33 -11.45 90.83 39.43 -12.52 coo -9.52 75.74 33.62 -8.85 73.74 33.93 97.94 39.27 -5.03 98.08 38.70 -2.97 coo -4.44 67.20 42.32 -7.50 62.41 40.49 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1ax4_c06 TRYPTOPHANASE user 22 3 # 22 C 130 PHE C 150 PHE^? 10.02 MG MG C 301 C 223 ASP C 35 ASP^? 16.42 MG MG C 302 C 265 LYS C 90 LYS^? 18.24 MG MG C 302 coo -6.55 73.45 23.60 -6.77 71.48 21.66 82.11 17.28 -4.80 81.16 15.47 -6.75 coo -9.52 75.74 33.62 -8.85 73.74 33.93 84.40 16.53 -16.68 82.83 17.91 -16.28 coo -4.44 67.20 42.32 -7.50 62.41 40.49 72.37 23.25 -18.94 76.11 26.52 -20.97 ULMN 3 1ax4_c06 TRYPTOPHANASE user 23 3 # 23 C 130 PHE C 150 PHE^? 10.02 MG MG C 301 C 223 ASP C 171 ASP^? 17.08 MG MG C 301 C 265 LYS C 166 LYS^? 22.53 MG MG C 301 coo -6.55 73.45 23.60 -6.77 71.48 21.66 82.11 17.28 -4.80 81.16 15.47 -6.75 coo -9.52 75.74 33.62 -8.85 73.74 33.93 92.57 16.68 -6.24 92.24 14.74 -7.03 coo -4.44 67.20 42.32 -7.50 62.41 40.49 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1ax4_c06 TRYPTOPHANASE user 24 3 # 24 C 130 PHE C 153 PHE^? 9.34 MG MG C 302 C 223 ASP C 35 ASP^? 16.42 MG MG C 302 C 265 LYS C 90 LYS^? 18.24 MG MG C 302 coo -6.55 73.45 23.60 -6.77 71.48 21.66 87.15 23.83 -7.29 84.55 23.79 -6.26 coo -9.52 75.74 33.62 -8.85 73.74 33.93 84.40 16.53 -16.68 82.83 17.91 -16.28 coo -4.44 67.20 42.32 -7.50 62.41 40.49 72.37 23.25 -18.94 76.11 26.52 -20.97 ULMN 3 1ax4_c06 TRYPTOPHANASE user 25 3 # 25 C 130 PHE C 161 PHE^? 25.47 MG MG D 302 C 223 ASP D 35 ASP^? 16.80 MG MG D 302 C 265 LYS D 90 LYS^? 18.98 MG MG D 302 coo -6.55 73.45 23.60 -6.77 71.48 21.66 98.98 35.62 -26.76 97.40 37.84 -27.44 coo -9.52 75.74 33.62 -8.85 73.74 33.93 93.83 42.00 -33.14 91.74 41.83 -33.51 coo -4.44 67.20 42.32 -7.50 62.41 40.49 79.83 44.38 -31.44 80.32 39.55 -29.40 ULMN 3 1ax4_c06 TRYPTOPHANASE user 26 3 # 26 C 130 PHE C 164 PHE^? 25.79 MG MG C 302 C 223 ASP C 160 ASP^? 31.63 MG MG D 302 C 265 LYS C 61 LYS^? 21.91 MG MG D 302 coo -6.55 73.45 23.60 -6.77 71.48 21.66 97.62 27.66 -19.56 95.28 28.38 -20.99 coo -9.52 75.74 33.62 -8.85 73.74 33.93 102.50 38.00 -23.28 102.43 39.97 -22.46 coo -4.44 67.20 42.32 -7.50 62.41 40.49 93.60 48.56 -24.05 90.39 44.71 -27.98 ULMN 3 1ax4_c06 TRYPTOPHANASE user 27 3 # 27 C 130 PHE C 164 PHE^? 25.79 MG MG C 302 C 223 ASP C 160 ASP^? 31.63 MG MG D 302 C 265 LYS C 136 LYS^? 30.63 MG MG C 302 coo -6.55 73.45 23.60 -6.77 71.48 21.66 97.62 27.66 -19.56 95.28 28.38 -20.99 coo -9.52 75.74 33.62 -8.85 73.74 33.93 102.50 38.00 -23.28 102.43 39.97 -22.46 coo -4.44 67.20 42.32 -7.50 62.41 40.49 99.75 44.04 -11.38 100.98 45.13 -6.77 ULMN 3 1ax4_c06 TRYPTOPHANASE user 28 3 # 28 C 130 PHE C 164 PHE^? 25.79 MG MG C 302 C 223 ASP C 160 ASP^? 31.63 MG MG D 302 C 265 LYS C 137 LYS^? 35.41 MG MG C 302 coo -6.55 73.45 23.60 -6.77 71.48 21.66 97.62 27.66 -19.56 95.28 28.38 -20.99 coo -9.52 75.74 33.62 -8.85 73.74 33.93 102.50 38.00 -23.28 102.43 39.97 -22.46 coo -4.44 67.20 42.32 -7.50 62.41 40.49 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 1ax4_c06 TRYPTOPHANASE user 29 3 # 29 C 130 PHE C 172 PHE^? 13.00 MG MG C 301 C 223 ASP C 35 ASP^? 16.42 MG MG C 302 C 265 LYS C 90 LYS^? 18.24 MG MG C 302 coo -6.55 73.45 23.60 -6.77 71.48 21.66 86.45 15.28 -5.05 85.50 13.59 -7.08 coo -9.52 75.74 33.62 -8.85 73.74 33.93 84.40 16.53 -16.68 82.83 17.91 -16.28 coo -4.44 67.20 42.32 -7.50 62.41 40.49 72.37 23.25 -18.94 76.11 26.52 -20.97 ULMN 3 1ax4_c06 TRYPTOPHANASE user 30 3 # 30 C 130 PHE D 39 PHE^? 18.22 MG MG D 301 C 223 ASP D 35 ASP^? 16.80 MG MG D 302 C 265 LYS C 61 LYS^? 21.91 MG MG D 302 coo -6.55 73.45 23.60 -6.77 71.48 21.66 99.82 34.37 -37.74 99.04 35.33 -40.24 coo -9.52 75.74 33.62 -8.85 73.74 33.93 93.83 42.00 -33.14 91.74 41.83 -33.51 coo -4.44 67.20 42.32 -7.50 62.41 40.49 93.60 48.56 -24.05 90.39 44.71 -27.98 ULMN 3 1ax4_c06 TRYPTOPHANASE user 31 3 # 31 C 130 PHE D 150 PHE^? 10.21 MG MG D 301 C 223 ASP D 35 ASP^? 16.80 MG MG D 302 C 265 LYS D 90 LYS^? 18.98 MG MG D 302 coo -6.55 73.45 23.60 -6.77 71.48 21.66 91.92 42.74 -45.34 92.24 44.79 -43.44 coo -9.52 75.74 33.62 -8.85 73.74 33.93 93.83 42.00 -33.14 91.74 41.83 -33.51 coo -4.44 67.20 42.32 -7.50 62.41 40.49 79.83 44.38 -31.44 80.32 39.55 -29.40 ULMN 3 1ax4_c06 TRYPTOPHANASE user 32 3 # 32 C 130 PHE D 150 PHE^? 10.21 MG MG D 301 C 223 ASP D 171 ASP^? 16.95 MG MG D 301 C 265 LYS D 166 LYS^? 21.08 MG MG D 301 coo -6.55 73.45 23.60 -6.77 71.48 21.66 91.92 42.74 -45.34 92.24 44.79 -43.44 coo -9.52 75.74 33.62 -8.85 73.74 33.93 100.39 36.69 -43.49 101.13 38.51 -42.69 coo -4.44 67.20 42.32 -7.50 62.41 40.49 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1ax4_c06 TRYPTOPHANASE user 33 3 # 33 C 130 PHE D 153 PHE^? 9.11 MG MG D 302 C 223 ASP D 35 ASP^? 16.80 MG MG D 302 C 265 LYS D 90 LYS^? 18.98 MG MG D 302 coo -6.55 73.45 23.60 -6.77 71.48 21.66 91.67 34.35 -42.71 89.76 36.10 -43.73 coo -9.52 75.74 33.62 -8.85 73.74 33.93 93.83 42.00 -33.14 91.74 41.83 -33.51 coo -4.44 67.20 42.32 -7.50 62.41 40.49 79.83 44.38 -31.44 80.32 39.55 -29.40 ULMN 3 1ax4_c06 TRYPTOPHANASE user 34 3 # 34 C 130 PHE D 161 PHE^? 25.58 MG MG C 302 C 223 ASP C 35 ASP^? 16.42 MG MG C 302 C 265 LYS C 90 LYS^? 18.24 MG MG C 302 coo -6.55 73.45 23.60 -6.77 71.48 21.66 92.97 17.97 -22.91 90.24 17.44 -22.45 coo -9.52 75.74 33.62 -8.85 73.74 33.93 84.40 16.53 -16.68 82.83 17.91 -16.28 coo -4.44 67.20 42.32 -7.50 62.41 40.49 72.37 23.25 -18.94 76.11 26.52 -20.97 ULMN 3 1ax4_c06 TRYPTOPHANASE user 35 3 # 35 C 130 PHE D 164 PHE^? 25.90 MG MG D 302 C 223 ASP D 160 ASP^? 31.45 MG MG C 302 C 265 LYS D 61 LYS^? 21.93 MG MG C 302 coo -6.55 73.45 23.60 -6.77 71.48 21.66 97.06 25.02 -29.96 94.69 25.91 -28.78 coo -9.52 75.74 33.62 -8.85 73.74 33.93 94.15 13.98 -26.57 92.71 12.42 -26.99 coo -4.44 67.20 42.32 -7.50 62.41 40.49 80.64 11.23 -26.16 80.65 16.24 -22.36 ULMN 3 1ax4_c06 TRYPTOPHANASE user 36 3 # 36 C 130 PHE D 164 PHE^? 25.90 MG MG D 302 C 223 ASP D 160 ASP^? 31.45 MG MG C 302 C 265 LYS D 136 LYS^? 34.99 MG MG D 302 coo -6.55 73.45 23.60 -6.77 71.48 21.66 97.06 25.02 -29.96 94.69 25.91 -28.78 coo -9.52 75.74 33.62 -8.85 73.74 33.93 94.15 13.98 -26.57 92.71 12.42 -26.99 coo -4.44 67.20 42.32 -7.50 62.41 40.49 88.96 10.62 -38.53 90.77 6.00 -38.00 ULMN 3 1ax4_c06 TRYPTOPHANASE user 37 3 # 37 C 130 PHE D 164 PHE^? 25.90 MG MG D 302 C 223 ASP D 160 ASP^? 31.45 MG MG C 302 C 265 LYS D 137 LYS^? 37.57 MG MG D 302 coo -6.55 73.45 23.60 -6.77 71.48 21.66 97.06 25.02 -29.96 94.69 25.91 -28.78 coo -9.52 75.74 33.62 -8.85 73.74 33.93 94.15 13.98 -26.57 92.71 12.42 -26.99 coo -4.44 67.20 42.32 -7.50 62.41 40.49 88.48 8.58 -35.33 84.88 3.98 -33.96 ULMN 3 1ax4_c06 TRYPTOPHANASE user 38 3 # 38 C 130 PHE D 172 PHE^? 13.02 MG MG D 301 C 223 ASP D 35 ASP^? 16.80 MG MG D 302 C 265 LYS D 90 LYS^? 18.98 MG MG D 302 coo -6.55 73.45 23.60 -6.77 71.48 21.66 96.36 41.50 -44.84 96.77 43.66 -43.13 coo -9.52 75.74 33.62 -8.85 73.74 33.93 93.83 42.00 -33.14 91.74 41.83 -33.51 coo -4.44 67.20 42.32 -7.50 62.41 40.49 79.83 44.38 -31.44 80.32 39.55 -29.40 ULMN 3 1ax4_c06 TRYPTOPHANASE user 39 3 # 39 C 130 PHE D 190 PHE^? 14.83 MG MG D 301 C 223 ASP D 142 ASP^? 23.49 MG MG D 301 C 265 LYS D 137 LYS^? 37.57 MG MG D 302 coo -6.55 73.45 23.60 -6.77 71.48 21.66 93.52 26.32 -46.94 92.08 26.47 -44.56 coo -9.52 75.74 33.62 -8.85 73.74 33.93 90.90 15.58 -44.76 91.35 16.09 -46.79 coo -4.44 67.20 42.32 -7.50 62.41 40.49 88.48 8.58 -35.33 84.88 3.98 -33.96 ULMN 3 1ax4_c06 TRYPTOPHANASE user 40 3 # 40 C 130 PHE E 39 PHE^? 18.29 MG MG E 301 C 223 ASP E 35 ASP^? 16.91 MG MG E 302 C 265 LYS F 61 LYS^? 21.75 MG MG E 302 coo -6.55 73.45 23.60 -6.77 71.48 21.66 67.23 73.00 -57.46 68.07 72.02 -54.98 coo -9.52 75.74 33.62 -8.85 73.74 33.93 73.60 65.64 -62.00 73.13 63.73 -61.22 coo -4.44 67.20 42.32 -7.50 62.41 40.49 80.24 64.12 -71.01 76.23 61.95 -66.39 ULMN 3 1ax4_c06 TRYPTOPHANASE user 41 3 # 41 C 130 PHE E 150 PHE^? 10.10 MG MG E 301 C 223 ASP E 35 ASP^? 16.91 MG MG E 302 C 265 LYS E 90 LYS^? 19.16 MG MG E 302 coo -6.55 73.45 23.60 -6.77 71.48 21.66 74.01 63.99 -49.53 76.06 63.87 -51.45 coo -9.52 75.74 33.62 -8.85 73.74 33.93 73.60 65.64 -62.00 73.13 63.73 -61.22 coo -4.44 67.20 42.32 -7.50 62.41 40.49 73.81 51.50 -63.18 69.15 52.39 -65.65 ULMN 3 1ax4_c06 TRYPTOPHANASE user 42 3 # 42 C 130 PHE E 150 PHE^? 10.10 MG MG E 301 C 223 ASP E 171 ASP^? 16.73 MG MG E 301 C 265 LYS E 166 LYS^? 21.46 MG MG E 301 coo -6.55 73.45 23.60 -6.77 71.48 21.66 74.01 63.99 -49.53 76.06 63.87 -51.45 coo -9.52 75.74 33.62 -8.85 73.74 33.93 69.61 73.12 -51.56 71.50 73.53 -52.39 coo -4.44 67.20 42.32 -7.50 62.41 40.49 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1ax4_c06 TRYPTOPHANASE user 43 3 # 43 C 130 PHE E 153 PHE^? 9.50 MG MG E 302 C 223 ASP E 35 ASP^? 16.91 MG MG E 302 C 265 LYS E 90 LYS^? 19.16 MG MG E 302 coo -6.55 73.45 23.60 -6.77 71.48 21.66 65.86 64.95 -52.12 67.22 62.73 -51.09 coo -9.52 75.74 33.62 -8.85 73.74 33.93 73.60 65.64 -62.00 73.13 63.73 -61.22 coo -4.44 67.20 42.32 -7.50 62.41 40.49 73.81 51.50 -63.18 69.15 52.39 -65.65 ULMN 3 1ax4_c06 TRYPTOPHANASE user 44 3 # 44 C 130 PHE E 161 PHE^? 25.51 MG MG F 301 C 223 ASP F 35 ASP^? 16.93 MG MG F 301 C 265 LYS F 90 LYS^? 18.57 MG MG F 301 coo -6.55 73.45 23.60 -6.77 71.48 21.66 49.74 68.03 -71.94 48.60 65.47 -72.38 coo -9.52 75.74 33.62 -8.85 73.74 33.93 46.82 60.47 -77.63 48.00 58.79 -78.23 coo -4.44 67.20 42.32 -7.50 62.41 40.49 51.54 47.01 -75.58 55.05 50.31 -73.74 ULMN 3 1ax4_c06 TRYPTOPHANASE user 45 3 # 45 C 130 PHE E 164 PHE^? 25.87 MG MG E 302 C 223 ASP E 160 ASP^? 31.54 MG MG F 301 C 265 LYS E 136 LYS^? 31.27 MG MG E 302 coo -6.55 73.45 23.60 -6.77 71.48 21.66 57.42 71.31 -64.81 57.98 68.84 -66.03 coo -9.52 75.74 33.62 -8.85 73.74 33.93 45.81 70.00 -68.45 44.10 68.87 -67.77 coo -4.44 67.20 42.32 -7.50 62.41 40.49 42.12 65.93 -56.52 39.36 65.07 -51.83 ULMN 3 1ax4_c06 TRYPTOPHANASE user 46 3 # 46 C 130 PHE E 164 PHE^? 25.87 MG MG E 302 C 223 ASP E 160 ASP^? 31.54 MG MG F 301 C 265 LYS E 137 LYS^? 35.26 MG MG E 302 coo -6.55 73.45 23.60 -6.77 71.48 21.66 57.42 71.31 -64.81 57.98 68.84 -66.03 coo -9.52 75.74 33.62 -8.85 73.74 33.93 45.81 70.00 -68.45 44.10 68.87 -67.77 coo -4.44 67.20 42.32 -7.50 62.41 40.49 40.01 66.05 -59.66 36.65 60.99 -60.28 ULMN 3 1ax4_c06 TRYPTOPHANASE user 47 3 # 47 C 130 PHE E 172 PHE^? 12.71 MG MG E 301 C 223 ASP E 35 ASP^? 16.91 MG MG E 302 C 265 LYS E 90 LYS^? 19.16 MG MG E 302 coo -6.55 73.45 23.60 -6.77 71.48 21.66 73.54 68.41 -50.00 75.58 68.36 -51.87 coo -9.52 75.74 33.62 -8.85 73.74 33.93 73.60 65.64 -62.00 73.13 63.73 -61.22 coo -4.44 67.20 42.32 -7.50 62.41 40.49 73.81 51.50 -63.18 69.15 52.39 -65.65 ULMN 3 1ax4_c06 TRYPTOPHANASE user 48 3 # 48 C 130 PHE F 39 PHE^? 17.69 MG MG F 302 C 223 ASP F 35 ASP^? 16.93 MG MG F 301 C 265 LYS E 61 LYS^? 22.16 MG MG F 301 coo -6.55 73.45 23.60 -6.77 71.48 21.66 50.42 69.23 -82.87 49.95 67.86 -85.25 coo -9.52 75.74 33.62 -8.85 73.74 33.93 46.82 60.47 -77.63 48.00 58.79 -78.23 coo -4.44 67.20 42.32 -7.50 62.41 40.49 40.99 56.84 -68.48 45.99 56.72 -72.39 ULMN 3 1ax4_c06 TRYPTOPHANASE user 49 3 # 49 C 130 PHE F 150 PHE^? 9.82 MG MG F 302 C 223 ASP F 35 ASP^? 16.93 MG MG F 301 C 265 LYS F 90 LYS^? 18.57 MG MG F 301 coo -6.55 73.45 23.60 -6.77 71.48 21.66 47.10 57.70 -89.94 45.06 57.27 -88.04 coo -9.52 75.74 33.62 -8.85 73.74 33.93 46.82 60.47 -77.63 48.00 58.79 -78.23 coo -4.44 67.20 42.32 -7.50 62.41 40.49 51.54 47.01 -75.58 55.05 50.31 -73.74 ULMN 3 1ax4_c06 TRYPTOPHANASE user 50 3 # 50 C 130 PHE F 150 PHE^? 9.82 MG MG F 302 C 223 ASP F 171 ASP^? 16.35 MG MG F 302 C 265 LYS F 166 LYS^? 20.76 MG MG F 302 coo -6.55 73.45 23.60 -6.77 71.48 21.66 47.10 57.70 -89.94 45.06 57.27 -88.04 coo -9.52 75.74 33.62 -8.85 73.74 33.93 48.23 68.08 -88.47 46.26 68.02 -87.56 coo -4.44 67.20 42.32 -7.50 62.41 40.49 59.28 73.05 -82.63 55.63 74.15 -86.94 ULMN 3 1ax4_c06 TRYPTOPHANASE user 51 3 # 51 C 130 PHE F 153 PHE^? 9.26 MG MG F 302 C 223 ASP F 35 ASP^? 16.93 MG MG F 301 C 265 LYS F 90 LYS^? 18.57 MG MG F 301 coo -6.55 73.45 23.60 -6.77 71.48 21.66 54.49 61.65 -87.43 53.89 59.08 -88.37 coo -9.52 75.74 33.62 -8.85 73.74 33.93 46.82 60.47 -77.63 48.00 58.79 -78.23 coo -4.44 67.20 42.32 -7.50 62.41 40.49 51.54 47.01 -75.58 55.05 50.31 -73.74 ULMN 3 1ax4_c06 TRYPTOPHANASE user 52 3 # 52 C 130 PHE F 161 PHE^? 25.66 MG MG E 302 C 223 ASP E 35 ASP^? 16.91 MG MG E 302 C 265 LYS E 90 LYS^? 19.16 MG MG E 302 coo -6.55 73.45 23.60 -6.77 71.48 21.66 68.33 71.65 -68.19 70.12 69.57 -67.59 coo -9.52 75.74 33.62 -8.85 73.74 33.93 73.60 65.64 -62.00 73.13 63.73 -61.22 coo -4.44 67.20 42.32 -7.50 62.41 40.49 73.81 51.50 -63.18 69.15 52.39 -65.65 ULMN 3 1ax4_c06 TRYPTOPHANASE user 53 3 # 53 C 130 PHE F 164 PHE^? 26.17 MG MG F 301 C 223 ASP F 160 ASP^? 31.59 MG MG E 302 C 265 LYS F 136 LYS^? 30.53 MG MG F 301 coo -6.55 73.45 23.60 -6.77 71.48 21.66 60.03 71.53 -75.24 60.39 69.25 -73.67 coo -9.52 75.74 33.62 -8.85 73.74 33.93 71.27 74.59 -71.77 73.23 74.02 -72.37 coo -4.44 67.20 42.32 -7.50 62.41 40.49 76.49 71.19 -83.39 78.38 70.88 -88.47 ULMN 3 1ax4_c06 TRYPTOPHANASE user 54 3 # 54 C 130 PHE F 164 PHE^? 26.17 MG MG F 301 C 223 ASP F 160 ASP^? 31.59 MG MG E 302 C 265 LYS F 137 LYS^? 35.13 MG MG F 301 coo -6.55 73.45 23.60 -6.77 71.48 21.66 60.03 71.53 -75.24 60.39 69.25 -73.67 coo -9.52 75.74 33.62 -8.85 73.74 33.93 71.27 74.59 -71.77 73.23 74.02 -72.37 coo -4.44 67.20 42.32 -7.50 62.41 40.49 78.53 72.20 -80.30 83.01 68.64 -79.79 ULMN 3 1ax4_c06 TRYPTOPHANASE user 55 3 # 55 C 130 PHE F 172 PHE^? 12.43 MG MG F 302 C 223 ASP F 35 ASP^? 16.93 MG MG F 301 C 265 LYS F 90 LYS^? 18.57 MG MG F 301 coo -6.55 73.45 23.60 -6.77 71.48 21.66 45.85 62.23 -89.68 43.95 61.55 -87.75 coo -9.52 75.74 33.62 -8.85 73.74 33.93 46.82 60.47 -77.63 48.00 58.79 -78.23 coo -4.44 67.20 42.32 -7.50 62.41 40.49 51.54 47.01 -75.58 55.05 50.31 -73.74 1ax4_c06 source 1ax4 TRYPTOPHANASE : 55 hits 1ax4_c06 naa= 3 ULMN 3 1ax4_c07 TRYPTOPHANASE user 1 3 # 1 D 130 PHE A 39 PHE^? 18.63 MG MG A 302 D 223 ASP A 35 ASP^? 16.92 MG MG A 301 D 265 LYS B 61 LYS^? 22.03 MG MG A 301 coo -38.60 55.38 52.70 -40.06 57.72 53.04 31.04 21.84 30.70 31.32 23.06 33.20 coo -29.46 51.67 48.51 -28.63 53.31 49.56 34.49 31.10 26.54 36.41 31.82 27.10 coo -18.87 56.53 54.79 -19.47 62.22 53.03 32.50 37.62 17.61 36.68 34.92 21.51 ULMN 3 1ax4_c07 TRYPTOPHANASE user 2 3 # 2 D 130 PHE A 150 PHE^? 10.47 MG MG A 302 D 223 ASP A 35 ASP^? 16.92 MG MG A 301 D 265 LYS A 90 LYS^? 18.58 MG MG A 301 coo -38.60 55.38 52.70 -40.06 57.72 53.04 35.63 32.10 38.88 34.73 33.93 37.00 coo -29.46 51.67 48.51 -28.63 53.31 49.56 34.49 31.10 26.54 36.41 31.82 27.10 coo -18.87 56.53 54.79 -19.47 62.22 53.03 46.62 38.29 25.46 47.51 33.29 23.22 ULMN 3 1ax4_c07 TRYPTOPHANASE user 3 3 # 3 D 130 PHE A 150 PHE^? 10.47 MG MG A 302 D 223 ASP A 171 ASP^? 17.17 MG MG A 302 D 265 LYS A 166 LYS^? 20.93 MG MG A 302 coo -38.60 55.38 52.70 -40.06 57.72 53.04 35.63 32.10 38.88 34.73 33.93 37.00 coo -29.46 51.67 48.51 -28.63 53.31 49.56 29.78 23.67 36.63 28.48 25.11 35.71 coo -18.87 56.53 54.79 -19.47 62.22 53.03 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1ax4_c07 TRYPTOPHANASE user 4 3 # 4 D 130 PHE A 153 PHE^? 9.64 MG MG A 301 D 223 ASP A 35 ASP^? 16.92 MG MG A 301 D 265 LYS A 90 LYS^? 18.58 MG MG A 301 coo -38.60 55.38 52.70 -40.06 57.72 53.04 38.89 24.49 36.07 40.14 26.70 37.23 coo -29.46 51.67 48.51 -28.63 53.31 49.56 34.49 31.10 26.54 36.41 31.82 27.10 coo -18.87 56.53 54.79 -19.47 62.22 53.03 46.62 38.29 25.46 47.51 33.29 23.22 ULMN 3 1ax4_c07 TRYPTOPHANASE user 5 3 # 5 D 130 PHE A 161 PHE^? 25.62 MG MG B 302 D 223 ASP B 35 ASP^? 16.92 MG MG B 302 D 265 LYS B 90 LYS^? 18.68 MG MG B 302 coo -38.60 55.38 52.70 -40.06 57.72 53.04 44.24 9.29 16.03 46.90 9.95 15.56 coo -29.46 51.67 48.51 -28.63 53.31 49.56 52.63 11.07 10.18 53.68 12.85 9.94 coo -18.87 56.53 54.79 -19.47 62.22 53.03 61.66 21.61 12.88 56.74 22.88 14.81 ULMN 3 1ax4_c07 TRYPTOPHANASE user 6 3 # 6 D 130 PHE A 164 PHE^? 26.07 MG MG A 301 D 223 ASP A 160 ASP^? 31.61 MG MG B 302 D 265 LYS A 61 LYS^? 21.99 MG MG B 302 coo -38.60 55.38 52.70 -40.06 57.72 53.04 37.51 14.27 23.18 39.37 15.97 21.97 coo -29.46 51.67 48.51 -28.63 53.31 49.56 44.21 5.00 19.54 46.02 3.84 19.76 coo -18.87 56.53 54.79 -19.47 62.22 53.03 57.78 7.35 19.60 56.77 12.20 15.61 ULMN 3 1ax4_c07 TRYPTOPHANASE user 7 3 # 7 D 130 PHE A 164 PHE^? 26.07 MG MG A 301 D 223 ASP A 160 ASP^? 31.61 MG MG B 302 D 265 LYS A 136 LYS^? 30.58 MG MG A 302 coo -38.60 55.38 52.70 -40.06 57.72 53.04 37.51 14.27 23.18 39.37 15.97 21.97 coo -29.46 51.67 48.51 -28.63 53.31 49.56 44.21 5.00 19.54 46.02 3.84 19.76 coo -18.87 56.53 54.79 -19.47 62.22 53.03 50.14 3.36 31.42 51.28 2.21 35.89 ULMN 3 1ax4_c07 TRYPTOPHANASE user 8 3 # 8 D 130 PHE A 164 PHE^? 26.07 MG MG A 301 D 223 ASP A 160 ASP^? 31.61 MG MG B 302 D 265 LYS A 137 LYS^? 34.85 MG MG A 301 coo -38.60 55.38 52.70 -40.06 57.72 53.04 37.51 14.27 23.18 39.37 15.97 21.97 coo -29.46 51.67 48.51 -28.63 53.31 49.56 44.21 5.00 19.54 46.02 3.84 19.76 coo -18.87 56.53 54.79 -19.47 62.22 53.03 50.97 1.58 28.14 56.13 1.49 28.03 ULMN 3 1ax4_c07 TRYPTOPHANASE user 9 3 # 9 D 130 PHE A 172 PHE^? 13.28 MG MG A 302 D 223 ASP A 35 ASP^? 16.92 MG MG A 301 D 265 LYS A 90 LYS^? 18.58 MG MG A 301 coo -38.60 55.38 52.70 -40.06 57.72 53.04 31.82 29.57 38.19 30.91 31.55 36.40 coo -29.46 51.67 48.51 -28.63 53.31 49.56 34.49 31.10 26.54 36.41 31.82 27.10 coo -18.87 56.53 54.79 -19.47 62.22 53.03 46.62 38.29 25.46 47.51 33.29 23.22 ULMN 3 1ax4_c07 TRYPTOPHANASE user 10 3 # 10 D 130 PHE B 39 PHE^? 18.11 MG MG B 301 D 223 ASP B 35 ASP^? 16.92 MG MG B 302 D 265 LYS A 61 LYS^? 21.99 MG MG B 302 coo -38.60 55.38 52.70 -40.06 57.72 53.04 43.21 9.88 5.15 44.59 10.44 2.80 coo -29.46 51.67 48.51 -28.63 53.31 49.56 52.63 11.07 10.18 53.68 12.85 9.94 coo -18.87 56.53 54.79 -19.47 62.22 53.03 57.78 7.35 19.60 56.77 12.20 15.61 ULMN 3 1ax4_c07 TRYPTOPHANASE user 11 3 # 11 D 130 PHE B 150 PHE^? 9.88 MG MG B 301 D 223 ASP B 35 ASP^? 16.92 MG MG B 302 D 265 LYS B 90 LYS^? 18.68 MG MG B 302 coo -38.60 55.38 52.70 -40.06 57.72 53.04 54.70 12.86 -1.84 56.31 11.50 0.05 coo -29.46 51.67 48.51 -28.63 53.31 49.56 52.63 11.07 10.18 53.68 12.85 9.94 coo -18.87 56.53 54.79 -19.47 62.22 53.03 61.66 21.61 12.88 56.74 22.88 14.81 ULMN 3 1ax4_c07 TRYPTOPHANASE user 12 3 # 12 D 130 PHE B 150 PHE^? 9.88 MG MG B 301 D 223 ASP B 171 ASP^? 16.92 MG MG B 301 D 265 LYS B 166 LYS^? 22.75 MG MG B 301 coo -38.60 55.38 52.70 -40.06 57.72 53.04 54.70 12.86 -1.84 56.31 11.50 0.05 coo -29.46 51.67 48.51 -28.63 53.31 49.56 45.30 8.50 -0.71 46.30 6.81 0.12 coo -18.87 56.53 54.79 -19.47 62.22 53.03 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1ax4_c07 TRYPTOPHANASE user 13 3 # 13 D 130 PHE B 153 PHE^? 9.59 MG MG B 302 D 223 ASP B 35 ASP^? 16.92 MG MG B 302 D 265 LYS B 90 LYS^? 18.68 MG MG B 302 coo -38.60 55.38 52.70 -40.06 57.72 53.04 47.54 17.09 0.77 50.03 17.91 -0.19 coo -29.46 51.67 48.51 -28.63 53.31 49.56 52.63 11.07 10.18 53.68 12.85 9.94 coo -18.87 56.53 54.79 -19.47 62.22 53.03 61.66 21.61 12.88 56.74 22.88 14.81 ULMN 3 1ax4_c07 TRYPTOPHANASE user 14 3 # 14 D 130 PHE B 161 PHE^? 25.78 MG MG A 301 D 223 ASP A 35 ASP^? 16.92 MG MG A 301 D 265 LYS A 90 LYS^? 18.58 MG MG A 301 coo -38.60 55.38 52.70 -40.06 57.72 53.04 31.87 23.58 19.99 32.61 26.21 20.65 coo -29.46 51.67 48.51 -28.63 53.31 49.56 34.49 31.10 26.54 36.41 31.82 27.10 coo -18.87 56.53 54.79 -19.47 62.22 53.03 46.62 38.29 25.46 47.51 33.29 23.22 ULMN 3 1ax4_c07 TRYPTOPHANASE user 15 3 # 15 D 130 PHE B 164 PHE^? 25.95 MG MG B 302 D 223 ASP B 160 ASP^? 31.65 MG MG A 301 D 265 LYS B 61 LYS^? 22.03 MG MG A 301 coo -38.60 55.38 52.70 -40.06 57.72 53.04 36.16 16.77 12.72 38.04 18.41 13.99 coo -29.46 51.67 48.51 -28.63 53.31 49.56 28.01 24.83 16.38 27.44 26.81 15.80 coo -18.87 56.53 54.79 -19.47 62.22 53.03 32.50 37.62 17.61 36.68 34.92 21.51 ULMN 3 1ax4_c07 TRYPTOPHANASE user 16 3 # 16 D 130 PHE B 164 PHE^? 25.95 MG MG B 302 D 223 ASP B 160 ASP^? 31.65 MG MG A 301 D 265 LYS B 136 LYS^? 33.75 MG MG B 302 coo -38.60 55.38 52.70 -40.06 57.72 53.04 36.16 16.77 12.72 38.04 18.41 13.99 coo -29.46 51.67 48.51 -28.63 53.31 49.56 28.01 24.83 16.38 27.44 26.81 15.80 coo -18.87 56.53 54.79 -19.47 62.22 53.03 28.47 31.35 4.78 24.04 31.81 1.99 ULMN 3 1ax4_c07 TRYPTOPHANASE user 17 3 # 17 D 130 PHE B 164 PHE^? 25.95 MG MG B 302 D 223 ASP B 160 ASP^? 31.65 MG MG A 301 D 265 LYS B 137 LYS^? 34.56 MG MG B 302 coo -38.60 55.38 52.70 -40.06 57.72 53.04 36.16 16.77 12.72 38.04 18.41 13.99 coo -29.46 51.67 48.51 -28.63 53.31 49.56 28.01 24.83 16.38 27.44 26.81 15.80 coo -18.87 56.53 54.79 -19.47 62.22 53.03 26.56 32.46 7.93 27.87 37.71 9.31 ULMN 3 1ax4_c07 TRYPTOPHANASE user 18 3 # 18 D 130 PHE B 172 PHE^? 12.81 MG MG B 301 D 223 ASP B 35 ASP^? 16.92 MG MG B 302 D 265 LYS B 90 LYS^? 18.68 MG MG B 302 coo -38.60 55.38 52.70 -40.06 57.72 53.04 51.51 9.59 -1.64 53.03 8.15 0.22 coo -29.46 51.67 48.51 -28.63 53.31 49.56 52.63 11.07 10.18 53.68 12.85 9.94 coo -18.87 56.53 54.79 -19.47 62.22 53.03 61.66 21.61 12.88 56.74 22.88 14.81 ULMN 3 1ax4_c07 TRYPTOPHANASE user 19 3 # 19 D 130 PHE B 190 PHE^? 14.80 MG MG B 301 D 223 ASP B 142 ASP^? 23.97 MG MG B 301 D 265 LYS B 137 LYS^? 34.56 MG MG B 302 coo -38.60 55.38 52.70 -40.06 57.72 53.04 40.06 19.97 -3.89 40.77 21.13 -1.45 coo -29.46 51.67 48.51 -28.63 53.31 49.56 31.69 27.40 -1.31 32.10 27.37 -3.38 coo -18.87 56.53 54.79 -19.47 62.22 53.03 26.56 32.46 7.93 27.87 37.71 9.31 ULMN 3 1ax4_c07 TRYPTOPHANASE user 20 3 # 20 D 130 PHE C 39 PHE^? 18.26 MG MG C 301 D 223 ASP C 35 ASP^? 16.42 MG MG C 302 D 265 LYS D 61 LYS^? 21.93 MG MG C 302 coo -38.60 55.38 52.70 -40.06 57.72 53.04 93.83 18.63 -11.96 92.54 18.49 -9.49 coo -29.46 51.67 48.51 -28.63 53.31 49.56 84.40 16.53 -16.68 82.83 17.91 -16.28 coo -18.87 56.53 54.79 -19.47 62.22 53.03 80.64 11.23 -26.16 80.65 16.24 -22.36 ULMN 3 1ax4_c07 TRYPTOPHANASE user 21 3 # 21 D 130 PHE C 150 PHE^? 10.02 MG MG C 301 D 223 ASP C 35 ASP^? 16.42 MG MG C 302 D 265 LYS C 90 LYS^? 18.24 MG MG C 302 coo -38.60 55.38 52.70 -40.06 57.72 53.04 82.11 17.28 -4.80 81.16 15.47 -6.75 coo -29.46 51.67 48.51 -28.63 53.31 49.56 84.40 16.53 -16.68 82.83 17.91 -16.28 coo -18.87 56.53 54.79 -19.47 62.22 53.03 72.37 23.25 -18.94 76.11 26.52 -20.97 ULMN 3 1ax4_c07 TRYPTOPHANASE user 22 3 # 22 D 130 PHE C 150 PHE^? 10.02 MG MG C 301 D 223 ASP C 171 ASP^? 17.08 MG MG C 301 D 265 LYS C 166 LYS^? 22.53 MG MG C 301 coo -38.60 55.38 52.70 -40.06 57.72 53.04 82.11 17.28 -4.80 81.16 15.47 -6.75 coo -29.46 51.67 48.51 -28.63 53.31 49.56 92.57 16.68 -6.24 92.24 14.74 -7.03 coo -18.87 56.53 54.79 -19.47 62.22 53.03 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1ax4_c07 TRYPTOPHANASE user 23 3 # 23 D 130 PHE C 153 PHE^? 9.34 MG MG C 302 D 223 ASP C 35 ASP^? 16.42 MG MG C 302 D 265 LYS C 90 LYS^? 18.24 MG MG C 302 coo -38.60 55.38 52.70 -40.06 57.72 53.04 87.15 23.83 -7.29 84.55 23.79 -6.26 coo -29.46 51.67 48.51 -28.63 53.31 49.56 84.40 16.53 -16.68 82.83 17.91 -16.28 coo -18.87 56.53 54.79 -19.47 62.22 53.03 72.37 23.25 -18.94 76.11 26.52 -20.97 ULMN 3 1ax4_c07 TRYPTOPHANASE user 24 3 # 24 D 130 PHE C 161 PHE^? 25.47 MG MG D 302 D 223 ASP D 35 ASP^? 16.80 MG MG D 302 D 265 LYS D 90 LYS^? 18.98 MG MG D 302 coo -38.60 55.38 52.70 -40.06 57.72 53.04 98.98 35.62 -26.76 97.40 37.84 -27.44 coo -29.46 51.67 48.51 -28.63 53.31 49.56 93.83 42.00 -33.14 91.74 41.83 -33.51 coo -18.87 56.53 54.79 -19.47 62.22 53.03 79.83 44.38 -31.44 80.32 39.55 -29.40 ULMN 3 1ax4_c07 TRYPTOPHANASE user 25 3 # 25 D 130 PHE C 164 PHE^? 25.79 MG MG C 302 D 223 ASP C 160 ASP^? 31.63 MG MG D 302 D 265 LYS C 61 LYS^? 21.91 MG MG D 302 coo -38.60 55.38 52.70 -40.06 57.72 53.04 97.62 27.66 -19.56 95.28 28.38 -20.99 coo -29.46 51.67 48.51 -28.63 53.31 49.56 102.50 38.00 -23.28 102.43 39.97 -22.46 coo -18.87 56.53 54.79 -19.47 62.22 53.03 93.60 48.56 -24.05 90.39 44.71 -27.98 ULMN 3 1ax4_c07 TRYPTOPHANASE user 26 3 # 26 D 130 PHE C 164 PHE^? 25.79 MG MG C 302 D 223 ASP C 160 ASP^? 31.63 MG MG D 302 D 265 LYS C 136 LYS^? 30.63 MG MG C 302 coo -38.60 55.38 52.70 -40.06 57.72 53.04 97.62 27.66 -19.56 95.28 28.38 -20.99 coo -29.46 51.67 48.51 -28.63 53.31 49.56 102.50 38.00 -23.28 102.43 39.97 -22.46 coo -18.87 56.53 54.79 -19.47 62.22 53.03 99.75 44.04 -11.38 100.98 45.13 -6.77 ULMN 3 1ax4_c07 TRYPTOPHANASE user 27 3 # 27 D 130 PHE C 164 PHE^? 25.79 MG MG C 302 D 223 ASP C 160 ASP^? 31.63 MG MG D 302 D 265 LYS C 137 LYS^? 35.41 MG MG C 302 coo -38.60 55.38 52.70 -40.06 57.72 53.04 97.62 27.66 -19.56 95.28 28.38 -20.99 coo -29.46 51.67 48.51 -28.63 53.31 49.56 102.50 38.00 -23.28 102.43 39.97 -22.46 coo -18.87 56.53 54.79 -19.47 62.22 53.03 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 1ax4_c07 TRYPTOPHANASE user 28 3 # 28 D 130 PHE C 172 PHE^? 13.00 MG MG C 301 D 223 ASP C 35 ASP^? 16.42 MG MG C 302 D 265 LYS C 90 LYS^? 18.24 MG MG C 302 coo -38.60 55.38 52.70 -40.06 57.72 53.04 86.45 15.28 -5.05 85.50 13.59 -7.08 coo -29.46 51.67 48.51 -28.63 53.31 49.56 84.40 16.53 -16.68 82.83 17.91 -16.28 coo -18.87 56.53 54.79 -19.47 62.22 53.03 72.37 23.25 -18.94 76.11 26.52 -20.97 ULMN 3 1ax4_c07 TRYPTOPHANASE user 29 3 # 29 D 130 PHE C 190 PHE^? 14.91 MG MG C 301 D 223 ASP C 142 ASP^? 23.76 MG MG C 301 D 265 LYS C 137 LYS^? 35.41 MG MG C 302 coo -38.60 55.38 52.70 -40.06 57.72 53.04 93.44 29.01 -2.85 92.36 29.94 -5.20 coo -29.46 51.67 48.51 -28.63 53.31 49.56 97.94 39.27 -5.03 98.08 38.70 -2.97 coo -18.87 56.53 54.79 -19.47 62.22 53.03 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 1ax4_c07 TRYPTOPHANASE user 30 3 # 30 D 130 PHE D 39 PHE^? 18.22 MG MG D 301 D 223 ASP D 35 ASP^? 16.80 MG MG D 302 D 265 LYS C 61 LYS^? 21.91 MG MG D 302 coo -38.60 55.38 52.70 -40.06 57.72 53.04 99.82 34.37 -37.74 99.04 35.33 -40.24 coo -29.46 51.67 48.51 -28.63 53.31 49.56 93.83 42.00 -33.14 91.74 41.83 -33.51 coo -18.87 56.53 54.79 -19.47 62.22 53.03 93.60 48.56 -24.05 90.39 44.71 -27.98 ULMN 3 1ax4_c07 TRYPTOPHANASE user 31 3 # 31 D 130 PHE D 150 PHE^? 10.21 MG MG D 301 D 223 ASP D 35 ASP^? 16.80 MG MG D 302 D 265 LYS D 90 LYS^? 18.98 MG MG D 302 coo -38.60 55.38 52.70 -40.06 57.72 53.04 91.92 42.74 -45.34 92.24 44.79 -43.44 coo -29.46 51.67 48.51 -28.63 53.31 49.56 93.83 42.00 -33.14 91.74 41.83 -33.51 coo -18.87 56.53 54.79 -19.47 62.22 53.03 79.83 44.38 -31.44 80.32 39.55 -29.40 ULMN 3 1ax4_c07 TRYPTOPHANASE user 32 3 # 32 D 130 PHE D 150 PHE^? 10.21 MG MG D 301 D 223 ASP D 171 ASP^? 16.95 MG MG D 301 D 265 LYS D 166 LYS^? 21.08 MG MG D 301 coo -38.60 55.38 52.70 -40.06 57.72 53.04 91.92 42.74 -45.34 92.24 44.79 -43.44 coo -29.46 51.67 48.51 -28.63 53.31 49.56 100.39 36.69 -43.49 101.13 38.51 -42.69 coo -18.87 56.53 54.79 -19.47 62.22 53.03 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1ax4_c07 TRYPTOPHANASE user 33 3 # 33 D 130 PHE D 153 PHE^? 9.11 MG MG D 302 D 223 ASP D 35 ASP^? 16.80 MG MG D 302 D 265 LYS D 90 LYS^? 18.98 MG MG D 302 coo -38.60 55.38 52.70 -40.06 57.72 53.04 91.67 34.35 -42.71 89.76 36.10 -43.73 coo -29.46 51.67 48.51 -28.63 53.31 49.56 93.83 42.00 -33.14 91.74 41.83 -33.51 coo -18.87 56.53 54.79 -19.47 62.22 53.03 79.83 44.38 -31.44 80.32 39.55 -29.40 ULMN 3 1ax4_c07 TRYPTOPHANASE user 34 3 # 34 D 130 PHE D 161 PHE^? 25.58 MG MG C 302 D 223 ASP C 35 ASP^? 16.42 MG MG C 302 D 265 LYS C 90 LYS^? 18.24 MG MG C 302 coo -38.60 55.38 52.70 -40.06 57.72 53.04 92.97 17.97 -22.91 90.24 17.44 -22.45 coo -29.46 51.67 48.51 -28.63 53.31 49.56 84.40 16.53 -16.68 82.83 17.91 -16.28 coo -18.87 56.53 54.79 -19.47 62.22 53.03 72.37 23.25 -18.94 76.11 26.52 -20.97 ULMN 3 1ax4_c07 TRYPTOPHANASE user 35 3 # 35 D 130 PHE D 164 PHE^? 25.90 MG MG D 302 D 223 ASP D 160 ASP^? 31.45 MG MG C 302 D 265 LYS D 61 LYS^? 21.93 MG MG C 302 coo -38.60 55.38 52.70 -40.06 57.72 53.04 97.06 25.02 -29.96 94.69 25.91 -28.78 coo -29.46 51.67 48.51 -28.63 53.31 49.56 94.15 13.98 -26.57 92.71 12.42 -26.99 coo -18.87 56.53 54.79 -19.47 62.22 53.03 80.64 11.23 -26.16 80.65 16.24 -22.36 ULMN 3 1ax4_c07 TRYPTOPHANASE user 36 3 # 36 D 130 PHE D 164 PHE^? 25.90 MG MG D 302 D 223 ASP D 160 ASP^? 31.45 MG MG C 302 D 265 LYS D 136 LYS^? 34.99 MG MG D 302 coo -38.60 55.38 52.70 -40.06 57.72 53.04 97.06 25.02 -29.96 94.69 25.91 -28.78 coo -29.46 51.67 48.51 -28.63 53.31 49.56 94.15 13.98 -26.57 92.71 12.42 -26.99 coo -18.87 56.53 54.79 -19.47 62.22 53.03 88.96 10.62 -38.53 90.77 6.00 -38.00 ULMN 3 1ax4_c07 TRYPTOPHANASE user 37 3 # 37 D 130 PHE D 164 PHE^? 25.90 MG MG D 302 D 223 ASP D 160 ASP^? 31.45 MG MG C 302 D 265 LYS D 137 LYS^? 37.57 MG MG D 302 coo -38.60 55.38 52.70 -40.06 57.72 53.04 97.06 25.02 -29.96 94.69 25.91 -28.78 coo -29.46 51.67 48.51 -28.63 53.31 49.56 94.15 13.98 -26.57 92.71 12.42 -26.99 coo -18.87 56.53 54.79 -19.47 62.22 53.03 88.48 8.58 -35.33 84.88 3.98 -33.96 ULMN 3 1ax4_c07 TRYPTOPHANASE user 38 3 # 38 D 130 PHE D 172 PHE^? 13.02 MG MG D 301 D 223 ASP D 35 ASP^? 16.80 MG MG D 302 D 265 LYS D 90 LYS^? 18.98 MG MG D 302 coo -38.60 55.38 52.70 -40.06 57.72 53.04 96.36 41.50 -44.84 96.77 43.66 -43.13 coo -29.46 51.67 48.51 -28.63 53.31 49.56 93.83 42.00 -33.14 91.74 41.83 -33.51 coo -18.87 56.53 54.79 -19.47 62.22 53.03 79.83 44.38 -31.44 80.32 39.55 -29.40 ULMN 3 1ax4_c07 TRYPTOPHANASE user 39 3 # 39 D 130 PHE D 190 PHE^? 14.83 MG MG D 301 D 223 ASP D 142 ASP^? 23.49 MG MG D 301 D 265 LYS D 137 LYS^? 37.57 MG MG D 302 coo -38.60 55.38 52.70 -40.06 57.72 53.04 93.52 26.32 -46.94 92.08 26.47 -44.56 coo -29.46 51.67 48.51 -28.63 53.31 49.56 90.90 15.58 -44.76 91.35 16.09 -46.79 coo -18.87 56.53 54.79 -19.47 62.22 53.03 88.48 8.58 -35.33 84.88 3.98 -33.96 ULMN 3 1ax4_c07 TRYPTOPHANASE user 40 3 # 40 D 130 PHE E 39 PHE^? 18.29 MG MG E 301 D 223 ASP E 35 ASP^? 16.91 MG MG E 302 D 265 LYS F 61 LYS^? 21.75 MG MG E 302 coo -38.60 55.38 52.70 -40.06 57.72 53.04 67.23 73.00 -57.46 68.07 72.02 -54.98 coo -29.46 51.67 48.51 -28.63 53.31 49.56 73.60 65.64 -62.00 73.13 63.73 -61.22 coo -18.87 56.53 54.79 -19.47 62.22 53.03 80.24 64.12 -71.01 76.23 61.95 -66.39 ULMN 3 1ax4_c07 TRYPTOPHANASE user 41 3 # 41 D 130 PHE E 150 PHE^? 10.10 MG MG E 301 D 223 ASP E 35 ASP^? 16.91 MG MG E 302 D 265 LYS E 90 LYS^? 19.16 MG MG E 302 coo -38.60 55.38 52.70 -40.06 57.72 53.04 74.01 63.99 -49.53 76.06 63.87 -51.45 coo -29.46 51.67 48.51 -28.63 53.31 49.56 73.60 65.64 -62.00 73.13 63.73 -61.22 coo -18.87 56.53 54.79 -19.47 62.22 53.03 73.81 51.50 -63.18 69.15 52.39 -65.65 ULMN 3 1ax4_c07 TRYPTOPHANASE user 42 3 # 42 D 130 PHE E 150 PHE^? 10.10 MG MG E 301 D 223 ASP E 171 ASP^? 16.73 MG MG E 301 D 265 LYS E 166 LYS^? 21.46 MG MG E 301 coo -38.60 55.38 52.70 -40.06 57.72 53.04 74.01 63.99 -49.53 76.06 63.87 -51.45 coo -29.46 51.67 48.51 -28.63 53.31 49.56 69.61 73.12 -51.56 71.50 73.53 -52.39 coo -18.87 56.53 54.79 -19.47 62.22 53.03 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1ax4_c07 TRYPTOPHANASE user 43 3 # 43 D 130 PHE E 153 PHE^? 9.50 MG MG E 302 D 223 ASP E 35 ASP^? 16.91 MG MG E 302 D 265 LYS E 90 LYS^? 19.16 MG MG E 302 coo -38.60 55.38 52.70 -40.06 57.72 53.04 65.86 64.95 -52.12 67.22 62.73 -51.09 coo -29.46 51.67 48.51 -28.63 53.31 49.56 73.60 65.64 -62.00 73.13 63.73 -61.22 coo -18.87 56.53 54.79 -19.47 62.22 53.03 73.81 51.50 -63.18 69.15 52.39 -65.65 ULMN 3 1ax4_c07 TRYPTOPHANASE user 44 3 # 44 D 130 PHE E 161 PHE^? 25.51 MG MG F 301 D 223 ASP F 35 ASP^? 16.93 MG MG F 301 D 265 LYS F 90 LYS^? 18.57 MG MG F 301 coo -38.60 55.38 52.70 -40.06 57.72 53.04 49.74 68.03 -71.94 48.60 65.47 -72.38 coo -29.46 51.67 48.51 -28.63 53.31 49.56 46.82 60.47 -77.63 48.00 58.79 -78.23 coo -18.87 56.53 54.79 -19.47 62.22 53.03 51.54 47.01 -75.58 55.05 50.31 -73.74 ULMN 3 1ax4_c07 TRYPTOPHANASE user 45 3 # 45 D 130 PHE E 164 PHE^? 25.87 MG MG E 302 D 223 ASP E 160 ASP^? 31.54 MG MG F 301 D 265 LYS E 136 LYS^? 31.27 MG MG E 302 coo -38.60 55.38 52.70 -40.06 57.72 53.04 57.42 71.31 -64.81 57.98 68.84 -66.03 coo -29.46 51.67 48.51 -28.63 53.31 49.56 45.81 70.00 -68.45 44.10 68.87 -67.77 coo -18.87 56.53 54.79 -19.47 62.22 53.03 42.12 65.93 -56.52 39.36 65.07 -51.83 ULMN 3 1ax4_c07 TRYPTOPHANASE user 46 3 # 46 D 130 PHE E 164 PHE^? 25.87 MG MG E 302 D 223 ASP E 160 ASP^? 31.54 MG MG F 301 D 265 LYS E 137 LYS^? 35.26 MG MG E 302 coo -38.60 55.38 52.70 -40.06 57.72 53.04 57.42 71.31 -64.81 57.98 68.84 -66.03 coo -29.46 51.67 48.51 -28.63 53.31 49.56 45.81 70.00 -68.45 44.10 68.87 -67.77 coo -18.87 56.53 54.79 -19.47 62.22 53.03 40.01 66.05 -59.66 36.65 60.99 -60.28 ULMN 3 1ax4_c07 TRYPTOPHANASE user 47 3 # 47 D 130 PHE E 172 PHE^? 12.71 MG MG E 301 D 223 ASP E 35 ASP^? 16.91 MG MG E 302 D 265 LYS E 90 LYS^? 19.16 MG MG E 302 coo -38.60 55.38 52.70 -40.06 57.72 53.04 73.54 68.41 -50.00 75.58 68.36 -51.87 coo -29.46 51.67 48.51 -28.63 53.31 49.56 73.60 65.64 -62.00 73.13 63.73 -61.22 coo -18.87 56.53 54.79 -19.47 62.22 53.03 73.81 51.50 -63.18 69.15 52.39 -65.65 ULMN 3 1ax4_c07 TRYPTOPHANASE user 48 3 # 48 D 130 PHE E 190 PHE^? 14.70 MG MG E 301 D 223 ASP E 142 ASP^? 23.66 MG MG E 301 D 265 LYS E 137 LYS^? 35.26 MG MG E 302 coo -38.60 55.38 52.70 -40.06 57.72 53.04 58.27 67.97 -47.86 58.03 66.58 -50.23 coo -29.46 51.67 48.51 -28.63 53.31 49.56 47.19 67.15 -50.37 47.44 67.18 -48.23 coo -18.87 56.53 54.79 -19.47 62.22 53.03 40.01 66.05 -59.66 36.65 60.99 -60.28 ULMN 3 1ax4_c07 TRYPTOPHANASE user 49 3 # 49 D 130 PHE F 39 PHE^? 17.69 MG MG F 302 D 223 ASP F 35 ASP^? 16.93 MG MG F 301 D 265 LYS E 61 LYS^? 22.16 MG MG F 301 coo -38.60 55.38 52.70 -40.06 57.72 53.04 50.42 69.23 -82.87 49.95 67.86 -85.25 coo -29.46 51.67 48.51 -28.63 53.31 49.56 46.82 60.47 -77.63 48.00 58.79 -78.23 coo -18.87 56.53 54.79 -19.47 62.22 53.03 40.99 56.84 -68.48 45.99 56.72 -72.39 ULMN 3 1ax4_c07 TRYPTOPHANASE user 50 3 # 50 D 130 PHE F 150 PHE^? 9.82 MG MG F 302 D 223 ASP F 35 ASP^? 16.93 MG MG F 301 D 265 LYS F 90 LYS^? 18.57 MG MG F 301 coo -38.60 55.38 52.70 -40.06 57.72 53.04 47.10 57.70 -89.94 45.06 57.27 -88.04 coo -29.46 51.67 48.51 -28.63 53.31 49.56 46.82 60.47 -77.63 48.00 58.79 -78.23 coo -18.87 56.53 54.79 -19.47 62.22 53.03 51.54 47.01 -75.58 55.05 50.31 -73.74 ULMN 3 1ax4_c07 TRYPTOPHANASE user 51 3 # 51 D 130 PHE F 150 PHE^? 9.82 MG MG F 302 D 223 ASP F 171 ASP^? 16.35 MG MG F 302 D 265 LYS F 166 LYS^? 20.76 MG MG F 302 coo -38.60 55.38 52.70 -40.06 57.72 53.04 47.10 57.70 -89.94 45.06 57.27 -88.04 coo -29.46 51.67 48.51 -28.63 53.31 49.56 48.23 68.08 -88.47 46.26 68.02 -87.56 coo -18.87 56.53 54.79 -19.47 62.22 53.03 59.28 73.05 -82.63 55.63 74.15 -86.94 ULMN 3 1ax4_c07 TRYPTOPHANASE user 52 3 # 52 D 130 PHE F 153 PHE^? 9.26 MG MG F 302 D 223 ASP F 35 ASP^? 16.93 MG MG F 301 D 265 LYS F 90 LYS^? 18.57 MG MG F 301 coo -38.60 55.38 52.70 -40.06 57.72 53.04 54.49 61.65 -87.43 53.89 59.08 -88.37 coo -29.46 51.67 48.51 -28.63 53.31 49.56 46.82 60.47 -77.63 48.00 58.79 -78.23 coo -18.87 56.53 54.79 -19.47 62.22 53.03 51.54 47.01 -75.58 55.05 50.31 -73.74 ULMN 3 1ax4_c07 TRYPTOPHANASE user 53 3 # 53 D 130 PHE F 161 PHE^? 25.66 MG MG E 302 D 223 ASP E 35 ASP^? 16.91 MG MG E 302 D 265 LYS E 90 LYS^? 19.16 MG MG E 302 coo -38.60 55.38 52.70 -40.06 57.72 53.04 68.33 71.65 -68.19 70.12 69.57 -67.59 coo -29.46 51.67 48.51 -28.63 53.31 49.56 73.60 65.64 -62.00 73.13 63.73 -61.22 coo -18.87 56.53 54.79 -19.47 62.22 53.03 73.81 51.50 -63.18 69.15 52.39 -65.65 ULMN 3 1ax4_c07 TRYPTOPHANASE user 54 3 # 54 D 130 PHE F 164 PHE^? 26.17 MG MG F 301 D 223 ASP F 160 ASP^? 31.59 MG MG E 302 D 265 LYS F 136 LYS^? 30.53 MG MG F 301 coo -38.60 55.38 52.70 -40.06 57.72 53.04 60.03 71.53 -75.24 60.39 69.25 -73.67 coo -29.46 51.67 48.51 -28.63 53.31 49.56 71.27 74.59 -71.77 73.23 74.02 -72.37 coo -18.87 56.53 54.79 -19.47 62.22 53.03 76.49 71.19 -83.39 78.38 70.88 -88.47 ULMN 3 1ax4_c07 TRYPTOPHANASE user 55 3 # 55 D 130 PHE F 164 PHE^? 26.17 MG MG F 301 D 223 ASP F 160 ASP^? 31.59 MG MG E 302 D 265 LYS F 137 LYS^? 35.13 MG MG F 301 coo -38.60 55.38 52.70 -40.06 57.72 53.04 60.03 71.53 -75.24 60.39 69.25 -73.67 coo -29.46 51.67 48.51 -28.63 53.31 49.56 71.27 74.59 -71.77 73.23 74.02 -72.37 coo -18.87 56.53 54.79 -19.47 62.22 53.03 78.53 72.20 -80.30 83.01 68.64 -79.79 ULMN 3 1ax4_c07 TRYPTOPHANASE user 56 3 # 56 D 130 PHE F 172 PHE^? 12.43 MG MG F 302 D 223 ASP F 35 ASP^? 16.93 MG MG F 301 D 265 LYS F 90 LYS^? 18.57 MG MG F 301 coo -38.60 55.38 52.70 -40.06 57.72 53.04 45.85 62.23 -89.68 43.95 61.55 -87.75 coo -29.46 51.67 48.51 -28.63 53.31 49.56 46.82 60.47 -77.63 48.00 58.79 -78.23 coo -18.87 56.53 54.79 -19.47 62.22 53.03 51.54 47.01 -75.58 55.05 50.31 -73.74 1ax4_c07 source 1ax4 TRYPTOPHANASE : 56 hits 1ax4_c07 naa= 3 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 1 3 # 1 A 140 TRP A 103 TRP^? 29.78 MG MG A 301 A 222 ASP A 58 ASP^? 26.75 MG MG B 302 A 258 LYS A 136 LYS^? 30.58 MG MG A 302 coo 89.83 15.40 0.01 90.61 18.86 1.71 59.99 9.32 29.49 57.09 7.83 27.30 coo 82.92 20.43 2.47 84.82 20.45 1.55 53.93 9.80 21.09 53.83 8.90 19.15 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 50.14 3.36 31.42 51.28 2.21 35.89 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 2 3 # 2 A 140 TRP B 17 TRP^? 23.10 MG MG B 302 A 222 ASP B 35 ASP^? 16.92 MG MG B 302 A 258 LYS A 61 LYS^? 21.99 MG MG B 302 coo 89.83 15.40 0.01 90.61 18.86 1.71 60.58 4.12 10.09 62.84 6.94 11.57 coo 82.92 20.43 2.47 84.82 20.45 1.55 52.63 11.07 10.18 53.68 12.85 9.94 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 57.78 7.35 19.60 56.77 12.20 15.61 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 3 3 # 3 A 140 TRP B 103 TRP^? 29.74 MG MG B 302 A 222 ASP B 58 ASP^? 26.73 MG MG A 301 A 258 LYS B 136 LYS^? 33.75 MG MG B 302 coo 89.83 15.40 0.01 90.61 18.86 1.71 35.60 40.22 7.93 33.65 37.37 9.82 coo 82.92 20.43 2.47 84.82 20.45 1.55 34.42 33.56 15.74 33.50 33.49 17.59 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 28.47 31.35 4.78 24.04 31.81 1.99 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 4 3 # 4 A 140 TRP C 103 TRP^? 29.51 MG MG C 302 A 222 ASP C 58 ASP^? 26.67 MG MG D 302 A 258 LYS C 136 LYS^? 30.63 MG MG C 302 coo 89.83 15.40 0.01 90.61 18.86 1.71 90.16 49.24 -14.37 93.26 47.67 -16.22 coo 82.92 20.43 2.47 84.82 20.45 1.55 93.40 43.81 -22.27 94.18 44.45 -24.11 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 99.75 44.04 -11.38 100.98 45.13 -6.77 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 5 3 # 5 A 140 TRP D 103 TRP^? 29.85 MG MG D 302 A 222 ASP D 58 ASP^? 26.59 MG MG C 302 A 258 LYS D 136 LYS^? 34.99 MG MG D 302 coo 89.83 15.40 0.01 90.61 18.86 1.71 77.64 12.56 -35.88 81.02 12.20 -33.92 coo 82.92 20.43 2.47 84.82 20.45 1.55 83.38 14.85 -27.71 84.09 14.12 -25.85 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 88.96 10.62 -38.53 90.77 6.00 -38.00 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 6 3 # 6 A 140 TRP E 103 TRP^? 29.56 MG MG E 302 A 222 ASP E 58 ASP^? 26.76 MG MG F 301 A 258 LYS E 136 LYS^? 31.27 MG MG E 302 coo 89.83 15.40 0.01 90.61 18.86 1.71 42.03 54.00 -58.74 42.60 57.21 -60.89 coo 82.92 20.43 2.47 84.82 20.45 1.55 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 42.12 65.93 -56.52 39.36 65.07 -51.83 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 7 3 # 7 A 140 TRP F 103 TRP^? 29.78 MG MG F 301 A 222 ASP F 58 ASP^? 26.87 MG MG E 302 A 258 LYS F 136 LYS^? 30.53 MG MG F 301 coo 89.83 15.40 0.01 90.61 18.86 1.71 80.05 60.24 -80.06 79.17 63.82 -78.73 coo 82.92 20.43 2.47 84.82 20.45 1.55 75.55 64.68 -72.56 76.21 65.63 -70.79 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 76.49 71.19 -83.39 78.38 70.88 -88.47 1ay4_c02 source 1ay4 AROMATIC AMINO ACID AMINOTRANSFERASE : 7 hits 1ay4_c02 naa= 3 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 1 3 # 1 B 140 TRP A 103 TRP^? 29.78 MG MG A 301 B 222 ASP A 58 ASP^? 26.75 MG MG B 302 B 258 LYS A 136 LYS^? 30.58 MG MG A 302 coo 103.45 44.39 16.20 102.66 41.02 14.32 59.99 9.32 29.49 57.09 7.83 27.30 coo 110.10 38.66 15.58 108.40 39.41 14.53 53.93 9.80 21.09 53.83 8.90 19.15 coo 107.51 45.54 4.76 105.41 44.51 10.25 50.14 3.36 31.42 51.28 2.21 35.89 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 2 3 # 2 B 140 TRP A 103 TRP^? 29.78 MG MG A 301 B 222 ASP A 58 ASP^? 26.75 MG MG B 302 B 258 LYS A 137 LYS^? 34.85 MG MG A 301 coo 103.45 44.39 16.20 102.66 41.02 14.32 59.99 9.32 29.49 57.09 7.83 27.30 coo 110.10 38.66 15.58 108.40 39.41 14.53 53.93 9.80 21.09 53.83 8.90 19.15 coo 107.51 45.54 4.76 105.41 44.51 10.25 50.97 1.58 28.14 56.13 1.49 28.03 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 3 3 # 3 B 140 TRP B 17 TRP^? 23.10 MG MG B 302 B 222 ASP B 35 ASP^? 16.92 MG MG B 302 B 258 LYS A 61 LYS^? 21.99 MG MG B 302 coo 103.45 44.39 16.20 102.66 41.02 14.32 60.58 4.12 10.09 62.84 6.94 11.57 coo 110.10 38.66 15.58 108.40 39.41 14.53 52.63 11.07 10.18 53.68 12.85 9.94 coo 107.51 45.54 4.76 105.41 44.51 10.25 57.78 7.35 19.60 56.77 12.20 15.61 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 4 3 # 4 B 140 TRP B 103 TRP^? 29.74 MG MG B 302 B 222 ASP B 58 ASP^? 26.73 MG MG A 301 B 258 LYS B 136 LYS^? 33.75 MG MG B 302 coo 103.45 44.39 16.20 102.66 41.02 14.32 35.60 40.22 7.93 33.65 37.37 9.82 coo 110.10 38.66 15.58 108.40 39.41 14.53 34.42 33.56 15.74 33.50 33.49 17.59 coo 107.51 45.54 4.76 105.41 44.51 10.25 28.47 31.35 4.78 24.04 31.81 1.99 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 5 3 # 5 B 140 TRP B 103 TRP^? 29.74 MG MG B 302 B 222 ASP B 58 ASP^? 26.73 MG MG A 301 B 258 LYS B 137 LYS^? 34.56 MG MG B 302 coo 103.45 44.39 16.20 102.66 41.02 14.32 35.60 40.22 7.93 33.65 37.37 9.82 coo 110.10 38.66 15.58 108.40 39.41 14.53 34.42 33.56 15.74 33.50 33.49 17.59 coo 107.51 45.54 4.76 105.41 44.51 10.25 26.56 32.46 7.93 27.87 37.71 9.31 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 6 3 # 6 B 140 TRP C 103 TRP^? 29.51 MG MG C 302 B 222 ASP C 58 ASP^? 26.67 MG MG D 302 B 258 LYS C 136 LYS^? 30.63 MG MG C 302 coo 103.45 44.39 16.20 102.66 41.02 14.32 90.16 49.24 -14.37 93.26 47.67 -16.22 coo 110.10 38.66 15.58 108.40 39.41 14.53 93.40 43.81 -22.27 94.18 44.45 -24.11 coo 107.51 45.54 4.76 105.41 44.51 10.25 99.75 44.04 -11.38 100.98 45.13 -6.77 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 7 3 # 7 B 140 TRP C 103 TRP^? 29.51 MG MG C 302 B 222 ASP C 58 ASP^? 26.67 MG MG D 302 B 258 LYS C 137 LYS^? 35.41 MG MG C 302 coo 103.45 44.39 16.20 102.66 41.02 14.32 90.16 49.24 -14.37 93.26 47.67 -16.22 coo 110.10 38.66 15.58 108.40 39.41 14.53 93.40 43.81 -22.27 94.18 44.45 -24.11 coo 107.51 45.54 4.76 105.41 44.51 10.25 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 8 3 # 8 B 140 TRP D 17 TRP^? 22.77 MG MG D 302 B 222 ASP D 35 ASP^? 16.80 MG MG D 302 B 258 LYS C 61 LYS^? 21.91 MG MG D 302 coo 103.45 44.39 16.20 102.66 41.02 14.32 95.68 52.30 -33.46 91.97 52.85 -32.32 coo 110.10 38.66 15.58 108.40 39.41 14.53 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 107.51 45.54 4.76 105.41 44.51 10.25 93.60 48.56 -24.05 90.39 44.71 -27.98 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 9 3 # 9 B 140 TRP D 103 TRP^? 29.85 MG MG D 302 B 222 ASP D 58 ASP^? 26.59 MG MG C 302 B 258 LYS D 136 LYS^? 34.99 MG MG D 302 coo 103.45 44.39 16.20 102.66 41.02 14.32 77.64 12.56 -35.88 81.02 12.20 -33.92 coo 110.10 38.66 15.58 108.40 39.41 14.53 83.38 14.85 -27.71 84.09 14.12 -25.85 coo 107.51 45.54 4.76 105.41 44.51 10.25 88.96 10.62 -38.53 90.77 6.00 -38.00 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 10 3 # 10 B 140 TRP D 103 TRP^? 29.85 MG MG D 302 B 222 ASP D 58 ASP^? 26.59 MG MG C 302 B 258 LYS D 137 LYS^? 37.57 MG MG D 302 coo 103.45 44.39 16.20 102.66 41.02 14.32 77.64 12.56 -35.88 81.02 12.20 -33.92 coo 110.10 38.66 15.58 108.40 39.41 14.53 83.38 14.85 -27.71 84.09 14.12 -25.85 coo 107.51 45.54 4.76 105.41 44.51 10.25 88.48 8.58 -35.33 84.88 3.98 -33.96 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 11 3 # 11 B 140 TRP E 103 TRP^? 29.56 MG MG E 302 B 222 ASP E 58 ASP^? 26.76 MG MG F 301 B 258 LYS E 136 LYS^? 31.27 MG MG E 302 coo 103.45 44.39 16.20 102.66 41.02 14.32 42.03 54.00 -58.74 42.60 57.21 -60.89 coo 110.10 38.66 15.58 108.40 39.41 14.53 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 107.51 45.54 4.76 105.41 44.51 10.25 42.12 65.93 -56.52 39.36 65.07 -51.83 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 12 3 # 12 B 140 TRP E 103 TRP^? 29.56 MG MG E 302 B 222 ASP E 58 ASP^? 26.76 MG MG F 301 B 258 LYS E 137 LYS^? 35.26 MG MG E 302 coo 103.45 44.39 16.20 102.66 41.02 14.32 42.03 54.00 -58.74 42.60 57.21 -60.89 coo 110.10 38.66 15.58 108.40 39.41 14.53 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 107.51 45.54 4.76 105.41 44.51 10.25 40.01 66.05 -59.66 36.65 60.99 -60.28 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 13 3 # 13 B 140 TRP F 103 TRP^? 29.78 MG MG F 301 B 222 ASP F 58 ASP^? 26.87 MG MG E 302 B 258 LYS F 136 LYS^? 30.53 MG MG F 301 coo 103.45 44.39 16.20 102.66 41.02 14.32 80.05 60.24 -80.06 79.17 63.82 -78.73 coo 110.10 38.66 15.58 108.40 39.41 14.53 75.55 64.68 -72.56 76.21 65.63 -70.79 coo 107.51 45.54 4.76 105.41 44.51 10.25 76.49 71.19 -83.39 78.38 70.88 -88.47 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 14 3 # 14 B 140 TRP F 103 TRP^? 29.78 MG MG F 301 B 222 ASP F 58 ASP^? 26.87 MG MG E 302 B 258 LYS F 137 LYS^? 35.13 MG MG F 301 coo 103.45 44.39 16.20 102.66 41.02 14.32 80.05 60.24 -80.06 79.17 63.82 -78.73 coo 110.10 38.66 15.58 108.40 39.41 14.53 75.55 64.68 -72.56 76.21 65.63 -70.79 coo 107.51 45.54 4.76 105.41 44.51 10.25 78.53 72.20 -80.30 83.01 68.64 -79.79 1ay4_c03 source 1ay4 AROMATIC AMINO ACID AMINOTRANSFERASE : 14 hits 1ay4_c03 naa= 3 ULMN 3 1azw_c00 PROLINE IMINOPEPTIDASE user 1 3 # 1 A 110 SER A 189 SER^? 11.75 MG MG A 302 A 266 ASP A 148 ASP^? 2.72 MG MG A 301s A 294 HIS A 147 HIS^? 9.20 MG MG A 302 coo 32.07 25.76 77.83 34.46 26.05 77.46 40.99 19.00 44.32 41.51 18.14 46.48 coo 33.07 35.01 79.81 33.39 33.02 79.13 41.50 28.88 41.13 43.33 29.67 41.93 coo 35.53 30.26 79.89 34.62 28.71 78.80 40.24 23.10 39.83 38.32 22.34 40.22 ULMN 3 1azw_c00 PROLINE IMINOPEPTIDASE user 2 3 # 2 A 110 SER B 189 SER^? 12.11 MG MG B 301 A 266 ASP B 148 ASP^? 2.58 MG MG B 302s A 294 HIS B 147 HIS^? 9.27 MG MG B 301 coo 32.07 25.76 77.83 34.46 26.05 77.46 43.10 20.95 -7.74 42.82 21.56 -10.02 coo 33.07 35.01 79.81 33.39 33.02 79.13 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 35.53 30.26 79.89 34.62 28.71 78.80 46.73 18.97 -3.05 45.63 17.32 -3.73 ULMN 3 1azw_c00 PROLINE IMINOPEPTIDASE user 3 3 # 3 A 110 SER C 189 SER^? 12.09 MG MG C 301 A 266 ASP C 148 ASP^? 2.75 MG MG C 302s A 294 HIS C 147 HIS^? 9.44 MG MG C 301 coo 32.07 25.76 77.83 34.46 26.05 77.46 90.33 28.79 1.19 90.26 29.61 3.45 coo 33.07 35.01 79.81 33.39 33.02 79.13 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 35.53 30.26 79.89 34.62 28.71 78.80 87.61 25.71 -3.59 89.22 24.50 -2.99 ULMN 3 1azw_c00 PROLINE IMINOPEPTIDASE user 4 3 # 4 A 110 SER D 189 SER^? 12.12 MG MG D 301 A 266 ASP D 148 ASP^? 2.35 MG MG D 302s A 294 HIS D 147 HIS^? 9.43 MG MG D 301 coo 32.07 25.76 77.83 34.46 26.05 77.46 91.62 28.58 -50.95 91.45 27.78 -53.25 coo 33.07 35.01 79.81 33.39 33.02 79.13 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 35.53 30.26 79.89 34.62 28.71 78.80 90.95 32.51 -46.42 92.98 32.42 -46.93 ULMN 3 1azw_c00 PROLINE IMINOPEPTIDASE user 5 3 # 5 A 110 SER D 189 SER^? 12.12 MG MG D 301 A 266 ASP D 187 ASP^? -2.95 MG MG D 301s A 294 HIS D 147 HIS^? 9.43 MG MG D 301 coo 32.07 25.76 77.83 34.46 26.05 77.46 91.62 28.58 -50.95 91.45 27.78 -53.25 coo 33.07 35.01 79.81 33.39 33.02 79.13 90.40 36.34 -52.69 89.24 37.98 -51.99 coo 35.53 30.26 79.89 34.62 28.71 78.80 90.95 32.51 -46.42 92.98 32.42 -46.93 ULMN 3 1azw_c00 PROLINE IMINOPEPTIDASE user 6 3 # 6 A 110 SER E 189 SER^? 11.91 MG MG E 301 A 266 ASP E 148 ASP^? 2.62 MG MG E 302s A 294 HIS E 147 HIS^? 9.22 MG MG E 301 coo 32.07 25.76 77.83 34.46 26.05 77.46 60.13 65.61 -43.87 59.01 65.34 -41.74 coo 33.07 35.01 79.81 33.39 33.02 79.13 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 35.53 30.26 79.89 34.62 28.71 78.80 63.87 64.43 -48.39 64.18 66.45 -47.92 ULMN 3 1azw_c00 PROLINE IMINOPEPTIDASE user 7 3 # 7 A 110 SER F 189 SER^? 11.88 MG MG F 302 A 266 ASP F 148 ASP^? 2.72 MG MG F 301s A 294 HIS F 147 HIS^? 8.79 MG MG F 302 coo 32.07 25.76 77.83 34.46 26.05 77.46 59.91 63.90 -95.91 60.70 64.22 -98.13 coo 33.07 35.01 79.81 33.39 33.02 79.13 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 35.53 30.26 79.89 34.62 28.71 78.80 56.63 61.66 -91.16 55.69 63.43 -91.80 1azw_c00 source 1azw PROLINE IMINOPEPTIDASE : 7 hits 1azw_c00 naa= 3 ULMN 3 1azw_c01 PROLINE IMINOPEPTIDASE user 1 3 # 1 B 110 SER A 189 SER^? 11.75 MG MG A 302 B 266 ASP A 148 ASP^? 2.72 MG MG A 301s B 294 HIS A 147 HIS^? 9.20 MG MG A 302 coo 51.18 33.22 36.61 49.29 31.79 37.02 40.99 19.00 44.32 41.51 18.14 46.48 coo 44.19 39.32 34.54 45.21 37.66 35.38 41.50 28.88 41.13 43.33 29.67 41.93 coo 45.79 34.26 34.63 47.54 33.80 35.70 40.24 23.10 39.83 38.32 22.34 40.22 ULMN 3 1azw_c01 PROLINE IMINOPEPTIDASE user 2 3 # 2 B 110 SER B 189 SER^? 12.11 MG MG B 301 B 266 ASP B 148 ASP^? 2.58 MG MG B 302s B 294 HIS B 147 HIS^? 9.27 MG MG B 301 coo 51.18 33.22 36.61 49.29 31.79 37.02 43.10 20.95 -7.74 42.82 21.56 -10.02 coo 44.19 39.32 34.54 45.21 37.66 35.38 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 45.79 34.26 34.63 47.54 33.80 35.70 46.73 18.97 -3.05 45.63 17.32 -3.73 ULMN 3 1azw_c01 PROLINE IMINOPEPTIDASE user 3 3 # 3 B 110 SER C 189 SER^? 12.09 MG MG C 301 B 266 ASP C 148 ASP^? 2.75 MG MG C 302s B 294 HIS C 147 HIS^? 9.44 MG MG C 301 coo 51.18 33.22 36.61 49.29 31.79 37.02 90.33 28.79 1.19 90.26 29.61 3.45 coo 44.19 39.32 34.54 45.21 37.66 35.38 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 45.79 34.26 34.63 47.54 33.80 35.70 87.61 25.71 -3.59 89.22 24.50 -2.99 ULMN 3 1azw_c01 PROLINE IMINOPEPTIDASE user 4 3 # 4 B 110 SER D 189 SER^? 12.12 MG MG D 301 B 266 ASP D 148 ASP^? 2.35 MG MG D 302s B 294 HIS D 147 HIS^? 9.43 MG MG D 301 coo 51.18 33.22 36.61 49.29 31.79 37.02 91.62 28.58 -50.95 91.45 27.78 -53.25 coo 44.19 39.32 34.54 45.21 37.66 35.38 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 45.79 34.26 34.63 47.54 33.80 35.70 90.95 32.51 -46.42 92.98 32.42 -46.93 ULMN 3 1azw_c01 PROLINE IMINOPEPTIDASE user 5 3 # 5 B 110 SER E 189 SER^? 11.91 MG MG E 301 B 266 ASP E 148 ASP^? 2.62 MG MG E 302s B 294 HIS E 147 HIS^? 9.22 MG MG E 301 coo 51.18 33.22 36.61 49.29 31.79 37.02 60.13 65.61 -43.87 59.01 65.34 -41.74 coo 44.19 39.32 34.54 45.21 37.66 35.38 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 45.79 34.26 34.63 47.54 33.80 35.70 63.87 64.43 -48.39 64.18 66.45 -47.92 ULMN 3 1azw_c01 PROLINE IMINOPEPTIDASE user 6 3 # 6 B 110 SER F 189 SER^? 11.88 MG MG F 302 B 266 ASP F 148 ASP^? 2.72 MG MG F 301s B 294 HIS F 147 HIS^? 8.79 MG MG F 302 coo 51.18 33.22 36.61 49.29 31.79 37.02 59.91 63.90 -95.91 60.70 64.22 -98.13 coo 44.19 39.32 34.54 45.21 37.66 35.38 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 45.79 34.26 34.63 47.54 33.80 35.70 56.63 61.66 -91.16 55.69 63.43 -91.80 1azw_c01 source 1azw PROLINE IMINOPEPTIDASE : 6 hits 1azw_c01 naa= 3 ULMN 3 1b02_c01 THYMIDYLATE SYNTHASE user 1 3 # 1 A 161 CYH A 134 CYH^? 26.26 MG MG A 301 A 192 ASN A 132 ASN^? 16.38 MG MG A 301 A 195 GLN A 144 GLN^? 19.77 MG MG A 302 coo -2.78 50.68 10.78 -4.68 50.49 8.71 50.20 8.98 35.26 50.67 6.53 36.33 coo -0.10 43.44 8.03 -1.33 45.05 7.36 50.16 14.55 39.76 50.61 16.24 40.93 coo 3.53 43.81 4.75 2.30 45.38 4.00 46.49 12.77 42.93 46.53 10.83 42.06 1b02_c01 source 1b02 THYMIDYLATE SYNTHASE : 1 hits 1b02_c01 naa= 3 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 1 3 # 1 A 109 ASP B 58 ASP^? 26.73 MG MG A 301 A 182 GLU A 33 GLU^? 22.87 MG MG A 301 A 286 ASN B 3 ASN^? 29.91 MG MG A 301 coo 26.03 44.66 108.90 25.67 42.61 108.82 34.42 33.56 15.74 33.50 33.49 17.59 coo 18.06 44.02 105.38 18.08 45.37 107.03 33.74 38.67 24.96 34.13 38.85 22.87 coo 25.47 38.28 112.06 27.26 39.30 111.54 28.49 30.55 17.19 26.69 31.26 18.05 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 2 3 # 2 A 109 ASP D 58 ASP^? 26.59 MG MG C 302 A 182 GLU C 33 GLU^? 22.71 MG MG C 302 A 286 ASN D 3 ASN^? 28.85 MG MG C 302 coo 26.03 44.66 108.90 25.67 42.61 108.82 83.38 14.85 -27.71 84.09 14.12 -25.85 coo 18.06 44.02 105.38 18.08 45.37 107.03 78.39 11.67 -18.82 78.34 12.01 -20.91 coo 25.47 38.28 112.06 27.26 39.30 111.54 89.53 11.43 -25.56 88.66 9.94 -24.30 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 3 3 # 3 A 109 ASP E 58 ASP^? 26.76 MG MG F 301 A 182 GLU F 33 GLU^? 22.46 MG MG F 301 A 286 ASN E 3 ASN^? 30.27 MG MG F 301 coo 26.03 44.66 108.90 25.67 42.61 108.82 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 18.06 44.02 105.38 18.08 45.37 107.03 41.88 55.13 -75.91 42.06 54.64 -73.84 coo 25.47 38.28 112.06 27.26 39.30 111.54 42.47 65.36 -68.69 40.59 66.02 -69.39 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 4 3 # 4 A 109 ASP F 58 ASP^? 26.87 MG MG E 302 A 182 GLU E 33 GLU^? 22.81 MG MG E 302 A 286 ASN F 3 ASN^? 30.46 MG MG E 302 coo 26.03 44.66 108.90 25.67 42.61 108.82 75.55 64.68 -72.56 76.21 65.63 -70.79 coo 18.06 44.02 105.38 18.08 45.37 107.03 80.16 62.57 -63.35 80.54 62.13 -65.43 coo 25.47 38.28 112.06 27.26 39.30 111.54 76.18 71.56 -71.39 78.06 72.28 -70.84 1b57_c00 source 1b57 FRUCTOSE-BISPHOSPHATE ALDOLASE II : 4 hits 1b57_c00 naa= 3 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 1 3 # 1 B 109 ASP A 58 ASP^? 26.75 MG MG B 302 B 182 GLU B 33 GLU^? 22.65 MG MG B 302 B 286 ASN A 3 ASN.? 30.14 MG MG B 302 coo 13.82 69.26 132.27 11.87 70.14 132.51 53.93 9.80 21.09 53.83 8.90 19.15 coo 8.74 63.05 136.42 9.87 62.19 134.79 59.88 9.09 12.22 59.91 9.49 14.33 coo 8.26 72.60 129.22 10.14 73.45 129.80 50.04 4.36 19.09 51.05 2.61 18.36 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 2 3 # 2 B 109 ASP B 58 ASP^? 26.73 MG MG A 301 B 182 GLU A 33 GLU^? 22.87 MG MG A 301 B 286 ASN B 3 ASN^? 29.91 MG MG A 301 coo 13.82 69.26 132.27 11.87 70.14 132.51 34.42 33.56 15.74 33.50 33.49 17.59 coo 8.74 63.05 136.42 9.87 62.19 134.79 33.74 38.67 24.96 34.13 38.85 22.87 coo 8.26 72.60 129.22 10.14 73.45 129.80 28.49 30.55 17.19 26.69 31.26 18.05 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 3 3 # 3 B 109 ASP C 58 ASP^? 26.67 MG MG D 302 B 182 GLU D 33 GLU^? 22.23 MG MG D 302 B 286 ASN C 3 ASN^? 29.15 MG MG D 302 coo 13.82 69.26 132.27 11.87 70.14 132.51 93.40 43.81 -22.27 94.18 44.45 -24.11 coo 8.74 63.05 136.42 9.87 62.19 134.79 91.55 48.87 -31.66 91.12 48.92 -29.63 coo 8.26 72.60 129.22 10.14 73.45 129.80 100.26 42.79 -23.94 100.99 44.40 -25.14 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 4 3 # 4 B 109 ASP D 58 ASP^? 26.59 MG MG C 302 B 182 GLU C 33 GLU^? 22.71 MG MG C 302 B 286 ASN D 3 ASN^? 28.85 MG MG C 302 coo 13.82 69.26 132.27 11.87 70.14 132.51 83.38 14.85 -27.71 84.09 14.12 -25.85 coo 8.74 63.05 136.42 9.87 62.19 134.79 78.39 11.67 -18.82 78.34 12.01 -20.91 coo 8.26 72.60 129.22 10.14 73.45 129.80 89.53 11.43 -25.56 88.66 9.94 -24.30 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 5 3 # 5 B 109 ASP E 58 ASP^? 26.76 MG MG F 301 B 182 GLU F 33 GLU^? 22.46 MG MG F 301 B 286 ASN E 3 ASN^? 30.27 MG MG F 301 coo 13.82 69.26 132.27 11.87 70.14 132.51 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 8.74 63.05 136.42 9.87 62.19 134.79 41.88 55.13 -75.91 42.06 54.64 -73.84 coo 8.26 72.60 129.22 10.14 73.45 129.80 42.47 65.36 -68.69 40.59 66.02 -69.39 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 6 3 # 6 B 109 ASP F 58 ASP^? 26.87 MG MG E 302 B 182 GLU E 33 GLU^? 22.81 MG MG E 302 B 286 ASN F 3 ASN^? 30.46 MG MG E 302 coo 13.82 69.26 132.27 11.87 70.14 132.51 75.55 64.68 -72.56 76.21 65.63 -70.79 coo 8.74 63.05 136.42 9.87 62.19 134.79 80.16 62.57 -63.35 80.54 62.13 -65.43 coo 8.26 72.60 129.22 10.14 73.45 129.80 76.18 71.56 -71.39 78.06 72.28 -70.84 1b57_c01 source 1b57 FRUCTOSE-BISPHOSPHATE ALDOLASE II : 6 hits 1b57_c01 naa= 3 ULMN 3 1b5d_c00 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 1 3 # 1 A 148 CYH A 98 CYH^? 20.08 MG MG A 301 A 179 ASP A 100 ASP^? 19.37 MG MG A 301 A 183 GLN A 109 GLN^? 25.68 MG MG A 301 coo 21.87 3.71 21.27 20.32 3.55 23.64 54.28 20.21 31.25 53.90 17.78 30.01 coo 17.09 11.24 20.19 17.85 10.05 21.76 57.94 16.31 36.90 58.41 17.97 38.14 coo 19.54 13.23 15.90 21.64 12.89 15.61 55.18 9.98 36.68 55.20 8.30 38.04 1b5d_c00 source 1b5d DEOXYCYTIDYLATE HYDROXYMETHYLASE : 1 hits 1b5d_c00 naa= 3 ULMN 3 1b5d_c01 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 1 3 # 1 B 148 CYH A 98 CYH^? 20.08 MG MG A 301 B 179 ASP A 100 ASP^? 19.37 MG MG A 301 B 183 GLN A 109 GLN^? 25.68 MG MG A 301 coo 30.30 0.93 3.58 31.01 1.18 0.88 54.28 20.21 31.25 53.90 17.78 30.01 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 57.94 16.31 36.90 58.41 17.97 38.14 coo 24.68 -8.53 5.16 25.68 -8.09 7.00 55.18 9.98 36.68 55.20 8.30 38.04 1b5d_c01 source 1b5d DEOXYCYTIDYLATE HYDROXYMETHYLASE : 1 hits 1b5d_c01 naa= 3 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 1 3 # 1 A 60 GLU A 52 GLU^? 19.89 MG MG A 301 A 148 CYH A 152 CYH^? 15.18 MG MG A 302 A 179 ASP A 35 ASP^? 16.92 MG MG A 301 coo 20.47 15.77 27.32 19.04 14.27 26.94 42.67 25.16 24.80 42.61 25.77 22.75 coo 21.87 3.71 21.27 20.32 3.55 23.64 34.81 26.51 34.70 32.10 26.95 34.06 coo 17.09 11.24 20.19 17.85 10.05 21.76 34.49 31.10 26.54 36.41 31.82 27.10 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 2 3 # 2 A 60 GLU A 146 GLU^? 9.80 MG MG A 302 A 148 CYH A 152 CYH^? 15.18 MG MG A 302 A 179 ASP A 148 ASP^? 2.72 MG MG A 301s coo 20.47 15.77 27.32 19.04 14.27 26.94 45.17 20.35 44.20 46.68 21.21 45.40 coo 21.87 3.71 21.27 20.32 3.55 23.64 34.81 26.51 34.70 32.10 26.95 34.06 coo 17.09 11.24 20.19 17.85 10.05 21.76 41.50 28.88 41.13 43.33 29.67 41.93 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 3 3 # 3 A 60 GLU B 25 GLU^? 12.88 MG MG C 301 A 148 CYH C 152 CYH^? 14.61 MG MG C 301 A 179 ASP C 177 ASP^? 8.84 MG MG C 301 coo 20.47 15.77 27.32 19.04 14.27 26.94 79.57 9.59 -3.08 79.20 11.68 -3.64 coo 21.87 3.71 21.27 20.32 3.55 23.64 87.66 19.43 -8.58 88.77 17.04 -8.78 coo 17.09 11.24 20.19 17.85 10.05 21.76 85.60 16.42 -0.31 86.51 17.71 1.09 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 4 3 # 4 A 60 GLU B 52 GLU^? 20.06 MG MG B 302 A 148 CYH B 152 CYH^? 14.66 MG MG B 301 A 179 ASP B 35 ASP^? 16.92 MG MG B 302 coo 20.47 15.77 27.32 19.04 14.27 26.94 47.87 20.25 12.36 48.11 19.69 14.43 coo 21.87 3.71 21.27 20.32 3.55 23.64 48.74 12.82 1.93 48.51 10.17 2.19 coo 17.09 11.24 20.19 17.85 10.05 21.76 52.63 11.07 10.18 53.68 12.85 9.94 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 5 3 # 5 A 60 GLU B 146 GLU^? 10.54 MG MG B 301 A 148 CYH B 152 CYH^? 14.66 MG MG B 301 A 179 ASP B 148 ASP^? 2.58 MG MG B 302s coo 20.47 15.77 27.32 19.04 14.27 26.94 45.13 24.51 -7.01 46.08 25.99 -8.13 coo 21.87 3.71 21.27 20.32 3.55 23.64 48.74 12.82 1.93 48.51 10.17 2.19 coo 17.09 11.24 20.19 17.85 10.05 21.76 52.73 19.23 -3.77 53.81 20.99 -4.31 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 6 3 # 6 A 60 GLU C 25 GLU^? 12.27 MG MG B 301 A 148 CYH B 152 CYH^? 14.66 MG MG B 301 A 179 ASP B 177 ASP^? 9.03 MG MG B 301 coo 20.47 15.77 27.32 19.04 14.27 26.94 58.50 6.48 -3.59 57.94 8.54 -3.41 coo 21.87 3.71 21.27 20.32 3.55 23.64 48.74 12.82 1.93 48.51 10.17 2.19 coo 17.09 11.24 20.19 17.85 10.05 21.76 51.97 11.04 -6.64 50.39 11.62 -7.94 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 7 3 # 7 A 60 GLU C 52 GLU^? 19.67 MG MG C 302 A 148 CYH C 152 CYH^? 14.61 MG MG C 301 A 179 ASP C 35 ASP^? 16.42 MG MG C 302 coo 20.47 15.77 27.32 19.04 14.27 26.94 84.27 26.98 -19.19 85.21 26.16 -20.96 coo 21.87 3.71 21.27 20.32 3.55 23.64 87.66 19.43 -8.58 88.77 17.04 -8.78 coo 17.09 11.24 20.19 17.85 10.05 21.76 84.40 16.53 -16.68 82.83 17.91 -16.28 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 8 3 # 8 A 60 GLU C 146 GLU^? 10.46 MG MG C 301 A 148 CYH C 152 CYH^? 14.61 MG MG C 301 A 179 ASP C 148 ASP^? 2.75 MG MG C 302s coo 20.47 15.77 27.32 19.04 14.27 26.94 87.01 31.93 0.25 85.57 32.56 1.72 coo 21.87 3.71 21.27 20.32 3.55 23.64 87.66 19.43 -8.58 88.77 17.04 -8.78 coo 17.09 11.24 20.19 17.85 10.05 21.76 81.96 23.83 -2.68 80.24 25.11 -2.27 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 9 3 # 9 A 60 GLU D 25 GLU^? 12.44 MG MG E 301 A 148 CYH E 152 CYH^? 14.64 MG MG E 301 A 179 ASP E 177 ASP^? 8.55 MG MG E 301 coo 20.47 15.77 27.32 19.04 14.27 26.94 81.26 66.22 -47.78 79.52 64.98 -48.06 coo 21.87 3.71 21.27 20.32 3.55 23.64 69.49 67.27 -53.54 71.02 69.50 -54.03 coo 17.09 11.24 20.19 17.85 10.05 21.76 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 10 3 # 10 A 60 GLU D 33 GLU^? 22.23 MG MG D 302 A 148 CYH D 152 CYH^? 14.66 MG MG D 301 A 179 ASP D 35 ASP^? 16.80 MG MG D 302 coo 20.47 15.77 27.32 19.04 14.27 26.94 91.55 48.87 -31.66 91.12 48.92 -29.63 coo 21.87 3.71 21.27 20.32 3.55 23.64 94.69 37.43 -41.36 96.92 38.83 -40.94 coo 17.09 11.24 20.19 17.85 10.05 21.76 93.83 42.00 -33.14 91.74 41.83 -33.51 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 11 3 # 11 A 60 GLU D 146 GLU^? 10.62 MG MG D 301 A 148 CYH D 152 CYH^? 14.66 MG MG D 301 A 179 ASP D 148 ASP^? 2.35 MG MG D 302s coo 20.47 15.77 27.32 19.04 14.27 26.94 87.24 28.82 -50.92 85.47 28.08 -51.67 coo 21.87 3.71 21.27 20.32 3.55 23.64 94.69 37.43 -41.36 96.92 38.83 -40.94 coo 17.09 11.24 20.19 17.85 10.05 21.76 87.78 37.50 -47.56 85.79 37.49 -48.28 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 12 3 # 12 A 60 GLU E 25 GLU^? 12.55 MG MG D 301 A 148 CYH D 152 CYH^? 14.66 MG MG D 301 A 179 ASP D 177 ASP^? 8.43 MG MG D 301 coo 20.47 15.77 27.32 19.04 14.27 26.94 95.44 49.40 -47.17 93.82 48.00 -47.21 coo 21.87 3.71 21.27 20.32 3.55 23.64 94.69 37.43 -41.36 96.92 38.83 -40.94 coo 17.09 11.24 20.19 17.85 10.05 21.76 95.74 41.01 -49.76 94.81 39.90 -51.24 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 13 3 # 13 A 60 GLU E 33 GLU^? 22.81 MG MG E 302 A 148 CYH E 152 CYH^? 14.64 MG MG E 301 A 179 ASP E 35 ASP^? 16.91 MG MG E 302 coo 20.47 15.77 27.32 19.04 14.27 26.94 80.16 62.57 -63.35 80.54 62.13 -65.43 coo 21.87 3.71 21.27 20.32 3.55 23.64 69.49 67.27 -53.54 71.02 69.50 -54.03 coo 17.09 11.24 20.19 17.85 10.05 21.76 73.60 65.64 -62.00 73.13 63.73 -61.22 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 14 3 # 14 A 60 GLU E 52 GLU^? 19.96 MG MG E 302 A 148 CYH E 152 CYH^? 14.64 MG MG E 301 A 179 ASP E 35 ASP^? 16.91 MG MG E 302 coo 20.47 15.77 27.32 19.04 14.27 26.94 64.71 60.06 -63.78 64.69 61.36 -65.58 coo 21.87 3.71 21.27 20.32 3.55 23.64 69.49 67.27 -53.54 71.02 69.50 -54.03 coo 17.09 11.24 20.19 17.85 10.05 21.76 73.60 65.64 -62.00 73.13 63.73 -61.22 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 15 3 # 15 A 60 GLU E 146 GLU^? 10.15 MG MG E 301 A 148 CYH E 152 CYH^? 14.64 MG MG E 301 A 179 ASP E 148 ASP^? 2.62 MG MG E 302s coo 20.47 15.77 27.32 19.04 14.27 26.94 58.72 60.89 -44.51 59.23 60.24 -42.54 coo 21.87 3.71 21.27 20.32 3.55 23.64 69.49 67.27 -53.54 71.02 69.50 -54.03 coo 17.09 11.24 20.19 17.85 10.05 21.76 68.29 60.44 -47.29 68.03 58.42 -46.50 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 16 3 # 16 A 60 GLU F 33 GLU^? 22.46 MG MG F 301 A 148 CYH F 152 CYH^? 14.14 MG MG F 302 A 179 ASP F 35 ASP^? 16.93 MG MG F 301 coo 20.47 15.77 27.32 19.04 14.27 26.94 41.88 55.13 -75.91 42.06 54.64 -73.84 coo 21.87 3.71 21.27 20.32 3.55 23.64 50.28 62.76 -86.08 48.12 64.34 -85.77 coo 17.09 11.24 20.19 17.85 10.05 21.76 46.82 60.47 -77.63 48.00 58.79 -78.23 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 17 3 # 17 A 60 GLU F 52 GLU^? 20.13 MG MG F 301 A 148 CYH F 152 CYH^? 14.14 MG MG F 302 A 179 ASP F 35 ASP^? 16.93 MG MG F 301 coo 20.47 15.77 27.32 19.04 14.27 26.94 57.09 59.62 -75.76 56.76 59.40 -73.62 coo 21.87 3.71 21.27 20.32 3.55 23.64 50.28 62.76 -86.08 48.12 64.34 -85.77 coo 17.09 11.24 20.19 17.85 10.05 21.76 46.82 60.47 -77.63 48.00 58.79 -78.23 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 18 3 # 18 A 60 GLU F 146 GLU^? 10.36 MG MG F 302 A 148 CYH F 152 CYH^? 14.14 MG MG F 302 A 179 ASP F 148 ASP^? 2.72 MG MG F 301s coo 20.47 15.77 27.32 19.04 14.27 26.94 61.95 60.17 -95.28 62.87 58.56 -96.19 coo 21.87 3.71 21.27 20.32 3.55 23.64 50.28 62.76 -86.08 48.12 64.34 -85.77 coo 17.09 11.24 20.19 17.85 10.05 21.76 53.64 56.47 -91.98 54.61 54.68 -92.64 1b5d_c04 source 1b5d DEOXYCYTIDYLATE HYDROXYMETHYLASE : 18 hits 1b5d_c04 naa= 3 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 1 3 # 1 B 60 GLU A 52 GLU^? 19.89 MG MG A 301 B 148 CYH A 152 CYH^? 15.18 MG MG A 302 B 179 ASP A 35 ASP^? 16.92 MG MG A 301 coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 42.67 25.16 24.80 42.61 25.77 22.75 coo 30.30 0.93 3.58 31.01 1.18 0.88 34.81 26.51 34.70 32.10 26.95 34.06 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 34.49 31.10 26.54 36.41 31.82 27.10 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 2 3 # 2 B 60 GLU A 146 GLU^? 9.80 MG MG A 302 B 148 CYH A 152 CYH^? 15.18 MG MG A 302 B 179 ASP A 148 ASP^? 2.72 MG MG A 301s coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 45.17 20.35 44.20 46.68 21.21 45.40 coo 30.30 0.93 3.58 31.01 1.18 0.88 34.81 26.51 34.70 32.10 26.95 34.06 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 41.50 28.88 41.13 43.33 29.67 41.93 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 3 3 # 3 B 60 GLU B 25 GLU^? 12.88 MG MG C 301 B 148 CYH C 152 CYH^? 14.61 MG MG C 301 B 179 ASP C 177 ASP^? 8.84 MG MG C 301 coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 79.57 9.59 -3.08 79.20 11.68 -3.64 coo 30.30 0.93 3.58 31.01 1.18 0.88 87.66 19.43 -8.58 88.77 17.04 -8.78 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 85.60 16.42 -0.31 86.51 17.71 1.09 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 4 3 # 4 B 60 GLU B 52 GLU^? 20.06 MG MG B 302 B 148 CYH B 152 CYH^? 14.66 MG MG B 301 B 179 ASP B 35 ASP^? 16.92 MG MG B 302 coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 47.87 20.25 12.36 48.11 19.69 14.43 coo 30.30 0.93 3.58 31.01 1.18 0.88 48.74 12.82 1.93 48.51 10.17 2.19 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 52.63 11.07 10.18 53.68 12.85 9.94 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 5 3 # 5 B 60 GLU B 146 GLU^? 10.54 MG MG B 301 B 148 CYH B 152 CYH^? 14.66 MG MG B 301 B 179 ASP B 148 ASP^? 2.58 MG MG B 302s coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 45.13 24.51 -7.01 46.08 25.99 -8.13 coo 30.30 0.93 3.58 31.01 1.18 0.88 48.74 12.82 1.93 48.51 10.17 2.19 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 52.73 19.23 -3.77 53.81 20.99 -4.31 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 6 3 # 6 B 60 GLU C 25 GLU^? 12.27 MG MG B 301 B 148 CYH B 152 CYH^? 14.66 MG MG B 301 B 179 ASP B 177 ASP^? 9.03 MG MG B 301 coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 58.50 6.48 -3.59 57.94 8.54 -3.41 coo 30.30 0.93 3.58 31.01 1.18 0.88 48.74 12.82 1.93 48.51 10.17 2.19 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 51.97 11.04 -6.64 50.39 11.62 -7.94 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 7 3 # 7 B 60 GLU C 52 GLU^? 19.67 MG MG C 302 B 148 CYH C 152 CYH^? 14.61 MG MG C 301 B 179 ASP C 35 ASP^? 16.42 MG MG C 302 coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 84.27 26.98 -19.19 85.21 26.16 -20.96 coo 30.30 0.93 3.58 31.01 1.18 0.88 87.66 19.43 -8.58 88.77 17.04 -8.78 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 84.40 16.53 -16.68 82.83 17.91 -16.28 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 8 3 # 8 B 60 GLU C 146 GLU^? 10.46 MG MG C 301 B 148 CYH C 152 CYH^? 14.61 MG MG C 301 B 179 ASP C 148 ASP^? 2.75 MG MG C 302s coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 87.01 31.93 0.25 85.57 32.56 1.72 coo 30.30 0.93 3.58 31.01 1.18 0.88 87.66 19.43 -8.58 88.77 17.04 -8.78 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 81.96 23.83 -2.68 80.24 25.11 -2.27 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 9 3 # 9 B 60 GLU D 25 GLU^? 12.44 MG MG E 301 B 148 CYH E 152 CYH^? 14.64 MG MG E 301 B 179 ASP E 177 ASP^? 8.55 MG MG E 301 coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 81.26 66.22 -47.78 79.52 64.98 -48.06 coo 30.30 0.93 3.58 31.01 1.18 0.88 69.49 67.27 -53.54 71.02 69.50 -54.03 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 10 3 # 10 B 60 GLU D 33 GLU^? 22.23 MG MG D 302 B 148 CYH D 152 CYH^? 14.66 MG MG D 301 B 179 ASP D 35 ASP^? 16.80 MG MG D 302 coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 91.55 48.87 -31.66 91.12 48.92 -29.63 coo 30.30 0.93 3.58 31.01 1.18 0.88 94.69 37.43 -41.36 96.92 38.83 -40.94 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 93.83 42.00 -33.14 91.74 41.83 -33.51 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 11 3 # 11 B 60 GLU D 146 GLU^? 10.62 MG MG D 301 B 148 CYH D 152 CYH^? 14.66 MG MG D 301 B 179 ASP D 148 ASP^? 2.35 MG MG D 302s coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 87.24 28.82 -50.92 85.47 28.08 -51.67 coo 30.30 0.93 3.58 31.01 1.18 0.88 94.69 37.43 -41.36 96.92 38.83 -40.94 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 87.78 37.50 -47.56 85.79 37.49 -48.28 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 12 3 # 12 B 60 GLU E 25 GLU^? 12.55 MG MG D 301 B 148 CYH D 152 CYH^? 14.66 MG MG D 301 B 179 ASP D 177 ASP^? 8.43 MG MG D 301 coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 95.44 49.40 -47.17 93.82 48.00 -47.21 coo 30.30 0.93 3.58 31.01 1.18 0.88 94.69 37.43 -41.36 96.92 38.83 -40.94 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 95.74 41.01 -49.76 94.81 39.90 -51.24 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 13 3 # 13 B 60 GLU E 33 GLU^? 22.81 MG MG E 302 B 148 CYH E 152 CYH^? 14.64 MG MG E 301 B 179 ASP E 35 ASP^? 16.91 MG MG E 302 coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 80.16 62.57 -63.35 80.54 62.13 -65.43 coo 30.30 0.93 3.58 31.01 1.18 0.88 69.49 67.27 -53.54 71.02 69.50 -54.03 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 73.60 65.64 -62.00 73.13 63.73 -61.22 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 14 3 # 14 B 60 GLU E 52 GLU^? 19.96 MG MG E 302 B 148 CYH E 152 CYH^? 14.64 MG MG E 301 B 179 ASP E 35 ASP^? 16.91 MG MG E 302 coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 64.71 60.06 -63.78 64.69 61.36 -65.58 coo 30.30 0.93 3.58 31.01 1.18 0.88 69.49 67.27 -53.54 71.02 69.50 -54.03 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 73.60 65.64 -62.00 73.13 63.73 -61.22 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 15 3 # 15 B 60 GLU E 146 GLU^? 10.15 MG MG E 301 B 148 CYH E 152 CYH^? 14.64 MG MG E 301 B 179 ASP E 148 ASP^? 2.62 MG MG E 302s coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 58.72 60.89 -44.51 59.23 60.24 -42.54 coo 30.30 0.93 3.58 31.01 1.18 0.88 69.49 67.27 -53.54 71.02 69.50 -54.03 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 68.29 60.44 -47.29 68.03 58.42 -46.50 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 16 3 # 16 B 60 GLU F 33 GLU^? 22.46 MG MG F 301 B 148 CYH F 152 CYH^? 14.14 MG MG F 302 B 179 ASP F 35 ASP^? 16.93 MG MG F 301 coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 41.88 55.13 -75.91 42.06 54.64 -73.84 coo 30.30 0.93 3.58 31.01 1.18 0.88 50.28 62.76 -86.08 48.12 64.34 -85.77 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 46.82 60.47 -77.63 48.00 58.79 -78.23 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 17 3 # 17 B 60 GLU F 52 GLU^? 20.13 MG MG F 301 B 148 CYH F 152 CYH^? 14.14 MG MG F 302 B 179 ASP F 35 ASP^? 16.93 MG MG F 301 coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 57.09 59.62 -75.76 56.76 59.40 -73.62 coo 30.30 0.93 3.58 31.01 1.18 0.88 50.28 62.76 -86.08 48.12 64.34 -85.77 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 46.82 60.47 -77.63 48.00 58.79 -78.23 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 18 3 # 18 B 60 GLU F 146 GLU^? 10.36 MG MG F 302 B 148 CYH F 152 CYH^? 14.14 MG MG F 302 B 179 ASP F 148 ASP^? 2.72 MG MG F 301s coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 61.95 60.17 -95.28 62.87 58.56 -96.19 coo 30.30 0.93 3.58 31.01 1.18 0.88 50.28 62.76 -86.08 48.12 64.34 -85.77 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 53.64 56.47 -91.98 54.61 54.68 -92.64 1b5d_c05 source 1b5d DEOXYCYTIDYLATE HYDROXYMETHYLASE : 18 hits 1b5d_c05 naa= 3 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 1 3 # 1 A 133 GLU A 33 GLU^? 22.87 MG MG A 301 B 88 ASP C 148 ASP^? 2.75 MG MG C 302s B 89 HIS C 147 HIS^? 9.44 MG MG C 301 coo 44.53 38.98 5.35 43.53 40.60 6.22 33.74 38.67 24.96 34.13 38.85 22.87 coo 58.74 13.49 55.78 58.72 14.38 57.67 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 60.89 12.20 60.42 60.43 13.81 61.68 87.61 25.71 -3.59 89.22 24.50 -2.99 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 2 3 # 2 A 133 GLU A 75 GLU^? 20.23 MG MG A 301 B 88 ASP C 148 ASP^? 2.75 MG MG C 302s B 89 HIS C 147 HIS^? 9.44 MG MG C 301 coo 44.53 38.98 5.35 43.53 40.60 6.22 38.99 46.65 28.68 39.94 47.65 30.33 coo 58.74 13.49 55.78 58.72 14.38 57.67 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 60.89 12.20 60.42 60.43 13.81 61.68 87.61 25.71 -3.59 89.22 24.50 -2.99 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 3 3 # 3 A 133 GLU A 146 GLU^? 9.80 MG MG A 302 B 88 ASP C 148 ASP^? 2.75 MG MG C 302s B 89 HIS C 147 HIS^? 9.44 MG MG C 301 coo 44.53 38.98 5.35 43.53 40.60 6.22 45.17 20.35 44.20 46.68 21.21 45.40 coo 58.74 13.49 55.78 58.72 14.38 57.67 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 60.89 12.20 60.42 60.43 13.81 61.68 87.61 25.71 -3.59 89.22 24.50 -2.99 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 4 3 # 4 A 133 GLU A 154 GLU^? 19.22 MG MG A 301 B 88 ASP C 177 ASP^? 8.84 MG MG C 301 B 89 HIS C 170 HIS^? 10.68 MG MG C 301 coo 44.53 38.98 5.35 43.53 40.60 6.22 36.54 21.95 29.78 35.14 22.21 28.17 coo 58.74 13.49 55.78 58.72 14.38 57.67 85.60 16.42 -0.31 86.51 17.71 1.09 coo 60.89 12.20 60.42 60.43 13.81 61.68 89.96 21.05 -3.85 88.74 19.88 -2.61 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 5 3 # 5 A 133 GLU A 165 GLU^? 29.56 MG MG A 302 B 88 ASP C 148 ASP^? 2.75 MG MG C 302s B 89 HIS C 147 HIS^? 9.44 MG MG C 301 coo 44.53 38.98 5.35 43.53 40.60 6.22 36.12 8.31 27.27 37.25 6.55 27.60 coo 58.74 13.49 55.78 58.72 14.38 57.67 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 60.89 12.20 60.42 60.43 13.81 61.68 87.61 25.71 -3.59 89.22 24.50 -2.99 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 6 3 # 6 A 133 GLU A 165 GLU^? 29.56 MG MG A 302 B 88 ASP C 177 ASP^? 8.84 MG MG C 301 B 89 HIS C 170 HIS^? 10.68 MG MG C 301 coo 44.53 38.98 5.35 43.53 40.60 6.22 36.12 8.31 27.27 37.25 6.55 27.60 coo 58.74 13.49 55.78 58.72 14.38 57.67 85.60 16.42 -0.31 86.51 17.71 1.09 coo 60.89 12.20 60.42 60.43 13.81 61.68 89.96 21.05 -3.85 88.74 19.88 -2.61 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 7 3 # 7 A 133 GLU C 33 GLU^? 22.71 MG MG C 302 B 88 ASP E 148 ASP^? 2.62 MG MG E 302s B 89 HIS E 147 HIS^? 9.22 MG MG E 301 coo 44.53 38.98 5.35 43.53 40.60 6.22 78.39 11.67 -18.82 78.34 12.01 -20.91 coo 58.74 13.49 55.78 58.72 14.38 57.67 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 60.89 12.20 60.42 60.43 13.81 61.68 63.87 64.43 -48.39 64.18 66.45 -47.92 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 8 3 # 8 A 133 GLU C 75 GLU^? 16.14 MG MG B 301 B 88 ASP E 148 ASP^? 2.62 MG MG E 302s B 89 HIS E 147 HIS^? 9.22 MG MG E 301 coo 44.53 38.98 5.35 43.53 40.60 6.22 69.49 12.18 -14.30 67.44 12.65 -13.83 coo 58.74 13.49 55.78 58.72 14.38 57.67 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 60.89 12.20 60.42 60.43 13.81 61.68 63.87 64.43 -48.39 64.18 66.45 -47.92 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 9 3 # 9 A 133 GLU C 146 GLU^? 10.46 MG MG C 301 B 88 ASP E 148 ASP^? 2.62 MG MG E 302s B 89 HIS E 147 HIS^? 9.22 MG MG E 301 coo 44.53 38.98 5.35 43.53 40.60 6.22 87.01 31.93 0.25 85.57 32.56 1.72 coo 58.74 13.49 55.78 58.72 14.38 57.67 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 60.89 12.20 60.42 60.43 13.81 61.68 63.87 64.43 -48.39 64.18 66.45 -47.92 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 10 3 # 10 A 133 GLU C 146 GLU^? 10.46 MG MG C 301 B 88 ASP E 177 ASP^? 8.55 MG MG E 301 B 89 HIS E 170 HIS^? 10.33 MG MG E 301 coo 44.53 38.98 5.35 43.53 40.60 6.22 87.01 31.93 0.25 85.57 32.56 1.72 coo 58.74 13.49 55.78 58.72 14.38 57.67 72.81 67.32 -45.03 71.14 67.96 -43.95 coo 60.89 12.20 60.42 60.43 13.81 61.68 66.96 68.76 -48.87 68.36 68.54 -47.33 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 11 3 # 11 A 133 GLU C 154 GLU^? 18.91 MG MG C 302 B 88 ASP E 177 ASP^? 8.55 MG MG E 301 B 89 HIS E 170 HIS^? 10.33 MG MG E 301 coo 44.53 38.98 5.35 43.53 40.60 6.22 91.15 23.27 -13.33 91.61 21.91 -14.95 coo 58.74 13.49 55.78 58.72 14.38 57.67 72.81 67.32 -45.03 71.14 67.96 -43.95 coo 60.89 12.20 60.42 60.43 13.81 61.68 66.96 68.76 -48.87 68.36 68.54 -47.33 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 12 3 # 12 A 133 GLU C 165 GLU^? 29.32 MG MG C 302 B 88 ASP E 148 ASP^? 2.62 MG MG E 302s B 89 HIS E 147 HIS^? 9.22 MG MG E 301 coo 44.53 38.98 5.35 43.53 40.60 6.22 103.18 29.99 -15.18 103.57 32.09 -14.86 coo 58.74 13.49 55.78 58.72 14.38 57.67 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 60.89 12.20 60.42 60.43 13.81 61.68 63.87 64.43 -48.39 64.18 66.45 -47.92 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 13 3 # 13 A 133 GLU C 165 GLU^? 29.32 MG MG C 302 B 88 ASP E 177 ASP^? 8.55 MG MG E 301 B 89 HIS E 170 HIS^? 10.33 MG MG E 301 coo 44.53 38.98 5.35 43.53 40.60 6.22 103.18 29.99 -15.18 103.57 32.09 -14.86 coo 58.74 13.49 55.78 58.72 14.38 57.67 72.81 67.32 -45.03 71.14 67.96 -43.95 coo 60.89 12.20 60.42 60.43 13.81 61.68 66.96 68.76 -48.87 68.36 68.54 -47.33 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 14 3 # 14 A 133 GLU D 75 GLU^? 15.53 MG MG E 301 B 88 ASP B 148 ASP^? 2.58 MG MG B 302s B 89 HIS B 147 HIS^? 9.27 MG MG B 301 coo 44.53 38.98 5.35 43.53 40.60 6.22 84.53 54.81 -36.40 82.75 56.01 -36.42 coo 58.74 13.49 55.78 58.72 14.38 57.67 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 60.89 12.20 60.42 60.43 13.81 61.68 46.73 18.97 -3.05 45.63 17.32 -3.73 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 15 3 # 15 A 133 GLU D 146 GLU^? 10.62 MG MG D 301 B 88 ASP B 148 ASP^? 2.58 MG MG B 302s B 89 HIS B 147 HIS^? 9.27 MG MG B 301 coo 44.53 38.98 5.35 43.53 40.60 6.22 87.24 28.82 -50.92 85.47 28.08 -51.67 coo 58.74 13.49 55.78 58.72 14.38 57.67 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 60.89 12.20 60.42 60.43 13.81 61.68 46.73 18.97 -3.05 45.63 17.32 -3.73 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 16 3 # 16 A 133 GLU D 165 GLU^? 29.85 MG MG D 302 B 88 ASP B 148 ASP^? 2.58 MG MG B 302s B 89 HIS B 147 HIS^? 9.27 MG MG B 301 coo 44.53 38.98 5.35 43.53 40.60 6.22 100.60 20.11 -34.27 100.38 17.96 -34.49 coo 58.74 13.49 55.78 58.72 14.38 57.67 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 60.89 12.20 60.42 60.43 13.81 61.68 46.73 18.97 -3.05 45.63 17.32 -3.73 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 17 3 # 17 A 133 GLU F 33 GLU^? 22.46 MG MG F 301 B 88 ASP D 148 ASP^? 2.35 MG MG D 302s B 89 HIS D 147 HIS^? 9.43 MG MG D 301 coo 44.53 38.98 5.35 43.53 40.60 6.22 41.88 55.13 -75.91 42.06 54.64 -73.84 coo 58.74 13.49 55.78 58.72 14.38 57.67 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 60.89 12.20 60.42 60.43 13.81 61.68 90.95 32.51 -46.42 92.98 32.42 -46.93 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 18 3 # 18 A 133 GLU F 75 GLU^? 19.96 MG MG F 301 B 88 ASP D 148 ASP^? 2.35 MG MG D 302s B 89 HIS D 147 HIS^? 9.43 MG MG D 301 coo 44.53 38.98 5.35 43.53 40.60 6.22 40.19 46.06 -80.81 40.09 43.94 -81.24 coo 58.74 13.49 55.78 58.72 14.38 57.67 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 60.89 12.20 60.42 60.43 13.81 61.68 90.95 32.51 -46.42 92.98 32.42 -46.93 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 19 3 # 19 A 133 GLU F 146 GLU^? 10.36 MG MG F 302 B 88 ASP D 148 ASP^? 2.35 MG MG D 302s B 89 HIS D 147 HIS^? 9.43 MG MG D 301 coo 44.53 38.98 5.35 43.53 40.60 6.22 61.95 60.17 -95.28 62.87 58.56 -96.19 coo 58.74 13.49 55.78 58.72 14.38 57.67 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 60.89 12.20 60.42 60.43 13.81 61.68 90.95 32.51 -46.42 92.98 32.42 -46.93 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 20 3 # 20 A 133 GLU F 146 GLU^? 10.36 MG MG F 302 B 88 ASP D 177 ASP^? 8.43 MG MG D 301 B 89 HIS D 170 HIS^? 10.59 MG MG D 301 coo 44.53 38.98 5.35 43.53 40.60 6.22 61.95 60.17 -95.28 62.87 58.56 -96.19 coo 58.74 13.49 55.78 58.72 14.38 57.67 95.74 41.01 -49.76 94.81 39.90 -51.24 coo 60.89 12.20 60.42 60.43 13.81 61.68 95.57 34.81 -46.05 95.59 36.24 -47.59 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 21 3 # 21 A 133 GLU F 154 GLU^? 18.97 MG MG F 301 B 88 ASP D 177 ASP^? 8.43 MG MG D 301 B 89 HIS D 170 HIS^? 10.59 MG MG D 301 coo 44.53 38.98 5.35 43.53 40.60 6.22 54.57 65.67 -81.55 53.36 66.51 -80.09 coo 58.74 13.49 55.78 58.72 14.38 57.67 95.74 41.01 -49.76 94.81 39.90 -51.24 coo 60.89 12.20 60.42 60.43 13.81 61.68 95.57 34.81 -46.05 95.59 36.24 -47.59 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 22 3 # 22 A 133 GLU F 165 GLU^? 29.11 MG MG F 302 B 88 ASP D 177 ASP^? 8.43 MG MG D 301 B 89 HIS D 170 HIS^? 10.59 MG MG D 301 coo 44.53 38.98 5.35 43.53 40.60 6.22 63.01 76.49 -79.50 64.84 77.22 -80.35 coo 58.74 13.49 55.78 58.72 14.38 57.67 95.74 41.01 -49.76 94.81 39.90 -51.24 coo 60.89 12.20 60.42 60.43 13.81 61.68 95.57 34.81 -46.05 95.59 36.24 -47.59 1b66_c00 source 1b66 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASE : 22 hits 1b66_c00 naa= 3 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 1 3 # 1 A 133 GLU A 33 GLU^? 22.87 MG MG A 301 B 88 ASP C 148 ASP^? 2.75 MG MG C 302s B 89 HIS C 147 HIS^? 9.44 MG MG C 301 coo 44.53 38.98 5.35 43.53 40.60 6.22 33.74 38.67 24.96 34.13 38.85 22.87 coo 58.74 13.49 55.78 58.72 14.38 57.67 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 60.89 12.20 60.42 60.43 13.81 61.68 87.61 25.71 -3.59 89.22 24.50 -2.99 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 2 3 # 2 A 133 GLU A 75 GLU^? 20.23 MG MG A 301 B 88 ASP C 148 ASP^? 2.75 MG MG C 302s B 89 HIS C 147 HIS^? 9.44 MG MG C 301 coo 44.53 38.98 5.35 43.53 40.60 6.22 38.99 46.65 28.68 39.94 47.65 30.33 coo 58.74 13.49 55.78 58.72 14.38 57.67 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 60.89 12.20 60.42 60.43 13.81 61.68 87.61 25.71 -3.59 89.22 24.50 -2.99 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 3 3 # 3 A 133 GLU A 146 GLU^? 9.80 MG MG A 302 B 88 ASP C 148 ASP^? 2.75 MG MG C 302s B 89 HIS C 147 HIS^? 9.44 MG MG C 301 coo 44.53 38.98 5.35 43.53 40.60 6.22 45.17 20.35 44.20 46.68 21.21 45.40 coo 58.74 13.49 55.78 58.72 14.38 57.67 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 60.89 12.20 60.42 60.43 13.81 61.68 87.61 25.71 -3.59 89.22 24.50 -2.99 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 4 3 # 4 A 133 GLU A 154 GLU^? 19.22 MG MG A 301 B 88 ASP C 177 ASP^? 8.84 MG MG C 301 B 89 HIS C 170 HIS^? 10.68 MG MG C 301 coo 44.53 38.98 5.35 43.53 40.60 6.22 36.54 21.95 29.78 35.14 22.21 28.17 coo 58.74 13.49 55.78 58.72 14.38 57.67 85.60 16.42 -0.31 86.51 17.71 1.09 coo 60.89 12.20 60.42 60.43 13.81 61.68 89.96 21.05 -3.85 88.74 19.88 -2.61 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 5 3 # 5 A 133 GLU A 165 GLU^? 29.56 MG MG A 302 B 88 ASP C 148 ASP^? 2.75 MG MG C 302s B 89 HIS C 147 HIS^? 9.44 MG MG C 301 coo 44.53 38.98 5.35 43.53 40.60 6.22 36.12 8.31 27.27 37.25 6.55 27.60 coo 58.74 13.49 55.78 58.72 14.38 57.67 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 60.89 12.20 60.42 60.43 13.81 61.68 87.61 25.71 -3.59 89.22 24.50 -2.99 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 6 3 # 6 A 133 GLU A 165 GLU^? 29.56 MG MG A 302 B 88 ASP C 177 ASP^? 8.84 MG MG C 301 B 89 HIS C 170 HIS^? 10.68 MG MG C 301 coo 44.53 38.98 5.35 43.53 40.60 6.22 36.12 8.31 27.27 37.25 6.55 27.60 coo 58.74 13.49 55.78 58.72 14.38 57.67 85.60 16.42 -0.31 86.51 17.71 1.09 coo 60.89 12.20 60.42 60.43 13.81 61.68 89.96 21.05 -3.85 88.74 19.88 -2.61 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 7 3 # 7 A 133 GLU C 33 GLU^? 22.71 MG MG C 302 B 88 ASP E 148 ASP^? 2.62 MG MG E 302s B 89 HIS E 147 HIS^? 9.22 MG MG E 301 coo 44.53 38.98 5.35 43.53 40.60 6.22 78.39 11.67 -18.82 78.34 12.01 -20.91 coo 58.74 13.49 55.78 58.72 14.38 57.67 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 60.89 12.20 60.42 60.43 13.81 61.68 63.87 64.43 -48.39 64.18 66.45 -47.92 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 8 3 # 8 A 133 GLU C 75 GLU^? 16.14 MG MG B 301 B 88 ASP E 148 ASP^? 2.62 MG MG E 302s B 89 HIS E 147 HIS^? 9.22 MG MG E 301 coo 44.53 38.98 5.35 43.53 40.60 6.22 69.49 12.18 -14.30 67.44 12.65 -13.83 coo 58.74 13.49 55.78 58.72 14.38 57.67 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 60.89 12.20 60.42 60.43 13.81 61.68 63.87 64.43 -48.39 64.18 66.45 -47.92 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 9 3 # 9 A 133 GLU C 146 GLU^? 10.46 MG MG C 301 B 88 ASP E 148 ASP^? 2.62 MG MG E 302s B 89 HIS E 147 HIS^? 9.22 MG MG E 301 coo 44.53 38.98 5.35 43.53 40.60 6.22 87.01 31.93 0.25 85.57 32.56 1.72 coo 58.74 13.49 55.78 58.72 14.38 57.67 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 60.89 12.20 60.42 60.43 13.81 61.68 63.87 64.43 -48.39 64.18 66.45 -47.92 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 10 3 # 10 A 133 GLU C 146 GLU^? 10.46 MG MG C 301 B 88 ASP E 177 ASP^? 8.55 MG MG E 301 B 89 HIS E 170 HIS^? 10.33 MG MG E 301 coo 44.53 38.98 5.35 43.53 40.60 6.22 87.01 31.93 0.25 85.57 32.56 1.72 coo 58.74 13.49 55.78 58.72 14.38 57.67 72.81 67.32 -45.03 71.14 67.96 -43.95 coo 60.89 12.20 60.42 60.43 13.81 61.68 66.96 68.76 -48.87 68.36 68.54 -47.33 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 11 3 # 11 A 133 GLU C 154 GLU^? 18.91 MG MG C 302 B 88 ASP E 177 ASP^? 8.55 MG MG E 301 B 89 HIS E 170 HIS^? 10.33 MG MG E 301 coo 44.53 38.98 5.35 43.53 40.60 6.22 91.15 23.27 -13.33 91.61 21.91 -14.95 coo 58.74 13.49 55.78 58.72 14.38 57.67 72.81 67.32 -45.03 71.14 67.96 -43.95 coo 60.89 12.20 60.42 60.43 13.81 61.68 66.96 68.76 -48.87 68.36 68.54 -47.33 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 12 3 # 12 A 133 GLU C 165 GLU^? 29.32 MG MG C 302 B 88 ASP E 148 ASP^? 2.62 MG MG E 302s B 89 HIS E 147 HIS^? 9.22 MG MG E 301 coo 44.53 38.98 5.35 43.53 40.60 6.22 103.18 29.99 -15.18 103.57 32.09 -14.86 coo 58.74 13.49 55.78 58.72 14.38 57.67 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 60.89 12.20 60.42 60.43 13.81 61.68 63.87 64.43 -48.39 64.18 66.45 -47.92 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 13 3 # 13 A 133 GLU C 165 GLU^? 29.32 MG MG C 302 B 88 ASP E 177 ASP^? 8.55 MG MG E 301 B 89 HIS E 170 HIS^? 10.33 MG MG E 301 coo 44.53 38.98 5.35 43.53 40.60 6.22 103.18 29.99 -15.18 103.57 32.09 -14.86 coo 58.74 13.49 55.78 58.72 14.38 57.67 72.81 67.32 -45.03 71.14 67.96 -43.95 coo 60.89 12.20 60.42 60.43 13.81 61.68 66.96 68.76 -48.87 68.36 68.54 -47.33 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 14 3 # 14 A 133 GLU D 75 GLU^? 15.53 MG MG E 301 B 88 ASP B 148 ASP^? 2.58 MG MG B 302s B 89 HIS B 147 HIS^? 9.27 MG MG B 301 coo 44.53 38.98 5.35 43.53 40.60 6.22 84.53 54.81 -36.40 82.75 56.01 -36.42 coo 58.74 13.49 55.78 58.72 14.38 57.67 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 60.89 12.20 60.42 60.43 13.81 61.68 46.73 18.97 -3.05 45.63 17.32 -3.73 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 15 3 # 15 A 133 GLU D 146 GLU^? 10.62 MG MG D 301 B 88 ASP B 148 ASP^? 2.58 MG MG B 302s B 89 HIS B 147 HIS^? 9.27 MG MG B 301 coo 44.53 38.98 5.35 43.53 40.60 6.22 87.24 28.82 -50.92 85.47 28.08 -51.67 coo 58.74 13.49 55.78 58.72 14.38 57.67 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 60.89 12.20 60.42 60.43 13.81 61.68 46.73 18.97 -3.05 45.63 17.32 -3.73 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 16 3 # 16 A 133 GLU D 165 GLU^? 29.85 MG MG D 302 B 88 ASP B 148 ASP^? 2.58 MG MG B 302s B 89 HIS B 147 HIS^? 9.27 MG MG B 301 coo 44.53 38.98 5.35 43.53 40.60 6.22 100.60 20.11 -34.27 100.38 17.96 -34.49 coo 58.74 13.49 55.78 58.72 14.38 57.67 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 60.89 12.20 60.42 60.43 13.81 61.68 46.73 18.97 -3.05 45.63 17.32 -3.73 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 17 3 # 17 A 133 GLU F 33 GLU^? 22.46 MG MG F 301 B 88 ASP D 148 ASP^? 2.35 MG MG D 302s B 89 HIS D 147 HIS^? 9.43 MG MG D 301 coo 44.53 38.98 5.35 43.53 40.60 6.22 41.88 55.13 -75.91 42.06 54.64 -73.84 coo 58.74 13.49 55.78 58.72 14.38 57.67 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 60.89 12.20 60.42 60.43 13.81 61.68 90.95 32.51 -46.42 92.98 32.42 -46.93 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 18 3 # 18 A 133 GLU F 75 GLU^? 19.96 MG MG F 301 B 88 ASP D 148 ASP^? 2.35 MG MG D 302s B 89 HIS D 147 HIS^? 9.43 MG MG D 301 coo 44.53 38.98 5.35 43.53 40.60 6.22 40.19 46.06 -80.81 40.09 43.94 -81.24 coo 58.74 13.49 55.78 58.72 14.38 57.67 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 60.89 12.20 60.42 60.43 13.81 61.68 90.95 32.51 -46.42 92.98 32.42 -46.93 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 19 3 # 19 A 133 GLU F 146 GLU^? 10.36 MG MG F 302 B 88 ASP D 148 ASP^? 2.35 MG MG D 302s B 89 HIS D 147 HIS^? 9.43 MG MG D 301 coo 44.53 38.98 5.35 43.53 40.60 6.22 61.95 60.17 -95.28 62.87 58.56 -96.19 coo 58.74 13.49 55.78 58.72 14.38 57.67 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 60.89 12.20 60.42 60.43 13.81 61.68 90.95 32.51 -46.42 92.98 32.42 -46.93 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 20 3 # 20 A 133 GLU F 146 GLU^? 10.36 MG MG F 302 B 88 ASP D 177 ASP^? 8.43 MG MG D 301 B 89 HIS D 170 HIS^? 10.59 MG MG D 301 coo 44.53 38.98 5.35 43.53 40.60 6.22 61.95 60.17 -95.28 62.87 58.56 -96.19 coo 58.74 13.49 55.78 58.72 14.38 57.67 95.74 41.01 -49.76 94.81 39.90 -51.24 coo 60.89 12.20 60.42 60.43 13.81 61.68 95.57 34.81 -46.05 95.59 36.24 -47.59 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 21 3 # 21 A 133 GLU F 154 GLU^? 18.97 MG MG F 301 B 88 ASP D 177 ASP^? 8.43 MG MG D 301 B 89 HIS D 170 HIS^? 10.59 MG MG D 301 coo 44.53 38.98 5.35 43.53 40.60 6.22 54.57 65.67 -81.55 53.36 66.51 -80.09 coo 58.74 13.49 55.78 58.72 14.38 57.67 95.74 41.01 -49.76 94.81 39.90 -51.24 coo 60.89 12.20 60.42 60.43 13.81 61.68 95.57 34.81 -46.05 95.59 36.24 -47.59 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 22 3 # 22 A 133 GLU F 165 GLU^? 29.11 MG MG F 302 B 88 ASP D 177 ASP^? 8.43 MG MG D 301 B 89 HIS D 170 HIS^? 10.59 MG MG D 301 coo 44.53 38.98 5.35 43.53 40.60 6.22 63.01 76.49 -79.50 64.84 77.22 -80.35 coo 58.74 13.49 55.78 58.72 14.38 57.67 95.74 41.01 -49.76 94.81 39.90 -51.24 coo 60.89 12.20 60.42 60.43 13.81 61.68 95.57 34.81 -46.05 95.59 36.24 -47.59 1b66_c02 source 1b66 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASE : 22 hits 1b66_c02 naa= 3 ULMN 3 1b6g_c00 HALOALKANE DEHALOGENASE user 1 3 # 1 124 ASP A 171 ASP^? 17.17 MG MG A 302 260 ASP A 177 ASP^? 8.44 MG MG A 302 289 HIS A 170 HIS^? 10.56 MG MG A 302 coo 30.43 27.27 28.31 29.04 28.69 29.00 29.78 23.67 36.63 28.48 25.11 35.71 coo 34.79 33.03 22.11 33.47 32.83 23.76 33.02 29.04 43.18 33.79 27.88 44.78 coo 30.83 30.57 23.91 30.62 30.06 25.92 34.91 23.57 39.32 34.35 24.95 40.81 ULMN 3 1b6g_c00 HALOALKANE DEHALOGENASE user 2 3 # 2 124 ASP A 177 ASP^? 8.44 MG MG A 302 260 ASP A 171 ASP^? 17.17 MG MG A 302 289 HIS A 170 HIS^? 10.56 MG MG A 302 coo 30.43 27.27 28.31 29.04 28.69 29.00 33.02 29.04 43.18 33.79 27.88 44.78 coo 34.79 33.03 22.11 33.47 32.83 23.76 29.78 23.67 36.63 28.48 25.11 35.71 coo 30.83 30.57 23.91 30.62 30.06 25.92 34.91 23.57 39.32 34.35 24.95 40.81 ULMN 3 1b6g_c00 HALOALKANE DEHALOGENASE user 3 3 # 3 124 ASP B 177 ASP^? 9.03 MG MG B 301 260 ASP B 171 ASP^? 16.92 MG MG B 301 289 HIS B 170 HIS^? 10.51 MG MG B 301 coo 30.43 27.27 28.31 29.04 28.69 29.00 51.97 11.04 -6.64 50.39 11.62 -7.94 coo 34.79 33.03 22.11 33.47 32.83 23.76 45.30 8.50 -0.71 46.30 6.81 0.12 coo 30.83 30.57 23.91 30.62 30.06 25.92 46.22 13.75 -2.72 47.53 13.11 -4.24 ULMN 3 1b6g_c00 HALOALKANE DEHALOGENASE user 4 3 # 4 124 ASP C 177 ASP^? 8.84 MG MG C 301 260 ASP C 171 ASP^? 17.08 MG MG C 301 289 HIS C 170 HIS^? 10.68 MG MG C 301 coo 30.43 27.27 28.31 29.04 28.69 29.00 85.60 16.42 -0.31 86.51 17.71 1.09 coo 34.79 33.03 22.11 33.47 32.83 23.76 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 30.83 30.57 23.91 30.62 30.06 25.92 89.96 21.05 -3.85 88.74 19.88 -2.61 ULMN 3 1b6g_c00 HALOALKANE DEHALOGENASE user 5 3 # 5 124 ASP D 177 ASP^? 8.43 MG MG D 301 260 ASP D 171 ASP^? 16.95 MG MG D 301 289 HIS D 170 HIS^? 10.59 MG MG D 301 coo 30.43 27.27 28.31 29.04 28.69 29.00 95.74 41.01 -49.76 94.81 39.90 -51.24 coo 34.79 33.03 22.11 33.47 32.83 23.76 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 30.83 30.57 23.91 30.62 30.06 25.92 95.57 34.81 -46.05 95.59 36.24 -47.59 ULMN 3 1b6g_c00 HALOALKANE DEHALOGENASE user 6 3 # 6 124 ASP E 177 ASP^? 8.55 MG MG E 301 260 ASP E 171 ASP^? 16.73 MG MG E 301 289 HIS E 170 HIS^? 10.33 MG MG E 301 coo 30.43 27.27 28.31 29.04 28.69 29.00 72.81 67.32 -45.03 71.14 67.96 -43.95 coo 34.79 33.03 22.11 33.47 32.83 23.76 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 30.83 30.57 23.91 30.62 30.06 25.92 66.96 68.76 -48.87 68.36 68.54 -47.33 ULMN 3 1b6g_c00 HALOALKANE DEHALOGENASE user 7 3 # 7 124 ASP F 177 ASP^? 8.15 MG MG F 302 260 ASP F 171 ASP^? 16.35 MG MG F 302 289 HIS F 170 HIS^? 9.84 MG MG F 302 coo 30.43 27.27 28.31 29.04 28.69 29.00 47.18 61.22 -94.50 48.48 62.32 -95.73 coo 34.79 33.03 22.11 33.47 32.83 23.76 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 30.83 30.57 23.91 30.62 30.06 25.92 52.25 64.82 -90.91 50.95 63.88 -92.26 1b6g_c00 source 1b6g HALOALKANE DEHALOGENASE : 7 hits 1b6g_c00 naa= 3 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 3 # 1 A 145 TYR A 60 TYR^? 27.11 MG MG B 302 A 230 ASP A 58 ASP^? 26.75 MG MG B 302 A 273 LYS A 137 LYS^? 34.85 MG MG A 301 coo 9.23 21.44 106.88 10.18 19.34 105.31 55.01 4.24 16.98 56.13 3.24 14.65 coo 1.45 22.80 104.16 2.58 21.02 104.01 53.93 9.80 21.09 53.83 8.90 19.15 coo 2.97 11.64 107.87 6.59 15.13 107.03 50.97 1.58 28.14 56.13 1.49 28.03 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 2 3 # 2 A 145 TYR A 129 TYR^? 10.90 MG MG A 301 A 230 ASP A 128 ASP^? -3.32 MG MG A 301s A 273 LYS A 111 LYS^? 15.16 MG MG A 301 coo 9.23 21.44 106.88 10.18 19.34 105.31 44.80 23.54 35.75 45.57 23.36 33.08 coo 1.45 22.80 104.16 2.58 21.02 104.01 46.50 28.23 39.77 47.49 30.10 39.82 coo 2.97 11.64 107.87 6.59 15.13 107.03 52.67 17.19 35.90 54.65 19.90 40.50 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 3 3 # 3 A 145 TYR B 60 TYR^? 27.11 MG MG A 301 A 230 ASP B 58 ASP^? 26.73 MG MG A 301 A 273 LYS B 137 LYS^? 34.56 MG MG B 302 coo 9.23 21.44 106.88 10.18 19.34 105.31 28.84 35.27 19.49 28.03 36.56 21.83 coo 1.45 22.80 104.16 2.58 21.02 104.01 34.42 33.56 15.74 33.50 33.49 17.59 coo 2.97 11.64 107.87 6.59 15.13 107.03 26.56 32.46 7.93 27.87 37.71 9.31 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 4 3 # 4 A 145 TYR C 60 TYR^? 26.95 MG MG D 302 A 230 ASP C 58 ASP^? 26.67 MG MG D 302 A 273 LYS C 137 LYS^? 35.41 MG MG C 302 coo 9.23 21.44 106.88 10.18 19.34 105.31 97.75 47.69 -25.92 97.82 49.25 -28.26 coo 1.45 22.80 104.16 2.58 21.02 104.01 93.40 43.81 -22.27 94.18 44.45 -24.11 coo 2.97 11.64 107.87 6.59 15.13 107.03 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 5 3 # 5 A 145 TYR D 60 TYR^? 26.93 MG MG C 302 A 230 ASP D 58 ASP^? 26.59 MG MG C 302 A 273 LYS D 137 LYS^? 37.57 MG MG D 302 coo 9.23 21.44 106.88 10.18 19.34 105.31 84.40 9.28 -23.74 83.45 7.90 -21.49 coo 1.45 22.80 104.16 2.58 21.02 104.01 83.38 14.85 -27.71 84.09 14.12 -25.85 coo 2.97 11.64 107.87 6.59 15.13 107.03 88.48 8.58 -35.33 84.88 3.98 -33.96 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 6 3 # 6 A 145 TYR D 129 TYR^? 10.79 MG MG D 302 A 230 ASP D 128 ASP^? -3.70 MG MG D 302s A 273 LYS D 111 LYS^? 15.85 MG MG D 302 coo 9.23 21.44 106.88 10.18 19.34 105.31 86.45 31.36 -42.20 86.02 30.90 -39.46 coo 1.45 22.80 104.16 2.58 21.02 104.01 83.33 35.45 -46.13 81.57 36.63 -46.10 coo 2.97 11.64 107.87 6.59 15.13 107.03 81.21 22.69 -42.10 78.68 23.89 -46.57 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 7 3 # 7 A 145 TYR E 60 TYR^? 27.19 MG MG F 301 A 230 ASP E 58 ASP^? 26.76 MG MG F 301 A 273 LYS E 137 LYS^? 35.26 MG MG E 302 coo 9.23 21.44 106.88 10.18 19.34 105.31 39.82 61.07 -70.68 38.29 60.72 -72.98 coo 1.45 22.80 104.16 2.58 21.02 104.01 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 2.97 11.64 107.87 6.59 15.13 107.03 40.01 66.05 -59.66 36.65 60.99 -60.28 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 8 3 # 8 A 145 TYR E 129 TYR^? 10.89 MG MG E 302 A 230 ASP E 128 ASP^? -3.53 MG MG E 302s A 273 LYS E 111 LYS^? 14.52 MG MG E 302 coo 9.23 21.44 106.88 10.18 19.34 105.31 62.09 60.15 -52.83 61.47 59.53 -55.45 coo 1.45 22.80 104.16 2.58 21.02 104.01 65.38 56.57 -48.58 66.15 54.57 -48.61 coo 2.97 11.64 107.87 6.59 15.13 107.03 52.49 56.44 -52.43 54.52 53.78 -47.52 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 9 3 # 9 A 145 TYR F 60 TYR^? 27.07 MG MG E 302 A 230 ASP F 58 ASP^? 26.87 MG MG E 302 A 273 LYS F 137 LYS^? 35.13 MG MG F 301 coo 9.23 21.44 106.88 10.18 19.34 105.31 79.79 68.64 -68.89 81.11 68.86 -66.46 coo 1.45 22.80 104.16 2.58 21.02 104.01 75.55 64.68 -72.56 76.21 65.63 -70.79 coo 2.97 11.64 107.87 6.59 15.13 107.03 78.53 72.20 -80.30 83.01 68.64 -79.79 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 10 3 # 10 A 145 TYR F 129 TYR^? 10.92 MG MG F 301 A 230 ASP F 128 ASP^? -3.41 MG MG F 301s A 273 LYS F 111 LYS^? 15.21 MG MG F 301 coo 9.23 21.44 106.88 10.18 19.34 105.31 59.69 58.61 -86.67 60.36 58.48 -83.96 coo 1.45 22.80 104.16 2.58 21.02 104.01 57.76 53.73 -90.50 57.46 51.64 -90.28 coo 2.97 11.64 107.87 6.59 15.13 107.03 69.70 58.57 -86.86 69.67 53.74 -90.29 1b8g_c04 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 10 hits 1b8g_c04 naa= 3 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 3 # 1 B 145 TYR A 60 TYR^? 27.11 MG MG B 302 B 230 ASP A 58 ASP^? 26.75 MG MG B 302 B 273 LYS A 137 LYS^? 34.85 MG MG A 301 coo 11.81 13.41 73.03 10.00 13.03 75.12 55.01 4.24 16.98 56.13 3.24 14.65 coo 19.17 11.01 76.14 17.26 10.42 76.77 53.93 9.80 21.09 53.83 8.90 19.15 coo 11.10 2.31 76.60 10.24 7.24 75.62 50.97 1.58 28.14 56.13 1.49 28.03 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 2 3 # 2 B 145 TYR A 129 TYR^? 10.90 MG MG A 301 B 230 ASP A 128 ASP^? -3.32 MG MG A 301s B 273 LYS A 111 LYS^? 15.16 MG MG A 301 coo 11.81 13.41 73.03 10.00 13.03 75.12 44.80 23.54 35.75 45.57 23.36 33.08 coo 19.17 11.01 76.14 17.26 10.42 76.77 46.50 28.23 39.77 47.49 30.10 39.82 coo 11.10 2.31 76.60 10.24 7.24 75.62 52.67 17.19 35.90 54.65 19.90 40.50 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 3 3 # 3 B 145 TYR B 60 TYR^? 27.11 MG MG A 301 B 230 ASP B 58 ASP^? 26.73 MG MG A 301 B 273 LYS B 137 LYS^? 34.56 MG MG B 302 coo 11.81 13.41 73.03 10.00 13.03 75.12 28.84 35.27 19.49 28.03 36.56 21.83 coo 19.17 11.01 76.14 17.26 10.42 76.77 34.42 33.56 15.74 33.50 33.49 17.59 coo 11.10 2.31 76.60 10.24 7.24 75.62 26.56 32.46 7.93 27.87 37.71 9.31 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 4 3 # 4 B 145 TYR B 129 TYR^? 10.63 MG MG B 302 B 230 ASP B 128 ASP^? -3.57 MG MG B 302s B 273 LYS B 111 LYS^? 13.75 MG MG B 302 coo 11.81 13.41 73.03 10.00 13.03 75.12 47.85 23.00 1.51 47.62 23.50 4.24 coo 19.17 11.01 76.14 17.26 10.42 76.77 52.92 24.09 -2.19 54.73 25.14 -1.90 coo 11.10 2.31 76.60 10.24 7.24 75.62 42.84 32.14 1.80 46.84 32.68 -2.87 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 5 3 # 5 B 145 TYR C 60 TYR^? 26.95 MG MG D 302 B 230 ASP C 58 ASP^? 26.67 MG MG D 302 B 273 LYS C 137 LYS^? 35.41 MG MG C 302 coo 11.81 13.41 73.03 10.00 13.03 75.12 97.75 47.69 -25.92 97.82 49.25 -28.26 coo 19.17 11.01 76.14 17.26 10.42 76.77 93.40 43.81 -22.27 94.18 44.45 -24.11 coo 11.10 2.31 76.60 10.24 7.24 75.62 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 6 3 # 6 B 145 TYR D 60 TYR^? 26.93 MG MG C 302 B 230 ASP D 58 ASP^? 26.59 MG MG C 302 B 273 LYS D 137 LYS^? 37.57 MG MG D 302 coo 11.81 13.41 73.03 10.00 13.03 75.12 84.40 9.28 -23.74 83.45 7.90 -21.49 coo 19.17 11.01 76.14 17.26 10.42 76.77 83.38 14.85 -27.71 84.09 14.12 -25.85 coo 11.10 2.31 76.60 10.24 7.24 75.62 88.48 8.58 -35.33 84.88 3.98 -33.96 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 7 3 # 7 B 145 TYR D 129 TYR^? 10.79 MG MG D 302 B 230 ASP D 128 ASP^? -3.70 MG MG D 302s B 273 LYS D 111 LYS^? 15.85 MG MG D 302 coo 11.81 13.41 73.03 10.00 13.03 75.12 86.45 31.36 -42.20 86.02 30.90 -39.46 coo 19.17 11.01 76.14 17.26 10.42 76.77 83.33 35.45 -46.13 81.57 36.63 -46.10 coo 11.10 2.31 76.60 10.24 7.24 75.62 81.21 22.69 -42.10 78.68 23.89 -46.57 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 8 3 # 8 B 145 TYR E 60 TYR^? 27.19 MG MG F 301 B 230 ASP E 58 ASP^? 26.76 MG MG F 301 B 273 LYS E 137 LYS^? 35.26 MG MG E 302 coo 11.81 13.41 73.03 10.00 13.03 75.12 39.82 61.07 -70.68 38.29 60.72 -72.98 coo 19.17 11.01 76.14 17.26 10.42 76.77 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 11.10 2.31 76.60 10.24 7.24 75.62 40.01 66.05 -59.66 36.65 60.99 -60.28 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 9 3 # 9 B 145 TYR E 129 TYR^? 10.89 MG MG E 302 B 230 ASP E 128 ASP^? -3.53 MG MG E 302s B 273 LYS E 111 LYS^? 14.52 MG MG E 302 coo 11.81 13.41 73.03 10.00 13.03 75.12 62.09 60.15 -52.83 61.47 59.53 -55.45 coo 19.17 11.01 76.14 17.26 10.42 76.77 65.38 56.57 -48.58 66.15 54.57 -48.61 coo 11.10 2.31 76.60 10.24 7.24 75.62 52.49 56.44 -52.43 54.52 53.78 -47.52 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 10 3 # 10 B 145 TYR F 60 TYR^? 27.07 MG MG E 302 B 230 ASP F 58 ASP^? 26.87 MG MG E 302 B 273 LYS F 137 LYS^? 35.13 MG MG F 301 coo 11.81 13.41 73.03 10.00 13.03 75.12 79.79 68.64 -68.89 81.11 68.86 -66.46 coo 19.17 11.01 76.14 17.26 10.42 76.77 75.55 64.68 -72.56 76.21 65.63 -70.79 coo 11.10 2.31 76.60 10.24 7.24 75.62 78.53 72.20 -80.30 83.01 68.64 -79.79 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 11 3 # 11 B 145 TYR F 129 TYR^? 10.92 MG MG F 301 B 230 ASP F 128 ASP^? -3.41 MG MG F 301s B 273 LYS F 111 LYS^? 15.21 MG MG F 301 coo 11.81 13.41 73.03 10.00 13.03 75.12 59.69 58.61 -86.67 60.36 58.48 -83.96 coo 19.17 11.01 76.14 17.26 10.42 76.77 57.76 53.73 -90.50 57.46 51.64 -90.28 coo 11.10 2.31 76.60 10.24 7.24 75.62 69.70 58.57 -86.86 69.67 53.74 -90.29 1b8g_c05 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 11 hits 1b8g_c05 naa= 3 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 1 3 # 1 A 88 PHE A 59 PHE^? 31.59 MG MG A 301 A 159 ASP A 138 ASP^? 33.08 MG MG A 302 A 188 LYS A 6 LYS^? 25.88 MG MG A 301 coo 13.91 34.58 14.67 12.95 36.00 12.47 52.93 4.70 25.02 52.08 5.30 27.62 coo 20.97 28.40 16.26 20.19 30.15 15.34 47.10 -0.97 29.63 45.89 0.22 30.96 coo 22.55 41.65 15.60 18.92 37.20 14.63 46.20 12.82 24.71 44.50 16.64 20.52 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 2 3 # 2 A 88 PHE A 110 PHE^? 21.60 MG MG A 301 A 159 ASP A 142 ASP^? 23.70 MG MG A 302 A 188 LYS A 6 LYS^? 25.88 MG MG A 301 coo 13.91 34.58 14.67 12.95 36.00 12.47 53.06 14.15 32.16 50.69 13.44 30.81 coo 20.97 28.40 16.26 20.19 30.15 15.34 46.39 7.18 37.53 46.28 7.18 39.63 coo 22.55 41.65 15.60 18.92 37.20 14.63 46.20 12.82 24.71 44.50 16.64 20.52 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 3 3 # 3 A 88 PHE A 110 PHE^? 21.60 MG MG A 301 A 159 ASP A 142 ASP^? 23.70 MG MG A 302 A 188 LYS A 157 LYS^? 28.65 MG MG A 302 coo 13.91 34.58 14.67 12.95 36.00 12.47 53.06 14.15 32.16 50.69 13.44 30.81 coo 20.97 28.40 16.26 20.19 30.15 15.34 46.39 7.18 37.53 46.28 7.18 39.63 coo 22.55 41.65 15.60 18.92 37.20 14.63 41.42 12.06 27.58 41.46 5.93 29.41 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 4 3 # 4 A 88 PHE A 153 PHE^? 9.64 MG MG A 301 A 159 ASP A 171 ASP^? 17.17 MG MG A 302 A 188 LYS A 166 LYS^? 20.93 MG MG A 302 coo 13.91 34.58 14.67 12.95 36.00 12.47 38.89 24.49 36.07 40.14 26.70 37.23 coo 20.97 28.40 16.26 20.19 30.15 15.34 29.78 23.67 36.63 28.48 25.11 35.71 coo 22.55 41.65 15.60 18.92 37.20 14.63 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 5 3 # 5 A 88 PHE A 161 PHE^? 25.62 MG MG B 302 A 159 ASP A 58 ASP^? 26.75 MG MG B 302 A 188 LYS A 157 LYS^? 28.65 MG MG A 302 coo 13.91 34.58 14.67 12.95 36.00 12.47 44.24 9.29 16.03 46.90 9.95 15.56 coo 20.97 28.40 16.26 20.19 30.15 15.34 53.93 9.80 21.09 53.83 8.90 19.15 coo 22.55 41.65 15.60 18.92 37.20 14.63 41.42 12.06 27.58 41.46 5.93 29.41 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 6 3 # 6 A 88 PHE B 59 PHE^? 31.31 MG MG B 302 A 159 ASP B 138 ASP^? 33.32 MG MG B 302 A 188 LYS B 6 LYS^? 25.90 MG MG B 302 coo 13.91 34.58 14.67 12.95 36.00 12.47 29.63 33.55 11.36 30.42 32.81 8.75 coo 20.97 28.40 16.26 20.19 30.15 15.34 23.42 29.01 6.78 24.36 28.48 4.94 coo 22.55 41.65 15.60 18.92 37.20 14.63 36.26 25.44 11.74 39.65 23.12 16.29 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 7 3 # 7 A 88 PHE B 110 PHE^? 21.49 MG MG B 302 A 159 ASP B 142 ASP^? 23.97 MG MG B 301 A 188 LYS B 6 LYS^? 25.90 MG MG B 302 coo 13.91 34.58 14.67 12.95 36.00 12.47 39.39 32.59 5.17 38.42 30.20 6.23 coo 20.97 28.40 16.26 20.19 30.15 15.34 31.69 27.40 -1.31 32.10 27.37 -3.38 coo 22.55 41.65 15.60 18.92 37.20 14.63 36.26 25.44 11.74 39.65 23.12 16.29 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 8 3 # 8 A 88 PHE B 110 PHE^? 21.49 MG MG B 302 A 159 ASP B 142 ASP^? 23.97 MG MG B 301 A 188 LYS B 137 LYS^? 34.56 MG MG B 302 coo 13.91 34.58 14.67 12.95 36.00 12.47 39.39 32.59 5.17 38.42 30.20 6.23 coo 20.97 28.40 16.26 20.19 30.15 15.34 31.69 27.40 -1.31 32.10 27.37 -3.38 coo 22.55 41.65 15.60 18.92 37.20 14.63 26.56 32.46 7.93 27.87 37.71 9.31 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 9 3 # 9 A 88 PHE B 110 PHE^? 21.49 MG MG B 302 A 159 ASP B 142 ASP^? 23.97 MG MG B 301 A 188 LYS B 157 LYS^? 28.85 MG MG B 302 coo 13.91 34.58 14.67 12.95 36.00 12.47 39.39 32.59 5.17 38.42 30.20 6.23 coo 20.97 28.40 16.26 20.19 30.15 15.34 31.69 27.40 -1.31 32.10 27.37 -3.38 coo 22.55 41.65 15.60 18.92 37.20 14.63 34.97 21.28 8.44 29.03 22.82 6.58 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 10 3 # 10 A 88 PHE B 153 PHE^? 9.59 MG MG B 302 A 159 ASP B 171 ASP^? 16.92 MG MG B 301 A 188 LYS B 166 LYS^? 22.75 MG MG B 301 coo 13.91 34.58 14.67 12.95 36.00 12.47 47.54 17.09 0.77 50.03 17.91 -0.19 coo 20.97 28.40 16.26 20.19 30.15 15.34 45.30 8.50 -0.71 46.30 6.81 0.12 coo 22.55 41.65 15.60 18.92 37.20 14.63 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 11 3 # 11 A 88 PHE B 161 PHE^? 25.78 MG MG A 301 A 159 ASP B 58 ASP^? 26.73 MG MG A 301 A 188 LYS B 157 LYS^? 28.85 MG MG B 302 coo 13.91 34.58 14.67 12.95 36.00 12.47 31.87 23.58 19.99 32.61 26.21 20.65 coo 20.97 28.40 16.26 20.19 30.15 15.34 34.42 33.56 15.74 33.50 33.49 17.59 coo 22.55 41.65 15.60 18.92 37.20 14.63 34.97 21.28 8.44 29.03 22.82 6.58 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 12 3 # 12 A 88 PHE B 190 PHE^? 14.80 MG MG B 301 A 159 ASP B 142 ASP^? 23.97 MG MG B 301 A 188 LYS B 166 LYS^? 22.75 MG MG B 301 coo 13.91 34.58 14.67 12.95 36.00 12.47 40.06 19.97 -3.89 40.77 21.13 -1.45 coo 20.97 28.40 16.26 20.19 30.15 15.34 31.69 27.40 -1.31 32.10 27.37 -3.38 coo 22.55 41.65 15.60 18.92 37.20 14.63 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 13 3 # 13 A 88 PHE C 59 PHE^? 31.23 MG MG C 302 A 159 ASP C 138 ASP^? 33.43 MG MG C 302 A 188 LYS C 6 LYS^? 25.73 MG MG C 302 coo 13.91 34.58 14.67 12.95 36.00 12.47 98.06 45.52 -18.00 97.73 44.36 -15.53 coo 20.97 28.40 16.26 20.19 30.15 15.34 105.43 43.97 -13.30 104.85 43.08 -11.43 coo 22.55 41.65 15.60 18.92 37.20 14.63 94.42 35.68 -18.56 92.21 32.03 -23.05 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 14 3 # 14 A 88 PHE C 110 PHE^? 21.25 MG MG C 302 A 159 ASP C 142 ASP^? 23.76 MG MG C 301 A 188 LYS C 6 LYS^? 25.73 MG MG C 302 coo 13.91 34.58 14.67 12.95 36.00 12.47 89.08 41.33 -11.45 90.83 39.43 -12.52 coo 20.97 28.40 16.26 20.19 30.15 15.34 97.94 39.27 -5.03 98.08 38.70 -2.97 coo 22.55 41.65 15.60 18.92 37.20 14.63 94.42 35.68 -18.56 92.21 32.03 -23.05 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 15 3 # 15 A 88 PHE C 110 PHE^? 21.25 MG MG C 302 A 159 ASP C 142 ASP^? 23.76 MG MG C 301 A 188 LYS C 157 LYS^? 28.15 MG MG C 302 coo 13.91 34.58 14.67 12.95 36.00 12.47 89.08 41.33 -11.45 90.83 39.43 -12.52 coo 20.97 28.40 16.26 20.19 30.15 15.34 97.94 39.27 -5.03 98.08 38.70 -2.97 coo 22.55 41.65 15.60 18.92 37.20 14.63 97.55 32.04 -15.10 101.49 36.24 -13.39 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 16 3 # 16 A 88 PHE C 161 PHE^? 25.47 MG MG D 302 A 159 ASP C 58 ASP^? 26.67 MG MG D 302 A 188 LYS C 157 LYS^? 28.15 MG MG C 302 coo 13.91 34.58 14.67 12.95 36.00 12.47 98.98 35.62 -26.76 97.40 37.84 -27.44 coo 20.97 28.40 16.26 20.19 30.15 15.34 93.40 43.81 -22.27 94.18 44.45 -24.11 coo 22.55 41.65 15.60 18.92 37.20 14.63 97.55 32.04 -15.10 101.49 36.24 -13.39 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 17 3 # 17 A 88 PHE C 190 PHE^? 14.91 MG MG C 301 A 159 ASP C 142 ASP^? 23.76 MG MG C 301 A 188 LYS C 166 LYS^? 22.53 MG MG C 301 coo 13.91 34.58 14.67 12.95 36.00 12.47 93.44 29.01 -2.85 92.36 29.94 -5.20 coo 20.97 28.40 16.26 20.19 30.15 15.34 97.94 39.27 -5.03 98.08 38.70 -2.97 coo 22.55 41.65 15.60 18.92 37.20 14.63 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 18 3 # 18 A 88 PHE D 59 PHE^? 31.49 MG MG D 302 A 159 ASP D 138 ASP^? 33.64 MG MG D 302 A 188 LYS D 6 LYS^? 25.98 MG MG D 302 coo 13.91 34.58 14.67 12.95 36.00 12.47 86.17 10.70 -31.86 86.41 11.56 -34.53 coo 20.97 28.40 16.26 20.19 30.15 15.34 93.00 7.50 -35.79 93.88 8.48 -37.45 coo 22.55 41.65 15.60 18.92 37.20 14.63 89.78 20.68 -31.57 90.15 24.89 -27.02 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 19 3 # 19 A 88 PHE D 110 PHE^? 21.56 MG MG D 302 A 159 ASP D 142 ASP^? 23.49 MG MG D 301 A 188 LYS D 6 LYS^? 25.98 MG MG D 302 coo 13.91 34.58 14.67 12.95 36.00 12.47 82.28 19.60 -38.58 84.73 19.89 -37.32 coo 20.97 28.40 16.26 20.19 30.15 15.34 90.90 15.58 -44.76 91.35 16.09 -46.79 coo 22.55 41.65 15.60 18.92 37.20 14.63 89.78 20.68 -31.57 90.15 24.89 -27.02 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 20 3 # 20 A 88 PHE D 110 PHE^? 21.56 MG MG D 302 A 159 ASP D 142 ASP^? 23.49 MG MG D 301 A 188 LYS D 137 LYS^? 37.57 MG MG D 302 coo 13.91 34.58 14.67 12.95 36.00 12.47 82.28 19.60 -38.58 84.73 19.89 -37.32 coo 20.97 28.40 16.26 20.19 30.15 15.34 90.90 15.58 -44.76 91.35 16.09 -46.79 coo 22.55 41.65 15.60 18.92 37.20 14.63 88.48 8.58 -35.33 84.88 3.98 -33.96 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 21 3 # 21 A 88 PHE D 110 PHE^? 21.56 MG MG D 302 A 159 ASP D 142 ASP^? 23.49 MG MG D 301 A 188 LYS D 157 LYS^? 28.67 MG MG D 302 coo 13.91 34.58 14.67 12.95 36.00 12.47 82.28 19.60 -38.58 84.73 19.89 -37.32 coo 20.97 28.40 16.26 20.19 30.15 15.34 90.90 15.58 -44.76 91.35 16.09 -46.79 coo 22.55 41.65 15.60 18.92 37.20 14.63 94.17 21.71 -34.34 96.11 15.89 -35.92 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 22 3 # 22 A 88 PHE D 161 PHE^? 25.58 MG MG C 302 A 159 ASP D 58 ASP^? 26.59 MG MG C 302 A 188 LYS D 157 LYS^? 28.67 MG MG D 302 coo 13.91 34.58 14.67 12.95 36.00 12.47 92.97 17.97 -22.91 90.24 17.44 -22.45 coo 20.97 28.40 16.26 20.19 30.15 15.34 83.38 14.85 -27.71 84.09 14.12 -25.85 coo 22.55 41.65 15.60 18.92 37.20 14.63 94.17 21.71 -34.34 96.11 15.89 -35.92 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 23 3 # 23 A 88 PHE D 190 PHE^? 14.83 MG MG D 301 A 159 ASP D 142 ASP^? 23.49 MG MG D 301 A 188 LYS D 166 LYS^? 21.08 MG MG D 301 coo 13.91 34.58 14.67 12.95 36.00 12.47 93.52 26.32 -46.94 92.08 26.47 -44.56 coo 20.97 28.40 16.26 20.19 30.15 15.34 90.90 15.58 -44.76 91.35 16.09 -46.79 coo 22.55 41.65 15.60 18.92 37.20 14.63 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 24 3 # 24 A 88 PHE E 59 PHE^? 31.36 MG MG E 302 A 159 ASP E 138 ASP^? 33.31 MG MG E 302 A 188 LYS E 6 LYS^? 25.59 MG MG E 302 coo 13.91 34.58 14.67 12.95 36.00 12.47 41.55 62.67 -62.73 42.33 62.92 -60.06 coo 20.97 28.40 16.26 20.19 30.15 15.34 39.58 70.77 -58.63 40.74 70.78 -56.80 coo 22.55 41.65 15.60 18.92 37.20 14.63 51.95 64.70 -63.33 56.16 64.03 -67.52 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 25 3 # 25 A 88 PHE E 110 PHE^? 21.45 MG MG E 302 A 159 ASP E 142 ASP^? 23.66 MG MG E 301 A 188 LYS E 6 LYS^? 25.59 MG MG E 302 coo 13.91 34.58 14.67 12.95 36.00 12.47 49.73 57.83 -56.11 50.46 60.21 -57.41 coo 20.97 28.40 16.26 20.19 30.15 15.34 47.19 67.15 -50.37 47.44 67.18 -48.23 coo 22.55 41.65 15.60 18.92 37.20 14.63 51.95 64.70 -63.33 56.16 64.03 -67.52 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 26 3 # 26 A 88 PHE E 110 PHE^? 21.45 MG MG E 302 A 159 ASP E 142 ASP^? 23.66 MG MG E 301 A 188 LYS E 157 LYS^? 28.40 MG MG E 302 coo 13.91 34.58 14.67 12.95 36.00 12.47 49.73 57.83 -56.11 50.46 60.21 -57.41 coo 20.97 28.40 16.26 20.19 30.15 15.34 47.19 67.15 -50.37 47.44 67.18 -48.23 coo 22.55 41.65 15.60 18.92 37.20 14.63 53.63 69.16 -60.42 48.34 71.81 -58.40 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 27 3 # 27 A 88 PHE E 153 PHE^? 9.50 MG MG E 302 A 159 ASP E 171 ASP^? 16.73 MG MG E 301 A 188 LYS E 166 LYS^? 21.46 MG MG E 301 coo 13.91 34.58 14.67 12.95 36.00 12.47 65.86 64.95 -52.12 67.22 62.73 -51.09 coo 20.97 28.40 16.26 20.19 30.15 15.34 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 22.55 41.65 15.60 18.92 37.20 14.63 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 28 3 # 28 A 88 PHE E 161 PHE^? 25.51 MG MG F 301 A 159 ASP E 58 ASP^? 26.76 MG MG F 301 A 188 LYS E 157 LYS^? 28.40 MG MG E 302 coo 13.91 34.58 14.67 12.95 36.00 12.47 49.74 68.03 -71.94 48.60 65.47 -72.38 coo 20.97 28.40 16.26 20.19 30.15 15.34 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 22.55 41.65 15.60 18.92 37.20 14.63 53.63 69.16 -60.42 48.34 71.81 -58.40 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 29 3 # 29 A 88 PHE E 190 PHE^? 14.70 MG MG E 301 A 159 ASP E 142 ASP^? 23.66 MG MG E 301 A 188 LYS E 166 LYS^? 21.46 MG MG E 301 coo 13.91 34.58 14.67 12.95 36.00 12.47 58.27 67.97 -47.86 58.03 66.58 -50.23 coo 20.97 28.40 16.26 20.19 30.15 15.34 47.19 67.15 -50.37 47.44 67.18 -48.23 coo 22.55 41.65 15.60 18.92 37.20 14.63 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 30 3 # 30 A 88 PHE F 59 PHE^? 31.53 MG MG F 301 A 159 ASP F 138 ASP^? 33.51 MG MG F 302 A 188 LYS F 6 LYS^? 26.09 MG MG F 301 coo 13.91 34.58 14.67 12.95 36.00 12.47 77.96 68.89 -76.99 76.86 68.73 -79.55 coo 20.97 28.40 16.26 20.19 30.15 15.34 77.17 76.66 -81.48 76.14 76.33 -83.32 coo 22.55 41.65 15.60 18.92 37.20 14.63 67.53 67.03 -76.43 64.05 65.33 -71.86 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 31 3 # 31 A 88 PHE F 110 PHE^? 21.65 MG MG F 301 A 159 ASP F 142 ASP^? 23.43 MG MG F 302 A 188 LYS F 6 LYS^? 26.09 MG MG F 301 coo 13.91 34.58 14.67 12.95 36.00 12.47 72.02 60.99 -83.27 70.61 63.10 -82.08 coo 20.97 28.40 16.26 20.19 30.15 15.34 71.46 69.88 -89.76 71.03 69.93 -91.81 coo 22.55 41.65 15.60 18.92 37.20 14.63 67.53 67.03 -76.43 64.05 65.33 -71.86 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 32 3 # 32 A 88 PHE F 110 PHE^? 21.65 MG MG F 301 A 159 ASP F 142 ASP^? 23.43 MG MG F 302 A 188 LYS F 157 LYS^? 28.36 MG MG F 302 coo 13.91 34.58 14.67 12.95 36.00 12.47 72.02 60.99 -83.27 70.61 63.10 -82.08 coo 20.97 28.40 16.26 20.19 30.15 15.34 71.46 69.88 -89.76 71.03 69.93 -91.81 coo 22.55 41.65 15.60 18.92 37.20 14.63 64.43 70.47 -79.54 68.32 74.80 -81.65 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 33 3 # 33 A 88 PHE F 161 PHE^? 25.66 MG MG E 302 A 159 ASP F 58 ASP^? 26.87 MG MG E 302 A 188 LYS F 157 LYS^? 28.36 MG MG F 302 coo 13.91 34.58 14.67 12.95 36.00 12.47 68.33 71.65 -68.19 70.12 69.57 -67.59 coo 20.97 28.40 16.26 20.19 30.15 15.34 75.55 64.68 -72.56 76.21 65.63 -70.79 coo 22.55 41.65 15.60 18.92 37.20 14.63 64.43 70.47 -79.54 68.32 74.80 -81.65 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 34 3 # 34 A 88 PHE F 190 PHE^? 14.21 MG MG F 302 A 159 ASP F 142 ASP^? 23.43 MG MG F 302 A 188 LYS F 166 LYS^? 20.76 MG MG F 302 coo 13.91 34.58 14.67 12.95 36.00 12.47 60.66 66.91 -91.97 61.14 65.56 -89.57 coo 20.97 28.40 16.26 20.19 30.15 15.34 71.46 69.88 -89.76 71.03 69.93 -91.81 coo 22.55 41.65 15.60 18.92 37.20 14.63 59.28 73.05 -82.63 55.63 74.15 -86.94 1b9h_c02 source 1b9h 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHASE : 34 hits 1b9h_c02 naa= 3 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 A 137 ARG A 37 ARG^? 18.99 MG MG A 301 A 141 THR A 46 THR^? 24.24 MG MG A 301 A 235 ASP A 171 ASP^? 17.17 MG MG A 302 coo 6.21 93.81 36.58 4.58 96.33 37.17 32.99 26.50 25.19 35.50 25.33 26.51 coo 6.80 92.87 28.33 4.91 92.74 27.40 38.63 28.11 18.80 36.62 27.50 19.27 coo 12.98 90.36 47.57 11.26 89.62 46.62 29.78 23.67 36.63 28.48 25.11 35.71 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 A 137 ARG A 50 ARG^? 15.98 MG MG A 301 A 141 THR A 18 THR.? 15.77 MG MG A 301 A 235 ASP A 128 ASP^? -3.32 MG MG A 301s coo 6.21 93.81 36.58 4.58 96.33 37.17 38.44 33.02 29.31 39.55 34.58 26.90 coo 6.80 92.87 28.33 4.91 92.74 27.40 32.02 38.89 33.13 34.18 39.03 32.98 coo 12.98 90.36 47.57 11.26 89.62 46.62 46.50 28.23 39.77 47.49 30.10 39.82 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 A 137 ARG A 50 ARG^? 15.98 MG MG A 301 A 141 THR A 70 THR^? 14.66 MG MG A 301 A 235 ASP A 171 ASP^? 17.17 MG MG A 302 coo 6.21 93.81 36.58 4.58 96.33 37.17 38.44 33.02 29.31 39.55 34.58 26.90 coo 6.80 92.87 28.33 4.91 92.74 27.40 45.68 31.52 26.25 47.33 32.60 27.12 coo 12.98 90.36 47.57 11.26 89.62 46.62 29.78 23.67 36.63 28.48 25.11 35.71 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 A 137 ARG A 50 ARG^? 15.98 MG MG A 301 A 141 THR A 73 THR^? 15.13 MG MG A 301 A 235 ASP A 171 ASP^? 17.17 MG MG A 302 coo 6.21 93.81 36.58 4.58 96.33 37.17 38.44 33.02 29.31 39.55 34.58 26.90 coo 6.80 92.87 28.33 4.91 92.74 27.40 40.93 39.17 26.72 41.99 38.78 28.61 coo 12.98 90.36 47.57 11.26 89.62 46.62 29.78 23.67 36.63 28.48 25.11 35.71 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 A 137 ARG A 50 ARG^? 15.98 MG MG A 301 A 141 THR A 74 THR^? 21.85 MG MG A 301 A 235 ASP A 128 ASP^? -3.32 MG MG A 301s coo 6.21 93.81 36.58 4.58 96.33 37.17 38.44 33.02 29.31 39.55 34.58 26.90 coo 6.80 92.87 28.33 4.91 92.74 27.40 38.65 41.92 25.57 37.60 41.76 23.73 coo 12.98 90.36 47.57 11.26 89.62 46.62 46.50 28.23 39.77 47.49 30.10 39.82 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 A 137 ARG A 50 ARG^? 15.98 MG MG A 301 A 141 THR A 74 THR^? 21.85 MG MG A 301 A 235 ASP A 148 ASP^? 2.72 MG MG A 301s coo 6.21 93.81 36.58 4.58 96.33 37.17 38.44 33.02 29.31 39.55 34.58 26.90 coo 6.80 92.87 28.33 4.91 92.74 27.40 38.65 41.92 25.57 37.60 41.76 23.73 coo 12.98 90.36 47.57 11.26 89.62 46.62 41.50 28.88 41.13 43.33 29.67 41.93 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 7 3 # 7 A 137 ARG A 87 ARG^? 20.70 MG MG A 301 A 141 THR A 73 THR^? 15.13 MG MG A 301 A 235 ASP A 23 ASP^? 22.90 MG MG A 301 coo 6.21 93.81 36.58 4.58 96.33 37.17 43.15 49.03 26.22 43.83 48.14 29.12 coo 6.80 92.87 28.33 4.91 92.74 27.40 40.93 39.17 26.72 41.99 38.78 28.61 coo 12.98 90.36 47.57 11.26 89.62 46.62 36.40 52.47 38.61 38.03 53.36 39.72 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 8 3 # 8 A 137 ARG B 37 ARG^? 19.17 MG MG B 302 A 141 THR B 46 THR^? 23.88 MG MG B 302 A 235 ASP B 171 ASP^? 16.92 MG MG B 301 coo 6.21 93.81 36.58 4.58 96.33 37.17 47.41 10.20 11.40 46.99 12.91 10.22 coo 6.80 92.87 28.33 4.91 92.74 27.40 49.71 15.16 18.13 48.80 13.51 17.14 coo 12.98 90.36 47.57 11.26 89.62 46.62 45.30 8.50 -0.71 46.30 6.81 0.12 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 9 3 # 9 A 137 ARG B 50 ARG^? 16.38 MG MG B 302 A 141 THR B 18 THR^? 16.08 MG MG B 302 A 235 ASP B 128 ASP^? -3.57 MG MG B 302s coo 6.21 93.81 36.58 4.58 96.33 37.17 55.38 14.91 7.80 56.60 14.73 10.62 coo 6.80 92.87 28.33 4.91 92.74 27.40 60.02 7.32 3.97 60.86 9.29 4.05 coo 12.98 90.36 47.57 11.26 89.62 46.62 52.92 24.09 -2.19 54.73 25.14 -1.90 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 10 3 # 10 A 137 ARG B 50 ARG^? 16.38 MG MG B 302 A 141 THR B 70 THR^? 14.69 MG MG B 302 A 235 ASP B 171 ASP^? 16.92 MG MG B 301 coo 6.21 93.81 36.58 4.58 96.33 37.17 55.38 14.91 7.80 56.60 14.73 10.62 coo 6.80 92.87 28.33 4.91 92.74 27.40 54.82 21.76 11.59 56.34 23.17 10.82 coo 12.98 90.36 47.57 11.26 89.62 46.62 45.30 8.50 -0.71 46.30 6.81 0.12 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 11 3 # 11 A 137 ARG B 50 ARG^? 16.38 MG MG B 302 A 141 THR B 70 THR^? 14.69 MG MG B 302 A 235 ASP B 177 ASP^? 9.03 MG MG B 301 coo 6.21 93.81 36.58 4.58 96.33 37.17 55.38 14.91 7.80 56.60 14.73 10.62 coo 6.80 92.87 28.33 4.91 92.74 27.40 54.82 21.76 11.59 56.34 23.17 10.82 coo 12.98 90.36 47.57 11.26 89.62 46.62 51.97 11.04 -6.64 50.39 11.62 -7.94 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 12 3 # 12 A 137 ARG B 50 ARG^? 16.38 MG MG B 302 A 141 THR B 73 THR^? 15.28 MG MG B 302 A 235 ASP B 171 ASP^? 16.92 MG MG B 301 coo 6.21 93.81 36.58 4.58 96.33 37.17 55.38 14.91 7.80 56.60 14.73 10.62 coo 6.80 92.87 28.33 4.91 92.74 27.40 61.79 16.15 11.00 62.15 17.08 9.05 coo 12.98 90.36 47.57 11.26 89.62 46.62 45.30 8.50 -0.71 46.30 6.81 0.12 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 13 3 # 13 A 137 ARG B 50 ARG^? 16.38 MG MG B 302 A 141 THR B 73 THR^? 15.28 MG MG B 302 A 235 ASP B 177 ASP^? 9.03 MG MG B 301 coo 6.21 93.81 36.58 4.58 96.33 37.17 55.38 14.91 7.80 56.60 14.73 10.62 coo 6.80 92.87 28.33 4.91 92.74 27.40 61.79 16.15 11.00 62.15 17.08 9.05 coo 12.98 90.36 47.57 11.26 89.62 46.62 51.97 11.04 -6.64 50.39 11.62 -7.94 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 14 3 # 14 A 137 ARG B 50 ARG^? 16.38 MG MG B 302 A 141 THR B 74 THR^? 21.68 MG MG B 302 A 235 ASP B 128 ASP^? -3.57 MG MG B 302s coo 6.21 93.81 36.58 4.58 96.33 37.17 55.38 14.91 7.80 56.60 14.73 10.62 coo 6.80 92.87 28.33 4.91 92.74 27.40 63.99 13.20 11.95 63.36 12.32 13.84 coo 12.98 90.36 47.57 11.26 89.62 46.62 52.92 24.09 -2.19 54.73 25.14 -1.90 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 15 3 # 15 A 137 ARG B 50 ARG^? 16.38 MG MG B 302 A 141 THR B 74 THR^? 21.68 MG MG B 302 A 235 ASP B 148 ASP^? 2.58 MG MG B 302s coo 6.21 93.81 36.58 4.58 96.33 37.17 55.38 14.91 7.80 56.60 14.73 10.62 coo 6.80 92.87 28.33 4.91 92.74 27.40 63.99 13.20 11.95 63.36 12.32 13.84 coo 12.98 90.36 47.57 11.26 89.62 46.62 52.73 19.23 -3.77 53.81 20.99 -4.31 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 16 3 # 16 A 137 ARG B 50 ARG^? 16.38 MG MG B 302 A 141 THR B 74 THR^? 21.68 MG MG B 302 A 235 ASP B 177 ASP^? 9.03 MG MG B 301 coo 6.21 93.81 36.58 4.58 96.33 37.17 55.38 14.91 7.80 56.60 14.73 10.62 coo 6.80 92.87 28.33 4.91 92.74 27.40 63.99 13.20 11.95 63.36 12.32 13.84 coo 12.98 90.36 47.57 11.26 89.62 46.62 51.97 11.04 -6.64 50.39 11.62 -7.94 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 17 3 # 17 A 137 ARG B 87 ARG^? 13.84 MG MG C 301 A 141 THR B 88 THR^? 22.44 MG MG C 301 A 235 ASP B 23 ASP^? 15.67 MG MG C 301 coo 6.21 93.81 36.58 4.58 96.33 37.17 72.30 15.49 11.27 71.00 17.29 9.11 coo 6.80 92.87 28.33 4.91 92.74 27.40 66.42 16.42 14.22 65.45 16.28 16.18 coo 12.98 90.36 47.57 11.26 89.62 46.62 74.31 7.55 -1.09 75.08 9.17 -2.23 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 18 3 # 18 A 137 ARG B 173 ARG^? 18.75 MG MG B 301 A 141 THR B 175 THR^? 12.15 MG MG B 301 A 235 ASP B 35 ASP^? 16.92 MG MG B 302 coo 6.21 93.81 36.58 4.58 96.33 37.17 49.83 5.55 0.39 48.19 5.30 3.03 coo 6.80 92.87 28.33 4.91 92.74 27.40 46.88 7.94 -7.07 47.05 10.06 -6.52 coo 12.98 90.36 47.57 11.26 89.62 46.62 52.63 11.07 10.18 53.68 12.85 9.94 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 19 3 # 19 A 137 ARG B 193 ARG^? 28.40 MG MG B 301 A 141 THR B 191 THR^? 19.68 MG MG B 301 A 235 ASP B 138 ASP^? 33.32 MG MG B 302 coo 6.21 93.81 36.58 4.58 96.33 37.17 29.25 23.93 -4.74 26.96 25.70 -3.52 coo 6.80 92.87 28.33 4.91 92.74 27.40 36.37 22.10 -5.64 35.04 22.83 -7.26 coo 12.98 90.36 47.57 11.26 89.62 46.62 23.42 29.01 6.78 24.36 28.48 4.94 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 20 3 # 20 A 137 ARG C 37 ARG^? 19.01 MG MG C 302 A 141 THR C 46 THR^? 24.02 MG MG C 302 A 235 ASP C 171 ASP^? 17.08 MG MG C 301 coo 6.21 93.81 36.58 4.58 96.33 37.17 89.36 17.23 -17.57 89.29 20.20 -16.76 coo 6.80 92.87 28.33 4.91 92.74 27.40 85.56 21.34 -24.69 87.12 20.00 -24.12 coo 12.98 90.36 47.57 11.26 89.62 46.62 92.57 16.68 -6.24 92.24 14.74 -7.03 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 21 3 # 21 A 137 ARG C 50 ARG^? 16.05 MG MG C 302 A 141 THR C 18 THR^? 15.72 MG MG C 302 A 235 ASP C 128 ASP^? -3.22 MG MG C 302s coo 6.21 93.81 36.58 4.58 96.33 37.17 80.61 19.03 -14.42 79.16 18.55 -17.10 coo 6.80 92.87 28.33 4.91 92.74 27.40 79.00 10.43 -10.53 77.64 12.10 -10.65 coo 12.98 90.36 47.57 11.26 89.62 46.62 80.05 28.39 -4.25 77.97 28.60 -4.21 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 22 3 # 22 A 137 ARG C 50 ARG^? 16.05 MG MG C 302 A 141 THR C 70 THR^? 14.45 MG MG C 302 A 235 ASP C 171 ASP^? 17.08 MG MG C 301 coo 6.21 93.81 36.58 4.58 96.33 37.17 80.61 19.03 -14.42 79.16 18.55 -17.10 coo 6.80 92.87 28.33 4.91 92.74 27.40 78.63 25.77 -17.76 76.70 26.55 -17.21 coo 12.98 90.36 47.57 11.26 89.62 46.62 92.57 16.68 -6.24 92.24 14.74 -7.03 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 23 3 # 23 A 137 ARG C 50 ARG^? 16.05 MG MG C 302 A 141 THR C 70 THR^? 14.45 MG MG C 302 A 235 ASP C 177 ASP^? 8.84 MG MG C 301 coo 6.21 93.81 36.58 4.58 96.33 37.17 80.61 19.03 -14.42 79.16 18.55 -17.10 coo 6.80 92.87 28.33 4.91 92.74 27.40 78.63 25.77 -17.76 76.70 26.55 -17.21 coo 12.98 90.36 47.57 11.26 89.62 46.62 85.60 16.42 -0.31 86.51 17.71 1.09 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 24 3 # 24 A 137 ARG C 50 ARG^? 16.05 MG MG C 302 A 141 THR C 73 THR^? 14.95 MG MG C 302 A 235 ASP C 171 ASP^? 17.08 MG MG C 301 coo 6.21 93.81 36.58 4.58 96.33 37.17 80.61 19.03 -14.42 79.16 18.55 -17.10 coo 6.80 92.87 28.33 4.91 92.74 27.40 74.44 18.04 -17.45 73.99 18.64 -15.48 coo 12.98 90.36 47.57 11.26 89.62 46.62 92.57 16.68 -6.24 92.24 14.74 -7.03 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 25 3 # 25 A 137 ARG C 50 ARG^? 16.05 MG MG C 302 A 141 THR C 73 THR^? 14.95 MG MG C 302 A 235 ASP C 177 ASP^? 8.84 MG MG C 301 coo 6.21 93.81 36.58 4.58 96.33 37.17 80.61 19.03 -14.42 79.16 18.55 -17.10 coo 6.80 92.87 28.33 4.91 92.74 27.40 74.44 18.04 -17.45 73.99 18.64 -15.48 coo 12.98 90.36 47.57 11.26 89.62 46.62 85.60 16.42 -0.31 86.51 17.71 1.09 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 26 3 # 26 A 137 ARG C 50 ARG^? 16.05 MG MG C 302 A 141 THR C 74 THR^? 21.64 MG MG C 302 A 235 ASP C 128 ASP^? -3.22 MG MG C 302s coo 6.21 93.81 36.58 4.58 96.33 37.17 80.61 19.03 -14.42 79.16 18.55 -17.10 coo 6.80 92.87 28.33 4.91 92.74 27.40 73.35 14.53 -18.47 73.89 13.78 -20.47 coo 12.98 90.36 47.57 11.26 89.62 46.62 80.05 28.39 -4.25 77.97 28.60 -4.21 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 27 3 # 27 A 137 ARG C 50 ARG^? 16.05 MG MG C 302 A 141 THR C 74 THR^? 21.64 MG MG C 302 A 235 ASP C 148 ASP^? 2.75 MG MG C 302s coo 6.21 93.81 36.58 4.58 96.33 37.17 80.61 19.03 -14.42 79.16 18.55 -17.10 coo 6.80 92.87 28.33 4.91 92.74 27.40 73.35 14.53 -18.47 73.89 13.78 -20.47 coo 12.98 90.36 47.57 11.26 89.62 46.62 81.96 23.83 -2.68 80.24 25.11 -2.27 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 28 3 # 28 A 137 ARG C 50 ARG^? 16.05 MG MG C 302 A 141 THR C 74 THR^? 21.64 MG MG C 302 A 235 ASP C 177 ASP^? 8.84 MG MG C 301 coo 6.21 93.81 36.58 4.58 96.33 37.17 80.61 19.03 -14.42 79.16 18.55 -17.10 coo 6.80 92.87 28.33 4.91 92.74 27.40 73.35 14.53 -18.47 73.89 13.78 -20.47 coo 12.98 90.36 47.57 11.26 89.62 46.62 85.60 16.42 -0.31 86.51 17.71 1.09 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 29 3 # 29 A 137 ARG C 193 ARG^? 28.20 MG MG C 301 A 141 THR C 191 THR^? 19.69 MG MG C 301 A 235 ASP C 138 ASP^? 33.43 MG MG C 302 coo 6.21 93.81 36.58 4.58 96.33 37.17 102.52 36.87 -2.60 102.78 39.94 -3.05 coo 6.80 92.87 28.33 4.91 92.74 27.40 96.18 32.27 -1.09 96.82 33.98 0.08 coo 12.98 90.36 47.57 11.26 89.62 46.62 105.43 43.97 -13.30 104.85 43.08 -11.43 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 30 3 # 30 A 137 ARG D 37 ARG^? 18.81 MG MG D 302 A 141 THR D 46 THR^? 23.86 MG MG D 302 A 235 ASP D 171 ASP^? 16.95 MG MG D 301 coo 6.21 93.81 36.58 4.58 96.33 37.17 96.81 38.21 -31.63 94.97 36.32 -33.06 coo 6.80 92.87 28.33 4.91 92.74 27.40 91.28 37.63 -25.27 93.05 36.72 -26.12 coo 12.98 90.36 47.57 11.26 89.62 46.62 100.39 36.69 -43.49 101.13 38.51 -42.69 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 31 3 # 31 A 137 ARG D 50 ARG^? 16.15 MG MG D 302 A 141 THR D 18 THR^? 15.54 MG MG D 302 A 235 ASP C 58 ASP^? 26.67 MG MG D 302 coo 6.21 93.81 36.58 4.58 96.33 37.17 88.00 43.26 -36.30 88.86 43.23 -33.34 coo 6.80 92.87 28.33 4.91 92.74 27.40 93.52 49.91 -39.68 91.41 49.57 -39.76 coo 12.98 90.36 47.57 11.26 89.62 46.62 93.40 43.81 -22.27 94.18 44.45 -24.11 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 32 3 # 32 A 137 ARG D 50 ARG^? 16.15 MG MG D 302 A 141 THR D 18 THR^? 15.54 MG MG D 302 A 235 ASP D 128 ASP^? -3.70 MG MG D 302s coo 6.21 93.81 36.58 4.58 96.33 37.17 88.00 43.26 -36.30 88.86 43.23 -33.34 coo 6.80 92.87 28.33 4.91 92.74 27.40 93.52 49.91 -39.68 91.41 49.57 -39.76 coo 12.98 90.36 47.57 11.26 89.62 46.62 83.33 35.45 -46.13 81.57 36.63 -46.10 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 33 3 # 33 A 137 ARG D 50 ARG^? 16.15 MG MG D 302 A 141 THR D 74 THR^? 21.71 MG MG D 302 A 235 ASP D 128 ASP^? -3.70 MG MG D 302s coo 6.21 93.81 36.58 4.58 96.33 37.17 88.00 43.26 -36.30 88.86 43.23 -33.34 coo 6.80 92.87 28.33 4.91 92.74 27.40 86.03 50.57 -32.19 86.96 50.83 -30.24 coo 12.98 90.36 47.57 11.26 89.62 46.62 83.33 35.45 -46.13 81.57 36.63 -46.10 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 34 3 # 34 A 137 ARG D 50 ARG^? 16.15 MG MG D 302 A 141 THR D 74 THR^? 21.71 MG MG D 302 A 235 ASP D 148 ASP^? 2.35 MG MG D 302s coo 6.21 93.81 36.58 4.58 96.33 37.17 88.00 43.26 -36.30 88.86 43.23 -33.34 coo 6.80 92.87 28.33 4.91 92.74 27.40 86.03 50.57 -32.19 86.96 50.83 -30.24 coo 12.98 90.36 47.57 11.26 89.62 46.62 87.78 37.50 -47.56 85.79 37.49 -48.28 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 35 3 # 35 A 137 ARG D 87 ARG^? 13.34 MG MG E 301 A 141 THR D 88 THR^? 22.15 MG MG E 301 A 235 ASP D 23 ASP^? 15.37 MG MG E 301 coo 6.21 93.81 36.58 4.58 96.33 37.17 79.72 56.28 -33.10 79.15 54.81 -35.72 coo 6.80 92.87 28.33 4.91 92.74 27.40 81.92 51.17 -30.12 82.55 50.45 -28.12 coo 12.98 90.36 47.57 11.26 89.62 46.62 85.70 62.10 -45.60 84.07 62.13 -46.93 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 36 3 # 36 A 137 ARG D 173 ARG^? 18.88 MG MG D 301 A 141 THR D 175 THR^? 12.60 MG MG D 301 A 235 ASP D 35 ASP^? 16.80 MG MG D 302 coo 6.21 93.81 36.58 4.58 96.33 37.17 100.48 42.57 -42.43 101.55 40.79 -40.06 coo 6.80 92.87 28.33 4.91 92.74 27.40 100.33 38.24 -50.15 98.81 36.95 -49.29 coo 12.98 90.36 47.57 11.26 89.62 46.62 93.83 42.00 -33.14 91.74 41.83 -33.51 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 37 3 # 37 A 137 ARG D 193 ARG^? 27.92 MG MG D 301 A 141 THR D 191 THR^? 18.81 MG MG D 301 A 235 ASP D 138 ASP^? 33.64 MG MG D 302 coo 6.21 93.81 36.58 4.58 96.33 37.17 95.76 15.06 -47.43 94.58 12.31 -46.69 coo 6.80 92.87 28.33 4.91 92.74 27.40 93.38 21.98 -48.52 93.15 21.07 -50.52 coo 12.98 90.36 47.57 11.26 89.62 46.62 93.00 7.50 -35.79 93.88 8.48 -37.45 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 38 3 # 38 A 137 ARG E 37 ARG^? 19.17 MG MG E 302 A 141 THR E 46 THR^? 24.08 MG MG E 302 A 235 ASP E 171 ASP^? 16.73 MG MG E 301 coo 6.21 93.81 36.58 4.58 96.33 37.17 70.82 68.02 -63.63 68.17 67.46 -62.14 coo 6.80 92.87 28.33 4.91 92.74 27.40 68.80 63.64 -69.48 69.18 65.66 -68.86 coo 12.98 90.36 47.57 11.26 89.62 46.62 69.61 73.12 -51.56 71.50 73.53 -52.39 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 39 3 # 39 A 137 ARG E 50 ARG^? 15.97 MG MG E 302 A 141 THR E 18 THR^? 15.84 MG MG E 302 A 235 ASP E 128 ASP^? -3.53 MG MG E 302s coo 6.21 93.81 36.58 4.58 96.33 37.17 73.62 60.83 -58.23 74.10 60.41 -61.24 coo 6.80 92.87 28.33 4.91 92.74 27.40 81.45 64.25 -55.27 80.73 62.21 -55.24 coo 12.98 90.36 47.57 11.26 89.62 46.62 65.38 56.57 -48.58 66.15 54.57 -48.61 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 40 3 # 40 A 137 ARG E 50 ARG^? 15.97 MG MG E 302 A 141 THR E 70 THR^? 14.75 MG MG E 302 A 235 ASP E 171 ASP^? 16.73 MG MG E 301 coo 6.21 93.81 36.58 4.58 96.33 37.17 73.62 60.83 -58.23 74.10 60.41 -61.24 coo 6.80 92.87 28.33 4.91 92.74 27.40 68.45 55.77 -62.07 68.75 53.75 -61.41 coo 12.98 90.36 47.57 11.26 89.62 46.62 69.61 73.12 -51.56 71.50 73.53 -52.39 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 41 3 # 41 A 137 ARG E 50 ARG^? 15.97 MG MG E 302 A 141 THR E 70 THR^? 14.75 MG MG E 302 A 235 ASP E 177 ASP^? 8.55 MG MG E 301 coo 6.21 93.81 36.58 4.58 96.33 37.17 73.62 60.83 -58.23 74.10 60.41 -61.24 coo 6.80 92.87 28.33 4.91 92.74 27.40 68.45 55.77 -62.07 68.75 53.75 -61.41 coo 12.98 90.36 47.57 11.26 89.62 46.62 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 42 3 # 42 A 137 ARG E 50 ARG^? 15.97 MG MG E 302 A 141 THR E 73 THR^? 15.13 MG MG E 302 A 235 ASP E 171 ASP^? 16.73 MG MG E 301 coo 6.21 93.81 36.58 4.58 96.33 37.17 73.62 60.83 -58.23 74.10 60.41 -61.24 coo 6.80 92.87 28.33 4.91 92.74 27.40 77.31 55.78 -61.57 77.11 55.21 -59.48 coo 12.98 90.36 47.57 11.26 89.62 46.62 69.61 73.12 -51.56 71.50 73.53 -52.39 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 43 3 # 43 A 137 ARG E 50 ARG^? 15.97 MG MG E 302 A 141 THR E 73 THR^? 15.13 MG MG E 302 A 235 ASP E 177 ASP^? 8.55 MG MG E 301 coo 6.21 93.81 36.58 4.58 96.33 37.17 73.62 60.83 -58.23 74.10 60.41 -61.24 coo 6.80 92.87 28.33 4.91 92.74 27.40 77.31 55.78 -61.57 77.11 55.21 -59.48 coo 12.98 90.36 47.57 11.26 89.62 46.62 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 44 3 # 44 A 137 ARG E 50 ARG^? 15.97 MG MG E 302 A 141 THR E 74 THR^? 21.51 MG MG E 302 A 235 ASP E 128 ASP^? -3.53 MG MG E 302s coo 6.21 93.81 36.58 4.58 96.33 37.17 73.62 60.83 -58.23 74.10 60.41 -61.24 coo 6.80 92.87 28.33 4.91 92.74 27.40 80.89 56.59 -62.50 81.13 57.37 -64.43 coo 12.98 90.36 47.57 11.26 89.62 46.62 65.38 56.57 -48.58 66.15 54.57 -48.61 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 45 3 # 45 A 137 ARG E 50 ARG^? 15.97 MG MG E 302 A 141 THR E 74 THR^? 21.51 MG MG E 302 A 235 ASP E 148 ASP^? 2.62 MG MG E 302s coo 6.21 93.81 36.58 4.58 96.33 37.17 73.62 60.83 -58.23 74.10 60.41 -61.24 coo 6.80 92.87 28.33 4.91 92.74 27.40 80.89 56.59 -62.50 81.13 57.37 -64.43 coo 12.98 90.36 47.57 11.26 89.62 46.62 68.29 60.44 -47.29 68.03 58.42 -46.50 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 46 3 # 46 A 137 ARG E 50 ARG^? 15.97 MG MG E 302 A 141 THR E 74 THR^? 21.51 MG MG E 302 A 235 ASP E 177 ASP^? 8.55 MG MG E 301 coo 6.21 93.81 36.58 4.58 96.33 37.17 73.62 60.83 -58.23 74.10 60.41 -61.24 coo 6.80 92.87 28.33 4.91 92.74 27.40 80.89 56.59 -62.50 81.13 57.37 -64.43 coo 12.98 90.36 47.57 11.26 89.62 46.62 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 47 3 # 47 A 137 ARG E 87 ARG^? 13.25 MG MG D 301 A 141 THR E 73 THR^? 15.13 MG MG E 302 A 235 ASP E 23 ASP^? 15.43 MG MG D 301 coo 6.21 93.81 36.58 4.58 96.33 37.17 85.24 49.22 -61.34 83.59 49.18 -58.71 coo 6.80 92.87 28.33 4.91 92.74 27.40 77.31 55.78 -61.57 77.11 55.21 -59.48 coo 12.98 90.36 47.57 11.26 89.62 46.62 91.98 54.64 -49.37 91.93 52.78 -48.33 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 48 3 # 48 A 137 ARG E 87 ARG^? 13.25 MG MG D 301 A 141 THR E 88 THR^? 21.98 MG MG D 301 A 235 ASP E 23 ASP^? 15.43 MG MG D 301 coo 6.21 93.81 36.58 4.58 96.33 37.17 85.24 49.22 -61.34 83.59 49.18 -58.71 coo 6.80 92.87 28.33 4.91 92.74 27.40 80.56 52.52 -64.50 80.70 53.32 -66.53 coo 12.98 90.36 47.57 11.26 89.62 46.62 91.98 54.64 -49.37 91.93 52.78 -48.33 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 49 3 # 49 A 137 ARG E 173 ARG^? 18.66 MG MG E 301 A 141 THR E 175 THR^? 12.38 MG MG E 301 A 235 ASP E 35 ASP^? 16.91 MG MG E 302 coo 6.21 93.81 36.58 4.58 96.33 37.17 75.16 72.26 -52.56 73.67 73.54 -55.01 coo 6.80 92.87 28.33 4.91 92.74 27.40 71.20 72.92 -44.89 69.57 71.76 -45.77 coo 12.98 90.36 47.57 11.26 89.62 46.62 73.60 65.64 -62.00 73.13 63.73 -61.22 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 50 3 # 50 A 137 ARG E 193 ARG^? 28.25 MG MG E 301 A 141 THR E 191 THR^? 19.16 MG MG E 301 A 235 ASP E 138 ASP^? 33.31 MG MG E 302 coo 6.21 93.81 36.58 4.58 96.33 37.17 47.02 71.25 -47.53 44.19 71.23 -48.93 coo 6.80 92.87 28.33 4.91 92.74 27.40 54.11 68.77 -46.13 52.75 69.16 -44.48 coo 12.98 90.36 47.57 11.26 89.62 46.62 39.58 70.77 -58.63 40.74 70.78 -56.80 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 51 3 # 51 A 137 ARG F 37 ARG^? 19.14 MG MG F 301 A 141 THR F 46 THR^? 24.16 MG MG F 301 A 235 ASP F 171 ASP^? 16.35 MG MG F 302 coo 6.21 93.81 36.58 4.58 96.33 37.17 48.80 64.46 -76.37 51.50 64.15 -77.79 coo 6.80 92.87 28.33 4.91 92.74 27.40 51.99 60.48 -70.07 50.88 62.21 -70.66 coo 12.98 90.36 47.57 11.26 89.62 46.62 48.23 68.08 -88.47 46.26 68.02 -87.56 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 52 3 # 52 A 137 ARG F 50 ARG^? 16.24 MG MG F 301 A 141 THR F 18 THR^? 15.93 MG MG F 301 A 235 ASP F 128 ASP^? -3.41 MG MG F 301s coo 6.21 93.81 36.58 4.58 96.33 37.17 48.85 56.05 -80.24 48.26 54.66 -77.55 coo 6.80 92.87 28.33 4.91 92.74 27.40 39.95 55.99 -83.96 41.26 54.27 -83.96 coo 12.98 90.36 47.57 11.26 89.62 46.62 57.76 53.73 -90.50 57.46 51.64 -90.28 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 53 3 # 53 A 137 ARG F 50 ARG^? 16.24 MG MG F 301 A 141 THR F 70 THR^? 14.73 MG MG F 301 A 235 ASP F 171 ASP^? 16.35 MG MG F 302 coo 6.21 93.81 36.58 4.58 96.33 37.17 48.85 56.05 -80.24 48.26 54.66 -77.55 coo 6.80 92.87 28.33 4.91 92.74 27.40 55.11 52.83 -76.85 55.53 50.86 -77.56 coo 12.98 90.36 47.57 11.26 89.62 46.62 48.23 68.08 -88.47 46.26 68.02 -87.56 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 54 3 # 54 A 137 ARG F 50 ARG^? 16.24 MG MG F 301 A 141 THR F 70 THR^? 14.73 MG MG F 301 A 235 ASP F 177 ASP^? 8.15 MG MG F 302 coo 6.21 93.81 36.58 4.58 96.33 37.17 48.85 56.05 -80.24 48.26 54.66 -77.55 coo 6.80 92.87 28.33 4.91 92.74 27.40 55.11 52.83 -76.85 55.53 50.86 -77.56 coo 12.98 90.36 47.57 11.26 89.62 46.62 47.18 61.22 -94.50 48.48 62.32 -95.73 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 55 3 # 55 A 137 ARG F 50 ARG^? 16.24 MG MG F 301 A 141 THR F 73 THR^? 15.13 MG MG F 301 A 235 ASP F 171 ASP^? 16.35 MG MG F 302 coo 6.21 93.81 36.58 4.58 96.33 37.17 48.85 56.05 -80.24 48.26 54.66 -77.55 coo 6.80 92.87 28.33 4.91 92.74 27.40 46.81 49.68 -77.46 47.14 48.99 -79.45 coo 12.98 90.36 47.57 11.26 89.62 46.62 48.23 68.08 -88.47 46.26 68.02 -87.56 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 56 3 # 56 A 137 ARG F 50 ARG^? 16.24 MG MG F 301 A 141 THR F 73 THR^? 15.13 MG MG F 301 A 235 ASP F 177 ASP^? 8.15 MG MG F 302 coo 6.21 93.81 36.58 4.58 96.33 37.17 48.85 56.05 -80.24 48.26 54.66 -77.55 coo 6.80 92.87 28.33 4.91 92.74 27.40 46.81 49.68 -77.46 47.14 48.99 -79.45 coo 12.98 90.36 47.57 11.26 89.62 46.62 47.18 61.22 -94.50 48.48 62.32 -95.73 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 57 3 # 57 A 137 ARG F 50 ARG^? 16.24 MG MG F 301 A 141 THR F 74 THR^? 21.46 MG MG F 301 A 235 ASP F 128 ASP^? -3.41 MG MG F 301s coo 6.21 93.81 36.58 4.58 96.33 37.17 48.85 56.05 -80.24 48.26 54.66 -77.55 coo 6.80 92.87 28.33 4.91 92.74 27.40 43.07 49.39 -76.61 42.46 50.11 -74.68 coo 12.98 90.36 47.57 11.26 89.62 46.62 57.76 53.73 -90.50 57.46 51.64 -90.28 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 58 3 # 58 A 137 ARG F 50 ARG^? 16.24 MG MG F 301 A 141 THR F 74 THR^? 21.46 MG MG F 301 A 235 ASP F 148 ASP^? 2.72 MG MG F 301s coo 6.21 93.81 36.58 4.58 96.33 37.17 48.85 56.05 -80.24 48.26 54.66 -77.55 coo 6.80 92.87 28.33 4.91 92.74 27.40 43.07 49.39 -76.61 42.46 50.11 -74.68 coo 12.98 90.36 47.57 11.26 89.62 46.62 53.64 56.47 -91.98 54.61 54.68 -92.64 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 59 3 # 59 A 137 ARG F 50 ARG^? 16.24 MG MG F 301 A 141 THR F 74 THR^? 21.46 MG MG F 301 A 235 ASP F 177 ASP^? 8.15 MG MG F 302 coo 6.21 93.81 36.58 4.58 96.33 37.17 48.85 56.05 -80.24 48.26 54.66 -77.55 coo 6.80 92.87 28.33 4.91 92.74 27.40 43.07 49.39 -76.61 42.46 50.11 -74.68 coo 12.98 90.36 47.57 11.26 89.62 46.62 47.18 61.22 -94.50 48.48 62.32 -95.73 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 60 3 # 60 A 137 ARG F 193 ARG^? 27.27 MG MG F 302 A 141 THR F 191 THR^? 18.93 MG MG F 302 A 235 ASP F 138 ASP^? 33.51 MG MG F 302 coo 6.21 93.81 36.58 4.58 96.33 37.17 70.24 75.04 -91.81 72.97 73.73 -92.20 coo 6.80 92.87 28.33 4.91 92.74 27.40 64.36 69.12 -93.82 65.88 69.37 -95.36 coo 12.98 90.36 47.57 11.26 89.62 46.62 77.17 76.66 -81.48 76.14 76.33 -83.32 1bd3_c00 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 60 hits 1bd3_c00 naa= 3 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 D 137 ARG A 37 ARG^? 18.99 MG MG A 301 D 141 THR A 46 THR^? 24.24 MG MG A 301 D 235 ASP A 171 ASP^? 17.17 MG MG A 302 coo -8.33 92.80 100.06 -7.71 95.33 98.44 32.99 26.50 25.19 35.50 25.33 26.51 coo -9.24 93.49 108.77 -7.37 94.21 109.61 38.63 28.11 18.80 36.62 27.50 19.27 coo -14.64 87.74 89.51 -12.89 87.43 90.65 29.78 23.67 36.63 28.48 25.11 35.71 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 D 137 ARG A 50 ARG^? 15.98 MG MG A 301 D 141 THR A 18 THR.? 15.77 MG MG A 301 D 235 ASP A 128 ASP^? -3.32 MG MG A 301s coo -8.33 92.80 100.06 -7.71 95.33 98.44 38.44 33.02 29.31 39.55 34.58 26.90 coo -9.24 93.49 108.77 -7.37 94.21 109.61 32.02 38.89 33.13 34.18 39.03 32.98 coo -14.64 87.74 89.51 -12.89 87.43 90.65 46.50 28.23 39.77 47.49 30.10 39.82 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 D 137 ARG A 50 ARG^? 15.98 MG MG A 301 D 141 THR A 70 THR^? 14.66 MG MG A 301 D 235 ASP A 171 ASP^? 17.17 MG MG A 302 coo -8.33 92.80 100.06 -7.71 95.33 98.44 38.44 33.02 29.31 39.55 34.58 26.90 coo -9.24 93.49 108.77 -7.37 94.21 109.61 45.68 31.52 26.25 47.33 32.60 27.12 coo -14.64 87.74 89.51 -12.89 87.43 90.65 29.78 23.67 36.63 28.48 25.11 35.71 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 D 137 ARG A 50 ARG^? 15.98 MG MG A 301 D 141 THR A 73 THR^? 15.13 MG MG A 301 D 235 ASP A 171 ASP^? 17.17 MG MG A 302 coo -8.33 92.80 100.06 -7.71 95.33 98.44 38.44 33.02 29.31 39.55 34.58 26.90 coo -9.24 93.49 108.77 -7.37 94.21 109.61 40.93 39.17 26.72 41.99 38.78 28.61 coo -14.64 87.74 89.51 -12.89 87.43 90.65 29.78 23.67 36.63 28.48 25.11 35.71 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 D 137 ARG A 50 ARG^? 15.98 MG MG A 301 D 141 THR A 74 THR^? 21.85 MG MG A 301 D 235 ASP A 128 ASP^? -3.32 MG MG A 301s coo -8.33 92.80 100.06 -7.71 95.33 98.44 38.44 33.02 29.31 39.55 34.58 26.90 coo -9.24 93.49 108.77 -7.37 94.21 109.61 38.65 41.92 25.57 37.60 41.76 23.73 coo -14.64 87.74 89.51 -12.89 87.43 90.65 46.50 28.23 39.77 47.49 30.10 39.82 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 D 137 ARG A 50 ARG^? 15.98 MG MG A 301 D 141 THR A 74 THR^? 21.85 MG MG A 301 D 235 ASP A 148 ASP^? 2.72 MG MG A 301s coo -8.33 92.80 100.06 -7.71 95.33 98.44 38.44 33.02 29.31 39.55 34.58 26.90 coo -9.24 93.49 108.77 -7.37 94.21 109.61 38.65 41.92 25.57 37.60 41.76 23.73 coo -14.64 87.74 89.51 -12.89 87.43 90.65 41.50 28.88 41.13 43.33 29.67 41.93 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 7 3 # 7 D 137 ARG A 193 ARG^? 28.88 MG MG A 302 D 141 THR A 191 THR^? 19.40 MG MG A 302 D 235 ASP A 138 ASP^? 33.08 MG MG A 302 coo -8.33 92.80 100.06 -7.71 95.33 98.44 43.09 4.06 39.01 41.78 1.42 39.93 coo -9.24 93.49 108.77 -7.37 94.21 109.61 41.09 12.09 41.99 41.84 10.51 43.34 coo -14.64 87.74 89.51 -12.89 87.43 90.65 47.10 -0.97 29.63 45.89 0.22 30.96 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 8 3 # 8 D 137 ARG B 37 ARG^? 19.17 MG MG B 302 D 141 THR B 46 THR^? 23.88 MG MG B 302 D 235 ASP B 171 ASP^? 16.92 MG MG B 301 coo -8.33 92.80 100.06 -7.71 95.33 98.44 47.41 10.20 11.40 46.99 12.91 10.22 coo -9.24 93.49 108.77 -7.37 94.21 109.61 49.71 15.16 18.13 48.80 13.51 17.14 coo -14.64 87.74 89.51 -12.89 87.43 90.65 45.30 8.50 -0.71 46.30 6.81 0.12 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 9 3 # 9 D 137 ARG B 50 ARG^? 16.38 MG MG B 302 D 141 THR B 18 THR^? 16.08 MG MG B 302 D 235 ASP B 128 ASP^? -3.57 MG MG B 302s coo -8.33 92.80 100.06 -7.71 95.33 98.44 55.38 14.91 7.80 56.60 14.73 10.62 coo -9.24 93.49 108.77 -7.37 94.21 109.61 60.02 7.32 3.97 60.86 9.29 4.05 coo -14.64 87.74 89.51 -12.89 87.43 90.65 52.92 24.09 -2.19 54.73 25.14 -1.90 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 10 3 # 10 D 137 ARG B 50 ARG^? 16.38 MG MG B 302 D 141 THR B 70 THR^? 14.69 MG MG B 302 D 235 ASP B 171 ASP^? 16.92 MG MG B 301 coo -8.33 92.80 100.06 -7.71 95.33 98.44 55.38 14.91 7.80 56.60 14.73 10.62 coo -9.24 93.49 108.77 -7.37 94.21 109.61 54.82 21.76 11.59 56.34 23.17 10.82 coo -14.64 87.74 89.51 -12.89 87.43 90.65 45.30 8.50 -0.71 46.30 6.81 0.12 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 11 3 # 11 D 137 ARG B 50 ARG^? 16.38 MG MG B 302 D 141 THR B 73 THR^? 15.28 MG MG B 302 D 235 ASP B 171 ASP^? 16.92 MG MG B 301 coo -8.33 92.80 100.06 -7.71 95.33 98.44 55.38 14.91 7.80 56.60 14.73 10.62 coo -9.24 93.49 108.77 -7.37 94.21 109.61 61.79 16.15 11.00 62.15 17.08 9.05 coo -14.64 87.74 89.51 -12.89 87.43 90.65 45.30 8.50 -0.71 46.30 6.81 0.12 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 12 3 # 12 D 137 ARG B 50 ARG^? 16.38 MG MG B 302 D 141 THR B 74 THR^? 21.68 MG MG B 302 D 235 ASP B 128 ASP^? -3.57 MG MG B 302s coo -8.33 92.80 100.06 -7.71 95.33 98.44 55.38 14.91 7.80 56.60 14.73 10.62 coo -9.24 93.49 108.77 -7.37 94.21 109.61 63.99 13.20 11.95 63.36 12.32 13.84 coo -14.64 87.74 89.51 -12.89 87.43 90.65 52.92 24.09 -2.19 54.73 25.14 -1.90 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 13 3 # 13 D 137 ARG B 50 ARG^? 16.38 MG MG B 302 D 141 THR B 74 THR^? 21.68 MG MG B 302 D 235 ASP B 148 ASP^? 2.58 MG MG B 302s coo -8.33 92.80 100.06 -7.71 95.33 98.44 55.38 14.91 7.80 56.60 14.73 10.62 coo -9.24 93.49 108.77 -7.37 94.21 109.61 63.99 13.20 11.95 63.36 12.32 13.84 coo -14.64 87.74 89.51 -12.89 87.43 90.65 52.73 19.23 -3.77 53.81 20.99 -4.31 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 14 3 # 14 D 137 ARG B 87 ARG^? 13.84 MG MG C 301 D 141 THR B 73 THR^? 15.28 MG MG B 302 D 235 ASP B 23 ASP^? 15.67 MG MG C 301 coo -8.33 92.80 100.06 -7.71 95.33 98.44 72.30 15.49 11.27 71.00 17.29 9.11 coo -9.24 93.49 108.77 -7.37 94.21 109.61 61.79 16.15 11.00 62.15 17.08 9.05 coo -14.64 87.74 89.51 -12.89 87.43 90.65 74.31 7.55 -1.09 75.08 9.17 -2.23 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 15 3 # 15 D 137 ARG B 193 ARG^? 28.40 MG MG B 301 D 141 THR B 191 THR^? 19.68 MG MG B 301 D 235 ASP B 138 ASP^? 33.32 MG MG B 302 coo -8.33 92.80 100.06 -7.71 95.33 98.44 29.25 23.93 -4.74 26.96 25.70 -3.52 coo -9.24 93.49 108.77 -7.37 94.21 109.61 36.37 22.10 -5.64 35.04 22.83 -7.26 coo -14.64 87.74 89.51 -12.89 87.43 90.65 23.42 29.01 6.78 24.36 28.48 4.94 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 16 3 # 16 D 137 ARG C 37 ARG^? 19.01 MG MG C 302 D 141 THR C 46 THR^? 24.02 MG MG C 302 D 235 ASP C 171 ASP^? 17.08 MG MG C 301 coo -8.33 92.80 100.06 -7.71 95.33 98.44 89.36 17.23 -17.57 89.29 20.20 -16.76 coo -9.24 93.49 108.77 -7.37 94.21 109.61 85.56 21.34 -24.69 87.12 20.00 -24.12 coo -14.64 87.74 89.51 -12.89 87.43 90.65 92.57 16.68 -6.24 92.24 14.74 -7.03 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 17 3 # 17 D 137 ARG C 50 ARG^? 16.05 MG MG C 302 D 141 THR C 18 THR^? 15.72 MG MG C 302 D 235 ASP C 128 ASP^? -3.22 MG MG C 302s coo -8.33 92.80 100.06 -7.71 95.33 98.44 80.61 19.03 -14.42 79.16 18.55 -17.10 coo -9.24 93.49 108.77 -7.37 94.21 109.61 79.00 10.43 -10.53 77.64 12.10 -10.65 coo -14.64 87.74 89.51 -12.89 87.43 90.65 80.05 28.39 -4.25 77.97 28.60 -4.21 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 18 3 # 18 D 137 ARG C 50 ARG^? 16.05 MG MG C 302 D 141 THR C 70 THR^? 14.45 MG MG C 302 D 235 ASP C 171 ASP^? 17.08 MG MG C 301 coo -8.33 92.80 100.06 -7.71 95.33 98.44 80.61 19.03 -14.42 79.16 18.55 -17.10 coo -9.24 93.49 108.77 -7.37 94.21 109.61 78.63 25.77 -17.76 76.70 26.55 -17.21 coo -14.64 87.74 89.51 -12.89 87.43 90.65 92.57 16.68 -6.24 92.24 14.74 -7.03 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 19 3 # 19 D 137 ARG C 50 ARG^? 16.05 MG MG C 302 D 141 THR C 70 THR^? 14.45 MG MG C 302 D 235 ASP C 177 ASP^? 8.84 MG MG C 301 coo -8.33 92.80 100.06 -7.71 95.33 98.44 80.61 19.03 -14.42 79.16 18.55 -17.10 coo -9.24 93.49 108.77 -7.37 94.21 109.61 78.63 25.77 -17.76 76.70 26.55 -17.21 coo -14.64 87.74 89.51 -12.89 87.43 90.65 85.60 16.42 -0.31 86.51 17.71 1.09 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 20 3 # 20 D 137 ARG C 50 ARG^? 16.05 MG MG C 302 D 141 THR C 73 THR^? 14.95 MG MG C 302 D 235 ASP C 171 ASP^? 17.08 MG MG C 301 coo -8.33 92.80 100.06 -7.71 95.33 98.44 80.61 19.03 -14.42 79.16 18.55 -17.10 coo -9.24 93.49 108.77 -7.37 94.21 109.61 74.44 18.04 -17.45 73.99 18.64 -15.48 coo -14.64 87.74 89.51 -12.89 87.43 90.65 92.57 16.68 -6.24 92.24 14.74 -7.03 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 21 3 # 21 D 137 ARG C 50 ARG^? 16.05 MG MG C 302 D 141 THR C 73 THR^? 14.95 MG MG C 302 D 235 ASP C 177 ASP^? 8.84 MG MG C 301 coo -8.33 92.80 100.06 -7.71 95.33 98.44 80.61 19.03 -14.42 79.16 18.55 -17.10 coo -9.24 93.49 108.77 -7.37 94.21 109.61 74.44 18.04 -17.45 73.99 18.64 -15.48 coo -14.64 87.74 89.51 -12.89 87.43 90.65 85.60 16.42 -0.31 86.51 17.71 1.09 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 22 3 # 22 D 137 ARG C 50 ARG^? 16.05 MG MG C 302 D 141 THR C 74 THR^? 21.64 MG MG C 302 D 235 ASP C 128 ASP^? -3.22 MG MG C 302s coo -8.33 92.80 100.06 -7.71 95.33 98.44 80.61 19.03 -14.42 79.16 18.55 -17.10 coo -9.24 93.49 108.77 -7.37 94.21 109.61 73.35 14.53 -18.47 73.89 13.78 -20.47 coo -14.64 87.74 89.51 -12.89 87.43 90.65 80.05 28.39 -4.25 77.97 28.60 -4.21 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 23 3 # 23 D 137 ARG C 50 ARG^? 16.05 MG MG C 302 D 141 THR C 74 THR^? 21.64 MG MG C 302 D 235 ASP C 148 ASP^? 2.75 MG MG C 302s coo -8.33 92.80 100.06 -7.71 95.33 98.44 80.61 19.03 -14.42 79.16 18.55 -17.10 coo -9.24 93.49 108.77 -7.37 94.21 109.61 73.35 14.53 -18.47 73.89 13.78 -20.47 coo -14.64 87.74 89.51 -12.89 87.43 90.65 81.96 23.83 -2.68 80.24 25.11 -2.27 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 24 3 # 24 D 137 ARG C 50 ARG^? 16.05 MG MG C 302 D 141 THR C 74 THR^? 21.64 MG MG C 302 D 235 ASP C 177 ASP^? 8.84 MG MG C 301 coo -8.33 92.80 100.06 -7.71 95.33 98.44 80.61 19.03 -14.42 79.16 18.55 -17.10 coo -9.24 93.49 108.77 -7.37 94.21 109.61 73.35 14.53 -18.47 73.89 13.78 -20.47 coo -14.64 87.74 89.51 -12.89 87.43 90.65 85.60 16.42 -0.31 86.51 17.71 1.09 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 25 3 # 25 D 137 ARG C 87 ARG^? 14.11 MG MG B 301 D 141 THR C 73 THR^? 14.95 MG MG C 302 D 235 ASP C 23 ASP^? 15.39 MG MG B 301 coo -8.33 92.80 100.06 -7.71 95.33 98.44 64.80 14.21 -18.13 65.25 15.52 -15.36 coo -9.24 93.49 108.77 -7.37 94.21 109.61 74.44 18.04 -17.45 73.99 18.64 -15.48 coo -14.64 87.74 89.51 -12.89 87.43 90.65 65.24 6.82 -5.11 63.43 7.54 -4.15 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 26 3 # 26 D 137 ARG C 193 ARG^? 28.20 MG MG C 301 D 141 THR C 191 THR^? 19.69 MG MG C 301 D 235 ASP C 138 ASP^? 33.43 MG MG C 302 coo -8.33 92.80 100.06 -7.71 95.33 98.44 102.52 36.87 -2.60 102.78 39.94 -3.05 coo -9.24 93.49 108.77 -7.37 94.21 109.61 96.18 32.27 -1.09 96.82 33.98 0.08 coo -14.64 87.74 89.51 -12.89 87.43 90.65 105.43 43.97 -13.30 104.85 43.08 -11.43 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 27 3 # 27 D 137 ARG D 37 ARG^? 18.81 MG MG D 302 D 141 THR D 46 THR^? 23.86 MG MG D 302 D 235 ASP D 171 ASP^? 16.95 MG MG D 301 coo -8.33 92.80 100.06 -7.71 95.33 98.44 96.81 38.21 -31.63 94.97 36.32 -33.06 coo -9.24 93.49 108.77 -7.37 94.21 109.61 91.28 37.63 -25.27 93.05 36.72 -26.12 coo -14.64 87.74 89.51 -12.89 87.43 90.65 100.39 36.69 -43.49 101.13 38.51 -42.69 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 28 3 # 28 D 137 ARG D 50 ARG^? 16.15 MG MG D 302 D 141 THR D 18 THR^? 15.54 MG MG D 302 D 235 ASP D 128 ASP^? -3.70 MG MG D 302s coo -8.33 92.80 100.06 -7.71 95.33 98.44 88.00 43.26 -36.30 88.86 43.23 -33.34 coo -9.24 93.49 108.77 -7.37 94.21 109.61 93.52 49.91 -39.68 91.41 49.57 -39.76 coo -14.64 87.74 89.51 -12.89 87.43 90.65 83.33 35.45 -46.13 81.57 36.63 -46.10 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 29 3 # 29 D 137 ARG D 50 ARG^? 16.15 MG MG D 302 D 141 THR D 74 THR^? 21.71 MG MG D 302 D 235 ASP D 128 ASP^? -3.70 MG MG D 302s coo -8.33 92.80 100.06 -7.71 95.33 98.44 88.00 43.26 -36.30 88.86 43.23 -33.34 coo -9.24 93.49 108.77 -7.37 94.21 109.61 86.03 50.57 -32.19 86.96 50.83 -30.24 coo -14.64 87.74 89.51 -12.89 87.43 90.65 83.33 35.45 -46.13 81.57 36.63 -46.10 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 30 3 # 30 D 137 ARG D 50 ARG^? 16.15 MG MG D 302 D 141 THR D 74 THR^? 21.71 MG MG D 302 D 235 ASP D 148 ASP^? 2.35 MG MG D 302s coo -8.33 92.80 100.06 -7.71 95.33 98.44 88.00 43.26 -36.30 88.86 43.23 -33.34 coo -9.24 93.49 108.77 -7.37 94.21 109.61 86.03 50.57 -32.19 86.96 50.83 -30.24 coo -14.64 87.74 89.51 -12.89 87.43 90.65 87.78 37.50 -47.56 85.79 37.49 -48.28 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 31 3 # 31 D 137 ARG D 87 ARG^? 13.34 MG MG E 301 D 141 THR D 73 THR^? 15.26 MG MG D 302 D 235 ASP D 23 ASP^? 15.37 MG MG E 301 coo -8.33 92.80 100.06 -7.71 95.33 98.44 79.72 56.28 -33.10 79.15 54.81 -35.72 coo -9.24 93.49 108.77 -7.37 94.21 109.61 84.65 47.16 -33.26 83.69 47.10 -35.24 coo -14.64 87.74 89.51 -12.89 87.43 90.65 85.70 62.10 -45.60 84.07 62.13 -46.93 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 32 3 # 32 D 137 ARG D 193 ARG^? 27.92 MG MG D 301 D 141 THR D 191 THR^? 18.81 MG MG D 301 D 235 ASP D 138 ASP^? 33.64 MG MG D 302 coo -8.33 92.80 100.06 -7.71 95.33 98.44 95.76 15.06 -47.43 94.58 12.31 -46.69 coo -9.24 93.49 108.77 -7.37 94.21 109.61 93.38 21.98 -48.52 93.15 21.07 -50.52 coo -14.64 87.74 89.51 -12.89 87.43 90.65 93.00 7.50 -35.79 93.88 8.48 -37.45 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 33 3 # 33 D 137 ARG E 37 ARG^? 19.17 MG MG E 302 D 141 THR E 46 THR^? 24.08 MG MG E 302 D 235 ASP E 171 ASP^? 16.73 MG MG E 301 coo -8.33 92.80 100.06 -7.71 95.33 98.44 70.82 68.02 -63.63 68.17 67.46 -62.14 coo -9.24 93.49 108.77 -7.37 94.21 109.61 68.80 63.64 -69.48 69.18 65.66 -68.86 coo -14.64 87.74 89.51 -12.89 87.43 90.65 69.61 73.12 -51.56 71.50 73.53 -52.39 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 34 3 # 34 D 137 ARG E 50 ARG^? 15.97 MG MG E 302 D 141 THR E 18 THR^? 15.84 MG MG E 302 D 235 ASP E 128 ASP^? -3.53 MG MG E 302s coo -8.33 92.80 100.06 -7.71 95.33 98.44 73.62 60.83 -58.23 74.10 60.41 -61.24 coo -9.24 93.49 108.77 -7.37 94.21 109.61 81.45 64.25 -55.27 80.73 62.21 -55.24 coo -14.64 87.74 89.51 -12.89 87.43 90.65 65.38 56.57 -48.58 66.15 54.57 -48.61 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 35 3 # 35 D 137 ARG E 50 ARG^? 15.97 MG MG E 302 D 141 THR E 70 THR^? 14.75 MG MG E 302 D 235 ASP E 171 ASP^? 16.73 MG MG E 301 coo -8.33 92.80 100.06 -7.71 95.33 98.44 73.62 60.83 -58.23 74.10 60.41 -61.24 coo -9.24 93.49 108.77 -7.37 94.21 109.61 68.45 55.77 -62.07 68.75 53.75 -61.41 coo -14.64 87.74 89.51 -12.89 87.43 90.65 69.61 73.12 -51.56 71.50 73.53 -52.39 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 36 3 # 36 D 137 ARG E 50 ARG^? 15.97 MG MG E 302 D 141 THR E 70 THR^? 14.75 MG MG E 302 D 235 ASP E 177 ASP^? 8.55 MG MG E 301 coo -8.33 92.80 100.06 -7.71 95.33 98.44 73.62 60.83 -58.23 74.10 60.41 -61.24 coo -9.24 93.49 108.77 -7.37 94.21 109.61 68.45 55.77 -62.07 68.75 53.75 -61.41 coo -14.64 87.74 89.51 -12.89 87.43 90.65 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 37 3 # 37 D 137 ARG E 50 ARG^? 15.97 MG MG E 302 D 141 THR E 73 THR^? 15.13 MG MG E 302 D 235 ASP E 171 ASP^? 16.73 MG MG E 301 coo -8.33 92.80 100.06 -7.71 95.33 98.44 73.62 60.83 -58.23 74.10 60.41 -61.24 coo -9.24 93.49 108.77 -7.37 94.21 109.61 77.31 55.78 -61.57 77.11 55.21 -59.48 coo -14.64 87.74 89.51 -12.89 87.43 90.65 69.61 73.12 -51.56 71.50 73.53 -52.39 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 38 3 # 38 D 137 ARG E 50 ARG^? 15.97 MG MG E 302 D 141 THR E 73 THR^? 15.13 MG MG E 302 D 235 ASP E 177 ASP^? 8.55 MG MG E 301 coo -8.33 92.80 100.06 -7.71 95.33 98.44 73.62 60.83 -58.23 74.10 60.41 -61.24 coo -9.24 93.49 108.77 -7.37 94.21 109.61 77.31 55.78 -61.57 77.11 55.21 -59.48 coo -14.64 87.74 89.51 -12.89 87.43 90.65 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 39 3 # 39 D 137 ARG E 50 ARG^? 15.97 MG MG E 302 D 141 THR E 74 THR^? 21.51 MG MG E 302 D 235 ASP E 128 ASP^? -3.53 MG MG E 302s coo -8.33 92.80 100.06 -7.71 95.33 98.44 73.62 60.83 -58.23 74.10 60.41 -61.24 coo -9.24 93.49 108.77 -7.37 94.21 109.61 80.89 56.59 -62.50 81.13 57.37 -64.43 coo -14.64 87.74 89.51 -12.89 87.43 90.65 65.38 56.57 -48.58 66.15 54.57 -48.61 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 40 3 # 40 D 137 ARG E 50 ARG^? 15.97 MG MG E 302 D 141 THR E 74 THR^? 21.51 MG MG E 302 D 235 ASP E 148 ASP^? 2.62 MG MG E 302s coo -8.33 92.80 100.06 -7.71 95.33 98.44 73.62 60.83 -58.23 74.10 60.41 -61.24 coo -9.24 93.49 108.77 -7.37 94.21 109.61 80.89 56.59 -62.50 81.13 57.37 -64.43 coo -14.64 87.74 89.51 -12.89 87.43 90.65 68.29 60.44 -47.29 68.03 58.42 -46.50 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 41 3 # 41 D 137 ARG E 50 ARG^? 15.97 MG MG E 302 D 141 THR E 74 THR^? 21.51 MG MG E 302 D 235 ASP E 177 ASP^? 8.55 MG MG E 301 coo -8.33 92.80 100.06 -7.71 95.33 98.44 73.62 60.83 -58.23 74.10 60.41 -61.24 coo -9.24 93.49 108.77 -7.37 94.21 109.61 80.89 56.59 -62.50 81.13 57.37 -64.43 coo -14.64 87.74 89.51 -12.89 87.43 90.65 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 42 3 # 42 D 137 ARG E 87 ARG^? 13.25 MG MG D 301 D 141 THR E 73 THR^? 15.13 MG MG E 302 D 235 ASP E 23 ASP^? 15.43 MG MG D 301 coo -8.33 92.80 100.06 -7.71 95.33 98.44 85.24 49.22 -61.34 83.59 49.18 -58.71 coo -9.24 93.49 108.77 -7.37 94.21 109.61 77.31 55.78 -61.57 77.11 55.21 -59.48 coo -14.64 87.74 89.51 -12.89 87.43 90.65 91.98 54.64 -49.37 91.93 52.78 -48.33 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 43 3 # 43 D 137 ARG E 193 ARG^? 28.25 MG MG E 301 D 141 THR E 191 THR^? 19.16 MG MG E 301 D 235 ASP E 138 ASP^? 33.31 MG MG E 302 coo -8.33 92.80 100.06 -7.71 95.33 98.44 47.02 71.25 -47.53 44.19 71.23 -48.93 coo -9.24 93.49 108.77 -7.37 94.21 109.61 54.11 68.77 -46.13 52.75 69.16 -44.48 coo -14.64 87.74 89.51 -12.89 87.43 90.65 39.58 70.77 -58.63 40.74 70.78 -56.80 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 44 3 # 44 D 137 ARG F 37 ARG^? 19.14 MG MG F 301 D 141 THR F 46 THR^? 24.16 MG MG F 301 D 235 ASP F 171 ASP^? 16.35 MG MG F 302 coo -8.33 92.80 100.06 -7.71 95.33 98.44 48.80 64.46 -76.37 51.50 64.15 -77.79 coo -9.24 93.49 108.77 -7.37 94.21 109.61 51.99 60.48 -70.07 50.88 62.21 -70.66 coo -14.64 87.74 89.51 -12.89 87.43 90.65 48.23 68.08 -88.47 46.26 68.02 -87.56 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 45 3 # 45 D 137 ARG F 50 ARG^? 16.24 MG MG F 301 D 141 THR F 18 THR^? 15.93 MG MG F 301 D 235 ASP F 128 ASP^? -3.41 MG MG F 301s coo -8.33 92.80 100.06 -7.71 95.33 98.44 48.85 56.05 -80.24 48.26 54.66 -77.55 coo -9.24 93.49 108.77 -7.37 94.21 109.61 39.95 55.99 -83.96 41.26 54.27 -83.96 coo -14.64 87.74 89.51 -12.89 87.43 90.65 57.76 53.73 -90.50 57.46 51.64 -90.28 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 46 3 # 46 D 137 ARG F 50 ARG^? 16.24 MG MG F 301 D 141 THR F 70 THR^? 14.73 MG MG F 301 D 235 ASP F 171 ASP^? 16.35 MG MG F 302 coo -8.33 92.80 100.06 -7.71 95.33 98.44 48.85 56.05 -80.24 48.26 54.66 -77.55 coo -9.24 93.49 108.77 -7.37 94.21 109.61 55.11 52.83 -76.85 55.53 50.86 -77.56 coo -14.64 87.74 89.51 -12.89 87.43 90.65 48.23 68.08 -88.47 46.26 68.02 -87.56 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 47 3 # 47 D 137 ARG F 50 ARG^? 16.24 MG MG F 301 D 141 THR F 70 THR^? 14.73 MG MG F 301 D 235 ASP F 177 ASP^? 8.15 MG MG F 302 coo -8.33 92.80 100.06 -7.71 95.33 98.44 48.85 56.05 -80.24 48.26 54.66 -77.55 coo -9.24 93.49 108.77 -7.37 94.21 109.61 55.11 52.83 -76.85 55.53 50.86 -77.56 coo -14.64 87.74 89.51 -12.89 87.43 90.65 47.18 61.22 -94.50 48.48 62.32 -95.73 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 48 3 # 48 D 137 ARG F 50 ARG^? 16.24 MG MG F 301 D 141 THR F 73 THR^? 15.13 MG MG F 301 D 235 ASP F 171 ASP^? 16.35 MG MG F 302 coo -8.33 92.80 100.06 -7.71 95.33 98.44 48.85 56.05 -80.24 48.26 54.66 -77.55 coo -9.24 93.49 108.77 -7.37 94.21 109.61 46.81 49.68 -77.46 47.14 48.99 -79.45 coo -14.64 87.74 89.51 -12.89 87.43 90.65 48.23 68.08 -88.47 46.26 68.02 -87.56 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 49 3 # 49 D 137 ARG F 50 ARG^? 16.24 MG MG F 301 D 141 THR F 73 THR^? 15.13 MG MG F 301 D 235 ASP F 177 ASP^? 8.15 MG MG F 302 coo -8.33 92.80 100.06 -7.71 95.33 98.44 48.85 56.05 -80.24 48.26 54.66 -77.55 coo -9.24 93.49 108.77 -7.37 94.21 109.61 46.81 49.68 -77.46 47.14 48.99 -79.45 coo -14.64 87.74 89.51 -12.89 87.43 90.65 47.18 61.22 -94.50 48.48 62.32 -95.73 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 50 3 # 50 D 137 ARG F 50 ARG^? 16.24 MG MG F 301 D 141 THR F 74 THR^? 21.46 MG MG F 301 D 235 ASP F 128 ASP^? -3.41 MG MG F 301s coo -8.33 92.80 100.06 -7.71 95.33 98.44 48.85 56.05 -80.24 48.26 54.66 -77.55 coo -9.24 93.49 108.77 -7.37 94.21 109.61 43.07 49.39 -76.61 42.46 50.11 -74.68 coo -14.64 87.74 89.51 -12.89 87.43 90.65 57.76 53.73 -90.50 57.46 51.64 -90.28 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 51 3 # 51 D 137 ARG F 50 ARG^? 16.24 MG MG F 301 D 141 THR F 74 THR^? 21.46 MG MG F 301 D 235 ASP F 148 ASP^? 2.72 MG MG F 301s coo -8.33 92.80 100.06 -7.71 95.33 98.44 48.85 56.05 -80.24 48.26 54.66 -77.55 coo -9.24 93.49 108.77 -7.37 94.21 109.61 43.07 49.39 -76.61 42.46 50.11 -74.68 coo -14.64 87.74 89.51 -12.89 87.43 90.65 53.64 56.47 -91.98 54.61 54.68 -92.64 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 52 3 # 52 D 137 ARG F 50 ARG^? 16.24 MG MG F 301 D 141 THR F 74 THR^? 21.46 MG MG F 301 D 235 ASP F 171 ASP^? 16.35 MG MG F 302 coo -8.33 92.80 100.06 -7.71 95.33 98.44 48.85 56.05 -80.24 48.26 54.66 -77.55 coo -9.24 93.49 108.77 -7.37 94.21 109.61 43.07 49.39 -76.61 42.46 50.11 -74.68 coo -14.64 87.74 89.51 -12.89 87.43 90.65 48.23 68.08 -88.47 46.26 68.02 -87.56 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 53 3 # 53 D 137 ARG F 50 ARG^? 16.24 MG MG F 301 D 141 THR F 74 THR^? 21.46 MG MG F 301 D 235 ASP F 177 ASP^? 8.15 MG MG F 302 coo -8.33 92.80 100.06 -7.71 95.33 98.44 48.85 56.05 -80.24 48.26 54.66 -77.55 coo -9.24 93.49 108.77 -7.37 94.21 109.61 43.07 49.39 -76.61 42.46 50.11 -74.68 coo -14.64 87.74 89.51 -12.89 87.43 90.65 47.18 61.22 -94.50 48.48 62.32 -95.73 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 54 3 # 54 D 137 ARG F 193 ARG^? 27.27 MG MG F 302 D 141 THR F 191 THR^? 18.93 MG MG F 302 D 235 ASP F 138 ASP^? 33.51 MG MG F 302 coo -8.33 92.80 100.06 -7.71 95.33 98.44 70.24 75.04 -91.81 72.97 73.73 -92.20 coo -9.24 93.49 108.77 -7.37 94.21 109.61 64.36 69.12 -93.82 65.88 69.37 -95.36 coo -14.64 87.74 89.51 -12.89 87.43 90.65 77.17 76.66 -81.48 76.14 76.33 -83.32 1bd3_c01 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 54 hits 1bd3_c01 naa= 3 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 C 137 ARG A 37 ARG^? 18.99 MG MG A 301 C 141 THR A 46 THR^? 24.24 MG MG A 301 C 235 ASP A 171 ASP^? 17.17 MG MG A 302 coo -5.79 67.26 36.83 -4.57 64.58 37.74 32.99 26.50 25.19 35.50 25.33 26.51 coo -6.81 68.31 28.28 -4.82 68.47 27.57 38.63 28.11 18.80 36.62 27.50 19.27 coo -13.01 70.96 47.58 -11.44 71.65 46.34 29.78 23.67 36.63 28.48 25.11 35.71 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 C 137 ARG A 50 ARG^? 15.98 MG MG A 301 C 141 THR A 18 THR.? 15.77 MG MG A 301 C 235 ASP A 128 ASP^? -3.32 MG MG A 301s coo -5.79 67.26 36.83 -4.57 64.58 37.74 38.44 33.02 29.31 39.55 34.58 26.90 coo -6.81 68.31 28.28 -4.82 68.47 27.57 32.02 38.89 33.13 34.18 39.03 32.98 coo -13.01 70.96 47.58 -11.44 71.65 46.34 46.50 28.23 39.77 47.49 30.10 39.82 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 C 137 ARG A 50 ARG^? 15.98 MG MG A 301 C 141 THR A 70 THR^? 14.66 MG MG A 301 C 235 ASP A 171 ASP^? 17.17 MG MG A 302 coo -5.79 67.26 36.83 -4.57 64.58 37.74 38.44 33.02 29.31 39.55 34.58 26.90 coo -6.81 68.31 28.28 -4.82 68.47 27.57 45.68 31.52 26.25 47.33 32.60 27.12 coo -13.01 70.96 47.58 -11.44 71.65 46.34 29.78 23.67 36.63 28.48 25.11 35.71 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 C 137 ARG A 50 ARG^? 15.98 MG MG A 301 C 141 THR A 70 THR^? 14.66 MG MG A 301 C 235 ASP A 177 ASP^? 8.44 MG MG A 302 coo -5.79 67.26 36.83 -4.57 64.58 37.74 38.44 33.02 29.31 39.55 34.58 26.90 coo -6.81 68.31 28.28 -4.82 68.47 27.57 45.68 31.52 26.25 47.33 32.60 27.12 coo -13.01 70.96 47.58 -11.44 71.65 46.34 33.02 29.04 43.18 33.79 27.88 44.78 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 C 137 ARG A 50 ARG^? 15.98 MG MG A 301 C 141 THR A 73 THR^? 15.13 MG MG A 301 C 235 ASP A 171 ASP^? 17.17 MG MG A 302 coo -5.79 67.26 36.83 -4.57 64.58 37.74 38.44 33.02 29.31 39.55 34.58 26.90 coo -6.81 68.31 28.28 -4.82 68.47 27.57 40.93 39.17 26.72 41.99 38.78 28.61 coo -13.01 70.96 47.58 -11.44 71.65 46.34 29.78 23.67 36.63 28.48 25.11 35.71 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 C 137 ARG A 50 ARG^? 15.98 MG MG A 301 C 141 THR A 73 THR^? 15.13 MG MG A 301 C 235 ASP A 177 ASP^? 8.44 MG MG A 302 coo -5.79 67.26 36.83 -4.57 64.58 37.74 38.44 33.02 29.31 39.55 34.58 26.90 coo -6.81 68.31 28.28 -4.82 68.47 27.57 40.93 39.17 26.72 41.99 38.78 28.61 coo -13.01 70.96 47.58 -11.44 71.65 46.34 33.02 29.04 43.18 33.79 27.88 44.78 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 7 3 # 7 C 137 ARG A 50 ARG^? 15.98 MG MG A 301 C 141 THR A 74 THR^? 21.85 MG MG A 301 C 235 ASP A 128 ASP^? -3.32 MG MG A 301s coo -5.79 67.26 36.83 -4.57 64.58 37.74 38.44 33.02 29.31 39.55 34.58 26.90 coo -6.81 68.31 28.28 -4.82 68.47 27.57 38.65 41.92 25.57 37.60 41.76 23.73 coo -13.01 70.96 47.58 -11.44 71.65 46.34 46.50 28.23 39.77 47.49 30.10 39.82 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 8 3 # 8 C 137 ARG A 50 ARG^? 15.98 MG MG A 301 C 141 THR A 74 THR^? 21.85 MG MG A 301 C 235 ASP A 148 ASP^? 2.72 MG MG A 301s coo -5.79 67.26 36.83 -4.57 64.58 37.74 38.44 33.02 29.31 39.55 34.58 26.90 coo -6.81 68.31 28.28 -4.82 68.47 27.57 38.65 41.92 25.57 37.60 41.76 23.73 coo -13.01 70.96 47.58 -11.44 71.65 46.34 41.50 28.88 41.13 43.33 29.67 41.93 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 9 3 # 9 C 137 ARG A 87 ARG^? 20.70 MG MG A 301 C 141 THR A 73 THR^? 15.13 MG MG A 301 C 235 ASP A 23 ASP^? 22.90 MG MG A 301 coo -5.79 67.26 36.83 -4.57 64.58 37.74 43.15 49.03 26.22 43.83 48.14 29.12 coo -6.81 68.31 28.28 -4.82 68.47 27.57 40.93 39.17 26.72 41.99 38.78 28.61 coo -13.01 70.96 47.58 -11.44 71.65 46.34 36.40 52.47 38.61 38.03 53.36 39.72 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 10 3 # 10 C 137 ARG B 37 ARG^? 19.17 MG MG B 302 C 141 THR B 46 THR^? 23.88 MG MG B 302 C 235 ASP B 171 ASP^? 16.92 MG MG B 301 coo -5.79 67.26 36.83 -4.57 64.58 37.74 47.41 10.20 11.40 46.99 12.91 10.22 coo -6.81 68.31 28.28 -4.82 68.47 27.57 49.71 15.16 18.13 48.80 13.51 17.14 coo -13.01 70.96 47.58 -11.44 71.65 46.34 45.30 8.50 -0.71 46.30 6.81 0.12 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 11 3 # 11 C 137 ARG B 50 ARG^? 16.38 MG MG B 302 C 141 THR B 18 THR^? 16.08 MG MG B 302 C 235 ASP B 128 ASP^? -3.57 MG MG B 302s coo -5.79 67.26 36.83 -4.57 64.58 37.74 55.38 14.91 7.80 56.60 14.73 10.62 coo -6.81 68.31 28.28 -4.82 68.47 27.57 60.02 7.32 3.97 60.86 9.29 4.05 coo -13.01 70.96 47.58 -11.44 71.65 46.34 52.92 24.09 -2.19 54.73 25.14 -1.90 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 12 3 # 12 C 137 ARG B 50 ARG^? 16.38 MG MG B 302 C 141 THR B 70 THR^? 14.69 MG MG B 302 C 235 ASP B 171 ASP^? 16.92 MG MG B 301 coo -5.79 67.26 36.83 -4.57 64.58 37.74 55.38 14.91 7.80 56.60 14.73 10.62 coo -6.81 68.31 28.28 -4.82 68.47 27.57 54.82 21.76 11.59 56.34 23.17 10.82 coo -13.01 70.96 47.58 -11.44 71.65 46.34 45.30 8.50 -0.71 46.30 6.81 0.12 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 13 3 # 13 C 137 ARG B 50 ARG^? 16.38 MG MG B 302 C 141 THR B 70 THR^? 14.69 MG MG B 302 C 235 ASP B 177 ASP^? 9.03 MG MG B 301 coo -5.79 67.26 36.83 -4.57 64.58 37.74 55.38 14.91 7.80 56.60 14.73 10.62 coo -6.81 68.31 28.28 -4.82 68.47 27.57 54.82 21.76 11.59 56.34 23.17 10.82 coo -13.01 70.96 47.58 -11.44 71.65 46.34 51.97 11.04 -6.64 50.39 11.62 -7.94 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 14 3 # 14 C 137 ARG B 50 ARG^? 16.38 MG MG B 302 C 141 THR B 73 THR^? 15.28 MG MG B 302 C 235 ASP B 171 ASP^? 16.92 MG MG B 301 coo -5.79 67.26 36.83 -4.57 64.58 37.74 55.38 14.91 7.80 56.60 14.73 10.62 coo -6.81 68.31 28.28 -4.82 68.47 27.57 61.79 16.15 11.00 62.15 17.08 9.05 coo -13.01 70.96 47.58 -11.44 71.65 46.34 45.30 8.50 -0.71 46.30 6.81 0.12 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 15 3 # 15 C 137 ARG B 50 ARG^? 16.38 MG MG B 302 C 141 THR B 73 THR^? 15.28 MG MG B 302 C 235 ASP B 177 ASP^? 9.03 MG MG B 301 coo -5.79 67.26 36.83 -4.57 64.58 37.74 55.38 14.91 7.80 56.60 14.73 10.62 coo -6.81 68.31 28.28 -4.82 68.47 27.57 61.79 16.15 11.00 62.15 17.08 9.05 coo -13.01 70.96 47.58 -11.44 71.65 46.34 51.97 11.04 -6.64 50.39 11.62 -7.94 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 16 3 # 16 C 137 ARG B 50 ARG^? 16.38 MG MG B 302 C 141 THR B 74 THR^? 21.68 MG MG B 302 C 235 ASP B 128 ASP^? -3.57 MG MG B 302s coo -5.79 67.26 36.83 -4.57 64.58 37.74 55.38 14.91 7.80 56.60 14.73 10.62 coo -6.81 68.31 28.28 -4.82 68.47 27.57 63.99 13.20 11.95 63.36 12.32 13.84 coo -13.01 70.96 47.58 -11.44 71.65 46.34 52.92 24.09 -2.19 54.73 25.14 -1.90 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 17 3 # 17 C 137 ARG B 50 ARG^? 16.38 MG MG B 302 C 141 THR B 74 THR^? 21.68 MG MG B 302 C 235 ASP B 148 ASP^? 2.58 MG MG B 302s coo -5.79 67.26 36.83 -4.57 64.58 37.74 55.38 14.91 7.80 56.60 14.73 10.62 coo -6.81 68.31 28.28 -4.82 68.47 27.57 63.99 13.20 11.95 63.36 12.32 13.84 coo -13.01 70.96 47.58 -11.44 71.65 46.34 52.73 19.23 -3.77 53.81 20.99 -4.31 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 18 3 # 18 C 137 ARG B 50 ARG^? 16.38 MG MG B 302 C 141 THR B 74 THR^? 21.68 MG MG B 302 C 235 ASP B 177 ASP^? 9.03 MG MG B 301 coo -5.79 67.26 36.83 -4.57 64.58 37.74 55.38 14.91 7.80 56.60 14.73 10.62 coo -6.81 68.31 28.28 -4.82 68.47 27.57 63.99 13.20 11.95 63.36 12.32 13.84 coo -13.01 70.96 47.58 -11.44 71.65 46.34 51.97 11.04 -6.64 50.39 11.62 -7.94 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 19 3 # 19 C 137 ARG B 87 ARG^? 13.84 MG MG C 301 C 141 THR B 73 THR^? 15.28 MG MG B 302 C 235 ASP B 23 ASP^? 15.67 MG MG C 301 coo -5.79 67.26 36.83 -4.57 64.58 37.74 72.30 15.49 11.27 71.00 17.29 9.11 coo -6.81 68.31 28.28 -4.82 68.47 27.57 61.79 16.15 11.00 62.15 17.08 9.05 coo -13.01 70.96 47.58 -11.44 71.65 46.34 74.31 7.55 -1.09 75.08 9.17 -2.23 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 20 3 # 20 C 137 ARG B 173 ARG^? 18.75 MG MG B 301 C 141 THR B 175 THR^? 12.15 MG MG B 301 C 235 ASP B 35 ASP^? 16.92 MG MG B 302 coo -5.79 67.26 36.83 -4.57 64.58 37.74 49.83 5.55 0.39 48.19 5.30 3.03 coo -6.81 68.31 28.28 -4.82 68.47 27.57 46.88 7.94 -7.07 47.05 10.06 -6.52 coo -13.01 70.96 47.58 -11.44 71.65 46.34 52.63 11.07 10.18 53.68 12.85 9.94 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 21 3 # 21 C 137 ARG B 193 ARG^? 28.40 MG MG B 301 C 141 THR B 191 THR^? 19.68 MG MG B 301 C 235 ASP B 138 ASP^? 33.32 MG MG B 302 coo -5.79 67.26 36.83 -4.57 64.58 37.74 29.25 23.93 -4.74 26.96 25.70 -3.52 coo -6.81 68.31 28.28 -4.82 68.47 27.57 36.37 22.10 -5.64 35.04 22.83 -7.26 coo -13.01 70.96 47.58 -11.44 71.65 46.34 23.42 29.01 6.78 24.36 28.48 4.94 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 22 3 # 22 C 137 ARG C 37 ARG^? 19.01 MG MG C 302 C 141 THR C 46 THR^? 24.02 MG MG C 302 C 235 ASP C 171 ASP^? 17.08 MG MG C 301 coo -5.79 67.26 36.83 -4.57 64.58 37.74 89.36 17.23 -17.57 89.29 20.20 -16.76 coo -6.81 68.31 28.28 -4.82 68.47 27.57 85.56 21.34 -24.69 87.12 20.00 -24.12 coo -13.01 70.96 47.58 -11.44 71.65 46.34 92.57 16.68 -6.24 92.24 14.74 -7.03 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 23 3 # 23 C 137 ARG C 50 ARG^? 16.05 MG MG C 302 C 141 THR C 18 THR^? 15.72 MG MG C 302 C 235 ASP C 128 ASP^? -3.22 MG MG C 302s coo -5.79 67.26 36.83 -4.57 64.58 37.74 80.61 19.03 -14.42 79.16 18.55 -17.10 coo -6.81 68.31 28.28 -4.82 68.47 27.57 79.00 10.43 -10.53 77.64 12.10 -10.65 coo -13.01 70.96 47.58 -11.44 71.65 46.34 80.05 28.39 -4.25 77.97 28.60 -4.21 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 24 3 # 24 C 137 ARG C 50 ARG^? 16.05 MG MG C 302 C 141 THR C 70 THR^? 14.45 MG MG C 302 C 235 ASP C 171 ASP^? 17.08 MG MG C 301 coo -5.79 67.26 36.83 -4.57 64.58 37.74 80.61 19.03 -14.42 79.16 18.55 -17.10 coo -6.81 68.31 28.28 -4.82 68.47 27.57 78.63 25.77 -17.76 76.70 26.55 -17.21 coo -13.01 70.96 47.58 -11.44 71.65 46.34 92.57 16.68 -6.24 92.24 14.74 -7.03 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 25 3 # 25 C 137 ARG C 50 ARG^? 16.05 MG MG C 302 C 141 THR C 70 THR^? 14.45 MG MG C 302 C 235 ASP C 177 ASP^? 8.84 MG MG C 301 coo -5.79 67.26 36.83 -4.57 64.58 37.74 80.61 19.03 -14.42 79.16 18.55 -17.10 coo -6.81 68.31 28.28 -4.82 68.47 27.57 78.63 25.77 -17.76 76.70 26.55 -17.21 coo -13.01 70.96 47.58 -11.44 71.65 46.34 85.60 16.42 -0.31 86.51 17.71 1.09 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 26 3 # 26 C 137 ARG C 50 ARG^? 16.05 MG MG C 302 C 141 THR C 73 THR^? 14.95 MG MG C 302 C 235 ASP C 171 ASP^? 17.08 MG MG C 301 coo -5.79 67.26 36.83 -4.57 64.58 37.74 80.61 19.03 -14.42 79.16 18.55 -17.10 coo -6.81 68.31 28.28 -4.82 68.47 27.57 74.44 18.04 -17.45 73.99 18.64 -15.48 coo -13.01 70.96 47.58 -11.44 71.65 46.34 92.57 16.68 -6.24 92.24 14.74 -7.03 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 27 3 # 27 C 137 ARG C 50 ARG^? 16.05 MG MG C 302 C 141 THR C 73 THR^? 14.95 MG MG C 302 C 235 ASP C 177 ASP^? 8.84 MG MG C 301 coo -5.79 67.26 36.83 -4.57 64.58 37.74 80.61 19.03 -14.42 79.16 18.55 -17.10 coo -6.81 68.31 28.28 -4.82 68.47 27.57 74.44 18.04 -17.45 73.99 18.64 -15.48 coo -13.01 70.96 47.58 -11.44 71.65 46.34 85.60 16.42 -0.31 86.51 17.71 1.09 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 28 3 # 28 C 137 ARG C 50 ARG^? 16.05 MG MG C 302 C 141 THR C 74 THR^? 21.64 MG MG C 302 C 235 ASP C 128 ASP^? -3.22 MG MG C 302s coo -5.79 67.26 36.83 -4.57 64.58 37.74 80.61 19.03 -14.42 79.16 18.55 -17.10 coo -6.81 68.31 28.28 -4.82 68.47 27.57 73.35 14.53 -18.47 73.89 13.78 -20.47 coo -13.01 70.96 47.58 -11.44 71.65 46.34 80.05 28.39 -4.25 77.97 28.60 -4.21 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 29 3 # 29 C 137 ARG C 50 ARG^? 16.05 MG MG C 302 C 141 THR C 74 THR^? 21.64 MG MG C 302 C 235 ASP C 148 ASP^? 2.75 MG MG C 302s coo -5.79 67.26 36.83 -4.57 64.58 37.74 80.61 19.03 -14.42 79.16 18.55 -17.10 coo -6.81 68.31 28.28 -4.82 68.47 27.57 73.35 14.53 -18.47 73.89 13.78 -20.47 coo -13.01 70.96 47.58 -11.44 71.65 46.34 81.96 23.83 -2.68 80.24 25.11 -2.27 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 30 3 # 30 C 137 ARG C 50 ARG^? 16.05 MG MG C 302 C 141 THR C 74 THR^? 21.64 MG MG C 302 C 235 ASP C 177 ASP^? 8.84 MG MG C 301 coo -5.79 67.26 36.83 -4.57 64.58 37.74 80.61 19.03 -14.42 79.16 18.55 -17.10 coo -6.81 68.31 28.28 -4.82 68.47 27.57 73.35 14.53 -18.47 73.89 13.78 -20.47 coo -13.01 70.96 47.58 -11.44 71.65 46.34 85.60 16.42 -0.31 86.51 17.71 1.09 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 31 3 # 31 C 137 ARG C 87 ARG^? 14.11 MG MG B 301 C 141 THR C 73 THR^? 14.95 MG MG C 302 C 235 ASP C 23 ASP^? 15.39 MG MG B 301 coo -5.79 67.26 36.83 -4.57 64.58 37.74 64.80 14.21 -18.13 65.25 15.52 -15.36 coo -6.81 68.31 28.28 -4.82 68.47 27.57 74.44 18.04 -17.45 73.99 18.64 -15.48 coo -13.01 70.96 47.58 -11.44 71.65 46.34 65.24 6.82 -5.11 63.43 7.54 -4.15 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 32 3 # 32 C 137 ARG C 193 ARG^? 28.20 MG MG C 301 C 141 THR C 191 THR^? 19.69 MG MG C 301 C 235 ASP C 138 ASP^? 33.43 MG MG C 302 coo -5.79 67.26 36.83 -4.57 64.58 37.74 102.52 36.87 -2.60 102.78 39.94 -3.05 coo -6.81 68.31 28.28 -4.82 68.47 27.57 96.18 32.27 -1.09 96.82 33.98 0.08 coo -13.01 70.96 47.58 -11.44 71.65 46.34 105.43 43.97 -13.30 104.85 43.08 -11.43 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 33 3 # 33 C 137 ARG D 37 ARG^? 18.81 MG MG D 302 C 141 THR D 46 THR^? 23.86 MG MG D 302 C 235 ASP D 171 ASP^? 16.95 MG MG D 301 coo -5.79 67.26 36.83 -4.57 64.58 37.74 96.81 38.21 -31.63 94.97 36.32 -33.06 coo -6.81 68.31 28.28 -4.82 68.47 27.57 91.28 37.63 -25.27 93.05 36.72 -26.12 coo -13.01 70.96 47.58 -11.44 71.65 46.34 100.39 36.69 -43.49 101.13 38.51 -42.69 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 34 3 # 34 C 137 ARG D 50 ARG^? 16.15 MG MG D 302 C 141 THR D 18 THR^? 15.54 MG MG D 302 C 235 ASP C 58 ASP^? 26.67 MG MG D 302 coo -5.79 67.26 36.83 -4.57 64.58 37.74 88.00 43.26 -36.30 88.86 43.23 -33.34 coo -6.81 68.31 28.28 -4.82 68.47 27.57 93.52 49.91 -39.68 91.41 49.57 -39.76 coo -13.01 70.96 47.58 -11.44 71.65 46.34 93.40 43.81 -22.27 94.18 44.45 -24.11 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 35 3 # 35 C 137 ARG D 50 ARG^? 16.15 MG MG D 302 C 141 THR D 18 THR^? 15.54 MG MG D 302 C 235 ASP D 128 ASP^? -3.70 MG MG D 302s coo -5.79 67.26 36.83 -4.57 64.58 37.74 88.00 43.26 -36.30 88.86 43.23 -33.34 coo -6.81 68.31 28.28 -4.82 68.47 27.57 93.52 49.91 -39.68 91.41 49.57 -39.76 coo -13.01 70.96 47.58 -11.44 71.65 46.34 83.33 35.45 -46.13 81.57 36.63 -46.10 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 36 3 # 36 C 137 ARG D 50 ARG^? 16.15 MG MG D 302 C 141 THR D 74 THR^? 21.71 MG MG D 302 C 235 ASP D 128 ASP^? -3.70 MG MG D 302s coo -5.79 67.26 36.83 -4.57 64.58 37.74 88.00 43.26 -36.30 88.86 43.23 -33.34 coo -6.81 68.31 28.28 -4.82 68.47 27.57 86.03 50.57 -32.19 86.96 50.83 -30.24 coo -13.01 70.96 47.58 -11.44 71.65 46.34 83.33 35.45 -46.13 81.57 36.63 -46.10 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 37 3 # 37 C 137 ARG D 50 ARG^? 16.15 MG MG D 302 C 141 THR D 74 THR^? 21.71 MG MG D 302 C 235 ASP D 148 ASP^? 2.35 MG MG D 302s coo -5.79 67.26 36.83 -4.57 64.58 37.74 88.00 43.26 -36.30 88.86 43.23 -33.34 coo -6.81 68.31 28.28 -4.82 68.47 27.57 86.03 50.57 -32.19 86.96 50.83 -30.24 coo -13.01 70.96 47.58 -11.44 71.65 46.34 87.78 37.50 -47.56 85.79 37.49 -48.28 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 38 3 # 38 C 137 ARG D 87 ARG^? 13.34 MG MG E 301 C 141 THR D 73 THR^? 15.26 MG MG D 302 C 235 ASP D 23 ASP^? 15.37 MG MG E 301 coo -5.79 67.26 36.83 -4.57 64.58 37.74 79.72 56.28 -33.10 79.15 54.81 -35.72 coo -6.81 68.31 28.28 -4.82 68.47 27.57 84.65 47.16 -33.26 83.69 47.10 -35.24 coo -13.01 70.96 47.58 -11.44 71.65 46.34 85.70 62.10 -45.60 84.07 62.13 -46.93 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 39 3 # 39 C 137 ARG D 193 ARG^? 27.92 MG MG D 301 C 141 THR D 191 THR^? 18.81 MG MG D 301 C 235 ASP D 138 ASP^? 33.64 MG MG D 302 coo -5.79 67.26 36.83 -4.57 64.58 37.74 95.76 15.06 -47.43 94.58 12.31 -46.69 coo -6.81 68.31 28.28 -4.82 68.47 27.57 93.38 21.98 -48.52 93.15 21.07 -50.52 coo -13.01 70.96 47.58 -11.44 71.65 46.34 93.00 7.50 -35.79 93.88 8.48 -37.45 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 40 3 # 40 C 137 ARG E 37 ARG^? 19.17 MG MG E 302 C 141 THR E 46 THR^? 24.08 MG MG E 302 C 235 ASP E 171 ASP^? 16.73 MG MG E 301 coo -5.79 67.26 36.83 -4.57 64.58 37.74 70.82 68.02 -63.63 68.17 67.46 -62.14 coo -6.81 68.31 28.28 -4.82 68.47 27.57 68.80 63.64 -69.48 69.18 65.66 -68.86 coo -13.01 70.96 47.58 -11.44 71.65 46.34 69.61 73.12 -51.56 71.50 73.53 -52.39 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 41 3 # 41 C 137 ARG E 50 ARG^? 15.97 MG MG E 302 C 141 THR E 18 THR^? 15.84 MG MG E 302 C 235 ASP E 128 ASP^? -3.53 MG MG E 302s coo -5.79 67.26 36.83 -4.57 64.58 37.74 73.62 60.83 -58.23 74.10 60.41 -61.24 coo -6.81 68.31 28.28 -4.82 68.47 27.57 81.45 64.25 -55.27 80.73 62.21 -55.24 coo -13.01 70.96 47.58 -11.44 71.65 46.34 65.38 56.57 -48.58 66.15 54.57 -48.61 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 42 3 # 42 C 137 ARG E 50 ARG^? 15.97 MG MG E 302 C 141 THR E 70 THR^? 14.75 MG MG E 302 C 235 ASP E 171 ASP^? 16.73 MG MG E 301 coo -5.79 67.26 36.83 -4.57 64.58 37.74 73.62 60.83 -58.23 74.10 60.41 -61.24 coo -6.81 68.31 28.28 -4.82 68.47 27.57 68.45 55.77 -62.07 68.75 53.75 -61.41 coo -13.01 70.96 47.58 -11.44 71.65 46.34 69.61 73.12 -51.56 71.50 73.53 -52.39 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 43 3 # 43 C 137 ARG E 50 ARG^? 15.97 MG MG E 302 C 141 THR E 70 THR^? 14.75 MG MG E 302 C 235 ASP E 177 ASP^? 8.55 MG MG E 301 coo -5.79 67.26 36.83 -4.57 64.58 37.74 73.62 60.83 -58.23 74.10 60.41 -61.24 coo -6.81 68.31 28.28 -4.82 68.47 27.57 68.45 55.77 -62.07 68.75 53.75 -61.41 coo -13.01 70.96 47.58 -11.44 71.65 46.34 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 44 3 # 44 C 137 ARG E 50 ARG^? 15.97 MG MG E 302 C 141 THR E 73 THR^? 15.13 MG MG E 302 C 235 ASP E 171 ASP^? 16.73 MG MG E 301 coo -5.79 67.26 36.83 -4.57 64.58 37.74 73.62 60.83 -58.23 74.10 60.41 -61.24 coo -6.81 68.31 28.28 -4.82 68.47 27.57 77.31 55.78 -61.57 77.11 55.21 -59.48 coo -13.01 70.96 47.58 -11.44 71.65 46.34 69.61 73.12 -51.56 71.50 73.53 -52.39 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 45 3 # 45 C 137 ARG E 50 ARG^? 15.97 MG MG E 302 C 141 THR E 73 THR^? 15.13 MG MG E 302 C 235 ASP E 177 ASP^? 8.55 MG MG E 301 coo -5.79 67.26 36.83 -4.57 64.58 37.74 73.62 60.83 -58.23 74.10 60.41 -61.24 coo -6.81 68.31 28.28 -4.82 68.47 27.57 77.31 55.78 -61.57 77.11 55.21 -59.48 coo -13.01 70.96 47.58 -11.44 71.65 46.34 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 46 3 # 46 C 137 ARG E 50 ARG^? 15.97 MG MG E 302 C 141 THR E 74 THR^? 21.51 MG MG E 302 C 235 ASP E 128 ASP^? -3.53 MG MG E 302s coo -5.79 67.26 36.83 -4.57 64.58 37.74 73.62 60.83 -58.23 74.10 60.41 -61.24 coo -6.81 68.31 28.28 -4.82 68.47 27.57 80.89 56.59 -62.50 81.13 57.37 -64.43 coo -13.01 70.96 47.58 -11.44 71.65 46.34 65.38 56.57 -48.58 66.15 54.57 -48.61 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 47 3 # 47 C 137 ARG E 50 ARG^? 15.97 MG MG E 302 C 141 THR E 74 THR^? 21.51 MG MG E 302 C 235 ASP E 148 ASP^? 2.62 MG MG E 302s coo -5.79 67.26 36.83 -4.57 64.58 37.74 73.62 60.83 -58.23 74.10 60.41 -61.24 coo -6.81 68.31 28.28 -4.82 68.47 27.57 80.89 56.59 -62.50 81.13 57.37 -64.43 coo -13.01 70.96 47.58 -11.44 71.65 46.34 68.29 60.44 -47.29 68.03 58.42 -46.50 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 48 3 # 48 C 137 ARG E 50 ARG^? 15.97 MG MG E 302 C 141 THR E 74 THR^? 21.51 MG MG E 302 C 235 ASP E 177 ASP^? 8.55 MG MG E 301 coo -5.79 67.26 36.83 -4.57 64.58 37.74 73.62 60.83 -58.23 74.10 60.41 -61.24 coo -6.81 68.31 28.28 -4.82 68.47 27.57 80.89 56.59 -62.50 81.13 57.37 -64.43 coo -13.01 70.96 47.58 -11.44 71.65 46.34 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 49 3 # 49 C 137 ARG E 87 ARG^? 13.25 MG MG D 301 C 141 THR E 73 THR^? 15.13 MG MG E 302 C 235 ASP E 23 ASP^? 15.43 MG MG D 301 coo -5.79 67.26 36.83 -4.57 64.58 37.74 85.24 49.22 -61.34 83.59 49.18 -58.71 coo -6.81 68.31 28.28 -4.82 68.47 27.57 77.31 55.78 -61.57 77.11 55.21 -59.48 coo -13.01 70.96 47.58 -11.44 71.65 46.34 91.98 54.64 -49.37 91.93 52.78 -48.33 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 50 3 # 50 C 137 ARG E 173 ARG^? 18.66 MG MG E 301 C 141 THR E 175 THR^? 12.38 MG MG E 301 C 235 ASP E 35 ASP^? 16.91 MG MG E 302 coo -5.79 67.26 36.83 -4.57 64.58 37.74 75.16 72.26 -52.56 73.67 73.54 -55.01 coo -6.81 68.31 28.28 -4.82 68.47 27.57 71.20 72.92 -44.89 69.57 71.76 -45.77 coo -13.01 70.96 47.58 -11.44 71.65 46.34 73.60 65.64 -62.00 73.13 63.73 -61.22 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 51 3 # 51 C 137 ARG E 193 ARG^? 28.25 MG MG E 301 C 141 THR E 191 THR^? 19.16 MG MG E 301 C 235 ASP E 138 ASP^? 33.31 MG MG E 302 coo -5.79 67.26 36.83 -4.57 64.58 37.74 47.02 71.25 -47.53 44.19 71.23 -48.93 coo -6.81 68.31 28.28 -4.82 68.47 27.57 54.11 68.77 -46.13 52.75 69.16 -44.48 coo -13.01 70.96 47.58 -11.44 71.65 46.34 39.58 70.77 -58.63 40.74 70.78 -56.80 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 52 3 # 52 C 137 ARG F 37 ARG^? 19.14 MG MG F 301 C 141 THR F 46 THR^? 24.16 MG MG F 301 C 235 ASP F 171 ASP^? 16.35 MG MG F 302 coo -5.79 67.26 36.83 -4.57 64.58 37.74 48.80 64.46 -76.37 51.50 64.15 -77.79 coo -6.81 68.31 28.28 -4.82 68.47 27.57 51.99 60.48 -70.07 50.88 62.21 -70.66 coo -13.01 70.96 47.58 -11.44 71.65 46.34 48.23 68.08 -88.47 46.26 68.02 -87.56 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 53 3 # 53 C 137 ARG F 50 ARG^? 16.24 MG MG F 301 C 141 THR F 18 THR^? 15.93 MG MG F 301 C 235 ASP F 128 ASP^? -3.41 MG MG F 301s coo -5.79 67.26 36.83 -4.57 64.58 37.74 48.85 56.05 -80.24 48.26 54.66 -77.55 coo -6.81 68.31 28.28 -4.82 68.47 27.57 39.95 55.99 -83.96 41.26 54.27 -83.96 coo -13.01 70.96 47.58 -11.44 71.65 46.34 57.76 53.73 -90.50 57.46 51.64 -90.28 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 54 3 # 54 C 137 ARG F 50 ARG^? 16.24 MG MG F 301 C 141 THR F 70 THR^? 14.73 MG MG F 301 C 235 ASP F 171 ASP^? 16.35 MG MG F 302 coo -5.79 67.26 36.83 -4.57 64.58 37.74 48.85 56.05 -80.24 48.26 54.66 -77.55 coo -6.81 68.31 28.28 -4.82 68.47 27.57 55.11 52.83 -76.85 55.53 50.86 -77.56 coo -13.01 70.96 47.58 -11.44 71.65 46.34 48.23 68.08 -88.47 46.26 68.02 -87.56 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 55 3 # 55 C 137 ARG F 50 ARG^? 16.24 MG MG F 301 C 141 THR F 70 THR^? 14.73 MG MG F 301 C 235 ASP F 177 ASP^? 8.15 MG MG F 302 coo -5.79 67.26 36.83 -4.57 64.58 37.74 48.85 56.05 -80.24 48.26 54.66 -77.55 coo -6.81 68.31 28.28 -4.82 68.47 27.57 55.11 52.83 -76.85 55.53 50.86 -77.56 coo -13.01 70.96 47.58 -11.44 71.65 46.34 47.18 61.22 -94.50 48.48 62.32 -95.73 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 56 3 # 56 C 137 ARG F 50 ARG^? 16.24 MG MG F 301 C 141 THR F 73 THR^? 15.13 MG MG F 301 C 235 ASP F 171 ASP^? 16.35 MG MG F 302 coo -5.79 67.26 36.83 -4.57 64.58 37.74 48.85 56.05 -80.24 48.26 54.66 -77.55 coo -6.81 68.31 28.28 -4.82 68.47 27.57 46.81 49.68 -77.46 47.14 48.99 -79.45 coo -13.01 70.96 47.58 -11.44 71.65 46.34 48.23 68.08 -88.47 46.26 68.02 -87.56 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 57 3 # 57 C 137 ARG F 50 ARG^? 16.24 MG MG F 301 C 141 THR F 73 THR^? 15.13 MG MG F 301 C 235 ASP F 177 ASP^? 8.15 MG MG F 302 coo -5.79 67.26 36.83 -4.57 64.58 37.74 48.85 56.05 -80.24 48.26 54.66 -77.55 coo -6.81 68.31 28.28 -4.82 68.47 27.57 46.81 49.68 -77.46 47.14 48.99 -79.45 coo -13.01 70.96 47.58 -11.44 71.65 46.34 47.18 61.22 -94.50 48.48 62.32 -95.73 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 58 3 # 58 C 137 ARG F 50 ARG^? 16.24 MG MG F 301 C 141 THR F 74 THR^? 21.46 MG MG F 301 C 235 ASP F 128 ASP^? -3.41 MG MG F 301s coo -5.79 67.26 36.83 -4.57 64.58 37.74 48.85 56.05 -80.24 48.26 54.66 -77.55 coo -6.81 68.31 28.28 -4.82 68.47 27.57 43.07 49.39 -76.61 42.46 50.11 -74.68 coo -13.01 70.96 47.58 -11.44 71.65 46.34 57.76 53.73 -90.50 57.46 51.64 -90.28 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 59 3 # 59 C 137 ARG F 50 ARG^? 16.24 MG MG F 301 C 141 THR F 74 THR^? 21.46 MG MG F 301 C 235 ASP F 148 ASP^? 2.72 MG MG F 301s coo -5.79 67.26 36.83 -4.57 64.58 37.74 48.85 56.05 -80.24 48.26 54.66 -77.55 coo -6.81 68.31 28.28 -4.82 68.47 27.57 43.07 49.39 -76.61 42.46 50.11 -74.68 coo -13.01 70.96 47.58 -11.44 71.65 46.34 53.64 56.47 -91.98 54.61 54.68 -92.64 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 60 3 # 60 C 137 ARG F 50 ARG^? 16.24 MG MG F 301 C 141 THR F 74 THR^? 21.46 MG MG F 301 C 235 ASP F 177 ASP^? 8.15 MG MG F 302 coo -5.79 67.26 36.83 -4.57 64.58 37.74 48.85 56.05 -80.24 48.26 54.66 -77.55 coo -6.81 68.31 28.28 -4.82 68.47 27.57 43.07 49.39 -76.61 42.46 50.11 -74.68 coo -13.01 70.96 47.58 -11.44 71.65 46.34 47.18 61.22 -94.50 48.48 62.32 -95.73 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 61 3 # 61 C 137 ARG F 193 ARG^? 27.27 MG MG F 302 C 141 THR F 191 THR^? 18.93 MG MG F 302 C 235 ASP F 138 ASP^? 33.51 MG MG F 302 coo -5.79 67.26 36.83 -4.57 64.58 37.74 70.24 75.04 -91.81 72.97 73.73 -92.20 coo -6.81 68.31 28.28 -4.82 68.47 27.57 64.36 69.12 -93.82 65.88 69.37 -95.36 coo -13.01 70.96 47.58 -11.44 71.65 46.34 77.17 76.66 -81.48 76.14 76.33 -83.32 1bd3_c02 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 61 hits 1bd3_c02 naa= 3 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 B 137 ARG A 8 ARG^? 20.36 MG MG A 301 B 141 THR A 40 THR^? 24.69 MG MG A 301 B 235 ASP A 160 ASP^? 31.61 MG MG B 302 coo 8.13 67.41 100.27 7.18 68.35 97.45 40.62 19.52 24.63 40.98 22.51 23.88 coo 8.28 67.78 108.81 6.22 67.65 109.43 32.64 20.47 25.22 32.40 21.22 23.20 coo 14.55 73.52 89.47 12.81 73.95 90.56 44.21 5.00 19.54 46.02 3.84 19.76 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 B 137 ARG A 37 ARG^? 18.99 MG MG A 301 B 141 THR A 46 THR^? 24.24 MG MG A 301 B 235 ASP A 171 ASP^? 17.17 MG MG A 302 coo 8.13 67.41 100.27 7.18 68.35 97.45 32.99 26.50 25.19 35.50 25.33 26.51 coo 8.28 67.78 108.81 6.22 67.65 109.43 38.63 28.11 18.80 36.62 27.50 19.27 coo 14.55 73.52 89.47 12.81 73.95 90.56 29.78 23.67 36.63 28.48 25.11 35.71 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 B 137 ARG A 50 ARG^? 15.98 MG MG A 301 B 141 THR A 18 THR.? 15.77 MG MG A 301 B 235 ASP A 128 ASP^? -3.32 MG MG A 301s coo 8.13 67.41 100.27 7.18 68.35 97.45 38.44 33.02 29.31 39.55 34.58 26.90 coo 8.28 67.78 108.81 6.22 67.65 109.43 32.02 38.89 33.13 34.18 39.03 32.98 coo 14.55 73.52 89.47 12.81 73.95 90.56 46.50 28.23 39.77 47.49 30.10 39.82 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 B 137 ARG A 50 ARG^? 15.98 MG MG A 301 B 141 THR A 70 THR^? 14.66 MG MG A 301 B 235 ASP A 171 ASP^? 17.17 MG MG A 302 coo 8.13 67.41 100.27 7.18 68.35 97.45 38.44 33.02 29.31 39.55 34.58 26.90 coo 8.28 67.78 108.81 6.22 67.65 109.43 45.68 31.52 26.25 47.33 32.60 27.12 coo 14.55 73.52 89.47 12.81 73.95 90.56 29.78 23.67 36.63 28.48 25.11 35.71 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 B 137 ARG A 50 ARG^? 15.98 MG MG A 301 B 141 THR A 70 THR^? 14.66 MG MG A 301 B 235 ASP A 177 ASP^? 8.44 MG MG A 302 coo 8.13 67.41 100.27 7.18 68.35 97.45 38.44 33.02 29.31 39.55 34.58 26.90 coo 8.28 67.78 108.81 6.22 67.65 109.43 45.68 31.52 26.25 47.33 32.60 27.12 coo 14.55 73.52 89.47 12.81 73.95 90.56 33.02 29.04 43.18 33.79 27.88 44.78 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 B 137 ARG A 50 ARG^? 15.98 MG MG A 301 B 141 THR A 73 THR^? 15.13 MG MG A 301 B 235 ASP A 171 ASP^? 17.17 MG MG A 302 coo 8.13 67.41 100.27 7.18 68.35 97.45 38.44 33.02 29.31 39.55 34.58 26.90 coo 8.28 67.78 108.81 6.22 67.65 109.43 40.93 39.17 26.72 41.99 38.78 28.61 coo 14.55 73.52 89.47 12.81 73.95 90.56 29.78 23.67 36.63 28.48 25.11 35.71 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 7 3 # 7 B 137 ARG A 50 ARG^? 15.98 MG MG A 301 B 141 THR A 73 THR^? 15.13 MG MG A 301 B 235 ASP A 177 ASP^? 8.44 MG MG A 302 coo 8.13 67.41 100.27 7.18 68.35 97.45 38.44 33.02 29.31 39.55 34.58 26.90 coo 8.28 67.78 108.81 6.22 67.65 109.43 40.93 39.17 26.72 41.99 38.78 28.61 coo 14.55 73.52 89.47 12.81 73.95 90.56 33.02 29.04 43.18 33.79 27.88 44.78 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 8 3 # 8 B 137 ARG A 50 ARG^? 15.98 MG MG A 301 B 141 THR A 74 THR^? 21.85 MG MG A 301 B 235 ASP A 128 ASP^? -3.32 MG MG A 301s coo 8.13 67.41 100.27 7.18 68.35 97.45 38.44 33.02 29.31 39.55 34.58 26.90 coo 8.28 67.78 108.81 6.22 67.65 109.43 38.65 41.92 25.57 37.60 41.76 23.73 coo 14.55 73.52 89.47 12.81 73.95 90.56 46.50 28.23 39.77 47.49 30.10 39.82 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 9 3 # 9 B 137 ARG A 50 ARG^? 15.98 MG MG A 301 B 141 THR A 74 THR^? 21.85 MG MG A 301 B 235 ASP A 148 ASP^? 2.72 MG MG A 301s coo 8.13 67.41 100.27 7.18 68.35 97.45 38.44 33.02 29.31 39.55 34.58 26.90 coo 8.28 67.78 108.81 6.22 67.65 109.43 38.65 41.92 25.57 37.60 41.76 23.73 coo 14.55 73.52 89.47 12.81 73.95 90.56 41.50 28.88 41.13 43.33 29.67 41.93 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 10 3 # 10 B 137 ARG A 50 ARG^? 15.98 MG MG A 301 B 141 THR A 74 THR^? 21.85 MG MG A 301 B 235 ASP A 177 ASP^? 8.44 MG MG A 302 coo 8.13 67.41 100.27 7.18 68.35 97.45 38.44 33.02 29.31 39.55 34.58 26.90 coo 8.28 67.78 108.81 6.22 67.65 109.43 38.65 41.92 25.57 37.60 41.76 23.73 coo 14.55 73.52 89.47 12.81 73.95 90.56 33.02 29.04 43.18 33.79 27.88 44.78 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 11 3 # 11 B 137 ARG B 8 ARG^? 20.39 MG MG B 302 B 141 THR B 40 THR^? 24.25 MG MG B 302 B 235 ASP B 160 ASP^? 31.65 MG MG A 301 coo 8.13 67.41 100.27 7.18 68.35 97.45 41.99 18.82 11.83 44.91 18.76 12.93 coo 8.28 67.78 108.81 6.22 67.65 109.43 41.77 11.06 10.77 42.63 10.70 12.73 coo 14.55 73.52 89.47 12.81 73.95 90.56 28.01 24.83 16.38 27.44 26.81 15.80 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 12 3 # 12 B 137 ARG B 37 ARG^? 19.17 MG MG B 302 B 141 THR B 46 THR^? 23.88 MG MG B 302 B 235 ASP B 171 ASP^? 16.92 MG MG B 301 coo 8.13 67.41 100.27 7.18 68.35 97.45 47.41 10.20 11.40 46.99 12.91 10.22 coo 8.28 67.78 108.81 6.22 67.65 109.43 49.71 15.16 18.13 48.80 13.51 17.14 coo 14.55 73.52 89.47 12.81 73.95 90.56 45.30 8.50 -0.71 46.30 6.81 0.12 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 13 3 # 13 B 137 ARG B 50 ARG^? 16.38 MG MG B 302 B 141 THR B 18 THR^? 16.08 MG MG B 302 B 235 ASP B 128 ASP^? -3.57 MG MG B 302s coo 8.13 67.41 100.27 7.18 68.35 97.45 55.38 14.91 7.80 56.60 14.73 10.62 coo 8.28 67.78 108.81 6.22 67.65 109.43 60.02 7.32 3.97 60.86 9.29 4.05 coo 14.55 73.52 89.47 12.81 73.95 90.56 52.92 24.09 -2.19 54.73 25.14 -1.90 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 14 3 # 14 B 137 ARG B 50 ARG^? 16.38 MG MG B 302 B 141 THR B 70 THR^? 14.69 MG MG B 302 B 235 ASP B 171 ASP^? 16.92 MG MG B 301 coo 8.13 67.41 100.27 7.18 68.35 97.45 55.38 14.91 7.80 56.60 14.73 10.62 coo 8.28 67.78 108.81 6.22 67.65 109.43 54.82 21.76 11.59 56.34 23.17 10.82 coo 14.55 73.52 89.47 12.81 73.95 90.56 45.30 8.50 -0.71 46.30 6.81 0.12 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 15 3 # 15 B 137 ARG B 50 ARG^? 16.38 MG MG B 302 B 141 THR B 70 THR^? 14.69 MG MG B 302 B 235 ASP B 177 ASP^? 9.03 MG MG B 301 coo 8.13 67.41 100.27 7.18 68.35 97.45 55.38 14.91 7.80 56.60 14.73 10.62 coo 8.28 67.78 108.81 6.22 67.65 109.43 54.82 21.76 11.59 56.34 23.17 10.82 coo 14.55 73.52 89.47 12.81 73.95 90.56 51.97 11.04 -6.64 50.39 11.62 -7.94 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 16 3 # 16 B 137 ARG B 50 ARG^? 16.38 MG MG B 302 B 141 THR B 73 THR^? 15.28 MG MG B 302 B 235 ASP B 171 ASP^? 16.92 MG MG B 301 coo 8.13 67.41 100.27 7.18 68.35 97.45 55.38 14.91 7.80 56.60 14.73 10.62 coo 8.28 67.78 108.81 6.22 67.65 109.43 61.79 16.15 11.00 62.15 17.08 9.05 coo 14.55 73.52 89.47 12.81 73.95 90.56 45.30 8.50 -0.71 46.30 6.81 0.12 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 17 3 # 17 B 137 ARG B 50 ARG^? 16.38 MG MG B 302 B 141 THR B 73 THR^? 15.28 MG MG B 302 B 235 ASP B 177 ASP^? 9.03 MG MG B 301 coo 8.13 67.41 100.27 7.18 68.35 97.45 55.38 14.91 7.80 56.60 14.73 10.62 coo 8.28 67.78 108.81 6.22 67.65 109.43 61.79 16.15 11.00 62.15 17.08 9.05 coo 14.55 73.52 89.47 12.81 73.95 90.56 51.97 11.04 -6.64 50.39 11.62 -7.94 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 18 3 # 18 B 137 ARG B 50 ARG^? 16.38 MG MG B 302 B 141 THR B 74 THR^? 21.68 MG MG B 302 B 235 ASP B 128 ASP^? -3.57 MG MG B 302s coo 8.13 67.41 100.27 7.18 68.35 97.45 55.38 14.91 7.80 56.60 14.73 10.62 coo 8.28 67.78 108.81 6.22 67.65 109.43 63.99 13.20 11.95 63.36 12.32 13.84 coo 14.55 73.52 89.47 12.81 73.95 90.56 52.92 24.09 -2.19 54.73 25.14 -1.90 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 19 3 # 19 B 137 ARG B 50 ARG^? 16.38 MG MG B 302 B 141 THR B 74 THR^? 21.68 MG MG B 302 B 235 ASP B 148 ASP^? 2.58 MG MG B 302s coo 8.13 67.41 100.27 7.18 68.35 97.45 55.38 14.91 7.80 56.60 14.73 10.62 coo 8.28 67.78 108.81 6.22 67.65 109.43 63.99 13.20 11.95 63.36 12.32 13.84 coo 14.55 73.52 89.47 12.81 73.95 90.56 52.73 19.23 -3.77 53.81 20.99 -4.31 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 20 3 # 20 B 137 ARG B 50 ARG^? 16.38 MG MG B 302 B 141 THR B 74 THR^? 21.68 MG MG B 302 B 235 ASP B 171 ASP^? 16.92 MG MG B 301 coo 8.13 67.41 100.27 7.18 68.35 97.45 55.38 14.91 7.80 56.60 14.73 10.62 coo 8.28 67.78 108.81 6.22 67.65 109.43 63.99 13.20 11.95 63.36 12.32 13.84 coo 14.55 73.52 89.47 12.81 73.95 90.56 45.30 8.50 -0.71 46.30 6.81 0.12 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 21 3 # 21 B 137 ARG B 50 ARG^? 16.38 MG MG B 302 B 141 THR B 74 THR^? 21.68 MG MG B 302 B 235 ASP B 177 ASP^? 9.03 MG MG B 301 coo 8.13 67.41 100.27 7.18 68.35 97.45 55.38 14.91 7.80 56.60 14.73 10.62 coo 8.28 67.78 108.81 6.22 67.65 109.43 63.99 13.20 11.95 63.36 12.32 13.84 coo 14.55 73.52 89.47 12.81 73.95 90.56 51.97 11.04 -6.64 50.39 11.62 -7.94 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 22 3 # 22 B 137 ARG B 87 ARG^? 13.84 MG MG C 301 B 141 THR B 88 THR^? 22.44 MG MG C 301 B 235 ASP B 23 ASP^? 15.67 MG MG C 301 coo 8.13 67.41 100.27 7.18 68.35 97.45 72.30 15.49 11.27 71.00 17.29 9.11 coo 8.28 67.78 108.81 6.22 67.65 109.43 66.42 16.42 14.22 65.45 16.28 16.18 coo 14.55 73.52 89.47 12.81 73.95 90.56 74.31 7.55 -1.09 75.08 9.17 -2.23 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 23 3 # 23 B 137 ARG B 193 ARG^? 28.40 MG MG B 301 B 141 THR B 191 THR^? 19.68 MG MG B 301 B 235 ASP B 138 ASP^? 33.32 MG MG B 302 coo 8.13 67.41 100.27 7.18 68.35 97.45 29.25 23.93 -4.74 26.96 25.70 -3.52 coo 8.28 67.78 108.81 6.22 67.65 109.43 36.37 22.10 -5.64 35.04 22.83 -7.26 coo 14.55 73.52 89.47 12.81 73.95 90.56 23.42 29.01 6.78 24.36 28.48 4.94 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 24 3 # 24 B 137 ARG C 8 ARG^? 20.00 MG MG C 302 B 141 THR C 40 THR^? 24.02 MG MG C 302 B 235 ASP C 160 ASP^? 31.63 MG MG D 302 coo 8.13 67.41 100.27 7.18 68.35 97.45 91.42 27.61 -18.53 88.82 26.28 -19.38 coo 8.28 67.78 108.81 6.22 67.65 109.43 94.40 20.37 -17.61 93.73 19.75 -19.59 coo 14.55 73.52 89.47 12.81 73.95 90.56 102.50 38.00 -23.28 102.43 39.97 -22.46 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 25 3 # 25 B 137 ARG C 50 ARG^? 16.05 MG MG C 302 B 141 THR C 70 THR^? 14.45 MG MG C 302 B 235 ASP C 171 ASP^? 17.08 MG MG C 301 coo 8.13 67.41 100.27 7.18 68.35 97.45 80.61 19.03 -14.42 79.16 18.55 -17.10 coo 8.28 67.78 108.81 6.22 67.65 109.43 78.63 25.77 -17.76 76.70 26.55 -17.21 coo 14.55 73.52 89.47 12.81 73.95 90.56 92.57 16.68 -6.24 92.24 14.74 -7.03 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 26 3 # 26 B 137 ARG C 50 ARG^? 16.05 MG MG C 302 B 141 THR C 70 THR^? 14.45 MG MG C 302 B 235 ASP C 177 ASP^? 8.84 MG MG C 301 coo 8.13 67.41 100.27 7.18 68.35 97.45 80.61 19.03 -14.42 79.16 18.55 -17.10 coo 8.28 67.78 108.81 6.22 67.65 109.43 78.63 25.77 -17.76 76.70 26.55 -17.21 coo 14.55 73.52 89.47 12.81 73.95 90.56 85.60 16.42 -0.31 86.51 17.71 1.09 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 27 3 # 27 B 137 ARG C 50 ARG^? 16.05 MG MG C 302 B 141 THR C 73 THR^? 14.95 MG MG C 302 B 235 ASP C 171 ASP^? 17.08 MG MG C 301 coo 8.13 67.41 100.27 7.18 68.35 97.45 80.61 19.03 -14.42 79.16 18.55 -17.10 coo 8.28 67.78 108.81 6.22 67.65 109.43 74.44 18.04 -17.45 73.99 18.64 -15.48 coo 14.55 73.52 89.47 12.81 73.95 90.56 92.57 16.68 -6.24 92.24 14.74 -7.03 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 28 3 # 28 B 137 ARG C 50 ARG^? 16.05 MG MG C 302 B 141 THR C 73 THR^? 14.95 MG MG C 302 B 235 ASP C 177 ASP^? 8.84 MG MG C 301 coo 8.13 67.41 100.27 7.18 68.35 97.45 80.61 19.03 -14.42 79.16 18.55 -17.10 coo 8.28 67.78 108.81 6.22 67.65 109.43 74.44 18.04 -17.45 73.99 18.64 -15.48 coo 14.55 73.52 89.47 12.81 73.95 90.56 85.60 16.42 -0.31 86.51 17.71 1.09 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 29 3 # 29 B 137 ARG C 50 ARG^? 16.05 MG MG C 302 B 141 THR C 74 THR^? 21.64 MG MG C 302 B 235 ASP C 128 ASP^? -3.22 MG MG C 302s coo 8.13 67.41 100.27 7.18 68.35 97.45 80.61 19.03 -14.42 79.16 18.55 -17.10 coo 8.28 67.78 108.81 6.22 67.65 109.43 73.35 14.53 -18.47 73.89 13.78 -20.47 coo 14.55 73.52 89.47 12.81 73.95 90.56 80.05 28.39 -4.25 77.97 28.60 -4.21 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 30 3 # 30 B 137 ARG C 50 ARG^? 16.05 MG MG C 302 B 141 THR C 74 THR^? 21.64 MG MG C 302 B 235 ASP C 148 ASP^? 2.75 MG MG C 302s coo 8.13 67.41 100.27 7.18 68.35 97.45 80.61 19.03 -14.42 79.16 18.55 -17.10 coo 8.28 67.78 108.81 6.22 67.65 109.43 73.35 14.53 -18.47 73.89 13.78 -20.47 coo 14.55 73.52 89.47 12.81 73.95 90.56 81.96 23.83 -2.68 80.24 25.11 -2.27 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 31 3 # 31 B 137 ARG C 50 ARG^? 16.05 MG MG C 302 B 141 THR C 74 THR^? 21.64 MG MG C 302 B 235 ASP C 171 ASP^? 17.08 MG MG C 301 coo 8.13 67.41 100.27 7.18 68.35 97.45 80.61 19.03 -14.42 79.16 18.55 -17.10 coo 8.28 67.78 108.81 6.22 67.65 109.43 73.35 14.53 -18.47 73.89 13.78 -20.47 coo 14.55 73.52 89.47 12.81 73.95 90.56 92.57 16.68 -6.24 92.24 14.74 -7.03 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 32 3 # 32 B 137 ARG C 50 ARG^? 16.05 MG MG C 302 B 141 THR C 74 THR^? 21.64 MG MG C 302 B 235 ASP C 177 ASP^? 8.84 MG MG C 301 coo 8.13 67.41 100.27 7.18 68.35 97.45 80.61 19.03 -14.42 79.16 18.55 -17.10 coo 8.28 67.78 108.81 6.22 67.65 109.43 73.35 14.53 -18.47 73.89 13.78 -20.47 coo 14.55 73.52 89.47 12.81 73.95 90.56 85.60 16.42 -0.31 86.51 17.71 1.09 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 33 3 # 33 B 137 ARG C 193 ARG^? 28.20 MG MG C 301 B 141 THR C 191 THR^? 19.69 MG MG C 301 B 235 ASP C 138 ASP^? 33.43 MG MG C 302 coo 8.13 67.41 100.27 7.18 68.35 97.45 102.52 36.87 -2.60 102.78 39.94 -3.05 coo 8.28 67.78 108.81 6.22 67.65 109.43 96.18 32.27 -1.09 96.82 33.98 0.08 coo 14.55 73.52 89.47 12.81 73.95 90.56 105.43 43.97 -13.30 104.85 43.08 -11.43 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 34 3 # 34 B 137 ARG D 8 ARG^? 20.22 MG MG D 302 B 141 THR D 40 THR^? 24.02 MG MG D 302 B 235 ASP D 160 ASP^? 31.45 MG MG C 302 coo 8.13 67.41 100.27 7.18 68.35 97.45 92.22 28.83 -31.23 90.93 31.55 -30.54 coo 8.28 67.78 108.81 6.22 67.65 109.43 99.14 32.63 -32.12 99.04 33.58 -30.18 coo 14.55 73.52 89.47 12.81 73.95 90.56 94.15 13.98 -26.57 92.71 12.42 -26.99 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 35 3 # 35 B 137 ARG D 37 ARG^? 18.81 MG MG D 302 B 141 THR D 46 THR^? 23.86 MG MG D 302 B 235 ASP D 171 ASP^? 16.95 MG MG D 301 coo 8.13 67.41 100.27 7.18 68.35 97.45 96.81 38.21 -31.63 94.97 36.32 -33.06 coo 8.28 67.78 108.81 6.22 67.65 109.43 91.28 37.63 -25.27 93.05 36.72 -26.12 coo 14.55 73.52 89.47 12.81 73.95 90.56 100.39 36.69 -43.49 101.13 38.51 -42.69 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 36 3 # 36 B 137 ARG D 50 ARG^? 16.15 MG MG D 302 B 141 THR D 70 THR^? 14.99 MG MG D 302 B 235 ASP D 171 ASP^? 16.95 MG MG D 301 coo 8.13 67.41 100.27 7.18 68.35 97.45 88.00 43.26 -36.30 88.86 43.23 -33.34 coo 8.28 67.78 108.81 6.22 67.65 109.43 83.38 38.35 -32.45 81.51 39.04 -33.23 coo 14.55 73.52 89.47 12.81 73.95 90.56 100.39 36.69 -43.49 101.13 38.51 -42.69 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 37 3 # 37 B 137 ARG D 50 ARG^? 16.15 MG MG D 302 B 141 THR D 70 THR^? 14.99 MG MG D 302 B 235 ASP D 177 ASP^? 8.43 MG MG D 301 coo 8.13 67.41 100.27 7.18 68.35 97.45 88.00 43.26 -36.30 88.86 43.23 -33.34 coo 8.28 67.78 108.81 6.22 67.65 109.43 83.38 38.35 -32.45 81.51 39.04 -33.23 coo 14.55 73.52 89.47 12.81 73.95 90.56 95.74 41.01 -49.76 94.81 39.90 -51.24 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 38 3 # 38 B 137 ARG D 50 ARG^? 16.15 MG MG D 302 B 141 THR D 74 THR^? 21.71 MG MG D 302 B 235 ASP D 128 ASP^? -3.70 MG MG D 302s coo 8.13 67.41 100.27 7.18 68.35 97.45 88.00 43.26 -36.30 88.86 43.23 -33.34 coo 8.28 67.78 108.81 6.22 67.65 109.43 86.03 50.57 -32.19 86.96 50.83 -30.24 coo 14.55 73.52 89.47 12.81 73.95 90.56 83.33 35.45 -46.13 81.57 36.63 -46.10 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 39 3 # 39 B 137 ARG D 50 ARG^? 16.15 MG MG D 302 B 141 THR D 74 THR^? 21.71 MG MG D 302 B 235 ASP D 148 ASP^? 2.35 MG MG D 302s coo 8.13 67.41 100.27 7.18 68.35 97.45 88.00 43.26 -36.30 88.86 43.23 -33.34 coo 8.28 67.78 108.81 6.22 67.65 109.43 86.03 50.57 -32.19 86.96 50.83 -30.24 coo 14.55 73.52 89.47 12.81 73.95 90.56 87.78 37.50 -47.56 85.79 37.49 -48.28 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 40 3 # 40 B 137 ARG D 50 ARG^? 16.15 MG MG D 302 B 141 THR D 74 THR^? 21.71 MG MG D 302 B 235 ASP D 171 ASP^? 16.95 MG MG D 301 coo 8.13 67.41 100.27 7.18 68.35 97.45 88.00 43.26 -36.30 88.86 43.23 -33.34 coo 8.28 67.78 108.81 6.22 67.65 109.43 86.03 50.57 -32.19 86.96 50.83 -30.24 coo 14.55 73.52 89.47 12.81 73.95 90.56 100.39 36.69 -43.49 101.13 38.51 -42.69 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 41 3 # 41 B 137 ARG D 50 ARG^? 16.15 MG MG D 302 B 141 THR D 74 THR^? 21.71 MG MG D 302 B 235 ASP D 177 ASP^? 8.43 MG MG D 301 coo 8.13 67.41 100.27 7.18 68.35 97.45 88.00 43.26 -36.30 88.86 43.23 -33.34 coo 8.28 67.78 108.81 6.22 67.65 109.43 86.03 50.57 -32.19 86.96 50.83 -30.24 coo 14.55 73.52 89.47 12.81 73.95 90.56 95.74 41.01 -49.76 94.81 39.90 -51.24 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 42 3 # 42 B 137 ARG D 87 ARG^? 13.34 MG MG E 301 B 141 THR D 73 THR^? 15.26 MG MG D 302 B 235 ASP D 23 ASP^? 15.37 MG MG E 301 coo 8.13 67.41 100.27 7.18 68.35 97.45 79.72 56.28 -33.10 79.15 54.81 -35.72 coo 8.28 67.78 108.81 6.22 67.65 109.43 84.65 47.16 -33.26 83.69 47.10 -35.24 coo 14.55 73.52 89.47 12.81 73.95 90.56 85.70 62.10 -45.60 84.07 62.13 -46.93 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 43 3 # 43 B 137 ARG D 193 ARG^? 27.92 MG MG D 301 B 141 THR D 191 THR^? 18.81 MG MG D 301 B 235 ASP D 138 ASP^? 33.64 MG MG D 302 coo 8.13 67.41 100.27 7.18 68.35 97.45 95.76 15.06 -47.43 94.58 12.31 -46.69 coo 8.28 67.78 108.81 6.22 67.65 109.43 93.38 21.98 -48.52 93.15 21.07 -50.52 coo 14.55 73.52 89.47 12.81 73.95 90.56 93.00 7.50 -35.79 93.88 8.48 -37.45 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 44 3 # 44 B 137 ARG E 8 ARG^? 20.19 MG MG E 302 B 141 THR E 40 THR^? 24.66 MG MG E 302 B 235 ASP E 160 ASP^? 31.54 MG MG F 301 coo 8.13 67.41 100.27 7.18 68.35 97.45 60.42 66.09 -63.48 62.84 64.38 -64.17 coo 8.28 67.78 108.81 6.22 67.65 109.43 65.26 72.42 -63.00 65.97 72.32 -65.06 coo 14.55 73.52 89.47 12.81 73.95 90.56 45.81 70.00 -68.45 44.10 68.87 -67.77 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 45 3 # 45 B 137 ARG E 37 ARG^? 19.17 MG MG E 302 B 141 THR E 46 THR^? 24.08 MG MG E 302 B 235 ASP E 171 ASP^? 16.73 MG MG E 301 coo 8.13 67.41 100.27 7.18 68.35 97.45 70.82 68.02 -63.63 68.17 67.46 -62.14 coo 8.28 67.78 108.81 6.22 67.65 109.43 68.80 63.64 -69.48 69.18 65.66 -68.86 coo 14.55 73.52 89.47 12.81 73.95 90.56 69.61 73.12 -51.56 71.50 73.53 -52.39 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 46 3 # 46 B 137 ARG E 50 ARG^? 15.97 MG MG E 302 B 141 THR E 70 THR^? 14.75 MG MG E 302 B 235 ASP E 171 ASP^? 16.73 MG MG E 301 coo 8.13 67.41 100.27 7.18 68.35 97.45 73.62 60.83 -58.23 74.10 60.41 -61.24 coo 8.28 67.78 108.81 6.22 67.65 109.43 68.45 55.77 -62.07 68.75 53.75 -61.41 coo 14.55 73.52 89.47 12.81 73.95 90.56 69.61 73.12 -51.56 71.50 73.53 -52.39 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 47 3 # 47 B 137 ARG E 50 ARG^? 15.97 MG MG E 302 B 141 THR E 70 THR^? 14.75 MG MG E 302 B 235 ASP E 177 ASP^? 8.55 MG MG E 301 coo 8.13 67.41 100.27 7.18 68.35 97.45 73.62 60.83 -58.23 74.10 60.41 -61.24 coo 8.28 67.78 108.81 6.22 67.65 109.43 68.45 55.77 -62.07 68.75 53.75 -61.41 coo 14.55 73.52 89.47 12.81 73.95 90.56 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 48 3 # 48 B 137 ARG E 50 ARG^? 15.97 MG MG E 302 B 141 THR E 73 THR^? 15.13 MG MG E 302 B 235 ASP E 171 ASP^? 16.73 MG MG E 301 coo 8.13 67.41 100.27 7.18 68.35 97.45 73.62 60.83 -58.23 74.10 60.41 -61.24 coo 8.28 67.78 108.81 6.22 67.65 109.43 77.31 55.78 -61.57 77.11 55.21 -59.48 coo 14.55 73.52 89.47 12.81 73.95 90.56 69.61 73.12 -51.56 71.50 73.53 -52.39 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 49 3 # 49 B 137 ARG E 50 ARG^? 15.97 MG MG E 302 B 141 THR E 73 THR^? 15.13 MG MG E 302 B 235 ASP E 177 ASP^? 8.55 MG MG E 301 coo 8.13 67.41 100.27 7.18 68.35 97.45 73.62 60.83 -58.23 74.10 60.41 -61.24 coo 8.28 67.78 108.81 6.22 67.65 109.43 77.31 55.78 -61.57 77.11 55.21 -59.48 coo 14.55 73.52 89.47 12.81 73.95 90.56 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 50 3 # 50 B 137 ARG E 50 ARG^? 15.97 MG MG E 302 B 141 THR E 74 THR^? 21.51 MG MG E 302 B 235 ASP E 128 ASP^? -3.53 MG MG E 302s coo 8.13 67.41 100.27 7.18 68.35 97.45 73.62 60.83 -58.23 74.10 60.41 -61.24 coo 8.28 67.78 108.81 6.22 67.65 109.43 80.89 56.59 -62.50 81.13 57.37 -64.43 coo 14.55 73.52 89.47 12.81 73.95 90.56 65.38 56.57 -48.58 66.15 54.57 -48.61 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 51 3 # 51 B 137 ARG E 50 ARG^? 15.97 MG MG E 302 B 141 THR E 74 THR^? 21.51 MG MG E 302 B 235 ASP E 148 ASP^? 2.62 MG MG E 302s coo 8.13 67.41 100.27 7.18 68.35 97.45 73.62 60.83 -58.23 74.10 60.41 -61.24 coo 8.28 67.78 108.81 6.22 67.65 109.43 80.89 56.59 -62.50 81.13 57.37 -64.43 coo 14.55 73.52 89.47 12.81 73.95 90.56 68.29 60.44 -47.29 68.03 58.42 -46.50 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 52 3 # 52 B 137 ARG E 50 ARG^? 15.97 MG MG E 302 B 141 THR E 74 THR^? 21.51 MG MG E 302 B 235 ASP E 171 ASP^? 16.73 MG MG E 301 coo 8.13 67.41 100.27 7.18 68.35 97.45 73.62 60.83 -58.23 74.10 60.41 -61.24 coo 8.28 67.78 108.81 6.22 67.65 109.43 80.89 56.59 -62.50 81.13 57.37 -64.43 coo 14.55 73.52 89.47 12.81 73.95 90.56 69.61 73.12 -51.56 71.50 73.53 -52.39 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 53 3 # 53 B 137 ARG E 50 ARG^? 15.97 MG MG E 302 B 141 THR E 74 THR^? 21.51 MG MG E 302 B 235 ASP E 177 ASP^? 8.55 MG MG E 301 coo 8.13 67.41 100.27 7.18 68.35 97.45 73.62 60.83 -58.23 74.10 60.41 -61.24 coo 8.28 67.78 108.81 6.22 67.65 109.43 80.89 56.59 -62.50 81.13 57.37 -64.43 coo 14.55 73.52 89.47 12.81 73.95 90.56 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 54 3 # 54 B 137 ARG E 87 ARG^? 13.25 MG MG D 301 B 141 THR E 73 THR^? 15.13 MG MG E 302 B 235 ASP E 23 ASP^? 15.43 MG MG D 301 coo 8.13 67.41 100.27 7.18 68.35 97.45 85.24 49.22 -61.34 83.59 49.18 -58.71 coo 8.28 67.78 108.81 6.22 67.65 109.43 77.31 55.78 -61.57 77.11 55.21 -59.48 coo 14.55 73.52 89.47 12.81 73.95 90.56 91.98 54.64 -49.37 91.93 52.78 -48.33 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 55 3 # 55 B 137 ARG E 193 ARG^? 28.25 MG MG E 301 B 141 THR E 191 THR^? 19.16 MG MG E 301 B 235 ASP E 138 ASP^? 33.31 MG MG E 302 coo 8.13 67.41 100.27 7.18 68.35 97.45 47.02 71.25 -47.53 44.19 71.23 -48.93 coo 8.28 67.78 108.81 6.22 67.65 109.43 54.11 68.77 -46.13 52.75 69.16 -44.48 coo 14.55 73.52 89.47 12.81 73.95 90.56 39.58 70.77 -58.63 40.74 70.78 -56.80 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 56 3 # 56 B 137 ARG F 37 ARG^? 19.14 MG MG F 301 B 141 THR F 46 THR^? 24.16 MG MG F 301 B 235 ASP F 171 ASP^? 16.35 MG MG F 302 coo 8.13 67.41 100.27 7.18 68.35 97.45 48.80 64.46 -76.37 51.50 64.15 -77.79 coo 8.28 67.78 108.81 6.22 67.65 109.43 51.99 60.48 -70.07 50.88 62.21 -70.66 coo 14.55 73.52 89.47 12.81 73.95 90.56 48.23 68.08 -88.47 46.26 68.02 -87.56 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 57 3 # 57 B 137 ARG F 50 ARG^? 16.24 MG MG F 301 B 141 THR F 18 THR^? 15.93 MG MG F 301 B 235 ASP F 128 ASP^? -3.41 MG MG F 301s coo 8.13 67.41 100.27 7.18 68.35 97.45 48.85 56.05 -80.24 48.26 54.66 -77.55 coo 8.28 67.78 108.81 6.22 67.65 109.43 39.95 55.99 -83.96 41.26 54.27 -83.96 coo 14.55 73.52 89.47 12.81 73.95 90.56 57.76 53.73 -90.50 57.46 51.64 -90.28 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 58 3 # 58 B 137 ARG F 50 ARG^? 16.24 MG MG F 301 B 141 THR F 70 THR^? 14.73 MG MG F 301 B 235 ASP F 171 ASP^? 16.35 MG MG F 302 coo 8.13 67.41 100.27 7.18 68.35 97.45 48.85 56.05 -80.24 48.26 54.66 -77.55 coo 8.28 67.78 108.81 6.22 67.65 109.43 55.11 52.83 -76.85 55.53 50.86 -77.56 coo 14.55 73.52 89.47 12.81 73.95 90.56 48.23 68.08 -88.47 46.26 68.02 -87.56 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 59 3 # 59 B 137 ARG F 50 ARG^? 16.24 MG MG F 301 B 141 THR F 70 THR^? 14.73 MG MG F 301 B 235 ASP F 177 ASP^? 8.15 MG MG F 302 coo 8.13 67.41 100.27 7.18 68.35 97.45 48.85 56.05 -80.24 48.26 54.66 -77.55 coo 8.28 67.78 108.81 6.22 67.65 109.43 55.11 52.83 -76.85 55.53 50.86 -77.56 coo 14.55 73.52 89.47 12.81 73.95 90.56 47.18 61.22 -94.50 48.48 62.32 -95.73 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 60 3 # 60 B 137 ARG F 50 ARG^? 16.24 MG MG F 301 B 141 THR F 73 THR^? 15.13 MG MG F 301 B 235 ASP F 171 ASP^? 16.35 MG MG F 302 coo 8.13 67.41 100.27 7.18 68.35 97.45 48.85 56.05 -80.24 48.26 54.66 -77.55 coo 8.28 67.78 108.81 6.22 67.65 109.43 46.81 49.68 -77.46 47.14 48.99 -79.45 coo 14.55 73.52 89.47 12.81 73.95 90.56 48.23 68.08 -88.47 46.26 68.02 -87.56 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 61 3 # 61 B 137 ARG F 50 ARG^? 16.24 MG MG F 301 B 141 THR F 73 THR^? 15.13 MG MG F 301 B 235 ASP F 177 ASP^? 8.15 MG MG F 302 coo 8.13 67.41 100.27 7.18 68.35 97.45 48.85 56.05 -80.24 48.26 54.66 -77.55 coo 8.28 67.78 108.81 6.22 67.65 109.43 46.81 49.68 -77.46 47.14 48.99 -79.45 coo 14.55 73.52 89.47 12.81 73.95 90.56 47.18 61.22 -94.50 48.48 62.32 -95.73 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 62 3 # 62 B 137 ARG F 50 ARG^? 16.24 MG MG F 301 B 141 THR F 74 THR^? 21.46 MG MG F 301 B 235 ASP F 128 ASP^? -3.41 MG MG F 301s coo 8.13 67.41 100.27 7.18 68.35 97.45 48.85 56.05 -80.24 48.26 54.66 -77.55 coo 8.28 67.78 108.81 6.22 67.65 109.43 43.07 49.39 -76.61 42.46 50.11 -74.68 coo 14.55 73.52 89.47 12.81 73.95 90.56 57.76 53.73 -90.50 57.46 51.64 -90.28 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 63 3 # 63 B 137 ARG F 50 ARG^? 16.24 MG MG F 301 B 141 THR F 74 THR^? 21.46 MG MG F 301 B 235 ASP F 148 ASP^? 2.72 MG MG F 301s coo 8.13 67.41 100.27 7.18 68.35 97.45 48.85 56.05 -80.24 48.26 54.66 -77.55 coo 8.28 67.78 108.81 6.22 67.65 109.43 43.07 49.39 -76.61 42.46 50.11 -74.68 coo 14.55 73.52 89.47 12.81 73.95 90.56 53.64 56.47 -91.98 54.61 54.68 -92.64 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 64 3 # 64 B 137 ARG F 50 ARG^? 16.24 MG MG F 301 B 141 THR F 74 THR^? 21.46 MG MG F 301 B 235 ASP F 171 ASP^? 16.35 MG MG F 302 coo 8.13 67.41 100.27 7.18 68.35 97.45 48.85 56.05 -80.24 48.26 54.66 -77.55 coo 8.28 67.78 108.81 6.22 67.65 109.43 43.07 49.39 -76.61 42.46 50.11 -74.68 coo 14.55 73.52 89.47 12.81 73.95 90.56 48.23 68.08 -88.47 46.26 68.02 -87.56 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 65 3 # 65 B 137 ARG F 50 ARG^? 16.24 MG MG F 301 B 141 THR F 74 THR^? 21.46 MG MG F 301 B 235 ASP F 177 ASP^? 8.15 MG MG F 302 coo 8.13 67.41 100.27 7.18 68.35 97.45 48.85 56.05 -80.24 48.26 54.66 -77.55 coo 8.28 67.78 108.81 6.22 67.65 109.43 43.07 49.39 -76.61 42.46 50.11 -74.68 coo 14.55 73.52 89.47 12.81 73.95 90.56 47.18 61.22 -94.50 48.48 62.32 -95.73 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 66 3 # 66 B 137 ARG F 87 ARG^? 20.27 MG MG F 301 B 141 THR F 73 THR^? 15.13 MG MG F 301 B 235 ASP F 23 ASP^? 23.03 MG MG F 301 coo 8.13 67.41 100.27 7.18 68.35 97.45 41.14 41.21 -77.31 42.93 41.07 -79.84 coo 8.28 67.78 108.81 6.22 67.65 109.43 46.81 49.68 -77.46 47.14 48.99 -79.45 coo 14.55 73.52 89.47 12.81 73.95 90.56 31.30 43.61 -89.40 33.44 43.69 -89.02 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 67 3 # 67 B 137 ARG F 87 ARG^? 20.27 MG MG F 301 B 141 THR F 88 THR^? 23.06 MG MG F 301 B 235 ASP F 23 ASP^? 23.03 MG MG F 301 coo 8.13 67.41 100.27 7.18 68.35 97.45 41.14 41.21 -77.31 42.93 41.07 -79.84 coo 8.28 67.78 108.81 6.22 67.65 109.43 44.71 45.78 -74.10 45.06 46.44 -72.02 coo 14.55 73.52 89.47 12.81 73.95 90.56 31.30 43.61 -89.40 33.44 43.69 -89.02 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 68 3 # 68 B 137 ARG F 193 ARG^? 27.27 MG MG F 302 B 141 THR F 191 THR^? 18.93 MG MG F 302 B 235 ASP F 138 ASP^? 33.51 MG MG F 302 coo 8.13 67.41 100.27 7.18 68.35 97.45 70.24 75.04 -91.81 72.97 73.73 -92.20 coo 8.28 67.78 108.81 6.22 67.65 109.43 64.36 69.12 -93.82 65.88 69.37 -95.36 coo 14.55 73.52 89.47 12.81 73.95 90.56 77.17 76.66 -81.48 76.14 76.33 -83.32 1bd3_c03 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 68 hits 1bd3_c03 naa= 3 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 1 3 # 1 14 ASP A 177 ASP^? 8.44 MG MG A 302 16 HIS A 170 HIS^? 10.56 MG MG A 302 67 GLY A 71 GLY^? 17.05 MG MG A 301 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 33.02 29.04 43.18 33.79 27.88 44.78 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 34.91 23.57 39.32 34.35 24.95 40.81 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 42.53 33.15 24.80 43.14 33.53 25.16 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 2 3 # 2 14 ASP A 187 ASP^? -3.29 MG MG A 302s 16 HIS A 147 HIS^? 9.20 MG MG A 302 67 GLY A 34 GLY^? 18.18 MG MG A 301 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 39.43 26.57 46.78 39.37 27.83 45.03 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 40.24 23.10 39.83 38.32 22.34 40.22 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 33.66 35.41 27.99 33.72 35.64 27.21 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 3 3 # 3 14 ASP A 187 ASP^? -3.29 MG MG A 302s 16 HIS A 147 HIS^? 9.20 MG MG A 302 67 GLY A 71 GLY^? 17.05 MG MG A 301 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 39.43 26.57 46.78 39.37 27.83 45.03 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 40.24 23.10 39.83 38.32 22.34 40.22 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 42.53 33.15 24.80 43.14 33.53 25.16 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 4 3 # 4 14 ASP B 148 ASP^? 2.58 MG MG B 302s 16 HIS B 170 HIS^? 10.51 MG MG B 301 67 GLY C 27 GLY^? 19.87 MG MG B 301 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 52.73 19.23 -3.77 53.81 20.99 -4.31 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 63.15 1.80 -8.18 63.38 2.56 -8.31 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 5 3 # 5 14 ASP B 171 ASP^? 16.92 MG MG B 301 16 HIS B 170 HIS^? 10.51 MG MG B 301 67 GLY C 27 GLY^? 19.87 MG MG B 301 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 45.30 8.50 -0.71 46.30 6.81 0.12 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 63.15 1.80 -8.18 63.38 2.56 -8.31 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 6 3 # 6 14 ASP B 177 ASP^? 9.03 MG MG B 301 16 HIS B 170 HIS^? 10.51 MG MG B 301 67 GLY B 71 GLY^? 17.03 MG MG B 302 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 51.97 11.04 -6.64 50.39 11.62 -7.94 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 56.04 18.34 12.69 56.53 18.94 12.41 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 7 3 # 7 14 ASP B 187 ASP^? -3.44 MG MG B 301s 16 HIS B 147 HIS^? 9.27 MG MG B 301 67 GLY B 34 GLY^? 18.20 MG MG B 302 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 50.64 18.14 -9.69 51.74 17.63 -7.86 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 56.73 9.38 8.85 56.97 9.44 9.63 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 8 3 # 8 14 ASP B 187 ASP^? -3.44 MG MG B 301s 16 HIS B 147 HIS^? 9.27 MG MG B 301 67 GLY B 71 GLY^? 17.03 MG MG B 302 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 50.64 18.14 -9.69 51.74 17.63 -7.86 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 56.04 18.34 12.69 56.53 18.94 12.41 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 9 3 # 9 14 ASP C 177 ASP^? 8.84 MG MG C 301 16 HIS C 170 HIS^? 10.68 MG MG C 301 67 GLY C 71 GLY^? 16.48 MG MG C 302 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 85.60 16.42 -0.31 86.51 17.71 1.09 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 78.74 22.16 -18.87 78.10 22.58 -18.62 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 10 3 # 10 14 ASP C 187 ASP^? -3.72 MG MG C 301s 16 HIS C 147 HIS^? 9.44 MG MG C 301 67 GLY C 34 GLY^? 18.00 MG MG C 302 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 84.01 23.73 3.39 83.47 22.54 1.59 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 81.22 13.31 -15.34 80.98 13.29 -16.15 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 11 3 # 11 14 ASP D 148 ASP^? 2.35 MG MG D 302s 16 HIS D 170 HIS^? 10.59 MG MG D 301 67 GLY E 27 GLY^? 20.34 MG MG D 301 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 87.78 37.50 -47.56 85.79 37.49 -48.28 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 97.08 55.99 -51.80 96.40 55.63 -52.03 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 12 3 # 12 14 ASP D 171 ASP^? 16.95 MG MG D 301 16 HIS D 170 HIS^? 10.59 MG MG D 301 67 GLY E 27 GLY^? 20.34 MG MG D 301 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 100.39 36.69 -43.49 101.13 38.51 -42.69 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 97.08 55.99 -51.80 96.40 55.63 -52.03 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 13 3 # 13 14 ASP D 177 ASP^? 8.43 MG MG D 301 16 HIS D 170 HIS^? 10.59 MG MG D 301 67 GLY D 71 GLY^? 17.24 MG MG D 302 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 95.74 41.01 -49.76 94.81 39.90 -51.24 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 85.63 41.02 -31.04 84.94 41.10 -31.48 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 14 3 # 14 14 ASP D 187 ASP^? -2.95 MG MG D 301s 16 HIS D 147 HIS^? 9.43 MG MG D 301 67 GLY D 34 GLY^? 17.73 MG MG D 302 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 90.40 36.34 -52.69 89.24 37.98 -51.99 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 93.02 46.29 -34.84 92.89 46.52 -34.02 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 15 3 # 15 14 ASP D 187 ASP^? -2.95 MG MG D 301s 16 HIS D 147 HIS^? 9.43 MG MG D 301 67 GLY D 71 GLY^? 17.24 MG MG D 302 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 90.40 36.34 -52.69 89.24 37.98 -51.99 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 85.63 41.02 -31.04 84.94 41.10 -31.48 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 16 3 # 16 14 ASP D 187 ASP^? -2.95 MG MG D 301s 16 HIS D 170 HIS^? 10.59 MG MG D 301 67 GLY D 71 GLY^? 17.24 MG MG D 302 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 90.40 36.34 -52.69 89.24 37.98 -51.99 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 85.63 41.02 -31.04 84.94 41.10 -31.48 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 17 3 # 17 14 ASP D 187 ASP^? -2.95 MG MG D 301s 16 HIS D 170 HIS^? 10.59 MG MG D 301 67 GLY E 27 GLY^? 20.34 MG MG D 301 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 90.40 36.34 -52.69 89.24 37.98 -51.99 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 97.08 55.99 -51.80 96.40 55.63 -52.03 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 18 3 # 18 14 ASP E 148 ASP^? 2.62 MG MG E 302s 16 HIS E 170 HIS^? 10.33 MG MG E 301 67 GLY D 27 GLY^? 19.64 MG MG E 301 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 68.29 60.44 -47.29 68.03 58.42 -46.50 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 87.58 66.90 -43.17 87.20 66.21 -42.95 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 19 3 # 19 14 ASP E 171 ASP^? 16.73 MG MG E 301 16 HIS E 170 HIS^? 10.33 MG MG E 301 67 GLY D 27 GLY^? 19.64 MG MG E 301 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 69.61 73.12 -51.56 71.50 73.53 -52.39 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 87.58 66.90 -43.17 87.20 66.21 -42.95 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 20 3 # 20 14 ASP E 177 ASP^? 8.55 MG MG E 301 16 HIS E 170 HIS^? 10.33 MG MG E 301 67 GLY E 71 GLY^? 16.95 MG MG E 302 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 72.81 67.32 -45.03 71.14 67.96 -43.95 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 71.48 57.52 -63.50 71.50 56.77 -63.11 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 21 3 # 21 14 ASP E 187 ASP^? -2.71 MG MG E 301s 16 HIS E 147 HIS^? 9.22 MG MG E 301 67 GLY E 34 GLY^? 17.96 MG MG E 302 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 67.50 63.43 -41.69 68.97 62.26 -42.81 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 77.63 64.22 -60.15 77.94 64.12 -60.90 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 22 3 # 22 14 ASP E 187 ASP^? -2.71 MG MG E 301s 16 HIS E 147 HIS^? 9.22 MG MG E 301 67 GLY E 71 GLY^? 16.95 MG MG E 302 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 67.50 63.43 -41.69 68.97 62.26 -42.81 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 71.48 57.52 -63.50 71.50 56.77 -63.11 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 23 3 # 23 14 ASP F 177 ASP^? 8.15 MG MG F 302 16 HIS F 170 HIS^? 9.84 MG MG F 302 67 GLY F 71 GLY^? 16.93 MG MG F 301 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 47.18 61.22 -94.50 48.48 62.32 -95.73 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 51.61 53.62 -75.65 51.89 52.91 -76.00 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 24 3 # 24 14 ASP F 187 ASP^? -3.27 MG MG F 302s 16 HIS F 147 HIS^? 8.79 MG MG F 302 67 GLY F 34 GLY^? 17.95 MG MG F 301 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 53.93 58.87 -98.14 52.45 58.62 -96.61 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 43.60 57.46 -79.20 43.37 57.32 -78.41 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 25 3 # 25 14 ASP F 187 ASP^? -3.27 MG MG F 302s 16 HIS F 147 HIS^? 8.79 MG MG F 302 67 GLY F 71 GLY^? 16.93 MG MG F 301 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 53.93 58.87 -98.14 52.45 58.62 -96.61 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 51.61 53.62 -75.65 51.89 52.91 -76.00 1be1_c02 source 1be1 GLUTAMATE MUTASE : 25 hits 1be1_c02 naa= 3 ULMN 3 1bf2_c00 ISOAMYLASE user 1 3 # 1 375 ASP D 171 ASP^? 16.95 MG MG D 301 435 GLU D 174 GLU^? 19.76 MG MG D 301 510 ASP D 177 ASP^? 8.43 MG MG D 301 coo 88.62 69.90 41.16 89.05 70.67 43.04 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 89.52 76.11 40.17 89.01 75.16 41.97 104.29 37.18 -46.00 105.30 38.94 -45.21 coo 84.89 77.60 46.67 85.63 75.79 46.03 95.74 41.01 -49.76 94.81 39.90 -51.24 ULMN 3 1bf2_c00 ISOAMYLASE user 2 3 # 2 375 ASP D 187 ASP^? -2.95 MG MG D 301s 435 GLU D 146 GLU^? 10.62 MG MG D 301 510 ASP D 128 ASP^? -3.70 MG MG D 302s coo 88.62 69.90 41.16 89.05 70.67 43.04 90.40 36.34 -52.69 89.24 37.98 -51.99 coo 89.52 76.11 40.17 89.01 75.16 41.97 87.24 28.82 -50.92 85.47 28.08 -51.67 coo 84.89 77.60 46.67 85.63 75.79 46.03 83.33 35.45 -46.13 81.57 36.63 -46.10 1bf2_c00 source 1bf2 ISOAMYLASE : 2 hits 1bf2_c00 naa= 3 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 1 3 # 1 A 461 GLU A 52 GLU^? 19.89 MG MG A 301 A 503 TYR A 156 TYR^? 21.80 MG MG A 301 A 537 GLU A 154 GLU^? 19.22 MG MG A 301 coo 24.06 146.21 11.09 22.89 146.18 9.36 42.67 25.16 24.80 42.61 25.77 22.75 coo 15.91 140.69 8.32 15.71 143.39 9.13 37.50 16.28 27.75 35.30 17.94 28.08 coo 16.65 144.44 13.24 18.34 145.22 12.33 36.54 21.95 29.78 35.14 22.21 28.17 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 2 3 # 2 A 461 GLU B 52 GLU^? 20.06 MG MG B 302 A 503 TYR B 156 TYR^? 21.63 MG MG B 302 A 537 GLU B 154 GLU^? 19.05 MG MG B 302 coo 24.06 146.21 11.09 22.89 146.18 9.36 47.87 20.25 12.36 48.11 19.69 14.43 coo 15.91 140.69 8.32 15.71 143.39 9.13 38.56 16.71 8.27 39.91 14.31 7.86 coo 16.65 144.44 13.24 18.34 145.22 12.33 44.04 15.11 6.74 44.19 13.59 8.30 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 3 3 # 3 A 461 GLU B 63 GLU^? 27.83 MG MG A 301 A 503 TYR B 60 TYR^? 27.11 MG MG A 301 A 537 GLU A 33 GLU^? 22.87 MG MG A 301 coo 24.06 146.21 11.09 22.89 146.18 9.36 36.89 38.35 16.01 38.64 39.45 15.67 coo 15.91 140.69 8.32 15.71 143.39 9.13 28.84 35.27 19.49 28.03 36.56 21.83 coo 16.65 144.44 13.24 18.34 145.22 12.33 33.74 38.67 24.96 34.13 38.85 22.87 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 4 3 # 4 A 461 GLU C 52 GLU^? 19.67 MG MG C 302 A 503 TYR C 156 TYR^? 21.58 MG MG C 302 A 537 GLU C 154 GLU^? 18.91 MG MG C 302 coo 24.06 146.21 11.09 22.89 146.18 9.36 84.27 26.98 -19.19 85.21 26.16 -20.96 coo 15.91 140.69 8.32 15.71 143.39 9.13 95.64 26.50 -15.14 95.25 23.76 -14.77 coo 16.65 144.44 13.24 18.34 145.22 12.33 91.15 23.27 -13.33 91.61 21.91 -14.95 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 5 3 # 5 A 461 GLU D 52 GLU^? 19.94 MG MG D 302 A 503 TYR D 156 TYR^? 21.34 MG MG D 302 A 537 GLU D 154 GLU^? 18.75 MG MG D 302 coo 24.06 146.21 11.09 22.89 146.18 9.36 87.13 33.17 -30.97 88.40 33.70 -29.31 coo 15.91 140.69 8.32 15.71 143.39 9.13 96.25 27.10 -34.64 97.58 29.48 -35.03 coo 16.65 144.44 13.24 18.34 145.22 12.33 94.87 32.52 -36.42 96.07 33.39 -34.88 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 6 3 # 6 A 461 GLU D 63 GLU^? 27.62 MG MG C 302 A 503 TYR D 60 TYR^? 26.93 MG MG C 302 A 537 GLU C 33 GLU^? 22.71 MG MG C 302 coo 24.06 146.21 11.09 22.89 146.18 9.36 77.46 14.75 -28.07 75.93 16.12 -28.66 coo 15.91 140.69 8.32 15.71 143.39 9.13 84.40 9.28 -23.74 83.45 7.90 -21.49 coo 16.65 144.44 13.24 18.34 145.22 12.33 78.39 11.67 -18.82 78.34 12.01 -20.91 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 7 3 # 7 A 461 GLU E 52 GLU^? 19.96 MG MG E 302 A 503 TYR E 156 TYR^? 21.59 MG MG E 302 A 537 GLU E 154 GLU^? 19.05 MG MG E 302 coo 24.06 146.21 11.09 22.89 146.18 9.36 64.71 60.06 -63.78 64.69 61.36 -65.58 coo 15.91 140.69 8.32 15.71 143.39 9.13 59.31 70.31 -60.22 61.84 71.39 -59.92 coo 16.65 144.44 13.24 18.34 145.22 12.33 64.41 68.21 -58.47 65.40 69.20 -60.08 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 8 3 # 8 A 461 GLU E 63 GLU^? 28.08 MG MG F 301 A 503 TYR E 60 TYR^? 27.19 MG MG F 301 A 537 GLU F 33 GLU^? 22.46 MG MG F 301 coo 24.06 146.21 11.09 22.89 146.18 9.36 44.04 53.99 -66.79 43.77 51.93 -66.35 coo 15.91 140.69 8.32 15.71 143.39 9.13 39.82 61.07 -70.68 38.29 60.72 -72.98 coo 16.65 144.44 13.24 18.34 145.22 12.33 41.88 55.13 -75.91 42.06 54.64 -73.84 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 9 3 # 9 A 461 GLU F 52 GLU^? 20.13 MG MG F 301 A 503 TYR F 156 TYR^? 21.68 MG MG F 302 A 537 GLU F 154 GLU^? 18.97 MG MG F 301 coo 24.06 146.21 11.09 22.89 146.18 9.36 57.09 59.62 -75.76 56.76 59.40 -73.62 coo 15.91 140.69 8.32 15.71 143.39 9.13 58.80 69.55 -79.65 56.09 69.80 -80.15 coo 16.65 144.44 13.24 18.34 145.22 12.33 54.57 65.67 -81.55 53.36 66.51 -80.09 1bgl_c08 source 1bgl BETA-GALACTOSIDASE : 9 hits 1bgl_c08 naa= 3 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 1 3 # 1 A 451 GLU A 52 GLU^? 19.89 MG MG A 301 A 504 TYR A 156 TYR^? 21.80 MG MG A 301 A 540 GLU A 154 GLU^? 19.22 MG MG A 301 coo 81.34 87.29 87.22 82.36 86.09 88.61 42.67 25.16 24.80 42.61 25.77 22.75 coo 80.85 81.34 94.77 81.70 80.16 92.41 37.50 16.28 27.75 35.30 17.94 28.08 coo 79.94 80.46 88.84 81.11 81.36 87.27 36.54 21.95 29.78 35.14 22.21 28.17 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 2 3 # 2 A 451 GLU B 52 GLU^? 20.06 MG MG B 302 A 504 TYR B 156 TYR^? 21.63 MG MG B 302 A 540 GLU B 154 GLU^? 19.05 MG MG B 302 coo 81.34 87.29 87.22 82.36 86.09 88.61 47.87 20.25 12.36 48.11 19.69 14.43 coo 80.85 81.34 94.77 81.70 80.16 92.41 38.56 16.71 8.27 39.91 14.31 7.86 coo 79.94 80.46 88.84 81.11 81.36 87.27 44.04 15.11 6.74 44.19 13.59 8.30 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 3 3 # 3 A 451 GLU F 52 GLU^? 20.13 MG MG F 301 A 504 TYR F 156 TYR^? 21.68 MG MG F 302 A 540 GLU F 154 GLU^? 18.97 MG MG F 301 coo 81.34 87.29 87.22 82.36 86.09 88.61 57.09 59.62 -75.76 56.76 59.40 -73.62 coo 80.85 81.34 94.77 81.70 80.16 92.41 58.80 69.55 -79.65 56.09 69.80 -80.15 coo 79.94 80.46 88.84 81.11 81.36 87.27 54.57 65.67 -81.55 53.36 66.51 -80.09 1bhg_c02 source 1bhg BETA-GLUCURONIDASE : 3 hits 1bhg_c02 naa= 3 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 1 3 # 1 B 451 GLU A 52 GLU^? 19.89 MG MG A 301 B 504 TYR A 156 TYR^? 21.80 MG MG A 301 B 540 GLU A 54 GLU^? 22.98 MG MG A 301 coo 86.52 35.28 112.74 87.08 36.38 110.99 42.67 25.16 24.80 42.61 25.77 22.75 coo 84.93 40.21 105.31 85.72 41.45 107.72 37.50 16.28 27.75 35.30 17.94 28.08 coo 83.38 41.19 112.55 85.47 40.59 112.72 45.06 19.97 24.02 44.05 19.39 22.19 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 2 3 # 2 B 451 GLU A 52 GLU^? 19.89 MG MG A 301 B 504 TYR A 156 TYR^? 21.80 MG MG A 301 B 540 GLU A 154 GLU^? 19.22 MG MG A 301 coo 86.52 35.28 112.74 87.08 36.38 110.99 42.67 25.16 24.80 42.61 25.77 22.75 coo 84.93 40.21 105.31 85.72 41.45 107.72 37.50 16.28 27.75 35.30 17.94 28.08 coo 83.38 41.19 112.55 85.47 40.59 112.72 36.54 21.95 29.78 35.14 22.21 28.17 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 3 3 # 3 B 451 GLU B 52 GLU^? 20.06 MG MG B 302 B 504 TYR B 156 TYR^? 21.63 MG MG B 302 B 540 GLU B 54 GLU^? 22.94 MG MG B 302 coo 86.52 35.28 112.74 87.08 36.38 110.99 47.87 20.25 12.36 48.11 19.69 14.43 coo 84.93 40.21 105.31 85.72 41.45 107.72 38.56 16.71 8.27 39.91 14.31 7.86 coo 83.38 41.19 112.55 85.47 40.59 112.72 43.18 23.27 12.99 42.40 22.23 14.68 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 4 3 # 4 B 451 GLU B 52 GLU^? 20.06 MG MG B 302 B 504 TYR B 156 TYR^? 21.63 MG MG B 302 B 540 GLU B 154 GLU^? 19.05 MG MG B 302 coo 86.52 35.28 112.74 87.08 36.38 110.99 47.87 20.25 12.36 48.11 19.69 14.43 coo 84.93 40.21 105.31 85.72 41.45 107.72 38.56 16.71 8.27 39.91 14.31 7.86 coo 83.38 41.19 112.55 85.47 40.59 112.72 44.04 15.11 6.74 44.19 13.59 8.30 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 5 3 # 5 B 451 GLU F 52 GLU^? 20.13 MG MG F 301 B 504 TYR F 156 TYR^? 21.68 MG MG F 302 B 540 GLU F 54 GLU^? 22.98 MG MG F 301 coo 86.52 35.28 112.74 87.08 36.38 110.99 57.09 59.62 -75.76 56.76 59.40 -73.62 coo 84.93 40.21 105.31 85.72 41.45 107.72 58.80 69.55 -79.65 56.09 69.80 -80.15 coo 83.38 41.19 112.55 85.47 40.59 112.72 62.26 62.27 -75.30 61.72 63.47 -73.60 1bhg_c03 source 1bhg BETA-GLUCURONIDASE : 5 hits 1bhg_c03 naa= 3 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 1 3 # 1 A 382 ARG A 37 ARG^? 18.99 MG MG A 301 A 451 GLU A 52 GLU^? 19.89 MG MG A 301 A 540 GLU A 154 GLU^? 19.22 MG MG A 301 coo 79.04 80.20 80.81 79.58 81.40 83.63 32.99 26.50 25.19 35.50 25.33 26.51 coo 81.34 87.29 87.22 82.36 86.09 88.61 42.67 25.16 24.80 42.61 25.77 22.75 coo 79.94 80.46 88.84 81.11 81.36 87.27 36.54 21.95 29.78 35.14 22.21 28.17 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 2 3 # 2 A 382 ARG A 50 ARG^? 15.98 MG MG A 301 A 451 GLU A 154 GLU^? 19.22 MG MG A 301 A 540 GLU A 52 GLU^? 19.89 MG MG A 301 coo 79.04 80.20 80.81 79.58 81.40 83.63 38.44 33.02 29.31 39.55 34.58 26.90 coo 81.34 87.29 87.22 82.36 86.09 88.61 36.54 21.95 29.78 35.14 22.21 28.17 coo 79.94 80.46 88.84 81.11 81.36 87.27 42.67 25.16 24.80 42.61 25.77 22.75 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 3 3 # 3 A 382 ARG B 37 ARG^? 19.17 MG MG B 302 A 451 GLU B 52 GLU^? 20.06 MG MG B 302 A 540 GLU B 154 GLU^? 19.05 MG MG B 302 coo 79.04 80.20 80.81 79.58 81.40 83.63 47.41 10.20 11.40 46.99 12.91 10.22 coo 81.34 87.29 87.22 82.36 86.09 88.61 47.87 20.25 12.36 48.11 19.69 14.43 coo 79.94 80.46 88.84 81.11 81.36 87.27 44.04 15.11 6.74 44.19 13.59 8.30 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 4 3 # 4 A 382 ARG F 37 ARG^? 19.14 MG MG F 301 A 451 GLU F 52 GLU^? 20.13 MG MG F 301 A 540 GLU F 154 GLU^? 18.97 MG MG F 301 coo 79.04 80.20 80.81 79.58 81.40 83.63 48.80 64.46 -76.37 51.50 64.15 -77.79 coo 81.34 87.29 87.22 82.36 86.09 88.61 57.09 59.62 -75.76 56.76 59.40 -73.62 coo 79.94 80.46 88.84 81.11 81.36 87.27 54.57 65.67 -81.55 53.36 66.51 -80.09 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 5 3 # 5 A 382 ARG F 37 ARG^? 19.14 MG MG F 301 A 451 GLU F 154 GLU^? 18.97 MG MG F 301 A 540 GLU F 52 GLU^? 20.13 MG MG F 301 coo 79.04 80.20 80.81 79.58 81.40 83.63 48.80 64.46 -76.37 51.50 64.15 -77.79 coo 81.34 87.29 87.22 82.36 86.09 88.61 54.57 65.67 -81.55 53.36 66.51 -80.09 coo 79.94 80.46 88.84 81.11 81.36 87.27 57.09 59.62 -75.76 56.76 59.40 -73.62 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 6 3 # 6 A 382 ARG F 50 ARG^? 16.24 MG MG F 301 A 451 GLU F 154 GLU^? 18.97 MG MG F 301 A 540 GLU F 52 GLU^? 20.13 MG MG F 301 coo 79.04 80.20 80.81 79.58 81.40 83.63 48.85 56.05 -80.24 48.26 54.66 -77.55 coo 81.34 87.29 87.22 82.36 86.09 88.61 54.57 65.67 -81.55 53.36 66.51 -80.09 coo 79.94 80.46 88.84 81.11 81.36 87.27 57.09 59.62 -75.76 56.76 59.40 -73.62 1bhg_c04 source 1bhg BETA-GLUCURONIDASE : 6 hits 1bhg_c04 naa= 3 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 1 3 # 1 B 382 ARG A 37 ARG^? 18.99 MG MG A 301 B 451 GLU A 52 GLU^? 19.89 MG MG A 301 B 540 GLU A 154 GLU^? 19.22 MG MG A 301 coo 82.21 41.07 119.14 83.95 40.66 116.59 32.99 26.50 25.19 35.50 25.33 26.51 coo 86.52 35.28 112.74 87.08 36.38 110.99 42.67 25.16 24.80 42.61 25.77 22.75 coo 83.38 41.19 112.55 85.47 40.59 112.72 36.54 21.95 29.78 35.14 22.21 28.17 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 2 3 # 2 B 382 ARG B 37 ARG^? 19.17 MG MG B 302 B 451 GLU B 52 GLU^? 20.06 MG MG B 302 B 540 GLU B 154 GLU^? 19.05 MG MG B 302 coo 82.21 41.07 119.14 83.95 40.66 116.59 47.41 10.20 11.40 46.99 12.91 10.22 coo 86.52 35.28 112.74 87.08 36.38 110.99 47.87 20.25 12.36 48.11 19.69 14.43 coo 83.38 41.19 112.55 85.47 40.59 112.72 44.04 15.11 6.74 44.19 13.59 8.30 1bhg_c05 source 1bhg BETA-GLUCURONIDASE : 2 hits 1bhg_c05 naa= 3 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 1 3 # 1 118 ARG A 193 ARG^? 28.88 MG MG A 302 183 LYS A 136 LYS^? 30.58 MG MG A 302 317 ARG A 8 ARG^? 20.36 MG MG A 301 coo 76.57 109.19 73.41 73.86 110.26 72.16 43.09 4.06 39.01 41.78 1.42 39.93 coo 82.09 117.51 66.37 80.60 114.32 71.44 50.14 3.36 31.42 51.28 2.21 35.89 coo 65.21 120.62 58.76 63.62 123.14 59.66 40.62 19.52 24.63 40.98 22.51 23.88 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 2 3 # 2 118 ARG B 193 ARG^? 28.40 MG MG B 301 183 LYS B 136 LYS^? 33.75 MG MG B 302 317 ARG B 8 ARG^? 20.39 MG MG B 302 coo 76.57 109.19 73.41 73.86 110.26 72.16 29.25 23.93 -4.74 26.96 25.70 -3.52 coo 82.09 117.51 66.37 80.60 114.32 71.44 28.47 31.35 4.78 24.04 31.81 1.99 coo 65.21 120.62 58.76 63.62 123.14 59.66 41.99 18.82 11.83 44.91 18.76 12.93 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 3 3 # 3 118 ARG C 193 ARG^? 28.20 MG MG C 301 183 LYS C 136 LYS^? 30.63 MG MG C 302 317 ARG C 8 ARG^? 20.00 MG MG C 302 coo 76.57 109.19 73.41 73.86 110.26 72.16 102.52 36.87 -2.60 102.78 39.94 -3.05 coo 82.09 117.51 66.37 80.60 114.32 71.44 99.75 44.04 -11.38 100.98 45.13 -6.77 coo 65.21 120.62 58.76 63.62 123.14 59.66 91.42 27.61 -18.53 88.82 26.28 -19.38 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 4 3 # 4 118 ARG D 193 ARG^? 27.92 MG MG D 301 183 LYS D 136 LYS^? 34.99 MG MG D 302 317 ARG D 8 ARG^? 20.22 MG MG D 302 coo 76.57 109.19 73.41 73.86 110.26 72.16 95.76 15.06 -47.43 94.58 12.31 -46.69 coo 82.09 117.51 66.37 80.60 114.32 71.44 88.96 10.62 -38.53 90.77 6.00 -38.00 coo 65.21 120.62 58.76 63.62 123.14 59.66 92.22 28.83 -31.23 90.93 31.55 -30.54 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 5 3 # 5 118 ARG E 193 ARG^? 28.25 MG MG E 301 183 LYS E 136 LYS^? 31.27 MG MG E 302 317 ARG E 8 ARG^? 20.19 MG MG E 302 coo 76.57 109.19 73.41 73.86 110.26 72.16 47.02 71.25 -47.53 44.19 71.23 -48.93 coo 82.09 117.51 66.37 80.60 114.32 71.44 42.12 65.93 -56.52 39.36 65.07 -51.83 coo 65.21 120.62 58.76 63.62 123.14 59.66 60.42 66.09 -63.48 62.84 64.38 -64.17 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 6 3 # 6 118 ARG F 193 ARG^? 27.27 MG MG F 302 183 LYS F 136 LYS^? 30.53 MG MG F 301 317 ARG F 8 ARG^? 20.20 MG MG F 301 coo 76.57 109.19 73.41 73.86 110.26 72.16 70.24 75.04 -91.81 72.97 73.73 -92.20 coo 82.09 117.51 66.37 80.60 114.32 71.44 76.49 71.19 -83.39 78.38 70.88 -88.47 coo 65.21 120.62 58.76 63.62 123.14 59.66 58.98 65.22 -76.31 57.29 62.84 -75.38 1bib_c00 source 1bib BIRA BIFUNCTIONAL PROTEIN (ACTS AS BIOTIN OPER: 6 hits 1bib_c00 naa= 3 ULMN 3 1boo_c00 N-4 CYTOSINE-SPECIFIC METHYLTRANSFERuser 1 3 # 1 A 53 SER A 79 SER^? 29.65 MG MG A 301 A 54 PRO A 80 PRO^? 31.21 MG MG A 301 A 96 ASP A 81 ASP^? 34.50 MG MG A 301 coo -9.03 45.15 44.45 -7.51 43.26 44.28 32.57 55.71 29.63 34.63 56.10 28.47 coo -12.82 46.62 43.11 -11.69 44.75 42.79 32.73 58.72 32.72 31.18 57.87 31.37 coo -5.86 47.39 44.34 -4.55 46.60 42.83 31.12 60.71 27.43 31.74 59.35 25.95 ULMN 3 1boo_c00 N-4 CYTOSINE-SPECIFIC METHYLTRANSFERuser 2 3 # 2 A 53 SER A 115 SER^? 6.34 MG MG A 301 A 54 PRO A 126 PRO^? -4.21 MG MG A 301s A 96 ASP A 128 ASP^? -3.32 MG MG A 301s coo -9.03 45.15 44.45 -7.51 43.26 44.28 48.89 29.76 35.69 49.85 31.26 37.35 coo -12.82 46.62 43.11 -11.69 44.75 42.79 48.05 33.88 39.22 46.06 34.75 38.63 coo -5.86 47.39 44.34 -4.55 46.60 42.83 46.50 28.23 39.77 47.49 30.10 39.82 ULMN 3 1boo_c00 N-4 CYTOSINE-SPECIFIC METHYLTRANSFERuser 3 3 # 3 A 53 SER B 115 SER^? 6.48 MG MG B 302 A 54 PRO B 126 PRO^? -4.33 MG MG B 302s A 96 ASP B 128 ASP^? -3.57 MG MG B 302s coo -9.03 45.15 44.45 -7.51 43.26 44.28 54.36 25.96 2.48 56.06 26.75 0.95 coo -12.82 46.62 43.11 -11.69 44.75 42.79 58.71 24.63 -1.36 59.10 22.59 -0.55 coo -5.86 47.39 44.34 -4.55 46.60 42.83 52.92 24.09 -2.19 54.73 25.14 -1.90 ULMN 3 1boo_c00 N-4 CYTOSINE-SPECIFIC METHYLTRANSFERuser 4 3 # 4 A 53 SER C 115 SER^? 5.99 MG MG C 302 A 54 PRO C 126 PRO^? -3.94 MG MG C 302s A 96 ASP C 128 ASP^? -3.22 MG MG C 302s coo -9.03 45.15 44.45 -7.51 43.26 44.28 77.67 29.66 -8.53 76.02 29.92 -6.77 coo -12.82 46.62 43.11 -11.69 44.75 42.79 74.33 26.71 -5.04 74.81 24.60 -5.60 coo -5.86 47.39 44.34 -4.55 46.60 42.83 80.05 28.39 -4.25 77.97 28.60 -4.21 ULMN 3 1boo_c00 N-4 CYTOSINE-SPECIFIC METHYLTRANSFERuser 5 3 # 5 A 53 SER D 115 SER^? 7.08 MG MG D 302 A 54 PRO D 126 PRO^? -5.21 MG MG D 302s A 96 ASP D 128 ASP^? -3.70 MG MG D 302s coo -9.03 45.15 44.45 -7.51 43.26 44.28 80.50 35.70 -41.83 78.94 36.81 -43.34 coo -12.82 46.62 43.11 -11.69 44.75 42.79 79.29 40.42 -44.88 81.33 41.33 -44.79 coo -5.86 47.39 44.34 -4.55 46.60 42.83 83.33 35.45 -46.13 81.57 36.63 -46.10 ULMN 3 1boo_c00 N-4 CYTOSINE-SPECIFIC METHYLTRANSFERuser 6 3 # 6 A 53 SER E 79 SER^? 19.77 MG MG D 301 A 54 PRO E 80 PRO^? 21.88 MG MG D 301 A 96 ASP E 81 ASP^? 24.19 MG MG D 301 coo -9.03 45.15 44.45 -7.51 43.26 44.28 96.22 56.25 -58.39 95.94 54.06 -59.20 coo -12.82 46.62 43.11 -11.69 44.75 42.79 98.91 55.30 -55.13 98.69 56.90 -56.64 coo -5.86 47.39 44.34 -4.55 46.60 42.83 101.61 56.30 -60.24 100.25 55.53 -61.72 ULMN 3 1boo_c00 N-4 CYTOSINE-SPECIFIC METHYLTRANSFERuser 7 3 # 7 A 53 SER E 115 SER^? 6.17 MG MG E 302 A 54 PRO E 126 PRO^? -4.77 MG MG E 302s A 96 ASP E 128 ASP^? -3.53 MG MG E 302s coo -9.03 45.15 44.45 -7.51 43.26 44.28 65.46 53.67 -52.76 66.19 52.26 -50.99 coo -12.82 46.62 43.11 -11.69 44.75 42.79 69.75 51.61 -49.67 71.03 53.46 -49.85 coo -5.86 47.39 44.34 -4.55 46.60 42.83 65.38 56.57 -48.58 66.15 54.57 -48.61 ULMN 3 1boo_c00 N-4 CYTOSINE-SPECIFIC METHYLTRANSFERuser 8 3 # 8 A 53 SER F 115 SER^? 6.67 MG MG F 301 A 54 PRO F 126 PRO^? -4.52 MG MG F 301s A 96 ASP F 128 ASP^? -3.41 MG MG F 301s coo -9.03 45.15 44.45 -7.51 43.26 44.28 58.74 51.50 -86.07 58.73 49.57 -87.50 coo -12.82 46.62 43.11 -11.69 44.75 42.79 55.34 48.15 -89.40 53.37 49.17 -88.97 coo -5.86 47.39 44.34 -4.55 46.60 42.83 57.76 53.73 -90.50 57.46 51.64 -90.28 1boo_c00 source 1boo N-4 CYTOSINE-SPECIFIC METHYLTRANSFERASE PVU II: 8 hits 1boo_c00 naa= 3 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 1 3 # 1 30 GLY C 145 GLY^? 13.72 MG MG C 301 48 HIS C 170 HIS^? 10.68 MG MG C 301 99 ASP C 171 ASP^? 17.08 MG MG C 301 coo 12.38 5.55 24.25 13.27 5.59 24.39 90.12 32.13 -3.16 90.38 32.11 -2.40 coo 18.80 12.68 24.53 17.69 13.54 26.08 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 17.07 18.51 26.62 16.67 17.07 28.09 92.57 16.68 -6.24 92.24 14.74 -7.03 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 2 3 # 2 30 GLY D 176 GLY^? 13.91 MG MG D 301 48 HIS D 170 HIS^? 10.59 MG MG D 301 99 ASP D 148 ASP^? 2.35 MG MG D 302s coo 12.38 5.55 24.25 13.27 5.59 24.39 99.98 41.95 -51.04 99.39 41.45 -50.84 coo 18.80 12.68 24.53 17.69 13.54 26.08 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 17.07 18.51 26.62 16.67 17.07 28.09 87.78 37.50 -47.56 85.79 37.49 -48.28 1bp2_c00 source 1bp2 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSPHATIDE AC: 2 hits 1bp2_c00 naa= 3 ULMN 3 1bqc_c01 BETA-MANNANASE user 1 3 # 1 A 50 ARG C 8 ARG^? 20.00 MG MG C 302 A 128 GLU C 52 GLU^? 19.67 MG MG C 302 A 225 GLU C 54 GLU^? 22.77 MG MG C 302 coo 38.56 19.11 14.83 37.12 21.00 16.76 91.42 27.61 -18.53 88.82 26.28 -19.38 coo 36.48 24.43 22.02 36.86 26.34 21.13 84.27 26.98 -19.19 85.21 26.16 -20.96 coo 40.16 23.71 17.01 38.52 24.96 17.40 88.91 31.25 -19.52 89.97 30.69 -21.29 ULMN 3 1bqc_c01 BETA-MANNANASE user 2 3 # 2 A 50 ARG E 8 ARG^? 20.19 MG MG E 302 A 128 GLU E 52 GLU^? 19.96 MG MG E 302 A 225 GLU E 54 GLU^? 22.83 MG MG E 302 coo 38.56 19.11 14.83 37.12 21.00 16.76 60.42 66.09 -63.48 62.84 64.38 -64.17 coo 36.48 24.43 22.02 36.86 26.34 21.13 64.71 60.06 -63.78 64.69 61.36 -65.58 coo 40.16 23.71 17.01 38.52 24.96 17.40 58.39 62.16 -64.12 58.73 62.98 -66.04 1bqc_c01 source 1bqc BETA-MANNANASE : 2 hits 1bqc_c01 naa= 3 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 1 3 # 1 A 109 PHE A 59 PHE^? 31.59 MG MG A 301 A 205 ASP A 142 ASP^? 23.70 MG MG A 302 A 236 LYS A 157 LYS^? 28.65 MG MG A 302 coo 4.14 2.10 36.34 6.69 3.08 36.92 52.93 4.70 25.02 52.08 5.30 27.62 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 46.39 7.18 37.53 46.28 7.18 39.63 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 41.42 12.06 27.58 41.46 5.93 29.41 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 2 3 # 2 A 109 PHE A 65 PHE^? 25.49 MG MG B 302 A 205 ASP A 160 ASP^? 31.61 MG MG B 302 A 236 LYS A 157 LYS^? 28.65 MG MG A 302 coo 4.14 2.10 36.34 6.69 3.08 36.92 54.96 15.58 21.17 56.65 13.84 19.74 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 44.21 5.00 19.54 46.02 3.84 19.76 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 41.42 12.06 27.58 41.46 5.93 29.41 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 3 3 # 3 A 109 PHE A 155 PHE^? 14.59 MG MG A 301 A 205 ASP A 142 ASP^? 23.70 MG MG A 302 A 236 LYS A 111 LYS^? 15.16 MG MG A 301 coo 4.14 2.10 36.34 6.69 3.08 36.92 40.89 18.60 33.43 41.76 20.84 34.84 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 46.39 7.18 37.53 46.28 7.18 39.63 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 52.67 17.19 35.90 54.65 19.90 40.50 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 4 3 # 4 A 109 PHE B 59 PHE^? 31.31 MG MG B 302 A 205 ASP B 142 ASP^? 23.97 MG MG B 301 A 236 LYS B 157 LYS^? 28.85 MG MG B 302 coo 4.14 2.10 36.34 6.69 3.08 36.92 29.63 33.55 11.36 30.42 32.81 8.75 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 31.69 27.40 -1.31 32.10 27.37 -3.38 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 34.97 21.28 8.44 29.03 22.82 6.58 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 5 3 # 5 A 109 PHE B 65 PHE^? 25.48 MG MG A 301 A 205 ASP B 160 ASP^? 31.65 MG MG A 301 A 236 LYS B 157 LYS^? 28.85 MG MG B 302 coo 4.14 2.10 36.34 6.69 3.08 36.92 40.29 33.39 16.17 38.73 35.25 17.59 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 28.01 24.83 16.38 27.44 26.81 15.80 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 34.97 21.28 8.44 29.03 22.82 6.58 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 6 3 # 6 A 109 PHE B 155 PHE^? 14.47 MG MG B 302 A 205 ASP B 142 ASP^? 23.97 MG MG B 301 A 236 LYS B 111 LYS^? 13.75 MG MG B 302 coo 4.14 2.10 36.34 6.69 3.08 36.92 41.83 19.89 3.03 44.27 20.46 1.74 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 31.69 27.40 -1.31 32.10 27.37 -3.38 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 42.84 32.14 1.80 46.84 32.68 -2.87 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 7 3 # 7 A 109 PHE C 59 PHE^? 31.23 MG MG C 302 A 205 ASP C 142 ASP^? 23.76 MG MG C 301 A 236 LYS C 157 LYS^? 28.15 MG MG C 302 coo 4.14 2.10 36.34 6.69 3.08 36.92 98.06 45.52 -18.00 97.73 44.36 -15.53 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 97.94 39.27 -5.03 98.08 38.70 -2.97 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 97.55 32.04 -15.10 101.49 36.24 -13.39 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 8 3 # 8 A 109 PHE C 65 PHE^? 25.41 MG MG D 302 A 205 ASP C 160 ASP^? 31.63 MG MG D 302 A 236 LYS C 157 LYS^? 28.15 MG MG C 302 coo 4.14 2.10 36.34 6.69 3.08 36.92 87.79 41.78 -22.56 88.44 44.04 -24.09 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 102.50 38.00 -23.28 102.43 39.97 -22.46 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 97.55 32.04 -15.10 101.49 36.24 -13.39 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 9 3 # 9 A 109 PHE C 155 PHE^? 14.45 MG MG C 302 A 205 ASP C 142 ASP^? 23.76 MG MG C 301 A 236 LYS C 111 LYS^? 16.56 MG MG C 302 coo 4.14 2.10 36.34 6.69 3.08 36.92 91.63 28.51 -9.66 89.28 28.13 -8.17 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 97.94 39.27 -5.03 98.08 38.70 -2.97 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 86.36 39.56 -8.06 84.36 40.84 -3.15 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 10 3 # 10 A 109 PHE D 59 PHE^? 31.49 MG MG D 302 A 205 ASP D 142 ASP^? 23.49 MG MG D 301 A 236 LYS D 157 LYS^? 28.67 MG MG D 302 coo 4.14 2.10 36.34 6.69 3.08 36.92 86.17 10.70 -31.86 86.41 11.56 -34.53 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 90.90 15.58 -44.76 91.35 16.09 -46.79 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 94.17 21.71 -34.34 96.11 15.89 -35.92 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 11 3 # 11 A 109 PHE D 65 PHE^? 25.04 MG MG C 302 A 205 ASP D 160 ASP^? 31.45 MG MG C 302 A 236 LYS D 157 LYS^? 28.67 MG MG D 302 coo 4.14 2.10 36.34 6.69 3.08 36.92 80.36 20.18 -27.62 79.13 18.18 -26.16 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 94.15 13.98 -26.57 92.71 12.42 -26.99 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 94.17 21.71 -34.34 96.11 15.89 -35.92 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 12 3 # 12 A 109 PHE D 155 PHE^? 14.27 MG MG D 302 A 205 ASP D 142 ASP^? 23.49 MG MG D 301 A 236 LYS D 111 LYS^? 15.85 MG MG D 302 coo 4.14 2.10 36.34 6.69 3.08 36.92 92.10 28.06 -40.17 90.44 29.86 -41.52 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 90.90 15.58 -44.76 91.35 16.09 -46.79 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 81.21 22.69 -42.10 78.68 23.89 -46.57 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 13 3 # 13 A 109 PHE D 164 PHE^? 25.90 MG MG D 302 A 205 ASP C 160 ASP^? 31.63 MG MG D 302 A 236 LYS C 6 LYS^? 25.73 MG MG C 302 coo 4.14 2.10 36.34 6.69 3.08 36.92 97.06 25.02 -29.96 94.69 25.91 -28.78 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 102.50 38.00 -23.28 102.43 39.97 -22.46 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 94.42 35.68 -18.56 92.21 32.03 -23.05 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 14 3 # 14 A 109 PHE E 59 PHE^? 31.36 MG MG E 302 A 205 ASP E 142 ASP^? 23.66 MG MG E 301 A 236 LYS E 157 LYS^? 28.40 MG MG E 302 coo 4.14 2.10 36.34 6.69 3.08 36.92 41.55 62.67 -62.73 42.33 62.92 -60.06 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 47.19 67.15 -50.37 47.44 67.18 -48.23 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 53.63 69.16 -60.42 48.34 71.81 -58.40 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 15 3 # 15 A 109 PHE E 65 PHE^? 25.27 MG MG F 301 A 205 ASP E 160 ASP^? 31.54 MG MG F 301 A 236 LYS E 157 LYS^? 28.40 MG MG E 302 coo 4.14 2.10 36.34 6.69 3.08 36.92 49.98 55.58 -67.11 47.62 55.01 -68.64 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 45.81 70.00 -68.45 44.10 68.87 -67.77 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 53.63 69.16 -60.42 48.34 71.81 -58.40 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 16 3 # 16 A 109 PHE E 155 PHE^? 14.42 MG MG E 302 A 205 ASP E 142 ASP^? 23.66 MG MG E 301 A 236 LYS E 111 LYS^? 14.52 MG MG E 302 coo 4.14 2.10 36.34 6.69 3.08 36.92 59.64 66.20 -54.61 61.24 64.46 -53.08 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 47.19 67.15 -50.37 47.44 67.18 -48.23 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 52.49 56.44 -52.43 54.52 53.78 -47.52 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 17 3 # 17 A 109 PHE F 59 PHE^? 31.53 MG MG F 301 A 205 ASP F 142 ASP^? 23.43 MG MG F 302 A 236 LYS F 157 LYS^? 28.36 MG MG F 302 coo 4.14 2.10 36.34 6.69 3.08 36.92 77.96 68.89 -76.99 76.86 68.73 -79.55 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 71.46 69.88 -89.76 71.03 69.93 -91.81 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 64.43 70.47 -79.54 68.32 74.80 -81.65 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 18 3 # 18 A 109 PHE F 65 PHE^? 25.37 MG MG E 302 A 205 ASP F 160 ASP^? 31.59 MG MG E 302 A 236 LYS F 157 LYS^? 28.36 MG MG F 302 coo 4.14 2.10 36.34 6.69 3.08 36.92 72.59 59.42 -72.14 74.91 60.01 -70.72 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 71.27 74.59 -71.77 73.23 74.02 -72.37 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 64.43 70.47 -79.54 68.32 74.80 -81.65 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 19 3 # 19 A 109 PHE F 155 PHE^? 14.54 MG MG F 301 A 205 ASP F 142 ASP^? 23.43 MG MG F 302 A 236 LYS F 111 LYS^? 15.21 MG MG F 301 coo 4.14 2.10 36.34 6.69 3.08 36.92 59.83 65.32 -85.14 59.10 62.92 -86.45 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 71.46 69.88 -89.76 71.03 69.93 -91.81 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 69.70 58.57 -86.86 69.67 53.74 -90.29 1bs0_c01 source 1bs0 8-AMINO-7-OXONANOATE SYNTHASE : 19 hits 1bs0_c01 naa= 3 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN A 144 GLN^? 19.77 MG MG A 302 A 91 LEU A 131 LEU^? 14.90 MG MG A 301 A 133 GLU A 146 GLU^? 9.80 MG MG A 302 coo 43.58 43.67 66.73 42.32 42.78 68.15 46.49 12.77 42.93 46.53 10.83 42.06 coo 38.58 45.09 70.44 38.28 45.21 72.59 46.54 17.43 36.47 44.61 18.15 35.88 coo 44.05 36.87 70.65 43.15 38.64 69.97 45.17 20.35 44.20 46.68 21.21 45.40 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN B 144 GLN^? 20.13 MG MG B 301 A 91 LEU B 131 LEU^? 14.77 MG MG B 302 A 133 GLU B 146 GLU^? 10.54 MG MG B 301 coo 43.58 43.67 66.73 42.32 42.78 68.15 37.08 26.58 -5.56 36.43 28.52 -6.04 coo 38.58 45.09 70.44 38.28 45.21 72.59 42.21 26.02 0.98 42.26 23.91 1.14 coo 44.05 36.87 70.65 43.15 38.64 69.97 45.13 24.51 -7.01 46.08 25.99 -8.13 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 3 3 # 3 A 50 GLN C 144 GLN^? 20.37 MG MG C 301 A 91 LEU C 131 LEU^? 14.94 MG MG C 302 A 133 GLU C 146 GLU^? 10.46 MG MG C 301 coo 43.58 43.67 66.73 42.32 42.78 68.15 92.57 37.16 -1.30 94.53 37.81 -1.71 coo 38.58 45.09 70.44 38.28 45.21 72.59 89.30 34.23 -7.37 90.05 32.20 -7.57 coo 44.05 36.87 70.65 43.15 38.64 69.97 87.01 31.93 0.25 85.57 32.56 1.72 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 4 3 # 4 A 50 GLN D 144 GLN^? 19.85 MG MG D 301 A 91 LEU D 131 LEU^? 14.92 MG MG D 302 A 133 GLU D 146 GLU^? 10.62 MG MG D 301 coo 43.58 43.67 66.73 42.32 42.78 68.15 89.60 20.24 -48.38 88.70 18.97 -49.74 coo 38.58 45.09 70.44 38.28 45.21 72.59 86.71 25.11 -42.43 88.69 25.97 -42.33 coo 44.05 36.87 70.65 43.15 38.64 69.97 87.24 28.82 -50.92 85.47 28.08 -51.67 1bs4_c00 source 1bs4 PEPTIDE DEFORMYLASE : 4 hits 1bs4_c00 naa= 3 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 1 3 # 1 B 550 GLN A 144 GLN^? 19.77 MG MG A 302 B 591 LEU A 131 LEU^? 14.90 MG MG A 301 B 633 GLU A 146 GLU^? 9.80 MG MG A 302 coo 88.06 44.34 57.19 89.06 45.53 55.74 46.49 12.77 42.93 46.53 10.83 42.06 coo 86.70 48.66 52.61 87.15 48.69 50.51 46.54 17.43 36.47 44.61 18.15 35.88 coo 95.42 44.52 54.43 93.46 45.31 54.70 45.17 20.35 44.20 46.68 21.21 45.40 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 2 3 # 2 B 550 GLN B 144 GLN^? 20.13 MG MG B 301 B 591 LEU B 131 LEU^? 14.77 MG MG B 302 B 633 GLU B 146 GLU^? 10.54 MG MG B 301 coo 88.06 44.34 57.19 89.06 45.53 55.74 37.08 26.58 -5.56 36.43 28.52 -6.04 coo 86.70 48.66 52.61 87.15 48.69 50.51 42.21 26.02 0.98 42.26 23.91 1.14 coo 95.42 44.52 54.43 93.46 45.31 54.70 45.13 24.51 -7.01 46.08 25.99 -8.13 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 3 3 # 3 B 550 GLN C 144 GLN^? 20.37 MG MG C 301 B 591 LEU C 131 LEU^? 14.94 MG MG C 302 B 633 GLU C 146 GLU^? 10.46 MG MG C 301 coo 88.06 44.34 57.19 89.06 45.53 55.74 92.57 37.16 -1.30 94.53 37.81 -1.71 coo 86.70 48.66 52.61 87.15 48.69 50.51 89.30 34.23 -7.37 90.05 32.20 -7.57 coo 95.42 44.52 54.43 93.46 45.31 54.70 87.01 31.93 0.25 85.57 32.56 1.72 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 4 3 # 4 B 550 GLN D 144 GLN^? 19.85 MG MG D 301 B 591 LEU D 131 LEU^? 14.92 MG MG D 302 B 633 GLU D 146 GLU^? 10.62 MG MG D 301 coo 88.06 44.34 57.19 89.06 45.53 55.74 89.60 20.24 -48.38 88.70 18.97 -49.74 coo 86.70 48.66 52.61 87.15 48.69 50.51 86.71 25.11 -42.43 88.69 25.97 -42.33 coo 95.42 44.52 54.43 93.46 45.31 54.70 87.24 28.82 -50.92 85.47 28.08 -51.67 1bs4_c01 source 1bs4 PEPTIDE DEFORMYLASE : 4 hits 1bs4_c01 naa= 3 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 1 3 # 1 C1050 GLN A 144 GLN^? 19.77 MG MG A 302 C1091 LEU A 131 LEU^? 14.90 MG MG A 301 C1133 GLU A 146 GLU^? 9.80 MG MG A 302 coo 68.29 34.44 43.03 66.67 34.74 44.37 46.49 12.77 42.93 46.53 10.83 42.06 coo 65.83 38.95 47.05 65.46 38.90 49.20 46.54 17.43 36.47 44.61 18.15 35.88 coo 63.14 29.39 46.25 63.84 31.31 45.74 45.17 20.35 44.20 46.68 21.21 45.40 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 2 3 # 2 C1050 GLN B 144 GLN^? 20.13 MG MG B 301 C1091 LEU B 131 LEU^? 14.77 MG MG B 302 C1133 GLU B 146 GLU^? 10.54 MG MG B 301 coo 68.29 34.44 43.03 66.67 34.74 44.37 37.08 26.58 -5.56 36.43 28.52 -6.04 coo 65.83 38.95 47.05 65.46 38.90 49.20 42.21 26.02 0.98 42.26 23.91 1.14 coo 63.14 29.39 46.25 63.84 31.31 45.74 45.13 24.51 -7.01 46.08 25.99 -8.13 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 3 3 # 3 C1050 GLN C 144 GLN^? 20.37 MG MG C 301 C1091 LEU C 131 LEU^? 14.94 MG MG C 302 C1133 GLU C 146 GLU^? 10.46 MG MG C 301 coo 68.29 34.44 43.03 66.67 34.74 44.37 92.57 37.16 -1.30 94.53 37.81 -1.71 coo 65.83 38.95 47.05 65.46 38.90 49.20 89.30 34.23 -7.37 90.05 32.20 -7.57 coo 63.14 29.39 46.25 63.84 31.31 45.74 87.01 31.93 0.25 85.57 32.56 1.72 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 4 3 # 4 C1050 GLN D 144 GLN^? 19.85 MG MG D 301 C1091 LEU D 131 LEU^? 14.92 MG MG D 302 C1133 GLU D 146 GLU^? 10.62 MG MG D 301 coo 68.29 34.44 43.03 66.67 34.74 44.37 89.60 20.24 -48.38 88.70 18.97 -49.74 coo 65.83 38.95 47.05 65.46 38.90 49.20 86.71 25.11 -42.43 88.69 25.97 -42.33 coo 63.14 29.39 46.25 63.84 31.31 45.74 87.24 28.82 -50.92 85.47 28.08 -51.67 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 5 3 # 5 C1050 GLN E 144 GLN^? 20.26 MG MG E 301 C1091 LEU E 131 LEU^? 14.79 MG MG E 302 C1133 GLU E 146 GLU^? 10.15 MG MG E 301 coo 68.29 34.44 43.03 66.67 34.74 44.37 51.74 64.42 -45.34 50.01 64.85 -46.49 coo 65.83 38.95 47.05 65.46 38.90 49.20 55.95 61.46 -52.09 57.35 63.09 -52.46 coo 63.14 29.39 46.25 63.84 31.31 45.74 58.72 60.89 -44.51 59.23 60.24 -42.54 1bs4_c02 source 1bs4 PEPTIDE DEFORMYLASE : 5 hits 1bs4_c02 naa= 3 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN B 144 GLN^? 20.13 MG MG B 301 A 91 LEU B 131 LEU^? 14.77 MG MG B 302 A 133 GLU B 146 GLU^? 10.54 MG MG B 301 coo 38.23 53.34 67.59 38.84 53.87 69.56 37.08 26.58 -5.56 36.43 28.52 -6.04 coo 35.40 53.22 73.30 35.37 54.87 74.74 42.21 26.02 0.98 42.26 23.91 1.14 coo 45.08 56.04 70.60 43.15 55.19 70.77 45.13 24.51 -7.01 46.08 25.99 -8.13 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN D 144 GLN^? 19.85 MG MG D 301 A 91 LEU D 131 LEU^? 14.92 MG MG D 302 A 133 GLU D 146 GLU^? 10.62 MG MG D 301 coo 38.23 53.34 67.59 38.84 53.87 69.56 89.60 20.24 -48.38 88.70 18.97 -49.74 coo 35.40 53.22 73.30 35.37 54.87 74.74 86.71 25.11 -42.43 88.69 25.97 -42.33 coo 45.08 56.04 70.60 43.15 55.19 70.77 87.24 28.82 -50.92 85.47 28.08 -51.67 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 3 3 # 3 A 50 GLN F 53 GLN^? 15.06 MG MG F 301 A 91 LEU F 131 LEU^? 14.81 MG MG F 301 A 133 GLU F 54 GLU^? 22.98 MG MG F 301 coo 38.23 53.34 67.59 38.84 53.87 69.56 63.34 58.26 -79.73 63.90 57.42 -81.62 coo 35.40 53.22 73.30 35.37 54.87 74.74 64.89 61.59 -87.10 63.34 63.04 -87.61 coo 45.08 56.04 70.60 43.15 55.19 70.77 62.26 62.27 -75.30 61.72 63.47 -73.60 1bsj_c00 source 1bsj PEPTIDE DEFORMYLASE : 3 hits 1bsj_c00 naa= 3 ULMN 3 1bu7_c02 CYTOCHROME P450 user 1 3 # 1 A 268 THR A 18 THR.? 15.77 MG MG A 301 A 393 PHE A 150 PHE^? 10.47 MG MG A 302 A 400 CYH A 152 CYH^? 15.18 MG MG A 302 coo 45.81 71.19 43.26 47.70 70.19 43.25 32.02 38.89 33.13 34.18 39.03 32.98 coo 48.54 63.17 48.16 46.74 64.99 49.22 35.63 32.10 38.88 34.73 33.93 37.00 coo 53.76 64.39 46.87 52.06 66.55 47.33 34.81 26.51 34.70 32.10 26.95 34.06 ULMN 3 1bu7_c02 CYTOCHROME P450 user 2 3 # 2 A 268 THR A 18 THR.? 15.77 MG MG A 301 A 393 PHE A 172 PHE^? 13.28 MG MG A 302 A 400 CYH A 152 CYH^? 15.18 MG MG A 302 coo 45.81 71.19 43.26 47.70 70.19 43.25 32.02 38.89 33.13 34.18 39.03 32.98 coo 48.54 63.17 48.16 46.74 64.99 49.22 31.82 29.57 38.19 30.91 31.55 36.40 coo 53.76 64.39 46.87 52.06 66.55 47.33 34.81 26.51 34.70 32.10 26.95 34.06 ULMN 3 1bu7_c02 CYTOCHROME P450 user 3 3 # 3 A 268 THR A 40 THR^? 24.69 MG MG A 301 A 393 PHE A 12 PHE^? 17.15 MG MG A 301 A 400 CYH A 152 CYH^? 15.18 MG MG A 302 coo 45.81 71.19 43.26 47.70 70.19 43.25 32.64 20.47 25.22 32.40 21.22 23.20 coo 48.54 63.17 48.16 46.74 64.99 49.22 34.93 27.27 29.42 32.88 25.47 30.10 coo 53.76 64.39 46.87 52.06 66.55 47.33 34.81 26.51 34.70 32.10 26.95 34.06 ULMN 3 1bu7_c02 CYTOCHROME P450 user 4 3 # 4 A 268 THR A 175 THR^? 12.07 MG MG A 302 A 393 PHE A 150 PHE^? 10.47 MG MG A 302 A 400 CYH A 152 CYH^? 15.18 MG MG A 302 coo 45.81 71.19 43.26 47.70 70.19 43.25 29.08 25.19 42.91 31.22 24.90 42.83 coo 48.54 63.17 48.16 46.74 64.99 49.22 35.63 32.10 38.88 34.73 33.93 37.00 coo 53.76 64.39 46.87 52.06 66.55 47.33 34.81 26.51 34.70 32.10 26.95 34.06 ULMN 3 1bu7_c02 CYTOCHROME P450 user 5 3 # 5 A 268 THR B 18 THR^? 16.08 MG MG B 302 A 393 PHE B 150 PHE^? 9.88 MG MG B 301 A 400 CYH B 152 CYH^? 14.66 MG MG B 301 coo 45.81 71.19 43.26 47.70 70.19 43.25 60.02 7.32 3.97 60.86 9.29 4.05 coo 48.54 63.17 48.16 46.74 64.99 49.22 54.70 12.86 -1.84 56.31 11.50 0.05 coo 53.76 64.39 46.87 52.06 66.55 47.33 48.74 12.82 1.93 48.51 10.17 2.19 ULMN 3 1bu7_c02 CYTOCHROME P450 user 6 3 # 6 A 268 THR B 18 THR^? 16.08 MG MG B 302 A 393 PHE B 172 PHE^? 12.81 MG MG B 301 A 400 CYH B 152 CYH^? 14.66 MG MG B 301 coo 45.81 71.19 43.26 47.70 70.19 43.25 60.02 7.32 3.97 60.86 9.29 4.05 coo 48.54 63.17 48.16 46.74 64.99 49.22 51.51 9.59 -1.64 53.03 8.15 0.22 coo 53.76 64.39 46.87 52.06 66.55 47.33 48.74 12.82 1.93 48.51 10.17 2.19 ULMN 3 1bu7_c02 CYTOCHROME P450 user 7 3 # 7 A 268 THR B 40 THR^? 24.25 MG MG B 302 A 393 PHE B 12 PHE^? 17.13 MG MG B 302 A 400 CYH B 152 CYH^? 14.66 MG MG B 301 coo 45.81 71.19 43.26 47.70 70.19 43.25 41.77 11.06 10.77 42.63 10.70 12.73 coo 48.54 63.17 48.16 46.74 64.99 49.22 49.02 12.29 7.19 47.01 10.60 6.19 coo 53.76 64.39 46.87 52.06 66.55 47.33 48.74 12.82 1.93 48.51 10.17 2.19 ULMN 3 1bu7_c02 CYTOCHROME P450 user 8 3 # 8 A 268 THR B 175 THR^? 12.15 MG MG B 301 A 393 PHE B 150 PHE^? 9.88 MG MG B 301 A 400 CYH B 152 CYH^? 14.66 MG MG B 301 coo 45.81 71.19 43.26 47.70 70.19 43.25 46.88 7.94 -7.07 47.05 10.06 -6.52 coo 48.54 63.17 48.16 46.74 64.99 49.22 54.70 12.86 -1.84 56.31 11.50 0.05 coo 53.76 64.39 46.87 52.06 66.55 47.33 48.74 12.82 1.93 48.51 10.17 2.19 ULMN 3 1bu7_c02 CYTOCHROME P450 user 9 3 # 9 A 268 THR C 18 THR^? 15.72 MG MG C 302 A 393 PHE C 150 PHE^? 10.02 MG MG C 301 A 400 CYH C 152 CYH^? 14.61 MG MG C 301 coo 45.81 71.19 43.26 47.70 70.19 43.25 79.00 10.43 -10.53 77.64 12.10 -10.65 coo 48.54 63.17 48.16 46.74 64.99 49.22 82.11 17.28 -4.80 81.16 15.47 -6.75 coo 53.76 64.39 46.87 52.06 66.55 47.33 87.66 19.43 -8.58 88.77 17.04 -8.78 ULMN 3 1bu7_c02 CYTOCHROME P450 user 10 3 # 10 A 268 THR C 18 THR^? 15.72 MG MG C 302 A 393 PHE C 172 PHE^? 13.00 MG MG C 301 A 400 CYH C 152 CYH^? 14.61 MG MG C 301 coo 45.81 71.19 43.26 47.70 70.19 43.25 79.00 10.43 -10.53 77.64 12.10 -10.65 coo 48.54 63.17 48.16 46.74 64.99 49.22 86.45 15.28 -5.05 85.50 13.59 -7.08 coo 53.76 64.39 46.87 52.06 66.55 47.33 87.66 19.43 -8.58 88.77 17.04 -8.78 ULMN 3 1bu7_c02 CYTOCHROME P450 user 11 3 # 11 A 268 THR C 40 THR^? 24.02 MG MG C 302 A 393 PHE C 12 PHE^? 16.92 MG MG C 302 A 400 CYH C 152 CYH^? 14.61 MG MG C 301 coo 45.81 71.19 43.26 47.70 70.19 43.25 94.40 20.37 -17.61 93.73 19.75 -19.59 coo 48.54 63.17 48.16 46.74 64.99 49.22 87.42 18.93 -13.86 90.00 18.25 -12.97 coo 53.76 64.39 46.87 52.06 66.55 47.33 87.66 19.43 -8.58 88.77 17.04 -8.78 ULMN 3 1bu7_c02 CYTOCHROME P450 user 12 3 # 12 A 268 THR C 175 THR^? 12.73 MG MG C 301 A 393 PHE C 150 PHE^? 10.02 MG MG C 301 A 400 CYH C 152 CYH^? 14.61 MG MG C 301 coo 45.81 71.19 43.26 47.70 70.19 43.25 91.24 15.45 0.47 90.99 17.39 -0.47 coo 48.54 63.17 48.16 46.74 64.99 49.22 82.11 17.28 -4.80 81.16 15.47 -6.75 coo 53.76 64.39 46.87 52.06 66.55 47.33 87.66 19.43 -8.58 88.77 17.04 -8.78 ULMN 3 1bu7_c02 CYTOCHROME P450 user 13 3 # 13 A 268 THR D 18 THR^? 15.54 MG MG D 302 A 393 PHE D 150 PHE^? 10.21 MG MG D 301 A 400 CYH D 152 CYH^? 14.66 MG MG D 301 coo 45.81 71.19 43.26 47.70 70.19 43.25 93.52 49.91 -39.68 91.41 49.57 -39.76 coo 48.54 63.17 48.16 46.74 64.99 49.22 91.92 42.74 -45.34 92.24 44.79 -43.44 coo 53.76 64.39 46.87 52.06 66.55 47.33 94.69 37.43 -41.36 96.92 38.83 -40.94 ULMN 3 1bu7_c02 CYTOCHROME P450 user 14 3 # 14 A 268 THR D 18 THR^? 15.54 MG MG D 302 A 393 PHE D 172 PHE^? 13.02 MG MG D 301 A 400 CYH D 152 CYH^? 14.66 MG MG D 301 coo 45.81 71.19 43.26 47.70 70.19 43.25 93.52 49.91 -39.68 91.41 49.57 -39.76 coo 48.54 63.17 48.16 46.74 64.99 49.22 96.36 41.50 -44.84 96.77 43.66 -43.13 coo 53.76 64.39 46.87 52.06 66.55 47.33 94.69 37.43 -41.36 96.92 38.83 -40.94 ULMN 3 1bu7_c02 CYTOCHROME P450 user 15 3 # 15 A 268 THR D 40 THR^? 24.02 MG MG D 302 A 393 PHE D 12 PHE^? 16.78 MG MG D 302 A 400 CYH D 152 CYH^? 14.66 MG MG D 301 coo 45.81 71.19 43.26 47.70 70.19 43.25 99.14 32.63 -32.12 99.04 33.58 -30.18 coo 48.54 63.17 48.16 46.74 64.99 49.22 94.68 38.11 -36.05 97.16 37.10 -36.83 coo 53.76 64.39 46.87 52.06 66.55 47.33 94.69 37.43 -41.36 96.92 38.83 -40.94 ULMN 3 1bu7_c02 CYTOCHROME P450 user 16 3 # 16 A 268 THR D 175 THR^? 12.60 MG MG D 301 A 393 PHE D 150 PHE^? 10.21 MG MG D 301 A 400 CYH D 152 CYH^? 14.66 MG MG D 301 coo 45.81 71.19 43.26 47.70 70.19 43.25 100.33 38.24 -50.15 98.81 36.95 -49.29 coo 48.54 63.17 48.16 46.74 64.99 49.22 91.92 42.74 -45.34 92.24 44.79 -43.44 coo 53.76 64.39 46.87 52.06 66.55 47.33 94.69 37.43 -41.36 96.92 38.83 -40.94 ULMN 3 1bu7_c02 CYTOCHROME P450 user 17 3 # 17 A 268 THR E 18 THR^? 15.84 MG MG E 302 A 393 PHE E 150 PHE^? 10.10 MG MG E 301 A 400 CYH E 152 CYH^? 14.64 MG MG E 301 coo 45.81 71.19 43.26 47.70 70.19 43.25 81.45 64.25 -55.27 80.73 62.21 -55.24 coo 48.54 63.17 48.16 46.74 64.99 49.22 74.01 63.99 -49.53 76.06 63.87 -51.45 coo 53.76 64.39 46.87 52.06 66.55 47.33 69.49 67.27 -53.54 71.02 69.50 -54.03 ULMN 3 1bu7_c02 CYTOCHROME P450 user 18 3 # 18 A 268 THR E 18 THR^? 15.84 MG MG E 302 A 393 PHE E 172 PHE^? 12.71 MG MG E 301 A 400 CYH E 152 CYH^? 14.64 MG MG E 301 coo 45.81 71.19 43.26 47.70 70.19 43.25 81.45 64.25 -55.27 80.73 62.21 -55.24 coo 48.54 63.17 48.16 46.74 64.99 49.22 73.54 68.41 -50.00 75.58 68.36 -51.87 coo 53.76 64.39 46.87 52.06 66.55 47.33 69.49 67.27 -53.54 71.02 69.50 -54.03 ULMN 3 1bu7_c02 CYTOCHROME P450 user 19 3 # 19 A 268 THR E 40 THR^? 24.66 MG MG E 302 A 393 PHE E 12 PHE^? 17.09 MG MG E 302 A 400 CYH E 152 CYH^? 14.64 MG MG E 301 coo 45.81 71.19 43.26 47.70 70.19 43.25 65.26 72.42 -63.00 65.97 72.32 -65.06 coo 48.54 63.17 48.16 46.74 64.99 49.22 70.06 67.18 -58.76 69.33 69.81 -58.07 coo 53.76 64.39 46.87 52.06 66.55 47.33 69.49 67.27 -53.54 71.02 69.50 -54.03 ULMN 3 1bu7_c02 CYTOCHROME P450 user 20 3 # 20 A 268 THR E 175 THR^? 12.38 MG MG E 301 A 393 PHE E 150 PHE^? 10.10 MG MG E 301 A 400 CYH E 152 CYH^? 14.64 MG MG E 301 coo 45.81 71.19 43.26 47.70 70.19 43.25 71.20 72.92 -44.89 69.57 71.76 -45.77 coo 48.54 63.17 48.16 46.74 64.99 49.22 74.01 63.99 -49.53 76.06 63.87 -51.45 coo 53.76 64.39 46.87 52.06 66.55 47.33 69.49 67.27 -53.54 71.02 69.50 -54.03 ULMN 3 1bu7_c02 CYTOCHROME P450 user 21 3 # 21 A 268 THR F 18 THR^? 15.93 MG MG F 301 A 393 PHE F 150 PHE^? 9.82 MG MG F 302 A 400 CYH F 152 CYH^? 14.14 MG MG F 302 coo 45.81 71.19 43.26 47.70 70.19 43.25 39.95 55.99 -83.96 41.26 54.27 -83.96 coo 48.54 63.17 48.16 46.74 64.99 49.22 47.10 57.70 -89.94 45.06 57.27 -88.04 coo 53.76 64.39 46.87 52.06 66.55 47.33 50.28 62.76 -86.08 48.12 64.34 -85.77 ULMN 3 1bu7_c02 CYTOCHROME P450 user 22 3 # 22 A 268 THR F 18 THR^? 15.93 MG MG F 301 A 393 PHE F 172 PHE^? 12.43 MG MG F 302 A 400 CYH F 152 CYH^? 14.14 MG MG F 302 coo 45.81 71.19 43.26 47.70 70.19 43.25 39.95 55.99 -83.96 41.26 54.27 -83.96 coo 48.54 63.17 48.16 46.74 64.99 49.22 45.85 62.23 -89.68 43.95 61.55 -87.75 coo 53.76 64.39 46.87 52.06 66.55 47.33 50.28 62.76 -86.08 48.12 64.34 -85.77 ULMN 3 1bu7_c02 CYTOCHROME P450 user 23 3 # 23 A 268 THR F 40 THR^? 24.18 MG MG F 301 A 393 PHE F 12 PHE^? 17.12 MG MG F 301 A 400 CYH F 152 CYH^? 14.14 MG MG F 302 coo 45.81 71.19 43.26 47.70 70.19 43.25 52.32 69.62 -77.21 51.38 69.00 -75.36 coo 48.54 63.17 48.16 46.74 64.99 49.22 49.70 62.79 -80.90 49.37 65.44 -81.67 coo 53.76 64.39 46.87 52.06 66.55 47.33 50.28 62.76 -86.08 48.12 64.34 -85.77 ULMN 3 1bu7_c02 CYTOCHROME P450 user 24 3 # 24 A 268 THR F 175 THR^? 11.83 MG MG F 302 A 393 PHE F 150 PHE^? 9.82 MG MG F 302 A 400 CYH F 152 CYH^? 14.14 MG MG F 302 coo 45.81 71.19 43.26 47.70 70.19 43.25 46.82 66.80 -95.29 48.97 66.65 -95.25 coo 48.54 63.17 48.16 46.74 64.99 49.22 47.10 57.70 -89.94 45.06 57.27 -88.04 coo 53.76 64.39 46.87 52.06 66.55 47.33 50.28 62.76 -86.08 48.12 64.34 -85.77 1bu7_c02 source 1bu7 CYTOCHROME P450 : 24 hits 1bu7_c02 naa= 3 ULMN 3 1bu7_c03 CYTOCHROME P450 user 1 3 # 1 B 268 THR A 18 THR.? 15.77 MG MG A 301 B 393 PHE A 150 PHE^? 10.47 MG MG A 302 B 400 CYH A 152 CYH^? 15.18 MG MG A 302 coo 37.20 116.32 52.00 35.18 117.07 52.13 32.02 38.89 33.13 34.18 39.03 32.98 coo 33.81 121.65 59.26 35.49 119.55 59.81 35.63 32.10 38.88 34.73 33.93 37.00 coo 28.79 121.15 57.00 30.51 118.99 56.70 34.81 26.51 34.70 32.10 26.95 34.06 ULMN 3 1bu7_c03 CYTOCHROME P450 user 2 3 # 2 B 268 THR A 18 THR.? 15.77 MG MG A 301 B 393 PHE A 172 PHE^? 13.28 MG MG A 302 B 400 CYH A 152 CYH^? 15.18 MG MG A 302 coo 37.20 116.32 52.00 35.18 117.07 52.13 32.02 38.89 33.13 34.18 39.03 32.98 coo 33.81 121.65 59.26 35.49 119.55 59.81 31.82 29.57 38.19 30.91 31.55 36.40 coo 28.79 121.15 57.00 30.51 118.99 56.70 34.81 26.51 34.70 32.10 26.95 34.06 ULMN 3 1bu7_c03 CYTOCHROME P450 user 3 3 # 3 B 268 THR A 40 THR^? 24.69 MG MG A 301 B 393 PHE A 12 PHE^? 17.15 MG MG A 301 B 400 CYH A 152 CYH^? 15.18 MG MG A 302 coo 37.20 116.32 52.00 35.18 117.07 52.13 32.64 20.47 25.22 32.40 21.22 23.20 coo 33.81 121.65 59.26 35.49 119.55 59.81 34.93 27.27 29.42 32.88 25.47 30.10 coo 28.79 121.15 57.00 30.51 118.99 56.70 34.81 26.51 34.70 32.10 26.95 34.06 ULMN 3 1bu7_c03 CYTOCHROME P450 user 4 3 # 4 B 268 THR A 175 THR^? 12.07 MG MG A 302 B 393 PHE A 150 PHE^? 10.47 MG MG A 302 B 400 CYH A 152 CYH^? 15.18 MG MG A 302 coo 37.20 116.32 52.00 35.18 117.07 52.13 29.08 25.19 42.91 31.22 24.90 42.83 coo 33.81 121.65 59.26 35.49 119.55 59.81 35.63 32.10 38.88 34.73 33.93 37.00 coo 28.79 121.15 57.00 30.51 118.99 56.70 34.81 26.51 34.70 32.10 26.95 34.06 ULMN 3 1bu7_c03 CYTOCHROME P450 user 5 3 # 5 B 268 THR B 18 THR^? 16.08 MG MG B 302 B 393 PHE B 150 PHE^? 9.88 MG MG B 301 B 400 CYH B 152 CYH^? 14.66 MG MG B 301 coo 37.20 116.32 52.00 35.18 117.07 52.13 60.02 7.32 3.97 60.86 9.29 4.05 coo 33.81 121.65 59.26 35.49 119.55 59.81 54.70 12.86 -1.84 56.31 11.50 0.05 coo 28.79 121.15 57.00 30.51 118.99 56.70 48.74 12.82 1.93 48.51 10.17 2.19 ULMN 3 1bu7_c03 CYTOCHROME P450 user 6 3 # 6 B 268 THR B 18 THR^? 16.08 MG MG B 302 B 393 PHE B 172 PHE^? 12.81 MG MG B 301 B 400 CYH B 152 CYH^? 14.66 MG MG B 301 coo 37.20 116.32 52.00 35.18 117.07 52.13 60.02 7.32 3.97 60.86 9.29 4.05 coo 33.81 121.65 59.26 35.49 119.55 59.81 51.51 9.59 -1.64 53.03 8.15 0.22 coo 28.79 121.15 57.00 30.51 118.99 56.70 48.74 12.82 1.93 48.51 10.17 2.19 ULMN 3 1bu7_c03 CYTOCHROME P450 user 7 3 # 7 B 268 THR B 40 THR^? 24.25 MG MG B 302 B 393 PHE B 12 PHE^? 17.13 MG MG B 302 B 400 CYH B 152 CYH^? 14.66 MG MG B 301 coo 37.20 116.32 52.00 35.18 117.07 52.13 41.77 11.06 10.77 42.63 10.70 12.73 coo 33.81 121.65 59.26 35.49 119.55 59.81 49.02 12.29 7.19 47.01 10.60 6.19 coo 28.79 121.15 57.00 30.51 118.99 56.70 48.74 12.82 1.93 48.51 10.17 2.19 ULMN 3 1bu7_c03 CYTOCHROME P450 user 8 3 # 8 B 268 THR B 175 THR^? 12.15 MG MG B 301 B 393 PHE B 150 PHE^? 9.88 MG MG B 301 B 400 CYH B 152 CYH^? 14.66 MG MG B 301 coo 37.20 116.32 52.00 35.18 117.07 52.13 46.88 7.94 -7.07 47.05 10.06 -6.52 coo 33.81 121.65 59.26 35.49 119.55 59.81 54.70 12.86 -1.84 56.31 11.50 0.05 coo 28.79 121.15 57.00 30.51 118.99 56.70 48.74 12.82 1.93 48.51 10.17 2.19 ULMN 3 1bu7_c03 CYTOCHROME P450 user 9 3 # 9 B 268 THR C 18 THR^? 15.72 MG MG C 302 B 393 PHE C 150 PHE^? 10.02 MG MG C 301 B 400 CYH C 152 CYH^? 14.61 MG MG C 301 coo 37.20 116.32 52.00 35.18 117.07 52.13 79.00 10.43 -10.53 77.64 12.10 -10.65 coo 33.81 121.65 59.26 35.49 119.55 59.81 82.11 17.28 -4.80 81.16 15.47 -6.75 coo 28.79 121.15 57.00 30.51 118.99 56.70 87.66 19.43 -8.58 88.77 17.04 -8.78 ULMN 3 1bu7_c03 CYTOCHROME P450 user 10 3 # 10 B 268 THR C 18 THR^? 15.72 MG MG C 302 B 393 PHE C 172 PHE^? 13.00 MG MG C 301 B 400 CYH C 152 CYH^? 14.61 MG MG C 301 coo 37.20 116.32 52.00 35.18 117.07 52.13 79.00 10.43 -10.53 77.64 12.10 -10.65 coo 33.81 121.65 59.26 35.49 119.55 59.81 86.45 15.28 -5.05 85.50 13.59 -7.08 coo 28.79 121.15 57.00 30.51 118.99 56.70 87.66 19.43 -8.58 88.77 17.04 -8.78 ULMN 3 1bu7_c03 CYTOCHROME P450 user 11 3 # 11 B 268 THR C 40 THR^? 24.02 MG MG C 302 B 393 PHE C 12 PHE^? 16.92 MG MG C 302 B 400 CYH C 152 CYH^? 14.61 MG MG C 301 coo 37.20 116.32 52.00 35.18 117.07 52.13 94.40 20.37 -17.61 93.73 19.75 -19.59 coo 33.81 121.65 59.26 35.49 119.55 59.81 87.42 18.93 -13.86 90.00 18.25 -12.97 coo 28.79 121.15 57.00 30.51 118.99 56.70 87.66 19.43 -8.58 88.77 17.04 -8.78 ULMN 3 1bu7_c03 CYTOCHROME P450 user 12 3 # 12 B 268 THR C 175 THR^? 12.73 MG MG C 301 B 393 PHE C 150 PHE^? 10.02 MG MG C 301 B 400 CYH C 152 CYH^? 14.61 MG MG C 301 coo 37.20 116.32 52.00 35.18 117.07 52.13 91.24 15.45 0.47 90.99 17.39 -0.47 coo 33.81 121.65 59.26 35.49 119.55 59.81 82.11 17.28 -4.80 81.16 15.47 -6.75 coo 28.79 121.15 57.00 30.51 118.99 56.70 87.66 19.43 -8.58 88.77 17.04 -8.78 ULMN 3 1bu7_c03 CYTOCHROME P450 user 13 3 # 13 B 268 THR D 18 THR^? 15.54 MG MG D 302 B 393 PHE D 150 PHE^? 10.21 MG MG D 301 B 400 CYH D 152 CYH^? 14.66 MG MG D 301 coo 37.20 116.32 52.00 35.18 117.07 52.13 93.52 49.91 -39.68 91.41 49.57 -39.76 coo 33.81 121.65 59.26 35.49 119.55 59.81 91.92 42.74 -45.34 92.24 44.79 -43.44 coo 28.79 121.15 57.00 30.51 118.99 56.70 94.69 37.43 -41.36 96.92 38.83 -40.94 ULMN 3 1bu7_c03 CYTOCHROME P450 user 14 3 # 14 B 268 THR D 18 THR^? 15.54 MG MG D 302 B 393 PHE D 172 PHE^? 13.02 MG MG D 301 B 400 CYH D 152 CYH^? 14.66 MG MG D 301 coo 37.20 116.32 52.00 35.18 117.07 52.13 93.52 49.91 -39.68 91.41 49.57 -39.76 coo 33.81 121.65 59.26 35.49 119.55 59.81 96.36 41.50 -44.84 96.77 43.66 -43.13 coo 28.79 121.15 57.00 30.51 118.99 56.70 94.69 37.43 -41.36 96.92 38.83 -40.94 ULMN 3 1bu7_c03 CYTOCHROME P450 user 15 3 # 15 B 268 THR D 40 THR^? 24.02 MG MG D 302 B 393 PHE D 12 PHE^? 16.78 MG MG D 302 B 400 CYH D 152 CYH^? 14.66 MG MG D 301 coo 37.20 116.32 52.00 35.18 117.07 52.13 99.14 32.63 -32.12 99.04 33.58 -30.18 coo 33.81 121.65 59.26 35.49 119.55 59.81 94.68 38.11 -36.05 97.16 37.10 -36.83 coo 28.79 121.15 57.00 30.51 118.99 56.70 94.69 37.43 -41.36 96.92 38.83 -40.94 ULMN 3 1bu7_c03 CYTOCHROME P450 user 16 3 # 16 B 268 THR D 175 THR^? 12.60 MG MG D 301 B 393 PHE D 150 PHE^? 10.21 MG MG D 301 B 400 CYH D 152 CYH^? 14.66 MG MG D 301 coo 37.20 116.32 52.00 35.18 117.07 52.13 100.33 38.24 -50.15 98.81 36.95 -49.29 coo 33.81 121.65 59.26 35.49 119.55 59.81 91.92 42.74 -45.34 92.24 44.79 -43.44 coo 28.79 121.15 57.00 30.51 118.99 56.70 94.69 37.43 -41.36 96.92 38.83 -40.94 ULMN 3 1bu7_c03 CYTOCHROME P450 user 17 3 # 17 B 268 THR E 18 THR^? 15.84 MG MG E 302 B 393 PHE E 150 PHE^? 10.10 MG MG E 301 B 400 CYH E 152 CYH^? 14.64 MG MG E 301 coo 37.20 116.32 52.00 35.18 117.07 52.13 81.45 64.25 -55.27 80.73 62.21 -55.24 coo 33.81 121.65 59.26 35.49 119.55 59.81 74.01 63.99 -49.53 76.06 63.87 -51.45 coo 28.79 121.15 57.00 30.51 118.99 56.70 69.49 67.27 -53.54 71.02 69.50 -54.03 ULMN 3 1bu7_c03 CYTOCHROME P450 user 18 3 # 18 B 268 THR E 18 THR^? 15.84 MG MG E 302 B 393 PHE E 172 PHE^? 12.71 MG MG E 301 B 400 CYH E 152 CYH^? 14.64 MG MG E 301 coo 37.20 116.32 52.00 35.18 117.07 52.13 81.45 64.25 -55.27 80.73 62.21 -55.24 coo 33.81 121.65 59.26 35.49 119.55 59.81 73.54 68.41 -50.00 75.58 68.36 -51.87 coo 28.79 121.15 57.00 30.51 118.99 56.70 69.49 67.27 -53.54 71.02 69.50 -54.03 ULMN 3 1bu7_c03 CYTOCHROME P450 user 19 3 # 19 B 268 THR E 40 THR^? 24.66 MG MG E 302 B 393 PHE E 12 PHE^? 17.09 MG MG E 302 B 400 CYH E 152 CYH^? 14.64 MG MG E 301 coo 37.20 116.32 52.00 35.18 117.07 52.13 65.26 72.42 -63.00 65.97 72.32 -65.06 coo 33.81 121.65 59.26 35.49 119.55 59.81 70.06 67.18 -58.76 69.33 69.81 -58.07 coo 28.79 121.15 57.00 30.51 118.99 56.70 69.49 67.27 -53.54 71.02 69.50 -54.03 ULMN 3 1bu7_c03 CYTOCHROME P450 user 20 3 # 20 B 268 THR E 175 THR^? 12.38 MG MG E 301 B 393 PHE E 150 PHE^? 10.10 MG MG E 301 B 400 CYH E 152 CYH^? 14.64 MG MG E 301 coo 37.20 116.32 52.00 35.18 117.07 52.13 71.20 72.92 -44.89 69.57 71.76 -45.77 coo 33.81 121.65 59.26 35.49 119.55 59.81 74.01 63.99 -49.53 76.06 63.87 -51.45 coo 28.79 121.15 57.00 30.51 118.99 56.70 69.49 67.27 -53.54 71.02 69.50 -54.03 ULMN 3 1bu7_c03 CYTOCHROME P450 user 21 3 # 21 B 268 THR F 18 THR^? 15.93 MG MG F 301 B 393 PHE F 150 PHE^? 9.82 MG MG F 302 B 400 CYH F 152 CYH^? 14.14 MG MG F 302 coo 37.20 116.32 52.00 35.18 117.07 52.13 39.95 55.99 -83.96 41.26 54.27 -83.96 coo 33.81 121.65 59.26 35.49 119.55 59.81 47.10 57.70 -89.94 45.06 57.27 -88.04 coo 28.79 121.15 57.00 30.51 118.99 56.70 50.28 62.76 -86.08 48.12 64.34 -85.77 ULMN 3 1bu7_c03 CYTOCHROME P450 user 22 3 # 22 B 268 THR F 18 THR^? 15.93 MG MG F 301 B 393 PHE F 172 PHE^? 12.43 MG MG F 302 B 400 CYH F 152 CYH^? 14.14 MG MG F 302 coo 37.20 116.32 52.00 35.18 117.07 52.13 39.95 55.99 -83.96 41.26 54.27 -83.96 coo 33.81 121.65 59.26 35.49 119.55 59.81 45.85 62.23 -89.68 43.95 61.55 -87.75 coo 28.79 121.15 57.00 30.51 118.99 56.70 50.28 62.76 -86.08 48.12 64.34 -85.77 ULMN 3 1bu7_c03 CYTOCHROME P450 user 23 3 # 23 B 268 THR F 40 THR^? 24.18 MG MG F 301 B 393 PHE F 12 PHE^? 17.12 MG MG F 301 B 400 CYH F 152 CYH^? 14.14 MG MG F 302 coo 37.20 116.32 52.00 35.18 117.07 52.13 52.32 69.62 -77.21 51.38 69.00 -75.36 coo 33.81 121.65 59.26 35.49 119.55 59.81 49.70 62.79 -80.90 49.37 65.44 -81.67 coo 28.79 121.15 57.00 30.51 118.99 56.70 50.28 62.76 -86.08 48.12 64.34 -85.77 ULMN 3 1bu7_c03 CYTOCHROME P450 user 24 3 # 24 B 268 THR F 175 THR^? 11.83 MG MG F 302 B 393 PHE F 150 PHE^? 9.82 MG MG F 302 B 400 CYH F 152 CYH^? 14.14 MG MG F 302 coo 37.20 116.32 52.00 35.18 117.07 52.13 46.82 66.80 -95.29 48.97 66.65 -95.25 coo 33.81 121.65 59.26 35.49 119.55 59.81 47.10 57.70 -89.94 45.06 57.27 -88.04 coo 28.79 121.15 57.00 30.51 118.99 56.70 50.28 62.76 -86.08 48.12 64.34 -85.77 1bu7_c03 source 1bu7 CYTOCHROME P450 : 24 hits 1bu7_c03 naa= 3 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 1 3 # 1 A 325 ASP A 35 ASP^? 16.92 MG MG A 301 A 354 GLU A 33 GLU^? 22.87 MG MG A 301 A 421 ASP B 58 ASP^? 26.73 MG MG A 301 coo 31.05 49.37 64.51 31.97 51.11 63.85 34.49 31.10 26.54 36.41 31.82 27.10 coo 29.07 50.42 58.36 29.02 52.18 59.49 33.74 38.67 24.96 34.13 38.85 22.87 coo 30.82 59.76 58.47 31.12 59.02 60.40 34.42 33.56 15.74 33.50 33.49 17.59 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 2 3 # 2 A 325 ASP B 35 ASP^? 16.92 MG MG B 302 A 354 GLU B 33 GLU^? 22.65 MG MG B 302 A 421 ASP A 58 ASP^? 26.75 MG MG B 302 coo 31.05 49.37 64.51 31.97 51.11 63.85 52.63 11.07 10.18 53.68 12.85 9.94 coo 29.07 50.42 58.36 29.02 52.18 59.49 59.88 9.09 12.22 59.91 9.49 14.33 coo 30.82 59.76 58.47 31.12 59.02 60.40 53.93 9.80 21.09 53.83 8.90 19.15 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 3 3 # 3 A 325 ASP C 35 ASP^? 16.42 MG MG C 302 A 354 GLU C 33 GLU^? 22.71 MG MG C 302 A 421 ASP D 58 ASP^? 26.59 MG MG C 302 coo 31.05 49.37 64.51 31.97 51.11 63.85 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 29.07 50.42 58.36 29.02 52.18 59.49 78.39 11.67 -18.82 78.34 12.01 -20.91 coo 30.82 59.76 58.47 31.12 59.02 60.40 83.38 14.85 -27.71 84.09 14.12 -25.85 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 4 3 # 4 A 325 ASP D 23 ASP^? 15.37 MG MG E 301 A 354 GLU D 25 GLU^? 12.44 MG MG E 301 A 421 ASP E 177 ASP^? 8.55 MG MG E 301 coo 31.05 49.37 64.51 31.97 51.11 63.85 85.70 62.10 -45.60 84.07 62.13 -46.93 coo 29.07 50.42 58.36 29.02 52.18 59.49 81.26 66.22 -47.78 79.52 64.98 -48.06 coo 30.82 59.76 58.47 31.12 59.02 60.40 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 5 3 # 5 A 325 ASP D 35 ASP^? 16.80 MG MG D 302 A 354 GLU D 33 GLU^? 22.23 MG MG D 302 A 421 ASP C 58 ASP^? 26.67 MG MG D 302 coo 31.05 49.37 64.51 31.97 51.11 63.85 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 29.07 50.42 58.36 29.02 52.18 59.49 91.55 48.87 -31.66 91.12 48.92 -29.63 coo 30.82 59.76 58.47 31.12 59.02 60.40 93.40 43.81 -22.27 94.18 44.45 -24.11 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 6 3 # 6 A 325 ASP E 35 ASP^? 16.91 MG MG E 302 A 354 GLU E 33 GLU^? 22.81 MG MG E 302 A 421 ASP F 58 ASP^? 26.87 MG MG E 302 coo 31.05 49.37 64.51 31.97 51.11 63.85 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 29.07 50.42 58.36 29.02 52.18 59.49 80.16 62.57 -63.35 80.54 62.13 -65.43 coo 30.82 59.76 58.47 31.12 59.02 60.40 75.55 64.68 -72.56 76.21 65.63 -70.79 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 7 3 # 7 A 325 ASP F 35 ASP^? 16.93 MG MG F 301 A 354 GLU F 33 GLU^? 22.46 MG MG F 301 A 421 ASP E 58 ASP^? 26.76 MG MG F 301 coo 31.05 49.37 64.51 31.97 51.11 63.85 46.82 60.47 -77.63 48.00 58.79 -78.23 coo 29.07 50.42 58.36 29.02 52.18 59.49 41.88 55.13 -75.91 42.06 54.64 -73.84 coo 30.82 59.76 58.47 31.12 59.02 60.40 45.39 59.31 -66.83 44.62 59.88 -68.72 1bvz_c08 source 1bvz ALPHA-AMYLASE II : 7 hits 1bvz_c08 naa= 3 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 1 3 # 1 B 325 ASP A 35 ASP^? 16.92 MG MG A 301 B 354 GLU A 33 GLU^? 22.87 MG MG A 301 B 421 ASP B 58 ASP^? 26.73 MG MG A 301 coo 25.90 8.19 53.87 25.36 6.97 52.29 34.49 31.10 26.54 36.41 31.82 27.10 coo 27.87 10.66 47.95 27.82 8.60 48.27 33.74 38.67 24.96 34.13 38.85 22.87 coo 26.02 1.87 43.38 25.90 1.97 45.49 34.42 33.56 15.74 33.50 33.49 17.59 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 2 3 # 2 B 325 ASP B 35 ASP^? 16.92 MG MG B 302 B 354 GLU B 33 GLU^? 22.65 MG MG B 302 B 421 ASP A 58 ASP^? 26.75 MG MG B 302 coo 25.90 8.19 53.87 25.36 6.97 52.29 52.63 11.07 10.18 53.68 12.85 9.94 coo 27.87 10.66 47.95 27.82 8.60 48.27 59.88 9.09 12.22 59.91 9.49 14.33 coo 26.02 1.87 43.38 25.90 1.97 45.49 53.93 9.80 21.09 53.83 8.90 19.15 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 3 3 # 3 B 325 ASP B 171 ASP^? 16.92 MG MG B 301 B 354 GLU B 38 GLU^? 21.75 MG MG B 301 B 421 ASP B 35 ASP^? 16.92 MG MG B 302 coo 25.90 8.19 53.87 25.36 6.97 52.29 45.30 8.50 -0.71 46.30 6.81 0.12 coo 27.87 10.66 47.95 27.82 8.60 48.27 44.79 4.95 7.12 46.66 4.47 6.21 coo 26.02 1.87 43.38 25.90 1.97 45.49 52.63 11.07 10.18 53.68 12.85 9.94 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 4 3 # 4 B 325 ASP C 23 ASP^? 15.39 MG MG B 301 B 354 GLU B 19 GLU^? 18.96 MG MG B 301 B 421 ASP B 177 ASP^? 9.03 MG MG B 301 coo 25.90 8.19 53.87 25.36 6.97 52.29 65.24 6.82 -5.11 63.43 7.54 -4.15 coo 27.87 10.66 47.95 27.82 8.60 48.27 59.29 4.54 -0.16 58.81 2.51 -0.44 coo 26.02 1.87 43.38 25.90 1.97 45.49 51.97 11.04 -6.64 50.39 11.62 -7.94 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 5 3 # 5 B 325 ASP C 23 ASP^? 15.39 MG MG B 301 B 354 GLU C 25 GLU^? 12.27 MG MG B 301 B 421 ASP B 177 ASP^? 9.03 MG MG B 301 coo 25.90 8.19 53.87 25.36 6.97 52.29 65.24 6.82 -5.11 63.43 7.54 -4.15 coo 27.87 10.66 47.95 27.82 8.60 48.27 58.50 6.48 -3.59 57.94 8.54 -3.41 coo 26.02 1.87 43.38 25.90 1.97 45.49 51.97 11.04 -6.64 50.39 11.62 -7.94 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 6 3 # 6 B 325 ASP C 35 ASP^? 16.42 MG MG C 302 B 354 GLU C 33 GLU^? 22.71 MG MG C 302 B 421 ASP D 58 ASP^? 26.59 MG MG C 302 coo 25.90 8.19 53.87 25.36 6.97 52.29 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 27.87 10.66 47.95 27.82 8.60 48.27 78.39 11.67 -18.82 78.34 12.01 -20.91 coo 26.02 1.87 43.38 25.90 1.97 45.49 83.38 14.85 -27.71 84.09 14.12 -25.85 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 7 3 # 7 B 325 ASP D 23 ASP^? 15.37 MG MG E 301 B 354 GLU D 25 GLU^? 12.44 MG MG E 301 B 421 ASP E 177 ASP^? 8.55 MG MG E 301 coo 25.90 8.19 53.87 25.36 6.97 52.29 85.70 62.10 -45.60 84.07 62.13 -46.93 coo 27.87 10.66 47.95 27.82 8.60 48.27 81.26 66.22 -47.78 79.52 64.98 -48.06 coo 26.02 1.87 43.38 25.90 1.97 45.49 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 8 3 # 8 B 325 ASP D 23 ASP^? 15.37 MG MG E 301 B 354 GLU E 19 GLU^? 18.42 MG MG E 301 B 421 ASP E 177 ASP^? 8.55 MG MG E 301 coo 25.90 8.19 53.87 25.36 6.97 52.29 85.70 62.10 -45.60 84.07 62.13 -46.93 coo 27.87 10.66 47.95 27.82 8.60 48.27 82.78 67.13 -51.44 83.71 68.75 -50.40 coo 26.02 1.87 43.38 25.90 1.97 45.49 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 9 3 # 9 B 325 ASP D 35 ASP^? 16.80 MG MG D 302 B 354 GLU D 33 GLU^? 22.23 MG MG D 302 B 421 ASP C 58 ASP^? 26.67 MG MG D 302 coo 25.90 8.19 53.87 25.36 6.97 52.29 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 27.87 10.66 47.95 27.82 8.60 48.27 91.55 48.87 -31.66 91.12 48.92 -29.63 coo 26.02 1.87 43.38 25.90 1.97 45.49 93.40 43.81 -22.27 94.18 44.45 -24.11 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 10 3 # 10 B 325 ASP E 23 ASP^? 15.43 MG MG D 301 B 354 GLU E 25 GLU^? 12.55 MG MG D 301 B 421 ASP D 177 ASP^? 8.43 MG MG D 301 coo 25.90 8.19 53.87 25.36 6.97 52.29 91.98 54.64 -49.37 91.93 52.78 -48.33 coo 27.87 10.66 47.95 27.82 8.60 48.27 95.44 49.40 -47.17 93.82 48.00 -47.21 coo 26.02 1.87 43.38 25.90 1.97 45.49 95.74 41.01 -49.76 94.81 39.90 -51.24 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 11 3 # 11 B 325 ASP E 35 ASP^? 16.91 MG MG E 302 B 354 GLU E 33 GLU^? 22.81 MG MG E 302 B 421 ASP F 58 ASP^? 26.87 MG MG E 302 coo 25.90 8.19 53.87 25.36 6.97 52.29 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 27.87 10.66 47.95 27.82 8.60 48.27 80.16 62.57 -63.35 80.54 62.13 -65.43 coo 26.02 1.87 43.38 25.90 1.97 45.49 75.55 64.68 -72.56 76.21 65.63 -70.79 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 12 3 # 12 B 325 ASP F 35 ASP^? 16.93 MG MG F 301 B 354 GLU F 33 GLU^? 22.46 MG MG F 301 B 421 ASP E 58 ASP^? 26.76 MG MG F 301 coo 25.90 8.19 53.87 25.36 6.97 52.29 46.82 60.47 -77.63 48.00 58.79 -78.23 coo 27.87 10.66 47.95 27.82 8.60 48.27 41.88 55.13 -75.91 42.06 54.64 -73.84 coo 26.02 1.87 43.38 25.90 1.97 45.49 45.39 59.31 -66.83 44.62 59.88 -68.72 1bvz_c09 source 1bvz ALPHA-AMYLASE II : 12 hits 1bvz_c09 naa= 3 ULMN 3 1bwd_c02 INOSAMINE-PHOSPHATE AMIDINOTRANSFERAuser 1 3 # 1 A 179 ASP A 148 ASP^? 2.72 MG MG A 301s A 227 HIS A 147 HIS^? 9.20 MG MG A 302 A 332 CYH A 152 CYH^? 15.18 MG MG A 302 coo 123.98 30.59 1.90 124.68 28.67 1.28 41.50 28.88 41.13 43.33 29.67 41.93 coo 119.16 28.51 2.63 120.67 28.31 1.13 40.24 23.10 39.83 38.32 22.34 40.22 coo 114.70 31.13 -3.42 115.96 29.28 -1.69 34.81 26.51 34.70 32.10 26.95 34.06 ULMN 3 1bwd_c02 INOSAMINE-PHOSPHATE AMIDINOTRANSFERAuser 2 3 # 2 A 179 ASP B 148 ASP^? 2.58 MG MG B 302s A 227 HIS B 147 HIS^? 9.27 MG MG B 301 A 332 CYH B 152 CYH^? 14.66 MG MG B 301 coo 123.98 30.59 1.90 124.68 28.67 1.28 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 119.16 28.51 2.63 120.67 28.31 1.13 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 114.70 31.13 -3.42 115.96 29.28 -1.69 48.74 12.82 1.93 48.51 10.17 2.19 ULMN 3 1bwd_c02 INOSAMINE-PHOSPHATE AMIDINOTRANSFERAuser 3 3 # 3 A 179 ASP C 148 ASP^? 2.75 MG MG C 302s A 227 HIS C 147 HIS^? 9.44 MG MG C 301 A 332 CYH C 152 CYH^? 14.61 MG MG C 301 coo 123.98 30.59 1.90 124.68 28.67 1.28 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 119.16 28.51 2.63 120.67 28.31 1.13 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 114.70 31.13 -3.42 115.96 29.28 -1.69 87.66 19.43 -8.58 88.77 17.04 -8.78 ULMN 3 1bwd_c02 INOSAMINE-PHOSPHATE AMIDINOTRANSFERAuser 4 3 # 4 A 179 ASP D 148 ASP^? 2.35 MG MG D 302s A 227 HIS D 147 HIS^? 9.43 MG MG D 301 A 332 CYH D 152 CYH^? 14.66 MG MG D 301 coo 123.98 30.59 1.90 124.68 28.67 1.28 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 119.16 28.51 2.63 120.67 28.31 1.13 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 114.70 31.13 -3.42 115.96 29.28 -1.69 94.69 37.43 -41.36 96.92 38.83 -40.94 ULMN 3 1bwd_c02 INOSAMINE-PHOSPHATE AMIDINOTRANSFERAuser 5 3 # 5 A 179 ASP E 148 ASP^? 2.62 MG MG E 302s A 227 HIS E 147 HIS^? 9.22 MG MG E 301 A 332 CYH E 152 CYH^? 14.64 MG MG E 301 coo 123.98 30.59 1.90 124.68 28.67 1.28 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 119.16 28.51 2.63 120.67 28.31 1.13 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 114.70 31.13 -3.42 115.96 29.28 -1.69 69.49 67.27 -53.54 71.02 69.50 -54.03 ULMN 3 1bwd_c02 INOSAMINE-PHOSPHATE AMIDINOTRANSFERAuser 6 3 # 6 A 179 ASP F 148 ASP^? 2.72 MG MG F 301s A 227 HIS F 147 HIS^? 8.79 MG MG F 302 A 332 CYH F 152 CYH^? 14.14 MG MG F 302 coo 123.98 30.59 1.90 124.68 28.67 1.28 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 119.16 28.51 2.63 120.67 28.31 1.13 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 114.70 31.13 -3.42 115.96 29.28 -1.69 50.28 62.76 -86.08 48.12 64.34 -85.77 1bwd_c02 source 1bwd INOSAMINE-PHOSPHATE AMIDINOTRANSFERASE : 6 hits 1bwd_c02 naa= 3 ULMN 3 1bwd_c03 INOSAMINE-PHOSPHATE AMIDINOTRANSFERAuser 1 3 # 1 B 179 ASP A 148 ASP^? 2.72 MG MG A 301s B 227 HIS A 147 HIS^? 9.20 MG MG A 302 B 332 CYH A 152 CYH^? 15.18 MG MG A 302 coo 94.18 76.57 24.23 93.74 77.97 22.66 41.50 28.88 41.13 43.33 29.67 41.93 coo 89.34 74.44 23.40 90.11 76.41 23.55 40.24 23.10 39.83 38.32 22.34 40.22 coo 85.03 76.39 29.77 85.85 76.14 27.06 34.81 26.51 34.70 32.10 26.95 34.06 ULMN 3 1bwd_c03 INOSAMINE-PHOSPHATE AMIDINOTRANSFERAuser 2 3 # 2 B 179 ASP B 148 ASP^? 2.58 MG MG B 302s B 227 HIS B 147 HIS^? 9.27 MG MG B 301 B 332 CYH B 152 CYH^? 14.66 MG MG B 301 coo 94.18 76.57 24.23 93.74 77.97 22.66 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 89.34 74.44 23.40 90.11 76.41 23.55 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 85.03 76.39 29.77 85.85 76.14 27.06 48.74 12.82 1.93 48.51 10.17 2.19 ULMN 3 1bwd_c03 INOSAMINE-PHOSPHATE AMIDINOTRANSFERAuser 3 3 # 3 B 179 ASP C 148 ASP^? 2.75 MG MG C 302s B 227 HIS C 147 HIS^? 9.44 MG MG C 301 B 332 CYH C 152 CYH^? 14.61 MG MG C 301 coo 94.18 76.57 24.23 93.74 77.97 22.66 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 89.34 74.44 23.40 90.11 76.41 23.55 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 85.03 76.39 29.77 85.85 76.14 27.06 87.66 19.43 -8.58 88.77 17.04 -8.78 ULMN 3 1bwd_c03 INOSAMINE-PHOSPHATE AMIDINOTRANSFERAuser 4 3 # 4 B 179 ASP D 148 ASP^? 2.35 MG MG D 302s B 227 HIS D 147 HIS^? 9.43 MG MG D 301 B 332 CYH D 152 CYH^? 14.66 MG MG D 301 coo 94.18 76.57 24.23 93.74 77.97 22.66 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 89.34 74.44 23.40 90.11 76.41 23.55 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 85.03 76.39 29.77 85.85 76.14 27.06 94.69 37.43 -41.36 96.92 38.83 -40.94 ULMN 3 1bwd_c03 INOSAMINE-PHOSPHATE AMIDINOTRANSFERAuser 5 3 # 5 B 179 ASP D 187 ASP^? -2.95 MG MG D 301s B 227 HIS D 147 HIS^? 9.43 MG MG D 301 B 332 CYH D 152 CYH^? 14.66 MG MG D 301 coo 94.18 76.57 24.23 93.74 77.97 22.66 90.40 36.34 -52.69 89.24 37.98 -51.99 coo 89.34 74.44 23.40 90.11 76.41 23.55 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 85.03 76.39 29.77 85.85 76.14 27.06 94.69 37.43 -41.36 96.92 38.83 -40.94 ULMN 3 1bwd_c03 INOSAMINE-PHOSPHATE AMIDINOTRANSFERAuser 6 3 # 6 B 179 ASP E 148 ASP^? 2.62 MG MG E 302s B 227 HIS E 147 HIS^? 9.22 MG MG E 301 B 332 CYH E 152 CYH^? 14.64 MG MG E 301 coo 94.18 76.57 24.23 93.74 77.97 22.66 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 89.34 74.44 23.40 90.11 76.41 23.55 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 85.03 76.39 29.77 85.85 76.14 27.06 69.49 67.27 -53.54 71.02 69.50 -54.03 ULMN 3 1bwd_c03 INOSAMINE-PHOSPHATE AMIDINOTRANSFERAuser 7 3 # 7 B 179 ASP F 148 ASP^? 2.72 MG MG F 301s B 227 HIS F 147 HIS^? 8.79 MG MG F 302 B 332 CYH F 152 CYH^? 14.14 MG MG F 302 coo 94.18 76.57 24.23 93.74 77.97 22.66 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 89.34 74.44 23.40 90.11 76.41 23.55 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 85.03 76.39 29.77 85.85 76.14 27.06 50.28 62.76 -86.08 48.12 64.34 -85.77 1bwd_c03 source 1bwd INOSAMINE-PHOSPHATE AMIDINOTRANSFERASE : 7 hits 1bwd_c03 naa= 3 ULMN 3 1c4x_c00 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIEuser 1 3 # 1 A 110 SER A 189 SER^? 11.75 MG MG A 302 A 235 ASP A 148 ASP^? 2.72 MG MG A 301s A 263 HIS A 147 HIS^? 9.20 MG MG A 302 coo 30.32 56.27 16.76 31.62 57.99 17.94 40.99 19.00 44.32 41.51 18.14 46.48 coo 31.33 62.80 9.68 31.68 62.04 11.62 41.50 28.88 41.13 43.33 29.67 41.93 coo 30.23 62.32 14.77 30.86 60.47 15.53 40.24 23.10 39.83 38.32 22.34 40.22 ULMN 3 1c4x_c00 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIEuser 2 3 # 2 A 110 SER B 189 SER^? 12.11 MG MG B 301 A 235 ASP B 148 ASP^? 2.58 MG MG B 302s A 263 HIS B 147 HIS^? 9.27 MG MG B 301 coo 30.32 56.27 16.76 31.62 57.99 17.94 43.10 20.95 -7.74 42.82 21.56 -10.02 coo 31.33 62.80 9.68 31.68 62.04 11.62 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 30.23 62.32 14.77 30.86 60.47 15.53 46.73 18.97 -3.05 45.63 17.32 -3.73 ULMN 3 1c4x_c00 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIEuser 3 3 # 3 A 110 SER C 189 SER^? 12.09 MG MG C 301 A 235 ASP C 148 ASP^? 2.75 MG MG C 302s A 263 HIS C 147 HIS^? 9.44 MG MG C 301 coo 30.32 56.27 16.76 31.62 57.99 17.94 90.33 28.79 1.19 90.26 29.61 3.45 coo 31.33 62.80 9.68 31.68 62.04 11.62 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 30.23 62.32 14.77 30.86 60.47 15.53 87.61 25.71 -3.59 89.22 24.50 -2.99 ULMN 3 1c4x_c00 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIEuser 4 3 # 4 A 110 SER D 189 SER^? 12.12 MG MG D 301 A 235 ASP D 148 ASP^? 2.35 MG MG D 302s A 263 HIS D 147 HIS^? 9.43 MG MG D 301 coo 30.32 56.27 16.76 31.62 57.99 17.94 91.62 28.58 -50.95 91.45 27.78 -53.25 coo 31.33 62.80 9.68 31.68 62.04 11.62 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 30.23 62.32 14.77 30.86 60.47 15.53 90.95 32.51 -46.42 92.98 32.42 -46.93 ULMN 3 1c4x_c00 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIEuser 5 3 # 5 A 110 SER E 189 SER^? 11.91 MG MG E 301 A 235 ASP E 148 ASP^? 2.62 MG MG E 302s A 263 HIS E 147 HIS^? 9.22 MG MG E 301 coo 30.32 56.27 16.76 31.62 57.99 17.94 60.13 65.61 -43.87 59.01 65.34 -41.74 coo 31.33 62.80 9.68 31.68 62.04 11.62 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 30.23 62.32 14.77 30.86 60.47 15.53 63.87 64.43 -48.39 64.18 66.45 -47.92 ULMN 3 1c4x_c00 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIEuser 6 3 # 6 A 110 SER F 189 SER^? 11.88 MG MG F 302 A 235 ASP F 148 ASP^? 2.72 MG MG F 301s A 263 HIS F 147 HIS^? 8.79 MG MG F 302 coo 30.32 56.27 16.76 31.62 57.99 17.94 59.91 63.90 -95.91 60.70 64.22 -98.13 coo 31.33 62.80 9.68 31.68 62.04 11.62 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 30.23 62.32 14.77 30.86 60.47 15.53 56.63 61.66 -91.16 55.69 63.43 -91.80 1c4x_c00 source 1c4x 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIENOATE HYDR: 6 hits 1c4x_c00 naa= 3 ULMN 3 1c54_c00 RIBONUCLEASE SA user 1 3 # 1 A 54 GLU A 52 GLU^? 19.89 MG MG A 301 A 65 ARG A 37 ARG^? 18.99 MG MG A 301 A 85 HIS A 42 HIS^? 28.45 MG MG A 301 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 42.67 25.16 24.80 42.61 25.77 22.75 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 32.99 26.50 25.19 35.50 25.33 26.51 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 34.62 18.32 19.57 34.29 16.25 19.41 ULMN 3 1c54_c00 RIBONUCLEASE SA user 2 3 # 2 A 54 GLU B 52 GLU^? 20.06 MG MG B 302 A 65 ARG B 37 ARG^? 19.17 MG MG B 302 A 85 HIS B 42 HIS^? 28.37 MG MG B 302 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 47.87 20.25 12.36 48.11 19.69 14.43 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 47.41 10.20 11.40 46.99 12.91 10.22 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 39.34 12.99 16.30 37.26 13.24 16.40 ULMN 3 1c54_c00 RIBONUCLEASE SA user 3 3 # 3 A 54 GLU D 52 GLU^? 19.94 MG MG D 302 A 65 ARG D 37 ARG^? 18.81 MG MG D 302 A 85 HIS D 42 HIS^? 28.21 MG MG D 302 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 87.13 33.17 -30.97 88.40 33.70 -29.31 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 96.81 38.21 -31.63 94.97 36.32 -33.06 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 98.45 29.90 -26.44 99.32 28.02 -26.13 ULMN 3 1c54_c00 RIBONUCLEASE SA user 4 3 # 4 A 54 GLU E 154 GLU^? 19.05 MG MG E 302 A 65 ARG E 37 ARG^? 19.17 MG MG E 302 A 85 HIS E 42 HIS^? 28.20 MG MG E 302 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 64.41 68.21 -58.47 65.40 69.20 -60.08 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 70.82 68.02 -63.63 68.17 67.46 -62.14 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 62.33 71.93 -68.30 60.54 72.96 -68.64 ULMN 3 1c54_c00 RIBONUCLEASE SA user 5 3 # 5 A 54 GLU E 165 GLU^? 29.48 MG MG E 301 A 65 ARG E 8 ARG^? 20.19 MG MG E 302 A 85 HIS E 42 HIS^? 28.20 MG MG E 302 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 52.92 74.97 -61.04 50.84 74.87 -60.51 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 60.42 66.09 -63.48 62.84 64.38 -64.17 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 62.33 71.93 -68.30 60.54 72.96 -68.64 ULMN 3 1c54_c00 RIBONUCLEASE SA user 6 3 # 6 A 54 GLU E 165 GLU^? 29.48 MG MG E 301 A 65 ARG E 8 ARG^? 20.19 MG MG E 302 A 85 HIS F 42 HIS^? 28.34 MG MG F 301 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 52.92 74.97 -61.04 50.84 74.87 -60.51 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 60.42 66.09 -63.48 62.84 64.38 -64.17 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 55.11 70.50 -71.64 56.29 72.22 -71.48 ULMN 3 1c54_c00 RIBONUCLEASE SA user 7 3 # 7 A 54 GLU F 52 GLU^? 20.13 MG MG F 301 A 65 ARG F 37 ARG^? 19.14 MG MG F 301 A 85 HIS F 42 HIS^? 28.34 MG MG F 301 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 57.09 59.62 -75.76 56.76 59.40 -73.62 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 48.80 64.46 -76.37 51.50 64.15 -77.79 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 55.11 70.50 -71.64 56.29 72.22 -71.48 1c54_c00 source 1c54 RIBONUCLEASE SA : 7 hits 1c54_c00 naa= 3 ULMN 3 1c82_c02 HYALURONATE LYASE user 1 3 # 1 A 399 HIS A 170 HIS^? 10.56 MG MG A 302 A 408 TYR A 168 TYR^? 14.52 MG MG A 302 A 480 ARG A 193 ARG^? 28.88 MG MG A 302 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 34.91 23.57 39.32 34.35 24.95 40.81 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 37.31 16.98 37.59 36.65 18.86 39.55 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 43.09 4.06 39.01 41.78 1.42 39.93 1c82_c02 source 1c82 HYALURONATE LYASE : 1 hits 1c82_c02 naa= 3 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 1 3 # 1 A 14 ASP A 148 ASP^? 2.72 MG MG A 301s A 16 HIS A 147 HIS^? 9.20 MG MG A 302 A 67 GLY A 183 GLY^? -4.64 MG MG A 301s coo 11.02 -13.08 77.25 10.70 -11.13 76.52 41.50 28.88 41.13 43.33 29.67 41.93 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 40.24 23.10 39.83 38.32 22.34 40.22 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 42.94 34.42 44.60 42.51 33.67 44.58 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 2 3 # 2 A 14 ASP A 148 ASP^? 2.72 MG MG A 301s A 16 HIS A 147 HIS^? 9.20 MG MG A 302 A 67 GLY A 184 GLY^? 4.07 MG MG A 302 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 41.50 28.88 41.13 43.33 29.67 41.93 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 40.24 23.10 39.83 38.32 22.34 40.22 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 44.11 32.36 47.58 44.42 32.35 46.80 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 3 3 # 3 A 14 ASP A 187 ASP^? -3.29 MG MG A 302s A 16 HIS A 147 HIS^? 9.20 MG MG A 302 A 67 GLY A 183 GLY^? -4.64 MG MG A 301s coo 11.02 -13.08 77.25 10.70 -11.13 76.52 39.43 26.57 46.78 39.37 27.83 45.03 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 40.24 23.10 39.83 38.32 22.34 40.22 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 42.94 34.42 44.60 42.51 33.67 44.58 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 4 3 # 4 A 14 ASP A 187 ASP^? -3.29 MG MG A 302s A 16 HIS A 147 HIS^? 9.20 MG MG A 302 A 67 GLY A 184 GLY^? 4.07 MG MG A 302 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 39.43 26.57 46.78 39.37 27.83 45.03 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 40.24 23.10 39.83 38.32 22.34 40.22 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 44.11 32.36 47.58 44.42 32.35 46.80 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 5 3 # 5 A 14 ASP B 148 ASP^? 2.58 MG MG B 302s A 16 HIS B 147 HIS^? 9.27 MG MG B 301 A 67 GLY B 183 GLY^? -4.35 MG MG B 301s coo 11.02 -13.08 77.25 10.70 -11.13 76.52 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 58.74 20.22 -6.73 58.00 19.87 -6.89 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 6 3 # 6 A 14 ASP B 148 ASP^? 2.58 MG MG B 302s A 16 HIS B 147 HIS^? 9.27 MG MG B 301 A 67 GLY B 184 GLY^? 4.47 MG MG B 301 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 57.32 22.02 -9.75 57.17 22.15 -8.93 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 7 3 # 7 A 14 ASP B 187 ASP^? -3.44 MG MG B 301s A 16 HIS B 147 HIS^? 9.27 MG MG B 301 A 67 GLY B 183 GLY^? -4.35 MG MG B 301s coo 11.02 -13.08 77.25 10.70 -11.13 76.52 50.64 18.14 -9.69 51.74 17.63 -7.86 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 58.74 20.22 -6.73 58.00 19.87 -6.89 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 8 3 # 8 A 14 ASP B 187 ASP^? -3.44 MG MG B 301s A 16 HIS B 147 HIS^? 9.27 MG MG B 301 A 67 GLY B 184 GLY^? 4.47 MG MG B 301 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 50.64 18.14 -9.69 51.74 17.63 -7.86 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 57.32 22.02 -9.75 57.17 22.15 -8.93 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 9 3 # 9 A 14 ASP C 148 ASP^? 2.75 MG MG C 302s A 16 HIS C 147 HIS^? 9.44 MG MG C 301 A 67 GLY C 183 GLY^? -4.00 MG MG C 301s coo 11.02 -13.08 77.25 10.70 -11.13 76.52 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 76.27 22.45 0.43 77.06 22.50 0.60 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 10 3 # 10 A 14 ASP C 148 ASP^? 2.75 MG MG C 302s A 16 HIS C 147 HIS^? 9.44 MG MG C 301 A 67 GLY C 184 GLY^? 4.50 MG MG C 301 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 76.47 24.88 3.34 76.71 25.04 2.53 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 11 3 # 11 A 14 ASP D 148 ASP^? 2.35 MG MG D 302s A 16 HIS D 147 HIS^? 9.43 MG MG D 301 A 67 GLY D 183 GLY^? -4.40 MG MG D 301s coo 11.02 -13.08 77.25 10.70 -11.13 76.52 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 84.07 42.30 -50.78 84.70 41.81 -50.82 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 12 3 # 12 A 14 ASP D 148 ASP^? 2.35 MG MG D 302s A 16 HIS D 147 HIS^? 9.43 MG MG D 301 A 67 GLY D 184 GLY^? 4.28 MG MG D 301 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 83.33 40.04 -53.77 83.20 39.83 -52.97 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 13 3 # 13 A 14 ASP D 171 ASP^? 16.95 MG MG D 301 A 16 HIS D 170 HIS^? 10.59 MG MG D 301 A 67 GLY D 176 GLY^? 13.91 MG MG D 301 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 99.98 41.95 -51.04 99.39 41.45 -50.84 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 14 3 # 14 A 14 ASP D 187 ASP^? -2.95 MG MG D 301s A 16 HIS D 147 HIS^? 9.43 MG MG D 301 A 67 GLY D 183 GLY^? -4.40 MG MG D 301s coo 11.02 -13.08 77.25 10.70 -11.13 76.52 90.40 36.34 -52.69 89.24 37.98 -51.99 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 84.07 42.30 -50.78 84.70 41.81 -50.82 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 15 3 # 15 A 14 ASP D 187 ASP^? -2.95 MG MG D 301s A 16 HIS D 147 HIS^? 9.43 MG MG D 301 A 67 GLY D 184 GLY^? 4.28 MG MG D 301 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 90.40 36.34 -52.69 89.24 37.98 -51.99 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 83.33 40.04 -53.77 83.20 39.83 -52.97 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 16 3 # 16 A 14 ASP E 148 ASP^? 2.62 MG MG E 302s A 16 HIS E 147 HIS^? 9.22 MG MG E 301 A 67 GLY E 183 GLY^? -4.49 MG MG E 301s coo 11.02 -13.08 77.25 10.70 -11.13 76.52 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 72.33 56.33 -43.87 71.83 56.99 -43.77 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 17 3 # 17 A 14 ASP E 148 ASP^? 2.62 MG MG E 302s A 16 HIS E 147 HIS^? 9.22 MG MG E 301 A 67 GLY E 184 GLY^? 4.85 MG MG E 301 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 69.91 55.36 -41.13 69.77 55.58 -41.87 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 18 3 # 18 A 14 ASP E 187 ASP^? -2.71 MG MG E 301s A 16 HIS E 147 HIS^? 9.22 MG MG E 301 A 67 GLY E 183 GLY^? -4.49 MG MG E 301s coo 11.02 -13.08 77.25 10.70 -11.13 76.52 67.50 63.43 -41.69 68.97 62.26 -42.81 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 72.33 56.33 -43.87 71.83 56.99 -43.77 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 19 3 # 19 A 14 ASP E 187 ASP^? -2.71 MG MG E 301s A 16 HIS E 147 HIS^? 9.22 MG MG E 301 A 67 GLY E 184 GLY^? 4.85 MG MG E 301 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 67.50 63.43 -41.69 68.97 62.26 -42.81 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 69.91 55.36 -41.13 69.77 55.58 -41.87 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 20 3 # 20 A 14 ASP F 148 ASP^? 2.72 MG MG F 301s A 16 HIS F 147 HIS^? 8.79 MG MG F 302 A 67 GLY F 183 GLY^? -4.39 MG MG F 301s coo 11.02 -13.08 77.25 10.70 -11.13 76.52 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 51.40 50.96 -94.96 51.47 51.79 -95.11 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 21 3 # 21 A 14 ASP F 148 ASP^? 2.72 MG MG F 301s A 16 HIS F 147 HIS^? 8.79 MG MG F 302 A 67 GLY F 184 GLY^? 4.93 MG MG F 302 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 53.59 51.24 -98.07 53.82 51.26 -97.25 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 22 3 # 22 A 14 ASP F 171 ASP^? 16.35 MG MG F 302 A 16 HIS F 170 HIS^? 9.84 MG MG F 302 A 67 GLY F 176 GLY^? 12.78 MG MG F 302 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 43.85 64.48 -95.77 44.59 64.31 -95.63 1cb7_c06 source 1cb7 GLUTAMATE MUTASE : 22 hits 1cb7_c06 naa= 3 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 1 3 # 1 C 14 ASP A 148 ASP^? 2.72 MG MG A 301s C 16 HIS A 147 HIS^? 9.20 MG MG A 302 C 67 GLY A 183 GLY^? -4.64 MG MG A 301s coo 10.04 44.27 88.44 9.47 42.32 89.03 41.50 28.88 41.13 43.33 29.67 41.93 coo 6.38 39.80 88.71 6.88 38.89 86.87 40.24 23.10 39.83 38.32 22.34 40.22 coo 17.63 42.50 89.25 18.11 42.29 88.64 42.94 34.42 44.60 42.51 33.67 44.58 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 2 3 # 2 C 14 ASP A 148 ASP^? 2.72 MG MG A 301s C 16 HIS A 147 HIS^? 9.20 MG MG A 302 C 67 GLY A 184 GLY^? 4.07 MG MG A 302 coo 10.04 44.27 88.44 9.47 42.32 89.03 41.50 28.88 41.13 43.33 29.67 41.93 coo 6.38 39.80 88.71 6.88 38.89 86.87 40.24 23.10 39.83 38.32 22.34 40.22 coo 17.63 42.50 89.25 18.11 42.29 88.64 44.11 32.36 47.58 44.42 32.35 46.80 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 3 3 # 3 C 14 ASP A 171 ASP^? 17.17 MG MG A 302 C 16 HIS A 170 HIS^? 10.56 MG MG A 302 C 67 GLY A 176 GLY^? 13.62 MG MG A 302 coo 10.04 44.27 88.44 9.47 42.32 89.03 29.78 23.67 36.63 28.48 25.11 35.71 coo 6.38 39.80 88.71 6.88 38.89 86.87 34.91 23.57 39.32 34.35 24.95 40.81 coo 17.63 42.50 89.25 18.11 42.29 88.64 28.44 28.55 44.52 29.08 28.46 44.03 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 4 3 # 4 C 14 ASP B 148 ASP^? 2.58 MG MG B 302s C 16 HIS B 147 HIS^? 9.27 MG MG B 301 C 67 GLY B 183 GLY^? -4.35 MG MG B 301s coo 10.04 44.27 88.44 9.47 42.32 89.03 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 6.38 39.80 88.71 6.88 38.89 86.87 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 17.63 42.50 89.25 18.11 42.29 88.64 58.74 20.22 -6.73 58.00 19.87 -6.89 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 5 3 # 5 C 14 ASP B 148 ASP^? 2.58 MG MG B 302s C 16 HIS B 147 HIS^? 9.27 MG MG B 301 C 67 GLY B 184 GLY^? 4.47 MG MG B 301 coo 10.04 44.27 88.44 9.47 42.32 89.03 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 6.38 39.80 88.71 6.88 38.89 86.87 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 17.63 42.50 89.25 18.11 42.29 88.64 57.32 22.02 -9.75 57.17 22.15 -8.93 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 6 3 # 6 C 14 ASP B 171 ASP^? 16.92 MG MG B 301 C 16 HIS B 170 HIS^? 10.51 MG MG B 301 C 67 GLY B 176 GLY^? 13.46 MG MG B 301 coo 10.04 44.27 88.44 9.47 42.32 89.03 45.30 8.50 -0.71 46.30 6.81 0.12 coo 6.38 39.80 88.71 6.88 38.89 86.87 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 17.63 42.50 89.25 18.11 42.29 88.64 50.45 6.82 -7.94 50.29 7.54 -7.72 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 7 3 # 7 C 14 ASP B 187 ASP^? -3.44 MG MG B 301s C 16 HIS B 147 HIS^? 9.27 MG MG B 301 C 67 GLY B 183 GLY^? -4.35 MG MG B 301s coo 10.04 44.27 88.44 9.47 42.32 89.03 50.64 18.14 -9.69 51.74 17.63 -7.86 coo 6.38 39.80 88.71 6.88 38.89 86.87 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 17.63 42.50 89.25 18.11 42.29 88.64 58.74 20.22 -6.73 58.00 19.87 -6.89 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 8 3 # 8 C 14 ASP B 187 ASP^? -3.44 MG MG B 301s C 16 HIS B 147 HIS^? 9.27 MG MG B 301 C 67 GLY B 184 GLY^? 4.47 MG MG B 301 coo 10.04 44.27 88.44 9.47 42.32 89.03 50.64 18.14 -9.69 51.74 17.63 -7.86 coo 6.38 39.80 88.71 6.88 38.89 86.87 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 17.63 42.50 89.25 18.11 42.29 88.64 57.32 22.02 -9.75 57.17 22.15 -8.93 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 9 3 # 9 C 14 ASP C 148 ASP^? 2.75 MG MG C 302s C 16 HIS C 147 HIS^? 9.44 MG MG C 301 C 67 GLY C 183 GLY^? -4.00 MG MG C 301s coo 10.04 44.27 88.44 9.47 42.32 89.03 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 6.38 39.80 88.71 6.88 38.89 86.87 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 17.63 42.50 89.25 18.11 42.29 88.64 76.27 22.45 0.43 77.06 22.50 0.60 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 10 3 # 10 C 14 ASP C 148 ASP^? 2.75 MG MG C 302s C 16 HIS C 147 HIS^? 9.44 MG MG C 301 C 67 GLY C 184 GLY^? 4.50 MG MG C 301 coo 10.04 44.27 88.44 9.47 42.32 89.03 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 6.38 39.80 88.71 6.88 38.89 86.87 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 17.63 42.50 89.25 18.11 42.29 88.64 76.47 24.88 3.34 76.71 25.04 2.53 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 11 3 # 11 C 14 ASP C 171 ASP^? 17.08 MG MG C 301 C 16 HIS C 170 HIS^? 10.68 MG MG C 301 C 67 GLY C 176 GLY^? 13.69 MG MG C 301 coo 10.04 44.27 88.44 9.47 42.32 89.03 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 6.38 39.80 88.71 6.88 38.89 86.87 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 17.63 42.50 89.25 18.11 42.29 88.64 88.42 12.91 1.06 88.29 13.68 0.87 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 12 3 # 12 C 14 ASP D 148 ASP^? 2.35 MG MG D 302s C 16 HIS D 147 HIS^? 9.43 MG MG D 301 C 67 GLY D 183 GLY^? -4.40 MG MG D 301s coo 10.04 44.27 88.44 9.47 42.32 89.03 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 6.38 39.80 88.71 6.88 38.89 86.87 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 17.63 42.50 89.25 18.11 42.29 88.64 84.07 42.30 -50.78 84.70 41.81 -50.82 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 13 3 # 13 C 14 ASP D 148 ASP^? 2.35 MG MG D 302s C 16 HIS D 147 HIS^? 9.43 MG MG D 301 C 67 GLY D 184 GLY^? 4.28 MG MG D 301 coo 10.04 44.27 88.44 9.47 42.32 89.03 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 6.38 39.80 88.71 6.88 38.89 86.87 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 17.63 42.50 89.25 18.11 42.29 88.64 83.33 40.04 -53.77 83.20 39.83 -52.97 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 14 3 # 14 C 14 ASP D 171 ASP^? 16.95 MG MG D 301 C 16 HIS D 170 HIS^? 10.59 MG MG D 301 C 67 GLY D 176 GLY^? 13.91 MG MG D 301 coo 10.04 44.27 88.44 9.47 42.32 89.03 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 6.38 39.80 88.71 6.88 38.89 86.87 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 17.63 42.50 89.25 18.11 42.29 88.64 99.98 41.95 -51.04 99.39 41.45 -50.84 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 15 3 # 15 C 14 ASP D 187 ASP^? -2.95 MG MG D 301s C 16 HIS D 147 HIS^? 9.43 MG MG D 301 C 67 GLY D 183 GLY^? -4.40 MG MG D 301s coo 10.04 44.27 88.44 9.47 42.32 89.03 90.40 36.34 -52.69 89.24 37.98 -51.99 coo 6.38 39.80 88.71 6.88 38.89 86.87 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 17.63 42.50 89.25 18.11 42.29 88.64 84.07 42.30 -50.78 84.70 41.81 -50.82 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 16 3 # 16 C 14 ASP D 187 ASP^? -2.95 MG MG D 301s C 16 HIS D 147 HIS^? 9.43 MG MG D 301 C 67 GLY D 184 GLY^? 4.28 MG MG D 301 coo 10.04 44.27 88.44 9.47 42.32 89.03 90.40 36.34 -52.69 89.24 37.98 -51.99 coo 6.38 39.80 88.71 6.88 38.89 86.87 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 17.63 42.50 89.25 18.11 42.29 88.64 83.33 40.04 -53.77 83.20 39.83 -52.97 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 17 3 # 17 C 14 ASP E 148 ASP^? 2.62 MG MG E 302s C 16 HIS E 147 HIS^? 9.22 MG MG E 301 C 67 GLY E 183 GLY^? -4.49 MG MG E 301s coo 10.04 44.27 88.44 9.47 42.32 89.03 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 6.38 39.80 88.71 6.88 38.89 86.87 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 17.63 42.50 89.25 18.11 42.29 88.64 72.33 56.33 -43.87 71.83 56.99 -43.77 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 18 3 # 18 C 14 ASP E 148 ASP^? 2.62 MG MG E 302s C 16 HIS E 147 HIS^? 9.22 MG MG E 301 C 67 GLY E 184 GLY^? 4.85 MG MG E 301 coo 10.04 44.27 88.44 9.47 42.32 89.03 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 6.38 39.80 88.71 6.88 38.89 86.87 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 17.63 42.50 89.25 18.11 42.29 88.64 69.91 55.36 -41.13 69.77 55.58 -41.87 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 19 3 # 19 C 14 ASP E 187 ASP^? -2.71 MG MG E 301s C 16 HIS E 147 HIS^? 9.22 MG MG E 301 C 67 GLY E 183 GLY^? -4.49 MG MG E 301s coo 10.04 44.27 88.44 9.47 42.32 89.03 67.50 63.43 -41.69 68.97 62.26 -42.81 coo 6.38 39.80 88.71 6.88 38.89 86.87 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 17.63 42.50 89.25 18.11 42.29 88.64 72.33 56.33 -43.87 71.83 56.99 -43.77 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 20 3 # 20 C 14 ASP E 187 ASP^? -2.71 MG MG E 301s C 16 HIS E 147 HIS^? 9.22 MG MG E 301 C 67 GLY E 184 GLY^? 4.85 MG MG E 301 coo 10.04 44.27 88.44 9.47 42.32 89.03 67.50 63.43 -41.69 68.97 62.26 -42.81 coo 6.38 39.80 88.71 6.88 38.89 86.87 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 17.63 42.50 89.25 18.11 42.29 88.64 69.91 55.36 -41.13 69.77 55.58 -41.87 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 21 3 # 21 C 14 ASP F 148 ASP^? 2.72 MG MG F 301s C 16 HIS F 147 HIS^? 8.79 MG MG F 302 C 67 GLY F 183 GLY^? -4.39 MG MG F 301s coo 10.04 44.27 88.44 9.47 42.32 89.03 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 6.38 39.80 88.71 6.88 38.89 86.87 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 17.63 42.50 89.25 18.11 42.29 88.64 51.40 50.96 -94.96 51.47 51.79 -95.11 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 22 3 # 22 C 14 ASP F 148 ASP^? 2.72 MG MG F 301s C 16 HIS F 147 HIS^? 8.79 MG MG F 302 C 67 GLY F 184 GLY^? 4.93 MG MG F 302 coo 10.04 44.27 88.44 9.47 42.32 89.03 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 6.38 39.80 88.71 6.88 38.89 86.87 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 17.63 42.50 89.25 18.11 42.29 88.64 53.59 51.24 -98.07 53.82 51.26 -97.25 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 23 3 # 23 C 14 ASP F 171 ASP^? 16.35 MG MG F 302 C 16 HIS F 170 HIS^? 9.84 MG MG F 302 C 67 GLY F 176 GLY^? 12.78 MG MG F 302 coo 10.04 44.27 88.44 9.47 42.32 89.03 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 6.38 39.80 88.71 6.88 38.89 86.87 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 17.63 42.50 89.25 18.11 42.29 88.64 43.85 64.48 -95.77 44.59 64.31 -95.63 1cb7_c07 source 1cb7 GLUTAMATE MUTASE : 23 hits 1cb7_c07 naa= 3 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 1 3 # 1 71 ARG C 37 ARG^? 19.01 MG MG C 302 127 ARG C 48 ARG^? 25.02 MG MG C 302 270 GLU C 52 GLU^? 19.67 MG MG C 302 coo -0.83 25.63 1.57 0.97 28.05 0.90 89.36 17.23 -17.57 89.29 20.20 -16.76 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 84.94 16.06 -21.53 85.81 13.55 -23.08 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 84.27 26.98 -19.19 85.21 26.16 -20.96 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 2 3 # 2 71 ARG C 48 ARG^? 25.02 MG MG C 302 127 ARG C 37 ARG^? 19.01 MG MG C 302 270 GLU C 52 GLU^? 19.67 MG MG C 302 coo -0.83 25.63 1.57 0.97 28.05 0.90 84.94 16.06 -21.53 85.81 13.55 -23.08 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 89.36 17.23 -17.57 89.29 20.20 -16.76 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 84.27 26.98 -19.19 85.21 26.16 -20.96 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 3 3 # 3 71 ARG D 37 ARG^? 18.81 MG MG D 302 127 ARG D 48 ARG^? 24.87 MG MG D 302 270 GLU D 52 GLU^? 19.94 MG MG D 302 coo -0.83 25.63 1.57 0.97 28.05 0.90 96.81 38.21 -31.63 94.97 36.32 -33.06 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 94.06 41.76 -28.37 96.24 43.38 -26.96 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 87.13 33.17 -30.97 88.40 33.70 -29.31 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 4 3 # 4 71 ARG D 48 ARG^? 24.87 MG MG D 302 127 ARG D 37 ARG^? 18.81 MG MG D 302 270 GLU D 52 GLU^? 19.94 MG MG D 302 coo -0.83 25.63 1.57 0.97 28.05 0.90 94.06 41.76 -28.37 96.24 43.38 -26.96 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 96.81 38.21 -31.63 94.97 36.32 -33.06 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 87.13 33.17 -30.97 88.40 33.70 -29.31 1cbx_c01 source 1cbx CARBOXYPEPTIDASE A (E.C.3.4.17.1) COMPLEX WITH: 4 hits 1cbx_c01 naa= 3 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 3 # 1 229 ASP A 35 ASP^? 16.92 MG MG A 301 264 GLU B 54 GLU^? 22.94 MG MG B 302 328 ASP B 58 ASP^? 26.73 MG MG A 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 34.49 31.10 26.54 36.41 31.82 27.10 coo 59.69 92.71 39.85 58.53 92.03 41.47 43.18 23.27 12.99 42.40 22.23 14.68 coo 45.39 90.72 40.63 45.07 89.14 41.90 34.42 33.56 15.74 33.50 33.49 17.59 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 2 3 # 2 229 ASP A 58 ASP^? 26.75 MG MG B 302 264 GLU B 54 GLU^? 22.94 MG MG B 302 328 ASP B 35 ASP^? 16.92 MG MG B 302 coo 45.62 80.42 43.69 45.65 82.01 45.07 53.93 9.80 21.09 53.83 8.90 19.15 coo 59.69 92.71 39.85 58.53 92.03 41.47 43.18 23.27 12.99 42.40 22.23 14.68 coo 45.39 90.72 40.63 45.07 89.14 41.90 52.63 11.07 10.18 53.68 12.85 9.94 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 3 3 # 3 229 ASP A 58 ASP^? 26.75 MG MG B 302 264 GLU B 75 GLU^? 15.82 MG MG C 301 328 ASP B 35 ASP^? 16.92 MG MG B 302 coo 45.62 80.42 43.69 45.65 82.01 45.07 53.93 9.80 21.09 53.83 8.90 19.15 coo 59.69 92.71 39.85 58.53 92.03 41.47 68.81 12.14 8.61 69.95 13.49 7.45 coo 45.39 90.72 40.63 45.07 89.14 41.90 52.63 11.07 10.18 53.68 12.85 9.94 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 4 3 # 4 229 ASP A 58 ASP^? 26.75 MG MG B 302 264 GLU B 154 GLU^? 19.05 MG MG B 302 328 ASP A 160 ASP^? 31.61 MG MG B 302 coo 45.62 80.42 43.69 45.65 82.01 45.07 53.93 9.80 21.09 53.83 8.90 19.15 coo 59.69 92.71 39.85 58.53 92.03 41.47 44.04 15.11 6.74 44.19 13.59 8.30 coo 45.39 90.72 40.63 45.07 89.14 41.90 44.21 5.00 19.54 46.02 3.84 19.76 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 5 3 # 5 229 ASP A 138 ASP^? 33.08 MG MG A 302 264 GLU A 63 GLU^? 28.10 MG MG B 302 328 ASP A 160 ASP^? 31.61 MG MG B 302 coo 45.62 80.42 43.69 45.65 82.01 45.07 47.10 -0.97 29.63 45.89 0.22 30.96 coo 59.69 92.71 39.85 58.53 92.03 41.47 59.13 11.55 21.47 60.51 12.96 22.22 coo 45.39 90.72 40.63 45.07 89.14 41.90 44.21 5.00 19.54 46.02 3.84 19.76 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 6 3 # 6 229 ASP A 160 ASP^? 31.61 MG MG B 302 264 GLU B 52 GLU^? 20.06 MG MG B 302 328 ASP A 58 ASP^? 26.75 MG MG B 302 coo 45.62 80.42 43.69 45.65 82.01 45.07 44.21 5.00 19.54 46.02 3.84 19.76 coo 59.69 92.71 39.85 58.53 92.03 41.47 47.87 20.25 12.36 48.11 19.69 14.43 coo 45.39 90.72 40.63 45.07 89.14 41.90 53.93 9.80 21.09 53.83 8.90 19.15 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 7 3 # 7 229 ASP A 171 ASP^? 17.17 MG MG A 302 264 GLU A 146 GLU^? 9.80 MG MG A 302 328 ASP A 177 ASP^? 8.44 MG MG A 302 coo 45.62 80.42 43.69 45.65 82.01 45.07 29.78 23.67 36.63 28.48 25.11 35.71 coo 59.69 92.71 39.85 58.53 92.03 41.47 45.17 20.35 44.20 46.68 21.21 45.40 coo 45.39 90.72 40.63 45.07 89.14 41.90 33.02 29.04 43.18 33.79 27.88 44.78 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 8 3 # 8 229 ASP A 187 ASP^? -3.29 MG MG A 302s 264 GLU A 154 GLU^? 19.22 MG MG A 301 328 ASP A 128 ASP^? -3.32 MG MG A 301s coo 45.62 80.42 43.69 45.65 82.01 45.07 39.43 26.57 46.78 39.37 27.83 45.03 coo 59.69 92.71 39.85 58.53 92.03 41.47 36.54 21.95 29.78 35.14 22.21 28.17 coo 45.39 90.72 40.63 45.07 89.14 41.90 46.50 28.23 39.77 47.49 30.10 39.82 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 9 3 # 9 229 ASP B 35 ASP^? 16.92 MG MG B 302 264 GLU A 54 GLU^? 22.98 MG MG A 301 328 ASP A 58 ASP^? 26.75 MG MG B 302 coo 45.62 80.42 43.69 45.65 82.01 45.07 52.63 11.07 10.18 53.68 12.85 9.94 coo 59.69 92.71 39.85 58.53 92.03 41.47 45.06 19.97 24.02 44.05 19.39 22.19 coo 45.39 90.72 40.63 45.07 89.14 41.90 53.93 9.80 21.09 53.83 8.90 19.15 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 10 3 # 10 229 ASP B 58 ASP^? 26.73 MG MG A 301 264 GLU A 54 GLU^? 22.98 MG MG A 301 328 ASP A 35 ASP^? 16.92 MG MG A 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 34.42 33.56 15.74 33.50 33.49 17.59 coo 59.69 92.71 39.85 58.53 92.03 41.47 45.06 19.97 24.02 44.05 19.39 22.19 coo 45.39 90.72 40.63 45.07 89.14 41.90 34.49 31.10 26.54 36.41 31.82 27.10 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 11 3 # 11 229 ASP B 58 ASP^? 26.73 MG MG A 301 264 GLU A 75 GLU^? 20.23 MG MG A 301 328 ASP A 35 ASP^? 16.92 MG MG A 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 34.42 33.56 15.74 33.50 33.49 17.59 coo 59.69 92.71 39.85 58.53 92.03 41.47 38.99 46.65 28.68 39.94 47.65 30.33 coo 45.39 90.72 40.63 45.07 89.14 41.90 34.49 31.10 26.54 36.41 31.82 27.10 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 12 3 # 12 229 ASP B 58 ASP^? 26.73 MG MG A 301 264 GLU A 154 GLU^? 19.22 MG MG A 301 328 ASP B 160 ASP^? 31.65 MG MG A 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 34.42 33.56 15.74 33.50 33.49 17.59 coo 59.69 92.71 39.85 58.53 92.03 41.47 36.54 21.95 29.78 35.14 22.21 28.17 coo 45.39 90.72 40.63 45.07 89.14 41.90 28.01 24.83 16.38 27.44 26.81 15.80 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 13 3 # 13 229 ASP B 128 ASP^? -3.57 MG MG B 302s 264 GLU C 25 GLU^? 12.27 MG MG B 301 328 ASP B 187 ASP^? -3.44 MG MG B 301s coo 45.62 80.42 43.69 45.65 82.01 45.07 52.92 24.09 -2.19 54.73 25.14 -1.90 coo 59.69 92.71 39.85 58.53 92.03 41.47 58.50 6.48 -3.59 57.94 8.54 -3.41 coo 45.39 90.72 40.63 45.07 89.14 41.90 50.64 18.14 -9.69 51.74 17.63 -7.86 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 14 3 # 14 229 ASP B 138 ASP^? 33.32 MG MG B 302 264 GLU B 63 GLU^? 27.83 MG MG A 301 328 ASP B 160 ASP^? 31.65 MG MG A 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 23.42 29.01 6.78 24.36 28.48 4.94 coo 59.69 92.71 39.85 58.53 92.03 41.47 36.89 38.35 16.01 38.64 39.45 15.67 coo 45.39 90.72 40.63 45.07 89.14 41.90 28.01 24.83 16.38 27.44 26.81 15.80 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 15 3 # 15 229 ASP B 171 ASP^? 16.92 MG MG B 301 264 GLU B 146 GLU^? 10.54 MG MG B 301 328 ASP B 177 ASP^? 9.03 MG MG B 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 45.30 8.50 -0.71 46.30 6.81 0.12 coo 59.69 92.71 39.85 58.53 92.03 41.47 45.13 24.51 -7.01 46.08 25.99 -8.13 coo 45.39 90.72 40.63 45.07 89.14 41.90 51.97 11.04 -6.64 50.39 11.62 -7.94 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 16 3 # 16 229 ASP B 187 ASP^? -3.44 MG MG B 301s 264 GLU B 154 GLU^? 19.05 MG MG B 302 328 ASP B 128 ASP^? -3.57 MG MG B 302s coo 45.62 80.42 43.69 45.65 82.01 45.07 50.64 18.14 -9.69 51.74 17.63 -7.86 coo 59.69 92.71 39.85 58.53 92.03 41.47 44.04 15.11 6.74 44.19 13.59 8.30 coo 45.39 90.72 40.63 45.07 89.14 41.90 52.92 24.09 -2.19 54.73 25.14 -1.90 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 17 3 # 17 229 ASP C 35 ASP^? 16.42 MG MG C 302 264 GLU D 54 GLU^? 22.96 MG MG D 302 328 ASP D 58 ASP^? 26.59 MG MG C 302 coo 45.62 80.42 43.69 45.65 82.01 45.07 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 59.69 92.71 39.85 58.53 92.03 41.47 87.96 27.60 -30.52 89.07 27.55 -28.72 coo 45.39 90.72 40.63 45.07 89.14 41.90 83.38 14.85 -27.71 84.09 14.12 -25.85 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 18 3 # 18 229 ASP C 58 ASP^? 26.67 MG MG D 302 264 GLU D 54 GLU^? 22.96 MG MG D 302 328 ASP D 35 ASP^? 16.80 MG MG D 302 coo 45.62 80.42 43.69 45.65 82.01 45.07 93.40 43.81 -22.27 94.18 44.45 -24.11 coo 59.69 92.71 39.85 58.53 92.03 41.47 87.96 27.60 -30.52 89.07 27.55 -28.72 coo 45.39 90.72 40.63 45.07 89.14 41.90 93.83 42.00 -33.14 91.74 41.83 -33.51 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 19 3 # 19 229 ASP C 58 ASP^? 26.67 MG MG D 302 264 GLU D 75 GLU^? 15.53 MG MG E 301 328 ASP D 35 ASP^? 16.80 MG MG D 302 coo 45.62 80.42 43.69 45.65 82.01 45.07 93.40 43.81 -22.27 94.18 44.45 -24.11 coo 59.69 92.71 39.85 58.53 92.03 41.47 84.53 54.81 -36.40 82.75 56.01 -36.42 coo 45.39 90.72 40.63 45.07 89.14 41.90 93.83 42.00 -33.14 91.74 41.83 -33.51 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 20 3 # 20 229 ASP C 58 ASP^? 26.67 MG MG D 302 264 GLU D 154 GLU^? 18.75 MG MG D 302 328 ASP C 160 ASP^? 31.63 MG MG D 302 coo 45.62 80.42 43.69 45.65 82.01 45.07 93.40 43.81 -22.27 94.18 44.45 -24.11 coo 59.69 92.71 39.85 58.53 92.03 41.47 94.87 32.52 -36.42 96.07 33.39 -34.88 coo 45.39 90.72 40.63 45.07 89.14 41.90 102.50 38.00 -23.28 102.43 39.97 -22.46 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 21 3 # 21 229 ASP C 128 ASP^? -3.22 MG MG C 302s 264 GLU B 25 GLU^? 12.88 MG MG C 301 328 ASP C 187 ASP^? -3.72 MG MG C 301s coo 45.62 80.42 43.69 45.65 82.01 45.07 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 59.69 92.71 39.85 58.53 92.03 41.47 79.57 9.59 -3.08 79.20 11.68 -3.64 coo 45.39 90.72 40.63 45.07 89.14 41.90 84.01 23.73 3.39 83.47 22.54 1.59 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 22 3 # 22 229 ASP C 128 ASP^? -3.22 MG MG C 302s 264 GLU C 174 GLU^? 19.72 MG MG C 301 328 ASP C 187 ASP^? -3.72 MG MG C 301s coo 45.62 80.42 43.69 45.65 82.01 45.07 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 59.69 92.71 39.85 58.53 92.03 41.47 95.09 14.29 -3.63 95.25 12.23 -4.17 coo 45.39 90.72 40.63 45.07 89.14 41.90 84.01 23.73 3.39 83.47 22.54 1.59 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 23 3 # 23 229 ASP C 138 ASP^? 33.43 MG MG C 302 264 GLU C 63 GLU^? 27.26 MG MG D 302 328 ASP C 160 ASP^? 31.63 MG MG D 302 coo 45.62 80.42 43.69 45.65 82.01 45.07 105.43 43.97 -13.30 104.85 43.08 -11.43 coo 59.69 92.71 39.85 58.53 92.03 41.47 89.51 47.54 -22.35 87.55 48.20 -22.72 coo 45.39 90.72 40.63 45.07 89.14 41.90 102.50 38.00 -23.28 102.43 39.97 -22.46 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 24 3 # 24 229 ASP C 160 ASP^? 31.63 MG MG D 302 264 GLU D 52 GLU^? 19.94 MG MG D 302 328 ASP C 58 ASP^? 26.67 MG MG D 302 coo 45.62 80.42 43.69 45.65 82.01 45.07 102.50 38.00 -23.28 102.43 39.97 -22.46 coo 59.69 92.71 39.85 58.53 92.03 41.47 87.13 33.17 -30.97 88.40 33.70 -29.31 coo 45.39 90.72 40.63 45.07 89.14 41.90 93.40 43.81 -22.27 94.18 44.45 -24.11 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 25 3 # 25 229 ASP C 171 ASP^? 17.08 MG MG C 301 264 GLU C 146 GLU^? 10.46 MG MG C 301 328 ASP C 177 ASP^? 8.84 MG MG C 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 59.69 92.71 39.85 58.53 92.03 41.47 87.01 31.93 0.25 85.57 32.56 1.72 coo 45.39 90.72 40.63 45.07 89.14 41.90 85.60 16.42 -0.31 86.51 17.71 1.09 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 26 3 # 26 229 ASP C 187 ASP^? -3.72 MG MG C 301s 264 GLU C 154 GLU^? 18.91 MG MG C 302 328 ASP C 128 ASP^? -3.22 MG MG C 302s coo 45.62 80.42 43.69 45.65 82.01 45.07 84.01 23.73 3.39 83.47 22.54 1.59 coo 59.69 92.71 39.85 58.53 92.03 41.47 91.15 23.27 -13.33 91.61 21.91 -14.95 coo 45.39 90.72 40.63 45.07 89.14 41.90 80.05 28.39 -4.25 77.97 28.60 -4.21 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 27 3 # 27 229 ASP D 35 ASP^? 16.80 MG MG D 302 264 GLU C 54 GLU^? 22.77 MG MG C 302 328 ASP C 58 ASP^? 26.67 MG MG D 302 coo 45.62 80.42 43.69 45.65 82.01 45.07 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 59.69 92.71 39.85 58.53 92.03 41.47 88.91 31.25 -19.52 89.97 30.69 -21.29 coo 45.39 90.72 40.63 45.07 89.14 41.90 93.40 43.81 -22.27 94.18 44.45 -24.11 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 28 3 # 28 229 ASP D 58 ASP^? 26.59 MG MG C 302 264 GLU C 54 GLU^? 22.77 MG MG C 302 328 ASP C 35 ASP^? 16.42 MG MG C 302 coo 45.62 80.42 43.69 45.65 82.01 45.07 83.38 14.85 -27.71 84.09 14.12 -25.85 coo 59.69 92.71 39.85 58.53 92.03 41.47 88.91 31.25 -19.52 89.97 30.69 -21.29 coo 45.39 90.72 40.63 45.07 89.14 41.90 84.40 16.53 -16.68 82.83 17.91 -16.28 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 29 3 # 29 229 ASP D 58 ASP^? 26.59 MG MG C 302 264 GLU C 75 GLU^? 16.14 MG MG B 301 328 ASP C 35 ASP^? 16.42 MG MG C 302 coo 45.62 80.42 43.69 45.65 82.01 45.07 83.38 14.85 -27.71 84.09 14.12 -25.85 coo 59.69 92.71 39.85 58.53 92.03 41.47 69.49 12.18 -14.30 67.44 12.65 -13.83 coo 45.39 90.72 40.63 45.07 89.14 41.90 84.40 16.53 -16.68 82.83 17.91 -16.28 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 30 3 # 30 229 ASP D 58 ASP^? 26.59 MG MG C 302 264 GLU C 154 GLU^? 18.91 MG MG C 302 328 ASP D 160 ASP^? 31.45 MG MG C 302 coo 45.62 80.42 43.69 45.65 82.01 45.07 83.38 14.85 -27.71 84.09 14.12 -25.85 coo 59.69 92.71 39.85 58.53 92.03 41.47 91.15 23.27 -13.33 91.61 21.91 -14.95 coo 45.39 90.72 40.63 45.07 89.14 41.90 94.15 13.98 -26.57 92.71 12.42 -26.99 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 31 3 # 31 229 ASP D 128 ASP^? -3.70 MG MG D 302s 264 GLU D 174 GLU^? 19.76 MG MG D 301 328 ASP D 187 ASP^? -2.95 MG MG D 301s coo 45.62 80.42 43.69 45.65 82.01 45.07 83.33 35.45 -46.13 81.57 36.63 -46.10 coo 59.69 92.71 39.85 58.53 92.03 41.47 104.29 37.18 -46.00 105.30 38.94 -45.21 coo 45.39 90.72 40.63 45.07 89.14 41.90 90.40 36.34 -52.69 89.24 37.98 -51.99 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 32 3 # 32 229 ASP D 128 ASP^? -3.70 MG MG D 302s 264 GLU E 25 GLU^? 12.55 MG MG D 301 328 ASP D 187 ASP^? -2.95 MG MG D 301s coo 45.62 80.42 43.69 45.65 82.01 45.07 83.33 35.45 -46.13 81.57 36.63 -46.10 coo 59.69 92.71 39.85 58.53 92.03 41.47 95.44 49.40 -47.17 93.82 48.00 -47.21 coo 45.39 90.72 40.63 45.07 89.14 41.90 90.40 36.34 -52.69 89.24 37.98 -51.99 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 33 3 # 33 229 ASP D 160 ASP^? 31.45 MG MG C 302 264 GLU C 52 GLU^? 19.67 MG MG C 302 328 ASP D 58 ASP^? 26.59 MG MG C 302 coo 45.62 80.42 43.69 45.65 82.01 45.07 94.15 13.98 -26.57 92.71 12.42 -26.99 coo 59.69 92.71 39.85 58.53 92.03 41.47 84.27 26.98 -19.19 85.21 26.16 -20.96 coo 45.39 90.72 40.63 45.07 89.14 41.90 83.38 14.85 -27.71 84.09 14.12 -25.85 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 34 3 # 34 229 ASP D 187 ASP^? -2.95 MG MG D 301s 264 GLU D 154 GLU^? 18.75 MG MG D 302 328 ASP D 128 ASP^? -3.70 MG MG D 302s coo 45.62 80.42 43.69 45.65 82.01 45.07 90.40 36.34 -52.69 89.24 37.98 -51.99 coo 59.69 92.71 39.85 58.53 92.03 41.47 94.87 32.52 -36.42 96.07 33.39 -34.88 coo 45.39 90.72 40.63 45.07 89.14 41.90 83.33 35.45 -46.13 81.57 36.63 -46.10 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 35 3 # 35 229 ASP E 35 ASP^? 16.91 MG MG E 302 264 GLU F 54 GLU^? 22.98 MG MG F 301 328 ASP F 58 ASP^? 26.87 MG MG E 302 coo 45.62 80.42 43.69 45.65 82.01 45.07 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 59.69 92.71 39.85 58.53 92.03 41.47 62.26 62.27 -75.30 61.72 63.47 -73.60 coo 45.39 90.72 40.63 45.07 89.14 41.90 75.55 64.68 -72.56 76.21 65.63 -70.79 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 36 3 # 36 229 ASP E 58 ASP^? 26.76 MG MG F 301 264 GLU F 54 GLU^? 22.98 MG MG F 301 328 ASP F 35 ASP^? 16.93 MG MG F 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 59.69 92.71 39.85 58.53 92.03 41.47 62.26 62.27 -75.30 61.72 63.47 -73.60 coo 45.39 90.72 40.63 45.07 89.14 41.90 46.82 60.47 -77.63 48.00 58.79 -78.23 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 37 3 # 37 229 ASP E 58 ASP^? 26.76 MG MG F 301 264 GLU F 75 GLU^? 19.96 MG MG F 301 328 ASP F 35 ASP^? 16.93 MG MG F 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 59.69 92.71 39.85 58.53 92.03 41.47 40.19 46.06 -80.81 40.09 43.94 -81.24 coo 45.39 90.72 40.63 45.07 89.14 41.90 46.82 60.47 -77.63 48.00 58.79 -78.23 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 38 3 # 38 229 ASP E 58 ASP^? 26.76 MG MG F 301 264 GLU F 154 GLU^? 18.97 MG MG F 301 328 ASP E 160 ASP^? 31.54 MG MG F 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 59.69 92.71 39.85 58.53 92.03 41.47 54.57 65.67 -81.55 53.36 66.51 -80.09 coo 45.39 90.72 40.63 45.07 89.14 41.90 45.81 70.00 -68.45 44.10 68.87 -67.77 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 39 3 # 39 229 ASP E 128 ASP^? -3.53 MG MG E 302s 264 GLU D 25 GLU^? 12.44 MG MG E 301 328 ASP E 187 ASP^? -2.71 MG MG E 301s coo 45.62 80.42 43.69 45.65 82.01 45.07 65.38 56.57 -48.58 66.15 54.57 -48.61 coo 59.69 92.71 39.85 58.53 92.03 41.47 81.26 66.22 -47.78 79.52 64.98 -48.06 coo 45.39 90.72 40.63 45.07 89.14 41.90 67.50 63.43 -41.69 68.97 62.26 -42.81 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 40 3 # 40 229 ASP E 128 ASP^? -3.53 MG MG E 302s 264 GLU E 174 GLU^? 19.83 MG MG E 301 328 ASP E 187 ASP^? -2.71 MG MG E 301s coo 45.62 80.42 43.69 45.65 82.01 45.07 65.38 56.57 -48.58 66.15 54.57 -48.61 coo 59.69 92.71 39.85 58.53 92.03 41.47 70.48 76.62 -49.45 71.76 78.34 -49.45 coo 45.39 90.72 40.63 45.07 89.14 41.90 67.50 63.43 -41.69 68.97 62.26 -42.81 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 41 3 # 41 229 ASP E 138 ASP^? 33.31 MG MG E 302 264 GLU E 63 GLU^? 28.08 MG MG F 301 328 ASP E 160 ASP^? 31.54 MG MG F 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 39.58 70.77 -58.63 40.74 70.78 -56.80 coo 59.69 92.71 39.85 58.53 92.03 41.47 44.04 53.99 -66.79 43.77 51.93 -66.35 coo 45.39 90.72 40.63 45.07 89.14 41.90 45.81 70.00 -68.45 44.10 68.87 -67.77 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 42 3 # 42 229 ASP E 171 ASP^? 16.73 MG MG E 301 264 GLU E 146 GLU^? 10.15 MG MG E 301 328 ASP E 177 ASP^? 8.55 MG MG E 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 59.69 92.71 39.85 58.53 92.03 41.47 58.72 60.89 -44.51 59.23 60.24 -42.54 coo 45.39 90.72 40.63 45.07 89.14 41.90 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 43 3 # 43 229 ASP E 187 ASP^? -2.71 MG MG E 301s 264 GLU E 154 GLU^? 19.05 MG MG E 302 328 ASP E 128 ASP^? -3.53 MG MG E 302s coo 45.62 80.42 43.69 45.65 82.01 45.07 67.50 63.43 -41.69 68.97 62.26 -42.81 coo 59.69 92.71 39.85 58.53 92.03 41.47 64.41 68.21 -58.47 65.40 69.20 -60.08 coo 45.39 90.72 40.63 45.07 89.14 41.90 65.38 56.57 -48.58 66.15 54.57 -48.61 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 44 3 # 44 229 ASP F 35 ASP^? 16.93 MG MG F 301 264 GLU E 54 GLU^? 22.83 MG MG E 302 328 ASP E 58 ASP^? 26.76 MG MG F 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 46.82 60.47 -77.63 48.00 58.79 -78.23 coo 59.69 92.71 39.85 58.53 92.03 41.47 58.39 62.16 -64.12 58.73 62.98 -66.04 coo 45.39 90.72 40.63 45.07 89.14 41.90 45.39 59.31 -66.83 44.62 59.88 -68.72 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 45 3 # 45 229 ASP F 58 ASP^? 26.87 MG MG E 302 264 GLU E 54 GLU^? 22.83 MG MG E 302 328 ASP E 35 ASP^? 16.91 MG MG E 302 coo 45.62 80.42 43.69 45.65 82.01 45.07 75.55 64.68 -72.56 76.21 65.63 -70.79 coo 59.69 92.71 39.85 58.53 92.03 41.47 58.39 62.16 -64.12 58.73 62.98 -66.04 coo 45.39 90.72 40.63 45.07 89.14 41.90 73.60 65.64 -62.00 73.13 63.73 -61.22 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 46 3 # 46 229 ASP F 58 ASP^? 26.87 MG MG E 302 264 GLU E 75 GLU^? 15.76 MG MG D 301 328 ASP E 35 ASP^? 16.91 MG MG E 302 coo 45.62 80.42 43.69 45.65 82.01 45.07 75.55 64.68 -72.56 76.21 65.63 -70.79 coo 59.69 92.71 39.85 58.53 92.03 41.47 84.65 53.96 -59.58 85.64 52.81 -58.05 coo 45.39 90.72 40.63 45.07 89.14 41.90 73.60 65.64 -62.00 73.13 63.73 -61.22 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 47 3 # 47 229 ASP F 58 ASP^? 26.87 MG MG E 302 264 GLU E 154 GLU^? 19.05 MG MG E 302 328 ASP F 160 ASP^? 31.59 MG MG E 302 coo 45.62 80.42 43.69 45.65 82.01 45.07 75.55 64.68 -72.56 76.21 65.63 -70.79 coo 59.69 92.71 39.85 58.53 92.03 41.47 64.41 68.21 -58.47 65.40 69.20 -60.08 coo 45.39 90.72 40.63 45.07 89.14 41.90 71.27 74.59 -71.77 73.23 74.02 -72.37 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 48 3 # 48 229 ASP F 128 ASP^? -3.41 MG MG F 301s 264 GLU F 174 GLU^? 18.79 MG MG F 302 328 ASP F 187 ASP^? -3.27 MG MG F 302s coo 45.62 80.42 43.69 45.65 82.01 45.07 57.76 53.73 -90.50 57.46 51.64 -90.28 coo 59.69 92.71 39.85 58.53 92.03 41.47 46.19 70.73 -90.91 44.19 71.42 -90.89 coo 45.39 90.72 40.63 45.07 89.14 41.90 53.93 58.87 -98.14 52.45 58.62 -96.61 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 49 3 # 49 229 ASP F 138 ASP^? 33.51 MG MG F 302 264 GLU F 63 GLU^? 27.81 MG MG E 302 328 ASP F 160 ASP^? 31.59 MG MG E 302 coo 45.62 80.42 43.69 45.65 82.01 45.07 77.17 76.66 -81.48 76.14 76.33 -83.32 coo 59.69 92.71 39.85 58.53 92.03 41.47 78.38 60.07 -72.34 78.48 58.04 -72.84 coo 45.39 90.72 40.63 45.07 89.14 41.90 71.27 74.59 -71.77 73.23 74.02 -72.37 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 50 3 # 50 229 ASP F 160 ASP^? 31.59 MG MG E 302 264 GLU E 52 GLU^? 19.96 MG MG E 302 328 ASP F 58 ASP^? 26.87 MG MG E 302 coo 45.62 80.42 43.69 45.65 82.01 45.07 71.27 74.59 -71.77 73.23 74.02 -72.37 coo 59.69 92.71 39.85 58.53 92.03 41.47 64.71 60.06 -63.78 64.69 61.36 -65.58 coo 45.39 90.72 40.63 45.07 89.14 41.90 75.55 64.68 -72.56 76.21 65.63 -70.79 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 51 3 # 51 229 ASP F 171 ASP^? 16.35 MG MG F 302 264 GLU F 146 GLU^? 10.36 MG MG F 302 328 ASP F 177 ASP^? 8.15 MG MG F 302 coo 45.62 80.42 43.69 45.65 82.01 45.07 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 59.69 92.71 39.85 58.53 92.03 41.47 61.95 60.17 -95.28 62.87 58.56 -96.19 coo 45.39 90.72 40.63 45.07 89.14 41.90 47.18 61.22 -94.50 48.48 62.32 -95.73 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 52 3 # 52 229 ASP F 187 ASP^? -3.27 MG MG F 302s 264 GLU F 154 GLU^? 18.97 MG MG F 301 328 ASP F 128 ASP^? -3.41 MG MG F 301s coo 45.62 80.42 43.69 45.65 82.01 45.07 53.93 58.87 -98.14 52.45 58.62 -96.61 coo 59.69 92.71 39.85 58.53 92.03 41.47 54.57 65.67 -81.55 53.36 66.51 -80.09 coo 45.39 90.72 40.63 45.07 89.14 41.90 57.76 53.73 -90.50 57.46 51.64 -90.28 1cdg_c00 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 52 hits 1cdg_c00 naa= 3 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 1 3 # 1 A 232 HIS A 42 HIS^? 28.45 MG MG A 301 A 262 GLU A 154 GLU^? 19.22 MG MG A 301 A 358 GLU A 52 GLU^? 19.89 MG MG A 301 coo 26.19 60.87 43.98 27.48 59.27 43.30 34.62 18.32 19.57 34.29 16.25 19.41 coo 27.13 54.07 50.45 26.96 54.19 48.35 36.54 21.95 29.78 35.14 22.21 28.17 coo 27.06 50.43 44.36 27.99 52.27 44.74 42.67 25.16 24.80 42.61 25.77 22.75 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 2 3 # 2 A 232 HIS B 42 HIS^? 28.37 MG MG B 302 A 262 GLU B 154 GLU^? 19.05 MG MG B 302 A 358 GLU B 52 GLU^? 20.06 MG MG B 302 coo 26.19 60.87 43.98 27.48 59.27 43.30 39.34 12.99 16.30 37.26 13.24 16.40 coo 27.13 54.07 50.45 26.96 54.19 48.35 44.04 15.11 6.74 44.19 13.59 8.30 coo 27.06 50.43 44.36 27.99 52.27 44.74 47.87 20.25 12.36 48.11 19.69 14.43 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 3 3 # 3 A 232 HIS F 42 HIS^? 28.34 MG MG F 301 A 262 GLU F 154 GLU^? 18.97 MG MG F 301 A 358 GLU F 52 GLU^? 20.13 MG MG F 301 coo 26.19 60.87 43.98 27.48 59.27 43.30 55.11 70.50 -71.64 56.29 72.22 -71.48 coo 27.13 54.07 50.45 26.96 54.19 48.35 54.57 65.67 -81.55 53.36 66.51 -80.09 coo 27.06 50.43 44.36 27.99 52.27 44.74 57.09 59.62 -75.76 56.76 59.40 -73.62 1chm_c00 source 1chm CREATINE AMIDINOHYDROLASE (E.C.3.5.3.3) : 3 hits 1chm_c00 naa= 3 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 1 3 # 1 B 232 HIS A 42 HIS^? 28.45 MG MG A 301 B 262 GLU A 154 GLU^? 19.22 MG MG A 301 B 358 GLU A 52 GLU^? 19.89 MG MG A 301 coo 44.98 77.01 48.39 44.42 78.67 47.18 34.62 18.32 19.57 34.29 16.25 19.41 coo 41.60 83.57 54.16 42.46 83.24 52.25 36.54 21.95 29.78 35.14 22.21 28.17 coo 44.05 87.61 48.73 43.15 85.67 48.52 42.67 25.16 24.80 42.61 25.77 22.75 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 2 3 # 2 B 232 HIS B 42 HIS^? 28.37 MG MG B 302 B 262 GLU B 154 GLU^? 19.05 MG MG B 302 B 358 GLU B 52 GLU^? 20.06 MG MG B 302 coo 44.98 77.01 48.39 44.42 78.67 47.18 39.34 12.99 16.30 37.26 13.24 16.40 coo 41.60 83.57 54.16 42.46 83.24 52.25 44.04 15.11 6.74 44.19 13.59 8.30 coo 44.05 87.61 48.73 43.15 85.67 48.52 47.87 20.25 12.36 48.11 19.69 14.43 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 3 3 # 3 B 232 HIS F 42 HIS^? 28.34 MG MG F 301 B 262 GLU F 154 GLU^? 18.97 MG MG F 301 B 358 GLU F 52 GLU^? 20.13 MG MG F 301 coo 44.98 77.01 48.39 44.42 78.67 47.18 55.11 70.50 -71.64 56.29 72.22 -71.48 coo 41.60 83.57 54.16 42.46 83.24 52.25 54.57 65.67 -81.55 53.36 66.51 -80.09 coo 44.05 87.61 48.73 43.15 85.67 48.52 57.09 59.62 -75.76 56.76 59.40 -73.62 1chm_c01 source 1chm CREATINE AMIDINOHYDROLASE (E.C.3.5.3.3) : 3 hits 1chm_c01 naa= 3 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 A 198 GLY A 27 GLY^? 28.36 MG MG A 301 A 228 SER A 79 SER^? 29.65 MG MG A 301 A 549 ASP A 81 ASP^? 34.50 MG MG A 301 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 32.99 56.72 36.23 33.54 56.10 35.99 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 32.57 55.71 29.63 34.63 56.10 28.47 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 31.12 60.71 27.43 31.74 59.35 25.95 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 A 198 GLY A 71 GLY^? 17.05 MG MG A 301 A 228 SER A 49 SER^? 17.63 MG MG A 301 A 549 ASP A 35 ASP^? 16.92 MG MG A 301 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 42.53 33.15 24.80 43.14 33.53 25.16 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 38.68 29.52 26.48 39.52 27.49 25.41 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 34.49 31.10 26.54 36.41 31.82 27.10 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 3 3 # 3 A 198 GLY B 27 GLY^? 20.96 MG MG C 301 A 228 SER B 79 SER^? 20.24 MG MG C 301 A 549 ASP B 81 ASP^? 24.85 MG MG C 301 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 77.29 2.95 1.20 76.99 3.70 1.33 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 76.03 3.33 7.67 77.04 5.28 8.60 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 79.93 -0.44 10.01 79.44 1.19 11.29 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 4 3 # 4 A 198 GLY B 71 GLY^? 17.03 MG MG B 302 A 228 SER B 49 SER^? 17.51 MG MG B 302 A 549 ASP B 35 ASP^? 16.92 MG MG B 302 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 56.04 18.34 12.69 56.53 18.94 12.41 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 51.67 15.70 10.57 49.37 16.19 11.15 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 52.63 11.07 10.18 53.68 12.85 9.94 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 5 3 # 5 A 198 GLY C 27 GLY^? 19.87 MG MG B 301 A 228 SER C 79 SER^? 19.92 MG MG B 301 A 549 ASP C 81 ASP^? 23.42 MG MG B 301 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 63.15 1.80 -8.18 63.38 2.56 -8.31 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 64.38 1.95 -14.66 62.69 3.45 -15.45 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 60.68 -2.08 -16.91 61.02 -0.17 -17.89 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 6 3 # 6 A 198 GLY C 71 GLY^? 16.48 MG MG C 302 A 228 SER C 49 SER^? 17.53 MG MG C 302 A 549 ASP C 35 ASP^? 16.42 MG MG C 302 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 78.74 22.16 -18.87 78.10 22.58 -18.62 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 83.83 21.24 -17.13 85.75 22.50 -18.00 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 84.40 16.53 -16.68 82.83 17.91 -16.28 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 7 3 # 7 A 198 GLY D 27 GLY^? 19.64 MG MG E 301 A 228 SER D 79 SER^? 19.41 MG MG E 301 A 549 ASP D 81 ASP^? 23.25 MG MG E 301 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 87.58 66.90 -43.17 87.20 66.21 -42.95 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 88.38 65.91 -36.56 86.13 65.62 -35.70 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 89.25 71.36 -34.47 87.72 70.06 -33.67 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 8 3 # 8 A 198 GLY D 71 GLY^? 17.24 MG MG D 302 A 228 SER D 49 SER^? 17.22 MG MG D 302 A 549 ASP D 35 ASP^? 16.80 MG MG D 302 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 85.63 41.02 -31.04 84.94 41.10 -31.48 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 90.26 38.73 -32.99 91.21 36.48 -32.65 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 93.83 42.00 -33.14 91.74 41.83 -33.51 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 9 3 # 9 A 198 GLY E 27 GLY^? 20.34 MG MG D 301 A 228 SER E 79 SER^? 19.77 MG MG D 301 A 549 ASP E 81 ASP^? 24.19 MG MG D 301 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 97.08 55.99 -51.80 96.40 55.63 -52.03 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 96.22 56.25 -58.39 95.94 54.06 -59.20 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 101.61 56.30 -60.24 100.25 55.53 -61.72 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 10 3 # 10 A 198 GLY E 71 GLY^? 16.95 MG MG E 302 A 228 SER E 49 SER^? 17.46 MG MG E 302 A 549 ASP E 35 ASP^? 16.91 MG MG E 302 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 71.48 57.52 -63.50 71.50 56.77 -63.11 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 69.86 62.56 -61.93 67.83 63.87 -62.36 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 73.60 65.64 -62.00 73.13 63.73 -61.22 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 11 3 # 11 A 198 GLY F 27 GLY^? 29.60 MG MG F 301 A 228 SER F 79 SER^? 30.22 MG MG F 301 A 549 ASP F 81 ASP^? 34.61 MG MG F 301 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 26.40 45.24 -86.71 27.11 44.80 -86.61 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 28.21 44.39 -80.24 29.11 42.36 -79.32 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 23.08 43.10 -77.79 24.94 42.10 -77.55 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 12 3 # 12 A 198 GLY F 71 GLY^? 16.93 MG MG F 301 A 228 SER F 49 SER^? 17.41 MG MG F 301 A 549 ASP F 35 ASP^? 16.93 MG MG F 301 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 51.61 53.62 -75.65 51.89 52.91 -76.00 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 51.43 58.69 -77.53 52.81 60.66 -77.24 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 46.82 60.47 -77.63 48.00 58.79 -78.23 1cjy_c00 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 12 hits 1cjy_c00 naa= 3 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 B1198 GLY A 27 GLY^? 28.36 MG MG A 301 B1228 SER A 79 SER^? 29.65 MG MG A 301 B1549 ASP A 81 ASP^? 34.50 MG MG A 301 coo 126.34 72.75 125.66 125.95 73.27 126.11 32.99 56.72 36.23 33.54 56.10 35.99 coo 131.65 74.68 129.41 130.31 72.73 128.82 32.57 55.71 29.63 34.63 56.10 28.47 coo 134.72 69.43 130.42 133.03 70.65 130.08 31.12 60.71 27.43 31.74 59.35 25.95 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 B1198 GLY A 71 GLY^? 17.05 MG MG A 301 B1228 SER A 49 SER^? 17.63 MG MG A 301 B1549 ASP A 35 ASP^? 16.92 MG MG A 301 coo 126.34 72.75 125.66 125.95 73.27 126.11 42.53 33.15 24.80 43.14 33.53 25.16 coo 131.65 74.68 129.41 130.31 72.73 128.82 38.68 29.52 26.48 39.52 27.49 25.41 coo 134.72 69.43 130.42 133.03 70.65 130.08 34.49 31.10 26.54 36.41 31.82 27.10 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 3 3 # 3 B1198 GLY A 145 GLY^? 13.39 MG MG A 302 B1228 SER A 189 SER^? 11.75 MG MG A 302 B1549 ASP A 187 ASP^? -3.29 MG MG A 302s coo 126.34 72.75 125.66 125.95 73.27 126.11 44.20 17.56 40.29 44.09 17.33 41.06 coo 131.65 74.68 129.41 130.31 72.73 128.82 40.99 19.00 44.32 41.51 18.14 46.48 coo 134.72 69.43 130.42 133.03 70.65 130.08 39.43 26.57 46.78 39.37 27.83 45.03 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 4 3 # 4 B1198 GLY B 27 GLY^? 20.96 MG MG C 301 B1228 SER B 79 SER^? 20.24 MG MG C 301 B1549 ASP B 81 ASP^? 24.85 MG MG C 301 coo 126.34 72.75 125.66 125.95 73.27 126.11 77.29 2.95 1.20 76.99 3.70 1.33 coo 131.65 74.68 129.41 130.31 72.73 128.82 76.03 3.33 7.67 77.04 5.28 8.60 coo 134.72 69.43 130.42 133.03 70.65 130.08 79.93 -0.44 10.01 79.44 1.19 11.29 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 5 3 # 5 B1198 GLY B 71 GLY^? 17.03 MG MG B 302 B1228 SER B 49 SER^? 17.51 MG MG B 302 B1549 ASP B 35 ASP^? 16.92 MG MG B 302 coo 126.34 72.75 125.66 125.95 73.27 126.11 56.04 18.34 12.69 56.53 18.94 12.41 coo 131.65 74.68 129.41 130.31 72.73 128.82 51.67 15.70 10.57 49.37 16.19 11.15 coo 134.72 69.43 130.42 133.03 70.65 130.08 52.63 11.07 10.18 53.68 12.85 9.94 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 6 3 # 6 B1198 GLY C 27 GLY^? 19.87 MG MG B 301 B1228 SER C 79 SER^? 19.92 MG MG B 301 B1549 ASP C 81 ASP^? 23.42 MG MG B 301 coo 126.34 72.75 125.66 125.95 73.27 126.11 63.15 1.80 -8.18 63.38 2.56 -8.31 coo 131.65 74.68 129.41 130.31 72.73 128.82 64.38 1.95 -14.66 62.69 3.45 -15.45 coo 134.72 69.43 130.42 133.03 70.65 130.08 60.68 -2.08 -16.91 61.02 -0.17 -17.89 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 7 3 # 7 B1198 GLY C 71 GLY^? 16.48 MG MG C 302 B1228 SER C 49 SER^? 17.53 MG MG C 302 B1549 ASP C 35 ASP^? 16.42 MG MG C 302 coo 126.34 72.75 125.66 125.95 73.27 126.11 78.74 22.16 -18.87 78.10 22.58 -18.62 coo 131.65 74.68 129.41 130.31 72.73 128.82 83.83 21.24 -17.13 85.75 22.50 -18.00 coo 134.72 69.43 130.42 133.03 70.65 130.08 84.40 16.53 -16.68 82.83 17.91 -16.28 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 8 3 # 8 B1198 GLY D 27 GLY^? 19.64 MG MG E 301 B1228 SER D 79 SER^? 19.41 MG MG E 301 B1549 ASP D 81 ASP^? 23.25 MG MG E 301 coo 126.34 72.75 125.66 125.95 73.27 126.11 87.58 66.90 -43.17 87.20 66.21 -42.95 coo 131.65 74.68 129.41 130.31 72.73 128.82 88.38 65.91 -36.56 86.13 65.62 -35.70 coo 134.72 69.43 130.42 133.03 70.65 130.08 89.25 71.36 -34.47 87.72 70.06 -33.67 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 9 3 # 9 B1198 GLY D 71 GLY^? 17.24 MG MG D 302 B1228 SER D 49 SER^? 17.22 MG MG D 302 B1549 ASP D 35 ASP^? 16.80 MG MG D 302 coo 126.34 72.75 125.66 125.95 73.27 126.11 85.63 41.02 -31.04 84.94 41.10 -31.48 coo 131.65 74.68 129.41 130.31 72.73 128.82 90.26 38.73 -32.99 91.21 36.48 -32.65 coo 134.72 69.43 130.42 133.03 70.65 130.08 93.83 42.00 -33.14 91.74 41.83 -33.51 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 10 3 # 10 B1198 GLY D 145 GLY^? 13.51 MG MG D 301 B1228 SER D 189 SER^? 12.12 MG MG D 301 B1549 ASP D 187 ASP^? -2.95 MG MG D 301s coo 126.34 72.75 125.66 125.95 73.27 126.11 88.90 26.07 -46.90 89.21 25.93 -47.57 coo 131.65 74.68 129.41 130.31 72.73 128.82 91.62 28.58 -50.95 91.45 27.78 -53.25 coo 134.72 69.43 130.42 133.03 70.65 130.08 90.40 36.34 -52.69 89.24 37.98 -51.99 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 11 3 # 11 B1198 GLY E 27 GLY^? 20.34 MG MG D 301 B1228 SER E 79 SER^? 19.77 MG MG D 301 B1549 ASP E 81 ASP^? 24.19 MG MG D 301 coo 126.34 72.75 125.66 125.95 73.27 126.11 97.08 55.99 -51.80 96.40 55.63 -52.03 coo 131.65 74.68 129.41 130.31 72.73 128.82 96.22 56.25 -58.39 95.94 54.06 -59.20 coo 134.72 69.43 130.42 133.03 70.65 130.08 101.61 56.30 -60.24 100.25 55.53 -61.72 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 12 3 # 12 B1198 GLY E 71 GLY^? 16.95 MG MG E 302 B1228 SER E 49 SER^? 17.46 MG MG E 302 B1549 ASP E 35 ASP^? 16.91 MG MG E 302 coo 126.34 72.75 125.66 125.95 73.27 126.11 71.48 57.52 -63.50 71.50 56.77 -63.11 coo 131.65 74.68 129.41 130.31 72.73 128.82 69.86 62.56 -61.93 67.83 63.87 -62.36 coo 134.72 69.43 130.42 133.03 70.65 130.08 73.60 65.64 -62.00 73.13 63.73 -61.22 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 13 3 # 13 B1198 GLY E 145 GLY^? 13.69 MG MG E 301 B1228 SER E 189 SER^? 11.91 MG MG E 301 B1549 ASP E 187 ASP^? -2.71 MG MG E 301s coo 126.34 72.75 125.66 125.95 73.27 126.11 57.08 63.68 -47.92 56.95 63.88 -47.12 coo 131.65 74.68 129.41 130.31 72.73 128.82 60.13 65.61 -43.87 59.01 65.34 -41.74 coo 134.72 69.43 130.42 133.03 70.65 130.08 67.50 63.43 -41.69 68.97 62.26 -42.81 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 14 3 # 14 B1198 GLY F 27 GLY^? 29.60 MG MG F 301 B1228 SER F 79 SER^? 30.22 MG MG F 301 B1549 ASP F 81 ASP^? 34.61 MG MG F 301 coo 126.34 72.75 125.66 125.95 73.27 126.11 26.40 45.24 -86.71 27.11 44.80 -86.61 coo 131.65 74.68 129.41 130.31 72.73 128.82 28.21 44.39 -80.24 29.11 42.36 -79.32 coo 134.72 69.43 130.42 133.03 70.65 130.08 23.08 43.10 -77.79 24.94 42.10 -77.55 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 15 3 # 15 B1198 GLY F 71 GLY^? 16.93 MG MG F 301 B1228 SER F 49 SER^? 17.41 MG MG F 301 B1549 ASP F 35 ASP^? 16.93 MG MG F 301 coo 126.34 72.75 125.66 125.95 73.27 126.11 51.61 53.62 -75.65 51.89 52.91 -76.00 coo 131.65 74.68 129.41 130.31 72.73 128.82 51.43 58.69 -77.53 52.81 60.66 -77.24 coo 134.72 69.43 130.42 133.03 70.65 130.08 46.82 60.47 -77.63 48.00 58.79 -78.23 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 16 3 # 16 B1198 GLY F 145 GLY^? 13.40 MG MG F 302 B1228 SER F 189 SER^? 11.88 MG MG F 302 B1549 ASP F 187 ASP^? -3.27 MG MG F 302s coo 126.34 72.75 125.66 125.95 73.27 126.11 63.24 63.21 -91.82 63.24 63.42 -92.59 coo 131.65 74.68 129.41 130.31 72.73 128.82 59.91 63.90 -95.91 60.70 64.22 -98.13 coo 134.72 69.43 130.42 133.03 70.65 130.08 53.93 58.87 -98.14 52.45 58.62 -96.61 1cjy_c01 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 16 hits 1cjy_c01 naa= 3 ULMN 3 1cns_c00 CHITINASE user 1 3 # 1 A 67 GLU A 54 GLU^? 22.98 MG MG A 301 A 89 GLU A 154 GLU^? 19.22 MG MG A 301 A 120 SER A 49 SER^? 17.63 MG MG A 301 coo -24.35 9.53 67.64 -25.07 11.29 68.60 45.06 19.97 24.02 44.05 19.39 22.19 coo -31.18 6.91 75.60 -32.39 8.51 74.91 36.54 21.95 29.78 35.14 22.21 28.17 coo -34.73 8.57 68.21 -33.63 9.08 70.28 38.68 29.52 26.48 39.52 27.49 25.41 ULMN 3 1cns_c00 CHITINASE user 2 3 # 2 A 67 GLU B 54 GLU^? 22.94 MG MG B 302 A 89 GLU B 154 GLU^? 19.05 MG MG B 302 A 120 SER B 49 SER^? 17.51 MG MG B 302 coo -24.35 9.53 67.64 -25.07 11.29 68.60 43.18 23.27 12.99 42.40 22.23 14.68 coo -31.18 6.91 75.60 -32.39 8.51 74.91 44.04 15.11 6.74 44.19 13.59 8.30 coo -34.73 8.57 68.21 -33.63 9.08 70.28 51.67 15.70 10.57 49.37 16.19 11.15 ULMN 3 1cns_c00 CHITINASE user 3 3 # 3 A 67 GLU C 54 GLU^? 22.77 MG MG C 302 A 89 GLU C 154 GLU^? 18.91 MG MG C 302 A 120 SER C 49 SER^? 17.53 MG MG C 302 coo -24.35 9.53 67.64 -25.07 11.29 68.60 88.91 31.25 -19.52 89.97 30.69 -21.29 coo -31.18 6.91 75.60 -32.39 8.51 74.91 91.15 23.27 -13.33 91.61 21.91 -14.95 coo -34.73 8.57 68.21 -33.63 9.08 70.28 83.83 21.24 -17.13 85.75 22.50 -18.00 ULMN 3 1cns_c00 CHITINASE user 4 3 # 4 A 67 GLU D 54 GLU^? 22.96 MG MG D 302 A 89 GLU D 154 GLU^? 18.75 MG MG D 302 A 120 SER D 49 SER^? 17.22 MG MG D 302 coo -24.35 9.53 67.64 -25.07 11.29 68.60 87.96 27.60 -30.52 89.07 27.55 -28.72 coo -31.18 6.91 75.60 -32.39 8.51 74.91 94.87 32.52 -36.42 96.07 33.39 -34.88 coo -34.73 8.57 68.21 -33.63 9.08 70.28 90.26 38.73 -32.99 91.21 36.48 -32.65 ULMN 3 1cns_c00 CHITINASE user 5 3 # 5 A 67 GLU D 154 GLU^? 18.75 MG MG D 302 A 89 GLU D 52 GLU^? 19.94 MG MG D 302 A 120 SER D 49 SER^? 17.22 MG MG D 302 coo -24.35 9.53 67.64 -25.07 11.29 68.60 94.87 32.52 -36.42 96.07 33.39 -34.88 coo -31.18 6.91 75.60 -32.39 8.51 74.91 87.13 33.17 -30.97 88.40 33.70 -29.31 coo -34.73 8.57 68.21 -33.63 9.08 70.28 90.26 38.73 -32.99 91.21 36.48 -32.65 ULMN 3 1cns_c00 CHITINASE user 6 3 # 6 A 67 GLU E 52 GLU^? 19.96 MG MG E 302 A 89 GLU F 54 GLU^? 22.98 MG MG F 301 A 120 SER F 66 SER^? 21.35 MG MG F 301 coo -24.35 9.53 67.64 -25.07 11.29 68.60 64.71 60.06 -63.78 64.69 61.36 -65.58 coo -31.18 6.91 75.60 -32.39 8.51 74.91 62.26 62.27 -75.30 61.72 63.47 -73.60 coo -34.73 8.57 68.21 -33.63 9.08 70.28 68.12 57.69 -75.42 68.70 55.68 -76.54 ULMN 3 1cns_c00 CHITINASE user 7 3 # 7 A 67 GLU E 54 GLU^? 22.83 MG MG E 302 A 89 GLU E 154 GLU^? 19.05 MG MG E 302 A 120 SER E 49 SER^? 17.46 MG MG E 302 coo -24.35 9.53 67.64 -25.07 11.29 68.60 58.39 62.16 -64.12 58.73 62.98 -66.04 coo -31.18 6.91 75.60 -32.39 8.51 74.91 64.41 68.21 -58.47 65.40 69.20 -60.08 coo -34.73 8.57 68.21 -33.63 9.08 70.28 69.86 62.56 -61.93 67.83 63.87 -62.36 ULMN 3 1cns_c00 CHITINASE user 8 3 # 8 A 67 GLU F 54 GLU^? 22.98 MG MG F 301 A 89 GLU F 154 GLU^? 18.97 MG MG F 301 A 120 SER F 49 SER^? 17.41 MG MG F 301 coo -24.35 9.53 67.64 -25.07 11.29 68.60 62.26 62.27 -75.30 61.72 63.47 -73.60 coo -31.18 6.91 75.60 -32.39 8.51 74.91 54.57 65.67 -81.55 53.36 66.51 -80.09 coo -34.73 8.57 68.21 -33.63 9.08 70.28 51.43 58.69 -77.53 52.81 60.66 -77.24 1cns_c00 source 1cns CHITINASE : 8 hits 1cns_c00 naa= 3 ULMN 3 1cns_c01 CHITINASE user 1 3 # 1 B 67 GLU A 54 GLU^? 22.98 MG MG A 301 B 89 GLU A 154 GLU^? 19.22 MG MG A 301 B 120 SER A 49 SER^? 17.63 MG MG A 301 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 45.06 19.97 24.02 44.05 19.39 22.19 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 36.54 21.95 29.78 35.14 22.21 28.17 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 38.68 29.52 26.48 39.52 27.49 25.41 ULMN 3 1cns_c01 CHITINASE user 2 3 # 2 B 67 GLU A 154 GLU^? 19.22 MG MG A 301 B 89 GLU A 38 GLU^? 21.81 MG MG A 302 B 120 SER A 36 SER^? 23.25 MG MG A 301 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 36.54 21.95 29.78 35.14 22.21 28.17 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 26.42 25.01 28.02 26.98 25.90 29.89 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 29.88 32.10 25.40 29.53 34.39 24.57 ULMN 3 1cns_c01 CHITINASE user 3 3 # 3 B 67 GLU B 54 GLU^? 22.94 MG MG B 302 B 89 GLU B 154 GLU^? 19.05 MG MG B 302 B 120 SER B 49 SER^? 17.51 MG MG B 302 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 43.18 23.27 12.99 42.40 22.23 14.68 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 44.04 15.11 6.74 44.19 13.59 8.30 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 51.67 15.70 10.57 49.37 16.19 11.15 ULMN 3 1cns_c01 CHITINASE user 4 3 # 4 B 67 GLU B 154 GLU^? 19.05 MG MG B 302 B 89 GLU B 38 GLU^? 21.75 MG MG B 301 B 120 SER B 36 SER^? 24.04 MG MG B 302 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 44.04 15.11 6.74 44.19 13.59 8.30 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 44.79 4.95 7.12 46.66 4.47 6.21 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 52.58 6.45 11.01 53.61 4.84 12.41 ULMN 3 1cns_c01 CHITINASE user 5 3 # 5 B 67 GLU C 52 GLU^? 19.67 MG MG C 302 B 89 GLU D 52 GLU^? 19.94 MG MG D 302 B 120 SER D 66 SER^? 21.51 MG MG D 302 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 84.27 26.98 -19.19 85.21 26.16 -20.96 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 87.13 33.17 -30.97 88.40 33.70 -29.31 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 81.04 24.82 -31.14 78.93 25.00 -32.28 ULMN 3 1cns_c01 CHITINASE user 6 3 # 6 B 67 GLU C 52 GLU^? 19.67 MG MG C 302 B 89 GLU D 54 GLU^? 22.96 MG MG D 302 B 120 SER D 66 SER^? 21.51 MG MG D 302 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 84.27 26.98 -19.19 85.21 26.16 -20.96 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 87.96 27.60 -30.52 89.07 27.55 -28.72 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 81.04 24.82 -31.14 78.93 25.00 -32.28 ULMN 3 1cns_c01 CHITINASE user 7 3 # 7 B 67 GLU C 54 GLU^? 22.77 MG MG C 302 B 89 GLU C 154 GLU^? 18.91 MG MG C 302 B 120 SER C 49 SER^? 17.53 MG MG C 302 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 88.91 31.25 -19.52 89.97 30.69 -21.29 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 91.15 23.27 -13.33 91.61 21.91 -14.95 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 83.83 21.24 -17.13 85.75 22.50 -18.00 ULMN 3 1cns_c01 CHITINASE user 8 3 # 8 B 67 GLU C 154 GLU^? 18.91 MG MG C 302 B 89 GLU C 38 GLU^? 21.99 MG MG C 301 B 120 SER C 36 SER^? 23.69 MG MG C 302 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 91.15 23.27 -13.33 91.61 21.91 -14.95 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 93.66 12.78 -15.08 92.73 12.51 -13.19 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 86.07 12.19 -17.80 85.34 10.22 -18.98 ULMN 3 1cns_c01 CHITINASE user 9 3 # 9 B 67 GLU D 19 GLU^? 18.95 MG MG D 301 B 89 GLU D 33 GLU^? 22.23 MG MG D 302 B 120 SER D 36 SER^? 22.42 MG MG D 302 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 96.86 51.08 -43.04 98.60 51.44 -44.26 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 91.55 48.87 -31.66 91.12 48.92 -29.63 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 97.85 44.42 -32.20 96.60 46.20 -31.15 ULMN 3 1cns_c01 CHITINASE user 10 3 # 10 B 67 GLU D 52 GLU^? 19.94 MG MG D 302 B 89 GLU C 52 GLU^? 19.67 MG MG C 302 B 120 SER C 66 SER^? 20.91 MG MG C 302 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 87.13 33.17 -30.97 88.40 33.70 -29.31 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 84.27 26.98 -19.19 85.21 26.16 -20.96 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 85.39 37.79 -19.17 83.53 38.71 -18.09 ULMN 3 1cns_c01 CHITINASE user 11 3 # 11 B 67 GLU D 52 GLU^? 19.94 MG MG D 302 B 89 GLU C 54 GLU^? 22.77 MG MG C 302 B 120 SER C 66 SER^? 20.91 MG MG C 302 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 87.13 33.17 -30.97 88.40 33.70 -29.31 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 88.91 31.25 -19.52 89.97 30.69 -21.29 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 85.39 37.79 -19.17 83.53 38.71 -18.09 ULMN 3 1cns_c01 CHITINASE user 12 3 # 12 B 67 GLU D 54 GLU^? 22.96 MG MG D 302 B 89 GLU D 154 GLU^? 18.75 MG MG D 302 B 120 SER D 49 SER^? 17.22 MG MG D 302 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 87.96 27.60 -30.52 89.07 27.55 -28.72 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 94.87 32.52 -36.42 96.07 33.39 -34.88 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 90.26 38.73 -32.99 91.21 36.48 -32.65 ULMN 3 1cns_c01 CHITINASE user 13 3 # 13 B 67 GLU D 154 GLU^? 18.75 MG MG D 302 B 89 GLU D 38 GLU^? 21.83 MG MG D 301 B 120 SER D 36 SER^? 22.42 MG MG D 302 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 94.87 32.52 -36.42 96.07 33.39 -34.88 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 103.22 39.19 -34.75 102.77 39.81 -36.73 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 97.85 44.42 -32.20 96.60 46.20 -31.15 ULMN 3 1cns_c01 CHITINASE user 14 3 # 14 B 67 GLU E 52 GLU^? 19.96 MG MG E 302 B 89 GLU F 54 GLU^? 22.98 MG MG F 301 B 120 SER F 66 SER^? 21.35 MG MG F 301 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 64.71 60.06 -63.78 64.69 61.36 -65.58 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 62.26 62.27 -75.30 61.72 63.47 -73.60 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 68.12 57.69 -75.42 68.70 55.68 -76.54 ULMN 3 1cns_c01 CHITINASE user 15 3 # 15 B 67 GLU E 54 GLU^? 22.83 MG MG E 302 B 89 GLU E 154 GLU^? 19.05 MG MG E 302 B 120 SER E 49 SER^? 17.46 MG MG E 302 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 58.39 62.16 -64.12 58.73 62.98 -66.04 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 64.41 68.21 -58.47 65.40 69.20 -60.08 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 69.86 62.56 -61.93 67.83 63.87 -62.36 ULMN 3 1cns_c01 CHITINASE user 16 3 # 16 B 67 GLU F 54 GLU^? 22.98 MG MG F 301 B 89 GLU F 154 GLU^? 18.97 MG MG F 301 B 120 SER F 49 SER^? 17.41 MG MG F 301 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 62.26 62.27 -75.30 61.72 63.47 -73.60 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 54.57 65.67 -81.55 53.36 66.51 -80.09 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 51.43 58.69 -77.53 52.81 60.66 -77.24 ULMN 3 1cns_c01 CHITINASE user 17 3 # 17 B 67 GLU F 154 GLU^? 18.97 MG MG F 301 B 89 GLU F 38 GLU^? 21.28 MG MG F 302 B 120 SER F 36 SER^? 23.07 MG MG F 301 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 54.57 65.67 -81.55 53.36 66.51 -80.09 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 44.63 69.79 -79.91 44.13 69.05 -81.85 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 42.79 62.77 -76.96 42.19 61.23 -75.17 1cns_c01 source 1cns CHITINASE : 17 hits 1cns_c01 naa= 3 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 48 ARG A 37 ARG^? 18.99 MG MG A 301 D 101 TYR B 60 TYR^? 27.11 MG MG A 301 D 173 ASP B 58 ASP^? 26.73 MG MG A 301 coo 69.08 8.58 32.60 69.70 10.81 30.58 32.99 26.50 25.19 35.50 25.33 26.51 coo 71.77 11.86 24.26 70.23 12.22 26.56 28.84 35.27 19.49 28.03 36.56 21.83 coo 71.60 6.14 19.25 70.26 6.87 20.69 34.42 33.56 15.74 33.50 33.49 17.59 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 48 ARG C 37 ARG^? 19.01 MG MG C 302 D 101 TYR D 60 TYR^? 26.93 MG MG C 302 D 173 ASP D 58 ASP^? 26.59 MG MG C 302 coo 69.08 8.58 32.60 69.70 10.81 30.58 89.36 17.23 -17.57 89.29 20.20 -16.76 coo 71.77 11.86 24.26 70.23 12.22 26.56 84.40 9.28 -23.74 83.45 7.90 -21.49 coo 71.60 6.14 19.25 70.26 6.87 20.69 83.38 14.85 -27.71 84.09 14.12 -25.85 1cs1_c02 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1cs1_c02 naa= 3 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 1 3 # 1 313 ASP A 23 ASP^? 22.90 MG MG A 301 315 GLU A 25 GLU^? 25.87 MG MG A 301 390 TYR A 123 TYR^? 15.82 MG MG A 301 coo 32.46 99.13 19.34 30.94 100.38 20.07 36.40 52.47 38.61 38.03 53.36 39.72 coo 32.04 94.22 18.23 30.57 94.75 16.88 39.62 57.50 39.92 41.51 57.27 40.85 coo 21.10 94.74 18.36 23.09 96.71 18.59 44.25 46.10 40.65 45.04 48.81 40.82 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 2 3 # 2 313 ASP A 171 ASP^? 17.17 MG MG A 302 315 GLU A 174 GLU^? 20.39 MG MG A 302 390 TYR A 188 TYR^? 8.73 MG MG A 302 coo 32.46 99.13 19.34 30.94 100.38 20.07 29.78 23.67 36.63 28.48 25.11 35.71 coo 32.04 94.22 18.23 30.57 94.75 16.88 25.88 23.57 38.04 23.76 23.95 38.22 coo 21.10 94.74 18.36 23.09 96.71 18.59 37.17 23.04 44.09 34.69 24.12 44.73 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 3 3 # 3 313 ASP B 171 ASP^? 16.92 MG MG B 301 315 GLU B 174 GLU^? 19.69 MG MG B 301 390 TYR B 188 TYR^? 8.84 MG MG B 301 coo 32.46 99.13 19.34 30.94 100.38 20.07 45.30 8.50 -0.71 46.30 6.81 0.12 coo 32.04 94.22 18.23 30.57 94.75 16.88 43.72 4.95 -3.28 44.76 3.14 -2.69 coo 21.10 94.74 18.36 23.09 96.71 18.59 46.41 16.35 -7.52 47.38 13.88 -8.38 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 4 3 # 4 313 ASP C 171 ASP^? 17.08 MG MG C 301 315 GLU C 174 GLU^? 19.72 MG MG C 301 390 TYR C 188 TYR^? 8.98 MG MG C 301 coo 32.46 99.13 19.34 30.94 100.38 20.07 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 32.04 94.22 18.23 30.57 94.75 16.88 95.09 14.29 -3.63 95.25 12.23 -4.17 coo 21.10 94.74 18.36 23.09 96.71 18.59 88.74 23.30 0.93 88.91 20.61 1.57 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 5 3 # 5 313 ASP D 171 ASP^? 16.95 MG MG D 301 315 GLU D 174 GLU^? 19.76 MG MG D 301 390 TYR D 188 TYR^? 8.87 MG MG D 301 coo 32.46 99.13 19.34 30.94 100.38 20.07 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 32.04 94.22 18.23 30.57 94.75 16.88 104.29 37.18 -46.00 105.30 38.94 -45.21 coo 21.10 94.74 18.36 23.09 96.71 18.59 93.72 33.91 -50.86 95.36 36.03 -51.61 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 6 3 # 6 313 ASP E 171 ASP^? 16.73 MG MG E 301 315 GLU E 174 GLU^? 19.83 MG MG E 301 390 TYR E 188 TYR^? 8.62 MG MG E 301 coo 32.46 99.13 19.34 30.94 100.38 20.07 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 32.04 94.22 18.23 30.57 94.75 16.88 70.48 76.62 -49.45 71.76 78.34 -49.45 coo 21.10 94.74 18.36 23.09 96.71 18.59 65.58 67.09 -44.08 67.82 68.57 -43.41 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 7 3 # 7 313 ASP F 171 ASP^? 16.35 MG MG F 302 315 GLU F 174 GLU^? 18.79 MG MG F 302 390 TYR F 188 TYR^? 8.06 MG MG F 302 coo 32.46 99.13 19.34 30.94 100.38 20.07 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 32.04 94.22 18.23 30.57 94.75 16.88 46.19 70.73 -90.91 44.19 71.42 -90.89 coo 21.10 94.74 18.36 23.09 96.71 18.59 54.23 63.50 -95.64 51.58 63.66 -96.35 1ctn_c00 source 1ctn CHITINASE A (E.C.3.2.1.14) (PH 5.5, 4 DEGREES : 7 hits 1ctn_c00 naa= 3 ULMN 3 1cwy_c00 AMYLOMALTASE user 1 3 # 1 A 293 ASP A 171 ASP^? 17.17 MG MG A 302 A 340 GLU A 174 GLU^? 20.39 MG MG A 302 A 395 ASP A 177 ASP^? 8.44 MG MG A 302 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 29.78 23.67 36.63 28.48 25.11 35.71 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 25.88 23.57 38.04 23.76 23.95 38.22 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 33.02 29.04 43.18 33.79 27.88 44.78 ULMN 3 1cwy_c00 AMYLOMALTASE user 2 3 # 2 A 293 ASP B 171 ASP^? 16.92 MG MG B 301 A 340 GLU B 174 GLU^? 19.69 MG MG B 301 A 395 ASP B 177 ASP^? 9.03 MG MG B 301 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 45.30 8.50 -0.71 46.30 6.81 0.12 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 43.72 4.95 -3.28 44.76 3.14 -2.69 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 51.97 11.04 -6.64 50.39 11.62 -7.94 ULMN 3 1cwy_c00 AMYLOMALTASE user 3 3 # 3 A 293 ASP C 171 ASP^? 17.08 MG MG C 301 A 340 GLU C 174 GLU^? 19.72 MG MG C 301 A 395 ASP C 177 ASP^? 8.84 MG MG C 301 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 92.57 16.68 -6.24 92.24 14.74 -7.03 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 95.09 14.29 -3.63 95.25 12.23 -4.17 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 85.60 16.42 -0.31 86.51 17.71 1.09 ULMN 3 1cwy_c00 AMYLOMALTASE user 4 3 # 4 A 293 ASP D 171 ASP^? 16.95 MG MG D 301 A 340 GLU D 174 GLU^? 19.76 MG MG D 301 A 395 ASP D 177 ASP^? 8.43 MG MG D 301 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 100.39 36.69 -43.49 101.13 38.51 -42.69 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 104.29 37.18 -46.00 105.30 38.94 -45.21 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 95.74 41.01 -49.76 94.81 39.90 -51.24 ULMN 3 1cwy_c00 AMYLOMALTASE user 5 3 # 5 A 293 ASP E 171 ASP^? 16.73 MG MG E 301 A 340 GLU E 174 GLU^? 19.83 MG MG E 301 A 395 ASP E 177 ASP^? 8.55 MG MG E 301 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 69.61 73.12 -51.56 71.50 73.53 -52.39 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 70.48 76.62 -49.45 71.76 78.34 -49.45 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 1cwy_c00 AMYLOMALTASE user 6 3 # 6 A 293 ASP F 171 ASP^? 16.35 MG MG F 302 A 340 GLU F 174 GLU^? 18.79 MG MG F 302 A 395 ASP F 177 ASP^? 8.15 MG MG F 302 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 48.23 68.08 -88.47 46.26 68.02 -87.56 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 46.19 70.73 -90.91 44.19 71.42 -90.89 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 47.18 61.22 -94.50 48.48 62.32 -95.73 1cwy_c00 source 1cwy AMYLOMALTASE : 6 hits 1cwy_c00 naa= 3 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 1 3 # 1 A 37 ASP C 35 ASP^? 16.42 MG MG C 302 A 56 ILE D 4 ILE^? 27.61 MG MG C 302 A 82 TYR D 60 TYR^? 26.93 MG MG C 302 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 88.19 15.57 -26.88 88.32 16.65 -25.93 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 84.40 9.28 -23.74 83.45 7.90 -21.49 1d6o_c00 source 1d6o FK506-BINDING PROTEIN : 1 hits 1d6o_c00 naa= 3 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 1 3 # 1 B 37 ASP C 35 ASP^? 16.42 MG MG C 302 B 56 ILE D 4 ILE^? 27.61 MG MG C 302 B 82 TYR D 60 TYR^? 26.93 MG MG C 302 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 88.19 15.57 -26.88 88.32 16.65 -25.93 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 84.40 9.28 -23.74 83.45 7.90 -21.49 1d6o_c01 source 1d6o FK506-BINDING PROTEIN : 1 hits 1d6o_c01 naa= 3 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 1 3 # 1 A 138 TRP A 103 TRP^? 29.78 MG MG A 301 A 243 ASP A 58 ASP^? 26.75 MG MG B 302 A 272 LYS A 136 LYS^? 30.58 MG MG A 302 coo 18.21 54.75 18.05 19.91 55.17 21.59 59.99 9.32 29.49 57.09 7.83 27.30 coo 16.93 55.67 9.65 17.16 54.23 11.19 53.93 9.80 21.09 53.83 8.90 19.15 coo 14.13 45.79 13.40 14.25 49.41 18.30 50.14 3.36 31.42 51.28 2.21 35.89 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 2 3 # 2 A 138 TRP A 103 TRP^? 29.78 MG MG A 301 A 243 ASP A 58 ASP^? 26.75 MG MG B 302 A 272 LYS A 137 LYS^? 34.85 MG MG A 301 coo 18.21 54.75 18.05 19.91 55.17 21.59 59.99 9.32 29.49 57.09 7.83 27.30 coo 16.93 55.67 9.65 17.16 54.23 11.19 53.93 9.80 21.09 53.83 8.90 19.15 coo 14.13 45.79 13.40 14.25 49.41 18.30 50.97 1.58 28.14 56.13 1.49 28.03 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 3 3 # 3 A 138 TRP B 103 TRP^? 29.74 MG MG B 302 A 243 ASP B 58 ASP^? 26.73 MG MG A 301 A 272 LYS B 136 LYS^? 33.75 MG MG B 302 coo 18.21 54.75 18.05 19.91 55.17 21.59 35.60 40.22 7.93 33.65 37.37 9.82 coo 16.93 55.67 9.65 17.16 54.23 11.19 34.42 33.56 15.74 33.50 33.49 17.59 coo 14.13 45.79 13.40 14.25 49.41 18.30 28.47 31.35 4.78 24.04 31.81 1.99 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 4 3 # 4 A 138 TRP B 103 TRP^? 29.74 MG MG B 302 A 243 ASP B 58 ASP^? 26.73 MG MG A 301 A 272 LYS B 137 LYS^? 34.56 MG MG B 302 coo 18.21 54.75 18.05 19.91 55.17 21.59 35.60 40.22 7.93 33.65 37.37 9.82 coo 16.93 55.67 9.65 17.16 54.23 11.19 34.42 33.56 15.74 33.50 33.49 17.59 coo 14.13 45.79 13.40 14.25 49.41 18.30 26.56 32.46 7.93 27.87 37.71 9.31 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 5 3 # 5 A 138 TRP C 103 TRP^? 29.51 MG MG C 302 A 243 ASP C 58 ASP^? 26.67 MG MG D 302 A 272 LYS C 136 LYS^? 30.63 MG MG C 302 coo 18.21 54.75 18.05 19.91 55.17 21.59 90.16 49.24 -14.37 93.26 47.67 -16.22 coo 16.93 55.67 9.65 17.16 54.23 11.19 93.40 43.81 -22.27 94.18 44.45 -24.11 coo 14.13 45.79 13.40 14.25 49.41 18.30 99.75 44.04 -11.38 100.98 45.13 -6.77 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 6 3 # 6 A 138 TRP C 103 TRP^? 29.51 MG MG C 302 A 243 ASP C 58 ASP^? 26.67 MG MG D 302 A 272 LYS C 137 LYS^? 35.41 MG MG C 302 coo 18.21 54.75 18.05 19.91 55.17 21.59 90.16 49.24 -14.37 93.26 47.67 -16.22 coo 16.93 55.67 9.65 17.16 54.23 11.19 93.40 43.81 -22.27 94.18 44.45 -24.11 coo 14.13 45.79 13.40 14.25 49.41 18.30 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 7 3 # 7 A 138 TRP D 17 TRP^? 22.77 MG MG D 302 A 243 ASP D 35 ASP^? 16.80 MG MG D 302 A 272 LYS C 61 LYS^? 21.91 MG MG D 302 coo 18.21 54.75 18.05 19.91 55.17 21.59 95.68 52.30 -33.46 91.97 52.85 -32.32 coo 16.93 55.67 9.65 17.16 54.23 11.19 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 14.13 45.79 13.40 14.25 49.41 18.30 93.60 48.56 -24.05 90.39 44.71 -27.98 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 8 3 # 8 A 138 TRP D 103 TRP^? 29.85 MG MG D 302 A 243 ASP D 58 ASP^? 26.59 MG MG C 302 A 272 LYS D 136 LYS^? 34.99 MG MG D 302 coo 18.21 54.75 18.05 19.91 55.17 21.59 77.64 12.56 -35.88 81.02 12.20 -33.92 coo 16.93 55.67 9.65 17.16 54.23 11.19 83.38 14.85 -27.71 84.09 14.12 -25.85 coo 14.13 45.79 13.40 14.25 49.41 18.30 88.96 10.62 -38.53 90.77 6.00 -38.00 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 9 3 # 9 A 138 TRP D 103 TRP^? 29.85 MG MG D 302 A 243 ASP D 58 ASP^? 26.59 MG MG C 302 A 272 LYS D 137 LYS^? 37.57 MG MG D 302 coo 18.21 54.75 18.05 19.91 55.17 21.59 77.64 12.56 -35.88 81.02 12.20 -33.92 coo 16.93 55.67 9.65 17.16 54.23 11.19 83.38 14.85 -27.71 84.09 14.12 -25.85 coo 14.13 45.79 13.40 14.25 49.41 18.30 88.48 8.58 -35.33 84.88 3.98 -33.96 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 10 3 # 10 A 138 TRP E 103 TRP^? 29.56 MG MG E 302 A 243 ASP E 58 ASP^? 26.76 MG MG F 301 A 272 LYS E 136 LYS^? 31.27 MG MG E 302 coo 18.21 54.75 18.05 19.91 55.17 21.59 42.03 54.00 -58.74 42.60 57.21 -60.89 coo 16.93 55.67 9.65 17.16 54.23 11.19 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 14.13 45.79 13.40 14.25 49.41 18.30 42.12 65.93 -56.52 39.36 65.07 -51.83 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 11 3 # 11 A 138 TRP E 103 TRP^? 29.56 MG MG E 302 A 243 ASP E 58 ASP^? 26.76 MG MG F 301 A 272 LYS E 137 LYS^? 35.26 MG MG E 302 coo 18.21 54.75 18.05 19.91 55.17 21.59 42.03 54.00 -58.74 42.60 57.21 -60.89 coo 16.93 55.67 9.65 17.16 54.23 11.19 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 14.13 45.79 13.40 14.25 49.41 18.30 40.01 66.05 -59.66 36.65 60.99 -60.28 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 12 3 # 12 A 138 TRP F 103 TRP^? 29.78 MG MG F 301 A 243 ASP F 58 ASP^? 26.87 MG MG E 302 A 272 LYS F 136 LYS^? 30.53 MG MG F 301 coo 18.21 54.75 18.05 19.91 55.17 21.59 80.05 60.24 -80.06 79.17 63.82 -78.73 coo 16.93 55.67 9.65 17.16 54.23 11.19 75.55 64.68 -72.56 76.21 65.63 -70.79 coo 14.13 45.79 13.40 14.25 49.41 18.30 76.49 71.19 -83.39 78.38 70.88 -88.47 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 13 3 # 13 A 138 TRP F 103 TRP^? 29.78 MG MG F 301 A 243 ASP F 58 ASP^? 26.87 MG MG E 302 A 272 LYS F 137 LYS^? 35.13 MG MG F 301 coo 18.21 54.75 18.05 19.91 55.17 21.59 80.05 60.24 -80.06 79.17 63.82 -78.73 coo 16.93 55.67 9.65 17.16 54.23 11.19 75.55 64.68 -72.56 76.21 65.63 -70.79 coo 14.13 45.79 13.40 14.25 49.41 18.30 78.53 72.20 -80.30 83.01 68.64 -79.79 1d7r_c01 source 1d7r 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYRUVATE) : 13 hits 1d7r_c01 naa= 3 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 1 3 # 1 A 173 TYR A 67 TYR^? 21.33 MG MG A 301 A 243 ASP B 160 ASP^? 31.65 MG MG A 301 A 272 LYS B 137 LYS^? 34.56 MG MG B 302 coo 2.03 68.31 21.46 0.66 68.36 23.90 48.62 23.20 22.09 46.84 25.23 21.44 coo 16.93 55.67 9.65 17.16 54.23 11.19 28.01 24.83 16.38 27.44 26.81 15.80 coo 14.13 45.79 13.40 14.25 49.41 18.30 26.56 32.46 7.93 27.87 37.71 9.31 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 2 3 # 2 A 173 TYR A 123 TYR^? 15.82 MG MG A 301 A 243 ASP A 35 ASP^? 16.92 MG MG A 301 A 272 LYS B 61 LYS^? 22.03 MG MG A 301 coo 2.03 68.31 21.46 0.66 68.36 23.90 44.25 46.10 40.65 45.04 48.81 40.82 coo 16.93 55.67 9.65 17.16 54.23 11.19 34.49 31.10 26.54 36.41 31.82 27.10 coo 14.13 45.79 13.40 14.25 49.41 18.30 32.50 37.62 17.61 36.68 34.92 21.51 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 3 3 # 3 A 173 TYR A 129 TYR^? 10.90 MG MG A 301 A 243 ASP B 58 ASP^? 26.73 MG MG A 301 A 272 LYS B 6 LYS^? 25.90 MG MG B 302 coo 2.03 68.31 21.46 0.66 68.36 23.90 44.80 23.54 35.75 45.57 23.36 33.08 coo 16.93 55.67 9.65 17.16 54.23 11.19 34.42 33.56 15.74 33.50 33.49 17.59 coo 14.13 45.79 13.40 14.25 49.41 18.30 36.26 25.44 11.74 39.65 23.12 16.29 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 4 3 # 4 A 173 TYR A 156 TYR^? 21.80 MG MG A 301 A 243 ASP B 58 ASP^? 26.73 MG MG A 301 A 272 LYS B 137 LYS^? 34.56 MG MG B 302 coo 2.03 68.31 21.46 0.66 68.36 23.90 37.50 16.28 27.75 35.30 17.94 28.08 coo 16.93 55.67 9.65 17.16 54.23 11.19 34.42 33.56 15.74 33.50 33.49 17.59 coo 14.13 45.79 13.40 14.25 49.41 18.30 26.56 32.46 7.93 27.87 37.71 9.31 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 5 3 # 5 A 173 TYR A 168 TYR^? 14.52 MG MG A 302 A 243 ASP B 160 ASP^? 31.65 MG MG A 301 A 272 LYS B 6 LYS^? 25.90 MG MG B 302 coo 2.03 68.31 21.46 0.66 68.36 23.90 37.31 16.98 37.59 36.65 18.86 39.55 coo 16.93 55.67 9.65 17.16 54.23 11.19 28.01 24.83 16.38 27.44 26.81 15.80 coo 14.13 45.79 13.40 14.25 49.41 18.30 36.26 25.44 11.74 39.65 23.12 16.29 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 6 3 # 6 A 173 TYR B 67 TYR^? 21.41 MG MG B 302 A 243 ASP A 160 ASP^? 31.61 MG MG B 302 A 272 LYS A 137 LYS^? 34.85 MG MG A 301 coo 2.03 68.31 21.46 0.66 68.36 23.90 46.94 25.86 15.48 48.70 23.84 16.15 coo 16.93 55.67 9.65 17.16 54.23 11.19 44.21 5.00 19.54 46.02 3.84 19.76 coo 14.13 45.79 13.40 14.25 49.41 18.30 50.97 1.58 28.14 56.13 1.49 28.03 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 7 3 # 7 A 173 TYR B 129 TYR^? 10.63 MG MG B 302 A 243 ASP A 58 ASP^? 26.75 MG MG B 302 A 272 LYS A 6 LYS^? 25.88 MG MG A 301 coo 2.03 68.31 21.46 0.66 68.36 23.90 47.85 23.00 1.51 47.62 23.50 4.24 coo 16.93 55.67 9.65 17.16 54.23 11.19 53.93 9.80 21.09 53.83 8.90 19.15 coo 14.13 45.79 13.40 14.25 49.41 18.30 46.20 12.82 24.71 44.50 16.64 20.52 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 8 3 # 8 A 173 TYR B 156 TYR^? 21.63 MG MG B 302 A 243 ASP A 58 ASP^? 26.75 MG MG B 302 A 272 LYS A 137 LYS^? 34.85 MG MG A 301 coo 2.03 68.31 21.46 0.66 68.36 23.90 38.56 16.71 8.27 39.91 14.31 7.86 coo 16.93 55.67 9.65 17.16 54.23 11.19 53.93 9.80 21.09 53.83 8.90 19.15 coo 14.13 45.79 13.40 14.25 49.41 18.30 50.97 1.58 28.14 56.13 1.49 28.03 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 9 3 # 9 A 173 TYR B 168 TYR^? 14.66 MG MG B 301 A 243 ASP A 160 ASP^? 31.61 MG MG B 302 A 272 LYS A 6 LYS^? 25.88 MG MG A 301 coo 2.03 68.31 21.46 0.66 68.36 23.90 40.03 17.20 -1.34 41.92 16.43 -3.19 coo 16.93 55.67 9.65 17.16 54.23 11.19 44.21 5.00 19.54 46.02 3.84 19.76 coo 14.13 45.79 13.40 14.25 49.41 18.30 46.20 12.82 24.71 44.50 16.64 20.52 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 10 3 # 10 A 173 TYR C 67 TYR^? 21.03 MG MG C 302 A 243 ASP D 160 ASP^? 31.45 MG MG C 302 A 272 LYS D 137 LYS^? 37.57 MG MG D 302 coo 2.03 68.31 21.46 0.66 68.36 23.90 84.52 32.45 -21.76 83.69 29.84 -22.37 coo 16.93 55.67 9.65 17.16 54.23 11.19 94.15 13.98 -26.57 92.71 12.42 -26.99 coo 14.13 45.79 13.40 14.25 49.41 18.30 88.48 8.58 -35.33 84.88 3.98 -33.96 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 11 3 # 11 A 173 TYR C 123 TYR^? 10.31 MG MG B 302 A 243 ASP C 35 ASP^? 16.42 MG MG C 302 A 272 LYS D 61 LYS^? 21.93 MG MG C 302 coo 2.03 68.31 21.46 0.66 68.36 23.90 65.55 16.66 -3.72 62.85 15.86 -3.85 coo 16.93 55.67 9.65 17.16 54.23 11.19 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 14.13 45.79 13.40 14.25 49.41 18.30 80.64 11.23 -26.16 80.65 16.24 -22.36 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 12 3 # 12 A 173 TYR C 129 TYR^? 10.65 MG MG C 302 A 243 ASP D 58 ASP^? 26.59 MG MG C 302 A 272 LYS D 6 LYS^? 25.98 MG MG D 302 coo 2.03 68.31 21.46 0.66 68.36 23.90 84.95 29.43 -7.96 85.04 30.16 -10.69 coo 16.93 55.67 9.65 17.16 54.23 11.19 83.38 14.85 -27.71 84.09 14.12 -25.85 coo 14.13 45.79 13.40 14.25 49.41 18.30 89.78 20.68 -31.57 90.15 24.89 -27.02 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 13 3 # 13 A 173 TYR C 156 TYR^? 21.58 MG MG C 302 A 243 ASP D 58 ASP^? 26.59 MG MG C 302 A 272 LYS D 137 LYS^? 37.57 MG MG D 302 coo 2.03 68.31 21.46 0.66 68.36 23.90 95.64 26.50 -15.14 95.25 23.76 -14.77 coo 16.93 55.67 9.65 17.16 54.23 11.19 83.38 14.85 -27.71 84.09 14.12 -25.85 coo 14.13 45.79 13.40 14.25 49.41 18.30 88.48 8.58 -35.33 84.88 3.98 -33.96 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 14 3 # 14 A 173 TYR C 168 TYR^? 14.82 MG MG C 301 A 243 ASP D 160 ASP^? 31.45 MG MG C 302 A 272 LYS D 6 LYS^? 25.98 MG MG D 302 coo 2.03 68.31 21.46 0.66 68.36 23.90 94.44 26.43 -5.44 92.97 25.09 -3.55 coo 16.93 55.67 9.65 17.16 54.23 11.19 94.15 13.98 -26.57 92.71 12.42 -26.99 coo 14.13 45.79 13.40 14.25 49.41 18.30 89.78 20.68 -31.57 90.15 24.89 -27.02 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 15 3 # 15 A 173 TYR D 67 TYR^? 21.42 MG MG D 302 A 243 ASP C 160 ASP^? 31.63 MG MG D 302 A 272 LYS C 137 LYS^? 35.41 MG MG C 302 coo 2.03 68.31 21.46 0.66 68.36 23.90 83.62 29.64 -28.35 84.67 32.17 -27.90 coo 16.93 55.67 9.65 17.16 54.23 11.19 102.50 38.00 -23.28 102.43 39.97 -22.46 coo 14.13 45.79 13.40 14.25 49.41 18.30 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 16 3 # 16 A 173 TYR D 129 TYR^? 10.79 MG MG D 302 A 243 ASP C 58 ASP^? 26.67 MG MG D 302 A 272 LYS C 6 LYS^? 25.73 MG MG C 302 coo 2.03 68.31 21.46 0.66 68.36 23.90 86.45 31.36 -42.20 86.02 30.90 -39.46 coo 16.93 55.67 9.65 17.16 54.23 11.19 93.40 43.81 -22.27 94.18 44.45 -24.11 coo 14.13 45.79 13.40 14.25 49.41 18.30 94.42 35.68 -18.56 92.21 32.03 -23.05 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 17 3 # 17 A 173 TYR D 156 TYR^? 21.34 MG MG D 302 A 243 ASP C 58 ASP^? 26.67 MG MG D 302 A 272 LYS C 137 LYS^? 35.41 MG MG C 302 coo 2.03 68.31 21.46 0.66 68.36 23.90 96.25 27.10 -34.64 97.58 29.48 -35.03 coo 16.93 55.67 9.65 17.16 54.23 11.19 93.40 43.81 -22.27 94.18 44.45 -24.11 coo 14.13 45.79 13.40 14.25 49.41 18.30 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 18 3 # 18 A 173 TYR D 168 TYR^? 14.75 MG MG D 301 A 243 ASP C 160 ASP^? 31.63 MG MG D 302 A 272 LYS C 6 LYS^? 25.73 MG MG C 302 coo 2.03 68.31 21.46 0.66 68.36 23.90 95.79 27.80 -44.35 95.71 29.78 -46.32 coo 16.93 55.67 9.65 17.16 54.23 11.19 102.50 38.00 -23.28 102.43 39.97 -22.46 coo 14.13 45.79 13.40 14.25 49.41 18.30 94.42 35.68 -18.56 92.21 32.03 -23.05 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 19 3 # 19 A 173 TYR E 67 TYR^? 21.41 MG MG E 302 A 243 ASP F 160 ASP^? 31.59 MG MG E 302 A 272 LYS F 137 LYS^? 35.13 MG MG F 301 coo 2.03 68.31 21.46 0.66 68.36 23.90 59.76 57.41 -66.37 62.46 58.08 -67.03 coo 16.93 55.67 9.65 17.16 54.23 11.19 71.27 74.59 -71.77 73.23 74.02 -72.37 coo 14.13 45.79 13.40 14.25 49.41 18.30 78.53 72.20 -80.30 83.01 68.64 -79.79 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 20 3 # 20 A 173 TYR E 123 TYR^? 10.90 MG MG D 302 A 243 ASP E 35 ASP^? 16.91 MG MG E 302 A 272 LYS F 61 LYS^? 21.75 MG MG E 302 coo 2.03 68.31 21.46 0.66 68.36 23.90 82.15 50.70 -47.72 84.01 48.63 -47.87 coo 16.93 55.67 9.65 17.16 54.23 11.19 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 14.13 45.79 13.40 14.25 49.41 18.30 80.24 64.12 -71.01 76.23 61.95 -66.39 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 21 3 # 21 A 173 TYR E 129 TYR^? 10.89 MG MG E 302 A 243 ASP F 58 ASP^? 26.87 MG MG E 302 A 272 LYS F 6 LYS^? 26.09 MG MG F 301 coo 2.03 68.31 21.46 0.66 68.36 23.90 62.09 60.15 -52.83 61.47 59.53 -55.45 coo 16.93 55.67 9.65 17.16 54.23 11.19 75.55 64.68 -72.56 76.21 65.63 -70.79 coo 14.13 45.79 13.40 14.25 49.41 18.30 67.53 67.03 -76.43 64.05 65.33 -71.86 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 22 3 # 22 A 173 TYR E 156 TYR^? 21.59 MG MG E 302 A 243 ASP F 58 ASP^? 26.87 MG MG E 302 A 272 LYS F 137 LYS^? 35.13 MG MG F 301 coo 2.03 68.31 21.46 0.66 68.36 23.90 59.31 70.31 -60.22 61.84 71.39 -59.92 coo 16.93 55.67 9.65 17.16 54.23 11.19 75.55 64.68 -72.56 76.21 65.63 -70.79 coo 14.13 45.79 13.40 14.25 49.41 18.30 78.53 72.20 -80.30 83.01 68.64 -79.79 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 23 3 # 23 A 173 TYR E 168 TYR^? 14.43 MG MG E 301 A 243 ASP F 160 ASP^? 31.59 MG MG E 302 A 272 LYS F 6 LYS^? 26.09 MG MG F 301 coo 2.03 68.31 21.46 0.66 68.36 23.90 60.07 69.95 -50.54 61.99 69.37 -48.59 coo 16.93 55.67 9.65 17.16 54.23 11.19 71.27 74.59 -71.77 73.23 74.02 -72.37 coo 14.13 45.79 13.40 14.25 49.41 18.30 67.53 67.03 -76.43 64.05 65.33 -71.86 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 24 3 # 24 A 173 TYR F 67 TYR^? 21.41 MG MG F 301 A 243 ASP E 160 ASP^? 31.54 MG MG F 301 A 272 LYS E 137 LYS^? 35.26 MG MG E 302 coo 2.03 68.31 21.46 0.66 68.36 23.90 62.63 57.65 -72.90 59.95 57.21 -72.29 coo 16.93 55.67 9.65 17.16 54.23 11.19 45.81 70.00 -68.45 44.10 68.87 -67.77 coo 14.13 45.79 13.40 14.25 49.41 18.30 40.01 66.05 -59.66 36.65 60.99 -60.28 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 25 3 # 25 A 173 TYR F 123 TYR^? 15.37 MG MG F 301 A 243 ASP F 35 ASP^? 16.93 MG MG F 301 A 272 LYS E 61 LYS^? 22.16 MG MG F 301 coo 2.03 68.31 21.46 0.66 68.36 23.90 48.54 39.40 -89.96 48.96 36.69 -89.29 coo 16.93 55.67 9.65 17.16 54.23 11.19 46.82 60.47 -77.63 48.00 58.79 -78.23 coo 14.13 45.79 13.40 14.25 49.41 18.30 40.99 56.84 -68.48 45.99 56.72 -72.39 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 26 3 # 26 A 173 TYR F 129 TYR^? 10.92 MG MG F 301 A 243 ASP E 58 ASP^? 26.76 MG MG F 301 A 272 LYS E 6 LYS^? 25.59 MG MG E 302 coo 2.03 68.31 21.46 0.66 68.36 23.90 59.69 58.61 -86.67 60.36 58.48 -83.96 coo 16.93 55.67 9.65 17.16 54.23 11.19 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 14.13 45.79 13.40 14.25 49.41 18.30 51.95 64.70 -63.33 56.16 64.03 -67.52 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 27 3 # 27 A 173 TYR F 156 TYR^? 21.68 MG MG F 302 A 243 ASP E 58 ASP^? 26.76 MG MG F 301 A 272 LYS E 136 LYS^? 31.27 MG MG E 302 coo 2.03 68.31 21.46 0.66 68.36 23.90 58.80 69.55 -79.65 56.09 69.80 -80.15 coo 16.93 55.67 9.65 17.16 54.23 11.19 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 14.13 45.79 13.40 14.25 49.41 18.30 42.12 65.93 -56.52 39.36 65.07 -51.83 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 28 3 # 28 A 173 TYR F 156 TYR^? 21.68 MG MG F 302 A 243 ASP E 58 ASP^? 26.76 MG MG F 301 A 272 LYS E 137 LYS^? 35.26 MG MG E 302 coo 2.03 68.31 21.46 0.66 68.36 23.90 58.80 69.55 -79.65 56.09 69.80 -80.15 coo 16.93 55.67 9.65 17.16 54.23 11.19 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 14.13 45.79 13.40 14.25 49.41 18.30 40.01 66.05 -59.66 36.65 60.99 -60.28 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 29 3 # 29 A 173 TYR F 168 TYR^? 14.10 MG MG F 302 A 243 ASP E 160 ASP^? 31.54 MG MG F 301 A 272 LYS E 6 LYS^? 25.59 MG MG E 302 coo 2.03 68.31 21.46 0.66 68.36 23.90 58.29 68.32 -89.29 56.67 67.12 -91.21 coo 16.93 55.67 9.65 17.16 54.23 11.19 45.81 70.00 -68.45 44.10 68.87 -67.77 coo 14.13 45.79 13.40 14.25 49.41 18.30 51.95 64.70 -63.33 56.16 64.03 -67.52 1d7r_c02 source 1d7r 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYRUVATE) : 29 hits 1d7r_c02 naa= 3 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 A 145 LYS A 192 LYS^? 22.83 MG MG A 302 A 177 GLU A 165 GLU^? 29.56 MG MG A 302 A 201 LEU A 194 LEU^? 25.73 MG MG A 302 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 40.19 10.20 38.86 35.42 9.85 36.29 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 36.12 8.31 27.27 37.25 6.55 27.60 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 39.77 7.37 32.75 37.92 8.15 31.92 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 A 145 LYS B 192 LYS^? 23.73 MG MG B 301 A 177 GLU B 165 GLU^? 29.66 MG MG B 302 A 201 LEU B 194 LEU^? 25.91 MG MG B 301 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 33.83 21.17 -2.93 31.87 16.45 -0.74 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 30.38 16.84 8.28 28.95 18.37 7.83 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 30.23 20.99 3.10 31.41 19.32 3.54 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 3 3 # 3 A 145 LYS C 192 LYS^? 24.43 MG MG C 301 A 177 GLU C 165 GLU^? 29.32 MG MG C 302 A 201 LEU C 194 LEU^? 26.05 MG MG C 301 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 98.71 32.33 -3.93 102.89 29.25 -5.78 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 103.18 29.99 -15.18 103.57 32.09 -14.86 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 102.87 33.22 -9.43 101.26 32.08 -10.25 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 4 3 # 4 A 145 LYS D 192 LYS^? 24.09 MG MG D 301 A 177 GLU D 165 GLU^? 29.85 MG MG D 302 A 201 LEU D 194 LEU^? 25.91 MG MG D 301 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 95.35 20.28 -45.75 100.42 20.77 -43.05 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 100.60 20.11 -34.27 100.38 17.96 -34.49 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 97.36 18.14 -40.17 98.85 19.15 -38.94 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 5 3 # 5 A 145 LYS E 111 LYS^? 14.52 MG MG E 302 A 177 GLU E 146 GLU^? 10.15 MG MG E 301 A 201 LEU E 131 LEU^? 14.79 MG MG E 302 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 52.49 56.44 -52.43 54.52 53.78 -47.52 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 58.72 60.89 -44.51 59.23 60.24 -42.54 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 55.95 61.46 -52.09 57.35 63.09 -52.46 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 6 3 # 6 A 145 LYS E 192 LYS^? 23.62 MG MG E 301 A 177 GLU E 165 GLU^? 29.48 MG MG E 301 A 201 LEU E 194 LEU^? 25.55 MG MG E 301 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 52.64 70.58 -49.14 53.48 75.40 -50.95 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 52.92 74.97 -61.04 50.84 74.87 -60.51 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 50.82 73.83 -54.29 51.86 72.98 -56.01 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 7 3 # 7 A 145 LYS F 192 LYS^? 23.61 MG MG F 302 A 177 GLU F 165 GLU^? 29.11 MG MG F 302 A 201 LEU F 194 LEU^? 25.49 MG MG F 302 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 64.82 71.59 -91.06 62.22 76.11 -88.75 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 63.01 76.49 -79.50 64.84 77.22 -80.35 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 66.65 74.64 -84.95 64.49 75.02 -84.72 1daa_c00 source 1daa D-AMINO ACID AMINOTRANSFERASE : 7 hits 1daa_c00 naa= 3 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 B 145 LYS A 192 LYS^? 22.83 MG MG A 302 B 177 GLU A 165 GLU^? 29.56 MG MG A 302 B 201 LEU A 194 LEU^? 25.73 MG MG A 302 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 40.19 10.20 38.86 35.42 9.85 36.29 coo 27.00 6.35 51.01 26.30 4.53 50.18 36.12 8.31 27.27 37.25 6.55 27.60 coo 23.74 1.68 49.50 22.87 -0.24 49.97 39.77 7.37 32.75 37.92 8.15 31.92 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 B 145 LYS B 192 LYS^? 23.73 MG MG B 301 B 177 GLU B 165 GLU^? 29.66 MG MG B 302 B 201 LEU B 194 LEU^? 25.91 MG MG B 301 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 33.83 21.17 -2.93 31.87 16.45 -0.74 coo 27.00 6.35 51.01 26.30 4.53 50.18 30.38 16.84 8.28 28.95 18.37 7.83 coo 23.74 1.68 49.50 22.87 -0.24 49.97 30.23 20.99 3.10 31.41 19.32 3.54 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 3 3 # 3 B 145 LYS C 192 LYS^? 24.43 MG MG C 301 B 177 GLU C 165 GLU^? 29.32 MG MG C 302 B 201 LEU C 194 LEU^? 26.05 MG MG C 301 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 98.71 32.33 -3.93 102.89 29.25 -5.78 coo 27.00 6.35 51.01 26.30 4.53 50.18 103.18 29.99 -15.18 103.57 32.09 -14.86 coo 23.74 1.68 49.50 22.87 -0.24 49.97 102.87 33.22 -9.43 101.26 32.08 -10.25 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 4 3 # 4 B 145 LYS D 192 LYS^? 24.09 MG MG D 301 B 177 GLU D 165 GLU^? 29.85 MG MG D 302 B 201 LEU D 194 LEU^? 25.91 MG MG D 301 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 95.35 20.28 -45.75 100.42 20.77 -43.05 coo 27.00 6.35 51.01 26.30 4.53 50.18 100.60 20.11 -34.27 100.38 17.96 -34.49 coo 23.74 1.68 49.50 22.87 -0.24 49.97 97.36 18.14 -40.17 98.85 19.15 -38.94 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 5 3 # 5 B 145 LYS E 192 LYS^? 23.62 MG MG E 301 B 177 GLU E 165 GLU^? 29.48 MG MG E 301 B 201 LEU E 194 LEU^? 25.55 MG MG E 301 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 52.64 70.58 -49.14 53.48 75.40 -50.95 coo 27.00 6.35 51.01 26.30 4.53 50.18 52.92 74.97 -61.04 50.84 74.87 -60.51 coo 23.74 1.68 49.50 22.87 -0.24 49.97 50.82 73.83 -54.29 51.86 72.98 -56.01 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 6 3 # 6 B 145 LYS F 192 LYS^? 23.61 MG MG F 302 B 177 GLU F 165 GLU^? 29.11 MG MG F 302 B 201 LEU F 194 LEU^? 25.49 MG MG F 302 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 64.82 71.59 -91.06 62.22 76.11 -88.75 coo 27.00 6.35 51.01 26.30 4.53 50.18 63.01 76.49 -79.50 64.84 77.22 -80.35 coo 23.74 1.68 49.50 22.87 -0.24 49.97 66.65 74.64 -84.95 64.49 75.02 -84.72 1daa_c01 source 1daa D-AMINO ACID AMINOTRANSFERASE : 6 hits 1daa_c01 naa= 3 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 1 3 # 1 A 132 THR A 169 THR^? 18.45 MG MG A 302 A 156 TYR A 156 TYR^? 21.80 MG MG A 301 A 160 LYS A 166 LYS^? 20.93 MG MG A 302 coo 10.50 56.87 17.73 11.24 57.93 19.43 34.64 19.08 35.13 33.08 18.40 33.78 coo 11.64 63.07 23.95 11.76 62.47 21.20 37.50 16.28 27.75 35.30 17.94 28.08 coo 5.78 61.30 21.65 8.04 62.89 17.54 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 2 3 # 2 A 132 THR B 40 THR^? 24.25 MG MG B 302 A 156 TYR B 156 TYR^? 21.63 MG MG B 302 A 160 LYS B 166 LYS^? 22.75 MG MG B 301 coo 10.50 56.87 17.73 11.24 57.93 19.43 41.77 11.06 10.77 42.63 10.70 12.73 coo 11.64 63.07 23.95 11.76 62.47 21.20 38.56 16.71 8.27 39.91 14.31 7.86 coo 5.78 61.30 21.65 8.04 62.89 17.54 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 3 3 # 3 A 132 THR B 169 THR^? 18.43 MG MG B 301 A 156 TYR B 156 TYR^? 21.63 MG MG B 302 A 160 LYS B 166 LYS^? 22.75 MG MG B 301 coo 10.50 56.87 17.73 11.24 57.93 19.43 41.38 13.97 0.97 40.27 12.43 2.02 coo 11.64 63.07 23.95 11.76 62.47 21.20 38.56 16.71 8.27 39.91 14.31 7.86 coo 5.78 61.30 21.65 8.04 62.89 17.54 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 4 3 # 4 A 132 THR C 169 THR^? 18.51 MG MG C 301 A 156 TYR C 156 TYR^? 21.58 MG MG C 302 A 160 LYS C 166 LYS^? 22.53 MG MG C 301 coo 10.50 56.87 17.73 11.24 57.93 19.43 94.19 23.02 -7.83 95.56 21.86 -9.07 coo 11.64 63.07 23.95 11.76 62.47 21.20 95.64 26.50 -15.14 95.25 23.76 -14.77 coo 5.78 61.30 21.65 8.04 62.89 17.54 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 5 3 # 5 A 132 THR D 169 THR^? 18.47 MG MG D 301 A 156 TYR D 156 TYR^? 21.34 MG MG D 302 A 160 LYS D 166 LYS^? 21.08 MG MG D 301 coo 10.50 56.87 17.73 11.24 57.93 19.43 97.62 30.68 -41.94 99.48 30.62 -40.85 coo 11.64 63.07 23.95 11.76 62.47 21.20 96.25 27.10 -34.64 97.58 29.48 -35.03 coo 5.78 61.30 21.65 8.04 62.89 17.54 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 6 3 # 6 A 132 THR F 40 THR^? 24.18 MG MG F 301 A 156 TYR F 156 TYR^? 21.68 MG MG F 302 A 160 LYS F 166 LYS^? 20.76 MG MG F 302 coo 10.50 56.87 17.73 11.24 57.93 19.43 52.32 69.62 -77.21 51.38 69.00 -75.36 coo 11.64 63.07 23.95 11.76 62.47 21.20 58.80 69.55 -79.65 56.09 69.80 -80.15 coo 5.78 61.30 21.65 8.04 62.89 17.54 59.28 73.05 -82.63 55.63 74.15 -86.94 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 7 3 # 7 A 132 THR F 169 THR^? 17.93 MG MG F 302 A 156 TYR F 156 TYR^? 21.68 MG MG F 302 A 160 LYS F 166 LYS^? 20.76 MG MG F 302 coo 10.50 56.87 17.73 11.24 57.93 19.43 54.83 68.79 -86.99 54.09 70.44 -85.82 coo 11.64 63.07 23.95 11.76 62.47 21.20 58.80 69.55 -79.65 56.09 69.80 -80.15 coo 5.78 61.30 21.65 8.04 62.89 17.54 59.28 73.05 -82.63 55.63 74.15 -86.94 1db3_c01 source 1db3 GDP-MANNOSE 4,6-DEHYDRATASE : 7 hits 1db3_c01 naa= 3 ULMN 3 1dco_c00 DCOH user 1 3 # 1 A 62 HIS A 147 HIS^? 9.20 MG MG A 302 A 63 HIS A 170 HIS^? 10.56 MG MG A 302 A 89 ASP A 128 ASP^? -3.32 MG MG A 301s coo 49.66 36.74 42.37 48.88 35.30 43.64 40.24 23.10 39.83 38.32 22.34 40.22 coo 49.93 35.76 35.94 51.58 36.96 35.47 34.91 23.57 39.32 34.35 24.95 40.81 coo 46.15 35.33 47.12 47.46 33.99 46.29 46.50 28.23 39.77 47.49 30.10 39.82 ULMN 3 1dco_c00 DCOH user 2 3 # 2 A 62 HIS A 170 HIS^? 10.56 MG MG A 302 A 63 HIS A 147 HIS^? 9.20 MG MG A 302 A 89 ASP A 171 ASP^? 17.17 MG MG A 302 coo 49.66 36.74 42.37 48.88 35.30 43.64 34.91 23.57 39.32 34.35 24.95 40.81 coo 49.93 35.76 35.94 51.58 36.96 35.47 40.24 23.10 39.83 38.32 22.34 40.22 coo 46.15 35.33 47.12 47.46 33.99 46.29 29.78 23.67 36.63 28.48 25.11 35.71 ULMN 3 1dco_c00 DCOH user 3 3 # 3 A 62 HIS A 170 HIS^? 10.56 MG MG A 302 A 63 HIS A 147 HIS^? 9.20 MG MG A 302 A 89 ASP A 177 ASP^? 8.44 MG MG A 302 coo 49.66 36.74 42.37 48.88 35.30 43.64 34.91 23.57 39.32 34.35 24.95 40.81 coo 49.93 35.76 35.94 51.58 36.96 35.47 40.24 23.10 39.83 38.32 22.34 40.22 coo 46.15 35.33 47.12 47.46 33.99 46.29 33.02 29.04 43.18 33.79 27.88 44.78 ULMN 3 1dco_c00 DCOH user 4 3 # 4 A 62 HIS B 147 HIS^? 9.27 MG MG B 301 A 63 HIS B 170 HIS^? 10.51 MG MG B 301 A 89 ASP B 128 ASP^? -3.57 MG MG B 302s coo 49.66 36.74 42.37 48.88 35.30 43.64 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 49.93 35.76 35.94 51.58 36.96 35.47 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 46.15 35.33 47.12 47.46 33.99 46.29 52.92 24.09 -2.19 54.73 25.14 -1.90 ULMN 3 1dco_c00 DCOH user 5 3 # 5 A 62 HIS B 170 HIS^? 10.51 MG MG B 301 A 63 HIS B 147 HIS^? 9.27 MG MG B 301 A 89 ASP B 171 ASP^? 16.92 MG MG B 301 coo 49.66 36.74 42.37 48.88 35.30 43.64 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 49.93 35.76 35.94 51.58 36.96 35.47 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 46.15 35.33 47.12 47.46 33.99 46.29 45.30 8.50 -0.71 46.30 6.81 0.12 ULMN 3 1dco_c00 DCOH user 6 3 # 6 A 62 HIS B 170 HIS^? 10.51 MG MG B 301 A 63 HIS B 147 HIS^? 9.27 MG MG B 301 A 89 ASP B 177 ASP^? 9.03 MG MG B 301 coo 49.66 36.74 42.37 48.88 35.30 43.64 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 49.93 35.76 35.94 51.58 36.96 35.47 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 46.15 35.33 47.12 47.46 33.99 46.29 51.97 11.04 -6.64 50.39 11.62 -7.94 ULMN 3 1dco_c00 DCOH user 7 3 # 7 A 62 HIS C 147 HIS^? 9.44 MG MG C 301 A 63 HIS C 170 HIS^? 10.68 MG MG C 301 A 89 ASP C 128 ASP^? -3.22 MG MG C 302s coo 49.66 36.74 42.37 48.88 35.30 43.64 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 49.93 35.76 35.94 51.58 36.96 35.47 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 46.15 35.33 47.12 47.46 33.99 46.29 80.05 28.39 -4.25 77.97 28.60 -4.21 ULMN 3 1dco_c00 DCOH user 8 3 # 8 A 62 HIS C 170 HIS^? 10.68 MG MG C 301 A 63 HIS C 147 HIS^? 9.44 MG MG C 301 A 89 ASP C 171 ASP^? 17.08 MG MG C 301 coo 49.66 36.74 42.37 48.88 35.30 43.64 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 49.93 35.76 35.94 51.58 36.96 35.47 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 46.15 35.33 47.12 47.46 33.99 46.29 92.57 16.68 -6.24 92.24 14.74 -7.03 ULMN 3 1dco_c00 DCOH user 9 3 # 9 A 62 HIS C 170 HIS^? 10.68 MG MG C 301 A 63 HIS C 147 HIS^? 9.44 MG MG C 301 A 89 ASP C 177 ASP^? 8.84 MG MG C 301 coo 49.66 36.74 42.37 48.88 35.30 43.64 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 49.93 35.76 35.94 51.58 36.96 35.47 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 46.15 35.33 47.12 47.46 33.99 46.29 85.60 16.42 -0.31 86.51 17.71 1.09 ULMN 3 1dco_c00 DCOH user 10 3 # 10 A 62 HIS D 170 HIS^? 10.59 MG MG D 301 A 63 HIS D 147 HIS^? 9.43 MG MG D 301 A 89 ASP D 171 ASP^? 16.95 MG MG D 301 coo 49.66 36.74 42.37 48.88 35.30 43.64 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 49.93 35.76 35.94 51.58 36.96 35.47 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 46.15 35.33 47.12 47.46 33.99 46.29 100.39 36.69 -43.49 101.13 38.51 -42.69 ULMN 3 1dco_c00 DCOH user 11 3 # 11 A 62 HIS D 170 HIS^? 10.59 MG MG D 301 A 63 HIS D 147 HIS^? 9.43 MG MG D 301 A 89 ASP D 177 ASP^? 8.43 MG MG D 301 coo 49.66 36.74 42.37 48.88 35.30 43.64 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 49.93 35.76 35.94 51.58 36.96 35.47 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 46.15 35.33 47.12 47.46 33.99 46.29 95.74 41.01 -49.76 94.81 39.90 -51.24 ULMN 3 1dco_c00 DCOH user 12 3 # 12 A 62 HIS E 147 HIS^? 9.22 MG MG E 301 A 63 HIS E 170 HIS^? 10.33 MG MG E 301 A 89 ASP E 128 ASP^? -3.53 MG MG E 302s coo 49.66 36.74 42.37 48.88 35.30 43.64 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 49.93 35.76 35.94 51.58 36.96 35.47 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 46.15 35.33 47.12 47.46 33.99 46.29 65.38 56.57 -48.58 66.15 54.57 -48.61 ULMN 3 1dco_c00 DCOH user 13 3 # 13 A 62 HIS E 170 HIS^? 10.33 MG MG E 301 A 63 HIS E 147 HIS^? 9.22 MG MG E 301 A 89 ASP E 171 ASP^? 16.73 MG MG E 301 coo 49.66 36.74 42.37 48.88 35.30 43.64 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 49.93 35.76 35.94 51.58 36.96 35.47 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 46.15 35.33 47.12 47.46 33.99 46.29 69.61 73.12 -51.56 71.50 73.53 -52.39 ULMN 3 1dco_c00 DCOH user 14 3 # 14 A 62 HIS E 170 HIS^? 10.33 MG MG E 301 A 63 HIS E 147 HIS^? 9.22 MG MG E 301 A 89 ASP E 177 ASP^? 8.55 MG MG E 301 coo 49.66 36.74 42.37 48.88 35.30 43.64 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 49.93 35.76 35.94 51.58 36.96 35.47 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 46.15 35.33 47.12 47.46 33.99 46.29 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 1dco_c00 DCOH user 15 3 # 15 A 62 HIS F 147 HIS^? 8.79 MG MG F 302 A 63 HIS F 170 HIS^? 9.84 MG MG F 302 A 89 ASP F 128 ASP^? -3.41 MG MG F 301s coo 49.66 36.74 42.37 48.88 35.30 43.64 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 49.93 35.76 35.94 51.58 36.96 35.47 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 46.15 35.33 47.12 47.46 33.99 46.29 57.76 53.73 -90.50 57.46 51.64 -90.28 ULMN 3 1dco_c00 DCOH user 16 3 # 16 A 62 HIS F 170 HIS^? 9.84 MG MG F 302 A 63 HIS F 147 HIS^? 8.79 MG MG F 302 A 89 ASP F 171 ASP^? 16.35 MG MG F 302 coo 49.66 36.74 42.37 48.88 35.30 43.64 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 49.93 35.76 35.94 51.58 36.96 35.47 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 46.15 35.33 47.12 47.46 33.99 46.29 48.23 68.08 -88.47 46.26 68.02 -87.56 ULMN 3 1dco_c00 DCOH user 17 3 # 17 A 62 HIS F 170 HIS^? 9.84 MG MG F 302 A 63 HIS F 147 HIS^? 8.79 MG MG F 302 A 89 ASP F 177 ASP^? 8.15 MG MG F 302 coo 49.66 36.74 42.37 48.88 35.30 43.64 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 49.93 35.76 35.94 51.58 36.96 35.47 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 46.15 35.33 47.12 47.46 33.99 46.29 47.18 61.22 -94.50 48.48 62.32 -95.73 1dco_c00 source 1dco DCOH : 17 hits 1dco_c00 naa= 3 ULMN 3 1ddj_c12 PLASMINOGEN user 1 3 # 1 A 603 HIS A 147 HIS^? 9.20 MG MG A 302 A 646 ASP A 148 ASP^? 2.72 MG MG A 301s A 739 GLY A 176 GLY^? 13.62 MG MG A 302 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 40.24 23.10 39.83 38.32 22.34 40.22 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 41.50 28.88 41.13 43.33 29.67 41.93 coo 11.37 50.89 2.29 11.05 51.63 2.25 28.44 28.55 44.52 29.08 28.46 44.03 ULMN 3 1ddj_c12 PLASMINOGEN user 2 3 # 2 A 603 HIS B 147 HIS^? 9.27 MG MG B 301 A 646 ASP B 148 ASP^? 2.58 MG MG B 302s A 739 GLY B 176 GLY^? 13.46 MG MG B 301 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 11.37 50.89 2.29 11.05 51.63 2.25 50.45 6.82 -7.94 50.29 7.54 -7.72 ULMN 3 1ddj_c12 PLASMINOGEN user 3 3 # 3 A 603 HIS C 147 HIS^? 9.44 MG MG C 301 A 646 ASP C 148 ASP^? 2.75 MG MG C 302s A 739 GLY C 176 GLY^? 13.69 MG MG C 301 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 11.37 50.89 2.29 11.05 51.63 2.25 88.42 12.91 1.06 88.29 13.68 0.87 ULMN 3 1ddj_c12 PLASMINOGEN user 4 3 # 4 A 603 HIS C 147 HIS^? 9.44 MG MG C 301 A 646 ASP C 187 ASP^? -3.72 MG MG C 301s A 739 GLY C 176 GLY^? 13.69 MG MG C 301 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 84.01 23.73 3.39 83.47 22.54 1.59 coo 11.37 50.89 2.29 11.05 51.63 2.25 88.42 12.91 1.06 88.29 13.68 0.87 ULMN 3 1ddj_c12 PLASMINOGEN user 5 3 # 5 A 603 HIS D 147 HIS^? 9.43 MG MG D 301 A 646 ASP D 148 ASP^? 2.35 MG MG D 302s A 739 GLY D 176 GLY^? 13.91 MG MG D 301 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 11.37 50.89 2.29 11.05 51.63 2.25 99.98 41.95 -51.04 99.39 41.45 -50.84 ULMN 3 1ddj_c12 PLASMINOGEN user 6 3 # 6 A 603 HIS E 147 HIS^? 9.22 MG MG E 301 A 646 ASP E 148 ASP^? 2.62 MG MG E 302s A 739 GLY E 176 GLY^? 13.22 MG MG E 301 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 11.37 50.89 2.29 11.05 51.63 2.25 74.69 71.68 -44.17 74.06 71.19 -44.32 ULMN 3 1ddj_c12 PLASMINOGEN user 7 3 # 7 A 603 HIS F 147 HIS^? 8.79 MG MG F 302 A 646 ASP F 148 ASP^? 2.72 MG MG F 301s A 739 GLY F 176 GLY^? 12.78 MG MG F 302 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 11.37 50.89 2.29 11.05 51.63 2.25 43.85 64.48 -95.77 44.59 64.31 -95.63 1ddj_c12 source 1ddj PLASMINOGEN : 7 hits 1ddj_c12 naa= 3 ULMN 3 1ddj_c13 PLASMINOGEN user 1 3 # 1 B 603 HIS A 147 HIS^? 9.20 MG MG A 302 B 646 ASP A 148 ASP^? 2.72 MG MG A 301s B 739 GLY A 176 GLY^? 13.62 MG MG A 302 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 40.24 23.10 39.83 38.32 22.34 40.22 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 41.50 28.88 41.13 43.33 29.67 41.93 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 28.44 28.55 44.52 29.08 28.46 44.03 ULMN 3 1ddj_c13 PLASMINOGEN user 2 3 # 2 B 603 HIS A 170 HIS^? 10.56 MG MG A 302 B 646 ASP A 171 ASP^? 17.17 MG MG A 302 B 739 GLY A 145 GLY^? 13.39 MG MG A 302 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 34.91 23.57 39.32 34.35 24.95 40.81 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 29.78 23.67 36.63 28.48 25.11 35.71 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 44.20 17.56 40.29 44.09 17.33 41.06 ULMN 3 1ddj_c13 PLASMINOGEN user 3 3 # 3 B 603 HIS A 170 HIS^? 10.56 MG MG A 302 B 646 ASP A 177 ASP^? 8.44 MG MG A 302 B 739 GLY A 145 GLY^? 13.39 MG MG A 302 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 34.91 23.57 39.32 34.35 24.95 40.81 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 33.02 29.04 43.18 33.79 27.88 44.78 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 44.20 17.56 40.29 44.09 17.33 41.06 ULMN 3 1ddj_c13 PLASMINOGEN user 4 3 # 4 B 603 HIS B 147 HIS^? 9.27 MG MG B 301 B 646 ASP B 148 ASP^? 2.58 MG MG B 302s B 739 GLY B 176 GLY^? 13.46 MG MG B 301 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 46.73 18.97 -3.05 45.63 17.32 -3.73 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 52.73 19.23 -3.77 53.81 20.99 -4.31 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 50.45 6.82 -7.94 50.29 7.54 -7.72 ULMN 3 1ddj_c13 PLASMINOGEN user 5 3 # 5 B 603 HIS C 147 HIS^? 9.44 MG MG C 301 B 646 ASP C 148 ASP^? 2.75 MG MG C 302s B 739 GLY C 176 GLY^? 13.69 MG MG C 301 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 87.61 25.71 -3.59 89.22 24.50 -2.99 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 81.96 23.83 -2.68 80.24 25.11 -2.27 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 88.42 12.91 1.06 88.29 13.68 0.87 ULMN 3 1ddj_c13 PLASMINOGEN user 6 3 # 6 B 603 HIS C 170 HIS^? 10.68 MG MG C 301 B 646 ASP C 171 ASP^? 17.08 MG MG C 301 B 739 GLY C 145 GLY^? 13.72 MG MG C 301 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 89.96 21.05 -3.85 88.74 19.88 -2.61 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 92.57 16.68 -6.24 92.24 14.74 -7.03 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 90.12 32.13 -3.16 90.38 32.11 -2.40 ULMN 3 1ddj_c13 PLASMINOGEN user 7 3 # 7 B 603 HIS D 147 HIS^? 9.43 MG MG D 301 B 646 ASP D 148 ASP^? 2.35 MG MG D 302s B 739 GLY D 176 GLY^? 13.91 MG MG D 301 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 90.95 32.51 -46.42 92.98 32.42 -46.93 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 87.78 37.50 -47.56 85.79 37.49 -48.28 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 99.98 41.95 -51.04 99.39 41.45 -50.84 ULMN 3 1ddj_c13 PLASMINOGEN user 8 3 # 8 B 603 HIS E 147 HIS^? 9.22 MG MG E 301 B 646 ASP E 148 ASP^? 2.62 MG MG E 302s B 739 GLY E 176 GLY^? 13.22 MG MG E 301 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 63.87 64.43 -48.39 64.18 66.45 -47.92 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 68.29 60.44 -47.29 68.03 58.42 -46.50 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 74.69 71.68 -44.17 74.06 71.19 -44.32 ULMN 3 1ddj_c13 PLASMINOGEN user 9 3 # 9 B 603 HIS E 170 HIS^? 10.33 MG MG E 301 B 646 ASP E 171 ASP^? 16.73 MG MG E 301 B 739 GLY E 145 GLY^? 13.69 MG MG E 301 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 66.96 68.76 -48.87 68.36 68.54 -47.33 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 69.61 73.12 -51.56 71.50 73.53 -52.39 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 57.08 63.68 -47.92 56.95 63.88 -47.12 ULMN 3 1ddj_c13 PLASMINOGEN user 10 3 # 10 B 603 HIS E 170 HIS^? 10.33 MG MG E 301 B 646 ASP E 177 ASP^? 8.55 MG MG E 301 B 739 GLY E 145 GLY^? 13.69 MG MG E 301 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 66.96 68.76 -48.87 68.36 68.54 -47.33 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 72.81 67.32 -45.03 71.14 67.96 -43.95 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 57.08 63.68 -47.92 56.95 63.88 -47.12 ULMN 3 1ddj_c13 PLASMINOGEN user 11 3 # 11 B 603 HIS F 147 HIS^? 8.79 MG MG F 302 B 646 ASP F 148 ASP^? 2.72 MG MG F 301s B 739 GLY F 176 GLY^? 12.78 MG MG F 302 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 56.63 61.66 -91.16 55.69 63.43 -91.80 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 53.64 56.47 -91.98 54.61 54.68 -92.64 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 43.85 64.48 -95.77 44.59 64.31 -95.63 ULMN 3 1ddj_c13 PLASMINOGEN user 12 3 # 12 B 603 HIS F 170 HIS^? 9.84 MG MG F 302 B 646 ASP F 171 ASP^? 16.35 MG MG F 302 B 739 GLY F 145 GLY^? 13.40 MG MG F 302 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 52.25 64.82 -90.91 50.95 63.88 -92.26 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 48.23 68.08 -88.47 46.26 68.02 -87.56 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 63.24 63.21 -91.82 63.24 63.42 -92.59 ULMN 3 1ddj_c13 PLASMINOGEN user 13 3 # 13 B 603 HIS F 170 HIS^? 9.84 MG MG F 302 B 646 ASP F 177 ASP^? 8.15 MG MG F 302 B 739 GLY F 145 GLY^? 13.40 MG MG F 302 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 52.25 64.82 -90.91 50.95 63.88 -92.26 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 47.18 61.22 -94.50 48.48 62.32 -95.73 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 63.24 63.21 -91.82 63.24 63.42 -92.59 1ddj_c13 source 1ddj PLASMINOGEN : 13 hits 1ddj_c13 naa= 3 ULMN 3 1ddj_c14 PLASMINOGEN user 1 3 # 1 C 603 HIS A 147 HIS^? 9.20 MG MG A 302 C 646 ASP A 148 ASP^? 2.72 MG MG A 301s C 739 GLY A 176 GLY^? 13.62 MG MG A 302 coo 15.33 59.81 59.60 13.98 60.99 60.69 40.24 23.10 39.83 38.32 22.34 40.22 coo 16.06 55.72 54.73 15.97 56.49 56.70 41.50 28.88 41.13 43.33 29.67 41.93 coo 9.38 49.29 65.28 9.01 50.03 65.31 28.44 28.55 44.52 29.08 28.46 44.03 ULMN 3 1ddj_c14 PLASMINOGEN user 2 3 # 2 C 603 HIS A 170 HIS^? 10.56 MG MG A 302 C 646 ASP A 177 ASP^? 8.44 MG MG A 302 C 739 GLY A 184 GLY^? 4.07 MG MG A 302 coo 15.33 59.81 59.60 13.98 60.99 60.69 34.91 23.57 39.32 34.35 24.95 40.81 coo 16.06 55.72 54.73 15.97 56.49 56.70 33.02 29.04 43.18 33.79 27.88 44.78 coo 9.38 49.29 65.28 9.01 50.03 65.31 44.11 32.36 47.58 44.42 32.35 46.80 ULMN 3 1ddj_c14 PLASMINOGEN user 3 3 # 3 C 603 HIS B 147 HIS^? 9.27 MG MG B 301 C 646 ASP B 148 ASP^? 2.58 MG MG B 302s C 739 GLY B 176 GLY^? 13.46 MG MG B 301 coo 15.33 59.81 59.60 13.98 60.99 60.69 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 16.06 55.72 54.73 15.97 56.49 56.70 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 9.38 49.29 65.28 9.01 50.03 65.31 50.45 6.82 -7.94 50.29 7.54 -7.72 ULMN 3 1ddj_c14 PLASMINOGEN user 4 3 # 4 C 603 HIS C 147 HIS^? 9.44 MG MG C 301 C 646 ASP C 148 ASP^? 2.75 MG MG C 302s C 739 GLY C 176 GLY^? 13.69 MG MG C 301 coo 15.33 59.81 59.60 13.98 60.99 60.69 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 16.06 55.72 54.73 15.97 56.49 56.70 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 9.38 49.29 65.28 9.01 50.03 65.31 88.42 12.91 1.06 88.29 13.68 0.87 ULMN 3 1ddj_c14 PLASMINOGEN user 5 3 # 5 C 603 HIS D 147 HIS^? 9.43 MG MG D 301 C 646 ASP D 148 ASP^? 2.35 MG MG D 302s C 739 GLY D 176 GLY^? 13.91 MG MG D 301 coo 15.33 59.81 59.60 13.98 60.99 60.69 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 16.06 55.72 54.73 15.97 56.49 56.70 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 9.38 49.29 65.28 9.01 50.03 65.31 99.98 41.95 -51.04 99.39 41.45 -50.84 ULMN 3 1ddj_c14 PLASMINOGEN user 6 3 # 6 C 603 HIS D 170 HIS^? 10.59 MG MG D 301 C 646 ASP D 177 ASP^? 8.43 MG MG D 301 C 739 GLY D 184 GLY^? 4.28 MG MG D 301 coo 15.33 59.81 59.60 13.98 60.99 60.69 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 16.06 55.72 54.73 15.97 56.49 56.70 95.74 41.01 -49.76 94.81 39.90 -51.24 coo 9.38 49.29 65.28 9.01 50.03 65.31 83.33 40.04 -53.77 83.20 39.83 -52.97 ULMN 3 1ddj_c14 PLASMINOGEN user 7 3 # 7 C 603 HIS E 147 HIS^? 9.22 MG MG E 301 C 646 ASP E 148 ASP^? 2.62 MG MG E 302s C 739 GLY E 176 GLY^? 13.22 MG MG E 301 coo 15.33 59.81 59.60 13.98 60.99 60.69 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 16.06 55.72 54.73 15.97 56.49 56.70 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 9.38 49.29 65.28 9.01 50.03 65.31 74.69 71.68 -44.17 74.06 71.19 -44.32 ULMN 3 1ddj_c14 PLASMINOGEN user 8 3 # 8 C 603 HIS F 147 HIS^? 8.79 MG MG F 302 C 646 ASP F 148 ASP^? 2.72 MG MG F 301s C 739 GLY F 176 GLY^? 12.78 MG MG F 302 coo 15.33 59.81 59.60 13.98 60.99 60.69 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 16.06 55.72 54.73 15.97 56.49 56.70 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 9.38 49.29 65.28 9.01 50.03 65.31 43.85 64.48 -95.77 44.59 64.31 -95.63 1ddj_c14 source 1ddj PLASMINOGEN : 8 hits 1ddj_c14 naa= 3 ULMN 3 1ddj_c15 PLASMINOGEN user 1 3 # 1 D 603 HIS A 147 HIS^? 9.20 MG MG A 302 D 646 ASP A 148 ASP^? 2.72 MG MG A 301s D 739 GLY A 176 GLY^? 13.62 MG MG A 302 coo -30.51 33.83 43.05 -30.50 33.12 45.03 40.24 23.10 39.83 38.32 22.34 40.22 coo -25.73 33.05 39.28 -27.50 34.05 39.88 41.50 28.88 41.13 43.33 29.67 41.93 coo -27.66 47.32 40.66 -27.81 47.01 41.41 28.44 28.55 44.52 29.08 28.46 44.03 ULMN 3 1ddj_c15 PLASMINOGEN user 2 3 # 2 D 603 HIS B 147 HIS^? 9.27 MG MG B 301 D 646 ASP B 148 ASP^? 2.58 MG MG B 302s D 739 GLY B 176 GLY^? 13.46 MG MG B 301 coo -30.51 33.83 43.05 -30.50 33.12 45.03 46.73 18.97 -3.05 45.63 17.32 -3.73 coo -25.73 33.05 39.28 -27.50 34.05 39.88 52.73 19.23 -3.77 53.81 20.99 -4.31 coo -27.66 47.32 40.66 -27.81 47.01 41.41 50.45 6.82 -7.94 50.29 7.54 -7.72 ULMN 3 1ddj_c15 PLASMINOGEN user 3 3 # 3 D 603 HIS B 170 HIS^? 10.51 MG MG B 301 D 646 ASP B 177 ASP^? 9.03 MG MG B 301 D 739 GLY B 184 GLY^? 4.47 MG MG B 301 coo -30.51 33.83 43.05 -30.50 33.12 45.03 46.22 13.75 -2.72 47.53 13.11 -4.24 coo -25.73 33.05 39.28 -27.50 34.05 39.88 51.97 11.04 -6.64 50.39 11.62 -7.94 coo -27.66 47.32 40.66 -27.81 47.01 41.41 57.32 22.02 -9.75 57.17 22.15 -8.93 ULMN 3 1ddj_c15 PLASMINOGEN user 4 3 # 4 D 603 HIS C 147 HIS^? 9.44 MG MG C 301 D 646 ASP C 148 ASP^? 2.75 MG MG C 302s D 739 GLY C 176 GLY^? 13.69 MG MG C 301 coo -30.51 33.83 43.05 -30.50 33.12 45.03 87.61 25.71 -3.59 89.22 24.50 -2.99 coo -25.73 33.05 39.28 -27.50 34.05 39.88 81.96 23.83 -2.68 80.24 25.11 -2.27 coo -27.66 47.32 40.66 -27.81 47.01 41.41 88.42 12.91 1.06 88.29 13.68 0.87 ULMN 3 1ddj_c15 PLASMINOGEN user 5 3 # 5 D 603 HIS C 170 HIS^? 10.68 MG MG C 301 D 646 ASP C 177 ASP^? 8.84 MG MG C 301 D 739 GLY C 184 GLY^? 4.50 MG MG C 301 coo -30.51 33.83 43.05 -30.50 33.12 45.03 89.96 21.05 -3.85 88.74 19.88 -2.61 coo -25.73 33.05 39.28 -27.50 34.05 39.88 85.60 16.42 -0.31 86.51 17.71 1.09 coo -27.66 47.32 40.66 -27.81 47.01 41.41 76.47 24.88 3.34 76.71 25.04 2.53 ULMN 3 1ddj_c15 PLASMINOGEN user 6 3 # 6 D 603 HIS D 147 HIS^? 9.43 MG MG D 301 D 646 ASP D 148 ASP^? 2.35 MG MG D 302s D 739 GLY D 176 GLY^? 13.91 MG MG D 301 coo -30.51 33.83 43.05 -30.50 33.12 45.03 90.95 32.51 -46.42 92.98 32.42 -46.93 coo -25.73 33.05 39.28 -27.50 34.05 39.88 87.78 37.50 -47.56 85.79 37.49 -48.28 coo -27.66 47.32 40.66 -27.81 47.01 41.41 99.98 41.95 -51.04 99.39 41.45 -50.84 ULMN 3 1ddj_c15 PLASMINOGEN user 7 3 # 7 D 603 HIS D 170 HIS^? 10.59 MG MG D 301 D 646 ASP D 177 ASP^? 8.43 MG MG D 301 D 739 GLY D 184 GLY^? 4.28 MG MG D 301 coo -30.51 33.83 43.05 -30.50 33.12 45.03 95.57 34.81 -46.05 95.59 36.24 -47.59 coo -25.73 33.05 39.28 -27.50 34.05 39.88 95.74 41.01 -49.76 94.81 39.90 -51.24 coo -27.66 47.32 40.66 -27.81 47.01 41.41 83.33 40.04 -53.77 83.20 39.83 -52.97 ULMN 3 1ddj_c15 PLASMINOGEN user 8 3 # 8 D 603 HIS E 147 HIS^? 9.22 MG MG E 301 D 646 ASP E 148 ASP^? 2.62 MG MG E 302s D 739 GLY E 176 GLY^? 13.22 MG MG E 301 coo -30.51 33.83 43.05 -30.50 33.12 45.03 63.87 64.43 -48.39 64.18 66.45 -47.92 coo -25.73 33.05 39.28 -27.50 34.05 39.88 68.29 60.44 -47.29 68.03 58.42 -46.50 coo -27.66 47.32 40.66 -27.81 47.01 41.41 74.69 71.68 -44.17 74.06 71.19 -44.32 ULMN 3 1ddj_c15 PLASMINOGEN user 9 3 # 9 D 603 HIS E 170 HIS^? 10.33 MG MG E 301 D 646 ASP E 177 ASP^? 8.55 MG MG E 301 D 739 GLY E 184 GLY^? 4.85 MG MG E 301 coo -30.51 33.83 43.05 -30.50 33.12 45.03 66.96 68.76 -48.87 68.36 68.54 -47.33 coo -25.73 33.05 39.28 -27.50 34.05 39.88 72.81 67.32 -45.03 71.14 67.96 -43.95 coo -27.66 47.32 40.66 -27.81 47.01 41.41 69.91 55.36 -41.13 69.77 55.58 -41.87 ULMN 3 1ddj_c15 PLASMINOGEN user 10 3 # 10 D 603 HIS F 147 HIS^? 8.79 MG MG F 302 D 646 ASP F 148 ASP^? 2.72 MG MG F 301s D 739 GLY F 176 GLY^? 12.78 MG MG F 302 coo -30.51 33.83 43.05 -30.50 33.12 45.03 56.63 61.66 -91.16 55.69 63.43 -91.80 coo -25.73 33.05 39.28 -27.50 34.05 39.88 53.64 56.47 -91.98 54.61 54.68 -92.64 coo -27.66 47.32 40.66 -27.81 47.01 41.41 43.85 64.48 -95.77 44.59 64.31 -95.63 1ddj_c15 source 1ddj PLASMINOGEN : 10 hits 1ddj_c15 naa= 3 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 57 GLU A 19 GLU.? 16.46 MG MG A 302 A 226 THR A 169 THR^? 18.45 MG MG A 302 A 229 LYS A 166 LYS^? 20.93 MG MG A 302 coo 9.66 102.78 70.07 9.79 101.18 71.42 29.75 40.22 38.71 30.73 40.87 40.56 coo 7.24 97.46 49.60 8.11 95.69 48.80 34.64 19.08 35.13 33.08 18.40 33.78 coo 10.53 97.56 43.71 9.33 93.71 47.17 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 A 57 GLU A 25 GLU^? 25.87 MG MG A 301 A 226 THR A 73 THR^? 15.13 MG MG A 301 A 229 LYS A 90 LYS^? 18.58 MG MG A 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 39.62 57.50 39.92 41.51 57.27 40.85 coo 7.24 97.46 49.60 8.11 95.69 48.80 40.93 39.17 26.72 41.99 38.78 28.61 coo 10.53 97.56 43.71 9.33 93.71 47.17 46.62 38.29 25.46 47.51 33.29 23.22 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 A 57 GLU A 25 GLU^? 25.87 MG MG A 301 A 226 THR A 74 THR^? 21.85 MG MG A 301 A 229 LYS A 90 LYS^? 18.58 MG MG A 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 39.62 57.50 39.92 41.51 57.27 40.85 coo 7.24 97.46 49.60 8.11 95.69 48.80 38.65 41.92 25.57 37.60 41.76 23.73 coo 10.53 97.56 43.71 9.33 93.71 47.17 46.62 38.29 25.46 47.51 33.29 23.22 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 A 57 GLU A 25 GLU^? 25.87 MG MG A 301 A 226 THR A 88 THR^? 23.22 MG MG A 301 A 229 LYS A 90 LYS^? 18.58 MG MG A 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 39.62 57.50 39.92 41.51 57.27 40.85 coo 7.24 97.46 49.60 8.11 95.69 48.80 42.44 43.75 23.46 42.54 42.92 21.44 coo 10.53 97.56 43.71 9.33 93.71 47.17 46.62 38.29 25.46 47.51 33.29 23.22 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 A 57 GLU A 33 GLU^? 22.87 MG MG A 301 A 226 THR A 169 THR^? 18.45 MG MG A 302 A 229 LYS A 166 LYS^? 20.93 MG MG A 302 coo 9.66 102.78 70.07 9.79 101.18 71.42 33.74 38.67 24.96 34.13 38.85 22.87 coo 7.24 97.46 49.60 8.11 95.69 48.80 34.64 19.08 35.13 33.08 18.40 33.78 coo 10.53 97.56 43.71 9.33 93.71 47.17 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 A 57 GLU A 38 GLU^? 21.81 MG MG A 302 A 226 THR A 74 THR^? 21.85 MG MG A 301 A 229 LYS A 86 LYS^? 26.38 MG MG A 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 26.42 25.01 28.02 26.98 25.90 29.89 coo 7.24 97.46 49.60 8.11 95.69 48.80 38.65 41.92 25.57 37.60 41.76 23.73 coo 10.53 97.56 43.71 9.33 93.71 47.17 37.08 47.78 23.56 32.88 44.24 21.89 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 A 57 GLU A 54 GLU^? 22.98 MG MG A 301 A 226 THR A 74 THR^? 21.85 MG MG A 301 A 229 LYS A 76 LYS^? 25.42 MG MG A 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 45.06 19.97 24.02 44.05 19.39 22.19 coo 7.24 97.46 49.60 8.11 95.69 48.80 38.65 41.92 25.57 37.60 41.76 23.73 coo 10.53 97.56 43.71 9.33 93.71 47.17 34.45 46.53 27.28 28.88 44.93 27.25 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 A 57 GLU A 75 GLU^? 20.23 MG MG A 301 A 226 THR A 46 THR^? 24.24 MG MG A 301 A 229 LYS B 6 LYS^? 25.90 MG MG B 302 coo 9.66 102.78 70.07 9.79 101.18 71.42 38.99 46.65 28.68 39.94 47.65 30.33 coo 7.24 97.46 49.60 8.11 95.69 48.80 38.63 28.11 18.80 36.62 27.50 19.27 coo 10.53 97.56 43.71 9.33 93.71 47.17 36.26 25.44 11.74 39.65 23.12 16.29 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 A 57 GLU A 94 GLU^? 17.31 MG MG A 301 A 226 THR A 46 THR^? 24.24 MG MG A 301 A 229 LYS B 6 LYS^? 25.90 MG MG B 302 coo 9.66 102.78 70.07 9.79 101.18 71.42 57.11 32.79 29.92 57.45 34.91 29.85 coo 7.24 97.46 49.60 8.11 95.69 48.80 38.63 28.11 18.80 36.62 27.50 19.27 coo 10.53 97.56 43.71 9.33 93.71 47.17 36.26 25.44 11.74 39.65 23.12 16.29 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 A 57 GLU A 94 GLU^? 17.31 MG MG A 301 A 226 THR A 74 THR^? 21.85 MG MG A 301 A 229 LYS A 76 LYS^? 25.42 MG MG A 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 57.11 32.79 29.92 57.45 34.91 29.85 coo 7.24 97.46 49.60 8.11 95.69 48.80 38.65 41.92 25.57 37.60 41.76 23.73 coo 10.53 97.56 43.71 9.33 93.71 47.17 34.45 46.53 27.28 28.88 44.93 27.25 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 A 57 GLU A 94 GLU^? 17.31 MG MG A 301 A 226 THR A 74 THR^? 21.85 MG MG A 301 A 229 LYS A 86 LYS^? 26.38 MG MG A 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 57.11 32.79 29.92 57.45 34.91 29.85 coo 7.24 97.46 49.60 8.11 95.69 48.80 38.65 41.92 25.57 37.60 41.76 23.73 coo 10.53 97.56 43.71 9.33 93.71 47.17 37.08 47.78 23.56 32.88 44.24 21.89 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 A 57 GLU A 94 GLU^? 17.31 MG MG A 301 A 226 THR A 88 THR^? 23.22 MG MG A 301 A 229 LYS A 86 LYS^? 26.38 MG MG A 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 57.11 32.79 29.92 57.45 34.91 29.85 coo 7.24 97.46 49.60 8.11 95.69 48.80 42.44 43.75 23.46 42.54 42.92 21.44 coo 10.53 97.56 43.71 9.33 93.71 47.17 37.08 47.78 23.56 32.88 44.24 21.89 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 A 57 GLU A 146 GLU^? 9.80 MG MG A 302 A 226 THR A 70 THR^? 14.66 MG MG A 301 A 229 LYS A 90 LYS^? 18.58 MG MG A 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 45.17 20.35 44.20 46.68 21.21 45.40 coo 7.24 97.46 49.60 8.11 95.69 48.80 45.68 31.52 26.25 47.33 32.60 27.12 coo 10.53 97.56 43.71 9.33 93.71 47.17 46.62 38.29 25.46 47.51 33.29 23.22 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 14 3 # 14 A 57 GLU A 154 GLU^? 19.22 MG MG A 301 A 226 THR A 74 THR^? 21.85 MG MG A 301 A 229 LYS A 86 LYS^? 26.38 MG MG A 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 36.54 21.95 29.78 35.14 22.21 28.17 coo 7.24 97.46 49.60 8.11 95.69 48.80 38.65 41.92 25.57 37.60 41.76 23.73 coo 10.53 97.56 43.71 9.33 93.71 47.17 37.08 47.78 23.56 32.88 44.24 21.89 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 15 3 # 15 A 57 GLU A 154 GLU^? 19.22 MG MG A 301 A 226 THR B 2 THR^? 34.11 MG MG B 302 A 229 LYS B 137 LYS^? 34.56 MG MG B 302 coo 9.66 102.78 70.07 9.79 101.18 71.42 36.54 21.95 29.78 35.14 22.21 28.17 coo 7.24 97.46 49.60 8.11 95.69 48.80 25.51 29.18 13.74 26.24 28.19 11.93 coo 10.53 97.56 43.71 9.33 93.71 47.17 26.56 32.46 7.93 27.87 37.71 9.31 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 16 3 # 16 A 57 GLU B 19 GLU^? 18.96 MG MG B 301 A 226 THR B 169 THR^? 18.43 MG MG B 301 A 229 LYS B 166 LYS^? 22.75 MG MG B 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 59.29 4.54 -0.16 58.81 2.51 -0.44 coo 7.24 97.46 49.60 8.11 95.69 48.80 41.38 13.97 0.97 40.27 12.43 2.02 coo 10.53 97.56 43.71 9.33 93.71 47.17 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 17 3 # 17 A 57 GLU B 25 GLU^? 12.88 MG MG C 301 A 226 THR B 74 THR^? 21.68 MG MG B 302 A 229 LYS B 90 LYS^? 18.68 MG MG B 302 coo 9.66 102.78 70.07 9.79 101.18 71.42 79.57 9.59 -3.08 79.20 11.68 -3.64 coo 7.24 97.46 49.60 8.11 95.69 48.80 63.99 13.20 11.95 63.36 12.32 13.84 coo 10.53 97.56 43.71 9.33 93.71 47.17 61.66 21.61 12.88 56.74 22.88 14.81 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 18 3 # 18 A 57 GLU B 25 GLU^? 12.88 MG MG C 301 A 226 THR B 88 THR^? 22.44 MG MG C 301 A 229 LYS B 90 LYS^? 18.68 MG MG B 302 coo 9.66 102.78 70.07 9.79 101.18 71.42 79.57 9.59 -3.08 79.20 11.68 -3.64 coo 7.24 97.46 49.60 8.11 95.69 48.80 66.42 16.42 14.22 65.45 16.28 16.18 coo 10.53 97.56 43.71 9.33 93.71 47.17 61.66 21.61 12.88 56.74 22.88 14.81 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 19 3 # 19 A 57 GLU B 25 GLU^? 12.88 MG MG C 301 A 226 THR C 169 THR^? 18.51 MG MG C 301 A 229 LYS C 166 LYS^? 22.53 MG MG C 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 79.57 9.59 -3.08 79.20 11.68 -3.64 coo 7.24 97.46 49.60 8.11 95.69 48.80 94.19 23.02 -7.83 95.56 21.86 -9.07 coo 10.53 97.56 43.71 9.33 93.71 47.17 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 20 3 # 20 A 57 GLU B 33 GLU^? 22.65 MG MG B 302 A 226 THR B 169 THR^? 18.43 MG MG B 301 A 229 LYS B 166 LYS^? 22.75 MG MG B 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 59.88 9.09 12.22 59.91 9.49 14.33 coo 7.24 97.46 49.60 8.11 95.69 48.80 41.38 13.97 0.97 40.27 12.43 2.02 coo 10.53 97.56 43.71 9.33 93.71 47.17 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 21 3 # 21 A 57 GLU B 38 GLU^? 21.75 MG MG B 301 A 226 THR B 74 THR^? 21.68 MG MG B 302 A 229 LYS B 86 LYS^? 26.44 MG MG B 302 coo 9.66 102.78 70.07 9.79 101.18 71.42 44.79 4.95 7.12 46.66 4.47 6.21 coo 7.24 97.46 49.60 8.11 95.69 48.80 63.99 13.20 11.95 63.36 12.32 13.84 coo 10.53 97.56 43.71 9.33 93.71 47.17 69.25 10.45 13.86 65.27 7.74 16.08 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 22 3 # 22 A 57 GLU B 52 GLU^? 20.06 MG MG B 302 A 226 THR B 18 THR^? 16.08 MG MG B 302 A 229 LYS B 21 LYS^? 13.97 MG MG B 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 47.87 20.25 12.36 48.11 19.69 14.43 coo 7.24 97.46 49.60 8.11 95.69 48.80 60.02 7.32 3.97 60.86 9.29 4.05 coo 10.53 97.56 43.71 9.33 93.71 47.17 67.50 6.37 -0.39 64.53 11.03 -2.88 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 23 3 # 23 A 57 GLU B 54 GLU^? 22.94 MG MG B 302 A 226 THR A 74 THR^? 21.85 MG MG A 301 A 229 LYS A 76 LYS^? 25.42 MG MG A 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 43.18 23.27 12.99 42.40 22.23 14.68 coo 7.24 97.46 49.60 8.11 95.69 48.80 38.65 41.92 25.57 37.60 41.76 23.73 coo 10.53 97.56 43.71 9.33 93.71 47.17 34.45 46.53 27.28 28.88 44.93 27.25 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 24 3 # 24 A 57 GLU B 54 GLU^? 22.94 MG MG B 302 A 226 THR A 74 THR^? 21.85 MG MG A 301 A 229 LYS A 86 LYS^? 26.38 MG MG A 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 43.18 23.27 12.99 42.40 22.23 14.68 coo 7.24 97.46 49.60 8.11 95.69 48.80 38.65 41.92 25.57 37.60 41.76 23.73 coo 10.53 97.56 43.71 9.33 93.71 47.17 37.08 47.78 23.56 32.88 44.24 21.89 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 25 3 # 25 A 57 GLU B 54 GLU^? 22.94 MG MG B 302 A 226 THR A 88 THR^? 23.22 MG MG A 301 A 229 LYS A 86 LYS^? 26.38 MG MG A 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 43.18 23.27 12.99 42.40 22.23 14.68 coo 7.24 97.46 49.60 8.11 95.69 48.80 42.44 43.75 23.46 42.54 42.92 21.44 coo 10.53 97.56 43.71 9.33 93.71 47.17 37.08 47.78 23.56 32.88 44.24 21.89 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 26 3 # 26 A 57 GLU B 75 GLU^? 15.82 MG MG C 301 A 226 THR B 46 THR^? 23.88 MG MG B 302 A 229 LYS A 6 LYS^? 25.88 MG MG A 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 68.81 12.14 8.61 69.95 13.49 7.45 coo 7.24 97.46 49.60 8.11 95.69 48.80 49.71 15.16 18.13 48.80 13.51 17.14 coo 10.53 97.56 43.71 9.33 93.71 47.17 46.20 12.82 24.71 44.50 16.64 20.52 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 27 3 # 27 A 57 GLU B 94 GLU^? 15.34 MG MG B 302 A 226 THR B 46 THR^? 23.88 MG MG B 302 A 229 LYS A 6 LYS^? 25.88 MG MG A 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 58.44 31.30 7.43 60.35 32.14 7.14 coo 7.24 97.46 49.60 8.11 95.69 48.80 49.71 15.16 18.13 48.80 13.51 17.14 coo 10.53 97.56 43.71 9.33 93.71 47.17 46.20 12.82 24.71 44.50 16.64 20.52 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 28 3 # 28 A 57 GLU B 94 GLU^? 15.34 MG MG B 302 A 226 THR B 74 THR^? 21.68 MG MG B 302 A 229 LYS B 76 LYS^? 25.77 MG MG B 302 coo 9.66 102.78 70.07 9.79 101.18 71.42 58.44 31.30 7.43 60.35 32.14 7.14 coo 7.24 97.46 49.60 8.11 95.69 48.80 63.99 13.20 11.95 63.36 12.32 13.84 coo 10.53 97.56 43.71 9.33 93.71 47.17 67.82 8.19 10.14 64.96 3.09 10.62 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 29 3 # 29 A 57 GLU B 146 GLU^? 10.54 MG MG B 301 A 226 THR B 70 THR^? 14.69 MG MG B 302 A 229 LYS B 90 LYS^? 18.68 MG MG B 302 coo 9.66 102.78 70.07 9.79 101.18 71.42 45.13 24.51 -7.01 46.08 25.99 -8.13 coo 7.24 97.46 49.60 8.11 95.69 48.80 54.82 21.76 11.59 56.34 23.17 10.82 coo 10.53 97.56 43.71 9.33 93.71 47.17 61.66 21.61 12.88 56.74 22.88 14.81 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 30 3 # 30 A 57 GLU B 154 GLU^? 19.05 MG MG B 302 A 226 THR A 2 THR.? 34.64 MG MG A 301 A 229 LYS A 137 LYS^? 34.85 MG MG A 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 44.04 15.11 6.74 44.19 13.59 8.30 coo 7.24 97.46 49.60 8.11 95.69 48.80 47.80 1.72 22.09 46.70 1.88 23.97 coo 10.53 97.56 43.71 9.33 93.71 47.17 50.97 1.58 28.14 56.13 1.49 28.03 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 31 3 # 31 A 57 GLU B 154 GLU^? 19.05 MG MG B 302 A 226 THR B 74 THR^? 21.68 MG MG B 302 A 229 LYS B 76 LYS^? 25.77 MG MG B 302 coo 9.66 102.78 70.07 9.79 101.18 71.42 44.04 15.11 6.74 44.19 13.59 8.30 coo 7.24 97.46 49.60 8.11 95.69 48.80 63.99 13.20 11.95 63.36 12.32 13.84 coo 10.53 97.56 43.71 9.33 93.71 47.17 67.82 8.19 10.14 64.96 3.09 10.62 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 32 3 # 32 A 57 GLU B 154 GLU^? 19.05 MG MG B 302 A 226 THR B 74 THR^? 21.68 MG MG B 302 A 229 LYS B 86 LYS^? 26.44 MG MG B 302 coo 9.66 102.78 70.07 9.79 101.18 71.42 44.04 15.11 6.74 44.19 13.59 8.30 coo 7.24 97.46 49.60 8.11 95.69 48.80 63.99 13.20 11.95 63.36 12.32 13.84 coo 10.53 97.56 43.71 9.33 93.71 47.17 69.25 10.45 13.86 65.27 7.74 16.08 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 33 3 # 33 A 57 GLU C 19 GLU^? 19.08 MG MG C 301 A 226 THR C 169 THR^? 18.51 MG MG C 301 A 229 LYS C 166 LYS^? 22.53 MG MG C 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 80.46 7.67 -6.81 81.43 5.97 -5.99 coo 7.24 97.46 49.60 8.11 95.69 48.80 94.19 23.02 -7.83 95.56 21.86 -9.07 coo 10.53 97.56 43.71 9.33 93.71 47.17 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 34 3 # 34 A 57 GLU C 25 GLU^? 12.27 MG MG B 301 A 226 THR C 74 THR^? 21.64 MG MG C 302 A 229 LYS C 90 LYS^? 18.24 MG MG C 302 coo 9.66 102.78 70.07 9.79 101.18 71.42 58.50 6.48 -3.59 57.94 8.54 -3.41 coo 7.24 97.46 49.60 8.11 95.69 48.80 73.35 14.53 -18.47 73.89 13.78 -20.47 coo 10.53 97.56 43.71 9.33 93.71 47.17 72.37 23.25 -18.94 76.11 26.52 -20.97 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 35 3 # 35 A 57 GLU C 25 GLU^? 12.27 MG MG B 301 A 226 THR C 88 THR^? 22.58 MG MG B 301 A 229 LYS C 90 LYS^? 18.24 MG MG C 302 coo 9.66 102.78 70.07 9.79 101.18 71.42 58.50 6.48 -3.59 57.94 8.54 -3.41 coo 7.24 97.46 49.60 8.11 95.69 48.80 69.96 16.71 -20.56 70.75 16.33 -22.54 coo 10.53 97.56 43.71 9.33 93.71 47.17 72.37 23.25 -18.94 76.11 26.52 -20.97 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 36 3 # 36 A 57 GLU C 33 GLU^? 22.71 MG MG C 302 A 226 THR C 169 THR^? 18.51 MG MG C 301 A 229 LYS C 166 LYS^? 22.53 MG MG C 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 78.39 11.67 -18.82 78.34 12.01 -20.91 coo 7.24 97.46 49.60 8.11 95.69 48.80 94.19 23.02 -7.83 95.56 21.86 -9.07 coo 10.53 97.56 43.71 9.33 93.71 47.17 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 37 3 # 37 A 57 GLU C 38 GLU^? 21.99 MG MG C 301 A 226 THR C 74 THR^? 21.64 MG MG C 302 A 229 LYS C 86 LYS^? 27.34 MG MG C 302 coo 9.66 102.78 70.07 9.79 101.18 71.42 93.66 12.78 -15.08 92.73 12.51 -13.19 coo 7.24 97.46 49.60 8.11 95.69 48.80 73.35 14.53 -18.47 73.89 13.78 -20.47 coo 10.53 97.56 43.71 9.33 93.71 47.17 69.22 9.88 -20.56 74.70 7.02 -22.55 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 38 3 # 38 A 57 GLU C 54 GLU^? 22.77 MG MG C 302 A 226 THR D 74 THR^? 21.71 MG MG D 302 A 229 LYS D 86 LYS^? 25.80 MG MG D 302 coo 9.66 102.78 70.07 9.79 101.18 71.42 88.91 31.25 -19.52 89.97 30.69 -21.29 coo 7.24 97.46 49.60 8.11 95.69 48.80 86.03 50.57 -32.19 86.96 50.83 -30.24 coo 10.53 97.56 43.71 9.33 93.71 47.17 85.54 56.79 -30.27 90.24 54.54 -28.62 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 39 3 # 39 A 57 GLU C 75 GLU^? 16.14 MG MG B 301 A 226 THR C 46 THR^? 24.02 MG MG C 302 A 229 LYS D 6 LYS^? 25.98 MG MG D 302 coo 9.66 102.78 70.07 9.79 101.18 71.42 69.49 12.18 -14.30 67.44 12.65 -13.83 coo 7.24 97.46 49.60 8.11 95.69 48.80 85.56 21.34 -24.69 87.12 20.00 -24.12 coo 10.53 97.56 43.71 9.33 93.71 47.17 89.78 20.68 -31.57 90.15 24.89 -27.02 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 40 3 # 40 A 57 GLU C 94 GLU^? 16.62 MG MG C 302 A 226 THR C 46 THR^? 24.02 MG MG C 302 A 229 LYS D 6 LYS^? 25.98 MG MG D 302 coo 9.66 102.78 70.07 9.79 101.18 71.42 71.81 35.42 -14.68 69.88 35.53 -13.78 coo 7.24 97.46 49.60 8.11 95.69 48.80 85.56 21.34 -24.69 87.12 20.00 -24.12 coo 10.53 97.56 43.71 9.33 93.71 47.17 89.78 20.68 -31.57 90.15 24.89 -27.02 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 41 3 # 41 A 57 GLU C 94 GLU^? 16.62 MG MG C 302 A 226 THR C 74 THR^? 21.64 MG MG C 302 A 229 LYS C 76 LYS^? 24.95 MG MG C 302 coo 9.66 102.78 70.07 9.79 101.18 71.42 71.81 35.42 -14.68 69.88 35.53 -13.78 coo 7.24 97.46 49.60 8.11 95.69 48.80 73.35 14.53 -18.47 73.89 13.78 -20.47 coo 10.53 97.56 43.71 9.33 93.71 47.17 71.11 8.63 -16.76 75.44 5.17 -16.80 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 42 3 # 42 A 57 GLU C 94 GLU^? 16.62 MG MG C 302 A 226 THR C 74 THR^? 21.64 MG MG C 302 A 229 LYS C 86 LYS^? 27.34 MG MG C 302 coo 9.66 102.78 70.07 9.79 101.18 71.42 71.81 35.42 -14.68 69.88 35.53 -13.78 coo 7.24 97.46 49.60 8.11 95.69 48.80 73.35 14.53 -18.47 73.89 13.78 -20.47 coo 10.53 97.56 43.71 9.33 93.71 47.17 69.22 9.88 -20.56 74.70 7.02 -22.55 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 43 3 # 43 A 57 GLU C 94 GLU^? 16.62 MG MG C 302 A 226 THR C 88 THR^? 22.58 MG MG B 301 A 229 LYS C 86 LYS^? 27.34 MG MG C 302 coo 9.66 102.78 70.07 9.79 101.18 71.42 71.81 35.42 -14.68 69.88 35.53 -13.78 coo 7.24 97.46 49.60 8.11 95.69 48.80 69.96 16.71 -20.56 70.75 16.33 -22.54 coo 10.53 97.56 43.71 9.33 93.71 47.17 69.22 9.88 -20.56 74.70 7.02 -22.55 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 44 3 # 44 A 57 GLU C 146 GLU^? 10.46 MG MG C 301 A 226 THR C 70 THR^? 14.45 MG MG C 302 A 229 LYS C 90 LYS^? 18.24 MG MG C 302 coo 9.66 102.78 70.07 9.79 101.18 71.42 87.01 31.93 0.25 85.57 32.56 1.72 coo 7.24 97.46 49.60 8.11 95.69 48.80 78.63 25.77 -17.76 76.70 26.55 -17.21 coo 10.53 97.56 43.71 9.33 93.71 47.17 72.37 23.25 -18.94 76.11 26.52 -20.97 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 45 3 # 45 A 57 GLU C 154 GLU^? 18.91 MG MG C 302 A 226 THR C 74 THR^? 21.64 MG MG C 302 A 229 LYS C 76 LYS^? 24.95 MG MG C 302 coo 9.66 102.78 70.07 9.79 101.18 71.42 91.15 23.27 -13.33 91.61 21.91 -14.95 coo 7.24 97.46 49.60 8.11 95.69 48.80 73.35 14.53 -18.47 73.89 13.78 -20.47 coo 10.53 97.56 43.71 9.33 93.71 47.17 71.11 8.63 -16.76 75.44 5.17 -16.80 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 46 3 # 46 A 57 GLU C 154 GLU^? 18.91 MG MG C 302 A 226 THR C 74 THR^? 21.64 MG MG C 302 A 229 LYS C 86 LYS^? 27.34 MG MG C 302 coo 9.66 102.78 70.07 9.79 101.18 71.42 91.15 23.27 -13.33 91.61 21.91 -14.95 coo 7.24 97.46 49.60 8.11 95.69 48.80 73.35 14.53 -18.47 73.89 13.78 -20.47 coo 10.53 97.56 43.71 9.33 93.71 47.17 69.22 9.88 -20.56 74.70 7.02 -22.55 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 47 3 # 47 A 57 GLU C 154 GLU^? 18.91 MG MG C 302 A 226 THR D 2 THR^? 33.99 MG MG D 302 A 229 LYS D 137 LYS^? 37.57 MG MG D 302 coo 9.66 102.78 70.07 9.79 101.18 71.42 91.15 23.27 -13.33 91.61 21.91 -14.95 coo 7.24 97.46 49.60 8.11 95.69 48.80 91.82 9.34 -29.18 91.80 10.46 -31.03 coo 10.53 97.56 43.71 9.33 93.71 47.17 88.48 8.58 -35.33 84.88 3.98 -33.96 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 48 3 # 48 A 57 GLU D 19 GLU^? 18.95 MG MG D 301 A 226 THR D 169 THR^? 18.47 MG MG D 301 A 229 LYS D 166 LYS^? 21.08 MG MG D 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 96.86 51.08 -43.04 98.60 51.44 -44.26 coo 7.24 97.46 49.60 8.11 95.69 48.80 97.62 30.68 -41.94 99.48 30.62 -40.85 coo 10.53 97.56 43.71 9.33 93.71 47.17 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 49 3 # 49 A 57 GLU D 25 GLU^? 12.44 MG MG E 301 A 226 THR D 74 THR^? 21.71 MG MG D 302 A 229 LYS D 90 LYS^? 18.98 MG MG D 302 coo 9.66 102.78 70.07 9.79 101.18 71.42 81.26 66.22 -47.78 79.52 64.98 -48.06 coo 7.24 97.46 49.60 8.11 95.69 48.80 86.03 50.57 -32.19 86.96 50.83 -30.24 coo 10.53 97.56 43.71 9.33 93.71 47.17 79.83 44.38 -31.44 80.32 39.55 -29.40 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 50 3 # 50 A 57 GLU D 25 GLU^? 12.44 MG MG E 301 A 226 THR D 88 THR^? 22.15 MG MG E 301 A 229 LYS D 90 LYS^? 18.98 MG MG D 302 coo 9.66 102.78 70.07 9.79 101.18 71.42 81.26 66.22 -47.78 79.52 64.98 -48.06 coo 7.24 97.46 49.60 8.11 95.69 48.80 81.92 51.17 -30.12 82.55 50.45 -28.12 coo 10.53 97.56 43.71 9.33 93.71 47.17 79.83 44.38 -31.44 80.32 39.55 -29.40 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 51 3 # 51 A 57 GLU D 25 GLU^? 12.44 MG MG E 301 A 226 THR E 169 THR^? 18.18 MG MG E 301 A 229 LYS E 166 LYS^? 21.46 MG MG E 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 81.26 66.22 -47.78 79.52 64.98 -48.06 coo 7.24 97.46 49.60 8.11 95.69 48.80 63.17 71.31 -52.89 63.43 72.88 -54.31 coo 10.53 97.56 43.71 9.33 93.71 47.17 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 52 3 # 52 A 57 GLU D 33 GLU^? 22.23 MG MG D 302 A 226 THR D 169 THR^? 18.47 MG MG D 301 A 229 LYS D 166 LYS^? 21.08 MG MG D 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 91.55 48.87 -31.66 91.12 48.92 -29.63 coo 7.24 97.46 49.60 8.11 95.69 48.80 97.62 30.68 -41.94 99.48 30.62 -40.85 coo 10.53 97.56 43.71 9.33 93.71 47.17 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 53 3 # 53 A 57 GLU D 38 GLU^? 21.83 MG MG D 301 A 226 THR D 74 THR^? 21.71 MG MG D 302 A 229 LYS D 86 LYS^? 25.80 MG MG D 302 coo 9.66 102.78 70.07 9.79 101.18 71.42 103.22 39.19 -34.75 102.77 39.81 -36.73 coo 7.24 97.46 49.60 8.11 95.69 48.80 86.03 50.57 -32.19 86.96 50.83 -30.24 coo 10.53 97.56 43.71 9.33 93.71 47.17 85.54 56.79 -30.27 90.24 54.54 -28.62 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 54 3 # 54 A 57 GLU D 52 GLU^? 19.94 MG MG D 302 A 226 THR C 2 THR^? 33.69 MG MG C 302 A 229 LYS C 137 LYS^? 35.41 MG MG C 302 coo 9.66 102.78 70.07 9.79 101.18 71.42 87.13 33.17 -30.97 88.40 33.70 -29.31 coo 7.24 97.46 49.60 8.11 95.69 48.80 103.03 43.13 -20.15 102.74 41.72 -18.56 coo 10.53 97.56 43.71 9.33 93.71 47.17 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 55 3 # 55 A 57 GLU D 54 GLU^? 22.96 MG MG D 302 A 226 THR C 74 THR^? 21.64 MG MG C 302 A 229 LYS C 76 LYS^? 24.95 MG MG C 302 coo 9.66 102.78 70.07 9.79 101.18 71.42 87.96 27.60 -30.52 89.07 27.55 -28.72 coo 7.24 97.46 49.60 8.11 95.69 48.80 73.35 14.53 -18.47 73.89 13.78 -20.47 coo 10.53 97.56 43.71 9.33 93.71 47.17 71.11 8.63 -16.76 75.44 5.17 -16.80 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 56 3 # 56 A 57 GLU D 54 GLU^? 22.96 MG MG D 302 A 226 THR C 74 THR^? 21.64 MG MG C 302 A 229 LYS C 86 LYS^? 27.34 MG MG C 302 coo 9.66 102.78 70.07 9.79 101.18 71.42 87.96 27.60 -30.52 89.07 27.55 -28.72 coo 7.24 97.46 49.60 8.11 95.69 48.80 73.35 14.53 -18.47 73.89 13.78 -20.47 coo 10.53 97.56 43.71 9.33 93.71 47.17 69.22 9.88 -20.56 74.70 7.02 -22.55 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 57 3 # 57 A 57 GLU D 54 GLU^? 22.96 MG MG D 302 A 226 THR C 88 THR^? 22.58 MG MG B 301 A 229 LYS C 86 LYS^? 27.34 MG MG C 302 coo 9.66 102.78 70.07 9.79 101.18 71.42 87.96 27.60 -30.52 89.07 27.55 -28.72 coo 7.24 97.46 49.60 8.11 95.69 48.80 69.96 16.71 -20.56 70.75 16.33 -22.54 coo 10.53 97.56 43.71 9.33 93.71 47.17 69.22 9.88 -20.56 74.70 7.02 -22.55 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 58 3 # 58 A 57 GLU D 75 GLU^? 15.53 MG MG E 301 A 226 THR D 46 THR^? 23.86 MG MG D 302 A 229 LYS C 6 LYS^? 25.73 MG MG C 302 coo 9.66 102.78 70.07 9.79 101.18 71.42 84.53 54.81 -36.40 82.75 56.01 -36.42 coo 7.24 97.46 49.60 8.11 95.69 48.80 91.28 37.63 -25.27 93.05 36.72 -26.12 coo 10.53 97.56 43.71 9.33 93.71 47.17 94.42 35.68 -18.56 92.21 32.03 -23.05 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 59 3 # 59 A 57 GLU D 94 GLU^? 16.28 MG MG D 302 A 226 THR D 46 THR^? 23.86 MG MG D 302 A 229 LYS C 6 LYS^? 25.73 MG MG C 302 coo 9.66 102.78 70.07 9.79 101.18 71.42 72.85 36.59 -35.79 71.78 37.87 -37.16 coo 7.24 97.46 49.60 8.11 95.69 48.80 91.28 37.63 -25.27 93.05 36.72 -26.12 coo 10.53 97.56 43.71 9.33 93.71 47.17 94.42 35.68 -18.56 92.21 32.03 -23.05 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 60 3 # 60 A 57 GLU D 94 GLU^? 16.28 MG MG D 302 A 226 THR D 74 THR^? 21.71 MG MG D 302 A 229 LYS D 76 LYS^? 25.08 MG MG D 302 coo 9.66 102.78 70.07 9.79 101.18 71.42 72.85 36.59 -35.79 71.78 37.87 -37.16 coo 7.24 97.46 49.60 8.11 95.69 48.80 86.03 50.57 -32.19 86.96 50.83 -30.24 coo 10.53 97.56 43.71 9.33 93.71 47.17 88.18 56.35 -34.05 93.80 56.17 -32.93 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 61 3 # 61 A 57 GLU D 146 GLU^? 10.62 MG MG D 301 A 226 THR D 70 THR^? 14.99 MG MG D 302 A 229 LYS D 90 LYS^? 18.98 MG MG D 302 coo 9.66 102.78 70.07 9.79 101.18 71.42 87.24 28.82 -50.92 85.47 28.08 -51.67 coo 7.24 97.46 49.60 8.11 95.69 48.80 83.38 38.35 -32.45 81.51 39.04 -33.23 coo 10.53 97.56 43.71 9.33 93.71 47.17 79.83 44.38 -31.44 80.32 39.55 -29.40 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 62 3 # 62 A 57 GLU D 154 GLU^? 18.75 MG MG D 302 A 226 THR C 2 THR^? 33.69 MG MG C 302 A 229 LYS C 137 LYS^? 35.41 MG MG C 302 coo 9.66 102.78 70.07 9.79 101.18 71.42 94.87 32.52 -36.42 96.07 33.39 -34.88 coo 7.24 97.46 49.60 8.11 95.69 48.80 103.03 43.13 -20.15 102.74 41.72 -18.56 coo 10.53 97.56 43.71 9.33 93.71 47.17 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 63 3 # 63 A 57 GLU D 154 GLU^? 18.75 MG MG D 302 A 226 THR D 74 THR^? 21.71 MG MG D 302 A 229 LYS D 86 LYS^? 25.80 MG MG D 302 coo 9.66 102.78 70.07 9.79 101.18 71.42 94.87 32.52 -36.42 96.07 33.39 -34.88 coo 7.24 97.46 49.60 8.11 95.69 48.80 86.03 50.57 -32.19 86.96 50.83 -30.24 coo 10.53 97.56 43.71 9.33 93.71 47.17 85.54 56.79 -30.27 90.24 54.54 -28.62 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 64 3 # 64 A 57 GLU E 19 GLU^? 18.42 MG MG E 301 A 226 THR E 169 THR^? 18.18 MG MG E 301 A 229 LYS E 166 LYS^? 21.46 MG MG E 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 82.78 67.13 -51.44 83.71 68.75 -50.40 coo 7.24 97.46 49.60 8.11 95.69 48.80 63.17 71.31 -52.89 63.43 72.88 -54.31 coo 10.53 97.56 43.71 9.33 93.71 47.17 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 65 3 # 65 A 57 GLU E 25 GLU^? 12.55 MG MG D 301 A 226 THR D 169 THR^? 18.47 MG MG D 301 A 229 LYS D 166 LYS^? 21.08 MG MG D 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 95.44 49.40 -47.17 93.82 48.00 -47.21 coo 7.24 97.46 49.60 8.11 95.69 48.80 97.62 30.68 -41.94 99.48 30.62 -40.85 coo 10.53 97.56 43.71 9.33 93.71 47.17 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 66 3 # 66 A 57 GLU E 25 GLU^? 12.55 MG MG D 301 A 226 THR E 74 THR^? 21.51 MG MG E 302 A 229 LYS E 90 LYS^? 19.16 MG MG E 302 coo 9.66 102.78 70.07 9.79 101.18 71.42 95.44 49.40 -47.17 93.82 48.00 -47.21 coo 7.24 97.46 49.60 8.11 95.69 48.80 80.89 56.59 -62.50 81.13 57.37 -64.43 coo 10.53 97.56 43.71 9.33 93.71 47.17 73.81 51.50 -63.18 69.15 52.39 -65.65 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 67 3 # 67 A 57 GLU E 25 GLU^? 12.55 MG MG D 301 A 226 THR E 88 THR^? 21.98 MG MG D 301 A 229 LYS E 90 LYS^? 19.16 MG MG E 302 coo 9.66 102.78 70.07 9.79 101.18 71.42 95.44 49.40 -47.17 93.82 48.00 -47.21 coo 7.24 97.46 49.60 8.11 95.69 48.80 80.56 52.52 -64.50 80.70 53.32 -66.53 coo 10.53 97.56 43.71 9.33 93.71 47.17 73.81 51.50 -63.18 69.15 52.39 -65.65 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 68 3 # 68 A 57 GLU E 33 GLU^? 22.81 MG MG E 302 A 226 THR E 169 THR^? 18.18 MG MG E 301 A 229 LYS E 166 LYS^? 21.46 MG MG E 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 80.16 62.57 -63.35 80.54 62.13 -65.43 coo 7.24 97.46 49.60 8.11 95.69 48.80 63.17 71.31 -52.89 63.43 72.88 -54.31 coo 10.53 97.56 43.71 9.33 93.71 47.17 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 69 3 # 69 A 57 GLU E 38 GLU^? 21.68 MG MG E 301 A 226 THR E 74 THR^? 21.51 MG MG E 302 A 229 LYS E 86 LYS^? 26.73 MG MG D 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 72.42 75.53 -60.31 73.00 74.78 -58.42 coo 7.24 97.46 49.60 8.11 95.69 48.80 80.89 56.59 -62.50 81.13 57.37 -64.43 coo 10.53 97.56 43.71 9.33 93.71 47.17 86.84 54.85 -64.43 87.07 60.83 -66.10 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 70 3 # 70 A 57 GLU E 75 GLU^? 15.76 MG MG D 301 A 226 THR E 46 THR^? 24.08 MG MG E 302 A 229 LYS F 6 LYS^? 26.09 MG MG F 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 84.65 53.96 -59.58 85.64 52.81 -58.05 coo 7.24 97.46 49.60 8.11 95.69 48.80 68.80 63.64 -69.48 69.18 65.66 -68.86 coo 10.53 97.56 43.71 9.33 93.71 47.17 67.53 67.03 -76.43 64.05 65.33 -71.86 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 71 3 # 71 A 57 GLU E 94 GLU^? 18.90 MG MG E 302 A 226 THR E 46 THR^? 24.08 MG MG E 302 A 229 LYS F 6 LYS^? 26.09 MG MG F 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 62.96 45.14 -58.39 62.13 44.53 -60.28 coo 7.24 97.46 49.60 8.11 95.69 48.80 68.80 63.64 -69.48 69.18 65.66 -68.86 coo 10.53 97.56 43.71 9.33 93.71 47.17 67.53 67.03 -76.43 64.05 65.33 -71.86 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 72 3 # 72 A 57 GLU E 94 GLU^? 18.90 MG MG E 302 A 226 THR E 74 THR^? 21.51 MG MG E 302 A 229 LYS E 76 LYS^? 25.68 MG MG E 302 coo 9.66 102.78 70.07 9.79 101.18 71.42 62.96 45.14 -58.39 62.13 44.53 -60.28 coo 7.24 97.46 49.60 8.11 95.69 48.80 80.89 56.59 -62.50 81.13 57.37 -64.43 coo 10.53 97.56 43.71 9.33 93.71 47.17 87.09 58.11 -60.91 88.65 63.65 -61.27 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 73 3 # 73 A 57 GLU E 94 GLU^? 18.90 MG MG E 302 A 226 THR E 74 THR^? 21.51 MG MG E 302 A 229 LYS E 86 LYS^? 26.73 MG MG D 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 62.96 45.14 -58.39 62.13 44.53 -60.28 coo 7.24 97.46 49.60 8.11 95.69 48.80 80.89 56.59 -62.50 81.13 57.37 -64.43 coo 10.53 97.56 43.71 9.33 93.71 47.17 86.84 54.85 -64.43 87.07 60.83 -66.10 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 74 3 # 74 A 57 GLU E 94 GLU^? 18.90 MG MG E 302 A 226 THR E 88 THR^? 21.98 MG MG D 301 A 229 LYS E 86 LYS^? 26.73 MG MG D 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 62.96 45.14 -58.39 62.13 44.53 -60.28 coo 7.24 97.46 49.60 8.11 95.69 48.80 80.56 52.52 -64.50 80.70 53.32 -66.53 coo 10.53 97.56 43.71 9.33 93.71 47.17 86.84 54.85 -64.43 87.07 60.83 -66.10 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 75 3 # 75 A 57 GLU E 146 GLU^? 10.15 MG MG E 301 A 226 THR E 70 THR^? 14.75 MG MG E 302 A 229 LYS E 90 LYS^? 19.16 MG MG E 302 coo 9.66 102.78 70.07 9.79 101.18 71.42 58.72 60.89 -44.51 59.23 60.24 -42.54 coo 7.24 97.46 49.60 8.11 95.69 48.80 68.45 55.77 -62.07 68.75 53.75 -61.41 coo 10.53 97.56 43.71 9.33 93.71 47.17 73.81 51.50 -63.18 69.15 52.39 -65.65 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 76 3 # 76 A 57 GLU E 154 GLU^? 19.05 MG MG E 302 A 226 THR E 74 THR^? 21.51 MG MG E 302 A 229 LYS E 76 LYS^? 25.68 MG MG E 302 coo 9.66 102.78 70.07 9.79 101.18 71.42 64.41 68.21 -58.47 65.40 69.20 -60.08 coo 7.24 97.46 49.60 8.11 95.69 48.80 80.89 56.59 -62.50 81.13 57.37 -64.43 coo 10.53 97.56 43.71 9.33 93.71 47.17 87.09 58.11 -60.91 88.65 63.65 -61.27 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 77 3 # 77 A 57 GLU E 154 GLU^? 19.05 MG MG E 302 A 226 THR E 74 THR^? 21.51 MG MG E 302 A 229 LYS E 86 LYS^? 26.73 MG MG D 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 64.41 68.21 -58.47 65.40 69.20 -60.08 coo 7.24 97.46 49.60 8.11 95.69 48.80 80.89 56.59 -62.50 81.13 57.37 -64.43 coo 10.53 97.56 43.71 9.33 93.71 47.17 86.84 54.85 -64.43 87.07 60.83 -66.10 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 78 3 # 78 A 57 GLU E 154 GLU^? 19.05 MG MG E 302 A 226 THR F 2 THR^? 34.54 MG MG F 301 A 229 LYS F 137 LYS^? 35.13 MG MG F 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 64.41 68.21 -58.47 65.40 69.20 -60.08 coo 7.24 97.46 49.60 8.11 95.69 48.80 76.07 74.83 -74.70 74.98 75.15 -76.59 coo 10.53 97.56 43.71 9.33 93.71 47.17 78.53 72.20 -80.30 83.01 68.64 -79.79 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 79 3 # 79 A 57 GLU F 19 GLU^? 17.88 MG MG F 302 A 226 THR F 169 THR^? 17.93 MG MG F 302 A 229 LYS F 166 LYS^? 20.76 MG MG F 302 coo 9.66 102.78 70.07 9.79 101.18 71.42 36.39 58.51 -87.58 37.20 60.13 -88.66 coo 7.24 97.46 49.60 8.11 95.69 48.80 54.83 68.79 -86.99 54.09 70.44 -85.82 coo 10.53 97.56 43.71 9.33 93.71 47.17 59.28 73.05 -82.63 55.63 74.15 -86.94 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 80 3 # 80 A 57 GLU F 33 GLU^? 22.46 MG MG F 301 A 226 THR F 169 THR^? 17.93 MG MG F 302 A 229 LYS F 166 LYS^? 20.76 MG MG F 302 coo 9.66 102.78 70.07 9.79 101.18 71.42 41.88 55.13 -75.91 42.06 54.64 -73.84 coo 7.24 97.46 49.60 8.11 95.69 48.80 54.83 68.79 -86.99 54.09 70.44 -85.82 coo 10.53 97.56 43.71 9.33 93.71 47.17 59.28 73.05 -82.63 55.63 74.15 -86.94 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 81 3 # 81 A 57 GLU F 38 GLU^? 21.28 MG MG F 302 A 226 THR F 74 THR^? 21.46 MG MG F 301 A 229 LYS F 86 LYS^? 26.63 MG MG F 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 44.63 69.79 -79.91 44.13 69.05 -81.85 coo 7.24 97.46 49.60 8.11 95.69 48.80 43.07 49.39 -76.61 42.46 50.11 -74.68 coo 10.53 97.56 43.71 9.33 93.71 47.17 37.89 45.97 -74.42 36.47 51.71 -72.79 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 82 3 # 82 A 57 GLU F 75 GLU^? 19.96 MG MG F 301 A 226 THR F 46 THR^? 24.16 MG MG F 301 A 229 LYS E 6 LYS^? 25.59 MG MG E 302 coo 9.66 102.78 70.07 9.79 101.18 71.42 40.19 46.06 -80.81 40.09 43.94 -81.24 coo 7.24 97.46 49.60 8.11 95.69 48.80 51.99 60.48 -70.07 50.88 62.21 -70.66 coo 10.53 97.56 43.71 9.33 93.71 47.17 51.95 64.70 -63.33 56.16 64.03 -67.52 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 83 3 # 83 A 57 GLU F 94 GLU^? 17.06 MG MG F 301 A 226 THR F 74 THR^? 21.46 MG MG F 301 A 229 LYS F 76 LYS^? 25.89 MG MG F 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 62.58 44.49 -81.43 64.13 42.92 -81.30 coo 7.24 97.46 49.60 8.11 95.69 48.80 43.07 49.39 -76.61 42.46 50.11 -74.68 coo 10.53 97.56 43.71 9.33 93.71 47.17 36.96 48.52 -78.06 33.74 53.37 -77.06 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 84 3 # 84 A 57 GLU F 94 GLU^? 17.06 MG MG F 301 A 226 THR F 74 THR^? 21.46 MG MG F 301 A 229 LYS F 86 LYS^? 26.63 MG MG F 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 62.58 44.49 -81.43 64.13 42.92 -81.30 coo 7.24 97.46 49.60 8.11 95.69 48.80 43.07 49.39 -76.61 42.46 50.11 -74.68 coo 10.53 97.56 43.71 9.33 93.71 47.17 37.89 45.97 -74.42 36.47 51.71 -72.79 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 85 3 # 85 A 57 GLU F 94 GLU^? 17.06 MG MG F 301 A 226 THR F 88 THR^? 23.06 MG MG F 301 A 229 LYS F 86 LYS^? 26.63 MG MG F 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 62.58 44.49 -81.43 64.13 42.92 -81.30 coo 7.24 97.46 49.60 8.11 95.69 48.80 44.71 45.78 -74.10 45.06 46.44 -72.02 coo 10.53 97.56 43.71 9.33 93.71 47.17 37.89 45.97 -74.42 36.47 51.71 -72.79 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 86 3 # 86 A 57 GLU F 146 GLU^? 10.36 MG MG F 302 A 226 THR F 70 THR^? 14.73 MG MG F 301 A 229 LYS F 90 LYS^? 18.57 MG MG F 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 61.95 60.17 -95.28 62.87 58.56 -96.19 coo 7.24 97.46 49.60 8.11 95.69 48.80 55.11 52.83 -76.85 55.53 50.86 -77.56 coo 10.53 97.56 43.71 9.33 93.71 47.17 51.54 47.01 -75.58 55.05 50.31 -73.74 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 87 3 # 87 A 57 GLU F 154 GLU^? 18.97 MG MG F 301 A 226 THR E 2 THR^? 33.84 MG MG E 302 A 229 LYS E 137 LYS^? 35.26 MG MG E 302 coo 9.66 102.78 70.07 9.79 101.18 71.42 54.57 65.67 -81.55 53.36 66.51 -80.09 coo 7.24 97.46 49.60 8.11 95.69 48.80 41.32 68.37 -65.29 42.66 69.03 -63.78 coo 10.53 97.56 43.71 9.33 93.71 47.17 40.01 66.05 -59.66 36.65 60.99 -60.28 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 88 3 # 88 A 57 GLU F 154 GLU^? 18.97 MG MG F 301 A 226 THR F 74 THR^? 21.46 MG MG F 301 A 229 LYS F 86 LYS^? 26.63 MG MG F 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 54.57 65.67 -81.55 53.36 66.51 -80.09 coo 7.24 97.46 49.60 8.11 95.69 48.80 43.07 49.39 -76.61 42.46 50.11 -74.68 coo 10.53 97.56 43.71 9.33 93.71 47.17 37.89 45.97 -74.42 36.47 51.71 -72.79 1dfo_c04 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 88 hits 1dfo_c04 naa= 3 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 57 GLU A 19 GLU.? 16.46 MG MG A 302 B 226 THR A 169 THR^? 18.45 MG MG A 302 B 229 LYS A 166 LYS^? 20.93 MG MG A 302 coo 15.90 87.61 49.61 13.92 86.96 49.36 29.75 40.22 38.71 30.73 40.87 40.56 coo 20.74 95.78 68.68 19.29 96.84 69.83 34.64 19.08 35.13 33.08 18.40 33.78 coo 22.32 101.61 71.64 17.89 98.63 71.55 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 B 57 GLU A 25 GLU^? 25.87 MG MG A 301 B 226 THR A 73 THR^? 15.13 MG MG A 301 B 229 LYS A 90 LYS^? 18.58 MG MG A 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 39.62 57.50 39.92 41.51 57.27 40.85 coo 20.74 95.78 68.68 19.29 96.84 69.83 40.93 39.17 26.72 41.99 38.78 28.61 coo 22.32 101.61 71.64 17.89 98.63 71.55 46.62 38.29 25.46 47.51 33.29 23.22 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 B 57 GLU A 25 GLU^? 25.87 MG MG A 301 B 226 THR A 88 THR^? 23.22 MG MG A 301 B 229 LYS A 90 LYS^? 18.58 MG MG A 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 39.62 57.50 39.92 41.51 57.27 40.85 coo 20.74 95.78 68.68 19.29 96.84 69.83 42.44 43.75 23.46 42.54 42.92 21.44 coo 22.32 101.61 71.64 17.89 98.63 71.55 46.62 38.29 25.46 47.51 33.29 23.22 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 B 57 GLU A 33 GLU^? 22.87 MG MG A 301 B 226 THR A 169 THR^? 18.45 MG MG A 302 B 229 LYS A 166 LYS^? 20.93 MG MG A 302 coo 15.90 87.61 49.61 13.92 86.96 49.36 33.74 38.67 24.96 34.13 38.85 22.87 coo 20.74 95.78 68.68 19.29 96.84 69.83 34.64 19.08 35.13 33.08 18.40 33.78 coo 22.32 101.61 71.64 17.89 98.63 71.55 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 B 57 GLU A 38 GLU^? 21.81 MG MG A 302 B 226 THR A 74 THR^? 21.85 MG MG A 301 B 229 LYS A 86 LYS^? 26.38 MG MG A 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 26.42 25.01 28.02 26.98 25.90 29.89 coo 20.74 95.78 68.68 19.29 96.84 69.83 38.65 41.92 25.57 37.60 41.76 23.73 coo 22.32 101.61 71.64 17.89 98.63 71.55 37.08 47.78 23.56 32.88 44.24 21.89 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 B 57 GLU A 54 GLU^? 22.98 MG MG A 301 B 226 THR A 74 THR^? 21.85 MG MG A 301 B 229 LYS A 76 LYS^? 25.42 MG MG A 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 45.06 19.97 24.02 44.05 19.39 22.19 coo 20.74 95.78 68.68 19.29 96.84 69.83 38.65 41.92 25.57 37.60 41.76 23.73 coo 22.32 101.61 71.64 17.89 98.63 71.55 34.45 46.53 27.28 28.88 44.93 27.25 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 B 57 GLU A 75 GLU^? 20.23 MG MG A 301 B 226 THR A 46 THR^? 24.24 MG MG A 301 B 229 LYS B 6 LYS^? 25.90 MG MG B 302 coo 15.90 87.61 49.61 13.92 86.96 49.36 38.99 46.65 28.68 39.94 47.65 30.33 coo 20.74 95.78 68.68 19.29 96.84 69.83 38.63 28.11 18.80 36.62 27.50 19.27 coo 22.32 101.61 71.64 17.89 98.63 71.55 36.26 25.44 11.74 39.65 23.12 16.29 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 B 57 GLU A 94 GLU^? 17.31 MG MG A 301 B 226 THR A 46 THR^? 24.24 MG MG A 301 B 229 LYS B 6 LYS^? 25.90 MG MG B 302 coo 15.90 87.61 49.61 13.92 86.96 49.36 57.11 32.79 29.92 57.45 34.91 29.85 coo 20.74 95.78 68.68 19.29 96.84 69.83 38.63 28.11 18.80 36.62 27.50 19.27 coo 22.32 101.61 71.64 17.89 98.63 71.55 36.26 25.44 11.74 39.65 23.12 16.29 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 B 57 GLU A 94 GLU^? 17.31 MG MG A 301 B 226 THR A 74 THR^? 21.85 MG MG A 301 B 229 LYS A 76 LYS^? 25.42 MG MG A 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 57.11 32.79 29.92 57.45 34.91 29.85 coo 20.74 95.78 68.68 19.29 96.84 69.83 38.65 41.92 25.57 37.60 41.76 23.73 coo 22.32 101.61 71.64 17.89 98.63 71.55 34.45 46.53 27.28 28.88 44.93 27.25 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 B 57 GLU A 94 GLU^? 17.31 MG MG A 301 B 226 THR A 74 THR^? 21.85 MG MG A 301 B 229 LYS A 86 LYS^? 26.38 MG MG A 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 57.11 32.79 29.92 57.45 34.91 29.85 coo 20.74 95.78 68.68 19.29 96.84 69.83 38.65 41.92 25.57 37.60 41.76 23.73 coo 22.32 101.61 71.64 17.89 98.63 71.55 37.08 47.78 23.56 32.88 44.24 21.89 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 B 57 GLU A 94 GLU^? 17.31 MG MG A 301 B 226 THR A 88 THR^? 23.22 MG MG A 301 B 229 LYS A 86 LYS^? 26.38 MG MG A 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 57.11 32.79 29.92 57.45 34.91 29.85 coo 20.74 95.78 68.68 19.29 96.84 69.83 42.44 43.75 23.46 42.54 42.92 21.44 coo 22.32 101.61 71.64 17.89 98.63 71.55 37.08 47.78 23.56 32.88 44.24 21.89 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 B 57 GLU A 146 GLU^? 9.80 MG MG A 302 B 226 THR A 70 THR^? 14.66 MG MG A 301 B 229 LYS A 90 LYS^? 18.58 MG MG A 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 45.17 20.35 44.20 46.68 21.21 45.40 coo 20.74 95.78 68.68 19.29 96.84 69.83 45.68 31.52 26.25 47.33 32.60 27.12 coo 22.32 101.61 71.64 17.89 98.63 71.55 46.62 38.29 25.46 47.51 33.29 23.22 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 B 57 GLU A 154 GLU^? 19.22 MG MG A 301 B 226 THR A 74 THR^? 21.85 MG MG A 301 B 229 LYS A 86 LYS^? 26.38 MG MG A 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 36.54 21.95 29.78 35.14 22.21 28.17 coo 20.74 95.78 68.68 19.29 96.84 69.83 38.65 41.92 25.57 37.60 41.76 23.73 coo 22.32 101.61 71.64 17.89 98.63 71.55 37.08 47.78 23.56 32.88 44.24 21.89 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 14 3 # 14 B 57 GLU A 154 GLU^? 19.22 MG MG A 301 B 226 THR B 2 THR^? 34.11 MG MG B 302 B 229 LYS B 137 LYS^? 34.56 MG MG B 302 coo 15.90 87.61 49.61 13.92 86.96 49.36 36.54 21.95 29.78 35.14 22.21 28.17 coo 20.74 95.78 68.68 19.29 96.84 69.83 25.51 29.18 13.74 26.24 28.19 11.93 coo 22.32 101.61 71.64 17.89 98.63 71.55 26.56 32.46 7.93 27.87 37.71 9.31 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 15 3 # 15 B 57 GLU B 19 GLU^? 18.96 MG MG B 301 B 226 THR B 169 THR^? 18.43 MG MG B 301 B 229 LYS B 166 LYS^? 22.75 MG MG B 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 59.29 4.54 -0.16 58.81 2.51 -0.44 coo 20.74 95.78 68.68 19.29 96.84 69.83 41.38 13.97 0.97 40.27 12.43 2.02 coo 22.32 101.61 71.64 17.89 98.63 71.55 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 16 3 # 16 B 57 GLU B 25 GLU^? 12.88 MG MG C 301 B 226 THR B 88 THR^? 22.44 MG MG C 301 B 229 LYS B 90 LYS^? 18.68 MG MG B 302 coo 15.90 87.61 49.61 13.92 86.96 49.36 79.57 9.59 -3.08 79.20 11.68 -3.64 coo 20.74 95.78 68.68 19.29 96.84 69.83 66.42 16.42 14.22 65.45 16.28 16.18 coo 22.32 101.61 71.64 17.89 98.63 71.55 61.66 21.61 12.88 56.74 22.88 14.81 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 17 3 # 17 B 57 GLU B 25 GLU^? 12.88 MG MG C 301 B 226 THR C 169 THR^? 18.51 MG MG C 301 B 229 LYS C 166 LYS^? 22.53 MG MG C 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 79.57 9.59 -3.08 79.20 11.68 -3.64 coo 20.74 95.78 68.68 19.29 96.84 69.83 94.19 23.02 -7.83 95.56 21.86 -9.07 coo 22.32 101.61 71.64 17.89 98.63 71.55 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 18 3 # 18 B 57 GLU B 33 GLU^? 22.65 MG MG B 302 B 226 THR B 169 THR^? 18.43 MG MG B 301 B 229 LYS B 166 LYS^? 22.75 MG MG B 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 59.88 9.09 12.22 59.91 9.49 14.33 coo 20.74 95.78 68.68 19.29 96.84 69.83 41.38 13.97 0.97 40.27 12.43 2.02 coo 22.32 101.61 71.64 17.89 98.63 71.55 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 19 3 # 19 B 57 GLU B 38 GLU^? 21.75 MG MG B 301 B 226 THR B 74 THR^? 21.68 MG MG B 302 B 229 LYS B 86 LYS^? 26.44 MG MG B 302 coo 15.90 87.61 49.61 13.92 86.96 49.36 44.79 4.95 7.12 46.66 4.47 6.21 coo 20.74 95.78 68.68 19.29 96.84 69.83 63.99 13.20 11.95 63.36 12.32 13.84 coo 22.32 101.61 71.64 17.89 98.63 71.55 69.25 10.45 13.86 65.27 7.74 16.08 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 20 3 # 20 B 57 GLU B 54 GLU^? 22.94 MG MG B 302 B 226 THR A 74 THR^? 21.85 MG MG A 301 B 229 LYS A 76 LYS^? 25.42 MG MG A 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 43.18 23.27 12.99 42.40 22.23 14.68 coo 20.74 95.78 68.68 19.29 96.84 69.83 38.65 41.92 25.57 37.60 41.76 23.73 coo 22.32 101.61 71.64 17.89 98.63 71.55 34.45 46.53 27.28 28.88 44.93 27.25 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 21 3 # 21 B 57 GLU B 54 GLU^? 22.94 MG MG B 302 B 226 THR A 74 THR^? 21.85 MG MG A 301 B 229 LYS A 86 LYS^? 26.38 MG MG A 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 43.18 23.27 12.99 42.40 22.23 14.68 coo 20.74 95.78 68.68 19.29 96.84 69.83 38.65 41.92 25.57 37.60 41.76 23.73 coo 22.32 101.61 71.64 17.89 98.63 71.55 37.08 47.78 23.56 32.88 44.24 21.89 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 22 3 # 22 B 57 GLU B 54 GLU^? 22.94 MG MG B 302 B 226 THR A 88 THR^? 23.22 MG MG A 301 B 229 LYS A 86 LYS^? 26.38 MG MG A 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 43.18 23.27 12.99 42.40 22.23 14.68 coo 20.74 95.78 68.68 19.29 96.84 69.83 42.44 43.75 23.46 42.54 42.92 21.44 coo 22.32 101.61 71.64 17.89 98.63 71.55 37.08 47.78 23.56 32.88 44.24 21.89 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 23 3 # 23 B 57 GLU B 75 GLU^? 15.82 MG MG C 301 B 226 THR B 46 THR^? 23.88 MG MG B 302 B 229 LYS A 6 LYS^? 25.88 MG MG A 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 68.81 12.14 8.61 69.95 13.49 7.45 coo 20.74 95.78 68.68 19.29 96.84 69.83 49.71 15.16 18.13 48.80 13.51 17.14 coo 22.32 101.61 71.64 17.89 98.63 71.55 46.20 12.82 24.71 44.50 16.64 20.52 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 24 3 # 24 B 57 GLU B 94 GLU^? 15.34 MG MG B 302 B 226 THR B 46 THR^? 23.88 MG MG B 302 B 229 LYS A 6 LYS^? 25.88 MG MG A 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 58.44 31.30 7.43 60.35 32.14 7.14 coo 20.74 95.78 68.68 19.29 96.84 69.83 49.71 15.16 18.13 48.80 13.51 17.14 coo 22.32 101.61 71.64 17.89 98.63 71.55 46.20 12.82 24.71 44.50 16.64 20.52 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 25 3 # 25 B 57 GLU B 94 GLU^? 15.34 MG MG B 302 B 226 THR B 74 THR^? 21.68 MG MG B 302 B 229 LYS B 76 LYS^? 25.77 MG MG B 302 coo 15.90 87.61 49.61 13.92 86.96 49.36 58.44 31.30 7.43 60.35 32.14 7.14 coo 20.74 95.78 68.68 19.29 96.84 69.83 63.99 13.20 11.95 63.36 12.32 13.84 coo 22.32 101.61 71.64 17.89 98.63 71.55 67.82 8.19 10.14 64.96 3.09 10.62 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 26 3 # 26 B 57 GLU B 146 GLU^? 10.54 MG MG B 301 B 226 THR B 70 THR^? 14.69 MG MG B 302 B 229 LYS B 90 LYS^? 18.68 MG MG B 302 coo 15.90 87.61 49.61 13.92 86.96 49.36 45.13 24.51 -7.01 46.08 25.99 -8.13 coo 20.74 95.78 68.68 19.29 96.84 69.83 54.82 21.76 11.59 56.34 23.17 10.82 coo 22.32 101.61 71.64 17.89 98.63 71.55 61.66 21.61 12.88 56.74 22.88 14.81 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 27 3 # 27 B 57 GLU B 154 GLU^? 19.05 MG MG B 302 B 226 THR A 2 THR.? 34.64 MG MG A 301 B 229 LYS A 137 LYS^? 34.85 MG MG A 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 44.04 15.11 6.74 44.19 13.59 8.30 coo 20.74 95.78 68.68 19.29 96.84 69.83 47.80 1.72 22.09 46.70 1.88 23.97 coo 22.32 101.61 71.64 17.89 98.63 71.55 50.97 1.58 28.14 56.13 1.49 28.03 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 28 3 # 28 B 57 GLU B 154 GLU^? 19.05 MG MG B 302 B 226 THR B 74 THR^? 21.68 MG MG B 302 B 229 LYS B 76 LYS^? 25.77 MG MG B 302 coo 15.90 87.61 49.61 13.92 86.96 49.36 44.04 15.11 6.74 44.19 13.59 8.30 coo 20.74 95.78 68.68 19.29 96.84 69.83 63.99 13.20 11.95 63.36 12.32 13.84 coo 22.32 101.61 71.64 17.89 98.63 71.55 67.82 8.19 10.14 64.96 3.09 10.62 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 29 3 # 29 B 57 GLU B 154 GLU^? 19.05 MG MG B 302 B 226 THR B 74 THR^? 21.68 MG MG B 302 B 229 LYS B 86 LYS^? 26.44 MG MG B 302 coo 15.90 87.61 49.61 13.92 86.96 49.36 44.04 15.11 6.74 44.19 13.59 8.30 coo 20.74 95.78 68.68 19.29 96.84 69.83 63.99 13.20 11.95 63.36 12.32 13.84 coo 22.32 101.61 71.64 17.89 98.63 71.55 69.25 10.45 13.86 65.27 7.74 16.08 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 30 3 # 30 B 57 GLU C 19 GLU^? 19.08 MG MG C 301 B 226 THR C 169 THR^? 18.51 MG MG C 301 B 229 LYS C 166 LYS^? 22.53 MG MG C 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 80.46 7.67 -6.81 81.43 5.97 -5.99 coo 20.74 95.78 68.68 19.29 96.84 69.83 94.19 23.02 -7.83 95.56 21.86 -9.07 coo 22.32 101.61 71.64 17.89 98.63 71.55 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 31 3 # 31 B 57 GLU C 25 GLU^? 12.27 MG MG B 301 B 226 THR C 88 THR^? 22.58 MG MG B 301 B 229 LYS C 90 LYS^? 18.24 MG MG C 302 coo 15.90 87.61 49.61 13.92 86.96 49.36 58.50 6.48 -3.59 57.94 8.54 -3.41 coo 20.74 95.78 68.68 19.29 96.84 69.83 69.96 16.71 -20.56 70.75 16.33 -22.54 coo 22.32 101.61 71.64 17.89 98.63 71.55 72.37 23.25 -18.94 76.11 26.52 -20.97 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 32 3 # 32 B 57 GLU C 33 GLU^? 22.71 MG MG C 302 B 226 THR C 169 THR^? 18.51 MG MG C 301 B 229 LYS C 166 LYS^? 22.53 MG MG C 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 78.39 11.67 -18.82 78.34 12.01 -20.91 coo 20.74 95.78 68.68 19.29 96.84 69.83 94.19 23.02 -7.83 95.56 21.86 -9.07 coo 22.32 101.61 71.64 17.89 98.63 71.55 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 33 3 # 33 B 57 GLU C 38 GLU^? 21.99 MG MG C 301 B 226 THR C 74 THR^? 21.64 MG MG C 302 B 229 LYS C 86 LYS^? 27.34 MG MG C 302 coo 15.90 87.61 49.61 13.92 86.96 49.36 93.66 12.78 -15.08 92.73 12.51 -13.19 coo 20.74 95.78 68.68 19.29 96.84 69.83 73.35 14.53 -18.47 73.89 13.78 -20.47 coo 22.32 101.61 71.64 17.89 98.63 71.55 69.22 9.88 -20.56 74.70 7.02 -22.55 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 34 3 # 34 B 57 GLU C 54 GLU^? 22.77 MG MG C 302 B 226 THR D 74 THR^? 21.71 MG MG D 302 B 229 LYS D 86 LYS^? 25.80 MG MG D 302 coo 15.90 87.61 49.61 13.92 86.96 49.36 88.91 31.25 -19.52 89.97 30.69 -21.29 coo 20.74 95.78 68.68 19.29 96.84 69.83 86.03 50.57 -32.19 86.96 50.83 -30.24 coo 22.32 101.61 71.64 17.89 98.63 71.55 85.54 56.79 -30.27 90.24 54.54 -28.62 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 35 3 # 35 B 57 GLU C 75 GLU^? 16.14 MG MG B 301 B 226 THR C 46 THR^? 24.02 MG MG C 302 B 229 LYS D 6 LYS^? 25.98 MG MG D 302 coo 15.90 87.61 49.61 13.92 86.96 49.36 69.49 12.18 -14.30 67.44 12.65 -13.83 coo 20.74 95.78 68.68 19.29 96.84 69.83 85.56 21.34 -24.69 87.12 20.00 -24.12 coo 22.32 101.61 71.64 17.89 98.63 71.55 89.78 20.68 -31.57 90.15 24.89 -27.02 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 36 3 # 36 B 57 GLU C 94 GLU^? 16.62 MG MG C 302 B 226 THR C 46 THR^? 24.02 MG MG C 302 B 229 LYS D 6 LYS^? 25.98 MG MG D 302 coo 15.90 87.61 49.61 13.92 86.96 49.36 71.81 35.42 -14.68 69.88 35.53 -13.78 coo 20.74 95.78 68.68 19.29 96.84 69.83 85.56 21.34 -24.69 87.12 20.00 -24.12 coo 22.32 101.61 71.64 17.89 98.63 71.55 89.78 20.68 -31.57 90.15 24.89 -27.02 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 37 3 # 37 B 57 GLU C 94 GLU^? 16.62 MG MG C 302 B 226 THR C 74 THR^? 21.64 MG MG C 302 B 229 LYS C 76 LYS^? 24.95 MG MG C 302 coo 15.90 87.61 49.61 13.92 86.96 49.36 71.81 35.42 -14.68 69.88 35.53 -13.78 coo 20.74 95.78 68.68 19.29 96.84 69.83 73.35 14.53 -18.47 73.89 13.78 -20.47 coo 22.32 101.61 71.64 17.89 98.63 71.55 71.11 8.63 -16.76 75.44 5.17 -16.80 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 38 3 # 38 B 57 GLU C 94 GLU^? 16.62 MG MG C 302 B 226 THR C 74 THR^? 21.64 MG MG C 302 B 229 LYS C 86 LYS^? 27.34 MG MG C 302 coo 15.90 87.61 49.61 13.92 86.96 49.36 71.81 35.42 -14.68 69.88 35.53 -13.78 coo 20.74 95.78 68.68 19.29 96.84 69.83 73.35 14.53 -18.47 73.89 13.78 -20.47 coo 22.32 101.61 71.64 17.89 98.63 71.55 69.22 9.88 -20.56 74.70 7.02 -22.55 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 39 3 # 39 B 57 GLU C 94 GLU^? 16.62 MG MG C 302 B 226 THR C 88 THR^? 22.58 MG MG B 301 B 229 LYS C 86 LYS^? 27.34 MG MG C 302 coo 15.90 87.61 49.61 13.92 86.96 49.36 71.81 35.42 -14.68 69.88 35.53 -13.78 coo 20.74 95.78 68.68 19.29 96.84 69.83 69.96 16.71 -20.56 70.75 16.33 -22.54 coo 22.32 101.61 71.64 17.89 98.63 71.55 69.22 9.88 -20.56 74.70 7.02 -22.55 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 40 3 # 40 B 57 GLU C 146 GLU^? 10.46 MG MG C 301 B 226 THR C 70 THR^? 14.45 MG MG C 302 B 229 LYS C 90 LYS^? 18.24 MG MG C 302 coo 15.90 87.61 49.61 13.92 86.96 49.36 87.01 31.93 0.25 85.57 32.56 1.72 coo 20.74 95.78 68.68 19.29 96.84 69.83 78.63 25.77 -17.76 76.70 26.55 -17.21 coo 22.32 101.61 71.64 17.89 98.63 71.55 72.37 23.25 -18.94 76.11 26.52 -20.97 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 41 3 # 41 B 57 GLU C 154 GLU^? 18.91 MG MG C 302 B 226 THR C 74 THR^? 21.64 MG MG C 302 B 229 LYS C 76 LYS^? 24.95 MG MG C 302 coo 15.90 87.61 49.61 13.92 86.96 49.36 91.15 23.27 -13.33 91.61 21.91 -14.95 coo 20.74 95.78 68.68 19.29 96.84 69.83 73.35 14.53 -18.47 73.89 13.78 -20.47 coo 22.32 101.61 71.64 17.89 98.63 71.55 71.11 8.63 -16.76 75.44 5.17 -16.80 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 42 3 # 42 B 57 GLU C 154 GLU^? 18.91 MG MG C 302 B 226 THR C 74 THR^? 21.64 MG MG C 302 B 229 LYS C 86 LYS^? 27.34 MG MG C 302 coo 15.90 87.61 49.61 13.92 86.96 49.36 91.15 23.27 -13.33 91.61 21.91 -14.95 coo 20.74 95.78 68.68 19.29 96.84 69.83 73.35 14.53 -18.47 73.89 13.78 -20.47 coo 22.32 101.61 71.64 17.89 98.63 71.55 69.22 9.88 -20.56 74.70 7.02 -22.55 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 43 3 # 43 B 57 GLU C 154 GLU^? 18.91 MG MG C 302 B 226 THR D 2 THR^? 33.99 MG MG D 302 B 229 LYS D 137 LYS^? 37.57 MG MG D 302 coo 15.90 87.61 49.61 13.92 86.96 49.36 91.15 23.27 -13.33 91.61 21.91 -14.95 coo 20.74 95.78 68.68 19.29 96.84 69.83 91.82 9.34 -29.18 91.80 10.46 -31.03 coo 22.32 101.61 71.64 17.89 98.63 71.55 88.48 8.58 -35.33 84.88 3.98 -33.96 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 44 3 # 44 B 57 GLU D 19 GLU^? 18.95 MG MG D 301 B 226 THR D 169 THR^? 18.47 MG MG D 301 B 229 LYS D 166 LYS^? 21.08 MG MG D 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 96.86 51.08 -43.04 98.60 51.44 -44.26 coo 20.74 95.78 68.68 19.29 96.84 69.83 97.62 30.68 -41.94 99.48 30.62 -40.85 coo 22.32 101.61 71.64 17.89 98.63 71.55 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 45 3 # 45 B 57 GLU D 25 GLU^? 12.44 MG MG E 301 B 226 THR D 88 THR^? 22.15 MG MG E 301 B 229 LYS D 90 LYS^? 18.98 MG MG D 302 coo 15.90 87.61 49.61 13.92 86.96 49.36 81.26 66.22 -47.78 79.52 64.98 -48.06 coo 20.74 95.78 68.68 19.29 96.84 69.83 81.92 51.17 -30.12 82.55 50.45 -28.12 coo 22.32 101.61 71.64 17.89 98.63 71.55 79.83 44.38 -31.44 80.32 39.55 -29.40 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 46 3 # 46 B 57 GLU D 25 GLU^? 12.44 MG MG E 301 B 226 THR E 169 THR^? 18.18 MG MG E 301 B 229 LYS E 166 LYS^? 21.46 MG MG E 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 81.26 66.22 -47.78 79.52 64.98 -48.06 coo 20.74 95.78 68.68 19.29 96.84 69.83 63.17 71.31 -52.89 63.43 72.88 -54.31 coo 22.32 101.61 71.64 17.89 98.63 71.55 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 47 3 # 47 B 57 GLU D 33 GLU^? 22.23 MG MG D 302 B 226 THR D 169 THR^? 18.47 MG MG D 301 B 229 LYS D 166 LYS^? 21.08 MG MG D 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 91.55 48.87 -31.66 91.12 48.92 -29.63 coo 20.74 95.78 68.68 19.29 96.84 69.83 97.62 30.68 -41.94 99.48 30.62 -40.85 coo 22.32 101.61 71.64 17.89 98.63 71.55 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 48 3 # 48 B 57 GLU D 38 GLU^? 21.83 MG MG D 301 B 226 THR D 74 THR^? 21.71 MG MG D 302 B 229 LYS D 86 LYS^? 25.80 MG MG D 302 coo 15.90 87.61 49.61 13.92 86.96 49.36 103.22 39.19 -34.75 102.77 39.81 -36.73 coo 20.74 95.78 68.68 19.29 96.84 69.83 86.03 50.57 -32.19 86.96 50.83 -30.24 coo 22.32 101.61 71.64 17.89 98.63 71.55 85.54 56.79 -30.27 90.24 54.54 -28.62 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 49 3 # 49 B 57 GLU D 52 GLU^? 19.94 MG MG D 302 B 226 THR C 2 THR^? 33.69 MG MG C 302 B 229 LYS C 137 LYS^? 35.41 MG MG C 302 coo 15.90 87.61 49.61 13.92 86.96 49.36 87.13 33.17 -30.97 88.40 33.70 -29.31 coo 20.74 95.78 68.68 19.29 96.84 69.83 103.03 43.13 -20.15 102.74 41.72 -18.56 coo 22.32 101.61 71.64 17.89 98.63 71.55 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 50 3 # 50 B 57 GLU D 54 GLU^? 22.96 MG MG D 302 B 226 THR C 74 THR^? 21.64 MG MG C 302 B 229 LYS C 76 LYS^? 24.95 MG MG C 302 coo 15.90 87.61 49.61 13.92 86.96 49.36 87.96 27.60 -30.52 89.07 27.55 -28.72 coo 20.74 95.78 68.68 19.29 96.84 69.83 73.35 14.53 -18.47 73.89 13.78 -20.47 coo 22.32 101.61 71.64 17.89 98.63 71.55 71.11 8.63 -16.76 75.44 5.17 -16.80 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 51 3 # 51 B 57 GLU D 54 GLU^? 22.96 MG MG D 302 B 226 THR C 74 THR^? 21.64 MG MG C 302 B 229 LYS C 86 LYS^? 27.34 MG MG C 302 coo 15.90 87.61 49.61 13.92 86.96 49.36 87.96 27.60 -30.52 89.07 27.55 -28.72 coo 20.74 95.78 68.68 19.29 96.84 69.83 73.35 14.53 -18.47 73.89 13.78 -20.47 coo 22.32 101.61 71.64 17.89 98.63 71.55 69.22 9.88 -20.56 74.70 7.02 -22.55 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 52 3 # 52 B 57 GLU D 54 GLU^? 22.96 MG MG D 302 B 226 THR C 88 THR^? 22.58 MG MG B 301 B 229 LYS C 86 LYS^? 27.34 MG MG C 302 coo 15.90 87.61 49.61 13.92 86.96 49.36 87.96 27.60 -30.52 89.07 27.55 -28.72 coo 20.74 95.78 68.68 19.29 96.84 69.83 69.96 16.71 -20.56 70.75 16.33 -22.54 coo 22.32 101.61 71.64 17.89 98.63 71.55 69.22 9.88 -20.56 74.70 7.02 -22.55 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 53 3 # 53 B 57 GLU D 75 GLU^? 15.53 MG MG E 301 B 226 THR D 46 THR^? 23.86 MG MG D 302 B 229 LYS C 6 LYS^? 25.73 MG MG C 302 coo 15.90 87.61 49.61 13.92 86.96 49.36 84.53 54.81 -36.40 82.75 56.01 -36.42 coo 20.74 95.78 68.68 19.29 96.84 69.83 91.28 37.63 -25.27 93.05 36.72 -26.12 coo 22.32 101.61 71.64 17.89 98.63 71.55 94.42 35.68 -18.56 92.21 32.03 -23.05 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 54 3 # 54 B 57 GLU D 94 GLU^? 16.28 MG MG D 302 B 226 THR D 46 THR^? 23.86 MG MG D 302 B 229 LYS C 6 LYS^? 25.73 MG MG C 302 coo 15.90 87.61 49.61 13.92 86.96 49.36 72.85 36.59 -35.79 71.78 37.87 -37.16 coo 20.74 95.78 68.68 19.29 96.84 69.83 91.28 37.63 -25.27 93.05 36.72 -26.12 coo 22.32 101.61 71.64 17.89 98.63 71.55 94.42 35.68 -18.56 92.21 32.03 -23.05 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 55 3 # 55 B 57 GLU D 94 GLU^? 16.28 MG MG D 302 B 226 THR D 74 THR^? 21.71 MG MG D 302 B 229 LYS D 76 LYS^? 25.08 MG MG D 302 coo 15.90 87.61 49.61 13.92 86.96 49.36 72.85 36.59 -35.79 71.78 37.87 -37.16 coo 20.74 95.78 68.68 19.29 96.84 69.83 86.03 50.57 -32.19 86.96 50.83 -30.24 coo 22.32 101.61 71.64 17.89 98.63 71.55 88.18 56.35 -34.05 93.80 56.17 -32.93 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 56 3 # 56 B 57 GLU D 146 GLU^? 10.62 MG MG D 301 B 226 THR D 70 THR^? 14.99 MG MG D 302 B 229 LYS D 90 LYS^? 18.98 MG MG D 302 coo 15.90 87.61 49.61 13.92 86.96 49.36 87.24 28.82 -50.92 85.47 28.08 -51.67 coo 20.74 95.78 68.68 19.29 96.84 69.83 83.38 38.35 -32.45 81.51 39.04 -33.23 coo 22.32 101.61 71.64 17.89 98.63 71.55 79.83 44.38 -31.44 80.32 39.55 -29.40 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 57 3 # 57 B 57 GLU D 154 GLU^? 18.75 MG MG D 302 B 226 THR C 2 THR^? 33.69 MG MG C 302 B 229 LYS C 137 LYS^? 35.41 MG MG C 302 coo 15.90 87.61 49.61 13.92 86.96 49.36 94.87 32.52 -36.42 96.07 33.39 -34.88 coo 20.74 95.78 68.68 19.29 96.84 69.83 103.03 43.13 -20.15 102.74 41.72 -18.56 coo 22.32 101.61 71.64 17.89 98.63 71.55 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 58 3 # 58 B 57 GLU D 154 GLU^? 18.75 MG MG D 302 B 226 THR D 74 THR^? 21.71 MG MG D 302 B 229 LYS D 86 LYS^? 25.80 MG MG D 302 coo 15.90 87.61 49.61 13.92 86.96 49.36 94.87 32.52 -36.42 96.07 33.39 -34.88 coo 20.74 95.78 68.68 19.29 96.84 69.83 86.03 50.57 -32.19 86.96 50.83 -30.24 coo 22.32 101.61 71.64 17.89 98.63 71.55 85.54 56.79 -30.27 90.24 54.54 -28.62 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 59 3 # 59 B 57 GLU E 19 GLU^? 18.42 MG MG E 301 B 226 THR E 169 THR^? 18.18 MG MG E 301 B 229 LYS E 166 LYS^? 21.46 MG MG E 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 82.78 67.13 -51.44 83.71 68.75 -50.40 coo 20.74 95.78 68.68 19.29 96.84 69.83 63.17 71.31 -52.89 63.43 72.88 -54.31 coo 22.32 101.61 71.64 17.89 98.63 71.55 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 60 3 # 60 B 57 GLU E 25 GLU^? 12.55 MG MG D 301 B 226 THR D 169 THR^? 18.47 MG MG D 301 B 229 LYS D 166 LYS^? 21.08 MG MG D 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 95.44 49.40 -47.17 93.82 48.00 -47.21 coo 20.74 95.78 68.68 19.29 96.84 69.83 97.62 30.68 -41.94 99.48 30.62 -40.85 coo 22.32 101.61 71.64 17.89 98.63 71.55 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 61 3 # 61 B 57 GLU E 25 GLU^? 12.55 MG MG D 301 B 226 THR E 88 THR^? 21.98 MG MG D 301 B 229 LYS E 90 LYS^? 19.16 MG MG E 302 coo 15.90 87.61 49.61 13.92 86.96 49.36 95.44 49.40 -47.17 93.82 48.00 -47.21 coo 20.74 95.78 68.68 19.29 96.84 69.83 80.56 52.52 -64.50 80.70 53.32 -66.53 coo 22.32 101.61 71.64 17.89 98.63 71.55 73.81 51.50 -63.18 69.15 52.39 -65.65 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 62 3 # 62 B 57 GLU E 33 GLU^? 22.81 MG MG E 302 B 226 THR E 169 THR^? 18.18 MG MG E 301 B 229 LYS E 166 LYS^? 21.46 MG MG E 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 80.16 62.57 -63.35 80.54 62.13 -65.43 coo 20.74 95.78 68.68 19.29 96.84 69.83 63.17 71.31 -52.89 63.43 72.88 -54.31 coo 22.32 101.61 71.64 17.89 98.63 71.55 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 63 3 # 63 B 57 GLU E 38 GLU^? 21.68 MG MG E 301 B 226 THR E 74 THR^? 21.51 MG MG E 302 B 229 LYS E 86 LYS^? 26.73 MG MG D 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 72.42 75.53 -60.31 73.00 74.78 -58.42 coo 20.74 95.78 68.68 19.29 96.84 69.83 80.89 56.59 -62.50 81.13 57.37 -64.43 coo 22.32 101.61 71.64 17.89 98.63 71.55 86.84 54.85 -64.43 87.07 60.83 -66.10 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 64 3 # 64 B 57 GLU E 75 GLU^? 15.76 MG MG D 301 B 226 THR E 46 THR^? 24.08 MG MG E 302 B 229 LYS F 6 LYS^? 26.09 MG MG F 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 84.65 53.96 -59.58 85.64 52.81 -58.05 coo 20.74 95.78 68.68 19.29 96.84 69.83 68.80 63.64 -69.48 69.18 65.66 -68.86 coo 22.32 101.61 71.64 17.89 98.63 71.55 67.53 67.03 -76.43 64.05 65.33 -71.86 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 65 3 # 65 B 57 GLU E 94 GLU^? 18.90 MG MG E 302 B 226 THR E 46 THR^? 24.08 MG MG E 302 B 229 LYS F 6 LYS^? 26.09 MG MG F 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 62.96 45.14 -58.39 62.13 44.53 -60.28 coo 20.74 95.78 68.68 19.29 96.84 69.83 68.80 63.64 -69.48 69.18 65.66 -68.86 coo 22.32 101.61 71.64 17.89 98.63 71.55 67.53 67.03 -76.43 64.05 65.33 -71.86 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 66 3 # 66 B 57 GLU E 94 GLU^? 18.90 MG MG E 302 B 226 THR E 74 THR^? 21.51 MG MG E 302 B 229 LYS E 76 LYS^? 25.68 MG MG E 302 coo 15.90 87.61 49.61 13.92 86.96 49.36 62.96 45.14 -58.39 62.13 44.53 -60.28 coo 20.74 95.78 68.68 19.29 96.84 69.83 80.89 56.59 -62.50 81.13 57.37 -64.43 coo 22.32 101.61 71.64 17.89 98.63 71.55 87.09 58.11 -60.91 88.65 63.65 -61.27 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 67 3 # 67 B 57 GLU E 94 GLU^? 18.90 MG MG E 302 B 226 THR E 74 THR^? 21.51 MG MG E 302 B 229 LYS E 86 LYS^? 26.73 MG MG D 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 62.96 45.14 -58.39 62.13 44.53 -60.28 coo 20.74 95.78 68.68 19.29 96.84 69.83 80.89 56.59 -62.50 81.13 57.37 -64.43 coo 22.32 101.61 71.64 17.89 98.63 71.55 86.84 54.85 -64.43 87.07 60.83 -66.10 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 68 3 # 68 B 57 GLU E 94 GLU^? 18.90 MG MG E 302 B 226 THR E 88 THR^? 21.98 MG MG D 301 B 229 LYS E 86 LYS^? 26.73 MG MG D 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 62.96 45.14 -58.39 62.13 44.53 -60.28 coo 20.74 95.78 68.68 19.29 96.84 69.83 80.56 52.52 -64.50 80.70 53.32 -66.53 coo 22.32 101.61 71.64 17.89 98.63 71.55 86.84 54.85 -64.43 87.07 60.83 -66.10 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 69 3 # 69 B 57 GLU E 146 GLU^? 10.15 MG MG E 301 B 226 THR E 70 THR^? 14.75 MG MG E 302 B 229 LYS E 90 LYS^? 19.16 MG MG E 302 coo 15.90 87.61 49.61 13.92 86.96 49.36 58.72 60.89 -44.51 59.23 60.24 -42.54 coo 20.74 95.78 68.68 19.29 96.84 69.83 68.45 55.77 -62.07 68.75 53.75 -61.41 coo 22.32 101.61 71.64 17.89 98.63 71.55 73.81 51.50 -63.18 69.15 52.39 -65.65 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 70 3 # 70 B 57 GLU E 154 GLU^? 19.05 MG MG E 302 B 226 THR E 74 THR^? 21.51 MG MG E 302 B 229 LYS E 76 LYS^? 25.68 MG MG E 302 coo 15.90 87.61 49.61 13.92 86.96 49.36 64.41 68.21 -58.47 65.40 69.20 -60.08 coo 20.74 95.78 68.68 19.29 96.84 69.83 80.89 56.59 -62.50 81.13 57.37 -64.43 coo 22.32 101.61 71.64 17.89 98.63 71.55 87.09 58.11 -60.91 88.65 63.65 -61.27 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 71 3 # 71 B 57 GLU E 154 GLU^? 19.05 MG MG E 302 B 226 THR E 74 THR^? 21.51 MG MG E 302 B 229 LYS E 86 LYS^? 26.73 MG MG D 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 64.41 68.21 -58.47 65.40 69.20 -60.08 coo 20.74 95.78 68.68 19.29 96.84 69.83 80.89 56.59 -62.50 81.13 57.37 -64.43 coo 22.32 101.61 71.64 17.89 98.63 71.55 86.84 54.85 -64.43 87.07 60.83 -66.10 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 72 3 # 72 B 57 GLU E 154 GLU^? 19.05 MG MG E 302 B 226 THR F 2 THR^? 34.54 MG MG F 301 B 229 LYS F 137 LYS^? 35.13 MG MG F 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 64.41 68.21 -58.47 65.40 69.20 -60.08 coo 20.74 95.78 68.68 19.29 96.84 69.83 76.07 74.83 -74.70 74.98 75.15 -76.59 coo 22.32 101.61 71.64 17.89 98.63 71.55 78.53 72.20 -80.30 83.01 68.64 -79.79 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 73 3 # 73 B 57 GLU F 19 GLU^? 17.88 MG MG F 302 B 226 THR F 169 THR^? 17.93 MG MG F 302 B 229 LYS F 166 LYS^? 20.76 MG MG F 302 coo 15.90 87.61 49.61 13.92 86.96 49.36 36.39 58.51 -87.58 37.20 60.13 -88.66 coo 20.74 95.78 68.68 19.29 96.84 69.83 54.83 68.79 -86.99 54.09 70.44 -85.82 coo 22.32 101.61 71.64 17.89 98.63 71.55 59.28 73.05 -82.63 55.63 74.15 -86.94 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 74 3 # 74 B 57 GLU F 33 GLU^? 22.46 MG MG F 301 B 226 THR F 169 THR^? 17.93 MG MG F 302 B 229 LYS F 166 LYS^? 20.76 MG MG F 302 coo 15.90 87.61 49.61 13.92 86.96 49.36 41.88 55.13 -75.91 42.06 54.64 -73.84 coo 20.74 95.78 68.68 19.29 96.84 69.83 54.83 68.79 -86.99 54.09 70.44 -85.82 coo 22.32 101.61 71.64 17.89 98.63 71.55 59.28 73.05 -82.63 55.63 74.15 -86.94 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 75 3 # 75 B 57 GLU F 38 GLU^? 21.28 MG MG F 302 B 226 THR F 74 THR^? 21.46 MG MG F 301 B 229 LYS F 86 LYS^? 26.63 MG MG F 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 44.63 69.79 -79.91 44.13 69.05 -81.85 coo 20.74 95.78 68.68 19.29 96.84 69.83 43.07 49.39 -76.61 42.46 50.11 -74.68 coo 22.32 101.61 71.64 17.89 98.63 71.55 37.89 45.97 -74.42 36.47 51.71 -72.79 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 76 3 # 76 B 57 GLU F 75 GLU^? 19.96 MG MG F 301 B 226 THR F 46 THR^? 24.16 MG MG F 301 B 229 LYS E 6 LYS^? 25.59 MG MG E 302 coo 15.90 87.61 49.61 13.92 86.96 49.36 40.19 46.06 -80.81 40.09 43.94 -81.24 coo 20.74 95.78 68.68 19.29 96.84 69.83 51.99 60.48 -70.07 50.88 62.21 -70.66 coo 22.32 101.61 71.64 17.89 98.63 71.55 51.95 64.70 -63.33 56.16 64.03 -67.52 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 77 3 # 77 B 57 GLU F 94 GLU^? 17.06 MG MG F 301 B 226 THR F 74 THR^? 21.46 MG MG F 301 B 229 LYS F 76 LYS^? 25.89 MG MG F 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 62.58 44.49 -81.43 64.13 42.92 -81.30 coo 20.74 95.78 68.68 19.29 96.84 69.83 43.07 49.39 -76.61 42.46 50.11 -74.68 coo 22.32 101.61 71.64 17.89 98.63 71.55 36.96 48.52 -78.06 33.74 53.37 -77.06 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 78 3 # 78 B 57 GLU F 94 GLU^? 17.06 MG MG F 301 B 226 THR F 74 THR^? 21.46 MG MG F 301 B 229 LYS F 86 LYS^? 26.63 MG MG F 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 62.58 44.49 -81.43 64.13 42.92 -81.30 coo 20.74 95.78 68.68 19.29 96.84 69.83 43.07 49.39 -76.61 42.46 50.11 -74.68 coo 22.32 101.61 71.64 17.89 98.63 71.55 37.89 45.97 -74.42 36.47 51.71 -72.79 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 79 3 # 79 B 57 GLU F 94 GLU^? 17.06 MG MG F 301 B 226 THR F 88 THR^? 23.06 MG MG F 301 B 229 LYS F 86 LYS^? 26.63 MG MG F 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 62.58 44.49 -81.43 64.13 42.92 -81.30 coo 20.74 95.78 68.68 19.29 96.84 69.83 44.71 45.78 -74.10 45.06 46.44 -72.02 coo 22.32 101.61 71.64 17.89 98.63 71.55 37.89 45.97 -74.42 36.47 51.71 -72.79 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 80 3 # 80 B 57 GLU F 146 GLU^? 10.36 MG MG F 302 B 226 THR F 70 THR^? 14.73 MG MG F 301 B 229 LYS F 90 LYS^? 18.57 MG MG F 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 61.95 60.17 -95.28 62.87 58.56 -96.19 coo 20.74 95.78 68.68 19.29 96.84 69.83 55.11 52.83 -76.85 55.53 50.86 -77.56 coo 22.32 101.61 71.64 17.89 98.63 71.55 51.54 47.01 -75.58 55.05 50.31 -73.74 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 81 3 # 81 B 57 GLU F 154 GLU^? 18.97 MG MG F 301 B 226 THR E 2 THR^? 33.84 MG MG E 302 B 229 LYS E 137 LYS^? 35.26 MG MG E 302 coo 15.90 87.61 49.61 13.92 86.96 49.36 54.57 65.67 -81.55 53.36 66.51 -80.09 coo 20.74 95.78 68.68 19.29 96.84 69.83 41.32 68.37 -65.29 42.66 69.03 -63.78 coo 22.32 101.61 71.64 17.89 98.63 71.55 40.01 66.05 -59.66 36.65 60.99 -60.28 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 82 3 # 82 B 57 GLU F 154 GLU^? 18.97 MG MG F 301 B 226 THR F 74 THR^? 21.46 MG MG F 301 B 229 LYS F 86 LYS^? 26.63 MG MG F 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 54.57 65.67 -81.55 53.36 66.51 -80.09 coo 20.74 95.78 68.68 19.29 96.84 69.83 43.07 49.39 -76.61 42.46 50.11 -74.68 coo 22.32 101.61 71.64 17.89 98.63 71.55 37.89 45.97 -74.42 36.47 51.71 -72.79 1dfo_c05 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 82 hits 1dfo_c05 naa= 3 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 57 GLU A 19 GLU.? 16.46 MG MG A 302 C 226 THR A 169 THR^? 18.45 MG MG A 302 C 229 LYS A 166 LYS^? 20.93 MG MG A 302 coo 5.43 40.40 61.63 4.27 41.99 60.90 29.75 40.22 38.71 30.73 40.87 40.56 coo 22.16 45.88 73.63 23.23 47.70 73.25 34.64 19.08 35.13 33.08 18.40 33.78 coo 28.90 45.91 73.55 25.22 49.72 72.97 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 C 57 GLU A 25 GLU^? 25.87 MG MG A 301 C 226 THR A 73 THR^? 15.13 MG MG A 301 C 229 LYS A 90 LYS^? 18.58 MG MG A 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 39.62 57.50 39.92 41.51 57.27 40.85 coo 22.16 45.88 73.63 23.23 47.70 73.25 40.93 39.17 26.72 41.99 38.78 28.61 coo 28.90 45.91 73.55 25.22 49.72 72.97 46.62 38.29 25.46 47.51 33.29 23.22 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 C 57 GLU A 25 GLU^? 25.87 MG MG A 301 C 226 THR A 88 THR^? 23.22 MG MG A 301 C 229 LYS A 90 LYS^? 18.58 MG MG A 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 39.62 57.50 39.92 41.51 57.27 40.85 coo 22.16 45.88 73.63 23.23 47.70 73.25 42.44 43.75 23.46 42.54 42.92 21.44 coo 28.90 45.91 73.55 25.22 49.72 72.97 46.62 38.29 25.46 47.51 33.29 23.22 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 C 57 GLU A 33 GLU^? 22.87 MG MG A 301 C 226 THR A 169 THR^? 18.45 MG MG A 302 C 229 LYS A 166 LYS^? 20.93 MG MG A 302 coo 5.43 40.40 61.63 4.27 41.99 60.90 33.74 38.67 24.96 34.13 38.85 22.87 coo 22.16 45.88 73.63 23.23 47.70 73.25 34.64 19.08 35.13 33.08 18.40 33.78 coo 28.90 45.91 73.55 25.22 49.72 72.97 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 C 57 GLU A 38 GLU^? 21.81 MG MG A 302 C 226 THR A 74 THR^? 21.85 MG MG A 301 C 229 LYS A 86 LYS^? 26.38 MG MG A 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 26.42 25.01 28.02 26.98 25.90 29.89 coo 22.16 45.88 73.63 23.23 47.70 73.25 38.65 41.92 25.57 37.60 41.76 23.73 coo 28.90 45.91 73.55 25.22 49.72 72.97 37.08 47.78 23.56 32.88 44.24 21.89 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 C 57 GLU A 54 GLU^? 22.98 MG MG A 301 C 226 THR A 74 THR^? 21.85 MG MG A 301 C 229 LYS A 76 LYS^? 25.42 MG MG A 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 45.06 19.97 24.02 44.05 19.39 22.19 coo 22.16 45.88 73.63 23.23 47.70 73.25 38.65 41.92 25.57 37.60 41.76 23.73 coo 28.90 45.91 73.55 25.22 49.72 72.97 34.45 46.53 27.28 28.88 44.93 27.25 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 C 57 GLU A 75 GLU^? 20.23 MG MG A 301 C 226 THR A 46 THR^? 24.24 MG MG A 301 C 229 LYS B 6 LYS^? 25.90 MG MG B 302 coo 5.43 40.40 61.63 4.27 41.99 60.90 38.99 46.65 28.68 39.94 47.65 30.33 coo 22.16 45.88 73.63 23.23 47.70 73.25 38.63 28.11 18.80 36.62 27.50 19.27 coo 28.90 45.91 73.55 25.22 49.72 72.97 36.26 25.44 11.74 39.65 23.12 16.29 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 C 57 GLU A 94 GLU^? 17.31 MG MG A 301 C 226 THR A 46 THR^? 24.24 MG MG A 301 C 229 LYS B 6 LYS^? 25.90 MG MG B 302 coo 5.43 40.40 61.63 4.27 41.99 60.90 57.11 32.79 29.92 57.45 34.91 29.85 coo 22.16 45.88 73.63 23.23 47.70 73.25 38.63 28.11 18.80 36.62 27.50 19.27 coo 28.90 45.91 73.55 25.22 49.72 72.97 36.26 25.44 11.74 39.65 23.12 16.29 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 C 57 GLU A 94 GLU^? 17.31 MG MG A 301 C 226 THR A 74 THR^? 21.85 MG MG A 301 C 229 LYS A 76 LYS^? 25.42 MG MG A 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 57.11 32.79 29.92 57.45 34.91 29.85 coo 22.16 45.88 73.63 23.23 47.70 73.25 38.65 41.92 25.57 37.60 41.76 23.73 coo 28.90 45.91 73.55 25.22 49.72 72.97 34.45 46.53 27.28 28.88 44.93 27.25 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 C 57 GLU A 94 GLU^? 17.31 MG MG A 301 C 226 THR A 74 THR^? 21.85 MG MG A 301 C 229 LYS A 86 LYS^? 26.38 MG MG A 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 57.11 32.79 29.92 57.45 34.91 29.85 coo 22.16 45.88 73.63 23.23 47.70 73.25 38.65 41.92 25.57 37.60 41.76 23.73 coo 28.90 45.91 73.55 25.22 49.72 72.97 37.08 47.78 23.56 32.88 44.24 21.89 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 C 57 GLU A 94 GLU^? 17.31 MG MG A 301 C 226 THR A 88 THR^? 23.22 MG MG A 301 C 229 LYS A 86 LYS^? 26.38 MG MG A 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 57.11 32.79 29.92 57.45 34.91 29.85 coo 22.16 45.88 73.63 23.23 47.70 73.25 42.44 43.75 23.46 42.54 42.92 21.44 coo 28.90 45.91 73.55 25.22 49.72 72.97 37.08 47.78 23.56 32.88 44.24 21.89 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 C 57 GLU A 146 GLU^? 9.80 MG MG A 302 C 226 THR A 70 THR^? 14.66 MG MG A 301 C 229 LYS A 90 LYS^? 18.58 MG MG A 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 45.17 20.35 44.20 46.68 21.21 45.40 coo 22.16 45.88 73.63 23.23 47.70 73.25 45.68 31.52 26.25 47.33 32.60 27.12 coo 28.90 45.91 73.55 25.22 49.72 72.97 46.62 38.29 25.46 47.51 33.29 23.22 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 C 57 GLU A 154 GLU^? 19.22 MG MG A 301 C 226 THR A 74 THR^? 21.85 MG MG A 301 C 229 LYS A 86 LYS^? 26.38 MG MG A 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 36.54 21.95 29.78 35.14 22.21 28.17 coo 22.16 45.88 73.63 23.23 47.70 73.25 38.65 41.92 25.57 37.60 41.76 23.73 coo 28.90 45.91 73.55 25.22 49.72 72.97 37.08 47.78 23.56 32.88 44.24 21.89 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 14 3 # 14 C 57 GLU A 154 GLU^? 19.22 MG MG A 301 C 226 THR B 2 THR^? 34.11 MG MG B 302 C 229 LYS B 137 LYS^? 34.56 MG MG B 302 coo 5.43 40.40 61.63 4.27 41.99 60.90 36.54 21.95 29.78 35.14 22.21 28.17 coo 22.16 45.88 73.63 23.23 47.70 73.25 25.51 29.18 13.74 26.24 28.19 11.93 coo 28.90 45.91 73.55 25.22 49.72 72.97 26.56 32.46 7.93 27.87 37.71 9.31 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 15 3 # 15 C 57 GLU B 19 GLU^? 18.96 MG MG B 301 C 226 THR B 169 THR^? 18.43 MG MG B 301 C 229 LYS B 166 LYS^? 22.75 MG MG B 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 59.29 4.54 -0.16 58.81 2.51 -0.44 coo 22.16 45.88 73.63 23.23 47.70 73.25 41.38 13.97 0.97 40.27 12.43 2.02 coo 28.90 45.91 73.55 25.22 49.72 72.97 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 16 3 # 16 C 57 GLU B 25 GLU^? 12.88 MG MG C 301 C 226 THR B 88 THR^? 22.44 MG MG C 301 C 229 LYS B 90 LYS^? 18.68 MG MG B 302 coo 5.43 40.40 61.63 4.27 41.99 60.90 79.57 9.59 -3.08 79.20 11.68 -3.64 coo 22.16 45.88 73.63 23.23 47.70 73.25 66.42 16.42 14.22 65.45 16.28 16.18 coo 28.90 45.91 73.55 25.22 49.72 72.97 61.66 21.61 12.88 56.74 22.88 14.81 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 17 3 # 17 C 57 GLU B 25 GLU^? 12.88 MG MG C 301 C 226 THR C 169 THR^? 18.51 MG MG C 301 C 229 LYS C 166 LYS^? 22.53 MG MG C 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 79.57 9.59 -3.08 79.20 11.68 -3.64 coo 22.16 45.88 73.63 23.23 47.70 73.25 94.19 23.02 -7.83 95.56 21.86 -9.07 coo 28.90 45.91 73.55 25.22 49.72 72.97 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 18 3 # 18 C 57 GLU B 33 GLU^? 22.65 MG MG B 302 C 226 THR B 169 THR^? 18.43 MG MG B 301 C 229 LYS B 166 LYS^? 22.75 MG MG B 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 59.88 9.09 12.22 59.91 9.49 14.33 coo 22.16 45.88 73.63 23.23 47.70 73.25 41.38 13.97 0.97 40.27 12.43 2.02 coo 28.90 45.91 73.55 25.22 49.72 72.97 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 19 3 # 19 C 57 GLU B 38 GLU^? 21.75 MG MG B 301 C 226 THR B 74 THR^? 21.68 MG MG B 302 C 229 LYS B 86 LYS^? 26.44 MG MG B 302 coo 5.43 40.40 61.63 4.27 41.99 60.90 44.79 4.95 7.12 46.66 4.47 6.21 coo 22.16 45.88 73.63 23.23 47.70 73.25 63.99 13.20 11.95 63.36 12.32 13.84 coo 28.90 45.91 73.55 25.22 49.72 72.97 69.25 10.45 13.86 65.27 7.74 16.08 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 20 3 # 20 C 57 GLU B 54 GLU^? 22.94 MG MG B 302 C 226 THR A 74 THR^? 21.85 MG MG A 301 C 229 LYS A 76 LYS^? 25.42 MG MG A 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 43.18 23.27 12.99 42.40 22.23 14.68 coo 22.16 45.88 73.63 23.23 47.70 73.25 38.65 41.92 25.57 37.60 41.76 23.73 coo 28.90 45.91 73.55 25.22 49.72 72.97 34.45 46.53 27.28 28.88 44.93 27.25 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 21 3 # 21 C 57 GLU B 54 GLU^? 22.94 MG MG B 302 C 226 THR A 74 THR^? 21.85 MG MG A 301 C 229 LYS A 86 LYS^? 26.38 MG MG A 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 43.18 23.27 12.99 42.40 22.23 14.68 coo 22.16 45.88 73.63 23.23 47.70 73.25 38.65 41.92 25.57 37.60 41.76 23.73 coo 28.90 45.91 73.55 25.22 49.72 72.97 37.08 47.78 23.56 32.88 44.24 21.89 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 22 3 # 22 C 57 GLU B 54 GLU^? 22.94 MG MG B 302 C 226 THR A 88 THR^? 23.22 MG MG A 301 C 229 LYS A 86 LYS^? 26.38 MG MG A 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 43.18 23.27 12.99 42.40 22.23 14.68 coo 22.16 45.88 73.63 23.23 47.70 73.25 42.44 43.75 23.46 42.54 42.92 21.44 coo 28.90 45.91 73.55 25.22 49.72 72.97 37.08 47.78 23.56 32.88 44.24 21.89 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 23 3 # 23 C 57 GLU B 75 GLU^? 15.82 MG MG C 301 C 226 THR B 46 THR^? 23.88 MG MG B 302 C 229 LYS A 6 LYS^? 25.88 MG MG A 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 68.81 12.14 8.61 69.95 13.49 7.45 coo 22.16 45.88 73.63 23.23 47.70 73.25 49.71 15.16 18.13 48.80 13.51 17.14 coo 28.90 45.91 73.55 25.22 49.72 72.97 46.20 12.82 24.71 44.50 16.64 20.52 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 24 3 # 24 C 57 GLU B 94 GLU^? 15.34 MG MG B 302 C 226 THR B 46 THR^? 23.88 MG MG B 302 C 229 LYS A 6 LYS^? 25.88 MG MG A 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 58.44 31.30 7.43 60.35 32.14 7.14 coo 22.16 45.88 73.63 23.23 47.70 73.25 49.71 15.16 18.13 48.80 13.51 17.14 coo 28.90 45.91 73.55 25.22 49.72 72.97 46.20 12.82 24.71 44.50 16.64 20.52 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 25 3 # 25 C 57 GLU B 94 GLU^? 15.34 MG MG B 302 C 226 THR B 74 THR^? 21.68 MG MG B 302 C 229 LYS B 76 LYS^? 25.77 MG MG B 302 coo 5.43 40.40 61.63 4.27 41.99 60.90 58.44 31.30 7.43 60.35 32.14 7.14 coo 22.16 45.88 73.63 23.23 47.70 73.25 63.99 13.20 11.95 63.36 12.32 13.84 coo 28.90 45.91 73.55 25.22 49.72 72.97 67.82 8.19 10.14 64.96 3.09 10.62 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 26 3 # 26 C 57 GLU B 146 GLU^? 10.54 MG MG B 301 C 226 THR B 70 THR^? 14.69 MG MG B 302 C 229 LYS B 90 LYS^? 18.68 MG MG B 302 coo 5.43 40.40 61.63 4.27 41.99 60.90 45.13 24.51 -7.01 46.08 25.99 -8.13 coo 22.16 45.88 73.63 23.23 47.70 73.25 54.82 21.76 11.59 56.34 23.17 10.82 coo 28.90 45.91 73.55 25.22 49.72 72.97 61.66 21.61 12.88 56.74 22.88 14.81 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 27 3 # 27 C 57 GLU B 154 GLU^? 19.05 MG MG B 302 C 226 THR A 2 THR.? 34.64 MG MG A 301 C 229 LYS A 137 LYS^? 34.85 MG MG A 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 44.04 15.11 6.74 44.19 13.59 8.30 coo 22.16 45.88 73.63 23.23 47.70 73.25 47.80 1.72 22.09 46.70 1.88 23.97 coo 28.90 45.91 73.55 25.22 49.72 72.97 50.97 1.58 28.14 56.13 1.49 28.03 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 28 3 # 28 C 57 GLU B 154 GLU^? 19.05 MG MG B 302 C 226 THR B 74 THR^? 21.68 MG MG B 302 C 229 LYS B 76 LYS^? 25.77 MG MG B 302 coo 5.43 40.40 61.63 4.27 41.99 60.90 44.04 15.11 6.74 44.19 13.59 8.30 coo 22.16 45.88 73.63 23.23 47.70 73.25 63.99 13.20 11.95 63.36 12.32 13.84 coo 28.90 45.91 73.55 25.22 49.72 72.97 67.82 8.19 10.14 64.96 3.09 10.62 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 29 3 # 29 C 57 GLU B 154 GLU^? 19.05 MG MG B 302 C 226 THR B 74 THR^? 21.68 MG MG B 302 C 229 LYS B 86 LYS^? 26.44 MG MG B 302 coo 5.43 40.40 61.63 4.27 41.99 60.90 44.04 15.11 6.74 44.19 13.59 8.30 coo 22.16 45.88 73.63 23.23 47.70 73.25 63.99 13.20 11.95 63.36 12.32 13.84 coo 28.90 45.91 73.55 25.22 49.72 72.97 69.25 10.45 13.86 65.27 7.74 16.08 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 30 3 # 30 C 57 GLU C 19 GLU^? 19.08 MG MG C 301 C 226 THR C 169 THR^? 18.51 MG MG C 301 C 229 LYS C 166 LYS^? 22.53 MG MG C 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 80.46 7.67 -6.81 81.43 5.97 -5.99 coo 22.16 45.88 73.63 23.23 47.70 73.25 94.19 23.02 -7.83 95.56 21.86 -9.07 coo 28.90 45.91 73.55 25.22 49.72 72.97 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 31 3 # 31 C 57 GLU C 25 GLU^? 12.27 MG MG B 301 C 226 THR C 88 THR^? 22.58 MG MG B 301 C 229 LYS C 90 LYS^? 18.24 MG MG C 302 coo 5.43 40.40 61.63 4.27 41.99 60.90 58.50 6.48 -3.59 57.94 8.54 -3.41 coo 22.16 45.88 73.63 23.23 47.70 73.25 69.96 16.71 -20.56 70.75 16.33 -22.54 coo 28.90 45.91 73.55 25.22 49.72 72.97 72.37 23.25 -18.94 76.11 26.52 -20.97 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 32 3 # 32 C 57 GLU C 33 GLU^? 22.71 MG MG C 302 C 226 THR C 169 THR^? 18.51 MG MG C 301 C 229 LYS C 166 LYS^? 22.53 MG MG C 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 78.39 11.67 -18.82 78.34 12.01 -20.91 coo 22.16 45.88 73.63 23.23 47.70 73.25 94.19 23.02 -7.83 95.56 21.86 -9.07 coo 28.90 45.91 73.55 25.22 49.72 72.97 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 33 3 # 33 C 57 GLU C 38 GLU^? 21.99 MG MG C 301 C 226 THR C 74 THR^? 21.64 MG MG C 302 C 229 LYS C 86 LYS^? 27.34 MG MG C 302 coo 5.43 40.40 61.63 4.27 41.99 60.90 93.66 12.78 -15.08 92.73 12.51 -13.19 coo 22.16 45.88 73.63 23.23 47.70 73.25 73.35 14.53 -18.47 73.89 13.78 -20.47 coo 28.90 45.91 73.55 25.22 49.72 72.97 69.22 9.88 -20.56 74.70 7.02 -22.55 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 34 3 # 34 C 57 GLU C 54 GLU^? 22.77 MG MG C 302 C 226 THR D 74 THR^? 21.71 MG MG D 302 C 229 LYS D 86 LYS^? 25.80 MG MG D 302 coo 5.43 40.40 61.63 4.27 41.99 60.90 88.91 31.25 -19.52 89.97 30.69 -21.29 coo 22.16 45.88 73.63 23.23 47.70 73.25 86.03 50.57 -32.19 86.96 50.83 -30.24 coo 28.90 45.91 73.55 25.22 49.72 72.97 85.54 56.79 -30.27 90.24 54.54 -28.62 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 35 3 # 35 C 57 GLU C 75 GLU^? 16.14 MG MG B 301 C 226 THR C 46 THR^? 24.02 MG MG C 302 C 229 LYS D 6 LYS^? 25.98 MG MG D 302 coo 5.43 40.40 61.63 4.27 41.99 60.90 69.49 12.18 -14.30 67.44 12.65 -13.83 coo 22.16 45.88 73.63 23.23 47.70 73.25 85.56 21.34 -24.69 87.12 20.00 -24.12 coo 28.90 45.91 73.55 25.22 49.72 72.97 89.78 20.68 -31.57 90.15 24.89 -27.02 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 36 3 # 36 C 57 GLU C 94 GLU^? 16.62 MG MG C 302 C 226 THR C 46 THR^? 24.02 MG MG C 302 C 229 LYS D 6 LYS^? 25.98 MG MG D 302 coo 5.43 40.40 61.63 4.27 41.99 60.90 71.81 35.42 -14.68 69.88 35.53 -13.78 coo 22.16 45.88 73.63 23.23 47.70 73.25 85.56 21.34 -24.69 87.12 20.00 -24.12 coo 28.90 45.91 73.55 25.22 49.72 72.97 89.78 20.68 -31.57 90.15 24.89 -27.02 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 37 3 # 37 C 57 GLU C 94 GLU^? 16.62 MG MG C 302 C 226 THR C 74 THR^? 21.64 MG MG C 302 C 229 LYS C 76 LYS^? 24.95 MG MG C 302 coo 5.43 40.40 61.63 4.27 41.99 60.90 71.81 35.42 -14.68 69.88 35.53 -13.78 coo 22.16 45.88 73.63 23.23 47.70 73.25 73.35 14.53 -18.47 73.89 13.78 -20.47 coo 28.90 45.91 73.55 25.22 49.72 72.97 71.11 8.63 -16.76 75.44 5.17 -16.80 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 38 3 # 38 C 57 GLU C 94 GLU^? 16.62 MG MG C 302 C 226 THR C 74 THR^? 21.64 MG MG C 302 C 229 LYS C 86 LYS^? 27.34 MG MG C 302 coo 5.43 40.40 61.63 4.27 41.99 60.90 71.81 35.42 -14.68 69.88 35.53 -13.78 coo 22.16 45.88 73.63 23.23 47.70 73.25 73.35 14.53 -18.47 73.89 13.78 -20.47 coo 28.90 45.91 73.55 25.22 49.72 72.97 69.22 9.88 -20.56 74.70 7.02 -22.55 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 39 3 # 39 C 57 GLU C 94 GLU^? 16.62 MG MG C 302 C 226 THR C 88 THR^? 22.58 MG MG B 301 C 229 LYS C 86 LYS^? 27.34 MG MG C 302 coo 5.43 40.40 61.63 4.27 41.99 60.90 71.81 35.42 -14.68 69.88 35.53 -13.78 coo 22.16 45.88 73.63 23.23 47.70 73.25 69.96 16.71 -20.56 70.75 16.33 -22.54 coo 28.90 45.91 73.55 25.22 49.72 72.97 69.22 9.88 -20.56 74.70 7.02 -22.55 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 40 3 # 40 C 57 GLU C 146 GLU^? 10.46 MG MG C 301 C 226 THR C 70 THR^? 14.45 MG MG C 302 C 229 LYS C 90 LYS^? 18.24 MG MG C 302 coo 5.43 40.40 61.63 4.27 41.99 60.90 87.01 31.93 0.25 85.57 32.56 1.72 coo 22.16 45.88 73.63 23.23 47.70 73.25 78.63 25.77 -17.76 76.70 26.55 -17.21 coo 28.90 45.91 73.55 25.22 49.72 72.97 72.37 23.25 -18.94 76.11 26.52 -20.97 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 41 3 # 41 C 57 GLU C 154 GLU^? 18.91 MG MG C 302 C 226 THR C 74 THR^? 21.64 MG MG C 302 C 229 LYS C 76 LYS^? 24.95 MG MG C 302 coo 5.43 40.40 61.63 4.27 41.99 60.90 91.15 23.27 -13.33 91.61 21.91 -14.95 coo 22.16 45.88 73.63 23.23 47.70 73.25 73.35 14.53 -18.47 73.89 13.78 -20.47 coo 28.90 45.91 73.55 25.22 49.72 72.97 71.11 8.63 -16.76 75.44 5.17 -16.80 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 42 3 # 42 C 57 GLU C 154 GLU^? 18.91 MG MG C 302 C 226 THR C 74 THR^? 21.64 MG MG C 302 C 229 LYS C 86 LYS^? 27.34 MG MG C 302 coo 5.43 40.40 61.63 4.27 41.99 60.90 91.15 23.27 -13.33 91.61 21.91 -14.95 coo 22.16 45.88 73.63 23.23 47.70 73.25 73.35 14.53 -18.47 73.89 13.78 -20.47 coo 28.90 45.91 73.55 25.22 49.72 72.97 69.22 9.88 -20.56 74.70 7.02 -22.55 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 43 3 # 43 C 57 GLU C 154 GLU^? 18.91 MG MG C 302 C 226 THR D 2 THR^? 33.99 MG MG D 302 C 229 LYS D 137 LYS^? 37.57 MG MG D 302 coo 5.43 40.40 61.63 4.27 41.99 60.90 91.15 23.27 -13.33 91.61 21.91 -14.95 coo 22.16 45.88 73.63 23.23 47.70 73.25 91.82 9.34 -29.18 91.80 10.46 -31.03 coo 28.90 45.91 73.55 25.22 49.72 72.97 88.48 8.58 -35.33 84.88 3.98 -33.96 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 44 3 # 44 C 57 GLU D 19 GLU^? 18.95 MG MG D 301 C 226 THR D 169 THR^? 18.47 MG MG D 301 C 229 LYS D 166 LYS^? 21.08 MG MG D 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 96.86 51.08 -43.04 98.60 51.44 -44.26 coo 22.16 45.88 73.63 23.23 47.70 73.25 97.62 30.68 -41.94 99.48 30.62 -40.85 coo 28.90 45.91 73.55 25.22 49.72 72.97 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 45 3 # 45 C 57 GLU D 25 GLU^? 12.44 MG MG E 301 C 226 THR D 88 THR^? 22.15 MG MG E 301 C 229 LYS D 90 LYS^? 18.98 MG MG D 302 coo 5.43 40.40 61.63 4.27 41.99 60.90 81.26 66.22 -47.78 79.52 64.98 -48.06 coo 22.16 45.88 73.63 23.23 47.70 73.25 81.92 51.17 -30.12 82.55 50.45 -28.12 coo 28.90 45.91 73.55 25.22 49.72 72.97 79.83 44.38 -31.44 80.32 39.55 -29.40 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 46 3 # 46 C 57 GLU D 25 GLU^? 12.44 MG MG E 301 C 226 THR E 169 THR^? 18.18 MG MG E 301 C 229 LYS E 166 LYS^? 21.46 MG MG E 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 81.26 66.22 -47.78 79.52 64.98 -48.06 coo 22.16 45.88 73.63 23.23 47.70 73.25 63.17 71.31 -52.89 63.43 72.88 -54.31 coo 28.90 45.91 73.55 25.22 49.72 72.97 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 47 3 # 47 C 57 GLU D 33 GLU^? 22.23 MG MG D 302 C 226 THR D 169 THR^? 18.47 MG MG D 301 C 229 LYS D 166 LYS^? 21.08 MG MG D 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 91.55 48.87 -31.66 91.12 48.92 -29.63 coo 22.16 45.88 73.63 23.23 47.70 73.25 97.62 30.68 -41.94 99.48 30.62 -40.85 coo 28.90 45.91 73.55 25.22 49.72 72.97 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 48 3 # 48 C 57 GLU D 38 GLU^? 21.83 MG MG D 301 C 226 THR D 74 THR^? 21.71 MG MG D 302 C 229 LYS D 86 LYS^? 25.80 MG MG D 302 coo 5.43 40.40 61.63 4.27 41.99 60.90 103.22 39.19 -34.75 102.77 39.81 -36.73 coo 22.16 45.88 73.63 23.23 47.70 73.25 86.03 50.57 -32.19 86.96 50.83 -30.24 coo 28.90 45.91 73.55 25.22 49.72 72.97 85.54 56.79 -30.27 90.24 54.54 -28.62 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 49 3 # 49 C 57 GLU D 52 GLU^? 19.94 MG MG D 302 C 226 THR C 2 THR^? 33.69 MG MG C 302 C 229 LYS C 137 LYS^? 35.41 MG MG C 302 coo 5.43 40.40 61.63 4.27 41.99 60.90 87.13 33.17 -30.97 88.40 33.70 -29.31 coo 22.16 45.88 73.63 23.23 47.70 73.25 103.03 43.13 -20.15 102.74 41.72 -18.56 coo 28.90 45.91 73.55 25.22 49.72 72.97 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 50 3 # 50 C 57 GLU D 54 GLU^? 22.96 MG MG D 302 C 226 THR C 74 THR^? 21.64 MG MG C 302 C 229 LYS C 76 LYS^? 24.95 MG MG C 302 coo 5.43 40.40 61.63 4.27 41.99 60.90 87.96 27.60 -30.52 89.07 27.55 -28.72 coo 22.16 45.88 73.63 23.23 47.70 73.25 73.35 14.53 -18.47 73.89 13.78 -20.47 coo 28.90 45.91 73.55 25.22 49.72 72.97 71.11 8.63 -16.76 75.44 5.17 -16.80 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 51 3 # 51 C 57 GLU D 54 GLU^? 22.96 MG MG D 302 C 226 THR C 74 THR^? 21.64 MG MG C 302 C 229 LYS C 86 LYS^? 27.34 MG MG C 302 coo 5.43 40.40 61.63 4.27 41.99 60.90 87.96 27.60 -30.52 89.07 27.55 -28.72 coo 22.16 45.88 73.63 23.23 47.70 73.25 73.35 14.53 -18.47 73.89 13.78 -20.47 coo 28.90 45.91 73.55 25.22 49.72 72.97 69.22 9.88 -20.56 74.70 7.02 -22.55 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 52 3 # 52 C 57 GLU D 54 GLU^? 22.96 MG MG D 302 C 226 THR C 88 THR^? 22.58 MG MG B 301 C 229 LYS C 86 LYS^? 27.34 MG MG C 302 coo 5.43 40.40 61.63 4.27 41.99 60.90 87.96 27.60 -30.52 89.07 27.55 -28.72 coo 22.16 45.88 73.63 23.23 47.70 73.25 69.96 16.71 -20.56 70.75 16.33 -22.54 coo 28.90 45.91 73.55 25.22 49.72 72.97 69.22 9.88 -20.56 74.70 7.02 -22.55 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 53 3 # 53 C 57 GLU D 75 GLU^? 15.53 MG MG E 301 C 226 THR D 46 THR^? 23.86 MG MG D 302 C 229 LYS C 6 LYS^? 25.73 MG MG C 302 coo 5.43 40.40 61.63 4.27 41.99 60.90 84.53 54.81 -36.40 82.75 56.01 -36.42 coo 22.16 45.88 73.63 23.23 47.70 73.25 91.28 37.63 -25.27 93.05 36.72 -26.12 coo 28.90 45.91 73.55 25.22 49.72 72.97 94.42 35.68 -18.56 92.21 32.03 -23.05 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 54 3 # 54 C 57 GLU D 94 GLU^? 16.28 MG MG D 302 C 226 THR D 46 THR^? 23.86 MG MG D 302 C 229 LYS C 6 LYS^? 25.73 MG MG C 302 coo 5.43 40.40 61.63 4.27 41.99 60.90 72.85 36.59 -35.79 71.78 37.87 -37.16 coo 22.16 45.88 73.63 23.23 47.70 73.25 91.28 37.63 -25.27 93.05 36.72 -26.12 coo 28.90 45.91 73.55 25.22 49.72 72.97 94.42 35.68 -18.56 92.21 32.03 -23.05 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 55 3 # 55 C 57 GLU D 94 GLU^? 16.28 MG MG D 302 C 226 THR D 74 THR^? 21.71 MG MG D 302 C 229 LYS D 76 LYS^? 25.08 MG MG D 302 coo 5.43 40.40 61.63 4.27 41.99 60.90 72.85 36.59 -35.79 71.78 37.87 -37.16 coo 22.16 45.88 73.63 23.23 47.70 73.25 86.03 50.57 -32.19 86.96 50.83 -30.24 coo 28.90 45.91 73.55 25.22 49.72 72.97 88.18 56.35 -34.05 93.80 56.17 -32.93 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 56 3 # 56 C 57 GLU D 146 GLU^? 10.62 MG MG D 301 C 226 THR D 70 THR^? 14.99 MG MG D 302 C 229 LYS D 90 LYS^? 18.98 MG MG D 302 coo 5.43 40.40 61.63 4.27 41.99 60.90 87.24 28.82 -50.92 85.47 28.08 -51.67 coo 22.16 45.88 73.63 23.23 47.70 73.25 83.38 38.35 -32.45 81.51 39.04 -33.23 coo 28.90 45.91 73.55 25.22 49.72 72.97 79.83 44.38 -31.44 80.32 39.55 -29.40 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 57 3 # 57 C 57 GLU D 154 GLU^? 18.75 MG MG D 302 C 226 THR C 2 THR^? 33.69 MG MG C 302 C 229 LYS C 137 LYS^? 35.41 MG MG C 302 coo 5.43 40.40 61.63 4.27 41.99 60.90 94.87 32.52 -36.42 96.07 33.39 -34.88 coo 22.16 45.88 73.63 23.23 47.70 73.25 103.03 43.13 -20.15 102.74 41.72 -18.56 coo 28.90 45.91 73.55 25.22 49.72 72.97 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 58 3 # 58 C 57 GLU D 154 GLU^? 18.75 MG MG D 302 C 226 THR D 74 THR^? 21.71 MG MG D 302 C 229 LYS D 86 LYS^? 25.80 MG MG D 302 coo 5.43 40.40 61.63 4.27 41.99 60.90 94.87 32.52 -36.42 96.07 33.39 -34.88 coo 22.16 45.88 73.63 23.23 47.70 73.25 86.03 50.57 -32.19 86.96 50.83 -30.24 coo 28.90 45.91 73.55 25.22 49.72 72.97 85.54 56.79 -30.27 90.24 54.54 -28.62 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 59 3 # 59 C 57 GLU E 19 GLU^? 18.42 MG MG E 301 C 226 THR E 169 THR^? 18.18 MG MG E 301 C 229 LYS E 166 LYS^? 21.46 MG MG E 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 82.78 67.13 -51.44 83.71 68.75 -50.40 coo 22.16 45.88 73.63 23.23 47.70 73.25 63.17 71.31 -52.89 63.43 72.88 -54.31 coo 28.90 45.91 73.55 25.22 49.72 72.97 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 60 3 # 60 C 57 GLU E 25 GLU^? 12.55 MG MG D 301 C 226 THR D 169 THR^? 18.47 MG MG D 301 C 229 LYS D 166 LYS^? 21.08 MG MG D 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 95.44 49.40 -47.17 93.82 48.00 -47.21 coo 22.16 45.88 73.63 23.23 47.70 73.25 97.62 30.68 -41.94 99.48 30.62 -40.85 coo 28.90 45.91 73.55 25.22 49.72 72.97 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 61 3 # 61 C 57 GLU E 25 GLU^? 12.55 MG MG D 301 C 226 THR E 88 THR^? 21.98 MG MG D 301 C 229 LYS E 90 LYS^? 19.16 MG MG E 302 coo 5.43 40.40 61.63 4.27 41.99 60.90 95.44 49.40 -47.17 93.82 48.00 -47.21 coo 22.16 45.88 73.63 23.23 47.70 73.25 80.56 52.52 -64.50 80.70 53.32 -66.53 coo 28.90 45.91 73.55 25.22 49.72 72.97 73.81 51.50 -63.18 69.15 52.39 -65.65 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 62 3 # 62 C 57 GLU E 33 GLU^? 22.81 MG MG E 302 C 226 THR E 169 THR^? 18.18 MG MG E 301 C 229 LYS E 166 LYS^? 21.46 MG MG E 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 80.16 62.57 -63.35 80.54 62.13 -65.43 coo 22.16 45.88 73.63 23.23 47.70 73.25 63.17 71.31 -52.89 63.43 72.88 -54.31 coo 28.90 45.91 73.55 25.22 49.72 72.97 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 63 3 # 63 C 57 GLU E 38 GLU^? 21.68 MG MG E 301 C 226 THR E 74 THR^? 21.51 MG MG E 302 C 229 LYS E 86 LYS^? 26.73 MG MG D 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 72.42 75.53 -60.31 73.00 74.78 -58.42 coo 22.16 45.88 73.63 23.23 47.70 73.25 80.89 56.59 -62.50 81.13 57.37 -64.43 coo 28.90 45.91 73.55 25.22 49.72 72.97 86.84 54.85 -64.43 87.07 60.83 -66.10 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 64 3 # 64 C 57 GLU E 75 GLU^? 15.76 MG MG D 301 C 226 THR E 46 THR^? 24.08 MG MG E 302 C 229 LYS F 6 LYS^? 26.09 MG MG F 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 84.65 53.96 -59.58 85.64 52.81 -58.05 coo 22.16 45.88 73.63 23.23 47.70 73.25 68.80 63.64 -69.48 69.18 65.66 -68.86 coo 28.90 45.91 73.55 25.22 49.72 72.97 67.53 67.03 -76.43 64.05 65.33 -71.86 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 65 3 # 65 C 57 GLU E 94 GLU^? 18.90 MG MG E 302 C 226 THR E 46 THR^? 24.08 MG MG E 302 C 229 LYS F 6 LYS^? 26.09 MG MG F 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 62.96 45.14 -58.39 62.13 44.53 -60.28 coo 22.16 45.88 73.63 23.23 47.70 73.25 68.80 63.64 -69.48 69.18 65.66 -68.86 coo 28.90 45.91 73.55 25.22 49.72 72.97 67.53 67.03 -76.43 64.05 65.33 -71.86 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 66 3 # 66 C 57 GLU E 94 GLU^? 18.90 MG MG E 302 C 226 THR E 74 THR^? 21.51 MG MG E 302 C 229 LYS E 76 LYS^? 25.68 MG MG E 302 coo 5.43 40.40 61.63 4.27 41.99 60.90 62.96 45.14 -58.39 62.13 44.53 -60.28 coo 22.16 45.88 73.63 23.23 47.70 73.25 80.89 56.59 -62.50 81.13 57.37 -64.43 coo 28.90 45.91 73.55 25.22 49.72 72.97 87.09 58.11 -60.91 88.65 63.65 -61.27 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 67 3 # 67 C 57 GLU E 94 GLU^? 18.90 MG MG E 302 C 226 THR E 74 THR^? 21.51 MG MG E 302 C 229 LYS E 86 LYS^? 26.73 MG MG D 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 62.96 45.14 -58.39 62.13 44.53 -60.28 coo 22.16 45.88 73.63 23.23 47.70 73.25 80.89 56.59 -62.50 81.13 57.37 -64.43 coo 28.90 45.91 73.55 25.22 49.72 72.97 86.84 54.85 -64.43 87.07 60.83 -66.10 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 68 3 # 68 C 57 GLU E 94 GLU^? 18.90 MG MG E 302 C 226 THR E 88 THR^? 21.98 MG MG D 301 C 229 LYS E 86 LYS^? 26.73 MG MG D 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 62.96 45.14 -58.39 62.13 44.53 -60.28 coo 22.16 45.88 73.63 23.23 47.70 73.25 80.56 52.52 -64.50 80.70 53.32 -66.53 coo 28.90 45.91 73.55 25.22 49.72 72.97 86.84 54.85 -64.43 87.07 60.83 -66.10 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 69 3 # 69 C 57 GLU E 146 GLU^? 10.15 MG MG E 301 C 226 THR E 70 THR^? 14.75 MG MG E 302 C 229 LYS E 90 LYS^? 19.16 MG MG E 302 coo 5.43 40.40 61.63 4.27 41.99 60.90 58.72 60.89 -44.51 59.23 60.24 -42.54 coo 22.16 45.88 73.63 23.23 47.70 73.25 68.45 55.77 -62.07 68.75 53.75 -61.41 coo 28.90 45.91 73.55 25.22 49.72 72.97 73.81 51.50 -63.18 69.15 52.39 -65.65 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 70 3 # 70 C 57 GLU E 154 GLU^? 19.05 MG MG E 302 C 226 THR E 74 THR^? 21.51 MG MG E 302 C 229 LYS E 76 LYS^? 25.68 MG MG E 302 coo 5.43 40.40 61.63 4.27 41.99 60.90 64.41 68.21 -58.47 65.40 69.20 -60.08 coo 22.16 45.88 73.63 23.23 47.70 73.25 80.89 56.59 -62.50 81.13 57.37 -64.43 coo 28.90 45.91 73.55 25.22 49.72 72.97 87.09 58.11 -60.91 88.65 63.65 -61.27 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 71 3 # 71 C 57 GLU E 154 GLU^? 19.05 MG MG E 302 C 226 THR E 74 THR^? 21.51 MG MG E 302 C 229 LYS E 86 LYS^? 26.73 MG MG D 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 64.41 68.21 -58.47 65.40 69.20 -60.08 coo 22.16 45.88 73.63 23.23 47.70 73.25 80.89 56.59 -62.50 81.13 57.37 -64.43 coo 28.90 45.91 73.55 25.22 49.72 72.97 86.84 54.85 -64.43 87.07 60.83 -66.10 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 72 3 # 72 C 57 GLU E 154 GLU^? 19.05 MG MG E 302 C 226 THR F 2 THR^? 34.54 MG MG F 301 C 229 LYS F 137 LYS^? 35.13 MG MG F 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 64.41 68.21 -58.47 65.40 69.20 -60.08 coo 22.16 45.88 73.63 23.23 47.70 73.25 76.07 74.83 -74.70 74.98 75.15 -76.59 coo 28.90 45.91 73.55 25.22 49.72 72.97 78.53 72.20 -80.30 83.01 68.64 -79.79 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 73 3 # 73 C 57 GLU F 19 GLU^? 17.88 MG MG F 302 C 226 THR F 169 THR^? 17.93 MG MG F 302 C 229 LYS F 166 LYS^? 20.76 MG MG F 302 coo 5.43 40.40 61.63 4.27 41.99 60.90 36.39 58.51 -87.58 37.20 60.13 -88.66 coo 22.16 45.88 73.63 23.23 47.70 73.25 54.83 68.79 -86.99 54.09 70.44 -85.82 coo 28.90 45.91 73.55 25.22 49.72 72.97 59.28 73.05 -82.63 55.63 74.15 -86.94 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 74 3 # 74 C 57 GLU F 33 GLU^? 22.46 MG MG F 301 C 226 THR F 169 THR^? 17.93 MG MG F 302 C 229 LYS F 166 LYS^? 20.76 MG MG F 302 coo 5.43 40.40 61.63 4.27 41.99 60.90 41.88 55.13 -75.91 42.06 54.64 -73.84 coo 22.16 45.88 73.63 23.23 47.70 73.25 54.83 68.79 -86.99 54.09 70.44 -85.82 coo 28.90 45.91 73.55 25.22 49.72 72.97 59.28 73.05 -82.63 55.63 74.15 -86.94 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 75 3 # 75 C 57 GLU F 38 GLU^? 21.28 MG MG F 302 C 226 THR F 74 THR^? 21.46 MG MG F 301 C 229 LYS F 86 LYS^? 26.63 MG MG F 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 44.63 69.79 -79.91 44.13 69.05 -81.85 coo 22.16 45.88 73.63 23.23 47.70 73.25 43.07 49.39 -76.61 42.46 50.11 -74.68 coo 28.90 45.91 73.55 25.22 49.72 72.97 37.89 45.97 -74.42 36.47 51.71 -72.79 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 76 3 # 76 C 57 GLU F 75 GLU^? 19.96 MG MG F 301 C 226 THR F 46 THR^? 24.16 MG MG F 301 C 229 LYS E 6 LYS^? 25.59 MG MG E 302 coo 5.43 40.40 61.63 4.27 41.99 60.90 40.19 46.06 -80.81 40.09 43.94 -81.24 coo 22.16 45.88 73.63 23.23 47.70 73.25 51.99 60.48 -70.07 50.88 62.21 -70.66 coo 28.90 45.91 73.55 25.22 49.72 72.97 51.95 64.70 -63.33 56.16 64.03 -67.52 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 77 3 # 77 C 57 GLU F 94 GLU^? 17.06 MG MG F 301 C 226 THR F 74 THR^? 21.46 MG MG F 301 C 229 LYS F 76 LYS^? 25.89 MG MG F 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 62.58 44.49 -81.43 64.13 42.92 -81.30 coo 22.16 45.88 73.63 23.23 47.70 73.25 43.07 49.39 -76.61 42.46 50.11 -74.68 coo 28.90 45.91 73.55 25.22 49.72 72.97 36.96 48.52 -78.06 33.74 53.37 -77.06 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 78 3 # 78 C 57 GLU F 94 GLU^? 17.06 MG MG F 301 C 226 THR F 74 THR^? 21.46 MG MG F 301 C 229 LYS F 86 LYS^? 26.63 MG MG F 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 62.58 44.49 -81.43 64.13 42.92 -81.30 coo 22.16 45.88 73.63 23.23 47.70 73.25 43.07 49.39 -76.61 42.46 50.11 -74.68 coo 28.90 45.91 73.55 25.22 49.72 72.97 37.89 45.97 -74.42 36.47 51.71 -72.79 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 79 3 # 79 C 57 GLU F 94 GLU^? 17.06 MG MG F 301 C 226 THR F 88 THR^? 23.06 MG MG F 301 C 229 LYS F 86 LYS^? 26.63 MG MG F 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 62.58 44.49 -81.43 64.13 42.92 -81.30 coo 22.16 45.88 73.63 23.23 47.70 73.25 44.71 45.78 -74.10 45.06 46.44 -72.02 coo 28.90 45.91 73.55 25.22 49.72 72.97 37.89 45.97 -74.42 36.47 51.71 -72.79 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 80 3 # 80 C 57 GLU F 146 GLU^? 10.36 MG MG F 302 C 226 THR F 70 THR^? 14.73 MG MG F 301 C 229 LYS F 90 LYS^? 18.57 MG MG F 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 61.95 60.17 -95.28 62.87 58.56 -96.19 coo 22.16 45.88 73.63 23.23 47.70 73.25 55.11 52.83 -76.85 55.53 50.86 -77.56 coo 28.90 45.91 73.55 25.22 49.72 72.97 51.54 47.01 -75.58 55.05 50.31 -73.74 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 81 3 # 81 C 57 GLU F 154 GLU^? 18.97 MG MG F 301 C 226 THR E 2 THR^? 33.84 MG MG E 302 C 229 LYS E 137 LYS^? 35.26 MG MG E 302 coo 5.43 40.40 61.63 4.27 41.99 60.90 54.57 65.67 -81.55 53.36 66.51 -80.09 coo 22.16 45.88 73.63 23.23 47.70 73.25 41.32 68.37 -65.29 42.66 69.03 -63.78 coo 28.90 45.91 73.55 25.22 49.72 72.97 40.01 66.05 -59.66 36.65 60.99 -60.28 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 82 3 # 82 C 57 GLU F 154 GLU^? 18.97 MG MG F 301 C 226 THR F 74 THR^? 21.46 MG MG F 301 C 229 LYS F 86 LYS^? 26.63 MG MG F 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 54.57 65.67 -81.55 53.36 66.51 -80.09 coo 22.16 45.88 73.63 23.23 47.70 73.25 43.07 49.39 -76.61 42.46 50.11 -74.68 coo 28.90 45.91 73.55 25.22 49.72 72.97 37.89 45.97 -74.42 36.47 51.71 -72.79 1dfo_c06 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 82 hits 1dfo_c06 naa= 3 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 57 GLU A 19 GLU.? 16.46 MG MG A 302 D 226 THR A 169 THR^? 18.45 MG MG A 302 D 229 LYS A 166 LYS^? 20.93 MG MG A 302 coo 26.07 55.89 66.14 25.33 56.50 68.01 29.75 40.22 38.71 30.73 40.87 40.56 coo 11.79 47.62 52.67 10.10 46.51 53.39 34.64 19.08 35.13 33.08 18.40 33.78 coo 10.05 41.79 49.80 7.94 44.71 53.76 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 D 57 GLU A 25 GLU^? 25.87 MG MG A 301 D 226 THR A 73 THR^? 15.13 MG MG A 301 D 229 LYS A 90 LYS^? 18.58 MG MG A 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 39.62 57.50 39.92 41.51 57.27 40.85 coo 11.79 47.62 52.67 10.10 46.51 53.39 40.93 39.17 26.72 41.99 38.78 28.61 coo 10.05 41.79 49.80 7.94 44.71 53.76 46.62 38.29 25.46 47.51 33.29 23.22 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 D 57 GLU A 25 GLU^? 25.87 MG MG A 301 D 226 THR A 88 THR^? 23.22 MG MG A 301 D 229 LYS A 90 LYS^? 18.58 MG MG A 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 39.62 57.50 39.92 41.51 57.27 40.85 coo 11.79 47.62 52.67 10.10 46.51 53.39 42.44 43.75 23.46 42.54 42.92 21.44 coo 10.05 41.79 49.80 7.94 44.71 53.76 46.62 38.29 25.46 47.51 33.29 23.22 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 D 57 GLU A 33 GLU^? 22.87 MG MG A 301 D 226 THR A 169 THR^? 18.45 MG MG A 302 D 229 LYS A 166 LYS^? 20.93 MG MG A 302 coo 26.07 55.89 66.14 25.33 56.50 68.01 33.74 38.67 24.96 34.13 38.85 22.87 coo 11.79 47.62 52.67 10.10 46.51 53.39 34.64 19.08 35.13 33.08 18.40 33.78 coo 10.05 41.79 49.80 7.94 44.71 53.76 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 D 57 GLU A 38 GLU^? 21.81 MG MG A 302 D 226 THR A 74 THR^? 21.85 MG MG A 301 D 229 LYS A 86 LYS^? 26.38 MG MG A 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 26.42 25.01 28.02 26.98 25.90 29.89 coo 11.79 47.62 52.67 10.10 46.51 53.39 38.65 41.92 25.57 37.60 41.76 23.73 coo 10.05 41.79 49.80 7.94 44.71 53.76 37.08 47.78 23.56 32.88 44.24 21.89 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 D 57 GLU A 54 GLU^? 22.98 MG MG A 301 D 226 THR A 74 THR^? 21.85 MG MG A 301 D 229 LYS A 76 LYS^? 25.42 MG MG A 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 45.06 19.97 24.02 44.05 19.39 22.19 coo 11.79 47.62 52.67 10.10 46.51 53.39 38.65 41.92 25.57 37.60 41.76 23.73 coo 10.05 41.79 49.80 7.94 44.71 53.76 34.45 46.53 27.28 28.88 44.93 27.25 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 D 57 GLU A 75 GLU^? 20.23 MG MG A 301 D 226 THR A 46 THR^? 24.24 MG MG A 301 D 229 LYS B 6 LYS^? 25.90 MG MG B 302 coo 26.07 55.89 66.14 25.33 56.50 68.01 38.99 46.65 28.68 39.94 47.65 30.33 coo 11.79 47.62 52.67 10.10 46.51 53.39 38.63 28.11 18.80 36.62 27.50 19.27 coo 10.05 41.79 49.80 7.94 44.71 53.76 36.26 25.44 11.74 39.65 23.12 16.29 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 D 57 GLU A 94 GLU^? 17.31 MG MG A 301 D 226 THR A 46 THR^? 24.24 MG MG A 301 D 229 LYS B 6 LYS^? 25.90 MG MG B 302 coo 26.07 55.89 66.14 25.33 56.50 68.01 57.11 32.79 29.92 57.45 34.91 29.85 coo 11.79 47.62 52.67 10.10 46.51 53.39 38.63 28.11 18.80 36.62 27.50 19.27 coo 10.05 41.79 49.80 7.94 44.71 53.76 36.26 25.44 11.74 39.65 23.12 16.29 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 D 57 GLU A 94 GLU^? 17.31 MG MG A 301 D 226 THR A 74 THR^? 21.85 MG MG A 301 D 229 LYS A 76 LYS^? 25.42 MG MG A 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 57.11 32.79 29.92 57.45 34.91 29.85 coo 11.79 47.62 52.67 10.10 46.51 53.39 38.65 41.92 25.57 37.60 41.76 23.73 coo 10.05 41.79 49.80 7.94 44.71 53.76 34.45 46.53 27.28 28.88 44.93 27.25 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 D 57 GLU A 94 GLU^? 17.31 MG MG A 301 D 226 THR A 74 THR^? 21.85 MG MG A 301 D 229 LYS A 86 LYS^? 26.38 MG MG A 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 57.11 32.79 29.92 57.45 34.91 29.85 coo 11.79 47.62 52.67 10.10 46.51 53.39 38.65 41.92 25.57 37.60 41.76 23.73 coo 10.05 41.79 49.80 7.94 44.71 53.76 37.08 47.78 23.56 32.88 44.24 21.89 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 D 57 GLU A 94 GLU^? 17.31 MG MG A 301 D 226 THR A 88 THR^? 23.22 MG MG A 301 D 229 LYS A 86 LYS^? 26.38 MG MG A 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 57.11 32.79 29.92 57.45 34.91 29.85 coo 11.79 47.62 52.67 10.10 46.51 53.39 42.44 43.75 23.46 42.54 42.92 21.44 coo 10.05 41.79 49.80 7.94 44.71 53.76 37.08 47.78 23.56 32.88 44.24 21.89 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 D 57 GLU A 146 GLU^? 9.80 MG MG A 302 D 226 THR A 70 THR^? 14.66 MG MG A 301 D 229 LYS A 90 LYS^? 18.58 MG MG A 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 45.17 20.35 44.20 46.68 21.21 45.40 coo 11.79 47.62 52.67 10.10 46.51 53.39 45.68 31.52 26.25 47.33 32.60 27.12 coo 10.05 41.79 49.80 7.94 44.71 53.76 46.62 38.29 25.46 47.51 33.29 23.22 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 D 57 GLU A 154 GLU^? 19.22 MG MG A 301 D 226 THR A 74 THR^? 21.85 MG MG A 301 D 229 LYS A 86 LYS^? 26.38 MG MG A 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 36.54 21.95 29.78 35.14 22.21 28.17 coo 11.79 47.62 52.67 10.10 46.51 53.39 38.65 41.92 25.57 37.60 41.76 23.73 coo 10.05 41.79 49.80 7.94 44.71 53.76 37.08 47.78 23.56 32.88 44.24 21.89 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 14 3 # 14 D 57 GLU A 154 GLU^? 19.22 MG MG A 301 D 226 THR B 2 THR^? 34.11 MG MG B 302 D 229 LYS B 137 LYS^? 34.56 MG MG B 302 coo 26.07 55.89 66.14 25.33 56.50 68.01 36.54 21.95 29.78 35.14 22.21 28.17 coo 11.79 47.62 52.67 10.10 46.51 53.39 25.51 29.18 13.74 26.24 28.19 11.93 coo 10.05 41.79 49.80 7.94 44.71 53.76 26.56 32.46 7.93 27.87 37.71 9.31 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 15 3 # 15 D 57 GLU B 19 GLU^? 18.96 MG MG B 301 D 226 THR B 169 THR^? 18.43 MG MG B 301 D 229 LYS B 166 LYS^? 22.75 MG MG B 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 59.29 4.54 -0.16 58.81 2.51 -0.44 coo 11.79 47.62 52.67 10.10 46.51 53.39 41.38 13.97 0.97 40.27 12.43 2.02 coo 10.05 41.79 49.80 7.94 44.71 53.76 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 16 3 # 16 D 57 GLU B 25 GLU^? 12.88 MG MG C 301 D 226 THR B 88 THR^? 22.44 MG MG C 301 D 229 LYS B 90 LYS^? 18.68 MG MG B 302 coo 26.07 55.89 66.14 25.33 56.50 68.01 79.57 9.59 -3.08 79.20 11.68 -3.64 coo 11.79 47.62 52.67 10.10 46.51 53.39 66.42 16.42 14.22 65.45 16.28 16.18 coo 10.05 41.79 49.80 7.94 44.71 53.76 61.66 21.61 12.88 56.74 22.88 14.81 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 17 3 # 17 D 57 GLU B 25 GLU^? 12.88 MG MG C 301 D 226 THR C 169 THR^? 18.51 MG MG C 301 D 229 LYS C 166 LYS^? 22.53 MG MG C 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 79.57 9.59 -3.08 79.20 11.68 -3.64 coo 11.79 47.62 52.67 10.10 46.51 53.39 94.19 23.02 -7.83 95.56 21.86 -9.07 coo 10.05 41.79 49.80 7.94 44.71 53.76 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 18 3 # 18 D 57 GLU B 33 GLU^? 22.65 MG MG B 302 D 226 THR B 169 THR^? 18.43 MG MG B 301 D 229 LYS B 166 LYS^? 22.75 MG MG B 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 59.88 9.09 12.22 59.91 9.49 14.33 coo 11.79 47.62 52.67 10.10 46.51 53.39 41.38 13.97 0.97 40.27 12.43 2.02 coo 10.05 41.79 49.80 7.94 44.71 53.76 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 19 3 # 19 D 57 GLU B 38 GLU^? 21.75 MG MG B 301 D 226 THR B 74 THR^? 21.68 MG MG B 302 D 229 LYS B 86 LYS^? 26.44 MG MG B 302 coo 26.07 55.89 66.14 25.33 56.50 68.01 44.79 4.95 7.12 46.66 4.47 6.21 coo 11.79 47.62 52.67 10.10 46.51 53.39 63.99 13.20 11.95 63.36 12.32 13.84 coo 10.05 41.79 49.80 7.94 44.71 53.76 69.25 10.45 13.86 65.27 7.74 16.08 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 20 3 # 20 D 57 GLU B 54 GLU^? 22.94 MG MG B 302 D 226 THR A 74 THR^? 21.85 MG MG A 301 D 229 LYS A 76 LYS^? 25.42 MG MG A 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 43.18 23.27 12.99 42.40 22.23 14.68 coo 11.79 47.62 52.67 10.10 46.51 53.39 38.65 41.92 25.57 37.60 41.76 23.73 coo 10.05 41.79 49.80 7.94 44.71 53.76 34.45 46.53 27.28 28.88 44.93 27.25 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 21 3 # 21 D 57 GLU B 54 GLU^? 22.94 MG MG B 302 D 226 THR A 74 THR^? 21.85 MG MG A 301 D 229 LYS A 86 LYS^? 26.38 MG MG A 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 43.18 23.27 12.99 42.40 22.23 14.68 coo 11.79 47.62 52.67 10.10 46.51 53.39 38.65 41.92 25.57 37.60 41.76 23.73 coo 10.05 41.79 49.80 7.94 44.71 53.76 37.08 47.78 23.56 32.88 44.24 21.89 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 22 3 # 22 D 57 GLU B 54 GLU^? 22.94 MG MG B 302 D 226 THR A 88 THR^? 23.22 MG MG A 301 D 229 LYS A 86 LYS^? 26.38 MG MG A 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 43.18 23.27 12.99 42.40 22.23 14.68 coo 11.79 47.62 52.67 10.10 46.51 53.39 42.44 43.75 23.46 42.54 42.92 21.44 coo 10.05 41.79 49.80 7.94 44.71 53.76 37.08 47.78 23.56 32.88 44.24 21.89 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 23 3 # 23 D 57 GLU B 75 GLU^? 15.82 MG MG C 301 D 226 THR B 46 THR^? 23.88 MG MG B 302 D 229 LYS A 6 LYS^? 25.88 MG MG A 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 68.81 12.14 8.61 69.95 13.49 7.45 coo 11.79 47.62 52.67 10.10 46.51 53.39 49.71 15.16 18.13 48.80 13.51 17.14 coo 10.05 41.79 49.80 7.94 44.71 53.76 46.20 12.82 24.71 44.50 16.64 20.52 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 24 3 # 24 D 57 GLU B 94 GLU^? 15.34 MG MG B 302 D 226 THR B 46 THR^? 23.88 MG MG B 302 D 229 LYS A 6 LYS^? 25.88 MG MG A 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 58.44 31.30 7.43 60.35 32.14 7.14 coo 11.79 47.62 52.67 10.10 46.51 53.39 49.71 15.16 18.13 48.80 13.51 17.14 coo 10.05 41.79 49.80 7.94 44.71 53.76 46.20 12.82 24.71 44.50 16.64 20.52 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 25 3 # 25 D 57 GLU B 94 GLU^? 15.34 MG MG B 302 D 226 THR B 74 THR^? 21.68 MG MG B 302 D 229 LYS B 76 LYS^? 25.77 MG MG B 302 coo 26.07 55.89 66.14 25.33 56.50 68.01 58.44 31.30 7.43 60.35 32.14 7.14 coo 11.79 47.62 52.67 10.10 46.51 53.39 63.99 13.20 11.95 63.36 12.32 13.84 coo 10.05 41.79 49.80 7.94 44.71 53.76 67.82 8.19 10.14 64.96 3.09 10.62 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 26 3 # 26 D 57 GLU B 146 GLU^? 10.54 MG MG B 301 D 226 THR B 70 THR^? 14.69 MG MG B 302 D 229 LYS B 90 LYS^? 18.68 MG MG B 302 coo 26.07 55.89 66.14 25.33 56.50 68.01 45.13 24.51 -7.01 46.08 25.99 -8.13 coo 11.79 47.62 52.67 10.10 46.51 53.39 54.82 21.76 11.59 56.34 23.17 10.82 coo 10.05 41.79 49.80 7.94 44.71 53.76 61.66 21.61 12.88 56.74 22.88 14.81 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 27 3 # 27 D 57 GLU B 154 GLU^? 19.05 MG MG B 302 D 226 THR A 2 THR.? 34.64 MG MG A 301 D 229 LYS A 137 LYS^? 34.85 MG MG A 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 44.04 15.11 6.74 44.19 13.59 8.30 coo 11.79 47.62 52.67 10.10 46.51 53.39 47.80 1.72 22.09 46.70 1.88 23.97 coo 10.05 41.79 49.80 7.94 44.71 53.76 50.97 1.58 28.14 56.13 1.49 28.03 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 28 3 # 28 D 57 GLU B 154 GLU^? 19.05 MG MG B 302 D 226 THR B 74 THR^? 21.68 MG MG B 302 D 229 LYS B 76 LYS^? 25.77 MG MG B 302 coo 26.07 55.89 66.14 25.33 56.50 68.01 44.04 15.11 6.74 44.19 13.59 8.30 coo 11.79 47.62 52.67 10.10 46.51 53.39 63.99 13.20 11.95 63.36 12.32 13.84 coo 10.05 41.79 49.80 7.94 44.71 53.76 67.82 8.19 10.14 64.96 3.09 10.62 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 29 3 # 29 D 57 GLU B 154 GLU^? 19.05 MG MG B 302 D 226 THR B 74 THR^? 21.68 MG MG B 302 D 229 LYS B 86 LYS^? 26.44 MG MG B 302 coo 26.07 55.89 66.14 25.33 56.50 68.01 44.04 15.11 6.74 44.19 13.59 8.30 coo 11.79 47.62 52.67 10.10 46.51 53.39 63.99 13.20 11.95 63.36 12.32 13.84 coo 10.05 41.79 49.80 7.94 44.71 53.76 69.25 10.45 13.86 65.27 7.74 16.08 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 30 3 # 30 D 57 GLU C 19 GLU^? 19.08 MG MG C 301 D 226 THR C 169 THR^? 18.51 MG MG C 301 D 229 LYS C 166 LYS^? 22.53 MG MG C 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 80.46 7.67 -6.81 81.43 5.97 -5.99 coo 11.79 47.62 52.67 10.10 46.51 53.39 94.19 23.02 -7.83 95.56 21.86 -9.07 coo 10.05 41.79 49.80 7.94 44.71 53.76 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 31 3 # 31 D 57 GLU C 25 GLU^? 12.27 MG MG B 301 D 226 THR C 88 THR^? 22.58 MG MG B 301 D 229 LYS C 90 LYS^? 18.24 MG MG C 302 coo 26.07 55.89 66.14 25.33 56.50 68.01 58.50 6.48 -3.59 57.94 8.54 -3.41 coo 11.79 47.62 52.67 10.10 46.51 53.39 69.96 16.71 -20.56 70.75 16.33 -22.54 coo 10.05 41.79 49.80 7.94 44.71 53.76 72.37 23.25 -18.94 76.11 26.52 -20.97 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 32 3 # 32 D 57 GLU C 33 GLU^? 22.71 MG MG C 302 D 226 THR C 169 THR^? 18.51 MG MG C 301 D 229 LYS C 166 LYS^? 22.53 MG MG C 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 78.39 11.67 -18.82 78.34 12.01 -20.91 coo 11.79 47.62 52.67 10.10 46.51 53.39 94.19 23.02 -7.83 95.56 21.86 -9.07 coo 10.05 41.79 49.80 7.94 44.71 53.76 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 33 3 # 33 D 57 GLU C 38 GLU^? 21.99 MG MG C 301 D 226 THR C 74 THR^? 21.64 MG MG C 302 D 229 LYS C 86 LYS^? 27.34 MG MG C 302 coo 26.07 55.89 66.14 25.33 56.50 68.01 93.66 12.78 -15.08 92.73 12.51 -13.19 coo 11.79 47.62 52.67 10.10 46.51 53.39 73.35 14.53 -18.47 73.89 13.78 -20.47 coo 10.05 41.79 49.80 7.94 44.71 53.76 69.22 9.88 -20.56 74.70 7.02 -22.55 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 34 3 # 34 D 57 GLU C 54 GLU^? 22.77 MG MG C 302 D 226 THR D 74 THR^? 21.71 MG MG D 302 D 229 LYS D 86 LYS^? 25.80 MG MG D 302 coo 26.07 55.89 66.14 25.33 56.50 68.01 88.91 31.25 -19.52 89.97 30.69 -21.29 coo 11.79 47.62 52.67 10.10 46.51 53.39 86.03 50.57 -32.19 86.96 50.83 -30.24 coo 10.05 41.79 49.80 7.94 44.71 53.76 85.54 56.79 -30.27 90.24 54.54 -28.62 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 35 3 # 35 D 57 GLU C 75 GLU^? 16.14 MG MG B 301 D 226 THR C 46 THR^? 24.02 MG MG C 302 D 229 LYS D 6 LYS^? 25.98 MG MG D 302 coo 26.07 55.89 66.14 25.33 56.50 68.01 69.49 12.18 -14.30 67.44 12.65 -13.83 coo 11.79 47.62 52.67 10.10 46.51 53.39 85.56 21.34 -24.69 87.12 20.00 -24.12 coo 10.05 41.79 49.80 7.94 44.71 53.76 89.78 20.68 -31.57 90.15 24.89 -27.02 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 36 3 # 36 D 57 GLU C 94 GLU^? 16.62 MG MG C 302 D 226 THR C 46 THR^? 24.02 MG MG C 302 D 229 LYS D 6 LYS^? 25.98 MG MG D 302 coo 26.07 55.89 66.14 25.33 56.50 68.01 71.81 35.42 -14.68 69.88 35.53 -13.78 coo 11.79 47.62 52.67 10.10 46.51 53.39 85.56 21.34 -24.69 87.12 20.00 -24.12 coo 10.05 41.79 49.80 7.94 44.71 53.76 89.78 20.68 -31.57 90.15 24.89 -27.02 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 37 3 # 37 D 57 GLU C 94 GLU^? 16.62 MG MG C 302 D 226 THR C 74 THR^? 21.64 MG MG C 302 D 229 LYS C 76 LYS^? 24.95 MG MG C 302 coo 26.07 55.89 66.14 25.33 56.50 68.01 71.81 35.42 -14.68 69.88 35.53 -13.78 coo 11.79 47.62 52.67 10.10 46.51 53.39 73.35 14.53 -18.47 73.89 13.78 -20.47 coo 10.05 41.79 49.80 7.94 44.71 53.76 71.11 8.63 -16.76 75.44 5.17 -16.80 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 38 3 # 38 D 57 GLU C 94 GLU^? 16.62 MG MG C 302 D 226 THR C 74 THR^? 21.64 MG MG C 302 D 229 LYS C 86 LYS^? 27.34 MG MG C 302 coo 26.07 55.89 66.14 25.33 56.50 68.01 71.81 35.42 -14.68 69.88 35.53 -13.78 coo 11.79 47.62 52.67 10.10 46.51 53.39 73.35 14.53 -18.47 73.89 13.78 -20.47 coo 10.05 41.79 49.80 7.94 44.71 53.76 69.22 9.88 -20.56 74.70 7.02 -22.55 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 39 3 # 39 D 57 GLU C 94 GLU^? 16.62 MG MG C 302 D 226 THR C 88 THR^? 22.58 MG MG B 301 D 229 LYS C 86 LYS^? 27.34 MG MG C 302 coo 26.07 55.89 66.14 25.33 56.50 68.01 71.81 35.42 -14.68 69.88 35.53 -13.78 coo 11.79 47.62 52.67 10.10 46.51 53.39 69.96 16.71 -20.56 70.75 16.33 -22.54 coo 10.05 41.79 49.80 7.94 44.71 53.76 69.22 9.88 -20.56 74.70 7.02 -22.55 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 40 3 # 40 D 57 GLU C 146 GLU^? 10.46 MG MG C 301 D 226 THR C 70 THR^? 14.45 MG MG C 302 D 229 LYS C 90 LYS^? 18.24 MG MG C 302 coo 26.07 55.89 66.14 25.33 56.50 68.01 87.01 31.93 0.25 85.57 32.56 1.72 coo 11.79 47.62 52.67 10.10 46.51 53.39 78.63 25.77 -17.76 76.70 26.55 -17.21 coo 10.05 41.79 49.80 7.94 44.71 53.76 72.37 23.25 -18.94 76.11 26.52 -20.97 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 41 3 # 41 D 57 GLU C 154 GLU^? 18.91 MG MG C 302 D 226 THR C 74 THR^? 21.64 MG MG C 302 D 229 LYS C 76 LYS^? 24.95 MG MG C 302 coo 26.07 55.89 66.14 25.33 56.50 68.01 91.15 23.27 -13.33 91.61 21.91 -14.95 coo 11.79 47.62 52.67 10.10 46.51 53.39 73.35 14.53 -18.47 73.89 13.78 -20.47 coo 10.05 41.79 49.80 7.94 44.71 53.76 71.11 8.63 -16.76 75.44 5.17 -16.80 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 42 3 # 42 D 57 GLU C 154 GLU^? 18.91 MG MG C 302 D 226 THR C 74 THR^? 21.64 MG MG C 302 D 229 LYS C 86 LYS^? 27.34 MG MG C 302 coo 26.07 55.89 66.14 25.33 56.50 68.01 91.15 23.27 -13.33 91.61 21.91 -14.95 coo 11.79 47.62 52.67 10.10 46.51 53.39 73.35 14.53 -18.47 73.89 13.78 -20.47 coo 10.05 41.79 49.80 7.94 44.71 53.76 69.22 9.88 -20.56 74.70 7.02 -22.55 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 43 3 # 43 D 57 GLU C 154 GLU^? 18.91 MG MG C 302 D 226 THR D 2 THR^? 33.99 MG MG D 302 D 229 LYS D 137 LYS^? 37.57 MG MG D 302 coo 26.07 55.89 66.14 25.33 56.50 68.01 91.15 23.27 -13.33 91.61 21.91 -14.95 coo 11.79 47.62 52.67 10.10 46.51 53.39 91.82 9.34 -29.18 91.80 10.46 -31.03 coo 10.05 41.79 49.80 7.94 44.71 53.76 88.48 8.58 -35.33 84.88 3.98 -33.96 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 44 3 # 44 D 57 GLU D 19 GLU^? 18.95 MG MG D 301 D 226 THR D 169 THR^? 18.47 MG MG D 301 D 229 LYS D 166 LYS^? 21.08 MG MG D 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 96.86 51.08 -43.04 98.60 51.44 -44.26 coo 11.79 47.62 52.67 10.10 46.51 53.39 97.62 30.68 -41.94 99.48 30.62 -40.85 coo 10.05 41.79 49.80 7.94 44.71 53.76 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 45 3 # 45 D 57 GLU D 25 GLU^? 12.44 MG MG E 301 D 226 THR D 88 THR^? 22.15 MG MG E 301 D 229 LYS D 90 LYS^? 18.98 MG MG D 302 coo 26.07 55.89 66.14 25.33 56.50 68.01 81.26 66.22 -47.78 79.52 64.98 -48.06 coo 11.79 47.62 52.67 10.10 46.51 53.39 81.92 51.17 -30.12 82.55 50.45 -28.12 coo 10.05 41.79 49.80 7.94 44.71 53.76 79.83 44.38 -31.44 80.32 39.55 -29.40 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 46 3 # 46 D 57 GLU D 25 GLU^? 12.44 MG MG E 301 D 226 THR E 169 THR^? 18.18 MG MG E 301 D 229 LYS E 166 LYS^? 21.46 MG MG E 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 81.26 66.22 -47.78 79.52 64.98 -48.06 coo 11.79 47.62 52.67 10.10 46.51 53.39 63.17 71.31 -52.89 63.43 72.88 -54.31 coo 10.05 41.79 49.80 7.94 44.71 53.76 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 47 3 # 47 D 57 GLU D 33 GLU^? 22.23 MG MG D 302 D 226 THR D 169 THR^? 18.47 MG MG D 301 D 229 LYS D 166 LYS^? 21.08 MG MG D 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 91.55 48.87 -31.66 91.12 48.92 -29.63 coo 11.79 47.62 52.67 10.10 46.51 53.39 97.62 30.68 -41.94 99.48 30.62 -40.85 coo 10.05 41.79 49.80 7.94 44.71 53.76 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 48 3 # 48 D 57 GLU D 38 GLU^? 21.83 MG MG D 301 D 226 THR D 74 THR^? 21.71 MG MG D 302 D 229 LYS D 86 LYS^? 25.80 MG MG D 302 coo 26.07 55.89 66.14 25.33 56.50 68.01 103.22 39.19 -34.75 102.77 39.81 -36.73 coo 11.79 47.62 52.67 10.10 46.51 53.39 86.03 50.57 -32.19 86.96 50.83 -30.24 coo 10.05 41.79 49.80 7.94 44.71 53.76 85.54 56.79 -30.27 90.24 54.54 -28.62 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 49 3 # 49 D 57 GLU D 52 GLU^? 19.94 MG MG D 302 D 226 THR C 2 THR^? 33.69 MG MG C 302 D 229 LYS C 137 LYS^? 35.41 MG MG C 302 coo 26.07 55.89 66.14 25.33 56.50 68.01 87.13 33.17 -30.97 88.40 33.70 -29.31 coo 11.79 47.62 52.67 10.10 46.51 53.39 103.03 43.13 -20.15 102.74 41.72 -18.56 coo 10.05 41.79 49.80 7.94 44.71 53.76 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 50 3 # 50 D 57 GLU D 54 GLU^? 22.96 MG MG D 302 D 226 THR C 74 THR^? 21.64 MG MG C 302 D 229 LYS C 76 LYS^? 24.95 MG MG C 302 coo 26.07 55.89 66.14 25.33 56.50 68.01 87.96 27.60 -30.52 89.07 27.55 -28.72 coo 11.79 47.62 52.67 10.10 46.51 53.39 73.35 14.53 -18.47 73.89 13.78 -20.47 coo 10.05 41.79 49.80 7.94 44.71 53.76 71.11 8.63 -16.76 75.44 5.17 -16.80 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 51 3 # 51 D 57 GLU D 54 GLU^? 22.96 MG MG D 302 D 226 THR C 74 THR^? 21.64 MG MG C 302 D 229 LYS C 86 LYS^? 27.34 MG MG C 302 coo 26.07 55.89 66.14 25.33 56.50 68.01 87.96 27.60 -30.52 89.07 27.55 -28.72 coo 11.79 47.62 52.67 10.10 46.51 53.39 73.35 14.53 -18.47 73.89 13.78 -20.47 coo 10.05 41.79 49.80 7.94 44.71 53.76 69.22 9.88 -20.56 74.70 7.02 -22.55 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 52 3 # 52 D 57 GLU D 54 GLU^? 22.96 MG MG D 302 D 226 THR C 88 THR^? 22.58 MG MG B 301 D 229 LYS C 86 LYS^? 27.34 MG MG C 302 coo 26.07 55.89 66.14 25.33 56.50 68.01 87.96 27.60 -30.52 89.07 27.55 -28.72 coo 11.79 47.62 52.67 10.10 46.51 53.39 69.96 16.71 -20.56 70.75 16.33 -22.54 coo 10.05 41.79 49.80 7.94 44.71 53.76 69.22 9.88 -20.56 74.70 7.02 -22.55 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 53 3 # 53 D 57 GLU D 75 GLU^? 15.53 MG MG E 301 D 226 THR D 46 THR^? 23.86 MG MG D 302 D 229 LYS C 6 LYS^? 25.73 MG MG C 302 coo 26.07 55.89 66.14 25.33 56.50 68.01 84.53 54.81 -36.40 82.75 56.01 -36.42 coo 11.79 47.62 52.67 10.10 46.51 53.39 91.28 37.63 -25.27 93.05 36.72 -26.12 coo 10.05 41.79 49.80 7.94 44.71 53.76 94.42 35.68 -18.56 92.21 32.03 -23.05 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 54 3 # 54 D 57 GLU D 94 GLU^? 16.28 MG MG D 302 D 226 THR D 46 THR^? 23.86 MG MG D 302 D 229 LYS C 6 LYS^? 25.73 MG MG C 302 coo 26.07 55.89 66.14 25.33 56.50 68.01 72.85 36.59 -35.79 71.78 37.87 -37.16 coo 11.79 47.62 52.67 10.10 46.51 53.39 91.28 37.63 -25.27 93.05 36.72 -26.12 coo 10.05 41.79 49.80 7.94 44.71 53.76 94.42 35.68 -18.56 92.21 32.03 -23.05 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 55 3 # 55 D 57 GLU D 94 GLU^? 16.28 MG MG D 302 D 226 THR D 74 THR^? 21.71 MG MG D 302 D 229 LYS D 76 LYS^? 25.08 MG MG D 302 coo 26.07 55.89 66.14 25.33 56.50 68.01 72.85 36.59 -35.79 71.78 37.87 -37.16 coo 11.79 47.62 52.67 10.10 46.51 53.39 86.03 50.57 -32.19 86.96 50.83 -30.24 coo 10.05 41.79 49.80 7.94 44.71 53.76 88.18 56.35 -34.05 93.80 56.17 -32.93 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 56 3 # 56 D 57 GLU D 146 GLU^? 10.62 MG MG D 301 D 226 THR D 70 THR^? 14.99 MG MG D 302 D 229 LYS D 90 LYS^? 18.98 MG MG D 302 coo 26.07 55.89 66.14 25.33 56.50 68.01 87.24 28.82 -50.92 85.47 28.08 -51.67 coo 11.79 47.62 52.67 10.10 46.51 53.39 83.38 38.35 -32.45 81.51 39.04 -33.23 coo 10.05 41.79 49.80 7.94 44.71 53.76 79.83 44.38 -31.44 80.32 39.55 -29.40 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 57 3 # 57 D 57 GLU D 154 GLU^? 18.75 MG MG D 302 D 226 THR C 2 THR^? 33.69 MG MG C 302 D 229 LYS C 137 LYS^? 35.41 MG MG C 302 coo 26.07 55.89 66.14 25.33 56.50 68.01 94.87 32.52 -36.42 96.07 33.39 -34.88 coo 11.79 47.62 52.67 10.10 46.51 53.39 103.03 43.13 -20.15 102.74 41.72 -18.56 coo 10.05 41.79 49.80 7.94 44.71 53.76 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 58 3 # 58 D 57 GLU D 154 GLU^? 18.75 MG MG D 302 D 226 THR D 74 THR^? 21.71 MG MG D 302 D 229 LYS D 86 LYS^? 25.80 MG MG D 302 coo 26.07 55.89 66.14 25.33 56.50 68.01 94.87 32.52 -36.42 96.07 33.39 -34.88 coo 11.79 47.62 52.67 10.10 46.51 53.39 86.03 50.57 -32.19 86.96 50.83 -30.24 coo 10.05 41.79 49.80 7.94 44.71 53.76 85.54 56.79 -30.27 90.24 54.54 -28.62 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 59 3 # 59 D 57 GLU E 19 GLU^? 18.42 MG MG E 301 D 226 THR E 169 THR^? 18.18 MG MG E 301 D 229 LYS E 166 LYS^? 21.46 MG MG E 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 82.78 67.13 -51.44 83.71 68.75 -50.40 coo 11.79 47.62 52.67 10.10 46.51 53.39 63.17 71.31 -52.89 63.43 72.88 -54.31 coo 10.05 41.79 49.80 7.94 44.71 53.76 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 60 3 # 60 D 57 GLU E 25 GLU^? 12.55 MG MG D 301 D 226 THR D 169 THR^? 18.47 MG MG D 301 D 229 LYS D 166 LYS^? 21.08 MG MG D 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 95.44 49.40 -47.17 93.82 48.00 -47.21 coo 11.79 47.62 52.67 10.10 46.51 53.39 97.62 30.68 -41.94 99.48 30.62 -40.85 coo 10.05 41.79 49.80 7.94 44.71 53.76 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 61 3 # 61 D 57 GLU E 25 GLU^? 12.55 MG MG D 301 D 226 THR E 88 THR^? 21.98 MG MG D 301 D 229 LYS E 90 LYS^? 19.16 MG MG E 302 coo 26.07 55.89 66.14 25.33 56.50 68.01 95.44 49.40 -47.17 93.82 48.00 -47.21 coo 11.79 47.62 52.67 10.10 46.51 53.39 80.56 52.52 -64.50 80.70 53.32 -66.53 coo 10.05 41.79 49.80 7.94 44.71 53.76 73.81 51.50 -63.18 69.15 52.39 -65.65 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 62 3 # 62 D 57 GLU E 33 GLU^? 22.81 MG MG E 302 D 226 THR E 169 THR^? 18.18 MG MG E 301 D 229 LYS E 166 LYS^? 21.46 MG MG E 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 80.16 62.57 -63.35 80.54 62.13 -65.43 coo 11.79 47.62 52.67 10.10 46.51 53.39 63.17 71.31 -52.89 63.43 72.88 -54.31 coo 10.05 41.79 49.80 7.94 44.71 53.76 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 63 3 # 63 D 57 GLU E 38 GLU^? 21.68 MG MG E 301 D 226 THR E 74 THR^? 21.51 MG MG E 302 D 229 LYS E 86 LYS^? 26.73 MG MG D 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 72.42 75.53 -60.31 73.00 74.78 -58.42 coo 11.79 47.62 52.67 10.10 46.51 53.39 80.89 56.59 -62.50 81.13 57.37 -64.43 coo 10.05 41.79 49.80 7.94 44.71 53.76 86.84 54.85 -64.43 87.07 60.83 -66.10 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 64 3 # 64 D 57 GLU E 75 GLU^? 15.76 MG MG D 301 D 226 THR E 46 THR^? 24.08 MG MG E 302 D 229 LYS F 6 LYS^? 26.09 MG MG F 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 84.65 53.96 -59.58 85.64 52.81 -58.05 coo 11.79 47.62 52.67 10.10 46.51 53.39 68.80 63.64 -69.48 69.18 65.66 -68.86 coo 10.05 41.79 49.80 7.94 44.71 53.76 67.53 67.03 -76.43 64.05 65.33 -71.86 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 65 3 # 65 D 57 GLU E 94 GLU^? 18.90 MG MG E 302 D 226 THR E 46 THR^? 24.08 MG MG E 302 D 229 LYS F 6 LYS^? 26.09 MG MG F 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 62.96 45.14 -58.39 62.13 44.53 -60.28 coo 11.79 47.62 52.67 10.10 46.51 53.39 68.80 63.64 -69.48 69.18 65.66 -68.86 coo 10.05 41.79 49.80 7.94 44.71 53.76 67.53 67.03 -76.43 64.05 65.33 -71.86 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 66 3 # 66 D 57 GLU E 94 GLU^? 18.90 MG MG E 302 D 226 THR E 74 THR^? 21.51 MG MG E 302 D 229 LYS E 76 LYS^? 25.68 MG MG E 302 coo 26.07 55.89 66.14 25.33 56.50 68.01 62.96 45.14 -58.39 62.13 44.53 -60.28 coo 11.79 47.62 52.67 10.10 46.51 53.39 80.89 56.59 -62.50 81.13 57.37 -64.43 coo 10.05 41.79 49.80 7.94 44.71 53.76 87.09 58.11 -60.91 88.65 63.65 -61.27 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 67 3 # 67 D 57 GLU E 94 GLU^? 18.90 MG MG E 302 D 226 THR E 74 THR^? 21.51 MG MG E 302 D 229 LYS E 86 LYS^? 26.73 MG MG D 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 62.96 45.14 -58.39 62.13 44.53 -60.28 coo 11.79 47.62 52.67 10.10 46.51 53.39 80.89 56.59 -62.50 81.13 57.37 -64.43 coo 10.05 41.79 49.80 7.94 44.71 53.76 86.84 54.85 -64.43 87.07 60.83 -66.10 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 68 3 # 68 D 57 GLU E 94 GLU^? 18.90 MG MG E 302 D 226 THR E 88 THR^? 21.98 MG MG D 301 D 229 LYS E 86 LYS^? 26.73 MG MG D 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 62.96 45.14 -58.39 62.13 44.53 -60.28 coo 11.79 47.62 52.67 10.10 46.51 53.39 80.56 52.52 -64.50 80.70 53.32 -66.53 coo 10.05 41.79 49.80 7.94 44.71 53.76 86.84 54.85 -64.43 87.07 60.83 -66.10 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 69 3 # 69 D 57 GLU E 146 GLU^? 10.15 MG MG E 301 D 226 THR E 70 THR^? 14.75 MG MG E 302 D 229 LYS E 90 LYS^? 19.16 MG MG E 302 coo 26.07 55.89 66.14 25.33 56.50 68.01 58.72 60.89 -44.51 59.23 60.24 -42.54 coo 11.79 47.62 52.67 10.10 46.51 53.39 68.45 55.77 -62.07 68.75 53.75 -61.41 coo 10.05 41.79 49.80 7.94 44.71 53.76 73.81 51.50 -63.18 69.15 52.39 -65.65 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 70 3 # 70 D 57 GLU E 154 GLU^? 19.05 MG MG E 302 D 226 THR E 74 THR^? 21.51 MG MG E 302 D 229 LYS E 76 LYS^? 25.68 MG MG E 302 coo 26.07 55.89 66.14 25.33 56.50 68.01 64.41 68.21 -58.47 65.40 69.20 -60.08 coo 11.79 47.62 52.67 10.10 46.51 53.39 80.89 56.59 -62.50 81.13 57.37 -64.43 coo 10.05 41.79 49.80 7.94 44.71 53.76 87.09 58.11 -60.91 88.65 63.65 -61.27 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 71 3 # 71 D 57 GLU E 154 GLU^? 19.05 MG MG E 302 D 226 THR E 74 THR^? 21.51 MG MG E 302 D 229 LYS E 86 LYS^? 26.73 MG MG D 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 64.41 68.21 -58.47 65.40 69.20 -60.08 coo 11.79 47.62 52.67 10.10 46.51 53.39 80.89 56.59 -62.50 81.13 57.37 -64.43 coo 10.05 41.79 49.80 7.94 44.71 53.76 86.84 54.85 -64.43 87.07 60.83 -66.10 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 72 3 # 72 D 57 GLU E 154 GLU^? 19.05 MG MG E 302 D 226 THR F 2 THR^? 34.54 MG MG F 301 D 229 LYS F 137 LYS^? 35.13 MG MG F 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 64.41 68.21 -58.47 65.40 69.20 -60.08 coo 11.79 47.62 52.67 10.10 46.51 53.39 76.07 74.83 -74.70 74.98 75.15 -76.59 coo 10.05 41.79 49.80 7.94 44.71 53.76 78.53 72.20 -80.30 83.01 68.64 -79.79 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 73 3 # 73 D 57 GLU F 19 GLU^? 17.88 MG MG F 302 D 226 THR F 169 THR^? 17.93 MG MG F 302 D 229 LYS F 166 LYS^? 20.76 MG MG F 302 coo 26.07 55.89 66.14 25.33 56.50 68.01 36.39 58.51 -87.58 37.20 60.13 -88.66 coo 11.79 47.62 52.67 10.10 46.51 53.39 54.83 68.79 -86.99 54.09 70.44 -85.82 coo 10.05 41.79 49.80 7.94 44.71 53.76 59.28 73.05 -82.63 55.63 74.15 -86.94 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 74 3 # 74 D 57 GLU F 33 GLU^? 22.46 MG MG F 301 D 226 THR F 169 THR^? 17.93 MG MG F 302 D 229 LYS F 166 LYS^? 20.76 MG MG F 302 coo 26.07 55.89 66.14 25.33 56.50 68.01 41.88 55.13 -75.91 42.06 54.64 -73.84 coo 11.79 47.62 52.67 10.10 46.51 53.39 54.83 68.79 -86.99 54.09 70.44 -85.82 coo 10.05 41.79 49.80 7.94 44.71 53.76 59.28 73.05 -82.63 55.63 74.15 -86.94 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 75 3 # 75 D 57 GLU F 38 GLU^? 21.28 MG MG F 302 D 226 THR F 74 THR^? 21.46 MG MG F 301 D 229 LYS F 86 LYS^? 26.63 MG MG F 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 44.63 69.79 -79.91 44.13 69.05 -81.85 coo 11.79 47.62 52.67 10.10 46.51 53.39 43.07 49.39 -76.61 42.46 50.11 -74.68 coo 10.05 41.79 49.80 7.94 44.71 53.76 37.89 45.97 -74.42 36.47 51.71 -72.79 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 76 3 # 76 D 57 GLU F 75 GLU^? 19.96 MG MG F 301 D 226 THR F 46 THR^? 24.16 MG MG F 301 D 229 LYS E 6 LYS^? 25.59 MG MG E 302 coo 26.07 55.89 66.14 25.33 56.50 68.01 40.19 46.06 -80.81 40.09 43.94 -81.24 coo 11.79 47.62 52.67 10.10 46.51 53.39 51.99 60.48 -70.07 50.88 62.21 -70.66 coo 10.05 41.79 49.80 7.94 44.71 53.76 51.95 64.70 -63.33 56.16 64.03 -67.52 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 77 3 # 77 D 57 GLU F 94 GLU^? 17.06 MG MG F 301 D 226 THR F 74 THR^? 21.46 MG MG F 301 D 229 LYS F 76 LYS^? 25.89 MG MG F 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 62.58 44.49 -81.43 64.13 42.92 -81.30 coo 11.79 47.62 52.67 10.10 46.51 53.39 43.07 49.39 -76.61 42.46 50.11 -74.68 coo 10.05 41.79 49.80 7.94 44.71 53.76 36.96 48.52 -78.06 33.74 53.37 -77.06 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 78 3 # 78 D 57 GLU F 94 GLU^? 17.06 MG MG F 301 D 226 THR F 74 THR^? 21.46 MG MG F 301 D 229 LYS F 86 LYS^? 26.63 MG MG F 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 62.58 44.49 -81.43 64.13 42.92 -81.30 coo 11.79 47.62 52.67 10.10 46.51 53.39 43.07 49.39 -76.61 42.46 50.11 -74.68 coo 10.05 41.79 49.80 7.94 44.71 53.76 37.89 45.97 -74.42 36.47 51.71 -72.79 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 79 3 # 79 D 57 GLU F 94 GLU^? 17.06 MG MG F 301 D 226 THR F 88 THR^? 23.06 MG MG F 301 D 229 LYS F 86 LYS^? 26.63 MG MG F 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 62.58 44.49 -81.43 64.13 42.92 -81.30 coo 11.79 47.62 52.67 10.10 46.51 53.39 44.71 45.78 -74.10 45.06 46.44 -72.02 coo 10.05 41.79 49.80 7.94 44.71 53.76 37.89 45.97 -74.42 36.47 51.71 -72.79 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 80 3 # 80 D 57 GLU F 146 GLU^? 10.36 MG MG F 302 D 226 THR F 70 THR^? 14.73 MG MG F 301 D 229 LYS F 90 LYS^? 18.57 MG MG F 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 61.95 60.17 -95.28 62.87 58.56 -96.19 coo 11.79 47.62 52.67 10.10 46.51 53.39 55.11 52.83 -76.85 55.53 50.86 -77.56 coo 10.05 41.79 49.80 7.94 44.71 53.76 51.54 47.01 -75.58 55.05 50.31 -73.74 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 81 3 # 81 D 57 GLU F 154 GLU^? 18.97 MG MG F 301 D 226 THR E 2 THR^? 33.84 MG MG E 302 D 229 LYS E 137 LYS^? 35.26 MG MG E 302 coo 26.07 55.89 66.14 25.33 56.50 68.01 54.57 65.67 -81.55 53.36 66.51 -80.09 coo 11.79 47.62 52.67 10.10 46.51 53.39 41.32 68.37 -65.29 42.66 69.03 -63.78 coo 10.05 41.79 49.80 7.94 44.71 53.76 40.01 66.05 -59.66 36.65 60.99 -60.28 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 82 3 # 82 D 57 GLU F 154 GLU^? 18.97 MG MG F 301 D 226 THR F 74 THR^? 21.46 MG MG F 301 D 229 LYS F 86 LYS^? 26.63 MG MG F 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 54.57 65.67 -81.55 53.36 66.51 -80.09 coo 11.79 47.62 52.67 10.10 46.51 53.39 43.07 49.39 -76.61 42.46 50.11 -74.68 coo 10.05 41.79 49.80 7.94 44.71 53.76 37.89 45.97 -74.42 36.47 51.71 -72.79 1dfo_c07 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 82 hits 1dfo_c07 naa= 3 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 123 HIS A 42 HIS^? 28.45 MG MG A 301 A 200 ASP A 35 ASP^? 16.92 MG MG A 301 A 229 LYS A 90 LYS^? 18.58 MG MG A 301 coo 1.13 77.49 40.64 0.62 75.57 39.98 34.62 18.32 19.57 34.29 16.25 19.41 coo 0.84 91.24 49.01 2.91 91.61 49.23 34.49 31.10 26.54 36.41 31.82 27.10 coo 10.53 97.56 43.71 9.33 93.71 47.17 46.62 38.29 25.46 47.51 33.29 23.22 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 A 123 HIS A 42 HIS^? 28.45 MG MG A 301 A 200 ASP B 58 ASP^? 26.73 MG MG A 301 A 229 LYS B 136 LYS^? 33.75 MG MG B 302 coo 1.13 77.49 40.64 0.62 75.57 39.98 34.62 18.32 19.57 34.29 16.25 19.41 coo 0.84 91.24 49.01 2.91 91.61 49.23 34.42 33.56 15.74 33.50 33.49 17.59 coo 10.53 97.56 43.71 9.33 93.71 47.17 28.47 31.35 4.78 24.04 31.81 1.99 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 A 123 HIS A 147 HIS^? 9.20 MG MG A 302 A 200 ASP A 35 ASP^? 16.92 MG MG A 301 A 229 LYS A 90 LYS^? 18.58 MG MG A 301 coo 1.13 77.49 40.64 0.62 75.57 39.98 40.24 23.10 39.83 38.32 22.34 40.22 coo 0.84 91.24 49.01 2.91 91.61 49.23 34.49 31.10 26.54 36.41 31.82 27.10 coo 10.53 97.56 43.71 9.33 93.71 47.17 46.62 38.29 25.46 47.51 33.29 23.22 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 A 123 HIS A 170 HIS^? 10.56 MG MG A 302 A 200 ASP A 35 ASP^? 16.92 MG MG A 301 A 229 LYS A 90 LYS^? 18.58 MG MG A 301 coo 1.13 77.49 40.64 0.62 75.57 39.98 34.91 23.57 39.32 34.35 24.95 40.81 coo 0.84 91.24 49.01 2.91 91.61 49.23 34.49 31.10 26.54 36.41 31.82 27.10 coo 10.53 97.56 43.71 9.33 93.71 47.17 46.62 38.29 25.46 47.51 33.29 23.22 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 A 123 HIS B 42 HIS^? 28.37 MG MG B 302 A 200 ASP A 58 ASP^? 26.75 MG MG B 302 A 229 LYS A 136 LYS^? 30.58 MG MG A 302 coo 1.13 77.49 40.64 0.62 75.57 39.98 39.34 12.99 16.30 37.26 13.24 16.40 coo 0.84 91.24 49.01 2.91 91.61 49.23 53.93 9.80 21.09 53.83 8.90 19.15 coo 10.53 97.56 43.71 9.33 93.71 47.17 50.14 3.36 31.42 51.28 2.21 35.89 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 A 123 HIS B 42 HIS^? 28.37 MG MG B 302 A 200 ASP B 35 ASP^? 16.92 MG MG B 302 A 229 LYS B 90 LYS^? 18.68 MG MG B 302 coo 1.13 77.49 40.64 0.62 75.57 39.98 39.34 12.99 16.30 37.26 13.24 16.40 coo 0.84 91.24 49.01 2.91 91.61 49.23 52.63 11.07 10.18 53.68 12.85 9.94 coo 10.53 97.56 43.71 9.33 93.71 47.17 61.66 21.61 12.88 56.74 22.88 14.81 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 A 123 HIS B 42 HIS^? 28.37 MG MG B 302 A 200 ASP B 160 ASP^? 31.65 MG MG A 301 A 229 LYS B 136 LYS^? 33.75 MG MG B 302 coo 1.13 77.49 40.64 0.62 75.57 39.98 39.34 12.99 16.30 37.26 13.24 16.40 coo 0.84 91.24 49.01 2.91 91.61 49.23 28.01 24.83 16.38 27.44 26.81 15.80 coo 10.53 97.56 43.71 9.33 93.71 47.17 28.47 31.35 4.78 24.04 31.81 1.99 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 A 123 HIS B 147 HIS^? 9.27 MG MG B 301 A 200 ASP B 35 ASP^? 16.92 MG MG B 302 A 229 LYS B 90 LYS^? 18.68 MG MG B 302 coo 1.13 77.49 40.64 0.62 75.57 39.98 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 0.84 91.24 49.01 2.91 91.61 49.23 52.63 11.07 10.18 53.68 12.85 9.94 coo 10.53 97.56 43.71 9.33 93.71 47.17 61.66 21.61 12.88 56.74 22.88 14.81 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 A 123 HIS B 170 HIS^? 10.51 MG MG B 301 A 200 ASP B 35 ASP^? 16.92 MG MG B 302 A 229 LYS B 90 LYS^? 18.68 MG MG B 302 coo 1.13 77.49 40.64 0.62 75.57 39.98 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 0.84 91.24 49.01 2.91 91.61 49.23 52.63 11.07 10.18 53.68 12.85 9.94 coo 10.53 97.56 43.71 9.33 93.71 47.17 61.66 21.61 12.88 56.74 22.88 14.81 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 A 123 HIS C 42 HIS^? 28.09 MG MG C 302 A 200 ASP C 35 ASP^? 16.42 MG MG C 302 A 229 LYS C 90 LYS^? 18.24 MG MG C 302 coo 1.13 77.49 40.64 0.62 75.57 39.98 95.93 22.96 -23.11 97.92 23.62 -23.02 coo 0.84 91.24 49.01 2.91 91.61 49.23 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 10.53 97.56 43.71 9.33 93.71 47.17 72.37 23.25 -18.94 76.11 26.52 -20.97 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 A 123 HIS C 42 HIS^? 28.09 MG MG C 302 A 200 ASP D 58 ASP^? 26.59 MG MG C 302 A 229 LYS D 136 LYS^? 34.99 MG MG D 302 coo 1.13 77.49 40.64 0.62 75.57 39.98 95.93 22.96 -23.11 97.92 23.62 -23.02 coo 0.84 91.24 49.01 2.91 91.61 49.23 83.38 14.85 -27.71 84.09 14.12 -25.85 coo 10.53 97.56 43.71 9.33 93.71 47.17 88.96 10.62 -38.53 90.77 6.00 -38.00 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 A 123 HIS C 147 HIS^? 9.44 MG MG C 301 A 200 ASP C 35 ASP^? 16.42 MG MG C 302 A 229 LYS C 90 LYS^? 18.24 MG MG C 302 coo 1.13 77.49 40.64 0.62 75.57 39.98 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 0.84 91.24 49.01 2.91 91.61 49.23 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 10.53 97.56 43.71 9.33 93.71 47.17 72.37 23.25 -18.94 76.11 26.52 -20.97 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 A 123 HIS C 170 HIS^? 10.68 MG MG C 301 A 200 ASP C 35 ASP^? 16.42 MG MG C 302 A 229 LYS C 90 LYS^? 18.24 MG MG C 302 coo 1.13 77.49 40.64 0.62 75.57 39.98 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 0.84 91.24 49.01 2.91 91.61 49.23 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 10.53 97.56 43.71 9.33 93.71 47.17 72.37 23.25 -18.94 76.11 26.52 -20.97 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 14 3 # 14 A 123 HIS D 42 HIS^? 28.21 MG MG D 302 A 200 ASP C 58 ASP^? 26.67 MG MG D 302 A 229 LYS C 136 LYS^? 30.63 MG MG C 302 coo 1.13 77.49 40.64 0.62 75.57 39.98 98.45 29.90 -26.44 99.32 28.02 -26.13 coo 0.84 91.24 49.01 2.91 91.61 49.23 93.40 43.81 -22.27 94.18 44.45 -24.11 coo 10.53 97.56 43.71 9.33 93.71 47.17 99.75 44.04 -11.38 100.98 45.13 -6.77 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 15 3 # 15 A 123 HIS D 42 HIS^? 28.21 MG MG D 302 A 200 ASP D 35 ASP^? 16.80 MG MG D 302 A 229 LYS D 90 LYS^? 18.98 MG MG D 302 coo 1.13 77.49 40.64 0.62 75.57 39.98 98.45 29.90 -26.44 99.32 28.02 -26.13 coo 0.84 91.24 49.01 2.91 91.61 49.23 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 10.53 97.56 43.71 9.33 93.71 47.17 79.83 44.38 -31.44 80.32 39.55 -29.40 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 16 3 # 16 A 123 HIS D 147 HIS^? 9.43 MG MG D 301 A 200 ASP D 35 ASP^? 16.80 MG MG D 302 A 229 LYS D 90 LYS^? 18.98 MG MG D 302 coo 1.13 77.49 40.64 0.62 75.57 39.98 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 0.84 91.24 49.01 2.91 91.61 49.23 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 10.53 97.56 43.71 9.33 93.71 47.17 79.83 44.38 -31.44 80.32 39.55 -29.40 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 17 3 # 17 A 123 HIS D 170 HIS^? 10.59 MG MG D 301 A 200 ASP D 35 ASP^? 16.80 MG MG D 302 A 229 LYS D 90 LYS^? 18.98 MG MG D 302 coo 1.13 77.49 40.64 0.62 75.57 39.98 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 0.84 91.24 49.01 2.91 91.61 49.23 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 10.53 97.56 43.71 9.33 93.71 47.17 79.83 44.38 -31.44 80.32 39.55 -29.40 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 18 3 # 18 A 123 HIS E 42 HIS^? 28.20 MG MG E 302 A 200 ASP E 35 ASP^? 16.91 MG MG E 302 A 229 LYS E 90 LYS^? 19.16 MG MG E 302 coo 1.13 77.49 40.64 0.62 75.57 39.98 62.33 71.93 -68.30 60.54 72.96 -68.64 coo 0.84 91.24 49.01 2.91 91.61 49.23 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 10.53 97.56 43.71 9.33 93.71 47.17 73.81 51.50 -63.18 69.15 52.39 -65.65 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 19 3 # 19 A 123 HIS E 42 HIS^? 28.20 MG MG E 302 A 200 ASP E 160 ASP^? 31.54 MG MG F 301 A 229 LYS E 136 LYS^? 31.27 MG MG E 302 coo 1.13 77.49 40.64 0.62 75.57 39.98 62.33 71.93 -68.30 60.54 72.96 -68.64 coo 0.84 91.24 49.01 2.91 91.61 49.23 45.81 70.00 -68.45 44.10 68.87 -67.77 coo 10.53 97.56 43.71 9.33 93.71 47.17 42.12 65.93 -56.52 39.36 65.07 -51.83 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 20 3 # 20 A 123 HIS E 42 HIS^? 28.20 MG MG E 302 A 200 ASP F 58 ASP^? 26.87 MG MG E 302 A 229 LYS F 136 LYS^? 30.53 MG MG F 301 coo 1.13 77.49 40.64 0.62 75.57 39.98 62.33 71.93 -68.30 60.54 72.96 -68.64 coo 0.84 91.24 49.01 2.91 91.61 49.23 75.55 64.68 -72.56 76.21 65.63 -70.79 coo 10.53 97.56 43.71 9.33 93.71 47.17 76.49 71.19 -83.39 78.38 70.88 -88.47 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 21 3 # 21 A 123 HIS E 147 HIS^? 9.22 MG MG E 301 A 200 ASP E 35 ASP^? 16.91 MG MG E 302 A 229 LYS E 90 LYS^? 19.16 MG MG E 302 coo 1.13 77.49 40.64 0.62 75.57 39.98 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 0.84 91.24 49.01 2.91 91.61 49.23 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 10.53 97.56 43.71 9.33 93.71 47.17 73.81 51.50 -63.18 69.15 52.39 -65.65 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 22 3 # 22 A 123 HIS E 170 HIS^? 10.33 MG MG E 301 A 200 ASP E 35 ASP^? 16.91 MG MG E 302 A 229 LYS E 90 LYS^? 19.16 MG MG E 302 coo 1.13 77.49 40.64 0.62 75.57 39.98 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 0.84 91.24 49.01 2.91 91.61 49.23 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 10.53 97.56 43.71 9.33 93.71 47.17 73.81 51.50 -63.18 69.15 52.39 -65.65 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 23 3 # 23 A 123 HIS F 42 HIS^? 28.34 MG MG F 301 A 200 ASP E 58 ASP^? 26.76 MG MG F 301 A 229 LYS E 136 LYS^? 31.27 MG MG E 302 coo 1.13 77.49 40.64 0.62 75.57 39.98 55.11 70.50 -71.64 56.29 72.22 -71.48 coo 0.84 91.24 49.01 2.91 91.61 49.23 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 10.53 97.56 43.71 9.33 93.71 47.17 42.12 65.93 -56.52 39.36 65.07 -51.83 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 24 3 # 24 A 123 HIS F 42 HIS^? 28.34 MG MG F 301 A 200 ASP F 35 ASP^? 16.93 MG MG F 301 A 229 LYS F 90 LYS^? 18.57 MG MG F 301 coo 1.13 77.49 40.64 0.62 75.57 39.98 55.11 70.50 -71.64 56.29 72.22 -71.48 coo 0.84 91.24 49.01 2.91 91.61 49.23 46.82 60.47 -77.63 48.00 58.79 -78.23 coo 10.53 97.56 43.71 9.33 93.71 47.17 51.54 47.01 -75.58 55.05 50.31 -73.74 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 25 3 # 25 A 123 HIS F 147 HIS^? 8.79 MG MG F 302 A 200 ASP F 35 ASP^? 16.93 MG MG F 301 A 229 LYS F 90 LYS^? 18.57 MG MG F 301 coo 1.13 77.49 40.64 0.62 75.57 39.98 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 0.84 91.24 49.01 2.91 91.61 49.23 46.82 60.47 -77.63 48.00 58.79 -78.23 coo 10.53 97.56 43.71 9.33 93.71 47.17 51.54 47.01 -75.58 55.05 50.31 -73.74 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 26 3 # 26 A 123 HIS F 170 HIS^? 9.84 MG MG F 302 A 200 ASP F 35 ASP^? 16.93 MG MG F 301 A 229 LYS F 90 LYS^? 18.57 MG MG F 301 coo 1.13 77.49 40.64 0.62 75.57 39.98 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 0.84 91.24 49.01 2.91 91.61 49.23 46.82 60.47 -77.63 48.00 58.79 -78.23 coo 10.53 97.56 43.71 9.33 93.71 47.17 51.54 47.01 -75.58 55.05 50.31 -73.74 1dfo_c12 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 26 hits 1dfo_c12 naa= 3 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 123 HIS A 42 HIS^? 28.45 MG MG A 301 B 200 ASP A 35 ASP^? 16.92 MG MG A 301 B 229 LYS A 90 LYS^? 18.58 MG MG A 301 coo 9.24 94.26 88.22 8.02 94.07 89.92 34.62 18.32 19.57 34.29 16.25 19.41 coo 17.54 90.31 75.01 17.17 92.01 73.80 34.49 31.10 26.54 36.41 31.82 27.10 coo 22.32 101.61 71.64 17.89 98.63 71.55 46.62 38.29 25.46 47.51 33.29 23.22 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 B 123 HIS A 42 HIS^? 28.45 MG MG A 301 B 200 ASP B 58 ASP^? 26.73 MG MG A 301 B 229 LYS B 136 LYS^? 33.75 MG MG B 302 coo 9.24 94.26 88.22 8.02 94.07 89.92 34.62 18.32 19.57 34.29 16.25 19.41 coo 17.54 90.31 75.01 17.17 92.01 73.80 34.42 33.56 15.74 33.50 33.49 17.59 coo 22.32 101.61 71.64 17.89 98.63 71.55 28.47 31.35 4.78 24.04 31.81 1.99 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 B 123 HIS A 147 HIS^? 9.20 MG MG A 302 B 200 ASP A 35 ASP^? 16.92 MG MG A 301 B 229 LYS A 90 LYS^? 18.58 MG MG A 301 coo 9.24 94.26 88.22 8.02 94.07 89.92 40.24 23.10 39.83 38.32 22.34 40.22 coo 17.54 90.31 75.01 17.17 92.01 73.80 34.49 31.10 26.54 36.41 31.82 27.10 coo 22.32 101.61 71.64 17.89 98.63 71.55 46.62 38.29 25.46 47.51 33.29 23.22 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 B 123 HIS A 170 HIS^? 10.56 MG MG A 302 B 200 ASP A 35 ASP^? 16.92 MG MG A 301 B 229 LYS A 90 LYS^? 18.58 MG MG A 301 coo 9.24 94.26 88.22 8.02 94.07 89.92 34.91 23.57 39.32 34.35 24.95 40.81 coo 17.54 90.31 75.01 17.17 92.01 73.80 34.49 31.10 26.54 36.41 31.82 27.10 coo 22.32 101.61 71.64 17.89 98.63 71.55 46.62 38.29 25.46 47.51 33.29 23.22 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 B 123 HIS B 42 HIS^? 28.37 MG MG B 302 B 200 ASP A 58 ASP^? 26.75 MG MG B 302 B 229 LYS A 136 LYS^? 30.58 MG MG A 302 coo 9.24 94.26 88.22 8.02 94.07 89.92 39.34 12.99 16.30 37.26 13.24 16.40 coo 17.54 90.31 75.01 17.17 92.01 73.80 53.93 9.80 21.09 53.83 8.90 19.15 coo 22.32 101.61 71.64 17.89 98.63 71.55 50.14 3.36 31.42 51.28 2.21 35.89 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 B 123 HIS B 42 HIS^? 28.37 MG MG B 302 B 200 ASP B 35 ASP^? 16.92 MG MG B 302 B 229 LYS B 90 LYS^? 18.68 MG MG B 302 coo 9.24 94.26 88.22 8.02 94.07 89.92 39.34 12.99 16.30 37.26 13.24 16.40 coo 17.54 90.31 75.01 17.17 92.01 73.80 52.63 11.07 10.18 53.68 12.85 9.94 coo 22.32 101.61 71.64 17.89 98.63 71.55 61.66 21.61 12.88 56.74 22.88 14.81 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 B 123 HIS B 42 HIS^? 28.37 MG MG B 302 B 200 ASP B 160 ASP^? 31.65 MG MG A 301 B 229 LYS B 136 LYS^? 33.75 MG MG B 302 coo 9.24 94.26 88.22 8.02 94.07 89.92 39.34 12.99 16.30 37.26 13.24 16.40 coo 17.54 90.31 75.01 17.17 92.01 73.80 28.01 24.83 16.38 27.44 26.81 15.80 coo 22.32 101.61 71.64 17.89 98.63 71.55 28.47 31.35 4.78 24.04 31.81 1.99 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 B 123 HIS B 147 HIS^? 9.27 MG MG B 301 B 200 ASP B 35 ASP^? 16.92 MG MG B 302 B 229 LYS B 90 LYS^? 18.68 MG MG B 302 coo 9.24 94.26 88.22 8.02 94.07 89.92 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 17.54 90.31 75.01 17.17 92.01 73.80 52.63 11.07 10.18 53.68 12.85 9.94 coo 22.32 101.61 71.64 17.89 98.63 71.55 61.66 21.61 12.88 56.74 22.88 14.81 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 B 123 HIS B 170 HIS^? 10.51 MG MG B 301 B 200 ASP B 35 ASP^? 16.92 MG MG B 302 B 229 LYS B 90 LYS^? 18.68 MG MG B 302 coo 9.24 94.26 88.22 8.02 94.07 89.92 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 17.54 90.31 75.01 17.17 92.01 73.80 52.63 11.07 10.18 53.68 12.85 9.94 coo 22.32 101.61 71.64 17.89 98.63 71.55 61.66 21.61 12.88 56.74 22.88 14.81 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 B 123 HIS C 42 HIS^? 28.09 MG MG C 302 B 200 ASP C 35 ASP^? 16.42 MG MG C 302 B 229 LYS C 90 LYS^? 18.24 MG MG C 302 coo 9.24 94.26 88.22 8.02 94.07 89.92 95.93 22.96 -23.11 97.92 23.62 -23.02 coo 17.54 90.31 75.01 17.17 92.01 73.80 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 22.32 101.61 71.64 17.89 98.63 71.55 72.37 23.25 -18.94 76.11 26.52 -20.97 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 B 123 HIS C 42 HIS^? 28.09 MG MG C 302 B 200 ASP D 58 ASP^? 26.59 MG MG C 302 B 229 LYS D 136 LYS^? 34.99 MG MG D 302 coo 9.24 94.26 88.22 8.02 94.07 89.92 95.93 22.96 -23.11 97.92 23.62 -23.02 coo 17.54 90.31 75.01 17.17 92.01 73.80 83.38 14.85 -27.71 84.09 14.12 -25.85 coo 22.32 101.61 71.64 17.89 98.63 71.55 88.96 10.62 -38.53 90.77 6.00 -38.00 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 B 123 HIS C 147 HIS^? 9.44 MG MG C 301 B 200 ASP C 35 ASP^? 16.42 MG MG C 302 B 229 LYS C 90 LYS^? 18.24 MG MG C 302 coo 9.24 94.26 88.22 8.02 94.07 89.92 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 17.54 90.31 75.01 17.17 92.01 73.80 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 22.32 101.61 71.64 17.89 98.63 71.55 72.37 23.25 -18.94 76.11 26.52 -20.97 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 B 123 HIS C 170 HIS^? 10.68 MG MG C 301 B 200 ASP C 35 ASP^? 16.42 MG MG C 302 B 229 LYS C 90 LYS^? 18.24 MG MG C 302 coo 9.24 94.26 88.22 8.02 94.07 89.92 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 17.54 90.31 75.01 17.17 92.01 73.80 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 22.32 101.61 71.64 17.89 98.63 71.55 72.37 23.25 -18.94 76.11 26.52 -20.97 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 14 3 # 14 B 123 HIS D 42 HIS^? 28.21 MG MG D 302 B 200 ASP C 58 ASP^? 26.67 MG MG D 302 B 229 LYS C 136 LYS^? 30.63 MG MG C 302 coo 9.24 94.26 88.22 8.02 94.07 89.92 98.45 29.90 -26.44 99.32 28.02 -26.13 coo 17.54 90.31 75.01 17.17 92.01 73.80 93.40 43.81 -22.27 94.18 44.45 -24.11 coo 22.32 101.61 71.64 17.89 98.63 71.55 99.75 44.04 -11.38 100.98 45.13 -6.77 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 15 3 # 15 B 123 HIS D 42 HIS^? 28.21 MG MG D 302 B 200 ASP D 35 ASP^? 16.80 MG MG D 302 B 229 LYS D 90 LYS^? 18.98 MG MG D 302 coo 9.24 94.26 88.22 8.02 94.07 89.92 98.45 29.90 -26.44 99.32 28.02 -26.13 coo 17.54 90.31 75.01 17.17 92.01 73.80 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 22.32 101.61 71.64 17.89 98.63 71.55 79.83 44.38 -31.44 80.32 39.55 -29.40 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 16 3 # 16 B 123 HIS D 147 HIS^? 9.43 MG MG D 301 B 200 ASP D 35 ASP^? 16.80 MG MG D 302 B 229 LYS D 90 LYS^? 18.98 MG MG D 302 coo 9.24 94.26 88.22 8.02 94.07 89.92 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 17.54 90.31 75.01 17.17 92.01 73.80 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 22.32 101.61 71.64 17.89 98.63 71.55 79.83 44.38 -31.44 80.32 39.55 -29.40 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 17 3 # 17 B 123 HIS D 170 HIS^? 10.59 MG MG D 301 B 200 ASP D 35 ASP^? 16.80 MG MG D 302 B 229 LYS D 90 LYS^? 18.98 MG MG D 302 coo 9.24 94.26 88.22 8.02 94.07 89.92 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 17.54 90.31 75.01 17.17 92.01 73.80 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 22.32 101.61 71.64 17.89 98.63 71.55 79.83 44.38 -31.44 80.32 39.55 -29.40 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 18 3 # 18 B 123 HIS E 42 HIS^? 28.20 MG MG E 302 B 200 ASP E 35 ASP^? 16.91 MG MG E 302 B 229 LYS E 90 LYS^? 19.16 MG MG E 302 coo 9.24 94.26 88.22 8.02 94.07 89.92 62.33 71.93 -68.30 60.54 72.96 -68.64 coo 17.54 90.31 75.01 17.17 92.01 73.80 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 22.32 101.61 71.64 17.89 98.63 71.55 73.81 51.50 -63.18 69.15 52.39 -65.65 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 19 3 # 19 B 123 HIS E 42 HIS^? 28.20 MG MG E 302 B 200 ASP E 160 ASP^? 31.54 MG MG F 301 B 229 LYS E 136 LYS^? 31.27 MG MG E 302 coo 9.24 94.26 88.22 8.02 94.07 89.92 62.33 71.93 -68.30 60.54 72.96 -68.64 coo 17.54 90.31 75.01 17.17 92.01 73.80 45.81 70.00 -68.45 44.10 68.87 -67.77 coo 22.32 101.61 71.64 17.89 98.63 71.55 42.12 65.93 -56.52 39.36 65.07 -51.83 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 20 3 # 20 B 123 HIS E 42 HIS^? 28.20 MG MG E 302 B 200 ASP F 58 ASP^? 26.87 MG MG E 302 B 229 LYS F 136 LYS^? 30.53 MG MG F 301 coo 9.24 94.26 88.22 8.02 94.07 89.92 62.33 71.93 -68.30 60.54 72.96 -68.64 coo 17.54 90.31 75.01 17.17 92.01 73.80 75.55 64.68 -72.56 76.21 65.63 -70.79 coo 22.32 101.61 71.64 17.89 98.63 71.55 76.49 71.19 -83.39 78.38 70.88 -88.47 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 21 3 # 21 B 123 HIS E 147 HIS^? 9.22 MG MG E 301 B 200 ASP E 35 ASP^? 16.91 MG MG E 302 B 229 LYS E 90 LYS^? 19.16 MG MG E 302 coo 9.24 94.26 88.22 8.02 94.07 89.92 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 17.54 90.31 75.01 17.17 92.01 73.80 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 22.32 101.61 71.64 17.89 98.63 71.55 73.81 51.50 -63.18 69.15 52.39 -65.65 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 22 3 # 22 B 123 HIS E 170 HIS^? 10.33 MG MG E 301 B 200 ASP E 35 ASP^? 16.91 MG MG E 302 B 229 LYS E 90 LYS^? 19.16 MG MG E 302 coo 9.24 94.26 88.22 8.02 94.07 89.92 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 17.54 90.31 75.01 17.17 92.01 73.80 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 22.32 101.61 71.64 17.89 98.63 71.55 73.81 51.50 -63.18 69.15 52.39 -65.65 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 23 3 # 23 B 123 HIS F 42 HIS^? 28.34 MG MG F 301 B 200 ASP E 58 ASP^? 26.76 MG MG F 301 B 229 LYS E 136 LYS^? 31.27 MG MG E 302 coo 9.24 94.26 88.22 8.02 94.07 89.92 55.11 70.50 -71.64 56.29 72.22 -71.48 coo 17.54 90.31 75.01 17.17 92.01 73.80 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 22.32 101.61 71.64 17.89 98.63 71.55 42.12 65.93 -56.52 39.36 65.07 -51.83 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 24 3 # 24 B 123 HIS F 42 HIS^? 28.34 MG MG F 301 B 200 ASP F 35 ASP^? 16.93 MG MG F 301 B 229 LYS F 90 LYS^? 18.57 MG MG F 301 coo 9.24 94.26 88.22 8.02 94.07 89.92 55.11 70.50 -71.64 56.29 72.22 -71.48 coo 17.54 90.31 75.01 17.17 92.01 73.80 46.82 60.47 -77.63 48.00 58.79 -78.23 coo 22.32 101.61 71.64 17.89 98.63 71.55 51.54 47.01 -75.58 55.05 50.31 -73.74 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 25 3 # 25 B 123 HIS F 147 HIS^? 8.79 MG MG F 302 B 200 ASP F 35 ASP^? 16.93 MG MG F 301 B 229 LYS F 90 LYS^? 18.57 MG MG F 301 coo 9.24 94.26 88.22 8.02 94.07 89.92 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 17.54 90.31 75.01 17.17 92.01 73.80 46.82 60.47 -77.63 48.00 58.79 -78.23 coo 22.32 101.61 71.64 17.89 98.63 71.55 51.54 47.01 -75.58 55.05 50.31 -73.74 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 26 3 # 26 B 123 HIS F 170 HIS^? 9.84 MG MG F 302 B 200 ASP F 35 ASP^? 16.93 MG MG F 301 B 229 LYS F 90 LYS^? 18.57 MG MG F 301 coo 9.24 94.26 88.22 8.02 94.07 89.92 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 17.54 90.31 75.01 17.17 92.01 73.80 46.82 60.47 -77.63 48.00 58.79 -78.23 coo 22.32 101.61 71.64 17.89 98.63 71.55 51.54 47.01 -75.58 55.05 50.31 -73.74 1dfo_c13 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 26 hits 1dfo_c13 naa= 3 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 123 HIS A 42 HIS^? 28.45 MG MG A 301 C 200 ASP A 35 ASP^? 16.92 MG MG A 301 C 229 LYS A 90 LYS^? 18.58 MG MG A 301 coo 26.77 65.84 83.49 27.06 67.76 84.27 34.62 18.32 19.57 34.29 16.25 19.41 coo 19.52 52.01 79.59 20.28 51.65 77.65 34.49 31.10 26.54 36.41 31.82 27.10 coo 28.90 45.91 73.55 25.22 49.72 72.97 46.62 38.29 25.46 47.51 33.29 23.22 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 C 123 HIS A 42 HIS^? 28.45 MG MG A 301 C 200 ASP B 58 ASP^? 26.73 MG MG A 301 C 229 LYS B 136 LYS^? 33.75 MG MG B 302 coo 26.77 65.84 83.49 27.06 67.76 84.27 34.62 18.32 19.57 34.29 16.25 19.41 coo 19.52 52.01 79.59 20.28 51.65 77.65 34.42 33.56 15.74 33.50 33.49 17.59 coo 28.90 45.91 73.55 25.22 49.72 72.97 28.47 31.35 4.78 24.04 31.81 1.99 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 C 123 HIS A 147 HIS^? 9.20 MG MG A 302 C 200 ASP A 35 ASP^? 16.92 MG MG A 301 C 229 LYS A 90 LYS^? 18.58 MG MG A 301 coo 26.77 65.84 83.49 27.06 67.76 84.27 40.24 23.10 39.83 38.32 22.34 40.22 coo 19.52 52.01 79.59 20.28 51.65 77.65 34.49 31.10 26.54 36.41 31.82 27.10 coo 28.90 45.91 73.55 25.22 49.72 72.97 46.62 38.29 25.46 47.51 33.29 23.22 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 C 123 HIS A 170 HIS^? 10.56 MG MG A 302 C 200 ASP A 35 ASP^? 16.92 MG MG A 301 C 229 LYS A 90 LYS^? 18.58 MG MG A 301 coo 26.77 65.84 83.49 27.06 67.76 84.27 34.91 23.57 39.32 34.35 24.95 40.81 coo 19.52 52.01 79.59 20.28 51.65 77.65 34.49 31.10 26.54 36.41 31.82 27.10 coo 28.90 45.91 73.55 25.22 49.72 72.97 46.62 38.29 25.46 47.51 33.29 23.22 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 C 123 HIS B 42 HIS^? 28.37 MG MG B 302 C 200 ASP A 58 ASP^? 26.75 MG MG B 302 C 229 LYS A 136 LYS^? 30.58 MG MG A 302 coo 26.77 65.84 83.49 27.06 67.76 84.27 39.34 12.99 16.30 37.26 13.24 16.40 coo 19.52 52.01 79.59 20.28 51.65 77.65 53.93 9.80 21.09 53.83 8.90 19.15 coo 28.90 45.91 73.55 25.22 49.72 72.97 50.14 3.36 31.42 51.28 2.21 35.89 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 C 123 HIS B 42 HIS^? 28.37 MG MG B 302 C 200 ASP B 35 ASP^? 16.92 MG MG B 302 C 229 LYS B 90 LYS^? 18.68 MG MG B 302 coo 26.77 65.84 83.49 27.06 67.76 84.27 39.34 12.99 16.30 37.26 13.24 16.40 coo 19.52 52.01 79.59 20.28 51.65 77.65 52.63 11.07 10.18 53.68 12.85 9.94 coo 28.90 45.91 73.55 25.22 49.72 72.97 61.66 21.61 12.88 56.74 22.88 14.81 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 C 123 HIS B 42 HIS^? 28.37 MG MG B 302 C 200 ASP B 160 ASP^? 31.65 MG MG A 301 C 229 LYS B 136 LYS^? 33.75 MG MG B 302 coo 26.77 65.84 83.49 27.06 67.76 84.27 39.34 12.99 16.30 37.26 13.24 16.40 coo 19.52 52.01 79.59 20.28 51.65 77.65 28.01 24.83 16.38 27.44 26.81 15.80 coo 28.90 45.91 73.55 25.22 49.72 72.97 28.47 31.35 4.78 24.04 31.81 1.99 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 C 123 HIS B 147 HIS^? 9.27 MG MG B 301 C 200 ASP B 35 ASP^? 16.92 MG MG B 302 C 229 LYS B 90 LYS^? 18.68 MG MG B 302 coo 26.77 65.84 83.49 27.06 67.76 84.27 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 19.52 52.01 79.59 20.28 51.65 77.65 52.63 11.07 10.18 53.68 12.85 9.94 coo 28.90 45.91 73.55 25.22 49.72 72.97 61.66 21.61 12.88 56.74 22.88 14.81 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 C 123 HIS B 170 HIS^? 10.51 MG MG B 301 C 200 ASP B 35 ASP^? 16.92 MG MG B 302 C 229 LYS B 90 LYS^? 18.68 MG MG B 302 coo 26.77 65.84 83.49 27.06 67.76 84.27 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 19.52 52.01 79.59 20.28 51.65 77.65 52.63 11.07 10.18 53.68 12.85 9.94 coo 28.90 45.91 73.55 25.22 49.72 72.97 61.66 21.61 12.88 56.74 22.88 14.81 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 C 123 HIS C 42 HIS^? 28.09 MG MG C 302 C 200 ASP C 35 ASP^? 16.42 MG MG C 302 C 229 LYS C 90 LYS^? 18.24 MG MG C 302 coo 26.77 65.84 83.49 27.06 67.76 84.27 95.93 22.96 -23.11 97.92 23.62 -23.02 coo 19.52 52.01 79.59 20.28 51.65 77.65 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 28.90 45.91 73.55 25.22 49.72 72.97 72.37 23.25 -18.94 76.11 26.52 -20.97 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 C 123 HIS C 42 HIS^? 28.09 MG MG C 302 C 200 ASP D 58 ASP^? 26.59 MG MG C 302 C 229 LYS D 136 LYS^? 34.99 MG MG D 302 coo 26.77 65.84 83.49 27.06 67.76 84.27 95.93 22.96 -23.11 97.92 23.62 -23.02 coo 19.52 52.01 79.59 20.28 51.65 77.65 83.38 14.85 -27.71 84.09 14.12 -25.85 coo 28.90 45.91 73.55 25.22 49.72 72.97 88.96 10.62 -38.53 90.77 6.00 -38.00 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 C 123 HIS C 147 HIS^? 9.44 MG MG C 301 C 200 ASP C 35 ASP^? 16.42 MG MG C 302 C 229 LYS C 90 LYS^? 18.24 MG MG C 302 coo 26.77 65.84 83.49 27.06 67.76 84.27 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 19.52 52.01 79.59 20.28 51.65 77.65 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 28.90 45.91 73.55 25.22 49.72 72.97 72.37 23.25 -18.94 76.11 26.52 -20.97 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 C 123 HIS C 170 HIS^? 10.68 MG MG C 301 C 200 ASP C 35 ASP^? 16.42 MG MG C 302 C 229 LYS C 90 LYS^? 18.24 MG MG C 302 coo 26.77 65.84 83.49 27.06 67.76 84.27 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 19.52 52.01 79.59 20.28 51.65 77.65 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 28.90 45.91 73.55 25.22 49.72 72.97 72.37 23.25 -18.94 76.11 26.52 -20.97 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 14 3 # 14 C 123 HIS D 42 HIS^? 28.21 MG MG D 302 C 200 ASP C 58 ASP^? 26.67 MG MG D 302 C 229 LYS C 136 LYS^? 30.63 MG MG C 302 coo 26.77 65.84 83.49 27.06 67.76 84.27 98.45 29.90 -26.44 99.32 28.02 -26.13 coo 19.52 52.01 79.59 20.28 51.65 77.65 93.40 43.81 -22.27 94.18 44.45 -24.11 coo 28.90 45.91 73.55 25.22 49.72 72.97 99.75 44.04 -11.38 100.98 45.13 -6.77 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 15 3 # 15 C 123 HIS D 42 HIS^? 28.21 MG MG D 302 C 200 ASP D 35 ASP^? 16.80 MG MG D 302 C 229 LYS D 90 LYS^? 18.98 MG MG D 302 coo 26.77 65.84 83.49 27.06 67.76 84.27 98.45 29.90 -26.44 99.32 28.02 -26.13 coo 19.52 52.01 79.59 20.28 51.65 77.65 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 28.90 45.91 73.55 25.22 49.72 72.97 79.83 44.38 -31.44 80.32 39.55 -29.40 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 16 3 # 16 C 123 HIS D 147 HIS^? 9.43 MG MG D 301 C 200 ASP D 35 ASP^? 16.80 MG MG D 302 C 229 LYS D 90 LYS^? 18.98 MG MG D 302 coo 26.77 65.84 83.49 27.06 67.76 84.27 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 19.52 52.01 79.59 20.28 51.65 77.65 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 28.90 45.91 73.55 25.22 49.72 72.97 79.83 44.38 -31.44 80.32 39.55 -29.40 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 17 3 # 17 C 123 HIS D 170 HIS^? 10.59 MG MG D 301 C 200 ASP D 35 ASP^? 16.80 MG MG D 302 C 229 LYS D 90 LYS^? 18.98 MG MG D 302 coo 26.77 65.84 83.49 27.06 67.76 84.27 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 19.52 52.01 79.59 20.28 51.65 77.65 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 28.90 45.91 73.55 25.22 49.72 72.97 79.83 44.38 -31.44 80.32 39.55 -29.40 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 18 3 # 18 C 123 HIS E 42 HIS^? 28.20 MG MG E 302 C 200 ASP E 35 ASP^? 16.91 MG MG E 302 C 229 LYS E 90 LYS^? 19.16 MG MG E 302 coo 26.77 65.84 83.49 27.06 67.76 84.27 62.33 71.93 -68.30 60.54 72.96 -68.64 coo 19.52 52.01 79.59 20.28 51.65 77.65 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 28.90 45.91 73.55 25.22 49.72 72.97 73.81 51.50 -63.18 69.15 52.39 -65.65 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 19 3 # 19 C 123 HIS E 42 HIS^? 28.20 MG MG E 302 C 200 ASP E 160 ASP^? 31.54 MG MG F 301 C 229 LYS E 136 LYS^? 31.27 MG MG E 302 coo 26.77 65.84 83.49 27.06 67.76 84.27 62.33 71.93 -68.30 60.54 72.96 -68.64 coo 19.52 52.01 79.59 20.28 51.65 77.65 45.81 70.00 -68.45 44.10 68.87 -67.77 coo 28.90 45.91 73.55 25.22 49.72 72.97 42.12 65.93 -56.52 39.36 65.07 -51.83 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 20 3 # 20 C 123 HIS E 42 HIS^? 28.20 MG MG E 302 C 200 ASP F 58 ASP^? 26.87 MG MG E 302 C 229 LYS F 136 LYS^? 30.53 MG MG F 301 coo 26.77 65.84 83.49 27.06 67.76 84.27 62.33 71.93 -68.30 60.54 72.96 -68.64 coo 19.52 52.01 79.59 20.28 51.65 77.65 75.55 64.68 -72.56 76.21 65.63 -70.79 coo 28.90 45.91 73.55 25.22 49.72 72.97 76.49 71.19 -83.39 78.38 70.88 -88.47 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 21 3 # 21 C 123 HIS E 147 HIS^? 9.22 MG MG E 301 C 200 ASP E 35 ASP^? 16.91 MG MG E 302 C 229 LYS E 90 LYS^? 19.16 MG MG E 302 coo 26.77 65.84 83.49 27.06 67.76 84.27 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 19.52 52.01 79.59 20.28 51.65 77.65 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 28.90 45.91 73.55 25.22 49.72 72.97 73.81 51.50 -63.18 69.15 52.39 -65.65 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 22 3 # 22 C 123 HIS E 170 HIS^? 10.33 MG MG E 301 C 200 ASP E 35 ASP^? 16.91 MG MG E 302 C 229 LYS E 90 LYS^? 19.16 MG MG E 302 coo 26.77 65.84 83.49 27.06 67.76 84.27 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 19.52 52.01 79.59 20.28 51.65 77.65 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 28.90 45.91 73.55 25.22 49.72 72.97 73.81 51.50 -63.18 69.15 52.39 -65.65 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 23 3 # 23 C 123 HIS F 42 HIS^? 28.34 MG MG F 301 C 200 ASP E 58 ASP^? 26.76 MG MG F 301 C 229 LYS E 136 LYS^? 31.27 MG MG E 302 coo 26.77 65.84 83.49 27.06 67.76 84.27 55.11 70.50 -71.64 56.29 72.22 -71.48 coo 19.52 52.01 79.59 20.28 51.65 77.65 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 28.90 45.91 73.55 25.22 49.72 72.97 42.12 65.93 -56.52 39.36 65.07 -51.83 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 24 3 # 24 C 123 HIS F 42 HIS^? 28.34 MG MG F 301 C 200 ASP F 35 ASP^? 16.93 MG MG F 301 C 229 LYS F 90 LYS^? 18.57 MG MG F 301 coo 26.77 65.84 83.49 27.06 67.76 84.27 55.11 70.50 -71.64 56.29 72.22 -71.48 coo 19.52 52.01 79.59 20.28 51.65 77.65 46.82 60.47 -77.63 48.00 58.79 -78.23 coo 28.90 45.91 73.55 25.22 49.72 72.97 51.54 47.01 -75.58 55.05 50.31 -73.74 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 25 3 # 25 C 123 HIS F 147 HIS^? 8.79 MG MG F 302 C 200 ASP F 35 ASP^? 16.93 MG MG F 301 C 229 LYS F 90 LYS^? 18.57 MG MG F 301 coo 26.77 65.84 83.49 27.06 67.76 84.27 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 19.52 52.01 79.59 20.28 51.65 77.65 46.82 60.47 -77.63 48.00 58.79 -78.23 coo 28.90 45.91 73.55 25.22 49.72 72.97 51.54 47.01 -75.58 55.05 50.31 -73.74 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 26 3 # 26 C 123 HIS F 170 HIS^? 9.84 MG MG F 302 C 200 ASP F 35 ASP^? 16.93 MG MG F 301 C 229 LYS F 90 LYS^? 18.57 MG MG F 301 coo 26.77 65.84 83.49 27.06 67.76 84.27 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 19.52 52.01 79.59 20.28 51.65 77.65 46.82 60.47 -77.63 48.00 58.79 -78.23 coo 28.90 45.91 73.55 25.22 49.72 72.97 51.54 47.01 -75.58 55.05 50.31 -73.74 1dfo_c14 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 26 hits 1dfo_c14 naa= 3 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 123 HIS A 42 HIS^? 28.45 MG MG A 301 D 200 ASP A 35 ASP^? 16.92 MG MG A 301 D 229 LYS A 90 LYS^? 18.58 MG MG A 301 coo -10.90 48.74 53.41 -12.98 48.90 53.67 34.62 18.32 19.57 34.29 16.25 19.41 coo 4.60 52.95 52.50 5.57 51.29 53.40 34.49 31.10 26.54 36.41 31.82 27.10 coo 10.05 41.79 49.80 7.94 44.71 53.76 46.62 38.29 25.46 47.51 33.29 23.22 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 D 123 HIS A 42 HIS^? 28.45 MG MG A 301 D 200 ASP B 58 ASP^? 26.73 MG MG A 301 D 229 LYS B 136 LYS^? 33.75 MG MG B 302 coo -10.90 48.74 53.41 -12.98 48.90 53.67 34.62 18.32 19.57 34.29 16.25 19.41 coo 4.60 52.95 52.50 5.57 51.29 53.40 34.42 33.56 15.74 33.50 33.49 17.59 coo 10.05 41.79 49.80 7.94 44.71 53.76 28.47 31.35 4.78 24.04 31.81 1.99 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 D 123 HIS A 147 HIS^? 9.20 MG MG A 302 D 200 ASP A 35 ASP^? 16.92 MG MG A 301 D 229 LYS A 90 LYS^? 18.58 MG MG A 301 coo -10.90 48.74 53.41 -12.98 48.90 53.67 40.24 23.10 39.83 38.32 22.34 40.22 coo 4.60 52.95 52.50 5.57 51.29 53.40 34.49 31.10 26.54 36.41 31.82 27.10 coo 10.05 41.79 49.80 7.94 44.71 53.76 46.62 38.29 25.46 47.51 33.29 23.22 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 D 123 HIS A 170 HIS^? 10.56 MG MG A 302 D 200 ASP A 35 ASP^? 16.92 MG MG A 301 D 229 LYS A 90 LYS^? 18.58 MG MG A 301 coo -10.90 48.74 53.41 -12.98 48.90 53.67 34.91 23.57 39.32 34.35 24.95 40.81 coo 4.60 52.95 52.50 5.57 51.29 53.40 34.49 31.10 26.54 36.41 31.82 27.10 coo 10.05 41.79 49.80 7.94 44.71 53.76 46.62 38.29 25.46 47.51 33.29 23.22 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 D 123 HIS B 42 HIS^? 28.37 MG MG B 302 D 200 ASP A 58 ASP^? 26.75 MG MG B 302 D 229 LYS A 136 LYS^? 30.58 MG MG A 302 coo -10.90 48.74 53.41 -12.98 48.90 53.67 39.34 12.99 16.30 37.26 13.24 16.40 coo 4.60 52.95 52.50 5.57 51.29 53.40 53.93 9.80 21.09 53.83 8.90 19.15 coo 10.05 41.79 49.80 7.94 44.71 53.76 50.14 3.36 31.42 51.28 2.21 35.89 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 D 123 HIS B 42 HIS^? 28.37 MG MG B 302 D 200 ASP B 35 ASP^? 16.92 MG MG B 302 D 229 LYS B 90 LYS^? 18.68 MG MG B 302 coo -10.90 48.74 53.41 -12.98 48.90 53.67 39.34 12.99 16.30 37.26 13.24 16.40 coo 4.60 52.95 52.50 5.57 51.29 53.40 52.63 11.07 10.18 53.68 12.85 9.94 coo 10.05 41.79 49.80 7.94 44.71 53.76 61.66 21.61 12.88 56.74 22.88 14.81 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 D 123 HIS B 42 HIS^? 28.37 MG MG B 302 D 200 ASP B 160 ASP^? 31.65 MG MG A 301 D 229 LYS B 136 LYS^? 33.75 MG MG B 302 coo -10.90 48.74 53.41 -12.98 48.90 53.67 39.34 12.99 16.30 37.26 13.24 16.40 coo 4.60 52.95 52.50 5.57 51.29 53.40 28.01 24.83 16.38 27.44 26.81 15.80 coo 10.05 41.79 49.80 7.94 44.71 53.76 28.47 31.35 4.78 24.04 31.81 1.99 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 D 123 HIS B 147 HIS^? 9.27 MG MG B 301 D 200 ASP B 35 ASP^? 16.92 MG MG B 302 D 229 LYS B 90 LYS^? 18.68 MG MG B 302 coo -10.90 48.74 53.41 -12.98 48.90 53.67 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 4.60 52.95 52.50 5.57 51.29 53.40 52.63 11.07 10.18 53.68 12.85 9.94 coo 10.05 41.79 49.80 7.94 44.71 53.76 61.66 21.61 12.88 56.74 22.88 14.81 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 D 123 HIS B 170 HIS^? 10.51 MG MG B 301 D 200 ASP B 35 ASP^? 16.92 MG MG B 302 D 229 LYS B 90 LYS^? 18.68 MG MG B 302 coo -10.90 48.74 53.41 -12.98 48.90 53.67 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 4.60 52.95 52.50 5.57 51.29 53.40 52.63 11.07 10.18 53.68 12.85 9.94 coo 10.05 41.79 49.80 7.94 44.71 53.76 61.66 21.61 12.88 56.74 22.88 14.81 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 D 123 HIS C 42 HIS^? 28.09 MG MG C 302 D 200 ASP C 35 ASP^? 16.42 MG MG C 302 D 229 LYS C 90 LYS^? 18.24 MG MG C 302 coo -10.90 48.74 53.41 -12.98 48.90 53.67 95.93 22.96 -23.11 97.92 23.62 -23.02 coo 4.60 52.95 52.50 5.57 51.29 53.40 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 10.05 41.79 49.80 7.94 44.71 53.76 72.37 23.25 -18.94 76.11 26.52 -20.97 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 D 123 HIS C 42 HIS^? 28.09 MG MG C 302 D 200 ASP D 58 ASP^? 26.59 MG MG C 302 D 229 LYS D 136 LYS^? 34.99 MG MG D 302 coo -10.90 48.74 53.41 -12.98 48.90 53.67 95.93 22.96 -23.11 97.92 23.62 -23.02 coo 4.60 52.95 52.50 5.57 51.29 53.40 83.38 14.85 -27.71 84.09 14.12 -25.85 coo 10.05 41.79 49.80 7.94 44.71 53.76 88.96 10.62 -38.53 90.77 6.00 -38.00 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 D 123 HIS C 147 HIS^? 9.44 MG MG C 301 D 200 ASP C 35 ASP^? 16.42 MG MG C 302 D 229 LYS C 90 LYS^? 18.24 MG MG C 302 coo -10.90 48.74 53.41 -12.98 48.90 53.67 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 4.60 52.95 52.50 5.57 51.29 53.40 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 10.05 41.79 49.80 7.94 44.71 53.76 72.37 23.25 -18.94 76.11 26.52 -20.97 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 D 123 HIS C 170 HIS^? 10.68 MG MG C 301 D 200 ASP C 35 ASP^? 16.42 MG MG C 302 D 229 LYS C 90 LYS^? 18.24 MG MG C 302 coo -10.90 48.74 53.41 -12.98 48.90 53.67 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 4.60 52.95 52.50 5.57 51.29 53.40 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 10.05 41.79 49.80 7.94 44.71 53.76 72.37 23.25 -18.94 76.11 26.52 -20.97 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 14 3 # 14 D 123 HIS D 42 HIS^? 28.21 MG MG D 302 D 200 ASP C 58 ASP^? 26.67 MG MG D 302 D 229 LYS C 136 LYS^? 30.63 MG MG C 302 coo -10.90 48.74 53.41 -12.98 48.90 53.67 98.45 29.90 -26.44 99.32 28.02 -26.13 coo 4.60 52.95 52.50 5.57 51.29 53.40 93.40 43.81 -22.27 94.18 44.45 -24.11 coo 10.05 41.79 49.80 7.94 44.71 53.76 99.75 44.04 -11.38 100.98 45.13 -6.77 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 15 3 # 15 D 123 HIS D 42 HIS^? 28.21 MG MG D 302 D 200 ASP D 35 ASP^? 16.80 MG MG D 302 D 229 LYS D 90 LYS^? 18.98 MG MG D 302 coo -10.90 48.74 53.41 -12.98 48.90 53.67 98.45 29.90 -26.44 99.32 28.02 -26.13 coo 4.60 52.95 52.50 5.57 51.29 53.40 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 10.05 41.79 49.80 7.94 44.71 53.76 79.83 44.38 -31.44 80.32 39.55 -29.40 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 16 3 # 16 D 123 HIS D 147 HIS^? 9.43 MG MG D 301 D 200 ASP D 35 ASP^? 16.80 MG MG D 302 D 229 LYS D 90 LYS^? 18.98 MG MG D 302 coo -10.90 48.74 53.41 -12.98 48.90 53.67 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 4.60 52.95 52.50 5.57 51.29 53.40 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 10.05 41.79 49.80 7.94 44.71 53.76 79.83 44.38 -31.44 80.32 39.55 -29.40 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 17 3 # 17 D 123 HIS D 170 HIS^? 10.59 MG MG D 301 D 200 ASP D 35 ASP^? 16.80 MG MG D 302 D 229 LYS D 90 LYS^? 18.98 MG MG D 302 coo -10.90 48.74 53.41 -12.98 48.90 53.67 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 4.60 52.95 52.50 5.57 51.29 53.40 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 10.05 41.79 49.80 7.94 44.71 53.76 79.83 44.38 -31.44 80.32 39.55 -29.40 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 18 3 # 18 D 123 HIS E 42 HIS^? 28.20 MG MG E 302 D 200 ASP E 35 ASP^? 16.91 MG MG E 302 D 229 LYS E 90 LYS^? 19.16 MG MG E 302 coo -10.90 48.74 53.41 -12.98 48.90 53.67 62.33 71.93 -68.30 60.54 72.96 -68.64 coo 4.60 52.95 52.50 5.57 51.29 53.40 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 10.05 41.79 49.80 7.94 44.71 53.76 73.81 51.50 -63.18 69.15 52.39 -65.65 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 19 3 # 19 D 123 HIS E 42 HIS^? 28.20 MG MG E 302 D 200 ASP E 160 ASP^? 31.54 MG MG F 301 D 229 LYS E 136 LYS^? 31.27 MG MG E 302 coo -10.90 48.74 53.41 -12.98 48.90 53.67 62.33 71.93 -68.30 60.54 72.96 -68.64 coo 4.60 52.95 52.50 5.57 51.29 53.40 45.81 70.00 -68.45 44.10 68.87 -67.77 coo 10.05 41.79 49.80 7.94 44.71 53.76 42.12 65.93 -56.52 39.36 65.07 -51.83 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 20 3 # 20 D 123 HIS E 42 HIS^? 28.20 MG MG E 302 D 200 ASP F 58 ASP^? 26.87 MG MG E 302 D 229 LYS F 136 LYS^? 30.53 MG MG F 301 coo -10.90 48.74 53.41 -12.98 48.90 53.67 62.33 71.93 -68.30 60.54 72.96 -68.64 coo 4.60 52.95 52.50 5.57 51.29 53.40 75.55 64.68 -72.56 76.21 65.63 -70.79 coo 10.05 41.79 49.80 7.94 44.71 53.76 76.49 71.19 -83.39 78.38 70.88 -88.47 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 21 3 # 21 D 123 HIS E 147 HIS^? 9.22 MG MG E 301 D 200 ASP E 35 ASP^? 16.91 MG MG E 302 D 229 LYS E 90 LYS^? 19.16 MG MG E 302 coo -10.90 48.74 53.41 -12.98 48.90 53.67 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 4.60 52.95 52.50 5.57 51.29 53.40 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 10.05 41.79 49.80 7.94 44.71 53.76 73.81 51.50 -63.18 69.15 52.39 -65.65 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 22 3 # 22 D 123 HIS E 170 HIS^? 10.33 MG MG E 301 D 200 ASP E 35 ASP^? 16.91 MG MG E 302 D 229 LYS E 90 LYS^? 19.16 MG MG E 302 coo -10.90 48.74 53.41 -12.98 48.90 53.67 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 4.60 52.95 52.50 5.57 51.29 53.40 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 10.05 41.79 49.80 7.94 44.71 53.76 73.81 51.50 -63.18 69.15 52.39 -65.65 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 23 3 # 23 D 123 HIS F 42 HIS^? 28.34 MG MG F 301 D 200 ASP E 58 ASP^? 26.76 MG MG F 301 D 229 LYS E 136 LYS^? 31.27 MG MG E 302 coo -10.90 48.74 53.41 -12.98 48.90 53.67 55.11 70.50 -71.64 56.29 72.22 -71.48 coo 4.60 52.95 52.50 5.57 51.29 53.40 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 10.05 41.79 49.80 7.94 44.71 53.76 42.12 65.93 -56.52 39.36 65.07 -51.83 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 24 3 # 24 D 123 HIS F 42 HIS^? 28.34 MG MG F 301 D 200 ASP F 35 ASP^? 16.93 MG MG F 301 D 229 LYS F 90 LYS^? 18.57 MG MG F 301 coo -10.90 48.74 53.41 -12.98 48.90 53.67 55.11 70.50 -71.64 56.29 72.22 -71.48 coo 4.60 52.95 52.50 5.57 51.29 53.40 46.82 60.47 -77.63 48.00 58.79 -78.23 coo 10.05 41.79 49.80 7.94 44.71 53.76 51.54 47.01 -75.58 55.05 50.31 -73.74 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 25 3 # 25 D 123 HIS F 147 HIS^? 8.79 MG MG F 302 D 200 ASP F 35 ASP^? 16.93 MG MG F 301 D 229 LYS F 90 LYS^? 18.57 MG MG F 301 coo -10.90 48.74 53.41 -12.98 48.90 53.67 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 4.60 52.95 52.50 5.57 51.29 53.40 46.82 60.47 -77.63 48.00 58.79 -78.23 coo 10.05 41.79 49.80 7.94 44.71 53.76 51.54 47.01 -75.58 55.05 50.31 -73.74 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 26 3 # 26 D 123 HIS F 170 HIS^? 9.84 MG MG F 302 D 200 ASP F 35 ASP^? 16.93 MG MG F 301 D 229 LYS F 90 LYS^? 18.57 MG MG F 301 coo -10.90 48.74 53.41 -12.98 48.90 53.67 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 4.60 52.95 52.50 5.57 51.29 53.40 46.82 60.47 -77.63 48.00 58.79 -78.23 coo 10.05 41.79 49.80 7.94 44.71 53.76 51.54 47.01 -75.58 55.05 50.31 -73.74 1dfo_c15 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 26 hits 1dfo_c15 naa= 3 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 A 44 THR A 74 THR^? 21.85 MG MG A 301 A 45 THR A 73 THR^? 15.13 MG MG A 301 A 161 LYS A 21 LYS^? 14.51 MG MG A 301 coo 26.16 88.25 79.16 25.22 89.47 80.71 38.65 41.92 25.57 37.60 41.76 23.73 coo 27.73 89.90 76.08 29.24 91.46 75.95 40.93 39.17 26.72 41.99 38.78 28.61 coo 33.83 91.15 88.62 31.07 91.06 83.02 32.50 46.40 37.91 34.61 41.52 40.01 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 A 44 THR A 74 THR^? 21.85 MG MG A 301 A 45 THR A 73 THR^? 15.13 MG MG A 301 A 161 LYS B 61 LYS^? 22.03 MG MG A 301 coo 26.16 88.25 79.16 25.22 89.47 80.71 38.65 41.92 25.57 37.60 41.76 23.73 coo 27.73 89.90 76.08 29.24 91.46 75.95 40.93 39.17 26.72 41.99 38.78 28.61 coo 33.83 91.15 88.62 31.07 91.06 83.02 32.50 37.62 17.61 36.68 34.92 21.51 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 A 44 THR A 74 THR^? 21.85 MG MG A 301 A 45 THR A 88 THR^? 23.22 MG MG A 301 A 161 LYS B 61 LYS^? 22.03 MG MG A 301 coo 26.16 88.25 79.16 25.22 89.47 80.71 38.65 41.92 25.57 37.60 41.76 23.73 coo 27.73 89.90 76.08 29.24 91.46 75.95 42.44 43.75 23.46 42.54 42.92 21.44 coo 33.83 91.15 88.62 31.07 91.06 83.02 32.50 37.62 17.61 36.68 34.92 21.51 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 4 3 # 4 A 44 THR B 73 THR^? 15.28 MG MG B 302 A 45 THR B 88 THR^? 22.44 MG MG C 301 A 161 LYS A 61 LYS^? 21.99 MG MG B 302 coo 26.16 88.25 79.16 25.22 89.47 80.71 61.79 16.15 11.00 62.15 17.08 9.05 coo 27.73 89.90 76.08 29.24 91.46 75.95 66.42 16.42 14.22 65.45 16.28 16.18 coo 33.83 91.15 88.62 31.07 91.06 83.02 57.78 7.35 19.60 56.77 12.20 15.61 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 5 3 # 5 A 44 THR B 74 THR^? 21.68 MG MG B 302 A 45 THR B 73 THR^? 15.28 MG MG B 302 A 161 LYS A 61 LYS^? 21.99 MG MG B 302 coo 26.16 88.25 79.16 25.22 89.47 80.71 63.99 13.20 11.95 63.36 12.32 13.84 coo 27.73 89.90 76.08 29.24 91.46 75.95 61.79 16.15 11.00 62.15 17.08 9.05 coo 33.83 91.15 88.62 31.07 91.06 83.02 57.78 7.35 19.60 56.77 12.20 15.61 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 6 3 # 6 A 44 THR B 74 THR^? 21.68 MG MG B 302 A 45 THR B 88 THR^? 22.44 MG MG C 301 A 161 LYS A 61 LYS^? 21.99 MG MG B 302 coo 26.16 88.25 79.16 25.22 89.47 80.71 63.99 13.20 11.95 63.36 12.32 13.84 coo 27.73 89.90 76.08 29.24 91.46 75.95 66.42 16.42 14.22 65.45 16.28 16.18 coo 33.83 91.15 88.62 31.07 91.06 83.02 57.78 7.35 19.60 56.77 12.20 15.61 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 7 3 # 7 A 44 THR B 88 THR^? 22.44 MG MG C 301 A 45 THR B 73 THR^? 15.28 MG MG B 302 A 161 LYS A 61 LYS^? 21.99 MG MG B 302 coo 26.16 88.25 79.16 25.22 89.47 80.71 66.42 16.42 14.22 65.45 16.28 16.18 coo 27.73 89.90 76.08 29.24 91.46 75.95 61.79 16.15 11.00 62.15 17.08 9.05 coo 33.83 91.15 88.62 31.07 91.06 83.02 57.78 7.35 19.60 56.77 12.20 15.61 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 8 3 # 8 A 44 THR C 73 THR^? 14.95 MG MG C 302 A 45 THR C 88 THR^? 22.58 MG MG B 301 A 161 LYS D 61 LYS^? 21.93 MG MG C 302 coo 26.16 88.25 79.16 25.22 89.47 80.71 74.44 18.04 -17.45 73.99 18.64 -15.48 coo 27.73 89.90 76.08 29.24 91.46 75.95 69.96 16.71 -20.56 70.75 16.33 -22.54 coo 33.83 91.15 88.62 31.07 91.06 83.02 80.64 11.23 -26.16 80.65 16.24 -22.36 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 9 3 # 9 A 44 THR C 74 THR^? 21.64 MG MG C 302 A 45 THR C 73 THR^? 14.95 MG MG C 302 A 161 LYS D 61 LYS^? 21.93 MG MG C 302 coo 26.16 88.25 79.16 25.22 89.47 80.71 73.35 14.53 -18.47 73.89 13.78 -20.47 coo 27.73 89.90 76.08 29.24 91.46 75.95 74.44 18.04 -17.45 73.99 18.64 -15.48 coo 33.83 91.15 88.62 31.07 91.06 83.02 80.64 11.23 -26.16 80.65 16.24 -22.36 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 10 3 # 10 A 44 THR C 74 THR^? 21.64 MG MG C 302 A 45 THR C 88 THR^? 22.58 MG MG B 301 A 161 LYS D 61 LYS^? 21.93 MG MG C 302 coo 26.16 88.25 79.16 25.22 89.47 80.71 73.35 14.53 -18.47 73.89 13.78 -20.47 coo 27.73 89.90 76.08 29.24 91.46 75.95 69.96 16.71 -20.56 70.75 16.33 -22.54 coo 33.83 91.15 88.62 31.07 91.06 83.02 80.64 11.23 -26.16 80.65 16.24 -22.36 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 11 3 # 11 A 44 THR C 88 THR^? 22.58 MG MG B 301 A 45 THR C 73 THR^? 14.95 MG MG C 302 A 161 LYS D 61 LYS^? 21.93 MG MG C 302 coo 26.16 88.25 79.16 25.22 89.47 80.71 69.96 16.71 -20.56 70.75 16.33 -22.54 coo 27.73 89.90 76.08 29.24 91.46 75.95 74.44 18.04 -17.45 73.99 18.64 -15.48 coo 33.83 91.15 88.62 31.07 91.06 83.02 80.64 11.23 -26.16 80.65 16.24 -22.36 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 12 3 # 12 A 44 THR D 73 THR^? 15.26 MG MG D 302 A 45 THR D 88 THR^? 22.15 MG MG E 301 A 161 LYS C 61 LYS^? 21.91 MG MG D 302 coo 26.16 88.25 79.16 25.22 89.47 80.71 84.65 47.16 -33.26 83.69 47.10 -35.24 coo 27.73 89.90 76.08 29.24 91.46 75.95 81.92 51.17 -30.12 82.55 50.45 -28.12 coo 33.83 91.15 88.62 31.07 91.06 83.02 93.60 48.56 -24.05 90.39 44.71 -27.98 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 13 3 # 13 A 44 THR D 74 THR^? 21.71 MG MG D 302 A 45 THR D 73 THR^? 15.26 MG MG D 302 A 161 LYS C 61 LYS^? 21.91 MG MG D 302 coo 26.16 88.25 79.16 25.22 89.47 80.71 86.03 50.57 -32.19 86.96 50.83 -30.24 coo 27.73 89.90 76.08 29.24 91.46 75.95 84.65 47.16 -33.26 83.69 47.10 -35.24 coo 33.83 91.15 88.62 31.07 91.06 83.02 93.60 48.56 -24.05 90.39 44.71 -27.98 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 14 3 # 14 A 44 THR D 74 THR^? 21.71 MG MG D 302 A 45 THR D 88 THR^? 22.15 MG MG E 301 A 161 LYS C 61 LYS^? 21.91 MG MG D 302 coo 26.16 88.25 79.16 25.22 89.47 80.71 86.03 50.57 -32.19 86.96 50.83 -30.24 coo 27.73 89.90 76.08 29.24 91.46 75.95 81.92 51.17 -30.12 82.55 50.45 -28.12 coo 33.83 91.15 88.62 31.07 91.06 83.02 93.60 48.56 -24.05 90.39 44.71 -27.98 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 15 3 # 15 A 44 THR D 88 THR^? 22.15 MG MG E 301 A 45 THR D 73 THR^? 15.26 MG MG D 302 A 161 LYS C 61 LYS^? 21.91 MG MG D 302 coo 26.16 88.25 79.16 25.22 89.47 80.71 81.92 51.17 -30.12 82.55 50.45 -28.12 coo 27.73 89.90 76.08 29.24 91.46 75.95 84.65 47.16 -33.26 83.69 47.10 -35.24 coo 33.83 91.15 88.62 31.07 91.06 83.02 93.60 48.56 -24.05 90.39 44.71 -27.98 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 16 3 # 16 A 44 THR E 73 THR^? 15.13 MG MG E 302 A 45 THR E 88 THR^? 21.98 MG MG D 301 A 161 LYS F 61 LYS^? 21.75 MG MG E 302 coo 26.16 88.25 79.16 25.22 89.47 80.71 77.31 55.78 -61.57 77.11 55.21 -59.48 coo 27.73 89.90 76.08 29.24 91.46 75.95 80.56 52.52 -64.50 80.70 53.32 -66.53 coo 33.83 91.15 88.62 31.07 91.06 83.02 80.24 64.12 -71.01 76.23 61.95 -66.39 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 17 3 # 17 A 44 THR E 74 THR^? 21.51 MG MG E 302 A 45 THR E 73 THR^? 15.13 MG MG E 302 A 161 LYS F 61 LYS^? 21.75 MG MG E 302 coo 26.16 88.25 79.16 25.22 89.47 80.71 80.89 56.59 -62.50 81.13 57.37 -64.43 coo 27.73 89.90 76.08 29.24 91.46 75.95 77.31 55.78 -61.57 77.11 55.21 -59.48 coo 33.83 91.15 88.62 31.07 91.06 83.02 80.24 64.12 -71.01 76.23 61.95 -66.39 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 18 3 # 18 A 44 THR E 74 THR^? 21.51 MG MG E 302 A 45 THR E 88 THR^? 21.98 MG MG D 301 A 161 LYS F 61 LYS^? 21.75 MG MG E 302 coo 26.16 88.25 79.16 25.22 89.47 80.71 80.89 56.59 -62.50 81.13 57.37 -64.43 coo 27.73 89.90 76.08 29.24 91.46 75.95 80.56 52.52 -64.50 80.70 53.32 -66.53 coo 33.83 91.15 88.62 31.07 91.06 83.02 80.24 64.12 -71.01 76.23 61.95 -66.39 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 19 3 # 19 A 44 THR E 88 THR^? 21.98 MG MG D 301 A 45 THR E 73 THR^? 15.13 MG MG E 302 A 161 LYS F 61 LYS^? 21.75 MG MG E 302 coo 26.16 88.25 79.16 25.22 89.47 80.71 80.56 52.52 -64.50 80.70 53.32 -66.53 coo 27.73 89.90 76.08 29.24 91.46 75.95 77.31 55.78 -61.57 77.11 55.21 -59.48 coo 33.83 91.15 88.62 31.07 91.06 83.02 80.24 64.12 -71.01 76.23 61.95 -66.39 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 20 3 # 20 A 44 THR F 73 THR^? 15.13 MG MG F 301 A 45 THR F 88 THR^? 23.06 MG MG F 301 A 161 LYS E 61 LYS^? 22.16 MG MG F 301 coo 26.16 88.25 79.16 25.22 89.47 80.71 46.81 49.68 -77.46 47.14 48.99 -79.45 coo 27.73 89.90 76.08 29.24 91.46 75.95 44.71 45.78 -74.10 45.06 46.44 -72.02 coo 33.83 91.15 88.62 31.07 91.06 83.02 40.99 56.84 -68.48 45.99 56.72 -72.39 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 21 3 # 21 A 44 THR F 74 THR^? 21.46 MG MG F 301 A 45 THR F 73 THR^? 15.13 MG MG F 301 A 161 LYS E 61 LYS^? 22.16 MG MG F 301 coo 26.16 88.25 79.16 25.22 89.47 80.71 43.07 49.39 -76.61 42.46 50.11 -74.68 coo 27.73 89.90 76.08 29.24 91.46 75.95 46.81 49.68 -77.46 47.14 48.99 -79.45 coo 33.83 91.15 88.62 31.07 91.06 83.02 40.99 56.84 -68.48 45.99 56.72 -72.39 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 22 3 # 22 A 44 THR F 74 THR^? 21.46 MG MG F 301 A 45 THR F 88 THR^? 23.06 MG MG F 301 A 161 LYS E 61 LYS^? 22.16 MG MG F 301 coo 26.16 88.25 79.16 25.22 89.47 80.71 43.07 49.39 -76.61 42.46 50.11 -74.68 coo 27.73 89.90 76.08 29.24 91.46 75.95 44.71 45.78 -74.10 45.06 46.44 -72.02 coo 33.83 91.15 88.62 31.07 91.06 83.02 40.99 56.84 -68.48 45.99 56.72 -72.39 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 23 3 # 23 A 44 THR F 88 THR^? 23.06 MG MG F 301 A 45 THR F 73 THR^? 15.13 MG MG F 301 A 161 LYS E 61 LYS^? 22.16 MG MG F 301 coo 26.16 88.25 79.16 25.22 89.47 80.71 44.71 45.78 -74.10 45.06 46.44 -72.02 coo 27.73 89.90 76.08 29.24 91.46 75.95 46.81 49.68 -77.46 47.14 48.99 -79.45 coo 33.83 91.15 88.62 31.07 91.06 83.02 40.99 56.84 -68.48 45.99 56.72 -72.39 1dhp_c02 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 23 hits 1dhp_c02 naa= 3 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 B 44 THR A 74 THR^? 21.85 MG MG A 301 B 45 THR A 73 THR^? 15.13 MG MG A 301 B 161 LYS A 21 LYS^? 14.51 MG MG A 301 coo 7.39 128.28 94.56 8.34 126.36 94.79 38.65 41.92 25.57 37.60 41.76 23.73 coo 5.75 129.25 91.25 4.29 128.16 90.07 40.93 39.17 26.72 41.99 38.78 28.61 coo -0.17 119.75 99.65 2.51 123.83 95.70 32.50 46.40 37.91 34.61 41.52 40.01 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 B 44 THR A 74 THR^? 21.85 MG MG A 301 B 45 THR A 73 THR^? 15.13 MG MG A 301 B 161 LYS B 61 LYS^? 22.03 MG MG A 301 coo 7.39 128.28 94.56 8.34 126.36 94.79 38.65 41.92 25.57 37.60 41.76 23.73 coo 5.75 129.25 91.25 4.29 128.16 90.07 40.93 39.17 26.72 41.99 38.78 28.61 coo -0.17 119.75 99.65 2.51 123.83 95.70 32.50 37.62 17.61 36.68 34.92 21.51 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 B 44 THR A 74 THR^? 21.85 MG MG A 301 B 45 THR A 88 THR^? 23.22 MG MG A 301 B 161 LYS B 61 LYS^? 22.03 MG MG A 301 coo 7.39 128.28 94.56 8.34 126.36 94.79 38.65 41.92 25.57 37.60 41.76 23.73 coo 5.75 129.25 91.25 4.29 128.16 90.07 42.44 43.75 23.46 42.54 42.92 21.44 coo -0.17 119.75 99.65 2.51 123.83 95.70 32.50 37.62 17.61 36.68 34.92 21.51 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 4 3 # 4 B 44 THR B 73 THR^? 15.28 MG MG B 302 B 45 THR B 88 THR^? 22.44 MG MG C 301 B 161 LYS A 61 LYS^? 21.99 MG MG B 302 coo 7.39 128.28 94.56 8.34 126.36 94.79 61.79 16.15 11.00 62.15 17.08 9.05 coo 5.75 129.25 91.25 4.29 128.16 90.07 66.42 16.42 14.22 65.45 16.28 16.18 coo -0.17 119.75 99.65 2.51 123.83 95.70 57.78 7.35 19.60 56.77 12.20 15.61 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 5 3 # 5 B 44 THR B 74 THR^? 21.68 MG MG B 302 B 45 THR B 73 THR^? 15.28 MG MG B 302 B 161 LYS A 61 LYS^? 21.99 MG MG B 302 coo 7.39 128.28 94.56 8.34 126.36 94.79 63.99 13.20 11.95 63.36 12.32 13.84 coo 5.75 129.25 91.25 4.29 128.16 90.07 61.79 16.15 11.00 62.15 17.08 9.05 coo -0.17 119.75 99.65 2.51 123.83 95.70 57.78 7.35 19.60 56.77 12.20 15.61 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 6 3 # 6 B 44 THR B 74 THR^? 21.68 MG MG B 302 B 45 THR B 88 THR^? 22.44 MG MG C 301 B 161 LYS A 61 LYS^? 21.99 MG MG B 302 coo 7.39 128.28 94.56 8.34 126.36 94.79 63.99 13.20 11.95 63.36 12.32 13.84 coo 5.75 129.25 91.25 4.29 128.16 90.07 66.42 16.42 14.22 65.45 16.28 16.18 coo -0.17 119.75 99.65 2.51 123.83 95.70 57.78 7.35 19.60 56.77 12.20 15.61 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 7 3 # 7 B 44 THR B 88 THR^? 22.44 MG MG C 301 B 45 THR B 73 THR^? 15.28 MG MG B 302 B 161 LYS A 61 LYS^? 21.99 MG MG B 302 coo 7.39 128.28 94.56 8.34 126.36 94.79 66.42 16.42 14.22 65.45 16.28 16.18 coo 5.75 129.25 91.25 4.29 128.16 90.07 61.79 16.15 11.00 62.15 17.08 9.05 coo -0.17 119.75 99.65 2.51 123.83 95.70 57.78 7.35 19.60 56.77 12.20 15.61 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 8 3 # 8 B 44 THR C 73 THR^? 14.95 MG MG C 302 B 45 THR C 88 THR^? 22.58 MG MG B 301 B 161 LYS D 61 LYS^? 21.93 MG MG C 302 coo 7.39 128.28 94.56 8.34 126.36 94.79 74.44 18.04 -17.45 73.99 18.64 -15.48 coo 5.75 129.25 91.25 4.29 128.16 90.07 69.96 16.71 -20.56 70.75 16.33 -22.54 coo -0.17 119.75 99.65 2.51 123.83 95.70 80.64 11.23 -26.16 80.65 16.24 -22.36 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 9 3 # 9 B 44 THR C 74 THR^? 21.64 MG MG C 302 B 45 THR C 73 THR^? 14.95 MG MG C 302 B 161 LYS D 61 LYS^? 21.93 MG MG C 302 coo 7.39 128.28 94.56 8.34 126.36 94.79 73.35 14.53 -18.47 73.89 13.78 -20.47 coo 5.75 129.25 91.25 4.29 128.16 90.07 74.44 18.04 -17.45 73.99 18.64 -15.48 coo -0.17 119.75 99.65 2.51 123.83 95.70 80.64 11.23 -26.16 80.65 16.24 -22.36 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 10 3 # 10 B 44 THR C 74 THR^? 21.64 MG MG C 302 B 45 THR C 88 THR^? 22.58 MG MG B 301 B 161 LYS D 61 LYS^? 21.93 MG MG C 302 coo 7.39 128.28 94.56 8.34 126.36 94.79 73.35 14.53 -18.47 73.89 13.78 -20.47 coo 5.75 129.25 91.25 4.29 128.16 90.07 69.96 16.71 -20.56 70.75 16.33 -22.54 coo -0.17 119.75 99.65 2.51 123.83 95.70 80.64 11.23 -26.16 80.65 16.24 -22.36 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 11 3 # 11 B 44 THR C 88 THR^? 22.58 MG MG B 301 B 45 THR C 73 THR^? 14.95 MG MG C 302 B 161 LYS D 61 LYS^? 21.93 MG MG C 302 coo 7.39 128.28 94.56 8.34 126.36 94.79 69.96 16.71 -20.56 70.75 16.33 -22.54 coo 5.75 129.25 91.25 4.29 128.16 90.07 74.44 18.04 -17.45 73.99 18.64 -15.48 coo -0.17 119.75 99.65 2.51 123.83 95.70 80.64 11.23 -26.16 80.65 16.24 -22.36 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 12 3 # 12 B 44 THR D 73 THR^? 15.26 MG MG D 302 B 45 THR D 88 THR^? 22.15 MG MG E 301 B 161 LYS C 61 LYS^? 21.91 MG MG D 302 coo 7.39 128.28 94.56 8.34 126.36 94.79 84.65 47.16 -33.26 83.69 47.10 -35.24 coo 5.75 129.25 91.25 4.29 128.16 90.07 81.92 51.17 -30.12 82.55 50.45 -28.12 coo -0.17 119.75 99.65 2.51 123.83 95.70 93.60 48.56 -24.05 90.39 44.71 -27.98 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 13 3 # 13 B 44 THR D 74 THR^? 21.71 MG MG D 302 B 45 THR D 73 THR^? 15.26 MG MG D 302 B 161 LYS C 61 LYS^? 21.91 MG MG D 302 coo 7.39 128.28 94.56 8.34 126.36 94.79 86.03 50.57 -32.19 86.96 50.83 -30.24 coo 5.75 129.25 91.25 4.29 128.16 90.07 84.65 47.16 -33.26 83.69 47.10 -35.24 coo -0.17 119.75 99.65 2.51 123.83 95.70 93.60 48.56 -24.05 90.39 44.71 -27.98 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 14 3 # 14 B 44 THR D 74 THR^? 21.71 MG MG D 302 B 45 THR D 88 THR^? 22.15 MG MG E 301 B 161 LYS C 61 LYS^? 21.91 MG MG D 302 coo 7.39 128.28 94.56 8.34 126.36 94.79 86.03 50.57 -32.19 86.96 50.83 -30.24 coo 5.75 129.25 91.25 4.29 128.16 90.07 81.92 51.17 -30.12 82.55 50.45 -28.12 coo -0.17 119.75 99.65 2.51 123.83 95.70 93.60 48.56 -24.05 90.39 44.71 -27.98 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 15 3 # 15 B 44 THR D 88 THR^? 22.15 MG MG E 301 B 45 THR D 73 THR^? 15.26 MG MG D 302 B 161 LYS C 61 LYS^? 21.91 MG MG D 302 coo 7.39 128.28 94.56 8.34 126.36 94.79 81.92 51.17 -30.12 82.55 50.45 -28.12 coo 5.75 129.25 91.25 4.29 128.16 90.07 84.65 47.16 -33.26 83.69 47.10 -35.24 coo -0.17 119.75 99.65 2.51 123.83 95.70 93.60 48.56 -24.05 90.39 44.71 -27.98 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 16 3 # 16 B 44 THR E 73 THR^? 15.13 MG MG E 302 B 45 THR E 88 THR^? 21.98 MG MG D 301 B 161 LYS F 61 LYS^? 21.75 MG MG E 302 coo 7.39 128.28 94.56 8.34 126.36 94.79 77.31 55.78 -61.57 77.11 55.21 -59.48 coo 5.75 129.25 91.25 4.29 128.16 90.07 80.56 52.52 -64.50 80.70 53.32 -66.53 coo -0.17 119.75 99.65 2.51 123.83 95.70 80.24 64.12 -71.01 76.23 61.95 -66.39 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 17 3 # 17 B 44 THR E 74 THR^? 21.51 MG MG E 302 B 45 THR E 73 THR^? 15.13 MG MG E 302 B 161 LYS F 61 LYS^? 21.75 MG MG E 302 coo 7.39 128.28 94.56 8.34 126.36 94.79 80.89 56.59 -62.50 81.13 57.37 -64.43 coo 5.75 129.25 91.25 4.29 128.16 90.07 77.31 55.78 -61.57 77.11 55.21 -59.48 coo -0.17 119.75 99.65 2.51 123.83 95.70 80.24 64.12 -71.01 76.23 61.95 -66.39 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 18 3 # 18 B 44 THR E 74 THR^? 21.51 MG MG E 302 B 45 THR E 88 THR^? 21.98 MG MG D 301 B 161 LYS F 61 LYS^? 21.75 MG MG E 302 coo 7.39 128.28 94.56 8.34 126.36 94.79 80.89 56.59 -62.50 81.13 57.37 -64.43 coo 5.75 129.25 91.25 4.29 128.16 90.07 80.56 52.52 -64.50 80.70 53.32 -66.53 coo -0.17 119.75 99.65 2.51 123.83 95.70 80.24 64.12 -71.01 76.23 61.95 -66.39 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 19 3 # 19 B 44 THR E 88 THR^? 21.98 MG MG D 301 B 45 THR E 73 THR^? 15.13 MG MG E 302 B 161 LYS F 61 LYS^? 21.75 MG MG E 302 coo 7.39 128.28 94.56 8.34 126.36 94.79 80.56 52.52 -64.50 80.70 53.32 -66.53 coo 5.75 129.25 91.25 4.29 128.16 90.07 77.31 55.78 -61.57 77.11 55.21 -59.48 coo -0.17 119.75 99.65 2.51 123.83 95.70 80.24 64.12 -71.01 76.23 61.95 -66.39 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 20 3 # 20 B 44 THR F 73 THR^? 15.13 MG MG F 301 B 45 THR F 88 THR^? 23.06 MG MG F 301 B 161 LYS E 61 LYS^? 22.16 MG MG F 301 coo 7.39 128.28 94.56 8.34 126.36 94.79 46.81 49.68 -77.46 47.14 48.99 -79.45 coo 5.75 129.25 91.25 4.29 128.16 90.07 44.71 45.78 -74.10 45.06 46.44 -72.02 coo -0.17 119.75 99.65 2.51 123.83 95.70 40.99 56.84 -68.48 45.99 56.72 -72.39 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 21 3 # 21 B 44 THR F 74 THR^? 21.46 MG MG F 301 B 45 THR F 73 THR^? 15.13 MG MG F 301 B 161 LYS E 61 LYS^? 22.16 MG MG F 301 coo 7.39 128.28 94.56 8.34 126.36 94.79 43.07 49.39 -76.61 42.46 50.11 -74.68 coo 5.75 129.25 91.25 4.29 128.16 90.07 46.81 49.68 -77.46 47.14 48.99 -79.45 coo -0.17 119.75 99.65 2.51 123.83 95.70 40.99 56.84 -68.48 45.99 56.72 -72.39 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 22 3 # 22 B 44 THR F 74 THR^? 21.46 MG MG F 301 B 45 THR F 88 THR^? 23.06 MG MG F 301 B 161 LYS E 61 LYS^? 22.16 MG MG F 301 coo 7.39 128.28 94.56 8.34 126.36 94.79 43.07 49.39 -76.61 42.46 50.11 -74.68 coo 5.75 129.25 91.25 4.29 128.16 90.07 44.71 45.78 -74.10 45.06 46.44 -72.02 coo -0.17 119.75 99.65 2.51 123.83 95.70 40.99 56.84 -68.48 45.99 56.72 -72.39 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 23 3 # 23 B 44 THR F 88 THR^? 23.06 MG MG F 301 B 45 THR F 73 THR^? 15.13 MG MG F 301 B 161 LYS E 61 LYS^? 22.16 MG MG F 301 coo 7.39 128.28 94.56 8.34 126.36 94.79 44.71 45.78 -74.10 45.06 46.44 -72.02 coo 5.75 129.25 91.25 4.29 128.16 90.07 46.81 49.68 -77.46 47.14 48.99 -79.45 coo -0.17 119.75 99.65 2.51 123.83 95.70 40.99 56.84 -68.48 45.99 56.72 -72.39 1dhp_c03 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 23 hits 1dhp_c03 naa= 3 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 1 3 # 1 146 TYR A 156 TYR^? 21.80 MG MG A 301 150 LYS A 157 LYS^? 28.65 MG MG A 302 186 ASN A 45 ASN^? 24.62 MG MG B 302 coo 32.88 50.55 24.33 31.89 51.78 26.65 37.50 16.28 27.75 35.30 17.94 28.08 coo 27.04 52.42 22.30 26.88 49.99 27.00 41.42 12.06 27.58 41.46 5.93 29.41 coo 36.98 50.30 37.29 35.85 50.29 35.50 42.72 26.12 17.32 44.44 25.00 17.78 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 2 3 # 2 146 TYR A 156 TYR^? 21.80 MG MG A 301 150 LYS A 166 LYS^? 20.93 MG MG A 302 186 ASN A 45 ASN^? 24.62 MG MG B 302 coo 32.88 50.55 24.33 31.89 51.78 26.65 37.50 16.28 27.75 35.30 17.94 28.08 coo 27.04 52.42 22.30 26.88 49.99 27.00 35.34 13.14 30.41 31.67 15.04 34.58 coo 36.98 50.30 37.29 35.85 50.29 35.50 42.72 26.12 17.32 44.44 25.00 17.78 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 3 3 # 3 146 TYR A 156 TYR^? 21.80 MG MG A 301 150 LYS A 166 LYS^? 20.93 MG MG A 302 186 ASN B 45 ASN^? 24.27 MG MG A 301 coo 32.88 50.55 24.33 31.89 51.78 26.65 37.50 16.28 27.75 35.30 17.94 28.08 coo 27.04 52.42 22.30 26.88 49.99 27.00 35.34 13.14 30.41 31.67 15.04 34.58 coo 36.98 50.30 37.29 35.85 50.29 35.50 47.87 19.20 19.75 47.40 21.26 19.77 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 4 3 # 4 146 TYR A 168 TYR^? 14.52 MG MG A 302 150 LYS A 166 LYS^? 20.93 MG MG A 302 186 ASN A 132 ASN^? 16.38 MG MG A 301 coo 32.88 50.55 24.33 31.89 51.78 26.65 37.31 16.98 37.59 36.65 18.86 39.55 coo 27.04 52.42 22.30 26.88 49.99 27.00 35.34 13.14 30.41 31.67 15.04 34.58 coo 36.98 50.30 37.29 35.85 50.29 35.50 50.16 14.55 39.76 50.61 16.24 40.93 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 5 3 # 5 146 TYR B 156 TYR^? 21.63 MG MG B 302 150 LYS B 157 LYS^? 28.85 MG MG B 302 186 ASN B 45 ASN^? 24.27 MG MG A 301 coo 32.88 50.55 24.33 31.89 51.78 26.65 38.56 16.71 8.27 39.91 14.31 7.86 coo 27.04 52.42 22.30 26.88 49.99 27.00 34.97 21.28 8.44 29.03 22.82 6.58 coo 36.98 50.30 37.29 35.85 50.29 35.50 47.87 19.20 19.75 47.40 21.26 19.77 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 6 3 # 6 146 TYR B 156 TYR^? 21.63 MG MG B 302 150 LYS B 166 LYS^? 22.75 MG MG B 301 186 ASN A 45 ASN^? 24.62 MG MG B 302 coo 32.88 50.55 24.33 31.89 51.78 26.65 38.56 16.71 8.27 39.91 14.31 7.86 coo 27.04 52.42 22.30 26.88 49.99 27.00 35.27 15.38 5.31 37.27 9.81 3.93 coo 36.98 50.30 37.29 35.85 50.29 35.50 42.72 26.12 17.32 44.44 25.00 17.78 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 7 3 # 7 146 TYR B 156 TYR^? 21.63 MG MG B 302 150 LYS B 166 LYS^? 22.75 MG MG B 301 186 ASN B 45 ASN^? 24.27 MG MG A 301 coo 32.88 50.55 24.33 31.89 51.78 26.65 38.56 16.71 8.27 39.91 14.31 7.86 coo 27.04 52.42 22.30 26.88 49.99 27.00 35.27 15.38 5.31 37.27 9.81 3.93 coo 36.98 50.30 37.29 35.85 50.29 35.50 47.87 19.20 19.75 47.40 21.26 19.77 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 8 3 # 8 146 TYR B 168 TYR^? 14.66 MG MG B 301 150 LYS B 166 LYS^? 22.75 MG MG B 301 186 ASN B 132 ASN^? 16.42 MG MG B 302 coo 32.88 50.55 24.33 31.89 51.78 26.65 40.03 17.20 -1.34 41.92 16.43 -3.19 coo 27.04 52.42 22.30 26.88 49.99 27.00 35.27 15.38 5.31 37.27 9.81 3.93 coo 36.98 50.30 37.29 35.85 50.29 35.50 40.27 30.00 -2.76 41.98 31.07 -3.41 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 9 3 # 9 146 TYR C 156 TYR^? 21.58 MG MG C 302 150 LYS C 157 LYS^? 28.15 MG MG C 302 186 ASN C 45 ASN^? 24.54 MG MG C 302 coo 32.88 50.55 24.33 31.89 51.78 26.65 95.64 26.50 -15.14 95.25 23.76 -14.77 coo 27.04 52.42 22.30 26.88 49.99 27.00 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 36.98 50.30 37.29 35.85 50.29 35.50 85.43 25.82 -26.31 85.43 27.91 -25.97 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 10 3 # 10 146 TYR C 156 TYR^? 21.58 MG MG C 302 150 LYS C 166 LYS^? 22.53 MG MG C 301 186 ASN C 45 ASN^? 24.54 MG MG C 302 coo 32.88 50.55 24.33 31.89 51.78 26.65 95.64 26.50 -15.14 95.25 23.76 -14.77 coo 27.04 52.42 22.30 26.88 49.99 27.00 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 36.98 50.30 37.29 35.85 50.29 35.50 85.43 25.82 -26.31 85.43 27.91 -25.97 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 11 3 # 11 146 TYR C 156 TYR^? 21.58 MG MG C 302 150 LYS C 166 LYS^? 22.53 MG MG C 301 186 ASN D 45 ASN^? 24.33 MG MG C 302 coo 32.88 50.55 24.33 31.89 51.78 26.65 95.64 26.50 -15.14 95.25 23.76 -14.77 coo 27.04 52.42 22.30 26.88 49.99 27.00 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 36.98 50.30 37.29 35.85 50.29 35.50 88.35 34.04 -23.87 86.82 32.62 -24.25 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 12 3 # 12 146 TYR C 168 TYR^? 14.82 MG MG C 301 150 LYS C 166 LYS^? 22.53 MG MG C 301 186 ASN C 132 ASN^? 16.52 MG MG C 302 coo 32.88 50.55 24.33 31.89 51.78 26.65 94.44 26.43 -5.44 92.97 25.09 -3.55 coo 27.04 52.42 22.30 26.88 49.99 27.00 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 36.98 50.30 37.29 35.85 50.29 35.50 89.66 38.54 -3.77 87.74 38.77 -2.97 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 13 3 # 13 146 TYR D 156 TYR^? 21.34 MG MG D 302 150 LYS D 157 LYS^? 28.67 MG MG D 302 186 ASN D 45 ASN^? 24.33 MG MG C 302 coo 32.88 50.55 24.33 31.89 51.78 26.65 96.25 27.10 -34.64 97.58 29.48 -35.03 coo 27.04 52.42 22.30 26.88 49.99 27.00 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 36.98 50.30 37.29 35.85 50.29 35.50 88.35 34.04 -23.87 86.82 32.62 -24.25 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 14 3 # 14 146 TYR D 156 TYR^? 21.34 MG MG D 302 150 LYS D 166 LYS^? 21.08 MG MG D 301 186 ASN C 45 ASN^? 24.54 MG MG C 302 coo 32.88 50.55 24.33 31.89 51.78 26.65 96.25 27.10 -34.64 97.58 29.48 -35.03 coo 27.04 52.42 22.30 26.88 49.99 27.00 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 36.98 50.30 37.29 35.85 50.29 35.50 85.43 25.82 -26.31 85.43 27.91 -25.97 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 15 3 # 15 146 TYR D 156 TYR^? 21.34 MG MG D 302 150 LYS D 166 LYS^? 21.08 MG MG D 301 186 ASN D 45 ASN^? 24.33 MG MG C 302 coo 32.88 50.55 24.33 31.89 51.78 26.65 96.25 27.10 -34.64 97.58 29.48 -35.03 coo 27.04 52.42 22.30 26.88 49.99 27.00 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 36.98 50.30 37.29 35.85 50.29 35.50 88.35 34.04 -23.87 86.82 32.62 -24.25 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 16 3 # 16 146 TYR D 168 TYR^? 14.75 MG MG D 301 150 LYS D 166 LYS^? 21.08 MG MG D 301 186 ASN D 132 ASN^? 16.46 MG MG D 302 coo 32.88 50.55 24.33 31.89 51.78 26.65 95.79 27.80 -44.35 95.71 29.78 -46.32 coo 27.04 52.42 22.30 26.88 49.99 27.00 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 36.98 50.30 37.29 35.85 50.29 35.50 84.64 21.31 -46.24 83.02 22.38 -47.10 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 17 3 # 17 146 TYR E 156 TYR^? 21.59 MG MG E 302 150 LYS E 157 LYS^? 28.40 MG MG E 302 186 ASN E 45 ASN^? 24.46 MG MG F 301 coo 32.88 50.55 24.33 31.89 51.78 26.65 59.31 70.31 -60.22 61.84 71.39 -59.92 coo 27.04 52.42 22.30 26.88 49.99 27.00 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 36.98 50.30 37.29 35.85 50.29 35.50 64.97 61.33 -71.05 63.29 60.06 -70.79 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 18 3 # 18 146 TYR E 168 TYR^? 14.43 MG MG E 301 150 LYS E 166 LYS^? 21.46 MG MG E 301 186 ASN E 132 ASN^? 16.39 MG MG E 302 coo 32.88 50.55 24.33 31.89 51.78 26.65 60.07 69.95 -50.54 61.99 69.37 -48.59 coo 27.04 52.42 22.30 26.88 49.99 27.00 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 36.98 50.30 37.29 35.85 50.29 35.50 51.80 60.19 -48.38 52.68 58.51 -47.42 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 19 3 # 19 146 TYR F 156 TYR^? 21.68 MG MG F 302 150 LYS F 157 LYS^? 28.36 MG MG F 302 186 ASN F 45 ASN^? 24.43 MG MG E 302 coo 32.88 50.55 24.33 31.89 51.78 26.65 58.80 69.55 -79.65 56.09 69.80 -80.15 coo 27.04 52.42 22.30 26.88 49.99 27.00 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 36.98 50.30 37.29 35.85 50.29 35.50 56.42 59.79 -68.43 58.48 59.32 -68.69 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 20 3 # 20 146 TYR F 156 TYR^? 21.68 MG MG F 302 150 LYS F 166 LYS^? 20.76 MG MG F 302 186 ASN E 45 ASN^? 24.46 MG MG F 301 coo 32.88 50.55 24.33 31.89 51.78 26.65 58.80 69.55 -79.65 56.09 69.80 -80.15 coo 27.04 52.42 22.30 26.88 49.99 27.00 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 36.98 50.30 37.29 35.85 50.29 35.50 64.97 61.33 -71.05 63.29 60.06 -70.79 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 21 3 # 21 146 TYR F 156 TYR^? 21.68 MG MG F 302 150 LYS F 166 LYS^? 20.76 MG MG F 302 186 ASN F 45 ASN^? 24.43 MG MG E 302 coo 32.88 50.55 24.33 31.89 51.78 26.65 58.80 69.55 -79.65 56.09 69.80 -80.15 coo 27.04 52.42 22.30 26.88 49.99 27.00 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 36.98 50.30 37.29 35.85 50.29 35.50 56.42 59.79 -68.43 58.48 59.32 -68.69 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 22 3 # 22 146 TYR F 168 TYR^? 14.10 MG MG F 302 150 LYS F 166 LYS^? 20.76 MG MG F 302 186 ASN F 132 ASN^? 16.48 MG MG F 301 coo 32.88 50.55 24.33 31.89 51.78 26.65 58.29 68.32 -89.29 56.67 67.12 -91.21 coo 27.04 52.42 22.30 26.88 49.99 27.00 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 36.98 50.30 37.29 35.85 50.29 35.50 69.23 61.88 -90.93 69.10 59.95 -91.77 1dhr_c00 source 1dhr DIHYDROPTERIDINE REDUCTASE (DHPR) (E.C.1.6.99.: 22 hits 1dhr_c00 naa= 3 ULMN 3 1din_c00 DIENELACTONE HYDROLASE user 1 3 # 1 123 CYH A 152 CYH^? 15.18 MG MG A 302 171 ASP A 148 ASP^? 2.72 MG MG A 301s 202 HIS A 147 HIS^? 9.20 MG MG A 302 coo 13.53 50.63 6.92 14.43 49.91 4.38 34.81 26.51 34.70 32.10 26.95 34.06 coo 11.86 58.52 0.90 11.25 56.63 1.71 41.50 28.88 41.13 43.33 29.67 41.93 coo 12.37 53.26 1.34 11.86 52.62 3.19 40.24 23.10 39.83 38.32 22.34 40.22 ULMN 3 1din_c00 DIENELACTONE HYDROLASE user 2 3 # 2 123 CYH A 152 CYH^? 15.18 MG MG A 302 171 ASP A 177 ASP^? 8.44 MG MG A 302 202 HIS A 170 HIS^? 10.56 MG MG A 302 coo 13.53 50.63 6.92 14.43 49.91 4.38 34.81 26.51 34.70 32.10 26.95 34.06 coo 11.86 58.52 0.90 11.25 56.63 1.71 33.02 29.04 43.18 33.79 27.88 44.78 coo 12.37 53.26 1.34 11.86 52.62 3.19 34.91 23.57 39.32 34.35 24.95 40.81 ULMN 3 1din_c00 DIENELACTONE HYDROLASE user 3 3 # 3 123 CYH B 152 CYH^? 14.66 MG MG B 301 171 ASP B 148 ASP^? 2.58 MG MG B 302s 202 HIS B 147 HIS^? 9.27 MG MG B 301 coo 13.53 50.63 6.92 14.43 49.91 4.38 48.74 12.82 1.93 48.51 10.17 2.19 coo 11.86 58.52 0.90 11.25 56.63 1.71 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 12.37 53.26 1.34 11.86 52.62 3.19 46.73 18.97 -3.05 45.63 17.32 -3.73 ULMN 3 1din_c00 DIENELACTONE HYDROLASE user 4 3 # 4 123 CYH C 152 CYH^? 14.61 MG MG C 301 171 ASP C 148 ASP^? 2.75 MG MG C 302s 202 HIS C 147 HIS^? 9.44 MG MG C 301 coo 13.53 50.63 6.92 14.43 49.91 4.38 87.66 19.43 -8.58 88.77 17.04 -8.78 coo 11.86 58.52 0.90 11.25 56.63 1.71 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 12.37 53.26 1.34 11.86 52.62 3.19 87.61 25.71 -3.59 89.22 24.50 -2.99 ULMN 3 1din_c00 DIENELACTONE HYDROLASE user 5 3 # 5 123 CYH C 152 CYH^? 14.61 MG MG C 301 171 ASP C 177 ASP^? 8.84 MG MG C 301 202 HIS C 170 HIS^? 10.68 MG MG C 301 coo 13.53 50.63 6.92 14.43 49.91 4.38 87.66 19.43 -8.58 88.77 17.04 -8.78 coo 11.86 58.52 0.90 11.25 56.63 1.71 85.60 16.42 -0.31 86.51 17.71 1.09 coo 12.37 53.26 1.34 11.86 52.62 3.19 89.96 21.05 -3.85 88.74 19.88 -2.61 ULMN 3 1din_c00 DIENELACTONE HYDROLASE user 6 3 # 6 123 CYH D 152 CYH^? 14.66 MG MG D 301 171 ASP D 148 ASP^? 2.35 MG MG D 302s 202 HIS D 147 HIS^? 9.43 MG MG D 301 coo 13.53 50.63 6.92 14.43 49.91 4.38 94.69 37.43 -41.36 96.92 38.83 -40.94 coo 11.86 58.52 0.90 11.25 56.63 1.71 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 12.37 53.26 1.34 11.86 52.62 3.19 90.95 32.51 -46.42 92.98 32.42 -46.93 ULMN 3 1din_c00 DIENELACTONE HYDROLASE user 7 3 # 7 123 CYH D 152 CYH^? 14.66 MG MG D 301 171 ASP D 177 ASP^? 8.43 MG MG D 301 202 HIS D 170 HIS^? 10.59 MG MG D 301 coo 13.53 50.63 6.92 14.43 49.91 4.38 94.69 37.43 -41.36 96.92 38.83 -40.94 coo 11.86 58.52 0.90 11.25 56.63 1.71 95.74 41.01 -49.76 94.81 39.90 -51.24 coo 12.37 53.26 1.34 11.86 52.62 3.19 95.57 34.81 -46.05 95.59 36.24 -47.59 ULMN 3 1din_c00 DIENELACTONE HYDROLASE user 8 3 # 8 123 CYH E 152 CYH^? 14.64 MG MG E 301 171 ASP E 148 ASP^? 2.62 MG MG E 302s 202 HIS E 147 HIS^? 9.22 MG MG E 301 coo 13.53 50.63 6.92 14.43 49.91 4.38 69.49 67.27 -53.54 71.02 69.50 -54.03 coo 11.86 58.52 0.90 11.25 56.63 1.71 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 12.37 53.26 1.34 11.86 52.62 3.19 63.87 64.43 -48.39 64.18 66.45 -47.92 ULMN 3 1din_c00 DIENELACTONE HYDROLASE user 9 3 # 9 123 CYH E 152 CYH^? 14.64 MG MG E 301 171 ASP E 177 ASP^? 8.55 MG MG E 301 202 HIS E 170 HIS^? 10.33 MG MG E 301 coo 13.53 50.63 6.92 14.43 49.91 4.38 69.49 67.27 -53.54 71.02 69.50 -54.03 coo 11.86 58.52 0.90 11.25 56.63 1.71 72.81 67.32 -45.03 71.14 67.96 -43.95 coo 12.37 53.26 1.34 11.86 52.62 3.19 66.96 68.76 -48.87 68.36 68.54 -47.33 ULMN 3 1din_c00 DIENELACTONE HYDROLASE user 10 3 # 10 123 CYH F 152 CYH^? 14.14 MG MG F 302 171 ASP F 148 ASP^? 2.72 MG MG F 301s 202 HIS F 147 HIS^? 8.79 MG MG F 302 coo 13.53 50.63 6.92 14.43 49.91 4.38 50.28 62.76 -86.08 48.12 64.34 -85.77 coo 11.86 58.52 0.90 11.25 56.63 1.71 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 12.37 53.26 1.34 11.86 52.62 3.19 56.63 61.66 -91.16 55.69 63.43 -91.80 ULMN 3 1din_c00 DIENELACTONE HYDROLASE user 11 3 # 11 123 CYH F 152 CYH^? 14.14 MG MG F 302 171 ASP F 177 ASP^? 8.15 MG MG F 302 202 HIS F 170 HIS^? 9.84 MG MG F 302 coo 13.53 50.63 6.92 14.43 49.91 4.38 50.28 62.76 -86.08 48.12 64.34 -85.77 coo 11.86 58.52 0.90 11.25 56.63 1.71 47.18 61.22 -94.50 48.48 62.32 -95.73 coo 12.37 53.26 1.34 11.86 52.62 3.19 52.25 64.82 -90.91 50.95 63.88 -92.26 1din_c00 source 1din DIENELACTONE HYDROLASE : 11 hits 1din_c00 naa= 3 ULMN 3 1do8_c00 MALIC ENZYME user 1 3 # 1 A 112 TYR A 168 TYR^? 14.52 MG MG A 302 A 183 LYS A 192 LYS^? 22.83 MG MG A 302 A 278 ASP A 142 ASP^? 23.70 MG MG A 302 coo 19.43 18.53 42.32 17.66 18.80 40.15 37.31 16.98 37.59 36.65 18.86 39.55 coo 21.92 15.80 36.19 17.64 19.44 36.35 40.19 10.20 38.86 35.42 9.85 36.29 coo 15.46 19.03 31.40 15.01 18.25 33.31 46.39 7.18 37.53 46.28 7.18 39.63 ULMN 3 1do8_c00 MALIC ENZYME user 2 3 # 2 A 112 TYR B 168 TYR^? 14.66 MG MG B 301 A 183 LYS B 192 LYS^? 23.73 MG MG B 301 A 278 ASP B 142 ASP^? 23.97 MG MG B 301 coo 19.43 18.53 42.32 17.66 18.80 40.15 40.03 17.20 -1.34 41.92 16.43 -3.19 coo 21.92 15.80 36.19 17.64 19.44 36.35 33.83 21.17 -2.93 31.87 16.45 -0.74 coo 15.46 19.03 31.40 15.01 18.25 33.31 31.69 27.40 -1.31 32.10 27.37 -3.38 ULMN 3 1do8_c00 MALIC ENZYME user 3 3 # 3 A 112 TYR C 168 TYR^? 14.82 MG MG C 301 A 183 LYS C 192 LYS^? 24.43 MG MG C 301 A 278 ASP C 142 ASP^? 23.76 MG MG C 301 coo 19.43 18.53 42.32 17.66 18.80 40.15 94.44 26.43 -5.44 92.97 25.09 -3.55 coo 21.92 15.80 36.19 17.64 19.44 36.35 98.71 32.33 -3.93 102.89 29.25 -5.78 coo 15.46 19.03 31.40 15.01 18.25 33.31 97.94 39.27 -5.03 98.08 38.70 -2.97 ULMN 3 1do8_c00 MALIC ENZYME user 4 3 # 4 A 112 TYR F 168 TYR^? 14.10 MG MG F 302 A 183 LYS F 192 LYS^? 23.61 MG MG F 302 A 278 ASP F 142 ASP^? 23.43 MG MG F 302 coo 19.43 18.53 42.32 17.66 18.80 40.15 58.29 68.32 -89.29 56.67 67.12 -91.21 coo 21.92 15.80 36.19 17.64 19.44 36.35 64.82 71.59 -91.06 62.22 76.11 -88.75 coo 15.46 19.03 31.40 15.01 18.25 33.31 71.46 69.88 -89.76 71.03 69.93 -91.81 1do8_c00 source 1do8 MALIC ENZYME : 4 hits 1do8_c00 naa= 3 ULMN 3 1do8_c01 MALIC ENZYME user 1 3 # 1 B 112 TYR A 168 TYR^? 14.52 MG MG A 302 B 183 LYS A 192 LYS^? 22.83 MG MG A 302 B 278 ASP A 142 ASP^? 23.70 MG MG A 302 coo 58.62 15.99 58.34 60.98 14.60 58.93 37.31 16.98 37.59 36.65 18.86 39.55 coo 60.11 10.60 53.63 62.59 10.74 58.67 40.19 10.20 38.86 35.42 9.85 36.29 coo 66.50 7.32 58.45 66.26 9.42 58.23 46.39 7.18 37.53 46.28 7.18 39.63 ULMN 3 1do8_c01 MALIC ENZYME user 2 3 # 2 B 112 TYR B 168 TYR^? 14.66 MG MG B 301 B 183 LYS B 192 LYS^? 23.73 MG MG B 301 B 278 ASP B 142 ASP^? 23.97 MG MG B 301 coo 58.62 15.99 58.34 60.98 14.60 58.93 40.03 17.20 -1.34 41.92 16.43 -3.19 coo 60.11 10.60 53.63 62.59 10.74 58.67 33.83 21.17 -2.93 31.87 16.45 -0.74 coo 66.50 7.32 58.45 66.26 9.42 58.23 31.69 27.40 -1.31 32.10 27.37 -3.38 ULMN 3 1do8_c01 MALIC ENZYME user 3 3 # 3 B 112 TYR C 168 TYR^? 14.82 MG MG C 301 B 183 LYS C 192 LYS^? 24.43 MG MG C 301 B 278 ASP C 142 ASP^? 23.76 MG MG C 301 coo 58.62 15.99 58.34 60.98 14.60 58.93 94.44 26.43 -5.44 92.97 25.09 -3.55 coo 60.11 10.60 53.63 62.59 10.74 58.67 98.71 32.33 -3.93 102.89 29.25 -5.78 coo 66.50 7.32 58.45 66.26 9.42 58.23 97.94 39.27 -5.03 98.08 38.70 -2.97 ULMN 3 1do8_c01 MALIC ENZYME user 4 3 # 4 B 112 TYR F 168 TYR^? 14.10 MG MG F 302 B 183 LYS F 192 LYS^? 23.61 MG MG F 302 B 278 ASP F 142 ASP^? 23.43 MG MG F 302 coo 58.62 15.99 58.34 60.98 14.60 58.93 58.29 68.32 -89.29 56.67 67.12 -91.21 coo 60.11 10.60 53.63 62.59 10.74 58.67 64.82 71.59 -91.06 62.22 76.11 -88.75 coo 66.50 7.32 58.45 66.26 9.42 58.23 71.46 69.88 -89.76 71.03 69.93 -91.81 1do8_c01 source 1do8 MALIC ENZYME : 4 hits 1do8_c01 naa= 3 ULMN 3 1do8_c02 MALIC ENZYME user 1 3 # 1 C 112 TYR A 168 TYR^? 14.52 MG MG A 302 C 183 LYS A 192 LYS^? 22.83 MG MG A 302 C 278 ASP A 142 ASP^? 23.70 MG MG A 302 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 37.31 16.98 37.59 36.65 18.86 39.55 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 40.19 10.20 38.86 35.42 9.85 36.29 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 46.39 7.18 37.53 46.28 7.18 39.63 ULMN 3 1do8_c02 MALIC ENZYME user 2 3 # 2 C 112 TYR B 168 TYR^? 14.66 MG MG B 301 C 183 LYS B 192 LYS^? 23.73 MG MG B 301 C 278 ASP B 142 ASP^? 23.97 MG MG B 301 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 40.03 17.20 -1.34 41.92 16.43 -3.19 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 33.83 21.17 -2.93 31.87 16.45 -0.74 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 31.69 27.40 -1.31 32.10 27.37 -3.38 ULMN 3 1do8_c02 MALIC ENZYME user 3 3 # 3 C 112 TYR C 168 TYR^? 14.82 MG MG C 301 C 183 LYS C 192 LYS^? 24.43 MG MG C 301 C 278 ASP C 142 ASP^? 23.76 MG MG C 301 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 94.44 26.43 -5.44 92.97 25.09 -3.55 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 98.71 32.33 -3.93 102.89 29.25 -5.78 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 97.94 39.27 -5.03 98.08 38.70 -2.97 ULMN 3 1do8_c02 MALIC ENZYME user 4 3 # 4 C 112 TYR F 168 TYR^? 14.10 MG MG F 302 C 183 LYS F 192 LYS^? 23.61 MG MG F 302 C 278 ASP F 142 ASP^? 23.43 MG MG F 302 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 58.29 68.32 -89.29 56.67 67.12 -91.21 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 64.82 71.59 -91.06 62.22 76.11 -88.75 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 71.46 69.88 -89.76 71.03 69.93 -91.81 1do8_c02 source 1do8 MALIC ENZYME : 4 hits 1do8_c02 naa= 3 ULMN 3 1do8_c03 MALIC ENZYME user 1 3 # 1 D 112 TYR A 168 TYR^? 14.52 MG MG A 302 D 183 LYS A 192 LYS^? 22.83 MG MG A 302 D 278 ASP A 142 ASP^? 23.70 MG MG A 302 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 37.31 16.98 37.59 36.65 18.86 39.55 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 40.19 10.20 38.86 35.42 9.85 36.29 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 46.39 7.18 37.53 46.28 7.18 39.63 ULMN 3 1do8_c03 MALIC ENZYME user 2 3 # 2 D 112 TYR B 168 TYR^? 14.66 MG MG B 301 D 183 LYS B 192 LYS^? 23.73 MG MG B 301 D 278 ASP B 142 ASP^? 23.97 MG MG B 301 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 40.03 17.20 -1.34 41.92 16.43 -3.19 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 33.83 21.17 -2.93 31.87 16.45 -0.74 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 31.69 27.40 -1.31 32.10 27.37 -3.38 ULMN 3 1do8_c03 MALIC ENZYME user 3 3 # 3 D 112 TYR C 168 TYR^? 14.82 MG MG C 301 D 183 LYS C 192 LYS^? 24.43 MG MG C 301 D 278 ASP C 142 ASP^? 23.76 MG MG C 301 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 94.44 26.43 -5.44 92.97 25.09 -3.55 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 98.71 32.33 -3.93 102.89 29.25 -5.78 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 97.94 39.27 -5.03 98.08 38.70 -2.97 ULMN 3 1do8_c03 MALIC ENZYME user 4 3 # 4 D 112 TYR F 168 TYR^? 14.10 MG MG F 302 D 183 LYS F 192 LYS^? 23.61 MG MG F 302 D 278 ASP F 142 ASP^? 23.43 MG MG F 302 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 58.29 68.32 -89.29 56.67 67.12 -91.21 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 64.82 71.59 -91.06 62.22 76.11 -88.75 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 71.46 69.88 -89.76 71.03 69.93 -91.81 1do8_c03 source 1do8 MALIC ENZYME : 4 hits 1do8_c03 naa= 3 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 1 3 # 1 E 57 HIS A 170 HIS^? 10.56 MG MG A 302 E 102 ASP A 171 ASP^? 17.17 MG MG A 302 E 193 GLY A 145 GLY^? 13.39 MG MG A 302 coo 11.39 26.86 25.95 9.85 26.64 27.36 34.91 23.57 39.32 34.35 24.95 40.81 coo 10.90 32.83 25.96 10.83 30.68 25.98 29.78 23.67 36.63 28.48 25.11 35.71 coo 4.57 20.60 30.29 4.74 21.36 30.66 44.20 17.56 40.29 44.09 17.33 41.06 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 2 3 # 2 E 57 HIS A 170 HIS^? 10.56 MG MG A 302 E 102 ASP A 177 ASP^? 8.44 MG MG A 302 E 193 GLY A 145 GLY^? 13.39 MG MG A 302 coo 11.39 26.86 25.95 9.85 26.64 27.36 34.91 23.57 39.32 34.35 24.95 40.81 coo 10.90 32.83 25.96 10.83 30.68 25.98 33.02 29.04 43.18 33.79 27.88 44.78 coo 4.57 20.60 30.29 4.74 21.36 30.66 44.20 17.56 40.29 44.09 17.33 41.06 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 3 3 # 3 E 57 HIS B 170 HIS^? 10.51 MG MG B 301 E 102 ASP B 171 ASP^? 16.92 MG MG B 301 E 193 GLY B 145 GLY^? 13.71 MG MG B 301 coo 11.39 26.86 25.95 9.85 26.64 27.36 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 10.90 32.83 25.96 10.83 30.68 25.98 45.30 8.50 -0.71 46.30 6.81 0.12 coo 4.57 20.60 30.29 4.74 21.36 30.66 42.04 23.97 -3.40 41.83 23.90 -4.16 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 4 3 # 4 E 57 HIS C 170 HIS^? 10.68 MG MG C 301 E 102 ASP C 171 ASP^? 17.08 MG MG C 301 E 193 GLY C 145 GLY^? 13.72 MG MG C 301 coo 11.39 26.86 25.95 9.85 26.64 27.36 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 10.90 32.83 25.96 10.83 30.68 25.98 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 4.57 20.60 30.29 4.74 21.36 30.66 90.12 32.13 -3.16 90.38 32.11 -2.40 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 5 3 # 5 E 57 HIS D 170 HIS^? 10.59 MG MG D 301 E 102 ASP D 171 ASP^? 16.95 MG MG D 301 E 193 GLY D 145 GLY^? 13.51 MG MG D 301 coo 11.39 26.86 25.95 9.85 26.64 27.36 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 10.90 32.83 25.96 10.83 30.68 25.98 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 4.57 20.60 30.29 4.74 21.36 30.66 88.90 26.07 -46.90 89.21 25.93 -47.57 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 6 3 # 6 E 57 HIS E 170 HIS^? 10.33 MG MG E 301 E 102 ASP E 171 ASP^? 16.73 MG MG E 301 E 193 GLY E 145 GLY^? 13.69 MG MG E 301 coo 11.39 26.86 25.95 9.85 26.64 27.36 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 10.90 32.83 25.96 10.83 30.68 25.98 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 4.57 20.60 30.29 4.74 21.36 30.66 57.08 63.68 -47.92 56.95 63.88 -47.12 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 7 3 # 7 E 57 HIS F 170 HIS^? 9.84 MG MG F 302 E 102 ASP F 171 ASP^? 16.35 MG MG F 302 E 193 GLY F 145 GLY^? 13.40 MG MG F 302 coo 11.39 26.86 25.95 9.85 26.64 27.36 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 10.90 32.83 25.96 10.83 30.68 25.98 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 4.57 20.60 30.29 4.74 21.36 30.66 63.24 63.21 -91.82 63.24 63.42 -92.59 1ds2_c02 source 1ds2 PROTEINASE B (SGPB : 7 hits 1ds2_c02 naa= 3 ULMN 3 1dwo_c00 HYDROXYNITRILE LYASE user 1 3 # 1 A 80 SER A 189 SER^? 11.75 MG MG A 302 A 208 ASP A 148 ASP^? 2.72 MG MG A 301s A 236 HIS A 147 HIS^? 9.20 MG MG A 302 coo 49.19 42.85 125.39 50.92 43.54 123.63 40.99 19.00 44.32 41.51 18.14 46.48 coo 57.80 42.94 129.59 56.47 43.28 127.93 41.50 28.88 41.13 43.33 29.67 41.93 coo 55.54 41.70 125.00 53.71 42.50 124.53 40.24 23.10 39.83 38.32 22.34 40.22 ULMN 3 1dwo_c00 HYDROXYNITRILE LYASE user 2 3 # 2 A 80 SER B 189 SER^? 12.11 MG MG B 301 A 208 ASP B 148 ASP^? 2.58 MG MG B 302s A 236 HIS B 147 HIS^? 9.27 MG MG B 301 coo 49.19 42.85 125.39 50.92 43.54 123.63 43.10 20.95 -7.74 42.82 21.56 -10.02 coo 57.80 42.94 129.59 56.47 43.28 127.93 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 55.54 41.70 125.00 53.71 42.50 124.53 46.73 18.97 -3.05 45.63 17.32 -3.73 ULMN 3 1dwo_c00 HYDROXYNITRILE LYASE user 3 3 # 3 A 80 SER C 189 SER^? 12.09 MG MG C 301 A 208 ASP C 148 ASP^? 2.75 MG MG C 302s A 236 HIS C 147 HIS^? 9.44 MG MG C 301 coo 49.19 42.85 125.39 50.92 43.54 123.63 90.33 28.79 1.19 90.26 29.61 3.45 coo 57.80 42.94 129.59 56.47 43.28 127.93 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 55.54 41.70 125.00 53.71 42.50 124.53 87.61 25.71 -3.59 89.22 24.50 -2.99 ULMN 3 1dwo_c00 HYDROXYNITRILE LYASE user 4 3 # 4 A 80 SER D 189 SER^? 12.12 MG MG D 301 A 208 ASP D 148 ASP^? 2.35 MG MG D 302s A 236 HIS D 147 HIS^? 9.43 MG MG D 301 coo 49.19 42.85 125.39 50.92 43.54 123.63 91.62 28.58 -50.95 91.45 27.78 -53.25 coo 57.80 42.94 129.59 56.47 43.28 127.93 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 55.54 41.70 125.00 53.71 42.50 124.53 90.95 32.51 -46.42 92.98 32.42 -46.93 ULMN 3 1dwo_c00 HYDROXYNITRILE LYASE user 5 3 # 5 A 80 SER E 189 SER^? 11.91 MG MG E 301 A 208 ASP E 148 ASP^? 2.62 MG MG E 302s A 236 HIS E 147 HIS^? 9.22 MG MG E 301 coo 49.19 42.85 125.39 50.92 43.54 123.63 60.13 65.61 -43.87 59.01 65.34 -41.74 coo 57.80 42.94 129.59 56.47 43.28 127.93 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 55.54 41.70 125.00 53.71 42.50 124.53 63.87 64.43 -48.39 64.18 66.45 -47.92 ULMN 3 1dwo_c00 HYDROXYNITRILE LYASE user 6 3 # 6 A 80 SER F 189 SER^? 11.88 MG MG F 302 A 208 ASP F 148 ASP^? 2.72 MG MG F 301s A 236 HIS F 147 HIS^? 8.79 MG MG F 302 coo 49.19 42.85 125.39 50.92 43.54 123.63 59.91 63.90 -95.91 60.70 64.22 -98.13 coo 57.80 42.94 129.59 56.47 43.28 127.93 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 55.54 41.70 125.00 53.71 42.50 124.53 56.63 61.66 -91.16 55.69 63.43 -91.80 1dwo_c00 source 1dwo HYDROXYNITRILE LYASE : 6 hits 1dwo_c00 naa= 3 ULMN 3 1dwo_c01 HYDROXYNITRILE LYASE user 1 3 # 1 B 80 SER A 189 SER^? 11.75 MG MG A 302 B 208 ASP A 148 ASP^? 2.72 MG MG A 301s B 236 HIS A 147 HIS^? 9.20 MG MG A 302 coo 55.25 19.46 97.60 53.04 19.32 98.76 40.99 19.00 44.32 41.51 18.14 46.48 coo 57.34 11.46 102.30 56.11 13.10 101.70 41.50 28.88 41.13 43.33 29.67 41.93 coo 55.03 16.17 103.08 54.39 17.23 101.45 40.24 23.10 39.83 38.32 22.34 40.22 ULMN 3 1dwo_c01 HYDROXYNITRILE LYASE user 2 3 # 2 B 80 SER B 189 SER^? 12.11 MG MG B 301 B 208 ASP B 148 ASP^? 2.58 MG MG B 302s B 236 HIS B 147 HIS^? 9.27 MG MG B 301 coo 55.25 19.46 97.60 53.04 19.32 98.76 43.10 20.95 -7.74 42.82 21.56 -10.02 coo 57.34 11.46 102.30 56.11 13.10 101.70 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 55.03 16.17 103.08 54.39 17.23 101.45 46.73 18.97 -3.05 45.63 17.32 -3.73 ULMN 3 1dwo_c01 HYDROXYNITRILE LYASE user 3 3 # 3 B 80 SER C 189 SER^? 12.09 MG MG C 301 B 208 ASP C 148 ASP^? 2.75 MG MG C 302s B 236 HIS C 147 HIS^? 9.44 MG MG C 301 coo 55.25 19.46 97.60 53.04 19.32 98.76 90.33 28.79 1.19 90.26 29.61 3.45 coo 57.34 11.46 102.30 56.11 13.10 101.70 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 55.03 16.17 103.08 54.39 17.23 101.45 87.61 25.71 -3.59 89.22 24.50 -2.99 ULMN 3 1dwo_c01 HYDROXYNITRILE LYASE user 4 3 # 4 B 80 SER D 189 SER^? 12.12 MG MG D 301 B 208 ASP D 148 ASP^? 2.35 MG MG D 302s B 236 HIS D 147 HIS^? 9.43 MG MG D 301 coo 55.25 19.46 97.60 53.04 19.32 98.76 91.62 28.58 -50.95 91.45 27.78 -53.25 coo 57.34 11.46 102.30 56.11 13.10 101.70 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 55.03 16.17 103.08 54.39 17.23 101.45 90.95 32.51 -46.42 92.98 32.42 -46.93 ULMN 3 1dwo_c01 HYDROXYNITRILE LYASE user 5 3 # 5 B 80 SER E 189 SER^? 11.91 MG MG E 301 B 208 ASP E 148 ASP^? 2.62 MG MG E 302s B 236 HIS E 147 HIS^? 9.22 MG MG E 301 coo 55.25 19.46 97.60 53.04 19.32 98.76 60.13 65.61 -43.87 59.01 65.34 -41.74 coo 57.34 11.46 102.30 56.11 13.10 101.70 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 55.03 16.17 103.08 54.39 17.23 101.45 63.87 64.43 -48.39 64.18 66.45 -47.92 ULMN 3 1dwo_c01 HYDROXYNITRILE LYASE user 6 3 # 6 B 80 SER F 189 SER^? 11.88 MG MG F 302 B 208 ASP F 148 ASP^? 2.72 MG MG F 301s B 236 HIS F 147 HIS^? 8.79 MG MG F 302 coo 55.25 19.46 97.60 53.04 19.32 98.76 59.91 63.90 -95.91 60.70 64.22 -98.13 coo 57.34 11.46 102.30 56.11 13.10 101.70 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 55.03 16.17 103.08 54.39 17.23 101.45 56.63 61.66 -91.16 55.69 63.43 -91.80 1dwo_c01 source 1dwo HYDROXYNITRILE LYASE : 6 hits 1dwo_c01 naa= 3 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 1 3 # 1 A 131 LYS A 6 LYS^? 25.88 MG MG A 301 A 215 LYS A 166 LYS^? 20.93 MG MG A 302 A 277 LYS A 192 LYS^? 22.83 MG MG A 302 coo 0.50 24.09 51.68 1.51 29.34 52.35 46.20 12.82 24.71 44.50 16.64 20.52 coo 13.06 30.79 51.73 11.40 35.76 53.48 35.34 13.14 30.41 31.67 15.04 34.58 coo 13.04 31.88 60.72 10.57 35.34 57.49 40.19 10.20 38.86 35.42 9.85 36.29 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 2 3 # 2 A 131 LYS A 111 LYS^? 15.16 MG MG A 301 A 215 LYS A 192 LYS^? 22.83 MG MG A 302 A 277 LYS A 166 LYS^? 20.93 MG MG A 302 coo 0.50 24.09 51.68 1.51 29.34 52.35 52.67 17.19 35.90 54.65 19.90 40.50 coo 13.06 30.79 51.73 11.40 35.76 53.48 40.19 10.20 38.86 35.42 9.85 36.29 coo 13.04 31.88 60.72 10.57 35.34 57.49 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 3 3 # 3 A 131 LYS A 136 LYS^? 30.58 MG MG A 302 A 215 LYS A 192 LYS^? 22.83 MG MG A 302 A 277 LYS A 166 LYS^? 20.93 MG MG A 302 coo 0.50 24.09 51.68 1.51 29.34 52.35 50.14 3.36 31.42 51.28 2.21 35.89 coo 13.06 30.79 51.73 11.40 35.76 53.48 40.19 10.20 38.86 35.42 9.85 36.29 coo 13.04 31.88 60.72 10.57 35.34 57.49 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 4 3 # 4 A 131 LYS B 111 LYS^? 13.75 MG MG B 302 A 215 LYS B 192 LYS^? 23.73 MG MG B 301 A 277 LYS B 166 LYS^? 22.75 MG MG B 301 coo 0.50 24.09 51.68 1.51 29.34 52.35 42.84 32.14 1.80 46.84 32.68 -2.87 coo 13.06 30.79 51.73 11.40 35.76 53.48 33.83 21.17 -2.93 31.87 16.45 -0.74 coo 13.04 31.88 60.72 10.57 35.34 57.49 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 5 3 # 5 A 131 LYS B 136 LYS^? 33.75 MG MG B 302 A 215 LYS B 192 LYS^? 23.73 MG MG B 301 A 277 LYS B 166 LYS^? 22.75 MG MG B 301 coo 0.50 24.09 51.68 1.51 29.34 52.35 28.47 31.35 4.78 24.04 31.81 1.99 coo 13.06 30.79 51.73 11.40 35.76 53.48 33.83 21.17 -2.93 31.87 16.45 -0.74 coo 13.04 31.88 60.72 10.57 35.34 57.49 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 6 3 # 6 A 131 LYS C 111 LYS^? 16.56 MG MG C 302 A 215 LYS C 192 LYS^? 24.43 MG MG C 301 A 277 LYS C 166 LYS^? 22.53 MG MG C 301 coo 0.50 24.09 51.68 1.51 29.34 52.35 86.36 39.56 -8.06 84.36 40.84 -3.15 coo 13.06 30.79 51.73 11.40 35.76 53.48 98.71 32.33 -3.93 102.89 29.25 -5.78 coo 13.04 31.88 60.72 10.57 35.34 57.49 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 7 3 # 7 A 131 LYS C 136 LYS^? 30.63 MG MG C 302 A 215 LYS C 192 LYS^? 24.43 MG MG C 301 A 277 LYS C 166 LYS^? 22.53 MG MG C 301 coo 0.50 24.09 51.68 1.51 29.34 52.35 99.75 44.04 -11.38 100.98 45.13 -6.77 coo 13.06 30.79 51.73 11.40 35.76 53.48 98.71 32.33 -3.93 102.89 29.25 -5.78 coo 13.04 31.88 60.72 10.57 35.34 57.49 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 8 3 # 8 A 131 LYS D 111 LYS^? 15.85 MG MG D 302 A 215 LYS D 192 LYS^? 24.09 MG MG D 301 A 277 LYS D 166 LYS^? 21.08 MG MG D 301 coo 0.50 24.09 51.68 1.51 29.34 52.35 81.21 22.69 -42.10 78.68 23.89 -46.57 coo 13.06 30.79 51.73 11.40 35.76 53.48 95.35 20.28 -45.75 100.42 20.77 -43.05 coo 13.04 31.88 60.72 10.57 35.34 57.49 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 9 3 # 9 A 131 LYS D 136 LYS^? 34.99 MG MG D 302 A 215 LYS D 192 LYS^? 24.09 MG MG D 301 A 277 LYS D 166 LYS^? 21.08 MG MG D 301 coo 0.50 24.09 51.68 1.51 29.34 52.35 88.96 10.62 -38.53 90.77 6.00 -38.00 coo 13.06 30.79 51.73 11.40 35.76 53.48 95.35 20.28 -45.75 100.42 20.77 -43.05 coo 13.04 31.88 60.72 10.57 35.34 57.49 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 10 3 # 10 A 131 LYS E 111 LYS^? 14.52 MG MG E 302 A 215 LYS E 192 LYS^? 23.62 MG MG E 301 A 277 LYS E 166 LYS^? 21.46 MG MG E 301 coo 0.50 24.09 51.68 1.51 29.34 52.35 52.49 56.44 -52.43 54.52 53.78 -47.52 coo 13.06 30.79 51.73 11.40 35.76 53.48 52.64 70.58 -49.14 53.48 75.40 -50.95 coo 13.04 31.88 60.72 10.57 35.34 57.49 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 11 3 # 11 A 131 LYS E 136 LYS^? 31.27 MG MG E 302 A 215 LYS E 192 LYS^? 23.62 MG MG E 301 A 277 LYS E 166 LYS^? 21.46 MG MG E 301 coo 0.50 24.09 51.68 1.51 29.34 52.35 42.12 65.93 -56.52 39.36 65.07 -51.83 coo 13.06 30.79 51.73 11.40 35.76 53.48 52.64 70.58 -49.14 53.48 75.40 -50.95 coo 13.04 31.88 60.72 10.57 35.34 57.49 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 12 3 # 12 A 131 LYS F 111 LYS^? 15.21 MG MG F 301 A 215 LYS F 192 LYS^? 23.61 MG MG F 302 A 277 LYS F 166 LYS^? 20.76 MG MG F 302 coo 0.50 24.09 51.68 1.51 29.34 52.35 69.70 58.57 -86.86 69.67 53.74 -90.29 coo 13.06 30.79 51.73 11.40 35.76 53.48 64.82 71.59 -91.06 62.22 76.11 -88.75 coo 13.04 31.88 60.72 10.57 35.34 57.49 59.28 73.05 -82.63 55.63 74.15 -86.94 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 13 3 # 13 A 131 LYS F 136 LYS^? 30.53 MG MG F 301 A 215 LYS F 192 LYS^? 23.61 MG MG F 302 A 277 LYS F 166 LYS^? 20.76 MG MG F 302 coo 0.50 24.09 51.68 1.51 29.34 52.35 76.49 71.19 -83.39 78.38 70.88 -88.47 coo 13.06 30.79 51.73 11.40 35.76 53.48 64.82 71.59 -91.06 62.22 76.11 -88.75 coo 13.04 31.88 60.72 10.57 35.34 57.49 59.28 73.05 -82.63 55.63 74.15 -86.94 1e19_c00 source 1e19 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPHATE SYNTH: 13 hits 1e19_c00 naa= 3 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 1 3 # 1 B 131 LYS A 6 LYS^? 25.88 MG MG A 301 B 215 LYS A 166 LYS^? 20.93 MG MG A 302 B 277 LYS A 192 LYS^? 22.83 MG MG A 302 coo 6.78 45.91 16.15 7.82 40.81 15.84 46.20 12.82 24.71 44.50 16.64 20.52 coo 17.88 38.77 19.81 16.38 34.23 17.24 35.34 13.14 30.41 31.67 15.04 34.58 coo 20.33 37.78 11.20 16.77 34.53 13.47 40.19 10.20 38.86 35.42 9.85 36.29 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 2 3 # 2 B 131 LYS A 136 LYS^? 30.58 MG MG A 302 B 215 LYS A 192 LYS^? 22.83 MG MG A 302 B 277 LYS A 166 LYS^? 20.93 MG MG A 302 coo 6.78 45.91 16.15 7.82 40.81 15.84 50.14 3.36 31.42 51.28 2.21 35.89 coo 17.88 38.77 19.81 16.38 34.23 17.24 40.19 10.20 38.86 35.42 9.85 36.29 coo 20.33 37.78 11.20 16.77 34.53 13.47 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 3 3 # 3 B 131 LYS B 6 LYS^? 25.90 MG MG B 302 B 215 LYS B 166 LYS^? 22.75 MG MG B 301 B 277 LYS B 192 LYS^? 23.73 MG MG B 301 coo 6.78 45.91 16.15 7.82 40.81 15.84 36.26 25.44 11.74 39.65 23.12 16.29 coo 17.88 38.77 19.81 16.38 34.23 17.24 35.27 15.38 5.31 37.27 9.81 3.93 coo 20.33 37.78 11.20 16.77 34.53 13.47 33.83 21.17 -2.93 31.87 16.45 -0.74 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 4 3 # 4 B 131 LYS B 136 LYS^? 33.75 MG MG B 302 B 215 LYS B 192 LYS^? 23.73 MG MG B 301 B 277 LYS B 166 LYS^? 22.75 MG MG B 301 coo 6.78 45.91 16.15 7.82 40.81 15.84 28.47 31.35 4.78 24.04 31.81 1.99 coo 17.88 38.77 19.81 16.38 34.23 17.24 33.83 21.17 -2.93 31.87 16.45 -0.74 coo 20.33 37.78 11.20 16.77 34.53 13.47 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 5 3 # 5 B 131 LYS C 6 LYS^? 25.73 MG MG C 302 B 215 LYS C 166 LYS^? 22.53 MG MG C 301 B 277 LYS C 192 LYS^? 24.43 MG MG C 301 coo 6.78 45.91 16.15 7.82 40.81 15.84 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 17.88 38.77 19.81 16.38 34.23 17.24 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 20.33 37.78 11.20 16.77 34.53 13.47 98.71 32.33 -3.93 102.89 29.25 -5.78 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 6 3 # 6 B 131 LYS C 136 LYS^? 30.63 MG MG C 302 B 215 LYS C 192 LYS^? 24.43 MG MG C 301 B 277 LYS C 166 LYS^? 22.53 MG MG C 301 coo 6.78 45.91 16.15 7.82 40.81 15.84 99.75 44.04 -11.38 100.98 45.13 -6.77 coo 17.88 38.77 19.81 16.38 34.23 17.24 98.71 32.33 -3.93 102.89 29.25 -5.78 coo 20.33 37.78 11.20 16.77 34.53 13.47 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 7 3 # 7 B 131 LYS D 6 LYS^? 25.98 MG MG D 302 B 215 LYS D 166 LYS^? 21.08 MG MG D 301 B 277 LYS D 192 LYS^? 24.09 MG MG D 301 coo 6.78 45.91 16.15 7.82 40.81 15.84 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 17.88 38.77 19.81 16.38 34.23 17.24 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 20.33 37.78 11.20 16.77 34.53 13.47 95.35 20.28 -45.75 100.42 20.77 -43.05 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 8 3 # 8 B 131 LYS D 136 LYS^? 34.99 MG MG D 302 B 215 LYS D 192 LYS^? 24.09 MG MG D 301 B 277 LYS D 166 LYS^? 21.08 MG MG D 301 coo 6.78 45.91 16.15 7.82 40.81 15.84 88.96 10.62 -38.53 90.77 6.00 -38.00 coo 17.88 38.77 19.81 16.38 34.23 17.24 95.35 20.28 -45.75 100.42 20.77 -43.05 coo 20.33 37.78 11.20 16.77 34.53 13.47 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 9 3 # 9 B 131 LYS E 6 LYS^? 25.59 MG MG E 302 B 215 LYS E 166 LYS^? 21.46 MG MG E 301 B 277 LYS E 192 LYS^? 23.62 MG MG E 301 coo 6.78 45.91 16.15 7.82 40.81 15.84 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 17.88 38.77 19.81 16.38 34.23 17.24 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 20.33 37.78 11.20 16.77 34.53 13.47 52.64 70.58 -49.14 53.48 75.40 -50.95 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 10 3 # 10 B 131 LYS E 136 LYS^? 31.27 MG MG E 302 B 215 LYS E 192 LYS^? 23.62 MG MG E 301 B 277 LYS E 166 LYS^? 21.46 MG MG E 301 coo 6.78 45.91 16.15 7.82 40.81 15.84 42.12 65.93 -56.52 39.36 65.07 -51.83 coo 17.88 38.77 19.81 16.38 34.23 17.24 52.64 70.58 -49.14 53.48 75.40 -50.95 coo 20.33 37.78 11.20 16.77 34.53 13.47 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 11 3 # 11 B 131 LYS F 6 LYS^? 26.09 MG MG F 301 B 215 LYS F 166 LYS^? 20.76 MG MG F 302 B 277 LYS F 192 LYS^? 23.61 MG MG F 302 coo 6.78 45.91 16.15 7.82 40.81 15.84 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 17.88 38.77 19.81 16.38 34.23 17.24 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 20.33 37.78 11.20 16.77 34.53 13.47 64.82 71.59 -91.06 62.22 76.11 -88.75 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 12 3 # 12 B 131 LYS F 111 LYS^? 15.21 MG MG F 301 B 215 LYS F 192 LYS^? 23.61 MG MG F 302 B 277 LYS F 166 LYS^? 20.76 MG MG F 302 coo 6.78 45.91 16.15 7.82 40.81 15.84 69.70 58.57 -86.86 69.67 53.74 -90.29 coo 17.88 38.77 19.81 16.38 34.23 17.24 64.82 71.59 -91.06 62.22 76.11 -88.75 coo 20.33 37.78 11.20 16.77 34.53 13.47 59.28 73.05 -82.63 55.63 74.15 -86.94 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 13 3 # 13 B 131 LYS F 136 LYS^? 30.53 MG MG F 301 B 215 LYS F 192 LYS^? 23.61 MG MG F 302 B 277 LYS F 166 LYS^? 20.76 MG MG F 302 coo 6.78 45.91 16.15 7.82 40.81 15.84 76.49 71.19 -83.39 78.38 70.88 -88.47 coo 17.88 38.77 19.81 16.38 34.23 17.24 64.82 71.59 -91.06 62.22 76.11 -88.75 coo 20.33 37.78 11.20 16.77 34.53 13.47 59.28 73.05 -82.63 55.63 74.15 -86.94 1e19_c01 source 1e19 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPHATE SYNTH: 13 hits 1e19_c01 naa= 3 ULMN 3 1e2t_c00 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 1 3 # 1 A 69 CYH A 152 CYH^? 15.18 MG MG A 302 A 107 HIS A 170 HIS^? 10.56 MG MG A 302 A 122 ASP A 148 ASP^? 2.72 MG MG A 301s coo 107.06 101.85 70.21 107.82 99.27 70.56 34.81 26.51 34.70 32.10 26.95 34.06 coo 112.02 99.34 69.11 112.26 101.12 70.20 34.91 23.57 39.32 34.35 24.95 40.81 coo 114.37 105.59 70.16 113.40 104.00 71.21 41.50 28.88 41.13 43.33 29.67 41.93 ULMN 3 1e2t_c00 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 2 3 # 2 A 69 CYH A 152 CYH^? 15.18 MG MG A 302 A 107 HIS A 170 HIS^? 10.56 MG MG A 302 A 122 ASP A 177 ASP^? 8.44 MG MG A 302 coo 107.06 101.85 70.21 107.82 99.27 70.56 34.81 26.51 34.70 32.10 26.95 34.06 coo 112.02 99.34 69.11 112.26 101.12 70.20 34.91 23.57 39.32 34.35 24.95 40.81 coo 114.37 105.59 70.16 113.40 104.00 71.21 33.02 29.04 43.18 33.79 27.88 44.78 ULMN 3 1e2t_c00 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 3 3 # 3 A 69 CYH B 152 CYH^? 14.66 MG MG B 301 A 107 HIS B 170 HIS^? 10.51 MG MG B 301 A 122 ASP B 148 ASP^? 2.58 MG MG B 302s coo 107.06 101.85 70.21 107.82 99.27 70.56 48.74 12.82 1.93 48.51 10.17 2.19 coo 112.02 99.34 69.11 112.26 101.12 70.20 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 114.37 105.59 70.16 113.40 104.00 71.21 52.73 19.23 -3.77 53.81 20.99 -4.31 ULMN 3 1e2t_c00 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 4 3 # 4 A 69 CYH B 152 CYH^? 14.66 MG MG B 301 A 107 HIS B 170 HIS^? 10.51 MG MG B 301 A 122 ASP B 177 ASP^? 9.03 MG MG B 301 coo 107.06 101.85 70.21 107.82 99.27 70.56 48.74 12.82 1.93 48.51 10.17 2.19 coo 112.02 99.34 69.11 112.26 101.12 70.20 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 114.37 105.59 70.16 113.40 104.00 71.21 51.97 11.04 -6.64 50.39 11.62 -7.94 ULMN 3 1e2t_c00 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 5 3 # 5 A 69 CYH C 152 CYH^? 14.61 MG MG C 301 A 107 HIS C 170 HIS^? 10.68 MG MG C 301 A 122 ASP C 148 ASP^? 2.75 MG MG C 302s coo 107.06 101.85 70.21 107.82 99.27 70.56 87.66 19.43 -8.58 88.77 17.04 -8.78 coo 112.02 99.34 69.11 112.26 101.12 70.20 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 114.37 105.59 70.16 113.40 104.00 71.21 81.96 23.83 -2.68 80.24 25.11 -2.27 ULMN 3 1e2t_c00 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 6 3 # 6 A 69 CYH C 152 CYH^? 14.61 MG MG C 301 A 107 HIS C 170 HIS^? 10.68 MG MG C 301 A 122 ASP C 177 ASP^? 8.84 MG MG C 301 coo 107.06 101.85 70.21 107.82 99.27 70.56 87.66 19.43 -8.58 88.77 17.04 -8.78 coo 112.02 99.34 69.11 112.26 101.12 70.20 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 114.37 105.59 70.16 113.40 104.00 71.21 85.60 16.42 -0.31 86.51 17.71 1.09 ULMN 3 1e2t_c00 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 7 3 # 7 A 69 CYH D 152 CYH^? 14.66 MG MG D 301 A 107 HIS D 170 HIS^? 10.59 MG MG D 301 A 122 ASP D 148 ASP^? 2.35 MG MG D 302s coo 107.06 101.85 70.21 107.82 99.27 70.56 94.69 37.43 -41.36 96.92 38.83 -40.94 coo 112.02 99.34 69.11 112.26 101.12 70.20 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 114.37 105.59 70.16 113.40 104.00 71.21 87.78 37.50 -47.56 85.79 37.49 -48.28 ULMN 3 1e2t_c00 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 8 3 # 8 A 69 CYH D 152 CYH^? 14.66 MG MG D 301 A 107 HIS D 170 HIS^? 10.59 MG MG D 301 A 122 ASP D 177 ASP^? 8.43 MG MG D 301 coo 107.06 101.85 70.21 107.82 99.27 70.56 94.69 37.43 -41.36 96.92 38.83 -40.94 coo 112.02 99.34 69.11 112.26 101.12 70.20 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 114.37 105.59 70.16 113.40 104.00 71.21 95.74 41.01 -49.76 94.81 39.90 -51.24 ULMN 3 1e2t_c00 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 9 3 # 9 A 69 CYH E 152 CYH^? 14.64 MG MG E 301 A 107 HIS E 170 HIS^? 10.33 MG MG E 301 A 122 ASP E 148 ASP^? 2.62 MG MG E 302s coo 107.06 101.85 70.21 107.82 99.27 70.56 69.49 67.27 -53.54 71.02 69.50 -54.03 coo 112.02 99.34 69.11 112.26 101.12 70.20 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 114.37 105.59 70.16 113.40 104.00 71.21 68.29 60.44 -47.29 68.03 58.42 -46.50 ULMN 3 1e2t_c00 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 10 3 # 10 A 69 CYH E 152 CYH^? 14.64 MG MG E 301 A 107 HIS E 170 HIS^? 10.33 MG MG E 301 A 122 ASP E 177 ASP^? 8.55 MG MG E 301 coo 107.06 101.85 70.21 107.82 99.27 70.56 69.49 67.27 -53.54 71.02 69.50 -54.03 coo 112.02 99.34 69.11 112.26 101.12 70.20 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 114.37 105.59 70.16 113.40 104.00 71.21 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 1e2t_c00 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 11 3 # 11 A 69 CYH F 152 CYH^? 14.14 MG MG F 302 A 107 HIS F 170 HIS^? 9.84 MG MG F 302 A 122 ASP F 148 ASP^? 2.72 MG MG F 301s coo 107.06 101.85 70.21 107.82 99.27 70.56 50.28 62.76 -86.08 48.12 64.34 -85.77 coo 112.02 99.34 69.11 112.26 101.12 70.20 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 114.37 105.59 70.16 113.40 104.00 71.21 53.64 56.47 -91.98 54.61 54.68 -92.64 ULMN 3 1e2t_c00 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 12 3 # 12 A 69 CYH F 152 CYH^? 14.14 MG MG F 302 A 107 HIS F 170 HIS^? 9.84 MG MG F 302 A 122 ASP F 177 ASP^? 8.15 MG MG F 302 coo 107.06 101.85 70.21 107.82 99.27 70.56 50.28 62.76 -86.08 48.12 64.34 -85.77 coo 112.02 99.34 69.11 112.26 101.12 70.20 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 114.37 105.59 70.16 113.40 104.00 71.21 47.18 61.22 -94.50 48.48 62.32 -95.73 1e2t_c00 source 1e2t N-HYDROXYARYLAMINE O-ACETYLTRANSFERASE : 12 hits 1e2t_c00 naa= 3 ULMN 3 1e2t_c01 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 1 3 # 1 B 69 CYH A 152 CYH^? 15.18 MG MG A 302 B 107 HIS A 170 HIS^? 10.56 MG MG A 302 B 122 ASP A 148 ASP^? 2.72 MG MG A 301s coo 71.18 90.15 69.62 72.19 87.91 68.26 34.81 26.51 34.70 32.10 26.95 34.06 coo 68.66 85.12 69.19 67.36 86.67 68.68 34.91 23.57 39.32 34.35 24.95 40.81 coo 63.06 88.82 69.94 64.68 88.56 68.63 41.50 28.88 41.13 43.33 29.67 41.93 ULMN 3 1e2t_c01 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 2 3 # 2 B 69 CYH A 152 CYH^? 15.18 MG MG A 302 B 107 HIS A 170 HIS^? 10.56 MG MG A 302 B 122 ASP A 177 ASP^? 8.44 MG MG A 302 coo 71.18 90.15 69.62 72.19 87.91 68.26 34.81 26.51 34.70 32.10 26.95 34.06 coo 68.66 85.12 69.19 67.36 86.67 68.68 34.91 23.57 39.32 34.35 24.95 40.81 coo 63.06 88.82 69.94 64.68 88.56 68.63 33.02 29.04 43.18 33.79 27.88 44.78 ULMN 3 1e2t_c01 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 3 3 # 3 B 69 CYH B 152 CYH^? 14.66 MG MG B 301 B 107 HIS B 170 HIS^? 10.51 MG MG B 301 B 122 ASP B 148 ASP^? 2.58 MG MG B 302s coo 71.18 90.15 69.62 72.19 87.91 68.26 48.74 12.82 1.93 48.51 10.17 2.19 coo 68.66 85.12 69.19 67.36 86.67 68.68 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 63.06 88.82 69.94 64.68 88.56 68.63 52.73 19.23 -3.77 53.81 20.99 -4.31 ULMN 3 1e2t_c01 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 4 3 # 4 B 69 CYH B 152 CYH^? 14.66 MG MG B 301 B 107 HIS B 170 HIS^? 10.51 MG MG B 301 B 122 ASP B 177 ASP^? 9.03 MG MG B 301 coo 71.18 90.15 69.62 72.19 87.91 68.26 48.74 12.82 1.93 48.51 10.17 2.19 coo 68.66 85.12 69.19 67.36 86.67 68.68 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 63.06 88.82 69.94 64.68 88.56 68.63 51.97 11.04 -6.64 50.39 11.62 -7.94 ULMN 3 1e2t_c01 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 5 3 # 5 B 69 CYH C 152 CYH^? 14.61 MG MG C 301 B 107 HIS C 170 HIS^? 10.68 MG MG C 301 B 122 ASP C 148 ASP^? 2.75 MG MG C 302s coo 71.18 90.15 69.62 72.19 87.91 68.26 87.66 19.43 -8.58 88.77 17.04 -8.78 coo 68.66 85.12 69.19 67.36 86.67 68.68 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 63.06 88.82 69.94 64.68 88.56 68.63 81.96 23.83 -2.68 80.24 25.11 -2.27 ULMN 3 1e2t_c01 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 6 3 # 6 B 69 CYH C 152 CYH^? 14.61 MG MG C 301 B 107 HIS C 170 HIS^? 10.68 MG MG C 301 B 122 ASP C 177 ASP^? 8.84 MG MG C 301 coo 71.18 90.15 69.62 72.19 87.91 68.26 87.66 19.43 -8.58 88.77 17.04 -8.78 coo 68.66 85.12 69.19 67.36 86.67 68.68 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 63.06 88.82 69.94 64.68 88.56 68.63 85.60 16.42 -0.31 86.51 17.71 1.09 ULMN 3 1e2t_c01 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 7 3 # 7 B 69 CYH D 152 CYH^? 14.66 MG MG D 301 B 107 HIS D 170 HIS^? 10.59 MG MG D 301 B 122 ASP D 148 ASP^? 2.35 MG MG D 302s coo 71.18 90.15 69.62 72.19 87.91 68.26 94.69 37.43 -41.36 96.92 38.83 -40.94 coo 68.66 85.12 69.19 67.36 86.67 68.68 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 63.06 88.82 69.94 64.68 88.56 68.63 87.78 37.50 -47.56 85.79 37.49 -48.28 ULMN 3 1e2t_c01 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 8 3 # 8 B 69 CYH D 152 CYH^? 14.66 MG MG D 301 B 107 HIS D 170 HIS^? 10.59 MG MG D 301 B 122 ASP D 177 ASP^? 8.43 MG MG D 301 coo 71.18 90.15 69.62 72.19 87.91 68.26 94.69 37.43 -41.36 96.92 38.83 -40.94 coo 68.66 85.12 69.19 67.36 86.67 68.68 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 63.06 88.82 69.94 64.68 88.56 68.63 95.74 41.01 -49.76 94.81 39.90 -51.24 ULMN 3 1e2t_c01 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 9 3 # 9 B 69 CYH E 152 CYH^? 14.64 MG MG E 301 B 107 HIS E 170 HIS^? 10.33 MG MG E 301 B 122 ASP E 148 ASP^? 2.62 MG MG E 302s coo 71.18 90.15 69.62 72.19 87.91 68.26 69.49 67.27 -53.54 71.02 69.50 -54.03 coo 68.66 85.12 69.19 67.36 86.67 68.68 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 63.06 88.82 69.94 64.68 88.56 68.63 68.29 60.44 -47.29 68.03 58.42 -46.50 ULMN 3 1e2t_c01 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 10 3 # 10 B 69 CYH E 152 CYH^? 14.64 MG MG E 301 B 107 HIS E 170 HIS^? 10.33 MG MG E 301 B 122 ASP E 177 ASP^? 8.55 MG MG E 301 coo 71.18 90.15 69.62 72.19 87.91 68.26 69.49 67.27 -53.54 71.02 69.50 -54.03 coo 68.66 85.12 69.19 67.36 86.67 68.68 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 63.06 88.82 69.94 64.68 88.56 68.63 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 1e2t_c01 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 11 3 # 11 B 69 CYH F 152 CYH^? 14.14 MG MG F 302 B 107 HIS F 170 HIS^? 9.84 MG MG F 302 B 122 ASP F 148 ASP^? 2.72 MG MG F 301s coo 71.18 90.15 69.62 72.19 87.91 68.26 50.28 62.76 -86.08 48.12 64.34 -85.77 coo 68.66 85.12 69.19 67.36 86.67 68.68 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 63.06 88.82 69.94 64.68 88.56 68.63 53.64 56.47 -91.98 54.61 54.68 -92.64 ULMN 3 1e2t_c01 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 12 3 # 12 B 69 CYH F 152 CYH^? 14.14 MG MG F 302 B 107 HIS F 170 HIS^? 9.84 MG MG F 302 B 122 ASP F 177 ASP^? 8.15 MG MG F 302 coo 71.18 90.15 69.62 72.19 87.91 68.26 50.28 62.76 -86.08 48.12 64.34 -85.77 coo 68.66 85.12 69.19 67.36 86.67 68.68 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 63.06 88.82 69.94 64.68 88.56 68.63 47.18 61.22 -94.50 48.48 62.32 -95.73 1e2t_c01 source 1e2t N-HYDROXYARYLAMINE O-ACETYLTRANSFERASE : 12 hits 1e2t_c01 naa= 3 ULMN 3 1e2t_c02 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 1 3 # 1 C 69 CYH A 152 CYH^? 15.18 MG MG A 302 C 107 HIS A 170 HIS^? 10.56 MG MG A 302 C 122 ASP A 148 ASP^? 2.72 MG MG A 301s coo 87.22 70.88 82.51 87.10 73.53 83.33 34.81 26.51 34.70 32.10 26.95 34.06 coo 83.94 73.51 86.28 84.82 71.77 87.03 34.91 23.57 39.32 34.35 24.95 40.81 coo 83.85 67.31 89.02 85.24 68.84 88.61 41.50 28.88 41.13 43.33 29.67 41.93 ULMN 3 1e2t_c02 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 2 3 # 2 C 69 CYH A 152 CYH^? 15.18 MG MG A 302 C 107 HIS A 170 HIS^? 10.56 MG MG A 302 C 122 ASP A 177 ASP^? 8.44 MG MG A 302 coo 87.22 70.88 82.51 87.10 73.53 83.33 34.81 26.51 34.70 32.10 26.95 34.06 coo 83.94 73.51 86.28 84.82 71.77 87.03 34.91 23.57 39.32 34.35 24.95 40.81 coo 83.85 67.31 89.02 85.24 68.84 88.61 33.02 29.04 43.18 33.79 27.88 44.78 ULMN 3 1e2t_c02 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 3 3 # 3 C 69 CYH B 152 CYH^? 14.66 MG MG B 301 C 107 HIS B 170 HIS^? 10.51 MG MG B 301 C 122 ASP B 148 ASP^? 2.58 MG MG B 302s coo 87.22 70.88 82.51 87.10 73.53 83.33 48.74 12.82 1.93 48.51 10.17 2.19 coo 83.94 73.51 86.28 84.82 71.77 87.03 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 83.85 67.31 89.02 85.24 68.84 88.61 52.73 19.23 -3.77 53.81 20.99 -4.31 ULMN 3 1e2t_c02 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 4 3 # 4 C 69 CYH B 152 CYH^? 14.66 MG MG B 301 C 107 HIS B 170 HIS^? 10.51 MG MG B 301 C 122 ASP B 177 ASP^? 9.03 MG MG B 301 coo 87.22 70.88 82.51 87.10 73.53 83.33 48.74 12.82 1.93 48.51 10.17 2.19 coo 83.94 73.51 86.28 84.82 71.77 87.03 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 83.85 67.31 89.02 85.24 68.84 88.61 51.97 11.04 -6.64 50.39 11.62 -7.94 ULMN 3 1e2t_c02 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 5 3 # 5 C 69 CYH C 152 CYH^? 14.61 MG MG C 301 C 107 HIS C 170 HIS^? 10.68 MG MG C 301 C 122 ASP C 148 ASP^? 2.75 MG MG C 302s coo 87.22 70.88 82.51 87.10 73.53 83.33 87.66 19.43 -8.58 88.77 17.04 -8.78 coo 83.94 73.51 86.28 84.82 71.77 87.03 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 83.85 67.31 89.02 85.24 68.84 88.61 81.96 23.83 -2.68 80.24 25.11 -2.27 ULMN 3 1e2t_c02 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 6 3 # 6 C 69 CYH C 152 CYH^? 14.61 MG MG C 301 C 107 HIS C 170 HIS^? 10.68 MG MG C 301 C 122 ASP C 177 ASP^? 8.84 MG MG C 301 coo 87.22 70.88 82.51 87.10 73.53 83.33 87.66 19.43 -8.58 88.77 17.04 -8.78 coo 83.94 73.51 86.28 84.82 71.77 87.03 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 83.85 67.31 89.02 85.24 68.84 88.61 85.60 16.42 -0.31 86.51 17.71 1.09 ULMN 3 1e2t_c02 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 7 3 # 7 C 69 CYH D 152 CYH^? 14.66 MG MG D 301 C 107 HIS D 170 HIS^? 10.59 MG MG D 301 C 122 ASP D 148 ASP^? 2.35 MG MG D 302s coo 87.22 70.88 82.51 87.10 73.53 83.33 94.69 37.43 -41.36 96.92 38.83 -40.94 coo 83.94 73.51 86.28 84.82 71.77 87.03 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 83.85 67.31 89.02 85.24 68.84 88.61 87.78 37.50 -47.56 85.79 37.49 -48.28 ULMN 3 1e2t_c02 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 8 3 # 8 C 69 CYH D 152 CYH^? 14.66 MG MG D 301 C 107 HIS D 170 HIS^? 10.59 MG MG D 301 C 122 ASP D 177 ASP^? 8.43 MG MG D 301 coo 87.22 70.88 82.51 87.10 73.53 83.33 94.69 37.43 -41.36 96.92 38.83 -40.94 coo 83.94 73.51 86.28 84.82 71.77 87.03 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 83.85 67.31 89.02 85.24 68.84 88.61 95.74 41.01 -49.76 94.81 39.90 -51.24 ULMN 3 1e2t_c02 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 9 3 # 9 C 69 CYH E 152 CYH^? 14.64 MG MG E 301 C 107 HIS E 170 HIS^? 10.33 MG MG E 301 C 122 ASP E 148 ASP^? 2.62 MG MG E 302s coo 87.22 70.88 82.51 87.10 73.53 83.33 69.49 67.27 -53.54 71.02 69.50 -54.03 coo 83.94 73.51 86.28 84.82 71.77 87.03 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 83.85 67.31 89.02 85.24 68.84 88.61 68.29 60.44 -47.29 68.03 58.42 -46.50 ULMN 3 1e2t_c02 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 10 3 # 10 C 69 CYH E 152 CYH^? 14.64 MG MG E 301 C 107 HIS E 170 HIS^? 10.33 MG MG E 301 C 122 ASP E 177 ASP^? 8.55 MG MG E 301 coo 87.22 70.88 82.51 87.10 73.53 83.33 69.49 67.27 -53.54 71.02 69.50 -54.03 coo 83.94 73.51 86.28 84.82 71.77 87.03 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 83.85 67.31 89.02 85.24 68.84 88.61 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 1e2t_c02 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 11 3 # 11 C 69 CYH F 152 CYH^? 14.14 MG MG F 302 C 107 HIS F 170 HIS^? 9.84 MG MG F 302 C 122 ASP F 148 ASP^? 2.72 MG MG F 301s coo 87.22 70.88 82.51 87.10 73.53 83.33 50.28 62.76 -86.08 48.12 64.34 -85.77 coo 83.94 73.51 86.28 84.82 71.77 87.03 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 83.85 67.31 89.02 85.24 68.84 88.61 53.64 56.47 -91.98 54.61 54.68 -92.64 ULMN 3 1e2t_c02 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 12 3 # 12 C 69 CYH F 152 CYH^? 14.14 MG MG F 302 C 107 HIS F 170 HIS^? 9.84 MG MG F 302 C 122 ASP F 177 ASP^? 8.15 MG MG F 302 coo 87.22 70.88 82.51 87.10 73.53 83.33 50.28 62.76 -86.08 48.12 64.34 -85.77 coo 83.94 73.51 86.28 84.82 71.77 87.03 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 83.85 67.31 89.02 85.24 68.84 88.61 47.18 61.22 -94.50 48.48 62.32 -95.73 1e2t_c02 source 1e2t N-HYDROXYARYLAMINE O-ACETYLTRANSFERASE : 12 hits 1e2t_c02 naa= 3 ULMN 3 1e2t_c03 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 1 3 # 1 D 69 CYH A 152 CYH^? 15.18 MG MG A 302 D 107 HIS A 170 HIS^? 10.56 MG MG A 302 D 122 ASP A 148 ASP^? 2.72 MG MG A 301s coo 103.83 82.01 50.25 102.30 84.27 50.28 34.81 26.51 34.70 32.10 26.95 34.06 coo 104.67 87.04 47.86 104.93 85.42 46.57 34.91 23.57 39.32 34.35 24.95 40.81 coo 108.03 83.30 43.35 106.06 83.62 44.11 41.50 28.88 41.13 43.33 29.67 41.93 ULMN 3 1e2t_c03 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 2 3 # 2 D 69 CYH A 152 CYH^? 15.18 MG MG A 302 D 107 HIS A 170 HIS^? 10.56 MG MG A 302 D 122 ASP A 177 ASP^? 8.44 MG MG A 302 coo 103.83 82.01 50.25 102.30 84.27 50.28 34.81 26.51 34.70 32.10 26.95 34.06 coo 104.67 87.04 47.86 104.93 85.42 46.57 34.91 23.57 39.32 34.35 24.95 40.81 coo 108.03 83.30 43.35 106.06 83.62 44.11 33.02 29.04 43.18 33.79 27.88 44.78 ULMN 3 1e2t_c03 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 3 3 # 3 D 69 CYH B 152 CYH^? 14.66 MG MG B 301 D 107 HIS B 170 HIS^? 10.51 MG MG B 301 D 122 ASP B 148 ASP^? 2.58 MG MG B 302s coo 103.83 82.01 50.25 102.30 84.27 50.28 48.74 12.82 1.93 48.51 10.17 2.19 coo 104.67 87.04 47.86 104.93 85.42 46.57 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 108.03 83.30 43.35 106.06 83.62 44.11 52.73 19.23 -3.77 53.81 20.99 -4.31 ULMN 3 1e2t_c03 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 4 3 # 4 D 69 CYH B 152 CYH^? 14.66 MG MG B 301 D 107 HIS B 170 HIS^? 10.51 MG MG B 301 D 122 ASP B 177 ASP^? 9.03 MG MG B 301 coo 103.83 82.01 50.25 102.30 84.27 50.28 48.74 12.82 1.93 48.51 10.17 2.19 coo 104.67 87.04 47.86 104.93 85.42 46.57 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 108.03 83.30 43.35 106.06 83.62 44.11 51.97 11.04 -6.64 50.39 11.62 -7.94 ULMN 3 1e2t_c03 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 5 3 # 5 D 69 CYH C 152 CYH^? 14.61 MG MG C 301 D 107 HIS C 170 HIS^? 10.68 MG MG C 301 D 122 ASP C 148 ASP^? 2.75 MG MG C 302s coo 103.83 82.01 50.25 102.30 84.27 50.28 87.66 19.43 -8.58 88.77 17.04 -8.78 coo 104.67 87.04 47.86 104.93 85.42 46.57 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 108.03 83.30 43.35 106.06 83.62 44.11 81.96 23.83 -2.68 80.24 25.11 -2.27 ULMN 3 1e2t_c03 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 6 3 # 6 D 69 CYH C 152 CYH^? 14.61 MG MG C 301 D 107 HIS C 170 HIS^? 10.68 MG MG C 301 D 122 ASP C 177 ASP^? 8.84 MG MG C 301 coo 103.83 82.01 50.25 102.30 84.27 50.28 87.66 19.43 -8.58 88.77 17.04 -8.78 coo 104.67 87.04 47.86 104.93 85.42 46.57 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 108.03 83.30 43.35 106.06 83.62 44.11 85.60 16.42 -0.31 86.51 17.71 1.09 ULMN 3 1e2t_c03 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 7 3 # 7 D 69 CYH D 152 CYH^? 14.66 MG MG D 301 D 107 HIS D 170 HIS^? 10.59 MG MG D 301 D 122 ASP D 148 ASP^? 2.35 MG MG D 302s coo 103.83 82.01 50.25 102.30 84.27 50.28 94.69 37.43 -41.36 96.92 38.83 -40.94 coo 104.67 87.04 47.86 104.93 85.42 46.57 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 108.03 83.30 43.35 106.06 83.62 44.11 87.78 37.50 -47.56 85.79 37.49 -48.28 ULMN 3 1e2t_c03 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 8 3 # 8 D 69 CYH D 152 CYH^? 14.66 MG MG D 301 D 107 HIS D 170 HIS^? 10.59 MG MG D 301 D 122 ASP D 177 ASP^? 8.43 MG MG D 301 coo 103.83 82.01 50.25 102.30 84.27 50.28 94.69 37.43 -41.36 96.92 38.83 -40.94 coo 104.67 87.04 47.86 104.93 85.42 46.57 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 108.03 83.30 43.35 106.06 83.62 44.11 95.74 41.01 -49.76 94.81 39.90 -51.24 ULMN 3 1e2t_c03 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 9 3 # 9 D 69 CYH E 152 CYH^? 14.64 MG MG E 301 D 107 HIS E 170 HIS^? 10.33 MG MG E 301 D 122 ASP E 148 ASP^? 2.62 MG MG E 302s coo 103.83 82.01 50.25 102.30 84.27 50.28 69.49 67.27 -53.54 71.02 69.50 -54.03 coo 104.67 87.04 47.86 104.93 85.42 46.57 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 108.03 83.30 43.35 106.06 83.62 44.11 68.29 60.44 -47.29 68.03 58.42 -46.50 ULMN 3 1e2t_c03 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 10 3 # 10 D 69 CYH E 152 CYH^? 14.64 MG MG E 301 D 107 HIS E 170 HIS^? 10.33 MG MG E 301 D 122 ASP E 177 ASP^? 8.55 MG MG E 301 coo 103.83 82.01 50.25 102.30 84.27 50.28 69.49 67.27 -53.54 71.02 69.50 -54.03 coo 104.67 87.04 47.86 104.93 85.42 46.57 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 108.03 83.30 43.35 106.06 83.62 44.11 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 1e2t_c03 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 11 3 # 11 D 69 CYH F 152 CYH^? 14.14 MG MG F 302 D 107 HIS F 170 HIS^? 9.84 MG MG F 302 D 122 ASP F 148 ASP^? 2.72 MG MG F 301s coo 103.83 82.01 50.25 102.30 84.27 50.28 50.28 62.76 -86.08 48.12 64.34 -85.77 coo 104.67 87.04 47.86 104.93 85.42 46.57 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 108.03 83.30 43.35 106.06 83.62 44.11 53.64 56.47 -91.98 54.61 54.68 -92.64 ULMN 3 1e2t_c03 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 12 3 # 12 D 69 CYH F 152 CYH^? 14.14 MG MG F 302 D 107 HIS F 170 HIS^? 9.84 MG MG F 302 D 122 ASP F 177 ASP^? 8.15 MG MG F 302 coo 103.83 82.01 50.25 102.30 84.27 50.28 50.28 62.76 -86.08 48.12 64.34 -85.77 coo 104.67 87.04 47.86 104.93 85.42 46.57 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 108.03 83.30 43.35 106.06 83.62 44.11 47.18 61.22 -94.50 48.48 62.32 -95.73 1e2t_c03 source 1e2t N-HYDROXYARYLAMINE O-ACETYLTRANSFERASE : 12 hits 1e2t_c03 naa= 3 ULMN 3 1e2t_c04 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 1 3 # 1 E 69 CYH A 152 CYH^? 15.18 MG MG A 302 E 107 HIS A 170 HIS^? 10.56 MG MG A 302 E 122 ASP A 148 ASP^? 2.72 MG MG A 301s coo 26.92 104.93 15.26 26.00 102.32 15.14 34.81 26.51 34.70 32.10 26.95 34.06 coo 21.83 102.75 16.48 21.72 104.53 15.38 34.91 23.57 39.32 34.35 24.95 40.81 coo 19.90 109.15 15.39 20.77 107.51 14.36 41.50 28.88 41.13 43.33 29.67 41.93 ULMN 3 1e2t_c04 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 2 3 # 2 E 69 CYH A 152 CYH^? 15.18 MG MG A 302 E 107 HIS A 170 HIS^? 10.56 MG MG A 302 E 122 ASP A 177 ASP^? 8.44 MG MG A 302 coo 26.92 104.93 15.26 26.00 102.32 15.14 34.81 26.51 34.70 32.10 26.95 34.06 coo 21.83 102.75 16.48 21.72 104.53 15.38 34.91 23.57 39.32 34.35 24.95 40.81 coo 19.90 109.15 15.39 20.77 107.51 14.36 33.02 29.04 43.18 33.79 27.88 44.78 ULMN 3 1e2t_c04 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 3 3 # 3 E 69 CYH B 152 CYH^? 14.66 MG MG B 301 E 107 HIS B 170 HIS^? 10.51 MG MG B 301 E 122 ASP B 148 ASP^? 2.58 MG MG B 302s coo 26.92 104.93 15.26 26.00 102.32 15.14 48.74 12.82 1.93 48.51 10.17 2.19 coo 21.83 102.75 16.48 21.72 104.53 15.38 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 19.90 109.15 15.39 20.77 107.51 14.36 52.73 19.23 -3.77 53.81 20.99 -4.31 ULMN 3 1e2t_c04 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 4 3 # 4 E 69 CYH B 152 CYH^? 14.66 MG MG B 301 E 107 HIS B 170 HIS^? 10.51 MG MG B 301 E 122 ASP B 177 ASP^? 9.03 MG MG B 301 coo 26.92 104.93 15.26 26.00 102.32 15.14 48.74 12.82 1.93 48.51 10.17 2.19 coo 21.83 102.75 16.48 21.72 104.53 15.38 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 19.90 109.15 15.39 20.77 107.51 14.36 51.97 11.04 -6.64 50.39 11.62 -7.94 ULMN 3 1e2t_c04 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 5 3 # 5 E 69 CYH C 152 CYH^? 14.61 MG MG C 301 E 107 HIS C 170 HIS^? 10.68 MG MG C 301 E 122 ASP C 148 ASP^? 2.75 MG MG C 302s coo 26.92 104.93 15.26 26.00 102.32 15.14 87.66 19.43 -8.58 88.77 17.04 -8.78 coo 21.83 102.75 16.48 21.72 104.53 15.38 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 19.90 109.15 15.39 20.77 107.51 14.36 81.96 23.83 -2.68 80.24 25.11 -2.27 ULMN 3 1e2t_c04 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 6 3 # 6 E 69 CYH C 152 CYH^? 14.61 MG MG C 301 E 107 HIS C 170 HIS^? 10.68 MG MG C 301 E 122 ASP C 177 ASP^? 8.84 MG MG C 301 coo 26.92 104.93 15.26 26.00 102.32 15.14 87.66 19.43 -8.58 88.77 17.04 -8.78 coo 21.83 102.75 16.48 21.72 104.53 15.38 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 19.90 109.15 15.39 20.77 107.51 14.36 85.60 16.42 -0.31 86.51 17.71 1.09 ULMN 3 1e2t_c04 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 7 3 # 7 E 69 CYH D 152 CYH^? 14.66 MG MG D 301 E 107 HIS D 170 HIS^? 10.59 MG MG D 301 E 122 ASP D 148 ASP^? 2.35 MG MG D 302s coo 26.92 104.93 15.26 26.00 102.32 15.14 94.69 37.43 -41.36 96.92 38.83 -40.94 coo 21.83 102.75 16.48 21.72 104.53 15.38 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 19.90 109.15 15.39 20.77 107.51 14.36 87.78 37.50 -47.56 85.79 37.49 -48.28 ULMN 3 1e2t_c04 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 8 3 # 8 E 69 CYH D 152 CYH^? 14.66 MG MG D 301 E 107 HIS D 170 HIS^? 10.59 MG MG D 301 E 122 ASP D 177 ASP^? 8.43 MG MG D 301 coo 26.92 104.93 15.26 26.00 102.32 15.14 94.69 37.43 -41.36 96.92 38.83 -40.94 coo 21.83 102.75 16.48 21.72 104.53 15.38 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 19.90 109.15 15.39 20.77 107.51 14.36 95.74 41.01 -49.76 94.81 39.90 -51.24 ULMN 3 1e2t_c04 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 9 3 # 9 E 69 CYH E 152 CYH^? 14.64 MG MG E 301 E 107 HIS E 170 HIS^? 10.33 MG MG E 301 E 122 ASP E 148 ASP^? 2.62 MG MG E 302s coo 26.92 104.93 15.26 26.00 102.32 15.14 69.49 67.27 -53.54 71.02 69.50 -54.03 coo 21.83 102.75 16.48 21.72 104.53 15.38 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 19.90 109.15 15.39 20.77 107.51 14.36 68.29 60.44 -47.29 68.03 58.42 -46.50 ULMN 3 1e2t_c04 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 10 3 # 10 E 69 CYH E 152 CYH^? 14.64 MG MG E 301 E 107 HIS E 170 HIS^? 10.33 MG MG E 301 E 122 ASP E 177 ASP^? 8.55 MG MG E 301 coo 26.92 104.93 15.26 26.00 102.32 15.14 69.49 67.27 -53.54 71.02 69.50 -54.03 coo 21.83 102.75 16.48 21.72 104.53 15.38 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 19.90 109.15 15.39 20.77 107.51 14.36 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 1e2t_c04 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 11 3 # 11 E 69 CYH F 152 CYH^? 14.14 MG MG F 302 E 107 HIS F 170 HIS^? 9.84 MG MG F 302 E 122 ASP F 148 ASP^? 2.72 MG MG F 301s coo 26.92 104.93 15.26 26.00 102.32 15.14 50.28 62.76 -86.08 48.12 64.34 -85.77 coo 21.83 102.75 16.48 21.72 104.53 15.38 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 19.90 109.15 15.39 20.77 107.51 14.36 53.64 56.47 -91.98 54.61 54.68 -92.64 ULMN 3 1e2t_c04 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 12 3 # 12 E 69 CYH F 152 CYH^? 14.14 MG MG F 302 E 107 HIS F 170 HIS^? 9.84 MG MG F 302 E 122 ASP F 177 ASP^? 8.15 MG MG F 302 coo 26.92 104.93 15.26 26.00 102.32 15.14 50.28 62.76 -86.08 48.12 64.34 -85.77 coo 21.83 102.75 16.48 21.72 104.53 15.38 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 19.90 109.15 15.39 20.77 107.51 14.36 47.18 61.22 -94.50 48.48 62.32 -95.73 1e2t_c04 source 1e2t N-HYDROXYARYLAMINE O-ACETYLTRANSFERASE : 12 hits 1e2t_c04 naa= 3 ULMN 3 1e2t_c05 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 1 3 # 1 F 69 CYH A 152 CYH^? 15.18 MG MG A 302 F 107 HIS A 170 HIS^? 10.56 MG MG A 302 F 122 ASP A 148 ASP^? 2.72 MG MG A 301s coo 61.95 90.52 15.40 60.72 88.41 16.77 34.81 26.51 34.70 32.10 26.95 34.06 coo 64.03 85.31 15.74 65.44 86.77 16.21 34.91 23.57 39.32 34.35 24.95 40.81 coo 69.94 88.54 14.99 68.36 88.38 16.36 41.50 28.88 41.13 43.33 29.67 41.93 ULMN 3 1e2t_c05 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 2 3 # 2 F 69 CYH A 152 CYH^? 15.18 MG MG A 302 F 107 HIS A 170 HIS^? 10.56 MG MG A 302 F 122 ASP A 177 ASP^? 8.44 MG MG A 302 coo 61.95 90.52 15.40 60.72 88.41 16.77 34.81 26.51 34.70 32.10 26.95 34.06 coo 64.03 85.31 15.74 65.44 86.77 16.21 34.91 23.57 39.32 34.35 24.95 40.81 coo 69.94 88.54 14.99 68.36 88.38 16.36 33.02 29.04 43.18 33.79 27.88 44.78 ULMN 3 1e2t_c05 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 3 3 # 3 F 69 CYH B 152 CYH^? 14.66 MG MG B 301 F 107 HIS B 170 HIS^? 10.51 MG MG B 301 F 122 ASP B 148 ASP^? 2.58 MG MG B 302s coo 61.95 90.52 15.40 60.72 88.41 16.77 48.74 12.82 1.93 48.51 10.17 2.19 coo 64.03 85.31 15.74 65.44 86.77 16.21 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 69.94 88.54 14.99 68.36 88.38 16.36 52.73 19.23 -3.77 53.81 20.99 -4.31 ULMN 3 1e2t_c05 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 4 3 # 4 F 69 CYH B 152 CYH^? 14.66 MG MG B 301 F 107 HIS B 170 HIS^? 10.51 MG MG B 301 F 122 ASP B 177 ASP^? 9.03 MG MG B 301 coo 61.95 90.52 15.40 60.72 88.41 16.77 48.74 12.82 1.93 48.51 10.17 2.19 coo 64.03 85.31 15.74 65.44 86.77 16.21 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 69.94 88.54 14.99 68.36 88.38 16.36 51.97 11.04 -6.64 50.39 11.62 -7.94 ULMN 3 1e2t_c05 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 5 3 # 5 F 69 CYH C 152 CYH^? 14.61 MG MG C 301 F 107 HIS C 170 HIS^? 10.68 MG MG C 301 F 122 ASP C 148 ASP^? 2.75 MG MG C 302s coo 61.95 90.52 15.40 60.72 88.41 16.77 87.66 19.43 -8.58 88.77 17.04 -8.78 coo 64.03 85.31 15.74 65.44 86.77 16.21 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 69.94 88.54 14.99 68.36 88.38 16.36 81.96 23.83 -2.68 80.24 25.11 -2.27 ULMN 3 1e2t_c05 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 6 3 # 6 F 69 CYH C 152 CYH^? 14.61 MG MG C 301 F 107 HIS C 170 HIS^? 10.68 MG MG C 301 F 122 ASP C 177 ASP^? 8.84 MG MG C 301 coo 61.95 90.52 15.40 60.72 88.41 16.77 87.66 19.43 -8.58 88.77 17.04 -8.78 coo 64.03 85.31 15.74 65.44 86.77 16.21 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 69.94 88.54 14.99 68.36 88.38 16.36 85.60 16.42 -0.31 86.51 17.71 1.09 ULMN 3 1e2t_c05 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 7 3 # 7 F 69 CYH D 152 CYH^? 14.66 MG MG D 301 F 107 HIS D 170 HIS^? 10.59 MG MG D 301 F 122 ASP D 148 ASP^? 2.35 MG MG D 302s coo 61.95 90.52 15.40 60.72 88.41 16.77 94.69 37.43 -41.36 96.92 38.83 -40.94 coo 64.03 85.31 15.74 65.44 86.77 16.21 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 69.94 88.54 14.99 68.36 88.38 16.36 87.78 37.50 -47.56 85.79 37.49 -48.28 ULMN 3 1e2t_c05 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 8 3 # 8 F 69 CYH D 152 CYH^? 14.66 MG MG D 301 F 107 HIS D 170 HIS^? 10.59 MG MG D 301 F 122 ASP D 177 ASP^? 8.43 MG MG D 301 coo 61.95 90.52 15.40 60.72 88.41 16.77 94.69 37.43 -41.36 96.92 38.83 -40.94 coo 64.03 85.31 15.74 65.44 86.77 16.21 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 69.94 88.54 14.99 68.36 88.38 16.36 95.74 41.01 -49.76 94.81 39.90 -51.24 ULMN 3 1e2t_c05 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 9 3 # 9 F 69 CYH E 152 CYH^? 14.64 MG MG E 301 F 107 HIS E 170 HIS^? 10.33 MG MG E 301 F 122 ASP E 148 ASP^? 2.62 MG MG E 302s coo 61.95 90.52 15.40 60.72 88.41 16.77 69.49 67.27 -53.54 71.02 69.50 -54.03 coo 64.03 85.31 15.74 65.44 86.77 16.21 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 69.94 88.54 14.99 68.36 88.38 16.36 68.29 60.44 -47.29 68.03 58.42 -46.50 ULMN 3 1e2t_c05 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 10 3 # 10 F 69 CYH E 152 CYH^? 14.64 MG MG E 301 F 107 HIS E 170 HIS^? 10.33 MG MG E 301 F 122 ASP E 177 ASP^? 8.55 MG MG E 301 coo 61.95 90.52 15.40 60.72 88.41 16.77 69.49 67.27 -53.54 71.02 69.50 -54.03 coo 64.03 85.31 15.74 65.44 86.77 16.21 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 69.94 88.54 14.99 68.36 88.38 16.36 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 1e2t_c05 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 11 3 # 11 F 69 CYH F 152 CYH^? 14.14 MG MG F 302 F 107 HIS F 170 HIS^? 9.84 MG MG F 302 F 122 ASP F 148 ASP^? 2.72 MG MG F 301s coo 61.95 90.52 15.40 60.72 88.41 16.77 50.28 62.76 -86.08 48.12 64.34 -85.77 coo 64.03 85.31 15.74 65.44 86.77 16.21 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 69.94 88.54 14.99 68.36 88.38 16.36 53.64 56.47 -91.98 54.61 54.68 -92.64 ULMN 3 1e2t_c05 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 12 3 # 12 F 69 CYH F 152 CYH^? 14.14 MG MG F 302 F 107 HIS F 170 HIS^? 9.84 MG MG F 302 F 122 ASP F 177 ASP^? 8.15 MG MG F 302 coo 61.95 90.52 15.40 60.72 88.41 16.77 50.28 62.76 -86.08 48.12 64.34 -85.77 coo 64.03 85.31 15.74 65.44 86.77 16.21 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 69.94 88.54 14.99 68.36 88.38 16.36 47.18 61.22 -94.50 48.48 62.32 -95.73 1e2t_c05 source 1e2t N-HYDROXYARYLAMINE O-ACETYLTRANSFERASE : 12 hits 1e2t_c05 naa= 3 ULMN 3 1e2t_c06 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 1 3 # 1 G 69 CYH A 152 CYH^? 15.18 MG MG A 302 G 107 HIS A 170 HIS^? 10.56 MG MG A 302 G 122 ASP A 148 ASP^? 2.72 MG MG A 301s coo 29.36 85.15 35.54 31.07 87.28 35.30 34.81 26.51 34.70 32.10 26.95 34.06 coo 28.98 90.29 37.87 28.74 88.77 39.28 34.91 23.57 39.32 34.35 24.95 40.81 coo 25.53 86.86 42.58 27.46 86.99 41.71 41.50 28.88 41.13 43.33 29.67 41.93 ULMN 3 1e2t_c06 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 2 3 # 2 G 69 CYH A 152 CYH^? 15.18 MG MG A 302 G 107 HIS A 170 HIS^? 10.56 MG MG A 302 G 122 ASP A 177 ASP^? 8.44 MG MG A 302 coo 29.36 85.15 35.54 31.07 87.28 35.30 34.81 26.51 34.70 32.10 26.95 34.06 coo 28.98 90.29 37.87 28.74 88.77 39.28 34.91 23.57 39.32 34.35 24.95 40.81 coo 25.53 86.86 42.58 27.46 86.99 41.71 33.02 29.04 43.18 33.79 27.88 44.78 ULMN 3 1e2t_c06 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 3 3 # 3 G 69 CYH B 152 CYH^? 14.66 MG MG B 301 G 107 HIS B 170 HIS^? 10.51 MG MG B 301 G 122 ASP B 148 ASP^? 2.58 MG MG B 302s coo 29.36 85.15 35.54 31.07 87.28 35.30 48.74 12.82 1.93 48.51 10.17 2.19 coo 28.98 90.29 37.87 28.74 88.77 39.28 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 25.53 86.86 42.58 27.46 86.99 41.71 52.73 19.23 -3.77 53.81 20.99 -4.31 ULMN 3 1e2t_c06 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 4 3 # 4 G 69 CYH B 152 CYH^? 14.66 MG MG B 301 G 107 HIS B 170 HIS^? 10.51 MG MG B 301 G 122 ASP B 177 ASP^? 9.03 MG MG B 301 coo 29.36 85.15 35.54 31.07 87.28 35.30 48.74 12.82 1.93 48.51 10.17 2.19 coo 28.98 90.29 37.87 28.74 88.77 39.28 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 25.53 86.86 42.58 27.46 86.99 41.71 51.97 11.04 -6.64 50.39 11.62 -7.94 ULMN 3 1e2t_c06 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 5 3 # 5 G 69 CYH C 152 CYH^? 14.61 MG MG C 301 G 107 HIS C 170 HIS^? 10.68 MG MG C 301 G 122 ASP C 148 ASP^? 2.75 MG MG C 302s coo 29.36 85.15 35.54 31.07 87.28 35.30 87.66 19.43 -8.58 88.77 17.04 -8.78 coo 28.98 90.29 37.87 28.74 88.77 39.28 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 25.53 86.86 42.58 27.46 86.99 41.71 81.96 23.83 -2.68 80.24 25.11 -2.27 ULMN 3 1e2t_c06 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 6 3 # 6 G 69 CYH C 152 CYH^? 14.61 MG MG C 301 G 107 HIS C 170 HIS^? 10.68 MG MG C 301 G 122 ASP C 177 ASP^? 8.84 MG MG C 301 coo 29.36 85.15 35.54 31.07 87.28 35.30 87.66 19.43 -8.58 88.77 17.04 -8.78 coo 28.98 90.29 37.87 28.74 88.77 39.28 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 25.53 86.86 42.58 27.46 86.99 41.71 85.60 16.42 -0.31 86.51 17.71 1.09 ULMN 3 1e2t_c06 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 7 3 # 7 G 69 CYH D 152 CYH^? 14.66 MG MG D 301 G 107 HIS D 170 HIS^? 10.59 MG MG D 301 G 122 ASP D 148 ASP^? 2.35 MG MG D 302s coo 29.36 85.15 35.54 31.07 87.28 35.30 94.69 37.43 -41.36 96.92 38.83 -40.94 coo 28.98 90.29 37.87 28.74 88.77 39.28 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 25.53 86.86 42.58 27.46 86.99 41.71 87.78 37.50 -47.56 85.79 37.49 -48.28 ULMN 3 1e2t_c06 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 8 3 # 8 G 69 CYH D 152 CYH^? 14.66 MG MG D 301 G 107 HIS D 170 HIS^? 10.59 MG MG D 301 G 122 ASP D 177 ASP^? 8.43 MG MG D 301 coo 29.36 85.15 35.54 31.07 87.28 35.30 94.69 37.43 -41.36 96.92 38.83 -40.94 coo 28.98 90.29 37.87 28.74 88.77 39.28 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 25.53 86.86 42.58 27.46 86.99 41.71 95.74 41.01 -49.76 94.81 39.90 -51.24 ULMN 3 1e2t_c06 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 9 3 # 9 G 69 CYH E 152 CYH^? 14.64 MG MG E 301 G 107 HIS E 170 HIS^? 10.33 MG MG E 301 G 122 ASP E 148 ASP^? 2.62 MG MG E 302s coo 29.36 85.15 35.54 31.07 87.28 35.30 69.49 67.27 -53.54 71.02 69.50 -54.03 coo 28.98 90.29 37.87 28.74 88.77 39.28 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 25.53 86.86 42.58 27.46 86.99 41.71 68.29 60.44 -47.29 68.03 58.42 -46.50 ULMN 3 1e2t_c06 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 10 3 # 10 G 69 CYH E 152 CYH^? 14.64 MG MG E 301 G 107 HIS E 170 HIS^? 10.33 MG MG E 301 G 122 ASP E 177 ASP^? 8.55 MG MG E 301 coo 29.36 85.15 35.54 31.07 87.28 35.30 69.49 67.27 -53.54 71.02 69.50 -54.03 coo 28.98 90.29 37.87 28.74 88.77 39.28 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 25.53 86.86 42.58 27.46 86.99 41.71 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 1e2t_c06 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 11 3 # 11 G 69 CYH F 152 CYH^? 14.14 MG MG F 302 G 107 HIS F 170 HIS^? 9.84 MG MG F 302 G 122 ASP F 148 ASP^? 2.72 MG MG F 301s coo 29.36 85.15 35.54 31.07 87.28 35.30 50.28 62.76 -86.08 48.12 64.34 -85.77 coo 28.98 90.29 37.87 28.74 88.77 39.28 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 25.53 86.86 42.58 27.46 86.99 41.71 53.64 56.47 -91.98 54.61 54.68 -92.64 ULMN 3 1e2t_c06 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 12 3 # 12 G 69 CYH F 152 CYH^? 14.14 MG MG F 302 G 107 HIS F 170 HIS^? 9.84 MG MG F 302 G 122 ASP F 177 ASP^? 8.15 MG MG F 302 coo 29.36 85.15 35.54 31.07 87.28 35.30 50.28 62.76 -86.08 48.12 64.34 -85.77 coo 28.98 90.29 37.87 28.74 88.77 39.28 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 25.53 86.86 42.58 27.46 86.99 41.71 47.18 61.22 -94.50 48.48 62.32 -95.73 1e2t_c06 source 1e2t N-HYDROXYARYLAMINE O-ACETYLTRANSFERASE : 12 hits 1e2t_c06 naa= 3 ULMN 3 1e2t_c07 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 1 3 # 1 H 69 CYH A 152 CYH^? 15.18 MG MG A 302 H 107 HIS A 170 HIS^? 10.56 MG MG A 302 H 122 ASP A 148 ASP^? 2.72 MG MG A 301s coo 44.08 72.69 2.52 44.26 75.30 1.64 34.81 26.51 34.70 32.10 26.95 34.06 coo 47.49 75.16 -1.32 46.47 73.52 -2.11 34.91 23.57 39.32 34.35 24.95 40.81 coo 47.09 69.01 -4.12 45.87 70.66 -3.64 41.50 28.88 41.13 43.33 29.67 41.93 ULMN 3 1e2t_c07 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 2 3 # 2 H 69 CYH A 152 CYH^? 15.18 MG MG A 302 H 107 HIS A 170 HIS^? 10.56 MG MG A 302 H 122 ASP A 177 ASP^? 8.44 MG MG A 302 coo 44.08 72.69 2.52 44.26 75.30 1.64 34.81 26.51 34.70 32.10 26.95 34.06 coo 47.49 75.16 -1.32 46.47 73.52 -2.11 34.91 23.57 39.32 34.35 24.95 40.81 coo 47.09 69.01 -4.12 45.87 70.66 -3.64 33.02 29.04 43.18 33.79 27.88 44.78 ULMN 3 1e2t_c07 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 3 3 # 3 H 69 CYH B 152 CYH^? 14.66 MG MG B 301 H 107 HIS B 170 HIS^? 10.51 MG MG B 301 H 122 ASP B 148 ASP^? 2.58 MG MG B 302s coo 44.08 72.69 2.52 44.26 75.30 1.64 48.74 12.82 1.93 48.51 10.17 2.19 coo 47.49 75.16 -1.32 46.47 73.52 -2.11 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 47.09 69.01 -4.12 45.87 70.66 -3.64 52.73 19.23 -3.77 53.81 20.99 -4.31 ULMN 3 1e2t_c07 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 4 3 # 4 H 69 CYH B 152 CYH^? 14.66 MG MG B 301 H 107 HIS B 170 HIS^? 10.51 MG MG B 301 H 122 ASP B 177 ASP^? 9.03 MG MG B 301 coo 44.08 72.69 2.52 44.26 75.30 1.64 48.74 12.82 1.93 48.51 10.17 2.19 coo 47.49 75.16 -1.32 46.47 73.52 -2.11 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 47.09 69.01 -4.12 45.87 70.66 -3.64 51.97 11.04 -6.64 50.39 11.62 -7.94 ULMN 3 1e2t_c07 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 5 3 # 5 H 69 CYH C 152 CYH^? 14.61 MG MG C 301 H 107 HIS C 170 HIS^? 10.68 MG MG C 301 H 122 ASP C 148 ASP^? 2.75 MG MG C 302s coo 44.08 72.69 2.52 44.26 75.30 1.64 87.66 19.43 -8.58 88.77 17.04 -8.78 coo 47.49 75.16 -1.32 46.47 73.52 -2.11 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 47.09 69.01 -4.12 45.87 70.66 -3.64 81.96 23.83 -2.68 80.24 25.11 -2.27 ULMN 3 1e2t_c07 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 6 3 # 6 H 69 CYH C 152 CYH^? 14.61 MG MG C 301 H 107 HIS C 170 HIS^? 10.68 MG MG C 301 H 122 ASP C 177 ASP^? 8.84 MG MG C 301 coo 44.08 72.69 2.52 44.26 75.30 1.64 87.66 19.43 -8.58 88.77 17.04 -8.78 coo 47.49 75.16 -1.32 46.47 73.52 -2.11 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 47.09 69.01 -4.12 45.87 70.66 -3.64 85.60 16.42 -0.31 86.51 17.71 1.09 ULMN 3 1e2t_c07 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 7 3 # 7 H 69 CYH D 152 CYH^? 14.66 MG MG D 301 H 107 HIS D 170 HIS^? 10.59 MG MG D 301 H 122 ASP D 148 ASP^? 2.35 MG MG D 302s coo 44.08 72.69 2.52 44.26 75.30 1.64 94.69 37.43 -41.36 96.92 38.83 -40.94 coo 47.49 75.16 -1.32 46.47 73.52 -2.11 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 47.09 69.01 -4.12 45.87 70.66 -3.64 87.78 37.50 -47.56 85.79 37.49 -48.28 ULMN 3 1e2t_c07 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 8 3 # 8 H 69 CYH D 152 CYH^? 14.66 MG MG D 301 H 107 HIS D 170 HIS^? 10.59 MG MG D 301 H 122 ASP D 177 ASP^? 8.43 MG MG D 301 coo 44.08 72.69 2.52 44.26 75.30 1.64 94.69 37.43 -41.36 96.92 38.83 -40.94 coo 47.49 75.16 -1.32 46.47 73.52 -2.11 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 47.09 69.01 -4.12 45.87 70.66 -3.64 95.74 41.01 -49.76 94.81 39.90 -51.24 ULMN 3 1e2t_c07 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 9 3 # 9 H 69 CYH E 152 CYH^? 14.64 MG MG E 301 H 107 HIS E 170 HIS^? 10.33 MG MG E 301 H 122 ASP E 148 ASP^? 2.62 MG MG E 302s coo 44.08 72.69 2.52 44.26 75.30 1.64 69.49 67.27 -53.54 71.02 69.50 -54.03 coo 47.49 75.16 -1.32 46.47 73.52 -2.11 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 47.09 69.01 -4.12 45.87 70.66 -3.64 68.29 60.44 -47.29 68.03 58.42 -46.50 ULMN 3 1e2t_c07 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 10 3 # 10 H 69 CYH E 152 CYH^? 14.64 MG MG E 301 H 107 HIS E 170 HIS^? 10.33 MG MG E 301 H 122 ASP E 177 ASP^? 8.55 MG MG E 301 coo 44.08 72.69 2.52 44.26 75.30 1.64 69.49 67.27 -53.54 71.02 69.50 -54.03 coo 47.49 75.16 -1.32 46.47 73.52 -2.11 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 47.09 69.01 -4.12 45.87 70.66 -3.64 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 1e2t_c07 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 11 3 # 11 H 69 CYH F 152 CYH^? 14.14 MG MG F 302 H 107 HIS F 170 HIS^? 9.84 MG MG F 302 H 122 ASP F 148 ASP^? 2.72 MG MG F 301s coo 44.08 72.69 2.52 44.26 75.30 1.64 50.28 62.76 -86.08 48.12 64.34 -85.77 coo 47.49 75.16 -1.32 46.47 73.52 -2.11 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 47.09 69.01 -4.12 45.87 70.66 -3.64 53.64 56.47 -91.98 54.61 54.68 -92.64 ULMN 3 1e2t_c07 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 12 3 # 12 H 69 CYH F 152 CYH^? 14.14 MG MG F 302 H 107 HIS F 170 HIS^? 9.84 MG MG F 302 H 122 ASP F 177 ASP^? 8.15 MG MG F 302 coo 44.08 72.69 2.52 44.26 75.30 1.64 50.28 62.76 -86.08 48.12 64.34 -85.77 coo 47.49 75.16 -1.32 46.47 73.52 -2.11 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 47.09 69.01 -4.12 45.87 70.66 -3.64 47.18 61.22 -94.50 48.48 62.32 -95.73 1e2t_c07 source 1e2t N-HYDROXYARYLAMINE O-ACETYLTRANSFERASE : 12 hits 1e2t_c07 naa= 3 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR A 129 TYR^? 10.90 MG MG A 301 A 40 ASP A 187 ASP^? -3.29 MG MG A 302s A 103 ASP A 128 ASP^? -3.32 MG MG A 301s coo 3.86 -20.80 85.74 4.58 -18.11 85.73 44.80 23.54 35.75 45.57 23.36 33.08 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 39.43 26.57 46.78 39.37 27.83 45.03 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 46.50 28.23 39.77 47.49 30.10 39.82 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 2 3 # 2 A 16 TYR A 129 TYR^? 10.90 MG MG A 301 A 40 ASP A 187 ASP^? -3.29 MG MG A 302s A 103 ASP A 148 ASP^? 2.72 MG MG A 301s coo 3.86 -20.80 85.74 4.58 -18.11 85.73 44.80 23.54 35.75 45.57 23.36 33.08 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 39.43 26.57 46.78 39.37 27.83 45.03 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 41.50 28.88 41.13 43.33 29.67 41.93 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 3 3 # 3 A 16 TYR A 188 TYR^? 8.73 MG MG A 302 A 40 ASP A 171 ASP^? 17.17 MG MG A 302 A 103 ASP A 177 ASP^? 8.44 MG MG A 302 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 37.17 23.04 44.09 34.69 24.12 44.73 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 29.78 23.67 36.63 28.48 25.11 35.71 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 33.02 29.04 43.18 33.79 27.88 44.78 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 4 3 # 4 A 16 TYR B 129 TYR^? 10.63 MG MG B 302 A 40 ASP B 187 ASP^? -3.44 MG MG B 301s A 103 ASP B 128 ASP^? -3.57 MG MG B 302s coo 3.86 -20.80 85.74 4.58 -18.11 85.73 47.85 23.00 1.51 47.62 23.50 4.24 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 50.64 18.14 -9.69 51.74 17.63 -7.86 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 52.92 24.09 -2.19 54.73 25.14 -1.90 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 5 3 # 5 A 16 TYR B 188 TYR^? 8.84 MG MG B 301 A 40 ASP B 171 ASP^? 16.92 MG MG B 301 A 103 ASP B 177 ASP^? 9.03 MG MG B 301 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 46.41 16.35 -7.52 47.38 13.88 -8.38 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 45.30 8.50 -0.71 46.30 6.81 0.12 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 51.97 11.04 -6.64 50.39 11.62 -7.94 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 6 3 # 6 A 16 TYR C 129 TYR^? 10.65 MG MG C 302 A 40 ASP C 187 ASP^? -3.72 MG MG C 301s A 103 ASP C 128 ASP^? -3.22 MG MG C 302s coo 3.86 -20.80 85.74 4.58 -18.11 85.73 84.95 29.43 -7.96 85.04 30.16 -10.69 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 84.01 23.73 3.39 83.47 22.54 1.59 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 80.05 28.39 -4.25 77.97 28.60 -4.21 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 7 3 # 7 A 16 TYR C 129 TYR^? 10.65 MG MG C 302 A 40 ASP C 187 ASP^? -3.72 MG MG C 301s A 103 ASP C 148 ASP^? 2.75 MG MG C 302s coo 3.86 -20.80 85.74 4.58 -18.11 85.73 84.95 29.43 -7.96 85.04 30.16 -10.69 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 84.01 23.73 3.39 83.47 22.54 1.59 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 81.96 23.83 -2.68 80.24 25.11 -2.27 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 8 3 # 8 A 16 TYR C 188 TYR^? 8.98 MG MG C 301 A 40 ASP C 128 ASP^? -3.22 MG MG C 302s A 103 ASP C 187 ASP^? -3.72 MG MG C 301s coo 3.86 -20.80 85.74 4.58 -18.11 85.73 88.74 23.30 0.93 88.91 20.61 1.57 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 84.01 23.73 3.39 83.47 22.54 1.59 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 9 3 # 9 A 16 TYR C 188 TYR^? 8.98 MG MG C 301 A 40 ASP C 171 ASP^? 17.08 MG MG C 301 A 103 ASP C 177 ASP^? 8.84 MG MG C 301 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 88.74 23.30 0.93 88.91 20.61 1.57 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 85.60 16.42 -0.31 86.51 17.71 1.09 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 10 3 # 10 A 16 TYR D 129 TYR^? 10.79 MG MG D 302 A 40 ASP D 187 ASP^? -2.95 MG MG D 301s A 103 ASP D 128 ASP^? -3.70 MG MG D 302s coo 3.86 -20.80 85.74 4.58 -18.11 85.73 86.45 31.36 -42.20 86.02 30.90 -39.46 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 90.40 36.34 -52.69 89.24 37.98 -51.99 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 83.33 35.45 -46.13 81.57 36.63 -46.10 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 11 3 # 11 A 16 TYR D 188 TYR^? 8.87 MG MG D 301 A 40 ASP D 171 ASP^? 16.95 MG MG D 301 A 103 ASP D 177 ASP^? 8.43 MG MG D 301 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 93.72 33.91 -50.86 95.36 36.03 -51.61 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 95.74 41.01 -49.76 94.81 39.90 -51.24 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 12 3 # 12 A 16 TYR E 129 TYR^? 10.89 MG MG E 302 A 40 ASP E 187 ASP^? -2.71 MG MG E 301s A 103 ASP E 128 ASP^? -3.53 MG MG E 302s coo 3.86 -20.80 85.74 4.58 -18.11 85.73 62.09 60.15 -52.83 61.47 59.53 -55.45 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 67.50 63.43 -41.69 68.97 62.26 -42.81 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 65.38 56.57 -48.58 66.15 54.57 -48.61 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 13 3 # 13 A 16 TYR E 188 TYR^? 8.62 MG MG E 301 A 40 ASP E 171 ASP^? 16.73 MG MG E 301 A 103 ASP E 177 ASP^? 8.55 MG MG E 301 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 65.58 67.09 -44.08 67.82 68.57 -43.41 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 14 3 # 14 A 16 TYR F 129 TYR^? 10.92 MG MG F 301 A 40 ASP F 187 ASP^? -3.27 MG MG F 302s A 103 ASP F 128 ASP^? -3.41 MG MG F 301s coo 3.86 -20.80 85.74 4.58 -18.11 85.73 59.69 58.61 -86.67 60.36 58.48 -83.96 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 53.93 58.87 -98.14 52.45 58.62 -96.61 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 57.76 53.73 -90.50 57.46 51.64 -90.28 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 15 3 # 15 A 16 TYR F 129 TYR^? 10.92 MG MG F 301 A 40 ASP F 187 ASP^? -3.27 MG MG F 302s A 103 ASP F 148 ASP^? 2.72 MG MG F 301s coo 3.86 -20.80 85.74 4.58 -18.11 85.73 59.69 58.61 -86.67 60.36 58.48 -83.96 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 53.93 58.87 -98.14 52.45 58.62 -96.61 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 53.64 56.47 -91.98 54.61 54.68 -92.64 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 16 3 # 16 A 16 TYR F 188 TYR^? 8.06 MG MG F 302 A 40 ASP F 128 ASP^? -3.41 MG MG F 301s A 103 ASP F 187 ASP^? -3.27 MG MG F 302s coo 3.86 -20.80 85.74 4.58 -18.11 85.73 54.23 63.50 -95.64 51.58 63.66 -96.35 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 57.76 53.73 -90.50 57.46 51.64 -90.28 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 53.93 58.87 -98.14 52.45 58.62 -96.61 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 17 3 # 17 A 16 TYR F 188 TYR^? 8.06 MG MG F 302 A 40 ASP F 171 ASP^? 16.35 MG MG F 302 A 103 ASP F 177 ASP^? 8.15 MG MG F 302 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 54.23 63.50 -95.64 51.58 63.66 -96.35 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 47.18 61.22 -94.50 48.48 62.32 -95.73 1e3v_c02 source 1e3v STEROID DELTA-ISOMERASE : 17 hits 1e3v_c02 naa= 3 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR A 129 TYR^? 10.90 MG MG A 301 B 40 ASP A 187 ASP^? -3.29 MG MG A 302s B 103 ASP A 128 ASP^? -3.32 MG MG A 301s coo 4.95 -16.38 58.56 5.78 -19.05 58.68 44.80 23.54 35.75 45.57 23.36 33.08 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 39.43 26.57 46.78 39.37 27.83 45.03 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 46.50 28.23 39.77 47.49 30.10 39.82 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 2 3 # 2 B 16 TYR A 188 TYR^? 8.73 MG MG A 302 B 40 ASP A 171 ASP^? 17.17 MG MG A 302 B 103 ASP A 177 ASP^? 8.44 MG MG A 302 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 37.17 23.04 44.09 34.69 24.12 44.73 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 29.78 23.67 36.63 28.48 25.11 35.71 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 33.02 29.04 43.18 33.79 27.88 44.78 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 3 3 # 3 B 16 TYR B 129 TYR^? 10.63 MG MG B 302 B 40 ASP B 187 ASP^? -3.44 MG MG B 301s B 103 ASP B 128 ASP^? -3.57 MG MG B 302s coo 4.95 -16.38 58.56 5.78 -19.05 58.68 47.85 23.00 1.51 47.62 23.50 4.24 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 50.64 18.14 -9.69 51.74 17.63 -7.86 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 52.92 24.09 -2.19 54.73 25.14 -1.90 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 4 3 # 4 B 16 TYR B 188 TYR^? 8.84 MG MG B 301 B 40 ASP B 171 ASP^? 16.92 MG MG B 301 B 103 ASP B 177 ASP^? 9.03 MG MG B 301 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 46.41 16.35 -7.52 47.38 13.88 -8.38 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 45.30 8.50 -0.71 46.30 6.81 0.12 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 51.97 11.04 -6.64 50.39 11.62 -7.94 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 5 3 # 5 B 16 TYR C 129 TYR^? 10.65 MG MG C 302 B 40 ASP C 187 ASP^? -3.72 MG MG C 301s B 103 ASP C 128 ASP^? -3.22 MG MG C 302s coo 4.95 -16.38 58.56 5.78 -19.05 58.68 84.95 29.43 -7.96 85.04 30.16 -10.69 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 84.01 23.73 3.39 83.47 22.54 1.59 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 80.05 28.39 -4.25 77.97 28.60 -4.21 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 6 3 # 6 B 16 TYR C 188 TYR^? 8.98 MG MG C 301 B 40 ASP C 128 ASP^? -3.22 MG MG C 302s B 103 ASP C 187 ASP^? -3.72 MG MG C 301s coo 4.95 -16.38 58.56 5.78 -19.05 58.68 88.74 23.30 0.93 88.91 20.61 1.57 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 84.01 23.73 3.39 83.47 22.54 1.59 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 7 3 # 7 B 16 TYR C 188 TYR^? 8.98 MG MG C 301 B 40 ASP C 171 ASP^? 17.08 MG MG C 301 B 103 ASP C 177 ASP^? 8.84 MG MG C 301 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 88.74 23.30 0.93 88.91 20.61 1.57 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 85.60 16.42 -0.31 86.51 17.71 1.09 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 8 3 # 8 B 16 TYR D 129 TYR^? 10.79 MG MG D 302 B 40 ASP D 187 ASP^? -2.95 MG MG D 301s B 103 ASP D 128 ASP^? -3.70 MG MG D 302s coo 4.95 -16.38 58.56 5.78 -19.05 58.68 86.45 31.36 -42.20 86.02 30.90 -39.46 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 90.40 36.34 -52.69 89.24 37.98 -51.99 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 83.33 35.45 -46.13 81.57 36.63 -46.10 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 9 3 # 9 B 16 TYR D 188 TYR^? 8.87 MG MG D 301 B 40 ASP D 171 ASP^? 16.95 MG MG D 301 B 103 ASP D 177 ASP^? 8.43 MG MG D 301 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 93.72 33.91 -50.86 95.36 36.03 -51.61 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 95.74 41.01 -49.76 94.81 39.90 -51.24 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 10 3 # 10 B 16 TYR E 129 TYR^? 10.89 MG MG E 302 B 40 ASP E 187 ASP^? -2.71 MG MG E 301s B 103 ASP E 128 ASP^? -3.53 MG MG E 302s coo 4.95 -16.38 58.56 5.78 -19.05 58.68 62.09 60.15 -52.83 61.47 59.53 -55.45 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 67.50 63.43 -41.69 68.97 62.26 -42.81 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 65.38 56.57 -48.58 66.15 54.57 -48.61 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 11 3 # 11 B 16 TYR E 188 TYR^? 8.62 MG MG E 301 B 40 ASP E 171 ASP^? 16.73 MG MG E 301 B 103 ASP E 177 ASP^? 8.55 MG MG E 301 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 65.58 67.09 -44.08 67.82 68.57 -43.41 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 12 3 # 12 B 16 TYR F 129 TYR^? 10.92 MG MG F 301 B 40 ASP F 187 ASP^? -3.27 MG MG F 302s B 103 ASP F 128 ASP^? -3.41 MG MG F 301s coo 4.95 -16.38 58.56 5.78 -19.05 58.68 59.69 58.61 -86.67 60.36 58.48 -83.96 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 53.93 58.87 -98.14 52.45 58.62 -96.61 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 57.76 53.73 -90.50 57.46 51.64 -90.28 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 13 3 # 13 B 16 TYR F 129 TYR^? 10.92 MG MG F 301 B 40 ASP F 187 ASP^? -3.27 MG MG F 302s B 103 ASP F 148 ASP^? 2.72 MG MG F 301s coo 4.95 -16.38 58.56 5.78 -19.05 58.68 59.69 58.61 -86.67 60.36 58.48 -83.96 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 53.93 58.87 -98.14 52.45 58.62 -96.61 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 53.64 56.47 -91.98 54.61 54.68 -92.64 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 14 3 # 14 B 16 TYR F 188 TYR^? 8.06 MG MG F 302 B 40 ASP F 128 ASP^? -3.41 MG MG F 301s B 103 ASP F 187 ASP^? -3.27 MG MG F 302s coo 4.95 -16.38 58.56 5.78 -19.05 58.68 54.23 63.50 -95.64 51.58 63.66 -96.35 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 57.76 53.73 -90.50 57.46 51.64 -90.28 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 53.93 58.87 -98.14 52.45 58.62 -96.61 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 15 3 # 15 B 16 TYR F 188 TYR^? 8.06 MG MG F 302 B 40 ASP F 171 ASP^? 16.35 MG MG F 302 B 103 ASP F 177 ASP^? 8.15 MG MG F 302 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 54.23 63.50 -95.64 51.58 63.66 -96.35 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 47.18 61.22 -94.50 48.48 62.32 -95.73 1e3v_c03 source 1e3v STEROID DELTA-ISOMERASE : 15 hits 1e3v_c03 naa= 3 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 1 3 # 1 B 41 HIS A 147 HIS^? 9.20 MG MG A 302 B 43 HIS A 170 HIS^? 10.56 MG MG A 302 B 65 GLU A 154 GLU^? 19.22 MG MG A 301 coo 20.15 22.08 34.36 20.84 20.10 34.21 40.24 23.10 39.83 38.32 22.34 40.22 coo 19.55 18.91 30.27 18.21 18.65 31.84 34.91 23.57 39.32 34.35 24.95 40.81 coo 10.90 21.31 28.81 12.14 22.15 30.31 36.54 21.95 29.78 35.14 22.21 28.17 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 2 3 # 2 B 41 HIS A 170 HIS^? 10.56 MG MG A 302 B 43 HIS A 147 HIS^? 9.20 MG MG A 302 B 65 GLU A 146 GLU^? 9.80 MG MG A 302 coo 20.15 22.08 34.36 20.84 20.10 34.21 34.91 23.57 39.32 34.35 24.95 40.81 coo 19.55 18.91 30.27 18.21 18.65 31.84 40.24 23.10 39.83 38.32 22.34 40.22 coo 10.90 21.31 28.81 12.14 22.15 30.31 45.17 20.35 44.20 46.68 21.21 45.40 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 3 3 # 3 B 41 HIS A 170 HIS^? 10.56 MG MG A 302 B 43 HIS A 147 HIS^? 9.20 MG MG A 302 B 65 GLU A 154 GLU^? 19.22 MG MG A 301 coo 20.15 22.08 34.36 20.84 20.10 34.21 34.91 23.57 39.32 34.35 24.95 40.81 coo 19.55 18.91 30.27 18.21 18.65 31.84 40.24 23.10 39.83 38.32 22.34 40.22 coo 10.90 21.31 28.81 12.14 22.15 30.31 36.54 21.95 29.78 35.14 22.21 28.17 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 4 3 # 4 B 41 HIS B 147 HIS^? 9.27 MG MG B 301 B 43 HIS B 170 HIS^? 10.51 MG MG B 301 B 65 GLU B 154 GLU^? 19.05 MG MG B 302 coo 20.15 22.08 34.36 20.84 20.10 34.21 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 19.55 18.91 30.27 18.21 18.65 31.84 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 10.90 21.31 28.81 12.14 22.15 30.31 44.04 15.11 6.74 44.19 13.59 8.30 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 5 3 # 5 B 41 HIS B 170 HIS^? 10.51 MG MG B 301 B 43 HIS B 147 HIS^? 9.27 MG MG B 301 B 65 GLU B 154 GLU^? 19.05 MG MG B 302 coo 20.15 22.08 34.36 20.84 20.10 34.21 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 19.55 18.91 30.27 18.21 18.65 31.84 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 10.90 21.31 28.81 12.14 22.15 30.31 44.04 15.11 6.74 44.19 13.59 8.30 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 6 3 # 6 B 41 HIS C 147 HIS^? 9.44 MG MG C 301 B 43 HIS C 170 HIS^? 10.68 MG MG C 301 B 65 GLU C 154 GLU^? 18.91 MG MG C 302 coo 20.15 22.08 34.36 20.84 20.10 34.21 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 19.55 18.91 30.27 18.21 18.65 31.84 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 10.90 21.31 28.81 12.14 22.15 30.31 91.15 23.27 -13.33 91.61 21.91 -14.95 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 7 3 # 7 B 41 HIS C 170 HIS^? 10.68 MG MG C 301 B 43 HIS C 147 HIS^? 9.44 MG MG C 301 B 65 GLU C 146 GLU^? 10.46 MG MG C 301 coo 20.15 22.08 34.36 20.84 20.10 34.21 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 19.55 18.91 30.27 18.21 18.65 31.84 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 10.90 21.31 28.81 12.14 22.15 30.31 87.01 31.93 0.25 85.57 32.56 1.72 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 8 3 # 8 B 41 HIS C 170 HIS^? 10.68 MG MG C 301 B 43 HIS C 147 HIS^? 9.44 MG MG C 301 B 65 GLU C 154 GLU^? 18.91 MG MG C 302 coo 20.15 22.08 34.36 20.84 20.10 34.21 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 19.55 18.91 30.27 18.21 18.65 31.84 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 10.90 21.31 28.81 12.14 22.15 30.31 91.15 23.27 -13.33 91.61 21.91 -14.95 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 9 3 # 9 B 41 HIS D 147 HIS^? 9.43 MG MG D 301 B 43 HIS D 170 HIS^? 10.59 MG MG D 301 B 65 GLU D 154 GLU^? 18.75 MG MG D 302 coo 20.15 22.08 34.36 20.84 20.10 34.21 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 19.55 18.91 30.27 18.21 18.65 31.84 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 10.90 21.31 28.81 12.14 22.15 30.31 94.87 32.52 -36.42 96.07 33.39 -34.88 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 10 3 # 10 B 41 HIS D 170 HIS^? 10.59 MG MG D 301 B 43 HIS D 147 HIS^? 9.43 MG MG D 301 B 65 GLU D 154 GLU^? 18.75 MG MG D 302 coo 20.15 22.08 34.36 20.84 20.10 34.21 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 19.55 18.91 30.27 18.21 18.65 31.84 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 10.90 21.31 28.81 12.14 22.15 30.31 94.87 32.52 -36.42 96.07 33.39 -34.88 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 11 3 # 11 B 41 HIS E 147 HIS^? 9.22 MG MG E 301 B 43 HIS E 170 HIS^? 10.33 MG MG E 301 B 65 GLU E 154 GLU^? 19.05 MG MG E 302 coo 20.15 22.08 34.36 20.84 20.10 34.21 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 19.55 18.91 30.27 18.21 18.65 31.84 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 10.90 21.31 28.81 12.14 22.15 30.31 64.41 68.21 -58.47 65.40 69.20 -60.08 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 12 3 # 12 B 41 HIS E 170 HIS^? 10.33 MG MG E 301 B 43 HIS E 147 HIS^? 9.22 MG MG E 301 B 65 GLU E 146 GLU^? 10.15 MG MG E 301 coo 20.15 22.08 34.36 20.84 20.10 34.21 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 19.55 18.91 30.27 18.21 18.65 31.84 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 10.90 21.31 28.81 12.14 22.15 30.31 58.72 60.89 -44.51 59.23 60.24 -42.54 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 13 3 # 13 B 41 HIS E 170 HIS^? 10.33 MG MG E 301 B 43 HIS E 147 HIS^? 9.22 MG MG E 301 B 65 GLU E 154 GLU^? 19.05 MG MG E 302 coo 20.15 22.08 34.36 20.84 20.10 34.21 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 19.55 18.91 30.27 18.21 18.65 31.84 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 10.90 21.31 28.81 12.14 22.15 30.31 64.41 68.21 -58.47 65.40 69.20 -60.08 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 14 3 # 14 B 41 HIS F 147 HIS^? 8.79 MG MG F 302 B 43 HIS F 170 HIS^? 9.84 MG MG F 302 B 65 GLU F 154 GLU^? 18.97 MG MG F 301 coo 20.15 22.08 34.36 20.84 20.10 34.21 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 19.55 18.91 30.27 18.21 18.65 31.84 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 10.90 21.31 28.81 12.14 22.15 30.31 54.57 65.67 -81.55 53.36 66.51 -80.09 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 15 3 # 15 B 41 HIS F 170 HIS^? 9.84 MG MG F 302 B 43 HIS F 147 HIS^? 8.79 MG MG F 302 B 65 GLU F 154 GLU^? 18.97 MG MG F 301 coo 20.15 22.08 34.36 20.84 20.10 34.21 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 19.55 18.91 30.27 18.21 18.65 31.84 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 10.90 21.31 28.81 12.14 22.15 30.31 54.57 65.67 -81.55 53.36 66.51 -80.09 1e7l_c01 source 1e7l RECOMBINATION ENDONUCLEASE VII : 15 hits 1e7l_c01 naa= 3 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 1 3 # 1 A 107 ALA A 9 ALA^? 15.22 MG MG A 301 A 136 TYR A 156 TYR^? 21.80 MG MG A 301 A 140 LYS A 157 LYS^? 28.65 MG MG A 302 coo 55.90 7.49 23.83 56.71 8.23 22.76 42.54 20.81 29.78 43.62 21.07 30.77 coo 59.38 10.02 17.51 59.95 9.89 20.21 37.50 16.28 27.75 35.30 17.94 28.08 coo 59.52 3.69 18.67 62.31 6.19 22.58 41.42 12.06 27.58 41.46 5.93 29.41 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 2 3 # 2 A 107 ALA B 9 ALA^? 15.20 MG MG B 302 A 136 TYR B 156 TYR^? 21.63 MG MG B 302 A 140 LYS B 157 LYS^? 28.85 MG MG B 302 coo 55.90 7.49 23.83 56.71 8.23 22.76 44.07 20.95 7.16 44.62 22.08 6.31 coo 59.38 10.02 17.51 59.95 9.89 20.21 38.56 16.71 8.27 39.91 14.31 7.86 coo 59.52 3.69 18.67 62.31 6.19 22.58 34.97 21.28 8.44 29.03 22.82 6.58 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 3 3 # 3 A 107 ALA C 9 ALA^? 15.00 MG MG C 302 A 136 TYR C 156 TYR^? 21.58 MG MG C 302 A 140 LYS C 157 LYS^? 28.15 MG MG C 302 coo 55.90 7.49 23.83 56.71 8.23 22.76 89.05 28.81 -13.58 88.16 29.64 -12.74 coo 59.38 10.02 17.51 59.95 9.89 20.21 95.64 26.50 -15.14 95.25 23.76 -14.77 coo 59.52 3.69 18.67 62.31 6.19 22.58 97.55 32.04 -15.10 101.49 36.24 -13.39 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 4 3 # 4 A 107 ALA D 9 ALA^? 15.02 MG MG D 302 A 136 TYR D 156 TYR^? 21.34 MG MG D 302 A 140 LYS D 157 LYS^? 28.67 MG MG D 302 coo 55.90 7.49 23.83 56.71 8.23 22.76 89.67 29.50 -36.34 88.55 29.40 -37.31 coo 59.38 10.02 17.51 59.95 9.89 20.21 96.25 27.10 -34.64 97.58 29.48 -35.03 coo 59.52 3.69 18.67 62.31 6.19 22.58 94.17 21.71 -34.34 96.11 15.89 -35.92 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 5 3 # 5 A 107 ALA E 9 ALA^? 15.19 MG MG E 302 A 136 TYR E 156 TYR^? 21.59 MG MG E 302 A 140 LYS E 157 LYS^? 28.40 MG MG E 302 coo 55.90 7.49 23.83 56.71 8.23 22.76 60.74 63.76 -58.54 60.44 62.76 -57.48 coo 59.38 10.02 17.51 59.95 9.89 20.21 59.31 70.31 -60.22 61.84 71.39 -59.92 coo 59.52 3.69 18.67 62.31 6.19 22.58 53.63 69.16 -60.42 48.34 71.81 -58.40 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 6 3 # 6 A 107 ALA F 9 ALA^? 15.22 MG MG F 301 A 136 TYR F 156 TYR^? 21.68 MG MG F 302 A 140 LYS F 157 LYS^? 28.36 MG MG F 302 coo 55.90 7.49 23.83 56.71 8.23 22.76 59.78 62.63 -81.12 60.54 61.63 -82.00 coo 59.38 10.02 17.51 59.95 9.89 20.21 58.80 69.55 -79.65 56.09 69.80 -80.15 coo 59.52 3.69 18.67 62.31 6.19 22.58 64.43 70.47 -79.54 68.32 74.80 -81.65 1e7q_c01 source 1e7q GDP-FUCOSE SYNTHETASE : 6 hits 1e7q_c01 naa= 3 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 1 3 # 1 A 205 LYS A 6 LYS^? 25.88 MG MG A 301 A 207 LYS A 157 LYS^? 28.65 MG MG A 302 A 366 ASP A 160 ASP^? 31.61 MG MG B 302 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 46.20 12.82 24.71 44.50 16.64 20.52 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 41.42 12.06 27.58 41.46 5.93 29.41 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 44.21 5.00 19.54 46.02 3.84 19.76 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 2 3 # 2 A 205 LYS B 6 LYS^? 25.90 MG MG B 302 A 207 LYS B 157 LYS^? 28.85 MG MG B 302 A 366 ASP B 160 ASP^? 31.65 MG MG A 301 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 36.26 25.44 11.74 39.65 23.12 16.29 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 34.97 21.28 8.44 29.03 22.82 6.58 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 28.01 24.83 16.38 27.44 26.81 15.80 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 3 3 # 3 A 205 LYS C 6 LYS^? 25.73 MG MG C 302 A 207 LYS C 157 LYS^? 28.15 MG MG C 302 A 366 ASP C 160 ASP^? 31.63 MG MG D 302 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 94.42 35.68 -18.56 92.21 32.03 -23.05 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 97.55 32.04 -15.10 101.49 36.24 -13.39 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 102.50 38.00 -23.28 102.43 39.97 -22.46 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 4 3 # 4 A 205 LYS D 6 LYS^? 25.98 MG MG D 302 A 207 LYS D 157 LYS^? 28.67 MG MG D 302 A 366 ASP D 160 ASP^? 31.45 MG MG C 302 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 89.78 20.68 -31.57 90.15 24.89 -27.02 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 94.17 21.71 -34.34 96.11 15.89 -35.92 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 94.15 13.98 -26.57 92.71 12.42 -26.99 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 5 3 # 5 A 205 LYS E 6 LYS^? 25.59 MG MG E 302 A 207 LYS E 157 LYS^? 28.40 MG MG E 302 A 366 ASP E 160 ASP^? 31.54 MG MG F 301 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 51.95 64.70 -63.33 56.16 64.03 -67.52 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 53.63 69.16 -60.42 48.34 71.81 -58.40 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 45.81 70.00 -68.45 44.10 68.87 -67.77 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 6 3 # 6 A 205 LYS F 6 LYS^? 26.09 MG MG F 301 A 207 LYS F 157 LYS^? 28.36 MG MG F 302 A 366 ASP F 160 ASP^? 31.59 MG MG E 302 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 67.53 67.03 -76.43 64.05 65.33 -71.86 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 64.43 70.47 -79.54 68.32 74.80 -81.65 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 71.27 74.59 -71.77 73.23 74.02 -72.37 1ec9_c04 source 1ec9 GLUCARATE DEHYDRATASE : 6 hits 1ec9_c04 naa= 3 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 1 3 # 1 B 205 LYS A 6 LYS^? 25.88 MG MG A 301 B 207 LYS A 157 LYS^? 28.65 MG MG A 302 B 366 ASP A 160 ASP^? 31.61 MG MG B 302 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 46.20 12.82 24.71 44.50 16.64 20.52 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 41.42 12.06 27.58 41.46 5.93 29.41 coo -11.13 25.71 4.86 -10.82 24.43 3.24 44.21 5.00 19.54 46.02 3.84 19.76 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 2 3 # 2 B 205 LYS B 6 LYS^? 25.90 MG MG B 302 B 207 LYS B 157 LYS^? 28.85 MG MG B 302 B 366 ASP B 160 ASP^? 31.65 MG MG A 301 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 36.26 25.44 11.74 39.65 23.12 16.29 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 34.97 21.28 8.44 29.03 22.82 6.58 coo -11.13 25.71 4.86 -10.82 24.43 3.24 28.01 24.83 16.38 27.44 26.81 15.80 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 3 3 # 3 B 205 LYS C 6 LYS^? 25.73 MG MG C 302 B 207 LYS C 157 LYS^? 28.15 MG MG C 302 B 366 ASP C 160 ASP^? 31.63 MG MG D 302 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 94.42 35.68 -18.56 92.21 32.03 -23.05 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 97.55 32.04 -15.10 101.49 36.24 -13.39 coo -11.13 25.71 4.86 -10.82 24.43 3.24 102.50 38.00 -23.28 102.43 39.97 -22.46 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 4 3 # 4 B 205 LYS D 6 LYS^? 25.98 MG MG D 302 B 207 LYS D 157 LYS^? 28.67 MG MG D 302 B 366 ASP D 160 ASP^? 31.45 MG MG C 302 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 89.78 20.68 -31.57 90.15 24.89 -27.02 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 94.17 21.71 -34.34 96.11 15.89 -35.92 coo -11.13 25.71 4.86 -10.82 24.43 3.24 94.15 13.98 -26.57 92.71 12.42 -26.99 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 5 3 # 5 B 205 LYS E 6 LYS^? 25.59 MG MG E 302 B 207 LYS E 157 LYS^? 28.40 MG MG E 302 B 366 ASP E 160 ASP^? 31.54 MG MG F 301 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 51.95 64.70 -63.33 56.16 64.03 -67.52 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 53.63 69.16 -60.42 48.34 71.81 -58.40 coo -11.13 25.71 4.86 -10.82 24.43 3.24 45.81 70.00 -68.45 44.10 68.87 -67.77 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 6 3 # 6 B 205 LYS F 6 LYS^? 26.09 MG MG F 301 B 207 LYS F 157 LYS^? 28.36 MG MG F 302 B 366 ASP F 160 ASP^? 31.59 MG MG E 302 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 67.53 67.03 -76.43 64.05 65.33 -71.86 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 64.43 70.47 -79.54 68.32 74.80 -81.65 coo -11.13 25.71 4.86 -10.82 24.43 3.24 71.27 74.59 -71.77 73.23 74.02 -72.37 1ec9_c05 source 1ec9 GLUCARATE DEHYDRATASE : 6 hits 1ec9_c05 naa= 3 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 1 3 # 1 C 205 LYS A 6 LYS^? 25.88 MG MG A 301 C 207 LYS A 157 LYS^? 28.65 MG MG A 302 C 366 ASP A 160 ASP^? 31.61 MG MG B 302 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 46.20 12.82 24.71 44.50 16.64 20.52 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 41.42 12.06 27.58 41.46 5.93 29.41 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 44.21 5.00 19.54 46.02 3.84 19.76 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 2 3 # 2 C 205 LYS B 6 LYS^? 25.90 MG MG B 302 C 207 LYS B 157 LYS^? 28.85 MG MG B 302 C 366 ASP B 160 ASP^? 31.65 MG MG A 301 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 36.26 25.44 11.74 39.65 23.12 16.29 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 34.97 21.28 8.44 29.03 22.82 6.58 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 28.01 24.83 16.38 27.44 26.81 15.80 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 3 3 # 3 C 205 LYS C 6 LYS^? 25.73 MG MG C 302 C 207 LYS C 157 LYS^? 28.15 MG MG C 302 C 366 ASP C 160 ASP^? 31.63 MG MG D 302 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 102.50 38.00 -23.28 102.43 39.97 -22.46 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 4 3 # 4 C 205 LYS D 6 LYS^? 25.98 MG MG D 302 C 207 LYS D 157 LYS^? 28.67 MG MG D 302 C 366 ASP D 160 ASP^? 31.45 MG MG C 302 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 94.15 13.98 -26.57 92.71 12.42 -26.99 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 5 3 # 5 C 205 LYS E 6 LYS^? 25.59 MG MG E 302 C 207 LYS E 157 LYS^? 28.40 MG MG E 302 C 366 ASP E 160 ASP^? 31.54 MG MG F 301 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 45.81 70.00 -68.45 44.10 68.87 -67.77 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 6 3 # 6 C 205 LYS F 6 LYS^? 26.09 MG MG F 301 C 207 LYS F 157 LYS^? 28.36 MG MG F 302 C 366 ASP F 160 ASP^? 31.59 MG MG E 302 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 71.27 74.59 -71.77 73.23 74.02 -72.37 1ec9_c06 source 1ec9 GLUCARATE DEHYDRATASE : 6 hits 1ec9_c06 naa= 3 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 1 3 # 1 D 205 LYS A 6 LYS^? 25.88 MG MG A 301 D 207 LYS A 157 LYS^? 28.65 MG MG A 302 D 366 ASP A 160 ASP^? 31.61 MG MG B 302 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 46.20 12.82 24.71 44.50 16.64 20.52 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 41.42 12.06 27.58 41.46 5.93 29.41 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 44.21 5.00 19.54 46.02 3.84 19.76 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 2 3 # 2 D 205 LYS B 6 LYS^? 25.90 MG MG B 302 D 207 LYS B 157 LYS^? 28.85 MG MG B 302 D 366 ASP B 160 ASP^? 31.65 MG MG A 301 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 36.26 25.44 11.74 39.65 23.12 16.29 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 34.97 21.28 8.44 29.03 22.82 6.58 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 28.01 24.83 16.38 27.44 26.81 15.80 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 3 3 # 3 D 205 LYS C 6 LYS^? 25.73 MG MG C 302 D 207 LYS C 157 LYS^? 28.15 MG MG C 302 D 366 ASP C 160 ASP^? 31.63 MG MG D 302 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 102.50 38.00 -23.28 102.43 39.97 -22.46 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 4 3 # 4 D 205 LYS D 6 LYS^? 25.98 MG MG D 302 D 207 LYS D 157 LYS^? 28.67 MG MG D 302 D 366 ASP D 160 ASP^? 31.45 MG MG C 302 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 94.15 13.98 -26.57 92.71 12.42 -26.99 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 5 3 # 5 D 205 LYS E 6 LYS^? 25.59 MG MG E 302 D 207 LYS E 157 LYS^? 28.40 MG MG E 302 D 366 ASP E 160 ASP^? 31.54 MG MG F 301 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 45.81 70.00 -68.45 44.10 68.87 -67.77 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 6 3 # 6 D 205 LYS F 6 LYS^? 26.09 MG MG F 301 D 207 LYS F 157 LYS^? 28.36 MG MG F 302 D 366 ASP F 160 ASP^? 31.59 MG MG E 302 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 71.27 74.59 -71.77 73.23 74.02 -72.37 1ec9_c07 source 1ec9 GLUCARATE DEHYDRATASE : 6 hits 1ec9_c07 naa= 3 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 1 3 # 1 A 99 HIS A 170 HIS^? 10.56 MG MG A 302 A 177 ASP A 171 ASP^? 17.17 MG MG A 302 A 203 LYS A 166 LYS^? 20.93 MG MG A 302 coo 8.74 45.76 47.19 9.33 46.93 45.56 34.91 23.57 39.32 34.35 24.95 40.81 coo 11.68 42.31 52.96 12.05 43.92 51.65 29.78 23.67 36.63 28.48 25.11 35.71 coo 18.07 52.81 49.62 14.17 49.99 48.07 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 2 3 # 2 A 99 HIS B 170 HIS^? 10.51 MG MG B 301 A 177 ASP B 171 ASP^? 16.92 MG MG B 301 A 203 LYS B 166 LYS^? 22.75 MG MG B 301 coo 8.74 45.76 47.19 9.33 46.93 45.56 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 11.68 42.31 52.96 12.05 43.92 51.65 45.30 8.50 -0.71 46.30 6.81 0.12 coo 18.07 52.81 49.62 14.17 49.99 48.07 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 3 3 # 3 A 99 HIS C 170 HIS^? 10.68 MG MG C 301 A 177 ASP C 171 ASP^? 17.08 MG MG C 301 A 203 LYS C 166 LYS^? 22.53 MG MG C 301 coo 8.74 45.76 47.19 9.33 46.93 45.56 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 11.68 42.31 52.96 12.05 43.92 51.65 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 18.07 52.81 49.62 14.17 49.99 48.07 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 4 3 # 4 A 99 HIS D 170 HIS^? 10.59 MG MG D 301 A 177 ASP D 171 ASP^? 16.95 MG MG D 301 A 203 LYS D 166 LYS^? 21.08 MG MG D 301 coo 8.74 45.76 47.19 9.33 46.93 45.56 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 11.68 42.31 52.96 12.05 43.92 51.65 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 18.07 52.81 49.62 14.17 49.99 48.07 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 5 3 # 5 A 99 HIS E 170 HIS^? 10.33 MG MG E 301 A 177 ASP E 171 ASP^? 16.73 MG MG E 301 A 203 LYS E 166 LYS^? 21.46 MG MG E 301 coo 8.74 45.76 47.19 9.33 46.93 45.56 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 11.68 42.31 52.96 12.05 43.92 51.65 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 18.07 52.81 49.62 14.17 49.99 48.07 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 6 3 # 6 A 99 HIS F 170 HIS^? 9.84 MG MG F 302 A 177 ASP F 171 ASP^? 16.35 MG MG F 302 A 203 LYS F 166 LYS^? 20.76 MG MG F 302 coo 8.74 45.76 47.19 9.33 46.93 45.56 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 11.68 42.31 52.96 12.05 43.92 51.65 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 18.07 52.81 49.62 14.17 49.99 48.07 59.28 73.05 -82.63 55.63 74.15 -86.94 1ecx_c02 source 1ecx AMINOTRANSFERASE : 6 hits 1ecx_c02 naa= 3 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 1 3 # 1 B 99 HIS A 170 HIS^? 10.56 MG MG A 302 B 177 ASP A 171 ASP^? 17.17 MG MG A 302 B 203 LYS A 166 LYS^? 20.93 MG MG A 302 coo 14.87 88.04 21.51 13.64 87.90 19.81 34.91 23.57 39.32 34.35 24.95 40.81 coo 15.87 92.46 27.37 14.46 91.76 25.94 29.78 23.67 36.63 28.48 25.11 35.71 coo 3.60 91.42 23.52 8.20 89.55 22.63 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 2 3 # 2 B 99 HIS B 170 HIS^? 10.51 MG MG B 301 B 177 ASP B 171 ASP^? 16.92 MG MG B 301 B 203 LYS B 166 LYS^? 22.75 MG MG B 301 coo 14.87 88.04 21.51 13.64 87.90 19.81 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 15.87 92.46 27.37 14.46 91.76 25.94 45.30 8.50 -0.71 46.30 6.81 0.12 coo 3.60 91.42 23.52 8.20 89.55 22.63 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 3 3 # 3 B 99 HIS C 170 HIS^? 10.68 MG MG C 301 B 177 ASP C 171 ASP^? 17.08 MG MG C 301 B 203 LYS C 166 LYS^? 22.53 MG MG C 301 coo 14.87 88.04 21.51 13.64 87.90 19.81 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 15.87 92.46 27.37 14.46 91.76 25.94 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 3.60 91.42 23.52 8.20 89.55 22.63 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 4 3 # 4 B 99 HIS D 170 HIS^? 10.59 MG MG D 301 B 177 ASP D 171 ASP^? 16.95 MG MG D 301 B 203 LYS D 166 LYS^? 21.08 MG MG D 301 coo 14.87 88.04 21.51 13.64 87.90 19.81 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 15.87 92.46 27.37 14.46 91.76 25.94 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 3.60 91.42 23.52 8.20 89.55 22.63 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 5 3 # 5 B 99 HIS E 170 HIS^? 10.33 MG MG E 301 B 177 ASP E 171 ASP^? 16.73 MG MG E 301 B 203 LYS E 166 LYS^? 21.46 MG MG E 301 coo 14.87 88.04 21.51 13.64 87.90 19.81 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 15.87 92.46 27.37 14.46 91.76 25.94 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 3.60 91.42 23.52 8.20 89.55 22.63 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 6 3 # 6 B 99 HIS F 170 HIS^? 9.84 MG MG F 302 B 177 ASP F 171 ASP^? 16.35 MG MG F 302 B 203 LYS F 166 LYS^? 20.76 MG MG F 302 coo 14.87 88.04 21.51 13.64 87.90 19.81 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 15.87 92.46 27.37 14.46 91.76 25.94 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 3.60 91.42 23.52 8.20 89.55 22.63 59.28 73.05 -82.63 55.63 74.15 -86.94 1ecx_c03 source 1ecx AMINOTRANSFERASE : 6 hits 1ecx_c03 naa= 3 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 A 107 ASP A 148 ASP^? 2.72 MG MG A 301s A 246 ASP A 171 ASP^? 17.17 MG MG A 302 A 275 HIS A 147 HIS^? 9.20 MG MG A 302 coo 28.44 37.56 46.79 26.87 37.11 48.10 41.50 28.88 41.13 43.33 29.67 41.93 coo 22.84 50.35 52.24 23.24 48.32 52.90 29.78 23.67 36.63 28.48 25.11 35.71 coo 26.67 42.94 48.26 27.49 41.07 48.73 40.24 23.10 39.83 38.32 22.34 40.22 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 A 107 ASP A 171 ASP^? 17.17 MG MG A 302 A 246 ASP A 148 ASP^? 2.72 MG MG A 301s A 275 HIS A 170 HIS^? 10.56 MG MG A 302 coo 28.44 37.56 46.79 26.87 37.11 48.10 29.78 23.67 36.63 28.48 25.11 35.71 coo 22.84 50.35 52.24 23.24 48.32 52.90 41.50 28.88 41.13 43.33 29.67 41.93 coo 26.67 42.94 48.26 27.49 41.07 48.73 34.91 23.57 39.32 34.35 24.95 40.81 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 3 3 # 3 A 107 ASP A 171 ASP^? 17.17 MG MG A 302 A 246 ASP A 187 ASP^? -3.29 MG MG A 302s A 275 HIS A 170 HIS^? 10.56 MG MG A 302 coo 28.44 37.56 46.79 26.87 37.11 48.10 29.78 23.67 36.63 28.48 25.11 35.71 coo 22.84 50.35 52.24 23.24 48.32 52.90 39.43 26.57 46.78 39.37 27.83 45.03 coo 26.67 42.94 48.26 27.49 41.07 48.73 34.91 23.57 39.32 34.35 24.95 40.81 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 4 3 # 4 A 107 ASP A 187 ASP^? -3.29 MG MG A 302s A 246 ASP A 171 ASP^? 17.17 MG MG A 302 A 275 HIS A 147 HIS^? 9.20 MG MG A 302 coo 28.44 37.56 46.79 26.87 37.11 48.10 39.43 26.57 46.78 39.37 27.83 45.03 coo 22.84 50.35 52.24 23.24 48.32 52.90 29.78 23.67 36.63 28.48 25.11 35.71 coo 26.67 42.94 48.26 27.49 41.07 48.73 40.24 23.10 39.83 38.32 22.34 40.22 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 5 3 # 5 A 107 ASP B 148 ASP^? 2.58 MG MG B 302s A 246 ASP B 171 ASP^? 16.92 MG MG B 301 A 275 HIS B 147 HIS^? 9.27 MG MG B 301 coo 28.44 37.56 46.79 26.87 37.11 48.10 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 22.84 50.35 52.24 23.24 48.32 52.90 45.30 8.50 -0.71 46.30 6.81 0.12 coo 26.67 42.94 48.26 27.49 41.07 48.73 46.73 18.97 -3.05 45.63 17.32 -3.73 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 6 3 # 6 A 107 ASP B 171 ASP^? 16.92 MG MG B 301 A 246 ASP B 148 ASP^? 2.58 MG MG B 302s A 275 HIS B 170 HIS^? 10.51 MG MG B 301 coo 28.44 37.56 46.79 26.87 37.11 48.10 45.30 8.50 -0.71 46.30 6.81 0.12 coo 22.84 50.35 52.24 23.24 48.32 52.90 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 26.67 42.94 48.26 27.49 41.07 48.73 46.22 13.75 -2.72 47.53 13.11 -4.24 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 7 3 # 7 A 107 ASP B 171 ASP^? 16.92 MG MG B 301 A 246 ASP B 187 ASP^? -3.44 MG MG B 301s A 275 HIS B 170 HIS^? 10.51 MG MG B 301 coo 28.44 37.56 46.79 26.87 37.11 48.10 45.30 8.50 -0.71 46.30 6.81 0.12 coo 22.84 50.35 52.24 23.24 48.32 52.90 50.64 18.14 -9.69 51.74 17.63 -7.86 coo 26.67 42.94 48.26 27.49 41.07 48.73 46.22 13.75 -2.72 47.53 13.11 -4.24 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 8 3 # 8 A 107 ASP B 187 ASP^? -3.44 MG MG B 301s A 246 ASP B 171 ASP^? 16.92 MG MG B 301 A 275 HIS B 147 HIS^? 9.27 MG MG B 301 coo 28.44 37.56 46.79 26.87 37.11 48.10 50.64 18.14 -9.69 51.74 17.63 -7.86 coo 22.84 50.35 52.24 23.24 48.32 52.90 45.30 8.50 -0.71 46.30 6.81 0.12 coo 26.67 42.94 48.26 27.49 41.07 48.73 46.73 18.97 -3.05 45.63 17.32 -3.73 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 9 3 # 9 A 107 ASP C 148 ASP^? 2.75 MG MG C 302s A 246 ASP C 171 ASP^? 17.08 MG MG C 301 A 275 HIS C 147 HIS^? 9.44 MG MG C 301 coo 28.44 37.56 46.79 26.87 37.11 48.10 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 22.84 50.35 52.24 23.24 48.32 52.90 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 26.67 42.94 48.26 27.49 41.07 48.73 87.61 25.71 -3.59 89.22 24.50 -2.99 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 10 3 # 10 A 107 ASP C 171 ASP^? 17.08 MG MG C 301 A 246 ASP C 148 ASP^? 2.75 MG MG C 302s A 275 HIS C 170 HIS^? 10.68 MG MG C 301 coo 28.44 37.56 46.79 26.87 37.11 48.10 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 22.84 50.35 52.24 23.24 48.32 52.90 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 26.67 42.94 48.26 27.49 41.07 48.73 89.96 21.05 -3.85 88.74 19.88 -2.61 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 11 3 # 11 A 107 ASP C 171 ASP^? 17.08 MG MG C 301 A 246 ASP C 187 ASP^? -3.72 MG MG C 301s A 275 HIS C 170 HIS^? 10.68 MG MG C 301 coo 28.44 37.56 46.79 26.87 37.11 48.10 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 22.84 50.35 52.24 23.24 48.32 52.90 84.01 23.73 3.39 83.47 22.54 1.59 coo 26.67 42.94 48.26 27.49 41.07 48.73 89.96 21.05 -3.85 88.74 19.88 -2.61 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 12 3 # 12 A 107 ASP D 148 ASP^? 2.35 MG MG D 302s A 246 ASP D 171 ASP^? 16.95 MG MG D 301 A 275 HIS D 147 HIS^? 9.43 MG MG D 301 coo 28.44 37.56 46.79 26.87 37.11 48.10 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 22.84 50.35 52.24 23.24 48.32 52.90 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 26.67 42.94 48.26 27.49 41.07 48.73 90.95 32.51 -46.42 92.98 32.42 -46.93 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 13 3 # 13 A 107 ASP D 171 ASP^? 16.95 MG MG D 301 A 246 ASP D 148 ASP^? 2.35 MG MG D 302s A 275 HIS D 170 HIS^? 10.59 MG MG D 301 coo 28.44 37.56 46.79 26.87 37.11 48.10 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 22.84 50.35 52.24 23.24 48.32 52.90 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 26.67 42.94 48.26 27.49 41.07 48.73 95.57 34.81 -46.05 95.59 36.24 -47.59 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 14 3 # 14 A 107 ASP D 171 ASP^? 16.95 MG MG D 301 A 246 ASP D 187 ASP^? -2.95 MG MG D 301s A 275 HIS D 170 HIS^? 10.59 MG MG D 301 coo 28.44 37.56 46.79 26.87 37.11 48.10 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 22.84 50.35 52.24 23.24 48.32 52.90 90.40 36.34 -52.69 89.24 37.98 -51.99 coo 26.67 42.94 48.26 27.49 41.07 48.73 95.57 34.81 -46.05 95.59 36.24 -47.59 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 15 3 # 15 A 107 ASP D 187 ASP^? -2.95 MG MG D 301s A 246 ASP D 171 ASP^? 16.95 MG MG D 301 A 275 HIS D 147 HIS^? 9.43 MG MG D 301 coo 28.44 37.56 46.79 26.87 37.11 48.10 90.40 36.34 -52.69 89.24 37.98 -51.99 coo 22.84 50.35 52.24 23.24 48.32 52.90 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 26.67 42.94 48.26 27.49 41.07 48.73 90.95 32.51 -46.42 92.98 32.42 -46.93 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 16 3 # 16 A 107 ASP E 148 ASP^? 2.62 MG MG E 302s A 246 ASP E 171 ASP^? 16.73 MG MG E 301 A 275 HIS E 147 HIS^? 9.22 MG MG E 301 coo 28.44 37.56 46.79 26.87 37.11 48.10 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 22.84 50.35 52.24 23.24 48.32 52.90 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 26.67 42.94 48.26 27.49 41.07 48.73 63.87 64.43 -48.39 64.18 66.45 -47.92 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 17 3 # 17 A 107 ASP E 171 ASP^? 16.73 MG MG E 301 A 246 ASP E 148 ASP^? 2.62 MG MG E 302s A 275 HIS E 170 HIS^? 10.33 MG MG E 301 coo 28.44 37.56 46.79 26.87 37.11 48.10 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 22.84 50.35 52.24 23.24 48.32 52.90 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 26.67 42.94 48.26 27.49 41.07 48.73 66.96 68.76 -48.87 68.36 68.54 -47.33 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 18 3 # 18 A 107 ASP E 171 ASP^? 16.73 MG MG E 301 A 246 ASP E 187 ASP^? -2.71 MG MG E 301s A 275 HIS E 170 HIS^? 10.33 MG MG E 301 coo 28.44 37.56 46.79 26.87 37.11 48.10 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 22.84 50.35 52.24 23.24 48.32 52.90 67.50 63.43 -41.69 68.97 62.26 -42.81 coo 26.67 42.94 48.26 27.49 41.07 48.73 66.96 68.76 -48.87 68.36 68.54 -47.33 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 19 3 # 19 A 107 ASP E 187 ASP^? -2.71 MG MG E 301s A 246 ASP E 171 ASP^? 16.73 MG MG E 301 A 275 HIS E 147 HIS^? 9.22 MG MG E 301 coo 28.44 37.56 46.79 26.87 37.11 48.10 67.50 63.43 -41.69 68.97 62.26 -42.81 coo 22.84 50.35 52.24 23.24 48.32 52.90 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 26.67 42.94 48.26 27.49 41.07 48.73 63.87 64.43 -48.39 64.18 66.45 -47.92 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 20 3 # 20 A 107 ASP F 148 ASP^? 2.72 MG MG F 301s A 246 ASP F 171 ASP^? 16.35 MG MG F 302 A 275 HIS F 147 HIS^? 8.79 MG MG F 302 coo 28.44 37.56 46.79 26.87 37.11 48.10 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 22.84 50.35 52.24 23.24 48.32 52.90 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 26.67 42.94 48.26 27.49 41.07 48.73 56.63 61.66 -91.16 55.69 63.43 -91.80 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 21 3 # 21 A 107 ASP F 171 ASP^? 16.35 MG MG F 302 A 246 ASP F 148 ASP^? 2.72 MG MG F 301s A 275 HIS F 170 HIS^? 9.84 MG MG F 302 coo 28.44 37.56 46.79 26.87 37.11 48.10 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 22.84 50.35 52.24 23.24 48.32 52.90 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 26.67 42.94 48.26 27.49 41.07 48.73 52.25 64.82 -90.91 50.95 63.88 -92.26 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 22 3 # 22 A 107 ASP F 171 ASP^? 16.35 MG MG F 302 A 246 ASP F 187 ASP^? -3.27 MG MG F 302s A 275 HIS F 170 HIS^? 9.84 MG MG F 302 coo 28.44 37.56 46.79 26.87 37.11 48.10 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 22.84 50.35 52.24 23.24 48.32 52.90 53.93 58.87 -98.14 52.45 58.62 -96.61 coo 26.67 42.94 48.26 27.49 41.07 48.73 52.25 64.82 -90.91 50.95 63.88 -92.26 1ehy_c00 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 22 hits 1ehy_c00 naa= 3 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 B 107 ASP A 171 ASP^? 17.17 MG MG A 302 B 246 ASP A 128 ASP^? -3.32 MG MG A 301s B 275 HIS A 170 HIS^? 10.56 MG MG A 302 coo 34.84 56.77 81.62 34.95 54.74 82.03 29.78 23.67 36.63 28.48 25.11 35.71 coo 43.18 49.30 68.39 44.75 49.87 69.78 46.50 28.23 39.77 47.49 30.10 39.82 coo 38.73 55.10 77.62 36.80 55.01 78.46 34.91 23.57 39.32 34.35 24.95 40.81 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 B 107 ASP B 171 ASP^? 16.92 MG MG B 301 B 246 ASP B 128 ASP^? -3.57 MG MG B 302s B 275 HIS B 170 HIS^? 10.51 MG MG B 301 coo 34.84 56.77 81.62 34.95 54.74 82.03 45.30 8.50 -0.71 46.30 6.81 0.12 coo 43.18 49.30 68.39 44.75 49.87 69.78 52.92 24.09 -2.19 54.73 25.14 -1.90 coo 38.73 55.10 77.62 36.80 55.01 78.46 46.22 13.75 -2.72 47.53 13.11 -4.24 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 3 3 # 3 B 107 ASP C 171 ASP^? 17.08 MG MG C 301 B 246 ASP C 128 ASP^? -3.22 MG MG C 302s B 275 HIS C 170 HIS^? 10.68 MG MG C 301 coo 34.84 56.77 81.62 34.95 54.74 82.03 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 43.18 49.30 68.39 44.75 49.87 69.78 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 38.73 55.10 77.62 36.80 55.01 78.46 89.96 21.05 -3.85 88.74 19.88 -2.61 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 4 3 # 4 B 107 ASP D 171 ASP^? 16.95 MG MG D 301 B 246 ASP D 128 ASP^? -3.70 MG MG D 302s B 275 HIS D 170 HIS^? 10.59 MG MG D 301 coo 34.84 56.77 81.62 34.95 54.74 82.03 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 43.18 49.30 68.39 44.75 49.87 69.78 83.33 35.45 -46.13 81.57 36.63 -46.10 coo 38.73 55.10 77.62 36.80 55.01 78.46 95.57 34.81 -46.05 95.59 36.24 -47.59 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 5 3 # 5 B 107 ASP E 171 ASP^? 16.73 MG MG E 301 B 246 ASP E 128 ASP^? -3.53 MG MG E 302s B 275 HIS E 170 HIS^? 10.33 MG MG E 301 coo 34.84 56.77 81.62 34.95 54.74 82.03 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 43.18 49.30 68.39 44.75 49.87 69.78 65.38 56.57 -48.58 66.15 54.57 -48.61 coo 38.73 55.10 77.62 36.80 55.01 78.46 66.96 68.76 -48.87 68.36 68.54 -47.33 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 6 3 # 6 B 107 ASP F 171 ASP^? 16.35 MG MG F 302 B 246 ASP F 128 ASP^? -3.41 MG MG F 301s B 275 HIS F 170 HIS^? 9.84 MG MG F 302 coo 34.84 56.77 81.62 34.95 54.74 82.03 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 43.18 49.30 68.39 44.75 49.87 69.78 57.76 53.73 -90.50 57.46 51.64 -90.28 coo 38.73 55.10 77.62 36.80 55.01 78.46 52.25 64.82 -90.91 50.95 63.88 -92.26 1ehy_c01 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 6 hits 1ehy_c01 naa= 3 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 C 107 ASP A 171 ASP^? 17.17 MG MG A 302 C 246 ASP A 128 ASP^? -3.32 MG MG A 301s C 275 HIS A 170 HIS^? 10.56 MG MG A 302 coo 1.90 35.26 72.76 3.20 35.74 71.18 29.78 23.67 36.63 28.48 25.11 35.71 coo 12.03 20.33 71.56 10.48 19.25 70.56 46.50 28.23 39.77 47.49 30.10 39.82 coo 3.92 29.96 71.75 4.22 31.96 72.31 34.91 23.57 39.32 34.35 24.95 40.81 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 C 107 ASP B 171 ASP^? 16.92 MG MG B 301 C 246 ASP B 128 ASP^? -3.57 MG MG B 302s C 275 HIS B 170 HIS^? 10.51 MG MG B 301 coo 1.90 35.26 72.76 3.20 35.74 71.18 45.30 8.50 -0.71 46.30 6.81 0.12 coo 12.03 20.33 71.56 10.48 19.25 70.56 52.92 24.09 -2.19 54.73 25.14 -1.90 coo 3.92 29.96 71.75 4.22 31.96 72.31 46.22 13.75 -2.72 47.53 13.11 -4.24 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 3 3 # 3 C 107 ASP C 171 ASP^? 17.08 MG MG C 301 C 246 ASP C 128 ASP^? -3.22 MG MG C 302s C 275 HIS C 170 HIS^? 10.68 MG MG C 301 coo 1.90 35.26 72.76 3.20 35.74 71.18 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 12.03 20.33 71.56 10.48 19.25 70.56 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 3.92 29.96 71.75 4.22 31.96 72.31 89.96 21.05 -3.85 88.74 19.88 -2.61 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 4 3 # 4 C 107 ASP D 171 ASP^? 16.95 MG MG D 301 C 246 ASP D 128 ASP^? -3.70 MG MG D 302s C 275 HIS D 170 HIS^? 10.59 MG MG D 301 coo 1.90 35.26 72.76 3.20 35.74 71.18 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 12.03 20.33 71.56 10.48 19.25 70.56 83.33 35.45 -46.13 81.57 36.63 -46.10 coo 3.92 29.96 71.75 4.22 31.96 72.31 95.57 34.81 -46.05 95.59 36.24 -47.59 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 5 3 # 5 C 107 ASP E 171 ASP^? 16.73 MG MG E 301 C 246 ASP E 128 ASP^? -3.53 MG MG E 302s C 275 HIS E 170 HIS^? 10.33 MG MG E 301 coo 1.90 35.26 72.76 3.20 35.74 71.18 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 12.03 20.33 71.56 10.48 19.25 70.56 65.38 56.57 -48.58 66.15 54.57 -48.61 coo 3.92 29.96 71.75 4.22 31.96 72.31 66.96 68.76 -48.87 68.36 68.54 -47.33 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 6 3 # 6 C 107 ASP F 171 ASP^? 16.35 MG MG F 302 C 246 ASP F 128 ASP^? -3.41 MG MG F 301s C 275 HIS F 170 HIS^? 9.84 MG MG F 302 coo 1.90 35.26 72.76 3.20 35.74 71.18 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 12.03 20.33 71.56 10.48 19.25 70.56 57.76 53.73 -90.50 57.46 51.64 -90.28 coo 3.92 29.96 71.75 4.22 31.96 72.31 52.25 64.82 -90.91 50.95 63.88 -92.26 1ehy_c02 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 6 hits 1ehy_c02 naa= 3 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 D 107 ASP A 171 ASP^? 17.17 MG MG A 302 D 246 ASP A 128 ASP^? -3.32 MG MG A 301s D 275 HIS A 170 HIS^? 10.56 MG MG A 302 coo 37.41 19.89 81.58 37.64 21.98 81.53 29.78 23.67 36.63 28.48 25.11 35.71 coo 23.50 26.43 88.52 24.76 26.47 90.29 46.50 28.23 39.77 47.49 30.10 39.82 coo 33.16 21.44 85.29 34.07 21.53 83.40 34.91 23.57 39.32 34.35 24.95 40.81 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 D 107 ASP B 171 ASP^? 16.92 MG MG B 301 D 246 ASP B 128 ASP^? -3.57 MG MG B 302s D 275 HIS B 170 HIS^? 10.51 MG MG B 301 coo 37.41 19.89 81.58 37.64 21.98 81.53 45.30 8.50 -0.71 46.30 6.81 0.12 coo 23.50 26.43 88.52 24.76 26.47 90.29 52.92 24.09 -2.19 54.73 25.14 -1.90 coo 33.16 21.44 85.29 34.07 21.53 83.40 46.22 13.75 -2.72 47.53 13.11 -4.24 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 3 3 # 3 D 107 ASP C 171 ASP^? 17.08 MG MG C 301 D 246 ASP C 128 ASP^? -3.22 MG MG C 302s D 275 HIS C 170 HIS^? 10.68 MG MG C 301 coo 37.41 19.89 81.58 37.64 21.98 81.53 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 23.50 26.43 88.52 24.76 26.47 90.29 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 33.16 21.44 85.29 34.07 21.53 83.40 89.96 21.05 -3.85 88.74 19.88 -2.61 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 4 3 # 4 D 107 ASP D 171 ASP^? 16.95 MG MG D 301 D 246 ASP D 128 ASP^? -3.70 MG MG D 302s D 275 HIS D 170 HIS^? 10.59 MG MG D 301 coo 37.41 19.89 81.58 37.64 21.98 81.53 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 23.50 26.43 88.52 24.76 26.47 90.29 83.33 35.45 -46.13 81.57 36.63 -46.10 coo 33.16 21.44 85.29 34.07 21.53 83.40 95.57 34.81 -46.05 95.59 36.24 -47.59 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 5 3 # 5 D 107 ASP E 171 ASP^? 16.73 MG MG E 301 D 246 ASP E 128 ASP^? -3.53 MG MG E 302s D 275 HIS E 170 HIS^? 10.33 MG MG E 301 coo 37.41 19.89 81.58 37.64 21.98 81.53 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 23.50 26.43 88.52 24.76 26.47 90.29 65.38 56.57 -48.58 66.15 54.57 -48.61 coo 33.16 21.44 85.29 34.07 21.53 83.40 66.96 68.76 -48.87 68.36 68.54 -47.33 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 6 3 # 6 D 107 ASP F 171 ASP^? 16.35 MG MG F 302 D 246 ASP F 128 ASP^? -3.41 MG MG F 301s D 275 HIS F 170 HIS^? 9.84 MG MG F 302 coo 37.41 19.89 81.58 37.64 21.98 81.53 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 23.50 26.43 88.52 24.76 26.47 90.29 57.76 53.73 -90.50 57.46 51.64 -90.28 coo 33.16 21.44 85.29 34.07 21.53 83.40 52.25 64.82 -90.91 50.95 63.88 -92.26 1ehy_c03 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 6 hits 1ehy_c03 naa= 3 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 1 3 # 1 A 114 HIS A 147 HIS^? 9.20 MG MG A 302 A 197 ASP A 128 ASP^? -3.32 MG MG A 301s A 223 LYS A 111 LYS^? 15.16 MG MG A 301 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 40.24 23.10 39.83 38.32 22.34 40.22 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 46.50 28.23 39.77 47.49 30.10 39.82 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 52.67 17.19 35.90 54.65 19.90 40.50 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 2 3 # 2 A 114 HIS A 170 HIS^? 10.56 MG MG A 302 A 197 ASP A 171 ASP^? 17.17 MG MG A 302 A 223 LYS A 166 LYS^? 20.93 MG MG A 302 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 34.91 23.57 39.32 34.35 24.95 40.81 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 29.78 23.67 36.63 28.48 25.11 35.71 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 3 3 # 3 A 114 HIS B 147 HIS^? 9.27 MG MG B 301 A 197 ASP B 128 ASP^? -3.57 MG MG B 302s A 223 LYS B 111 LYS^? 13.75 MG MG B 302 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 46.73 18.97 -3.05 45.63 17.32 -3.73 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 52.92 24.09 -2.19 54.73 25.14 -1.90 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 42.84 32.14 1.80 46.84 32.68 -2.87 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 4 3 # 4 A 114 HIS B 170 HIS^? 10.51 MG MG B 301 A 197 ASP B 171 ASP^? 16.92 MG MG B 301 A 223 LYS B 166 LYS^? 22.75 MG MG B 301 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 46.22 13.75 -2.72 47.53 13.11 -4.24 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 45.30 8.50 -0.71 46.30 6.81 0.12 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 5 3 # 5 A 114 HIS C 147 HIS^? 9.44 MG MG C 301 A 197 ASP C 128 ASP^? -3.22 MG MG C 302s A 223 LYS C 111 LYS^? 16.56 MG MG C 302 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 87.61 25.71 -3.59 89.22 24.50 -2.99 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 80.05 28.39 -4.25 77.97 28.60 -4.21 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 86.36 39.56 -8.06 84.36 40.84 -3.15 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 6 3 # 6 A 114 HIS C 170 HIS^? 10.68 MG MG C 301 A 197 ASP C 171 ASP^? 17.08 MG MG C 301 A 223 LYS C 166 LYS^? 22.53 MG MG C 301 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 89.96 21.05 -3.85 88.74 19.88 -2.61 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 92.57 16.68 -6.24 92.24 14.74 -7.03 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 7 3 # 7 A 114 HIS D 147 HIS^? 9.43 MG MG D 301 A 197 ASP D 128 ASP^? -3.70 MG MG D 302s A 223 LYS D 111 LYS^? 15.85 MG MG D 302 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 90.95 32.51 -46.42 92.98 32.42 -46.93 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 83.33 35.45 -46.13 81.57 36.63 -46.10 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 81.21 22.69 -42.10 78.68 23.89 -46.57 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 8 3 # 8 A 114 HIS D 170 HIS^? 10.59 MG MG D 301 A 197 ASP D 171 ASP^? 16.95 MG MG D 301 A 223 LYS D 166 LYS^? 21.08 MG MG D 301 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 95.57 34.81 -46.05 95.59 36.24 -47.59 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 100.39 36.69 -43.49 101.13 38.51 -42.69 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 9 3 # 9 A 114 HIS E 147 HIS^? 9.22 MG MG E 301 A 197 ASP E 128 ASP^? -3.53 MG MG E 302s A 223 LYS E 111 LYS^? 14.52 MG MG E 302 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 63.87 64.43 -48.39 64.18 66.45 -47.92 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 65.38 56.57 -48.58 66.15 54.57 -48.61 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 52.49 56.44 -52.43 54.52 53.78 -47.52 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 10 3 # 10 A 114 HIS E 170 HIS^? 10.33 MG MG E 301 A 197 ASP E 171 ASP^? 16.73 MG MG E 301 A 223 LYS E 166 LYS^? 21.46 MG MG E 301 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 66.96 68.76 -48.87 68.36 68.54 -47.33 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 69.61 73.12 -51.56 71.50 73.53 -52.39 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 11 3 # 11 A 114 HIS F 147 HIS^? 8.79 MG MG F 302 A 197 ASP F 128 ASP^? -3.41 MG MG F 301s A 223 LYS F 111 LYS^? 15.21 MG MG F 301 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 56.63 61.66 -91.16 55.69 63.43 -91.80 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 57.76 53.73 -90.50 57.46 51.64 -90.28 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 69.70 58.57 -86.86 69.67 53.74 -90.29 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 12 3 # 12 A 114 HIS F 170 HIS^? 9.84 MG MG F 302 A 197 ASP F 171 ASP^? 16.35 MG MG F 302 A 223 LYS F 166 LYS^? 20.76 MG MG F 302 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 52.25 64.82 -90.91 50.95 63.88 -92.26 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 48.23 68.08 -88.47 46.26 68.02 -87.56 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 59.28 73.05 -82.63 55.63 74.15 -86.94 1elq_c02 source 1elq L-CYSTEINE/L-CYSTINE C-S LYASE : 12 hits 1elq_c02 naa= 3 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 1 3 # 1 B 114 HIS A 147 HIS^? 9.20 MG MG A 302 B 197 ASP A 128 ASP^? -3.32 MG MG A 301s B 223 LYS A 111 LYS^? 15.16 MG MG A 301 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 40.24 23.10 39.83 38.32 22.34 40.22 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 46.50 28.23 39.77 47.49 30.10 39.82 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 52.67 17.19 35.90 54.65 19.90 40.50 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 2 3 # 2 B 114 HIS A 170 HIS^? 10.56 MG MG A 302 B 197 ASP A 171 ASP^? 17.17 MG MG A 302 B 223 LYS A 166 LYS^? 20.93 MG MG A 302 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 34.91 23.57 39.32 34.35 24.95 40.81 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 29.78 23.67 36.63 28.48 25.11 35.71 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 3 3 # 3 B 114 HIS B 147 HIS^? 9.27 MG MG B 301 B 197 ASP B 128 ASP^? -3.57 MG MG B 302s B 223 LYS B 111 LYS^? 13.75 MG MG B 302 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 46.73 18.97 -3.05 45.63 17.32 -3.73 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 52.92 24.09 -2.19 54.73 25.14 -1.90 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 42.84 32.14 1.80 46.84 32.68 -2.87 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 4 3 # 4 B 114 HIS B 170 HIS^? 10.51 MG MG B 301 B 197 ASP B 171 ASP^? 16.92 MG MG B 301 B 223 LYS B 166 LYS^? 22.75 MG MG B 301 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 46.22 13.75 -2.72 47.53 13.11 -4.24 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 45.30 8.50 -0.71 46.30 6.81 0.12 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 5 3 # 5 B 114 HIS C 147 HIS^? 9.44 MG MG C 301 B 197 ASP C 128 ASP^? -3.22 MG MG C 302s B 223 LYS C 111 LYS^? 16.56 MG MG C 302 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 87.61 25.71 -3.59 89.22 24.50 -2.99 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 80.05 28.39 -4.25 77.97 28.60 -4.21 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 86.36 39.56 -8.06 84.36 40.84 -3.15 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 6 3 # 6 B 114 HIS C 170 HIS^? 10.68 MG MG C 301 B 197 ASP C 171 ASP^? 17.08 MG MG C 301 B 223 LYS C 166 LYS^? 22.53 MG MG C 301 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 89.96 21.05 -3.85 88.74 19.88 -2.61 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 92.57 16.68 -6.24 92.24 14.74 -7.03 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 7 3 # 7 B 114 HIS D 147 HIS^? 9.43 MG MG D 301 B 197 ASP D 128 ASP^? -3.70 MG MG D 302s B 223 LYS D 111 LYS^? 15.85 MG MG D 302 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 90.95 32.51 -46.42 92.98 32.42 -46.93 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 83.33 35.45 -46.13 81.57 36.63 -46.10 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 81.21 22.69 -42.10 78.68 23.89 -46.57 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 8 3 # 8 B 114 HIS D 170 HIS^? 10.59 MG MG D 301 B 197 ASP D 171 ASP^? 16.95 MG MG D 301 B 223 LYS D 166 LYS^? 21.08 MG MG D 301 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 95.57 34.81 -46.05 95.59 36.24 -47.59 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 100.39 36.69 -43.49 101.13 38.51 -42.69 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 9 3 # 9 B 114 HIS E 147 HIS^? 9.22 MG MG E 301 B 197 ASP E 128 ASP^? -3.53 MG MG E 302s B 223 LYS E 111 LYS^? 14.52 MG MG E 302 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 63.87 64.43 -48.39 64.18 66.45 -47.92 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 65.38 56.57 -48.58 66.15 54.57 -48.61 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 52.49 56.44 -52.43 54.52 53.78 -47.52 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 10 3 # 10 B 114 HIS E 170 HIS^? 10.33 MG MG E 301 B 197 ASP E 171 ASP^? 16.73 MG MG E 301 B 223 LYS E 166 LYS^? 21.46 MG MG E 301 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 66.96 68.76 -48.87 68.36 68.54 -47.33 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 69.61 73.12 -51.56 71.50 73.53 -52.39 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 11 3 # 11 B 114 HIS F 147 HIS^? 8.79 MG MG F 302 B 197 ASP F 128 ASP^? -3.41 MG MG F 301s B 223 LYS F 111 LYS^? 15.21 MG MG F 301 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 56.63 61.66 -91.16 55.69 63.43 -91.80 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 57.76 53.73 -90.50 57.46 51.64 -90.28 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 69.70 58.57 -86.86 69.67 53.74 -90.29 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 12 3 # 12 B 114 HIS F 170 HIS^? 9.84 MG MG F 302 B 197 ASP F 171 ASP^? 16.35 MG MG F 302 B 223 LYS F 166 LYS^? 20.76 MG MG F 302 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 52.25 64.82 -90.91 50.95 63.88 -92.26 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 48.23 68.08 -88.47 46.26 68.02 -87.56 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 59.28 73.05 -82.63 55.63 74.15 -86.94 1elq_c03 source 1elq L-CYSTEINE/L-CYSTINE C-S LYASE : 12 hits 1elq_c03 naa= 3 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 1 3 # 1 150 ASP A 171 ASP^? 17.17 MG MG A 302 153 ARG A 173 ARG^? 19.27 MG MG A 302 177 HIS A 170 HIS^? 10.56 MG MG A 302 coo 6.83 2.75 19.17 7.40 0.75 19.11 29.78 23.67 36.63 28.48 25.11 35.71 coo 1.78 0.50 17.43 2.55 -2.31 16.44 27.76 29.24 35.14 27.46 27.11 32.86 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 34.91 23.57 39.32 34.35 24.95 40.81 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 2 3 # 2 150 ASP B 171 ASP^? 16.92 MG MG B 301 153 ARG B 173 ARG^? 18.75 MG MG B 301 177 HIS B 170 HIS^? 10.51 MG MG B 301 coo 6.83 2.75 19.17 7.40 0.75 19.11 45.30 8.50 -0.71 46.30 6.81 0.12 coo 1.78 0.50 17.43 2.55 -2.31 16.44 49.83 5.55 0.39 48.19 5.30 3.03 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 46.22 13.75 -2.72 47.53 13.11 -4.24 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 3 3 # 3 150 ASP C 171 ASP^? 17.08 MG MG C 301 153 ARG C 173 ARG^? 18.96 MG MG C 301 177 HIS C 170 HIS^? 10.68 MG MG C 301 coo 6.83 2.75 19.17 7.40 0.75 19.11 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 1.78 0.50 17.43 2.55 -2.31 16.44 89.11 11.40 -7.73 91.21 12.63 -9.73 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 89.96 21.05 -3.85 88.74 19.88 -2.61 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 4 3 # 4 150 ASP D 171 ASP^? 16.95 MG MG D 301 153 ARG D 173 ARG^? 18.88 MG MG D 301 177 HIS D 170 HIS^? 10.59 MG MG D 301 coo 6.83 2.75 19.17 7.40 0.75 19.11 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 1.78 0.50 17.43 2.55 -2.31 16.44 100.48 42.57 -42.43 101.55 40.79 -40.06 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 95.57 34.81 -46.05 95.59 36.24 -47.59 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 5 3 # 5 150 ASP E 171 ASP^? 16.73 MG MG E 301 153 ARG E 173 ARG^? 18.66 MG MG E 301 177 HIS E 170 HIS^? 10.33 MG MG E 301 coo 6.83 2.75 19.17 7.40 0.75 19.11 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 1.78 0.50 17.43 2.55 -2.31 16.44 75.16 72.26 -52.56 73.67 73.54 -55.01 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 66.96 68.76 -48.87 68.36 68.54 -47.33 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 6 3 # 6 150 ASP F 171 ASP^? 16.35 MG MG F 302 153 ARG F 173 ARG^? 18.61 MG MG F 302 177 HIS F 170 HIS^? 9.84 MG MG F 302 coo 6.83 2.75 19.17 7.40 0.75 19.11 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 1.78 0.50 17.43 2.55 -2.31 16.44 43.18 65.58 -86.96 44.06 67.55 -84.65 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 52.25 64.82 -90.91 50.95 63.88 -92.26 1emd_c01 source 1emd MALATE DEHYDROGENASE (E.C.1.1.1.37) : 6 hits 1emd_c01 naa= 3 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 1 3 # 1 A 229 ALA A 114 ALA^? 10.07 MG MG A 301 A 257 ALA A 116 ALA^? 9.46 MG MG A 301 A 328 ASP A 148 ASP^? 2.72 MG MG A 301s coo 39.84 24.12 8.44 38.50 24.23 9.11 48.76 26.30 34.29 47.48 26.05 33.56 coo 43.22 26.73 5.37 41.81 27.09 5.79 47.49 32.63 33.63 46.88 32.21 32.30 coo 38.17 34.10 6.67 37.72 32.06 6.84 41.50 28.88 41.13 43.33 29.67 41.93 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 2 3 # 2 A 229 ALA A 116 ALA^? 9.46 MG MG A 301 A 257 ALA A 114 ALA^? 10.07 MG MG A 301 A 328 ASP A 148 ASP^? 2.72 MG MG A 301s coo 39.84 24.12 8.44 38.50 24.23 9.11 47.49 32.63 33.63 46.88 32.21 32.30 coo 43.22 26.73 5.37 41.81 27.09 5.79 48.76 26.30 34.29 47.48 26.05 33.56 coo 38.17 34.10 6.67 37.72 32.06 6.84 41.50 28.88 41.13 43.33 29.67 41.93 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 3 3 # 3 A 229 ALA A 179 ALA^? 10.50 MG MG A 302 A 257 ALA A 180 ALA^? 8.42 MG MG A 302 A 328 ASP A 148 ASP^? 2.72 MG MG A 301s coo 39.84 24.12 8.44 38.50 24.23 9.11 35.90 35.25 40.82 35.84 36.46 39.90 coo 43.22 26.73 5.37 41.81 27.09 5.79 37.01 35.73 44.42 36.08 35.79 45.62 coo 38.17 34.10 6.67 37.72 32.06 6.84 41.50 28.88 41.13 43.33 29.67 41.93 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 4 3 # 4 A 229 ALA A 179 ALA^? 10.50 MG MG A 302 A 257 ALA A 180 ALA^? 8.42 MG MG A 302 A 328 ASP A 187 ASP^? -3.29 MG MG A 302s coo 39.84 24.12 8.44 38.50 24.23 9.11 35.90 35.25 40.82 35.84 36.46 39.90 coo 43.22 26.73 5.37 41.81 27.09 5.79 37.01 35.73 44.42 36.08 35.79 45.62 coo 38.17 34.10 6.67 37.72 32.06 6.84 39.43 26.57 46.78 39.37 27.83 45.03 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 5 3 # 5 A 229 ALA A 180 ALA^? 8.42 MG MG A 302 A 257 ALA A 179 ALA^? 10.50 MG MG A 302 A 328 ASP A 148 ASP^? 2.72 MG MG A 301s coo 39.84 24.12 8.44 38.50 24.23 9.11 37.01 35.73 44.42 36.08 35.79 45.62 coo 43.22 26.73 5.37 41.81 27.09 5.79 35.90 35.25 40.82 35.84 36.46 39.90 coo 38.17 34.10 6.67 37.72 32.06 6.84 41.50 28.88 41.13 43.33 29.67 41.93 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 6 3 # 6 A 229 ALA B 114 ALA^? 10.05 MG MG B 302 A 257 ALA B 116 ALA^? 9.34 MG MG B 302 A 328 ASP B 148 ASP^? 2.58 MG MG B 302s coo 39.84 24.12 8.44 38.50 24.23 9.11 50.76 26.40 3.41 50.25 25.15 3.98 coo 43.22 26.73 5.37 41.81 27.09 5.79 56.90 23.91 4.45 56.31 22.97 5.47 coo 38.17 34.10 6.67 37.72 32.06 6.84 52.73 19.23 -3.77 53.81 20.99 -4.31 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 7 3 # 7 A 229 ALA B 116 ALA^? 9.34 MG MG B 302 A 257 ALA B 114 ALA^? 10.05 MG MG B 302 A 328 ASP B 148 ASP^? 2.58 MG MG B 302s coo 39.84 24.12 8.44 38.50 24.23 9.11 56.90 23.91 4.45 56.31 22.97 5.47 coo 43.22 26.73 5.37 41.81 27.09 5.79 50.76 26.40 3.41 50.25 25.15 3.98 coo 38.17 34.10 6.67 37.72 32.06 6.84 52.73 19.23 -3.77 53.81 20.99 -4.31 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 8 3 # 8 A 229 ALA B 179 ALA^? 10.09 MG MG B 301 A 257 ALA B 180 ALA^? 7.87 MG MG B 301 A 328 ASP B 148 ASP^? 2.58 MG MG B 302s coo 39.84 24.12 8.44 38.50 24.23 9.11 58.26 12.57 -3.59 59.34 12.14 -2.62 coo 43.22 26.73 5.37 41.81 27.09 5.79 59.08 14.28 -6.88 59.39 13.60 -8.19 coo 38.17 34.10 6.67 37.72 32.06 6.84 52.73 19.23 -3.77 53.81 20.99 -4.31 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 9 3 # 9 A 229 ALA B 179 ALA^? 10.09 MG MG B 301 A 257 ALA B 180 ALA^? 7.87 MG MG B 301 A 328 ASP B 187 ASP^? -3.44 MG MG B 301s coo 39.84 24.12 8.44 38.50 24.23 9.11 58.26 12.57 -3.59 59.34 12.14 -2.62 coo 43.22 26.73 5.37 41.81 27.09 5.79 59.08 14.28 -6.88 59.39 13.60 -8.19 coo 38.17 34.10 6.67 37.72 32.06 6.84 50.64 18.14 -9.69 51.74 17.63 -7.86 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 10 3 # 10 A 229 ALA B 179 ALA^? 10.09 MG MG B 301 A 257 ALA B 180 ALA^? 7.87 MG MG B 301 A 328 ASP C 23 ASP^? 15.39 MG MG B 301 coo 39.84 24.12 8.44 38.50 24.23 9.11 58.26 12.57 -3.59 59.34 12.14 -2.62 coo 43.22 26.73 5.37 41.81 27.09 5.79 59.08 14.28 -6.88 59.39 13.60 -8.19 coo 38.17 34.10 6.67 37.72 32.06 6.84 65.24 6.82 -5.11 63.43 7.54 -4.15 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 11 3 # 11 A 229 ALA B 180 ALA^? 7.87 MG MG B 301 A 257 ALA B 179 ALA^? 10.09 MG MG B 301 A 328 ASP B 148 ASP^? 2.58 MG MG B 302s coo 39.84 24.12 8.44 38.50 24.23 9.11 59.08 14.28 -6.88 59.39 13.60 -8.19 coo 43.22 26.73 5.37 41.81 27.09 5.79 58.26 12.57 -3.59 59.34 12.14 -2.62 coo 38.17 34.10 6.67 37.72 32.06 6.84 52.73 19.23 -3.77 53.81 20.99 -4.31 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 12 3 # 12 A 229 ALA B 180 ALA^? 7.87 MG MG B 301 A 257 ALA B 179 ALA^? 10.09 MG MG B 301 A 328 ASP C 23 ASP^? 15.39 MG MG B 301 coo 39.84 24.12 8.44 38.50 24.23 9.11 59.08 14.28 -6.88 59.39 13.60 -8.19 coo 43.22 26.73 5.37 41.81 27.09 5.79 58.26 12.57 -3.59 59.34 12.14 -2.62 coo 38.17 34.10 6.67 37.72 32.06 6.84 65.24 6.82 -5.11 63.43 7.54 -4.15 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 13 3 # 13 A 229 ALA C 114 ALA^? 9.93 MG MG C 302 A 257 ALA C 116 ALA^? 9.08 MG MG C 302 A 328 ASP C 148 ASP^? 2.75 MG MG C 302s coo 39.84 24.12 8.44 38.50 24.23 9.11 80.78 31.40 -9.72 81.74 30.48 -10.49 coo 43.22 26.73 5.37 41.81 27.09 5.79 75.92 26.98 -10.66 76.76 26.56 -11.82 coo 38.17 34.10 6.67 37.72 32.06 6.84 81.96 23.83 -2.68 80.24 25.11 -2.27 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 14 3 # 14 A 229 ALA C 116 ALA^? 9.08 MG MG C 302 A 257 ALA C 114 ALA^? 9.93 MG MG C 302 A 328 ASP C 148 ASP^? 2.75 MG MG C 302s coo 39.84 24.12 8.44 38.50 24.23 9.11 75.92 26.98 -10.66 76.76 26.56 -11.82 coo 43.22 26.73 5.37 41.81 27.09 5.79 80.78 31.40 -9.72 81.74 30.48 -10.49 coo 38.17 34.10 6.67 37.72 32.06 6.84 81.96 23.83 -2.68 80.24 25.11 -2.27 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 15 3 # 15 A 229 ALA C 179 ALA^? 10.20 MG MG C 301 A 257 ALA C 180 ALA^? 7.92 MG MG C 301 A 328 ASP B 23 ASP^? 15.67 MG MG C 301 coo 39.84 24.12 8.44 38.50 24.23 9.11 78.98 15.73 -3.05 77.99 14.95 -3.93 coo 43.22 26.73 5.37 41.81 27.09 5.79 77.97 16.90 0.41 78.13 16.09 1.70 coo 38.17 34.10 6.67 37.72 32.06 6.84 74.31 7.55 -1.09 75.08 9.17 -2.23 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 16 3 # 16 A 229 ALA C 179 ALA^? 10.20 MG MG C 301 A 257 ALA C 180 ALA^? 7.92 MG MG C 301 A 328 ASP C 148 ASP^? 2.75 MG MG C 302s coo 39.84 24.12 8.44 38.50 24.23 9.11 78.98 15.73 -3.05 77.99 14.95 -3.93 coo 43.22 26.73 5.37 41.81 27.09 5.79 77.97 16.90 0.41 78.13 16.09 1.70 coo 38.17 34.10 6.67 37.72 32.06 6.84 81.96 23.83 -2.68 80.24 25.11 -2.27 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 17 3 # 17 A 229 ALA C 179 ALA^? 10.20 MG MG C 301 A 257 ALA C 180 ALA^? 7.92 MG MG C 301 A 328 ASP C 187 ASP^? -3.72 MG MG C 301s coo 39.84 24.12 8.44 38.50 24.23 9.11 78.98 15.73 -3.05 77.99 14.95 -3.93 coo 43.22 26.73 5.37 41.81 27.09 5.79 77.97 16.90 0.41 78.13 16.09 1.70 coo 38.17 34.10 6.67 37.72 32.06 6.84 84.01 23.73 3.39 83.47 22.54 1.59 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 18 3 # 18 A 229 ALA C 180 ALA^? 7.92 MG MG C 301 A 257 ALA C 179 ALA^? 10.20 MG MG C 301 A 328 ASP B 23 ASP^? 15.67 MG MG C 301 coo 39.84 24.12 8.44 38.50 24.23 9.11 77.97 16.90 0.41 78.13 16.09 1.70 coo 43.22 26.73 5.37 41.81 27.09 5.79 78.98 15.73 -3.05 77.99 14.95 -3.93 coo 38.17 34.10 6.67 37.72 32.06 6.84 74.31 7.55 -1.09 75.08 9.17 -2.23 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 19 3 # 19 A 229 ALA C 180 ALA^? 7.92 MG MG C 301 A 257 ALA C 179 ALA^? 10.20 MG MG C 301 A 328 ASP C 148 ASP^? 2.75 MG MG C 302s coo 39.84 24.12 8.44 38.50 24.23 9.11 77.97 16.90 0.41 78.13 16.09 1.70 coo 43.22 26.73 5.37 41.81 27.09 5.79 78.98 15.73 -3.05 77.99 14.95 -3.93 coo 38.17 34.10 6.67 37.72 32.06 6.84 81.96 23.83 -2.68 80.24 25.11 -2.27 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 20 3 # 20 A 229 ALA D 114 ALA^? 10.14 MG MG D 302 A 257 ALA D 116 ALA^? 9.63 MG MG D 302 A 328 ASP D 148 ASP^? 2.35 MG MG D 302s coo 39.84 24.12 8.44 38.50 24.23 9.11 82.02 32.47 -40.60 83.33 32.76 -39.91 coo 43.22 26.73 5.37 41.81 27.09 5.79 80.74 38.94 -39.77 81.69 38.81 -38.65 coo 38.17 34.10 6.67 37.72 32.06 6.84 87.78 37.50 -47.56 85.79 37.49 -48.28 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 21 3 # 21 A 229 ALA D 116 ALA^? 9.63 MG MG D 302 A 257 ALA D 114 ALA^? 10.14 MG MG D 302 A 328 ASP D 148 ASP^? 2.35 MG MG D 302s coo 39.84 24.12 8.44 38.50 24.23 9.11 80.74 38.94 -39.77 81.69 38.81 -38.65 coo 43.22 26.73 5.37 41.81 27.09 5.79 82.02 32.47 -40.60 83.33 32.76 -39.91 coo 38.17 34.10 6.67 37.72 32.06 6.84 87.78 37.50 -47.56 85.79 37.49 -48.28 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 22 3 # 22 A 229 ALA D 179 ALA^? 10.20 MG MG D 301 A 257 ALA D 180 ALA^? 8.04 MG MG D 301 A 328 ASP D 148 ASP^? 2.35 MG MG D 302s coo 39.84 24.12 8.44 38.50 24.23 9.11 90.58 45.61 -47.30 90.29 46.82 -46.46 coo 43.22 26.73 5.37 41.81 27.09 5.79 88.96 45.51 -50.74 89.59 46.01 -52.03 coo 38.17 34.10 6.67 37.72 32.06 6.84 87.78 37.50 -47.56 85.79 37.49 -48.28 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 23 3 # 23 A 229 ALA D 179 ALA^? 10.20 MG MG D 301 A 257 ALA D 180 ALA^? 8.04 MG MG D 301 A 328 ASP D 187 ASP^? -2.95 MG MG D 301s coo 39.84 24.12 8.44 38.50 24.23 9.11 90.58 45.61 -47.30 90.29 46.82 -46.46 coo 43.22 26.73 5.37 41.81 27.09 5.79 88.96 45.51 -50.74 89.59 46.01 -52.03 coo 38.17 34.10 6.67 37.72 32.06 6.84 90.40 36.34 -52.69 89.24 37.98 -51.99 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 24 3 # 24 A 229 ALA D 179 ALA^? 10.20 MG MG D 301 A 257 ALA D 180 ALA^? 8.04 MG MG D 301 A 328 ASP E 23 ASP^? 15.43 MG MG D 301 coo 39.84 24.12 8.44 38.50 24.23 9.11 90.58 45.61 -47.30 90.29 46.82 -46.46 coo 43.22 26.73 5.37 41.81 27.09 5.79 88.96 45.51 -50.74 89.59 46.01 -52.03 coo 38.17 34.10 6.67 37.72 32.06 6.84 91.98 54.64 -49.37 91.93 52.78 -48.33 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 25 3 # 25 A 229 ALA D 180 ALA^? 8.04 MG MG D 301 A 257 ALA D 179 ALA^? 10.20 MG MG D 301 A 328 ASP D 148 ASP^? 2.35 MG MG D 302s coo 39.84 24.12 8.44 38.50 24.23 9.11 88.96 45.51 -50.74 89.59 46.01 -52.03 coo 43.22 26.73 5.37 41.81 27.09 5.79 90.58 45.61 -47.30 90.29 46.82 -46.46 coo 38.17 34.10 6.67 37.72 32.06 6.84 87.78 37.50 -47.56 85.79 37.49 -48.28 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 26 3 # 26 A 229 ALA D 180 ALA^? 8.04 MG MG D 301 A 257 ALA D 179 ALA^? 10.20 MG MG D 301 A 328 ASP D 187 ASP^? -2.95 MG MG D 301s coo 39.84 24.12 8.44 38.50 24.23 9.11 88.96 45.51 -50.74 89.59 46.01 -52.03 coo 43.22 26.73 5.37 41.81 27.09 5.79 90.58 45.61 -47.30 90.29 46.82 -46.46 coo 38.17 34.10 6.67 37.72 32.06 6.84 90.40 36.34 -52.69 89.24 37.98 -51.99 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 27 3 # 27 A 229 ALA D 180 ALA^? 8.04 MG MG D 301 A 257 ALA D 179 ALA^? 10.20 MG MG D 301 A 328 ASP E 23 ASP^? 15.43 MG MG D 301 coo 39.84 24.12 8.44 38.50 24.23 9.11 88.96 45.51 -50.74 89.59 46.01 -52.03 coo 43.22 26.73 5.37 41.81 27.09 5.79 90.58 45.61 -47.30 90.29 46.82 -46.46 coo 38.17 34.10 6.67 37.72 32.06 6.84 91.98 54.64 -49.37 91.93 52.78 -48.33 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 28 3 # 28 A 229 ALA E 114 ALA^? 9.94 MG MG E 302 A 257 ALA E 116 ALA^? 9.37 MG MG E 302 A 328 ASP E 148 ASP^? 2.62 MG MG E 302s coo 39.84 24.12 8.44 38.50 24.23 9.11 62.47 55.47 -54.12 62.92 56.71 -54.76 coo 43.22 26.73 5.37 41.81 27.09 5.79 68.64 53.26 -54.80 68.60 54.11 -56.01 coo 38.17 34.10 6.67 37.72 32.06 6.84 68.29 60.44 -47.29 68.03 58.42 -46.50 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 29 3 # 29 A 229 ALA E 116 ALA^? 9.37 MG MG E 302 A 257 ALA E 114 ALA^? 9.94 MG MG E 302 A 328 ASP E 148 ASP^? 2.62 MG MG E 302s coo 39.84 24.12 8.44 38.50 24.23 9.11 68.64 53.26 -54.80 68.60 54.11 -56.01 coo 43.22 26.73 5.37 41.81 27.09 5.79 62.47 55.47 -54.12 62.92 56.71 -54.76 coo 38.17 34.10 6.67 37.72 32.06 6.84 68.29 60.44 -47.29 68.03 58.42 -46.50 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 30 3 # 30 A 229 ALA E 179 ALA^? 10.17 MG MG E 301 A 257 ALA E 180 ALA^? 7.76 MG MG E 301 A 328 ASP D 23 ASP^? 15.37 MG MG E 301 coo 39.84 24.12 8.44 38.50 24.23 9.11 76.81 62.00 -47.52 77.96 61.52 -48.40 coo 43.22 26.73 5.37 41.81 27.09 5.79 76.35 60.44 -44.08 76.96 60.95 -42.80 coo 38.17 34.10 6.67 37.72 32.06 6.84 85.70 62.10 -45.60 84.07 62.13 -46.93 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 31 3 # 31 A 229 ALA E 179 ALA^? 10.17 MG MG E 301 A 257 ALA E 180 ALA^? 7.76 MG MG E 301 A 328 ASP E 148 ASP^? 2.62 MG MG E 302s coo 39.84 24.12 8.44 38.50 24.23 9.11 76.81 62.00 -47.52 77.96 61.52 -48.40 coo 43.22 26.73 5.37 41.81 27.09 5.79 76.35 60.44 -44.08 76.96 60.95 -42.80 coo 38.17 34.10 6.67 37.72 32.06 6.84 68.29 60.44 -47.29 68.03 58.42 -46.50 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 32 3 # 32 A 229 ALA E 179 ALA^? 10.17 MG MG E 301 A 257 ALA E 180 ALA^? 7.76 MG MG E 301 A 328 ASP E 187 ASP^? -2.71 MG MG E 301s coo 39.84 24.12 8.44 38.50 24.23 9.11 76.81 62.00 -47.52 77.96 61.52 -48.40 coo 43.22 26.73 5.37 41.81 27.09 5.79 76.35 60.44 -44.08 76.96 60.95 -42.80 coo 38.17 34.10 6.67 37.72 32.06 6.84 67.50 63.43 -41.69 68.97 62.26 -42.81 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 33 3 # 33 A 229 ALA E 180 ALA^? 7.76 MG MG E 301 A 257 ALA E 179 ALA^? 10.17 MG MG E 301 A 328 ASP D 23 ASP^? 15.37 MG MG E 301 coo 39.84 24.12 8.44 38.50 24.23 9.11 76.35 60.44 -44.08 76.96 60.95 -42.80 coo 43.22 26.73 5.37 41.81 27.09 5.79 76.81 62.00 -47.52 77.96 61.52 -48.40 coo 38.17 34.10 6.67 37.72 32.06 6.84 85.70 62.10 -45.60 84.07 62.13 -46.93 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 34 3 # 34 A 229 ALA E 180 ALA^? 7.76 MG MG E 301 A 257 ALA E 179 ALA^? 10.17 MG MG E 301 A 328 ASP E 148 ASP^? 2.62 MG MG E 302s coo 39.84 24.12 8.44 38.50 24.23 9.11 76.35 60.44 -44.08 76.96 60.95 -42.80 coo 43.22 26.73 5.37 41.81 27.09 5.79 76.81 62.00 -47.52 77.96 61.52 -48.40 coo 38.17 34.10 6.67 37.72 32.06 6.84 68.29 60.44 -47.29 68.03 58.42 -46.50 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 35 3 # 35 A 229 ALA F 114 ALA^? 10.19 MG MG F 301 A 257 ALA F 116 ALA^? 9.46 MG MG F 301 A 328 ASP F 148 ASP^? 2.72 MG MG F 301s coo 39.84 24.12 8.44 38.50 24.23 9.11 60.93 54.30 -84.85 60.06 55.37 -84.26 coo 43.22 26.73 5.37 41.81 27.09 5.79 55.95 50.15 -83.85 55.52 51.16 -82.84 coo 38.17 34.10 6.67 37.72 32.06 6.84 53.64 56.47 -91.98 54.61 54.68 -92.64 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 36 3 # 36 A 229 ALA F 116 ALA^? 9.46 MG MG F 301 A 257 ALA F 114 ALA^? 10.19 MG MG F 301 A 328 ASP F 148 ASP^? 2.72 MG MG F 301s coo 39.84 24.12 8.44 38.50 24.23 9.11 55.95 50.15 -83.85 55.52 51.16 -82.84 coo 43.22 26.73 5.37 41.81 27.09 5.79 60.93 54.30 -84.85 60.06 55.37 -84.26 coo 38.17 34.10 6.67 37.72 32.06 6.84 53.64 56.47 -91.98 54.61 54.68 -92.64 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 37 3 # 37 A 229 ALA F 179 ALA^? 10.29 MG MG F 302 A 257 ALA F 180 ALA^? 8.00 MG MG F 302 A 328 ASP F 148 ASP^? 2.72 MG MG F 301s coo 39.84 24.12 8.44 38.50 24.23 9.11 44.99 54.95 -91.60 44.02 54.12 -90.83 coo 43.22 26.73 5.37 41.81 27.09 5.79 45.97 53.39 -94.93 45.23 53.59 -96.27 coo 38.17 34.10 6.67 37.72 32.06 6.84 53.64 56.47 -91.98 54.61 54.68 -92.64 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 38 3 # 38 A 229 ALA F 179 ALA^? 10.29 MG MG F 302 A 257 ALA F 180 ALA^? 8.00 MG MG F 302 A 328 ASP F 187 ASP^? -3.27 MG MG F 302s coo 39.84 24.12 8.44 38.50 24.23 9.11 44.99 54.95 -91.60 44.02 54.12 -90.83 coo 43.22 26.73 5.37 41.81 27.09 5.79 45.97 53.39 -94.93 45.23 53.59 -96.27 coo 38.17 34.10 6.67 37.72 32.06 6.84 53.93 58.87 -98.14 52.45 58.62 -96.61 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 39 3 # 39 A 229 ALA F 180 ALA^? 8.00 MG MG F 302 A 257 ALA F 179 ALA^? 10.29 MG MG F 302 A 328 ASP F 148 ASP^? 2.72 MG MG F 301s coo 39.84 24.12 8.44 38.50 24.23 9.11 45.97 53.39 -94.93 45.23 53.59 -96.27 coo 43.22 26.73 5.37 41.81 27.09 5.79 44.99 54.95 -91.60 44.02 54.12 -90.83 coo 38.17 34.10 6.67 37.72 32.06 6.84 53.64 56.47 -91.98 54.61 54.68 -92.64 1eo7_c00 source 1eo7 CYCLODEXTRIN GLYCOSYLTRANSFERASE : 39 hits 1eo7_c00 naa= 3 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 159 LYS A 111 LYS^? 15.16 MG MG A 301 A 193 GLU A 146 GLU^? 9.80 MG MG A 302 A 217 VAL A 130 VAL^? 10.84 MG MG A 301 coo 2.10 10.68 61.44 -2.14 13.16 60.61 52.67 17.19 35.90 54.65 19.90 40.50 coo -5.33 11.71 69.72 -4.62 11.92 67.73 45.17 20.35 44.20 46.68 21.21 45.40 coo 0.07 12.29 66.53 -0.24 11.95 64.38 47.95 21.50 38.50 49.44 21.85 40.12 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 159 LYS B 6 LYS^? 25.90 MG MG B 302 A 193 GLU B 165 GLU^? 29.66 MG MG B 302 A 217 VAL B 159 VAL^? 30.69 MG MG B 302 coo 2.10 10.68 61.44 -2.14 13.16 60.61 36.26 25.44 11.74 39.65 23.12 16.29 coo -5.33 11.71 69.72 -4.62 11.92 67.73 30.38 16.84 8.28 28.95 18.37 7.83 coo 0.07 12.29 66.53 -0.24 11.95 64.38 30.65 23.49 13.04 29.01 23.58 11.52 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 3 3 # 3 A 159 LYS B 111 LYS^? 13.75 MG MG B 302 A 193 GLU B 146 GLU^? 10.54 MG MG B 301 A 217 VAL B 130 VAL^? 10.89 MG MG B 302 coo 2.10 10.68 61.44 -2.14 13.16 60.61 42.84 32.14 1.80 46.84 32.68 -2.87 coo -5.33 11.71 69.72 -4.62 11.92 67.73 45.13 24.51 -7.01 46.08 25.99 -8.13 coo 0.07 12.29 66.53 -0.24 11.95 64.38 46.44 26.83 -1.04 46.59 28.22 -2.73 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 4 3 # 4 A 159 LYS C 6 LYS^? 25.73 MG MG C 302 A 193 GLU C 165 GLU^? 29.32 MG MG C 302 A 217 VAL C 159 VAL^? 30.76 MG MG C 302 coo 2.10 10.68 61.44 -2.14 13.16 60.61 94.42 35.68 -18.56 92.21 32.03 -23.05 coo -5.33 11.71 69.72 -4.62 11.92 67.73 103.18 29.99 -15.18 103.57 32.09 -14.86 coo 0.07 12.29 66.53 -0.24 11.95 64.38 100.61 35.95 -19.75 102.23 36.77 -18.52 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 5 3 # 5 A 159 LYS C 111 LYS^? 16.56 MG MG C 302 A 193 GLU C 146 GLU^? 10.46 MG MG C 301 A 217 VAL C 130 VAL^? 10.78 MG MG C 302 coo 2.10 10.68 61.44 -2.14 13.16 60.61 86.36 39.56 -8.06 84.36 40.84 -3.15 coo -5.33 11.71 69.72 -4.62 11.92 67.73 87.01 31.93 0.25 85.57 32.56 1.72 coo 0.07 12.29 66.53 -0.24 11.95 64.38 85.07 33.19 -5.25 83.98 34.44 -3.79 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 6 3 # 6 A 159 LYS D 6 LYS^? 25.98 MG MG D 302 A 193 GLU D 165 GLU^? 29.85 MG MG D 302 A 217 VAL D 159 VAL^? 30.97 MG MG D 302 coo 2.10 10.68 61.44 -2.14 13.16 60.61 89.78 20.68 -31.57 90.15 24.89 -27.02 coo -5.33 11.71 69.72 -4.62 11.92 67.73 100.60 20.11 -34.27 100.38 17.96 -34.49 coo 0.07 12.29 66.53 -0.24 11.95 64.38 94.39 16.65 -30.09 95.18 14.76 -30.99 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 7 3 # 7 A 159 LYS D 111 LYS^? 15.85 MG MG D 302 A 193 GLU D 146 GLU^? 10.62 MG MG D 301 A 217 VAL D 130 VAL^? 10.70 MG MG D 302 coo 2.10 10.68 61.44 -2.14 13.16 60.61 81.21 22.69 -42.10 78.68 23.89 -46.57 coo -5.33 11.71 69.72 -4.62 11.92 67.73 87.24 28.82 -50.92 85.47 28.08 -51.67 coo 0.07 12.29 66.53 -0.24 11.95 64.38 84.11 28.34 -44.88 82.85 28.34 -46.72 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 8 3 # 8 A 159 LYS E 6 LYS^? 25.59 MG MG E 302 A 193 GLU E 165 GLU^? 29.48 MG MG E 301 A 217 VAL E 159 VAL^? 30.79 MG MG E 302 coo 2.10 10.68 61.44 -2.14 13.16 60.61 51.95 64.70 -63.33 56.16 64.03 -67.52 coo -5.33 11.71 69.72 -4.62 11.92 67.73 52.92 74.97 -61.04 50.84 74.87 -60.51 coo 0.07 12.29 66.53 -0.24 11.95 64.38 48.63 69.65 -65.05 47.27 70.77 -63.68 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 9 3 # 9 A 159 LYS E 111 LYS^? 14.52 MG MG E 302 A 193 GLU E 146 GLU^? 10.15 MG MG E 301 A 217 VAL E 130 VAL^? 10.91 MG MG E 302 coo 2.10 10.68 61.44 -2.14 13.16 60.61 52.49 56.44 -52.43 54.52 53.78 -47.52 coo -5.33 11.71 69.72 -4.62 11.92 67.73 58.72 60.89 -44.51 59.23 60.24 -42.54 coo 0.07 12.29 66.53 -0.24 11.95 64.38 58.77 58.48 -49.78 57.89 57.27 -48.12 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 10 3 # 10 A 159 LYS F 6 LYS^? 26.09 MG MG F 301 A 193 GLU F 165 GLU^? 29.11 MG MG F 302 A 217 VAL F 159 VAL^? 30.90 MG MG F 301 coo 2.10 10.68 61.44 -2.14 13.16 60.61 67.53 67.03 -76.43 64.05 65.33 -71.86 coo -5.33 11.71 69.72 -4.62 11.92 67.73 63.01 76.49 -79.50 64.84 77.22 -80.35 coo 0.07 12.29 66.53 -0.24 11.95 64.38 68.71 73.10 -75.22 69.68 74.58 -76.56 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 11 3 # 11 A 159 LYS F 111 LYS^? 15.21 MG MG F 301 A 193 GLU F 146 GLU^? 10.36 MG MG F 302 A 217 VAL F 130 VAL^? 10.67 MG MG F 301 coo 2.10 10.68 61.44 -2.14 13.16 60.61 69.70 58.57 -86.86 69.67 53.74 -90.29 coo -5.33 11.71 69.72 -4.62 11.92 67.73 61.95 60.17 -95.28 62.87 58.56 -96.19 coo 0.07 12.29 66.53 -0.24 11.95 64.38 63.42 57.91 -89.52 64.07 56.72 -91.31 1et0_c00 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 11 hits 1et0_c00 naa= 3 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 38 THR A 2 THR.? 34.64 MG MG A 301 A 159 LYS A 6 LYS^? 25.88 MG MG A 301 A 193 GLU A 165 GLU^? 29.56 MG MG A 302 coo -2.58 16.31 54.79 -4.02 14.93 55.64 47.80 1.72 22.09 46.70 1.88 23.97 coo 2.10 10.68 61.44 -2.14 13.16 60.61 46.20 12.82 24.71 44.50 16.64 20.52 coo -5.33 11.71 69.72 -4.62 11.92 67.73 36.12 8.31 27.27 37.25 6.55 27.60 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 38 THR A 46 THR^? 24.24 MG MG A 301 A 159 LYS B 6 LYS^? 25.90 MG MG B 302 A 193 GLU B 165 GLU^? 29.66 MG MG B 302 coo -2.58 16.31 54.79 -4.02 14.93 55.64 38.63 28.11 18.80 36.62 27.50 19.27 coo 2.10 10.68 61.44 -2.14 13.16 60.61 36.26 25.44 11.74 39.65 23.12 16.29 coo -5.33 11.71 69.72 -4.62 11.92 67.73 30.38 16.84 8.28 28.95 18.37 7.83 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 3 3 # 3 A 38 THR A 169 THR^? 18.45 MG MG A 302 A 159 LYS A 192 LYS^? 22.83 MG MG A 302 A 193 GLU A 146 GLU^? 9.80 MG MG A 302 coo -2.58 16.31 54.79 -4.02 14.93 55.64 34.64 19.08 35.13 33.08 18.40 33.78 coo 2.10 10.68 61.44 -2.14 13.16 60.61 40.19 10.20 38.86 35.42 9.85 36.29 coo -5.33 11.71 69.72 -4.62 11.92 67.73 45.17 20.35 44.20 46.68 21.21 45.40 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 4 3 # 4 A 38 THR B 2 THR^? 34.11 MG MG B 302 A 159 LYS B 6 LYS^? 25.90 MG MG B 302 A 193 GLU B 165 GLU^? 29.66 MG MG B 302 coo -2.58 16.31 54.79 -4.02 14.93 55.64 25.51 29.18 13.74 26.24 28.19 11.93 coo 2.10 10.68 61.44 -2.14 13.16 60.61 36.26 25.44 11.74 39.65 23.12 16.29 coo -5.33 11.71 69.72 -4.62 11.92 67.73 30.38 16.84 8.28 28.95 18.37 7.83 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 5 3 # 5 A 38 THR B 26 THR^? 15.26 MG MG C 301 A 159 LYS B 21 LYS^? 13.97 MG MG B 301 A 193 GLU B 75 GLU^? 15.82 MG MG C 301 coo -2.58 16.31 54.79 -4.02 14.93 55.64 78.84 6.55 0.66 78.10 8.59 1.24 coo 2.10 10.68 61.44 -2.14 13.16 60.61 67.50 6.37 -0.39 64.53 11.03 -2.88 coo -5.33 11.71 69.72 -4.62 11.92 67.73 68.81 12.14 8.61 69.95 13.49 7.45 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 6 3 # 6 A 38 THR C 2 THR^? 33.69 MG MG C 302 A 159 LYS C 6 LYS^? 25.73 MG MG C 302 A 193 GLU C 165 GLU^? 29.32 MG MG C 302 coo -2.58 16.31 54.79 -4.02 14.93 55.64 103.03 43.13 -20.15 102.74 41.72 -18.56 coo 2.10 10.68 61.44 -2.14 13.16 60.61 94.42 35.68 -18.56 92.21 32.03 -23.05 coo -5.33 11.71 69.72 -4.62 11.92 67.73 103.18 29.99 -15.18 103.57 32.09 -14.86 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 7 3 # 7 A 38 THR C 46 THR^? 24.02 MG MG C 302 A 159 LYS D 6 LYS^? 25.98 MG MG D 302 A 193 GLU D 165 GLU^? 29.85 MG MG D 302 coo -2.58 16.31 54.79 -4.02 14.93 55.64 85.56 21.34 -24.69 87.12 20.00 -24.12 coo 2.10 10.68 61.44 -2.14 13.16 60.61 89.78 20.68 -31.57 90.15 24.89 -27.02 coo -5.33 11.71 69.72 -4.62 11.92 67.73 100.60 20.11 -34.27 100.38 17.96 -34.49 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 8 3 # 8 A 38 THR C 74 THR^? 21.64 MG MG C 302 A 159 LYS C 90 LYS^? 18.24 MG MG C 302 A 193 GLU C 52 GLU^? 19.67 MG MG C 302 coo -2.58 16.31 54.79 -4.02 14.93 55.64 73.35 14.53 -18.47 73.89 13.78 -20.47 coo 2.10 10.68 61.44 -2.14 13.16 60.61 72.37 23.25 -18.94 76.11 26.52 -20.97 coo -5.33 11.71 69.72 -4.62 11.92 67.73 84.27 26.98 -19.19 85.21 26.16 -20.96 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 9 3 # 9 A 38 THR C 169 THR^? 18.51 MG MG C 301 A 159 LYS C 192 LYS^? 24.43 MG MG C 301 A 193 GLU C 146 GLU^? 10.46 MG MG C 301 coo -2.58 16.31 54.79 -4.02 14.93 55.64 94.19 23.02 -7.83 95.56 21.86 -9.07 coo 2.10 10.68 61.44 -2.14 13.16 60.61 98.71 32.33 -3.93 102.89 29.25 -5.78 coo -5.33 11.71 69.72 -4.62 11.92 67.73 87.01 31.93 0.25 85.57 32.56 1.72 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 10 3 # 10 A 38 THR D 2 THR^? 33.99 MG MG D 302 A 159 LYS D 6 LYS^? 25.98 MG MG D 302 A 193 GLU D 165 GLU^? 29.85 MG MG D 302 coo -2.58 16.31 54.79 -4.02 14.93 55.64 91.82 9.34 -29.18 91.80 10.46 -31.03 coo 2.10 10.68 61.44 -2.14 13.16 60.61 89.78 20.68 -31.57 90.15 24.89 -27.02 coo -5.33 11.71 69.72 -4.62 11.92 67.73 100.60 20.11 -34.27 100.38 17.96 -34.49 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 11 3 # 11 A 38 THR E 2 THR^? 33.84 MG MG E 302 A 159 LYS E 6 LYS^? 25.59 MG MG E 302 A 193 GLU E 165 GLU^? 29.48 MG MG E 301 coo -2.58 16.31 54.79 -4.02 14.93 55.64 41.32 68.37 -65.29 42.66 69.03 -63.78 coo 2.10 10.68 61.44 -2.14 13.16 60.61 51.95 64.70 -63.33 56.16 64.03 -67.52 coo -5.33 11.71 69.72 -4.62 11.92 67.73 52.92 74.97 -61.04 50.84 74.87 -60.51 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 12 3 # 12 A 38 THR E 26 THR^? 15.11 MG MG D 301 A 159 LYS E 21 LYS^? 14.42 MG MG E 301 A 193 GLU E 75 GLU^? 15.76 MG MG D 301 coo -2.58 16.31 54.79 -4.02 14.93 55.64 96.37 52.25 -51.33 94.44 51.47 -51.78 coo 2.10 10.68 61.44 -2.14 13.16 60.61 87.88 60.38 -50.25 83.05 58.57 -47.65 coo -5.33 11.71 69.72 -4.62 11.92 67.73 84.65 53.96 -59.58 85.64 52.81 -58.05 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 13 3 # 13 A 38 THR E 74 THR^? 21.51 MG MG E 302 A 159 LYS E 90 LYS^? 19.16 MG MG E 302 A 193 GLU E 52 GLU^? 19.96 MG MG E 302 coo -2.58 16.31 54.79 -4.02 14.93 55.64 80.89 56.59 -62.50 81.13 57.37 -64.43 coo 2.10 10.68 61.44 -2.14 13.16 60.61 73.81 51.50 -63.18 69.15 52.39 -65.65 coo -5.33 11.71 69.72 -4.62 11.92 67.73 64.71 60.06 -63.78 64.69 61.36 -65.58 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 14 3 # 14 A 38 THR E 169 THR^? 18.18 MG MG E 301 A 159 LYS E 192 LYS^? 23.62 MG MG E 301 A 193 GLU E 146 GLU^? 10.15 MG MG E 301 coo -2.58 16.31 54.79 -4.02 14.93 55.64 63.17 71.31 -52.89 63.43 72.88 -54.31 coo 2.10 10.68 61.44 -2.14 13.16 60.61 52.64 70.58 -49.14 53.48 75.40 -50.95 coo -5.33 11.71 69.72 -4.62 11.92 67.73 58.72 60.89 -44.51 59.23 60.24 -42.54 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 15 3 # 15 A 38 THR F 2 THR^? 34.54 MG MG F 301 A 159 LYS F 6 LYS^? 26.09 MG MG F 301 A 193 GLU F 165 GLU^? 29.11 MG MG F 302 coo -2.58 16.31 54.79 -4.02 14.93 55.64 76.07 74.83 -74.70 74.98 75.15 -76.59 coo 2.10 10.68 61.44 -2.14 13.16 60.61 67.53 67.03 -76.43 64.05 65.33 -71.86 coo -5.33 11.71 69.72 -4.62 11.92 67.73 63.01 76.49 -79.50 64.84 77.22 -80.35 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 16 3 # 16 A 38 THR F 46 THR^? 24.16 MG MG F 301 A 159 LYS E 6 LYS^? 25.59 MG MG E 302 A 193 GLU E 165 GLU^? 29.48 MG MG E 301 coo -2.58 16.31 54.79 -4.02 14.93 55.64 51.99 60.48 -70.07 50.88 62.21 -70.66 coo 2.10 10.68 61.44 -2.14 13.16 60.61 51.95 64.70 -63.33 56.16 64.03 -67.52 coo -5.33 11.71 69.72 -4.62 11.92 67.73 52.92 74.97 -61.04 50.84 74.87 -60.51 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 17 3 # 17 A 38 THR F 169 THR^? 17.93 MG MG F 302 A 159 LYS F 192 LYS^? 23.61 MG MG F 302 A 193 GLU F 146 GLU^? 10.36 MG MG F 302 coo -2.58 16.31 54.79 -4.02 14.93 55.64 54.83 68.79 -86.99 54.09 70.44 -85.82 coo 2.10 10.68 61.44 -2.14 13.16 60.61 64.82 71.59 -91.06 62.22 76.11 -88.75 coo -5.33 11.71 69.72 -4.62 11.92 67.73 61.95 60.17 -95.28 62.87 58.56 -96.19 1et0_c02 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 17 hits 1et0_c02 naa= 3 ULMN 3 1euu_c00 SIALIDASE user 1 3 # 1 92 ASP A 128 ASP^? -3.32 MG MG A 301s 260 GLU A 146 GLU^? 9.80 MG MG A 302 370 TYR A 188 TYR^? 8.73 MG MG A 302 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 46.50 28.23 39.77 47.49 30.10 39.82 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 45.17 20.35 44.20 46.68 21.21 45.40 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 37.17 23.04 44.09 34.69 24.12 44.73 ULMN 3 1euu_c00 SIALIDASE user 2 3 # 2 92 ASP A 171 ASP^? 17.17 MG MG A 302 260 GLU A 154 GLU^? 19.22 MG MG A 301 370 TYR A 168 TYR^? 14.52 MG MG A 302 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 29.78 23.67 36.63 28.48 25.11 35.71 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 36.54 21.95 29.78 35.14 22.21 28.17 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 37.31 16.98 37.59 36.65 18.86 39.55 ULMN 3 1euu_c00 SIALIDASE user 3 3 # 3 92 ASP A 187 ASP^? -3.29 MG MG A 302s 260 GLU A 146 GLU^? 9.80 MG MG A 302 370 TYR A 129 TYR^? 10.90 MG MG A 301 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 39.43 26.57 46.78 39.37 27.83 45.03 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 45.17 20.35 44.20 46.68 21.21 45.40 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 44.80 23.54 35.75 45.57 23.36 33.08 ULMN 3 1euu_c00 SIALIDASE user 4 3 # 4 92 ASP B 128 ASP^? -3.57 MG MG B 302s 260 GLU B 146 GLU^? 10.54 MG MG B 301 370 TYR B 188 TYR^? 8.84 MG MG B 301 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 52.92 24.09 -2.19 54.73 25.14 -1.90 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 45.13 24.51 -7.01 46.08 25.99 -8.13 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 46.41 16.35 -7.52 47.38 13.88 -8.38 ULMN 3 1euu_c00 SIALIDASE user 5 3 # 5 92 ASP B 171 ASP^? 16.92 MG MG B 301 260 GLU B 154 GLU^? 19.05 MG MG B 302 370 TYR B 168 TYR^? 14.66 MG MG B 301 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 45.30 8.50 -0.71 46.30 6.81 0.12 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 44.04 15.11 6.74 44.19 13.59 8.30 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 40.03 17.20 -1.34 41.92 16.43 -3.19 ULMN 3 1euu_c00 SIALIDASE user 6 3 # 6 92 ASP B 187 ASP^? -3.44 MG MG B 301s 260 GLU B 146 GLU^? 10.54 MG MG B 301 370 TYR B 129 TYR^? 10.63 MG MG B 302 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 50.64 18.14 -9.69 51.74 17.63 -7.86 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 45.13 24.51 -7.01 46.08 25.99 -8.13 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 47.85 23.00 1.51 47.62 23.50 4.24 ULMN 3 1euu_c00 SIALIDASE user 7 3 # 7 92 ASP C 128 ASP^? -3.22 MG MG C 302s 260 GLU C 146 GLU^? 10.46 MG MG C 301 370 TYR C 188 TYR^? 8.98 MG MG C 301 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 87.01 31.93 0.25 85.57 32.56 1.72 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 88.74 23.30 0.93 88.91 20.61 1.57 ULMN 3 1euu_c00 SIALIDASE user 8 3 # 8 92 ASP C 171 ASP^? 17.08 MG MG C 301 260 GLU C 154 GLU^? 18.91 MG MG C 302 370 TYR C 168 TYR^? 14.82 MG MG C 301 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 91.15 23.27 -13.33 91.61 21.91 -14.95 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 94.44 26.43 -5.44 92.97 25.09 -3.55 ULMN 3 1euu_c00 SIALIDASE user 9 3 # 9 92 ASP C 187 ASP^? -3.72 MG MG C 301s 260 GLU C 146 GLU^? 10.46 MG MG C 301 370 TYR C 129 TYR^? 10.65 MG MG C 302 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 84.01 23.73 3.39 83.47 22.54 1.59 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 87.01 31.93 0.25 85.57 32.56 1.72 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 84.95 29.43 -7.96 85.04 30.16 -10.69 ULMN 3 1euu_c00 SIALIDASE user 10 3 # 10 92 ASP D 128 ASP^? -3.70 MG MG D 302s 260 GLU D 146 GLU^? 10.62 MG MG D 301 370 TYR D 188 TYR^? 8.87 MG MG D 301 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 83.33 35.45 -46.13 81.57 36.63 -46.10 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 87.24 28.82 -50.92 85.47 28.08 -51.67 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 93.72 33.91 -50.86 95.36 36.03 -51.61 ULMN 3 1euu_c00 SIALIDASE user 11 3 # 11 92 ASP D 171 ASP^? 16.95 MG MG D 301 260 GLU D 154 GLU^? 18.75 MG MG D 302 370 TYR D 168 TYR^? 14.75 MG MG D 301 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 94.87 32.52 -36.42 96.07 33.39 -34.88 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 95.79 27.80 -44.35 95.71 29.78 -46.32 ULMN 3 1euu_c00 SIALIDASE user 12 3 # 12 92 ASP E 128 ASP^? -3.53 MG MG E 302s 260 GLU E 146 GLU^? 10.15 MG MG E 301 370 TYR E 188 TYR^? 8.62 MG MG E 301 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 65.38 56.57 -48.58 66.15 54.57 -48.61 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 58.72 60.89 -44.51 59.23 60.24 -42.54 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 65.58 67.09 -44.08 67.82 68.57 -43.41 ULMN 3 1euu_c00 SIALIDASE user 13 3 # 13 92 ASP E 171 ASP^? 16.73 MG MG E 301 260 GLU E 154 GLU^? 19.05 MG MG E 302 370 TYR E 168 TYR^? 14.43 MG MG E 301 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 64.41 68.21 -58.47 65.40 69.20 -60.08 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 60.07 69.95 -50.54 61.99 69.37 -48.59 ULMN 3 1euu_c00 SIALIDASE user 14 3 # 14 92 ASP E 187 ASP^? -2.71 MG MG E 301s 260 GLU E 146 GLU^? 10.15 MG MG E 301 370 TYR E 129 TYR^? 10.89 MG MG E 302 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 67.50 63.43 -41.69 68.97 62.26 -42.81 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 58.72 60.89 -44.51 59.23 60.24 -42.54 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 62.09 60.15 -52.83 61.47 59.53 -55.45 ULMN 3 1euu_c00 SIALIDASE user 15 3 # 15 92 ASP F 128 ASP^? -3.41 MG MG F 301s 260 GLU F 146 GLU^? 10.36 MG MG F 302 370 TYR F 188 TYR^? 8.06 MG MG F 302 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 57.76 53.73 -90.50 57.46 51.64 -90.28 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 61.95 60.17 -95.28 62.87 58.56 -96.19 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 54.23 63.50 -95.64 51.58 63.66 -96.35 ULMN 3 1euu_c00 SIALIDASE user 16 3 # 16 92 ASP F 171 ASP^? 16.35 MG MG F 302 260 GLU F 154 GLU^? 18.97 MG MG F 301 370 TYR F 168 TYR^? 14.10 MG MG F 302 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 54.57 65.67 -81.55 53.36 66.51 -80.09 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 58.29 68.32 -89.29 56.67 67.12 -91.21 1euu_c00 source 1euu SIALIDASE : 16 hits 1euu_c00 naa= 3 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 1 3 # 1 A 34 GLU A 75 GLU^? 20.23 MG MG A 301 A 260 ARG A 50 ARG^? 15.98 MG MG A 301 A 270 LYS A 90 LYS^? 18.58 MG MG A 301 coo 50.99 29.43 12.86 52.11 29.45 14.65 38.99 46.65 28.68 39.94 47.65 30.33 coo 39.80 27.50 22.98 42.20 26.56 21.34 38.44 33.02 29.31 39.55 34.58 26.90 coo 48.83 21.70 19.50 47.44 24.99 15.25 46.62 38.29 25.46 47.51 33.29 23.22 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 2 3 # 2 A 34 GLU B 94 GLU^? 15.34 MG MG B 302 A 260 ARG B 50 ARG^? 16.38 MG MG B 302 A 270 LYS B 90 LYS^? 18.68 MG MG B 302 coo 50.99 29.43 12.86 52.11 29.45 14.65 58.44 31.30 7.43 60.35 32.14 7.14 coo 39.80 27.50 22.98 42.20 26.56 21.34 55.38 14.91 7.80 56.60 14.73 10.62 coo 48.83 21.70 19.50 47.44 24.99 15.25 61.66 21.61 12.88 56.74 22.88 14.81 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 3 3 # 3 A 34 GLU D 94 GLU^? 16.28 MG MG D 302 A 260 ARG D 50 ARG^? 16.15 MG MG D 302 A 270 LYS D 90 LYS^? 18.98 MG MG D 302 coo 50.99 29.43 12.86 52.11 29.45 14.65 72.85 36.59 -35.79 71.78 37.87 -37.16 coo 39.80 27.50 22.98 42.20 26.56 21.34 88.00 43.26 -36.30 88.86 43.23 -33.34 coo 48.83 21.70 19.50 47.44 24.99 15.25 79.83 44.38 -31.44 80.32 39.55 -29.40 1euy_c00 source 1euy GLUTAMINYL-TRNA SYNTHETASE : 3 hits 1euy_c00 naa= 3 ULMN 3 1eyi_c00 FRUCTOSE-1,6-BISPHOSPHATASE user 1 3 # 1 A 68 ASP D 177 ASP^? 8.43 MG MG D 301 A 74 ASP D 171 ASP^? 16.95 MG MG D 301 A 98 GLU D 174 GLU^? 19.76 MG MG D 301 coo 17.19 9.05 25.28 15.77 9.98 26.53 95.74 41.01 -49.76 94.81 39.90 -51.24 coo 15.99 8.54 17.36 14.96 7.80 19.05 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 16.31 12.85 18.11 16.71 11.79 19.90 104.29 37.18 -46.00 105.30 38.94 -45.21 1eyi_c00 source 1eyi FRUCTOSE-1,6-BISPHOSPHATASE : 1 hits 1eyi_c00 naa= 3 ULMN 3 1ez2_c00 PHOSPHOTRIESTERASE user 1 3 # 1 A 233 ASP A 177 ASP^? 8.44 MG MG A 302 A 254 HIS A 170 HIS^? 10.56 MG MG A 302 A 301 ASP A 171 ASP^? 17.17 MG MG A 302 coo 54.85 -0.50 33.94 53.35 -1.92 34.23 33.02 29.04 43.18 33.79 27.88 44.78 coo 49.60 -2.04 34.84 49.44 -3.48 33.35 34.91 23.57 39.32 34.35 24.95 40.81 coo 45.28 -3.05 33.32 45.60 -4.40 31.72 29.78 23.67 36.63 28.48 25.11 35.71 ULMN 3 1ez2_c00 PHOSPHOTRIESTERASE user 2 3 # 2 A 233 ASP B 177 ASP^? 9.03 MG MG B 301 A 254 HIS B 170 HIS^? 10.51 MG MG B 301 A 301 ASP B 171 ASP^? 16.92 MG MG B 301 coo 54.85 -0.50 33.94 53.35 -1.92 34.23 51.97 11.04 -6.64 50.39 11.62 -7.94 coo 49.60 -2.04 34.84 49.44 -3.48 33.35 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 45.28 -3.05 33.32 45.60 -4.40 31.72 45.30 8.50 -0.71 46.30 6.81 0.12 ULMN 3 1ez2_c00 PHOSPHOTRIESTERASE user 3 3 # 3 A 233 ASP C 177 ASP^? 8.84 MG MG C 301 A 254 HIS C 170 HIS^? 10.68 MG MG C 301 A 301 ASP C 171 ASP^? 17.08 MG MG C 301 coo 54.85 -0.50 33.94 53.35 -1.92 34.23 85.60 16.42 -0.31 86.51 17.71 1.09 coo 49.60 -2.04 34.84 49.44 -3.48 33.35 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 45.28 -3.05 33.32 45.60 -4.40 31.72 92.57 16.68 -6.24 92.24 14.74 -7.03 ULMN 3 1ez2_c00 PHOSPHOTRIESTERASE user 4 3 # 4 A 233 ASP D 177 ASP^? 8.43 MG MG D 301 A 254 HIS D 170 HIS^? 10.59 MG MG D 301 A 301 ASP D 171 ASP^? 16.95 MG MG D 301 coo 54.85 -0.50 33.94 53.35 -1.92 34.23 95.74 41.01 -49.76 94.81 39.90 -51.24 coo 49.60 -2.04 34.84 49.44 -3.48 33.35 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 45.28 -3.05 33.32 45.60 -4.40 31.72 100.39 36.69 -43.49 101.13 38.51 -42.69 ULMN 3 1ez2_c00 PHOSPHOTRIESTERASE user 5 3 # 5 A 233 ASP E 177 ASP^? 8.55 MG MG E 301 A 254 HIS E 170 HIS^? 10.33 MG MG E 301 A 301 ASP E 171 ASP^? 16.73 MG MG E 301 coo 54.85 -0.50 33.94 53.35 -1.92 34.23 72.81 67.32 -45.03 71.14 67.96 -43.95 coo 49.60 -2.04 34.84 49.44 -3.48 33.35 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 45.28 -3.05 33.32 45.60 -4.40 31.72 69.61 73.12 -51.56 71.50 73.53 -52.39 ULMN 3 1ez2_c00 PHOSPHOTRIESTERASE user 6 3 # 6 A 233 ASP F 177 ASP^? 8.15 MG MG F 302 A 254 HIS F 170 HIS^? 9.84 MG MG F 302 A 301 ASP F 171 ASP^? 16.35 MG MG F 302 coo 54.85 -0.50 33.94 53.35 -1.92 34.23 47.18 61.22 -94.50 48.48 62.32 -95.73 coo 49.60 -2.04 34.84 49.44 -3.48 33.35 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 45.28 -3.05 33.32 45.60 -4.40 31.72 48.23 68.08 -88.47 46.26 68.02 -87.56 1ez2_c00 source 1ez2 PHOSPHOTRIESTERASE : 6 hits 1ez2_c00 naa= 3 ULMN 3 1ez2_c01 PHOSPHOTRIESTERASE user 1 3 # 1 B 233 ASP A 177 ASP^? 8.44 MG MG A 302 B 254 HIS A 170 HIS^? 10.56 MG MG A 302 B 301 ASP A 171 ASP^? 17.17 MG MG A 302 coo 56.25 -34.15 2.23 54.65 -32.85 1.82 33.02 29.04 43.18 33.79 27.88 44.78 coo 50.90 -32.78 1.00 50.77 -31.41 2.56 34.91 23.57 39.32 34.35 24.95 40.81 coo 46.50 -31.79 2.21 46.79 -30.43 3.83 29.78 23.67 36.63 28.48 25.11 35.71 ULMN 3 1ez2_c01 PHOSPHOTRIESTERASE user 2 3 # 2 B 233 ASP B 177 ASP^? 9.03 MG MG B 301 B 254 HIS B 170 HIS^? 10.51 MG MG B 301 B 301 ASP B 171 ASP^? 16.92 MG MG B 301 coo 56.25 -34.15 2.23 54.65 -32.85 1.82 51.97 11.04 -6.64 50.39 11.62 -7.94 coo 50.90 -32.78 1.00 50.77 -31.41 2.56 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 46.50 -31.79 2.21 46.79 -30.43 3.83 45.30 8.50 -0.71 46.30 6.81 0.12 ULMN 3 1ez2_c01 PHOSPHOTRIESTERASE user 3 3 # 3 B 233 ASP C 177 ASP^? 8.84 MG MG C 301 B 254 HIS C 170 HIS^? 10.68 MG MG C 301 B 301 ASP C 171 ASP^? 17.08 MG MG C 301 coo 56.25 -34.15 2.23 54.65 -32.85 1.82 85.60 16.42 -0.31 86.51 17.71 1.09 coo 50.90 -32.78 1.00 50.77 -31.41 2.56 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 46.50 -31.79 2.21 46.79 -30.43 3.83 92.57 16.68 -6.24 92.24 14.74 -7.03 ULMN 3 1ez2_c01 PHOSPHOTRIESTERASE user 4 3 # 4 B 233 ASP D 177 ASP^? 8.43 MG MG D 301 B 254 HIS D 170 HIS^? 10.59 MG MG D 301 B 301 ASP D 171 ASP^? 16.95 MG MG D 301 coo 56.25 -34.15 2.23 54.65 -32.85 1.82 95.74 41.01 -49.76 94.81 39.90 -51.24 coo 50.90 -32.78 1.00 50.77 -31.41 2.56 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 46.50 -31.79 2.21 46.79 -30.43 3.83 100.39 36.69 -43.49 101.13 38.51 -42.69 ULMN 3 1ez2_c01 PHOSPHOTRIESTERASE user 5 3 # 5 B 233 ASP E 177 ASP^? 8.55 MG MG E 301 B 254 HIS E 170 HIS^? 10.33 MG MG E 301 B 301 ASP E 171 ASP^? 16.73 MG MG E 301 coo 56.25 -34.15 2.23 54.65 -32.85 1.82 72.81 67.32 -45.03 71.14 67.96 -43.95 coo 50.90 -32.78 1.00 50.77 -31.41 2.56 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 46.50 -31.79 2.21 46.79 -30.43 3.83 69.61 73.12 -51.56 71.50 73.53 -52.39 ULMN 3 1ez2_c01 PHOSPHOTRIESTERASE user 6 3 # 6 B 233 ASP F 177 ASP^? 8.15 MG MG F 302 B 254 HIS F 170 HIS^? 9.84 MG MG F 302 B 301 ASP F 171 ASP^? 16.35 MG MG F 302 coo 56.25 -34.15 2.23 54.65 -32.85 1.82 47.18 61.22 -94.50 48.48 62.32 -95.73 coo 50.90 -32.78 1.00 50.77 -31.41 2.56 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 46.50 -31.79 2.21 46.79 -30.43 3.83 48.23 68.08 -88.47 46.26 68.02 -87.56 1ez2_c01 source 1ez2 PHOSPHOTRIESTERASE : 6 hits 1ez2_c01 naa= 3 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 1 3 # 1 C 95 ASP A 171 ASP^? 17.17 MG MG A 302 C 117 GLU A 38 GLU^? 21.81 MG MG A 302 C 131 GLU A 174 GLU^? 20.39 MG MG A 302 coo 68.01 56.37 72.57 68.42 56.10 70.51 29.78 23.67 36.63 28.48 25.11 35.71 coo 66.59 62.50 67.44 67.57 60.64 67.12 26.42 25.01 28.02 26.98 25.90 29.89 coo 69.24 52.27 71.96 69.91 50.26 71.89 25.88 23.57 38.04 23.76 23.95 38.22 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 2 3 # 2 C 95 ASP B 171 ASP^? 16.92 MG MG B 301 C 117 GLU B 38 GLU^? 21.75 MG MG B 301 C 131 GLU B 174 GLU^? 19.69 MG MG B 301 coo 68.01 56.37 72.57 68.42 56.10 70.51 45.30 8.50 -0.71 46.30 6.81 0.12 coo 66.59 62.50 67.44 67.57 60.64 67.12 44.79 4.95 7.12 46.66 4.47 6.21 coo 69.24 52.27 71.96 69.91 50.26 71.89 43.72 4.95 -3.28 44.76 3.14 -2.69 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 3 3 # 3 C 95 ASP C 171 ASP^? 17.08 MG MG C 301 C 117 GLU C 38 GLU^? 21.99 MG MG C 301 C 131 GLU C 174 GLU^? 19.72 MG MG C 301 coo 68.01 56.37 72.57 68.42 56.10 70.51 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 66.59 62.50 67.44 67.57 60.64 67.12 93.66 12.78 -15.08 92.73 12.51 -13.19 coo 69.24 52.27 71.96 69.91 50.26 71.89 95.09 14.29 -3.63 95.25 12.23 -4.17 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 4 3 # 4 C 95 ASP D 171 ASP^? 16.95 MG MG D 301 C 117 GLU D 38 GLU^? 21.83 MG MG D 301 C 131 GLU D 174 GLU^? 19.76 MG MG D 301 coo 68.01 56.37 72.57 68.42 56.10 70.51 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 66.59 62.50 67.44 67.57 60.64 67.12 103.22 39.19 -34.75 102.77 39.81 -36.73 coo 69.24 52.27 71.96 69.91 50.26 71.89 104.29 37.18 -46.00 105.30 38.94 -45.21 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 5 3 # 5 C 95 ASP E 171 ASP^? 16.73 MG MG E 301 C 117 GLU E 38 GLU^? 21.68 MG MG E 301 C 131 GLU E 174 GLU^? 19.83 MG MG E 301 coo 68.01 56.37 72.57 68.42 56.10 70.51 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 66.59 62.50 67.44 67.57 60.64 67.12 72.42 75.53 -60.31 73.00 74.78 -58.42 coo 69.24 52.27 71.96 69.91 50.26 71.89 70.48 76.62 -49.45 71.76 78.34 -49.45 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 6 3 # 6 C 95 ASP F 171 ASP^? 16.35 MG MG F 302 C 117 GLU F 38 GLU^? 21.28 MG MG F 302 C 131 GLU F 174 GLU^? 18.79 MG MG F 302 coo 68.01 56.37 72.57 68.42 56.10 70.51 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 66.59 62.50 67.44 67.57 60.64 67.12 44.63 69.79 -79.91 44.13 69.05 -81.85 coo 69.24 52.27 71.96 69.91 50.26 71.89 46.19 70.73 -90.91 44.19 71.42 -90.89 1f6d_c02 source 1f6d UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE : 6 hits 1f6d_c02 naa= 3 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 1 3 # 1 A 105 HIS A 147 HIS^? 9.20 MG MG A 302 C 62 LYS A 111 LYS^? 15.16 MG MG A 301 F 35 ASP A 128 ASP^? -3.32 MG MG A 301s coo 15.40 22.79 16.66 13.93 24.10 15.98 40.24 23.10 39.83 38.32 22.34 40.22 coo 19.95 18.98 4.81 18.82 20.94 10.49 52.67 17.19 35.90 54.65 19.90 40.50 coo 16.32 15.30 17.19 17.71 14.73 18.69 46.50 28.23 39.77 47.49 30.10 39.82 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 2 3 # 2 A 105 HIS A 170 HIS^? 10.56 MG MG A 302 C 62 LYS A 166 LYS^? 20.93 MG MG A 302 F 35 ASP A 171 ASP^? 17.17 MG MG A 302 coo 15.40 22.79 16.66 13.93 24.10 15.98 34.91 23.57 39.32 34.35 24.95 40.81 coo 19.95 18.98 4.81 18.82 20.94 10.49 35.34 13.14 30.41 31.67 15.04 34.58 coo 16.32 15.30 17.19 17.71 14.73 18.69 29.78 23.67 36.63 28.48 25.11 35.71 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 3 3 # 3 A 105 HIS B 147 HIS^? 9.27 MG MG B 301 C 62 LYS B 111 LYS^? 13.75 MG MG B 302 F 35 ASP B 128 ASP^? -3.57 MG MG B 302s coo 15.40 22.79 16.66 13.93 24.10 15.98 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 19.95 18.98 4.81 18.82 20.94 10.49 42.84 32.14 1.80 46.84 32.68 -2.87 coo 16.32 15.30 17.19 17.71 14.73 18.69 52.92 24.09 -2.19 54.73 25.14 -1.90 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 4 3 # 4 A 105 HIS B 170 HIS^? 10.51 MG MG B 301 C 62 LYS B 166 LYS^? 22.75 MG MG B 301 F 35 ASP B 171 ASP^? 16.92 MG MG B 301 coo 15.40 22.79 16.66 13.93 24.10 15.98 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 19.95 18.98 4.81 18.82 20.94 10.49 35.27 15.38 5.31 37.27 9.81 3.93 coo 16.32 15.30 17.19 17.71 14.73 18.69 45.30 8.50 -0.71 46.30 6.81 0.12 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 5 3 # 5 A 105 HIS C 147 HIS^? 9.44 MG MG C 301 C 62 LYS C 111 LYS^? 16.56 MG MG C 302 F 35 ASP C 128 ASP^? -3.22 MG MG C 302s coo 15.40 22.79 16.66 13.93 24.10 15.98 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 19.95 18.98 4.81 18.82 20.94 10.49 86.36 39.56 -8.06 84.36 40.84 -3.15 coo 16.32 15.30 17.19 17.71 14.73 18.69 80.05 28.39 -4.25 77.97 28.60 -4.21 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 6 3 # 6 A 105 HIS C 170 HIS^? 10.68 MG MG C 301 C 62 LYS C 166 LYS^? 22.53 MG MG C 301 F 35 ASP C 171 ASP^? 17.08 MG MG C 301 coo 15.40 22.79 16.66 13.93 24.10 15.98 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 19.95 18.98 4.81 18.82 20.94 10.49 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 16.32 15.30 17.19 17.71 14.73 18.69 92.57 16.68 -6.24 92.24 14.74 -7.03 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 7 3 # 7 A 105 HIS D 147 HIS^? 9.43 MG MG D 301 C 62 LYS D 111 LYS^? 15.85 MG MG D 302 F 35 ASP D 128 ASP^? -3.70 MG MG D 302s coo 15.40 22.79 16.66 13.93 24.10 15.98 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 19.95 18.98 4.81 18.82 20.94 10.49 81.21 22.69 -42.10 78.68 23.89 -46.57 coo 16.32 15.30 17.19 17.71 14.73 18.69 83.33 35.45 -46.13 81.57 36.63 -46.10 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 8 3 # 8 A 105 HIS D 170 HIS^? 10.59 MG MG D 301 C 62 LYS D 166 LYS^? 21.08 MG MG D 301 F 35 ASP D 171 ASP^? 16.95 MG MG D 301 coo 15.40 22.79 16.66 13.93 24.10 15.98 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 19.95 18.98 4.81 18.82 20.94 10.49 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 16.32 15.30 17.19 17.71 14.73 18.69 100.39 36.69 -43.49 101.13 38.51 -42.69 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 9 3 # 9 A 105 HIS E 147 HIS^? 9.22 MG MG E 301 C 62 LYS E 111 LYS^? 14.52 MG MG E 302 F 35 ASP E 128 ASP^? -3.53 MG MG E 302s coo 15.40 22.79 16.66 13.93 24.10 15.98 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 19.95 18.98 4.81 18.82 20.94 10.49 52.49 56.44 -52.43 54.52 53.78 -47.52 coo 16.32 15.30 17.19 17.71 14.73 18.69 65.38 56.57 -48.58 66.15 54.57 -48.61 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 10 3 # 10 A 105 HIS E 170 HIS^? 10.33 MG MG E 301 C 62 LYS E 166 LYS^? 21.46 MG MG E 301 F 35 ASP E 171 ASP^? 16.73 MG MG E 301 coo 15.40 22.79 16.66 13.93 24.10 15.98 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 19.95 18.98 4.81 18.82 20.94 10.49 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 16.32 15.30 17.19 17.71 14.73 18.69 69.61 73.12 -51.56 71.50 73.53 -52.39 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 11 3 # 11 A 105 HIS F 147 HIS^? 8.79 MG MG F 302 C 62 LYS F 111 LYS^? 15.21 MG MG F 301 F 35 ASP F 128 ASP^? -3.41 MG MG F 301s coo 15.40 22.79 16.66 13.93 24.10 15.98 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 19.95 18.98 4.81 18.82 20.94 10.49 69.70 58.57 -86.86 69.67 53.74 -90.29 coo 16.32 15.30 17.19 17.71 14.73 18.69 57.76 53.73 -90.50 57.46 51.64 -90.28 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 12 3 # 12 A 105 HIS F 170 HIS^? 9.84 MG MG F 302 C 62 LYS F 166 LYS^? 20.76 MG MG F 302 F 35 ASP F 171 ASP^? 16.35 MG MG F 302 coo 15.40 22.79 16.66 13.93 24.10 15.98 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 19.95 18.98 4.81 18.82 20.94 10.49 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 16.32 15.30 17.19 17.71 14.73 18.69 48.23 68.08 -88.47 46.26 68.02 -87.56 1f80_c03 source 1f80 ACYL CARRIER PROTEIN : 12 hits 1f80_c03 naa= 3 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 1 3 # 1 B 62 LYS A 111 LYS^? 15.16 MG MG A 301 C 105 HIS A 147 HIS^? 9.20 MG MG A 302 D 35 ASP A 128 ASP^? -3.32 MG MG A 301s coo 38.76 28.25 7.87 36.33 26.41 13.58 52.67 17.19 35.90 54.65 19.90 40.50 coo 34.93 19.72 17.37 34.72 18.17 15.98 40.24 23.10 39.83 38.32 22.34 40.22 coo 41.01 23.02 20.83 40.65 24.26 22.55 46.50 28.23 39.77 47.49 30.10 39.82 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 2 3 # 2 B 62 LYS A 166 LYS^? 20.93 MG MG A 302 C 105 HIS A 170 HIS^? 10.56 MG MG A 302 D 35 ASP A 171 ASP^? 17.17 MG MG A 302 coo 38.76 28.25 7.87 36.33 26.41 13.58 35.34 13.14 30.41 31.67 15.04 34.58 coo 34.93 19.72 17.37 34.72 18.17 15.98 34.91 23.57 39.32 34.35 24.95 40.81 coo 41.01 23.02 20.83 40.65 24.26 22.55 29.78 23.67 36.63 28.48 25.11 35.71 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 3 3 # 3 B 62 LYS B 111 LYS^? 13.75 MG MG B 302 C 105 HIS B 147 HIS^? 9.27 MG MG B 301 D 35 ASP B 128 ASP^? -3.57 MG MG B 302s coo 38.76 28.25 7.87 36.33 26.41 13.58 42.84 32.14 1.80 46.84 32.68 -2.87 coo 34.93 19.72 17.37 34.72 18.17 15.98 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 41.01 23.02 20.83 40.65 24.26 22.55 52.92 24.09 -2.19 54.73 25.14 -1.90 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 4 3 # 4 B 62 LYS C 111 LYS^? 16.56 MG MG C 302 C 105 HIS C 147 HIS^? 9.44 MG MG C 301 D 35 ASP C 128 ASP^? -3.22 MG MG C 302s coo 38.76 28.25 7.87 36.33 26.41 13.58 86.36 39.56 -8.06 84.36 40.84 -3.15 coo 34.93 19.72 17.37 34.72 18.17 15.98 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 41.01 23.02 20.83 40.65 24.26 22.55 80.05 28.39 -4.25 77.97 28.60 -4.21 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 5 3 # 5 B 62 LYS C 166 LYS^? 22.53 MG MG C 301 C 105 HIS D 42 HIS^? 28.21 MG MG D 302 D 35 ASP C 160 ASP^? 31.63 MG MG D 302 coo 38.76 28.25 7.87 36.33 26.41 13.58 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 34.93 19.72 17.37 34.72 18.17 15.98 98.45 29.90 -26.44 99.32 28.02 -26.13 coo 41.01 23.02 20.83 40.65 24.26 22.55 102.50 38.00 -23.28 102.43 39.97 -22.46 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 6 3 # 6 B 62 LYS D 111 LYS^? 15.85 MG MG D 302 C 105 HIS D 147 HIS^? 9.43 MG MG D 301 D 35 ASP D 128 ASP^? -3.70 MG MG D 302s coo 38.76 28.25 7.87 36.33 26.41 13.58 81.21 22.69 -42.10 78.68 23.89 -46.57 coo 34.93 19.72 17.37 34.72 18.17 15.98 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 41.01 23.02 20.83 40.65 24.26 22.55 83.33 35.45 -46.13 81.57 36.63 -46.10 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 7 3 # 7 B 62 LYS D 166 LYS^? 21.08 MG MG D 301 C 105 HIS D 170 HIS^? 10.59 MG MG D 301 D 35 ASP D 171 ASP^? 16.95 MG MG D 301 coo 38.76 28.25 7.87 36.33 26.41 13.58 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 34.93 19.72 17.37 34.72 18.17 15.98 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 41.01 23.02 20.83 40.65 24.26 22.55 100.39 36.69 -43.49 101.13 38.51 -42.69 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 8 3 # 8 B 62 LYS E 111 LYS^? 14.52 MG MG E 302 C 105 HIS E 147 HIS^? 9.22 MG MG E 301 D 35 ASP E 128 ASP^? -3.53 MG MG E 302s coo 38.76 28.25 7.87 36.33 26.41 13.58 52.49 56.44 -52.43 54.52 53.78 -47.52 coo 34.93 19.72 17.37 34.72 18.17 15.98 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 41.01 23.02 20.83 40.65 24.26 22.55 65.38 56.57 -48.58 66.15 54.57 -48.61 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 9 3 # 9 B 62 LYS E 166 LYS^? 21.46 MG MG E 301 C 105 HIS E 170 HIS^? 10.33 MG MG E 301 D 35 ASP E 171 ASP^? 16.73 MG MG E 301 coo 38.76 28.25 7.87 36.33 26.41 13.58 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 34.93 19.72 17.37 34.72 18.17 15.98 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 41.01 23.02 20.83 40.65 24.26 22.55 69.61 73.12 -51.56 71.50 73.53 -52.39 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 10 3 # 10 B 62 LYS F 111 LYS^? 15.21 MG MG F 301 C 105 HIS F 147 HIS^? 8.79 MG MG F 302 D 35 ASP F 128 ASP^? -3.41 MG MG F 301s coo 38.76 28.25 7.87 36.33 26.41 13.58 69.70 58.57 -86.86 69.67 53.74 -90.29 coo 34.93 19.72 17.37 34.72 18.17 15.98 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 41.01 23.02 20.83 40.65 24.26 22.55 57.76 53.73 -90.50 57.46 51.64 -90.28 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 11 3 # 11 B 62 LYS F 166 LYS^? 20.76 MG MG F 302 C 105 HIS F 170 HIS^? 9.84 MG MG F 302 D 35 ASP F 171 ASP^? 16.35 MG MG F 302 coo 38.76 28.25 7.87 36.33 26.41 13.58 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 34.93 19.72 17.37 34.72 18.17 15.98 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 41.01 23.02 20.83 40.65 24.26 22.55 48.23 68.08 -88.47 46.26 68.02 -87.56 1f80_c04 source 1f80 ACYL CARRIER PROTEIN : 11 hits 1f80_c04 naa= 3 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 1 3 # 1 A 62 LYS A 111 LYS^? 15.16 MG MG A 301 B 105 HIS A 147 HIS^? 9.20 MG MG A 302 E 35 ASP A 128 ASP^? -3.32 MG MG A 301s coo 20.51 39.76 8.83 21.23 37.38 14.18 52.67 17.19 35.90 54.65 19.90 40.50 coo 27.18 37.56 20.68 29.07 38.28 20.13 40.24 23.10 39.83 38.32 22.34 40.22 coo 19.97 40.39 22.03 18.53 39.30 23.18 46.50 28.23 39.77 47.49 30.10 39.82 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 2 3 # 2 A 62 LYS B 111 LYS^? 13.75 MG MG B 302 B 105 HIS B 147 HIS^? 9.27 MG MG B 301 E 35 ASP B 128 ASP^? -3.57 MG MG B 302s coo 20.51 39.76 8.83 21.23 37.38 14.18 42.84 32.14 1.80 46.84 32.68 -2.87 coo 27.18 37.56 20.68 29.07 38.28 20.13 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 19.97 40.39 22.03 18.53 39.30 23.18 52.92 24.09 -2.19 54.73 25.14 -1.90 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 3 3 # 3 A 62 LYS C 111 LYS^? 16.56 MG MG C 302 B 105 HIS C 147 HIS^? 9.44 MG MG C 301 E 35 ASP C 128 ASP^? -3.22 MG MG C 302s coo 20.51 39.76 8.83 21.23 37.38 14.18 86.36 39.56 -8.06 84.36 40.84 -3.15 coo 27.18 37.56 20.68 29.07 38.28 20.13 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 19.97 40.39 22.03 18.53 39.30 23.18 80.05 28.39 -4.25 77.97 28.60 -4.21 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 4 3 # 4 A 62 LYS D 111 LYS^? 15.85 MG MG D 302 B 105 HIS D 147 HIS^? 9.43 MG MG D 301 E 35 ASP D 128 ASP^? -3.70 MG MG D 302s coo 20.51 39.76 8.83 21.23 37.38 14.18 81.21 22.69 -42.10 78.68 23.89 -46.57 coo 27.18 37.56 20.68 29.07 38.28 20.13 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 19.97 40.39 22.03 18.53 39.30 23.18 83.33 35.45 -46.13 81.57 36.63 -46.10 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 5 3 # 5 A 62 LYS E 111 LYS^? 14.52 MG MG E 302 B 105 HIS E 147 HIS^? 9.22 MG MG E 301 E 35 ASP E 128 ASP^? -3.53 MG MG E 302s coo 20.51 39.76 8.83 21.23 37.38 14.18 52.49 56.44 -52.43 54.52 53.78 -47.52 coo 27.18 37.56 20.68 29.07 38.28 20.13 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 19.97 40.39 22.03 18.53 39.30 23.18 65.38 56.57 -48.58 66.15 54.57 -48.61 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 6 3 # 6 A 62 LYS F 111 LYS^? 15.21 MG MG F 301 B 105 HIS F 147 HIS^? 8.79 MG MG F 302 E 35 ASP F 128 ASP^? -3.41 MG MG F 301s coo 20.51 39.76 8.83 21.23 37.38 14.18 69.70 58.57 -86.86 69.67 53.74 -90.29 coo 27.18 37.56 20.68 29.07 38.28 20.13 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 19.97 40.39 22.03 18.53 39.30 23.18 57.76 53.73 -90.50 57.46 51.64 -90.28 1f80_c05 source 1f80 ACYL CARRIER PROTEIN : 6 hits 1f80_c05 naa= 3 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 112 PHE A 12 PHE^? 17.15 MG MG A 301 A 210 ASP A 171 ASP^? 17.17 MG MG A 302 A 244 LYS A 166 LYS^? 20.93 MG MG A 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 34.93 27.27 29.42 32.88 25.47 30.10 coo 10.51 37.86 19.71 9.07 39.38 20.04 29.78 23.67 36.63 28.48 25.11 35.71 coo -1.20 42.34 17.67 3.19 45.13 19.06 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 112 PHE A 32 PHE^? 15.95 MG MG A 301 A 210 ASP A 35 ASP^? 16.92 MG MG A 301 A 244 LYS B 61 LYS^? 22.03 MG MG A 301 coo 9.23 46.77 25.11 11.48 48.39 24.76 37.63 41.69 31.55 39.27 43.59 32.74 coo 10.51 37.86 19.71 9.07 39.38 20.04 34.49 31.10 26.54 36.41 31.82 27.10 coo -1.20 42.34 17.67 3.19 45.13 19.06 32.50 37.62 17.61 36.68 34.92 21.51 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 A 112 PHE A 59 PHE^? 31.59 MG MG A 301 A 210 ASP A 138 ASP^? 33.08 MG MG A 302 A 244 LYS A 157 LYS^? 28.65 MG MG A 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 52.93 4.70 25.02 52.08 5.30 27.62 coo 10.51 37.86 19.71 9.07 39.38 20.04 47.10 -0.97 29.63 45.89 0.22 30.96 coo -1.20 42.34 17.67 3.19 45.13 19.06 41.42 12.06 27.58 41.46 5.93 29.41 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 A 112 PHE A 59 PHE^? 31.59 MG MG A 301 A 210 ASP A 160 ASP^? 31.61 MG MG B 302 A 244 LYS A 157 LYS^? 28.65 MG MG A 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 52.93 4.70 25.02 52.08 5.30 27.62 coo 10.51 37.86 19.71 9.07 39.38 20.04 44.21 5.00 19.54 46.02 3.84 19.76 coo -1.20 42.34 17.67 3.19 45.13 19.06 41.42 12.06 27.58 41.46 5.93 29.41 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 A 112 PHE A 65 PHE^? 25.49 MG MG B 302 A 210 ASP B 35 ASP^? 16.92 MG MG B 302 A 244 LYS B 90 LYS^? 18.68 MG MG B 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 54.96 15.58 21.17 56.65 13.84 19.74 coo 10.51 37.86 19.71 9.07 39.38 20.04 52.63 11.07 10.18 53.68 12.85 9.94 coo -1.20 42.34 17.67 3.19 45.13 19.06 61.66 21.61 12.88 56.74 22.88 14.81 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 A 112 PHE A 110 PHE^? 21.60 MG MG A 301 A 210 ASP A 58 ASP^? 26.75 MG MG B 302 A 244 LYS A 137 LYS^? 34.85 MG MG A 301 coo 9.23 46.77 25.11 11.48 48.39 24.76 53.06 14.15 32.16 50.69 13.44 30.81 coo 10.51 37.86 19.71 9.07 39.38 20.04 53.93 9.80 21.09 53.83 8.90 19.15 coo -1.20 42.34 17.67 3.19 45.13 19.06 50.97 1.58 28.14 56.13 1.49 28.03 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 A 112 PHE A 110 PHE^? 21.60 MG MG A 301 A 210 ASP A 58 ASP^? 26.75 MG MG B 302 A 244 LYS A 157 LYS^? 28.65 MG MG A 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 53.06 14.15 32.16 50.69 13.44 30.81 coo 10.51 37.86 19.71 9.07 39.38 20.04 53.93 9.80 21.09 53.83 8.90 19.15 coo -1.20 42.34 17.67 3.19 45.13 19.06 41.42 12.06 27.58 41.46 5.93 29.41 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 A 112 PHE A 110 PHE^? 21.60 MG MG A 301 A 210 ASP A 142 ASP^? 23.70 MG MG A 302 A 244 LYS A 137 LYS^? 34.85 MG MG A 301 coo 9.23 46.77 25.11 11.48 48.39 24.76 53.06 14.15 32.16 50.69 13.44 30.81 coo 10.51 37.86 19.71 9.07 39.38 20.04 46.39 7.18 37.53 46.28 7.18 39.63 coo -1.20 42.34 17.67 3.19 45.13 19.06 50.97 1.58 28.14 56.13 1.49 28.03 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 9 3 # 9 A 112 PHE A 110 PHE^? 21.60 MG MG A 301 A 210 ASP A 142 ASP^? 23.70 MG MG A 302 A 244 LYS A 157 LYS^? 28.65 MG MG A 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 53.06 14.15 32.16 50.69 13.44 30.81 coo 10.51 37.86 19.71 9.07 39.38 20.04 46.39 7.18 37.53 46.28 7.18 39.63 coo -1.20 42.34 17.67 3.19 45.13 19.06 41.42 12.06 27.58 41.46 5.93 29.41 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 10 3 # 10 A 112 PHE A 153 PHE^? 9.64 MG MG A 301 A 210 ASP A 128 ASP^? -3.32 MG MG A 301s A 244 LYS A 111 LYS^? 15.16 MG MG A 301 coo 9.23 46.77 25.11 11.48 48.39 24.76 38.89 24.49 36.07 40.14 26.70 37.23 coo 10.51 37.86 19.71 9.07 39.38 20.04 46.50 28.23 39.77 47.49 30.10 39.82 coo -1.20 42.34 17.67 3.19 45.13 19.06 52.67 17.19 35.90 54.65 19.90 40.50 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 11 3 # 11 A 112 PHE A 153 PHE^? 9.64 MG MG A 301 A 210 ASP A 171 ASP^? 17.17 MG MG A 302 A 244 LYS A 166 LYS^? 20.93 MG MG A 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 38.89 24.49 36.07 40.14 26.70 37.23 coo 10.51 37.86 19.71 9.07 39.38 20.04 29.78 23.67 36.63 28.48 25.11 35.71 coo -1.20 42.34 17.67 3.19 45.13 19.06 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 12 3 # 12 A 112 PHE A 161 PHE^? 25.62 MG MG B 302 A 210 ASP A 58 ASP^? 26.75 MG MG B 302 A 244 LYS A 157 LYS^? 28.65 MG MG A 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 44.24 9.29 16.03 46.90 9.95 15.56 coo 10.51 37.86 19.71 9.07 39.38 20.04 53.93 9.80 21.09 53.83 8.90 19.15 coo -1.20 42.34 17.67 3.19 45.13 19.06 41.42 12.06 27.58 41.46 5.93 29.41 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 13 3 # 13 A 112 PHE A 161 PHE^? 25.62 MG MG B 302 A 210 ASP B 35 ASP^? 16.92 MG MG B 302 A 244 LYS A 61 LYS^? 21.99 MG MG B 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 44.24 9.29 16.03 46.90 9.95 15.56 coo 10.51 37.86 19.71 9.07 39.38 20.04 52.63 11.07 10.18 53.68 12.85 9.94 coo -1.20 42.34 17.67 3.19 45.13 19.06 57.78 7.35 19.60 56.77 12.20 15.61 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 14 3 # 14 A 112 PHE A 190 PHE^? 14.49 MG MG A 302 A 210 ASP A 142 ASP^? 23.70 MG MG A 302 A 244 LYS A 111 LYS^? 15.16 MG MG A 301 coo 9.23 46.77 25.11 11.48 48.39 24.76 39.84 16.38 40.26 41.25 17.12 37.97 coo 10.51 37.86 19.71 9.07 39.38 20.04 46.39 7.18 37.53 46.28 7.18 39.63 coo -1.20 42.34 17.67 3.19 45.13 19.06 52.67 17.19 35.90 54.65 19.90 40.50 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 15 3 # 15 A 112 PHE A 190 PHE^? 14.49 MG MG A 302 A 210 ASP A 142 ASP^? 23.70 MG MG A 302 A 244 LYS A 157 LYS^? 28.65 MG MG A 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 39.84 16.38 40.26 41.25 17.12 37.97 coo 10.51 37.86 19.71 9.07 39.38 20.04 46.39 7.18 37.53 46.28 7.18 39.63 coo -1.20 42.34 17.67 3.19 45.13 19.06 41.42 12.06 27.58 41.46 5.93 29.41 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 16 3 # 16 A 112 PHE B 12 PHE^? 17.13 MG MG B 302 A 210 ASP B 171 ASP^? 16.92 MG MG B 301 A 244 LYS B 166 LYS^? 22.75 MG MG B 301 coo 9.23 46.77 25.11 11.48 48.39 24.76 49.02 12.29 7.19 47.01 10.60 6.19 coo 10.51 37.86 19.71 9.07 39.38 20.04 45.30 8.50 -0.71 46.30 6.81 0.12 coo -1.20 42.34 17.67 3.19 45.13 19.06 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 17 3 # 17 A 112 PHE B 32 PHE^? 15.77 MG MG B 302 A 210 ASP B 35 ASP^? 16.92 MG MG B 302 A 244 LYS B 90 LYS^? 18.68 MG MG B 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 63.68 12.44 5.83 65.90 13.72 4.72 coo 10.51 37.86 19.71 9.07 39.38 20.04 52.63 11.07 10.18 53.68 12.85 9.94 coo -1.20 42.34 17.67 3.19 45.13 19.06 61.66 21.61 12.88 56.74 22.88 14.81 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 18 3 # 18 A 112 PHE B 59 PHE^? 31.31 MG MG B 302 A 210 ASP B 138 ASP^? 33.32 MG MG B 302 A 244 LYS B 157 LYS^? 28.85 MG MG B 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 29.63 33.55 11.36 30.42 32.81 8.75 coo 10.51 37.86 19.71 9.07 39.38 20.04 23.42 29.01 6.78 24.36 28.48 4.94 coo -1.20 42.34 17.67 3.19 45.13 19.06 34.97 21.28 8.44 29.03 22.82 6.58 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 19 3 # 19 A 112 PHE B 59 PHE^? 31.31 MG MG B 302 A 210 ASP B 160 ASP^? 31.65 MG MG A 301 A 244 LYS B 157 LYS^? 28.85 MG MG B 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 29.63 33.55 11.36 30.42 32.81 8.75 coo 10.51 37.86 19.71 9.07 39.38 20.04 28.01 24.83 16.38 27.44 26.81 15.80 coo -1.20 42.34 17.67 3.19 45.13 19.06 34.97 21.28 8.44 29.03 22.82 6.58 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 20 3 # 20 A 112 PHE B 65 PHE^? 25.48 MG MG A 301 A 210 ASP A 35 ASP^? 16.92 MG MG A 301 A 244 LYS A 90 LYS^? 18.58 MG MG A 301 coo 9.23 46.77 25.11 11.48 48.39 24.76 40.29 33.39 16.17 38.73 35.25 17.59 coo 10.51 37.86 19.71 9.07 39.38 20.04 34.49 31.10 26.54 36.41 31.82 27.10 coo -1.20 42.34 17.67 3.19 45.13 19.06 46.62 38.29 25.46 47.51 33.29 23.22 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 21 3 # 21 A 112 PHE B 110 PHE^? 21.49 MG MG B 302 A 210 ASP B 58 ASP^? 26.73 MG MG A 301 A 244 LYS B 137 LYS^? 34.56 MG MG B 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 39.39 32.59 5.17 38.42 30.20 6.23 coo 10.51 37.86 19.71 9.07 39.38 20.04 34.42 33.56 15.74 33.50 33.49 17.59 coo -1.20 42.34 17.67 3.19 45.13 19.06 26.56 32.46 7.93 27.87 37.71 9.31 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 22 3 # 22 A 112 PHE B 110 PHE^? 21.49 MG MG B 302 A 210 ASP B 58 ASP^? 26.73 MG MG A 301 A 244 LYS B 157 LYS^? 28.85 MG MG B 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 39.39 32.59 5.17 38.42 30.20 6.23 coo 10.51 37.86 19.71 9.07 39.38 20.04 34.42 33.56 15.74 33.50 33.49 17.59 coo -1.20 42.34 17.67 3.19 45.13 19.06 34.97 21.28 8.44 29.03 22.82 6.58 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 23 3 # 23 A 112 PHE B 110 PHE^? 21.49 MG MG B 302 A 210 ASP B 142 ASP^? 23.97 MG MG B 301 A 244 LYS B 137 LYS^? 34.56 MG MG B 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 39.39 32.59 5.17 38.42 30.20 6.23 coo 10.51 37.86 19.71 9.07 39.38 20.04 31.69 27.40 -1.31 32.10 27.37 -3.38 coo -1.20 42.34 17.67 3.19 45.13 19.06 26.56 32.46 7.93 27.87 37.71 9.31 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 24 3 # 24 A 112 PHE B 110 PHE^? 21.49 MG MG B 302 A 210 ASP B 142 ASP^? 23.97 MG MG B 301 A 244 LYS B 157 LYS^? 28.85 MG MG B 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 39.39 32.59 5.17 38.42 30.20 6.23 coo 10.51 37.86 19.71 9.07 39.38 20.04 31.69 27.40 -1.31 32.10 27.37 -3.38 coo -1.20 42.34 17.67 3.19 45.13 19.06 34.97 21.28 8.44 29.03 22.82 6.58 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 25 3 # 25 A 112 PHE B 153 PHE^? 9.59 MG MG B 302 A 210 ASP B 171 ASP^? 16.92 MG MG B 301 A 244 LYS B 166 LYS^? 22.75 MG MG B 301 coo 9.23 46.77 25.11 11.48 48.39 24.76 47.54 17.09 0.77 50.03 17.91 -0.19 coo 10.51 37.86 19.71 9.07 39.38 20.04 45.30 8.50 -0.71 46.30 6.81 0.12 coo -1.20 42.34 17.67 3.19 45.13 19.06 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 26 3 # 26 A 112 PHE B 161 PHE^? 25.78 MG MG A 301 A 210 ASP A 35 ASP^? 16.92 MG MG A 301 A 244 LYS B 61 LYS^? 22.03 MG MG A 301 coo 9.23 46.77 25.11 11.48 48.39 24.76 31.87 23.58 19.99 32.61 26.21 20.65 coo 10.51 37.86 19.71 9.07 39.38 20.04 34.49 31.10 26.54 36.41 31.82 27.10 coo -1.20 42.34 17.67 3.19 45.13 19.06 32.50 37.62 17.61 36.68 34.92 21.51 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 27 3 # 27 A 112 PHE B 161 PHE^? 25.78 MG MG A 301 A 210 ASP B 58 ASP^? 26.73 MG MG A 301 A 244 LYS B 157 LYS^? 28.85 MG MG B 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 31.87 23.58 19.99 32.61 26.21 20.65 coo 10.51 37.86 19.71 9.07 39.38 20.04 34.42 33.56 15.74 33.50 33.49 17.59 coo -1.20 42.34 17.67 3.19 45.13 19.06 34.97 21.28 8.44 29.03 22.82 6.58 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 28 3 # 28 A 112 PHE B 190 PHE^? 14.80 MG MG B 301 A 210 ASP B 142 ASP^? 23.97 MG MG B 301 A 244 LYS B 111 LYS^? 13.75 MG MG B 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 40.06 19.97 -3.89 40.77 21.13 -1.45 coo 10.51 37.86 19.71 9.07 39.38 20.04 31.69 27.40 -1.31 32.10 27.37 -3.38 coo -1.20 42.34 17.67 3.19 45.13 19.06 42.84 32.14 1.80 46.84 32.68 -2.87 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 29 3 # 29 A 112 PHE B 190 PHE^? 14.80 MG MG B 301 A 210 ASP B 142 ASP^? 23.97 MG MG B 301 A 244 LYS B 157 LYS^? 28.85 MG MG B 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 40.06 19.97 -3.89 40.77 21.13 -1.45 coo 10.51 37.86 19.71 9.07 39.38 20.04 31.69 27.40 -1.31 32.10 27.37 -3.38 coo -1.20 42.34 17.67 3.19 45.13 19.06 34.97 21.28 8.44 29.03 22.82 6.58 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 30 3 # 30 A 112 PHE C 12 PHE^? 16.92 MG MG C 302 A 210 ASP C 171 ASP^? 17.08 MG MG C 301 A 244 LYS C 166 LYS^? 22.53 MG MG C 301 coo 9.23 46.77 25.11 11.48 48.39 24.76 87.42 18.93 -13.86 90.00 18.25 -12.97 coo 10.51 37.86 19.71 9.07 39.38 20.04 92.57 16.68 -6.24 92.24 14.74 -7.03 coo -1.20 42.34 17.67 3.19 45.13 19.06 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 31 3 # 31 A 112 PHE C 32 PHE^? 15.72 MG MG C 302 A 210 ASP C 35 ASP^? 16.42 MG MG C 302 A 244 LYS C 90 LYS^? 18.24 MG MG C 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 73.89 13.66 -12.38 71.29 14.19 -11.42 coo 10.51 37.86 19.71 9.07 39.38 20.04 84.40 16.53 -16.68 82.83 17.91 -16.28 coo -1.20 42.34 17.67 3.19 45.13 19.06 72.37 23.25 -18.94 76.11 26.52 -20.97 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 32 3 # 32 A 112 PHE C 32 PHE^? 15.72 MG MG C 302 A 210 ASP C 35 ASP^? 16.42 MG MG C 302 A 244 LYS D 61 LYS^? 21.93 MG MG C 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 73.89 13.66 -12.38 71.29 14.19 -11.42 coo 10.51 37.86 19.71 9.07 39.38 20.04 84.40 16.53 -16.68 82.83 17.91 -16.28 coo -1.20 42.34 17.67 3.19 45.13 19.06 80.64 11.23 -26.16 80.65 16.24 -22.36 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 33 3 # 33 A 112 PHE C 59 PHE^? 31.23 MG MG C 302 A 210 ASP C 138 ASP^? 33.43 MG MG C 302 A 244 LYS C 157 LYS^? 28.15 MG MG C 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 98.06 45.52 -18.00 97.73 44.36 -15.53 coo 10.51 37.86 19.71 9.07 39.38 20.04 105.43 43.97 -13.30 104.85 43.08 -11.43 coo -1.20 42.34 17.67 3.19 45.13 19.06 97.55 32.04 -15.10 101.49 36.24 -13.39 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 34 3 # 34 A 112 PHE C 59 PHE^? 31.23 MG MG C 302 A 210 ASP C 160 ASP^? 31.63 MG MG D 302 A 244 LYS C 157 LYS^? 28.15 MG MG C 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 98.06 45.52 -18.00 97.73 44.36 -15.53 coo 10.51 37.86 19.71 9.07 39.38 20.04 102.50 38.00 -23.28 102.43 39.97 -22.46 coo -1.20 42.34 17.67 3.19 45.13 19.06 97.55 32.04 -15.10 101.49 36.24 -13.39 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 35 3 # 35 A 112 PHE C 65 PHE^? 25.41 MG MG D 302 A 210 ASP D 35 ASP^? 16.80 MG MG D 302 A 244 LYS D 90 LYS^? 18.98 MG MG D 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 87.79 41.78 -22.56 88.44 44.04 -24.09 coo 10.51 37.86 19.71 9.07 39.38 20.04 93.83 42.00 -33.14 91.74 41.83 -33.51 coo -1.20 42.34 17.67 3.19 45.13 19.06 79.83 44.38 -31.44 80.32 39.55 -29.40 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 36 3 # 36 A 112 PHE C 110 PHE^? 21.25 MG MG C 302 A 210 ASP C 58 ASP^? 26.67 MG MG D 302 A 244 LYS C 137 LYS^? 35.41 MG MG C 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 89.08 41.33 -11.45 90.83 39.43 -12.52 coo 10.51 37.86 19.71 9.07 39.38 20.04 93.40 43.81 -22.27 94.18 44.45 -24.11 coo -1.20 42.34 17.67 3.19 45.13 19.06 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 37 3 # 37 A 112 PHE C 110 PHE^? 21.25 MG MG C 302 A 210 ASP C 58 ASP^? 26.67 MG MG D 302 A 244 LYS C 157 LYS^? 28.15 MG MG C 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 89.08 41.33 -11.45 90.83 39.43 -12.52 coo 10.51 37.86 19.71 9.07 39.38 20.04 93.40 43.81 -22.27 94.18 44.45 -24.11 coo -1.20 42.34 17.67 3.19 45.13 19.06 97.55 32.04 -15.10 101.49 36.24 -13.39 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 38 3 # 38 A 112 PHE C 110 PHE^? 21.25 MG MG C 302 A 210 ASP C 142 ASP^? 23.76 MG MG C 301 A 244 LYS C 137 LYS^? 35.41 MG MG C 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 89.08 41.33 -11.45 90.83 39.43 -12.52 coo 10.51 37.86 19.71 9.07 39.38 20.04 97.94 39.27 -5.03 98.08 38.70 -2.97 coo -1.20 42.34 17.67 3.19 45.13 19.06 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 39 3 # 39 A 112 PHE C 110 PHE^? 21.25 MG MG C 302 A 210 ASP C 142 ASP^? 23.76 MG MG C 301 A 244 LYS C 157 LYS^? 28.15 MG MG C 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 89.08 41.33 -11.45 90.83 39.43 -12.52 coo 10.51 37.86 19.71 9.07 39.38 20.04 97.94 39.27 -5.03 98.08 38.70 -2.97 coo -1.20 42.34 17.67 3.19 45.13 19.06 97.55 32.04 -15.10 101.49 36.24 -13.39 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 40 3 # 40 A 112 PHE C 153 PHE^? 9.34 MG MG C 302 A 210 ASP C 171 ASP^? 17.08 MG MG C 301 A 244 LYS C 166 LYS^? 22.53 MG MG C 301 coo 9.23 46.77 25.11 11.48 48.39 24.76 87.15 23.83 -7.29 84.55 23.79 -6.26 coo 10.51 37.86 19.71 9.07 39.38 20.04 92.57 16.68 -6.24 92.24 14.74 -7.03 coo -1.20 42.34 17.67 3.19 45.13 19.06 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 41 3 # 41 A 112 PHE C 161 PHE^? 25.47 MG MG D 302 A 210 ASP C 58 ASP^? 26.67 MG MG D 302 A 244 LYS C 157 LYS^? 28.15 MG MG C 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 98.98 35.62 -26.76 97.40 37.84 -27.44 coo 10.51 37.86 19.71 9.07 39.38 20.04 93.40 43.81 -22.27 94.18 44.45 -24.11 coo -1.20 42.34 17.67 3.19 45.13 19.06 97.55 32.04 -15.10 101.49 36.24 -13.39 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 42 3 # 42 A 112 PHE C 161 PHE^? 25.47 MG MG D 302 A 210 ASP D 35 ASP^? 16.80 MG MG D 302 A 244 LYS C 61 LYS^? 21.91 MG MG D 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 98.98 35.62 -26.76 97.40 37.84 -27.44 coo 10.51 37.86 19.71 9.07 39.38 20.04 93.83 42.00 -33.14 91.74 41.83 -33.51 coo -1.20 42.34 17.67 3.19 45.13 19.06 93.60 48.56 -24.05 90.39 44.71 -27.98 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 43 3 # 43 A 112 PHE C 190 PHE^? 14.91 MG MG C 301 A 210 ASP C 142 ASP^? 23.76 MG MG C 301 A 244 LYS C 111 LYS^? 16.56 MG MG C 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 93.44 29.01 -2.85 92.36 29.94 -5.20 coo 10.51 37.86 19.71 9.07 39.38 20.04 97.94 39.27 -5.03 98.08 38.70 -2.97 coo -1.20 42.34 17.67 3.19 45.13 19.06 86.36 39.56 -8.06 84.36 40.84 -3.15 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 44 3 # 44 A 112 PHE C 190 PHE^? 14.91 MG MG C 301 A 210 ASP C 142 ASP^? 23.76 MG MG C 301 A 244 LYS C 157 LYS^? 28.15 MG MG C 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 93.44 29.01 -2.85 92.36 29.94 -5.20 coo 10.51 37.86 19.71 9.07 39.38 20.04 97.94 39.27 -5.03 98.08 38.70 -2.97 coo -1.20 42.34 17.67 3.19 45.13 19.06 97.55 32.04 -15.10 101.49 36.24 -13.39 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 45 3 # 45 A 112 PHE D 12 PHE^? 16.78 MG MG D 302 A 210 ASP D 171 ASP^? 16.95 MG MG D 301 A 244 LYS D 166 LYS^? 21.08 MG MG D 301 coo 9.23 46.77 25.11 11.48 48.39 24.76 94.68 38.11 -36.05 97.16 37.10 -36.83 coo 10.51 37.86 19.71 9.07 39.38 20.04 100.39 36.69 -43.49 101.13 38.51 -42.69 coo -1.20 42.34 17.67 3.19 45.13 19.06 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 46 3 # 46 A 112 PHE D 32 PHE^? 15.68 MG MG D 302 A 210 ASP D 35 ASP^? 16.80 MG MG D 302 A 244 LYS C 61 LYS^? 21.91 MG MG D 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 87.15 50.70 -38.09 84.99 51.79 -39.44 coo 10.51 37.86 19.71 9.07 39.38 20.04 93.83 42.00 -33.14 91.74 41.83 -33.51 coo -1.20 42.34 17.67 3.19 45.13 19.06 93.60 48.56 -24.05 90.39 44.71 -27.98 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 47 3 # 47 A 112 PHE D 32 PHE^? 15.68 MG MG D 302 A 210 ASP D 35 ASP^? 16.80 MG MG D 302 A 244 LYS D 90 LYS^? 18.98 MG MG D 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 87.15 50.70 -38.09 84.99 51.79 -39.44 coo 10.51 37.86 19.71 9.07 39.38 20.04 93.83 42.00 -33.14 91.74 41.83 -33.51 coo -1.20 42.34 17.67 3.19 45.13 19.06 79.83 44.38 -31.44 80.32 39.55 -29.40 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 48 3 # 48 A 112 PHE D 59 PHE^? 31.49 MG MG D 302 A 210 ASP D 138 ASP^? 33.64 MG MG D 302 A 244 LYS D 157 LYS^? 28.67 MG MG D 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 86.17 10.70 -31.86 86.41 11.56 -34.53 coo 10.51 37.86 19.71 9.07 39.38 20.04 93.00 7.50 -35.79 93.88 8.48 -37.45 coo -1.20 42.34 17.67 3.19 45.13 19.06 94.17 21.71 -34.34 96.11 15.89 -35.92 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 49 3 # 49 A 112 PHE D 59 PHE^? 31.49 MG MG D 302 A 210 ASP D 160 ASP^? 31.45 MG MG C 302 A 244 LYS D 157 LYS^? 28.67 MG MG D 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 86.17 10.70 -31.86 86.41 11.56 -34.53 coo 10.51 37.86 19.71 9.07 39.38 20.04 94.15 13.98 -26.57 92.71 12.42 -26.99 coo -1.20 42.34 17.67 3.19 45.13 19.06 94.17 21.71 -34.34 96.11 15.89 -35.92 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 50 3 # 50 A 112 PHE D 65 PHE^? 25.04 MG MG C 302 A 210 ASP C 35 ASP^? 16.42 MG MG C 302 A 244 LYS C 90 LYS^? 18.24 MG MG C 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 80.36 20.18 -27.62 79.13 18.18 -26.16 coo 10.51 37.86 19.71 9.07 39.38 20.04 84.40 16.53 -16.68 82.83 17.91 -16.28 coo -1.20 42.34 17.67 3.19 45.13 19.06 72.37 23.25 -18.94 76.11 26.52 -20.97 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 51 3 # 51 A 112 PHE D 110 PHE^? 21.56 MG MG D 302 A 210 ASP D 58 ASP^? 26.59 MG MG C 302 A 244 LYS D 137 LYS^? 37.57 MG MG D 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 82.28 19.60 -38.58 84.73 19.89 -37.32 coo 10.51 37.86 19.71 9.07 39.38 20.04 83.38 14.85 -27.71 84.09 14.12 -25.85 coo -1.20 42.34 17.67 3.19 45.13 19.06 88.48 8.58 -35.33 84.88 3.98 -33.96 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 52 3 # 52 A 112 PHE D 110 PHE^? 21.56 MG MG D 302 A 210 ASP D 58 ASP^? 26.59 MG MG C 302 A 244 LYS D 157 LYS^? 28.67 MG MG D 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 82.28 19.60 -38.58 84.73 19.89 -37.32 coo 10.51 37.86 19.71 9.07 39.38 20.04 83.38 14.85 -27.71 84.09 14.12 -25.85 coo -1.20 42.34 17.67 3.19 45.13 19.06 94.17 21.71 -34.34 96.11 15.89 -35.92 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 53 3 # 53 A 112 PHE D 110 PHE^? 21.56 MG MG D 302 A 210 ASP D 142 ASP^? 23.49 MG MG D 301 A 244 LYS D 137 LYS^? 37.57 MG MG D 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 82.28 19.60 -38.58 84.73 19.89 -37.32 coo 10.51 37.86 19.71 9.07 39.38 20.04 90.90 15.58 -44.76 91.35 16.09 -46.79 coo -1.20 42.34 17.67 3.19 45.13 19.06 88.48 8.58 -35.33 84.88 3.98 -33.96 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 54 3 # 54 A 112 PHE D 110 PHE^? 21.56 MG MG D 302 A 210 ASP D 142 ASP^? 23.49 MG MG D 301 A 244 LYS D 157 LYS^? 28.67 MG MG D 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 82.28 19.60 -38.58 84.73 19.89 -37.32 coo 10.51 37.86 19.71 9.07 39.38 20.04 90.90 15.58 -44.76 91.35 16.09 -46.79 coo -1.20 42.34 17.67 3.19 45.13 19.06 94.17 21.71 -34.34 96.11 15.89 -35.92 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 55 3 # 55 A 112 PHE D 153 PHE^? 9.11 MG MG D 302 A 210 ASP D 171 ASP^? 16.95 MG MG D 301 A 244 LYS D 166 LYS^? 21.08 MG MG D 301 coo 9.23 46.77 25.11 11.48 48.39 24.76 91.67 34.35 -42.71 89.76 36.10 -43.73 coo 10.51 37.86 19.71 9.07 39.38 20.04 100.39 36.69 -43.49 101.13 38.51 -42.69 coo -1.20 42.34 17.67 3.19 45.13 19.06 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 56 3 # 56 A 112 PHE D 161 PHE^? 25.58 MG MG C 302 A 210 ASP C 35 ASP^? 16.42 MG MG C 302 A 244 LYS D 61 LYS^? 21.93 MG MG C 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 92.97 17.97 -22.91 90.24 17.44 -22.45 coo 10.51 37.86 19.71 9.07 39.38 20.04 84.40 16.53 -16.68 82.83 17.91 -16.28 coo -1.20 42.34 17.67 3.19 45.13 19.06 80.64 11.23 -26.16 80.65 16.24 -22.36 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 57 3 # 57 A 112 PHE D 161 PHE^? 25.58 MG MG C 302 A 210 ASP D 58 ASP^? 26.59 MG MG C 302 A 244 LYS D 157 LYS^? 28.67 MG MG D 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 92.97 17.97 -22.91 90.24 17.44 -22.45 coo 10.51 37.86 19.71 9.07 39.38 20.04 83.38 14.85 -27.71 84.09 14.12 -25.85 coo -1.20 42.34 17.67 3.19 45.13 19.06 94.17 21.71 -34.34 96.11 15.89 -35.92 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 58 3 # 58 A 112 PHE D 190 PHE^? 14.83 MG MG D 301 A 210 ASP D 142 ASP^? 23.49 MG MG D 301 A 244 LYS D 111 LYS^? 15.85 MG MG D 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 93.52 26.32 -46.94 92.08 26.47 -44.56 coo 10.51 37.86 19.71 9.07 39.38 20.04 90.90 15.58 -44.76 91.35 16.09 -46.79 coo -1.20 42.34 17.67 3.19 45.13 19.06 81.21 22.69 -42.10 78.68 23.89 -46.57 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 59 3 # 59 A 112 PHE D 190 PHE^? 14.83 MG MG D 301 A 210 ASP D 142 ASP^? 23.49 MG MG D 301 A 244 LYS D 157 LYS^? 28.67 MG MG D 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 93.52 26.32 -46.94 92.08 26.47 -44.56 coo 10.51 37.86 19.71 9.07 39.38 20.04 90.90 15.58 -44.76 91.35 16.09 -46.79 coo -1.20 42.34 17.67 3.19 45.13 19.06 94.17 21.71 -34.34 96.11 15.89 -35.92 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 60 3 # 60 A 112 PHE E 12 PHE^? 17.09 MG MG E 302 A 210 ASP E 171 ASP^? 16.73 MG MG E 301 A 244 LYS E 166 LYS^? 21.46 MG MG E 301 coo 9.23 46.77 25.11 11.48 48.39 24.76 70.06 67.18 -58.76 69.33 69.81 -58.07 coo 10.51 37.86 19.71 9.07 39.38 20.04 69.61 73.12 -51.56 71.50 73.53 -52.39 coo -1.20 42.34 17.67 3.19 45.13 19.06 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 61 3 # 61 A 112 PHE E 32 PHE^? 15.82 MG MG E 302 A 210 ASP E 35 ASP^? 16.91 MG MG E 302 A 244 LYS E 90 LYS^? 19.16 MG MG E 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 81.32 57.98 -56.67 82.02 55.52 -55.49 coo 10.51 37.86 19.71 9.07 39.38 20.04 73.60 65.64 -62.00 73.13 63.73 -61.22 coo -1.20 42.34 17.67 3.19 45.13 19.06 73.81 51.50 -63.18 69.15 52.39 -65.65 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 62 3 # 62 A 112 PHE E 59 PHE^? 31.36 MG MG E 302 A 210 ASP E 138 ASP^? 33.31 MG MG E 302 A 244 LYS E 157 LYS^? 28.40 MG MG E 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 41.55 62.67 -62.73 42.33 62.92 -60.06 coo 10.51 37.86 19.71 9.07 39.38 20.04 39.58 70.77 -58.63 40.74 70.78 -56.80 coo -1.20 42.34 17.67 3.19 45.13 19.06 53.63 69.16 -60.42 48.34 71.81 -58.40 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 63 3 # 63 A 112 PHE E 59 PHE^? 31.36 MG MG E 302 A 210 ASP E 160 ASP^? 31.54 MG MG F 301 A 244 LYS E 157 LYS^? 28.40 MG MG E 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 41.55 62.67 -62.73 42.33 62.92 -60.06 coo 10.51 37.86 19.71 9.07 39.38 20.04 45.81 70.00 -68.45 44.10 68.87 -67.77 coo -1.20 42.34 17.67 3.19 45.13 19.06 53.63 69.16 -60.42 48.34 71.81 -58.40 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 64 3 # 64 A 112 PHE E 65 PHE^? 25.27 MG MG F 301 A 210 ASP F 35 ASP^? 16.93 MG MG F 301 A 244 LYS F 90 LYS^? 18.57 MG MG F 301 coo 9.23 46.77 25.11 11.48 48.39 24.76 49.98 55.58 -67.11 47.62 55.01 -68.64 coo 10.51 37.86 19.71 9.07 39.38 20.04 46.82 60.47 -77.63 48.00 58.79 -78.23 coo -1.20 42.34 17.67 3.19 45.13 19.06 51.54 47.01 -75.58 55.05 50.31 -73.74 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 65 3 # 65 A 112 PHE E 110 PHE^? 21.45 MG MG E 302 A 210 ASP E 58 ASP^? 26.76 MG MG F 301 A 244 LYS E 137 LYS^? 35.26 MG MG E 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 49.73 57.83 -56.11 50.46 60.21 -57.41 coo 10.51 37.86 19.71 9.07 39.38 20.04 45.39 59.31 -66.83 44.62 59.88 -68.72 coo -1.20 42.34 17.67 3.19 45.13 19.06 40.01 66.05 -59.66 36.65 60.99 -60.28 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 66 3 # 66 A 112 PHE E 110 PHE^? 21.45 MG MG E 302 A 210 ASP E 58 ASP^? 26.76 MG MG F 301 A 244 LYS E 157 LYS^? 28.40 MG MG E 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 49.73 57.83 -56.11 50.46 60.21 -57.41 coo 10.51 37.86 19.71 9.07 39.38 20.04 45.39 59.31 -66.83 44.62 59.88 -68.72 coo -1.20 42.34 17.67 3.19 45.13 19.06 53.63 69.16 -60.42 48.34 71.81 -58.40 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 67 3 # 67 A 112 PHE E 110 PHE^? 21.45 MG MG E 302 A 210 ASP E 142 ASP^? 23.66 MG MG E 301 A 244 LYS E 137 LYS^? 35.26 MG MG E 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 49.73 57.83 -56.11 50.46 60.21 -57.41 coo 10.51 37.86 19.71 9.07 39.38 20.04 47.19 67.15 -50.37 47.44 67.18 -48.23 coo -1.20 42.34 17.67 3.19 45.13 19.06 40.01 66.05 -59.66 36.65 60.99 -60.28 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 68 3 # 68 A 112 PHE E 110 PHE^? 21.45 MG MG E 302 A 210 ASP E 142 ASP^? 23.66 MG MG E 301 A 244 LYS E 157 LYS^? 28.40 MG MG E 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 49.73 57.83 -56.11 50.46 60.21 -57.41 coo 10.51 37.86 19.71 9.07 39.38 20.04 47.19 67.15 -50.37 47.44 67.18 -48.23 coo -1.20 42.34 17.67 3.19 45.13 19.06 53.63 69.16 -60.42 48.34 71.81 -58.40 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 69 3 # 69 A 112 PHE E 153 PHE^? 9.50 MG MG E 302 A 210 ASP E 171 ASP^? 16.73 MG MG E 301 A 244 LYS E 166 LYS^? 21.46 MG MG E 301 coo 9.23 46.77 25.11 11.48 48.39 24.76 65.86 64.95 -52.12 67.22 62.73 -51.09 coo 10.51 37.86 19.71 9.07 39.38 20.04 69.61 73.12 -51.56 71.50 73.53 -52.39 coo -1.20 42.34 17.67 3.19 45.13 19.06 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 70 3 # 70 A 112 PHE E 161 PHE^? 25.51 MG MG F 301 A 210 ASP E 58 ASP^? 26.76 MG MG F 301 A 244 LYS E 157 LYS^? 28.40 MG MG E 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 49.74 68.03 -71.94 48.60 65.47 -72.38 coo 10.51 37.86 19.71 9.07 39.38 20.04 45.39 59.31 -66.83 44.62 59.88 -68.72 coo -1.20 42.34 17.67 3.19 45.13 19.06 53.63 69.16 -60.42 48.34 71.81 -58.40 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 71 3 # 71 A 112 PHE E 161 PHE^? 25.51 MG MG F 301 A 210 ASP F 35 ASP^? 16.93 MG MG F 301 A 244 LYS E 61 LYS^? 22.16 MG MG F 301 coo 9.23 46.77 25.11 11.48 48.39 24.76 49.74 68.03 -71.94 48.60 65.47 -72.38 coo 10.51 37.86 19.71 9.07 39.38 20.04 46.82 60.47 -77.63 48.00 58.79 -78.23 coo -1.20 42.34 17.67 3.19 45.13 19.06 40.99 56.84 -68.48 45.99 56.72 -72.39 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 72 3 # 72 A 112 PHE E 190 PHE^? 14.70 MG MG E 301 A 210 ASP E 142 ASP^? 23.66 MG MG E 301 A 244 LYS E 111 LYS^? 14.52 MG MG E 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 58.27 67.97 -47.86 58.03 66.58 -50.23 coo 10.51 37.86 19.71 9.07 39.38 20.04 47.19 67.15 -50.37 47.44 67.18 -48.23 coo -1.20 42.34 17.67 3.19 45.13 19.06 52.49 56.44 -52.43 54.52 53.78 -47.52 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 73 3 # 73 A 112 PHE E 190 PHE^? 14.70 MG MG E 301 A 210 ASP E 142 ASP^? 23.66 MG MG E 301 A 244 LYS E 157 LYS^? 28.40 MG MG E 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 58.27 67.97 -47.86 58.03 66.58 -50.23 coo 10.51 37.86 19.71 9.07 39.38 20.04 47.19 67.15 -50.37 47.44 67.18 -48.23 coo -1.20 42.34 17.67 3.19 45.13 19.06 53.63 69.16 -60.42 48.34 71.81 -58.40 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 74 3 # 74 A 112 PHE F 12 PHE^? 17.12 MG MG F 301 A 210 ASP F 171 ASP^? 16.35 MG MG F 302 A 244 LYS F 166 LYS^? 20.76 MG MG F 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 49.70 62.79 -80.90 49.37 65.44 -81.67 coo 10.51 37.86 19.71 9.07 39.38 20.04 48.23 68.08 -88.47 46.26 68.02 -87.56 coo -1.20 42.34 17.67 3.19 45.13 19.06 59.28 73.05 -82.63 55.63 74.15 -86.94 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 75 3 # 75 A 112 PHE F 32 PHE^? 15.64 MG MG F 301 A 210 ASP F 35 ASP^? 16.93 MG MG F 301 A 244 LYS E 61 LYS^? 22.16 MG MG F 301 coo 9.23 46.77 25.11 11.48 48.39 24.76 42.40 50.26 -82.52 42.59 47.55 -83.32 coo 10.51 37.86 19.71 9.07 39.38 20.04 46.82 60.47 -77.63 48.00 58.79 -78.23 coo -1.20 42.34 17.67 3.19 45.13 19.06 40.99 56.84 -68.48 45.99 56.72 -72.39 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 76 3 # 76 A 112 PHE F 32 PHE^? 15.64 MG MG F 301 A 210 ASP F 35 ASP^? 16.93 MG MG F 301 A 244 LYS F 90 LYS^? 18.57 MG MG F 301 coo 9.23 46.77 25.11 11.48 48.39 24.76 42.40 50.26 -82.52 42.59 47.55 -83.32 coo 10.51 37.86 19.71 9.07 39.38 20.04 46.82 60.47 -77.63 48.00 58.79 -78.23 coo -1.20 42.34 17.67 3.19 45.13 19.06 51.54 47.01 -75.58 55.05 50.31 -73.74 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 77 3 # 77 A 112 PHE F 59 PHE^? 31.53 MG MG F 301 A 210 ASP F 138 ASP^? 33.51 MG MG F 302 A 244 LYS F 157 LYS^? 28.36 MG MG F 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 77.96 68.89 -76.99 76.86 68.73 -79.55 coo 10.51 37.86 19.71 9.07 39.38 20.04 77.17 76.66 -81.48 76.14 76.33 -83.32 coo -1.20 42.34 17.67 3.19 45.13 19.06 64.43 70.47 -79.54 68.32 74.80 -81.65 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 78 3 # 78 A 112 PHE F 59 PHE^? 31.53 MG MG F 301 A 210 ASP F 160 ASP^? 31.59 MG MG E 302 A 244 LYS F 157 LYS^? 28.36 MG MG F 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 77.96 68.89 -76.99 76.86 68.73 -79.55 coo 10.51 37.86 19.71 9.07 39.38 20.04 71.27 74.59 -71.77 73.23 74.02 -72.37 coo -1.20 42.34 17.67 3.19 45.13 19.06 64.43 70.47 -79.54 68.32 74.80 -81.65 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 79 3 # 79 A 112 PHE F 65 PHE^? 25.37 MG MG E 302 A 210 ASP E 35 ASP^? 16.91 MG MG E 302 A 244 LYS E 90 LYS^? 19.16 MG MG E 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 72.59 59.42 -72.14 74.91 60.01 -70.72 coo 10.51 37.86 19.71 9.07 39.38 20.04 73.60 65.64 -62.00 73.13 63.73 -61.22 coo -1.20 42.34 17.67 3.19 45.13 19.06 73.81 51.50 -63.18 69.15 52.39 -65.65 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 80 3 # 80 A 112 PHE F 110 PHE^? 21.65 MG MG F 301 A 210 ASP F 58 ASP^? 26.87 MG MG E 302 A 244 LYS F 137 LYS^? 35.13 MG MG F 301 coo 9.23 46.77 25.11 11.48 48.39 24.76 72.02 60.99 -83.27 70.61 63.10 -82.08 coo 10.51 37.86 19.71 9.07 39.38 20.04 75.55 64.68 -72.56 76.21 65.63 -70.79 coo -1.20 42.34 17.67 3.19 45.13 19.06 78.53 72.20 -80.30 83.01 68.64 -79.79 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 81 3 # 81 A 112 PHE F 110 PHE^? 21.65 MG MG F 301 A 210 ASP F 58 ASP^? 26.87 MG MG E 302 A 244 LYS F 157 LYS^? 28.36 MG MG F 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 72.02 60.99 -83.27 70.61 63.10 -82.08 coo 10.51 37.86 19.71 9.07 39.38 20.04 75.55 64.68 -72.56 76.21 65.63 -70.79 coo -1.20 42.34 17.67 3.19 45.13 19.06 64.43 70.47 -79.54 68.32 74.80 -81.65 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 82 3 # 82 A 112 PHE F 110 PHE^? 21.65 MG MG F 301 A 210 ASP F 142 ASP^? 23.43 MG MG F 302 A 244 LYS F 137 LYS^? 35.13 MG MG F 301 coo 9.23 46.77 25.11 11.48 48.39 24.76 72.02 60.99 -83.27 70.61 63.10 -82.08 coo 10.51 37.86 19.71 9.07 39.38 20.04 71.46 69.88 -89.76 71.03 69.93 -91.81 coo -1.20 42.34 17.67 3.19 45.13 19.06 78.53 72.20 -80.30 83.01 68.64 -79.79 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 83 3 # 83 A 112 PHE F 110 PHE^? 21.65 MG MG F 301 A 210 ASP F 142 ASP^? 23.43 MG MG F 302 A 244 LYS F 157 LYS^? 28.36 MG MG F 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 72.02 60.99 -83.27 70.61 63.10 -82.08 coo 10.51 37.86 19.71 9.07 39.38 20.04 71.46 69.88 -89.76 71.03 69.93 -91.81 coo -1.20 42.34 17.67 3.19 45.13 19.06 64.43 70.47 -79.54 68.32 74.80 -81.65 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 84 3 # 84 A 112 PHE F 153 PHE^? 9.26 MG MG F 302 A 210 ASP F 128 ASP^? -3.41 MG MG F 301s A 244 LYS F 111 LYS^? 15.21 MG MG F 301 coo 9.23 46.77 25.11 11.48 48.39 24.76 54.49 61.65 -87.43 53.89 59.08 -88.37 coo 10.51 37.86 19.71 9.07 39.38 20.04 57.76 53.73 -90.50 57.46 51.64 -90.28 coo -1.20 42.34 17.67 3.19 45.13 19.06 69.70 58.57 -86.86 69.67 53.74 -90.29 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 85 3 # 85 A 112 PHE F 153 PHE^? 9.26 MG MG F 302 A 210 ASP F 171 ASP^? 16.35 MG MG F 302 A 244 LYS F 166 LYS^? 20.76 MG MG F 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 54.49 61.65 -87.43 53.89 59.08 -88.37 coo 10.51 37.86 19.71 9.07 39.38 20.04 48.23 68.08 -88.47 46.26 68.02 -87.56 coo -1.20 42.34 17.67 3.19 45.13 19.06 59.28 73.05 -82.63 55.63 74.15 -86.94 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 86 3 # 86 A 112 PHE F 161 PHE^? 25.66 MG MG E 302 A 210 ASP E 35 ASP^? 16.91 MG MG E 302 A 244 LYS F 61 LYS^? 21.75 MG MG E 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 68.33 71.65 -68.19 70.12 69.57 -67.59 coo 10.51 37.86 19.71 9.07 39.38 20.04 73.60 65.64 -62.00 73.13 63.73 -61.22 coo -1.20 42.34 17.67 3.19 45.13 19.06 80.24 64.12 -71.01 76.23 61.95 -66.39 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 87 3 # 87 A 112 PHE F 161 PHE^? 25.66 MG MG E 302 A 210 ASP F 58 ASP^? 26.87 MG MG E 302 A 244 LYS F 157 LYS^? 28.36 MG MG F 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 68.33 71.65 -68.19 70.12 69.57 -67.59 coo 10.51 37.86 19.71 9.07 39.38 20.04 75.55 64.68 -72.56 76.21 65.63 -70.79 coo -1.20 42.34 17.67 3.19 45.13 19.06 64.43 70.47 -79.54 68.32 74.80 -81.65 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 88 3 # 88 A 112 PHE F 190 PHE^? 14.21 MG MG F 302 A 210 ASP F 142 ASP^? 23.43 MG MG F 302 A 244 LYS F 111 LYS^? 15.21 MG MG F 301 coo 9.23 46.77 25.11 11.48 48.39 24.76 60.66 66.91 -91.97 61.14 65.56 -89.57 coo 10.51 37.86 19.71 9.07 39.38 20.04 71.46 69.88 -89.76 71.03 69.93 -91.81 coo -1.20 42.34 17.67 3.19 45.13 19.06 69.70 58.57 -86.86 69.67 53.74 -90.29 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 89 3 # 89 A 112 PHE F 190 PHE^? 14.21 MG MG F 302 A 210 ASP F 142 ASP^? 23.43 MG MG F 302 A 244 LYS F 157 LYS^? 28.36 MG MG F 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 60.66 66.91 -91.97 61.14 65.56 -89.57 coo 10.51 37.86 19.71 9.07 39.38 20.04 71.46 69.88 -89.76 71.03 69.93 -91.81 coo -1.20 42.34 17.67 3.19 45.13 19.06 64.43 70.47 -79.54 68.32 74.80 -81.65 1fc4_c02 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 89 hits 1fc4_c02 naa= 3 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 112 PHE A 12 PHE^? 17.15 MG MG A 301 B 210 ASP A 171 ASP^? 17.17 MG MG A 302 B 244 LYS A 166 LYS^? 20.93 MG MG A 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 34.93 27.27 29.42 32.88 25.47 30.10 coo 9.06 56.85 40.30 7.71 55.27 39.90 29.78 23.67 36.63 28.48 25.11 35.71 coo -2.38 51.82 41.62 2.07 49.19 40.42 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 112 PHE A 32 PHE^? 15.95 MG MG A 301 B 210 ASP A 35 ASP^? 16.92 MG MG A 301 B 244 LYS B 61 LYS^? 22.03 MG MG A 301 coo 8.76 47.85 34.91 11.08 46.36 35.41 37.63 41.69 31.55 39.27 43.59 32.74 coo 9.06 56.85 40.30 7.71 55.27 39.90 34.49 31.10 26.54 36.41 31.82 27.10 coo -2.38 51.82 41.62 2.07 49.19 40.42 32.50 37.62 17.61 36.68 34.92 21.51 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 B 112 PHE A 59 PHE^? 31.59 MG MG A 301 B 210 ASP A 138 ASP^? 33.08 MG MG A 302 B 244 LYS A 157 LYS^? 28.65 MG MG A 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 52.93 4.70 25.02 52.08 5.30 27.62 coo 9.06 56.85 40.30 7.71 55.27 39.90 47.10 -0.97 29.63 45.89 0.22 30.96 coo -2.38 51.82 41.62 2.07 49.19 40.42 41.42 12.06 27.58 41.46 5.93 29.41 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 B 112 PHE A 59 PHE^? 31.59 MG MG A 301 B 210 ASP A 160 ASP^? 31.61 MG MG B 302 B 244 LYS A 157 LYS^? 28.65 MG MG A 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 52.93 4.70 25.02 52.08 5.30 27.62 coo 9.06 56.85 40.30 7.71 55.27 39.90 44.21 5.00 19.54 46.02 3.84 19.76 coo -2.38 51.82 41.62 2.07 49.19 40.42 41.42 12.06 27.58 41.46 5.93 29.41 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 B 112 PHE A 65 PHE^? 25.49 MG MG B 302 B 210 ASP B 35 ASP^? 16.92 MG MG B 302 B 244 LYS B 90 LYS^? 18.68 MG MG B 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 54.96 15.58 21.17 56.65 13.84 19.74 coo 9.06 56.85 40.30 7.71 55.27 39.90 52.63 11.07 10.18 53.68 12.85 9.94 coo -2.38 51.82 41.62 2.07 49.19 40.42 61.66 21.61 12.88 56.74 22.88 14.81 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 B 112 PHE A 110 PHE^? 21.60 MG MG A 301 B 210 ASP A 58 ASP^? 26.75 MG MG B 302 B 244 LYS A 137 LYS^? 34.85 MG MG A 301 coo 8.76 47.85 34.91 11.08 46.36 35.41 53.06 14.15 32.16 50.69 13.44 30.81 coo 9.06 56.85 40.30 7.71 55.27 39.90 53.93 9.80 21.09 53.83 8.90 19.15 coo -2.38 51.82 41.62 2.07 49.19 40.42 50.97 1.58 28.14 56.13 1.49 28.03 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 B 112 PHE A 110 PHE^? 21.60 MG MG A 301 B 210 ASP A 58 ASP^? 26.75 MG MG B 302 B 244 LYS A 157 LYS^? 28.65 MG MG A 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 53.06 14.15 32.16 50.69 13.44 30.81 coo 9.06 56.85 40.30 7.71 55.27 39.90 53.93 9.80 21.09 53.83 8.90 19.15 coo -2.38 51.82 41.62 2.07 49.19 40.42 41.42 12.06 27.58 41.46 5.93 29.41 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 B 112 PHE A 110 PHE^? 21.60 MG MG A 301 B 210 ASP A 142 ASP^? 23.70 MG MG A 302 B 244 LYS A 137 LYS^? 34.85 MG MG A 301 coo 8.76 47.85 34.91 11.08 46.36 35.41 53.06 14.15 32.16 50.69 13.44 30.81 coo 9.06 56.85 40.30 7.71 55.27 39.90 46.39 7.18 37.53 46.28 7.18 39.63 coo -2.38 51.82 41.62 2.07 49.19 40.42 50.97 1.58 28.14 56.13 1.49 28.03 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 9 3 # 9 B 112 PHE A 110 PHE^? 21.60 MG MG A 301 B 210 ASP A 142 ASP^? 23.70 MG MG A 302 B 244 LYS A 157 LYS^? 28.65 MG MG A 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 53.06 14.15 32.16 50.69 13.44 30.81 coo 9.06 56.85 40.30 7.71 55.27 39.90 46.39 7.18 37.53 46.28 7.18 39.63 coo -2.38 51.82 41.62 2.07 49.19 40.42 41.42 12.06 27.58 41.46 5.93 29.41 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 10 3 # 10 B 112 PHE A 153 PHE^? 9.64 MG MG A 301 B 210 ASP A 128 ASP^? -3.32 MG MG A 301s B 244 LYS A 111 LYS^? 15.16 MG MG A 301 coo 8.76 47.85 34.91 11.08 46.36 35.41 38.89 24.49 36.07 40.14 26.70 37.23 coo 9.06 56.85 40.30 7.71 55.27 39.90 46.50 28.23 39.77 47.49 30.10 39.82 coo -2.38 51.82 41.62 2.07 49.19 40.42 52.67 17.19 35.90 54.65 19.90 40.50 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 11 3 # 11 B 112 PHE A 153 PHE^? 9.64 MG MG A 301 B 210 ASP A 171 ASP^? 17.17 MG MG A 302 B 244 LYS A 166 LYS^? 20.93 MG MG A 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 38.89 24.49 36.07 40.14 26.70 37.23 coo 9.06 56.85 40.30 7.71 55.27 39.90 29.78 23.67 36.63 28.48 25.11 35.71 coo -2.38 51.82 41.62 2.07 49.19 40.42 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 12 3 # 12 B 112 PHE A 161 PHE^? 25.62 MG MG B 302 B 210 ASP A 58 ASP^? 26.75 MG MG B 302 B 244 LYS A 157 LYS^? 28.65 MG MG A 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 44.24 9.29 16.03 46.90 9.95 15.56 coo 9.06 56.85 40.30 7.71 55.27 39.90 53.93 9.80 21.09 53.83 8.90 19.15 coo -2.38 51.82 41.62 2.07 49.19 40.42 41.42 12.06 27.58 41.46 5.93 29.41 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 13 3 # 13 B 112 PHE A 161 PHE^? 25.62 MG MG B 302 B 210 ASP B 35 ASP^? 16.92 MG MG B 302 B 244 LYS A 61 LYS^? 21.99 MG MG B 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 44.24 9.29 16.03 46.90 9.95 15.56 coo 9.06 56.85 40.30 7.71 55.27 39.90 52.63 11.07 10.18 53.68 12.85 9.94 coo -2.38 51.82 41.62 2.07 49.19 40.42 57.78 7.35 19.60 56.77 12.20 15.61 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 14 3 # 14 B 112 PHE A 190 PHE^? 14.49 MG MG A 302 B 210 ASP A 142 ASP^? 23.70 MG MG A 302 B 244 LYS A 111 LYS^? 15.16 MG MG A 301 coo 8.76 47.85 34.91 11.08 46.36 35.41 39.84 16.38 40.26 41.25 17.12 37.97 coo 9.06 56.85 40.30 7.71 55.27 39.90 46.39 7.18 37.53 46.28 7.18 39.63 coo -2.38 51.82 41.62 2.07 49.19 40.42 52.67 17.19 35.90 54.65 19.90 40.50 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 15 3 # 15 B 112 PHE A 190 PHE^? 14.49 MG MG A 302 B 210 ASP A 142 ASP^? 23.70 MG MG A 302 B 244 LYS A 157 LYS^? 28.65 MG MG A 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 39.84 16.38 40.26 41.25 17.12 37.97 coo 9.06 56.85 40.30 7.71 55.27 39.90 46.39 7.18 37.53 46.28 7.18 39.63 coo -2.38 51.82 41.62 2.07 49.19 40.42 41.42 12.06 27.58 41.46 5.93 29.41 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 16 3 # 16 B 112 PHE B 12 PHE^? 17.13 MG MG B 302 B 210 ASP B 171 ASP^? 16.92 MG MG B 301 B 244 LYS B 166 LYS^? 22.75 MG MG B 301 coo 8.76 47.85 34.91 11.08 46.36 35.41 49.02 12.29 7.19 47.01 10.60 6.19 coo 9.06 56.85 40.30 7.71 55.27 39.90 45.30 8.50 -0.71 46.30 6.81 0.12 coo -2.38 51.82 41.62 2.07 49.19 40.42 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 17 3 # 17 B 112 PHE B 32 PHE^? 15.77 MG MG B 302 B 210 ASP B 35 ASP^? 16.92 MG MG B 302 B 244 LYS B 90 LYS^? 18.68 MG MG B 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 63.68 12.44 5.83 65.90 13.72 4.72 coo 9.06 56.85 40.30 7.71 55.27 39.90 52.63 11.07 10.18 53.68 12.85 9.94 coo -2.38 51.82 41.62 2.07 49.19 40.42 61.66 21.61 12.88 56.74 22.88 14.81 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 18 3 # 18 B 112 PHE B 59 PHE^? 31.31 MG MG B 302 B 210 ASP B 138 ASP^? 33.32 MG MG B 302 B 244 LYS B 157 LYS^? 28.85 MG MG B 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 29.63 33.55 11.36 30.42 32.81 8.75 coo 9.06 56.85 40.30 7.71 55.27 39.90 23.42 29.01 6.78 24.36 28.48 4.94 coo -2.38 51.82 41.62 2.07 49.19 40.42 34.97 21.28 8.44 29.03 22.82 6.58 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 19 3 # 19 B 112 PHE B 59 PHE^? 31.31 MG MG B 302 B 210 ASP B 160 ASP^? 31.65 MG MG A 301 B 244 LYS B 157 LYS^? 28.85 MG MG B 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 29.63 33.55 11.36 30.42 32.81 8.75 coo 9.06 56.85 40.30 7.71 55.27 39.90 28.01 24.83 16.38 27.44 26.81 15.80 coo -2.38 51.82 41.62 2.07 49.19 40.42 34.97 21.28 8.44 29.03 22.82 6.58 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 20 3 # 20 B 112 PHE B 65 PHE^? 25.48 MG MG A 301 B 210 ASP A 35 ASP^? 16.92 MG MG A 301 B 244 LYS A 90 LYS^? 18.58 MG MG A 301 coo 8.76 47.85 34.91 11.08 46.36 35.41 40.29 33.39 16.17 38.73 35.25 17.59 coo 9.06 56.85 40.30 7.71 55.27 39.90 34.49 31.10 26.54 36.41 31.82 27.10 coo -2.38 51.82 41.62 2.07 49.19 40.42 46.62 38.29 25.46 47.51 33.29 23.22 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 21 3 # 21 B 112 PHE B 110 PHE^? 21.49 MG MG B 302 B 210 ASP B 58 ASP^? 26.73 MG MG A 301 B 244 LYS B 137 LYS^? 34.56 MG MG B 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 39.39 32.59 5.17 38.42 30.20 6.23 coo 9.06 56.85 40.30 7.71 55.27 39.90 34.42 33.56 15.74 33.50 33.49 17.59 coo -2.38 51.82 41.62 2.07 49.19 40.42 26.56 32.46 7.93 27.87 37.71 9.31 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 22 3 # 22 B 112 PHE B 110 PHE^? 21.49 MG MG B 302 B 210 ASP B 58 ASP^? 26.73 MG MG A 301 B 244 LYS B 157 LYS^? 28.85 MG MG B 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 39.39 32.59 5.17 38.42 30.20 6.23 coo 9.06 56.85 40.30 7.71 55.27 39.90 34.42 33.56 15.74 33.50 33.49 17.59 coo -2.38 51.82 41.62 2.07 49.19 40.42 34.97 21.28 8.44 29.03 22.82 6.58 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 23 3 # 23 B 112 PHE B 110 PHE^? 21.49 MG MG B 302 B 210 ASP B 142 ASP^? 23.97 MG MG B 301 B 244 LYS B 137 LYS^? 34.56 MG MG B 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 39.39 32.59 5.17 38.42 30.20 6.23 coo 9.06 56.85 40.30 7.71 55.27 39.90 31.69 27.40 -1.31 32.10 27.37 -3.38 coo -2.38 51.82 41.62 2.07 49.19 40.42 26.56 32.46 7.93 27.87 37.71 9.31 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 24 3 # 24 B 112 PHE B 110 PHE^? 21.49 MG MG B 302 B 210 ASP B 142 ASP^? 23.97 MG MG B 301 B 244 LYS B 157 LYS^? 28.85 MG MG B 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 39.39 32.59 5.17 38.42 30.20 6.23 coo 9.06 56.85 40.30 7.71 55.27 39.90 31.69 27.40 -1.31 32.10 27.37 -3.38 coo -2.38 51.82 41.62 2.07 49.19 40.42 34.97 21.28 8.44 29.03 22.82 6.58 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 25 3 # 25 B 112 PHE B 153 PHE^? 9.59 MG MG B 302 B 210 ASP B 171 ASP^? 16.92 MG MG B 301 B 244 LYS B 166 LYS^? 22.75 MG MG B 301 coo 8.76 47.85 34.91 11.08 46.36 35.41 47.54 17.09 0.77 50.03 17.91 -0.19 coo 9.06 56.85 40.30 7.71 55.27 39.90 45.30 8.50 -0.71 46.30 6.81 0.12 coo -2.38 51.82 41.62 2.07 49.19 40.42 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 26 3 # 26 B 112 PHE B 161 PHE^? 25.78 MG MG A 301 B 210 ASP A 35 ASP^? 16.92 MG MG A 301 B 244 LYS B 61 LYS^? 22.03 MG MG A 301 coo 8.76 47.85 34.91 11.08 46.36 35.41 31.87 23.58 19.99 32.61 26.21 20.65 coo 9.06 56.85 40.30 7.71 55.27 39.90 34.49 31.10 26.54 36.41 31.82 27.10 coo -2.38 51.82 41.62 2.07 49.19 40.42 32.50 37.62 17.61 36.68 34.92 21.51 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 27 3 # 27 B 112 PHE B 161 PHE^? 25.78 MG MG A 301 B 210 ASP B 58 ASP^? 26.73 MG MG A 301 B 244 LYS B 157 LYS^? 28.85 MG MG B 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 31.87 23.58 19.99 32.61 26.21 20.65 coo 9.06 56.85 40.30 7.71 55.27 39.90 34.42 33.56 15.74 33.50 33.49 17.59 coo -2.38 51.82 41.62 2.07 49.19 40.42 34.97 21.28 8.44 29.03 22.82 6.58 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 28 3 # 28 B 112 PHE B 190 PHE^? 14.80 MG MG B 301 B 210 ASP B 142 ASP^? 23.97 MG MG B 301 B 244 LYS B 111 LYS^? 13.75 MG MG B 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 40.06 19.97 -3.89 40.77 21.13 -1.45 coo 9.06 56.85 40.30 7.71 55.27 39.90 31.69 27.40 -1.31 32.10 27.37 -3.38 coo -2.38 51.82 41.62 2.07 49.19 40.42 42.84 32.14 1.80 46.84 32.68 -2.87 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 29 3 # 29 B 112 PHE B 190 PHE^? 14.80 MG MG B 301 B 210 ASP B 142 ASP^? 23.97 MG MG B 301 B 244 LYS B 157 LYS^? 28.85 MG MG B 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 40.06 19.97 -3.89 40.77 21.13 -1.45 coo 9.06 56.85 40.30 7.71 55.27 39.90 31.69 27.40 -1.31 32.10 27.37 -3.38 coo -2.38 51.82 41.62 2.07 49.19 40.42 34.97 21.28 8.44 29.03 22.82 6.58 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 30 3 # 30 B 112 PHE C 12 PHE^? 16.92 MG MG C 302 B 210 ASP C 171 ASP^? 17.08 MG MG C 301 B 244 LYS C 166 LYS^? 22.53 MG MG C 301 coo 8.76 47.85 34.91 11.08 46.36 35.41 87.42 18.93 -13.86 90.00 18.25 -12.97 coo 9.06 56.85 40.30 7.71 55.27 39.90 92.57 16.68 -6.24 92.24 14.74 -7.03 coo -2.38 51.82 41.62 2.07 49.19 40.42 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 31 3 # 31 B 112 PHE C 32 PHE^? 15.72 MG MG C 302 B 210 ASP C 35 ASP^? 16.42 MG MG C 302 B 244 LYS C 90 LYS^? 18.24 MG MG C 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 73.89 13.66 -12.38 71.29 14.19 -11.42 coo 9.06 56.85 40.30 7.71 55.27 39.90 84.40 16.53 -16.68 82.83 17.91 -16.28 coo -2.38 51.82 41.62 2.07 49.19 40.42 72.37 23.25 -18.94 76.11 26.52 -20.97 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 32 3 # 32 B 112 PHE C 32 PHE^? 15.72 MG MG C 302 B 210 ASP C 35 ASP^? 16.42 MG MG C 302 B 244 LYS D 61 LYS^? 21.93 MG MG C 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 73.89 13.66 -12.38 71.29 14.19 -11.42 coo 9.06 56.85 40.30 7.71 55.27 39.90 84.40 16.53 -16.68 82.83 17.91 -16.28 coo -2.38 51.82 41.62 2.07 49.19 40.42 80.64 11.23 -26.16 80.65 16.24 -22.36 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 33 3 # 33 B 112 PHE C 59 PHE^? 31.23 MG MG C 302 B 210 ASP C 138 ASP^? 33.43 MG MG C 302 B 244 LYS C 157 LYS^? 28.15 MG MG C 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 98.06 45.52 -18.00 97.73 44.36 -15.53 coo 9.06 56.85 40.30 7.71 55.27 39.90 105.43 43.97 -13.30 104.85 43.08 -11.43 coo -2.38 51.82 41.62 2.07 49.19 40.42 97.55 32.04 -15.10 101.49 36.24 -13.39 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 34 3 # 34 B 112 PHE C 59 PHE^? 31.23 MG MG C 302 B 210 ASP C 160 ASP^? 31.63 MG MG D 302 B 244 LYS C 157 LYS^? 28.15 MG MG C 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 98.06 45.52 -18.00 97.73 44.36 -15.53 coo 9.06 56.85 40.30 7.71 55.27 39.90 102.50 38.00 -23.28 102.43 39.97 -22.46 coo -2.38 51.82 41.62 2.07 49.19 40.42 97.55 32.04 -15.10 101.49 36.24 -13.39 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 35 3 # 35 B 112 PHE C 65 PHE^? 25.41 MG MG D 302 B 210 ASP D 35 ASP^? 16.80 MG MG D 302 B 244 LYS D 90 LYS^? 18.98 MG MG D 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 87.79 41.78 -22.56 88.44 44.04 -24.09 coo 9.06 56.85 40.30 7.71 55.27 39.90 93.83 42.00 -33.14 91.74 41.83 -33.51 coo -2.38 51.82 41.62 2.07 49.19 40.42 79.83 44.38 -31.44 80.32 39.55 -29.40 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 36 3 # 36 B 112 PHE C 110 PHE^? 21.25 MG MG C 302 B 210 ASP C 58 ASP^? 26.67 MG MG D 302 B 244 LYS C 137 LYS^? 35.41 MG MG C 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 89.08 41.33 -11.45 90.83 39.43 -12.52 coo 9.06 56.85 40.30 7.71 55.27 39.90 93.40 43.81 -22.27 94.18 44.45 -24.11 coo -2.38 51.82 41.62 2.07 49.19 40.42 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 37 3 # 37 B 112 PHE C 110 PHE^? 21.25 MG MG C 302 B 210 ASP C 58 ASP^? 26.67 MG MG D 302 B 244 LYS C 157 LYS^? 28.15 MG MG C 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 89.08 41.33 -11.45 90.83 39.43 -12.52 coo 9.06 56.85 40.30 7.71 55.27 39.90 93.40 43.81 -22.27 94.18 44.45 -24.11 coo -2.38 51.82 41.62 2.07 49.19 40.42 97.55 32.04 -15.10 101.49 36.24 -13.39 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 38 3 # 38 B 112 PHE C 110 PHE^? 21.25 MG MG C 302 B 210 ASP C 142 ASP^? 23.76 MG MG C 301 B 244 LYS C 137 LYS^? 35.41 MG MG C 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 89.08 41.33 -11.45 90.83 39.43 -12.52 coo 9.06 56.85 40.30 7.71 55.27 39.90 97.94 39.27 -5.03 98.08 38.70 -2.97 coo -2.38 51.82 41.62 2.07 49.19 40.42 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 39 3 # 39 B 112 PHE C 110 PHE^? 21.25 MG MG C 302 B 210 ASP C 142 ASP^? 23.76 MG MG C 301 B 244 LYS C 157 LYS^? 28.15 MG MG C 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 89.08 41.33 -11.45 90.83 39.43 -12.52 coo 9.06 56.85 40.30 7.71 55.27 39.90 97.94 39.27 -5.03 98.08 38.70 -2.97 coo -2.38 51.82 41.62 2.07 49.19 40.42 97.55 32.04 -15.10 101.49 36.24 -13.39 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 40 3 # 40 B 112 PHE C 153 PHE^? 9.34 MG MG C 302 B 210 ASP C 171 ASP^? 17.08 MG MG C 301 B 244 LYS C 166 LYS^? 22.53 MG MG C 301 coo 8.76 47.85 34.91 11.08 46.36 35.41 87.15 23.83 -7.29 84.55 23.79 -6.26 coo 9.06 56.85 40.30 7.71 55.27 39.90 92.57 16.68 -6.24 92.24 14.74 -7.03 coo -2.38 51.82 41.62 2.07 49.19 40.42 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 41 3 # 41 B 112 PHE C 161 PHE^? 25.47 MG MG D 302 B 210 ASP C 58 ASP^? 26.67 MG MG D 302 B 244 LYS C 157 LYS^? 28.15 MG MG C 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 98.98 35.62 -26.76 97.40 37.84 -27.44 coo 9.06 56.85 40.30 7.71 55.27 39.90 93.40 43.81 -22.27 94.18 44.45 -24.11 coo -2.38 51.82 41.62 2.07 49.19 40.42 97.55 32.04 -15.10 101.49 36.24 -13.39 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 42 3 # 42 B 112 PHE C 161 PHE^? 25.47 MG MG D 302 B 210 ASP D 35 ASP^? 16.80 MG MG D 302 B 244 LYS C 61 LYS^? 21.91 MG MG D 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 98.98 35.62 -26.76 97.40 37.84 -27.44 coo 9.06 56.85 40.30 7.71 55.27 39.90 93.83 42.00 -33.14 91.74 41.83 -33.51 coo -2.38 51.82 41.62 2.07 49.19 40.42 93.60 48.56 -24.05 90.39 44.71 -27.98 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 43 3 # 43 B 112 PHE C 190 PHE^? 14.91 MG MG C 301 B 210 ASP C 142 ASP^? 23.76 MG MG C 301 B 244 LYS C 111 LYS^? 16.56 MG MG C 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 93.44 29.01 -2.85 92.36 29.94 -5.20 coo 9.06 56.85 40.30 7.71 55.27 39.90 97.94 39.27 -5.03 98.08 38.70 -2.97 coo -2.38 51.82 41.62 2.07 49.19 40.42 86.36 39.56 -8.06 84.36 40.84 -3.15 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 44 3 # 44 B 112 PHE C 190 PHE^? 14.91 MG MG C 301 B 210 ASP C 142 ASP^? 23.76 MG MG C 301 B 244 LYS C 157 LYS^? 28.15 MG MG C 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 93.44 29.01 -2.85 92.36 29.94 -5.20 coo 9.06 56.85 40.30 7.71 55.27 39.90 97.94 39.27 -5.03 98.08 38.70 -2.97 coo -2.38 51.82 41.62 2.07 49.19 40.42 97.55 32.04 -15.10 101.49 36.24 -13.39 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 45 3 # 45 B 112 PHE D 12 PHE^? 16.78 MG MG D 302 B 210 ASP D 171 ASP^? 16.95 MG MG D 301 B 244 LYS D 166 LYS^? 21.08 MG MG D 301 coo 8.76 47.85 34.91 11.08 46.36 35.41 94.68 38.11 -36.05 97.16 37.10 -36.83 coo 9.06 56.85 40.30 7.71 55.27 39.90 100.39 36.69 -43.49 101.13 38.51 -42.69 coo -2.38 51.82 41.62 2.07 49.19 40.42 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 46 3 # 46 B 112 PHE D 32 PHE^? 15.68 MG MG D 302 B 210 ASP D 35 ASP^? 16.80 MG MG D 302 B 244 LYS C 61 LYS^? 21.91 MG MG D 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 87.15 50.70 -38.09 84.99 51.79 -39.44 coo 9.06 56.85 40.30 7.71 55.27 39.90 93.83 42.00 -33.14 91.74 41.83 -33.51 coo -2.38 51.82 41.62 2.07 49.19 40.42 93.60 48.56 -24.05 90.39 44.71 -27.98 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 47 3 # 47 B 112 PHE D 32 PHE^? 15.68 MG MG D 302 B 210 ASP D 35 ASP^? 16.80 MG MG D 302 B 244 LYS D 90 LYS^? 18.98 MG MG D 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 87.15 50.70 -38.09 84.99 51.79 -39.44 coo 9.06 56.85 40.30 7.71 55.27 39.90 93.83 42.00 -33.14 91.74 41.83 -33.51 coo -2.38 51.82 41.62 2.07 49.19 40.42 79.83 44.38 -31.44 80.32 39.55 -29.40 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 48 3 # 48 B 112 PHE D 59 PHE^? 31.49 MG MG D 302 B 210 ASP D 138 ASP^? 33.64 MG MG D 302 B 244 LYS D 157 LYS^? 28.67 MG MG D 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 86.17 10.70 -31.86 86.41 11.56 -34.53 coo 9.06 56.85 40.30 7.71 55.27 39.90 93.00 7.50 -35.79 93.88 8.48 -37.45 coo -2.38 51.82 41.62 2.07 49.19 40.42 94.17 21.71 -34.34 96.11 15.89 -35.92 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 49 3 # 49 B 112 PHE D 59 PHE^? 31.49 MG MG D 302 B 210 ASP D 160 ASP^? 31.45 MG MG C 302 B 244 LYS D 157 LYS^? 28.67 MG MG D 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 86.17 10.70 -31.86 86.41 11.56 -34.53 coo 9.06 56.85 40.30 7.71 55.27 39.90 94.15 13.98 -26.57 92.71 12.42 -26.99 coo -2.38 51.82 41.62 2.07 49.19 40.42 94.17 21.71 -34.34 96.11 15.89 -35.92 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 50 3 # 50 B 112 PHE D 65 PHE^? 25.04 MG MG C 302 B 210 ASP C 35 ASP^? 16.42 MG MG C 302 B 244 LYS C 90 LYS^? 18.24 MG MG C 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 80.36 20.18 -27.62 79.13 18.18 -26.16 coo 9.06 56.85 40.30 7.71 55.27 39.90 84.40 16.53 -16.68 82.83 17.91 -16.28 coo -2.38 51.82 41.62 2.07 49.19 40.42 72.37 23.25 -18.94 76.11 26.52 -20.97 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 51 3 # 51 B 112 PHE D 110 PHE^? 21.56 MG MG D 302 B 210 ASP D 58 ASP^? 26.59 MG MG C 302 B 244 LYS D 137 LYS^? 37.57 MG MG D 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 82.28 19.60 -38.58 84.73 19.89 -37.32 coo 9.06 56.85 40.30 7.71 55.27 39.90 83.38 14.85 -27.71 84.09 14.12 -25.85 coo -2.38 51.82 41.62 2.07 49.19 40.42 88.48 8.58 -35.33 84.88 3.98 -33.96 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 52 3 # 52 B 112 PHE D 110 PHE^? 21.56 MG MG D 302 B 210 ASP D 58 ASP^? 26.59 MG MG C 302 B 244 LYS D 157 LYS^? 28.67 MG MG D 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 82.28 19.60 -38.58 84.73 19.89 -37.32 coo 9.06 56.85 40.30 7.71 55.27 39.90 83.38 14.85 -27.71 84.09 14.12 -25.85 coo -2.38 51.82 41.62 2.07 49.19 40.42 94.17 21.71 -34.34 96.11 15.89 -35.92 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 53 3 # 53 B 112 PHE D 110 PHE^? 21.56 MG MG D 302 B 210 ASP D 142 ASP^? 23.49 MG MG D 301 B 244 LYS D 137 LYS^? 37.57 MG MG D 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 82.28 19.60 -38.58 84.73 19.89 -37.32 coo 9.06 56.85 40.30 7.71 55.27 39.90 90.90 15.58 -44.76 91.35 16.09 -46.79 coo -2.38 51.82 41.62 2.07 49.19 40.42 88.48 8.58 -35.33 84.88 3.98 -33.96 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 54 3 # 54 B 112 PHE D 110 PHE^? 21.56 MG MG D 302 B 210 ASP D 142 ASP^? 23.49 MG MG D 301 B 244 LYS D 157 LYS^? 28.67 MG MG D 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 82.28 19.60 -38.58 84.73 19.89 -37.32 coo 9.06 56.85 40.30 7.71 55.27 39.90 90.90 15.58 -44.76 91.35 16.09 -46.79 coo -2.38 51.82 41.62 2.07 49.19 40.42 94.17 21.71 -34.34 96.11 15.89 -35.92 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 55 3 # 55 B 112 PHE D 153 PHE^? 9.11 MG MG D 302 B 210 ASP D 171 ASP^? 16.95 MG MG D 301 B 244 LYS D 166 LYS^? 21.08 MG MG D 301 coo 8.76 47.85 34.91 11.08 46.36 35.41 91.67 34.35 -42.71 89.76 36.10 -43.73 coo 9.06 56.85 40.30 7.71 55.27 39.90 100.39 36.69 -43.49 101.13 38.51 -42.69 coo -2.38 51.82 41.62 2.07 49.19 40.42 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 56 3 # 56 B 112 PHE D 161 PHE^? 25.58 MG MG C 302 B 210 ASP C 35 ASP^? 16.42 MG MG C 302 B 244 LYS D 61 LYS^? 21.93 MG MG C 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 92.97 17.97 -22.91 90.24 17.44 -22.45 coo 9.06 56.85 40.30 7.71 55.27 39.90 84.40 16.53 -16.68 82.83 17.91 -16.28 coo -2.38 51.82 41.62 2.07 49.19 40.42 80.64 11.23 -26.16 80.65 16.24 -22.36 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 57 3 # 57 B 112 PHE D 161 PHE^? 25.58 MG MG C 302 B 210 ASP D 58 ASP^? 26.59 MG MG C 302 B 244 LYS D 157 LYS^? 28.67 MG MG D 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 92.97 17.97 -22.91 90.24 17.44 -22.45 coo 9.06 56.85 40.30 7.71 55.27 39.90 83.38 14.85 -27.71 84.09 14.12 -25.85 coo -2.38 51.82 41.62 2.07 49.19 40.42 94.17 21.71 -34.34 96.11 15.89 -35.92 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 58 3 # 58 B 112 PHE D 190 PHE^? 14.83 MG MG D 301 B 210 ASP D 142 ASP^? 23.49 MG MG D 301 B 244 LYS D 111 LYS^? 15.85 MG MG D 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 93.52 26.32 -46.94 92.08 26.47 -44.56 coo 9.06 56.85 40.30 7.71 55.27 39.90 90.90 15.58 -44.76 91.35 16.09 -46.79 coo -2.38 51.82 41.62 2.07 49.19 40.42 81.21 22.69 -42.10 78.68 23.89 -46.57 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 59 3 # 59 B 112 PHE D 190 PHE^? 14.83 MG MG D 301 B 210 ASP D 142 ASP^? 23.49 MG MG D 301 B 244 LYS D 157 LYS^? 28.67 MG MG D 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 93.52 26.32 -46.94 92.08 26.47 -44.56 coo 9.06 56.85 40.30 7.71 55.27 39.90 90.90 15.58 -44.76 91.35 16.09 -46.79 coo -2.38 51.82 41.62 2.07 49.19 40.42 94.17 21.71 -34.34 96.11 15.89 -35.92 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 60 3 # 60 B 112 PHE E 12 PHE^? 17.09 MG MG E 302 B 210 ASP E 171 ASP^? 16.73 MG MG E 301 B 244 LYS E 166 LYS^? 21.46 MG MG E 301 coo 8.76 47.85 34.91 11.08 46.36 35.41 70.06 67.18 -58.76 69.33 69.81 -58.07 coo 9.06 56.85 40.30 7.71 55.27 39.90 69.61 73.12 -51.56 71.50 73.53 -52.39 coo -2.38 51.82 41.62 2.07 49.19 40.42 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 61 3 # 61 B 112 PHE E 32 PHE^? 15.82 MG MG E 302 B 210 ASP E 35 ASP^? 16.91 MG MG E 302 B 244 LYS E 90 LYS^? 19.16 MG MG E 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 81.32 57.98 -56.67 82.02 55.52 -55.49 coo 9.06 56.85 40.30 7.71 55.27 39.90 73.60 65.64 -62.00 73.13 63.73 -61.22 coo -2.38 51.82 41.62 2.07 49.19 40.42 73.81 51.50 -63.18 69.15 52.39 -65.65 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 62 3 # 62 B 112 PHE E 59 PHE^? 31.36 MG MG E 302 B 210 ASP E 138 ASP^? 33.31 MG MG E 302 B 244 LYS E 157 LYS^? 28.40 MG MG E 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 41.55 62.67 -62.73 42.33 62.92 -60.06 coo 9.06 56.85 40.30 7.71 55.27 39.90 39.58 70.77 -58.63 40.74 70.78 -56.80 coo -2.38 51.82 41.62 2.07 49.19 40.42 53.63 69.16 -60.42 48.34 71.81 -58.40 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 63 3 # 63 B 112 PHE E 59 PHE^? 31.36 MG MG E 302 B 210 ASP E 160 ASP^? 31.54 MG MG F 301 B 244 LYS E 157 LYS^? 28.40 MG MG E 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 41.55 62.67 -62.73 42.33 62.92 -60.06 coo 9.06 56.85 40.30 7.71 55.27 39.90 45.81 70.00 -68.45 44.10 68.87 -67.77 coo -2.38 51.82 41.62 2.07 49.19 40.42 53.63 69.16 -60.42 48.34 71.81 -58.40 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 64 3 # 64 B 112 PHE E 65 PHE^? 25.27 MG MG F 301 B 210 ASP F 35 ASP^? 16.93 MG MG F 301 B 244 LYS F 90 LYS^? 18.57 MG MG F 301 coo 8.76 47.85 34.91 11.08 46.36 35.41 49.98 55.58 -67.11 47.62 55.01 -68.64 coo 9.06 56.85 40.30 7.71 55.27 39.90 46.82 60.47 -77.63 48.00 58.79 -78.23 coo -2.38 51.82 41.62 2.07 49.19 40.42 51.54 47.01 -75.58 55.05 50.31 -73.74 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 65 3 # 65 B 112 PHE E 110 PHE^? 21.45 MG MG E 302 B 210 ASP E 58 ASP^? 26.76 MG MG F 301 B 244 LYS E 137 LYS^? 35.26 MG MG E 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 49.73 57.83 -56.11 50.46 60.21 -57.41 coo 9.06 56.85 40.30 7.71 55.27 39.90 45.39 59.31 -66.83 44.62 59.88 -68.72 coo -2.38 51.82 41.62 2.07 49.19 40.42 40.01 66.05 -59.66 36.65 60.99 -60.28 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 66 3 # 66 B 112 PHE E 110 PHE^? 21.45 MG MG E 302 B 210 ASP E 58 ASP^? 26.76 MG MG F 301 B 244 LYS E 157 LYS^? 28.40 MG MG E 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 49.73 57.83 -56.11 50.46 60.21 -57.41 coo 9.06 56.85 40.30 7.71 55.27 39.90 45.39 59.31 -66.83 44.62 59.88 -68.72 coo -2.38 51.82 41.62 2.07 49.19 40.42 53.63 69.16 -60.42 48.34 71.81 -58.40 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 67 3 # 67 B 112 PHE E 110 PHE^? 21.45 MG MG E 302 B 210 ASP E 142 ASP^? 23.66 MG MG E 301 B 244 LYS E 137 LYS^? 35.26 MG MG E 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 49.73 57.83 -56.11 50.46 60.21 -57.41 coo 9.06 56.85 40.30 7.71 55.27 39.90 47.19 67.15 -50.37 47.44 67.18 -48.23 coo -2.38 51.82 41.62 2.07 49.19 40.42 40.01 66.05 -59.66 36.65 60.99 -60.28 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 68 3 # 68 B 112 PHE E 110 PHE^? 21.45 MG MG E 302 B 210 ASP E 142 ASP^? 23.66 MG MG E 301 B 244 LYS E 157 LYS^? 28.40 MG MG E 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 49.73 57.83 -56.11 50.46 60.21 -57.41 coo 9.06 56.85 40.30 7.71 55.27 39.90 47.19 67.15 -50.37 47.44 67.18 -48.23 coo -2.38 51.82 41.62 2.07 49.19 40.42 53.63 69.16 -60.42 48.34 71.81 -58.40 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 69 3 # 69 B 112 PHE E 153 PHE^? 9.50 MG MG E 302 B 210 ASP E 171 ASP^? 16.73 MG MG E 301 B 244 LYS E 166 LYS^? 21.46 MG MG E 301 coo 8.76 47.85 34.91 11.08 46.36 35.41 65.86 64.95 -52.12 67.22 62.73 -51.09 coo 9.06 56.85 40.30 7.71 55.27 39.90 69.61 73.12 -51.56 71.50 73.53 -52.39 coo -2.38 51.82 41.62 2.07 49.19 40.42 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 70 3 # 70 B 112 PHE E 161 PHE^? 25.51 MG MG F 301 B 210 ASP E 58 ASP^? 26.76 MG MG F 301 B 244 LYS E 157 LYS^? 28.40 MG MG E 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 49.74 68.03 -71.94 48.60 65.47 -72.38 coo 9.06 56.85 40.30 7.71 55.27 39.90 45.39 59.31 -66.83 44.62 59.88 -68.72 coo -2.38 51.82 41.62 2.07 49.19 40.42 53.63 69.16 -60.42 48.34 71.81 -58.40 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 71 3 # 71 B 112 PHE E 161 PHE^? 25.51 MG MG F 301 B 210 ASP F 35 ASP^? 16.93 MG MG F 301 B 244 LYS E 61 LYS^? 22.16 MG MG F 301 coo 8.76 47.85 34.91 11.08 46.36 35.41 49.74 68.03 -71.94 48.60 65.47 -72.38 coo 9.06 56.85 40.30 7.71 55.27 39.90 46.82 60.47 -77.63 48.00 58.79 -78.23 coo -2.38 51.82 41.62 2.07 49.19 40.42 40.99 56.84 -68.48 45.99 56.72 -72.39 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 72 3 # 72 B 112 PHE E 190 PHE^? 14.70 MG MG E 301 B 210 ASP E 142 ASP^? 23.66 MG MG E 301 B 244 LYS E 111 LYS^? 14.52 MG MG E 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 58.27 67.97 -47.86 58.03 66.58 -50.23 coo 9.06 56.85 40.30 7.71 55.27 39.90 47.19 67.15 -50.37 47.44 67.18 -48.23 coo -2.38 51.82 41.62 2.07 49.19 40.42 52.49 56.44 -52.43 54.52 53.78 -47.52 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 73 3 # 73 B 112 PHE E 190 PHE^? 14.70 MG MG E 301 B 210 ASP E 142 ASP^? 23.66 MG MG E 301 B 244 LYS E 157 LYS^? 28.40 MG MG E 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 58.27 67.97 -47.86 58.03 66.58 -50.23 coo 9.06 56.85 40.30 7.71 55.27 39.90 47.19 67.15 -50.37 47.44 67.18 -48.23 coo -2.38 51.82 41.62 2.07 49.19 40.42 53.63 69.16 -60.42 48.34 71.81 -58.40 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 74 3 # 74 B 112 PHE F 12 PHE^? 17.12 MG MG F 301 B 210 ASP F 171 ASP^? 16.35 MG MG F 302 B 244 LYS F 166 LYS^? 20.76 MG MG F 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 49.70 62.79 -80.90 49.37 65.44 -81.67 coo 9.06 56.85 40.30 7.71 55.27 39.90 48.23 68.08 -88.47 46.26 68.02 -87.56 coo -2.38 51.82 41.62 2.07 49.19 40.42 59.28 73.05 -82.63 55.63 74.15 -86.94 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 75 3 # 75 B 112 PHE F 32 PHE^? 15.64 MG MG F 301 B 210 ASP F 35 ASP^? 16.93 MG MG F 301 B 244 LYS E 61 LYS^? 22.16 MG MG F 301 coo 8.76 47.85 34.91 11.08 46.36 35.41 42.40 50.26 -82.52 42.59 47.55 -83.32 coo 9.06 56.85 40.30 7.71 55.27 39.90 46.82 60.47 -77.63 48.00 58.79 -78.23 coo -2.38 51.82 41.62 2.07 49.19 40.42 40.99 56.84 -68.48 45.99 56.72 -72.39 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 76 3 # 76 B 112 PHE F 32 PHE^? 15.64 MG MG F 301 B 210 ASP F 35 ASP^? 16.93 MG MG F 301 B 244 LYS F 90 LYS^? 18.57 MG MG F 301 coo 8.76 47.85 34.91 11.08 46.36 35.41 42.40 50.26 -82.52 42.59 47.55 -83.32 coo 9.06 56.85 40.30 7.71 55.27 39.90 46.82 60.47 -77.63 48.00 58.79 -78.23 coo -2.38 51.82 41.62 2.07 49.19 40.42 51.54 47.01 -75.58 55.05 50.31 -73.74 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 77 3 # 77 B 112 PHE F 59 PHE^? 31.53 MG MG F 301 B 210 ASP F 138 ASP^? 33.51 MG MG F 302 B 244 LYS F 157 LYS^? 28.36 MG MG F 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 77.96 68.89 -76.99 76.86 68.73 -79.55 coo 9.06 56.85 40.30 7.71 55.27 39.90 77.17 76.66 -81.48 76.14 76.33 -83.32 coo -2.38 51.82 41.62 2.07 49.19 40.42 64.43 70.47 -79.54 68.32 74.80 -81.65 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 78 3 # 78 B 112 PHE F 59 PHE^? 31.53 MG MG F 301 B 210 ASP F 160 ASP^? 31.59 MG MG E 302 B 244 LYS F 157 LYS^? 28.36 MG MG F 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 77.96 68.89 -76.99 76.86 68.73 -79.55 coo 9.06 56.85 40.30 7.71 55.27 39.90 71.27 74.59 -71.77 73.23 74.02 -72.37 coo -2.38 51.82 41.62 2.07 49.19 40.42 64.43 70.47 -79.54 68.32 74.80 -81.65 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 79 3 # 79 B 112 PHE F 65 PHE^? 25.37 MG MG E 302 B 210 ASP E 35 ASP^? 16.91 MG MG E 302 B 244 LYS E 90 LYS^? 19.16 MG MG E 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 72.59 59.42 -72.14 74.91 60.01 -70.72 coo 9.06 56.85 40.30 7.71 55.27 39.90 73.60 65.64 -62.00 73.13 63.73 -61.22 coo -2.38 51.82 41.62 2.07 49.19 40.42 73.81 51.50 -63.18 69.15 52.39 -65.65 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 80 3 # 80 B 112 PHE F 110 PHE^? 21.65 MG MG F 301 B 210 ASP F 58 ASP^? 26.87 MG MG E 302 B 244 LYS F 137 LYS^? 35.13 MG MG F 301 coo 8.76 47.85 34.91 11.08 46.36 35.41 72.02 60.99 -83.27 70.61 63.10 -82.08 coo 9.06 56.85 40.30 7.71 55.27 39.90 75.55 64.68 -72.56 76.21 65.63 -70.79 coo -2.38 51.82 41.62 2.07 49.19 40.42 78.53 72.20 -80.30 83.01 68.64 -79.79 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 81 3 # 81 B 112 PHE F 110 PHE^? 21.65 MG MG F 301 B 210 ASP F 58 ASP^? 26.87 MG MG E 302 B 244 LYS F 157 LYS^? 28.36 MG MG F 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 72.02 60.99 -83.27 70.61 63.10 -82.08 coo 9.06 56.85 40.30 7.71 55.27 39.90 75.55 64.68 -72.56 76.21 65.63 -70.79 coo -2.38 51.82 41.62 2.07 49.19 40.42 64.43 70.47 -79.54 68.32 74.80 -81.65 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 82 3 # 82 B 112 PHE F 110 PHE^? 21.65 MG MG F 301 B 210 ASP F 142 ASP^? 23.43 MG MG F 302 B 244 LYS F 137 LYS^? 35.13 MG MG F 301 coo 8.76 47.85 34.91 11.08 46.36 35.41 72.02 60.99 -83.27 70.61 63.10 -82.08 coo 9.06 56.85 40.30 7.71 55.27 39.90 71.46 69.88 -89.76 71.03 69.93 -91.81 coo -2.38 51.82 41.62 2.07 49.19 40.42 78.53 72.20 -80.30 83.01 68.64 -79.79 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 83 3 # 83 B 112 PHE F 110 PHE^? 21.65 MG MG F 301 B 210 ASP F 142 ASP^? 23.43 MG MG F 302 B 244 LYS F 157 LYS^? 28.36 MG MG F 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 72.02 60.99 -83.27 70.61 63.10 -82.08 coo 9.06 56.85 40.30 7.71 55.27 39.90 71.46 69.88 -89.76 71.03 69.93 -91.81 coo -2.38 51.82 41.62 2.07 49.19 40.42 64.43 70.47 -79.54 68.32 74.80 -81.65 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 84 3 # 84 B 112 PHE F 153 PHE^? 9.26 MG MG F 302 B 210 ASP F 128 ASP^? -3.41 MG MG F 301s B 244 LYS F 111 LYS^? 15.21 MG MG F 301 coo 8.76 47.85 34.91 11.08 46.36 35.41 54.49 61.65 -87.43 53.89 59.08 -88.37 coo 9.06 56.85 40.30 7.71 55.27 39.90 57.76 53.73 -90.50 57.46 51.64 -90.28 coo -2.38 51.82 41.62 2.07 49.19 40.42 69.70 58.57 -86.86 69.67 53.74 -90.29 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 85 3 # 85 B 112 PHE F 153 PHE^? 9.26 MG MG F 302 B 210 ASP F 171 ASP^? 16.35 MG MG F 302 B 244 LYS F 166 LYS^? 20.76 MG MG F 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 54.49 61.65 -87.43 53.89 59.08 -88.37 coo 9.06 56.85 40.30 7.71 55.27 39.90 48.23 68.08 -88.47 46.26 68.02 -87.56 coo -2.38 51.82 41.62 2.07 49.19 40.42 59.28 73.05 -82.63 55.63 74.15 -86.94 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 86 3 # 86 B 112 PHE F 161 PHE^? 25.66 MG MG E 302 B 210 ASP E 35 ASP^? 16.91 MG MG E 302 B 244 LYS F 61 LYS^? 21.75 MG MG E 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 68.33 71.65 -68.19 70.12 69.57 -67.59 coo 9.06 56.85 40.30 7.71 55.27 39.90 73.60 65.64 -62.00 73.13 63.73 -61.22 coo -2.38 51.82 41.62 2.07 49.19 40.42 80.24 64.12 -71.01 76.23 61.95 -66.39 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 87 3 # 87 B 112 PHE F 161 PHE^? 25.66 MG MG E 302 B 210 ASP F 58 ASP^? 26.87 MG MG E 302 B 244 LYS F 157 LYS^? 28.36 MG MG F 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 68.33 71.65 -68.19 70.12 69.57 -67.59 coo 9.06 56.85 40.30 7.71 55.27 39.90 75.55 64.68 -72.56 76.21 65.63 -70.79 coo -2.38 51.82 41.62 2.07 49.19 40.42 64.43 70.47 -79.54 68.32 74.80 -81.65 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 88 3 # 88 B 112 PHE F 190 PHE^? 14.21 MG MG F 302 B 210 ASP F 142 ASP^? 23.43 MG MG F 302 B 244 LYS F 111 LYS^? 15.21 MG MG F 301 coo 8.76 47.85 34.91 11.08 46.36 35.41 60.66 66.91 -91.97 61.14 65.56 -89.57 coo 9.06 56.85 40.30 7.71 55.27 39.90 71.46 69.88 -89.76 71.03 69.93 -91.81 coo -2.38 51.82 41.62 2.07 49.19 40.42 69.70 58.57 -86.86 69.67 53.74 -90.29 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 89 3 # 89 B 112 PHE F 190 PHE^? 14.21 MG MG F 302 B 210 ASP F 142 ASP^? 23.43 MG MG F 302 B 244 LYS F 157 LYS^? 28.36 MG MG F 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 60.66 66.91 -91.97 61.14 65.56 -89.57 coo 9.06 56.85 40.30 7.71 55.27 39.90 71.46 69.88 -89.76 71.03 69.93 -91.81 coo -2.38 51.82 41.62 2.07 49.19 40.42 64.43 70.47 -79.54 68.32 74.80 -81.65 1fc4_c03 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 89 hits 1fc4_c03 naa= 3 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 136 HIS A 147 HIS^? 9.20 MG MG A 302 A 210 ASP A 128 ASP^? -3.32 MG MG A 301s A 244 LYS A 111 LYS^? 15.16 MG MG A 301 coo 11.28 44.53 18.60 9.91 46.00 19.20 40.24 23.10 39.83 38.32 22.34 40.22 coo 10.51 37.86 19.71 9.07 39.38 20.04 46.50 28.23 39.77 47.49 30.10 39.82 coo -1.20 42.34 17.67 3.19 45.13 19.06 52.67 17.19 35.90 54.65 19.90 40.50 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 136 HIS A 170 HIS^? 10.56 MG MG A 302 A 210 ASP A 171 ASP^? 17.17 MG MG A 302 A 244 LYS A 166 LYS^? 20.93 MG MG A 302 coo 11.28 44.53 18.60 9.91 46.00 19.20 34.91 23.57 39.32 34.35 24.95 40.81 coo 10.51 37.86 19.71 9.07 39.38 20.04 29.78 23.67 36.63 28.48 25.11 35.71 coo -1.20 42.34 17.67 3.19 45.13 19.06 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 A 136 HIS B 147 HIS^? 9.27 MG MG B 301 A 210 ASP B 128 ASP^? -3.57 MG MG B 302s A 244 LYS B 111 LYS^? 13.75 MG MG B 302 coo 11.28 44.53 18.60 9.91 46.00 19.20 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 10.51 37.86 19.71 9.07 39.38 20.04 52.92 24.09 -2.19 54.73 25.14 -1.90 coo -1.20 42.34 17.67 3.19 45.13 19.06 42.84 32.14 1.80 46.84 32.68 -2.87 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 A 136 HIS B 170 HIS^? 10.51 MG MG B 301 A 210 ASP B 171 ASP^? 16.92 MG MG B 301 A 244 LYS B 166 LYS^? 22.75 MG MG B 301 coo 11.28 44.53 18.60 9.91 46.00 19.20 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 10.51 37.86 19.71 9.07 39.38 20.04 45.30 8.50 -0.71 46.30 6.81 0.12 coo -1.20 42.34 17.67 3.19 45.13 19.06 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 A 136 HIS C 147 HIS^? 9.44 MG MG C 301 A 210 ASP C 128 ASP^? -3.22 MG MG C 302s A 244 LYS C 111 LYS^? 16.56 MG MG C 302 coo 11.28 44.53 18.60 9.91 46.00 19.20 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 10.51 37.86 19.71 9.07 39.38 20.04 80.05 28.39 -4.25 77.97 28.60 -4.21 coo -1.20 42.34 17.67 3.19 45.13 19.06 86.36 39.56 -8.06 84.36 40.84 -3.15 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 A 136 HIS C 170 HIS^? 10.68 MG MG C 301 A 210 ASP C 171 ASP^? 17.08 MG MG C 301 A 244 LYS C 166 LYS^? 22.53 MG MG C 301 coo 11.28 44.53 18.60 9.91 46.00 19.20 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 10.51 37.86 19.71 9.07 39.38 20.04 92.57 16.68 -6.24 92.24 14.74 -7.03 coo -1.20 42.34 17.67 3.19 45.13 19.06 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 A 136 HIS D 147 HIS^? 9.43 MG MG D 301 A 210 ASP D 128 ASP^? -3.70 MG MG D 302s A 244 LYS D 111 LYS^? 15.85 MG MG D 302 coo 11.28 44.53 18.60 9.91 46.00 19.20 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 10.51 37.86 19.71 9.07 39.38 20.04 83.33 35.45 -46.13 81.57 36.63 -46.10 coo -1.20 42.34 17.67 3.19 45.13 19.06 81.21 22.69 -42.10 78.68 23.89 -46.57 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 A 136 HIS D 170 HIS^? 10.59 MG MG D 301 A 210 ASP D 171 ASP^? 16.95 MG MG D 301 A 244 LYS D 166 LYS^? 21.08 MG MG D 301 coo 11.28 44.53 18.60 9.91 46.00 19.20 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 10.51 37.86 19.71 9.07 39.38 20.04 100.39 36.69 -43.49 101.13 38.51 -42.69 coo -1.20 42.34 17.67 3.19 45.13 19.06 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 9 3 # 9 A 136 HIS E 147 HIS^? 9.22 MG MG E 301 A 210 ASP E 128 ASP^? -3.53 MG MG E 302s A 244 LYS E 111 LYS^? 14.52 MG MG E 302 coo 11.28 44.53 18.60 9.91 46.00 19.20 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 10.51 37.86 19.71 9.07 39.38 20.04 65.38 56.57 -48.58 66.15 54.57 -48.61 coo -1.20 42.34 17.67 3.19 45.13 19.06 52.49 56.44 -52.43 54.52 53.78 -47.52 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 10 3 # 10 A 136 HIS E 170 HIS^? 10.33 MG MG E 301 A 210 ASP E 171 ASP^? 16.73 MG MG E 301 A 244 LYS E 166 LYS^? 21.46 MG MG E 301 coo 11.28 44.53 18.60 9.91 46.00 19.20 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 10.51 37.86 19.71 9.07 39.38 20.04 69.61 73.12 -51.56 71.50 73.53 -52.39 coo -1.20 42.34 17.67 3.19 45.13 19.06 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 11 3 # 11 A 136 HIS F 147 HIS^? 8.79 MG MG F 302 A 210 ASP F 128 ASP^? -3.41 MG MG F 301s A 244 LYS F 111 LYS^? 15.21 MG MG F 301 coo 11.28 44.53 18.60 9.91 46.00 19.20 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 10.51 37.86 19.71 9.07 39.38 20.04 57.76 53.73 -90.50 57.46 51.64 -90.28 coo -1.20 42.34 17.67 3.19 45.13 19.06 69.70 58.57 -86.86 69.67 53.74 -90.29 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 12 3 # 12 A 136 HIS F 170 HIS^? 9.84 MG MG F 302 A 210 ASP F 171 ASP^? 16.35 MG MG F 302 A 244 LYS F 166 LYS^? 20.76 MG MG F 302 coo 11.28 44.53 18.60 9.91 46.00 19.20 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 10.51 37.86 19.71 9.07 39.38 20.04 48.23 68.08 -88.47 46.26 68.02 -87.56 coo -1.20 42.34 17.67 3.19 45.13 19.06 59.28 73.05 -82.63 55.63 74.15 -86.94 1fc4_c04 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 12 hits 1fc4_c04 naa= 3 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 136 HIS A 147 HIS^? 9.20 MG MG A 302 B 210 ASP A 128 ASP^? -3.32 MG MG A 301s B 244 LYS A 111 LYS^? 15.16 MG MG A 301 coo 10.08 50.18 41.78 8.91 48.61 41.04 40.24 23.10 39.83 38.32 22.34 40.22 coo 9.06 56.85 40.30 7.71 55.27 39.90 46.50 28.23 39.77 47.49 30.10 39.82 coo -2.38 51.82 41.62 2.07 49.19 40.42 52.67 17.19 35.90 54.65 19.90 40.50 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 136 HIS A 170 HIS^? 10.56 MG MG A 302 B 210 ASP A 171 ASP^? 17.17 MG MG A 302 B 244 LYS A 166 LYS^? 20.93 MG MG A 302 coo 10.08 50.18 41.78 8.91 48.61 41.04 34.91 23.57 39.32 34.35 24.95 40.81 coo 9.06 56.85 40.30 7.71 55.27 39.90 29.78 23.67 36.63 28.48 25.11 35.71 coo -2.38 51.82 41.62 2.07 49.19 40.42 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 B 136 HIS B 147 HIS^? 9.27 MG MG B 301 B 210 ASP B 128 ASP^? -3.57 MG MG B 302s B 244 LYS B 111 LYS^? 13.75 MG MG B 302 coo 10.08 50.18 41.78 8.91 48.61 41.04 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 9.06 56.85 40.30 7.71 55.27 39.90 52.92 24.09 -2.19 54.73 25.14 -1.90 coo -2.38 51.82 41.62 2.07 49.19 40.42 42.84 32.14 1.80 46.84 32.68 -2.87 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 B 136 HIS B 170 HIS^? 10.51 MG MG B 301 B 210 ASP B 171 ASP^? 16.92 MG MG B 301 B 244 LYS B 166 LYS^? 22.75 MG MG B 301 coo 10.08 50.18 41.78 8.91 48.61 41.04 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 9.06 56.85 40.30 7.71 55.27 39.90 45.30 8.50 -0.71 46.30 6.81 0.12 coo -2.38 51.82 41.62 2.07 49.19 40.42 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 B 136 HIS C 170 HIS^? 10.68 MG MG C 301 B 210 ASP C 171 ASP^? 17.08 MG MG C 301 B 244 LYS C 166 LYS^? 22.53 MG MG C 301 coo 10.08 50.18 41.78 8.91 48.61 41.04 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 9.06 56.85 40.30 7.71 55.27 39.90 92.57 16.68 -6.24 92.24 14.74 -7.03 coo -2.38 51.82 41.62 2.07 49.19 40.42 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 B 136 HIS D 147 HIS^? 9.43 MG MG D 301 B 210 ASP D 128 ASP^? -3.70 MG MG D 302s B 244 LYS D 111 LYS^? 15.85 MG MG D 302 coo 10.08 50.18 41.78 8.91 48.61 41.04 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 9.06 56.85 40.30 7.71 55.27 39.90 83.33 35.45 -46.13 81.57 36.63 -46.10 coo -2.38 51.82 41.62 2.07 49.19 40.42 81.21 22.69 -42.10 78.68 23.89 -46.57 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 B 136 HIS D 170 HIS^? 10.59 MG MG D 301 B 210 ASP D 171 ASP^? 16.95 MG MG D 301 B 244 LYS D 166 LYS^? 21.08 MG MG D 301 coo 10.08 50.18 41.78 8.91 48.61 41.04 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 9.06 56.85 40.30 7.71 55.27 39.90 100.39 36.69 -43.49 101.13 38.51 -42.69 coo -2.38 51.82 41.62 2.07 49.19 40.42 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 B 136 HIS E 147 HIS^? 9.22 MG MG E 301 B 210 ASP E 128 ASP^? -3.53 MG MG E 302s B 244 LYS E 111 LYS^? 14.52 MG MG E 302 coo 10.08 50.18 41.78 8.91 48.61 41.04 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 9.06 56.85 40.30 7.71 55.27 39.90 65.38 56.57 -48.58 66.15 54.57 -48.61 coo -2.38 51.82 41.62 2.07 49.19 40.42 52.49 56.44 -52.43 54.52 53.78 -47.52 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 9 3 # 9 B 136 HIS E 170 HIS^? 10.33 MG MG E 301 B 210 ASP E 171 ASP^? 16.73 MG MG E 301 B 244 LYS E 166 LYS^? 21.46 MG MG E 301 coo 10.08 50.18 41.78 8.91 48.61 41.04 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 9.06 56.85 40.30 7.71 55.27 39.90 69.61 73.12 -51.56 71.50 73.53 -52.39 coo -2.38 51.82 41.62 2.07 49.19 40.42 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 10 3 # 10 B 136 HIS F 147 HIS^? 8.79 MG MG F 302 B 210 ASP F 128 ASP^? -3.41 MG MG F 301s B 244 LYS F 111 LYS^? 15.21 MG MG F 301 coo 10.08 50.18 41.78 8.91 48.61 41.04 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 9.06 56.85 40.30 7.71 55.27 39.90 57.76 53.73 -90.50 57.46 51.64 -90.28 coo -2.38 51.82 41.62 2.07 49.19 40.42 69.70 58.57 -86.86 69.67 53.74 -90.29 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 11 3 # 11 B 136 HIS F 170 HIS^? 9.84 MG MG F 302 B 210 ASP F 171 ASP^? 16.35 MG MG F 302 B 244 LYS F 166 LYS^? 20.76 MG MG F 302 coo 10.08 50.18 41.78 8.91 48.61 41.04 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 9.06 56.85 40.30 7.71 55.27 39.90 48.23 68.08 -88.47 46.26 68.02 -87.56 coo -2.38 51.82 41.62 2.07 49.19 40.42 59.28 73.05 -82.63 55.63 74.15 -86.94 1fc4_c05 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 11 hits 1fc4_c05 naa= 3 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 137 TYR F 168 TYR^? 14.10 MG MG F 302 A 142 LEU F 131 LEU^? 14.81 MG MG F 301 A 165 LYS F 192 LYS^? 23.61 MG MG F 302 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 58.29 68.32 -89.29 56.67 67.12 -91.21 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 64.89 61.59 -87.10 63.34 63.04 -87.61 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 64.82 71.59 -91.06 62.22 76.11 -88.75 1fdy_c00 source 1fdy N-ACETYLNEURAMINATE LYASE : 1 hits 1fdy_c00 naa= 3 ULMN 3 1fnb_c00 FERREDOXIN:NADP+ OXIDOREDUCTASE (FERuser 1 3 # 1 96 SER A 49 SER^? 17.63 MG MG A 301 272 CYH A 152 CYH^? 15.18 MG MG A 302 312 GLU A 154 GLU^? 19.22 MG MG A 301 coo 27.57 5.78 14.13 25.30 6.31 13.99 38.68 29.52 26.48 39.52 27.49 25.41 coo 18.48 7.50 15.98 21.17 6.92 15.38 34.81 26.51 34.70 32.10 26.95 34.06 coo 22.30 10.15 12.52 24.07 9.52 13.47 36.54 21.95 29.78 35.14 22.21 28.17 ULMN 3 1fnb_c00 FERREDOXIN:NADP+ OXIDOREDUCTASE (FERuser 2 3 # 2 96 SER B 49 SER^? 17.51 MG MG B 302 272 CYH B 152 CYH^? 14.66 MG MG B 301 312 GLU B 154 GLU^? 19.05 MG MG B 302 coo 27.57 5.78 14.13 25.30 6.31 13.99 51.67 15.70 10.57 49.37 16.19 11.15 coo 18.48 7.50 15.98 21.17 6.92 15.38 48.74 12.82 1.93 48.51 10.17 2.19 coo 22.30 10.15 12.52 24.07 9.52 13.47 44.04 15.11 6.74 44.19 13.59 8.30 ULMN 3 1fnb_c00 FERREDOXIN:NADP+ OXIDOREDUCTASE (FERuser 3 3 # 3 96 SER C 49 SER^? 17.53 MG MG C 302 272 CYH C 152 CYH^? 14.61 MG MG C 301 312 GLU C 154 GLU^? 18.91 MG MG C 302 coo 27.57 5.78 14.13 25.30 6.31 13.99 83.83 21.24 -17.13 85.75 22.50 -18.00 coo 18.48 7.50 15.98 21.17 6.92 15.38 87.66 19.43 -8.58 88.77 17.04 -8.78 coo 22.30 10.15 12.52 24.07 9.52 13.47 91.15 23.27 -13.33 91.61 21.91 -14.95 ULMN 3 1fnb_c00 FERREDOXIN:NADP+ OXIDOREDUCTASE (FERuser 4 3 # 4 96 SER D 49 SER^? 17.22 MG MG D 302 272 CYH D 152 CYH^? 14.66 MG MG D 301 312 GLU D 154 GLU^? 18.75 MG MG D 302 coo 27.57 5.78 14.13 25.30 6.31 13.99 90.26 38.73 -32.99 91.21 36.48 -32.65 coo 18.48 7.50 15.98 21.17 6.92 15.38 94.69 37.43 -41.36 96.92 38.83 -40.94 coo 22.30 10.15 12.52 24.07 9.52 13.47 94.87 32.52 -36.42 96.07 33.39 -34.88 ULMN 3 1fnb_c00 FERREDOXIN:NADP+ OXIDOREDUCTASE (FERuser 5 3 # 5 96 SER E 49 SER^? 17.46 MG MG E 302 272 CYH E 152 CYH^? 14.64 MG MG E 301 312 GLU E 154 GLU^? 19.05 MG MG E 302 coo 27.57 5.78 14.13 25.30 6.31 13.99 69.86 62.56 -61.93 67.83 63.87 -62.36 coo 18.48 7.50 15.98 21.17 6.92 15.38 69.49 67.27 -53.54 71.02 69.50 -54.03 coo 22.30 10.15 12.52 24.07 9.52 13.47 64.41 68.21 -58.47 65.40 69.20 -60.08 ULMN 3 1fnb_c00 FERREDOXIN:NADP+ OXIDOREDUCTASE (FERuser 6 3 # 6 96 SER F 49 SER^? 17.41 MG MG F 301 272 CYH F 152 CYH^? 14.14 MG MG F 302 312 GLU F 154 GLU^? 18.97 MG MG F 301 coo 27.57 5.78 14.13 25.30 6.31 13.99 51.43 58.69 -77.53 52.81 60.66 -77.24 coo 18.48 7.50 15.98 21.17 6.92 15.38 50.28 62.76 -86.08 48.12 64.34 -85.77 coo 22.30 10.15 12.52 24.07 9.52 13.47 54.57 65.67 -81.55 53.36 66.51 -80.09 1fnb_c00 source 1fnb FERREDOXIN:NADP+ OXIDOREDUCTASE (FERREDOXIN RE: 6 hits 1fnb_c00 naa= 3 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 1 3 # 1 A 54 ASP A 35 ASP^? 16.92 MG MG A 301 A 281 ARG A 37 ARG^? 18.99 MG MG A 301 A 289 TYR B 60 TYR^? 27.11 MG MG A 301 coo 54.86 40.00 47.23 55.57 38.60 48.67 34.49 31.10 26.54 36.41 31.82 27.10 coo 52.08 40.18 50.14 50.83 38.93 47.73 32.99 26.50 25.19 35.50 25.33 26.51 coo 57.82 31.70 50.73 57.94 34.00 49.17 28.84 35.27 19.49 28.03 36.56 21.83 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 2 3 # 2 A 54 ASP B 35 ASP^? 16.92 MG MG B 302 A 281 ARG B 37 ARG^? 19.17 MG MG B 302 A 289 TYR A 60 TYR^? 27.11 MG MG B 302 coo 54.86 40.00 47.23 55.57 38.60 48.67 52.63 11.07 10.18 53.68 12.85 9.94 coo 52.08 40.18 50.14 50.83 38.93 47.73 47.41 10.20 11.40 46.99 12.91 10.22 coo 57.82 31.70 50.73 57.94 34.00 49.17 55.01 4.24 16.98 56.13 3.24 14.65 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 3 3 # 3 A 54 ASP C 35 ASP^? 16.42 MG MG C 302 A 281 ARG C 37 ARG^? 19.01 MG MG C 302 A 289 TYR D 60 TYR^? 26.93 MG MG C 302 coo 54.86 40.00 47.23 55.57 38.60 48.67 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 52.08 40.18 50.14 50.83 38.93 47.73 89.36 17.23 -17.57 89.29 20.20 -16.76 coo 57.82 31.70 50.73 57.94 34.00 49.17 84.40 9.28 -23.74 83.45 7.90 -21.49 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 4 3 # 4 A 54 ASP D 35 ASP^? 16.80 MG MG D 302 A 281 ARG D 37 ARG^? 18.81 MG MG D 302 A 289 TYR C 60 TYR^? 26.95 MG MG D 302 coo 54.86 40.00 47.23 55.57 38.60 48.67 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 52.08 40.18 50.14 50.83 38.93 47.73 96.81 38.21 -31.63 94.97 36.32 -33.06 coo 57.82 31.70 50.73 57.94 34.00 49.17 97.75 47.69 -25.92 97.82 49.25 -28.26 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 5 3 # 5 A 54 ASP E 35 ASP^? 16.91 MG MG E 302 A 281 ARG E 37 ARG^? 19.17 MG MG E 302 A 289 TYR F 60 TYR^? 27.07 MG MG E 302 coo 54.86 40.00 47.23 55.57 38.60 48.67 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 52.08 40.18 50.14 50.83 38.93 47.73 70.82 68.02 -63.63 68.17 67.46 -62.14 coo 57.82 31.70 50.73 57.94 34.00 49.17 79.79 68.64 -68.89 81.11 68.86 -66.46 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 6 3 # 6 A 54 ASP F 35 ASP^? 16.93 MG MG F 301 A 281 ARG F 37 ARG^? 19.14 MG MG F 301 A 289 TYR E 60 TYR^? 27.19 MG MG F 301 coo 54.86 40.00 47.23 55.57 38.60 48.67 46.82 60.47 -77.63 48.00 58.79 -78.23 coo 52.08 40.18 50.14 50.83 38.93 47.73 48.80 64.46 -76.37 51.50 64.15 -77.79 coo 57.82 31.70 50.73 57.94 34.00 49.17 39.82 61.07 -70.68 38.29 60.72 -72.98 1foh_c00 source 1foh PHENOL HYDROXYLASE : 6 hits 1foh_c00 naa= 3 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 1 3 # 1 B 54 ASP A 35 ASP^? 16.92 MG MG A 301 B 281 ARG A 37 ARG^? 18.99 MG MG A 301 B 289 TYR B 60 TYR^? 27.11 MG MG A 301 coo 90.56 80.24 98.04 90.36 81.53 96.34 34.49 31.10 26.54 36.41 31.82 27.10 coo 86.62 80.67 97.51 87.37 82.00 100.10 32.99 26.50 25.19 35.50 25.33 26.51 coo 91.83 88.28 92.88 92.60 85.93 94.14 28.84 35.27 19.49 28.03 36.56 21.83 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 2 3 # 2 B 54 ASP B 35 ASP^? 16.92 MG MG B 302 B 281 ARG B 37 ARG^? 19.17 MG MG B 302 B 289 TYR A 60 TYR^? 27.11 MG MG B 302 coo 90.56 80.24 98.04 90.36 81.53 96.34 52.63 11.07 10.18 53.68 12.85 9.94 coo 86.62 80.67 97.51 87.37 82.00 100.10 47.41 10.20 11.40 46.99 12.91 10.22 coo 91.83 88.28 92.88 92.60 85.93 94.14 55.01 4.24 16.98 56.13 3.24 14.65 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 3 3 # 3 B 54 ASP C 35 ASP^? 16.42 MG MG C 302 B 281 ARG C 37 ARG^? 19.01 MG MG C 302 B 289 TYR D 60 TYR^? 26.93 MG MG C 302 coo 90.56 80.24 98.04 90.36 81.53 96.34 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 86.62 80.67 97.51 87.37 82.00 100.10 89.36 17.23 -17.57 89.29 20.20 -16.76 coo 91.83 88.28 92.88 92.60 85.93 94.14 84.40 9.28 -23.74 83.45 7.90 -21.49 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 4 3 # 4 B 54 ASP D 35 ASP^? 16.80 MG MG D 302 B 281 ARG D 37 ARG^? 18.81 MG MG D 302 B 289 TYR C 60 TYR^? 26.95 MG MG D 302 coo 90.56 80.24 98.04 90.36 81.53 96.34 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 86.62 80.67 97.51 87.37 82.00 100.10 96.81 38.21 -31.63 94.97 36.32 -33.06 coo 91.83 88.28 92.88 92.60 85.93 94.14 97.75 47.69 -25.92 97.82 49.25 -28.26 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 5 3 # 5 B 54 ASP E 35 ASP^? 16.91 MG MG E 302 B 281 ARG E 37 ARG^? 19.17 MG MG E 302 B 289 TYR F 60 TYR^? 27.07 MG MG E 302 coo 90.56 80.24 98.04 90.36 81.53 96.34 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 86.62 80.67 97.51 87.37 82.00 100.10 70.82 68.02 -63.63 68.17 67.46 -62.14 coo 91.83 88.28 92.88 92.60 85.93 94.14 79.79 68.64 -68.89 81.11 68.86 -66.46 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 6 3 # 6 B 54 ASP F 35 ASP^? 16.93 MG MG F 301 B 281 ARG F 37 ARG^? 19.14 MG MG F 301 B 289 TYR E 60 TYR^? 27.19 MG MG F 301 coo 90.56 80.24 98.04 90.36 81.53 96.34 46.82 60.47 -77.63 48.00 58.79 -78.23 coo 86.62 80.67 97.51 87.37 82.00 100.10 48.80 64.46 -76.37 51.50 64.15 -77.79 coo 91.83 88.28 92.88 92.60 85.93 94.14 39.82 61.07 -70.68 38.29 60.72 -72.98 1foh_c01 source 1foh PHENOL HYDROXYLASE : 6 hits 1foh_c01 naa= 3 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 1 3 # 1 C 54 ASP A 35 ASP^? 16.92 MG MG A 301 C 281 ARG A 37 ARG^? 18.99 MG MG A 301 C 289 TYR B 60 TYR^? 27.11 MG MG A 301 coo 42.34 76.83 49.10 43.06 78.59 50.01 34.49 31.10 26.54 36.41 31.82 27.10 coo 46.12 77.15 48.13 44.44 77.61 45.70 32.99 26.50 25.19 35.50 25.33 26.51 coo 42.69 86.18 51.69 41.59 83.63 51.54 28.84 35.27 19.49 28.03 36.56 21.83 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 2 3 # 2 C 54 ASP B 35 ASP^? 16.92 MG MG B 302 C 281 ARG B 37 ARG^? 19.17 MG MG B 302 C 289 TYR A 60 TYR^? 27.11 MG MG B 302 coo 42.34 76.83 49.10 43.06 78.59 50.01 52.63 11.07 10.18 53.68 12.85 9.94 coo 46.12 77.15 48.13 44.44 77.61 45.70 47.41 10.20 11.40 46.99 12.91 10.22 coo 42.69 86.18 51.69 41.59 83.63 51.54 55.01 4.24 16.98 56.13 3.24 14.65 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 3 3 # 3 C 54 ASP C 35 ASP^? 16.42 MG MG C 302 C 281 ARG C 37 ARG^? 19.01 MG MG C 302 C 289 TYR D 60 TYR^? 26.93 MG MG C 302 coo 42.34 76.83 49.10 43.06 78.59 50.01 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 46.12 77.15 48.13 44.44 77.61 45.70 89.36 17.23 -17.57 89.29 20.20 -16.76 coo 42.69 86.18 51.69 41.59 83.63 51.54 84.40 9.28 -23.74 83.45 7.90 -21.49 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 4 3 # 4 C 54 ASP D 35 ASP^? 16.80 MG MG D 302 C 281 ARG D 37 ARG^? 18.81 MG MG D 302 C 289 TYR C 60 TYR^? 26.95 MG MG D 302 coo 42.34 76.83 49.10 43.06 78.59 50.01 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 46.12 77.15 48.13 44.44 77.61 45.70 96.81 38.21 -31.63 94.97 36.32 -33.06 coo 42.69 86.18 51.69 41.59 83.63 51.54 97.75 47.69 -25.92 97.82 49.25 -28.26 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 5 3 # 5 C 54 ASP E 35 ASP^? 16.91 MG MG E 302 C 281 ARG E 37 ARG^? 19.17 MG MG E 302 C 289 TYR F 60 TYR^? 27.07 MG MG E 302 coo 42.34 76.83 49.10 43.06 78.59 50.01 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 46.12 77.15 48.13 44.44 77.61 45.70 70.82 68.02 -63.63 68.17 67.46 -62.14 coo 42.69 86.18 51.69 41.59 83.63 51.54 79.79 68.64 -68.89 81.11 68.86 -66.46 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 6 3 # 6 C 54 ASP F 35 ASP^? 16.93 MG MG F 301 C 281 ARG F 37 ARG^? 19.14 MG MG F 301 C 289 TYR E 60 TYR^? 27.19 MG MG F 301 coo 42.34 76.83 49.10 43.06 78.59 50.01 46.82 60.47 -77.63 48.00 58.79 -78.23 coo 46.12 77.15 48.13 44.44 77.61 45.70 48.80 64.46 -76.37 51.50 64.15 -77.79 coo 42.69 86.18 51.69 41.59 83.63 51.54 39.82 61.07 -70.68 38.29 60.72 -72.98 1foh_c02 source 1foh PHENOL HYDROXYLASE : 6 hits 1foh_c02 naa= 3 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 1 3 # 1 D 54 ASP A 35 ASP^? 16.92 MG MG A 301 D 281 ARG A 37 ARG^? 18.99 MG MG A 301 D 289 TYR B 60 TYR^? 27.11 MG MG A 301 coo 75.05 45.80 106.18 74.73 43.88 105.51 34.49 31.10 26.54 36.41 31.82 27.10 coo 78.52 44.93 104.78 78.72 44.49 107.76 32.99 26.50 25.19 35.50 25.33 26.51 coo 72.35 36.51 104.82 72.00 39.20 105.46 28.84 35.27 19.49 28.03 36.56 21.83 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 2 3 # 2 D 54 ASP B 35 ASP^? 16.92 MG MG B 302 D 281 ARG B 37 ARG^? 19.17 MG MG B 302 D 289 TYR A 60 TYR^? 27.11 MG MG B 302 coo 75.05 45.80 106.18 74.73 43.88 105.51 52.63 11.07 10.18 53.68 12.85 9.94 coo 78.52 44.93 104.78 78.72 44.49 107.76 47.41 10.20 11.40 46.99 12.91 10.22 coo 72.35 36.51 104.82 72.00 39.20 105.46 55.01 4.24 16.98 56.13 3.24 14.65 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 3 3 # 3 D 54 ASP C 35 ASP^? 16.42 MG MG C 302 D 281 ARG C 37 ARG^? 19.01 MG MG C 302 D 289 TYR D 60 TYR^? 26.93 MG MG C 302 coo 75.05 45.80 106.18 74.73 43.88 105.51 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 78.52 44.93 104.78 78.72 44.49 107.76 89.36 17.23 -17.57 89.29 20.20 -16.76 coo 72.35 36.51 104.82 72.00 39.20 105.46 84.40 9.28 -23.74 83.45 7.90 -21.49 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 4 3 # 4 D 54 ASP D 35 ASP^? 16.80 MG MG D 302 D 281 ARG D 37 ARG^? 18.81 MG MG D 302 D 289 TYR C 60 TYR^? 26.95 MG MG D 302 coo 75.05 45.80 106.18 74.73 43.88 105.51 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 78.52 44.93 104.78 78.72 44.49 107.76 96.81 38.21 -31.63 94.97 36.32 -33.06 coo 72.35 36.51 104.82 72.00 39.20 105.46 97.75 47.69 -25.92 97.82 49.25 -28.26 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 5 3 # 5 D 54 ASP E 35 ASP^? 16.91 MG MG E 302 D 281 ARG E 37 ARG^? 19.17 MG MG E 302 D 289 TYR F 60 TYR^? 27.07 MG MG E 302 coo 75.05 45.80 106.18 74.73 43.88 105.51 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 78.52 44.93 104.78 78.72 44.49 107.76 70.82 68.02 -63.63 68.17 67.46 -62.14 coo 72.35 36.51 104.82 72.00 39.20 105.46 79.79 68.64 -68.89 81.11 68.86 -66.46 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 6 3 # 6 D 54 ASP F 35 ASP^? 16.93 MG MG F 301 D 281 ARG F 37 ARG^? 19.14 MG MG F 301 D 289 TYR E 60 TYR^? 27.19 MG MG F 301 coo 75.05 45.80 106.18 74.73 43.88 105.51 46.82 60.47 -77.63 48.00 58.79 -78.23 coo 78.52 44.93 104.78 78.72 44.49 107.76 48.80 64.46 -76.37 51.50 64.15 -77.79 coo 72.35 36.51 104.82 72.00 39.20 105.46 39.82 61.07 -70.68 38.29 60.72 -72.98 1foh_c03 source 1foh PHENOL HYDROXYLASE : 6 hits 1foh_c03 naa= 3 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 1 3 # 1 A 317 GLU A 33 GLU^? 22.87 MG MG A 301 A 319 ASP A 35 ASP^? 16.92 MG MG A 301 A 359 ARG A 37 ARG^? 18.99 MG MG A 301 coo 14.41 12.40 16.42 12.92 13.74 15.71 33.74 38.67 24.96 34.13 38.85 22.87 coo 12.25 13.04 23.85 11.56 15.02 23.93 34.49 31.10 26.54 36.41 31.82 27.10 coo 10.89 14.95 28.28 12.39 12.53 29.31 32.99 26.50 25.19 35.50 25.33 26.51 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 2 3 # 2 A 317 GLU A 154 GLU^? 19.22 MG MG A 301 A 319 ASP A 171 ASP^? 17.17 MG MG A 302 A 359 ARG A 173 ARG^? 19.27 MG MG A 302 coo 14.41 12.40 16.42 12.92 13.74 15.71 36.54 21.95 29.78 35.14 22.21 28.17 coo 12.25 13.04 23.85 11.56 15.02 23.93 29.78 23.67 36.63 28.48 25.11 35.71 coo 10.89 14.95 28.28 12.39 12.53 29.31 27.76 29.24 35.14 27.46 27.11 32.86 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 3 3 # 3 A 317 GLU B 33 GLU^? 22.65 MG MG B 302 A 319 ASP B 35 ASP^? 16.92 MG MG B 302 A 359 ARG B 37 ARG^? 19.17 MG MG B 302 coo 14.41 12.40 16.42 12.92 13.74 15.71 59.88 9.09 12.22 59.91 9.49 14.33 coo 12.25 13.04 23.85 11.56 15.02 23.93 52.63 11.07 10.18 53.68 12.85 9.94 coo 10.89 14.95 28.28 12.39 12.53 29.31 47.41 10.20 11.40 46.99 12.91 10.22 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 4 3 # 4 A 317 GLU C 33 GLU^? 22.71 MG MG C 302 A 319 ASP C 35 ASP^? 16.42 MG MG C 302 A 359 ARG C 37 ARG^? 19.01 MG MG C 302 coo 14.41 12.40 16.42 12.92 13.74 15.71 78.39 11.67 -18.82 78.34 12.01 -20.91 coo 12.25 13.04 23.85 11.56 15.02 23.93 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 10.89 14.95 28.28 12.39 12.53 29.31 89.36 17.23 -17.57 89.29 20.20 -16.76 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 5 3 # 5 A 317 GLU C 154 GLU^? 18.91 MG MG C 302 A 319 ASP C 171 ASP^? 17.08 MG MG C 301 A 359 ARG C 173 ARG^? 18.96 MG MG C 301 coo 14.41 12.40 16.42 12.92 13.74 15.71 91.15 23.27 -13.33 91.61 21.91 -14.95 coo 12.25 13.04 23.85 11.56 15.02 23.93 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 10.89 14.95 28.28 12.39 12.53 29.31 89.11 11.40 -7.73 91.21 12.63 -9.73 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 6 3 # 6 A 317 GLU D 33 GLU^? 22.23 MG MG D 302 A 319 ASP D 35 ASP^? 16.80 MG MG D 302 A 359 ARG D 37 ARG^? 18.81 MG MG D 302 coo 14.41 12.40 16.42 12.92 13.74 15.71 91.55 48.87 -31.66 91.12 48.92 -29.63 coo 12.25 13.04 23.85 11.56 15.02 23.93 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 10.89 14.95 28.28 12.39 12.53 29.31 96.81 38.21 -31.63 94.97 36.32 -33.06 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 7 3 # 7 A 317 GLU E 33 GLU^? 22.81 MG MG E 302 A 319 ASP E 35 ASP^? 16.91 MG MG E 302 A 359 ARG E 37 ARG^? 19.17 MG MG E 302 coo 14.41 12.40 16.42 12.92 13.74 15.71 80.16 62.57 -63.35 80.54 62.13 -65.43 coo 12.25 13.04 23.85 11.56 15.02 23.93 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 10.89 14.95 28.28 12.39 12.53 29.31 70.82 68.02 -63.63 68.17 67.46 -62.14 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 8 3 # 8 A 317 GLU F 33 GLU^? 22.46 MG MG F 301 A 319 ASP F 35 ASP^? 16.93 MG MG F 301 A 359 ARG F 37 ARG^? 19.14 MG MG F 301 coo 14.41 12.40 16.42 12.92 13.74 15.71 41.88 55.13 -75.91 42.06 54.64 -73.84 coo 12.25 13.04 23.85 11.56 15.02 23.93 46.82 60.47 -77.63 48.00 58.79 -78.23 coo 10.89 14.95 28.28 12.39 12.53 29.31 48.80 64.46 -76.37 51.50 64.15 -77.79 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 9 3 # 9 A 317 GLU F 154 GLU^? 18.97 MG MG F 301 A 319 ASP F 171 ASP^? 16.35 MG MG F 302 A 359 ARG F 173 ARG^? 18.61 MG MG F 302 coo 14.41 12.40 16.42 12.92 13.74 15.71 54.57 65.67 -81.55 53.36 66.51 -80.09 coo 12.25 13.04 23.85 11.56 15.02 23.93 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 10.89 14.95 28.28 12.39 12.53 29.31 43.18 65.58 -86.96 44.06 67.55 -84.65 1fr8_c00 source 1fr8 BETA 1,4 GALACTOSYLTRANSFERASE : 9 hits 1fr8_c00 naa= 3 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 1 3 # 1 B 317 GLU A 33 GLU^? 22.87 MG MG A 301 B 319 ASP A 35 ASP^? 16.92 MG MG A 301 B 359 ARG A 37 ARG^? 18.99 MG MG A 301 coo 10.77 13.13 40.94 11.03 14.73 39.51 33.74 38.67 24.96 34.13 38.85 22.87 coo 3.77 12.64 38.21 3.35 14.53 37.39 34.49 31.10 26.54 36.41 31.82 27.10 coo -1.16 15.32 35.60 -3.32 13.56 36.98 32.99 26.50 25.19 35.50 25.33 26.51 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 2 3 # 2 B 317 GLU B 33 GLU^? 22.65 MG MG B 302 B 319 ASP B 35 ASP^? 16.92 MG MG B 302 B 359 ARG B 37 ARG^? 19.17 MG MG B 302 coo 10.77 13.13 40.94 11.03 14.73 39.51 59.88 9.09 12.22 59.91 9.49 14.33 coo 3.77 12.64 38.21 3.35 14.53 37.39 52.63 11.07 10.18 53.68 12.85 9.94 coo -1.16 15.32 35.60 -3.32 13.56 36.98 47.41 10.20 11.40 46.99 12.91 10.22 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 3 3 # 3 B 317 GLU C 33 GLU^? 22.71 MG MG C 302 B 319 ASP C 35 ASP^? 16.42 MG MG C 302 B 359 ARG C 37 ARG^? 19.01 MG MG C 302 coo 10.77 13.13 40.94 11.03 14.73 39.51 78.39 11.67 -18.82 78.34 12.01 -20.91 coo 3.77 12.64 38.21 3.35 14.53 37.39 84.40 16.53 -16.68 82.83 17.91 -16.28 coo -1.16 15.32 35.60 -3.32 13.56 36.98 89.36 17.23 -17.57 89.29 20.20 -16.76 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 4 3 # 4 B 317 GLU D 33 GLU^? 22.23 MG MG D 302 B 319 ASP D 35 ASP^? 16.80 MG MG D 302 B 359 ARG D 37 ARG^? 18.81 MG MG D 302 coo 10.77 13.13 40.94 11.03 14.73 39.51 91.55 48.87 -31.66 91.12 48.92 -29.63 coo 3.77 12.64 38.21 3.35 14.53 37.39 93.83 42.00 -33.14 91.74 41.83 -33.51 coo -1.16 15.32 35.60 -3.32 13.56 36.98 96.81 38.21 -31.63 94.97 36.32 -33.06 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 5 3 # 5 B 317 GLU F 33 GLU^? 22.46 MG MG F 301 B 319 ASP F 35 ASP^? 16.93 MG MG F 301 B 359 ARG F 37 ARG^? 19.14 MG MG F 301 coo 10.77 13.13 40.94 11.03 14.73 39.51 41.88 55.13 -75.91 42.06 54.64 -73.84 coo 3.77 12.64 38.21 3.35 14.53 37.39 46.82 60.47 -77.63 48.00 58.79 -78.23 coo -1.16 15.32 35.60 -3.32 13.56 36.98 48.80 64.46 -76.37 51.50 64.15 -77.79 1fr8_c01 source 1fr8 BETA 1,4 GALACTOSYLTRANSFERASE : 5 hits 1fr8_c01 naa= 3 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 1 3 # 1 A 197 ARG B 50 ARG^? 16.38 MG MG B 302 A 201 HIS B 147 HIS^? 9.27 MG MG B 301 A 204 HIS B 170 HIS^? 10.51 MG MG B 301 coo -27.47 20.45 37.96 -26.70 17.86 36.51 55.38 14.91 7.80 56.60 14.73 10.62 coo -15.08 14.90 41.58 -16.70 13.64 42.02 46.73 18.97 -3.05 45.63 17.32 -3.73 coo -15.44 20.23 39.72 -16.43 18.87 38.47 46.22 13.75 -2.72 47.53 13.11 -4.24 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 2 3 # 2 A 197 ARG C 173 ARG^? 18.96 MG MG C 301 A 201 HIS C 147 HIS^? 9.44 MG MG C 301 A 204 HIS C 170 HIS^? 10.68 MG MG C 301 coo -27.47 20.45 37.96 -26.70 17.86 36.51 89.11 11.40 -7.73 91.21 12.63 -9.73 coo -15.08 14.90 41.58 -16.70 13.64 42.02 87.61 25.71 -3.59 89.22 24.50 -2.99 coo -15.44 20.23 39.72 -16.43 18.87 38.47 89.96 21.05 -3.85 88.74 19.88 -2.61 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 3 3 # 3 A 197 ARG E 50 ARG^? 15.97 MG MG E 302 A 201 HIS E 147 HIS^? 9.22 MG MG E 301 A 204 HIS E 170 HIS^? 10.33 MG MG E 301 coo -27.47 20.45 37.96 -26.70 17.86 36.51 73.62 60.83 -58.23 74.10 60.41 -61.24 coo -15.08 14.90 41.58 -16.70 13.64 42.02 63.87 64.43 -48.39 64.18 66.45 -47.92 coo -15.44 20.23 39.72 -16.43 18.87 38.47 66.96 68.76 -48.87 68.36 68.54 -47.33 1g8f_c00 source 1g8f SULFATE ADENYLYLTRANSFERASE : 3 hits 1g8f_c00 naa= 3 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 1 3 # 1 A 314 TRP A 17 TRP.? 23.08 MG MG A 301 A 317 GLU A 33 GLU^? 22.87 MG MG A 301 A 365 ARG A 173 ARG^? 19.27 MG MG A 302 coo 79.91 26.87 38.77 78.95 23.18 37.81 28.76 40.52 27.21 32.16 42.08 26.00 coo 85.55 26.30 41.25 85.59 24.97 39.65 33.74 38.67 24.96 34.13 38.85 22.87 coo 83.47 25.30 27.10 83.44 27.82 25.29 27.76 29.24 35.14 27.46 27.11 32.86 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 2 3 # 2 A 314 TRP C 17 TRP^? 23.10 MG MG C 302 A 317 GLU C 33 GLU^? 22.71 MG MG C 302 A 365 ARG C 173 ARG^? 18.96 MG MG C 301 coo 79.91 26.87 38.77 78.95 23.18 37.81 79.70 6.66 -16.37 76.53 8.49 -17.82 coo 85.55 26.30 41.25 85.59 24.97 39.65 78.39 11.67 -18.82 78.34 12.01 -20.91 coo 83.47 25.30 27.10 83.44 27.82 25.29 89.11 11.40 -7.73 91.21 12.63 -9.73 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 3 3 # 3 A 314 TRP D 17 TRP^? 22.77 MG MG D 302 A 317 GLU D 33 GLU^? 22.23 MG MG D 302 A 365 ARG D 173 ARG^? 18.88 MG MG D 301 coo 79.91 26.87 38.77 78.95 23.18 37.81 95.68 52.30 -33.46 91.97 52.85 -32.32 coo 85.55 26.30 41.25 85.59 24.97 39.65 91.55 48.87 -31.66 91.12 48.92 -29.63 coo 83.47 25.30 27.10 83.44 27.82 25.29 100.48 42.57 -42.43 101.55 40.79 -40.06 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 4 3 # 4 A 314 TRP E 17 TRP^? 23.16 MG MG E 302 A 317 GLU E 33 GLU^? 22.81 MG MG E 302 A 365 ARG E 173 ARG^? 18.66 MG MG E 301 coo 79.91 26.87 38.77 78.95 23.18 37.81 84.58 65.99 -61.17 84.39 62.29 -62.50 coo 85.55 26.30 41.25 85.59 24.97 39.65 80.16 62.57 -63.35 80.54 62.13 -65.43 coo 83.47 25.30 27.10 83.44 27.82 25.29 75.16 72.26 -52.56 73.67 73.54 -55.01 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 5 3 # 5 A 314 TRP F 17 TRP^? 22.92 MG MG F 301 A 317 GLU F 33 GLU^? 22.46 MG MG F 301 A 365 ARG F 173 ARG^? 18.61 MG MG F 302 coo 79.91 26.87 38.77 78.95 23.18 37.81 36.94 56.86 -77.76 38.25 53.31 -76.79 coo 85.55 26.30 41.25 85.59 24.97 39.65 41.88 55.13 -75.91 42.06 54.64 -73.84 coo 83.47 25.30 27.10 83.44 27.82 25.29 43.18 65.58 -86.96 44.06 67.55 -84.65 1g8o_c01 source 1g8o N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALACTOSYLTRA: 5 hits 1g8o_c01 naa= 3 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 1 3 # 1 412 GLU A 146 GLU^? 9.80 MG MG A 302 516 HIS A 170 HIS^? 10.56 MG MG A 302 559 HIS A 147 HIS^? 9.20 MG MG A 302 coo 49.01 14.50 52.53 46.99 14.61 52.78 45.17 20.35 44.20 46.68 21.21 45.40 coo 41.59 7.83 54.15 41.16 9.87 53.87 34.91 23.57 39.32 34.35 24.95 40.81 coo 42.22 14.55 52.50 43.91 14.87 53.60 40.24 23.10 39.83 38.32 22.34 40.22 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 2 3 # 2 412 GLU B 146 GLU^? 10.54 MG MG B 301 516 HIS B 170 HIS^? 10.51 MG MG B 301 559 HIS B 147 HIS^? 9.27 MG MG B 301 coo 49.01 14.50 52.53 46.99 14.61 52.78 45.13 24.51 -7.01 46.08 25.99 -8.13 coo 41.59 7.83 54.15 41.16 9.87 53.87 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 42.22 14.55 52.50 43.91 14.87 53.60 46.73 18.97 -3.05 45.63 17.32 -3.73 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 3 3 # 3 412 GLU C 146 GLU^? 10.46 MG MG C 301 516 HIS C 170 HIS^? 10.68 MG MG C 301 559 HIS C 147 HIS^? 9.44 MG MG C 301 coo 49.01 14.50 52.53 46.99 14.61 52.78 87.01 31.93 0.25 85.57 32.56 1.72 coo 41.59 7.83 54.15 41.16 9.87 53.87 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 42.22 14.55 52.50 43.91 14.87 53.60 87.61 25.71 -3.59 89.22 24.50 -2.99 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 4 3 # 4 412 GLU D 146 GLU^? 10.62 MG MG D 301 516 HIS D 170 HIS^? 10.59 MG MG D 301 559 HIS D 147 HIS^? 9.43 MG MG D 301 coo 49.01 14.50 52.53 46.99 14.61 52.78 87.24 28.82 -50.92 85.47 28.08 -51.67 coo 41.59 7.83 54.15 41.16 9.87 53.87 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 42.22 14.55 52.50 43.91 14.87 53.60 90.95 32.51 -46.42 92.98 32.42 -46.93 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 5 3 # 5 412 GLU F 146 GLU^? 10.36 MG MG F 302 516 HIS F 170 HIS^? 9.84 MG MG F 302 559 HIS F 147 HIS^? 8.79 MG MG F 302 coo 49.01 14.50 52.53 46.99 14.61 52.78 61.95 60.17 -95.28 62.87 58.56 -96.19 coo 41.59 7.83 54.15 41.16 9.87 53.87 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 42.22 14.55 52.50 43.91 14.87 53.60 56.63 61.66 -91.16 55.69 63.43 -91.80 1gal_c00 source 1gal GLUCOSE OXIDASE (E.C.1.1.3.4) : 5 hits 1gal_c00 naa= 3 ULMN 3 1gns_c00 SUBTILISIN BPN' user 1 3 # 1 A 32 ASP A 148 ASP^? 2.72 MG MG A 301s A 64 HIS A 147 HIS^? 9.20 MG MG A 302 A 155 ASN A 132 ASN^? 16.38 MG MG A 301 coo 3.12 38.70 24.20 3.24 38.59 26.33 41.50 28.88 41.13 43.33 29.67 41.93 coo 1.90 38.00 29.77 3.91 38.35 29.95 40.24 23.10 39.83 38.32 22.34 40.22 coo 9.89 36.55 37.38 9.27 37.99 36.08 50.16 14.55 39.76 50.61 16.24 40.93 ULMN 3 1gns_c00 SUBTILISIN BPN' user 2 3 # 2 A 32 ASP B 148 ASP^? 2.58 MG MG B 302s A 64 HIS B 147 HIS^? 9.27 MG MG B 301 A 155 ASN B 132 ASN^? 16.42 MG MG B 302 coo 3.12 38.70 24.20 3.24 38.59 26.33 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 1.90 38.00 29.77 3.91 38.35 29.95 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 9.89 36.55 37.38 9.27 37.99 36.08 40.27 30.00 -2.76 41.98 31.07 -3.41 ULMN 3 1gns_c00 SUBTILISIN BPN' user 3 3 # 3 A 32 ASP C 148 ASP^? 2.75 MG MG C 302s A 64 HIS C 147 HIS^? 9.44 MG MG C 301 A 155 ASN C 132 ASN^? 16.52 MG MG C 302 coo 3.12 38.70 24.20 3.24 38.59 26.33 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 1.90 38.00 29.77 3.91 38.35 29.95 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 9.89 36.55 37.38 9.27 37.99 36.08 89.66 38.54 -3.77 87.74 38.77 -2.97 ULMN 3 1gns_c00 SUBTILISIN BPN' user 4 3 # 4 A 32 ASP D 148 ASP^? 2.35 MG MG D 302s A 64 HIS D 147 HIS^? 9.43 MG MG D 301 A 155 ASN D 132 ASN^? 16.46 MG MG D 302 coo 3.12 38.70 24.20 3.24 38.59 26.33 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 1.90 38.00 29.77 3.91 38.35 29.95 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 9.89 36.55 37.38 9.27 37.99 36.08 84.64 21.31 -46.24 83.02 22.38 -47.10 ULMN 3 1gns_c00 SUBTILISIN BPN' user 5 3 # 5 A 32 ASP E 148 ASP^? 2.62 MG MG E 302s A 64 HIS E 147 HIS^? 9.22 MG MG E 301 A 155 ASN E 132 ASN^? 16.39 MG MG E 302 coo 3.12 38.70 24.20 3.24 38.59 26.33 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 1.90 38.00 29.77 3.91 38.35 29.95 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 9.89 36.55 37.38 9.27 37.99 36.08 51.80 60.19 -48.38 52.68 58.51 -47.42 ULMN 3 1gns_c00 SUBTILISIN BPN' user 6 3 # 6 A 32 ASP F 148 ASP^? 2.72 MG MG F 301s A 64 HIS F 147 HIS^? 8.79 MG MG F 302 A 155 ASN F 132 ASN^? 16.48 MG MG F 301 coo 3.12 38.70 24.20 3.24 38.59 26.33 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 1.90 38.00 29.77 3.91 38.35 29.95 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 9.89 36.55 37.38 9.27 37.99 36.08 69.23 61.88 -90.93 69.10 59.95 -91.77 1gns_c00 source 1gns SUBTILISIN BPN' : 6 hits 1gns_c00 naa= 3 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 1 3 # 1 160 LYS A 76 LYS^? 25.42 MG MG A 301 210 ARG A 37 ARG^? 18.99 MG MG A 301 225 ARG A 48 ARG^? 25.29 MG MG A 301 coo 17.51 28.50 73.42 17.24 23.02 75.86 34.45 46.53 27.28 28.88 44.93 27.25 coo 24.74 11.56 73.05 25.29 14.32 71.80 32.99 26.50 25.19 35.50 25.33 26.51 coo 27.81 15.44 77.10 25.66 16.50 75.19 33.88 31.17 22.03 31.48 31.85 20.30 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 2 3 # 2 160 LYS A 137 LYS^? 34.85 MG MG A 301 210 ARG B 37 ARG^? 19.17 MG MG B 302 225 ARG B 48 ARG^? 25.20 MG MG B 302 coo 17.51 28.50 73.42 17.24 23.02 75.86 50.97 1.58 28.14 56.13 1.49 28.03 coo 24.74 11.56 73.05 25.29 14.32 71.80 47.41 10.20 11.40 46.99 12.91 10.22 coo 27.81 15.44 77.10 25.66 16.50 75.19 52.22 10.51 15.00 52.46 7.79 16.39 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 3 3 # 3 160 LYS A 157 LYS^? 28.65 MG MG A 302 210 ARG B 37 ARG^? 19.17 MG MG B 302 225 ARG B 48 ARG^? 25.20 MG MG B 302 coo 17.51 28.50 73.42 17.24 23.02 75.86 41.42 12.06 27.58 41.46 5.93 29.41 coo 24.74 11.56 73.05 25.29 14.32 71.80 47.41 10.20 11.40 46.99 12.91 10.22 coo 27.81 15.44 77.10 25.66 16.50 75.19 52.22 10.51 15.00 52.46 7.79 16.39 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 4 3 # 4 160 LYS A 157 LYS^? 28.65 MG MG A 302 210 ARG B 48 ARG^? 25.20 MG MG B 302 225 ARG B 37 ARG^? 19.17 MG MG B 302 coo 17.51 28.50 73.42 17.24 23.02 75.86 41.42 12.06 27.58 41.46 5.93 29.41 coo 24.74 11.56 73.05 25.29 14.32 71.80 52.22 10.51 15.00 52.46 7.79 16.39 coo 27.81 15.44 77.10 25.66 16.50 75.19 47.41 10.20 11.40 46.99 12.91 10.22 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 5 3 # 5 160 LYS B 137 LYS^? 34.56 MG MG B 302 210 ARG A 37 ARG^? 18.99 MG MG A 301 225 ARG A 48 ARG^? 25.29 MG MG A 301 coo 17.51 28.50 73.42 17.24 23.02 75.86 26.56 32.46 7.93 27.87 37.71 9.31 coo 24.74 11.56 73.05 25.29 14.32 71.80 32.99 26.50 25.19 35.50 25.33 26.51 coo 27.81 15.44 77.10 25.66 16.50 75.19 33.88 31.17 22.03 31.48 31.85 20.30 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 6 3 # 6 160 LYS B 157 LYS^? 28.85 MG MG B 302 210 ARG A 37 ARG^? 18.99 MG MG A 301 225 ARG A 48 ARG^? 25.29 MG MG A 301 coo 17.51 28.50 73.42 17.24 23.02 75.86 34.97 21.28 8.44 29.03 22.82 6.58 coo 24.74 11.56 73.05 25.29 14.32 71.80 32.99 26.50 25.19 35.50 25.33 26.51 coo 27.81 15.44 77.10 25.66 16.50 75.19 33.88 31.17 22.03 31.48 31.85 20.30 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 7 3 # 7 160 LYS B 157 LYS^? 28.85 MG MG B 302 210 ARG A 48 ARG^? 25.29 MG MG A 301 225 ARG A 37 ARG^? 18.99 MG MG A 301 coo 17.51 28.50 73.42 17.24 23.02 75.86 34.97 21.28 8.44 29.03 22.82 6.58 coo 24.74 11.56 73.05 25.29 14.32 71.80 33.88 31.17 22.03 31.48 31.85 20.30 coo 27.81 15.44 77.10 25.66 16.50 75.19 32.99 26.50 25.19 35.50 25.33 26.51 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 8 3 # 8 160 LYS C 76 LYS^? 24.95 MG MG C 302 210 ARG C 37 ARG^? 19.01 MG MG C 302 225 ARG C 48 ARG^? 25.02 MG MG C 302 coo 17.51 28.50 73.42 17.24 23.02 75.86 71.11 8.63 -16.76 75.44 5.17 -16.80 coo 24.74 11.56 73.05 25.29 14.32 71.80 89.36 17.23 -17.57 89.29 20.20 -16.76 coo 27.81 15.44 77.10 25.66 16.50 75.19 84.94 16.06 -21.53 85.81 13.55 -23.08 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 9 3 # 9 160 LYS C 137 LYS^? 35.41 MG MG C 302 210 ARG D 37 ARG^? 18.81 MG MG D 302 225 ARG D 48 ARG^? 24.87 MG MG D 302 coo 17.51 28.50 73.42 17.24 23.02 75.86 101.12 45.96 -14.37 98.71 51.44 -14.96 coo 24.74 11.56 73.05 25.29 14.32 71.80 96.81 38.21 -31.63 94.97 36.32 -33.06 coo 27.81 15.44 77.10 25.66 16.50 75.19 94.06 41.76 -28.37 96.24 43.38 -26.96 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 10 3 # 10 160 LYS C 157 LYS^? 28.15 MG MG C 302 210 ARG D 37 ARG^? 18.81 MG MG D 302 225 ARG D 48 ARG^? 24.87 MG MG D 302 coo 17.51 28.50 73.42 17.24 23.02 75.86 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 24.74 11.56 73.05 25.29 14.32 71.80 96.81 38.21 -31.63 94.97 36.32 -33.06 coo 27.81 15.44 77.10 25.66 16.50 75.19 94.06 41.76 -28.37 96.24 43.38 -26.96 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 11 3 # 11 160 LYS C 157 LYS^? 28.15 MG MG C 302 210 ARG D 48 ARG^? 24.87 MG MG D 302 225 ARG D 37 ARG^? 18.81 MG MG D 302 coo 17.51 28.50 73.42 17.24 23.02 75.86 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 24.74 11.56 73.05 25.29 14.32 71.80 94.06 41.76 -28.37 96.24 43.38 -26.96 coo 27.81 15.44 77.10 25.66 16.50 75.19 96.81 38.21 -31.63 94.97 36.32 -33.06 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 12 3 # 12 160 LYS D 76 LYS^? 25.08 MG MG D 302 210 ARG D 37 ARG^? 18.81 MG MG D 302 225 ARG D 48 ARG^? 24.87 MG MG D 302 coo 17.51 28.50 73.42 17.24 23.02 75.86 88.18 56.35 -34.05 93.80 56.17 -32.93 coo 24.74 11.56 73.05 25.29 14.32 71.80 96.81 38.21 -31.63 94.97 36.32 -33.06 coo 27.81 15.44 77.10 25.66 16.50 75.19 94.06 41.76 -28.37 96.24 43.38 -26.96 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 13 3 # 13 160 LYS D 137 LYS^? 37.57 MG MG D 302 210 ARG C 37 ARG^? 19.01 MG MG C 302 225 ARG C 48 ARG^? 25.02 MG MG C 302 coo 17.51 28.50 73.42 17.24 23.02 75.86 88.48 8.58 -35.33 84.88 3.98 -33.96 coo 24.74 11.56 73.05 25.29 14.32 71.80 89.36 17.23 -17.57 89.29 20.20 -16.76 coo 27.81 15.44 77.10 25.66 16.50 75.19 84.94 16.06 -21.53 85.81 13.55 -23.08 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 14 3 # 14 160 LYS D 157 LYS^? 28.67 MG MG D 302 210 ARG C 37 ARG^? 19.01 MG MG C 302 225 ARG C 48 ARG^? 25.02 MG MG C 302 coo 17.51 28.50 73.42 17.24 23.02 75.86 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 24.74 11.56 73.05 25.29 14.32 71.80 89.36 17.23 -17.57 89.29 20.20 -16.76 coo 27.81 15.44 77.10 25.66 16.50 75.19 84.94 16.06 -21.53 85.81 13.55 -23.08 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 15 3 # 15 160 LYS D 157 LYS^? 28.67 MG MG D 302 210 ARG C 48 ARG^? 25.02 MG MG C 302 225 ARG C 37 ARG^? 19.01 MG MG C 302 coo 17.51 28.50 73.42 17.24 23.02 75.86 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 24.74 11.56 73.05 25.29 14.32 71.80 84.94 16.06 -21.53 85.81 13.55 -23.08 coo 27.81 15.44 77.10 25.66 16.50 75.19 89.36 17.23 -17.57 89.29 20.20 -16.76 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 16 3 # 16 160 LYS E 76 LYS^? 25.68 MG MG E 302 210 ARG E 37 ARG^? 19.17 MG MG E 302 225 ARG E 48 ARG^? 25.02 MG MG E 302 coo 17.51 28.50 73.42 17.24 23.02 75.86 87.09 58.11 -60.91 88.65 63.65 -61.27 coo 24.74 11.56 73.05 25.29 14.32 71.80 70.82 68.02 -63.63 68.17 67.46 -62.14 coo 27.81 15.44 77.10 25.66 16.50 75.19 73.60 65.75 -66.57 75.51 67.67 -67.91 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 17 3 # 17 160 LYS E 137 LYS^? 35.26 MG MG E 302 210 ARG F 37 ARG^? 19.14 MG MG F 301 225 ARG F 48 ARG^? 25.18 MG MG F 301 coo 17.51 28.50 73.42 17.24 23.02 75.86 40.01 66.05 -59.66 36.65 60.99 -60.28 coo 24.74 11.56 73.05 25.29 14.32 71.80 48.80 64.46 -76.37 51.50 64.15 -77.79 coo 27.81 15.44 77.10 25.66 16.50 75.19 46.82 60.90 -73.07 44.43 61.88 -71.46 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 18 3 # 18 160 LYS E 157 LYS^? 28.40 MG MG E 302 210 ARG F 37 ARG^? 19.14 MG MG F 301 225 ARG F 48 ARG^? 25.18 MG MG F 301 coo 17.51 28.50 73.42 17.24 23.02 75.86 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 24.74 11.56 73.05 25.29 14.32 71.80 48.80 64.46 -76.37 51.50 64.15 -77.79 coo 27.81 15.44 77.10 25.66 16.50 75.19 46.82 60.90 -73.07 44.43 61.88 -71.46 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 19 3 # 19 160 LYS E 157 LYS^? 28.40 MG MG E 302 210 ARG F 48 ARG^? 25.18 MG MG F 301 225 ARG F 37 ARG^? 19.14 MG MG F 301 coo 17.51 28.50 73.42 17.24 23.02 75.86 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 24.74 11.56 73.05 25.29 14.32 71.80 46.82 60.90 -73.07 44.43 61.88 -71.46 coo 27.81 15.44 77.10 25.66 16.50 75.19 48.80 64.46 -76.37 51.50 64.15 -77.79 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 20 3 # 20 160 LYS E 166 LYS^? 21.46 MG MG E 301 210 ARG E 48 ARG^? 25.02 MG MG E 302 225 ARG E 37 ARG^? 19.17 MG MG E 302 coo 17.51 28.50 73.42 17.24 23.02 75.86 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 24.74 11.56 73.05 25.29 14.32 71.80 73.60 65.75 -66.57 75.51 67.67 -67.91 coo 27.81 15.44 77.10 25.66 16.50 75.19 70.82 68.02 -63.63 68.17 67.46 -62.14 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 21 3 # 21 160 LYS F 76 LYS^? 25.89 MG MG F 301 210 ARG F 37 ARG^? 19.14 MG MG F 301 225 ARG F 48 ARG^? 25.18 MG MG F 301 coo 17.51 28.50 73.42 17.24 23.02 75.86 36.96 48.52 -78.06 33.74 53.37 -77.06 coo 24.74 11.56 73.05 25.29 14.32 71.80 48.80 64.46 -76.37 51.50 64.15 -77.79 coo 27.81 15.44 77.10 25.66 16.50 75.19 46.82 60.90 -73.07 44.43 61.88 -71.46 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 22 3 # 22 160 LYS F 137 LYS^? 35.13 MG MG F 301 210 ARG E 37 ARG^? 19.17 MG MG E 302 225 ARG E 48 ARG^? 25.02 MG MG E 302 coo 17.51 28.50 73.42 17.24 23.02 75.86 78.53 72.20 -80.30 83.01 68.64 -79.79 coo 24.74 11.56 73.05 25.29 14.32 71.80 70.82 68.02 -63.63 68.17 67.46 -62.14 coo 27.81 15.44 77.10 25.66 16.50 75.19 73.60 65.75 -66.57 75.51 67.67 -67.91 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 23 3 # 23 160 LYS F 157 LYS^? 28.36 MG MG F 302 210 ARG E 37 ARG^? 19.17 MG MG E 302 225 ARG E 48 ARG^? 25.02 MG MG E 302 coo 17.51 28.50 73.42 17.24 23.02 75.86 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 24.74 11.56 73.05 25.29 14.32 71.80 70.82 68.02 -63.63 68.17 67.46 -62.14 coo 27.81 15.44 77.10 25.66 16.50 75.19 73.60 65.75 -66.57 75.51 67.67 -67.91 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 24 3 # 24 160 LYS F 157 LYS^? 28.36 MG MG F 302 210 ARG E 48 ARG^? 25.02 MG MG E 302 225 ARG E 37 ARG^? 19.17 MG MG E 302 coo 17.51 28.50 73.42 17.24 23.02 75.86 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 24.74 11.56 73.05 25.29 14.32 71.80 73.60 65.75 -66.57 75.51 67.67 -67.91 coo 27.81 15.44 77.10 25.66 16.50 75.19 70.82 68.02 -63.63 68.17 67.46 -62.14 1gsa_c00 source 1gsa GLUTATHIONE SYNTHETASE : 24 hits 1gsa_c00 naa= 3 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 A 189 PHE A 12 PHE^? 17.15 MG MG A 301 A 298 ASP A 171 ASP^? 17.17 MG MG A 302 A 329 LYS A 166 LYS^? 20.93 MG MG A 302 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 34.93 27.27 29.42 32.88 25.47 30.10 coo 2.59 0.29 25.55 4.65 0.18 25.07 29.78 23.67 36.63 28.48 25.11 35.71 coo 12.42 6.10 23.27 9.95 1.57 20.16 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 A 189 PHE A 59 PHE^? 31.59 MG MG A 301 A 298 ASP A 160 ASP^? 31.61 MG MG B 302 A 329 LYS A 157 LYS^? 28.65 MG MG A 302 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 52.93 4.70 25.02 52.08 5.30 27.62 coo 2.59 0.29 25.55 4.65 0.18 25.07 44.21 5.00 19.54 46.02 3.84 19.76 coo 12.42 6.10 23.27 9.95 1.57 20.16 41.42 12.06 27.58 41.46 5.93 29.41 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 A 189 PHE A 153 PHE^? 9.64 MG MG A 301 A 298 ASP A 171 ASP^? 17.17 MG MG A 302 A 329 LYS A 166 LYS^? 20.93 MG MG A 302 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 38.89 24.49 36.07 40.14 26.70 37.23 coo 2.59 0.29 25.55 4.65 0.18 25.07 29.78 23.67 36.63 28.48 25.11 35.71 coo 12.42 6.10 23.27 9.95 1.57 20.16 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 A 189 PHE A 161 PHE^? 25.62 MG MG B 302 A 298 ASP B 35 ASP^? 16.92 MG MG B 302 A 329 LYS A 61 LYS^? 21.99 MG MG B 302 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 44.24 9.29 16.03 46.90 9.95 15.56 coo 2.59 0.29 25.55 4.65 0.18 25.07 52.63 11.07 10.18 53.68 12.85 9.94 coo 12.42 6.10 23.27 9.95 1.57 20.16 57.78 7.35 19.60 56.77 12.20 15.61 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 A 189 PHE B 12 PHE^? 17.13 MG MG B 302 A 298 ASP B 171 ASP^? 16.92 MG MG B 301 A 329 LYS B 166 LYS^? 22.75 MG MG B 301 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 49.02 12.29 7.19 47.01 10.60 6.19 coo 2.59 0.29 25.55 4.65 0.18 25.07 45.30 8.50 -0.71 46.30 6.81 0.12 coo 12.42 6.10 23.27 9.95 1.57 20.16 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 A 189 PHE B 59 PHE^? 31.31 MG MG B 302 A 298 ASP B 160 ASP^? 31.65 MG MG A 301 A 329 LYS B 157 LYS^? 28.85 MG MG B 302 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 29.63 33.55 11.36 30.42 32.81 8.75 coo 2.59 0.29 25.55 4.65 0.18 25.07 28.01 24.83 16.38 27.44 26.81 15.80 coo 12.42 6.10 23.27 9.95 1.57 20.16 34.97 21.28 8.44 29.03 22.82 6.58 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 A 189 PHE B 153 PHE^? 9.59 MG MG B 302 A 298 ASP B 171 ASP^? 16.92 MG MG B 301 A 329 LYS B 166 LYS^? 22.75 MG MG B 301 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 47.54 17.09 0.77 50.03 17.91 -0.19 coo 2.59 0.29 25.55 4.65 0.18 25.07 45.30 8.50 -0.71 46.30 6.81 0.12 coo 12.42 6.10 23.27 9.95 1.57 20.16 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 A 189 PHE B 161 PHE^? 25.78 MG MG A 301 A 298 ASP A 35 ASP^? 16.92 MG MG A 301 A 329 LYS B 61 LYS^? 22.03 MG MG A 301 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 31.87 23.58 19.99 32.61 26.21 20.65 coo 2.59 0.29 25.55 4.65 0.18 25.07 34.49 31.10 26.54 36.41 31.82 27.10 coo 12.42 6.10 23.27 9.95 1.57 20.16 32.50 37.62 17.61 36.68 34.92 21.51 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 9 3 # 9 A 189 PHE C 12 PHE^? 16.92 MG MG C 302 A 298 ASP C 171 ASP^? 17.08 MG MG C 301 A 329 LYS C 166 LYS^? 22.53 MG MG C 301 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 87.42 18.93 -13.86 90.00 18.25 -12.97 coo 2.59 0.29 25.55 4.65 0.18 25.07 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 12.42 6.10 23.27 9.95 1.57 20.16 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 10 3 # 10 A 189 PHE C 59 PHE^? 31.23 MG MG C 302 A 298 ASP C 160 ASP^? 31.63 MG MG D 302 A 329 LYS C 157 LYS^? 28.15 MG MG C 302 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 98.06 45.52 -18.00 97.73 44.36 -15.53 coo 2.59 0.29 25.55 4.65 0.18 25.07 102.50 38.00 -23.28 102.43 39.97 -22.46 coo 12.42 6.10 23.27 9.95 1.57 20.16 97.55 32.04 -15.10 101.49 36.24 -13.39 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 11 3 # 11 A 189 PHE C 153 PHE^? 9.34 MG MG C 302 A 298 ASP C 171 ASP^? 17.08 MG MG C 301 A 329 LYS C 166 LYS^? 22.53 MG MG C 301 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 87.15 23.83 -7.29 84.55 23.79 -6.26 coo 2.59 0.29 25.55 4.65 0.18 25.07 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 12.42 6.10 23.27 9.95 1.57 20.16 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 12 3 # 12 A 189 PHE C 161 PHE^? 25.47 MG MG D 302 A 298 ASP D 35 ASP^? 16.80 MG MG D 302 A 329 LYS C 61 LYS^? 21.91 MG MG D 302 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 98.98 35.62 -26.76 97.40 37.84 -27.44 coo 2.59 0.29 25.55 4.65 0.18 25.07 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 12.42 6.10 23.27 9.95 1.57 20.16 93.60 48.56 -24.05 90.39 44.71 -27.98 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 13 3 # 13 A 189 PHE D 12 PHE^? 16.78 MG MG D 302 A 298 ASP D 171 ASP^? 16.95 MG MG D 301 A 329 LYS D 166 LYS^? 21.08 MG MG D 301 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 94.68 38.11 -36.05 97.16 37.10 -36.83 coo 2.59 0.29 25.55 4.65 0.18 25.07 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 12.42 6.10 23.27 9.95 1.57 20.16 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 14 3 # 14 A 189 PHE D 59 PHE^? 31.49 MG MG D 302 A 298 ASP D 160 ASP^? 31.45 MG MG C 302 A 329 LYS D 157 LYS^? 28.67 MG MG D 302 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 86.17 10.70 -31.86 86.41 11.56 -34.53 coo 2.59 0.29 25.55 4.65 0.18 25.07 94.15 13.98 -26.57 92.71 12.42 -26.99 coo 12.42 6.10 23.27 9.95 1.57 20.16 94.17 21.71 -34.34 96.11 15.89 -35.92 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 15 3 # 15 A 189 PHE D 153 PHE^? 9.11 MG MG D 302 A 298 ASP D 171 ASP^? 16.95 MG MG D 301 A 329 LYS D 166 LYS^? 21.08 MG MG D 301 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 91.67 34.35 -42.71 89.76 36.10 -43.73 coo 2.59 0.29 25.55 4.65 0.18 25.07 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 12.42 6.10 23.27 9.95 1.57 20.16 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 16 3 # 16 A 189 PHE D 161 PHE^? 25.58 MG MG C 302 A 298 ASP C 35 ASP^? 16.42 MG MG C 302 A 329 LYS D 61 LYS^? 21.93 MG MG C 302 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 92.97 17.97 -22.91 90.24 17.44 -22.45 coo 2.59 0.29 25.55 4.65 0.18 25.07 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 12.42 6.10 23.27 9.95 1.57 20.16 80.64 11.23 -26.16 80.65 16.24 -22.36 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 17 3 # 17 A 189 PHE E 12 PHE^? 17.09 MG MG E 302 A 298 ASP E 171 ASP^? 16.73 MG MG E 301 A 329 LYS E 166 LYS^? 21.46 MG MG E 301 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 70.06 67.18 -58.76 69.33 69.81 -58.07 coo 2.59 0.29 25.55 4.65 0.18 25.07 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 12.42 6.10 23.27 9.95 1.57 20.16 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 18 3 # 18 A 189 PHE E 59 PHE^? 31.36 MG MG E 302 A 298 ASP E 160 ASP^? 31.54 MG MG F 301 A 329 LYS E 157 LYS^? 28.40 MG MG E 302 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 41.55 62.67 -62.73 42.33 62.92 -60.06 coo 2.59 0.29 25.55 4.65 0.18 25.07 45.81 70.00 -68.45 44.10 68.87 -67.77 coo 12.42 6.10 23.27 9.95 1.57 20.16 53.63 69.16 -60.42 48.34 71.81 -58.40 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 19 3 # 19 A 189 PHE E 153 PHE^? 9.50 MG MG E 302 A 298 ASP E 171 ASP^? 16.73 MG MG E 301 A 329 LYS E 166 LYS^? 21.46 MG MG E 301 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 65.86 64.95 -52.12 67.22 62.73 -51.09 coo 2.59 0.29 25.55 4.65 0.18 25.07 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 12.42 6.10 23.27 9.95 1.57 20.16 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 20 3 # 20 A 189 PHE F 12 PHE^? 17.12 MG MG F 301 A 298 ASP F 171 ASP^? 16.35 MG MG F 302 A 329 LYS F 166 LYS^? 20.76 MG MG F 302 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 49.70 62.79 -80.90 49.37 65.44 -81.67 coo 2.59 0.29 25.55 4.65 0.18 25.07 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 12.42 6.10 23.27 9.95 1.57 20.16 59.28 73.05 -82.63 55.63 74.15 -86.94 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 21 3 # 21 A 189 PHE F 59 PHE^? 31.53 MG MG F 301 A 298 ASP F 160 ASP^? 31.59 MG MG E 302 A 329 LYS F 6 LYS^? 26.09 MG MG F 301 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 77.96 68.89 -76.99 76.86 68.73 -79.55 coo 2.59 0.29 25.55 4.65 0.18 25.07 71.27 74.59 -71.77 73.23 74.02 -72.37 coo 12.42 6.10 23.27 9.95 1.57 20.16 67.53 67.03 -76.43 64.05 65.33 -71.86 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 22 3 # 22 A 189 PHE F 59 PHE^? 31.53 MG MG F 301 A 298 ASP F 160 ASP^? 31.59 MG MG E 302 A 329 LYS F 157 LYS^? 28.36 MG MG F 302 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 77.96 68.89 -76.99 76.86 68.73 -79.55 coo 2.59 0.29 25.55 4.65 0.18 25.07 71.27 74.59 -71.77 73.23 74.02 -72.37 coo 12.42 6.10 23.27 9.95 1.57 20.16 64.43 70.47 -79.54 68.32 74.80 -81.65 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 23 3 # 23 A 189 PHE F 153 PHE^? 9.26 MG MG F 302 A 298 ASP F 171 ASP^? 16.35 MG MG F 302 A 329 LYS F 166 LYS^? 20.76 MG MG F 302 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 54.49 61.65 -87.43 53.89 59.08 -88.37 coo 2.59 0.29 25.55 4.65 0.18 25.07 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 12.42 6.10 23.27 9.95 1.57 20.16 59.28 73.05 -82.63 55.63 74.15 -86.94 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 24 3 # 24 A 189 PHE F 161 PHE^? 25.66 MG MG E 302 A 298 ASP E 35 ASP^? 16.91 MG MG E 302 A 329 LYS F 61 LYS^? 21.75 MG MG E 302 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 68.33 71.65 -68.19 70.12 69.57 -67.59 coo 2.59 0.29 25.55 4.65 0.18 25.07 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 12.42 6.10 23.27 9.95 1.57 20.16 80.24 64.12 -71.01 76.23 61.95 -66.39 1gtx_c00 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 24 hits 1gtx_c00 naa= 3 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 B 189 PHE A 12 PHE^? 17.15 MG MG A 301 B 298 ASP A 171 ASP^? 17.17 MG MG A 302 B 329 LYS A 166 LYS^? 20.93 MG MG A 302 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 34.93 27.27 29.42 32.88 25.47 30.10 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 29.78 23.67 36.63 28.48 25.11 35.71 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 B 189 PHE A 59 PHE^? 31.59 MG MG A 301 B 298 ASP A 160 ASP^? 31.61 MG MG B 302 B 329 LYS A 157 LYS^? 28.65 MG MG A 302 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 52.93 4.70 25.02 52.08 5.30 27.62 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 44.21 5.00 19.54 46.02 3.84 19.76 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 41.42 12.06 27.58 41.46 5.93 29.41 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 B 189 PHE A 153 PHE^? 9.64 MG MG A 301 B 298 ASP A 171 ASP^? 17.17 MG MG A 302 B 329 LYS A 166 LYS^? 20.93 MG MG A 302 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 38.89 24.49 36.07 40.14 26.70 37.23 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 29.78 23.67 36.63 28.48 25.11 35.71 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 B 189 PHE A 161 PHE^? 25.62 MG MG B 302 B 298 ASP B 35 ASP^? 16.92 MG MG B 302 B 329 LYS A 61 LYS^? 21.99 MG MG B 302 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 44.24 9.29 16.03 46.90 9.95 15.56 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 52.63 11.07 10.18 53.68 12.85 9.94 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 57.78 7.35 19.60 56.77 12.20 15.61 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 B 189 PHE B 12 PHE^? 17.13 MG MG B 302 B 298 ASP B 171 ASP^? 16.92 MG MG B 301 B 329 LYS B 166 LYS^? 22.75 MG MG B 301 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 49.02 12.29 7.19 47.01 10.60 6.19 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 45.30 8.50 -0.71 46.30 6.81 0.12 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 B 189 PHE B 59 PHE^? 31.31 MG MG B 302 B 298 ASP B 160 ASP^? 31.65 MG MG A 301 B 329 LYS B 157 LYS^? 28.85 MG MG B 302 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 29.63 33.55 11.36 30.42 32.81 8.75 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 28.01 24.83 16.38 27.44 26.81 15.80 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 34.97 21.28 8.44 29.03 22.82 6.58 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 B 189 PHE B 153 PHE^? 9.59 MG MG B 302 B 298 ASP B 171 ASP^? 16.92 MG MG B 301 B 329 LYS B 166 LYS^? 22.75 MG MG B 301 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 47.54 17.09 0.77 50.03 17.91 -0.19 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 45.30 8.50 -0.71 46.30 6.81 0.12 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 B 189 PHE B 161 PHE^? 25.78 MG MG A 301 B 298 ASP A 35 ASP^? 16.92 MG MG A 301 B 329 LYS B 61 LYS^? 22.03 MG MG A 301 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 31.87 23.58 19.99 32.61 26.21 20.65 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 34.49 31.10 26.54 36.41 31.82 27.10 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 32.50 37.62 17.61 36.68 34.92 21.51 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 9 3 # 9 B 189 PHE C 12 PHE^? 16.92 MG MG C 302 B 298 ASP C 171 ASP^? 17.08 MG MG C 301 B 329 LYS C 166 LYS^? 22.53 MG MG C 301 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 87.42 18.93 -13.86 90.00 18.25 -12.97 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 10 3 # 10 B 189 PHE C 59 PHE^? 31.23 MG MG C 302 B 298 ASP C 160 ASP^? 31.63 MG MG D 302 B 329 LYS C 157 LYS^? 28.15 MG MG C 302 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 98.06 45.52 -18.00 97.73 44.36 -15.53 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 102.50 38.00 -23.28 102.43 39.97 -22.46 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 97.55 32.04 -15.10 101.49 36.24 -13.39 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 11 3 # 11 B 189 PHE C 153 PHE^? 9.34 MG MG C 302 B 298 ASP C 171 ASP^? 17.08 MG MG C 301 B 329 LYS C 166 LYS^? 22.53 MG MG C 301 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 87.15 23.83 -7.29 84.55 23.79 -6.26 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 12 3 # 12 B 189 PHE C 161 PHE^? 25.47 MG MG D 302 B 298 ASP D 35 ASP^? 16.80 MG MG D 302 B 329 LYS C 61 LYS^? 21.91 MG MG D 302 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 98.98 35.62 -26.76 97.40 37.84 -27.44 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 93.60 48.56 -24.05 90.39 44.71 -27.98 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 13 3 # 13 B 189 PHE D 12 PHE^? 16.78 MG MG D 302 B 298 ASP D 171 ASP^? 16.95 MG MG D 301 B 329 LYS D 166 LYS^? 21.08 MG MG D 301 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 94.68 38.11 -36.05 97.16 37.10 -36.83 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 14 3 # 14 B 189 PHE D 59 PHE^? 31.49 MG MG D 302 B 298 ASP D 160 ASP^? 31.45 MG MG C 302 B 329 LYS D 157 LYS^? 28.67 MG MG D 302 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 86.17 10.70 -31.86 86.41 11.56 -34.53 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 94.15 13.98 -26.57 92.71 12.42 -26.99 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 94.17 21.71 -34.34 96.11 15.89 -35.92 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 15 3 # 15 B 189 PHE D 153 PHE^? 9.11 MG MG D 302 B 298 ASP D 171 ASP^? 16.95 MG MG D 301 B 329 LYS D 166 LYS^? 21.08 MG MG D 301 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 91.67 34.35 -42.71 89.76 36.10 -43.73 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 16 3 # 16 B 189 PHE D 161 PHE^? 25.58 MG MG C 302 B 298 ASP C 35 ASP^? 16.42 MG MG C 302 B 329 LYS D 61 LYS^? 21.93 MG MG C 302 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 92.97 17.97 -22.91 90.24 17.44 -22.45 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 80.64 11.23 -26.16 80.65 16.24 -22.36 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 17 3 # 17 B 189 PHE E 12 PHE^? 17.09 MG MG E 302 B 298 ASP E 171 ASP^? 16.73 MG MG E 301 B 329 LYS E 166 LYS^? 21.46 MG MG E 301 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 70.06 67.18 -58.76 69.33 69.81 -58.07 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 18 3 # 18 B 189 PHE E 59 PHE^? 31.36 MG MG E 302 B 298 ASP E 160 ASP^? 31.54 MG MG F 301 B 329 LYS E 157 LYS^? 28.40 MG MG E 302 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 41.55 62.67 -62.73 42.33 62.92 -60.06 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 45.81 70.00 -68.45 44.10 68.87 -67.77 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 53.63 69.16 -60.42 48.34 71.81 -58.40 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 19 3 # 19 B 189 PHE E 153 PHE^? 9.50 MG MG E 302 B 298 ASP E 171 ASP^? 16.73 MG MG E 301 B 329 LYS E 166 LYS^? 21.46 MG MG E 301 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 65.86 64.95 -52.12 67.22 62.73 -51.09 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 20 3 # 20 B 189 PHE F 12 PHE^? 17.12 MG MG F 301 B 298 ASP F 171 ASP^? 16.35 MG MG F 302 B 329 LYS F 166 LYS^? 20.76 MG MG F 302 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 49.70 62.79 -80.90 49.37 65.44 -81.67 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 59.28 73.05 -82.63 55.63 74.15 -86.94 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 21 3 # 21 B 189 PHE F 59 PHE^? 31.53 MG MG F 301 B 298 ASP F 160 ASP^? 31.59 MG MG E 302 B 329 LYS F 6 LYS^? 26.09 MG MG F 301 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 77.96 68.89 -76.99 76.86 68.73 -79.55 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 71.27 74.59 -71.77 73.23 74.02 -72.37 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 67.53 67.03 -76.43 64.05 65.33 -71.86 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 22 3 # 22 B 189 PHE F 59 PHE^? 31.53 MG MG F 301 B 298 ASP F 160 ASP^? 31.59 MG MG E 302 B 329 LYS F 157 LYS^? 28.36 MG MG F 302 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 77.96 68.89 -76.99 76.86 68.73 -79.55 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 71.27 74.59 -71.77 73.23 74.02 -72.37 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 64.43 70.47 -79.54 68.32 74.80 -81.65 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 23 3 # 23 B 189 PHE F 153 PHE^? 9.26 MG MG F 302 B 298 ASP F 171 ASP^? 16.35 MG MG F 302 B 329 LYS F 166 LYS^? 20.76 MG MG F 302 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 54.49 61.65 -87.43 53.89 59.08 -88.37 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 59.28 73.05 -82.63 55.63 74.15 -86.94 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 24 3 # 24 B 189 PHE F 161 PHE^? 25.66 MG MG E 302 B 298 ASP E 35 ASP^? 16.91 MG MG E 302 B 329 LYS F 61 LYS^? 21.75 MG MG E 302 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 68.33 71.65 -68.19 70.12 69.57 -67.59 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 80.24 64.12 -71.01 76.23 61.95 -66.39 1gtx_c01 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 24 hits 1gtx_c01 naa= 3 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 C 189 PHE A 12 PHE^? 17.15 MG MG A 301 C 298 ASP A 171 ASP^? 17.17 MG MG A 302 C 329 LYS A 166 LYS^? 20.93 MG MG A 302 coo 17.41 60.57 64.39 18.40 58.12 65.34 34.93 27.27 29.42 32.88 25.47 30.10 coo 24.10 66.43 63.33 24.18 64.30 63.40 29.78 23.67 36.63 28.48 25.11 35.71 coo 27.64 56.61 58.17 22.18 57.92 60.36 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 C 189 PHE A 59 PHE^? 31.59 MG MG A 301 C 298 ASP A 160 ASP^? 31.61 MG MG B 302 C 329 LYS A 157 LYS^? 28.65 MG MG A 302 coo 17.41 60.57 64.39 18.40 58.12 65.34 52.93 4.70 25.02 52.08 5.30 27.62 coo 24.10 66.43 63.33 24.18 64.30 63.40 44.21 5.00 19.54 46.02 3.84 19.76 coo 27.64 56.61 58.17 22.18 57.92 60.36 41.42 12.06 27.58 41.46 5.93 29.41 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 C 189 PHE A 153 PHE^? 9.64 MG MG A 301 C 298 ASP A 171 ASP^? 17.17 MG MG A 302 C 329 LYS A 166 LYS^? 20.93 MG MG A 302 coo 17.41 60.57 64.39 18.40 58.12 65.34 38.89 24.49 36.07 40.14 26.70 37.23 coo 24.10 66.43 63.33 24.18 64.30 63.40 29.78 23.67 36.63 28.48 25.11 35.71 coo 27.64 56.61 58.17 22.18 57.92 60.36 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 C 189 PHE A 161 PHE^? 25.62 MG MG B 302 C 298 ASP B 35 ASP^? 16.92 MG MG B 302 C 329 LYS A 61 LYS^? 21.99 MG MG B 302 coo 17.41 60.57 64.39 18.40 58.12 65.34 44.24 9.29 16.03 46.90 9.95 15.56 coo 24.10 66.43 63.33 24.18 64.30 63.40 52.63 11.07 10.18 53.68 12.85 9.94 coo 27.64 56.61 58.17 22.18 57.92 60.36 57.78 7.35 19.60 56.77 12.20 15.61 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 C 189 PHE B 12 PHE^? 17.13 MG MG B 302 C 298 ASP B 171 ASP^? 16.92 MG MG B 301 C 329 LYS B 166 LYS^? 22.75 MG MG B 301 coo 17.41 60.57 64.39 18.40 58.12 65.34 49.02 12.29 7.19 47.01 10.60 6.19 coo 24.10 66.43 63.33 24.18 64.30 63.40 45.30 8.50 -0.71 46.30 6.81 0.12 coo 27.64 56.61 58.17 22.18 57.92 60.36 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 C 189 PHE B 59 PHE^? 31.31 MG MG B 302 C 298 ASP B 160 ASP^? 31.65 MG MG A 301 C 329 LYS B 157 LYS^? 28.85 MG MG B 302 coo 17.41 60.57 64.39 18.40 58.12 65.34 29.63 33.55 11.36 30.42 32.81 8.75 coo 24.10 66.43 63.33 24.18 64.30 63.40 28.01 24.83 16.38 27.44 26.81 15.80 coo 27.64 56.61 58.17 22.18 57.92 60.36 34.97 21.28 8.44 29.03 22.82 6.58 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 C 189 PHE B 153 PHE^? 9.59 MG MG B 302 C 298 ASP B 171 ASP^? 16.92 MG MG B 301 C 329 LYS B 166 LYS^? 22.75 MG MG B 301 coo 17.41 60.57 64.39 18.40 58.12 65.34 47.54 17.09 0.77 50.03 17.91 -0.19 coo 24.10 66.43 63.33 24.18 64.30 63.40 45.30 8.50 -0.71 46.30 6.81 0.12 coo 27.64 56.61 58.17 22.18 57.92 60.36 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 C 189 PHE B 161 PHE^? 25.78 MG MG A 301 C 298 ASP A 35 ASP^? 16.92 MG MG A 301 C 329 LYS B 61 LYS^? 22.03 MG MG A 301 coo 17.41 60.57 64.39 18.40 58.12 65.34 31.87 23.58 19.99 32.61 26.21 20.65 coo 24.10 66.43 63.33 24.18 64.30 63.40 34.49 31.10 26.54 36.41 31.82 27.10 coo 27.64 56.61 58.17 22.18 57.92 60.36 32.50 37.62 17.61 36.68 34.92 21.51 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 9 3 # 9 C 189 PHE C 12 PHE^? 16.92 MG MG C 302 C 298 ASP C 171 ASP^? 17.08 MG MG C 301 C 329 LYS C 166 LYS^? 22.53 MG MG C 301 coo 17.41 60.57 64.39 18.40 58.12 65.34 87.42 18.93 -13.86 90.00 18.25 -12.97 coo 24.10 66.43 63.33 24.18 64.30 63.40 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 27.64 56.61 58.17 22.18 57.92 60.36 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 10 3 # 10 C 189 PHE C 59 PHE^? 31.23 MG MG C 302 C 298 ASP C 160 ASP^? 31.63 MG MG D 302 C 329 LYS C 157 LYS^? 28.15 MG MG C 302 coo 17.41 60.57 64.39 18.40 58.12 65.34 98.06 45.52 -18.00 97.73 44.36 -15.53 coo 24.10 66.43 63.33 24.18 64.30 63.40 102.50 38.00 -23.28 102.43 39.97 -22.46 coo 27.64 56.61 58.17 22.18 57.92 60.36 97.55 32.04 -15.10 101.49 36.24 -13.39 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 11 3 # 11 C 189 PHE C 153 PHE^? 9.34 MG MG C 302 C 298 ASP C 171 ASP^? 17.08 MG MG C 301 C 329 LYS C 166 LYS^? 22.53 MG MG C 301 coo 17.41 60.57 64.39 18.40 58.12 65.34 87.15 23.83 -7.29 84.55 23.79 -6.26 coo 24.10 66.43 63.33 24.18 64.30 63.40 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 27.64 56.61 58.17 22.18 57.92 60.36 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 12 3 # 12 C 189 PHE C 161 PHE^? 25.47 MG MG D 302 C 298 ASP D 35 ASP^? 16.80 MG MG D 302 C 329 LYS C 61 LYS^? 21.91 MG MG D 302 coo 17.41 60.57 64.39 18.40 58.12 65.34 98.98 35.62 -26.76 97.40 37.84 -27.44 coo 24.10 66.43 63.33 24.18 64.30 63.40 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 27.64 56.61 58.17 22.18 57.92 60.36 93.60 48.56 -24.05 90.39 44.71 -27.98 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 13 3 # 13 C 189 PHE D 12 PHE^? 16.78 MG MG D 302 C 298 ASP D 171 ASP^? 16.95 MG MG D 301 C 329 LYS D 166 LYS^? 21.08 MG MG D 301 coo 17.41 60.57 64.39 18.40 58.12 65.34 94.68 38.11 -36.05 97.16 37.10 -36.83 coo 24.10 66.43 63.33 24.18 64.30 63.40 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 27.64 56.61 58.17 22.18 57.92 60.36 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 14 3 # 14 C 189 PHE D 59 PHE^? 31.49 MG MG D 302 C 298 ASP D 160 ASP^? 31.45 MG MG C 302 C 329 LYS D 157 LYS^? 28.67 MG MG D 302 coo 17.41 60.57 64.39 18.40 58.12 65.34 86.17 10.70 -31.86 86.41 11.56 -34.53 coo 24.10 66.43 63.33 24.18 64.30 63.40 94.15 13.98 -26.57 92.71 12.42 -26.99 coo 27.64 56.61 58.17 22.18 57.92 60.36 94.17 21.71 -34.34 96.11 15.89 -35.92 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 15 3 # 15 C 189 PHE D 153 PHE^? 9.11 MG MG D 302 C 298 ASP D 171 ASP^? 16.95 MG MG D 301 C 329 LYS D 166 LYS^? 21.08 MG MG D 301 coo 17.41 60.57 64.39 18.40 58.12 65.34 91.67 34.35 -42.71 89.76 36.10 -43.73 coo 24.10 66.43 63.33 24.18 64.30 63.40 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 27.64 56.61 58.17 22.18 57.92 60.36 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 16 3 # 16 C 189 PHE D 161 PHE^? 25.58 MG MG C 302 C 298 ASP C 35 ASP^? 16.42 MG MG C 302 C 329 LYS D 61 LYS^? 21.93 MG MG C 302 coo 17.41 60.57 64.39 18.40 58.12 65.34 92.97 17.97 -22.91 90.24 17.44 -22.45 coo 24.10 66.43 63.33 24.18 64.30 63.40 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 27.64 56.61 58.17 22.18 57.92 60.36 80.64 11.23 -26.16 80.65 16.24 -22.36 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 17 3 # 17 C 189 PHE E 12 PHE^? 17.09 MG MG E 302 C 298 ASP E 171 ASP^? 16.73 MG MG E 301 C 329 LYS E 166 LYS^? 21.46 MG MG E 301 coo 17.41 60.57 64.39 18.40 58.12 65.34 70.06 67.18 -58.76 69.33 69.81 -58.07 coo 24.10 66.43 63.33 24.18 64.30 63.40 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 27.64 56.61 58.17 22.18 57.92 60.36 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 18 3 # 18 C 189 PHE E 59 PHE^? 31.36 MG MG E 302 C 298 ASP E 160 ASP^? 31.54 MG MG F 301 C 329 LYS E 157 LYS^? 28.40 MG MG E 302 coo 17.41 60.57 64.39 18.40 58.12 65.34 41.55 62.67 -62.73 42.33 62.92 -60.06 coo 24.10 66.43 63.33 24.18 64.30 63.40 45.81 70.00 -68.45 44.10 68.87 -67.77 coo 27.64 56.61 58.17 22.18 57.92 60.36 53.63 69.16 -60.42 48.34 71.81 -58.40 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 19 3 # 19 C 189 PHE E 153 PHE^? 9.50 MG MG E 302 C 298 ASP E 171 ASP^? 16.73 MG MG E 301 C 329 LYS E 166 LYS^? 21.46 MG MG E 301 coo 17.41 60.57 64.39 18.40 58.12 65.34 65.86 64.95 -52.12 67.22 62.73 -51.09 coo 24.10 66.43 63.33 24.18 64.30 63.40 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 27.64 56.61 58.17 22.18 57.92 60.36 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 20 3 # 20 C 189 PHE F 12 PHE^? 17.12 MG MG F 301 C 298 ASP F 171 ASP^? 16.35 MG MG F 302 C 329 LYS F 166 LYS^? 20.76 MG MG F 302 coo 17.41 60.57 64.39 18.40 58.12 65.34 49.70 62.79 -80.90 49.37 65.44 -81.67 coo 24.10 66.43 63.33 24.18 64.30 63.40 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 27.64 56.61 58.17 22.18 57.92 60.36 59.28 73.05 -82.63 55.63 74.15 -86.94 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 21 3 # 21 C 189 PHE F 59 PHE^? 31.53 MG MG F 301 C 298 ASP F 160 ASP^? 31.59 MG MG E 302 C 329 LYS F 6 LYS^? 26.09 MG MG F 301 coo 17.41 60.57 64.39 18.40 58.12 65.34 77.96 68.89 -76.99 76.86 68.73 -79.55 coo 24.10 66.43 63.33 24.18 64.30 63.40 71.27 74.59 -71.77 73.23 74.02 -72.37 coo 27.64 56.61 58.17 22.18 57.92 60.36 67.53 67.03 -76.43 64.05 65.33 -71.86 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 22 3 # 22 C 189 PHE F 59 PHE^? 31.53 MG MG F 301 C 298 ASP F 160 ASP^? 31.59 MG MG E 302 C 329 LYS F 157 LYS^? 28.36 MG MG F 302 coo 17.41 60.57 64.39 18.40 58.12 65.34 77.96 68.89 -76.99 76.86 68.73 -79.55 coo 24.10 66.43 63.33 24.18 64.30 63.40 71.27 74.59 -71.77 73.23 74.02 -72.37 coo 27.64 56.61 58.17 22.18 57.92 60.36 64.43 70.47 -79.54 68.32 74.80 -81.65 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 23 3 # 23 C 189 PHE F 153 PHE^? 9.26 MG MG F 302 C 298 ASP F 171 ASP^? 16.35 MG MG F 302 C 329 LYS F 166 LYS^? 20.76 MG MG F 302 coo 17.41 60.57 64.39 18.40 58.12 65.34 54.49 61.65 -87.43 53.89 59.08 -88.37 coo 24.10 66.43 63.33 24.18 64.30 63.40 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 27.64 56.61 58.17 22.18 57.92 60.36 59.28 73.05 -82.63 55.63 74.15 -86.94 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 24 3 # 24 C 189 PHE F 161 PHE^? 25.66 MG MG E 302 C 298 ASP E 35 ASP^? 16.91 MG MG E 302 C 329 LYS F 61 LYS^? 21.75 MG MG E 302 coo 17.41 60.57 64.39 18.40 58.12 65.34 68.33 71.65 -68.19 70.12 69.57 -67.59 coo 24.10 66.43 63.33 24.18 64.30 63.40 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 27.64 56.61 58.17 22.18 57.92 60.36 80.24 64.12 -71.01 76.23 61.95 -66.39 1gtx_c02 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 24 hits 1gtx_c02 naa= 3 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 D 189 PHE A 12 PHE^? 17.15 MG MG A 301 D 298 ASP A 171 ASP^? 17.17 MG MG A 302 D 329 LYS A 166 LYS^? 20.93 MG MG A 302 coo 35.44 53.35 83.81 35.65 54.53 81.28 34.93 27.27 29.42 32.88 25.47 30.10 coo 29.72 46.46 83.60 30.79 47.36 81.99 29.78 23.67 36.63 28.48 25.11 35.71 coo 36.89 44.91 74.55 37.33 48.94 79.01 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 D 189 PHE A 59 PHE^? 31.59 MG MG A 301 D 298 ASP A 160 ASP^? 31.61 MG MG B 302 D 329 LYS A 157 LYS^? 28.65 MG MG A 302 coo 35.44 53.35 83.81 35.65 54.53 81.28 52.93 4.70 25.02 52.08 5.30 27.62 coo 29.72 46.46 83.60 30.79 47.36 81.99 44.21 5.00 19.54 46.02 3.84 19.76 coo 36.89 44.91 74.55 37.33 48.94 79.01 41.42 12.06 27.58 41.46 5.93 29.41 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 D 189 PHE A 153 PHE^? 9.64 MG MG A 301 D 298 ASP A 171 ASP^? 17.17 MG MG A 302 D 329 LYS A 166 LYS^? 20.93 MG MG A 302 coo 35.44 53.35 83.81 35.65 54.53 81.28 38.89 24.49 36.07 40.14 26.70 37.23 coo 29.72 46.46 83.60 30.79 47.36 81.99 29.78 23.67 36.63 28.48 25.11 35.71 coo 36.89 44.91 74.55 37.33 48.94 79.01 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 D 189 PHE A 161 PHE^? 25.62 MG MG B 302 D 298 ASP B 35 ASP^? 16.92 MG MG B 302 D 329 LYS A 61 LYS^? 21.99 MG MG B 302 coo 35.44 53.35 83.81 35.65 54.53 81.28 44.24 9.29 16.03 46.90 9.95 15.56 coo 29.72 46.46 83.60 30.79 47.36 81.99 52.63 11.07 10.18 53.68 12.85 9.94 coo 36.89 44.91 74.55 37.33 48.94 79.01 57.78 7.35 19.60 56.77 12.20 15.61 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 D 189 PHE B 12 PHE^? 17.13 MG MG B 302 D 298 ASP B 171 ASP^? 16.92 MG MG B 301 D 329 LYS B 166 LYS^? 22.75 MG MG B 301 coo 35.44 53.35 83.81 35.65 54.53 81.28 49.02 12.29 7.19 47.01 10.60 6.19 coo 29.72 46.46 83.60 30.79 47.36 81.99 45.30 8.50 -0.71 46.30 6.81 0.12 coo 36.89 44.91 74.55 37.33 48.94 79.01 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 D 189 PHE B 59 PHE^? 31.31 MG MG B 302 D 298 ASP B 160 ASP^? 31.65 MG MG A 301 D 329 LYS B 157 LYS^? 28.85 MG MG B 302 coo 35.44 53.35 83.81 35.65 54.53 81.28 29.63 33.55 11.36 30.42 32.81 8.75 coo 29.72 46.46 83.60 30.79 47.36 81.99 28.01 24.83 16.38 27.44 26.81 15.80 coo 36.89 44.91 74.55 37.33 48.94 79.01 34.97 21.28 8.44 29.03 22.82 6.58 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 D 189 PHE B 153 PHE^? 9.59 MG MG B 302 D 298 ASP B 171 ASP^? 16.92 MG MG B 301 D 329 LYS B 166 LYS^? 22.75 MG MG B 301 coo 35.44 53.35 83.81 35.65 54.53 81.28 47.54 17.09 0.77 50.03 17.91 -0.19 coo 29.72 46.46 83.60 30.79 47.36 81.99 45.30 8.50 -0.71 46.30 6.81 0.12 coo 36.89 44.91 74.55 37.33 48.94 79.01 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 D 189 PHE B 161 PHE^? 25.78 MG MG A 301 D 298 ASP A 35 ASP^? 16.92 MG MG A 301 D 329 LYS B 61 LYS^? 22.03 MG MG A 301 coo 35.44 53.35 83.81 35.65 54.53 81.28 31.87 23.58 19.99 32.61 26.21 20.65 coo 29.72 46.46 83.60 30.79 47.36 81.99 34.49 31.10 26.54 36.41 31.82 27.10 coo 36.89 44.91 74.55 37.33 48.94 79.01 32.50 37.62 17.61 36.68 34.92 21.51 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 9 3 # 9 D 189 PHE C 12 PHE^? 16.92 MG MG C 302 D 298 ASP C 171 ASP^? 17.08 MG MG C 301 D 329 LYS C 166 LYS^? 22.53 MG MG C 301 coo 35.44 53.35 83.81 35.65 54.53 81.28 87.42 18.93 -13.86 90.00 18.25 -12.97 coo 29.72 46.46 83.60 30.79 47.36 81.99 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 36.89 44.91 74.55 37.33 48.94 79.01 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 10 3 # 10 D 189 PHE C 59 PHE^? 31.23 MG MG C 302 D 298 ASP C 160 ASP^? 31.63 MG MG D 302 D 329 LYS C 157 LYS^? 28.15 MG MG C 302 coo 35.44 53.35 83.81 35.65 54.53 81.28 98.06 45.52 -18.00 97.73 44.36 -15.53 coo 29.72 46.46 83.60 30.79 47.36 81.99 102.50 38.00 -23.28 102.43 39.97 -22.46 coo 36.89 44.91 74.55 37.33 48.94 79.01 97.55 32.04 -15.10 101.49 36.24 -13.39 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 11 3 # 11 D 189 PHE C 153 PHE^? 9.34 MG MG C 302 D 298 ASP C 171 ASP^? 17.08 MG MG C 301 D 329 LYS C 166 LYS^? 22.53 MG MG C 301 coo 35.44 53.35 83.81 35.65 54.53 81.28 87.15 23.83 -7.29 84.55 23.79 -6.26 coo 29.72 46.46 83.60 30.79 47.36 81.99 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 36.89 44.91 74.55 37.33 48.94 79.01 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 12 3 # 12 D 189 PHE C 161 PHE^? 25.47 MG MG D 302 D 298 ASP D 35 ASP^? 16.80 MG MG D 302 D 329 LYS C 61 LYS^? 21.91 MG MG D 302 coo 35.44 53.35 83.81 35.65 54.53 81.28 98.98 35.62 -26.76 97.40 37.84 -27.44 coo 29.72 46.46 83.60 30.79 47.36 81.99 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 36.89 44.91 74.55 37.33 48.94 79.01 93.60 48.56 -24.05 90.39 44.71 -27.98 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 13 3 # 13 D 189 PHE D 12 PHE^? 16.78 MG MG D 302 D 298 ASP D 171 ASP^? 16.95 MG MG D 301 D 329 LYS D 166 LYS^? 21.08 MG MG D 301 coo 35.44 53.35 83.81 35.65 54.53 81.28 94.68 38.11 -36.05 97.16 37.10 -36.83 coo 29.72 46.46 83.60 30.79 47.36 81.99 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 36.89 44.91 74.55 37.33 48.94 79.01 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 14 3 # 14 D 189 PHE D 59 PHE^? 31.49 MG MG D 302 D 298 ASP D 160 ASP^? 31.45 MG MG C 302 D 329 LYS D 157 LYS^? 28.67 MG MG D 302 coo 35.44 53.35 83.81 35.65 54.53 81.28 86.17 10.70 -31.86 86.41 11.56 -34.53 coo 29.72 46.46 83.60 30.79 47.36 81.99 94.15 13.98 -26.57 92.71 12.42 -26.99 coo 36.89 44.91 74.55 37.33 48.94 79.01 94.17 21.71 -34.34 96.11 15.89 -35.92 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 15 3 # 15 D 189 PHE D 153 PHE^? 9.11 MG MG D 302 D 298 ASP D 171 ASP^? 16.95 MG MG D 301 D 329 LYS D 166 LYS^? 21.08 MG MG D 301 coo 35.44 53.35 83.81 35.65 54.53 81.28 91.67 34.35 -42.71 89.76 36.10 -43.73 coo 29.72 46.46 83.60 30.79 47.36 81.99 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 36.89 44.91 74.55 37.33 48.94 79.01 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 16 3 # 16 D 189 PHE D 161 PHE^? 25.58 MG MG C 302 D 298 ASP C 35 ASP^? 16.42 MG MG C 302 D 329 LYS D 61 LYS^? 21.93 MG MG C 302 coo 35.44 53.35 83.81 35.65 54.53 81.28 92.97 17.97 -22.91 90.24 17.44 -22.45 coo 29.72 46.46 83.60 30.79 47.36 81.99 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 36.89 44.91 74.55 37.33 48.94 79.01 80.64 11.23 -26.16 80.65 16.24 -22.36 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 17 3 # 17 D 189 PHE E 12 PHE^? 17.09 MG MG E 302 D 298 ASP E 171 ASP^? 16.73 MG MG E 301 D 329 LYS E 166 LYS^? 21.46 MG MG E 301 coo 35.44 53.35 83.81 35.65 54.53 81.28 70.06 67.18 -58.76 69.33 69.81 -58.07 coo 29.72 46.46 83.60 30.79 47.36 81.99 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 36.89 44.91 74.55 37.33 48.94 79.01 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 18 3 # 18 D 189 PHE E 59 PHE^? 31.36 MG MG E 302 D 298 ASP E 160 ASP^? 31.54 MG MG F 301 D 329 LYS E 157 LYS^? 28.40 MG MG E 302 coo 35.44 53.35 83.81 35.65 54.53 81.28 41.55 62.67 -62.73 42.33 62.92 -60.06 coo 29.72 46.46 83.60 30.79 47.36 81.99 45.81 70.00 -68.45 44.10 68.87 -67.77 coo 36.89 44.91 74.55 37.33 48.94 79.01 53.63 69.16 -60.42 48.34 71.81 -58.40 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 19 3 # 19 D 189 PHE E 153 PHE^? 9.50 MG MG E 302 D 298 ASP E 171 ASP^? 16.73 MG MG E 301 D 329 LYS E 166 LYS^? 21.46 MG MG E 301 coo 35.44 53.35 83.81 35.65 54.53 81.28 65.86 64.95 -52.12 67.22 62.73 -51.09 coo 29.72 46.46 83.60 30.79 47.36 81.99 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 36.89 44.91 74.55 37.33 48.94 79.01 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 20 3 # 20 D 189 PHE F 12 PHE^? 17.12 MG MG F 301 D 298 ASP F 171 ASP^? 16.35 MG MG F 302 D 329 LYS F 166 LYS^? 20.76 MG MG F 302 coo 35.44 53.35 83.81 35.65 54.53 81.28 49.70 62.79 -80.90 49.37 65.44 -81.67 coo 29.72 46.46 83.60 30.79 47.36 81.99 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 36.89 44.91 74.55 37.33 48.94 79.01 59.28 73.05 -82.63 55.63 74.15 -86.94 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 21 3 # 21 D 189 PHE F 59 PHE^? 31.53 MG MG F 301 D 298 ASP F 160 ASP^? 31.59 MG MG E 302 D 329 LYS F 6 LYS^? 26.09 MG MG F 301 coo 35.44 53.35 83.81 35.65 54.53 81.28 77.96 68.89 -76.99 76.86 68.73 -79.55 coo 29.72 46.46 83.60 30.79 47.36 81.99 71.27 74.59 -71.77 73.23 74.02 -72.37 coo 36.89 44.91 74.55 37.33 48.94 79.01 67.53 67.03 -76.43 64.05 65.33 -71.86 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 22 3 # 22 D 189 PHE F 59 PHE^? 31.53 MG MG F 301 D 298 ASP F 160 ASP^? 31.59 MG MG E 302 D 329 LYS F 157 LYS^? 28.36 MG MG F 302 coo 35.44 53.35 83.81 35.65 54.53 81.28 77.96 68.89 -76.99 76.86 68.73 -79.55 coo 29.72 46.46 83.60 30.79 47.36 81.99 71.27 74.59 -71.77 73.23 74.02 -72.37 coo 36.89 44.91 74.55 37.33 48.94 79.01 64.43 70.47 -79.54 68.32 74.80 -81.65 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 23 3 # 23 D 189 PHE F 153 PHE^? 9.26 MG MG F 302 D 298 ASP F 171 ASP^? 16.35 MG MG F 302 D 329 LYS F 166 LYS^? 20.76 MG MG F 302 coo 35.44 53.35 83.81 35.65 54.53 81.28 54.49 61.65 -87.43 53.89 59.08 -88.37 coo 29.72 46.46 83.60 30.79 47.36 81.99 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 36.89 44.91 74.55 37.33 48.94 79.01 59.28 73.05 -82.63 55.63 74.15 -86.94 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 24 3 # 24 D 189 PHE F 161 PHE^? 25.66 MG MG E 302 D 298 ASP E 35 ASP^? 16.91 MG MG E 302 D 329 LYS F 61 LYS^? 21.75 MG MG E 302 coo 35.44 53.35 83.81 35.65 54.53 81.28 68.33 71.65 -68.19 70.12 69.57 -67.59 coo 29.72 46.46 83.60 30.79 47.36 81.99 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 36.89 44.91 74.55 37.33 48.94 79.01 80.24 64.12 -71.01 76.23 61.95 -66.39 1gtx_c03 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 24 hits 1gtx_c03 naa= 3 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 1 3 # 1 A 271 GLN A 53 GLN^? 15.00 MG MG A 301 A 296 GLU A 52 GLU^? 19.89 MG MG A 301 A 383 TYR A 156 TYR^? 21.80 MG MG A 301 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 48.51 22.34 28.72 49.24 22.16 30.72 coo 40.93 4.45 2.36 38.91 3.75 2.26 42.67 25.16 24.80 42.61 25.77 22.75 coo 30.54 7.22 6.23 31.38 5.79 3.97 37.50 16.28 27.75 35.30 17.94 28.08 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 2 3 # 2 A 271 GLN A 53 GLN^? 15.00 MG MG A 301 A 296 GLU A 52 GLU^? 19.89 MG MG A 301 A 383 TYR B 67 TYR^? 21.41 MG MG B 302 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 48.51 22.34 28.72 49.24 22.16 30.72 coo 40.93 4.45 2.36 38.91 3.75 2.26 42.67 25.16 24.80 42.61 25.77 22.75 coo 30.54 7.22 6.23 31.38 5.79 3.97 46.94 25.86 15.48 48.70 23.84 16.15 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 3 3 # 3 A 271 GLN A 53 GLN^? 15.00 MG MG A 301 A 296 GLU A 54 GLU^? 22.98 MG MG A 301 A 383 TYR B 67 TYR^? 21.41 MG MG B 302 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 48.51 22.34 28.72 49.24 22.16 30.72 coo 40.93 4.45 2.36 38.91 3.75 2.26 45.06 19.97 24.02 44.05 19.39 22.19 coo 30.54 7.22 6.23 31.38 5.79 3.97 46.94 25.86 15.48 48.70 23.84 16.15 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 4 3 # 4 A 271 GLN A 144 GLN^? 19.77 MG MG A 302 A 296 GLU A 146 GLU^? 9.80 MG MG A 302 A 383 TYR A 168 TYR^? 14.52 MG MG A 302 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 46.49 12.77 42.93 46.53 10.83 42.06 coo 40.93 4.45 2.36 38.91 3.75 2.26 45.17 20.35 44.20 46.68 21.21 45.40 coo 30.54 7.22 6.23 31.38 5.79 3.97 37.31 16.98 37.59 36.65 18.86 39.55 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 5 3 # 5 A 271 GLN B 53 GLN^? 14.94 MG MG B 302 A 296 GLU B 52 GLU^? 20.06 MG MG B 302 A 383 TYR B 156 TYR^? 21.63 MG MG B 302 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 46.20 26.35 8.70 46.62 27.22 6.80 coo 40.93 4.45 2.36 38.91 3.75 2.26 47.87 20.25 12.36 48.11 19.69 14.43 coo 30.54 7.22 6.23 31.38 5.79 3.97 38.56 16.71 8.27 39.91 14.31 7.86 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 6 3 # 6 A 271 GLN B 144 GLN^? 20.13 MG MG B 301 A 296 GLU B 146 GLU^? 10.54 MG MG B 301 A 383 TYR B 168 TYR^? 14.66 MG MG B 301 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 37.08 26.58 -5.56 36.43 28.52 -6.04 coo 40.93 4.45 2.36 38.91 3.75 2.26 45.13 24.51 -7.01 46.08 25.99 -8.13 coo 30.54 7.22 6.23 31.38 5.79 3.97 40.03 17.20 -1.34 41.92 16.43 -3.19 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 7 3 # 7 A 271 GLN C 53 GLN^? 14.81 MG MG C 302 A 296 GLU C 52 GLU^? 19.67 MG MG C 302 A 383 TYR C 156 TYR^? 21.58 MG MG C 302 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 85.10 33.09 -15.04 84.28 33.88 -13.22 coo 40.93 4.45 2.36 38.91 3.75 2.26 84.27 26.98 -19.19 85.21 26.16 -20.96 coo 30.54 7.22 6.23 31.38 5.79 3.97 95.64 26.50 -15.14 95.25 23.76 -14.77 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 8 3 # 8 A 271 GLN C 144 GLN^? 20.37 MG MG C 301 A 296 GLU C 146 GLU^? 10.46 MG MG C 301 A 383 TYR C 168 TYR^? 14.82 MG MG C 301 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 92.57 37.16 -1.30 94.53 37.81 -1.71 coo 40.93 4.45 2.36 38.91 3.75 2.26 87.01 31.93 0.25 85.57 32.56 1.72 coo 30.54 7.22 6.23 31.38 5.79 3.97 94.44 26.43 -5.44 92.97 25.09 -3.55 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 9 3 # 9 A 271 GLN D 53 GLN^? 15.01 MG MG D 302 A 296 GLU D 52 GLU^? 19.94 MG MG D 302 A 383 TYR D 156 TYR^? 21.34 MG MG D 302 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 83.68 28.79 -35.08 83.11 28.49 -37.14 coo 40.93 4.45 2.36 38.91 3.75 2.26 87.13 33.17 -30.97 88.40 33.70 -29.31 coo 30.54 7.22 6.23 31.38 5.79 3.97 96.25 27.10 -34.64 97.58 29.48 -35.03 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 10 3 # 10 A 271 GLN E 53 GLN^? 15.16 MG MG E 302 A 296 GLU E 52 GLU^? 19.96 MG MG E 302 A 383 TYR E 156 TYR^? 21.59 MG MG E 302 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 58.99 57.94 -59.66 58.42 57.10 -57.76 coo 40.93 4.45 2.36 38.91 3.75 2.26 64.71 60.06 -63.78 64.69 61.36 -65.58 coo 30.54 7.22 6.23 31.38 5.79 3.97 59.31 70.31 -60.22 61.84 71.39 -59.92 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 11 3 # 11 A 271 GLN E 53 GLN^? 15.16 MG MG E 302 A 296 GLU E 52 GLU^? 19.96 MG MG E 302 A 383 TYR F 67 TYR^? 21.41 MG MG F 301 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 58.99 57.94 -59.66 58.42 57.10 -57.76 coo 40.93 4.45 2.36 38.91 3.75 2.26 64.71 60.06 -63.78 64.69 61.36 -65.58 coo 30.54 7.22 6.23 31.38 5.79 3.97 62.63 57.65 -72.90 59.95 57.21 -72.29 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 12 3 # 12 A 271 GLN E 53 GLN^? 15.16 MG MG E 302 A 296 GLU E 54 GLU^? 22.83 MG MG E 302 A 383 TYR F 67 TYR^? 21.41 MG MG F 301 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 58.99 57.94 -59.66 58.42 57.10 -57.76 coo 40.93 4.45 2.36 38.91 3.75 2.26 58.39 62.16 -64.12 58.73 62.98 -66.04 coo 30.54 7.22 6.23 31.38 5.79 3.97 62.63 57.65 -72.90 59.95 57.21 -72.29 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 13 3 # 13 A 271 GLN E 144 GLN^? 20.26 MG MG E 301 A 296 GLU E 146 GLU^? 10.15 MG MG E 301 A 383 TYR E 168 TYR^? 14.43 MG MG E 301 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 51.74 64.42 -45.34 50.01 64.85 -46.49 coo 40.93 4.45 2.36 38.91 3.75 2.26 58.72 60.89 -44.51 59.23 60.24 -42.54 coo 30.54 7.22 6.23 31.38 5.79 3.97 60.07 69.95 -50.54 61.99 69.37 -48.59 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 14 3 # 14 A 271 GLN F 53 GLN^? 15.06 MG MG F 301 A 296 GLU F 52 GLU^? 20.13 MG MG F 301 A 383 TYR F 156 TYR^? 21.68 MG MG F 302 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 63.34 58.26 -79.73 63.90 57.42 -81.62 coo 40.93 4.45 2.36 38.91 3.75 2.26 57.09 59.62 -75.76 56.76 59.40 -73.62 coo 30.54 7.22 6.23 31.38 5.79 3.97 58.80 69.55 -79.65 56.09 69.80 -80.15 1h19_c00 source 1h19 LEUKOTRIENE A-4 HYDROLASE : 14 hits 1h19_c00 naa= 3 ULMN 3 1h2r_c00 PERIPLASMIC [NIFE] HYDROGENASE LARGEuser 1 3 # 1 S 18 THR F 40 THR^? 24.18 MG MG F 301 L 34 GLU F 154 GLU^? 18.97 MG MG F 301 L 546 CYH F 152 CYH^? 14.14 MG MG F 302 coo 59.66 41.78 78.85 58.82 40.81 80.62 52.32 69.62 -77.21 51.38 69.00 -75.36 coo 58.67 42.52 83.67 60.77 42.68 84.14 54.57 65.67 -81.55 53.36 66.51 -80.09 coo 58.67 44.02 88.31 58.41 45.45 86.02 50.28 62.76 -86.08 48.12 64.34 -85.77 1h2r_c00 source 1h2r PERIPLASMIC [NIFE] HYDROGENASE LARGE SUBUNIT : 1 hits 1h2r_c00 naa= 3 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 1 3 # 1 A 50 ASP A 58 ASP^? 26.75 MG MG B 302 A 327 GLU C 174 GLU^? 19.72 MG MG C 301 A 339 ARG C 173 ARG^? 18.96 MG MG C 301 coo 85.81 57.99 116.01 86.03 55.86 115.89 53.93 9.80 21.09 53.83 8.90 19.15 coo 75.11 41.01 160.30 76.65 40.06 161.41 95.09 14.29 -3.63 95.25 12.23 -4.17 coo 82.23 40.35 159.87 85.09 40.67 161.01 89.11 11.40 -7.73 91.21 12.63 -9.73 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 2 3 # 2 A 50 ASP A 128 ASP^? -3.32 MG MG A 301s A 327 GLU B 174 GLU^? 19.69 MG MG B 301 A 339 ARG B 173 ARG^? 18.75 MG MG B 301 coo 85.81 57.99 116.01 86.03 55.86 115.89 46.50 28.23 39.77 47.49 30.10 39.82 coo 75.11 41.01 160.30 76.65 40.06 161.41 43.72 4.95 -3.28 44.76 3.14 -2.69 coo 82.23 40.35 159.87 85.09 40.67 161.01 49.83 5.55 0.39 48.19 5.30 3.03 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 3 3 # 3 A 50 ASP A 148 ASP^? 2.72 MG MG A 301s A 327 GLU B 174 GLU^? 19.69 MG MG B 301 A 339 ARG B 173 ARG^? 18.75 MG MG B 301 coo 85.81 57.99 116.01 86.03 55.86 115.89 41.50 28.88 41.13 43.33 29.67 41.93 coo 75.11 41.01 160.30 76.65 40.06 161.41 43.72 4.95 -3.28 44.76 3.14 -2.69 coo 82.23 40.35 159.87 85.09 40.67 161.01 49.83 5.55 0.39 48.19 5.30 3.03 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 4 3 # 4 A 50 ASP B 23 ASP^? 15.67 MG MG C 301 A 327 GLU D 154 GLU^? 18.75 MG MG D 302 A 339 ARG D 37 ARG^? 18.81 MG MG D 302 coo 85.81 57.99 116.01 86.03 55.86 115.89 74.31 7.55 -1.09 75.08 9.17 -2.23 coo 75.11 41.01 160.30 76.65 40.06 161.41 94.87 32.52 -36.42 96.07 33.39 -34.88 coo 82.23 40.35 159.87 85.09 40.67 161.01 96.81 38.21 -31.63 94.97 36.32 -33.06 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 5 3 # 5 A 50 ASP B 35 ASP^? 16.92 MG MG B 302 A 327 GLU C 38 GLU^? 21.99 MG MG C 301 A 339 ARG C 37 ARG^? 19.01 MG MG C 302 coo 85.81 57.99 116.01 86.03 55.86 115.89 52.63 11.07 10.18 53.68 12.85 9.94 coo 75.11 41.01 160.30 76.65 40.06 161.41 93.66 12.78 -15.08 92.73 12.51 -13.19 coo 82.23 40.35 159.87 85.09 40.67 161.01 89.36 17.23 -17.57 89.29 20.20 -16.76 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 6 3 # 6 A 50 ASP B 35 ASP^? 16.92 MG MG B 302 A 327 GLU C 154 GLU^? 18.91 MG MG C 302 A 339 ARG C 37 ARG^? 19.01 MG MG C 302 coo 85.81 57.99 116.01 86.03 55.86 115.89 52.63 11.07 10.18 53.68 12.85 9.94 coo 75.11 41.01 160.30 76.65 40.06 161.41 91.15 23.27 -13.33 91.61 21.91 -14.95 coo 82.23 40.35 159.87 85.09 40.67 161.01 89.36 17.23 -17.57 89.29 20.20 -16.76 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 7 3 # 7 A 50 ASP B 81 ASP^? 24.85 MG MG C 301 A 327 GLU A 52 GLU^? 19.89 MG MG A 301 A 339 ARG A 8 ARG^? 20.36 MG MG A 301 coo 85.81 57.99 116.01 86.03 55.86 115.89 79.93 -0.44 10.01 79.44 1.19 11.29 coo 75.11 41.01 160.30 76.65 40.06 161.41 42.67 25.16 24.80 42.61 25.77 22.75 coo 82.23 40.35 159.87 85.09 40.67 161.01 40.62 19.52 24.63 40.98 22.51 23.88 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 8 3 # 8 A 50 ASP B 148 ASP^? 2.58 MG MG B 302s A 327 GLU A 174 GLU^? 20.39 MG MG A 302 A 339 ARG A 173 ARG^? 19.27 MG MG A 302 coo 85.81 57.99 116.01 86.03 55.86 115.89 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 75.11 41.01 160.30 76.65 40.06 161.41 25.88 23.57 38.04 23.76 23.95 38.22 coo 82.23 40.35 159.87 85.09 40.67 161.01 27.76 29.24 35.14 27.46 27.11 32.86 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 9 3 # 9 A 50 ASP B 171 ASP^? 16.92 MG MG B 301 A 327 GLU A 75 GLU^? 20.23 MG MG A 301 A 339 ARG A 87 ARG^? 20.70 MG MG A 301 coo 85.81 57.99 116.01 86.03 55.86 115.89 45.30 8.50 -0.71 46.30 6.81 0.12 coo 75.11 41.01 160.30 76.65 40.06 161.41 38.99 46.65 28.68 39.94 47.65 30.33 coo 82.23 40.35 159.87 85.09 40.67 161.01 43.15 49.03 26.22 43.83 48.14 29.12 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 10 3 # 10 A 50 ASP B 171 ASP^? 16.92 MG MG B 301 A 327 GLU C 154 GLU^? 18.91 MG MG C 302 A 339 ARG C 37 ARG^? 19.01 MG MG C 302 coo 85.81 57.99 116.01 86.03 55.86 115.89 45.30 8.50 -0.71 46.30 6.81 0.12 coo 75.11 41.01 160.30 76.65 40.06 161.41 91.15 23.27 -13.33 91.61 21.91 -14.95 coo 82.23 40.35 159.87 85.09 40.67 161.01 89.36 17.23 -17.57 89.29 20.20 -16.76 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 11 3 # 11 A 50 ASP B 187 ASP^? -3.44 MG MG B 301s A 327 GLU A 75 GLU^? 20.23 MG MG A 301 A 339 ARG A 87 ARG^? 20.70 MG MG A 301 coo 85.81 57.99 116.01 86.03 55.86 115.89 50.64 18.14 -9.69 51.74 17.63 -7.86 coo 75.11 41.01 160.30 76.65 40.06 161.41 38.99 46.65 28.68 39.94 47.65 30.33 coo 82.23 40.35 159.87 85.09 40.67 161.01 43.15 49.03 26.22 43.83 48.14 29.12 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 12 3 # 12 A 50 ASP C 23 ASP^? 15.39 MG MG B 301 A 327 GLU A 154 GLU^? 19.22 MG MG A 301 A 339 ARG A 37 ARG^? 18.99 MG MG A 301 coo 85.81 57.99 116.01 86.03 55.86 115.89 65.24 6.82 -5.11 63.43 7.54 -4.15 coo 75.11 41.01 160.30 76.65 40.06 161.41 36.54 21.95 29.78 35.14 22.21 28.17 coo 82.23 40.35 159.87 85.09 40.67 161.01 32.99 26.50 25.19 35.50 25.33 26.51 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 13 3 # 13 A 50 ASP C 35 ASP^? 16.42 MG MG C 302 A 327 GLU B 38 GLU^? 21.75 MG MG B 301 A 339 ARG B 37 ARG^? 19.17 MG MG B 302 coo 85.81 57.99 116.01 86.03 55.86 115.89 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 75.11 41.01 160.30 76.65 40.06 161.41 44.79 4.95 7.12 46.66 4.47 6.21 coo 82.23 40.35 159.87 85.09 40.67 161.01 47.41 10.20 11.40 46.99 12.91 10.22 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 14 3 # 14 A 50 ASP C 35 ASP^? 16.42 MG MG C 302 A 327 GLU B 154 GLU^? 19.05 MG MG B 302 A 339 ARG B 37 ARG^? 19.17 MG MG B 302 coo 85.81 57.99 116.01 86.03 55.86 115.89 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 75.11 41.01 160.30 76.65 40.06 161.41 44.04 15.11 6.74 44.19 13.59 8.30 coo 82.23 40.35 159.87 85.09 40.67 161.01 47.41 10.20 11.40 46.99 12.91 10.22 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 15 3 # 15 A 50 ASP C 128 ASP^? -3.22 MG MG C 302s A 327 GLU D 174 GLU^? 19.76 MG MG D 301 A 339 ARG D 173 ARG^? 18.88 MG MG D 301 coo 85.81 57.99 116.01 86.03 55.86 115.89 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 75.11 41.01 160.30 76.65 40.06 161.41 104.29 37.18 -46.00 105.30 38.94 -45.21 coo 82.23 40.35 159.87 85.09 40.67 161.01 100.48 42.57 -42.43 101.55 40.79 -40.06 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 16 3 # 16 A 50 ASP C 148 ASP^? 2.75 MG MG C 302s A 327 GLU D 174 GLU^? 19.76 MG MG D 301 A 339 ARG D 173 ARG^? 18.88 MG MG D 301 coo 85.81 57.99 116.01 86.03 55.86 115.89 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 75.11 41.01 160.30 76.65 40.06 161.41 104.29 37.18 -46.00 105.30 38.94 -45.21 coo 82.23 40.35 159.87 85.09 40.67 161.01 100.48 42.57 -42.43 101.55 40.79 -40.06 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 17 3 # 17 A 50 ASP C 171 ASP^? 17.08 MG MG C 301 A 327 GLU B 154 GLU^? 19.05 MG MG B 302 A 339 ARG B 37 ARG^? 19.17 MG MG B 302 coo 85.81 57.99 116.01 86.03 55.86 115.89 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 75.11 41.01 160.30 76.65 40.06 161.41 44.04 15.11 6.74 44.19 13.59 8.30 coo 82.23 40.35 159.87 85.09 40.67 161.01 47.41 10.20 11.40 46.99 12.91 10.22 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 18 3 # 18 A 50 ASP C 187 ASP^? -3.72 MG MG C 301s A 327 GLU D 75 GLU^? 15.53 MG MG E 301 A 339 ARG D 87 ARG^? 13.34 MG MG E 301 coo 85.81 57.99 116.01 86.03 55.86 115.89 84.01 23.73 3.39 83.47 22.54 1.59 coo 75.11 41.01 160.30 76.65 40.06 161.41 84.53 54.81 -36.40 82.75 56.01 -36.42 coo 82.23 40.35 159.87 85.09 40.67 161.01 79.72 56.28 -33.10 79.15 54.81 -35.72 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 19 3 # 19 A 50 ASP D 23 ASP^? 15.37 MG MG E 301 A 327 GLU F 154 GLU^? 18.97 MG MG F 301 A 339 ARG F 37 ARG^? 19.14 MG MG F 301 coo 85.81 57.99 116.01 86.03 55.86 115.89 85.70 62.10 -45.60 84.07 62.13 -46.93 coo 75.11 41.01 160.30 76.65 40.06 161.41 54.57 65.67 -81.55 53.36 66.51 -80.09 coo 82.23 40.35 159.87 85.09 40.67 161.01 48.80 64.46 -76.37 51.50 64.15 -77.79 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 20 3 # 20 A 50 ASP D 35 ASP^? 16.80 MG MG D 302 A 327 GLU E 38 GLU^? 21.68 MG MG E 301 A 339 ARG E 37 ARG^? 19.17 MG MG E 302 coo 85.81 57.99 116.01 86.03 55.86 115.89 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 75.11 41.01 160.30 76.65 40.06 161.41 72.42 75.53 -60.31 73.00 74.78 -58.42 coo 82.23 40.35 159.87 85.09 40.67 161.01 70.82 68.02 -63.63 68.17 67.46 -62.14 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 21 3 # 21 A 50 ASP D 35 ASP^? 16.80 MG MG D 302 A 327 GLU E 154 GLU^? 19.05 MG MG E 302 A 339 ARG E 37 ARG^? 19.17 MG MG E 302 coo 85.81 57.99 116.01 86.03 55.86 115.89 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 75.11 41.01 160.30 76.65 40.06 161.41 64.41 68.21 -58.47 65.40 69.20 -60.08 coo 82.23 40.35 159.87 85.09 40.67 161.01 70.82 68.02 -63.63 68.17 67.46 -62.14 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 22 3 # 22 A 50 ASP D 81 ASP^? 23.25 MG MG E 301 A 327 GLU C 52 GLU^? 19.67 MG MG C 302 A 339 ARG C 8 ARG^? 20.00 MG MG C 302 coo 85.81 57.99 116.01 86.03 55.86 115.89 89.25 71.36 -34.47 87.72 70.06 -33.67 coo 75.11 41.01 160.30 76.65 40.06 161.41 84.27 26.98 -19.19 85.21 26.16 -20.96 coo 82.23 40.35 159.87 85.09 40.67 161.01 91.42 27.61 -18.53 88.82 26.28 -19.38 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 23 3 # 23 A 50 ASP D 128 ASP^? -3.70 MG MG D 302s A 327 GLU C 174 GLU^? 19.72 MG MG C 301 A 339 ARG C 173 ARG^? 18.96 MG MG C 301 coo 85.81 57.99 116.01 86.03 55.86 115.89 83.33 35.45 -46.13 81.57 36.63 -46.10 coo 75.11 41.01 160.30 76.65 40.06 161.41 95.09 14.29 -3.63 95.25 12.23 -4.17 coo 82.23 40.35 159.87 85.09 40.67 161.01 89.11 11.40 -7.73 91.21 12.63 -9.73 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 24 3 # 24 A 50 ASP D 148 ASP^? 2.35 MG MG D 302s A 327 GLU C 174 GLU^? 19.72 MG MG C 301 A 339 ARG C 173 ARG^? 18.96 MG MG C 301 coo 85.81 57.99 116.01 86.03 55.86 115.89 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 75.11 41.01 160.30 76.65 40.06 161.41 95.09 14.29 -3.63 95.25 12.23 -4.17 coo 82.23 40.35 159.87 85.09 40.67 161.01 89.11 11.40 -7.73 91.21 12.63 -9.73 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 25 3 # 25 A 50 ASP D 148 ASP^? 2.35 MG MG D 302s A 327 GLU F 52 GLU^? 20.13 MG MG F 301 A 339 ARG F 8 ARG^? 20.20 MG MG F 301 coo 85.81 57.99 116.01 86.03 55.86 115.89 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 75.11 41.01 160.30 76.65 40.06 161.41 57.09 59.62 -75.76 56.76 59.40 -73.62 coo 82.23 40.35 159.87 85.09 40.67 161.01 58.98 65.22 -76.31 57.29 62.84 -75.38 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 26 3 # 26 A 50 ASP D 171 ASP^? 16.95 MG MG D 301 A 327 GLU C 75 GLU^? 16.14 MG MG B 301 A 339 ARG C 87 ARG^? 14.11 MG MG B 301 coo 85.81 57.99 116.01 86.03 55.86 115.89 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 75.11 41.01 160.30 76.65 40.06 161.41 69.49 12.18 -14.30 67.44 12.65 -13.83 coo 82.23 40.35 159.87 85.09 40.67 161.01 64.80 14.21 -18.13 65.25 15.52 -15.36 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 27 3 # 27 A 50 ASP D 171 ASP^? 16.95 MG MG D 301 A 327 GLU E 154 GLU^? 19.05 MG MG E 302 A 339 ARG E 37 ARG^? 19.17 MG MG E 302 coo 85.81 57.99 116.01 86.03 55.86 115.89 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 75.11 41.01 160.30 76.65 40.06 161.41 64.41 68.21 -58.47 65.40 69.20 -60.08 coo 82.23 40.35 159.87 85.09 40.67 161.01 70.82 68.02 -63.63 68.17 67.46 -62.14 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 28 3 # 28 A 50 ASP D 187 ASP^? -2.95 MG MG D 301s A 327 GLU C 75 GLU^? 16.14 MG MG B 301 A 339 ARG C 87 ARG^? 14.11 MG MG B 301 coo 85.81 57.99 116.01 86.03 55.86 115.89 90.40 36.34 -52.69 89.24 37.98 -51.99 coo 75.11 41.01 160.30 76.65 40.06 161.41 69.49 12.18 -14.30 67.44 12.65 -13.83 coo 82.23 40.35 159.87 85.09 40.67 161.01 64.80 14.21 -18.13 65.25 15.52 -15.36 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 29 3 # 29 A 50 ASP D 187 ASP^? -2.95 MG MG D 301s A 327 GLU F 52 GLU^? 20.13 MG MG F 301 A 339 ARG F 8 ARG^? 20.20 MG MG F 301 coo 85.81 57.99 116.01 86.03 55.86 115.89 90.40 36.34 -52.69 89.24 37.98 -51.99 coo 75.11 41.01 160.30 76.65 40.06 161.41 57.09 59.62 -75.76 56.76 59.40 -73.62 coo 82.23 40.35 159.87 85.09 40.67 161.01 58.98 65.22 -76.31 57.29 62.84 -75.38 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 30 3 # 30 A 50 ASP E 23 ASP^? 15.43 MG MG D 301 A 327 GLU C 154 GLU^? 18.91 MG MG C 302 A 339 ARG C 37 ARG^? 19.01 MG MG C 302 coo 85.81 57.99 116.01 86.03 55.86 115.89 91.98 54.64 -49.37 91.93 52.78 -48.33 coo 75.11 41.01 160.30 76.65 40.06 161.41 91.15 23.27 -13.33 91.61 21.91 -14.95 coo 82.23 40.35 159.87 85.09 40.67 161.01 89.36 17.23 -17.57 89.29 20.20 -16.76 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 31 3 # 31 A 50 ASP E 35 ASP^? 16.91 MG MG E 302 A 327 GLU D 38 GLU^? 21.83 MG MG D 301 A 339 ARG D 37 ARG^? 18.81 MG MG D 302 coo 85.81 57.99 116.01 86.03 55.86 115.89 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 75.11 41.01 160.30 76.65 40.06 161.41 103.22 39.19 -34.75 102.77 39.81 -36.73 coo 82.23 40.35 159.87 85.09 40.67 161.01 96.81 38.21 -31.63 94.97 36.32 -33.06 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 32 3 # 32 A 50 ASP E 35 ASP^? 16.91 MG MG E 302 A 327 GLU D 154 GLU^? 18.75 MG MG D 302 A 339 ARG D 37 ARG^? 18.81 MG MG D 302 coo 85.81 57.99 116.01 86.03 55.86 115.89 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 75.11 41.01 160.30 76.65 40.06 161.41 94.87 32.52 -36.42 96.07 33.39 -34.88 coo 82.23 40.35 159.87 85.09 40.67 161.01 96.81 38.21 -31.63 94.97 36.32 -33.06 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 33 3 # 33 A 50 ASP E 58 ASP^? 26.76 MG MG F 301 A 327 GLU D 75 GLU^? 15.53 MG MG E 301 A 339 ARG D 87 ARG^? 13.34 MG MG E 301 coo 85.81 57.99 116.01 86.03 55.86 115.89 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 75.11 41.01 160.30 76.65 40.06 161.41 84.53 54.81 -36.40 82.75 56.01 -36.42 coo 82.23 40.35 159.87 85.09 40.67 161.01 79.72 56.28 -33.10 79.15 54.81 -35.72 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 34 3 # 34 A 50 ASP E 81 ASP^? 24.19 MG MG D 301 A 327 GLU F 52 GLU^? 20.13 MG MG F 301 A 339 ARG F 8 ARG^? 20.20 MG MG F 301 coo 85.81 57.99 116.01 86.03 55.86 115.89 101.61 56.30 -60.24 100.25 55.53 -61.72 coo 75.11 41.01 160.30 76.65 40.06 161.41 57.09 59.62 -75.76 56.76 59.40 -73.62 coo 82.23 40.35 159.87 85.09 40.67 161.01 58.98 65.22 -76.31 57.29 62.84 -75.38 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 35 3 # 35 A 50 ASP E 148 ASP^? 2.62 MG MG E 302s A 327 GLU F 174 GLU^? 18.79 MG MG F 302 A 339 ARG F 173 ARG^? 18.61 MG MG F 302 coo 85.81 57.99 116.01 86.03 55.86 115.89 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 75.11 41.01 160.30 76.65 40.06 161.41 46.19 70.73 -90.91 44.19 71.42 -90.89 coo 82.23 40.35 159.87 85.09 40.67 161.01 43.18 65.58 -86.96 44.06 67.55 -84.65 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 36 3 # 36 A 50 ASP E 171 ASP^? 16.73 MG MG E 301 A 327 GLU D 154 GLU^? 18.75 MG MG D 302 A 339 ARG D 37 ARG^? 18.81 MG MG D 302 coo 85.81 57.99 116.01 86.03 55.86 115.89 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 75.11 41.01 160.30 76.65 40.06 161.41 94.87 32.52 -36.42 96.07 33.39 -34.88 coo 82.23 40.35 159.87 85.09 40.67 161.01 96.81 38.21 -31.63 94.97 36.32 -33.06 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 37 3 # 37 A 50 ASP F 81 ASP^? 34.61 MG MG F 301 A 327 GLU E 52 GLU^? 19.96 MG MG E 302 A 339 ARG E 8 ARG^? 20.19 MG MG E 302 coo 85.81 57.99 116.01 86.03 55.86 115.89 23.08 43.10 -77.79 24.94 42.10 -77.55 coo 75.11 41.01 160.30 76.65 40.06 161.41 64.71 60.06 -63.78 64.69 61.36 -65.58 coo 82.23 40.35 159.87 85.09 40.67 161.01 60.42 66.09 -63.48 62.84 64.38 -64.17 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 38 3 # 38 A 50 ASP F 128 ASP^? -3.41 MG MG F 301s A 327 GLU E 174 GLU^? 19.83 MG MG E 301 A 339 ARG E 173 ARG^? 18.66 MG MG E 301 coo 85.81 57.99 116.01 86.03 55.86 115.89 57.76 53.73 -90.50 57.46 51.64 -90.28 coo 75.11 41.01 160.30 76.65 40.06 161.41 70.48 76.62 -49.45 71.76 78.34 -49.45 coo 82.23 40.35 159.87 85.09 40.67 161.01 75.16 72.26 -52.56 73.67 73.54 -55.01 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 39 3 # 39 A 50 ASP F 148 ASP^? 2.72 MG MG F 301s A 327 GLU E 174 GLU^? 19.83 MG MG E 301 A 339 ARG E 173 ARG^? 18.66 MG MG E 301 coo 85.81 57.99 116.01 86.03 55.86 115.89 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 75.11 41.01 160.30 76.65 40.06 161.41 70.48 76.62 -49.45 71.76 78.34 -49.45 coo 82.23 40.35 159.87 85.09 40.67 161.01 75.16 72.26 -52.56 73.67 73.54 -55.01 1hto_c00 source 1hto GLUTAMINE SYNTHETASE : 39 hits 1hto_c00 naa= 3 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 1 3 # 1 A 311 GLU A 52 GLU^? 19.89 MG MG A 301 A 475 GLU A 54 GLU^? 22.98 MG MG A 301 A 477 ARG A 8 ARG^? 20.36 MG MG A 301 coo 13.27 46.15 59.96 13.96 44.19 59.76 42.67 25.16 24.80 42.61 25.77 22.75 coo 9.69 44.01 59.12 10.58 42.11 58.89 45.06 19.97 24.02 44.05 19.39 22.19 coo 13.49 45.17 55.56 13.84 42.22 54.75 40.62 19.52 24.63 40.98 22.51 23.88 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 2 3 # 2 A 311 GLU A 54 GLU^? 22.98 MG MG A 301 A 475 GLU A 52 GLU^? 19.89 MG MG A 301 A 477 ARG A 8 ARG^? 20.36 MG MG A 301 coo 13.27 46.15 59.96 13.96 44.19 59.76 45.06 19.97 24.02 44.05 19.39 22.19 coo 9.69 44.01 59.12 10.58 42.11 58.89 42.67 25.16 24.80 42.61 25.77 22.75 coo 13.49 45.17 55.56 13.84 42.22 54.75 40.62 19.52 24.63 40.98 22.51 23.88 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 3 3 # 3 A 311 GLU B 52 GLU^? 20.06 MG MG B 302 A 475 GLU B 54 GLU^? 22.94 MG MG B 302 A 477 ARG B 8 ARG^? 20.39 MG MG B 302 coo 13.27 46.15 59.96 13.96 44.19 59.76 47.87 20.25 12.36 48.11 19.69 14.43 coo 9.69 44.01 59.12 10.58 42.11 58.89 43.18 23.27 12.99 42.40 22.23 14.68 coo 13.49 45.17 55.56 13.84 42.22 54.75 41.99 18.82 11.83 44.91 18.76 12.93 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 4 3 # 4 A 311 GLU B 54 GLU^? 22.94 MG MG B 302 A 475 GLU B 52 GLU^? 20.06 MG MG B 302 A 477 ARG B 8 ARG^? 20.39 MG MG B 302 coo 13.27 46.15 59.96 13.96 44.19 59.76 43.18 23.27 12.99 42.40 22.23 14.68 coo 9.69 44.01 59.12 10.58 42.11 58.89 47.87 20.25 12.36 48.11 19.69 14.43 coo 13.49 45.17 55.56 13.84 42.22 54.75 41.99 18.82 11.83 44.91 18.76 12.93 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 5 3 # 5 A 311 GLU D 54 GLU^? 22.96 MG MG D 302 A 475 GLU D 52 GLU^? 19.94 MG MG D 302 A 477 ARG D 8 ARG^? 20.22 MG MG D 302 coo 13.27 46.15 59.96 13.96 44.19 59.76 87.96 27.60 -30.52 89.07 27.55 -28.72 coo 9.69 44.01 59.12 10.58 42.11 58.89 87.13 33.17 -30.97 88.40 33.70 -29.31 coo 13.49 45.17 55.56 13.84 42.22 54.75 92.22 28.83 -31.23 90.93 31.55 -30.54 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 6 3 # 6 A 311 GLU F 52 GLU^? 20.13 MG MG F 301 A 475 GLU F 54 GLU^? 22.98 MG MG F 301 A 477 ARG F 8 ARG^? 20.20 MG MG F 301 coo 13.27 46.15 59.96 13.96 44.19 59.76 57.09 59.62 -75.76 56.76 59.40 -73.62 coo 9.69 44.01 59.12 10.58 42.11 58.89 62.26 62.27 -75.30 61.72 63.47 -73.60 coo 13.49 45.17 55.56 13.84 42.22 54.75 58.98 65.22 -76.31 57.29 62.84 -75.38 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 7 3 # 7 A 311 GLU F 54 GLU^? 22.98 MG MG F 301 A 475 GLU F 52 GLU^? 20.13 MG MG F 301 A 477 ARG F 8 ARG^? 20.20 MG MG F 301 coo 13.27 46.15 59.96 13.96 44.19 59.76 62.26 62.27 -75.30 61.72 63.47 -73.60 coo 9.69 44.01 59.12 10.58 42.11 58.89 57.09 59.62 -75.76 56.76 59.40 -73.62 coo 13.49 45.17 55.56 13.84 42.22 54.75 58.98 65.22 -76.31 57.29 62.84 -75.38 1i19_c00 source 1i19 CHOLESTEROL OXIDASE : 7 hits 1i19_c00 naa= 3 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 1 3 # 1 B 311 GLU A 52 GLU^? 19.89 MG MG A 301 B 475 GLU A 54 GLU^? 22.98 MG MG A 301 B 477 ARG A 8 ARG^? 20.36 MG MG A 301 coo 42.69 29.93 84.57 42.00 28.96 82.83 42.67 25.16 24.80 42.61 25.77 22.75 coo 46.14 28.45 82.89 45.10 27.86 81.15 45.06 19.97 24.02 44.05 19.39 22.19 coo 42.47 25.53 85.29 42.25 23.66 82.85 40.62 19.52 24.63 40.98 22.51 23.88 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 2 3 # 2 B 311 GLU A 54 GLU^? 22.98 MG MG A 301 B 475 GLU A 52 GLU^? 19.89 MG MG A 301 B 477 ARG A 8 ARG^? 20.36 MG MG A 301 coo 42.69 29.93 84.57 42.00 28.96 82.83 45.06 19.97 24.02 44.05 19.39 22.19 coo 46.14 28.45 82.89 45.10 27.86 81.15 42.67 25.16 24.80 42.61 25.77 22.75 coo 42.47 25.53 85.29 42.25 23.66 82.85 40.62 19.52 24.63 40.98 22.51 23.88 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 3 3 # 3 B 311 GLU B 52 GLU^? 20.06 MG MG B 302 B 475 GLU B 54 GLU^? 22.94 MG MG B 302 B 477 ARG B 8 ARG^? 20.39 MG MG B 302 coo 42.69 29.93 84.57 42.00 28.96 82.83 47.87 20.25 12.36 48.11 19.69 14.43 coo 46.14 28.45 82.89 45.10 27.86 81.15 43.18 23.27 12.99 42.40 22.23 14.68 coo 42.47 25.53 85.29 42.25 23.66 82.85 41.99 18.82 11.83 44.91 18.76 12.93 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 4 3 # 4 B 311 GLU B 54 GLU^? 22.94 MG MG B 302 B 475 GLU B 52 GLU^? 20.06 MG MG B 302 B 477 ARG B 8 ARG^? 20.39 MG MG B 302 coo 42.69 29.93 84.57 42.00 28.96 82.83 43.18 23.27 12.99 42.40 22.23 14.68 coo 46.14 28.45 82.89 45.10 27.86 81.15 47.87 20.25 12.36 48.11 19.69 14.43 coo 42.47 25.53 85.29 42.25 23.66 82.85 41.99 18.82 11.83 44.91 18.76 12.93 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 5 3 # 5 B 311 GLU D 54 GLU^? 22.96 MG MG D 302 B 475 GLU D 52 GLU^? 19.94 MG MG D 302 B 477 ARG D 8 ARG^? 20.22 MG MG D 302 coo 42.69 29.93 84.57 42.00 28.96 82.83 87.96 27.60 -30.52 89.07 27.55 -28.72 coo 46.14 28.45 82.89 45.10 27.86 81.15 87.13 33.17 -30.97 88.40 33.70 -29.31 coo 42.47 25.53 85.29 42.25 23.66 82.85 92.22 28.83 -31.23 90.93 31.55 -30.54 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 6 3 # 6 B 311 GLU F 52 GLU^? 20.13 MG MG F 301 B 475 GLU F 54 GLU^? 22.98 MG MG F 301 B 477 ARG F 8 ARG^? 20.20 MG MG F 301 coo 42.69 29.93 84.57 42.00 28.96 82.83 57.09 59.62 -75.76 56.76 59.40 -73.62 coo 46.14 28.45 82.89 45.10 27.86 81.15 62.26 62.27 -75.30 61.72 63.47 -73.60 coo 42.47 25.53 85.29 42.25 23.66 82.85 58.98 65.22 -76.31 57.29 62.84 -75.38 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 7 3 # 7 B 311 GLU F 54 GLU^? 22.98 MG MG F 301 B 475 GLU F 52 GLU^? 20.13 MG MG F 301 B 477 ARG F 8 ARG^? 20.20 MG MG F 301 coo 42.69 29.93 84.57 42.00 28.96 82.83 62.26 62.27 -75.30 61.72 63.47 -73.60 coo 46.14 28.45 82.89 45.10 27.86 81.15 57.09 59.62 -75.76 56.76 59.40 -73.62 coo 42.47 25.53 85.29 42.25 23.66 82.85 58.98 65.22 -76.31 57.29 62.84 -75.38 1i19_c01 source 1i19 CHOLESTEROL OXIDASE : 7 hits 1i19_c01 naa= 3 ULMN 3 1i29_c01 CSDB user 1 3 # 1 A 123 HIS A 147 HIS^? 9.20 MG MG A 302 A 200 ASP A 128 ASP^? -3.32 MG MG A 301s A 226 LYS A 111 LYS^? 15.16 MG MG A 301 coo 23.24 46.58 4.39 24.43 46.59 2.66 40.24 23.10 39.83 38.32 22.34 40.22 coo 24.51 43.28 11.18 25.17 44.50 9.58 46.50 28.23 39.77 47.49 30.10 39.82 coo 34.47 51.09 7.19 28.58 51.18 7.53 52.67 17.19 35.90 54.65 19.90 40.50 ULMN 3 1i29_c01 CSDB user 2 3 # 2 A 123 HIS A 170 HIS^? 10.56 MG MG A 302 A 200 ASP A 171 ASP^? 17.17 MG MG A 302 A 226 LYS A 166 LYS^? 20.93 MG MG A 302 coo 23.24 46.58 4.39 24.43 46.59 2.66 34.91 23.57 39.32 34.35 24.95 40.81 coo 24.51 43.28 11.18 25.17 44.50 9.58 29.78 23.67 36.63 28.48 25.11 35.71 coo 34.47 51.09 7.19 28.58 51.18 7.53 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1i29_c01 CSDB user 3 3 # 3 A 123 HIS D 170 HIS^? 10.59 MG MG D 301 A 200 ASP D 171 ASP^? 16.95 MG MG D 301 A 226 LYS D 166 LYS^? 21.08 MG MG D 301 coo 23.24 46.58 4.39 24.43 46.59 2.66 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 24.51 43.28 11.18 25.17 44.50 9.58 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 34.47 51.09 7.19 28.58 51.18 7.53 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1i29_c01 CSDB user 4 3 # 4 A 123 HIS E 170 HIS^? 10.33 MG MG E 301 A 200 ASP E 171 ASP^? 16.73 MG MG E 301 A 226 LYS E 166 LYS^? 21.46 MG MG E 301 coo 23.24 46.58 4.39 24.43 46.59 2.66 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 24.51 43.28 11.18 25.17 44.50 9.58 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 34.47 51.09 7.19 28.58 51.18 7.53 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1i29_c01 CSDB user 5 3 # 5 A 123 HIS F 147 HIS^? 8.79 MG MG F 302 A 200 ASP F 128 ASP^? -3.41 MG MG F 301s A 226 LYS F 111 LYS^? 15.21 MG MG F 301 coo 23.24 46.58 4.39 24.43 46.59 2.66 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 24.51 43.28 11.18 25.17 44.50 9.58 57.76 53.73 -90.50 57.46 51.64 -90.28 coo 34.47 51.09 7.19 28.58 51.18 7.53 69.70 58.57 -86.86 69.67 53.74 -90.29 ULMN 3 1i29_c01 CSDB user 6 3 # 6 A 123 HIS F 170 HIS^? 9.84 MG MG F 302 A 200 ASP F 171 ASP^? 16.35 MG MG F 302 A 226 LYS F 166 LYS^? 20.76 MG MG F 302 coo 23.24 46.58 4.39 24.43 46.59 2.66 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 24.51 43.28 11.18 25.17 44.50 9.58 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 34.47 51.09 7.19 28.58 51.18 7.53 59.28 73.05 -82.63 55.63 74.15 -86.94 1i29_c01 source 1i29 CSDB : 6 hits 1i29_c01 naa= 3 ULMN 3 1i29_c03 CSDB user 1 3 # 1 A 128 VAL A 44 VAL^? 23.47 MG MG A 301 A 200 ASP B 58 ASP^? 26.73 MG MG A 301 A 226 LYS B 136 LYS^? 33.75 MG MG B 302 coo 19.13 38.05 1.41 19.72 38.80 -0.53 40.71 23.59 20.27 42.01 21.87 20.17 coo 24.51 43.28 11.18 25.17 44.50 9.58 34.42 33.56 15.74 33.50 33.49 17.59 coo 34.47 51.09 7.19 28.58 51.18 7.53 28.47 31.35 4.78 24.04 31.81 1.99 ULMN 3 1i29_c03 CSDB user 2 3 # 2 A 128 VAL A 44 VAL^? 23.47 MG MG A 301 A 200 ASP B 160 ASP^? 31.65 MG MG A 301 A 226 LYS B 136 LYS^? 33.75 MG MG B 302 coo 19.13 38.05 1.41 19.72 38.80 -0.53 40.71 23.59 20.27 42.01 21.87 20.17 coo 24.51 43.28 11.18 25.17 44.50 9.58 28.01 24.83 16.38 27.44 26.81 15.80 coo 34.47 51.09 7.19 28.58 51.18 7.53 28.47 31.35 4.78 24.04 31.81 1.99 ULMN 3 1i29_c03 CSDB user 3 3 # 3 A 128 VAL A 44 VAL^? 23.47 MG MG A 301 A 200 ASP B 160 ASP^? 31.65 MG MG A 301 A 226 LYS B 137 LYS^? 34.56 MG MG B 302 coo 19.13 38.05 1.41 19.72 38.80 -0.53 40.71 23.59 20.27 42.01 21.87 20.17 coo 24.51 43.28 11.18 25.17 44.50 9.58 28.01 24.83 16.38 27.44 26.81 15.80 coo 34.47 51.09 7.19 28.58 51.18 7.53 26.56 32.46 7.93 27.87 37.71 9.31 ULMN 3 1i29_c03 CSDB user 4 3 # 4 A 128 VAL A 102 VAL^? 26.67 MG MG A 301 A 200 ASP A 58 ASP^? 26.75 MG MG B 302 A 226 LYS A 157 LYS^? 28.65 MG MG A 302 coo 19.13 38.05 1.41 19.72 38.80 -0.53 59.49 10.42 34.08 60.28 10.39 36.14 coo 24.51 43.28 11.18 25.17 44.50 9.58 53.93 9.80 21.09 53.83 8.90 19.15 coo 34.47 51.09 7.19 28.58 51.18 7.53 41.42 12.06 27.58 41.46 5.93 29.41 ULMN 3 1i29_c03 CSDB user 5 3 # 5 A 128 VAL A 102 VAL^? 26.67 MG MG A 301 A 200 ASP A 142 ASP^? 23.70 MG MG A 302 A 226 LYS A 157 LYS^? 28.65 MG MG A 302 coo 19.13 38.05 1.41 19.72 38.80 -0.53 59.49 10.42 34.08 60.28 10.39 36.14 coo 24.51 43.28 11.18 25.17 44.50 9.58 46.39 7.18 37.53 46.28 7.18 39.63 coo 34.47 51.09 7.19 28.58 51.18 7.53 41.42 12.06 27.58 41.46 5.93 29.41 ULMN 3 1i29_c03 CSDB user 6 3 # 6 A 128 VAL A 108 VAL^? 27.28 MG MG A 301 A 200 ASP A 142 ASP^? 23.70 MG MG A 302 A 226 LYS A 166 LYS^? 20.93 MG MG A 302 coo 19.13 38.05 1.41 19.72 38.80 -0.53 55.06 7.72 31.92 55.04 9.26 30.34 coo 24.51 43.28 11.18 25.17 44.50 9.58 46.39 7.18 37.53 46.28 7.18 39.63 coo 34.47 51.09 7.19 28.58 51.18 7.53 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1i29_c03 CSDB user 7 3 # 7 A 128 VAL B 29 VAL^? 22.54 MG MG C 301 A 200 ASP C 23 ASP^? 15.39 MG MG B 301 A 226 LYS C 76 LYS^? 24.95 MG MG C 302 coo 19.13 38.05 1.41 19.72 38.80 -0.53 70.87 4.49 3.48 69.69 2.66 3.36 coo 24.51 43.28 11.18 25.17 44.50 9.58 65.24 6.82 -5.11 63.43 7.54 -4.15 coo 34.47 51.09 7.19 28.58 51.18 7.53 71.11 8.63 -16.76 75.44 5.17 -16.80 ULMN 3 1i29_c03 CSDB user 8 3 # 8 A 128 VAL B 44 VAL^? 23.27 MG MG B 302 A 200 ASP A 58 ASP^? 26.75 MG MG B 302 A 226 LYS A 136 LYS^? 30.58 MG MG A 302 coo 19.13 38.05 1.41 19.72 38.80 -0.53 45.60 17.91 16.34 44.07 19.42 16.19 coo 24.51 43.28 11.18 25.17 44.50 9.58 53.93 9.80 21.09 53.83 8.90 19.15 coo 34.47 51.09 7.19 28.58 51.18 7.53 50.14 3.36 31.42 51.28 2.21 35.89 ULMN 3 1i29_c03 CSDB user 9 3 # 9 A 128 VAL B 44 VAL^? 23.27 MG MG B 302 A 200 ASP A 160 ASP^? 31.61 MG MG B 302 A 226 LYS A 136 LYS^? 30.58 MG MG A 302 coo 19.13 38.05 1.41 19.72 38.80 -0.53 45.60 17.91 16.34 44.07 19.42 16.19 coo 24.51 43.28 11.18 25.17 44.50 9.58 44.21 5.00 19.54 46.02 3.84 19.76 coo 34.47 51.09 7.19 28.58 51.18 7.53 50.14 3.36 31.42 51.28 2.21 35.89 ULMN 3 1i29_c03 CSDB user 10 3 # 10 A 128 VAL B 44 VAL^? 23.27 MG MG B 302 A 200 ASP A 160 ASP^? 31.61 MG MG B 302 A 226 LYS A 137 LYS^? 34.85 MG MG A 301 coo 19.13 38.05 1.41 19.72 38.80 -0.53 45.60 17.91 16.34 44.07 19.42 16.19 coo 24.51 43.28 11.18 25.17 44.50 9.58 44.21 5.00 19.54 46.02 3.84 19.76 coo 34.47 51.09 7.19 28.58 51.18 7.53 50.97 1.58 28.14 56.13 1.49 28.03 ULMN 3 1i29_c03 CSDB user 11 3 # 11 A 128 VAL B 102 VAL^? 26.46 MG MG B 302 A 200 ASP B 58 ASP^? 26.73 MG MG A 301 A 226 LYS B 157 LYS^? 28.85 MG MG B 302 coo 19.13 38.05 1.41 19.72 38.80 -0.53 37.09 39.54 3.35 37.30 40.50 1.39 coo 24.51 43.28 11.18 25.17 44.50 9.58 34.42 33.56 15.74 33.50 33.49 17.59 coo 34.47 51.09 7.19 28.58 51.18 7.53 34.97 21.28 8.44 29.03 22.82 6.58 ULMN 3 1i29_c03 CSDB user 12 3 # 12 A 128 VAL B 102 VAL^? 26.46 MG MG B 302 A 200 ASP B 142 ASP^? 23.97 MG MG B 301 A 226 LYS B 157 LYS^? 28.85 MG MG B 302 coo 19.13 38.05 1.41 19.72 38.80 -0.53 37.09 39.54 3.35 37.30 40.50 1.39 coo 24.51 43.28 11.18 25.17 44.50 9.58 31.69 27.40 -1.31 32.10 27.37 -3.38 coo 34.47 51.09 7.19 28.58 51.18 7.53 34.97 21.28 8.44 29.03 22.82 6.58 ULMN 3 1i29_c03 CSDB user 13 3 # 13 A 128 VAL B 108 VAL^? 27.21 MG MG B 302 A 200 ASP B 142 ASP^? 23.97 MG MG B 301 A 226 LYS B 166 LYS^? 22.75 MG MG B 301 coo 19.13 38.05 1.41 19.72 38.80 -0.53 33.40 35.67 4.87 34.73 35.30 6.57 coo 24.51 43.28 11.18 25.17 44.50 9.58 31.69 27.40 -1.31 32.10 27.37 -3.38 coo 34.47 51.09 7.19 28.58 51.18 7.53 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1i29_c03 CSDB user 14 3 # 14 A 128 VAL C 29 VAL^? 22.84 MG MG B 301 A 200 ASP B 23 ASP^? 15.67 MG MG C 301 A 226 LYS B 76 LYS^? 25.77 MG MG B 302 coo 19.13 38.05 1.41 19.72 38.80 -0.53 69.29 3.97 -10.09 70.60 2.20 -9.84 coo 24.51 43.28 11.18 25.17 44.50 9.58 74.31 7.55 -1.09 75.08 9.17 -2.23 coo 34.47 51.09 7.19 28.58 51.18 7.53 67.82 8.19 10.14 64.96 3.09 10.62 ULMN 3 1i29_c03 CSDB user 15 3 # 15 A 128 VAL C 44 VAL^? 22.99 MG MG C 302 A 200 ASP D 58 ASP^? 26.59 MG MG C 302 A 226 LYS D 136 LYS^? 34.99 MG MG D 302 coo 19.13 38.05 1.41 19.72 38.80 -0.53 88.23 25.46 -22.96 89.26 27.37 -22.88 coo 24.51 43.28 11.18 25.17 44.50 9.58 83.38 14.85 -27.71 84.09 14.12 -25.85 coo 34.47 51.09 7.19 28.58 51.18 7.53 88.96 10.62 -38.53 90.77 6.00 -38.00 ULMN 3 1i29_c03 CSDB user 16 3 # 16 A 128 VAL C 44 VAL^? 22.99 MG MG C 302 A 200 ASP D 160 ASP^? 31.45 MG MG C 302 A 226 LYS D 136 LYS^? 34.99 MG MG D 302 coo 19.13 38.05 1.41 19.72 38.80 -0.53 88.23 25.46 -22.96 89.26 27.37 -22.88 coo 24.51 43.28 11.18 25.17 44.50 9.58 94.15 13.98 -26.57 92.71 12.42 -26.99 coo 34.47 51.09 7.19 28.58 51.18 7.53 88.96 10.62 -38.53 90.77 6.00 -38.00 ULMN 3 1i29_c03 CSDB user 17 3 # 17 A 128 VAL C 44 VAL^? 22.99 MG MG C 302 A 200 ASP D 160 ASP^? 31.45 MG MG C 302 A 226 LYS D 137 LYS^? 37.57 MG MG D 302 coo 19.13 38.05 1.41 19.72 38.80 -0.53 88.23 25.46 -22.96 89.26 27.37 -22.88 coo 24.51 43.28 11.18 25.17 44.50 9.58 94.15 13.98 -26.57 92.71 12.42 -26.99 coo 34.47 51.09 7.19 28.58 51.18 7.53 88.48 8.58 -35.33 84.88 3.98 -33.96 ULMN 3 1i29_c03 CSDB user 18 3 # 18 A 128 VAL C 102 VAL^? 26.67 MG MG C 302 A 200 ASP C 58 ASP^? 26.67 MG MG D 302 A 226 LYS C 157 LYS^? 28.15 MG MG C 302 coo 19.13 38.05 1.41 19.72 38.80 -0.53 88.82 48.77 -9.96 88.46 49.65 -8.01 coo 24.51 43.28 11.18 25.17 44.50 9.58 93.40 43.81 -22.27 94.18 44.45 -24.11 coo 34.47 51.09 7.19 28.58 51.18 7.53 97.55 32.04 -15.10 101.49 36.24 -13.39 ULMN 3 1i29_c03 CSDB user 19 3 # 19 A 128 VAL C 102 VAL^? 26.67 MG MG C 302 A 200 ASP C 142 ASP^? 23.76 MG MG C 301 A 226 LYS C 157 LYS^? 28.15 MG MG C 302 coo 19.13 38.05 1.41 19.72 38.80 -0.53 88.82 48.77 -9.96 88.46 49.65 -8.01 coo 24.51 43.28 11.18 25.17 44.50 9.58 97.94 39.27 -5.03 98.08 38.70 -2.97 coo 34.47 51.09 7.19 28.58 51.18 7.53 97.55 32.04 -15.10 101.49 36.24 -13.39 ULMN 3 1i29_c03 CSDB user 20 3 # 20 A 128 VAL C 108 VAL^? 26.95 MG MG C 302 A 200 ASP C 142 ASP^? 23.76 MG MG C 301 A 226 LYS C 166 LYS^? 22.53 MG MG C 301 coo 19.13 38.05 1.41 19.72 38.80 -0.53 93.61 46.17 -11.54 92.36 45.26 -13.13 coo 24.51 43.28 11.18 25.17 44.50 9.58 97.94 39.27 -5.03 98.08 38.70 -2.97 coo 34.47 51.09 7.19 28.58 51.18 7.53 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1i29_c03 CSDB user 21 3 # 21 A 128 VAL C 130 VAL^? 10.78 MG MG C 302 A 200 ASP C 142 ASP^? 23.76 MG MG C 301 A 226 LYS C 137 LYS^? 35.41 MG MG C 302 coo 19.13 38.05 1.41 19.72 38.80 -0.53 85.07 33.19 -5.25 83.98 34.44 -3.79 coo 24.51 43.28 11.18 25.17 44.50 9.58 97.94 39.27 -5.03 98.08 38.70 -2.97 coo 34.47 51.09 7.19 28.58 51.18 7.53 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 1i29_c03 CSDB user 22 3 # 22 A 128 VAL D 29 VAL^? 22.08 MG MG E 301 A 200 ASP E 23 ASP^? 15.43 MG MG D 301 A 226 LYS E 76 LYS^? 25.68 MG MG E 302 coo 19.13 38.05 1.41 19.72 38.80 -0.53 90.14 60.83 -40.60 92.30 60.78 -40.81 coo 24.51 43.28 11.18 25.17 44.50 9.58 91.98 54.64 -49.37 91.93 52.78 -48.33 coo 34.47 51.09 7.19 28.58 51.18 7.53 87.09 58.11 -60.91 88.65 63.65 -61.27 ULMN 3 1i29_c03 CSDB user 23 3 # 23 A 128 VAL D 44 VAL^? 23.17 MG MG D 302 A 200 ASP C 58 ASP^? 26.67 MG MG D 302 A 226 LYS C 136 LYS^? 30.63 MG MG C 302 coo 19.13 38.05 1.41 19.72 38.80 -0.53 90.88 32.60 -27.10 90.06 30.62 -26.95 coo 24.51 43.28 11.18 25.17 44.50 9.58 93.40 43.81 -22.27 94.18 44.45 -24.11 coo 34.47 51.09 7.19 28.58 51.18 7.53 99.75 44.04 -11.38 100.98 45.13 -6.77 ULMN 3 1i29_c03 CSDB user 24 3 # 24 A 128 VAL D 44 VAL^? 23.17 MG MG D 302 A 200 ASP C 160 ASP^? 31.63 MG MG D 302 A 226 LYS C 136 LYS^? 30.63 MG MG C 302 coo 19.13 38.05 1.41 19.72 38.80 -0.53 90.88 32.60 -27.10 90.06 30.62 -26.95 coo 24.51 43.28 11.18 25.17 44.50 9.58 102.50 38.00 -23.28 102.43 39.97 -22.46 coo 34.47 51.09 7.19 28.58 51.18 7.53 99.75 44.04 -11.38 100.98 45.13 -6.77 ULMN 3 1i29_c03 CSDB user 25 3 # 25 A 128 VAL D 44 VAL^? 23.17 MG MG D 302 A 200 ASP C 160 ASP^? 31.63 MG MG D 302 A 226 LYS C 137 LYS^? 35.41 MG MG C 302 coo 19.13 38.05 1.41 19.72 38.80 -0.53 90.88 32.60 -27.10 90.06 30.62 -26.95 coo 24.51 43.28 11.18 25.17 44.50 9.58 102.50 38.00 -23.28 102.43 39.97 -22.46 coo 34.47 51.09 7.19 28.58 51.18 7.53 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 1i29_c03 CSDB user 26 3 # 26 A 128 VAL D 102 VAL^? 26.84 MG MG D 302 A 200 ASP D 58 ASP^? 26.59 MG MG C 302 A 226 LYS D 157 LYS^? 28.67 MG MG D 302 coo 19.13 38.05 1.41 19.72 38.80 -0.53 77.64 13.77 -40.57 77.24 13.30 -42.66 coo 24.51 43.28 11.18 25.17 44.50 9.58 83.38 14.85 -27.71 84.09 14.12 -25.85 coo 34.47 51.09 7.19 28.58 51.18 7.53 94.17 21.71 -34.34 96.11 15.89 -35.92 ULMN 3 1i29_c03 CSDB user 27 3 # 27 A 128 VAL D 102 VAL^? 26.84 MG MG D 302 A 200 ASP D 142 ASP^? 23.49 MG MG D 301 A 226 LYS D 157 LYS^? 28.67 MG MG D 302 coo 19.13 38.05 1.41 19.72 38.80 -0.53 77.64 13.77 -40.57 77.24 13.30 -42.66 coo 24.51 43.28 11.18 25.17 44.50 9.58 90.90 15.58 -44.76 91.35 16.09 -46.79 coo 34.47 51.09 7.19 28.58 51.18 7.53 94.17 21.71 -34.34 96.11 15.89 -35.92 ULMN 3 1i29_c03 CSDB user 28 3 # 28 A 128 VAL D 108 VAL^? 27.35 MG MG D 302 A 200 ASP D 142 ASP^? 23.49 MG MG D 301 A 226 LYS D 166 LYS^? 21.08 MG MG D 301 coo 19.13 38.05 1.41 19.72 38.80 -0.53 82.79 12.78 -38.53 82.49 14.23 -36.90 coo 24.51 43.28 11.18 25.17 44.50 9.58 90.90 15.58 -44.76 91.35 16.09 -46.79 coo 34.47 51.09 7.19 28.58 51.18 7.53 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1i29_c03 CSDB user 29 3 # 29 A 128 VAL E 29 VAL^? 22.78 MG MG D 301 A 200 ASP D 23 ASP^? 15.37 MG MG E 301 A 226 LYS D 76 LYS^? 25.08 MG MG D 302 coo 19.13 38.05 1.41 19.72 38.80 -0.53 91.84 59.45 -54.17 92.53 61.54 -54.13 coo 24.51 43.28 11.18 25.17 44.50 9.58 85.70 62.10 -45.60 84.07 62.13 -46.93 coo 34.47 51.09 7.19 28.58 51.18 7.53 88.18 56.35 -34.05 93.80 56.17 -32.93 ULMN 3 1i29_c03 CSDB user 30 3 # 30 A 128 VAL E 44 VAL^? 23.25 MG MG E 302 A 200 ASP F 58 ASP^? 26.87 MG MG E 302 A 226 LYS F 136 LYS^? 30.53 MG MG F 301 coo 19.13 38.05 1.41 19.72 38.80 -0.53 63.87 63.92 -67.77 61.69 63.98 -67.81 coo 24.51 43.28 11.18 25.17 44.50 9.58 75.55 64.68 -72.56 76.21 65.63 -70.79 coo 34.47 51.09 7.19 28.58 51.18 7.53 76.49 71.19 -83.39 78.38 70.88 -88.47 ULMN 3 1i29_c03 CSDB user 31 3 # 31 A 128 VAL E 44 VAL^? 23.25 MG MG E 302 A 200 ASP F 160 ASP^? 31.59 MG MG E 302 A 226 LYS F 136 LYS^? 30.53 MG MG F 301 coo 19.13 38.05 1.41 19.72 38.80 -0.53 63.87 63.92 -67.77 61.69 63.98 -67.81 coo 24.51 43.28 11.18 25.17 44.50 9.58 71.27 74.59 -71.77 73.23 74.02 -72.37 coo 34.47 51.09 7.19 28.58 51.18 7.53 76.49 71.19 -83.39 78.38 70.88 -88.47 ULMN 3 1i29_c03 CSDB user 32 3 # 32 A 128 VAL E 44 VAL^? 23.25 MG MG E 302 A 200 ASP F 160 ASP^? 31.59 MG MG E 302 A 226 LYS F 137 LYS^? 35.13 MG MG F 301 coo 19.13 38.05 1.41 19.72 38.80 -0.53 63.87 63.92 -67.77 61.69 63.98 -67.81 coo 24.51 43.28 11.18 25.17 44.50 9.58 71.27 74.59 -71.77 73.23 74.02 -72.37 coo 34.47 51.09 7.19 28.58 51.18 7.53 78.53 72.20 -80.30 83.01 68.64 -79.79 ULMN 3 1i29_c03 CSDB user 33 3 # 33 A 128 VAL E 102 VAL^? 26.66 MG MG E 302 A 200 ASP E 58 ASP^? 26.76 MG MG F 301 A 226 LYS E 157 LYS^? 28.40 MG MG E 302 coo 19.13 38.05 1.41 19.72 38.80 -0.53 43.20 54.24 -53.87 42.71 53.94 -51.78 coo 24.51 43.28 11.18 25.17 44.50 9.58 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 34.47 51.09 7.19 28.58 51.18 7.53 53.63 69.16 -60.42 48.34 71.81 -58.40 ULMN 3 1i29_c03 CSDB user 34 3 # 34 A 128 VAL E 102 VAL^? 26.66 MG MG E 302 A 200 ASP E 142 ASP^? 23.66 MG MG E 301 A 226 LYS E 157 LYS^? 28.40 MG MG E 302 coo 19.13 38.05 1.41 19.72 38.80 -0.53 43.20 54.24 -53.87 42.71 53.94 -51.78 coo 24.51 43.28 11.18 25.17 44.50 9.58 47.19 67.15 -50.37 47.44 67.18 -48.23 coo 34.47 51.09 7.19 28.58 51.18 7.53 53.63 69.16 -60.42 48.34 71.81 -58.40 ULMN 3 1i29_c03 CSDB user 35 3 # 35 A 128 VAL E 108 VAL^? 27.13 MG MG E 302 A 200 ASP E 142 ASP^? 23.66 MG MG E 301 A 226 LYS E 166 LYS^? 21.46 MG MG E 301 coo 19.13 38.05 1.41 19.72 38.80 -0.53 43.16 59.43 -56.03 44.49 58.60 -57.60 coo 24.51 43.28 11.18 25.17 44.50 9.58 47.19 67.15 -50.37 47.44 67.18 -48.23 coo 34.47 51.09 7.19 28.58 51.18 7.53 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1i29_c03 CSDB user 36 3 # 36 A 128 VAL F 44 VAL^? 23.29 MG MG F 301 A 200 ASP E 58 ASP^? 26.76 MG MG F 301 A 226 LYS E 136 LYS^? 31.27 MG MG E 302 coo 19.13 38.05 1.41 19.72 38.80 -0.53 56.46 62.56 -71.76 58.56 63.03 -71.80 coo 24.51 43.28 11.18 25.17 44.50 9.58 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 34.47 51.09 7.19 28.58 51.18 7.53 42.12 65.93 -56.52 39.36 65.07 -51.83 ULMN 3 1i29_c03 CSDB user 37 3 # 37 A 128 VAL F 44 VAL^? 23.29 MG MG F 301 A 200 ASP E 160 ASP^? 31.54 MG MG F 301 A 226 LYS E 136 LYS^? 31.27 MG MG E 302 coo 19.13 38.05 1.41 19.72 38.80 -0.53 56.46 62.56 -71.76 58.56 63.03 -71.80 coo 24.51 43.28 11.18 25.17 44.50 9.58 45.81 70.00 -68.45 44.10 68.87 -67.77 coo 34.47 51.09 7.19 28.58 51.18 7.53 42.12 65.93 -56.52 39.36 65.07 -51.83 ULMN 3 1i29_c03 CSDB user 38 3 # 38 A 128 VAL F 102 VAL^? 26.64 MG MG F 301 A 200 ASP F 58 ASP^? 26.87 MG MG E 302 A 226 LYS F 157 LYS^? 28.36 MG MG F 302 coo 19.13 38.05 1.41 19.72 38.80 -0.53 79.26 59.39 -85.07 79.88 59.18 -87.15 coo 24.51 43.28 11.18 25.17 44.50 9.58 75.55 64.68 -72.56 76.21 65.63 -70.79 coo 34.47 51.09 7.19 28.58 51.18 7.53 64.43 70.47 -79.54 68.32 74.80 -81.65 ULMN 3 1i29_c03 CSDB user 39 3 # 39 A 128 VAL F 102 VAL^? 26.64 MG MG F 301 A 200 ASP F 142 ASP^? 23.43 MG MG F 302 A 226 LYS F 157 LYS^? 28.36 MG MG F 302 coo 19.13 38.05 1.41 19.72 38.80 -0.53 79.26 59.39 -85.07 79.88 59.18 -87.15 coo 24.51 43.28 11.18 25.17 44.50 9.58 71.46 69.88 -89.76 71.03 69.93 -91.81 coo 34.47 51.09 7.19 28.58 51.18 7.53 64.43 70.47 -79.54 68.32 74.80 -81.65 ULMN 3 1i29_c03 CSDB user 40 3 # 40 A 128 VAL F 108 VAL^? 27.30 MG MG F 301 A 200 ASP F 142 ASP^? 23.43 MG MG F 302 A 226 LYS F 166 LYS^? 20.76 MG MG F 302 coo 19.13 38.05 1.41 19.72 38.80 -0.53 77.71 64.56 -83.43 76.61 63.66 -81.75 coo 24.51 43.28 11.18 25.17 44.50 9.58 71.46 69.88 -89.76 71.03 69.93 -91.81 coo 34.47 51.09 7.19 28.58 51.18 7.53 59.28 73.05 -82.63 55.63 74.15 -86.94 1i29_c03 source 1i29 CSDB : 40 hits 1i29_c03 naa= 3 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 3 # 1 A 14 LYS A 157 LYS^? 28.65 MG MG A 302 A 74 LYS A 6 LYS^? 25.88 MG MG A 301 A 165 GLU A 52 GLU^? 19.89 MG MG A 301 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 41.42 12.06 27.58 41.46 5.93 29.41 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 46.20 12.82 24.71 44.50 16.64 20.52 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 42.67 25.16 24.80 42.61 25.77 22.75 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 2 3 # 2 A 14 LYS A 157 LYS^? 28.65 MG MG A 302 A 74 LYS A 166 LYS^? 20.93 MG MG A 302 A 165 GLU A 52 GLU^? 19.89 MG MG A 301 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 41.42 12.06 27.58 41.46 5.93 29.41 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 35.34 13.14 30.41 31.67 15.04 34.58 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 42.67 25.16 24.80 42.61 25.77 22.75 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 3 3 # 3 A 14 LYS A 166 LYS^? 20.93 MG MG A 302 A 74 LYS A 157 LYS^? 28.65 MG MG A 302 A 165 GLU A 52 GLU^? 19.89 MG MG A 301 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 35.34 13.14 30.41 31.67 15.04 34.58 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 41.42 12.06 27.58 41.46 5.93 29.41 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 42.67 25.16 24.80 42.61 25.77 22.75 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 4 3 # 4 A 14 LYS B 157 LYS^? 28.85 MG MG B 302 A 74 LYS B 6 LYS^? 25.90 MG MG B 302 A 165 GLU B 52 GLU^? 20.06 MG MG B 302 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 34.97 21.28 8.44 29.03 22.82 6.58 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 36.26 25.44 11.74 39.65 23.12 16.29 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 47.87 20.25 12.36 48.11 19.69 14.43 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 5 3 # 5 A 14 LYS B 157 LYS^? 28.85 MG MG B 302 A 74 LYS B 166 LYS^? 22.75 MG MG B 301 A 165 GLU B 52 GLU^? 20.06 MG MG B 302 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 34.97 21.28 8.44 29.03 22.82 6.58 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 35.27 15.38 5.31 37.27 9.81 3.93 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 47.87 20.25 12.36 48.11 19.69 14.43 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 6 3 # 6 A 14 LYS B 166 LYS^? 22.75 MG MG B 301 A 74 LYS B 157 LYS^? 28.85 MG MG B 302 A 165 GLU B 52 GLU^? 20.06 MG MG B 302 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 35.27 15.38 5.31 37.27 9.81 3.93 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 34.97 21.28 8.44 29.03 22.82 6.58 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 47.87 20.25 12.36 48.11 19.69 14.43 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 7 3 # 7 A 14 LYS C 6 LYS^? 25.73 MG MG C 302 A 74 LYS C 157 LYS^? 28.15 MG MG C 302 A 165 GLU C 52 GLU^? 19.67 MG MG C 302 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 84.27 26.98 -19.19 85.21 26.16 -20.96 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 8 3 # 8 A 14 LYS C 157 LYS^? 28.15 MG MG C 302 A 74 LYS C 6 LYS^? 25.73 MG MG C 302 A 165 GLU C 52 GLU^? 19.67 MG MG C 302 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 84.27 26.98 -19.19 85.21 26.16 -20.96 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 9 3 # 9 A 14 LYS C 157 LYS^? 28.15 MG MG C 302 A 74 LYS C 166 LYS^? 22.53 MG MG C 301 A 165 GLU C 52 GLU^? 19.67 MG MG C 302 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 84.27 26.98 -19.19 85.21 26.16 -20.96 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 10 3 # 10 A 14 LYS C 166 LYS^? 22.53 MG MG C 301 A 74 LYS C 157 LYS^? 28.15 MG MG C 302 A 165 GLU C 52 GLU^? 19.67 MG MG C 302 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 84.27 26.98 -19.19 85.21 26.16 -20.96 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 11 3 # 11 A 14 LYS D 157 LYS^? 28.67 MG MG D 302 A 74 LYS D 6 LYS^? 25.98 MG MG D 302 A 165 GLU D 52 GLU^? 19.94 MG MG D 302 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 87.13 33.17 -30.97 88.40 33.70 -29.31 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 12 3 # 12 A 14 LYS D 157 LYS^? 28.67 MG MG D 302 A 74 LYS D 166 LYS^? 21.08 MG MG D 301 A 165 GLU D 52 GLU^? 19.94 MG MG D 302 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 87.13 33.17 -30.97 88.40 33.70 -29.31 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 13 3 # 13 A 14 LYS D 166 LYS^? 21.08 MG MG D 301 A 74 LYS D 157 LYS^? 28.67 MG MG D 302 A 165 GLU D 52 GLU^? 19.94 MG MG D 302 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 87.13 33.17 -30.97 88.40 33.70 -29.31 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 14 3 # 14 A 14 LYS E 6 LYS^? 25.59 MG MG E 302 A 74 LYS E 157 LYS^? 28.40 MG MG E 302 A 165 GLU E 52 GLU^? 19.96 MG MG E 302 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 64.71 60.06 -63.78 64.69 61.36 -65.58 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 15 3 # 15 A 14 LYS E 157 LYS^? 28.40 MG MG E 302 A 74 LYS E 6 LYS^? 25.59 MG MG E 302 A 165 GLU E 52 GLU^? 19.96 MG MG E 302 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 64.71 60.06 -63.78 64.69 61.36 -65.58 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 16 3 # 16 A 14 LYS E 157 LYS^? 28.40 MG MG E 302 A 74 LYS E 166 LYS^? 21.46 MG MG E 301 A 165 GLU E 52 GLU^? 19.96 MG MG E 302 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 64.71 60.06 -63.78 64.69 61.36 -65.58 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 17 3 # 17 A 14 LYS E 166 LYS^? 21.46 MG MG E 301 A 74 LYS E 157 LYS^? 28.40 MG MG E 302 A 165 GLU E 52 GLU^? 19.96 MG MG E 302 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 64.71 60.06 -63.78 64.69 61.36 -65.58 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 18 3 # 18 A 14 LYS F 157 LYS^? 28.36 MG MG F 302 A 74 LYS F 6 LYS^? 26.09 MG MG F 301 A 165 GLU F 52 GLU^? 20.13 MG MG F 301 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 57.09 59.62 -75.76 56.76 59.40 -73.62 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 19 3 # 19 A 14 LYS F 157 LYS^? 28.36 MG MG F 302 A 74 LYS F 166 LYS^? 20.76 MG MG F 302 A 165 GLU F 52 GLU^? 20.13 MG MG F 301 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 57.09 59.62 -75.76 56.76 59.40 -73.62 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 20 3 # 20 A 14 LYS F 166 LYS^? 20.76 MG MG F 302 A 74 LYS F 157 LYS^? 28.36 MG MG F 302 A 165 GLU F 52 GLU^? 20.13 MG MG F 301 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 57.09 59.62 -75.76 56.76 59.40 -73.62 1idt_c00 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 20 hits 1idt_c00 naa= 3 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 3 # 1 B 14 LYS A 166 LYS^? 20.93 MG MG A 302 B 74 LYS A 157 LYS^? 28.65 MG MG A 302 B 165 GLU A 52 GLU^? 19.89 MG MG A 301 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 35.34 13.14 30.41 31.67 15.04 34.58 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 41.42 12.06 27.58 41.46 5.93 29.41 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 42.67 25.16 24.80 42.61 25.77 22.75 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 2 3 # 2 B 14 LYS B 166 LYS^? 22.75 MG MG B 301 B 74 LYS B 157 LYS^? 28.85 MG MG B 302 B 165 GLU B 52 GLU^? 20.06 MG MG B 302 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 35.27 15.38 5.31 37.27 9.81 3.93 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 34.97 21.28 8.44 29.03 22.82 6.58 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 47.87 20.25 12.36 48.11 19.69 14.43 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 3 3 # 3 B 14 LYS C 157 LYS^? 28.15 MG MG C 302 B 74 LYS C 6 LYS^? 25.73 MG MG C 302 B 165 GLU C 52 GLU^? 19.67 MG MG C 302 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 97.55 32.04 -15.10 101.49 36.24 -13.39 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 94.42 35.68 -18.56 92.21 32.03 -23.05 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 84.27 26.98 -19.19 85.21 26.16 -20.96 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 4 3 # 4 B 14 LYS C 157 LYS^? 28.15 MG MG C 302 B 74 LYS C 166 LYS^? 22.53 MG MG C 301 B 165 GLU C 52 GLU^? 19.67 MG MG C 302 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 97.55 32.04 -15.10 101.49 36.24 -13.39 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 99.24 26.71 -12.25 100.23 21.90 -8.99 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 84.27 26.98 -19.19 85.21 26.16 -20.96 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 5 3 # 5 B 14 LYS C 166 LYS^? 22.53 MG MG C 301 B 74 LYS C 157 LYS^? 28.15 MG MG C 302 B 165 GLU C 52 GLU^? 19.67 MG MG C 302 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 99.24 26.71 -12.25 100.23 21.90 -8.99 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 97.55 32.04 -15.10 101.49 36.24 -13.39 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 84.27 26.98 -19.19 85.21 26.16 -20.96 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 6 3 # 6 B 14 LYS D 157 LYS^? 28.67 MG MG D 302 B 74 LYS D 166 LYS^? 21.08 MG MG D 301 B 165 GLU D 52 GLU^? 19.94 MG MG D 302 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 94.17 21.71 -34.34 96.11 15.89 -35.92 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 99.23 24.85 -37.31 101.73 27.34 -42.07 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 87.13 33.17 -30.97 88.40 33.70 -29.31 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 7 3 # 7 B 14 LYS D 166 LYS^? 21.08 MG MG D 301 B 74 LYS D 157 LYS^? 28.67 MG MG D 302 B 165 GLU D 52 GLU^? 19.94 MG MG D 302 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 99.23 24.85 -37.31 101.73 27.34 -42.07 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 94.17 21.71 -34.34 96.11 15.89 -35.92 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 87.13 33.17 -30.97 88.40 33.70 -29.31 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 8 3 # 8 B 14 LYS E 157 LYS^? 28.40 MG MG E 302 B 74 LYS E 6 LYS^? 25.59 MG MG E 302 B 165 GLU E 52 GLU^? 19.96 MG MG E 302 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 53.63 69.16 -60.42 48.34 71.81 -58.40 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 51.95 64.70 -63.33 56.16 64.03 -67.52 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 64.71 60.06 -63.78 64.69 61.36 -65.58 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 9 3 # 9 B 14 LYS E 157 LYS^? 28.40 MG MG E 302 B 74 LYS E 166 LYS^? 21.46 MG MG E 301 B 165 GLU E 52 GLU^? 19.96 MG MG E 302 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 53.63 69.16 -60.42 48.34 71.81 -58.40 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 57.66 73.57 -57.60 60.27 76.17 -53.59 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 64.71 60.06 -63.78 64.69 61.36 -65.58 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 10 3 # 10 B 14 LYS E 166 LYS^? 21.46 MG MG E 301 B 74 LYS E 157 LYS^? 28.40 MG MG E 302 B 165 GLU E 52 GLU^? 19.96 MG MG E 302 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 57.66 73.57 -57.60 60.27 76.17 -53.59 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 53.63 69.16 -60.42 48.34 71.81 -58.40 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 64.71 60.06 -63.78 64.69 61.36 -65.58 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 11 3 # 11 B 14 LYS F 157 LYS^? 28.36 MG MG F 302 B 74 LYS F 166 LYS^? 20.76 MG MG F 302 B 165 GLU F 52 GLU^? 20.13 MG MG F 301 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 64.43 70.47 -79.54 68.32 74.80 -81.65 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 59.28 73.05 -82.63 55.63 74.15 -86.94 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 57.09 59.62 -75.76 56.76 59.40 -73.62 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 12 3 # 12 B 14 LYS F 166 LYS^? 20.76 MG MG F 302 B 74 LYS F 157 LYS^? 28.36 MG MG F 302 B 165 GLU F 52 GLU^? 20.13 MG MG F 301 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 59.28 73.05 -82.63 55.63 74.15 -86.94 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 64.43 70.47 -79.54 68.32 74.80 -81.65 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 57.09 59.62 -75.76 56.76 59.40 -73.62 1idt_c01 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 12 hits 1idt_c01 naa= 3 ULMN 3 1ig8_c00 HEXOKINASE PII user 1 3 # 1 A 158 SER A 79 SER^? 29.65 MG MG A 301 A 173 ARG A 87 ARG^? 20.70 MG MG A 301 A 211 ASP A 81 ASP^? 34.50 MG MG A 301 coo 22.72 76.24 0.23 24.60 76.86 -1.25 32.57 55.71 29.63 34.63 56.10 28.47 coo 18.77 77.82 11.69 20.55 80.22 10.73 43.15 49.03 26.22 43.83 48.14 29.12 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 31.12 60.71 27.43 31.74 59.35 25.95 ULMN 3 1ig8_c00 HEXOKINASE PII user 2 3 # 2 A 158 SER B 79 SER^? 20.24 MG MG C 301 A 173 ARG B 87 ARG^? 13.84 MG MG C 301 A 211 ASP B 81 ASP^? 24.85 MG MG C 301 coo 22.72 76.24 0.23 24.60 76.86 -1.25 76.03 3.33 7.67 77.04 5.28 8.60 coo 18.77 77.82 11.69 20.55 80.22 10.73 72.30 15.49 11.27 71.00 17.29 9.11 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 79.93 -0.44 10.01 79.44 1.19 11.29 ULMN 3 1ig8_c00 HEXOKINASE PII user 3 3 # 3 A 158 SER B 83 SER^? 24.53 MG MG C 301 A 173 ARG B 87 ARG^? 13.84 MG MG C 301 A 211 ASP B 81 ASP^? 24.85 MG MG C 301 coo 22.72 76.24 0.23 24.60 76.86 -1.25 75.19 1.98 12.89 77.54 2.36 12.62 coo 18.77 77.82 11.69 20.55 80.22 10.73 72.30 15.49 11.27 71.00 17.29 9.11 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 79.93 -0.44 10.01 79.44 1.19 11.29 ULMN 3 1ig8_c00 HEXOKINASE PII user 4 3 # 4 A 158 SER C 79 SER^? 19.92 MG MG B 301 A 173 ARG C 87 ARG^? 14.11 MG MG B 301 A 211 ASP C 81 ASP^? 23.42 MG MG B 301 coo 22.72 76.24 0.23 24.60 76.86 -1.25 64.38 1.95 -14.66 62.69 3.45 -15.45 coo 18.77 77.82 11.69 20.55 80.22 10.73 64.80 14.21 -18.13 65.25 15.52 -15.36 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 60.68 -2.08 -16.91 61.02 -0.17 -17.89 ULMN 3 1ig8_c00 HEXOKINASE PII user 5 3 # 5 A 158 SER C 83 SER^? 23.40 MG MG B 301 A 173 ARG C 87 ARG^? 14.11 MG MG B 301 A 211 ASP C 81 ASP^? 23.42 MG MG B 301 coo 22.72 76.24 0.23 24.60 76.86 -1.25 65.19 0.76 -19.73 62.87 1.43 -19.33 coo 18.77 77.82 11.69 20.55 80.22 10.73 64.80 14.21 -18.13 65.25 15.52 -15.36 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 60.68 -2.08 -16.91 61.02 -0.17 -17.89 ULMN 3 1ig8_c00 HEXOKINASE PII user 6 3 # 6 A 158 SER D 79 SER^? 19.41 MG MG E 301 A 173 ARG D 87 ARG^? 13.34 MG MG E 301 A 211 ASP D 81 ASP^? 23.25 MG MG E 301 coo 22.72 76.24 0.23 24.60 76.86 -1.25 88.38 65.91 -36.56 86.13 65.62 -35.70 coo 18.77 77.82 11.69 20.55 80.22 10.73 79.72 56.28 -33.10 79.15 54.81 -35.72 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 89.25 71.36 -34.47 87.72 70.06 -33.67 ULMN 3 1ig8_c00 HEXOKINASE PII user 7 3 # 7 A 158 SER D 83 SER^? 23.07 MG MG E 301 A 173 ARG D 87 ARG^? 13.34 MG MG E 301 A 211 ASP D 81 ASP^? 23.25 MG MG E 301 coo 22.72 76.24 0.23 24.60 76.86 -1.25 89.47 66.32 -31.33 87.79 67.80 -32.19 coo 18.77 77.82 11.69 20.55 80.22 10.73 79.72 56.28 -33.10 79.15 54.81 -35.72 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 89.25 71.36 -34.47 87.72 70.06 -33.67 ULMN 3 1ig8_c00 HEXOKINASE PII user 8 3 # 8 A 158 SER E 79 SER^? 19.77 MG MG D 301 A 173 ARG E 87 ARG^? 13.25 MG MG D 301 A 211 ASP E 81 ASP^? 24.19 MG MG D 301 coo 22.72 76.24 0.23 24.60 76.86 -1.25 96.22 56.25 -58.39 95.94 54.06 -59.20 coo 18.77 77.82 11.69 20.55 80.22 10.73 85.24 49.22 -61.34 83.59 49.18 -58.71 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 101.61 56.30 -60.24 100.25 55.53 -61.72 ULMN 3 1ig8_c00 HEXOKINASE PII user 9 3 # 9 A 158 SER F 79 SER^? 30.22 MG MG F 301 A 173 ARG F 87 ARG^? 20.27 MG MG F 301 A 211 ASP F 81 ASP^? 34.61 MG MG F 301 coo 22.72 76.24 0.23 24.60 76.86 -1.25 28.21 44.39 -80.24 29.11 42.36 -79.32 coo 18.77 77.82 11.69 20.55 80.22 10.73 41.14 41.21 -77.31 42.93 41.07 -79.84 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 23.08 43.10 -77.79 24.94 42.10 -77.55 1ig8_c00 source 1ig8 HEXOKINASE PII : 9 hits 1ig8_c00 naa= 3 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 1 3 # 1 54 ASP A 35 ASP^? 16.92 MG MG A 301 158 THR A 46 THR^? 24.24 MG MG A 301 317 ASP B 160 ASP^? 31.65 MG MG A 301 coo -2.63 8.40 35.07 -3.66 9.81 36.17 34.49 31.10 26.54 36.41 31.82 27.10 coo -5.30 12.75 41.86 -4.34 13.05 39.99 38.63 28.11 18.80 36.62 27.50 19.27 coo -12.63 17.64 33.66 -10.65 17.90 34.40 28.01 24.83 16.38 27.44 26.81 15.80 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 2 3 # 2 54 ASP A 138 ASP^? 33.08 MG MG A 302 158 THR A 2 THR.? 34.64 MG MG A 301 317 ASP A 58 ASP^? 26.75 MG MG B 302 coo -2.63 8.40 35.07 -3.66 9.81 36.17 47.10 -0.97 29.63 45.89 0.22 30.96 coo -5.30 12.75 41.86 -4.34 13.05 39.99 47.80 1.72 22.09 46.70 1.88 23.97 coo -12.63 17.64 33.66 -10.65 17.90 34.40 53.93 9.80 21.09 53.83 8.90 19.15 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 3 3 # 3 54 ASP A 148 ASP^? 2.72 MG MG A 301s 158 THR A 178 THR^? 11.01 MG MG A 302 317 ASP A 171 ASP^? 17.17 MG MG A 302 coo -2.63 8.40 35.07 -3.66 9.81 36.17 41.50 28.88 41.13 43.33 29.67 41.93 coo -5.30 12.75 41.86 -4.34 13.05 39.99 32.90 33.33 42.26 32.53 35.14 43.38 coo -12.63 17.64 33.66 -10.65 17.90 34.40 29.78 23.67 36.63 28.48 25.11 35.71 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 4 3 # 4 54 ASP A 171 ASP^? 17.17 MG MG A 302 158 THR A 169 THR^? 18.45 MG MG A 302 317 ASP A 148 ASP^? 2.72 MG MG A 301s coo -2.63 8.40 35.07 -3.66 9.81 36.17 29.78 23.67 36.63 28.48 25.11 35.71 coo -5.30 12.75 41.86 -4.34 13.05 39.99 34.64 19.08 35.13 33.08 18.40 33.78 coo -12.63 17.64 33.66 -10.65 17.90 34.40 41.50 28.88 41.13 43.33 29.67 41.93 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 5 3 # 5 54 ASP A 187 ASP^? -3.29 MG MG A 302s 158 THR A 178 THR^? 11.01 MG MG A 302 317 ASP A 171 ASP^? 17.17 MG MG A 302 coo -2.63 8.40 35.07 -3.66 9.81 36.17 39.43 26.57 46.78 39.37 27.83 45.03 coo -5.30 12.75 41.86 -4.34 13.05 39.99 32.90 33.33 42.26 32.53 35.14 43.38 coo -12.63 17.64 33.66 -10.65 17.90 34.40 29.78 23.67 36.63 28.48 25.11 35.71 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 6 3 # 6 54 ASP B 35 ASP^? 16.92 MG MG B 302 158 THR B 46 THR^? 23.88 MG MG B 302 317 ASP A 160 ASP^? 31.61 MG MG B 302 coo -2.63 8.40 35.07 -3.66 9.81 36.17 52.63 11.07 10.18 53.68 12.85 9.94 coo -5.30 12.75 41.86 -4.34 13.05 39.99 49.71 15.16 18.13 48.80 13.51 17.14 coo -12.63 17.64 33.66 -10.65 17.90 34.40 44.21 5.00 19.54 46.02 3.84 19.76 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 7 3 # 7 54 ASP B 138 ASP^? 33.32 MG MG B 302 158 THR B 2 THR^? 34.11 MG MG B 302 317 ASP B 58 ASP^? 26.73 MG MG A 301 coo -2.63 8.40 35.07 -3.66 9.81 36.17 23.42 29.01 6.78 24.36 28.48 4.94 coo -5.30 12.75 41.86 -4.34 13.05 39.99 25.51 29.18 13.74 26.24 28.19 11.93 coo -12.63 17.64 33.66 -10.65 17.90 34.40 34.42 33.56 15.74 33.50 33.49 17.59 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 8 3 # 8 54 ASP B 148 ASP^? 2.58 MG MG B 302s 158 THR B 178 THR^? 10.48 MG MG B 301 317 ASP B 171 ASP^? 16.92 MG MG B 301 coo -2.63 8.40 35.07 -3.66 9.81 36.17 52.73 19.23 -3.77 53.81 20.99 -4.31 coo -5.30 12.75 41.86 -4.34 13.05 39.99 56.23 10.27 -5.85 58.11 9.83 -6.86 coo -12.63 17.64 33.66 -10.65 17.90 34.40 45.30 8.50 -0.71 46.30 6.81 0.12 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 9 3 # 9 54 ASP B 171 ASP^? 16.92 MG MG B 301 158 THR B 169 THR^? 18.43 MG MG B 301 317 ASP B 148 ASP^? 2.58 MG MG B 302s coo -2.63 8.40 35.07 -3.66 9.81 36.17 45.30 8.50 -0.71 46.30 6.81 0.12 coo -5.30 12.75 41.86 -4.34 13.05 39.99 41.38 13.97 0.97 40.27 12.43 2.02 coo -12.63 17.64 33.66 -10.65 17.90 34.40 52.73 19.23 -3.77 53.81 20.99 -4.31 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 10 3 # 10 54 ASP B 171 ASP^? 16.92 MG MG B 301 158 THR B 175 THR^? 12.15 MG MG B 301 317 ASP B 148 ASP^? 2.58 MG MG B 302s coo -2.63 8.40 35.07 -3.66 9.81 36.17 45.30 8.50 -0.71 46.30 6.81 0.12 coo -5.30 12.75 41.86 -4.34 13.05 39.99 46.88 7.94 -7.07 47.05 10.06 -6.52 coo -12.63 17.64 33.66 -10.65 17.90 34.40 52.73 19.23 -3.77 53.81 20.99 -4.31 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 11 3 # 11 54 ASP B 171 ASP^? 16.92 MG MG B 301 158 THR B 175 THR^? 12.15 MG MG B 301 317 ASP B 187 ASP^? -3.44 MG MG B 301s coo -2.63 8.40 35.07 -3.66 9.81 36.17 45.30 8.50 -0.71 46.30 6.81 0.12 coo -5.30 12.75 41.86 -4.34 13.05 39.99 46.88 7.94 -7.07 47.05 10.06 -6.52 coo -12.63 17.64 33.66 -10.65 17.90 34.40 50.64 18.14 -9.69 51.74 17.63 -7.86 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 12 3 # 12 54 ASP B 187 ASP^? -3.44 MG MG B 301s 158 THR B 178 THR^? 10.48 MG MG B 301 317 ASP B 171 ASP^? 16.92 MG MG B 301 coo -2.63 8.40 35.07 -3.66 9.81 36.17 50.64 18.14 -9.69 51.74 17.63 -7.86 coo -5.30 12.75 41.86 -4.34 13.05 39.99 56.23 10.27 -5.85 58.11 9.83 -6.86 coo -12.63 17.64 33.66 -10.65 17.90 34.40 45.30 8.50 -0.71 46.30 6.81 0.12 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 13 3 # 13 54 ASP C 23 ASP^? 15.39 MG MG B 301 158 THR B 18 THR^? 16.08 MG MG B 302 317 ASP B 177 ASP^? 9.03 MG MG B 301 coo -2.63 8.40 35.07 -3.66 9.81 36.17 65.24 6.82 -5.11 63.43 7.54 -4.15 coo -5.30 12.75 41.86 -4.34 13.05 39.99 60.02 7.32 3.97 60.86 9.29 4.05 coo -12.63 17.64 33.66 -10.65 17.90 34.40 51.97 11.04 -6.64 50.39 11.62 -7.94 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 14 3 # 14 54 ASP C 35 ASP^? 16.42 MG MG C 302 158 THR C 46 THR^? 24.02 MG MG C 302 317 ASP D 160 ASP^? 31.45 MG MG C 302 coo -2.63 8.40 35.07 -3.66 9.81 36.17 84.40 16.53 -16.68 82.83 17.91 -16.28 coo -5.30 12.75 41.86 -4.34 13.05 39.99 85.56 21.34 -24.69 87.12 20.00 -24.12 coo -12.63 17.64 33.66 -10.65 17.90 34.40 94.15 13.98 -26.57 92.71 12.42 -26.99 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 15 3 # 15 54 ASP C 148 ASP^? 2.75 MG MG C 302s 158 THR C 178 THR^? 9.80 MG MG C 301 317 ASP C 171 ASP^? 17.08 MG MG C 301 coo -2.63 8.40 35.07 -3.66 9.81 36.17 81.96 23.83 -2.68 80.24 25.11 -2.27 coo -5.30 12.75 41.86 -4.34 13.05 39.99 81.90 14.29 -1.08 80.31 13.94 0.39 coo -12.63 17.64 33.66 -10.65 17.90 34.40 92.57 16.68 -6.24 92.24 14.74 -7.03 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 16 3 # 16 54 ASP C 171 ASP^? 17.08 MG MG C 301 158 THR C 169 THR^? 18.51 MG MG C 301 317 ASP C 148 ASP^? 2.75 MG MG C 302s coo -2.63 8.40 35.07 -3.66 9.81 36.17 92.57 16.68 -6.24 92.24 14.74 -7.03 coo -5.30 12.75 41.86 -4.34 13.05 39.99 94.19 23.02 -7.83 95.56 21.86 -9.07 coo -12.63 17.64 33.66 -10.65 17.90 34.40 81.96 23.83 -2.68 80.24 25.11 -2.27 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 17 3 # 17 54 ASP C 171 ASP^? 17.08 MG MG C 301 158 THR C 175 THR^? 12.73 MG MG C 301 317 ASP C 148 ASP^? 2.75 MG MG C 302s coo -2.63 8.40 35.07 -3.66 9.81 36.17 92.57 16.68 -6.24 92.24 14.74 -7.03 coo -5.30 12.75 41.86 -4.34 13.05 39.99 91.24 15.45 0.47 90.99 17.39 -0.47 coo -12.63 17.64 33.66 -10.65 17.90 34.40 81.96 23.83 -2.68 80.24 25.11 -2.27 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 18 3 # 18 54 ASP C 171 ASP^? 17.08 MG MG C 301 158 THR C 175 THR^? 12.73 MG MG C 301 317 ASP C 187 ASP^? -3.72 MG MG C 301s coo -2.63 8.40 35.07 -3.66 9.81 36.17 92.57 16.68 -6.24 92.24 14.74 -7.03 coo -5.30 12.75 41.86 -4.34 13.05 39.99 91.24 15.45 0.47 90.99 17.39 -0.47 coo -12.63 17.64 33.66 -10.65 17.90 34.40 84.01 23.73 3.39 83.47 22.54 1.59 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 19 3 # 19 54 ASP D 35 ASP^? 16.80 MG MG D 302 158 THR D 46 THR^? 23.86 MG MG D 302 317 ASP C 160 ASP^? 31.63 MG MG D 302 coo -2.63 8.40 35.07 -3.66 9.81 36.17 93.83 42.00 -33.14 91.74 41.83 -33.51 coo -5.30 12.75 41.86 -4.34 13.05 39.99 91.28 37.63 -25.27 93.05 36.72 -26.12 coo -12.63 17.64 33.66 -10.65 17.90 34.40 102.50 38.00 -23.28 102.43 39.97 -22.46 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 20 3 # 20 54 ASP D 138 ASP^? 33.64 MG MG D 302 158 THR D 2 THR^? 33.99 MG MG D 302 317 ASP D 58 ASP^? 26.59 MG MG C 302 coo -2.63 8.40 35.07 -3.66 9.81 36.17 93.00 7.50 -35.79 93.88 8.48 -37.45 coo -5.30 12.75 41.86 -4.34 13.05 39.99 91.82 9.34 -29.18 91.80 10.46 -31.03 coo -12.63 17.64 33.66 -10.65 17.90 34.40 83.38 14.85 -27.71 84.09 14.12 -25.85 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 21 3 # 21 54 ASP D 148 ASP^? 2.35 MG MG D 302s 158 THR D 178 THR^? 10.95 MG MG D 301 317 ASP D 171 ASP^? 16.95 MG MG D 301 coo -2.63 8.40 35.07 -3.66 9.81 36.17 87.78 37.50 -47.56 85.79 37.49 -48.28 coo -5.30 12.75 41.86 -4.34 13.05 39.99 93.76 44.98 -49.28 93.73 46.80 -50.45 coo -12.63 17.64 33.66 -10.65 17.90 34.40 100.39 36.69 -43.49 101.13 38.51 -42.69 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 22 3 # 22 54 ASP D 171 ASP^? 16.95 MG MG D 301 158 THR D 169 THR^? 18.47 MG MG D 301 317 ASP D 148 ASP^? 2.35 MG MG D 302s coo -2.63 8.40 35.07 -3.66 9.81 36.17 100.39 36.69 -43.49 101.13 38.51 -42.69 coo -5.30 12.75 41.86 -4.34 13.05 39.99 97.62 30.68 -41.94 99.48 30.62 -40.85 coo -12.63 17.64 33.66 -10.65 17.90 34.40 87.78 37.50 -47.56 85.79 37.49 -48.28 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 23 3 # 23 54 ASP D 171 ASP^? 16.95 MG MG D 301 158 THR D 175 THR^? 12.60 MG MG D 301 317 ASP D 148 ASP^? 2.35 MG MG D 302s coo -2.63 8.40 35.07 -3.66 9.81 36.17 100.39 36.69 -43.49 101.13 38.51 -42.69 coo -5.30 12.75 41.86 -4.34 13.05 39.99 100.33 38.24 -50.15 98.81 36.95 -49.29 coo -12.63 17.64 33.66 -10.65 17.90 34.40 87.78 37.50 -47.56 85.79 37.49 -48.28 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 24 3 # 24 54 ASP D 171 ASP^? 16.95 MG MG D 301 158 THR D 175 THR^? 12.60 MG MG D 301 317 ASP D 187 ASP^? -2.95 MG MG D 301s coo -2.63 8.40 35.07 -3.66 9.81 36.17 100.39 36.69 -43.49 101.13 38.51 -42.69 coo -5.30 12.75 41.86 -4.34 13.05 39.99 100.33 38.24 -50.15 98.81 36.95 -49.29 coo -12.63 17.64 33.66 -10.65 17.90 34.40 90.40 36.34 -52.69 89.24 37.98 -51.99 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 25 3 # 25 54 ASP D 187 ASP^? -2.95 MG MG D 301s 158 THR D 178 THR^? 10.95 MG MG D 301 317 ASP D 171 ASP^? 16.95 MG MG D 301 coo -2.63 8.40 35.07 -3.66 9.81 36.17 90.40 36.34 -52.69 89.24 37.98 -51.99 coo -5.30 12.75 41.86 -4.34 13.05 39.99 93.76 44.98 -49.28 93.73 46.80 -50.45 coo -12.63 17.64 33.66 -10.65 17.90 34.40 100.39 36.69 -43.49 101.13 38.51 -42.69 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 26 3 # 26 54 ASP E 35 ASP^? 16.91 MG MG E 302 158 THR E 46 THR^? 24.08 MG MG E 302 317 ASP F 160 ASP^? 31.59 MG MG E 302 coo -2.63 8.40 35.07 -3.66 9.81 36.17 73.60 65.64 -62.00 73.13 63.73 -61.22 coo -5.30 12.75 41.86 -4.34 13.05 39.99 68.80 63.64 -69.48 69.18 65.66 -68.86 coo -12.63 17.64 33.66 -10.65 17.90 34.40 71.27 74.59 -71.77 73.23 74.02 -72.37 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 27 3 # 27 54 ASP E 138 ASP^? 33.31 MG MG E 302 158 THR E 2 THR^? 33.84 MG MG E 302 317 ASP E 58 ASP^? 26.76 MG MG F 301 coo -2.63 8.40 35.07 -3.66 9.81 36.17 39.58 70.77 -58.63 40.74 70.78 -56.80 coo -5.30 12.75 41.86 -4.34 13.05 39.99 41.32 68.37 -65.29 42.66 69.03 -63.78 coo -12.63 17.64 33.66 -10.65 17.90 34.40 45.39 59.31 -66.83 44.62 59.88 -68.72 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 28 3 # 28 54 ASP E 148 ASP^? 2.62 MG MG E 302s 158 THR E 178 THR^? 10.20 MG MG E 301 317 ASP E 171 ASP^? 16.73 MG MG E 301 coo -2.63 8.40 35.07 -3.66 9.81 36.17 68.29 60.44 -47.29 68.03 58.42 -46.50 coo -5.30 12.75 41.86 -4.34 13.05 39.99 76.63 65.42 -45.81 78.18 64.57 -44.51 coo -12.63 17.64 33.66 -10.65 17.90 34.40 69.61 73.12 -51.56 71.50 73.53 -52.39 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 29 3 # 29 54 ASP E 171 ASP^? 16.73 MG MG E 301 158 THR E 169 THR^? 18.18 MG MG E 301 317 ASP E 148 ASP^? 2.62 MG MG E 302s coo -2.63 8.40 35.07 -3.66 9.81 36.17 69.61 73.12 -51.56 71.50 73.53 -52.39 coo -5.30 12.75 41.86 -4.34 13.05 39.99 63.17 71.31 -52.89 63.43 72.88 -54.31 coo -12.63 17.64 33.66 -10.65 17.90 34.40 68.29 60.44 -47.29 68.03 58.42 -46.50 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 30 3 # 30 54 ASP E 171 ASP^? 16.73 MG MG E 301 158 THR E 175 THR^? 12.38 MG MG E 301 317 ASP E 148 ASP^? 2.62 MG MG E 302s coo -2.63 8.40 35.07 -3.66 9.81 36.17 69.61 73.12 -51.56 71.50 73.53 -52.39 coo -5.30 12.75 41.86 -4.34 13.05 39.99 71.20 72.92 -44.89 69.57 71.76 -45.77 coo -12.63 17.64 33.66 -10.65 17.90 34.40 68.29 60.44 -47.29 68.03 58.42 -46.50 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 31 3 # 31 54 ASP E 171 ASP^? 16.73 MG MG E 301 158 THR E 175 THR^? 12.38 MG MG E 301 317 ASP E 187 ASP^? -2.71 MG MG E 301s coo -2.63 8.40 35.07 -3.66 9.81 36.17 69.61 73.12 -51.56 71.50 73.53 -52.39 coo -5.30 12.75 41.86 -4.34 13.05 39.99 71.20 72.92 -44.89 69.57 71.76 -45.77 coo -12.63 17.64 33.66 -10.65 17.90 34.40 67.50 63.43 -41.69 68.97 62.26 -42.81 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 32 3 # 32 54 ASP E 187 ASP^? -2.71 MG MG E 301s 158 THR E 178 THR^? 10.20 MG MG E 301 317 ASP E 171 ASP^? 16.73 MG MG E 301 coo -2.63 8.40 35.07 -3.66 9.81 36.17 67.50 63.43 -41.69 68.97 62.26 -42.81 coo -5.30 12.75 41.86 -4.34 13.05 39.99 76.63 65.42 -45.81 78.18 64.57 -44.51 coo -12.63 17.64 33.66 -10.65 17.90 34.40 69.61 73.12 -51.56 71.50 73.53 -52.39 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 33 3 # 33 54 ASP F 35 ASP^? 16.93 MG MG F 301 158 THR F 46 THR^? 24.16 MG MG F 301 317 ASP E 160 ASP^? 31.54 MG MG F 301 coo -2.63 8.40 35.07 -3.66 9.81 36.17 46.82 60.47 -77.63 48.00 58.79 -78.23 coo -5.30 12.75 41.86 -4.34 13.05 39.99 51.99 60.48 -70.07 50.88 62.21 -70.66 coo -12.63 17.64 33.66 -10.65 17.90 34.40 45.81 70.00 -68.45 44.10 68.87 -67.77 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 34 3 # 34 54 ASP F 138 ASP^? 33.51 MG MG F 302 158 THR F 2 THR^? 34.54 MG MG F 301 317 ASP F 58 ASP^? 26.87 MG MG E 302 coo -2.63 8.40 35.07 -3.66 9.81 36.17 77.17 76.66 -81.48 76.14 76.33 -83.32 coo -5.30 12.75 41.86 -4.34 13.05 39.99 76.07 74.83 -74.70 74.98 75.15 -76.59 coo -12.63 17.64 33.66 -10.65 17.90 34.40 75.55 64.68 -72.56 76.21 65.63 -70.79 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 35 3 # 35 54 ASP F 148 ASP^? 2.72 MG MG F 301s 158 THR F 178 THR^? 10.42 MG MG F 302 317 ASP F 171 ASP^? 16.35 MG MG F 302 coo -2.63 8.40 35.07 -3.66 9.81 36.17 53.64 56.47 -91.98 54.61 54.68 -92.64 coo -5.30 12.75 41.86 -4.34 13.05 39.99 44.23 58.04 -93.68 42.69 56.98 -94.82 coo -12.63 17.64 33.66 -10.65 17.90 34.40 48.23 68.08 -88.47 46.26 68.02 -87.56 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 36 3 # 36 54 ASP F 171 ASP^? 16.35 MG MG F 302 158 THR F 169 THR^? 17.93 MG MG F 302 317 ASP F 148 ASP^? 2.72 MG MG F 301s coo -2.63 8.40 35.07 -3.66 9.81 36.17 48.23 68.08 -88.47 46.26 68.02 -87.56 coo -5.30 12.75 41.86 -4.34 13.05 39.99 54.83 68.79 -86.99 54.09 70.44 -85.82 coo -12.63 17.64 33.66 -10.65 17.90 34.40 53.64 56.47 -91.98 54.61 54.68 -92.64 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 37 3 # 37 54 ASP F 171 ASP^? 16.35 MG MG F 302 158 THR F 175 THR^? 11.83 MG MG F 302 317 ASP F 148 ASP^? 2.72 MG MG F 301s coo -2.63 8.40 35.07 -3.66 9.81 36.17 48.23 68.08 -88.47 46.26 68.02 -87.56 coo -5.30 12.75 41.86 -4.34 13.05 39.99 46.82 66.80 -95.29 48.97 66.65 -95.25 coo -12.63 17.64 33.66 -10.65 17.90 34.40 53.64 56.47 -91.98 54.61 54.68 -92.64 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 38 3 # 38 54 ASP F 171 ASP^? 16.35 MG MG F 302 158 THR F 175 THR^? 11.83 MG MG F 302 317 ASP F 187 ASP^? -3.27 MG MG F 302s coo -2.63 8.40 35.07 -3.66 9.81 36.17 48.23 68.08 -88.47 46.26 68.02 -87.56 coo -5.30 12.75 41.86 -4.34 13.05 39.99 46.82 66.80 -95.29 48.97 66.65 -95.25 coo -12.63 17.64 33.66 -10.65 17.90 34.40 53.93 58.87 -98.14 52.45 58.62 -96.61 1inp_c02 source 1inp INOSITOL POLYPHOSPHATE 1-PHOSPHATASE (1-PTASE): 38 hits 1inp_c02 naa= 3 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 1 3 # 1 A 202 ASP A 23 ASP^? 22.90 MG MG A 301 A 204 GLU A 25 GLU^? 25.87 MG MG A 301 A 279 TYR A 123 TYR^? 15.82 MG MG A 301 coo 5.85 5.60 30.32 5.00 7.49 29.88 36.40 52.47 38.61 38.03 53.36 39.72 coo 7.79 1.83 27.81 9.08 3.25 26.92 39.62 57.50 39.92 41.51 57.27 40.85 coo 8.22 7.77 18.64 7.58 8.47 21.28 44.25 46.10 40.65 45.04 48.81 40.82 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 2 3 # 2 A 202 ASP A 171 ASP^? 17.17 MG MG A 302 A 204 GLU A 174 GLU^? 20.39 MG MG A 302 A 279 TYR A 188 TYR^? 8.73 MG MG A 302 coo 5.85 5.60 30.32 5.00 7.49 29.88 29.78 23.67 36.63 28.48 25.11 35.71 coo 7.79 1.83 27.81 9.08 3.25 26.92 25.88 23.57 38.04 23.76 23.95 38.22 coo 8.22 7.77 18.64 7.58 8.47 21.28 37.17 23.04 44.09 34.69 24.12 44.73 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 3 3 # 3 A 202 ASP B 171 ASP^? 16.92 MG MG B 301 A 204 GLU B 174 GLU^? 19.69 MG MG B 301 A 279 TYR B 188 TYR^? 8.84 MG MG B 301 coo 5.85 5.60 30.32 5.00 7.49 29.88 45.30 8.50 -0.71 46.30 6.81 0.12 coo 7.79 1.83 27.81 9.08 3.25 26.92 43.72 4.95 -3.28 44.76 3.14 -2.69 coo 8.22 7.77 18.64 7.58 8.47 21.28 46.41 16.35 -7.52 47.38 13.88 -8.38 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 4 3 # 4 A 202 ASP C 171 ASP^? 17.08 MG MG C 301 A 204 GLU C 174 GLU^? 19.72 MG MG C 301 A 279 TYR C 188 TYR^? 8.98 MG MG C 301 coo 5.85 5.60 30.32 5.00 7.49 29.88 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 7.79 1.83 27.81 9.08 3.25 26.92 95.09 14.29 -3.63 95.25 12.23 -4.17 coo 8.22 7.77 18.64 7.58 8.47 21.28 88.74 23.30 0.93 88.91 20.61 1.57 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 5 3 # 5 A 202 ASP D 171 ASP^? 16.95 MG MG D 301 A 204 GLU D 174 GLU^? 19.76 MG MG D 301 A 279 TYR D 188 TYR^? 8.87 MG MG D 301 coo 5.85 5.60 30.32 5.00 7.49 29.88 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 7.79 1.83 27.81 9.08 3.25 26.92 104.29 37.18 -46.00 105.30 38.94 -45.21 coo 8.22 7.77 18.64 7.58 8.47 21.28 93.72 33.91 -50.86 95.36 36.03 -51.61 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 6 3 # 6 A 202 ASP E 171 ASP^? 16.73 MG MG E 301 A 204 GLU E 174 GLU^? 19.83 MG MG E 301 A 279 TYR E 168 TYR^? 14.43 MG MG E 301 coo 5.85 5.60 30.32 5.00 7.49 29.88 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 7.79 1.83 27.81 9.08 3.25 26.92 70.48 76.62 -49.45 71.76 78.34 -49.45 coo 8.22 7.77 18.64 7.58 8.47 21.28 60.07 69.95 -50.54 61.99 69.37 -48.59 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 7 3 # 7 A 202 ASP E 171 ASP^? 16.73 MG MG E 301 A 204 GLU E 174 GLU^? 19.83 MG MG E 301 A 279 TYR E 188 TYR^? 8.62 MG MG E 301 coo 5.85 5.60 30.32 5.00 7.49 29.88 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 7.79 1.83 27.81 9.08 3.25 26.92 70.48 76.62 -49.45 71.76 78.34 -49.45 coo 8.22 7.77 18.64 7.58 8.47 21.28 65.58 67.09 -44.08 67.82 68.57 -43.41 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 8 3 # 8 A 202 ASP F 171 ASP^? 16.35 MG MG F 302 A 204 GLU F 174 GLU^? 18.79 MG MG F 302 A 279 TYR F 188 TYR^? 8.06 MG MG F 302 coo 5.85 5.60 30.32 5.00 7.49 29.88 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 7.79 1.83 27.81 9.08 3.25 26.92 46.19 70.73 -90.91 44.19 71.42 -90.89 coo 8.22 7.77 18.64 7.58 8.47 21.28 54.23 63.50 -95.64 51.58 63.66 -96.35 1itx_c00 source 1itx GLYCOSYL HYDROLASE : 8 hits 1itx_c00 naa= 3 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 1 3 # 1 A 14 GLU C 174 GLU^? 19.72 MG MG C 301 A 61 GLU C 154 GLU^? 18.91 MG MG C 302 A 162 HIS C 170 HIS^? 10.68 MG MG C 301 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 95.09 14.29 -3.63 95.25 12.23 -4.17 coo -4.89 20.85 5.22 -3.95 21.69 6.91 91.15 23.27 -13.33 91.61 21.91 -14.95 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 89.96 21.05 -3.85 88.74 19.88 -2.61 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 2 3 # 2 A 14 GLU E 174 GLU^? 19.83 MG MG E 301 A 61 GLU E 154 GLU^? 19.05 MG MG E 302 A 162 HIS E 170 HIS^? 10.33 MG MG E 301 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 70.48 76.62 -49.45 71.76 78.34 -49.45 coo -4.89 20.85 5.22 -3.95 21.69 6.91 64.41 68.21 -58.47 65.40 69.20 -60.08 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 66.96 68.76 -48.87 68.36 68.54 -47.33 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 3 3 # 3 A 14 GLU F 174 GLU^? 18.79 MG MG F 302 A 61 GLU F 154 GLU^? 18.97 MG MG F 301 A 162 HIS F 170 HIS^? 9.84 MG MG F 302 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 46.19 70.73 -90.91 44.19 71.42 -90.89 coo -4.89 20.85 5.22 -3.95 21.69 6.91 54.57 65.67 -81.55 53.36 66.51 -80.09 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 52.25 64.82 -90.91 50.95 63.88 -92.26 1j53_c00 source 1j53 DNA POLYMERASE III, EPSILON CHAIN : 3 hits 1j53_c00 naa= 3 ULMN 3 1j70_c00 ATP SULPHURYLASE user 1 3 # 1 A 197 ARG A 50 ARG^? 15.98 MG MG A 301 A 201 HIS A 147 HIS^? 9.20 MG MG A 302 A 204 HIS A 170 HIS^? 10.56 MG MG A 302 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 38.44 33.02 29.31 39.55 34.58 26.90 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 40.24 23.10 39.83 38.32 22.34 40.22 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 34.91 23.57 39.32 34.35 24.95 40.81 ULMN 3 1j70_c00 ATP SULPHURYLASE user 2 3 # 2 A 197 ARG B 50 ARG^? 16.38 MG MG B 302 A 201 HIS B 147 HIS^? 9.27 MG MG B 301 A 204 HIS B 170 HIS^? 10.51 MG MG B 301 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 55.38 14.91 7.80 56.60 14.73 10.62 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 46.73 18.97 -3.05 45.63 17.32 -3.73 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 46.22 13.75 -2.72 47.53 13.11 -4.24 ULMN 3 1j70_c00 ATP SULPHURYLASE user 3 3 # 3 A 197 ARG C 50 ARG^? 16.05 MG MG C 302 A 201 HIS C 147 HIS^? 9.44 MG MG C 301 A 204 HIS C 170 HIS^? 10.68 MG MG C 301 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 80.61 19.03 -14.42 79.16 18.55 -17.10 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 87.61 25.71 -3.59 89.22 24.50 -2.99 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 89.96 21.05 -3.85 88.74 19.88 -2.61 ULMN 3 1j70_c00 ATP SULPHURYLASE user 4 3 # 4 A 197 ARG C 173 ARG^? 18.96 MG MG C 301 A 201 HIS C 147 HIS^? 9.44 MG MG C 301 A 204 HIS C 170 HIS^? 10.68 MG MG C 301 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 89.11 11.40 -7.73 91.21 12.63 -9.73 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 87.61 25.71 -3.59 89.22 24.50 -2.99 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 89.96 21.05 -3.85 88.74 19.88 -2.61 ULMN 3 1j70_c00 ATP SULPHURYLASE user 5 3 # 5 A 197 ARG E 50 ARG^? 15.97 MG MG E 302 A 201 HIS E 147 HIS^? 9.22 MG MG E 301 A 204 HIS E 170 HIS^? 10.33 MG MG E 301 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 73.62 60.83 -58.23 74.10 60.41 -61.24 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 63.87 64.43 -48.39 64.18 66.45 -47.92 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 66.96 68.76 -48.87 68.36 68.54 -47.33 ULMN 3 1j70_c00 ATP SULPHURYLASE user 6 3 # 6 A 197 ARG F 50 ARG^? 16.24 MG MG F 301 A 201 HIS F 147 HIS^? 8.79 MG MG F 302 A 204 HIS F 170 HIS^? 9.84 MG MG F 302 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 48.85 56.05 -80.24 48.26 54.66 -77.55 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 56.63 61.66 -91.16 55.69 63.43 -91.80 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 52.25 64.82 -90.91 50.95 63.88 -92.26 1j70_c00 source 1j70 ATP SULPHURYLASE : 6 hits 1j70_c00 naa= 3 ULMN 3 1j70_c01 ATP SULPHURYLASE user 1 3 # 1 B 197 ARG A 50 ARG^? 15.98 MG MG A 301 B 201 HIS A 147 HIS^? 9.20 MG MG A 302 B 204 HIS A 170 HIS^? 10.56 MG MG A 302 coo -18.85 104.93 27.44 -18.03 106.58 29.88 38.44 33.02 29.31 39.55 34.58 26.90 coo -8.48 114.03 24.38 -10.47 114.55 23.97 40.24 23.10 39.83 38.32 22.34 40.22 coo -6.99 108.94 26.28 -8.54 109.57 27.55 34.91 23.57 39.32 34.35 24.95 40.81 ULMN 3 1j70_c01 ATP SULPHURYLASE user 2 3 # 2 B 197 ARG A 50 ARG^? 15.98 MG MG A 301 B 201 HIS A 170 HIS^? 10.56 MG MG A 302 B 204 HIS A 147 HIS^? 9.20 MG MG A 302 coo -18.85 104.93 27.44 -18.03 106.58 29.88 38.44 33.02 29.31 39.55 34.58 26.90 coo -8.48 114.03 24.38 -10.47 114.55 23.97 34.91 23.57 39.32 34.35 24.95 40.81 coo -6.99 108.94 26.28 -8.54 109.57 27.55 40.24 23.10 39.83 38.32 22.34 40.22 ULMN 3 1j70_c01 ATP SULPHURYLASE user 3 3 # 3 B 197 ARG B 50 ARG^? 16.38 MG MG B 302 B 201 HIS B 147 HIS^? 9.27 MG MG B 301 B 204 HIS B 170 HIS^? 10.51 MG MG B 301 coo -18.85 104.93 27.44 -18.03 106.58 29.88 55.38 14.91 7.80 56.60 14.73 10.62 coo -8.48 114.03 24.38 -10.47 114.55 23.97 46.73 18.97 -3.05 45.63 17.32 -3.73 coo -6.99 108.94 26.28 -8.54 109.57 27.55 46.22 13.75 -2.72 47.53 13.11 -4.24 ULMN 3 1j70_c01 ATP SULPHURYLASE user 4 3 # 4 B 197 ARG B 50 ARG^? 16.38 MG MG B 302 B 201 HIS B 170 HIS^? 10.51 MG MG B 301 B 204 HIS B 147 HIS^? 9.27 MG MG B 301 coo -18.85 104.93 27.44 -18.03 106.58 29.88 55.38 14.91 7.80 56.60 14.73 10.62 coo -8.48 114.03 24.38 -10.47 114.55 23.97 46.22 13.75 -2.72 47.53 13.11 -4.24 coo -6.99 108.94 26.28 -8.54 109.57 27.55 46.73 18.97 -3.05 45.63 17.32 -3.73 ULMN 3 1j70_c01 ATP SULPHURYLASE user 5 3 # 5 B 197 ARG C 50 ARG^? 16.05 MG MG C 302 B 201 HIS C 147 HIS^? 9.44 MG MG C 301 B 204 HIS C 170 HIS^? 10.68 MG MG C 301 coo -18.85 104.93 27.44 -18.03 106.58 29.88 80.61 19.03 -14.42 79.16 18.55 -17.10 coo -8.48 114.03 24.38 -10.47 114.55 23.97 87.61 25.71 -3.59 89.22 24.50 -2.99 coo -6.99 108.94 26.28 -8.54 109.57 27.55 89.96 21.05 -3.85 88.74 19.88 -2.61 ULMN 3 1j70_c01 ATP SULPHURYLASE user 6 3 # 6 B 197 ARG C 50 ARG^? 16.05 MG MG C 302 B 201 HIS C 170 HIS^? 10.68 MG MG C 301 B 204 HIS C 147 HIS^? 9.44 MG MG C 301 coo -18.85 104.93 27.44 -18.03 106.58 29.88 80.61 19.03 -14.42 79.16 18.55 -17.10 coo -8.48 114.03 24.38 -10.47 114.55 23.97 89.96 21.05 -3.85 88.74 19.88 -2.61 coo -6.99 108.94 26.28 -8.54 109.57 27.55 87.61 25.71 -3.59 89.22 24.50 -2.99 ULMN 3 1j70_c01 ATP SULPHURYLASE user 7 3 # 7 B 197 ARG E 50 ARG^? 15.97 MG MG E 302 B 201 HIS E 147 HIS^? 9.22 MG MG E 301 B 204 HIS E 170 HIS^? 10.33 MG MG E 301 coo -18.85 104.93 27.44 -18.03 106.58 29.88 73.62 60.83 -58.23 74.10 60.41 -61.24 coo -8.48 114.03 24.38 -10.47 114.55 23.97 63.87 64.43 -48.39 64.18 66.45 -47.92 coo -6.99 108.94 26.28 -8.54 109.57 27.55 66.96 68.76 -48.87 68.36 68.54 -47.33 ULMN 3 1j70_c01 ATP SULPHURYLASE user 8 3 # 8 B 197 ARG E 50 ARG^? 15.97 MG MG E 302 B 201 HIS E 170 HIS^? 10.33 MG MG E 301 B 204 HIS E 147 HIS^? 9.22 MG MG E 301 coo -18.85 104.93 27.44 -18.03 106.58 29.88 73.62 60.83 -58.23 74.10 60.41 -61.24 coo -8.48 114.03 24.38 -10.47 114.55 23.97 66.96 68.76 -48.87 68.36 68.54 -47.33 coo -6.99 108.94 26.28 -8.54 109.57 27.55 63.87 64.43 -48.39 64.18 66.45 -47.92 ULMN 3 1j70_c01 ATP SULPHURYLASE user 9 3 # 9 B 197 ARG F 50 ARG^? 16.24 MG MG F 301 B 201 HIS F 147 HIS^? 8.79 MG MG F 302 B 204 HIS F 170 HIS^? 9.84 MG MG F 302 coo -18.85 104.93 27.44 -18.03 106.58 29.88 48.85 56.05 -80.24 48.26 54.66 -77.55 coo -8.48 114.03 24.38 -10.47 114.55 23.97 56.63 61.66 -91.16 55.69 63.43 -91.80 coo -6.99 108.94 26.28 -8.54 109.57 27.55 52.25 64.82 -90.91 50.95 63.88 -92.26 ULMN 3 1j70_c01 ATP SULPHURYLASE user 10 3 # 10 B 197 ARG F 50 ARG^? 16.24 MG MG F 301 B 201 HIS F 170 HIS^? 9.84 MG MG F 302 B 204 HIS F 147 HIS^? 8.79 MG MG F 302 coo -18.85 104.93 27.44 -18.03 106.58 29.88 48.85 56.05 -80.24 48.26 54.66 -77.55 coo -8.48 114.03 24.38 -10.47 114.55 23.97 52.25 64.82 -90.91 50.95 63.88 -92.26 coo -6.99 108.94 26.28 -8.54 109.57 27.55 56.63 61.66 -91.16 55.69 63.43 -91.80 1j70_c01 source 1j70 ATP SULPHURYLASE : 10 hits 1j70_c01 naa= 3 ULMN 3 1j70_c02 ATP SULPHURYLASE user 1 3 # 1 C 197 ARG A 50 ARG^? 15.98 MG MG A 301 C 201 HIS A 147 HIS^? 9.20 MG MG A 302 C 204 HIS A 170 HIS^? 10.56 MG MG A 302 coo 30.92 14.23 15.70 28.82 13.90 13.48 38.44 33.02 29.31 39.55 34.58 26.90 coo 20.16 5.55 18.86 20.00 7.59 19.34 40.24 23.10 39.83 38.32 22.34 40.22 coo 24.92 3.29 16.90 24.41 4.92 15.69 34.91 23.57 39.32 34.35 24.95 40.81 ULMN 3 1j70_c02 ATP SULPHURYLASE user 2 3 # 2 C 197 ARG B 50 ARG^? 16.38 MG MG B 302 C 201 HIS B 147 HIS^? 9.27 MG MG B 301 C 204 HIS B 170 HIS^? 10.51 MG MG B 301 coo 30.92 14.23 15.70 28.82 13.90 13.48 55.38 14.91 7.80 56.60 14.73 10.62 coo 20.16 5.55 18.86 20.00 7.59 19.34 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 24.92 3.29 16.90 24.41 4.92 15.69 46.22 13.75 -2.72 47.53 13.11 -4.24 ULMN 3 1j70_c02 ATP SULPHURYLASE user 3 3 # 3 C 197 ARG B 50 ARG^? 16.38 MG MG B 302 C 201 HIS B 170 HIS^? 10.51 MG MG B 301 C 204 HIS B 147 HIS^? 9.27 MG MG B 301 coo 30.92 14.23 15.70 28.82 13.90 13.48 55.38 14.91 7.80 56.60 14.73 10.62 coo 20.16 5.55 18.86 20.00 7.59 19.34 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 24.92 3.29 16.90 24.41 4.92 15.69 46.73 18.97 -3.05 45.63 17.32 -3.73 ULMN 3 1j70_c02 ATP SULPHURYLASE user 4 3 # 4 C 197 ARG C 50 ARG^? 16.05 MG MG C 302 C 201 HIS C 147 HIS^? 9.44 MG MG C 301 C 204 HIS C 170 HIS^? 10.68 MG MG C 301 coo 30.92 14.23 15.70 28.82 13.90 13.48 80.61 19.03 -14.42 79.16 18.55 -17.10 coo 20.16 5.55 18.86 20.00 7.59 19.34 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 24.92 3.29 16.90 24.41 4.92 15.69 89.96 21.05 -3.85 88.74 19.88 -2.61 ULMN 3 1j70_c02 ATP SULPHURYLASE user 5 3 # 5 C 197 ARG E 50 ARG^? 15.97 MG MG E 302 C 201 HIS E 147 HIS^? 9.22 MG MG E 301 C 204 HIS E 170 HIS^? 10.33 MG MG E 301 coo 30.92 14.23 15.70 28.82 13.90 13.48 73.62 60.83 -58.23 74.10 60.41 -61.24 coo 20.16 5.55 18.86 20.00 7.59 19.34 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 24.92 3.29 16.90 24.41 4.92 15.69 66.96 68.76 -48.87 68.36 68.54 -47.33 ULMN 3 1j70_c02 ATP SULPHURYLASE user 6 3 # 6 C 197 ARG E 50 ARG^? 15.97 MG MG E 302 C 201 HIS E 170 HIS^? 10.33 MG MG E 301 C 204 HIS E 147 HIS^? 9.22 MG MG E 301 coo 30.92 14.23 15.70 28.82 13.90 13.48 73.62 60.83 -58.23 74.10 60.41 -61.24 coo 20.16 5.55 18.86 20.00 7.59 19.34 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 24.92 3.29 16.90 24.41 4.92 15.69 63.87 64.43 -48.39 64.18 66.45 -47.92 ULMN 3 1j70_c02 ATP SULPHURYLASE user 7 3 # 7 C 197 ARG F 50 ARG^? 16.24 MG MG F 301 C 201 HIS F 147 HIS^? 8.79 MG MG F 302 C 204 HIS F 170 HIS^? 9.84 MG MG F 302 coo 30.92 14.23 15.70 28.82 13.90 13.48 48.85 56.05 -80.24 48.26 54.66 -77.55 coo 20.16 5.55 18.86 20.00 7.59 19.34 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 24.92 3.29 16.90 24.41 4.92 15.69 52.25 64.82 -90.91 50.95 63.88 -92.26 1j70_c02 source 1j70 ATP SULPHURYLASE : 7 hits 1j70_c02 naa= 3 ULMN 3 1j7g_c00 D-TYROSYL-TRNA(TYR) DEACYLASE user 1 3 # 1 A 78 GLN A 31 GLN^? 22.39 MG MG A 301 A 79 PHE A 32 PHE^? 15.95 MG MG A 301 A 80 THR A 18 THR.? 15.77 MG MG A 301 coo 18.18 6.97 -1.14 17.20 5.70 -2.56 31.14 44.15 31.07 29.13 43.58 31.45 coo 24.87 4.39 -2.11 26.74 2.89 -0.67 37.63 41.69 31.55 39.27 43.59 32.74 coo 21.26 8.65 -4.24 19.54 7.67 -5.04 32.02 38.89 33.13 34.18 39.03 32.98 ULMN 3 1j7g_c00 D-TYROSYL-TRNA(TYR) DEACYLASE user 2 3 # 2 A 78 GLN A 144 GLN^? 19.77 MG MG A 302 A 79 PHE A 190 PHE^? 14.49 MG MG A 302 A 80 THR A 191 THR^? 19.40 MG MG A 302 coo 18.18 6.97 -1.14 17.20 5.70 -2.56 46.49 12.77 42.93 46.53 10.83 42.06 coo 24.87 4.39 -2.11 26.74 2.89 -0.67 39.84 16.38 40.26 41.25 17.12 37.97 coo 21.26 8.65 -4.24 19.54 7.67 -5.04 41.09 12.09 41.99 41.84 10.51 43.34 ULMN 3 1j7g_c00 D-TYROSYL-TRNA(TYR) DEACYLASE user 3 3 # 3 A 78 GLN B 31 GLN^? 22.67 MG MG B 302 A 79 PHE B 32 PHE^? 15.77 MG MG B 302 A 80 THR B 18 THR^? 16.08 MG MG B 302 coo 18.18 6.97 -1.14 17.20 5.70 -2.56 64.85 5.67 6.51 64.18 3.71 5.97 coo 24.87 4.39 -2.11 26.74 2.89 -0.67 63.68 12.44 5.83 65.90 13.72 4.72 coo 21.26 8.65 -4.24 19.54 7.67 -5.04 60.02 7.32 3.97 60.86 9.29 4.05 ULMN 3 1j7g_c00 D-TYROSYL-TRNA(TYR) DEACYLASE user 4 3 # 4 A 78 GLN B 144 GLN^? 20.13 MG MG B 301 A 79 PHE B 190 PHE^? 14.80 MG MG B 301 A 80 THR B 191 THR^? 19.68 MG MG B 301 coo 18.18 6.97 -1.14 17.20 5.70 -2.56 37.08 26.58 -5.56 36.43 28.52 -6.04 coo 24.87 4.39 -2.11 26.74 2.89 -0.67 40.06 19.97 -3.89 40.77 21.13 -1.45 coo 21.26 8.65 -4.24 19.54 7.67 -5.04 36.37 22.10 -5.64 35.04 22.83 -7.26 ULMN 3 1j7g_c00 D-TYROSYL-TRNA(TYR) DEACYLASE user 5 3 # 5 A 78 GLN C 31 GLN^? 23.04 MG MG C 302 A 79 PHE C 32 PHE^? 15.72 MG MG C 302 A 80 THR C 18 THR^? 15.72 MG MG C 302 coo 18.18 6.97 -1.14 17.20 5.70 -2.56 75.42 6.53 -11.91 76.62 4.98 -12.81 coo 24.87 4.39 -2.11 26.74 2.89 -0.67 73.89 13.66 -12.38 71.29 14.19 -11.42 coo 21.26 8.65 -4.24 19.54 7.67 -5.04 79.00 10.43 -10.53 77.64 12.10 -10.65 ULMN 3 1j7g_c00 D-TYROSYL-TRNA(TYR) DEACYLASE user 6 3 # 6 A 78 GLN C 144 GLN^? 20.37 MG MG C 301 A 79 PHE C 190 PHE^? 14.91 MG MG C 301 A 80 THR C 191 THR^? 19.69 MG MG C 301 coo 18.18 6.97 -1.14 17.20 5.70 -2.56 92.57 37.16 -1.30 94.53 37.81 -1.71 coo 24.87 4.39 -2.11 26.74 2.89 -0.67 93.44 29.01 -2.85 92.36 29.94 -5.20 coo 21.26 8.65 -4.24 19.54 7.67 -5.04 96.18 32.27 -1.09 96.82 33.98 0.08 ULMN 3 1j7g_c00 D-TYROSYL-TRNA(TYR) DEACYLASE user 7 3 # 7 A 78 GLN D 31 GLN^? 22.20 MG MG D 302 A 79 PHE D 32 PHE^? 15.68 MG MG D 302 A 80 THR D 18 THR^? 15.54 MG MG D 302 coo 18.18 6.97 -1.14 17.20 5.70 -2.56 92.28 55.58 -37.94 94.36 55.52 -37.90 coo 24.87 4.39 -2.11 26.74 2.89 -0.67 87.15 50.70 -38.09 84.99 51.79 -39.44 coo 21.26 8.65 -4.24 19.54 7.67 -5.04 93.52 49.91 -39.68 91.41 49.57 -39.76 ULMN 3 1j7g_c00 D-TYROSYL-TRNA(TYR) DEACYLASE user 8 3 # 8 A 78 GLN D 144 GLN^? 19.85 MG MG D 301 A 79 PHE D 190 PHE^? 14.83 MG MG D 301 A 80 THR D 191 THR^? 18.81 MG MG D 301 coo 18.18 6.97 -1.14 17.20 5.70 -2.56 89.60 20.24 -48.38 88.70 18.97 -49.74 coo 24.87 4.39 -2.11 26.74 2.89 -0.67 93.52 26.32 -46.94 92.08 26.47 -44.56 coo 21.26 8.65 -4.24 19.54 7.67 -5.04 93.38 21.98 -48.52 93.15 21.07 -50.52 ULMN 3 1j7g_c00 D-TYROSYL-TRNA(TYR) DEACYLASE user 9 3 # 9 A 78 GLN E 31 GLN^? 23.24 MG MG E 302 A 79 PHE E 32 PHE^? 15.82 MG MG E 302 A 80 THR E 18 THR^? 15.84 MG MG E 302 coo 18.18 6.97 -1.14 17.20 5.70 -2.56 86.72 61.78 -58.15 88.75 61.32 -57.58 coo 24.87 4.39 -2.11 26.74 2.89 -0.67 81.32 57.98 -56.67 82.02 55.52 -55.49 coo 21.26 8.65 -4.24 19.54 7.67 -5.04 81.45 64.25 -55.27 80.73 62.21 -55.24 ULMN 3 1j7g_c00 D-TYROSYL-TRNA(TYR) DEACYLASE user 10 3 # 10 A 78 GLN E 144 GLN^? 20.26 MG MG E 301 A 79 PHE E 190 PHE^? 14.70 MG MG E 301 A 80 THR E 191 THR^? 19.16 MG MG E 301 coo 18.18 6.97 -1.14 17.20 5.70 -2.56 51.74 64.42 -45.34 50.01 64.85 -46.49 coo 24.87 4.39 -2.11 26.74 2.89 -0.67 58.27 67.97 -47.86 58.03 66.58 -50.23 coo 21.26 8.65 -4.24 19.54 7.67 -5.04 54.11 68.77 -46.13 52.75 69.16 -44.48 ULMN 3 1j7g_c00 D-TYROSYL-TRNA(TYR) DEACYLASE user 11 3 # 11 A 78 GLN F 31 GLN^? 22.77 MG MG F 301 A 79 PHE F 32 PHE^? 15.64 MG MG F 301 A 80 THR F 18 THR^? 15.93 MG MG F 301 coo 18.18 6.97 -1.14 17.20 5.70 -2.56 35.83 52.89 -82.79 34.54 54.19 -81.84 coo 24.87 4.39 -2.11 26.74 2.89 -0.67 42.40 50.26 -82.52 42.59 47.55 -83.32 coo 21.26 8.65 -4.24 19.54 7.67 -5.04 39.95 55.99 -83.96 41.26 54.27 -83.96 ULMN 3 1j7g_c00 D-TYROSYL-TRNA(TYR) DEACYLASE user 12 3 # 12 A 78 GLN F 144 GLN^? 20.16 MG MG F 302 A 79 PHE F 190 PHE^? 14.21 MG MG F 302 A 80 THR F 191 THR^? 18.93 MG MG F 302 coo 18.18 6.97 -1.14 17.20 5.70 -2.56 68.06 66.27 -93.88 70.14 65.97 -94.00 coo 24.87 4.39 -2.11 26.74 2.89 -0.67 60.66 66.91 -91.97 61.14 65.56 -89.57 coo 21.26 8.65 -4.24 19.54 7.67 -5.04 64.36 69.12 -93.82 65.88 69.37 -95.36 1j7g_c00 source 1j7g D-TYROSYL-TRNA(TYR) DEACYLASE : 12 hits 1j7g_c00 naa= 3 ULMN 3 1jdw_c01 L-ARGININE-GLYCINE AMIDINOTRANSFERASuser 1 3 # 1 254 ASP A 148 ASP^? 2.72 MG MG A 301s 303 HIS A 147 HIS^? 9.20 MG MG A 302 407 CYH A 152 CYH^? 15.18 MG MG A 302 coo 49.08 66.55 9.14 50.71 67.89 8.88 41.50 28.88 41.13 43.33 29.67 41.93 coo 47.11 68.57 13.19 49.07 68.74 12.45 40.24 23.10 39.83 38.32 22.34 40.22 coo 49.32 64.84 19.61 47.95 67.13 18.88 34.81 26.51 34.70 32.10 26.95 34.06 ULMN 3 1jdw_c01 L-ARGININE-GLYCINE AMIDINOTRANSFERASuser 2 3 # 2 254 ASP B 148 ASP^? 2.58 MG MG B 302s 303 HIS B 147 HIS^? 9.27 MG MG B 301 407 CYH B 152 CYH^? 14.66 MG MG B 301 coo 49.08 66.55 9.14 50.71 67.89 8.88 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 47.11 68.57 13.19 49.07 68.74 12.45 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 49.32 64.84 19.61 47.95 67.13 18.88 48.74 12.82 1.93 48.51 10.17 2.19 ULMN 3 1jdw_c01 L-ARGININE-GLYCINE AMIDINOTRANSFERASuser 3 3 # 3 254 ASP C 148 ASP^? 2.75 MG MG C 302s 303 HIS C 147 HIS^? 9.44 MG MG C 301 407 CYH C 152 CYH^? 14.61 MG MG C 301 coo 49.08 66.55 9.14 50.71 67.89 8.88 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 47.11 68.57 13.19 49.07 68.74 12.45 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 49.32 64.84 19.61 47.95 67.13 18.88 87.66 19.43 -8.58 88.77 17.04 -8.78 ULMN 3 1jdw_c01 L-ARGININE-GLYCINE AMIDINOTRANSFERASuser 4 3 # 4 254 ASP D 148 ASP^? 2.35 MG MG D 302s 303 HIS D 147 HIS^? 9.43 MG MG D 301 407 CYH D 152 CYH^? 14.66 MG MG D 301 coo 49.08 66.55 9.14 50.71 67.89 8.88 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 47.11 68.57 13.19 49.07 68.74 12.45 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 49.32 64.84 19.61 47.95 67.13 18.88 94.69 37.43 -41.36 96.92 38.83 -40.94 ULMN 3 1jdw_c01 L-ARGININE-GLYCINE AMIDINOTRANSFERASuser 5 3 # 5 254 ASP E 148 ASP^? 2.62 MG MG E 302s 303 HIS E 147 HIS^? 9.22 MG MG E 301 407 CYH E 152 CYH^? 14.64 MG MG E 301 coo 49.08 66.55 9.14 50.71 67.89 8.88 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 47.11 68.57 13.19 49.07 68.74 12.45 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 49.32 64.84 19.61 47.95 67.13 18.88 69.49 67.27 -53.54 71.02 69.50 -54.03 ULMN 3 1jdw_c01 L-ARGININE-GLYCINE AMIDINOTRANSFERASuser 6 3 # 6 254 ASP F 148 ASP^? 2.72 MG MG F 301s 303 HIS F 147 HIS^? 8.79 MG MG F 302 407 CYH F 152 CYH^? 14.14 MG MG F 302 coo 49.08 66.55 9.14 50.71 67.89 8.88 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 47.11 68.57 13.19 49.07 68.74 12.45 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 49.32 64.84 19.61 47.95 67.13 18.88 50.28 62.76 -86.08 48.12 64.34 -85.77 1jdw_c01 source 1jdw L-ARGININE-GLYCINE AMIDINOTRANSFERASE : 6 hits 1jdw_c01 naa= 3 ULMN 3 1jkm_c00 BREFELDIN A ESTERASE user 1 3 # 1 A 202 SER A 189 SER^? 11.75 MG MG A 302 A 308 ASP A 148 ASP^? 2.72 MG MG A 301s A 338 HIS A 147 HIS^? 9.20 MG MG A 302 coo 37.44 15.05 21.90 37.18 17.02 20.71 40.99 19.00 44.32 41.51 18.14 46.48 coo 45.75 18.77 19.41 43.72 18.70 19.99 41.50 28.88 41.13 43.33 29.67 41.93 coo 41.13 18.39 17.83 39.67 17.70 19.17 40.24 23.10 39.83 38.32 22.34 40.22 ULMN 3 1jkm_c00 BREFELDIN A ESTERASE user 2 3 # 2 A 202 SER B 189 SER^? 12.11 MG MG B 301 A 308 ASP B 148 ASP^? 2.58 MG MG B 302s A 338 HIS B 147 HIS^? 9.27 MG MG B 301 coo 37.44 15.05 21.90 37.18 17.02 20.71 43.10 20.95 -7.74 42.82 21.56 -10.02 coo 45.75 18.77 19.41 43.72 18.70 19.99 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 41.13 18.39 17.83 39.67 17.70 19.17 46.73 18.97 -3.05 45.63 17.32 -3.73 ULMN 3 1jkm_c00 BREFELDIN A ESTERASE user 3 3 # 3 A 202 SER C 189 SER^? 12.09 MG MG C 301 A 308 ASP C 148 ASP^? 2.75 MG MG C 302s A 338 HIS C 147 HIS^? 9.44 MG MG C 301 coo 37.44 15.05 21.90 37.18 17.02 20.71 90.33 28.79 1.19 90.26 29.61 3.45 coo 45.75 18.77 19.41 43.72 18.70 19.99 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 41.13 18.39 17.83 39.67 17.70 19.17 87.61 25.71 -3.59 89.22 24.50 -2.99 ULMN 3 1jkm_c00 BREFELDIN A ESTERASE user 4 3 # 4 A 202 SER D 189 SER^? 12.12 MG MG D 301 A 308 ASP D 148 ASP^? 2.35 MG MG D 302s A 338 HIS D 147 HIS^? 9.43 MG MG D 301 coo 37.44 15.05 21.90 37.18 17.02 20.71 91.62 28.58 -50.95 91.45 27.78 -53.25 coo 45.75 18.77 19.41 43.72 18.70 19.99 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 41.13 18.39 17.83 39.67 17.70 19.17 90.95 32.51 -46.42 92.98 32.42 -46.93 ULMN 3 1jkm_c00 BREFELDIN A ESTERASE user 5 3 # 5 A 202 SER E 189 SER^? 11.91 MG MG E 301 A 308 ASP E 148 ASP^? 2.62 MG MG E 302s A 338 HIS E 147 HIS^? 9.22 MG MG E 301 coo 37.44 15.05 21.90 37.18 17.02 20.71 60.13 65.61 -43.87 59.01 65.34 -41.74 coo 45.75 18.77 19.41 43.72 18.70 19.99 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 41.13 18.39 17.83 39.67 17.70 19.17 63.87 64.43 -48.39 64.18 66.45 -47.92 ULMN 3 1jkm_c00 BREFELDIN A ESTERASE user 6 3 # 6 A 202 SER F 189 SER^? 11.88 MG MG F 302 A 308 ASP F 148 ASP^? 2.72 MG MG F 301s A 338 HIS F 147 HIS^? 8.79 MG MG F 302 coo 37.44 15.05 21.90 37.18 17.02 20.71 59.91 63.90 -95.91 60.70 64.22 -98.13 coo 45.75 18.77 19.41 43.72 18.70 19.99 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 41.13 18.39 17.83 39.67 17.70 19.17 56.63 61.66 -91.16 55.69 63.43 -91.80 1jkm_c00 source 1jkm BREFELDIN A ESTERASE : 6 hits 1jkm_c00 naa= 3 ULMN 3 1jkm_c01 BREFELDIN A ESTERASE user 1 3 # 1 B 202 SER A 189 SER^? 11.75 MG MG A 302 B 308 ASP A 148 ASP^? 2.72 MG MG A 301s B 338 HIS A 147 HIS^? 9.20 MG MG A 302 coo 67.81 2.11 21.29 69.09 3.00 23.04 40.99 19.00 44.32 41.51 18.14 46.48 coo 64.20 9.21 26.15 65.67 7.96 25.24 41.50 28.88 41.13 43.33 29.67 41.93 coo 66.92 5.20 26.82 67.69 4.22 25.14 40.24 23.10 39.83 38.32 22.34 40.22 ULMN 3 1jkm_c01 BREFELDIN A ESTERASE user 2 3 # 2 B 202 SER B 189 SER^? 12.11 MG MG B 301 B 308 ASP B 148 ASP^? 2.58 MG MG B 302s B 338 HIS B 147 HIS^? 9.27 MG MG B 301 coo 67.81 2.11 21.29 69.09 3.00 23.04 43.10 20.95 -7.74 42.82 21.56 -10.02 coo 64.20 9.21 26.15 65.67 7.96 25.24 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 66.92 5.20 26.82 67.69 4.22 25.14 46.73 18.97 -3.05 45.63 17.32 -3.73 ULMN 3 1jkm_c01 BREFELDIN A ESTERASE user 3 3 # 3 B 202 SER C 189 SER^? 12.09 MG MG C 301 B 308 ASP C 148 ASP^? 2.75 MG MG C 302s B 338 HIS C 147 HIS^? 9.44 MG MG C 301 coo 67.81 2.11 21.29 69.09 3.00 23.04 90.33 28.79 1.19 90.26 29.61 3.45 coo 64.20 9.21 26.15 65.67 7.96 25.24 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 66.92 5.20 26.82 67.69 4.22 25.14 87.61 25.71 -3.59 89.22 24.50 -2.99 ULMN 3 1jkm_c01 BREFELDIN A ESTERASE user 4 3 # 4 B 202 SER D 189 SER^? 12.12 MG MG D 301 B 308 ASP D 148 ASP^? 2.35 MG MG D 302s B 338 HIS D 147 HIS^? 9.43 MG MG D 301 coo 67.81 2.11 21.29 69.09 3.00 23.04 91.62 28.58 -50.95 91.45 27.78 -53.25 coo 64.20 9.21 26.15 65.67 7.96 25.24 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 66.92 5.20 26.82 67.69 4.22 25.14 90.95 32.51 -46.42 92.98 32.42 -46.93 ULMN 3 1jkm_c01 BREFELDIN A ESTERASE user 5 3 # 5 B 202 SER E 189 SER^? 11.91 MG MG E 301 B 308 ASP E 148 ASP^? 2.62 MG MG E 302s B 338 HIS E 147 HIS^? 9.22 MG MG E 301 coo 67.81 2.11 21.29 69.09 3.00 23.04 60.13 65.61 -43.87 59.01 65.34 -41.74 coo 64.20 9.21 26.15 65.67 7.96 25.24 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 66.92 5.20 26.82 67.69 4.22 25.14 63.87 64.43 -48.39 64.18 66.45 -47.92 ULMN 3 1jkm_c01 BREFELDIN A ESTERASE user 6 3 # 6 B 202 SER F 189 SER^? 11.88 MG MG F 302 B 308 ASP F 148 ASP^? 2.72 MG MG F 301s B 338 HIS F 147 HIS^? 8.79 MG MG F 302 coo 67.81 2.11 21.29 69.09 3.00 23.04 59.91 63.90 -95.91 60.70 64.22 -98.13 coo 64.20 9.21 26.15 65.67 7.96 25.24 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 66.92 5.20 26.82 67.69 4.22 25.14 56.63 61.66 -91.16 55.69 63.43 -91.80 1jkm_c01 source 1jkm BREFELDIN A ESTERASE : 6 hits 1jkm_c01 naa= 3 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 1 3 # 1 A 55 ASP A 128 ASP^? -3.32 MG MG A 301s A 58 ASP A 148 ASP^? 2.72 MG MG A 301s A 424 GLU A 146 GLU^? 9.80 MG MG A 302 coo 58.42 47.76 20.67 58.01 49.10 19.12 46.50 28.23 39.77 47.49 30.10 39.82 coo 58.59 41.80 18.81 58.94 43.89 18.94 41.50 28.88 41.13 43.33 29.67 41.93 coo 52.85 46.34 13.34 54.09 44.97 14.42 45.17 20.35 44.20 46.68 21.21 45.40 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 2 3 # 2 A 55 ASP A 148 ASP^? 2.72 MG MG A 301s A 58 ASP A 128 ASP^? -3.32 MG MG A 301s A 424 GLU A 146 GLU^? 9.80 MG MG A 302 coo 58.42 47.76 20.67 58.01 49.10 19.12 41.50 28.88 41.13 43.33 29.67 41.93 coo 58.59 41.80 18.81 58.94 43.89 18.94 46.50 28.23 39.77 47.49 30.10 39.82 coo 52.85 46.34 13.34 54.09 44.97 14.42 45.17 20.35 44.20 46.68 21.21 45.40 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 3 3 # 3 A 55 ASP A 148 ASP^? 2.72 MG MG A 301s A 58 ASP A 187 ASP^? -3.29 MG MG A 302s A 424 GLU A 146 GLU^? 9.80 MG MG A 302 coo 58.42 47.76 20.67 58.01 49.10 19.12 41.50 28.88 41.13 43.33 29.67 41.93 coo 58.59 41.80 18.81 58.94 43.89 18.94 39.43 26.57 46.78 39.37 27.83 45.03 coo 52.85 46.34 13.34 54.09 44.97 14.42 45.17 20.35 44.20 46.68 21.21 45.40 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 4 3 # 4 A 55 ASP A 187 ASP^? -3.29 MG MG A 302s A 58 ASP A 148 ASP^? 2.72 MG MG A 301s A 424 GLU A 146 GLU^? 9.80 MG MG A 302 coo 58.42 47.76 20.67 58.01 49.10 19.12 39.43 26.57 46.78 39.37 27.83 45.03 coo 58.59 41.80 18.81 58.94 43.89 18.94 41.50 28.88 41.13 43.33 29.67 41.93 coo 52.85 46.34 13.34 54.09 44.97 14.42 45.17 20.35 44.20 46.68 21.21 45.40 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 5 3 # 5 A 55 ASP B 128 ASP^? -3.57 MG MG B 302s A 58 ASP B 148 ASP^? 2.58 MG MG B 302s A 424 GLU B 146 GLU^? 10.54 MG MG B 301 coo 58.42 47.76 20.67 58.01 49.10 19.12 52.92 24.09 -2.19 54.73 25.14 -1.90 coo 58.59 41.80 18.81 58.94 43.89 18.94 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 52.85 46.34 13.34 54.09 44.97 14.42 45.13 24.51 -7.01 46.08 25.99 -8.13 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 6 3 # 6 A 55 ASP B 148 ASP^? 2.58 MG MG B 302s A 58 ASP B 128 ASP^? -3.57 MG MG B 302s A 424 GLU B 146 GLU^? 10.54 MG MG B 301 coo 58.42 47.76 20.67 58.01 49.10 19.12 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 58.59 41.80 18.81 58.94 43.89 18.94 52.92 24.09 -2.19 54.73 25.14 -1.90 coo 52.85 46.34 13.34 54.09 44.97 14.42 45.13 24.51 -7.01 46.08 25.99 -8.13 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 7 3 # 7 A 55 ASP B 148 ASP^? 2.58 MG MG B 302s A 58 ASP B 187 ASP^? -3.44 MG MG B 301s A 424 GLU B 146 GLU^? 10.54 MG MG B 301 coo 58.42 47.76 20.67 58.01 49.10 19.12 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 58.59 41.80 18.81 58.94 43.89 18.94 50.64 18.14 -9.69 51.74 17.63 -7.86 coo 52.85 46.34 13.34 54.09 44.97 14.42 45.13 24.51 -7.01 46.08 25.99 -8.13 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 8 3 # 8 A 55 ASP B 187 ASP^? -3.44 MG MG B 301s A 58 ASP B 148 ASP^? 2.58 MG MG B 302s A 424 GLU B 146 GLU^? 10.54 MG MG B 301 coo 58.42 47.76 20.67 58.01 49.10 19.12 50.64 18.14 -9.69 51.74 17.63 -7.86 coo 58.59 41.80 18.81 58.94 43.89 18.94 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 52.85 46.34 13.34 54.09 44.97 14.42 45.13 24.51 -7.01 46.08 25.99 -8.13 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 9 3 # 9 A 55 ASP C 128 ASP^? -3.22 MG MG C 302s A 58 ASP C 148 ASP^? 2.75 MG MG C 302s A 424 GLU C 146 GLU^? 10.46 MG MG C 301 coo 58.42 47.76 20.67 58.01 49.10 19.12 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 58.59 41.80 18.81 58.94 43.89 18.94 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 52.85 46.34 13.34 54.09 44.97 14.42 87.01 31.93 0.25 85.57 32.56 1.72 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 10 3 # 10 A 55 ASP C 148 ASP^? 2.75 MG MG C 302s A 58 ASP C 128 ASP^? -3.22 MG MG C 302s A 424 GLU C 146 GLU^? 10.46 MG MG C 301 coo 58.42 47.76 20.67 58.01 49.10 19.12 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 58.59 41.80 18.81 58.94 43.89 18.94 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 52.85 46.34 13.34 54.09 44.97 14.42 87.01 31.93 0.25 85.57 32.56 1.72 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 11 3 # 11 A 55 ASP C 148 ASP^? 2.75 MG MG C 302s A 58 ASP C 187 ASP^? -3.72 MG MG C 301s A 424 GLU C 146 GLU^? 10.46 MG MG C 301 coo 58.42 47.76 20.67 58.01 49.10 19.12 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 58.59 41.80 18.81 58.94 43.89 18.94 84.01 23.73 3.39 83.47 22.54 1.59 coo 52.85 46.34 13.34 54.09 44.97 14.42 87.01 31.93 0.25 85.57 32.56 1.72 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 12 3 # 12 A 55 ASP C 187 ASP^? -3.72 MG MG C 301s A 58 ASP C 148 ASP^? 2.75 MG MG C 302s A 424 GLU C 146 GLU^? 10.46 MG MG C 301 coo 58.42 47.76 20.67 58.01 49.10 19.12 84.01 23.73 3.39 83.47 22.54 1.59 coo 58.59 41.80 18.81 58.94 43.89 18.94 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 52.85 46.34 13.34 54.09 44.97 14.42 87.01 31.93 0.25 85.57 32.56 1.72 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 13 3 # 13 A 55 ASP D 128 ASP^? -3.70 MG MG D 302s A 58 ASP D 148 ASP^? 2.35 MG MG D 302s A 424 GLU D 146 GLU^? 10.62 MG MG D 301 coo 58.42 47.76 20.67 58.01 49.10 19.12 83.33 35.45 -46.13 81.57 36.63 -46.10 coo 58.59 41.80 18.81 58.94 43.89 18.94 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 52.85 46.34 13.34 54.09 44.97 14.42 87.24 28.82 -50.92 85.47 28.08 -51.67 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 14 3 # 14 A 55 ASP D 148 ASP^? 2.35 MG MG D 302s A 58 ASP D 128 ASP^? -3.70 MG MG D 302s A 424 GLU D 146 GLU^? 10.62 MG MG D 301 coo 58.42 47.76 20.67 58.01 49.10 19.12 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 58.59 41.80 18.81 58.94 43.89 18.94 83.33 35.45 -46.13 81.57 36.63 -46.10 coo 52.85 46.34 13.34 54.09 44.97 14.42 87.24 28.82 -50.92 85.47 28.08 -51.67 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 15 3 # 15 A 55 ASP D 148 ASP^? 2.35 MG MG D 302s A 58 ASP D 187 ASP^? -2.95 MG MG D 301s A 424 GLU D 146 GLU^? 10.62 MG MG D 301 coo 58.42 47.76 20.67 58.01 49.10 19.12 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 58.59 41.80 18.81 58.94 43.89 18.94 90.40 36.34 -52.69 89.24 37.98 -51.99 coo 52.85 46.34 13.34 54.09 44.97 14.42 87.24 28.82 -50.92 85.47 28.08 -51.67 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 16 3 # 16 A 55 ASP D 187 ASP^? -2.95 MG MG D 301s A 58 ASP D 148 ASP^? 2.35 MG MG D 302s A 424 GLU D 146 GLU^? 10.62 MG MG D 301 coo 58.42 47.76 20.67 58.01 49.10 19.12 90.40 36.34 -52.69 89.24 37.98 -51.99 coo 58.59 41.80 18.81 58.94 43.89 18.94 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 52.85 46.34 13.34 54.09 44.97 14.42 87.24 28.82 -50.92 85.47 28.08 -51.67 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 17 3 # 17 A 55 ASP E 128 ASP^? -3.53 MG MG E 302s A 58 ASP E 148 ASP^? 2.62 MG MG E 302s A 424 GLU E 146 GLU^? 10.15 MG MG E 301 coo 58.42 47.76 20.67 58.01 49.10 19.12 65.38 56.57 -48.58 66.15 54.57 -48.61 coo 58.59 41.80 18.81 58.94 43.89 18.94 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 52.85 46.34 13.34 54.09 44.97 14.42 58.72 60.89 -44.51 59.23 60.24 -42.54 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 18 3 # 18 A 55 ASP E 148 ASP^? 2.62 MG MG E 302s A 58 ASP E 128 ASP^? -3.53 MG MG E 302s A 424 GLU E 146 GLU^? 10.15 MG MG E 301 coo 58.42 47.76 20.67 58.01 49.10 19.12 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 58.59 41.80 18.81 58.94 43.89 18.94 65.38 56.57 -48.58 66.15 54.57 -48.61 coo 52.85 46.34 13.34 54.09 44.97 14.42 58.72 60.89 -44.51 59.23 60.24 -42.54 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 19 3 # 19 A 55 ASP E 148 ASP^? 2.62 MG MG E 302s A 58 ASP E 187 ASP^? -2.71 MG MG E 301s A 424 GLU E 146 GLU^? 10.15 MG MG E 301 coo 58.42 47.76 20.67 58.01 49.10 19.12 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 58.59 41.80 18.81 58.94 43.89 18.94 67.50 63.43 -41.69 68.97 62.26 -42.81 coo 52.85 46.34 13.34 54.09 44.97 14.42 58.72 60.89 -44.51 59.23 60.24 -42.54 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 20 3 # 20 A 55 ASP E 187 ASP^? -2.71 MG MG E 301s A 58 ASP E 148 ASP^? 2.62 MG MG E 302s A 424 GLU E 146 GLU^? 10.15 MG MG E 301 coo 58.42 47.76 20.67 58.01 49.10 19.12 67.50 63.43 -41.69 68.97 62.26 -42.81 coo 58.59 41.80 18.81 58.94 43.89 18.94 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 52.85 46.34 13.34 54.09 44.97 14.42 58.72 60.89 -44.51 59.23 60.24 -42.54 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 21 3 # 21 A 55 ASP F 128 ASP^? -3.41 MG MG F 301s A 58 ASP F 148 ASP^? 2.72 MG MG F 301s A 424 GLU F 146 GLU^? 10.36 MG MG F 302 coo 58.42 47.76 20.67 58.01 49.10 19.12 57.76 53.73 -90.50 57.46 51.64 -90.28 coo 58.59 41.80 18.81 58.94 43.89 18.94 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 52.85 46.34 13.34 54.09 44.97 14.42 61.95 60.17 -95.28 62.87 58.56 -96.19 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 22 3 # 22 A 55 ASP F 148 ASP^? 2.72 MG MG F 301s A 58 ASP F 128 ASP^? -3.41 MG MG F 301s A 424 GLU F 146 GLU^? 10.36 MG MG F 302 coo 58.42 47.76 20.67 58.01 49.10 19.12 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 58.59 41.80 18.81 58.94 43.89 18.94 57.76 53.73 -90.50 57.46 51.64 -90.28 coo 52.85 46.34 13.34 54.09 44.97 14.42 61.95 60.17 -95.28 62.87 58.56 -96.19 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 23 3 # 23 A 55 ASP F 148 ASP^? 2.72 MG MG F 301s A 58 ASP F 187 ASP^? -3.27 MG MG F 302s A 424 GLU F 146 GLU^? 10.36 MG MG F 302 coo 58.42 47.76 20.67 58.01 49.10 19.12 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 58.59 41.80 18.81 58.94 43.89 18.94 53.93 58.87 -98.14 52.45 58.62 -96.61 coo 52.85 46.34 13.34 54.09 44.97 14.42 61.95 60.17 -95.28 62.87 58.56 -96.19 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 24 3 # 24 A 55 ASP F 187 ASP^? -3.27 MG MG F 302s A 58 ASP F 148 ASP^? 2.72 MG MG F 301s A 424 GLU F 146 GLU^? 10.36 MG MG F 302 coo 58.42 47.76 20.67 58.01 49.10 19.12 53.93 58.87 -98.14 52.45 58.62 -96.61 coo 58.59 41.80 18.81 58.94 43.89 18.94 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 52.85 46.34 13.34 54.09 44.97 14.42 61.95 60.17 -95.28 62.87 58.56 -96.19 1js4_c00 source 1js4 ENDO-EXOCELLULASE E4 : 24 hits 1js4_c00 naa= 3 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 1 3 # 1 B 55 ASP A 128 ASP^? -3.32 MG MG A 301s B 58 ASP A 148 ASP^? 2.72 MG MG A 301s B 424 GLU A 146 GLU^? 9.80 MG MG A 302 coo 112.10 61.46 19.99 111.82 60.65 18.07 46.50 28.23 39.77 47.49 30.10 39.82 coo 117.85 63.62 21.08 115.96 63.25 20.18 41.50 28.88 41.13 43.33 29.67 41.93 coo 118.47 57.23 15.57 119.32 58.77 16.73 45.17 20.35 44.20 46.68 21.21 45.40 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 2 3 # 2 B 55 ASP A 148 ASP^? 2.72 MG MG A 301s B 58 ASP A 128 ASP^? -3.32 MG MG A 301s B 424 GLU A 146 GLU^? 9.80 MG MG A 302 coo 112.10 61.46 19.99 111.82 60.65 18.07 41.50 28.88 41.13 43.33 29.67 41.93 coo 117.85 63.62 21.08 115.96 63.25 20.18 46.50 28.23 39.77 47.49 30.10 39.82 coo 118.47 57.23 15.57 119.32 58.77 16.73 45.17 20.35 44.20 46.68 21.21 45.40 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 3 3 # 3 B 55 ASP A 148 ASP^? 2.72 MG MG A 301s B 58 ASP A 187 ASP^? -3.29 MG MG A 302s B 424 GLU A 146 GLU^? 9.80 MG MG A 302 coo 112.10 61.46 19.99 111.82 60.65 18.07 41.50 28.88 41.13 43.33 29.67 41.93 coo 117.85 63.62 21.08 115.96 63.25 20.18 39.43 26.57 46.78 39.37 27.83 45.03 coo 118.47 57.23 15.57 119.32 58.77 16.73 45.17 20.35 44.20 46.68 21.21 45.40 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 4 3 # 4 B 55 ASP A 187 ASP^? -3.29 MG MG A 302s B 58 ASP A 148 ASP^? 2.72 MG MG A 301s B 424 GLU A 146 GLU^? 9.80 MG MG A 302 coo 112.10 61.46 19.99 111.82 60.65 18.07 39.43 26.57 46.78 39.37 27.83 45.03 coo 117.85 63.62 21.08 115.96 63.25 20.18 41.50 28.88 41.13 43.33 29.67 41.93 coo 118.47 57.23 15.57 119.32 58.77 16.73 45.17 20.35 44.20 46.68 21.21 45.40 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 5 3 # 5 B 55 ASP B 128 ASP^? -3.57 MG MG B 302s B 58 ASP B 148 ASP^? 2.58 MG MG B 302s B 424 GLU B 146 GLU^? 10.54 MG MG B 301 coo 112.10 61.46 19.99 111.82 60.65 18.07 52.92 24.09 -2.19 54.73 25.14 -1.90 coo 117.85 63.62 21.08 115.96 63.25 20.18 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 118.47 57.23 15.57 119.32 58.77 16.73 45.13 24.51 -7.01 46.08 25.99 -8.13 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 6 3 # 6 B 55 ASP B 148 ASP^? 2.58 MG MG B 302s B 58 ASP B 128 ASP^? -3.57 MG MG B 302s B 424 GLU B 146 GLU^? 10.54 MG MG B 301 coo 112.10 61.46 19.99 111.82 60.65 18.07 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 117.85 63.62 21.08 115.96 63.25 20.18 52.92 24.09 -2.19 54.73 25.14 -1.90 coo 118.47 57.23 15.57 119.32 58.77 16.73 45.13 24.51 -7.01 46.08 25.99 -8.13 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 7 3 # 7 B 55 ASP B 148 ASP^? 2.58 MG MG B 302s B 58 ASP B 187 ASP^? -3.44 MG MG B 301s B 424 GLU B 146 GLU^? 10.54 MG MG B 301 coo 112.10 61.46 19.99 111.82 60.65 18.07 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 117.85 63.62 21.08 115.96 63.25 20.18 50.64 18.14 -9.69 51.74 17.63 -7.86 coo 118.47 57.23 15.57 119.32 58.77 16.73 45.13 24.51 -7.01 46.08 25.99 -8.13 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 8 3 # 8 B 55 ASP B 187 ASP^? -3.44 MG MG B 301s B 58 ASP B 148 ASP^? 2.58 MG MG B 302s B 424 GLU B 146 GLU^? 10.54 MG MG B 301 coo 112.10 61.46 19.99 111.82 60.65 18.07 50.64 18.14 -9.69 51.74 17.63 -7.86 coo 117.85 63.62 21.08 115.96 63.25 20.18 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 118.47 57.23 15.57 119.32 58.77 16.73 45.13 24.51 -7.01 46.08 25.99 -8.13 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 9 3 # 9 B 55 ASP C 128 ASP^? -3.22 MG MG C 302s B 58 ASP C 148 ASP^? 2.75 MG MG C 302s B 424 GLU C 146 GLU^? 10.46 MG MG C 301 coo 112.10 61.46 19.99 111.82 60.65 18.07 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 117.85 63.62 21.08 115.96 63.25 20.18 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 118.47 57.23 15.57 119.32 58.77 16.73 87.01 31.93 0.25 85.57 32.56 1.72 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 10 3 # 10 B 55 ASP C 148 ASP^? 2.75 MG MG C 302s B 58 ASP C 128 ASP^? -3.22 MG MG C 302s B 424 GLU C 146 GLU^? 10.46 MG MG C 301 coo 112.10 61.46 19.99 111.82 60.65 18.07 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 117.85 63.62 21.08 115.96 63.25 20.18 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 118.47 57.23 15.57 119.32 58.77 16.73 87.01 31.93 0.25 85.57 32.56 1.72 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 11 3 # 11 B 55 ASP C 148 ASP^? 2.75 MG MG C 302s B 58 ASP C 187 ASP^? -3.72 MG MG C 301s B 424 GLU C 146 GLU^? 10.46 MG MG C 301 coo 112.10 61.46 19.99 111.82 60.65 18.07 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 117.85 63.62 21.08 115.96 63.25 20.18 84.01 23.73 3.39 83.47 22.54 1.59 coo 118.47 57.23 15.57 119.32 58.77 16.73 87.01 31.93 0.25 85.57 32.56 1.72 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 12 3 # 12 B 55 ASP C 187 ASP^? -3.72 MG MG C 301s B 58 ASP C 148 ASP^? 2.75 MG MG C 302s B 424 GLU C 146 GLU^? 10.46 MG MG C 301 coo 112.10 61.46 19.99 111.82 60.65 18.07 84.01 23.73 3.39 83.47 22.54 1.59 coo 117.85 63.62 21.08 115.96 63.25 20.18 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 118.47 57.23 15.57 119.32 58.77 16.73 87.01 31.93 0.25 85.57 32.56 1.72 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 13 3 # 13 B 55 ASP D 128 ASP^? -3.70 MG MG D 302s B 58 ASP D 148 ASP^? 2.35 MG MG D 302s B 424 GLU D 146 GLU^? 10.62 MG MG D 301 coo 112.10 61.46 19.99 111.82 60.65 18.07 83.33 35.45 -46.13 81.57 36.63 -46.10 coo 117.85 63.62 21.08 115.96 63.25 20.18 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 118.47 57.23 15.57 119.32 58.77 16.73 87.24 28.82 -50.92 85.47 28.08 -51.67 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 14 3 # 14 B 55 ASP D 148 ASP^? 2.35 MG MG D 302s B 58 ASP D 128 ASP^? -3.70 MG MG D 302s B 424 GLU D 146 GLU^? 10.62 MG MG D 301 coo 112.10 61.46 19.99 111.82 60.65 18.07 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 117.85 63.62 21.08 115.96 63.25 20.18 83.33 35.45 -46.13 81.57 36.63 -46.10 coo 118.47 57.23 15.57 119.32 58.77 16.73 87.24 28.82 -50.92 85.47 28.08 -51.67 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 15 3 # 15 B 55 ASP D 148 ASP^? 2.35 MG MG D 302s B 58 ASP D 187 ASP^? -2.95 MG MG D 301s B 424 GLU D 146 GLU^? 10.62 MG MG D 301 coo 112.10 61.46 19.99 111.82 60.65 18.07 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 117.85 63.62 21.08 115.96 63.25 20.18 90.40 36.34 -52.69 89.24 37.98 -51.99 coo 118.47 57.23 15.57 119.32 58.77 16.73 87.24 28.82 -50.92 85.47 28.08 -51.67 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 16 3 # 16 B 55 ASP D 187 ASP^? -2.95 MG MG D 301s B 58 ASP D 148 ASP^? 2.35 MG MG D 302s B 424 GLU D 146 GLU^? 10.62 MG MG D 301 coo 112.10 61.46 19.99 111.82 60.65 18.07 90.40 36.34 -52.69 89.24 37.98 -51.99 coo 117.85 63.62 21.08 115.96 63.25 20.18 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 118.47 57.23 15.57 119.32 58.77 16.73 87.24 28.82 -50.92 85.47 28.08 -51.67 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 17 3 # 17 B 55 ASP E 128 ASP^? -3.53 MG MG E 302s B 58 ASP E 148 ASP^? 2.62 MG MG E 302s B 424 GLU E 146 GLU^? 10.15 MG MG E 301 coo 112.10 61.46 19.99 111.82 60.65 18.07 65.38 56.57 -48.58 66.15 54.57 -48.61 coo 117.85 63.62 21.08 115.96 63.25 20.18 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 118.47 57.23 15.57 119.32 58.77 16.73 58.72 60.89 -44.51 59.23 60.24 -42.54 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 18 3 # 18 B 55 ASP E 148 ASP^? 2.62 MG MG E 302s B 58 ASP E 128 ASP^? -3.53 MG MG E 302s B 424 GLU E 146 GLU^? 10.15 MG MG E 301 coo 112.10 61.46 19.99 111.82 60.65 18.07 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 117.85 63.62 21.08 115.96 63.25 20.18 65.38 56.57 -48.58 66.15 54.57 -48.61 coo 118.47 57.23 15.57 119.32 58.77 16.73 58.72 60.89 -44.51 59.23 60.24 -42.54 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 19 3 # 19 B 55 ASP E 148 ASP^? 2.62 MG MG E 302s B 58 ASP E 187 ASP^? -2.71 MG MG E 301s B 424 GLU E 146 GLU^? 10.15 MG MG E 301 coo 112.10 61.46 19.99 111.82 60.65 18.07 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 117.85 63.62 21.08 115.96 63.25 20.18 67.50 63.43 -41.69 68.97 62.26 -42.81 coo 118.47 57.23 15.57 119.32 58.77 16.73 58.72 60.89 -44.51 59.23 60.24 -42.54 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 20 3 # 20 B 55 ASP E 187 ASP^? -2.71 MG MG E 301s B 58 ASP E 148 ASP^? 2.62 MG MG E 302s B 424 GLU E 146 GLU^? 10.15 MG MG E 301 coo 112.10 61.46 19.99 111.82 60.65 18.07 67.50 63.43 -41.69 68.97 62.26 -42.81 coo 117.85 63.62 21.08 115.96 63.25 20.18 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 118.47 57.23 15.57 119.32 58.77 16.73 58.72 60.89 -44.51 59.23 60.24 -42.54 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 21 3 # 21 B 55 ASP F 128 ASP^? -3.41 MG MG F 301s B 58 ASP F 148 ASP^? 2.72 MG MG F 301s B 424 GLU F 146 GLU^? 10.36 MG MG F 302 coo 112.10 61.46 19.99 111.82 60.65 18.07 57.76 53.73 -90.50 57.46 51.64 -90.28 coo 117.85 63.62 21.08 115.96 63.25 20.18 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 118.47 57.23 15.57 119.32 58.77 16.73 61.95 60.17 -95.28 62.87 58.56 -96.19 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 22 3 # 22 B 55 ASP F 148 ASP^? 2.72 MG MG F 301s B 58 ASP F 128 ASP^? -3.41 MG MG F 301s B 424 GLU F 146 GLU^? 10.36 MG MG F 302 coo 112.10 61.46 19.99 111.82 60.65 18.07 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 117.85 63.62 21.08 115.96 63.25 20.18 57.76 53.73 -90.50 57.46 51.64 -90.28 coo 118.47 57.23 15.57 119.32 58.77 16.73 61.95 60.17 -95.28 62.87 58.56 -96.19 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 23 3 # 23 B 55 ASP F 148 ASP^? 2.72 MG MG F 301s B 58 ASP F 187 ASP^? -3.27 MG MG F 302s B 424 GLU F 146 GLU^? 10.36 MG MG F 302 coo 112.10 61.46 19.99 111.82 60.65 18.07 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 117.85 63.62 21.08 115.96 63.25 20.18 53.93 58.87 -98.14 52.45 58.62 -96.61 coo 118.47 57.23 15.57 119.32 58.77 16.73 61.95 60.17 -95.28 62.87 58.56 -96.19 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 24 3 # 24 B 55 ASP F 187 ASP^? -3.27 MG MG F 302s B 58 ASP F 148 ASP^? 2.72 MG MG F 301s B 424 GLU F 146 GLU^? 10.36 MG MG F 302 coo 112.10 61.46 19.99 111.82 60.65 18.07 53.93 58.87 -98.14 52.45 58.62 -96.61 coo 117.85 63.62 21.08 115.96 63.25 20.18 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 118.47 57.23 15.57 119.32 58.77 16.73 61.95 60.17 -95.28 62.87 58.56 -96.19 1js4_c01 source 1js4 ENDO-EXOCELLULASE E4 : 24 hits 1js4_c01 naa= 3 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 A 2 GLU A 54 GLU^? 22.98 MG MG A 301 A 56 LYS A 6 LYS^? 25.88 MG MG A 301 A 258 ARG B 8 ARG^? 20.39 MG MG B 302 coo 42.33 1.56 26.99 42.38 2.91 28.66 45.06 19.97 24.02 44.05 19.39 22.19 coo 38.45 -0.44 19.89 37.36 0.90 25.90 46.20 12.82 24.71 44.50 16.64 20.52 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 41.99 18.82 11.83 44.91 18.76 12.93 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 A 2 GLU A 54 GLU^? 22.98 MG MG A 301 A 56 LYS A 157 LYS^? 28.65 MG MG A 302 A 258 ARG B 8 ARG^? 20.39 MG MG B 302 coo 42.33 1.56 26.99 42.38 2.91 28.66 45.06 19.97 24.02 44.05 19.39 22.19 coo 38.45 -0.44 19.89 37.36 0.90 25.90 41.42 12.06 27.58 41.46 5.93 29.41 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 41.99 18.82 11.83 44.91 18.76 12.93 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 A 2 GLU B 19 GLU^? 18.96 MG MG B 301 A 56 LYS B 21 LYS^? 13.97 MG MG B 301 A 258 ARG B 173 ARG^? 18.75 MG MG B 301 coo 42.33 1.56 26.99 42.38 2.91 28.66 59.29 4.54 -0.16 58.81 2.51 -0.44 coo 38.45 -0.44 19.89 37.36 0.90 25.90 67.50 6.37 -0.39 64.53 11.03 -2.88 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 49.83 5.55 0.39 48.19 5.30 3.03 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 A 2 GLU B 25 GLU^? 12.88 MG MG C 301 A 56 LYS C 21 LYS^? 14.49 MG MG C 302 A 258 ARG C 173 ARG^? 18.96 MG MG C 301 coo 42.33 1.56 26.99 42.38 2.91 28.66 79.57 9.59 -3.08 79.20 11.68 -3.64 coo 38.45 -0.44 19.89 37.36 0.90 25.90 72.10 6.87 -6.14 72.84 12.21 -4.93 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 89.11 11.40 -7.73 91.21 12.63 -9.73 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 A 2 GLU B 54 GLU^? 22.94 MG MG B 302 A 56 LYS B 6 LYS^? 25.90 MG MG B 302 A 258 ARG A 8 ARG^? 20.36 MG MG A 301 coo 42.33 1.56 26.99 42.38 2.91 28.66 43.18 23.27 12.99 42.40 22.23 14.68 coo 38.45 -0.44 19.89 37.36 0.90 25.90 36.26 25.44 11.74 39.65 23.12 16.29 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 40.62 19.52 24.63 40.98 22.51 23.88 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 6 3 # 6 A 2 GLU B 54 GLU^? 22.94 MG MG B 302 A 56 LYS B 157 LYS^? 28.85 MG MG B 302 A 258 ARG A 8 ARG^? 20.36 MG MG A 301 coo 42.33 1.56 26.99 42.38 2.91 28.66 43.18 23.27 12.99 42.40 22.23 14.68 coo 38.45 -0.44 19.89 37.36 0.90 25.90 34.97 21.28 8.44 29.03 22.82 6.58 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 40.62 19.52 24.63 40.98 22.51 23.88 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 7 3 # 7 A 2 GLU C 19 GLU^? 19.08 MG MG C 301 A 56 LYS C 21 LYS^? 14.49 MG MG C 302 A 258 ARG C 173 ARG^? 18.96 MG MG C 301 coo 42.33 1.56 26.99 42.38 2.91 28.66 80.46 7.67 -6.81 81.43 5.97 -5.99 coo 38.45 -0.44 19.89 37.36 0.90 25.90 72.10 6.87 -6.14 72.84 12.21 -4.93 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 89.11 11.40 -7.73 91.21 12.63 -9.73 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 8 3 # 8 A 2 GLU C 25 GLU^? 12.27 MG MG B 301 A 56 LYS B 21 LYS^? 13.97 MG MG B 301 A 258 ARG B 173 ARG^? 18.75 MG MG B 301 coo 42.33 1.56 26.99 42.38 2.91 28.66 58.50 6.48 -3.59 57.94 8.54 -3.41 coo 38.45 -0.44 19.89 37.36 0.90 25.90 67.50 6.37 -0.39 64.53 11.03 -2.88 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 49.83 5.55 0.39 48.19 5.30 3.03 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 9 3 # 9 A 2 GLU C 54 GLU^? 22.77 MG MG C 302 A 56 LYS C 6 LYS^? 25.73 MG MG C 302 A 258 ARG D 8 ARG^? 20.22 MG MG D 302 coo 42.33 1.56 26.99 42.38 2.91 28.66 88.91 31.25 -19.52 89.97 30.69 -21.29 coo 38.45 -0.44 19.89 37.36 0.90 25.90 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 92.22 28.83 -31.23 90.93 31.55 -30.54 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 10 3 # 10 A 2 GLU C 54 GLU^? 22.77 MG MG C 302 A 56 LYS C 157 LYS^? 28.15 MG MG C 302 A 258 ARG D 8 ARG^? 20.22 MG MG D 302 coo 42.33 1.56 26.99 42.38 2.91 28.66 88.91 31.25 -19.52 89.97 30.69 -21.29 coo 38.45 -0.44 19.89 37.36 0.90 25.90 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 92.22 28.83 -31.23 90.93 31.55 -30.54 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 11 3 # 11 A 2 GLU D 19 GLU^? 18.95 MG MG D 301 A 56 LYS D 21 LYS^? 14.47 MG MG D 302 A 258 ARG D 173 ARG^? 18.88 MG MG D 301 coo 42.33 1.56 26.99 42.38 2.91 28.66 96.86 51.08 -43.04 98.60 51.44 -44.26 coo 38.45 -0.44 19.89 37.36 0.90 25.90 90.57 56.85 -44.52 87.39 52.68 -46.00 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 100.48 42.57 -42.43 101.55 40.79 -40.06 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 12 3 # 12 A 2 GLU D 25 GLU^? 12.44 MG MG E 301 A 56 LYS E 21 LYS^? 14.42 MG MG E 301 A 258 ARG E 173 ARG^? 18.66 MG MG E 301 coo 42.33 1.56 26.99 42.38 2.91 28.66 81.26 66.22 -47.78 79.52 64.98 -48.06 coo 38.45 -0.44 19.89 37.36 0.90 25.90 87.88 60.38 -50.25 83.05 58.57 -47.65 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 75.16 72.26 -52.56 73.67 73.54 -55.01 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 13 3 # 13 A 2 GLU D 54 GLU^? 22.96 MG MG D 302 A 56 LYS D 6 LYS^? 25.98 MG MG D 302 A 258 ARG C 8 ARG^? 20.00 MG MG C 302 coo 42.33 1.56 26.99 42.38 2.91 28.66 87.96 27.60 -30.52 89.07 27.55 -28.72 coo 38.45 -0.44 19.89 37.36 0.90 25.90 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 91.42 27.61 -18.53 88.82 26.28 -19.38 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 14 3 # 14 A 2 GLU D 54 GLU^? 22.96 MG MG D 302 A 56 LYS D 157 LYS^? 28.67 MG MG D 302 A 258 ARG C 8 ARG^? 20.00 MG MG C 302 coo 42.33 1.56 26.99 42.38 2.91 28.66 87.96 27.60 -30.52 89.07 27.55 -28.72 coo 38.45 -0.44 19.89 37.36 0.90 25.90 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 91.42 27.61 -18.53 88.82 26.28 -19.38 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 15 3 # 15 A 2 GLU D 75 GLU^? 15.53 MG MG E 301 A 56 LYS D 86 LYS^? 25.80 MG MG D 302 A 258 ARG D 50 ARG^? 16.15 MG MG D 302 coo 42.33 1.56 26.99 42.38 2.91 28.66 84.53 54.81 -36.40 82.75 56.01 -36.42 coo 38.45 -0.44 19.89 37.36 0.90 25.90 85.54 56.79 -30.27 90.24 54.54 -28.62 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 88.00 43.26 -36.30 88.86 43.23 -33.34 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 16 3 # 16 A 2 GLU E 19 GLU^? 18.42 MG MG E 301 A 56 LYS E 21 LYS^? 14.42 MG MG E 301 A 258 ARG E 173 ARG^? 18.66 MG MG E 301 coo 42.33 1.56 26.99 42.38 2.91 28.66 82.78 67.13 -51.44 83.71 68.75 -50.40 coo 38.45 -0.44 19.89 37.36 0.90 25.90 87.88 60.38 -50.25 83.05 58.57 -47.65 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 75.16 72.26 -52.56 73.67 73.54 -55.01 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 17 3 # 17 A 2 GLU E 25 GLU^? 12.55 MG MG D 301 A 56 LYS D 21 LYS^? 14.47 MG MG D 302 A 258 ARG D 173 ARG^? 18.88 MG MG D 301 coo 42.33 1.56 26.99 42.38 2.91 28.66 95.44 49.40 -47.17 93.82 48.00 -47.21 coo 38.45 -0.44 19.89 37.36 0.90 25.90 90.57 56.85 -44.52 87.39 52.68 -46.00 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 100.48 42.57 -42.43 101.55 40.79 -40.06 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 18 3 # 18 A 2 GLU E 54 GLU^? 22.83 MG MG E 302 A 56 LYS E 6 LYS^? 25.59 MG MG E 302 A 258 ARG F 8 ARG^? 20.20 MG MG F 301 coo 42.33 1.56 26.99 42.38 2.91 28.66 58.39 62.16 -64.12 58.73 62.98 -66.04 coo 38.45 -0.44 19.89 37.36 0.90 25.90 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 58.98 65.22 -76.31 57.29 62.84 -75.38 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 19 3 # 19 A 2 GLU E 54 GLU^? 22.83 MG MG E 302 A 56 LYS E 157 LYS^? 28.40 MG MG E 302 A 258 ARG F 8 ARG^? 20.20 MG MG F 301 coo 42.33 1.56 26.99 42.38 2.91 28.66 58.39 62.16 -64.12 58.73 62.98 -66.04 coo 38.45 -0.44 19.89 37.36 0.90 25.90 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 58.98 65.22 -76.31 57.29 62.84 -75.38 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 20 3 # 20 A 2 GLU F 19 GLU^? 17.88 MG MG F 302 A 56 LYS F 21 LYS^? 14.14 MG MG F 301 A 258 ARG F 173 ARG^? 18.61 MG MG F 302 coo 42.33 1.56 26.99 42.38 2.91 28.66 36.39 58.51 -87.58 37.20 60.13 -88.66 coo 38.45 -0.44 19.89 37.36 0.90 25.90 35.01 50.26 -88.61 40.89 49.42 -90.41 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 43.18 65.58 -86.96 44.06 67.55 -84.65 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 21 3 # 21 A 2 GLU F 54 GLU^? 22.98 MG MG F 301 A 56 LYS F 6 LYS^? 26.09 MG MG F 301 A 258 ARG E 8 ARG^? 20.19 MG MG E 302 coo 42.33 1.56 26.99 42.38 2.91 28.66 62.26 62.27 -75.30 61.72 63.47 -73.60 coo 38.45 -0.44 19.89 37.36 0.90 25.90 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 60.42 66.09 -63.48 62.84 64.38 -64.17 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 22 3 # 22 A 2 GLU F 54 GLU^? 22.98 MG MG F 301 A 56 LYS F 157 LYS^? 28.36 MG MG F 302 A 258 ARG E 8 ARG^? 20.19 MG MG E 302 coo 42.33 1.56 26.99 42.38 2.91 28.66 62.26 62.27 -75.30 61.72 63.47 -73.60 coo 38.45 -0.44 19.89 37.36 0.90 25.90 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 60.42 66.09 -63.48 62.84 64.38 -64.17 1k82_c00 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 22 hits 1k82_c00 naa= 3 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 B 2 GLU A 54 GLU^? 22.98 MG MG A 301 B 56 LYS A 6 LYS^? 25.88 MG MG A 301 B 258 ARG B 8 ARG^? 20.39 MG MG B 302 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 45.06 19.97 24.02 44.05 19.39 22.19 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 46.20 12.82 24.71 44.50 16.64 20.52 coo 2.64 1.83 34.81 1.56 1.13 32.02 41.99 18.82 11.83 44.91 18.76 12.93 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 B 2 GLU A 54 GLU^? 22.98 MG MG A 301 B 56 LYS A 157 LYS^? 28.65 MG MG A 302 B 258 ARG B 8 ARG^? 20.39 MG MG B 302 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 45.06 19.97 24.02 44.05 19.39 22.19 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 41.42 12.06 27.58 41.46 5.93 29.41 coo 2.64 1.83 34.81 1.56 1.13 32.02 41.99 18.82 11.83 44.91 18.76 12.93 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 B 2 GLU B 19 GLU^? 18.96 MG MG B 301 B 56 LYS B 21 LYS^? 13.97 MG MG B 301 B 258 ARG B 173 ARG^? 18.75 MG MG B 301 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 59.29 4.54 -0.16 58.81 2.51 -0.44 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 67.50 6.37 -0.39 64.53 11.03 -2.88 coo 2.64 1.83 34.81 1.56 1.13 32.02 49.83 5.55 0.39 48.19 5.30 3.03 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 B 2 GLU B 25 GLU^? 12.88 MG MG C 301 B 56 LYS C 21 LYS^? 14.49 MG MG C 302 B 258 ARG C 173 ARG^? 18.96 MG MG C 301 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 79.57 9.59 -3.08 79.20 11.68 -3.64 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 72.10 6.87 -6.14 72.84 12.21 -4.93 coo 2.64 1.83 34.81 1.56 1.13 32.02 89.11 11.40 -7.73 91.21 12.63 -9.73 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 B 2 GLU B 54 GLU^? 22.94 MG MG B 302 B 56 LYS B 6 LYS^? 25.90 MG MG B 302 B 258 ARG A 8 ARG^? 20.36 MG MG A 301 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 43.18 23.27 12.99 42.40 22.23 14.68 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 36.26 25.44 11.74 39.65 23.12 16.29 coo 2.64 1.83 34.81 1.56 1.13 32.02 40.62 19.52 24.63 40.98 22.51 23.88 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 6 3 # 6 B 2 GLU B 54 GLU^? 22.94 MG MG B 302 B 56 LYS B 157 LYS^? 28.85 MG MG B 302 B 258 ARG A 8 ARG^? 20.36 MG MG A 301 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 43.18 23.27 12.99 42.40 22.23 14.68 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 34.97 21.28 8.44 29.03 22.82 6.58 coo 2.64 1.83 34.81 1.56 1.13 32.02 40.62 19.52 24.63 40.98 22.51 23.88 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 7 3 # 7 B 2 GLU C 19 GLU^? 19.08 MG MG C 301 B 56 LYS C 21 LYS^? 14.49 MG MG C 302 B 258 ARG C 173 ARG^? 18.96 MG MG C 301 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 80.46 7.67 -6.81 81.43 5.97 -5.99 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 72.10 6.87 -6.14 72.84 12.21 -4.93 coo 2.64 1.83 34.81 1.56 1.13 32.02 89.11 11.40 -7.73 91.21 12.63 -9.73 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 8 3 # 8 B 2 GLU C 25 GLU^? 12.27 MG MG B 301 B 56 LYS B 21 LYS^? 13.97 MG MG B 301 B 258 ARG B 173 ARG^? 18.75 MG MG B 301 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 58.50 6.48 -3.59 57.94 8.54 -3.41 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 67.50 6.37 -0.39 64.53 11.03 -2.88 coo 2.64 1.83 34.81 1.56 1.13 32.02 49.83 5.55 0.39 48.19 5.30 3.03 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 9 3 # 9 B 2 GLU C 54 GLU^? 22.77 MG MG C 302 B 56 LYS C 6 LYS^? 25.73 MG MG C 302 B 258 ARG D 8 ARG^? 20.22 MG MG D 302 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 88.91 31.25 -19.52 89.97 30.69 -21.29 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 2.64 1.83 34.81 1.56 1.13 32.02 92.22 28.83 -31.23 90.93 31.55 -30.54 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 10 3 # 10 B 2 GLU C 54 GLU^? 22.77 MG MG C 302 B 56 LYS C 157 LYS^? 28.15 MG MG C 302 B 258 ARG D 8 ARG^? 20.22 MG MG D 302 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 88.91 31.25 -19.52 89.97 30.69 -21.29 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 2.64 1.83 34.81 1.56 1.13 32.02 92.22 28.83 -31.23 90.93 31.55 -30.54 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 11 3 # 11 B 2 GLU D 19 GLU^? 18.95 MG MG D 301 B 56 LYS D 21 LYS^? 14.47 MG MG D 302 B 258 ARG D 173 ARG^? 18.88 MG MG D 301 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 96.86 51.08 -43.04 98.60 51.44 -44.26 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 90.57 56.85 -44.52 87.39 52.68 -46.00 coo 2.64 1.83 34.81 1.56 1.13 32.02 100.48 42.57 -42.43 101.55 40.79 -40.06 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 12 3 # 12 B 2 GLU D 25 GLU^? 12.44 MG MG E 301 B 56 LYS E 21 LYS^? 14.42 MG MG E 301 B 258 ARG E 173 ARG^? 18.66 MG MG E 301 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 81.26 66.22 -47.78 79.52 64.98 -48.06 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 87.88 60.38 -50.25 83.05 58.57 -47.65 coo 2.64 1.83 34.81 1.56 1.13 32.02 75.16 72.26 -52.56 73.67 73.54 -55.01 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 13 3 # 13 B 2 GLU D 54 GLU^? 22.96 MG MG D 302 B 56 LYS D 6 LYS^? 25.98 MG MG D 302 B 258 ARG C 8 ARG^? 20.00 MG MG C 302 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 87.96 27.60 -30.52 89.07 27.55 -28.72 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 2.64 1.83 34.81 1.56 1.13 32.02 91.42 27.61 -18.53 88.82 26.28 -19.38 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 14 3 # 14 B 2 GLU D 54 GLU^? 22.96 MG MG D 302 B 56 LYS D 157 LYS^? 28.67 MG MG D 302 B 258 ARG C 8 ARG^? 20.00 MG MG C 302 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 87.96 27.60 -30.52 89.07 27.55 -28.72 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 2.64 1.83 34.81 1.56 1.13 32.02 91.42 27.61 -18.53 88.82 26.28 -19.38 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 15 3 # 15 B 2 GLU D 75 GLU^? 15.53 MG MG E 301 B 56 LYS D 21 LYS^? 14.47 MG MG D 302 B 258 ARG D 50 ARG^? 16.15 MG MG D 302 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 84.53 54.81 -36.40 82.75 56.01 -36.42 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 90.57 56.85 -44.52 87.39 52.68 -46.00 coo 2.64 1.83 34.81 1.56 1.13 32.02 88.00 43.26 -36.30 88.86 43.23 -33.34 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 16 3 # 16 B 2 GLU D 75 GLU^? 15.53 MG MG E 301 B 56 LYS D 86 LYS^? 25.80 MG MG D 302 B 258 ARG D 50 ARG^? 16.15 MG MG D 302 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 84.53 54.81 -36.40 82.75 56.01 -36.42 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 85.54 56.79 -30.27 90.24 54.54 -28.62 coo 2.64 1.83 34.81 1.56 1.13 32.02 88.00 43.26 -36.30 88.86 43.23 -33.34 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 17 3 # 17 B 2 GLU E 19 GLU^? 18.42 MG MG E 301 B 56 LYS E 21 LYS^? 14.42 MG MG E 301 B 258 ARG E 173 ARG^? 18.66 MG MG E 301 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 82.78 67.13 -51.44 83.71 68.75 -50.40 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 87.88 60.38 -50.25 83.05 58.57 -47.65 coo 2.64 1.83 34.81 1.56 1.13 32.02 75.16 72.26 -52.56 73.67 73.54 -55.01 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 18 3 # 18 B 2 GLU E 25 GLU^? 12.55 MG MG D 301 B 56 LYS D 21 LYS^? 14.47 MG MG D 302 B 258 ARG D 173 ARG^? 18.88 MG MG D 301 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 95.44 49.40 -47.17 93.82 48.00 -47.21 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 90.57 56.85 -44.52 87.39 52.68 -46.00 coo 2.64 1.83 34.81 1.56 1.13 32.02 100.48 42.57 -42.43 101.55 40.79 -40.06 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 19 3 # 19 B 2 GLU E 54 GLU^? 22.83 MG MG E 302 B 56 LYS E 6 LYS^? 25.59 MG MG E 302 B 258 ARG F 8 ARG^? 20.20 MG MG F 301 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 58.39 62.16 -64.12 58.73 62.98 -66.04 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 2.64 1.83 34.81 1.56 1.13 32.02 58.98 65.22 -76.31 57.29 62.84 -75.38 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 20 3 # 20 B 2 GLU E 54 GLU^? 22.83 MG MG E 302 B 56 LYS E 157 LYS^? 28.40 MG MG E 302 B 258 ARG F 8 ARG^? 20.20 MG MG F 301 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 58.39 62.16 -64.12 58.73 62.98 -66.04 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 2.64 1.83 34.81 1.56 1.13 32.02 58.98 65.22 -76.31 57.29 62.84 -75.38 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 21 3 # 21 B 2 GLU F 19 GLU^? 17.88 MG MG F 302 B 56 LYS F 21 LYS^? 14.14 MG MG F 301 B 258 ARG F 173 ARG^? 18.61 MG MG F 302 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 36.39 58.51 -87.58 37.20 60.13 -88.66 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 35.01 50.26 -88.61 40.89 49.42 -90.41 coo 2.64 1.83 34.81 1.56 1.13 32.02 43.18 65.58 -86.96 44.06 67.55 -84.65 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 22 3 # 22 B 2 GLU F 54 GLU^? 22.98 MG MG F 301 B 56 LYS F 6 LYS^? 26.09 MG MG F 301 B 258 ARG E 8 ARG^? 20.19 MG MG E 302 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 62.26 62.27 -75.30 61.72 63.47 -73.60 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 2.64 1.83 34.81 1.56 1.13 32.02 60.42 66.09 -63.48 62.84 64.38 -64.17 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 23 3 # 23 B 2 GLU F 54 GLU^? 22.98 MG MG F 301 B 56 LYS F 157 LYS^? 28.36 MG MG F 302 B 258 ARG E 8 ARG^? 20.19 MG MG E 302 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 62.26 62.27 -75.30 61.72 63.47 -73.60 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 2.64 1.83 34.81 1.56 1.13 32.02 60.42 66.09 -63.48 62.84 64.38 -64.17 1k82_c01 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 23 hits 1k82_c01 naa= 3 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 C 2 GLU A 54 GLU^? 22.98 MG MG A 301 C 56 LYS A 6 LYS^? 25.88 MG MG A 301 C 258 ARG B 8 ARG^? 20.39 MG MG B 302 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 45.06 19.97 24.02 44.05 19.39 22.19 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 46.20 12.82 24.71 44.50 16.64 20.52 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 41.99 18.82 11.83 44.91 18.76 12.93 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 C 2 GLU A 54 GLU^? 22.98 MG MG A 301 C 56 LYS A 157 LYS^? 28.65 MG MG A 302 C 258 ARG B 8 ARG^? 20.39 MG MG B 302 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 45.06 19.97 24.02 44.05 19.39 22.19 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 41.42 12.06 27.58 41.46 5.93 29.41 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 41.99 18.82 11.83 44.91 18.76 12.93 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 C 2 GLU B 25 GLU^? 12.88 MG MG C 301 C 56 LYS C 21 LYS^? 14.49 MG MG C 302 C 258 ARG C 173 ARG^? 18.96 MG MG C 301 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 79.57 9.59 -3.08 79.20 11.68 -3.64 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 72.10 6.87 -6.14 72.84 12.21 -4.93 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 89.11 11.40 -7.73 91.21 12.63 -9.73 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 C 2 GLU B 54 GLU^? 22.94 MG MG B 302 C 56 LYS B 6 LYS^? 25.90 MG MG B 302 C 258 ARG A 8 ARG^? 20.36 MG MG A 301 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 43.18 23.27 12.99 42.40 22.23 14.68 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 36.26 25.44 11.74 39.65 23.12 16.29 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 40.62 19.52 24.63 40.98 22.51 23.88 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 C 2 GLU B 54 GLU^? 22.94 MG MG B 302 C 56 LYS B 157 LYS^? 28.85 MG MG B 302 C 258 ARG A 8 ARG^? 20.36 MG MG A 301 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 43.18 23.27 12.99 42.40 22.23 14.68 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 34.97 21.28 8.44 29.03 22.82 6.58 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 40.62 19.52 24.63 40.98 22.51 23.88 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 6 3 # 6 C 2 GLU C 19 GLU^? 19.08 MG MG C 301 C 56 LYS C 21 LYS^? 14.49 MG MG C 302 C 258 ARG C 173 ARG^? 18.96 MG MG C 301 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 80.46 7.67 -6.81 81.43 5.97 -5.99 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 72.10 6.87 -6.14 72.84 12.21 -4.93 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 89.11 11.40 -7.73 91.21 12.63 -9.73 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 7 3 # 7 C 2 GLU C 54 GLU^? 22.77 MG MG C 302 C 56 LYS C 6 LYS^? 25.73 MG MG C 302 C 258 ARG D 8 ARG^? 20.22 MG MG D 302 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 88.91 31.25 -19.52 89.97 30.69 -21.29 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 92.22 28.83 -31.23 90.93 31.55 -30.54 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 8 3 # 8 C 2 GLU C 54 GLU^? 22.77 MG MG C 302 C 56 LYS C 157 LYS^? 28.15 MG MG C 302 C 258 ARG D 8 ARG^? 20.22 MG MG D 302 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 88.91 31.25 -19.52 89.97 30.69 -21.29 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 92.22 28.83 -31.23 90.93 31.55 -30.54 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 9 3 # 9 C 2 GLU D 19 GLU^? 18.95 MG MG D 301 C 56 LYS D 21 LYS^? 14.47 MG MG D 302 C 258 ARG D 173 ARG^? 18.88 MG MG D 301 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 96.86 51.08 -43.04 98.60 51.44 -44.26 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 90.57 56.85 -44.52 87.39 52.68 -46.00 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 100.48 42.57 -42.43 101.55 40.79 -40.06 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 10 3 # 10 C 2 GLU D 25 GLU^? 12.44 MG MG E 301 C 56 LYS E 21 LYS^? 14.42 MG MG E 301 C 258 ARG E 173 ARG^? 18.66 MG MG E 301 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 81.26 66.22 -47.78 79.52 64.98 -48.06 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 87.88 60.38 -50.25 83.05 58.57 -47.65 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 75.16 72.26 -52.56 73.67 73.54 -55.01 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 11 3 # 11 C 2 GLU D 54 GLU^? 22.96 MG MG D 302 C 56 LYS D 6 LYS^? 25.98 MG MG D 302 C 258 ARG C 8 ARG^? 20.00 MG MG C 302 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 87.96 27.60 -30.52 89.07 27.55 -28.72 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 91.42 27.61 -18.53 88.82 26.28 -19.38 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 12 3 # 12 C 2 GLU D 54 GLU^? 22.96 MG MG D 302 C 56 LYS D 157 LYS^? 28.67 MG MG D 302 C 258 ARG C 8 ARG^? 20.00 MG MG C 302 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 87.96 27.60 -30.52 89.07 27.55 -28.72 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 91.42 27.61 -18.53 88.82 26.28 -19.38 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 13 3 # 13 C 2 GLU D 75 GLU^? 15.53 MG MG E 301 C 56 LYS D 21 LYS^? 14.47 MG MG D 302 C 258 ARG D 50 ARG^? 16.15 MG MG D 302 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 84.53 54.81 -36.40 82.75 56.01 -36.42 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 90.57 56.85 -44.52 87.39 52.68 -46.00 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 88.00 43.26 -36.30 88.86 43.23 -33.34 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 14 3 # 14 C 2 GLU D 75 GLU^? 15.53 MG MG E 301 C 56 LYS D 86 LYS^? 25.80 MG MG D 302 C 258 ARG D 50 ARG^? 16.15 MG MG D 302 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 84.53 54.81 -36.40 82.75 56.01 -36.42 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 85.54 56.79 -30.27 90.24 54.54 -28.62 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 88.00 43.26 -36.30 88.86 43.23 -33.34 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 15 3 # 15 C 2 GLU E 19 GLU^? 18.42 MG MG E 301 C 56 LYS E 21 LYS^? 14.42 MG MG E 301 C 258 ARG E 173 ARG^? 18.66 MG MG E 301 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 82.78 67.13 -51.44 83.71 68.75 -50.40 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 87.88 60.38 -50.25 83.05 58.57 -47.65 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 75.16 72.26 -52.56 73.67 73.54 -55.01 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 16 3 # 16 C 2 GLU E 25 GLU^? 12.55 MG MG D 301 C 56 LYS D 21 LYS^? 14.47 MG MG D 302 C 258 ARG D 173 ARG^? 18.88 MG MG D 301 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 95.44 49.40 -47.17 93.82 48.00 -47.21 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 90.57 56.85 -44.52 87.39 52.68 -46.00 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 100.48 42.57 -42.43 101.55 40.79 -40.06 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 17 3 # 17 C 2 GLU E 54 GLU^? 22.83 MG MG E 302 C 56 LYS E 6 LYS^? 25.59 MG MG E 302 C 258 ARG F 8 ARG^? 20.20 MG MG F 301 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 58.39 62.16 -64.12 58.73 62.98 -66.04 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 58.98 65.22 -76.31 57.29 62.84 -75.38 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 18 3 # 18 C 2 GLU E 54 GLU^? 22.83 MG MG E 302 C 56 LYS E 157 LYS^? 28.40 MG MG E 302 C 258 ARG F 8 ARG^? 20.20 MG MG F 301 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 58.39 62.16 -64.12 58.73 62.98 -66.04 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 58.98 65.22 -76.31 57.29 62.84 -75.38 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 19 3 # 19 C 2 GLU F 19 GLU^? 17.88 MG MG F 302 C 56 LYS F 21 LYS^? 14.14 MG MG F 301 C 258 ARG F 173 ARG^? 18.61 MG MG F 302 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 36.39 58.51 -87.58 37.20 60.13 -88.66 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 35.01 50.26 -88.61 40.89 49.42 -90.41 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 43.18 65.58 -86.96 44.06 67.55 -84.65 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 20 3 # 20 C 2 GLU F 54 GLU^? 22.98 MG MG F 301 C 56 LYS F 6 LYS^? 26.09 MG MG F 301 C 258 ARG E 8 ARG^? 20.19 MG MG E 302 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 62.26 62.27 -75.30 61.72 63.47 -73.60 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 60.42 66.09 -63.48 62.84 64.38 -64.17 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 21 3 # 21 C 2 GLU F 54 GLU^? 22.98 MG MG F 301 C 56 LYS F 157 LYS^? 28.36 MG MG F 302 C 258 ARG E 8 ARG^? 20.19 MG MG E 302 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 62.26 62.27 -75.30 61.72 63.47 -73.60 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 60.42 66.09 -63.48 62.84 64.38 -64.17 1k82_c02 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 21 hits 1k82_c02 naa= 3 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 D 2 GLU A 54 GLU^? 22.98 MG MG A 301 D 56 LYS A 6 LYS^? 25.88 MG MG A 301 D 258 ARG B 8 ARG^? 20.39 MG MG B 302 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 45.06 19.97 24.02 44.05 19.39 22.19 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 46.20 12.82 24.71 44.50 16.64 20.52 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 41.99 18.82 11.83 44.91 18.76 12.93 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 D 2 GLU A 54 GLU^? 22.98 MG MG A 301 D 56 LYS A 157 LYS^? 28.65 MG MG A 302 D 258 ARG B 8 ARG^? 20.39 MG MG B 302 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 45.06 19.97 24.02 44.05 19.39 22.19 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 41.42 12.06 27.58 41.46 5.93 29.41 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 41.99 18.82 11.83 44.91 18.76 12.93 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 D 2 GLU B 25 GLU^? 12.88 MG MG C 301 D 56 LYS C 21 LYS^? 14.49 MG MG C 302 D 258 ARG C 173 ARG^? 18.96 MG MG C 301 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 79.57 9.59 -3.08 79.20 11.68 -3.64 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 72.10 6.87 -6.14 72.84 12.21 -4.93 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 89.11 11.40 -7.73 91.21 12.63 -9.73 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 D 2 GLU B 54 GLU^? 22.94 MG MG B 302 D 56 LYS B 6 LYS^? 25.90 MG MG B 302 D 258 ARG A 8 ARG^? 20.36 MG MG A 301 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 43.18 23.27 12.99 42.40 22.23 14.68 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 36.26 25.44 11.74 39.65 23.12 16.29 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 40.62 19.52 24.63 40.98 22.51 23.88 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 D 2 GLU B 54 GLU^? 22.94 MG MG B 302 D 56 LYS B 157 LYS^? 28.85 MG MG B 302 D 258 ARG A 8 ARG^? 20.36 MG MG A 301 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 43.18 23.27 12.99 42.40 22.23 14.68 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 34.97 21.28 8.44 29.03 22.82 6.58 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 40.62 19.52 24.63 40.98 22.51 23.88 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 6 3 # 6 D 2 GLU C 19 GLU^? 19.08 MG MG C 301 D 56 LYS C 21 LYS^? 14.49 MG MG C 302 D 258 ARG C 173 ARG^? 18.96 MG MG C 301 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 80.46 7.67 -6.81 81.43 5.97 -5.99 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 72.10 6.87 -6.14 72.84 12.21 -4.93 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 89.11 11.40 -7.73 91.21 12.63 -9.73 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 7 3 # 7 D 2 GLU C 54 GLU^? 22.77 MG MG C 302 D 56 LYS C 6 LYS^? 25.73 MG MG C 302 D 258 ARG D 8 ARG^? 20.22 MG MG D 302 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 88.91 31.25 -19.52 89.97 30.69 -21.29 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 92.22 28.83 -31.23 90.93 31.55 -30.54 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 8 3 # 8 D 2 GLU C 54 GLU^? 22.77 MG MG C 302 D 56 LYS C 157 LYS^? 28.15 MG MG C 302 D 258 ARG D 8 ARG^? 20.22 MG MG D 302 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 88.91 31.25 -19.52 89.97 30.69 -21.29 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 92.22 28.83 -31.23 90.93 31.55 -30.54 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 9 3 # 9 D 2 GLU D 19 GLU^? 18.95 MG MG D 301 D 56 LYS D 21 LYS^? 14.47 MG MG D 302 D 258 ARG D 173 ARG^? 18.88 MG MG D 301 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 96.86 51.08 -43.04 98.60 51.44 -44.26 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 90.57 56.85 -44.52 87.39 52.68 -46.00 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 100.48 42.57 -42.43 101.55 40.79 -40.06 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 10 3 # 10 D 2 GLU D 25 GLU^? 12.44 MG MG E 301 D 56 LYS E 21 LYS^? 14.42 MG MG E 301 D 258 ARG E 173 ARG^? 18.66 MG MG E 301 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 81.26 66.22 -47.78 79.52 64.98 -48.06 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 87.88 60.38 -50.25 83.05 58.57 -47.65 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 75.16 72.26 -52.56 73.67 73.54 -55.01 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 11 3 # 11 D 2 GLU D 54 GLU^? 22.96 MG MG D 302 D 56 LYS D 6 LYS^? 25.98 MG MG D 302 D 258 ARG C 8 ARG^? 20.00 MG MG C 302 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 87.96 27.60 -30.52 89.07 27.55 -28.72 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 91.42 27.61 -18.53 88.82 26.28 -19.38 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 12 3 # 12 D 2 GLU D 54 GLU^? 22.96 MG MG D 302 D 56 LYS D 157 LYS^? 28.67 MG MG D 302 D 258 ARG C 8 ARG^? 20.00 MG MG C 302 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 87.96 27.60 -30.52 89.07 27.55 -28.72 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 91.42 27.61 -18.53 88.82 26.28 -19.38 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 13 3 # 13 D 2 GLU D 75 GLU^? 15.53 MG MG E 301 D 56 LYS D 21 LYS^? 14.47 MG MG D 302 D 258 ARG D 50 ARG^? 16.15 MG MG D 302 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 84.53 54.81 -36.40 82.75 56.01 -36.42 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 90.57 56.85 -44.52 87.39 52.68 -46.00 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 88.00 43.26 -36.30 88.86 43.23 -33.34 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 14 3 # 14 D 2 GLU D 75 GLU^? 15.53 MG MG E 301 D 56 LYS D 86 LYS^? 25.80 MG MG D 302 D 258 ARG D 50 ARG^? 16.15 MG MG D 302 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 84.53 54.81 -36.40 82.75 56.01 -36.42 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 85.54 56.79 -30.27 90.24 54.54 -28.62 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 88.00 43.26 -36.30 88.86 43.23 -33.34 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 15 3 # 15 D 2 GLU E 19 GLU^? 18.42 MG MG E 301 D 56 LYS E 21 LYS^? 14.42 MG MG E 301 D 258 ARG E 173 ARG^? 18.66 MG MG E 301 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 82.78 67.13 -51.44 83.71 68.75 -50.40 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 87.88 60.38 -50.25 83.05 58.57 -47.65 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 75.16 72.26 -52.56 73.67 73.54 -55.01 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 16 3 # 16 D 2 GLU E 25 GLU^? 12.55 MG MG D 301 D 56 LYS D 21 LYS^? 14.47 MG MG D 302 D 258 ARG D 173 ARG^? 18.88 MG MG D 301 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 95.44 49.40 -47.17 93.82 48.00 -47.21 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 90.57 56.85 -44.52 87.39 52.68 -46.00 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 100.48 42.57 -42.43 101.55 40.79 -40.06 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 17 3 # 17 D 2 GLU E 54 GLU^? 22.83 MG MG E 302 D 56 LYS E 6 LYS^? 25.59 MG MG E 302 D 258 ARG F 8 ARG^? 20.20 MG MG F 301 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 58.39 62.16 -64.12 58.73 62.98 -66.04 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 58.98 65.22 -76.31 57.29 62.84 -75.38 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 18 3 # 18 D 2 GLU E 54 GLU^? 22.83 MG MG E 302 D 56 LYS E 157 LYS^? 28.40 MG MG E 302 D 258 ARG F 8 ARG^? 20.20 MG MG F 301 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 58.39 62.16 -64.12 58.73 62.98 -66.04 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 58.98 65.22 -76.31 57.29 62.84 -75.38 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 19 3 # 19 D 2 GLU F 19 GLU^? 17.88 MG MG F 302 D 56 LYS F 21 LYS^? 14.14 MG MG F 301 D 258 ARG F 173 ARG^? 18.61 MG MG F 302 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 36.39 58.51 -87.58 37.20 60.13 -88.66 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 35.01 50.26 -88.61 40.89 49.42 -90.41 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 43.18 65.58 -86.96 44.06 67.55 -84.65 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 20 3 # 20 D 2 GLU F 54 GLU^? 22.98 MG MG F 301 D 56 LYS F 6 LYS^? 26.09 MG MG F 301 D 258 ARG E 8 ARG^? 20.19 MG MG E 302 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 62.26 62.27 -75.30 61.72 63.47 -73.60 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 60.42 66.09 -63.48 62.84 64.38 -64.17 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 21 3 # 21 D 2 GLU F 54 GLU^? 22.98 MG MG F 301 D 56 LYS F 157 LYS^? 28.36 MG MG F 302 D 258 ARG E 8 ARG^? 20.19 MG MG E 302 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 62.26 62.27 -75.30 61.72 63.47 -73.60 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 60.42 66.09 -63.48 62.84 64.38 -64.17 1k82_c03 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 21 hits 1k82_c03 naa= 3 ULMN 3 1kim_c00 THYMIDINE KINASE user 1 3 # 1 A 83 GLU A 154 GLU^? 19.22 MG MG A 301 A 163 ARG A 8 ARG^? 20.36 MG MG A 301 A 222 ARG A 37 ARG^? 18.99 MG MG A 301 coo 51.27 81.34 48.31 51.67 80.79 50.28 36.54 21.95 29.78 35.14 22.21 28.17 coo 48.06 78.22 50.94 48.51 78.27 53.98 40.62 19.52 24.63 40.98 22.51 23.88 coo 54.85 84.16 52.60 54.26 81.23 53.34 32.99 26.50 25.19 35.50 25.33 26.51 ULMN 3 1kim_c00 THYMIDINE KINASE user 2 3 # 2 A 83 GLU B 154 GLU^? 19.05 MG MG B 302 A 163 ARG B 8 ARG^? 20.39 MG MG B 302 A 222 ARG B 37 ARG^? 19.17 MG MG B 302 coo 51.27 81.34 48.31 51.67 80.79 50.28 44.04 15.11 6.74 44.19 13.59 8.30 coo 48.06 78.22 50.94 48.51 78.27 53.98 41.99 18.82 11.83 44.91 18.76 12.93 coo 54.85 84.16 52.60 54.26 81.23 53.34 47.41 10.20 11.40 46.99 12.91 10.22 ULMN 3 1kim_c00 THYMIDINE KINASE user 3 3 # 3 A 83 GLU C 154 GLU^? 18.91 MG MG C 302 A 163 ARG C 8 ARG^? 20.00 MG MG C 302 A 222 ARG C 37 ARG^? 19.01 MG MG C 302 coo 51.27 81.34 48.31 51.67 80.79 50.28 91.15 23.27 -13.33 91.61 21.91 -14.95 coo 48.06 78.22 50.94 48.51 78.27 53.98 91.42 27.61 -18.53 88.82 26.28 -19.38 coo 54.85 84.16 52.60 54.26 81.23 53.34 89.36 17.23 -17.57 89.29 20.20 -16.76 ULMN 3 1kim_c00 THYMIDINE KINASE user 4 3 # 4 A 83 GLU D 154 GLU^? 18.75 MG MG D 302 A 163 ARG D 8 ARG^? 20.22 MG MG D 302 A 222 ARG D 37 ARG^? 18.81 MG MG D 302 coo 51.27 81.34 48.31 51.67 80.79 50.28 94.87 32.52 -36.42 96.07 33.39 -34.88 coo 48.06 78.22 50.94 48.51 78.27 53.98 92.22 28.83 -31.23 90.93 31.55 -30.54 coo 54.85 84.16 52.60 54.26 81.23 53.34 96.81 38.21 -31.63 94.97 36.32 -33.06 ULMN 3 1kim_c00 THYMIDINE KINASE user 5 3 # 5 A 83 GLU E 154 GLU^? 19.05 MG MG E 302 A 163 ARG E 8 ARG^? 20.19 MG MG E 302 A 222 ARG E 37 ARG^? 19.17 MG MG E 302 coo 51.27 81.34 48.31 51.67 80.79 50.28 64.41 68.21 -58.47 65.40 69.20 -60.08 coo 48.06 78.22 50.94 48.51 78.27 53.98 60.42 66.09 -63.48 62.84 64.38 -64.17 coo 54.85 84.16 52.60 54.26 81.23 53.34 70.82 68.02 -63.63 68.17 67.46 -62.14 ULMN 3 1kim_c00 THYMIDINE KINASE user 6 3 # 6 A 83 GLU F 154 GLU^? 18.97 MG MG F 301 A 163 ARG F 8 ARG^? 20.20 MG MG F 301 A 222 ARG F 37 ARG^? 19.14 MG MG F 301 coo 51.27 81.34 48.31 51.67 80.79 50.28 54.57 65.67 -81.55 53.36 66.51 -80.09 coo 48.06 78.22 50.94 48.51 78.27 53.98 58.98 65.22 -76.31 57.29 62.84 -75.38 coo 54.85 84.16 52.60 54.26 81.23 53.34 48.80 64.46 -76.37 51.50 64.15 -77.79 1kim_c00 source 1kim THYMIDINE KINASE : 6 hits 1kim_c00 naa= 3 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 A 14 LYS A 166 LYS^? 20.93 MG MG A 302 A 74 LYS A 157 LYS^? 28.65 MG MG A 302 A 165 GLU A 52 GLU^? 19.89 MG MG A 301 coo 24.97 5.82 58.78 26.79 1.97 55.46 35.34 13.14 30.41 31.67 15.04 34.58 coo 19.46 3.44 61.93 23.95 1.12 60.13 41.42 12.06 27.58 41.46 5.93 29.41 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 42.67 25.16 24.80 42.61 25.77 22.75 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 A 14 LYS B 157 LYS^? 28.85 MG MG B 302 A 74 LYS B 166 LYS^? 22.75 MG MG B 301 A 165 GLU B 52 GLU^? 20.06 MG MG B 302 coo 24.97 5.82 58.78 26.79 1.97 55.46 34.97 21.28 8.44 29.03 22.82 6.58 coo 19.46 3.44 61.93 23.95 1.12 60.13 35.27 15.38 5.31 37.27 9.81 3.93 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 47.87 20.25 12.36 48.11 19.69 14.43 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 A 14 LYS B 166 LYS^? 22.75 MG MG B 301 A 74 LYS B 157 LYS^? 28.85 MG MG B 302 A 165 GLU B 52 GLU^? 20.06 MG MG B 302 coo 24.97 5.82 58.78 26.79 1.97 55.46 35.27 15.38 5.31 37.27 9.81 3.93 coo 19.46 3.44 61.93 23.95 1.12 60.13 34.97 21.28 8.44 29.03 22.82 6.58 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 47.87 20.25 12.36 48.11 19.69 14.43 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 A 14 LYS C 157 LYS^? 28.15 MG MG C 302 A 74 LYS C 6 LYS^? 25.73 MG MG C 302 A 165 GLU C 52 GLU^? 19.67 MG MG C 302 coo 24.97 5.82 58.78 26.79 1.97 55.46 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 19.46 3.44 61.93 23.95 1.12 60.13 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 84.27 26.98 -19.19 85.21 26.16 -20.96 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 A 14 LYS C 157 LYS^? 28.15 MG MG C 302 A 74 LYS C 166 LYS^? 22.53 MG MG C 301 A 165 GLU C 52 GLU^? 19.67 MG MG C 302 coo 24.97 5.82 58.78 26.79 1.97 55.46 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 19.46 3.44 61.93 23.95 1.12 60.13 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 84.27 26.98 -19.19 85.21 26.16 -20.96 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 A 14 LYS C 166 LYS^? 22.53 MG MG C 301 A 74 LYS C 157 LYS^? 28.15 MG MG C 302 A 165 GLU C 52 GLU^? 19.67 MG MG C 302 coo 24.97 5.82 58.78 26.79 1.97 55.46 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 19.46 3.44 61.93 23.95 1.12 60.13 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 84.27 26.98 -19.19 85.21 26.16 -20.96 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 A 14 LYS D 157 LYS^? 28.67 MG MG D 302 A 74 LYS D 166 LYS^? 21.08 MG MG D 301 A 165 GLU D 52 GLU^? 19.94 MG MG D 302 coo 24.97 5.82 58.78 26.79 1.97 55.46 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 19.46 3.44 61.93 23.95 1.12 60.13 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 87.13 33.17 -30.97 88.40 33.70 -29.31 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 A 14 LYS D 166 LYS^? 21.08 MG MG D 301 A 74 LYS D 157 LYS^? 28.67 MG MG D 302 A 165 GLU D 52 GLU^? 19.94 MG MG D 302 coo 24.97 5.82 58.78 26.79 1.97 55.46 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 19.46 3.44 61.93 23.95 1.12 60.13 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 87.13 33.17 -30.97 88.40 33.70 -29.31 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 A 14 LYS E 6 LYS^? 25.59 MG MG E 302 A 74 LYS E 157 LYS^? 28.40 MG MG E 302 A 165 GLU E 52 GLU^? 19.96 MG MG E 302 coo 24.97 5.82 58.78 26.79 1.97 55.46 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 19.46 3.44 61.93 23.95 1.12 60.13 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 64.71 60.06 -63.78 64.69 61.36 -65.58 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 A 14 LYS E 157 LYS^? 28.40 MG MG E 302 A 74 LYS E 6 LYS^? 25.59 MG MG E 302 A 165 GLU E 52 GLU^? 19.96 MG MG E 302 coo 24.97 5.82 58.78 26.79 1.97 55.46 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 19.46 3.44 61.93 23.95 1.12 60.13 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 64.71 60.06 -63.78 64.69 61.36 -65.58 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 A 14 LYS E 157 LYS^? 28.40 MG MG E 302 A 74 LYS E 166 LYS^? 21.46 MG MG E 301 A 165 GLU E 52 GLU^? 19.96 MG MG E 302 coo 24.97 5.82 58.78 26.79 1.97 55.46 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 19.46 3.44 61.93 23.95 1.12 60.13 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 64.71 60.06 -63.78 64.69 61.36 -65.58 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 A 14 LYS E 166 LYS^? 21.46 MG MG E 301 A 74 LYS E 157 LYS^? 28.40 MG MG E 302 A 165 GLU E 52 GLU^? 19.96 MG MG E 302 coo 24.97 5.82 58.78 26.79 1.97 55.46 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 19.46 3.44 61.93 23.95 1.12 60.13 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 64.71 60.06 -63.78 64.69 61.36 -65.58 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 A 14 LYS F 157 LYS^? 28.36 MG MG F 302 A 74 LYS F 6 LYS^? 26.09 MG MG F 301 A 165 GLU F 52 GLU^? 20.13 MG MG F 301 coo 24.97 5.82 58.78 26.79 1.97 55.46 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 19.46 3.44 61.93 23.95 1.12 60.13 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 57.09 59.62 -75.76 56.76 59.40 -73.62 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 A 14 LYS F 157 LYS^? 28.36 MG MG F 302 A 74 LYS F 166 LYS^? 20.76 MG MG F 302 A 165 GLU F 52 GLU^? 20.13 MG MG F 301 coo 24.97 5.82 58.78 26.79 1.97 55.46 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 19.46 3.44 61.93 23.95 1.12 60.13 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 57.09 59.62 -75.76 56.76 59.40 -73.62 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 A 14 LYS F 166 LYS^? 20.76 MG MG F 302 A 74 LYS F 157 LYS^? 28.36 MG MG F 302 A 165 GLU F 52 GLU^? 20.13 MG MG F 301 coo 24.97 5.82 58.78 26.79 1.97 55.46 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 19.46 3.44 61.93 23.95 1.12 60.13 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 57.09 59.62 -75.76 56.76 59.40 -73.62 1kqc_c00 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 15 hits 1kqc_c00 naa= 3 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 B 14 LYS A 157 LYS^? 28.65 MG MG A 302 B 74 LYS A 6 LYS^? 25.88 MG MG A 301 B 165 GLU A 52 GLU^? 19.89 MG MG A 301 coo 4.84 5.09 23.75 3.30 1.39 27.48 41.42 12.06 27.58 41.46 5.93 29.41 coo 10.43 2.88 20.75 5.72 0.41 23.95 46.20 12.82 24.71 44.50 16.64 20.52 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 42.67 25.16 24.80 42.61 25.77 22.75 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 B 14 LYS A 157 LYS^? 28.65 MG MG A 302 B 74 LYS A 166 LYS^? 20.93 MG MG A 302 B 165 GLU A 52 GLU^? 19.89 MG MG A 301 coo 4.84 5.09 23.75 3.30 1.39 27.48 41.42 12.06 27.58 41.46 5.93 29.41 coo 10.43 2.88 20.75 5.72 0.41 23.95 35.34 13.14 30.41 31.67 15.04 34.58 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 42.67 25.16 24.80 42.61 25.77 22.75 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 B 14 LYS A 166 LYS^? 20.93 MG MG A 302 B 74 LYS A 157 LYS^? 28.65 MG MG A 302 B 165 GLU A 52 GLU^? 19.89 MG MG A 301 coo 4.84 5.09 23.75 3.30 1.39 27.48 35.34 13.14 30.41 31.67 15.04 34.58 coo 10.43 2.88 20.75 5.72 0.41 23.95 41.42 12.06 27.58 41.46 5.93 29.41 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 42.67 25.16 24.80 42.61 25.77 22.75 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 B 14 LYS B 157 LYS^? 28.85 MG MG B 302 B 74 LYS B 166 LYS^? 22.75 MG MG B 301 B 165 GLU B 52 GLU^? 20.06 MG MG B 302 coo 4.84 5.09 23.75 3.30 1.39 27.48 34.97 21.28 8.44 29.03 22.82 6.58 coo 10.43 2.88 20.75 5.72 0.41 23.95 35.27 15.38 5.31 37.27 9.81 3.93 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 47.87 20.25 12.36 48.11 19.69 14.43 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 B 14 LYS B 166 LYS^? 22.75 MG MG B 301 B 74 LYS B 157 LYS^? 28.85 MG MG B 302 B 165 GLU B 52 GLU^? 20.06 MG MG B 302 coo 4.84 5.09 23.75 3.30 1.39 27.48 35.27 15.38 5.31 37.27 9.81 3.93 coo 10.43 2.88 20.75 5.72 0.41 23.95 34.97 21.28 8.44 29.03 22.82 6.58 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 47.87 20.25 12.36 48.11 19.69 14.43 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 B 14 LYS C 157 LYS^? 28.15 MG MG C 302 B 74 LYS C 6 LYS^? 25.73 MG MG C 302 B 165 GLU C 52 GLU^? 19.67 MG MG C 302 coo 4.84 5.09 23.75 3.30 1.39 27.48 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 10.43 2.88 20.75 5.72 0.41 23.95 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 84.27 26.98 -19.19 85.21 26.16 -20.96 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 B 14 LYS C 157 LYS^? 28.15 MG MG C 302 B 74 LYS C 166 LYS^? 22.53 MG MG C 301 B 165 GLU C 52 GLU^? 19.67 MG MG C 302 coo 4.84 5.09 23.75 3.30 1.39 27.48 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 10.43 2.88 20.75 5.72 0.41 23.95 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 84.27 26.98 -19.19 85.21 26.16 -20.96 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 B 14 LYS C 166 LYS^? 22.53 MG MG C 301 B 74 LYS C 157 LYS^? 28.15 MG MG C 302 B 165 GLU C 52 GLU^? 19.67 MG MG C 302 coo 4.84 5.09 23.75 3.30 1.39 27.48 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 10.43 2.88 20.75 5.72 0.41 23.95 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 84.27 26.98 -19.19 85.21 26.16 -20.96 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 B 14 LYS D 157 LYS^? 28.67 MG MG D 302 B 74 LYS D 166 LYS^? 21.08 MG MG D 301 B 165 GLU D 52 GLU^? 19.94 MG MG D 302 coo 4.84 5.09 23.75 3.30 1.39 27.48 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 10.43 2.88 20.75 5.72 0.41 23.95 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 87.13 33.17 -30.97 88.40 33.70 -29.31 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 B 14 LYS D 166 LYS^? 21.08 MG MG D 301 B 74 LYS D 157 LYS^? 28.67 MG MG D 302 B 165 GLU D 52 GLU^? 19.94 MG MG D 302 coo 4.84 5.09 23.75 3.30 1.39 27.48 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 10.43 2.88 20.75 5.72 0.41 23.95 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 87.13 33.17 -30.97 88.40 33.70 -29.31 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 B 14 LYS E 6 LYS^? 25.59 MG MG E 302 B 74 LYS E 157 LYS^? 28.40 MG MG E 302 B 165 GLU E 52 GLU^? 19.96 MG MG E 302 coo 4.84 5.09 23.75 3.30 1.39 27.48 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 10.43 2.88 20.75 5.72 0.41 23.95 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 64.71 60.06 -63.78 64.69 61.36 -65.58 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 B 14 LYS E 157 LYS^? 28.40 MG MG E 302 B 74 LYS E 6 LYS^? 25.59 MG MG E 302 B 165 GLU E 52 GLU^? 19.96 MG MG E 302 coo 4.84 5.09 23.75 3.30 1.39 27.48 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 10.43 2.88 20.75 5.72 0.41 23.95 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 64.71 60.06 -63.78 64.69 61.36 -65.58 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 B 14 LYS E 157 LYS^? 28.40 MG MG E 302 B 74 LYS E 166 LYS^? 21.46 MG MG E 301 B 165 GLU E 52 GLU^? 19.96 MG MG E 302 coo 4.84 5.09 23.75 3.30 1.39 27.48 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 10.43 2.88 20.75 5.72 0.41 23.95 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 64.71 60.06 -63.78 64.69 61.36 -65.58 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 B 14 LYS E 166 LYS^? 21.46 MG MG E 301 B 74 LYS E 157 LYS^? 28.40 MG MG E 302 B 165 GLU E 52 GLU^? 19.96 MG MG E 302 coo 4.84 5.09 23.75 3.30 1.39 27.48 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 10.43 2.88 20.75 5.72 0.41 23.95 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 64.71 60.06 -63.78 64.69 61.36 -65.58 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 B 14 LYS F 157 LYS^? 28.36 MG MG F 302 B 74 LYS F 6 LYS^? 26.09 MG MG F 301 B 165 GLU F 52 GLU^? 20.13 MG MG F 301 coo 4.84 5.09 23.75 3.30 1.39 27.48 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 10.43 2.88 20.75 5.72 0.41 23.95 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 57.09 59.62 -75.76 56.76 59.40 -73.62 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 16 3 # 16 B 14 LYS F 157 LYS^? 28.36 MG MG F 302 B 74 LYS F 166 LYS^? 20.76 MG MG F 302 B 165 GLU F 52 GLU^? 20.13 MG MG F 301 coo 4.84 5.09 23.75 3.30 1.39 27.48 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 10.43 2.88 20.75 5.72 0.41 23.95 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 57.09 59.62 -75.76 56.76 59.40 -73.62 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 17 3 # 17 B 14 LYS F 166 LYS^? 20.76 MG MG F 302 B 74 LYS F 157 LYS^? 28.36 MG MG F 302 B 165 GLU F 52 GLU^? 20.13 MG MG F 301 coo 4.84 5.09 23.75 3.30 1.39 27.48 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 10.43 2.88 20.75 5.72 0.41 23.95 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 57.09 59.62 -75.76 56.76 59.40 -73.62 1kqc_c01 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 17 hits 1kqc_c01 naa= 3 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 C 14 LYS A 157 LYS^? 28.65 MG MG A 302 C 74 LYS A 6 LYS^? 25.88 MG MG A 301 C 165 GLU A 52 GLU^? 19.89 MG MG A 301 coo 17.59 37.25 25.80 19.64 34.15 21.60 41.42 12.06 27.58 41.46 5.93 29.41 coo 12.29 34.52 28.11 16.84 32.47 25.43 46.20 12.82 24.71 44.50 16.64 20.52 coo 12.06 27.10 15.56 13.23 27.02 13.80 42.67 25.16 24.80 42.61 25.77 22.75 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 C 14 LYS A 157 LYS^? 28.65 MG MG A 302 C 74 LYS A 166 LYS^? 20.93 MG MG A 302 C 165 GLU A 52 GLU^? 19.89 MG MG A 301 coo 17.59 37.25 25.80 19.64 34.15 21.60 41.42 12.06 27.58 41.46 5.93 29.41 coo 12.29 34.52 28.11 16.84 32.47 25.43 35.34 13.14 30.41 31.67 15.04 34.58 coo 12.06 27.10 15.56 13.23 27.02 13.80 42.67 25.16 24.80 42.61 25.77 22.75 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 C 14 LYS A 166 LYS^? 20.93 MG MG A 302 C 74 LYS A 157 LYS^? 28.65 MG MG A 302 C 165 GLU A 52 GLU^? 19.89 MG MG A 301 coo 17.59 37.25 25.80 19.64 34.15 21.60 35.34 13.14 30.41 31.67 15.04 34.58 coo 12.29 34.52 28.11 16.84 32.47 25.43 41.42 12.06 27.58 41.46 5.93 29.41 coo 12.06 27.10 15.56 13.23 27.02 13.80 42.67 25.16 24.80 42.61 25.77 22.75 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 C 14 LYS B 76 LYS^? 25.77 MG MG B 302 C 74 LYS B 86 LYS^? 26.44 MG MG B 302 C 165 GLU A 63 GLU^? 28.10 MG MG B 302 coo 17.59 37.25 25.80 19.64 34.15 21.60 67.82 8.19 10.14 64.96 3.09 10.62 coo 12.29 34.52 28.11 16.84 32.47 25.43 69.25 10.45 13.86 65.27 7.74 16.08 coo 12.06 27.10 15.56 13.23 27.02 13.80 59.13 11.55 21.47 60.51 12.96 22.22 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 C 14 LYS B 157 LYS^? 28.85 MG MG B 302 C 74 LYS B 6 LYS^? 25.90 MG MG B 302 C 165 GLU B 52 GLU^? 20.06 MG MG B 302 coo 17.59 37.25 25.80 19.64 34.15 21.60 34.97 21.28 8.44 29.03 22.82 6.58 coo 12.29 34.52 28.11 16.84 32.47 25.43 36.26 25.44 11.74 39.65 23.12 16.29 coo 12.06 27.10 15.56 13.23 27.02 13.80 47.87 20.25 12.36 48.11 19.69 14.43 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 C 14 LYS B 157 LYS^? 28.85 MG MG B 302 C 74 LYS B 166 LYS^? 22.75 MG MG B 301 C 165 GLU B 52 GLU^? 20.06 MG MG B 302 coo 17.59 37.25 25.80 19.64 34.15 21.60 34.97 21.28 8.44 29.03 22.82 6.58 coo 12.29 34.52 28.11 16.84 32.47 25.43 35.27 15.38 5.31 37.27 9.81 3.93 coo 12.06 27.10 15.56 13.23 27.02 13.80 47.87 20.25 12.36 48.11 19.69 14.43 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 C 14 LYS B 166 LYS^? 22.75 MG MG B 301 C 74 LYS B 157 LYS^? 28.85 MG MG B 302 C 165 GLU B 52 GLU^? 20.06 MG MG B 302 coo 17.59 37.25 25.80 19.64 34.15 21.60 35.27 15.38 5.31 37.27 9.81 3.93 coo 12.29 34.52 28.11 16.84 32.47 25.43 34.97 21.28 8.44 29.03 22.82 6.58 coo 12.06 27.10 15.56 13.23 27.02 13.80 47.87 20.25 12.36 48.11 19.69 14.43 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 C 14 LYS C 157 LYS^? 28.15 MG MG C 302 C 74 LYS C 6 LYS^? 25.73 MG MG C 302 C 165 GLU C 52 GLU^? 19.67 MG MG C 302 coo 17.59 37.25 25.80 19.64 34.15 21.60 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 12.29 34.52 28.11 16.84 32.47 25.43 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 12.06 27.10 15.56 13.23 27.02 13.80 84.27 26.98 -19.19 85.21 26.16 -20.96 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 C 14 LYS C 157 LYS^? 28.15 MG MG C 302 C 74 LYS C 166 LYS^? 22.53 MG MG C 301 C 165 GLU C 52 GLU^? 19.67 MG MG C 302 coo 17.59 37.25 25.80 19.64 34.15 21.60 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 12.29 34.52 28.11 16.84 32.47 25.43 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 12.06 27.10 15.56 13.23 27.02 13.80 84.27 26.98 -19.19 85.21 26.16 -20.96 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 C 14 LYS C 166 LYS^? 22.53 MG MG C 301 C 74 LYS C 157 LYS^? 28.15 MG MG C 302 C 165 GLU C 52 GLU^? 19.67 MG MG C 302 coo 17.59 37.25 25.80 19.64 34.15 21.60 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 12.29 34.52 28.11 16.84 32.47 25.43 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 12.06 27.10 15.56 13.23 27.02 13.80 84.27 26.98 -19.19 85.21 26.16 -20.96 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 C 14 LYS D 76 LYS^? 25.08 MG MG D 302 C 74 LYS D 86 LYS^? 25.80 MG MG D 302 C 165 GLU C 63 GLU^? 27.26 MG MG D 302 coo 17.59 37.25 25.80 19.64 34.15 21.60 88.18 56.35 -34.05 93.80 56.17 -32.93 coo 12.29 34.52 28.11 16.84 32.47 25.43 85.54 56.79 -30.27 90.24 54.54 -28.62 coo 12.06 27.10 15.56 13.23 27.02 13.80 89.51 47.54 -22.35 87.55 48.20 -22.72 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 C 14 LYS D 157 LYS^? 28.67 MG MG D 302 C 74 LYS D 6 LYS^? 25.98 MG MG D 302 C 165 GLU D 52 GLU^? 19.94 MG MG D 302 coo 17.59 37.25 25.80 19.64 34.15 21.60 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 12.29 34.52 28.11 16.84 32.47 25.43 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 12.06 27.10 15.56 13.23 27.02 13.80 87.13 33.17 -30.97 88.40 33.70 -29.31 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 C 14 LYS D 157 LYS^? 28.67 MG MG D 302 C 74 LYS D 166 LYS^? 21.08 MG MG D 301 C 165 GLU D 52 GLU^? 19.94 MG MG D 302 coo 17.59 37.25 25.80 19.64 34.15 21.60 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 12.29 34.52 28.11 16.84 32.47 25.43 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 12.06 27.10 15.56 13.23 27.02 13.80 87.13 33.17 -30.97 88.40 33.70 -29.31 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 C 14 LYS D 166 LYS^? 21.08 MG MG D 301 C 74 LYS D 157 LYS^? 28.67 MG MG D 302 C 165 GLU D 52 GLU^? 19.94 MG MG D 302 coo 17.59 37.25 25.80 19.64 34.15 21.60 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 12.29 34.52 28.11 16.84 32.47 25.43 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 12.06 27.10 15.56 13.23 27.02 13.80 87.13 33.17 -30.97 88.40 33.70 -29.31 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 C 14 LYS E 6 LYS^? 25.59 MG MG E 302 C 74 LYS E 157 LYS^? 28.40 MG MG E 302 C 165 GLU E 52 GLU^? 19.96 MG MG E 302 coo 17.59 37.25 25.80 19.64 34.15 21.60 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 12.29 34.52 28.11 16.84 32.47 25.43 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 12.06 27.10 15.56 13.23 27.02 13.80 64.71 60.06 -63.78 64.69 61.36 -65.58 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 16 3 # 16 C 14 LYS E 76 LYS^? 25.68 MG MG E 302 C 74 LYS E 86 LYS^? 26.73 MG MG D 301 C 165 GLU F 63 GLU^? 27.81 MG MG E 302 coo 17.59 37.25 25.80 19.64 34.15 21.60 87.09 58.11 -60.91 88.65 63.65 -61.27 coo 12.29 34.52 28.11 16.84 32.47 25.43 86.84 54.85 -64.43 87.07 60.83 -66.10 coo 12.06 27.10 15.56 13.23 27.02 13.80 78.38 60.07 -72.34 78.48 58.04 -72.84 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 17 3 # 17 C 14 LYS E 157 LYS^? 28.40 MG MG E 302 C 74 LYS E 6 LYS^? 25.59 MG MG E 302 C 165 GLU E 52 GLU^? 19.96 MG MG E 302 coo 17.59 37.25 25.80 19.64 34.15 21.60 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 12.29 34.52 28.11 16.84 32.47 25.43 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 12.06 27.10 15.56 13.23 27.02 13.80 64.71 60.06 -63.78 64.69 61.36 -65.58 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 18 3 # 18 C 14 LYS E 157 LYS^? 28.40 MG MG E 302 C 74 LYS E 166 LYS^? 21.46 MG MG E 301 C 165 GLU E 52 GLU^? 19.96 MG MG E 302 coo 17.59 37.25 25.80 19.64 34.15 21.60 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 12.29 34.52 28.11 16.84 32.47 25.43 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 12.06 27.10 15.56 13.23 27.02 13.80 64.71 60.06 -63.78 64.69 61.36 -65.58 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 19 3 # 19 C 14 LYS E 166 LYS^? 21.46 MG MG E 301 C 74 LYS E 157 LYS^? 28.40 MG MG E 302 C 165 GLU E 52 GLU^? 19.96 MG MG E 302 coo 17.59 37.25 25.80 19.64 34.15 21.60 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 12.29 34.52 28.11 16.84 32.47 25.43 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 12.06 27.10 15.56 13.23 27.02 13.80 64.71 60.06 -63.78 64.69 61.36 -65.58 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 20 3 # 20 C 14 LYS F 76 LYS^? 25.89 MG MG F 301 C 74 LYS F 86 LYS^? 26.63 MG MG F 301 C 165 GLU E 63 GLU^? 28.08 MG MG F 301 coo 17.59 37.25 25.80 19.64 34.15 21.60 36.96 48.52 -78.06 33.74 53.37 -77.06 coo 12.29 34.52 28.11 16.84 32.47 25.43 37.89 45.97 -74.42 36.47 51.71 -72.79 coo 12.06 27.10 15.56 13.23 27.02 13.80 44.04 53.99 -66.79 43.77 51.93 -66.35 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 21 3 # 21 C 14 LYS F 157 LYS^? 28.36 MG MG F 302 C 74 LYS F 6 LYS^? 26.09 MG MG F 301 C 165 GLU F 52 GLU^? 20.13 MG MG F 301 coo 17.59 37.25 25.80 19.64 34.15 21.60 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 12.29 34.52 28.11 16.84 32.47 25.43 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 12.06 27.10 15.56 13.23 27.02 13.80 57.09 59.62 -75.76 56.76 59.40 -73.62 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 22 3 # 22 C 14 LYS F 157 LYS^? 28.36 MG MG F 302 C 74 LYS F 166 LYS^? 20.76 MG MG F 302 C 165 GLU F 52 GLU^? 20.13 MG MG F 301 coo 17.59 37.25 25.80 19.64 34.15 21.60 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 12.29 34.52 28.11 16.84 32.47 25.43 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 12.06 27.10 15.56 13.23 27.02 13.80 57.09 59.62 -75.76 56.76 59.40 -73.62 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 23 3 # 23 C 14 LYS F 166 LYS^? 20.76 MG MG F 302 C 74 LYS F 157 LYS^? 28.36 MG MG F 302 C 165 GLU F 52 GLU^? 20.13 MG MG F 301 coo 17.59 37.25 25.80 19.64 34.15 21.60 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 12.29 34.52 28.11 16.84 32.47 25.43 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 12.06 27.10 15.56 13.23 27.02 13.80 57.09 59.62 -75.76 56.76 59.40 -73.62 1kqc_c02 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 23 hits 1kqc_c02 naa= 3 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 D 14 LYS A 157 LYS^? 28.65 MG MG A 302 D 74 LYS A 6 LYS^? 25.88 MG MG A 301 D 165 GLU A 52 GLU^? 19.89 MG MG A 301 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 41.42 12.06 27.58 41.46 5.93 29.41 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 46.20 12.82 24.71 44.50 16.64 20.52 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 42.67 25.16 24.80 42.61 25.77 22.75 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 D 14 LYS A 157 LYS^? 28.65 MG MG A 302 D 74 LYS A 166 LYS^? 20.93 MG MG A 302 D 165 GLU A 52 GLU^? 19.89 MG MG A 301 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 41.42 12.06 27.58 41.46 5.93 29.41 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 35.34 13.14 30.41 31.67 15.04 34.58 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 42.67 25.16 24.80 42.61 25.77 22.75 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 D 14 LYS A 166 LYS^? 20.93 MG MG A 302 D 74 LYS A 157 LYS^? 28.65 MG MG A 302 D 165 GLU A 52 GLU^? 19.89 MG MG A 301 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 35.34 13.14 30.41 31.67 15.04 34.58 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 41.42 12.06 27.58 41.46 5.93 29.41 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 42.67 25.16 24.80 42.61 25.77 22.75 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 D 14 LYS B 157 LYS^? 28.85 MG MG B 302 D 74 LYS B 6 LYS^? 25.90 MG MG B 302 D 165 GLU B 52 GLU^? 20.06 MG MG B 302 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 34.97 21.28 8.44 29.03 22.82 6.58 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 36.26 25.44 11.74 39.65 23.12 16.29 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 47.87 20.25 12.36 48.11 19.69 14.43 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 D 14 LYS B 157 LYS^? 28.85 MG MG B 302 D 74 LYS B 166 LYS^? 22.75 MG MG B 301 D 165 GLU B 52 GLU^? 20.06 MG MG B 302 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 34.97 21.28 8.44 29.03 22.82 6.58 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 35.27 15.38 5.31 37.27 9.81 3.93 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 47.87 20.25 12.36 48.11 19.69 14.43 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 D 14 LYS B 166 LYS^? 22.75 MG MG B 301 D 74 LYS B 157 LYS^? 28.85 MG MG B 302 D 165 GLU B 52 GLU^? 20.06 MG MG B 302 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 35.27 15.38 5.31 37.27 9.81 3.93 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 34.97 21.28 8.44 29.03 22.82 6.58 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 47.87 20.25 12.36 48.11 19.69 14.43 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 D 14 LYS C 157 LYS^? 28.15 MG MG C 302 D 74 LYS C 6 LYS^? 25.73 MG MG C 302 D 165 GLU C 52 GLU^? 19.67 MG MG C 302 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 84.27 26.98 -19.19 85.21 26.16 -20.96 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 D 14 LYS C 157 LYS^? 28.15 MG MG C 302 D 74 LYS C 166 LYS^? 22.53 MG MG C 301 D 165 GLU C 52 GLU^? 19.67 MG MG C 302 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 84.27 26.98 -19.19 85.21 26.16 -20.96 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 D 14 LYS C 166 LYS^? 22.53 MG MG C 301 D 74 LYS C 157 LYS^? 28.15 MG MG C 302 D 165 GLU C 52 GLU^? 19.67 MG MG C 302 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 84.27 26.98 -19.19 85.21 26.16 -20.96 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 D 14 LYS D 157 LYS^? 28.67 MG MG D 302 D 74 LYS D 6 LYS^? 25.98 MG MG D 302 D 165 GLU D 52 GLU^? 19.94 MG MG D 302 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 87.13 33.17 -30.97 88.40 33.70 -29.31 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 D 14 LYS D 157 LYS^? 28.67 MG MG D 302 D 74 LYS D 166 LYS^? 21.08 MG MG D 301 D 165 GLU D 52 GLU^? 19.94 MG MG D 302 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 87.13 33.17 -30.97 88.40 33.70 -29.31 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 D 14 LYS D 166 LYS^? 21.08 MG MG D 301 D 74 LYS D 157 LYS^? 28.67 MG MG D 302 D 165 GLU D 52 GLU^? 19.94 MG MG D 302 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 87.13 33.17 -30.97 88.40 33.70 -29.31 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 D 14 LYS E 6 LYS^? 25.59 MG MG E 302 D 74 LYS E 157 LYS^? 28.40 MG MG E 302 D 165 GLU E 52 GLU^? 19.96 MG MG E 302 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 64.71 60.06 -63.78 64.69 61.36 -65.58 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 D 14 LYS E 76 LYS^? 25.68 MG MG E 302 D 74 LYS E 86 LYS^? 26.73 MG MG D 301 D 165 GLU F 63 GLU^? 27.81 MG MG E 302 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 87.09 58.11 -60.91 88.65 63.65 -61.27 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 86.84 54.85 -64.43 87.07 60.83 -66.10 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 78.38 60.07 -72.34 78.48 58.04 -72.84 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 D 14 LYS E 157 LYS^? 28.40 MG MG E 302 D 74 LYS E 6 LYS^? 25.59 MG MG E 302 D 165 GLU E 52 GLU^? 19.96 MG MG E 302 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 64.71 60.06 -63.78 64.69 61.36 -65.58 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 16 3 # 16 D 14 LYS E 157 LYS^? 28.40 MG MG E 302 D 74 LYS E 166 LYS^? 21.46 MG MG E 301 D 165 GLU E 52 GLU^? 19.96 MG MG E 302 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 64.71 60.06 -63.78 64.69 61.36 -65.58 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 17 3 # 17 D 14 LYS E 166 LYS^? 21.46 MG MG E 301 D 74 LYS E 157 LYS^? 28.40 MG MG E 302 D 165 GLU E 52 GLU^? 19.96 MG MG E 302 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 64.71 60.06 -63.78 64.69 61.36 -65.58 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 18 3 # 18 D 14 LYS F 157 LYS^? 28.36 MG MG F 302 D 74 LYS F 6 LYS^? 26.09 MG MG F 301 D 165 GLU F 52 GLU^? 20.13 MG MG F 301 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 57.09 59.62 -75.76 56.76 59.40 -73.62 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 19 3 # 19 D 14 LYS F 157 LYS^? 28.36 MG MG F 302 D 74 LYS F 166 LYS^? 20.76 MG MG F 302 D 165 GLU F 52 GLU^? 20.13 MG MG F 301 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 57.09 59.62 -75.76 56.76 59.40 -73.62 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 20 3 # 20 D 14 LYS F 166 LYS^? 20.76 MG MG F 302 D 74 LYS F 157 LYS^? 28.36 MG MG F 302 D 165 GLU F 52 GLU^? 20.13 MG MG F 301 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 57.09 59.62 -75.76 56.76 59.40 -73.62 1kqc_c03 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 20 hits 1kqc_c03 naa= 3 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 1 3 # 1 255 ASP A 23 ASP^? 22.90 MG MG A 301 262 LYS A 21 LYS^? 14.51 MG MG A 301 336 ARG A 87 ARG^? 20.70 MG MG A 301 coo 61.88 50.78 12.96 63.84 50.60 13.71 36.40 52.47 38.61 38.03 53.36 39.72 coo 63.59 44.40 18.32 63.20 49.74 17.95 32.50 46.40 37.91 34.61 41.52 40.01 coo 72.60 57.42 15.86 71.61 56.68 18.70 43.15 49.03 26.22 43.83 48.14 29.12 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 2 3 # 2 255 ASP B 23 ASP^? 15.67 MG MG C 301 262 LYS B 21 LYS^? 13.97 MG MG B 301 336 ARG B 87 ARG^? 13.84 MG MG C 301 coo 61.88 50.78 12.96 63.84 50.60 13.71 74.31 7.55 -1.09 75.08 9.17 -2.23 coo 63.59 44.40 18.32 63.20 49.74 17.95 67.50 6.37 -0.39 64.53 11.03 -2.88 coo 72.60 57.42 15.86 71.61 56.68 18.70 72.30 15.49 11.27 71.00 17.29 9.11 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 3 3 # 3 255 ASP D 58 ASP^? 26.59 MG MG C 302 262 LYS D 6 LYS^? 25.98 MG MG D 302 336 ARG C 37 ARG^? 19.01 MG MG C 302 coo 61.88 50.78 12.96 63.84 50.60 13.71 83.38 14.85 -27.71 84.09 14.12 -25.85 coo 63.59 44.40 18.32 63.20 49.74 17.95 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 72.60 57.42 15.86 71.61 56.68 18.70 89.36 17.23 -17.57 89.29 20.20 -16.76 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 4 3 # 4 255 ASP E 23 ASP^? 15.43 MG MG D 301 262 LYS E 21 LYS^? 14.42 MG MG E 301 336 ARG E 87 ARG^? 13.25 MG MG D 301 coo 61.88 50.78 12.96 63.84 50.60 13.71 91.98 54.64 -49.37 91.93 52.78 -48.33 coo 63.59 44.40 18.32 63.20 49.74 17.95 87.88 60.38 -50.25 83.05 58.57 -47.65 coo 72.60 57.42 15.86 71.61 56.68 18.70 85.24 49.22 -61.34 83.59 49.18 -58.71 1lam_c00 source 1lam LEUCINE AMINOPEPTIDASE : 4 hits 1lam_c00 naa= 3 ULMN 3 1lcb_c00 THYMIDYLATE SYNTHASE user 1 3 # 1 198 CYH C 98 CYH^? 19.94 MG MG C 302 229 ASN C 95 ASN^? 11.50 MG MG C 302 232 SER C 92 SER^? 15.15 MG MG C 302 coo 9.92 49.50 -53.84 12.48 47.89 -53.69 83.46 39.21 -12.87 85.90 40.15 -13.80 coo 9.79 43.22 -47.74 11.15 44.81 -48.24 75.34 33.15 -10.39 73.27 33.38 -10.21 coo 7.03 45.16 -41.61 9.10 46.34 -42.68 72.40 29.17 -16.07 71.43 31.32 -15.46 1lcb_c00 source 1lcb THYMIDYLATE SYNTHASE : 1 hits 1lcb_c00 naa= 3 ULMN 3 1lci_c00 LUCIFERASE user 1 3 # 1 218 ARG A 37 ARG^? 18.99 MG MG A 301 245 HIS A 170 HIS^? 10.56 MG MG A 302 343 THR A 169 THR^? 18.45 MG MG A 302 coo 18.11 85.25 41.19 18.04 83.33 43.59 32.99 26.50 25.19 35.50 25.33 26.51 coo 5.34 86.23 43.48 6.16 87.26 45.12 34.91 23.57 39.32 34.35 24.95 40.81 coo 9.06 92.76 42.80 7.04 92.63 42.14 34.64 19.08 35.13 33.08 18.40 33.78 ULMN 3 1lci_c00 LUCIFERASE user 2 3 # 2 218 ARG A 48 ARG^? 25.29 MG MG A 301 245 HIS A 42 HIS^? 28.45 MG MG A 301 343 THR A 40 THR^? 24.69 MG MG A 301 coo 18.11 85.25 41.19 18.04 83.33 43.59 33.88 31.17 22.03 31.48 31.85 20.30 coo 5.34 86.23 43.48 6.16 87.26 45.12 34.62 18.32 19.57 34.29 16.25 19.41 coo 9.06 92.76 42.80 7.04 92.63 42.14 32.64 20.47 25.22 32.40 21.22 23.20 ULMN 3 1lci_c00 LUCIFERASE user 3 3 # 3 218 ARG A 173 ARG^? 19.27 MG MG A 302 245 HIS A 147 HIS^? 9.20 MG MG A 302 343 THR A 169 THR^? 18.45 MG MG A 302 coo 18.11 85.25 41.19 18.04 83.33 43.59 27.76 29.24 35.14 27.46 27.11 32.86 coo 5.34 86.23 43.48 6.16 87.26 45.12 40.24 23.10 39.83 38.32 22.34 40.22 coo 9.06 92.76 42.80 7.04 92.63 42.14 34.64 19.08 35.13 33.08 18.40 33.78 ULMN 3 1lci_c00 LUCIFERASE user 4 3 # 4 218 ARG B 37 ARG^? 19.17 MG MG B 302 245 HIS B 170 HIS^? 10.51 MG MG B 301 343 THR B 169 THR^? 18.43 MG MG B 301 coo 18.11 85.25 41.19 18.04 83.33 43.59 47.41 10.20 11.40 46.99 12.91 10.22 coo 5.34 86.23 43.48 6.16 87.26 45.12 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 9.06 92.76 42.80 7.04 92.63 42.14 41.38 13.97 0.97 40.27 12.43 2.02 ULMN 3 1lci_c00 LUCIFERASE user 5 3 # 5 218 ARG B 48 ARG^? 25.20 MG MG B 302 245 HIS B 42 HIS^? 28.37 MG MG B 302 343 THR B 40 THR^? 24.25 MG MG B 302 coo 18.11 85.25 41.19 18.04 83.33 43.59 52.22 10.51 15.00 52.46 7.79 16.39 coo 5.34 86.23 43.48 6.16 87.26 45.12 39.34 12.99 16.30 37.26 13.24 16.40 coo 9.06 92.76 42.80 7.04 92.63 42.14 41.77 11.06 10.77 42.63 10.70 12.73 ULMN 3 1lci_c00 LUCIFERASE user 6 3 # 6 218 ARG B 173 ARG^? 18.75 MG MG B 301 245 HIS B 147 HIS^? 9.27 MG MG B 301 343 THR B 169 THR^? 18.43 MG MG B 301 coo 18.11 85.25 41.19 18.04 83.33 43.59 49.83 5.55 0.39 48.19 5.30 3.03 coo 5.34 86.23 43.48 6.16 87.26 45.12 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 9.06 92.76 42.80 7.04 92.63 42.14 41.38 13.97 0.97 40.27 12.43 2.02 ULMN 3 1lci_c00 LUCIFERASE user 7 3 # 7 218 ARG C 37 ARG^? 19.01 MG MG C 302 245 HIS C 170 HIS^? 10.68 MG MG C 301 343 THR C 169 THR^? 18.51 MG MG C 301 coo 18.11 85.25 41.19 18.04 83.33 43.59 89.36 17.23 -17.57 89.29 20.20 -16.76 coo 5.34 86.23 43.48 6.16 87.26 45.12 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 9.06 92.76 42.80 7.04 92.63 42.14 94.19 23.02 -7.83 95.56 21.86 -9.07 ULMN 3 1lci_c00 LUCIFERASE user 8 3 # 8 218 ARG C 48 ARG^? 25.02 MG MG C 302 245 HIS C 42 HIS^? 28.09 MG MG C 302 343 THR C 40 THR^? 24.02 MG MG C 302 coo 18.11 85.25 41.19 18.04 83.33 43.59 84.94 16.06 -21.53 85.81 13.55 -23.08 coo 5.34 86.23 43.48 6.16 87.26 45.12 95.93 22.96 -23.11 97.92 23.62 -23.02 coo 9.06 92.76 42.80 7.04 92.63 42.14 94.40 20.37 -17.61 93.73 19.75 -19.59 ULMN 3 1lci_c00 LUCIFERASE user 9 3 # 9 218 ARG C 173 ARG^? 18.96 MG MG C 301 245 HIS C 147 HIS^? 9.44 MG MG C 301 343 THR C 169 THR^? 18.51 MG MG C 301 coo 18.11 85.25 41.19 18.04 83.33 43.59 89.11 11.40 -7.73 91.21 12.63 -9.73 coo 5.34 86.23 43.48 6.16 87.26 45.12 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 9.06 92.76 42.80 7.04 92.63 42.14 94.19 23.02 -7.83 95.56 21.86 -9.07 ULMN 3 1lci_c00 LUCIFERASE user 10 3 # 10 218 ARG D 37 ARG^? 18.81 MG MG D 302 245 HIS D 170 HIS^? 10.59 MG MG D 301 343 THR D 169 THR^? 18.47 MG MG D 301 coo 18.11 85.25 41.19 18.04 83.33 43.59 96.81 38.21 -31.63 94.97 36.32 -33.06 coo 5.34 86.23 43.48 6.16 87.26 45.12 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 9.06 92.76 42.80 7.04 92.63 42.14 97.62 30.68 -41.94 99.48 30.62 -40.85 ULMN 3 1lci_c00 LUCIFERASE user 11 3 # 11 218 ARG D 48 ARG^? 24.87 MG MG D 302 245 HIS D 42 HIS^? 28.21 MG MG D 302 343 THR D 40 THR^? 24.02 MG MG D 302 coo 18.11 85.25 41.19 18.04 83.33 43.59 94.06 41.76 -28.37 96.24 43.38 -26.96 coo 5.34 86.23 43.48 6.16 87.26 45.12 98.45 29.90 -26.44 99.32 28.02 -26.13 coo 9.06 92.76 42.80 7.04 92.63 42.14 99.14 32.63 -32.12 99.04 33.58 -30.18 ULMN 3 1lci_c00 LUCIFERASE user 12 3 # 12 218 ARG D 173 ARG^? 18.88 MG MG D 301 245 HIS D 147 HIS^? 9.43 MG MG D 301 343 THR D 169 THR^? 18.47 MG MG D 301 coo 18.11 85.25 41.19 18.04 83.33 43.59 100.48 42.57 -42.43 101.55 40.79 -40.06 coo 5.34 86.23 43.48 6.16 87.26 45.12 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 9.06 92.76 42.80 7.04 92.63 42.14 97.62 30.68 -41.94 99.48 30.62 -40.85 ULMN 3 1lci_c00 LUCIFERASE user 13 3 # 13 218 ARG E 48 ARG^? 25.02 MG MG E 302 245 HIS E 42 HIS^? 28.20 MG MG E 302 343 THR E 40 THR^? 24.66 MG MG E 302 coo 18.11 85.25 41.19 18.04 83.33 43.59 73.60 65.75 -66.57 75.51 67.67 -67.91 coo 5.34 86.23 43.48 6.16 87.26 45.12 62.33 71.93 -68.30 60.54 72.96 -68.64 coo 9.06 92.76 42.80 7.04 92.63 42.14 65.26 72.42 -63.00 65.97 72.32 -65.06 ULMN 3 1lci_c00 LUCIFERASE user 14 3 # 14 218 ARG E 173 ARG^? 18.66 MG MG E 301 245 HIS E 147 HIS^? 9.22 MG MG E 301 343 THR E 169 THR^? 18.18 MG MG E 301 coo 18.11 85.25 41.19 18.04 83.33 43.59 75.16 72.26 -52.56 73.67 73.54 -55.01 coo 5.34 86.23 43.48 6.16 87.26 45.12 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 9.06 92.76 42.80 7.04 92.63 42.14 63.17 71.31 -52.89 63.43 72.88 -54.31 ULMN 3 1lci_c00 LUCIFERASE user 15 3 # 15 218 ARG F 37 ARG^? 19.14 MG MG F 301 245 HIS F 170 HIS^? 9.84 MG MG F 302 343 THR F 169 THR^? 17.93 MG MG F 302 coo 18.11 85.25 41.19 18.04 83.33 43.59 48.80 64.46 -76.37 51.50 64.15 -77.79 coo 5.34 86.23 43.48 6.16 87.26 45.12 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 9.06 92.76 42.80 7.04 92.63 42.14 54.83 68.79 -86.99 54.09 70.44 -85.82 ULMN 3 1lci_c00 LUCIFERASE user 16 3 # 16 218 ARG F 48 ARG^? 25.18 MG MG F 301 245 HIS F 42 HIS^? 28.34 MG MG F 301 343 THR F 40 THR^? 24.18 MG MG F 301 coo 18.11 85.25 41.19 18.04 83.33 43.59 46.82 60.90 -73.07 44.43 61.88 -71.46 coo 5.34 86.23 43.48 6.16 87.26 45.12 55.11 70.50 -71.64 56.29 72.22 -71.48 coo 9.06 92.76 42.80 7.04 92.63 42.14 52.32 69.62 -77.21 51.38 69.00 -75.36 ULMN 3 1lci_c00 LUCIFERASE user 17 3 # 17 218 ARG F 173 ARG^? 18.61 MG MG F 302 245 HIS F 147 HIS^? 8.79 MG MG F 302 343 THR F 169 THR^? 17.93 MG MG F 302 coo 18.11 85.25 41.19 18.04 83.33 43.59 43.18 65.58 -86.96 44.06 67.55 -84.65 coo 5.34 86.23 43.48 6.16 87.26 45.12 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 9.06 92.76 42.80 7.04 92.63 42.14 54.83 68.79 -86.99 54.09 70.44 -85.82 1lci_c00 source 1lci LUCIFERASE : 17 hits 1lci_c00 naa= 3 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 1 3 # 1 166 ASP A 171 ASP^? 17.17 MG MG A 302 169 ARG A 173 ARG^? 19.27 MG MG A 302 193 HIS A 170 HIS^? 10.56 MG MG A 302 coo 20.88 15.91 3.60 20.25 17.72 4.50 29.78 23.67 36.63 28.48 25.11 35.71 coo 17.70 17.91 -0.80 15.74 19.74 0.84 27.76 29.24 35.14 27.46 27.11 32.86 coo 18.81 19.85 7.63 17.55 19.89 5.97 34.91 23.57 39.32 34.35 24.95 40.81 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 2 3 # 2 166 ASP B 171 ASP^? 16.92 MG MG B 301 169 ARG B 173 ARG^? 18.75 MG MG B 301 193 HIS B 170 HIS^? 10.51 MG MG B 301 coo 20.88 15.91 3.60 20.25 17.72 4.50 45.30 8.50 -0.71 46.30 6.81 0.12 coo 17.70 17.91 -0.80 15.74 19.74 0.84 49.83 5.55 0.39 48.19 5.30 3.03 coo 18.81 19.85 7.63 17.55 19.89 5.97 46.22 13.75 -2.72 47.53 13.11 -4.24 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 3 3 # 3 166 ASP C 171 ASP^? 17.08 MG MG C 301 169 ARG C 173 ARG^? 18.96 MG MG C 301 193 HIS C 170 HIS^? 10.68 MG MG C 301 coo 20.88 15.91 3.60 20.25 17.72 4.50 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 17.70 17.91 -0.80 15.74 19.74 0.84 89.11 11.40 -7.73 91.21 12.63 -9.73 coo 18.81 19.85 7.63 17.55 19.89 5.97 89.96 21.05 -3.85 88.74 19.88 -2.61 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 4 3 # 4 166 ASP D 171 ASP^? 16.95 MG MG D 301 169 ARG D 173 ARG^? 18.88 MG MG D 301 193 HIS D 170 HIS^? 10.59 MG MG D 301 coo 20.88 15.91 3.60 20.25 17.72 4.50 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 17.70 17.91 -0.80 15.74 19.74 0.84 100.48 42.57 -42.43 101.55 40.79 -40.06 coo 18.81 19.85 7.63 17.55 19.89 5.97 95.57 34.81 -46.05 95.59 36.24 -47.59 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 5 3 # 5 166 ASP E 171 ASP^? 16.73 MG MG E 301 169 ARG E 173 ARG^? 18.66 MG MG E 301 193 HIS E 170 HIS^? 10.33 MG MG E 301 coo 20.88 15.91 3.60 20.25 17.72 4.50 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 17.70 17.91 -0.80 15.74 19.74 0.84 75.16 72.26 -52.56 73.67 73.54 -55.01 coo 18.81 19.85 7.63 17.55 19.89 5.97 66.96 68.76 -48.87 68.36 68.54 -47.33 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 6 3 # 6 166 ASP F 171 ASP^? 16.35 MG MG F 302 169 ARG F 173 ARG^? 18.61 MG MG F 302 193 HIS F 170 HIS^? 9.84 MG MG F 302 coo 20.88 15.91 3.60 20.25 17.72 4.50 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 17.70 17.91 -0.80 15.74 19.74 0.84 43.18 65.58 -86.96 44.06 67.55 -84.65 coo 18.81 19.85 7.63 17.55 19.89 5.97 52.25 64.82 -90.91 50.95 63.88 -92.26 1ldm_c01 source 1ldm M4 LACTATE DEHYDROGENASE : 6 hits 1ldm_c01 naa= 3 ULMN 3 1lij_c01 ADENOSINE KINASE user 1 3 # 1 A 316 ALA A 181 ALA^? -5.18 MG MG A 302s A 317 GLY A 149 GLY^? 6.01 MG MG A 302 A 318 ASP A 148 ASP^? 2.72 MG MG A 301s coo 144.15 17.54 -4.21 144.96 16.79 -5.26 38.08 32.08 44.23 37.12 30.96 43.87 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 37.26 27.53 42.29 37.61 28.00 41.76 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 41.50 28.88 41.13 43.33 29.67 41.93 ULMN 3 1lij_c01 ADENOSINE KINASE user 2 3 # 2 A 316 ALA A 181 ALA^? -5.18 MG MG A 302s A 317 GLY A 149 GLY^? 6.01 MG MG A 302 A 318 ASP A 177 ASP^? 8.44 MG MG A 302 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 38.08 32.08 44.23 37.12 30.96 43.87 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 37.26 27.53 42.29 37.61 28.00 41.76 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 33.02 29.04 43.18 33.79 27.88 44.78 ULMN 3 1lij_c01 ADENOSINE KINASE user 3 3 # 3 A 316 ALA A 181 ALA^? -5.18 MG MG A 302s A 317 GLY A 149 GLY^? 6.01 MG MG A 302 A 318 ASP A 187 ASP^? -3.29 MG MG A 302s coo 144.15 17.54 -4.21 144.96 16.79 -5.26 38.08 32.08 44.23 37.12 30.96 43.87 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 37.26 27.53 42.29 37.61 28.00 41.76 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 39.43 26.57 46.78 39.37 27.83 45.03 ULMN 3 1lij_c01 ADENOSINE KINASE user 4 3 # 4 A 316 ALA A 181 ALA^? -5.18 MG MG A 302s A 317 GLY A 183 GLY^? -4.64 MG MG A 301s A 318 ASP A 148 ASP^? 2.72 MG MG A 301s coo 144.15 17.54 -4.21 144.96 16.79 -5.26 38.08 32.08 44.23 37.12 30.96 43.87 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 42.94 34.42 44.60 42.51 33.67 44.58 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 41.50 28.88 41.13 43.33 29.67 41.93 ULMN 3 1lij_c01 ADENOSINE KINASE user 5 3 # 5 A 316 ALA B 181 ALA^? -4.86 MG MG B 301s A 317 GLY B 149 GLY^? 5.93 MG MG B 301 A 318 ASP B 148 ASP^? 2.58 MG MG B 302s coo 144.15 17.54 -4.21 144.96 16.79 -5.26 55.54 15.65 -6.80 54.26 14.84 -6.58 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 50.72 15.48 -5.33 51.24 15.67 -4.78 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 52.73 19.23 -3.77 53.81 20.99 -4.31 ULMN 3 1lij_c01 ADENOSINE KINASE user 6 3 # 6 A 316 ALA B 181 ALA^? -4.86 MG MG B 301s A 317 GLY B 149 GLY^? 5.93 MG MG B 301 A 318 ASP B 177 ASP^? 9.03 MG MG B 301 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 55.54 15.65 -6.80 54.26 14.84 -6.58 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 50.72 15.48 -5.33 51.24 15.67 -4.78 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 51.97 11.04 -6.64 50.39 11.62 -7.94 ULMN 3 1lij_c01 ADENOSINE KINASE user 7 3 # 7 A 316 ALA B 181 ALA^? -4.86 MG MG B 301s A 317 GLY B 149 GLY^? 5.93 MG MG B 301 A 318 ASP B 187 ASP^? -3.44 MG MG B 301s coo 144.15 17.54 -4.21 144.96 16.79 -5.26 55.54 15.65 -6.80 54.26 14.84 -6.58 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 50.72 15.48 -5.33 51.24 15.67 -4.78 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 50.64 18.14 -9.69 51.74 17.63 -7.86 ULMN 3 1lij_c01 ADENOSINE KINASE user 8 3 # 8 A 316 ALA B 181 ALA^? -4.86 MG MG B 301s A 317 GLY B 183 GLY^? -4.35 MG MG B 301s A 318 ASP B 148 ASP^? 2.58 MG MG B 302s coo 144.15 17.54 -4.21 144.96 16.79 -5.26 55.54 15.65 -6.80 54.26 14.84 -6.58 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 58.74 20.22 -6.73 58.00 19.87 -6.89 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 52.73 19.23 -3.77 53.81 20.99 -4.31 ULMN 3 1lij_c01 ADENOSINE KINASE user 9 3 # 9 A 316 ALA C 181 ALA^? -4.94 MG MG C 301s A 317 GLY C 149 GLY^? 6.13 MG MG C 301 A 318 ASP C 148 ASP^? 2.75 MG MG C 302s coo 144.15 17.54 -4.21 144.96 16.79 -5.26 80.65 19.58 0.32 82.11 19.32 0.03 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 85.09 20.92 -1.20 84.51 20.95 -1.73 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 81.96 23.83 -2.68 80.24 25.11 -2.27 ULMN 3 1lij_c01 ADENOSINE KINASE user 10 3 # 10 A 316 ALA C 181 ALA^? -4.94 MG MG C 301s A 317 GLY C 149 GLY^? 6.13 MG MG C 301 A 318 ASP C 177 ASP^? 8.84 MG MG C 301 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 80.65 19.58 0.32 82.11 19.32 0.03 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 85.09 20.92 -1.20 84.51 20.95 -1.73 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 85.60 16.42 -0.31 86.51 17.71 1.09 ULMN 3 1lij_c01 ADENOSINE KINASE user 11 3 # 11 A 316 ALA C 181 ALA^? -4.94 MG MG C 301s A 317 GLY C 149 GLY^? 6.13 MG MG C 301 A 318 ASP C 187 ASP^? -3.72 MG MG C 301s coo 144.15 17.54 -4.21 144.96 16.79 -5.26 80.65 19.58 0.32 82.11 19.32 0.03 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 85.09 20.92 -1.20 84.51 20.95 -1.73 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 84.01 23.73 3.39 83.47 22.54 1.59 ULMN 3 1lij_c01 ADENOSINE KINASE user 12 3 # 12 A 316 ALA C 181 ALA^? -4.94 MG MG C 301s A 317 GLY C 183 GLY^? -4.00 MG MG C 301s A 318 ASP C 148 ASP^? 2.75 MG MG C 302s coo 144.15 17.54 -4.21 144.96 16.79 -5.26 80.65 19.58 0.32 82.11 19.32 0.03 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 76.27 22.45 0.43 77.06 22.50 0.60 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 81.96 23.83 -2.68 80.24 25.11 -2.27 ULMN 3 1lij_c01 ADENOSINE KINASE user 13 3 # 13 A 316 ALA D 181 ALA^? -4.93 MG MG D 301s A 317 GLY D 149 GLY^? 6.12 MG MG D 301 A 318 ASP D 148 ASP^? 2.35 MG MG D 302s coo 144.15 17.54 -4.21 144.96 16.79 -5.26 89.39 41.74 -50.56 90.67 41.02 -50.20 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 92.07 37.87 -48.88 91.62 38.12 -48.34 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 87.78 37.50 -47.56 85.79 37.49 -48.28 ULMN 3 1lij_c01 ADENOSINE KINASE user 14 3 # 14 A 316 ALA D 181 ALA^? -4.93 MG MG D 301s A 317 GLY D 149 GLY^? 6.12 MG MG D 301 A 318 ASP D 177 ASP^? 8.43 MG MG D 301 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 89.39 41.74 -50.56 90.67 41.02 -50.20 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 92.07 37.87 -48.88 91.62 38.12 -48.34 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 95.74 41.01 -49.76 94.81 39.90 -51.24 ULMN 3 1lij_c01 ADENOSINE KINASE user 15 3 # 15 A 316 ALA D 181 ALA^? -4.93 MG MG D 301s A 317 GLY D 149 GLY^? 6.12 MG MG D 301 A 318 ASP D 187 ASP^? -2.95 MG MG D 301s coo 144.15 17.54 -4.21 144.96 16.79 -5.26 89.39 41.74 -50.56 90.67 41.02 -50.20 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 92.07 37.87 -48.88 91.62 38.12 -48.34 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 90.40 36.34 -52.69 89.24 37.98 -51.99 ULMN 3 1lij_c01 ADENOSINE KINASE user 16 3 # 16 A 316 ALA D 181 ALA^? -4.93 MG MG D 301s A 317 GLY D 183 GLY^? -4.40 MG MG D 301s A 318 ASP D 148 ASP^? 2.35 MG MG D 302s coo 144.15 17.54 -4.21 144.96 16.79 -5.26 89.39 41.74 -50.56 90.67 41.02 -50.20 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 84.07 42.30 -50.78 84.70 41.81 -50.82 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 87.78 37.50 -47.56 85.79 37.49 -48.28 ULMN 3 1lij_c01 ADENOSINE KINASE user 17 3 # 17 A 316 ALA E 181 ALA^? -4.51 MG MG E 301s A 317 GLY E 149 GLY^? 5.75 MG MG E 301 A 318 ASP E 148 ASP^? 2.62 MG MG E 302s coo 144.15 17.54 -4.21 144.96 16.79 -5.26 72.69 61.53 -44.13 72.20 62.95 -44.39 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 69.31 64.70 -46.05 69.60 64.17 -46.61 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 68.29 60.44 -47.29 68.03 58.42 -46.50 ULMN 3 1lij_c01 ADENOSINE KINASE user 18 3 # 18 A 316 ALA E 181 ALA^? -4.51 MG MG E 301s A 317 GLY E 149 GLY^? 5.75 MG MG E 301 A 318 ASP E 177 ASP^? 8.55 MG MG E 301 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 72.69 61.53 -44.13 72.20 62.95 -44.39 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 69.31 64.70 -46.05 69.60 64.17 -46.61 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 1lij_c01 ADENOSINE KINASE user 19 3 # 19 A 316 ALA E 181 ALA^? -4.51 MG MG E 301s A 317 GLY E 149 GLY^? 5.75 MG MG E 301 A 318 ASP E 187 ASP^? -2.71 MG MG E 301s coo 144.15 17.54 -4.21 144.96 16.79 -5.26 72.69 61.53 -44.13 72.20 62.95 -44.39 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 69.31 64.70 -46.05 69.60 64.17 -46.61 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 67.50 63.43 -41.69 68.97 62.26 -42.81 ULMN 3 1lij_c01 ADENOSINE KINASE user 20 3 # 20 A 316 ALA E 181 ALA^? -4.51 MG MG E 301s A 317 GLY E 183 GLY^? -4.49 MG MG E 301s A 318 ASP E 148 ASP^? 2.62 MG MG E 302s coo 144.15 17.54 -4.21 144.96 16.79 -5.26 72.69 61.53 -44.13 72.20 62.95 -44.39 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 72.33 56.33 -43.87 71.83 56.99 -43.77 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 68.29 60.44 -47.29 68.03 58.42 -46.50 ULMN 3 1lij_c01 ADENOSINE KINASE user 21 3 # 21 A 316 ALA F 181 ALA^? -4.41 MG MG F 302s A 317 GLY F 149 GLY^? 5.34 MG MG F 302 A 318 ASP F 148 ASP^? 2.72 MG MG F 301s coo 144.15 17.54 -4.21 144.96 16.79 -5.26 49.03 55.67 -94.95 49.00 57.19 -94.78 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 51.31 60.07 -93.46 51.26 59.51 -92.90 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 53.64 56.47 -91.98 54.61 54.68 -92.64 ULMN 3 1lij_c01 ADENOSINE KINASE user 22 3 # 22 A 316 ALA F 181 ALA^? -4.41 MG MG F 302s A 317 GLY F 149 GLY^? 5.34 MG MG F 302 A 318 ASP F 177 ASP^? 8.15 MG MG F 302 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 49.03 55.67 -94.95 49.00 57.19 -94.78 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 51.31 60.07 -93.46 51.26 59.51 -92.90 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 47.18 61.22 -94.50 48.48 62.32 -95.73 ULMN 3 1lij_c01 ADENOSINE KINASE user 23 3 # 23 A 316 ALA F 181 ALA^? -4.41 MG MG F 302s A 317 GLY F 149 GLY^? 5.34 MG MG F 302 A 318 ASP F 187 ASP^? -3.27 MG MG F 302s coo 144.15 17.54 -4.21 144.96 16.79 -5.26 49.03 55.67 -94.95 49.00 57.19 -94.78 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 51.31 60.07 -93.46 51.26 59.51 -92.90 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 53.93 58.87 -98.14 52.45 58.62 -96.61 ULMN 3 1lij_c01 ADENOSINE KINASE user 24 3 # 24 A 316 ALA F 181 ALA^? -4.41 MG MG F 302s A 317 GLY F 183 GLY^? -4.39 MG MG F 301s A 318 ASP F 148 ASP^? 2.72 MG MG F 301s coo 144.15 17.54 -4.21 144.96 16.79 -5.26 49.03 55.67 -94.95 49.00 57.19 -94.78 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 51.40 50.96 -94.96 51.47 51.79 -95.11 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 53.64 56.47 -91.98 54.61 54.68 -92.64 1lij_c01 source 1lij ADENOSINE KINASE : 24 hits 1lij_c01 naa= 3 ULMN 3 1lio_c01 ADENOSINE KINASE user 1 3 # 1 A 316 ALA A 181 ALA^? -5.18 MG MG A 302s A 317 GLY A 149 GLY^? 6.01 MG MG A 302 A 318 ASP A 148 ASP^? 2.72 MG MG A 301s coo 27.04 23.54 41.85 25.72 24.19 42.18 38.08 32.08 44.23 37.12 30.96 43.87 coo 27.87 23.16 38.17 28.43 22.97 38.87 37.26 27.53 42.29 37.61 28.00 41.76 coo 32.11 22.71 40.58 33.42 24.22 39.78 41.50 28.88 41.13 43.33 29.67 41.93 ULMN 3 1lio_c01 ADENOSINE KINASE user 2 3 # 2 A 316 ALA A 181 ALA^? -5.18 MG MG A 302s A 317 GLY A 149 GLY^? 6.01 MG MG A 302 A 318 ASP A 177 ASP^? 8.44 MG MG A 302 coo 27.04 23.54 41.85 25.72 24.19 42.18 38.08 32.08 44.23 37.12 30.96 43.87 coo 27.87 23.16 38.17 28.43 22.97 38.87 37.26 27.53 42.29 37.61 28.00 41.76 coo 32.11 22.71 40.58 33.42 24.22 39.78 33.02 29.04 43.18 33.79 27.88 44.78 ULMN 3 1lio_c01 ADENOSINE KINASE user 3 3 # 3 A 316 ALA A 181 ALA^? -5.18 MG MG A 302s A 317 GLY A 149 GLY^? 6.01 MG MG A 302 A 318 ASP A 187 ASP^? -3.29 MG MG A 302s coo 27.04 23.54 41.85 25.72 24.19 42.18 38.08 32.08 44.23 37.12 30.96 43.87 coo 27.87 23.16 38.17 28.43 22.97 38.87 37.26 27.53 42.29 37.61 28.00 41.76 coo 32.11 22.71 40.58 33.42 24.22 39.78 39.43 26.57 46.78 39.37 27.83 45.03 ULMN 3 1lio_c01 ADENOSINE KINASE user 4 3 # 4 A 316 ALA A 181 ALA^? -5.18 MG MG A 302s A 317 GLY A 183 GLY^? -4.64 MG MG A 301s A 318 ASP A 148 ASP^? 2.72 MG MG A 301s coo 27.04 23.54 41.85 25.72 24.19 42.18 38.08 32.08 44.23 37.12 30.96 43.87 coo 27.87 23.16 38.17 28.43 22.97 38.87 42.94 34.42 44.60 42.51 33.67 44.58 coo 32.11 22.71 40.58 33.42 24.22 39.78 41.50 28.88 41.13 43.33 29.67 41.93 ULMN 3 1lio_c01 ADENOSINE KINASE user 5 3 # 5 A 316 ALA B 181 ALA^? -4.86 MG MG B 301s A 317 GLY B 149 GLY^? 5.93 MG MG B 301 A 318 ASP B 148 ASP^? 2.58 MG MG B 302s coo 27.04 23.54 41.85 25.72 24.19 42.18 55.54 15.65 -6.80 54.26 14.84 -6.58 coo 27.87 23.16 38.17 28.43 22.97 38.87 50.72 15.48 -5.33 51.24 15.67 -4.78 coo 32.11 22.71 40.58 33.42 24.22 39.78 52.73 19.23 -3.77 53.81 20.99 -4.31 ULMN 3 1lio_c01 ADENOSINE KINASE user 6 3 # 6 A 316 ALA B 181 ALA^? -4.86 MG MG B 301s A 317 GLY B 149 GLY^? 5.93 MG MG B 301 A 318 ASP B 177 ASP^? 9.03 MG MG B 301 coo 27.04 23.54 41.85 25.72 24.19 42.18 55.54 15.65 -6.80 54.26 14.84 -6.58 coo 27.87 23.16 38.17 28.43 22.97 38.87 50.72 15.48 -5.33 51.24 15.67 -4.78 coo 32.11 22.71 40.58 33.42 24.22 39.78 51.97 11.04 -6.64 50.39 11.62 -7.94 ULMN 3 1lio_c01 ADENOSINE KINASE user 7 3 # 7 A 316 ALA B 181 ALA^? -4.86 MG MG B 301s A 317 GLY B 149 GLY^? 5.93 MG MG B 301 A 318 ASP B 187 ASP^? -3.44 MG MG B 301s coo 27.04 23.54 41.85 25.72 24.19 42.18 55.54 15.65 -6.80 54.26 14.84 -6.58 coo 27.87 23.16 38.17 28.43 22.97 38.87 50.72 15.48 -5.33 51.24 15.67 -4.78 coo 32.11 22.71 40.58 33.42 24.22 39.78 50.64 18.14 -9.69 51.74 17.63 -7.86 ULMN 3 1lio_c01 ADENOSINE KINASE user 8 3 # 8 A 316 ALA B 181 ALA^? -4.86 MG MG B 301s A 317 GLY B 183 GLY^? -4.35 MG MG B 301s A 318 ASP B 148 ASP^? 2.58 MG MG B 302s coo 27.04 23.54 41.85 25.72 24.19 42.18 55.54 15.65 -6.80 54.26 14.84 -6.58 coo 27.87 23.16 38.17 28.43 22.97 38.87 58.74 20.22 -6.73 58.00 19.87 -6.89 coo 32.11 22.71 40.58 33.42 24.22 39.78 52.73 19.23 -3.77 53.81 20.99 -4.31 ULMN 3 1lio_c01 ADENOSINE KINASE user 9 3 # 9 A 316 ALA C 181 ALA^? -4.94 MG MG C 301s A 317 GLY C 149 GLY^? 6.13 MG MG C 301 A 318 ASP C 148 ASP^? 2.75 MG MG C 302s coo 27.04 23.54 41.85 25.72 24.19 42.18 80.65 19.58 0.32 82.11 19.32 0.03 coo 27.87 23.16 38.17 28.43 22.97 38.87 85.09 20.92 -1.20 84.51 20.95 -1.73 coo 32.11 22.71 40.58 33.42 24.22 39.78 81.96 23.83 -2.68 80.24 25.11 -2.27 ULMN 3 1lio_c01 ADENOSINE KINASE user 10 3 # 10 A 316 ALA C 181 ALA^? -4.94 MG MG C 301s A 317 GLY C 149 GLY^? 6.13 MG MG C 301 A 318 ASP C 177 ASP^? 8.84 MG MG C 301 coo 27.04 23.54 41.85 25.72 24.19 42.18 80.65 19.58 0.32 82.11 19.32 0.03 coo 27.87 23.16 38.17 28.43 22.97 38.87 85.09 20.92 -1.20 84.51 20.95 -1.73 coo 32.11 22.71 40.58 33.42 24.22 39.78 85.60 16.42 -0.31 86.51 17.71 1.09 ULMN 3 1lio_c01 ADENOSINE KINASE user 11 3 # 11 A 316 ALA C 181 ALA^? -4.94 MG MG C 301s A 317 GLY C 149 GLY^? 6.13 MG MG C 301 A 318 ASP C 187 ASP^? -3.72 MG MG C 301s coo 27.04 23.54 41.85 25.72 24.19 42.18 80.65 19.58 0.32 82.11 19.32 0.03 coo 27.87 23.16 38.17 28.43 22.97 38.87 85.09 20.92 -1.20 84.51 20.95 -1.73 coo 32.11 22.71 40.58 33.42 24.22 39.78 84.01 23.73 3.39 83.47 22.54 1.59 ULMN 3 1lio_c01 ADENOSINE KINASE user 12 3 # 12 A 316 ALA C 181 ALA^? -4.94 MG MG C 301s A 317 GLY C 183 GLY^? -4.00 MG MG C 301s A 318 ASP C 148 ASP^? 2.75 MG MG C 302s coo 27.04 23.54 41.85 25.72 24.19 42.18 80.65 19.58 0.32 82.11 19.32 0.03 coo 27.87 23.16 38.17 28.43 22.97 38.87 76.27 22.45 0.43 77.06 22.50 0.60 coo 32.11 22.71 40.58 33.42 24.22 39.78 81.96 23.83 -2.68 80.24 25.11 -2.27 ULMN 3 1lio_c01 ADENOSINE KINASE user 13 3 # 13 A 316 ALA D 181 ALA^? -4.93 MG MG D 301s A 317 GLY D 149 GLY^? 6.12 MG MG D 301 A 318 ASP D 148 ASP^? 2.35 MG MG D 302s coo 27.04 23.54 41.85 25.72 24.19 42.18 89.39 41.74 -50.56 90.67 41.02 -50.20 coo 27.87 23.16 38.17 28.43 22.97 38.87 92.07 37.87 -48.88 91.62 38.12 -48.34 coo 32.11 22.71 40.58 33.42 24.22 39.78 87.78 37.50 -47.56 85.79 37.49 -48.28 ULMN 3 1lio_c01 ADENOSINE KINASE user 14 3 # 14 A 316 ALA D 181 ALA^? -4.93 MG MG D 301s A 317 GLY D 149 GLY^? 6.12 MG MG D 301 A 318 ASP D 177 ASP^? 8.43 MG MG D 301 coo 27.04 23.54 41.85 25.72 24.19 42.18 89.39 41.74 -50.56 90.67 41.02 -50.20 coo 27.87 23.16 38.17 28.43 22.97 38.87 92.07 37.87 -48.88 91.62 38.12 -48.34 coo 32.11 22.71 40.58 33.42 24.22 39.78 95.74 41.01 -49.76 94.81 39.90 -51.24 ULMN 3 1lio_c01 ADENOSINE KINASE user 15 3 # 15 A 316 ALA D 181 ALA^? -4.93 MG MG D 301s A 317 GLY D 149 GLY^? 6.12 MG MG D 301 A 318 ASP D 187 ASP^? -2.95 MG MG D 301s coo 27.04 23.54 41.85 25.72 24.19 42.18 89.39 41.74 -50.56 90.67 41.02 -50.20 coo 27.87 23.16 38.17 28.43 22.97 38.87 92.07 37.87 -48.88 91.62 38.12 -48.34 coo 32.11 22.71 40.58 33.42 24.22 39.78 90.40 36.34 -52.69 89.24 37.98 -51.99 ULMN 3 1lio_c01 ADENOSINE KINASE user 16 3 # 16 A 316 ALA D 181 ALA^? -4.93 MG MG D 301s A 317 GLY D 183 GLY^? -4.40 MG MG D 301s A 318 ASP D 148 ASP^? 2.35 MG MG D 302s coo 27.04 23.54 41.85 25.72 24.19 42.18 89.39 41.74 -50.56 90.67 41.02 -50.20 coo 27.87 23.16 38.17 28.43 22.97 38.87 84.07 42.30 -50.78 84.70 41.81 -50.82 coo 32.11 22.71 40.58 33.42 24.22 39.78 87.78 37.50 -47.56 85.79 37.49 -48.28 ULMN 3 1lio_c01 ADENOSINE KINASE user 17 3 # 17 A 316 ALA E 181 ALA^? -4.51 MG MG E 301s A 317 GLY E 149 GLY^? 5.75 MG MG E 301 A 318 ASP E 148 ASP^? 2.62 MG MG E 302s coo 27.04 23.54 41.85 25.72 24.19 42.18 72.69 61.53 -44.13 72.20 62.95 -44.39 coo 27.87 23.16 38.17 28.43 22.97 38.87 69.31 64.70 -46.05 69.60 64.17 -46.61 coo 32.11 22.71 40.58 33.42 24.22 39.78 68.29 60.44 -47.29 68.03 58.42 -46.50 ULMN 3 1lio_c01 ADENOSINE KINASE user 18 3 # 18 A 316 ALA E 181 ALA^? -4.51 MG MG E 301s A 317 GLY E 149 GLY^? 5.75 MG MG E 301 A 318 ASP E 177 ASP^? 8.55 MG MG E 301 coo 27.04 23.54 41.85 25.72 24.19 42.18 72.69 61.53 -44.13 72.20 62.95 -44.39 coo 27.87 23.16 38.17 28.43 22.97 38.87 69.31 64.70 -46.05 69.60 64.17 -46.61 coo 32.11 22.71 40.58 33.42 24.22 39.78 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 1lio_c01 ADENOSINE KINASE user 19 3 # 19 A 316 ALA E 181 ALA^? -4.51 MG MG E 301s A 317 GLY E 149 GLY^? 5.75 MG MG E 301 A 318 ASP E 187 ASP^? -2.71 MG MG E 301s coo 27.04 23.54 41.85 25.72 24.19 42.18 72.69 61.53 -44.13 72.20 62.95 -44.39 coo 27.87 23.16 38.17 28.43 22.97 38.87 69.31 64.70 -46.05 69.60 64.17 -46.61 coo 32.11 22.71 40.58 33.42 24.22 39.78 67.50 63.43 -41.69 68.97 62.26 -42.81 ULMN 3 1lio_c01 ADENOSINE KINASE user 20 3 # 20 A 316 ALA E 181 ALA^? -4.51 MG MG E 301s A 317 GLY E 183 GLY^? -4.49 MG MG E 301s A 318 ASP E 148 ASP^? 2.62 MG MG E 302s coo 27.04 23.54 41.85 25.72 24.19 42.18 72.69 61.53 -44.13 72.20 62.95 -44.39 coo 27.87 23.16 38.17 28.43 22.97 38.87 72.33 56.33 -43.87 71.83 56.99 -43.77 coo 32.11 22.71 40.58 33.42 24.22 39.78 68.29 60.44 -47.29 68.03 58.42 -46.50 ULMN 3 1lio_c01 ADENOSINE KINASE user 21 3 # 21 A 316 ALA F 181 ALA^? -4.41 MG MG F 302s A 317 GLY F 149 GLY^? 5.34 MG MG F 302 A 318 ASP F 148 ASP^? 2.72 MG MG F 301s coo 27.04 23.54 41.85 25.72 24.19 42.18 49.03 55.67 -94.95 49.00 57.19 -94.78 coo 27.87 23.16 38.17 28.43 22.97 38.87 51.31 60.07 -93.46 51.26 59.51 -92.90 coo 32.11 22.71 40.58 33.42 24.22 39.78 53.64 56.47 -91.98 54.61 54.68 -92.64 ULMN 3 1lio_c01 ADENOSINE KINASE user 22 3 # 22 A 316 ALA F 181 ALA^? -4.41 MG MG F 302s A 317 GLY F 149 GLY^? 5.34 MG MG F 302 A 318 ASP F 177 ASP^? 8.15 MG MG F 302 coo 27.04 23.54 41.85 25.72 24.19 42.18 49.03 55.67 -94.95 49.00 57.19 -94.78 coo 27.87 23.16 38.17 28.43 22.97 38.87 51.31 60.07 -93.46 51.26 59.51 -92.90 coo 32.11 22.71 40.58 33.42 24.22 39.78 47.18 61.22 -94.50 48.48 62.32 -95.73 ULMN 3 1lio_c01 ADENOSINE KINASE user 23 3 # 23 A 316 ALA F 181 ALA^? -4.41 MG MG F 302s A 317 GLY F 149 GLY^? 5.34 MG MG F 302 A 318 ASP F 187 ASP^? -3.27 MG MG F 302s coo 27.04 23.54 41.85 25.72 24.19 42.18 49.03 55.67 -94.95 49.00 57.19 -94.78 coo 27.87 23.16 38.17 28.43 22.97 38.87 51.31 60.07 -93.46 51.26 59.51 -92.90 coo 32.11 22.71 40.58 33.42 24.22 39.78 53.93 58.87 -98.14 52.45 58.62 -96.61 ULMN 3 1lio_c01 ADENOSINE KINASE user 24 3 # 24 A 316 ALA F 181 ALA^? -4.41 MG MG F 302s A 317 GLY F 183 GLY^? -4.39 MG MG F 301s A 318 ASP F 148 ASP^? 2.72 MG MG F 301s coo 27.04 23.54 41.85 25.72 24.19 42.18 49.03 55.67 -94.95 49.00 57.19 -94.78 coo 27.87 23.16 38.17 28.43 22.97 38.87 51.40 50.96 -94.96 51.47 51.79 -95.11 coo 32.11 22.71 40.58 33.42 24.22 39.78 53.64 56.47 -91.98 54.61 54.68 -92.64 1lio_c01 source 1lio ADENOSINE KINASE : 24 hits 1lio_c01 naa= 3 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 1 3 # 1 A 44 HIS A 147 HIS^? 9.20 MG MG A 302 A 45 HIS A 170 HIS^? 10.56 MG MG A 302 A 261 PHE A 12 PHE^? 17.15 MG MG A 301 coo 49.89 1.93 30.83 50.54 1.43 32.81 40.24 23.10 39.83 38.32 22.34 40.22 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 34.91 23.57 39.32 34.35 24.95 40.81 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 34.93 27.27 29.42 32.88 25.47 30.10 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 2 3 # 2 A 44 HIS B 147 HIS^? 9.27 MG MG B 301 A 45 HIS B 170 HIS^? 10.51 MG MG B 301 A 261 PHE B 12 PHE^? 17.13 MG MG B 302 coo 49.89 1.93 30.83 50.54 1.43 32.81 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 49.02 12.29 7.19 47.01 10.60 6.19 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 3 3 # 3 A 44 HIS C 147 HIS^? 9.44 MG MG C 301 A 45 HIS C 170 HIS^? 10.68 MG MG C 301 A 261 PHE C 12 PHE^? 16.92 MG MG C 302 coo 49.89 1.93 30.83 50.54 1.43 32.81 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 87.42 18.93 -13.86 90.00 18.25 -12.97 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 4 3 # 4 A 44 HIS D 147 HIS^? 9.43 MG MG D 301 A 45 HIS D 170 HIS^? 10.59 MG MG D 301 A 261 PHE D 12 PHE^? 16.78 MG MG D 302 coo 49.89 1.93 30.83 50.54 1.43 32.81 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 94.68 38.11 -36.05 97.16 37.10 -36.83 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 5 3 # 5 A 44 HIS E 147 HIS^? 9.22 MG MG E 301 A 45 HIS E 170 HIS^? 10.33 MG MG E 301 A 261 PHE E 12 PHE^? 17.09 MG MG E 302 coo 49.89 1.93 30.83 50.54 1.43 32.81 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 70.06 67.18 -58.76 69.33 69.81 -58.07 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 6 3 # 6 A 44 HIS F 147 HIS^? 8.79 MG MG F 302 A 45 HIS F 170 HIS^? 9.84 MG MG F 302 A 261 PHE F 12 PHE^? 17.12 MG MG F 301 coo 49.89 1.93 30.83 50.54 1.43 32.81 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 49.70 62.79 -80.90 49.37 65.44 -81.67 1luc_c00 source 1luc BACTERIAL LUCIFERASE : 6 hits 1luc_c00 naa= 3 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 1 3 # 1 A 123 LYS A 61 LYS^? 21.99 MG MG B 302 A 202 SER B 16 SER^? 23.97 MG MG B 302 A 226 SER B 36 SER^? 24.04 MG MG B 302 coo 1.62 6.10 69.30 3.81 1.25 65.91 57.78 7.35 19.60 56.77 12.20 15.61 coo 4.43 1.89 61.79 4.31 0.09 63.40 56.70 5.18 9.63 55.76 3.58 11.01 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 52.58 6.45 11.01 53.61 4.84 12.41 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 2 3 # 2 A 123 LYS A 61 LYS^? 21.99 MG MG B 302 A 202 SER B 36 SER^? 24.04 MG MG B 302 A 226 SER B 16 SER^? 23.97 MG MG B 302 coo 1.62 6.10 69.30 3.81 1.25 65.91 57.78 7.35 19.60 56.77 12.20 15.61 coo 4.43 1.89 61.79 4.31 0.09 63.40 52.58 6.45 11.01 53.61 4.84 12.41 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 56.70 5.18 9.63 55.76 3.58 11.01 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 3 3 # 3 A 123 LYS A 76 LYS^? 25.42 MG MG A 301 A 202 SER A 79 SER^? 29.65 MG MG A 301 A 226 SER A 83 SER^? 32.41 MG MG A 301 coo 1.62 6.10 69.30 3.81 1.25 65.91 34.45 46.53 27.28 28.88 44.93 27.25 coo 4.43 1.89 61.79 4.31 0.09 63.40 32.57 55.71 29.63 34.63 56.10 28.47 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 30.60 55.84 24.53 32.97 55.99 23.96 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 4 3 # 4 A 123 LYS A 76 LYS^? 25.42 MG MG A 301 A 202 SER A 83 SER^? 32.41 MG MG A 301 A 226 SER A 79 SER^? 29.65 MG MG A 301 coo 1.62 6.10 69.30 3.81 1.25 65.91 34.45 46.53 27.28 28.88 44.93 27.25 coo 4.43 1.89 61.79 4.31 0.09 63.40 30.60 55.84 24.53 32.97 55.99 23.96 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 32.57 55.71 29.63 34.63 56.10 28.47 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 5 3 # 5 A 123 LYS A 86 LYS^? 26.38 MG MG A 301 A 202 SER A 79 SER^? 29.65 MG MG A 301 A 226 SER A 83 SER^? 32.41 MG MG A 301 coo 1.62 6.10 69.30 3.81 1.25 65.91 37.08 47.78 23.56 32.88 44.24 21.89 coo 4.43 1.89 61.79 4.31 0.09 63.40 32.57 55.71 29.63 34.63 56.10 28.47 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 30.60 55.84 24.53 32.97 55.99 23.96 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 6 3 # 6 A 123 LYS A 86 LYS^? 26.38 MG MG A 301 A 202 SER A 83 SER^? 32.41 MG MG A 301 A 226 SER A 79 SER^? 29.65 MG MG A 301 coo 1.62 6.10 69.30 3.81 1.25 65.91 37.08 47.78 23.56 32.88 44.24 21.89 coo 4.43 1.89 61.79 4.31 0.09 63.40 30.60 55.84 24.53 32.97 55.99 23.96 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 32.57 55.71 29.63 34.63 56.10 28.47 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 7 3 # 7 A 123 LYS B 61 LYS^? 22.03 MG MG A 301 A 202 SER A 16 SER.? 24.16 MG MG A 301 A 226 SER A 36 SER^? 23.25 MG MG A 301 coo 1.62 6.10 69.30 3.81 1.25 65.91 32.50 37.62 17.61 36.68 34.92 21.51 coo 4.43 1.89 61.79 4.31 0.09 63.40 29.26 36.32 27.22 27.38 35.99 25.78 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 29.88 32.10 25.40 29.53 34.39 24.57 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 8 3 # 8 A 123 LYS B 61 LYS^? 22.03 MG MG A 301 A 202 SER A 36 SER^? 23.25 MG MG A 301 A 226 SER A 16 SER.? 24.16 MG MG A 301 coo 1.62 6.10 69.30 3.81 1.25 65.91 32.50 37.62 17.61 36.68 34.92 21.51 coo 4.43 1.89 61.79 4.31 0.09 63.40 29.88 32.10 25.40 29.53 34.39 24.57 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 29.26 36.32 27.22 27.38 35.99 25.78 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 9 3 # 9 A 123 LYS B 76 LYS^? 25.77 MG MG B 302 A 202 SER B 79 SER^? 20.24 MG MG C 301 A 226 SER B 83 SER^? 24.53 MG MG C 301 coo 1.62 6.10 69.30 3.81 1.25 65.91 67.82 8.19 10.14 64.96 3.09 10.62 coo 4.43 1.89 61.79 4.31 0.09 63.40 76.03 3.33 7.67 77.04 5.28 8.60 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 75.19 1.98 12.89 77.54 2.36 12.62 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 10 3 # 10 A 123 LYS B 76 LYS^? 25.77 MG MG B 302 A 202 SER B 83 SER^? 24.53 MG MG C 301 A 226 SER B 79 SER^? 20.24 MG MG C 301 coo 1.62 6.10 69.30 3.81 1.25 65.91 67.82 8.19 10.14 64.96 3.09 10.62 coo 4.43 1.89 61.79 4.31 0.09 63.40 75.19 1.98 12.89 77.54 2.36 12.62 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 76.03 3.33 7.67 77.04 5.28 8.60 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 11 3 # 11 A 123 LYS B 86 LYS^? 26.44 MG MG B 302 A 202 SER B 83 SER^? 24.53 MG MG C 301 A 226 SER B 79 SER^? 20.24 MG MG C 301 coo 1.62 6.10 69.30 3.81 1.25 65.91 69.25 10.45 13.86 65.27 7.74 16.08 coo 4.43 1.89 61.79 4.31 0.09 63.40 75.19 1.98 12.89 77.54 2.36 12.62 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 76.03 3.33 7.67 77.04 5.28 8.60 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 12 3 # 12 A 123 LYS C 61 LYS^? 21.91 MG MG D 302 A 202 SER D 16 SER^? 23.71 MG MG D 302 A 226 SER D 36 SER^? 22.42 MG MG D 302 coo 1.62 6.10 69.30 3.81 1.25 65.91 93.60 48.56 -24.05 90.39 44.71 -27.98 coo 4.43 1.89 61.79 4.31 0.09 63.40 96.73 48.43 -33.75 98.58 48.68 -32.31 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 97.85 44.42 -32.20 96.60 46.20 -31.15 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 13 3 # 13 A 123 LYS C 61 LYS^? 21.91 MG MG D 302 A 202 SER D 36 SER^? 22.42 MG MG D 302 A 226 SER D 16 SER^? 23.71 MG MG D 302 coo 1.62 6.10 69.30 3.81 1.25 65.91 93.60 48.56 -24.05 90.39 44.71 -27.98 coo 4.43 1.89 61.79 4.31 0.09 63.40 97.85 44.42 -32.20 96.60 46.20 -31.15 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 96.73 48.43 -33.75 98.58 48.68 -32.31 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 14 3 # 14 A 123 LYS C 76 LYS^? 24.95 MG MG C 302 A 202 SER C 79 SER^? 19.92 MG MG B 301 A 226 SER C 83 SER^? 23.40 MG MG B 301 coo 1.62 6.10 69.30 3.81 1.25 65.91 71.11 8.63 -16.76 75.44 5.17 -16.80 coo 4.43 1.89 61.79 4.31 0.09 63.40 64.38 1.95 -14.66 62.69 3.45 -15.45 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 65.19 0.76 -19.73 62.87 1.43 -19.33 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 15 3 # 15 A 123 LYS C 76 LYS^? 24.95 MG MG C 302 A 202 SER C 83 SER^? 23.40 MG MG B 301 A 226 SER C 79 SER^? 19.92 MG MG B 301 coo 1.62 6.10 69.30 3.81 1.25 65.91 71.11 8.63 -16.76 75.44 5.17 -16.80 coo 4.43 1.89 61.79 4.31 0.09 63.40 65.19 0.76 -19.73 62.87 1.43 -19.33 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 64.38 1.95 -14.66 62.69 3.45 -15.45 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 16 3 # 16 A 123 LYS C 86 LYS^? 27.34 MG MG C 302 A 202 SER C 83 SER^? 23.40 MG MG B 301 A 226 SER C 79 SER^? 19.92 MG MG B 301 coo 1.62 6.10 69.30 3.81 1.25 65.91 69.22 9.88 -20.56 74.70 7.02 -22.55 coo 4.43 1.89 61.79 4.31 0.09 63.40 65.19 0.76 -19.73 62.87 1.43 -19.33 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 64.38 1.95 -14.66 62.69 3.45 -15.45 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 17 3 # 17 A 123 LYS D 61 LYS^? 21.93 MG MG C 302 A 202 SER C 16 SER^? 24.15 MG MG C 302 A 226 SER C 36 SER^? 23.69 MG MG C 302 coo 1.62 6.10 69.30 3.81 1.25 65.91 80.64 11.23 -26.16 80.65 16.24 -22.36 coo 4.43 1.89 61.79 4.31 0.09 63.40 82.88 9.31 -16.30 84.27 7.80 -17.58 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 86.07 12.19 -17.80 85.34 10.22 -18.98 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 18 3 # 18 A 123 LYS D 61 LYS^? 21.93 MG MG C 302 A 202 SER C 36 SER^? 23.69 MG MG C 302 A 226 SER C 16 SER^? 24.15 MG MG C 302 coo 1.62 6.10 69.30 3.81 1.25 65.91 80.64 11.23 -26.16 80.65 16.24 -22.36 coo 4.43 1.89 61.79 4.31 0.09 63.40 86.07 12.19 -17.80 85.34 10.22 -18.98 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 82.88 9.31 -16.30 84.27 7.80 -17.58 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 19 3 # 19 A 123 LYS D 76 LYS^? 25.08 MG MG D 302 A 202 SER D 79 SER^? 19.41 MG MG E 301 A 226 SER D 83 SER^? 23.07 MG MG E 301 coo 1.62 6.10 69.30 3.81 1.25 65.91 88.18 56.35 -34.05 93.80 56.17 -32.93 coo 4.43 1.89 61.79 4.31 0.09 63.40 88.38 65.91 -36.56 86.13 65.62 -35.70 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 89.47 66.32 -31.33 87.79 67.80 -32.19 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 20 3 # 20 A 123 LYS D 76 LYS^? 25.08 MG MG D 302 A 202 SER D 83 SER^? 23.07 MG MG E 301 A 226 SER D 79 SER^? 19.41 MG MG E 301 coo 1.62 6.10 69.30 3.81 1.25 65.91 88.18 56.35 -34.05 93.80 56.17 -32.93 coo 4.43 1.89 61.79 4.31 0.09 63.40 89.47 66.32 -31.33 87.79 67.80 -32.19 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 88.38 65.91 -36.56 86.13 65.62 -35.70 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 21 3 # 21 A 123 LYS D 86 LYS^? 25.80 MG MG D 302 A 202 SER D 83 SER^? 23.07 MG MG E 301 A 226 SER D 79 SER^? 19.41 MG MG E 301 coo 1.62 6.10 69.30 3.81 1.25 65.91 85.54 56.79 -30.27 90.24 54.54 -28.62 coo 4.43 1.89 61.79 4.31 0.09 63.40 89.47 66.32 -31.33 87.79 67.80 -32.19 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 88.38 65.91 -36.56 86.13 65.62 -35.70 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 22 3 # 22 A 123 LYS E 61 LYS^? 22.16 MG MG F 301 A 202 SER F 16 SER^? 24.10 MG MG F 301 A 226 SER F 36 SER^? 23.07 MG MG F 301 coo 1.62 6.10 69.30 3.81 1.25 65.91 40.99 56.84 -68.48 45.99 56.72 -72.39 coo 4.43 1.89 61.79 4.31 0.09 63.40 39.77 59.81 -78.14 38.80 61.26 -76.65 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 42.79 62.77 -76.96 42.19 61.23 -75.17 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 23 3 # 23 A 123 LYS E 61 LYS^? 22.16 MG MG F 301 A 202 SER F 36 SER^? 23.07 MG MG F 301 A 226 SER F 16 SER^? 24.10 MG MG F 301 coo 1.62 6.10 69.30 3.81 1.25 65.91 40.99 56.84 -68.48 45.99 56.72 -72.39 coo 4.43 1.89 61.79 4.31 0.09 63.40 42.79 62.77 -76.96 42.19 61.23 -75.17 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 39.77 59.81 -78.14 38.80 61.26 -76.65 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 24 3 # 24 A 123 LYS E 76 LYS^? 25.68 MG MG E 302 A 202 SER E 79 SER^? 19.77 MG MG D 301 A 226 SER E 83 SER^? 23.44 MG MG D 301 coo 1.62 6.10 69.30 3.81 1.25 65.91 87.09 58.11 -60.91 88.65 63.65 -61.27 coo 4.43 1.89 61.79 4.31 0.09 63.40 96.22 56.25 -58.39 95.94 54.06 -59.20 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 96.88 57.42 -63.66 97.96 55.45 -62.84 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 25 3 # 25 A 123 LYS E 76 LYS^? 25.68 MG MG E 302 A 202 SER E 83 SER^? 23.44 MG MG D 301 A 226 SER E 79 SER^? 19.77 MG MG D 301 coo 1.62 6.10 69.30 3.81 1.25 65.91 87.09 58.11 -60.91 88.65 63.65 -61.27 coo 4.43 1.89 61.79 4.31 0.09 63.40 96.88 57.42 -63.66 97.96 55.45 -62.84 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 96.22 56.25 -58.39 95.94 54.06 -59.20 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 26 3 # 26 A 123 LYS E 86 LYS^? 26.73 MG MG D 301 A 202 SER E 83 SER^? 23.44 MG MG D 301 A 226 SER E 79 SER^? 19.77 MG MG D 301 coo 1.62 6.10 69.30 3.81 1.25 65.91 86.84 54.85 -64.43 87.07 60.83 -66.10 coo 4.43 1.89 61.79 4.31 0.09 63.40 96.88 57.42 -63.66 97.96 55.45 -62.84 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 96.22 56.25 -58.39 95.94 54.06 -59.20 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 27 3 # 27 A 123 LYS F 61 LYS^? 21.75 MG MG E 302 A 202 SER E 16 SER^? 24.21 MG MG E 302 A 226 SER E 36 SER^? 22.92 MG MG E 302 coo 1.62 6.10 69.30 3.81 1.25 65.91 80.24 64.12 -71.01 76.23 61.95 -66.39 coo 4.43 1.89 61.79 4.31 0.09 63.40 80.65 67.65 -61.22 81.30 69.49 -62.59 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 76.63 69.18 -62.93 78.20 67.77 -64.11 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 28 3 # 28 A 123 LYS F 61 LYS^? 21.75 MG MG E 302 A 202 SER E 36 SER^? 22.92 MG MG E 302 A 226 SER E 16 SER^? 24.21 MG MG E 302 coo 1.62 6.10 69.30 3.81 1.25 65.91 80.24 64.12 -71.01 76.23 61.95 -66.39 coo 4.43 1.89 61.79 4.31 0.09 63.40 76.63 69.18 -62.93 78.20 67.77 -64.11 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 80.65 67.65 -61.22 81.30 69.49 -62.59 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 29 3 # 29 A 123 LYS F 76 LYS^? 25.89 MG MG F 301 A 202 SER F 79 SER^? 30.22 MG MG F 301 A 226 SER F 83 SER^? 33.16 MG MG F 301 coo 1.62 6.10 69.30 3.81 1.25 65.91 36.96 48.52 -78.06 33.74 53.37 -77.06 coo 4.43 1.89 61.79 4.31 0.09 63.40 28.21 44.39 -80.24 29.11 42.36 -79.32 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 27.54 45.11 -75.18 28.33 43.06 -74.18 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 30 3 # 30 A 123 LYS F 76 LYS^? 25.89 MG MG F 301 A 202 SER F 83 SER^? 33.16 MG MG F 301 A 226 SER F 79 SER^? 30.22 MG MG F 301 coo 1.62 6.10 69.30 3.81 1.25 65.91 36.96 48.52 -78.06 33.74 53.37 -77.06 coo 4.43 1.89 61.79 4.31 0.09 63.40 27.54 45.11 -75.18 28.33 43.06 -74.18 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 28.21 44.39 -80.24 29.11 42.36 -79.32 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 31 3 # 31 A 123 LYS F 86 LYS^? 26.63 MG MG F 301 A 202 SER F 83 SER^? 33.16 MG MG F 301 A 226 SER F 79 SER^? 30.22 MG MG F 301 coo 1.62 6.10 69.30 3.81 1.25 65.91 37.89 45.97 -74.42 36.47 51.71 -72.79 coo 4.43 1.89 61.79 4.31 0.09 63.40 27.54 45.11 -75.18 28.33 43.06 -74.18 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 28.21 44.39 -80.24 29.11 42.36 -79.32 1m21_c00 source 1m21 PEPTIDE AMIDASE : 31 hits 1m21_c00 naa= 3 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 1 3 # 1 B 123 LYS A 61 LYS^? 21.99 MG MG B 302 B 202 SER B 16 SER^? 23.97 MG MG B 302 B 226 SER B 36 SER^? 24.04 MG MG B 302 coo 35.67 -0.01 18.11 33.47 4.84 14.73 57.78 7.35 19.60 56.77 12.20 15.61 coo 32.81 4.27 10.70 32.87 6.07 12.31 56.70 5.18 9.63 55.76 3.58 11.01 coo 28.77 6.36 12.44 30.83 7.25 11.75 52.58 6.45 11.01 53.61 4.84 12.41 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 2 3 # 2 B 123 LYS A 61 LYS^? 21.99 MG MG B 302 B 202 SER B 36 SER^? 24.04 MG MG B 302 B 226 SER B 16 SER^? 23.97 MG MG B 302 coo 35.67 -0.01 18.11 33.47 4.84 14.73 57.78 7.35 19.60 56.77 12.20 15.61 coo 32.81 4.27 10.70 32.87 6.07 12.31 52.58 6.45 11.01 53.61 4.84 12.41 coo 28.77 6.36 12.44 30.83 7.25 11.75 56.70 5.18 9.63 55.76 3.58 11.01 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 3 3 # 3 B 123 LYS A 76 LYS^? 25.42 MG MG A 301 B 202 SER A 79 SER^? 29.65 MG MG A 301 B 226 SER A 83 SER^? 32.41 MG MG A 301 coo 35.67 -0.01 18.11 33.47 4.84 14.73 34.45 46.53 27.28 28.88 44.93 27.25 coo 32.81 4.27 10.70 32.87 6.07 12.31 32.57 55.71 29.63 34.63 56.10 28.47 coo 28.77 6.36 12.44 30.83 7.25 11.75 30.60 55.84 24.53 32.97 55.99 23.96 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 4 3 # 4 B 123 LYS A 76 LYS^? 25.42 MG MG A 301 B 202 SER A 83 SER^? 32.41 MG MG A 301 B 226 SER A 79 SER^? 29.65 MG MG A 301 coo 35.67 -0.01 18.11 33.47 4.84 14.73 34.45 46.53 27.28 28.88 44.93 27.25 coo 32.81 4.27 10.70 32.87 6.07 12.31 30.60 55.84 24.53 32.97 55.99 23.96 coo 28.77 6.36 12.44 30.83 7.25 11.75 32.57 55.71 29.63 34.63 56.10 28.47 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 5 3 # 5 B 123 LYS A 86 LYS^? 26.38 MG MG A 301 B 202 SER A 79 SER^? 29.65 MG MG A 301 B 226 SER A 83 SER^? 32.41 MG MG A 301 coo 35.67 -0.01 18.11 33.47 4.84 14.73 37.08 47.78 23.56 32.88 44.24 21.89 coo 32.81 4.27 10.70 32.87 6.07 12.31 32.57 55.71 29.63 34.63 56.10 28.47 coo 28.77 6.36 12.44 30.83 7.25 11.75 30.60 55.84 24.53 32.97 55.99 23.96 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 6 3 # 6 B 123 LYS A 86 LYS^? 26.38 MG MG A 301 B 202 SER A 83 SER^? 32.41 MG MG A 301 B 226 SER A 79 SER^? 29.65 MG MG A 301 coo 35.67 -0.01 18.11 33.47 4.84 14.73 37.08 47.78 23.56 32.88 44.24 21.89 coo 32.81 4.27 10.70 32.87 6.07 12.31 30.60 55.84 24.53 32.97 55.99 23.96 coo 28.77 6.36 12.44 30.83 7.25 11.75 32.57 55.71 29.63 34.63 56.10 28.47 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 7 3 # 7 B 123 LYS B 61 LYS^? 22.03 MG MG A 301 B 202 SER A 16 SER.? 24.16 MG MG A 301 B 226 SER A 36 SER^? 23.25 MG MG A 301 coo 35.67 -0.01 18.11 33.47 4.84 14.73 32.50 37.62 17.61 36.68 34.92 21.51 coo 32.81 4.27 10.70 32.87 6.07 12.31 29.26 36.32 27.22 27.38 35.99 25.78 coo 28.77 6.36 12.44 30.83 7.25 11.75 29.88 32.10 25.40 29.53 34.39 24.57 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 8 3 # 8 B 123 LYS B 61 LYS^? 22.03 MG MG A 301 B 202 SER A 36 SER^? 23.25 MG MG A 301 B 226 SER A 16 SER.? 24.16 MG MG A 301 coo 35.67 -0.01 18.11 33.47 4.84 14.73 32.50 37.62 17.61 36.68 34.92 21.51 coo 32.81 4.27 10.70 32.87 6.07 12.31 29.88 32.10 25.40 29.53 34.39 24.57 coo 28.77 6.36 12.44 30.83 7.25 11.75 29.26 36.32 27.22 27.38 35.99 25.78 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 9 3 # 9 B 123 LYS B 76 LYS^? 25.77 MG MG B 302 B 202 SER B 79 SER^? 20.24 MG MG C 301 B 226 SER B 83 SER^? 24.53 MG MG C 301 coo 35.67 -0.01 18.11 33.47 4.84 14.73 67.82 8.19 10.14 64.96 3.09 10.62 coo 32.81 4.27 10.70 32.87 6.07 12.31 76.03 3.33 7.67 77.04 5.28 8.60 coo 28.77 6.36 12.44 30.83 7.25 11.75 75.19 1.98 12.89 77.54 2.36 12.62 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 10 3 # 10 B 123 LYS B 76 LYS^? 25.77 MG MG B 302 B 202 SER B 83 SER^? 24.53 MG MG C 301 B 226 SER B 79 SER^? 20.24 MG MG C 301 coo 35.67 -0.01 18.11 33.47 4.84 14.73 67.82 8.19 10.14 64.96 3.09 10.62 coo 32.81 4.27 10.70 32.87 6.07 12.31 75.19 1.98 12.89 77.54 2.36 12.62 coo 28.77 6.36 12.44 30.83 7.25 11.75 76.03 3.33 7.67 77.04 5.28 8.60 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 11 3 # 11 B 123 LYS B 86 LYS^? 26.44 MG MG B 302 B 202 SER B 83 SER^? 24.53 MG MG C 301 B 226 SER B 79 SER^? 20.24 MG MG C 301 coo 35.67 -0.01 18.11 33.47 4.84 14.73 69.25 10.45 13.86 65.27 7.74 16.08 coo 32.81 4.27 10.70 32.87 6.07 12.31 75.19 1.98 12.89 77.54 2.36 12.62 coo 28.77 6.36 12.44 30.83 7.25 11.75 76.03 3.33 7.67 77.04 5.28 8.60 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 12 3 # 12 B 123 LYS C 61 LYS^? 21.91 MG MG D 302 B 202 SER D 16 SER^? 23.71 MG MG D 302 B 226 SER D 36 SER^? 22.42 MG MG D 302 coo 35.67 -0.01 18.11 33.47 4.84 14.73 93.60 48.56 -24.05 90.39 44.71 -27.98 coo 32.81 4.27 10.70 32.87 6.07 12.31 96.73 48.43 -33.75 98.58 48.68 -32.31 coo 28.77 6.36 12.44 30.83 7.25 11.75 97.85 44.42 -32.20 96.60 46.20 -31.15 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 13 3 # 13 B 123 LYS C 61 LYS^? 21.91 MG MG D 302 B 202 SER D 36 SER^? 22.42 MG MG D 302 B 226 SER D 16 SER^? 23.71 MG MG D 302 coo 35.67 -0.01 18.11 33.47 4.84 14.73 93.60 48.56 -24.05 90.39 44.71 -27.98 coo 32.81 4.27 10.70 32.87 6.07 12.31 97.85 44.42 -32.20 96.60 46.20 -31.15 coo 28.77 6.36 12.44 30.83 7.25 11.75 96.73 48.43 -33.75 98.58 48.68 -32.31 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 14 3 # 14 B 123 LYS C 76 LYS^? 24.95 MG MG C 302 B 202 SER C 79 SER^? 19.92 MG MG B 301 B 226 SER C 83 SER^? 23.40 MG MG B 301 coo 35.67 -0.01 18.11 33.47 4.84 14.73 71.11 8.63 -16.76 75.44 5.17 -16.80 coo 32.81 4.27 10.70 32.87 6.07 12.31 64.38 1.95 -14.66 62.69 3.45 -15.45 coo 28.77 6.36 12.44 30.83 7.25 11.75 65.19 0.76 -19.73 62.87 1.43 -19.33 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 15 3 # 15 B 123 LYS C 76 LYS^? 24.95 MG MG C 302 B 202 SER C 83 SER^? 23.40 MG MG B 301 B 226 SER C 79 SER^? 19.92 MG MG B 301 coo 35.67 -0.01 18.11 33.47 4.84 14.73 71.11 8.63 -16.76 75.44 5.17 -16.80 coo 32.81 4.27 10.70 32.87 6.07 12.31 65.19 0.76 -19.73 62.87 1.43 -19.33 coo 28.77 6.36 12.44 30.83 7.25 11.75 64.38 1.95 -14.66 62.69 3.45 -15.45 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 16 3 # 16 B 123 LYS C 86 LYS^? 27.34 MG MG C 302 B 202 SER C 83 SER^? 23.40 MG MG B 301 B 226 SER C 79 SER^? 19.92 MG MG B 301 coo 35.67 -0.01 18.11 33.47 4.84 14.73 69.22 9.88 -20.56 74.70 7.02 -22.55 coo 32.81 4.27 10.70 32.87 6.07 12.31 65.19 0.76 -19.73 62.87 1.43 -19.33 coo 28.77 6.36 12.44 30.83 7.25 11.75 64.38 1.95 -14.66 62.69 3.45 -15.45 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 17 3 # 17 B 123 LYS D 61 LYS^? 21.93 MG MG C 302 B 202 SER C 16 SER^? 24.15 MG MG C 302 B 226 SER C 36 SER^? 23.69 MG MG C 302 coo 35.67 -0.01 18.11 33.47 4.84 14.73 80.64 11.23 -26.16 80.65 16.24 -22.36 coo 32.81 4.27 10.70 32.87 6.07 12.31 82.88 9.31 -16.30 84.27 7.80 -17.58 coo 28.77 6.36 12.44 30.83 7.25 11.75 86.07 12.19 -17.80 85.34 10.22 -18.98 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 18 3 # 18 B 123 LYS D 61 LYS^? 21.93 MG MG C 302 B 202 SER C 36 SER^? 23.69 MG MG C 302 B 226 SER C 16 SER^? 24.15 MG MG C 302 coo 35.67 -0.01 18.11 33.47 4.84 14.73 80.64 11.23 -26.16 80.65 16.24 -22.36 coo 32.81 4.27 10.70 32.87 6.07 12.31 86.07 12.19 -17.80 85.34 10.22 -18.98 coo 28.77 6.36 12.44 30.83 7.25 11.75 82.88 9.31 -16.30 84.27 7.80 -17.58 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 19 3 # 19 B 123 LYS D 76 LYS^? 25.08 MG MG D 302 B 202 SER D 79 SER^? 19.41 MG MG E 301 B 226 SER D 83 SER^? 23.07 MG MG E 301 coo 35.67 -0.01 18.11 33.47 4.84 14.73 88.18 56.35 -34.05 93.80 56.17 -32.93 coo 32.81 4.27 10.70 32.87 6.07 12.31 88.38 65.91 -36.56 86.13 65.62 -35.70 coo 28.77 6.36 12.44 30.83 7.25 11.75 89.47 66.32 -31.33 87.79 67.80 -32.19 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 20 3 # 20 B 123 LYS D 76 LYS^? 25.08 MG MG D 302 B 202 SER D 83 SER^? 23.07 MG MG E 301 B 226 SER D 79 SER^? 19.41 MG MG E 301 coo 35.67 -0.01 18.11 33.47 4.84 14.73 88.18 56.35 -34.05 93.80 56.17 -32.93 coo 32.81 4.27 10.70 32.87 6.07 12.31 89.47 66.32 -31.33 87.79 67.80 -32.19 coo 28.77 6.36 12.44 30.83 7.25 11.75 88.38 65.91 -36.56 86.13 65.62 -35.70 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 21 3 # 21 B 123 LYS D 86 LYS^? 25.80 MG MG D 302 B 202 SER D 83 SER^? 23.07 MG MG E 301 B 226 SER D 79 SER^? 19.41 MG MG E 301 coo 35.67 -0.01 18.11 33.47 4.84 14.73 85.54 56.79 -30.27 90.24 54.54 -28.62 coo 32.81 4.27 10.70 32.87 6.07 12.31 89.47 66.32 -31.33 87.79 67.80 -32.19 coo 28.77 6.36 12.44 30.83 7.25 11.75 88.38 65.91 -36.56 86.13 65.62 -35.70 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 22 3 # 22 B 123 LYS E 61 LYS^? 22.16 MG MG F 301 B 202 SER F 16 SER^? 24.10 MG MG F 301 B 226 SER F 36 SER^? 23.07 MG MG F 301 coo 35.67 -0.01 18.11 33.47 4.84 14.73 40.99 56.84 -68.48 45.99 56.72 -72.39 coo 32.81 4.27 10.70 32.87 6.07 12.31 39.77 59.81 -78.14 38.80 61.26 -76.65 coo 28.77 6.36 12.44 30.83 7.25 11.75 42.79 62.77 -76.96 42.19 61.23 -75.17 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 23 3 # 23 B 123 LYS E 61 LYS^? 22.16 MG MG F 301 B 202 SER F 36 SER^? 23.07 MG MG F 301 B 226 SER F 16 SER^? 24.10 MG MG F 301 coo 35.67 -0.01 18.11 33.47 4.84 14.73 40.99 56.84 -68.48 45.99 56.72 -72.39 coo 32.81 4.27 10.70 32.87 6.07 12.31 42.79 62.77 -76.96 42.19 61.23 -75.17 coo 28.77 6.36 12.44 30.83 7.25 11.75 39.77 59.81 -78.14 38.80 61.26 -76.65 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 24 3 # 24 B 123 LYS E 76 LYS^? 25.68 MG MG E 302 B 202 SER E 79 SER^? 19.77 MG MG D 301 B 226 SER E 83 SER^? 23.44 MG MG D 301 coo 35.67 -0.01 18.11 33.47 4.84 14.73 87.09 58.11 -60.91 88.65 63.65 -61.27 coo 32.81 4.27 10.70 32.87 6.07 12.31 96.22 56.25 -58.39 95.94 54.06 -59.20 coo 28.77 6.36 12.44 30.83 7.25 11.75 96.88 57.42 -63.66 97.96 55.45 -62.84 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 25 3 # 25 B 123 LYS E 76 LYS^? 25.68 MG MG E 302 B 202 SER E 83 SER^? 23.44 MG MG D 301 B 226 SER E 79 SER^? 19.77 MG MG D 301 coo 35.67 -0.01 18.11 33.47 4.84 14.73 87.09 58.11 -60.91 88.65 63.65 -61.27 coo 32.81 4.27 10.70 32.87 6.07 12.31 96.88 57.42 -63.66 97.96 55.45 -62.84 coo 28.77 6.36 12.44 30.83 7.25 11.75 96.22 56.25 -58.39 95.94 54.06 -59.20 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 26 3 # 26 B 123 LYS E 86 LYS^? 26.73 MG MG D 301 B 202 SER E 83 SER^? 23.44 MG MG D 301 B 226 SER E 79 SER^? 19.77 MG MG D 301 coo 35.67 -0.01 18.11 33.47 4.84 14.73 86.84 54.85 -64.43 87.07 60.83 -66.10 coo 32.81 4.27 10.70 32.87 6.07 12.31 96.88 57.42 -63.66 97.96 55.45 -62.84 coo 28.77 6.36 12.44 30.83 7.25 11.75 96.22 56.25 -58.39 95.94 54.06 -59.20 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 27 3 # 27 B 123 LYS F 61 LYS^? 21.75 MG MG E 302 B 202 SER E 16 SER^? 24.21 MG MG E 302 B 226 SER E 36 SER^? 22.92 MG MG E 302 coo 35.67 -0.01 18.11 33.47 4.84 14.73 80.24 64.12 -71.01 76.23 61.95 -66.39 coo 32.81 4.27 10.70 32.87 6.07 12.31 80.65 67.65 -61.22 81.30 69.49 -62.59 coo 28.77 6.36 12.44 30.83 7.25 11.75 76.63 69.18 -62.93 78.20 67.77 -64.11 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 28 3 # 28 B 123 LYS F 61 LYS^? 21.75 MG MG E 302 B 202 SER E 36 SER^? 22.92 MG MG E 302 B 226 SER E 16 SER^? 24.21 MG MG E 302 coo 35.67 -0.01 18.11 33.47 4.84 14.73 80.24 64.12 -71.01 76.23 61.95 -66.39 coo 32.81 4.27 10.70 32.87 6.07 12.31 76.63 69.18 -62.93 78.20 67.77 -64.11 coo 28.77 6.36 12.44 30.83 7.25 11.75 80.65 67.65 -61.22 81.30 69.49 -62.59 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 29 3 # 29 B 123 LYS F 76 LYS^? 25.89 MG MG F 301 B 202 SER F 79 SER^? 30.22 MG MG F 301 B 226 SER F 83 SER^? 33.16 MG MG F 301 coo 35.67 -0.01 18.11 33.47 4.84 14.73 36.96 48.52 -78.06 33.74 53.37 -77.06 coo 32.81 4.27 10.70 32.87 6.07 12.31 28.21 44.39 -80.24 29.11 42.36 -79.32 coo 28.77 6.36 12.44 30.83 7.25 11.75 27.54 45.11 -75.18 28.33 43.06 -74.18 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 30 3 # 30 B 123 LYS F 76 LYS^? 25.89 MG MG F 301 B 202 SER F 83 SER^? 33.16 MG MG F 301 B 226 SER F 79 SER^? 30.22 MG MG F 301 coo 35.67 -0.01 18.11 33.47 4.84 14.73 36.96 48.52 -78.06 33.74 53.37 -77.06 coo 32.81 4.27 10.70 32.87 6.07 12.31 27.54 45.11 -75.18 28.33 43.06 -74.18 coo 28.77 6.36 12.44 30.83 7.25 11.75 28.21 44.39 -80.24 29.11 42.36 -79.32 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 31 3 # 31 B 123 LYS F 86 LYS^? 26.63 MG MG F 301 B 202 SER F 83 SER^? 33.16 MG MG F 301 B 226 SER F 79 SER^? 30.22 MG MG F 301 coo 35.67 -0.01 18.11 33.47 4.84 14.73 37.89 45.97 -74.42 36.47 51.71 -72.79 coo 32.81 4.27 10.70 32.87 6.07 12.31 27.54 45.11 -75.18 28.33 43.06 -74.18 coo 28.77 6.36 12.44 30.83 7.25 11.75 28.21 44.39 -80.24 29.11 42.36 -79.32 1m21_c01 source 1m21 PEPTIDE AMIDASE : 31 hits 1m21_c01 naa= 3 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 35 ASP^? 16.92 MG MG A 301 A 265 GLU A 75 GLU^? 20.23 MG MG A 301 A 369 ASP B 58 ASP^? 26.73 MG MG A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 34.49 31.10 26.54 36.41 31.82 27.10 coo 17.36 23.57 72.04 18.68 21.92 71.98 38.99 46.65 28.68 39.94 47.65 30.33 coo 12.19 31.08 87.29 11.13 32.66 86.38 34.42 33.56 15.74 33.50 33.49 17.59 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 58 ASP^? 26.75 MG MG B 302 A 265 GLU B 54 GLU^? 22.94 MG MG B 302 A 369 ASP A 160 ASP^? 31.61 MG MG B 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 53.93 9.80 21.09 53.83 8.90 19.15 coo 17.36 23.57 72.04 18.68 21.92 71.98 43.18 23.27 12.99 42.40 22.23 14.68 coo 12.19 31.08 87.29 11.13 32.66 86.38 44.21 5.00 19.54 46.02 3.84 19.76 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP A 58 ASP^? 26.75 MG MG B 302 A 265 GLU B 75 GLU^? 15.82 MG MG C 301 A 369 ASP B 35 ASP^? 16.92 MG MG B 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 53.93 9.80 21.09 53.83 8.90 19.15 coo 17.36 23.57 72.04 18.68 21.92 71.98 68.81 12.14 8.61 69.95 13.49 7.45 coo 12.19 31.08 87.29 11.13 32.66 86.38 52.63 11.07 10.18 53.68 12.85 9.94 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP A 58 ASP^? 26.75 MG MG B 302 A 265 GLU B 154 GLU^? 19.05 MG MG B 302 A 369 ASP A 160 ASP^? 31.61 MG MG B 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 53.93 9.80 21.09 53.83 8.90 19.15 coo 17.36 23.57 72.04 18.68 21.92 71.98 44.04 15.11 6.74 44.19 13.59 8.30 coo 12.19 31.08 87.29 11.13 32.66 86.38 44.21 5.00 19.54 46.02 3.84 19.76 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 5 3 # 5 A 241 ASP A 160 ASP^? 31.61 MG MG B 302 A 265 GLU B 54 GLU^? 22.94 MG MG B 302 A 369 ASP A 58 ASP^? 26.75 MG MG B 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 44.21 5.00 19.54 46.02 3.84 19.76 coo 17.36 23.57 72.04 18.68 21.92 71.98 43.18 23.27 12.99 42.40 22.23 14.68 coo 12.19 31.08 87.29 11.13 32.66 86.38 53.93 9.80 21.09 53.83 8.90 19.15 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 6 3 # 6 A 241 ASP A 160 ASP^? 31.61 MG MG B 302 A 265 GLU B 154 GLU^? 19.05 MG MG B 302 A 369 ASP A 58 ASP^? 26.75 MG MG B 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 44.21 5.00 19.54 46.02 3.84 19.76 coo 17.36 23.57 72.04 18.68 21.92 71.98 44.04 15.11 6.74 44.19 13.59 8.30 coo 12.19 31.08 87.29 11.13 32.66 86.38 53.93 9.80 21.09 53.83 8.90 19.15 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 7 3 # 7 A 241 ASP B 23 ASP^? 15.67 MG MG C 301 A 265 GLU C 33 GLU^? 22.71 MG MG C 302 A 369 ASP C 23 ASP^? 15.39 MG MG B 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 74.31 7.55 -1.09 75.08 9.17 -2.23 coo 17.36 23.57 72.04 18.68 21.92 71.98 78.39 11.67 -18.82 78.34 12.01 -20.91 coo 12.19 31.08 87.29 11.13 32.66 86.38 65.24 6.82 -5.11 63.43 7.54 -4.15 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 8 3 # 8 A 241 ASP B 35 ASP^? 16.92 MG MG B 302 A 265 GLU B 54 GLU^? 22.94 MG MG B 302 A 369 ASP A 58 ASP^? 26.75 MG MG B 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 52.63 11.07 10.18 53.68 12.85 9.94 coo 17.36 23.57 72.04 18.68 21.92 71.98 43.18 23.27 12.99 42.40 22.23 14.68 coo 12.19 31.08 87.29 11.13 32.66 86.38 53.93 9.80 21.09 53.83 8.90 19.15 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 9 3 # 9 A 241 ASP B 35 ASP^? 16.92 MG MG B 302 A 265 GLU B 75 GLU^? 15.82 MG MG C 301 A 369 ASP A 58 ASP^? 26.75 MG MG B 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 52.63 11.07 10.18 53.68 12.85 9.94 coo 17.36 23.57 72.04 18.68 21.92 71.98 68.81 12.14 8.61 69.95 13.49 7.45 coo 12.19 31.08 87.29 11.13 32.66 86.38 53.93 9.80 21.09 53.83 8.90 19.15 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 10 3 # 10 A 241 ASP B 58 ASP^? 26.73 MG MG A 301 A 265 GLU A 54 GLU^? 22.98 MG MG A 301 A 369 ASP B 160 ASP^? 31.65 MG MG A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 34.42 33.56 15.74 33.50 33.49 17.59 coo 17.36 23.57 72.04 18.68 21.92 71.98 45.06 19.97 24.02 44.05 19.39 22.19 coo 12.19 31.08 87.29 11.13 32.66 86.38 28.01 24.83 16.38 27.44 26.81 15.80 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 11 3 # 11 A 241 ASP B 58 ASP^? 26.73 MG MG A 301 A 265 GLU A 75 GLU^? 20.23 MG MG A 301 A 369 ASP A 35 ASP^? 16.92 MG MG A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 34.42 33.56 15.74 33.50 33.49 17.59 coo 17.36 23.57 72.04 18.68 21.92 71.98 38.99 46.65 28.68 39.94 47.65 30.33 coo 12.19 31.08 87.29 11.13 32.66 86.38 34.49 31.10 26.54 36.41 31.82 27.10 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 12 3 # 12 A 241 ASP B 58 ASP^? 26.73 MG MG A 301 A 265 GLU A 154 GLU^? 19.22 MG MG A 301 A 369 ASP B 160 ASP^? 31.65 MG MG A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 34.42 33.56 15.74 33.50 33.49 17.59 coo 17.36 23.57 72.04 18.68 21.92 71.98 36.54 21.95 29.78 35.14 22.21 28.17 coo 12.19 31.08 87.29 11.13 32.66 86.38 28.01 24.83 16.38 27.44 26.81 15.80 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 13 3 # 13 A 241 ASP B 138 ASP^? 33.32 MG MG B 302 A 265 GLU B 63 GLU^? 27.83 MG MG A 301 A 369 ASP B 160 ASP^? 31.65 MG MG A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 23.42 29.01 6.78 24.36 28.48 4.94 coo 17.36 23.57 72.04 18.68 21.92 71.98 36.89 38.35 16.01 38.64 39.45 15.67 coo 12.19 31.08 87.29 11.13 32.66 86.38 28.01 24.83 16.38 27.44 26.81 15.80 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 14 3 # 14 A 241 ASP B 160 ASP^? 31.65 MG MG A 301 A 265 GLU A 54 GLU^? 22.98 MG MG A 301 A 369 ASP B 58 ASP^? 26.73 MG MG A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 28.01 24.83 16.38 27.44 26.81 15.80 coo 17.36 23.57 72.04 18.68 21.92 71.98 45.06 19.97 24.02 44.05 19.39 22.19 coo 12.19 31.08 87.29 11.13 32.66 86.38 34.42 33.56 15.74 33.50 33.49 17.59 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 15 3 # 15 A 241 ASP B 160 ASP^? 31.65 MG MG A 301 A 265 GLU A 154 GLU^? 19.22 MG MG A 301 A 369 ASP B 58 ASP^? 26.73 MG MG A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 28.01 24.83 16.38 27.44 26.81 15.80 coo 17.36 23.57 72.04 18.68 21.92 71.98 36.54 21.95 29.78 35.14 22.21 28.17 coo 12.19 31.08 87.29 11.13 32.66 86.38 34.42 33.56 15.74 33.50 33.49 17.59 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 16 3 # 16 A 241 ASP B 160 ASP^? 31.65 MG MG A 301 A 265 GLU B 63 GLU^? 27.83 MG MG A 301 A 369 ASP B 138 ASP^? 33.32 MG MG B 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 28.01 24.83 16.38 27.44 26.81 15.80 coo 17.36 23.57 72.04 18.68 21.92 71.98 36.89 38.35 16.01 38.64 39.45 15.67 coo 12.19 31.08 87.29 11.13 32.66 86.38 23.42 29.01 6.78 24.36 28.48 4.94 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 17 3 # 17 A 241 ASP B 177 ASP^? 9.03 MG MG B 301 A 265 GLU B 38 GLU^? 21.75 MG MG B 301 A 369 ASP B 148 ASP^? 2.58 MG MG B 302s coo 11.74 38.14 80.19 10.63 36.40 80.65 51.97 11.04 -6.64 50.39 11.62 -7.94 coo 17.36 23.57 72.04 18.68 21.92 71.98 44.79 4.95 7.12 46.66 4.47 6.21 coo 12.19 31.08 87.29 11.13 32.66 86.38 52.73 19.23 -3.77 53.81 20.99 -4.31 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 18 3 # 18 A 241 ASP C 23 ASP^? 15.39 MG MG B 301 A 265 GLU B 33 GLU^? 22.65 MG MG B 302 A 369 ASP B 23 ASP^? 15.67 MG MG C 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 65.24 6.82 -5.11 63.43 7.54 -4.15 coo 17.36 23.57 72.04 18.68 21.92 71.98 59.88 9.09 12.22 59.91 9.49 14.33 coo 12.19 31.08 87.29 11.13 32.66 86.38 74.31 7.55 -1.09 75.08 9.17 -2.23 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 19 3 # 19 A 241 ASP C 35 ASP^? 16.42 MG MG C 302 A 265 GLU C 54 GLU^? 22.77 MG MG C 302 A 369 ASP D 58 ASP^? 26.59 MG MG C 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 17.36 23.57 72.04 18.68 21.92 71.98 88.91 31.25 -19.52 89.97 30.69 -21.29 coo 12.19 31.08 87.29 11.13 32.66 86.38 83.38 14.85 -27.71 84.09 14.12 -25.85 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 20 3 # 20 A 241 ASP C 35 ASP^? 16.42 MG MG C 302 A 265 GLU C 75 GLU^? 16.14 MG MG B 301 A 369 ASP D 58 ASP^? 26.59 MG MG C 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 17.36 23.57 72.04 18.68 21.92 71.98 69.49 12.18 -14.30 67.44 12.65 -13.83 coo 12.19 31.08 87.29 11.13 32.66 86.38 83.38 14.85 -27.71 84.09 14.12 -25.85 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 21 3 # 21 A 241 ASP C 58 ASP^? 26.67 MG MG D 302 A 265 GLU D 54 GLU^? 22.96 MG MG D 302 A 369 ASP C 160 ASP^? 31.63 MG MG D 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 93.40 43.81 -22.27 94.18 44.45 -24.11 coo 17.36 23.57 72.04 18.68 21.92 71.98 87.96 27.60 -30.52 89.07 27.55 -28.72 coo 12.19 31.08 87.29 11.13 32.66 86.38 102.50 38.00 -23.28 102.43 39.97 -22.46 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 22 3 # 22 A 241 ASP C 58 ASP^? 26.67 MG MG D 302 A 265 GLU D 154 GLU^? 18.75 MG MG D 302 A 369 ASP C 160 ASP^? 31.63 MG MG D 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 93.40 43.81 -22.27 94.18 44.45 -24.11 coo 17.36 23.57 72.04 18.68 21.92 71.98 94.87 32.52 -36.42 96.07 33.39 -34.88 coo 12.19 31.08 87.29 11.13 32.66 86.38 102.50 38.00 -23.28 102.43 39.97 -22.46 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 23 3 # 23 A 241 ASP C 128 ASP^? -3.22 MG MG C 302s A 265 GLU B 25 GLU^? 12.88 MG MG C 301 A 369 ASP C 187 ASP^? -3.72 MG MG C 301s coo 11.74 38.14 80.19 10.63 36.40 80.65 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 17.36 23.57 72.04 18.68 21.92 71.98 79.57 9.59 -3.08 79.20 11.68 -3.64 coo 12.19 31.08 87.29 11.13 32.66 86.38 84.01 23.73 3.39 83.47 22.54 1.59 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 24 3 # 24 A 241 ASP C 138 ASP^? 33.43 MG MG C 302 A 265 GLU C 63 GLU^? 27.26 MG MG D 302 A 369 ASP C 160 ASP^? 31.63 MG MG D 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 105.43 43.97 -13.30 104.85 43.08 -11.43 coo 17.36 23.57 72.04 18.68 21.92 71.98 89.51 47.54 -22.35 87.55 48.20 -22.72 coo 12.19 31.08 87.29 11.13 32.66 86.38 102.50 38.00 -23.28 102.43 39.97 -22.46 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 25 3 # 25 A 241 ASP C 160 ASP^? 31.63 MG MG D 302 A 265 GLU C 63 GLU^? 27.26 MG MG D 302 A 369 ASP C 138 ASP^? 33.43 MG MG C 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 102.50 38.00 -23.28 102.43 39.97 -22.46 coo 17.36 23.57 72.04 18.68 21.92 71.98 89.51 47.54 -22.35 87.55 48.20 -22.72 coo 12.19 31.08 87.29 11.13 32.66 86.38 105.43 43.97 -13.30 104.85 43.08 -11.43 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 26 3 # 26 A 241 ASP C 160 ASP^? 31.63 MG MG D 302 A 265 GLU D 54 GLU^? 22.96 MG MG D 302 A 369 ASP C 58 ASP^? 26.67 MG MG D 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 102.50 38.00 -23.28 102.43 39.97 -22.46 coo 17.36 23.57 72.04 18.68 21.92 71.98 87.96 27.60 -30.52 89.07 27.55 -28.72 coo 12.19 31.08 87.29 11.13 32.66 86.38 93.40 43.81 -22.27 94.18 44.45 -24.11 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 27 3 # 27 A 241 ASP C 160 ASP^? 31.63 MG MG D 302 A 265 GLU D 154 GLU^? 18.75 MG MG D 302 A 369 ASP C 58 ASP^? 26.67 MG MG D 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 102.50 38.00 -23.28 102.43 39.97 -22.46 coo 17.36 23.57 72.04 18.68 21.92 71.98 94.87 32.52 -36.42 96.07 33.39 -34.88 coo 12.19 31.08 87.29 11.13 32.66 86.38 93.40 43.81 -22.27 94.18 44.45 -24.11 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 28 3 # 28 A 241 ASP C 177 ASP^? 8.84 MG MG C 301 A 265 GLU C 154 GLU^? 18.91 MG MG C 302 A 369 ASP C 187 ASP^? -3.72 MG MG C 301s coo 11.74 38.14 80.19 10.63 36.40 80.65 85.60 16.42 -0.31 86.51 17.71 1.09 coo 17.36 23.57 72.04 18.68 21.92 71.98 91.15 23.27 -13.33 91.61 21.91 -14.95 coo 12.19 31.08 87.29 11.13 32.66 86.38 84.01 23.73 3.39 83.47 22.54 1.59 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 29 3 # 29 A 241 ASP C 187 ASP^? -3.72 MG MG C 301s A 265 GLU B 25 GLU^? 12.88 MG MG C 301 A 369 ASP C 128 ASP^? -3.22 MG MG C 302s coo 11.74 38.14 80.19 10.63 36.40 80.65 84.01 23.73 3.39 83.47 22.54 1.59 coo 17.36 23.57 72.04 18.68 21.92 71.98 79.57 9.59 -3.08 79.20 11.68 -3.64 coo 12.19 31.08 87.29 11.13 32.66 86.38 80.05 28.39 -4.25 77.97 28.60 -4.21 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 30 3 # 30 A 241 ASP D 35 ASP^? 16.80 MG MG D 302 A 265 GLU D 54 GLU^? 22.96 MG MG D 302 A 369 ASP C 58 ASP^? 26.67 MG MG D 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 17.36 23.57 72.04 18.68 21.92 71.98 87.96 27.60 -30.52 89.07 27.55 -28.72 coo 12.19 31.08 87.29 11.13 32.66 86.38 93.40 43.81 -22.27 94.18 44.45 -24.11 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 31 3 # 31 A 241 ASP D 58 ASP^? 26.59 MG MG C 302 A 265 GLU C 54 GLU^? 22.77 MG MG C 302 A 369 ASP D 160 ASP^? 31.45 MG MG C 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 83.38 14.85 -27.71 84.09 14.12 -25.85 coo 17.36 23.57 72.04 18.68 21.92 71.98 88.91 31.25 -19.52 89.97 30.69 -21.29 coo 12.19 31.08 87.29 11.13 32.66 86.38 94.15 13.98 -26.57 92.71 12.42 -26.99 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 32 3 # 32 A 241 ASP D 58 ASP^? 26.59 MG MG C 302 A 265 GLU C 154 GLU^? 18.91 MG MG C 302 A 369 ASP D 160 ASP^? 31.45 MG MG C 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 83.38 14.85 -27.71 84.09 14.12 -25.85 coo 17.36 23.57 72.04 18.68 21.92 71.98 91.15 23.27 -13.33 91.61 21.91 -14.95 coo 12.19 31.08 87.29 11.13 32.66 86.38 94.15 13.98 -26.57 92.71 12.42 -26.99 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 33 3 # 33 A 241 ASP D 138 ASP^? 33.64 MG MG D 302 A 265 GLU D 63 GLU^? 27.62 MG MG C 302 A 369 ASP D 160 ASP^? 31.45 MG MG C 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 93.00 7.50 -35.79 93.88 8.48 -37.45 coo 17.36 23.57 72.04 18.68 21.92 71.98 77.46 14.75 -28.07 75.93 16.12 -28.66 coo 12.19 31.08 87.29 11.13 32.66 86.38 94.15 13.98 -26.57 92.71 12.42 -26.99 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 34 3 # 34 A 241 ASP D 160 ASP^? 31.45 MG MG C 302 A 265 GLU C 54 GLU^? 22.77 MG MG C 302 A 369 ASP D 58 ASP^? 26.59 MG MG C 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 94.15 13.98 -26.57 92.71 12.42 -26.99 coo 17.36 23.57 72.04 18.68 21.92 71.98 88.91 31.25 -19.52 89.97 30.69 -21.29 coo 12.19 31.08 87.29 11.13 32.66 86.38 83.38 14.85 -27.71 84.09 14.12 -25.85 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 35 3 # 35 A 241 ASP D 160 ASP^? 31.45 MG MG C 302 A 265 GLU C 154 GLU^? 18.91 MG MG C 302 A 369 ASP D 58 ASP^? 26.59 MG MG C 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 94.15 13.98 -26.57 92.71 12.42 -26.99 coo 17.36 23.57 72.04 18.68 21.92 71.98 91.15 23.27 -13.33 91.61 21.91 -14.95 coo 12.19 31.08 87.29 11.13 32.66 86.38 83.38 14.85 -27.71 84.09 14.12 -25.85 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 36 3 # 36 A 241 ASP D 160 ASP^? 31.45 MG MG C 302 A 265 GLU D 63 GLU^? 27.62 MG MG C 302 A 369 ASP D 138 ASP^? 33.64 MG MG D 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 94.15 13.98 -26.57 92.71 12.42 -26.99 coo 17.36 23.57 72.04 18.68 21.92 71.98 77.46 14.75 -28.07 75.93 16.12 -28.66 coo 12.19 31.08 87.29 11.13 32.66 86.38 93.00 7.50 -35.79 93.88 8.48 -37.45 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 37 3 # 37 A 241 ASP E 35 ASP^? 16.91 MG MG E 302 A 265 GLU E 54 GLU^? 22.83 MG MG E 302 A 369 ASP F 58 ASP^? 26.87 MG MG E 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 17.36 23.57 72.04 18.68 21.92 71.98 58.39 62.16 -64.12 58.73 62.98 -66.04 coo 12.19 31.08 87.29 11.13 32.66 86.38 75.55 64.68 -72.56 76.21 65.63 -70.79 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 38 3 # 38 A 241 ASP E 35 ASP^? 16.91 MG MG E 302 A 265 GLU E 75 GLU^? 15.76 MG MG D 301 A 369 ASP F 58 ASP^? 26.87 MG MG E 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 17.36 23.57 72.04 18.68 21.92 71.98 84.65 53.96 -59.58 85.64 52.81 -58.05 coo 12.19 31.08 87.29 11.13 32.66 86.38 75.55 64.68 -72.56 76.21 65.63 -70.79 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 39 3 # 39 A 241 ASP E 58 ASP^? 26.76 MG MG F 301 A 265 GLU F 54 GLU^? 22.98 MG MG F 301 A 369 ASP E 160 ASP^? 31.54 MG MG F 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 17.36 23.57 72.04 18.68 21.92 71.98 62.26 62.27 -75.30 61.72 63.47 -73.60 coo 12.19 31.08 87.29 11.13 32.66 86.38 45.81 70.00 -68.45 44.10 68.87 -67.77 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 40 3 # 40 A 241 ASP E 58 ASP^? 26.76 MG MG F 301 A 265 GLU F 154 GLU^? 18.97 MG MG F 301 A 369 ASP E 160 ASP^? 31.54 MG MG F 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 17.36 23.57 72.04 18.68 21.92 71.98 54.57 65.67 -81.55 53.36 66.51 -80.09 coo 12.19 31.08 87.29 11.13 32.66 86.38 45.81 70.00 -68.45 44.10 68.87 -67.77 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 41 3 # 41 A 241 ASP E 138 ASP^? 33.31 MG MG E 302 A 265 GLU E 63 GLU^? 28.08 MG MG F 301 A 369 ASP E 160 ASP^? 31.54 MG MG F 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 39.58 70.77 -58.63 40.74 70.78 -56.80 coo 17.36 23.57 72.04 18.68 21.92 71.98 44.04 53.99 -66.79 43.77 51.93 -66.35 coo 12.19 31.08 87.29 11.13 32.66 86.38 45.81 70.00 -68.45 44.10 68.87 -67.77 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 42 3 # 42 A 241 ASP E 160 ASP^? 31.54 MG MG F 301 A 265 GLU E 63 GLU^? 28.08 MG MG F 301 A 369 ASP E 138 ASP^? 33.31 MG MG E 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 45.81 70.00 -68.45 44.10 68.87 -67.77 coo 17.36 23.57 72.04 18.68 21.92 71.98 44.04 53.99 -66.79 43.77 51.93 -66.35 coo 12.19 31.08 87.29 11.13 32.66 86.38 39.58 70.77 -58.63 40.74 70.78 -56.80 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 43 3 # 43 A 241 ASP E 160 ASP^? 31.54 MG MG F 301 A 265 GLU F 54 GLU^? 22.98 MG MG F 301 A 369 ASP E 58 ASP^? 26.76 MG MG F 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 45.81 70.00 -68.45 44.10 68.87 -67.77 coo 17.36 23.57 72.04 18.68 21.92 71.98 62.26 62.27 -75.30 61.72 63.47 -73.60 coo 12.19 31.08 87.29 11.13 32.66 86.38 45.39 59.31 -66.83 44.62 59.88 -68.72 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 44 3 # 44 A 241 ASP E 160 ASP^? 31.54 MG MG F 301 A 265 GLU F 154 GLU^? 18.97 MG MG F 301 A 369 ASP E 58 ASP^? 26.76 MG MG F 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 45.81 70.00 -68.45 44.10 68.87 -67.77 coo 17.36 23.57 72.04 18.68 21.92 71.98 54.57 65.67 -81.55 53.36 66.51 -80.09 coo 12.19 31.08 87.29 11.13 32.66 86.38 45.39 59.31 -66.83 44.62 59.88 -68.72 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 45 3 # 45 A 241 ASP F 35 ASP^? 16.93 MG MG F 301 A 265 GLU F 54 GLU^? 22.98 MG MG F 301 A 369 ASP E 58 ASP^? 26.76 MG MG F 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 46.82 60.47 -77.63 48.00 58.79 -78.23 coo 17.36 23.57 72.04 18.68 21.92 71.98 62.26 62.27 -75.30 61.72 63.47 -73.60 coo 12.19 31.08 87.29 11.13 32.66 86.38 45.39 59.31 -66.83 44.62 59.88 -68.72 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 46 3 # 46 A 241 ASP F 58 ASP^? 26.87 MG MG E 302 A 265 GLU E 54 GLU^? 22.83 MG MG E 302 A 369 ASP F 160 ASP^? 31.59 MG MG E 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 75.55 64.68 -72.56 76.21 65.63 -70.79 coo 17.36 23.57 72.04 18.68 21.92 71.98 58.39 62.16 -64.12 58.73 62.98 -66.04 coo 12.19 31.08 87.29 11.13 32.66 86.38 71.27 74.59 -71.77 73.23 74.02 -72.37 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 47 3 # 47 A 241 ASP F 58 ASP^? 26.87 MG MG E 302 A 265 GLU E 75 GLU^? 15.76 MG MG D 301 A 369 ASP E 35 ASP^? 16.91 MG MG E 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 75.55 64.68 -72.56 76.21 65.63 -70.79 coo 17.36 23.57 72.04 18.68 21.92 71.98 84.65 53.96 -59.58 85.64 52.81 -58.05 coo 12.19 31.08 87.29 11.13 32.66 86.38 73.60 65.64 -62.00 73.13 63.73 -61.22 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 48 3 # 48 A 241 ASP F 58 ASP^? 26.87 MG MG E 302 A 265 GLU E 154 GLU^? 19.05 MG MG E 302 A 369 ASP F 160 ASP^? 31.59 MG MG E 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 75.55 64.68 -72.56 76.21 65.63 -70.79 coo 17.36 23.57 72.04 18.68 21.92 71.98 64.41 68.21 -58.47 65.40 69.20 -60.08 coo 12.19 31.08 87.29 11.13 32.66 86.38 71.27 74.59 -71.77 73.23 74.02 -72.37 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 49 3 # 49 A 241 ASP F 138 ASP^? 33.51 MG MG F 302 A 265 GLU F 63 GLU^? 27.81 MG MG E 302 A 369 ASP F 160 ASP^? 31.59 MG MG E 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 77.17 76.66 -81.48 76.14 76.33 -83.32 coo 17.36 23.57 72.04 18.68 21.92 71.98 78.38 60.07 -72.34 78.48 58.04 -72.84 coo 12.19 31.08 87.29 11.13 32.66 86.38 71.27 74.59 -71.77 73.23 74.02 -72.37 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 50 3 # 50 A 241 ASP F 160 ASP^? 31.59 MG MG E 302 A 265 GLU E 54 GLU^? 22.83 MG MG E 302 A 369 ASP F 58 ASP^? 26.87 MG MG E 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 71.27 74.59 -71.77 73.23 74.02 -72.37 coo 17.36 23.57 72.04 18.68 21.92 71.98 58.39 62.16 -64.12 58.73 62.98 -66.04 coo 12.19 31.08 87.29 11.13 32.66 86.38 75.55 64.68 -72.56 76.21 65.63 -70.79 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 51 3 # 51 A 241 ASP F 160 ASP^? 31.59 MG MG E 302 A 265 GLU E 154 GLU^? 19.05 MG MG E 302 A 369 ASP F 58 ASP^? 26.87 MG MG E 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 71.27 74.59 -71.77 73.23 74.02 -72.37 coo 17.36 23.57 72.04 18.68 21.92 71.98 64.41 68.21 -58.47 65.40 69.20 -60.08 coo 12.19 31.08 87.29 11.13 32.66 86.38 75.55 64.68 -72.56 76.21 65.63 -70.79 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 52 3 # 52 A 241 ASP F 160 ASP^? 31.59 MG MG E 302 A 265 GLU F 63 GLU^? 27.81 MG MG E 302 A 369 ASP F 138 ASP^? 33.51 MG MG F 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 71.27 74.59 -71.77 73.23 74.02 -72.37 coo 17.36 23.57 72.04 18.68 21.92 71.98 78.38 60.07 -72.34 78.48 58.04 -72.84 coo 12.19 31.08 87.29 11.13 32.66 86.38 77.17 76.66 -81.48 76.14 76.33 -83.32 1m53_c05 source 1m53 ISOMALTULOSE SYNTHASE : 52 hits 1m53_c05 naa= 3 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 58 ASP^? 26.75 MG MG B 302 A 279 GLU B 75 GLU^? 15.82 MG MG C 301 A 369 ASP A 160 ASP^? 31.61 MG MG B 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 53.93 9.80 21.09 53.83 8.90 19.15 coo 16.54 46.37 63.94 14.77 45.79 62.95 68.81 12.14 8.61 69.95 13.49 7.45 coo 12.19 31.08 87.29 11.13 32.66 86.38 44.21 5.00 19.54 46.02 3.84 19.76 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 148 ASP^? 2.72 MG MG A 301s A 279 GLU A 94 GLU^? 17.31 MG MG A 301 A 369 ASP A 177 ASP^? 8.44 MG MG A 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 41.50 28.88 41.13 43.33 29.67 41.93 coo 16.54 46.37 63.94 14.77 45.79 62.95 57.11 32.79 29.92 57.45 34.91 29.85 coo 12.19 31.08 87.29 11.13 32.66 86.38 33.02 29.04 43.18 33.79 27.88 44.78 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP A 171 ASP^? 17.17 MG MG A 302 A 279 GLU A 165 GLU^? 29.56 MG MG A 302 A 369 ASP A 177 ASP^? 8.44 MG MG A 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 29.78 23.67 36.63 28.48 25.11 35.71 coo 16.54 46.37 63.94 14.77 45.79 62.95 36.12 8.31 27.27 37.25 6.55 27.60 coo 12.19 31.08 87.29 11.13 32.66 86.38 33.02 29.04 43.18 33.79 27.88 44.78 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP B 35 ASP^? 16.92 MG MG B 302 A 279 GLU B 174 GLU^? 19.69 MG MG B 301 A 369 ASP A 58 ASP^? 26.75 MG MG B 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 52.63 11.07 10.18 53.68 12.85 9.94 coo 16.54 46.37 63.94 14.77 45.79 62.95 43.72 4.95 -3.28 44.76 3.14 -2.69 coo 12.19 31.08 87.29 11.13 32.66 86.38 53.93 9.80 21.09 53.83 8.90 19.15 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 5 3 # 5 A 241 ASP B 58 ASP^? 26.73 MG MG A 301 A 279 GLU A 75 GLU^? 20.23 MG MG A 301 A 369 ASP B 160 ASP^? 31.65 MG MG A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 34.42 33.56 15.74 33.50 33.49 17.59 coo 16.54 46.37 63.94 14.77 45.79 62.95 38.99 46.65 28.68 39.94 47.65 30.33 coo 12.19 31.08 87.29 11.13 32.66 86.38 28.01 24.83 16.38 27.44 26.81 15.80 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 6 3 # 6 A 241 ASP B 160 ASP^? 31.65 MG MG A 301 A 279 GLU A 52 GLU^? 19.89 MG MG A 301 A 369 ASP B 138 ASP^? 33.32 MG MG B 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 28.01 24.83 16.38 27.44 26.81 15.80 coo 16.54 46.37 63.94 14.77 45.79 62.95 42.67 25.16 24.80 42.61 25.77 22.75 coo 12.19 31.08 87.29 11.13 32.66 86.38 23.42 29.01 6.78 24.36 28.48 4.94 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 7 3 # 7 A 241 ASP B 160 ASP^? 31.65 MG MG A 301 A 279 GLU A 54 GLU^? 22.98 MG MG A 301 A 369 ASP B 138 ASP^? 33.32 MG MG B 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 28.01 24.83 16.38 27.44 26.81 15.80 coo 16.54 46.37 63.94 14.77 45.79 62.95 45.06 19.97 24.02 44.05 19.39 22.19 coo 12.19 31.08 87.29 11.13 32.66 86.38 23.42 29.01 6.78 24.36 28.48 4.94 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 8 3 # 8 A 241 ASP B 160 ASP^? 31.65 MG MG A 301 A 279 GLU B 52 GLU^? 20.06 MG MG B 302 A 369 ASP B 138 ASP^? 33.32 MG MG B 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 28.01 24.83 16.38 27.44 26.81 15.80 coo 16.54 46.37 63.94 14.77 45.79 62.95 47.87 20.25 12.36 48.11 19.69 14.43 coo 12.19 31.08 87.29 11.13 32.66 86.38 23.42 29.01 6.78 24.36 28.48 4.94 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 9 3 # 9 A 241 ASP B 171 ASP^? 16.92 MG MG B 301 A 279 GLU B 165 GLU^? 29.66 MG MG B 302 A 369 ASP B 177 ASP^? 9.03 MG MG B 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 45.30 8.50 -0.71 46.30 6.81 0.12 coo 16.54 46.37 63.94 14.77 45.79 62.95 30.38 16.84 8.28 28.95 18.37 7.83 coo 12.19 31.08 87.29 11.13 32.66 86.38 51.97 11.04 -6.64 50.39 11.62 -7.94 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 10 3 # 10 A 241 ASP B 177 ASP^? 9.03 MG MG B 301 A 279 GLU C 75 GLU^? 16.14 MG MG B 301 A 369 ASP B 171 ASP^? 16.92 MG MG B 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 51.97 11.04 -6.64 50.39 11.62 -7.94 coo 16.54 46.37 63.94 14.77 45.79 62.95 69.49 12.18 -14.30 67.44 12.65 -13.83 coo 12.19 31.08 87.29 11.13 32.66 86.38 45.30 8.50 -0.71 46.30 6.81 0.12 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 11 3 # 11 A 241 ASP C 35 ASP^? 16.42 MG MG C 302 A 279 GLU C 174 GLU^? 19.72 MG MG C 301 A 369 ASP D 58 ASP^? 26.59 MG MG C 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 16.54 46.37 63.94 14.77 45.79 62.95 95.09 14.29 -3.63 95.25 12.23 -4.17 coo 12.19 31.08 87.29 11.13 32.66 86.38 83.38 14.85 -27.71 84.09 14.12 -25.85 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 12 3 # 12 A 241 ASP C 58 ASP^? 26.67 MG MG D 302 A 279 GLU D 75 GLU^? 15.53 MG MG E 301 A 369 ASP C 160 ASP^? 31.63 MG MG D 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 93.40 43.81 -22.27 94.18 44.45 -24.11 coo 16.54 46.37 63.94 14.77 45.79 62.95 84.53 54.81 -36.40 82.75 56.01 -36.42 coo 12.19 31.08 87.29 11.13 32.66 86.38 102.50 38.00 -23.28 102.43 39.97 -22.46 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 13 3 # 13 A 241 ASP C 148 ASP^? 2.75 MG MG C 302s A 279 GLU C 94 GLU^? 16.62 MG MG C 302 A 369 ASP C 177 ASP^? 8.84 MG MG C 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 16.54 46.37 63.94 14.77 45.79 62.95 71.81 35.42 -14.68 69.88 35.53 -13.78 coo 12.19 31.08 87.29 11.13 32.66 86.38 85.60 16.42 -0.31 86.51 17.71 1.09 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 14 3 # 14 A 241 ASP C 160 ASP^? 31.63 MG MG D 302 A 279 GLU D 52 GLU^? 19.94 MG MG D 302 A 369 ASP C 138 ASP^? 33.43 MG MG C 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 102.50 38.00 -23.28 102.43 39.97 -22.46 coo 16.54 46.37 63.94 14.77 45.79 62.95 87.13 33.17 -30.97 88.40 33.70 -29.31 coo 12.19 31.08 87.29 11.13 32.66 86.38 105.43 43.97 -13.30 104.85 43.08 -11.43 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 15 3 # 15 A 241 ASP C 160 ASP^? 31.63 MG MG D 302 A 279 GLU D 54 GLU^? 22.96 MG MG D 302 A 369 ASP C 138 ASP^? 33.43 MG MG C 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 102.50 38.00 -23.28 102.43 39.97 -22.46 coo 16.54 46.37 63.94 14.77 45.79 62.95 87.96 27.60 -30.52 89.07 27.55 -28.72 coo 12.19 31.08 87.29 11.13 32.66 86.38 105.43 43.97 -13.30 104.85 43.08 -11.43 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 16 3 # 16 A 241 ASP C 171 ASP^? 17.08 MG MG C 301 A 279 GLU C 165 GLU^? 29.32 MG MG C 302 A 369 ASP C 177 ASP^? 8.84 MG MG C 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 16.54 46.37 63.94 14.77 45.79 62.95 103.18 29.99 -15.18 103.57 32.09 -14.86 coo 12.19 31.08 87.29 11.13 32.66 86.38 85.60 16.42 -0.31 86.51 17.71 1.09 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 17 3 # 17 A 241 ASP C 177 ASP^? 8.84 MG MG C 301 A 279 GLU B 75 GLU^? 15.82 MG MG C 301 A 369 ASP C 171 ASP^? 17.08 MG MG C 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 85.60 16.42 -0.31 86.51 17.71 1.09 coo 16.54 46.37 63.94 14.77 45.79 62.95 68.81 12.14 8.61 69.95 13.49 7.45 coo 12.19 31.08 87.29 11.13 32.66 86.38 92.57 16.68 -6.24 92.24 14.74 -7.03 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 18 3 # 18 A 241 ASP D 35 ASP^? 16.80 MG MG D 302 A 279 GLU D 174 GLU^? 19.76 MG MG D 301 A 369 ASP C 58 ASP^? 26.67 MG MG D 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 16.54 46.37 63.94 14.77 45.79 62.95 104.29 37.18 -46.00 105.30 38.94 -45.21 coo 12.19 31.08 87.29 11.13 32.66 86.38 93.40 43.81 -22.27 94.18 44.45 -24.11 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 19 3 # 19 A 241 ASP D 58 ASP^? 26.59 MG MG C 302 A 279 GLU C 75 GLU^? 16.14 MG MG B 301 A 369 ASP D 160 ASP^? 31.45 MG MG C 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 83.38 14.85 -27.71 84.09 14.12 -25.85 coo 16.54 46.37 63.94 14.77 45.79 62.95 69.49 12.18 -14.30 67.44 12.65 -13.83 coo 12.19 31.08 87.29 11.13 32.66 86.38 94.15 13.98 -26.57 92.71 12.42 -26.99 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 20 3 # 20 A 241 ASP D 148 ASP^? 2.35 MG MG D 302s A 279 GLU D 94 GLU^? 16.28 MG MG D 302 A 369 ASP D 177 ASP^? 8.43 MG MG D 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 16.54 46.37 63.94 14.77 45.79 62.95 72.85 36.59 -35.79 71.78 37.87 -37.16 coo 12.19 31.08 87.29 11.13 32.66 86.38 95.74 41.01 -49.76 94.81 39.90 -51.24 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 21 3 # 21 A 241 ASP D 160 ASP^? 31.45 MG MG C 302 A 279 GLU C 52 GLU^? 19.67 MG MG C 302 A 369 ASP D 138 ASP^? 33.64 MG MG D 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 94.15 13.98 -26.57 92.71 12.42 -26.99 coo 16.54 46.37 63.94 14.77 45.79 62.95 84.27 26.98 -19.19 85.21 26.16 -20.96 coo 12.19 31.08 87.29 11.13 32.66 86.38 93.00 7.50 -35.79 93.88 8.48 -37.45 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 22 3 # 22 A 241 ASP D 160 ASP^? 31.45 MG MG C 302 A 279 GLU C 54 GLU^? 22.77 MG MG C 302 A 369 ASP D 138 ASP^? 33.64 MG MG D 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 94.15 13.98 -26.57 92.71 12.42 -26.99 coo 16.54 46.37 63.94 14.77 45.79 62.95 88.91 31.25 -19.52 89.97 30.69 -21.29 coo 12.19 31.08 87.29 11.13 32.66 86.38 93.00 7.50 -35.79 93.88 8.48 -37.45 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 23 3 # 23 A 241 ASP D 171 ASP^? 16.95 MG MG D 301 A 279 GLU D 165 GLU^? 29.85 MG MG D 302 A 369 ASP D 177 ASP^? 8.43 MG MG D 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 16.54 46.37 63.94 14.77 45.79 62.95 100.60 20.11 -34.27 100.38 17.96 -34.49 coo 12.19 31.08 87.29 11.13 32.66 86.38 95.74 41.01 -49.76 94.81 39.90 -51.24 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 24 3 # 24 A 241 ASP D 177 ASP^? 8.43 MG MG D 301 A 279 GLU E 75 GLU^? 15.76 MG MG D 301 A 369 ASP D 171 ASP^? 16.95 MG MG D 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 95.74 41.01 -49.76 94.81 39.90 -51.24 coo 16.54 46.37 63.94 14.77 45.79 62.95 84.65 53.96 -59.58 85.64 52.81 -58.05 coo 12.19 31.08 87.29 11.13 32.66 86.38 100.39 36.69 -43.49 101.13 38.51 -42.69 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 25 3 # 25 A 241 ASP E 35 ASP^? 16.91 MG MG E 302 A 279 GLU E 174 GLU^? 19.83 MG MG E 301 A 369 ASP F 58 ASP^? 26.87 MG MG E 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 16.54 46.37 63.94 14.77 45.79 62.95 70.48 76.62 -49.45 71.76 78.34 -49.45 coo 12.19 31.08 87.29 11.13 32.66 86.38 75.55 64.68 -72.56 76.21 65.63 -70.79 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 26 3 # 26 A 241 ASP E 58 ASP^? 26.76 MG MG F 301 A 279 GLU F 75 GLU^? 19.96 MG MG F 301 A 369 ASP E 160 ASP^? 31.54 MG MG F 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 16.54 46.37 63.94 14.77 45.79 62.95 40.19 46.06 -80.81 40.09 43.94 -81.24 coo 12.19 31.08 87.29 11.13 32.66 86.38 45.81 70.00 -68.45 44.10 68.87 -67.77 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 27 3 # 27 A 241 ASP E 148 ASP^? 2.62 MG MG E 302s A 279 GLU E 94 GLU^? 18.90 MG MG E 302 A 369 ASP E 177 ASP^? 8.55 MG MG E 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 16.54 46.37 63.94 14.77 45.79 62.95 62.96 45.14 -58.39 62.13 44.53 -60.28 coo 12.19 31.08 87.29 11.13 32.66 86.38 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 28 3 # 28 A 241 ASP E 160 ASP^? 31.54 MG MG F 301 A 279 GLU F 52 GLU^? 20.13 MG MG F 301 A 369 ASP E 138 ASP^? 33.31 MG MG E 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 45.81 70.00 -68.45 44.10 68.87 -67.77 coo 16.54 46.37 63.94 14.77 45.79 62.95 57.09 59.62 -75.76 56.76 59.40 -73.62 coo 12.19 31.08 87.29 11.13 32.66 86.38 39.58 70.77 -58.63 40.74 70.78 -56.80 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 29 3 # 29 A 241 ASP E 160 ASP^? 31.54 MG MG F 301 A 279 GLU F 54 GLU^? 22.98 MG MG F 301 A 369 ASP E 138 ASP^? 33.31 MG MG E 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 45.81 70.00 -68.45 44.10 68.87 -67.77 coo 16.54 46.37 63.94 14.77 45.79 62.95 62.26 62.27 -75.30 61.72 63.47 -73.60 coo 12.19 31.08 87.29 11.13 32.66 86.38 39.58 70.77 -58.63 40.74 70.78 -56.80 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 30 3 # 30 A 241 ASP E 171 ASP^? 16.73 MG MG E 301 A 279 GLU E 165 GLU^? 29.48 MG MG E 301 A 369 ASP E 177 ASP^? 8.55 MG MG E 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 16.54 46.37 63.94 14.77 45.79 62.95 52.92 74.97 -61.04 50.84 74.87 -60.51 coo 12.19 31.08 87.29 11.13 32.66 86.38 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 31 3 # 31 A 241 ASP E 177 ASP^? 8.55 MG MG E 301 A 279 GLU D 75 GLU^? 15.53 MG MG E 301 A 369 ASP E 171 ASP^? 16.73 MG MG E 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 72.81 67.32 -45.03 71.14 67.96 -43.95 coo 16.54 46.37 63.94 14.77 45.79 62.95 84.53 54.81 -36.40 82.75 56.01 -36.42 coo 12.19 31.08 87.29 11.13 32.66 86.38 69.61 73.12 -51.56 71.50 73.53 -52.39 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 32 3 # 32 A 241 ASP F 58 ASP^? 26.87 MG MG E 302 A 279 GLU E 75 GLU^? 15.76 MG MG D 301 A 369 ASP F 160 ASP^? 31.59 MG MG E 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 75.55 64.68 -72.56 76.21 65.63 -70.79 coo 16.54 46.37 63.94 14.77 45.79 62.95 84.65 53.96 -59.58 85.64 52.81 -58.05 coo 12.19 31.08 87.29 11.13 32.66 86.38 71.27 74.59 -71.77 73.23 74.02 -72.37 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 33 3 # 33 A 241 ASP F 148 ASP^? 2.72 MG MG F 301s A 279 GLU F 94 GLU^? 17.06 MG MG F 301 A 369 ASP F 177 ASP^? 8.15 MG MG F 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 16.54 46.37 63.94 14.77 45.79 62.95 62.58 44.49 -81.43 64.13 42.92 -81.30 coo 12.19 31.08 87.29 11.13 32.66 86.38 47.18 61.22 -94.50 48.48 62.32 -95.73 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 34 3 # 34 A 241 ASP F 160 ASP^? 31.59 MG MG E 302 A 279 GLU E 52 GLU^? 19.96 MG MG E 302 A 369 ASP F 138 ASP^? 33.51 MG MG F 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 71.27 74.59 -71.77 73.23 74.02 -72.37 coo 16.54 46.37 63.94 14.77 45.79 62.95 64.71 60.06 -63.78 64.69 61.36 -65.58 coo 12.19 31.08 87.29 11.13 32.66 86.38 77.17 76.66 -81.48 76.14 76.33 -83.32 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 35 3 # 35 A 241 ASP F 160 ASP^? 31.59 MG MG E 302 A 279 GLU E 54 GLU^? 22.83 MG MG E 302 A 369 ASP F 138 ASP^? 33.51 MG MG F 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 71.27 74.59 -71.77 73.23 74.02 -72.37 coo 16.54 46.37 63.94 14.77 45.79 62.95 58.39 62.16 -64.12 58.73 62.98 -66.04 coo 12.19 31.08 87.29 11.13 32.66 86.38 77.17 76.66 -81.48 76.14 76.33 -83.32 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 36 3 # 36 A 241 ASP F 171 ASP^? 16.35 MG MG F 302 A 279 GLU F 165 GLU^? 29.11 MG MG F 302 A 369 ASP F 177 ASP^? 8.15 MG MG F 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 16.54 46.37 63.94 14.77 45.79 62.95 63.01 76.49 -79.50 64.84 77.22 -80.35 coo 12.19 31.08 87.29 11.13 32.66 86.38 47.18 61.22 -94.50 48.48 62.32 -95.73 1m53_c06 source 1m53 ISOMALTULOSE SYNTHASE : 36 hits 1m53_c06 naa= 3 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 1 3 # 1 159 ARG A 8 ARG^? 20.36 MG MG A 301 229 SER A 49 SER^? 17.63 MG MG A 301 325 GLU A 52 GLU^? 19.89 MG MG A 301 coo 2.54 15.84 18.57 3.24 17.85 16.30 40.62 19.52 24.63 40.98 22.51 23.88 coo 10.17 13.48 15.92 9.61 15.76 15.27 38.68 29.52 26.48 39.52 27.49 25.41 coo 5.42 13.04 19.75 5.74 13.81 17.79 42.67 25.16 24.80 42.61 25.77 22.75 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 2 3 # 2 159 ARG B 8 ARG^? 20.39 MG MG B 302 229 SER B 49 SER^? 17.51 MG MG B 302 325 GLU B 52 GLU^? 20.06 MG MG B 302 coo 2.54 15.84 18.57 3.24 17.85 16.30 41.99 18.82 11.83 44.91 18.76 12.93 coo 10.17 13.48 15.92 9.61 15.76 15.27 51.67 15.70 10.57 49.37 16.19 11.15 coo 5.42 13.04 19.75 5.74 13.81 17.79 47.87 20.25 12.36 48.11 19.69 14.43 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 3 3 # 3 159 ARG F 8 ARG^? 20.20 MG MG F 301 229 SER F 49 SER^? 17.41 MG MG F 301 325 GLU F 52 GLU^? 20.13 MG MG F 301 coo 2.54 15.84 18.57 3.24 17.85 16.30 58.98 65.22 -76.31 57.29 62.84 -75.38 coo 10.17 13.48 15.92 9.61 15.76 15.27 51.43 58.69 -77.53 52.81 60.66 -77.24 coo 5.42 13.04 19.75 5.74 13.81 17.79 57.09 59.62 -75.76 56.76 59.40 -73.62 1mbb_c00 source 1mbb URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYLGLUCOSAMI: 3 hits 1mbb_c00 naa= 3 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 1 3 # 1 164 LYS A 6 LYS^? 25.88 MG MG A 301 166 LYS A 157 LYS^? 28.65 MG MG A 302 324 SER A 92 SER^? 15.40 MG MG A 301 coo 25.93 8.11 25.51 26.40 7.80 19.66 46.20 12.82 24.71 44.50 16.64 20.52 coo 27.27 1.43 25.09 29.18 5.25 22.89 41.42 12.06 27.58 41.46 5.93 29.41 coo 46.32 14.55 19.93 45.95 12.72 21.27 51.45 35.15 28.48 53.73 34.74 29.17 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 2 3 # 2 164 LYS A 6 LYS^? 25.88 MG MG A 301 166 LYS A 157 LYS^? 28.65 MG MG A 302 324 SER B 66 SER^? 21.21 MG MG B 302 coo 25.93 8.11 25.51 26.40 7.80 19.66 46.20 12.82 24.71 44.50 16.64 20.52 coo 27.27 1.43 25.09 29.18 5.25 22.89 41.42 12.06 27.58 41.46 5.93 29.41 coo 46.32 14.55 19.93 45.95 12.72 21.27 44.21 30.46 12.82 45.29 32.17 11.68 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 3 3 # 3 164 LYS A 157 LYS^? 28.65 MG MG A 302 166 LYS A 6 LYS^? 25.88 MG MG A 301 324 SER A 36 SER^? 23.25 MG MG A 301 coo 25.93 8.11 25.51 26.40 7.80 19.66 41.42 12.06 27.58 41.46 5.93 29.41 coo 27.27 1.43 25.09 29.18 5.25 22.89 46.20 12.82 24.71 44.50 16.64 20.52 coo 46.32 14.55 19.93 45.95 12.72 21.27 29.88 32.10 25.40 29.53 34.39 24.57 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 4 3 # 4 164 LYS A 157 LYS^? 28.65 MG MG A 302 166 LYS A 166 LYS^? 20.93 MG MG A 302 324 SER A 115 SER^? 6.34 MG MG A 301 coo 25.93 8.11 25.51 26.40 7.80 19.66 41.42 12.06 27.58 41.46 5.93 29.41 coo 27.27 1.43 25.09 29.18 5.25 22.89 35.34 13.14 30.41 31.67 15.04 34.58 coo 46.32 14.55 19.93 45.95 12.72 21.27 48.89 29.76 35.69 49.85 31.26 37.35 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 5 3 # 5 164 LYS A 166 LYS^? 20.93 MG MG A 302 166 LYS A 157 LYS^? 28.65 MG MG A 302 324 SER A 36 SER^? 23.25 MG MG A 301 coo 25.93 8.11 25.51 26.40 7.80 19.66 35.34 13.14 30.41 31.67 15.04 34.58 coo 27.27 1.43 25.09 29.18 5.25 22.89 41.42 12.06 27.58 41.46 5.93 29.41 coo 46.32 14.55 19.93 45.95 12.72 21.27 29.88 32.10 25.40 29.53 34.39 24.57 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 6 3 # 6 164 LYS B 6 LYS^? 25.90 MG MG B 302 166 LYS B 157 LYS^? 28.85 MG MG B 302 324 SER A 16 SER.? 24.16 MG MG A 301 coo 25.93 8.11 25.51 26.40 7.80 19.66 36.26 25.44 11.74 39.65 23.12 16.29 coo 27.27 1.43 25.09 29.18 5.25 22.89 34.97 21.28 8.44 29.03 22.82 6.58 coo 46.32 14.55 19.93 45.95 12.72 21.27 29.26 36.32 27.22 27.38 35.99 25.78 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 7 3 # 7 164 LYS B 6 LYS^? 25.90 MG MG B 302 166 LYS B 157 LYS^? 28.85 MG MG B 302 324 SER A 66 SER^? 21.38 MG MG A 301 coo 25.93 8.11 25.51 26.40 7.80 19.66 36.26 25.44 11.74 39.65 23.12 16.29 coo 27.27 1.43 25.09 29.18 5.25 22.89 34.97 21.28 8.44 29.03 22.82 6.58 coo 46.32 14.55 19.93 45.95 12.72 21.27 52.67 19.58 24.88 54.49 20.94 25.63 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 8 3 # 8 164 LYS B 6 LYS^? 25.90 MG MG B 302 166 LYS B 157 LYS^? 28.85 MG MG B 302 324 SER B 92 SER^? 15.63 MG MG B 302 coo 25.93 8.11 25.51 26.40 7.80 19.66 36.26 25.44 11.74 39.65 23.12 16.29 coo 27.27 1.43 25.09 29.18 5.25 22.89 34.97 21.28 8.44 29.03 22.82 6.58 coo 46.32 14.55 19.93 45.95 12.72 21.27 59.57 27.12 10.15 59.58 29.43 9.62 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 9 3 # 9 164 LYS B 157 LYS^? 28.85 MG MG B 302 166 LYS B 6 LYS^? 25.90 MG MG B 302 324 SER B 36 SER^? 24.04 MG MG B 302 coo 25.93 8.11 25.51 26.40 7.80 19.66 34.97 21.28 8.44 29.03 22.82 6.58 coo 27.27 1.43 25.09 29.18 5.25 22.89 36.26 25.44 11.74 39.65 23.12 16.29 coo 46.32 14.55 19.93 45.95 12.72 21.27 52.58 6.45 11.01 53.61 4.84 12.41 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 10 3 # 10 164 LYS B 157 LYS^? 28.85 MG MG B 302 166 LYS B 166 LYS^? 22.75 MG MG B 301 324 SER A 49 SER^? 17.63 MG MG A 301 coo 25.93 8.11 25.51 26.40 7.80 19.66 34.97 21.28 8.44 29.03 22.82 6.58 coo 27.27 1.43 25.09 29.18 5.25 22.89 35.27 15.38 5.31 37.27 9.81 3.93 coo 46.32 14.55 19.93 45.95 12.72 21.27 38.68 29.52 26.48 39.52 27.49 25.41 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 11 3 # 11 164 LYS B 157 LYS^? 28.85 MG MG B 302 166 LYS B 166 LYS^? 22.75 MG MG B 301 324 SER B 115 SER^? 6.48 MG MG B 302 coo 25.93 8.11 25.51 26.40 7.80 19.66 34.97 21.28 8.44 29.03 22.82 6.58 coo 27.27 1.43 25.09 29.18 5.25 22.89 35.27 15.38 5.31 37.27 9.81 3.93 coo 46.32 14.55 19.93 45.95 12.72 21.27 54.36 25.96 2.48 56.06 26.75 0.95 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 12 3 # 12 164 LYS B 166 LYS^? 22.75 MG MG B 301 166 LYS B 157 LYS^? 28.85 MG MG B 302 324 SER B 36 SER^? 24.04 MG MG B 302 coo 25.93 8.11 25.51 26.40 7.80 19.66 35.27 15.38 5.31 37.27 9.81 3.93 coo 27.27 1.43 25.09 29.18 5.25 22.89 34.97 21.28 8.44 29.03 22.82 6.58 coo 46.32 14.55 19.93 45.95 12.72 21.27 52.58 6.45 11.01 53.61 4.84 12.41 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 13 3 # 13 164 LYS C 6 LYS^? 25.73 MG MG C 302 166 LYS C 157 LYS^? 28.15 MG MG C 302 324 SER C 92 SER^? 15.15 MG MG C 302 coo 25.93 8.11 25.51 26.40 7.80 19.66 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 27.27 1.43 25.09 29.18 5.25 22.89 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 46.32 14.55 19.93 45.95 12.72 21.27 72.40 29.17 -16.07 71.43 31.32 -15.46 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 14 3 # 14 164 LYS C 6 LYS^? 25.73 MG MG C 302 166 LYS C 157 LYS^? 28.15 MG MG C 302 324 SER D 66 SER^? 21.51 MG MG D 302 coo 25.93 8.11 25.51 26.40 7.80 19.66 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 27.27 1.43 25.09 29.18 5.25 22.89 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 46.32 14.55 19.93 45.95 12.72 21.27 81.04 24.82 -31.14 78.93 25.00 -32.28 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 15 3 # 15 164 LYS C 157 LYS^? 28.15 MG MG C 302 166 LYS C 6 LYS^? 25.73 MG MG C 302 324 SER C 36 SER^? 23.69 MG MG C 302 coo 25.93 8.11 25.51 26.40 7.80 19.66 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 27.27 1.43 25.09 29.18 5.25 22.89 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 46.32 14.55 19.93 45.95 12.72 21.27 86.07 12.19 -17.80 85.34 10.22 -18.98 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 16 3 # 16 164 LYS C 157 LYS^? 28.15 MG MG C 302 166 LYS C 166 LYS^? 22.53 MG MG C 301 324 SER C 115 SER^? 5.99 MG MG C 302 coo 25.93 8.11 25.51 26.40 7.80 19.66 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 27.27 1.43 25.09 29.18 5.25 22.89 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 46.32 14.55 19.93 45.95 12.72 21.27 77.67 29.66 -8.53 76.02 29.92 -6.77 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 17 3 # 17 164 LYS C 157 LYS^? 28.15 MG MG C 302 166 LYS C 166 LYS^? 22.53 MG MG C 301 324 SER D 49 SER^? 17.22 MG MG D 302 coo 25.93 8.11 25.51 26.40 7.80 19.66 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 27.27 1.43 25.09 29.18 5.25 22.89 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 46.32 14.55 19.93 45.95 12.72 21.27 90.26 38.73 -32.99 91.21 36.48 -32.65 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 18 3 # 18 164 LYS C 166 LYS^? 22.53 MG MG C 301 166 LYS C 157 LYS^? 28.15 MG MG C 302 324 SER C 36 SER^? 23.69 MG MG C 302 coo 25.93 8.11 25.51 26.40 7.80 19.66 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 27.27 1.43 25.09 29.18 5.25 22.89 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 46.32 14.55 19.93 45.95 12.72 21.27 86.07 12.19 -17.80 85.34 10.22 -18.98 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 19 3 # 19 164 LYS D 6 LYS^? 25.98 MG MG D 302 166 LYS D 157 LYS^? 28.67 MG MG D 302 324 SER C 16 SER^? 24.15 MG MG C 302 coo 25.93 8.11 25.51 26.40 7.80 19.66 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 27.27 1.43 25.09 29.18 5.25 22.89 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 46.32 14.55 19.93 45.95 12.72 21.27 82.88 9.31 -16.30 84.27 7.80 -17.58 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 20 3 # 20 164 LYS D 6 LYS^? 25.98 MG MG D 302 166 LYS D 157 LYS^? 28.67 MG MG D 302 324 SER C 66 SER^? 20.91 MG MG C 302 coo 25.93 8.11 25.51 26.40 7.80 19.66 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 27.27 1.43 25.09 29.18 5.25 22.89 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 46.32 14.55 19.93 45.95 12.72 21.27 85.39 37.79 -19.17 83.53 38.71 -18.09 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 21 3 # 21 164 LYS D 6 LYS^? 25.98 MG MG D 302 166 LYS D 157 LYS^? 28.67 MG MG D 302 324 SER D 92 SER^? 16.26 MG MG D 302 coo 25.93 8.11 25.51 26.40 7.80 19.66 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 27.27 1.43 25.09 29.18 5.25 22.89 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 46.32 14.55 19.93 45.95 12.72 21.27 76.41 39.72 -34.40 74.28 38.75 -34.89 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 22 3 # 22 164 LYS D 157 LYS^? 28.67 MG MG D 302 166 LYS D 6 LYS^? 25.98 MG MG D 302 324 SER D 36 SER^? 22.42 MG MG D 302 coo 25.93 8.11 25.51 26.40 7.80 19.66 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 27.27 1.43 25.09 29.18 5.25 22.89 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 46.32 14.55 19.93 45.95 12.72 21.27 97.85 44.42 -32.20 96.60 46.20 -31.15 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 23 3 # 23 164 LYS D 157 LYS^? 28.67 MG MG D 302 166 LYS D 166 LYS^? 21.08 MG MG D 301 324 SER D 115 SER^? 7.08 MG MG D 302 coo 25.93 8.11 25.51 26.40 7.80 19.66 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 27.27 1.43 25.09 29.18 5.25 22.89 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 46.32 14.55 19.93 45.95 12.72 21.27 80.50 35.70 -41.83 78.94 36.81 -43.34 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 24 3 # 24 164 LYS D 166 LYS^? 21.08 MG MG D 301 166 LYS D 157 LYS^? 28.67 MG MG D 302 324 SER D 36 SER^? 22.42 MG MG D 302 coo 25.93 8.11 25.51 26.40 7.80 19.66 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 27.27 1.43 25.09 29.18 5.25 22.89 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 46.32 14.55 19.93 45.95 12.72 21.27 97.85 44.42 -32.20 96.60 46.20 -31.15 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 25 3 # 25 164 LYS E 6 LYS^? 25.59 MG MG E 302 166 LYS E 157 LYS^? 28.40 MG MG E 302 324 SER E 92 SER^? 15.58 MG MG E 302 coo 25.93 8.11 25.51 26.40 7.80 19.66 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 27.27 1.43 25.09 29.18 5.25 22.89 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 46.32 14.55 19.93 45.95 12.72 21.27 68.69 48.93 -60.16 67.14 47.20 -59.59 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 26 3 # 26 164 LYS E 6 LYS^? 25.59 MG MG E 302 166 LYS E 157 LYS^? 28.40 MG MG E 302 324 SER F 66 SER^? 21.35 MG MG F 301 coo 25.93 8.11 25.51 26.40 7.80 19.66 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 27.27 1.43 25.09 29.18 5.25 22.89 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 46.32 14.55 19.93 45.95 12.72 21.27 68.12 57.69 -75.42 68.70 55.68 -76.54 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 27 3 # 27 164 LYS E 76 LYS^? 25.68 MG MG E 302 166 LYS E 86 LYS^? 26.73 MG MG D 301 324 SER E 10 SER^? 16.92 MG MG E 302 coo 25.93 8.11 25.51 26.40 7.80 19.66 87.09 58.11 -60.91 88.65 63.65 -61.27 coo 27.27 1.43 25.09 29.18 5.25 22.89 86.84 54.85 -64.43 87.07 60.83 -66.10 coo 46.32 14.55 19.93 45.95 12.72 21.27 64.47 64.04 -59.12 65.96 65.01 -60.83 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 28 3 # 28 164 LYS E 76 LYS^? 25.68 MG MG E 302 166 LYS E 86 LYS^? 26.73 MG MG D 301 324 SER E 115 SER^? 6.17 MG MG E 302 coo 25.93 8.11 25.51 26.40 7.80 19.66 87.09 58.11 -60.91 88.65 63.65 -61.27 coo 27.27 1.43 25.09 29.18 5.25 22.89 86.84 54.85 -64.43 87.07 60.83 -66.10 coo 46.32 14.55 19.93 45.95 12.72 21.27 65.46 53.67 -52.76 66.19 52.26 -50.99 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 29 3 # 29 164 LYS E 76 LYS^? 25.68 MG MG E 302 166 LYS E 86 LYS^? 26.73 MG MG D 301 324 SER F 66 SER^? 21.35 MG MG F 301 coo 25.93 8.11 25.51 26.40 7.80 19.66 87.09 58.11 -60.91 88.65 63.65 -61.27 coo 27.27 1.43 25.09 29.18 5.25 22.89 86.84 54.85 -64.43 87.07 60.83 -66.10 coo 46.32 14.55 19.93 45.95 12.72 21.27 68.12 57.69 -75.42 68.70 55.68 -76.54 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 30 3 # 30 164 LYS E 86 LYS^? 26.73 MG MG D 301 166 LYS E 76 LYS^? 25.68 MG MG E 302 324 SER F 66 SER^? 21.35 MG MG F 301 coo 25.93 8.11 25.51 26.40 7.80 19.66 86.84 54.85 -64.43 87.07 60.83 -66.10 coo 27.27 1.43 25.09 29.18 5.25 22.89 87.09 58.11 -60.91 88.65 63.65 -61.27 coo 46.32 14.55 19.93 45.95 12.72 21.27 68.12 57.69 -75.42 68.70 55.68 -76.54 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 31 3 # 31 164 LYS E 86 LYS^? 26.73 MG MG D 301 166 LYS E 76 LYS^? 25.68 MG MG E 302 324 SER F 105 SER^? 35.88 MG MG F 301 coo 25.93 8.11 25.51 26.40 7.80 19.66 86.84 54.85 -64.43 87.07 60.83 -66.10 coo 27.27 1.43 25.09 29.18 5.25 22.89 87.09 58.11 -60.91 88.65 63.65 -61.27 coo 46.32 14.55 19.93 45.95 12.72 21.27 85.11 67.66 -83.88 85.77 68.77 -85.94 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 32 3 # 32 164 LYS E 157 LYS^? 28.40 MG MG E 302 166 LYS E 6 LYS^? 25.59 MG MG E 302 324 SER E 36 SER^? 22.92 MG MG E 302 coo 25.93 8.11 25.51 26.40 7.80 19.66 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 27.27 1.43 25.09 29.18 5.25 22.89 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 46.32 14.55 19.93 45.95 12.72 21.27 76.63 69.18 -62.93 78.20 67.77 -64.11 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 33 3 # 33 164 LYS E 157 LYS^? 28.40 MG MG E 302 166 LYS E 166 LYS^? 21.46 MG MG E 301 324 SER E 115 SER^? 6.17 MG MG E 302 coo 25.93 8.11 25.51 26.40 7.80 19.66 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 27.27 1.43 25.09 29.18 5.25 22.89 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 46.32 14.55 19.93 45.95 12.72 21.27 65.46 53.67 -52.76 66.19 52.26 -50.99 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 34 3 # 34 164 LYS E 157 LYS^? 28.40 MG MG E 302 166 LYS E 166 LYS^? 21.46 MG MG E 301 324 SER F 49 SER^? 17.41 MG MG F 301 coo 25.93 8.11 25.51 26.40 7.80 19.66 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 27.27 1.43 25.09 29.18 5.25 22.89 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 46.32 14.55 19.93 45.95 12.72 21.27 51.43 58.69 -77.53 52.81 60.66 -77.24 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 35 3 # 35 164 LYS E 166 LYS^? 21.46 MG MG E 301 166 LYS E 157 LYS^? 28.40 MG MG E 302 324 SER E 36 SER^? 22.92 MG MG E 302 coo 25.93 8.11 25.51 26.40 7.80 19.66 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 27.27 1.43 25.09 29.18 5.25 22.89 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 46.32 14.55 19.93 45.95 12.72 21.27 76.63 69.18 -62.93 78.20 67.77 -64.11 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 36 3 # 36 164 LYS F 6 LYS^? 26.09 MG MG F 301 166 LYS F 157 LYS^? 28.36 MG MG F 302 324 SER E 66 SER^? 21.23 MG MG E 302 coo 25.93 8.11 25.51 26.40 7.80 19.66 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 27.27 1.43 25.09 29.18 5.25 22.89 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 46.32 14.55 19.93 45.95 12.72 21.27 54.72 55.62 -63.56 54.90 53.49 -62.62 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 37 3 # 37 164 LYS F 6 LYS^? 26.09 MG MG F 301 166 LYS F 157 LYS^? 28.36 MG MG F 302 324 SER F 92 SER^? 15.48 MG MG F 301 coo 25.93 8.11 25.51 26.40 7.80 19.66 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 27.27 1.43 25.09 29.18 5.25 22.89 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 46.32 14.55 19.93 45.95 12.72 21.27 57.23 46.17 -78.28 59.17 45.10 -79.10 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 38 3 # 38 164 LYS F 157 LYS^? 28.36 MG MG F 302 166 LYS F 6 LYS^? 26.09 MG MG F 301 324 SER F 36 SER^? 23.07 MG MG F 301 coo 25.93 8.11 25.51 26.40 7.80 19.66 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 27.27 1.43 25.09 29.18 5.25 22.89 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 46.32 14.55 19.93 45.95 12.72 21.27 42.79 62.77 -76.96 42.19 61.23 -75.17 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 39 3 # 39 164 LYS F 157 LYS^? 28.36 MG MG F 302 166 LYS F 166 LYS^? 20.76 MG MG F 302 324 SER F 115 SER^? 6.67 MG MG F 301 coo 25.93 8.11 25.51 26.40 7.80 19.66 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 27.27 1.43 25.09 29.18 5.25 22.89 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 46.32 14.55 19.93 45.95 12.72 21.27 58.74 51.50 -86.07 58.73 49.57 -87.50 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 40 3 # 40 164 LYS F 166 LYS^? 20.76 MG MG F 302 166 LYS F 157 LYS^? 28.36 MG MG F 302 324 SER F 36 SER^? 23.07 MG MG F 301 coo 25.93 8.11 25.51 26.40 7.80 19.66 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 27.27 1.43 25.09 29.18 5.25 22.89 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 46.32 14.55 19.93 45.95 12.72 21.27 42.79 62.77 -76.96 42.19 61.23 -75.17 1mdr_c01 source 1mdr MANDELATE RACEMASE (E.C.5.1.2.2) : 40 hits 1mdr_c01 naa= 3 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 1 3 # 1 A 199 HIS A 42 HIS^? 28.45 MG MG A 301 A 246 HIS B 42 HIS^? 28.37 MG MG B 302 A 255 TYR B 156 TYR^? 21.63 MG MG B 302 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 34.62 18.32 19.57 34.29 16.25 19.41 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 39.34 12.99 16.30 37.26 13.24 16.40 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 38.56 16.71 8.27 39.91 14.31 7.86 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 2 3 # 2 A 199 HIS B 42 HIS^? 28.37 MG MG B 302 A 246 HIS A 42 HIS^? 28.45 MG MG A 301 A 255 TYR A 156 TYR^? 21.80 MG MG A 301 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 39.34 12.99 16.30 37.26 13.24 16.40 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 34.62 18.32 19.57 34.29 16.25 19.41 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 37.50 16.28 27.75 35.30 17.94 28.08 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 3 3 # 3 A 199 HIS C 42 HIS^? 28.09 MG MG C 302 A 246 HIS D 42 HIS^? 28.21 MG MG D 302 A 255 TYR D 156 TYR^? 21.34 MG MG D 302 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 95.93 22.96 -23.11 97.92 23.62 -23.02 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 98.45 29.90 -26.44 99.32 28.02 -26.13 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 96.25 27.10 -34.64 97.58 29.48 -35.03 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 4 3 # 4 A 199 HIS D 42 HIS^? 28.21 MG MG D 302 A 246 HIS C 42 HIS^? 28.09 MG MG C 302 A 255 TYR C 156 TYR^? 21.58 MG MG C 302 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 98.45 29.90 -26.44 99.32 28.02 -26.13 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 95.93 22.96 -23.11 97.92 23.62 -23.02 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 95.64 26.50 -15.14 95.25 23.76 -14.77 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 5 3 # 5 A 199 HIS E 42 HIS^? 28.20 MG MG E 302 A 246 HIS F 42 HIS^? 28.34 MG MG F 301 A 255 TYR F 156 TYR^? 21.68 MG MG F 302 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 62.33 71.93 -68.30 60.54 72.96 -68.64 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 55.11 70.50 -71.64 56.29 72.22 -71.48 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 58.80 69.55 -79.65 56.09 69.80 -80.15 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 6 3 # 6 A 199 HIS F 42 HIS^? 28.34 MG MG F 301 A 246 HIS E 42 HIS^? 28.20 MG MG E 302 A 255 TYR E 156 TYR^? 21.59 MG MG E 302 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 55.11 70.50 -71.64 56.29 72.22 -71.48 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 62.33 71.93 -68.30 60.54 72.96 -68.64 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 59.31 70.31 -60.22 61.84 71.39 -59.92 1mpy_c00 source 1mpy CATECHOL 2,3-DIOXYGENASE : 6 hits 1mpy_c00 naa= 3 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 1 3 # 1 B 199 HIS A 42 HIS^? 28.45 MG MG A 301 B 246 HIS B 42 HIS^? 28.37 MG MG B 302 B 255 TYR B 156 TYR^? 21.63 MG MG B 302 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 34.62 18.32 19.57 34.29 16.25 19.41 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 39.34 12.99 16.30 37.26 13.24 16.40 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 38.56 16.71 8.27 39.91 14.31 7.86 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 2 3 # 2 B 199 HIS B 42 HIS^? 28.37 MG MG B 302 B 246 HIS A 42 HIS^? 28.45 MG MG A 301 B 255 TYR A 156 TYR^? 21.80 MG MG A 301 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 39.34 12.99 16.30 37.26 13.24 16.40 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 34.62 18.32 19.57 34.29 16.25 19.41 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 37.50 16.28 27.75 35.30 17.94 28.08 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 3 3 # 3 B 199 HIS C 42 HIS^? 28.09 MG MG C 302 B 246 HIS D 42 HIS^? 28.21 MG MG D 302 B 255 TYR D 156 TYR^? 21.34 MG MG D 302 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 95.93 22.96 -23.11 97.92 23.62 -23.02 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 98.45 29.90 -26.44 99.32 28.02 -26.13 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 96.25 27.10 -34.64 97.58 29.48 -35.03 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 4 3 # 4 B 199 HIS D 42 HIS^? 28.21 MG MG D 302 B 246 HIS C 42 HIS^? 28.09 MG MG C 302 B 255 TYR C 156 TYR^? 21.58 MG MG C 302 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 98.45 29.90 -26.44 99.32 28.02 -26.13 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 95.93 22.96 -23.11 97.92 23.62 -23.02 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 95.64 26.50 -15.14 95.25 23.76 -14.77 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 5 3 # 5 B 199 HIS E 42 HIS^? 28.20 MG MG E 302 B 246 HIS F 42 HIS^? 28.34 MG MG F 301 B 255 TYR F 156 TYR^? 21.68 MG MG F 302 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 62.33 71.93 -68.30 60.54 72.96 -68.64 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 55.11 70.50 -71.64 56.29 72.22 -71.48 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 58.80 69.55 -79.65 56.09 69.80 -80.15 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 6 3 # 6 B 199 HIS F 42 HIS^? 28.34 MG MG F 301 B 246 HIS E 42 HIS^? 28.20 MG MG E 302 B 255 TYR E 156 TYR^? 21.59 MG MG E 302 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 55.11 70.50 -71.64 56.29 72.22 -71.48 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 62.33 71.93 -68.30 60.54 72.96 -68.64 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 59.31 70.31 -60.22 61.84 71.39 -59.92 1mpy_c01 source 1mpy CATECHOL 2,3-DIOXYGENASE : 6 hits 1mpy_c01 naa= 3 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 1 3 # 1 C 199 HIS A 42 HIS^? 28.45 MG MG A 301 C 246 HIS B 42 HIS^? 28.37 MG MG B 302 C 255 TYR B 156 TYR^? 21.63 MG MG B 302 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 34.62 18.32 19.57 34.29 16.25 19.41 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 39.34 12.99 16.30 37.26 13.24 16.40 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 38.56 16.71 8.27 39.91 14.31 7.86 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 2 3 # 2 C 199 HIS B 42 HIS^? 28.37 MG MG B 302 C 246 HIS A 42 HIS^? 28.45 MG MG A 301 C 255 TYR A 156 TYR^? 21.80 MG MG A 301 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 39.34 12.99 16.30 37.26 13.24 16.40 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 34.62 18.32 19.57 34.29 16.25 19.41 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 37.50 16.28 27.75 35.30 17.94 28.08 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 3 3 # 3 C 199 HIS C 42 HIS^? 28.09 MG MG C 302 C 246 HIS D 42 HIS^? 28.21 MG MG D 302 C 255 TYR D 156 TYR^? 21.34 MG MG D 302 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 95.93 22.96 -23.11 97.92 23.62 -23.02 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 98.45 29.90 -26.44 99.32 28.02 -26.13 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 96.25 27.10 -34.64 97.58 29.48 -35.03 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 4 3 # 4 C 199 HIS D 42 HIS^? 28.21 MG MG D 302 C 246 HIS C 42 HIS^? 28.09 MG MG C 302 C 255 TYR C 156 TYR^? 21.58 MG MG C 302 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 98.45 29.90 -26.44 99.32 28.02 -26.13 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 95.93 22.96 -23.11 97.92 23.62 -23.02 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 95.64 26.50 -15.14 95.25 23.76 -14.77 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 5 3 # 5 C 199 HIS E 42 HIS^? 28.20 MG MG E 302 C 246 HIS F 42 HIS^? 28.34 MG MG F 301 C 255 TYR F 156 TYR^? 21.68 MG MG F 302 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 62.33 71.93 -68.30 60.54 72.96 -68.64 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 55.11 70.50 -71.64 56.29 72.22 -71.48 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 58.80 69.55 -79.65 56.09 69.80 -80.15 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 6 3 # 6 C 199 HIS F 42 HIS^? 28.34 MG MG F 301 C 246 HIS E 42 HIS^? 28.20 MG MG E 302 C 255 TYR E 156 TYR^? 21.59 MG MG E 302 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 55.11 70.50 -71.64 56.29 72.22 -71.48 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 62.33 71.93 -68.30 60.54 72.96 -68.64 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 59.31 70.31 -60.22 61.84 71.39 -59.92 1mpy_c02 source 1mpy CATECHOL 2,3-DIOXYGENASE : 6 hits 1mpy_c02 naa= 3 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 1 3 # 1 D 199 HIS A 42 HIS^? 28.45 MG MG A 301 D 246 HIS B 42 HIS^? 28.37 MG MG B 302 D 255 TYR B 156 TYR^? 21.63 MG MG B 302 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 34.62 18.32 19.57 34.29 16.25 19.41 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 39.34 12.99 16.30 37.26 13.24 16.40 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 38.56 16.71 8.27 39.91 14.31 7.86 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 2 3 # 2 D 199 HIS B 42 HIS^? 28.37 MG MG B 302 D 246 HIS A 42 HIS^? 28.45 MG MG A 301 D 255 TYR A 156 TYR^? 21.80 MG MG A 301 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 39.34 12.99 16.30 37.26 13.24 16.40 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 34.62 18.32 19.57 34.29 16.25 19.41 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 37.50 16.28 27.75 35.30 17.94 28.08 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 3 3 # 3 D 199 HIS C 42 HIS^? 28.09 MG MG C 302 D 246 HIS D 42 HIS^? 28.21 MG MG D 302 D 255 TYR D 156 TYR^? 21.34 MG MG D 302 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 95.93 22.96 -23.11 97.92 23.62 -23.02 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 98.45 29.90 -26.44 99.32 28.02 -26.13 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 96.25 27.10 -34.64 97.58 29.48 -35.03 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 4 3 # 4 D 199 HIS D 42 HIS^? 28.21 MG MG D 302 D 246 HIS C 42 HIS^? 28.09 MG MG C 302 D 255 TYR C 156 TYR^? 21.58 MG MG C 302 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 98.45 29.90 -26.44 99.32 28.02 -26.13 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 95.93 22.96 -23.11 97.92 23.62 -23.02 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 95.64 26.50 -15.14 95.25 23.76 -14.77 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 5 3 # 5 D 199 HIS E 42 HIS^? 28.20 MG MG E 302 D 246 HIS F 42 HIS^? 28.34 MG MG F 301 D 255 TYR F 156 TYR^? 21.68 MG MG F 302 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 62.33 71.93 -68.30 60.54 72.96 -68.64 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 55.11 70.50 -71.64 56.29 72.22 -71.48 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 58.80 69.55 -79.65 56.09 69.80 -80.15 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 6 3 # 6 D 199 HIS F 42 HIS^? 28.34 MG MG F 301 D 246 HIS E 42 HIS^? 28.20 MG MG E 302 D 255 TYR E 156 TYR^? 21.59 MG MG E 302 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 55.11 70.50 -71.64 56.29 72.22 -71.48 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 62.33 71.93 -68.30 60.54 72.96 -68.64 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 59.31 70.31 -60.22 61.84 71.39 -59.92 1mpy_c03 source 1mpy CATECHOL 2,3-DIOXYGENASE : 6 hits 1mpy_c03 naa= 3 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 1 3 # 1 A 465 GLY A 145 GLY^? 13.39 MG MG A 302 A 501 ASP A 35 ASP^? 16.92 MG MG A 301 B 367 TYR A 60 TYR^? 27.11 MG MG B 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 44.20 17.56 40.29 44.09 17.33 41.06 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 34.49 31.10 26.54 36.41 31.82 27.10 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 55.01 4.24 16.98 56.13 3.24 14.65 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 2 3 # 2 A 465 GLY A 149 GLY^? 6.01 MG MG A 302 A 501 ASP A 100 ASP^? 19.37 MG MG A 301 B 367 TYR B 60 TYR^? 27.11 MG MG A 301 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 37.26 27.53 42.29 37.61 28.00 41.76 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 57.94 16.31 36.90 58.41 17.97 38.14 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 28.84 35.27 19.49 28.03 36.56 21.83 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 3 3 # 3 A 465 GLY A 149 GLY^? 6.01 MG MG A 302 A 501 ASP A 142 ASP^? 23.70 MG MG A 302 B 367 TYR B 60 TYR^? 27.11 MG MG A 301 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 37.26 27.53 42.29 37.61 28.00 41.76 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 46.39 7.18 37.53 46.28 7.18 39.63 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 28.84 35.27 19.49 28.03 36.56 21.83 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 4 3 # 4 A 465 GLY A 162 GLY^? 31.98 MG MG B 302 A 501 ASP B 171 ASP^? 16.92 MG MG B 301 B 367 TYR B 60 TYR^? 27.11 MG MG A 301 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 39.06 7.86 19.11 39.37 8.59 19.31 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 45.30 8.50 -0.71 46.30 6.81 0.12 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 28.84 35.27 19.49 28.03 36.56 21.83 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 5 3 # 5 A 465 GLY A 184 GLY^? 4.07 MG MG A 302 A 501 ASP A 23 ASP^? 22.90 MG MG A 301 B 367 TYR A 67 TYR^? 21.33 MG MG A 301 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 44.11 32.36 47.58 44.42 32.35 46.80 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 36.40 52.47 38.61 38.03 53.36 39.72 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 48.62 23.20 22.09 46.84 25.23 21.44 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 6 3 # 6 A 465 GLY A 184 GLY^? 4.07 MG MG A 302 A 501 ASP A 23 ASP^? 22.90 MG MG A 301 B 367 TYR A 156 TYR^? 21.80 MG MG A 301 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 44.11 32.36 47.58 44.42 32.35 46.80 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 36.40 52.47 38.61 38.03 53.36 39.72 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 37.50 16.28 27.75 35.30 17.94 28.08 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 7 3 # 7 A 465 GLY B 27 GLY^? 20.96 MG MG C 301 A 501 ASP C 148 ASP^? 2.75 MG MG C 302s B 367 TYR A 60 TYR^? 27.11 MG MG B 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 77.29 2.95 1.20 76.99 3.70 1.33 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 55.01 4.24 16.98 56.13 3.24 14.65 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 8 3 # 8 A 465 GLY B 27 GLY^? 20.96 MG MG C 301 A 501 ASP C 187 ASP^? -3.72 MG MG C 301s B 367 TYR A 60 TYR^? 27.11 MG MG B 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 77.29 2.95 1.20 76.99 3.70 1.33 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 84.01 23.73 3.39 83.47 22.54 1.59 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 55.01 4.24 16.98 56.13 3.24 14.65 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 9 3 # 9 A 465 GLY B 89 GLY^? 19.24 MG MG B 302 A 501 ASP B 23 ASP^? 15.67 MG MG C 301 B 367 TYR B 156 TYR^? 21.63 MG MG B 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 64.90 19.68 12.95 64.28 19.13 13.13 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 74.31 7.55 -1.09 75.08 9.17 -2.23 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 38.56 16.71 8.27 39.91 14.31 7.86 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 10 3 # 10 A 465 GLY B 89 GLY^? 19.24 MG MG B 302 A 501 ASP B 23 ASP^? 15.67 MG MG C 301 B 367 TYR B 168 TYR^? 14.66 MG MG B 301 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 64.90 19.68 12.95 64.28 19.13 13.13 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 74.31 7.55 -1.09 75.08 9.17 -2.23 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 40.03 17.20 -1.34 41.92 16.43 -3.19 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 11 3 # 11 A 465 GLY B 89 GLY^? 19.24 MG MG B 302 A 501 ASP B 148 ASP^? 2.58 MG MG B 302s B 367 TYR C 188 TYR^? 8.98 MG MG C 301 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 64.90 19.68 12.95 64.28 19.13 13.13 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 88.74 23.30 0.93 88.91 20.61 1.57 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 12 3 # 12 A 465 GLY B 89 GLY^? 19.24 MG MG B 302 A 501 ASP C 148 ASP^? 2.75 MG MG C 302s B 367 TYR B 188 TYR^? 8.84 MG MG B 301 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 64.90 19.68 12.95 64.28 19.13 13.13 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 46.41 16.35 -7.52 47.38 13.88 -8.38 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 13 3 # 13 A 465 GLY B 145 GLY^? 13.71 MG MG B 301 A 501 ASP B 35 ASP^? 16.92 MG MG B 302 B 367 TYR B 60 TYR^? 27.11 MG MG A 301 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 42.04 23.97 -3.40 41.83 23.90 -4.16 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 52.63 11.07 10.18 53.68 12.85 9.94 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 28.84 35.27 19.49 28.03 36.56 21.83 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 14 3 # 14 A 465 GLY B 149 GLY^? 5.93 MG MG B 301 A 501 ASP B 100 ASP^? 19.41 MG MG B 302 B 367 TYR A 60 TYR^? 27.11 MG MG B 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 50.72 15.48 -5.33 51.24 15.67 -4.78 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 42.99 37.37 0.88 44.84 37.85 0.06 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 55.01 4.24 16.98 56.13 3.24 14.65 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 15 3 # 15 A 465 GLY B 149 GLY^? 5.93 MG MG B 301 A 501 ASP B 142 ASP^? 23.97 MG MG B 301 B 367 TYR A 60 TYR^? 27.11 MG MG B 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 50.72 15.48 -5.33 51.24 15.67 -4.78 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 31.69 27.40 -1.31 32.10 27.37 -3.38 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 55.01 4.24 16.98 56.13 3.24 14.65 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 16 3 # 16 A 465 GLY B 149 GLY^? 5.93 MG MG B 301 A 501 ASP C 81 ASP^? 23.42 MG MG B 301 B 367 TYR A 60 TYR^? 27.11 MG MG B 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 50.72 15.48 -5.33 51.24 15.67 -4.78 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 60.68 -2.08 -16.91 61.02 -0.17 -17.89 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 55.01 4.24 16.98 56.13 3.24 14.65 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 17 3 # 17 A 465 GLY B 183 GLY^? -4.35 MG MG B 301s A 501 ASP B 23 ASP^? 15.67 MG MG C 301 B 367 TYR B 67 TYR^? 21.41 MG MG B 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 58.74 20.22 -6.73 58.00 19.87 -6.89 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 74.31 7.55 -1.09 75.08 9.17 -2.23 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 46.94 25.86 15.48 48.70 23.84 16.15 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 18 3 # 18 A 465 GLY B 183 GLY^? -4.35 MG MG B 301s A 501 ASP B 23 ASP^? 15.67 MG MG C 301 B 367 TYR B 156 TYR^? 21.63 MG MG B 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 58.74 20.22 -6.73 58.00 19.87 -6.89 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 74.31 7.55 -1.09 75.08 9.17 -2.23 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 38.56 16.71 8.27 39.91 14.31 7.86 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 19 3 # 19 A 465 GLY B 183 GLY^? -4.35 MG MG B 301s A 501 ASP C 128 ASP^? -3.22 MG MG C 302s B 367 TYR B 67 TYR^? 21.41 MG MG B 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 58.74 20.22 -6.73 58.00 19.87 -6.89 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 46.94 25.86 15.48 48.70 23.84 16.15 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 20 3 # 20 A 465 GLY B 183 GLY^? -4.35 MG MG B 301s A 501 ASP C 148 ASP^? 2.75 MG MG C 302s B 367 TYR A 60 TYR^? 27.11 MG MG B 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 58.74 20.22 -6.73 58.00 19.87 -6.89 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 55.01 4.24 16.98 56.13 3.24 14.65 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 21 3 # 21 A 465 GLY B 184 GLY^? 4.47 MG MG B 301 A 501 ASP B 23 ASP^? 15.67 MG MG C 301 B 367 TYR B 67 TYR^? 21.41 MG MG B 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 57.32 22.02 -9.75 57.17 22.15 -8.93 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 74.31 7.55 -1.09 75.08 9.17 -2.23 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 46.94 25.86 15.48 48.70 23.84 16.15 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 22 3 # 22 A 465 GLY B 184 GLY^? 4.47 MG MG B 301 A 501 ASP B 23 ASP^? 15.67 MG MG C 301 B 367 TYR B 156 TYR^? 21.63 MG MG B 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 57.32 22.02 -9.75 57.17 22.15 -8.93 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 74.31 7.55 -1.09 75.08 9.17 -2.23 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 38.56 16.71 8.27 39.91 14.31 7.86 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 23 3 # 23 A 465 GLY B 184 GLY^? 4.47 MG MG B 301 A 501 ASP C 128 ASP^? -3.22 MG MG C 302s B 367 TYR B 67 TYR^? 21.41 MG MG B 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 57.32 22.02 -9.75 57.17 22.15 -8.93 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 46.94 25.86 15.48 48.70 23.84 16.15 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 24 3 # 24 A 465 GLY C 27 GLY^? 19.87 MG MG B 301 A 501 ASP B 148 ASP^? 2.58 MG MG B 302s B 367 TYR D 60 TYR^? 26.93 MG MG C 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 63.15 1.80 -8.18 63.38 2.56 -8.31 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 84.40 9.28 -23.74 83.45 7.90 -21.49 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 25 3 # 25 A 465 GLY C 27 GLY^? 19.87 MG MG B 301 A 501 ASP B 187 ASP^? -3.44 MG MG B 301s B 367 TYR D 60 TYR^? 26.93 MG MG C 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 63.15 1.80 -8.18 63.38 2.56 -8.31 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 50.64 18.14 -9.69 51.74 17.63 -7.86 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 84.40 9.28 -23.74 83.45 7.90 -21.49 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 26 3 # 26 A 465 GLY C 89 GLY^? 18.96 MG MG C 302 A 501 ASP B 148 ASP^? 2.58 MG MG B 302s B 367 TYR C 188 TYR^? 8.98 MG MG C 301 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 69.98 20.32 -19.31 70.77 19.99 -19.37 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 88.74 23.30 0.93 88.91 20.61 1.57 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 27 3 # 27 A 465 GLY C 89 GLY^? 18.96 MG MG C 302 A 501 ASP C 148 ASP^? 2.75 MG MG C 302s B 367 TYR B 188 TYR^? 8.84 MG MG B 301 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 69.98 20.32 -19.31 70.77 19.99 -19.37 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 46.41 16.35 -7.52 47.38 13.88 -8.38 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 28 3 # 28 A 465 GLY C 145 GLY^? 13.72 MG MG C 301 A 501 ASP C 35 ASP^? 16.42 MG MG C 302 B 367 TYR C 60 TYR^? 26.95 MG MG D 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 90.12 32.13 -3.16 90.38 32.11 -2.40 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 97.75 47.69 -25.92 97.82 49.25 -28.26 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 29 3 # 29 A 465 GLY C 149 GLY^? 6.13 MG MG C 301 A 501 ASP C 100 ASP^? 19.40 MG MG C 302 B 367 TYR D 60 TYR^? 26.93 MG MG C 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 85.09 20.92 -1.20 84.51 20.95 -1.73 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 84.40 44.48 -7.24 82.54 44.18 -6.18 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 84.40 9.28 -23.74 83.45 7.90 -21.49 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 30 3 # 30 A 465 GLY C 149 GLY^? 6.13 MG MG C 301 A 501 ASP C 142 ASP^? 23.76 MG MG C 301 B 367 TYR D 60 TYR^? 26.93 MG MG C 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 85.09 20.92 -1.20 84.51 20.95 -1.73 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 97.94 39.27 -5.03 98.08 38.70 -2.97 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 84.40 9.28 -23.74 83.45 7.90 -21.49 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 31 3 # 31 A 465 GLY C 183 GLY^? -4.00 MG MG C 301s A 501 ASP B 128 ASP^? -3.57 MG MG B 302s B 367 TYR C 67 TYR^? 21.03 MG MG C 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 76.27 22.45 0.43 77.06 22.50 0.60 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 52.92 24.09 -2.19 54.73 25.14 -1.90 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 84.52 32.45 -21.76 83.69 29.84 -22.37 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 32 3 # 32 A 465 GLY C 183 GLY^? -4.00 MG MG C 301s A 501 ASP B 148 ASP^? 2.58 MG MG B 302s B 367 TYR C 67 TYR^? 21.03 MG MG C 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 76.27 22.45 0.43 77.06 22.50 0.60 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 84.52 32.45 -21.76 83.69 29.84 -22.37 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 33 3 # 33 A 465 GLY C 183 GLY^? -4.00 MG MG C 301s A 501 ASP B 148 ASP^? 2.58 MG MG B 302s B 367 TYR D 60 TYR^? 26.93 MG MG C 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 76.27 22.45 0.43 77.06 22.50 0.60 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 84.40 9.28 -23.74 83.45 7.90 -21.49 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 34 3 # 34 A 465 GLY C 184 GLY^? 4.50 MG MG C 301 A 501 ASP B 128 ASP^? -3.57 MG MG B 302s B 367 TYR C 67 TYR^? 21.03 MG MG C 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 76.47 24.88 3.34 76.71 25.04 2.53 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 52.92 24.09 -2.19 54.73 25.14 -1.90 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 84.52 32.45 -21.76 83.69 29.84 -22.37 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 35 3 # 35 A 465 GLY C 184 GLY^? 4.50 MG MG C 301 A 501 ASP C 23 ASP^? 15.39 MG MG B 301 B 367 TYR C 67 TYR^? 21.03 MG MG C 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 76.47 24.88 3.34 76.71 25.04 2.53 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 65.24 6.82 -5.11 63.43 7.54 -4.15 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 84.52 32.45 -21.76 83.69 29.84 -22.37 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 36 3 # 36 A 465 GLY C 184 GLY^? 4.50 MG MG C 301 A 501 ASP C 23 ASP^? 15.39 MG MG B 301 B 367 TYR C 156 TYR^? 21.58 MG MG C 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 76.47 24.88 3.34 76.71 25.04 2.53 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 65.24 6.82 -5.11 63.43 7.54 -4.15 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 95.64 26.50 -15.14 95.25 23.76 -14.77 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 37 3 # 37 A 465 GLY D 27 GLY^? 19.64 MG MG E 301 A 501 ASP E 148 ASP^? 2.62 MG MG E 302s B 367 TYR C 60 TYR^? 26.95 MG MG D 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 87.58 66.90 -43.17 87.20 66.21 -42.95 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 97.75 47.69 -25.92 97.82 49.25 -28.26 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 38 3 # 38 A 465 GLY D 27 GLY^? 19.64 MG MG E 301 A 501 ASP E 187 ASP^? -2.71 MG MG E 301s B 367 TYR C 60 TYR^? 26.95 MG MG D 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 87.58 66.90 -43.17 87.20 66.21 -42.95 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 67.50 63.43 -41.69 68.97 62.26 -42.81 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 97.75 47.69 -25.92 97.82 49.25 -28.26 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 39 3 # 39 A 465 GLY D 89 GLY^? 19.56 MG MG D 302 A 501 ASP D 23 ASP^? 15.37 MG MG E 301 B 367 TYR D 156 TYR^? 21.34 MG MG D 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 79.91 48.18 -31.33 80.69 47.93 -31.18 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 85.70 62.10 -45.60 84.07 62.13 -46.93 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 96.25 27.10 -34.64 97.58 29.48 -35.03 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 40 3 # 40 A 465 GLY D 89 GLY^? 19.56 MG MG D 302 A 501 ASP D 23 ASP^? 15.37 MG MG E 301 B 367 TYR D 168 TYR^? 14.75 MG MG D 301 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 79.91 48.18 -31.33 80.69 47.93 -31.18 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 85.70 62.10 -45.60 84.07 62.13 -46.93 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 95.79 27.80 -44.35 95.71 29.78 -46.32 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 41 3 # 41 A 465 GLY D 89 GLY^? 19.56 MG MG D 302 A 501 ASP D 148 ASP^? 2.35 MG MG D 302s B 367 TYR E 188 TYR^? 8.62 MG MG E 301 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 79.91 48.18 -31.33 80.69 47.93 -31.18 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 65.58 67.09 -44.08 67.82 68.57 -43.41 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 42 3 # 42 A 465 GLY D 89 GLY^? 19.56 MG MG D 302 A 501 ASP E 128 ASP^? -3.53 MG MG E 302s B 367 TYR D 188 TYR^? 8.87 MG MG D 301 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 79.91 48.18 -31.33 80.69 47.93 -31.18 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 65.38 56.57 -48.58 66.15 54.57 -48.61 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 93.72 33.91 -50.86 95.36 36.03 -51.61 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 43 3 # 43 A 465 GLY D 89 GLY^? 19.56 MG MG D 302 A 501 ASP E 148 ASP^? 2.62 MG MG E 302s B 367 TYR D 188 TYR^? 8.87 MG MG D 301 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 79.91 48.18 -31.33 80.69 47.93 -31.18 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 93.72 33.91 -50.86 95.36 36.03 -51.61 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 44 3 # 44 A 465 GLY D 145 GLY^? 13.51 MG MG D 301 A 501 ASP D 35 ASP^? 16.80 MG MG D 302 B 367 TYR D 60 TYR^? 26.93 MG MG C 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 88.90 26.07 -46.90 89.21 25.93 -47.57 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 84.40 9.28 -23.74 83.45 7.90 -21.49 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 45 3 # 45 A 465 GLY D 149 GLY^? 6.12 MG MG D 301 A 501 ASP D 142 ASP^? 23.49 MG MG D 301 B 367 TYR C 60 TYR^? 26.95 MG MG D 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 92.07 37.87 -48.88 91.62 38.12 -48.34 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 90.90 15.58 -44.76 91.35 16.09 -46.79 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 97.75 47.69 -25.92 97.82 49.25 -28.26 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 46 3 # 46 A 465 GLY D 149 GLY^? 6.12 MG MG D 301 A 501 ASP E 81 ASP^? 24.19 MG MG D 301 B 367 TYR C 60 TYR^? 26.95 MG MG D 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 92.07 37.87 -48.88 91.62 38.12 -48.34 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 101.61 56.30 -60.24 100.25 55.53 -61.72 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 97.75 47.69 -25.92 97.82 49.25 -28.26 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 47 3 # 47 A 465 GLY D 183 GLY^? -4.40 MG MG D 301s A 501 ASP D 23 ASP^? 15.37 MG MG E 301 B 367 TYR D 67 TYR^? 21.42 MG MG D 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 84.07 42.30 -50.78 84.70 41.81 -50.82 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 85.70 62.10 -45.60 84.07 62.13 -46.93 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 83.62 29.64 -28.35 84.67 32.17 -27.90 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 48 3 # 48 A 465 GLY D 183 GLY^? -4.40 MG MG D 301s A 501 ASP E 81 ASP^? 24.19 MG MG D 301 B 367 TYR C 60 TYR^? 26.95 MG MG D 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 84.07 42.30 -50.78 84.70 41.81 -50.82 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 101.61 56.30 -60.24 100.25 55.53 -61.72 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 97.75 47.69 -25.92 97.82 49.25 -28.26 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 49 3 # 49 A 465 GLY D 183 GLY^? -4.40 MG MG D 301s A 501 ASP E 128 ASP^? -3.53 MG MG E 302s B 367 TYR D 67 TYR^? 21.42 MG MG D 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 84.07 42.30 -50.78 84.70 41.81 -50.82 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 65.38 56.57 -48.58 66.15 54.57 -48.61 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 83.62 29.64 -28.35 84.67 32.17 -27.90 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 50 3 # 50 A 465 GLY D 183 GLY^? -4.40 MG MG D 301s A 501 ASP E 148 ASP^? 2.62 MG MG E 302s B 367 TYR C 60 TYR^? 26.95 MG MG D 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 84.07 42.30 -50.78 84.70 41.81 -50.82 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 97.75 47.69 -25.92 97.82 49.25 -28.26 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 51 3 # 51 A 465 GLY D 184 GLY^? 4.28 MG MG D 301 A 501 ASP D 23 ASP^? 15.37 MG MG E 301 B 367 TYR D 67 TYR^? 21.42 MG MG D 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 83.33 40.04 -53.77 83.20 39.83 -52.97 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 85.70 62.10 -45.60 84.07 62.13 -46.93 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 83.62 29.64 -28.35 84.67 32.17 -27.90 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 52 3 # 52 A 465 GLY D 184 GLY^? 4.28 MG MG D 301 A 501 ASP D 23 ASP^? 15.37 MG MG E 301 B 367 TYR D 156 TYR^? 21.34 MG MG D 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 83.33 40.04 -53.77 83.20 39.83 -52.97 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 85.70 62.10 -45.60 84.07 62.13 -46.93 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 96.25 27.10 -34.64 97.58 29.48 -35.03 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 53 3 # 53 A 465 GLY E 27 GLY^? 20.34 MG MG D 301 A 501 ASP D 148 ASP^? 2.35 MG MG D 302s B 367 TYR F 60 TYR^? 27.07 MG MG E 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 97.08 55.99 -51.80 96.40 55.63 -52.03 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 79.79 68.64 -68.89 81.11 68.86 -66.46 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 54 3 # 54 A 465 GLY E 27 GLY^? 20.34 MG MG D 301 A 501 ASP D 187 ASP^? -2.95 MG MG D 301s B 367 TYR F 60 TYR^? 27.07 MG MG E 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 97.08 55.99 -51.80 96.40 55.63 -52.03 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 90.40 36.34 -52.69 89.24 37.98 -51.99 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 79.79 68.64 -68.89 81.11 68.86 -66.46 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 55 3 # 55 A 465 GLY E 89 GLY^? 19.25 MG MG D 301 A 501 ASP D 128 ASP^? -3.70 MG MG D 302s B 367 TYR E 188 TYR^? 8.62 MG MG E 301 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 77.50 50.68 -63.25 77.41 51.57 -63.34 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 83.33 35.45 -46.13 81.57 36.63 -46.10 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 65.58 67.09 -44.08 67.82 68.57 -43.41 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 56 3 # 56 A 465 GLY E 89 GLY^? 19.25 MG MG D 301 A 501 ASP D 148 ASP^? 2.35 MG MG D 302s B 367 TYR E 188 TYR^? 8.62 MG MG E 301 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 77.50 50.68 -63.25 77.41 51.57 -63.34 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 65.58 67.09 -44.08 67.82 68.57 -43.41 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 57 3 # 57 A 465 GLY E 89 GLY^? 19.25 MG MG D 301 A 501 ASP E 23 ASP^? 15.43 MG MG D 301 B 367 TYR E 156 TYR^? 21.59 MG MG E 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 77.50 50.68 -63.25 77.41 51.57 -63.34 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 91.98 54.64 -49.37 91.93 52.78 -48.33 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 59.31 70.31 -60.22 61.84 71.39 -59.92 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 58 3 # 58 A 465 GLY E 89 GLY^? 19.25 MG MG D 301 A 501 ASP E 23 ASP^? 15.43 MG MG D 301 B 367 TYR E 168 TYR^? 14.43 MG MG E 301 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 77.50 50.68 -63.25 77.41 51.57 -63.34 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 91.98 54.64 -49.37 91.93 52.78 -48.33 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 60.07 69.95 -50.54 61.99 69.37 -48.59 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 59 3 # 59 A 465 GLY E 89 GLY^? 19.25 MG MG D 301 A 501 ASP E 148 ASP^? 2.62 MG MG E 302s B 367 TYR D 188 TYR^? 8.87 MG MG D 301 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 77.50 50.68 -63.25 77.41 51.57 -63.34 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 93.72 33.91 -50.86 95.36 36.03 -51.61 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 60 3 # 60 A 465 GLY E 145 GLY^? 13.69 MG MG E 301 A 501 ASP E 35 ASP^? 16.91 MG MG E 302 B 367 TYR E 60 TYR^? 27.19 MG MG F 301 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 57.08 63.68 -47.92 56.95 63.88 -47.12 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 39.82 61.07 -70.68 38.29 60.72 -72.98 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 61 3 # 61 A 465 GLY E 149 GLY^? 5.75 MG MG E 301 A 501 ASP D 81 ASP^? 23.25 MG MG E 301 B 367 TYR F 60 TYR^? 27.07 MG MG E 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 69.31 64.70 -46.05 69.60 64.17 -46.61 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 89.25 71.36 -34.47 87.72 70.06 -33.67 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 79.79 68.64 -68.89 81.11 68.86 -66.46 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 62 3 # 62 A 465 GLY E 149 GLY^? 5.75 MG MG E 301 A 501 ASP E 100 ASP^? 19.27 MG MG E 302 B 367 TYR F 60 TYR^? 27.07 MG MG E 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 69.31 64.70 -46.05 69.60 64.17 -46.61 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 49.30 52.58 -51.44 50.47 51.29 -50.20 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 79.79 68.64 -68.89 81.11 68.86 -66.46 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 63 3 # 63 A 465 GLY E 149 GLY^? 5.75 MG MG E 301 A 501 ASP E 142 ASP^? 23.66 MG MG E 301 B 367 TYR F 60 TYR^? 27.07 MG MG E 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 69.31 64.70 -46.05 69.60 64.17 -46.61 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 47.19 67.15 -50.37 47.44 67.18 -48.23 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 79.79 68.64 -68.89 81.11 68.86 -66.46 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 64 3 # 64 A 465 GLY E 183 GLY^? -4.49 MG MG E 301s A 501 ASP D 128 ASP^? -3.70 MG MG D 302s B 367 TYR E 67 TYR^? 21.41 MG MG E 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 72.33 56.33 -43.87 71.83 56.99 -43.77 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 83.33 35.45 -46.13 81.57 36.63 -46.10 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 59.76 57.41 -66.37 62.46 58.08 -67.03 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 65 3 # 65 A 465 GLY E 183 GLY^? -4.49 MG MG E 301s A 501 ASP E 23 ASP^? 15.43 MG MG D 301 B 367 TYR E 67 TYR^? 21.41 MG MG E 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 72.33 56.33 -43.87 71.83 56.99 -43.77 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 91.98 54.64 -49.37 91.93 52.78 -48.33 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 59.76 57.41 -66.37 62.46 58.08 -67.03 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 66 3 # 66 A 465 GLY E 184 GLY^? 4.85 MG MG E 301 A 501 ASP E 23 ASP^? 15.43 MG MG D 301 B 367 TYR E 67 TYR^? 21.41 MG MG E 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 69.91 55.36 -41.13 69.77 55.58 -41.87 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 91.98 54.64 -49.37 91.93 52.78 -48.33 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 59.76 57.41 -66.37 62.46 58.08 -67.03 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 67 3 # 67 A 465 GLY E 184 GLY^? 4.85 MG MG E 301 A 501 ASP E 23 ASP^? 15.43 MG MG D 301 B 367 TYR E 156 TYR^? 21.59 MG MG E 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 69.91 55.36 -41.13 69.77 55.58 -41.87 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 91.98 54.64 -49.37 91.93 52.78 -48.33 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 59.31 70.31 -60.22 61.84 71.39 -59.92 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 68 3 # 68 A 465 GLY F 89 GLY^? 19.22 MG MG F 301 A 501 ASP F 23 ASP^? 23.03 MG MG F 301 B 367 TYR F 168 TYR^? 14.10 MG MG F 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 48.22 45.17 -75.46 48.08 46.04 -75.34 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 31.30 43.61 -89.40 33.44 43.69 -89.02 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 58.29 68.32 -89.29 56.67 67.12 -91.21 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 69 3 # 69 A 465 GLY F 107 GLY^? 30.90 MG MG F 301 A 501 ASP E 35 ASP^? 16.91 MG MG E 302 B 367 TYR F 188 TYR^? 8.06 MG MG F 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 79.49 67.91 -82.95 80.01 67.39 -83.35 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 54.23 63.50 -95.64 51.58 63.66 -96.35 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 70 3 # 70 A 465 GLY F 145 GLY^? 13.40 MG MG F 302 A 501 ASP F 35 ASP^? 16.93 MG MG F 301 B 367 TYR F 60 TYR^? 27.07 MG MG E 302 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 63.24 63.21 -91.82 63.24 63.42 -92.59 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 46.82 60.47 -77.63 48.00 58.79 -78.23 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 79.79 68.64 -68.89 81.11 68.86 -66.46 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 71 3 # 71 A 465 GLY F 149 GLY^? 5.34 MG MG F 302 A 501 ASP F 100 ASP^? 19.36 MG MG F 301 B 367 TYR E 60 TYR^? 27.19 MG MG F 301 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 51.31 60.07 -93.46 51.26 59.51 -92.90 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 74.18 55.53 -87.58 73.63 53.79 -88.67 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 39.82 61.07 -70.68 38.29 60.72 -72.98 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 72 3 # 72 A 465 GLY F 149 GLY^? 5.34 MG MG F 302 A 501 ASP F 142 ASP^? 23.43 MG MG F 302 B 367 TYR E 60 TYR^? 27.19 MG MG F 301 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 51.31 60.07 -93.46 51.26 59.51 -92.90 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 71.46 69.88 -89.76 71.03 69.93 -91.81 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 39.82 61.07 -70.68 38.29 60.72 -72.98 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 73 3 # 73 A 465 GLY F 183 GLY^? -4.39 MG MG F 301s A 501 ASP F 23 ASP^? 23.03 MG MG F 301 B 367 TYR F 67 TYR^? 21.41 MG MG F 301 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 51.40 50.96 -94.96 51.47 51.79 -95.11 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 31.30 43.61 -89.40 33.44 43.69 -89.02 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 62.63 57.65 -72.90 59.95 57.21 -72.29 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 74 3 # 74 A 465 GLY F 183 GLY^? -4.39 MG MG F 301s A 501 ASP F 100 ASP^? 19.36 MG MG F 301 B 367 TYR E 60 TYR^? 27.19 MG MG F 301 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 51.40 50.96 -94.96 51.47 51.79 -95.11 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 74.18 55.53 -87.58 73.63 53.79 -88.67 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 39.82 61.07 -70.68 38.29 60.72 -72.98 1mro_c00 source 1mro METHYL-COENZYME M REDUCTASE : 74 hits 1mro_c00 naa= 3 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 1 3 # 1 D 465 GLY A 145 GLY^? 13.39 MG MG A 302 D 501 ASP A 35 ASP^? 16.92 MG MG A 301 E 367 TYR A 60 TYR^? 27.11 MG MG B 302 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 44.20 17.56 40.29 44.09 17.33 41.06 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 34.49 31.10 26.54 36.41 31.82 27.10 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 55.01 4.24 16.98 56.13 3.24 14.65 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 2 3 # 2 D 465 GLY A 149 GLY^? 6.01 MG MG A 302 D 501 ASP A 142 ASP^? 23.70 MG MG A 302 E 367 TYR B 60 TYR^? 27.11 MG MG A 301 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 37.26 27.53 42.29 37.61 28.00 41.76 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 46.39 7.18 37.53 46.28 7.18 39.63 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 28.84 35.27 19.49 28.03 36.56 21.83 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 3 3 # 3 D 465 GLY A 184 GLY^? 4.07 MG MG A 302 D 501 ASP A 23 ASP^? 22.90 MG MG A 301 E 367 TYR A 67 TYR^? 21.33 MG MG A 301 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 44.11 32.36 47.58 44.42 32.35 46.80 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 36.40 52.47 38.61 38.03 53.36 39.72 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 48.62 23.20 22.09 46.84 25.23 21.44 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 4 3 # 4 D 465 GLY A 184 GLY^? 4.07 MG MG A 302 D 501 ASP A 23 ASP^? 22.90 MG MG A 301 E 367 TYR A 156 TYR^? 21.80 MG MG A 301 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 44.11 32.36 47.58 44.42 32.35 46.80 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 36.40 52.47 38.61 38.03 53.36 39.72 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 37.50 16.28 27.75 35.30 17.94 28.08 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 5 3 # 5 D 465 GLY B 27 GLY^? 20.96 MG MG C 301 D 501 ASP C 148 ASP^? 2.75 MG MG C 302s E 367 TYR A 60 TYR^? 27.11 MG MG B 302 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 77.29 2.95 1.20 76.99 3.70 1.33 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 55.01 4.24 16.98 56.13 3.24 14.65 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 6 3 # 6 D 465 GLY B 27 GLY^? 20.96 MG MG C 301 D 501 ASP C 187 ASP^? -3.72 MG MG C 301s E 367 TYR A 60 TYR^? 27.11 MG MG B 302 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 77.29 2.95 1.20 76.99 3.70 1.33 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 84.01 23.73 3.39 83.47 22.54 1.59 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 55.01 4.24 16.98 56.13 3.24 14.65 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 7 3 # 7 D 465 GLY B 89 GLY^? 19.24 MG MG B 302 D 501 ASP B 23 ASP^? 15.67 MG MG C 301 E 367 TYR B 156 TYR^? 21.63 MG MG B 302 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 64.90 19.68 12.95 64.28 19.13 13.13 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 74.31 7.55 -1.09 75.08 9.17 -2.23 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 38.56 16.71 8.27 39.91 14.31 7.86 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 8 3 # 8 D 465 GLY B 89 GLY^? 19.24 MG MG B 302 D 501 ASP B 23 ASP^? 15.67 MG MG C 301 E 367 TYR B 168 TYR^? 14.66 MG MG B 301 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 64.90 19.68 12.95 64.28 19.13 13.13 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 74.31 7.55 -1.09 75.08 9.17 -2.23 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 40.03 17.20 -1.34 41.92 16.43 -3.19 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 9 3 # 9 D 465 GLY B 89 GLY^? 19.24 MG MG B 302 D 501 ASP B 148 ASP^? 2.58 MG MG B 302s E 367 TYR C 188 TYR^? 8.98 MG MG C 301 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 64.90 19.68 12.95 64.28 19.13 13.13 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 88.74 23.30 0.93 88.91 20.61 1.57 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 10 3 # 10 D 465 GLY B 89 GLY^? 19.24 MG MG B 302 D 501 ASP C 148 ASP^? 2.75 MG MG C 302s E 367 TYR B 188 TYR^? 8.84 MG MG B 301 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 64.90 19.68 12.95 64.28 19.13 13.13 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 46.41 16.35 -7.52 47.38 13.88 -8.38 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 11 3 # 11 D 465 GLY B 145 GLY^? 13.71 MG MG B 301 D 501 ASP B 35 ASP^? 16.92 MG MG B 302 E 367 TYR B 60 TYR^? 27.11 MG MG A 301 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 42.04 23.97 -3.40 41.83 23.90 -4.16 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 52.63 11.07 10.18 53.68 12.85 9.94 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 28.84 35.27 19.49 28.03 36.56 21.83 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 12 3 # 12 D 465 GLY B 149 GLY^? 5.93 MG MG B 301 D 501 ASP B 100 ASP^? 19.41 MG MG B 302 E 367 TYR A 60 TYR^? 27.11 MG MG B 302 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 50.72 15.48 -5.33 51.24 15.67 -4.78 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 42.99 37.37 0.88 44.84 37.85 0.06 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 55.01 4.24 16.98 56.13 3.24 14.65 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 13 3 # 13 D 465 GLY B 149 GLY^? 5.93 MG MG B 301 D 501 ASP B 142 ASP^? 23.97 MG MG B 301 E 367 TYR A 60 TYR^? 27.11 MG MG B 302 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 50.72 15.48 -5.33 51.24 15.67 -4.78 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 31.69 27.40 -1.31 32.10 27.37 -3.38 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 55.01 4.24 16.98 56.13 3.24 14.65 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 14 3 # 14 D 465 GLY B 149 GLY^? 5.93 MG MG B 301 D 501 ASP C 81 ASP^? 23.42 MG MG B 301 E 367 TYR A 60 TYR^? 27.11 MG MG B 302 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 50.72 15.48 -5.33 51.24 15.67 -4.78 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 60.68 -2.08 -16.91 61.02 -0.17 -17.89 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 55.01 4.24 16.98 56.13 3.24 14.65 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 15 3 # 15 D 465 GLY B 183 GLY^? -4.35 MG MG B 301s D 501 ASP B 23 ASP^? 15.67 MG MG C 301 E 367 TYR B 67 TYR^? 21.41 MG MG B 302 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 58.74 20.22 -6.73 58.00 19.87 -6.89 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 74.31 7.55 -1.09 75.08 9.17 -2.23 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 46.94 25.86 15.48 48.70 23.84 16.15 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 16 3 # 16 D 465 GLY B 183 GLY^? -4.35 MG MG B 301s D 501 ASP B 23 ASP^? 15.67 MG MG C 301 E 367 TYR B 156 TYR^? 21.63 MG MG B 302 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 58.74 20.22 -6.73 58.00 19.87 -6.89 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 74.31 7.55 -1.09 75.08 9.17 -2.23 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 38.56 16.71 8.27 39.91 14.31 7.86 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 17 3 # 17 D 465 GLY B 183 GLY^? -4.35 MG MG B 301s D 501 ASP C 128 ASP^? -3.22 MG MG C 302s E 367 TYR B 67 TYR^? 21.41 MG MG B 302 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 58.74 20.22 -6.73 58.00 19.87 -6.89 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 46.94 25.86 15.48 48.70 23.84 16.15 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 18 3 # 18 D 465 GLY B 183 GLY^? -4.35 MG MG B 301s D 501 ASP C 148 ASP^? 2.75 MG MG C 302s E 367 TYR A 60 TYR^? 27.11 MG MG B 302 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 58.74 20.22 -6.73 58.00 19.87 -6.89 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 55.01 4.24 16.98 56.13 3.24 14.65 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 19 3 # 19 D 465 GLY B 184 GLY^? 4.47 MG MG B 301 D 501 ASP B 23 ASP^? 15.67 MG MG C 301 E 367 TYR B 67 TYR^? 21.41 MG MG B 302 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 57.32 22.02 -9.75 57.17 22.15 -8.93 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 74.31 7.55 -1.09 75.08 9.17 -2.23 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 46.94 25.86 15.48 48.70 23.84 16.15 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 20 3 # 20 D 465 GLY B 184 GLY^? 4.47 MG MG B 301 D 501 ASP B 23 ASP^? 15.67 MG MG C 301 E 367 TYR B 156 TYR^? 21.63 MG MG B 302 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 57.32 22.02 -9.75 57.17 22.15 -8.93 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 74.31 7.55 -1.09 75.08 9.17 -2.23 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 38.56 16.71 8.27 39.91 14.31 7.86 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 21 3 # 21 D 465 GLY B 184 GLY^? 4.47 MG MG B 301 D 501 ASP C 128 ASP^? -3.22 MG MG C 302s E 367 TYR B 67 TYR^? 21.41 MG MG B 302 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 57.32 22.02 -9.75 57.17 22.15 -8.93 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 46.94 25.86 15.48 48.70 23.84 16.15 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 22 3 # 22 D 465 GLY C 27 GLY^? 19.87 MG MG B 301 D 501 ASP B 148 ASP^? 2.58 MG MG B 302s E 367 TYR D 60 TYR^? 26.93 MG MG C 302 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 63.15 1.80 -8.18 63.38 2.56 -8.31 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 84.40 9.28 -23.74 83.45 7.90 -21.49 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 23 3 # 23 D 465 GLY C 27 GLY^? 19.87 MG MG B 301 D 501 ASP B 187 ASP^? -3.44 MG MG B 301s E 367 TYR D 60 TYR^? 26.93 MG MG C 302 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 63.15 1.80 -8.18 63.38 2.56 -8.31 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 50.64 18.14 -9.69 51.74 17.63 -7.86 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 84.40 9.28 -23.74 83.45 7.90 -21.49 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 24 3 # 24 D 465 GLY C 89 GLY^? 18.96 MG MG C 302 D 501 ASP B 148 ASP^? 2.58 MG MG B 302s E 367 TYR C 188 TYR^? 8.98 MG MG C 301 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 69.98 20.32 -19.31 70.77 19.99 -19.37 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 88.74 23.30 0.93 88.91 20.61 1.57 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 25 3 # 25 D 465 GLY C 89 GLY^? 18.96 MG MG C 302 D 501 ASP C 148 ASP^? 2.75 MG MG C 302s E 367 TYR B 188 TYR^? 8.84 MG MG B 301 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 69.98 20.32 -19.31 70.77 19.99 -19.37 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 46.41 16.35 -7.52 47.38 13.88 -8.38 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 26 3 # 26 D 465 GLY C 145 GLY^? 13.72 MG MG C 301 D 501 ASP C 35 ASP^? 16.42 MG MG C 302 E 367 TYR C 60 TYR^? 26.95 MG MG D 302 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 90.12 32.13 -3.16 90.38 32.11 -2.40 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 97.75 47.69 -25.92 97.82 49.25 -28.26 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 27 3 # 27 D 465 GLY C 149 GLY^? 6.13 MG MG C 301 D 501 ASP C 142 ASP^? 23.76 MG MG C 301 E 367 TYR D 60 TYR^? 26.93 MG MG C 302 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 85.09 20.92 -1.20 84.51 20.95 -1.73 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 97.94 39.27 -5.03 98.08 38.70 -2.97 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 84.40 9.28 -23.74 83.45 7.90 -21.49 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 28 3 # 28 D 465 GLY C 183 GLY^? -4.00 MG MG C 301s D 501 ASP B 128 ASP^? -3.57 MG MG B 302s E 367 TYR C 67 TYR^? 21.03 MG MG C 302 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 76.27 22.45 0.43 77.06 22.50 0.60 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 52.92 24.09 -2.19 54.73 25.14 -1.90 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 84.52 32.45 -21.76 83.69 29.84 -22.37 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 29 3 # 29 D 465 GLY C 183 GLY^? -4.00 MG MG C 301s D 501 ASP B 148 ASP^? 2.58 MG MG B 302s E 367 TYR D 60 TYR^? 26.93 MG MG C 302 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 76.27 22.45 0.43 77.06 22.50 0.60 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 84.40 9.28 -23.74 83.45 7.90 -21.49 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 30 3 # 30 D 465 GLY C 184 GLY^? 4.50 MG MG C 301 D 501 ASP B 128 ASP^? -3.57 MG MG B 302s E 367 TYR C 67 TYR^? 21.03 MG MG C 302 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 76.47 24.88 3.34 76.71 25.04 2.53 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 52.92 24.09 -2.19 54.73 25.14 -1.90 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 84.52 32.45 -21.76 83.69 29.84 -22.37 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 31 3 # 31 D 465 GLY C 184 GLY^? 4.50 MG MG C 301 D 501 ASP C 23 ASP^? 15.39 MG MG B 301 E 367 TYR C 67 TYR^? 21.03 MG MG C 302 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 76.47 24.88 3.34 76.71 25.04 2.53 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 65.24 6.82 -5.11 63.43 7.54 -4.15 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 84.52 32.45 -21.76 83.69 29.84 -22.37 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 32 3 # 32 D 465 GLY C 184 GLY^? 4.50 MG MG C 301 D 501 ASP C 23 ASP^? 15.39 MG MG B 301 E 367 TYR C 156 TYR^? 21.58 MG MG C 302 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 76.47 24.88 3.34 76.71 25.04 2.53 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 65.24 6.82 -5.11 63.43 7.54 -4.15 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 95.64 26.50 -15.14 95.25 23.76 -14.77 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 33 3 # 33 D 465 GLY D 27 GLY^? 19.64 MG MG E 301 D 501 ASP E 148 ASP^? 2.62 MG MG E 302s E 367 TYR C 60 TYR^? 26.95 MG MG D 302 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 87.58 66.90 -43.17 87.20 66.21 -42.95 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 97.75 47.69 -25.92 97.82 49.25 -28.26 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 34 3 # 34 D 465 GLY D 27 GLY^? 19.64 MG MG E 301 D 501 ASP E 187 ASP^? -2.71 MG MG E 301s E 367 TYR C 60 TYR^? 26.95 MG MG D 302 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 87.58 66.90 -43.17 87.20 66.21 -42.95 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 67.50 63.43 -41.69 68.97 62.26 -42.81 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 97.75 47.69 -25.92 97.82 49.25 -28.26 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 35 3 # 35 D 465 GLY D 89 GLY^? 19.56 MG MG D 302 D 501 ASP D 23 ASP^? 15.37 MG MG E 301 E 367 TYR D 156 TYR^? 21.34 MG MG D 302 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 79.91 48.18 -31.33 80.69 47.93 -31.18 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 85.70 62.10 -45.60 84.07 62.13 -46.93 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 96.25 27.10 -34.64 97.58 29.48 -35.03 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 36 3 # 36 D 465 GLY D 89 GLY^? 19.56 MG MG D 302 D 501 ASP D 23 ASP^? 15.37 MG MG E 301 E 367 TYR D 168 TYR^? 14.75 MG MG D 301 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 79.91 48.18 -31.33 80.69 47.93 -31.18 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 85.70 62.10 -45.60 84.07 62.13 -46.93 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 95.79 27.80 -44.35 95.71 29.78 -46.32 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 37 3 # 37 D 465 GLY D 89 GLY^? 19.56 MG MG D 302 D 501 ASP D 148 ASP^? 2.35 MG MG D 302s E 367 TYR E 188 TYR^? 8.62 MG MG E 301 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 79.91 48.18 -31.33 80.69 47.93 -31.18 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 65.58 67.09 -44.08 67.82 68.57 -43.41 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 38 3 # 38 D 465 GLY D 89 GLY^? 19.56 MG MG D 302 D 501 ASP E 128 ASP^? -3.53 MG MG E 302s E 367 TYR D 188 TYR^? 8.87 MG MG D 301 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 79.91 48.18 -31.33 80.69 47.93 -31.18 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 65.38 56.57 -48.58 66.15 54.57 -48.61 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 93.72 33.91 -50.86 95.36 36.03 -51.61 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 39 3 # 39 D 465 GLY D 89 GLY^? 19.56 MG MG D 302 D 501 ASP E 148 ASP^? 2.62 MG MG E 302s E 367 TYR D 188 TYR^? 8.87 MG MG D 301 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 79.91 48.18 -31.33 80.69 47.93 -31.18 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 93.72 33.91 -50.86 95.36 36.03 -51.61 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 40 3 # 40 D 465 GLY D 145 GLY^? 13.51 MG MG D 301 D 501 ASP D 35 ASP^? 16.80 MG MG D 302 E 367 TYR D 60 TYR^? 26.93 MG MG C 302 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 88.90 26.07 -46.90 89.21 25.93 -47.57 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 84.40 9.28 -23.74 83.45 7.90 -21.49 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 41 3 # 41 D 465 GLY D 149 GLY^? 6.12 MG MG D 301 D 501 ASP D 142 ASP^? 23.49 MG MG D 301 E 367 TYR C 60 TYR^? 26.95 MG MG D 302 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 92.07 37.87 -48.88 91.62 38.12 -48.34 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 90.90 15.58 -44.76 91.35 16.09 -46.79 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 97.75 47.69 -25.92 97.82 49.25 -28.26 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 42 3 # 42 D 465 GLY D 149 GLY^? 6.12 MG MG D 301 D 501 ASP E 81 ASP^? 24.19 MG MG D 301 E 367 TYR C 60 TYR^? 26.95 MG MG D 302 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 92.07 37.87 -48.88 91.62 38.12 -48.34 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 101.61 56.30 -60.24 100.25 55.53 -61.72 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 97.75 47.69 -25.92 97.82 49.25 -28.26 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 43 3 # 43 D 465 GLY D 183 GLY^? -4.40 MG MG D 301s D 501 ASP D 23 ASP^? 15.37 MG MG E 301 E 367 TYR D 67 TYR^? 21.42 MG MG D 302 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 84.07 42.30 -50.78 84.70 41.81 -50.82 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 85.70 62.10 -45.60 84.07 62.13 -46.93 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 83.62 29.64 -28.35 84.67 32.17 -27.90 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 44 3 # 44 D 465 GLY D 183 GLY^? -4.40 MG MG D 301s D 501 ASP D 23 ASP^? 15.37 MG MG E 301 E 367 TYR D 156 TYR^? 21.34 MG MG D 302 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 84.07 42.30 -50.78 84.70 41.81 -50.82 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 85.70 62.10 -45.60 84.07 62.13 -46.93 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 96.25 27.10 -34.64 97.58 29.48 -35.03 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 45 3 # 45 D 465 GLY D 183 GLY^? -4.40 MG MG D 301s D 501 ASP E 81 ASP^? 24.19 MG MG D 301 E 367 TYR C 60 TYR^? 26.95 MG MG D 302 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 84.07 42.30 -50.78 84.70 41.81 -50.82 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 101.61 56.30 -60.24 100.25 55.53 -61.72 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 97.75 47.69 -25.92 97.82 49.25 -28.26 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 46 3 # 46 D 465 GLY D 183 GLY^? -4.40 MG MG D 301s D 501 ASP E 128 ASP^? -3.53 MG MG E 302s E 367 TYR D 67 TYR^? 21.42 MG MG D 302 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 84.07 42.30 -50.78 84.70 41.81 -50.82 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 65.38 56.57 -48.58 66.15 54.57 -48.61 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 83.62 29.64 -28.35 84.67 32.17 -27.90 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 47 3 # 47 D 465 GLY D 183 GLY^? -4.40 MG MG D 301s D 501 ASP E 148 ASP^? 2.62 MG MG E 302s E 367 TYR C 60 TYR^? 26.95 MG MG D 302 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 84.07 42.30 -50.78 84.70 41.81 -50.82 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 97.75 47.69 -25.92 97.82 49.25 -28.26 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 48 3 # 48 D 465 GLY D 184 GLY^? 4.28 MG MG D 301 D 501 ASP D 23 ASP^? 15.37 MG MG E 301 E 367 TYR D 67 TYR^? 21.42 MG MG D 302 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 83.33 40.04 -53.77 83.20 39.83 -52.97 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 85.70 62.10 -45.60 84.07 62.13 -46.93 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 83.62 29.64 -28.35 84.67 32.17 -27.90 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 49 3 # 49 D 465 GLY D 184 GLY^? 4.28 MG MG D 301 D 501 ASP D 23 ASP^? 15.37 MG MG E 301 E 367 TYR D 156 TYR^? 21.34 MG MG D 302 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 83.33 40.04 -53.77 83.20 39.83 -52.97 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 85.70 62.10 -45.60 84.07 62.13 -46.93 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 96.25 27.10 -34.64 97.58 29.48 -35.03 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 50 3 # 50 D 465 GLY E 27 GLY^? 20.34 MG MG D 301 D 501 ASP D 148 ASP^? 2.35 MG MG D 302s E 367 TYR F 60 TYR^? 27.07 MG MG E 302 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 97.08 55.99 -51.80 96.40 55.63 -52.03 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 79.79 68.64 -68.89 81.11 68.86 -66.46 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 51 3 # 51 D 465 GLY E 27 GLY^? 20.34 MG MG D 301 D 501 ASP D 187 ASP^? -2.95 MG MG D 301s E 367 TYR F 60 TYR^? 27.07 MG MG E 302 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 97.08 55.99 -51.80 96.40 55.63 -52.03 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 90.40 36.34 -52.69 89.24 37.98 -51.99 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 79.79 68.64 -68.89 81.11 68.86 -66.46 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 52 3 # 52 D 465 GLY E 89 GLY^? 19.25 MG MG D 301 D 501 ASP D 128 ASP^? -3.70 MG MG D 302s E 367 TYR E 188 TYR^? 8.62 MG MG E 301 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 77.50 50.68 -63.25 77.41 51.57 -63.34 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 83.33 35.45 -46.13 81.57 36.63 -46.10 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 65.58 67.09 -44.08 67.82 68.57 -43.41 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 53 3 # 53 D 465 GLY E 89 GLY^? 19.25 MG MG D 301 D 501 ASP D 148 ASP^? 2.35 MG MG D 302s E 367 TYR E 188 TYR^? 8.62 MG MG E 301 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 77.50 50.68 -63.25 77.41 51.57 -63.34 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 65.58 67.09 -44.08 67.82 68.57 -43.41 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 54 3 # 54 D 465 GLY E 89 GLY^? 19.25 MG MG D 301 D 501 ASP E 23 ASP^? 15.43 MG MG D 301 E 367 TYR E 156 TYR^? 21.59 MG MG E 302 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 77.50 50.68 -63.25 77.41 51.57 -63.34 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 91.98 54.64 -49.37 91.93 52.78 -48.33 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 59.31 70.31 -60.22 61.84 71.39 -59.92 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 55 3 # 55 D 465 GLY E 89 GLY^? 19.25 MG MG D 301 D 501 ASP E 23 ASP^? 15.43 MG MG D 301 E 367 TYR E 168 TYR^? 14.43 MG MG E 301 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 77.50 50.68 -63.25 77.41 51.57 -63.34 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 91.98 54.64 -49.37 91.93 52.78 -48.33 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 60.07 69.95 -50.54 61.99 69.37 -48.59 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 56 3 # 56 D 465 GLY E 89 GLY^? 19.25 MG MG D 301 D 501 ASP E 148 ASP^? 2.62 MG MG E 302s E 367 TYR D 188 TYR^? 8.87 MG MG D 301 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 77.50 50.68 -63.25 77.41 51.57 -63.34 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 93.72 33.91 -50.86 95.36 36.03 -51.61 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 57 3 # 57 D 465 GLY E 145 GLY^? 13.69 MG MG E 301 D 501 ASP E 35 ASP^? 16.91 MG MG E 302 E 367 TYR E 60 TYR^? 27.19 MG MG F 301 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 57.08 63.68 -47.92 56.95 63.88 -47.12 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 39.82 61.07 -70.68 38.29 60.72 -72.98 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 58 3 # 58 D 465 GLY E 149 GLY^? 5.75 MG MG E 301 D 501 ASP D 81 ASP^? 23.25 MG MG E 301 E 367 TYR F 60 TYR^? 27.07 MG MG E 302 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 69.31 64.70 -46.05 69.60 64.17 -46.61 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 89.25 71.36 -34.47 87.72 70.06 -33.67 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 79.79 68.64 -68.89 81.11 68.86 -66.46 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 59 3 # 59 D 465 GLY E 149 GLY^? 5.75 MG MG E 301 D 501 ASP E 100 ASP^? 19.27 MG MG E 302 E 367 TYR F 60 TYR^? 27.07 MG MG E 302 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 69.31 64.70 -46.05 69.60 64.17 -46.61 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 49.30 52.58 -51.44 50.47 51.29 -50.20 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 79.79 68.64 -68.89 81.11 68.86 -66.46 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 60 3 # 60 D 465 GLY E 149 GLY^? 5.75 MG MG E 301 D 501 ASP E 142 ASP^? 23.66 MG MG E 301 E 367 TYR F 60 TYR^? 27.07 MG MG E 302 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 69.31 64.70 -46.05 69.60 64.17 -46.61 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 47.19 67.15 -50.37 47.44 67.18 -48.23 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 79.79 68.64 -68.89 81.11 68.86 -66.46 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 61 3 # 61 D 465 GLY E 183 GLY^? -4.49 MG MG E 301s D 501 ASP D 128 ASP^? -3.70 MG MG D 302s E 367 TYR E 67 TYR^? 21.41 MG MG E 302 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 72.33 56.33 -43.87 71.83 56.99 -43.77 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 83.33 35.45 -46.13 81.57 36.63 -46.10 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 59.76 57.41 -66.37 62.46 58.08 -67.03 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 62 3 # 62 D 465 GLY E 183 GLY^? -4.49 MG MG E 301s D 501 ASP E 23 ASP^? 15.43 MG MG D 301 E 367 TYR E 67 TYR^? 21.41 MG MG E 302 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 72.33 56.33 -43.87 71.83 56.99 -43.77 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 91.98 54.64 -49.37 91.93 52.78 -48.33 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 59.76 57.41 -66.37 62.46 58.08 -67.03 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 63 3 # 63 D 465 GLY E 184 GLY^? 4.85 MG MG E 301 D 501 ASP E 23 ASP^? 15.43 MG MG D 301 E 367 TYR E 67 TYR^? 21.41 MG MG E 302 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 69.91 55.36 -41.13 69.77 55.58 -41.87 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 91.98 54.64 -49.37 91.93 52.78 -48.33 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 59.76 57.41 -66.37 62.46 58.08 -67.03 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 64 3 # 64 D 465 GLY E 184 GLY^? 4.85 MG MG E 301 D 501 ASP E 23 ASP^? 15.43 MG MG D 301 E 367 TYR E 156 TYR^? 21.59 MG MG E 302 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 69.91 55.36 -41.13 69.77 55.58 -41.87 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 91.98 54.64 -49.37 91.93 52.78 -48.33 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 59.31 70.31 -60.22 61.84 71.39 -59.92 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 65 3 # 65 D 465 GLY F 89 GLY^? 19.22 MG MG F 301 D 501 ASP F 23 ASP^? 23.03 MG MG F 301 E 367 TYR F 168 TYR^? 14.10 MG MG F 302 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 48.22 45.17 -75.46 48.08 46.04 -75.34 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 31.30 43.61 -89.40 33.44 43.69 -89.02 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 58.29 68.32 -89.29 56.67 67.12 -91.21 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 66 3 # 66 D 465 GLY F 145 GLY^? 13.40 MG MG F 302 D 501 ASP F 35 ASP^? 16.93 MG MG F 301 E 367 TYR F 60 TYR^? 27.07 MG MG E 302 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 63.24 63.21 -91.82 63.24 63.42 -92.59 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 46.82 60.47 -77.63 48.00 58.79 -78.23 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 79.79 68.64 -68.89 81.11 68.86 -66.46 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 67 3 # 67 D 465 GLY F 149 GLY^? 5.34 MG MG F 302 D 501 ASP F 100 ASP^? 19.36 MG MG F 301 E 367 TYR E 60 TYR^? 27.19 MG MG F 301 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 51.31 60.07 -93.46 51.26 59.51 -92.90 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 74.18 55.53 -87.58 73.63 53.79 -88.67 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 39.82 61.07 -70.68 38.29 60.72 -72.98 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 68 3 # 68 D 465 GLY F 149 GLY^? 5.34 MG MG F 302 D 501 ASP F 142 ASP^? 23.43 MG MG F 302 E 367 TYR E 60 TYR^? 27.19 MG MG F 301 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 51.31 60.07 -93.46 51.26 59.51 -92.90 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 71.46 69.88 -89.76 71.03 69.93 -91.81 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 39.82 61.07 -70.68 38.29 60.72 -72.98 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 69 3 # 69 D 465 GLY F 183 GLY^? -4.39 MG MG F 301s D 501 ASP F 23 ASP^? 23.03 MG MG F 301 E 367 TYR F 67 TYR^? 21.41 MG MG F 301 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 51.40 50.96 -94.96 51.47 51.79 -95.11 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 31.30 43.61 -89.40 33.44 43.69 -89.02 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 62.63 57.65 -72.90 59.95 57.21 -72.29 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 70 3 # 70 D 465 GLY F 183 GLY^? -4.39 MG MG F 301s D 501 ASP F 100 ASP^? 19.36 MG MG F 301 E 367 TYR E 60 TYR^? 27.19 MG MG F 301 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 51.40 50.96 -94.96 51.47 51.79 -95.11 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 74.18 55.53 -87.58 73.63 53.79 -88.67 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 39.82 61.07 -70.68 38.29 60.72 -72.98 1mro_c01 source 1mro METHYL-COENZYME M REDUCTASE : 70 hits 1mro_c01 naa= 3 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 A 142 LYS A 61 LYS^? 21.99 MG MG B 302 A 217 SER B 16 SER^? 23.97 MG MG B 302 A 241 SER B 36 SER^? 24.04 MG MG B 302 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 57.78 7.35 19.60 56.77 12.20 15.61 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 56.70 5.18 9.63 55.76 3.58 11.01 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 52.58 6.45 11.01 53.61 4.84 12.41 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 A 142 LYS A 61 LYS^? 21.99 MG MG B 302 A 217 SER B 36 SER^? 24.04 MG MG B 302 A 241 SER B 16 SER^? 23.97 MG MG B 302 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 57.78 7.35 19.60 56.77 12.20 15.61 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 52.58 6.45 11.01 53.61 4.84 12.41 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 56.70 5.18 9.63 55.76 3.58 11.01 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 A 142 LYS A 76 LYS^? 25.42 MG MG A 301 A 217 SER A 79 SER^? 29.65 MG MG A 301 A 241 SER A 83 SER^? 32.41 MG MG A 301 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 34.45 46.53 27.28 28.88 44.93 27.25 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 32.57 55.71 29.63 34.63 56.10 28.47 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 30.60 55.84 24.53 32.97 55.99 23.96 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 A 142 LYS A 76 LYS^? 25.42 MG MG A 301 A 217 SER A 83 SER^? 32.41 MG MG A 301 A 241 SER A 79 SER^? 29.65 MG MG A 301 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 34.45 46.53 27.28 28.88 44.93 27.25 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 30.60 55.84 24.53 32.97 55.99 23.96 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 32.57 55.71 29.63 34.63 56.10 28.47 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 A 142 LYS A 86 LYS^? 26.38 MG MG A 301 A 217 SER A 83 SER^? 32.41 MG MG A 301 A 241 SER A 79 SER^? 29.65 MG MG A 301 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 37.08 47.78 23.56 32.88 44.24 21.89 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 30.60 55.84 24.53 32.97 55.99 23.96 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 32.57 55.71 29.63 34.63 56.10 28.47 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 A 142 LYS B 61 LYS^? 22.03 MG MG A 301 A 217 SER A 16 SER.? 24.16 MG MG A 301 A 241 SER A 36 SER^? 23.25 MG MG A 301 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 32.50 37.62 17.61 36.68 34.92 21.51 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 29.26 36.32 27.22 27.38 35.99 25.78 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 29.88 32.10 25.40 29.53 34.39 24.57 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 A 142 LYS B 61 LYS^? 22.03 MG MG A 301 A 217 SER A 36 SER^? 23.25 MG MG A 301 A 241 SER A 16 SER.? 24.16 MG MG A 301 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 32.50 37.62 17.61 36.68 34.92 21.51 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 29.88 32.10 25.40 29.53 34.39 24.57 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 29.26 36.32 27.22 27.38 35.99 25.78 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 A 142 LYS B 76 LYS^? 25.77 MG MG B 302 A 217 SER B 79 SER^? 20.24 MG MG C 301 A 241 SER B 83 SER^? 24.53 MG MG C 301 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 67.82 8.19 10.14 64.96 3.09 10.62 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 76.03 3.33 7.67 77.04 5.28 8.60 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 75.19 1.98 12.89 77.54 2.36 12.62 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 9 3 # 9 A 142 LYS B 76 LYS^? 25.77 MG MG B 302 A 217 SER B 83 SER^? 24.53 MG MG C 301 A 241 SER B 79 SER^? 20.24 MG MG C 301 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 67.82 8.19 10.14 64.96 3.09 10.62 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 75.19 1.98 12.89 77.54 2.36 12.62 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 76.03 3.33 7.67 77.04 5.28 8.60 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 10 3 # 10 A 142 LYS B 86 LYS^? 26.44 MG MG B 302 A 217 SER B 83 SER^? 24.53 MG MG C 301 A 241 SER B 79 SER^? 20.24 MG MG C 301 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 69.25 10.45 13.86 65.27 7.74 16.08 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 75.19 1.98 12.89 77.54 2.36 12.62 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 76.03 3.33 7.67 77.04 5.28 8.60 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 11 3 # 11 A 142 LYS C 61 LYS^? 21.91 MG MG D 302 A 217 SER D 16 SER^? 23.71 MG MG D 302 A 241 SER D 36 SER^? 22.42 MG MG D 302 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 93.60 48.56 -24.05 90.39 44.71 -27.98 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 96.73 48.43 -33.75 98.58 48.68 -32.31 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 97.85 44.42 -32.20 96.60 46.20 -31.15 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 12 3 # 12 A 142 LYS C 61 LYS^? 21.91 MG MG D 302 A 217 SER D 36 SER^? 22.42 MG MG D 302 A 241 SER D 16 SER^? 23.71 MG MG D 302 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 93.60 48.56 -24.05 90.39 44.71 -27.98 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 97.85 44.42 -32.20 96.60 46.20 -31.15 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 96.73 48.43 -33.75 98.58 48.68 -32.31 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 13 3 # 13 A 142 LYS C 76 LYS^? 24.95 MG MG C 302 A 217 SER C 79 SER^? 19.92 MG MG B 301 A 241 SER C 83 SER^? 23.40 MG MG B 301 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 71.11 8.63 -16.76 75.44 5.17 -16.80 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 64.38 1.95 -14.66 62.69 3.45 -15.45 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 65.19 0.76 -19.73 62.87 1.43 -19.33 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 14 3 # 14 A 142 LYS C 76 LYS^? 24.95 MG MG C 302 A 217 SER C 83 SER^? 23.40 MG MG B 301 A 241 SER C 79 SER^? 19.92 MG MG B 301 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 71.11 8.63 -16.76 75.44 5.17 -16.80 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 65.19 0.76 -19.73 62.87 1.43 -19.33 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 64.38 1.95 -14.66 62.69 3.45 -15.45 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 15 3 # 15 A 142 LYS C 86 LYS^? 27.34 MG MG C 302 A 217 SER C 83 SER^? 23.40 MG MG B 301 A 241 SER C 79 SER^? 19.92 MG MG B 301 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 69.22 9.88 -20.56 74.70 7.02 -22.55 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 65.19 0.76 -19.73 62.87 1.43 -19.33 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 64.38 1.95 -14.66 62.69 3.45 -15.45 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 16 3 # 16 A 142 LYS D 61 LYS^? 21.93 MG MG C 302 A 217 SER C 16 SER^? 24.15 MG MG C 302 A 241 SER C 36 SER^? 23.69 MG MG C 302 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 80.64 11.23 -26.16 80.65 16.24 -22.36 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 82.88 9.31 -16.30 84.27 7.80 -17.58 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 86.07 12.19 -17.80 85.34 10.22 -18.98 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 17 3 # 17 A 142 LYS D 61 LYS^? 21.93 MG MG C 302 A 217 SER C 36 SER^? 23.69 MG MG C 302 A 241 SER C 16 SER^? 24.15 MG MG C 302 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 80.64 11.23 -26.16 80.65 16.24 -22.36 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 86.07 12.19 -17.80 85.34 10.22 -18.98 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 82.88 9.31 -16.30 84.27 7.80 -17.58 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 18 3 # 18 A 142 LYS D 76 LYS^? 25.08 MG MG D 302 A 217 SER D 79 SER^? 19.41 MG MG E 301 A 241 SER D 83 SER^? 23.07 MG MG E 301 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 88.18 56.35 -34.05 93.80 56.17 -32.93 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 88.38 65.91 -36.56 86.13 65.62 -35.70 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 89.47 66.32 -31.33 87.79 67.80 -32.19 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 19 3 # 19 A 142 LYS D 76 LYS^? 25.08 MG MG D 302 A 217 SER D 83 SER^? 23.07 MG MG E 301 A 241 SER D 79 SER^? 19.41 MG MG E 301 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 88.18 56.35 -34.05 93.80 56.17 -32.93 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 89.47 66.32 -31.33 87.79 67.80 -32.19 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 88.38 65.91 -36.56 86.13 65.62 -35.70 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 20 3 # 20 A 142 LYS D 86 LYS^? 25.80 MG MG D 302 A 217 SER D 83 SER^? 23.07 MG MG E 301 A 241 SER D 79 SER^? 19.41 MG MG E 301 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 85.54 56.79 -30.27 90.24 54.54 -28.62 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 89.47 66.32 -31.33 87.79 67.80 -32.19 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 88.38 65.91 -36.56 86.13 65.62 -35.70 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 21 3 # 21 A 142 LYS E 61 LYS^? 22.16 MG MG F 301 A 217 SER F 16 SER^? 24.10 MG MG F 301 A 241 SER F 36 SER^? 23.07 MG MG F 301 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 40.99 56.84 -68.48 45.99 56.72 -72.39 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 39.77 59.81 -78.14 38.80 61.26 -76.65 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 42.79 62.77 -76.96 42.19 61.23 -75.17 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 22 3 # 22 A 142 LYS E 61 LYS^? 22.16 MG MG F 301 A 217 SER F 36 SER^? 23.07 MG MG F 301 A 241 SER F 16 SER^? 24.10 MG MG F 301 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 40.99 56.84 -68.48 45.99 56.72 -72.39 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 42.79 62.77 -76.96 42.19 61.23 -75.17 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 39.77 59.81 -78.14 38.80 61.26 -76.65 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 23 3 # 23 A 142 LYS E 76 LYS^? 25.68 MG MG E 302 A 217 SER E 79 SER^? 19.77 MG MG D 301 A 241 SER E 83 SER^? 23.44 MG MG D 301 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 87.09 58.11 -60.91 88.65 63.65 -61.27 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 96.22 56.25 -58.39 95.94 54.06 -59.20 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 96.88 57.42 -63.66 97.96 55.45 -62.84 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 24 3 # 24 A 142 LYS E 76 LYS^? 25.68 MG MG E 302 A 217 SER E 83 SER^? 23.44 MG MG D 301 A 241 SER E 79 SER^? 19.77 MG MG D 301 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 87.09 58.11 -60.91 88.65 63.65 -61.27 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 96.88 57.42 -63.66 97.96 55.45 -62.84 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 96.22 56.25 -58.39 95.94 54.06 -59.20 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 25 3 # 25 A 142 LYS E 86 LYS^? 26.73 MG MG D 301 A 217 SER E 83 SER^? 23.44 MG MG D 301 A 241 SER E 79 SER^? 19.77 MG MG D 301 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 86.84 54.85 -64.43 87.07 60.83 -66.10 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 96.88 57.42 -63.66 97.96 55.45 -62.84 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 96.22 56.25 -58.39 95.94 54.06 -59.20 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 26 3 # 26 A 142 LYS F 61 LYS^? 21.75 MG MG E 302 A 217 SER E 16 SER^? 24.21 MG MG E 302 A 241 SER E 36 SER^? 22.92 MG MG E 302 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 80.24 64.12 -71.01 76.23 61.95 -66.39 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 80.65 67.65 -61.22 81.30 69.49 -62.59 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 76.63 69.18 -62.93 78.20 67.77 -64.11 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 27 3 # 27 A 142 LYS F 61 LYS^? 21.75 MG MG E 302 A 217 SER E 36 SER^? 22.92 MG MG E 302 A 241 SER E 16 SER^? 24.21 MG MG E 302 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 80.24 64.12 -71.01 76.23 61.95 -66.39 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 76.63 69.18 -62.93 78.20 67.77 -64.11 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 80.65 67.65 -61.22 81.30 69.49 -62.59 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 28 3 # 28 A 142 LYS F 76 LYS^? 25.89 MG MG F 301 A 217 SER F 79 SER^? 30.22 MG MG F 301 A 241 SER F 83 SER^? 33.16 MG MG F 301 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 36.96 48.52 -78.06 33.74 53.37 -77.06 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 28.21 44.39 -80.24 29.11 42.36 -79.32 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 27.54 45.11 -75.18 28.33 43.06 -74.18 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 29 3 # 29 A 142 LYS F 76 LYS^? 25.89 MG MG F 301 A 217 SER F 83 SER^? 33.16 MG MG F 301 A 241 SER F 79 SER^? 30.22 MG MG F 301 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 36.96 48.52 -78.06 33.74 53.37 -77.06 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 27.54 45.11 -75.18 28.33 43.06 -74.18 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 28.21 44.39 -80.24 29.11 42.36 -79.32 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 30 3 # 30 A 142 LYS F 86 LYS^? 26.63 MG MG F 301 A 217 SER F 83 SER^? 33.16 MG MG F 301 A 241 SER F 79 SER^? 30.22 MG MG F 301 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 37.89 45.97 -74.42 36.47 51.71 -72.79 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 27.54 45.11 -75.18 28.33 43.06 -74.18 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 28.21 44.39 -80.24 29.11 42.36 -79.32 1mt5_c00 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 30 hits 1mt5_c00 naa= 3 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 B 142 LYS A 61 LYS^? 21.99 MG MG B 302 B 217 SER B 16 SER^? 23.97 MG MG B 302 B 241 SER B 36 SER^? 24.04 MG MG B 302 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 57.78 7.35 19.60 56.77 12.20 15.61 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 56.70 5.18 9.63 55.76 3.58 11.01 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 52.58 6.45 11.01 53.61 4.84 12.41 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 B 142 LYS A 61 LYS^? 21.99 MG MG B 302 B 217 SER B 36 SER^? 24.04 MG MG B 302 B 241 SER B 16 SER^? 23.97 MG MG B 302 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 57.78 7.35 19.60 56.77 12.20 15.61 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 52.58 6.45 11.01 53.61 4.84 12.41 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 56.70 5.18 9.63 55.76 3.58 11.01 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 B 142 LYS A 76 LYS^? 25.42 MG MG A 301 B 217 SER A 79 SER^? 29.65 MG MG A 301 B 241 SER A 83 SER^? 32.41 MG MG A 301 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 34.45 46.53 27.28 28.88 44.93 27.25 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 32.57 55.71 29.63 34.63 56.10 28.47 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 30.60 55.84 24.53 32.97 55.99 23.96 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 B 142 LYS A 76 LYS^? 25.42 MG MG A 301 B 217 SER A 83 SER^? 32.41 MG MG A 301 B 241 SER A 79 SER^? 29.65 MG MG A 301 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 34.45 46.53 27.28 28.88 44.93 27.25 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 30.60 55.84 24.53 32.97 55.99 23.96 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 32.57 55.71 29.63 34.63 56.10 28.47 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 B 142 LYS A 86 LYS^? 26.38 MG MG A 301 B 217 SER A 83 SER^? 32.41 MG MG A 301 B 241 SER A 79 SER^? 29.65 MG MG A 301 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 37.08 47.78 23.56 32.88 44.24 21.89 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 30.60 55.84 24.53 32.97 55.99 23.96 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 32.57 55.71 29.63 34.63 56.10 28.47 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 B 142 LYS B 61 LYS^? 22.03 MG MG A 301 B 217 SER A 16 SER.? 24.16 MG MG A 301 B 241 SER A 36 SER^? 23.25 MG MG A 301 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 32.50 37.62 17.61 36.68 34.92 21.51 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 29.26 36.32 27.22 27.38 35.99 25.78 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 29.88 32.10 25.40 29.53 34.39 24.57 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 B 142 LYS B 61 LYS^? 22.03 MG MG A 301 B 217 SER A 36 SER^? 23.25 MG MG A 301 B 241 SER A 16 SER.? 24.16 MG MG A 301 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 32.50 37.62 17.61 36.68 34.92 21.51 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 29.88 32.10 25.40 29.53 34.39 24.57 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 29.26 36.32 27.22 27.38 35.99 25.78 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 B 142 LYS B 76 LYS^? 25.77 MG MG B 302 B 217 SER B 79 SER^? 20.24 MG MG C 301 B 241 SER B 83 SER^? 24.53 MG MG C 301 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 67.82 8.19 10.14 64.96 3.09 10.62 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 76.03 3.33 7.67 77.04 5.28 8.60 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 75.19 1.98 12.89 77.54 2.36 12.62 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 9 3 # 9 B 142 LYS B 76 LYS^? 25.77 MG MG B 302 B 217 SER B 83 SER^? 24.53 MG MG C 301 B 241 SER B 79 SER^? 20.24 MG MG C 301 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 67.82 8.19 10.14 64.96 3.09 10.62 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 75.19 1.98 12.89 77.54 2.36 12.62 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 76.03 3.33 7.67 77.04 5.28 8.60 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 10 3 # 10 B 142 LYS B 86 LYS^? 26.44 MG MG B 302 B 217 SER B 83 SER^? 24.53 MG MG C 301 B 241 SER B 79 SER^? 20.24 MG MG C 301 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 69.25 10.45 13.86 65.27 7.74 16.08 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 75.19 1.98 12.89 77.54 2.36 12.62 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 76.03 3.33 7.67 77.04 5.28 8.60 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 11 3 # 11 B 142 LYS C 61 LYS^? 21.91 MG MG D 302 B 217 SER D 16 SER^? 23.71 MG MG D 302 B 241 SER D 36 SER^? 22.42 MG MG D 302 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 93.60 48.56 -24.05 90.39 44.71 -27.98 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 96.73 48.43 -33.75 98.58 48.68 -32.31 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 97.85 44.42 -32.20 96.60 46.20 -31.15 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 12 3 # 12 B 142 LYS C 61 LYS^? 21.91 MG MG D 302 B 217 SER D 36 SER^? 22.42 MG MG D 302 B 241 SER D 16 SER^? 23.71 MG MG D 302 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 93.60 48.56 -24.05 90.39 44.71 -27.98 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 97.85 44.42 -32.20 96.60 46.20 -31.15 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 96.73 48.43 -33.75 98.58 48.68 -32.31 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 13 3 # 13 B 142 LYS C 76 LYS^? 24.95 MG MG C 302 B 217 SER C 79 SER^? 19.92 MG MG B 301 B 241 SER C 83 SER^? 23.40 MG MG B 301 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 71.11 8.63 -16.76 75.44 5.17 -16.80 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 64.38 1.95 -14.66 62.69 3.45 -15.45 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 65.19 0.76 -19.73 62.87 1.43 -19.33 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 14 3 # 14 B 142 LYS C 76 LYS^? 24.95 MG MG C 302 B 217 SER C 83 SER^? 23.40 MG MG B 301 B 241 SER C 79 SER^? 19.92 MG MG B 301 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 71.11 8.63 -16.76 75.44 5.17 -16.80 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 65.19 0.76 -19.73 62.87 1.43 -19.33 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 64.38 1.95 -14.66 62.69 3.45 -15.45 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 15 3 # 15 B 142 LYS C 86 LYS^? 27.34 MG MG C 302 B 217 SER C 83 SER^? 23.40 MG MG B 301 B 241 SER C 79 SER^? 19.92 MG MG B 301 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 69.22 9.88 -20.56 74.70 7.02 -22.55 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 65.19 0.76 -19.73 62.87 1.43 -19.33 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 64.38 1.95 -14.66 62.69 3.45 -15.45 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 16 3 # 16 B 142 LYS D 61 LYS^? 21.93 MG MG C 302 B 217 SER C 16 SER^? 24.15 MG MG C 302 B 241 SER C 36 SER^? 23.69 MG MG C 302 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 80.64 11.23 -26.16 80.65 16.24 -22.36 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 82.88 9.31 -16.30 84.27 7.80 -17.58 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 86.07 12.19 -17.80 85.34 10.22 -18.98 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 17 3 # 17 B 142 LYS D 61 LYS^? 21.93 MG MG C 302 B 217 SER C 36 SER^? 23.69 MG MG C 302 B 241 SER C 16 SER^? 24.15 MG MG C 302 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 80.64 11.23 -26.16 80.65 16.24 -22.36 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 86.07 12.19 -17.80 85.34 10.22 -18.98 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 82.88 9.31 -16.30 84.27 7.80 -17.58 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 18 3 # 18 B 142 LYS D 76 LYS^? 25.08 MG MG D 302 B 217 SER D 79 SER^? 19.41 MG MG E 301 B 241 SER D 83 SER^? 23.07 MG MG E 301 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 88.18 56.35 -34.05 93.80 56.17 -32.93 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 88.38 65.91 -36.56 86.13 65.62 -35.70 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 89.47 66.32 -31.33 87.79 67.80 -32.19 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 19 3 # 19 B 142 LYS D 76 LYS^? 25.08 MG MG D 302 B 217 SER D 83 SER^? 23.07 MG MG E 301 B 241 SER D 79 SER^? 19.41 MG MG E 301 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 88.18 56.35 -34.05 93.80 56.17 -32.93 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 89.47 66.32 -31.33 87.79 67.80 -32.19 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 88.38 65.91 -36.56 86.13 65.62 -35.70 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 20 3 # 20 B 142 LYS D 86 LYS^? 25.80 MG MG D 302 B 217 SER D 83 SER^? 23.07 MG MG E 301 B 241 SER D 79 SER^? 19.41 MG MG E 301 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 85.54 56.79 -30.27 90.24 54.54 -28.62 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 89.47 66.32 -31.33 87.79 67.80 -32.19 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 88.38 65.91 -36.56 86.13 65.62 -35.70 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 21 3 # 21 B 142 LYS E 61 LYS^? 22.16 MG MG F 301 B 217 SER F 16 SER^? 24.10 MG MG F 301 B 241 SER F 36 SER^? 23.07 MG MG F 301 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 40.99 56.84 -68.48 45.99 56.72 -72.39 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 39.77 59.81 -78.14 38.80 61.26 -76.65 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 42.79 62.77 -76.96 42.19 61.23 -75.17 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 22 3 # 22 B 142 LYS E 61 LYS^? 22.16 MG MG F 301 B 217 SER F 36 SER^? 23.07 MG MG F 301 B 241 SER F 16 SER^? 24.10 MG MG F 301 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 40.99 56.84 -68.48 45.99 56.72 -72.39 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 42.79 62.77 -76.96 42.19 61.23 -75.17 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 39.77 59.81 -78.14 38.80 61.26 -76.65 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 23 3 # 23 B 142 LYS E 76 LYS^? 25.68 MG MG E 302 B 217 SER E 79 SER^? 19.77 MG MG D 301 B 241 SER E 83 SER^? 23.44 MG MG D 301 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 87.09 58.11 -60.91 88.65 63.65 -61.27 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 96.22 56.25 -58.39 95.94 54.06 -59.20 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 96.88 57.42 -63.66 97.96 55.45 -62.84 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 24 3 # 24 B 142 LYS E 76 LYS^? 25.68 MG MG E 302 B 217 SER E 83 SER^? 23.44 MG MG D 301 B 241 SER E 79 SER^? 19.77 MG MG D 301 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 87.09 58.11 -60.91 88.65 63.65 -61.27 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 96.88 57.42 -63.66 97.96 55.45 -62.84 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 96.22 56.25 -58.39 95.94 54.06 -59.20 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 25 3 # 25 B 142 LYS E 86 LYS^? 26.73 MG MG D 301 B 217 SER E 83 SER^? 23.44 MG MG D 301 B 241 SER E 79 SER^? 19.77 MG MG D 301 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 86.84 54.85 -64.43 87.07 60.83 -66.10 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 96.88 57.42 -63.66 97.96 55.45 -62.84 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 96.22 56.25 -58.39 95.94 54.06 -59.20 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 26 3 # 26 B 142 LYS F 61 LYS^? 21.75 MG MG E 302 B 217 SER E 16 SER^? 24.21 MG MG E 302 B 241 SER E 36 SER^? 22.92 MG MG E 302 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 80.24 64.12 -71.01 76.23 61.95 -66.39 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 80.65 67.65 -61.22 81.30 69.49 -62.59 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 76.63 69.18 -62.93 78.20 67.77 -64.11 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 27 3 # 27 B 142 LYS F 61 LYS^? 21.75 MG MG E 302 B 217 SER E 36 SER^? 22.92 MG MG E 302 B 241 SER E 16 SER^? 24.21 MG MG E 302 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 80.24 64.12 -71.01 76.23 61.95 -66.39 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 76.63 69.18 -62.93 78.20 67.77 -64.11 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 80.65 67.65 -61.22 81.30 69.49 -62.59 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 28 3 # 28 B 142 LYS F 76 LYS^? 25.89 MG MG F 301 B 217 SER F 79 SER^? 30.22 MG MG F 301 B 241 SER F 83 SER^? 33.16 MG MG F 301 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 36.96 48.52 -78.06 33.74 53.37 -77.06 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 28.21 44.39 -80.24 29.11 42.36 -79.32 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 27.54 45.11 -75.18 28.33 43.06 -74.18 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 29 3 # 29 B 142 LYS F 76 LYS^? 25.89 MG MG F 301 B 217 SER F 83 SER^? 33.16 MG MG F 301 B 241 SER F 79 SER^? 30.22 MG MG F 301 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 36.96 48.52 -78.06 33.74 53.37 -77.06 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 27.54 45.11 -75.18 28.33 43.06 -74.18 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 28.21 44.39 -80.24 29.11 42.36 -79.32 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 30 3 # 30 B 142 LYS F 86 LYS^? 26.63 MG MG F 301 B 217 SER F 83 SER^? 33.16 MG MG F 301 B 241 SER F 79 SER^? 30.22 MG MG F 301 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 37.89 45.97 -74.42 36.47 51.71 -72.79 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 27.54 45.11 -75.18 28.33 43.06 -74.18 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 28.21 44.39 -80.24 29.11 42.36 -79.32 1mt5_c01 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 30 hits 1mt5_c01 naa= 3 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 C 142 LYS A 61 LYS^? 21.99 MG MG B 302 C 217 SER B 16 SER^? 23.97 MG MG B 302 C 241 SER B 36 SER^? 24.04 MG MG B 302 coo -12.07 2.83 63.52 -8.95 7.56 61.01 57.78 7.35 19.60 56.77 12.20 15.61 coo -11.64 10.12 58.62 -9.34 9.31 58.79 56.70 5.18 9.63 55.76 3.58 11.01 coo -9.31 12.91 61.58 -8.56 11.90 59.50 52.58 6.45 11.01 53.61 4.84 12.41 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 C 142 LYS A 61 LYS^? 21.99 MG MG B 302 C 217 SER B 36 SER^? 24.04 MG MG B 302 C 241 SER B 16 SER^? 23.97 MG MG B 302 coo -12.07 2.83 63.52 -8.95 7.56 61.01 57.78 7.35 19.60 56.77 12.20 15.61 coo -11.64 10.12 58.62 -9.34 9.31 58.79 52.58 6.45 11.01 53.61 4.84 12.41 coo -9.31 12.91 61.58 -8.56 11.90 59.50 56.70 5.18 9.63 55.76 3.58 11.01 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 C 142 LYS A 76 LYS^? 25.42 MG MG A 301 C 217 SER A 79 SER^? 29.65 MG MG A 301 C 241 SER A 83 SER^? 32.41 MG MG A 301 coo -12.07 2.83 63.52 -8.95 7.56 61.01 34.45 46.53 27.28 28.88 44.93 27.25 coo -11.64 10.12 58.62 -9.34 9.31 58.79 32.57 55.71 29.63 34.63 56.10 28.47 coo -9.31 12.91 61.58 -8.56 11.90 59.50 30.60 55.84 24.53 32.97 55.99 23.96 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 C 142 LYS A 76 LYS^? 25.42 MG MG A 301 C 217 SER A 83 SER^? 32.41 MG MG A 301 C 241 SER A 79 SER^? 29.65 MG MG A 301 coo -12.07 2.83 63.52 -8.95 7.56 61.01 34.45 46.53 27.28 28.88 44.93 27.25 coo -11.64 10.12 58.62 -9.34 9.31 58.79 30.60 55.84 24.53 32.97 55.99 23.96 coo -9.31 12.91 61.58 -8.56 11.90 59.50 32.57 55.71 29.63 34.63 56.10 28.47 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 C 142 LYS A 86 LYS^? 26.38 MG MG A 301 C 217 SER A 83 SER^? 32.41 MG MG A 301 C 241 SER A 79 SER^? 29.65 MG MG A 301 coo -12.07 2.83 63.52 -8.95 7.56 61.01 37.08 47.78 23.56 32.88 44.24 21.89 coo -11.64 10.12 58.62 -9.34 9.31 58.79 30.60 55.84 24.53 32.97 55.99 23.96 coo -9.31 12.91 61.58 -8.56 11.90 59.50 32.57 55.71 29.63 34.63 56.10 28.47 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 C 142 LYS B 61 LYS^? 22.03 MG MG A 301 C 217 SER A 16 SER.? 24.16 MG MG A 301 C 241 SER A 36 SER^? 23.25 MG MG A 301 coo -12.07 2.83 63.52 -8.95 7.56 61.01 32.50 37.62 17.61 36.68 34.92 21.51 coo -11.64 10.12 58.62 -9.34 9.31 58.79 29.26 36.32 27.22 27.38 35.99 25.78 coo -9.31 12.91 61.58 -8.56 11.90 59.50 29.88 32.10 25.40 29.53 34.39 24.57 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 C 142 LYS B 61 LYS^? 22.03 MG MG A 301 C 217 SER A 36 SER^? 23.25 MG MG A 301 C 241 SER A 16 SER.? 24.16 MG MG A 301 coo -12.07 2.83 63.52 -8.95 7.56 61.01 32.50 37.62 17.61 36.68 34.92 21.51 coo -11.64 10.12 58.62 -9.34 9.31 58.79 29.88 32.10 25.40 29.53 34.39 24.57 coo -9.31 12.91 61.58 -8.56 11.90 59.50 29.26 36.32 27.22 27.38 35.99 25.78 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 C 142 LYS B 76 LYS^? 25.77 MG MG B 302 C 217 SER B 79 SER^? 20.24 MG MG C 301 C 241 SER B 83 SER^? 24.53 MG MG C 301 coo -12.07 2.83 63.52 -8.95 7.56 61.01 67.82 8.19 10.14 64.96 3.09 10.62 coo -11.64 10.12 58.62 -9.34 9.31 58.79 76.03 3.33 7.67 77.04 5.28 8.60 coo -9.31 12.91 61.58 -8.56 11.90 59.50 75.19 1.98 12.89 77.54 2.36 12.62 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 9 3 # 9 C 142 LYS B 76 LYS^? 25.77 MG MG B 302 C 217 SER B 83 SER^? 24.53 MG MG C 301 C 241 SER B 79 SER^? 20.24 MG MG C 301 coo -12.07 2.83 63.52 -8.95 7.56 61.01 67.82 8.19 10.14 64.96 3.09 10.62 coo -11.64 10.12 58.62 -9.34 9.31 58.79 75.19 1.98 12.89 77.54 2.36 12.62 coo -9.31 12.91 61.58 -8.56 11.90 59.50 76.03 3.33 7.67 77.04 5.28 8.60 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 10 3 # 10 C 142 LYS B 86 LYS^? 26.44 MG MG B 302 C 217 SER B 83 SER^? 24.53 MG MG C 301 C 241 SER B 79 SER^? 20.24 MG MG C 301 coo -12.07 2.83 63.52 -8.95 7.56 61.01 69.25 10.45 13.86 65.27 7.74 16.08 coo -11.64 10.12 58.62 -9.34 9.31 58.79 75.19 1.98 12.89 77.54 2.36 12.62 coo -9.31 12.91 61.58 -8.56 11.90 59.50 76.03 3.33 7.67 77.04 5.28 8.60 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 11 3 # 11 C 142 LYS C 61 LYS^? 21.91 MG MG D 302 C 217 SER D 16 SER^? 23.71 MG MG D 302 C 241 SER D 36 SER^? 22.42 MG MG D 302 coo -12.07 2.83 63.52 -8.95 7.56 61.01 93.60 48.56 -24.05 90.39 44.71 -27.98 coo -11.64 10.12 58.62 -9.34 9.31 58.79 96.73 48.43 -33.75 98.58 48.68 -32.31 coo -9.31 12.91 61.58 -8.56 11.90 59.50 97.85 44.42 -32.20 96.60 46.20 -31.15 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 12 3 # 12 C 142 LYS C 61 LYS^? 21.91 MG MG D 302 C 217 SER D 36 SER^? 22.42 MG MG D 302 C 241 SER D 16 SER^? 23.71 MG MG D 302 coo -12.07 2.83 63.52 -8.95 7.56 61.01 93.60 48.56 -24.05 90.39 44.71 -27.98 coo -11.64 10.12 58.62 -9.34 9.31 58.79 97.85 44.42 -32.20 96.60 46.20 -31.15 coo -9.31 12.91 61.58 -8.56 11.90 59.50 96.73 48.43 -33.75 98.58 48.68 -32.31 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 13 3 # 13 C 142 LYS C 76 LYS^? 24.95 MG MG C 302 C 217 SER C 79 SER^? 19.92 MG MG B 301 C 241 SER C 83 SER^? 23.40 MG MG B 301 coo -12.07 2.83 63.52 -8.95 7.56 61.01 71.11 8.63 -16.76 75.44 5.17 -16.80 coo -11.64 10.12 58.62 -9.34 9.31 58.79 64.38 1.95 -14.66 62.69 3.45 -15.45 coo -9.31 12.91 61.58 -8.56 11.90 59.50 65.19 0.76 -19.73 62.87 1.43 -19.33 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 14 3 # 14 C 142 LYS C 76 LYS^? 24.95 MG MG C 302 C 217 SER C 83 SER^? 23.40 MG MG B 301 C 241 SER C 79 SER^? 19.92 MG MG B 301 coo -12.07 2.83 63.52 -8.95 7.56 61.01 71.11 8.63 -16.76 75.44 5.17 -16.80 coo -11.64 10.12 58.62 -9.34 9.31 58.79 65.19 0.76 -19.73 62.87 1.43 -19.33 coo -9.31 12.91 61.58 -8.56 11.90 59.50 64.38 1.95 -14.66 62.69 3.45 -15.45 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 15 3 # 15 C 142 LYS C 86 LYS^? 27.34 MG MG C 302 C 217 SER C 83 SER^? 23.40 MG MG B 301 C 241 SER C 79 SER^? 19.92 MG MG B 301 coo -12.07 2.83 63.52 -8.95 7.56 61.01 69.22 9.88 -20.56 74.70 7.02 -22.55 coo -11.64 10.12 58.62 -9.34 9.31 58.79 65.19 0.76 -19.73 62.87 1.43 -19.33 coo -9.31 12.91 61.58 -8.56 11.90 59.50 64.38 1.95 -14.66 62.69 3.45 -15.45 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 16 3 # 16 C 142 LYS D 61 LYS^? 21.93 MG MG C 302 C 217 SER C 16 SER^? 24.15 MG MG C 302 C 241 SER C 36 SER^? 23.69 MG MG C 302 coo -12.07 2.83 63.52 -8.95 7.56 61.01 80.64 11.23 -26.16 80.65 16.24 -22.36 coo -11.64 10.12 58.62 -9.34 9.31 58.79 82.88 9.31 -16.30 84.27 7.80 -17.58 coo -9.31 12.91 61.58 -8.56 11.90 59.50 86.07 12.19 -17.80 85.34 10.22 -18.98 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 17 3 # 17 C 142 LYS D 61 LYS^? 21.93 MG MG C 302 C 217 SER C 36 SER^? 23.69 MG MG C 302 C 241 SER C 16 SER^? 24.15 MG MG C 302 coo -12.07 2.83 63.52 -8.95 7.56 61.01 80.64 11.23 -26.16 80.65 16.24 -22.36 coo -11.64 10.12 58.62 -9.34 9.31 58.79 86.07 12.19 -17.80 85.34 10.22 -18.98 coo -9.31 12.91 61.58 -8.56 11.90 59.50 82.88 9.31 -16.30 84.27 7.80 -17.58 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 18 3 # 18 C 142 LYS D 76 LYS^? 25.08 MG MG D 302 C 217 SER D 79 SER^? 19.41 MG MG E 301 C 241 SER D 83 SER^? 23.07 MG MG E 301 coo -12.07 2.83 63.52 -8.95 7.56 61.01 88.18 56.35 -34.05 93.80 56.17 -32.93 coo -11.64 10.12 58.62 -9.34 9.31 58.79 88.38 65.91 -36.56 86.13 65.62 -35.70 coo -9.31 12.91 61.58 -8.56 11.90 59.50 89.47 66.32 -31.33 87.79 67.80 -32.19 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 19 3 # 19 C 142 LYS D 76 LYS^? 25.08 MG MG D 302 C 217 SER D 83 SER^? 23.07 MG MG E 301 C 241 SER D 79 SER^? 19.41 MG MG E 301 coo -12.07 2.83 63.52 -8.95 7.56 61.01 88.18 56.35 -34.05 93.80 56.17 -32.93 coo -11.64 10.12 58.62 -9.34 9.31 58.79 89.47 66.32 -31.33 87.79 67.80 -32.19 coo -9.31 12.91 61.58 -8.56 11.90 59.50 88.38 65.91 -36.56 86.13 65.62 -35.70 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 20 3 # 20 C 142 LYS D 86 LYS^? 25.80 MG MG D 302 C 217 SER D 83 SER^? 23.07 MG MG E 301 C 241 SER D 79 SER^? 19.41 MG MG E 301 coo -12.07 2.83 63.52 -8.95 7.56 61.01 85.54 56.79 -30.27 90.24 54.54 -28.62 coo -11.64 10.12 58.62 -9.34 9.31 58.79 89.47 66.32 -31.33 87.79 67.80 -32.19 coo -9.31 12.91 61.58 -8.56 11.90 59.50 88.38 65.91 -36.56 86.13 65.62 -35.70 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 21 3 # 21 C 142 LYS E 61 LYS^? 22.16 MG MG F 301 C 217 SER F 16 SER^? 24.10 MG MG F 301 C 241 SER F 36 SER^? 23.07 MG MG F 301 coo -12.07 2.83 63.52 -8.95 7.56 61.01 40.99 56.84 -68.48 45.99 56.72 -72.39 coo -11.64 10.12 58.62 -9.34 9.31 58.79 39.77 59.81 -78.14 38.80 61.26 -76.65 coo -9.31 12.91 61.58 -8.56 11.90 59.50 42.79 62.77 -76.96 42.19 61.23 -75.17 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 22 3 # 22 C 142 LYS E 61 LYS^? 22.16 MG MG F 301 C 217 SER F 36 SER^? 23.07 MG MG F 301 C 241 SER F 16 SER^? 24.10 MG MG F 301 coo -12.07 2.83 63.52 -8.95 7.56 61.01 40.99 56.84 -68.48 45.99 56.72 -72.39 coo -11.64 10.12 58.62 -9.34 9.31 58.79 42.79 62.77 -76.96 42.19 61.23 -75.17 coo -9.31 12.91 61.58 -8.56 11.90 59.50 39.77 59.81 -78.14 38.80 61.26 -76.65 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 23 3 # 23 C 142 LYS E 76 LYS^? 25.68 MG MG E 302 C 217 SER E 79 SER^? 19.77 MG MG D 301 C 241 SER E 83 SER^? 23.44 MG MG D 301 coo -12.07 2.83 63.52 -8.95 7.56 61.01 87.09 58.11 -60.91 88.65 63.65 -61.27 coo -11.64 10.12 58.62 -9.34 9.31 58.79 96.22 56.25 -58.39 95.94 54.06 -59.20 coo -9.31 12.91 61.58 -8.56 11.90 59.50 96.88 57.42 -63.66 97.96 55.45 -62.84 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 24 3 # 24 C 142 LYS E 76 LYS^? 25.68 MG MG E 302 C 217 SER E 83 SER^? 23.44 MG MG D 301 C 241 SER E 79 SER^? 19.77 MG MG D 301 coo -12.07 2.83 63.52 -8.95 7.56 61.01 87.09 58.11 -60.91 88.65 63.65 -61.27 coo -11.64 10.12 58.62 -9.34 9.31 58.79 96.88 57.42 -63.66 97.96 55.45 -62.84 coo -9.31 12.91 61.58 -8.56 11.90 59.50 96.22 56.25 -58.39 95.94 54.06 -59.20 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 25 3 # 25 C 142 LYS E 86 LYS^? 26.73 MG MG D 301 C 217 SER E 83 SER^? 23.44 MG MG D 301 C 241 SER E 79 SER^? 19.77 MG MG D 301 coo -12.07 2.83 63.52 -8.95 7.56 61.01 86.84 54.85 -64.43 87.07 60.83 -66.10 coo -11.64 10.12 58.62 -9.34 9.31 58.79 96.88 57.42 -63.66 97.96 55.45 -62.84 coo -9.31 12.91 61.58 -8.56 11.90 59.50 96.22 56.25 -58.39 95.94 54.06 -59.20 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 26 3 # 26 C 142 LYS F 61 LYS^? 21.75 MG MG E 302 C 217 SER E 16 SER^? 24.21 MG MG E 302 C 241 SER E 36 SER^? 22.92 MG MG E 302 coo -12.07 2.83 63.52 -8.95 7.56 61.01 80.24 64.12 -71.01 76.23 61.95 -66.39 coo -11.64 10.12 58.62 -9.34 9.31 58.79 80.65 67.65 -61.22 81.30 69.49 -62.59 coo -9.31 12.91 61.58 -8.56 11.90 59.50 76.63 69.18 -62.93 78.20 67.77 -64.11 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 27 3 # 27 C 142 LYS F 61 LYS^? 21.75 MG MG E 302 C 217 SER E 36 SER^? 22.92 MG MG E 302 C 241 SER E 16 SER^? 24.21 MG MG E 302 coo -12.07 2.83 63.52 -8.95 7.56 61.01 80.24 64.12 -71.01 76.23 61.95 -66.39 coo -11.64 10.12 58.62 -9.34 9.31 58.79 76.63 69.18 -62.93 78.20 67.77 -64.11 coo -9.31 12.91 61.58 -8.56 11.90 59.50 80.65 67.65 -61.22 81.30 69.49 -62.59 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 28 3 # 28 C 142 LYS F 76 LYS^? 25.89 MG MG F 301 C 217 SER F 79 SER^? 30.22 MG MG F 301 C 241 SER F 83 SER^? 33.16 MG MG F 301 coo -12.07 2.83 63.52 -8.95 7.56 61.01 36.96 48.52 -78.06 33.74 53.37 -77.06 coo -11.64 10.12 58.62 -9.34 9.31 58.79 28.21 44.39 -80.24 29.11 42.36 -79.32 coo -9.31 12.91 61.58 -8.56 11.90 59.50 27.54 45.11 -75.18 28.33 43.06 -74.18 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 29 3 # 29 C 142 LYS F 76 LYS^? 25.89 MG MG F 301 C 217 SER F 83 SER^? 33.16 MG MG F 301 C 241 SER F 79 SER^? 30.22 MG MG F 301 coo -12.07 2.83 63.52 -8.95 7.56 61.01 36.96 48.52 -78.06 33.74 53.37 -77.06 coo -11.64 10.12 58.62 -9.34 9.31 58.79 27.54 45.11 -75.18 28.33 43.06 -74.18 coo -9.31 12.91 61.58 -8.56 11.90 59.50 28.21 44.39 -80.24 29.11 42.36 -79.32 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 30 3 # 30 C 142 LYS F 86 LYS^? 26.63 MG MG F 301 C 217 SER F 83 SER^? 33.16 MG MG F 301 C 241 SER F 79 SER^? 30.22 MG MG F 301 coo -12.07 2.83 63.52 -8.95 7.56 61.01 37.89 45.97 -74.42 36.47 51.71 -72.79 coo -11.64 10.12 58.62 -9.34 9.31 58.79 27.54 45.11 -75.18 28.33 43.06 -74.18 coo -9.31 12.91 61.58 -8.56 11.90 59.50 28.21 44.39 -80.24 29.11 42.36 -79.32 1mt5_c02 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 30 hits 1mt5_c02 naa= 3 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 D 142 LYS A 61 LYS^? 21.99 MG MG B 302 D 217 SER B 16 SER^? 23.97 MG MG B 302 D 241 SER B 36 SER^? 24.04 MG MG B 302 coo 32.93 17.78 71.88 30.89 13.50 67.83 57.78 7.35 19.60 56.77 12.20 15.61 coo 34.38 11.17 66.10 32.18 12.14 65.65 56.70 5.18 9.63 55.76 3.58 11.01 coo 31.34 7.96 67.74 31.44 9.08 65.62 52.58 6.45 11.01 53.61 4.84 12.41 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 D 142 LYS A 61 LYS^? 21.99 MG MG B 302 D 217 SER B 36 SER^? 24.04 MG MG B 302 D 241 SER B 16 SER^? 23.97 MG MG B 302 coo 32.93 17.78 71.88 30.89 13.50 67.83 57.78 7.35 19.60 56.77 12.20 15.61 coo 34.38 11.17 66.10 32.18 12.14 65.65 52.58 6.45 11.01 53.61 4.84 12.41 coo 31.34 7.96 67.74 31.44 9.08 65.62 56.70 5.18 9.63 55.76 3.58 11.01 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 D 142 LYS A 76 LYS^? 25.42 MG MG A 301 D 217 SER A 79 SER^? 29.65 MG MG A 301 D 241 SER A 83 SER^? 32.41 MG MG A 301 coo 32.93 17.78 71.88 30.89 13.50 67.83 34.45 46.53 27.28 28.88 44.93 27.25 coo 34.38 11.17 66.10 32.18 12.14 65.65 32.57 55.71 29.63 34.63 56.10 28.47 coo 31.34 7.96 67.74 31.44 9.08 65.62 30.60 55.84 24.53 32.97 55.99 23.96 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 D 142 LYS A 76 LYS^? 25.42 MG MG A 301 D 217 SER A 83 SER^? 32.41 MG MG A 301 D 241 SER A 79 SER^? 29.65 MG MG A 301 coo 32.93 17.78 71.88 30.89 13.50 67.83 34.45 46.53 27.28 28.88 44.93 27.25 coo 34.38 11.17 66.10 32.18 12.14 65.65 30.60 55.84 24.53 32.97 55.99 23.96 coo 31.34 7.96 67.74 31.44 9.08 65.62 32.57 55.71 29.63 34.63 56.10 28.47 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 D 142 LYS A 86 LYS^? 26.38 MG MG A 301 D 217 SER A 83 SER^? 32.41 MG MG A 301 D 241 SER A 79 SER^? 29.65 MG MG A 301 coo 32.93 17.78 71.88 30.89 13.50 67.83 37.08 47.78 23.56 32.88 44.24 21.89 coo 34.38 11.17 66.10 32.18 12.14 65.65 30.60 55.84 24.53 32.97 55.99 23.96 coo 31.34 7.96 67.74 31.44 9.08 65.62 32.57 55.71 29.63 34.63 56.10 28.47 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 D 142 LYS B 61 LYS^? 22.03 MG MG A 301 D 217 SER A 16 SER.? 24.16 MG MG A 301 D 241 SER A 36 SER^? 23.25 MG MG A 301 coo 32.93 17.78 71.88 30.89 13.50 67.83 32.50 37.62 17.61 36.68 34.92 21.51 coo 34.38 11.17 66.10 32.18 12.14 65.65 29.26 36.32 27.22 27.38 35.99 25.78 coo 31.34 7.96 67.74 31.44 9.08 65.62 29.88 32.10 25.40 29.53 34.39 24.57 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 D 142 LYS B 61 LYS^? 22.03 MG MG A 301 D 217 SER A 36 SER^? 23.25 MG MG A 301 D 241 SER A 16 SER.? 24.16 MG MG A 301 coo 32.93 17.78 71.88 30.89 13.50 67.83 32.50 37.62 17.61 36.68 34.92 21.51 coo 34.38 11.17 66.10 32.18 12.14 65.65 29.88 32.10 25.40 29.53 34.39 24.57 coo 31.34 7.96 67.74 31.44 9.08 65.62 29.26 36.32 27.22 27.38 35.99 25.78 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 D 142 LYS B 76 LYS^? 25.77 MG MG B 302 D 217 SER B 79 SER^? 20.24 MG MG C 301 D 241 SER B 83 SER^? 24.53 MG MG C 301 coo 32.93 17.78 71.88 30.89 13.50 67.83 67.82 8.19 10.14 64.96 3.09 10.62 coo 34.38 11.17 66.10 32.18 12.14 65.65 76.03 3.33 7.67 77.04 5.28 8.60 coo 31.34 7.96 67.74 31.44 9.08 65.62 75.19 1.98 12.89 77.54 2.36 12.62 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 9 3 # 9 D 142 LYS B 76 LYS^? 25.77 MG MG B 302 D 217 SER B 83 SER^? 24.53 MG MG C 301 D 241 SER B 79 SER^? 20.24 MG MG C 301 coo 32.93 17.78 71.88 30.89 13.50 67.83 67.82 8.19 10.14 64.96 3.09 10.62 coo 34.38 11.17 66.10 32.18 12.14 65.65 75.19 1.98 12.89 77.54 2.36 12.62 coo 31.34 7.96 67.74 31.44 9.08 65.62 76.03 3.33 7.67 77.04 5.28 8.60 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 10 3 # 10 D 142 LYS B 86 LYS^? 26.44 MG MG B 302 D 217 SER B 83 SER^? 24.53 MG MG C 301 D 241 SER B 79 SER^? 20.24 MG MG C 301 coo 32.93 17.78 71.88 30.89 13.50 67.83 69.25 10.45 13.86 65.27 7.74 16.08 coo 34.38 11.17 66.10 32.18 12.14 65.65 75.19 1.98 12.89 77.54 2.36 12.62 coo 31.34 7.96 67.74 31.44 9.08 65.62 76.03 3.33 7.67 77.04 5.28 8.60 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 11 3 # 11 D 142 LYS C 61 LYS^? 21.91 MG MG D 302 D 217 SER D 16 SER^? 23.71 MG MG D 302 D 241 SER D 36 SER^? 22.42 MG MG D 302 coo 32.93 17.78 71.88 30.89 13.50 67.83 93.60 48.56 -24.05 90.39 44.71 -27.98 coo 34.38 11.17 66.10 32.18 12.14 65.65 96.73 48.43 -33.75 98.58 48.68 -32.31 coo 31.34 7.96 67.74 31.44 9.08 65.62 97.85 44.42 -32.20 96.60 46.20 -31.15 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 12 3 # 12 D 142 LYS C 61 LYS^? 21.91 MG MG D 302 D 217 SER D 36 SER^? 22.42 MG MG D 302 D 241 SER D 16 SER^? 23.71 MG MG D 302 coo 32.93 17.78 71.88 30.89 13.50 67.83 93.60 48.56 -24.05 90.39 44.71 -27.98 coo 34.38 11.17 66.10 32.18 12.14 65.65 97.85 44.42 -32.20 96.60 46.20 -31.15 coo 31.34 7.96 67.74 31.44 9.08 65.62 96.73 48.43 -33.75 98.58 48.68 -32.31 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 13 3 # 13 D 142 LYS C 76 LYS^? 24.95 MG MG C 302 D 217 SER C 79 SER^? 19.92 MG MG B 301 D 241 SER C 83 SER^? 23.40 MG MG B 301 coo 32.93 17.78 71.88 30.89 13.50 67.83 71.11 8.63 -16.76 75.44 5.17 -16.80 coo 34.38 11.17 66.10 32.18 12.14 65.65 64.38 1.95 -14.66 62.69 3.45 -15.45 coo 31.34 7.96 67.74 31.44 9.08 65.62 65.19 0.76 -19.73 62.87 1.43 -19.33 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 14 3 # 14 D 142 LYS C 76 LYS^? 24.95 MG MG C 302 D 217 SER C 83 SER^? 23.40 MG MG B 301 D 241 SER C 79 SER^? 19.92 MG MG B 301 coo 32.93 17.78 71.88 30.89 13.50 67.83 71.11 8.63 -16.76 75.44 5.17 -16.80 coo 34.38 11.17 66.10 32.18 12.14 65.65 65.19 0.76 -19.73 62.87 1.43 -19.33 coo 31.34 7.96 67.74 31.44 9.08 65.62 64.38 1.95 -14.66 62.69 3.45 -15.45 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 15 3 # 15 D 142 LYS C 86 LYS^? 27.34 MG MG C 302 D 217 SER C 83 SER^? 23.40 MG MG B 301 D 241 SER C 79 SER^? 19.92 MG MG B 301 coo 32.93 17.78 71.88 30.89 13.50 67.83 69.22 9.88 -20.56 74.70 7.02 -22.55 coo 34.38 11.17 66.10 32.18 12.14 65.65 65.19 0.76 -19.73 62.87 1.43 -19.33 coo 31.34 7.96 67.74 31.44 9.08 65.62 64.38 1.95 -14.66 62.69 3.45 -15.45 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 16 3 # 16 D 142 LYS D 61 LYS^? 21.93 MG MG C 302 D 217 SER C 16 SER^? 24.15 MG MG C 302 D 241 SER C 36 SER^? 23.69 MG MG C 302 coo 32.93 17.78 71.88 30.89 13.50 67.83 80.64 11.23 -26.16 80.65 16.24 -22.36 coo 34.38 11.17 66.10 32.18 12.14 65.65 82.88 9.31 -16.30 84.27 7.80 -17.58 coo 31.34 7.96 67.74 31.44 9.08 65.62 86.07 12.19 -17.80 85.34 10.22 -18.98 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 17 3 # 17 D 142 LYS D 61 LYS^? 21.93 MG MG C 302 D 217 SER C 36 SER^? 23.69 MG MG C 302 D 241 SER C 16 SER^? 24.15 MG MG C 302 coo 32.93 17.78 71.88 30.89 13.50 67.83 80.64 11.23 -26.16 80.65 16.24 -22.36 coo 34.38 11.17 66.10 32.18 12.14 65.65 86.07 12.19 -17.80 85.34 10.22 -18.98 coo 31.34 7.96 67.74 31.44 9.08 65.62 82.88 9.31 -16.30 84.27 7.80 -17.58 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 18 3 # 18 D 142 LYS D 76 LYS^? 25.08 MG MG D 302 D 217 SER D 79 SER^? 19.41 MG MG E 301 D 241 SER D 83 SER^? 23.07 MG MG E 301 coo 32.93 17.78 71.88 30.89 13.50 67.83 88.18 56.35 -34.05 93.80 56.17 -32.93 coo 34.38 11.17 66.10 32.18 12.14 65.65 88.38 65.91 -36.56 86.13 65.62 -35.70 coo 31.34 7.96 67.74 31.44 9.08 65.62 89.47 66.32 -31.33 87.79 67.80 -32.19 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 19 3 # 19 D 142 LYS D 76 LYS^? 25.08 MG MG D 302 D 217 SER D 83 SER^? 23.07 MG MG E 301 D 241 SER D 79 SER^? 19.41 MG MG E 301 coo 32.93 17.78 71.88 30.89 13.50 67.83 88.18 56.35 -34.05 93.80 56.17 -32.93 coo 34.38 11.17 66.10 32.18 12.14 65.65 89.47 66.32 -31.33 87.79 67.80 -32.19 coo 31.34 7.96 67.74 31.44 9.08 65.62 88.38 65.91 -36.56 86.13 65.62 -35.70 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 20 3 # 20 D 142 LYS D 86 LYS^? 25.80 MG MG D 302 D 217 SER D 83 SER^? 23.07 MG MG E 301 D 241 SER D 79 SER^? 19.41 MG MG E 301 coo 32.93 17.78 71.88 30.89 13.50 67.83 85.54 56.79 -30.27 90.24 54.54 -28.62 coo 34.38 11.17 66.10 32.18 12.14 65.65 89.47 66.32 -31.33 87.79 67.80 -32.19 coo 31.34 7.96 67.74 31.44 9.08 65.62 88.38 65.91 -36.56 86.13 65.62 -35.70 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 21 3 # 21 D 142 LYS E 61 LYS^? 22.16 MG MG F 301 D 217 SER F 16 SER^? 24.10 MG MG F 301 D 241 SER F 36 SER^? 23.07 MG MG F 301 coo 32.93 17.78 71.88 30.89 13.50 67.83 40.99 56.84 -68.48 45.99 56.72 -72.39 coo 34.38 11.17 66.10 32.18 12.14 65.65 39.77 59.81 -78.14 38.80 61.26 -76.65 coo 31.34 7.96 67.74 31.44 9.08 65.62 42.79 62.77 -76.96 42.19 61.23 -75.17 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 22 3 # 22 D 142 LYS E 61 LYS^? 22.16 MG MG F 301 D 217 SER F 36 SER^? 23.07 MG MG F 301 D 241 SER F 16 SER^? 24.10 MG MG F 301 coo 32.93 17.78 71.88 30.89 13.50 67.83 40.99 56.84 -68.48 45.99 56.72 -72.39 coo 34.38 11.17 66.10 32.18 12.14 65.65 42.79 62.77 -76.96 42.19 61.23 -75.17 coo 31.34 7.96 67.74 31.44 9.08 65.62 39.77 59.81 -78.14 38.80 61.26 -76.65 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 23 3 # 23 D 142 LYS E 76 LYS^? 25.68 MG MG E 302 D 217 SER E 79 SER^? 19.77 MG MG D 301 D 241 SER E 83 SER^? 23.44 MG MG D 301 coo 32.93 17.78 71.88 30.89 13.50 67.83 87.09 58.11 -60.91 88.65 63.65 -61.27 coo 34.38 11.17 66.10 32.18 12.14 65.65 96.22 56.25 -58.39 95.94 54.06 -59.20 coo 31.34 7.96 67.74 31.44 9.08 65.62 96.88 57.42 -63.66 97.96 55.45 -62.84 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 24 3 # 24 D 142 LYS E 76 LYS^? 25.68 MG MG E 302 D 217 SER E 83 SER^? 23.44 MG MG D 301 D 241 SER E 79 SER^? 19.77 MG MG D 301 coo 32.93 17.78 71.88 30.89 13.50 67.83 87.09 58.11 -60.91 88.65 63.65 -61.27 coo 34.38 11.17 66.10 32.18 12.14 65.65 96.88 57.42 -63.66 97.96 55.45 -62.84 coo 31.34 7.96 67.74 31.44 9.08 65.62 96.22 56.25 -58.39 95.94 54.06 -59.20 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 25 3 # 25 D 142 LYS E 86 LYS^? 26.73 MG MG D 301 D 217 SER E 83 SER^? 23.44 MG MG D 301 D 241 SER E 79 SER^? 19.77 MG MG D 301 coo 32.93 17.78 71.88 30.89 13.50 67.83 86.84 54.85 -64.43 87.07 60.83 -66.10 coo 34.38 11.17 66.10 32.18 12.14 65.65 96.88 57.42 -63.66 97.96 55.45 -62.84 coo 31.34 7.96 67.74 31.44 9.08 65.62 96.22 56.25 -58.39 95.94 54.06 -59.20 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 26 3 # 26 D 142 LYS F 61 LYS^? 21.75 MG MG E 302 D 217 SER E 16 SER^? 24.21 MG MG E 302 D 241 SER E 36 SER^? 22.92 MG MG E 302 coo 32.93 17.78 71.88 30.89 13.50 67.83 80.24 64.12 -71.01 76.23 61.95 -66.39 coo 34.38 11.17 66.10 32.18 12.14 65.65 80.65 67.65 -61.22 81.30 69.49 -62.59 coo 31.34 7.96 67.74 31.44 9.08 65.62 76.63 69.18 -62.93 78.20 67.77 -64.11 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 27 3 # 27 D 142 LYS F 61 LYS^? 21.75 MG MG E 302 D 217 SER E 36 SER^? 22.92 MG MG E 302 D 241 SER E 16 SER^? 24.21 MG MG E 302 coo 32.93 17.78 71.88 30.89 13.50 67.83 80.24 64.12 -71.01 76.23 61.95 -66.39 coo 34.38 11.17 66.10 32.18 12.14 65.65 76.63 69.18 -62.93 78.20 67.77 -64.11 coo 31.34 7.96 67.74 31.44 9.08 65.62 80.65 67.65 -61.22 81.30 69.49 -62.59 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 28 3 # 28 D 142 LYS F 76 LYS^? 25.89 MG MG F 301 D 217 SER F 79 SER^? 30.22 MG MG F 301 D 241 SER F 83 SER^? 33.16 MG MG F 301 coo 32.93 17.78 71.88 30.89 13.50 67.83 36.96 48.52 -78.06 33.74 53.37 -77.06 coo 34.38 11.17 66.10 32.18 12.14 65.65 28.21 44.39 -80.24 29.11 42.36 -79.32 coo 31.34 7.96 67.74 31.44 9.08 65.62 27.54 45.11 -75.18 28.33 43.06 -74.18 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 29 3 # 29 D 142 LYS F 76 LYS^? 25.89 MG MG F 301 D 217 SER F 83 SER^? 33.16 MG MG F 301 D 241 SER F 79 SER^? 30.22 MG MG F 301 coo 32.93 17.78 71.88 30.89 13.50 67.83 36.96 48.52 -78.06 33.74 53.37 -77.06 coo 34.38 11.17 66.10 32.18 12.14 65.65 27.54 45.11 -75.18 28.33 43.06 -74.18 coo 31.34 7.96 67.74 31.44 9.08 65.62 28.21 44.39 -80.24 29.11 42.36 -79.32 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 30 3 # 30 D 142 LYS F 86 LYS^? 26.63 MG MG F 301 D 217 SER F 83 SER^? 33.16 MG MG F 301 D 241 SER F 79 SER^? 30.22 MG MG F 301 coo 32.93 17.78 71.88 30.89 13.50 67.83 37.89 45.97 -74.42 36.47 51.71 -72.79 coo 34.38 11.17 66.10 32.18 12.14 65.65 27.54 45.11 -75.18 28.33 43.06 -74.18 coo 31.34 7.96 67.74 31.44 9.08 65.62 28.21 44.39 -80.24 29.11 42.36 -79.32 1mt5_c03 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 30 hits 1mt5_c03 naa= 3 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 E 142 LYS A 61 LYS^? 21.99 MG MG B 302 E 217 SER B 16 SER^? 23.97 MG MG B 302 E 241 SER B 36 SER^? 24.04 MG MG B 302 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 57.78 7.35 19.60 56.77 12.20 15.61 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 56.70 5.18 9.63 55.76 3.58 11.01 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 52.58 6.45 11.01 53.61 4.84 12.41 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 E 142 LYS A 61 LYS^? 21.99 MG MG B 302 E 217 SER B 36 SER^? 24.04 MG MG B 302 E 241 SER B 16 SER^? 23.97 MG MG B 302 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 57.78 7.35 19.60 56.77 12.20 15.61 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 52.58 6.45 11.01 53.61 4.84 12.41 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 56.70 5.18 9.63 55.76 3.58 11.01 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 E 142 LYS A 76 LYS^? 25.42 MG MG A 301 E 217 SER A 79 SER^? 29.65 MG MG A 301 E 241 SER A 83 SER^? 32.41 MG MG A 301 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 34.45 46.53 27.28 28.88 44.93 27.25 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 32.57 55.71 29.63 34.63 56.10 28.47 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 30.60 55.84 24.53 32.97 55.99 23.96 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 E 142 LYS A 76 LYS^? 25.42 MG MG A 301 E 217 SER A 83 SER^? 32.41 MG MG A 301 E 241 SER A 79 SER^? 29.65 MG MG A 301 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 34.45 46.53 27.28 28.88 44.93 27.25 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 30.60 55.84 24.53 32.97 55.99 23.96 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 32.57 55.71 29.63 34.63 56.10 28.47 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 E 142 LYS A 86 LYS^? 26.38 MG MG A 301 E 217 SER A 83 SER^? 32.41 MG MG A 301 E 241 SER A 79 SER^? 29.65 MG MG A 301 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 37.08 47.78 23.56 32.88 44.24 21.89 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 30.60 55.84 24.53 32.97 55.99 23.96 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 32.57 55.71 29.63 34.63 56.10 28.47 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 E 142 LYS B 61 LYS^? 22.03 MG MG A 301 E 217 SER A 16 SER.? 24.16 MG MG A 301 E 241 SER A 36 SER^? 23.25 MG MG A 301 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 32.50 37.62 17.61 36.68 34.92 21.51 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 29.26 36.32 27.22 27.38 35.99 25.78 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 29.88 32.10 25.40 29.53 34.39 24.57 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 E 142 LYS B 61 LYS^? 22.03 MG MG A 301 E 217 SER A 36 SER^? 23.25 MG MG A 301 E 241 SER A 16 SER.? 24.16 MG MG A 301 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 32.50 37.62 17.61 36.68 34.92 21.51 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 29.88 32.10 25.40 29.53 34.39 24.57 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 29.26 36.32 27.22 27.38 35.99 25.78 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 E 142 LYS B 76 LYS^? 25.77 MG MG B 302 E 217 SER B 79 SER^? 20.24 MG MG C 301 E 241 SER B 83 SER^? 24.53 MG MG C 301 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 67.82 8.19 10.14 64.96 3.09 10.62 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 76.03 3.33 7.67 77.04 5.28 8.60 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 75.19 1.98 12.89 77.54 2.36 12.62 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 9 3 # 9 E 142 LYS B 76 LYS^? 25.77 MG MG B 302 E 217 SER B 83 SER^? 24.53 MG MG C 301 E 241 SER B 79 SER^? 20.24 MG MG C 301 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 67.82 8.19 10.14 64.96 3.09 10.62 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 75.19 1.98 12.89 77.54 2.36 12.62 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 76.03 3.33 7.67 77.04 5.28 8.60 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 10 3 # 10 E 142 LYS B 86 LYS^? 26.44 MG MG B 302 E 217 SER B 83 SER^? 24.53 MG MG C 301 E 241 SER B 79 SER^? 20.24 MG MG C 301 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 69.25 10.45 13.86 65.27 7.74 16.08 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 75.19 1.98 12.89 77.54 2.36 12.62 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 76.03 3.33 7.67 77.04 5.28 8.60 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 11 3 # 11 E 142 LYS C 61 LYS^? 21.91 MG MG D 302 E 217 SER D 16 SER^? 23.71 MG MG D 302 E 241 SER D 36 SER^? 22.42 MG MG D 302 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 93.60 48.56 -24.05 90.39 44.71 -27.98 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 96.73 48.43 -33.75 98.58 48.68 -32.31 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 97.85 44.42 -32.20 96.60 46.20 -31.15 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 12 3 # 12 E 142 LYS C 61 LYS^? 21.91 MG MG D 302 E 217 SER D 36 SER^? 22.42 MG MG D 302 E 241 SER D 16 SER^? 23.71 MG MG D 302 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 93.60 48.56 -24.05 90.39 44.71 -27.98 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 97.85 44.42 -32.20 96.60 46.20 -31.15 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 96.73 48.43 -33.75 98.58 48.68 -32.31 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 13 3 # 13 E 142 LYS C 76 LYS^? 24.95 MG MG C 302 E 217 SER C 79 SER^? 19.92 MG MG B 301 E 241 SER C 83 SER^? 23.40 MG MG B 301 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 71.11 8.63 -16.76 75.44 5.17 -16.80 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 64.38 1.95 -14.66 62.69 3.45 -15.45 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 65.19 0.76 -19.73 62.87 1.43 -19.33 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 14 3 # 14 E 142 LYS C 76 LYS^? 24.95 MG MG C 302 E 217 SER C 83 SER^? 23.40 MG MG B 301 E 241 SER C 79 SER^? 19.92 MG MG B 301 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 71.11 8.63 -16.76 75.44 5.17 -16.80 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 65.19 0.76 -19.73 62.87 1.43 -19.33 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 64.38 1.95 -14.66 62.69 3.45 -15.45 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 15 3 # 15 E 142 LYS C 86 LYS^? 27.34 MG MG C 302 E 217 SER C 83 SER^? 23.40 MG MG B 301 E 241 SER C 79 SER^? 19.92 MG MG B 301 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 69.22 9.88 -20.56 74.70 7.02 -22.55 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 65.19 0.76 -19.73 62.87 1.43 -19.33 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 64.38 1.95 -14.66 62.69 3.45 -15.45 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 16 3 # 16 E 142 LYS D 61 LYS^? 21.93 MG MG C 302 E 217 SER C 16 SER^? 24.15 MG MG C 302 E 241 SER C 36 SER^? 23.69 MG MG C 302 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 80.64 11.23 -26.16 80.65 16.24 -22.36 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 82.88 9.31 -16.30 84.27 7.80 -17.58 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 86.07 12.19 -17.80 85.34 10.22 -18.98 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 17 3 # 17 E 142 LYS D 61 LYS^? 21.93 MG MG C 302 E 217 SER C 36 SER^? 23.69 MG MG C 302 E 241 SER C 16 SER^? 24.15 MG MG C 302 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 80.64 11.23 -26.16 80.65 16.24 -22.36 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 86.07 12.19 -17.80 85.34 10.22 -18.98 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 82.88 9.31 -16.30 84.27 7.80 -17.58 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 18 3 # 18 E 142 LYS D 76 LYS^? 25.08 MG MG D 302 E 217 SER D 79 SER^? 19.41 MG MG E 301 E 241 SER D 83 SER^? 23.07 MG MG E 301 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 88.18 56.35 -34.05 93.80 56.17 -32.93 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 88.38 65.91 -36.56 86.13 65.62 -35.70 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 89.47 66.32 -31.33 87.79 67.80 -32.19 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 19 3 # 19 E 142 LYS D 76 LYS^? 25.08 MG MG D 302 E 217 SER D 83 SER^? 23.07 MG MG E 301 E 241 SER D 79 SER^? 19.41 MG MG E 301 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 88.18 56.35 -34.05 93.80 56.17 -32.93 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 89.47 66.32 -31.33 87.79 67.80 -32.19 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 88.38 65.91 -36.56 86.13 65.62 -35.70 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 20 3 # 20 E 142 LYS D 86 LYS^? 25.80 MG MG D 302 E 217 SER D 83 SER^? 23.07 MG MG E 301 E 241 SER D 79 SER^? 19.41 MG MG E 301 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 85.54 56.79 -30.27 90.24 54.54 -28.62 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 89.47 66.32 -31.33 87.79 67.80 -32.19 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 88.38 65.91 -36.56 86.13 65.62 -35.70 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 21 3 # 21 E 142 LYS E 61 LYS^? 22.16 MG MG F 301 E 217 SER F 16 SER^? 24.10 MG MG F 301 E 241 SER F 36 SER^? 23.07 MG MG F 301 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 40.99 56.84 -68.48 45.99 56.72 -72.39 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 39.77 59.81 -78.14 38.80 61.26 -76.65 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 42.79 62.77 -76.96 42.19 61.23 -75.17 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 22 3 # 22 E 142 LYS E 61 LYS^? 22.16 MG MG F 301 E 217 SER F 36 SER^? 23.07 MG MG F 301 E 241 SER F 16 SER^? 24.10 MG MG F 301 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 40.99 56.84 -68.48 45.99 56.72 -72.39 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 42.79 62.77 -76.96 42.19 61.23 -75.17 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 39.77 59.81 -78.14 38.80 61.26 -76.65 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 23 3 # 23 E 142 LYS E 76 LYS^? 25.68 MG MG E 302 E 217 SER E 79 SER^? 19.77 MG MG D 301 E 241 SER E 83 SER^? 23.44 MG MG D 301 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 87.09 58.11 -60.91 88.65 63.65 -61.27 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 96.22 56.25 -58.39 95.94 54.06 -59.20 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 96.88 57.42 -63.66 97.96 55.45 -62.84 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 24 3 # 24 E 142 LYS E 76 LYS^? 25.68 MG MG E 302 E 217 SER E 83 SER^? 23.44 MG MG D 301 E 241 SER E 79 SER^? 19.77 MG MG D 301 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 87.09 58.11 -60.91 88.65 63.65 -61.27 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 96.88 57.42 -63.66 97.96 55.45 -62.84 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 96.22 56.25 -58.39 95.94 54.06 -59.20 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 25 3 # 25 E 142 LYS E 86 LYS^? 26.73 MG MG D 301 E 217 SER E 83 SER^? 23.44 MG MG D 301 E 241 SER E 79 SER^? 19.77 MG MG D 301 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 86.84 54.85 -64.43 87.07 60.83 -66.10 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 96.88 57.42 -63.66 97.96 55.45 -62.84 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 96.22 56.25 -58.39 95.94 54.06 -59.20 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 26 3 # 26 E 142 LYS F 61 LYS^? 21.75 MG MG E 302 E 217 SER E 16 SER^? 24.21 MG MG E 302 E 241 SER E 36 SER^? 22.92 MG MG E 302 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 80.24 64.12 -71.01 76.23 61.95 -66.39 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 80.65 67.65 -61.22 81.30 69.49 -62.59 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 76.63 69.18 -62.93 78.20 67.77 -64.11 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 27 3 # 27 E 142 LYS F 61 LYS^? 21.75 MG MG E 302 E 217 SER E 36 SER^? 22.92 MG MG E 302 E 241 SER E 16 SER^? 24.21 MG MG E 302 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 80.24 64.12 -71.01 76.23 61.95 -66.39 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 76.63 69.18 -62.93 78.20 67.77 -64.11 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 80.65 67.65 -61.22 81.30 69.49 -62.59 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 28 3 # 28 E 142 LYS F 76 LYS^? 25.89 MG MG F 301 E 217 SER F 79 SER^? 30.22 MG MG F 301 E 241 SER F 83 SER^? 33.16 MG MG F 301 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 36.96 48.52 -78.06 33.74 53.37 -77.06 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 28.21 44.39 -80.24 29.11 42.36 -79.32 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 27.54 45.11 -75.18 28.33 43.06 -74.18 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 29 3 # 29 E 142 LYS F 76 LYS^? 25.89 MG MG F 301 E 217 SER F 83 SER^? 33.16 MG MG F 301 E 241 SER F 79 SER^? 30.22 MG MG F 301 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 36.96 48.52 -78.06 33.74 53.37 -77.06 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 27.54 45.11 -75.18 28.33 43.06 -74.18 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 28.21 44.39 -80.24 29.11 42.36 -79.32 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 30 3 # 30 E 142 LYS F 86 LYS^? 26.63 MG MG F 301 E 217 SER F 83 SER^? 33.16 MG MG F 301 E 241 SER F 79 SER^? 30.22 MG MG F 301 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 37.89 45.97 -74.42 36.47 51.71 -72.79 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 27.54 45.11 -75.18 28.33 43.06 -74.18 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 28.21 44.39 -80.24 29.11 42.36 -79.32 1mt5_c04 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 30 hits 1mt5_c04 naa= 3 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 F 142 LYS A 61 LYS^? 21.99 MG MG B 302 F 217 SER B 16 SER^? 23.97 MG MG B 302 F 241 SER B 36 SER^? 24.04 MG MG B 302 coo 85.78 13.19 64.96 85.47 13.47 58.63 57.78 7.35 19.60 56.77 12.20 15.61 coo 87.43 17.13 57.15 85.84 15.39 56.76 56.70 5.18 9.63 55.76 3.58 11.01 coo 89.69 13.60 54.86 87.60 14.67 54.46 52.58 6.45 11.01 53.61 4.84 12.41 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 F 142 LYS A 61 LYS^? 21.99 MG MG B 302 F 217 SER B 36 SER^? 24.04 MG MG B 302 F 241 SER B 16 SER^? 23.97 MG MG B 302 coo 85.78 13.19 64.96 85.47 13.47 58.63 57.78 7.35 19.60 56.77 12.20 15.61 coo 87.43 17.13 57.15 85.84 15.39 56.76 52.58 6.45 11.01 53.61 4.84 12.41 coo 89.69 13.60 54.86 87.60 14.67 54.46 56.70 5.18 9.63 55.76 3.58 11.01 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 F 142 LYS A 76 LYS^? 25.42 MG MG A 301 F 217 SER A 79 SER^? 29.65 MG MG A 301 F 241 SER A 83 SER^? 32.41 MG MG A 301 coo 85.78 13.19 64.96 85.47 13.47 58.63 34.45 46.53 27.28 28.88 44.93 27.25 coo 87.43 17.13 57.15 85.84 15.39 56.76 32.57 55.71 29.63 34.63 56.10 28.47 coo 89.69 13.60 54.86 87.60 14.67 54.46 30.60 55.84 24.53 32.97 55.99 23.96 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 F 142 LYS A 76 LYS^? 25.42 MG MG A 301 F 217 SER A 83 SER^? 32.41 MG MG A 301 F 241 SER A 79 SER^? 29.65 MG MG A 301 coo 85.78 13.19 64.96 85.47 13.47 58.63 34.45 46.53 27.28 28.88 44.93 27.25 coo 87.43 17.13 57.15 85.84 15.39 56.76 30.60 55.84 24.53 32.97 55.99 23.96 coo 89.69 13.60 54.86 87.60 14.67 54.46 32.57 55.71 29.63 34.63 56.10 28.47 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 F 142 LYS A 86 LYS^? 26.38 MG MG A 301 F 217 SER A 83 SER^? 32.41 MG MG A 301 F 241 SER A 79 SER^? 29.65 MG MG A 301 coo 85.78 13.19 64.96 85.47 13.47 58.63 37.08 47.78 23.56 32.88 44.24 21.89 coo 87.43 17.13 57.15 85.84 15.39 56.76 30.60 55.84 24.53 32.97 55.99 23.96 coo 89.69 13.60 54.86 87.60 14.67 54.46 32.57 55.71 29.63 34.63 56.10 28.47 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 F 142 LYS B 61 LYS^? 22.03 MG MG A 301 F 217 SER A 16 SER.? 24.16 MG MG A 301 F 241 SER A 36 SER^? 23.25 MG MG A 301 coo 85.78 13.19 64.96 85.47 13.47 58.63 32.50 37.62 17.61 36.68 34.92 21.51 coo 87.43 17.13 57.15 85.84 15.39 56.76 29.26 36.32 27.22 27.38 35.99 25.78 coo 89.69 13.60 54.86 87.60 14.67 54.46 29.88 32.10 25.40 29.53 34.39 24.57 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 F 142 LYS B 61 LYS^? 22.03 MG MG A 301 F 217 SER A 36 SER^? 23.25 MG MG A 301 F 241 SER A 16 SER.? 24.16 MG MG A 301 coo 85.78 13.19 64.96 85.47 13.47 58.63 32.50 37.62 17.61 36.68 34.92 21.51 coo 87.43 17.13 57.15 85.84 15.39 56.76 29.88 32.10 25.40 29.53 34.39 24.57 coo 89.69 13.60 54.86 87.60 14.67 54.46 29.26 36.32 27.22 27.38 35.99 25.78 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 F 142 LYS B 76 LYS^? 25.77 MG MG B 302 F 217 SER B 79 SER^? 20.24 MG MG C 301 F 241 SER B 83 SER^? 24.53 MG MG C 301 coo 85.78 13.19 64.96 85.47 13.47 58.63 67.82 8.19 10.14 64.96 3.09 10.62 coo 87.43 17.13 57.15 85.84 15.39 56.76 76.03 3.33 7.67 77.04 5.28 8.60 coo 89.69 13.60 54.86 87.60 14.67 54.46 75.19 1.98 12.89 77.54 2.36 12.62 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 9 3 # 9 F 142 LYS B 76 LYS^? 25.77 MG MG B 302 F 217 SER B 83 SER^? 24.53 MG MG C 301 F 241 SER B 79 SER^? 20.24 MG MG C 301 coo 85.78 13.19 64.96 85.47 13.47 58.63 67.82 8.19 10.14 64.96 3.09 10.62 coo 87.43 17.13 57.15 85.84 15.39 56.76 75.19 1.98 12.89 77.54 2.36 12.62 coo 89.69 13.60 54.86 87.60 14.67 54.46 76.03 3.33 7.67 77.04 5.28 8.60 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 10 3 # 10 F 142 LYS B 86 LYS^? 26.44 MG MG B 302 F 217 SER B 83 SER^? 24.53 MG MG C 301 F 241 SER B 79 SER^? 20.24 MG MG C 301 coo 85.78 13.19 64.96 85.47 13.47 58.63 69.25 10.45 13.86 65.27 7.74 16.08 coo 87.43 17.13 57.15 85.84 15.39 56.76 75.19 1.98 12.89 77.54 2.36 12.62 coo 89.69 13.60 54.86 87.60 14.67 54.46 76.03 3.33 7.67 77.04 5.28 8.60 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 11 3 # 11 F 142 LYS C 61 LYS^? 21.91 MG MG D 302 F 217 SER D 16 SER^? 23.71 MG MG D 302 F 241 SER D 36 SER^? 22.42 MG MG D 302 coo 85.78 13.19 64.96 85.47 13.47 58.63 93.60 48.56 -24.05 90.39 44.71 -27.98 coo 87.43 17.13 57.15 85.84 15.39 56.76 96.73 48.43 -33.75 98.58 48.68 -32.31 coo 89.69 13.60 54.86 87.60 14.67 54.46 97.85 44.42 -32.20 96.60 46.20 -31.15 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 12 3 # 12 F 142 LYS C 61 LYS^? 21.91 MG MG D 302 F 217 SER D 36 SER^? 22.42 MG MG D 302 F 241 SER D 16 SER^? 23.71 MG MG D 302 coo 85.78 13.19 64.96 85.47 13.47 58.63 93.60 48.56 -24.05 90.39 44.71 -27.98 coo 87.43 17.13 57.15 85.84 15.39 56.76 97.85 44.42 -32.20 96.60 46.20 -31.15 coo 89.69 13.60 54.86 87.60 14.67 54.46 96.73 48.43 -33.75 98.58 48.68 -32.31 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 13 3 # 13 F 142 LYS C 76 LYS^? 24.95 MG MG C 302 F 217 SER C 79 SER^? 19.92 MG MG B 301 F 241 SER C 83 SER^? 23.40 MG MG B 301 coo 85.78 13.19 64.96 85.47 13.47 58.63 71.11 8.63 -16.76 75.44 5.17 -16.80 coo 87.43 17.13 57.15 85.84 15.39 56.76 64.38 1.95 -14.66 62.69 3.45 -15.45 coo 89.69 13.60 54.86 87.60 14.67 54.46 65.19 0.76 -19.73 62.87 1.43 -19.33 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 14 3 # 14 F 142 LYS C 76 LYS^? 24.95 MG MG C 302 F 217 SER C 83 SER^? 23.40 MG MG B 301 F 241 SER C 79 SER^? 19.92 MG MG B 301 coo 85.78 13.19 64.96 85.47 13.47 58.63 71.11 8.63 -16.76 75.44 5.17 -16.80 coo 87.43 17.13 57.15 85.84 15.39 56.76 65.19 0.76 -19.73 62.87 1.43 -19.33 coo 89.69 13.60 54.86 87.60 14.67 54.46 64.38 1.95 -14.66 62.69 3.45 -15.45 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 15 3 # 15 F 142 LYS C 86 LYS^? 27.34 MG MG C 302 F 217 SER C 83 SER^? 23.40 MG MG B 301 F 241 SER C 79 SER^? 19.92 MG MG B 301 coo 85.78 13.19 64.96 85.47 13.47 58.63 69.22 9.88 -20.56 74.70 7.02 -22.55 coo 87.43 17.13 57.15 85.84 15.39 56.76 65.19 0.76 -19.73 62.87 1.43 -19.33 coo 89.69 13.60 54.86 87.60 14.67 54.46 64.38 1.95 -14.66 62.69 3.45 -15.45 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 16 3 # 16 F 142 LYS D 61 LYS^? 21.93 MG MG C 302 F 217 SER C 16 SER^? 24.15 MG MG C 302 F 241 SER C 36 SER^? 23.69 MG MG C 302 coo 85.78 13.19 64.96 85.47 13.47 58.63 80.64 11.23 -26.16 80.65 16.24 -22.36 coo 87.43 17.13 57.15 85.84 15.39 56.76 82.88 9.31 -16.30 84.27 7.80 -17.58 coo 89.69 13.60 54.86 87.60 14.67 54.46 86.07 12.19 -17.80 85.34 10.22 -18.98 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 17 3 # 17 F 142 LYS D 61 LYS^? 21.93 MG MG C 302 F 217 SER C 36 SER^? 23.69 MG MG C 302 F 241 SER C 16 SER^? 24.15 MG MG C 302 coo 85.78 13.19 64.96 85.47 13.47 58.63 80.64 11.23 -26.16 80.65 16.24 -22.36 coo 87.43 17.13 57.15 85.84 15.39 56.76 86.07 12.19 -17.80 85.34 10.22 -18.98 coo 89.69 13.60 54.86 87.60 14.67 54.46 82.88 9.31 -16.30 84.27 7.80 -17.58 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 18 3 # 18 F 142 LYS D 76 LYS^? 25.08 MG MG D 302 F 217 SER D 79 SER^? 19.41 MG MG E 301 F 241 SER D 83 SER^? 23.07 MG MG E 301 coo 85.78 13.19 64.96 85.47 13.47 58.63 88.18 56.35 -34.05 93.80 56.17 -32.93 coo 87.43 17.13 57.15 85.84 15.39 56.76 88.38 65.91 -36.56 86.13 65.62 -35.70 coo 89.69 13.60 54.86 87.60 14.67 54.46 89.47 66.32 -31.33 87.79 67.80 -32.19 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 19 3 # 19 F 142 LYS D 76 LYS^? 25.08 MG MG D 302 F 217 SER D 83 SER^? 23.07 MG MG E 301 F 241 SER D 79 SER^? 19.41 MG MG E 301 coo 85.78 13.19 64.96 85.47 13.47 58.63 88.18 56.35 -34.05 93.80 56.17 -32.93 coo 87.43 17.13 57.15 85.84 15.39 56.76 89.47 66.32 -31.33 87.79 67.80 -32.19 coo 89.69 13.60 54.86 87.60 14.67 54.46 88.38 65.91 -36.56 86.13 65.62 -35.70 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 20 3 # 20 F 142 LYS D 86 LYS^? 25.80 MG MG D 302 F 217 SER D 83 SER^? 23.07 MG MG E 301 F 241 SER D 79 SER^? 19.41 MG MG E 301 coo 85.78 13.19 64.96 85.47 13.47 58.63 85.54 56.79 -30.27 90.24 54.54 -28.62 coo 87.43 17.13 57.15 85.84 15.39 56.76 89.47 66.32 -31.33 87.79 67.80 -32.19 coo 89.69 13.60 54.86 87.60 14.67 54.46 88.38 65.91 -36.56 86.13 65.62 -35.70 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 21 3 # 21 F 142 LYS E 61 LYS^? 22.16 MG MG F 301 F 217 SER F 16 SER^? 24.10 MG MG F 301 F 241 SER F 36 SER^? 23.07 MG MG F 301 coo 85.78 13.19 64.96 85.47 13.47 58.63 40.99 56.84 -68.48 45.99 56.72 -72.39 coo 87.43 17.13 57.15 85.84 15.39 56.76 39.77 59.81 -78.14 38.80 61.26 -76.65 coo 89.69 13.60 54.86 87.60 14.67 54.46 42.79 62.77 -76.96 42.19 61.23 -75.17 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 22 3 # 22 F 142 LYS E 61 LYS^? 22.16 MG MG F 301 F 217 SER F 36 SER^? 23.07 MG MG F 301 F 241 SER F 16 SER^? 24.10 MG MG F 301 coo 85.78 13.19 64.96 85.47 13.47 58.63 40.99 56.84 -68.48 45.99 56.72 -72.39 coo 87.43 17.13 57.15 85.84 15.39 56.76 42.79 62.77 -76.96 42.19 61.23 -75.17 coo 89.69 13.60 54.86 87.60 14.67 54.46 39.77 59.81 -78.14 38.80 61.26 -76.65 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 23 3 # 23 F 142 LYS E 76 LYS^? 25.68 MG MG E 302 F 217 SER E 79 SER^? 19.77 MG MG D 301 F 241 SER E 83 SER^? 23.44 MG MG D 301 coo 85.78 13.19 64.96 85.47 13.47 58.63 87.09 58.11 -60.91 88.65 63.65 -61.27 coo 87.43 17.13 57.15 85.84 15.39 56.76 96.22 56.25 -58.39 95.94 54.06 -59.20 coo 89.69 13.60 54.86 87.60 14.67 54.46 96.88 57.42 -63.66 97.96 55.45 -62.84 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 24 3 # 24 F 142 LYS E 76 LYS^? 25.68 MG MG E 302 F 217 SER E 83 SER^? 23.44 MG MG D 301 F 241 SER E 79 SER^? 19.77 MG MG D 301 coo 85.78 13.19 64.96 85.47 13.47 58.63 87.09 58.11 -60.91 88.65 63.65 -61.27 coo 87.43 17.13 57.15 85.84 15.39 56.76 96.88 57.42 -63.66 97.96 55.45 -62.84 coo 89.69 13.60 54.86 87.60 14.67 54.46 96.22 56.25 -58.39 95.94 54.06 -59.20 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 25 3 # 25 F 142 LYS E 86 LYS^? 26.73 MG MG D 301 F 217 SER E 83 SER^? 23.44 MG MG D 301 F 241 SER E 79 SER^? 19.77 MG MG D 301 coo 85.78 13.19 64.96 85.47 13.47 58.63 86.84 54.85 -64.43 87.07 60.83 -66.10 coo 87.43 17.13 57.15 85.84 15.39 56.76 96.88 57.42 -63.66 97.96 55.45 -62.84 coo 89.69 13.60 54.86 87.60 14.67 54.46 96.22 56.25 -58.39 95.94 54.06 -59.20 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 26 3 # 26 F 142 LYS F 61 LYS^? 21.75 MG MG E 302 F 217 SER E 16 SER^? 24.21 MG MG E 302 F 241 SER E 36 SER^? 22.92 MG MG E 302 coo 85.78 13.19 64.96 85.47 13.47 58.63 80.24 64.12 -71.01 76.23 61.95 -66.39 coo 87.43 17.13 57.15 85.84 15.39 56.76 80.65 67.65 -61.22 81.30 69.49 -62.59 coo 89.69 13.60 54.86 87.60 14.67 54.46 76.63 69.18 -62.93 78.20 67.77 -64.11 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 27 3 # 27 F 142 LYS F 61 LYS^? 21.75 MG MG E 302 F 217 SER E 36 SER^? 22.92 MG MG E 302 F 241 SER E 16 SER^? 24.21 MG MG E 302 coo 85.78 13.19 64.96 85.47 13.47 58.63 80.24 64.12 -71.01 76.23 61.95 -66.39 coo 87.43 17.13 57.15 85.84 15.39 56.76 76.63 69.18 -62.93 78.20 67.77 -64.11 coo 89.69 13.60 54.86 87.60 14.67 54.46 80.65 67.65 -61.22 81.30 69.49 -62.59 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 28 3 # 28 F 142 LYS F 76 LYS^? 25.89 MG MG F 301 F 217 SER F 79 SER^? 30.22 MG MG F 301 F 241 SER F 83 SER^? 33.16 MG MG F 301 coo 85.78 13.19 64.96 85.47 13.47 58.63 36.96 48.52 -78.06 33.74 53.37 -77.06 coo 87.43 17.13 57.15 85.84 15.39 56.76 28.21 44.39 -80.24 29.11 42.36 -79.32 coo 89.69 13.60 54.86 87.60 14.67 54.46 27.54 45.11 -75.18 28.33 43.06 -74.18 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 29 3 # 29 F 142 LYS F 76 LYS^? 25.89 MG MG F 301 F 217 SER F 83 SER^? 33.16 MG MG F 301 F 241 SER F 79 SER^? 30.22 MG MG F 301 coo 85.78 13.19 64.96 85.47 13.47 58.63 36.96 48.52 -78.06 33.74 53.37 -77.06 coo 87.43 17.13 57.15 85.84 15.39 56.76 27.54 45.11 -75.18 28.33 43.06 -74.18 coo 89.69 13.60 54.86 87.60 14.67 54.46 28.21 44.39 -80.24 29.11 42.36 -79.32 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 30 3 # 30 F 142 LYS F 86 LYS^? 26.63 MG MG F 301 F 217 SER F 83 SER^? 33.16 MG MG F 301 F 241 SER F 79 SER^? 30.22 MG MG F 301 coo 85.78 13.19 64.96 85.47 13.47 58.63 37.89 45.97 -74.42 36.47 51.71 -72.79 coo 87.43 17.13 57.15 85.84 15.39 56.76 27.54 45.11 -75.18 28.33 43.06 -74.18 coo 89.69 13.60 54.86 87.60 14.67 54.46 28.21 44.39 -80.24 29.11 42.36 -79.32 1mt5_c05 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 30 hits 1mt5_c05 naa= 3 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 G 142 LYS A 61 LYS^? 21.99 MG MG B 302 G 217 SER B 16 SER^? 23.97 MG MG B 302 G 241 SER B 36 SER^? 24.04 MG MG B 302 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 57.78 7.35 19.60 56.77 12.20 15.61 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 56.70 5.18 9.63 55.76 3.58 11.01 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 52.58 6.45 11.01 53.61 4.84 12.41 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 G 142 LYS A 61 LYS^? 21.99 MG MG B 302 G 217 SER B 36 SER^? 24.04 MG MG B 302 G 241 SER B 16 SER^? 23.97 MG MG B 302 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 57.78 7.35 19.60 56.77 12.20 15.61 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 52.58 6.45 11.01 53.61 4.84 12.41 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 56.70 5.18 9.63 55.76 3.58 11.01 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 G 142 LYS A 76 LYS^? 25.42 MG MG A 301 G 217 SER A 79 SER^? 29.65 MG MG A 301 G 241 SER A 83 SER^? 32.41 MG MG A 301 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 34.45 46.53 27.28 28.88 44.93 27.25 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 32.57 55.71 29.63 34.63 56.10 28.47 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 30.60 55.84 24.53 32.97 55.99 23.96 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 G 142 LYS A 76 LYS^? 25.42 MG MG A 301 G 217 SER A 83 SER^? 32.41 MG MG A 301 G 241 SER A 79 SER^? 29.65 MG MG A 301 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 34.45 46.53 27.28 28.88 44.93 27.25 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 30.60 55.84 24.53 32.97 55.99 23.96 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 32.57 55.71 29.63 34.63 56.10 28.47 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 G 142 LYS A 86 LYS^? 26.38 MG MG A 301 G 217 SER A 83 SER^? 32.41 MG MG A 301 G 241 SER A 79 SER^? 29.65 MG MG A 301 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 37.08 47.78 23.56 32.88 44.24 21.89 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 30.60 55.84 24.53 32.97 55.99 23.96 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 32.57 55.71 29.63 34.63 56.10 28.47 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 G 142 LYS B 61 LYS^? 22.03 MG MG A 301 G 217 SER A 16 SER.? 24.16 MG MG A 301 G 241 SER A 36 SER^? 23.25 MG MG A 301 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 32.50 37.62 17.61 36.68 34.92 21.51 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 29.26 36.32 27.22 27.38 35.99 25.78 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 29.88 32.10 25.40 29.53 34.39 24.57 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 G 142 LYS B 61 LYS^? 22.03 MG MG A 301 G 217 SER A 36 SER^? 23.25 MG MG A 301 G 241 SER A 16 SER.? 24.16 MG MG A 301 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 32.50 37.62 17.61 36.68 34.92 21.51 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 29.88 32.10 25.40 29.53 34.39 24.57 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 29.26 36.32 27.22 27.38 35.99 25.78 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 G 142 LYS B 76 LYS^? 25.77 MG MG B 302 G 217 SER B 79 SER^? 20.24 MG MG C 301 G 241 SER B 83 SER^? 24.53 MG MG C 301 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 67.82 8.19 10.14 64.96 3.09 10.62 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 76.03 3.33 7.67 77.04 5.28 8.60 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 75.19 1.98 12.89 77.54 2.36 12.62 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 9 3 # 9 G 142 LYS B 76 LYS^? 25.77 MG MG B 302 G 217 SER B 83 SER^? 24.53 MG MG C 301 G 241 SER B 79 SER^? 20.24 MG MG C 301 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 67.82 8.19 10.14 64.96 3.09 10.62 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 75.19 1.98 12.89 77.54 2.36 12.62 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 76.03 3.33 7.67 77.04 5.28 8.60 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 10 3 # 10 G 142 LYS B 86 LYS^? 26.44 MG MG B 302 G 217 SER B 83 SER^? 24.53 MG MG C 301 G 241 SER B 79 SER^? 20.24 MG MG C 301 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 69.25 10.45 13.86 65.27 7.74 16.08 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 75.19 1.98 12.89 77.54 2.36 12.62 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 76.03 3.33 7.67 77.04 5.28 8.60 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 11 3 # 11 G 142 LYS C 61 LYS^? 21.91 MG MG D 302 G 217 SER D 16 SER^? 23.71 MG MG D 302 G 241 SER D 36 SER^? 22.42 MG MG D 302 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 93.60 48.56 -24.05 90.39 44.71 -27.98 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 96.73 48.43 -33.75 98.58 48.68 -32.31 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 97.85 44.42 -32.20 96.60 46.20 -31.15 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 12 3 # 12 G 142 LYS C 61 LYS^? 21.91 MG MG D 302 G 217 SER D 36 SER^? 22.42 MG MG D 302 G 241 SER D 16 SER^? 23.71 MG MG D 302 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 93.60 48.56 -24.05 90.39 44.71 -27.98 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 97.85 44.42 -32.20 96.60 46.20 -31.15 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 96.73 48.43 -33.75 98.58 48.68 -32.31 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 13 3 # 13 G 142 LYS C 76 LYS^? 24.95 MG MG C 302 G 217 SER C 79 SER^? 19.92 MG MG B 301 G 241 SER C 83 SER^? 23.40 MG MG B 301 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 71.11 8.63 -16.76 75.44 5.17 -16.80 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 64.38 1.95 -14.66 62.69 3.45 -15.45 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 65.19 0.76 -19.73 62.87 1.43 -19.33 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 14 3 # 14 G 142 LYS C 76 LYS^? 24.95 MG MG C 302 G 217 SER C 83 SER^? 23.40 MG MG B 301 G 241 SER C 79 SER^? 19.92 MG MG B 301 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 71.11 8.63 -16.76 75.44 5.17 -16.80 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 65.19 0.76 -19.73 62.87 1.43 -19.33 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 64.38 1.95 -14.66 62.69 3.45 -15.45 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 15 3 # 15 G 142 LYS C 86 LYS^? 27.34 MG MG C 302 G 217 SER C 83 SER^? 23.40 MG MG B 301 G 241 SER C 79 SER^? 19.92 MG MG B 301 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 69.22 9.88 -20.56 74.70 7.02 -22.55 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 65.19 0.76 -19.73 62.87 1.43 -19.33 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 64.38 1.95 -14.66 62.69 3.45 -15.45 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 16 3 # 16 G 142 LYS D 61 LYS^? 21.93 MG MG C 302 G 217 SER C 16 SER^? 24.15 MG MG C 302 G 241 SER C 36 SER^? 23.69 MG MG C 302 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 80.64 11.23 -26.16 80.65 16.24 -22.36 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 82.88 9.31 -16.30 84.27 7.80 -17.58 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 86.07 12.19 -17.80 85.34 10.22 -18.98 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 17 3 # 17 G 142 LYS D 61 LYS^? 21.93 MG MG C 302 G 217 SER C 36 SER^? 23.69 MG MG C 302 G 241 SER C 16 SER^? 24.15 MG MG C 302 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 80.64 11.23 -26.16 80.65 16.24 -22.36 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 86.07 12.19 -17.80 85.34 10.22 -18.98 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 82.88 9.31 -16.30 84.27 7.80 -17.58 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 18 3 # 18 G 142 LYS D 76 LYS^? 25.08 MG MG D 302 G 217 SER D 79 SER^? 19.41 MG MG E 301 G 241 SER D 83 SER^? 23.07 MG MG E 301 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 88.18 56.35 -34.05 93.80 56.17 -32.93 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 88.38 65.91 -36.56 86.13 65.62 -35.70 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 89.47 66.32 -31.33 87.79 67.80 -32.19 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 19 3 # 19 G 142 LYS D 76 LYS^? 25.08 MG MG D 302 G 217 SER D 83 SER^? 23.07 MG MG E 301 G 241 SER D 79 SER^? 19.41 MG MG E 301 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 88.18 56.35 -34.05 93.80 56.17 -32.93 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 89.47 66.32 -31.33 87.79 67.80 -32.19 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 88.38 65.91 -36.56 86.13 65.62 -35.70 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 20 3 # 20 G 142 LYS D 86 LYS^? 25.80 MG MG D 302 G 217 SER D 83 SER^? 23.07 MG MG E 301 G 241 SER D 79 SER^? 19.41 MG MG E 301 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 85.54 56.79 -30.27 90.24 54.54 -28.62 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 89.47 66.32 -31.33 87.79 67.80 -32.19 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 88.38 65.91 -36.56 86.13 65.62 -35.70 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 21 3 # 21 G 142 LYS E 61 LYS^? 22.16 MG MG F 301 G 217 SER F 16 SER^? 24.10 MG MG F 301 G 241 SER F 36 SER^? 23.07 MG MG F 301 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 40.99 56.84 -68.48 45.99 56.72 -72.39 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 39.77 59.81 -78.14 38.80 61.26 -76.65 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 42.79 62.77 -76.96 42.19 61.23 -75.17 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 22 3 # 22 G 142 LYS E 61 LYS^? 22.16 MG MG F 301 G 217 SER F 36 SER^? 23.07 MG MG F 301 G 241 SER F 16 SER^? 24.10 MG MG F 301 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 40.99 56.84 -68.48 45.99 56.72 -72.39 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 42.79 62.77 -76.96 42.19 61.23 -75.17 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 39.77 59.81 -78.14 38.80 61.26 -76.65 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 23 3 # 23 G 142 LYS E 76 LYS^? 25.68 MG MG E 302 G 217 SER E 79 SER^? 19.77 MG MG D 301 G 241 SER E 83 SER^? 23.44 MG MG D 301 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 87.09 58.11 -60.91 88.65 63.65 -61.27 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 96.22 56.25 -58.39 95.94 54.06 -59.20 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 96.88 57.42 -63.66 97.96 55.45 -62.84 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 24 3 # 24 G 142 LYS E 76 LYS^? 25.68 MG MG E 302 G 217 SER E 83 SER^? 23.44 MG MG D 301 G 241 SER E 79 SER^? 19.77 MG MG D 301 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 87.09 58.11 -60.91 88.65 63.65 -61.27 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 96.88 57.42 -63.66 97.96 55.45 -62.84 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 96.22 56.25 -58.39 95.94 54.06 -59.20 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 25 3 # 25 G 142 LYS E 86 LYS^? 26.73 MG MG D 301 G 217 SER E 83 SER^? 23.44 MG MG D 301 G 241 SER E 79 SER^? 19.77 MG MG D 301 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 86.84 54.85 -64.43 87.07 60.83 -66.10 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 96.88 57.42 -63.66 97.96 55.45 -62.84 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 96.22 56.25 -58.39 95.94 54.06 -59.20 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 26 3 # 26 G 142 LYS F 61 LYS^? 21.75 MG MG E 302 G 217 SER E 16 SER^? 24.21 MG MG E 302 G 241 SER E 36 SER^? 22.92 MG MG E 302 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 80.24 64.12 -71.01 76.23 61.95 -66.39 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 80.65 67.65 -61.22 81.30 69.49 -62.59 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 76.63 69.18 -62.93 78.20 67.77 -64.11 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 27 3 # 27 G 142 LYS F 61 LYS^? 21.75 MG MG E 302 G 217 SER E 36 SER^? 22.92 MG MG E 302 G 241 SER E 16 SER^? 24.21 MG MG E 302 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 80.24 64.12 -71.01 76.23 61.95 -66.39 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 76.63 69.18 -62.93 78.20 67.77 -64.11 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 80.65 67.65 -61.22 81.30 69.49 -62.59 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 28 3 # 28 G 142 LYS F 76 LYS^? 25.89 MG MG F 301 G 217 SER F 79 SER^? 30.22 MG MG F 301 G 241 SER F 83 SER^? 33.16 MG MG F 301 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 36.96 48.52 -78.06 33.74 53.37 -77.06 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 28.21 44.39 -80.24 29.11 42.36 -79.32 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 27.54 45.11 -75.18 28.33 43.06 -74.18 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 29 3 # 29 G 142 LYS F 76 LYS^? 25.89 MG MG F 301 G 217 SER F 83 SER^? 33.16 MG MG F 301 G 241 SER F 79 SER^? 30.22 MG MG F 301 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 36.96 48.52 -78.06 33.74 53.37 -77.06 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 27.54 45.11 -75.18 28.33 43.06 -74.18 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 28.21 44.39 -80.24 29.11 42.36 -79.32 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 30 3 # 30 G 142 LYS F 86 LYS^? 26.63 MG MG F 301 G 217 SER F 83 SER^? 33.16 MG MG F 301 G 241 SER F 79 SER^? 30.22 MG MG F 301 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 37.89 45.97 -74.42 36.47 51.71 -72.79 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 27.54 45.11 -75.18 28.33 43.06 -74.18 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 28.21 44.39 -80.24 29.11 42.36 -79.32 1mt5_c06 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 30 hits 1mt5_c06 naa= 3 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 H 142 LYS A 61 LYS^? 21.99 MG MG B 302 H 217 SER B 16 SER^? 23.97 MG MG B 302 H 241 SER B 36 SER^? 24.04 MG MG B 302 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 57.78 7.35 19.60 56.77 12.20 15.61 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 56.70 5.18 9.63 55.76 3.58 11.01 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 52.58 6.45 11.01 53.61 4.84 12.41 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 H 142 LYS A 61 LYS^? 21.99 MG MG B 302 H 217 SER B 36 SER^? 24.04 MG MG B 302 H 241 SER B 16 SER^? 23.97 MG MG B 302 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 57.78 7.35 19.60 56.77 12.20 15.61 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 52.58 6.45 11.01 53.61 4.84 12.41 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 56.70 5.18 9.63 55.76 3.58 11.01 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 H 142 LYS A 76 LYS^? 25.42 MG MG A 301 H 217 SER A 79 SER^? 29.65 MG MG A 301 H 241 SER A 83 SER^? 32.41 MG MG A 301 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 34.45 46.53 27.28 28.88 44.93 27.25 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 32.57 55.71 29.63 34.63 56.10 28.47 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 30.60 55.84 24.53 32.97 55.99 23.96 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 H 142 LYS A 76 LYS^? 25.42 MG MG A 301 H 217 SER A 83 SER^? 32.41 MG MG A 301 H 241 SER A 79 SER^? 29.65 MG MG A 301 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 34.45 46.53 27.28 28.88 44.93 27.25 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 30.60 55.84 24.53 32.97 55.99 23.96 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 32.57 55.71 29.63 34.63 56.10 28.47 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 H 142 LYS A 86 LYS^? 26.38 MG MG A 301 H 217 SER A 83 SER^? 32.41 MG MG A 301 H 241 SER A 79 SER^? 29.65 MG MG A 301 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 37.08 47.78 23.56 32.88 44.24 21.89 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 30.60 55.84 24.53 32.97 55.99 23.96 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 32.57 55.71 29.63 34.63 56.10 28.47 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 H 142 LYS B 61 LYS^? 22.03 MG MG A 301 H 217 SER A 16 SER.? 24.16 MG MG A 301 H 241 SER A 36 SER^? 23.25 MG MG A 301 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 32.50 37.62 17.61 36.68 34.92 21.51 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 29.26 36.32 27.22 27.38 35.99 25.78 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 29.88 32.10 25.40 29.53 34.39 24.57 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 H 142 LYS B 61 LYS^? 22.03 MG MG A 301 H 217 SER A 36 SER^? 23.25 MG MG A 301 H 241 SER A 16 SER.? 24.16 MG MG A 301 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 32.50 37.62 17.61 36.68 34.92 21.51 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 29.88 32.10 25.40 29.53 34.39 24.57 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 29.26 36.32 27.22 27.38 35.99 25.78 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 H 142 LYS B 76 LYS^? 25.77 MG MG B 302 H 217 SER B 79 SER^? 20.24 MG MG C 301 H 241 SER B 83 SER^? 24.53 MG MG C 301 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 67.82 8.19 10.14 64.96 3.09 10.62 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 76.03 3.33 7.67 77.04 5.28 8.60 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 75.19 1.98 12.89 77.54 2.36 12.62 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 9 3 # 9 H 142 LYS B 76 LYS^? 25.77 MG MG B 302 H 217 SER B 83 SER^? 24.53 MG MG C 301 H 241 SER B 79 SER^? 20.24 MG MG C 301 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 67.82 8.19 10.14 64.96 3.09 10.62 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 75.19 1.98 12.89 77.54 2.36 12.62 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 76.03 3.33 7.67 77.04 5.28 8.60 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 10 3 # 10 H 142 LYS B 86 LYS^? 26.44 MG MG B 302 H 217 SER B 83 SER^? 24.53 MG MG C 301 H 241 SER B 79 SER^? 20.24 MG MG C 301 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 69.25 10.45 13.86 65.27 7.74 16.08 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 75.19 1.98 12.89 77.54 2.36 12.62 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 76.03 3.33 7.67 77.04 5.28 8.60 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 11 3 # 11 H 142 LYS C 61 LYS^? 21.91 MG MG D 302 H 217 SER D 16 SER^? 23.71 MG MG D 302 H 241 SER D 36 SER^? 22.42 MG MG D 302 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 93.60 48.56 -24.05 90.39 44.71 -27.98 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 96.73 48.43 -33.75 98.58 48.68 -32.31 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 97.85 44.42 -32.20 96.60 46.20 -31.15 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 12 3 # 12 H 142 LYS C 61 LYS^? 21.91 MG MG D 302 H 217 SER D 36 SER^? 22.42 MG MG D 302 H 241 SER D 16 SER^? 23.71 MG MG D 302 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 93.60 48.56 -24.05 90.39 44.71 -27.98 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 97.85 44.42 -32.20 96.60 46.20 -31.15 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 96.73 48.43 -33.75 98.58 48.68 -32.31 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 13 3 # 13 H 142 LYS C 76 LYS^? 24.95 MG MG C 302 H 217 SER C 79 SER^? 19.92 MG MG B 301 H 241 SER C 83 SER^? 23.40 MG MG B 301 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 71.11 8.63 -16.76 75.44 5.17 -16.80 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 64.38 1.95 -14.66 62.69 3.45 -15.45 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 65.19 0.76 -19.73 62.87 1.43 -19.33 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 14 3 # 14 H 142 LYS C 76 LYS^? 24.95 MG MG C 302 H 217 SER C 83 SER^? 23.40 MG MG B 301 H 241 SER C 79 SER^? 19.92 MG MG B 301 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 71.11 8.63 -16.76 75.44 5.17 -16.80 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 65.19 0.76 -19.73 62.87 1.43 -19.33 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 64.38 1.95 -14.66 62.69 3.45 -15.45 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 15 3 # 15 H 142 LYS C 86 LYS^? 27.34 MG MG C 302 H 217 SER C 83 SER^? 23.40 MG MG B 301 H 241 SER C 79 SER^? 19.92 MG MG B 301 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 69.22 9.88 -20.56 74.70 7.02 -22.55 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 65.19 0.76 -19.73 62.87 1.43 -19.33 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 64.38 1.95 -14.66 62.69 3.45 -15.45 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 16 3 # 16 H 142 LYS D 61 LYS^? 21.93 MG MG C 302 H 217 SER C 16 SER^? 24.15 MG MG C 302 H 241 SER C 36 SER^? 23.69 MG MG C 302 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 80.64 11.23 -26.16 80.65 16.24 -22.36 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 82.88 9.31 -16.30 84.27 7.80 -17.58 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 86.07 12.19 -17.80 85.34 10.22 -18.98 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 17 3 # 17 H 142 LYS D 61 LYS^? 21.93 MG MG C 302 H 217 SER C 36 SER^? 23.69 MG MG C 302 H 241 SER C 16 SER^? 24.15 MG MG C 302 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 80.64 11.23 -26.16 80.65 16.24 -22.36 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 86.07 12.19 -17.80 85.34 10.22 -18.98 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 82.88 9.31 -16.30 84.27 7.80 -17.58 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 18 3 # 18 H 142 LYS D 76 LYS^? 25.08 MG MG D 302 H 217 SER D 79 SER^? 19.41 MG MG E 301 H 241 SER D 83 SER^? 23.07 MG MG E 301 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 88.18 56.35 -34.05 93.80 56.17 -32.93 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 88.38 65.91 -36.56 86.13 65.62 -35.70 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 89.47 66.32 -31.33 87.79 67.80 -32.19 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 19 3 # 19 H 142 LYS D 76 LYS^? 25.08 MG MG D 302 H 217 SER D 83 SER^? 23.07 MG MG E 301 H 241 SER D 79 SER^? 19.41 MG MG E 301 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 88.18 56.35 -34.05 93.80 56.17 -32.93 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 89.47 66.32 -31.33 87.79 67.80 -32.19 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 88.38 65.91 -36.56 86.13 65.62 -35.70 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 20 3 # 20 H 142 LYS D 86 LYS^? 25.80 MG MG D 302 H 217 SER D 83 SER^? 23.07 MG MG E 301 H 241 SER D 79 SER^? 19.41 MG MG E 301 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 85.54 56.79 -30.27 90.24 54.54 -28.62 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 89.47 66.32 -31.33 87.79 67.80 -32.19 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 88.38 65.91 -36.56 86.13 65.62 -35.70 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 21 3 # 21 H 142 LYS E 61 LYS^? 22.16 MG MG F 301 H 217 SER F 16 SER^? 24.10 MG MG F 301 H 241 SER F 36 SER^? 23.07 MG MG F 301 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 40.99 56.84 -68.48 45.99 56.72 -72.39 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 39.77 59.81 -78.14 38.80 61.26 -76.65 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 42.79 62.77 -76.96 42.19 61.23 -75.17 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 22 3 # 22 H 142 LYS E 61 LYS^? 22.16 MG MG F 301 H 217 SER F 36 SER^? 23.07 MG MG F 301 H 241 SER F 16 SER^? 24.10 MG MG F 301 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 40.99 56.84 -68.48 45.99 56.72 -72.39 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 42.79 62.77 -76.96 42.19 61.23 -75.17 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 39.77 59.81 -78.14 38.80 61.26 -76.65 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 23 3 # 23 H 142 LYS E 76 LYS^? 25.68 MG MG E 302 H 217 SER E 79 SER^? 19.77 MG MG D 301 H 241 SER E 83 SER^? 23.44 MG MG D 301 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 87.09 58.11 -60.91 88.65 63.65 -61.27 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 96.22 56.25 -58.39 95.94 54.06 -59.20 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 96.88 57.42 -63.66 97.96 55.45 -62.84 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 24 3 # 24 H 142 LYS E 76 LYS^? 25.68 MG MG E 302 H 217 SER E 83 SER^? 23.44 MG MG D 301 H 241 SER E 79 SER^? 19.77 MG MG D 301 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 87.09 58.11 -60.91 88.65 63.65 -61.27 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 96.88 57.42 -63.66 97.96 55.45 -62.84 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 96.22 56.25 -58.39 95.94 54.06 -59.20 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 25 3 # 25 H 142 LYS E 86 LYS^? 26.73 MG MG D 301 H 217 SER E 83 SER^? 23.44 MG MG D 301 H 241 SER E 79 SER^? 19.77 MG MG D 301 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 86.84 54.85 -64.43 87.07 60.83 -66.10 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 96.88 57.42 -63.66 97.96 55.45 -62.84 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 96.22 56.25 -58.39 95.94 54.06 -59.20 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 26 3 # 26 H 142 LYS F 61 LYS^? 21.75 MG MG E 302 H 217 SER E 16 SER^? 24.21 MG MG E 302 H 241 SER E 36 SER^? 22.92 MG MG E 302 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 80.24 64.12 -71.01 76.23 61.95 -66.39 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 80.65 67.65 -61.22 81.30 69.49 -62.59 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 76.63 69.18 -62.93 78.20 67.77 -64.11 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 27 3 # 27 H 142 LYS F 61 LYS^? 21.75 MG MG E 302 H 217 SER E 36 SER^? 22.92 MG MG E 302 H 241 SER E 16 SER^? 24.21 MG MG E 302 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 80.24 64.12 -71.01 76.23 61.95 -66.39 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 76.63 69.18 -62.93 78.20 67.77 -64.11 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 80.65 67.65 -61.22 81.30 69.49 -62.59 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 28 3 # 28 H 142 LYS F 76 LYS^? 25.89 MG MG F 301 H 217 SER F 79 SER^? 30.22 MG MG F 301 H 241 SER F 83 SER^? 33.16 MG MG F 301 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 36.96 48.52 -78.06 33.74 53.37 -77.06 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 28.21 44.39 -80.24 29.11 42.36 -79.32 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 27.54 45.11 -75.18 28.33 43.06 -74.18 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 29 3 # 29 H 142 LYS F 76 LYS^? 25.89 MG MG F 301 H 217 SER F 83 SER^? 33.16 MG MG F 301 H 241 SER F 79 SER^? 30.22 MG MG F 301 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 36.96 48.52 -78.06 33.74 53.37 -77.06 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 27.54 45.11 -75.18 28.33 43.06 -74.18 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 28.21 44.39 -80.24 29.11 42.36 -79.32 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 30 3 # 30 H 142 LYS F 86 LYS^? 26.63 MG MG F 301 H 217 SER F 83 SER^? 33.16 MG MG F 301 H 241 SER F 79 SER^? 30.22 MG MG F 301 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 37.89 45.97 -74.42 36.47 51.71 -72.79 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 27.54 45.11 -75.18 28.33 43.06 -74.18 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 28.21 44.39 -80.24 29.11 42.36 -79.32 1mt5_c07 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 30 hits 1mt5_c07 naa= 3 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 I 142 LYS A 61 LYS^? 21.99 MG MG B 302 I 217 SER B 16 SER^? 23.97 MG MG B 302 I 241 SER B 36 SER^? 24.04 MG MG B 302 coo -5.05 91.11 27.04 -1.24 87.39 30.21 57.78 7.35 19.60 56.77 12.20 15.61 coo 2.83 88.63 29.54 1.30 86.82 30.03 56.70 5.18 9.63 55.76 3.58 11.01 coo 2.37 88.32 34.25 2.82 86.58 32.61 52.58 6.45 11.01 53.61 4.84 12.41 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 I 142 LYS A 61 LYS^? 21.99 MG MG B 302 I 217 SER B 36 SER^? 24.04 MG MG B 302 I 241 SER B 16 SER^? 23.97 MG MG B 302 coo -5.05 91.11 27.04 -1.24 87.39 30.21 57.78 7.35 19.60 56.77 12.20 15.61 coo 2.83 88.63 29.54 1.30 86.82 30.03 52.58 6.45 11.01 53.61 4.84 12.41 coo 2.37 88.32 34.25 2.82 86.58 32.61 56.70 5.18 9.63 55.76 3.58 11.01 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 I 142 LYS A 76 LYS^? 25.42 MG MG A 301 I 217 SER A 79 SER^? 29.65 MG MG A 301 I 241 SER A 83 SER^? 32.41 MG MG A 301 coo -5.05 91.11 27.04 -1.24 87.39 30.21 34.45 46.53 27.28 28.88 44.93 27.25 coo 2.83 88.63 29.54 1.30 86.82 30.03 32.57 55.71 29.63 34.63 56.10 28.47 coo 2.37 88.32 34.25 2.82 86.58 32.61 30.60 55.84 24.53 32.97 55.99 23.96 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 I 142 LYS A 76 LYS^? 25.42 MG MG A 301 I 217 SER A 83 SER^? 32.41 MG MG A 301 I 241 SER A 79 SER^? 29.65 MG MG A 301 coo -5.05 91.11 27.04 -1.24 87.39 30.21 34.45 46.53 27.28 28.88 44.93 27.25 coo 2.83 88.63 29.54 1.30 86.82 30.03 30.60 55.84 24.53 32.97 55.99 23.96 coo 2.37 88.32 34.25 2.82 86.58 32.61 32.57 55.71 29.63 34.63 56.10 28.47 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 I 142 LYS A 86 LYS^? 26.38 MG MG A 301 I 217 SER A 83 SER^? 32.41 MG MG A 301 I 241 SER A 79 SER^? 29.65 MG MG A 301 coo -5.05 91.11 27.04 -1.24 87.39 30.21 37.08 47.78 23.56 32.88 44.24 21.89 coo 2.83 88.63 29.54 1.30 86.82 30.03 30.60 55.84 24.53 32.97 55.99 23.96 coo 2.37 88.32 34.25 2.82 86.58 32.61 32.57 55.71 29.63 34.63 56.10 28.47 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 I 142 LYS B 61 LYS^? 22.03 MG MG A 301 I 217 SER A 16 SER.? 24.16 MG MG A 301 I 241 SER A 36 SER^? 23.25 MG MG A 301 coo -5.05 91.11 27.04 -1.24 87.39 30.21 32.50 37.62 17.61 36.68 34.92 21.51 coo 2.83 88.63 29.54 1.30 86.82 30.03 29.26 36.32 27.22 27.38 35.99 25.78 coo 2.37 88.32 34.25 2.82 86.58 32.61 29.88 32.10 25.40 29.53 34.39 24.57 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 I 142 LYS B 61 LYS^? 22.03 MG MG A 301 I 217 SER A 36 SER^? 23.25 MG MG A 301 I 241 SER A 16 SER.? 24.16 MG MG A 301 coo -5.05 91.11 27.04 -1.24 87.39 30.21 32.50 37.62 17.61 36.68 34.92 21.51 coo 2.83 88.63 29.54 1.30 86.82 30.03 29.88 32.10 25.40 29.53 34.39 24.57 coo 2.37 88.32 34.25 2.82 86.58 32.61 29.26 36.32 27.22 27.38 35.99 25.78 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 I 142 LYS B 76 LYS^? 25.77 MG MG B 302 I 217 SER B 79 SER^? 20.24 MG MG C 301 I 241 SER B 83 SER^? 24.53 MG MG C 301 coo -5.05 91.11 27.04 -1.24 87.39 30.21 67.82 8.19 10.14 64.96 3.09 10.62 coo 2.83 88.63 29.54 1.30 86.82 30.03 76.03 3.33 7.67 77.04 5.28 8.60 coo 2.37 88.32 34.25 2.82 86.58 32.61 75.19 1.98 12.89 77.54 2.36 12.62 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 9 3 # 9 I 142 LYS B 76 LYS^? 25.77 MG MG B 302 I 217 SER B 83 SER^? 24.53 MG MG C 301 I 241 SER B 79 SER^? 20.24 MG MG C 301 coo -5.05 91.11 27.04 -1.24 87.39 30.21 67.82 8.19 10.14 64.96 3.09 10.62 coo 2.83 88.63 29.54 1.30 86.82 30.03 75.19 1.98 12.89 77.54 2.36 12.62 coo 2.37 88.32 34.25 2.82 86.58 32.61 76.03 3.33 7.67 77.04 5.28 8.60 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 10 3 # 10 I 142 LYS B 86 LYS^? 26.44 MG MG B 302 I 217 SER B 83 SER^? 24.53 MG MG C 301 I 241 SER B 79 SER^? 20.24 MG MG C 301 coo -5.05 91.11 27.04 -1.24 87.39 30.21 69.25 10.45 13.86 65.27 7.74 16.08 coo 2.83 88.63 29.54 1.30 86.82 30.03 75.19 1.98 12.89 77.54 2.36 12.62 coo 2.37 88.32 34.25 2.82 86.58 32.61 76.03 3.33 7.67 77.04 5.28 8.60 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 11 3 # 11 I 142 LYS C 61 LYS^? 21.91 MG MG D 302 I 217 SER D 16 SER^? 23.71 MG MG D 302 I 241 SER D 36 SER^? 22.42 MG MG D 302 coo -5.05 91.11 27.04 -1.24 87.39 30.21 93.60 48.56 -24.05 90.39 44.71 -27.98 coo 2.83 88.63 29.54 1.30 86.82 30.03 96.73 48.43 -33.75 98.58 48.68 -32.31 coo 2.37 88.32 34.25 2.82 86.58 32.61 97.85 44.42 -32.20 96.60 46.20 -31.15 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 12 3 # 12 I 142 LYS C 61 LYS^? 21.91 MG MG D 302 I 217 SER D 36 SER^? 22.42 MG MG D 302 I 241 SER D 16 SER^? 23.71 MG MG D 302 coo -5.05 91.11 27.04 -1.24 87.39 30.21 93.60 48.56 -24.05 90.39 44.71 -27.98 coo 2.83 88.63 29.54 1.30 86.82 30.03 97.85 44.42 -32.20 96.60 46.20 -31.15 coo 2.37 88.32 34.25 2.82 86.58 32.61 96.73 48.43 -33.75 98.58 48.68 -32.31 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 13 3 # 13 I 142 LYS C 76 LYS^? 24.95 MG MG C 302 I 217 SER C 79 SER^? 19.92 MG MG B 301 I 241 SER C 83 SER^? 23.40 MG MG B 301 coo -5.05 91.11 27.04 -1.24 87.39 30.21 71.11 8.63 -16.76 75.44 5.17 -16.80 coo 2.83 88.63 29.54 1.30 86.82 30.03 64.38 1.95 -14.66 62.69 3.45 -15.45 coo 2.37 88.32 34.25 2.82 86.58 32.61 65.19 0.76 -19.73 62.87 1.43 -19.33 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 14 3 # 14 I 142 LYS C 76 LYS^? 24.95 MG MG C 302 I 217 SER C 83 SER^? 23.40 MG MG B 301 I 241 SER C 79 SER^? 19.92 MG MG B 301 coo -5.05 91.11 27.04 -1.24 87.39 30.21 71.11 8.63 -16.76 75.44 5.17 -16.80 coo 2.83 88.63 29.54 1.30 86.82 30.03 65.19 0.76 -19.73 62.87 1.43 -19.33 coo 2.37 88.32 34.25 2.82 86.58 32.61 64.38 1.95 -14.66 62.69 3.45 -15.45 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 15 3 # 15 I 142 LYS C 86 LYS^? 27.34 MG MG C 302 I 217 SER C 83 SER^? 23.40 MG MG B 301 I 241 SER C 79 SER^? 19.92 MG MG B 301 coo -5.05 91.11 27.04 -1.24 87.39 30.21 69.22 9.88 -20.56 74.70 7.02 -22.55 coo 2.83 88.63 29.54 1.30 86.82 30.03 65.19 0.76 -19.73 62.87 1.43 -19.33 coo 2.37 88.32 34.25 2.82 86.58 32.61 64.38 1.95 -14.66 62.69 3.45 -15.45 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 16 3 # 16 I 142 LYS D 61 LYS^? 21.93 MG MG C 302 I 217 SER C 16 SER^? 24.15 MG MG C 302 I 241 SER C 36 SER^? 23.69 MG MG C 302 coo -5.05 91.11 27.04 -1.24 87.39 30.21 80.64 11.23 -26.16 80.65 16.24 -22.36 coo 2.83 88.63 29.54 1.30 86.82 30.03 82.88 9.31 -16.30 84.27 7.80 -17.58 coo 2.37 88.32 34.25 2.82 86.58 32.61 86.07 12.19 -17.80 85.34 10.22 -18.98 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 17 3 # 17 I 142 LYS D 61 LYS^? 21.93 MG MG C 302 I 217 SER C 36 SER^? 23.69 MG MG C 302 I 241 SER C 16 SER^? 24.15 MG MG C 302 coo -5.05 91.11 27.04 -1.24 87.39 30.21 80.64 11.23 -26.16 80.65 16.24 -22.36 coo 2.83 88.63 29.54 1.30 86.82 30.03 86.07 12.19 -17.80 85.34 10.22 -18.98 coo 2.37 88.32 34.25 2.82 86.58 32.61 82.88 9.31 -16.30 84.27 7.80 -17.58 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 18 3 # 18 I 142 LYS D 76 LYS^? 25.08 MG MG D 302 I 217 SER D 79 SER^? 19.41 MG MG E 301 I 241 SER D 83 SER^? 23.07 MG MG E 301 coo -5.05 91.11 27.04 -1.24 87.39 30.21 88.18 56.35 -34.05 93.80 56.17 -32.93 coo 2.83 88.63 29.54 1.30 86.82 30.03 88.38 65.91 -36.56 86.13 65.62 -35.70 coo 2.37 88.32 34.25 2.82 86.58 32.61 89.47 66.32 -31.33 87.79 67.80 -32.19 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 19 3 # 19 I 142 LYS D 76 LYS^? 25.08 MG MG D 302 I 217 SER D 83 SER^? 23.07 MG MG E 301 I 241 SER D 79 SER^? 19.41 MG MG E 301 coo -5.05 91.11 27.04 -1.24 87.39 30.21 88.18 56.35 -34.05 93.80 56.17 -32.93 coo 2.83 88.63 29.54 1.30 86.82 30.03 89.47 66.32 -31.33 87.79 67.80 -32.19 coo 2.37 88.32 34.25 2.82 86.58 32.61 88.38 65.91 -36.56 86.13 65.62 -35.70 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 20 3 # 20 I 142 LYS D 86 LYS^? 25.80 MG MG D 302 I 217 SER D 83 SER^? 23.07 MG MG E 301 I 241 SER D 79 SER^? 19.41 MG MG E 301 coo -5.05 91.11 27.04 -1.24 87.39 30.21 85.54 56.79 -30.27 90.24 54.54 -28.62 coo 2.83 88.63 29.54 1.30 86.82 30.03 89.47 66.32 -31.33 87.79 67.80 -32.19 coo 2.37 88.32 34.25 2.82 86.58 32.61 88.38 65.91 -36.56 86.13 65.62 -35.70 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 21 3 # 21 I 142 LYS E 61 LYS^? 22.16 MG MG F 301 I 217 SER F 16 SER^? 24.10 MG MG F 301 I 241 SER F 36 SER^? 23.07 MG MG F 301 coo -5.05 91.11 27.04 -1.24 87.39 30.21 40.99 56.84 -68.48 45.99 56.72 -72.39 coo 2.83 88.63 29.54 1.30 86.82 30.03 39.77 59.81 -78.14 38.80 61.26 -76.65 coo 2.37 88.32 34.25 2.82 86.58 32.61 42.79 62.77 -76.96 42.19 61.23 -75.17 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 22 3 # 22 I 142 LYS E 61 LYS^? 22.16 MG MG F 301 I 217 SER F 36 SER^? 23.07 MG MG F 301 I 241 SER F 16 SER^? 24.10 MG MG F 301 coo -5.05 91.11 27.04 -1.24 87.39 30.21 40.99 56.84 -68.48 45.99 56.72 -72.39 coo 2.83 88.63 29.54 1.30 86.82 30.03 42.79 62.77 -76.96 42.19 61.23 -75.17 coo 2.37 88.32 34.25 2.82 86.58 32.61 39.77 59.81 -78.14 38.80 61.26 -76.65 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 23 3 # 23 I 142 LYS E 76 LYS^? 25.68 MG MG E 302 I 217 SER E 79 SER^? 19.77 MG MG D 301 I 241 SER E 83 SER^? 23.44 MG MG D 301 coo -5.05 91.11 27.04 -1.24 87.39 30.21 87.09 58.11 -60.91 88.65 63.65 -61.27 coo 2.83 88.63 29.54 1.30 86.82 30.03 96.22 56.25 -58.39 95.94 54.06 -59.20 coo 2.37 88.32 34.25 2.82 86.58 32.61 96.88 57.42 -63.66 97.96 55.45 -62.84 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 24 3 # 24 I 142 LYS E 76 LYS^? 25.68 MG MG E 302 I 217 SER E 83 SER^? 23.44 MG MG D 301 I 241 SER E 79 SER^? 19.77 MG MG D 301 coo -5.05 91.11 27.04 -1.24 87.39 30.21 87.09 58.11 -60.91 88.65 63.65 -61.27 coo 2.83 88.63 29.54 1.30 86.82 30.03 96.88 57.42 -63.66 97.96 55.45 -62.84 coo 2.37 88.32 34.25 2.82 86.58 32.61 96.22 56.25 -58.39 95.94 54.06 -59.20 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 25 3 # 25 I 142 LYS E 86 LYS^? 26.73 MG MG D 301 I 217 SER E 83 SER^? 23.44 MG MG D 301 I 241 SER E 79 SER^? 19.77 MG MG D 301 coo -5.05 91.11 27.04 -1.24 87.39 30.21 86.84 54.85 -64.43 87.07 60.83 -66.10 coo 2.83 88.63 29.54 1.30 86.82 30.03 96.88 57.42 -63.66 97.96 55.45 -62.84 coo 2.37 88.32 34.25 2.82 86.58 32.61 96.22 56.25 -58.39 95.94 54.06 -59.20 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 26 3 # 26 I 142 LYS F 61 LYS^? 21.75 MG MG E 302 I 217 SER E 16 SER^? 24.21 MG MG E 302 I 241 SER E 36 SER^? 22.92 MG MG E 302 coo -5.05 91.11 27.04 -1.24 87.39 30.21 80.24 64.12 -71.01 76.23 61.95 -66.39 coo 2.83 88.63 29.54 1.30 86.82 30.03 80.65 67.65 -61.22 81.30 69.49 -62.59 coo 2.37 88.32 34.25 2.82 86.58 32.61 76.63 69.18 -62.93 78.20 67.77 -64.11 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 27 3 # 27 I 142 LYS F 61 LYS^? 21.75 MG MG E 302 I 217 SER E 36 SER^? 22.92 MG MG E 302 I 241 SER E 16 SER^? 24.21 MG MG E 302 coo -5.05 91.11 27.04 -1.24 87.39 30.21 80.24 64.12 -71.01 76.23 61.95 -66.39 coo 2.83 88.63 29.54 1.30 86.82 30.03 76.63 69.18 -62.93 78.20 67.77 -64.11 coo 2.37 88.32 34.25 2.82 86.58 32.61 80.65 67.65 -61.22 81.30 69.49 -62.59 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 28 3 # 28 I 142 LYS F 76 LYS^? 25.89 MG MG F 301 I 217 SER F 79 SER^? 30.22 MG MG F 301 I 241 SER F 83 SER^? 33.16 MG MG F 301 coo -5.05 91.11 27.04 -1.24 87.39 30.21 36.96 48.52 -78.06 33.74 53.37 -77.06 coo 2.83 88.63 29.54 1.30 86.82 30.03 28.21 44.39 -80.24 29.11 42.36 -79.32 coo 2.37 88.32 34.25 2.82 86.58 32.61 27.54 45.11 -75.18 28.33 43.06 -74.18 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 29 3 # 29 I 142 LYS F 76 LYS^? 25.89 MG MG F 301 I 217 SER F 83 SER^? 33.16 MG MG F 301 I 241 SER F 79 SER^? 30.22 MG MG F 301 coo -5.05 91.11 27.04 -1.24 87.39 30.21 36.96 48.52 -78.06 33.74 53.37 -77.06 coo 2.83 88.63 29.54 1.30 86.82 30.03 27.54 45.11 -75.18 28.33 43.06 -74.18 coo 2.37 88.32 34.25 2.82 86.58 32.61 28.21 44.39 -80.24 29.11 42.36 -79.32 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 30 3 # 30 I 142 LYS F 86 LYS^? 26.63 MG MG F 301 I 217 SER F 83 SER^? 33.16 MG MG F 301 I 241 SER F 79 SER^? 30.22 MG MG F 301 coo -5.05 91.11 27.04 -1.24 87.39 30.21 37.89 45.97 -74.42 36.47 51.71 -72.79 coo 2.83 88.63 29.54 1.30 86.82 30.03 27.54 45.11 -75.18 28.33 43.06 -74.18 coo 2.37 88.32 34.25 2.82 86.58 32.61 28.21 44.39 -80.24 29.11 42.36 -79.32 1mt5_c08 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 30 hits 1mt5_c08 naa= 3 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 J 142 LYS A 61 LYS^? 21.99 MG MG B 302 J 217 SER B 16 SER^? 23.97 MG MG B 302 J 241 SER B 36 SER^? 24.04 MG MG B 302 coo -16.11 59.78 61.53 -15.92 58.68 55.43 57.78 7.35 19.60 56.77 12.20 15.61 coo -17.65 54.92 54.17 -15.81 56.46 53.79 56.70 5.18 9.63 55.76 3.58 11.01 coo -19.92 58.10 51.57 -17.75 57.08 51.34 52.58 6.45 11.01 53.61 4.84 12.41 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 J 142 LYS A 61 LYS^? 21.99 MG MG B 302 J 217 SER B 36 SER^? 24.04 MG MG B 302 J 241 SER B 16 SER^? 23.97 MG MG B 302 coo -16.11 59.78 61.53 -15.92 58.68 55.43 57.78 7.35 19.60 56.77 12.20 15.61 coo -17.65 54.92 54.17 -15.81 56.46 53.79 52.58 6.45 11.01 53.61 4.84 12.41 coo -19.92 58.10 51.57 -17.75 57.08 51.34 56.70 5.18 9.63 55.76 3.58 11.01 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 J 142 LYS A 76 LYS^? 25.42 MG MG A 301 J 217 SER A 79 SER^? 29.65 MG MG A 301 J 241 SER A 83 SER^? 32.41 MG MG A 301 coo -16.11 59.78 61.53 -15.92 58.68 55.43 34.45 46.53 27.28 28.88 44.93 27.25 coo -17.65 54.92 54.17 -15.81 56.46 53.79 32.57 55.71 29.63 34.63 56.10 28.47 coo -19.92 58.10 51.57 -17.75 57.08 51.34 30.60 55.84 24.53 32.97 55.99 23.96 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 J 142 LYS A 76 LYS^? 25.42 MG MG A 301 J 217 SER A 83 SER^? 32.41 MG MG A 301 J 241 SER A 79 SER^? 29.65 MG MG A 301 coo -16.11 59.78 61.53 -15.92 58.68 55.43 34.45 46.53 27.28 28.88 44.93 27.25 coo -17.65 54.92 54.17 -15.81 56.46 53.79 30.60 55.84 24.53 32.97 55.99 23.96 coo -19.92 58.10 51.57 -17.75 57.08 51.34 32.57 55.71 29.63 34.63 56.10 28.47 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 J 142 LYS A 86 LYS^? 26.38 MG MG A 301 J 217 SER A 79 SER^? 29.65 MG MG A 301 J 241 SER A 83 SER^? 32.41 MG MG A 301 coo -16.11 59.78 61.53 -15.92 58.68 55.43 37.08 47.78 23.56 32.88 44.24 21.89 coo -17.65 54.92 54.17 -15.81 56.46 53.79 32.57 55.71 29.63 34.63 56.10 28.47 coo -19.92 58.10 51.57 -17.75 57.08 51.34 30.60 55.84 24.53 32.97 55.99 23.96 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 J 142 LYS A 86 LYS^? 26.38 MG MG A 301 J 217 SER A 83 SER^? 32.41 MG MG A 301 J 241 SER A 79 SER^? 29.65 MG MG A 301 coo -16.11 59.78 61.53 -15.92 58.68 55.43 37.08 47.78 23.56 32.88 44.24 21.89 coo -17.65 54.92 54.17 -15.81 56.46 53.79 30.60 55.84 24.53 32.97 55.99 23.96 coo -19.92 58.10 51.57 -17.75 57.08 51.34 32.57 55.71 29.63 34.63 56.10 28.47 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 J 142 LYS B 61 LYS^? 22.03 MG MG A 301 J 217 SER A 16 SER.? 24.16 MG MG A 301 J 241 SER A 36 SER^? 23.25 MG MG A 301 coo -16.11 59.78 61.53 -15.92 58.68 55.43 32.50 37.62 17.61 36.68 34.92 21.51 coo -17.65 54.92 54.17 -15.81 56.46 53.79 29.26 36.32 27.22 27.38 35.99 25.78 coo -19.92 58.10 51.57 -17.75 57.08 51.34 29.88 32.10 25.40 29.53 34.39 24.57 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 J 142 LYS B 61 LYS^? 22.03 MG MG A 301 J 217 SER A 36 SER^? 23.25 MG MG A 301 J 241 SER A 16 SER.? 24.16 MG MG A 301 coo -16.11 59.78 61.53 -15.92 58.68 55.43 32.50 37.62 17.61 36.68 34.92 21.51 coo -17.65 54.92 54.17 -15.81 56.46 53.79 29.88 32.10 25.40 29.53 34.39 24.57 coo -19.92 58.10 51.57 -17.75 57.08 51.34 29.26 36.32 27.22 27.38 35.99 25.78 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 9 3 # 9 J 142 LYS B 76 LYS^? 25.77 MG MG B 302 J 217 SER B 79 SER^? 20.24 MG MG C 301 J 241 SER B 83 SER^? 24.53 MG MG C 301 coo -16.11 59.78 61.53 -15.92 58.68 55.43 67.82 8.19 10.14 64.96 3.09 10.62 coo -17.65 54.92 54.17 -15.81 56.46 53.79 76.03 3.33 7.67 77.04 5.28 8.60 coo -19.92 58.10 51.57 -17.75 57.08 51.34 75.19 1.98 12.89 77.54 2.36 12.62 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 10 3 # 10 J 142 LYS B 76 LYS^? 25.77 MG MG B 302 J 217 SER B 83 SER^? 24.53 MG MG C 301 J 241 SER B 79 SER^? 20.24 MG MG C 301 coo -16.11 59.78 61.53 -15.92 58.68 55.43 67.82 8.19 10.14 64.96 3.09 10.62 coo -17.65 54.92 54.17 -15.81 56.46 53.79 75.19 1.98 12.89 77.54 2.36 12.62 coo -19.92 58.10 51.57 -17.75 57.08 51.34 76.03 3.33 7.67 77.04 5.28 8.60 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 11 3 # 11 J 142 LYS B 86 LYS^? 26.44 MG MG B 302 J 217 SER B 83 SER^? 24.53 MG MG C 301 J 241 SER B 79 SER^? 20.24 MG MG C 301 coo -16.11 59.78 61.53 -15.92 58.68 55.43 69.25 10.45 13.86 65.27 7.74 16.08 coo -17.65 54.92 54.17 -15.81 56.46 53.79 75.19 1.98 12.89 77.54 2.36 12.62 coo -19.92 58.10 51.57 -17.75 57.08 51.34 76.03 3.33 7.67 77.04 5.28 8.60 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 12 3 # 12 J 142 LYS C 61 LYS^? 21.91 MG MG D 302 J 217 SER D 16 SER^? 23.71 MG MG D 302 J 241 SER D 36 SER^? 22.42 MG MG D 302 coo -16.11 59.78 61.53 -15.92 58.68 55.43 93.60 48.56 -24.05 90.39 44.71 -27.98 coo -17.65 54.92 54.17 -15.81 56.46 53.79 96.73 48.43 -33.75 98.58 48.68 -32.31 coo -19.92 58.10 51.57 -17.75 57.08 51.34 97.85 44.42 -32.20 96.60 46.20 -31.15 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 13 3 # 13 J 142 LYS C 61 LYS^? 21.91 MG MG D 302 J 217 SER D 36 SER^? 22.42 MG MG D 302 J 241 SER D 16 SER^? 23.71 MG MG D 302 coo -16.11 59.78 61.53 -15.92 58.68 55.43 93.60 48.56 -24.05 90.39 44.71 -27.98 coo -17.65 54.92 54.17 -15.81 56.46 53.79 97.85 44.42 -32.20 96.60 46.20 -31.15 coo -19.92 58.10 51.57 -17.75 57.08 51.34 96.73 48.43 -33.75 98.58 48.68 -32.31 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 14 3 # 14 J 142 LYS C 76 LYS^? 24.95 MG MG C 302 J 217 SER C 79 SER^? 19.92 MG MG B 301 J 241 SER C 83 SER^? 23.40 MG MG B 301 coo -16.11 59.78 61.53 -15.92 58.68 55.43 71.11 8.63 -16.76 75.44 5.17 -16.80 coo -17.65 54.92 54.17 -15.81 56.46 53.79 64.38 1.95 -14.66 62.69 3.45 -15.45 coo -19.92 58.10 51.57 -17.75 57.08 51.34 65.19 0.76 -19.73 62.87 1.43 -19.33 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 15 3 # 15 J 142 LYS C 76 LYS^? 24.95 MG MG C 302 J 217 SER C 83 SER^? 23.40 MG MG B 301 J 241 SER C 79 SER^? 19.92 MG MG B 301 coo -16.11 59.78 61.53 -15.92 58.68 55.43 71.11 8.63 -16.76 75.44 5.17 -16.80 coo -17.65 54.92 54.17 -15.81 56.46 53.79 65.19 0.76 -19.73 62.87 1.43 -19.33 coo -19.92 58.10 51.57 -17.75 57.08 51.34 64.38 1.95 -14.66 62.69 3.45 -15.45 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 16 3 # 16 J 142 LYS C 86 LYS^? 27.34 MG MG C 302 J 217 SER C 83 SER^? 23.40 MG MG B 301 J 241 SER C 79 SER^? 19.92 MG MG B 301 coo -16.11 59.78 61.53 -15.92 58.68 55.43 69.22 9.88 -20.56 74.70 7.02 -22.55 coo -17.65 54.92 54.17 -15.81 56.46 53.79 65.19 0.76 -19.73 62.87 1.43 -19.33 coo -19.92 58.10 51.57 -17.75 57.08 51.34 64.38 1.95 -14.66 62.69 3.45 -15.45 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 17 3 # 17 J 142 LYS D 61 LYS^? 21.93 MG MG C 302 J 217 SER C 16 SER^? 24.15 MG MG C 302 J 241 SER C 36 SER^? 23.69 MG MG C 302 coo -16.11 59.78 61.53 -15.92 58.68 55.43 80.64 11.23 -26.16 80.65 16.24 -22.36 coo -17.65 54.92 54.17 -15.81 56.46 53.79 82.88 9.31 -16.30 84.27 7.80 -17.58 coo -19.92 58.10 51.57 -17.75 57.08 51.34 86.07 12.19 -17.80 85.34 10.22 -18.98 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 18 3 # 18 J 142 LYS D 61 LYS^? 21.93 MG MG C 302 J 217 SER C 36 SER^? 23.69 MG MG C 302 J 241 SER C 16 SER^? 24.15 MG MG C 302 coo -16.11 59.78 61.53 -15.92 58.68 55.43 80.64 11.23 -26.16 80.65 16.24 -22.36 coo -17.65 54.92 54.17 -15.81 56.46 53.79 86.07 12.19 -17.80 85.34 10.22 -18.98 coo -19.92 58.10 51.57 -17.75 57.08 51.34 82.88 9.31 -16.30 84.27 7.80 -17.58 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 19 3 # 19 J 142 LYS D 76 LYS^? 25.08 MG MG D 302 J 217 SER D 79 SER^? 19.41 MG MG E 301 J 241 SER D 83 SER^? 23.07 MG MG E 301 coo -16.11 59.78 61.53 -15.92 58.68 55.43 88.18 56.35 -34.05 93.80 56.17 -32.93 coo -17.65 54.92 54.17 -15.81 56.46 53.79 88.38 65.91 -36.56 86.13 65.62 -35.70 coo -19.92 58.10 51.57 -17.75 57.08 51.34 89.47 66.32 -31.33 87.79 67.80 -32.19 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 20 3 # 20 J 142 LYS D 76 LYS^? 25.08 MG MG D 302 J 217 SER D 83 SER^? 23.07 MG MG E 301 J 241 SER D 79 SER^? 19.41 MG MG E 301 coo -16.11 59.78 61.53 -15.92 58.68 55.43 88.18 56.35 -34.05 93.80 56.17 -32.93 coo -17.65 54.92 54.17 -15.81 56.46 53.79 89.47 66.32 -31.33 87.79 67.80 -32.19 coo -19.92 58.10 51.57 -17.75 57.08 51.34 88.38 65.91 -36.56 86.13 65.62 -35.70 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 21 3 # 21 J 142 LYS D 86 LYS^? 25.80 MG MG D 302 J 217 SER D 83 SER^? 23.07 MG MG E 301 J 241 SER D 79 SER^? 19.41 MG MG E 301 coo -16.11 59.78 61.53 -15.92 58.68 55.43 85.54 56.79 -30.27 90.24 54.54 -28.62 coo -17.65 54.92 54.17 -15.81 56.46 53.79 89.47 66.32 -31.33 87.79 67.80 -32.19 coo -19.92 58.10 51.57 -17.75 57.08 51.34 88.38 65.91 -36.56 86.13 65.62 -35.70 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 22 3 # 22 J 142 LYS E 61 LYS^? 22.16 MG MG F 301 J 217 SER F 16 SER^? 24.10 MG MG F 301 J 241 SER F 36 SER^? 23.07 MG MG F 301 coo -16.11 59.78 61.53 -15.92 58.68 55.43 40.99 56.84 -68.48 45.99 56.72 -72.39 coo -17.65 54.92 54.17 -15.81 56.46 53.79 39.77 59.81 -78.14 38.80 61.26 -76.65 coo -19.92 58.10 51.57 -17.75 57.08 51.34 42.79 62.77 -76.96 42.19 61.23 -75.17 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 23 3 # 23 J 142 LYS E 61 LYS^? 22.16 MG MG F 301 J 217 SER F 36 SER^? 23.07 MG MG F 301 J 241 SER F 16 SER^? 24.10 MG MG F 301 coo -16.11 59.78 61.53 -15.92 58.68 55.43 40.99 56.84 -68.48 45.99 56.72 -72.39 coo -17.65 54.92 54.17 -15.81 56.46 53.79 42.79 62.77 -76.96 42.19 61.23 -75.17 coo -19.92 58.10 51.57 -17.75 57.08 51.34 39.77 59.81 -78.14 38.80 61.26 -76.65 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 24 3 # 24 J 142 LYS E 76 LYS^? 25.68 MG MG E 302 J 217 SER E 79 SER^? 19.77 MG MG D 301 J 241 SER E 83 SER^? 23.44 MG MG D 301 coo -16.11 59.78 61.53 -15.92 58.68 55.43 87.09 58.11 -60.91 88.65 63.65 -61.27 coo -17.65 54.92 54.17 -15.81 56.46 53.79 96.22 56.25 -58.39 95.94 54.06 -59.20 coo -19.92 58.10 51.57 -17.75 57.08 51.34 96.88 57.42 -63.66 97.96 55.45 -62.84 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 25 3 # 25 J 142 LYS E 76 LYS^? 25.68 MG MG E 302 J 217 SER E 83 SER^? 23.44 MG MG D 301 J 241 SER E 79 SER^? 19.77 MG MG D 301 coo -16.11 59.78 61.53 -15.92 58.68 55.43 87.09 58.11 -60.91 88.65 63.65 -61.27 coo -17.65 54.92 54.17 -15.81 56.46 53.79 96.88 57.42 -63.66 97.96 55.45 -62.84 coo -19.92 58.10 51.57 -17.75 57.08 51.34 96.22 56.25 -58.39 95.94 54.06 -59.20 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 26 3 # 26 J 142 LYS E 86 LYS^? 26.73 MG MG D 301 J 217 SER E 83 SER^? 23.44 MG MG D 301 J 241 SER E 79 SER^? 19.77 MG MG D 301 coo -16.11 59.78 61.53 -15.92 58.68 55.43 86.84 54.85 -64.43 87.07 60.83 -66.10 coo -17.65 54.92 54.17 -15.81 56.46 53.79 96.88 57.42 -63.66 97.96 55.45 -62.84 coo -19.92 58.10 51.57 -17.75 57.08 51.34 96.22 56.25 -58.39 95.94 54.06 -59.20 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 27 3 # 27 J 142 LYS F 61 LYS^? 21.75 MG MG E 302 J 217 SER E 16 SER^? 24.21 MG MG E 302 J 241 SER E 36 SER^? 22.92 MG MG E 302 coo -16.11 59.78 61.53 -15.92 58.68 55.43 80.24 64.12 -71.01 76.23 61.95 -66.39 coo -17.65 54.92 54.17 -15.81 56.46 53.79 80.65 67.65 -61.22 81.30 69.49 -62.59 coo -19.92 58.10 51.57 -17.75 57.08 51.34 76.63 69.18 -62.93 78.20 67.77 -64.11 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 28 3 # 28 J 142 LYS F 61 LYS^? 21.75 MG MG E 302 J 217 SER E 36 SER^? 22.92 MG MG E 302 J 241 SER E 16 SER^? 24.21 MG MG E 302 coo -16.11 59.78 61.53 -15.92 58.68 55.43 80.24 64.12 -71.01 76.23 61.95 -66.39 coo -17.65 54.92 54.17 -15.81 56.46 53.79 76.63 69.18 -62.93 78.20 67.77 -64.11 coo -19.92 58.10 51.57 -17.75 57.08 51.34 80.65 67.65 -61.22 81.30 69.49 -62.59 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 29 3 # 29 J 142 LYS F 76 LYS^? 25.89 MG MG F 301 J 217 SER F 79 SER^? 30.22 MG MG F 301 J 241 SER F 83 SER^? 33.16 MG MG F 301 coo -16.11 59.78 61.53 -15.92 58.68 55.43 36.96 48.52 -78.06 33.74 53.37 -77.06 coo -17.65 54.92 54.17 -15.81 56.46 53.79 28.21 44.39 -80.24 29.11 42.36 -79.32 coo -19.92 58.10 51.57 -17.75 57.08 51.34 27.54 45.11 -75.18 28.33 43.06 -74.18 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 30 3 # 30 J 142 LYS F 76 LYS^? 25.89 MG MG F 301 J 217 SER F 83 SER^? 33.16 MG MG F 301 J 241 SER F 79 SER^? 30.22 MG MG F 301 coo -16.11 59.78 61.53 -15.92 58.68 55.43 36.96 48.52 -78.06 33.74 53.37 -77.06 coo -17.65 54.92 54.17 -15.81 56.46 53.79 27.54 45.11 -75.18 28.33 43.06 -74.18 coo -19.92 58.10 51.57 -17.75 57.08 51.34 28.21 44.39 -80.24 29.11 42.36 -79.32 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 31 3 # 31 J 142 LYS F 86 LYS^? 26.63 MG MG F 301 J 217 SER F 83 SER^? 33.16 MG MG F 301 J 241 SER F 79 SER^? 30.22 MG MG F 301 coo -16.11 59.78 61.53 -15.92 58.68 55.43 37.89 45.97 -74.42 36.47 51.71 -72.79 coo -17.65 54.92 54.17 -15.81 56.46 53.79 27.54 45.11 -75.18 28.33 43.06 -74.18 coo -19.92 58.10 51.57 -17.75 57.08 51.34 28.21 44.39 -80.24 29.11 42.36 -79.32 1mt5_c09 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 31 hits 1mt5_c09 naa= 3 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 K 142 LYS A 61 LYS^? 21.99 MG MG B 302 K 217 SER B 16 SER^? 23.97 MG MG B 302 K 241 SER B 36 SER^? 24.04 MG MG B 302 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 57.78 7.35 19.60 56.77 12.20 15.61 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 56.70 5.18 9.63 55.76 3.58 11.01 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 52.58 6.45 11.01 53.61 4.84 12.41 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 K 142 LYS A 61 LYS^? 21.99 MG MG B 302 K 217 SER B 36 SER^? 24.04 MG MG B 302 K 241 SER B 16 SER^? 23.97 MG MG B 302 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 57.78 7.35 19.60 56.77 12.20 15.61 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 52.58 6.45 11.01 53.61 4.84 12.41 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 56.70 5.18 9.63 55.76 3.58 11.01 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 K 142 LYS A 76 LYS^? 25.42 MG MG A 301 K 217 SER A 79 SER^? 29.65 MG MG A 301 K 241 SER A 83 SER^? 32.41 MG MG A 301 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 34.45 46.53 27.28 28.88 44.93 27.25 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 32.57 55.71 29.63 34.63 56.10 28.47 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 30.60 55.84 24.53 32.97 55.99 23.96 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 K 142 LYS A 76 LYS^? 25.42 MG MG A 301 K 217 SER A 83 SER^? 32.41 MG MG A 301 K 241 SER A 79 SER^? 29.65 MG MG A 301 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 34.45 46.53 27.28 28.88 44.93 27.25 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 30.60 55.84 24.53 32.97 55.99 23.96 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 32.57 55.71 29.63 34.63 56.10 28.47 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 K 142 LYS A 86 LYS^? 26.38 MG MG A 301 K 217 SER A 83 SER^? 32.41 MG MG A 301 K 241 SER A 79 SER^? 29.65 MG MG A 301 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 37.08 47.78 23.56 32.88 44.24 21.89 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 30.60 55.84 24.53 32.97 55.99 23.96 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 32.57 55.71 29.63 34.63 56.10 28.47 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 K 142 LYS B 61 LYS^? 22.03 MG MG A 301 K 217 SER A 16 SER.? 24.16 MG MG A 301 K 241 SER A 36 SER^? 23.25 MG MG A 301 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 32.50 37.62 17.61 36.68 34.92 21.51 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 29.26 36.32 27.22 27.38 35.99 25.78 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 29.88 32.10 25.40 29.53 34.39 24.57 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 K 142 LYS B 61 LYS^? 22.03 MG MG A 301 K 217 SER A 36 SER^? 23.25 MG MG A 301 K 241 SER A 16 SER.? 24.16 MG MG A 301 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 32.50 37.62 17.61 36.68 34.92 21.51 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 29.88 32.10 25.40 29.53 34.39 24.57 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 29.26 36.32 27.22 27.38 35.99 25.78 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 K 142 LYS B 76 LYS^? 25.77 MG MG B 302 K 217 SER B 79 SER^? 20.24 MG MG C 301 K 241 SER B 83 SER^? 24.53 MG MG C 301 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 67.82 8.19 10.14 64.96 3.09 10.62 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 76.03 3.33 7.67 77.04 5.28 8.60 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 75.19 1.98 12.89 77.54 2.36 12.62 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 9 3 # 9 K 142 LYS B 76 LYS^? 25.77 MG MG B 302 K 217 SER B 83 SER^? 24.53 MG MG C 301 K 241 SER B 79 SER^? 20.24 MG MG C 301 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 67.82 8.19 10.14 64.96 3.09 10.62 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 75.19 1.98 12.89 77.54 2.36 12.62 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 76.03 3.33 7.67 77.04 5.28 8.60 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 10 3 # 10 K 142 LYS B 86 LYS^? 26.44 MG MG B 302 K 217 SER B 83 SER^? 24.53 MG MG C 301 K 241 SER B 79 SER^? 20.24 MG MG C 301 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 69.25 10.45 13.86 65.27 7.74 16.08 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 75.19 1.98 12.89 77.54 2.36 12.62 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 76.03 3.33 7.67 77.04 5.28 8.60 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 11 3 # 11 K 142 LYS C 61 LYS^? 21.91 MG MG D 302 K 217 SER D 16 SER^? 23.71 MG MG D 302 K 241 SER D 36 SER^? 22.42 MG MG D 302 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 93.60 48.56 -24.05 90.39 44.71 -27.98 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 96.73 48.43 -33.75 98.58 48.68 -32.31 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 97.85 44.42 -32.20 96.60 46.20 -31.15 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 12 3 # 12 K 142 LYS C 61 LYS^? 21.91 MG MG D 302 K 217 SER D 36 SER^? 22.42 MG MG D 302 K 241 SER D 16 SER^? 23.71 MG MG D 302 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 93.60 48.56 -24.05 90.39 44.71 -27.98 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 97.85 44.42 -32.20 96.60 46.20 -31.15 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 96.73 48.43 -33.75 98.58 48.68 -32.31 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 13 3 # 13 K 142 LYS C 76 LYS^? 24.95 MG MG C 302 K 217 SER C 79 SER^? 19.92 MG MG B 301 K 241 SER C 83 SER^? 23.40 MG MG B 301 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 71.11 8.63 -16.76 75.44 5.17 -16.80 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 64.38 1.95 -14.66 62.69 3.45 -15.45 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 65.19 0.76 -19.73 62.87 1.43 -19.33 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 14 3 # 14 K 142 LYS C 76 LYS^? 24.95 MG MG C 302 K 217 SER C 83 SER^? 23.40 MG MG B 301 K 241 SER C 79 SER^? 19.92 MG MG B 301 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 71.11 8.63 -16.76 75.44 5.17 -16.80 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 65.19 0.76 -19.73 62.87 1.43 -19.33 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 64.38 1.95 -14.66 62.69 3.45 -15.45 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 15 3 # 15 K 142 LYS C 86 LYS^? 27.34 MG MG C 302 K 217 SER C 83 SER^? 23.40 MG MG B 301 K 241 SER C 79 SER^? 19.92 MG MG B 301 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 69.22 9.88 -20.56 74.70 7.02 -22.55 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 65.19 0.76 -19.73 62.87 1.43 -19.33 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 64.38 1.95 -14.66 62.69 3.45 -15.45 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 16 3 # 16 K 142 LYS D 61 LYS^? 21.93 MG MG C 302 K 217 SER C 16 SER^? 24.15 MG MG C 302 K 241 SER C 36 SER^? 23.69 MG MG C 302 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 80.64 11.23 -26.16 80.65 16.24 -22.36 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 82.88 9.31 -16.30 84.27 7.80 -17.58 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 86.07 12.19 -17.80 85.34 10.22 -18.98 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 17 3 # 17 K 142 LYS D 61 LYS^? 21.93 MG MG C 302 K 217 SER C 36 SER^? 23.69 MG MG C 302 K 241 SER C 16 SER^? 24.15 MG MG C 302 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 80.64 11.23 -26.16 80.65 16.24 -22.36 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 86.07 12.19 -17.80 85.34 10.22 -18.98 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 82.88 9.31 -16.30 84.27 7.80 -17.58 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 18 3 # 18 K 142 LYS D 76 LYS^? 25.08 MG MG D 302 K 217 SER D 79 SER^? 19.41 MG MG E 301 K 241 SER D 83 SER^? 23.07 MG MG E 301 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 88.18 56.35 -34.05 93.80 56.17 -32.93 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 88.38 65.91 -36.56 86.13 65.62 -35.70 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 89.47 66.32 -31.33 87.79 67.80 -32.19 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 19 3 # 19 K 142 LYS D 76 LYS^? 25.08 MG MG D 302 K 217 SER D 83 SER^? 23.07 MG MG E 301 K 241 SER D 79 SER^? 19.41 MG MG E 301 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 88.18 56.35 -34.05 93.80 56.17 -32.93 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 89.47 66.32 -31.33 87.79 67.80 -32.19 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 88.38 65.91 -36.56 86.13 65.62 -35.70 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 20 3 # 20 K 142 LYS D 86 LYS^? 25.80 MG MG D 302 K 217 SER D 83 SER^? 23.07 MG MG E 301 K 241 SER D 79 SER^? 19.41 MG MG E 301 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 85.54 56.79 -30.27 90.24 54.54 -28.62 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 89.47 66.32 -31.33 87.79 67.80 -32.19 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 88.38 65.91 -36.56 86.13 65.62 -35.70 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 21 3 # 21 K 142 LYS E 61 LYS^? 22.16 MG MG F 301 K 217 SER F 16 SER^? 24.10 MG MG F 301 K 241 SER F 36 SER^? 23.07 MG MG F 301 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 40.99 56.84 -68.48 45.99 56.72 -72.39 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 39.77 59.81 -78.14 38.80 61.26 -76.65 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 42.79 62.77 -76.96 42.19 61.23 -75.17 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 22 3 # 22 K 142 LYS E 61 LYS^? 22.16 MG MG F 301 K 217 SER F 36 SER^? 23.07 MG MG F 301 K 241 SER F 16 SER^? 24.10 MG MG F 301 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 40.99 56.84 -68.48 45.99 56.72 -72.39 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 42.79 62.77 -76.96 42.19 61.23 -75.17 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 39.77 59.81 -78.14 38.80 61.26 -76.65 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 23 3 # 23 K 142 LYS E 76 LYS^? 25.68 MG MG E 302 K 217 SER E 79 SER^? 19.77 MG MG D 301 K 241 SER E 83 SER^? 23.44 MG MG D 301 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 87.09 58.11 -60.91 88.65 63.65 -61.27 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 96.22 56.25 -58.39 95.94 54.06 -59.20 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 96.88 57.42 -63.66 97.96 55.45 -62.84 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 24 3 # 24 K 142 LYS E 76 LYS^? 25.68 MG MG E 302 K 217 SER E 83 SER^? 23.44 MG MG D 301 K 241 SER E 79 SER^? 19.77 MG MG D 301 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 87.09 58.11 -60.91 88.65 63.65 -61.27 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 96.88 57.42 -63.66 97.96 55.45 -62.84 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 96.22 56.25 -58.39 95.94 54.06 -59.20 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 25 3 # 25 K 142 LYS E 86 LYS^? 26.73 MG MG D 301 K 217 SER E 83 SER^? 23.44 MG MG D 301 K 241 SER E 79 SER^? 19.77 MG MG D 301 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 86.84 54.85 -64.43 87.07 60.83 -66.10 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 96.88 57.42 -63.66 97.96 55.45 -62.84 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 96.22 56.25 -58.39 95.94 54.06 -59.20 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 26 3 # 26 K 142 LYS F 61 LYS^? 21.75 MG MG E 302 K 217 SER E 16 SER^? 24.21 MG MG E 302 K 241 SER E 36 SER^? 22.92 MG MG E 302 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 80.24 64.12 -71.01 76.23 61.95 -66.39 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 80.65 67.65 -61.22 81.30 69.49 -62.59 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 76.63 69.18 -62.93 78.20 67.77 -64.11 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 27 3 # 27 K 142 LYS F 61 LYS^? 21.75 MG MG E 302 K 217 SER E 36 SER^? 22.92 MG MG E 302 K 241 SER E 16 SER^? 24.21 MG MG E 302 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 80.24 64.12 -71.01 76.23 61.95 -66.39 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 76.63 69.18 -62.93 78.20 67.77 -64.11 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 80.65 67.65 -61.22 81.30 69.49 -62.59 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 28 3 # 28 K 142 LYS F 76 LYS^? 25.89 MG MG F 301 K 217 SER F 79 SER^? 30.22 MG MG F 301 K 241 SER F 83 SER^? 33.16 MG MG F 301 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 36.96 48.52 -78.06 33.74 53.37 -77.06 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 28.21 44.39 -80.24 29.11 42.36 -79.32 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 27.54 45.11 -75.18 28.33 43.06 -74.18 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 29 3 # 29 K 142 LYS F 76 LYS^? 25.89 MG MG F 301 K 217 SER F 83 SER^? 33.16 MG MG F 301 K 241 SER F 79 SER^? 30.22 MG MG F 301 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 36.96 48.52 -78.06 33.74 53.37 -77.06 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 27.54 45.11 -75.18 28.33 43.06 -74.18 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 28.21 44.39 -80.24 29.11 42.36 -79.32 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 30 3 # 30 K 142 LYS F 86 LYS^? 26.63 MG MG F 301 K 217 SER F 83 SER^? 33.16 MG MG F 301 K 241 SER F 79 SER^? 30.22 MG MG F 301 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 37.89 45.97 -74.42 36.47 51.71 -72.79 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 27.54 45.11 -75.18 28.33 43.06 -74.18 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 28.21 44.39 -80.24 29.11 42.36 -79.32 1mt5_c10 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 30 hits 1mt5_c10 naa= 3 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 L 142 LYS A 61 LYS^? 21.99 MG MG B 302 L 217 SER B 16 SER^? 23.97 MG MG B 302 L 241 SER B 36 SER^? 24.04 MG MG B 302 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 57.78 7.35 19.60 56.77 12.20 15.61 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 56.70 5.18 9.63 55.76 3.58 11.01 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 52.58 6.45 11.01 53.61 4.84 12.41 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 L 142 LYS A 61 LYS^? 21.99 MG MG B 302 L 217 SER B 36 SER^? 24.04 MG MG B 302 L 241 SER B 16 SER^? 23.97 MG MG B 302 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 57.78 7.35 19.60 56.77 12.20 15.61 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 52.58 6.45 11.01 53.61 4.84 12.41 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 56.70 5.18 9.63 55.76 3.58 11.01 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 L 142 LYS A 76 LYS^? 25.42 MG MG A 301 L 217 SER A 79 SER^? 29.65 MG MG A 301 L 241 SER A 83 SER^? 32.41 MG MG A 301 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 34.45 46.53 27.28 28.88 44.93 27.25 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 32.57 55.71 29.63 34.63 56.10 28.47 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 30.60 55.84 24.53 32.97 55.99 23.96 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 L 142 LYS A 76 LYS^? 25.42 MG MG A 301 L 217 SER A 83 SER^? 32.41 MG MG A 301 L 241 SER A 79 SER^? 29.65 MG MG A 301 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 34.45 46.53 27.28 28.88 44.93 27.25 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 30.60 55.84 24.53 32.97 55.99 23.96 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 32.57 55.71 29.63 34.63 56.10 28.47 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 L 142 LYS A 86 LYS^? 26.38 MG MG A 301 L 217 SER A 83 SER^? 32.41 MG MG A 301 L 241 SER A 79 SER^? 29.65 MG MG A 301 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 37.08 47.78 23.56 32.88 44.24 21.89 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 30.60 55.84 24.53 32.97 55.99 23.96 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 32.57 55.71 29.63 34.63 56.10 28.47 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 L 142 LYS B 61 LYS^? 22.03 MG MG A 301 L 217 SER A 16 SER.? 24.16 MG MG A 301 L 241 SER A 36 SER^? 23.25 MG MG A 301 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 32.50 37.62 17.61 36.68 34.92 21.51 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 29.26 36.32 27.22 27.38 35.99 25.78 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 29.88 32.10 25.40 29.53 34.39 24.57 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 L 142 LYS B 61 LYS^? 22.03 MG MG A 301 L 217 SER A 36 SER^? 23.25 MG MG A 301 L 241 SER A 16 SER.? 24.16 MG MG A 301 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 32.50 37.62 17.61 36.68 34.92 21.51 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 29.88 32.10 25.40 29.53 34.39 24.57 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 29.26 36.32 27.22 27.38 35.99 25.78 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 L 142 LYS B 76 LYS^? 25.77 MG MG B 302 L 217 SER B 79 SER^? 20.24 MG MG C 301 L 241 SER B 83 SER^? 24.53 MG MG C 301 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 67.82 8.19 10.14 64.96 3.09 10.62 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 76.03 3.33 7.67 77.04 5.28 8.60 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 75.19 1.98 12.89 77.54 2.36 12.62 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 9 3 # 9 L 142 LYS B 76 LYS^? 25.77 MG MG B 302 L 217 SER B 83 SER^? 24.53 MG MG C 301 L 241 SER B 79 SER^? 20.24 MG MG C 301 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 67.82 8.19 10.14 64.96 3.09 10.62 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 75.19 1.98 12.89 77.54 2.36 12.62 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 76.03 3.33 7.67 77.04 5.28 8.60 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 10 3 # 10 L 142 LYS B 86 LYS^? 26.44 MG MG B 302 L 217 SER B 83 SER^? 24.53 MG MG C 301 L 241 SER B 79 SER^? 20.24 MG MG C 301 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 69.25 10.45 13.86 65.27 7.74 16.08 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 75.19 1.98 12.89 77.54 2.36 12.62 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 76.03 3.33 7.67 77.04 5.28 8.60 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 11 3 # 11 L 142 LYS C 61 LYS^? 21.91 MG MG D 302 L 217 SER D 16 SER^? 23.71 MG MG D 302 L 241 SER D 36 SER^? 22.42 MG MG D 302 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 93.60 48.56 -24.05 90.39 44.71 -27.98 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 96.73 48.43 -33.75 98.58 48.68 -32.31 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 97.85 44.42 -32.20 96.60 46.20 -31.15 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 12 3 # 12 L 142 LYS C 61 LYS^? 21.91 MG MG D 302 L 217 SER D 36 SER^? 22.42 MG MG D 302 L 241 SER D 16 SER^? 23.71 MG MG D 302 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 93.60 48.56 -24.05 90.39 44.71 -27.98 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 97.85 44.42 -32.20 96.60 46.20 -31.15 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 96.73 48.43 -33.75 98.58 48.68 -32.31 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 13 3 # 13 L 142 LYS C 76 LYS^? 24.95 MG MG C 302 L 217 SER C 79 SER^? 19.92 MG MG B 301 L 241 SER C 83 SER^? 23.40 MG MG B 301 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 71.11 8.63 -16.76 75.44 5.17 -16.80 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 64.38 1.95 -14.66 62.69 3.45 -15.45 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 65.19 0.76 -19.73 62.87 1.43 -19.33 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 14 3 # 14 L 142 LYS C 76 LYS^? 24.95 MG MG C 302 L 217 SER C 83 SER^? 23.40 MG MG B 301 L 241 SER C 79 SER^? 19.92 MG MG B 301 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 71.11 8.63 -16.76 75.44 5.17 -16.80 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 65.19 0.76 -19.73 62.87 1.43 -19.33 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 64.38 1.95 -14.66 62.69 3.45 -15.45 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 15 3 # 15 L 142 LYS C 86 LYS^? 27.34 MG MG C 302 L 217 SER C 83 SER^? 23.40 MG MG B 301 L 241 SER C 79 SER^? 19.92 MG MG B 301 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 69.22 9.88 -20.56 74.70 7.02 -22.55 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 65.19 0.76 -19.73 62.87 1.43 -19.33 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 64.38 1.95 -14.66 62.69 3.45 -15.45 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 16 3 # 16 L 142 LYS D 61 LYS^? 21.93 MG MG C 302 L 217 SER C 16 SER^? 24.15 MG MG C 302 L 241 SER C 36 SER^? 23.69 MG MG C 302 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 80.64 11.23 -26.16 80.65 16.24 -22.36 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 82.88 9.31 -16.30 84.27 7.80 -17.58 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 86.07 12.19 -17.80 85.34 10.22 -18.98 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 17 3 # 17 L 142 LYS D 61 LYS^? 21.93 MG MG C 302 L 217 SER C 36 SER^? 23.69 MG MG C 302 L 241 SER C 16 SER^? 24.15 MG MG C 302 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 80.64 11.23 -26.16 80.65 16.24 -22.36 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 86.07 12.19 -17.80 85.34 10.22 -18.98 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 82.88 9.31 -16.30 84.27 7.80 -17.58 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 18 3 # 18 L 142 LYS D 76 LYS^? 25.08 MG MG D 302 L 217 SER D 79 SER^? 19.41 MG MG E 301 L 241 SER D 83 SER^? 23.07 MG MG E 301 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 88.18 56.35 -34.05 93.80 56.17 -32.93 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 88.38 65.91 -36.56 86.13 65.62 -35.70 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 89.47 66.32 -31.33 87.79 67.80 -32.19 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 19 3 # 19 L 142 LYS D 76 LYS^? 25.08 MG MG D 302 L 217 SER D 83 SER^? 23.07 MG MG E 301 L 241 SER D 79 SER^? 19.41 MG MG E 301 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 88.18 56.35 -34.05 93.80 56.17 -32.93 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 89.47 66.32 -31.33 87.79 67.80 -32.19 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 88.38 65.91 -36.56 86.13 65.62 -35.70 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 20 3 # 20 L 142 LYS D 86 LYS^? 25.80 MG MG D 302 L 217 SER D 83 SER^? 23.07 MG MG E 301 L 241 SER D 79 SER^? 19.41 MG MG E 301 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 85.54 56.79 -30.27 90.24 54.54 -28.62 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 89.47 66.32 -31.33 87.79 67.80 -32.19 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 88.38 65.91 -36.56 86.13 65.62 -35.70 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 21 3 # 21 L 142 LYS E 61 LYS^? 22.16 MG MG F 301 L 217 SER F 16 SER^? 24.10 MG MG F 301 L 241 SER F 36 SER^? 23.07 MG MG F 301 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 40.99 56.84 -68.48 45.99 56.72 -72.39 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 39.77 59.81 -78.14 38.80 61.26 -76.65 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 42.79 62.77 -76.96 42.19 61.23 -75.17 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 22 3 # 22 L 142 LYS E 61 LYS^? 22.16 MG MG F 301 L 217 SER F 36 SER^? 23.07 MG MG F 301 L 241 SER F 16 SER^? 24.10 MG MG F 301 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 40.99 56.84 -68.48 45.99 56.72 -72.39 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 42.79 62.77 -76.96 42.19 61.23 -75.17 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 39.77 59.81 -78.14 38.80 61.26 -76.65 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 23 3 # 23 L 142 LYS E 76 LYS^? 25.68 MG MG E 302 L 217 SER E 79 SER^? 19.77 MG MG D 301 L 241 SER E 83 SER^? 23.44 MG MG D 301 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 87.09 58.11 -60.91 88.65 63.65 -61.27 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 96.22 56.25 -58.39 95.94 54.06 -59.20 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 96.88 57.42 -63.66 97.96 55.45 -62.84 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 24 3 # 24 L 142 LYS E 76 LYS^? 25.68 MG MG E 302 L 217 SER E 83 SER^? 23.44 MG MG D 301 L 241 SER E 79 SER^? 19.77 MG MG D 301 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 87.09 58.11 -60.91 88.65 63.65 -61.27 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 96.88 57.42 -63.66 97.96 55.45 -62.84 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 96.22 56.25 -58.39 95.94 54.06 -59.20 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 25 3 # 25 L 142 LYS E 86 LYS^? 26.73 MG MG D 301 L 217 SER E 83 SER^? 23.44 MG MG D 301 L 241 SER E 79 SER^? 19.77 MG MG D 301 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 86.84 54.85 -64.43 87.07 60.83 -66.10 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 96.88 57.42 -63.66 97.96 55.45 -62.84 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 96.22 56.25 -58.39 95.94 54.06 -59.20 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 26 3 # 26 L 142 LYS F 61 LYS^? 21.75 MG MG E 302 L 217 SER E 16 SER^? 24.21 MG MG E 302 L 241 SER E 36 SER^? 22.92 MG MG E 302 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 80.24 64.12 -71.01 76.23 61.95 -66.39 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 80.65 67.65 -61.22 81.30 69.49 -62.59 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 76.63 69.18 -62.93 78.20 67.77 -64.11 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 27 3 # 27 L 142 LYS F 61 LYS^? 21.75 MG MG E 302 L 217 SER E 36 SER^? 22.92 MG MG E 302 L 241 SER E 16 SER^? 24.21 MG MG E 302 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 80.24 64.12 -71.01 76.23 61.95 -66.39 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 76.63 69.18 -62.93 78.20 67.77 -64.11 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 80.65 67.65 -61.22 81.30 69.49 -62.59 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 28 3 # 28 L 142 LYS F 76 LYS^? 25.89 MG MG F 301 L 217 SER F 79 SER^? 30.22 MG MG F 301 L 241 SER F 83 SER^? 33.16 MG MG F 301 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 36.96 48.52 -78.06 33.74 53.37 -77.06 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 28.21 44.39 -80.24 29.11 42.36 -79.32 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 27.54 45.11 -75.18 28.33 43.06 -74.18 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 29 3 # 29 L 142 LYS F 76 LYS^? 25.89 MG MG F 301 L 217 SER F 83 SER^? 33.16 MG MG F 301 L 241 SER F 79 SER^? 30.22 MG MG F 301 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 36.96 48.52 -78.06 33.74 53.37 -77.06 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 27.54 45.11 -75.18 28.33 43.06 -74.18 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 28.21 44.39 -80.24 29.11 42.36 -79.32 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 30 3 # 30 L 142 LYS F 86 LYS^? 26.63 MG MG F 301 L 217 SER F 83 SER^? 33.16 MG MG F 301 L 241 SER F 79 SER^? 30.22 MG MG F 301 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 37.89 45.97 -74.42 36.47 51.71 -72.79 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 27.54 45.11 -75.18 28.33 43.06 -74.18 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 28.21 44.39 -80.24 29.11 42.36 -79.32 1mt5_c11 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 30 hits 1mt5_c11 naa= 3 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 M 142 LYS A 61 LYS^? 21.99 MG MG B 302 M 217 SER B 16 SER^? 23.97 MG MG B 302 M 241 SER B 36 SER^? 24.04 MG MG B 302 coo 57.83 99.61 24.25 54.90 95.14 20.60 57.78 7.35 19.60 56.77 12.20 15.61 coo 51.07 94.66 21.52 53.18 93.49 22.20 56.70 5.18 9.63 55.76 3.58 11.01 coo 51.67 94.23 16.93 51.60 92.47 18.57 52.58 6.45 11.01 53.61 4.84 12.41 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 M 142 LYS A 61 LYS^? 21.99 MG MG B 302 M 217 SER B 36 SER^? 24.04 MG MG B 302 M 241 SER B 16 SER^? 23.97 MG MG B 302 coo 57.83 99.61 24.25 54.90 95.14 20.60 57.78 7.35 19.60 56.77 12.20 15.61 coo 51.07 94.66 21.52 53.18 93.49 22.20 52.58 6.45 11.01 53.61 4.84 12.41 coo 51.67 94.23 16.93 51.60 92.47 18.57 56.70 5.18 9.63 55.76 3.58 11.01 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 M 142 LYS A 76 LYS^? 25.42 MG MG A 301 M 217 SER A 79 SER^? 29.65 MG MG A 301 M 241 SER A 83 SER^? 32.41 MG MG A 301 coo 57.83 99.61 24.25 54.90 95.14 20.60 34.45 46.53 27.28 28.88 44.93 27.25 coo 51.07 94.66 21.52 53.18 93.49 22.20 32.57 55.71 29.63 34.63 56.10 28.47 coo 51.67 94.23 16.93 51.60 92.47 18.57 30.60 55.84 24.53 32.97 55.99 23.96 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 M 142 LYS A 76 LYS^? 25.42 MG MG A 301 M 217 SER A 83 SER^? 32.41 MG MG A 301 M 241 SER A 79 SER^? 29.65 MG MG A 301 coo 57.83 99.61 24.25 54.90 95.14 20.60 34.45 46.53 27.28 28.88 44.93 27.25 coo 51.07 94.66 21.52 53.18 93.49 22.20 30.60 55.84 24.53 32.97 55.99 23.96 coo 51.67 94.23 16.93 51.60 92.47 18.57 32.57 55.71 29.63 34.63 56.10 28.47 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 M 142 LYS A 86 LYS^? 26.38 MG MG A 301 M 217 SER A 83 SER^? 32.41 MG MG A 301 M 241 SER A 79 SER^? 29.65 MG MG A 301 coo 57.83 99.61 24.25 54.90 95.14 20.60 37.08 47.78 23.56 32.88 44.24 21.89 coo 51.07 94.66 21.52 53.18 93.49 22.20 30.60 55.84 24.53 32.97 55.99 23.96 coo 51.67 94.23 16.93 51.60 92.47 18.57 32.57 55.71 29.63 34.63 56.10 28.47 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 M 142 LYS B 61 LYS^? 22.03 MG MG A 301 M 217 SER A 16 SER.? 24.16 MG MG A 301 M 241 SER A 36 SER^? 23.25 MG MG A 301 coo 57.83 99.61 24.25 54.90 95.14 20.60 32.50 37.62 17.61 36.68 34.92 21.51 coo 51.07 94.66 21.52 53.18 93.49 22.20 29.26 36.32 27.22 27.38 35.99 25.78 coo 51.67 94.23 16.93 51.60 92.47 18.57 29.88 32.10 25.40 29.53 34.39 24.57 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 M 142 LYS B 61 LYS^? 22.03 MG MG A 301 M 217 SER A 36 SER^? 23.25 MG MG A 301 M 241 SER A 16 SER.? 24.16 MG MG A 301 coo 57.83 99.61 24.25 54.90 95.14 20.60 32.50 37.62 17.61 36.68 34.92 21.51 coo 51.07 94.66 21.52 53.18 93.49 22.20 29.88 32.10 25.40 29.53 34.39 24.57 coo 51.67 94.23 16.93 51.60 92.47 18.57 29.26 36.32 27.22 27.38 35.99 25.78 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 M 142 LYS B 76 LYS^? 25.77 MG MG B 302 M 217 SER B 79 SER^? 20.24 MG MG C 301 M 241 SER B 83 SER^? 24.53 MG MG C 301 coo 57.83 99.61 24.25 54.90 95.14 20.60 67.82 8.19 10.14 64.96 3.09 10.62 coo 51.07 94.66 21.52 53.18 93.49 22.20 76.03 3.33 7.67 77.04 5.28 8.60 coo 51.67 94.23 16.93 51.60 92.47 18.57 75.19 1.98 12.89 77.54 2.36 12.62 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 9 3 # 9 M 142 LYS B 76 LYS^? 25.77 MG MG B 302 M 217 SER B 83 SER^? 24.53 MG MG C 301 M 241 SER B 79 SER^? 20.24 MG MG C 301 coo 57.83 99.61 24.25 54.90 95.14 20.60 67.82 8.19 10.14 64.96 3.09 10.62 coo 51.07 94.66 21.52 53.18 93.49 22.20 75.19 1.98 12.89 77.54 2.36 12.62 coo 51.67 94.23 16.93 51.60 92.47 18.57 76.03 3.33 7.67 77.04 5.28 8.60 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 10 3 # 10 M 142 LYS B 86 LYS^? 26.44 MG MG B 302 M 217 SER B 83 SER^? 24.53 MG MG C 301 M 241 SER B 79 SER^? 20.24 MG MG C 301 coo 57.83 99.61 24.25 54.90 95.14 20.60 69.25 10.45 13.86 65.27 7.74 16.08 coo 51.07 94.66 21.52 53.18 93.49 22.20 75.19 1.98 12.89 77.54 2.36 12.62 coo 51.67 94.23 16.93 51.60 92.47 18.57 76.03 3.33 7.67 77.04 5.28 8.60 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 11 3 # 11 M 142 LYS C 61 LYS^? 21.91 MG MG D 302 M 217 SER D 16 SER^? 23.71 MG MG D 302 M 241 SER D 36 SER^? 22.42 MG MG D 302 coo 57.83 99.61 24.25 54.90 95.14 20.60 93.60 48.56 -24.05 90.39 44.71 -27.98 coo 51.07 94.66 21.52 53.18 93.49 22.20 96.73 48.43 -33.75 98.58 48.68 -32.31 coo 51.67 94.23 16.93 51.60 92.47 18.57 97.85 44.42 -32.20 96.60 46.20 -31.15 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 12 3 # 12 M 142 LYS C 61 LYS^? 21.91 MG MG D 302 M 217 SER D 36 SER^? 22.42 MG MG D 302 M 241 SER D 16 SER^? 23.71 MG MG D 302 coo 57.83 99.61 24.25 54.90 95.14 20.60 93.60 48.56 -24.05 90.39 44.71 -27.98 coo 51.07 94.66 21.52 53.18 93.49 22.20 97.85 44.42 -32.20 96.60 46.20 -31.15 coo 51.67 94.23 16.93 51.60 92.47 18.57 96.73 48.43 -33.75 98.58 48.68 -32.31 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 13 3 # 13 M 142 LYS C 76 LYS^? 24.95 MG MG C 302 M 217 SER C 79 SER^? 19.92 MG MG B 301 M 241 SER C 83 SER^? 23.40 MG MG B 301 coo 57.83 99.61 24.25 54.90 95.14 20.60 71.11 8.63 -16.76 75.44 5.17 -16.80 coo 51.07 94.66 21.52 53.18 93.49 22.20 64.38 1.95 -14.66 62.69 3.45 -15.45 coo 51.67 94.23 16.93 51.60 92.47 18.57 65.19 0.76 -19.73 62.87 1.43 -19.33 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 14 3 # 14 M 142 LYS C 76 LYS^? 24.95 MG MG C 302 M 217 SER C 83 SER^? 23.40 MG MG B 301 M 241 SER C 79 SER^? 19.92 MG MG B 301 coo 57.83 99.61 24.25 54.90 95.14 20.60 71.11 8.63 -16.76 75.44 5.17 -16.80 coo 51.07 94.66 21.52 53.18 93.49 22.20 65.19 0.76 -19.73 62.87 1.43 -19.33 coo 51.67 94.23 16.93 51.60 92.47 18.57 64.38 1.95 -14.66 62.69 3.45 -15.45 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 15 3 # 15 M 142 LYS C 86 LYS^? 27.34 MG MG C 302 M 217 SER C 83 SER^? 23.40 MG MG B 301 M 241 SER C 79 SER^? 19.92 MG MG B 301 coo 57.83 99.61 24.25 54.90 95.14 20.60 69.22 9.88 -20.56 74.70 7.02 -22.55 coo 51.07 94.66 21.52 53.18 93.49 22.20 65.19 0.76 -19.73 62.87 1.43 -19.33 coo 51.67 94.23 16.93 51.60 92.47 18.57 64.38 1.95 -14.66 62.69 3.45 -15.45 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 16 3 # 16 M 142 LYS D 61 LYS^? 21.93 MG MG C 302 M 217 SER C 16 SER^? 24.15 MG MG C 302 M 241 SER C 36 SER^? 23.69 MG MG C 302 coo 57.83 99.61 24.25 54.90 95.14 20.60 80.64 11.23 -26.16 80.65 16.24 -22.36 coo 51.07 94.66 21.52 53.18 93.49 22.20 82.88 9.31 -16.30 84.27 7.80 -17.58 coo 51.67 94.23 16.93 51.60 92.47 18.57 86.07 12.19 -17.80 85.34 10.22 -18.98 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 17 3 # 17 M 142 LYS D 61 LYS^? 21.93 MG MG C 302 M 217 SER C 36 SER^? 23.69 MG MG C 302 M 241 SER C 16 SER^? 24.15 MG MG C 302 coo 57.83 99.61 24.25 54.90 95.14 20.60 80.64 11.23 -26.16 80.65 16.24 -22.36 coo 51.07 94.66 21.52 53.18 93.49 22.20 86.07 12.19 -17.80 85.34 10.22 -18.98 coo 51.67 94.23 16.93 51.60 92.47 18.57 82.88 9.31 -16.30 84.27 7.80 -17.58 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 18 3 # 18 M 142 LYS D 76 LYS^? 25.08 MG MG D 302 M 217 SER D 79 SER^? 19.41 MG MG E 301 M 241 SER D 83 SER^? 23.07 MG MG E 301 coo 57.83 99.61 24.25 54.90 95.14 20.60 88.18 56.35 -34.05 93.80 56.17 -32.93 coo 51.07 94.66 21.52 53.18 93.49 22.20 88.38 65.91 -36.56 86.13 65.62 -35.70 coo 51.67 94.23 16.93 51.60 92.47 18.57 89.47 66.32 -31.33 87.79 67.80 -32.19 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 19 3 # 19 M 142 LYS D 76 LYS^? 25.08 MG MG D 302 M 217 SER D 83 SER^? 23.07 MG MG E 301 M 241 SER D 79 SER^? 19.41 MG MG E 301 coo 57.83 99.61 24.25 54.90 95.14 20.60 88.18 56.35 -34.05 93.80 56.17 -32.93 coo 51.07 94.66 21.52 53.18 93.49 22.20 89.47 66.32 -31.33 87.79 67.80 -32.19 coo 51.67 94.23 16.93 51.60 92.47 18.57 88.38 65.91 -36.56 86.13 65.62 -35.70 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 20 3 # 20 M 142 LYS D 86 LYS^? 25.80 MG MG D 302 M 217 SER D 83 SER^? 23.07 MG MG E 301 M 241 SER D 79 SER^? 19.41 MG MG E 301 coo 57.83 99.61 24.25 54.90 95.14 20.60 85.54 56.79 -30.27 90.24 54.54 -28.62 coo 51.07 94.66 21.52 53.18 93.49 22.20 89.47 66.32 -31.33 87.79 67.80 -32.19 coo 51.67 94.23 16.93 51.60 92.47 18.57 88.38 65.91 -36.56 86.13 65.62 -35.70 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 21 3 # 21 M 142 LYS E 61 LYS^? 22.16 MG MG F 301 M 217 SER F 16 SER^? 24.10 MG MG F 301 M 241 SER F 36 SER^? 23.07 MG MG F 301 coo 57.83 99.61 24.25 54.90 95.14 20.60 40.99 56.84 -68.48 45.99 56.72 -72.39 coo 51.07 94.66 21.52 53.18 93.49 22.20 39.77 59.81 -78.14 38.80 61.26 -76.65 coo 51.67 94.23 16.93 51.60 92.47 18.57 42.79 62.77 -76.96 42.19 61.23 -75.17 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 22 3 # 22 M 142 LYS E 61 LYS^? 22.16 MG MG F 301 M 217 SER F 36 SER^? 23.07 MG MG F 301 M 241 SER F 16 SER^? 24.10 MG MG F 301 coo 57.83 99.61 24.25 54.90 95.14 20.60 40.99 56.84 -68.48 45.99 56.72 -72.39 coo 51.07 94.66 21.52 53.18 93.49 22.20 42.79 62.77 -76.96 42.19 61.23 -75.17 coo 51.67 94.23 16.93 51.60 92.47 18.57 39.77 59.81 -78.14 38.80 61.26 -76.65 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 23 3 # 23 M 142 LYS E 76 LYS^? 25.68 MG MG E 302 M 217 SER E 79 SER^? 19.77 MG MG D 301 M 241 SER E 83 SER^? 23.44 MG MG D 301 coo 57.83 99.61 24.25 54.90 95.14 20.60 87.09 58.11 -60.91 88.65 63.65 -61.27 coo 51.07 94.66 21.52 53.18 93.49 22.20 96.22 56.25 -58.39 95.94 54.06 -59.20 coo 51.67 94.23 16.93 51.60 92.47 18.57 96.88 57.42 -63.66 97.96 55.45 -62.84 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 24 3 # 24 M 142 LYS E 76 LYS^? 25.68 MG MG E 302 M 217 SER E 83 SER^? 23.44 MG MG D 301 M 241 SER E 79 SER^? 19.77 MG MG D 301 coo 57.83 99.61 24.25 54.90 95.14 20.60 87.09 58.11 -60.91 88.65 63.65 -61.27 coo 51.07 94.66 21.52 53.18 93.49 22.20 96.88 57.42 -63.66 97.96 55.45 -62.84 coo 51.67 94.23 16.93 51.60 92.47 18.57 96.22 56.25 -58.39 95.94 54.06 -59.20 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 25 3 # 25 M 142 LYS E 86 LYS^? 26.73 MG MG D 301 M 217 SER E 83 SER^? 23.44 MG MG D 301 M 241 SER E 79 SER^? 19.77 MG MG D 301 coo 57.83 99.61 24.25 54.90 95.14 20.60 86.84 54.85 -64.43 87.07 60.83 -66.10 coo 51.07 94.66 21.52 53.18 93.49 22.20 96.88 57.42 -63.66 97.96 55.45 -62.84 coo 51.67 94.23 16.93 51.60 92.47 18.57 96.22 56.25 -58.39 95.94 54.06 -59.20 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 26 3 # 26 M 142 LYS F 61 LYS^? 21.75 MG MG E 302 M 217 SER E 16 SER^? 24.21 MG MG E 302 M 241 SER E 36 SER^? 22.92 MG MG E 302 coo 57.83 99.61 24.25 54.90 95.14 20.60 80.24 64.12 -71.01 76.23 61.95 -66.39 coo 51.07 94.66 21.52 53.18 93.49 22.20 80.65 67.65 -61.22 81.30 69.49 -62.59 coo 51.67 94.23 16.93 51.60 92.47 18.57 76.63 69.18 -62.93 78.20 67.77 -64.11 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 27 3 # 27 M 142 LYS F 61 LYS^? 21.75 MG MG E 302 M 217 SER E 36 SER^? 22.92 MG MG E 302 M 241 SER E 16 SER^? 24.21 MG MG E 302 coo 57.83 99.61 24.25 54.90 95.14 20.60 80.24 64.12 -71.01 76.23 61.95 -66.39 coo 51.07 94.66 21.52 53.18 93.49 22.20 76.63 69.18 -62.93 78.20 67.77 -64.11 coo 51.67 94.23 16.93 51.60 92.47 18.57 80.65 67.65 -61.22 81.30 69.49 -62.59 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 28 3 # 28 M 142 LYS F 76 LYS^? 25.89 MG MG F 301 M 217 SER F 79 SER^? 30.22 MG MG F 301 M 241 SER F 83 SER^? 33.16 MG MG F 301 coo 57.83 99.61 24.25 54.90 95.14 20.60 36.96 48.52 -78.06 33.74 53.37 -77.06 coo 51.07 94.66 21.52 53.18 93.49 22.20 28.21 44.39 -80.24 29.11 42.36 -79.32 coo 51.67 94.23 16.93 51.60 92.47 18.57 27.54 45.11 -75.18 28.33 43.06 -74.18 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 29 3 # 29 M 142 LYS F 76 LYS^? 25.89 MG MG F 301 M 217 SER F 83 SER^? 33.16 MG MG F 301 M 241 SER F 79 SER^? 30.22 MG MG F 301 coo 57.83 99.61 24.25 54.90 95.14 20.60 36.96 48.52 -78.06 33.74 53.37 -77.06 coo 51.07 94.66 21.52 53.18 93.49 22.20 27.54 45.11 -75.18 28.33 43.06 -74.18 coo 51.67 94.23 16.93 51.60 92.47 18.57 28.21 44.39 -80.24 29.11 42.36 -79.32 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 30 3 # 30 M 142 LYS F 86 LYS^? 26.63 MG MG F 301 M 217 SER F 83 SER^? 33.16 MG MG F 301 M 241 SER F 79 SER^? 30.22 MG MG F 301 coo 57.83 99.61 24.25 54.90 95.14 20.60 37.89 45.97 -74.42 36.47 51.71 -72.79 coo 51.07 94.66 21.52 53.18 93.49 22.20 27.54 45.11 -75.18 28.33 43.06 -74.18 coo 51.67 94.23 16.93 51.60 92.47 18.57 28.21 44.39 -80.24 29.11 42.36 -79.32 1mt5_c12 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 30 hits 1mt5_c12 naa= 3 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 N 142 LYS A 61 LYS^? 21.99 MG MG B 302 N 217 SER B 16 SER^? 23.97 MG MG B 302 N 241 SER B 36 SER^? 24.04 MG MG B 302 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 57.78 7.35 19.60 56.77 12.20 15.61 coo 81.67 67.31 -0.58 79.53 68.28 0.00 56.70 5.18 9.63 55.76 3.58 11.01 coo 82.47 71.15 2.07 80.82 69.44 2.28 52.58 6.45 11.01 53.61 4.84 12.41 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 N 142 LYS A 61 LYS^? 21.99 MG MG B 302 N 217 SER B 36 SER^? 24.04 MG MG B 302 N 241 SER B 16 SER^? 23.97 MG MG B 302 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 57.78 7.35 19.60 56.77 12.20 15.61 coo 81.67 67.31 -0.58 79.53 68.28 0.00 52.58 6.45 11.01 53.61 4.84 12.41 coo 82.47 71.15 2.07 80.82 69.44 2.28 56.70 5.18 9.63 55.76 3.58 11.01 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 N 142 LYS A 76 LYS^? 25.42 MG MG A 301 N 217 SER A 79 SER^? 29.65 MG MG A 301 N 241 SER A 83 SER^? 32.41 MG MG A 301 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 34.45 46.53 27.28 28.88 44.93 27.25 coo 81.67 67.31 -0.58 79.53 68.28 0.00 32.57 55.71 29.63 34.63 56.10 28.47 coo 82.47 71.15 2.07 80.82 69.44 2.28 30.60 55.84 24.53 32.97 55.99 23.96 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 N 142 LYS A 76 LYS^? 25.42 MG MG A 301 N 217 SER A 83 SER^? 32.41 MG MG A 301 N 241 SER A 79 SER^? 29.65 MG MG A 301 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 34.45 46.53 27.28 28.88 44.93 27.25 coo 81.67 67.31 -0.58 79.53 68.28 0.00 30.60 55.84 24.53 32.97 55.99 23.96 coo 82.47 71.15 2.07 80.82 69.44 2.28 32.57 55.71 29.63 34.63 56.10 28.47 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 N 142 LYS A 86 LYS^? 26.38 MG MG A 301 N 217 SER A 83 SER^? 32.41 MG MG A 301 N 241 SER A 79 SER^? 29.65 MG MG A 301 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 37.08 47.78 23.56 32.88 44.24 21.89 coo 81.67 67.31 -0.58 79.53 68.28 0.00 30.60 55.84 24.53 32.97 55.99 23.96 coo 82.47 71.15 2.07 80.82 69.44 2.28 32.57 55.71 29.63 34.63 56.10 28.47 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 N 142 LYS B 61 LYS^? 22.03 MG MG A 301 N 217 SER A 16 SER.? 24.16 MG MG A 301 N 241 SER A 36 SER^? 23.25 MG MG A 301 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 32.50 37.62 17.61 36.68 34.92 21.51 coo 81.67 67.31 -0.58 79.53 68.28 0.00 29.26 36.32 27.22 27.38 35.99 25.78 coo 82.47 71.15 2.07 80.82 69.44 2.28 29.88 32.10 25.40 29.53 34.39 24.57 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 N 142 LYS B 61 LYS^? 22.03 MG MG A 301 N 217 SER A 36 SER^? 23.25 MG MG A 301 N 241 SER A 16 SER.? 24.16 MG MG A 301 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 32.50 37.62 17.61 36.68 34.92 21.51 coo 81.67 67.31 -0.58 79.53 68.28 0.00 29.88 32.10 25.40 29.53 34.39 24.57 coo 82.47 71.15 2.07 80.82 69.44 2.28 29.26 36.32 27.22 27.38 35.99 25.78 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 N 142 LYS B 76 LYS^? 25.77 MG MG B 302 N 217 SER B 79 SER^? 20.24 MG MG C 301 N 241 SER B 83 SER^? 24.53 MG MG C 301 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 67.82 8.19 10.14 64.96 3.09 10.62 coo 81.67 67.31 -0.58 79.53 68.28 0.00 76.03 3.33 7.67 77.04 5.28 8.60 coo 82.47 71.15 2.07 80.82 69.44 2.28 75.19 1.98 12.89 77.54 2.36 12.62 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 9 3 # 9 N 142 LYS B 76 LYS^? 25.77 MG MG B 302 N 217 SER B 83 SER^? 24.53 MG MG C 301 N 241 SER B 79 SER^? 20.24 MG MG C 301 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 67.82 8.19 10.14 64.96 3.09 10.62 coo 81.67 67.31 -0.58 79.53 68.28 0.00 75.19 1.98 12.89 77.54 2.36 12.62 coo 82.47 71.15 2.07 80.82 69.44 2.28 76.03 3.33 7.67 77.04 5.28 8.60 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 10 3 # 10 N 142 LYS B 86 LYS^? 26.44 MG MG B 302 N 217 SER B 83 SER^? 24.53 MG MG C 301 N 241 SER B 79 SER^? 20.24 MG MG C 301 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 69.25 10.45 13.86 65.27 7.74 16.08 coo 81.67 67.31 -0.58 79.53 68.28 0.00 75.19 1.98 12.89 77.54 2.36 12.62 coo 82.47 71.15 2.07 80.82 69.44 2.28 76.03 3.33 7.67 77.04 5.28 8.60 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 11 3 # 11 N 142 LYS C 61 LYS^? 21.91 MG MG D 302 N 217 SER D 16 SER^? 23.71 MG MG D 302 N 241 SER D 36 SER^? 22.42 MG MG D 302 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 93.60 48.56 -24.05 90.39 44.71 -27.98 coo 81.67 67.31 -0.58 79.53 68.28 0.00 96.73 48.43 -33.75 98.58 48.68 -32.31 coo 82.47 71.15 2.07 80.82 69.44 2.28 97.85 44.42 -32.20 96.60 46.20 -31.15 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 12 3 # 12 N 142 LYS C 61 LYS^? 21.91 MG MG D 302 N 217 SER D 36 SER^? 22.42 MG MG D 302 N 241 SER D 16 SER^? 23.71 MG MG D 302 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 93.60 48.56 -24.05 90.39 44.71 -27.98 coo 81.67 67.31 -0.58 79.53 68.28 0.00 97.85 44.42 -32.20 96.60 46.20 -31.15 coo 82.47 71.15 2.07 80.82 69.44 2.28 96.73 48.43 -33.75 98.58 48.68 -32.31 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 13 3 # 13 N 142 LYS C 76 LYS^? 24.95 MG MG C 302 N 217 SER C 79 SER^? 19.92 MG MG B 301 N 241 SER C 83 SER^? 23.40 MG MG B 301 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 71.11 8.63 -16.76 75.44 5.17 -16.80 coo 81.67 67.31 -0.58 79.53 68.28 0.00 64.38 1.95 -14.66 62.69 3.45 -15.45 coo 82.47 71.15 2.07 80.82 69.44 2.28 65.19 0.76 -19.73 62.87 1.43 -19.33 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 14 3 # 14 N 142 LYS C 76 LYS^? 24.95 MG MG C 302 N 217 SER C 83 SER^? 23.40 MG MG B 301 N 241 SER C 79 SER^? 19.92 MG MG B 301 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 71.11 8.63 -16.76 75.44 5.17 -16.80 coo 81.67 67.31 -0.58 79.53 68.28 0.00 65.19 0.76 -19.73 62.87 1.43 -19.33 coo 82.47 71.15 2.07 80.82 69.44 2.28 64.38 1.95 -14.66 62.69 3.45 -15.45 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 15 3 # 15 N 142 LYS C 86 LYS^? 27.34 MG MG C 302 N 217 SER C 83 SER^? 23.40 MG MG B 301 N 241 SER C 79 SER^? 19.92 MG MG B 301 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 69.22 9.88 -20.56 74.70 7.02 -22.55 coo 81.67 67.31 -0.58 79.53 68.28 0.00 65.19 0.76 -19.73 62.87 1.43 -19.33 coo 82.47 71.15 2.07 80.82 69.44 2.28 64.38 1.95 -14.66 62.69 3.45 -15.45 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 16 3 # 16 N 142 LYS D 61 LYS^? 21.93 MG MG C 302 N 217 SER C 16 SER^? 24.15 MG MG C 302 N 241 SER C 36 SER^? 23.69 MG MG C 302 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 80.64 11.23 -26.16 80.65 16.24 -22.36 coo 81.67 67.31 -0.58 79.53 68.28 0.00 82.88 9.31 -16.30 84.27 7.80 -17.58 coo 82.47 71.15 2.07 80.82 69.44 2.28 86.07 12.19 -17.80 85.34 10.22 -18.98 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 17 3 # 17 N 142 LYS D 61 LYS^? 21.93 MG MG C 302 N 217 SER C 36 SER^? 23.69 MG MG C 302 N 241 SER C 16 SER^? 24.15 MG MG C 302 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 80.64 11.23 -26.16 80.65 16.24 -22.36 coo 81.67 67.31 -0.58 79.53 68.28 0.00 86.07 12.19 -17.80 85.34 10.22 -18.98 coo 82.47 71.15 2.07 80.82 69.44 2.28 82.88 9.31 -16.30 84.27 7.80 -17.58 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 18 3 # 18 N 142 LYS D 76 LYS^? 25.08 MG MG D 302 N 217 SER D 79 SER^? 19.41 MG MG E 301 N 241 SER D 83 SER^? 23.07 MG MG E 301 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 88.18 56.35 -34.05 93.80 56.17 -32.93 coo 81.67 67.31 -0.58 79.53 68.28 0.00 88.38 65.91 -36.56 86.13 65.62 -35.70 coo 82.47 71.15 2.07 80.82 69.44 2.28 89.47 66.32 -31.33 87.79 67.80 -32.19 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 19 3 # 19 N 142 LYS D 76 LYS^? 25.08 MG MG D 302 N 217 SER D 83 SER^? 23.07 MG MG E 301 N 241 SER D 79 SER^? 19.41 MG MG E 301 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 88.18 56.35 -34.05 93.80 56.17 -32.93 coo 81.67 67.31 -0.58 79.53 68.28 0.00 89.47 66.32 -31.33 87.79 67.80 -32.19 coo 82.47 71.15 2.07 80.82 69.44 2.28 88.38 65.91 -36.56 86.13 65.62 -35.70 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 20 3 # 20 N 142 LYS D 86 LYS^? 25.80 MG MG D 302 N 217 SER D 83 SER^? 23.07 MG MG E 301 N 241 SER D 79 SER^? 19.41 MG MG E 301 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 85.54 56.79 -30.27 90.24 54.54 -28.62 coo 81.67 67.31 -0.58 79.53 68.28 0.00 89.47 66.32 -31.33 87.79 67.80 -32.19 coo 82.47 71.15 2.07 80.82 69.44 2.28 88.38 65.91 -36.56 86.13 65.62 -35.70 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 21 3 # 21 N 142 LYS E 61 LYS^? 22.16 MG MG F 301 N 217 SER F 16 SER^? 24.10 MG MG F 301 N 241 SER F 36 SER^? 23.07 MG MG F 301 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 40.99 56.84 -68.48 45.99 56.72 -72.39 coo 81.67 67.31 -0.58 79.53 68.28 0.00 39.77 59.81 -78.14 38.80 61.26 -76.65 coo 82.47 71.15 2.07 80.82 69.44 2.28 42.79 62.77 -76.96 42.19 61.23 -75.17 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 22 3 # 22 N 142 LYS E 61 LYS^? 22.16 MG MG F 301 N 217 SER F 36 SER^? 23.07 MG MG F 301 N 241 SER F 16 SER^? 24.10 MG MG F 301 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 40.99 56.84 -68.48 45.99 56.72 -72.39 coo 81.67 67.31 -0.58 79.53 68.28 0.00 42.79 62.77 -76.96 42.19 61.23 -75.17 coo 82.47 71.15 2.07 80.82 69.44 2.28 39.77 59.81 -78.14 38.80 61.26 -76.65 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 23 3 # 23 N 142 LYS E 76 LYS^? 25.68 MG MG E 302 N 217 SER E 79 SER^? 19.77 MG MG D 301 N 241 SER E 83 SER^? 23.44 MG MG D 301 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 87.09 58.11 -60.91 88.65 63.65 -61.27 coo 81.67 67.31 -0.58 79.53 68.28 0.00 96.22 56.25 -58.39 95.94 54.06 -59.20 coo 82.47 71.15 2.07 80.82 69.44 2.28 96.88 57.42 -63.66 97.96 55.45 -62.84 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 24 3 # 24 N 142 LYS E 76 LYS^? 25.68 MG MG E 302 N 217 SER E 83 SER^? 23.44 MG MG D 301 N 241 SER E 79 SER^? 19.77 MG MG D 301 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 87.09 58.11 -60.91 88.65 63.65 -61.27 coo 81.67 67.31 -0.58 79.53 68.28 0.00 96.88 57.42 -63.66 97.96 55.45 -62.84 coo 82.47 71.15 2.07 80.82 69.44 2.28 96.22 56.25 -58.39 95.94 54.06 -59.20 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 25 3 # 25 N 142 LYS E 86 LYS^? 26.73 MG MG D 301 N 217 SER E 83 SER^? 23.44 MG MG D 301 N 241 SER E 79 SER^? 19.77 MG MG D 301 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 86.84 54.85 -64.43 87.07 60.83 -66.10 coo 81.67 67.31 -0.58 79.53 68.28 0.00 96.88 57.42 -63.66 97.96 55.45 -62.84 coo 82.47 71.15 2.07 80.82 69.44 2.28 96.22 56.25 -58.39 95.94 54.06 -59.20 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 26 3 # 26 N 142 LYS F 61 LYS^? 21.75 MG MG E 302 N 217 SER E 16 SER^? 24.21 MG MG E 302 N 241 SER E 36 SER^? 22.92 MG MG E 302 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 80.24 64.12 -71.01 76.23 61.95 -66.39 coo 81.67 67.31 -0.58 79.53 68.28 0.00 80.65 67.65 -61.22 81.30 69.49 -62.59 coo 82.47 71.15 2.07 80.82 69.44 2.28 76.63 69.18 -62.93 78.20 67.77 -64.11 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 27 3 # 27 N 142 LYS F 61 LYS^? 21.75 MG MG E 302 N 217 SER E 36 SER^? 22.92 MG MG E 302 N 241 SER E 16 SER^? 24.21 MG MG E 302 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 80.24 64.12 -71.01 76.23 61.95 -66.39 coo 81.67 67.31 -0.58 79.53 68.28 0.00 76.63 69.18 -62.93 78.20 67.77 -64.11 coo 82.47 71.15 2.07 80.82 69.44 2.28 80.65 67.65 -61.22 81.30 69.49 -62.59 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 28 3 # 28 N 142 LYS F 76 LYS^? 25.89 MG MG F 301 N 217 SER F 79 SER^? 30.22 MG MG F 301 N 241 SER F 83 SER^? 33.16 MG MG F 301 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 36.96 48.52 -78.06 33.74 53.37 -77.06 coo 81.67 67.31 -0.58 79.53 68.28 0.00 28.21 44.39 -80.24 29.11 42.36 -79.32 coo 82.47 71.15 2.07 80.82 69.44 2.28 27.54 45.11 -75.18 28.33 43.06 -74.18 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 29 3 # 29 N 142 LYS F 76 LYS^? 25.89 MG MG F 301 N 217 SER F 83 SER^? 33.16 MG MG F 301 N 241 SER F 79 SER^? 30.22 MG MG F 301 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 36.96 48.52 -78.06 33.74 53.37 -77.06 coo 81.67 67.31 -0.58 79.53 68.28 0.00 27.54 45.11 -75.18 28.33 43.06 -74.18 coo 82.47 71.15 2.07 80.82 69.44 2.28 28.21 44.39 -80.24 29.11 42.36 -79.32 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 30 3 # 30 N 142 LYS F 86 LYS^? 26.63 MG MG F 301 N 217 SER F 83 SER^? 33.16 MG MG F 301 N 241 SER F 79 SER^? 30.22 MG MG F 301 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 37.89 45.97 -74.42 36.47 51.71 -72.79 coo 81.67 67.31 -0.58 79.53 68.28 0.00 27.54 45.11 -75.18 28.33 43.06 -74.18 coo 82.47 71.15 2.07 80.82 69.44 2.28 28.21 44.39 -80.24 29.11 42.36 -79.32 1mt5_c13 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 30 hits 1mt5_c13 naa= 3 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 O 142 LYS A 61 LYS^? 21.99 MG MG B 302 O 217 SER B 16 SER^? 23.97 MG MG B 302 O 241 SER B 36 SER^? 24.04 MG MG B 302 coo 81.67 70.12 58.71 78.82 64.87 57.22 57.78 7.35 19.60 56.77 12.20 15.61 coo 81.62 62.23 55.05 79.32 62.93 55.20 56.70 5.18 9.63 55.76 3.58 11.01 coo 79.39 59.54 58.42 78.72 60.00 56.11 52.58 6.45 11.01 53.61 4.84 12.41 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 O 142 LYS A 61 LYS^? 21.99 MG MG B 302 O 217 SER B 36 SER^? 24.04 MG MG B 302 O 241 SER B 16 SER^? 23.97 MG MG B 302 coo 81.67 70.12 58.71 78.82 64.87 57.22 57.78 7.35 19.60 56.77 12.20 15.61 coo 81.62 62.23 55.05 79.32 62.93 55.20 52.58 6.45 11.01 53.61 4.84 12.41 coo 79.39 59.54 58.42 78.72 60.00 56.11 56.70 5.18 9.63 55.76 3.58 11.01 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 O 142 LYS A 76 LYS^? 25.42 MG MG A 301 O 217 SER A 79 SER^? 29.65 MG MG A 301 O 241 SER A 83 SER^? 32.41 MG MG A 301 coo 81.67 70.12 58.71 78.82 64.87 57.22 34.45 46.53 27.28 28.88 44.93 27.25 coo 81.62 62.23 55.05 79.32 62.93 55.20 32.57 55.71 29.63 34.63 56.10 28.47 coo 79.39 59.54 58.42 78.72 60.00 56.11 30.60 55.84 24.53 32.97 55.99 23.96 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 O 142 LYS A 76 LYS^? 25.42 MG MG A 301 O 217 SER A 83 SER^? 32.41 MG MG A 301 O 241 SER A 79 SER^? 29.65 MG MG A 301 coo 81.67 70.12 58.71 78.82 64.87 57.22 34.45 46.53 27.28 28.88 44.93 27.25 coo 81.62 62.23 55.05 79.32 62.93 55.20 30.60 55.84 24.53 32.97 55.99 23.96 coo 79.39 59.54 58.42 78.72 60.00 56.11 32.57 55.71 29.63 34.63 56.10 28.47 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 O 142 LYS A 86 LYS^? 26.38 MG MG A 301 O 217 SER A 83 SER^? 32.41 MG MG A 301 O 241 SER A 79 SER^? 29.65 MG MG A 301 coo 81.67 70.12 58.71 78.82 64.87 57.22 37.08 47.78 23.56 32.88 44.24 21.89 coo 81.62 62.23 55.05 79.32 62.93 55.20 30.60 55.84 24.53 32.97 55.99 23.96 coo 79.39 59.54 58.42 78.72 60.00 56.11 32.57 55.71 29.63 34.63 56.10 28.47 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 O 142 LYS B 61 LYS^? 22.03 MG MG A 301 O 217 SER A 16 SER.? 24.16 MG MG A 301 O 241 SER A 36 SER^? 23.25 MG MG A 301 coo 81.67 70.12 58.71 78.82 64.87 57.22 32.50 37.62 17.61 36.68 34.92 21.51 coo 81.62 62.23 55.05 79.32 62.93 55.20 29.26 36.32 27.22 27.38 35.99 25.78 coo 79.39 59.54 58.42 78.72 60.00 56.11 29.88 32.10 25.40 29.53 34.39 24.57 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 O 142 LYS B 61 LYS^? 22.03 MG MG A 301 O 217 SER A 36 SER^? 23.25 MG MG A 301 O 241 SER A 16 SER.? 24.16 MG MG A 301 coo 81.67 70.12 58.71 78.82 64.87 57.22 32.50 37.62 17.61 36.68 34.92 21.51 coo 81.62 62.23 55.05 79.32 62.93 55.20 29.88 32.10 25.40 29.53 34.39 24.57 coo 79.39 59.54 58.42 78.72 60.00 56.11 29.26 36.32 27.22 27.38 35.99 25.78 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 O 142 LYS B 76 LYS^? 25.77 MG MG B 302 O 217 SER B 79 SER^? 20.24 MG MG C 301 O 241 SER B 83 SER^? 24.53 MG MG C 301 coo 81.67 70.12 58.71 78.82 64.87 57.22 67.82 8.19 10.14 64.96 3.09 10.62 coo 81.62 62.23 55.05 79.32 62.93 55.20 76.03 3.33 7.67 77.04 5.28 8.60 coo 79.39 59.54 58.42 78.72 60.00 56.11 75.19 1.98 12.89 77.54 2.36 12.62 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 9 3 # 9 O 142 LYS B 76 LYS^? 25.77 MG MG B 302 O 217 SER B 83 SER^? 24.53 MG MG C 301 O 241 SER B 79 SER^? 20.24 MG MG C 301 coo 81.67 70.12 58.71 78.82 64.87 57.22 67.82 8.19 10.14 64.96 3.09 10.62 coo 81.62 62.23 55.05 79.32 62.93 55.20 75.19 1.98 12.89 77.54 2.36 12.62 coo 79.39 59.54 58.42 78.72 60.00 56.11 76.03 3.33 7.67 77.04 5.28 8.60 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 10 3 # 10 O 142 LYS B 86 LYS^? 26.44 MG MG B 302 O 217 SER B 83 SER^? 24.53 MG MG C 301 O 241 SER B 79 SER^? 20.24 MG MG C 301 coo 81.67 70.12 58.71 78.82 64.87 57.22 69.25 10.45 13.86 65.27 7.74 16.08 coo 81.62 62.23 55.05 79.32 62.93 55.20 75.19 1.98 12.89 77.54 2.36 12.62 coo 79.39 59.54 58.42 78.72 60.00 56.11 76.03 3.33 7.67 77.04 5.28 8.60 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 11 3 # 11 O 142 LYS C 61 LYS^? 21.91 MG MG D 302 O 217 SER D 16 SER^? 23.71 MG MG D 302 O 241 SER D 36 SER^? 22.42 MG MG D 302 coo 81.67 70.12 58.71 78.82 64.87 57.22 93.60 48.56 -24.05 90.39 44.71 -27.98 coo 81.62 62.23 55.05 79.32 62.93 55.20 96.73 48.43 -33.75 98.58 48.68 -32.31 coo 79.39 59.54 58.42 78.72 60.00 56.11 97.85 44.42 -32.20 96.60 46.20 -31.15 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 12 3 # 12 O 142 LYS C 61 LYS^? 21.91 MG MG D 302 O 217 SER D 36 SER^? 22.42 MG MG D 302 O 241 SER D 16 SER^? 23.71 MG MG D 302 coo 81.67 70.12 58.71 78.82 64.87 57.22 93.60 48.56 -24.05 90.39 44.71 -27.98 coo 81.62 62.23 55.05 79.32 62.93 55.20 97.85 44.42 -32.20 96.60 46.20 -31.15 coo 79.39 59.54 58.42 78.72 60.00 56.11 96.73 48.43 -33.75 98.58 48.68 -32.31 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 13 3 # 13 O 142 LYS C 76 LYS^? 24.95 MG MG C 302 O 217 SER C 79 SER^? 19.92 MG MG B 301 O 241 SER C 83 SER^? 23.40 MG MG B 301 coo 81.67 70.12 58.71 78.82 64.87 57.22 71.11 8.63 -16.76 75.44 5.17 -16.80 coo 81.62 62.23 55.05 79.32 62.93 55.20 64.38 1.95 -14.66 62.69 3.45 -15.45 coo 79.39 59.54 58.42 78.72 60.00 56.11 65.19 0.76 -19.73 62.87 1.43 -19.33 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 14 3 # 14 O 142 LYS C 76 LYS^? 24.95 MG MG C 302 O 217 SER C 83 SER^? 23.40 MG MG B 301 O 241 SER C 79 SER^? 19.92 MG MG B 301 coo 81.67 70.12 58.71 78.82 64.87 57.22 71.11 8.63 -16.76 75.44 5.17 -16.80 coo 81.62 62.23 55.05 79.32 62.93 55.20 65.19 0.76 -19.73 62.87 1.43 -19.33 coo 79.39 59.54 58.42 78.72 60.00 56.11 64.38 1.95 -14.66 62.69 3.45 -15.45 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 15 3 # 15 O 142 LYS C 86 LYS^? 27.34 MG MG C 302 O 217 SER C 83 SER^? 23.40 MG MG B 301 O 241 SER C 79 SER^? 19.92 MG MG B 301 coo 81.67 70.12 58.71 78.82 64.87 57.22 69.22 9.88 -20.56 74.70 7.02 -22.55 coo 81.62 62.23 55.05 79.32 62.93 55.20 65.19 0.76 -19.73 62.87 1.43 -19.33 coo 79.39 59.54 58.42 78.72 60.00 56.11 64.38 1.95 -14.66 62.69 3.45 -15.45 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 16 3 # 16 O 142 LYS D 61 LYS^? 21.93 MG MG C 302 O 217 SER C 16 SER^? 24.15 MG MG C 302 O 241 SER C 36 SER^? 23.69 MG MG C 302 coo 81.67 70.12 58.71 78.82 64.87 57.22 80.64 11.23 -26.16 80.65 16.24 -22.36 coo 81.62 62.23 55.05 79.32 62.93 55.20 82.88 9.31 -16.30 84.27 7.80 -17.58 coo 79.39 59.54 58.42 78.72 60.00 56.11 86.07 12.19 -17.80 85.34 10.22 -18.98 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 17 3 # 17 O 142 LYS D 61 LYS^? 21.93 MG MG C 302 O 217 SER C 36 SER^? 23.69 MG MG C 302 O 241 SER C 16 SER^? 24.15 MG MG C 302 coo 81.67 70.12 58.71 78.82 64.87 57.22 80.64 11.23 -26.16 80.65 16.24 -22.36 coo 81.62 62.23 55.05 79.32 62.93 55.20 86.07 12.19 -17.80 85.34 10.22 -18.98 coo 79.39 59.54 58.42 78.72 60.00 56.11 82.88 9.31 -16.30 84.27 7.80 -17.58 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 18 3 # 18 O 142 LYS D 76 LYS^? 25.08 MG MG D 302 O 217 SER D 79 SER^? 19.41 MG MG E 301 O 241 SER D 83 SER^? 23.07 MG MG E 301 coo 81.67 70.12 58.71 78.82 64.87 57.22 88.18 56.35 -34.05 93.80 56.17 -32.93 coo 81.62 62.23 55.05 79.32 62.93 55.20 88.38 65.91 -36.56 86.13 65.62 -35.70 coo 79.39 59.54 58.42 78.72 60.00 56.11 89.47 66.32 -31.33 87.79 67.80 -32.19 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 19 3 # 19 O 142 LYS D 76 LYS^? 25.08 MG MG D 302 O 217 SER D 83 SER^? 23.07 MG MG E 301 O 241 SER D 79 SER^? 19.41 MG MG E 301 coo 81.67 70.12 58.71 78.82 64.87 57.22 88.18 56.35 -34.05 93.80 56.17 -32.93 coo 81.62 62.23 55.05 79.32 62.93 55.20 89.47 66.32 -31.33 87.79 67.80 -32.19 coo 79.39 59.54 58.42 78.72 60.00 56.11 88.38 65.91 -36.56 86.13 65.62 -35.70 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 20 3 # 20 O 142 LYS D 86 LYS^? 25.80 MG MG D 302 O 217 SER D 83 SER^? 23.07 MG MG E 301 O 241 SER D 79 SER^? 19.41 MG MG E 301 coo 81.67 70.12 58.71 78.82 64.87 57.22 85.54 56.79 -30.27 90.24 54.54 -28.62 coo 81.62 62.23 55.05 79.32 62.93 55.20 89.47 66.32 -31.33 87.79 67.80 -32.19 coo 79.39 59.54 58.42 78.72 60.00 56.11 88.38 65.91 -36.56 86.13 65.62 -35.70 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 21 3 # 21 O 142 LYS E 61 LYS^? 22.16 MG MG F 301 O 217 SER F 16 SER^? 24.10 MG MG F 301 O 241 SER F 36 SER^? 23.07 MG MG F 301 coo 81.67 70.12 58.71 78.82 64.87 57.22 40.99 56.84 -68.48 45.99 56.72 -72.39 coo 81.62 62.23 55.05 79.32 62.93 55.20 39.77 59.81 -78.14 38.80 61.26 -76.65 coo 79.39 59.54 58.42 78.72 60.00 56.11 42.79 62.77 -76.96 42.19 61.23 -75.17 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 22 3 # 22 O 142 LYS E 61 LYS^? 22.16 MG MG F 301 O 217 SER F 36 SER^? 23.07 MG MG F 301 O 241 SER F 16 SER^? 24.10 MG MG F 301 coo 81.67 70.12 58.71 78.82 64.87 57.22 40.99 56.84 -68.48 45.99 56.72 -72.39 coo 81.62 62.23 55.05 79.32 62.93 55.20 42.79 62.77 -76.96 42.19 61.23 -75.17 coo 79.39 59.54 58.42 78.72 60.00 56.11 39.77 59.81 -78.14 38.80 61.26 -76.65 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 23 3 # 23 O 142 LYS E 76 LYS^? 25.68 MG MG E 302 O 217 SER E 79 SER^? 19.77 MG MG D 301 O 241 SER E 83 SER^? 23.44 MG MG D 301 coo 81.67 70.12 58.71 78.82 64.87 57.22 87.09 58.11 -60.91 88.65 63.65 -61.27 coo 81.62 62.23 55.05 79.32 62.93 55.20 96.22 56.25 -58.39 95.94 54.06 -59.20 coo 79.39 59.54 58.42 78.72 60.00 56.11 96.88 57.42 -63.66 97.96 55.45 -62.84 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 24 3 # 24 O 142 LYS E 76 LYS^? 25.68 MG MG E 302 O 217 SER E 83 SER^? 23.44 MG MG D 301 O 241 SER E 79 SER^? 19.77 MG MG D 301 coo 81.67 70.12 58.71 78.82 64.87 57.22 87.09 58.11 -60.91 88.65 63.65 -61.27 coo 81.62 62.23 55.05 79.32 62.93 55.20 96.88 57.42 -63.66 97.96 55.45 -62.84 coo 79.39 59.54 58.42 78.72 60.00 56.11 96.22 56.25 -58.39 95.94 54.06 -59.20 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 25 3 # 25 O 142 LYS E 86 LYS^? 26.73 MG MG D 301 O 217 SER E 83 SER^? 23.44 MG MG D 301 O 241 SER E 79 SER^? 19.77 MG MG D 301 coo 81.67 70.12 58.71 78.82 64.87 57.22 86.84 54.85 -64.43 87.07 60.83 -66.10 coo 81.62 62.23 55.05 79.32 62.93 55.20 96.88 57.42 -63.66 97.96 55.45 -62.84 coo 79.39 59.54 58.42 78.72 60.00 56.11 96.22 56.25 -58.39 95.94 54.06 -59.20 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 26 3 # 26 O 142 LYS F 61 LYS^? 21.75 MG MG E 302 O 217 SER E 16 SER^? 24.21 MG MG E 302 O 241 SER E 36 SER^? 22.92 MG MG E 302 coo 81.67 70.12 58.71 78.82 64.87 57.22 80.24 64.12 -71.01 76.23 61.95 -66.39 coo 81.62 62.23 55.05 79.32 62.93 55.20 80.65 67.65 -61.22 81.30 69.49 -62.59 coo 79.39 59.54 58.42 78.72 60.00 56.11 76.63 69.18 -62.93 78.20 67.77 -64.11 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 27 3 # 27 O 142 LYS F 61 LYS^? 21.75 MG MG E 302 O 217 SER E 36 SER^? 22.92 MG MG E 302 O 241 SER E 16 SER^? 24.21 MG MG E 302 coo 81.67 70.12 58.71 78.82 64.87 57.22 80.24 64.12 -71.01 76.23 61.95 -66.39 coo 81.62 62.23 55.05 79.32 62.93 55.20 76.63 69.18 -62.93 78.20 67.77 -64.11 coo 79.39 59.54 58.42 78.72 60.00 56.11 80.65 67.65 -61.22 81.30 69.49 -62.59 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 28 3 # 28 O 142 LYS F 76 LYS^? 25.89 MG MG F 301 O 217 SER F 79 SER^? 30.22 MG MG F 301 O 241 SER F 83 SER^? 33.16 MG MG F 301 coo 81.67 70.12 58.71 78.82 64.87 57.22 36.96 48.52 -78.06 33.74 53.37 -77.06 coo 81.62 62.23 55.05 79.32 62.93 55.20 28.21 44.39 -80.24 29.11 42.36 -79.32 coo 79.39 59.54 58.42 78.72 60.00 56.11 27.54 45.11 -75.18 28.33 43.06 -74.18 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 29 3 # 29 O 142 LYS F 76 LYS^? 25.89 MG MG F 301 O 217 SER F 83 SER^? 33.16 MG MG F 301 O 241 SER F 79 SER^? 30.22 MG MG F 301 coo 81.67 70.12 58.71 78.82 64.87 57.22 36.96 48.52 -78.06 33.74 53.37 -77.06 coo 81.62 62.23 55.05 79.32 62.93 55.20 27.54 45.11 -75.18 28.33 43.06 -74.18 coo 79.39 59.54 58.42 78.72 60.00 56.11 28.21 44.39 -80.24 29.11 42.36 -79.32 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 30 3 # 30 O 142 LYS F 86 LYS^? 26.63 MG MG F 301 O 217 SER F 83 SER^? 33.16 MG MG F 301 O 241 SER F 79 SER^? 30.22 MG MG F 301 coo 81.67 70.12 58.71 78.82 64.87 57.22 37.89 45.97 -74.42 36.47 51.71 -72.79 coo 81.62 62.23 55.05 79.32 62.93 55.20 27.54 45.11 -75.18 28.33 43.06 -74.18 coo 79.39 59.54 58.42 78.72 60.00 56.11 28.21 44.39 -80.24 29.11 42.36 -79.32 1mt5_c14 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 30 hits 1mt5_c14 naa= 3 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 P 142 LYS A 61 LYS^? 21.99 MG MG B 302 P 217 SER B 16 SER^? 23.97 MG MG B 302 P 241 SER B 36 SER^? 24.04 MG MG B 302 coo 37.29 55.72 69.54 38.73 59.85 65.07 57.78 7.35 19.60 56.77 12.20 15.61 coo 35.55 61.40 62.96 37.72 60.41 62.66 56.70 5.18 9.63 55.76 3.58 11.01 coo 38.60 64.77 64.10 38.63 63.28 62.26 52.58 6.45 11.01 53.61 4.84 12.41 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 P 142 LYS A 61 LYS^? 21.99 MG MG B 302 P 217 SER B 36 SER^? 24.04 MG MG B 302 P 241 SER B 16 SER^? 23.97 MG MG B 302 coo 37.29 55.72 69.54 38.73 59.85 65.07 57.78 7.35 19.60 56.77 12.20 15.61 coo 35.55 61.40 62.96 37.72 60.41 62.66 52.58 6.45 11.01 53.61 4.84 12.41 coo 38.60 64.77 64.10 38.63 63.28 62.26 56.70 5.18 9.63 55.76 3.58 11.01 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 P 142 LYS A 76 LYS^? 25.42 MG MG A 301 P 217 SER A 79 SER^? 29.65 MG MG A 301 P 241 SER A 83 SER^? 32.41 MG MG A 301 coo 37.29 55.72 69.54 38.73 59.85 65.07 34.45 46.53 27.28 28.88 44.93 27.25 coo 35.55 61.40 62.96 37.72 60.41 62.66 32.57 55.71 29.63 34.63 56.10 28.47 coo 38.60 64.77 64.10 38.63 63.28 62.26 30.60 55.84 24.53 32.97 55.99 23.96 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 P 142 LYS A 76 LYS^? 25.42 MG MG A 301 P 217 SER A 83 SER^? 32.41 MG MG A 301 P 241 SER A 79 SER^? 29.65 MG MG A 301 coo 37.29 55.72 69.54 38.73 59.85 65.07 34.45 46.53 27.28 28.88 44.93 27.25 coo 35.55 61.40 62.96 37.72 60.41 62.66 30.60 55.84 24.53 32.97 55.99 23.96 coo 38.60 64.77 64.10 38.63 63.28 62.26 32.57 55.71 29.63 34.63 56.10 28.47 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 P 142 LYS A 86 LYS^? 26.38 MG MG A 301 P 217 SER A 83 SER^? 32.41 MG MG A 301 P 241 SER A 79 SER^? 29.65 MG MG A 301 coo 37.29 55.72 69.54 38.73 59.85 65.07 37.08 47.78 23.56 32.88 44.24 21.89 coo 35.55 61.40 62.96 37.72 60.41 62.66 30.60 55.84 24.53 32.97 55.99 23.96 coo 38.60 64.77 64.10 38.63 63.28 62.26 32.57 55.71 29.63 34.63 56.10 28.47 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 P 142 LYS B 61 LYS^? 22.03 MG MG A 301 P 217 SER A 16 SER.? 24.16 MG MG A 301 P 241 SER A 36 SER^? 23.25 MG MG A 301 coo 37.29 55.72 69.54 38.73 59.85 65.07 32.50 37.62 17.61 36.68 34.92 21.51 coo 35.55 61.40 62.96 37.72 60.41 62.66 29.26 36.32 27.22 27.38 35.99 25.78 coo 38.60 64.77 64.10 38.63 63.28 62.26 29.88 32.10 25.40 29.53 34.39 24.57 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 P 142 LYS B 61 LYS^? 22.03 MG MG A 301 P 217 SER A 36 SER^? 23.25 MG MG A 301 P 241 SER A 16 SER.? 24.16 MG MG A 301 coo 37.29 55.72 69.54 38.73 59.85 65.07 32.50 37.62 17.61 36.68 34.92 21.51 coo 35.55 61.40 62.96 37.72 60.41 62.66 29.88 32.10 25.40 29.53 34.39 24.57 coo 38.60 64.77 64.10 38.63 63.28 62.26 29.26 36.32 27.22 27.38 35.99 25.78 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 P 142 LYS B 76 LYS^? 25.77 MG MG B 302 P 217 SER B 79 SER^? 20.24 MG MG C 301 P 241 SER B 83 SER^? 24.53 MG MG C 301 coo 37.29 55.72 69.54 38.73 59.85 65.07 67.82 8.19 10.14 64.96 3.09 10.62 coo 35.55 61.40 62.96 37.72 60.41 62.66 76.03 3.33 7.67 77.04 5.28 8.60 coo 38.60 64.77 64.10 38.63 63.28 62.26 75.19 1.98 12.89 77.54 2.36 12.62 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 9 3 # 9 P 142 LYS B 76 LYS^? 25.77 MG MG B 302 P 217 SER B 83 SER^? 24.53 MG MG C 301 P 241 SER B 79 SER^? 20.24 MG MG C 301 coo 37.29 55.72 69.54 38.73 59.85 65.07 67.82 8.19 10.14 64.96 3.09 10.62 coo 35.55 61.40 62.96 37.72 60.41 62.66 75.19 1.98 12.89 77.54 2.36 12.62 coo 38.60 64.77 64.10 38.63 63.28 62.26 76.03 3.33 7.67 77.04 5.28 8.60 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 10 3 # 10 P 142 LYS B 86 LYS^? 26.44 MG MG B 302 P 217 SER B 83 SER^? 24.53 MG MG C 301 P 241 SER B 79 SER^? 20.24 MG MG C 301 coo 37.29 55.72 69.54 38.73 59.85 65.07 69.25 10.45 13.86 65.27 7.74 16.08 coo 35.55 61.40 62.96 37.72 60.41 62.66 75.19 1.98 12.89 77.54 2.36 12.62 coo 38.60 64.77 64.10 38.63 63.28 62.26 76.03 3.33 7.67 77.04 5.28 8.60 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 11 3 # 11 P 142 LYS C 61 LYS^? 21.91 MG MG D 302 P 217 SER D 16 SER^? 23.71 MG MG D 302 P 241 SER D 36 SER^? 22.42 MG MG D 302 coo 37.29 55.72 69.54 38.73 59.85 65.07 93.60 48.56 -24.05 90.39 44.71 -27.98 coo 35.55 61.40 62.96 37.72 60.41 62.66 96.73 48.43 -33.75 98.58 48.68 -32.31 coo 38.60 64.77 64.10 38.63 63.28 62.26 97.85 44.42 -32.20 96.60 46.20 -31.15 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 12 3 # 12 P 142 LYS C 61 LYS^? 21.91 MG MG D 302 P 217 SER D 36 SER^? 22.42 MG MG D 302 P 241 SER D 16 SER^? 23.71 MG MG D 302 coo 37.29 55.72 69.54 38.73 59.85 65.07 93.60 48.56 -24.05 90.39 44.71 -27.98 coo 35.55 61.40 62.96 37.72 60.41 62.66 97.85 44.42 -32.20 96.60 46.20 -31.15 coo 38.60 64.77 64.10 38.63 63.28 62.26 96.73 48.43 -33.75 98.58 48.68 -32.31 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 13 3 # 13 P 142 LYS C 76 LYS^? 24.95 MG MG C 302 P 217 SER C 79 SER^? 19.92 MG MG B 301 P 241 SER C 83 SER^? 23.40 MG MG B 301 coo 37.29 55.72 69.54 38.73 59.85 65.07 71.11 8.63 -16.76 75.44 5.17 -16.80 coo 35.55 61.40 62.96 37.72 60.41 62.66 64.38 1.95 -14.66 62.69 3.45 -15.45 coo 38.60 64.77 64.10 38.63 63.28 62.26 65.19 0.76 -19.73 62.87 1.43 -19.33 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 14 3 # 14 P 142 LYS C 76 LYS^? 24.95 MG MG C 302 P 217 SER C 83 SER^? 23.40 MG MG B 301 P 241 SER C 79 SER^? 19.92 MG MG B 301 coo 37.29 55.72 69.54 38.73 59.85 65.07 71.11 8.63 -16.76 75.44 5.17 -16.80 coo 35.55 61.40 62.96 37.72 60.41 62.66 65.19 0.76 -19.73 62.87 1.43 -19.33 coo 38.60 64.77 64.10 38.63 63.28 62.26 64.38 1.95 -14.66 62.69 3.45 -15.45 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 15 3 # 15 P 142 LYS C 86 LYS^? 27.34 MG MG C 302 P 217 SER C 83 SER^? 23.40 MG MG B 301 P 241 SER C 79 SER^? 19.92 MG MG B 301 coo 37.29 55.72 69.54 38.73 59.85 65.07 69.22 9.88 -20.56 74.70 7.02 -22.55 coo 35.55 61.40 62.96 37.72 60.41 62.66 65.19 0.76 -19.73 62.87 1.43 -19.33 coo 38.60 64.77 64.10 38.63 63.28 62.26 64.38 1.95 -14.66 62.69 3.45 -15.45 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 16 3 # 16 P 142 LYS D 61 LYS^? 21.93 MG MG C 302 P 217 SER C 16 SER^? 24.15 MG MG C 302 P 241 SER C 36 SER^? 23.69 MG MG C 302 coo 37.29 55.72 69.54 38.73 59.85 65.07 80.64 11.23 -26.16 80.65 16.24 -22.36 coo 35.55 61.40 62.96 37.72 60.41 62.66 82.88 9.31 -16.30 84.27 7.80 -17.58 coo 38.60 64.77 64.10 38.63 63.28 62.26 86.07 12.19 -17.80 85.34 10.22 -18.98 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 17 3 # 17 P 142 LYS D 61 LYS^? 21.93 MG MG C 302 P 217 SER C 36 SER^? 23.69 MG MG C 302 P 241 SER C 16 SER^? 24.15 MG MG C 302 coo 37.29 55.72 69.54 38.73 59.85 65.07 80.64 11.23 -26.16 80.65 16.24 -22.36 coo 35.55 61.40 62.96 37.72 60.41 62.66 86.07 12.19 -17.80 85.34 10.22 -18.98 coo 38.60 64.77 64.10 38.63 63.28 62.26 82.88 9.31 -16.30 84.27 7.80 -17.58 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 18 3 # 18 P 142 LYS D 76 LYS^? 25.08 MG MG D 302 P 217 SER D 79 SER^? 19.41 MG MG E 301 P 241 SER D 83 SER^? 23.07 MG MG E 301 coo 37.29 55.72 69.54 38.73 59.85 65.07 88.18 56.35 -34.05 93.80 56.17 -32.93 coo 35.55 61.40 62.96 37.72 60.41 62.66 88.38 65.91 -36.56 86.13 65.62 -35.70 coo 38.60 64.77 64.10 38.63 63.28 62.26 89.47 66.32 -31.33 87.79 67.80 -32.19 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 19 3 # 19 P 142 LYS D 76 LYS^? 25.08 MG MG D 302 P 217 SER D 83 SER^? 23.07 MG MG E 301 P 241 SER D 79 SER^? 19.41 MG MG E 301 coo 37.29 55.72 69.54 38.73 59.85 65.07 88.18 56.35 -34.05 93.80 56.17 -32.93 coo 35.55 61.40 62.96 37.72 60.41 62.66 89.47 66.32 -31.33 87.79 67.80 -32.19 coo 38.60 64.77 64.10 38.63 63.28 62.26 88.38 65.91 -36.56 86.13 65.62 -35.70 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 20 3 # 20 P 142 LYS D 86 LYS^? 25.80 MG MG D 302 P 217 SER D 83 SER^? 23.07 MG MG E 301 P 241 SER D 79 SER^? 19.41 MG MG E 301 coo 37.29 55.72 69.54 38.73 59.85 65.07 85.54 56.79 -30.27 90.24 54.54 -28.62 coo 35.55 61.40 62.96 37.72 60.41 62.66 89.47 66.32 -31.33 87.79 67.80 -32.19 coo 38.60 64.77 64.10 38.63 63.28 62.26 88.38 65.91 -36.56 86.13 65.62 -35.70 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 21 3 # 21 P 142 LYS E 61 LYS^? 22.16 MG MG F 301 P 217 SER F 16 SER^? 24.10 MG MG F 301 P 241 SER F 36 SER^? 23.07 MG MG F 301 coo 37.29 55.72 69.54 38.73 59.85 65.07 40.99 56.84 -68.48 45.99 56.72 -72.39 coo 35.55 61.40 62.96 37.72 60.41 62.66 39.77 59.81 -78.14 38.80 61.26 -76.65 coo 38.60 64.77 64.10 38.63 63.28 62.26 42.79 62.77 -76.96 42.19 61.23 -75.17 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 22 3 # 22 P 142 LYS E 61 LYS^? 22.16 MG MG F 301 P 217 SER F 36 SER^? 23.07 MG MG F 301 P 241 SER F 16 SER^? 24.10 MG MG F 301 coo 37.29 55.72 69.54 38.73 59.85 65.07 40.99 56.84 -68.48 45.99 56.72 -72.39 coo 35.55 61.40 62.96 37.72 60.41 62.66 42.79 62.77 -76.96 42.19 61.23 -75.17 coo 38.60 64.77 64.10 38.63 63.28 62.26 39.77 59.81 -78.14 38.80 61.26 -76.65 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 23 3 # 23 P 142 LYS E 76 LYS^? 25.68 MG MG E 302 P 217 SER E 79 SER^? 19.77 MG MG D 301 P 241 SER E 83 SER^? 23.44 MG MG D 301 coo 37.29 55.72 69.54 38.73 59.85 65.07 87.09 58.11 -60.91 88.65 63.65 -61.27 coo 35.55 61.40 62.96 37.72 60.41 62.66 96.22 56.25 -58.39 95.94 54.06 -59.20 coo 38.60 64.77 64.10 38.63 63.28 62.26 96.88 57.42 -63.66 97.96 55.45 -62.84 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 24 3 # 24 P 142 LYS E 76 LYS^? 25.68 MG MG E 302 P 217 SER E 83 SER^? 23.44 MG MG D 301 P 241 SER E 79 SER^? 19.77 MG MG D 301 coo 37.29 55.72 69.54 38.73 59.85 65.07 87.09 58.11 -60.91 88.65 63.65 -61.27 coo 35.55 61.40 62.96 37.72 60.41 62.66 96.88 57.42 -63.66 97.96 55.45 -62.84 coo 38.60 64.77 64.10 38.63 63.28 62.26 96.22 56.25 -58.39 95.94 54.06 -59.20 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 25 3 # 25 P 142 LYS E 86 LYS^? 26.73 MG MG D 301 P 217 SER E 83 SER^? 23.44 MG MG D 301 P 241 SER E 79 SER^? 19.77 MG MG D 301 coo 37.29 55.72 69.54 38.73 59.85 65.07 86.84 54.85 -64.43 87.07 60.83 -66.10 coo 35.55 61.40 62.96 37.72 60.41 62.66 96.88 57.42 -63.66 97.96 55.45 -62.84 coo 38.60 64.77 64.10 38.63 63.28 62.26 96.22 56.25 -58.39 95.94 54.06 -59.20 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 26 3 # 26 P 142 LYS F 61 LYS^? 21.75 MG MG E 302 P 217 SER E 16 SER^? 24.21 MG MG E 302 P 241 SER E 36 SER^? 22.92 MG MG E 302 coo 37.29 55.72 69.54 38.73 59.85 65.07 80.24 64.12 -71.01 76.23 61.95 -66.39 coo 35.55 61.40 62.96 37.72 60.41 62.66 80.65 67.65 -61.22 81.30 69.49 -62.59 coo 38.60 64.77 64.10 38.63 63.28 62.26 76.63 69.18 -62.93 78.20 67.77 -64.11 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 27 3 # 27 P 142 LYS F 61 LYS^? 21.75 MG MG E 302 P 217 SER E 36 SER^? 22.92 MG MG E 302 P 241 SER E 16 SER^? 24.21 MG MG E 302 coo 37.29 55.72 69.54 38.73 59.85 65.07 80.24 64.12 -71.01 76.23 61.95 -66.39 coo 35.55 61.40 62.96 37.72 60.41 62.66 76.63 69.18 -62.93 78.20 67.77 -64.11 coo 38.60 64.77 64.10 38.63 63.28 62.26 80.65 67.65 -61.22 81.30 69.49 -62.59 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 28 3 # 28 P 142 LYS F 76 LYS^? 25.89 MG MG F 301 P 217 SER F 79 SER^? 30.22 MG MG F 301 P 241 SER F 83 SER^? 33.16 MG MG F 301 coo 37.29 55.72 69.54 38.73 59.85 65.07 36.96 48.52 -78.06 33.74 53.37 -77.06 coo 35.55 61.40 62.96 37.72 60.41 62.66 28.21 44.39 -80.24 29.11 42.36 -79.32 coo 38.60 64.77 64.10 38.63 63.28 62.26 27.54 45.11 -75.18 28.33 43.06 -74.18 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 29 3 # 29 P 142 LYS F 76 LYS^? 25.89 MG MG F 301 P 217 SER F 83 SER^? 33.16 MG MG F 301 P 241 SER F 79 SER^? 30.22 MG MG F 301 coo 37.29 55.72 69.54 38.73 59.85 65.07 36.96 48.52 -78.06 33.74 53.37 -77.06 coo 35.55 61.40 62.96 37.72 60.41 62.66 27.54 45.11 -75.18 28.33 43.06 -74.18 coo 38.60 64.77 64.10 38.63 63.28 62.26 28.21 44.39 -80.24 29.11 42.36 -79.32 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 30 3 # 30 P 142 LYS F 86 LYS^? 26.63 MG MG F 301 P 217 SER F 83 SER^? 33.16 MG MG F 301 P 241 SER F 79 SER^? 30.22 MG MG F 301 coo 37.29 55.72 69.54 38.73 59.85 65.07 37.89 45.97 -74.42 36.47 51.71 -72.79 coo 35.55 61.40 62.96 37.72 60.41 62.66 27.54 45.11 -75.18 28.33 43.06 -74.18 coo 38.60 64.77 64.10 38.63 63.28 62.26 28.21 44.39 -80.24 29.11 42.36 -79.32 1mt5_c15 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 30 hits 1mt5_c15 naa= 3 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 1 3 # 1 A 167 LYS A 76 LYS^? 25.42 MG MG A 301 A 169 LYS A 86 LYS^? 26.38 MG MG A 301 A 327 GLU A 33 GLU^? 22.87 MG MG A 301 coo 20.73 15.53 25.54 22.09 15.64 19.40 34.45 46.53 27.28 28.88 44.93 27.25 coo 24.31 10.25 23.71 29.02 12.05 20.75 37.08 47.78 23.56 32.88 44.24 21.89 coo 21.86 20.40 18.59 22.12 18.33 18.33 33.74 38.67 24.96 34.13 38.85 22.87 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 2 3 # 2 A 167 LYS A 157 LYS^? 28.65 MG MG A 302 A 169 LYS A 166 LYS^? 20.93 MG MG A 302 A 327 GLU A 54 GLU^? 22.98 MG MG A 301 coo 20.73 15.53 25.54 22.09 15.64 19.40 41.42 12.06 27.58 41.46 5.93 29.41 coo 24.31 10.25 23.71 29.02 12.05 20.75 35.34 13.14 30.41 31.67 15.04 34.58 coo 21.86 20.40 18.59 22.12 18.33 18.33 45.06 19.97 24.02 44.05 19.39 22.19 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 3 3 # 3 A 167 LYS A 166 LYS^? 20.93 MG MG A 302 A 169 LYS A 157 LYS^? 28.65 MG MG A 302 A 327 GLU A 154 GLU^? 19.22 MG MG A 301 coo 20.73 15.53 25.54 22.09 15.64 19.40 35.34 13.14 30.41 31.67 15.04 34.58 coo 24.31 10.25 23.71 29.02 12.05 20.75 41.42 12.06 27.58 41.46 5.93 29.41 coo 21.86 20.40 18.59 22.12 18.33 18.33 36.54 21.95 29.78 35.14 22.21 28.17 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 4 3 # 4 A 167 LYS B 157 LYS^? 28.85 MG MG B 302 A 169 LYS B 166 LYS^? 22.75 MG MG B 301 A 327 GLU B 54 GLU^? 22.94 MG MG B 302 coo 20.73 15.53 25.54 22.09 15.64 19.40 34.97 21.28 8.44 29.03 22.82 6.58 coo 24.31 10.25 23.71 29.02 12.05 20.75 35.27 15.38 5.31 37.27 9.81 3.93 coo 21.86 20.40 18.59 22.12 18.33 18.33 43.18 23.27 12.99 42.40 22.23 14.68 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 5 3 # 5 A 167 LYS B 166 LYS^? 22.75 MG MG B 301 A 169 LYS B 157 LYS^? 28.85 MG MG B 302 A 327 GLU B 154 GLU^? 19.05 MG MG B 302 coo 20.73 15.53 25.54 22.09 15.64 19.40 35.27 15.38 5.31 37.27 9.81 3.93 coo 24.31 10.25 23.71 29.02 12.05 20.75 34.97 21.28 8.44 29.03 22.82 6.58 coo 21.86 20.40 18.59 22.12 18.33 18.33 44.04 15.11 6.74 44.19 13.59 8.30 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 6 3 # 6 A 167 LYS C 6 LYS^? 25.73 MG MG C 302 A 169 LYS C 157 LYS^? 28.15 MG MG C 302 A 327 GLU C 54 GLU^? 22.77 MG MG C 302 coo 20.73 15.53 25.54 22.09 15.64 19.40 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 24.31 10.25 23.71 29.02 12.05 20.75 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 21.86 20.40 18.59 22.12 18.33 18.33 88.91 31.25 -19.52 89.97 30.69 -21.29 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 7 3 # 7 A 167 LYS C 21 LYS^? 14.49 MG MG C 302 A 169 LYS B 21 LYS^? 13.97 MG MG B 301 A 327 GLU B 25 GLU^? 12.88 MG MG C 301 coo 20.73 15.53 25.54 22.09 15.64 19.40 72.10 6.87 -6.14 72.84 12.21 -4.93 coo 24.31 10.25 23.71 29.02 12.05 20.75 67.50 6.37 -0.39 64.53 11.03 -2.88 coo 21.86 20.40 18.59 22.12 18.33 18.33 79.57 9.59 -3.08 79.20 11.68 -3.64 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 8 3 # 8 A 167 LYS C 157 LYS^? 28.15 MG MG C 302 A 169 LYS C 166 LYS^? 22.53 MG MG C 301 A 327 GLU C 54 GLU^? 22.77 MG MG C 302 coo 20.73 15.53 25.54 22.09 15.64 19.40 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 24.31 10.25 23.71 29.02 12.05 20.75 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 21.86 20.40 18.59 22.12 18.33 18.33 88.91 31.25 -19.52 89.97 30.69 -21.29 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 9 3 # 9 A 167 LYS C 166 LYS^? 22.53 MG MG C 301 A 169 LYS C 157 LYS^? 28.15 MG MG C 302 A 327 GLU C 154 GLU^? 18.91 MG MG C 302 coo 20.73 15.53 25.54 22.09 15.64 19.40 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 24.31 10.25 23.71 29.02 12.05 20.75 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 21.86 20.40 18.59 22.12 18.33 18.33 91.15 23.27 -13.33 91.61 21.91 -14.95 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 10 3 # 10 A 167 LYS D 76 LYS^? 25.08 MG MG D 302 A 169 LYS D 86 LYS^? 25.80 MG MG D 302 A 327 GLU D 33 GLU^? 22.23 MG MG D 302 coo 20.73 15.53 25.54 22.09 15.64 19.40 88.18 56.35 -34.05 93.80 56.17 -32.93 coo 24.31 10.25 23.71 29.02 12.05 20.75 85.54 56.79 -30.27 90.24 54.54 -28.62 coo 21.86 20.40 18.59 22.12 18.33 18.33 91.55 48.87 -31.66 91.12 48.92 -29.63 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 11 3 # 11 A 167 LYS D 157 LYS^? 28.67 MG MG D 302 A 169 LYS D 6 LYS^? 25.98 MG MG D 302 A 327 GLU D 165 GLU^? 29.85 MG MG D 302 coo 20.73 15.53 25.54 22.09 15.64 19.40 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 24.31 10.25 23.71 29.02 12.05 20.75 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 21.86 20.40 18.59 22.12 18.33 18.33 100.60 20.11 -34.27 100.38 17.96 -34.49 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 12 3 # 12 A 167 LYS D 157 LYS^? 28.67 MG MG D 302 A 169 LYS D 166 LYS^? 21.08 MG MG D 301 A 327 GLU D 54 GLU^? 22.96 MG MG D 302 coo 20.73 15.53 25.54 22.09 15.64 19.40 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 24.31 10.25 23.71 29.02 12.05 20.75 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 21.86 20.40 18.59 22.12 18.33 18.33 87.96 27.60 -30.52 89.07 27.55 -28.72 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 13 3 # 13 A 167 LYS D 166 LYS^? 21.08 MG MG D 301 A 169 LYS D 157 LYS^? 28.67 MG MG D 302 A 327 GLU D 154 GLU^? 18.75 MG MG D 302 coo 20.73 15.53 25.54 22.09 15.64 19.40 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 24.31 10.25 23.71 29.02 12.05 20.75 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 21.86 20.40 18.59 22.12 18.33 18.33 94.87 32.52 -36.42 96.07 33.39 -34.88 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 14 3 # 14 A 167 LYS E 76 LYS^? 25.68 MG MG E 302 A 169 LYS E 86 LYS^? 26.73 MG MG D 301 A 327 GLU E 33 GLU^? 22.81 MG MG E 302 coo 20.73 15.53 25.54 22.09 15.64 19.40 87.09 58.11 -60.91 88.65 63.65 -61.27 coo 24.31 10.25 23.71 29.02 12.05 20.75 86.84 54.85 -64.43 87.07 60.83 -66.10 coo 21.86 20.40 18.59 22.12 18.33 18.33 80.16 62.57 -63.35 80.54 62.13 -65.43 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 15 3 # 15 A 167 LYS E 157 LYS^? 28.40 MG MG E 302 A 169 LYS E 166 LYS^? 21.46 MG MG E 301 A 327 GLU E 54 GLU^? 22.83 MG MG E 302 coo 20.73 15.53 25.54 22.09 15.64 19.40 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 24.31 10.25 23.71 29.02 12.05 20.75 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 21.86 20.40 18.59 22.12 18.33 18.33 58.39 62.16 -64.12 58.73 62.98 -66.04 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 16 3 # 16 A 167 LYS E 166 LYS^? 21.46 MG MG E 301 A 169 LYS E 157 LYS^? 28.40 MG MG E 302 A 327 GLU E 154 GLU^? 19.05 MG MG E 302 coo 20.73 15.53 25.54 22.09 15.64 19.40 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 24.31 10.25 23.71 29.02 12.05 20.75 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 21.86 20.40 18.59 22.12 18.33 18.33 64.41 68.21 -58.47 65.40 69.20 -60.08 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 17 3 # 17 A 167 LYS F 157 LYS^? 28.36 MG MG F 302 A 169 LYS F 166 LYS^? 20.76 MG MG F 302 A 327 GLU F 54 GLU^? 22.98 MG MG F 301 coo 20.73 15.53 25.54 22.09 15.64 19.40 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 24.31 10.25 23.71 29.02 12.05 20.75 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 21.86 20.40 18.59 22.12 18.33 18.33 62.26 62.27 -75.30 61.72 63.47 -73.60 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 18 3 # 18 A 167 LYS F 166 LYS^? 20.76 MG MG F 302 A 169 LYS F 157 LYS^? 28.36 MG MG F 302 A 327 GLU F 154 GLU^? 18.97 MG MG F 301 coo 20.73 15.53 25.54 22.09 15.64 19.40 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 24.31 10.25 23.71 29.02 12.05 20.75 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 21.86 20.40 18.59 22.12 18.33 18.33 54.57 65.67 -81.55 53.36 66.51 -80.09 1muc_c00 source 1muc MUCONATE LACTONIZING ENZYME : 18 hits 1muc_c00 naa= 3 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 1 3 # 1 B 167 LYS A 76 LYS^? 25.42 MG MG A 301 B 169 LYS A 86 LYS^? 26.38 MG MG A 301 B 327 GLU A 33 GLU^? 22.87 MG MG A 301 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 34.45 46.53 27.28 28.88 44.93 27.25 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 37.08 47.78 23.56 32.88 44.24 21.89 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 33.74 38.67 24.96 34.13 38.85 22.87 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 2 3 # 2 B 167 LYS A 157 LYS^? 28.65 MG MG A 302 B 169 LYS A 166 LYS^? 20.93 MG MG A 302 B 327 GLU A 54 GLU^? 22.98 MG MG A 301 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 41.42 12.06 27.58 41.46 5.93 29.41 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 35.34 13.14 30.41 31.67 15.04 34.58 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 45.06 19.97 24.02 44.05 19.39 22.19 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 3 3 # 3 B 167 LYS A 166 LYS^? 20.93 MG MG A 302 B 169 LYS A 157 LYS^? 28.65 MG MG A 302 B 327 GLU A 154 GLU^? 19.22 MG MG A 301 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 35.34 13.14 30.41 31.67 15.04 34.58 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 41.42 12.06 27.58 41.46 5.93 29.41 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 36.54 21.95 29.78 35.14 22.21 28.17 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 4 3 # 4 B 167 LYS B 157 LYS^? 28.85 MG MG B 302 B 169 LYS B 166 LYS^? 22.75 MG MG B 301 B 327 GLU B 54 GLU^? 22.94 MG MG B 302 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 34.97 21.28 8.44 29.03 22.82 6.58 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 35.27 15.38 5.31 37.27 9.81 3.93 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 43.18 23.27 12.99 42.40 22.23 14.68 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 5 3 # 5 B 167 LYS B 166 LYS^? 22.75 MG MG B 301 B 169 LYS B 157 LYS^? 28.85 MG MG B 302 B 327 GLU B 154 GLU^? 19.05 MG MG B 302 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 35.27 15.38 5.31 37.27 9.81 3.93 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 34.97 21.28 8.44 29.03 22.82 6.58 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 44.04 15.11 6.74 44.19 13.59 8.30 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 6 3 # 6 B 167 LYS C 6 LYS^? 25.73 MG MG C 302 B 169 LYS C 157 LYS^? 28.15 MG MG C 302 B 327 GLU C 54 GLU^? 22.77 MG MG C 302 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 88.91 31.25 -19.52 89.97 30.69 -21.29 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 7 3 # 7 B 167 LYS C 21 LYS^? 14.49 MG MG C 302 B 169 LYS B 21 LYS^? 13.97 MG MG B 301 B 327 GLU B 25 GLU^? 12.88 MG MG C 301 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 72.10 6.87 -6.14 72.84 12.21 -4.93 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 67.50 6.37 -0.39 64.53 11.03 -2.88 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 79.57 9.59 -3.08 79.20 11.68 -3.64 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 8 3 # 8 B 167 LYS C 157 LYS^? 28.15 MG MG C 302 B 169 LYS C 166 LYS^? 22.53 MG MG C 301 B 327 GLU C 54 GLU^? 22.77 MG MG C 302 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 88.91 31.25 -19.52 89.97 30.69 -21.29 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 9 3 # 9 B 167 LYS C 166 LYS^? 22.53 MG MG C 301 B 169 LYS C 157 LYS^? 28.15 MG MG C 302 B 327 GLU C 154 GLU^? 18.91 MG MG C 302 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 91.15 23.27 -13.33 91.61 21.91 -14.95 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 10 3 # 10 B 167 LYS D 76 LYS^? 25.08 MG MG D 302 B 169 LYS D 86 LYS^? 25.80 MG MG D 302 B 327 GLU D 33 GLU^? 22.23 MG MG D 302 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 88.18 56.35 -34.05 93.80 56.17 -32.93 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 85.54 56.79 -30.27 90.24 54.54 -28.62 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 91.55 48.87 -31.66 91.12 48.92 -29.63 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 11 3 # 11 B 167 LYS D 157 LYS^? 28.67 MG MG D 302 B 169 LYS D 166 LYS^? 21.08 MG MG D 301 B 327 GLU D 54 GLU^? 22.96 MG MG D 302 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 87.96 27.60 -30.52 89.07 27.55 -28.72 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 12 3 # 12 B 167 LYS D 166 LYS^? 21.08 MG MG D 301 B 169 LYS D 157 LYS^? 28.67 MG MG D 302 B 327 GLU D 154 GLU^? 18.75 MG MG D 302 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 94.87 32.52 -36.42 96.07 33.39 -34.88 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 13 3 # 13 B 167 LYS E 76 LYS^? 25.68 MG MG E 302 B 169 LYS E 86 LYS^? 26.73 MG MG D 301 B 327 GLU E 33 GLU^? 22.81 MG MG E 302 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 87.09 58.11 -60.91 88.65 63.65 -61.27 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 86.84 54.85 -64.43 87.07 60.83 -66.10 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 80.16 62.57 -63.35 80.54 62.13 -65.43 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 14 3 # 14 B 167 LYS E 157 LYS^? 28.40 MG MG E 302 B 169 LYS E 166 LYS^? 21.46 MG MG E 301 B 327 GLU E 54 GLU^? 22.83 MG MG E 302 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 58.39 62.16 -64.12 58.73 62.98 -66.04 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 15 3 # 15 B 167 LYS E 166 LYS^? 21.46 MG MG E 301 B 169 LYS E 157 LYS^? 28.40 MG MG E 302 B 327 GLU E 154 GLU^? 19.05 MG MG E 302 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 64.41 68.21 -58.47 65.40 69.20 -60.08 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 16 3 # 16 B 167 LYS F 157 LYS^? 28.36 MG MG F 302 B 169 LYS F 166 LYS^? 20.76 MG MG F 302 B 327 GLU F 54 GLU^? 22.98 MG MG F 301 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 62.26 62.27 -75.30 61.72 63.47 -73.60 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 17 3 # 17 B 167 LYS F 166 LYS^? 20.76 MG MG F 302 B 169 LYS F 157 LYS^? 28.36 MG MG F 302 B 327 GLU F 154 GLU^? 18.97 MG MG F 301 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 54.57 65.67 -81.55 53.36 66.51 -80.09 1muc_c01 source 1muc MUCONATE LACTONIZING ENZYME : 17 hits 1muc_c01 naa= 3 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 A 114 HIS A 147 HIS^? 9.20 MG MG A 302 A 197 ASP A 128 ASP^? -3.32 MG MG A 301s A 223 ALA A 179 ALA^? 10.50 MG MG A 302 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 40.24 23.10 39.83 38.32 22.34 40.22 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 46.50 28.23 39.77 47.49 30.10 39.82 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 35.90 35.25 40.82 35.84 36.46 39.90 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 A 114 HIS A 147 HIS^? 9.20 MG MG A 302 A 197 ASP A 128 ASP^? -3.32 MG MG A 301s A 223 ALA A 180 ALA^? 8.42 MG MG A 302 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 40.24 23.10 39.83 38.32 22.34 40.22 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 46.50 28.23 39.77 47.49 30.10 39.82 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 37.01 35.73 44.42 36.08 35.79 45.62 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 3 3 # 3 A 114 HIS A 170 HIS^? 10.56 MG MG A 302 A 197 ASP A 148 ASP^? 2.72 MG MG A 301s A 223 ALA A 9 ALA^? 15.22 MG MG A 301 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 34.91 23.57 39.32 34.35 24.95 40.81 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 41.50 28.88 41.13 43.33 29.67 41.93 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 42.54 20.81 29.78 43.62 21.07 30.77 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 4 3 # 4 A 114 HIS A 170 HIS^? 10.56 MG MG A 302 A 197 ASP A 171 ASP^? 17.17 MG MG A 302 A 223 ALA A 9 ALA^? 15.22 MG MG A 301 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 34.91 23.57 39.32 34.35 24.95 40.81 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 29.78 23.67 36.63 28.48 25.11 35.71 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 42.54 20.81 29.78 43.62 21.07 30.77 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 5 3 # 5 A 114 HIS A 170 HIS^? 10.56 MG MG A 302 A 197 ASP A 171 ASP^? 17.17 MG MG A 302 A 223 ALA A 179 ALA^? 10.50 MG MG A 302 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 34.91 23.57 39.32 34.35 24.95 40.81 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 29.78 23.67 36.63 28.48 25.11 35.71 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 35.90 35.25 40.82 35.84 36.46 39.90 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 6 3 # 6 A 114 HIS B 147 HIS^? 9.27 MG MG B 301 A 197 ASP B 128 ASP^? -3.57 MG MG B 302s A 223 ALA B 179 ALA^? 10.09 MG MG B 301 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 46.73 18.97 -3.05 45.63 17.32 -3.73 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 52.92 24.09 -2.19 54.73 25.14 -1.90 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 58.26 12.57 -3.59 59.34 12.14 -2.62 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 7 3 # 7 A 114 HIS B 147 HIS^? 9.27 MG MG B 301 A 197 ASP B 128 ASP^? -3.57 MG MG B 302s A 223 ALA B 180 ALA^? 7.87 MG MG B 301 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 46.73 18.97 -3.05 45.63 17.32 -3.73 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 52.92 24.09 -2.19 54.73 25.14 -1.90 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 59.08 14.28 -6.88 59.39 13.60 -8.19 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 8 3 # 8 A 114 HIS B 170 HIS^? 10.51 MG MG B 301 A 197 ASP B 148 ASP^? 2.58 MG MG B 302s A 223 ALA B 9 ALA^? 15.20 MG MG B 302 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 46.22 13.75 -2.72 47.53 13.11 -4.24 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 52.73 19.23 -3.77 53.81 20.99 -4.31 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 44.07 20.95 7.16 44.62 22.08 6.31 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 9 3 # 9 A 114 HIS B 170 HIS^? 10.51 MG MG B 301 A 197 ASP B 171 ASP^? 16.92 MG MG B 301 A 223 ALA B 9 ALA^? 15.20 MG MG B 302 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 46.22 13.75 -2.72 47.53 13.11 -4.24 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 45.30 8.50 -0.71 46.30 6.81 0.12 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 44.07 20.95 7.16 44.62 22.08 6.31 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 10 3 # 10 A 114 HIS B 170 HIS^? 10.51 MG MG B 301 A 197 ASP B 171 ASP^? 16.92 MG MG B 301 A 223 ALA B 179 ALA^? 10.09 MG MG B 301 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 46.22 13.75 -2.72 47.53 13.11 -4.24 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 45.30 8.50 -0.71 46.30 6.81 0.12 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 58.26 12.57 -3.59 59.34 12.14 -2.62 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 11 3 # 11 A 114 HIS C 147 HIS^? 9.44 MG MG C 301 A 197 ASP C 128 ASP^? -3.22 MG MG C 302s A 223 ALA C 179 ALA^? 10.20 MG MG C 301 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 87.61 25.71 -3.59 89.22 24.50 -2.99 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 80.05 28.39 -4.25 77.97 28.60 -4.21 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 78.98 15.73 -3.05 77.99 14.95 -3.93 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 12 3 # 12 A 114 HIS C 147 HIS^? 9.44 MG MG C 301 A 197 ASP C 128 ASP^? -3.22 MG MG C 302s A 223 ALA C 180 ALA^? 7.92 MG MG C 301 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 87.61 25.71 -3.59 89.22 24.50 -2.99 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 80.05 28.39 -4.25 77.97 28.60 -4.21 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 77.97 16.90 0.41 78.13 16.09 1.70 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 13 3 # 13 A 114 HIS C 147 HIS^? 9.44 MG MG C 301 A 197 ASP C 187 ASP^? -3.72 MG MG C 301s A 223 ALA C 179 ALA^? 10.20 MG MG C 301 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 87.61 25.71 -3.59 89.22 24.50 -2.99 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 84.01 23.73 3.39 83.47 22.54 1.59 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 78.98 15.73 -3.05 77.99 14.95 -3.93 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 14 3 # 14 A 114 HIS C 170 HIS^? 10.68 MG MG C 301 A 197 ASP C 148 ASP^? 2.75 MG MG C 302s A 223 ALA C 9 ALA^? 15.00 MG MG C 302 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 89.96 21.05 -3.85 88.74 19.88 -2.61 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 81.96 23.83 -2.68 80.24 25.11 -2.27 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 89.05 28.81 -13.58 88.16 29.64 -12.74 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 15 3 # 15 A 114 HIS C 170 HIS^? 10.68 MG MG C 301 A 197 ASP C 171 ASP^? 17.08 MG MG C 301 A 223 ALA C 9 ALA^? 15.00 MG MG C 302 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 89.96 21.05 -3.85 88.74 19.88 -2.61 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 92.57 16.68 -6.24 92.24 14.74 -7.03 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 89.05 28.81 -13.58 88.16 29.64 -12.74 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 16 3 # 16 A 114 HIS C 170 HIS^? 10.68 MG MG C 301 A 197 ASP C 171 ASP^? 17.08 MG MG C 301 A 223 ALA C 179 ALA^? 10.20 MG MG C 301 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 89.96 21.05 -3.85 88.74 19.88 -2.61 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 92.57 16.68 -6.24 92.24 14.74 -7.03 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 78.98 15.73 -3.05 77.99 14.95 -3.93 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 17 3 # 17 A 114 HIS D 147 HIS^? 9.43 MG MG D 301 A 197 ASP D 128 ASP^? -3.70 MG MG D 302s A 223 ALA D 179 ALA^? 10.20 MG MG D 301 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 90.95 32.51 -46.42 92.98 32.42 -46.93 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 83.33 35.45 -46.13 81.57 36.63 -46.10 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 90.58 45.61 -47.30 90.29 46.82 -46.46 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 18 3 # 18 A 114 HIS D 147 HIS^? 9.43 MG MG D 301 A 197 ASP D 128 ASP^? -3.70 MG MG D 302s A 223 ALA D 180 ALA^? 8.04 MG MG D 301 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 90.95 32.51 -46.42 92.98 32.42 -46.93 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 83.33 35.45 -46.13 81.57 36.63 -46.10 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 88.96 45.51 -50.74 89.59 46.01 -52.03 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 19 3 # 19 A 114 HIS D 170 HIS^? 10.59 MG MG D 301 A 197 ASP D 148 ASP^? 2.35 MG MG D 302s A 223 ALA D 9 ALA^? 15.02 MG MG D 302 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 95.57 34.81 -46.05 95.59 36.24 -47.59 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 87.78 37.50 -47.56 85.79 37.49 -48.28 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 89.67 29.50 -36.34 88.55 29.40 -37.31 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 20 3 # 20 A 114 HIS D 170 HIS^? 10.59 MG MG D 301 A 197 ASP D 171 ASP^? 16.95 MG MG D 301 A 223 ALA D 9 ALA^? 15.02 MG MG D 302 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 95.57 34.81 -46.05 95.59 36.24 -47.59 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 100.39 36.69 -43.49 101.13 38.51 -42.69 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 89.67 29.50 -36.34 88.55 29.40 -37.31 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 21 3 # 21 A 114 HIS D 170 HIS^? 10.59 MG MG D 301 A 197 ASP D 171 ASP^? 16.95 MG MG D 301 A 223 ALA D 179 ALA^? 10.20 MG MG D 301 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 95.57 34.81 -46.05 95.59 36.24 -47.59 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 100.39 36.69 -43.49 101.13 38.51 -42.69 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 90.58 45.61 -47.30 90.29 46.82 -46.46 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 22 3 # 22 A 114 HIS D 170 HIS^? 10.59 MG MG D 301 A 197 ASP D 187 ASP^? -2.95 MG MG D 301s A 223 ALA D 114 ALA^? 10.14 MG MG D 302 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 95.57 34.81 -46.05 95.59 36.24 -47.59 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 90.40 36.34 -52.69 89.24 37.98 -51.99 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 82.02 32.47 -40.60 83.33 32.76 -39.91 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 23 3 # 23 A 114 HIS E 147 HIS^? 9.22 MG MG E 301 A 197 ASP E 128 ASP^? -3.53 MG MG E 302s A 223 ALA E 179 ALA^? 10.17 MG MG E 301 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 63.87 64.43 -48.39 64.18 66.45 -47.92 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 65.38 56.57 -48.58 66.15 54.57 -48.61 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 76.81 62.00 -47.52 77.96 61.52 -48.40 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 24 3 # 24 A 114 HIS E 147 HIS^? 9.22 MG MG E 301 A 197 ASP E 128 ASP^? -3.53 MG MG E 302s A 223 ALA E 180 ALA^? 7.76 MG MG E 301 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 63.87 64.43 -48.39 64.18 66.45 -47.92 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 65.38 56.57 -48.58 66.15 54.57 -48.61 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 76.35 60.44 -44.08 76.96 60.95 -42.80 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 25 3 # 25 A 114 HIS E 170 HIS^? 10.33 MG MG E 301 A 197 ASP E 148 ASP^? 2.62 MG MG E 302s A 223 ALA E 9 ALA^? 15.19 MG MG E 302 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 66.96 68.76 -48.87 68.36 68.54 -47.33 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 68.29 60.44 -47.29 68.03 58.42 -46.50 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 60.74 63.76 -58.54 60.44 62.76 -57.48 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 26 3 # 26 A 114 HIS E 170 HIS^? 10.33 MG MG E 301 A 197 ASP E 171 ASP^? 16.73 MG MG E 301 A 223 ALA E 9 ALA^? 15.19 MG MG E 302 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 66.96 68.76 -48.87 68.36 68.54 -47.33 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 69.61 73.12 -51.56 71.50 73.53 -52.39 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 60.74 63.76 -58.54 60.44 62.76 -57.48 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 27 3 # 27 A 114 HIS E 170 HIS^? 10.33 MG MG E 301 A 197 ASP E 171 ASP^? 16.73 MG MG E 301 A 223 ALA E 179 ALA^? 10.17 MG MG E 301 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 66.96 68.76 -48.87 68.36 68.54 -47.33 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 69.61 73.12 -51.56 71.50 73.53 -52.39 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 76.81 62.00 -47.52 77.96 61.52 -48.40 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 28 3 # 28 A 114 HIS F 147 HIS^? 8.79 MG MG F 302 A 197 ASP F 128 ASP^? -3.41 MG MG F 301s A 223 ALA F 179 ALA^? 10.29 MG MG F 302 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 56.63 61.66 -91.16 55.69 63.43 -91.80 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 57.76 53.73 -90.50 57.46 51.64 -90.28 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 44.99 54.95 -91.60 44.02 54.12 -90.83 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 29 3 # 29 A 114 HIS F 147 HIS^? 8.79 MG MG F 302 A 197 ASP F 128 ASP^? -3.41 MG MG F 301s A 223 ALA F 180 ALA^? 8.00 MG MG F 302 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 56.63 61.66 -91.16 55.69 63.43 -91.80 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 57.76 53.73 -90.50 57.46 51.64 -90.28 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 45.97 53.39 -94.93 45.23 53.59 -96.27 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 30 3 # 30 A 114 HIS F 147 HIS^? 8.79 MG MG F 302 A 197 ASP F 187 ASP^? -3.27 MG MG F 302s A 223 ALA F 179 ALA^? 10.29 MG MG F 302 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 56.63 61.66 -91.16 55.69 63.43 -91.80 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 53.93 58.87 -98.14 52.45 58.62 -96.61 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 44.99 54.95 -91.60 44.02 54.12 -90.83 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 31 3 # 31 A 114 HIS F 170 HIS^? 9.84 MG MG F 302 A 197 ASP F 148 ASP^? 2.72 MG MG F 301s A 223 ALA F 9 ALA^? 15.22 MG MG F 301 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 52.25 64.82 -90.91 50.95 63.88 -92.26 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 53.64 56.47 -91.98 54.61 54.68 -92.64 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 59.78 62.63 -81.12 60.54 61.63 -82.00 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 32 3 # 32 A 114 HIS F 170 HIS^? 9.84 MG MG F 302 A 197 ASP F 171 ASP^? 16.35 MG MG F 302 A 223 ALA F 9 ALA^? 15.22 MG MG F 301 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 52.25 64.82 -90.91 50.95 63.88 -92.26 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 48.23 68.08 -88.47 46.26 68.02 -87.56 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 59.78 62.63 -81.12 60.54 61.63 -82.00 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 33 3 # 33 A 114 HIS F 170 HIS^? 9.84 MG MG F 302 A 197 ASP F 171 ASP^? 16.35 MG MG F 302 A 223 ALA F 179 ALA^? 10.29 MG MG F 302 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 52.25 64.82 -90.91 50.95 63.88 -92.26 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 48.23 68.08 -88.47 46.26 68.02 -87.56 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 44.99 54.95 -91.60 44.02 54.12 -90.83 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 34 3 # 34 A 114 HIS F 170 HIS^? 9.84 MG MG F 302 A 197 ASP F 187 ASP^? -3.27 MG MG F 302s A 223 ALA F 179 ALA^? 10.29 MG MG F 302 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 52.25 64.82 -90.91 50.95 63.88 -92.26 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 53.93 58.87 -98.14 52.45 58.62 -96.61 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 44.99 54.95 -91.60 44.02 54.12 -90.83 1n2t_c02 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 34 hits 1n2t_c02 naa= 3 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 B 114 HIS A 147 HIS^? 9.20 MG MG A 302 B 197 ASP A 128 ASP^? -3.32 MG MG A 301s B 223 ALA A 179 ALA^? 10.50 MG MG A 302 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 40.24 23.10 39.83 38.32 22.34 40.22 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 46.50 28.23 39.77 47.49 30.10 39.82 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 35.90 35.25 40.82 35.84 36.46 39.90 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 B 114 HIS A 147 HIS^? 9.20 MG MG A 302 B 197 ASP A 128 ASP^? -3.32 MG MG A 301s B 223 ALA A 180 ALA^? 8.42 MG MG A 302 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 40.24 23.10 39.83 38.32 22.34 40.22 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 46.50 28.23 39.77 47.49 30.10 39.82 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 37.01 35.73 44.42 36.08 35.79 45.62 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 3 3 # 3 B 114 HIS A 170 HIS^? 10.56 MG MG A 302 B 197 ASP A 148 ASP^? 2.72 MG MG A 301s B 223 ALA A 9 ALA^? 15.22 MG MG A 301 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 34.91 23.57 39.32 34.35 24.95 40.81 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 41.50 28.88 41.13 43.33 29.67 41.93 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 42.54 20.81 29.78 43.62 21.07 30.77 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 4 3 # 4 B 114 HIS A 170 HIS^? 10.56 MG MG A 302 B 197 ASP A 171 ASP^? 17.17 MG MG A 302 B 223 ALA A 9 ALA^? 15.22 MG MG A 301 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 34.91 23.57 39.32 34.35 24.95 40.81 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 29.78 23.67 36.63 28.48 25.11 35.71 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 42.54 20.81 29.78 43.62 21.07 30.77 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 5 3 # 5 B 114 HIS A 170 HIS^? 10.56 MG MG A 302 B 197 ASP A 171 ASP^? 17.17 MG MG A 302 B 223 ALA A 179 ALA^? 10.50 MG MG A 302 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 34.91 23.57 39.32 34.35 24.95 40.81 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 29.78 23.67 36.63 28.48 25.11 35.71 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 35.90 35.25 40.82 35.84 36.46 39.90 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 6 3 # 6 B 114 HIS B 147 HIS^? 9.27 MG MG B 301 B 197 ASP B 128 ASP^? -3.57 MG MG B 302s B 223 ALA B 179 ALA^? 10.09 MG MG B 301 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 46.73 18.97 -3.05 45.63 17.32 -3.73 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 52.92 24.09 -2.19 54.73 25.14 -1.90 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 58.26 12.57 -3.59 59.34 12.14 -2.62 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 7 3 # 7 B 114 HIS B 147 HIS^? 9.27 MG MG B 301 B 197 ASP B 128 ASP^? -3.57 MG MG B 302s B 223 ALA B 180 ALA^? 7.87 MG MG B 301 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 46.73 18.97 -3.05 45.63 17.32 -3.73 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 52.92 24.09 -2.19 54.73 25.14 -1.90 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 59.08 14.28 -6.88 59.39 13.60 -8.19 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 8 3 # 8 B 114 HIS B 170 HIS^? 10.51 MG MG B 301 B 197 ASP B 148 ASP^? 2.58 MG MG B 302s B 223 ALA B 9 ALA^? 15.20 MG MG B 302 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 46.22 13.75 -2.72 47.53 13.11 -4.24 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 52.73 19.23 -3.77 53.81 20.99 -4.31 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 44.07 20.95 7.16 44.62 22.08 6.31 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 9 3 # 9 B 114 HIS B 170 HIS^? 10.51 MG MG B 301 B 197 ASP B 171 ASP^? 16.92 MG MG B 301 B 223 ALA B 9 ALA^? 15.20 MG MG B 302 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 46.22 13.75 -2.72 47.53 13.11 -4.24 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 45.30 8.50 -0.71 46.30 6.81 0.12 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 44.07 20.95 7.16 44.62 22.08 6.31 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 10 3 # 10 B 114 HIS B 170 HIS^? 10.51 MG MG B 301 B 197 ASP B 171 ASP^? 16.92 MG MG B 301 B 223 ALA B 179 ALA^? 10.09 MG MG B 301 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 46.22 13.75 -2.72 47.53 13.11 -4.24 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 45.30 8.50 -0.71 46.30 6.81 0.12 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 58.26 12.57 -3.59 59.34 12.14 -2.62 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 11 3 # 11 B 114 HIS C 147 HIS^? 9.44 MG MG C 301 B 197 ASP C 128 ASP^? -3.22 MG MG C 302s B 223 ALA C 179 ALA^? 10.20 MG MG C 301 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 87.61 25.71 -3.59 89.22 24.50 -2.99 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 80.05 28.39 -4.25 77.97 28.60 -4.21 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 78.98 15.73 -3.05 77.99 14.95 -3.93 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 12 3 # 12 B 114 HIS C 147 HIS^? 9.44 MG MG C 301 B 197 ASP C 128 ASP^? -3.22 MG MG C 302s B 223 ALA C 180 ALA^? 7.92 MG MG C 301 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 87.61 25.71 -3.59 89.22 24.50 -2.99 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 80.05 28.39 -4.25 77.97 28.60 -4.21 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 77.97 16.90 0.41 78.13 16.09 1.70 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 13 3 # 13 B 114 HIS C 147 HIS^? 9.44 MG MG C 301 B 197 ASP C 187 ASP^? -3.72 MG MG C 301s B 223 ALA C 179 ALA^? 10.20 MG MG C 301 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 87.61 25.71 -3.59 89.22 24.50 -2.99 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 84.01 23.73 3.39 83.47 22.54 1.59 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 78.98 15.73 -3.05 77.99 14.95 -3.93 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 14 3 # 14 B 114 HIS C 170 HIS^? 10.68 MG MG C 301 B 197 ASP C 148 ASP^? 2.75 MG MG C 302s B 223 ALA C 9 ALA^? 15.00 MG MG C 302 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 89.96 21.05 -3.85 88.74 19.88 -2.61 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 81.96 23.83 -2.68 80.24 25.11 -2.27 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 89.05 28.81 -13.58 88.16 29.64 -12.74 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 15 3 # 15 B 114 HIS C 170 HIS^? 10.68 MG MG C 301 B 197 ASP C 171 ASP^? 17.08 MG MG C 301 B 223 ALA C 9 ALA^? 15.00 MG MG C 302 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 89.96 21.05 -3.85 88.74 19.88 -2.61 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 92.57 16.68 -6.24 92.24 14.74 -7.03 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 89.05 28.81 -13.58 88.16 29.64 -12.74 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 16 3 # 16 B 114 HIS C 170 HIS^? 10.68 MG MG C 301 B 197 ASP C 171 ASP^? 17.08 MG MG C 301 B 223 ALA C 179 ALA^? 10.20 MG MG C 301 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 89.96 21.05 -3.85 88.74 19.88 -2.61 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 92.57 16.68 -6.24 92.24 14.74 -7.03 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 78.98 15.73 -3.05 77.99 14.95 -3.93 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 17 3 # 17 B 114 HIS D 147 HIS^? 9.43 MG MG D 301 B 197 ASP D 128 ASP^? -3.70 MG MG D 302s B 223 ALA D 179 ALA^? 10.20 MG MG D 301 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 90.95 32.51 -46.42 92.98 32.42 -46.93 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 83.33 35.45 -46.13 81.57 36.63 -46.10 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 90.58 45.61 -47.30 90.29 46.82 -46.46 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 18 3 # 18 B 114 HIS D 147 HIS^? 9.43 MG MG D 301 B 197 ASP D 128 ASP^? -3.70 MG MG D 302s B 223 ALA D 180 ALA^? 8.04 MG MG D 301 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 90.95 32.51 -46.42 92.98 32.42 -46.93 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 83.33 35.45 -46.13 81.57 36.63 -46.10 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 88.96 45.51 -50.74 89.59 46.01 -52.03 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 19 3 # 19 B 114 HIS D 170 HIS^? 10.59 MG MG D 301 B 197 ASP D 148 ASP^? 2.35 MG MG D 302s B 223 ALA D 9 ALA^? 15.02 MG MG D 302 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 95.57 34.81 -46.05 95.59 36.24 -47.59 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 87.78 37.50 -47.56 85.79 37.49 -48.28 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 89.67 29.50 -36.34 88.55 29.40 -37.31 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 20 3 # 20 B 114 HIS D 170 HIS^? 10.59 MG MG D 301 B 197 ASP D 171 ASP^? 16.95 MG MG D 301 B 223 ALA D 9 ALA^? 15.02 MG MG D 302 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 95.57 34.81 -46.05 95.59 36.24 -47.59 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 100.39 36.69 -43.49 101.13 38.51 -42.69 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 89.67 29.50 -36.34 88.55 29.40 -37.31 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 21 3 # 21 B 114 HIS D 170 HIS^? 10.59 MG MG D 301 B 197 ASP D 171 ASP^? 16.95 MG MG D 301 B 223 ALA D 179 ALA^? 10.20 MG MG D 301 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 95.57 34.81 -46.05 95.59 36.24 -47.59 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 100.39 36.69 -43.49 101.13 38.51 -42.69 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 90.58 45.61 -47.30 90.29 46.82 -46.46 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 22 3 # 22 B 114 HIS D 170 HIS^? 10.59 MG MG D 301 B 197 ASP D 187 ASP^? -2.95 MG MG D 301s B 223 ALA D 114 ALA^? 10.14 MG MG D 302 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 95.57 34.81 -46.05 95.59 36.24 -47.59 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 90.40 36.34 -52.69 89.24 37.98 -51.99 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 82.02 32.47 -40.60 83.33 32.76 -39.91 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 23 3 # 23 B 114 HIS E 147 HIS^? 9.22 MG MG E 301 B 197 ASP E 128 ASP^? -3.53 MG MG E 302s B 223 ALA E 179 ALA^? 10.17 MG MG E 301 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 63.87 64.43 -48.39 64.18 66.45 -47.92 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 65.38 56.57 -48.58 66.15 54.57 -48.61 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 76.81 62.00 -47.52 77.96 61.52 -48.40 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 24 3 # 24 B 114 HIS E 147 HIS^? 9.22 MG MG E 301 B 197 ASP E 128 ASP^? -3.53 MG MG E 302s B 223 ALA E 180 ALA^? 7.76 MG MG E 301 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 63.87 64.43 -48.39 64.18 66.45 -47.92 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 65.38 56.57 -48.58 66.15 54.57 -48.61 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 76.35 60.44 -44.08 76.96 60.95 -42.80 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 25 3 # 25 B 114 HIS E 170 HIS^? 10.33 MG MG E 301 B 197 ASP E 148 ASP^? 2.62 MG MG E 302s B 223 ALA E 9 ALA^? 15.19 MG MG E 302 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 66.96 68.76 -48.87 68.36 68.54 -47.33 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 68.29 60.44 -47.29 68.03 58.42 -46.50 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 60.74 63.76 -58.54 60.44 62.76 -57.48 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 26 3 # 26 B 114 HIS E 170 HIS^? 10.33 MG MG E 301 B 197 ASP E 171 ASP^? 16.73 MG MG E 301 B 223 ALA E 9 ALA^? 15.19 MG MG E 302 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 66.96 68.76 -48.87 68.36 68.54 -47.33 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 69.61 73.12 -51.56 71.50 73.53 -52.39 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 60.74 63.76 -58.54 60.44 62.76 -57.48 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 27 3 # 27 B 114 HIS E 170 HIS^? 10.33 MG MG E 301 B 197 ASP E 171 ASP^? 16.73 MG MG E 301 B 223 ALA E 179 ALA^? 10.17 MG MG E 301 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 66.96 68.76 -48.87 68.36 68.54 -47.33 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 69.61 73.12 -51.56 71.50 73.53 -52.39 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 76.81 62.00 -47.52 77.96 61.52 -48.40 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 28 3 # 28 B 114 HIS F 147 HIS^? 8.79 MG MG F 302 B 197 ASP F 128 ASP^? -3.41 MG MG F 301s B 223 ALA F 179 ALA^? 10.29 MG MG F 302 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 56.63 61.66 -91.16 55.69 63.43 -91.80 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 57.76 53.73 -90.50 57.46 51.64 -90.28 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 44.99 54.95 -91.60 44.02 54.12 -90.83 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 29 3 # 29 B 114 HIS F 147 HIS^? 8.79 MG MG F 302 B 197 ASP F 128 ASP^? -3.41 MG MG F 301s B 223 ALA F 180 ALA^? 8.00 MG MG F 302 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 56.63 61.66 -91.16 55.69 63.43 -91.80 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 57.76 53.73 -90.50 57.46 51.64 -90.28 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 45.97 53.39 -94.93 45.23 53.59 -96.27 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 30 3 # 30 B 114 HIS F 147 HIS^? 8.79 MG MG F 302 B 197 ASP F 187 ASP^? -3.27 MG MG F 302s B 223 ALA F 179 ALA^? 10.29 MG MG F 302 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 56.63 61.66 -91.16 55.69 63.43 -91.80 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 53.93 58.87 -98.14 52.45 58.62 -96.61 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 44.99 54.95 -91.60 44.02 54.12 -90.83 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 31 3 # 31 B 114 HIS F 170 HIS^? 9.84 MG MG F 302 B 197 ASP F 148 ASP^? 2.72 MG MG F 301s B 223 ALA F 9 ALA^? 15.22 MG MG F 301 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 52.25 64.82 -90.91 50.95 63.88 -92.26 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 53.64 56.47 -91.98 54.61 54.68 -92.64 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 59.78 62.63 -81.12 60.54 61.63 -82.00 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 32 3 # 32 B 114 HIS F 170 HIS^? 9.84 MG MG F 302 B 197 ASP F 171 ASP^? 16.35 MG MG F 302 B 223 ALA F 9 ALA^? 15.22 MG MG F 301 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 52.25 64.82 -90.91 50.95 63.88 -92.26 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 48.23 68.08 -88.47 46.26 68.02 -87.56 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 59.78 62.63 -81.12 60.54 61.63 -82.00 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 33 3 # 33 B 114 HIS F 170 HIS^? 9.84 MG MG F 302 B 197 ASP F 171 ASP^? 16.35 MG MG F 302 B 223 ALA F 179 ALA^? 10.29 MG MG F 302 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 52.25 64.82 -90.91 50.95 63.88 -92.26 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 48.23 68.08 -88.47 46.26 68.02 -87.56 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 44.99 54.95 -91.60 44.02 54.12 -90.83 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 34 3 # 34 B 114 HIS F 170 HIS^? 9.84 MG MG F 302 B 197 ASP F 187 ASP^? -3.27 MG MG F 302s B 223 ALA F 179 ALA^? 10.29 MG MG F 302 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 52.25 64.82 -90.91 50.95 63.88 -92.26 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 53.93 58.87 -98.14 52.45 58.62 -96.61 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 44.99 54.95 -91.60 44.02 54.12 -90.83 1n2t_c03 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 34 hits 1n2t_c03 naa= 3 ULMN 3 1ndo_c00 NAPTHALENE 1,2-DIOXYGENASE user 1 3 # 1 A 205 ASP A 148 ASP^? 2.72 MG MG A 301s A 208 HIS A 147 HIS^? 9.20 MG MG A 302 C 104 HIS A 170 HIS^? 10.56 MG MG A 302 coo 20.72 31.33 73.27 20.15 33.36 73.56 41.50 28.88 41.13 43.33 29.67 41.93 coo 17.00 33.82 71.84 16.59 31.98 70.88 40.24 23.10 39.83 38.32 22.34 40.22 coo 20.06 38.06 74.21 21.19 36.81 72.96 34.91 23.57 39.32 34.35 24.95 40.81 ULMN 3 1ndo_c00 NAPTHALENE 1,2-DIOXYGENASE user 2 3 # 2 A 205 ASP B 148 ASP^? 2.58 MG MG B 302s A 208 HIS B 147 HIS^? 9.27 MG MG B 301 C 104 HIS B 170 HIS^? 10.51 MG MG B 301 coo 20.72 31.33 73.27 20.15 33.36 73.56 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 17.00 33.82 71.84 16.59 31.98 70.88 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 20.06 38.06 74.21 21.19 36.81 72.96 46.22 13.75 -2.72 47.53 13.11 -4.24 ULMN 3 1ndo_c00 NAPTHALENE 1,2-DIOXYGENASE user 3 3 # 3 A 205 ASP C 148 ASP^? 2.75 MG MG C 302s A 208 HIS C 147 HIS^? 9.44 MG MG C 301 C 104 HIS C 170 HIS^? 10.68 MG MG C 301 coo 20.72 31.33 73.27 20.15 33.36 73.56 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 17.00 33.82 71.84 16.59 31.98 70.88 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 20.06 38.06 74.21 21.19 36.81 72.96 89.96 21.05 -3.85 88.74 19.88 -2.61 ULMN 3 1ndo_c00 NAPTHALENE 1,2-DIOXYGENASE user 4 3 # 4 A 205 ASP D 148 ASP^? 2.35 MG MG D 302s A 208 HIS D 147 HIS^? 9.43 MG MG D 301 C 104 HIS D 170 HIS^? 10.59 MG MG D 301 coo 20.72 31.33 73.27 20.15 33.36 73.56 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 17.00 33.82 71.84 16.59 31.98 70.88 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 20.06 38.06 74.21 21.19 36.81 72.96 95.57 34.81 -46.05 95.59 36.24 -47.59 ULMN 3 1ndo_c00 NAPTHALENE 1,2-DIOXYGENASE user 5 3 # 5 A 205 ASP E 148 ASP^? 2.62 MG MG E 302s A 208 HIS E 147 HIS^? 9.22 MG MG E 301 C 104 HIS E 170 HIS^? 10.33 MG MG E 301 coo 20.72 31.33 73.27 20.15 33.36 73.56 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 17.00 33.82 71.84 16.59 31.98 70.88 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 20.06 38.06 74.21 21.19 36.81 72.96 66.96 68.76 -48.87 68.36 68.54 -47.33 ULMN 3 1ndo_c00 NAPTHALENE 1,2-DIOXYGENASE user 6 3 # 6 A 205 ASP F 148 ASP^? 2.72 MG MG F 301s A 208 HIS F 147 HIS^? 8.79 MG MG F 302 C 104 HIS F 170 HIS^? 9.84 MG MG F 302 coo 20.72 31.33 73.27 20.15 33.36 73.56 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 17.00 33.82 71.84 16.59 31.98 70.88 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 20.06 38.06 74.21 21.19 36.81 72.96 52.25 64.82 -90.91 50.95 63.88 -92.26 1ndo_c00 source 1ndo NAPTHALENE 1,2-DIOXYGENASE : 6 hits 1ndo_c00 naa= 3 ULMN 3 1ndo_c01 NAPTHALENE 1,2-DIOXYGENASE user 1 3 # 1 A 104 HIS A 170 HIS^? 10.56 MG MG A 302 E 205 ASP A 148 ASP^? 2.72 MG MG A 301s E 208 HIS A 147 HIS^? 9.20 MG MG A 302 coo 36.32 11.24 30.83 37.00 13.22 30.81 34.91 23.57 39.32 34.35 24.95 40.81 coo 38.79 15.70 26.44 37.66 14.35 27.62 41.50 28.88 41.13 43.33 29.67 41.93 coo 34.24 14.63 26.81 34.14 16.25 25.49 40.24 23.10 39.83 38.32 22.34 40.22 ULMN 3 1ndo_c01 NAPTHALENE 1,2-DIOXYGENASE user 2 3 # 2 A 104 HIS B 170 HIS^? 10.51 MG MG B 301 E 205 ASP B 148 ASP^? 2.58 MG MG B 302s E 208 HIS B 147 HIS^? 9.27 MG MG B 301 coo 36.32 11.24 30.83 37.00 13.22 30.81 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 38.79 15.70 26.44 37.66 14.35 27.62 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 34.24 14.63 26.81 34.14 16.25 25.49 46.73 18.97 -3.05 45.63 17.32 -3.73 ULMN 3 1ndo_c01 NAPTHALENE 1,2-DIOXYGENASE user 3 3 # 3 A 104 HIS C 170 HIS^? 10.68 MG MG C 301 E 205 ASP C 148 ASP^? 2.75 MG MG C 302s E 208 HIS C 147 HIS^? 9.44 MG MG C 301 coo 36.32 11.24 30.83 37.00 13.22 30.81 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 38.79 15.70 26.44 37.66 14.35 27.62 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 34.24 14.63 26.81 34.14 16.25 25.49 87.61 25.71 -3.59 89.22 24.50 -2.99 ULMN 3 1ndo_c01 NAPTHALENE 1,2-DIOXYGENASE user 4 3 # 4 A 104 HIS D 170 HIS^? 10.59 MG MG D 301 E 205 ASP D 148 ASP^? 2.35 MG MG D 302s E 208 HIS D 147 HIS^? 9.43 MG MG D 301 coo 36.32 11.24 30.83 37.00 13.22 30.81 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 38.79 15.70 26.44 37.66 14.35 27.62 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 34.24 14.63 26.81 34.14 16.25 25.49 90.95 32.51 -46.42 92.98 32.42 -46.93 ULMN 3 1ndo_c01 NAPTHALENE 1,2-DIOXYGENASE user 5 3 # 5 A 104 HIS E 170 HIS^? 10.33 MG MG E 301 E 205 ASP E 148 ASP^? 2.62 MG MG E 302s E 208 HIS E 147 HIS^? 9.22 MG MG E 301 coo 36.32 11.24 30.83 37.00 13.22 30.81 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 38.79 15.70 26.44 37.66 14.35 27.62 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 34.24 14.63 26.81 34.14 16.25 25.49 63.87 64.43 -48.39 64.18 66.45 -47.92 ULMN 3 1ndo_c01 NAPTHALENE 1,2-DIOXYGENASE user 6 3 # 6 A 104 HIS F 170 HIS^? 9.84 MG MG F 302 E 205 ASP F 148 ASP^? 2.72 MG MG F 301s E 208 HIS F 147 HIS^? 8.79 MG MG F 302 coo 36.32 11.24 30.83 37.00 13.22 30.81 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 38.79 15.70 26.44 37.66 14.35 27.62 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 34.24 14.63 26.81 34.14 16.25 25.49 56.63 61.66 -91.16 55.69 63.43 -91.80 1ndo_c01 source 1ndo NAPTHALENE 1,2-DIOXYGENASE : 6 hits 1ndo_c01 naa= 3 ULMN 3 1ndo_c02 NAPTHALENE 1,2-DIOXYGENASE user 1 3 # 1 C 205 ASP A 148 ASP^? 2.72 MG MG A 301s C 208 HIS A 147 HIS^? 9.20 MG MG A 302 E 104 HIS A 170 HIS^? 10.56 MG MG A 302 coo 36.50 67.03 37.59 36.77 66.38 35.61 41.50 28.88 41.13 43.33 29.67 41.93 coo 33.45 66.12 34.16 32.13 66.40 35.76 40.24 23.10 39.83 38.32 22.34 40.22 coo 38.29 64.94 31.33 38.08 64.16 33.27 34.91 23.57 39.32 34.35 24.95 40.81 ULMN 3 1ndo_c02 NAPTHALENE 1,2-DIOXYGENASE user 2 3 # 2 C 205 ASP B 148 ASP^? 2.58 MG MG B 302s C 208 HIS B 147 HIS^? 9.27 MG MG B 301 E 104 HIS B 170 HIS^? 10.51 MG MG B 301 coo 36.50 67.03 37.59 36.77 66.38 35.61 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 33.45 66.12 34.16 32.13 66.40 35.76 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 38.29 64.94 31.33 38.08 64.16 33.27 46.22 13.75 -2.72 47.53 13.11 -4.24 ULMN 3 1ndo_c02 NAPTHALENE 1,2-DIOXYGENASE user 3 3 # 3 C 205 ASP C 148 ASP^? 2.75 MG MG C 302s C 208 HIS C 147 HIS^? 9.44 MG MG C 301 E 104 HIS C 170 HIS^? 10.68 MG MG C 301 coo 36.50 67.03 37.59 36.77 66.38 35.61 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 33.45 66.12 34.16 32.13 66.40 35.76 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 38.29 64.94 31.33 38.08 64.16 33.27 89.96 21.05 -3.85 88.74 19.88 -2.61 ULMN 3 1ndo_c02 NAPTHALENE 1,2-DIOXYGENASE user 4 3 # 4 C 205 ASP D 148 ASP^? 2.35 MG MG D 302s C 208 HIS D 147 HIS^? 9.43 MG MG D 301 E 104 HIS D 170 HIS^? 10.59 MG MG D 301 coo 36.50 67.03 37.59 36.77 66.38 35.61 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 33.45 66.12 34.16 32.13 66.40 35.76 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 38.29 64.94 31.33 38.08 64.16 33.27 95.57 34.81 -46.05 95.59 36.24 -47.59 ULMN 3 1ndo_c02 NAPTHALENE 1,2-DIOXYGENASE user 5 3 # 5 C 205 ASP E 148 ASP^? 2.62 MG MG E 302s C 208 HIS E 147 HIS^? 9.22 MG MG E 301 E 104 HIS E 170 HIS^? 10.33 MG MG E 301 coo 36.50 67.03 37.59 36.77 66.38 35.61 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 33.45 66.12 34.16 32.13 66.40 35.76 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 38.29 64.94 31.33 38.08 64.16 33.27 66.96 68.76 -48.87 68.36 68.54 -47.33 ULMN 3 1ndo_c02 NAPTHALENE 1,2-DIOXYGENASE user 6 3 # 6 C 205 ASP F 148 ASP^? 2.72 MG MG F 301s C 208 HIS F 147 HIS^? 8.79 MG MG F 302 E 104 HIS F 170 HIS^? 9.84 MG MG F 302 coo 36.50 67.03 37.59 36.77 66.38 35.61 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 33.45 66.12 34.16 32.13 66.40 35.76 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 38.29 64.94 31.33 38.08 64.16 33.27 52.25 64.82 -90.91 50.95 63.88 -92.26 1ndo_c02 source 1ndo NAPTHALENE 1,2-DIOXYGENASE : 6 hits 1ndo_c02 naa= 3 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 1 3 # 1 A 264 HIS A 42 HIS^? 28.45 MG MG A 301 A 290 LYS B 6 LYS^? 25.90 MG MG B 302 A 405 ARG A 48 ARG^? 25.29 MG MG A 301 coo 41.33 25.99 28.05 41.95 26.95 29.80 34.62 18.32 19.57 34.29 16.25 19.41 coo 37.11 33.75 31.82 38.72 27.95 29.90 36.26 25.44 11.74 39.65 23.12 16.29 coo 42.28 27.98 41.30 43.16 28.14 38.35 33.88 31.17 22.03 31.48 31.85 20.30 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 2 3 # 2 A 264 HIS B 42 HIS^? 28.37 MG MG B 302 A 290 LYS A 6 LYS^? 25.88 MG MG A 301 A 405 ARG B 48 ARG^? 25.20 MG MG B 302 coo 41.33 25.99 28.05 41.95 26.95 29.80 39.34 12.99 16.30 37.26 13.24 16.40 coo 37.11 33.75 31.82 38.72 27.95 29.90 46.20 12.82 24.71 44.50 16.64 20.52 coo 42.28 27.98 41.30 43.16 28.14 38.35 52.22 10.51 15.00 52.46 7.79 16.39 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 3 3 # 3 A 264 HIS C 42 HIS^? 28.09 MG MG C 302 A 290 LYS D 6 LYS^? 25.98 MG MG D 302 A 405 ARG C 48 ARG^? 25.02 MG MG C 302 coo 41.33 25.99 28.05 41.95 26.95 29.80 95.93 22.96 -23.11 97.92 23.62 -23.02 coo 37.11 33.75 31.82 38.72 27.95 29.90 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 42.28 27.98 41.30 43.16 28.14 38.35 84.94 16.06 -21.53 85.81 13.55 -23.08 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 4 3 # 4 A 264 HIS D 42 HIS^? 28.21 MG MG D 302 A 290 LYS C 6 LYS^? 25.73 MG MG C 302 A 405 ARG D 48 ARG^? 24.87 MG MG D 302 coo 41.33 25.99 28.05 41.95 26.95 29.80 98.45 29.90 -26.44 99.32 28.02 -26.13 coo 37.11 33.75 31.82 38.72 27.95 29.90 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 42.28 27.98 41.30 43.16 28.14 38.35 94.06 41.76 -28.37 96.24 43.38 -26.96 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 5 3 # 5 A 264 HIS E 42 HIS^? 28.20 MG MG E 302 A 290 LYS F 6 LYS^? 26.09 MG MG F 301 A 405 ARG E 48 ARG^? 25.02 MG MG E 302 coo 41.33 25.99 28.05 41.95 26.95 29.80 62.33 71.93 -68.30 60.54 72.96 -68.64 coo 37.11 33.75 31.82 38.72 27.95 29.90 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 42.28 27.98 41.30 43.16 28.14 38.35 73.60 65.75 -66.57 75.51 67.67 -67.91 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 6 3 # 6 A 264 HIS F 42 HIS^? 28.34 MG MG F 301 A 290 LYS E 6 LYS^? 25.59 MG MG E 302 A 405 ARG F 48 ARG^? 25.18 MG MG F 301 coo 41.33 25.99 28.05 41.95 26.95 29.80 55.11 70.50 -71.64 56.29 72.22 -71.48 coo 37.11 33.75 31.82 38.72 27.95 29.90 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 42.28 27.98 41.30 43.16 28.14 38.35 46.82 60.90 -73.07 44.43 61.88 -71.46 1nhx_c00 source 1nhx PHOSPHOENOLPYRUVATE CARBOXYKINASE, CYTOSOLIC : 6 hits 1nhx_c00 naa= 3 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 1 3 # 1 549 LYS A 157 LYS^? 28.65 MG MG A 302 631 LYS B 6 LYS^? 25.90 MG MG B 302 708 LYS A 192 LYS^? 22.83 MG MG A 302 coo 8.61 33.06 11.15 10.12 29.19 8.82 41.42 12.06 27.58 41.46 5.93 29.41 coo -11.99 27.40 17.14 -13.60 24.52 11.71 36.26 25.44 11.74 39.65 23.12 16.29 coo 18.16 32.86 9.85 16.06 28.20 13.56 40.19 10.20 38.86 35.42 9.85 36.29 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 2 3 # 2 549 LYS A 157 LYS^? 28.65 MG MG A 302 631 LYS B 157 LYS^? 28.85 MG MG B 302 708 LYS A 192 LYS^? 22.83 MG MG A 302 coo 8.61 33.06 11.15 10.12 29.19 8.82 41.42 12.06 27.58 41.46 5.93 29.41 coo -11.99 27.40 17.14 -13.60 24.52 11.71 34.97 21.28 8.44 29.03 22.82 6.58 coo 18.16 32.86 9.85 16.06 28.20 13.56 40.19 10.20 38.86 35.42 9.85 36.29 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 3 3 # 3 549 LYS A 166 LYS^? 20.93 MG MG A 302 631 LYS B 6 LYS^? 25.90 MG MG B 302 708 LYS A 192 LYS^? 22.83 MG MG A 302 coo 8.61 33.06 11.15 10.12 29.19 8.82 35.34 13.14 30.41 31.67 15.04 34.58 coo -11.99 27.40 17.14 -13.60 24.52 11.71 36.26 25.44 11.74 39.65 23.12 16.29 coo 18.16 32.86 9.85 16.06 28.20 13.56 40.19 10.20 38.86 35.42 9.85 36.29 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 4 3 # 4 549 LYS A 166 LYS^? 20.93 MG MG A 302 631 LYS B 157 LYS^? 28.85 MG MG B 302 708 LYS A 192 LYS^? 22.83 MG MG A 302 coo 8.61 33.06 11.15 10.12 29.19 8.82 35.34 13.14 30.41 31.67 15.04 34.58 coo -11.99 27.40 17.14 -13.60 24.52 11.71 34.97 21.28 8.44 29.03 22.82 6.58 coo 18.16 32.86 9.85 16.06 28.20 13.56 40.19 10.20 38.86 35.42 9.85 36.29 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 5 3 # 5 549 LYS B 21 LYS^? 13.97 MG MG B 301 631 LYS C 86 LYS^? 27.34 MG MG C 302 708 LYS B 76 LYS^? 25.77 MG MG B 302 coo 8.61 33.06 11.15 10.12 29.19 8.82 67.50 6.37 -0.39 64.53 11.03 -2.88 coo -11.99 27.40 17.14 -13.60 24.52 11.71 69.22 9.88 -20.56 74.70 7.02 -22.55 coo 18.16 32.86 9.85 16.06 28.20 13.56 67.82 8.19 10.14 64.96 3.09 10.62 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 6 3 # 6 549 LYS B 157 LYS^? 28.85 MG MG B 302 631 LYS A 6 LYS^? 25.88 MG MG A 301 708 LYS B 192 LYS^? 23.73 MG MG B 301 coo 8.61 33.06 11.15 10.12 29.19 8.82 34.97 21.28 8.44 29.03 22.82 6.58 coo -11.99 27.40 17.14 -13.60 24.52 11.71 46.20 12.82 24.71 44.50 16.64 20.52 coo 18.16 32.86 9.85 16.06 28.20 13.56 33.83 21.17 -2.93 31.87 16.45 -0.74 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 7 3 # 7 549 LYS B 157 LYS^? 28.85 MG MG B 302 631 LYS A 157 LYS^? 28.65 MG MG A 302 708 LYS B 192 LYS^? 23.73 MG MG B 301 coo 8.61 33.06 11.15 10.12 29.19 8.82 34.97 21.28 8.44 29.03 22.82 6.58 coo -11.99 27.40 17.14 -13.60 24.52 11.71 41.42 12.06 27.58 41.46 5.93 29.41 coo 18.16 32.86 9.85 16.06 28.20 13.56 33.83 21.17 -2.93 31.87 16.45 -0.74 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 8 3 # 8 549 LYS B 166 LYS^? 22.75 MG MG B 301 631 LYS A 6 LYS^? 25.88 MG MG A 301 708 LYS B 192 LYS^? 23.73 MG MG B 301 coo 8.61 33.06 11.15 10.12 29.19 8.82 35.27 15.38 5.31 37.27 9.81 3.93 coo -11.99 27.40 17.14 -13.60 24.52 11.71 46.20 12.82 24.71 44.50 16.64 20.52 coo 18.16 32.86 9.85 16.06 28.20 13.56 33.83 21.17 -2.93 31.87 16.45 -0.74 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 9 3 # 9 549 LYS B 166 LYS^? 22.75 MG MG B 301 631 LYS A 157 LYS^? 28.65 MG MG A 302 708 LYS B 192 LYS^? 23.73 MG MG B 301 coo 8.61 33.06 11.15 10.12 29.19 8.82 35.27 15.38 5.31 37.27 9.81 3.93 coo -11.99 27.40 17.14 -13.60 24.52 11.71 41.42 12.06 27.58 41.46 5.93 29.41 coo 18.16 32.86 9.85 16.06 28.20 13.56 33.83 21.17 -2.93 31.87 16.45 -0.74 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 10 3 # 10 549 LYS C 21 LYS^? 14.49 MG MG C 302 631 LYS B 86 LYS^? 26.44 MG MG B 302 708 LYS C 76 LYS^? 24.95 MG MG C 302 coo 8.61 33.06 11.15 10.12 29.19 8.82 72.10 6.87 -6.14 72.84 12.21 -4.93 coo -11.99 27.40 17.14 -13.60 24.52 11.71 69.25 10.45 13.86 65.27 7.74 16.08 coo 18.16 32.86 9.85 16.06 28.20 13.56 71.11 8.63 -16.76 75.44 5.17 -16.80 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 11 3 # 11 549 LYS C 157 LYS^? 28.15 MG MG C 302 631 LYS D 6 LYS^? 25.98 MG MG D 302 708 LYS C 192 LYS^? 24.43 MG MG C 301 coo 8.61 33.06 11.15 10.12 29.19 8.82 97.55 32.04 -15.10 101.49 36.24 -13.39 coo -11.99 27.40 17.14 -13.60 24.52 11.71 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 18.16 32.86 9.85 16.06 28.20 13.56 98.71 32.33 -3.93 102.89 29.25 -5.78 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 12 3 # 12 549 LYS C 157 LYS^? 28.15 MG MG C 302 631 LYS D 157 LYS^? 28.67 MG MG D 302 708 LYS C 192 LYS^? 24.43 MG MG C 301 coo 8.61 33.06 11.15 10.12 29.19 8.82 97.55 32.04 -15.10 101.49 36.24 -13.39 coo -11.99 27.40 17.14 -13.60 24.52 11.71 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 18.16 32.86 9.85 16.06 28.20 13.56 98.71 32.33 -3.93 102.89 29.25 -5.78 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 13 3 # 13 549 LYS C 166 LYS^? 22.53 MG MG C 301 631 LYS D 6 LYS^? 25.98 MG MG D 302 708 LYS C 192 LYS^? 24.43 MG MG C 301 coo 8.61 33.06 11.15 10.12 29.19 8.82 99.24 26.71 -12.25 100.23 21.90 -8.99 coo -11.99 27.40 17.14 -13.60 24.52 11.71 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 18.16 32.86 9.85 16.06 28.20 13.56 98.71 32.33 -3.93 102.89 29.25 -5.78 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 14 3 # 14 549 LYS C 166 LYS^? 22.53 MG MG C 301 631 LYS D 157 LYS^? 28.67 MG MG D 302 708 LYS C 192 LYS^? 24.43 MG MG C 301 coo 8.61 33.06 11.15 10.12 29.19 8.82 99.24 26.71 -12.25 100.23 21.90 -8.99 coo -11.99 27.40 17.14 -13.60 24.52 11.71 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 18.16 32.86 9.85 16.06 28.20 13.56 98.71 32.33 -3.93 102.89 29.25 -5.78 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 15 3 # 15 549 LYS D 21 LYS^? 14.47 MG MG D 302 631 LYS E 86 LYS^? 26.73 MG MG D 301 708 LYS D 76 LYS^? 25.08 MG MG D 302 coo 8.61 33.06 11.15 10.12 29.19 8.82 90.57 56.85 -44.52 87.39 52.68 -46.00 coo -11.99 27.40 17.14 -13.60 24.52 11.71 86.84 54.85 -64.43 87.07 60.83 -66.10 coo 18.16 32.86 9.85 16.06 28.20 13.56 88.18 56.35 -34.05 93.80 56.17 -32.93 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 16 3 # 16 549 LYS D 157 LYS^? 28.67 MG MG D 302 631 LYS C 6 LYS^? 25.73 MG MG C 302 708 LYS D 192 LYS^? 24.09 MG MG D 301 coo 8.61 33.06 11.15 10.12 29.19 8.82 94.17 21.71 -34.34 96.11 15.89 -35.92 coo -11.99 27.40 17.14 -13.60 24.52 11.71 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 18.16 32.86 9.85 16.06 28.20 13.56 95.35 20.28 -45.75 100.42 20.77 -43.05 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 17 3 # 17 549 LYS D 157 LYS^? 28.67 MG MG D 302 631 LYS C 157 LYS^? 28.15 MG MG C 302 708 LYS D 192 LYS^? 24.09 MG MG D 301 coo 8.61 33.06 11.15 10.12 29.19 8.82 94.17 21.71 -34.34 96.11 15.89 -35.92 coo -11.99 27.40 17.14 -13.60 24.52 11.71 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 18.16 32.86 9.85 16.06 28.20 13.56 95.35 20.28 -45.75 100.42 20.77 -43.05 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 18 3 # 18 549 LYS D 166 LYS^? 21.08 MG MG D 301 631 LYS C 6 LYS^? 25.73 MG MG C 302 708 LYS D 192 LYS^? 24.09 MG MG D 301 coo 8.61 33.06 11.15 10.12 29.19 8.82 99.23 24.85 -37.31 101.73 27.34 -42.07 coo -11.99 27.40 17.14 -13.60 24.52 11.71 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 18.16 32.86 9.85 16.06 28.20 13.56 95.35 20.28 -45.75 100.42 20.77 -43.05 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 19 3 # 19 549 LYS D 166 LYS^? 21.08 MG MG D 301 631 LYS C 157 LYS^? 28.15 MG MG C 302 708 LYS D 192 LYS^? 24.09 MG MG D 301 coo 8.61 33.06 11.15 10.12 29.19 8.82 99.23 24.85 -37.31 101.73 27.34 -42.07 coo -11.99 27.40 17.14 -13.60 24.52 11.71 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 18.16 32.86 9.85 16.06 28.20 13.56 95.35 20.28 -45.75 100.42 20.77 -43.05 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 20 3 # 20 549 LYS E 21 LYS^? 14.42 MG MG E 301 631 LYS D 86 LYS^? 25.80 MG MG D 302 708 LYS E 76 LYS^? 25.68 MG MG E 302 coo 8.61 33.06 11.15 10.12 29.19 8.82 87.88 60.38 -50.25 83.05 58.57 -47.65 coo -11.99 27.40 17.14 -13.60 24.52 11.71 85.54 56.79 -30.27 90.24 54.54 -28.62 coo 18.16 32.86 9.85 16.06 28.20 13.56 87.09 58.11 -60.91 88.65 63.65 -61.27 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 21 3 # 21 549 LYS E 157 LYS^? 28.40 MG MG E 302 631 LYS F 6 LYS^? 26.09 MG MG F 301 708 LYS E 192 LYS^? 23.62 MG MG E 301 coo 8.61 33.06 11.15 10.12 29.19 8.82 53.63 69.16 -60.42 48.34 71.81 -58.40 coo -11.99 27.40 17.14 -13.60 24.52 11.71 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 18.16 32.86 9.85 16.06 28.20 13.56 52.64 70.58 -49.14 53.48 75.40 -50.95 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 22 3 # 22 549 LYS E 157 LYS^? 28.40 MG MG E 302 631 LYS F 157 LYS^? 28.36 MG MG F 302 708 LYS E 192 LYS^? 23.62 MG MG E 301 coo 8.61 33.06 11.15 10.12 29.19 8.82 53.63 69.16 -60.42 48.34 71.81 -58.40 coo -11.99 27.40 17.14 -13.60 24.52 11.71 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 18.16 32.86 9.85 16.06 28.20 13.56 52.64 70.58 -49.14 53.48 75.40 -50.95 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 23 3 # 23 549 LYS E 166 LYS^? 21.46 MG MG E 301 631 LYS F 6 LYS^? 26.09 MG MG F 301 708 LYS E 192 LYS^? 23.62 MG MG E 301 coo 8.61 33.06 11.15 10.12 29.19 8.82 57.66 73.57 -57.60 60.27 76.17 -53.59 coo -11.99 27.40 17.14 -13.60 24.52 11.71 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 18.16 32.86 9.85 16.06 28.20 13.56 52.64 70.58 -49.14 53.48 75.40 -50.95 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 24 3 # 24 549 LYS E 166 LYS^? 21.46 MG MG E 301 631 LYS F 157 LYS^? 28.36 MG MG F 302 708 LYS E 192 LYS^? 23.62 MG MG E 301 coo 8.61 33.06 11.15 10.12 29.19 8.82 57.66 73.57 -57.60 60.27 76.17 -53.59 coo -11.99 27.40 17.14 -13.60 24.52 11.71 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 18.16 32.86 9.85 16.06 28.20 13.56 52.64 70.58 -49.14 53.48 75.40 -50.95 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 25 3 # 25 549 LYS F 157 LYS^? 28.36 MG MG F 302 631 LYS E 6 LYS^? 25.59 MG MG E 302 708 LYS F 192 LYS^? 23.61 MG MG F 302 coo 8.61 33.06 11.15 10.12 29.19 8.82 64.43 70.47 -79.54 68.32 74.80 -81.65 coo -11.99 27.40 17.14 -13.60 24.52 11.71 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 18.16 32.86 9.85 16.06 28.20 13.56 64.82 71.59 -91.06 62.22 76.11 -88.75 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 26 3 # 26 549 LYS F 157 LYS^? 28.36 MG MG F 302 631 LYS E 157 LYS^? 28.40 MG MG E 302 708 LYS F 192 LYS^? 23.61 MG MG F 302 coo 8.61 33.06 11.15 10.12 29.19 8.82 64.43 70.47 -79.54 68.32 74.80 -81.65 coo -11.99 27.40 17.14 -13.60 24.52 11.71 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 18.16 32.86 9.85 16.06 28.20 13.56 64.82 71.59 -91.06 62.22 76.11 -88.75 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 27 3 # 27 549 LYS F 166 LYS^? 20.76 MG MG F 302 631 LYS E 6 LYS^? 25.59 MG MG E 302 708 LYS F 192 LYS^? 23.61 MG MG F 302 coo 8.61 33.06 11.15 10.12 29.19 8.82 59.28 73.05 -82.63 55.63 74.15 -86.94 coo -11.99 27.40 17.14 -13.60 24.52 11.71 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 18.16 32.86 9.85 16.06 28.20 13.56 64.82 71.59 -91.06 62.22 76.11 -88.75 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 28 3 # 28 549 LYS F 166 LYS^? 20.76 MG MG F 302 631 LYS E 157 LYS^? 28.40 MG MG E 302 708 LYS F 192 LYS^? 23.61 MG MG F 302 coo 8.61 33.06 11.15 10.12 29.19 8.82 59.28 73.05 -82.63 55.63 74.15 -86.94 coo -11.99 27.40 17.14 -13.60 24.52 11.71 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 18.16 32.86 9.85 16.06 28.20 13.56 64.82 71.59 -91.06 62.22 76.11 -88.75 1nsf_c00 source 1nsf N-ETHYLMALEIMIDE SENSITIVE FACTOR : 28 hits 1nsf_c00 naa= 3 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 A 99 ARG B 173 ARG^? 18.75 MG MG B 301 A 101 ASP B 171 ASP^? 16.92 MG MG B 301 A 132 ASP B 177 ASP^? 9.03 MG MG B 301 coo 11.61 22.83 17.30 14.06 21.71 15.78 49.83 5.55 0.39 48.19 5.30 3.03 coo 11.37 24.94 11.48 12.48 24.45 13.28 45.30 8.50 -0.71 46.30 6.81 0.12 coo 16.14 18.17 13.37 15.92 19.81 14.71 51.97 11.04 -6.64 50.39 11.62 -7.94 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 A 99 ARG D 173 ARG^? 18.88 MG MG D 301 A 101 ASP D 171 ASP^? 16.95 MG MG D 301 A 132 ASP D 177 ASP^? 8.43 MG MG D 301 coo 11.61 22.83 17.30 14.06 21.71 15.78 100.48 42.57 -42.43 101.55 40.79 -40.06 coo 11.37 24.94 11.48 12.48 24.45 13.28 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 16.14 18.17 13.37 15.92 19.81 14.71 95.74 41.01 -49.76 94.81 39.90 -51.24 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 3 3 # 3 A 99 ARG E 173 ARG^? 18.66 MG MG E 301 A 101 ASP E 171 ASP^? 16.73 MG MG E 301 A 132 ASP E 177 ASP^? 8.55 MG MG E 301 coo 11.61 22.83 17.30 14.06 21.71 15.78 75.16 72.26 -52.56 73.67 73.54 -55.01 coo 11.37 24.94 11.48 12.48 24.45 13.28 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 16.14 18.17 13.37 15.92 19.81 14.71 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 4 3 # 4 A 99 ARG F 173 ARG^? 18.61 MG MG F 302 A 101 ASP F 171 ASP^? 16.35 MG MG F 302 A 132 ASP F 177 ASP^? 8.15 MG MG F 302 coo 11.61 22.83 17.30 14.06 21.71 15.78 43.18 65.58 -86.96 44.06 67.55 -84.65 coo 11.37 24.94 11.48 12.48 24.45 13.28 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 16.14 18.17 13.37 15.92 19.81 14.71 47.18 61.22 -94.50 48.48 62.32 -95.73 1nu3_c00 source 1nu3 LIMONENE-1,2-EPOXIDE HYDROLASE : 4 hits 1nu3_c00 naa= 3 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 B 99 ARG B 173 ARG^? 18.75 MG MG B 301 B 101 ASP B 171 ASP^? 16.92 MG MG B 301 B 132 ASP B 177 ASP^? 9.03 MG MG B 301 coo 11.61 3.43 18.38 9.11 4.29 16.86 49.83 5.55 0.39 48.19 5.30 3.03 coo 11.74 0.51 12.98 10.75 1.32 14.67 45.30 8.50 -0.71 46.30 6.81 0.12 coo 6.93 7.52 14.08 7.18 6.08 15.65 51.97 11.04 -6.64 50.39 11.62 -7.94 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 B 99 ARG D 173 ARG^? 18.88 MG MG D 301 B 101 ASP D 171 ASP^? 16.95 MG MG D 301 B 132 ASP D 177 ASP^? 8.43 MG MG D 301 coo 11.61 3.43 18.38 9.11 4.29 16.86 100.48 42.57 -42.43 101.55 40.79 -40.06 coo 11.74 0.51 12.98 10.75 1.32 14.67 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 6.93 7.52 14.08 7.18 6.08 15.65 95.74 41.01 -49.76 94.81 39.90 -51.24 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 3 3 # 3 B 99 ARG E 173 ARG^? 18.66 MG MG E 301 B 101 ASP E 171 ASP^? 16.73 MG MG E 301 B 132 ASP E 177 ASP^? 8.55 MG MG E 301 coo 11.61 3.43 18.38 9.11 4.29 16.86 75.16 72.26 -52.56 73.67 73.54 -55.01 coo 11.74 0.51 12.98 10.75 1.32 14.67 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 6.93 7.52 14.08 7.18 6.08 15.65 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 4 3 # 4 B 99 ARG F 173 ARG^? 18.61 MG MG F 302 B 101 ASP F 171 ASP^? 16.35 MG MG F 302 B 132 ASP F 177 ASP^? 8.15 MG MG F 302 coo 11.61 3.43 18.38 9.11 4.29 16.86 43.18 65.58 -86.96 44.06 67.55 -84.65 coo 11.74 0.51 12.98 10.75 1.32 14.67 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 6.93 7.52 14.08 7.18 6.08 15.65 47.18 61.22 -94.50 48.48 62.32 -95.73 1nu3_c01 source 1nu3 LIMONENE-1,2-EPOXIDE HYDROLASE : 4 hits 1nu3_c01 naa= 3 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 A 99 ARG B 173 ARG^? 18.75 MG MG B 301 A 101 ASP B 171 ASP^? 16.92 MG MG B 301 A 132 ASP B 177 ASP^? 9.03 MG MG B 301 coo 11.50 22.77 17.24 14.00 21.62 15.86 49.83 5.55 0.39 48.19 5.30 3.03 coo 11.19 25.00 11.76 12.16 24.45 13.59 45.30 8.50 -0.71 46.30 6.81 0.12 coo 16.04 18.11 13.43 15.88 19.70 14.83 51.97 11.04 -6.64 50.39 11.62 -7.94 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 A 99 ARG D 173 ARG^? 18.88 MG MG D 301 A 101 ASP D 171 ASP^? 16.95 MG MG D 301 A 132 ASP D 177 ASP^? 8.43 MG MG D 301 coo 11.50 22.77 17.24 14.00 21.62 15.86 100.48 42.57 -42.43 101.55 40.79 -40.06 coo 11.19 25.00 11.76 12.16 24.45 13.59 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 16.04 18.11 13.43 15.88 19.70 14.83 95.74 41.01 -49.76 94.81 39.90 -51.24 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 3 3 # 3 A 99 ARG E 173 ARG^? 18.66 MG MG E 301 A 101 ASP E 171 ASP^? 16.73 MG MG E 301 A 132 ASP E 177 ASP^? 8.55 MG MG E 301 coo 11.50 22.77 17.24 14.00 21.62 15.86 75.16 72.26 -52.56 73.67 73.54 -55.01 coo 11.19 25.00 11.76 12.16 24.45 13.59 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 16.04 18.11 13.43 15.88 19.70 14.83 72.81 67.32 -45.03 71.14 67.96 -43.95 1nww_c02 source 1nww LIMONENE-1,2-EPOXIDE HYDROLASE : 3 hits 1nww_c02 naa= 3 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 B 99 ARG B 173 ARG^? 18.75 MG MG B 301 B 101 ASP B 171 ASP^? 16.92 MG MG B 301 B 132 ASP B 177 ASP^? 9.03 MG MG B 301 coo 11.48 3.09 18.25 9.01 4.07 16.77 49.83 5.55 0.39 48.19 5.30 3.03 coo 11.83 0.33 13.01 10.88 1.04 14.81 45.30 8.50 -0.71 46.30 6.81 0.12 coo 6.85 7.33 14.07 7.10 5.88 15.60 51.97 11.04 -6.64 50.39 11.62 -7.94 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 B 99 ARG D 173 ARG^? 18.88 MG MG D 301 B 101 ASP D 171 ASP^? 16.95 MG MG D 301 B 132 ASP D 177 ASP^? 8.43 MG MG D 301 coo 11.48 3.09 18.25 9.01 4.07 16.77 100.48 42.57 -42.43 101.55 40.79 -40.06 coo 11.83 0.33 13.01 10.88 1.04 14.81 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 6.85 7.33 14.07 7.10 5.88 15.60 95.74 41.01 -49.76 94.81 39.90 -51.24 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 3 3 # 3 B 99 ARG E 173 ARG^? 18.66 MG MG E 301 B 101 ASP E 171 ASP^? 16.73 MG MG E 301 B 132 ASP E 177 ASP^? 8.55 MG MG E 301 coo 11.48 3.09 18.25 9.01 4.07 16.77 75.16 72.26 -52.56 73.67 73.54 -55.01 coo 11.83 0.33 13.01 10.88 1.04 14.81 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 6.85 7.33 14.07 7.10 5.88 15.60 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 4 3 # 4 B 99 ARG F 173 ARG^? 18.61 MG MG F 302 B 101 ASP F 171 ASP^? 16.35 MG MG F 302 B 132 ASP F 177 ASP^? 8.15 MG MG F 302 coo 11.48 3.09 18.25 9.01 4.07 16.77 43.18 65.58 -86.96 44.06 67.55 -84.65 coo 11.83 0.33 13.01 10.88 1.04 14.81 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 6.85 7.33 14.07 7.10 5.88 15.60 47.18 61.22 -94.50 48.48 62.32 -95.73 1nww_c03 source 1nww LIMONENE-1,2-EPOXIDE HYDROLASE : 4 hits 1nww_c03 naa= 3 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 1 3 # 1 A 62 SER A 36 SER^? 23.25 MG MG A 301 A 154 ASP B 160 ASP^? 31.65 MG MG A 301 A 261 ARG A 37 ARG^? 18.99 MG MG A 301 coo 16.10 74.10 3.11 17.18 73.52 5.20 29.88 32.10 25.40 29.53 34.39 24.57 coo 16.07 84.71 8.14 15.20 82.81 8.14 28.01 24.83 16.38 27.44 26.81 15.80 coo 10.59 77.85 4.81 13.09 76.36 5.76 32.99 26.50 25.19 35.50 25.33 26.51 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 2 3 # 2 A 62 SER A 36 SER^? 23.25 MG MG A 301 A 154 ASP B 160 ASP^? 31.65 MG MG A 301 A 261 ARG A 48 ARG^? 25.29 MG MG A 301 coo 16.10 74.10 3.11 17.18 73.52 5.20 29.88 32.10 25.40 29.53 34.39 24.57 coo 16.07 84.71 8.14 15.20 82.81 8.14 28.01 24.83 16.38 27.44 26.81 15.80 coo 10.59 77.85 4.81 13.09 76.36 5.76 33.88 31.17 22.03 31.48 31.85 20.30 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 3 3 # 3 A 62 SER B 36 SER^? 24.04 MG MG B 302 A 154 ASP A 160 ASP^? 31.61 MG MG B 302 A 261 ARG B 37 ARG^? 19.17 MG MG B 302 coo 16.10 74.10 3.11 17.18 73.52 5.20 52.58 6.45 11.01 53.61 4.84 12.41 coo 16.07 84.71 8.14 15.20 82.81 8.14 44.21 5.00 19.54 46.02 3.84 19.76 coo 10.59 77.85 4.81 13.09 76.36 5.76 47.41 10.20 11.40 46.99 12.91 10.22 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 4 3 # 4 A 62 SER B 36 SER^? 24.04 MG MG B 302 A 154 ASP A 160 ASP^? 31.61 MG MG B 302 A 261 ARG B 48 ARG^? 25.20 MG MG B 302 coo 16.10 74.10 3.11 17.18 73.52 5.20 52.58 6.45 11.01 53.61 4.84 12.41 coo 16.07 84.71 8.14 15.20 82.81 8.14 44.21 5.00 19.54 46.02 3.84 19.76 coo 10.59 77.85 4.81 13.09 76.36 5.76 52.22 10.51 15.00 52.46 7.79 16.39 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 5 3 # 5 A 62 SER C 36 SER^? 23.69 MG MG C 302 A 154 ASP D 160 ASP^? 31.45 MG MG C 302 A 261 ARG C 37 ARG^? 19.01 MG MG C 302 coo 16.10 74.10 3.11 17.18 73.52 5.20 86.07 12.19 -17.80 85.34 10.22 -18.98 coo 16.07 84.71 8.14 15.20 82.81 8.14 94.15 13.98 -26.57 92.71 12.42 -26.99 coo 10.59 77.85 4.81 13.09 76.36 5.76 89.36 17.23 -17.57 89.29 20.20 -16.76 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 6 3 # 6 A 62 SER C 36 SER^? 23.69 MG MG C 302 A 154 ASP D 160 ASP^? 31.45 MG MG C 302 A 261 ARG C 48 ARG^? 25.02 MG MG C 302 coo 16.10 74.10 3.11 17.18 73.52 5.20 86.07 12.19 -17.80 85.34 10.22 -18.98 coo 16.07 84.71 8.14 15.20 82.81 8.14 94.15 13.98 -26.57 92.71 12.42 -26.99 coo 10.59 77.85 4.81 13.09 76.36 5.76 84.94 16.06 -21.53 85.81 13.55 -23.08 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 7 3 # 7 A 62 SER D 36 SER^? 22.42 MG MG D 302 A 154 ASP C 160 ASP^? 31.63 MG MG D 302 A 261 ARG D 37 ARG^? 18.81 MG MG D 302 coo 16.10 74.10 3.11 17.18 73.52 5.20 97.85 44.42 -32.20 96.60 46.20 -31.15 coo 16.07 84.71 8.14 15.20 82.81 8.14 102.50 38.00 -23.28 102.43 39.97 -22.46 coo 10.59 77.85 4.81 13.09 76.36 5.76 96.81 38.21 -31.63 94.97 36.32 -33.06 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 8 3 # 8 A 62 SER D 36 SER^? 22.42 MG MG D 302 A 154 ASP C 160 ASP^? 31.63 MG MG D 302 A 261 ARG D 48 ARG^? 24.87 MG MG D 302 coo 16.10 74.10 3.11 17.18 73.52 5.20 97.85 44.42 -32.20 96.60 46.20 -31.15 coo 16.07 84.71 8.14 15.20 82.81 8.14 102.50 38.00 -23.28 102.43 39.97 -22.46 coo 10.59 77.85 4.81 13.09 76.36 5.76 94.06 41.76 -28.37 96.24 43.38 -26.96 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 9 3 # 9 A 62 SER E 36 SER^? 22.92 MG MG E 302 A 154 ASP F 58 ASP^? 26.87 MG MG E 302 A 261 ARG E 37 ARG^? 19.17 MG MG E 302 coo 16.10 74.10 3.11 17.18 73.52 5.20 76.63 69.18 -62.93 78.20 67.77 -64.11 coo 16.07 84.71 8.14 15.20 82.81 8.14 75.55 64.68 -72.56 76.21 65.63 -70.79 coo 10.59 77.85 4.81 13.09 76.36 5.76 70.82 68.02 -63.63 68.17 67.46 -62.14 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 10 3 # 10 A 62 SER E 36 SER^? 22.92 MG MG E 302 A 154 ASP F 160 ASP^? 31.59 MG MG E 302 A 261 ARG E 37 ARG^? 19.17 MG MG E 302 coo 16.10 74.10 3.11 17.18 73.52 5.20 76.63 69.18 -62.93 78.20 67.77 -64.11 coo 16.07 84.71 8.14 15.20 82.81 8.14 71.27 74.59 -71.77 73.23 74.02 -72.37 coo 10.59 77.85 4.81 13.09 76.36 5.76 70.82 68.02 -63.63 68.17 67.46 -62.14 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 11 3 # 11 A 62 SER E 36 SER^? 22.92 MG MG E 302 A 154 ASP F 160 ASP^? 31.59 MG MG E 302 A 261 ARG E 48 ARG^? 25.02 MG MG E 302 coo 16.10 74.10 3.11 17.18 73.52 5.20 76.63 69.18 -62.93 78.20 67.77 -64.11 coo 16.07 84.71 8.14 15.20 82.81 8.14 71.27 74.59 -71.77 73.23 74.02 -72.37 coo 10.59 77.85 4.81 13.09 76.36 5.76 73.60 65.75 -66.57 75.51 67.67 -67.91 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 12 3 # 12 A 62 SER E 49 SER^? 17.46 MG MG E 302 A 154 ASP F 58 ASP^? 26.87 MG MG E 302 A 261 ARG E 37 ARG^? 19.17 MG MG E 302 coo 16.10 74.10 3.11 17.18 73.52 5.20 69.86 62.56 -61.93 67.83 63.87 -62.36 coo 16.07 84.71 8.14 15.20 82.81 8.14 75.55 64.68 -72.56 76.21 65.63 -70.79 coo 10.59 77.85 4.81 13.09 76.36 5.76 70.82 68.02 -63.63 68.17 67.46 -62.14 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 13 3 # 13 A 62 SER F 36 SER^? 23.07 MG MG F 301 A 154 ASP E 58 ASP^? 26.76 MG MG F 301 A 261 ARG F 37 ARG^? 19.14 MG MG F 301 coo 16.10 74.10 3.11 17.18 73.52 5.20 42.79 62.77 -76.96 42.19 61.23 -75.17 coo 16.07 84.71 8.14 15.20 82.81 8.14 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 10.59 77.85 4.81 13.09 76.36 5.76 48.80 64.46 -76.37 51.50 64.15 -77.79 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 14 3 # 14 A 62 SER F 36 SER^? 23.07 MG MG F 301 A 154 ASP E 160 ASP^? 31.54 MG MG F 301 A 261 ARG F 37 ARG^? 19.14 MG MG F 301 coo 16.10 74.10 3.11 17.18 73.52 5.20 42.79 62.77 -76.96 42.19 61.23 -75.17 coo 16.07 84.71 8.14 15.20 82.81 8.14 45.81 70.00 -68.45 44.10 68.87 -67.77 coo 10.59 77.85 4.81 13.09 76.36 5.76 48.80 64.46 -76.37 51.50 64.15 -77.79 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 15 3 # 15 A 62 SER F 36 SER^? 23.07 MG MG F 301 A 154 ASP E 160 ASP^? 31.54 MG MG F 301 A 261 ARG F 48 ARG^? 25.18 MG MG F 301 coo 16.10 74.10 3.11 17.18 73.52 5.20 42.79 62.77 -76.96 42.19 61.23 -75.17 coo 16.07 84.71 8.14 15.20 82.81 8.14 45.81 70.00 -68.45 44.10 68.87 -67.77 coo 10.59 77.85 4.81 13.09 76.36 5.76 46.82 60.90 -73.07 44.43 61.88 -71.46 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 16 3 # 16 A 62 SER F 49 SER^? 17.41 MG MG F 301 A 154 ASP E 58 ASP^? 26.76 MG MG F 301 A 261 ARG F 37 ARG^? 19.14 MG MG F 301 coo 16.10 74.10 3.11 17.18 73.52 5.20 51.43 58.69 -77.53 52.81 60.66 -77.24 coo 16.07 84.71 8.14 15.20 82.81 8.14 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 10.59 77.85 4.81 13.09 76.36 5.76 48.80 64.46 -76.37 51.50 64.15 -77.79 1o98_c00 source 1o98 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT PHOSPHOGLY: 16 hits 1o98_c00 naa= 3 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 1 3 # 1 A 1 CYH A 98 CYH^? 20.08 MG MG A 301 A 903 GLU B 63 GLU^? 27.83 MG MG A 301 A 972 LYS B 6 LYS^? 25.90 MG MG B 302 coo 88.42 112.53 24.94 87.72 110.88 27.11 54.28 20.21 31.25 53.90 17.78 30.01 coo 61.58 117.15 13.99 62.31 115.51 15.12 36.89 38.35 16.01 38.64 39.45 15.67 coo 60.18 107.64 21.53 58.13 110.55 17.14 36.26 25.44 11.74 39.65 23.12 16.29 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 2 3 # 2 A 1 CYH B 98 CYH^? 20.05 MG MG B 302 A 903 GLU A 63 GLU^? 28.10 MG MG B 302 A 972 LYS A 6 LYS^? 25.88 MG MG A 301 coo 88.42 112.53 24.94 87.72 110.88 27.11 45.60 32.73 6.62 42.99 32.75 7.44 coo 61.58 117.15 13.99 62.31 115.51 15.12 59.13 11.55 21.47 60.51 12.96 22.22 coo 60.18 107.64 21.53 58.13 110.55 17.14 46.20 12.82 24.71 44.50 16.64 20.52 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 3 3 # 3 A 1 CYH C 98 CYH^? 19.94 MG MG C 302 A 903 GLU D 63 GLU^? 27.62 MG MG C 302 A 972 LYS D 6 LYS^? 25.98 MG MG D 302 coo 88.42 112.53 24.94 87.72 110.88 27.11 83.46 39.21 -12.87 85.90 40.15 -13.80 coo 61.58 117.15 13.99 62.31 115.51 15.12 77.46 14.75 -28.07 75.93 16.12 -28.66 coo 60.18 107.64 21.53 58.13 110.55 17.14 89.78 20.68 -31.57 90.15 24.89 -27.02 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 4 3 # 4 A 1 CYH C 152 CYH^? 14.61 MG MG C 301 A 903 GLU C 63 GLU^? 27.26 MG MG D 302 A 972 LYS C 137 LYS^? 35.41 MG MG C 302 coo 88.42 112.53 24.94 87.72 110.88 27.11 87.66 19.43 -8.58 88.77 17.04 -8.78 coo 61.58 117.15 13.99 62.31 115.51 15.12 89.51 47.54 -22.35 87.55 48.20 -22.72 coo 60.18 107.64 21.53 58.13 110.55 17.14 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 5 3 # 5 A 1 CYH E 98 CYH^? 20.14 MG MG E 302 A 903 GLU F 63 GLU^? 27.81 MG MG E 302 A 972 LYS F 6 LYS^? 26.09 MG MG F 301 coo 88.42 112.53 24.94 87.72 110.88 27.11 54.33 53.74 -57.08 52.28 55.17 -58.24 coo 61.58 117.15 13.99 62.31 115.51 15.12 78.38 60.07 -72.34 78.48 58.04 -72.84 coo 60.18 107.64 21.53 58.13 110.55 17.14 67.53 67.03 -76.43 64.05 65.33 -71.86 1ofd_c02 source 1ofd FERREDOXIN-DEPENDENT GLUTAMATE SYNTHASE 2 : 5 hits 1ofd_c02 naa= 3 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 1 3 # 1 B 1 CYH A 98 CYH^? 20.08 MG MG A 301 B 903 GLU B 63 GLU^? 27.83 MG MG A 301 B 972 LYS B 6 LYS^? 25.90 MG MG B 302 coo 31.47 38.87 24.90 30.94 36.98 26.93 54.28 20.21 31.25 53.90 17.78 30.01 coo 4.13 40.53 14.21 5.06 38.89 15.19 36.89 38.35 16.01 38.64 39.45 15.67 coo 4.08 30.40 21.12 1.62 33.28 16.83 36.26 25.44 11.74 39.65 23.12 16.29 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 2 3 # 2 B 1 CYH B 98 CYH^? 20.05 MG MG B 302 B 903 GLU A 63 GLU^? 28.10 MG MG B 302 B 972 LYS A 6 LYS^? 25.88 MG MG A 301 coo 31.47 38.87 24.90 30.94 36.98 26.93 45.60 32.73 6.62 42.99 32.75 7.44 coo 4.13 40.53 14.21 5.06 38.89 15.19 59.13 11.55 21.47 60.51 12.96 22.22 coo 4.08 30.40 21.12 1.62 33.28 16.83 46.20 12.82 24.71 44.50 16.64 20.52 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 3 3 # 3 B 1 CYH C 98 CYH^? 19.94 MG MG C 302 B 903 GLU D 63 GLU^? 27.62 MG MG C 302 B 972 LYS D 6 LYS^? 25.98 MG MG D 302 coo 31.47 38.87 24.90 30.94 36.98 26.93 83.46 39.21 -12.87 85.90 40.15 -13.80 coo 4.13 40.53 14.21 5.06 38.89 15.19 77.46 14.75 -28.07 75.93 16.12 -28.66 coo 4.08 30.40 21.12 1.62 33.28 16.83 89.78 20.68 -31.57 90.15 24.89 -27.02 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 4 3 # 4 B 1 CYH C 152 CYH^? 14.61 MG MG C 301 B 903 GLU C 63 GLU^? 27.26 MG MG D 302 B 972 LYS C 137 LYS^? 35.41 MG MG C 302 coo 31.47 38.87 24.90 30.94 36.98 26.93 87.66 19.43 -8.58 88.77 17.04 -8.78 coo 4.13 40.53 14.21 5.06 38.89 15.19 89.51 47.54 -22.35 87.55 48.20 -22.72 coo 4.08 30.40 21.12 1.62 33.28 16.83 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 5 3 # 5 B 1 CYH E 98 CYH^? 20.14 MG MG E 302 B 903 GLU F 63 GLU^? 27.81 MG MG E 302 B 972 LYS F 6 LYS^? 26.09 MG MG F 301 coo 31.47 38.87 24.90 30.94 36.98 26.93 54.33 53.74 -57.08 52.28 55.17 -58.24 coo 4.13 40.53 14.21 5.06 38.89 15.19 78.38 60.07 -72.34 78.48 58.04 -72.84 coo 4.08 30.40 21.12 1.62 33.28 16.83 67.53 67.03 -76.43 64.05 65.33 -71.86 1ofd_c03 source 1ofd FERREDOXIN-DEPENDENT GLUTAMATE SYNTHASE 2 : 5 hits 1ofd_c03 naa= 3 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 1 3 # 1 A 175 LYS A 86 LYS^? 26.38 MG MG A 301 A 208 GLN A 31 GLN^? 22.39 MG MG A 301 A 209 LYS A 21 LYS^? 14.51 MG MG A 301 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 37.08 47.78 23.56 32.88 44.24 21.89 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 31.14 44.15 31.07 29.13 43.58 31.45 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 32.50 46.40 37.91 34.61 41.52 40.01 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 2 3 # 2 A 175 LYS A 136 LYS^? 30.58 MG MG A 302 A 208 GLN A 62 GLN^? 33.65 MG MG B 302 A 209 LYS A 61 LYS^? 21.99 MG MG B 302 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 50.14 3.36 31.42 51.28 2.21 35.89 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 59.94 4.97 23.43 61.84 3.95 23.67 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 57.78 7.35 19.60 56.77 12.20 15.61 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 3 3 # 3 A 175 LYS A 136 LYS^? 30.58 MG MG A 302 A 208 GLN A 109 GLN^? 25.68 MG MG A 301 A 209 LYS A 111 LYS^? 15.16 MG MG A 301 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 50.14 3.36 31.42 51.28 2.21 35.89 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 55.18 9.98 36.68 55.20 8.30 38.04 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 52.67 17.19 35.90 54.65 19.90 40.50 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 4 3 # 4 A 175 LYS A 137 LYS^? 34.85 MG MG A 301 A 208 GLN A 109 GLN^? 25.68 MG MG A 301 A 209 LYS A 111 LYS^? 15.16 MG MG A 301 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 50.97 1.58 28.14 56.13 1.49 28.03 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 55.18 9.98 36.68 55.20 8.30 38.04 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 52.67 17.19 35.90 54.65 19.90 40.50 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 5 3 # 5 A 175 LYS B 86 LYS^? 26.44 MG MG B 302 A 208 GLN B 31 GLN^? 22.67 MG MG B 302 A 209 LYS B 21 LYS^? 13.97 MG MG B 301 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 69.25 10.45 13.86 65.27 7.74 16.08 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 64.85 5.67 6.51 64.18 3.71 5.97 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 67.50 6.37 -0.39 64.53 11.03 -2.88 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 6 3 # 6 A 175 LYS B 111 LYS^? 13.75 MG MG B 302 A 208 GLN B 144 GLN^? 20.13 MG MG B 301 A 209 LYS B 192 LYS^? 23.73 MG MG B 301 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 42.84 32.14 1.80 46.84 32.68 -2.87 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 37.08 26.58 -5.56 36.43 28.52 -6.04 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 33.83 21.17 -2.93 31.87 16.45 -0.74 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 7 3 # 7 A 175 LYS B 136 LYS^? 33.75 MG MG B 302 A 208 GLN B 62 GLN^? 34.87 MG MG B 302 A 209 LYS B 61 LYS^? 22.03 MG MG A 301 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 28.47 31.35 4.78 24.04 31.81 1.99 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 30.84 39.50 12.81 30.50 40.90 11.24 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 32.50 37.62 17.61 36.68 34.92 21.51 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 8 3 # 8 A 175 LYS C 86 LYS^? 27.34 MG MG C 302 A 208 GLN C 31 GLN^? 23.04 MG MG C 302 A 209 LYS C 21 LYS^? 14.49 MG MG C 302 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 69.22 9.88 -20.56 74.70 7.02 -22.55 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 75.42 6.53 -11.91 76.62 4.98 -12.81 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 72.10 6.87 -6.14 72.84 12.21 -4.93 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 9 3 # 9 A 175 LYS C 136 LYS^? 30.63 MG MG C 302 A 208 GLN C 62 GLN^? 34.49 MG MG C 302 A 209 LYS C 61 LYS^? 21.91 MG MG D 302 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 99.75 44.04 -11.38 100.98 45.13 -6.77 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 93.29 50.60 -18.28 93.36 52.64 -17.54 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 93.60 48.56 -24.05 90.39 44.71 -27.98 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 10 3 # 10 A 175 LYS D 86 LYS^? 25.80 MG MG D 302 A 208 GLN D 31 GLN^? 22.20 MG MG D 302 A 209 LYS D 21 LYS^? 14.47 MG MG D 302 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 85.54 56.79 -30.27 90.24 54.54 -28.62 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 92.28 55.58 -37.94 94.36 55.52 -37.90 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 90.57 56.85 -44.52 87.39 52.68 -46.00 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 11 3 # 11 A 175 LYS D 111 LYS^? 15.85 MG MG D 302 A 208 GLN D 144 GLN^? 19.85 MG MG D 301 A 209 LYS D 192 LYS^? 24.09 MG MG D 301 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 81.21 22.69 -42.10 78.68 23.89 -46.57 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 89.60 20.24 -48.38 88.70 18.97 -49.74 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 95.35 20.28 -45.75 100.42 20.77 -43.05 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 12 3 # 12 A 175 LYS D 136 LYS^? 34.99 MG MG D 302 A 208 GLN D 62 GLN^? 34.39 MG MG C 302 A 209 LYS D 61 LYS^? 21.93 MG MG C 302 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 88.96 10.62 -38.53 90.77 6.00 -38.00 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 80.18 8.65 -30.13 80.18 7.15 -31.65 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 80.64 11.23 -26.16 80.65 16.24 -22.36 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 13 3 # 13 A 175 LYS E 111 LYS^? 14.52 MG MG E 302 A 208 GLN E 144 GLN^? 20.26 MG MG E 301 A 209 LYS E 192 LYS^? 23.62 MG MG E 301 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 52.49 56.44 -52.43 54.52 53.78 -47.52 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 51.74 64.42 -45.34 50.01 64.85 -46.49 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 52.64 70.58 -49.14 53.48 75.40 -50.95 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 14 3 # 14 A 175 LYS E 136 LYS^? 31.27 MG MG E 302 A 208 GLN E 62 GLN^? 34.31 MG MG E 302 A 209 LYS E 61 LYS^? 22.16 MG MG F 301 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 42.12 65.93 -56.52 39.36 65.07 -51.83 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 39.79 56.44 -62.65 37.98 55.76 -61.77 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 40.99 56.84 -68.48 45.99 56.72 -72.39 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 15 3 # 15 A 175 LYS F 86 LYS^? 26.63 MG MG F 301 A 208 GLN F 31 GLN^? 22.77 MG MG F 301 A 209 LYS F 21 LYS^? 14.14 MG MG F 301 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 37.89 45.97 -74.42 36.47 51.71 -72.79 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 35.83 52.89 -82.79 34.54 54.19 -81.84 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 35.01 50.26 -88.61 40.89 49.42 -90.41 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 16 3 # 16 A 175 LYS F 111 LYS^? 15.21 MG MG F 301 A 208 GLN F 144 GLN^? 20.16 MG MG F 302 A 209 LYS F 192 LYS^? 23.61 MG MG F 302 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 69.70 58.57 -86.86 69.67 53.74 -90.29 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 68.06 66.27 -93.88 70.14 65.97 -94.00 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 64.82 71.59 -91.06 62.22 76.11 -88.75 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 17 3 # 17 A 175 LYS F 136 LYS^? 30.53 MG MG F 301 A 208 GLN F 62 GLN^? 34.50 MG MG F 301 A 209 LYS F 61 LYS^? 21.75 MG MG E 302 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 76.49 71.19 -83.39 78.38 70.88 -88.47 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 82.29 64.54 -76.33 83.65 64.12 -77.92 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 80.24 64.12 -71.01 76.23 61.95 -66.39 1ohh_c06 source 1ohh ATP SYNTHASE ALPHA CHAIN HEART ISOFORM, MITOCH: 17 hits 1ohh_c06 naa= 3 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 1 3 # 1 B 175 LYS A 86 LYS^? 26.38 MG MG A 301 B 208 GLN A 31 GLN^? 22.39 MG MG A 301 B 209 LYS A 21 LYS^? 14.51 MG MG A 301 coo 105.03 46.01 19.55 106.59 42.35 15.55 37.08 47.78 23.56 32.88 44.24 21.89 coo 113.93 46.99 13.56 113.37 48.52 14.95 31.14 44.15 31.07 29.13 43.58 31.45 coo 115.66 49.12 8.60 111.19 49.52 4.73 32.50 46.40 37.91 34.61 41.52 40.01 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 2 3 # 2 B 175 LYS A 136 LYS^? 30.58 MG MG A 302 B 208 GLN A 62 GLN^? 33.65 MG MG B 302 B 209 LYS A 61 LYS^? 21.99 MG MG B 302 coo 105.03 46.01 19.55 106.59 42.35 15.55 50.14 3.36 31.42 51.28 2.21 35.89 coo 113.93 46.99 13.56 113.37 48.52 14.95 59.94 4.97 23.43 61.84 3.95 23.67 coo 115.66 49.12 8.60 111.19 49.52 4.73 57.78 7.35 19.60 56.77 12.20 15.61 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 3 3 # 3 B 175 LYS A 136 LYS^? 30.58 MG MG A 302 B 208 GLN A 109 GLN^? 25.68 MG MG A 301 B 209 LYS A 111 LYS^? 15.16 MG MG A 301 coo 105.03 46.01 19.55 106.59 42.35 15.55 50.14 3.36 31.42 51.28 2.21 35.89 coo 113.93 46.99 13.56 113.37 48.52 14.95 55.18 9.98 36.68 55.20 8.30 38.04 coo 115.66 49.12 8.60 111.19 49.52 4.73 52.67 17.19 35.90 54.65 19.90 40.50 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 4 3 # 4 B 175 LYS A 137 LYS^? 34.85 MG MG A 301 B 208 GLN A 109 GLN^? 25.68 MG MG A 301 B 209 LYS A 111 LYS^? 15.16 MG MG A 301 coo 105.03 46.01 19.55 106.59 42.35 15.55 50.97 1.58 28.14 56.13 1.49 28.03 coo 113.93 46.99 13.56 113.37 48.52 14.95 55.18 9.98 36.68 55.20 8.30 38.04 coo 115.66 49.12 8.60 111.19 49.52 4.73 52.67 17.19 35.90 54.65 19.90 40.50 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 5 3 # 5 B 175 LYS B 86 LYS^? 26.44 MG MG B 302 B 208 GLN B 31 GLN^? 22.67 MG MG B 302 B 209 LYS B 21 LYS^? 13.97 MG MG B 301 coo 105.03 46.01 19.55 106.59 42.35 15.55 69.25 10.45 13.86 65.27 7.74 16.08 coo 113.93 46.99 13.56 113.37 48.52 14.95 64.85 5.67 6.51 64.18 3.71 5.97 coo 115.66 49.12 8.60 111.19 49.52 4.73 67.50 6.37 -0.39 64.53 11.03 -2.88 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 6 3 # 6 B 175 LYS B 111 LYS^? 13.75 MG MG B 302 B 208 GLN B 144 GLN^? 20.13 MG MG B 301 B 209 LYS B 192 LYS^? 23.73 MG MG B 301 coo 105.03 46.01 19.55 106.59 42.35 15.55 42.84 32.14 1.80 46.84 32.68 -2.87 coo 113.93 46.99 13.56 113.37 48.52 14.95 37.08 26.58 -5.56 36.43 28.52 -6.04 coo 115.66 49.12 8.60 111.19 49.52 4.73 33.83 21.17 -2.93 31.87 16.45 -0.74 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 7 3 # 7 B 175 LYS B 136 LYS^? 33.75 MG MG B 302 B 208 GLN B 62 GLN^? 34.87 MG MG B 302 B 209 LYS B 61 LYS^? 22.03 MG MG A 301 coo 105.03 46.01 19.55 106.59 42.35 15.55 28.47 31.35 4.78 24.04 31.81 1.99 coo 113.93 46.99 13.56 113.37 48.52 14.95 30.84 39.50 12.81 30.50 40.90 11.24 coo 115.66 49.12 8.60 111.19 49.52 4.73 32.50 37.62 17.61 36.68 34.92 21.51 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 8 3 # 8 B 175 LYS C 86 LYS^? 27.34 MG MG C 302 B 208 GLN C 31 GLN^? 23.04 MG MG C 302 B 209 LYS C 21 LYS^? 14.49 MG MG C 302 coo 105.03 46.01 19.55 106.59 42.35 15.55 69.22 9.88 -20.56 74.70 7.02 -22.55 coo 113.93 46.99 13.56 113.37 48.52 14.95 75.42 6.53 -11.91 76.62 4.98 -12.81 coo 115.66 49.12 8.60 111.19 49.52 4.73 72.10 6.87 -6.14 72.84 12.21 -4.93 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 9 3 # 9 B 175 LYS C 136 LYS^? 30.63 MG MG C 302 B 208 GLN C 62 GLN^? 34.49 MG MG C 302 B 209 LYS C 61 LYS^? 21.91 MG MG D 302 coo 105.03 46.01 19.55 106.59 42.35 15.55 99.75 44.04 -11.38 100.98 45.13 -6.77 coo 113.93 46.99 13.56 113.37 48.52 14.95 93.29 50.60 -18.28 93.36 52.64 -17.54 coo 115.66 49.12 8.60 111.19 49.52 4.73 93.60 48.56 -24.05 90.39 44.71 -27.98 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 10 3 # 10 B 175 LYS D 86 LYS^? 25.80 MG MG D 302 B 208 GLN D 31 GLN^? 22.20 MG MG D 302 B 209 LYS D 21 LYS^? 14.47 MG MG D 302 coo 105.03 46.01 19.55 106.59 42.35 15.55 85.54 56.79 -30.27 90.24 54.54 -28.62 coo 113.93 46.99 13.56 113.37 48.52 14.95 92.28 55.58 -37.94 94.36 55.52 -37.90 coo 115.66 49.12 8.60 111.19 49.52 4.73 90.57 56.85 -44.52 87.39 52.68 -46.00 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 11 3 # 11 B 175 LYS D 111 LYS^? 15.85 MG MG D 302 B 208 GLN D 144 GLN^? 19.85 MG MG D 301 B 209 LYS D 192 LYS^? 24.09 MG MG D 301 coo 105.03 46.01 19.55 106.59 42.35 15.55 81.21 22.69 -42.10 78.68 23.89 -46.57 coo 113.93 46.99 13.56 113.37 48.52 14.95 89.60 20.24 -48.38 88.70 18.97 -49.74 coo 115.66 49.12 8.60 111.19 49.52 4.73 95.35 20.28 -45.75 100.42 20.77 -43.05 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 12 3 # 12 B 175 LYS D 136 LYS^? 34.99 MG MG D 302 B 208 GLN D 62 GLN^? 34.39 MG MG C 302 B 209 LYS D 61 LYS^? 21.93 MG MG C 302 coo 105.03 46.01 19.55 106.59 42.35 15.55 88.96 10.62 -38.53 90.77 6.00 -38.00 coo 113.93 46.99 13.56 113.37 48.52 14.95 80.18 8.65 -30.13 80.18 7.15 -31.65 coo 115.66 49.12 8.60 111.19 49.52 4.73 80.64 11.23 -26.16 80.65 16.24 -22.36 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 13 3 # 13 B 175 LYS E 111 LYS^? 14.52 MG MG E 302 B 208 GLN E 144 GLN^? 20.26 MG MG E 301 B 209 LYS E 192 LYS^? 23.62 MG MG E 301 coo 105.03 46.01 19.55 106.59 42.35 15.55 52.49 56.44 -52.43 54.52 53.78 -47.52 coo 113.93 46.99 13.56 113.37 48.52 14.95 51.74 64.42 -45.34 50.01 64.85 -46.49 coo 115.66 49.12 8.60 111.19 49.52 4.73 52.64 70.58 -49.14 53.48 75.40 -50.95 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 14 3 # 14 B 175 LYS E 136 LYS^? 31.27 MG MG E 302 B 208 GLN E 62 GLN^? 34.31 MG MG E 302 B 209 LYS E 61 LYS^? 22.16 MG MG F 301 coo 105.03 46.01 19.55 106.59 42.35 15.55 42.12 65.93 -56.52 39.36 65.07 -51.83 coo 113.93 46.99 13.56 113.37 48.52 14.95 39.79 56.44 -62.65 37.98 55.76 -61.77 coo 115.66 49.12 8.60 111.19 49.52 4.73 40.99 56.84 -68.48 45.99 56.72 -72.39 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 15 3 # 15 B 175 LYS F 86 LYS^? 26.63 MG MG F 301 B 208 GLN F 31 GLN^? 22.77 MG MG F 301 B 209 LYS F 21 LYS^? 14.14 MG MG F 301 coo 105.03 46.01 19.55 106.59 42.35 15.55 37.89 45.97 -74.42 36.47 51.71 -72.79 coo 113.93 46.99 13.56 113.37 48.52 14.95 35.83 52.89 -82.79 34.54 54.19 -81.84 coo 115.66 49.12 8.60 111.19 49.52 4.73 35.01 50.26 -88.61 40.89 49.42 -90.41 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 16 3 # 16 B 175 LYS F 111 LYS^? 15.21 MG MG F 301 B 208 GLN F 144 GLN^? 20.16 MG MG F 302 B 209 LYS F 192 LYS^? 23.61 MG MG F 302 coo 105.03 46.01 19.55 106.59 42.35 15.55 69.70 58.57 -86.86 69.67 53.74 -90.29 coo 113.93 46.99 13.56 113.37 48.52 14.95 68.06 66.27 -93.88 70.14 65.97 -94.00 coo 115.66 49.12 8.60 111.19 49.52 4.73 64.82 71.59 -91.06 62.22 76.11 -88.75 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 17 3 # 17 B 175 LYS F 136 LYS^? 30.53 MG MG F 301 B 208 GLN F 62 GLN^? 34.50 MG MG F 301 B 209 LYS F 61 LYS^? 21.75 MG MG E 302 coo 105.03 46.01 19.55 106.59 42.35 15.55 76.49 71.19 -83.39 78.38 70.88 -88.47 coo 113.93 46.99 13.56 113.37 48.52 14.95 82.29 64.54 -76.33 83.65 64.12 -77.92 coo 115.66 49.12 8.60 111.19 49.52 4.73 80.24 64.12 -71.01 76.23 61.95 -66.39 1ohh_c07 source 1ohh ATP SYNTHASE ALPHA CHAIN HEART ISOFORM, MITOCH: 17 hits 1ohh_c07 naa= 3 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 1 3 # 1 C 175 LYS A 136 LYS^? 30.58 MG MG A 302 C 208 GLN A 62 GLN^? 33.65 MG MG B 302 C 209 LYS A 61 LYS^? 21.99 MG MG B 302 coo 100.54 -2.78 25.52 103.29 2.02 24.05 50.14 3.36 31.42 51.28 2.21 35.89 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 59.94 4.97 23.43 61.84 3.95 23.67 coo 113.62 1.19 33.65 109.52 3.92 36.47 57.78 7.35 19.60 56.77 12.20 15.61 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 2 3 # 2 C 175 LYS B 136 LYS^? 33.75 MG MG B 302 C 208 GLN B 62 GLN^? 34.87 MG MG B 302 C 209 LYS B 61 LYS^? 22.03 MG MG A 301 coo 100.54 -2.78 25.52 103.29 2.02 24.05 28.47 31.35 4.78 24.04 31.81 1.99 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 30.84 39.50 12.81 30.50 40.90 11.24 coo 113.62 1.19 33.65 109.52 3.92 36.47 32.50 37.62 17.61 36.68 34.92 21.51 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 3 3 # 3 C 175 LYS C 136 LYS^? 30.63 MG MG C 302 C 208 GLN C 62 GLN^? 34.49 MG MG C 302 C 209 LYS C 61 LYS^? 21.91 MG MG D 302 coo 100.54 -2.78 25.52 103.29 2.02 24.05 99.75 44.04 -11.38 100.98 45.13 -6.77 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 93.29 50.60 -18.28 93.36 52.64 -17.54 coo 113.62 1.19 33.65 109.52 3.92 36.47 93.60 48.56 -24.05 90.39 44.71 -27.98 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 4 3 # 4 C 175 LYS D 111 LYS^? 15.85 MG MG D 302 C 208 GLN D 144 GLN^? 19.85 MG MG D 301 C 209 LYS D 192 LYS^? 24.09 MG MG D 301 coo 100.54 -2.78 25.52 103.29 2.02 24.05 81.21 22.69 -42.10 78.68 23.89 -46.57 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 89.60 20.24 -48.38 88.70 18.97 -49.74 coo 113.62 1.19 33.65 109.52 3.92 36.47 95.35 20.28 -45.75 100.42 20.77 -43.05 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 5 3 # 5 C 175 LYS D 136 LYS^? 34.99 MG MG D 302 C 208 GLN D 62 GLN^? 34.39 MG MG C 302 C 209 LYS D 61 LYS^? 21.93 MG MG C 302 coo 100.54 -2.78 25.52 103.29 2.02 24.05 88.96 10.62 -38.53 90.77 6.00 -38.00 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 80.18 8.65 -30.13 80.18 7.15 -31.65 coo 113.62 1.19 33.65 109.52 3.92 36.47 80.64 11.23 -26.16 80.65 16.24 -22.36 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 6 3 # 6 C 175 LYS E 136 LYS^? 31.27 MG MG E 302 C 208 GLN E 62 GLN^? 34.31 MG MG E 302 C 209 LYS E 61 LYS^? 22.16 MG MG F 301 coo 100.54 -2.78 25.52 103.29 2.02 24.05 42.12 65.93 -56.52 39.36 65.07 -51.83 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 39.79 56.44 -62.65 37.98 55.76 -61.77 coo 113.62 1.19 33.65 109.52 3.92 36.47 40.99 56.84 -68.48 45.99 56.72 -72.39 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 7 3 # 7 C 175 LYS F 86 LYS^? 26.63 MG MG F 301 C 208 GLN F 31 GLN^? 22.77 MG MG F 301 C 209 LYS F 21 LYS^? 14.14 MG MG F 301 coo 100.54 -2.78 25.52 103.29 2.02 24.05 37.89 45.97 -74.42 36.47 51.71 -72.79 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 35.83 52.89 -82.79 34.54 54.19 -81.84 coo 113.62 1.19 33.65 109.52 3.92 36.47 35.01 50.26 -88.61 40.89 49.42 -90.41 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 8 3 # 8 C 175 LYS F 136 LYS^? 30.53 MG MG F 301 C 208 GLN F 62 GLN^? 34.50 MG MG F 301 C 209 LYS F 61 LYS^? 21.75 MG MG E 302 coo 100.54 -2.78 25.52 103.29 2.02 24.05 76.49 71.19 -83.39 78.38 70.88 -88.47 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 82.29 64.54 -76.33 83.65 64.12 -77.92 coo 113.62 1.19 33.65 109.52 3.92 36.47 80.24 64.12 -71.01 76.23 61.95 -66.39 1ohh_c08 source 1ohh ATP SYNTHASE ALPHA CHAIN HEART ISOFORM, MITOCH: 8 hits 1ohh_c08 naa= 3 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 A 24 ASP A 171 ASP^? 17.17 MG MG A 302 A 146 TYR A 168 TYR^? 14.52 MG MG A 302 A 177 LYS A 166 LYS^? 20.93 MG MG A 302 coo -3.50 124.89 25.05 -2.25 124.77 23.26 29.78 23.67 36.63 28.48 25.11 35.71 coo 1.87 119.38 16.45 1.41 122.11 16.84 37.31 16.98 37.59 36.65 18.86 39.55 coo -2.59 124.07 12.67 -0.91 126.17 18.42 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 A 24 ASP B 142 ASP^? 23.97 MG MG B 301 A 146 TYR B 168 TYR^? 14.66 MG MG B 301 A 177 LYS B 166 LYS^? 22.75 MG MG B 301 coo -3.50 124.89 25.05 -2.25 124.77 23.26 31.69 27.40 -1.31 32.10 27.37 -3.38 coo 1.87 119.38 16.45 1.41 122.11 16.84 40.03 17.20 -1.34 41.92 16.43 -3.19 coo -2.59 124.07 12.67 -0.91 126.17 18.42 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 A 24 ASP B 171 ASP^? 16.92 MG MG B 301 A 146 TYR B 168 TYR^? 14.66 MG MG B 301 A 177 LYS B 166 LYS^? 22.75 MG MG B 301 coo -3.50 124.89 25.05 -2.25 124.77 23.26 45.30 8.50 -0.71 46.30 6.81 0.12 coo 1.87 119.38 16.45 1.41 122.11 16.84 40.03 17.20 -1.34 41.92 16.43 -3.19 coo -2.59 124.07 12.67 -0.91 126.17 18.42 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 A 24 ASP C 171 ASP^? 17.08 MG MG C 301 A 146 TYR C 168 TYR^? 14.82 MG MG C 301 A 177 LYS C 166 LYS^? 22.53 MG MG C 301 coo -3.50 124.89 25.05 -2.25 124.77 23.26 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 1.87 119.38 16.45 1.41 122.11 16.84 94.44 26.43 -5.44 92.97 25.09 -3.55 coo -2.59 124.07 12.67 -0.91 126.17 18.42 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 A 24 ASP D 171 ASP^? 16.95 MG MG D 301 A 146 TYR D 168 TYR^? 14.75 MG MG D 301 A 177 LYS D 166 LYS^? 21.08 MG MG D 301 coo -3.50 124.89 25.05 -2.25 124.77 23.26 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 1.87 119.38 16.45 1.41 122.11 16.84 95.79 27.80 -44.35 95.71 29.78 -46.32 coo -2.59 124.07 12.67 -0.91 126.17 18.42 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 A 24 ASP E 142 ASP^? 23.66 MG MG E 301 A 146 TYR E 168 TYR^? 14.43 MG MG E 301 A 177 LYS E 166 LYS^? 21.46 MG MG E 301 coo -3.50 124.89 25.05 -2.25 124.77 23.26 47.19 67.15 -50.37 47.44 67.18 -48.23 coo 1.87 119.38 16.45 1.41 122.11 16.84 60.07 69.95 -50.54 61.99 69.37 -48.59 coo -2.59 124.07 12.67 -0.91 126.17 18.42 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 A 24 ASP E 171 ASP^? 16.73 MG MG E 301 A 146 TYR E 168 TYR^? 14.43 MG MG E 301 A 177 LYS E 166 LYS^? 21.46 MG MG E 301 coo -3.50 124.89 25.05 -2.25 124.77 23.26 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 1.87 119.38 16.45 1.41 122.11 16.84 60.07 69.95 -50.54 61.99 69.37 -48.59 coo -2.59 124.07 12.67 -0.91 126.17 18.42 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 A 24 ASP F 171 ASP^? 16.35 MG MG F 302 A 146 TYR F 168 TYR^? 14.10 MG MG F 302 A 177 LYS F 166 LYS^? 20.76 MG MG F 302 coo -3.50 124.89 25.05 -2.25 124.77 23.26 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 1.87 119.38 16.45 1.41 122.11 16.84 58.29 68.32 -89.29 56.67 67.12 -91.21 coo -2.59 124.07 12.67 -0.91 126.17 18.42 59.28 73.05 -82.63 55.63 74.15 -86.94 1ok4_c00 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 8 hits 1ok4_c00 naa= 3 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 B 24 ASP A 171 ASP^? 17.17 MG MG A 302 B 146 TYR A 168 TYR^? 14.52 MG MG A 302 B 177 LYS A 166 LYS^? 20.93 MG MG A 302 coo -7.43 109.06 51.23 -5.84 110.54 50.86 29.78 23.67 36.63 28.48 25.11 35.71 coo 0.22 114.56 44.62 -0.76 115.18 47.18 37.31 16.98 37.59 36.65 18.86 39.55 coo -4.18 120.17 46.85 -4.02 115.31 51.00 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 B 24 ASP B 142 ASP^? 23.97 MG MG B 301 B 146 TYR B 168 TYR^? 14.66 MG MG B 301 B 177 LYS B 166 LYS^? 22.75 MG MG B 301 coo -7.43 109.06 51.23 -5.84 110.54 50.86 31.69 27.40 -1.31 32.10 27.37 -3.38 coo 0.22 114.56 44.62 -0.76 115.18 47.18 40.03 17.20 -1.34 41.92 16.43 -3.19 coo -4.18 120.17 46.85 -4.02 115.31 51.00 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 B 24 ASP B 171 ASP^? 16.92 MG MG B 301 B 146 TYR B 168 TYR^? 14.66 MG MG B 301 B 177 LYS B 166 LYS^? 22.75 MG MG B 301 coo -7.43 109.06 51.23 -5.84 110.54 50.86 45.30 8.50 -0.71 46.30 6.81 0.12 coo 0.22 114.56 44.62 -0.76 115.18 47.18 40.03 17.20 -1.34 41.92 16.43 -3.19 coo -4.18 120.17 46.85 -4.02 115.31 51.00 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 B 24 ASP C 171 ASP^? 17.08 MG MG C 301 B 146 TYR C 168 TYR^? 14.82 MG MG C 301 B 177 LYS C 166 LYS^? 22.53 MG MG C 301 coo -7.43 109.06 51.23 -5.84 110.54 50.86 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 0.22 114.56 44.62 -0.76 115.18 47.18 94.44 26.43 -5.44 92.97 25.09 -3.55 coo -4.18 120.17 46.85 -4.02 115.31 51.00 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 B 24 ASP D 171 ASP^? 16.95 MG MG D 301 B 146 TYR D 168 TYR^? 14.75 MG MG D 301 B 177 LYS D 166 LYS^? 21.08 MG MG D 301 coo -7.43 109.06 51.23 -5.84 110.54 50.86 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 0.22 114.56 44.62 -0.76 115.18 47.18 95.79 27.80 -44.35 95.71 29.78 -46.32 coo -4.18 120.17 46.85 -4.02 115.31 51.00 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 B 24 ASP E 142 ASP^? 23.66 MG MG E 301 B 146 TYR E 168 TYR^? 14.43 MG MG E 301 B 177 LYS E 166 LYS^? 21.46 MG MG E 301 coo -7.43 109.06 51.23 -5.84 110.54 50.86 47.19 67.15 -50.37 47.44 67.18 -48.23 coo 0.22 114.56 44.62 -0.76 115.18 47.18 60.07 69.95 -50.54 61.99 69.37 -48.59 coo -4.18 120.17 46.85 -4.02 115.31 51.00 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 B 24 ASP E 171 ASP^? 16.73 MG MG E 301 B 146 TYR E 168 TYR^? 14.43 MG MG E 301 B 177 LYS E 166 LYS^? 21.46 MG MG E 301 coo -7.43 109.06 51.23 -5.84 110.54 50.86 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 0.22 114.56 44.62 -0.76 115.18 47.18 60.07 69.95 -50.54 61.99 69.37 -48.59 coo -4.18 120.17 46.85 -4.02 115.31 51.00 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 B 24 ASP F 171 ASP^? 16.35 MG MG F 302 B 146 TYR F 168 TYR^? 14.10 MG MG F 302 B 177 LYS F 166 LYS^? 20.76 MG MG F 302 coo -7.43 109.06 51.23 -5.84 110.54 50.86 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 0.22 114.56 44.62 -0.76 115.18 47.18 58.29 68.32 -89.29 56.67 67.12 -91.21 coo -4.18 120.17 46.85 -4.02 115.31 51.00 59.28 73.05 -82.63 55.63 74.15 -86.94 1ok4_c01 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 8 hits 1ok4_c01 naa= 3 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 C 24 ASP A 171 ASP^? 17.17 MG MG A 302 C 146 TYR A 168 TYR^? 14.52 MG MG A 302 C 177 LYS A 166 LYS^? 20.93 MG MG A 302 coo -13.49 79.65 43.90 -12.13 80.29 45.45 29.78 23.67 36.63 28.48 25.11 35.71 coo -5.65 86.78 48.49 -7.16 84.72 49.65 37.31 16.98 37.59 36.65 18.86 39.55 coo -11.22 87.18 53.49 -10.94 81.64 50.31 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 C 24 ASP B 142 ASP^? 23.97 MG MG B 301 C 146 TYR B 168 TYR^? 14.66 MG MG B 301 C 177 LYS B 166 LYS^? 22.75 MG MG B 301 coo -13.49 79.65 43.90 -12.13 80.29 45.45 31.69 27.40 -1.31 32.10 27.37 -3.38 coo -5.65 86.78 48.49 -7.16 84.72 49.65 40.03 17.20 -1.34 41.92 16.43 -3.19 coo -11.22 87.18 53.49 -10.94 81.64 50.31 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 C 24 ASP B 171 ASP^? 16.92 MG MG B 301 C 146 TYR B 168 TYR^? 14.66 MG MG B 301 C 177 LYS B 166 LYS^? 22.75 MG MG B 301 coo -13.49 79.65 43.90 -12.13 80.29 45.45 45.30 8.50 -0.71 46.30 6.81 0.12 coo -5.65 86.78 48.49 -7.16 84.72 49.65 40.03 17.20 -1.34 41.92 16.43 -3.19 coo -11.22 87.18 53.49 -10.94 81.64 50.31 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 C 24 ASP C 171 ASP^? 17.08 MG MG C 301 C 146 TYR C 168 TYR^? 14.82 MG MG C 301 C 177 LYS C 166 LYS^? 22.53 MG MG C 301 coo -13.49 79.65 43.90 -12.13 80.29 45.45 92.57 16.68 -6.24 92.24 14.74 -7.03 coo -5.65 86.78 48.49 -7.16 84.72 49.65 94.44 26.43 -5.44 92.97 25.09 -3.55 coo -11.22 87.18 53.49 -10.94 81.64 50.31 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 C 24 ASP D 171 ASP^? 16.95 MG MG D 301 C 146 TYR D 168 TYR^? 14.75 MG MG D 301 C 177 LYS D 166 LYS^? 21.08 MG MG D 301 coo -13.49 79.65 43.90 -12.13 80.29 45.45 100.39 36.69 -43.49 101.13 38.51 -42.69 coo -5.65 86.78 48.49 -7.16 84.72 49.65 95.79 27.80 -44.35 95.71 29.78 -46.32 coo -11.22 87.18 53.49 -10.94 81.64 50.31 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 C 24 ASP E 142 ASP^? 23.66 MG MG E 301 C 146 TYR E 168 TYR^? 14.43 MG MG E 301 C 177 LYS E 166 LYS^? 21.46 MG MG E 301 coo -13.49 79.65 43.90 -12.13 80.29 45.45 47.19 67.15 -50.37 47.44 67.18 -48.23 coo -5.65 86.78 48.49 -7.16 84.72 49.65 60.07 69.95 -50.54 61.99 69.37 -48.59 coo -11.22 87.18 53.49 -10.94 81.64 50.31 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 C 24 ASP E 171 ASP^? 16.73 MG MG E 301 C 146 TYR E 168 TYR^? 14.43 MG MG E 301 C 177 LYS E 166 LYS^? 21.46 MG MG E 301 coo -13.49 79.65 43.90 -12.13 80.29 45.45 69.61 73.12 -51.56 71.50 73.53 -52.39 coo -5.65 86.78 48.49 -7.16 84.72 49.65 60.07 69.95 -50.54 61.99 69.37 -48.59 coo -11.22 87.18 53.49 -10.94 81.64 50.31 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 C 24 ASP F 171 ASP^? 16.35 MG MG F 302 C 146 TYR F 168 TYR^? 14.10 MG MG F 302 C 177 LYS F 166 LYS^? 20.76 MG MG F 302 coo -13.49 79.65 43.90 -12.13 80.29 45.45 48.23 68.08 -88.47 46.26 68.02 -87.56 coo -5.65 86.78 48.49 -7.16 84.72 49.65 58.29 68.32 -89.29 56.67 67.12 -91.21 coo -11.22 87.18 53.49 -10.94 81.64 50.31 59.28 73.05 -82.63 55.63 74.15 -86.94 1ok4_c02 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 8 hits 1ok4_c02 naa= 3 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 D 24 ASP A 171 ASP^? 17.17 MG MG A 302 D 146 TYR A 168 TYR^? 14.52 MG MG A 302 D 177 LYS A 166 LYS^? 20.93 MG MG A 302 coo -13.44 77.36 13.12 -12.53 75.97 14.48 29.78 23.67 36.63 28.48 25.11 35.71 coo -7.85 74.44 22.75 -9.22 72.86 20.89 37.31 16.98 37.59 36.65 18.86 39.55 coo -14.24 70.61 23.48 -12.55 71.73 17.42 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 D 24 ASP B 142 ASP^? 23.97 MG MG B 301 D 146 TYR B 168 TYR^? 14.66 MG MG B 301 D 177 LYS B 166 LYS^? 22.75 MG MG B 301 coo -13.44 77.36 13.12 -12.53 75.97 14.48 31.69 27.40 -1.31 32.10 27.37 -3.38 coo -7.85 74.44 22.75 -9.22 72.86 20.89 40.03 17.20 -1.34 41.92 16.43 -3.19 coo -14.24 70.61 23.48 -12.55 71.73 17.42 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 D 24 ASP B 171 ASP^? 16.92 MG MG B 301 D 146 TYR B 168 TYR^? 14.66 MG MG B 301 D 177 LYS B 166 LYS^? 22.75 MG MG B 301 coo -13.44 77.36 13.12 -12.53 75.97 14.48 45.30 8.50 -0.71 46.30 6.81 0.12 coo -7.85 74.44 22.75 -9.22 72.86 20.89 40.03 17.20 -1.34 41.92 16.43 -3.19 coo -14.24 70.61 23.48 -12.55 71.73 17.42 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 D 24 ASP C 171 ASP^? 17.08 MG MG C 301 D 146 TYR C 168 TYR^? 14.82 MG MG C 301 D 177 LYS C 166 LYS^? 22.53 MG MG C 301 coo -13.44 77.36 13.12 -12.53 75.97 14.48 92.57 16.68 -6.24 92.24 14.74 -7.03 coo -7.85 74.44 22.75 -9.22 72.86 20.89 94.44 26.43 -5.44 92.97 25.09 -3.55 coo -14.24 70.61 23.48 -12.55 71.73 17.42 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 D 24 ASP D 171 ASP^? 16.95 MG MG D 301 D 146 TYR D 168 TYR^? 14.75 MG MG D 301 D 177 LYS D 166 LYS^? 21.08 MG MG D 301 coo -13.44 77.36 13.12 -12.53 75.97 14.48 100.39 36.69 -43.49 101.13 38.51 -42.69 coo -7.85 74.44 22.75 -9.22 72.86 20.89 95.79 27.80 -44.35 95.71 29.78 -46.32 coo -14.24 70.61 23.48 -12.55 71.73 17.42 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 D 24 ASP E 142 ASP^? 23.66 MG MG E 301 D 146 TYR E 168 TYR^? 14.43 MG MG E 301 D 177 LYS E 166 LYS^? 21.46 MG MG E 301 coo -13.44 77.36 13.12 -12.53 75.97 14.48 47.19 67.15 -50.37 47.44 67.18 -48.23 coo -7.85 74.44 22.75 -9.22 72.86 20.89 60.07 69.95 -50.54 61.99 69.37 -48.59 coo -14.24 70.61 23.48 -12.55 71.73 17.42 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 D 24 ASP E 171 ASP^? 16.73 MG MG E 301 D 146 TYR E 168 TYR^? 14.43 MG MG E 301 D 177 LYS E 166 LYS^? 21.46 MG MG E 301 coo -13.44 77.36 13.12 -12.53 75.97 14.48 69.61 73.12 -51.56 71.50 73.53 -52.39 coo -7.85 74.44 22.75 -9.22 72.86 20.89 60.07 69.95 -50.54 61.99 69.37 -48.59 coo -14.24 70.61 23.48 -12.55 71.73 17.42 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 D 24 ASP F 171 ASP^? 16.35 MG MG F 302 D 146 TYR F 168 TYR^? 14.10 MG MG F 302 D 177 LYS F 166 LYS^? 20.76 MG MG F 302 coo -13.44 77.36 13.12 -12.53 75.97 14.48 48.23 68.08 -88.47 46.26 68.02 -87.56 coo -7.85 74.44 22.75 -9.22 72.86 20.89 58.29 68.32 -89.29 56.67 67.12 -91.21 coo -14.24 70.61 23.48 -12.55 71.73 17.42 59.28 73.05 -82.63 55.63 74.15 -86.94 1ok4_c03 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 8 hits 1ok4_c03 naa= 3 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 E 24 ASP A 171 ASP^? 17.17 MG MG A 302 E 146 TYR A 168 TYR^? 14.52 MG MG A 302 E 177 LYS A 166 LYS^? 20.93 MG MG A 302 coo -7.12 105.25 1.43 -6.30 103.34 0.77 29.78 23.67 36.63 28.48 25.11 35.71 coo -3.11 94.55 3.01 -3.83 95.92 0.66 37.31 16.98 37.59 36.65 18.86 39.55 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 E 24 ASP B 142 ASP^? 23.97 MG MG B 301 E 146 TYR B 168 TYR^? 14.66 MG MG B 301 E 177 LYS B 166 LYS^? 22.75 MG MG B 301 coo -7.12 105.25 1.43 -6.30 103.34 0.77 31.69 27.40 -1.31 32.10 27.37 -3.38 coo -3.11 94.55 3.01 -3.83 95.92 0.66 40.03 17.20 -1.34 41.92 16.43 -3.19 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 E 24 ASP B 171 ASP^? 16.92 MG MG B 301 E 146 TYR B 168 TYR^? 14.66 MG MG B 301 E 177 LYS B 166 LYS^? 22.75 MG MG B 301 coo -7.12 105.25 1.43 -6.30 103.34 0.77 45.30 8.50 -0.71 46.30 6.81 0.12 coo -3.11 94.55 3.01 -3.83 95.92 0.66 40.03 17.20 -1.34 41.92 16.43 -3.19 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 E 24 ASP C 171 ASP^? 17.08 MG MG C 301 E 146 TYR C 168 TYR^? 14.82 MG MG C 301 E 177 LYS C 166 LYS^? 22.53 MG MG C 301 coo -7.12 105.25 1.43 -6.30 103.34 0.77 92.57 16.68 -6.24 92.24 14.74 -7.03 coo -3.11 94.55 3.01 -3.83 95.92 0.66 94.44 26.43 -5.44 92.97 25.09 -3.55 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 E 24 ASP D 171 ASP^? 16.95 MG MG D 301 E 146 TYR D 168 TYR^? 14.75 MG MG D 301 E 177 LYS D 166 LYS^? 21.08 MG MG D 301 coo -7.12 105.25 1.43 -6.30 103.34 0.77 100.39 36.69 -43.49 101.13 38.51 -42.69 coo -3.11 94.55 3.01 -3.83 95.92 0.66 95.79 27.80 -44.35 95.71 29.78 -46.32 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 E 24 ASP E 142 ASP^? 23.66 MG MG E 301 E 146 TYR E 168 TYR^? 14.43 MG MG E 301 E 177 LYS E 166 LYS^? 21.46 MG MG E 301 coo -7.12 105.25 1.43 -6.30 103.34 0.77 47.19 67.15 -50.37 47.44 67.18 -48.23 coo -3.11 94.55 3.01 -3.83 95.92 0.66 60.07 69.95 -50.54 61.99 69.37 -48.59 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 E 24 ASP E 171 ASP^? 16.73 MG MG E 301 E 146 TYR E 168 TYR^? 14.43 MG MG E 301 E 177 LYS E 166 LYS^? 21.46 MG MG E 301 coo -7.12 105.25 1.43 -6.30 103.34 0.77 69.61 73.12 -51.56 71.50 73.53 -52.39 coo -3.11 94.55 3.01 -3.83 95.92 0.66 60.07 69.95 -50.54 61.99 69.37 -48.59 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 E 24 ASP F 171 ASP^? 16.35 MG MG F 302 E 146 TYR F 168 TYR^? 14.10 MG MG F 302 E 177 LYS F 166 LYS^? 20.76 MG MG F 302 coo -7.12 105.25 1.43 -6.30 103.34 0.77 48.23 68.08 -88.47 46.26 68.02 -87.56 coo -3.11 94.55 3.01 -3.83 95.92 0.66 58.29 68.32 -89.29 56.67 67.12 -91.21 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 59.28 73.05 -82.63 55.63 74.15 -86.94 1ok4_c04 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 8 hits 1ok4_c04 naa= 3 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 F 24 ASP A 171 ASP^? 17.17 MG MG A 302 F 146 TYR A 168 TYR^? 14.52 MG MG A 302 F 177 LYS A 166 LYS^? 20.93 MG MG A 302 coo -44.75 128.15 10.28 -45.68 129.67 11.55 29.78 23.67 36.63 28.48 25.11 35.71 coo -50.43 131.90 19.60 -49.04 133.31 17.60 37.31 16.98 37.59 36.65 18.86 39.55 coo -44.10 135.86 19.99 -45.67 134.21 14.07 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 F 24 ASP B 142 ASP^? 23.97 MG MG B 301 F 146 TYR B 168 TYR^? 14.66 MG MG B 301 F 177 LYS B 166 LYS^? 22.75 MG MG B 301 coo -44.75 128.15 10.28 -45.68 129.67 11.55 31.69 27.40 -1.31 32.10 27.37 -3.38 coo -50.43 131.90 19.60 -49.04 133.31 17.60 40.03 17.20 -1.34 41.92 16.43 -3.19 coo -44.10 135.86 19.99 -45.67 134.21 14.07 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 F 24 ASP B 171 ASP^? 16.92 MG MG B 301 F 146 TYR B 168 TYR^? 14.66 MG MG B 301 F 177 LYS B 166 LYS^? 22.75 MG MG B 301 coo -44.75 128.15 10.28 -45.68 129.67 11.55 45.30 8.50 -0.71 46.30 6.81 0.12 coo -50.43 131.90 19.60 -49.04 133.31 17.60 40.03 17.20 -1.34 41.92 16.43 -3.19 coo -44.10 135.86 19.99 -45.67 134.21 14.07 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 F 24 ASP C 171 ASP^? 17.08 MG MG C 301 F 146 TYR C 168 TYR^? 14.82 MG MG C 301 F 177 LYS C 166 LYS^? 22.53 MG MG C 301 coo -44.75 128.15 10.28 -45.68 129.67 11.55 92.57 16.68 -6.24 92.24 14.74 -7.03 coo -50.43 131.90 19.60 -49.04 133.31 17.60 94.44 26.43 -5.44 92.97 25.09 -3.55 coo -44.10 135.86 19.99 -45.67 134.21 14.07 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 F 24 ASP D 171 ASP^? 16.95 MG MG D 301 F 146 TYR D 168 TYR^? 14.75 MG MG D 301 F 177 LYS D 166 LYS^? 21.08 MG MG D 301 coo -44.75 128.15 10.28 -45.68 129.67 11.55 100.39 36.69 -43.49 101.13 38.51 -42.69 coo -50.43 131.90 19.60 -49.04 133.31 17.60 95.79 27.80 -44.35 95.71 29.78 -46.32 coo -44.10 135.86 19.99 -45.67 134.21 14.07 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 F 24 ASP E 142 ASP^? 23.66 MG MG E 301 F 146 TYR E 168 TYR^? 14.43 MG MG E 301 F 177 LYS E 166 LYS^? 21.46 MG MG E 301 coo -44.75 128.15 10.28 -45.68 129.67 11.55 47.19 67.15 -50.37 47.44 67.18 -48.23 coo -50.43 131.90 19.60 -49.04 133.31 17.60 60.07 69.95 -50.54 61.99 69.37 -48.59 coo -44.10 135.86 19.99 -45.67 134.21 14.07 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 F 24 ASP E 171 ASP^? 16.73 MG MG E 301 F 146 TYR E 168 TYR^? 14.43 MG MG E 301 F 177 LYS E 166 LYS^? 21.46 MG MG E 301 coo -44.75 128.15 10.28 -45.68 129.67 11.55 69.61 73.12 -51.56 71.50 73.53 -52.39 coo -50.43 131.90 19.60 -49.04 133.31 17.60 60.07 69.95 -50.54 61.99 69.37 -48.59 coo -44.10 135.86 19.99 -45.67 134.21 14.07 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 F 24 ASP F 171 ASP^? 16.35 MG MG F 302 F 146 TYR F 168 TYR^? 14.10 MG MG F 302 F 177 LYS F 166 LYS^? 20.76 MG MG F 302 coo -44.75 128.15 10.28 -45.68 129.67 11.55 48.23 68.08 -88.47 46.26 68.02 -87.56 coo -50.43 131.90 19.60 -49.04 133.31 17.60 58.29 68.32 -89.29 56.67 67.12 -91.21 coo -44.10 135.86 19.99 -45.67 134.21 14.07 59.28 73.05 -82.63 55.63 74.15 -86.94 1ok4_c05 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 8 hits 1ok4_c05 naa= 3 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 G 24 ASP A 171 ASP^? 17.17 MG MG A 302 G 146 TYR A 168 TYR^? 14.52 MG MG A 302 G 177 LYS A 166 LYS^? 20.93 MG MG A 302 coo -44.97 128.78 41.20 -46.32 128.26 42.83 29.78 23.67 36.63 28.48 25.11 35.71 coo -52.83 122.13 46.42 -51.31 124.30 47.39 37.31 16.98 37.59 36.65 18.86 39.55 coo -47.30 122.24 51.49 -47.46 127.44 47.81 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 G 24 ASP B 142 ASP^? 23.97 MG MG B 301 G 146 TYR B 168 TYR^? 14.66 MG MG B 301 G 177 LYS B 166 LYS^? 22.75 MG MG B 301 coo -44.97 128.78 41.20 -46.32 128.26 42.83 31.69 27.40 -1.31 32.10 27.37 -3.38 coo -52.83 122.13 46.42 -51.31 124.30 47.39 40.03 17.20 -1.34 41.92 16.43 -3.19 coo -47.30 122.24 51.49 -47.46 127.44 47.81 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 G 24 ASP B 171 ASP^? 16.92 MG MG B 301 G 146 TYR B 168 TYR^? 14.66 MG MG B 301 G 177 LYS B 166 LYS^? 22.75 MG MG B 301 coo -44.97 128.78 41.20 -46.32 128.26 42.83 45.30 8.50 -0.71 46.30 6.81 0.12 coo -52.83 122.13 46.42 -51.31 124.30 47.39 40.03 17.20 -1.34 41.92 16.43 -3.19 coo -47.30 122.24 51.49 -47.46 127.44 47.81 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 G 24 ASP C 171 ASP^? 17.08 MG MG C 301 G 146 TYR C 168 TYR^? 14.82 MG MG C 301 G 177 LYS C 166 LYS^? 22.53 MG MG C 301 coo -44.97 128.78 41.20 -46.32 128.26 42.83 92.57 16.68 -6.24 92.24 14.74 -7.03 coo -52.83 122.13 46.42 -51.31 124.30 47.39 94.44 26.43 -5.44 92.97 25.09 -3.55 coo -47.30 122.24 51.49 -47.46 127.44 47.81 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 G 24 ASP D 171 ASP^? 16.95 MG MG D 301 G 146 TYR D 168 TYR^? 14.75 MG MG D 301 G 177 LYS D 166 LYS^? 21.08 MG MG D 301 coo -44.97 128.78 41.20 -46.32 128.26 42.83 100.39 36.69 -43.49 101.13 38.51 -42.69 coo -52.83 122.13 46.42 -51.31 124.30 47.39 95.79 27.80 -44.35 95.71 29.78 -46.32 coo -47.30 122.24 51.49 -47.46 127.44 47.81 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 G 24 ASP E 142 ASP^? 23.66 MG MG E 301 G 146 TYR E 168 TYR^? 14.43 MG MG E 301 G 177 LYS E 166 LYS^? 21.46 MG MG E 301 coo -44.97 128.78 41.20 -46.32 128.26 42.83 47.19 67.15 -50.37 47.44 67.18 -48.23 coo -52.83 122.13 46.42 -51.31 124.30 47.39 60.07 69.95 -50.54 61.99 69.37 -48.59 coo -47.30 122.24 51.49 -47.46 127.44 47.81 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 G 24 ASP E 171 ASP^? 16.73 MG MG E 301 G 146 TYR E 168 TYR^? 14.43 MG MG E 301 G 177 LYS E 166 LYS^? 21.46 MG MG E 301 coo -44.97 128.78 41.20 -46.32 128.26 42.83 69.61 73.12 -51.56 71.50 73.53 -52.39 coo -52.83 122.13 46.42 -51.31 124.30 47.39 60.07 69.95 -50.54 61.99 69.37 -48.59 coo -47.30 122.24 51.49 -47.46 127.44 47.81 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 G 24 ASP F 171 ASP^? 16.35 MG MG F 302 G 146 TYR F 168 TYR^? 14.10 MG MG F 302 G 177 LYS F 166 LYS^? 20.76 MG MG F 302 coo -44.97 128.78 41.20 -46.32 128.26 42.83 48.23 68.08 -88.47 46.26 68.02 -87.56 coo -52.83 122.13 46.42 -51.31 124.30 47.39 58.29 68.32 -89.29 56.67 67.12 -91.21 coo -47.30 122.24 51.49 -47.46 127.44 47.81 59.28 73.05 -82.63 55.63 74.15 -86.94 1ok4_c06 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 8 hits 1ok4_c06 naa= 3 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 H 24 ASP A 171 ASP^? 17.17 MG MG A 302 H 146 TYR A 168 TYR^? 14.52 MG MG A 302 H 177 LYS A 166 LYS^? 20.93 MG MG A 302 coo -51.11 100.30 51.41 -52.67 98.82 51.12 29.78 23.67 36.63 28.48 25.11 35.71 coo -58.70 94.17 45.32 -57.76 93.82 47.92 37.31 16.98 37.59 36.65 18.86 39.55 coo -54.32 88.79 48.13 -54.61 94.04 51.74 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 H 24 ASP B 142 ASP^? 23.97 MG MG B 301 H 146 TYR B 168 TYR^? 14.66 MG MG B 301 H 177 LYS B 166 LYS^? 22.75 MG MG B 301 coo -51.11 100.30 51.41 -52.67 98.82 51.12 31.69 27.40 -1.31 32.10 27.37 -3.38 coo -58.70 94.17 45.32 -57.76 93.82 47.92 40.03 17.20 -1.34 41.92 16.43 -3.19 coo -54.32 88.79 48.13 -54.61 94.04 51.74 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 H 24 ASP B 171 ASP^? 16.92 MG MG B 301 H 146 TYR B 168 TYR^? 14.66 MG MG B 301 H 177 LYS B 166 LYS^? 22.75 MG MG B 301 coo -51.11 100.30 51.41 -52.67 98.82 51.12 45.30 8.50 -0.71 46.30 6.81 0.12 coo -58.70 94.17 45.32 -57.76 93.82 47.92 40.03 17.20 -1.34 41.92 16.43 -3.19 coo -54.32 88.79 48.13 -54.61 94.04 51.74 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 H 24 ASP C 171 ASP^? 17.08 MG MG C 301 H 146 TYR C 168 TYR^? 14.82 MG MG C 301 H 177 LYS C 166 LYS^? 22.53 MG MG C 301 coo -51.11 100.30 51.41 -52.67 98.82 51.12 92.57 16.68 -6.24 92.24 14.74 -7.03 coo -58.70 94.17 45.32 -57.76 93.82 47.92 94.44 26.43 -5.44 92.97 25.09 -3.55 coo -54.32 88.79 48.13 -54.61 94.04 51.74 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 H 24 ASP D 171 ASP^? 16.95 MG MG D 301 H 146 TYR D 168 TYR^? 14.75 MG MG D 301 H 177 LYS D 166 LYS^? 21.08 MG MG D 301 coo -51.11 100.30 51.41 -52.67 98.82 51.12 100.39 36.69 -43.49 101.13 38.51 -42.69 coo -58.70 94.17 45.32 -57.76 93.82 47.92 95.79 27.80 -44.35 95.71 29.78 -46.32 coo -54.32 88.79 48.13 -54.61 94.04 51.74 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 H 24 ASP E 142 ASP^? 23.66 MG MG E 301 H 146 TYR E 168 TYR^? 14.43 MG MG E 301 H 177 LYS E 166 LYS^? 21.46 MG MG E 301 coo -51.11 100.30 51.41 -52.67 98.82 51.12 47.19 67.15 -50.37 47.44 67.18 -48.23 coo -58.70 94.17 45.32 -57.76 93.82 47.92 60.07 69.95 -50.54 61.99 69.37 -48.59 coo -54.32 88.79 48.13 -54.61 94.04 51.74 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 H 24 ASP E 171 ASP^? 16.73 MG MG E 301 H 146 TYR E 168 TYR^? 14.43 MG MG E 301 H 177 LYS E 166 LYS^? 21.46 MG MG E 301 coo -51.11 100.30 51.41 -52.67 98.82 51.12 69.61 73.12 -51.56 71.50 73.53 -52.39 coo -58.70 94.17 45.32 -57.76 93.82 47.92 60.07 69.95 -50.54 61.99 69.37 -48.59 coo -54.32 88.79 48.13 -54.61 94.04 51.74 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 H 24 ASP F 171 ASP^? 16.35 MG MG F 302 H 146 TYR F 168 TYR^? 14.10 MG MG F 302 H 177 LYS F 166 LYS^? 20.76 MG MG F 302 coo -51.11 100.30 51.41 -52.67 98.82 51.12 48.23 68.08 -88.47 46.26 68.02 -87.56 coo -58.70 94.17 45.32 -57.76 93.82 47.92 58.29 68.32 -89.29 56.67 67.12 -91.21 coo -54.32 88.79 48.13 -54.61 94.04 51.74 59.28 73.05 -82.63 55.63 74.15 -86.94 1ok4_c07 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 8 hits 1ok4_c07 naa= 3 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 I 24 ASP A 171 ASP^? 17.17 MG MG A 302 I 146 TYR A 168 TYR^? 14.52 MG MG A 302 I 177 LYS A 166 LYS^? 20.93 MG MG A 302 coo -54.65 81.97 26.87 -55.88 81.89 25.07 29.78 23.67 36.63 28.48 25.11 35.71 coo -59.92 86.62 17.74 -59.42 83.94 18.40 37.31 16.98 37.59 36.65 18.86 39.55 coo -55.38 81.61 14.50 -57.11 80.05 20.41 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 I 24 ASP B 142 ASP^? 23.97 MG MG B 301 I 146 TYR B 168 TYR^? 14.66 MG MG B 301 I 177 LYS B 166 LYS^? 22.75 MG MG B 301 coo -54.65 81.97 26.87 -55.88 81.89 25.07 31.69 27.40 -1.31 32.10 27.37 -3.38 coo -59.92 86.62 17.74 -59.42 83.94 18.40 40.03 17.20 -1.34 41.92 16.43 -3.19 coo -55.38 81.61 14.50 -57.11 80.05 20.41 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 I 24 ASP B 171 ASP^? 16.92 MG MG B 301 I 146 TYR B 168 TYR^? 14.66 MG MG B 301 I 177 LYS B 166 LYS^? 22.75 MG MG B 301 coo -54.65 81.97 26.87 -55.88 81.89 25.07 45.30 8.50 -0.71 46.30 6.81 0.12 coo -59.92 86.62 17.74 -59.42 83.94 18.40 40.03 17.20 -1.34 41.92 16.43 -3.19 coo -55.38 81.61 14.50 -57.11 80.05 20.41 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 I 24 ASP C 171 ASP^? 17.08 MG MG C 301 I 146 TYR C 168 TYR^? 14.82 MG MG C 301 I 177 LYS C 166 LYS^? 22.53 MG MG C 301 coo -54.65 81.97 26.87 -55.88 81.89 25.07 92.57 16.68 -6.24 92.24 14.74 -7.03 coo -59.92 86.62 17.74 -59.42 83.94 18.40 94.44 26.43 -5.44 92.97 25.09 -3.55 coo -55.38 81.61 14.50 -57.11 80.05 20.41 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 I 24 ASP D 171 ASP^? 16.95 MG MG D 301 I 146 TYR D 168 TYR^? 14.75 MG MG D 301 I 177 LYS D 166 LYS^? 21.08 MG MG D 301 coo -54.65 81.97 26.87 -55.88 81.89 25.07 100.39 36.69 -43.49 101.13 38.51 -42.69 coo -59.92 86.62 17.74 -59.42 83.94 18.40 95.79 27.80 -44.35 95.71 29.78 -46.32 coo -55.38 81.61 14.50 -57.11 80.05 20.41 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 I 24 ASP E 142 ASP^? 23.66 MG MG E 301 I 146 TYR E 168 TYR^? 14.43 MG MG E 301 I 177 LYS E 166 LYS^? 21.46 MG MG E 301 coo -54.65 81.97 26.87 -55.88 81.89 25.07 47.19 67.15 -50.37 47.44 67.18 -48.23 coo -59.92 86.62 17.74 -59.42 83.94 18.40 60.07 69.95 -50.54 61.99 69.37 -48.59 coo -55.38 81.61 14.50 -57.11 80.05 20.41 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 I 24 ASP E 171 ASP^? 16.73 MG MG E 301 I 146 TYR E 168 TYR^? 14.43 MG MG E 301 I 177 LYS E 166 LYS^? 21.46 MG MG E 301 coo -54.65 81.97 26.87 -55.88 81.89 25.07 69.61 73.12 -51.56 71.50 73.53 -52.39 coo -59.92 86.62 17.74 -59.42 83.94 18.40 60.07 69.95 -50.54 61.99 69.37 -48.59 coo -55.38 81.61 14.50 -57.11 80.05 20.41 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 I 24 ASP F 171 ASP^? 16.35 MG MG F 302 I 146 TYR F 168 TYR^? 14.10 MG MG F 302 I 177 LYS F 166 LYS^? 20.76 MG MG F 302 coo -54.65 81.97 26.87 -55.88 81.89 25.07 48.23 68.08 -88.47 46.26 68.02 -87.56 coo -59.92 86.62 17.74 -59.42 83.94 18.40 58.29 68.32 -89.29 56.67 67.12 -91.21 coo -55.38 81.61 14.50 -57.11 80.05 20.41 59.28 73.05 -82.63 55.63 74.15 -86.94 1ok4_c08 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 8 hits 1ok4_c08 naa= 3 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 J 24 ASP A 171 ASP^? 17.17 MG MG A 302 J 146 TYR A 168 TYR^? 14.52 MG MG A 302 J 177 LYS A 166 LYS^? 20.93 MG MG A 302 coo -50.64 99.08 1.52 -51.52 100.83 0.67 29.78 23.67 36.63 28.48 25.11 35.71 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 37.31 16.98 37.59 36.65 18.86 39.55 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 J 24 ASP B 142 ASP^? 23.97 MG MG B 301 J 146 TYR B 168 TYR^? 14.66 MG MG B 301 J 177 LYS B 166 LYS^? 22.75 MG MG B 301 coo -50.64 99.08 1.52 -51.52 100.83 0.67 31.69 27.40 -1.31 32.10 27.37 -3.38 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 40.03 17.20 -1.34 41.92 16.43 -3.19 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 J 24 ASP B 171 ASP^? 16.92 MG MG B 301 J 146 TYR B 168 TYR^? 14.66 MG MG B 301 J 177 LYS B 166 LYS^? 22.75 MG MG B 301 coo -50.64 99.08 1.52 -51.52 100.83 0.67 45.30 8.50 -0.71 46.30 6.81 0.12 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 40.03 17.20 -1.34 41.92 16.43 -3.19 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 J 24 ASP C 171 ASP^? 17.08 MG MG C 301 J 146 TYR C 168 TYR^? 14.82 MG MG C 301 J 177 LYS C 166 LYS^? 22.53 MG MG C 301 coo -50.64 99.08 1.52 -51.52 100.83 0.67 92.57 16.68 -6.24 92.24 14.74 -7.03 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 94.44 26.43 -5.44 92.97 25.09 -3.55 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 J 24 ASP D 171 ASP^? 16.95 MG MG D 301 J 146 TYR D 168 TYR^? 14.75 MG MG D 301 J 177 LYS D 166 LYS^? 21.08 MG MG D 301 coo -50.64 99.08 1.52 -51.52 100.83 0.67 100.39 36.69 -43.49 101.13 38.51 -42.69 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 95.79 27.80 -44.35 95.71 29.78 -46.32 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 J 24 ASP E 142 ASP^? 23.66 MG MG E 301 J 146 TYR E 168 TYR^? 14.43 MG MG E 301 J 177 LYS E 166 LYS^? 21.46 MG MG E 301 coo -50.64 99.08 1.52 -51.52 100.83 0.67 47.19 67.15 -50.37 47.44 67.18 -48.23 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 60.07 69.95 -50.54 61.99 69.37 -48.59 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 J 24 ASP E 171 ASP^? 16.73 MG MG E 301 J 146 TYR E 168 TYR^? 14.43 MG MG E 301 J 177 LYS E 166 LYS^? 21.46 MG MG E 301 coo -50.64 99.08 1.52 -51.52 100.83 0.67 69.61 73.12 -51.56 71.50 73.53 -52.39 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 60.07 69.95 -50.54 61.99 69.37 -48.59 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 J 24 ASP F 171 ASP^? 16.35 MG MG F 302 J 146 TYR F 168 TYR^? 14.10 MG MG F 302 J 177 LYS F 166 LYS^? 20.76 MG MG F 302 coo -50.64 99.08 1.52 -51.52 100.83 0.67 48.23 68.08 -88.47 46.26 68.02 -87.56 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 58.29 68.32 -89.29 56.67 67.12 -91.21 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 59.28 73.05 -82.63 55.63 74.15 -86.94 1ok4_c09 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 8 hits 1ok4_c09 naa= 3 ULMN 3 1onr_c00 TRANSALDOLASE B user 1 3 # 1 A 17 ASP A 23 ASP^? 22.90 MG MG A 301 A 96 GLU A 75 GLU^? 20.23 MG MG A 301 A 132 LYS A 76 LYS^? 25.42 MG MG A 301 coo 31.23 12.29 16.44 30.82 11.56 18.39 36.40 52.47 38.61 38.03 53.36 39.72 coo 26.82 3.20 24.36 27.99 4.86 24.98 38.99 46.65 28.68 39.94 47.65 30.33 coo 29.99 0.62 22.18 30.38 6.69 20.81 34.45 46.53 27.28 28.88 44.93 27.25 ULMN 3 1onr_c00 TRANSALDOLASE B user 2 3 # 2 A 17 ASP A 35 ASP^? 16.92 MG MG A 301 A 96 GLU B 63 GLU^? 27.83 MG MG A 301 A 132 LYS B 61 LYS^? 22.03 MG MG A 301 coo 31.23 12.29 16.44 30.82 11.56 18.39 34.49 31.10 26.54 36.41 31.82 27.10 coo 26.82 3.20 24.36 27.99 4.86 24.98 36.89 38.35 16.01 38.64 39.45 15.67 coo 29.99 0.62 22.18 30.38 6.69 20.81 32.50 37.62 17.61 36.68 34.92 21.51 ULMN 3 1onr_c00 TRANSALDOLASE B user 3 3 # 3 A 17 ASP A 138 ASP^? 33.08 MG MG A 302 A 96 GLU A 165 GLU^? 29.56 MG MG A 302 A 132 LYS A 157 LYS^? 28.65 MG MG A 302 coo 31.23 12.29 16.44 30.82 11.56 18.39 47.10 -0.97 29.63 45.89 0.22 30.96 coo 26.82 3.20 24.36 27.99 4.86 24.98 36.12 8.31 27.27 37.25 6.55 27.60 coo 29.99 0.62 22.18 30.38 6.69 20.81 41.42 12.06 27.58 41.46 5.93 29.41 ULMN 3 1onr_c00 TRANSALDOLASE B user 4 3 # 4 A 17 ASP A 142 ASP^? 23.70 MG MG A 302 A 96 GLU A 165 GLU^? 29.56 MG MG A 302 A 132 LYS A 157 LYS^? 28.65 MG MG A 302 coo 31.23 12.29 16.44 30.82 11.56 18.39 46.39 7.18 37.53 46.28 7.18 39.63 coo 26.82 3.20 24.36 27.99 4.86 24.98 36.12 8.31 27.27 37.25 6.55 27.60 coo 29.99 0.62 22.18 30.38 6.69 20.81 41.42 12.06 27.58 41.46 5.93 29.41 ULMN 3 1onr_c00 TRANSALDOLASE B user 5 3 # 5 A 17 ASP A 142 ASP^? 23.70 MG MG A 302 A 96 GLU A 165 GLU^? 29.56 MG MG A 302 A 132 LYS A 166 LYS^? 20.93 MG MG A 302 coo 31.23 12.29 16.44 30.82 11.56 18.39 46.39 7.18 37.53 46.28 7.18 39.63 coo 26.82 3.20 24.36 27.99 4.86 24.98 36.12 8.31 27.27 37.25 6.55 27.60 coo 29.99 0.62 22.18 30.38 6.69 20.81 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1onr_c00 TRANSALDOLASE B user 6 3 # 6 A 17 ASP B 23 ASP^? 15.67 MG MG C 301 A 96 GLU B 75 GLU^? 15.82 MG MG C 301 A 132 LYS B 76 LYS^? 25.77 MG MG B 302 coo 31.23 12.29 16.44 30.82 11.56 18.39 74.31 7.55 -1.09 75.08 9.17 -2.23 coo 26.82 3.20 24.36 27.99 4.86 24.98 68.81 12.14 8.61 69.95 13.49 7.45 coo 29.99 0.62 22.18 30.38 6.69 20.81 67.82 8.19 10.14 64.96 3.09 10.62 ULMN 3 1onr_c00 TRANSALDOLASE B user 7 3 # 7 A 17 ASP B 35 ASP^? 16.92 MG MG B 302 A 96 GLU A 63 GLU^? 28.10 MG MG B 302 A 132 LYS A 61 LYS^? 21.99 MG MG B 302 coo 31.23 12.29 16.44 30.82 11.56 18.39 52.63 11.07 10.18 53.68 12.85 9.94 coo 26.82 3.20 24.36 27.99 4.86 24.98 59.13 11.55 21.47 60.51 12.96 22.22 coo 29.99 0.62 22.18 30.38 6.69 20.81 57.78 7.35 19.60 56.77 12.20 15.61 ULMN 3 1onr_c00 TRANSALDOLASE B user 8 3 # 8 A 17 ASP B 138 ASP^? 33.32 MG MG B 302 A 96 GLU B 165 GLU^? 29.66 MG MG B 302 A 132 LYS B 157 LYS^? 28.85 MG MG B 302 coo 31.23 12.29 16.44 30.82 11.56 18.39 23.42 29.01 6.78 24.36 28.48 4.94 coo 26.82 3.20 24.36 27.99 4.86 24.98 30.38 16.84 8.28 28.95 18.37 7.83 coo 29.99 0.62 22.18 30.38 6.69 20.81 34.97 21.28 8.44 29.03 22.82 6.58 ULMN 3 1onr_c00 TRANSALDOLASE B user 9 3 # 9 A 17 ASP B 142 ASP^? 23.97 MG MG B 301 A 96 GLU B 165 GLU^? 29.66 MG MG B 302 A 132 LYS B 157 LYS^? 28.85 MG MG B 302 coo 31.23 12.29 16.44 30.82 11.56 18.39 31.69 27.40 -1.31 32.10 27.37 -3.38 coo 26.82 3.20 24.36 27.99 4.86 24.98 30.38 16.84 8.28 28.95 18.37 7.83 coo 29.99 0.62 22.18 30.38 6.69 20.81 34.97 21.28 8.44 29.03 22.82 6.58 ULMN 3 1onr_c00 TRANSALDOLASE B user 10 3 # 10 A 17 ASP B 142 ASP^? 23.97 MG MG B 301 A 96 GLU B 165 GLU^? 29.66 MG MG B 302 A 132 LYS B 166 LYS^? 22.75 MG MG B 301 coo 31.23 12.29 16.44 30.82 11.56 18.39 31.69 27.40 -1.31 32.10 27.37 -3.38 coo 26.82 3.20 24.36 27.99 4.86 24.98 30.38 16.84 8.28 28.95 18.37 7.83 coo 29.99 0.62 22.18 30.38 6.69 20.81 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1onr_c00 TRANSALDOLASE B user 11 3 # 11 A 17 ASP B 160 ASP^? 31.65 MG MG A 301 A 96 GLU B 165 GLU^? 29.66 MG MG B 302 A 132 LYS B 157 LYS^? 28.85 MG MG B 302 coo 31.23 12.29 16.44 30.82 11.56 18.39 28.01 24.83 16.38 27.44 26.81 15.80 coo 26.82 3.20 24.36 27.99 4.86 24.98 30.38 16.84 8.28 28.95 18.37 7.83 coo 29.99 0.62 22.18 30.38 6.69 20.81 34.97 21.28 8.44 29.03 22.82 6.58 ULMN 3 1onr_c00 TRANSALDOLASE B user 12 3 # 12 A 17 ASP C 23 ASP^? 15.39 MG MG B 301 A 96 GLU C 75 GLU^? 16.14 MG MG B 301 A 132 LYS C 76 LYS^? 24.95 MG MG C 302 coo 31.23 12.29 16.44 30.82 11.56 18.39 65.24 6.82 -5.11 63.43 7.54 -4.15 coo 26.82 3.20 24.36 27.99 4.86 24.98 69.49 12.18 -14.30 67.44 12.65 -13.83 coo 29.99 0.62 22.18 30.38 6.69 20.81 71.11 8.63 -16.76 75.44 5.17 -16.80 ULMN 3 1onr_c00 TRANSALDOLASE B user 13 3 # 13 A 17 ASP C 35 ASP^? 16.42 MG MG C 302 A 96 GLU D 63 GLU^? 27.62 MG MG C 302 A 132 LYS D 61 LYS^? 21.93 MG MG C 302 coo 31.23 12.29 16.44 30.82 11.56 18.39 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 26.82 3.20 24.36 27.99 4.86 24.98 77.46 14.75 -28.07 75.93 16.12 -28.66 coo 29.99 0.62 22.18 30.38 6.69 20.81 80.64 11.23 -26.16 80.65 16.24 -22.36 ULMN 3 1onr_c00 TRANSALDOLASE B user 14 3 # 14 A 17 ASP C 138 ASP^? 33.43 MG MG C 302 A 96 GLU C 165 GLU^? 29.32 MG MG C 302 A 132 LYS C 157 LYS^? 28.15 MG MG C 302 coo 31.23 12.29 16.44 30.82 11.56 18.39 105.43 43.97 -13.30 104.85 43.08 -11.43 coo 26.82 3.20 24.36 27.99 4.86 24.98 103.18 29.99 -15.18 103.57 32.09 -14.86 coo 29.99 0.62 22.18 30.38 6.69 20.81 97.55 32.04 -15.10 101.49 36.24 -13.39 ULMN 3 1onr_c00 TRANSALDOLASE B user 15 3 # 15 A 17 ASP C 142 ASP^? 23.76 MG MG C 301 A 96 GLU C 165 GLU^? 29.32 MG MG C 302 A 132 LYS C 157 LYS^? 28.15 MG MG C 302 coo 31.23 12.29 16.44 30.82 11.56 18.39 97.94 39.27 -5.03 98.08 38.70 -2.97 coo 26.82 3.20 24.36 27.99 4.86 24.98 103.18 29.99 -15.18 103.57 32.09 -14.86 coo 29.99 0.62 22.18 30.38 6.69 20.81 97.55 32.04 -15.10 101.49 36.24 -13.39 ULMN 3 1onr_c00 TRANSALDOLASE B user 16 3 # 16 A 17 ASP C 142 ASP^? 23.76 MG MG C 301 A 96 GLU C 165 GLU^? 29.32 MG MG C 302 A 132 LYS C 166 LYS^? 22.53 MG MG C 301 coo 31.23 12.29 16.44 30.82 11.56 18.39 97.94 39.27 -5.03 98.08 38.70 -2.97 coo 26.82 3.20 24.36 27.99 4.86 24.98 103.18 29.99 -15.18 103.57 32.09 -14.86 coo 29.99 0.62 22.18 30.38 6.69 20.81 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1onr_c00 TRANSALDOLASE B user 17 3 # 17 A 17 ASP C 160 ASP^? 31.63 MG MG D 302 A 96 GLU C 165 GLU^? 29.32 MG MG C 302 A 132 LYS C 157 LYS^? 28.15 MG MG C 302 coo 31.23 12.29 16.44 30.82 11.56 18.39 102.50 38.00 -23.28 102.43 39.97 -22.46 coo 26.82 3.20 24.36 27.99 4.86 24.98 103.18 29.99 -15.18 103.57 32.09 -14.86 coo 29.99 0.62 22.18 30.38 6.69 20.81 97.55 32.04 -15.10 101.49 36.24 -13.39 ULMN 3 1onr_c00 TRANSALDOLASE B user 18 3 # 18 A 17 ASP D 23 ASP^? 15.37 MG MG E 301 A 96 GLU D 75 GLU^? 15.53 MG MG E 301 A 132 LYS D 76 LYS^? 25.08 MG MG D 302 coo 31.23 12.29 16.44 30.82 11.56 18.39 85.70 62.10 -45.60 84.07 62.13 -46.93 coo 26.82 3.20 24.36 27.99 4.86 24.98 84.53 54.81 -36.40 82.75 56.01 -36.42 coo 29.99 0.62 22.18 30.38 6.69 20.81 88.18 56.35 -34.05 93.80 56.17 -32.93 ULMN 3 1onr_c00 TRANSALDOLASE B user 19 3 # 19 A 17 ASP D 35 ASP^? 16.80 MG MG D 302 A 96 GLU C 63 GLU^? 27.26 MG MG D 302 A 132 LYS C 61 LYS^? 21.91 MG MG D 302 coo 31.23 12.29 16.44 30.82 11.56 18.39 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 26.82 3.20 24.36 27.99 4.86 24.98 89.51 47.54 -22.35 87.55 48.20 -22.72 coo 29.99 0.62 22.18 30.38 6.69 20.81 93.60 48.56 -24.05 90.39 44.71 -27.98 ULMN 3 1onr_c00 TRANSALDOLASE B user 20 3 # 20 A 17 ASP E 23 ASP^? 15.43 MG MG D 301 A 96 GLU E 75 GLU^? 15.76 MG MG D 301 A 132 LYS E 76 LYS^? 25.68 MG MG E 302 coo 31.23 12.29 16.44 30.82 11.56 18.39 91.98 54.64 -49.37 91.93 52.78 -48.33 coo 26.82 3.20 24.36 27.99 4.86 24.98 84.65 53.96 -59.58 85.64 52.81 -58.05 coo 29.99 0.62 22.18 30.38 6.69 20.81 87.09 58.11 -60.91 88.65 63.65 -61.27 ULMN 3 1onr_c00 TRANSALDOLASE B user 21 3 # 21 A 17 ASP E 35 ASP^? 16.91 MG MG E 302 A 96 GLU F 63 GLU^? 27.81 MG MG E 302 A 132 LYS F 61 LYS^? 21.75 MG MG E 302 coo 31.23 12.29 16.44 30.82 11.56 18.39 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 26.82 3.20 24.36 27.99 4.86 24.98 78.38 60.07 -72.34 78.48 58.04 -72.84 coo 29.99 0.62 22.18 30.38 6.69 20.81 80.24 64.12 -71.01 76.23 61.95 -66.39 ULMN 3 1onr_c00 TRANSALDOLASE B user 22 3 # 22 A 17 ASP E 138 ASP^? 33.31 MG MG E 302 A 96 GLU E 165 GLU^? 29.48 MG MG E 301 A 132 LYS E 157 LYS^? 28.40 MG MG E 302 coo 31.23 12.29 16.44 30.82 11.56 18.39 39.58 70.77 -58.63 40.74 70.78 -56.80 coo 26.82 3.20 24.36 27.99 4.86 24.98 52.92 74.97 -61.04 50.84 74.87 -60.51 coo 29.99 0.62 22.18 30.38 6.69 20.81 53.63 69.16 -60.42 48.34 71.81 -58.40 ULMN 3 1onr_c00 TRANSALDOLASE B user 23 3 # 23 A 17 ASP E 142 ASP^? 23.66 MG MG E 301 A 96 GLU E 165 GLU^? 29.48 MG MG E 301 A 132 LYS E 157 LYS^? 28.40 MG MG E 302 coo 31.23 12.29 16.44 30.82 11.56 18.39 47.19 67.15 -50.37 47.44 67.18 -48.23 coo 26.82 3.20 24.36 27.99 4.86 24.98 52.92 74.97 -61.04 50.84 74.87 -60.51 coo 29.99 0.62 22.18 30.38 6.69 20.81 53.63 69.16 -60.42 48.34 71.81 -58.40 ULMN 3 1onr_c00 TRANSALDOLASE B user 24 3 # 24 A 17 ASP E 142 ASP^? 23.66 MG MG E 301 A 96 GLU E 165 GLU^? 29.48 MG MG E 301 A 132 LYS E 166 LYS^? 21.46 MG MG E 301 coo 31.23 12.29 16.44 30.82 11.56 18.39 47.19 67.15 -50.37 47.44 67.18 -48.23 coo 26.82 3.20 24.36 27.99 4.86 24.98 52.92 74.97 -61.04 50.84 74.87 -60.51 coo 29.99 0.62 22.18 30.38 6.69 20.81 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1onr_c00 TRANSALDOLASE B user 25 3 # 25 A 17 ASP E 160 ASP^? 31.54 MG MG F 301 A 96 GLU E 165 GLU^? 29.48 MG MG E 301 A 132 LYS E 157 LYS^? 28.40 MG MG E 302 coo 31.23 12.29 16.44 30.82 11.56 18.39 45.81 70.00 -68.45 44.10 68.87 -67.77 coo 26.82 3.20 24.36 27.99 4.86 24.98 52.92 74.97 -61.04 50.84 74.87 -60.51 coo 29.99 0.62 22.18 30.38 6.69 20.81 53.63 69.16 -60.42 48.34 71.81 -58.40 ULMN 3 1onr_c00 TRANSALDOLASE B user 26 3 # 26 A 17 ASP F 23 ASP^? 23.03 MG MG F 301 A 96 GLU F 75 GLU^? 19.96 MG MG F 301 A 132 LYS F 76 LYS^? 25.89 MG MG F 301 coo 31.23 12.29 16.44 30.82 11.56 18.39 31.30 43.61 -89.40 33.44 43.69 -89.02 coo 26.82 3.20 24.36 27.99 4.86 24.98 40.19 46.06 -80.81 40.09 43.94 -81.24 coo 29.99 0.62 22.18 30.38 6.69 20.81 36.96 48.52 -78.06 33.74 53.37 -77.06 ULMN 3 1onr_c00 TRANSALDOLASE B user 27 3 # 27 A 17 ASP F 35 ASP^? 16.93 MG MG F 301 A 96 GLU E 63 GLU^? 28.08 MG MG F 301 A 132 LYS E 61 LYS^? 22.16 MG MG F 301 coo 31.23 12.29 16.44 30.82 11.56 18.39 46.82 60.47 -77.63 48.00 58.79 -78.23 coo 26.82 3.20 24.36 27.99 4.86 24.98 44.04 53.99 -66.79 43.77 51.93 -66.35 coo 29.99 0.62 22.18 30.38 6.69 20.81 40.99 56.84 -68.48 45.99 56.72 -72.39 ULMN 3 1onr_c00 TRANSALDOLASE B user 28 3 # 28 A 17 ASP F 138 ASP^? 33.51 MG MG F 302 A 96 GLU F 165 GLU^? 29.11 MG MG F 302 A 132 LYS F 157 LYS^? 28.36 MG MG F 302 coo 31.23 12.29 16.44 30.82 11.56 18.39 77.17 76.66 -81.48 76.14 76.33 -83.32 coo 26.82 3.20 24.36 27.99 4.86 24.98 63.01 76.49 -79.50 64.84 77.22 -80.35 coo 29.99 0.62 22.18 30.38 6.69 20.81 64.43 70.47 -79.54 68.32 74.80 -81.65 ULMN 3 1onr_c00 TRANSALDOLASE B user 29 3 # 29 A 17 ASP F 160 ASP^? 31.59 MG MG E 302 A 96 GLU F 165 GLU^? 29.11 MG MG F 302 A 132 LYS F 157 LYS^? 28.36 MG MG F 302 coo 31.23 12.29 16.44 30.82 11.56 18.39 71.27 74.59 -71.77 73.23 74.02 -72.37 coo 26.82 3.20 24.36 27.99 4.86 24.98 63.01 76.49 -79.50 64.84 77.22 -80.35 coo 29.99 0.62 22.18 30.38 6.69 20.81 64.43 70.47 -79.54 68.32 74.80 -81.65 1onr_c00 source 1onr TRANSALDOLASE B : 29 hits 1onr_c00 naa= 3 ULMN 3 1onr_c01 TRANSALDOLASE B user 1 3 # 1 B 17 ASP A 23 ASP^? 22.90 MG MG A 301 B 96 GLU A 75 GLU^? 20.23 MG MG A 301 B 132 LYS A 76 LYS^? 25.42 MG MG A 301 coo 31.16 57.31 -0.94 30.73 56.64 1.01 36.40 52.47 38.61 38.03 53.36 39.72 coo 26.69 48.45 7.18 27.85 50.13 7.74 38.99 46.65 28.68 39.94 47.65 30.33 coo 29.82 45.80 5.07 30.26 51.81 3.56 34.45 46.53 27.28 28.88 44.93 27.25 ULMN 3 1onr_c01 TRANSALDOLASE B user 2 3 # 2 B 17 ASP A 35 ASP^? 16.92 MG MG A 301 B 96 GLU B 63 GLU^? 27.83 MG MG A 301 B 132 LYS B 61 LYS^? 22.03 MG MG A 301 coo 31.16 57.31 -0.94 30.73 56.64 1.01 34.49 31.10 26.54 36.41 31.82 27.10 coo 26.69 48.45 7.18 27.85 50.13 7.74 36.89 38.35 16.01 38.64 39.45 15.67 coo 29.82 45.80 5.07 30.26 51.81 3.56 32.50 37.62 17.61 36.68 34.92 21.51 ULMN 3 1onr_c01 TRANSALDOLASE B user 3 3 # 3 B 17 ASP A 138 ASP^? 33.08 MG MG A 302 B 96 GLU A 165 GLU^? 29.56 MG MG A 302 B 132 LYS A 157 LYS^? 28.65 MG MG A 302 coo 31.16 57.31 -0.94 30.73 56.64 1.01 47.10 -0.97 29.63 45.89 0.22 30.96 coo 26.69 48.45 7.18 27.85 50.13 7.74 36.12 8.31 27.27 37.25 6.55 27.60 coo 29.82 45.80 5.07 30.26 51.81 3.56 41.42 12.06 27.58 41.46 5.93 29.41 ULMN 3 1onr_c01 TRANSALDOLASE B user 4 3 # 4 B 17 ASP A 142 ASP^? 23.70 MG MG A 302 B 96 GLU A 165 GLU^? 29.56 MG MG A 302 B 132 LYS A 157 LYS^? 28.65 MG MG A 302 coo 31.16 57.31 -0.94 30.73 56.64 1.01 46.39 7.18 37.53 46.28 7.18 39.63 coo 26.69 48.45 7.18 27.85 50.13 7.74 36.12 8.31 27.27 37.25 6.55 27.60 coo 29.82 45.80 5.07 30.26 51.81 3.56 41.42 12.06 27.58 41.46 5.93 29.41 ULMN 3 1onr_c01 TRANSALDOLASE B user 5 3 # 5 B 17 ASP A 142 ASP^? 23.70 MG MG A 302 B 96 GLU A 165 GLU^? 29.56 MG MG A 302 B 132 LYS A 166 LYS^? 20.93 MG MG A 302 coo 31.16 57.31 -0.94 30.73 56.64 1.01 46.39 7.18 37.53 46.28 7.18 39.63 coo 26.69 48.45 7.18 27.85 50.13 7.74 36.12 8.31 27.27 37.25 6.55 27.60 coo 29.82 45.80 5.07 30.26 51.81 3.56 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1onr_c01 TRANSALDOLASE B user 6 3 # 6 B 17 ASP B 23 ASP^? 15.67 MG MG C 301 B 96 GLU B 75 GLU^? 15.82 MG MG C 301 B 132 LYS B 76 LYS^? 25.77 MG MG B 302 coo 31.16 57.31 -0.94 30.73 56.64 1.01 74.31 7.55 -1.09 75.08 9.17 -2.23 coo 26.69 48.45 7.18 27.85 50.13 7.74 68.81 12.14 8.61 69.95 13.49 7.45 coo 29.82 45.80 5.07 30.26 51.81 3.56 67.82 8.19 10.14 64.96 3.09 10.62 ULMN 3 1onr_c01 TRANSALDOLASE B user 7 3 # 7 B 17 ASP B 35 ASP^? 16.92 MG MG B 302 B 96 GLU A 63 GLU^? 28.10 MG MG B 302 B 132 LYS A 61 LYS^? 21.99 MG MG B 302 coo 31.16 57.31 -0.94 30.73 56.64 1.01 52.63 11.07 10.18 53.68 12.85 9.94 coo 26.69 48.45 7.18 27.85 50.13 7.74 59.13 11.55 21.47 60.51 12.96 22.22 coo 29.82 45.80 5.07 30.26 51.81 3.56 57.78 7.35 19.60 56.77 12.20 15.61 ULMN 3 1onr_c01 TRANSALDOLASE B user 8 3 # 8 B 17 ASP B 138 ASP^? 33.32 MG MG B 302 B 96 GLU B 165 GLU^? 29.66 MG MG B 302 B 132 LYS B 157 LYS^? 28.85 MG MG B 302 coo 31.16 57.31 -0.94 30.73 56.64 1.01 23.42 29.01 6.78 24.36 28.48 4.94 coo 26.69 48.45 7.18 27.85 50.13 7.74 30.38 16.84 8.28 28.95 18.37 7.83 coo 29.82 45.80 5.07 30.26 51.81 3.56 34.97 21.28 8.44 29.03 22.82 6.58 ULMN 3 1onr_c01 TRANSALDOLASE B user 9 3 # 9 B 17 ASP B 142 ASP^? 23.97 MG MG B 301 B 96 GLU B 165 GLU^? 29.66 MG MG B 302 B 132 LYS B 157 LYS^? 28.85 MG MG B 302 coo 31.16 57.31 -0.94 30.73 56.64 1.01 31.69 27.40 -1.31 32.10 27.37 -3.38 coo 26.69 48.45 7.18 27.85 50.13 7.74 30.38 16.84 8.28 28.95 18.37 7.83 coo 29.82 45.80 5.07 30.26 51.81 3.56 34.97 21.28 8.44 29.03 22.82 6.58 ULMN 3 1onr_c01 TRANSALDOLASE B user 10 3 # 10 B 17 ASP B 142 ASP^? 23.97 MG MG B 301 B 96 GLU B 165 GLU^? 29.66 MG MG B 302 B 132 LYS B 166 LYS^? 22.75 MG MG B 301 coo 31.16 57.31 -0.94 30.73 56.64 1.01 31.69 27.40 -1.31 32.10 27.37 -3.38 coo 26.69 48.45 7.18 27.85 50.13 7.74 30.38 16.84 8.28 28.95 18.37 7.83 coo 29.82 45.80 5.07 30.26 51.81 3.56 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1onr_c01 TRANSALDOLASE B user 11 3 # 11 B 17 ASP B 160 ASP^? 31.65 MG MG A 301 B 96 GLU B 165 GLU^? 29.66 MG MG B 302 B 132 LYS B 157 LYS^? 28.85 MG MG B 302 coo 31.16 57.31 -0.94 30.73 56.64 1.01 28.01 24.83 16.38 27.44 26.81 15.80 coo 26.69 48.45 7.18 27.85 50.13 7.74 30.38 16.84 8.28 28.95 18.37 7.83 coo 29.82 45.80 5.07 30.26 51.81 3.56 34.97 21.28 8.44 29.03 22.82 6.58 ULMN 3 1onr_c01 TRANSALDOLASE B user 12 3 # 12 B 17 ASP C 23 ASP^? 15.39 MG MG B 301 B 96 GLU C 75 GLU^? 16.14 MG MG B 301 B 132 LYS C 76 LYS^? 24.95 MG MG C 302 coo 31.16 57.31 -0.94 30.73 56.64 1.01 65.24 6.82 -5.11 63.43 7.54 -4.15 coo 26.69 48.45 7.18 27.85 50.13 7.74 69.49 12.18 -14.30 67.44 12.65 -13.83 coo 29.82 45.80 5.07 30.26 51.81 3.56 71.11 8.63 -16.76 75.44 5.17 -16.80 ULMN 3 1onr_c01 TRANSALDOLASE B user 13 3 # 13 B 17 ASP C 35 ASP^? 16.42 MG MG C 302 B 96 GLU D 63 GLU^? 27.62 MG MG C 302 B 132 LYS D 61 LYS^? 21.93 MG MG C 302 coo 31.16 57.31 -0.94 30.73 56.64 1.01 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 26.69 48.45 7.18 27.85 50.13 7.74 77.46 14.75 -28.07 75.93 16.12 -28.66 coo 29.82 45.80 5.07 30.26 51.81 3.56 80.64 11.23 -26.16 80.65 16.24 -22.36 ULMN 3 1onr_c01 TRANSALDOLASE B user 14 3 # 14 B 17 ASP C 138 ASP^? 33.43 MG MG C 302 B 96 GLU C 165 GLU^? 29.32 MG MG C 302 B 132 LYS C 157 LYS^? 28.15 MG MG C 302 coo 31.16 57.31 -0.94 30.73 56.64 1.01 105.43 43.97 -13.30 104.85 43.08 -11.43 coo 26.69 48.45 7.18 27.85 50.13 7.74 103.18 29.99 -15.18 103.57 32.09 -14.86 coo 29.82 45.80 5.07 30.26 51.81 3.56 97.55 32.04 -15.10 101.49 36.24 -13.39 ULMN 3 1onr_c01 TRANSALDOLASE B user 15 3 # 15 B 17 ASP C 142 ASP^? 23.76 MG MG C 301 B 96 GLU C 165 GLU^? 29.32 MG MG C 302 B 132 LYS C 157 LYS^? 28.15 MG MG C 302 coo 31.16 57.31 -0.94 30.73 56.64 1.01 97.94 39.27 -5.03 98.08 38.70 -2.97 coo 26.69 48.45 7.18 27.85 50.13 7.74 103.18 29.99 -15.18 103.57 32.09 -14.86 coo 29.82 45.80 5.07 30.26 51.81 3.56 97.55 32.04 -15.10 101.49 36.24 -13.39 ULMN 3 1onr_c01 TRANSALDOLASE B user 16 3 # 16 B 17 ASP C 142 ASP^? 23.76 MG MG C 301 B 96 GLU C 165 GLU^? 29.32 MG MG C 302 B 132 LYS C 166 LYS^? 22.53 MG MG C 301 coo 31.16 57.31 -0.94 30.73 56.64 1.01 97.94 39.27 -5.03 98.08 38.70 -2.97 coo 26.69 48.45 7.18 27.85 50.13 7.74 103.18 29.99 -15.18 103.57 32.09 -14.86 coo 29.82 45.80 5.07 30.26 51.81 3.56 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1onr_c01 TRANSALDOLASE B user 17 3 # 17 B 17 ASP C 160 ASP^? 31.63 MG MG D 302 B 96 GLU C 165 GLU^? 29.32 MG MG C 302 B 132 LYS C 157 LYS^? 28.15 MG MG C 302 coo 31.16 57.31 -0.94 30.73 56.64 1.01 102.50 38.00 -23.28 102.43 39.97 -22.46 coo 26.69 48.45 7.18 27.85 50.13 7.74 103.18 29.99 -15.18 103.57 32.09 -14.86 coo 29.82 45.80 5.07 30.26 51.81 3.56 97.55 32.04 -15.10 101.49 36.24 -13.39 ULMN 3 1onr_c01 TRANSALDOLASE B user 18 3 # 18 B 17 ASP D 23 ASP^? 15.37 MG MG E 301 B 96 GLU D 75 GLU^? 15.53 MG MG E 301 B 132 LYS D 76 LYS^? 25.08 MG MG D 302 coo 31.16 57.31 -0.94 30.73 56.64 1.01 85.70 62.10 -45.60 84.07 62.13 -46.93 coo 26.69 48.45 7.18 27.85 50.13 7.74 84.53 54.81 -36.40 82.75 56.01 -36.42 coo 29.82 45.80 5.07 30.26 51.81 3.56 88.18 56.35 -34.05 93.80 56.17 -32.93 ULMN 3 1onr_c01 TRANSALDOLASE B user 19 3 # 19 B 17 ASP D 35 ASP^? 16.80 MG MG D 302 B 96 GLU C 63 GLU^? 27.26 MG MG D 302 B 132 LYS C 61 LYS^? 21.91 MG MG D 302 coo 31.16 57.31 -0.94 30.73 56.64 1.01 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 26.69 48.45 7.18 27.85 50.13 7.74 89.51 47.54 -22.35 87.55 48.20 -22.72 coo 29.82 45.80 5.07 30.26 51.81 3.56 93.60 48.56 -24.05 90.39 44.71 -27.98 ULMN 3 1onr_c01 TRANSALDOLASE B user 20 3 # 20 B 17 ASP E 23 ASP^? 15.43 MG MG D 301 B 96 GLU E 75 GLU^? 15.76 MG MG D 301 B 132 LYS E 76 LYS^? 25.68 MG MG E 302 coo 31.16 57.31 -0.94 30.73 56.64 1.01 91.98 54.64 -49.37 91.93 52.78 -48.33 coo 26.69 48.45 7.18 27.85 50.13 7.74 84.65 53.96 -59.58 85.64 52.81 -58.05 coo 29.82 45.80 5.07 30.26 51.81 3.56 87.09 58.11 -60.91 88.65 63.65 -61.27 ULMN 3 1onr_c01 TRANSALDOLASE B user 21 3 # 21 B 17 ASP E 35 ASP^? 16.91 MG MG E 302 B 96 GLU F 63 GLU^? 27.81 MG MG E 302 B 132 LYS F 61 LYS^? 21.75 MG MG E 302 coo 31.16 57.31 -0.94 30.73 56.64 1.01 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 26.69 48.45 7.18 27.85 50.13 7.74 78.38 60.07 -72.34 78.48 58.04 -72.84 coo 29.82 45.80 5.07 30.26 51.81 3.56 80.24 64.12 -71.01 76.23 61.95 -66.39 ULMN 3 1onr_c01 TRANSALDOLASE B user 22 3 # 22 B 17 ASP E 138 ASP^? 33.31 MG MG E 302 B 96 GLU E 165 GLU^? 29.48 MG MG E 301 B 132 LYS E 157 LYS^? 28.40 MG MG E 302 coo 31.16 57.31 -0.94 30.73 56.64 1.01 39.58 70.77 -58.63 40.74 70.78 -56.80 coo 26.69 48.45 7.18 27.85 50.13 7.74 52.92 74.97 -61.04 50.84 74.87 -60.51 coo 29.82 45.80 5.07 30.26 51.81 3.56 53.63 69.16 -60.42 48.34 71.81 -58.40 ULMN 3 1onr_c01 TRANSALDOLASE B user 23 3 # 23 B 17 ASP E 142 ASP^? 23.66 MG MG E 301 B 96 GLU E 165 GLU^? 29.48 MG MG E 301 B 132 LYS E 157 LYS^? 28.40 MG MG E 302 coo 31.16 57.31 -0.94 30.73 56.64 1.01 47.19 67.15 -50.37 47.44 67.18 -48.23 coo 26.69 48.45 7.18 27.85 50.13 7.74 52.92 74.97 -61.04 50.84 74.87 -60.51 coo 29.82 45.80 5.07 30.26 51.81 3.56 53.63 69.16 -60.42 48.34 71.81 -58.40 ULMN 3 1onr_c01 TRANSALDOLASE B user 24 3 # 24 B 17 ASP E 142 ASP^? 23.66 MG MG E 301 B 96 GLU E 165 GLU^? 29.48 MG MG E 301 B 132 LYS E 166 LYS^? 21.46 MG MG E 301 coo 31.16 57.31 -0.94 30.73 56.64 1.01 47.19 67.15 -50.37 47.44 67.18 -48.23 coo 26.69 48.45 7.18 27.85 50.13 7.74 52.92 74.97 -61.04 50.84 74.87 -60.51 coo 29.82 45.80 5.07 30.26 51.81 3.56 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1onr_c01 TRANSALDOLASE B user 25 3 # 25 B 17 ASP E 160 ASP^? 31.54 MG MG F 301 B 96 GLU E 165 GLU^? 29.48 MG MG E 301 B 132 LYS E 157 LYS^? 28.40 MG MG E 302 coo 31.16 57.31 -0.94 30.73 56.64 1.01 45.81 70.00 -68.45 44.10 68.87 -67.77 coo 26.69 48.45 7.18 27.85 50.13 7.74 52.92 74.97 -61.04 50.84 74.87 -60.51 coo 29.82 45.80 5.07 30.26 51.81 3.56 53.63 69.16 -60.42 48.34 71.81 -58.40 ULMN 3 1onr_c01 TRANSALDOLASE B user 26 3 # 26 B 17 ASP F 23 ASP^? 23.03 MG MG F 301 B 96 GLU F 75 GLU^? 19.96 MG MG F 301 B 132 LYS F 76 LYS^? 25.89 MG MG F 301 coo 31.16 57.31 -0.94 30.73 56.64 1.01 31.30 43.61 -89.40 33.44 43.69 -89.02 coo 26.69 48.45 7.18 27.85 50.13 7.74 40.19 46.06 -80.81 40.09 43.94 -81.24 coo 29.82 45.80 5.07 30.26 51.81 3.56 36.96 48.52 -78.06 33.74 53.37 -77.06 ULMN 3 1onr_c01 TRANSALDOLASE B user 27 3 # 27 B 17 ASP F 35 ASP^? 16.93 MG MG F 301 B 96 GLU E 63 GLU^? 28.08 MG MG F 301 B 132 LYS E 61 LYS^? 22.16 MG MG F 301 coo 31.16 57.31 -0.94 30.73 56.64 1.01 46.82 60.47 -77.63 48.00 58.79 -78.23 coo 26.69 48.45 7.18 27.85 50.13 7.74 44.04 53.99 -66.79 43.77 51.93 -66.35 coo 29.82 45.80 5.07 30.26 51.81 3.56 40.99 56.84 -68.48 45.99 56.72 -72.39 ULMN 3 1onr_c01 TRANSALDOLASE B user 28 3 # 28 B 17 ASP F 138 ASP^? 33.51 MG MG F 302 B 96 GLU F 165 GLU^? 29.11 MG MG F 302 B 132 LYS F 157 LYS^? 28.36 MG MG F 302 coo 31.16 57.31 -0.94 30.73 56.64 1.01 77.17 76.66 -81.48 76.14 76.33 -83.32 coo 26.69 48.45 7.18 27.85 50.13 7.74 63.01 76.49 -79.50 64.84 77.22 -80.35 coo 29.82 45.80 5.07 30.26 51.81 3.56 64.43 70.47 -79.54 68.32 74.80 -81.65 ULMN 3 1onr_c01 TRANSALDOLASE B user 29 3 # 29 B 17 ASP F 160 ASP^? 31.59 MG MG E 302 B 96 GLU F 165 GLU^? 29.11 MG MG F 302 B 132 LYS F 157 LYS^? 28.36 MG MG F 302 coo 31.16 57.31 -0.94 30.73 56.64 1.01 71.27 74.59 -71.77 73.23 74.02 -72.37 coo 26.69 48.45 7.18 27.85 50.13 7.74 63.01 76.49 -79.50 64.84 77.22 -80.35 coo 29.82 45.80 5.07 30.26 51.81 3.56 64.43 70.47 -79.54 68.32 74.80 -81.65 1onr_c01 source 1onr TRANSALDOLASE B : 29 hits 1onr_c01 naa= 3 ULMN 3 1opm_c00 1.14.17.0003 user 1 3 # 1 A 108 HIS A 42 HIS^? 28.45 MG MG A 301 A 170 GLN B 158 GLN^? 28.69 MG MG B 302 A 242 HIS B 42 HIS^? 28.37 MG MG B 302 coo 36.16 34.36 39.40 38.12 34.09 40.00 34.62 18.32 19.57 34.29 16.25 19.41 coo 40.85 35.41 43.73 41.85 33.73 42.88 33.79 20.43 14.36 35.22 19.91 15.87 coo 40.72 26.15 37.61 42.10 27.69 37.19 39.34 12.99 16.30 37.26 13.24 16.40 ULMN 3 1opm_c00 1.14.17.0003 user 2 3 # 2 A 108 HIS B 42 HIS^? 28.37 MG MG B 302 A 170 GLN A 158 GLN^? 28.59 MG MG A 301 A 242 HIS A 42 HIS^? 28.45 MG MG A 301 coo 36.16 34.36 39.40 38.12 34.09 40.00 39.34 12.99 16.30 37.26 13.24 16.40 coo 40.85 35.41 43.73 41.85 33.73 42.88 40.78 11.56 21.62 40.89 13.15 20.22 coo 40.72 26.15 37.61 42.10 27.69 37.19 34.62 18.32 19.57 34.29 16.25 19.41 ULMN 3 1opm_c00 1.14.17.0003 user 3 3 # 3 A 108 HIS C 42 HIS^? 28.09 MG MG C 302 A 170 GLN D 158 GLN^? 28.68 MG MG D 302 A 242 HIS D 42 HIS^? 28.21 MG MG D 302 coo 36.16 34.36 39.40 38.12 34.09 40.00 95.93 22.96 -23.11 97.92 23.62 -23.02 coo 40.85 35.41 43.73 41.85 33.73 42.88 95.08 21.18 -28.53 94.65 22.58 -26.99 coo 40.72 26.15 37.61 42.10 27.69 37.19 98.45 29.90 -26.44 99.32 28.02 -26.13 ULMN 3 1opm_c00 1.14.17.0003 user 4 3 # 4 A 108 HIS D 42 HIS^? 28.21 MG MG D 302 A 170 GLN C 158 GLN^? 28.28 MG MG C 302 A 242 HIS C 42 HIS^? 28.09 MG MG C 302 coo 36.16 34.36 39.40 38.12 34.09 40.00 98.45 29.90 -26.44 99.32 28.02 -26.13 coo 40.85 35.41 43.73 41.85 33.73 42.88 98.32 32.23 -21.13 97.36 30.85 -22.41 coo 40.72 26.15 37.61 42.10 27.69 37.19 95.93 22.96 -23.11 97.92 23.62 -23.02 ULMN 3 1opm_c00 1.14.17.0003 user 5 3 # 5 A 108 HIS E 42 HIS^? 28.20 MG MG E 302 A 170 GLN F 158 GLN^? 28.68 MG MG F 301 A 242 HIS F 42 HIS^? 28.34 MG MG F 301 coo 36.16 34.36 39.40 38.12 34.09 40.00 62.33 71.93 -68.30 60.54 72.96 -68.64 coo 40.85 35.41 43.73 41.85 33.73 42.88 64.61 71.63 -73.64 63.42 70.61 -72.23 coo 40.72 26.15 37.61 42.10 27.69 37.19 55.11 70.50 -71.64 56.29 72.22 -71.48 ULMN 3 1opm_c00 1.14.17.0003 user 6 3 # 6 A 108 HIS F 42 HIS^? 28.34 MG MG F 301 A 170 GLN E 158 GLN^? 28.44 MG MG E 302 A 242 HIS E 42 HIS^? 28.20 MG MG E 302 coo 36.16 34.36 39.40 38.12 34.09 40.00 55.11 70.50 -71.64 56.29 72.22 -71.48 coo 40.85 35.41 43.73 41.85 33.73 42.88 53.21 69.78 -66.26 54.74 69.25 -67.64 coo 40.72 26.15 37.61 42.10 27.69 37.19 62.33 71.93 -68.30 60.54 72.96 -68.64 1opm_c00 source 1opm 1.14.17.0003 : 6 hits 1opm_c00 naa= 3 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 1 3 # 1 A 170 SER A 66 SER^? 21.38 MG MG A 301 A 239 VAL A 56 VAL^? 25.99 MG MG A 301 A 413 ASN B 45 ASN^? 24.27 MG MG A 301 coo 80.14 40.76 52.28 77.73 40.59 51.94 52.67 19.58 24.88 54.49 20.94 25.63 coo 75.67 35.37 52.30 76.00 35.96 50.23 50.16 14.03 24.08 49.56 14.13 21.99 coo 81.75 35.21 52.13 80.92 37.12 51.69 47.87 19.20 19.75 47.40 21.26 19.77 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 2 3 # 2 A 170 SER A 79 SER^? 29.65 MG MG A 301 A 239 VAL A 77 VAL^? 24.44 MG MG A 301 A 413 ASN A 85 ASN^? 29.83 MG MG A 301 coo 80.14 40.76 52.28 77.73 40.59 51.94 32.57 55.71 29.63 34.63 56.10 28.47 coo 75.67 35.37 52.30 76.00 35.96 50.23 34.53 49.94 28.93 36.29 50.93 29.74 coo 81.75 35.21 52.13 80.92 37.12 51.69 36.44 52.20 24.38 35.62 54.19 24.50 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 3 3 # 3 A 170 SER A 79 SER^? 29.65 MG MG A 301 A 239 VAL A 84 VAL^? 29.73 MG MG A 301 A 413 ASN A 85 ASN^? 29.83 MG MG A 301 coo 80.14 40.76 52.28 77.73 40.59 51.94 32.57 55.71 29.63 34.63 56.10 28.47 coo 75.67 35.37 52.30 76.00 35.96 50.23 31.80 52.18 24.62 30.40 50.56 24.01 coo 81.75 35.21 52.13 80.92 37.12 51.69 36.44 52.20 24.38 35.62 54.19 24.50 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 4 3 # 4 A 170 SER A 83 SER^? 32.41 MG MG A 301 A 239 VAL A 77 VAL^? 24.44 MG MG A 301 A 413 ASN A 85 ASN^? 29.83 MG MG A 301 coo 80.14 40.76 52.28 77.73 40.59 51.94 30.60 55.84 24.53 32.97 55.99 23.96 coo 75.67 35.37 52.30 76.00 35.96 50.23 34.53 49.94 28.93 36.29 50.93 29.74 coo 81.75 35.21 52.13 80.92 37.12 51.69 36.44 52.20 24.38 35.62 54.19 24.50 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 5 3 # 5 A 170 SER A 105 SER^? 36.93 MG MG A 301 A 239 VAL A 108 VAL^? 27.28 MG MG A 301 A 413 ASN A 104 ASN^? 31.44 MG MG A 301 coo 80.14 40.76 52.28 77.73 40.59 51.94 58.68 0.04 31.71 59.83 -1.21 33.39 coo 75.67 35.37 52.30 76.00 35.96 50.23 55.06 7.72 31.92 55.04 9.26 30.34 coo 81.75 35.21 52.13 80.92 37.12 51.69 58.56 3.32 34.63 56.45 3.24 34.31 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 6 3 # 6 A 170 SER A 113 SER^? 12.78 MG MG A 301 A 239 VAL A 97 VAL^? 15.35 MG MG A 301 A 413 ASN A 95 ASN^? 11.82 MG MG A 301 coo 80.14 40.76 52.28 77.73 40.59 51.94 50.46 23.17 35.47 52.68 22.78 36.32 coo 75.67 35.37 52.30 76.00 35.96 50.23 53.92 23.93 31.23 55.30 24.92 32.57 coo 81.75 35.21 52.13 80.92 37.12 51.69 53.15 30.26 34.15 54.71 31.63 34.63 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 7 3 # 7 A 170 SER A 115 SER^? 6.34 MG MG A 301 A 239 VAL A 97 VAL^? 15.35 MG MG A 301 A 413 ASN A 95 ASN^? 11.82 MG MG A 301 coo 80.14 40.76 52.28 77.73 40.59 51.94 48.89 29.76 35.69 49.85 31.26 37.35 coo 75.67 35.37 52.30 76.00 35.96 50.23 53.92 23.93 31.23 55.30 24.92 32.57 coo 81.75 35.21 52.13 80.92 37.12 51.69 53.15 30.26 34.15 54.71 31.63 34.63 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 8 3 # 8 A 170 SER A 117 SER^? 9.60 MG MG A 301 A 239 VAL A 122 VAL^? 13.39 MG MG A 301 A 413 ASN A 118 ASN^? 13.27 MG MG A 301 coo 80.14 40.76 52.28 77.73 40.59 51.94 46.51 36.12 34.76 48.66 37.10 34.49 coo 75.67 35.37 52.30 76.00 35.96 50.23 46.72 43.52 36.89 48.81 44.16 36.44 coo 81.75 35.21 52.13 80.92 37.12 51.69 43.06 39.25 33.60 42.05 40.75 32.42 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 9 3 # 9 A 170 SER B 66 SER^? 21.21 MG MG B 302 A 239 VAL B 56 VAL^? 25.85 MG MG B 302 A 413 ASN A 45 ASN^? 24.62 MG MG B 302 coo 80.14 40.76 52.28 77.73 40.59 51.94 44.21 30.46 12.82 45.29 32.17 11.68 coo 75.67 35.37 52.30 76.00 35.96 50.23 38.20 29.23 12.75 38.04 28.49 14.74 coo 81.75 35.21 52.13 80.92 37.12 51.69 42.72 26.12 17.32 44.44 25.00 17.78 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 10 3 # 10 A 170 SER B 83 SER^? 24.53 MG MG C 301 A 239 VAL B 77 VAL^? 19.17 MG MG C 301 A 413 ASN B 85 ASN^? 20.68 MG MG C 301 coo 80.14 40.76 52.28 77.73 40.59 51.94 75.19 1.98 12.89 77.54 2.36 12.62 coo 75.67 35.37 52.30 76.00 35.96 50.23 71.13 7.26 8.54 72.49 8.75 7.68 coo 81.75 35.21 52.13 80.92 37.12 51.69 73.33 8.76 12.96 74.70 9.19 14.54 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 11 3 # 11 A 170 SER B 105 SER^? 35.94 MG MG B 302 A 239 VAL B 108 VAL^? 27.21 MG MG B 302 A 413 ASN B 104 ASN^? 29.09 MG MG B 302 coo 80.14 40.76 52.28 77.73 40.59 51.94 27.02 40.56 4.17 25.36 40.23 2.44 coo 75.67 35.37 52.30 76.00 35.96 50.23 33.40 35.67 4.87 34.73 35.30 6.57 coo 81.75 35.21 52.13 80.92 37.12 51.69 30.21 38.92 1.75 31.47 37.16 1.65 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 12 3 # 12 A 170 SER B 115 SER^? 6.48 MG MG B 302 A 239 VAL B 97 VAL^? 15.24 MG MG B 302 A 413 ASN B 95 ASN^? 11.72 MG MG B 302 coo 80.14 40.76 52.28 77.73 40.59 51.94 54.36 25.96 2.48 56.06 26.75 0.95 coo 75.67 35.37 52.30 76.00 35.96 50.23 49.14 31.55 6.72 50.67 32.74 5.69 coo 81.75 35.21 52.13 80.92 37.12 51.69 55.48 29.92 4.32 57.36 30.88 4.11 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 13 3 # 13 A 170 SER B 117 SER^? 9.14 MG MG B 302 A 239 VAL B 122 VAL^? 11.03 MG MG C 302 A 413 ASN B 118 ASN^? 13.44 MG MG B 302 coo 80.14 40.76 52.28 77.73 40.59 51.94 60.50 22.87 3.68 61.23 25.10 3.08 coo 75.67 35.37 52.30 76.00 35.96 50.23 67.59 23.75 2.30 68.60 25.61 3.00 coo 81.75 35.21 52.13 80.92 37.12 51.69 63.19 18.87 4.27 64.22 17.47 5.51 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 14 3 # 14 A 170 SER C 66 SER^? 20.91 MG MG C 302 A 239 VAL C 56 VAL^? 25.60 MG MG C 302 A 413 ASN D 45 ASN^? 24.33 MG MG C 302 coo 80.14 40.76 52.28 77.73 40.59 51.94 85.39 37.79 -19.17 83.53 38.71 -18.09 coo 75.67 35.37 52.30 76.00 35.96 50.23 91.33 38.54 -19.27 91.84 37.90 -21.25 coo 81.75 35.21 52.13 80.92 37.12 51.69 88.35 34.04 -23.87 86.82 32.62 -24.25 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 15 3 # 15 A 170 SER C 79 SER^? 19.92 MG MG B 301 A 239 VAL C 77 VAL^? 19.30 MG MG B 301 A 413 ASN C 85 ASN^? 21.44 MG MG B 301 coo 80.14 40.76 52.28 77.73 40.59 51.94 64.38 1.95 -14.66 62.69 3.45 -15.45 coo 75.67 35.37 52.30 76.00 35.96 50.23 68.24 6.87 -15.11 66.49 7.98 -14.47 coo 81.75 35.21 52.13 80.92 37.12 51.69 65.37 7.26 -19.82 63.94 6.11 -20.94 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 16 3 # 16 A 170 SER C 79 SER^? 19.92 MG MG B 301 A 239 VAL C 84 VAL^? 25.39 MG MG B 301 A 413 ASN C 85 ASN^? 21.44 MG MG B 301 coo 80.14 40.76 52.28 77.73 40.59 51.94 64.38 1.95 -14.66 62.69 3.45 -15.45 coo 75.67 35.37 52.30 76.00 35.96 50.23 67.88 3.44 -19.60 69.83 2.65 -20.37 coo 81.75 35.21 52.13 80.92 37.12 51.69 65.37 7.26 -19.82 63.94 6.11 -20.94 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 17 3 # 17 A 170 SER C 83 SER^? 23.40 MG MG B 301 A 239 VAL C 77 VAL^? 19.30 MG MG B 301 A 413 ASN C 85 ASN^? 21.44 MG MG B 301 coo 80.14 40.76 52.28 77.73 40.59 51.94 65.19 0.76 -19.73 62.87 1.43 -19.33 coo 75.67 35.37 52.30 76.00 35.96 50.23 68.24 6.87 -15.11 66.49 7.98 -14.47 coo 81.75 35.21 52.13 80.92 37.12 51.69 65.37 7.26 -19.82 63.94 6.11 -20.94 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 18 3 # 18 A 170 SER C 105 SER^? 36.42 MG MG C 302 A 239 VAL C 108 VAL^? 26.95 MG MG C 302 A 413 ASN C 104 ASN^? 31.05 MG MG C 302 coo 80.14 40.76 52.28 77.73 40.59 51.94 98.18 53.31 -11.48 99.44 54.08 -9.59 coo 75.67 35.37 52.30 76.00 35.96 50.23 93.61 46.17 -11.54 92.36 45.26 -13.13 coo 81.75 35.21 52.13 80.92 37.12 51.69 95.09 52.36 -8.91 95.46 50.61 -7.90 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 19 3 # 19 A 170 SER C 113 SER^? 12.16 MG MG C 302 A 239 VAL C 97 VAL^? 15.12 MG MG C 302 A 413 ASN C 95 ASN^? 11.50 MG MG C 302 coo 80.14 40.76 52.28 77.73 40.59 51.94 82.58 34.46 -8.42 81.10 36.27 -7.78 coo 75.67 35.37 52.30 76.00 35.96 50.23 80.64 36.81 -13.09 78.89 37.47 -11.89 coo 81.75 35.21 52.13 80.92 37.12 51.69 75.34 33.15 -10.39 73.27 33.38 -10.21 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 20 3 # 20 A 170 SER C 115 SER^? 5.99 MG MG C 302 A 239 VAL C 97 VAL^? 15.12 MG MG C 302 A 413 ASN C 95 ASN^? 11.50 MG MG C 302 coo 80.14 40.76 52.28 77.73 40.59 51.94 77.67 29.66 -8.53 76.02 29.92 -6.77 coo 75.67 35.37 52.30 76.00 35.96 50.23 80.64 36.81 -13.09 78.89 37.47 -11.89 coo 81.75 35.21 52.13 80.92 37.12 51.69 75.34 33.15 -10.39 73.27 33.38 -10.21 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 21 3 # 21 A 170 SER C 117 SER^? 8.92 MG MG C 302 A 239 VAL C 122 VAL^? 10.15 MG MG B 302 A 413 ASN C 118 ASN^? 13.08 MG MG C 302 coo 80.14 40.76 52.28 77.73 40.59 51.94 72.96 24.67 -9.95 71.40 26.26 -9.18 coo 75.67 35.37 52.30 76.00 35.96 50.23 66.23 20.18 -7.37 64.15 20.82 -7.67 coo 81.75 35.21 52.13 80.92 37.12 51.69 72.64 19.83 -10.69 72.07 18.17 -11.94 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 22 3 # 22 A 170 SER D 66 SER^? 21.51 MG MG D 302 A 239 VAL D 56 VAL^? 25.88 MG MG D 302 A 413 ASN C 45 ASN^? 24.54 MG MG C 302 coo 80.14 40.76 52.28 77.73 40.59 51.94 81.04 24.82 -31.14 78.93 25.00 -32.28 coo 75.67 35.37 52.30 76.00 35.96 50.23 85.31 20.38 -30.80 85.92 20.73 -28.73 coo 81.75 35.21 52.13 80.92 37.12 51.69 85.43 25.82 -26.31 85.43 27.91 -25.97 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 23 3 # 23 A 170 SER D 83 SER^? 23.07 MG MG E 301 A 239 VAL D 77 VAL^? 18.56 MG MG E 301 A 413 ASN D 85 ASN^? 20.22 MG MG E 301 coo 80.14 40.76 52.28 77.73 40.59 51.94 89.47 66.32 -31.33 87.79 67.80 -32.19 coo 75.67 35.37 52.30 76.00 35.96 50.23 87.45 59.70 -35.75 85.53 60.01 -36.78 coo 81.75 35.21 52.13 80.92 37.12 51.69 84.79 61.03 -31.29 84.23 62.62 -30.02 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 24 3 # 24 A 170 SER D 105 SER^? 37.56 MG MG D 302 A 239 VAL D 108 VAL^? 27.35 MG MG D 302 A 413 ASN D 104 ASN^? 31.04 MG MG D 302 coo 80.14 40.76 52.28 77.73 40.59 51.94 82.05 4.42 -38.94 83.24 2.29 -39.23 coo 75.67 35.37 52.30 76.00 35.96 50.23 82.79 12.78 -38.53 82.49 14.23 -36.90 coo 81.75 35.21 52.13 80.92 37.12 51.69 80.93 7.65 -41.49 82.88 8.50 -41.33 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 25 3 # 25 A 170 SER D 113 SER^? 11.39 MG MG D 302 A 239 VAL D 97 VAL^? 15.59 MG MG D 302 A 413 ASN D 95 ASN^? 12.56 MG MG D 302 coo 80.14 40.76 52.28 77.73 40.59 51.94 81.10 28.95 -41.82 79.08 29.86 -42.84 coo 75.67 35.37 52.30 76.00 35.96 50.23 78.03 28.42 -37.47 76.43 29.03 -38.84 coo 81.75 35.21 52.13 80.92 37.12 51.69 76.36 34.77 -40.14 74.34 35.29 -40.63 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 26 3 # 26 A 170 SER D 115 SER^? 7.08 MG MG D 302 A 239 VAL D 97 VAL^? 15.59 MG MG D 302 A 413 ASN D 95 ASN^? 12.56 MG MG D 302 coo 80.14 40.76 52.28 77.73 40.59 51.94 80.50 35.70 -41.83 78.94 36.81 -43.34 coo 75.67 35.37 52.30 76.00 35.96 50.23 78.03 28.42 -37.47 76.43 29.03 -38.84 coo 81.75 35.21 52.13 80.92 37.12 51.69 76.36 34.77 -40.14 74.34 35.29 -40.63 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 27 3 # 27 A 170 SER D 117 SER^? 9.64 MG MG D 302 A 239 VAL D 122 VAL^? 11.17 MG MG E 302 A 413 ASN D 118 ASN^? 13.31 MG MG D 302 coo 80.14 40.76 52.28 77.73 40.59 51.94 79.93 42.54 -40.62 77.69 42.23 -41.47 coo 75.67 35.37 52.30 76.00 35.96 50.23 75.72 48.13 -41.73 73.66 48.25 -40.90 coo 81.75 35.21 52.13 80.92 37.12 51.69 82.29 46.70 -39.94 83.03 48.22 -38.68 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 28 3 # 28 A 170 SER D 117 SER^? 9.64 MG MG D 302 A 239 VAL D 122 VAL^? 11.17 MG MG E 302 A 413 ASN D 121 ASN^? 14.25 MG MG E 302 coo 80.14 40.76 52.28 77.73 40.59 51.94 79.93 42.54 -40.62 77.69 42.23 -41.47 coo 75.67 35.37 52.30 76.00 35.96 50.23 75.72 48.13 -41.73 73.66 48.25 -40.90 coo 81.75 35.21 52.13 80.92 37.12 51.69 80.38 49.72 -41.99 81.55 51.54 -42.09 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 29 3 # 29 A 170 SER E 66 SER^? 21.23 MG MG E 302 A 239 VAL E 56 VAL^? 25.89 MG MG E 302 A 413 ASN F 45 ASN^? 24.43 MG MG E 302 coo 80.14 40.76 52.28 77.73 40.59 51.94 54.72 55.62 -63.56 54.90 53.49 -62.62 coo 75.67 35.37 52.30 76.00 35.96 50.23 50.96 60.53 -64.03 51.25 60.99 -66.05 coo 81.75 35.21 52.13 80.92 37.12 51.69 56.42 59.79 -68.43 58.48 59.32 -68.69 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 30 3 # 30 A 170 SER E 79 SER^? 19.77 MG MG D 301 A 239 VAL E 77 VAL^? 18.80 MG MG D 301 A 413 ASN E 85 ASN^? 18.39 MG MG D 301 coo 80.14 40.76 52.28 77.73 40.59 51.94 96.22 56.25 -58.39 95.94 54.06 -59.20 coo 75.67 35.37 52.30 76.00 35.96 50.23 90.04 56.55 -59.07 89.97 54.63 -58.04 coo 81.75 35.21 52.13 80.92 37.12 51.69 90.97 53.37 -63.23 89.62 51.76 -63.71 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 31 3 # 31 A 170 SER E 79 SER^? 19.77 MG MG D 301 A 239 VAL E 84 VAL^? 24.45 MG MG D 301 A 413 ASN E 85 ASN^? 18.39 MG MG D 301 coo 80.14 40.76 52.28 77.73 40.59 51.94 96.22 56.25 -58.39 95.94 54.06 -59.20 coo 75.67 35.37 52.30 76.00 35.96 50.23 93.10 57.56 -63.54 92.42 59.40 -64.54 coo 81.75 35.21 52.13 80.92 37.12 51.69 90.97 53.37 -63.23 89.62 51.76 -63.71 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 32 3 # 32 A 170 SER E 83 SER^? 23.44 MG MG D 301 A 239 VAL E 77 VAL^? 18.80 MG MG D 301 A 413 ASN E 85 ASN^? 18.39 MG MG D 301 coo 80.14 40.76 52.28 77.73 40.59 51.94 96.88 57.42 -63.66 97.96 55.45 -62.84 coo 75.67 35.37 52.30 76.00 35.96 50.23 90.04 56.55 -59.07 89.97 54.63 -58.04 coo 81.75 35.21 52.13 80.92 37.12 51.69 90.97 53.37 -63.23 89.62 51.76 -63.71 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 33 3 # 33 A 170 SER E 105 SER^? 37.13 MG MG E 302 A 239 VAL E 108 VAL^? 27.13 MG MG E 302 A 413 ASN E 104 ASN^? 31.37 MG MG E 302 coo 80.14 40.76 52.28 77.73 40.59 51.94 34.93 60.18 -56.74 32.96 59.33 -55.70 coo 75.67 35.37 52.30 76.00 35.96 50.23 43.16 59.43 -56.03 44.49 58.60 -57.60 coo 81.75 35.21 52.13 80.92 37.12 51.69 37.10 58.10 -53.77 38.39 59.70 -53.28 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 34 3 # 34 A 170 SER E 113 SER^? 12.49 MG MG E 302 A 239 VAL E 97 VAL^? 15.37 MG MG E 302 A 413 ASN E 95 ASN^? 11.73 MG MG E 302 coo 80.14 40.76 52.28 77.73 40.59 51.94 58.97 55.48 -52.80 57.49 54.03 -51.61 coo 75.67 35.37 52.30 76.00 35.96 50.23 57.80 52.34 -57.29 58.03 50.59 -55.98 coo 81.75 35.21 52.13 80.92 37.12 51.69 63.77 49.77 -54.50 64.30 47.82 -53.94 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 35 3 # 35 A 170 SER E 115 SER^? 6.17 MG MG E 302 A 239 VAL E 97 VAL^? 15.37 MG MG E 302 A 413 ASN E 95 ASN^? 11.73 MG MG E 302 coo 80.14 40.76 52.28 77.73 40.59 51.94 65.46 53.67 -52.76 66.19 52.26 -50.99 coo 75.67 35.37 52.30 76.00 35.96 50.23 57.80 52.34 -57.29 58.03 50.59 -55.98 coo 81.75 35.21 52.13 80.92 37.12 51.69 63.77 49.77 -54.50 64.30 47.82 -53.94 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 36 3 # 36 A 170 SER E 117 SER^? 9.12 MG MG E 302 A 239 VAL E 122 VAL^? 11.05 MG MG D 302 A 413 ASN E 118 ASN^? 13.13 MG MG E 302 coo 80.14 40.76 52.28 77.73 40.59 51.94 72.02 51.78 -53.96 71.28 49.71 -53.01 coo 75.67 35.37 52.30 76.00 35.96 50.23 79.05 49.32 -51.23 79.33 47.16 -51.56 coo 81.75 35.21 52.13 80.92 37.12 51.69 76.50 53.47 -54.63 78.11 53.97 -55.93 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 37 3 # 37 A 170 SER F 66 SER^? 21.35 MG MG F 301 A 239 VAL F 56 VAL^? 26.07 MG MG F 301 A 413 ASN E 45 ASN^? 24.46 MG MG F 301 coo 80.14 40.76 52.28 77.73 40.59 51.94 68.12 57.69 -75.42 68.70 55.68 -76.54 coo 75.67 35.37 52.30 76.00 35.96 50.23 69.93 63.52 -75.43 69.35 64.06 -73.41 coo 81.75 35.21 52.13 80.92 37.12 51.69 64.97 61.33 -71.05 63.29 60.06 -70.79 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 38 3 # 38 A 170 SER F 83 SER^? 33.16 MG MG F 301 A 239 VAL F 77 VAL^? 24.42 MG MG F 301 A 413 ASN F 85 ASN^? 27.49 MG MG F 301 coo 80.14 40.76 52.28 77.73 40.59 51.94 27.54 45.11 -75.18 28.33 43.06 -74.18 coo 75.67 35.37 52.30 76.00 35.96 50.23 34.29 46.26 -79.66 34.85 44.29 -80.54 coo 81.75 35.21 52.13 80.92 37.12 51.69 34.36 43.15 -75.19 36.11 42.05 -74.56 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 39 3 # 39 A 170 SER F 105 SER^? 35.88 MG MG F 301 A 239 VAL F 108 VAL^? 27.30 MG MG F 301 A 413 ASN F 104 ASN^? 31.05 MG MG F 301 coo 80.14 40.76 52.28 77.73 40.59 51.94 85.11 67.66 -83.88 85.77 68.77 -85.94 coo 75.67 35.37 52.30 76.00 35.96 50.23 77.71 64.56 -83.43 76.61 63.66 -81.75 coo 81.75 35.21 52.13 80.92 37.12 51.69 83.41 64.36 -86.23 81.96 65.80 -86.83 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 40 3 # 40 A 170 SER F 113 SER^? 11.59 MG MG F 301 A 239 VAL F 97 VAL^? 15.43 MG MG F 301 A 413 ASN F 95 ASN^? 12.10 MG MG F 301 coo 80.14 40.76 52.28 77.73 40.59 51.94 64.29 55.28 -86.32 64.81 52.88 -86.66 coo 75.67 35.37 52.30 76.00 35.96 50.23 66.34 53.03 -81.72 66.74 51.22 -82.97 coo 81.75 35.21 52.13 80.92 37.12 51.69 61.81 48.42 -84.18 62.16 46.40 -84.52 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 41 3 # 41 A 170 SER F 115 SER^? 6.67 MG MG F 301 A 239 VAL F 97 VAL^? 15.43 MG MG F 301 A 413 ASN F 95 ASN^? 12.10 MG MG F 301 coo 80.14 40.76 52.28 77.73 40.59 51.94 58.74 51.50 -86.07 58.73 49.57 -87.50 coo 75.67 35.37 52.30 76.00 35.96 50.23 66.34 53.03 -81.72 66.74 51.22 -82.97 coo 81.75 35.21 52.13 80.92 37.12 51.69 61.81 48.42 -84.18 62.16 46.40 -84.52 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 42 3 # 42 A 170 SER F 117 SER^? 9.96 MG MG F 301 A 239 VAL F 122 VAL^? 14.14 MG MG F 301 A 413 ASN F 118 ASN^? 13.34 MG MG F 301 coo 80.14 40.76 52.28 77.73 40.59 51.94 53.22 47.67 -84.89 54.09 45.48 -84.70 coo 75.67 35.37 52.30 76.00 35.96 50.23 50.21 40.95 -85.93 51.47 39.11 -85.51 coo 81.75 35.21 52.13 80.92 37.12 51.69 48.40 47.22 -84.16 46.70 46.61 -82.99 1oqz_c00 source 1oqz GLUTARYL ACYLASE : 42 hits 1oqz_c00 naa= 3 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 1 3 # 1 B 170 SER A 66 SER^? 21.38 MG MG A 301 B 239 VAL A 56 VAL^? 25.99 MG MG A 301 B 413 ASN B 45 ASN^? 24.27 MG MG A 301 coo 25.22 6.41 2.90 27.67 6.33 3.11 52.67 19.58 24.88 54.49 20.94 25.63 coo 29.71 1.00 2.66 29.43 1.57 4.74 50.16 14.03 24.08 49.56 14.13 21.99 coo 23.72 0.88 2.95 24.56 2.79 3.34 47.87 19.20 19.75 47.40 21.26 19.77 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 2 3 # 2 B 170 SER A 79 SER^? 29.65 MG MG A 301 B 239 VAL A 77 VAL^? 24.44 MG MG A 301 B 413 ASN A 85 ASN^? 29.83 MG MG A 301 coo 25.22 6.41 2.90 27.67 6.33 3.11 32.57 55.71 29.63 34.63 56.10 28.47 coo 29.71 1.00 2.66 29.43 1.57 4.74 34.53 49.94 28.93 36.29 50.93 29.74 coo 23.72 0.88 2.95 24.56 2.79 3.34 36.44 52.20 24.38 35.62 54.19 24.50 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 3 3 # 3 B 170 SER A 79 SER^? 29.65 MG MG A 301 B 239 VAL A 84 VAL^? 29.73 MG MG A 301 B 413 ASN A 85 ASN^? 29.83 MG MG A 301 coo 25.22 6.41 2.90 27.67 6.33 3.11 32.57 55.71 29.63 34.63 56.10 28.47 coo 29.71 1.00 2.66 29.43 1.57 4.74 31.80 52.18 24.62 30.40 50.56 24.01 coo 23.72 0.88 2.95 24.56 2.79 3.34 36.44 52.20 24.38 35.62 54.19 24.50 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 4 3 # 4 B 170 SER A 83 SER^? 32.41 MG MG A 301 B 239 VAL A 77 VAL^? 24.44 MG MG A 301 B 413 ASN A 85 ASN^? 29.83 MG MG A 301 coo 25.22 6.41 2.90 27.67 6.33 3.11 30.60 55.84 24.53 32.97 55.99 23.96 coo 29.71 1.00 2.66 29.43 1.57 4.74 34.53 49.94 28.93 36.29 50.93 29.74 coo 23.72 0.88 2.95 24.56 2.79 3.34 36.44 52.20 24.38 35.62 54.19 24.50 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 5 3 # 5 B 170 SER A 105 SER^? 36.93 MG MG A 301 B 239 VAL A 108 VAL^? 27.28 MG MG A 301 B 413 ASN A 104 ASN^? 31.44 MG MG A 301 coo 25.22 6.41 2.90 27.67 6.33 3.11 58.68 0.04 31.71 59.83 -1.21 33.39 coo 29.71 1.00 2.66 29.43 1.57 4.74 55.06 7.72 31.92 55.04 9.26 30.34 coo 23.72 0.88 2.95 24.56 2.79 3.34 58.56 3.32 34.63 56.45 3.24 34.31 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 6 3 # 6 B 170 SER A 113 SER^? 12.78 MG MG A 301 B 239 VAL A 97 VAL^? 15.35 MG MG A 301 B 413 ASN A 95 ASN^? 11.82 MG MG A 301 coo 25.22 6.41 2.90 27.67 6.33 3.11 50.46 23.17 35.47 52.68 22.78 36.32 coo 29.71 1.00 2.66 29.43 1.57 4.74 53.92 23.93 31.23 55.30 24.92 32.57 coo 23.72 0.88 2.95 24.56 2.79 3.34 53.15 30.26 34.15 54.71 31.63 34.63 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 7 3 # 7 B 170 SER A 115 SER^? 6.34 MG MG A 301 B 239 VAL A 97 VAL^? 15.35 MG MG A 301 B 413 ASN A 95 ASN^? 11.82 MG MG A 301 coo 25.22 6.41 2.90 27.67 6.33 3.11 48.89 29.76 35.69 49.85 31.26 37.35 coo 29.71 1.00 2.66 29.43 1.57 4.74 53.92 23.93 31.23 55.30 24.92 32.57 coo 23.72 0.88 2.95 24.56 2.79 3.34 53.15 30.26 34.15 54.71 31.63 34.63 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 8 3 # 8 B 170 SER A 117 SER^? 9.60 MG MG A 301 B 239 VAL A 122 VAL^? 13.39 MG MG A 301 B 413 ASN A 118 ASN^? 13.27 MG MG A 301 coo 25.22 6.41 2.90 27.67 6.33 3.11 46.51 36.12 34.76 48.66 37.10 34.49 coo 29.71 1.00 2.66 29.43 1.57 4.74 46.72 43.52 36.89 48.81 44.16 36.44 coo 23.72 0.88 2.95 24.56 2.79 3.34 43.06 39.25 33.60 42.05 40.75 32.42 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 9 3 # 9 B 170 SER B 66 SER^? 21.21 MG MG B 302 B 239 VAL B 56 VAL^? 25.85 MG MG B 302 B 413 ASN A 45 ASN^? 24.62 MG MG B 302 coo 25.22 6.41 2.90 27.67 6.33 3.11 44.21 30.46 12.82 45.29 32.17 11.68 coo 29.71 1.00 2.66 29.43 1.57 4.74 38.20 29.23 12.75 38.04 28.49 14.74 coo 23.72 0.88 2.95 24.56 2.79 3.34 42.72 26.12 17.32 44.44 25.00 17.78 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 10 3 # 10 B 170 SER B 83 SER^? 24.53 MG MG C 301 B 239 VAL B 77 VAL^? 19.17 MG MG C 301 B 413 ASN B 85 ASN^? 20.68 MG MG C 301 coo 25.22 6.41 2.90 27.67 6.33 3.11 75.19 1.98 12.89 77.54 2.36 12.62 coo 29.71 1.00 2.66 29.43 1.57 4.74 71.13 7.26 8.54 72.49 8.75 7.68 coo 23.72 0.88 2.95 24.56 2.79 3.34 73.33 8.76 12.96 74.70 9.19 14.54 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 11 3 # 11 B 170 SER B 105 SER^? 35.94 MG MG B 302 B 239 VAL B 108 VAL^? 27.21 MG MG B 302 B 413 ASN B 104 ASN^? 29.09 MG MG B 302 coo 25.22 6.41 2.90 27.67 6.33 3.11 27.02 40.56 4.17 25.36 40.23 2.44 coo 29.71 1.00 2.66 29.43 1.57 4.74 33.40 35.67 4.87 34.73 35.30 6.57 coo 23.72 0.88 2.95 24.56 2.79 3.34 30.21 38.92 1.75 31.47 37.16 1.65 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 12 3 # 12 B 170 SER B 115 SER^? 6.48 MG MG B 302 B 239 VAL B 97 VAL^? 15.24 MG MG B 302 B 413 ASN B 95 ASN^? 11.72 MG MG B 302 coo 25.22 6.41 2.90 27.67 6.33 3.11 54.36 25.96 2.48 56.06 26.75 0.95 coo 29.71 1.00 2.66 29.43 1.57 4.74 49.14 31.55 6.72 50.67 32.74 5.69 coo 23.72 0.88 2.95 24.56 2.79 3.34 55.48 29.92 4.32 57.36 30.88 4.11 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 13 3 # 13 B 170 SER B 117 SER^? 9.14 MG MG B 302 B 239 VAL B 122 VAL^? 11.03 MG MG C 302 B 413 ASN B 118 ASN^? 13.44 MG MG B 302 coo 25.22 6.41 2.90 27.67 6.33 3.11 60.50 22.87 3.68 61.23 25.10 3.08 coo 29.71 1.00 2.66 29.43 1.57 4.74 67.59 23.75 2.30 68.60 25.61 3.00 coo 23.72 0.88 2.95 24.56 2.79 3.34 63.19 18.87 4.27 64.22 17.47 5.51 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 14 3 # 14 B 170 SER C 66 SER^? 20.91 MG MG C 302 B 239 VAL C 56 VAL^? 25.60 MG MG C 302 B 413 ASN D 45 ASN^? 24.33 MG MG C 302 coo 25.22 6.41 2.90 27.67 6.33 3.11 85.39 37.79 -19.17 83.53 38.71 -18.09 coo 29.71 1.00 2.66 29.43 1.57 4.74 91.33 38.54 -19.27 91.84 37.90 -21.25 coo 23.72 0.88 2.95 24.56 2.79 3.34 88.35 34.04 -23.87 86.82 32.62 -24.25 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 15 3 # 15 B 170 SER C 79 SER^? 19.92 MG MG B 301 B 239 VAL C 77 VAL^? 19.30 MG MG B 301 B 413 ASN C 85 ASN^? 21.44 MG MG B 301 coo 25.22 6.41 2.90 27.67 6.33 3.11 64.38 1.95 -14.66 62.69 3.45 -15.45 coo 29.71 1.00 2.66 29.43 1.57 4.74 68.24 6.87 -15.11 66.49 7.98 -14.47 coo 23.72 0.88 2.95 24.56 2.79 3.34 65.37 7.26 -19.82 63.94 6.11 -20.94 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 16 3 # 16 B 170 SER C 79 SER^? 19.92 MG MG B 301 B 239 VAL C 84 VAL^? 25.39 MG MG B 301 B 413 ASN C 85 ASN^? 21.44 MG MG B 301 coo 25.22 6.41 2.90 27.67 6.33 3.11 64.38 1.95 -14.66 62.69 3.45 -15.45 coo 29.71 1.00 2.66 29.43 1.57 4.74 67.88 3.44 -19.60 69.83 2.65 -20.37 coo 23.72 0.88 2.95 24.56 2.79 3.34 65.37 7.26 -19.82 63.94 6.11 -20.94 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 17 3 # 17 B 170 SER C 83 SER^? 23.40 MG MG B 301 B 239 VAL C 77 VAL^? 19.30 MG MG B 301 B 413 ASN C 85 ASN^? 21.44 MG MG B 301 coo 25.22 6.41 2.90 27.67 6.33 3.11 65.19 0.76 -19.73 62.87 1.43 -19.33 coo 29.71 1.00 2.66 29.43 1.57 4.74 68.24 6.87 -15.11 66.49 7.98 -14.47 coo 23.72 0.88 2.95 24.56 2.79 3.34 65.37 7.26 -19.82 63.94 6.11 -20.94 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 18 3 # 18 B 170 SER C 105 SER^? 36.42 MG MG C 302 B 239 VAL C 108 VAL^? 26.95 MG MG C 302 B 413 ASN C 104 ASN^? 31.05 MG MG C 302 coo 25.22 6.41 2.90 27.67 6.33 3.11 98.18 53.31 -11.48 99.44 54.08 -9.59 coo 29.71 1.00 2.66 29.43 1.57 4.74 93.61 46.17 -11.54 92.36 45.26 -13.13 coo 23.72 0.88 2.95 24.56 2.79 3.34 95.09 52.36 -8.91 95.46 50.61 -7.90 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 19 3 # 19 B 170 SER C 113 SER^? 12.16 MG MG C 302 B 239 VAL C 97 VAL^? 15.12 MG MG C 302 B 413 ASN C 95 ASN^? 11.50 MG MG C 302 coo 25.22 6.41 2.90 27.67 6.33 3.11 82.58 34.46 -8.42 81.10 36.27 -7.78 coo 29.71 1.00 2.66 29.43 1.57 4.74 80.64 36.81 -13.09 78.89 37.47 -11.89 coo 23.72 0.88 2.95 24.56 2.79 3.34 75.34 33.15 -10.39 73.27 33.38 -10.21 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 20 3 # 20 B 170 SER C 115 SER^? 5.99 MG MG C 302 B 239 VAL C 97 VAL^? 15.12 MG MG C 302 B 413 ASN C 95 ASN^? 11.50 MG MG C 302 coo 25.22 6.41 2.90 27.67 6.33 3.11 77.67 29.66 -8.53 76.02 29.92 -6.77 coo 29.71 1.00 2.66 29.43 1.57 4.74 80.64 36.81 -13.09 78.89 37.47 -11.89 coo 23.72 0.88 2.95 24.56 2.79 3.34 75.34 33.15 -10.39 73.27 33.38 -10.21 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 21 3 # 21 B 170 SER C 117 SER^? 8.92 MG MG C 302 B 239 VAL C 122 VAL^? 10.15 MG MG B 302 B 413 ASN C 118 ASN^? 13.08 MG MG C 302 coo 25.22 6.41 2.90 27.67 6.33 3.11 72.96 24.67 -9.95 71.40 26.26 -9.18 coo 29.71 1.00 2.66 29.43 1.57 4.74 66.23 20.18 -7.37 64.15 20.82 -7.67 coo 23.72 0.88 2.95 24.56 2.79 3.34 72.64 19.83 -10.69 72.07 18.17 -11.94 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 22 3 # 22 B 170 SER D 66 SER^? 21.51 MG MG D 302 B 239 VAL D 56 VAL^? 25.88 MG MG D 302 B 413 ASN C 45 ASN^? 24.54 MG MG C 302 coo 25.22 6.41 2.90 27.67 6.33 3.11 81.04 24.82 -31.14 78.93 25.00 -32.28 coo 29.71 1.00 2.66 29.43 1.57 4.74 85.31 20.38 -30.80 85.92 20.73 -28.73 coo 23.72 0.88 2.95 24.56 2.79 3.34 85.43 25.82 -26.31 85.43 27.91 -25.97 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 23 3 # 23 B 170 SER D 83 SER^? 23.07 MG MG E 301 B 239 VAL D 77 VAL^? 18.56 MG MG E 301 B 413 ASN D 85 ASN^? 20.22 MG MG E 301 coo 25.22 6.41 2.90 27.67 6.33 3.11 89.47 66.32 -31.33 87.79 67.80 -32.19 coo 29.71 1.00 2.66 29.43 1.57 4.74 87.45 59.70 -35.75 85.53 60.01 -36.78 coo 23.72 0.88 2.95 24.56 2.79 3.34 84.79 61.03 -31.29 84.23 62.62 -30.02 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 24 3 # 24 B 170 SER D 105 SER^? 37.56 MG MG D 302 B 239 VAL D 108 VAL^? 27.35 MG MG D 302 B 413 ASN D 104 ASN^? 31.04 MG MG D 302 coo 25.22 6.41 2.90 27.67 6.33 3.11 82.05 4.42 -38.94 83.24 2.29 -39.23 coo 29.71 1.00 2.66 29.43 1.57 4.74 82.79 12.78 -38.53 82.49 14.23 -36.90 coo 23.72 0.88 2.95 24.56 2.79 3.34 80.93 7.65 -41.49 82.88 8.50 -41.33 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 25 3 # 25 B 170 SER D 113 SER^? 11.39 MG MG D 302 B 239 VAL D 97 VAL^? 15.59 MG MG D 302 B 413 ASN D 95 ASN^? 12.56 MG MG D 302 coo 25.22 6.41 2.90 27.67 6.33 3.11 81.10 28.95 -41.82 79.08 29.86 -42.84 coo 29.71 1.00 2.66 29.43 1.57 4.74 78.03 28.42 -37.47 76.43 29.03 -38.84 coo 23.72 0.88 2.95 24.56 2.79 3.34 76.36 34.77 -40.14 74.34 35.29 -40.63 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 26 3 # 26 B 170 SER D 115 SER^? 7.08 MG MG D 302 B 239 VAL D 97 VAL^? 15.59 MG MG D 302 B 413 ASN D 95 ASN^? 12.56 MG MG D 302 coo 25.22 6.41 2.90 27.67 6.33 3.11 80.50 35.70 -41.83 78.94 36.81 -43.34 coo 29.71 1.00 2.66 29.43 1.57 4.74 78.03 28.42 -37.47 76.43 29.03 -38.84 coo 23.72 0.88 2.95 24.56 2.79 3.34 76.36 34.77 -40.14 74.34 35.29 -40.63 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 27 3 # 27 B 170 SER D 117 SER^? 9.64 MG MG D 302 B 239 VAL D 122 VAL^? 11.17 MG MG E 302 B 413 ASN D 118 ASN^? 13.31 MG MG D 302 coo 25.22 6.41 2.90 27.67 6.33 3.11 79.93 42.54 -40.62 77.69 42.23 -41.47 coo 29.71 1.00 2.66 29.43 1.57 4.74 75.72 48.13 -41.73 73.66 48.25 -40.90 coo 23.72 0.88 2.95 24.56 2.79 3.34 82.29 46.70 -39.94 83.03 48.22 -38.68 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 28 3 # 28 B 170 SER D 117 SER^? 9.64 MG MG D 302 B 239 VAL D 122 VAL^? 11.17 MG MG E 302 B 413 ASN D 121 ASN^? 14.25 MG MG E 302 coo 25.22 6.41 2.90 27.67 6.33 3.11 79.93 42.54 -40.62 77.69 42.23 -41.47 coo 29.71 1.00 2.66 29.43 1.57 4.74 75.72 48.13 -41.73 73.66 48.25 -40.90 coo 23.72 0.88 2.95 24.56 2.79 3.34 80.38 49.72 -41.99 81.55 51.54 -42.09 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 29 3 # 29 B 170 SER E 66 SER^? 21.23 MG MG E 302 B 239 VAL E 56 VAL^? 25.89 MG MG E 302 B 413 ASN F 45 ASN^? 24.43 MG MG E 302 coo 25.22 6.41 2.90 27.67 6.33 3.11 54.72 55.62 -63.56 54.90 53.49 -62.62 coo 29.71 1.00 2.66 29.43 1.57 4.74 50.96 60.53 -64.03 51.25 60.99 -66.05 coo 23.72 0.88 2.95 24.56 2.79 3.34 56.42 59.79 -68.43 58.48 59.32 -68.69 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 30 3 # 30 B 170 SER E 79 SER^? 19.77 MG MG D 301 B 239 VAL E 77 VAL^? 18.80 MG MG D 301 B 413 ASN E 85 ASN^? 18.39 MG MG D 301 coo 25.22 6.41 2.90 27.67 6.33 3.11 96.22 56.25 -58.39 95.94 54.06 -59.20 coo 29.71 1.00 2.66 29.43 1.57 4.74 90.04 56.55 -59.07 89.97 54.63 -58.04 coo 23.72 0.88 2.95 24.56 2.79 3.34 90.97 53.37 -63.23 89.62 51.76 -63.71 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 31 3 # 31 B 170 SER E 79 SER^? 19.77 MG MG D 301 B 239 VAL E 84 VAL^? 24.45 MG MG D 301 B 413 ASN E 85 ASN^? 18.39 MG MG D 301 coo 25.22 6.41 2.90 27.67 6.33 3.11 96.22 56.25 -58.39 95.94 54.06 -59.20 coo 29.71 1.00 2.66 29.43 1.57 4.74 93.10 57.56 -63.54 92.42 59.40 -64.54 coo 23.72 0.88 2.95 24.56 2.79 3.34 90.97 53.37 -63.23 89.62 51.76 -63.71 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 32 3 # 32 B 170 SER E 83 SER^? 23.44 MG MG D 301 B 239 VAL E 77 VAL^? 18.80 MG MG D 301 B 413 ASN E 85 ASN^? 18.39 MG MG D 301 coo 25.22 6.41 2.90 27.67 6.33 3.11 96.88 57.42 -63.66 97.96 55.45 -62.84 coo 29.71 1.00 2.66 29.43 1.57 4.74 90.04 56.55 -59.07 89.97 54.63 -58.04 coo 23.72 0.88 2.95 24.56 2.79 3.34 90.97 53.37 -63.23 89.62 51.76 -63.71 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 33 3 # 33 B 170 SER E 105 SER^? 37.13 MG MG E 302 B 239 VAL E 108 VAL^? 27.13 MG MG E 302 B 413 ASN E 104 ASN^? 31.37 MG MG E 302 coo 25.22 6.41 2.90 27.67 6.33 3.11 34.93 60.18 -56.74 32.96 59.33 -55.70 coo 29.71 1.00 2.66 29.43 1.57 4.74 43.16 59.43 -56.03 44.49 58.60 -57.60 coo 23.72 0.88 2.95 24.56 2.79 3.34 37.10 58.10 -53.77 38.39 59.70 -53.28 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 34 3 # 34 B 170 SER E 113 SER^? 12.49 MG MG E 302 B 239 VAL E 97 VAL^? 15.37 MG MG E 302 B 413 ASN E 95 ASN^? 11.73 MG MG E 302 coo 25.22 6.41 2.90 27.67 6.33 3.11 58.97 55.48 -52.80 57.49 54.03 -51.61 coo 29.71 1.00 2.66 29.43 1.57 4.74 57.80 52.34 -57.29 58.03 50.59 -55.98 coo 23.72 0.88 2.95 24.56 2.79 3.34 63.77 49.77 -54.50 64.30 47.82 -53.94 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 35 3 # 35 B 170 SER E 115 SER^? 6.17 MG MG E 302 B 239 VAL E 97 VAL^? 15.37 MG MG E 302 B 413 ASN E 95 ASN^? 11.73 MG MG E 302 coo 25.22 6.41 2.90 27.67 6.33 3.11 65.46 53.67 -52.76 66.19 52.26 -50.99 coo 29.71 1.00 2.66 29.43 1.57 4.74 57.80 52.34 -57.29 58.03 50.59 -55.98 coo 23.72 0.88 2.95 24.56 2.79 3.34 63.77 49.77 -54.50 64.30 47.82 -53.94 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 36 3 # 36 B 170 SER E 117 SER^? 9.12 MG MG E 302 B 239 VAL E 122 VAL^? 11.05 MG MG D 302 B 413 ASN E 118 ASN^? 13.13 MG MG E 302 coo 25.22 6.41 2.90 27.67 6.33 3.11 72.02 51.78 -53.96 71.28 49.71 -53.01 coo 29.71 1.00 2.66 29.43 1.57 4.74 79.05 49.32 -51.23 79.33 47.16 -51.56 coo 23.72 0.88 2.95 24.56 2.79 3.34 76.50 53.47 -54.63 78.11 53.97 -55.93 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 37 3 # 37 B 170 SER F 66 SER^? 21.35 MG MG F 301 B 239 VAL F 56 VAL^? 26.07 MG MG F 301 B 413 ASN E 45 ASN^? 24.46 MG MG F 301 coo 25.22 6.41 2.90 27.67 6.33 3.11 68.12 57.69 -75.42 68.70 55.68 -76.54 coo 29.71 1.00 2.66 29.43 1.57 4.74 69.93 63.52 -75.43 69.35 64.06 -73.41 coo 23.72 0.88 2.95 24.56 2.79 3.34 64.97 61.33 -71.05 63.29 60.06 -70.79 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 38 3 # 38 B 170 SER F 83 SER^? 33.16 MG MG F 301 B 239 VAL F 77 VAL^? 24.42 MG MG F 301 B 413 ASN F 85 ASN^? 27.49 MG MG F 301 coo 25.22 6.41 2.90 27.67 6.33 3.11 27.54 45.11 -75.18 28.33 43.06 -74.18 coo 29.71 1.00 2.66 29.43 1.57 4.74 34.29 46.26 -79.66 34.85 44.29 -80.54 coo 23.72 0.88 2.95 24.56 2.79 3.34 34.36 43.15 -75.19 36.11 42.05 -74.56 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 39 3 # 39 B 170 SER F 105 SER^? 35.88 MG MG F 301 B 239 VAL F 108 VAL^? 27.30 MG MG F 301 B 413 ASN F 104 ASN^? 31.05 MG MG F 301 coo 25.22 6.41 2.90 27.67 6.33 3.11 85.11 67.66 -83.88 85.77 68.77 -85.94 coo 29.71 1.00 2.66 29.43 1.57 4.74 77.71 64.56 -83.43 76.61 63.66 -81.75 coo 23.72 0.88 2.95 24.56 2.79 3.34 83.41 64.36 -86.23 81.96 65.80 -86.83 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 40 3 # 40 B 170 SER F 113 SER^? 11.59 MG MG F 301 B 239 VAL F 97 VAL^? 15.43 MG MG F 301 B 413 ASN F 95 ASN^? 12.10 MG MG F 301 coo 25.22 6.41 2.90 27.67 6.33 3.11 64.29 55.28 -86.32 64.81 52.88 -86.66 coo 29.71 1.00 2.66 29.43 1.57 4.74 66.34 53.03 -81.72 66.74 51.22 -82.97 coo 23.72 0.88 2.95 24.56 2.79 3.34 61.81 48.42 -84.18 62.16 46.40 -84.52 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 41 3 # 41 B 170 SER F 115 SER^? 6.67 MG MG F 301 B 239 VAL F 97 VAL^? 15.43 MG MG F 301 B 413 ASN F 95 ASN^? 12.10 MG MG F 301 coo 25.22 6.41 2.90 27.67 6.33 3.11 58.74 51.50 -86.07 58.73 49.57 -87.50 coo 29.71 1.00 2.66 29.43 1.57 4.74 66.34 53.03 -81.72 66.74 51.22 -82.97 coo 23.72 0.88 2.95 24.56 2.79 3.34 61.81 48.42 -84.18 62.16 46.40 -84.52 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 42 3 # 42 B 170 SER F 117 SER^? 9.96 MG MG F 301 B 239 VAL F 122 VAL^? 14.14 MG MG F 301 B 413 ASN F 118 ASN^? 13.34 MG MG F 301 coo 25.22 6.41 2.90 27.67 6.33 3.11 53.22 47.67 -84.89 54.09 45.48 -84.70 coo 29.71 1.00 2.66 29.43 1.57 4.74 50.21 40.95 -85.93 51.47 39.11 -85.51 coo 23.72 0.88 2.95 24.56 2.79 3.34 48.40 47.22 -84.16 46.70 46.61 -82.99 1oqz_c01 source 1oqz GLUTARYL ACYLASE : 42 hits 1oqz_c01 naa= 3 ULMN 3 1oyg_c00 LEVANSUCRASE user 1 3 # 1 A 86 ASP D 128 ASP^? -3.70 MG MG D 302s A 247 ASP D 187 ASP^? -2.95 MG MG D 301s A 342 GLU D 146 GLU^? 10.62 MG MG D 301 coo 44.36 35.68 9.71 43.29 36.20 11.51 83.33 35.45 -46.13 81.57 36.63 -46.10 coo 41.40 28.81 12.91 40.82 30.90 12.97 90.40 36.34 -52.69 89.24 37.98 -51.99 coo 40.37 33.11 18.06 39.99 34.93 17.06 87.24 28.82 -50.92 85.47 28.08 -51.67 ULMN 3 1oyg_c00 LEVANSUCRASE user 2 3 # 2 A 86 ASP F 128 ASP^? -3.41 MG MG F 301s A 247 ASP F 187 ASP^? -3.27 MG MG F 302s A 342 GLU F 146 GLU^? 10.36 MG MG F 302 coo 44.36 35.68 9.71 43.29 36.20 11.51 57.76 53.73 -90.50 57.46 51.64 -90.28 coo 41.40 28.81 12.91 40.82 30.90 12.97 53.93 58.87 -98.14 52.45 58.62 -96.61 coo 40.37 33.11 18.06 39.99 34.93 17.06 61.95 60.17 -95.28 62.87 58.56 -96.19 ULMN 3 1oyg_c00 LEVANSUCRASE user 3 3 # 3 A 86 ASP F 148 ASP^? 2.72 MG MG F 301s A 247 ASP F 187 ASP^? -3.27 MG MG F 302s A 342 GLU F 146 GLU^? 10.36 MG MG F 302 coo 44.36 35.68 9.71 43.29 36.20 11.51 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 41.40 28.81 12.91 40.82 30.90 12.97 53.93 58.87 -98.14 52.45 58.62 -96.61 coo 40.37 33.11 18.06 39.99 34.93 17.06 61.95 60.17 -95.28 62.87 58.56 -96.19 1oyg_c00 source 1oyg LEVANSUCRASE : 3 hits 1oyg_c00 naa= 3 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 1 3 # 1 A 102 ASP B 160 ASP^? 31.65 MG MG A 301 A 167 LYS B 6 LYS^? 25.90 MG MG B 302 A 201 LYS B 157 LYS^? 28.85 MG MG B 302 coo 26.53 8.31 20.37 28.45 8.41 19.40 28.01 24.83 16.38 27.44 26.81 15.80 coo 24.92 6.08 13.38 27.75 4.33 18.83 36.26 25.44 11.74 39.65 23.12 16.29 coo 29.08 5.53 11.69 30.46 5.61 17.93 34.97 21.28 8.44 29.03 22.82 6.58 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 2 3 # 2 A 102 ASP D 160 ASP^? 31.45 MG MG C 302 A 167 LYS D 6 LYS^? 25.98 MG MG D 302 A 201 LYS D 157 LYS^? 28.67 MG MG D 302 coo 26.53 8.31 20.37 28.45 8.41 19.40 94.15 13.98 -26.57 92.71 12.42 -26.99 coo 24.92 6.08 13.38 27.75 4.33 18.83 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 29.08 5.53 11.69 30.46 5.61 17.93 94.17 21.71 -34.34 96.11 15.89 -35.92 1p1x_c00 source 1p1x DEOXYRIBOSE-PHOSPHATE ALDOLASE : 2 hits 1p1x_c00 naa= 3 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 1 3 # 1 B1102 ASP B 160 ASP^? 31.65 MG MG A 301 B1167 LYS B 6 LYS^? 25.90 MG MG B 302 B1201 LYS B 157 LYS^? 28.85 MG MG B 302 coo 26.10 12.11 49.61 24.19 12.48 50.51 28.01 24.83 16.38 27.44 26.81 15.80 coo 27.70 11.69 56.92 24.82 8.55 52.12 36.26 25.44 11.74 39.65 23.12 16.29 coo 23.50 11.64 58.67 22.19 10.19 52.59 34.97 21.28 8.44 29.03 22.82 6.58 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 2 3 # 2 B1102 ASP D 160 ASP^? 31.45 MG MG C 302 B1167 LYS D 6 LYS^? 25.98 MG MG D 302 B1201 LYS D 157 LYS^? 28.67 MG MG D 302 coo 26.10 12.11 49.61 24.19 12.48 50.51 94.15 13.98 -26.57 92.71 12.42 -26.99 coo 27.70 11.69 56.92 24.82 8.55 52.12 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 23.50 11.64 58.67 22.19 10.19 52.59 94.17 21.71 -34.34 96.11 15.89 -35.92 1p1x_c01 source 1p1x DEOXYRIBOSE-PHOSPHATE ALDOLASE : 2 hits 1p1x_c01 naa= 3 ULMN 3 1pfq_c00 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 A 630 SER A 189 SER^? 11.75 MG MG A 302 A 708 ASP A 148 ASP^? 2.72 MG MG A 301s A 740 HIS A 147 HIS^? 9.20 MG MG A 302 coo -7.09 7.44 6.22 -7.53 5.14 5.59 40.99 19.00 44.32 41.51 18.14 46.48 coo -5.35 2.36 14.19 -6.28 2.60 12.26 41.50 28.88 41.13 43.33 29.67 41.93 coo -8.70 2.86 9.96 -8.03 3.92 8.29 40.24 23.10 39.83 38.32 22.34 40.22 ULMN 3 1pfq_c00 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 2 3 # 2 A 630 SER B 189 SER^? 12.11 MG MG B 301 A 708 ASP B 148 ASP^? 2.58 MG MG B 302s A 740 HIS B 147 HIS^? 9.27 MG MG B 301 coo -7.09 7.44 6.22 -7.53 5.14 5.59 43.10 20.95 -7.74 42.82 21.56 -10.02 coo -5.35 2.36 14.19 -6.28 2.60 12.26 52.73 19.23 -3.77 53.81 20.99 -4.31 coo -8.70 2.86 9.96 -8.03 3.92 8.29 46.73 18.97 -3.05 45.63 17.32 -3.73 ULMN 3 1pfq_c00 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 3 3 # 3 A 630 SER C 189 SER^? 12.09 MG MG C 301 A 708 ASP C 148 ASP^? 2.75 MG MG C 302s A 740 HIS C 147 HIS^? 9.44 MG MG C 301 coo -7.09 7.44 6.22 -7.53 5.14 5.59 90.33 28.79 1.19 90.26 29.61 3.45 coo -5.35 2.36 14.19 -6.28 2.60 12.26 81.96 23.83 -2.68 80.24 25.11 -2.27 coo -8.70 2.86 9.96 -8.03 3.92 8.29 87.61 25.71 -3.59 89.22 24.50 -2.99 ULMN 3 1pfq_c00 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 4 3 # 4 A 630 SER D 189 SER^? 12.12 MG MG D 301 A 708 ASP D 148 ASP^? 2.35 MG MG D 302s A 740 HIS D 147 HIS^? 9.43 MG MG D 301 coo -7.09 7.44 6.22 -7.53 5.14 5.59 91.62 28.58 -50.95 91.45 27.78 -53.25 coo -5.35 2.36 14.19 -6.28 2.60 12.26 87.78 37.50 -47.56 85.79 37.49 -48.28 coo -8.70 2.86 9.96 -8.03 3.92 8.29 90.95 32.51 -46.42 92.98 32.42 -46.93 ULMN 3 1pfq_c00 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 5 3 # 5 A 630 SER D 189 SER^? 12.12 MG MG D 301 A 708 ASP D 187 ASP^? -2.95 MG MG D 301s A 740 HIS D 147 HIS^? 9.43 MG MG D 301 coo -7.09 7.44 6.22 -7.53 5.14 5.59 91.62 28.58 -50.95 91.45 27.78 -53.25 coo -5.35 2.36 14.19 -6.28 2.60 12.26 90.40 36.34 -52.69 89.24 37.98 -51.99 coo -8.70 2.86 9.96 -8.03 3.92 8.29 90.95 32.51 -46.42 92.98 32.42 -46.93 ULMN 3 1pfq_c00 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 6 3 # 6 A 630 SER E 189 SER^? 11.91 MG MG E 301 A 708 ASP E 148 ASP^? 2.62 MG MG E 302s A 740 HIS E 147 HIS^? 9.22 MG MG E 301 coo -7.09 7.44 6.22 -7.53 5.14 5.59 60.13 65.61 -43.87 59.01 65.34 -41.74 coo -5.35 2.36 14.19 -6.28 2.60 12.26 68.29 60.44 -47.29 68.03 58.42 -46.50 coo -8.70 2.86 9.96 -8.03 3.92 8.29 63.87 64.43 -48.39 64.18 66.45 -47.92 ULMN 3 1pfq_c00 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 7 3 # 7 A 630 SER F 189 SER^? 11.88 MG MG F 302 A 708 ASP F 148 ASP^? 2.72 MG MG F 301s A 740 HIS F 147 HIS^? 8.79 MG MG F 302 coo -7.09 7.44 6.22 -7.53 5.14 5.59 59.91 63.90 -95.91 60.70 64.22 -98.13 coo -5.35 2.36 14.19 -6.28 2.60 12.26 53.64 56.47 -91.98 54.61 54.68 -92.64 coo -8.70 2.86 9.96 -8.03 3.92 8.29 56.63 61.66 -91.16 55.69 63.43 -91.80 1pfq_c00 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 7 hits 1pfq_c00 naa= 3 ULMN 3 1pfq_c01 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 B 630 SER A 189 SER^? 11.75 MG MG A 302 B 708 ASP A 148 ASP^? 2.72 MG MG A 301s B 740 HIS A 147 HIS^? 9.20 MG MG A 302 coo 4.44 13.29 37.64 6.01 11.66 38.49 40.99 19.00 44.32 41.51 18.14 46.48 coo 6.39 7.18 30.33 6.92 8.20 32.17 41.50 28.88 41.13 43.33 29.67 41.93 coo 8.57 10.09 34.47 7.10 10.73 35.82 40.24 23.10 39.83 38.32 22.34 40.22 ULMN 3 1pfq_c01 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 2 3 # 2 B 630 SER B 189 SER^? 12.11 MG MG B 301 B 708 ASP B 148 ASP^? 2.58 MG MG B 302s B 740 HIS B 147 HIS^? 9.27 MG MG B 301 coo 4.44 13.29 37.64 6.01 11.66 38.49 43.10 20.95 -7.74 42.82 21.56 -10.02 coo 6.39 7.18 30.33 6.92 8.20 32.17 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 8.57 10.09 34.47 7.10 10.73 35.82 46.73 18.97 -3.05 45.63 17.32 -3.73 ULMN 3 1pfq_c01 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 3 3 # 3 B 630 SER C 189 SER^? 12.09 MG MG C 301 B 708 ASP C 148 ASP^? 2.75 MG MG C 302s B 740 HIS C 147 HIS^? 9.44 MG MG C 301 coo 4.44 13.29 37.64 6.01 11.66 38.49 90.33 28.79 1.19 90.26 29.61 3.45 coo 6.39 7.18 30.33 6.92 8.20 32.17 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 8.57 10.09 34.47 7.10 10.73 35.82 87.61 25.71 -3.59 89.22 24.50 -2.99 ULMN 3 1pfq_c01 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 4 3 # 4 B 630 SER D 189 SER^? 12.12 MG MG D 301 B 708 ASP D 148 ASP^? 2.35 MG MG D 302s B 740 HIS D 147 HIS^? 9.43 MG MG D 301 coo 4.44 13.29 37.64 6.01 11.66 38.49 91.62 28.58 -50.95 91.45 27.78 -53.25 coo 6.39 7.18 30.33 6.92 8.20 32.17 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 8.57 10.09 34.47 7.10 10.73 35.82 90.95 32.51 -46.42 92.98 32.42 -46.93 ULMN 3 1pfq_c01 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 5 3 # 5 B 630 SER D 189 SER^? 12.12 MG MG D 301 B 708 ASP D 187 ASP^? -2.95 MG MG D 301s B 740 HIS D 147 HIS^? 9.43 MG MG D 301 coo 4.44 13.29 37.64 6.01 11.66 38.49 91.62 28.58 -50.95 91.45 27.78 -53.25 coo 6.39 7.18 30.33 6.92 8.20 32.17 90.40 36.34 -52.69 89.24 37.98 -51.99 coo 8.57 10.09 34.47 7.10 10.73 35.82 90.95 32.51 -46.42 92.98 32.42 -46.93 ULMN 3 1pfq_c01 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 6 3 # 6 B 630 SER E 189 SER^? 11.91 MG MG E 301 B 708 ASP E 148 ASP^? 2.62 MG MG E 302s B 740 HIS E 147 HIS^? 9.22 MG MG E 301 coo 4.44 13.29 37.64 6.01 11.66 38.49 60.13 65.61 -43.87 59.01 65.34 -41.74 coo 6.39 7.18 30.33 6.92 8.20 32.17 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 8.57 10.09 34.47 7.10 10.73 35.82 63.87 64.43 -48.39 64.18 66.45 -47.92 ULMN 3 1pfq_c01 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 7 3 # 7 B 630 SER F 189 SER^? 11.88 MG MG F 302 B 708 ASP F 148 ASP^? 2.72 MG MG F 301s B 740 HIS F 147 HIS^? 8.79 MG MG F 302 coo 4.44 13.29 37.64 6.01 11.66 38.49 59.91 63.90 -95.91 60.70 64.22 -98.13 coo 6.39 7.18 30.33 6.92 8.20 32.17 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 8.57 10.09 34.47 7.10 10.73 35.82 56.63 61.66 -91.16 55.69 63.43 -91.80 1pfq_c01 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 7 hits 1pfq_c01 naa= 3 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 A 630 SER A 189 SER^? 11.75 MG MG A 302 A 709 ASP A 128 ASP^? -3.32 MG MG A 301s A 740 HIS A 147 HIS^? 9.20 MG MG A 302 coo -7.09 7.44 6.22 -7.53 5.14 5.59 40.99 19.00 44.32 41.51 18.14 46.48 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 46.50 28.23 39.77 47.49 30.10 39.82 coo -8.70 2.86 9.96 -8.03 3.92 8.29 40.24 23.10 39.83 38.32 22.34 40.22 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 2 3 # 2 A 630 SER B 189 SER^? 12.11 MG MG B 301 A 709 ASP B 128 ASP^? -3.57 MG MG B 302s A 740 HIS B 147 HIS^? 9.27 MG MG B 301 coo -7.09 7.44 6.22 -7.53 5.14 5.59 43.10 20.95 -7.74 42.82 21.56 -10.02 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 52.92 24.09 -2.19 54.73 25.14 -1.90 coo -8.70 2.86 9.96 -8.03 3.92 8.29 46.73 18.97 -3.05 45.63 17.32 -3.73 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 3 3 # 3 A 630 SER C 189 SER^? 12.09 MG MG C 301 A 709 ASP C 128 ASP^? -3.22 MG MG C 302s A 740 HIS C 147 HIS^? 9.44 MG MG C 301 coo -7.09 7.44 6.22 -7.53 5.14 5.59 90.33 28.79 1.19 90.26 29.61 3.45 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 80.05 28.39 -4.25 77.97 28.60 -4.21 coo -8.70 2.86 9.96 -8.03 3.92 8.29 87.61 25.71 -3.59 89.22 24.50 -2.99 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 4 3 # 4 A 630 SER D 189 SER^? 12.12 MG MG D 301 A 709 ASP D 128 ASP^? -3.70 MG MG D 302s A 740 HIS D 147 HIS^? 9.43 MG MG D 301 coo -7.09 7.44 6.22 -7.53 5.14 5.59 91.62 28.58 -50.95 91.45 27.78 -53.25 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 83.33 35.45 -46.13 81.57 36.63 -46.10 coo -8.70 2.86 9.96 -8.03 3.92 8.29 90.95 32.51 -46.42 92.98 32.42 -46.93 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 5 3 # 5 A 630 SER E 189 SER^? 11.91 MG MG E 301 A 709 ASP E 128 ASP^? -3.53 MG MG E 302s A 740 HIS E 147 HIS^? 9.22 MG MG E 301 coo -7.09 7.44 6.22 -7.53 5.14 5.59 60.13 65.61 -43.87 59.01 65.34 -41.74 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 65.38 56.57 -48.58 66.15 54.57 -48.61 coo -8.70 2.86 9.96 -8.03 3.92 8.29 63.87 64.43 -48.39 64.18 66.45 -47.92 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 6 3 # 6 A 630 SER F 189 SER^? 11.88 MG MG F 302 A 709 ASP F 128 ASP^? -3.41 MG MG F 301s A 740 HIS F 147 HIS^? 8.79 MG MG F 302 coo -7.09 7.44 6.22 -7.53 5.14 5.59 59.91 63.90 -95.91 60.70 64.22 -98.13 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 57.76 53.73 -90.50 57.46 51.64 -90.28 coo -8.70 2.86 9.96 -8.03 3.92 8.29 56.63 61.66 -91.16 55.69 63.43 -91.80 1pfq_c02 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 6 hits 1pfq_c02 naa= 3 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 B 630 SER A 189 SER^? 11.75 MG MG A 302 B 709 ASP A 128 ASP^? -3.32 MG MG A 301s B 740 HIS A 147 HIS^? 9.20 MG MG A 302 coo 4.44 13.29 37.64 6.01 11.66 38.49 40.99 19.00 44.32 41.51 18.14 46.48 coo 10.26 2.81 31.69 11.64 4.30 32.43 46.50 28.23 39.77 47.49 30.10 39.82 coo 8.57 10.09 34.47 7.10 10.73 35.82 40.24 23.10 39.83 38.32 22.34 40.22 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 2 3 # 2 B 630 SER A 189 SER^? 11.75 MG MG A 302 B 709 ASP A 177 ASP^? 8.44 MG MG A 302 B 740 HIS A 147 HIS^? 9.20 MG MG A 302 coo 4.44 13.29 37.64 6.01 11.66 38.49 40.99 19.00 44.32 41.51 18.14 46.48 coo 10.26 2.81 31.69 11.64 4.30 32.43 33.02 29.04 43.18 33.79 27.88 44.78 coo 8.57 10.09 34.47 7.10 10.73 35.82 40.24 23.10 39.83 38.32 22.34 40.22 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 3 3 # 3 B 630 SER B 189 SER^? 12.11 MG MG B 301 B 709 ASP B 128 ASP^? -3.57 MG MG B 302s B 740 HIS B 147 HIS^? 9.27 MG MG B 301 coo 4.44 13.29 37.64 6.01 11.66 38.49 43.10 20.95 -7.74 42.82 21.56 -10.02 coo 10.26 2.81 31.69 11.64 4.30 32.43 52.92 24.09 -2.19 54.73 25.14 -1.90 coo 8.57 10.09 34.47 7.10 10.73 35.82 46.73 18.97 -3.05 45.63 17.32 -3.73 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 4 3 # 4 B 630 SER C 189 SER^? 12.09 MG MG C 301 B 709 ASP C 128 ASP^? -3.22 MG MG C 302s B 740 HIS C 147 HIS^? 9.44 MG MG C 301 coo 4.44 13.29 37.64 6.01 11.66 38.49 90.33 28.79 1.19 90.26 29.61 3.45 coo 10.26 2.81 31.69 11.64 4.30 32.43 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 8.57 10.09 34.47 7.10 10.73 35.82 87.61 25.71 -3.59 89.22 24.50 -2.99 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 5 3 # 5 B 630 SER D 189 SER^? 12.12 MG MG D 301 B 709 ASP D 128 ASP^? -3.70 MG MG D 302s B 740 HIS D 147 HIS^? 9.43 MG MG D 301 coo 4.44 13.29 37.64 6.01 11.66 38.49 91.62 28.58 -50.95 91.45 27.78 -53.25 coo 10.26 2.81 31.69 11.64 4.30 32.43 83.33 35.45 -46.13 81.57 36.63 -46.10 coo 8.57 10.09 34.47 7.10 10.73 35.82 90.95 32.51 -46.42 92.98 32.42 -46.93 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 6 3 # 6 B 630 SER E 189 SER^? 11.91 MG MG E 301 B 709 ASP E 128 ASP^? -3.53 MG MG E 302s B 740 HIS E 147 HIS^? 9.22 MG MG E 301 coo 4.44 13.29 37.64 6.01 11.66 38.49 60.13 65.61 -43.87 59.01 65.34 -41.74 coo 10.26 2.81 31.69 11.64 4.30 32.43 65.38 56.57 -48.58 66.15 54.57 -48.61 coo 8.57 10.09 34.47 7.10 10.73 35.82 63.87 64.43 -48.39 64.18 66.45 -47.92 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 7 3 # 7 B 630 SER E 189 SER^? 11.91 MG MG E 301 B 709 ASP E 177 ASP^? 8.55 MG MG E 301 B 740 HIS E 147 HIS^? 9.22 MG MG E 301 coo 4.44 13.29 37.64 6.01 11.66 38.49 60.13 65.61 -43.87 59.01 65.34 -41.74 coo 10.26 2.81 31.69 11.64 4.30 32.43 72.81 67.32 -45.03 71.14 67.96 -43.95 coo 8.57 10.09 34.47 7.10 10.73 35.82 63.87 64.43 -48.39 64.18 66.45 -47.92 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 8 3 # 8 B 630 SER F 189 SER^? 11.88 MG MG F 302 B 709 ASP F 128 ASP^? -3.41 MG MG F 301s B 740 HIS F 147 HIS^? 8.79 MG MG F 302 coo 4.44 13.29 37.64 6.01 11.66 38.49 59.91 63.90 -95.91 60.70 64.22 -98.13 coo 10.26 2.81 31.69 11.64 4.30 32.43 57.76 53.73 -90.50 57.46 51.64 -90.28 coo 8.57 10.09 34.47 7.10 10.73 35.82 56.63 61.66 -91.16 55.69 63.43 -91.80 1pfq_c03 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 8 hits 1pfq_c03 naa= 3 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 1 3 # 1 A 225 HIS A 147 HIS^? 9.20 MG MG A 302 A 259 TYR A 129 TYR^? 10.90 MG MG A 301 A 552 ASP A 81 ASP^? 34.50 MG MG A 301 coo 11.34 95.90 25.54 12.13 96.42 23.67 40.24 23.10 39.83 38.32 22.34 40.22 coo 14.91 97.39 18.63 13.39 95.60 20.20 44.80 23.54 35.75 45.57 23.36 33.08 coo 46.37 82.54 38.83 45.97 84.66 38.77 31.12 60.71 27.43 31.74 59.35 25.95 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 2 3 # 2 A 225 HIS A 170 HIS^? 10.56 MG MG A 302 A 259 TYR A 168 TYR^? 14.52 MG MG A 302 A 552 ASP B 142 ASP^? 23.97 MG MG B 301 coo 11.34 95.90 25.54 12.13 96.42 23.67 34.91 23.57 39.32 34.35 24.95 40.81 coo 14.91 97.39 18.63 13.39 95.60 20.20 37.31 16.98 37.59 36.65 18.86 39.55 coo 46.37 82.54 38.83 45.97 84.66 38.77 31.69 27.40 -1.31 32.10 27.37 -3.38 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 3 3 # 3 A 225 HIS B 147 HIS^? 9.27 MG MG B 301 A 259 TYR B 129 TYR^? 10.63 MG MG B 302 A 552 ASP B 81 ASP^? 24.85 MG MG C 301 coo 11.34 95.90 25.54 12.13 96.42 23.67 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 14.91 97.39 18.63 13.39 95.60 20.20 47.85 23.00 1.51 47.62 23.50 4.24 coo 46.37 82.54 38.83 45.97 84.66 38.77 79.93 -0.44 10.01 79.44 1.19 11.29 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 4 3 # 4 A 225 HIS B 147 HIS^? 9.27 MG MG B 301 A 259 TYR B 129 TYR^? 10.63 MG MG B 302 A 552 ASP C 35 ASP^? 16.42 MG MG C 302 coo 11.34 95.90 25.54 12.13 96.42 23.67 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 14.91 97.39 18.63 13.39 95.60 20.20 47.85 23.00 1.51 47.62 23.50 4.24 coo 46.37 82.54 38.83 45.97 84.66 38.77 84.40 16.53 -16.68 82.83 17.91 -16.28 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 5 3 # 5 A 225 HIS B 147 HIS^? 9.27 MG MG B 301 A 259 TYR B 129 TYR^? 10.63 MG MG B 302 A 552 ASP C 177 ASP^? 8.84 MG MG C 301 coo 11.34 95.90 25.54 12.13 96.42 23.67 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 14.91 97.39 18.63 13.39 95.60 20.20 47.85 23.00 1.51 47.62 23.50 4.24 coo 46.37 82.54 38.83 45.97 84.66 38.77 85.60 16.42 -0.31 86.51 17.71 1.09 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 6 3 # 6 A 225 HIS B 170 HIS^? 10.51 MG MG B 301 A 259 TYR B 168 TYR^? 14.66 MG MG B 301 A 552 ASP A 142 ASP^? 23.70 MG MG A 302 coo 11.34 95.90 25.54 12.13 96.42 23.67 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 14.91 97.39 18.63 13.39 95.60 20.20 40.03 17.20 -1.34 41.92 16.43 -3.19 coo 46.37 82.54 38.83 45.97 84.66 38.77 46.39 7.18 37.53 46.28 7.18 39.63 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 7 3 # 7 A 225 HIS C 147 HIS^? 9.44 MG MG C 301 A 259 TYR C 129 TYR^? 10.65 MG MG C 302 A 552 ASP B 35 ASP^? 16.92 MG MG B 302 coo 11.34 95.90 25.54 12.13 96.42 23.67 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 14.91 97.39 18.63 13.39 95.60 20.20 84.95 29.43 -7.96 85.04 30.16 -10.69 coo 46.37 82.54 38.83 45.97 84.66 38.77 52.63 11.07 10.18 53.68 12.85 9.94 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 8 3 # 8 A 225 HIS C 147 HIS^? 9.44 MG MG C 301 A 259 TYR C 129 TYR^? 10.65 MG MG C 302 A 552 ASP C 81 ASP^? 23.42 MG MG B 301 coo 11.34 95.90 25.54 12.13 96.42 23.67 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 14.91 97.39 18.63 13.39 95.60 20.20 84.95 29.43 -7.96 85.04 30.16 -10.69 coo 46.37 82.54 38.83 45.97 84.66 38.77 60.68 -2.08 -16.91 61.02 -0.17 -17.89 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 9 3 # 9 A 225 HIS C 170 HIS^? 10.68 MG MG C 301 A 259 TYR C 168 TYR^? 14.82 MG MG C 301 A 552 ASP D 142 ASP^? 23.49 MG MG D 301 coo 11.34 95.90 25.54 12.13 96.42 23.67 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 14.91 97.39 18.63 13.39 95.60 20.20 94.44 26.43 -5.44 92.97 25.09 -3.55 coo 46.37 82.54 38.83 45.97 84.66 38.77 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 10 3 # 10 A 225 HIS D 147 HIS^? 9.43 MG MG D 301 A 259 TYR D 129 TYR^? 10.79 MG MG D 302 A 552 ASP D 81 ASP^? 23.25 MG MG E 301 coo 11.34 95.90 25.54 12.13 96.42 23.67 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 14.91 97.39 18.63 13.39 95.60 20.20 86.45 31.36 -42.20 86.02 30.90 -39.46 coo 46.37 82.54 38.83 45.97 84.66 38.77 89.25 71.36 -34.47 87.72 70.06 -33.67 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 11 3 # 11 A 225 HIS D 147 HIS^? 9.43 MG MG D 301 A 259 TYR D 129 TYR^? 10.79 MG MG D 302 A 552 ASP E 35 ASP^? 16.91 MG MG E 302 coo 11.34 95.90 25.54 12.13 96.42 23.67 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 14.91 97.39 18.63 13.39 95.60 20.20 86.45 31.36 -42.20 86.02 30.90 -39.46 coo 46.37 82.54 38.83 45.97 84.66 38.77 73.60 65.64 -62.00 73.13 63.73 -61.22 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 12 3 # 12 A 225 HIS D 147 HIS^? 9.43 MG MG D 301 A 259 TYR D 129 TYR^? 10.79 MG MG D 302 A 552 ASP E 177 ASP^? 8.55 MG MG E 301 coo 11.34 95.90 25.54 12.13 96.42 23.67 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 14.91 97.39 18.63 13.39 95.60 20.20 86.45 31.36 -42.20 86.02 30.90 -39.46 coo 46.37 82.54 38.83 45.97 84.66 38.77 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 13 3 # 13 A 225 HIS D 170 HIS^? 10.59 MG MG D 301 A 259 TYR D 168 TYR^? 14.75 MG MG D 301 A 552 ASP C 142 ASP^? 23.76 MG MG C 301 coo 11.34 95.90 25.54 12.13 96.42 23.67 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 14.91 97.39 18.63 13.39 95.60 20.20 95.79 27.80 -44.35 95.71 29.78 -46.32 coo 46.37 82.54 38.83 45.97 84.66 38.77 97.94 39.27 -5.03 98.08 38.70 -2.97 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 14 3 # 14 A 225 HIS E 147 HIS^? 9.22 MG MG E 301 A 259 TYR E 129 TYR^? 10.89 MG MG E 302 A 552 ASP D 35 ASP^? 16.80 MG MG D 302 coo 11.34 95.90 25.54 12.13 96.42 23.67 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 14.91 97.39 18.63 13.39 95.60 20.20 62.09 60.15 -52.83 61.47 59.53 -55.45 coo 46.37 82.54 38.83 45.97 84.66 38.77 93.83 42.00 -33.14 91.74 41.83 -33.51 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 15 3 # 15 A 225 HIS E 147 HIS^? 9.22 MG MG E 301 A 259 TYR E 129 TYR^? 10.89 MG MG E 302 A 552 ASP D 177 ASP^? 8.43 MG MG D 301 coo 11.34 95.90 25.54 12.13 96.42 23.67 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 14.91 97.39 18.63 13.39 95.60 20.20 62.09 60.15 -52.83 61.47 59.53 -55.45 coo 46.37 82.54 38.83 45.97 84.66 38.77 95.74 41.01 -49.76 94.81 39.90 -51.24 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 16 3 # 16 A 225 HIS E 147 HIS^? 9.22 MG MG E 301 A 259 TYR E 129 TYR^? 10.89 MG MG E 302 A 552 ASP E 81 ASP^? 24.19 MG MG D 301 coo 11.34 95.90 25.54 12.13 96.42 23.67 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 14.91 97.39 18.63 13.39 95.60 20.20 62.09 60.15 -52.83 61.47 59.53 -55.45 coo 46.37 82.54 38.83 45.97 84.66 38.77 101.61 56.30 -60.24 100.25 55.53 -61.72 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 17 3 # 17 A 225 HIS E 147 HIS^? 9.22 MG MG E 301 A 259 TYR E 168 TYR^? 14.43 MG MG E 301 A 552 ASP F 100 ASP^? 19.36 MG MG F 301 coo 11.34 95.90 25.54 12.13 96.42 23.67 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 14.91 97.39 18.63 13.39 95.60 20.20 60.07 69.95 -50.54 61.99 69.37 -48.59 coo 46.37 82.54 38.83 45.97 84.66 38.77 74.18 55.53 -87.58 73.63 53.79 -88.67 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 18 3 # 18 A 225 HIS E 170 HIS^? 10.33 MG MG E 301 A 259 TYR E 168 TYR^? 14.43 MG MG E 301 A 552 ASP F 100 ASP^? 19.36 MG MG F 301 coo 11.34 95.90 25.54 12.13 96.42 23.67 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 14.91 97.39 18.63 13.39 95.60 20.20 60.07 69.95 -50.54 61.99 69.37 -48.59 coo 46.37 82.54 38.83 45.97 84.66 38.77 74.18 55.53 -87.58 73.63 53.79 -88.67 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 19 3 # 19 A 225 HIS E 170 HIS^? 10.33 MG MG E 301 A 259 TYR E 168 TYR^? 14.43 MG MG E 301 A 552 ASP F 142 ASP^? 23.43 MG MG F 302 coo 11.34 95.90 25.54 12.13 96.42 23.67 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 14.91 97.39 18.63 13.39 95.60 20.20 60.07 69.95 -50.54 61.99 69.37 -48.59 coo 46.37 82.54 38.83 45.97 84.66 38.77 71.46 69.88 -89.76 71.03 69.93 -91.81 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 20 3 # 20 A 225 HIS F 42 HIS^? 28.34 MG MG F 301 A 259 TYR F 156 TYR^? 21.68 MG MG F 302 A 552 ASP F 23 ASP^? 23.03 MG MG F 301 coo 11.34 95.90 25.54 12.13 96.42 23.67 55.11 70.50 -71.64 56.29 72.22 -71.48 coo 14.91 97.39 18.63 13.39 95.60 20.20 58.80 69.55 -79.65 56.09 69.80 -80.15 coo 46.37 82.54 38.83 45.97 84.66 38.77 31.30 43.61 -89.40 33.44 43.69 -89.02 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 21 3 # 21 A 225 HIS F 147 HIS^? 8.79 MG MG F 302 A 259 TYR F 129 TYR^? 10.92 MG MG F 301 A 552 ASP F 81 ASP^? 34.61 MG MG F 301 coo 11.34 95.90 25.54 12.13 96.42 23.67 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 14.91 97.39 18.63 13.39 95.60 20.20 59.69 58.61 -86.67 60.36 58.48 -83.96 coo 46.37 82.54 38.83 45.97 84.66 38.77 23.08 43.10 -77.79 24.94 42.10 -77.55 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 22 3 # 22 A 225 HIS F 147 HIS^? 8.79 MG MG F 302 A 259 TYR F 168 TYR^? 14.10 MG MG F 302 A 552 ASP E 100 ASP^? 19.27 MG MG E 302 coo 11.34 95.90 25.54 12.13 96.42 23.67 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 14.91 97.39 18.63 13.39 95.60 20.20 58.29 68.32 -89.29 56.67 67.12 -91.21 coo 46.37 82.54 38.83 45.97 84.66 38.77 49.30 52.58 -51.44 50.47 51.29 -50.20 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 23 3 # 23 A 225 HIS F 170 HIS^? 9.84 MG MG F 302 A 259 TYR F 168 TYR^? 14.10 MG MG F 302 A 552 ASP E 100 ASP^? 19.27 MG MG E 302 coo 11.34 95.90 25.54 12.13 96.42 23.67 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 14.91 97.39 18.63 13.39 95.60 20.20 58.29 68.32 -89.29 56.67 67.12 -91.21 coo 46.37 82.54 38.83 45.97 84.66 38.77 49.30 52.58 -51.44 50.47 51.29 -50.20 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 24 3 # 24 A 225 HIS F 170 HIS^? 9.84 MG MG F 302 A 259 TYR F 168 TYR^? 14.10 MG MG F 302 A 552 ASP E 142 ASP^? 23.66 MG MG E 301 coo 11.34 95.90 25.54 12.13 96.42 23.67 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 14.91 97.39 18.63 13.39 95.60 20.20 58.29 68.32 -89.29 56.67 67.12 -91.21 coo 46.37 82.54 38.83 45.97 84.66 38.77 47.19 67.15 -50.37 47.44 67.18 -48.23 1pj5_c00 source 1pj5 N,N-DIMETHYLGLYCINE OXIDASE : 24 hits 1pj5_c00 naa= 3 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 1 3 # 1 A 248 ASP A 142 ASP^? 23.70 MG MG A 302 A 270 LYS A 136 LYS^? 30.58 MG MG A 302 A 382 MET A 112 MET?? 17.41 MG MG A 301 coo -27.63 121.99 45.48 -26.66 123.86 45.68 46.39 7.18 37.53 46.28 7.18 39.63 coo -32.20 115.91 49.56 -31.37 121.03 53.12 50.14 3.36 31.42 51.28 2.21 35.89 coo -23.75 127.89 58.42 -26.02 128.79 55.12 50.59 19.69 33.92 47.68 17.73 31.45 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 2 3 # 2 A 248 ASP B 142 ASP^? 23.97 MG MG B 301 A 270 LYS B 136 LYS^? 33.75 MG MG B 302 A 382 MET B 112 MET?? 17.57 MG MG B 302 coo -27.63 121.99 45.48 -26.66 123.86 45.68 31.69 27.40 -1.31 32.10 27.37 -3.38 coo -32.20 115.91 49.56 -31.37 121.03 53.12 28.47 31.35 4.78 24.04 31.81 1.99 coo -23.75 127.89 58.42 -26.02 128.79 55.12 44.66 29.37 3.65 41.80 26.83 5.61 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 3 3 # 3 A 248 ASP C 142 ASP^? 23.76 MG MG C 301 A 270 LYS C 136 LYS^? 30.63 MG MG C 302 A 382 MET C 112 MET?? 17.22 MG MG C 302 coo -27.63 121.99 45.48 -26.66 123.86 45.68 97.94 39.27 -5.03 98.08 38.70 -2.97 coo -32.20 115.91 49.56 -31.37 121.03 53.12 99.75 44.04 -11.38 100.98 45.13 -6.77 coo -23.75 127.89 58.42 -26.02 128.79 55.12 85.54 36.35 -9.87 88.95 34.88 -11.98 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 4 3 # 4 A 248 ASP D 142 ASP^? 23.49 MG MG D 301 A 270 LYS D 136 LYS^? 34.99 MG MG D 302 A 382 MET D 112 MET?? 17.47 MG MG D 302 coo -27.63 121.99 45.48 -26.66 123.86 45.68 90.90 15.58 -44.76 91.35 16.09 -46.79 coo -32.20 115.91 49.56 -31.37 121.03 53.12 88.96 10.62 -38.53 90.77 6.00 -38.00 coo -23.75 127.89 58.42 -26.02 128.79 55.12 82.50 25.77 -40.26 85.96 24.71 -37.92 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 5 3 # 5 A 248 ASP E 58 ASP^? 26.76 MG MG F 301 A 270 LYS E 6 LYS^? 25.59 MG MG E 302 A 382 MET E 1 MET?? 38.44 MG MG E 302 coo -27.63 121.99 45.48 -26.66 123.86 45.68 45.39 59.31 -66.83 44.62 59.88 -68.72 coo -32.20 115.91 49.56 -31.37 121.03 53.12 51.95 64.70 -63.33 56.16 64.03 -67.52 coo -23.75 127.89 58.42 -26.02 128.79 55.12 37.71 69.56 -65.55 36.51 70.70 -61.44 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 6 3 # 6 A 248 ASP E 142 ASP^? 23.66 MG MG E 301 A 270 LYS E 136 LYS^? 31.27 MG MG E 302 A 382 MET E 112 MET?? 17.35 MG MG E 302 coo -27.63 121.99 45.48 -26.66 123.86 45.68 47.19 67.15 -50.37 47.44 67.18 -48.23 coo -32.20 115.91 49.56 -31.37 121.03 53.12 42.12 65.93 -56.52 39.36 65.07 -51.83 coo -23.75 127.89 58.42 -26.02 128.79 55.12 55.80 57.05 -54.29 55.40 60.56 -56.76 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 7 3 # 7 A 248 ASP F 58 ASP^? 26.87 MG MG E 302 A 270 LYS F 6 LYS^? 26.09 MG MG F 301 A 382 MET F 1 MET?? 39.49 MG MG E 302 coo -27.63 121.99 45.48 -26.66 123.86 45.68 75.55 64.68 -72.56 76.21 65.63 -70.79 coo -32.20 115.91 49.56 -31.37 121.03 53.12 67.53 67.03 -76.43 64.05 65.33 -71.86 coo -23.75 127.89 58.42 -26.02 128.79 55.12 79.07 77.21 -74.29 79.52 78.98 -77.09 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 8 3 # 8 A 248 ASP F 142 ASP^? 23.43 MG MG F 302 A 270 LYS F 136 LYS^? 30.53 MG MG F 301 A 382 MET F 112 MET?? 17.48 MG MG F 301 coo -27.63 121.99 45.48 -26.66 123.86 45.68 71.46 69.88 -89.76 71.03 69.93 -91.81 coo -32.20 115.91 49.56 -31.37 121.03 53.12 76.49 71.19 -83.39 78.38 70.88 -88.47 coo -23.75 127.89 58.42 -26.02 128.79 55.12 66.53 57.97 -84.87 65.71 61.60 -82.66 1pjq_c02 source 1pjq SIROHEME SYNTHASE : 8 hits 1pjq_c02 naa= 3 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 1 3 # 1 B 248 ASP A 58 ASP^? 26.75 MG MG B 302 B 270 LYS A 6 LYS^? 25.88 MG MG A 301 B 382 MET A 1 MET?? 37.55 MG MG B 302 coo -11.82 154.51 43.38 -12.86 152.74 43.79 53.93 9.80 21.09 53.83 8.90 19.15 coo -5.09 158.39 43.41 -0.74 158.80 47.15 46.20 12.82 24.71 44.50 16.64 20.52 coo -2.79 145.52 50.38 -5.75 148.14 51.66 49.10 -1.87 21.66 47.17 -4.46 20.89 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 2 3 # 2 B 248 ASP A 142 ASP^? 23.70 MG MG A 302 B 270 LYS A 136 LYS^? 30.58 MG MG A 302 B 382 MET A 112 MET?? 17.41 MG MG A 301 coo -11.82 154.51 43.38 -12.86 152.74 43.79 46.39 7.18 37.53 46.28 7.18 39.63 coo -5.09 158.39 43.41 -0.74 158.80 47.15 50.14 3.36 31.42 51.28 2.21 35.89 coo -2.79 145.52 50.38 -5.75 148.14 51.66 50.59 19.69 33.92 47.68 17.73 31.45 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 3 3 # 3 B 248 ASP A 142 ASP^? 23.70 MG MG A 302 B 270 LYS A 192 LYS^? 22.83 MG MG A 302 B 382 MET A 112 MET?? 17.41 MG MG A 301 coo -11.82 154.51 43.38 -12.86 152.74 43.79 46.39 7.18 37.53 46.28 7.18 39.63 coo -5.09 158.39 43.41 -0.74 158.80 47.15 40.19 10.20 38.86 35.42 9.85 36.29 coo -2.79 145.52 50.38 -5.75 148.14 51.66 50.59 19.69 33.92 47.68 17.73 31.45 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 4 3 # 4 B 248 ASP B 142 ASP^? 23.97 MG MG B 301 B 270 LYS B 136 LYS^? 33.75 MG MG B 302 B 382 MET B 112 MET?? 17.57 MG MG B 302 coo -11.82 154.51 43.38 -12.86 152.74 43.79 31.69 27.40 -1.31 32.10 27.37 -3.38 coo -5.09 158.39 43.41 -0.74 158.80 47.15 28.47 31.35 4.78 24.04 31.81 1.99 coo -2.79 145.52 50.38 -5.75 148.14 51.66 44.66 29.37 3.65 41.80 26.83 5.61 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 5 3 # 5 B 248 ASP B 142 ASP^? 23.97 MG MG B 301 B 270 LYS B 192 LYS^? 23.73 MG MG B 301 B 382 MET B 112 MET?? 17.57 MG MG B 302 coo -11.82 154.51 43.38 -12.86 152.74 43.79 31.69 27.40 -1.31 32.10 27.37 -3.38 coo -5.09 158.39 43.41 -0.74 158.80 47.15 33.83 21.17 -2.93 31.87 16.45 -0.74 coo -2.79 145.52 50.38 -5.75 148.14 51.66 44.66 29.37 3.65 41.80 26.83 5.61 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 6 3 # 6 B 248 ASP C 142 ASP^? 23.76 MG MG C 301 B 270 LYS C 136 LYS^? 30.63 MG MG C 302 B 382 MET C 112 MET?? 17.22 MG MG C 302 coo -11.82 154.51 43.38 -12.86 152.74 43.79 97.94 39.27 -5.03 98.08 38.70 -2.97 coo -5.09 158.39 43.41 -0.74 158.80 47.15 99.75 44.04 -11.38 100.98 45.13 -6.77 coo -2.79 145.52 50.38 -5.75 148.14 51.66 85.54 36.35 -9.87 88.95 34.88 -11.98 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 7 3 # 7 B 248 ASP C 142 ASP^? 23.76 MG MG C 301 B 270 LYS C 192 LYS^? 24.43 MG MG C 301 B 382 MET C 112 MET?? 17.22 MG MG C 302 coo -11.82 154.51 43.38 -12.86 152.74 43.79 97.94 39.27 -5.03 98.08 38.70 -2.97 coo -5.09 158.39 43.41 -0.74 158.80 47.15 98.71 32.33 -3.93 102.89 29.25 -5.78 coo -2.79 145.52 50.38 -5.75 148.14 51.66 85.54 36.35 -9.87 88.95 34.88 -11.98 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 8 3 # 8 B 248 ASP D 142 ASP^? 23.49 MG MG D 301 B 270 LYS D 136 LYS^? 34.99 MG MG D 302 B 382 MET D 112 MET?? 17.47 MG MG D 302 coo -11.82 154.51 43.38 -12.86 152.74 43.79 90.90 15.58 -44.76 91.35 16.09 -46.79 coo -5.09 158.39 43.41 -0.74 158.80 47.15 88.96 10.62 -38.53 90.77 6.00 -38.00 coo -2.79 145.52 50.38 -5.75 148.14 51.66 82.50 25.77 -40.26 85.96 24.71 -37.92 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 9 3 # 9 B 248 ASP D 142 ASP^? 23.49 MG MG D 301 B 270 LYS D 192 LYS^? 24.09 MG MG D 301 B 382 MET D 112 MET?? 17.47 MG MG D 302 coo -11.82 154.51 43.38 -12.86 152.74 43.79 90.90 15.58 -44.76 91.35 16.09 -46.79 coo -5.09 158.39 43.41 -0.74 158.80 47.15 95.35 20.28 -45.75 100.42 20.77 -43.05 coo -2.79 145.52 50.38 -5.75 148.14 51.66 82.50 25.77 -40.26 85.96 24.71 -37.92 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 10 3 # 10 B 248 ASP E 58 ASP^? 26.76 MG MG F 301 B 270 LYS E 6 LYS^? 25.59 MG MG E 302 B 382 MET E 1 MET?? 38.44 MG MG E 302 coo -11.82 154.51 43.38 -12.86 152.74 43.79 45.39 59.31 -66.83 44.62 59.88 -68.72 coo -5.09 158.39 43.41 -0.74 158.80 47.15 51.95 64.70 -63.33 56.16 64.03 -67.52 coo -2.79 145.52 50.38 -5.75 148.14 51.66 37.71 69.56 -65.55 36.51 70.70 -61.44 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 11 3 # 11 B 248 ASP E 142 ASP^? 23.66 MG MG E 301 B 270 LYS E 136 LYS^? 31.27 MG MG E 302 B 382 MET E 112 MET?? 17.35 MG MG E 302 coo -11.82 154.51 43.38 -12.86 152.74 43.79 47.19 67.15 -50.37 47.44 67.18 -48.23 coo -5.09 158.39 43.41 -0.74 158.80 47.15 42.12 65.93 -56.52 39.36 65.07 -51.83 coo -2.79 145.52 50.38 -5.75 148.14 51.66 55.80 57.05 -54.29 55.40 60.56 -56.76 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 12 3 # 12 B 248 ASP E 142 ASP^? 23.66 MG MG E 301 B 270 LYS E 192 LYS^? 23.62 MG MG E 301 B 382 MET E 112 MET?? 17.35 MG MG E 302 coo -11.82 154.51 43.38 -12.86 152.74 43.79 47.19 67.15 -50.37 47.44 67.18 -48.23 coo -5.09 158.39 43.41 -0.74 158.80 47.15 52.64 70.58 -49.14 53.48 75.40 -50.95 coo -2.79 145.52 50.38 -5.75 148.14 51.66 55.80 57.05 -54.29 55.40 60.56 -56.76 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 13 3 # 13 B 248 ASP F 58 ASP^? 26.87 MG MG E 302 B 270 LYS F 6 LYS^? 26.09 MG MG F 301 B 382 MET F 1 MET?? 39.49 MG MG E 302 coo -11.82 154.51 43.38 -12.86 152.74 43.79 75.55 64.68 -72.56 76.21 65.63 -70.79 coo -5.09 158.39 43.41 -0.74 158.80 47.15 67.53 67.03 -76.43 64.05 65.33 -71.86 coo -2.79 145.52 50.38 -5.75 148.14 51.66 79.07 77.21 -74.29 79.52 78.98 -77.09 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 14 3 # 14 B 248 ASP F 142 ASP^? 23.43 MG MG F 302 B 270 LYS F 136 LYS^? 30.53 MG MG F 301 B 382 MET F 112 MET?? 17.48 MG MG F 301 coo -11.82 154.51 43.38 -12.86 152.74 43.79 71.46 69.88 -89.76 71.03 69.93 -91.81 coo -5.09 158.39 43.41 -0.74 158.80 47.15 76.49 71.19 -83.39 78.38 70.88 -88.47 coo -2.79 145.52 50.38 -5.75 148.14 51.66 66.53 57.97 -84.87 65.71 61.60 -82.66 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 15 3 # 15 B 248 ASP F 142 ASP^? 23.43 MG MG F 302 B 270 LYS F 192 LYS^? 23.61 MG MG F 302 B 382 MET F 112 MET?? 17.48 MG MG F 301 coo -11.82 154.51 43.38 -12.86 152.74 43.79 71.46 69.88 -89.76 71.03 69.93 -91.81 coo -5.09 158.39 43.41 -0.74 158.80 47.15 64.82 71.59 -91.06 62.22 76.11 -88.75 coo -2.79 145.52 50.38 -5.75 148.14 51.66 66.53 57.97 -84.87 65.71 61.60 -82.66 1pjq_c03 source 1pjq SIROHEME SYNTHASE : 15 hits 1pjq_c03 naa= 3 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 1 3 # 1 111 GLN D 144 GLN^? 19.85 MG MG D 301 294 GLU D 146 GLU^? 10.62 MG MG D 301 304 ARG D 193 ARG^? 27.92 MG MG D 301 coo 15.89 18.45 46.53 15.82 16.91 48.02 89.60 20.24 -48.38 88.70 18.97 -49.74 coo 22.84 13.44 52.91 20.84 13.18 52.38 87.24 28.82 -50.92 85.47 28.08 -51.67 coo 8.71 17.11 46.51 7.23 17.64 49.20 95.76 15.06 -47.43 94.58 12.31 -46.69 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 2 3 # 2 111 GLN F 144 GLN^? 20.16 MG MG F 302 294 GLU F 146 GLU^? 10.36 MG MG F 302 304 ARG F 193 ARG^? 27.27 MG MG F 302 coo 15.89 18.45 46.53 15.82 16.91 48.02 68.06 66.27 -93.88 70.14 65.97 -94.00 coo 22.84 13.44 52.91 20.84 13.18 52.38 61.95 60.17 -95.28 62.87 58.56 -96.19 coo 8.71 17.11 46.51 7.23 17.64 49.20 70.24 75.04 -91.81 72.97 73.73 -92.20 1pmi_c00 source 1pmi PHOSPHOMANNOSE ISOMERASE : 2 hits 1pmi_c00 naa= 3 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 1 3 # 1 B 1 SER A 92 SER^? 15.40 MG MG A 301 B 69 ALA A 116 ALA^? 9.46 MG MG A 301 B 241 ASN A 95 ASN^? 11.82 MG MG A 301 coo 13.24 41.94 33.13 13.08 39.54 33.17 51.45 35.15 28.48 53.73 34.74 29.17 coo 9.15 37.89 36.69 10.55 37.76 37.22 47.49 32.63 33.63 46.88 32.21 32.30 coo 10.91 43.03 38.47 11.81 41.82 36.93 53.15 30.26 34.15 54.71 31.63 34.63 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 2 3 # 2 B 1 SER A 117 SER^? 9.60 MG MG A 301 B 69 ALA A 91 ALA^? 12.93 MG MG A 301 B 241 ASN A 118 ASN^? 13.27 MG MG A 301 coo 13.24 41.94 33.13 13.08 39.54 33.17 46.51 36.12 34.76 48.66 37.10 34.49 coo 9.15 37.89 36.69 10.55 37.76 37.22 47.92 36.55 28.62 47.12 35.53 29.40 coo 10.91 43.03 38.47 11.81 41.82 36.93 43.06 39.25 33.60 42.05 40.75 32.42 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 3 3 # 3 B 1 SER A 117 SER^? 9.60 MG MG A 301 B 69 ALA A 124 ALA^? 9.26 MG MG A 301 B 241 ASN A 118 ASN^? 13.27 MG MG A 301 coo 13.24 41.94 33.13 13.08 39.54 33.17 46.51 36.12 34.76 48.66 37.10 34.49 coo 9.15 37.89 36.69 10.55 37.76 37.22 43.58 40.15 39.27 42.90 39.89 37.96 coo 10.91 43.03 38.47 11.81 41.82 36.93 43.06 39.25 33.60 42.05 40.75 32.42 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 4 3 # 4 B 1 SER B 92 SER^? 15.63 MG MG B 302 B 69 ALA B 116 ALA^? 9.34 MG MG B 302 B 241 ASN B 95 ASN^? 11.72 MG MG B 302 coo 13.24 41.94 33.13 13.08 39.54 33.17 59.57 27.12 10.15 59.58 29.43 9.62 coo 9.15 37.89 36.69 10.55 37.76 37.22 56.90 23.91 4.45 56.31 22.97 5.47 coo 10.91 43.03 38.47 11.81 41.82 36.93 55.48 29.92 4.32 57.36 30.88 4.11 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 5 3 # 5 B 1 SER B 117 SER^? 9.14 MG MG B 302 B 69 ALA B 124 ALA^? 10.06 MG MG B 302 B 241 ASN B 118 ASN^? 13.44 MG MG B 302 coo 13.24 41.94 33.13 13.08 39.54 33.17 60.50 22.87 3.68 61.23 25.10 3.08 coo 9.15 37.89 36.69 10.55 37.76 37.22 64.73 20.19 -1.01 64.58 19.15 0.11 coo 10.91 43.03 38.47 11.81 41.82 36.93 63.19 18.87 4.27 64.22 17.47 5.51 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 6 3 # 6 B 1 SER C 92 SER^? 15.15 MG MG C 302 B 69 ALA C 116 ALA^? 9.08 MG MG C 302 B 241 ASN C 95 ASN^? 11.50 MG MG C 302 coo 13.24 41.94 33.13 13.08 39.54 33.17 72.40 29.17 -16.07 71.43 31.32 -15.46 coo 9.15 37.89 36.69 10.55 37.76 37.22 75.92 26.98 -10.66 76.76 26.56 -11.82 coo 10.91 43.03 38.47 11.81 41.82 36.93 75.34 33.15 -10.39 73.27 33.38 -10.21 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 7 3 # 7 B 1 SER C 117 SER^? 8.92 MG MG C 302 B 69 ALA C 91 ALA^? 12.61 MG MG C 302 B 241 ASN C 118 ASN^? 13.08 MG MG C 302 coo 13.24 41.94 33.13 13.08 39.54 33.17 72.96 24.67 -9.95 71.40 26.26 -9.18 coo 9.15 37.89 36.69 10.55 37.76 37.22 72.87 25.42 -15.88 73.94 25.20 -14.87 coo 10.91 43.03 38.47 11.81 41.82 36.93 72.64 19.83 -10.69 72.07 18.17 -11.94 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 8 3 # 8 B 1 SER C 117 SER^? 8.92 MG MG C 302 B 69 ALA C 124 ALA^? 9.43 MG MG C 302 B 241 ASN C 118 ASN^? 13.08 MG MG C 302 coo 13.24 41.94 33.13 13.08 39.54 33.17 72.96 24.67 -9.95 71.40 26.26 -9.18 coo 9.15 37.89 36.69 10.55 37.76 37.22 70.87 19.73 -4.58 71.66 18.98 -5.68 coo 10.91 43.03 38.47 11.81 41.82 36.93 72.64 19.83 -10.69 72.07 18.17 -11.94 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 9 3 # 9 B 1 SER D 92 SER^? 16.26 MG MG D 302 B 69 ALA D 116 ALA^? 9.63 MG MG D 302 B 241 ASN D 95 ASN^? 12.56 MG MG D 302 coo 13.24 41.94 33.13 13.08 39.54 33.17 76.41 39.72 -34.40 74.28 38.75 -34.89 coo 9.15 37.89 36.69 10.55 37.76 37.22 80.74 38.94 -39.77 81.69 38.81 -38.65 coo 10.91 43.03 38.47 11.81 41.82 36.93 76.36 34.77 -40.14 74.34 35.29 -40.63 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 10 3 # 10 B 1 SER D 117 SER^? 9.64 MG MG D 302 B 69 ALA D 91 ALA^? 13.42 MG MG D 302 B 241 ASN D 118 ASN^? 13.31 MG MG D 302 coo 13.24 41.94 33.13 13.08 39.54 33.17 79.93 42.54 -40.62 77.69 42.23 -41.47 coo 9.15 37.89 36.69 10.55 37.76 37.22 79.15 42.27 -34.55 80.22 41.77 -35.47 coo 10.91 43.03 38.47 11.81 41.82 36.93 82.29 46.70 -39.94 83.03 48.22 -38.68 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 11 3 # 11 B 1 SER D 117 SER^? 9.64 MG MG D 302 B 69 ALA D 124 ALA^? 10.03 MG MG D 302 B 241 ASN D 118 ASN^? 13.31 MG MG D 302 coo 13.24 41.94 33.13 13.08 39.54 33.17 79.93 42.54 -40.62 77.69 42.23 -41.47 coo 9.15 37.89 36.69 10.55 37.76 37.22 80.12 47.19 -45.47 81.16 47.80 -44.53 coo 10.91 43.03 38.47 11.81 41.82 36.93 82.29 46.70 -39.94 83.03 48.22 -38.68 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 12 3 # 12 B 1 SER D 117 SER^? 9.64 MG MG D 302 B 69 ALA D 124 ALA^? 10.03 MG MG D 302 B 241 ASN D 121 ASN^? 14.25 MG MG E 302 coo 13.24 41.94 33.13 13.08 39.54 33.17 79.93 42.54 -40.62 77.69 42.23 -41.47 coo 9.15 37.89 36.69 10.55 37.76 37.22 80.12 47.19 -45.47 81.16 47.80 -44.53 coo 10.91 43.03 38.47 11.81 41.82 36.93 80.38 49.72 -41.99 81.55 51.54 -42.09 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 13 3 # 13 B 1 SER E 92 SER^? 15.58 MG MG E 302 B 69 ALA E 116 ALA^? 9.37 MG MG E 302 B 241 ASN E 95 ASN^? 11.73 MG MG E 302 coo 13.24 41.94 33.13 13.08 39.54 33.17 68.69 48.93 -60.16 67.14 47.20 -59.59 coo 9.15 37.89 36.69 10.55 37.76 37.22 68.64 53.26 -54.80 68.60 54.11 -56.01 coo 10.91 43.03 38.47 11.81 41.82 36.93 63.77 49.77 -54.50 64.30 47.82 -53.94 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 14 3 # 14 B 1 SER E 117 SER^? 9.12 MG MG E 302 B 69 ALA E 91 ALA^? 13.03 MG MG E 302 B 241 ASN E 118 ASN^? 13.13 MG MG E 302 coo 13.24 41.94 33.13 13.08 39.54 33.17 72.02 51.78 -53.96 71.28 49.71 -53.01 coo 9.15 37.89 36.69 10.55 37.76 37.22 71.73 51.22 -59.99 71.40 52.44 -59.12 coo 10.91 43.03 38.47 11.81 41.82 36.93 76.50 53.47 -54.63 78.11 53.97 -55.93 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 15 3 # 15 B 1 SER E 117 SER^? 9.12 MG MG E 302 B 69 ALA E 124 ALA^? 9.05 MG MG E 302 B 241 ASN E 118 ASN^? 13.13 MG MG E 302 coo 13.24 41.94 33.13 13.08 39.54 33.17 72.02 51.78 -53.96 71.28 49.71 -53.01 coo 9.15 37.89 36.69 10.55 37.76 37.22 76.88 53.67 -49.23 76.97 54.46 -50.55 coo 10.91 43.03 38.47 11.81 41.82 36.93 76.50 53.47 -54.63 78.11 53.97 -55.93 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 16 3 # 16 B 1 SER F 92 SER^? 15.48 MG MG F 301 B 69 ALA F 116 ALA^? 9.46 MG MG F 301 B 241 ASN F 95 ASN^? 12.10 MG MG F 301 coo 13.24 41.94 33.13 13.08 39.54 33.17 57.23 46.17 -78.28 59.17 45.10 -79.10 coo 9.15 37.89 36.69 10.55 37.76 37.22 55.95 50.15 -83.85 55.52 51.16 -82.84 coo 10.91 43.03 38.47 11.81 41.82 36.93 61.81 48.42 -84.18 62.16 46.40 -84.52 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 17 3 # 17 B 1 SER F 117 SER^? 9.96 MG MG F 301 B 69 ALA F 91 ALA^? 13.16 MG MG F 301 B 241 ASN F 118 ASN^? 13.34 MG MG F 301 coo 13.24 41.94 33.13 13.08 39.54 33.17 53.22 47.67 -84.89 54.09 45.48 -84.70 coo 9.15 37.89 36.69 10.55 37.76 37.22 53.65 47.28 -78.71 53.60 48.47 -79.59 coo 10.91 43.03 38.47 11.81 41.82 36.93 48.40 47.22 -84.16 46.70 46.61 -82.99 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 18 3 # 18 B 1 SER F 117 SER^? 9.96 MG MG F 301 B 69 ALA F 124 ALA^? 9.67 MG MG F 301 B 241 ASN F 118 ASN^? 13.34 MG MG F 301 coo 13.24 41.94 33.13 13.08 39.54 33.17 53.22 47.67 -84.89 54.09 45.48 -84.70 coo 9.15 37.89 36.69 10.55 37.76 37.22 48.65 45.47 -89.39 48.08 46.19 -88.18 coo 10.91 43.03 38.47 11.81 41.82 36.93 48.40 47.22 -84.16 46.70 46.61 -82.99 1pnl_c00 source 1pnl PENICILLIN AMIDOHYDROLASE : 18 hits 1pnl_c00 naa= 3 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 3 # 1 A 264 ARG A 37 ARG^? 18.99 MG MG A 301 A 479 PHE A 12 PHE^? 17.15 MG MG A 301 A 483 GLU A 154 GLU^? 19.22 MG MG A 301 coo 17.33 52.29 2.24 18.71 54.03 0.18 32.99 26.50 25.19 35.50 25.33 26.51 coo 20.06 57.44 1.28 18.39 56.19 3.12 34.93 27.27 29.42 32.88 25.47 30.10 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 36.54 21.95 29.78 35.14 22.21 28.17 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 2 3 # 2 A 264 ARG A 37 ARG^? 18.99 MG MG A 301 A 479 PHE A 39 PHE^? 18.63 MG MG A 302 A 483 GLU A 38 GLU^? 21.81 MG MG A 302 coo 17.33 52.29 2.24 18.71 54.03 0.18 32.99 26.50 25.19 35.50 25.33 26.51 coo 20.06 57.44 1.28 18.39 56.19 3.12 31.04 21.84 30.70 31.32 23.06 33.20 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 26.42 25.01 28.02 26.98 25.90 29.89 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 3 3 # 3 A 264 ARG A 37 ARG^? 18.99 MG MG A 301 A 479 PHE A 39 PHE^? 18.63 MG MG A 302 A 483 GLU A 154 GLU^? 19.22 MG MG A 301 coo 17.33 52.29 2.24 18.71 54.03 0.18 32.99 26.50 25.19 35.50 25.33 26.51 coo 20.06 57.44 1.28 18.39 56.19 3.12 31.04 21.84 30.70 31.32 23.06 33.20 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 36.54 21.95 29.78 35.14 22.21 28.17 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 4 3 # 4 A 264 ARG B 37 ARG^? 19.17 MG MG B 302 A 479 PHE B 12 PHE^? 17.13 MG MG B 302 A 483 GLU B 154 GLU^? 19.05 MG MG B 302 coo 17.33 52.29 2.24 18.71 54.03 0.18 47.41 10.20 11.40 46.99 12.91 10.22 coo 20.06 57.44 1.28 18.39 56.19 3.12 49.02 12.29 7.19 47.01 10.60 6.19 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 44.04 15.11 6.74 44.19 13.59 8.30 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 5 3 # 5 A 264 ARG B 37 ARG^? 19.17 MG MG B 302 A 479 PHE B 39 PHE^? 18.11 MG MG B 301 A 483 GLU B 38 GLU^? 21.75 MG MG B 301 coo 17.33 52.29 2.24 18.71 54.03 0.18 47.41 10.20 11.40 46.99 12.91 10.22 coo 20.06 57.44 1.28 18.39 56.19 3.12 43.21 9.88 5.15 44.59 10.44 2.80 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 44.79 4.95 7.12 46.66 4.47 6.21 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 6 3 # 6 A 264 ARG B 37 ARG^? 19.17 MG MG B 302 A 479 PHE B 39 PHE^? 18.11 MG MG B 301 A 483 GLU B 154 GLU^? 19.05 MG MG B 302 coo 17.33 52.29 2.24 18.71 54.03 0.18 47.41 10.20 11.40 46.99 12.91 10.22 coo 20.06 57.44 1.28 18.39 56.19 3.12 43.21 9.88 5.15 44.59 10.44 2.80 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 44.04 15.11 6.74 44.19 13.59 8.30 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 7 3 # 7 A 264 ARG C 37 ARG^? 19.01 MG MG C 302 A 479 PHE C 12 PHE^? 16.92 MG MG C 302 A 483 GLU C 154 GLU^? 18.91 MG MG C 302 coo 17.33 52.29 2.24 18.71 54.03 0.18 89.36 17.23 -17.57 89.29 20.20 -16.76 coo 20.06 57.44 1.28 18.39 56.19 3.12 87.42 18.93 -13.86 90.00 18.25 -12.97 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 91.15 23.27 -13.33 91.61 21.91 -14.95 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 8 3 # 8 A 264 ARG C 37 ARG^? 19.01 MG MG C 302 A 479 PHE C 39 PHE^? 18.26 MG MG C 301 A 483 GLU C 38 GLU^? 21.99 MG MG C 301 coo 17.33 52.29 2.24 18.71 54.03 0.18 89.36 17.23 -17.57 89.29 20.20 -16.76 coo 20.06 57.44 1.28 18.39 56.19 3.12 93.83 18.63 -11.96 92.54 18.49 -9.49 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 93.66 12.78 -15.08 92.73 12.51 -13.19 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 9 3 # 9 A 264 ARG C 37 ARG^? 19.01 MG MG C 302 A 479 PHE C 39 PHE^? 18.26 MG MG C 301 A 483 GLU C 154 GLU^? 18.91 MG MG C 302 coo 17.33 52.29 2.24 18.71 54.03 0.18 89.36 17.23 -17.57 89.29 20.20 -16.76 coo 20.06 57.44 1.28 18.39 56.19 3.12 93.83 18.63 -11.96 92.54 18.49 -9.49 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 91.15 23.27 -13.33 91.61 21.91 -14.95 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 10 3 # 10 A 264 ARG D 37 ARG^? 18.81 MG MG D 302 A 479 PHE D 12 PHE^? 16.78 MG MG D 302 A 483 GLU D 154 GLU^? 18.75 MG MG D 302 coo 17.33 52.29 2.24 18.71 54.03 0.18 96.81 38.21 -31.63 94.97 36.32 -33.06 coo 20.06 57.44 1.28 18.39 56.19 3.12 94.68 38.11 -36.05 97.16 37.10 -36.83 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 94.87 32.52 -36.42 96.07 33.39 -34.88 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 11 3 # 11 A 264 ARG D 37 ARG^? 18.81 MG MG D 302 A 479 PHE D 39 PHE^? 18.22 MG MG D 301 A 483 GLU D 38 GLU^? 21.83 MG MG D 301 coo 17.33 52.29 2.24 18.71 54.03 0.18 96.81 38.21 -31.63 94.97 36.32 -33.06 coo 20.06 57.44 1.28 18.39 56.19 3.12 99.82 34.37 -37.74 99.04 35.33 -40.24 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 103.22 39.19 -34.75 102.77 39.81 -36.73 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 12 3 # 12 A 264 ARG D 37 ARG^? 18.81 MG MG D 302 A 479 PHE D 39 PHE^? 18.22 MG MG D 301 A 483 GLU D 154 GLU^? 18.75 MG MG D 302 coo 17.33 52.29 2.24 18.71 54.03 0.18 96.81 38.21 -31.63 94.97 36.32 -33.06 coo 20.06 57.44 1.28 18.39 56.19 3.12 99.82 34.37 -37.74 99.04 35.33 -40.24 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 94.87 32.52 -36.42 96.07 33.39 -34.88 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 13 3 # 13 A 264 ARG F 37 ARG^? 19.14 MG MG F 301 A 479 PHE F 12 PHE^? 17.12 MG MG F 301 A 483 GLU F 154 GLU^? 18.97 MG MG F 301 coo 17.33 52.29 2.24 18.71 54.03 0.18 48.80 64.46 -76.37 51.50 64.15 -77.79 coo 20.06 57.44 1.28 18.39 56.19 3.12 49.70 62.79 -80.90 49.37 65.44 -81.67 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 54.57 65.67 -81.55 53.36 66.51 -80.09 1pow_c02 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 13 hits 1pow_c02 naa= 3 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 3 # 1 B 264 ARG A 37 ARG^? 18.99 MG MG A 301 B 479 PHE A 12 PHE^? 17.15 MG MG A 301 B 483 GLU A 154 GLU^? 19.22 MG MG A 301 coo -26.72 93.28 20.13 -28.02 93.55 17.39 32.99 26.50 25.19 35.50 25.33 26.51 coo -29.34 90.48 15.69 -27.62 89.95 17.80 34.93 27.27 29.42 32.88 25.47 30.10 coo -26.63 95.49 14.65 -25.77 93.77 13.77 36.54 21.95 29.78 35.14 22.21 28.17 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 2 3 # 2 B 264 ARG A 37 ARG^? 18.99 MG MG A 301 B 479 PHE A 39 PHE^? 18.63 MG MG A 302 B 483 GLU A 38 GLU^? 21.81 MG MG A 302 coo -26.72 93.28 20.13 -28.02 93.55 17.39 32.99 26.50 25.19 35.50 25.33 26.51 coo -29.34 90.48 15.69 -27.62 89.95 17.80 31.04 21.84 30.70 31.32 23.06 33.20 coo -26.63 95.49 14.65 -25.77 93.77 13.77 26.42 25.01 28.02 26.98 25.90 29.89 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 3 3 # 3 B 264 ARG A 37 ARG^? 18.99 MG MG A 301 B 479 PHE A 39 PHE^? 18.63 MG MG A 302 B 483 GLU A 154 GLU^? 19.22 MG MG A 301 coo -26.72 93.28 20.13 -28.02 93.55 17.39 32.99 26.50 25.19 35.50 25.33 26.51 coo -29.34 90.48 15.69 -27.62 89.95 17.80 31.04 21.84 30.70 31.32 23.06 33.20 coo -26.63 95.49 14.65 -25.77 93.77 13.77 36.54 21.95 29.78 35.14 22.21 28.17 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 4 3 # 4 B 264 ARG B 37 ARG^? 19.17 MG MG B 302 B 479 PHE B 12 PHE^? 17.13 MG MG B 302 B 483 GLU B 154 GLU^? 19.05 MG MG B 302 coo -26.72 93.28 20.13 -28.02 93.55 17.39 47.41 10.20 11.40 46.99 12.91 10.22 coo -29.34 90.48 15.69 -27.62 89.95 17.80 49.02 12.29 7.19 47.01 10.60 6.19 coo -26.63 95.49 14.65 -25.77 93.77 13.77 44.04 15.11 6.74 44.19 13.59 8.30 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 5 3 # 5 B 264 ARG B 37 ARG^? 19.17 MG MG B 302 B 479 PHE B 39 PHE^? 18.11 MG MG B 301 B 483 GLU B 38 GLU^? 21.75 MG MG B 301 coo -26.72 93.28 20.13 -28.02 93.55 17.39 47.41 10.20 11.40 46.99 12.91 10.22 coo -29.34 90.48 15.69 -27.62 89.95 17.80 43.21 9.88 5.15 44.59 10.44 2.80 coo -26.63 95.49 14.65 -25.77 93.77 13.77 44.79 4.95 7.12 46.66 4.47 6.21 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 6 3 # 6 B 264 ARG B 37 ARG^? 19.17 MG MG B 302 B 479 PHE B 39 PHE^? 18.11 MG MG B 301 B 483 GLU B 154 GLU^? 19.05 MG MG B 302 coo -26.72 93.28 20.13 -28.02 93.55 17.39 47.41 10.20 11.40 46.99 12.91 10.22 coo -29.34 90.48 15.69 -27.62 89.95 17.80 43.21 9.88 5.15 44.59 10.44 2.80 coo -26.63 95.49 14.65 -25.77 93.77 13.77 44.04 15.11 6.74 44.19 13.59 8.30 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 7 3 # 7 B 264 ARG C 37 ARG^? 19.01 MG MG C 302 B 479 PHE C 12 PHE^? 16.92 MG MG C 302 B 483 GLU C 154 GLU^? 18.91 MG MG C 302 coo -26.72 93.28 20.13 -28.02 93.55 17.39 89.36 17.23 -17.57 89.29 20.20 -16.76 coo -29.34 90.48 15.69 -27.62 89.95 17.80 87.42 18.93 -13.86 90.00 18.25 -12.97 coo -26.63 95.49 14.65 -25.77 93.77 13.77 91.15 23.27 -13.33 91.61 21.91 -14.95 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 8 3 # 8 B 264 ARG C 37 ARG^? 19.01 MG MG C 302 B 479 PHE C 39 PHE^? 18.26 MG MG C 301 B 483 GLU C 38 GLU^? 21.99 MG MG C 301 coo -26.72 93.28 20.13 -28.02 93.55 17.39 89.36 17.23 -17.57 89.29 20.20 -16.76 coo -29.34 90.48 15.69 -27.62 89.95 17.80 93.83 18.63 -11.96 92.54 18.49 -9.49 coo -26.63 95.49 14.65 -25.77 93.77 13.77 93.66 12.78 -15.08 92.73 12.51 -13.19 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 9 3 # 9 B 264 ARG C 37 ARG^? 19.01 MG MG C 302 B 479 PHE C 39 PHE^? 18.26 MG MG C 301 B 483 GLU C 154 GLU^? 18.91 MG MG C 302 coo -26.72 93.28 20.13 -28.02 93.55 17.39 89.36 17.23 -17.57 89.29 20.20 -16.76 coo -29.34 90.48 15.69 -27.62 89.95 17.80 93.83 18.63 -11.96 92.54 18.49 -9.49 coo -26.63 95.49 14.65 -25.77 93.77 13.77 91.15 23.27 -13.33 91.61 21.91 -14.95 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 10 3 # 10 B 264 ARG D 37 ARG^? 18.81 MG MG D 302 B 479 PHE D 12 PHE^? 16.78 MG MG D 302 B 483 GLU D 154 GLU^? 18.75 MG MG D 302 coo -26.72 93.28 20.13 -28.02 93.55 17.39 96.81 38.21 -31.63 94.97 36.32 -33.06 coo -29.34 90.48 15.69 -27.62 89.95 17.80 94.68 38.11 -36.05 97.16 37.10 -36.83 coo -26.63 95.49 14.65 -25.77 93.77 13.77 94.87 32.52 -36.42 96.07 33.39 -34.88 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 11 3 # 11 B 264 ARG D 37 ARG^? 18.81 MG MG D 302 B 479 PHE D 39 PHE^? 18.22 MG MG D 301 B 483 GLU D 38 GLU^? 21.83 MG MG D 301 coo -26.72 93.28 20.13 -28.02 93.55 17.39 96.81 38.21 -31.63 94.97 36.32 -33.06 coo -29.34 90.48 15.69 -27.62 89.95 17.80 99.82 34.37 -37.74 99.04 35.33 -40.24 coo -26.63 95.49 14.65 -25.77 93.77 13.77 103.22 39.19 -34.75 102.77 39.81 -36.73 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 12 3 # 12 B 264 ARG D 37 ARG^? 18.81 MG MG D 302 B 479 PHE D 39 PHE^? 18.22 MG MG D 301 B 483 GLU D 154 GLU^? 18.75 MG MG D 302 coo -26.72 93.28 20.13 -28.02 93.55 17.39 96.81 38.21 -31.63 94.97 36.32 -33.06 coo -29.34 90.48 15.69 -27.62 89.95 17.80 99.82 34.37 -37.74 99.04 35.33 -40.24 coo -26.63 95.49 14.65 -25.77 93.77 13.77 94.87 32.52 -36.42 96.07 33.39 -34.88 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 13 3 # 13 B 264 ARG F 37 ARG^? 19.14 MG MG F 301 B 479 PHE F 12 PHE^? 17.12 MG MG F 301 B 483 GLU F 154 GLU^? 18.97 MG MG F 301 coo -26.72 93.28 20.13 -28.02 93.55 17.39 48.80 64.46 -76.37 51.50 64.15 -77.79 coo -29.34 90.48 15.69 -27.62 89.95 17.80 49.70 62.79 -80.90 49.37 65.44 -81.67 coo -26.63 95.49 14.65 -25.77 93.77 13.77 54.57 65.67 -81.55 53.36 66.51 -80.09 1pow_c03 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 13 hits 1pow_c03 naa= 3 ULMN 3 1pyl_c00 RIBONUCLEASE user 1 3 # 1 A 56 GLU B 154 GLU^? 19.05 MG MG B 302 A 67 ARG B 37 ARG^? 19.17 MG MG B 302 A 86 HIS B 42 HIS^? 28.37 MG MG B 302 coo 18.15 3.28 18.56 20.10 2.92 19.20 44.04 15.11 6.74 44.19 13.59 8.30 coo 21.52 6.83 26.64 21.22 5.53 23.85 47.41 10.20 11.40 46.99 12.91 10.22 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 39.34 12.99 16.30 37.26 13.24 16.40 ULMN 3 1pyl_c00 RIBONUCLEASE user 2 3 # 2 A 56 GLU C 154 GLU^? 18.91 MG MG C 302 A 67 ARG C 37 ARG^? 19.01 MG MG C 302 A 86 HIS C 42 HIS^? 28.09 MG MG C 302 coo 18.15 3.28 18.56 20.10 2.92 19.20 91.15 23.27 -13.33 91.61 21.91 -14.95 coo 21.52 6.83 26.64 21.22 5.53 23.85 89.36 17.23 -17.57 89.29 20.20 -16.76 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 95.93 22.96 -23.11 97.92 23.62 -23.02 ULMN 3 1pyl_c00 RIBONUCLEASE user 3 3 # 3 A 56 GLU C 174 GLU^? 19.72 MG MG C 301 A 67 ARG C 173 ARG^? 18.96 MG MG C 301 A 86 HIS C 170 HIS^? 10.68 MG MG C 301 coo 18.15 3.28 18.56 20.10 2.92 19.20 95.09 14.29 -3.63 95.25 12.23 -4.17 coo 21.52 6.83 26.64 21.22 5.53 23.85 89.11 11.40 -7.73 91.21 12.63 -9.73 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 89.96 21.05 -3.85 88.74 19.88 -2.61 ULMN 3 1pyl_c00 RIBONUCLEASE user 4 3 # 4 A 56 GLU D 154 GLU^? 18.75 MG MG D 302 A 67 ARG D 37 ARG^? 18.81 MG MG D 302 A 86 HIS D 42 HIS^? 28.21 MG MG D 302 coo 18.15 3.28 18.56 20.10 2.92 19.20 94.87 32.52 -36.42 96.07 33.39 -34.88 coo 21.52 6.83 26.64 21.22 5.53 23.85 96.81 38.21 -31.63 94.97 36.32 -33.06 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 98.45 29.90 -26.44 99.32 28.02 -26.13 ULMN 3 1pyl_c00 RIBONUCLEASE user 5 3 # 5 A 56 GLU D 174 GLU^? 19.76 MG MG D 301 A 67 ARG D 173 ARG^? 18.88 MG MG D 301 A 86 HIS D 170 HIS^? 10.59 MG MG D 301 coo 18.15 3.28 18.56 20.10 2.92 19.20 104.29 37.18 -46.00 105.30 38.94 -45.21 coo 21.52 6.83 26.64 21.22 5.53 23.85 100.48 42.57 -42.43 101.55 40.79 -40.06 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 95.57 34.81 -46.05 95.59 36.24 -47.59 ULMN 3 1pyl_c00 RIBONUCLEASE user 6 3 # 6 A 56 GLU E 154 GLU^? 19.05 MG MG E 302 A 67 ARG E 37 ARG^? 19.17 MG MG E 302 A 86 HIS E 42 HIS^? 28.20 MG MG E 302 coo 18.15 3.28 18.56 20.10 2.92 19.20 64.41 68.21 -58.47 65.40 69.20 -60.08 coo 21.52 6.83 26.64 21.22 5.53 23.85 70.82 68.02 -63.63 68.17 67.46 -62.14 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 62.33 71.93 -68.30 60.54 72.96 -68.64 ULMN 3 1pyl_c00 RIBONUCLEASE user 7 3 # 7 A 56 GLU F 154 GLU^? 18.97 MG MG F 301 A 67 ARG F 37 ARG^? 19.14 MG MG F 301 A 86 HIS F 42 HIS^? 28.34 MG MG F 301 coo 18.15 3.28 18.56 20.10 2.92 19.20 54.57 65.67 -81.55 53.36 66.51 -80.09 coo 21.52 6.83 26.64 21.22 5.53 23.85 48.80 64.46 -76.37 51.50 64.15 -77.79 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 55.11 70.50 -71.64 56.29 72.22 -71.48 1pyl_c00 source 1pyl RIBONUCLEASE : 7 hits 1pyl_c00 naa= 3 ULMN 3 1pyl_c01 RIBONUCLEASE user 1 3 # 1 B 56 GLU A 154 GLU^? 19.22 MG MG A 301 B 67 ARG A 37 ARG^? 18.99 MG MG A 301 B 86 HIS A 42 HIS^? 28.45 MG MG A 301 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 36.54 21.95 29.78 35.14 22.21 28.17 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 32.99 26.50 25.19 35.50 25.33 26.51 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 34.62 18.32 19.57 34.29 16.25 19.41 ULMN 3 1pyl_c01 RIBONUCLEASE user 2 3 # 2 B 56 GLU B 154 GLU^? 19.05 MG MG B 302 B 67 ARG B 37 ARG^? 19.17 MG MG B 302 B 86 HIS B 42 HIS^? 28.37 MG MG B 302 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 44.04 15.11 6.74 44.19 13.59 8.30 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 47.41 10.20 11.40 46.99 12.91 10.22 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 39.34 12.99 16.30 37.26 13.24 16.40 ULMN 3 1pyl_c01 RIBONUCLEASE user 3 3 # 3 B 56 GLU C 154 GLU^? 18.91 MG MG C 302 B 67 ARG C 37 ARG^? 19.01 MG MG C 302 B 86 HIS C 42 HIS^? 28.09 MG MG C 302 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 91.15 23.27 -13.33 91.61 21.91 -14.95 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 89.36 17.23 -17.57 89.29 20.20 -16.76 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 95.93 22.96 -23.11 97.92 23.62 -23.02 ULMN 3 1pyl_c01 RIBONUCLEASE user 4 3 # 4 B 56 GLU C 174 GLU^? 19.72 MG MG C 301 B 67 ARG C 173 ARG^? 18.96 MG MG C 301 B 86 HIS C 170 HIS^? 10.68 MG MG C 301 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 95.09 14.29 -3.63 95.25 12.23 -4.17 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 89.11 11.40 -7.73 91.21 12.63 -9.73 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 89.96 21.05 -3.85 88.74 19.88 -2.61 ULMN 3 1pyl_c01 RIBONUCLEASE user 5 3 # 5 B 56 GLU D 154 GLU^? 18.75 MG MG D 302 B 67 ARG D 37 ARG^? 18.81 MG MG D 302 B 86 HIS D 42 HIS^? 28.21 MG MG D 302 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 94.87 32.52 -36.42 96.07 33.39 -34.88 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 96.81 38.21 -31.63 94.97 36.32 -33.06 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 98.45 29.90 -26.44 99.32 28.02 -26.13 ULMN 3 1pyl_c01 RIBONUCLEASE user 6 3 # 6 B 56 GLU D 174 GLU^? 19.76 MG MG D 301 B 67 ARG D 173 ARG^? 18.88 MG MG D 301 B 86 HIS D 170 HIS^? 10.59 MG MG D 301 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 104.29 37.18 -46.00 105.30 38.94 -45.21 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 100.48 42.57 -42.43 101.55 40.79 -40.06 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 95.57 34.81 -46.05 95.59 36.24 -47.59 ULMN 3 1pyl_c01 RIBONUCLEASE user 7 3 # 7 B 56 GLU E 154 GLU^? 19.05 MG MG E 302 B 67 ARG E 37 ARG^? 19.17 MG MG E 302 B 86 HIS E 42 HIS^? 28.20 MG MG E 302 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 64.41 68.21 -58.47 65.40 69.20 -60.08 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 70.82 68.02 -63.63 68.17 67.46 -62.14 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 62.33 71.93 -68.30 60.54 72.96 -68.64 ULMN 3 1pyl_c01 RIBONUCLEASE user 8 3 # 8 B 56 GLU F 154 GLU^? 18.97 MG MG F 301 B 67 ARG F 37 ARG^? 19.14 MG MG F 301 B 86 HIS F 42 HIS^? 28.34 MG MG F 301 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 54.57 65.67 -81.55 53.36 66.51 -80.09 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 48.80 64.46 -76.37 51.50 64.15 -77.79 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 55.11 70.50 -71.64 56.29 72.22 -71.48 1pyl_c01 source 1pyl RIBONUCLEASE : 8 hits 1pyl_c01 naa= 3 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 1 3 # 1 A 67 ASP A 177 ASP^? 8.44 MG MG A 302 A 68 ALA A 181 ALA^? -5.18 MG MG A 302s A 72 LEU A 182 LEU^? -5.34 MG MG A 301s coo 46.76 7.59 18.65 45.27 6.01 18.52 33.02 29.04 43.18 33.79 27.88 44.78 coo 48.88 4.35 16.59 48.73 5.09 15.20 38.08 32.08 44.23 37.12 30.96 43.87 coo 53.89 6.25 15.09 52.88 7.92 14.14 40.67 34.08 40.79 40.73 33.90 38.69 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 2 3 # 2 A 67 ASP A 187 ASP^? -3.29 MG MG A 302s A 68 ALA A 181 ALA^? -5.18 MG MG A 302s A 72 LEU A 182 LEU^? -5.34 MG MG A 301s coo 46.76 7.59 18.65 45.27 6.01 18.52 39.43 26.57 46.78 39.37 27.83 45.03 coo 48.88 4.35 16.59 48.73 5.09 15.20 38.08 32.08 44.23 37.12 30.96 43.87 coo 53.89 6.25 15.09 52.88 7.92 14.14 40.67 34.08 40.79 40.73 33.90 38.69 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 3 3 # 3 A 67 ASP B 177 ASP^? 9.03 MG MG B 301 A 68 ALA B 181 ALA^? -4.86 MG MG B 301s A 72 LEU B 182 LEU^? -5.73 MG MG B 302s coo 46.76 7.59 18.65 45.27 6.01 18.52 51.97 11.04 -6.64 50.39 11.62 -7.94 coo 48.88 4.35 16.59 48.73 5.09 15.20 55.54 15.65 -6.80 54.26 14.84 -6.58 coo 53.89 6.25 15.09 52.88 7.92 14.14 57.99 17.68 -3.09 57.36 16.73 -1.25 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 4 3 # 4 A 67 ASP B 187 ASP^? -3.44 MG MG B 301s A 68 ALA B 181 ALA^? -4.86 MG MG B 301s A 72 LEU B 182 LEU^? -5.73 MG MG B 302s coo 46.76 7.59 18.65 45.27 6.01 18.52 50.64 18.14 -9.69 51.74 17.63 -7.86 coo 48.88 4.35 16.59 48.73 5.09 15.20 55.54 15.65 -6.80 54.26 14.84 -6.58 coo 53.89 6.25 15.09 52.88 7.92 14.14 57.99 17.68 -3.09 57.36 16.73 -1.25 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 5 3 # 5 A 67 ASP C 177 ASP^? 8.84 MG MG C 301 A 68 ALA C 181 ALA^? -4.94 MG MG C 301s A 72 LEU C 182 LEU^? 5.58 MG MG C 302s coo 46.76 7.59 18.65 45.27 6.01 18.52 85.60 16.42 -0.31 86.51 17.71 1.09 coo 48.88 4.35 16.59 48.73 5.09 15.20 80.65 19.58 0.32 82.11 19.32 0.03 coo 53.89 6.25 15.09 52.88 7.92 14.14 77.67 20.58 -3.32 78.49 20.15 -5.31 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 6 3 # 6 A 67 ASP C 187 ASP^? -3.72 MG MG C 301s A 68 ALA C 181 ALA^? -4.94 MG MG C 301s A 72 LEU C 182 LEU^? 5.58 MG MG C 302s coo 46.76 7.59 18.65 45.27 6.01 18.52 84.01 23.73 3.39 83.47 22.54 1.59 coo 48.88 4.35 16.59 48.73 5.09 15.20 80.65 19.58 0.32 82.11 19.32 0.03 coo 53.89 6.25 15.09 52.88 7.92 14.14 77.67 20.58 -3.32 78.49 20.15 -5.31 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 7 3 # 7 A 67 ASP D 187 ASP^? -2.95 MG MG D 301s A 68 ALA D 181 ALA^? -4.93 MG MG D 301s A 72 LEU D 182 LEU^? -5.45 MG MG D 302s coo 46.76 7.59 18.65 45.27 6.01 18.52 90.40 36.34 -52.69 89.24 37.98 -51.99 coo 48.88 4.35 16.59 48.73 5.09 15.20 89.39 41.74 -50.56 90.67 41.02 -50.20 coo 53.89 6.25 15.09 52.88 7.92 14.14 86.38 43.00 -46.95 87.33 42.66 -44.92 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 8 3 # 8 A 67 ASP E 177 ASP^? 8.55 MG MG E 301 A 68 ALA E 181 ALA^? -4.51 MG MG E 301s A 72 LEU E 182 LEU^? -5.68 MG MG E 302s coo 46.76 7.59 18.65 45.27 6.01 18.52 72.81 67.32 -45.03 71.14 67.96 -43.95 coo 48.88 4.35 16.59 48.73 5.09 15.20 72.69 61.53 -44.13 72.20 62.95 -44.39 coo 53.89 6.25 15.09 52.88 7.92 14.14 73.35 58.39 -47.69 73.54 59.04 -49.77 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 9 3 # 9 A 67 ASP E 187 ASP^? -2.71 MG MG E 301s A 68 ALA E 181 ALA^? -4.51 MG MG E 301s A 72 LEU E 182 LEU^? -5.68 MG MG E 302s coo 46.76 7.59 18.65 45.27 6.01 18.52 67.50 63.43 -41.69 68.97 62.26 -42.81 coo 48.88 4.35 16.59 48.73 5.09 15.20 72.69 61.53 -44.13 72.20 62.95 -44.39 coo 53.89 6.25 15.09 52.88 7.92 14.14 73.35 58.39 -47.69 73.54 59.04 -49.77 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 10 3 # 10 A 67 ASP F 177 ASP^? 8.15 MG MG F 302 A 68 ALA F 181 ALA^? -4.41 MG MG F 302s A 72 LEU F 182 LEU^? -5.58 MG MG F 301s coo 46.76 7.59 18.65 45.27 6.01 18.52 47.18 61.22 -94.50 48.48 62.32 -95.73 coo 48.88 4.35 16.59 48.73 5.09 15.20 49.03 55.67 -94.95 49.00 57.19 -94.78 coo 53.89 6.25 15.09 52.88 7.92 14.14 49.69 52.80 -91.13 49.62 53.78 -89.21 1q6l_c05 source 1q6l 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE : 10 hits 1q6l_c05 naa= 3 ULMN 3 1qaz_c00 ALGINATE LYASE A1-III user 1 3 # 1 A 191 ASN A 3 ASN.? 30.14 MG MG B 302 A 239 ARG B 48 ARG^? 25.20 MG MG B 302 A 246 TYR A 60 TYR^? 27.11 MG MG B 302 coo 2.50 7.27 18.06 0.76 7.28 16.81 50.04 4.36 19.09 51.05 2.61 18.36 coo -1.16 0.95 13.41 -2.50 3.71 13.61 52.22 10.51 15.00 52.46 7.79 16.39 coo 1.59 5.18 12.30 -0.74 6.52 11.61 55.01 4.24 16.98 56.13 3.24 14.65 ULMN 3 1qaz_c00 ALGINATE LYASE A1-III user 2 3 # 2 A 191 ASN B 3 ASN^? 29.91 MG MG A 301 A 239 ARG A 48 ARG^? 25.29 MG MG A 301 A 246 TYR B 60 TYR^? 27.11 MG MG A 301 coo 2.50 7.27 18.06 0.76 7.28 16.81 28.49 30.55 17.19 26.69 31.26 18.05 coo -1.16 0.95 13.41 -2.50 3.71 13.61 33.88 31.17 22.03 31.48 31.85 20.30 coo 1.59 5.18 12.30 -0.74 6.52 11.61 28.84 35.27 19.49 28.03 36.56 21.83 ULMN 3 1qaz_c00 ALGINATE LYASE A1-III user 3 3 # 3 A 191 ASN D 3 ASN^? 28.85 MG MG C 302 A 239 ARG C 48 ARG^? 25.02 MG MG C 302 A 246 TYR D 60 TYR^? 26.93 MG MG C 302 coo 2.50 7.27 18.06 0.76 7.28 16.81 89.53 11.43 -25.56 88.66 9.94 -24.30 coo -1.16 0.95 13.41 -2.50 3.71 13.61 84.94 16.06 -21.53 85.81 13.55 -23.08 coo 1.59 5.18 12.30 -0.74 6.52 11.61 84.40 9.28 -23.74 83.45 7.90 -21.49 1qaz_c00 source 1qaz ALGINATE LYASE A1-III : 3 hits 1qaz_c00 naa= 3 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 1 3 # 1 A 396 ARG B 37 ARG^? 19.17 MG MG B 302 A 581 ARG B 48 ARG^? 25.20 MG MG B 302 A 713 ARG B 50 ARG^? 16.38 MG MG B 302 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 47.41 10.20 11.40 46.99 12.91 10.22 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 52.22 10.51 15.00 52.46 7.79 16.39 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 55.38 14.91 7.80 56.60 14.73 10.62 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 2 3 # 2 A 396 ARG B 48 ARG^? 25.20 MG MG B 302 A 581 ARG B 37 ARG^? 19.17 MG MG B 302 A 713 ARG B 50 ARG^? 16.38 MG MG B 302 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 52.22 10.51 15.00 52.46 7.79 16.39 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 47.41 10.20 11.40 46.99 12.91 10.22 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 55.38 14.91 7.80 56.60 14.73 10.62 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 3 3 # 3 A 396 ARG C 37 ARG^? 19.01 MG MG C 302 A 581 ARG C 48 ARG^? 25.02 MG MG C 302 A 713 ARG C 50 ARG^? 16.05 MG MG C 302 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 89.36 17.23 -17.57 89.29 20.20 -16.76 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 84.94 16.06 -21.53 85.81 13.55 -23.08 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 80.61 19.03 -14.42 79.16 18.55 -17.10 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 4 3 # 4 A 396 ARG C 48 ARG^? 25.02 MG MG C 302 A 581 ARG C 37 ARG^? 19.01 MG MG C 302 A 713 ARG C 50 ARG^? 16.05 MG MG C 302 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 84.94 16.06 -21.53 85.81 13.55 -23.08 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 89.36 17.23 -17.57 89.29 20.20 -16.76 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 80.61 19.03 -14.42 79.16 18.55 -17.10 1qb4_c01 source 1qb4 PHOSPHOENOLPYRUVATE CARBOXYLASE : 4 hits 1qb4_c01 naa= 3 ULMN 3 1qfm_c00 PROLYL OLIGOPEPTIDASE user 1 3 # 1 A 554 SER A 189 SER^? 11.75 MG MG A 302 A 641 ASP A 148 ASP^? 2.72 MG MG A 301s A 680 HIS A 147 HIS^? 9.20 MG MG A 302 coo 34.48 40.33 79.08 36.40 39.98 80.55 40.99 19.00 44.32 41.51 18.14 46.48 coo 40.64 47.22 77.43 39.90 45.49 78.43 41.50 28.88 41.13 43.33 29.67 41.93 coo 38.53 44.50 81.45 37.60 42.73 80.84 40.24 23.10 39.83 38.32 22.34 40.22 ULMN 3 1qfm_c00 PROLYL OLIGOPEPTIDASE user 2 3 # 2 A 554 SER B 189 SER^? 12.11 MG MG B 301 A 641 ASP B 148 ASP^? 2.58 MG MG B 302s A 680 HIS B 147 HIS^? 9.27 MG MG B 301 coo 34.48 40.33 79.08 36.40 39.98 80.55 43.10 20.95 -7.74 42.82 21.56 -10.02 coo 40.64 47.22 77.43 39.90 45.49 78.43 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 38.53 44.50 81.45 37.60 42.73 80.84 46.73 18.97 -3.05 45.63 17.32 -3.73 ULMN 3 1qfm_c00 PROLYL OLIGOPEPTIDASE user 3 3 # 3 A 554 SER C 189 SER^? 12.09 MG MG C 301 A 641 ASP C 148 ASP^? 2.75 MG MG C 302s A 680 HIS C 147 HIS^? 9.44 MG MG C 301 coo 34.48 40.33 79.08 36.40 39.98 80.55 90.33 28.79 1.19 90.26 29.61 3.45 coo 40.64 47.22 77.43 39.90 45.49 78.43 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 38.53 44.50 81.45 37.60 42.73 80.84 87.61 25.71 -3.59 89.22 24.50 -2.99 ULMN 3 1qfm_c00 PROLYL OLIGOPEPTIDASE user 4 3 # 4 A 554 SER D 189 SER^? 12.12 MG MG D 301 A 641 ASP D 148 ASP^? 2.35 MG MG D 302s A 680 HIS D 147 HIS^? 9.43 MG MG D 301 coo 34.48 40.33 79.08 36.40 39.98 80.55 91.62 28.58 -50.95 91.45 27.78 -53.25 coo 40.64 47.22 77.43 39.90 45.49 78.43 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 38.53 44.50 81.45 37.60 42.73 80.84 90.95 32.51 -46.42 92.98 32.42 -46.93 ULMN 3 1qfm_c00 PROLYL OLIGOPEPTIDASE user 5 3 # 5 A 554 SER E 189 SER^? 11.91 MG MG E 301 A 641 ASP E 148 ASP^? 2.62 MG MG E 302s A 680 HIS E 147 HIS^? 9.22 MG MG E 301 coo 34.48 40.33 79.08 36.40 39.98 80.55 60.13 65.61 -43.87 59.01 65.34 -41.74 coo 40.64 47.22 77.43 39.90 45.49 78.43 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 38.53 44.50 81.45 37.60 42.73 80.84 63.87 64.43 -48.39 64.18 66.45 -47.92 ULMN 3 1qfm_c00 PROLYL OLIGOPEPTIDASE user 6 3 # 6 A 554 SER F 189 SER^? 11.88 MG MG F 302 A 641 ASP F 148 ASP^? 2.72 MG MG F 301s A 680 HIS F 147 HIS^? 8.79 MG MG F 302 coo 34.48 40.33 79.08 36.40 39.98 80.55 59.91 63.90 -95.91 60.70 64.22 -98.13 coo 40.64 47.22 77.43 39.90 45.49 78.43 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 38.53 44.50 81.45 37.60 42.73 80.84 56.63 61.66 -91.16 55.69 63.43 -91.80 1qfm_c00 source 1qfm PROLYL OLIGOPEPTIDASE : 6 hits 1qfm_c00 naa= 3 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 155 HIS A 170 HIS^? 10.56 MG MG A 302 A 236 ASP A 142 ASP^? 23.70 MG MG A 302 A 261 LYS A 137 LYS^? 34.85 MG MG A 301 coo 55.45 46.76 42.08 57.34 46.16 42.75 34.91 23.57 39.32 34.35 24.95 40.81 coo 48.87 29.19 44.63 49.10 27.34 43.63 46.39 7.18 37.53 46.28 7.18 39.63 coo 47.58 17.35 41.83 51.40 20.85 40.83 50.97 1.58 28.14 56.13 1.49 28.03 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 155 HIS B 170 HIS^? 10.51 MG MG B 301 A 236 ASP B 142 ASP^? 23.97 MG MG B 301 A 261 LYS B 137 LYS^? 34.56 MG MG B 302 coo 55.45 46.76 42.08 57.34 46.16 42.75 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 48.87 29.19 44.63 49.10 27.34 43.63 31.69 27.40 -1.31 32.10 27.37 -3.38 coo 47.58 17.35 41.83 51.40 20.85 40.83 26.56 32.46 7.93 27.87 37.71 9.31 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 155 HIS B 170 HIS^? 10.51 MG MG B 301 A 236 ASP C 23 ASP^? 15.39 MG MG B 301 A 261 LYS C 76 LYS^? 24.95 MG MG C 302 coo 55.45 46.76 42.08 57.34 46.16 42.75 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 48.87 29.19 44.63 49.10 27.34 43.63 65.24 6.82 -5.11 63.43 7.54 -4.15 coo 47.58 17.35 41.83 51.40 20.85 40.83 71.11 8.63 -16.76 75.44 5.17 -16.80 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 155 HIS C 170 HIS^? 10.68 MG MG C 301 A 236 ASP B 23 ASP^? 15.67 MG MG C 301 A 261 LYS B 76 LYS^? 25.77 MG MG B 302 coo 55.45 46.76 42.08 57.34 46.16 42.75 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 48.87 29.19 44.63 49.10 27.34 43.63 74.31 7.55 -1.09 75.08 9.17 -2.23 coo 47.58 17.35 41.83 51.40 20.85 40.83 67.82 8.19 10.14 64.96 3.09 10.62 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 155 HIS C 170 HIS^? 10.68 MG MG C 301 A 236 ASP C 142 ASP^? 23.76 MG MG C 301 A 261 LYS C 137 LYS^? 35.41 MG MG C 302 coo 55.45 46.76 42.08 57.34 46.16 42.75 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 48.87 29.19 44.63 49.10 27.34 43.63 97.94 39.27 -5.03 98.08 38.70 -2.97 coo 47.58 17.35 41.83 51.40 20.85 40.83 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 155 HIS D 170 HIS^? 10.59 MG MG D 301 A 236 ASP D 142 ASP^? 23.49 MG MG D 301 A 261 LYS D 137 LYS^? 37.57 MG MG D 302 coo 55.45 46.76 42.08 57.34 46.16 42.75 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 48.87 29.19 44.63 49.10 27.34 43.63 90.90 15.58 -44.76 91.35 16.09 -46.79 coo 47.58 17.35 41.83 51.40 20.85 40.83 88.48 8.58 -35.33 84.88 3.98 -33.96 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 A 155 HIS D 170 HIS^? 10.59 MG MG D 301 A 236 ASP E 23 ASP^? 15.43 MG MG D 301 A 261 LYS E 76 LYS^? 25.68 MG MG E 302 coo 55.45 46.76 42.08 57.34 46.16 42.75 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 48.87 29.19 44.63 49.10 27.34 43.63 91.98 54.64 -49.37 91.93 52.78 -48.33 coo 47.58 17.35 41.83 51.40 20.85 40.83 87.09 58.11 -60.91 88.65 63.65 -61.27 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 A 155 HIS E 170 HIS^? 10.33 MG MG E 301 A 236 ASP D 23 ASP^? 15.37 MG MG E 301 A 261 LYS D 76 LYS^? 25.08 MG MG D 302 coo 55.45 46.76 42.08 57.34 46.16 42.75 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 48.87 29.19 44.63 49.10 27.34 43.63 85.70 62.10 -45.60 84.07 62.13 -46.93 coo 47.58 17.35 41.83 51.40 20.85 40.83 88.18 56.35 -34.05 93.80 56.17 -32.93 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 A 155 HIS E 170 HIS^? 10.33 MG MG E 301 A 236 ASP E 142 ASP^? 23.66 MG MG E 301 A 261 LYS E 137 LYS^? 35.26 MG MG E 302 coo 55.45 46.76 42.08 57.34 46.16 42.75 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 48.87 29.19 44.63 49.10 27.34 43.63 47.19 67.15 -50.37 47.44 67.18 -48.23 coo 47.58 17.35 41.83 51.40 20.85 40.83 40.01 66.05 -59.66 36.65 60.99 -60.28 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 A 155 HIS F 170 HIS^? 9.84 MG MG F 302 A 236 ASP F 142 ASP^? 23.43 MG MG F 302 A 261 LYS F 137 LYS^? 35.13 MG MG F 301 coo 55.45 46.76 42.08 57.34 46.16 42.75 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 48.87 29.19 44.63 49.10 27.34 43.63 71.46 69.88 -89.76 71.03 69.93 -91.81 coo 47.58 17.35 41.83 51.40 20.85 40.83 78.53 72.20 -80.30 83.01 68.64 -79.79 1qgn_c00 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 10 hits 1qgn_c00 naa= 3 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 155 HIS A 170 HIS^? 10.56 MG MG A 302 B 236 ASP A 142 ASP^? 23.70 MG MG A 302 B 261 LYS A 137 LYS^? 34.85 MG MG A 301 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 34.91 23.57 39.32 34.35 24.95 40.81 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 46.39 7.18 37.53 46.28 7.18 39.63 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 50.97 1.58 28.14 56.13 1.49 28.03 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 155 HIS B 170 HIS^? 10.51 MG MG B 301 B 236 ASP B 142 ASP^? 23.97 MG MG B 301 B 261 LYS B 137 LYS^? 34.56 MG MG B 302 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 31.69 27.40 -1.31 32.10 27.37 -3.38 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 26.56 32.46 7.93 27.87 37.71 9.31 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 155 HIS B 170 HIS^? 10.51 MG MG B 301 B 236 ASP C 23 ASP^? 15.39 MG MG B 301 B 261 LYS C 76 LYS^? 24.95 MG MG C 302 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 65.24 6.82 -5.11 63.43 7.54 -4.15 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 71.11 8.63 -16.76 75.44 5.17 -16.80 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 155 HIS C 170 HIS^? 10.68 MG MG C 301 B 236 ASP C 142 ASP^? 23.76 MG MG C 301 B 261 LYS C 137 LYS^? 35.41 MG MG C 302 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 97.94 39.27 -5.03 98.08 38.70 -2.97 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 155 HIS D 170 HIS^? 10.59 MG MG D 301 B 236 ASP D 142 ASP^? 23.49 MG MG D 301 B 261 LYS D 137 LYS^? 37.57 MG MG D 302 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 90.90 15.58 -44.76 91.35 16.09 -46.79 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 88.48 8.58 -35.33 84.88 3.98 -33.96 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 155 HIS D 170 HIS^? 10.59 MG MG D 301 B 236 ASP E 23 ASP^? 15.43 MG MG D 301 B 261 LYS E 76 LYS^? 25.68 MG MG E 302 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 91.98 54.64 -49.37 91.93 52.78 -48.33 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 87.09 58.11 -60.91 88.65 63.65 -61.27 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 B 155 HIS E 170 HIS^? 10.33 MG MG E 301 B 236 ASP D 23 ASP^? 15.37 MG MG E 301 B 261 LYS D 76 LYS^? 25.08 MG MG D 302 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 85.70 62.10 -45.60 84.07 62.13 -46.93 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 88.18 56.35 -34.05 93.80 56.17 -32.93 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 B 155 HIS E 170 HIS^? 10.33 MG MG E 301 B 236 ASP E 142 ASP^? 23.66 MG MG E 301 B 261 LYS E 137 LYS^? 35.26 MG MG E 302 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 47.19 67.15 -50.37 47.44 67.18 -48.23 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 40.01 66.05 -59.66 36.65 60.99 -60.28 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 B 155 HIS F 170 HIS^? 9.84 MG MG F 302 B 236 ASP F 142 ASP^? 23.43 MG MG F 302 B 261 LYS F 137 LYS^? 35.13 MG MG F 301 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 71.46 69.88 -89.76 71.03 69.93 -91.81 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 78.53 72.20 -80.30 83.01 68.64 -79.79 1qgn_c01 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 9 hits 1qgn_c01 naa= 3 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 C 155 HIS A 170 HIS^? 10.56 MG MG A 302 C 236 ASP A 142 ASP^? 23.70 MG MG A 302 C 261 LYS A 137 LYS^? 34.85 MG MG A 301 coo 55.11 47.10 12.61 53.44 47.85 11.58 34.91 23.57 39.32 34.35 24.95 40.81 coo 45.78 31.11 9.51 44.25 30.06 10.53 46.39 7.18 37.53 46.28 7.18 39.63 coo 37.54 22.37 12.10 37.83 27.55 13.24 50.97 1.58 28.14 56.13 1.49 28.03 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 C 155 HIS B 170 HIS^? 10.51 MG MG B 301 C 236 ASP B 142 ASP^? 23.97 MG MG B 301 C 261 LYS B 137 LYS^? 34.56 MG MG B 302 coo 55.11 47.10 12.61 53.44 47.85 11.58 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 45.78 31.11 9.51 44.25 30.06 10.53 31.69 27.40 -1.31 32.10 27.37 -3.38 coo 37.54 22.37 12.10 37.83 27.55 13.24 26.56 32.46 7.93 27.87 37.71 9.31 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 C 155 HIS B 170 HIS^? 10.51 MG MG B 301 C 236 ASP C 23 ASP^? 15.39 MG MG B 301 C 261 LYS C 76 LYS^? 24.95 MG MG C 302 coo 55.11 47.10 12.61 53.44 47.85 11.58 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 45.78 31.11 9.51 44.25 30.06 10.53 65.24 6.82 -5.11 63.43 7.54 -4.15 coo 37.54 22.37 12.10 37.83 27.55 13.24 71.11 8.63 -16.76 75.44 5.17 -16.80 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 C 155 HIS C 170 HIS^? 10.68 MG MG C 301 C 236 ASP C 142 ASP^? 23.76 MG MG C 301 C 261 LYS C 137 LYS^? 35.41 MG MG C 302 coo 55.11 47.10 12.61 53.44 47.85 11.58 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 45.78 31.11 9.51 44.25 30.06 10.53 97.94 39.27 -5.03 98.08 38.70 -2.97 coo 37.54 22.37 12.10 37.83 27.55 13.24 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 C 155 HIS D 170 HIS^? 10.59 MG MG D 301 C 236 ASP D 142 ASP^? 23.49 MG MG D 301 C 261 LYS D 137 LYS^? 37.57 MG MG D 302 coo 55.11 47.10 12.61 53.44 47.85 11.58 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 45.78 31.11 9.51 44.25 30.06 10.53 90.90 15.58 -44.76 91.35 16.09 -46.79 coo 37.54 22.37 12.10 37.83 27.55 13.24 88.48 8.58 -35.33 84.88 3.98 -33.96 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 C 155 HIS D 170 HIS^? 10.59 MG MG D 301 C 236 ASP E 23 ASP^? 15.43 MG MG D 301 C 261 LYS E 76 LYS^? 25.68 MG MG E 302 coo 55.11 47.10 12.61 53.44 47.85 11.58 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 45.78 31.11 9.51 44.25 30.06 10.53 91.98 54.64 -49.37 91.93 52.78 -48.33 coo 37.54 22.37 12.10 37.83 27.55 13.24 87.09 58.11 -60.91 88.65 63.65 -61.27 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 C 155 HIS E 170 HIS^? 10.33 MG MG E 301 C 236 ASP D 23 ASP^? 15.37 MG MG E 301 C 261 LYS D 76 LYS^? 25.08 MG MG D 302 coo 55.11 47.10 12.61 53.44 47.85 11.58 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 45.78 31.11 9.51 44.25 30.06 10.53 85.70 62.10 -45.60 84.07 62.13 -46.93 coo 37.54 22.37 12.10 37.83 27.55 13.24 88.18 56.35 -34.05 93.80 56.17 -32.93 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 C 155 HIS E 170 HIS^? 10.33 MG MG E 301 C 236 ASP E 142 ASP^? 23.66 MG MG E 301 C 261 LYS E 137 LYS^? 35.26 MG MG E 302 coo 55.11 47.10 12.61 53.44 47.85 11.58 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 45.78 31.11 9.51 44.25 30.06 10.53 47.19 67.15 -50.37 47.44 67.18 -48.23 coo 37.54 22.37 12.10 37.83 27.55 13.24 40.01 66.05 -59.66 36.65 60.99 -60.28 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 C 155 HIS F 170 HIS^? 9.84 MG MG F 302 C 236 ASP F 142 ASP^? 23.43 MG MG F 302 C 261 LYS F 137 LYS^? 35.13 MG MG F 301 coo 55.11 47.10 12.61 53.44 47.85 11.58 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 45.78 31.11 9.51 44.25 30.06 10.53 71.46 69.88 -89.76 71.03 69.93 -91.81 coo 37.54 22.37 12.10 37.83 27.55 13.24 78.53 72.20 -80.30 83.01 68.64 -79.79 1qgn_c02 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 9 hits 1qgn_c02 naa= 3 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 D 155 HIS A 170 HIS^? 10.56 MG MG A 302 D 236 ASP A 142 ASP^? 23.70 MG MG A 302 D 261 LYS A 137 LYS^? 34.85 MG MG A 301 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 34.91 23.57 39.32 34.35 24.95 40.81 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 46.39 7.18 37.53 46.28 7.18 39.63 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 50.97 1.58 28.14 56.13 1.49 28.03 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 D 155 HIS B 170 HIS^? 10.51 MG MG B 301 D 236 ASP B 142 ASP^? 23.97 MG MG B 301 D 261 LYS B 137 LYS^? 34.56 MG MG B 302 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 31.69 27.40 -1.31 32.10 27.37 -3.38 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 26.56 32.46 7.93 27.87 37.71 9.31 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 D 155 HIS B 170 HIS^? 10.51 MG MG B 301 D 236 ASP C 23 ASP^? 15.39 MG MG B 301 D 261 LYS C 76 LYS^? 24.95 MG MG C 302 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 65.24 6.82 -5.11 63.43 7.54 -4.15 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 71.11 8.63 -16.76 75.44 5.17 -16.80 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 D 155 HIS C 170 HIS^? 10.68 MG MG C 301 D 236 ASP B 23 ASP^? 15.67 MG MG C 301 D 261 LYS B 76 LYS^? 25.77 MG MG B 302 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 74.31 7.55 -1.09 75.08 9.17 -2.23 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 67.82 8.19 10.14 64.96 3.09 10.62 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 D 155 HIS C 170 HIS^? 10.68 MG MG C 301 D 236 ASP C 142 ASP^? 23.76 MG MG C 301 D 261 LYS C 137 LYS^? 35.41 MG MG C 302 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 97.94 39.27 -5.03 98.08 38.70 -2.97 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 D 155 HIS D 170 HIS^? 10.59 MG MG D 301 D 236 ASP D 142 ASP^? 23.49 MG MG D 301 D 261 LYS D 137 LYS^? 37.57 MG MG D 302 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 90.90 15.58 -44.76 91.35 16.09 -46.79 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 88.48 8.58 -35.33 84.88 3.98 -33.96 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 D 155 HIS D 170 HIS^? 10.59 MG MG D 301 D 236 ASP E 23 ASP^? 15.43 MG MG D 301 D 261 LYS E 76 LYS^? 25.68 MG MG E 302 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 91.98 54.64 -49.37 91.93 52.78 -48.33 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 87.09 58.11 -60.91 88.65 63.65 -61.27 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 D 155 HIS E 170 HIS^? 10.33 MG MG E 301 D 236 ASP D 23 ASP^? 15.37 MG MG E 301 D 261 LYS D 76 LYS^? 25.08 MG MG D 302 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 85.70 62.10 -45.60 84.07 62.13 -46.93 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 88.18 56.35 -34.05 93.80 56.17 -32.93 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 D 155 HIS E 170 HIS^? 10.33 MG MG E 301 D 236 ASP E 142 ASP^? 23.66 MG MG E 301 D 261 LYS E 137 LYS^? 35.26 MG MG E 302 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 47.19 67.15 -50.37 47.44 67.18 -48.23 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 40.01 66.05 -59.66 36.65 60.99 -60.28 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 D 155 HIS F 170 HIS^? 9.84 MG MG F 302 D 236 ASP F 142 ASP^? 23.43 MG MG F 302 D 261 LYS F 137 LYS^? 35.13 MG MG F 301 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 71.46 69.88 -89.76 71.03 69.93 -91.81 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 78.53 72.20 -80.30 83.01 68.64 -79.79 1qgn_c03 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 10 hits 1qgn_c03 naa= 3 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 155 HIS A 170 HIS^? 10.56 MG MG A 302 E 236 ASP A 142 ASP^? 23.70 MG MG A 302 E 261 LYS A 137 LYS^? 34.85 MG MG A 301 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 34.91 23.57 39.32 34.35 24.95 40.81 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 46.39 7.18 37.53 46.28 7.18 39.63 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 50.97 1.58 28.14 56.13 1.49 28.03 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 155 HIS B 170 HIS^? 10.51 MG MG B 301 E 236 ASP B 142 ASP^? 23.97 MG MG B 301 E 261 LYS B 137 LYS^? 34.56 MG MG B 302 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 31.69 27.40 -1.31 32.10 27.37 -3.38 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 26.56 32.46 7.93 27.87 37.71 9.31 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 155 HIS B 170 HIS^? 10.51 MG MG B 301 E 236 ASP C 23 ASP^? 15.39 MG MG B 301 E 261 LYS C 76 LYS^? 24.95 MG MG C 302 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 65.24 6.82 -5.11 63.43 7.54 -4.15 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 71.11 8.63 -16.76 75.44 5.17 -16.80 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 E 155 HIS C 170 HIS^? 10.68 MG MG C 301 E 236 ASP B 23 ASP^? 15.67 MG MG C 301 E 261 LYS B 76 LYS^? 25.77 MG MG B 302 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 74.31 7.55 -1.09 75.08 9.17 -2.23 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 67.82 8.19 10.14 64.96 3.09 10.62 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 E 155 HIS C 170 HIS^? 10.68 MG MG C 301 E 236 ASP C 142 ASP^? 23.76 MG MG C 301 E 261 LYS C 137 LYS^? 35.41 MG MG C 302 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 97.94 39.27 -5.03 98.08 38.70 -2.97 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 E 155 HIS D 170 HIS^? 10.59 MG MG D 301 E 236 ASP D 142 ASP^? 23.49 MG MG D 301 E 261 LYS D 137 LYS^? 37.57 MG MG D 302 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 90.90 15.58 -44.76 91.35 16.09 -46.79 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 88.48 8.58 -35.33 84.88 3.98 -33.96 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 E 155 HIS D 170 HIS^? 10.59 MG MG D 301 E 236 ASP E 23 ASP^? 15.43 MG MG D 301 E 261 LYS E 76 LYS^? 25.68 MG MG E 302 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 91.98 54.64 -49.37 91.93 52.78 -48.33 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 87.09 58.11 -60.91 88.65 63.65 -61.27 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 E 155 HIS E 170 HIS^? 10.33 MG MG E 301 E 236 ASP D 23 ASP^? 15.37 MG MG E 301 E 261 LYS D 76 LYS^? 25.08 MG MG D 302 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 85.70 62.10 -45.60 84.07 62.13 -46.93 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 88.18 56.35 -34.05 93.80 56.17 -32.93 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 E 155 HIS E 170 HIS^? 10.33 MG MG E 301 E 236 ASP E 142 ASP^? 23.66 MG MG E 301 E 261 LYS E 137 LYS^? 35.26 MG MG E 302 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 47.19 67.15 -50.37 47.44 67.18 -48.23 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 40.01 66.05 -59.66 36.65 60.99 -60.28 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 E 155 HIS F 170 HIS^? 9.84 MG MG F 302 E 236 ASP F 142 ASP^? 23.43 MG MG F 302 E 261 LYS F 137 LYS^? 35.13 MG MG F 301 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 71.46 69.88 -89.76 71.03 69.93 -91.81 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 78.53 72.20 -80.30 83.01 68.64 -79.79 1qgn_c04 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 10 hits 1qgn_c04 naa= 3 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 155 HIS A 170 HIS^? 10.56 MG MG A 302 F 236 ASP A 142 ASP^? 23.70 MG MG A 302 F 261 LYS A 137 LYS^? 34.85 MG MG A 301 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 34.91 23.57 39.32 34.35 24.95 40.81 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 46.39 7.18 37.53 46.28 7.18 39.63 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 50.97 1.58 28.14 56.13 1.49 28.03 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 155 HIS B 170 HIS^? 10.51 MG MG B 301 F 236 ASP B 142 ASP^? 23.97 MG MG B 301 F 261 LYS B 137 LYS^? 34.56 MG MG B 302 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 31.69 27.40 -1.31 32.10 27.37 -3.38 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 26.56 32.46 7.93 27.87 37.71 9.31 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 155 HIS B 170 HIS^? 10.51 MG MG B 301 F 236 ASP C 23 ASP^? 15.39 MG MG B 301 F 261 LYS C 76 LYS^? 24.95 MG MG C 302 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 65.24 6.82 -5.11 63.43 7.54 -4.15 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 71.11 8.63 -16.76 75.44 5.17 -16.80 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 F 155 HIS C 170 HIS^? 10.68 MG MG C 301 F 236 ASP C 142 ASP^? 23.76 MG MG C 301 F 261 LYS C 137 LYS^? 35.41 MG MG C 302 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 97.94 39.27 -5.03 98.08 38.70 -2.97 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 F 155 HIS D 170 HIS^? 10.59 MG MG D 301 F 236 ASP D 142 ASP^? 23.49 MG MG D 301 F 261 LYS D 137 LYS^? 37.57 MG MG D 302 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 90.90 15.58 -44.76 91.35 16.09 -46.79 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 88.48 8.58 -35.33 84.88 3.98 -33.96 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 F 155 HIS D 170 HIS^? 10.59 MG MG D 301 F 236 ASP E 23 ASP^? 15.43 MG MG D 301 F 261 LYS E 76 LYS^? 25.68 MG MG E 302 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 91.98 54.64 -49.37 91.93 52.78 -48.33 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 87.09 58.11 -60.91 88.65 63.65 -61.27 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 F 155 HIS E 170 HIS^? 10.33 MG MG E 301 F 236 ASP D 23 ASP^? 15.37 MG MG E 301 F 261 LYS D 76 LYS^? 25.08 MG MG D 302 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 85.70 62.10 -45.60 84.07 62.13 -46.93 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 88.18 56.35 -34.05 93.80 56.17 -32.93 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 F 155 HIS E 170 HIS^? 10.33 MG MG E 301 F 236 ASP E 142 ASP^? 23.66 MG MG E 301 F 261 LYS E 137 LYS^? 35.26 MG MG E 302 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 47.19 67.15 -50.37 47.44 67.18 -48.23 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 40.01 66.05 -59.66 36.65 60.99 -60.28 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 F 155 HIS F 170 HIS^? 9.84 MG MG F 302 F 236 ASP F 142 ASP^? 23.43 MG MG F 302 F 261 LYS F 137 LYS^? 35.13 MG MG F 301 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 71.46 69.88 -89.76 71.03 69.93 -91.81 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 78.53 72.20 -80.30 83.01 68.64 -79.79 1qgn_c05 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 9 hits 1qgn_c05 naa= 3 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 G 155 HIS A 170 HIS^? 10.56 MG MG A 302 G 236 ASP A 142 ASP^? 23.70 MG MG A 302 G 261 LYS A 137 LYS^? 34.85 MG MG A 301 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 34.91 23.57 39.32 34.35 24.95 40.81 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 46.39 7.18 37.53 46.28 7.18 39.63 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 50.97 1.58 28.14 56.13 1.49 28.03 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 G 155 HIS B 170 HIS^? 10.51 MG MG B 301 G 236 ASP B 142 ASP^? 23.97 MG MG B 301 G 261 LYS B 137 LYS^? 34.56 MG MG B 302 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 31.69 27.40 -1.31 32.10 27.37 -3.38 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 26.56 32.46 7.93 27.87 37.71 9.31 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 G 155 HIS B 170 HIS^? 10.51 MG MG B 301 G 236 ASP C 23 ASP^? 15.39 MG MG B 301 G 261 LYS C 76 LYS^? 24.95 MG MG C 302 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 65.24 6.82 -5.11 63.43 7.54 -4.15 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 71.11 8.63 -16.76 75.44 5.17 -16.80 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 G 155 HIS C 170 HIS^? 10.68 MG MG C 301 G 236 ASP C 142 ASP^? 23.76 MG MG C 301 G 261 LYS C 137 LYS^? 35.41 MG MG C 302 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 97.94 39.27 -5.03 98.08 38.70 -2.97 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 G 155 HIS D 170 HIS^? 10.59 MG MG D 301 G 236 ASP D 142 ASP^? 23.49 MG MG D 301 G 261 LYS D 137 LYS^? 37.57 MG MG D 302 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 90.90 15.58 -44.76 91.35 16.09 -46.79 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 88.48 8.58 -35.33 84.88 3.98 -33.96 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 G 155 HIS D 170 HIS^? 10.59 MG MG D 301 G 236 ASP E 23 ASP^? 15.43 MG MG D 301 G 261 LYS E 76 LYS^? 25.68 MG MG E 302 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 91.98 54.64 -49.37 91.93 52.78 -48.33 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 87.09 58.11 -60.91 88.65 63.65 -61.27 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 G 155 HIS E 170 HIS^? 10.33 MG MG E 301 G 236 ASP D 23 ASP^? 15.37 MG MG E 301 G 261 LYS D 76 LYS^? 25.08 MG MG D 302 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 85.70 62.10 -45.60 84.07 62.13 -46.93 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 88.18 56.35 -34.05 93.80 56.17 -32.93 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 G 155 HIS E 170 HIS^? 10.33 MG MG E 301 G 236 ASP E 142 ASP^? 23.66 MG MG E 301 G 261 LYS E 137 LYS^? 35.26 MG MG E 302 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 47.19 67.15 -50.37 47.44 67.18 -48.23 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 40.01 66.05 -59.66 36.65 60.99 -60.28 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 G 155 HIS F 170 HIS^? 9.84 MG MG F 302 G 236 ASP F 142 ASP^? 23.43 MG MG F 302 G 261 LYS F 137 LYS^? 35.13 MG MG F 301 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 71.46 69.88 -89.76 71.03 69.93 -91.81 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 78.53 72.20 -80.30 83.01 68.64 -79.79 1qgn_c06 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 9 hits 1qgn_c06 naa= 3 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 H 155 HIS A 170 HIS^? 10.56 MG MG A 302 H 236 ASP A 142 ASP^? 23.70 MG MG A 302 H 261 LYS A 137 LYS^? 34.85 MG MG A 301 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 34.91 23.57 39.32 34.35 24.95 40.81 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 46.39 7.18 37.53 46.28 7.18 39.63 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 50.97 1.58 28.14 56.13 1.49 28.03 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 H 155 HIS B 170 HIS^? 10.51 MG MG B 301 H 236 ASP B 142 ASP^? 23.97 MG MG B 301 H 261 LYS B 137 LYS^? 34.56 MG MG B 302 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 31.69 27.40 -1.31 32.10 27.37 -3.38 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 26.56 32.46 7.93 27.87 37.71 9.31 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 H 155 HIS B 170 HIS^? 10.51 MG MG B 301 H 236 ASP C 23 ASP^? 15.39 MG MG B 301 H 261 LYS C 76 LYS^? 24.95 MG MG C 302 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 65.24 6.82 -5.11 63.43 7.54 -4.15 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 71.11 8.63 -16.76 75.44 5.17 -16.80 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 H 155 HIS C 170 HIS^? 10.68 MG MG C 301 H 236 ASP B 23 ASP^? 15.67 MG MG C 301 H 261 LYS B 76 LYS^? 25.77 MG MG B 302 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 74.31 7.55 -1.09 75.08 9.17 -2.23 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 67.82 8.19 10.14 64.96 3.09 10.62 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 H 155 HIS C 170 HIS^? 10.68 MG MG C 301 H 236 ASP C 142 ASP^? 23.76 MG MG C 301 H 261 LYS C 137 LYS^? 35.41 MG MG C 302 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 97.94 39.27 -5.03 98.08 38.70 -2.97 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 H 155 HIS D 170 HIS^? 10.59 MG MG D 301 H 236 ASP D 142 ASP^? 23.49 MG MG D 301 H 261 LYS D 137 LYS^? 37.57 MG MG D 302 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 90.90 15.58 -44.76 91.35 16.09 -46.79 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 88.48 8.58 -35.33 84.88 3.98 -33.96 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 H 155 HIS D 170 HIS^? 10.59 MG MG D 301 H 236 ASP E 23 ASP^? 15.43 MG MG D 301 H 261 LYS E 76 LYS^? 25.68 MG MG E 302 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 91.98 54.64 -49.37 91.93 52.78 -48.33 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 87.09 58.11 -60.91 88.65 63.65 -61.27 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 H 155 HIS E 170 HIS^? 10.33 MG MG E 301 H 236 ASP D 23 ASP^? 15.37 MG MG E 301 H 261 LYS D 76 LYS^? 25.08 MG MG D 302 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 85.70 62.10 -45.60 84.07 62.13 -46.93 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 88.18 56.35 -34.05 93.80 56.17 -32.93 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 H 155 HIS E 170 HIS^? 10.33 MG MG E 301 H 236 ASP E 142 ASP^? 23.66 MG MG E 301 H 261 LYS E 137 LYS^? 35.26 MG MG E 302 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 47.19 67.15 -50.37 47.44 67.18 -48.23 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 40.01 66.05 -59.66 36.65 60.99 -60.28 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 H 155 HIS F 170 HIS^? 9.84 MG MG F 302 H 236 ASP F 142 ASP^? 23.43 MG MG F 302 H 261 LYS F 137 LYS^? 35.13 MG MG F 301 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 71.46 69.88 -89.76 71.03 69.93 -91.81 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 78.53 72.20 -80.30 83.01 68.64 -79.79 1qgn_c07 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 10 hits 1qgn_c07 naa= 3 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR A 60 TYR^? 27.11 MG MG B 302 A 236 ASP A 58 ASP^? 26.75 MG MG B 302 A 261 LYS A 137 LYS^? 34.85 MG MG A 301 coo 55.48 26.51 40.65 55.39 23.99 39.43 55.01 4.24 16.98 56.13 3.24 14.65 coo 48.87 29.19 44.63 49.10 27.34 43.63 53.93 9.80 21.09 53.83 8.90 19.15 coo 47.58 17.35 41.83 51.40 20.85 40.83 50.97 1.58 28.14 56.13 1.49 28.03 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 163 TYR B 60 TYR^? 27.11 MG MG A 301 A 236 ASP B 58 ASP^? 26.73 MG MG A 301 A 261 LYS B 137 LYS^? 34.56 MG MG B 302 coo 55.48 26.51 40.65 55.39 23.99 39.43 28.84 35.27 19.49 28.03 36.56 21.83 coo 48.87 29.19 44.63 49.10 27.34 43.63 34.42 33.56 15.74 33.50 33.49 17.59 coo 47.58 17.35 41.83 51.40 20.85 40.83 26.56 32.46 7.93 27.87 37.71 9.31 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 163 TYR B 129 TYR^? 10.63 MG MG B 302 A 236 ASP B 128 ASP^? -3.57 MG MG B 302s A 261 LYS B 111 LYS^? 13.75 MG MG B 302 coo 55.48 26.51 40.65 55.39 23.99 39.43 47.85 23.00 1.51 47.62 23.50 4.24 coo 48.87 29.19 44.63 49.10 27.34 43.63 52.92 24.09 -2.19 54.73 25.14 -1.90 coo 47.58 17.35 41.83 51.40 20.85 40.83 42.84 32.14 1.80 46.84 32.68 -2.87 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 163 TYR C 60 TYR^? 26.95 MG MG D 302 A 236 ASP C 58 ASP^? 26.67 MG MG D 302 A 261 LYS C 137 LYS^? 35.41 MG MG C 302 coo 55.48 26.51 40.65 55.39 23.99 39.43 97.75 47.69 -25.92 97.82 49.25 -28.26 coo 48.87 29.19 44.63 49.10 27.34 43.63 93.40 43.81 -22.27 94.18 44.45 -24.11 coo 47.58 17.35 41.83 51.40 20.85 40.83 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 163 TYR C 129 TYR^? 10.65 MG MG C 302 A 236 ASP C 128 ASP^? -3.22 MG MG C 302s A 261 LYS C 111 LYS^? 16.56 MG MG C 302 coo 55.48 26.51 40.65 55.39 23.99 39.43 84.95 29.43 -7.96 85.04 30.16 -10.69 coo 48.87 29.19 44.63 49.10 27.34 43.63 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 47.58 17.35 41.83 51.40 20.85 40.83 86.36 39.56 -8.06 84.36 40.84 -3.15 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 163 TYR D 60 TYR^? 26.93 MG MG C 302 A 236 ASP D 58 ASP^? 26.59 MG MG C 302 A 261 LYS D 137 LYS^? 37.57 MG MG D 302 coo 55.48 26.51 40.65 55.39 23.99 39.43 84.40 9.28 -23.74 83.45 7.90 -21.49 coo 48.87 29.19 44.63 49.10 27.34 43.63 83.38 14.85 -27.71 84.09 14.12 -25.85 coo 47.58 17.35 41.83 51.40 20.85 40.83 88.48 8.58 -35.33 84.88 3.98 -33.96 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 A 163 TYR E 60 TYR^? 27.19 MG MG F 301 A 236 ASP E 58 ASP^? 26.76 MG MG F 301 A 261 LYS E 137 LYS^? 35.26 MG MG E 302 coo 55.48 26.51 40.65 55.39 23.99 39.43 39.82 61.07 -70.68 38.29 60.72 -72.98 coo 48.87 29.19 44.63 49.10 27.34 43.63 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 47.58 17.35 41.83 51.40 20.85 40.83 40.01 66.05 -59.66 36.65 60.99 -60.28 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 A 163 TYR E 129 TYR^? 10.89 MG MG E 302 A 236 ASP E 128 ASP^? -3.53 MG MG E 302s A 261 LYS E 111 LYS^? 14.52 MG MG E 302 coo 55.48 26.51 40.65 55.39 23.99 39.43 62.09 60.15 -52.83 61.47 59.53 -55.45 coo 48.87 29.19 44.63 49.10 27.34 43.63 65.38 56.57 -48.58 66.15 54.57 -48.61 coo 47.58 17.35 41.83 51.40 20.85 40.83 52.49 56.44 -52.43 54.52 53.78 -47.52 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 A 163 TYR F 60 TYR^? 27.07 MG MG E 302 A 236 ASP F 58 ASP^? 26.87 MG MG E 302 A 261 LYS F 137 LYS^? 35.13 MG MG F 301 coo 55.48 26.51 40.65 55.39 23.99 39.43 79.79 68.64 -68.89 81.11 68.86 -66.46 coo 48.87 29.19 44.63 49.10 27.34 43.63 75.55 64.68 -72.56 76.21 65.63 -70.79 coo 47.58 17.35 41.83 51.40 20.85 40.83 78.53 72.20 -80.30 83.01 68.64 -79.79 1qgn_c08 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 9 hits 1qgn_c08 naa= 3 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR A 60 TYR^? 27.11 MG MG B 302 B 236 ASP A 58 ASP^? 26.75 MG MG B 302 B 261 LYS A 137 LYS^? 34.85 MG MG A 301 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 55.01 4.24 16.98 56.13 3.24 14.65 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 53.93 9.80 21.09 53.83 8.90 19.15 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 50.97 1.58 28.14 56.13 1.49 28.03 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR B 60 TYR^? 27.11 MG MG A 301 B 236 ASP B 58 ASP^? 26.73 MG MG A 301 B 261 LYS B 137 LYS^? 34.56 MG MG B 302 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 28.84 35.27 19.49 28.03 36.56 21.83 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 34.42 33.56 15.74 33.50 33.49 17.59 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 26.56 32.46 7.93 27.87 37.71 9.31 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 163 TYR B 129 TYR^? 10.63 MG MG B 302 B 236 ASP B 128 ASP^? -3.57 MG MG B 302s B 261 LYS B 111 LYS^? 13.75 MG MG B 302 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 47.85 23.00 1.51 47.62 23.50 4.24 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 52.92 24.09 -2.19 54.73 25.14 -1.90 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 42.84 32.14 1.80 46.84 32.68 -2.87 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 163 TYR C 60 TYR^? 26.95 MG MG D 302 B 236 ASP C 58 ASP^? 26.67 MG MG D 302 B 261 LYS C 137 LYS^? 35.41 MG MG C 302 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 97.75 47.69 -25.92 97.82 49.25 -28.26 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 93.40 43.81 -22.27 94.18 44.45 -24.11 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 163 TYR C 129 TYR^? 10.65 MG MG C 302 B 236 ASP C 128 ASP^? -3.22 MG MG C 302s B 261 LYS C 111 LYS^? 16.56 MG MG C 302 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 84.95 29.43 -7.96 85.04 30.16 -10.69 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 86.36 39.56 -8.06 84.36 40.84 -3.15 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 163 TYR D 60 TYR^? 26.93 MG MG C 302 B 236 ASP D 58 ASP^? 26.59 MG MG C 302 B 261 LYS D 137 LYS^? 37.57 MG MG D 302 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 84.40 9.28 -23.74 83.45 7.90 -21.49 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 83.38 14.85 -27.71 84.09 14.12 -25.85 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 88.48 8.58 -35.33 84.88 3.98 -33.96 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 B 163 TYR E 60 TYR^? 27.19 MG MG F 301 B 236 ASP E 58 ASP^? 26.76 MG MG F 301 B 261 LYS E 137 LYS^? 35.26 MG MG E 302 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 39.82 61.07 -70.68 38.29 60.72 -72.98 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 40.01 66.05 -59.66 36.65 60.99 -60.28 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 B 163 TYR E 129 TYR^? 10.89 MG MG E 302 B 236 ASP E 128 ASP^? -3.53 MG MG E 302s B 261 LYS E 111 LYS^? 14.52 MG MG E 302 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 62.09 60.15 -52.83 61.47 59.53 -55.45 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 65.38 56.57 -48.58 66.15 54.57 -48.61 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 52.49 56.44 -52.43 54.52 53.78 -47.52 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 B 163 TYR F 60 TYR^? 27.07 MG MG E 302 B 236 ASP F 58 ASP^? 26.87 MG MG E 302 B 261 LYS F 137 LYS^? 35.13 MG MG F 301 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 79.79 68.64 -68.89 81.11 68.86 -66.46 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 75.55 64.68 -72.56 76.21 65.63 -70.79 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 78.53 72.20 -80.30 83.01 68.64 -79.79 1qgn_c09 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 9 hits 1qgn_c09 naa= 3 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 C 163 TYR A 60 TYR^? 27.11 MG MG B 302 C 236 ASP A 58 ASP^? 26.75 MG MG B 302 C 261 LYS A 137 LYS^? 34.85 MG MG A 301 coo 39.51 34.34 13.63 37.63 32.61 14.79 55.01 4.24 16.98 56.13 3.24 14.65 coo 45.78 31.11 9.51 44.25 30.06 10.53 53.93 9.80 21.09 53.83 8.90 19.15 coo 37.54 22.37 12.10 37.83 27.55 13.24 50.97 1.58 28.14 56.13 1.49 28.03 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 C 163 TYR B 60 TYR^? 27.11 MG MG A 301 C 236 ASP B 58 ASP^? 26.73 MG MG A 301 C 261 LYS B 137 LYS^? 34.56 MG MG B 302 coo 39.51 34.34 13.63 37.63 32.61 14.79 28.84 35.27 19.49 28.03 36.56 21.83 coo 45.78 31.11 9.51 44.25 30.06 10.53 34.42 33.56 15.74 33.50 33.49 17.59 coo 37.54 22.37 12.10 37.83 27.55 13.24 26.56 32.46 7.93 27.87 37.71 9.31 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 C 163 TYR B 129 TYR^? 10.63 MG MG B 302 C 236 ASP B 128 ASP^? -3.57 MG MG B 302s C 261 LYS B 111 LYS^? 13.75 MG MG B 302 coo 39.51 34.34 13.63 37.63 32.61 14.79 47.85 23.00 1.51 47.62 23.50 4.24 coo 45.78 31.11 9.51 44.25 30.06 10.53 52.92 24.09 -2.19 54.73 25.14 -1.90 coo 37.54 22.37 12.10 37.83 27.55 13.24 42.84 32.14 1.80 46.84 32.68 -2.87 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 C 163 TYR C 60 TYR^? 26.95 MG MG D 302 C 236 ASP C 58 ASP^? 26.67 MG MG D 302 C 261 LYS C 137 LYS^? 35.41 MG MG C 302 coo 39.51 34.34 13.63 37.63 32.61 14.79 97.75 47.69 -25.92 97.82 49.25 -28.26 coo 45.78 31.11 9.51 44.25 30.06 10.53 93.40 43.81 -22.27 94.18 44.45 -24.11 coo 37.54 22.37 12.10 37.83 27.55 13.24 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 C 163 TYR C 129 TYR^? 10.65 MG MG C 302 C 236 ASP C 128 ASP^? -3.22 MG MG C 302s C 261 LYS C 111 LYS^? 16.56 MG MG C 302 coo 39.51 34.34 13.63 37.63 32.61 14.79 84.95 29.43 -7.96 85.04 30.16 -10.69 coo 45.78 31.11 9.51 44.25 30.06 10.53 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 37.54 22.37 12.10 37.83 27.55 13.24 86.36 39.56 -8.06 84.36 40.84 -3.15 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 C 163 TYR D 60 TYR^? 26.93 MG MG C 302 C 236 ASP D 58 ASP^? 26.59 MG MG C 302 C 261 LYS D 137 LYS^? 37.57 MG MG D 302 coo 39.51 34.34 13.63 37.63 32.61 14.79 84.40 9.28 -23.74 83.45 7.90 -21.49 coo 45.78 31.11 9.51 44.25 30.06 10.53 83.38 14.85 -27.71 84.09 14.12 -25.85 coo 37.54 22.37 12.10 37.83 27.55 13.24 88.48 8.58 -35.33 84.88 3.98 -33.96 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 C 163 TYR E 60 TYR^? 27.19 MG MG F 301 C 236 ASP E 58 ASP^? 26.76 MG MG F 301 C 261 LYS E 137 LYS^? 35.26 MG MG E 302 coo 39.51 34.34 13.63 37.63 32.61 14.79 39.82 61.07 -70.68 38.29 60.72 -72.98 coo 45.78 31.11 9.51 44.25 30.06 10.53 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 37.54 22.37 12.10 37.83 27.55 13.24 40.01 66.05 -59.66 36.65 60.99 -60.28 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 C 163 TYR E 129 TYR^? 10.89 MG MG E 302 C 236 ASP E 128 ASP^? -3.53 MG MG E 302s C 261 LYS E 111 LYS^? 14.52 MG MG E 302 coo 39.51 34.34 13.63 37.63 32.61 14.79 62.09 60.15 -52.83 61.47 59.53 -55.45 coo 45.78 31.11 9.51 44.25 30.06 10.53 65.38 56.57 -48.58 66.15 54.57 -48.61 coo 37.54 22.37 12.10 37.83 27.55 13.24 52.49 56.44 -52.43 54.52 53.78 -47.52 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 C 163 TYR F 60 TYR^? 27.07 MG MG E 302 C 236 ASP F 58 ASP^? 26.87 MG MG E 302 C 261 LYS F 137 LYS^? 35.13 MG MG F 301 coo 39.51 34.34 13.63 37.63 32.61 14.79 79.79 68.64 -68.89 81.11 68.86 -66.46 coo 45.78 31.11 9.51 44.25 30.06 10.53 75.55 64.68 -72.56 76.21 65.63 -70.79 coo 37.54 22.37 12.10 37.83 27.55 13.24 78.53 72.20 -80.30 83.01 68.64 -79.79 1qgn_c10 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 9 hits 1qgn_c10 naa= 3 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 D 163 TYR A 60 TYR^? 27.11 MG MG B 302 D 236 ASP A 58 ASP^? 26.75 MG MG B 302 D 261 LYS A 137 LYS^? 34.85 MG MG A 301 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 55.01 4.24 16.98 56.13 3.24 14.65 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 53.93 9.80 21.09 53.83 8.90 19.15 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 50.97 1.58 28.14 56.13 1.49 28.03 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 D 163 TYR B 60 TYR^? 27.11 MG MG A 301 D 236 ASP B 58 ASP^? 26.73 MG MG A 301 D 261 LYS B 137 LYS^? 34.56 MG MG B 302 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 28.84 35.27 19.49 28.03 36.56 21.83 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 34.42 33.56 15.74 33.50 33.49 17.59 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 26.56 32.46 7.93 27.87 37.71 9.31 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 D 163 TYR B 129 TYR^? 10.63 MG MG B 302 D 236 ASP B 128 ASP^? -3.57 MG MG B 302s D 261 LYS B 111 LYS^? 13.75 MG MG B 302 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 47.85 23.00 1.51 47.62 23.50 4.24 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 52.92 24.09 -2.19 54.73 25.14 -1.90 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 42.84 32.14 1.80 46.84 32.68 -2.87 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 D 163 TYR C 60 TYR^? 26.95 MG MG D 302 D 236 ASP C 58 ASP^? 26.67 MG MG D 302 D 261 LYS C 137 LYS^? 35.41 MG MG C 302 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 97.75 47.69 -25.92 97.82 49.25 -28.26 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 93.40 43.81 -22.27 94.18 44.45 -24.11 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 D 163 TYR C 129 TYR^? 10.65 MG MG C 302 D 236 ASP C 128 ASP^? -3.22 MG MG C 302s D 261 LYS C 111 LYS^? 16.56 MG MG C 302 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 84.95 29.43 -7.96 85.04 30.16 -10.69 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 86.36 39.56 -8.06 84.36 40.84 -3.15 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 D 163 TYR D 60 TYR^? 26.93 MG MG C 302 D 236 ASP D 58 ASP^? 26.59 MG MG C 302 D 261 LYS D 137 LYS^? 37.57 MG MG D 302 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 84.40 9.28 -23.74 83.45 7.90 -21.49 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 83.38 14.85 -27.71 84.09 14.12 -25.85 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 88.48 8.58 -35.33 84.88 3.98 -33.96 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 D 163 TYR E 60 TYR^? 27.19 MG MG F 301 D 236 ASP E 58 ASP^? 26.76 MG MG F 301 D 261 LYS E 137 LYS^? 35.26 MG MG E 302 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 39.82 61.07 -70.68 38.29 60.72 -72.98 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 40.01 66.05 -59.66 36.65 60.99 -60.28 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 D 163 TYR E 129 TYR^? 10.89 MG MG E 302 D 236 ASP E 128 ASP^? -3.53 MG MG E 302s D 261 LYS E 111 LYS^? 14.52 MG MG E 302 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 62.09 60.15 -52.83 61.47 59.53 -55.45 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 65.38 56.57 -48.58 66.15 54.57 -48.61 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 52.49 56.44 -52.43 54.52 53.78 -47.52 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 D 163 TYR F 60 TYR^? 27.07 MG MG E 302 D 236 ASP F 58 ASP^? 26.87 MG MG E 302 D 261 LYS F 137 LYS^? 35.13 MG MG F 301 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 79.79 68.64 -68.89 81.11 68.86 -66.46 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 75.55 64.68 -72.56 76.21 65.63 -70.79 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 78.53 72.20 -80.30 83.01 68.64 -79.79 1qgn_c11 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 9 hits 1qgn_c11 naa= 3 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR A 60 TYR^? 27.11 MG MG B 302 E 236 ASP A 58 ASP^? 26.75 MG MG B 302 E 261 LYS A 137 LYS^? 34.85 MG MG A 301 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 55.01 4.24 16.98 56.13 3.24 14.65 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 53.93 9.80 21.09 53.83 8.90 19.15 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 50.97 1.58 28.14 56.13 1.49 28.03 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 163 TYR A 129 TYR^? 10.90 MG MG A 301 E 236 ASP A 128 ASP^? -3.32 MG MG A 301s E 261 LYS A 111 LYS^? 15.16 MG MG A 301 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 44.80 23.54 35.75 45.57 23.36 33.08 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 46.50 28.23 39.77 47.49 30.10 39.82 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 52.67 17.19 35.90 54.65 19.90 40.50 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 163 TYR B 60 TYR^? 27.11 MG MG A 301 E 236 ASP B 58 ASP^? 26.73 MG MG A 301 E 261 LYS B 137 LYS^? 34.56 MG MG B 302 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 28.84 35.27 19.49 28.03 36.56 21.83 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 34.42 33.56 15.74 33.50 33.49 17.59 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 26.56 32.46 7.93 27.87 37.71 9.31 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 E 163 TYR B 129 TYR^? 10.63 MG MG B 302 E 236 ASP B 128 ASP^? -3.57 MG MG B 302s E 261 LYS B 111 LYS^? 13.75 MG MG B 302 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 47.85 23.00 1.51 47.62 23.50 4.24 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 52.92 24.09 -2.19 54.73 25.14 -1.90 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 42.84 32.14 1.80 46.84 32.68 -2.87 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 E 163 TYR C 60 TYR^? 26.95 MG MG D 302 E 236 ASP C 58 ASP^? 26.67 MG MG D 302 E 261 LYS C 137 LYS^? 35.41 MG MG C 302 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 97.75 47.69 -25.92 97.82 49.25 -28.26 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 93.40 43.81 -22.27 94.18 44.45 -24.11 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 E 163 TYR C 129 TYR^? 10.65 MG MG C 302 E 236 ASP C 128 ASP^? -3.22 MG MG C 302s E 261 LYS C 111 LYS^? 16.56 MG MG C 302 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 84.95 29.43 -7.96 85.04 30.16 -10.69 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 86.36 39.56 -8.06 84.36 40.84 -3.15 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 E 163 TYR D 60 TYR^? 26.93 MG MG C 302 E 236 ASP D 58 ASP^? 26.59 MG MG C 302 E 261 LYS D 137 LYS^? 37.57 MG MG D 302 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 84.40 9.28 -23.74 83.45 7.90 -21.49 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 83.38 14.85 -27.71 84.09 14.12 -25.85 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 88.48 8.58 -35.33 84.88 3.98 -33.96 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 E 163 TYR D 129 TYR^? 10.79 MG MG D 302 E 236 ASP D 128 ASP^? -3.70 MG MG D 302s E 261 LYS D 111 LYS^? 15.85 MG MG D 302 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 86.45 31.36 -42.20 86.02 30.90 -39.46 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 83.33 35.45 -46.13 81.57 36.63 -46.10 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 81.21 22.69 -42.10 78.68 23.89 -46.57 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 E 163 TYR E 60 TYR^? 27.19 MG MG F 301 E 236 ASP E 58 ASP^? 26.76 MG MG F 301 E 261 LYS E 137 LYS^? 35.26 MG MG E 302 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 39.82 61.07 -70.68 38.29 60.72 -72.98 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 40.01 66.05 -59.66 36.65 60.99 -60.28 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 E 163 TYR E 129 TYR^? 10.89 MG MG E 302 E 236 ASP E 128 ASP^? -3.53 MG MG E 302s E 261 LYS E 111 LYS^? 14.52 MG MG E 302 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 62.09 60.15 -52.83 61.47 59.53 -55.45 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 65.38 56.57 -48.58 66.15 54.57 -48.61 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 52.49 56.44 -52.43 54.52 53.78 -47.52 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 E 163 TYR F 60 TYR^? 27.07 MG MG E 302 E 236 ASP F 58 ASP^? 26.87 MG MG E 302 E 261 LYS F 137 LYS^? 35.13 MG MG F 301 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 79.79 68.64 -68.89 81.11 68.86 -66.46 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 75.55 64.68 -72.56 76.21 65.63 -70.79 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 78.53 72.20 -80.30 83.01 68.64 -79.79 1qgn_c12 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 11 hits 1qgn_c12 naa= 3 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR A 60 TYR^? 27.11 MG MG B 302 F 236 ASP A 58 ASP^? 26.75 MG MG B 302 F 261 LYS A 137 LYS^? 34.85 MG MG A 301 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 55.01 4.24 16.98 56.13 3.24 14.65 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 53.93 9.80 21.09 53.83 8.90 19.15 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 50.97 1.58 28.14 56.13 1.49 28.03 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 163 TYR A 129 TYR^? 10.90 MG MG A 301 F 236 ASP A 128 ASP^? -3.32 MG MG A 301s F 261 LYS A 111 LYS^? 15.16 MG MG A 301 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 44.80 23.54 35.75 45.57 23.36 33.08 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 46.50 28.23 39.77 47.49 30.10 39.82 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 52.67 17.19 35.90 54.65 19.90 40.50 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 163 TYR B 60 TYR^? 27.11 MG MG A 301 F 236 ASP B 58 ASP^? 26.73 MG MG A 301 F 261 LYS B 137 LYS^? 34.56 MG MG B 302 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 28.84 35.27 19.49 28.03 36.56 21.83 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 34.42 33.56 15.74 33.50 33.49 17.59 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 26.56 32.46 7.93 27.87 37.71 9.31 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 F 163 TYR B 129 TYR^? 10.63 MG MG B 302 F 236 ASP B 128 ASP^? -3.57 MG MG B 302s F 261 LYS B 111 LYS^? 13.75 MG MG B 302 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 47.85 23.00 1.51 47.62 23.50 4.24 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 52.92 24.09 -2.19 54.73 25.14 -1.90 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 42.84 32.14 1.80 46.84 32.68 -2.87 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 F 163 TYR C 60 TYR^? 26.95 MG MG D 302 F 236 ASP C 58 ASP^? 26.67 MG MG D 302 F 261 LYS C 137 LYS^? 35.41 MG MG C 302 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 97.75 47.69 -25.92 97.82 49.25 -28.26 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 93.40 43.81 -22.27 94.18 44.45 -24.11 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 F 163 TYR C 129 TYR^? 10.65 MG MG C 302 F 236 ASP C 128 ASP^? -3.22 MG MG C 302s F 261 LYS C 111 LYS^? 16.56 MG MG C 302 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 84.95 29.43 -7.96 85.04 30.16 -10.69 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 86.36 39.56 -8.06 84.36 40.84 -3.15 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 F 163 TYR D 60 TYR^? 26.93 MG MG C 302 F 236 ASP D 58 ASP^? 26.59 MG MG C 302 F 261 LYS D 137 LYS^? 37.57 MG MG D 302 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 84.40 9.28 -23.74 83.45 7.90 -21.49 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 83.38 14.85 -27.71 84.09 14.12 -25.85 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 88.48 8.58 -35.33 84.88 3.98 -33.96 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 F 163 TYR D 129 TYR^? 10.79 MG MG D 302 F 236 ASP D 128 ASP^? -3.70 MG MG D 302s F 261 LYS D 111 LYS^? 15.85 MG MG D 302 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 86.45 31.36 -42.20 86.02 30.90 -39.46 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 83.33 35.45 -46.13 81.57 36.63 -46.10 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 81.21 22.69 -42.10 78.68 23.89 -46.57 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 F 163 TYR E 60 TYR^? 27.19 MG MG F 301 F 236 ASP E 58 ASP^? 26.76 MG MG F 301 F 261 LYS E 137 LYS^? 35.26 MG MG E 302 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 39.82 61.07 -70.68 38.29 60.72 -72.98 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 40.01 66.05 -59.66 36.65 60.99 -60.28 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 F 163 TYR E 129 TYR^? 10.89 MG MG E 302 F 236 ASP E 128 ASP^? -3.53 MG MG E 302s F 261 LYS E 111 LYS^? 14.52 MG MG E 302 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 62.09 60.15 -52.83 61.47 59.53 -55.45 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 65.38 56.57 -48.58 66.15 54.57 -48.61 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 52.49 56.44 -52.43 54.52 53.78 -47.52 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 F 163 TYR F 60 TYR^? 27.07 MG MG E 302 F 236 ASP F 58 ASP^? 26.87 MG MG E 302 F 261 LYS F 137 LYS^? 35.13 MG MG F 301 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 79.79 68.64 -68.89 81.11 68.86 -66.46 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 75.55 64.68 -72.56 76.21 65.63 -70.79 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 78.53 72.20 -80.30 83.01 68.64 -79.79 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 F 163 TYR F 129 TYR^? 10.92 MG MG F 301 F 236 ASP F 128 ASP^? -3.41 MG MG F 301s F 261 LYS F 111 LYS^? 15.21 MG MG F 301 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 59.69 58.61 -86.67 60.36 58.48 -83.96 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 57.76 53.73 -90.50 57.46 51.64 -90.28 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 69.70 58.57 -86.86 69.67 53.74 -90.29 1qgn_c13 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 12 hits 1qgn_c13 naa= 3 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 G 163 TYR A 60 TYR^? 27.11 MG MG B 302 G 236 ASP A 58 ASP^? 26.75 MG MG B 302 G 261 LYS A 137 LYS^? 34.85 MG MG A 301 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 55.01 4.24 16.98 56.13 3.24 14.65 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 53.93 9.80 21.09 53.83 8.90 19.15 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 50.97 1.58 28.14 56.13 1.49 28.03 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 G 163 TYR B 60 TYR^? 27.11 MG MG A 301 G 236 ASP B 58 ASP^? 26.73 MG MG A 301 G 261 LYS B 137 LYS^? 34.56 MG MG B 302 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 28.84 35.27 19.49 28.03 36.56 21.83 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 34.42 33.56 15.74 33.50 33.49 17.59 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 26.56 32.46 7.93 27.87 37.71 9.31 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 G 163 TYR B 129 TYR^? 10.63 MG MG B 302 G 236 ASP B 128 ASP^? -3.57 MG MG B 302s G 261 LYS B 111 LYS^? 13.75 MG MG B 302 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 47.85 23.00 1.51 47.62 23.50 4.24 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 52.92 24.09 -2.19 54.73 25.14 -1.90 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 42.84 32.14 1.80 46.84 32.68 -2.87 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 G 163 TYR C 60 TYR^? 26.95 MG MG D 302 G 236 ASP C 58 ASP^? 26.67 MG MG D 302 G 261 LYS C 137 LYS^? 35.41 MG MG C 302 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 97.75 47.69 -25.92 97.82 49.25 -28.26 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 93.40 43.81 -22.27 94.18 44.45 -24.11 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 G 163 TYR C 129 TYR^? 10.65 MG MG C 302 G 236 ASP C 128 ASP^? -3.22 MG MG C 302s G 261 LYS C 111 LYS^? 16.56 MG MG C 302 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 84.95 29.43 -7.96 85.04 30.16 -10.69 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 86.36 39.56 -8.06 84.36 40.84 -3.15 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 G 163 TYR D 60 TYR^? 26.93 MG MG C 302 G 236 ASP D 58 ASP^? 26.59 MG MG C 302 G 261 LYS D 137 LYS^? 37.57 MG MG D 302 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 84.40 9.28 -23.74 83.45 7.90 -21.49 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 83.38 14.85 -27.71 84.09 14.12 -25.85 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 88.48 8.58 -35.33 84.88 3.98 -33.96 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 G 163 TYR E 60 TYR^? 27.19 MG MG F 301 G 236 ASP E 58 ASP^? 26.76 MG MG F 301 G 261 LYS E 137 LYS^? 35.26 MG MG E 302 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 39.82 61.07 -70.68 38.29 60.72 -72.98 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 40.01 66.05 -59.66 36.65 60.99 -60.28 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 G 163 TYR E 129 TYR^? 10.89 MG MG E 302 G 236 ASP E 128 ASP^? -3.53 MG MG E 302s G 261 LYS E 111 LYS^? 14.52 MG MG E 302 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 62.09 60.15 -52.83 61.47 59.53 -55.45 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 65.38 56.57 -48.58 66.15 54.57 -48.61 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 52.49 56.44 -52.43 54.52 53.78 -47.52 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 G 163 TYR F 60 TYR^? 27.07 MG MG E 302 G 236 ASP F 58 ASP^? 26.87 MG MG E 302 G 261 LYS F 137 LYS^? 35.13 MG MG F 301 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 79.79 68.64 -68.89 81.11 68.86 -66.46 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 75.55 64.68 -72.56 76.21 65.63 -70.79 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 78.53 72.20 -80.30 83.01 68.64 -79.79 1qgn_c14 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 9 hits 1qgn_c14 naa= 3 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 H 163 TYR A 60 TYR^? 27.11 MG MG B 302 H 236 ASP A 58 ASP^? 26.75 MG MG B 302 H 261 LYS A 137 LYS^? 34.85 MG MG A 301 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 55.01 4.24 16.98 56.13 3.24 14.65 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 53.93 9.80 21.09 53.83 8.90 19.15 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 50.97 1.58 28.14 56.13 1.49 28.03 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 H 163 TYR B 60 TYR^? 27.11 MG MG A 301 H 236 ASP B 58 ASP^? 26.73 MG MG A 301 H 261 LYS B 137 LYS^? 34.56 MG MG B 302 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 28.84 35.27 19.49 28.03 36.56 21.83 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 34.42 33.56 15.74 33.50 33.49 17.59 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 26.56 32.46 7.93 27.87 37.71 9.31 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 H 163 TYR B 129 TYR^? 10.63 MG MG B 302 H 236 ASP B 128 ASP^? -3.57 MG MG B 302s H 261 LYS B 111 LYS^? 13.75 MG MG B 302 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 47.85 23.00 1.51 47.62 23.50 4.24 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 52.92 24.09 -2.19 54.73 25.14 -1.90 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 42.84 32.14 1.80 46.84 32.68 -2.87 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 H 163 TYR C 60 TYR^? 26.95 MG MG D 302 H 236 ASP C 58 ASP^? 26.67 MG MG D 302 H 261 LYS C 137 LYS^? 35.41 MG MG C 302 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 97.75 47.69 -25.92 97.82 49.25 -28.26 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 93.40 43.81 -22.27 94.18 44.45 -24.11 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 H 163 TYR C 129 TYR^? 10.65 MG MG C 302 H 236 ASP C 128 ASP^? -3.22 MG MG C 302s H 261 LYS C 111 LYS^? 16.56 MG MG C 302 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 84.95 29.43 -7.96 85.04 30.16 -10.69 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 86.36 39.56 -8.06 84.36 40.84 -3.15 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 H 163 TYR D 60 TYR^? 26.93 MG MG C 302 H 236 ASP D 58 ASP^? 26.59 MG MG C 302 H 261 LYS D 137 LYS^? 37.57 MG MG D 302 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 84.40 9.28 -23.74 83.45 7.90 -21.49 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 83.38 14.85 -27.71 84.09 14.12 -25.85 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 88.48 8.58 -35.33 84.88 3.98 -33.96 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 H 163 TYR E 60 TYR^? 27.19 MG MG F 301 H 236 ASP E 58 ASP^? 26.76 MG MG F 301 H 261 LYS E 137 LYS^? 35.26 MG MG E 302 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 39.82 61.07 -70.68 38.29 60.72 -72.98 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 40.01 66.05 -59.66 36.65 60.99 -60.28 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 H 163 TYR E 129 TYR^? 10.89 MG MG E 302 H 236 ASP E 128 ASP^? -3.53 MG MG E 302s H 261 LYS E 111 LYS^? 14.52 MG MG E 302 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 62.09 60.15 -52.83 61.47 59.53 -55.45 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 65.38 56.57 -48.58 66.15 54.57 -48.61 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 52.49 56.44 -52.43 54.52 53.78 -47.52 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 H 163 TYR F 60 TYR^? 27.07 MG MG E 302 H 236 ASP F 58 ASP^? 26.87 MG MG E 302 H 261 LYS F 137 LYS^? 35.13 MG MG F 301 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 79.79 68.64 -68.89 81.11 68.86 -66.46 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 75.55 64.68 -72.56 76.21 65.63 -70.79 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 78.53 72.20 -80.30 83.01 68.64 -79.79 1qgn_c15 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 9 hits 1qgn_c15 naa= 3 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 1 3 # 1 A 49 ASP A 23 ASP^? 22.90 MG MG A 301 A 147 THR A 26 THR^? 25.44 MG MG A 301 A 294 ASP A 81 ASP^? 34.50 MG MG A 301 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 36.40 52.47 38.61 38.03 53.36 39.72 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 36.75 57.21 36.53 37.82 55.40 36.11 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 31.12 60.71 27.43 31.74 59.35 25.95 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 2 3 # 2 A 49 ASP A 138 ASP^? 33.08 MG MG A 302 A 147 THR A 2 THR.? 34.64 MG MG A 301 A 294 ASP A 58 ASP^? 26.75 MG MG B 302 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 47.10 -0.97 29.63 45.89 0.22 30.96 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 47.80 1.72 22.09 46.70 1.88 23.97 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 53.93 9.80 21.09 53.83 8.90 19.15 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 3 3 # 3 A 49 ASP A 171 ASP^? 17.17 MG MG A 302 A 147 THR A 169 THR^? 18.45 MG MG A 302 A 294 ASP A 148 ASP^? 2.72 MG MG A 301s coo 1.13 15.67 -24.51 2.35 14.34 -25.71 29.78 23.67 36.63 28.48 25.11 35.71 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 34.64 19.08 35.13 33.08 18.40 33.78 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 41.50 28.88 41.13 43.33 29.67 41.93 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 4 3 # 4 A 49 ASP A 171 ASP^? 17.17 MG MG A 302 A 147 THR A 175 THR^? 12.07 MG MG A 302 A 294 ASP A 148 ASP^? 2.72 MG MG A 301s coo 1.13 15.67 -24.51 2.35 14.34 -25.71 29.78 23.67 36.63 28.48 25.11 35.71 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 29.08 25.19 42.91 31.22 24.90 42.83 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 41.50 28.88 41.13 43.33 29.67 41.93 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 5 3 # 5 A 49 ASP A 171 ASP^? 17.17 MG MG A 302 A 147 THR A 175 THR^? 12.07 MG MG A 302 A 294 ASP A 187 ASP^? -3.29 MG MG A 302s coo 1.13 15.67 -24.51 2.35 14.34 -25.71 29.78 23.67 36.63 28.48 25.11 35.71 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 29.08 25.19 42.91 31.22 24.90 42.83 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 39.43 26.57 46.78 39.37 27.83 45.03 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 6 3 # 6 A 49 ASP B 138 ASP^? 33.32 MG MG B 302 A 147 THR B 2 THR^? 34.11 MG MG B 302 A 294 ASP B 58 ASP^? 26.73 MG MG A 301 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 23.42 29.01 6.78 24.36 28.48 4.94 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 25.51 29.18 13.74 26.24 28.19 11.93 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 34.42 33.56 15.74 33.50 33.49 17.59 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 7 3 # 7 A 49 ASP B 171 ASP^? 16.92 MG MG B 301 A 147 THR B 169 THR^? 18.43 MG MG B 301 A 294 ASP B 148 ASP^? 2.58 MG MG B 302s coo 1.13 15.67 -24.51 2.35 14.34 -25.71 45.30 8.50 -0.71 46.30 6.81 0.12 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 41.38 13.97 0.97 40.27 12.43 2.02 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 52.73 19.23 -3.77 53.81 20.99 -4.31 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 8 3 # 8 A 49 ASP B 171 ASP^? 16.92 MG MG B 301 A 147 THR B 175 THR^? 12.15 MG MG B 301 A 294 ASP B 148 ASP^? 2.58 MG MG B 302s coo 1.13 15.67 -24.51 2.35 14.34 -25.71 45.30 8.50 -0.71 46.30 6.81 0.12 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 46.88 7.94 -7.07 47.05 10.06 -6.52 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 52.73 19.23 -3.77 53.81 20.99 -4.31 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 9 3 # 9 A 49 ASP B 171 ASP^? 16.92 MG MG B 301 A 147 THR B 175 THR^? 12.15 MG MG B 301 A 294 ASP B 187 ASP^? -3.44 MG MG B 301s coo 1.13 15.67 -24.51 2.35 14.34 -25.71 45.30 8.50 -0.71 46.30 6.81 0.12 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 46.88 7.94 -7.07 47.05 10.06 -6.52 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 50.64 18.14 -9.69 51.74 17.63 -7.86 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 10 3 # 10 A 49 ASP C 23 ASP^? 15.39 MG MG B 301 A 147 THR C 26 THR^? 15.45 MG MG B 301 A 294 ASP B 177 ASP^? 9.03 MG MG B 301 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 65.24 6.82 -5.11 63.43 7.54 -4.15 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 60.72 4.69 -7.37 61.99 6.20 -8.33 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 51.97 11.04 -6.64 50.39 11.62 -7.94 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 11 3 # 11 A 49 ASP C 23 ASP^? 15.39 MG MG B 301 A 147 THR C 26 THR^? 15.45 MG MG B 301 A 294 ASP C 81 ASP^? 23.42 MG MG B 301 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 65.24 6.82 -5.11 63.43 7.54 -4.15 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 60.72 4.69 -7.37 61.99 6.20 -8.33 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 60.68 -2.08 -16.91 61.02 -0.17 -17.89 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 12 3 # 12 A 49 ASP C 138 ASP^? 33.43 MG MG C 302 A 147 THR C 2 THR^? 33.69 MG MG C 302 A 294 ASP C 58 ASP^? 26.67 MG MG D 302 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 105.43 43.97 -13.30 104.85 43.08 -11.43 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 103.03 43.13 -20.15 102.74 41.72 -18.56 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 93.40 43.81 -22.27 94.18 44.45 -24.11 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 13 3 # 13 A 49 ASP C 171 ASP^? 17.08 MG MG C 301 A 147 THR C 169 THR^? 18.51 MG MG C 301 A 294 ASP C 148 ASP^? 2.75 MG MG C 302s coo 1.13 15.67 -24.51 2.35 14.34 -25.71 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 94.19 23.02 -7.83 95.56 21.86 -9.07 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 81.96 23.83 -2.68 80.24 25.11 -2.27 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 14 3 # 14 A 49 ASP C 171 ASP^? 17.08 MG MG C 301 A 147 THR C 175 THR^? 12.73 MG MG C 301 A 294 ASP C 148 ASP^? 2.75 MG MG C 302s coo 1.13 15.67 -24.51 2.35 14.34 -25.71 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 91.24 15.45 0.47 90.99 17.39 -0.47 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 81.96 23.83 -2.68 80.24 25.11 -2.27 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 15 3 # 15 A 49 ASP C 171 ASP^? 17.08 MG MG C 301 A 147 THR C 175 THR^? 12.73 MG MG C 301 A 294 ASP C 187 ASP^? -3.72 MG MG C 301s coo 1.13 15.67 -24.51 2.35 14.34 -25.71 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 91.24 15.45 0.47 90.99 17.39 -0.47 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 84.01 23.73 3.39 83.47 22.54 1.59 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 16 3 # 16 A 49 ASP D 23 ASP^? 15.37 MG MG E 301 A 147 THR D 26 THR^? 14.34 MG MG E 301 A 294 ASP D 81 ASP^? 23.25 MG MG E 301 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 85.70 62.10 -45.60 84.07 62.13 -46.93 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 83.76 66.31 -43.53 82.86 64.39 -43.13 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 89.25 71.36 -34.47 87.72 70.06 -33.67 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 17 3 # 17 A 49 ASP D 23 ASP^? 15.37 MG MG E 301 A 147 THR D 26 THR^? 14.34 MG MG E 301 A 294 ASP E 177 ASP^? 8.55 MG MG E 301 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 85.70 62.10 -45.60 84.07 62.13 -46.93 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 83.76 66.31 -43.53 82.86 64.39 -43.13 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 18 3 # 18 A 49 ASP D 138 ASP^? 33.64 MG MG D 302 A 147 THR D 2 THR^? 33.99 MG MG D 302 A 294 ASP D 58 ASP^? 26.59 MG MG C 302 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 93.00 7.50 -35.79 93.88 8.48 -37.45 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 91.82 9.34 -29.18 91.80 10.46 -31.03 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 83.38 14.85 -27.71 84.09 14.12 -25.85 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 19 3 # 19 A 49 ASP D 171 ASP^? 16.95 MG MG D 301 A 147 THR D 169 THR^? 18.47 MG MG D 301 A 294 ASP D 148 ASP^? 2.35 MG MG D 302s coo 1.13 15.67 -24.51 2.35 14.34 -25.71 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 97.62 30.68 -41.94 99.48 30.62 -40.85 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 87.78 37.50 -47.56 85.79 37.49 -48.28 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 20 3 # 20 A 49 ASP D 171 ASP^? 16.95 MG MG D 301 A 147 THR D 175 THR^? 12.60 MG MG D 301 A 294 ASP D 148 ASP^? 2.35 MG MG D 302s coo 1.13 15.67 -24.51 2.35 14.34 -25.71 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 100.33 38.24 -50.15 98.81 36.95 -49.29 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 87.78 37.50 -47.56 85.79 37.49 -48.28 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 21 3 # 21 A 49 ASP D 171 ASP^? 16.95 MG MG D 301 A 147 THR D 175 THR^? 12.60 MG MG D 301 A 294 ASP D 187 ASP^? -2.95 MG MG D 301s coo 1.13 15.67 -24.51 2.35 14.34 -25.71 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 100.33 38.24 -50.15 98.81 36.95 -49.29 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 90.40 36.34 -52.69 89.24 37.98 -51.99 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 22 3 # 22 A 49 ASP E 23 ASP^? 15.43 MG MG D 301 A 147 THR E 26 THR^? 15.11 MG MG D 301 A 294 ASP D 177 ASP^? 8.43 MG MG D 301 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 91.98 54.64 -49.37 91.93 52.78 -48.33 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 96.37 52.25 -51.33 94.44 51.47 -51.78 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 95.74 41.01 -49.76 94.81 39.90 -51.24 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 23 3 # 23 A 49 ASP E 23 ASP^? 15.43 MG MG D 301 A 147 THR E 26 THR^? 15.11 MG MG D 301 A 294 ASP E 81 ASP^? 24.19 MG MG D 301 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 91.98 54.64 -49.37 91.93 52.78 -48.33 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 96.37 52.25 -51.33 94.44 51.47 -51.78 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 101.61 56.30 -60.24 100.25 55.53 -61.72 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 24 3 # 24 A 49 ASP E 138 ASP^? 33.31 MG MG E 302 A 147 THR E 2 THR^? 33.84 MG MG E 302 A 294 ASP E 58 ASP^? 26.76 MG MG F 301 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 39.58 70.77 -58.63 40.74 70.78 -56.80 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 41.32 68.37 -65.29 42.66 69.03 -63.78 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 45.39 59.31 -66.83 44.62 59.88 -68.72 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 25 3 # 25 A 49 ASP E 171 ASP^? 16.73 MG MG E 301 A 147 THR E 169 THR^? 18.18 MG MG E 301 A 294 ASP E 148 ASP^? 2.62 MG MG E 302s coo 1.13 15.67 -24.51 2.35 14.34 -25.71 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 63.17 71.31 -52.89 63.43 72.88 -54.31 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 68.29 60.44 -47.29 68.03 58.42 -46.50 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 26 3 # 26 A 49 ASP E 171 ASP^? 16.73 MG MG E 301 A 147 THR E 175 THR^? 12.38 MG MG E 301 A 294 ASP E 148 ASP^? 2.62 MG MG E 302s coo 1.13 15.67 -24.51 2.35 14.34 -25.71 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 71.20 72.92 -44.89 69.57 71.76 -45.77 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 68.29 60.44 -47.29 68.03 58.42 -46.50 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 27 3 # 27 A 49 ASP E 171 ASP^? 16.73 MG MG E 301 A 147 THR E 175 THR^? 12.38 MG MG E 301 A 294 ASP E 187 ASP^? -2.71 MG MG E 301s coo 1.13 15.67 -24.51 2.35 14.34 -25.71 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 71.20 72.92 -44.89 69.57 71.76 -45.77 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 67.50 63.43 -41.69 68.97 62.26 -42.81 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 28 3 # 28 A 49 ASP F 23 ASP^? 23.03 MG MG F 301 A 147 THR F 26 THR^? 28.34 MG MG F 301 A 294 ASP F 81 ASP^? 34.61 MG MG F 301 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 31.30 43.61 -89.40 33.44 43.69 -89.02 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 26.77 41.53 -87.68 28.88 41.46 -87.10 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 23.08 43.10 -77.79 24.94 42.10 -77.55 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 29 3 # 29 A 49 ASP F 138 ASP^? 33.51 MG MG F 302 A 147 THR F 2 THR^? 34.54 MG MG F 301 A 294 ASP F 58 ASP^? 26.87 MG MG E 302 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 77.17 76.66 -81.48 76.14 76.33 -83.32 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 76.07 74.83 -74.70 74.98 75.15 -76.59 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 75.55 64.68 -72.56 76.21 65.63 -70.79 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 30 3 # 30 A 49 ASP F 171 ASP^? 16.35 MG MG F 302 A 147 THR F 169 THR^? 17.93 MG MG F 302 A 294 ASP F 148 ASP^? 2.72 MG MG F 301s coo 1.13 15.67 -24.51 2.35 14.34 -25.71 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 54.83 68.79 -86.99 54.09 70.44 -85.82 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 53.64 56.47 -91.98 54.61 54.68 -92.64 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 31 3 # 31 A 49 ASP F 171 ASP^? 16.35 MG MG F 302 A 147 THR F 175 THR^? 11.83 MG MG F 302 A 294 ASP F 148 ASP^? 2.72 MG MG F 301s coo 1.13 15.67 -24.51 2.35 14.34 -25.71 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 46.82 66.80 -95.29 48.97 66.65 -95.25 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 53.64 56.47 -91.98 54.61 54.68 -92.64 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 32 3 # 32 A 49 ASP F 171 ASP^? 16.35 MG MG F 302 A 147 THR F 175 THR^? 11.83 MG MG F 302 A 294 ASP F 187 ASP^? -3.27 MG MG F 302s coo 1.13 15.67 -24.51 2.35 14.34 -25.71 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 46.82 66.80 -95.29 48.97 66.65 -95.25 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 53.93 58.87 -98.14 52.45 58.62 -96.61 1qgx_c02 source 1qgx 3',5'-ADENOSINE BISPHOSPHATASE : 32 hits 1qgx_c02 naa= 3 ULMN 3 1qho_c04 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP D 187 ASP^? -2.95 MG MG D 301s A 256 GLU D 146 GLU^? 10.62 MG MG D 301 A 329 ASP D 128 ASP^? -3.70 MG MG D 302s coo 28.46 69.88 26.74 30.40 70.70 26.53 90.40 36.34 -52.69 89.24 37.98 -51.99 coo 30.54 71.65 32.58 31.73 72.26 30.92 87.24 28.82 -50.92 85.47 28.08 -51.67 coo 37.87 70.12 31.80 36.61 69.74 30.15 83.33 35.45 -46.13 81.57 36.63 -46.10 1qho_c04 source 1qho ALPHA-AMYLASE : 1 hits 1qho_c04 naa= 3 ULMN 3 1qho_c05 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 128 ASP^? -3.32 MG MG A 301s A 261 ASP A 171 ASP^? 17.17 MG MG A 302 A 329 ASP A 187 ASP^? -3.29 MG MG A 302s coo 28.46 69.88 26.74 30.40 70.70 26.53 46.50 28.23 39.77 47.49 30.10 39.82 coo 34.02 79.89 42.60 34.73 78.01 41.86 29.78 23.67 36.63 28.48 25.11 35.71 coo 37.87 70.12 31.80 36.61 69.74 30.15 39.43 26.57 46.78 39.37 27.83 45.03 ULMN 3 1qho_c05 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 142 ASP^? 23.70 MG MG A 302 A 261 ASP A 58 ASP^? 26.75 MG MG B 302 A 329 ASP A 138 ASP^? 33.08 MG MG A 302 coo 28.46 69.88 26.74 30.40 70.70 26.53 46.39 7.18 37.53 46.28 7.18 39.63 coo 34.02 79.89 42.60 34.73 78.01 41.86 53.93 9.80 21.09 53.83 8.90 19.15 coo 37.87 70.12 31.80 36.61 69.74 30.15 47.10 -0.97 29.63 45.89 0.22 30.96 ULMN 3 1qho_c05 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP A 171 ASP^? 17.17 MG MG A 302 A 261 ASP A 128 ASP^? -3.32 MG MG A 301s A 329 ASP A 177 ASP^? 8.44 MG MG A 302 coo 28.46 69.88 26.74 30.40 70.70 26.53 29.78 23.67 36.63 28.48 25.11 35.71 coo 34.02 79.89 42.60 34.73 78.01 41.86 46.50 28.23 39.77 47.49 30.10 39.82 coo 37.87 70.12 31.80 36.61 69.74 30.15 33.02 29.04 43.18 33.79 27.88 44.78 ULMN 3 1qho_c05 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP B 142 ASP^? 23.97 MG MG B 301 A 261 ASP B 58 ASP^? 26.73 MG MG A 301 A 329 ASP B 138 ASP^? 33.32 MG MG B 302 coo 28.46 69.88 26.74 30.40 70.70 26.53 31.69 27.40 -1.31 32.10 27.37 -3.38 coo 34.02 79.89 42.60 34.73 78.01 41.86 34.42 33.56 15.74 33.50 33.49 17.59 coo 37.87 70.12 31.80 36.61 69.74 30.15 23.42 29.01 6.78 24.36 28.48 4.94 ULMN 3 1qho_c05 ALPHA-AMYLASE user 5 3 # 5 A 228 ASP B 148 ASP^? 2.58 MG MG B 302s A 261 ASP C 23 ASP^? 15.39 MG MG B 301 A 329 ASP B 177 ASP^? 9.03 MG MG B 301 coo 28.46 69.88 26.74 30.40 70.70 26.53 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 34.02 79.89 42.60 34.73 78.01 41.86 65.24 6.82 -5.11 63.43 7.54 -4.15 coo 37.87 70.12 31.80 36.61 69.74 30.15 51.97 11.04 -6.64 50.39 11.62 -7.94 ULMN 3 1qho_c05 ALPHA-AMYLASE user 6 3 # 6 A 228 ASP B 171 ASP^? 16.92 MG MG B 301 A 261 ASP C 23 ASP^? 15.39 MG MG B 301 A 329 ASP B 177 ASP^? 9.03 MG MG B 301 coo 28.46 69.88 26.74 30.40 70.70 26.53 45.30 8.50 -0.71 46.30 6.81 0.12 coo 34.02 79.89 42.60 34.73 78.01 41.86 65.24 6.82 -5.11 63.43 7.54 -4.15 coo 37.87 70.12 31.80 36.61 69.74 30.15 51.97 11.04 -6.64 50.39 11.62 -7.94 ULMN 3 1qho_c05 ALPHA-AMYLASE user 7 3 # 7 A 228 ASP C 142 ASP^? 23.76 MG MG C 301 A 261 ASP C 58 ASP^? 26.67 MG MG D 302 A 329 ASP C 138 ASP^? 33.43 MG MG C 302 coo 28.46 69.88 26.74 30.40 70.70 26.53 97.94 39.27 -5.03 98.08 38.70 -2.97 coo 34.02 79.89 42.60 34.73 78.01 41.86 93.40 43.81 -22.27 94.18 44.45 -24.11 coo 37.87 70.12 31.80 36.61 69.74 30.15 105.43 43.97 -13.30 104.85 43.08 -11.43 ULMN 3 1qho_c05 ALPHA-AMYLASE user 8 3 # 8 A 228 ASP C 171 ASP^? 17.08 MG MG C 301 A 261 ASP B 23 ASP^? 15.67 MG MG C 301 A 329 ASP C 177 ASP^? 8.84 MG MG C 301 coo 28.46 69.88 26.74 30.40 70.70 26.53 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 34.02 79.89 42.60 34.73 78.01 41.86 74.31 7.55 -1.09 75.08 9.17 -2.23 coo 37.87 70.12 31.80 36.61 69.74 30.15 85.60 16.42 -0.31 86.51 17.71 1.09 ULMN 3 1qho_c05 ALPHA-AMYLASE user 9 3 # 9 A 228 ASP D 142 ASP^? 23.49 MG MG D 301 A 261 ASP D 58 ASP^? 26.59 MG MG C 302 A 329 ASP D 138 ASP^? 33.64 MG MG D 302 coo 28.46 69.88 26.74 30.40 70.70 26.53 90.90 15.58 -44.76 91.35 16.09 -46.79 coo 34.02 79.89 42.60 34.73 78.01 41.86 83.38 14.85 -27.71 84.09 14.12 -25.85 coo 37.87 70.12 31.80 36.61 69.74 30.15 93.00 7.50 -35.79 93.88 8.48 -37.45 ULMN 3 1qho_c05 ALPHA-AMYLASE user 10 3 # 10 A 228 ASP D 148 ASP^? 2.35 MG MG D 302s A 261 ASP E 23 ASP^? 15.43 MG MG D 301 A 329 ASP D 177 ASP^? 8.43 MG MG D 301 coo 28.46 69.88 26.74 30.40 70.70 26.53 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 34.02 79.89 42.60 34.73 78.01 41.86 91.98 54.64 -49.37 91.93 52.78 -48.33 coo 37.87 70.12 31.80 36.61 69.74 30.15 95.74 41.01 -49.76 94.81 39.90 -51.24 ULMN 3 1qho_c05 ALPHA-AMYLASE user 11 3 # 11 A 228 ASP D 171 ASP^? 16.95 MG MG D 301 A 261 ASP E 23 ASP^? 15.43 MG MG D 301 A 329 ASP D 177 ASP^? 8.43 MG MG D 301 coo 28.46 69.88 26.74 30.40 70.70 26.53 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 34.02 79.89 42.60 34.73 78.01 41.86 91.98 54.64 -49.37 91.93 52.78 -48.33 coo 37.87 70.12 31.80 36.61 69.74 30.15 95.74 41.01 -49.76 94.81 39.90 -51.24 ULMN 3 1qho_c05 ALPHA-AMYLASE user 12 3 # 12 A 228 ASP E 142 ASP^? 23.66 MG MG E 301 A 261 ASP E 58 ASP^? 26.76 MG MG F 301 A 329 ASP E 138 ASP^? 33.31 MG MG E 302 coo 28.46 69.88 26.74 30.40 70.70 26.53 47.19 67.15 -50.37 47.44 67.18 -48.23 coo 34.02 79.89 42.60 34.73 78.01 41.86 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 37.87 70.12 31.80 36.61 69.74 30.15 39.58 70.77 -58.63 40.74 70.78 -56.80 ULMN 3 1qho_c05 ALPHA-AMYLASE user 13 3 # 13 A 228 ASP E 171 ASP^? 16.73 MG MG E 301 A 261 ASP D 23 ASP^? 15.37 MG MG E 301 A 329 ASP E 177 ASP^? 8.55 MG MG E 301 coo 28.46 69.88 26.74 30.40 70.70 26.53 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 34.02 79.89 42.60 34.73 78.01 41.86 85.70 62.10 -45.60 84.07 62.13 -46.93 coo 37.87 70.12 31.80 36.61 69.74 30.15 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 1qho_c05 ALPHA-AMYLASE user 14 3 # 14 A 228 ASP F 142 ASP^? 23.43 MG MG F 302 A 261 ASP F 58 ASP^? 26.87 MG MG E 302 A 329 ASP F 138 ASP^? 33.51 MG MG F 302 coo 28.46 69.88 26.74 30.40 70.70 26.53 71.46 69.88 -89.76 71.03 69.93 -91.81 coo 34.02 79.89 42.60 34.73 78.01 41.86 75.55 64.68 -72.56 76.21 65.63 -70.79 coo 37.87 70.12 31.80 36.61 69.74 30.15 77.17 76.66 -81.48 76.14 76.33 -83.32 1qho_c05 source 1qho ALPHA-AMYLASE : 14 hits 1qho_c05 naa= 3 ULMN 3 1qho_c07 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 128 ASP^? -3.32 MG MG A 301s A 260 ASP A 171 ASP^? 17.17 MG MG A 302 A 329 ASP A 187 ASP^? -3.29 MG MG A 302s coo 28.46 69.88 26.74 30.40 70.70 26.53 46.50 28.23 39.77 47.49 30.10 39.82 coo 30.73 81.29 37.61 31.23 82.07 35.69 29.78 23.67 36.63 28.48 25.11 35.71 coo 37.87 70.12 31.80 36.61 69.74 30.15 39.43 26.57 46.78 39.37 27.83 45.03 ULMN 3 1qho_c07 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 171 ASP^? 17.17 MG MG A 302 A 260 ASP A 128 ASP^? -3.32 MG MG A 301s A 329 ASP A 177 ASP^? 8.44 MG MG A 302 coo 28.46 69.88 26.74 30.40 70.70 26.53 29.78 23.67 36.63 28.48 25.11 35.71 coo 30.73 81.29 37.61 31.23 82.07 35.69 46.50 28.23 39.77 47.49 30.10 39.82 coo 37.87 70.12 31.80 36.61 69.74 30.15 33.02 29.04 43.18 33.79 27.88 44.78 ULMN 3 1qho_c07 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP A 177 ASP^? 8.44 MG MG A 302 A 260 ASP A 35 ASP^? 16.92 MG MG A 301 A 329 ASP A 148 ASP^? 2.72 MG MG A 301s coo 28.46 69.88 26.74 30.40 70.70 26.53 33.02 29.04 43.18 33.79 27.88 44.78 coo 30.73 81.29 37.61 31.23 82.07 35.69 34.49 31.10 26.54 36.41 31.82 27.10 coo 37.87 70.12 31.80 36.61 69.74 30.15 41.50 28.88 41.13 43.33 29.67 41.93 ULMN 3 1qho_c07 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP A 177 ASP^? 8.44 MG MG A 302 A 260 ASP A 35 ASP^? 16.92 MG MG A 301 A 329 ASP A 171 ASP^? 17.17 MG MG A 302 coo 28.46 69.88 26.74 30.40 70.70 26.53 33.02 29.04 43.18 33.79 27.88 44.78 coo 30.73 81.29 37.61 31.23 82.07 35.69 34.49 31.10 26.54 36.41 31.82 27.10 coo 37.87 70.12 31.80 36.61 69.74 30.15 29.78 23.67 36.63 28.48 25.11 35.71 ULMN 3 1qho_c07 ALPHA-AMYLASE user 5 3 # 5 A 228 ASP B 128 ASP^? -3.57 MG MG B 302s A 260 ASP B 171 ASP^? 16.92 MG MG B 301 A 329 ASP B 187 ASP^? -3.44 MG MG B 301s coo 28.46 69.88 26.74 30.40 70.70 26.53 52.92 24.09 -2.19 54.73 25.14 -1.90 coo 30.73 81.29 37.61 31.23 82.07 35.69 45.30 8.50 -0.71 46.30 6.81 0.12 coo 37.87 70.12 31.80 36.61 69.74 30.15 50.64 18.14 -9.69 51.74 17.63 -7.86 ULMN 3 1qho_c07 ALPHA-AMYLASE user 6 3 # 6 A 228 ASP B 148 ASP^? 2.58 MG MG B 302s A 260 ASP C 23 ASP^? 15.39 MG MG B 301 A 329 ASP B 177 ASP^? 9.03 MG MG B 301 coo 28.46 69.88 26.74 30.40 70.70 26.53 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 30.73 81.29 37.61 31.23 82.07 35.69 65.24 6.82 -5.11 63.43 7.54 -4.15 coo 37.87 70.12 31.80 36.61 69.74 30.15 51.97 11.04 -6.64 50.39 11.62 -7.94 ULMN 3 1qho_c07 ALPHA-AMYLASE user 7 3 # 7 A 228 ASP B 171 ASP^? 16.92 MG MG B 301 A 260 ASP B 128 ASP^? -3.57 MG MG B 302s A 329 ASP B 177 ASP^? 9.03 MG MG B 301 coo 28.46 69.88 26.74 30.40 70.70 26.53 45.30 8.50 -0.71 46.30 6.81 0.12 coo 30.73 81.29 37.61 31.23 82.07 35.69 52.92 24.09 -2.19 54.73 25.14 -1.90 coo 37.87 70.12 31.80 36.61 69.74 30.15 51.97 11.04 -6.64 50.39 11.62 -7.94 ULMN 3 1qho_c07 ALPHA-AMYLASE user 8 3 # 8 A 228 ASP B 177 ASP^? 9.03 MG MG B 301 A 260 ASP B 35 ASP^? 16.92 MG MG B 302 A 329 ASP B 148 ASP^? 2.58 MG MG B 302s coo 28.46 69.88 26.74 30.40 70.70 26.53 51.97 11.04 -6.64 50.39 11.62 -7.94 coo 30.73 81.29 37.61 31.23 82.07 35.69 52.63 11.07 10.18 53.68 12.85 9.94 coo 37.87 70.12 31.80 36.61 69.74 30.15 52.73 19.23 -3.77 53.81 20.99 -4.31 ULMN 3 1qho_c07 ALPHA-AMYLASE user 9 3 # 9 A 228 ASP B 177 ASP^? 9.03 MG MG B 301 A 260 ASP B 35 ASP^? 16.92 MG MG B 302 A 329 ASP B 171 ASP^? 16.92 MG MG B 301 coo 28.46 69.88 26.74 30.40 70.70 26.53 51.97 11.04 -6.64 50.39 11.62 -7.94 coo 30.73 81.29 37.61 31.23 82.07 35.69 52.63 11.07 10.18 53.68 12.85 9.94 coo 37.87 70.12 31.80 36.61 69.74 30.15 45.30 8.50 -0.71 46.30 6.81 0.12 ULMN 3 1qho_c07 ALPHA-AMYLASE user 10 3 # 10 A 228 ASP C 128 ASP^? -3.22 MG MG C 302s A 260 ASP C 171 ASP^? 17.08 MG MG C 301 A 329 ASP C 187 ASP^? -3.72 MG MG C 301s coo 28.46 69.88 26.74 30.40 70.70 26.53 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 30.73 81.29 37.61 31.23 82.07 35.69 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 37.87 70.12 31.80 36.61 69.74 30.15 84.01 23.73 3.39 83.47 22.54 1.59 ULMN 3 1qho_c07 ALPHA-AMYLASE user 11 3 # 11 A 228 ASP C 171 ASP^? 17.08 MG MG C 301 A 260 ASP C 128 ASP^? -3.22 MG MG C 302s A 329 ASP C 177 ASP^? 8.84 MG MG C 301 coo 28.46 69.88 26.74 30.40 70.70 26.53 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 30.73 81.29 37.61 31.23 82.07 35.69 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 37.87 70.12 31.80 36.61 69.74 30.15 85.60 16.42 -0.31 86.51 17.71 1.09 ULMN 3 1qho_c07 ALPHA-AMYLASE user 12 3 # 12 A 228 ASP C 177 ASP^? 8.84 MG MG C 301 A 260 ASP C 35 ASP^? 16.42 MG MG C 302 A 329 ASP C 171 ASP^? 17.08 MG MG C 301 coo 28.46 69.88 26.74 30.40 70.70 26.53 85.60 16.42 -0.31 86.51 17.71 1.09 coo 30.73 81.29 37.61 31.23 82.07 35.69 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 37.87 70.12 31.80 36.61 69.74 30.15 92.57 16.68 -6.24 92.24 14.74 -7.03 ULMN 3 1qho_c07 ALPHA-AMYLASE user 13 3 # 13 A 228 ASP D 128 ASP^? -3.70 MG MG D 302s A 260 ASP D 171 ASP^? 16.95 MG MG D 301 A 329 ASP D 187 ASP^? -2.95 MG MG D 301s coo 28.46 69.88 26.74 30.40 70.70 26.53 83.33 35.45 -46.13 81.57 36.63 -46.10 coo 30.73 81.29 37.61 31.23 82.07 35.69 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 37.87 70.12 31.80 36.61 69.74 30.15 90.40 36.34 -52.69 89.24 37.98 -51.99 ULMN 3 1qho_c07 ALPHA-AMYLASE user 14 3 # 14 A 228 ASP D 148 ASP^? 2.35 MG MG D 302s A 260 ASP E 23 ASP^? 15.43 MG MG D 301 A 329 ASP D 177 ASP^? 8.43 MG MG D 301 coo 28.46 69.88 26.74 30.40 70.70 26.53 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 30.73 81.29 37.61 31.23 82.07 35.69 91.98 54.64 -49.37 91.93 52.78 -48.33 coo 37.87 70.12 31.80 36.61 69.74 30.15 95.74 41.01 -49.76 94.81 39.90 -51.24 ULMN 3 1qho_c07 ALPHA-AMYLASE user 15 3 # 15 A 228 ASP D 171 ASP^? 16.95 MG MG D 301 A 260 ASP D 128 ASP^? -3.70 MG MG D 302s A 329 ASP D 177 ASP^? 8.43 MG MG D 301 coo 28.46 69.88 26.74 30.40 70.70 26.53 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 30.73 81.29 37.61 31.23 82.07 35.69 83.33 35.45 -46.13 81.57 36.63 -46.10 coo 37.87 70.12 31.80 36.61 69.74 30.15 95.74 41.01 -49.76 94.81 39.90 -51.24 ULMN 3 1qho_c07 ALPHA-AMYLASE user 16 3 # 16 A 228 ASP D 177 ASP^? 8.43 MG MG D 301 A 260 ASP D 35 ASP^? 16.80 MG MG D 302 A 329 ASP D 148 ASP^? 2.35 MG MG D 302s coo 28.46 69.88 26.74 30.40 70.70 26.53 95.74 41.01 -49.76 94.81 39.90 -51.24 coo 30.73 81.29 37.61 31.23 82.07 35.69 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 37.87 70.12 31.80 36.61 69.74 30.15 87.78 37.50 -47.56 85.79 37.49 -48.28 ULMN 3 1qho_c07 ALPHA-AMYLASE user 17 3 # 17 A 228 ASP D 177 ASP^? 8.43 MG MG D 301 A 260 ASP D 35 ASP^? 16.80 MG MG D 302 A 329 ASP D 171 ASP^? 16.95 MG MG D 301 coo 28.46 69.88 26.74 30.40 70.70 26.53 95.74 41.01 -49.76 94.81 39.90 -51.24 coo 30.73 81.29 37.61 31.23 82.07 35.69 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 37.87 70.12 31.80 36.61 69.74 30.15 100.39 36.69 -43.49 101.13 38.51 -42.69 ULMN 3 1qho_c07 ALPHA-AMYLASE user 18 3 # 18 A 228 ASP E 128 ASP^? -3.53 MG MG E 302s A 260 ASP E 171 ASP^? 16.73 MG MG E 301 A 329 ASP E 187 ASP^? -2.71 MG MG E 301s coo 28.46 69.88 26.74 30.40 70.70 26.53 65.38 56.57 -48.58 66.15 54.57 -48.61 coo 30.73 81.29 37.61 31.23 82.07 35.69 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 37.87 70.12 31.80 36.61 69.74 30.15 67.50 63.43 -41.69 68.97 62.26 -42.81 ULMN 3 1qho_c07 ALPHA-AMYLASE user 19 3 # 19 A 228 ASP E 171 ASP^? 16.73 MG MG E 301 A 260 ASP E 128 ASP^? -3.53 MG MG E 302s A 329 ASP E 177 ASP^? 8.55 MG MG E 301 coo 28.46 69.88 26.74 30.40 70.70 26.53 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 30.73 81.29 37.61 31.23 82.07 35.69 65.38 56.57 -48.58 66.15 54.57 -48.61 coo 37.87 70.12 31.80 36.61 69.74 30.15 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 1qho_c07 ALPHA-AMYLASE user 20 3 # 20 A 228 ASP E 177 ASP^? 8.55 MG MG E 301 A 260 ASP E 35 ASP^? 16.91 MG MG E 302 A 329 ASP E 171 ASP^? 16.73 MG MG E 301 coo 28.46 69.88 26.74 30.40 70.70 26.53 72.81 67.32 -45.03 71.14 67.96 -43.95 coo 30.73 81.29 37.61 31.23 82.07 35.69 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 37.87 70.12 31.80 36.61 69.74 30.15 69.61 73.12 -51.56 71.50 73.53 -52.39 ULMN 3 1qho_c07 ALPHA-AMYLASE user 21 3 # 21 A 228 ASP F 128 ASP^? -3.41 MG MG F 301s A 260 ASP F 171 ASP^? 16.35 MG MG F 302 A 329 ASP F 187 ASP^? -3.27 MG MG F 302s coo 28.46 69.88 26.74 30.40 70.70 26.53 57.76 53.73 -90.50 57.46 51.64 -90.28 coo 30.73 81.29 37.61 31.23 82.07 35.69 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 37.87 70.12 31.80 36.61 69.74 30.15 53.93 58.87 -98.14 52.45 58.62 -96.61 ULMN 3 1qho_c07 ALPHA-AMYLASE user 22 3 # 22 A 228 ASP F 171 ASP^? 16.35 MG MG F 302 A 260 ASP F 128 ASP^? -3.41 MG MG F 301s A 329 ASP F 177 ASP^? 8.15 MG MG F 302 coo 28.46 69.88 26.74 30.40 70.70 26.53 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 30.73 81.29 37.61 31.23 82.07 35.69 57.76 53.73 -90.50 57.46 51.64 -90.28 coo 37.87 70.12 31.80 36.61 69.74 30.15 47.18 61.22 -94.50 48.48 62.32 -95.73 ULMN 3 1qho_c07 ALPHA-AMYLASE user 23 3 # 23 A 228 ASP F 177 ASP^? 8.15 MG MG F 302 A 260 ASP F 35 ASP^? 16.93 MG MG F 301 A 329 ASP F 171 ASP^? 16.35 MG MG F 302 coo 28.46 69.88 26.74 30.40 70.70 26.53 47.18 61.22 -94.50 48.48 62.32 -95.73 coo 30.73 81.29 37.61 31.23 82.07 35.69 46.82 60.47 -77.63 48.00 58.79 -78.23 coo 37.87 70.12 31.80 36.61 69.74 30.15 48.23 68.08 -88.47 46.26 68.02 -87.56 1qho_c07 source 1qho ALPHA-AMYLASE : 23 hits 1qho_c07 naa= 3 ULMN 3 1qj4_c00 HYDROXYNITRILE LYASE user 1 3 # 1 A 80 SER A 189 SER^? 11.75 MG MG A 302 A 207 ASP A 148 ASP^? 2.72 MG MG A 301s A 235 HIS A 147 HIS^? 9.20 MG MG A 302 coo 15.54 46.73 17.13 17.06 48.44 16.17 40.99 19.00 44.32 41.51 18.14 46.48 coo 23.60 50.31 20.82 21.66 50.51 20.06 41.50 28.88 41.13 43.33 29.67 41.93 coo 20.17 51.16 17.08 18.31 50.28 17.44 40.24 23.10 39.83 38.32 22.34 40.22 ULMN 3 1qj4_c00 HYDROXYNITRILE LYASE user 2 3 # 2 A 80 SER B 189 SER^? 12.11 MG MG B 301 A 207 ASP B 148 ASP^? 2.58 MG MG B 302s A 235 HIS B 147 HIS^? 9.27 MG MG B 301 coo 15.54 46.73 17.13 17.06 48.44 16.17 43.10 20.95 -7.74 42.82 21.56 -10.02 coo 23.60 50.31 20.82 21.66 50.51 20.06 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 20.17 51.16 17.08 18.31 50.28 17.44 46.73 18.97 -3.05 45.63 17.32 -3.73 ULMN 3 1qj4_c00 HYDROXYNITRILE LYASE user 3 3 # 3 A 80 SER C 189 SER^? 12.09 MG MG C 301 A 207 ASP C 148 ASP^? 2.75 MG MG C 302s A 235 HIS C 147 HIS^? 9.44 MG MG C 301 coo 15.54 46.73 17.13 17.06 48.44 16.17 90.33 28.79 1.19 90.26 29.61 3.45 coo 23.60 50.31 20.82 21.66 50.51 20.06 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 20.17 51.16 17.08 18.31 50.28 17.44 87.61 25.71 -3.59 89.22 24.50 -2.99 ULMN 3 1qj4_c00 HYDROXYNITRILE LYASE user 4 3 # 4 A 80 SER D 189 SER^? 12.12 MG MG D 301 A 207 ASP D 148 ASP^? 2.35 MG MG D 302s A 235 HIS D 147 HIS^? 9.43 MG MG D 301 coo 15.54 46.73 17.13 17.06 48.44 16.17 91.62 28.58 -50.95 91.45 27.78 -53.25 coo 23.60 50.31 20.82 21.66 50.51 20.06 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 20.17 51.16 17.08 18.31 50.28 17.44 90.95 32.51 -46.42 92.98 32.42 -46.93 ULMN 3 1qj4_c00 HYDROXYNITRILE LYASE user 5 3 # 5 A 80 SER E 189 SER^? 11.91 MG MG E 301 A 207 ASP E 148 ASP^? 2.62 MG MG E 302s A 235 HIS E 147 HIS^? 9.22 MG MG E 301 coo 15.54 46.73 17.13 17.06 48.44 16.17 60.13 65.61 -43.87 59.01 65.34 -41.74 coo 23.60 50.31 20.82 21.66 50.51 20.06 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 20.17 51.16 17.08 18.31 50.28 17.44 63.87 64.43 -48.39 64.18 66.45 -47.92 ULMN 3 1qj4_c00 HYDROXYNITRILE LYASE user 6 3 # 6 A 80 SER F 189 SER^? 11.88 MG MG F 302 A 207 ASP F 148 ASP^? 2.72 MG MG F 301s A 235 HIS F 147 HIS^? 8.79 MG MG F 302 coo 15.54 46.73 17.13 17.06 48.44 16.17 59.91 63.90 -95.91 60.70 64.22 -98.13 coo 23.60 50.31 20.82 21.66 50.51 20.06 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 20.17 51.16 17.08 18.31 50.28 17.44 56.63 61.66 -91.16 55.69 63.43 -91.80 1qj4_c00 source 1qj4 HYDROXYNITRILE LYASE : 6 hits 1qj4_c00 naa= 3 ULMN 3 1qrz_c12 PLASMINOGEN user 1 3 # 1 A 603 HIS A 147 HIS^? 9.20 MG MG A 302 A 646 ASP A 128 ASP^? -3.32 MG MG A 301s A 741 SER A 189 SER^? 11.75 MG MG A 302 coo -20.72 2.99 34.37 -21.94 1.82 35.61 40.24 23.10 39.83 38.32 22.34 40.22 coo -18.83 7.68 26.86 -20.89 7.78 26.56 46.50 28.23 39.77 47.49 30.10 39.82 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 40.99 19.00 44.32 41.51 18.14 46.48 ULMN 3 1qrz_c12 PLASMINOGEN user 2 3 # 2 A 603 HIS A 147 HIS^? 9.20 MG MG A 302 A 646 ASP A 177 ASP^? 8.44 MG MG A 302 A 741 SER A 189 SER^? 11.75 MG MG A 302 coo -20.72 2.99 34.37 -21.94 1.82 35.61 40.24 23.10 39.83 38.32 22.34 40.22 coo -18.83 7.68 26.86 -20.89 7.78 26.56 33.02 29.04 43.18 33.79 27.88 44.78 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 40.99 19.00 44.32 41.51 18.14 46.48 ULMN 3 1qrz_c12 PLASMINOGEN user 3 3 # 3 A 603 HIS B 147 HIS^? 9.27 MG MG B 301 A 646 ASP B 128 ASP^? -3.57 MG MG B 302s A 741 SER B 189 SER^? 12.11 MG MG B 301 coo -20.72 2.99 34.37 -21.94 1.82 35.61 46.73 18.97 -3.05 45.63 17.32 -3.73 coo -18.83 7.68 26.86 -20.89 7.78 26.56 52.92 24.09 -2.19 54.73 25.14 -1.90 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 43.10 20.95 -7.74 42.82 21.56 -10.02 ULMN 3 1qrz_c12 PLASMINOGEN user 4 3 # 4 A 603 HIS C 147 HIS^? 9.44 MG MG C 301 A 646 ASP C 128 ASP^? -3.22 MG MG C 302s A 741 SER C 189 SER^? 12.09 MG MG C 301 coo -20.72 2.99 34.37 -21.94 1.82 35.61 87.61 25.71 -3.59 89.22 24.50 -2.99 coo -18.83 7.68 26.86 -20.89 7.78 26.56 80.05 28.39 -4.25 77.97 28.60 -4.21 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 90.33 28.79 1.19 90.26 29.61 3.45 ULMN 3 1qrz_c12 PLASMINOGEN user 5 3 # 5 A 603 HIS D 147 HIS^? 9.43 MG MG D 301 A 646 ASP D 128 ASP^? -3.70 MG MG D 302s A 741 SER D 189 SER^? 12.12 MG MG D 301 coo -20.72 2.99 34.37 -21.94 1.82 35.61 90.95 32.51 -46.42 92.98 32.42 -46.93 coo -18.83 7.68 26.86 -20.89 7.78 26.56 83.33 35.45 -46.13 81.57 36.63 -46.10 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 91.62 28.58 -50.95 91.45 27.78 -53.25 ULMN 3 1qrz_c12 PLASMINOGEN user 6 3 # 6 A 603 HIS E 147 HIS^? 9.22 MG MG E 301 A 646 ASP E 128 ASP^? -3.53 MG MG E 302s A 741 SER E 189 SER^? 11.91 MG MG E 301 coo -20.72 2.99 34.37 -21.94 1.82 35.61 63.87 64.43 -48.39 64.18 66.45 -47.92 coo -18.83 7.68 26.86 -20.89 7.78 26.56 65.38 56.57 -48.58 66.15 54.57 -48.61 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 60.13 65.61 -43.87 59.01 65.34 -41.74 ULMN 3 1qrz_c12 PLASMINOGEN user 7 3 # 7 A 603 HIS E 147 HIS^? 9.22 MG MG E 301 A 646 ASP E 177 ASP^? 8.55 MG MG E 301 A 741 SER E 189 SER^? 11.91 MG MG E 301 coo -20.72 2.99 34.37 -21.94 1.82 35.61 63.87 64.43 -48.39 64.18 66.45 -47.92 coo -18.83 7.68 26.86 -20.89 7.78 26.56 72.81 67.32 -45.03 71.14 67.96 -43.95 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 60.13 65.61 -43.87 59.01 65.34 -41.74 ULMN 3 1qrz_c12 PLASMINOGEN user 8 3 # 8 A 603 HIS F 147 HIS^? 8.79 MG MG F 302 A 646 ASP F 128 ASP^? -3.41 MG MG F 301s A 741 SER F 189 SER^? 11.88 MG MG F 302 coo -20.72 2.99 34.37 -21.94 1.82 35.61 56.63 61.66 -91.16 55.69 63.43 -91.80 coo -18.83 7.68 26.86 -20.89 7.78 26.56 57.76 53.73 -90.50 57.46 51.64 -90.28 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 59.91 63.90 -95.91 60.70 64.22 -98.13 ULMN 3 1qrz_c12 PLASMINOGEN user 9 3 # 9 A 603 HIS F 147 HIS^? 8.79 MG MG F 302 A 646 ASP F 177 ASP^? 8.15 MG MG F 302 A 741 SER F 189 SER^? 11.88 MG MG F 302 coo -20.72 2.99 34.37 -21.94 1.82 35.61 56.63 61.66 -91.16 55.69 63.43 -91.80 coo -18.83 7.68 26.86 -20.89 7.78 26.56 47.18 61.22 -94.50 48.48 62.32 -95.73 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 59.91 63.90 -95.91 60.70 64.22 -98.13 1qrz_c12 source 1qrz PLASMINOGEN : 9 hits 1qrz_c12 naa= 3 ULMN 3 1qrz_c13 PLASMINOGEN user 1 3 # 1 B 603 HIS A 147 HIS^? 9.20 MG MG A 302 B 646 ASP A 128 ASP^? -3.32 MG MG A 301s B 741 SER A 189 SER^? 11.75 MG MG A 302 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 40.24 23.10 39.83 38.32 22.34 40.22 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 46.50 28.23 39.77 47.49 30.10 39.82 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 40.99 19.00 44.32 41.51 18.14 46.48 ULMN 3 1qrz_c13 PLASMINOGEN user 2 3 # 2 B 603 HIS B 147 HIS^? 9.27 MG MG B 301 B 646 ASP B 128 ASP^? -3.57 MG MG B 302s B 741 SER B 189 SER^? 12.11 MG MG B 301 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 46.73 18.97 -3.05 45.63 17.32 -3.73 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 52.92 24.09 -2.19 54.73 25.14 -1.90 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 43.10 20.95 -7.74 42.82 21.56 -10.02 ULMN 3 1qrz_c13 PLASMINOGEN user 3 3 # 3 B 603 HIS C 147 HIS^? 9.44 MG MG C 301 B 646 ASP C 128 ASP^? -3.22 MG MG C 302s B 741 SER C 189 SER^? 12.09 MG MG C 301 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 87.61 25.71 -3.59 89.22 24.50 -2.99 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 80.05 28.39 -4.25 77.97 28.60 -4.21 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 90.33 28.79 1.19 90.26 29.61 3.45 ULMN 3 1qrz_c13 PLASMINOGEN user 4 3 # 4 B 603 HIS D 147 HIS^? 9.43 MG MG D 301 B 646 ASP D 128 ASP^? -3.70 MG MG D 302s B 741 SER D 189 SER^? 12.12 MG MG D 301 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 90.95 32.51 -46.42 92.98 32.42 -46.93 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 83.33 35.45 -46.13 81.57 36.63 -46.10 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 91.62 28.58 -50.95 91.45 27.78 -53.25 ULMN 3 1qrz_c13 PLASMINOGEN user 5 3 # 5 B 603 HIS D 170 HIS^? 10.59 MG MG D 301 B 646 ASP D 148 ASP^? 2.35 MG MG D 302s B 741 SER D 189 SER^? 12.12 MG MG D 301 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 95.57 34.81 -46.05 95.59 36.24 -47.59 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 87.78 37.50 -47.56 85.79 37.49 -48.28 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 91.62 28.58 -50.95 91.45 27.78 -53.25 ULMN 3 1qrz_c13 PLASMINOGEN user 6 3 # 6 B 603 HIS E 147 HIS^? 9.22 MG MG E 301 B 646 ASP E 128 ASP^? -3.53 MG MG E 302s B 741 SER E 189 SER^? 11.91 MG MG E 301 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 63.87 64.43 -48.39 64.18 66.45 -47.92 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 65.38 56.57 -48.58 66.15 54.57 -48.61 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 60.13 65.61 -43.87 59.01 65.34 -41.74 ULMN 3 1qrz_c13 PLASMINOGEN user 7 3 # 7 B 603 HIS F 147 HIS^? 8.79 MG MG F 302 B 646 ASP F 128 ASP^? -3.41 MG MG F 301s B 741 SER F 189 SER^? 11.88 MG MG F 302 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 56.63 61.66 -91.16 55.69 63.43 -91.80 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 57.76 53.73 -90.50 57.46 51.64 -90.28 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 59.91 63.90 -95.91 60.70 64.22 -98.13 1qrz_c13 source 1qrz PLASMINOGEN : 7 hits 1qrz_c13 naa= 3 ULMN 3 1qrz_c14 PLASMINOGEN user 1 3 # 1 C 603 HIS A 147 HIS^? 9.20 MG MG A 302 C 646 ASP A 128 ASP^? -3.32 MG MG A 301s C 741 SER A 189 SER^? 11.75 MG MG A 302 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 40.24 23.10 39.83 38.32 22.34 40.22 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 46.50 28.23 39.77 47.49 30.10 39.82 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 40.99 19.00 44.32 41.51 18.14 46.48 ULMN 3 1qrz_c14 PLASMINOGEN user 2 3 # 2 C 603 HIS A 147 HIS^? 9.20 MG MG A 302 C 646 ASP A 177 ASP^? 8.44 MG MG A 302 C 741 SER A 189 SER^? 11.75 MG MG A 302 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 40.24 23.10 39.83 38.32 22.34 40.22 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 33.02 29.04 43.18 33.79 27.88 44.78 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 40.99 19.00 44.32 41.51 18.14 46.48 ULMN 3 1qrz_c14 PLASMINOGEN user 3 3 # 3 C 603 HIS B 147 HIS^? 9.27 MG MG B 301 C 646 ASP B 128 ASP^? -3.57 MG MG B 302s C 741 SER B 189 SER^? 12.11 MG MG B 301 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 52.92 24.09 -2.19 54.73 25.14 -1.90 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 43.10 20.95 -7.74 42.82 21.56 -10.02 ULMN 3 1qrz_c14 PLASMINOGEN user 4 3 # 4 C 603 HIS C 147 HIS^? 9.44 MG MG C 301 C 646 ASP C 128 ASP^? -3.22 MG MG C 302s C 741 SER C 189 SER^? 12.09 MG MG C 301 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 90.33 28.79 1.19 90.26 29.61 3.45 ULMN 3 1qrz_c14 PLASMINOGEN user 5 3 # 5 C 603 HIS D 147 HIS^? 9.43 MG MG D 301 C 646 ASP D 128 ASP^? -3.70 MG MG D 302s C 741 SER D 189 SER^? 12.12 MG MG D 301 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 83.33 35.45 -46.13 81.57 36.63 -46.10 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 91.62 28.58 -50.95 91.45 27.78 -53.25 ULMN 3 1qrz_c14 PLASMINOGEN user 6 3 # 6 C 603 HIS E 147 HIS^? 9.22 MG MG E 301 C 646 ASP E 128 ASP^? -3.53 MG MG E 302s C 741 SER E 189 SER^? 11.91 MG MG E 301 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 65.38 56.57 -48.58 66.15 54.57 -48.61 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 60.13 65.61 -43.87 59.01 65.34 -41.74 ULMN 3 1qrz_c14 PLASMINOGEN user 7 3 # 7 C 603 HIS E 147 HIS^? 9.22 MG MG E 301 C 646 ASP E 177 ASP^? 8.55 MG MG E 301 C 741 SER E 189 SER^? 11.91 MG MG E 301 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 72.81 67.32 -45.03 71.14 67.96 -43.95 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 60.13 65.61 -43.87 59.01 65.34 -41.74 ULMN 3 1qrz_c14 PLASMINOGEN user 8 3 # 8 C 603 HIS F 147 HIS^? 8.79 MG MG F 302 C 646 ASP F 128 ASP^? -3.41 MG MG F 301s C 741 SER F 189 SER^? 11.88 MG MG F 302 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 57.76 53.73 -90.50 57.46 51.64 -90.28 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 59.91 63.90 -95.91 60.70 64.22 -98.13 1qrz_c14 source 1qrz PLASMINOGEN : 8 hits 1qrz_c14 naa= 3 ULMN 3 1qrz_c15 PLASMINOGEN user 1 3 # 1 D 603 HIS A 147 HIS^? 9.20 MG MG A 302 D 646 ASP A 128 ASP^? -3.32 MG MG A 301s D 741 SER A 189 SER^? 11.75 MG MG A 302 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 40.24 23.10 39.83 38.32 22.34 40.22 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 46.50 28.23 39.77 47.49 30.10 39.82 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 40.99 19.00 44.32 41.51 18.14 46.48 ULMN 3 1qrz_c15 PLASMINOGEN user 2 3 # 2 D 603 HIS A 147 HIS^? 9.20 MG MG A 302 D 646 ASP A 177 ASP^? 8.44 MG MG A 302 D 741 SER A 189 SER^? 11.75 MG MG A 302 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 40.24 23.10 39.83 38.32 22.34 40.22 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 33.02 29.04 43.18 33.79 27.88 44.78 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 40.99 19.00 44.32 41.51 18.14 46.48 ULMN 3 1qrz_c15 PLASMINOGEN user 3 3 # 3 D 603 HIS B 147 HIS^? 9.27 MG MG B 301 D 646 ASP B 128 ASP^? -3.57 MG MG B 302s D 741 SER B 189 SER^? 12.11 MG MG B 301 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 46.73 18.97 -3.05 45.63 17.32 -3.73 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 52.92 24.09 -2.19 54.73 25.14 -1.90 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 43.10 20.95 -7.74 42.82 21.56 -10.02 ULMN 3 1qrz_c15 PLASMINOGEN user 4 3 # 4 D 603 HIS C 147 HIS^? 9.44 MG MG C 301 D 646 ASP C 128 ASP^? -3.22 MG MG C 302s D 741 SER C 189 SER^? 12.09 MG MG C 301 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 87.61 25.71 -3.59 89.22 24.50 -2.99 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 80.05 28.39 -4.25 77.97 28.60 -4.21 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 90.33 28.79 1.19 90.26 29.61 3.45 ULMN 3 1qrz_c15 PLASMINOGEN user 5 3 # 5 D 603 HIS D 147 HIS^? 9.43 MG MG D 301 D 646 ASP D 128 ASP^? -3.70 MG MG D 302s D 741 SER D 189 SER^? 12.12 MG MG D 301 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 90.95 32.51 -46.42 92.98 32.42 -46.93 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 83.33 35.45 -46.13 81.57 36.63 -46.10 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 91.62 28.58 -50.95 91.45 27.78 -53.25 ULMN 3 1qrz_c15 PLASMINOGEN user 6 3 # 6 D 603 HIS E 147 HIS^? 9.22 MG MG E 301 D 646 ASP E 128 ASP^? -3.53 MG MG E 302s D 741 SER E 189 SER^? 11.91 MG MG E 301 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 63.87 64.43 -48.39 64.18 66.45 -47.92 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 65.38 56.57 -48.58 66.15 54.57 -48.61 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 60.13 65.61 -43.87 59.01 65.34 -41.74 ULMN 3 1qrz_c15 PLASMINOGEN user 7 3 # 7 D 603 HIS E 147 HIS^? 9.22 MG MG E 301 D 646 ASP E 177 ASP^? 8.55 MG MG E 301 D 741 SER E 189 SER^? 11.91 MG MG E 301 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 63.87 64.43 -48.39 64.18 66.45 -47.92 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 72.81 67.32 -45.03 71.14 67.96 -43.95 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 60.13 65.61 -43.87 59.01 65.34 -41.74 ULMN 3 1qrz_c15 PLASMINOGEN user 8 3 # 8 D 603 HIS F 147 HIS^? 8.79 MG MG F 302 D 646 ASP F 128 ASP^? -3.41 MG MG F 301s D 741 SER F 189 SER^? 11.88 MG MG F 302 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 56.63 61.66 -91.16 55.69 63.43 -91.80 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 57.76 53.73 -90.50 57.46 51.64 -90.28 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 59.91 63.90 -95.91 60.70 64.22 -98.13 1qrz_c15 source 1qrz PLASMINOGEN : 8 hits 1qrz_c15 naa= 3 ULMN 3 1qrz_c20 PLASMINOGEN user 1 3 # 1 A 603 HIS E 147 HIS^? 9.22 MG MG E 301 A 646 ASP E 128 ASP^? -3.53 MG MG E 302s A 739 GLY E 176 GLY^? 13.22 MG MG E 301 coo -20.72 2.99 34.37 -21.94 1.82 35.61 63.87 64.43 -48.39 64.18 66.45 -47.92 coo -18.83 7.68 26.86 -20.89 7.78 26.56 65.38 56.57 -48.58 66.15 54.57 -48.61 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 74.69 71.68 -44.17 74.06 71.19 -44.32 1qrz_c20 source 1qrz PLASMINOGEN : 1 hits 1qrz_c20 naa= 3 ULMN 3 1qz9_c02 KYNURENINASE user 1 3 # 1 A 129 PHE A 59 PHE^? 31.59 MG MG A 301 A 201 ASP A 58 ASP^? 26.75 MG MG B 302 A 227 LYS A 157 LYS^? 28.65 MG MG A 302 coo 23.39 49.81 32.16 21.33 51.68 32.26 52.93 4.70 25.02 52.08 5.30 27.62 coo 25.52 45.12 37.98 23.98 46.65 37.85 53.93 9.80 21.09 53.83 8.90 19.15 coo 12.68 46.83 36.69 18.26 48.67 34.51 41.42 12.06 27.58 41.46 5.93 29.41 ULMN 3 1qz9_c02 KYNURENINASE user 2 3 # 2 A 129 PHE A 59 PHE^? 31.59 MG MG A 301 A 201 ASP A 138 ASP^? 33.08 MG MG A 302 A 227 LYS A 6 LYS^? 25.88 MG MG A 301 coo 23.39 49.81 32.16 21.33 51.68 32.26 52.93 4.70 25.02 52.08 5.30 27.62 coo 25.52 45.12 37.98 23.98 46.65 37.85 47.10 -0.97 29.63 45.89 0.22 30.96 coo 12.68 46.83 36.69 18.26 48.67 34.51 46.20 12.82 24.71 44.50 16.64 20.52 ULMN 3 1qz9_c02 KYNURENINASE user 3 3 # 3 A 129 PHE A 59 PHE^? 31.59 MG MG A 301 A 201 ASP A 138 ASP^? 33.08 MG MG A 302 A 227 LYS A 157 LYS^? 28.65 MG MG A 302 coo 23.39 49.81 32.16 21.33 51.68 32.26 52.93 4.70 25.02 52.08 5.30 27.62 coo 25.52 45.12 37.98 23.98 46.65 37.85 47.10 -0.97 29.63 45.89 0.22 30.96 coo 12.68 46.83 36.69 18.26 48.67 34.51 41.42 12.06 27.58 41.46 5.93 29.41 ULMN 3 1qz9_c02 KYNURENINASE user 4 3 # 4 A 129 PHE A 153 PHE^? 9.64 MG MG A 301 A 201 ASP A 171 ASP^? 17.17 MG MG A 302 A 227 LYS A 166 LYS^? 20.93 MG MG A 302 coo 23.39 49.81 32.16 21.33 51.68 32.26 38.89 24.49 36.07 40.14 26.70 37.23 coo 25.52 45.12 37.98 23.98 46.65 37.85 29.78 23.67 36.63 28.48 25.11 35.71 coo 12.68 46.83 36.69 18.26 48.67 34.51 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 1qz9_c02 KYNURENINASE user 5 3 # 5 A 129 PHE B 59 PHE^? 31.31 MG MG B 302 A 201 ASP B 58 ASP^? 26.73 MG MG A 301 A 227 LYS B 157 LYS^? 28.85 MG MG B 302 coo 23.39 49.81 32.16 21.33 51.68 32.26 29.63 33.55 11.36 30.42 32.81 8.75 coo 25.52 45.12 37.98 23.98 46.65 37.85 34.42 33.56 15.74 33.50 33.49 17.59 coo 12.68 46.83 36.69 18.26 48.67 34.51 34.97 21.28 8.44 29.03 22.82 6.58 ULMN 3 1qz9_c02 KYNURENINASE user 6 3 # 6 A 129 PHE B 59 PHE^? 31.31 MG MG B 302 A 201 ASP B 138 ASP^? 33.32 MG MG B 302 A 227 LYS B 6 LYS^? 25.90 MG MG B 302 coo 23.39 49.81 32.16 21.33 51.68 32.26 29.63 33.55 11.36 30.42 32.81 8.75 coo 25.52 45.12 37.98 23.98 46.65 37.85 23.42 29.01 6.78 24.36 28.48 4.94 coo 12.68 46.83 36.69 18.26 48.67 34.51 36.26 25.44 11.74 39.65 23.12 16.29 ULMN 3 1qz9_c02 KYNURENINASE user 7 3 # 7 A 129 PHE B 59 PHE^? 31.31 MG MG B 302 A 201 ASP B 138 ASP^? 33.32 MG MG B 302 A 227 LYS B 157 LYS^? 28.85 MG MG B 302 coo 23.39 49.81 32.16 21.33 51.68 32.26 29.63 33.55 11.36 30.42 32.81 8.75 coo 25.52 45.12 37.98 23.98 46.65 37.85 23.42 29.01 6.78 24.36 28.48 4.94 coo 12.68 46.83 36.69 18.26 48.67 34.51 34.97 21.28 8.44 29.03 22.82 6.58 ULMN 3 1qz9_c02 KYNURENINASE user 8 3 # 8 A 129 PHE B 153 PHE^? 9.59 MG MG B 302 A 201 ASP B 171 ASP^? 16.92 MG MG B 301 A 227 LYS B 166 LYS^? 22.75 MG MG B 301 coo 23.39 49.81 32.16 21.33 51.68 32.26 47.54 17.09 0.77 50.03 17.91 -0.19 coo 25.52 45.12 37.98 23.98 46.65 37.85 45.30 8.50 -0.71 46.30 6.81 0.12 coo 12.68 46.83 36.69 18.26 48.67 34.51 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 1qz9_c02 KYNURENINASE user 9 3 # 9 A 129 PHE C 59 PHE^? 31.23 MG MG C 302 A 201 ASP C 58 ASP^? 26.67 MG MG D 302 A 227 LYS C 157 LYS^? 28.15 MG MG C 302 coo 23.39 49.81 32.16 21.33 51.68 32.26 98.06 45.52 -18.00 97.73 44.36 -15.53 coo 25.52 45.12 37.98 23.98 46.65 37.85 93.40 43.81 -22.27 94.18 44.45 -24.11 coo 12.68 46.83 36.69 18.26 48.67 34.51 97.55 32.04 -15.10 101.49 36.24 -13.39 ULMN 3 1qz9_c02 KYNURENINASE user 10 3 # 10 A 129 PHE C 59 PHE^? 31.23 MG MG C 302 A 201 ASP C 138 ASP^? 33.43 MG MG C 302 A 227 LYS C 6 LYS^? 25.73 MG MG C 302 coo 23.39 49.81 32.16 21.33 51.68 32.26 98.06 45.52 -18.00 97.73 44.36 -15.53 coo 25.52 45.12 37.98 23.98 46.65 37.85 105.43 43.97 -13.30 104.85 43.08 -11.43 coo 12.68 46.83 36.69 18.26 48.67 34.51 94.42 35.68 -18.56 92.21 32.03 -23.05 ULMN 3 1qz9_c02 KYNURENINASE user 11 3 # 11 A 129 PHE C 59 PHE^? 31.23 MG MG C 302 A 201 ASP C 138 ASP^? 33.43 MG MG C 302 A 227 LYS C 157 LYS^? 28.15 MG MG C 302 coo 23.39 49.81 32.16 21.33 51.68 32.26 98.06 45.52 -18.00 97.73 44.36 -15.53 coo 25.52 45.12 37.98 23.98 46.65 37.85 105.43 43.97 -13.30 104.85 43.08 -11.43 coo 12.68 46.83 36.69 18.26 48.67 34.51 97.55 32.04 -15.10 101.49 36.24 -13.39 ULMN 3 1qz9_c02 KYNURENINASE user 12 3 # 12 A 129 PHE C 153 PHE^? 9.34 MG MG C 302 A 201 ASP C 171 ASP^? 17.08 MG MG C 301 A 227 LYS C 166 LYS^? 22.53 MG MG C 301 coo 23.39 49.81 32.16 21.33 51.68 32.26 87.15 23.83 -7.29 84.55 23.79 -6.26 coo 25.52 45.12 37.98 23.98 46.65 37.85 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 12.68 46.83 36.69 18.26 48.67 34.51 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 1qz9_c02 KYNURENINASE user 13 3 # 13 A 129 PHE D 59 PHE^? 31.49 MG MG D 302 A 201 ASP D 58 ASP^? 26.59 MG MG C 302 A 227 LYS D 157 LYS^? 28.67 MG MG D 302 coo 23.39 49.81 32.16 21.33 51.68 32.26 86.17 10.70 -31.86 86.41 11.56 -34.53 coo 25.52 45.12 37.98 23.98 46.65 37.85 83.38 14.85 -27.71 84.09 14.12 -25.85 coo 12.68 46.83 36.69 18.26 48.67 34.51 94.17 21.71 -34.34 96.11 15.89 -35.92 ULMN 3 1qz9_c02 KYNURENINASE user 14 3 # 14 A 129 PHE D 59 PHE^? 31.49 MG MG D 302 A 201 ASP D 138 ASP^? 33.64 MG MG D 302 A 227 LYS D 6 LYS^? 25.98 MG MG D 302 coo 23.39 49.81 32.16 21.33 51.68 32.26 86.17 10.70 -31.86 86.41 11.56 -34.53 coo 25.52 45.12 37.98 23.98 46.65 37.85 93.00 7.50 -35.79 93.88 8.48 -37.45 coo 12.68 46.83 36.69 18.26 48.67 34.51 89.78 20.68 -31.57 90.15 24.89 -27.02 ULMN 3 1qz9_c02 KYNURENINASE user 15 3 # 15 A 129 PHE D 59 PHE^? 31.49 MG MG D 302 A 201 ASP D 138 ASP^? 33.64 MG MG D 302 A 227 LYS D 157 LYS^? 28.67 MG MG D 302 coo 23.39 49.81 32.16 21.33 51.68 32.26 86.17 10.70 -31.86 86.41 11.56 -34.53 coo 25.52 45.12 37.98 23.98 46.65 37.85 93.00 7.50 -35.79 93.88 8.48 -37.45 coo 12.68 46.83 36.69 18.26 48.67 34.51 94.17 21.71 -34.34 96.11 15.89 -35.92 ULMN 3 1qz9_c02 KYNURENINASE user 16 3 # 16 A 129 PHE D 153 PHE^? 9.11 MG MG D 302 A 201 ASP D 171 ASP^? 16.95 MG MG D 301 A 227 LYS D 166 LYS^? 21.08 MG MG D 301 coo 23.39 49.81 32.16 21.33 51.68 32.26 91.67 34.35 -42.71 89.76 36.10 -43.73 coo 25.52 45.12 37.98 23.98 46.65 37.85 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 12.68 46.83 36.69 18.26 48.67 34.51 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 1qz9_c02 KYNURENINASE user 17 3 # 17 A 129 PHE E 12 PHE^? 17.09 MG MG E 302 A 201 ASP E 171 ASP^? 16.73 MG MG E 301 A 227 LYS E 166 LYS^? 21.46 MG MG E 301 coo 23.39 49.81 32.16 21.33 51.68 32.26 70.06 67.18 -58.76 69.33 69.81 -58.07 coo 25.52 45.12 37.98 23.98 46.65 37.85 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 12.68 46.83 36.69 18.26 48.67 34.51 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1qz9_c02 KYNURENINASE user 18 3 # 18 A 129 PHE E 59 PHE^? 31.36 MG MG E 302 A 201 ASP E 58 ASP^? 26.76 MG MG F 301 A 227 LYS E 157 LYS^? 28.40 MG MG E 302 coo 23.39 49.81 32.16 21.33 51.68 32.26 41.55 62.67 -62.73 42.33 62.92 -60.06 coo 25.52 45.12 37.98 23.98 46.65 37.85 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 12.68 46.83 36.69 18.26 48.67 34.51 53.63 69.16 -60.42 48.34 71.81 -58.40 ULMN 3 1qz9_c02 KYNURENINASE user 19 3 # 19 A 129 PHE E 59 PHE^? 31.36 MG MG E 302 A 201 ASP E 138 ASP^? 33.31 MG MG E 302 A 227 LYS E 6 LYS^? 25.59 MG MG E 302 coo 23.39 49.81 32.16 21.33 51.68 32.26 41.55 62.67 -62.73 42.33 62.92 -60.06 coo 25.52 45.12 37.98 23.98 46.65 37.85 39.58 70.77 -58.63 40.74 70.78 -56.80 coo 12.68 46.83 36.69 18.26 48.67 34.51 51.95 64.70 -63.33 56.16 64.03 -67.52 ULMN 3 1qz9_c02 KYNURENINASE user 20 3 # 20 A 129 PHE E 59 PHE^? 31.36 MG MG E 302 A 201 ASP E 138 ASP^? 33.31 MG MG E 302 A 227 LYS E 157 LYS^? 28.40 MG MG E 302 coo 23.39 49.81 32.16 21.33 51.68 32.26 41.55 62.67 -62.73 42.33 62.92 -60.06 coo 25.52 45.12 37.98 23.98 46.65 37.85 39.58 70.77 -58.63 40.74 70.78 -56.80 coo 12.68 46.83 36.69 18.26 48.67 34.51 53.63 69.16 -60.42 48.34 71.81 -58.40 ULMN 3 1qz9_c02 KYNURENINASE user 21 3 # 21 A 129 PHE E 153 PHE^? 9.50 MG MG E 302 A 201 ASP E 171 ASP^? 16.73 MG MG E 301 A 227 LYS E 166 LYS^? 21.46 MG MG E 301 coo 23.39 49.81 32.16 21.33 51.68 32.26 65.86 64.95 -52.12 67.22 62.73 -51.09 coo 25.52 45.12 37.98 23.98 46.65 37.85 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 12.68 46.83 36.69 18.26 48.67 34.51 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 1qz9_c02 KYNURENINASE user 22 3 # 22 A 129 PHE F 59 PHE^? 31.53 MG MG F 301 A 201 ASP F 58 ASP^? 26.87 MG MG E 302 A 227 LYS F 157 LYS^? 28.36 MG MG F 302 coo 23.39 49.81 32.16 21.33 51.68 32.26 77.96 68.89 -76.99 76.86 68.73 -79.55 coo 25.52 45.12 37.98 23.98 46.65 37.85 75.55 64.68 -72.56 76.21 65.63 -70.79 coo 12.68 46.83 36.69 18.26 48.67 34.51 64.43 70.47 -79.54 68.32 74.80 -81.65 ULMN 3 1qz9_c02 KYNURENINASE user 23 3 # 23 A 129 PHE F 59 PHE^? 31.53 MG MG F 301 A 201 ASP F 138 ASP^? 33.51 MG MG F 302 A 227 LYS F 6 LYS^? 26.09 MG MG F 301 coo 23.39 49.81 32.16 21.33 51.68 32.26 77.96 68.89 -76.99 76.86 68.73 -79.55 coo 25.52 45.12 37.98 23.98 46.65 37.85 77.17 76.66 -81.48 76.14 76.33 -83.32 coo 12.68 46.83 36.69 18.26 48.67 34.51 67.53 67.03 -76.43 64.05 65.33 -71.86 ULMN 3 1qz9_c02 KYNURENINASE user 24 3 # 24 A 129 PHE F 59 PHE^? 31.53 MG MG F 301 A 201 ASP F 138 ASP^? 33.51 MG MG F 302 A 227 LYS F 157 LYS^? 28.36 MG MG F 302 coo 23.39 49.81 32.16 21.33 51.68 32.26 77.96 68.89 -76.99 76.86 68.73 -79.55 coo 25.52 45.12 37.98 23.98 46.65 37.85 77.17 76.66 -81.48 76.14 76.33 -83.32 coo 12.68 46.83 36.69 18.26 48.67 34.51 64.43 70.47 -79.54 68.32 74.80 -81.65 ULMN 3 1qz9_c02 KYNURENINASE user 25 3 # 25 A 129 PHE F 153 PHE^? 9.26 MG MG F 302 A 201 ASP F 171 ASP^? 16.35 MG MG F 302 A 227 LYS F 166 LYS^? 20.76 MG MG F 302 coo 23.39 49.81 32.16 21.33 51.68 32.26 54.49 61.65 -87.43 53.89 59.08 -88.37 coo 25.52 45.12 37.98 23.98 46.65 37.85 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 12.68 46.83 36.69 18.26 48.67 34.51 59.28 73.05 -82.63 55.63 74.15 -86.94 1qz9_c02 source 1qz9 KYNURENINASE : 25 hits 1qz9_c02 naa= 3 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 1 3 # 1 A 10 ASP A 58 ASP^? 26.75 MG MG B 302 A 186 ASN A 3 ASN.? 30.14 MG MG B 302 A 260 ALA B 43 ALA^? 21.96 MG MG B 302 coo 11.81 33.10 11.71 13.07 31.45 11.40 53.93 9.80 21.09 53.83 8.90 19.15 coo 11.43 26.53 7.41 13.01 27.56 8.43 50.04 4.36 19.09 51.05 2.61 18.36 coo 21.53 26.33 6.96 20.26 25.69 7.52 45.25 14.39 14.98 45.85 13.87 13.70 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 2 3 # 2 A 10 ASP A 128 ASP^? -3.32 MG MG A 301s A 186 ASN A 95 ASN^? 11.82 MG MG A 301 A 260 ALA A 91 ALA^? 12.93 MG MG A 301 coo 11.81 33.10 11.71 13.07 31.45 11.40 46.50 28.23 39.77 47.49 30.10 39.82 coo 11.43 26.53 7.41 13.01 27.56 8.43 53.15 30.26 34.15 54.71 31.63 34.63 coo 21.53 26.33 6.96 20.26 25.69 7.52 47.92 36.55 28.62 47.12 35.53 29.40 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 3 3 # 3 A 10 ASP B 58 ASP^? 26.73 MG MG A 301 A 186 ASN B 3 ASN^? 29.91 MG MG A 301 A 260 ALA A 43 ALA^? 22.11 MG MG A 301 coo 11.81 33.10 11.71 13.07 31.45 11.40 34.42 33.56 15.74 33.50 33.49 17.59 coo 11.43 26.53 7.41 13.01 27.56 8.43 28.49 30.55 17.19 26.69 31.26 18.05 coo 21.53 26.33 6.96 20.26 25.69 7.52 37.04 23.74 21.31 36.51 24.34 22.59 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 4 3 # 4 A 10 ASP B 128 ASP^? -3.57 MG MG B 302s A 186 ASN B 95 ASN^? 11.72 MG MG B 302 A 260 ALA B 91 ALA^? 13.14 MG MG B 302 coo 11.81 33.10 11.71 13.07 31.45 11.40 52.92 24.09 -2.19 54.73 25.14 -1.90 coo 11.43 26.53 7.41 13.01 27.56 8.43 55.48 29.92 4.32 57.36 30.88 4.11 coo 21.53 26.33 6.96 20.26 25.69 7.52 60.40 23.47 9.84 59.47 22.84 8.80 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 5 3 # 5 A 10 ASP B 128 ASP^? -3.57 MG MG B 302s A 186 ASN B 185 ASN^? -7.05 MG MG B 301s A 260 ALA B 180 ALA^? 7.87 MG MG B 301 coo 11.81 33.10 11.71 13.07 31.45 11.40 52.92 24.09 -2.19 54.73 25.14 -1.90 coo 11.43 26.53 7.41 13.01 27.56 8.43 52.96 23.67 -10.63 54.00 24.89 -11.96 coo 21.53 26.33 6.96 20.26 25.69 7.52 59.08 14.28 -6.88 59.39 13.60 -8.19 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 6 3 # 6 A 10 ASP C 58 ASP^? 26.67 MG MG D 302 A 186 ASN C 3 ASN^? 29.15 MG MG D 302 A 260 ALA D 43 ALA^? 21.51 MG MG D 302 coo 11.81 33.10 11.71 13.07 31.45 11.40 93.40 43.81 -22.27 94.18 44.45 -24.11 coo 11.43 26.53 7.41 13.01 27.56 8.43 100.26 42.79 -23.94 100.99 44.40 -25.14 coo 21.53 26.33 6.96 20.26 25.69 7.52 94.20 34.03 -28.30 94.29 34.60 -29.70 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 7 3 # 7 A 10 ASP C 128 ASP^? -3.22 MG MG C 302s A 186 ASN C 95 ASN^? 11.50 MG MG C 302 A 260 ALA C 91 ALA^? 12.61 MG MG C 302 coo 11.81 33.10 11.71 13.07 31.45 11.40 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 11.43 26.53 7.41 13.01 27.56 8.43 75.34 33.15 -10.39 73.27 33.38 -10.21 coo 21.53 26.33 6.96 20.26 25.69 7.52 72.87 25.42 -15.88 73.94 25.20 -14.87 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 8 3 # 8 A 10 ASP C 128 ASP^? -3.22 MG MG C 302s A 186 ASN C 185 ASN^? -7.11 MG MG C 301s A 260 ALA C 180 ALA^? 7.92 MG MG C 301 coo 11.81 33.10 11.71 13.07 31.45 11.40 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 11.43 26.53 7.41 13.01 27.56 8.43 80.06 27.66 4.46 78.78 28.93 5.51 coo 21.53 26.33 6.96 20.26 25.69 7.52 77.97 16.90 0.41 78.13 16.09 1.70 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 9 3 # 9 A 10 ASP D 58 ASP^? 26.59 MG MG C 302 A 186 ASN D 3 ASN^? 28.85 MG MG C 302 A 260 ALA C 43 ALA^? 21.49 MG MG C 302 coo 11.81 33.10 11.71 13.07 31.45 11.40 83.38 14.85 -27.71 84.09 14.12 -25.85 coo 11.43 26.53 7.41 13.01 27.56 8.43 89.53 11.43 -25.56 88.66 9.94 -24.30 coo 21.53 26.33 6.96 20.26 25.69 7.52 89.94 22.31 -21.67 89.53 21.88 -20.28 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 10 3 # 10 A 10 ASP D 128 ASP^? -3.70 MG MG D 302s A 186 ASN D 95 ASN^? 12.56 MG MG D 302 A 260 ALA D 91 ALA^? 13.42 MG MG D 302 coo 11.81 33.10 11.71 13.07 31.45 11.40 83.33 35.45 -46.13 81.57 36.63 -46.10 coo 11.43 26.53 7.41 13.01 27.56 8.43 76.36 34.77 -40.14 74.34 35.29 -40.63 coo 21.53 26.33 6.96 20.26 25.69 7.52 79.15 42.27 -34.55 80.22 41.77 -35.47 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 11 3 # 11 A 10 ASP D 128 ASP^? -3.70 MG MG D 302s A 186 ASN D 185 ASN^? -7.02 MG MG D 301s A 260 ALA D 180 ALA^? 8.04 MG MG D 301 coo 11.81 33.10 11.71 13.07 31.45 11.40 83.33 35.45 -46.13 81.57 36.63 -46.10 coo 11.43 26.53 7.41 13.01 27.56 8.43 83.84 35.36 -54.61 82.18 35.66 -55.90 coo 21.53 26.33 6.96 20.26 25.69 7.52 88.96 45.51 -50.74 89.59 46.01 -52.03 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 12 3 # 12 A 10 ASP E 58 ASP^? 26.76 MG MG F 301 A 186 ASN E 3 ASN^? 30.27 MG MG F 301 A 260 ALA F 43 ALA^? 21.71 MG MG F 301 coo 11.81 33.10 11.71 13.07 31.45 11.40 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 11.43 26.53 7.41 13.01 27.56 8.43 42.47 65.36 -68.69 40.59 66.02 -69.39 coo 21.53 26.33 6.96 20.26 25.69 7.52 53.63 64.70 -73.15 53.00 64.46 -74.53 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 13 3 # 13 A 10 ASP E 128 ASP^? -3.53 MG MG E 302s A 186 ASN E 95 ASN^? 11.73 MG MG E 302 A 260 ALA E 91 ALA^? 13.03 MG MG E 302 coo 11.81 33.10 11.71 13.07 31.45 11.40 65.38 56.57 -48.58 66.15 54.57 -48.61 coo 11.43 26.53 7.41 13.01 27.56 8.43 63.77 49.77 -54.50 64.30 47.82 -53.94 coo 21.53 26.33 6.96 20.26 25.69 7.52 71.73 51.22 -59.99 71.40 52.44 -59.12 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 14 3 # 14 A 10 ASP E 128 ASP^? -3.53 MG MG E 302s A 186 ASN E 185 ASN^? -7.20 MG MG E 301s A 260 ALA E 180 ALA^? 7.76 MG MG E 301 coo 11.81 33.10 11.71 13.07 31.45 11.40 65.38 56.57 -48.58 66.15 54.57 -48.61 coo 11.43 26.53 7.41 13.01 27.56 8.43 65.70 57.16 -40.06 65.41 55.24 -39.19 coo 21.53 26.33 6.96 20.26 25.69 7.52 76.35 60.44 -44.08 76.96 60.95 -42.80 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 15 3 # 15 A 10 ASP F 128 ASP^? -3.41 MG MG F 301s A 186 ASN F 95 ASN^? 12.10 MG MG F 301 A 260 ALA F 91 ALA^? 13.16 MG MG F 301 coo 11.81 33.10 11.71 13.07 31.45 11.40 57.76 53.73 -90.50 57.46 51.64 -90.28 coo 11.43 26.53 7.41 13.01 27.56 8.43 61.81 48.42 -84.18 62.16 46.40 -84.52 coo 21.53 26.33 6.96 20.26 25.69 7.52 53.65 47.28 -78.71 53.60 48.47 -79.59 1r4f_c00 source 1r4f IAG-NUCLEOSIDE HYDROLASE : 15 hits 1r4f_c00 naa= 3 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 1 3 # 1 A 12 HIS A 42 HIS^? 28.45 MG MG A 301 A 41 LYS A 166 LYS^? 20.93 MG MG A 302 A 119 HIS B 42 HIS^? 28.37 MG MG B 302 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 34.62 18.32 19.57 34.29 16.25 19.41 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 35.34 13.14 30.41 31.67 15.04 34.58 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 39.34 12.99 16.30 37.26 13.24 16.40 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 2 3 # 2 A 12 HIS A 42 HIS^? 28.45 MG MG A 301 A 41 LYS B 6 LYS^? 25.90 MG MG B 302 A 119 HIS B 42 HIS^? 28.37 MG MG B 302 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 34.62 18.32 19.57 34.29 16.25 19.41 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 36.26 25.44 11.74 39.65 23.12 16.29 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 39.34 12.99 16.30 37.26 13.24 16.40 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 3 3 # 3 A 12 HIS B 42 HIS^? 28.37 MG MG B 302 A 41 LYS A 6 LYS^? 25.88 MG MG A 301 A 119 HIS A 42 HIS^? 28.45 MG MG A 301 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 39.34 12.99 16.30 37.26 13.24 16.40 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 46.20 12.82 24.71 44.50 16.64 20.52 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 34.62 18.32 19.57 34.29 16.25 19.41 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 4 3 # 4 A 12 HIS B 42 HIS^? 28.37 MG MG B 302 A 41 LYS B 166 LYS^? 22.75 MG MG B 301 A 119 HIS A 42 HIS^? 28.45 MG MG A 301 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 39.34 12.99 16.30 37.26 13.24 16.40 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 35.27 15.38 5.31 37.27 9.81 3.93 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 34.62 18.32 19.57 34.29 16.25 19.41 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 5 3 # 5 A 12 HIS C 42 HIS^? 28.09 MG MG C 302 A 41 LYS C 166 LYS^? 22.53 MG MG C 301 A 119 HIS D 42 HIS^? 28.21 MG MG D 302 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 95.93 22.96 -23.11 97.92 23.62 -23.02 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 98.45 29.90 -26.44 99.32 28.02 -26.13 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 6 3 # 6 A 12 HIS C 42 HIS^? 28.09 MG MG C 302 A 41 LYS D 6 LYS^? 25.98 MG MG D 302 A 119 HIS D 42 HIS^? 28.21 MG MG D 302 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 95.93 22.96 -23.11 97.92 23.62 -23.02 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 98.45 29.90 -26.44 99.32 28.02 -26.13 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 7 3 # 7 A 12 HIS D 42 HIS^? 28.21 MG MG D 302 A 41 LYS C 6 LYS^? 25.73 MG MG C 302 A 119 HIS C 42 HIS^? 28.09 MG MG C 302 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 98.45 29.90 -26.44 99.32 28.02 -26.13 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 95.93 22.96 -23.11 97.92 23.62 -23.02 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 8 3 # 8 A 12 HIS D 42 HIS^? 28.21 MG MG D 302 A 41 LYS D 166 LYS^? 21.08 MG MG D 301 A 119 HIS C 42 HIS^? 28.09 MG MG C 302 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 98.45 29.90 -26.44 99.32 28.02 -26.13 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 95.93 22.96 -23.11 97.92 23.62 -23.02 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 9 3 # 9 A 12 HIS E 42 HIS^? 28.20 MG MG E 302 A 41 LYS E 166 LYS^? 21.46 MG MG E 301 A 119 HIS F 42 HIS^? 28.34 MG MG F 301 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 62.33 71.93 -68.30 60.54 72.96 -68.64 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 55.11 70.50 -71.64 56.29 72.22 -71.48 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 10 3 # 10 A 12 HIS E 42 HIS^? 28.20 MG MG E 302 A 41 LYS F 6 LYS^? 26.09 MG MG F 301 A 119 HIS F 42 HIS^? 28.34 MG MG F 301 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 62.33 71.93 -68.30 60.54 72.96 -68.64 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 55.11 70.50 -71.64 56.29 72.22 -71.48 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 11 3 # 11 A 12 HIS F 42 HIS^? 28.34 MG MG F 301 A 41 LYS E 6 LYS^? 25.59 MG MG E 302 A 119 HIS E 42 HIS^? 28.20 MG MG E 302 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 55.11 70.50 -71.64 56.29 72.22 -71.48 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 62.33 71.93 -68.30 60.54 72.96 -68.64 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 12 3 # 12 A 12 HIS F 42 HIS^? 28.34 MG MG F 301 A 41 LYS F 166 LYS^? 20.76 MG MG F 302 A 119 HIS E 42 HIS^? 28.20 MG MG E 302 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 55.11 70.50 -71.64 56.29 72.22 -71.48 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 62.33 71.93 -68.30 60.54 72.96 -68.64 1rbn_c01 source 1rbn RIBONUCLEASE A (E.C.3.1.27.5) DERIVATIVE II CO: 12 hits 1rbn_c01 naa= 3 ULMN 3 1rgq_c01 NS4A PEPTIDE user 1 3 # 1 B 60 HIS A 170 HIS^? 10.56 MG MG A 302 B 84 ASP A 171 ASP^? 17.17 MG MG A 302 B 140 GLY A 145 GLY^? 13.39 MG MG A 302 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 34.91 23.57 39.32 34.35 24.95 40.81 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 29.78 23.67 36.63 28.48 25.11 35.71 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 44.20 17.56 40.29 44.09 17.33 41.06 ULMN 3 1rgq_c01 NS4A PEPTIDE user 2 3 # 2 B 60 HIS A 170 HIS^? 10.56 MG MG A 302 B 84 ASP A 177 ASP^? 8.44 MG MG A 302 B 140 GLY A 145 GLY^? 13.39 MG MG A 302 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 34.91 23.57 39.32 34.35 24.95 40.81 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 33.02 29.04 43.18 33.79 27.88 44.78 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 44.20 17.56 40.29 44.09 17.33 41.06 ULMN 3 1rgq_c01 NS4A PEPTIDE user 3 3 # 3 B 60 HIS B 170 HIS^? 10.51 MG MG B 301 B 84 ASP B 171 ASP^? 16.92 MG MG B 301 B 140 GLY B 145 GLY^? 13.71 MG MG B 301 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 45.30 8.50 -0.71 46.30 6.81 0.12 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 42.04 23.97 -3.40 41.83 23.90 -4.16 ULMN 3 1rgq_c01 NS4A PEPTIDE user 4 3 # 4 B 60 HIS B 170 HIS^? 10.51 MG MG B 301 B 84 ASP B 177 ASP^? 9.03 MG MG B 301 B 140 GLY B 145 GLY^? 13.71 MG MG B 301 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 51.97 11.04 -6.64 50.39 11.62 -7.94 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 42.04 23.97 -3.40 41.83 23.90 -4.16 ULMN 3 1rgq_c01 NS4A PEPTIDE user 5 3 # 5 B 60 HIS C 170 HIS^? 10.68 MG MG C 301 B 84 ASP C 171 ASP^? 17.08 MG MG C 301 B 140 GLY C 145 GLY^? 13.72 MG MG C 301 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 90.12 32.13 -3.16 90.38 32.11 -2.40 ULMN 3 1rgq_c01 NS4A PEPTIDE user 6 3 # 6 B 60 HIS C 170 HIS^? 10.68 MG MG C 301 B 84 ASP C 177 ASP^? 8.84 MG MG C 301 B 140 GLY C 145 GLY^? 13.72 MG MG C 301 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 85.60 16.42 -0.31 86.51 17.71 1.09 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 90.12 32.13 -3.16 90.38 32.11 -2.40 ULMN 3 1rgq_c01 NS4A PEPTIDE user 7 3 # 7 B 60 HIS D 170 HIS^? 10.59 MG MG D 301 B 84 ASP D 171 ASP^? 16.95 MG MG D 301 B 140 GLY D 145 GLY^? 13.51 MG MG D 301 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 88.90 26.07 -46.90 89.21 25.93 -47.57 ULMN 3 1rgq_c01 NS4A PEPTIDE user 8 3 # 8 B 60 HIS D 170 HIS^? 10.59 MG MG D 301 B 84 ASP D 177 ASP^? 8.43 MG MG D 301 B 140 GLY D 145 GLY^? 13.51 MG MG D 301 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 95.74 41.01 -49.76 94.81 39.90 -51.24 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 88.90 26.07 -46.90 89.21 25.93 -47.57 ULMN 3 1rgq_c01 NS4A PEPTIDE user 9 3 # 9 B 60 HIS E 170 HIS^? 10.33 MG MG E 301 B 84 ASP E 171 ASP^? 16.73 MG MG E 301 B 140 GLY E 145 GLY^? 13.69 MG MG E 301 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 57.08 63.68 -47.92 56.95 63.88 -47.12 ULMN 3 1rgq_c01 NS4A PEPTIDE user 10 3 # 10 B 60 HIS E 170 HIS^? 10.33 MG MG E 301 B 84 ASP E 177 ASP^? 8.55 MG MG E 301 B 140 GLY E 145 GLY^? 13.69 MG MG E 301 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 72.81 67.32 -45.03 71.14 67.96 -43.95 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 57.08 63.68 -47.92 56.95 63.88 -47.12 ULMN 3 1rgq_c01 NS4A PEPTIDE user 11 3 # 11 B 60 HIS F 170 HIS^? 9.84 MG MG F 302 B 84 ASP F 171 ASP^? 16.35 MG MG F 302 B 140 GLY F 145 GLY^? 13.40 MG MG F 302 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 63.24 63.21 -91.82 63.24 63.42 -92.59 ULMN 3 1rgq_c01 NS4A PEPTIDE user 12 3 # 12 B 60 HIS F 170 HIS^? 9.84 MG MG F 302 B 84 ASP F 177 ASP^? 8.15 MG MG F 302 B 140 GLY F 145 GLY^? 13.40 MG MG F 302 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 47.18 61.22 -94.50 48.48 62.32 -95.73 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 63.24 63.21 -91.82 63.24 63.42 -92.59 1rgq_c01 source 1rgq NS4A PEPTIDE : 12 hits 1rgq_c01 naa= 3 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 1 3 # 1 32 ASP A 128 ASP^? -3.32 MG MG A 301s 35 SER A 115 SER^? 6.34 MG MG A 301 215 ASP A 148 ASP^? 2.72 MG MG A 301s coo 11.85 17.24 72.81 11.09 15.37 72.36 46.50 28.23 39.77 47.49 30.10 39.82 coo 12.20 12.71 75.45 13.69 13.84 74.03 48.89 29.76 35.69 49.85 31.26 37.35 coo 5.22 15.03 71.43 7.19 14.88 70.83 41.50 28.88 41.13 43.33 29.67 41.93 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 2 3 # 2 32 ASP B 128 ASP^? -3.57 MG MG B 302s 35 SER B 115 SER^? 6.48 MG MG B 302 215 ASP B 148 ASP^? 2.58 MG MG B 302s coo 11.85 17.24 72.81 11.09 15.37 72.36 52.92 24.09 -2.19 54.73 25.14 -1.90 coo 12.20 12.71 75.45 13.69 13.84 74.03 54.36 25.96 2.48 56.06 26.75 0.95 coo 5.22 15.03 71.43 7.19 14.88 70.83 52.73 19.23 -3.77 53.81 20.99 -4.31 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 3 3 # 3 32 ASP C 128 ASP^? -3.22 MG MG C 302s 35 SER C 115 SER^? 5.99 MG MG C 302 215 ASP C 148 ASP^? 2.75 MG MG C 302s coo 11.85 17.24 72.81 11.09 15.37 72.36 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 12.20 12.71 75.45 13.69 13.84 74.03 77.67 29.66 -8.53 76.02 29.92 -6.77 coo 5.22 15.03 71.43 7.19 14.88 70.83 81.96 23.83 -2.68 80.24 25.11 -2.27 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 4 3 # 4 32 ASP D 128 ASP^? -3.70 MG MG D 302s 35 SER D 115 SER^? 7.08 MG MG D 302 215 ASP D 148 ASP^? 2.35 MG MG D 302s coo 11.85 17.24 72.81 11.09 15.37 72.36 83.33 35.45 -46.13 81.57 36.63 -46.10 coo 12.20 12.71 75.45 13.69 13.84 74.03 80.50 35.70 -41.83 78.94 36.81 -43.34 coo 5.22 15.03 71.43 7.19 14.88 70.83 87.78 37.50 -47.56 85.79 37.49 -48.28 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 5 3 # 5 32 ASP F 128 ASP^? -3.41 MG MG F 301s 35 SER F 115 SER^? 6.67 MG MG F 301 215 ASP F 148 ASP^? 2.72 MG MG F 301s coo 11.85 17.24 72.81 11.09 15.37 72.36 57.76 53.73 -90.50 57.46 51.64 -90.28 coo 12.20 12.71 75.45 13.69 13.84 74.03 58.74 51.50 -86.07 58.73 49.57 -87.50 coo 5.22 15.03 71.43 7.19 14.88 70.83 53.64 56.47 -91.98 54.61 54.68 -92.64 1rne_c04 source 1rne RENIN (ACTIVATED, GLYCOSYLATED, INHIBITED) (E.: 5 hits 1rne_c04 naa= 3 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 A 137 GLU A 174 GLU^? 20.39 MG MG A 302 A 288 HIS A 42 HIS^? 28.45 MG MG A 301 A 329 LYS B 6 LYS^? 25.90 MG MG B 302 coo 29.27 18.78 14.99 27.16 18.62 14.76 25.88 23.57 38.04 23.76 23.95 38.22 coo 49.52 10.06 10.36 50.99 9.65 8.92 34.62 18.32 19.57 34.29 16.25 19.41 coo 57.80 12.92 13.83 53.77 8.42 12.15 36.26 25.44 11.74 39.65 23.12 16.29 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 2 3 # 2 A 137 GLU B 174 GLU^? 19.69 MG MG B 301 A 288 HIS B 42 HIS^? 28.37 MG MG B 302 A 329 LYS A 6 LYS^? 25.88 MG MG A 301 coo 29.27 18.78 14.99 27.16 18.62 14.76 43.72 4.95 -3.28 44.76 3.14 -2.69 coo 49.52 10.06 10.36 50.99 9.65 8.92 39.34 12.99 16.30 37.26 13.24 16.40 coo 57.80 12.92 13.83 53.77 8.42 12.15 46.20 12.82 24.71 44.50 16.64 20.52 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 3 3 # 3 A 137 GLU C 174 GLU^? 19.72 MG MG C 301 A 288 HIS C 42 HIS^? 28.09 MG MG C 302 A 329 LYS D 6 LYS^? 25.98 MG MG D 302 coo 29.27 18.78 14.99 27.16 18.62 14.76 95.09 14.29 -3.63 95.25 12.23 -4.17 coo 49.52 10.06 10.36 50.99 9.65 8.92 95.93 22.96 -23.11 97.92 23.62 -23.02 coo 57.80 12.92 13.83 53.77 8.42 12.15 89.78 20.68 -31.57 90.15 24.89 -27.02 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 4 3 # 4 A 137 GLU D 174 GLU^? 19.76 MG MG D 301 A 288 HIS D 42 HIS^? 28.21 MG MG D 302 A 329 LYS C 6 LYS^? 25.73 MG MG C 302 coo 29.27 18.78 14.99 27.16 18.62 14.76 104.29 37.18 -46.00 105.30 38.94 -45.21 coo 49.52 10.06 10.36 50.99 9.65 8.92 98.45 29.90 -26.44 99.32 28.02 -26.13 coo 57.80 12.92 13.83 53.77 8.42 12.15 94.42 35.68 -18.56 92.21 32.03 -23.05 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 5 3 # 5 A 137 GLU E 174 GLU^? 19.83 MG MG E 301 A 288 HIS E 42 HIS^? 28.20 MG MG E 302 A 329 LYS F 6 LYS^? 26.09 MG MG F 301 coo 29.27 18.78 14.99 27.16 18.62 14.76 70.48 76.62 -49.45 71.76 78.34 -49.45 coo 49.52 10.06 10.36 50.99 9.65 8.92 62.33 71.93 -68.30 60.54 72.96 -68.64 coo 57.80 12.92 13.83 53.77 8.42 12.15 67.53 67.03 -76.43 64.05 65.33 -71.86 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 6 3 # 6 A 137 GLU F 174 GLU^? 18.79 MG MG F 302 A 288 HIS F 42 HIS^? 28.34 MG MG F 301 A 329 LYS E 6 LYS^? 25.59 MG MG E 302 coo 29.27 18.78 14.99 27.16 18.62 14.76 46.19 70.73 -90.91 44.19 71.42 -90.89 coo 49.52 10.06 10.36 50.99 9.65 8.92 55.11 70.50 -71.64 56.29 72.22 -71.48 coo 57.80 12.92 13.83 53.77 8.42 12.15 51.95 64.70 -63.33 56.16 64.03 -67.52 1roz_c00 source 1roz DEOXYHYPUSINE SYNTHASE : 6 hits 1roz_c00 naa= 3 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 B 137 GLU A 174 GLU^? 20.39 MG MG A 302 B 288 HIS A 42 HIS^? 28.45 MG MG A 301 B 329 LYS B 6 LYS^? 25.90 MG MG B 302 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 25.88 23.57 38.04 23.76 23.95 38.22 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 34.62 18.32 19.57 34.29 16.25 19.41 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 36.26 25.44 11.74 39.65 23.12 16.29 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 2 3 # 2 B 137 GLU B 174 GLU^? 19.69 MG MG B 301 B 288 HIS B 42 HIS^? 28.37 MG MG B 302 B 329 LYS A 6 LYS^? 25.88 MG MG A 301 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 43.72 4.95 -3.28 44.76 3.14 -2.69 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 39.34 12.99 16.30 37.26 13.24 16.40 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 46.20 12.82 24.71 44.50 16.64 20.52 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 3 3 # 3 B 137 GLU C 174 GLU^? 19.72 MG MG C 301 B 288 HIS C 42 HIS^? 28.09 MG MG C 302 B 329 LYS D 6 LYS^? 25.98 MG MG D 302 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 95.09 14.29 -3.63 95.25 12.23 -4.17 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 95.93 22.96 -23.11 97.92 23.62 -23.02 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 89.78 20.68 -31.57 90.15 24.89 -27.02 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 4 3 # 4 B 137 GLU D 174 GLU^? 19.76 MG MG D 301 B 288 HIS D 42 HIS^? 28.21 MG MG D 302 B 329 LYS C 6 LYS^? 25.73 MG MG C 302 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 104.29 37.18 -46.00 105.30 38.94 -45.21 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 98.45 29.90 -26.44 99.32 28.02 -26.13 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 94.42 35.68 -18.56 92.21 32.03 -23.05 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 5 3 # 5 B 137 GLU E 174 GLU^? 19.83 MG MG E 301 B 288 HIS E 42 HIS^? 28.20 MG MG E 302 B 329 LYS F 6 LYS^? 26.09 MG MG F 301 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 70.48 76.62 -49.45 71.76 78.34 -49.45 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 62.33 71.93 -68.30 60.54 72.96 -68.64 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 67.53 67.03 -76.43 64.05 65.33 -71.86 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 6 3 # 6 B 137 GLU F 174 GLU^? 18.79 MG MG F 302 B 288 HIS F 42 HIS^? 28.34 MG MG F 301 B 329 LYS E 6 LYS^? 25.59 MG MG E 302 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 46.19 70.73 -90.91 44.19 71.42 -90.89 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 55.11 70.50 -71.64 56.29 72.22 -71.48 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 51.95 64.70 -63.33 56.16 64.03 -67.52 1roz_c01 source 1roz DEOXYHYPUSINE SYNTHASE : 6 hits 1roz_c01 naa= 3 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 1 3 # 1 B 57 HIS A 147 HIS^? 9.20 MG MG A 302 B 102 ASP A 148 ASP^? 2.72 MG MG A 301s B 195 SER A 189 SER^? 11.75 MG MG A 302 coo -4.60 27.52 42.88 -4.63 27.41 40.76 40.24 23.10 39.83 38.32 22.34 40.22 coo -0.27 31.24 43.51 -1.49 29.62 42.98 41.50 28.88 41.13 43.33 29.67 41.93 coo -2.83 25.96 36.71 -4.77 27.03 37.63 40.99 19.00 44.32 41.51 18.14 46.48 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 2 3 # 2 B 57 HIS B 147 HIS^? 9.27 MG MG B 301 B 102 ASP B 148 ASP^? 2.58 MG MG B 302s B 195 SER B 189 SER^? 12.11 MG MG B 301 coo -4.60 27.52 42.88 -4.63 27.41 40.76 46.73 18.97 -3.05 45.63 17.32 -3.73 coo -0.27 31.24 43.51 -1.49 29.62 42.98 52.73 19.23 -3.77 53.81 20.99 -4.31 coo -2.83 25.96 36.71 -4.77 27.03 37.63 43.10 20.95 -7.74 42.82 21.56 -10.02 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 3 3 # 3 B 57 HIS C 147 HIS^? 9.44 MG MG C 301 B 102 ASP C 148 ASP^? 2.75 MG MG C 302s B 195 SER C 189 SER^? 12.09 MG MG C 301 coo -4.60 27.52 42.88 -4.63 27.41 40.76 87.61 25.71 -3.59 89.22 24.50 -2.99 coo -0.27 31.24 43.51 -1.49 29.62 42.98 81.96 23.83 -2.68 80.24 25.11 -2.27 coo -2.83 25.96 36.71 -4.77 27.03 37.63 90.33 28.79 1.19 90.26 29.61 3.45 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 4 3 # 4 B 57 HIS D 147 HIS^? 9.43 MG MG D 301 B 102 ASP D 148 ASP^? 2.35 MG MG D 302s B 195 SER D 189 SER^? 12.12 MG MG D 301 coo -4.60 27.52 42.88 -4.63 27.41 40.76 90.95 32.51 -46.42 92.98 32.42 -46.93 coo -0.27 31.24 43.51 -1.49 29.62 42.98 87.78 37.50 -47.56 85.79 37.49 -48.28 coo -2.83 25.96 36.71 -4.77 27.03 37.63 91.62 28.58 -50.95 91.45 27.78 -53.25 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 5 3 # 5 B 57 HIS D 147 HIS^? 9.43 MG MG D 301 B 102 ASP D 187 ASP^? -2.95 MG MG D 301s B 195 SER D 189 SER^? 12.12 MG MG D 301 coo -4.60 27.52 42.88 -4.63 27.41 40.76 90.95 32.51 -46.42 92.98 32.42 -46.93 coo -0.27 31.24 43.51 -1.49 29.62 42.98 90.40 36.34 -52.69 89.24 37.98 -51.99 coo -2.83 25.96 36.71 -4.77 27.03 37.63 91.62 28.58 -50.95 91.45 27.78 -53.25 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 6 3 # 6 B 57 HIS E 147 HIS^? 9.22 MG MG E 301 B 102 ASP E 148 ASP^? 2.62 MG MG E 302s B 195 SER E 189 SER^? 11.91 MG MG E 301 coo -4.60 27.52 42.88 -4.63 27.41 40.76 63.87 64.43 -48.39 64.18 66.45 -47.92 coo -0.27 31.24 43.51 -1.49 29.62 42.98 68.29 60.44 -47.29 68.03 58.42 -46.50 coo -2.83 25.96 36.71 -4.77 27.03 37.63 60.13 65.61 -43.87 59.01 65.34 -41.74 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 7 3 # 7 B 57 HIS E 147 HIS^? 9.22 MG MG E 301 B 102 ASP E 187 ASP^? -2.71 MG MG E 301s B 195 SER E 189 SER^? 11.91 MG MG E 301 coo -4.60 27.52 42.88 -4.63 27.41 40.76 63.87 64.43 -48.39 64.18 66.45 -47.92 coo -0.27 31.24 43.51 -1.49 29.62 42.98 67.50 63.43 -41.69 68.97 62.26 -42.81 coo -2.83 25.96 36.71 -4.77 27.03 37.63 60.13 65.61 -43.87 59.01 65.34 -41.74 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 8 3 # 8 B 57 HIS F 147 HIS^? 8.79 MG MG F 302 B 102 ASP F 148 ASP^? 2.72 MG MG F 301s B 195 SER F 189 SER^? 11.88 MG MG F 302 coo -4.60 27.52 42.88 -4.63 27.41 40.76 56.63 61.66 -91.16 55.69 63.43 -91.80 coo -0.27 31.24 43.51 -1.49 29.62 42.98 53.64 56.47 -91.98 54.61 54.68 -92.64 coo -2.83 25.96 36.71 -4.77 27.03 37.63 59.91 63.90 -95.91 60.70 64.22 -98.13 1rtf_c03 source 1rtf TWO CHAIN TISSUE PLASMINOGEN ACTIVATOR : 8 hits 1rtf_c03 naa= 3 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 1 3 # 1 32 ASP A 148 ASP^? 2.72 MG MG A 301s 64 HIS A 147 HIS^? 9.20 MG MG A 302 221 SER A 189 SER^? 11.75 MG MG A 302 coo 80.16 73.25 62.48 80.01 71.25 61.82 41.50 28.88 41.13 43.33 29.67 41.93 coo 78.27 67.69 61.83 79.58 67.76 60.19 40.24 23.10 39.83 38.32 22.34 40.22 coo 83.63 66.07 58.16 81.31 66.75 57.98 40.99 19.00 44.32 41.51 18.14 46.48 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 2 3 # 2 32 ASP A 187 ASP^? -3.29 MG MG A 302s 64 HIS A 147 HIS^? 9.20 MG MG A 302 221 SER A 189 SER^? 11.75 MG MG A 302 coo 80.16 73.25 62.48 80.01 71.25 61.82 39.43 26.57 46.78 39.37 27.83 45.03 coo 78.27 67.69 61.83 79.58 67.76 60.19 40.24 23.10 39.83 38.32 22.34 40.22 coo 83.63 66.07 58.16 81.31 66.75 57.98 40.99 19.00 44.32 41.51 18.14 46.48 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 3 3 # 3 32 ASP B 148 ASP^? 2.58 MG MG B 302s 64 HIS B 147 HIS^? 9.27 MG MG B 301 221 SER B 189 SER^? 12.11 MG MG B 301 coo 80.16 73.25 62.48 80.01 71.25 61.82 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 78.27 67.69 61.83 79.58 67.76 60.19 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 83.63 66.07 58.16 81.31 66.75 57.98 43.10 20.95 -7.74 42.82 21.56 -10.02 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 4 3 # 4 32 ASP B 187 ASP^? -3.44 MG MG B 301s 64 HIS B 147 HIS^? 9.27 MG MG B 301 221 SER B 189 SER^? 12.11 MG MG B 301 coo 80.16 73.25 62.48 80.01 71.25 61.82 50.64 18.14 -9.69 51.74 17.63 -7.86 coo 78.27 67.69 61.83 79.58 67.76 60.19 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 83.63 66.07 58.16 81.31 66.75 57.98 43.10 20.95 -7.74 42.82 21.56 -10.02 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 5 3 # 5 32 ASP C 148 ASP^? 2.75 MG MG C 302s 64 HIS C 147 HIS^? 9.44 MG MG C 301 221 SER C 189 SER^? 12.09 MG MG C 301 coo 80.16 73.25 62.48 80.01 71.25 61.82 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 78.27 67.69 61.83 79.58 67.76 60.19 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 83.63 66.07 58.16 81.31 66.75 57.98 90.33 28.79 1.19 90.26 29.61 3.45 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 6 3 # 6 32 ASP D 148 ASP^? 2.35 MG MG D 302s 64 HIS D 147 HIS^? 9.43 MG MG D 301 221 SER D 189 SER^? 12.12 MG MG D 301 coo 80.16 73.25 62.48 80.01 71.25 61.82 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 78.27 67.69 61.83 79.58 67.76 60.19 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 83.63 66.07 58.16 81.31 66.75 57.98 91.62 28.58 -50.95 91.45 27.78 -53.25 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 7 3 # 7 32 ASP D 187 ASP^? -2.95 MG MG D 301s 64 HIS D 147 HIS^? 9.43 MG MG D 301 221 SER D 189 SER^? 12.12 MG MG D 301 coo 80.16 73.25 62.48 80.01 71.25 61.82 90.40 36.34 -52.69 89.24 37.98 -51.99 coo 78.27 67.69 61.83 79.58 67.76 60.19 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 83.63 66.07 58.16 81.31 66.75 57.98 91.62 28.58 -50.95 91.45 27.78 -53.25 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 8 3 # 8 32 ASP E 148 ASP^? 2.62 MG MG E 302s 64 HIS E 147 HIS^? 9.22 MG MG E 301 221 SER E 189 SER^? 11.91 MG MG E 301 coo 80.16 73.25 62.48 80.01 71.25 61.82 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 78.27 67.69 61.83 79.58 67.76 60.19 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 83.63 66.07 58.16 81.31 66.75 57.98 60.13 65.61 -43.87 59.01 65.34 -41.74 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 9 3 # 9 32 ASP E 187 ASP^? -2.71 MG MG E 301s 64 HIS E 147 HIS^? 9.22 MG MG E 301 221 SER E 189 SER^? 11.91 MG MG E 301 coo 80.16 73.25 62.48 80.01 71.25 61.82 67.50 63.43 -41.69 68.97 62.26 -42.81 coo 78.27 67.69 61.83 79.58 67.76 60.19 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 83.63 66.07 58.16 81.31 66.75 57.98 60.13 65.61 -43.87 59.01 65.34 -41.74 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 10 3 # 10 32 ASP F 148 ASP^? 2.72 MG MG F 301s 64 HIS F 147 HIS^? 8.79 MG MG F 302 221 SER F 189 SER^? 11.88 MG MG F 302 coo 80.16 73.25 62.48 80.01 71.25 61.82 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 78.27 67.69 61.83 79.58 67.76 60.19 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 83.63 66.07 58.16 81.31 66.75 57.98 59.91 63.90 -95.91 60.70 64.22 -98.13 1sca_c00 source 1sca SUBTILISIN CARLSBERG (E.C.3.4.21.62) (AQUEOUS : 10 hits 1sca_c00 naa= 3 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 1 3 # 1 32 ASP B 148 ASP^? 2.58 MG MG B 302s 64 HIS B 147 HIS^? 9.27 MG MG B 301 155 ASN B 132 ASN^? 16.42 MG MG B 302 coo 80.16 73.25 62.48 80.01 71.25 61.82 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 78.27 67.69 61.83 79.58 67.76 60.19 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 80.34 61.88 52.75 81.25 63.19 54.35 40.27 30.00 -2.76 41.98 31.07 -3.41 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 2 3 # 2 32 ASP C 148 ASP^? 2.75 MG MG C 302s 64 HIS C 147 HIS^? 9.44 MG MG C 301 155 ASN C 132 ASN^? 16.52 MG MG C 302 coo 80.16 73.25 62.48 80.01 71.25 61.82 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 78.27 67.69 61.83 79.58 67.76 60.19 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 80.34 61.88 52.75 81.25 63.19 54.35 89.66 38.54 -3.77 87.74 38.77 -2.97 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 3 3 # 3 32 ASP D 148 ASP^? 2.35 MG MG D 302s 64 HIS D 147 HIS^? 9.43 MG MG D 301 155 ASN D 132 ASN^? 16.46 MG MG D 302 coo 80.16 73.25 62.48 80.01 71.25 61.82 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 78.27 67.69 61.83 79.58 67.76 60.19 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 80.34 61.88 52.75 81.25 63.19 54.35 84.64 21.31 -46.24 83.02 22.38 -47.10 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 4 3 # 4 32 ASP E 148 ASP^? 2.62 MG MG E 302s 64 HIS E 147 HIS^? 9.22 MG MG E 301 155 ASN E 132 ASN^? 16.39 MG MG E 302 coo 80.16 73.25 62.48 80.01 71.25 61.82 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 78.27 67.69 61.83 79.58 67.76 60.19 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 80.34 61.88 52.75 81.25 63.19 54.35 51.80 60.19 -48.38 52.68 58.51 -47.42 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 5 3 # 5 32 ASP F 148 ASP^? 2.72 MG MG F 301s 64 HIS F 147 HIS^? 8.79 MG MG F 302 155 ASN F 132 ASN^? 16.48 MG MG F 301 coo 80.16 73.25 62.48 80.01 71.25 61.82 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 78.27 67.69 61.83 79.58 67.76 60.19 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 80.34 61.88 52.75 81.25 63.19 54.35 69.23 61.88 -90.93 69.10 59.95 -91.77 1sca_c01 source 1sca SUBTILISIN CARLSBERG (E.C.3.4.21.62) (AQUEOUS : 5 hits 1sca_c01 naa= 3 ULMN 3 1sll_c00 SIALIDASE L user 1 3 # 1 318 ASP A 128 ASP^? -3.32 MG MG A 301s 595 GLU A 146 GLU^? 9.80 MG MG A 302 713 TYR A 188 TYR^? 8.73 MG MG A 302 coo 5.64 2.82 38.49 4.59 4.19 37.25 46.50 28.23 39.77 47.49 30.10 39.82 coo 4.35 13.73 37.63 3.39 12.18 36.55 45.17 20.35 44.20 46.68 21.21 45.40 coo 3.76 10.25 31.38 3.16 9.87 34.10 37.17 23.04 44.09 34.69 24.12 44.73 ULMN 3 1sll_c00 SIALIDASE L user 2 3 # 2 318 ASP B 128 ASP^? -3.57 MG MG B 302s 595 GLU B 146 GLU^? 10.54 MG MG B 301 713 TYR B 188 TYR^? 8.84 MG MG B 301 coo 5.64 2.82 38.49 4.59 4.19 37.25 52.92 24.09 -2.19 54.73 25.14 -1.90 coo 4.35 13.73 37.63 3.39 12.18 36.55 45.13 24.51 -7.01 46.08 25.99 -8.13 coo 3.76 10.25 31.38 3.16 9.87 34.10 46.41 16.35 -7.52 47.38 13.88 -8.38 ULMN 3 1sll_c00 SIALIDASE L user 3 3 # 3 318 ASP C 128 ASP^? -3.22 MG MG C 302s 595 GLU C 146 GLU^? 10.46 MG MG C 301 713 TYR C 188 TYR^? 8.98 MG MG C 301 coo 5.64 2.82 38.49 4.59 4.19 37.25 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 4.35 13.73 37.63 3.39 12.18 36.55 87.01 31.93 0.25 85.57 32.56 1.72 coo 3.76 10.25 31.38 3.16 9.87 34.10 88.74 23.30 0.93 88.91 20.61 1.57 ULMN 3 1sll_c00 SIALIDASE L user 4 3 # 4 318 ASP C 171 ASP^? 17.08 MG MG C 301 595 GLU C 154 GLU^? 18.91 MG MG C 302 713 TYR C 168 TYR^? 14.82 MG MG C 301 coo 5.64 2.82 38.49 4.59 4.19 37.25 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 4.35 13.73 37.63 3.39 12.18 36.55 91.15 23.27 -13.33 91.61 21.91 -14.95 coo 3.76 10.25 31.38 3.16 9.87 34.10 94.44 26.43 -5.44 92.97 25.09 -3.55 ULMN 3 1sll_c00 SIALIDASE L user 5 3 # 5 318 ASP D 35 ASP^? 16.80 MG MG D 302 595 GLU C 63 GLU^? 27.26 MG MG D 302 713 TYR C 60 TYR^? 26.95 MG MG D 302 coo 5.64 2.82 38.49 4.59 4.19 37.25 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 4.35 13.73 37.63 3.39 12.18 36.55 89.51 47.54 -22.35 87.55 48.20 -22.72 coo 3.76 10.25 31.38 3.16 9.87 34.10 97.75 47.69 -25.92 97.82 49.25 -28.26 ULMN 3 1sll_c00 SIALIDASE L user 6 3 # 6 318 ASP D 128 ASP^? -3.70 MG MG D 302s 595 GLU D 146 GLU^? 10.62 MG MG D 301 713 TYR D 188 TYR^? 8.87 MG MG D 301 coo 5.64 2.82 38.49 4.59 4.19 37.25 83.33 35.45 -46.13 81.57 36.63 -46.10 coo 4.35 13.73 37.63 3.39 12.18 36.55 87.24 28.82 -50.92 85.47 28.08 -51.67 coo 3.76 10.25 31.38 3.16 9.87 34.10 93.72 33.91 -50.86 95.36 36.03 -51.61 ULMN 3 1sll_c00 SIALIDASE L user 7 3 # 7 318 ASP F 35 ASP^? 16.93 MG MG F 301 595 GLU E 63 GLU^? 28.08 MG MG F 301 713 TYR E 60 TYR^? 27.19 MG MG F 301 coo 5.64 2.82 38.49 4.59 4.19 37.25 46.82 60.47 -77.63 48.00 58.79 -78.23 coo 4.35 13.73 37.63 3.39 12.18 36.55 44.04 53.99 -66.79 43.77 51.93 -66.35 coo 3.76 10.25 31.38 3.16 9.87 34.10 39.82 61.07 -70.68 38.29 60.72 -72.98 ULMN 3 1sll_c00 SIALIDASE L user 8 3 # 8 318 ASP F 128 ASP^? -3.41 MG MG F 301s 595 GLU F 146 GLU^? 10.36 MG MG F 302 713 TYR F 188 TYR^? 8.06 MG MG F 302 coo 5.64 2.82 38.49 4.59 4.19 37.25 57.76 53.73 -90.50 57.46 51.64 -90.28 coo 4.35 13.73 37.63 3.39 12.18 36.55 61.95 60.17 -95.28 62.87 58.56 -96.19 coo 3.76 10.25 31.38 3.16 9.87 34.10 54.23 63.50 -95.64 51.58 63.66 -96.35 ULMN 3 1sll_c00 SIALIDASE L user 9 3 # 9 318 ASP F 171 ASP^? 16.35 MG MG F 302 595 GLU F 154 GLU^? 18.97 MG MG F 301 713 TYR F 168 TYR^? 14.10 MG MG F 302 coo 5.64 2.82 38.49 4.59 4.19 37.25 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 4.35 13.73 37.63 3.39 12.18 36.55 54.57 65.67 -81.55 53.36 66.51 -80.09 coo 3.76 10.25 31.38 3.16 9.87 34.10 58.29 68.32 -89.29 56.67 67.12 -91.21 1sll_c00 source 1sll SIALIDASE L : 9 hits 1sll_c00 naa= 3 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 1 3 # 1 A 87 ARG A 8 ARG^? 20.36 MG MG A 301 A 89 HIS B 42 HIS^? 28.37 MG MG B 302 A 119 ASN B 45 ASN^? 24.27 MG MG A 301 coo 28.44 23.52 73.95 30.13 24.84 76.11 40.62 19.52 24.63 40.98 22.51 23.88 coo 21.34 20.13 69.47 22.14 19.11 71.12 39.34 12.99 16.30 37.26 13.24 16.40 coo 19.69 29.00 71.61 19.80 26.98 72.20 47.87 19.20 19.75 47.40 21.26 19.77 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 2 3 # 2 A 87 ARG B 8 ARG^? 20.39 MG MG B 302 A 89 HIS B 42 HIS^? 28.37 MG MG B 302 A 119 ASN B 45 ASN^? 24.27 MG MG A 301 coo 28.44 23.52 73.95 30.13 24.84 76.11 41.99 18.82 11.83 44.91 18.76 12.93 coo 21.34 20.13 69.47 22.14 19.11 71.12 39.34 12.99 16.30 37.26 13.24 16.40 coo 19.69 29.00 71.61 19.80 26.98 72.20 47.87 19.20 19.75 47.40 21.26 19.77 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 3 3 # 3 A 87 ARG B 37 ARG^? 19.17 MG MG B 302 A 89 HIS B 42 HIS^? 28.37 MG MG B 302 A 119 ASN B 45 ASN^? 24.27 MG MG A 301 coo 28.44 23.52 73.95 30.13 24.84 76.11 47.41 10.20 11.40 46.99 12.91 10.22 coo 21.34 20.13 69.47 22.14 19.11 71.12 39.34 12.99 16.30 37.26 13.24 16.40 coo 19.69 29.00 71.61 19.80 26.98 72.20 47.87 19.20 19.75 47.40 21.26 19.77 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 4 3 # 4 A 87 ARG C 8 ARG^? 20.00 MG MG C 302 A 89 HIS D 42 HIS^? 28.21 MG MG D 302 A 119 ASN D 45 ASN^? 24.33 MG MG C 302 coo 28.44 23.52 73.95 30.13 24.84 76.11 91.42 27.61 -18.53 88.82 26.28 -19.38 coo 21.34 20.13 69.47 22.14 19.11 71.12 98.45 29.90 -26.44 99.32 28.02 -26.13 coo 19.69 29.00 71.61 19.80 26.98 72.20 88.35 34.04 -23.87 86.82 32.62 -24.25 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 5 3 # 5 A 87 ARG D 8 ARG^? 20.22 MG MG D 302 A 89 HIS D 42 HIS^? 28.21 MG MG D 302 A 119 ASN D 45 ASN^? 24.33 MG MG C 302 coo 28.44 23.52 73.95 30.13 24.84 76.11 92.22 28.83 -31.23 90.93 31.55 -30.54 coo 21.34 20.13 69.47 22.14 19.11 71.12 98.45 29.90 -26.44 99.32 28.02 -26.13 coo 19.69 29.00 71.61 19.80 26.98 72.20 88.35 34.04 -23.87 86.82 32.62 -24.25 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 6 3 # 6 A 87 ARG D 37 ARG^? 18.81 MG MG D 302 A 89 HIS D 42 HIS^? 28.21 MG MG D 302 A 119 ASN D 45 ASN^? 24.33 MG MG C 302 coo 28.44 23.52 73.95 30.13 24.84 76.11 96.81 38.21 -31.63 94.97 36.32 -33.06 coo 21.34 20.13 69.47 22.14 19.11 71.12 98.45 29.90 -26.44 99.32 28.02 -26.13 coo 19.69 29.00 71.61 19.80 26.98 72.20 88.35 34.04 -23.87 86.82 32.62 -24.25 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 7 3 # 7 A 87 ARG E 8 ARG^? 20.19 MG MG E 302 A 89 HIS E 42 HIS^? 28.20 MG MG E 302 A 119 ASN E 45 ASN^? 24.46 MG MG F 301 coo 28.44 23.52 73.95 30.13 24.84 76.11 60.42 66.09 -63.48 62.84 64.38 -64.17 coo 21.34 20.13 69.47 22.14 19.11 71.12 62.33 71.93 -68.30 60.54 72.96 -68.64 coo 19.69 29.00 71.61 19.80 26.98 72.20 64.97 61.33 -71.05 63.29 60.06 -70.79 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 8 3 # 8 A 87 ARG E 8 ARG^? 20.19 MG MG E 302 A 89 HIS F 42 HIS^? 28.34 MG MG F 301 A 119 ASN F 45 ASN^? 24.43 MG MG E 302 coo 28.44 23.52 73.95 30.13 24.84 76.11 60.42 66.09 -63.48 62.84 64.38 -64.17 coo 21.34 20.13 69.47 22.14 19.11 71.12 55.11 70.50 -71.64 56.29 72.22 -71.48 coo 19.69 29.00 71.61 19.80 26.98 72.20 56.42 59.79 -68.43 58.48 59.32 -68.69 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 9 3 # 9 A 87 ARG E 37 ARG^? 19.17 MG MG E 302 A 89 HIS E 42 HIS^? 28.20 MG MG E 302 A 119 ASN E 45 ASN^? 24.46 MG MG F 301 coo 28.44 23.52 73.95 30.13 24.84 76.11 70.82 68.02 -63.63 68.17 67.46 -62.14 coo 21.34 20.13 69.47 22.14 19.11 71.12 62.33 71.93 -68.30 60.54 72.96 -68.64 coo 19.69 29.00 71.61 19.80 26.98 72.20 64.97 61.33 -71.05 63.29 60.06 -70.79 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 10 3 # 10 A 87 ARG F 8 ARG^? 20.20 MG MG F 301 A 89 HIS E 42 HIS^? 28.20 MG MG E 302 A 119 ASN E 45 ASN^? 24.46 MG MG F 301 coo 28.44 23.52 73.95 30.13 24.84 76.11 58.98 65.22 -76.31 57.29 62.84 -75.38 coo 21.34 20.13 69.47 22.14 19.11 71.12 62.33 71.93 -68.30 60.54 72.96 -68.64 coo 19.69 29.00 71.61 19.80 26.98 72.20 64.97 61.33 -71.05 63.29 60.06 -70.79 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 11 3 # 11 A 87 ARG F 8 ARG^? 20.20 MG MG F 301 A 89 HIS F 42 HIS^? 28.34 MG MG F 301 A 119 ASN F 45 ASN^? 24.43 MG MG E 302 coo 28.44 23.52 73.95 30.13 24.84 76.11 58.98 65.22 -76.31 57.29 62.84 -75.38 coo 21.34 20.13 69.47 22.14 19.11 71.12 55.11 70.50 -71.64 56.29 72.22 -71.48 coo 19.69 29.00 71.61 19.80 26.98 72.20 56.42 59.79 -68.43 58.48 59.32 -68.69 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 12 3 # 12 A 87 ARG F 37 ARG^? 19.14 MG MG F 301 A 89 HIS F 42 HIS^? 28.34 MG MG F 301 A 119 ASN F 45 ASN^? 24.43 MG MG E 302 coo 28.44 23.52 73.95 30.13 24.84 76.11 48.80 64.46 -76.37 51.50 64.15 -77.79 coo 21.34 20.13 69.47 22.14 19.11 71.12 55.11 70.50 -71.64 56.29 72.22 -71.48 coo 19.69 29.00 71.61 19.80 26.98 72.20 56.42 59.79 -68.43 58.48 59.32 -68.69 1smn_c00 source 1smn EXTRACELLULAR ENDONUCLEASE : 12 hits 1smn_c00 naa= 3 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 1 3 # 1 B 87 ARG A 8 ARG^? 20.36 MG MG A 301 B 89 HIS B 42 HIS^? 28.37 MG MG B 302 B 119 ASN B 45 ASN^? 24.27 MG MG A 301 coo -30.08 23.20 29.48 -31.80 24.60 27.35 40.62 19.52 24.63 40.98 22.51 23.88 coo -22.85 19.92 33.92 -23.63 18.94 32.24 39.34 12.99 16.30 37.26 13.24 16.40 coo -21.28 28.91 31.84 -21.35 26.90 31.17 47.87 19.20 19.75 47.40 21.26 19.77 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 2 3 # 2 B 87 ARG B 8 ARG^? 20.39 MG MG B 302 B 89 HIS B 42 HIS^? 28.37 MG MG B 302 B 119 ASN B 45 ASN^? 24.27 MG MG A 301 coo -30.08 23.20 29.48 -31.80 24.60 27.35 41.99 18.82 11.83 44.91 18.76 12.93 coo -22.85 19.92 33.92 -23.63 18.94 32.24 39.34 12.99 16.30 37.26 13.24 16.40 coo -21.28 28.91 31.84 -21.35 26.90 31.17 47.87 19.20 19.75 47.40 21.26 19.77 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 3 3 # 3 B 87 ARG B 37 ARG^? 19.17 MG MG B 302 B 89 HIS B 42 HIS^? 28.37 MG MG B 302 B 119 ASN B 45 ASN^? 24.27 MG MG A 301 coo -30.08 23.20 29.48 -31.80 24.60 27.35 47.41 10.20 11.40 46.99 12.91 10.22 coo -22.85 19.92 33.92 -23.63 18.94 32.24 39.34 12.99 16.30 37.26 13.24 16.40 coo -21.28 28.91 31.84 -21.35 26.90 31.17 47.87 19.20 19.75 47.40 21.26 19.77 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 4 3 # 4 B 87 ARG C 8 ARG^? 20.00 MG MG C 302 B 89 HIS C 42 HIS^? 28.09 MG MG C 302 B 119 ASN C 45 ASN^? 24.54 MG MG C 302 coo -30.08 23.20 29.48 -31.80 24.60 27.35 91.42 27.61 -18.53 88.82 26.28 -19.38 coo -22.85 19.92 33.92 -23.63 18.94 32.24 95.93 22.96 -23.11 97.92 23.62 -23.02 coo -21.28 28.91 31.84 -21.35 26.90 31.17 85.43 25.82 -26.31 85.43 27.91 -25.97 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 5 3 # 5 B 87 ARG C 8 ARG^? 20.00 MG MG C 302 B 89 HIS D 42 HIS^? 28.21 MG MG D 302 B 119 ASN D 45 ASN^? 24.33 MG MG C 302 coo -30.08 23.20 29.48 -31.80 24.60 27.35 91.42 27.61 -18.53 88.82 26.28 -19.38 coo -22.85 19.92 33.92 -23.63 18.94 32.24 98.45 29.90 -26.44 99.32 28.02 -26.13 coo -21.28 28.91 31.84 -21.35 26.90 31.17 88.35 34.04 -23.87 86.82 32.62 -24.25 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 6 3 # 6 B 87 ARG D 8 ARG^? 20.22 MG MG D 302 B 89 HIS C 42 HIS^? 28.09 MG MG C 302 B 119 ASN C 45 ASN^? 24.54 MG MG C 302 coo -30.08 23.20 29.48 -31.80 24.60 27.35 92.22 28.83 -31.23 90.93 31.55 -30.54 coo -22.85 19.92 33.92 -23.63 18.94 32.24 95.93 22.96 -23.11 97.92 23.62 -23.02 coo -21.28 28.91 31.84 -21.35 26.90 31.17 85.43 25.82 -26.31 85.43 27.91 -25.97 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 7 3 # 7 B 87 ARG D 8 ARG^? 20.22 MG MG D 302 B 89 HIS D 42 HIS^? 28.21 MG MG D 302 B 119 ASN D 45 ASN^? 24.33 MG MG C 302 coo -30.08 23.20 29.48 -31.80 24.60 27.35 92.22 28.83 -31.23 90.93 31.55 -30.54 coo -22.85 19.92 33.92 -23.63 18.94 32.24 98.45 29.90 -26.44 99.32 28.02 -26.13 coo -21.28 28.91 31.84 -21.35 26.90 31.17 88.35 34.04 -23.87 86.82 32.62 -24.25 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 8 3 # 8 B 87 ARG D 37 ARG^? 18.81 MG MG D 302 B 89 HIS D 42 HIS^? 28.21 MG MG D 302 B 119 ASN D 45 ASN^? 24.33 MG MG C 302 coo -30.08 23.20 29.48 -31.80 24.60 27.35 96.81 38.21 -31.63 94.97 36.32 -33.06 coo -22.85 19.92 33.92 -23.63 18.94 32.24 98.45 29.90 -26.44 99.32 28.02 -26.13 coo -21.28 28.91 31.84 -21.35 26.90 31.17 88.35 34.04 -23.87 86.82 32.62 -24.25 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 9 3 # 9 B 87 ARG E 8 ARG^? 20.19 MG MG E 302 B 89 HIS E 42 HIS^? 28.20 MG MG E 302 B 119 ASN E 45 ASN^? 24.46 MG MG F 301 coo -30.08 23.20 29.48 -31.80 24.60 27.35 60.42 66.09 -63.48 62.84 64.38 -64.17 coo -22.85 19.92 33.92 -23.63 18.94 32.24 62.33 71.93 -68.30 60.54 72.96 -68.64 coo -21.28 28.91 31.84 -21.35 26.90 31.17 64.97 61.33 -71.05 63.29 60.06 -70.79 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 10 3 # 10 B 87 ARG E 8 ARG^? 20.19 MG MG E 302 B 89 HIS F 42 HIS^? 28.34 MG MG F 301 B 119 ASN F 45 ASN^? 24.43 MG MG E 302 coo -30.08 23.20 29.48 -31.80 24.60 27.35 60.42 66.09 -63.48 62.84 64.38 -64.17 coo -22.85 19.92 33.92 -23.63 18.94 32.24 55.11 70.50 -71.64 56.29 72.22 -71.48 coo -21.28 28.91 31.84 -21.35 26.90 31.17 56.42 59.79 -68.43 58.48 59.32 -68.69 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 11 3 # 11 B 87 ARG E 37 ARG^? 19.17 MG MG E 302 B 89 HIS E 42 HIS^? 28.20 MG MG E 302 B 119 ASN E 45 ASN^? 24.46 MG MG F 301 coo -30.08 23.20 29.48 -31.80 24.60 27.35 70.82 68.02 -63.63 68.17 67.46 -62.14 coo -22.85 19.92 33.92 -23.63 18.94 32.24 62.33 71.93 -68.30 60.54 72.96 -68.64 coo -21.28 28.91 31.84 -21.35 26.90 31.17 64.97 61.33 -71.05 63.29 60.06 -70.79 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 12 3 # 12 B 87 ARG F 8 ARG^? 20.20 MG MG F 301 B 89 HIS E 42 HIS^? 28.20 MG MG E 302 B 119 ASN E 45 ASN^? 24.46 MG MG F 301 coo -30.08 23.20 29.48 -31.80 24.60 27.35 58.98 65.22 -76.31 57.29 62.84 -75.38 coo -22.85 19.92 33.92 -23.63 18.94 32.24 62.33 71.93 -68.30 60.54 72.96 -68.64 coo -21.28 28.91 31.84 -21.35 26.90 31.17 64.97 61.33 -71.05 63.29 60.06 -70.79 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 13 3 # 13 B 87 ARG F 8 ARG^? 20.20 MG MG F 301 B 89 HIS F 42 HIS^? 28.34 MG MG F 301 B 119 ASN F 45 ASN^? 24.43 MG MG E 302 coo -30.08 23.20 29.48 -31.80 24.60 27.35 58.98 65.22 -76.31 57.29 62.84 -75.38 coo -22.85 19.92 33.92 -23.63 18.94 32.24 55.11 70.50 -71.64 56.29 72.22 -71.48 coo -21.28 28.91 31.84 -21.35 26.90 31.17 56.42 59.79 -68.43 58.48 59.32 -68.69 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 14 3 # 14 B 87 ARG F 37 ARG^? 19.14 MG MG F 301 B 89 HIS F 42 HIS^? 28.34 MG MG F 301 B 119 ASN F 45 ASN^? 24.43 MG MG E 302 coo -30.08 23.20 29.48 -31.80 24.60 27.35 48.80 64.46 -76.37 51.50 64.15 -77.79 coo -22.85 19.92 33.92 -23.63 18.94 32.24 55.11 70.50 -71.64 56.29 72.22 -71.48 coo -21.28 28.91 31.84 -21.35 26.90 31.17 56.42 59.79 -68.43 58.48 59.32 -68.69 1smn_c01 source 1smn EXTRACELLULAR ENDONUCLEASE : 14 hits 1smn_c01 naa= 3 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 1 3 # 1 E 166 ASP A 58 ASP^? 26.75 MG MG B 302 E 168 LYS A 6 LYS^? 25.88 MG MG A 301 E 201 THR B 46 THR^? 23.88 MG MG B 302 coo 5.36 16.20 22.10 3.88 17.00 23.31 53.93 9.80 21.09 53.83 8.90 19.15 coo 5.06 22.32 18.11 1.02 22.08 22.74 46.20 12.82 24.71 44.50 16.64 20.52 coo -1.79 18.29 19.05 -1.19 20.28 19.71 49.71 15.16 18.13 48.80 13.51 17.14 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 2 3 # 2 E 166 ASP A 138 ASP^? 33.08 MG MG A 302 E 168 LYS A 136 LYS^? 30.58 MG MG A 302 E 201 THR A 2 THR.? 34.64 MG MG A 301 coo 5.36 16.20 22.10 3.88 17.00 23.31 47.10 -0.97 29.63 45.89 0.22 30.96 coo 5.06 22.32 18.11 1.02 22.08 22.74 50.14 3.36 31.42 51.28 2.21 35.89 coo -1.79 18.29 19.05 -1.19 20.28 19.71 47.80 1.72 22.09 46.70 1.88 23.97 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 3 3 # 3 E 166 ASP B 58 ASP^? 26.73 MG MG A 301 E 168 LYS B 6 LYS^? 25.90 MG MG B 302 E 201 THR A 46 THR^? 24.24 MG MG A 301 coo 5.36 16.20 22.10 3.88 17.00 23.31 34.42 33.56 15.74 33.50 33.49 17.59 coo 5.06 22.32 18.11 1.02 22.08 22.74 36.26 25.44 11.74 39.65 23.12 16.29 coo -1.79 18.29 19.05 -1.19 20.28 19.71 38.63 28.11 18.80 36.62 27.50 19.27 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 4 3 # 4 E 166 ASP B 138 ASP^? 33.32 MG MG B 302 E 168 LYS B 136 LYS^? 33.75 MG MG B 302 E 201 THR B 2 THR^? 34.11 MG MG B 302 coo 5.36 16.20 22.10 3.88 17.00 23.31 23.42 29.01 6.78 24.36 28.48 4.94 coo 5.06 22.32 18.11 1.02 22.08 22.74 28.47 31.35 4.78 24.04 31.81 1.99 coo -1.79 18.29 19.05 -1.19 20.28 19.71 25.51 29.18 13.74 26.24 28.19 11.93 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 5 3 # 5 E 166 ASP C 58 ASP^? 26.67 MG MG D 302 E 168 LYS C 6 LYS^? 25.73 MG MG C 302 E 201 THR D 46 THR^? 23.86 MG MG D 302 coo 5.36 16.20 22.10 3.88 17.00 23.31 93.40 43.81 -22.27 94.18 44.45 -24.11 coo 5.06 22.32 18.11 1.02 22.08 22.74 94.42 35.68 -18.56 92.21 32.03 -23.05 coo -1.79 18.29 19.05 -1.19 20.28 19.71 91.28 37.63 -25.27 93.05 36.72 -26.12 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 6 3 # 6 E 166 ASP C 138 ASP^? 33.43 MG MG C 302 E 168 LYS C 136 LYS^? 30.63 MG MG C 302 E 201 THR C 2 THR^? 33.69 MG MG C 302 coo 5.36 16.20 22.10 3.88 17.00 23.31 105.43 43.97 -13.30 104.85 43.08 -11.43 coo 5.06 22.32 18.11 1.02 22.08 22.74 99.75 44.04 -11.38 100.98 45.13 -6.77 coo -1.79 18.29 19.05 -1.19 20.28 19.71 103.03 43.13 -20.15 102.74 41.72 -18.56 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 7 3 # 7 E 166 ASP D 138 ASP^? 33.64 MG MG D 302 E 168 LYS D 136 LYS^? 34.99 MG MG D 302 E 201 THR D 2 THR^? 33.99 MG MG D 302 coo 5.36 16.20 22.10 3.88 17.00 23.31 93.00 7.50 -35.79 93.88 8.48 -37.45 coo 5.06 22.32 18.11 1.02 22.08 22.74 88.96 10.62 -38.53 90.77 6.00 -38.00 coo -1.79 18.29 19.05 -1.19 20.28 19.71 91.82 9.34 -29.18 91.80 10.46 -31.03 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 8 3 # 8 E 166 ASP E 58 ASP^? 26.76 MG MG F 301 E 168 LYS E 6 LYS^? 25.59 MG MG E 302 E 201 THR F 46 THR^? 24.16 MG MG F 301 coo 5.36 16.20 22.10 3.88 17.00 23.31 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 5.06 22.32 18.11 1.02 22.08 22.74 51.95 64.70 -63.33 56.16 64.03 -67.52 coo -1.79 18.29 19.05 -1.19 20.28 19.71 51.99 60.48 -70.07 50.88 62.21 -70.66 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 9 3 # 9 E 166 ASP E 138 ASP^? 33.31 MG MG E 302 E 168 LYS E 136 LYS^? 31.27 MG MG E 302 E 201 THR E 2 THR^? 33.84 MG MG E 302 coo 5.36 16.20 22.10 3.88 17.00 23.31 39.58 70.77 -58.63 40.74 70.78 -56.80 coo 5.06 22.32 18.11 1.02 22.08 22.74 42.12 65.93 -56.52 39.36 65.07 -51.83 coo -1.79 18.29 19.05 -1.19 20.28 19.71 41.32 68.37 -65.29 42.66 69.03 -63.78 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 10 3 # 10 E 166 ASP F 58 ASP^? 26.87 MG MG E 302 E 168 LYS F 6 LYS^? 26.09 MG MG F 301 E 201 THR E 46 THR^? 24.08 MG MG E 302 coo 5.36 16.20 22.10 3.88 17.00 23.31 75.55 64.68 -72.56 76.21 65.63 -70.79 coo 5.06 22.32 18.11 1.02 22.08 22.74 67.53 67.03 -76.43 64.05 65.33 -71.86 coo -1.79 18.29 19.05 -1.19 20.28 19.71 68.80 63.64 -69.48 69.18 65.66 -68.86 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 11 3 # 11 E 166 ASP F 138 ASP^? 33.51 MG MG F 302 E 168 LYS F 136 LYS^? 30.53 MG MG F 301 E 201 THR F 2 THR^? 34.54 MG MG F 301 coo 5.36 16.20 22.10 3.88 17.00 23.31 77.17 76.66 -81.48 76.14 76.33 -83.32 coo 5.06 22.32 18.11 1.02 22.08 22.74 76.49 71.19 -83.39 78.38 70.88 -88.47 coo -1.79 18.29 19.05 -1.19 20.28 19.71 76.07 74.83 -74.70 74.98 75.15 -76.59 1stc_c02 source 1stc CAMP-DEPENDENT PROTEIN KINASE : 11 hits 1stc_c02 naa= 3 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 1 3 # 1 B 8 HIS A 147 HIS^? 9.20 MG MG A 302 B 80 GLU A 146 GLU^? 9.80 MG MG A 302 B 223 ARG B 37 ARG^? 19.17 MG MG B 302 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 40.24 23.10 39.83 38.32 22.34 40.22 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 45.17 20.35 44.20 46.68 21.21 45.40 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 47.41 10.20 11.40 46.99 12.91 10.22 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 2 3 # 2 B 8 HIS A 147 HIS^? 9.20 MG MG A 302 B 80 GLU A 146 GLU^? 9.80 MG MG A 302 B 223 ARG B 48 ARG^? 25.20 MG MG B 302 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 40.24 23.10 39.83 38.32 22.34 40.22 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 45.17 20.35 44.20 46.68 21.21 45.40 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 52.22 10.51 15.00 52.46 7.79 16.39 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 3 3 # 3 B 8 HIS B 147 HIS^? 9.27 MG MG B 301 B 80 GLU B 146 GLU^? 10.54 MG MG B 301 B 223 ARG A 37 ARG^? 18.99 MG MG A 301 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 46.73 18.97 -3.05 45.63 17.32 -3.73 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 45.13 24.51 -7.01 46.08 25.99 -8.13 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 32.99 26.50 25.19 35.50 25.33 26.51 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 4 3 # 4 B 8 HIS B 147 HIS^? 9.27 MG MG B 301 B 80 GLU B 146 GLU^? 10.54 MG MG B 301 B 223 ARG A 48 ARG^? 25.29 MG MG A 301 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 46.73 18.97 -3.05 45.63 17.32 -3.73 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 45.13 24.51 -7.01 46.08 25.99 -8.13 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 33.88 31.17 22.03 31.48 31.85 20.30 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 5 3 # 5 B 8 HIS C 147 HIS^? 9.44 MG MG C 301 B 80 GLU C 146 GLU^? 10.46 MG MG C 301 B 223 ARG D 37 ARG^? 18.81 MG MG D 302 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 87.61 25.71 -3.59 89.22 24.50 -2.99 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 87.01 31.93 0.25 85.57 32.56 1.72 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 96.81 38.21 -31.63 94.97 36.32 -33.06 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 6 3 # 6 B 8 HIS C 147 HIS^? 9.44 MG MG C 301 B 80 GLU C 146 GLU^? 10.46 MG MG C 301 B 223 ARG D 48 ARG^? 24.87 MG MG D 302 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 87.61 25.71 -3.59 89.22 24.50 -2.99 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 87.01 31.93 0.25 85.57 32.56 1.72 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 94.06 41.76 -28.37 96.24 43.38 -26.96 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 7 3 # 7 B 8 HIS D 147 HIS^? 9.43 MG MG D 301 B 80 GLU D 146 GLU^? 10.62 MG MG D 301 B 223 ARG C 48 ARG^? 25.02 MG MG C 302 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 90.95 32.51 -46.42 92.98 32.42 -46.93 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 87.24 28.82 -50.92 85.47 28.08 -51.67 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 84.94 16.06 -21.53 85.81 13.55 -23.08 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 8 3 # 8 B 8 HIS E 147 HIS^? 9.22 MG MG E 301 B 80 GLU E 146 GLU^? 10.15 MG MG E 301 B 223 ARG F 37 ARG^? 19.14 MG MG F 301 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 63.87 64.43 -48.39 64.18 66.45 -47.92 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 58.72 60.89 -44.51 59.23 60.24 -42.54 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 48.80 64.46 -76.37 51.50 64.15 -77.79 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 9 3 # 9 B 8 HIS E 147 HIS^? 9.22 MG MG E 301 B 80 GLU E 146 GLU^? 10.15 MG MG E 301 B 223 ARG F 48 ARG^? 25.18 MG MG F 301 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 63.87 64.43 -48.39 64.18 66.45 -47.92 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 58.72 60.89 -44.51 59.23 60.24 -42.54 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 46.82 60.90 -73.07 44.43 61.88 -71.46 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 10 3 # 10 B 8 HIS F 147 HIS^? 8.79 MG MG F 302 B 80 GLU F 146 GLU^? 10.36 MG MG F 302 B 223 ARG E 37 ARG^? 19.17 MG MG E 302 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 56.63 61.66 -91.16 55.69 63.43 -91.80 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 61.95 60.17 -95.28 62.87 58.56 -96.19 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 70.82 68.02 -63.63 68.17 67.46 -62.14 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 11 3 # 11 B 8 HIS F 147 HIS^? 8.79 MG MG F 302 B 80 GLU F 146 GLU^? 10.36 MG MG F 302 B 223 ARG E 48 ARG^? 25.02 MG MG E 302 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 56.63 61.66 -91.16 55.69 63.43 -91.80 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 61.95 60.17 -95.28 62.87 58.56 -96.19 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 73.60 65.75 -66.57 75.51 67.67 -67.91 1t0u_c01 source 1t0u URIDINE PHOSPHORYLASE : 11 hits 1t0u_c01 naa= 3 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 1 3 # 1 A 261 GLY A 34 GLY^? 18.18 MG MG A 301 B 17 GLN A 31 GLN^? 22.39 MG MG A 301 B 140 GLU A 33 GLU^? 22.87 MG MG A 301 coo 61.49 19.86 5.96 61.52 19.46 5.16 33.66 35.41 27.99 33.72 35.64 27.21 coo 63.76 11.90 7.93 65.18 13.07 6.77 31.14 44.15 31.07 29.13 43.58 31.45 coo 66.44 19.00 7.38 67.69 17.67 8.37 33.74 38.67 24.96 34.13 38.85 22.87 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 2 3 # 2 A 261 GLY B 34 GLY^? 18.20 MG MG B 302 B 17 GLN B 31 GLN^? 22.67 MG MG B 302 B 140 GLU B 33 GLU^? 22.65 MG MG B 302 coo 61.49 19.86 5.96 61.52 19.46 5.16 56.73 9.38 8.85 56.97 9.44 9.63 coo 63.76 11.90 7.93 65.18 13.07 6.77 64.85 5.67 6.51 64.18 3.71 5.97 coo 66.44 19.00 7.38 67.69 17.67 8.37 59.88 9.09 12.22 59.91 9.49 14.33 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 3 3 # 3 A 261 GLY C 34 GLY^? 18.00 MG MG C 302 B 17 GLN C 31 GLN^? 23.04 MG MG C 302 B 140 GLU C 33 GLU^? 22.71 MG MG C 302 coo 61.49 19.86 5.96 61.52 19.46 5.16 81.22 13.31 -15.34 80.98 13.29 -16.15 coo 63.76 11.90 7.93 65.18 13.07 6.77 75.42 6.53 -11.91 76.62 4.98 -12.81 coo 66.44 19.00 7.38 67.69 17.67 8.37 78.39 11.67 -18.82 78.34 12.01 -20.91 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 4 3 # 4 A 261 GLY D 34 GLY^? 17.73 MG MG D 302 B 17 GLN D 31 GLN^? 22.20 MG MG D 302 B 140 GLU D 33 GLU^? 22.23 MG MG D 302 coo 61.49 19.86 5.96 61.52 19.46 5.16 93.02 46.29 -34.84 92.89 46.52 -34.02 coo 63.76 11.90 7.93 65.18 13.07 6.77 92.28 55.58 -37.94 94.36 55.52 -37.90 coo 66.44 19.00 7.38 67.69 17.67 8.37 91.55 48.87 -31.66 91.12 48.92 -29.63 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 5 3 # 5 A 261 GLY E 34 GLY^? 17.96 MG MG E 302 B 17 GLN E 31 GLN^? 23.24 MG MG E 302 B 140 GLU E 33 GLU^? 22.81 MG MG E 302 coo 61.49 19.86 5.96 61.52 19.46 5.16 77.63 64.22 -60.15 77.94 64.12 -60.90 coo 63.76 11.90 7.93 65.18 13.07 6.77 86.72 61.78 -58.15 88.75 61.32 -57.58 coo 66.44 19.00 7.38 67.69 17.67 8.37 80.16 62.57 -63.35 80.54 62.13 -65.43 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 6 3 # 6 A 261 GLY F 34 GLY^? 17.95 MG MG F 301 B 17 GLN F 31 GLN^? 22.77 MG MG F 301 B 140 GLU F 33 GLU^? 22.46 MG MG F 301 coo 61.49 19.86 5.96 61.52 19.46 5.16 43.60 57.46 -79.20 43.37 57.32 -78.41 coo 63.76 11.90 7.93 65.18 13.07 6.77 35.83 52.89 -82.79 34.54 54.19 -81.84 coo 66.44 19.00 7.38 67.69 17.67 8.37 41.88 55.13 -75.91 42.06 54.64 -73.84 1t4c_c02 source 1t4c FORMYL-COENZYME A TRANSFERASE : 6 hits 1t4c_c02 naa= 3 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 1 3 # 1 A 88 SER A 83 SER^? 32.41 MG MG A 301 A 90 SER A 79 SER^? 29.65 MG MG A 301 A 145 LYS A 76 LYS^? 25.42 MG MG A 301 coo -3.31 40.95 15.56 -0.94 40.79 14.97 30.60 55.84 24.53 32.97 55.99 23.96 coo 1.47 40.03 18.48 2.45 41.37 16.68 32.57 55.71 29.63 34.63 56.10 28.47 coo 7.35 44.71 16.29 4.71 40.98 14.52 34.45 46.53 27.28 28.88 44.93 27.25 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 2 3 # 2 A 88 SER A 115 SER^? 6.34 MG MG A 301 A 90 SER A 113 SER^? 12.78 MG MG A 301 A 145 LYS A 111 LYS^? 15.16 MG MG A 301 coo -3.31 40.95 15.56 -0.94 40.79 14.97 48.89 29.76 35.69 49.85 31.26 37.35 coo 1.47 40.03 18.48 2.45 41.37 16.68 50.46 23.17 35.47 52.68 22.78 36.32 coo 7.35 44.71 16.29 4.71 40.98 14.52 52.67 17.19 35.90 54.65 19.90 40.50 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 3 3 # 3 A 88 SER B 115 SER^? 6.48 MG MG B 302 A 90 SER B 113 SER^? 11.94 MG MG B 302 A 145 LYS B 111 LYS^? 13.75 MG MG B 302 coo -3.31 40.95 15.56 -0.94 40.79 14.97 54.36 25.96 2.48 56.06 26.75 0.95 coo 1.47 40.03 18.48 2.45 41.37 16.68 48.02 28.73 2.06 49.36 30.67 1.74 coo 7.35 44.71 16.29 4.71 40.98 14.52 42.84 32.14 1.80 46.84 32.68 -2.87 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 4 3 # 4 A 88 SER C 83 SER^? 23.40 MG MG B 301 A 90 SER C 79 SER^? 19.92 MG MG B 301 A 145 LYS C 76 LYS^? 24.95 MG MG C 302 coo -3.31 40.95 15.56 -0.94 40.79 14.97 65.19 0.76 -19.73 62.87 1.43 -19.33 coo 1.47 40.03 18.48 2.45 41.37 16.68 64.38 1.95 -14.66 62.69 3.45 -15.45 coo 7.35 44.71 16.29 4.71 40.98 14.52 71.11 8.63 -16.76 75.44 5.17 -16.80 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 5 3 # 5 A 88 SER C 115 SER^? 5.99 MG MG C 302 A 90 SER C 113 SER^? 12.16 MG MG C 302 A 145 LYS C 111 LYS^? 16.56 MG MG C 302 coo -3.31 40.95 15.56 -0.94 40.79 14.97 77.67 29.66 -8.53 76.02 29.92 -6.77 coo 1.47 40.03 18.48 2.45 41.37 16.68 82.58 34.46 -8.42 81.10 36.27 -7.78 coo 7.35 44.71 16.29 4.71 40.98 14.52 86.36 39.56 -8.06 84.36 40.84 -3.15 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 6 3 # 6 A 88 SER D 115 SER^? 7.08 MG MG D 302 A 90 SER D 113 SER^? 11.39 MG MG D 302 A 145 LYS D 111 LYS^? 15.85 MG MG D 302 coo -3.31 40.95 15.56 -0.94 40.79 14.97 80.50 35.70 -41.83 78.94 36.81 -43.34 coo 1.47 40.03 18.48 2.45 41.37 16.68 81.10 28.95 -41.82 79.08 29.86 -42.84 coo 7.35 44.71 16.29 4.71 40.98 14.52 81.21 22.69 -42.10 78.68 23.89 -46.57 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 7 3 # 7 A 88 SER D 117 SER^? 9.64 MG MG D 302 A 90 SER D 92 SER^? 16.26 MG MG D 302 A 145 LYS D 90 LYS^? 18.98 MG MG D 302 coo -3.31 40.95 15.56 -0.94 40.79 14.97 79.93 42.54 -40.62 77.69 42.23 -41.47 coo 1.47 40.03 18.48 2.45 41.37 16.68 76.41 39.72 -34.40 74.28 38.75 -34.89 coo 7.35 44.71 16.29 4.71 40.98 14.52 79.83 44.38 -31.44 80.32 39.55 -29.40 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 8 3 # 8 A 88 SER E 83 SER^? 23.44 MG MG D 301 A 90 SER E 79 SER^? 19.77 MG MG D 301 A 145 LYS E 76 LYS^? 25.68 MG MG E 302 coo -3.31 40.95 15.56 -0.94 40.79 14.97 96.88 57.42 -63.66 97.96 55.45 -62.84 coo 1.47 40.03 18.48 2.45 41.37 16.68 96.22 56.25 -58.39 95.94 54.06 -59.20 coo 7.35 44.71 16.29 4.71 40.98 14.52 87.09 58.11 -60.91 88.65 63.65 -61.27 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 9 3 # 9 A 88 SER E 115 SER^? 6.17 MG MG E 302 A 90 SER E 113 SER^? 12.49 MG MG E 302 A 145 LYS E 111 LYS^? 14.52 MG MG E 302 coo -3.31 40.95 15.56 -0.94 40.79 14.97 65.46 53.67 -52.76 66.19 52.26 -50.99 coo 1.47 40.03 18.48 2.45 41.37 16.68 58.97 55.48 -52.80 57.49 54.03 -51.61 coo 7.35 44.71 16.29 4.71 40.98 14.52 52.49 56.44 -52.43 54.52 53.78 -47.52 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 10 3 # 10 A 88 SER E 117 SER^? 9.12 MG MG E 302 A 90 SER E 92 SER^? 15.58 MG MG E 302 A 145 LYS E 90 LYS^? 19.16 MG MG E 302 coo -3.31 40.95 15.56 -0.94 40.79 14.97 72.02 51.78 -53.96 71.28 49.71 -53.01 coo 1.47 40.03 18.48 2.45 41.37 16.68 68.69 48.93 -60.16 67.14 47.20 -59.59 coo 7.35 44.71 16.29 4.71 40.98 14.52 73.81 51.50 -63.18 69.15 52.39 -65.65 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 11 3 # 11 A 88 SER F 115 SER^? 6.67 MG MG F 301 A 90 SER F 113 SER^? 11.59 MG MG F 301 A 145 LYS F 111 LYS^? 15.21 MG MG F 301 coo -3.31 40.95 15.56 -0.94 40.79 14.97 58.74 51.50 -86.07 58.73 49.57 -87.50 coo 1.47 40.03 18.48 2.45 41.37 16.68 64.29 55.28 -86.32 64.81 52.88 -86.66 coo 7.35 44.71 16.29 4.71 40.98 14.52 69.70 58.57 -86.86 69.67 53.74 -90.29 1t7d_c00 source 1t7d SIGNAL PEPTIDASE I : 11 hits 1t7d_c00 naa= 3 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 1 3 # 1 B 88 SER A 83 SER^? 32.41 MG MG A 301 B 90 SER A 79 SER^? 29.65 MG MG A 301 B 145 LYS A 76 LYS^? 25.42 MG MG A 301 coo 61.01 10.03 12.97 58.78 10.97 12.69 30.60 55.84 24.53 32.97 55.99 23.96 coo 56.85 12.22 16.37 55.62 11.34 14.45 32.57 55.71 29.63 34.63 56.10 28.47 coo 49.80 9.51 14.88 53.14 11.99 12.77 34.45 46.53 27.28 28.88 44.93 27.25 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 2 3 # 2 B 88 SER A 115 SER^? 6.34 MG MG A 301 B 90 SER A 113 SER^? 12.78 MG MG A 301 B 145 LYS A 111 LYS^? 15.16 MG MG A 301 coo 61.01 10.03 12.97 58.78 10.97 12.69 48.89 29.76 35.69 49.85 31.26 37.35 coo 56.85 12.22 16.37 55.62 11.34 14.45 50.46 23.17 35.47 52.68 22.78 36.32 coo 49.80 9.51 14.88 53.14 11.99 12.77 52.67 17.19 35.90 54.65 19.90 40.50 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 3 3 # 3 B 88 SER B 115 SER^? 6.48 MG MG B 302 B 90 SER B 113 SER^? 11.94 MG MG B 302 B 145 LYS B 111 LYS^? 13.75 MG MG B 302 coo 61.01 10.03 12.97 58.78 10.97 12.69 54.36 25.96 2.48 56.06 26.75 0.95 coo 56.85 12.22 16.37 55.62 11.34 14.45 48.02 28.73 2.06 49.36 30.67 1.74 coo 49.80 9.51 14.88 53.14 11.99 12.77 42.84 32.14 1.80 46.84 32.68 -2.87 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 4 3 # 4 B 88 SER C 115 SER^? 5.99 MG MG C 302 B 90 SER C 113 SER^? 12.16 MG MG C 302 B 145 LYS C 111 LYS^? 16.56 MG MG C 302 coo 61.01 10.03 12.97 58.78 10.97 12.69 77.67 29.66 -8.53 76.02 29.92 -6.77 coo 56.85 12.22 16.37 55.62 11.34 14.45 82.58 34.46 -8.42 81.10 36.27 -7.78 coo 49.80 9.51 14.88 53.14 11.99 12.77 86.36 39.56 -8.06 84.36 40.84 -3.15 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 5 3 # 5 B 88 SER C 115 SER^? 5.99 MG MG C 302 B 90 SER C 117 SER^? 8.92 MG MG C 302 B 145 LYS C 90 LYS^? 18.24 MG MG C 302 coo 61.01 10.03 12.97 58.78 10.97 12.69 77.67 29.66 -8.53 76.02 29.92 -6.77 coo 56.85 12.22 16.37 55.62 11.34 14.45 72.96 24.67 -9.95 71.40 26.26 -9.18 coo 49.80 9.51 14.88 53.14 11.99 12.77 72.37 23.25 -18.94 76.11 26.52 -20.97 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 6 3 # 6 B 88 SER D 115 SER^? 7.08 MG MG D 302 B 90 SER D 113 SER^? 11.39 MG MG D 302 B 145 LYS D 111 LYS^? 15.85 MG MG D 302 coo 61.01 10.03 12.97 58.78 10.97 12.69 80.50 35.70 -41.83 78.94 36.81 -43.34 coo 56.85 12.22 16.37 55.62 11.34 14.45 81.10 28.95 -41.82 79.08 29.86 -42.84 coo 49.80 9.51 14.88 53.14 11.99 12.77 81.21 22.69 -42.10 78.68 23.89 -46.57 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 7 3 # 7 B 88 SER E 83 SER^? 23.44 MG MG D 301 B 90 SER E 79 SER^? 19.77 MG MG D 301 B 145 LYS E 76 LYS^? 25.68 MG MG E 302 coo 61.01 10.03 12.97 58.78 10.97 12.69 96.88 57.42 -63.66 97.96 55.45 -62.84 coo 56.85 12.22 16.37 55.62 11.34 14.45 96.22 56.25 -58.39 95.94 54.06 -59.20 coo 49.80 9.51 14.88 53.14 11.99 12.77 87.09 58.11 -60.91 88.65 63.65 -61.27 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 8 3 # 8 B 88 SER E 115 SER^? 6.17 MG MG E 302 B 90 SER E 113 SER^? 12.49 MG MG E 302 B 145 LYS E 111 LYS^? 14.52 MG MG E 302 coo 61.01 10.03 12.97 58.78 10.97 12.69 65.46 53.67 -52.76 66.19 52.26 -50.99 coo 56.85 12.22 16.37 55.62 11.34 14.45 58.97 55.48 -52.80 57.49 54.03 -51.61 coo 49.80 9.51 14.88 53.14 11.99 12.77 52.49 56.44 -52.43 54.52 53.78 -47.52 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 9 3 # 9 B 88 SER F 115 SER^? 6.67 MG MG F 301 B 90 SER F 113 SER^? 11.59 MG MG F 301 B 145 LYS F 111 LYS^? 15.21 MG MG F 301 coo 61.01 10.03 12.97 58.78 10.97 12.69 58.74 51.50 -86.07 58.73 49.57 -87.50 coo 56.85 12.22 16.37 55.62 11.34 14.45 64.29 55.28 -86.32 64.81 52.88 -86.66 coo 49.80 9.51 14.88 53.14 11.99 12.77 69.70 58.57 -86.86 69.67 53.74 -90.29 1t7d_c01 source 1t7d SIGNAL PEPTIDASE I : 9 hits 1t7d_c01 naa= 3 ULMN 3 1tah_c00 LIPASE user 1 3 # 1 B 87 SER A 189 SER^? 11.75 MG MG A 302 B 263 ASP A 148 ASP^? 2.72 MG MG A 301s B 285 HIS A 147 HIS^? 9.20 MG MG A 302 coo 22.42 -97.03 -8.07 21.76 -97.41 -5.67 40.99 19.00 44.32 41.51 18.14 46.48 coo 16.89 -89.90 -4.68 18.61 -91.11 -4.79 41.50 28.88 41.13 43.33 29.67 41.93 coo 17.98 -94.63 -4.37 19.67 -95.43 -5.31 40.24 23.10 39.83 38.32 22.34 40.22 ULMN 3 1tah_c00 LIPASE user 2 3 # 2 B 87 SER B 189 SER^? 12.11 MG MG B 301 B 263 ASP B 148 ASP^? 2.58 MG MG B 302s B 285 HIS B 147 HIS^? 9.27 MG MG B 301 coo 22.42 -97.03 -8.07 21.76 -97.41 -5.67 43.10 20.95 -7.74 42.82 21.56 -10.02 coo 16.89 -89.90 -4.68 18.61 -91.11 -4.79 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 17.98 -94.63 -4.37 19.67 -95.43 -5.31 46.73 18.97 -3.05 45.63 17.32 -3.73 ULMN 3 1tah_c00 LIPASE user 3 3 # 3 B 87 SER C 189 SER^? 12.09 MG MG C 301 B 263 ASP C 148 ASP^? 2.75 MG MG C 302s B 285 HIS C 147 HIS^? 9.44 MG MG C 301 coo 22.42 -97.03 -8.07 21.76 -97.41 -5.67 90.33 28.79 1.19 90.26 29.61 3.45 coo 16.89 -89.90 -4.68 18.61 -91.11 -4.79 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 17.98 -94.63 -4.37 19.67 -95.43 -5.31 87.61 25.71 -3.59 89.22 24.50 -2.99 ULMN 3 1tah_c00 LIPASE user 4 3 # 4 B 87 SER D 189 SER^? 12.12 MG MG D 301 B 263 ASP D 148 ASP^? 2.35 MG MG D 302s B 285 HIS D 147 HIS^? 9.43 MG MG D 301 coo 22.42 -97.03 -8.07 21.76 -97.41 -5.67 91.62 28.58 -50.95 91.45 27.78 -53.25 coo 16.89 -89.90 -4.68 18.61 -91.11 -4.79 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 17.98 -94.63 -4.37 19.67 -95.43 -5.31 90.95 32.51 -46.42 92.98 32.42 -46.93 ULMN 3 1tah_c00 LIPASE user 5 3 # 5 B 87 SER E 189 SER^? 11.91 MG MG E 301 B 263 ASP E 148 ASP^? 2.62 MG MG E 302s B 285 HIS E 147 HIS^? 9.22 MG MG E 301 coo 22.42 -97.03 -8.07 21.76 -97.41 -5.67 60.13 65.61 -43.87 59.01 65.34 -41.74 coo 16.89 -89.90 -4.68 18.61 -91.11 -4.79 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 17.98 -94.63 -4.37 19.67 -95.43 -5.31 63.87 64.43 -48.39 64.18 66.45 -47.92 ULMN 3 1tah_c00 LIPASE user 6 3 # 6 B 87 SER F 189 SER^? 11.88 MG MG F 302 B 263 ASP F 148 ASP^? 2.72 MG MG F 301s B 285 HIS F 147 HIS^? 8.79 MG MG F 302 coo 22.42 -97.03 -8.07 21.76 -97.41 -5.67 59.91 63.90 -95.91 60.70 64.22 -98.13 coo 16.89 -89.90 -4.68 18.61 -91.11 -4.79 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 17.98 -94.63 -4.37 19.67 -95.43 -5.31 56.63 61.66 -91.16 55.69 63.43 -91.80 1tah_c00 source 1tah LIPASE : 6 hits 1tah_c00 naa= 3 ULMN 3 1tah_c01 LIPASE user 1 3 # 1 A 87 SER A 189 SER^? 11.75 MG MG A 302 A 263 ASP A 148 ASP^? 2.72 MG MG A 301s A 285 HIS A 147 HIS^? 9.20 MG MG A 302 coo 22.12 -58.48 -5.22 21.49 -58.54 -7.64 40.99 19.00 44.32 41.51 18.14 46.48 coo 14.10 -63.60 -6.78 16.16 -63.15 -6.92 41.50 28.88 41.13 43.33 29.67 41.93 coo 16.85 -59.90 -8.29 18.78 -59.58 -7.55 40.24 23.10 39.83 38.32 22.34 40.22 ULMN 3 1tah_c01 LIPASE user 2 3 # 2 A 87 SER B 189 SER^? 12.11 MG MG B 301 A 263 ASP B 148 ASP^? 2.58 MG MG B 302s A 285 HIS B 147 HIS^? 9.27 MG MG B 301 coo 22.12 -58.48 -5.22 21.49 -58.54 -7.64 43.10 20.95 -7.74 42.82 21.56 -10.02 coo 14.10 -63.60 -6.78 16.16 -63.15 -6.92 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 16.85 -59.90 -8.29 18.78 -59.58 -7.55 46.73 18.97 -3.05 45.63 17.32 -3.73 ULMN 3 1tah_c01 LIPASE user 3 3 # 3 A 87 SER C 189 SER^? 12.09 MG MG C 301 A 263 ASP C 148 ASP^? 2.75 MG MG C 302s A 285 HIS C 147 HIS^? 9.44 MG MG C 301 coo 22.12 -58.48 -5.22 21.49 -58.54 -7.64 90.33 28.79 1.19 90.26 29.61 3.45 coo 14.10 -63.60 -6.78 16.16 -63.15 -6.92 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 16.85 -59.90 -8.29 18.78 -59.58 -7.55 87.61 25.71 -3.59 89.22 24.50 -2.99 ULMN 3 1tah_c01 LIPASE user 4 3 # 4 A 87 SER D 189 SER^? 12.12 MG MG D 301 A 263 ASP D 148 ASP^? 2.35 MG MG D 302s A 285 HIS D 147 HIS^? 9.43 MG MG D 301 coo 22.12 -58.48 -5.22 21.49 -58.54 -7.64 91.62 28.58 -50.95 91.45 27.78 -53.25 coo 14.10 -63.60 -6.78 16.16 -63.15 -6.92 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 16.85 -59.90 -8.29 18.78 -59.58 -7.55 90.95 32.51 -46.42 92.98 32.42 -46.93 ULMN 3 1tah_c01 LIPASE user 5 3 # 5 A 87 SER E 189 SER^? 11.91 MG MG E 301 A 263 ASP E 148 ASP^? 2.62 MG MG E 302s A 285 HIS E 147 HIS^? 9.22 MG MG E 301 coo 22.12 -58.48 -5.22 21.49 -58.54 -7.64 60.13 65.61 -43.87 59.01 65.34 -41.74 coo 14.10 -63.60 -6.78 16.16 -63.15 -6.92 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 16.85 -59.90 -8.29 18.78 -59.58 -7.55 63.87 64.43 -48.39 64.18 66.45 -47.92 ULMN 3 1tah_c01 LIPASE user 6 3 # 6 A 87 SER F 189 SER^? 11.88 MG MG F 302 A 263 ASP F 148 ASP^? 2.72 MG MG F 301s A 285 HIS F 147 HIS^? 8.79 MG MG F 302 coo 22.12 -58.48 -5.22 21.49 -58.54 -7.64 59.91 63.90 -95.91 60.70 64.22 -98.13 coo 14.10 -63.60 -6.78 16.16 -63.15 -6.92 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 16.85 -59.90 -8.29 18.78 -59.58 -7.55 56.63 61.66 -91.16 55.69 63.43 -91.80 1tah_c01 source 1tah LIPASE : 6 hits 1tah_c01 naa= 3 ULMN 3 1tah_c02 LIPASE user 1 3 # 1 C 87 SER A 189 SER^? 11.75 MG MG A 302 C 263 ASP A 148 ASP^? 2.72 MG MG A 301s C 285 HIS A 147 HIS^? 9.20 MG MG A 302 coo -11.81 -66.75 15.59 -10.14 -64.90 16.04 40.99 19.00 44.32 41.51 18.14 46.48 coo -12.58 -63.22 24.54 -12.69 -63.15 22.41 41.50 28.88 41.13 43.33 29.67 41.93 coo -9.60 -64.04 20.79 -10.32 -64.61 18.90 40.24 23.10 39.83 38.32 22.34 40.22 ULMN 3 1tah_c02 LIPASE user 2 3 # 2 C 87 SER B 189 SER^? 12.11 MG MG B 301 C 263 ASP B 148 ASP^? 2.58 MG MG B 302s C 285 HIS B 147 HIS^? 9.27 MG MG B 301 coo -11.81 -66.75 15.59 -10.14 -64.90 16.04 43.10 20.95 -7.74 42.82 21.56 -10.02 coo -12.58 -63.22 24.54 -12.69 -63.15 22.41 52.73 19.23 -3.77 53.81 20.99 -4.31 coo -9.60 -64.04 20.79 -10.32 -64.61 18.90 46.73 18.97 -3.05 45.63 17.32 -3.73 ULMN 3 1tah_c02 LIPASE user 3 3 # 3 C 87 SER C 189 SER^? 12.09 MG MG C 301 C 263 ASP C 148 ASP^? 2.75 MG MG C 302s C 285 HIS C 147 HIS^? 9.44 MG MG C 301 coo -11.81 -66.75 15.59 -10.14 -64.90 16.04 90.33 28.79 1.19 90.26 29.61 3.45 coo -12.58 -63.22 24.54 -12.69 -63.15 22.41 81.96 23.83 -2.68 80.24 25.11 -2.27 coo -9.60 -64.04 20.79 -10.32 -64.61 18.90 87.61 25.71 -3.59 89.22 24.50 -2.99 ULMN 3 1tah_c02 LIPASE user 4 3 # 4 C 87 SER D 189 SER^? 12.12 MG MG D 301 C 263 ASP D 148 ASP^? 2.35 MG MG D 302s C 285 HIS D 147 HIS^? 9.43 MG MG D 301 coo -11.81 -66.75 15.59 -10.14 -64.90 16.04 91.62 28.58 -50.95 91.45 27.78 -53.25 coo -12.58 -63.22 24.54 -12.69 -63.15 22.41 87.78 37.50 -47.56 85.79 37.49 -48.28 coo -9.60 -64.04 20.79 -10.32 -64.61 18.90 90.95 32.51 -46.42 92.98 32.42 -46.93 ULMN 3 1tah_c02 LIPASE user 5 3 # 5 C 87 SER E 189 SER^? 11.91 MG MG E 301 C 263 ASP E 148 ASP^? 2.62 MG MG E 302s C 285 HIS E 147 HIS^? 9.22 MG MG E 301 coo -11.81 -66.75 15.59 -10.14 -64.90 16.04 60.13 65.61 -43.87 59.01 65.34 -41.74 coo -12.58 -63.22 24.54 -12.69 -63.15 22.41 68.29 60.44 -47.29 68.03 58.42 -46.50 coo -9.60 -64.04 20.79 -10.32 -64.61 18.90 63.87 64.43 -48.39 64.18 66.45 -47.92 ULMN 3 1tah_c02 LIPASE user 6 3 # 6 C 87 SER F 189 SER^? 11.88 MG MG F 302 C 263 ASP F 148 ASP^? 2.72 MG MG F 301s C 285 HIS F 147 HIS^? 8.79 MG MG F 302 coo -11.81 -66.75 15.59 -10.14 -64.90 16.04 59.91 63.90 -95.91 60.70 64.22 -98.13 coo -12.58 -63.22 24.54 -12.69 -63.15 22.41 53.64 56.47 -91.98 54.61 54.68 -92.64 coo -9.60 -64.04 20.79 -10.32 -64.61 18.90 56.63 61.66 -91.16 55.69 63.43 -91.80 1tah_c02 source 1tah LIPASE : 6 hits 1tah_c02 naa= 3 ULMN 3 1tah_c03 LIPASE user 1 3 # 1 D 87 SER A 189 SER^? 11.75 MG MG A 302 D 263 ASP A 148 ASP^? 2.72 MG MG A 301s D 285 HIS A 147 HIS^? 9.20 MG MG A 302 coo -33.67 -57.82 -16.64 -34.00 -55.36 -17.02 40.99 19.00 44.32 41.51 18.14 46.48 coo -32.45 -52.67 -8.57 -33.54 -53.48 -10.22 41.50 28.88 41.13 43.33 29.67 41.93 coo -32.12 -52.68 -13.42 -32.95 -54.21 -14.59 40.24 23.10 39.83 38.32 22.34 40.22 ULMN 3 1tah_c03 LIPASE user 2 3 # 2 D 87 SER B 189 SER^? 12.11 MG MG B 301 D 263 ASP B 148 ASP^? 2.58 MG MG B 302s D 285 HIS B 147 HIS^? 9.27 MG MG B 301 coo -33.67 -57.82 -16.64 -34.00 -55.36 -17.02 43.10 20.95 -7.74 42.82 21.56 -10.02 coo -32.45 -52.67 -8.57 -33.54 -53.48 -10.22 52.73 19.23 -3.77 53.81 20.99 -4.31 coo -32.12 -52.68 -13.42 -32.95 -54.21 -14.59 46.73 18.97 -3.05 45.63 17.32 -3.73 ULMN 3 1tah_c03 LIPASE user 3 3 # 3 D 87 SER C 189 SER^? 12.09 MG MG C 301 D 263 ASP C 148 ASP^? 2.75 MG MG C 302s D 285 HIS C 147 HIS^? 9.44 MG MG C 301 coo -33.67 -57.82 -16.64 -34.00 -55.36 -17.02 90.33 28.79 1.19 90.26 29.61 3.45 coo -32.45 -52.67 -8.57 -33.54 -53.48 -10.22 81.96 23.83 -2.68 80.24 25.11 -2.27 coo -32.12 -52.68 -13.42 -32.95 -54.21 -14.59 87.61 25.71 -3.59 89.22 24.50 -2.99 ULMN 3 1tah_c03 LIPASE user 4 3 # 4 D 87 SER D 189 SER^? 12.12 MG MG D 301 D 263 ASP D 148 ASP^? 2.35 MG MG D 302s D 285 HIS D 147 HIS^? 9.43 MG MG D 301 coo -33.67 -57.82 -16.64 -34.00 -55.36 -17.02 91.62 28.58 -50.95 91.45 27.78 -53.25 coo -32.45 -52.67 -8.57 -33.54 -53.48 -10.22 87.78 37.50 -47.56 85.79 37.49 -48.28 coo -32.12 -52.68 -13.42 -32.95 -54.21 -14.59 90.95 32.51 -46.42 92.98 32.42 -46.93 ULMN 3 1tah_c03 LIPASE user 5 3 # 5 D 87 SER E 189 SER^? 11.91 MG MG E 301 D 263 ASP E 148 ASP^? 2.62 MG MG E 302s D 285 HIS E 147 HIS^? 9.22 MG MG E 301 coo -33.67 -57.82 -16.64 -34.00 -55.36 -17.02 60.13 65.61 -43.87 59.01 65.34 -41.74 coo -32.45 -52.67 -8.57 -33.54 -53.48 -10.22 68.29 60.44 -47.29 68.03 58.42 -46.50 coo -32.12 -52.68 -13.42 -32.95 -54.21 -14.59 63.87 64.43 -48.39 64.18 66.45 -47.92 ULMN 3 1tah_c03 LIPASE user 6 3 # 6 D 87 SER F 189 SER^? 11.88 MG MG F 302 D 263 ASP F 148 ASP^? 2.72 MG MG F 301s D 285 HIS F 147 HIS^? 8.79 MG MG F 302 coo -33.67 -57.82 -16.64 -34.00 -55.36 -17.02 59.91 63.90 -95.91 60.70 64.22 -98.13 coo -32.45 -52.67 -8.57 -33.54 -53.48 -10.22 53.64 56.47 -91.98 54.61 54.68 -92.64 coo -32.12 -52.68 -13.42 -32.95 -54.21 -14.59 56.63 61.66 -91.16 55.69 63.43 -91.80 1tah_c03 source 1tah LIPASE : 6 hits 1tah_c03 naa= 3 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 A 144 HIS A 42 HIS^? 28.45 MG MG A 301 A 174 ASP B 160 ASP^? 31.65 MG MG A 301 A 404 TYR A 156 TYR^? 21.80 MG MG A 301 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 34.62 18.32 19.57 34.29 16.25 19.41 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 28.01 24.83 16.38 27.44 26.81 15.80 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 37.50 16.28 27.75 35.30 17.94 28.08 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 A 144 HIS A 147 HIS^? 9.20 MG MG A 302 A 174 ASP A 128 ASP^? -3.32 MG MG A 301s A 404 TYR A 168 TYR^? 14.52 MG MG A 302 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 40.24 23.10 39.83 38.32 22.34 40.22 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 46.50 28.23 39.77 47.49 30.10 39.82 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 37.31 16.98 37.59 36.65 18.86 39.55 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 A 144 HIS A 147 HIS^? 9.20 MG MG A 302 A 174 ASP A 177 ASP^? 8.44 MG MG A 302 A 404 TYR A 168 TYR^? 14.52 MG MG A 302 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 40.24 23.10 39.83 38.32 22.34 40.22 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 33.02 29.04 43.18 33.79 27.88 44.78 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 37.31 16.98 37.59 36.65 18.86 39.55 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 A 144 HIS A 147 HIS^? 9.20 MG MG A 302 A 174 ASP A 187 ASP^? -3.29 MG MG A 302s A 404 TYR A 168 TYR^? 14.52 MG MG A 302 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 40.24 23.10 39.83 38.32 22.34 40.22 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 39.43 26.57 46.78 39.37 27.83 45.03 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 37.31 16.98 37.59 36.65 18.86 39.55 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 5 3 # 5 A 144 HIS A 170 HIS^? 10.56 MG MG A 302 A 174 ASP A 187 ASP^? -3.29 MG MG A 302s A 404 TYR A 168 TYR^? 14.52 MG MG A 302 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 34.91 23.57 39.32 34.35 24.95 40.81 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 39.43 26.57 46.78 39.37 27.83 45.03 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 37.31 16.98 37.59 36.65 18.86 39.55 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 6 3 # 6 A 144 HIS B 42 HIS^? 28.37 MG MG B 302 A 174 ASP A 160 ASP^? 31.61 MG MG B 302 A 404 TYR B 156 TYR^? 21.63 MG MG B 302 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 39.34 12.99 16.30 37.26 13.24 16.40 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 44.21 5.00 19.54 46.02 3.84 19.76 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 38.56 16.71 8.27 39.91 14.31 7.86 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 7 3 # 7 A 144 HIS B 147 HIS^? 9.27 MG MG B 301 A 174 ASP B 128 ASP^? -3.57 MG MG B 302s A 404 TYR B 168 TYR^? 14.66 MG MG B 301 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 52.92 24.09 -2.19 54.73 25.14 -1.90 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 40.03 17.20 -1.34 41.92 16.43 -3.19 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 8 3 # 8 A 144 HIS B 147 HIS^? 9.27 MG MG B 301 A 174 ASP B 177 ASP^? 9.03 MG MG B 301 A 404 TYR B 168 TYR^? 14.66 MG MG B 301 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 51.97 11.04 -6.64 50.39 11.62 -7.94 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 40.03 17.20 -1.34 41.92 16.43 -3.19 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 9 3 # 9 A 144 HIS B 147 HIS^? 9.27 MG MG B 301 A 174 ASP B 187 ASP^? -3.44 MG MG B 301s A 404 TYR B 168 TYR^? 14.66 MG MG B 301 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 50.64 18.14 -9.69 51.74 17.63 -7.86 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 40.03 17.20 -1.34 41.92 16.43 -3.19 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 10 3 # 10 A 144 HIS B 170 HIS^? 10.51 MG MG B 301 A 174 ASP B 177 ASP^? 9.03 MG MG B 301 A 404 TYR B 129 TYR^? 10.63 MG MG B 302 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 51.97 11.04 -6.64 50.39 11.62 -7.94 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 47.85 23.00 1.51 47.62 23.50 4.24 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 11 3 # 11 A 144 HIS B 170 HIS^? 10.51 MG MG B 301 A 174 ASP B 177 ASP^? 9.03 MG MG B 301 A 404 TYR B 168 TYR^? 14.66 MG MG B 301 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 51.97 11.04 -6.64 50.39 11.62 -7.94 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 40.03 17.20 -1.34 41.92 16.43 -3.19 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 12 3 # 12 A 144 HIS B 170 HIS^? 10.51 MG MG B 301 A 174 ASP B 187 ASP^? -3.44 MG MG B 301s A 404 TYR B 168 TYR^? 14.66 MG MG B 301 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 50.64 18.14 -9.69 51.74 17.63 -7.86 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 40.03 17.20 -1.34 41.92 16.43 -3.19 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 13 3 # 13 A 144 HIS C 42 HIS^? 28.09 MG MG C 302 A 174 ASP D 160 ASP^? 31.45 MG MG C 302 A 404 TYR C 156 TYR^? 21.58 MG MG C 302 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 95.93 22.96 -23.11 97.92 23.62 -23.02 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 94.15 13.98 -26.57 92.71 12.42 -26.99 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 95.64 26.50 -15.14 95.25 23.76 -14.77 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 14 3 # 14 A 144 HIS C 147 HIS^? 9.44 MG MG C 301 A 174 ASP C 128 ASP^? -3.22 MG MG C 302s A 404 TYR C 168 TYR^? 14.82 MG MG C 301 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 94.44 26.43 -5.44 92.97 25.09 -3.55 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 15 3 # 15 A 144 HIS C 147 HIS^? 9.44 MG MG C 301 A 174 ASP C 177 ASP^? 8.84 MG MG C 301 A 404 TYR C 168 TYR^? 14.82 MG MG C 301 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 85.60 16.42 -0.31 86.51 17.71 1.09 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 94.44 26.43 -5.44 92.97 25.09 -3.55 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 16 3 # 16 A 144 HIS C 147 HIS^? 9.44 MG MG C 301 A 174 ASP C 187 ASP^? -3.72 MG MG C 301s A 404 TYR C 168 TYR^? 14.82 MG MG C 301 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 84.01 23.73 3.39 83.47 22.54 1.59 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 94.44 26.43 -5.44 92.97 25.09 -3.55 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 17 3 # 17 A 144 HIS C 170 HIS^? 10.68 MG MG C 301 A 174 ASP C 177 ASP^? 8.84 MG MG C 301 A 404 TYR C 129 TYR^? 10.65 MG MG C 302 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 85.60 16.42 -0.31 86.51 17.71 1.09 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 84.95 29.43 -7.96 85.04 30.16 -10.69 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 18 3 # 18 A 144 HIS C 170 HIS^? 10.68 MG MG C 301 A 174 ASP C 177 ASP^? 8.84 MG MG C 301 A 404 TYR C 168 TYR^? 14.82 MG MG C 301 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 85.60 16.42 -0.31 86.51 17.71 1.09 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 94.44 26.43 -5.44 92.97 25.09 -3.55 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 19 3 # 19 A 144 HIS C 170 HIS^? 10.68 MG MG C 301 A 174 ASP C 187 ASP^? -3.72 MG MG C 301s A 404 TYR C 168 TYR^? 14.82 MG MG C 301 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 84.01 23.73 3.39 83.47 22.54 1.59 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 94.44 26.43 -5.44 92.97 25.09 -3.55 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 20 3 # 20 A 144 HIS D 42 HIS^? 28.21 MG MG D 302 A 174 ASP C 160 ASP^? 31.63 MG MG D 302 A 404 TYR D 156 TYR^? 21.34 MG MG D 302 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 98.45 29.90 -26.44 99.32 28.02 -26.13 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 102.50 38.00 -23.28 102.43 39.97 -22.46 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 96.25 27.10 -34.64 97.58 29.48 -35.03 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 21 3 # 21 A 144 HIS D 147 HIS^? 9.43 MG MG D 301 A 174 ASP D 128 ASP^? -3.70 MG MG D 302s A 404 TYR D 168 TYR^? 14.75 MG MG D 301 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 83.33 35.45 -46.13 81.57 36.63 -46.10 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 95.79 27.80 -44.35 95.71 29.78 -46.32 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 22 3 # 22 A 144 HIS D 147 HIS^? 9.43 MG MG D 301 A 174 ASP D 177 ASP^? 8.43 MG MG D 301 A 404 TYR D 168 TYR^? 14.75 MG MG D 301 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 95.74 41.01 -49.76 94.81 39.90 -51.24 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 95.79 27.80 -44.35 95.71 29.78 -46.32 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 23 3 # 23 A 144 HIS D 170 HIS^? 10.59 MG MG D 301 A 174 ASP D 177 ASP^? 8.43 MG MG D 301 A 404 TYR D 129 TYR^? 10.79 MG MG D 302 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 95.74 41.01 -49.76 94.81 39.90 -51.24 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 86.45 31.36 -42.20 86.02 30.90 -39.46 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 24 3 # 24 A 144 HIS D 170 HIS^? 10.59 MG MG D 301 A 174 ASP D 177 ASP^? 8.43 MG MG D 301 A 404 TYR D 168 TYR^? 14.75 MG MG D 301 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 95.74 41.01 -49.76 94.81 39.90 -51.24 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 95.79 27.80 -44.35 95.71 29.78 -46.32 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 25 3 # 25 A 144 HIS E 42 HIS^? 28.20 MG MG E 302 A 174 ASP F 160 ASP^? 31.59 MG MG E 302 A 404 TYR E 156 TYR^? 21.59 MG MG E 302 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 62.33 71.93 -68.30 60.54 72.96 -68.64 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 71.27 74.59 -71.77 73.23 74.02 -72.37 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 59.31 70.31 -60.22 61.84 71.39 -59.92 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 26 3 # 26 A 144 HIS E 147 HIS^? 9.22 MG MG E 301 A 174 ASP E 128 ASP^? -3.53 MG MG E 302s A 404 TYR E 168 TYR^? 14.43 MG MG E 301 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 65.38 56.57 -48.58 66.15 54.57 -48.61 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 60.07 69.95 -50.54 61.99 69.37 -48.59 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 27 3 # 27 A 144 HIS E 147 HIS^? 9.22 MG MG E 301 A 174 ASP E 177 ASP^? 8.55 MG MG E 301 A 404 TYR E 168 TYR^? 14.43 MG MG E 301 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 72.81 67.32 -45.03 71.14 67.96 -43.95 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 60.07 69.95 -50.54 61.99 69.37 -48.59 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 28 3 # 28 A 144 HIS E 170 HIS^? 10.33 MG MG E 301 A 174 ASP E 177 ASP^? 8.55 MG MG E 301 A 404 TYR E 129 TYR^? 10.89 MG MG E 302 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 72.81 67.32 -45.03 71.14 67.96 -43.95 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 62.09 60.15 -52.83 61.47 59.53 -55.45 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 29 3 # 29 A 144 HIS E 170 HIS^? 10.33 MG MG E 301 A 174 ASP E 177 ASP^? 8.55 MG MG E 301 A 404 TYR E 168 TYR^? 14.43 MG MG E 301 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 72.81 67.32 -45.03 71.14 67.96 -43.95 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 60.07 69.95 -50.54 61.99 69.37 -48.59 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 30 3 # 30 A 144 HIS F 42 HIS^? 28.34 MG MG F 301 A 174 ASP E 160 ASP^? 31.54 MG MG F 301 A 404 TYR F 156 TYR^? 21.68 MG MG F 302 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 55.11 70.50 -71.64 56.29 72.22 -71.48 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 45.81 70.00 -68.45 44.10 68.87 -67.77 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 58.80 69.55 -79.65 56.09 69.80 -80.15 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 31 3 # 31 A 144 HIS F 147 HIS^? 8.79 MG MG F 302 A 174 ASP F 128 ASP^? -3.41 MG MG F 301s A 404 TYR F 168 TYR^? 14.10 MG MG F 302 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 57.76 53.73 -90.50 57.46 51.64 -90.28 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 58.29 68.32 -89.29 56.67 67.12 -91.21 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 32 3 # 32 A 144 HIS F 147 HIS^? 8.79 MG MG F 302 A 174 ASP F 177 ASP^? 8.15 MG MG F 302 A 404 TYR F 168 TYR^? 14.10 MG MG F 302 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 47.18 61.22 -94.50 48.48 62.32 -95.73 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 58.29 68.32 -89.29 56.67 67.12 -91.21 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 33 3 # 33 A 144 HIS F 147 HIS^? 8.79 MG MG F 302 A 174 ASP F 187 ASP^? -3.27 MG MG F 302s A 404 TYR F 168 TYR^? 14.10 MG MG F 302 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 53.93 58.87 -98.14 52.45 58.62 -96.61 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 58.29 68.32 -89.29 56.67 67.12 -91.21 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 34 3 # 34 A 144 HIS F 170 HIS^? 9.84 MG MG F 302 A 174 ASP F 177 ASP^? 8.15 MG MG F 302 A 404 TYR F 129 TYR^? 10.92 MG MG F 301 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 47.18 61.22 -94.50 48.48 62.32 -95.73 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 59.69 58.61 -86.67 60.36 58.48 -83.96 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 35 3 # 35 A 144 HIS F 170 HIS^? 9.84 MG MG F 302 A 174 ASP F 177 ASP^? 8.15 MG MG F 302 A 404 TYR F 168 TYR^? 14.10 MG MG F 302 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 47.18 61.22 -94.50 48.48 62.32 -95.73 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 58.29 68.32 -89.29 56.67 67.12 -91.21 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 36 3 # 36 A 144 HIS F 170 HIS^? 9.84 MG MG F 302 A 174 ASP F 187 ASP^? -3.27 MG MG F 302s A 404 TYR F 168 TYR^? 14.10 MG MG F 302 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 53.93 58.87 -98.14 52.45 58.62 -96.61 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 58.29 68.32 -89.29 56.67 67.12 -91.21 1ti6_c06 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 36 hits 1ti6_c06 naa= 3 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 C 144 HIS A 42 HIS^? 28.45 MG MG A 301 C 174 ASP B 160 ASP^? 31.65 MG MG A 301 C 404 TYR A 156 TYR^? 21.80 MG MG A 301 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 34.62 18.32 19.57 34.29 16.25 19.41 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 28.01 24.83 16.38 27.44 26.81 15.80 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 37.50 16.28 27.75 35.30 17.94 28.08 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 C 144 HIS A 147 HIS^? 9.20 MG MG A 302 C 174 ASP A 128 ASP^? -3.32 MG MG A 301s C 404 TYR A 168 TYR^? 14.52 MG MG A 302 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 40.24 23.10 39.83 38.32 22.34 40.22 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 46.50 28.23 39.77 47.49 30.10 39.82 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 37.31 16.98 37.59 36.65 18.86 39.55 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 C 144 HIS A 147 HIS^? 9.20 MG MG A 302 C 174 ASP A 177 ASP^? 8.44 MG MG A 302 C 404 TYR A 168 TYR^? 14.52 MG MG A 302 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 40.24 23.10 39.83 38.32 22.34 40.22 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 33.02 29.04 43.18 33.79 27.88 44.78 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 37.31 16.98 37.59 36.65 18.86 39.55 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 C 144 HIS A 147 HIS^? 9.20 MG MG A 302 C 174 ASP A 187 ASP^? -3.29 MG MG A 302s C 404 TYR A 168 TYR^? 14.52 MG MG A 302 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 40.24 23.10 39.83 38.32 22.34 40.22 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 39.43 26.57 46.78 39.37 27.83 45.03 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 37.31 16.98 37.59 36.65 18.86 39.55 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 5 3 # 5 C 144 HIS A 170 HIS^? 10.56 MG MG A 302 C 174 ASP A 187 ASP^? -3.29 MG MG A 302s C 404 TYR A 168 TYR^? 14.52 MG MG A 302 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 34.91 23.57 39.32 34.35 24.95 40.81 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 39.43 26.57 46.78 39.37 27.83 45.03 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 37.31 16.98 37.59 36.65 18.86 39.55 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 6 3 # 6 C 144 HIS B 42 HIS^? 28.37 MG MG B 302 C 174 ASP A 160 ASP^? 31.61 MG MG B 302 C 404 TYR B 156 TYR^? 21.63 MG MG B 302 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 39.34 12.99 16.30 37.26 13.24 16.40 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 44.21 5.00 19.54 46.02 3.84 19.76 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 38.56 16.71 8.27 39.91 14.31 7.86 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 7 3 # 7 C 144 HIS B 147 HIS^? 9.27 MG MG B 301 C 174 ASP B 128 ASP^? -3.57 MG MG B 302s C 404 TYR B 168 TYR^? 14.66 MG MG B 301 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 46.73 18.97 -3.05 45.63 17.32 -3.73 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 52.92 24.09 -2.19 54.73 25.14 -1.90 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 40.03 17.20 -1.34 41.92 16.43 -3.19 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 8 3 # 8 C 144 HIS B 147 HIS^? 9.27 MG MG B 301 C 174 ASP B 177 ASP^? 9.03 MG MG B 301 C 404 TYR B 168 TYR^? 14.66 MG MG B 301 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 46.73 18.97 -3.05 45.63 17.32 -3.73 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 51.97 11.04 -6.64 50.39 11.62 -7.94 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 40.03 17.20 -1.34 41.92 16.43 -3.19 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 9 3 # 9 C 144 HIS B 147 HIS^? 9.27 MG MG B 301 C 174 ASP B 187 ASP^? -3.44 MG MG B 301s C 404 TYR B 168 TYR^? 14.66 MG MG B 301 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 46.73 18.97 -3.05 45.63 17.32 -3.73 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 50.64 18.14 -9.69 51.74 17.63 -7.86 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 40.03 17.20 -1.34 41.92 16.43 -3.19 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 10 3 # 10 C 144 HIS B 170 HIS^? 10.51 MG MG B 301 C 174 ASP B 177 ASP^? 9.03 MG MG B 301 C 404 TYR B 129 TYR^? 10.63 MG MG B 302 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 46.22 13.75 -2.72 47.53 13.11 -4.24 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 51.97 11.04 -6.64 50.39 11.62 -7.94 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 47.85 23.00 1.51 47.62 23.50 4.24 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 11 3 # 11 C 144 HIS B 170 HIS^? 10.51 MG MG B 301 C 174 ASP B 177 ASP^? 9.03 MG MG B 301 C 404 TYR B 168 TYR^? 14.66 MG MG B 301 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 46.22 13.75 -2.72 47.53 13.11 -4.24 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 51.97 11.04 -6.64 50.39 11.62 -7.94 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 40.03 17.20 -1.34 41.92 16.43 -3.19 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 12 3 # 12 C 144 HIS B 170 HIS^? 10.51 MG MG B 301 C 174 ASP B 187 ASP^? -3.44 MG MG B 301s C 404 TYR B 168 TYR^? 14.66 MG MG B 301 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 46.22 13.75 -2.72 47.53 13.11 -4.24 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 50.64 18.14 -9.69 51.74 17.63 -7.86 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 40.03 17.20 -1.34 41.92 16.43 -3.19 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 13 3 # 13 C 144 HIS C 42 HIS^? 28.09 MG MG C 302 C 174 ASP D 160 ASP^? 31.45 MG MG C 302 C 404 TYR C 156 TYR^? 21.58 MG MG C 302 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 95.93 22.96 -23.11 97.92 23.62 -23.02 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 94.15 13.98 -26.57 92.71 12.42 -26.99 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 95.64 26.50 -15.14 95.25 23.76 -14.77 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 14 3 # 14 C 144 HIS C 147 HIS^? 9.44 MG MG C 301 C 174 ASP C 128 ASP^? -3.22 MG MG C 302s C 404 TYR C 168 TYR^? 14.82 MG MG C 301 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 87.61 25.71 -3.59 89.22 24.50 -2.99 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 80.05 28.39 -4.25 77.97 28.60 -4.21 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 94.44 26.43 -5.44 92.97 25.09 -3.55 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 15 3 # 15 C 144 HIS C 147 HIS^? 9.44 MG MG C 301 C 174 ASP C 177 ASP^? 8.84 MG MG C 301 C 404 TYR C 168 TYR^? 14.82 MG MG C 301 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 87.61 25.71 -3.59 89.22 24.50 -2.99 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 85.60 16.42 -0.31 86.51 17.71 1.09 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 94.44 26.43 -5.44 92.97 25.09 -3.55 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 16 3 # 16 C 144 HIS C 147 HIS^? 9.44 MG MG C 301 C 174 ASP C 187 ASP^? -3.72 MG MG C 301s C 404 TYR C 168 TYR^? 14.82 MG MG C 301 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 87.61 25.71 -3.59 89.22 24.50 -2.99 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 84.01 23.73 3.39 83.47 22.54 1.59 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 94.44 26.43 -5.44 92.97 25.09 -3.55 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 17 3 # 17 C 144 HIS C 170 HIS^? 10.68 MG MG C 301 C 174 ASP C 177 ASP^? 8.84 MG MG C 301 C 404 TYR C 129 TYR^? 10.65 MG MG C 302 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 89.96 21.05 -3.85 88.74 19.88 -2.61 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 85.60 16.42 -0.31 86.51 17.71 1.09 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 84.95 29.43 -7.96 85.04 30.16 -10.69 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 18 3 # 18 C 144 HIS C 170 HIS^? 10.68 MG MG C 301 C 174 ASP C 177 ASP^? 8.84 MG MG C 301 C 404 TYR C 168 TYR^? 14.82 MG MG C 301 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 89.96 21.05 -3.85 88.74 19.88 -2.61 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 85.60 16.42 -0.31 86.51 17.71 1.09 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 94.44 26.43 -5.44 92.97 25.09 -3.55 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 19 3 # 19 C 144 HIS C 170 HIS^? 10.68 MG MG C 301 C 174 ASP C 187 ASP^? -3.72 MG MG C 301s C 404 TYR C 168 TYR^? 14.82 MG MG C 301 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 89.96 21.05 -3.85 88.74 19.88 -2.61 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 84.01 23.73 3.39 83.47 22.54 1.59 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 94.44 26.43 -5.44 92.97 25.09 -3.55 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 20 3 # 20 C 144 HIS D 42 HIS^? 28.21 MG MG D 302 C 174 ASP C 160 ASP^? 31.63 MG MG D 302 C 404 TYR D 156 TYR^? 21.34 MG MG D 302 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 98.45 29.90 -26.44 99.32 28.02 -26.13 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 102.50 38.00 -23.28 102.43 39.97 -22.46 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 96.25 27.10 -34.64 97.58 29.48 -35.03 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 21 3 # 21 C 144 HIS D 147 HIS^? 9.43 MG MG D 301 C 174 ASP D 128 ASP^? -3.70 MG MG D 302s C 404 TYR D 168 TYR^? 14.75 MG MG D 301 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 90.95 32.51 -46.42 92.98 32.42 -46.93 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 83.33 35.45 -46.13 81.57 36.63 -46.10 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 95.79 27.80 -44.35 95.71 29.78 -46.32 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 22 3 # 22 C 144 HIS D 147 HIS^? 9.43 MG MG D 301 C 174 ASP D 177 ASP^? 8.43 MG MG D 301 C 404 TYR D 168 TYR^? 14.75 MG MG D 301 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 90.95 32.51 -46.42 92.98 32.42 -46.93 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 95.74 41.01 -49.76 94.81 39.90 -51.24 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 95.79 27.80 -44.35 95.71 29.78 -46.32 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 23 3 # 23 C 144 HIS D 170 HIS^? 10.59 MG MG D 301 C 174 ASP D 177 ASP^? 8.43 MG MG D 301 C 404 TYR D 129 TYR^? 10.79 MG MG D 302 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 95.57 34.81 -46.05 95.59 36.24 -47.59 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 95.74 41.01 -49.76 94.81 39.90 -51.24 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 86.45 31.36 -42.20 86.02 30.90 -39.46 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 24 3 # 24 C 144 HIS D 170 HIS^? 10.59 MG MG D 301 C 174 ASP D 177 ASP^? 8.43 MG MG D 301 C 404 TYR D 168 TYR^? 14.75 MG MG D 301 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 95.57 34.81 -46.05 95.59 36.24 -47.59 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 95.74 41.01 -49.76 94.81 39.90 -51.24 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 95.79 27.80 -44.35 95.71 29.78 -46.32 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 25 3 # 25 C 144 HIS E 42 HIS^? 28.20 MG MG E 302 C 174 ASP F 160 ASP^? 31.59 MG MG E 302 C 404 TYR E 156 TYR^? 21.59 MG MG E 302 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 62.33 71.93 -68.30 60.54 72.96 -68.64 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 71.27 74.59 -71.77 73.23 74.02 -72.37 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 59.31 70.31 -60.22 61.84 71.39 -59.92 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 26 3 # 26 C 144 HIS E 147 HIS^? 9.22 MG MG E 301 C 174 ASP E 128 ASP^? -3.53 MG MG E 302s C 404 TYR E 168 TYR^? 14.43 MG MG E 301 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 63.87 64.43 -48.39 64.18 66.45 -47.92 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 65.38 56.57 -48.58 66.15 54.57 -48.61 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 60.07 69.95 -50.54 61.99 69.37 -48.59 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 27 3 # 27 C 144 HIS E 147 HIS^? 9.22 MG MG E 301 C 174 ASP E 177 ASP^? 8.55 MG MG E 301 C 404 TYR E 168 TYR^? 14.43 MG MG E 301 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 63.87 64.43 -48.39 64.18 66.45 -47.92 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 72.81 67.32 -45.03 71.14 67.96 -43.95 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 60.07 69.95 -50.54 61.99 69.37 -48.59 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 28 3 # 28 C 144 HIS E 170 HIS^? 10.33 MG MG E 301 C 174 ASP E 177 ASP^? 8.55 MG MG E 301 C 404 TYR E 129 TYR^? 10.89 MG MG E 302 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 66.96 68.76 -48.87 68.36 68.54 -47.33 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 72.81 67.32 -45.03 71.14 67.96 -43.95 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 62.09 60.15 -52.83 61.47 59.53 -55.45 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 29 3 # 29 C 144 HIS E 170 HIS^? 10.33 MG MG E 301 C 174 ASP E 177 ASP^? 8.55 MG MG E 301 C 404 TYR E 168 TYR^? 14.43 MG MG E 301 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 66.96 68.76 -48.87 68.36 68.54 -47.33 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 72.81 67.32 -45.03 71.14 67.96 -43.95 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 60.07 69.95 -50.54 61.99 69.37 -48.59 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 30 3 # 30 C 144 HIS F 42 HIS^? 28.34 MG MG F 301 C 174 ASP E 160 ASP^? 31.54 MG MG F 301 C 404 TYR F 156 TYR^? 21.68 MG MG F 302 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 55.11 70.50 -71.64 56.29 72.22 -71.48 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 45.81 70.00 -68.45 44.10 68.87 -67.77 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 58.80 69.55 -79.65 56.09 69.80 -80.15 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 31 3 # 31 C 144 HIS F 147 HIS^? 8.79 MG MG F 302 C 174 ASP F 128 ASP^? -3.41 MG MG F 301s C 404 TYR F 168 TYR^? 14.10 MG MG F 302 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 56.63 61.66 -91.16 55.69 63.43 -91.80 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 57.76 53.73 -90.50 57.46 51.64 -90.28 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 58.29 68.32 -89.29 56.67 67.12 -91.21 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 32 3 # 32 C 144 HIS F 147 HIS^? 8.79 MG MG F 302 C 174 ASP F 177 ASP^? 8.15 MG MG F 302 C 404 TYR F 168 TYR^? 14.10 MG MG F 302 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 56.63 61.66 -91.16 55.69 63.43 -91.80 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 47.18 61.22 -94.50 48.48 62.32 -95.73 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 58.29 68.32 -89.29 56.67 67.12 -91.21 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 33 3 # 33 C 144 HIS F 147 HIS^? 8.79 MG MG F 302 C 174 ASP F 187 ASP^? -3.27 MG MG F 302s C 404 TYR F 168 TYR^? 14.10 MG MG F 302 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 56.63 61.66 -91.16 55.69 63.43 -91.80 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 53.93 58.87 -98.14 52.45 58.62 -96.61 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 58.29 68.32 -89.29 56.67 67.12 -91.21 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 34 3 # 34 C 144 HIS F 170 HIS^? 9.84 MG MG F 302 C 174 ASP F 177 ASP^? 8.15 MG MG F 302 C 404 TYR F 129 TYR^? 10.92 MG MG F 301 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 52.25 64.82 -90.91 50.95 63.88 -92.26 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 47.18 61.22 -94.50 48.48 62.32 -95.73 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 59.69 58.61 -86.67 60.36 58.48 -83.96 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 35 3 # 35 C 144 HIS F 170 HIS^? 9.84 MG MG F 302 C 174 ASP F 177 ASP^? 8.15 MG MG F 302 C 404 TYR F 168 TYR^? 14.10 MG MG F 302 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 52.25 64.82 -90.91 50.95 63.88 -92.26 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 47.18 61.22 -94.50 48.48 62.32 -95.73 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 58.29 68.32 -89.29 56.67 67.12 -91.21 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 36 3 # 36 C 144 HIS F 170 HIS^? 9.84 MG MG F 302 C 174 ASP F 187 ASP^? -3.27 MG MG F 302s C 404 TYR F 168 TYR^? 14.10 MG MG F 302 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 52.25 64.82 -90.91 50.95 63.88 -92.26 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 53.93 58.87 -98.14 52.45 58.62 -96.61 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 58.29 68.32 -89.29 56.67 67.12 -91.21 1ti6_c07 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 36 hits 1ti6_c07 naa= 3 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 E 144 HIS A 42 HIS^? 28.45 MG MG A 301 E 174 ASP B 160 ASP^? 31.65 MG MG A 301 E 404 TYR A 156 TYR^? 21.80 MG MG A 301 coo -7.53-107.59 75.19 -8.14-106.04 76.47 34.62 18.32 19.57 34.29 16.25 19.41 coo -3.55-105.39 83.13 -5.21-106.24 82.09 28.01 24.83 16.38 27.44 26.81 15.80 coo -16.31-108.78 75.35 -14.20-107.14 76.16 37.50 16.28 27.75 35.30 17.94 28.08 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 E 144 HIS A 147 HIS^? 9.20 MG MG A 302 E 174 ASP A 128 ASP^? -3.32 MG MG A 301s E 404 TYR A 168 TYR^? 14.52 MG MG A 302 coo -7.53-107.59 75.19 -8.14-106.04 76.47 40.24 23.10 39.83 38.32 22.34 40.22 coo -3.55-105.39 83.13 -5.21-106.24 82.09 46.50 28.23 39.77 47.49 30.10 39.82 coo -16.31-108.78 75.35 -14.20-107.14 76.16 37.31 16.98 37.59 36.65 18.86 39.55 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 E 144 HIS A 147 HIS^? 9.20 MG MG A 302 E 174 ASP A 177 ASP^? 8.44 MG MG A 302 E 404 TYR A 168 TYR^? 14.52 MG MG A 302 coo -7.53-107.59 75.19 -8.14-106.04 76.47 40.24 23.10 39.83 38.32 22.34 40.22 coo -3.55-105.39 83.13 -5.21-106.24 82.09 33.02 29.04 43.18 33.79 27.88 44.78 coo -16.31-108.78 75.35 -14.20-107.14 76.16 37.31 16.98 37.59 36.65 18.86 39.55 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 E 144 HIS A 147 HIS^? 9.20 MG MG A 302 E 174 ASP A 187 ASP^? -3.29 MG MG A 302s E 404 TYR A 168 TYR^? 14.52 MG MG A 302 coo -7.53-107.59 75.19 -8.14-106.04 76.47 40.24 23.10 39.83 38.32 22.34 40.22 coo -3.55-105.39 83.13 -5.21-106.24 82.09 39.43 26.57 46.78 39.37 27.83 45.03 coo -16.31-108.78 75.35 -14.20-107.14 76.16 37.31 16.98 37.59 36.65 18.86 39.55 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 5 3 # 5 E 144 HIS A 170 HIS^? 10.56 MG MG A 302 E 174 ASP A 187 ASP^? -3.29 MG MG A 302s E 404 TYR A 168 TYR^? 14.52 MG MG A 302 coo -7.53-107.59 75.19 -8.14-106.04 76.47 34.91 23.57 39.32 34.35 24.95 40.81 coo -3.55-105.39 83.13 -5.21-106.24 82.09 39.43 26.57 46.78 39.37 27.83 45.03 coo -16.31-108.78 75.35 -14.20-107.14 76.16 37.31 16.98 37.59 36.65 18.86 39.55 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 6 3 # 6 E 144 HIS B 42 HIS^? 28.37 MG MG B 302 E 174 ASP A 160 ASP^? 31.61 MG MG B 302 E 404 TYR B 156 TYR^? 21.63 MG MG B 302 coo -7.53-107.59 75.19 -8.14-106.04 76.47 39.34 12.99 16.30 37.26 13.24 16.40 coo -3.55-105.39 83.13 -5.21-106.24 82.09 44.21 5.00 19.54 46.02 3.84 19.76 coo -16.31-108.78 75.35 -14.20-107.14 76.16 38.56 16.71 8.27 39.91 14.31 7.86 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 7 3 # 7 E 144 HIS B 147 HIS^? 9.27 MG MG B 301 E 174 ASP B 128 ASP^? -3.57 MG MG B 302s E 404 TYR B 168 TYR^? 14.66 MG MG B 301 coo -7.53-107.59 75.19 -8.14-106.04 76.47 46.73 18.97 -3.05 45.63 17.32 -3.73 coo -3.55-105.39 83.13 -5.21-106.24 82.09 52.92 24.09 -2.19 54.73 25.14 -1.90 coo -16.31-108.78 75.35 -14.20-107.14 76.16 40.03 17.20 -1.34 41.92 16.43 -3.19 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 8 3 # 8 E 144 HIS B 147 HIS^? 9.27 MG MG B 301 E 174 ASP B 177 ASP^? 9.03 MG MG B 301 E 404 TYR B 168 TYR^? 14.66 MG MG B 301 coo -7.53-107.59 75.19 -8.14-106.04 76.47 46.73 18.97 -3.05 45.63 17.32 -3.73 coo -3.55-105.39 83.13 -5.21-106.24 82.09 51.97 11.04 -6.64 50.39 11.62 -7.94 coo -16.31-108.78 75.35 -14.20-107.14 76.16 40.03 17.20 -1.34 41.92 16.43 -3.19 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 9 3 # 9 E 144 HIS B 147 HIS^? 9.27 MG MG B 301 E 174 ASP B 187 ASP^? -3.44 MG MG B 301s E 404 TYR B 168 TYR^? 14.66 MG MG B 301 coo -7.53-107.59 75.19 -8.14-106.04 76.47 46.73 18.97 -3.05 45.63 17.32 -3.73 coo -3.55-105.39 83.13 -5.21-106.24 82.09 50.64 18.14 -9.69 51.74 17.63 -7.86 coo -16.31-108.78 75.35 -14.20-107.14 76.16 40.03 17.20 -1.34 41.92 16.43 -3.19 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 10 3 # 10 E 144 HIS B 170 HIS^? 10.51 MG MG B 301 E 174 ASP B 177 ASP^? 9.03 MG MG B 301 E 404 TYR B 129 TYR^? 10.63 MG MG B 302 coo -7.53-107.59 75.19 -8.14-106.04 76.47 46.22 13.75 -2.72 47.53 13.11 -4.24 coo -3.55-105.39 83.13 -5.21-106.24 82.09 51.97 11.04 -6.64 50.39 11.62 -7.94 coo -16.31-108.78 75.35 -14.20-107.14 76.16 47.85 23.00 1.51 47.62 23.50 4.24 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 11 3 # 11 E 144 HIS B 170 HIS^? 10.51 MG MG B 301 E 174 ASP B 177 ASP^? 9.03 MG MG B 301 E 404 TYR B 168 TYR^? 14.66 MG MG B 301 coo -7.53-107.59 75.19 -8.14-106.04 76.47 46.22 13.75 -2.72 47.53 13.11 -4.24 coo -3.55-105.39 83.13 -5.21-106.24 82.09 51.97 11.04 -6.64 50.39 11.62 -7.94 coo -16.31-108.78 75.35 -14.20-107.14 76.16 40.03 17.20 -1.34 41.92 16.43 -3.19 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 12 3 # 12 E 144 HIS B 170 HIS^? 10.51 MG MG B 301 E 174 ASP B 187 ASP^? -3.44 MG MG B 301s E 404 TYR B 168 TYR^? 14.66 MG MG B 301 coo -7.53-107.59 75.19 -8.14-106.04 76.47 46.22 13.75 -2.72 47.53 13.11 -4.24 coo -3.55-105.39 83.13 -5.21-106.24 82.09 50.64 18.14 -9.69 51.74 17.63 -7.86 coo -16.31-108.78 75.35 -14.20-107.14 76.16 40.03 17.20 -1.34 41.92 16.43 -3.19 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 13 3 # 13 E 144 HIS C 42 HIS^? 28.09 MG MG C 302 E 174 ASP D 160 ASP^? 31.45 MG MG C 302 E 404 TYR C 156 TYR^? 21.58 MG MG C 302 coo -7.53-107.59 75.19 -8.14-106.04 76.47 95.93 22.96 -23.11 97.92 23.62 -23.02 coo -3.55-105.39 83.13 -5.21-106.24 82.09 94.15 13.98 -26.57 92.71 12.42 -26.99 coo -16.31-108.78 75.35 -14.20-107.14 76.16 95.64 26.50 -15.14 95.25 23.76 -14.77 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 14 3 # 14 E 144 HIS C 147 HIS^? 9.44 MG MG C 301 E 174 ASP C 128 ASP^? -3.22 MG MG C 302s E 404 TYR C 168 TYR^? 14.82 MG MG C 301 coo -7.53-107.59 75.19 -8.14-106.04 76.47 87.61 25.71 -3.59 89.22 24.50 -2.99 coo -3.55-105.39 83.13 -5.21-106.24 82.09 80.05 28.39 -4.25 77.97 28.60 -4.21 coo -16.31-108.78 75.35 -14.20-107.14 76.16 94.44 26.43 -5.44 92.97 25.09 -3.55 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 15 3 # 15 E 144 HIS C 147 HIS^? 9.44 MG MG C 301 E 174 ASP C 177 ASP^? 8.84 MG MG C 301 E 404 TYR C 168 TYR^? 14.82 MG MG C 301 coo -7.53-107.59 75.19 -8.14-106.04 76.47 87.61 25.71 -3.59 89.22 24.50 -2.99 coo -3.55-105.39 83.13 -5.21-106.24 82.09 85.60 16.42 -0.31 86.51 17.71 1.09 coo -16.31-108.78 75.35 -14.20-107.14 76.16 94.44 26.43 -5.44 92.97 25.09 -3.55 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 16 3 # 16 E 144 HIS C 147 HIS^? 9.44 MG MG C 301 E 174 ASP C 187 ASP^? -3.72 MG MG C 301s E 404 TYR C 168 TYR^? 14.82 MG MG C 301 coo -7.53-107.59 75.19 -8.14-106.04 76.47 87.61 25.71 -3.59 89.22 24.50 -2.99 coo -3.55-105.39 83.13 -5.21-106.24 82.09 84.01 23.73 3.39 83.47 22.54 1.59 coo -16.31-108.78 75.35 -14.20-107.14 76.16 94.44 26.43 -5.44 92.97 25.09 -3.55 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 17 3 # 17 E 144 HIS C 170 HIS^? 10.68 MG MG C 301 E 174 ASP C 177 ASP^? 8.84 MG MG C 301 E 404 TYR C 129 TYR^? 10.65 MG MG C 302 coo -7.53-107.59 75.19 -8.14-106.04 76.47 89.96 21.05 -3.85 88.74 19.88 -2.61 coo -3.55-105.39 83.13 -5.21-106.24 82.09 85.60 16.42 -0.31 86.51 17.71 1.09 coo -16.31-108.78 75.35 -14.20-107.14 76.16 84.95 29.43 -7.96 85.04 30.16 -10.69 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 18 3 # 18 E 144 HIS C 170 HIS^? 10.68 MG MG C 301 E 174 ASP C 177 ASP^? 8.84 MG MG C 301 E 404 TYR C 168 TYR^? 14.82 MG MG C 301 coo -7.53-107.59 75.19 -8.14-106.04 76.47 89.96 21.05 -3.85 88.74 19.88 -2.61 coo -3.55-105.39 83.13 -5.21-106.24 82.09 85.60 16.42 -0.31 86.51 17.71 1.09 coo -16.31-108.78 75.35 -14.20-107.14 76.16 94.44 26.43 -5.44 92.97 25.09 -3.55 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 19 3 # 19 E 144 HIS C 170 HIS^? 10.68 MG MG C 301 E 174 ASP C 187 ASP^? -3.72 MG MG C 301s E 404 TYR C 168 TYR^? 14.82 MG MG C 301 coo -7.53-107.59 75.19 -8.14-106.04 76.47 89.96 21.05 -3.85 88.74 19.88 -2.61 coo -3.55-105.39 83.13 -5.21-106.24 82.09 84.01 23.73 3.39 83.47 22.54 1.59 coo -16.31-108.78 75.35 -14.20-107.14 76.16 94.44 26.43 -5.44 92.97 25.09 -3.55 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 20 3 # 20 E 144 HIS D 42 HIS^? 28.21 MG MG D 302 E 174 ASP C 160 ASP^? 31.63 MG MG D 302 E 404 TYR D 156 TYR^? 21.34 MG MG D 302 coo -7.53-107.59 75.19 -8.14-106.04 76.47 98.45 29.90 -26.44 99.32 28.02 -26.13 coo -3.55-105.39 83.13 -5.21-106.24 82.09 102.50 38.00 -23.28 102.43 39.97 -22.46 coo -16.31-108.78 75.35 -14.20-107.14 76.16 96.25 27.10 -34.64 97.58 29.48 -35.03 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 21 3 # 21 E 144 HIS D 147 HIS^? 9.43 MG MG D 301 E 174 ASP D 128 ASP^? -3.70 MG MG D 302s E 404 TYR D 168 TYR^? 14.75 MG MG D 301 coo -7.53-107.59 75.19 -8.14-106.04 76.47 90.95 32.51 -46.42 92.98 32.42 -46.93 coo -3.55-105.39 83.13 -5.21-106.24 82.09 83.33 35.45 -46.13 81.57 36.63 -46.10 coo -16.31-108.78 75.35 -14.20-107.14 76.16 95.79 27.80 -44.35 95.71 29.78 -46.32 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 22 3 # 22 E 144 HIS D 147 HIS^? 9.43 MG MG D 301 E 174 ASP D 177 ASP^? 8.43 MG MG D 301 E 404 TYR D 168 TYR^? 14.75 MG MG D 301 coo -7.53-107.59 75.19 -8.14-106.04 76.47 90.95 32.51 -46.42 92.98 32.42 -46.93 coo -3.55-105.39 83.13 -5.21-106.24 82.09 95.74 41.01 -49.76 94.81 39.90 -51.24 coo -16.31-108.78 75.35 -14.20-107.14 76.16 95.79 27.80 -44.35 95.71 29.78 -46.32 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 23 3 # 23 E 144 HIS D 170 HIS^? 10.59 MG MG D 301 E 174 ASP D 177 ASP^? 8.43 MG MG D 301 E 404 TYR D 129 TYR^? 10.79 MG MG D 302 coo -7.53-107.59 75.19 -8.14-106.04 76.47 95.57 34.81 -46.05 95.59 36.24 -47.59 coo -3.55-105.39 83.13 -5.21-106.24 82.09 95.74 41.01 -49.76 94.81 39.90 -51.24 coo -16.31-108.78 75.35 -14.20-107.14 76.16 86.45 31.36 -42.20 86.02 30.90 -39.46 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 24 3 # 24 E 144 HIS D 170 HIS^? 10.59 MG MG D 301 E 174 ASP D 177 ASP^? 8.43 MG MG D 301 E 404 TYR D 168 TYR^? 14.75 MG MG D 301 coo -7.53-107.59 75.19 -8.14-106.04 76.47 95.57 34.81 -46.05 95.59 36.24 -47.59 coo -3.55-105.39 83.13 -5.21-106.24 82.09 95.74 41.01 -49.76 94.81 39.90 -51.24 coo -16.31-108.78 75.35 -14.20-107.14 76.16 95.79 27.80 -44.35 95.71 29.78 -46.32 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 25 3 # 25 E 144 HIS E 42 HIS^? 28.20 MG MG E 302 E 174 ASP F 160 ASP^? 31.59 MG MG E 302 E 404 TYR E 156 TYR^? 21.59 MG MG E 302 coo -7.53-107.59 75.19 -8.14-106.04 76.47 62.33 71.93 -68.30 60.54 72.96 -68.64 coo -3.55-105.39 83.13 -5.21-106.24 82.09 71.27 74.59 -71.77 73.23 74.02 -72.37 coo -16.31-108.78 75.35 -14.20-107.14 76.16 59.31 70.31 -60.22 61.84 71.39 -59.92 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 26 3 # 26 E 144 HIS E 147 HIS^? 9.22 MG MG E 301 E 174 ASP E 128 ASP^? -3.53 MG MG E 302s E 404 TYR E 168 TYR^? 14.43 MG MG E 301 coo -7.53-107.59 75.19 -8.14-106.04 76.47 63.87 64.43 -48.39 64.18 66.45 -47.92 coo -3.55-105.39 83.13 -5.21-106.24 82.09 65.38 56.57 -48.58 66.15 54.57 -48.61 coo -16.31-108.78 75.35 -14.20-107.14 76.16 60.07 69.95 -50.54 61.99 69.37 -48.59 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 27 3 # 27 E 144 HIS E 147 HIS^? 9.22 MG MG E 301 E 174 ASP E 177 ASP^? 8.55 MG MG E 301 E 404 TYR E 168 TYR^? 14.43 MG MG E 301 coo -7.53-107.59 75.19 -8.14-106.04 76.47 63.87 64.43 -48.39 64.18 66.45 -47.92 coo -3.55-105.39 83.13 -5.21-106.24 82.09 72.81 67.32 -45.03 71.14 67.96 -43.95 coo -16.31-108.78 75.35 -14.20-107.14 76.16 60.07 69.95 -50.54 61.99 69.37 -48.59 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 28 3 # 28 E 144 HIS E 170 HIS^? 10.33 MG MG E 301 E 174 ASP E 177 ASP^? 8.55 MG MG E 301 E 404 TYR E 129 TYR^? 10.89 MG MG E 302 coo -7.53-107.59 75.19 -8.14-106.04 76.47 66.96 68.76 -48.87 68.36 68.54 -47.33 coo -3.55-105.39 83.13 -5.21-106.24 82.09 72.81 67.32 -45.03 71.14 67.96 -43.95 coo -16.31-108.78 75.35 -14.20-107.14 76.16 62.09 60.15 -52.83 61.47 59.53 -55.45 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 29 3 # 29 E 144 HIS E 170 HIS^? 10.33 MG MG E 301 E 174 ASP E 177 ASP^? 8.55 MG MG E 301 E 404 TYR E 168 TYR^? 14.43 MG MG E 301 coo -7.53-107.59 75.19 -8.14-106.04 76.47 66.96 68.76 -48.87 68.36 68.54 -47.33 coo -3.55-105.39 83.13 -5.21-106.24 82.09 72.81 67.32 -45.03 71.14 67.96 -43.95 coo -16.31-108.78 75.35 -14.20-107.14 76.16 60.07 69.95 -50.54 61.99 69.37 -48.59 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 30 3 # 30 E 144 HIS F 42 HIS^? 28.34 MG MG F 301 E 174 ASP E 160 ASP^? 31.54 MG MG F 301 E 404 TYR F 156 TYR^? 21.68 MG MG F 302 coo -7.53-107.59 75.19 -8.14-106.04 76.47 55.11 70.50 -71.64 56.29 72.22 -71.48 coo -3.55-105.39 83.13 -5.21-106.24 82.09 45.81 70.00 -68.45 44.10 68.87 -67.77 coo -16.31-108.78 75.35 -14.20-107.14 76.16 58.80 69.55 -79.65 56.09 69.80 -80.15 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 31 3 # 31 E 144 HIS F 147 HIS^? 8.79 MG MG F 302 E 174 ASP F 128 ASP^? -3.41 MG MG F 301s E 404 TYR F 168 TYR^? 14.10 MG MG F 302 coo -7.53-107.59 75.19 -8.14-106.04 76.47 56.63 61.66 -91.16 55.69 63.43 -91.80 coo -3.55-105.39 83.13 -5.21-106.24 82.09 57.76 53.73 -90.50 57.46 51.64 -90.28 coo -16.31-108.78 75.35 -14.20-107.14 76.16 58.29 68.32 -89.29 56.67 67.12 -91.21 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 32 3 # 32 E 144 HIS F 147 HIS^? 8.79 MG MG F 302 E 174 ASP F 177 ASP^? 8.15 MG MG F 302 E 404 TYR F 168 TYR^? 14.10 MG MG F 302 coo -7.53-107.59 75.19 -8.14-106.04 76.47 56.63 61.66 -91.16 55.69 63.43 -91.80 coo -3.55-105.39 83.13 -5.21-106.24 82.09 47.18 61.22 -94.50 48.48 62.32 -95.73 coo -16.31-108.78 75.35 -14.20-107.14 76.16 58.29 68.32 -89.29 56.67 67.12 -91.21 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 33 3 # 33 E 144 HIS F 147 HIS^? 8.79 MG MG F 302 E 174 ASP F 187 ASP^? -3.27 MG MG F 302s E 404 TYR F 168 TYR^? 14.10 MG MG F 302 coo -7.53-107.59 75.19 -8.14-106.04 76.47 56.63 61.66 -91.16 55.69 63.43 -91.80 coo -3.55-105.39 83.13 -5.21-106.24 82.09 53.93 58.87 -98.14 52.45 58.62 -96.61 coo -16.31-108.78 75.35 -14.20-107.14 76.16 58.29 68.32 -89.29 56.67 67.12 -91.21 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 34 3 # 34 E 144 HIS F 170 HIS^? 9.84 MG MG F 302 E 174 ASP F 177 ASP^? 8.15 MG MG F 302 E 404 TYR F 129 TYR^? 10.92 MG MG F 301 coo -7.53-107.59 75.19 -8.14-106.04 76.47 52.25 64.82 -90.91 50.95 63.88 -92.26 coo -3.55-105.39 83.13 -5.21-106.24 82.09 47.18 61.22 -94.50 48.48 62.32 -95.73 coo -16.31-108.78 75.35 -14.20-107.14 76.16 59.69 58.61 -86.67 60.36 58.48 -83.96 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 35 3 # 35 E 144 HIS F 170 HIS^? 9.84 MG MG F 302 E 174 ASP F 177 ASP^? 8.15 MG MG F 302 E 404 TYR F 168 TYR^? 14.10 MG MG F 302 coo -7.53-107.59 75.19 -8.14-106.04 76.47 52.25 64.82 -90.91 50.95 63.88 -92.26 coo -3.55-105.39 83.13 -5.21-106.24 82.09 47.18 61.22 -94.50 48.48 62.32 -95.73 coo -16.31-108.78 75.35 -14.20-107.14 76.16 58.29 68.32 -89.29 56.67 67.12 -91.21 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 36 3 # 36 E 144 HIS F 170 HIS^? 9.84 MG MG F 302 E 174 ASP F 187 ASP^? -3.27 MG MG F 302s E 404 TYR F 168 TYR^? 14.10 MG MG F 302 coo -7.53-107.59 75.19 -8.14-106.04 76.47 52.25 64.82 -90.91 50.95 63.88 -92.26 coo -3.55-105.39 83.13 -5.21-106.24 82.09 53.93 58.87 -98.14 52.45 58.62 -96.61 coo -16.31-108.78 75.35 -14.20-107.14 76.16 58.29 68.32 -89.29 56.67 67.12 -91.21 1ti6_c08 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 36 hits 1ti6_c08 naa= 3 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 G 144 HIS A 42 HIS^? 28.45 MG MG A 301 G 174 ASP B 160 ASP^? 31.65 MG MG A 301 G 404 TYR A 156 TYR^? 21.80 MG MG A 301 coo 60.48-101.16 45.95 60.56-101.20 43.85 34.62 18.32 19.57 34.29 16.25 19.41 coo 58.10-108.15 40.62 59.57-106.86 41.51 28.01 24.83 16.38 27.44 26.81 15.80 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 37.50 16.28 27.75 35.30 17.94 28.08 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 G 144 HIS A 147 HIS^? 9.20 MG MG A 302 G 174 ASP A 128 ASP^? -3.32 MG MG A 301s G 404 TYR A 168 TYR^? 14.52 MG MG A 302 coo 60.48-101.16 45.95 60.56-101.20 43.85 40.24 23.10 39.83 38.32 22.34 40.22 coo 58.10-108.15 40.62 59.57-106.86 41.51 46.50 28.23 39.77 47.49 30.10 39.82 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 37.31 16.98 37.59 36.65 18.86 39.55 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 G 144 HIS A 147 HIS^? 9.20 MG MG A 302 G 174 ASP A 177 ASP^? 8.44 MG MG A 302 G 404 TYR A 168 TYR^? 14.52 MG MG A 302 coo 60.48-101.16 45.95 60.56-101.20 43.85 40.24 23.10 39.83 38.32 22.34 40.22 coo 58.10-108.15 40.62 59.57-106.86 41.51 33.02 29.04 43.18 33.79 27.88 44.78 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 37.31 16.98 37.59 36.65 18.86 39.55 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 G 144 HIS A 147 HIS^? 9.20 MG MG A 302 G 174 ASP A 187 ASP^? -3.29 MG MG A 302s G 404 TYR A 168 TYR^? 14.52 MG MG A 302 coo 60.48-101.16 45.95 60.56-101.20 43.85 40.24 23.10 39.83 38.32 22.34 40.22 coo 58.10-108.15 40.62 59.57-106.86 41.51 39.43 26.57 46.78 39.37 27.83 45.03 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 37.31 16.98 37.59 36.65 18.86 39.55 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 5 3 # 5 G 144 HIS A 170 HIS^? 10.56 MG MG A 302 G 174 ASP A 187 ASP^? -3.29 MG MG A 302s G 404 TYR A 168 TYR^? 14.52 MG MG A 302 coo 60.48-101.16 45.95 60.56-101.20 43.85 34.91 23.57 39.32 34.35 24.95 40.81 coo 58.10-108.15 40.62 59.57-106.86 41.51 39.43 26.57 46.78 39.37 27.83 45.03 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 37.31 16.98 37.59 36.65 18.86 39.55 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 6 3 # 6 G 144 HIS B 42 HIS^? 28.37 MG MG B 302 G 174 ASP A 160 ASP^? 31.61 MG MG B 302 G 404 TYR B 156 TYR^? 21.63 MG MG B 302 coo 60.48-101.16 45.95 60.56-101.20 43.85 39.34 12.99 16.30 37.26 13.24 16.40 coo 58.10-108.15 40.62 59.57-106.86 41.51 44.21 5.00 19.54 46.02 3.84 19.76 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 38.56 16.71 8.27 39.91 14.31 7.86 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 7 3 # 7 G 144 HIS B 147 HIS^? 9.27 MG MG B 301 G 174 ASP B 128 ASP^? -3.57 MG MG B 302s G 404 TYR B 168 TYR^? 14.66 MG MG B 301 coo 60.48-101.16 45.95 60.56-101.20 43.85 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 58.10-108.15 40.62 59.57-106.86 41.51 52.92 24.09 -2.19 54.73 25.14 -1.90 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 40.03 17.20 -1.34 41.92 16.43 -3.19 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 8 3 # 8 G 144 HIS B 147 HIS^? 9.27 MG MG B 301 G 174 ASP B 177 ASP^? 9.03 MG MG B 301 G 404 TYR B 168 TYR^? 14.66 MG MG B 301 coo 60.48-101.16 45.95 60.56-101.20 43.85 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 58.10-108.15 40.62 59.57-106.86 41.51 51.97 11.04 -6.64 50.39 11.62 -7.94 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 40.03 17.20 -1.34 41.92 16.43 -3.19 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 9 3 # 9 G 144 HIS B 147 HIS^? 9.27 MG MG B 301 G 174 ASP B 187 ASP^? -3.44 MG MG B 301s G 404 TYR B 168 TYR^? 14.66 MG MG B 301 coo 60.48-101.16 45.95 60.56-101.20 43.85 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 58.10-108.15 40.62 59.57-106.86 41.51 50.64 18.14 -9.69 51.74 17.63 -7.86 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 40.03 17.20 -1.34 41.92 16.43 -3.19 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 10 3 # 10 G 144 HIS B 170 HIS^? 10.51 MG MG B 301 G 174 ASP B 177 ASP^? 9.03 MG MG B 301 G 404 TYR B 129 TYR^? 10.63 MG MG B 302 coo 60.48-101.16 45.95 60.56-101.20 43.85 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 58.10-108.15 40.62 59.57-106.86 41.51 51.97 11.04 -6.64 50.39 11.62 -7.94 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 47.85 23.00 1.51 47.62 23.50 4.24 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 11 3 # 11 G 144 HIS B 170 HIS^? 10.51 MG MG B 301 G 174 ASP B 177 ASP^? 9.03 MG MG B 301 G 404 TYR B 168 TYR^? 14.66 MG MG B 301 coo 60.48-101.16 45.95 60.56-101.20 43.85 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 58.10-108.15 40.62 59.57-106.86 41.51 51.97 11.04 -6.64 50.39 11.62 -7.94 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 40.03 17.20 -1.34 41.92 16.43 -3.19 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 12 3 # 12 G 144 HIS B 170 HIS^? 10.51 MG MG B 301 G 174 ASP B 187 ASP^? -3.44 MG MG B 301s G 404 TYR B 168 TYR^? 14.66 MG MG B 301 coo 60.48-101.16 45.95 60.56-101.20 43.85 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 58.10-108.15 40.62 59.57-106.86 41.51 50.64 18.14 -9.69 51.74 17.63 -7.86 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 40.03 17.20 -1.34 41.92 16.43 -3.19 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 13 3 # 13 G 144 HIS C 42 HIS^? 28.09 MG MG C 302 G 174 ASP D 160 ASP^? 31.45 MG MG C 302 G 404 TYR C 156 TYR^? 21.58 MG MG C 302 coo 60.48-101.16 45.95 60.56-101.20 43.85 95.93 22.96 -23.11 97.92 23.62 -23.02 coo 58.10-108.15 40.62 59.57-106.86 41.51 94.15 13.98 -26.57 92.71 12.42 -26.99 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 95.64 26.50 -15.14 95.25 23.76 -14.77 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 14 3 # 14 G 144 HIS C 147 HIS^? 9.44 MG MG C 301 G 174 ASP C 128 ASP^? -3.22 MG MG C 302s G 404 TYR C 168 TYR^? 14.82 MG MG C 301 coo 60.48-101.16 45.95 60.56-101.20 43.85 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 58.10-108.15 40.62 59.57-106.86 41.51 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 94.44 26.43 -5.44 92.97 25.09 -3.55 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 15 3 # 15 G 144 HIS C 147 HIS^? 9.44 MG MG C 301 G 174 ASP C 177 ASP^? 8.84 MG MG C 301 G 404 TYR C 168 TYR^? 14.82 MG MG C 301 coo 60.48-101.16 45.95 60.56-101.20 43.85 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 58.10-108.15 40.62 59.57-106.86 41.51 85.60 16.42 -0.31 86.51 17.71 1.09 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 94.44 26.43 -5.44 92.97 25.09 -3.55 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 16 3 # 16 G 144 HIS C 147 HIS^? 9.44 MG MG C 301 G 174 ASP C 187 ASP^? -3.72 MG MG C 301s G 404 TYR C 168 TYR^? 14.82 MG MG C 301 coo 60.48-101.16 45.95 60.56-101.20 43.85 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 58.10-108.15 40.62 59.57-106.86 41.51 84.01 23.73 3.39 83.47 22.54 1.59 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 94.44 26.43 -5.44 92.97 25.09 -3.55 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 17 3 # 17 G 144 HIS C 170 HIS^? 10.68 MG MG C 301 G 174 ASP C 177 ASP^? 8.84 MG MG C 301 G 404 TYR C 129 TYR^? 10.65 MG MG C 302 coo 60.48-101.16 45.95 60.56-101.20 43.85 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 58.10-108.15 40.62 59.57-106.86 41.51 85.60 16.42 -0.31 86.51 17.71 1.09 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 84.95 29.43 -7.96 85.04 30.16 -10.69 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 18 3 # 18 G 144 HIS C 170 HIS^? 10.68 MG MG C 301 G 174 ASP C 177 ASP^? 8.84 MG MG C 301 G 404 TYR C 168 TYR^? 14.82 MG MG C 301 coo 60.48-101.16 45.95 60.56-101.20 43.85 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 58.10-108.15 40.62 59.57-106.86 41.51 85.60 16.42 -0.31 86.51 17.71 1.09 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 94.44 26.43 -5.44 92.97 25.09 -3.55 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 19 3 # 19 G 144 HIS C 170 HIS^? 10.68 MG MG C 301 G 174 ASP C 187 ASP^? -3.72 MG MG C 301s G 404 TYR C 168 TYR^? 14.82 MG MG C 301 coo 60.48-101.16 45.95 60.56-101.20 43.85 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 58.10-108.15 40.62 59.57-106.86 41.51 84.01 23.73 3.39 83.47 22.54 1.59 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 94.44 26.43 -5.44 92.97 25.09 -3.55 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 20 3 # 20 G 144 HIS D 42 HIS^? 28.21 MG MG D 302 G 174 ASP C 160 ASP^? 31.63 MG MG D 302 G 404 TYR D 156 TYR^? 21.34 MG MG D 302 coo 60.48-101.16 45.95 60.56-101.20 43.85 98.45 29.90 -26.44 99.32 28.02 -26.13 coo 58.10-108.15 40.62 59.57-106.86 41.51 102.50 38.00 -23.28 102.43 39.97 -22.46 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 96.25 27.10 -34.64 97.58 29.48 -35.03 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 21 3 # 21 G 144 HIS D 147 HIS^? 9.43 MG MG D 301 G 174 ASP D 128 ASP^? -3.70 MG MG D 302s G 404 TYR D 168 TYR^? 14.75 MG MG D 301 coo 60.48-101.16 45.95 60.56-101.20 43.85 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 58.10-108.15 40.62 59.57-106.86 41.51 83.33 35.45 -46.13 81.57 36.63 -46.10 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 95.79 27.80 -44.35 95.71 29.78 -46.32 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 22 3 # 22 G 144 HIS D 147 HIS^? 9.43 MG MG D 301 G 174 ASP D 177 ASP^? 8.43 MG MG D 301 G 404 TYR D 168 TYR^? 14.75 MG MG D 301 coo 60.48-101.16 45.95 60.56-101.20 43.85 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 58.10-108.15 40.62 59.57-106.86 41.51 95.74 41.01 -49.76 94.81 39.90 -51.24 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 95.79 27.80 -44.35 95.71 29.78 -46.32 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 23 3 # 23 G 144 HIS D 170 HIS^? 10.59 MG MG D 301 G 174 ASP D 177 ASP^? 8.43 MG MG D 301 G 404 TYR D 129 TYR^? 10.79 MG MG D 302 coo 60.48-101.16 45.95 60.56-101.20 43.85 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 58.10-108.15 40.62 59.57-106.86 41.51 95.74 41.01 -49.76 94.81 39.90 -51.24 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 86.45 31.36 -42.20 86.02 30.90 -39.46 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 24 3 # 24 G 144 HIS D 170 HIS^? 10.59 MG MG D 301 G 174 ASP D 177 ASP^? 8.43 MG MG D 301 G 404 TYR D 168 TYR^? 14.75 MG MG D 301 coo 60.48-101.16 45.95 60.56-101.20 43.85 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 58.10-108.15 40.62 59.57-106.86 41.51 95.74 41.01 -49.76 94.81 39.90 -51.24 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 95.79 27.80 -44.35 95.71 29.78 -46.32 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 25 3 # 25 G 144 HIS E 42 HIS^? 28.20 MG MG E 302 G 174 ASP F 160 ASP^? 31.59 MG MG E 302 G 404 TYR E 156 TYR^? 21.59 MG MG E 302 coo 60.48-101.16 45.95 60.56-101.20 43.85 62.33 71.93 -68.30 60.54 72.96 -68.64 coo 58.10-108.15 40.62 59.57-106.86 41.51 71.27 74.59 -71.77 73.23 74.02 -72.37 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 59.31 70.31 -60.22 61.84 71.39 -59.92 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 26 3 # 26 G 144 HIS E 147 HIS^? 9.22 MG MG E 301 G 174 ASP E 128 ASP^? -3.53 MG MG E 302s G 404 TYR E 168 TYR^? 14.43 MG MG E 301 coo 60.48-101.16 45.95 60.56-101.20 43.85 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 58.10-108.15 40.62 59.57-106.86 41.51 65.38 56.57 -48.58 66.15 54.57 -48.61 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 60.07 69.95 -50.54 61.99 69.37 -48.59 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 27 3 # 27 G 144 HIS E 147 HIS^? 9.22 MG MG E 301 G 174 ASP E 177 ASP^? 8.55 MG MG E 301 G 404 TYR E 168 TYR^? 14.43 MG MG E 301 coo 60.48-101.16 45.95 60.56-101.20 43.85 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 58.10-108.15 40.62 59.57-106.86 41.51 72.81 67.32 -45.03 71.14 67.96 -43.95 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 60.07 69.95 -50.54 61.99 69.37 -48.59 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 28 3 # 28 G 144 HIS E 170 HIS^? 10.33 MG MG E 301 G 174 ASP E 177 ASP^? 8.55 MG MG E 301 G 404 TYR E 129 TYR^? 10.89 MG MG E 302 coo 60.48-101.16 45.95 60.56-101.20 43.85 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 58.10-108.15 40.62 59.57-106.86 41.51 72.81 67.32 -45.03 71.14 67.96 -43.95 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 62.09 60.15 -52.83 61.47 59.53 -55.45 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 29 3 # 29 G 144 HIS E 170 HIS^? 10.33 MG MG E 301 G 174 ASP E 177 ASP^? 8.55 MG MG E 301 G 404 TYR E 168 TYR^? 14.43 MG MG E 301 coo 60.48-101.16 45.95 60.56-101.20 43.85 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 58.10-108.15 40.62 59.57-106.86 41.51 72.81 67.32 -45.03 71.14 67.96 -43.95 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 60.07 69.95 -50.54 61.99 69.37 -48.59 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 30 3 # 30 G 144 HIS F 42 HIS^? 28.34 MG MG F 301 G 174 ASP E 160 ASP^? 31.54 MG MG F 301 G 404 TYR F 156 TYR^? 21.68 MG MG F 302 coo 60.48-101.16 45.95 60.56-101.20 43.85 55.11 70.50 -71.64 56.29 72.22 -71.48 coo 58.10-108.15 40.62 59.57-106.86 41.51 45.81 70.00 -68.45 44.10 68.87 -67.77 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 58.80 69.55 -79.65 56.09 69.80 -80.15 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 31 3 # 31 G 144 HIS F 147 HIS^? 8.79 MG MG F 302 G 174 ASP F 128 ASP^? -3.41 MG MG F 301s G 404 TYR F 168 TYR^? 14.10 MG MG F 302 coo 60.48-101.16 45.95 60.56-101.20 43.85 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 58.10-108.15 40.62 59.57-106.86 41.51 57.76 53.73 -90.50 57.46 51.64 -90.28 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 58.29 68.32 -89.29 56.67 67.12 -91.21 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 32 3 # 32 G 144 HIS F 147 HIS^? 8.79 MG MG F 302 G 174 ASP F 177 ASP^? 8.15 MG MG F 302 G 404 TYR F 168 TYR^? 14.10 MG MG F 302 coo 60.48-101.16 45.95 60.56-101.20 43.85 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 58.10-108.15 40.62 59.57-106.86 41.51 47.18 61.22 -94.50 48.48 62.32 -95.73 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 58.29 68.32 -89.29 56.67 67.12 -91.21 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 33 3 # 33 G 144 HIS F 147 HIS^? 8.79 MG MG F 302 G 174 ASP F 187 ASP^? -3.27 MG MG F 302s G 404 TYR F 168 TYR^? 14.10 MG MG F 302 coo 60.48-101.16 45.95 60.56-101.20 43.85 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 58.10-108.15 40.62 59.57-106.86 41.51 53.93 58.87 -98.14 52.45 58.62 -96.61 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 58.29 68.32 -89.29 56.67 67.12 -91.21 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 34 3 # 34 G 144 HIS F 170 HIS^? 9.84 MG MG F 302 G 174 ASP F 177 ASP^? 8.15 MG MG F 302 G 404 TYR F 129 TYR^? 10.92 MG MG F 301 coo 60.48-101.16 45.95 60.56-101.20 43.85 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 58.10-108.15 40.62 59.57-106.86 41.51 47.18 61.22 -94.50 48.48 62.32 -95.73 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 59.69 58.61 -86.67 60.36 58.48 -83.96 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 35 3 # 35 G 144 HIS F 170 HIS^? 9.84 MG MG F 302 G 174 ASP F 177 ASP^? 8.15 MG MG F 302 G 404 TYR F 168 TYR^? 14.10 MG MG F 302 coo 60.48-101.16 45.95 60.56-101.20 43.85 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 58.10-108.15 40.62 59.57-106.86 41.51 47.18 61.22 -94.50 48.48 62.32 -95.73 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 58.29 68.32 -89.29 56.67 67.12 -91.21 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 36 3 # 36 G 144 HIS F 170 HIS^? 9.84 MG MG F 302 G 174 ASP F 187 ASP^? -3.27 MG MG F 302s G 404 TYR F 168 TYR^? 14.10 MG MG F 302 coo 60.48-101.16 45.95 60.56-101.20 43.85 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 58.10-108.15 40.62 59.57-106.86 41.51 53.93 58.87 -98.14 52.45 58.62 -96.61 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 58.29 68.32 -89.29 56.67 67.12 -91.21 1ti6_c09 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 36 hits 1ti6_c09 naa= 3 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 I 144 HIS A 42 HIS^? 28.45 MG MG A 301 I 174 ASP B 160 ASP^? 31.65 MG MG A 301 I 404 TYR A 156 TYR^? 21.80 MG MG A 301 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 34.62 18.32 19.57 34.29 16.25 19.41 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 28.01 24.83 16.38 27.44 26.81 15.80 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 37.50 16.28 27.75 35.30 17.94 28.08 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 I 144 HIS A 147 HIS^? 9.20 MG MG A 302 I 174 ASP A 128 ASP^? -3.32 MG MG A 301s I 404 TYR A 168 TYR^? 14.52 MG MG A 302 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 40.24 23.10 39.83 38.32 22.34 40.22 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 46.50 28.23 39.77 47.49 30.10 39.82 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 37.31 16.98 37.59 36.65 18.86 39.55 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 I 144 HIS A 147 HIS^? 9.20 MG MG A 302 I 174 ASP A 177 ASP^? 8.44 MG MG A 302 I 404 TYR A 168 TYR^? 14.52 MG MG A 302 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 40.24 23.10 39.83 38.32 22.34 40.22 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 33.02 29.04 43.18 33.79 27.88 44.78 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 37.31 16.98 37.59 36.65 18.86 39.55 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 I 144 HIS A 147 HIS^? 9.20 MG MG A 302 I 174 ASP A 187 ASP^? -3.29 MG MG A 302s I 404 TYR A 168 TYR^? 14.52 MG MG A 302 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 40.24 23.10 39.83 38.32 22.34 40.22 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 39.43 26.57 46.78 39.37 27.83 45.03 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 37.31 16.98 37.59 36.65 18.86 39.55 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 5 3 # 5 I 144 HIS A 170 HIS^? 10.56 MG MG A 302 I 174 ASP A 187 ASP^? -3.29 MG MG A 302s I 404 TYR A 168 TYR^? 14.52 MG MG A 302 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 34.91 23.57 39.32 34.35 24.95 40.81 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 39.43 26.57 46.78 39.37 27.83 45.03 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 37.31 16.98 37.59 36.65 18.86 39.55 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 6 3 # 6 I 144 HIS B 42 HIS^? 28.37 MG MG B 302 I 174 ASP A 160 ASP^? 31.61 MG MG B 302 I 404 TYR B 156 TYR^? 21.63 MG MG B 302 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 39.34 12.99 16.30 37.26 13.24 16.40 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 44.21 5.00 19.54 46.02 3.84 19.76 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 38.56 16.71 8.27 39.91 14.31 7.86 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 7 3 # 7 I 144 HIS B 147 HIS^? 9.27 MG MG B 301 I 174 ASP B 128 ASP^? -3.57 MG MG B 302s I 404 TYR B 168 TYR^? 14.66 MG MG B 301 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 46.73 18.97 -3.05 45.63 17.32 -3.73 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 52.92 24.09 -2.19 54.73 25.14 -1.90 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 40.03 17.20 -1.34 41.92 16.43 -3.19 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 8 3 # 8 I 144 HIS B 147 HIS^? 9.27 MG MG B 301 I 174 ASP B 177 ASP^? 9.03 MG MG B 301 I 404 TYR B 168 TYR^? 14.66 MG MG B 301 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 46.73 18.97 -3.05 45.63 17.32 -3.73 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 51.97 11.04 -6.64 50.39 11.62 -7.94 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 40.03 17.20 -1.34 41.92 16.43 -3.19 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 9 3 # 9 I 144 HIS B 147 HIS^? 9.27 MG MG B 301 I 174 ASP B 187 ASP^? -3.44 MG MG B 301s I 404 TYR B 168 TYR^? 14.66 MG MG B 301 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 46.73 18.97 -3.05 45.63 17.32 -3.73 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 50.64 18.14 -9.69 51.74 17.63 -7.86 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 40.03 17.20 -1.34 41.92 16.43 -3.19 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 10 3 # 10 I 144 HIS B 170 HIS^? 10.51 MG MG B 301 I 174 ASP B 177 ASP^? 9.03 MG MG B 301 I 404 TYR B 129 TYR^? 10.63 MG MG B 302 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 46.22 13.75 -2.72 47.53 13.11 -4.24 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 51.97 11.04 -6.64 50.39 11.62 -7.94 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 47.85 23.00 1.51 47.62 23.50 4.24 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 11 3 # 11 I 144 HIS B 170 HIS^? 10.51 MG MG B 301 I 174 ASP B 177 ASP^? 9.03 MG MG B 301 I 404 TYR B 168 TYR^? 14.66 MG MG B 301 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 46.22 13.75 -2.72 47.53 13.11 -4.24 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 51.97 11.04 -6.64 50.39 11.62 -7.94 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 40.03 17.20 -1.34 41.92 16.43 -3.19 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 12 3 # 12 I 144 HIS B 170 HIS^? 10.51 MG MG B 301 I 174 ASP B 187 ASP^? -3.44 MG MG B 301s I 404 TYR B 168 TYR^? 14.66 MG MG B 301 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 46.22 13.75 -2.72 47.53 13.11 -4.24 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 50.64 18.14 -9.69 51.74 17.63 -7.86 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 40.03 17.20 -1.34 41.92 16.43 -3.19 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 13 3 # 13 I 144 HIS C 42 HIS^? 28.09 MG MG C 302 I 174 ASP D 160 ASP^? 31.45 MG MG C 302 I 404 TYR C 156 TYR^? 21.58 MG MG C 302 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 95.93 22.96 -23.11 97.92 23.62 -23.02 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 94.15 13.98 -26.57 92.71 12.42 -26.99 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 95.64 26.50 -15.14 95.25 23.76 -14.77 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 14 3 # 14 I 144 HIS C 147 HIS^? 9.44 MG MG C 301 I 174 ASP C 128 ASP^? -3.22 MG MG C 302s I 404 TYR C 168 TYR^? 14.82 MG MG C 301 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 87.61 25.71 -3.59 89.22 24.50 -2.99 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 80.05 28.39 -4.25 77.97 28.60 -4.21 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 94.44 26.43 -5.44 92.97 25.09 -3.55 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 15 3 # 15 I 144 HIS C 147 HIS^? 9.44 MG MG C 301 I 174 ASP C 177 ASP^? 8.84 MG MG C 301 I 404 TYR C 168 TYR^? 14.82 MG MG C 301 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 87.61 25.71 -3.59 89.22 24.50 -2.99 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 85.60 16.42 -0.31 86.51 17.71 1.09 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 94.44 26.43 -5.44 92.97 25.09 -3.55 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 16 3 # 16 I 144 HIS C 147 HIS^? 9.44 MG MG C 301 I 174 ASP C 187 ASP^? -3.72 MG MG C 301s I 404 TYR C 168 TYR^? 14.82 MG MG C 301 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 87.61 25.71 -3.59 89.22 24.50 -2.99 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 84.01 23.73 3.39 83.47 22.54 1.59 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 94.44 26.43 -5.44 92.97 25.09 -3.55 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 17 3 # 17 I 144 HIS C 170 HIS^? 10.68 MG MG C 301 I 174 ASP C 177 ASP^? 8.84 MG MG C 301 I 404 TYR C 129 TYR^? 10.65 MG MG C 302 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 89.96 21.05 -3.85 88.74 19.88 -2.61 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 85.60 16.42 -0.31 86.51 17.71 1.09 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 84.95 29.43 -7.96 85.04 30.16 -10.69 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 18 3 # 18 I 144 HIS C 170 HIS^? 10.68 MG MG C 301 I 174 ASP C 177 ASP^? 8.84 MG MG C 301 I 404 TYR C 168 TYR^? 14.82 MG MG C 301 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 89.96 21.05 -3.85 88.74 19.88 -2.61 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 85.60 16.42 -0.31 86.51 17.71 1.09 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 94.44 26.43 -5.44 92.97 25.09 -3.55 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 19 3 # 19 I 144 HIS C 170 HIS^? 10.68 MG MG C 301 I 174 ASP C 187 ASP^? -3.72 MG MG C 301s I 404 TYR C 168 TYR^? 14.82 MG MG C 301 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 89.96 21.05 -3.85 88.74 19.88 -2.61 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 84.01 23.73 3.39 83.47 22.54 1.59 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 94.44 26.43 -5.44 92.97 25.09 -3.55 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 20 3 # 20 I 144 HIS D 42 HIS^? 28.21 MG MG D 302 I 174 ASP C 160 ASP^? 31.63 MG MG D 302 I 404 TYR D 156 TYR^? 21.34 MG MG D 302 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 98.45 29.90 -26.44 99.32 28.02 -26.13 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 102.50 38.00 -23.28 102.43 39.97 -22.46 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 96.25 27.10 -34.64 97.58 29.48 -35.03 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 21 3 # 21 I 144 HIS D 147 HIS^? 9.43 MG MG D 301 I 174 ASP D 128 ASP^? -3.70 MG MG D 302s I 404 TYR D 168 TYR^? 14.75 MG MG D 301 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 90.95 32.51 -46.42 92.98 32.42 -46.93 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 83.33 35.45 -46.13 81.57 36.63 -46.10 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 95.79 27.80 -44.35 95.71 29.78 -46.32 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 22 3 # 22 I 144 HIS D 147 HIS^? 9.43 MG MG D 301 I 174 ASP D 177 ASP^? 8.43 MG MG D 301 I 404 TYR D 168 TYR^? 14.75 MG MG D 301 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 90.95 32.51 -46.42 92.98 32.42 -46.93 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 95.74 41.01 -49.76 94.81 39.90 -51.24 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 95.79 27.80 -44.35 95.71 29.78 -46.32 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 23 3 # 23 I 144 HIS D 170 HIS^? 10.59 MG MG D 301 I 174 ASP D 177 ASP^? 8.43 MG MG D 301 I 404 TYR D 129 TYR^? 10.79 MG MG D 302 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 95.57 34.81 -46.05 95.59 36.24 -47.59 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 95.74 41.01 -49.76 94.81 39.90 -51.24 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 86.45 31.36 -42.20 86.02 30.90 -39.46 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 24 3 # 24 I 144 HIS D 170 HIS^? 10.59 MG MG D 301 I 174 ASP D 177 ASP^? 8.43 MG MG D 301 I 404 TYR D 168 TYR^? 14.75 MG MG D 301 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 95.57 34.81 -46.05 95.59 36.24 -47.59 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 95.74 41.01 -49.76 94.81 39.90 -51.24 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 95.79 27.80 -44.35 95.71 29.78 -46.32 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 25 3 # 25 I 144 HIS E 42 HIS^? 28.20 MG MG E 302 I 174 ASP F 160 ASP^? 31.59 MG MG E 302 I 404 TYR E 156 TYR^? 21.59 MG MG E 302 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 62.33 71.93 -68.30 60.54 72.96 -68.64 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 71.27 74.59 -71.77 73.23 74.02 -72.37 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 59.31 70.31 -60.22 61.84 71.39 -59.92 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 26 3 # 26 I 144 HIS E 147 HIS^? 9.22 MG MG E 301 I 174 ASP E 128 ASP^? -3.53 MG MG E 302s I 404 TYR E 168 TYR^? 14.43 MG MG E 301 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 63.87 64.43 -48.39 64.18 66.45 -47.92 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 65.38 56.57 -48.58 66.15 54.57 -48.61 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 60.07 69.95 -50.54 61.99 69.37 -48.59 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 27 3 # 27 I 144 HIS E 147 HIS^? 9.22 MG MG E 301 I 174 ASP E 177 ASP^? 8.55 MG MG E 301 I 404 TYR E 168 TYR^? 14.43 MG MG E 301 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 63.87 64.43 -48.39 64.18 66.45 -47.92 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 72.81 67.32 -45.03 71.14 67.96 -43.95 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 60.07 69.95 -50.54 61.99 69.37 -48.59 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 28 3 # 28 I 144 HIS E 170 HIS^? 10.33 MG MG E 301 I 174 ASP E 177 ASP^? 8.55 MG MG E 301 I 404 TYR E 129 TYR^? 10.89 MG MG E 302 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 66.96 68.76 -48.87 68.36 68.54 -47.33 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 72.81 67.32 -45.03 71.14 67.96 -43.95 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 62.09 60.15 -52.83 61.47 59.53 -55.45 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 29 3 # 29 I 144 HIS E 170 HIS^? 10.33 MG MG E 301 I 174 ASP E 177 ASP^? 8.55 MG MG E 301 I 404 TYR E 168 TYR^? 14.43 MG MG E 301 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 66.96 68.76 -48.87 68.36 68.54 -47.33 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 72.81 67.32 -45.03 71.14 67.96 -43.95 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 60.07 69.95 -50.54 61.99 69.37 -48.59 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 30 3 # 30 I 144 HIS F 42 HIS^? 28.34 MG MG F 301 I 174 ASP E 160 ASP^? 31.54 MG MG F 301 I 404 TYR F 156 TYR^? 21.68 MG MG F 302 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 55.11 70.50 -71.64 56.29 72.22 -71.48 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 45.81 70.00 -68.45 44.10 68.87 -67.77 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 58.80 69.55 -79.65 56.09 69.80 -80.15 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 31 3 # 31 I 144 HIS F 147 HIS^? 8.79 MG MG F 302 I 174 ASP F 128 ASP^? -3.41 MG MG F 301s I 404 TYR F 168 TYR^? 14.10 MG MG F 302 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 56.63 61.66 -91.16 55.69 63.43 -91.80 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 57.76 53.73 -90.50 57.46 51.64 -90.28 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 58.29 68.32 -89.29 56.67 67.12 -91.21 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 32 3 # 32 I 144 HIS F 147 HIS^? 8.79 MG MG F 302 I 174 ASP F 177 ASP^? 8.15 MG MG F 302 I 404 TYR F 168 TYR^? 14.10 MG MG F 302 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 56.63 61.66 -91.16 55.69 63.43 -91.80 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 47.18 61.22 -94.50 48.48 62.32 -95.73 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 58.29 68.32 -89.29 56.67 67.12 -91.21 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 33 3 # 33 I 144 HIS F 147 HIS^? 8.79 MG MG F 302 I 174 ASP F 187 ASP^? -3.27 MG MG F 302s I 404 TYR F 168 TYR^? 14.10 MG MG F 302 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 56.63 61.66 -91.16 55.69 63.43 -91.80 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 53.93 58.87 -98.14 52.45 58.62 -96.61 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 58.29 68.32 -89.29 56.67 67.12 -91.21 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 34 3 # 34 I 144 HIS F 170 HIS^? 9.84 MG MG F 302 I 174 ASP F 177 ASP^? 8.15 MG MG F 302 I 404 TYR F 129 TYR^? 10.92 MG MG F 301 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 52.25 64.82 -90.91 50.95 63.88 -92.26 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 47.18 61.22 -94.50 48.48 62.32 -95.73 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 59.69 58.61 -86.67 60.36 58.48 -83.96 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 35 3 # 35 I 144 HIS F 170 HIS^? 9.84 MG MG F 302 I 174 ASP F 177 ASP^? 8.15 MG MG F 302 I 404 TYR F 168 TYR^? 14.10 MG MG F 302 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 52.25 64.82 -90.91 50.95 63.88 -92.26 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 47.18 61.22 -94.50 48.48 62.32 -95.73 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 58.29 68.32 -89.29 56.67 67.12 -91.21 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 36 3 # 36 I 144 HIS F 170 HIS^? 9.84 MG MG F 302 I 174 ASP F 187 ASP^? -3.27 MG MG F 302s I 404 TYR F 168 TYR^? 14.10 MG MG F 302 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 52.25 64.82 -90.91 50.95 63.88 -92.26 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 53.93 58.87 -98.14 52.45 58.62 -96.61 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 58.29 68.32 -89.29 56.67 67.12 -91.21 1ti6_c10 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 36 hits 1ti6_c10 naa= 3 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 K 144 HIS A 42 HIS^? 28.45 MG MG A 301 K 174 ASP B 160 ASP^? 31.65 MG MG A 301 K 404 TYR A 156 TYR^? 21.80 MG MG A 301 coo 100.18 26.45 -1.32 99.24 26.12 0.53 34.62 18.32 19.57 34.29 16.25 19.41 coo 102.36 30.86 6.31 102.45 29.08 5.12 28.01 24.83 16.38 27.44 26.81 15.80 coo 99.93 17.48 -0.85 99.14 19.86 0.39 37.50 16.28 27.75 35.30 17.94 28.08 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 K 144 HIS A 147 HIS^? 9.20 MG MG A 302 K 174 ASP A 128 ASP^? -3.32 MG MG A 301s K 404 TYR A 168 TYR^? 14.52 MG MG A 302 coo 100.18 26.45 -1.32 99.24 26.12 0.53 40.24 23.10 39.83 38.32 22.34 40.22 coo 102.36 30.86 6.31 102.45 29.08 5.12 46.50 28.23 39.77 47.49 30.10 39.82 coo 99.93 17.48 -0.85 99.14 19.86 0.39 37.31 16.98 37.59 36.65 18.86 39.55 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 K 144 HIS A 147 HIS^? 9.20 MG MG A 302 K 174 ASP A 177 ASP^? 8.44 MG MG A 302 K 404 TYR A 168 TYR^? 14.52 MG MG A 302 coo 100.18 26.45 -1.32 99.24 26.12 0.53 40.24 23.10 39.83 38.32 22.34 40.22 coo 102.36 30.86 6.31 102.45 29.08 5.12 33.02 29.04 43.18 33.79 27.88 44.78 coo 99.93 17.48 -0.85 99.14 19.86 0.39 37.31 16.98 37.59 36.65 18.86 39.55 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 K 144 HIS A 147 HIS^? 9.20 MG MG A 302 K 174 ASP A 187 ASP^? -3.29 MG MG A 302s K 404 TYR A 168 TYR^? 14.52 MG MG A 302 coo 100.18 26.45 -1.32 99.24 26.12 0.53 40.24 23.10 39.83 38.32 22.34 40.22 coo 102.36 30.86 6.31 102.45 29.08 5.12 39.43 26.57 46.78 39.37 27.83 45.03 coo 99.93 17.48 -0.85 99.14 19.86 0.39 37.31 16.98 37.59 36.65 18.86 39.55 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 5 3 # 5 K 144 HIS A 170 HIS^? 10.56 MG MG A 302 K 174 ASP A 187 ASP^? -3.29 MG MG A 302s K 404 TYR A 168 TYR^? 14.52 MG MG A 302 coo 100.18 26.45 -1.32 99.24 26.12 0.53 34.91 23.57 39.32 34.35 24.95 40.81 coo 102.36 30.86 6.31 102.45 29.08 5.12 39.43 26.57 46.78 39.37 27.83 45.03 coo 99.93 17.48 -0.85 99.14 19.86 0.39 37.31 16.98 37.59 36.65 18.86 39.55 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 6 3 # 6 K 144 HIS B 42 HIS^? 28.37 MG MG B 302 K 174 ASP A 160 ASP^? 31.61 MG MG B 302 K 404 TYR B 156 TYR^? 21.63 MG MG B 302 coo 100.18 26.45 -1.32 99.24 26.12 0.53 39.34 12.99 16.30 37.26 13.24 16.40 coo 102.36 30.86 6.31 102.45 29.08 5.12 44.21 5.00 19.54 46.02 3.84 19.76 coo 99.93 17.48 -0.85 99.14 19.86 0.39 38.56 16.71 8.27 39.91 14.31 7.86 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 7 3 # 7 K 144 HIS B 147 HIS^? 9.27 MG MG B 301 K 174 ASP B 128 ASP^? -3.57 MG MG B 302s K 404 TYR B 168 TYR^? 14.66 MG MG B 301 coo 100.18 26.45 -1.32 99.24 26.12 0.53 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 102.36 30.86 6.31 102.45 29.08 5.12 52.92 24.09 -2.19 54.73 25.14 -1.90 coo 99.93 17.48 -0.85 99.14 19.86 0.39 40.03 17.20 -1.34 41.92 16.43 -3.19 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 8 3 # 8 K 144 HIS B 147 HIS^? 9.27 MG MG B 301 K 174 ASP B 177 ASP^? 9.03 MG MG B 301 K 404 TYR B 168 TYR^? 14.66 MG MG B 301 coo 100.18 26.45 -1.32 99.24 26.12 0.53 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 102.36 30.86 6.31 102.45 29.08 5.12 51.97 11.04 -6.64 50.39 11.62 -7.94 coo 99.93 17.48 -0.85 99.14 19.86 0.39 40.03 17.20 -1.34 41.92 16.43 -3.19 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 9 3 # 9 K 144 HIS B 147 HIS^? 9.27 MG MG B 301 K 174 ASP B 187 ASP^? -3.44 MG MG B 301s K 404 TYR B 168 TYR^? 14.66 MG MG B 301 coo 100.18 26.45 -1.32 99.24 26.12 0.53 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 102.36 30.86 6.31 102.45 29.08 5.12 50.64 18.14 -9.69 51.74 17.63 -7.86 coo 99.93 17.48 -0.85 99.14 19.86 0.39 40.03 17.20 -1.34 41.92 16.43 -3.19 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 10 3 # 10 K 144 HIS B 170 HIS^? 10.51 MG MG B 301 K 174 ASP B 177 ASP^? 9.03 MG MG B 301 K 404 TYR B 129 TYR^? 10.63 MG MG B 302 coo 100.18 26.45 -1.32 99.24 26.12 0.53 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 102.36 30.86 6.31 102.45 29.08 5.12 51.97 11.04 -6.64 50.39 11.62 -7.94 coo 99.93 17.48 -0.85 99.14 19.86 0.39 47.85 23.00 1.51 47.62 23.50 4.24 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 11 3 # 11 K 144 HIS B 170 HIS^? 10.51 MG MG B 301 K 174 ASP B 177 ASP^? 9.03 MG MG B 301 K 404 TYR B 168 TYR^? 14.66 MG MG B 301 coo 100.18 26.45 -1.32 99.24 26.12 0.53 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 102.36 30.86 6.31 102.45 29.08 5.12 51.97 11.04 -6.64 50.39 11.62 -7.94 coo 99.93 17.48 -0.85 99.14 19.86 0.39 40.03 17.20 -1.34 41.92 16.43 -3.19 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 12 3 # 12 K 144 HIS B 170 HIS^? 10.51 MG MG B 301 K 174 ASP B 187 ASP^? -3.44 MG MG B 301s K 404 TYR B 168 TYR^? 14.66 MG MG B 301 coo 100.18 26.45 -1.32 99.24 26.12 0.53 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 102.36 30.86 6.31 102.45 29.08 5.12 50.64 18.14 -9.69 51.74 17.63 -7.86 coo 99.93 17.48 -0.85 99.14 19.86 0.39 40.03 17.20 -1.34 41.92 16.43 -3.19 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 13 3 # 13 K 144 HIS C 42 HIS^? 28.09 MG MG C 302 K 174 ASP D 160 ASP^? 31.45 MG MG C 302 K 404 TYR C 156 TYR^? 21.58 MG MG C 302 coo 100.18 26.45 -1.32 99.24 26.12 0.53 95.93 22.96 -23.11 97.92 23.62 -23.02 coo 102.36 30.86 6.31 102.45 29.08 5.12 94.15 13.98 -26.57 92.71 12.42 -26.99 coo 99.93 17.48 -0.85 99.14 19.86 0.39 95.64 26.50 -15.14 95.25 23.76 -14.77 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 14 3 # 14 K 144 HIS C 147 HIS^? 9.44 MG MG C 301 K 174 ASP C 128 ASP^? -3.22 MG MG C 302s K 404 TYR C 168 TYR^? 14.82 MG MG C 301 coo 100.18 26.45 -1.32 99.24 26.12 0.53 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 102.36 30.86 6.31 102.45 29.08 5.12 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 99.93 17.48 -0.85 99.14 19.86 0.39 94.44 26.43 -5.44 92.97 25.09 -3.55 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 15 3 # 15 K 144 HIS C 147 HIS^? 9.44 MG MG C 301 K 174 ASP C 177 ASP^? 8.84 MG MG C 301 K 404 TYR C 168 TYR^? 14.82 MG MG C 301 coo 100.18 26.45 -1.32 99.24 26.12 0.53 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 102.36 30.86 6.31 102.45 29.08 5.12 85.60 16.42 -0.31 86.51 17.71 1.09 coo 99.93 17.48 -0.85 99.14 19.86 0.39 94.44 26.43 -5.44 92.97 25.09 -3.55 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 16 3 # 16 K 144 HIS C 147 HIS^? 9.44 MG MG C 301 K 174 ASP C 187 ASP^? -3.72 MG MG C 301s K 404 TYR C 168 TYR^? 14.82 MG MG C 301 coo 100.18 26.45 -1.32 99.24 26.12 0.53 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 102.36 30.86 6.31 102.45 29.08 5.12 84.01 23.73 3.39 83.47 22.54 1.59 coo 99.93 17.48 -0.85 99.14 19.86 0.39 94.44 26.43 -5.44 92.97 25.09 -3.55 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 17 3 # 17 K 144 HIS C 170 HIS^? 10.68 MG MG C 301 K 174 ASP C 177 ASP^? 8.84 MG MG C 301 K 404 TYR C 129 TYR^? 10.65 MG MG C 302 coo 100.18 26.45 -1.32 99.24 26.12 0.53 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 102.36 30.86 6.31 102.45 29.08 5.12 85.60 16.42 -0.31 86.51 17.71 1.09 coo 99.93 17.48 -0.85 99.14 19.86 0.39 84.95 29.43 -7.96 85.04 30.16 -10.69 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 18 3 # 18 K 144 HIS C 170 HIS^? 10.68 MG MG C 301 K 174 ASP C 177 ASP^? 8.84 MG MG C 301 K 404 TYR C 168 TYR^? 14.82 MG MG C 301 coo 100.18 26.45 -1.32 99.24 26.12 0.53 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 102.36 30.86 6.31 102.45 29.08 5.12 85.60 16.42 -0.31 86.51 17.71 1.09 coo 99.93 17.48 -0.85 99.14 19.86 0.39 94.44 26.43 -5.44 92.97 25.09 -3.55 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 19 3 # 19 K 144 HIS C 170 HIS^? 10.68 MG MG C 301 K 174 ASP C 187 ASP^? -3.72 MG MG C 301s K 404 TYR C 168 TYR^? 14.82 MG MG C 301 coo 100.18 26.45 -1.32 99.24 26.12 0.53 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 102.36 30.86 6.31 102.45 29.08 5.12 84.01 23.73 3.39 83.47 22.54 1.59 coo 99.93 17.48 -0.85 99.14 19.86 0.39 94.44 26.43 -5.44 92.97 25.09 -3.55 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 20 3 # 20 K 144 HIS D 42 HIS^? 28.21 MG MG D 302 K 174 ASP C 160 ASP^? 31.63 MG MG D 302 K 404 TYR D 156 TYR^? 21.34 MG MG D 302 coo 100.18 26.45 -1.32 99.24 26.12 0.53 98.45 29.90 -26.44 99.32 28.02 -26.13 coo 102.36 30.86 6.31 102.45 29.08 5.12 102.50 38.00 -23.28 102.43 39.97 -22.46 coo 99.93 17.48 -0.85 99.14 19.86 0.39 96.25 27.10 -34.64 97.58 29.48 -35.03 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 21 3 # 21 K 144 HIS D 147 HIS^? 9.43 MG MG D 301 K 174 ASP D 128 ASP^? -3.70 MG MG D 302s K 404 TYR D 168 TYR^? 14.75 MG MG D 301 coo 100.18 26.45 -1.32 99.24 26.12 0.53 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 102.36 30.86 6.31 102.45 29.08 5.12 83.33 35.45 -46.13 81.57 36.63 -46.10 coo 99.93 17.48 -0.85 99.14 19.86 0.39 95.79 27.80 -44.35 95.71 29.78 -46.32 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 22 3 # 22 K 144 HIS D 147 HIS^? 9.43 MG MG D 301 K 174 ASP D 177 ASP^? 8.43 MG MG D 301 K 404 TYR D 168 TYR^? 14.75 MG MG D 301 coo 100.18 26.45 -1.32 99.24 26.12 0.53 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 102.36 30.86 6.31 102.45 29.08 5.12 95.74 41.01 -49.76 94.81 39.90 -51.24 coo 99.93 17.48 -0.85 99.14 19.86 0.39 95.79 27.80 -44.35 95.71 29.78 -46.32 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 23 3 # 23 K 144 HIS D 170 HIS^? 10.59 MG MG D 301 K 174 ASP D 177 ASP^? 8.43 MG MG D 301 K 404 TYR D 129 TYR^? 10.79 MG MG D 302 coo 100.18 26.45 -1.32 99.24 26.12 0.53 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 102.36 30.86 6.31 102.45 29.08 5.12 95.74 41.01 -49.76 94.81 39.90 -51.24 coo 99.93 17.48 -0.85 99.14 19.86 0.39 86.45 31.36 -42.20 86.02 30.90 -39.46 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 24 3 # 24 K 144 HIS D 170 HIS^? 10.59 MG MG D 301 K 174 ASP D 177 ASP^? 8.43 MG MG D 301 K 404 TYR D 168 TYR^? 14.75 MG MG D 301 coo 100.18 26.45 -1.32 99.24 26.12 0.53 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 102.36 30.86 6.31 102.45 29.08 5.12 95.74 41.01 -49.76 94.81 39.90 -51.24 coo 99.93 17.48 -0.85 99.14 19.86 0.39 95.79 27.80 -44.35 95.71 29.78 -46.32 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 25 3 # 25 K 144 HIS E 42 HIS^? 28.20 MG MG E 302 K 174 ASP F 160 ASP^? 31.59 MG MG E 302 K 404 TYR E 156 TYR^? 21.59 MG MG E 302 coo 100.18 26.45 -1.32 99.24 26.12 0.53 62.33 71.93 -68.30 60.54 72.96 -68.64 coo 102.36 30.86 6.31 102.45 29.08 5.12 71.27 74.59 -71.77 73.23 74.02 -72.37 coo 99.93 17.48 -0.85 99.14 19.86 0.39 59.31 70.31 -60.22 61.84 71.39 -59.92 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 26 3 # 26 K 144 HIS E 147 HIS^? 9.22 MG MG E 301 K 174 ASP E 128 ASP^? -3.53 MG MG E 302s K 404 TYR E 168 TYR^? 14.43 MG MG E 301 coo 100.18 26.45 -1.32 99.24 26.12 0.53 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 102.36 30.86 6.31 102.45 29.08 5.12 65.38 56.57 -48.58 66.15 54.57 -48.61 coo 99.93 17.48 -0.85 99.14 19.86 0.39 60.07 69.95 -50.54 61.99 69.37 -48.59 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 27 3 # 27 K 144 HIS E 147 HIS^? 9.22 MG MG E 301 K 174 ASP E 177 ASP^? 8.55 MG MG E 301 K 404 TYR E 168 TYR^? 14.43 MG MG E 301 coo 100.18 26.45 -1.32 99.24 26.12 0.53 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 102.36 30.86 6.31 102.45 29.08 5.12 72.81 67.32 -45.03 71.14 67.96 -43.95 coo 99.93 17.48 -0.85 99.14 19.86 0.39 60.07 69.95 -50.54 61.99 69.37 -48.59 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 28 3 # 28 K 144 HIS E 170 HIS^? 10.33 MG MG E 301 K 174 ASP E 177 ASP^? 8.55 MG MG E 301 K 404 TYR E 129 TYR^? 10.89 MG MG E 302 coo 100.18 26.45 -1.32 99.24 26.12 0.53 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 102.36 30.86 6.31 102.45 29.08 5.12 72.81 67.32 -45.03 71.14 67.96 -43.95 coo 99.93 17.48 -0.85 99.14 19.86 0.39 62.09 60.15 -52.83 61.47 59.53 -55.45 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 29 3 # 29 K 144 HIS E 170 HIS^? 10.33 MG MG E 301 K 174 ASP E 177 ASP^? 8.55 MG MG E 301 K 404 TYR E 168 TYR^? 14.43 MG MG E 301 coo 100.18 26.45 -1.32 99.24 26.12 0.53 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 102.36 30.86 6.31 102.45 29.08 5.12 72.81 67.32 -45.03 71.14 67.96 -43.95 coo 99.93 17.48 -0.85 99.14 19.86 0.39 60.07 69.95 -50.54 61.99 69.37 -48.59 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 30 3 # 30 K 144 HIS F 42 HIS^? 28.34 MG MG F 301 K 174 ASP E 160 ASP^? 31.54 MG MG F 301 K 404 TYR F 156 TYR^? 21.68 MG MG F 302 coo 100.18 26.45 -1.32 99.24 26.12 0.53 55.11 70.50 -71.64 56.29 72.22 -71.48 coo 102.36 30.86 6.31 102.45 29.08 5.12 45.81 70.00 -68.45 44.10 68.87 -67.77 coo 99.93 17.48 -0.85 99.14 19.86 0.39 58.80 69.55 -79.65 56.09 69.80 -80.15 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 31 3 # 31 K 144 HIS F 147 HIS^? 8.79 MG MG F 302 K 174 ASP F 128 ASP^? -3.41 MG MG F 301s K 404 TYR F 168 TYR^? 14.10 MG MG F 302 coo 100.18 26.45 -1.32 99.24 26.12 0.53 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 102.36 30.86 6.31 102.45 29.08 5.12 57.76 53.73 -90.50 57.46 51.64 -90.28 coo 99.93 17.48 -0.85 99.14 19.86 0.39 58.29 68.32 -89.29 56.67 67.12 -91.21 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 32 3 # 32 K 144 HIS F 147 HIS^? 8.79 MG MG F 302 K 174 ASP F 177 ASP^? 8.15 MG MG F 302 K 404 TYR F 168 TYR^? 14.10 MG MG F 302 coo 100.18 26.45 -1.32 99.24 26.12 0.53 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 102.36 30.86 6.31 102.45 29.08 5.12 47.18 61.22 -94.50 48.48 62.32 -95.73 coo 99.93 17.48 -0.85 99.14 19.86 0.39 58.29 68.32 -89.29 56.67 67.12 -91.21 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 33 3 # 33 K 144 HIS F 147 HIS^? 8.79 MG MG F 302 K 174 ASP F 187 ASP^? -3.27 MG MG F 302s K 404 TYR F 168 TYR^? 14.10 MG MG F 302 coo 100.18 26.45 -1.32 99.24 26.12 0.53 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 102.36 30.86 6.31 102.45 29.08 5.12 53.93 58.87 -98.14 52.45 58.62 -96.61 coo 99.93 17.48 -0.85 99.14 19.86 0.39 58.29 68.32 -89.29 56.67 67.12 -91.21 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 34 3 # 34 K 144 HIS F 170 HIS^? 9.84 MG MG F 302 K 174 ASP F 177 ASP^? 8.15 MG MG F 302 K 404 TYR F 129 TYR^? 10.92 MG MG F 301 coo 100.18 26.45 -1.32 99.24 26.12 0.53 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 102.36 30.86 6.31 102.45 29.08 5.12 47.18 61.22 -94.50 48.48 62.32 -95.73 coo 99.93 17.48 -0.85 99.14 19.86 0.39 59.69 58.61 -86.67 60.36 58.48 -83.96 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 35 3 # 35 K 144 HIS F 170 HIS^? 9.84 MG MG F 302 K 174 ASP F 177 ASP^? 8.15 MG MG F 302 K 404 TYR F 168 TYR^? 14.10 MG MG F 302 coo 100.18 26.45 -1.32 99.24 26.12 0.53 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 102.36 30.86 6.31 102.45 29.08 5.12 47.18 61.22 -94.50 48.48 62.32 -95.73 coo 99.93 17.48 -0.85 99.14 19.86 0.39 58.29 68.32 -89.29 56.67 67.12 -91.21 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 36 3 # 36 K 144 HIS F 170 HIS^? 9.84 MG MG F 302 K 174 ASP F 187 ASP^? -3.27 MG MG F 302s K 404 TYR F 168 TYR^? 14.10 MG MG F 302 coo 100.18 26.45 -1.32 99.24 26.12 0.53 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 102.36 30.86 6.31 102.45 29.08 5.12 53.93 58.87 -98.14 52.45 58.62 -96.61 coo 99.93 17.48 -0.85 99.14 19.86 0.39 58.29 68.32 -89.29 56.67 67.12 -91.21 1ti6_c11 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 36 hits 1ti6_c11 naa= 3 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 1 3 # 1 A 250 ALA A 181 ALA^? -5.18 MG MG A 302s A 251 GLY A 149 GLY^? 6.01 MG MG A 302 A 252 ASP A 148 ASP^? 2.72 MG MG A 301s coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 38.08 32.08 44.23 37.12 30.96 43.87 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 37.26 27.53 42.29 37.61 28.00 41.76 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 41.50 28.88 41.13 43.33 29.67 41.93 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 2 3 # 2 A 250 ALA A 181 ALA^? -5.18 MG MG A 302s A 251 GLY A 149 GLY^? 6.01 MG MG A 302 A 252 ASP A 177 ASP^? 8.44 MG MG A 302 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 38.08 32.08 44.23 37.12 30.96 43.87 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 37.26 27.53 42.29 37.61 28.00 41.76 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 33.02 29.04 43.18 33.79 27.88 44.78 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 3 3 # 3 A 250 ALA A 181 ALA^? -5.18 MG MG A 302s A 251 GLY A 149 GLY^? 6.01 MG MG A 302 A 252 ASP A 187 ASP^? -3.29 MG MG A 302s coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 38.08 32.08 44.23 37.12 30.96 43.87 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 37.26 27.53 42.29 37.61 28.00 41.76 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 39.43 26.57 46.78 39.37 27.83 45.03 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 4 3 # 4 A 250 ALA A 181 ALA^? -5.18 MG MG A 302s A 251 GLY A 183 GLY^? -4.64 MG MG A 301s A 252 ASP A 148 ASP^? 2.72 MG MG A 301s coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 38.08 32.08 44.23 37.12 30.96 43.87 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 42.94 34.42 44.60 42.51 33.67 44.58 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 41.50 28.88 41.13 43.33 29.67 41.93 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 5 3 # 5 A 250 ALA B 181 ALA^? -4.86 MG MG B 301s A 251 GLY B 149 GLY^? 5.93 MG MG B 301 A 252 ASP B 148 ASP^? 2.58 MG MG B 302s coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 55.54 15.65 -6.80 54.26 14.84 -6.58 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 50.72 15.48 -5.33 51.24 15.67 -4.78 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 52.73 19.23 -3.77 53.81 20.99 -4.31 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 6 3 # 6 A 250 ALA B 181 ALA^? -4.86 MG MG B 301s A 251 GLY B 149 GLY^? 5.93 MG MG B 301 A 252 ASP B 177 ASP^? 9.03 MG MG B 301 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 55.54 15.65 -6.80 54.26 14.84 -6.58 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 50.72 15.48 -5.33 51.24 15.67 -4.78 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 51.97 11.04 -6.64 50.39 11.62 -7.94 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 7 3 # 7 A 250 ALA B 181 ALA^? -4.86 MG MG B 301s A 251 GLY B 149 GLY^? 5.93 MG MG B 301 A 252 ASP B 187 ASP^? -3.44 MG MG B 301s coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 55.54 15.65 -6.80 54.26 14.84 -6.58 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 50.72 15.48 -5.33 51.24 15.67 -4.78 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 50.64 18.14 -9.69 51.74 17.63 -7.86 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 8 3 # 8 A 250 ALA B 181 ALA^? -4.86 MG MG B 301s A 251 GLY B 183 GLY^? -4.35 MG MG B 301s A 252 ASP B 148 ASP^? 2.58 MG MG B 302s coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 55.54 15.65 -6.80 54.26 14.84 -6.58 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 58.74 20.22 -6.73 58.00 19.87 -6.89 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 52.73 19.23 -3.77 53.81 20.99 -4.31 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 9 3 # 9 A 250 ALA C 181 ALA^? -4.94 MG MG C 301s A 251 GLY C 149 GLY^? 6.13 MG MG C 301 A 252 ASP C 148 ASP^? 2.75 MG MG C 302s coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 80.65 19.58 0.32 82.11 19.32 0.03 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 85.09 20.92 -1.20 84.51 20.95 -1.73 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 81.96 23.83 -2.68 80.24 25.11 -2.27 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 10 3 # 10 A 250 ALA C 181 ALA^? -4.94 MG MG C 301s A 251 GLY C 149 GLY^? 6.13 MG MG C 301 A 252 ASP C 177 ASP^? 8.84 MG MG C 301 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 80.65 19.58 0.32 82.11 19.32 0.03 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 85.09 20.92 -1.20 84.51 20.95 -1.73 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 85.60 16.42 -0.31 86.51 17.71 1.09 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 11 3 # 11 A 250 ALA C 181 ALA^? -4.94 MG MG C 301s A 251 GLY C 149 GLY^? 6.13 MG MG C 301 A 252 ASP C 187 ASP^? -3.72 MG MG C 301s coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 80.65 19.58 0.32 82.11 19.32 0.03 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 85.09 20.92 -1.20 84.51 20.95 -1.73 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 84.01 23.73 3.39 83.47 22.54 1.59 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 12 3 # 12 A 250 ALA C 181 ALA^? -4.94 MG MG C 301s A 251 GLY C 183 GLY^? -4.00 MG MG C 301s A 252 ASP C 148 ASP^? 2.75 MG MG C 302s coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 80.65 19.58 0.32 82.11 19.32 0.03 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 76.27 22.45 0.43 77.06 22.50 0.60 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 81.96 23.83 -2.68 80.24 25.11 -2.27 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 13 3 # 13 A 250 ALA D 181 ALA^? -4.93 MG MG D 301s A 251 GLY D 149 GLY^? 6.12 MG MG D 301 A 252 ASP D 148 ASP^? 2.35 MG MG D 302s coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 89.39 41.74 -50.56 90.67 41.02 -50.20 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 92.07 37.87 -48.88 91.62 38.12 -48.34 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 87.78 37.50 -47.56 85.79 37.49 -48.28 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 14 3 # 14 A 250 ALA D 181 ALA^? -4.93 MG MG D 301s A 251 GLY D 149 GLY^? 6.12 MG MG D 301 A 252 ASP D 177 ASP^? 8.43 MG MG D 301 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 89.39 41.74 -50.56 90.67 41.02 -50.20 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 92.07 37.87 -48.88 91.62 38.12 -48.34 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 95.74 41.01 -49.76 94.81 39.90 -51.24 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 15 3 # 15 A 250 ALA D 181 ALA^? -4.93 MG MG D 301s A 251 GLY D 149 GLY^? 6.12 MG MG D 301 A 252 ASP D 187 ASP^? -2.95 MG MG D 301s coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 89.39 41.74 -50.56 90.67 41.02 -50.20 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 92.07 37.87 -48.88 91.62 38.12 -48.34 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 90.40 36.34 -52.69 89.24 37.98 -51.99 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 16 3 # 16 A 250 ALA E 181 ALA^? -4.51 MG MG E 301s A 251 GLY E 149 GLY^? 5.75 MG MG E 301 A 252 ASP E 148 ASP^? 2.62 MG MG E 302s coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 72.69 61.53 -44.13 72.20 62.95 -44.39 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 69.31 64.70 -46.05 69.60 64.17 -46.61 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 68.29 60.44 -47.29 68.03 58.42 -46.50 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 17 3 # 17 A 250 ALA E 181 ALA^? -4.51 MG MG E 301s A 251 GLY E 149 GLY^? 5.75 MG MG E 301 A 252 ASP E 177 ASP^? 8.55 MG MG E 301 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 72.69 61.53 -44.13 72.20 62.95 -44.39 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 69.31 64.70 -46.05 69.60 64.17 -46.61 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 18 3 # 18 A 250 ALA E 181 ALA^? -4.51 MG MG E 301s A 251 GLY E 149 GLY^? 5.75 MG MG E 301 A 252 ASP E 187 ASP^? -2.71 MG MG E 301s coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 72.69 61.53 -44.13 72.20 62.95 -44.39 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 69.31 64.70 -46.05 69.60 64.17 -46.61 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 67.50 63.43 -41.69 68.97 62.26 -42.81 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 19 3 # 19 A 250 ALA E 181 ALA^? -4.51 MG MG E 301s A 251 GLY E 183 GLY^? -4.49 MG MG E 301s A 252 ASP E 148 ASP^? 2.62 MG MG E 302s coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 72.69 61.53 -44.13 72.20 62.95 -44.39 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 72.33 56.33 -43.87 71.83 56.99 -43.77 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 68.29 60.44 -47.29 68.03 58.42 -46.50 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 20 3 # 20 A 250 ALA F 181 ALA^? -4.41 MG MG F 302s A 251 GLY F 149 GLY^? 5.34 MG MG F 302 A 252 ASP F 148 ASP^? 2.72 MG MG F 301s coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 49.03 55.67 -94.95 49.00 57.19 -94.78 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 51.31 60.07 -93.46 51.26 59.51 -92.90 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 53.64 56.47 -91.98 54.61 54.68 -92.64 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 21 3 # 21 A 250 ALA F 181 ALA^? -4.41 MG MG F 302s A 251 GLY F 149 GLY^? 5.34 MG MG F 302 A 252 ASP F 177 ASP^? 8.15 MG MG F 302 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 49.03 55.67 -94.95 49.00 57.19 -94.78 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 51.31 60.07 -93.46 51.26 59.51 -92.90 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 47.18 61.22 -94.50 48.48 62.32 -95.73 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 22 3 # 22 A 250 ALA F 181 ALA^? -4.41 MG MG F 302s A 251 GLY F 149 GLY^? 5.34 MG MG F 302 A 252 ASP F 187 ASP^? -3.27 MG MG F 302s coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 49.03 55.67 -94.95 49.00 57.19 -94.78 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 51.31 60.07 -93.46 51.26 59.51 -92.90 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 53.93 58.87 -98.14 52.45 58.62 -96.61 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 23 3 # 23 A 250 ALA F 181 ALA^? -4.41 MG MG F 302s A 251 GLY F 183 GLY^? -4.39 MG MG F 301s A 252 ASP F 148 ASP^? 2.72 MG MG F 301s coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 49.03 55.67 -94.95 49.00 57.19 -94.78 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 51.40 50.96 -94.96 51.47 51.79 -95.11 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 53.64 56.47 -91.98 54.61 54.68 -92.64 1tz3_c02 source 1tz3 PUTATIVE SUGAR KINASE : 23 hits 1tz3_c02 naa= 3 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 1 3 # 1 B 250 ALA A 181 ALA^? -5.18 MG MG A 302s B 251 GLY A 149 GLY^? 6.01 MG MG A 302 B 252 ASP A 148 ASP^? 2.72 MG MG A 301s coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 38.08 32.08 44.23 37.12 30.96 43.87 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 37.26 27.53 42.29 37.61 28.00 41.76 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 41.50 28.88 41.13 43.33 29.67 41.93 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 2 3 # 2 B 250 ALA A 181 ALA^? -5.18 MG MG A 302s B 251 GLY A 149 GLY^? 6.01 MG MG A 302 B 252 ASP A 177 ASP^? 8.44 MG MG A 302 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 38.08 32.08 44.23 37.12 30.96 43.87 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 37.26 27.53 42.29 37.61 28.00 41.76 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 33.02 29.04 43.18 33.79 27.88 44.78 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 3 3 # 3 B 250 ALA A 181 ALA^? -5.18 MG MG A 302s B 251 GLY A 149 GLY^? 6.01 MG MG A 302 B 252 ASP A 187 ASP^? -3.29 MG MG A 302s coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 38.08 32.08 44.23 37.12 30.96 43.87 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 37.26 27.53 42.29 37.61 28.00 41.76 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 39.43 26.57 46.78 39.37 27.83 45.03 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 4 3 # 4 B 250 ALA A 181 ALA^? -5.18 MG MG A 302s B 251 GLY A 183 GLY^? -4.64 MG MG A 301s B 252 ASP A 148 ASP^? 2.72 MG MG A 301s coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 38.08 32.08 44.23 37.12 30.96 43.87 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 42.94 34.42 44.60 42.51 33.67 44.58 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 41.50 28.88 41.13 43.33 29.67 41.93 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 5 3 # 5 B 250 ALA B 181 ALA^? -4.86 MG MG B 301s B 251 GLY B 149 GLY^? 5.93 MG MG B 301 B 252 ASP B 148 ASP^? 2.58 MG MG B 302s coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 55.54 15.65 -6.80 54.26 14.84 -6.58 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 50.72 15.48 -5.33 51.24 15.67 -4.78 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 52.73 19.23 -3.77 53.81 20.99 -4.31 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 6 3 # 6 B 250 ALA B 181 ALA^? -4.86 MG MG B 301s B 251 GLY B 149 GLY^? 5.93 MG MG B 301 B 252 ASP B 177 ASP^? 9.03 MG MG B 301 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 55.54 15.65 -6.80 54.26 14.84 -6.58 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 50.72 15.48 -5.33 51.24 15.67 -4.78 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 51.97 11.04 -6.64 50.39 11.62 -7.94 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 7 3 # 7 B 250 ALA B 181 ALA^? -4.86 MG MG B 301s B 251 GLY B 149 GLY^? 5.93 MG MG B 301 B 252 ASP B 187 ASP^? -3.44 MG MG B 301s coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 55.54 15.65 -6.80 54.26 14.84 -6.58 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 50.72 15.48 -5.33 51.24 15.67 -4.78 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 50.64 18.14 -9.69 51.74 17.63 -7.86 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 8 3 # 8 B 250 ALA B 181 ALA^? -4.86 MG MG B 301s B 251 GLY B 183 GLY^? -4.35 MG MG B 301s B 252 ASP B 148 ASP^? 2.58 MG MG B 302s coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 55.54 15.65 -6.80 54.26 14.84 -6.58 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 58.74 20.22 -6.73 58.00 19.87 -6.89 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 52.73 19.23 -3.77 53.81 20.99 -4.31 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 9 3 # 9 B 250 ALA C 181 ALA^? -4.94 MG MG C 301s B 251 GLY C 149 GLY^? 6.13 MG MG C 301 B 252 ASP C 148 ASP^? 2.75 MG MG C 302s coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 80.65 19.58 0.32 82.11 19.32 0.03 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 85.09 20.92 -1.20 84.51 20.95 -1.73 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 81.96 23.83 -2.68 80.24 25.11 -2.27 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 10 3 # 10 B 250 ALA C 181 ALA^? -4.94 MG MG C 301s B 251 GLY C 149 GLY^? 6.13 MG MG C 301 B 252 ASP C 177 ASP^? 8.84 MG MG C 301 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 80.65 19.58 0.32 82.11 19.32 0.03 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 85.09 20.92 -1.20 84.51 20.95 -1.73 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 85.60 16.42 -0.31 86.51 17.71 1.09 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 11 3 # 11 B 250 ALA C 181 ALA^? -4.94 MG MG C 301s B 251 GLY C 149 GLY^? 6.13 MG MG C 301 B 252 ASP C 187 ASP^? -3.72 MG MG C 301s coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 80.65 19.58 0.32 82.11 19.32 0.03 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 85.09 20.92 -1.20 84.51 20.95 -1.73 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 84.01 23.73 3.39 83.47 22.54 1.59 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 12 3 # 12 B 250 ALA C 181 ALA^? -4.94 MG MG C 301s B 251 GLY C 183 GLY^? -4.00 MG MG C 301s B 252 ASP C 148 ASP^? 2.75 MG MG C 302s coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 80.65 19.58 0.32 82.11 19.32 0.03 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 76.27 22.45 0.43 77.06 22.50 0.60 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 81.96 23.83 -2.68 80.24 25.11 -2.27 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 13 3 # 13 B 250 ALA D 181 ALA^? -4.93 MG MG D 301s B 251 GLY D 149 GLY^? 6.12 MG MG D 301 B 252 ASP D 148 ASP^? 2.35 MG MG D 302s coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 89.39 41.74 -50.56 90.67 41.02 -50.20 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 92.07 37.87 -48.88 91.62 38.12 -48.34 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 87.78 37.50 -47.56 85.79 37.49 -48.28 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 14 3 # 14 B 250 ALA D 181 ALA^? -4.93 MG MG D 301s B 251 GLY D 149 GLY^? 6.12 MG MG D 301 B 252 ASP D 177 ASP^? 8.43 MG MG D 301 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 89.39 41.74 -50.56 90.67 41.02 -50.20 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 92.07 37.87 -48.88 91.62 38.12 -48.34 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 95.74 41.01 -49.76 94.81 39.90 -51.24 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 15 3 # 15 B 250 ALA D 181 ALA^? -4.93 MG MG D 301s B 251 GLY D 149 GLY^? 6.12 MG MG D 301 B 252 ASP D 187 ASP^? -2.95 MG MG D 301s coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 89.39 41.74 -50.56 90.67 41.02 -50.20 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 92.07 37.87 -48.88 91.62 38.12 -48.34 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 90.40 36.34 -52.69 89.24 37.98 -51.99 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 16 3 # 16 B 250 ALA E 181 ALA^? -4.51 MG MG E 301s B 251 GLY E 149 GLY^? 5.75 MG MG E 301 B 252 ASP E 148 ASP^? 2.62 MG MG E 302s coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 72.69 61.53 -44.13 72.20 62.95 -44.39 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 69.31 64.70 -46.05 69.60 64.17 -46.61 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 68.29 60.44 -47.29 68.03 58.42 -46.50 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 17 3 # 17 B 250 ALA E 181 ALA^? -4.51 MG MG E 301s B 251 GLY E 149 GLY^? 5.75 MG MG E 301 B 252 ASP E 177 ASP^? 8.55 MG MG E 301 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 72.69 61.53 -44.13 72.20 62.95 -44.39 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 69.31 64.70 -46.05 69.60 64.17 -46.61 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 18 3 # 18 B 250 ALA E 181 ALA^? -4.51 MG MG E 301s B 251 GLY E 149 GLY^? 5.75 MG MG E 301 B 252 ASP E 187 ASP^? -2.71 MG MG E 301s coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 72.69 61.53 -44.13 72.20 62.95 -44.39 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 69.31 64.70 -46.05 69.60 64.17 -46.61 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 67.50 63.43 -41.69 68.97 62.26 -42.81 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 19 3 # 19 B 250 ALA E 181 ALA^? -4.51 MG MG E 301s B 251 GLY E 183 GLY^? -4.49 MG MG E 301s B 252 ASP E 148 ASP^? 2.62 MG MG E 302s coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 72.69 61.53 -44.13 72.20 62.95 -44.39 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 72.33 56.33 -43.87 71.83 56.99 -43.77 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 68.29 60.44 -47.29 68.03 58.42 -46.50 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 20 3 # 20 B 250 ALA F 181 ALA^? -4.41 MG MG F 302s B 251 GLY F 149 GLY^? 5.34 MG MG F 302 B 252 ASP F 148 ASP^? 2.72 MG MG F 301s coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 49.03 55.67 -94.95 49.00 57.19 -94.78 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 51.31 60.07 -93.46 51.26 59.51 -92.90 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 53.64 56.47 -91.98 54.61 54.68 -92.64 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 21 3 # 21 B 250 ALA F 181 ALA^? -4.41 MG MG F 302s B 251 GLY F 149 GLY^? 5.34 MG MG F 302 B 252 ASP F 177 ASP^? 8.15 MG MG F 302 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 49.03 55.67 -94.95 49.00 57.19 -94.78 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 51.31 60.07 -93.46 51.26 59.51 -92.90 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 47.18 61.22 -94.50 48.48 62.32 -95.73 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 22 3 # 22 B 250 ALA F 181 ALA^? -4.41 MG MG F 302s B 251 GLY F 149 GLY^? 5.34 MG MG F 302 B 252 ASP F 187 ASP^? -3.27 MG MG F 302s coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 49.03 55.67 -94.95 49.00 57.19 -94.78 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 51.31 60.07 -93.46 51.26 59.51 -92.90 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 53.93 58.87 -98.14 52.45 58.62 -96.61 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 23 3 # 23 B 250 ALA F 181 ALA^? -4.41 MG MG F 302s B 251 GLY F 183 GLY^? -4.39 MG MG F 301s B 252 ASP F 148 ASP^? 2.72 MG MG F 301s coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 49.03 55.67 -94.95 49.00 57.19 -94.78 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 51.40 50.96 -94.96 51.47 51.79 -95.11 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 53.64 56.47 -91.98 54.61 54.68 -92.64 1tz3_c03 source 1tz3 PUTATIVE SUGAR KINASE : 23 hits 1tz3_c03 naa= 3 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 1 3 # 1 A 46 GLU A 54 GLU^? 22.98 MG MG A 301 A 126 LYS A 6 LYS^? 25.88 MG MG A 301 A 171 ALA A 9 ALA^? 15.22 MG MG A 301 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 45.06 19.97 24.02 44.05 19.39 22.19 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 46.20 12.82 24.71 44.50 16.64 20.52 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 42.54 20.81 29.78 43.62 21.07 30.77 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 2 3 # 2 A 46 GLU A 54 GLU^? 22.98 MG MG A 301 A 126 LYS A 157 LYS^? 28.65 MG MG A 302 A 171 ALA A 9 ALA^? 15.22 MG MG A 301 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 45.06 19.97 24.02 44.05 19.39 22.19 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 41.42 12.06 27.58 41.46 5.93 29.41 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 42.54 20.81 29.78 43.62 21.07 30.77 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 3 3 # 3 A 46 GLU B 54 GLU^? 22.94 MG MG B 302 A 126 LYS B 6 LYS^? 25.90 MG MG B 302 A 171 ALA B 9 ALA^? 15.20 MG MG B 302 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 43.18 23.27 12.99 42.40 22.23 14.68 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 36.26 25.44 11.74 39.65 23.12 16.29 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 44.07 20.95 7.16 44.62 22.08 6.31 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 4 3 # 4 A 46 GLU B 54 GLU^? 22.94 MG MG B 302 A 126 LYS B 157 LYS^? 28.85 MG MG B 302 A 171 ALA B 9 ALA^? 15.20 MG MG B 302 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 43.18 23.27 12.99 42.40 22.23 14.68 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 34.97 21.28 8.44 29.03 22.82 6.58 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 44.07 20.95 7.16 44.62 22.08 6.31 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 5 3 # 5 A 46 GLU C 54 GLU^? 22.77 MG MG C 302 A 126 LYS C 6 LYS^? 25.73 MG MG C 302 A 171 ALA C 9 ALA^? 15.00 MG MG C 302 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 88.91 31.25 -19.52 89.97 30.69 -21.29 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 89.05 28.81 -13.58 88.16 29.64 -12.74 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 6 3 # 6 A 46 GLU C 54 GLU^? 22.77 MG MG C 302 A 126 LYS C 157 LYS^? 28.15 MG MG C 302 A 171 ALA C 9 ALA^? 15.00 MG MG C 302 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 88.91 31.25 -19.52 89.97 30.69 -21.29 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 89.05 28.81 -13.58 88.16 29.64 -12.74 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 7 3 # 7 A 46 GLU D 54 GLU^? 22.96 MG MG D 302 A 126 LYS D 6 LYS^? 25.98 MG MG D 302 A 171 ALA D 9 ALA^? 15.02 MG MG D 302 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 87.96 27.60 -30.52 89.07 27.55 -28.72 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 89.67 29.50 -36.34 88.55 29.40 -37.31 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 8 3 # 8 A 46 GLU D 54 GLU^? 22.96 MG MG D 302 A 126 LYS D 157 LYS^? 28.67 MG MG D 302 A 171 ALA D 9 ALA^? 15.02 MG MG D 302 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 87.96 27.60 -30.52 89.07 27.55 -28.72 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 89.67 29.50 -36.34 88.55 29.40 -37.31 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 9 3 # 9 A 46 GLU E 54 GLU^? 22.83 MG MG E 302 A 126 LYS E 6 LYS^? 25.59 MG MG E 302 A 171 ALA E 9 ALA^? 15.19 MG MG E 302 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 58.39 62.16 -64.12 58.73 62.98 -66.04 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 60.74 63.76 -58.54 60.44 62.76 -57.48 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 10 3 # 10 A 46 GLU E 54 GLU^? 22.83 MG MG E 302 A 126 LYS E 157 LYS^? 28.40 MG MG E 302 A 171 ALA E 9 ALA^? 15.19 MG MG E 302 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 58.39 62.16 -64.12 58.73 62.98 -66.04 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 60.74 63.76 -58.54 60.44 62.76 -57.48 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 11 3 # 11 A 46 GLU F 54 GLU^? 22.98 MG MG F 301 A 126 LYS F 6 LYS^? 26.09 MG MG F 301 A 171 ALA F 9 ALA^? 15.22 MG MG F 301 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 62.26 62.27 -75.30 61.72 63.47 -73.60 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 59.78 62.63 -81.12 60.54 61.63 -82.00 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 12 3 # 12 A 46 GLU F 54 GLU^? 22.98 MG MG F 301 A 126 LYS F 157 LYS^? 28.36 MG MG F 302 A 171 ALA F 9 ALA^? 15.22 MG MG F 301 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 62.26 62.27 -75.30 61.72 63.47 -73.60 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 59.78 62.63 -81.12 60.54 61.63 -82.00 1uf7_c00 source 1uf7 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE : 12 hits 1uf7_c00 naa= 3 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 1 3 # 1 B 46 GLU A 54 GLU^? 22.98 MG MG A 301 B 126 LYS A 6 LYS^? 25.88 MG MG A 301 B 171 ALA A 9 ALA^? 15.22 MG MG A 301 coo 20.47 87.42 16.54 20.16 87.17 14.45 45.06 19.97 24.02 44.05 19.39 22.19 coo 24.73 94.37 14.59 21.08 89.84 11.98 46.20 12.82 24.71 44.50 16.64 20.52 coo 24.38 86.32 12.71 22.88 86.54 12.71 42.54 20.81 29.78 43.62 21.07 30.77 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 2 3 # 2 B 46 GLU A 54 GLU^? 22.98 MG MG A 301 B 126 LYS A 157 LYS^? 28.65 MG MG A 302 B 171 ALA A 9 ALA^? 15.22 MG MG A 301 coo 20.47 87.42 16.54 20.16 87.17 14.45 45.06 19.97 24.02 44.05 19.39 22.19 coo 24.73 94.37 14.59 21.08 89.84 11.98 41.42 12.06 27.58 41.46 5.93 29.41 coo 24.38 86.32 12.71 22.88 86.54 12.71 42.54 20.81 29.78 43.62 21.07 30.77 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 3 3 # 3 B 46 GLU B 54 GLU^? 22.94 MG MG B 302 B 126 LYS B 6 LYS^? 25.90 MG MG B 302 B 171 ALA B 9 ALA^? 15.20 MG MG B 302 coo 20.47 87.42 16.54 20.16 87.17 14.45 43.18 23.27 12.99 42.40 22.23 14.68 coo 24.73 94.37 14.59 21.08 89.84 11.98 36.26 25.44 11.74 39.65 23.12 16.29 coo 24.38 86.32 12.71 22.88 86.54 12.71 44.07 20.95 7.16 44.62 22.08 6.31 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 4 3 # 4 B 46 GLU B 54 GLU^? 22.94 MG MG B 302 B 126 LYS B 157 LYS^? 28.85 MG MG B 302 B 171 ALA B 9 ALA^? 15.20 MG MG B 302 coo 20.47 87.42 16.54 20.16 87.17 14.45 43.18 23.27 12.99 42.40 22.23 14.68 coo 24.73 94.37 14.59 21.08 89.84 11.98 34.97 21.28 8.44 29.03 22.82 6.58 coo 24.38 86.32 12.71 22.88 86.54 12.71 44.07 20.95 7.16 44.62 22.08 6.31 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 5 3 # 5 B 46 GLU C 54 GLU^? 22.77 MG MG C 302 B 126 LYS C 6 LYS^? 25.73 MG MG C 302 B 171 ALA C 9 ALA^? 15.00 MG MG C 302 coo 20.47 87.42 16.54 20.16 87.17 14.45 88.91 31.25 -19.52 89.97 30.69 -21.29 coo 24.73 94.37 14.59 21.08 89.84 11.98 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 24.38 86.32 12.71 22.88 86.54 12.71 89.05 28.81 -13.58 88.16 29.64 -12.74 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 6 3 # 6 B 46 GLU C 54 GLU^? 22.77 MG MG C 302 B 126 LYS C 157 LYS^? 28.15 MG MG C 302 B 171 ALA C 9 ALA^? 15.00 MG MG C 302 coo 20.47 87.42 16.54 20.16 87.17 14.45 88.91 31.25 -19.52 89.97 30.69 -21.29 coo 24.73 94.37 14.59 21.08 89.84 11.98 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 24.38 86.32 12.71 22.88 86.54 12.71 89.05 28.81 -13.58 88.16 29.64 -12.74 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 7 3 # 7 B 46 GLU D 54 GLU^? 22.96 MG MG D 302 B 126 LYS D 6 LYS^? 25.98 MG MG D 302 B 171 ALA D 9 ALA^? 15.02 MG MG D 302 coo 20.47 87.42 16.54 20.16 87.17 14.45 87.96 27.60 -30.52 89.07 27.55 -28.72 coo 24.73 94.37 14.59 21.08 89.84 11.98 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 24.38 86.32 12.71 22.88 86.54 12.71 89.67 29.50 -36.34 88.55 29.40 -37.31 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 8 3 # 8 B 46 GLU D 54 GLU^? 22.96 MG MG D 302 B 126 LYS D 157 LYS^? 28.67 MG MG D 302 B 171 ALA D 9 ALA^? 15.02 MG MG D 302 coo 20.47 87.42 16.54 20.16 87.17 14.45 87.96 27.60 -30.52 89.07 27.55 -28.72 coo 24.73 94.37 14.59 21.08 89.84 11.98 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 24.38 86.32 12.71 22.88 86.54 12.71 89.67 29.50 -36.34 88.55 29.40 -37.31 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 9 3 # 9 B 46 GLU E 54 GLU^? 22.83 MG MG E 302 B 126 LYS E 6 LYS^? 25.59 MG MG E 302 B 171 ALA E 9 ALA^? 15.19 MG MG E 302 coo 20.47 87.42 16.54 20.16 87.17 14.45 58.39 62.16 -64.12 58.73 62.98 -66.04 coo 24.73 94.37 14.59 21.08 89.84 11.98 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 24.38 86.32 12.71 22.88 86.54 12.71 60.74 63.76 -58.54 60.44 62.76 -57.48 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 10 3 # 10 B 46 GLU E 54 GLU^? 22.83 MG MG E 302 B 126 LYS E 157 LYS^? 28.40 MG MG E 302 B 171 ALA E 9 ALA^? 15.19 MG MG E 302 coo 20.47 87.42 16.54 20.16 87.17 14.45 58.39 62.16 -64.12 58.73 62.98 -66.04 coo 24.73 94.37 14.59 21.08 89.84 11.98 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 24.38 86.32 12.71 22.88 86.54 12.71 60.74 63.76 -58.54 60.44 62.76 -57.48 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 11 3 # 11 B 46 GLU F 54 GLU^? 22.98 MG MG F 301 B 126 LYS F 6 LYS^? 26.09 MG MG F 301 B 171 ALA F 9 ALA^? 15.22 MG MG F 301 coo 20.47 87.42 16.54 20.16 87.17 14.45 62.26 62.27 -75.30 61.72 63.47 -73.60 coo 24.73 94.37 14.59 21.08 89.84 11.98 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 24.38 86.32 12.71 22.88 86.54 12.71 59.78 62.63 -81.12 60.54 61.63 -82.00 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 12 3 # 12 B 46 GLU F 54 GLU^? 22.98 MG MG F 301 B 126 LYS F 157 LYS^? 28.36 MG MG F 302 B 171 ALA F 9 ALA^? 15.22 MG MG F 301 coo 20.47 87.42 16.54 20.16 87.17 14.45 62.26 62.27 -75.30 61.72 63.47 -73.60 coo 24.73 94.37 14.59 21.08 89.84 11.98 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 24.38 86.32 12.71 22.88 86.54 12.71 59.78 62.63 -81.12 60.54 61.63 -82.00 1uf7_c01 source 1uf7 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE : 12 hits 1uf7_c01 naa= 3 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP D 187 ASP^? -2.95 MG MG D 301s 255 GLU D 146 GLU^? 10.62 MG MG D 301 329 ASP D 128 ASP^? -3.70 MG MG D 302s coo 49.16 35.16 15.19 51.08 34.43 15.65 90.40 36.34 -52.69 89.24 37.98 -51.99 coo 52.57 37.12 10.17 53.37 35.95 11.75 87.24 28.82 -50.92 85.47 28.08 -51.67 coo 59.16 37.82 13.95 57.63 37.03 15.12 83.33 35.45 -46.13 81.57 36.63 -46.10 1uok_c03 source 1uok OLIGO-1,6-GLUCOSIDASE : 1 hits 1uok_c03 naa= 3 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 58 ASP^? 26.75 MG MG B 302 218 GLU A 38 GLU^? 21.81 MG MG A 302 329 ASP A 160 ASP^? 31.61 MG MG B 302 coo 49.16 35.16 15.19 51.08 34.43 15.65 53.93 9.80 21.09 53.83 8.90 19.15 coo 70.09 11.71 8.46 70.56 12.89 6.77 26.42 25.01 28.02 26.98 25.90 29.89 coo 59.16 37.82 13.95 57.63 37.03 15.12 44.21 5.00 19.54 46.02 3.84 19.76 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 138 ASP^? 33.08 MG MG A 302 218 GLU A 38 GLU^? 21.81 MG MG A 302 329 ASP A 142 ASP^? 23.70 MG MG A 302 coo 49.16 35.16 15.19 51.08 34.43 15.65 47.10 -0.97 29.63 45.89 0.22 30.96 coo 70.09 11.71 8.46 70.56 12.89 6.77 26.42 25.01 28.02 26.98 25.90 29.89 coo 59.16 37.82 13.95 57.63 37.03 15.12 46.39 7.18 37.53 46.28 7.18 39.63 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP A 138 ASP^? 33.08 MG MG A 302 218 GLU A 38 GLU^? 21.81 MG MG A 302 329 ASP A 160 ASP^? 31.61 MG MG B 302 coo 49.16 35.16 15.19 51.08 34.43 15.65 47.10 -0.97 29.63 45.89 0.22 30.96 coo 70.09 11.71 8.46 70.56 12.89 6.77 26.42 25.01 28.02 26.98 25.90 29.89 coo 59.16 37.82 13.95 57.63 37.03 15.12 44.21 5.00 19.54 46.02 3.84 19.76 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP A 138 ASP^? 33.08 MG MG A 302 218 GLU B 75 GLU^? 15.82 MG MG C 301 329 ASP A 160 ASP^? 31.61 MG MG B 302 coo 49.16 35.16 15.19 51.08 34.43 15.65 47.10 -0.97 29.63 45.89 0.22 30.96 coo 70.09 11.71 8.46 70.56 12.89 6.77 68.81 12.14 8.61 69.95 13.49 7.45 coo 59.16 37.82 13.95 57.63 37.03 15.12 44.21 5.00 19.54 46.02 3.84 19.76 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP A 142 ASP^? 23.70 MG MG A 302 218 GLU B 154 GLU^? 19.05 MG MG B 302 329 ASP A 138 ASP^? 33.08 MG MG A 302 coo 49.16 35.16 15.19 51.08 34.43 15.65 46.39 7.18 37.53 46.28 7.18 39.63 coo 70.09 11.71 8.46 70.56 12.89 6.77 44.04 15.11 6.74 44.19 13.59 8.30 coo 59.16 37.82 13.95 57.63 37.03 15.12 47.10 -0.97 29.63 45.89 0.22 30.96 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP A 177 ASP^? 8.44 MG MG A 302 218 GLU B 54 GLU^? 22.94 MG MG B 302 329 ASP A 148 ASP^? 2.72 MG MG A 301s coo 49.16 35.16 15.19 51.08 34.43 15.65 33.02 29.04 43.18 33.79 27.88 44.78 coo 70.09 11.71 8.46 70.56 12.89 6.77 43.18 23.27 12.99 42.40 22.23 14.68 coo 59.16 37.82 13.95 57.63 37.03 15.12 41.50 28.88 41.13 43.33 29.67 41.93 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 7 3 # 7 199 ASP A 177 ASP^? 8.44 MG MG A 302 218 GLU B 54 GLU^? 22.94 MG MG B 302 329 ASP A 171 ASP^? 17.17 MG MG A 302 coo 49.16 35.16 15.19 51.08 34.43 15.65 33.02 29.04 43.18 33.79 27.88 44.78 coo 70.09 11.71 8.46 70.56 12.89 6.77 43.18 23.27 12.99 42.40 22.23 14.68 coo 59.16 37.82 13.95 57.63 37.03 15.12 29.78 23.67 36.63 28.48 25.11 35.71 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 8 3 # 8 199 ASP A 187 ASP^? -3.29 MG MG A 302s 218 GLU A 25 GLU^? 25.87 MG MG A 301 329 ASP A 128 ASP^? -3.32 MG MG A 301s coo 49.16 35.16 15.19 51.08 34.43 15.65 39.43 26.57 46.78 39.37 27.83 45.03 coo 70.09 11.71 8.46 70.56 12.89 6.77 39.62 57.50 39.92 41.51 57.27 40.85 coo 59.16 37.82 13.95 57.63 37.03 15.12 46.50 28.23 39.77 47.49 30.10 39.82 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 9 3 # 9 199 ASP A 187 ASP^? -3.29 MG MG A 302s 218 GLU B 63 GLU^? 27.83 MG MG A 301 329 ASP A 128 ASP^? -3.32 MG MG A 301s coo 49.16 35.16 15.19 51.08 34.43 15.65 39.43 26.57 46.78 39.37 27.83 45.03 coo 70.09 11.71 8.46 70.56 12.89 6.77 36.89 38.35 16.01 38.64 39.45 15.67 coo 59.16 37.82 13.95 57.63 37.03 15.12 46.50 28.23 39.77 47.49 30.10 39.82 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 10 3 # 10 199 ASP B 23 ASP^? 15.67 MG MG C 301 218 GLU B 52 GLU^? 20.06 MG MG B 302 329 ASP C 23 ASP^? 15.39 MG MG B 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 74.31 7.55 -1.09 75.08 9.17 -2.23 coo 70.09 11.71 8.46 70.56 12.89 6.77 47.87 20.25 12.36 48.11 19.69 14.43 coo 59.16 37.82 13.95 57.63 37.03 15.12 65.24 6.82 -5.11 63.43 7.54 -4.15 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 11 3 # 11 199 ASP B 58 ASP^? 26.73 MG MG A 301 218 GLU B 38 GLU^? 21.75 MG MG B 301 329 ASP B 160 ASP^? 31.65 MG MG A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 34.42 33.56 15.74 33.50 33.49 17.59 coo 70.09 11.71 8.46 70.56 12.89 6.77 44.79 4.95 7.12 46.66 4.47 6.21 coo 59.16 37.82 13.95 57.63 37.03 15.12 28.01 24.83 16.38 27.44 26.81 15.80 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 12 3 # 12 199 ASP B 128 ASP^? -3.57 MG MG B 302s 218 GLU C 33 GLU^? 22.71 MG MG C 302 329 ASP B 187 ASP^? -3.44 MG MG B 301s coo 49.16 35.16 15.19 51.08 34.43 15.65 52.92 24.09 -2.19 54.73 25.14 -1.90 coo 70.09 11.71 8.46 70.56 12.89 6.77 78.39 11.67 -18.82 78.34 12.01 -20.91 coo 59.16 37.82 13.95 57.63 37.03 15.12 50.64 18.14 -9.69 51.74 17.63 -7.86 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 13 3 # 13 199 ASP B 138 ASP^? 33.32 MG MG B 302 218 GLU A 75 GLU^? 20.23 MG MG A 301 329 ASP B 160 ASP^? 31.65 MG MG A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 23.42 29.01 6.78 24.36 28.48 4.94 coo 70.09 11.71 8.46 70.56 12.89 6.77 38.99 46.65 28.68 39.94 47.65 30.33 coo 59.16 37.82 13.95 57.63 37.03 15.12 28.01 24.83 16.38 27.44 26.81 15.80 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 14 3 # 14 199 ASP B 138 ASP^? 33.32 MG MG B 302 218 GLU B 38 GLU^? 21.75 MG MG B 301 329 ASP B 142 ASP^? 23.97 MG MG B 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 23.42 29.01 6.78 24.36 28.48 4.94 coo 70.09 11.71 8.46 70.56 12.89 6.77 44.79 4.95 7.12 46.66 4.47 6.21 coo 59.16 37.82 13.95 57.63 37.03 15.12 31.69 27.40 -1.31 32.10 27.37 -3.38 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 15 3 # 15 199 ASP B 138 ASP^? 33.32 MG MG B 302 218 GLU B 38 GLU^? 21.75 MG MG B 301 329 ASP B 160 ASP^? 31.65 MG MG A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 23.42 29.01 6.78 24.36 28.48 4.94 coo 70.09 11.71 8.46 70.56 12.89 6.77 44.79 4.95 7.12 46.66 4.47 6.21 coo 59.16 37.82 13.95 57.63 37.03 15.12 28.01 24.83 16.38 27.44 26.81 15.80 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 16 3 # 16 199 ASP B 142 ASP^? 23.97 MG MG B 301 218 GLU A 154 GLU^? 19.22 MG MG A 301 329 ASP B 138 ASP^? 33.32 MG MG B 302 coo 49.16 35.16 15.19 51.08 34.43 15.65 31.69 27.40 -1.31 32.10 27.37 -3.38 coo 70.09 11.71 8.46 70.56 12.89 6.77 36.54 21.95 29.78 35.14 22.21 28.17 coo 59.16 37.82 13.95 57.63 37.03 15.12 23.42 29.01 6.78 24.36 28.48 4.94 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 17 3 # 17 199 ASP B 148 ASP^? 2.58 MG MG B 302s 218 GLU C 19 GLU^? 19.08 MG MG C 301 329 ASP B 177 ASP^? 9.03 MG MG B 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 70.09 11.71 8.46 70.56 12.89 6.77 80.46 7.67 -6.81 81.43 5.97 -5.99 coo 59.16 37.82 13.95 57.63 37.03 15.12 51.97 11.04 -6.64 50.39 11.62 -7.94 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 18 3 # 18 199 ASP B 148 ASP^? 2.58 MG MG B 302s 218 GLU C 33 GLU^? 22.71 MG MG C 302 329 ASP B 177 ASP^? 9.03 MG MG B 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 70.09 11.71 8.46 70.56 12.89 6.77 78.39 11.67 -18.82 78.34 12.01 -20.91 coo 59.16 37.82 13.95 57.63 37.03 15.12 51.97 11.04 -6.64 50.39 11.62 -7.94 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 19 3 # 19 199 ASP B 177 ASP^? 9.03 MG MG B 301 218 GLU A 54 GLU^? 22.98 MG MG A 301 329 ASP B 148 ASP^? 2.58 MG MG B 302s coo 49.16 35.16 15.19 51.08 34.43 15.65 51.97 11.04 -6.64 50.39 11.62 -7.94 coo 70.09 11.71 8.46 70.56 12.89 6.77 45.06 19.97 24.02 44.05 19.39 22.19 coo 59.16 37.82 13.95 57.63 37.03 15.12 52.73 19.23 -3.77 53.81 20.99 -4.31 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 20 3 # 20 199 ASP B 177 ASP^? 9.03 MG MG B 301 218 GLU A 54 GLU^? 22.98 MG MG A 301 329 ASP B 171 ASP^? 16.92 MG MG B 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 51.97 11.04 -6.64 50.39 11.62 -7.94 coo 70.09 11.71 8.46 70.56 12.89 6.77 45.06 19.97 24.02 44.05 19.39 22.19 coo 59.16 37.82 13.95 57.63 37.03 15.12 45.30 8.50 -0.71 46.30 6.81 0.12 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 21 3 # 21 199 ASP B 177 ASP^? 9.03 MG MG B 301 218 GLU C 94 GLU^? 16.62 MG MG C 302 329 ASP B 148 ASP^? 2.58 MG MG B 302s coo 49.16 35.16 15.19 51.08 34.43 15.65 51.97 11.04 -6.64 50.39 11.62 -7.94 coo 70.09 11.71 8.46 70.56 12.89 6.77 71.81 35.42 -14.68 69.88 35.53 -13.78 coo 59.16 37.82 13.95 57.63 37.03 15.12 52.73 19.23 -3.77 53.81 20.99 -4.31 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 22 3 # 22 199 ASP B 187 ASP^? -3.44 MG MG B 301s 218 GLU A 63 GLU^? 28.10 MG MG B 302 329 ASP B 128 ASP^? -3.57 MG MG B 302s coo 49.16 35.16 15.19 51.08 34.43 15.65 50.64 18.14 -9.69 51.74 17.63 -7.86 coo 70.09 11.71 8.46 70.56 12.89 6.77 59.13 11.55 21.47 60.51 12.96 22.22 coo 59.16 37.82 13.95 57.63 37.03 15.12 52.92 24.09 -2.19 54.73 25.14 -1.90 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 23 3 # 23 199 ASP B 187 ASP^? -3.44 MG MG B 301s 218 GLU B 25 GLU^? 12.88 MG MG C 301 329 ASP B 128 ASP^? -3.57 MG MG B 302s coo 49.16 35.16 15.19 51.08 34.43 15.65 50.64 18.14 -9.69 51.74 17.63 -7.86 coo 70.09 11.71 8.46 70.56 12.89 6.77 79.57 9.59 -3.08 79.20 11.68 -3.64 coo 59.16 37.82 13.95 57.63 37.03 15.12 52.92 24.09 -2.19 54.73 25.14 -1.90 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 24 3 # 24 199 ASP C 23 ASP^? 15.39 MG MG B 301 218 GLU C 52 GLU^? 19.67 MG MG C 302 329 ASP B 23 ASP^? 15.67 MG MG C 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 65.24 6.82 -5.11 63.43 7.54 -4.15 coo 70.09 11.71 8.46 70.56 12.89 6.77 84.27 26.98 -19.19 85.21 26.16 -20.96 coo 59.16 37.82 13.95 57.63 37.03 15.12 74.31 7.55 -1.09 75.08 9.17 -2.23 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 25 3 # 25 199 ASP C 23 ASP^? 15.39 MG MG B 301 218 GLU C 146 GLU^? 10.46 MG MG C 301 329 ASP B 23 ASP^? 15.67 MG MG C 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 65.24 6.82 -5.11 63.43 7.54 -4.15 coo 70.09 11.71 8.46 70.56 12.89 6.77 87.01 31.93 0.25 85.57 32.56 1.72 coo 59.16 37.82 13.95 57.63 37.03 15.12 74.31 7.55 -1.09 75.08 9.17 -2.23 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 26 3 # 26 199 ASP C 58 ASP^? 26.67 MG MG D 302 218 GLU C 38 GLU^? 21.99 MG MG C 301 329 ASP C 160 ASP^? 31.63 MG MG D 302 coo 49.16 35.16 15.19 51.08 34.43 15.65 93.40 43.81 -22.27 94.18 44.45 -24.11 coo 70.09 11.71 8.46 70.56 12.89 6.77 93.66 12.78 -15.08 92.73 12.51 -13.19 coo 59.16 37.82 13.95 57.63 37.03 15.12 102.50 38.00 -23.28 102.43 39.97 -22.46 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 27 3 # 27 199 ASP C 128 ASP^? -3.22 MG MG C 302s 218 GLU B 33 GLU^? 22.65 MG MG B 302 329 ASP C 187 ASP^? -3.72 MG MG C 301s coo 49.16 35.16 15.19 51.08 34.43 15.65 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 70.09 11.71 8.46 70.56 12.89 6.77 59.88 9.09 12.22 59.91 9.49 14.33 coo 59.16 37.82 13.95 57.63 37.03 15.12 84.01 23.73 3.39 83.47 22.54 1.59 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 28 3 # 28 199 ASP C 138 ASP^? 33.43 MG MG C 302 218 GLU C 38 GLU^? 21.99 MG MG C 301 329 ASP C 142 ASP^? 23.76 MG MG C 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 105.43 43.97 -13.30 104.85 43.08 -11.43 coo 70.09 11.71 8.46 70.56 12.89 6.77 93.66 12.78 -15.08 92.73 12.51 -13.19 coo 59.16 37.82 13.95 57.63 37.03 15.12 97.94 39.27 -5.03 98.08 38.70 -2.97 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 29 3 # 29 199 ASP C 138 ASP^? 33.43 MG MG C 302 218 GLU C 38 GLU^? 21.99 MG MG C 301 329 ASP C 160 ASP^? 31.63 MG MG D 302 coo 49.16 35.16 15.19 51.08 34.43 15.65 105.43 43.97 -13.30 104.85 43.08 -11.43 coo 70.09 11.71 8.46 70.56 12.89 6.77 93.66 12.78 -15.08 92.73 12.51 -13.19 coo 59.16 37.82 13.95 57.63 37.03 15.12 102.50 38.00 -23.28 102.43 39.97 -22.46 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 30 3 # 30 199 ASP C 138 ASP^? 33.43 MG MG C 302 218 GLU D 75 GLU^? 15.53 MG MG E 301 329 ASP C 160 ASP^? 31.63 MG MG D 302 coo 49.16 35.16 15.19 51.08 34.43 15.65 105.43 43.97 -13.30 104.85 43.08 -11.43 coo 70.09 11.71 8.46 70.56 12.89 6.77 84.53 54.81 -36.40 82.75 56.01 -36.42 coo 59.16 37.82 13.95 57.63 37.03 15.12 102.50 38.00 -23.28 102.43 39.97 -22.46 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 31 3 # 31 199 ASP C 142 ASP^? 23.76 MG MG C 301 218 GLU D 154 GLU^? 18.75 MG MG D 302 329 ASP C 138 ASP^? 33.43 MG MG C 302 coo 49.16 35.16 15.19 51.08 34.43 15.65 97.94 39.27 -5.03 98.08 38.70 -2.97 coo 70.09 11.71 8.46 70.56 12.89 6.77 94.87 32.52 -36.42 96.07 33.39 -34.88 coo 59.16 37.82 13.95 57.63 37.03 15.12 105.43 43.97 -13.30 104.85 43.08 -11.43 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 32 3 # 32 199 ASP C 148 ASP^? 2.75 MG MG C 302s 218 GLU B 33 GLU^? 22.65 MG MG B 302 329 ASP C 177 ASP^? 8.84 MG MG C 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 70.09 11.71 8.46 70.56 12.89 6.77 59.88 9.09 12.22 59.91 9.49 14.33 coo 59.16 37.82 13.95 57.63 37.03 15.12 85.60 16.42 -0.31 86.51 17.71 1.09 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 33 3 # 33 199 ASP C 177 ASP^? 8.84 MG MG C 301 218 GLU D 54 GLU^? 22.96 MG MG D 302 329 ASP C 148 ASP^? 2.75 MG MG C 302s coo 49.16 35.16 15.19 51.08 34.43 15.65 85.60 16.42 -0.31 86.51 17.71 1.09 coo 70.09 11.71 8.46 70.56 12.89 6.77 87.96 27.60 -30.52 89.07 27.55 -28.72 coo 59.16 37.82 13.95 57.63 37.03 15.12 81.96 23.83 -2.68 80.24 25.11 -2.27 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 34 3 # 34 199 ASP C 177 ASP^? 8.84 MG MG C 301 218 GLU D 54 GLU^? 22.96 MG MG D 302 329 ASP C 171 ASP^? 17.08 MG MG C 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 85.60 16.42 -0.31 86.51 17.71 1.09 coo 70.09 11.71 8.46 70.56 12.89 6.77 87.96 27.60 -30.52 89.07 27.55 -28.72 coo 59.16 37.82 13.95 57.63 37.03 15.12 92.57 16.68 -6.24 92.24 14.74 -7.03 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 35 3 # 35 199 ASP C 187 ASP^? -3.72 MG MG C 301s 218 GLU C 25 GLU^? 12.27 MG MG B 301 329 ASP C 128 ASP^? -3.22 MG MG C 302s coo 49.16 35.16 15.19 51.08 34.43 15.65 84.01 23.73 3.39 83.47 22.54 1.59 coo 70.09 11.71 8.46 70.56 12.89 6.77 58.50 6.48 -3.59 57.94 8.54 -3.41 coo 59.16 37.82 13.95 57.63 37.03 15.12 80.05 28.39 -4.25 77.97 28.60 -4.21 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 36 3 # 36 199 ASP C 187 ASP^? -3.72 MG MG C 301s 218 GLU D 63 GLU^? 27.62 MG MG C 302 329 ASP C 128 ASP^? -3.22 MG MG C 302s coo 49.16 35.16 15.19 51.08 34.43 15.65 84.01 23.73 3.39 83.47 22.54 1.59 coo 70.09 11.71 8.46 70.56 12.89 6.77 77.46 14.75 -28.07 75.93 16.12 -28.66 coo 59.16 37.82 13.95 57.63 37.03 15.12 80.05 28.39 -4.25 77.97 28.60 -4.21 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 37 3 # 37 199 ASP D 23 ASP^? 15.37 MG MG E 301 218 GLU D 52 GLU^? 19.94 MG MG D 302 329 ASP E 23 ASP^? 15.43 MG MG D 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 85.70 62.10 -45.60 84.07 62.13 -46.93 coo 70.09 11.71 8.46 70.56 12.89 6.77 87.13 33.17 -30.97 88.40 33.70 -29.31 coo 59.16 37.82 13.95 57.63 37.03 15.12 91.98 54.64 -49.37 91.93 52.78 -48.33 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 38 3 # 38 199 ASP D 23 ASP^? 15.37 MG MG E 301 218 GLU D 94 GLU^? 16.28 MG MG D 302 329 ASP E 23 ASP^? 15.43 MG MG D 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 85.70 62.10 -45.60 84.07 62.13 -46.93 coo 70.09 11.71 8.46 70.56 12.89 6.77 72.85 36.59 -35.79 71.78 37.87 -37.16 coo 59.16 37.82 13.95 57.63 37.03 15.12 91.98 54.64 -49.37 91.93 52.78 -48.33 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 39 3 # 39 199 ASP D 58 ASP^? 26.59 MG MG C 302 218 GLU D 38 GLU^? 21.83 MG MG D 301 329 ASP D 160 ASP^? 31.45 MG MG C 302 coo 49.16 35.16 15.19 51.08 34.43 15.65 83.38 14.85 -27.71 84.09 14.12 -25.85 coo 70.09 11.71 8.46 70.56 12.89 6.77 103.22 39.19 -34.75 102.77 39.81 -36.73 coo 59.16 37.82 13.95 57.63 37.03 15.12 94.15 13.98 -26.57 92.71 12.42 -26.99 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 40 3 # 40 199 ASP D 128 ASP^? -3.70 MG MG D 302s 218 GLU E 33 GLU^? 22.81 MG MG E 302 329 ASP D 187 ASP^? -2.95 MG MG D 301s coo 49.16 35.16 15.19 51.08 34.43 15.65 83.33 35.45 -46.13 81.57 36.63 -46.10 coo 70.09 11.71 8.46 70.56 12.89 6.77 80.16 62.57 -63.35 80.54 62.13 -65.43 coo 59.16 37.82 13.95 57.63 37.03 15.12 90.40 36.34 -52.69 89.24 37.98 -51.99 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 41 3 # 41 199 ASP D 138 ASP^? 33.64 MG MG D 302 218 GLU C 75 GLU^? 16.14 MG MG B 301 329 ASP D 160 ASP^? 31.45 MG MG C 302 coo 49.16 35.16 15.19 51.08 34.43 15.65 93.00 7.50 -35.79 93.88 8.48 -37.45 coo 70.09 11.71 8.46 70.56 12.89 6.77 69.49 12.18 -14.30 67.44 12.65 -13.83 coo 59.16 37.82 13.95 57.63 37.03 15.12 94.15 13.98 -26.57 92.71 12.42 -26.99 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 42 3 # 42 199 ASP D 138 ASP^? 33.64 MG MG D 302 218 GLU D 38 GLU^? 21.83 MG MG D 301 329 ASP D 142 ASP^? 23.49 MG MG D 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 93.00 7.50 -35.79 93.88 8.48 -37.45 coo 70.09 11.71 8.46 70.56 12.89 6.77 103.22 39.19 -34.75 102.77 39.81 -36.73 coo 59.16 37.82 13.95 57.63 37.03 15.12 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 43 3 # 43 199 ASP D 138 ASP^? 33.64 MG MG D 302 218 GLU D 38 GLU^? 21.83 MG MG D 301 329 ASP D 160 ASP^? 31.45 MG MG C 302 coo 49.16 35.16 15.19 51.08 34.43 15.65 93.00 7.50 -35.79 93.88 8.48 -37.45 coo 70.09 11.71 8.46 70.56 12.89 6.77 103.22 39.19 -34.75 102.77 39.81 -36.73 coo 59.16 37.82 13.95 57.63 37.03 15.12 94.15 13.98 -26.57 92.71 12.42 -26.99 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 44 3 # 44 199 ASP D 142 ASP^? 23.49 MG MG D 301 218 GLU C 154 GLU^? 18.91 MG MG C 302 329 ASP D 138 ASP^? 33.64 MG MG D 302 coo 49.16 35.16 15.19 51.08 34.43 15.65 90.90 15.58 -44.76 91.35 16.09 -46.79 coo 70.09 11.71 8.46 70.56 12.89 6.77 91.15 23.27 -13.33 91.61 21.91 -14.95 coo 59.16 37.82 13.95 57.63 37.03 15.12 93.00 7.50 -35.79 93.88 8.48 -37.45 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 45 3 # 45 199 ASP D 148 ASP^? 2.35 MG MG D 302s 218 GLU E 19 GLU^? 18.42 MG MG E 301 329 ASP D 177 ASP^? 8.43 MG MG D 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 70.09 11.71 8.46 70.56 12.89 6.77 82.78 67.13 -51.44 83.71 68.75 -50.40 coo 59.16 37.82 13.95 57.63 37.03 15.12 95.74 41.01 -49.76 94.81 39.90 -51.24 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 46 3 # 46 199 ASP D 148 ASP^? 2.35 MG MG D 302s 218 GLU E 33 GLU^? 22.81 MG MG E 302 329 ASP D 177 ASP^? 8.43 MG MG D 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 70.09 11.71 8.46 70.56 12.89 6.77 80.16 62.57 -63.35 80.54 62.13 -65.43 coo 59.16 37.82 13.95 57.63 37.03 15.12 95.74 41.01 -49.76 94.81 39.90 -51.24 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 47 3 # 47 199 ASP D 160 ASP^? 31.45 MG MG C 302 218 GLU C 94 GLU^? 16.62 MG MG C 302 329 ASP D 58 ASP^? 26.59 MG MG C 302 coo 49.16 35.16 15.19 51.08 34.43 15.65 94.15 13.98 -26.57 92.71 12.42 -26.99 coo 70.09 11.71 8.46 70.56 12.89 6.77 71.81 35.42 -14.68 69.88 35.53 -13.78 coo 59.16 37.82 13.95 57.63 37.03 15.12 83.38 14.85 -27.71 84.09 14.12 -25.85 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 48 3 # 48 199 ASP D 177 ASP^? 8.43 MG MG D 301 218 GLU C 54 GLU^? 22.77 MG MG C 302 329 ASP D 148 ASP^? 2.35 MG MG D 302s coo 49.16 35.16 15.19 51.08 34.43 15.65 95.74 41.01 -49.76 94.81 39.90 -51.24 coo 70.09 11.71 8.46 70.56 12.89 6.77 88.91 31.25 -19.52 89.97 30.69 -21.29 coo 59.16 37.82 13.95 57.63 37.03 15.12 87.78 37.50 -47.56 85.79 37.49 -48.28 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 49 3 # 49 199 ASP D 177 ASP^? 8.43 MG MG D 301 218 GLU C 54 GLU^? 22.77 MG MG C 302 329 ASP D 171 ASP^? 16.95 MG MG D 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 95.74 41.01 -49.76 94.81 39.90 -51.24 coo 70.09 11.71 8.46 70.56 12.89 6.77 88.91 31.25 -19.52 89.97 30.69 -21.29 coo 59.16 37.82 13.95 57.63 37.03 15.12 100.39 36.69 -43.49 101.13 38.51 -42.69 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 50 3 # 50 199 ASP D 187 ASP^? -2.95 MG MG D 301s 218 GLU C 54 GLU^? 22.77 MG MG C 302 329 ASP D 128 ASP^? -3.70 MG MG D 302s coo 49.16 35.16 15.19 51.08 34.43 15.65 90.40 36.34 -52.69 89.24 37.98 -51.99 coo 70.09 11.71 8.46 70.56 12.89 6.77 88.91 31.25 -19.52 89.97 30.69 -21.29 coo 59.16 37.82 13.95 57.63 37.03 15.12 83.33 35.45 -46.13 81.57 36.63 -46.10 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 51 3 # 51 199 ASP D 187 ASP^? -2.95 MG MG D 301s 218 GLU C 63 GLU^? 27.26 MG MG D 302 329 ASP D 128 ASP^? -3.70 MG MG D 302s coo 49.16 35.16 15.19 51.08 34.43 15.65 90.40 36.34 -52.69 89.24 37.98 -51.99 coo 70.09 11.71 8.46 70.56 12.89 6.77 89.51 47.54 -22.35 87.55 48.20 -22.72 coo 59.16 37.82 13.95 57.63 37.03 15.12 83.33 35.45 -46.13 81.57 36.63 -46.10 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 52 3 # 52 199 ASP E 23 ASP^? 15.43 MG MG D 301 218 GLU E 52 GLU^? 19.96 MG MG E 302 329 ASP D 23 ASP^? 15.37 MG MG E 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 91.98 54.64 -49.37 91.93 52.78 -48.33 coo 70.09 11.71 8.46 70.56 12.89 6.77 64.71 60.06 -63.78 64.69 61.36 -65.58 coo 59.16 37.82 13.95 57.63 37.03 15.12 85.70 62.10 -45.60 84.07 62.13 -46.93 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 53 3 # 53 199 ASP E 58 ASP^? 26.76 MG MG F 301 218 GLU E 38 GLU^? 21.68 MG MG E 301 329 ASP E 160 ASP^? 31.54 MG MG F 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 70.09 11.71 8.46 70.56 12.89 6.77 72.42 75.53 -60.31 73.00 74.78 -58.42 coo 59.16 37.82 13.95 57.63 37.03 15.12 45.81 70.00 -68.45 44.10 68.87 -67.77 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 54 3 # 54 199 ASP E 128 ASP^? -3.53 MG MG E 302s 218 GLU D 33 GLU^? 22.23 MG MG D 302 329 ASP E 187 ASP^? -2.71 MG MG E 301s coo 49.16 35.16 15.19 51.08 34.43 15.65 65.38 56.57 -48.58 66.15 54.57 -48.61 coo 70.09 11.71 8.46 70.56 12.89 6.77 91.55 48.87 -31.66 91.12 48.92 -29.63 coo 59.16 37.82 13.95 57.63 37.03 15.12 67.50 63.43 -41.69 68.97 62.26 -42.81 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 55 3 # 55 199 ASP E 138 ASP^? 33.31 MG MG E 302 218 GLU E 38 GLU^? 21.68 MG MG E 301 329 ASP E 142 ASP^? 23.66 MG MG E 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 39.58 70.77 -58.63 40.74 70.78 -56.80 coo 70.09 11.71 8.46 70.56 12.89 6.77 72.42 75.53 -60.31 73.00 74.78 -58.42 coo 59.16 37.82 13.95 57.63 37.03 15.12 47.19 67.15 -50.37 47.44 67.18 -48.23 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 56 3 # 56 199 ASP E 138 ASP^? 33.31 MG MG E 302 218 GLU E 38 GLU^? 21.68 MG MG E 301 329 ASP E 160 ASP^? 31.54 MG MG F 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 39.58 70.77 -58.63 40.74 70.78 -56.80 coo 70.09 11.71 8.46 70.56 12.89 6.77 72.42 75.53 -60.31 73.00 74.78 -58.42 coo 59.16 37.82 13.95 57.63 37.03 15.12 45.81 70.00 -68.45 44.10 68.87 -67.77 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 57 3 # 57 199 ASP E 138 ASP^? 33.31 MG MG E 302 218 GLU F 75 GLU^? 19.96 MG MG F 301 329 ASP E 160 ASP^? 31.54 MG MG F 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 39.58 70.77 -58.63 40.74 70.78 -56.80 coo 70.09 11.71 8.46 70.56 12.89 6.77 40.19 46.06 -80.81 40.09 43.94 -81.24 coo 59.16 37.82 13.95 57.63 37.03 15.12 45.81 70.00 -68.45 44.10 68.87 -67.77 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 58 3 # 58 199 ASP E 142 ASP^? 23.66 MG MG E 301 218 GLU F 154 GLU^? 18.97 MG MG F 301 329 ASP E 138 ASP^? 33.31 MG MG E 302 coo 49.16 35.16 15.19 51.08 34.43 15.65 47.19 67.15 -50.37 47.44 67.18 -48.23 coo 70.09 11.71 8.46 70.56 12.89 6.77 54.57 65.67 -81.55 53.36 66.51 -80.09 coo 59.16 37.82 13.95 57.63 37.03 15.12 39.58 70.77 -58.63 40.74 70.78 -56.80 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 59 3 # 59 199 ASP E 148 ASP^? 2.62 MG MG E 302s 218 GLU D 19 GLU^? 18.95 MG MG D 301 329 ASP E 177 ASP^? 8.55 MG MG E 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 70.09 11.71 8.46 70.56 12.89 6.77 96.86 51.08 -43.04 98.60 51.44 -44.26 coo 59.16 37.82 13.95 57.63 37.03 15.12 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 60 3 # 60 199 ASP E 148 ASP^? 2.62 MG MG E 302s 218 GLU D 33 GLU^? 22.23 MG MG D 302 329 ASP E 177 ASP^? 8.55 MG MG E 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 70.09 11.71 8.46 70.56 12.89 6.77 91.55 48.87 -31.66 91.12 48.92 -29.63 coo 59.16 37.82 13.95 57.63 37.03 15.12 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 61 3 # 61 199 ASP E 160 ASP^? 31.54 MG MG F 301 218 GLU F 94 GLU^? 17.06 MG MG F 301 329 ASP E 58 ASP^? 26.76 MG MG F 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 45.81 70.00 -68.45 44.10 68.87 -67.77 coo 70.09 11.71 8.46 70.56 12.89 6.77 62.58 44.49 -81.43 64.13 42.92 -81.30 coo 59.16 37.82 13.95 57.63 37.03 15.12 45.39 59.31 -66.83 44.62 59.88 -68.72 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 62 3 # 62 199 ASP E 177 ASP^? 8.55 MG MG E 301 218 GLU D 94 GLU^? 16.28 MG MG D 302 329 ASP E 148 ASP^? 2.62 MG MG E 302s coo 49.16 35.16 15.19 51.08 34.43 15.65 72.81 67.32 -45.03 71.14 67.96 -43.95 coo 70.09 11.71 8.46 70.56 12.89 6.77 72.85 36.59 -35.79 71.78 37.87 -37.16 coo 59.16 37.82 13.95 57.63 37.03 15.12 68.29 60.44 -47.29 68.03 58.42 -46.50 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 63 3 # 63 199 ASP E 177 ASP^? 8.55 MG MG E 301 218 GLU F 54 GLU^? 22.98 MG MG F 301 329 ASP E 148 ASP^? 2.62 MG MG E 302s coo 49.16 35.16 15.19 51.08 34.43 15.65 72.81 67.32 -45.03 71.14 67.96 -43.95 coo 70.09 11.71 8.46 70.56 12.89 6.77 62.26 62.27 -75.30 61.72 63.47 -73.60 coo 59.16 37.82 13.95 57.63 37.03 15.12 68.29 60.44 -47.29 68.03 58.42 -46.50 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 64 3 # 64 199 ASP E 177 ASP^? 8.55 MG MG E 301 218 GLU F 54 GLU^? 22.98 MG MG F 301 329 ASP E 171 ASP^? 16.73 MG MG E 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 72.81 67.32 -45.03 71.14 67.96 -43.95 coo 70.09 11.71 8.46 70.56 12.89 6.77 62.26 62.27 -75.30 61.72 63.47 -73.60 coo 59.16 37.82 13.95 57.63 37.03 15.12 69.61 73.12 -51.56 71.50 73.53 -52.39 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 65 3 # 65 199 ASP E 187 ASP^? -2.71 MG MG E 301s 218 GLU F 54 GLU^? 22.98 MG MG F 301 329 ASP E 128 ASP^? -3.53 MG MG E 302s coo 49.16 35.16 15.19 51.08 34.43 15.65 67.50 63.43 -41.69 68.97 62.26 -42.81 coo 70.09 11.71 8.46 70.56 12.89 6.77 62.26 62.27 -75.30 61.72 63.47 -73.60 coo 59.16 37.82 13.95 57.63 37.03 15.12 65.38 56.57 -48.58 66.15 54.57 -48.61 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 66 3 # 66 199 ASP E 187 ASP^? -2.71 MG MG E 301s 218 GLU F 63 GLU^? 27.81 MG MG E 302 329 ASP E 128 ASP^? -3.53 MG MG E 302s coo 49.16 35.16 15.19 51.08 34.43 15.65 67.50 63.43 -41.69 68.97 62.26 -42.81 coo 70.09 11.71 8.46 70.56 12.89 6.77 78.38 60.07 -72.34 78.48 58.04 -72.84 coo 59.16 37.82 13.95 57.63 37.03 15.12 65.38 56.57 -48.58 66.15 54.57 -48.61 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 67 3 # 67 199 ASP F 58 ASP^? 26.87 MG MG E 302 218 GLU F 38 GLU^? 21.28 MG MG F 302 329 ASP F 160 ASP^? 31.59 MG MG E 302 coo 49.16 35.16 15.19 51.08 34.43 15.65 75.55 64.68 -72.56 76.21 65.63 -70.79 coo 70.09 11.71 8.46 70.56 12.89 6.77 44.63 69.79 -79.91 44.13 69.05 -81.85 coo 59.16 37.82 13.95 57.63 37.03 15.12 71.27 74.59 -71.77 73.23 74.02 -72.37 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 68 3 # 68 199 ASP F 138 ASP^? 33.51 MG MG F 302 218 GLU E 75 GLU^? 15.76 MG MG D 301 329 ASP F 160 ASP^? 31.59 MG MG E 302 coo 49.16 35.16 15.19 51.08 34.43 15.65 77.17 76.66 -81.48 76.14 76.33 -83.32 coo 70.09 11.71 8.46 70.56 12.89 6.77 84.65 53.96 -59.58 85.64 52.81 -58.05 coo 59.16 37.82 13.95 57.63 37.03 15.12 71.27 74.59 -71.77 73.23 74.02 -72.37 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 69 3 # 69 199 ASP F 138 ASP^? 33.51 MG MG F 302 218 GLU F 38 GLU^? 21.28 MG MG F 302 329 ASP F 142 ASP^? 23.43 MG MG F 302 coo 49.16 35.16 15.19 51.08 34.43 15.65 77.17 76.66 -81.48 76.14 76.33 -83.32 coo 70.09 11.71 8.46 70.56 12.89 6.77 44.63 69.79 -79.91 44.13 69.05 -81.85 coo 59.16 37.82 13.95 57.63 37.03 15.12 71.46 69.88 -89.76 71.03 69.93 -91.81 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 70 3 # 70 199 ASP F 138 ASP^? 33.51 MG MG F 302 218 GLU F 38 GLU^? 21.28 MG MG F 302 329 ASP F 160 ASP^? 31.59 MG MG E 302 coo 49.16 35.16 15.19 51.08 34.43 15.65 77.17 76.66 -81.48 76.14 76.33 -83.32 coo 70.09 11.71 8.46 70.56 12.89 6.77 44.63 69.79 -79.91 44.13 69.05 -81.85 coo 59.16 37.82 13.95 57.63 37.03 15.12 71.27 74.59 -71.77 73.23 74.02 -72.37 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 71 3 # 71 199 ASP F 142 ASP^? 23.43 MG MG F 302 218 GLU E 154 GLU^? 19.05 MG MG E 302 329 ASP F 138 ASP^? 33.51 MG MG F 302 coo 49.16 35.16 15.19 51.08 34.43 15.65 71.46 69.88 -89.76 71.03 69.93 -91.81 coo 70.09 11.71 8.46 70.56 12.89 6.77 64.41 68.21 -58.47 65.40 69.20 -60.08 coo 59.16 37.82 13.95 57.63 37.03 15.12 77.17 76.66 -81.48 76.14 76.33 -83.32 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 72 3 # 72 199 ASP F 148 ASP^? 2.72 MG MG F 301s 218 GLU F 25 GLU^? 31.76 MG MG F 302 329 ASP F 177 ASP^? 8.15 MG MG F 302 coo 49.16 35.16 15.19 51.08 34.43 15.65 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 70.09 11.71 8.46 70.56 12.89 6.77 25.46 39.69 -92.49 25.45 39.72 -94.61 coo 59.16 37.82 13.95 57.63 37.03 15.12 47.18 61.22 -94.50 48.48 62.32 -95.73 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 73 3 # 73 199 ASP F 160 ASP^? 31.59 MG MG E 302 218 GLU E 94 GLU^? 18.90 MG MG E 302 329 ASP F 58 ASP^? 26.87 MG MG E 302 coo 49.16 35.16 15.19 51.08 34.43 15.65 71.27 74.59 -71.77 73.23 74.02 -72.37 coo 70.09 11.71 8.46 70.56 12.89 6.77 62.96 45.14 -58.39 62.13 44.53 -60.28 coo 59.16 37.82 13.95 57.63 37.03 15.12 75.55 64.68 -72.56 76.21 65.63 -70.79 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 74 3 # 74 199 ASP F 177 ASP^? 8.15 MG MG F 302 218 GLU E 54 GLU^? 22.83 MG MG E 302 329 ASP F 148 ASP^? 2.72 MG MG F 301s coo 49.16 35.16 15.19 51.08 34.43 15.65 47.18 61.22 -94.50 48.48 62.32 -95.73 coo 70.09 11.71 8.46 70.56 12.89 6.77 58.39 62.16 -64.12 58.73 62.98 -66.04 coo 59.16 37.82 13.95 57.63 37.03 15.12 53.64 56.47 -91.98 54.61 54.68 -92.64 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 75 3 # 75 199 ASP F 177 ASP^? 8.15 MG MG F 302 218 GLU E 54 GLU^? 22.83 MG MG E 302 329 ASP F 171 ASP^? 16.35 MG MG F 302 coo 49.16 35.16 15.19 51.08 34.43 15.65 47.18 61.22 -94.50 48.48 62.32 -95.73 coo 70.09 11.71 8.46 70.56 12.89 6.77 58.39 62.16 -64.12 58.73 62.98 -66.04 coo 59.16 37.82 13.95 57.63 37.03 15.12 48.23 68.08 -88.47 46.26 68.02 -87.56 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 76 3 # 76 199 ASP F 187 ASP^? -3.27 MG MG F 302s 218 GLU E 63 GLU^? 28.08 MG MG F 301 329 ASP F 128 ASP^? -3.41 MG MG F 301s coo 49.16 35.16 15.19 51.08 34.43 15.65 53.93 58.87 -98.14 52.45 58.62 -96.61 coo 70.09 11.71 8.46 70.56 12.89 6.77 44.04 53.99 -66.79 43.77 51.93 -66.35 coo 59.16 37.82 13.95 57.63 37.03 15.12 57.76 53.73 -90.50 57.46 51.64 -90.28 1uok_c04 source 1uok OLIGO-1,6-GLUCOSIDASE : 76 hits 1uok_c04 naa= 3 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 160 ASP^? 31.61 MG MG B 302 242 GLU B 54 GLU^? 22.94 MG MG B 302 329 ASP A 138 ASP^? 33.08 MG MG A 302 coo 49.16 35.16 15.19 51.08 34.43 15.65 44.21 5.00 19.54 46.02 3.84 19.76 coo 30.42 34.74 5.00 29.09 35.09 3.38 43.18 23.27 12.99 42.40 22.23 14.68 coo 59.16 37.82 13.95 57.63 37.03 15.12 47.10 -0.97 29.63 45.89 0.22 30.96 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP B 23 ASP^? 15.67 MG MG C 301 242 GLU C 174 GLU^? 19.72 MG MG C 301 329 ASP C 23 ASP^? 15.39 MG MG B 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 74.31 7.55 -1.09 75.08 9.17 -2.23 coo 30.42 34.74 5.00 29.09 35.09 3.38 95.09 14.29 -3.63 95.25 12.23 -4.17 coo 59.16 37.82 13.95 57.63 37.03 15.12 65.24 6.82 -5.11 63.43 7.54 -4.15 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP B 138 ASP^? 33.32 MG MG B 302 242 GLU A 33 GLU^? 22.87 MG MG A 301 329 ASP B 142 ASP^? 23.97 MG MG B 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 23.42 29.01 6.78 24.36 28.48 4.94 coo 30.42 34.74 5.00 29.09 35.09 3.38 33.74 38.67 24.96 34.13 38.85 22.87 coo 59.16 37.82 13.95 57.63 37.03 15.12 31.69 27.40 -1.31 32.10 27.37 -3.38 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP B 138 ASP^? 33.32 MG MG B 302 242 GLU A 38 GLU^? 21.81 MG MG A 302 329 ASP B 142 ASP^? 23.97 MG MG B 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 23.42 29.01 6.78 24.36 28.48 4.94 coo 30.42 34.74 5.00 29.09 35.09 3.38 26.42 25.01 28.02 26.98 25.90 29.89 coo 59.16 37.82 13.95 57.63 37.03 15.12 31.69 27.40 -1.31 32.10 27.37 -3.38 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP B 160 ASP^? 31.65 MG MG A 301 242 GLU A 54 GLU^? 22.98 MG MG A 301 329 ASP B 138 ASP^? 33.32 MG MG B 302 coo 49.16 35.16 15.19 51.08 34.43 15.65 28.01 24.83 16.38 27.44 26.81 15.80 coo 30.42 34.74 5.00 29.09 35.09 3.38 45.06 19.97 24.02 44.05 19.39 22.19 coo 59.16 37.82 13.95 57.63 37.03 15.12 23.42 29.01 6.78 24.36 28.48 4.94 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP B 160 ASP^? 31.65 MG MG A 301 242 GLU A 165 GLU^? 29.56 MG MG A 302 329 ASP B 138 ASP^? 33.32 MG MG B 302 coo 49.16 35.16 15.19 51.08 34.43 15.65 28.01 24.83 16.38 27.44 26.81 15.80 coo 30.42 34.74 5.00 29.09 35.09 3.38 36.12 8.31 27.27 37.25 6.55 27.60 coo 59.16 37.82 13.95 57.63 37.03 15.12 23.42 29.01 6.78 24.36 28.48 4.94 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 7 3 # 7 199 ASP B 160 ASP^? 31.65 MG MG A 301 242 GLU A 174 GLU^? 20.39 MG MG A 302 329 ASP B 138 ASP^? 33.32 MG MG B 302 coo 49.16 35.16 15.19 51.08 34.43 15.65 28.01 24.83 16.38 27.44 26.81 15.80 coo 30.42 34.74 5.00 29.09 35.09 3.38 25.88 23.57 38.04 23.76 23.95 38.22 coo 59.16 37.82 13.95 57.63 37.03 15.12 23.42 29.01 6.78 24.36 28.48 4.94 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 8 3 # 8 199 ASP C 23 ASP^? 15.39 MG MG B 301 242 GLU B 174 GLU^? 19.69 MG MG B 301 329 ASP B 23 ASP^? 15.67 MG MG C 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 65.24 6.82 -5.11 63.43 7.54 -4.15 coo 30.42 34.74 5.00 29.09 35.09 3.38 43.72 4.95 -3.28 44.76 3.14 -2.69 coo 59.16 37.82 13.95 57.63 37.03 15.12 74.31 7.55 -1.09 75.08 9.17 -2.23 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 9 3 # 9 199 ASP C 138 ASP^? 33.43 MG MG C 302 242 GLU D 38 GLU^? 21.83 MG MG D 301 329 ASP C 142 ASP^? 23.76 MG MG C 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 105.43 43.97 -13.30 104.85 43.08 -11.43 coo 30.42 34.74 5.00 29.09 35.09 3.38 103.22 39.19 -34.75 102.77 39.81 -36.73 coo 59.16 37.82 13.95 57.63 37.03 15.12 97.94 39.27 -5.03 98.08 38.70 -2.97 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 10 3 # 10 199 ASP C 160 ASP^? 31.63 MG MG D 302 242 GLU D 165 GLU^? 29.85 MG MG D 302 329 ASP C 138 ASP^? 33.43 MG MG C 302 coo 49.16 35.16 15.19 51.08 34.43 15.65 102.50 38.00 -23.28 102.43 39.97 -22.46 coo 30.42 34.74 5.00 29.09 35.09 3.38 100.60 20.11 -34.27 100.38 17.96 -34.49 coo 59.16 37.82 13.95 57.63 37.03 15.12 105.43 43.97 -13.30 104.85 43.08 -11.43 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 11 3 # 11 199 ASP C 177 ASP^? 8.84 MG MG C 301 242 GLU B 75 GLU^? 15.82 MG MG C 301 329 ASP C 171 ASP^? 17.08 MG MG C 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 85.60 16.42 -0.31 86.51 17.71 1.09 coo 30.42 34.74 5.00 29.09 35.09 3.38 68.81 12.14 8.61 69.95 13.49 7.45 coo 59.16 37.82 13.95 57.63 37.03 15.12 92.57 16.68 -6.24 92.24 14.74 -7.03 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 12 3 # 12 199 ASP D 23 ASP^? 15.37 MG MG E 301 242 GLU E 174 GLU^? 19.83 MG MG E 301 329 ASP E 23 ASP^? 15.43 MG MG D 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 85.70 62.10 -45.60 84.07 62.13 -46.93 coo 30.42 34.74 5.00 29.09 35.09 3.38 70.48 76.62 -49.45 71.76 78.34 -49.45 coo 59.16 37.82 13.95 57.63 37.03 15.12 91.98 54.64 -49.37 91.93 52.78 -48.33 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 13 3 # 13 199 ASP D 138 ASP^? 33.64 MG MG D 302 242 GLU C 33 GLU^? 22.71 MG MG C 302 329 ASP D 142 ASP^? 23.49 MG MG D 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 93.00 7.50 -35.79 93.88 8.48 -37.45 coo 30.42 34.74 5.00 29.09 35.09 3.38 78.39 11.67 -18.82 78.34 12.01 -20.91 coo 59.16 37.82 13.95 57.63 37.03 15.12 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 14 3 # 14 199 ASP D 138 ASP^? 33.64 MG MG D 302 242 GLU C 38 GLU^? 21.99 MG MG C 301 329 ASP D 142 ASP^? 23.49 MG MG D 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 93.00 7.50 -35.79 93.88 8.48 -37.45 coo 30.42 34.74 5.00 29.09 35.09 3.38 93.66 12.78 -15.08 92.73 12.51 -13.19 coo 59.16 37.82 13.95 57.63 37.03 15.12 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 15 3 # 15 199 ASP D 160 ASP^? 31.45 MG MG C 302 242 GLU C 54 GLU^? 22.77 MG MG C 302 329 ASP D 138 ASP^? 33.64 MG MG D 302 coo 49.16 35.16 15.19 51.08 34.43 15.65 94.15 13.98 -26.57 92.71 12.42 -26.99 coo 30.42 34.74 5.00 29.09 35.09 3.38 88.91 31.25 -19.52 89.97 30.69 -21.29 coo 59.16 37.82 13.95 57.63 37.03 15.12 93.00 7.50 -35.79 93.88 8.48 -37.45 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 16 3 # 16 199 ASP D 160 ASP^? 31.45 MG MG C 302 242 GLU C 165 GLU^? 29.32 MG MG C 302 329 ASP D 138 ASP^? 33.64 MG MG D 302 coo 49.16 35.16 15.19 51.08 34.43 15.65 94.15 13.98 -26.57 92.71 12.42 -26.99 coo 30.42 34.74 5.00 29.09 35.09 3.38 103.18 29.99 -15.18 103.57 32.09 -14.86 coo 59.16 37.82 13.95 57.63 37.03 15.12 93.00 7.50 -35.79 93.88 8.48 -37.45 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 17 3 # 17 199 ASP D 177 ASP^? 8.43 MG MG D 301 242 GLU E 75 GLU^? 15.76 MG MG D 301 329 ASP D 171 ASP^? 16.95 MG MG D 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 95.74 41.01 -49.76 94.81 39.90 -51.24 coo 30.42 34.74 5.00 29.09 35.09 3.38 84.65 53.96 -59.58 85.64 52.81 -58.05 coo 59.16 37.82 13.95 57.63 37.03 15.12 100.39 36.69 -43.49 101.13 38.51 -42.69 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 18 3 # 18 199 ASP E 23 ASP^? 15.43 MG MG D 301 242 GLU D 174 GLU^? 19.76 MG MG D 301 329 ASP D 23 ASP^? 15.37 MG MG E 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 91.98 54.64 -49.37 91.93 52.78 -48.33 coo 30.42 34.74 5.00 29.09 35.09 3.38 104.29 37.18 -46.00 105.30 38.94 -45.21 coo 59.16 37.82 13.95 57.63 37.03 15.12 85.70 62.10 -45.60 84.07 62.13 -46.93 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 19 3 # 19 199 ASP E 138 ASP^? 33.31 MG MG E 302 242 GLU F 38 GLU^? 21.28 MG MG F 302 329 ASP E 142 ASP^? 23.66 MG MG E 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 39.58 70.77 -58.63 40.74 70.78 -56.80 coo 30.42 34.74 5.00 29.09 35.09 3.38 44.63 69.79 -79.91 44.13 69.05 -81.85 coo 59.16 37.82 13.95 57.63 37.03 15.12 47.19 67.15 -50.37 47.44 67.18 -48.23 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 20 3 # 20 199 ASP E 160 ASP^? 31.54 MG MG F 301 242 GLU F 54 GLU^? 22.98 MG MG F 301 329 ASP E 138 ASP^? 33.31 MG MG E 302 coo 49.16 35.16 15.19 51.08 34.43 15.65 45.81 70.00 -68.45 44.10 68.87 -67.77 coo 30.42 34.74 5.00 29.09 35.09 3.38 62.26 62.27 -75.30 61.72 63.47 -73.60 coo 59.16 37.82 13.95 57.63 37.03 15.12 39.58 70.77 -58.63 40.74 70.78 -56.80 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 21 3 # 21 199 ASP E 160 ASP^? 31.54 MG MG F 301 242 GLU F 165 GLU^? 29.11 MG MG F 302 329 ASP E 138 ASP^? 33.31 MG MG E 302 coo 49.16 35.16 15.19 51.08 34.43 15.65 45.81 70.00 -68.45 44.10 68.87 -67.77 coo 30.42 34.74 5.00 29.09 35.09 3.38 63.01 76.49 -79.50 64.84 77.22 -80.35 coo 59.16 37.82 13.95 57.63 37.03 15.12 39.58 70.77 -58.63 40.74 70.78 -56.80 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 22 3 # 22 199 ASP F 138 ASP^? 33.51 MG MG F 302 242 GLU E 33 GLU^? 22.81 MG MG E 302 329 ASP F 142 ASP^? 23.43 MG MG F 302 coo 49.16 35.16 15.19 51.08 34.43 15.65 77.17 76.66 -81.48 76.14 76.33 -83.32 coo 30.42 34.74 5.00 29.09 35.09 3.38 80.16 62.57 -63.35 80.54 62.13 -65.43 coo 59.16 37.82 13.95 57.63 37.03 15.12 71.46 69.88 -89.76 71.03 69.93 -91.81 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 23 3 # 23 199 ASP F 138 ASP^? 33.51 MG MG F 302 242 GLU E 38 GLU^? 21.68 MG MG E 301 329 ASP F 142 ASP^? 23.43 MG MG F 302 coo 49.16 35.16 15.19 51.08 34.43 15.65 77.17 76.66 -81.48 76.14 76.33 -83.32 coo 30.42 34.74 5.00 29.09 35.09 3.38 72.42 75.53 -60.31 73.00 74.78 -58.42 coo 59.16 37.82 13.95 57.63 37.03 15.12 71.46 69.88 -89.76 71.03 69.93 -91.81 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 24 3 # 24 199 ASP F 160 ASP^? 31.59 MG MG E 302 242 GLU E 54 GLU^? 22.83 MG MG E 302 329 ASP F 138 ASP^? 33.51 MG MG F 302 coo 49.16 35.16 15.19 51.08 34.43 15.65 71.27 74.59 -71.77 73.23 74.02 -72.37 coo 30.42 34.74 5.00 29.09 35.09 3.38 58.39 62.16 -64.12 58.73 62.98 -66.04 coo 59.16 37.82 13.95 57.63 37.03 15.12 77.17 76.66 -81.48 76.14 76.33 -83.32 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 25 3 # 25 199 ASP F 160 ASP^? 31.59 MG MG E 302 242 GLU E 165 GLU^? 29.48 MG MG E 301 329 ASP F 138 ASP^? 33.51 MG MG F 302 coo 49.16 35.16 15.19 51.08 34.43 15.65 71.27 74.59 -71.77 73.23 74.02 -72.37 coo 30.42 34.74 5.00 29.09 35.09 3.38 52.92 74.97 -61.04 50.84 74.87 -60.51 coo 59.16 37.82 13.95 57.63 37.03 15.12 77.17 76.66 -81.48 76.14 76.33 -83.32 1uok_c05 source 1uok OLIGO-1,6-GLUCOSIDASE : 25 hits 1uok_c05 naa= 3 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 1 3 # 1 A 581 GLU A 38 GLU^? 21.81 MG MG A 302 A 596 ARG A 37 ARG^? 18.99 MG MG A 301 A 647 ARG A 48 ARG^? 25.29 MG MG A 301 coo 69.13 32.20 28.58 68.39 32.96 30.44 26.42 25.01 28.02 26.98 25.90 29.89 coo 70.89 37.31 29.70 69.54 36.29 32.39 32.99 26.50 25.19 35.50 25.33 26.51 coo 66.09 40.54 34.70 66.92 37.69 35.49 33.88 31.17 22.03 31.48 31.85 20.30 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 2 3 # 2 A 581 GLU A 154 GLU^? 19.22 MG MG A 301 A 596 ARG A 37 ARG^? 18.99 MG MG A 301 A 647 ARG A 48 ARG^? 25.29 MG MG A 301 coo 69.13 32.20 28.58 68.39 32.96 30.44 36.54 21.95 29.78 35.14 22.21 28.17 coo 70.89 37.31 29.70 69.54 36.29 32.39 32.99 26.50 25.19 35.50 25.33 26.51 coo 66.09 40.54 34.70 66.92 37.69 35.49 33.88 31.17 22.03 31.48 31.85 20.30 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 3 3 # 3 A 581 GLU A 154 GLU^? 19.22 MG MG A 301 A 596 ARG A 37 ARG^? 18.99 MG MG A 301 A 647 ARG A 50 ARG^? 15.98 MG MG A 301 coo 69.13 32.20 28.58 68.39 32.96 30.44 36.54 21.95 29.78 35.14 22.21 28.17 coo 70.89 37.31 29.70 69.54 36.29 32.39 32.99 26.50 25.19 35.50 25.33 26.51 coo 66.09 40.54 34.70 66.92 37.69 35.49 38.44 33.02 29.31 39.55 34.58 26.90 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 4 3 # 4 A 581 GLU B 38 GLU^? 21.75 MG MG B 301 A 596 ARG B 37 ARG^? 19.17 MG MG B 302 A 647 ARG B 48 ARG^? 25.20 MG MG B 302 coo 69.13 32.20 28.58 68.39 32.96 30.44 44.79 4.95 7.12 46.66 4.47 6.21 coo 70.89 37.31 29.70 69.54 36.29 32.39 47.41 10.20 11.40 46.99 12.91 10.22 coo 66.09 40.54 34.70 66.92 37.69 35.49 52.22 10.51 15.00 52.46 7.79 16.39 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 5 3 # 5 A 581 GLU C 38 GLU^? 21.99 MG MG C 301 A 596 ARG C 37 ARG^? 19.01 MG MG C 302 A 647 ARG C 48 ARG^? 25.02 MG MG C 302 coo 69.13 32.20 28.58 68.39 32.96 30.44 93.66 12.78 -15.08 92.73 12.51 -13.19 coo 70.89 37.31 29.70 69.54 36.29 32.39 89.36 17.23 -17.57 89.29 20.20 -16.76 coo 66.09 40.54 34.70 66.92 37.69 35.49 84.94 16.06 -21.53 85.81 13.55 -23.08 1v0e_c00 source 1v0e ENDO-ALPHA-SIALIDASE : 5 hits 1v0e_c00 naa= 3 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 1 3 # 1 B 581 GLU A 38 GLU^? 21.81 MG MG A 302 B 596 ARG A 37 ARG^? 18.99 MG MG A 301 B 647 ARG A 48 ARG^? 25.29 MG MG A 301 coo 38.22 57.83 70.36 36.82 56.74 69.18 26.42 25.01 28.02 26.98 25.90 29.89 coo 34.24 60.89 68.08 33.31 57.93 67.63 32.99 26.50 25.19 35.50 25.33 26.51 coo 31.43 57.38 61.97 31.90 55.58 64.41 33.88 31.17 22.03 31.48 31.85 20.30 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 2 3 # 2 B 581 GLU A 154 GLU^? 19.22 MG MG A 301 B 596 ARG A 37 ARG^? 18.99 MG MG A 301 B 647 ARG A 48 ARG^? 25.29 MG MG A 301 coo 38.22 57.83 70.36 36.82 56.74 69.18 36.54 21.95 29.78 35.14 22.21 28.17 coo 34.24 60.89 68.08 33.31 57.93 67.63 32.99 26.50 25.19 35.50 25.33 26.51 coo 31.43 57.38 61.97 31.90 55.58 64.41 33.88 31.17 22.03 31.48 31.85 20.30 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 3 3 # 3 B 581 GLU A 154 GLU^? 19.22 MG MG A 301 B 596 ARG A 37 ARG^? 18.99 MG MG A 301 B 647 ARG A 50 ARG^? 15.98 MG MG A 301 coo 38.22 57.83 70.36 36.82 56.74 69.18 36.54 21.95 29.78 35.14 22.21 28.17 coo 34.24 60.89 68.08 33.31 57.93 67.63 32.99 26.50 25.19 35.50 25.33 26.51 coo 31.43 57.38 61.97 31.90 55.58 64.41 38.44 33.02 29.31 39.55 34.58 26.90 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 4 3 # 4 B 581 GLU B 38 GLU^? 21.75 MG MG B 301 B 596 ARG B 37 ARG^? 19.17 MG MG B 302 B 647 ARG B 48 ARG^? 25.20 MG MG B 302 coo 38.22 57.83 70.36 36.82 56.74 69.18 44.79 4.95 7.12 46.66 4.47 6.21 coo 34.24 60.89 68.08 33.31 57.93 67.63 47.41 10.20 11.40 46.99 12.91 10.22 coo 31.43 57.38 61.97 31.90 55.58 64.41 52.22 10.51 15.00 52.46 7.79 16.39 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 5 3 # 5 B 581 GLU C 38 GLU^? 21.99 MG MG C 301 B 596 ARG C 37 ARG^? 19.01 MG MG C 302 B 647 ARG C 48 ARG^? 25.02 MG MG C 302 coo 38.22 57.83 70.36 36.82 56.74 69.18 93.66 12.78 -15.08 92.73 12.51 -13.19 coo 34.24 60.89 68.08 33.31 57.93 67.63 89.36 17.23 -17.57 89.29 20.20 -16.76 coo 31.43 57.38 61.97 31.90 55.58 64.41 84.94 16.06 -21.53 85.81 13.55 -23.08 1v0e_c01 source 1v0e ENDO-ALPHA-SIALIDASE : 5 hits 1v0e_c01 naa= 3 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 1 3 # 1 C 581 GLU A 38 GLU^? 21.81 MG MG A 302 C 596 ARG A 37 ARG^? 18.99 MG MG A 301 C 647 ARG A 48 ARG^? 25.29 MG MG A 301 coo 11.31 31.26 27.00 13.31 30.71 26.58 26.42 25.01 28.02 26.98 25.90 29.89 coo 13.44 32.78 22.07 15.56 30.91 23.37 32.99 26.50 25.19 35.50 25.33 26.51 coo 21.00 33.35 22.82 19.83 30.82 24.09 33.88 31.17 22.03 31.48 31.85 20.30 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 2 3 # 2 C 581 GLU A 154 GLU^? 19.22 MG MG A 301 C 596 ARG A 37 ARG^? 18.99 MG MG A 301 C 647 ARG A 48 ARG^? 25.29 MG MG A 301 coo 11.31 31.26 27.00 13.31 30.71 26.58 36.54 21.95 29.78 35.14 22.21 28.17 coo 13.44 32.78 22.07 15.56 30.91 23.37 32.99 26.50 25.19 35.50 25.33 26.51 coo 21.00 33.35 22.82 19.83 30.82 24.09 33.88 31.17 22.03 31.48 31.85 20.30 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 3 3 # 3 C 581 GLU A 154 GLU^? 19.22 MG MG A 301 C 596 ARG A 37 ARG^? 18.99 MG MG A 301 C 647 ARG A 50 ARG^? 15.98 MG MG A 301 coo 11.31 31.26 27.00 13.31 30.71 26.58 36.54 21.95 29.78 35.14 22.21 28.17 coo 13.44 32.78 22.07 15.56 30.91 23.37 32.99 26.50 25.19 35.50 25.33 26.51 coo 21.00 33.35 22.82 19.83 30.82 24.09 38.44 33.02 29.31 39.55 34.58 26.90 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 4 3 # 4 C 581 GLU B 38 GLU^? 21.75 MG MG B 301 C 596 ARG B 37 ARG^? 19.17 MG MG B 302 C 647 ARG B 48 ARG^? 25.20 MG MG B 302 coo 11.31 31.26 27.00 13.31 30.71 26.58 44.79 4.95 7.12 46.66 4.47 6.21 coo 13.44 32.78 22.07 15.56 30.91 23.37 47.41 10.20 11.40 46.99 12.91 10.22 coo 21.00 33.35 22.82 19.83 30.82 24.09 52.22 10.51 15.00 52.46 7.79 16.39 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 5 3 # 5 C 581 GLU B 154 GLU^? 19.05 MG MG B 302 C 596 ARG B 37 ARG^? 19.17 MG MG B 302 C 647 ARG B 48 ARG^? 25.20 MG MG B 302 coo 11.31 31.26 27.00 13.31 30.71 26.58 44.04 15.11 6.74 44.19 13.59 8.30 coo 13.44 32.78 22.07 15.56 30.91 23.37 47.41 10.20 11.40 46.99 12.91 10.22 coo 21.00 33.35 22.82 19.83 30.82 24.09 52.22 10.51 15.00 52.46 7.79 16.39 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 6 3 # 6 C 581 GLU C 38 GLU^? 21.99 MG MG C 301 C 596 ARG C 37 ARG^? 19.01 MG MG C 302 C 647 ARG C 48 ARG^? 25.02 MG MG C 302 coo 11.31 31.26 27.00 13.31 30.71 26.58 93.66 12.78 -15.08 92.73 12.51 -13.19 coo 13.44 32.78 22.07 15.56 30.91 23.37 89.36 17.23 -17.57 89.29 20.20 -16.76 coo 21.00 33.35 22.82 19.83 30.82 24.09 84.94 16.06 -21.53 85.81 13.55 -23.08 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 7 3 # 7 C 581 GLU C 154 GLU^? 18.91 MG MG C 302 C 596 ARG C 37 ARG^? 19.01 MG MG C 302 C 647 ARG C 48 ARG^? 25.02 MG MG C 302 coo 11.31 31.26 27.00 13.31 30.71 26.58 91.15 23.27 -13.33 91.61 21.91 -14.95 coo 13.44 32.78 22.07 15.56 30.91 23.37 89.36 17.23 -17.57 89.29 20.20 -16.76 coo 21.00 33.35 22.82 19.83 30.82 24.09 84.94 16.06 -21.53 85.81 13.55 -23.08 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 8 3 # 8 C 581 GLU C 154 GLU^? 18.91 MG MG C 302 C 596 ARG C 37 ARG^? 19.01 MG MG C 302 C 647 ARG C 50 ARG^? 16.05 MG MG C 302 coo 11.31 31.26 27.00 13.31 30.71 26.58 91.15 23.27 -13.33 91.61 21.91 -14.95 coo 13.44 32.78 22.07 15.56 30.91 23.37 89.36 17.23 -17.57 89.29 20.20 -16.76 coo 21.00 33.35 22.82 19.83 30.82 24.09 80.61 19.03 -14.42 79.16 18.55 -17.10 1v0e_c02 source 1v0e ENDO-ALPHA-SIALIDASE : 8 hits 1v0e_c02 naa= 3 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 1 3 # 1 D 581 GLU A 38 GLU^? 21.81 MG MG A 302 D 596 ARG A 37 ARG^? 18.99 MG MG A 301 D 647 ARG A 48 ARG^? 25.29 MG MG A 301 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 26.42 25.01 28.02 26.98 25.90 29.89 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 32.99 26.50 25.19 35.50 25.33 26.51 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 33.88 31.17 22.03 31.48 31.85 20.30 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 2 3 # 2 D 581 GLU A 154 GLU^? 19.22 MG MG A 301 D 596 ARG A 37 ARG^? 18.99 MG MG A 301 D 647 ARG A 48 ARG^? 25.29 MG MG A 301 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 36.54 21.95 29.78 35.14 22.21 28.17 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 32.99 26.50 25.19 35.50 25.33 26.51 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 33.88 31.17 22.03 31.48 31.85 20.30 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 3 3 # 3 D 581 GLU A 154 GLU^? 19.22 MG MG A 301 D 596 ARG A 37 ARG^? 18.99 MG MG A 301 D 647 ARG A 50 ARG^? 15.98 MG MG A 301 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 36.54 21.95 29.78 35.14 22.21 28.17 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 32.99 26.50 25.19 35.50 25.33 26.51 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 38.44 33.02 29.31 39.55 34.58 26.90 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 4 3 # 4 D 581 GLU B 38 GLU^? 21.75 MG MG B 301 D 596 ARG B 37 ARG^? 19.17 MG MG B 302 D 647 ARG B 48 ARG^? 25.20 MG MG B 302 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 44.79 4.95 7.12 46.66 4.47 6.21 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 47.41 10.20 11.40 46.99 12.91 10.22 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 52.22 10.51 15.00 52.46 7.79 16.39 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 5 3 # 5 D 581 GLU C 38 GLU^? 21.99 MG MG C 301 D 596 ARG C 37 ARG^? 19.01 MG MG C 302 D 647 ARG C 48 ARG^? 25.02 MG MG C 302 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 93.66 12.78 -15.08 92.73 12.51 -13.19 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 89.36 17.23 -17.57 89.29 20.20 -16.76 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 84.94 16.06 -21.53 85.81 13.55 -23.08 1v0e_c03 source 1v0e ENDO-ALPHA-SIALIDASE : 5 hits 1v0e_c03 naa= 3 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 1 3 # 1 E 581 GLU A 38 GLU^? 21.81 MG MG A 302 E 596 ARG A 37 ARG^? 18.99 MG MG A 301 E 647 ARG A 48 ARG^? 25.29 MG MG A 301 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 26.42 25.01 28.02 26.98 25.90 29.89 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 32.99 26.50 25.19 35.50 25.33 26.51 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 33.88 31.17 22.03 31.48 31.85 20.30 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 2 3 # 2 E 581 GLU A 154 GLU^? 19.22 MG MG A 301 E 596 ARG A 37 ARG^? 18.99 MG MG A 301 E 647 ARG A 48 ARG^? 25.29 MG MG A 301 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 36.54 21.95 29.78 35.14 22.21 28.17 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 32.99 26.50 25.19 35.50 25.33 26.51 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 33.88 31.17 22.03 31.48 31.85 20.30 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 3 3 # 3 E 581 GLU A 154 GLU^? 19.22 MG MG A 301 E 596 ARG A 37 ARG^? 18.99 MG MG A 301 E 647 ARG A 50 ARG^? 15.98 MG MG A 301 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 36.54 21.95 29.78 35.14 22.21 28.17 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 32.99 26.50 25.19 35.50 25.33 26.51 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 38.44 33.02 29.31 39.55 34.58 26.90 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 4 3 # 4 E 581 GLU B 38 GLU^? 21.75 MG MG B 301 E 596 ARG B 37 ARG^? 19.17 MG MG B 302 E 647 ARG B 48 ARG^? 25.20 MG MG B 302 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 44.79 4.95 7.12 46.66 4.47 6.21 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 47.41 10.20 11.40 46.99 12.91 10.22 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 52.22 10.51 15.00 52.46 7.79 16.39 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 5 3 # 5 E 581 GLU C 38 GLU^? 21.99 MG MG C 301 E 596 ARG C 37 ARG^? 19.01 MG MG C 302 E 647 ARG C 48 ARG^? 25.02 MG MG C 302 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 93.66 12.78 -15.08 92.73 12.51 -13.19 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 89.36 17.23 -17.57 89.29 20.20 -16.76 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 84.94 16.06 -21.53 85.81 13.55 -23.08 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 6 3 # 6 E 581 GLU D 38 GLU^? 21.83 MG MG D 301 E 596 ARG D 37 ARG^? 18.81 MG MG D 302 E 647 ARG D 48 ARG^? 24.87 MG MG D 302 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 103.22 39.19 -34.75 102.77 39.81 -36.73 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 96.81 38.21 -31.63 94.97 36.32 -33.06 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 94.06 41.76 -28.37 96.24 43.38 -26.96 1v0e_c04 source 1v0e ENDO-ALPHA-SIALIDASE : 6 hits 1v0e_c04 naa= 3 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 1 3 # 1 F 581 GLU B 38 GLU^? 21.75 MG MG B 301 F 596 ARG B 37 ARG^? 19.17 MG MG B 302 F 647 ARG B 48 ARG^? 25.20 MG MG B 302 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 44.79 4.95 7.12 46.66 4.47 6.21 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 47.41 10.20 11.40 46.99 12.91 10.22 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 52.22 10.51 15.00 52.46 7.79 16.39 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 2 3 # 2 F 581 GLU C 38 GLU^? 21.99 MG MG C 301 F 596 ARG C 37 ARG^? 19.01 MG MG C 302 F 647 ARG C 48 ARG^? 25.02 MG MG C 302 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 93.66 12.78 -15.08 92.73 12.51 -13.19 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 89.36 17.23 -17.57 89.29 20.20 -16.76 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 84.94 16.06 -21.53 85.81 13.55 -23.08 1v0e_c05 source 1v0e ENDO-ALPHA-SIALIDASE : 2 hits 1v0e_c05 naa= 3 ULMN 3 1vom_c00 MYOSIN user 1 3 # 1 233 ASN A 45 ASN^? 24.62 MG MG B 302 457 GLY A 71 GLY^? 17.05 MG MG A 301 459 GLU A 52 GLU^? 19.89 MG MG A 301 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 42.72 26.12 17.32 44.44 25.00 17.78 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 42.53 33.15 24.80 43.14 33.53 25.16 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 42.67 25.16 24.80 42.61 25.77 22.75 ULMN 3 1vom_c00 MYOSIN user 2 3 # 2 233 ASN C 45 ASN^? 24.54 MG MG C 302 457 GLY C 71 GLY^? 16.48 MG MG C 302 459 GLU C 52 GLU^? 19.67 MG MG C 302 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 85.43 25.82 -26.31 85.43 27.91 -25.97 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 78.74 22.16 -18.87 78.10 22.58 -18.62 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 84.27 26.98 -19.19 85.21 26.16 -20.96 ULMN 3 1vom_c00 MYOSIN user 3 3 # 3 233 ASN E 45 ASN^? 24.46 MG MG F 301 457 GLY E 71 GLY^? 16.95 MG MG E 302 459 GLU E 52 GLU^? 19.96 MG MG E 302 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 64.97 61.33 -71.05 63.29 60.06 -70.79 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 71.48 57.52 -63.50 71.50 56.77 -63.11 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 64.71 60.06 -63.78 64.69 61.36 -65.58 ULMN 3 1vom_c00 MYOSIN user 4 3 # 4 233 ASN F 45 ASN^? 24.43 MG MG E 302 457 GLY F 71 GLY^? 16.93 MG MG F 301 459 GLU F 52 GLU^? 20.13 MG MG F 301 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 56.42 59.79 -68.43 58.48 59.32 -68.69 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 51.61 53.62 -75.65 51.89 52.91 -76.00 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 57.09 59.62 -75.76 56.76 59.40 -73.62 1vom_c00 source 1vom MYOSIN : 4 hits 1vom_c00 naa= 3 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 1 3 # 1 A 100 PHE C 32 PHE^? 15.72 MG MG C 302 A 197 ASN C 118 ASN^? 13.08 MG MG C 302 A 198 PRO C 119 PRO^? 14.18 MG MG C 302 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 73.89 13.66 -12.38 71.29 14.19 -11.42 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 72.64 19.83 -10.69 72.07 18.17 -11.94 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 70.85 21.90 -15.48 70.06 21.91 -13.40 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 2 3 # 2 A 100 PHE C 32 PHE^? 15.72 MG MG C 302 A 197 ASN C 121 ASN^? 13.53 MG MG C 302 A 198 PRO C 119 PRO^? 14.18 MG MG C 302 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 73.89 13.66 -12.38 71.29 14.19 -11.42 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 69.55 17.44 -9.40 69.18 16.30 -7.63 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 70.85 21.90 -15.48 70.06 21.91 -13.40 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 3 3 # 3 A 100 PHE D 32 PHE^? 15.68 MG MG D 302 A 197 ASN D 118 ASN^? 13.31 MG MG D 302 A 198 PRO D 119 PRO^? 14.74 MG MG D 302 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 87.15 50.70 -38.09 84.99 51.79 -39.44 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 82.29 46.70 -39.94 83.03 48.22 -38.68 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 79.79 46.26 -35.22 79.03 46.66 -37.29 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 4 3 # 4 A 100 PHE D 32 PHE^? 15.68 MG MG D 302 A 197 ASN D 121 ASN^? 14.25 MG MG E 302 A 198 PRO D 119 PRO^? 14.74 MG MG D 302 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 87.15 50.70 -38.09 84.99 51.79 -39.44 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 80.38 49.72 -41.99 81.55 51.54 -42.09 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 79.79 46.26 -35.22 79.03 46.66 -37.29 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 5 3 # 5 A 100 PHE E 32 PHE^? 15.82 MG MG E 302 A 197 ASN E 118 ASN^? 13.13 MG MG E 302 A 198 PRO E 119 PRO^? 14.53 MG MG E 302 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 81.32 57.98 -56.67 82.02 55.52 -55.49 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 76.50 53.47 -54.63 78.11 53.97 -55.93 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 75.96 51.35 -59.42 76.19 50.48 -57.34 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 6 3 # 6 A 100 PHE F 32 PHE^? 15.64 MG MG F 301 A 197 ASN F 118 ASN^? 13.34 MG MG F 301 A 198 PRO F 119 PRO^? 14.46 MG MG F 301 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 42.40 50.26 -82.52 42.59 47.55 -83.32 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 48.40 47.22 -84.16 46.70 46.61 -82.99 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 49.63 46.31 -79.28 50.07 45.00 -81.03 1vq1_c00 source 1vq1 N5-GLUTAMINE METHYLTRANSFERASE, HEMK : 6 hits 1vq1_c00 naa= 3 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 1 3 # 1 B 100 PHE A 32 PHE^? 15.95 MG MG A 301 B 197 ASN A 118 ASN^? 13.27 MG MG A 301 B 198 PRO A 119 PRO^? 14.31 MG MG A 301 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 37.63 41.69 31.55 39.27 43.59 32.74 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 43.06 39.25 33.60 42.05 40.75 32.42 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 45.83 39.92 29.07 46.23 40.45 31.16 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 2 3 # 2 B 100 PHE B 32 PHE^? 15.77 MG MG B 302 B 197 ASN B 118 ASN^? 13.44 MG MG B 302 B 198 PRO B 119 PRO^? 14.64 MG MG B 302 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 63.68 12.44 5.83 65.90 13.72 4.72 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 63.19 18.87 4.27 64.22 17.47 5.51 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 63.65 20.51 9.24 64.36 21.39 7.30 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 3 3 # 3 B 100 PHE C 32 PHE^? 15.72 MG MG C 302 B 197 ASN C 118 ASN^? 13.08 MG MG C 302 B 198 PRO C 119 PRO^? 14.18 MG MG C 302 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 73.89 13.66 -12.38 71.29 14.19 -11.42 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 72.64 19.83 -10.69 72.07 18.17 -11.94 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 70.85 21.90 -15.48 70.06 21.91 -13.40 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 4 3 # 4 B 100 PHE C 32 PHE^? 15.72 MG MG C 302 B 197 ASN C 121 ASN^? 13.53 MG MG C 302 B 198 PRO C 119 PRO^? 14.18 MG MG C 302 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 73.89 13.66 -12.38 71.29 14.19 -11.42 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 69.55 17.44 -9.40 69.18 16.30 -7.63 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 70.85 21.90 -15.48 70.06 21.91 -13.40 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 5 3 # 5 B 100 PHE D 32 PHE^? 15.68 MG MG D 302 B 197 ASN D 118 ASN^? 13.31 MG MG D 302 B 198 PRO D 119 PRO^? 14.74 MG MG D 302 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 87.15 50.70 -38.09 84.99 51.79 -39.44 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 82.29 46.70 -39.94 83.03 48.22 -38.68 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 79.79 46.26 -35.22 79.03 46.66 -37.29 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 6 3 # 6 B 100 PHE D 32 PHE^? 15.68 MG MG D 302 B 197 ASN D 121 ASN^? 14.25 MG MG E 302 B 198 PRO D 119 PRO^? 14.74 MG MG D 302 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 87.15 50.70 -38.09 84.99 51.79 -39.44 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 80.38 49.72 -41.99 81.55 51.54 -42.09 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 79.79 46.26 -35.22 79.03 46.66 -37.29 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 7 3 # 7 B 100 PHE E 32 PHE^? 15.82 MG MG E 302 B 197 ASN E 118 ASN^? 13.13 MG MG E 302 B 198 PRO E 119 PRO^? 14.53 MG MG E 302 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 81.32 57.98 -56.67 82.02 55.52 -55.49 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 76.50 53.47 -54.63 78.11 53.97 -55.93 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 75.96 51.35 -59.42 76.19 50.48 -57.34 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 8 3 # 8 B 100 PHE F 32 PHE^? 15.64 MG MG F 301 B 197 ASN F 118 ASN^? 13.34 MG MG F 301 B 198 PRO F 119 PRO^? 14.46 MG MG F 301 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 42.40 50.26 -82.52 42.59 47.55 -83.32 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 48.40 47.22 -84.16 46.70 46.61 -82.99 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 49.63 46.31 -79.28 50.07 45.00 -81.03 1vq1_c01 source 1vq1 N5-GLUTAMINE METHYLTRANSFERASE, HEMK : 8 hits 1vq1_c01 naa= 3 ULMN 3 1vzx_c02 2.04.01.0087 user 1 3 # 1 A 314 TYR A 67 TYR^? 21.33 MG MG A 301 A 317 GLU A 52 GLU^? 19.89 MG MG A 301 A 365 ARG B 8 ARG^? 20.39 MG MG B 302 coo 1.77 6.56 57.05 3.05 7.44 59.37 48.62 23.20 22.09 46.84 25.23 21.44 coo 3.06 2.85 52.79 4.83 3.89 53.24 42.67 25.16 24.80 42.61 25.77 22.75 coo 3.82 17.09 49.56 4.09 14.32 50.84 41.99 18.82 11.83 44.91 18.76 12.93 ULMN 3 1vzx_c02 2.04.01.0087 user 2 3 # 2 A 314 TYR A 67 TYR^? 21.33 MG MG A 301 A 317 GLU A 54 GLU^? 22.98 MG MG A 301 A 365 ARG B 8 ARG^? 20.39 MG MG B 302 coo 1.77 6.56 57.05 3.05 7.44 59.37 48.62 23.20 22.09 46.84 25.23 21.44 coo 3.06 2.85 52.79 4.83 3.89 53.24 45.06 19.97 24.02 44.05 19.39 22.19 coo 3.82 17.09 49.56 4.09 14.32 50.84 41.99 18.82 11.83 44.91 18.76 12.93 ULMN 3 1vzx_c02 2.04.01.0087 user 3 3 # 3 A 314 TYR A 67 TYR^? 21.33 MG MG A 301 A 317 GLU A 54 GLU^? 22.98 MG MG A 301 A 365 ARG B 48 ARG^? 25.20 MG MG B 302 coo 1.77 6.56 57.05 3.05 7.44 59.37 48.62 23.20 22.09 46.84 25.23 21.44 coo 3.06 2.85 52.79 4.83 3.89 53.24 45.06 19.97 24.02 44.05 19.39 22.19 coo 3.82 17.09 49.56 4.09 14.32 50.84 52.22 10.51 15.00 52.46 7.79 16.39 ULMN 3 1vzx_c02 2.04.01.0087 user 4 3 # 4 A 314 TYR B 67 TYR^? 21.41 MG MG B 302 A 317 GLU B 52 GLU^? 20.06 MG MG B 302 A 365 ARG A 8 ARG^? 20.36 MG MG A 301 coo 1.77 6.56 57.05 3.05 7.44 59.37 46.94 25.86 15.48 48.70 23.84 16.15 coo 3.06 2.85 52.79 4.83 3.89 53.24 47.87 20.25 12.36 48.11 19.69 14.43 coo 3.82 17.09 49.56 4.09 14.32 50.84 40.62 19.52 24.63 40.98 22.51 23.88 ULMN 3 1vzx_c02 2.04.01.0087 user 5 3 # 5 A 314 TYR C 67 TYR^? 21.03 MG MG C 302 A 317 GLU C 52 GLU^? 19.67 MG MG C 302 A 365 ARG D 8 ARG^? 20.22 MG MG D 302 coo 1.77 6.56 57.05 3.05 7.44 59.37 84.52 32.45 -21.76 83.69 29.84 -22.37 coo 3.06 2.85 52.79 4.83 3.89 53.24 84.27 26.98 -19.19 85.21 26.16 -20.96 coo 3.82 17.09 49.56 4.09 14.32 50.84 92.22 28.83 -31.23 90.93 31.55 -30.54 ULMN 3 1vzx_c02 2.04.01.0087 user 6 3 # 6 A 314 TYR C 67 TYR^? 21.03 MG MG C 302 A 317 GLU C 54 GLU^? 22.77 MG MG C 302 A 365 ARG D 48 ARG^? 24.87 MG MG D 302 coo 1.77 6.56 57.05 3.05 7.44 59.37 84.52 32.45 -21.76 83.69 29.84 -22.37 coo 3.06 2.85 52.79 4.83 3.89 53.24 88.91 31.25 -19.52 89.97 30.69 -21.29 coo 3.82 17.09 49.56 4.09 14.32 50.84 94.06 41.76 -28.37 96.24 43.38 -26.96 ULMN 3 1vzx_c02 2.04.01.0087 user 7 3 # 7 A 314 TYR D 67 TYR^? 21.42 MG MG D 302 A 317 GLU D 52 GLU^? 19.94 MG MG D 302 A 365 ARG C 8 ARG^? 20.00 MG MG C 302 coo 1.77 6.56 57.05 3.05 7.44 59.37 83.62 29.64 -28.35 84.67 32.17 -27.90 coo 3.06 2.85 52.79 4.83 3.89 53.24 87.13 33.17 -30.97 88.40 33.70 -29.31 coo 3.82 17.09 49.56 4.09 14.32 50.84 91.42 27.61 -18.53 88.82 26.28 -19.38 ULMN 3 1vzx_c02 2.04.01.0087 user 8 3 # 8 A 314 TYR E 67 TYR^? 21.41 MG MG E 302 A 317 GLU E 52 GLU^? 19.96 MG MG E 302 A 365 ARG F 8 ARG^? 20.20 MG MG F 301 coo 1.77 6.56 57.05 3.05 7.44 59.37 59.76 57.41 -66.37 62.46 58.08 -67.03 coo 3.06 2.85 52.79 4.83 3.89 53.24 64.71 60.06 -63.78 64.69 61.36 -65.58 coo 3.82 17.09 49.56 4.09 14.32 50.84 58.98 65.22 -76.31 57.29 62.84 -75.38 ULMN 3 1vzx_c02 2.04.01.0087 user 9 3 # 9 A 314 TYR E 67 TYR^? 21.41 MG MG E 302 A 317 GLU E 54 GLU^? 22.83 MG MG E 302 A 365 ARG F 48 ARG^? 25.18 MG MG F 301 coo 1.77 6.56 57.05 3.05 7.44 59.37 59.76 57.41 -66.37 62.46 58.08 -67.03 coo 3.06 2.85 52.79 4.83 3.89 53.24 58.39 62.16 -64.12 58.73 62.98 -66.04 coo 3.82 17.09 49.56 4.09 14.32 50.84 46.82 60.90 -73.07 44.43 61.88 -71.46 ULMN 3 1vzx_c02 2.04.01.0087 user 10 3 # 10 A 314 TYR F 67 TYR^? 21.41 MG MG F 301 A 317 GLU F 52 GLU^? 20.13 MG MG F 301 A 365 ARG E 8 ARG^? 20.19 MG MG E 302 coo 1.77 6.56 57.05 3.05 7.44 59.37 62.63 57.65 -72.90 59.95 57.21 -72.29 coo 3.06 2.85 52.79 4.83 3.89 53.24 57.09 59.62 -75.76 56.76 59.40 -73.62 coo 3.82 17.09 49.56 4.09 14.32 50.84 60.42 66.09 -63.48 62.84 64.38 -64.17 ULMN 3 1vzx_c02 2.04.01.0087 user 11 3 # 11 A 314 TYR F 67 TYR^? 21.41 MG MG F 301 A 317 GLU F 54 GLU^? 22.98 MG MG F 301 A 365 ARG E 48 ARG^? 25.02 MG MG E 302 coo 1.77 6.56 57.05 3.05 7.44 59.37 62.63 57.65 -72.90 59.95 57.21 -72.29 coo 3.06 2.85 52.79 4.83 3.89 53.24 62.26 62.27 -75.30 61.72 63.47 -73.60 coo 3.82 17.09 49.56 4.09 14.32 50.84 73.60 65.75 -66.57 75.51 67.67 -67.91 1vzx_c02 source 1vzx 2.04.01.0087 : 11 hits 1vzx_c02 naa= 3 ULMN 3 1vzx_c03 2.04.01.0087 user 1 3 # 1 B1314 TYR A 67 TYR^? 21.33 MG MG A 301 B1317 GLU A 52 GLU^? 19.89 MG MG A 301 B1365 ARG B 8 ARG^? 20.39 MG MG B 302 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 48.62 23.20 22.09 46.84 25.23 21.44 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 42.67 25.16 24.80 42.61 25.77 22.75 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 41.99 18.82 11.83 44.91 18.76 12.93 ULMN 3 1vzx_c03 2.04.01.0087 user 2 3 # 2 B1314 TYR A 67 TYR^? 21.33 MG MG A 301 B1317 GLU A 54 GLU^? 22.98 MG MG A 301 B1365 ARG B 48 ARG^? 25.20 MG MG B 302 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 48.62 23.20 22.09 46.84 25.23 21.44 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 45.06 19.97 24.02 44.05 19.39 22.19 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 52.22 10.51 15.00 52.46 7.79 16.39 ULMN 3 1vzx_c03 2.04.01.0087 user 3 3 # 3 B1314 TYR B 67 TYR^? 21.41 MG MG B 302 B1317 GLU B 52 GLU^? 20.06 MG MG B 302 B1365 ARG A 8 ARG^? 20.36 MG MG A 301 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 46.94 25.86 15.48 48.70 23.84 16.15 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 47.87 20.25 12.36 48.11 19.69 14.43 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 40.62 19.52 24.63 40.98 22.51 23.88 ULMN 3 1vzx_c03 2.04.01.0087 user 4 3 # 4 B1314 TYR C 67 TYR^? 21.03 MG MG C 302 B1317 GLU C 52 GLU^? 19.67 MG MG C 302 B1365 ARG D 8 ARG^? 20.22 MG MG D 302 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 84.52 32.45 -21.76 83.69 29.84 -22.37 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 84.27 26.98 -19.19 85.21 26.16 -20.96 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 92.22 28.83 -31.23 90.93 31.55 -30.54 ULMN 3 1vzx_c03 2.04.01.0087 user 5 3 # 5 B1314 TYR C 67 TYR^? 21.03 MG MG C 302 B1317 GLU C 54 GLU^? 22.77 MG MG C 302 B1365 ARG D 48 ARG^? 24.87 MG MG D 302 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 84.52 32.45 -21.76 83.69 29.84 -22.37 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 88.91 31.25 -19.52 89.97 30.69 -21.29 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 94.06 41.76 -28.37 96.24 43.38 -26.96 ULMN 3 1vzx_c03 2.04.01.0087 user 6 3 # 6 B1314 TYR D 67 TYR^? 21.42 MG MG D 302 B1317 GLU D 52 GLU^? 19.94 MG MG D 302 B1365 ARG C 8 ARG^? 20.00 MG MG C 302 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 83.62 29.64 -28.35 84.67 32.17 -27.90 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 87.13 33.17 -30.97 88.40 33.70 -29.31 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 91.42 27.61 -18.53 88.82 26.28 -19.38 ULMN 3 1vzx_c03 2.04.01.0087 user 7 3 # 7 B1314 TYR E 67 TYR^? 21.41 MG MG E 302 B1317 GLU E 52 GLU^? 19.96 MG MG E 302 B1365 ARG F 8 ARG^? 20.20 MG MG F 301 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 59.76 57.41 -66.37 62.46 58.08 -67.03 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 64.71 60.06 -63.78 64.69 61.36 -65.58 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 58.98 65.22 -76.31 57.29 62.84 -75.38 ULMN 3 1vzx_c03 2.04.01.0087 user 8 3 # 8 B1314 TYR E 67 TYR^? 21.41 MG MG E 302 B1317 GLU E 54 GLU^? 22.83 MG MG E 302 B1365 ARG F 48 ARG^? 25.18 MG MG F 301 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 59.76 57.41 -66.37 62.46 58.08 -67.03 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 58.39 62.16 -64.12 58.73 62.98 -66.04 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 46.82 60.90 -73.07 44.43 61.88 -71.46 ULMN 3 1vzx_c03 2.04.01.0087 user 9 3 # 9 B1314 TYR F 67 TYR^? 21.41 MG MG F 301 B1317 GLU F 52 GLU^? 20.13 MG MG F 301 B1365 ARG E 8 ARG^? 20.19 MG MG E 302 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 62.63 57.65 -72.90 59.95 57.21 -72.29 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 57.09 59.62 -75.76 56.76 59.40 -73.62 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 60.42 66.09 -63.48 62.84 64.38 -64.17 1vzx_c03 source 1vzx 2.04.01.0087 : 9 hits 1vzx_c03 naa= 3 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR B 123 TYR^? 6.98 MG MG C 302 A 40 ASP C 128 ASP^? -3.22 MG MG C 302s A 103 LEU C 182 LEU^? 5.58 MG MG C 302s coo 12.09 16.13 10.57 11.28 18.80 10.73 69.94 23.37 -1.64 72.13 24.82 -0.63 coo 7.55 25.51 14.34 9.65 25.73 14.24 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 11.83 18.73 16.99 10.99 19.71 15.26 77.67 20.58 -3.32 78.49 20.15 -5.31 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 2 3 # 2 A 16 TYR D 123 TYR^? 7.28 MG MG E 302 A 40 ASP E 128 ASP^? -3.53 MG MG E 302s A 103 LEU E 182 LEU^? -5.68 MG MG E 302s coo 12.09 16.13 10.57 11.28 18.80 10.73 74.61 49.90 -45.90 72.05 50.79 -45.27 coo 7.55 25.51 14.34 9.65 25.73 14.24 65.38 56.57 -48.58 66.15 54.57 -48.61 coo 11.83 18.73 16.99 10.99 19.71 15.26 73.35 58.39 -47.69 73.54 59.04 -49.77 1vzz_c00 source 1vzz STEROID DELTA-ISOMERASE : 2 hits 1vzz_c00 naa= 3 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR B 123 TYR^? 6.98 MG MG C 302 B 40 ASP C 128 ASP^? -3.22 MG MG C 302s B 103 LEU C 182 LEU^? 5.58 MG MG C 302s coo 14.25 20.09 37.35 13.48 17.40 37.38 69.94 23.37 -1.64 72.13 24.82 -0.63 coo 9.39 10.77 34.53 11.50 10.63 34.41 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 12.89 17.60 31.13 12.34 16.51 32.90 77.67 20.58 -3.32 78.49 20.15 -5.31 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 2 3 # 2 B 16 TYR D 123 TYR^? 7.28 MG MG E 302 B 40 ASP E 128 ASP^? -3.53 MG MG E 302s B 103 LEU E 182 LEU^? -5.68 MG MG E 302s coo 14.25 20.09 37.35 13.48 17.40 37.38 74.61 49.90 -45.90 72.05 50.79 -45.27 coo 9.39 10.77 34.53 11.50 10.63 34.41 65.38 56.57 -48.58 66.15 54.57 -48.61 coo 12.89 17.60 31.13 12.34 16.51 32.90 73.35 58.39 -47.69 73.54 59.04 -49.77 1vzz_c01 source 1vzz STEROID DELTA-ISOMERASE : 2 hits 1vzz_c01 naa= 3 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 1 3 # 1 A 105 HIS B 147 HIS^? 9.27 MG MG B 301 A 169 ASP B 171 ASP^? 16.92 MG MG B 301 A 288 GLU B 38 GLU^? 21.75 MG MG B 301 coo 67.72 35.99 30.87 69.77 36.13 31.33 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 73.17 30.66 22.56 72.87 30.30 20.46 45.30 8.50 -0.71 46.30 6.81 0.12 coo 74.06 28.51 15.92 73.77 29.56 17.73 44.79 4.95 7.12 46.66 4.47 6.21 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 2 3 # 2 A 105 HIS B 147 HIS^? 9.27 MG MG B 301 A 169 ASP B 177 ASP^? 9.03 MG MG B 301 A 288 GLU C 25 GLU^? 12.27 MG MG B 301 coo 67.72 35.99 30.87 69.77 36.13 31.33 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 73.17 30.66 22.56 72.87 30.30 20.46 51.97 11.04 -6.64 50.39 11.62 -7.94 coo 74.06 28.51 15.92 73.77 29.56 17.73 58.50 6.48 -3.59 57.94 8.54 -3.41 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 3 3 # 3 A 105 HIS D 147 HIS^? 9.43 MG MG D 301 A 169 ASP D 177 ASP^? 8.43 MG MG D 301 A 288 GLU E 25 GLU^? 12.55 MG MG D 301 coo 67.72 35.99 30.87 69.77 36.13 31.33 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 73.17 30.66 22.56 72.87 30.30 20.46 95.74 41.01 -49.76 94.81 39.90 -51.24 coo 74.06 28.51 15.92 73.77 29.56 17.73 95.44 49.40 -47.17 93.82 48.00 -47.21 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 4 3 # 4 A 105 HIS E 147 HIS^? 9.22 MG MG E 301 A 169 ASP E 177 ASP^? 8.55 MG MG E 301 A 288 GLU D 25 GLU^? 12.44 MG MG E 301 coo 67.72 35.99 30.87 69.77 36.13 31.33 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 73.17 30.66 22.56 72.87 30.30 20.46 72.81 67.32 -45.03 71.14 67.96 -43.95 coo 74.06 28.51 15.92 73.77 29.56 17.73 81.26 66.22 -47.78 79.52 64.98 -48.06 1w1o_c00 source 1w1o CYTOKININ DEHYDROGENASE 1 : 4 hits 1w1o_c00 naa= 3 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 1 3 # 1 A 183 GLY A 184 GLY^? 4.07 MG MG A 302 B 419 GLY A 183 GLY^? -4.64 MG MG A 301s B 420 ALA A 181 ALA^? -5.18 MG MG A 302s coo 26.12 -67.67-130.71 26.18 -67.32-131.45 44.11 32.36 47.58 44.42 32.35 46.80 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 42.94 34.42 44.60 42.51 33.67 44.58 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 38.08 32.08 44.23 37.12 30.96 43.87 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 2 3 # 2 A 183 GLY B 184 GLY^? 4.47 MG MG B 301 B 419 GLY B 183 GLY^? -4.35 MG MG B 301s B 420 ALA B 181 ALA^? -4.86 MG MG B 301s coo 26.12 -67.67-130.71 26.18 -67.32-131.45 57.32 22.02 -9.75 57.17 22.15 -8.93 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 58.74 20.22 -6.73 58.00 19.87 -6.89 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 55.54 15.65 -6.80 54.26 14.84 -6.58 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 3 3 # 3 A 183 GLY C 184 GLY^? 4.50 MG MG C 301 B 419 GLY C 183 GLY^? -4.00 MG MG C 301s B 420 ALA C 181 ALA^? -4.94 MG MG C 301s coo 26.12 -67.67-130.71 26.18 -67.32-131.45 76.47 24.88 3.34 76.71 25.04 2.53 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 76.27 22.45 0.43 77.06 22.50 0.60 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 80.65 19.58 0.32 82.11 19.32 0.03 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 4 3 # 4 A 183 GLY D 184 GLY^? 4.28 MG MG D 301 B 419 GLY D 183 GLY^? -4.40 MG MG D 301s B 420 ALA D 181 ALA^? -4.93 MG MG D 301s coo 26.12 -67.67-130.71 26.18 -67.32-131.45 83.33 40.04 -53.77 83.20 39.83 -52.97 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 84.07 42.30 -50.78 84.70 41.81 -50.82 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 89.39 41.74 -50.56 90.67 41.02 -50.20 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 5 3 # 5 A 183 GLY E 184 GLY^? 4.85 MG MG E 301 B 419 GLY E 183 GLY^? -4.49 MG MG E 301s B 420 ALA E 180 ALA^? 7.76 MG MG E 301 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 69.91 55.36 -41.13 69.77 55.58 -41.87 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 72.33 56.33 -43.87 71.83 56.99 -43.77 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 76.35 60.44 -44.08 76.96 60.95 -42.80 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 6 3 # 6 A 183 GLY E 184 GLY^? 4.85 MG MG E 301 B 419 GLY E 183 GLY^? -4.49 MG MG E 301s B 420 ALA E 181 ALA^? -4.51 MG MG E 301s coo 26.12 -67.67-130.71 26.18 -67.32-131.45 69.91 55.36 -41.13 69.77 55.58 -41.87 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 72.33 56.33 -43.87 71.83 56.99 -43.77 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 72.69 61.53 -44.13 72.20 62.95 -44.39 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 7 3 # 7 A 183 GLY F 184 GLY^? 4.93 MG MG F 302 B 419 GLY F 183 GLY^? -4.39 MG MG F 301s B 420 ALA F 181 ALA^? -4.41 MG MG F 302s coo 26.12 -67.67-130.71 26.18 -67.32-131.45 53.59 51.24 -98.07 53.82 51.26 -97.25 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 51.40 50.96 -94.96 51.47 51.79 -95.11 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 49.03 55.67 -94.95 49.00 57.19 -94.78 1xny_c00 source 1xny PROPIONYL-COA CARBOXYLASE COMPLEX B SUBUNIT : 7 hits 1xny_c00 naa= 3 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 1 3 # 1 A 420 ALA A 179 ALA^? 10.50 MG MG A 302 B 182 GLY A 184 GLY^? 4.07 MG MG A 302 B 183 GLY A 183 GLY^? -4.64 MG MG A 301s coo 38.36-101.47-135.52 39.62-101.29-136.35 35.90 35.25 40.82 35.84 36.46 39.90 coo 41.93-102.35-126.87 41.52-101.89-126.30 44.11 32.36 47.58 44.42 32.35 46.80 coo 38.37-101.99-128.11 38.63-102.24-127.37 42.94 34.42 44.60 42.51 33.67 44.58 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 2 3 # 2 A 420 ALA A 180 ALA^? 8.42 MG MG A 302 B 182 GLY A 184 GLY^? 4.07 MG MG A 302 B 183 GLY A 183 GLY^? -4.64 MG MG A 301s coo 38.36-101.47-135.52 39.62-101.29-136.35 37.01 35.73 44.42 36.08 35.79 45.62 coo 41.93-102.35-126.87 41.52-101.89-126.30 44.11 32.36 47.58 44.42 32.35 46.80 coo 38.37-101.99-128.11 38.63-102.24-127.37 42.94 34.42 44.60 42.51 33.67 44.58 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 3 3 # 3 A 420 ALA B 179 ALA^? 10.09 MG MG B 301 B 182 GLY B 184 GLY^? 4.47 MG MG B 301 B 183 GLY B 183 GLY^? -4.35 MG MG B 301s coo 38.36-101.47-135.52 39.62-101.29-136.35 58.26 12.57 -3.59 59.34 12.14 -2.62 coo 41.93-102.35-126.87 41.52-101.89-126.30 57.32 22.02 -9.75 57.17 22.15 -8.93 coo 38.37-101.99-128.11 38.63-102.24-127.37 58.74 20.22 -6.73 58.00 19.87 -6.89 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 4 3 # 4 A 420 ALA B 180 ALA^? 7.87 MG MG B 301 B 182 GLY B 184 GLY^? 4.47 MG MG B 301 B 183 GLY B 183 GLY^? -4.35 MG MG B 301s coo 38.36-101.47-135.52 39.62-101.29-136.35 59.08 14.28 -6.88 59.39 13.60 -8.19 coo 41.93-102.35-126.87 41.52-101.89-126.30 57.32 22.02 -9.75 57.17 22.15 -8.93 coo 38.37-101.99-128.11 38.63-102.24-127.37 58.74 20.22 -6.73 58.00 19.87 -6.89 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 5 3 # 5 A 420 ALA C 124 ALA^? 9.43 MG MG C 302 B 182 GLY C 184 GLY^? 4.50 MG MG C 301 B 183 GLY C 183 GLY^? -4.00 MG MG C 301s coo 38.36-101.47-135.52 39.62-101.29-136.35 70.87 19.73 -4.58 71.66 18.98 -5.68 coo 41.93-102.35-126.87 41.52-101.89-126.30 76.47 24.88 3.34 76.71 25.04 2.53 coo 38.37-101.99-128.11 38.63-102.24-127.37 76.27 22.45 0.43 77.06 22.50 0.60 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 6 3 # 6 A 420 ALA C 180 ALA^? 7.92 MG MG C 301 B 182 GLY C 184 GLY^? 4.50 MG MG C 301 B 183 GLY C 183 GLY^? -4.00 MG MG C 301s coo 38.36-101.47-135.52 39.62-101.29-136.35 77.97 16.90 0.41 78.13 16.09 1.70 coo 41.93-102.35-126.87 41.52-101.89-126.30 76.47 24.88 3.34 76.71 25.04 2.53 coo 38.37-101.99-128.11 38.63-102.24-127.37 76.27 22.45 0.43 77.06 22.50 0.60 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 7 3 # 7 A 420 ALA D 179 ALA^? 10.20 MG MG D 301 B 182 GLY D 184 GLY^? 4.28 MG MG D 301 B 183 GLY D 183 GLY^? -4.40 MG MG D 301s coo 38.36-101.47-135.52 39.62-101.29-136.35 90.58 45.61 -47.30 90.29 46.82 -46.46 coo 41.93-102.35-126.87 41.52-101.89-126.30 83.33 40.04 -53.77 83.20 39.83 -52.97 coo 38.37-101.99-128.11 38.63-102.24-127.37 84.07 42.30 -50.78 84.70 41.81 -50.82 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 8 3 # 8 A 420 ALA D 180 ALA^? 8.04 MG MG D 301 B 182 GLY D 184 GLY^? 4.28 MG MG D 301 B 183 GLY D 183 GLY^? -4.40 MG MG D 301s coo 38.36-101.47-135.52 39.62-101.29-136.35 88.96 45.51 -50.74 89.59 46.01 -52.03 coo 41.93-102.35-126.87 41.52-101.89-126.30 83.33 40.04 -53.77 83.20 39.83 -52.97 coo 38.37-101.99-128.11 38.63-102.24-127.37 84.07 42.30 -50.78 84.70 41.81 -50.82 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 9 3 # 9 A 420 ALA E 124 ALA^? 9.05 MG MG E 302 B 182 GLY E 184 GLY^? 4.85 MG MG E 301 B 183 GLY E 183 GLY^? -4.49 MG MG E 301s coo 38.36-101.47-135.52 39.62-101.29-136.35 76.88 53.67 -49.23 76.97 54.46 -50.55 coo 41.93-102.35-126.87 41.52-101.89-126.30 69.91 55.36 -41.13 69.77 55.58 -41.87 coo 38.37-101.99-128.11 38.63-102.24-127.37 72.33 56.33 -43.87 71.83 56.99 -43.77 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 10 3 # 10 A 420 ALA E 180 ALA^? 7.76 MG MG E 301 B 182 GLY E 184 GLY^? 4.85 MG MG E 301 B 183 GLY E 183 GLY^? -4.49 MG MG E 301s coo 38.36-101.47-135.52 39.62-101.29-136.35 76.35 60.44 -44.08 76.96 60.95 -42.80 coo 41.93-102.35-126.87 41.52-101.89-126.30 69.91 55.36 -41.13 69.77 55.58 -41.87 coo 38.37-101.99-128.11 38.63-102.24-127.37 72.33 56.33 -43.87 71.83 56.99 -43.77 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 11 3 # 11 A 420 ALA F 179 ALA^? 10.29 MG MG F 302 B 182 GLY F 184 GLY^? 4.93 MG MG F 302 B 183 GLY F 183 GLY^? -4.39 MG MG F 301s coo 38.36-101.47-135.52 39.62-101.29-136.35 44.99 54.95 -91.60 44.02 54.12 -90.83 coo 41.93-102.35-126.87 41.52-101.89-126.30 53.59 51.24 -98.07 53.82 51.26 -97.25 coo 38.37-101.99-128.11 38.63-102.24-127.37 51.40 50.96 -94.96 51.47 51.79 -95.11 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 12 3 # 12 A 420 ALA F 180 ALA^? 8.00 MG MG F 302 B 182 GLY F 184 GLY^? 4.93 MG MG F 302 B 183 GLY F 183 GLY^? -4.39 MG MG F 301s coo 38.36-101.47-135.52 39.62-101.29-136.35 45.97 53.39 -94.93 45.23 53.59 -96.27 coo 41.93-102.35-126.87 41.52-101.89-126.30 53.59 51.24 -98.07 53.82 51.26 -97.25 coo 38.37-101.99-128.11 38.63-102.24-127.37 51.40 50.96 -94.96 51.47 51.79 -95.11 1xny_c01 source 1xny PROPIONYL-COA CARBOXYLASE COMPLEX B SUBUNIT : 12 hits 1xny_c01 naa= 3 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 1 3 # 1 A 243 THR A 18 THR.? 15.77 MG MG A 301 A 345 PHE A 150 PHE^? 10.47 MG MG A 302 A 352 CYH A 152 CYH^? 15.18 MG MG A 302 coo 9.58 21.79 21.50 11.25 23.03 20.90 32.02 38.89 33.13 34.18 39.03 32.98 coo 19.40 19.75 18.58 17.39 17.81 18.80 35.63 32.10 38.88 34.73 33.93 37.00 coo 21.57 22.52 22.79 19.20 21.13 23.26 34.81 26.51 34.70 32.10 26.95 34.06 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 2 3 # 2 A 243 THR A 18 THR.? 15.77 MG MG A 301 A 345 PHE A 172 PHE^? 13.28 MG MG A 302 A 352 CYH A 152 CYH^? 15.18 MG MG A 302 coo 9.58 21.79 21.50 11.25 23.03 20.90 32.02 38.89 33.13 34.18 39.03 32.98 coo 19.40 19.75 18.58 17.39 17.81 18.80 31.82 29.57 38.19 30.91 31.55 36.40 coo 21.57 22.52 22.79 19.20 21.13 23.26 34.81 26.51 34.70 32.10 26.95 34.06 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 3 3 # 3 A 243 THR A 178 THR^? 11.01 MG MG A 302 A 345 PHE A 153 PHE^? 9.64 MG MG A 301 A 352 CYH A 152 CYH^? 15.18 MG MG A 302 coo 9.58 21.79 21.50 11.25 23.03 20.90 32.90 33.33 42.26 32.53 35.14 43.38 coo 19.40 19.75 18.58 17.39 17.81 18.80 38.89 24.49 36.07 40.14 26.70 37.23 coo 21.57 22.52 22.79 19.20 21.13 23.26 34.81 26.51 34.70 32.10 26.95 34.06 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 4 3 # 4 A 243 THR B 18 THR^? 16.08 MG MG B 302 A 345 PHE B 150 PHE^? 9.88 MG MG B 301 A 352 CYH B 152 CYH^? 14.66 MG MG B 301 coo 9.58 21.79 21.50 11.25 23.03 20.90 60.02 7.32 3.97 60.86 9.29 4.05 coo 19.40 19.75 18.58 17.39 17.81 18.80 54.70 12.86 -1.84 56.31 11.50 0.05 coo 21.57 22.52 22.79 19.20 21.13 23.26 48.74 12.82 1.93 48.51 10.17 2.19 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 5 3 # 5 A 243 THR B 18 THR^? 16.08 MG MG B 302 A 345 PHE B 172 PHE^? 12.81 MG MG B 301 A 352 CYH B 152 CYH^? 14.66 MG MG B 301 coo 9.58 21.79 21.50 11.25 23.03 20.90 60.02 7.32 3.97 60.86 9.29 4.05 coo 19.40 19.75 18.58 17.39 17.81 18.80 51.51 9.59 -1.64 53.03 8.15 0.22 coo 21.57 22.52 22.79 19.20 21.13 23.26 48.74 12.82 1.93 48.51 10.17 2.19 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 6 3 # 6 A 243 THR B 175 THR^? 12.15 MG MG B 301 A 345 PHE B 150 PHE^? 9.88 MG MG B 301 A 352 CYH B 152 CYH^? 14.66 MG MG B 301 coo 9.58 21.79 21.50 11.25 23.03 20.90 46.88 7.94 -7.07 47.05 10.06 -6.52 coo 19.40 19.75 18.58 17.39 17.81 18.80 54.70 12.86 -1.84 56.31 11.50 0.05 coo 21.57 22.52 22.79 19.20 21.13 23.26 48.74 12.82 1.93 48.51 10.17 2.19 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 7 3 # 7 A 243 THR B 175 THR^? 12.15 MG MG B 301 A 345 PHE B 153 PHE^? 9.59 MG MG B 302 A 352 CYH B 152 CYH^? 14.66 MG MG B 301 coo 9.58 21.79 21.50 11.25 23.03 20.90 46.88 7.94 -7.07 47.05 10.06 -6.52 coo 19.40 19.75 18.58 17.39 17.81 18.80 47.54 17.09 0.77 50.03 17.91 -0.19 coo 21.57 22.52 22.79 19.20 21.13 23.26 48.74 12.82 1.93 48.51 10.17 2.19 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 8 3 # 8 A 243 THR C 18 THR^? 15.72 MG MG C 302 A 345 PHE C 150 PHE^? 10.02 MG MG C 301 A 352 CYH C 152 CYH^? 14.61 MG MG C 301 coo 9.58 21.79 21.50 11.25 23.03 20.90 79.00 10.43 -10.53 77.64 12.10 -10.65 coo 19.40 19.75 18.58 17.39 17.81 18.80 82.11 17.28 -4.80 81.16 15.47 -6.75 coo 21.57 22.52 22.79 19.20 21.13 23.26 87.66 19.43 -8.58 88.77 17.04 -8.78 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 9 3 # 9 A 243 THR C 18 THR^? 15.72 MG MG C 302 A 345 PHE C 172 PHE^? 13.00 MG MG C 301 A 352 CYH C 152 CYH^? 14.61 MG MG C 301 coo 9.58 21.79 21.50 11.25 23.03 20.90 79.00 10.43 -10.53 77.64 12.10 -10.65 coo 19.40 19.75 18.58 17.39 17.81 18.80 86.45 15.28 -5.05 85.50 13.59 -7.08 coo 21.57 22.52 22.79 19.20 21.13 23.26 87.66 19.43 -8.58 88.77 17.04 -8.78 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 10 3 # 10 A 243 THR C 175 THR^? 12.73 MG MG C 301 A 345 PHE C 150 PHE^? 10.02 MG MG C 301 A 352 CYH C 152 CYH^? 14.61 MG MG C 301 coo 9.58 21.79 21.50 11.25 23.03 20.90 91.24 15.45 0.47 90.99 17.39 -0.47 coo 19.40 19.75 18.58 17.39 17.81 18.80 82.11 17.28 -4.80 81.16 15.47 -6.75 coo 21.57 22.52 22.79 19.20 21.13 23.26 87.66 19.43 -8.58 88.77 17.04 -8.78 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 11 3 # 11 A 243 THR C 175 THR^? 12.73 MG MG C 301 A 345 PHE C 153 PHE^? 9.34 MG MG C 302 A 352 CYH C 152 CYH^? 14.61 MG MG C 301 coo 9.58 21.79 21.50 11.25 23.03 20.90 91.24 15.45 0.47 90.99 17.39 -0.47 coo 19.40 19.75 18.58 17.39 17.81 18.80 87.15 23.83 -7.29 84.55 23.79 -6.26 coo 21.57 22.52 22.79 19.20 21.13 23.26 87.66 19.43 -8.58 88.77 17.04 -8.78 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 12 3 # 12 A 243 THR D 18 THR^? 15.54 MG MG D 302 A 345 PHE D 150 PHE^? 10.21 MG MG D 301 A 352 CYH D 152 CYH^? 14.66 MG MG D 301 coo 9.58 21.79 21.50 11.25 23.03 20.90 93.52 49.91 -39.68 91.41 49.57 -39.76 coo 19.40 19.75 18.58 17.39 17.81 18.80 91.92 42.74 -45.34 92.24 44.79 -43.44 coo 21.57 22.52 22.79 19.20 21.13 23.26 94.69 37.43 -41.36 96.92 38.83 -40.94 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 13 3 # 13 A 243 THR D 18 THR^? 15.54 MG MG D 302 A 345 PHE D 172 PHE^? 13.02 MG MG D 301 A 352 CYH D 152 CYH^? 14.66 MG MG D 301 coo 9.58 21.79 21.50 11.25 23.03 20.90 93.52 49.91 -39.68 91.41 49.57 -39.76 coo 19.40 19.75 18.58 17.39 17.81 18.80 96.36 41.50 -44.84 96.77 43.66 -43.13 coo 21.57 22.52 22.79 19.20 21.13 23.26 94.69 37.43 -41.36 96.92 38.83 -40.94 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 14 3 # 14 A 243 THR D 175 THR^? 12.60 MG MG D 301 A 345 PHE D 150 PHE^? 10.21 MG MG D 301 A 352 CYH D 152 CYH^? 14.66 MG MG D 301 coo 9.58 21.79 21.50 11.25 23.03 20.90 100.33 38.24 -50.15 98.81 36.95 -49.29 coo 19.40 19.75 18.58 17.39 17.81 18.80 91.92 42.74 -45.34 92.24 44.79 -43.44 coo 21.57 22.52 22.79 19.20 21.13 23.26 94.69 37.43 -41.36 96.92 38.83 -40.94 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 15 3 # 15 A 243 THR D 175 THR^? 12.60 MG MG D 301 A 345 PHE D 153 PHE^? 9.11 MG MG D 302 A 352 CYH D 152 CYH^? 14.66 MG MG D 301 coo 9.58 21.79 21.50 11.25 23.03 20.90 100.33 38.24 -50.15 98.81 36.95 -49.29 coo 19.40 19.75 18.58 17.39 17.81 18.80 91.67 34.35 -42.71 89.76 36.10 -43.73 coo 21.57 22.52 22.79 19.20 21.13 23.26 94.69 37.43 -41.36 96.92 38.83 -40.94 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 16 3 # 16 A 243 THR E 18 THR^? 15.84 MG MG E 302 A 345 PHE E 12 PHE^? 17.09 MG MG E 302 A 352 CYH E 152 CYH^? 14.64 MG MG E 301 coo 9.58 21.79 21.50 11.25 23.03 20.90 81.45 64.25 -55.27 80.73 62.21 -55.24 coo 19.40 19.75 18.58 17.39 17.81 18.80 70.06 67.18 -58.76 69.33 69.81 -58.07 coo 21.57 22.52 22.79 19.20 21.13 23.26 69.49 67.27 -53.54 71.02 69.50 -54.03 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 17 3 # 17 A 243 THR E 18 THR^? 15.84 MG MG E 302 A 345 PHE E 150 PHE^? 10.10 MG MG E 301 A 352 CYH E 152 CYH^? 14.64 MG MG E 301 coo 9.58 21.79 21.50 11.25 23.03 20.90 81.45 64.25 -55.27 80.73 62.21 -55.24 coo 19.40 19.75 18.58 17.39 17.81 18.80 74.01 63.99 -49.53 76.06 63.87 -51.45 coo 21.57 22.52 22.79 19.20 21.13 23.26 69.49 67.27 -53.54 71.02 69.50 -54.03 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 18 3 # 18 A 243 THR E 18 THR^? 15.84 MG MG E 302 A 345 PHE E 172 PHE^? 12.71 MG MG E 301 A 352 CYH E 152 CYH^? 14.64 MG MG E 301 coo 9.58 21.79 21.50 11.25 23.03 20.90 81.45 64.25 -55.27 80.73 62.21 -55.24 coo 19.40 19.75 18.58 17.39 17.81 18.80 73.54 68.41 -50.00 75.58 68.36 -51.87 coo 21.57 22.52 22.79 19.20 21.13 23.26 69.49 67.27 -53.54 71.02 69.50 -54.03 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 19 3 # 19 A 243 THR E 175 THR^? 12.38 MG MG E 301 A 345 PHE E 150 PHE^? 10.10 MG MG E 301 A 352 CYH E 152 CYH^? 14.64 MG MG E 301 coo 9.58 21.79 21.50 11.25 23.03 20.90 71.20 72.92 -44.89 69.57 71.76 -45.77 coo 19.40 19.75 18.58 17.39 17.81 18.80 74.01 63.99 -49.53 76.06 63.87 -51.45 coo 21.57 22.52 22.79 19.20 21.13 23.26 69.49 67.27 -53.54 71.02 69.50 -54.03 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 20 3 # 20 A 243 THR E 175 THR^? 12.38 MG MG E 301 A 345 PHE E 153 PHE^? 9.50 MG MG E 302 A 352 CYH E 152 CYH^? 14.64 MG MG E 301 coo 9.58 21.79 21.50 11.25 23.03 20.90 71.20 72.92 -44.89 69.57 71.76 -45.77 coo 19.40 19.75 18.58 17.39 17.81 18.80 65.86 64.95 -52.12 67.22 62.73 -51.09 coo 21.57 22.52 22.79 19.20 21.13 23.26 69.49 67.27 -53.54 71.02 69.50 -54.03 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 21 3 # 21 A 243 THR F 18 THR^? 15.93 MG MG F 301 A 345 PHE F 12 PHE^? 17.12 MG MG F 301 A 352 CYH F 152 CYH^? 14.14 MG MG F 302 coo 9.58 21.79 21.50 11.25 23.03 20.90 39.95 55.99 -83.96 41.26 54.27 -83.96 coo 19.40 19.75 18.58 17.39 17.81 18.80 49.70 62.79 -80.90 49.37 65.44 -81.67 coo 21.57 22.52 22.79 19.20 21.13 23.26 50.28 62.76 -86.08 48.12 64.34 -85.77 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 22 3 # 22 A 243 THR F 18 THR^? 15.93 MG MG F 301 A 345 PHE F 150 PHE^? 9.82 MG MG F 302 A 352 CYH F 152 CYH^? 14.14 MG MG F 302 coo 9.58 21.79 21.50 11.25 23.03 20.90 39.95 55.99 -83.96 41.26 54.27 -83.96 coo 19.40 19.75 18.58 17.39 17.81 18.80 47.10 57.70 -89.94 45.06 57.27 -88.04 coo 21.57 22.52 22.79 19.20 21.13 23.26 50.28 62.76 -86.08 48.12 64.34 -85.77 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 23 3 # 23 A 243 THR F 18 THR^? 15.93 MG MG F 301 A 345 PHE F 172 PHE^? 12.43 MG MG F 302 A 352 CYH F 152 CYH^? 14.14 MG MG F 302 coo 9.58 21.79 21.50 11.25 23.03 20.90 39.95 55.99 -83.96 41.26 54.27 -83.96 coo 19.40 19.75 18.58 17.39 17.81 18.80 45.85 62.23 -89.68 43.95 61.55 -87.75 coo 21.57 22.52 22.79 19.20 21.13 23.26 50.28 62.76 -86.08 48.12 64.34 -85.77 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 24 3 # 24 A 243 THR F 175 THR^? 11.83 MG MG F 302 A 345 PHE F 150 PHE^? 9.82 MG MG F 302 A 352 CYH F 152 CYH^? 14.14 MG MG F 302 coo 9.58 21.79 21.50 11.25 23.03 20.90 46.82 66.80 -95.29 48.97 66.65 -95.25 coo 19.40 19.75 18.58 17.39 17.81 18.80 47.10 57.70 -89.94 45.06 57.27 -88.04 coo 21.57 22.52 22.79 19.20 21.13 23.26 50.28 62.76 -86.08 48.12 64.34 -85.77 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 25 3 # 25 A 243 THR F 175 THR^? 11.83 MG MG F 302 A 345 PHE F 153 PHE^? 9.26 MG MG F 302 A 352 CYH F 152 CYH^? 14.14 MG MG F 302 coo 9.58 21.79 21.50 11.25 23.03 20.90 46.82 66.80 -95.29 48.97 66.65 -95.25 coo 19.40 19.75 18.58 17.39 17.81 18.80 54.49 61.65 -87.43 53.89 59.08 -88.37 coo 21.57 22.52 22.79 19.20 21.13 23.26 50.28 62.76 -86.08 48.12 64.34 -85.77 1xqd_c02 source 1xqd CYTOCHROME P450 55A1 : 25 hits 1xqd_c02 naa= 3 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 B 124 ALA A 43 ALA^? 22.11 MG MG A 301 B 126 ARG A 37 ARG^? 18.99 MG MG A 301 B 138 GLU A 54 GLU^? 22.98 MG MG A 301 coo 2.11 4.00 19.31 3.14 4.86 19.99 37.04 23.74 21.31 36.51 24.34 22.59 coo 2.45 5.53 11.28 3.59 7.56 13.29 32.99 26.50 25.19 35.50 25.33 26.51 coo 6.10 2.00 25.24 6.12 1.84 23.13 45.06 19.97 24.02 44.05 19.39 22.19 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 B 124 ALA A 43 ALA^? 22.11 MG MG A 301 B 126 ARG A 48 ARG^? 25.29 MG MG A 301 B 138 GLU A 54 GLU^? 22.98 MG MG A 301 coo 2.11 4.00 19.31 3.14 4.86 19.99 37.04 23.74 21.31 36.51 24.34 22.59 coo 2.45 5.53 11.28 3.59 7.56 13.29 33.88 31.17 22.03 31.48 31.85 20.30 coo 6.10 2.00 25.24 6.12 1.84 23.13 45.06 19.97 24.02 44.05 19.39 22.19 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 B 124 ALA B 43 ALA^? 21.96 MG MG B 302 B 126 ARG B 48 ARG^? 25.20 MG MG B 302 B 138 GLU B 54 GLU^? 22.94 MG MG B 302 coo 2.11 4.00 19.31 3.14 4.86 19.99 45.25 14.39 14.98 45.85 13.87 13.70 coo 2.45 5.53 11.28 3.59 7.56 13.29 52.22 10.51 15.00 52.46 7.79 16.39 coo 6.10 2.00 25.24 6.12 1.84 23.13 43.18 23.27 12.99 42.40 22.23 14.68 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 B 124 ALA B 91 ALA^? 13.14 MG MG B 302 B 126 ARG B 50 ARG^? 16.38 MG MG B 302 B 138 GLU B 94 GLU^? 15.34 MG MG B 302 coo 2.11 4.00 19.31 3.14 4.86 19.99 60.40 23.47 9.84 59.47 22.84 8.80 coo 2.45 5.53 11.28 3.59 7.56 13.29 55.38 14.91 7.80 56.60 14.73 10.62 coo 6.10 2.00 25.24 6.12 1.84 23.13 58.44 31.30 7.43 60.35 32.14 7.14 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 B 124 ALA B 116 ALA^? 9.34 MG MG B 302 B 126 ARG B 50 ARG^? 16.38 MG MG B 302 B 138 GLU B 94 GLU^? 15.34 MG MG B 302 coo 2.11 4.00 19.31 3.14 4.86 19.99 56.90 23.91 4.45 56.31 22.97 5.47 coo 2.45 5.53 11.28 3.59 7.56 13.29 55.38 14.91 7.80 56.60 14.73 10.62 coo 6.10 2.00 25.24 6.12 1.84 23.13 58.44 31.30 7.43 60.35 32.14 7.14 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 B 124 ALA C 43 ALA^? 21.49 MG MG C 302 B 126 ARG C 37 ARG^? 19.01 MG MG C 302 B 138 GLU C 54 GLU^? 22.77 MG MG C 302 coo 2.11 4.00 19.31 3.14 4.86 19.99 89.94 22.31 -21.67 89.53 21.88 -20.28 coo 2.45 5.53 11.28 3.59 7.56 13.29 89.36 17.23 -17.57 89.29 20.20 -16.76 coo 6.10 2.00 25.24 6.12 1.84 23.13 88.91 31.25 -19.52 89.97 30.69 -21.29 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 3 # 7 B 124 ALA C 43 ALA^? 21.49 MG MG C 302 B 126 ARG C 48 ARG^? 25.02 MG MG C 302 B 138 GLU C 54 GLU^? 22.77 MG MG C 302 coo 2.11 4.00 19.31 3.14 4.86 19.99 89.94 22.31 -21.67 89.53 21.88 -20.28 coo 2.45 5.53 11.28 3.59 7.56 13.29 84.94 16.06 -21.53 85.81 13.55 -23.08 coo 6.10 2.00 25.24 6.12 1.84 23.13 88.91 31.25 -19.52 89.97 30.69 -21.29 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 3 # 8 B 124 ALA D 43 ALA^? 21.51 MG MG D 302 B 126 ARG D 48 ARG^? 24.87 MG MG D 302 B 138 GLU D 54 GLU^? 22.96 MG MG D 302 coo 2.11 4.00 19.31 3.14 4.86 19.99 94.20 34.03 -28.30 94.29 34.60 -29.70 coo 2.45 5.53 11.28 3.59 7.56 13.29 94.06 41.76 -28.37 96.24 43.38 -26.96 coo 6.10 2.00 25.24 6.12 1.84 23.13 87.96 27.60 -30.52 89.07 27.55 -28.72 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 3 # 9 B 124 ALA D 91 ALA^? 13.42 MG MG D 302 B 126 ARG D 50 ARG^? 16.15 MG MG D 302 B 138 GLU D 94 GLU^? 16.28 MG MG D 302 coo 2.11 4.00 19.31 3.14 4.86 19.99 79.15 42.27 -34.55 80.22 41.77 -35.47 coo 2.45 5.53 11.28 3.59 7.56 13.29 88.00 43.26 -36.30 88.86 43.23 -33.34 coo 6.10 2.00 25.24 6.12 1.84 23.13 72.85 36.59 -35.79 71.78 37.87 -37.16 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 3 # 10 B 124 ALA D 116 ALA^? 9.63 MG MG D 302 B 126 ARG D 50 ARG^? 16.15 MG MG D 302 B 138 GLU D 94 GLU^? 16.28 MG MG D 302 coo 2.11 4.00 19.31 3.14 4.86 19.99 80.74 38.94 -39.77 81.69 38.81 -38.65 coo 2.45 5.53 11.28 3.59 7.56 13.29 88.00 43.26 -36.30 88.86 43.23 -33.34 coo 6.10 2.00 25.24 6.12 1.84 23.13 72.85 36.59 -35.79 71.78 37.87 -37.16 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 11 3 # 11 B 124 ALA E 43 ALA^? 21.87 MG MG E 302 B 126 ARG E 48 ARG^? 25.02 MG MG E 302 B 138 GLU E 54 GLU^? 22.83 MG MG E 302 coo 2.11 4.00 19.31 3.14 4.86 19.99 65.81 67.05 -66.75 66.56 67.21 -65.43 coo 2.45 5.53 11.28 3.59 7.56 13.29 73.60 65.75 -66.57 75.51 67.67 -67.91 coo 6.10 2.00 25.24 6.12 1.84 23.13 58.39 62.16 -64.12 58.73 62.98 -66.04 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 12 3 # 12 B 124 ALA F 43 ALA^? 21.71 MG MG F 301 B 126 ARG F 48 ARG^? 25.18 MG MG F 301 B 138 GLU F 54 GLU^? 22.98 MG MG F 301 coo 2.11 4.00 19.31 3.14 4.86 19.99 53.63 64.70 -73.15 53.00 64.46 -74.53 coo 2.45 5.53 11.28 3.59 7.56 13.29 46.82 60.90 -73.07 44.43 61.88 -71.46 coo 6.10 2.00 25.24 6.12 1.84 23.13 62.26 62.27 -75.30 61.72 63.47 -73.60 1xs1_c07 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 12 hits 1xs1_c07 naa= 3 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 C 124 ALA A 43 ALA^? 22.11 MG MG A 301 C 126 ARG A 37 ARG^? 18.99 MG MG A 301 C 138 GLU A 54 GLU^? 22.98 MG MG A 301 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 37.04 23.74 21.31 36.51 24.34 22.59 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 32.99 26.50 25.19 35.50 25.33 26.51 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 45.06 19.97 24.02 44.05 19.39 22.19 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 C 124 ALA A 43 ALA^? 22.11 MG MG A 301 C 126 ARG A 48 ARG^? 25.29 MG MG A 301 C 138 GLU A 54 GLU^? 22.98 MG MG A 301 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 37.04 23.74 21.31 36.51 24.34 22.59 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 33.88 31.17 22.03 31.48 31.85 20.30 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 45.06 19.97 24.02 44.05 19.39 22.19 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 C 124 ALA B 91 ALA^? 13.14 MG MG B 302 C 126 ARG B 50 ARG^? 16.38 MG MG B 302 C 138 GLU B 94 GLU^? 15.34 MG MG B 302 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 60.40 23.47 9.84 59.47 22.84 8.80 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 55.38 14.91 7.80 56.60 14.73 10.62 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 58.44 31.30 7.43 60.35 32.14 7.14 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 C 124 ALA B 116 ALA^? 9.34 MG MG B 302 C 126 ARG B 50 ARG^? 16.38 MG MG B 302 C 138 GLU B 94 GLU^? 15.34 MG MG B 302 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 56.90 23.91 4.45 56.31 22.97 5.47 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 55.38 14.91 7.80 56.60 14.73 10.62 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 58.44 31.30 7.43 60.35 32.14 7.14 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 C 124 ALA C 43 ALA^? 21.49 MG MG C 302 C 126 ARG C 37 ARG^? 19.01 MG MG C 302 C 138 GLU C 54 GLU^? 22.77 MG MG C 302 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 89.94 22.31 -21.67 89.53 21.88 -20.28 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 89.36 17.23 -17.57 89.29 20.20 -16.76 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 88.91 31.25 -19.52 89.97 30.69 -21.29 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 C 124 ALA C 43 ALA^? 21.49 MG MG C 302 C 126 ARG C 48 ARG^? 25.02 MG MG C 302 C 138 GLU C 54 GLU^? 22.77 MG MG C 302 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 89.94 22.31 -21.67 89.53 21.88 -20.28 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 84.94 16.06 -21.53 85.81 13.55 -23.08 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 88.91 31.25 -19.52 89.97 30.69 -21.29 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 3 # 7 C 124 ALA D 43 ALA^? 21.51 MG MG D 302 C 126 ARG D 48 ARG^? 24.87 MG MG D 302 C 138 GLU D 54 GLU^? 22.96 MG MG D 302 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 94.20 34.03 -28.30 94.29 34.60 -29.70 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 94.06 41.76 -28.37 96.24 43.38 -26.96 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 87.96 27.60 -30.52 89.07 27.55 -28.72 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 3 # 8 C 124 ALA D 91 ALA^? 13.42 MG MG D 302 C 126 ARG D 50 ARG^? 16.15 MG MG D 302 C 138 GLU D 94 GLU^? 16.28 MG MG D 302 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 79.15 42.27 -34.55 80.22 41.77 -35.47 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 88.00 43.26 -36.30 88.86 43.23 -33.34 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 72.85 36.59 -35.79 71.78 37.87 -37.16 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 3 # 9 C 124 ALA D 116 ALA^? 9.63 MG MG D 302 C 126 ARG D 50 ARG^? 16.15 MG MG D 302 C 138 GLU D 94 GLU^? 16.28 MG MG D 302 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 80.74 38.94 -39.77 81.69 38.81 -38.65 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 88.00 43.26 -36.30 88.86 43.23 -33.34 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 72.85 36.59 -35.79 71.78 37.87 -37.16 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 3 # 10 C 124 ALA E 43 ALA^? 21.87 MG MG E 302 C 126 ARG E 48 ARG^? 25.02 MG MG E 302 C 138 GLU E 54 GLU^? 22.83 MG MG E 302 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 65.81 67.05 -66.75 66.56 67.21 -65.43 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 73.60 65.75 -66.57 75.51 67.67 -67.91 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 58.39 62.16 -64.12 58.73 62.98 -66.04 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 11 3 # 11 C 124 ALA F 43 ALA^? 21.71 MG MG F 301 C 126 ARG F 48 ARG^? 25.18 MG MG F 301 C 138 GLU F 54 GLU^? 22.98 MG MG F 301 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 53.63 64.70 -73.15 53.00 64.46 -74.53 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 46.82 60.90 -73.07 44.43 61.88 -71.46 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 62.26 62.27 -75.30 61.72 63.47 -73.60 1xs1_c08 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 11 hits 1xs1_c08 naa= 3 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 D 124 ALA A 43 ALA^? 22.11 MG MG A 301 D 126 ARG A 37 ARG^? 18.99 MG MG A 301 D 138 GLU A 54 GLU^? 22.98 MG MG A 301 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 37.04 23.74 21.31 36.51 24.34 22.59 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 32.99 26.50 25.19 35.50 25.33 26.51 coo 6.23 0.50 57.10 5.93 0.72 59.19 45.06 19.97 24.02 44.05 19.39 22.19 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 D 124 ALA A 43 ALA^? 22.11 MG MG A 301 D 126 ARG A 48 ARG^? 25.29 MG MG A 301 D 138 GLU A 54 GLU^? 22.98 MG MG A 301 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 37.04 23.74 21.31 36.51 24.34 22.59 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 33.88 31.17 22.03 31.48 31.85 20.30 coo 6.23 0.50 57.10 5.93 0.72 59.19 45.06 19.97 24.02 44.05 19.39 22.19 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 D 124 ALA B 43 ALA^? 21.96 MG MG B 302 D 126 ARG B 48 ARG^? 25.20 MG MG B 302 D 138 GLU B 54 GLU^? 22.94 MG MG B 302 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 45.25 14.39 14.98 45.85 13.87 13.70 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 52.22 10.51 15.00 52.46 7.79 16.39 coo 6.23 0.50 57.10 5.93 0.72 59.19 43.18 23.27 12.99 42.40 22.23 14.68 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 D 124 ALA B 116 ALA^? 9.34 MG MG B 302 D 126 ARG B 50 ARG^? 16.38 MG MG B 302 D 138 GLU B 94 GLU^? 15.34 MG MG B 302 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 56.90 23.91 4.45 56.31 22.97 5.47 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 55.38 14.91 7.80 56.60 14.73 10.62 coo 6.23 0.50 57.10 5.93 0.72 59.19 58.44 31.30 7.43 60.35 32.14 7.14 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 D 124 ALA C 43 ALA^? 21.49 MG MG C 302 D 126 ARG C 37 ARG^? 19.01 MG MG C 302 D 138 GLU C 54 GLU^? 22.77 MG MG C 302 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 89.94 22.31 -21.67 89.53 21.88 -20.28 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 89.36 17.23 -17.57 89.29 20.20 -16.76 coo 6.23 0.50 57.10 5.93 0.72 59.19 88.91 31.25 -19.52 89.97 30.69 -21.29 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 D 124 ALA C 43 ALA^? 21.49 MG MG C 302 D 126 ARG C 48 ARG^? 25.02 MG MG C 302 D 138 GLU C 54 GLU^? 22.77 MG MG C 302 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 89.94 22.31 -21.67 89.53 21.88 -20.28 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 84.94 16.06 -21.53 85.81 13.55 -23.08 coo 6.23 0.50 57.10 5.93 0.72 59.19 88.91 31.25 -19.52 89.97 30.69 -21.29 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 3 # 7 D 124 ALA D 43 ALA^? 21.51 MG MG D 302 D 126 ARG D 48 ARG^? 24.87 MG MG D 302 D 138 GLU D 54 GLU^? 22.96 MG MG D 302 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 94.20 34.03 -28.30 94.29 34.60 -29.70 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 94.06 41.76 -28.37 96.24 43.38 -26.96 coo 6.23 0.50 57.10 5.93 0.72 59.19 87.96 27.60 -30.52 89.07 27.55 -28.72 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 3 # 8 D 124 ALA D 91 ALA^? 13.42 MG MG D 302 D 126 ARG D 50 ARG^? 16.15 MG MG D 302 D 138 GLU D 94 GLU^? 16.28 MG MG D 302 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 79.15 42.27 -34.55 80.22 41.77 -35.47 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 88.00 43.26 -36.30 88.86 43.23 -33.34 coo 6.23 0.50 57.10 5.93 0.72 59.19 72.85 36.59 -35.79 71.78 37.87 -37.16 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 3 # 9 D 124 ALA D 116 ALA^? 9.63 MG MG D 302 D 126 ARG D 50 ARG^? 16.15 MG MG D 302 D 138 GLU D 94 GLU^? 16.28 MG MG D 302 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 80.74 38.94 -39.77 81.69 38.81 -38.65 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 88.00 43.26 -36.30 88.86 43.23 -33.34 coo 6.23 0.50 57.10 5.93 0.72 59.19 72.85 36.59 -35.79 71.78 37.87 -37.16 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 3 # 10 D 124 ALA E 43 ALA^? 21.87 MG MG E 302 D 126 ARG E 48 ARG^? 25.02 MG MG E 302 D 138 GLU E 54 GLU^? 22.83 MG MG E 302 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 65.81 67.05 -66.75 66.56 67.21 -65.43 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 73.60 65.75 -66.57 75.51 67.67 -67.91 coo 6.23 0.50 57.10 5.93 0.72 59.19 58.39 62.16 -64.12 58.73 62.98 -66.04 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 11 3 # 11 D 124 ALA F 43 ALA^? 21.71 MG MG F 301 D 126 ARG F 48 ARG^? 25.18 MG MG F 301 D 138 GLU F 54 GLU^? 22.98 MG MG F 301 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 53.63 64.70 -73.15 53.00 64.46 -74.53 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 46.82 60.90 -73.07 44.43 61.88 -71.46 coo 6.23 0.50 57.10 5.93 0.72 59.19 62.26 62.27 -75.30 61.72 63.47 -73.60 1xs1_c09 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 11 hits 1xs1_c09 naa= 3 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 E 124 ALA A 43 ALA^? 22.11 MG MG A 301 E 126 ARG A 37 ARG^? 18.99 MG MG A 301 E 138 GLU A 54 GLU^? 22.98 MG MG A 301 coo -4.56 10.03 62.36 -4.38 11.31 61.55 37.04 23.74 21.31 36.51 24.34 22.59 coo -3.02 12.00 70.07 -1.94 13.84 67.82 32.99 26.50 25.19 35.50 25.33 26.51 coo -8.67 12.22 56.54 -8.68 12.09 58.65 45.06 19.97 24.02 44.05 19.39 22.19 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 E 124 ALA A 43 ALA^? 22.11 MG MG A 301 E 126 ARG A 48 ARG^? 25.29 MG MG A 301 E 138 GLU A 54 GLU^? 22.98 MG MG A 301 coo -4.56 10.03 62.36 -4.38 11.31 61.55 37.04 23.74 21.31 36.51 24.34 22.59 coo -3.02 12.00 70.07 -1.94 13.84 67.82 33.88 31.17 22.03 31.48 31.85 20.30 coo -8.67 12.22 56.54 -8.68 12.09 58.65 45.06 19.97 24.02 44.05 19.39 22.19 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 E 124 ALA B 43 ALA^? 21.96 MG MG B 302 E 126 ARG B 48 ARG^? 25.20 MG MG B 302 E 138 GLU B 54 GLU^? 22.94 MG MG B 302 coo -4.56 10.03 62.36 -4.38 11.31 61.55 45.25 14.39 14.98 45.85 13.87 13.70 coo -3.02 12.00 70.07 -1.94 13.84 67.82 52.22 10.51 15.00 52.46 7.79 16.39 coo -8.67 12.22 56.54 -8.68 12.09 58.65 43.18 23.27 12.99 42.40 22.23 14.68 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 E 124 ALA B 116 ALA^? 9.34 MG MG B 302 E 126 ARG B 50 ARG^? 16.38 MG MG B 302 E 138 GLU B 94 GLU^? 15.34 MG MG B 302 coo -4.56 10.03 62.36 -4.38 11.31 61.55 56.90 23.91 4.45 56.31 22.97 5.47 coo -3.02 12.00 70.07 -1.94 13.84 67.82 55.38 14.91 7.80 56.60 14.73 10.62 coo -8.67 12.22 56.54 -8.68 12.09 58.65 58.44 31.30 7.43 60.35 32.14 7.14 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 E 124 ALA C 43 ALA^? 21.49 MG MG C 302 E 126 ARG C 37 ARG^? 19.01 MG MG C 302 E 138 GLU C 54 GLU^? 22.77 MG MG C 302 coo -4.56 10.03 62.36 -4.38 11.31 61.55 89.94 22.31 -21.67 89.53 21.88 -20.28 coo -3.02 12.00 70.07 -1.94 13.84 67.82 89.36 17.23 -17.57 89.29 20.20 -16.76 coo -8.67 12.22 56.54 -8.68 12.09 58.65 88.91 31.25 -19.52 89.97 30.69 -21.29 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 E 124 ALA C 43 ALA^? 21.49 MG MG C 302 E 126 ARG C 48 ARG^? 25.02 MG MG C 302 E 138 GLU C 54 GLU^? 22.77 MG MG C 302 coo -4.56 10.03 62.36 -4.38 11.31 61.55 89.94 22.31 -21.67 89.53 21.88 -20.28 coo -3.02 12.00 70.07 -1.94 13.84 67.82 84.94 16.06 -21.53 85.81 13.55 -23.08 coo -8.67 12.22 56.54 -8.68 12.09 58.65 88.91 31.25 -19.52 89.97 30.69 -21.29 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 3 # 7 E 124 ALA D 43 ALA^? 21.51 MG MG D 302 E 126 ARG D 48 ARG^? 24.87 MG MG D 302 E 138 GLU D 54 GLU^? 22.96 MG MG D 302 coo -4.56 10.03 62.36 -4.38 11.31 61.55 94.20 34.03 -28.30 94.29 34.60 -29.70 coo -3.02 12.00 70.07 -1.94 13.84 67.82 94.06 41.76 -28.37 96.24 43.38 -26.96 coo -8.67 12.22 56.54 -8.68 12.09 58.65 87.96 27.60 -30.52 89.07 27.55 -28.72 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 3 # 8 E 124 ALA D 91 ALA^? 13.42 MG MG D 302 E 126 ARG D 50 ARG^? 16.15 MG MG D 302 E 138 GLU D 94 GLU^? 16.28 MG MG D 302 coo -4.56 10.03 62.36 -4.38 11.31 61.55 79.15 42.27 -34.55 80.22 41.77 -35.47 coo -3.02 12.00 70.07 -1.94 13.84 67.82 88.00 43.26 -36.30 88.86 43.23 -33.34 coo -8.67 12.22 56.54 -8.68 12.09 58.65 72.85 36.59 -35.79 71.78 37.87 -37.16 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 3 # 9 E 124 ALA D 116 ALA^? 9.63 MG MG D 302 E 126 ARG D 50 ARG^? 16.15 MG MG D 302 E 138 GLU D 94 GLU^? 16.28 MG MG D 302 coo -4.56 10.03 62.36 -4.38 11.31 61.55 80.74 38.94 -39.77 81.69 38.81 -38.65 coo -3.02 12.00 70.07 -1.94 13.84 67.82 88.00 43.26 -36.30 88.86 43.23 -33.34 coo -8.67 12.22 56.54 -8.68 12.09 58.65 72.85 36.59 -35.79 71.78 37.87 -37.16 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 3 # 10 E 124 ALA E 43 ALA^? 21.87 MG MG E 302 E 126 ARG E 48 ARG^? 25.02 MG MG E 302 E 138 GLU E 54 GLU^? 22.83 MG MG E 302 coo -4.56 10.03 62.36 -4.38 11.31 61.55 65.81 67.05 -66.75 66.56 67.21 -65.43 coo -3.02 12.00 70.07 -1.94 13.84 67.82 73.60 65.75 -66.57 75.51 67.67 -67.91 coo -8.67 12.22 56.54 -8.68 12.09 58.65 58.39 62.16 -64.12 58.73 62.98 -66.04 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 11 3 # 11 E 124 ALA F 43 ALA^? 21.71 MG MG F 301 E 126 ARG F 48 ARG^? 25.18 MG MG F 301 E 138 GLU F 54 GLU^? 22.98 MG MG F 301 coo -4.56 10.03 62.36 -4.38 11.31 61.55 53.63 64.70 -73.15 53.00 64.46 -74.53 coo -3.02 12.00 70.07 -1.94 13.84 67.82 46.82 60.90 -73.07 44.43 61.88 -71.46 coo -8.67 12.22 56.54 -8.68 12.09 58.65 62.26 62.27 -75.30 61.72 63.47 -73.60 1xs1_c10 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 11 hits 1xs1_c10 naa= 3 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 F 124 ALA A 43 ALA^? 22.11 MG MG A 301 F 126 ARG A 37 ARG^? 18.99 MG MG A 301 F 138 GLU A 54 GLU^? 22.98 MG MG A 301 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 37.04 23.74 21.31 36.51 24.34 22.59 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 32.99 26.50 25.19 35.50 25.33 26.51 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 45.06 19.97 24.02 44.05 19.39 22.19 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 F 124 ALA A 43 ALA^? 22.11 MG MG A 301 F 126 ARG A 48 ARG^? 25.29 MG MG A 301 F 138 GLU A 54 GLU^? 22.98 MG MG A 301 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 37.04 23.74 21.31 36.51 24.34 22.59 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 33.88 31.17 22.03 31.48 31.85 20.30 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 45.06 19.97 24.02 44.05 19.39 22.19 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 F 124 ALA B 91 ALA^? 13.14 MG MG B 302 F 126 ARG B 50 ARG^? 16.38 MG MG B 302 F 138 GLU B 94 GLU^? 15.34 MG MG B 302 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 60.40 23.47 9.84 59.47 22.84 8.80 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 55.38 14.91 7.80 56.60 14.73 10.62 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 58.44 31.30 7.43 60.35 32.14 7.14 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 F 124 ALA B 116 ALA^? 9.34 MG MG B 302 F 126 ARG B 50 ARG^? 16.38 MG MG B 302 F 138 GLU B 94 GLU^? 15.34 MG MG B 302 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 56.90 23.91 4.45 56.31 22.97 5.47 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 55.38 14.91 7.80 56.60 14.73 10.62 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 58.44 31.30 7.43 60.35 32.14 7.14 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 F 124 ALA C 43 ALA^? 21.49 MG MG C 302 F 126 ARG C 37 ARG^? 19.01 MG MG C 302 F 138 GLU C 54 GLU^? 22.77 MG MG C 302 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 89.94 22.31 -21.67 89.53 21.88 -20.28 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 89.36 17.23 -17.57 89.29 20.20 -16.76 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 88.91 31.25 -19.52 89.97 30.69 -21.29 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 F 124 ALA C 43 ALA^? 21.49 MG MG C 302 F 126 ARG C 48 ARG^? 25.02 MG MG C 302 F 138 GLU C 54 GLU^? 22.77 MG MG C 302 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 89.94 22.31 -21.67 89.53 21.88 -20.28 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 84.94 16.06 -21.53 85.81 13.55 -23.08 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 88.91 31.25 -19.52 89.97 30.69 -21.29 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 3 # 7 F 124 ALA D 43 ALA^? 21.51 MG MG D 302 F 126 ARG D 48 ARG^? 24.87 MG MG D 302 F 138 GLU D 54 GLU^? 22.96 MG MG D 302 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 94.20 34.03 -28.30 94.29 34.60 -29.70 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 94.06 41.76 -28.37 96.24 43.38 -26.96 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 87.96 27.60 -30.52 89.07 27.55 -28.72 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 3 # 8 F 124 ALA D 91 ALA^? 13.42 MG MG D 302 F 126 ARG D 50 ARG^? 16.15 MG MG D 302 F 138 GLU D 94 GLU^? 16.28 MG MG D 302 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 79.15 42.27 -34.55 80.22 41.77 -35.47 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 88.00 43.26 -36.30 88.86 43.23 -33.34 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 72.85 36.59 -35.79 71.78 37.87 -37.16 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 3 # 9 F 124 ALA D 116 ALA^? 9.63 MG MG D 302 F 126 ARG D 50 ARG^? 16.15 MG MG D 302 F 138 GLU D 94 GLU^? 16.28 MG MG D 302 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 80.74 38.94 -39.77 81.69 38.81 -38.65 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 88.00 43.26 -36.30 88.86 43.23 -33.34 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 72.85 36.59 -35.79 71.78 37.87 -37.16 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 3 # 10 F 124 ALA E 43 ALA^? 21.87 MG MG E 302 F 126 ARG E 48 ARG^? 25.02 MG MG E 302 F 138 GLU E 54 GLU^? 22.83 MG MG E 302 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 65.81 67.05 -66.75 66.56 67.21 -65.43 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 73.60 65.75 -66.57 75.51 67.67 -67.91 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 58.39 62.16 -64.12 58.73 62.98 -66.04 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 11 3 # 11 F 124 ALA F 43 ALA^? 21.71 MG MG F 301 F 126 ARG F 48 ARG^? 25.18 MG MG F 301 F 138 GLU F 54 GLU^? 22.98 MG MG F 301 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 53.63 64.70 -73.15 53.00 64.46 -74.53 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 46.82 60.90 -73.07 44.43 61.88 -71.46 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 62.26 62.27 -75.30 61.72 63.47 -73.60 1xs1_c11 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 11 hits 1xs1_c11 naa= 3 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 1 3 # 1 B 137 GLY A 34 GLY^? 18.18 MG MG A 301 B 175 ARG A 48 ARG^? 25.29 MG MG A 301 B 242 TYR B 60 TYR^? 27.11 MG MG A 301 coo 99.45 58.28 3.33 99.57 58.61 4.10 33.66 35.41 27.99 33.72 35.64 27.21 coo 106.37 63.53 0.89 108.02 63.40 -1.62 33.88 31.17 22.03 31.48 31.85 20.30 coo 100.93 69.04 4.38 99.52 68.48 2.09 28.84 35.27 19.49 28.03 36.56 21.83 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 2 3 # 2 B 137 GLY B 34 GLY^? 18.20 MG MG B 302 B 175 ARG B 48 ARG^? 25.20 MG MG B 302 B 242 TYR A 60 TYR^? 27.11 MG MG B 302 coo 99.45 58.28 3.33 99.57 58.61 4.10 56.73 9.38 8.85 56.97 9.44 9.63 coo 106.37 63.53 0.89 108.02 63.40 -1.62 52.22 10.51 15.00 52.46 7.79 16.39 coo 100.93 69.04 4.38 99.52 68.48 2.09 55.01 4.24 16.98 56.13 3.24 14.65 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 3 3 # 3 B 137 GLY C 34 GLY^? 18.00 MG MG C 302 B 175 ARG C 48 ARG^? 25.02 MG MG C 302 B 242 TYR D 60 TYR^? 26.93 MG MG C 302 coo 99.45 58.28 3.33 99.57 58.61 4.10 81.22 13.31 -15.34 80.98 13.29 -16.15 coo 106.37 63.53 0.89 108.02 63.40 -1.62 84.94 16.06 -21.53 85.81 13.55 -23.08 coo 100.93 69.04 4.38 99.52 68.48 2.09 84.40 9.28 -23.74 83.45 7.90 -21.49 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 4 3 # 4 B 137 GLY D 34 GLY^? 17.73 MG MG D 302 B 175 ARG D 48 ARG^? 24.87 MG MG D 302 B 242 TYR C 60 TYR^? 26.95 MG MG D 302 coo 99.45 58.28 3.33 99.57 58.61 4.10 93.02 46.29 -34.84 92.89 46.52 -34.02 coo 106.37 63.53 0.89 108.02 63.40 -1.62 94.06 41.76 -28.37 96.24 43.38 -26.96 coo 100.93 69.04 4.38 99.52 68.48 2.09 97.75 47.69 -25.92 97.82 49.25 -28.26 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 5 3 # 5 B 137 GLY E 34 GLY^? 17.96 MG MG E 302 B 175 ARG E 37 ARG^? 19.17 MG MG E 302 B 242 TYR F 60 TYR^? 27.07 MG MG E 302 coo 99.45 58.28 3.33 99.57 58.61 4.10 77.63 64.22 -60.15 77.94 64.12 -60.90 coo 106.37 63.53 0.89 108.02 63.40 -1.62 70.82 68.02 -63.63 68.17 67.46 -62.14 coo 100.93 69.04 4.38 99.52 68.48 2.09 79.79 68.64 -68.89 81.11 68.86 -66.46 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 6 3 # 6 B 137 GLY E 34 GLY^? 17.96 MG MG E 302 B 175 ARG E 48 ARG^? 25.02 MG MG E 302 B 242 TYR F 60 TYR^? 27.07 MG MG E 302 coo 99.45 58.28 3.33 99.57 58.61 4.10 77.63 64.22 -60.15 77.94 64.12 -60.90 coo 106.37 63.53 0.89 108.02 63.40 -1.62 73.60 65.75 -66.57 75.51 67.67 -67.91 coo 100.93 69.04 4.38 99.52 68.48 2.09 79.79 68.64 -68.89 81.11 68.86 -66.46 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 7 3 # 7 B 137 GLY F 34 GLY^? 17.95 MG MG F 301 B 175 ARG F 48 ARG^? 25.18 MG MG F 301 B 242 TYR E 60 TYR^? 27.19 MG MG F 301 coo 99.45 58.28 3.33 99.57 58.61 4.10 43.60 57.46 -79.20 43.37 57.32 -78.41 coo 106.37 63.53 0.89 108.02 63.40 -1.62 46.82 60.90 -73.07 44.43 61.88 -71.46 coo 100.93 69.04 4.38 99.52 68.48 2.09 39.82 61.07 -70.68 38.29 60.72 -72.98 1xva_c03 source 1xva GLYCINE N-METHYLTRANSFERASE : 7 hits 1xva_c03 naa= 3 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 A 14 LYS A 157 LYS^? 28.65 MG MG A 302 A 74 LYS A 6 LYS^? 25.88 MG MG A 301 A 165 GLU A 52 GLU^? 19.89 MG MG A 301 coo 18.28 7.83 36.39 22.82 8.75 39.52 41.42 12.06 27.58 41.46 5.93 29.41 coo 14.16 13.09 37.03 20.00 12.44 37.49 46.20 12.82 24.71 44.50 16.64 20.52 coo 22.22 16.06 48.76 23.94 15.33 49.78 42.67 25.16 24.80 42.61 25.77 22.75 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 A 14 LYS A 157 LYS^? 28.65 MG MG A 302 A 74 LYS A 166 LYS^? 20.93 MG MG A 302 A 165 GLU A 52 GLU^? 19.89 MG MG A 301 coo 18.28 7.83 36.39 22.82 8.75 39.52 41.42 12.06 27.58 41.46 5.93 29.41 coo 14.16 13.09 37.03 20.00 12.44 37.49 35.34 13.14 30.41 31.67 15.04 34.58 coo 22.22 16.06 48.76 23.94 15.33 49.78 42.67 25.16 24.80 42.61 25.77 22.75 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 A 14 LYS A 166 LYS^? 20.93 MG MG A 302 A 74 LYS A 157 LYS^? 28.65 MG MG A 302 A 165 GLU A 52 GLU^? 19.89 MG MG A 301 coo 18.28 7.83 36.39 22.82 8.75 39.52 35.34 13.14 30.41 31.67 15.04 34.58 coo 14.16 13.09 37.03 20.00 12.44 37.49 41.42 12.06 27.58 41.46 5.93 29.41 coo 22.22 16.06 48.76 23.94 15.33 49.78 42.67 25.16 24.80 42.61 25.77 22.75 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 A 14 LYS B 157 LYS^? 28.85 MG MG B 302 A 74 LYS B 6 LYS^? 25.90 MG MG B 302 A 165 GLU B 52 GLU^? 20.06 MG MG B 302 coo 18.28 7.83 36.39 22.82 8.75 39.52 34.97 21.28 8.44 29.03 22.82 6.58 coo 14.16 13.09 37.03 20.00 12.44 37.49 36.26 25.44 11.74 39.65 23.12 16.29 coo 22.22 16.06 48.76 23.94 15.33 49.78 47.87 20.25 12.36 48.11 19.69 14.43 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 A 14 LYS B 157 LYS^? 28.85 MG MG B 302 A 74 LYS B 166 LYS^? 22.75 MG MG B 301 A 165 GLU B 52 GLU^? 20.06 MG MG B 302 coo 18.28 7.83 36.39 22.82 8.75 39.52 34.97 21.28 8.44 29.03 22.82 6.58 coo 14.16 13.09 37.03 20.00 12.44 37.49 35.27 15.38 5.31 37.27 9.81 3.93 coo 22.22 16.06 48.76 23.94 15.33 49.78 47.87 20.25 12.36 48.11 19.69 14.43 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 A 14 LYS B 166 LYS^? 22.75 MG MG B 301 A 74 LYS B 157 LYS^? 28.85 MG MG B 302 A 165 GLU B 52 GLU^? 20.06 MG MG B 302 coo 18.28 7.83 36.39 22.82 8.75 39.52 35.27 15.38 5.31 37.27 9.81 3.93 coo 14.16 13.09 37.03 20.00 12.44 37.49 34.97 21.28 8.44 29.03 22.82 6.58 coo 22.22 16.06 48.76 23.94 15.33 49.78 47.87 20.25 12.36 48.11 19.69 14.43 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 A 14 LYS C 157 LYS^? 28.15 MG MG C 302 A 74 LYS C 6 LYS^? 25.73 MG MG C 302 A 165 GLU C 52 GLU^? 19.67 MG MG C 302 coo 18.28 7.83 36.39 22.82 8.75 39.52 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 14.16 13.09 37.03 20.00 12.44 37.49 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 22.22 16.06 48.76 23.94 15.33 49.78 84.27 26.98 -19.19 85.21 26.16 -20.96 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 A 14 LYS C 166 LYS^? 22.53 MG MG C 301 A 74 LYS C 157 LYS^? 28.15 MG MG C 302 A 165 GLU C 52 GLU^? 19.67 MG MG C 302 coo 18.28 7.83 36.39 22.82 8.75 39.52 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 14.16 13.09 37.03 20.00 12.44 37.49 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 22.22 16.06 48.76 23.94 15.33 49.78 84.27 26.98 -19.19 85.21 26.16 -20.96 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 A 14 LYS D 157 LYS^? 28.67 MG MG D 302 A 74 LYS D 6 LYS^? 25.98 MG MG D 302 A 165 GLU D 52 GLU^? 19.94 MG MG D 302 coo 18.28 7.83 36.39 22.82 8.75 39.52 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 14.16 13.09 37.03 20.00 12.44 37.49 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 22.22 16.06 48.76 23.94 15.33 49.78 87.13 33.17 -30.97 88.40 33.70 -29.31 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 A 14 LYS D 157 LYS^? 28.67 MG MG D 302 A 74 LYS D 166 LYS^? 21.08 MG MG D 301 A 165 GLU D 52 GLU^? 19.94 MG MG D 302 coo 18.28 7.83 36.39 22.82 8.75 39.52 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 14.16 13.09 37.03 20.00 12.44 37.49 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 22.22 16.06 48.76 23.94 15.33 49.78 87.13 33.17 -30.97 88.40 33.70 -29.31 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 A 14 LYS D 166 LYS^? 21.08 MG MG D 301 A 74 LYS D 157 LYS^? 28.67 MG MG D 302 A 165 GLU D 52 GLU^? 19.94 MG MG D 302 coo 18.28 7.83 36.39 22.82 8.75 39.52 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 14.16 13.09 37.03 20.00 12.44 37.49 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 22.22 16.06 48.76 23.94 15.33 49.78 87.13 33.17 -30.97 88.40 33.70 -29.31 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 A 14 LYS E 6 LYS^? 25.59 MG MG E 302 A 74 LYS E 157 LYS^? 28.40 MG MG E 302 A 165 GLU E 52 GLU^? 19.96 MG MG E 302 coo 18.28 7.83 36.39 22.82 8.75 39.52 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 14.16 13.09 37.03 20.00 12.44 37.49 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 22.22 16.06 48.76 23.94 15.33 49.78 64.71 60.06 -63.78 64.69 61.36 -65.58 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 A 14 LYS E 76 LYS^? 25.68 MG MG E 302 A 74 LYS E 86 LYS^? 26.73 MG MG D 301 A 165 GLU F 63 GLU^? 27.81 MG MG E 302 coo 18.28 7.83 36.39 22.82 8.75 39.52 87.09 58.11 -60.91 88.65 63.65 -61.27 coo 14.16 13.09 37.03 20.00 12.44 37.49 86.84 54.85 -64.43 87.07 60.83 -66.10 coo 22.22 16.06 48.76 23.94 15.33 49.78 78.38 60.07 -72.34 78.48 58.04 -72.84 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 A 14 LYS E 157 LYS^? 28.40 MG MG E 302 A 74 LYS E 6 LYS^? 25.59 MG MG E 302 A 165 GLU E 52 GLU^? 19.96 MG MG E 302 coo 18.28 7.83 36.39 22.82 8.75 39.52 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 14.16 13.09 37.03 20.00 12.44 37.49 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 22.22 16.06 48.76 23.94 15.33 49.78 64.71 60.06 -63.78 64.69 61.36 -65.58 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 A 14 LYS E 157 LYS^? 28.40 MG MG E 302 A 74 LYS E 166 LYS^? 21.46 MG MG E 301 A 165 GLU E 52 GLU^? 19.96 MG MG E 302 coo 18.28 7.83 36.39 22.82 8.75 39.52 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 14.16 13.09 37.03 20.00 12.44 37.49 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 22.22 16.06 48.76 23.94 15.33 49.78 64.71 60.06 -63.78 64.69 61.36 -65.58 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 16 3 # 16 A 14 LYS E 166 LYS^? 21.46 MG MG E 301 A 74 LYS E 157 LYS^? 28.40 MG MG E 302 A 165 GLU E 52 GLU^? 19.96 MG MG E 302 coo 18.28 7.83 36.39 22.82 8.75 39.52 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 14.16 13.09 37.03 20.00 12.44 37.49 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 22.22 16.06 48.76 23.94 15.33 49.78 64.71 60.06 -63.78 64.69 61.36 -65.58 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 17 3 # 17 A 14 LYS F 157 LYS^? 28.36 MG MG F 302 A 74 LYS F 6 LYS^? 26.09 MG MG F 301 A 165 GLU F 52 GLU^? 20.13 MG MG F 301 coo 18.28 7.83 36.39 22.82 8.75 39.52 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 14.16 13.09 37.03 20.00 12.44 37.49 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 22.22 16.06 48.76 23.94 15.33 49.78 57.09 59.62 -75.76 56.76 59.40 -73.62 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 18 3 # 18 A 14 LYS F 157 LYS^? 28.36 MG MG F 302 A 74 LYS F 166 LYS^? 20.76 MG MG F 302 A 165 GLU F 52 GLU^? 20.13 MG MG F 301 coo 18.28 7.83 36.39 22.82 8.75 39.52 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 14.16 13.09 37.03 20.00 12.44 37.49 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 22.22 16.06 48.76 23.94 15.33 49.78 57.09 59.62 -75.76 56.76 59.40 -73.62 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 19 3 # 19 A 14 LYS F 166 LYS^? 20.76 MG MG F 302 A 74 LYS F 157 LYS^? 28.36 MG MG F 302 A 165 GLU F 52 GLU^? 20.13 MG MG F 301 coo 18.28 7.83 36.39 22.82 8.75 39.52 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 14.16 13.09 37.03 20.00 12.44 37.49 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 22.22 16.06 48.76 23.94 15.33 49.78 57.09 59.62 -75.76 56.76 59.40 -73.62 1ylu_c00 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 19 hits 1ylu_c00 naa= 3 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 B 14 LYS A 157 LYS^? 28.65 MG MG A 302 B 74 LYS A 6 LYS^? 25.88 MG MG A 301 B 165 GLU A 52 GLU^? 19.89 MG MG A 301 coo 13.51 0.92 76.10 12.98 6.13 74.68 41.42 12.06 27.58 41.46 5.93 29.41 coo 19.89 -0.55 76.51 17.10 4.32 77.43 46.20 12.82 24.71 44.50 16.64 20.52 coo 21.39 11.56 68.52 20.24 13.13 67.73 42.67 25.16 24.80 42.61 25.77 22.75 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 B 14 LYS A 157 LYS^? 28.65 MG MG A 302 B 74 LYS A 166 LYS^? 20.93 MG MG A 302 B 165 GLU A 52 GLU^? 19.89 MG MG A 301 coo 13.51 0.92 76.10 12.98 6.13 74.68 41.42 12.06 27.58 41.46 5.93 29.41 coo 19.89 -0.55 76.51 17.10 4.32 77.43 35.34 13.14 30.41 31.67 15.04 34.58 coo 21.39 11.56 68.52 20.24 13.13 67.73 42.67 25.16 24.80 42.61 25.77 22.75 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 B 14 LYS A 166 LYS^? 20.93 MG MG A 302 B 74 LYS A 157 LYS^? 28.65 MG MG A 302 B 165 GLU A 52 GLU^? 19.89 MG MG A 301 coo 13.51 0.92 76.10 12.98 6.13 74.68 35.34 13.14 30.41 31.67 15.04 34.58 coo 19.89 -0.55 76.51 17.10 4.32 77.43 41.42 12.06 27.58 41.46 5.93 29.41 coo 21.39 11.56 68.52 20.24 13.13 67.73 42.67 25.16 24.80 42.61 25.77 22.75 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 B 14 LYS B 157 LYS^? 28.85 MG MG B 302 B 74 LYS B 6 LYS^? 25.90 MG MG B 302 B 165 GLU B 52 GLU^? 20.06 MG MG B 302 coo 13.51 0.92 76.10 12.98 6.13 74.68 34.97 21.28 8.44 29.03 22.82 6.58 coo 19.89 -0.55 76.51 17.10 4.32 77.43 36.26 25.44 11.74 39.65 23.12 16.29 coo 21.39 11.56 68.52 20.24 13.13 67.73 47.87 20.25 12.36 48.11 19.69 14.43 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 B 14 LYS B 157 LYS^? 28.85 MG MG B 302 B 74 LYS B 166 LYS^? 22.75 MG MG B 301 B 165 GLU B 52 GLU^? 20.06 MG MG B 302 coo 13.51 0.92 76.10 12.98 6.13 74.68 34.97 21.28 8.44 29.03 22.82 6.58 coo 19.89 -0.55 76.51 17.10 4.32 77.43 35.27 15.38 5.31 37.27 9.81 3.93 coo 21.39 11.56 68.52 20.24 13.13 67.73 47.87 20.25 12.36 48.11 19.69 14.43 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 B 14 LYS B 166 LYS^? 22.75 MG MG B 301 B 74 LYS B 157 LYS^? 28.85 MG MG B 302 B 165 GLU B 52 GLU^? 20.06 MG MG B 302 coo 13.51 0.92 76.10 12.98 6.13 74.68 35.27 15.38 5.31 37.27 9.81 3.93 coo 19.89 -0.55 76.51 17.10 4.32 77.43 34.97 21.28 8.44 29.03 22.82 6.58 coo 21.39 11.56 68.52 20.24 13.13 67.73 47.87 20.25 12.36 48.11 19.69 14.43 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 B 14 LYS C 6 LYS^? 25.73 MG MG C 302 B 74 LYS C 157 LYS^? 28.15 MG MG C 302 B 165 GLU C 52 GLU^? 19.67 MG MG C 302 coo 13.51 0.92 76.10 12.98 6.13 74.68 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 19.89 -0.55 76.51 17.10 4.32 77.43 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 21.39 11.56 68.52 20.24 13.13 67.73 84.27 26.98 -19.19 85.21 26.16 -20.96 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 B 14 LYS C 157 LYS^? 28.15 MG MG C 302 B 74 LYS C 6 LYS^? 25.73 MG MG C 302 B 165 GLU C 52 GLU^? 19.67 MG MG C 302 coo 13.51 0.92 76.10 12.98 6.13 74.68 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 19.89 -0.55 76.51 17.10 4.32 77.43 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 21.39 11.56 68.52 20.24 13.13 67.73 84.27 26.98 -19.19 85.21 26.16 -20.96 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 B 14 LYS C 157 LYS^? 28.15 MG MG C 302 B 74 LYS C 166 LYS^? 22.53 MG MG C 301 B 165 GLU C 52 GLU^? 19.67 MG MG C 302 coo 13.51 0.92 76.10 12.98 6.13 74.68 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 19.89 -0.55 76.51 17.10 4.32 77.43 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 21.39 11.56 68.52 20.24 13.13 67.73 84.27 26.98 -19.19 85.21 26.16 -20.96 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 B 14 LYS C 166 LYS^? 22.53 MG MG C 301 B 74 LYS C 157 LYS^? 28.15 MG MG C 302 B 165 GLU C 52 GLU^? 19.67 MG MG C 302 coo 13.51 0.92 76.10 12.98 6.13 74.68 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 19.89 -0.55 76.51 17.10 4.32 77.43 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 21.39 11.56 68.52 20.24 13.13 67.73 84.27 26.98 -19.19 85.21 26.16 -20.96 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 B 14 LYS D 76 LYS^? 25.08 MG MG D 302 B 74 LYS D 86 LYS^? 25.80 MG MG D 302 B 165 GLU C 63 GLU^? 27.26 MG MG D 302 coo 13.51 0.92 76.10 12.98 6.13 74.68 88.18 56.35 -34.05 93.80 56.17 -32.93 coo 19.89 -0.55 76.51 17.10 4.32 77.43 85.54 56.79 -30.27 90.24 54.54 -28.62 coo 21.39 11.56 68.52 20.24 13.13 67.73 89.51 47.54 -22.35 87.55 48.20 -22.72 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 B 14 LYS D 157 LYS^? 28.67 MG MG D 302 B 74 LYS D 6 LYS^? 25.98 MG MG D 302 B 165 GLU D 52 GLU^? 19.94 MG MG D 302 coo 13.51 0.92 76.10 12.98 6.13 74.68 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 19.89 -0.55 76.51 17.10 4.32 77.43 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 21.39 11.56 68.52 20.24 13.13 67.73 87.13 33.17 -30.97 88.40 33.70 -29.31 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 B 14 LYS D 157 LYS^? 28.67 MG MG D 302 B 74 LYS D 166 LYS^? 21.08 MG MG D 301 B 165 GLU D 52 GLU^? 19.94 MG MG D 302 coo 13.51 0.92 76.10 12.98 6.13 74.68 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 19.89 -0.55 76.51 17.10 4.32 77.43 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 21.39 11.56 68.52 20.24 13.13 67.73 87.13 33.17 -30.97 88.40 33.70 -29.31 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 B 14 LYS D 166 LYS^? 21.08 MG MG D 301 B 74 LYS D 157 LYS^? 28.67 MG MG D 302 B 165 GLU D 52 GLU^? 19.94 MG MG D 302 coo 13.51 0.92 76.10 12.98 6.13 74.68 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 19.89 -0.55 76.51 17.10 4.32 77.43 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 21.39 11.56 68.52 20.24 13.13 67.73 87.13 33.17 -30.97 88.40 33.70 -29.31 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 B 14 LYS E 6 LYS^? 25.59 MG MG E 302 B 74 LYS E 157 LYS^? 28.40 MG MG E 302 B 165 GLU E 52 GLU^? 19.96 MG MG E 302 coo 13.51 0.92 76.10 12.98 6.13 74.68 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 19.89 -0.55 76.51 17.10 4.32 77.43 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 21.39 11.56 68.52 20.24 13.13 67.73 64.71 60.06 -63.78 64.69 61.36 -65.58 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 16 3 # 16 B 14 LYS E 76 LYS^? 25.68 MG MG E 302 B 74 LYS E 86 LYS^? 26.73 MG MG D 301 B 165 GLU F 63 GLU^? 27.81 MG MG E 302 coo 13.51 0.92 76.10 12.98 6.13 74.68 87.09 58.11 -60.91 88.65 63.65 -61.27 coo 19.89 -0.55 76.51 17.10 4.32 77.43 86.84 54.85 -64.43 87.07 60.83 -66.10 coo 21.39 11.56 68.52 20.24 13.13 67.73 78.38 60.07 -72.34 78.48 58.04 -72.84 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 17 3 # 17 B 14 LYS E 157 LYS^? 28.40 MG MG E 302 B 74 LYS E 6 LYS^? 25.59 MG MG E 302 B 165 GLU E 52 GLU^? 19.96 MG MG E 302 coo 13.51 0.92 76.10 12.98 6.13 74.68 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 19.89 -0.55 76.51 17.10 4.32 77.43 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 21.39 11.56 68.52 20.24 13.13 67.73 64.71 60.06 -63.78 64.69 61.36 -65.58 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 18 3 # 18 B 14 LYS E 157 LYS^? 28.40 MG MG E 302 B 74 LYS E 166 LYS^? 21.46 MG MG E 301 B 165 GLU E 52 GLU^? 19.96 MG MG E 302 coo 13.51 0.92 76.10 12.98 6.13 74.68 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 19.89 -0.55 76.51 17.10 4.32 77.43 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 21.39 11.56 68.52 20.24 13.13 67.73 64.71 60.06 -63.78 64.69 61.36 -65.58 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 19 3 # 19 B 14 LYS E 166 LYS^? 21.46 MG MG E 301 B 74 LYS E 157 LYS^? 28.40 MG MG E 302 B 165 GLU E 52 GLU^? 19.96 MG MG E 302 coo 13.51 0.92 76.10 12.98 6.13 74.68 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 19.89 -0.55 76.51 17.10 4.32 77.43 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 21.39 11.56 68.52 20.24 13.13 67.73 64.71 60.06 -63.78 64.69 61.36 -65.58 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 20 3 # 20 B 14 LYS F 157 LYS^? 28.36 MG MG F 302 B 74 LYS F 6 LYS^? 26.09 MG MG F 301 B 165 GLU F 52 GLU^? 20.13 MG MG F 301 coo 13.51 0.92 76.10 12.98 6.13 74.68 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 19.89 -0.55 76.51 17.10 4.32 77.43 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 21.39 11.56 68.52 20.24 13.13 67.73 57.09 59.62 -75.76 56.76 59.40 -73.62 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 21 3 # 21 B 14 LYS F 157 LYS^? 28.36 MG MG F 302 B 74 LYS F 166 LYS^? 20.76 MG MG F 302 B 165 GLU F 52 GLU^? 20.13 MG MG F 301 coo 13.51 0.92 76.10 12.98 6.13 74.68 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 19.89 -0.55 76.51 17.10 4.32 77.43 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 21.39 11.56 68.52 20.24 13.13 67.73 57.09 59.62 -75.76 56.76 59.40 -73.62 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 22 3 # 22 B 14 LYS F 166 LYS^? 20.76 MG MG F 302 B 74 LYS F 157 LYS^? 28.36 MG MG F 302 B 165 GLU F 52 GLU^? 20.13 MG MG F 301 coo 13.51 0.92 76.10 12.98 6.13 74.68 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 19.89 -0.55 76.51 17.10 4.32 77.43 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 21.39 11.56 68.52 20.24 13.13 67.73 57.09 59.62 -75.76 56.76 59.40 -73.62 1ylu_c01 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 22 hits 1ylu_c01 naa= 3 ULMN 3 1ysc_c01 SERINE CARBOXYPEPTIDASE (CPY, CPD-Y,user 1 3 # 1 146 SER A 189 SER^? 11.75 MG MG A 302 338 ASP A 148 ASP^? 2.72 MG MG A 301s 397 HIS A 147 HIS^? 9.20 MG MG A 302 coo 45.26 -1.97 35.69 47.76 -2.02 35.82 40.99 19.00 44.32 41.51 18.14 46.48 coo 43.14 -11.10 34.55 44.24 -9.84 35.75 41.50 28.88 41.13 43.33 29.67 41.93 coo 46.65 -7.57 34.11 46.60 -5.84 35.18 40.24 23.10 39.83 38.32 22.34 40.22 ULMN 3 1ysc_c01 SERINE CARBOXYPEPTIDASE (CPY, CPD-Y,user 2 3 # 2 146 SER B 189 SER^? 12.11 MG MG B 301 338 ASP B 148 ASP^? 2.58 MG MG B 302s 397 HIS B 147 HIS^? 9.27 MG MG B 301 coo 45.26 -1.97 35.69 47.76 -2.02 35.82 43.10 20.95 -7.74 42.82 21.56 -10.02 coo 43.14 -11.10 34.55 44.24 -9.84 35.75 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 46.65 -7.57 34.11 46.60 -5.84 35.18 46.73 18.97 -3.05 45.63 17.32 -3.73 ULMN 3 1ysc_c01 SERINE CARBOXYPEPTIDASE (CPY, CPD-Y,user 3 3 # 3 146 SER C 189 SER^? 12.09 MG MG C 301 338 ASP C 148 ASP^? 2.75 MG MG C 302s 397 HIS C 147 HIS^? 9.44 MG MG C 301 coo 45.26 -1.97 35.69 47.76 -2.02 35.82 90.33 28.79 1.19 90.26 29.61 3.45 coo 43.14 -11.10 34.55 44.24 -9.84 35.75 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 46.65 -7.57 34.11 46.60 -5.84 35.18 87.61 25.71 -3.59 89.22 24.50 -2.99 ULMN 3 1ysc_c01 SERINE CARBOXYPEPTIDASE (CPY, CPD-Y,user 4 3 # 4 146 SER D 189 SER^? 12.12 MG MG D 301 338 ASP D 148 ASP^? 2.35 MG MG D 302s 397 HIS D 147 HIS^? 9.43 MG MG D 301 coo 45.26 -1.97 35.69 47.76 -2.02 35.82 91.62 28.58 -50.95 91.45 27.78 -53.25 coo 43.14 -11.10 34.55 44.24 -9.84 35.75 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 46.65 -7.57 34.11 46.60 -5.84 35.18 90.95 32.51 -46.42 92.98 32.42 -46.93 ULMN 3 1ysc_c01 SERINE CARBOXYPEPTIDASE (CPY, CPD-Y,user 5 3 # 5 146 SER E 189 SER^? 11.91 MG MG E 301 338 ASP E 148 ASP^? 2.62 MG MG E 302s 397 HIS E 147 HIS^? 9.22 MG MG E 301 coo 45.26 -1.97 35.69 47.76 -2.02 35.82 60.13 65.61 -43.87 59.01 65.34 -41.74 coo 43.14 -11.10 34.55 44.24 -9.84 35.75 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 46.65 -7.57 34.11 46.60 -5.84 35.18 63.87 64.43 -48.39 64.18 66.45 -47.92 ULMN 3 1ysc_c01 SERINE CARBOXYPEPTIDASE (CPY, CPD-Y,user 6 3 # 6 146 SER F 189 SER^? 11.88 MG MG F 302 338 ASP F 148 ASP^? 2.72 MG MG F 301s 397 HIS F 147 HIS^? 8.79 MG MG F 302 coo 45.26 -1.97 35.69 47.76 -2.02 35.82 59.91 63.90 -95.91 60.70 64.22 -98.13 coo 43.14 -11.10 34.55 44.24 -9.84 35.75 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 46.65 -7.57 34.11 46.60 -5.84 35.18 56.63 61.66 -91.16 55.69 63.43 -91.80 1ysc_c01 source 1ysc SERINE CARBOXYPEPTIDASE (CPY, CPD-Y, OR PROTEI: 6 hits 1ysc_c01 naa= 3 ULMN 3 1zoi_c00 ESTERASE user 1 3 # 1 A 97 SER A 189 SER^? 11.75 MG MG A 302 A 227 ASP A 148 ASP^? 2.72 MG MG A 301s A 256 HIS A 147 HIS^? 9.20 MG MG A 302 coo 64.84 24.93 59.62 66.28 24.42 57.72 40.99 19.00 44.32 41.51 18.14 46.48 coo 73.80 27.56 60.96 72.24 26.45 60.08 41.50 28.88 41.13 43.33 29.67 41.93 coo 70.86 23.63 59.28 68.91 24.23 58.80 40.24 23.10 39.83 38.32 22.34 40.22 ULMN 3 1zoi_c00 ESTERASE user 2 3 # 2 A 97 SER B 189 SER^? 12.11 MG MG B 301 A 227 ASP B 148 ASP^? 2.58 MG MG B 302s A 256 HIS B 147 HIS^? 9.27 MG MG B 301 coo 64.84 24.93 59.62 66.28 24.42 57.72 43.10 20.95 -7.74 42.82 21.56 -10.02 coo 73.80 27.56 60.96 72.24 26.45 60.08 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 70.86 23.63 59.28 68.91 24.23 58.80 46.73 18.97 -3.05 45.63 17.32 -3.73 ULMN 3 1zoi_c00 ESTERASE user 3 3 # 3 A 97 SER C 189 SER^? 12.09 MG MG C 301 A 227 ASP C 148 ASP^? 2.75 MG MG C 302s A 256 HIS C 147 HIS^? 9.44 MG MG C 301 coo 64.84 24.93 59.62 66.28 24.42 57.72 90.33 28.79 1.19 90.26 29.61 3.45 coo 73.80 27.56 60.96 72.24 26.45 60.08 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 70.86 23.63 59.28 68.91 24.23 58.80 87.61 25.71 -3.59 89.22 24.50 -2.99 ULMN 3 1zoi_c00 ESTERASE user 4 3 # 4 A 97 SER D 189 SER^? 12.12 MG MG D 301 A 227 ASP D 148 ASP^? 2.35 MG MG D 302s A 256 HIS D 147 HIS^? 9.43 MG MG D 301 coo 64.84 24.93 59.62 66.28 24.42 57.72 91.62 28.58 -50.95 91.45 27.78 -53.25 coo 73.80 27.56 60.96 72.24 26.45 60.08 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 70.86 23.63 59.28 68.91 24.23 58.80 90.95 32.51 -46.42 92.98 32.42 -46.93 ULMN 3 1zoi_c00 ESTERASE user 5 3 # 5 A 97 SER E 189 SER^? 11.91 MG MG E 301 A 227 ASP E 148 ASP^? 2.62 MG MG E 302s A 256 HIS E 147 HIS^? 9.22 MG MG E 301 coo 64.84 24.93 59.62 66.28 24.42 57.72 60.13 65.61 -43.87 59.01 65.34 -41.74 coo 73.80 27.56 60.96 72.24 26.45 60.08 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 70.86 23.63 59.28 68.91 24.23 58.80 63.87 64.43 -48.39 64.18 66.45 -47.92 ULMN 3 1zoi_c00 ESTERASE user 6 3 # 6 A 97 SER F 189 SER^? 11.88 MG MG F 302 A 227 ASP F 148 ASP^? 2.72 MG MG F 301s A 256 HIS F 147 HIS^? 8.79 MG MG F 302 coo 64.84 24.93 59.62 66.28 24.42 57.72 59.91 63.90 -95.91 60.70 64.22 -98.13 coo 73.80 27.56 60.96 72.24 26.45 60.08 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 70.86 23.63 59.28 68.91 24.23 58.80 56.63 61.66 -91.16 55.69 63.43 -91.80 1zoi_c00 source 1zoi ESTERASE : 6 hits 1zoi_c00 naa= 3 ULMN 3 1zoi_c01 ESTERASE user 1 3 # 1 B 97 SER A 189 SER^? 11.75 MG MG A 302 B 227 ASP A 148 ASP^? 2.72 MG MG A 301s B 256 HIS A 147 HIS^? 9.20 MG MG A 302 coo 64.71 -1.59 29.78 66.19 -2.95 31.16 40.99 19.00 44.32 41.51 18.14 46.48 coo 73.58 -1.50 26.67 72.07 -1.71 28.10 41.50 28.88 41.13 43.33 29.67 41.93 coo 70.69 -1.01 30.98 68.78 -1.84 30.74 40.24 23.10 39.83 38.32 22.34 40.22 ULMN 3 1zoi_c01 ESTERASE user 2 3 # 2 B 97 SER B 189 SER^? 12.11 MG MG B 301 B 227 ASP B 148 ASP^? 2.58 MG MG B 302s B 256 HIS B 147 HIS^? 9.27 MG MG B 301 coo 64.71 -1.59 29.78 66.19 -2.95 31.16 43.10 20.95 -7.74 42.82 21.56 -10.02 coo 73.58 -1.50 26.67 72.07 -1.71 28.10 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 70.69 -1.01 30.98 68.78 -1.84 30.74 46.73 18.97 -3.05 45.63 17.32 -3.73 ULMN 3 1zoi_c01 ESTERASE user 3 3 # 3 B 97 SER C 189 SER^? 12.09 MG MG C 301 B 227 ASP C 148 ASP^? 2.75 MG MG C 302s B 256 HIS C 147 HIS^? 9.44 MG MG C 301 coo 64.71 -1.59 29.78 66.19 -2.95 31.16 90.33 28.79 1.19 90.26 29.61 3.45 coo 73.58 -1.50 26.67 72.07 -1.71 28.10 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 70.69 -1.01 30.98 68.78 -1.84 30.74 87.61 25.71 -3.59 89.22 24.50 -2.99 ULMN 3 1zoi_c01 ESTERASE user 4 3 # 4 B 97 SER D 189 SER^? 12.12 MG MG D 301 B 227 ASP D 148 ASP^? 2.35 MG MG D 302s B 256 HIS D 147 HIS^? 9.43 MG MG D 301 coo 64.71 -1.59 29.78 66.19 -2.95 31.16 91.62 28.58 -50.95 91.45 27.78 -53.25 coo 73.58 -1.50 26.67 72.07 -1.71 28.10 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 70.69 -1.01 30.98 68.78 -1.84 30.74 90.95 32.51 -46.42 92.98 32.42 -46.93 ULMN 3 1zoi_c01 ESTERASE user 5 3 # 5 B 97 SER E 189 SER^? 11.91 MG MG E 301 B 227 ASP E 148 ASP^? 2.62 MG MG E 302s B 256 HIS E 147 HIS^? 9.22 MG MG E 301 coo 64.71 -1.59 29.78 66.19 -2.95 31.16 60.13 65.61 -43.87 59.01 65.34 -41.74 coo 73.58 -1.50 26.67 72.07 -1.71 28.10 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 70.69 -1.01 30.98 68.78 -1.84 30.74 63.87 64.43 -48.39 64.18 66.45 -47.92 ULMN 3 1zoi_c01 ESTERASE user 6 3 # 6 B 97 SER F 189 SER^? 11.88 MG MG F 302 B 227 ASP F 148 ASP^? 2.72 MG MG F 301s B 256 HIS F 147 HIS^? 8.79 MG MG F 302 coo 64.71 -1.59 29.78 66.19 -2.95 31.16 59.91 63.90 -95.91 60.70 64.22 -98.13 coo 73.58 -1.50 26.67 72.07 -1.71 28.10 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 70.69 -1.01 30.98 68.78 -1.84 30.74 56.63 61.66 -91.16 55.69 63.43 -91.80 1zoi_c01 source 1zoi ESTERASE : 6 hits 1zoi_c01 naa= 3 ULMN 3 1zoi_c02 ESTERASE user 1 3 # 1 C 97 SER A 189 SER^? 11.75 MG MG A 302 C 227 ASP A 148 ASP^? 2.72 MG MG A 301s C 256 HIS A 147 HIS^? 9.20 MG MG A 302 coo 65.79 -14.04 67.57 66.89 -11.91 68.05 40.99 19.00 44.32 41.51 18.14 46.48 coo 74.87 -16.69 68.52 73.28 -15.36 68.17 41.50 28.88 41.13 43.33 29.67 41.93 coo 71.71 -13.16 66.29 69.81 -13.09 67.19 40.24 23.10 39.83 38.32 22.34 40.22 ULMN 3 1zoi_c02 ESTERASE user 2 3 # 2 C 97 SER B 189 SER^? 12.11 MG MG B 301 C 227 ASP B 148 ASP^? 2.58 MG MG B 302s C 256 HIS B 147 HIS^? 9.27 MG MG B 301 coo 65.79 -14.04 67.57 66.89 -11.91 68.05 43.10 20.95 -7.74 42.82 21.56 -10.02 coo 74.87 -16.69 68.52 73.28 -15.36 68.17 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 71.71 -13.16 66.29 69.81 -13.09 67.19 46.73 18.97 -3.05 45.63 17.32 -3.73 ULMN 3 1zoi_c02 ESTERASE user 3 3 # 3 C 97 SER C 189 SER^? 12.09 MG MG C 301 C 227 ASP C 148 ASP^? 2.75 MG MG C 302s C 256 HIS C 147 HIS^? 9.44 MG MG C 301 coo 65.79 -14.04 67.57 66.89 -11.91 68.05 90.33 28.79 1.19 90.26 29.61 3.45 coo 74.87 -16.69 68.52 73.28 -15.36 68.17 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 71.71 -13.16 66.29 69.81 -13.09 67.19 87.61 25.71 -3.59 89.22 24.50 -2.99 ULMN 3 1zoi_c02 ESTERASE user 4 3 # 4 C 97 SER D 189 SER^? 12.12 MG MG D 301 C 227 ASP D 148 ASP^? 2.35 MG MG D 302s C 256 HIS D 147 HIS^? 9.43 MG MG D 301 coo 65.79 -14.04 67.57 66.89 -11.91 68.05 91.62 28.58 -50.95 91.45 27.78 -53.25 coo 74.87 -16.69 68.52 73.28 -15.36 68.17 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 71.71 -13.16 66.29 69.81 -13.09 67.19 90.95 32.51 -46.42 92.98 32.42 -46.93 ULMN 3 1zoi_c02 ESTERASE user 5 3 # 5 C 97 SER E 189 SER^? 11.91 MG MG E 301 C 227 ASP E 148 ASP^? 2.62 MG MG E 302s C 256 HIS E 147 HIS^? 9.22 MG MG E 301 coo 65.79 -14.04 67.57 66.89 -11.91 68.05 60.13 65.61 -43.87 59.01 65.34 -41.74 coo 74.87 -16.69 68.52 73.28 -15.36 68.17 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 71.71 -13.16 66.29 69.81 -13.09 67.19 63.87 64.43 -48.39 64.18 66.45 -47.92 ULMN 3 1zoi_c02 ESTERASE user 6 3 # 6 C 97 SER F 189 SER^? 11.88 MG MG F 302 C 227 ASP F 148 ASP^? 2.72 MG MG F 301s C 256 HIS F 147 HIS^? 8.79 MG MG F 302 coo 65.79 -14.04 67.57 66.89 -11.91 68.05 59.91 63.90 -95.91 60.70 64.22 -98.13 coo 74.87 -16.69 68.52 73.28 -15.36 68.17 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 71.71 -13.16 66.29 69.81 -13.09 67.19 56.63 61.66 -91.16 55.69 63.43 -91.80 1zoi_c02 source 1zoi ESTERASE : 6 hits 1zoi_c02 naa= 3 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 1 3 # 1 A 369 ASP A 58 ASP^? 26.75 MG MG B 302 A 371 LYS A 6 LYS^? 25.88 MG MG A 301 A 407 THR B 46 THR^? 23.88 MG MG B 302 coo -5.17 31.09 15.73 -7.07 31.12 16.73 53.93 9.80 21.09 53.83 8.90 19.15 coo -4.43 30.92 22.89 -6.61 31.91 19.71 46.20 12.82 24.71 44.50 16.64 20.52 coo -8.38 36.02 19.06 -8.83 34.10 19.89 49.71 15.16 18.13 48.80 13.51 17.14 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 2 3 # 2 A 369 ASP C 58 ASP^? 26.67 MG MG D 302 A 371 LYS C 6 LYS^? 25.73 MG MG C 302 A 407 THR D 46 THR^? 23.86 MG MG D 302 coo -5.17 31.09 15.73 -7.07 31.12 16.73 93.40 43.81 -22.27 94.18 44.45 -24.11 coo -4.43 30.92 22.89 -6.61 31.91 19.71 94.42 35.68 -18.56 92.21 32.03 -23.05 coo -8.38 36.02 19.06 -8.83 34.10 19.89 91.28 37.63 -25.27 93.05 36.72 -26.12 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 3 3 # 3 A 369 ASP C 138 ASP^? 33.43 MG MG C 302 A 371 LYS C 136 LYS^? 30.63 MG MG C 302 A 407 THR C 2 THR^? 33.69 MG MG C 302 coo -5.17 31.09 15.73 -7.07 31.12 16.73 105.43 43.97 -13.30 104.85 43.08 -11.43 coo -4.43 30.92 22.89 -6.61 31.91 19.71 99.75 44.04 -11.38 100.98 45.13 -6.77 coo -8.38 36.02 19.06 -8.83 34.10 19.89 103.03 43.13 -20.15 102.74 41.72 -18.56 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 4 3 # 4 A 369 ASP E 58 ASP^? 26.76 MG MG F 301 A 371 LYS E 6 LYS^? 25.59 MG MG E 302 A 407 THR F 46 THR^? 24.16 MG MG F 301 coo -5.17 31.09 15.73 -7.07 31.12 16.73 45.39 59.31 -66.83 44.62 59.88 -68.72 coo -4.43 30.92 22.89 -6.61 31.91 19.71 51.95 64.70 -63.33 56.16 64.03 -67.52 coo -8.38 36.02 19.06 -8.83 34.10 19.89 51.99 60.48 -70.07 50.88 62.21 -70.66 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 5 3 # 5 A 369 ASP E 138 ASP^? 33.31 MG MG E 302 A 371 LYS E 136 LYS^? 31.27 MG MG E 302 A 407 THR E 2 THR^? 33.84 MG MG E 302 coo -5.17 31.09 15.73 -7.07 31.12 16.73 39.58 70.77 -58.63 40.74 70.78 -56.80 coo -4.43 30.92 22.89 -6.61 31.91 19.71 42.12 65.93 -56.52 39.36 65.07 -51.83 coo -8.38 36.02 19.06 -8.83 34.10 19.89 41.32 68.37 -65.29 42.66 69.03 -63.78 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 6 3 # 6 A 369 ASP F 138 ASP^? 33.51 MG MG F 302 A 371 LYS F 136 LYS^? 30.53 MG MG F 301 A 407 THR F 2 THR^? 34.54 MG MG F 301 coo -5.17 31.09 15.73 -7.07 31.12 16.73 77.17 76.66 -81.48 76.14 76.33 -83.32 coo -4.43 30.92 22.89 -6.61 31.91 19.71 76.49 71.19 -83.39 78.38 70.88 -88.47 coo -8.38 36.02 19.06 -8.83 34.10 19.89 76.07 74.83 -74.70 74.98 75.15 -76.59 1zrz_c02 source 1zrz PROTEIN KINASE C, IOTA : 6 hits 1zrz_c02 naa= 3 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 1 3 # 1 A 43 ASP B 160 ASP^? 31.65 MG MG A 301 A 48 HIS A 42 HIS^? 28.45 MG MG A 301 A 77 LYS B 6 LYS^? 25.90 MG MG B 302 coo 13.04 30.41 72.50 12.95 30.65 70.36 28.01 24.83 16.38 27.44 26.81 15.80 coo 12.77 23.50 68.33 13.58 25.42 68.49 34.62 18.32 19.57 34.29 16.25 19.41 coo 7.53 29.84 65.06 12.29 29.41 67.79 36.26 25.44 11.74 39.65 23.12 16.29 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 2 3 # 2 A 43 ASP C 160 ASP^? 31.63 MG MG D 302 A 48 HIS D 42 HIS^? 28.21 MG MG D 302 A 77 LYS C 6 LYS^? 25.73 MG MG C 302 coo 13.04 30.41 72.50 12.95 30.65 70.36 102.50 38.00 -23.28 102.43 39.97 -22.46 coo 12.77 23.50 68.33 13.58 25.42 68.49 98.45 29.90 -26.44 99.32 28.02 -26.13 coo 7.53 29.84 65.06 12.29 29.41 67.79 94.42 35.68 -18.56 92.21 32.03 -23.05 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 3 3 # 3 A 43 ASP D 160 ASP^? 31.45 MG MG C 302 A 48 HIS C 42 HIS^? 28.09 MG MG C 302 A 77 LYS D 6 LYS^? 25.98 MG MG D 302 coo 13.04 30.41 72.50 12.95 30.65 70.36 94.15 13.98 -26.57 92.71 12.42 -26.99 coo 12.77 23.50 68.33 13.58 25.42 68.49 95.93 22.96 -23.11 97.92 23.62 -23.02 coo 7.53 29.84 65.06 12.29 29.41 67.79 89.78 20.68 -31.57 90.15 24.89 -27.02 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 4 3 # 4 A 43 ASP E 160 ASP^? 31.54 MG MG F 301 A 48 HIS F 42 HIS^? 28.34 MG MG F 301 A 77 LYS E 6 LYS^? 25.59 MG MG E 302 coo 13.04 30.41 72.50 12.95 30.65 70.36 45.81 70.00 -68.45 44.10 68.87 -67.77 coo 12.77 23.50 68.33 13.58 25.42 68.49 55.11 70.50 -71.64 56.29 72.22 -71.48 coo 7.53 29.84 65.06 12.29 29.41 67.79 51.95 64.70 -63.33 56.16 64.03 -67.52 2acu_c01 source 2acu ALDOSE REDUCTASE (E.C.1.1.1.21) MUTANT WITH TY: 4 hits 2acu_c01 naa= 3 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 1 3 # 1 B 29 HIS A 42 HIS^? 28.45 MG MG A 301 B 50 GLU B 54 GLU^? 22.94 MG MG B 302 B 113 GLN B 158 GLN^? 28.69 MG MG B 302 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 34.62 18.32 19.57 34.29 16.25 19.41 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 43.18 23.27 12.99 42.40 22.23 14.68 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 33.79 20.43 14.36 35.22 19.91 15.87 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 2 3 # 2 B 29 HIS B 42 HIS^? 28.37 MG MG B 302 B 50 GLU A 54 GLU^? 22.98 MG MG A 301 B 113 GLN A 158 GLN^? 28.59 MG MG A 301 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 39.34 12.99 16.30 37.26 13.24 16.40 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 45.06 19.97 24.02 44.05 19.39 22.19 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 40.78 11.56 21.62 40.89 13.15 20.22 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 3 3 # 3 B 29 HIS C 42 HIS^? 28.09 MG MG C 302 B 50 GLU D 54 GLU^? 22.96 MG MG D 302 B 113 GLN D 158 GLN^? 28.68 MG MG D 302 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 95.93 22.96 -23.11 97.92 23.62 -23.02 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 87.96 27.60 -30.52 89.07 27.55 -28.72 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 95.08 21.18 -28.53 94.65 22.58 -26.99 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 4 3 # 4 B 29 HIS D 42 HIS^? 28.21 MG MG D 302 B 50 GLU C 54 GLU^? 22.77 MG MG C 302 B 113 GLN C 158 GLN^? 28.28 MG MG C 302 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 98.45 29.90 -26.44 99.32 28.02 -26.13 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 88.91 31.25 -19.52 89.97 30.69 -21.29 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 98.32 32.23 -21.13 97.36 30.85 -22.41 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 5 3 # 5 B 29 HIS E 42 HIS^? 28.20 MG MG E 302 B 50 GLU F 54 GLU^? 22.98 MG MG F 301 B 113 GLN F 158 GLN^? 28.68 MG MG F 301 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 62.33 71.93 -68.30 60.54 72.96 -68.64 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 62.26 62.27 -75.30 61.72 63.47 -73.60 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 64.61 71.63 -73.64 63.42 70.61 -72.23 2ag0_c04 source 2ag0 BENZALDEHYDE LYASE : 5 hits 2ag0_c04 naa= 3 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 1 3 # 1 B 29 HIS A 42 HIS^? 28.45 MG MG A 301 B 50 GLU B 54 GLU^? 22.94 MG MG B 302 B 113 GLN B 158 GLN^? 28.69 MG MG B 302 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 34.62 18.32 19.57 34.29 16.25 19.41 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 43.18 23.27 12.99 42.40 22.23 14.68 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 33.79 20.43 14.36 35.22 19.91 15.87 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 2 3 # 2 B 29 HIS B 42 HIS^? 28.37 MG MG B 302 B 50 GLU A 54 GLU^? 22.98 MG MG A 301 B 113 GLN A 158 GLN^? 28.59 MG MG A 301 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 39.34 12.99 16.30 37.26 13.24 16.40 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 45.06 19.97 24.02 44.05 19.39 22.19 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 40.78 11.56 21.62 40.89 13.15 20.22 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 3 3 # 3 B 29 HIS C 42 HIS^? 28.09 MG MG C 302 B 50 GLU D 54 GLU^? 22.96 MG MG D 302 B 113 GLN D 158 GLN^? 28.68 MG MG D 302 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 95.93 22.96 -23.11 97.92 23.62 -23.02 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 87.96 27.60 -30.52 89.07 27.55 -28.72 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 95.08 21.18 -28.53 94.65 22.58 -26.99 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 4 3 # 4 B 29 HIS D 42 HIS^? 28.21 MG MG D 302 B 50 GLU C 54 GLU^? 22.77 MG MG C 302 B 113 GLN C 158 GLN^? 28.28 MG MG C 302 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 98.45 29.90 -26.44 99.32 28.02 -26.13 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 88.91 31.25 -19.52 89.97 30.69 -21.29 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 98.32 32.23 -21.13 97.36 30.85 -22.41 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 5 3 # 5 B 29 HIS E 42 HIS^? 28.20 MG MG E 302 B 50 GLU F 54 GLU^? 22.98 MG MG F 301 B 113 GLN F 158 GLN^? 28.68 MG MG F 301 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 62.33 71.93 -68.30 60.54 72.96 -68.64 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 62.26 62.27 -75.30 61.72 63.47 -73.60 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 64.61 71.63 -73.64 63.42 70.61 -72.23 2ag0_c08 source 2ag0 BENZALDEHYDE LYASE : 5 hits 2ag0_c08 naa= 3 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 1 3 # 1 A 29 HIS A 42 HIS^? 28.45 MG MG A 301 A 50 GLU B 54 GLU^? 22.94 MG MG B 302 A 113 GLN B 158 GLN^? 28.69 MG MG B 302 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 34.62 18.32 19.57 34.29 16.25 19.41 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 43.18 23.27 12.99 42.40 22.23 14.68 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 33.79 20.43 14.36 35.22 19.91 15.87 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 2 3 # 2 A 29 HIS B 42 HIS^? 28.37 MG MG B 302 A 50 GLU A 54 GLU^? 22.98 MG MG A 301 A 113 GLN A 158 GLN^? 28.59 MG MG A 301 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 39.34 12.99 16.30 37.26 13.24 16.40 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 45.06 19.97 24.02 44.05 19.39 22.19 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 40.78 11.56 21.62 40.89 13.15 20.22 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 3 3 # 3 A 29 HIS C 42 HIS^? 28.09 MG MG C 302 A 50 GLU D 54 GLU^? 22.96 MG MG D 302 A 113 GLN D 158 GLN^? 28.68 MG MG D 302 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 95.93 22.96 -23.11 97.92 23.62 -23.02 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 87.96 27.60 -30.52 89.07 27.55 -28.72 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 95.08 21.18 -28.53 94.65 22.58 -26.99 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 4 3 # 4 A 29 HIS D 42 HIS^? 28.21 MG MG D 302 A 50 GLU C 54 GLU^? 22.77 MG MG C 302 A 113 GLN C 158 GLN^? 28.28 MG MG C 302 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 98.45 29.90 -26.44 99.32 28.02 -26.13 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 88.91 31.25 -19.52 89.97 30.69 -21.29 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 98.32 32.23 -21.13 97.36 30.85 -22.41 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 5 3 # 5 A 29 HIS E 42 HIS^? 28.20 MG MG E 302 A 50 GLU F 54 GLU^? 22.98 MG MG F 301 A 113 GLN F 158 GLN^? 28.68 MG MG F 301 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 62.33 71.93 -68.30 60.54 72.96 -68.64 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 62.26 62.27 -75.30 61.72 63.47 -73.60 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 64.61 71.63 -73.64 63.42 70.61 -72.23 2ag0_c09 source 2ag0 BENZALDEHYDE LYASE : 5 hits 2ag0_c09 naa= 3 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 1 3 # 1 C 29 HIS A 42 HIS^? 28.45 MG MG A 301 C 50 GLU B 54 GLU^? 22.94 MG MG B 302 C 113 GLN B 158 GLN^? 28.69 MG MG B 302 coo 74.92 8.52 28.42 74.88 6.86 29.70 34.62 18.32 19.57 34.29 16.25 19.41 coo 65.25 15.95 28.73 65.73 15.63 30.78 43.18 23.27 12.99 42.40 22.23 14.68 coo 70.80 6.73 32.72 71.88 8.55 32.53 33.79 20.43 14.36 35.22 19.91 15.87 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 2 3 # 2 C 29 HIS B 42 HIS^? 28.37 MG MG B 302 C 50 GLU A 54 GLU^? 22.98 MG MG A 301 C 113 GLN A 158 GLN^? 28.59 MG MG A 301 coo 74.92 8.52 28.42 74.88 6.86 29.70 39.34 12.99 16.30 37.26 13.24 16.40 coo 65.25 15.95 28.73 65.73 15.63 30.78 45.06 19.97 24.02 44.05 19.39 22.19 coo 70.80 6.73 32.72 71.88 8.55 32.53 40.78 11.56 21.62 40.89 13.15 20.22 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 3 3 # 3 C 29 HIS C 42 HIS^? 28.09 MG MG C 302 C 50 GLU D 54 GLU^? 22.96 MG MG D 302 C 113 GLN D 158 GLN^? 28.68 MG MG D 302 coo 74.92 8.52 28.42 74.88 6.86 29.70 95.93 22.96 -23.11 97.92 23.62 -23.02 coo 65.25 15.95 28.73 65.73 15.63 30.78 87.96 27.60 -30.52 89.07 27.55 -28.72 coo 70.80 6.73 32.72 71.88 8.55 32.53 95.08 21.18 -28.53 94.65 22.58 -26.99 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 4 3 # 4 C 29 HIS D 42 HIS^? 28.21 MG MG D 302 C 50 GLU C 54 GLU^? 22.77 MG MG C 302 C 113 GLN C 158 GLN^? 28.28 MG MG C 302 coo 74.92 8.52 28.42 74.88 6.86 29.70 98.45 29.90 -26.44 99.32 28.02 -26.13 coo 65.25 15.95 28.73 65.73 15.63 30.78 88.91 31.25 -19.52 89.97 30.69 -21.29 coo 70.80 6.73 32.72 71.88 8.55 32.53 98.32 32.23 -21.13 97.36 30.85 -22.41 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 5 3 # 5 C 29 HIS E 42 HIS^? 28.20 MG MG E 302 C 50 GLU F 54 GLU^? 22.98 MG MG F 301 C 113 GLN F 158 GLN^? 28.68 MG MG F 301 coo 74.92 8.52 28.42 74.88 6.86 29.70 62.33 71.93 -68.30 60.54 72.96 -68.64 coo 65.25 15.95 28.73 65.73 15.63 30.78 62.26 62.27 -75.30 61.72 63.47 -73.60 coo 70.80 6.73 32.72 71.88 8.55 32.53 64.61 71.63 -73.64 63.42 70.61 -72.23 2ag0_c10 source 2ag0 BENZALDEHYDE LYASE : 5 hits 2ag0_c10 naa= 3 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 1 3 # 1 D 29 HIS A 42 HIS^? 28.45 MG MG A 301 D 50 GLU B 54 GLU^? 22.94 MG MG B 302 D 113 GLN B 158 GLN^? 28.69 MG MG B 302 coo 38.66 11.31 27.15 38.67 12.13 25.22 34.62 18.32 19.57 34.29 16.25 19.41 coo 48.72 12.85 33.83 48.36 14.77 32.95 43.18 23.27 12.99 42.40 22.23 14.68 coo 42.85 14.77 24.15 41.85 15.11 26.02 33.79 20.43 14.36 35.22 19.91 15.87 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 2 3 # 2 D 29 HIS B 42 HIS^? 28.37 MG MG B 302 D 50 GLU A 54 GLU^? 22.98 MG MG A 301 D 113 GLN A 158 GLN^? 28.59 MG MG A 301 coo 38.66 11.31 27.15 38.67 12.13 25.22 39.34 12.99 16.30 37.26 13.24 16.40 coo 48.72 12.85 33.83 48.36 14.77 32.95 45.06 19.97 24.02 44.05 19.39 22.19 coo 42.85 14.77 24.15 41.85 15.11 26.02 40.78 11.56 21.62 40.89 13.15 20.22 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 3 3 # 3 D 29 HIS C 42 HIS^? 28.09 MG MG C 302 D 50 GLU D 54 GLU^? 22.96 MG MG D 302 D 113 GLN D 158 GLN^? 28.68 MG MG D 302 coo 38.66 11.31 27.15 38.67 12.13 25.22 95.93 22.96 -23.11 97.92 23.62 -23.02 coo 48.72 12.85 33.83 48.36 14.77 32.95 87.96 27.60 -30.52 89.07 27.55 -28.72 coo 42.85 14.77 24.15 41.85 15.11 26.02 95.08 21.18 -28.53 94.65 22.58 -26.99 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 4 3 # 4 D 29 HIS D 42 HIS^? 28.21 MG MG D 302 D 50 GLU C 54 GLU^? 22.77 MG MG C 302 D 113 GLN C 158 GLN^? 28.28 MG MG C 302 coo 38.66 11.31 27.15 38.67 12.13 25.22 98.45 29.90 -26.44 99.32 28.02 -26.13 coo 48.72 12.85 33.83 48.36 14.77 32.95 88.91 31.25 -19.52 89.97 30.69 -21.29 coo 42.85 14.77 24.15 41.85 15.11 26.02 98.32 32.23 -21.13 97.36 30.85 -22.41 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 5 3 # 5 D 29 HIS E 42 HIS^? 28.20 MG MG E 302 D 50 GLU F 54 GLU^? 22.98 MG MG F 301 D 113 GLN F 158 GLN^? 28.68 MG MG F 301 coo 38.66 11.31 27.15 38.67 12.13 25.22 62.33 71.93 -68.30 60.54 72.96 -68.64 coo 48.72 12.85 33.83 48.36 14.77 32.95 62.26 62.27 -75.30 61.72 63.47 -73.60 coo 42.85 14.77 24.15 41.85 15.11 26.02 64.61 71.63 -73.64 63.42 70.61 -72.23 2ag0_c11 source 2ag0 BENZALDEHYDE LYASE : 5 hits 2ag0_c11 naa= 3 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP A 187 ASP^? -3.29 MG MG A 302s 219 GLU A 146 GLU^? 9.80 MG MG A 302 294 ASP A 128 ASP^? -3.32 MG MG A 301s coo 27.89 102.52 14.98 29.35 101.92 13.57 39.43 26.57 46.78 39.37 27.83 45.03 coo 25.84 105.87 9.06 27.86 105.55 8.74 45.17 20.35 44.20 46.68 21.21 45.40 coo 33.16 106.80 7.72 33.34 104.87 6.92 46.50 28.23 39.77 47.49 30.10 39.82 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 3 # 2 193 ASP B 187 ASP^? -3.44 MG MG B 301s 219 GLU B 146 GLU^? 10.54 MG MG B 301 294 ASP B 128 ASP^? -3.57 MG MG B 302s coo 27.89 102.52 14.98 29.35 101.92 13.57 50.64 18.14 -9.69 51.74 17.63 -7.86 coo 25.84 105.87 9.06 27.86 105.55 8.74 45.13 24.51 -7.01 46.08 25.99 -8.13 coo 33.16 106.80 7.72 33.34 104.87 6.92 52.92 24.09 -2.19 54.73 25.14 -1.90 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 3 3 # 3 193 ASP C 128 ASP^? -3.22 MG MG C 302s 219 GLU C 146 GLU^? 10.46 MG MG C 301 294 ASP C 187 ASP^? -3.72 MG MG C 301s coo 27.89 102.52 14.98 29.35 101.92 13.57 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 25.84 105.87 9.06 27.86 105.55 8.74 87.01 31.93 0.25 85.57 32.56 1.72 coo 33.16 106.80 7.72 33.34 104.87 6.92 84.01 23.73 3.39 83.47 22.54 1.59 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 4 3 # 4 193 ASP D 128 ASP^? -3.70 MG MG D 302s 219 GLU D 146 GLU^? 10.62 MG MG D 301 294 ASP D 187 ASP^? -2.95 MG MG D 301s coo 27.89 102.52 14.98 29.35 101.92 13.57 83.33 35.45 -46.13 81.57 36.63 -46.10 coo 25.84 105.87 9.06 27.86 105.55 8.74 87.24 28.82 -50.92 85.47 28.08 -51.67 coo 33.16 106.80 7.72 33.34 104.87 6.92 90.40 36.34 -52.69 89.24 37.98 -51.99 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 5 3 # 5 193 ASP D 187 ASP^? -2.95 MG MG D 301s 219 GLU D 146 GLU^? 10.62 MG MG D 301 294 ASP D 128 ASP^? -3.70 MG MG D 302s coo 27.89 102.52 14.98 29.35 101.92 13.57 90.40 36.34 -52.69 89.24 37.98 -51.99 coo 25.84 105.87 9.06 27.86 105.55 8.74 87.24 28.82 -50.92 85.47 28.08 -51.67 coo 33.16 106.80 7.72 33.34 104.87 6.92 83.33 35.45 -46.13 81.57 36.63 -46.10 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 6 3 # 6 193 ASP F 128 ASP^? -3.41 MG MG F 301s 219 GLU F 146 GLU^? 10.36 MG MG F 302 294 ASP F 187 ASP^? -3.27 MG MG F 302s coo 27.89 102.52 14.98 29.35 101.92 13.57 57.76 53.73 -90.50 57.46 51.64 -90.28 coo 25.84 105.87 9.06 27.86 105.55 8.74 61.95 60.17 -95.28 62.87 58.56 -96.19 coo 33.16 106.80 7.72 33.34 104.87 6.92 53.93 58.87 -98.14 52.45 58.62 -96.61 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 7 3 # 7 193 ASP F 187 ASP^? -3.27 MG MG F 302s 219 GLU F 146 GLU^? 10.36 MG MG F 302 294 ASP F 128 ASP^? -3.41 MG MG F 301s coo 27.89 102.52 14.98 29.35 101.92 13.57 53.93 58.87 -98.14 52.45 58.62 -96.61 coo 25.84 105.87 9.06 27.86 105.55 8.74 61.95 60.17 -95.28 62.87 58.56 -96.19 coo 33.16 106.80 7.72 33.34 104.87 6.92 57.76 53.73 -90.50 57.46 51.64 -90.28 2amg_c02 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 7 hits 2amg_c02 naa= 3 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP A 148 ASP^? 2.72 MG MG A 301s 231 ASP A 23 ASP^? 22.90 MG MG A 301 294 ASP A 177 ASP^? 8.44 MG MG A 302 coo 27.89 102.52 14.98 29.35 101.92 13.57 41.50 28.88 41.13 43.33 29.67 41.93 coo 14.74 93.05 -1.00 14.30 94.22 0.73 36.40 52.47 38.61 38.03 53.36 39.72 coo 33.16 106.80 7.72 33.34 104.87 6.92 33.02 29.04 43.18 33.79 27.88 44.78 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 3 # 2 193 ASP A 148 ASP^? 2.72 MG MG A 301s 231 ASP A 142 ASP^? 23.70 MG MG A 302 294 ASP A 177 ASP^? 8.44 MG MG A 302 coo 27.89 102.52 14.98 29.35 101.92 13.57 41.50 28.88 41.13 43.33 29.67 41.93 coo 14.74 93.05 -1.00 14.30 94.22 0.73 46.39 7.18 37.53 46.28 7.18 39.63 coo 33.16 106.80 7.72 33.34 104.87 6.92 33.02 29.04 43.18 33.79 27.88 44.78 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 3 3 # 3 193 ASP A 171 ASP^? 17.17 MG MG A 302 231 ASP A 142 ASP^? 23.70 MG MG A 302 294 ASP A 177 ASP^? 8.44 MG MG A 302 coo 27.89 102.52 14.98 29.35 101.92 13.57 29.78 23.67 36.63 28.48 25.11 35.71 coo 14.74 93.05 -1.00 14.30 94.22 0.73 46.39 7.18 37.53 46.28 7.18 39.63 coo 33.16 106.80 7.72 33.34 104.87 6.92 33.02 29.04 43.18 33.79 27.88 44.78 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 4 3 # 4 193 ASP A 177 ASP^? 8.44 MG MG A 302 231 ASP A 23 ASP^? 22.90 MG MG A 301 294 ASP A 148 ASP^? 2.72 MG MG A 301s coo 27.89 102.52 14.98 29.35 101.92 13.57 33.02 29.04 43.18 33.79 27.88 44.78 coo 14.74 93.05 -1.00 14.30 94.22 0.73 36.40 52.47 38.61 38.03 53.36 39.72 coo 33.16 106.80 7.72 33.34 104.87 6.92 41.50 28.88 41.13 43.33 29.67 41.93 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 5 3 # 5 193 ASP B 23 ASP^? 15.67 MG MG C 301 231 ASP C 128 ASP^? -3.22 MG MG C 302s 294 ASP C 23 ASP^? 15.39 MG MG B 301 coo 27.89 102.52 14.98 29.35 101.92 13.57 74.31 7.55 -1.09 75.08 9.17 -2.23 coo 14.74 93.05 -1.00 14.30 94.22 0.73 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 33.16 106.80 7.72 33.34 104.87 6.92 65.24 6.82 -5.11 63.43 7.54 -4.15 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 6 3 # 6 193 ASP B 128 ASP^? -3.57 MG MG B 302s 231 ASP B 142 ASP^? 23.97 MG MG B 301 294 ASP B 187 ASP^? -3.44 MG MG B 301s coo 27.89 102.52 14.98 29.35 101.92 13.57 52.92 24.09 -2.19 54.73 25.14 -1.90 coo 14.74 93.05 -1.00 14.30 94.22 0.73 31.69 27.40 -1.31 32.10 27.37 -3.38 coo 33.16 106.80 7.72 33.34 104.87 6.92 50.64 18.14 -9.69 51.74 17.63 -7.86 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 7 3 # 7 193 ASP B 138 ASP^? 33.32 MG MG B 302 231 ASP B 100 ASP^? 19.41 MG MG B 302 294 ASP B 160 ASP^? 31.65 MG MG A 301 coo 27.89 102.52 14.98 29.35 101.92 13.57 23.42 29.01 6.78 24.36 28.48 4.94 coo 14.74 93.05 -1.00 14.30 94.22 0.73 42.99 37.37 0.88 44.84 37.85 0.06 coo 33.16 106.80 7.72 33.34 104.87 6.92 28.01 24.83 16.38 27.44 26.81 15.80 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 8 3 # 8 193 ASP B 148 ASP^? 2.58 MG MG B 302s 231 ASP B 23 ASP^? 15.67 MG MG C 301 294 ASP B 177 ASP^? 9.03 MG MG B 301 coo 27.89 102.52 14.98 29.35 101.92 13.57 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 14.74 93.05 -1.00 14.30 94.22 0.73 74.31 7.55 -1.09 75.08 9.17 -2.23 coo 33.16 106.80 7.72 33.34 104.87 6.92 51.97 11.04 -6.64 50.39 11.62 -7.94 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 9 3 # 9 193 ASP B 148 ASP^? 2.58 MG MG B 302s 231 ASP B 142 ASP^? 23.97 MG MG B 301 294 ASP B 177 ASP^? 9.03 MG MG B 301 coo 27.89 102.52 14.98 29.35 101.92 13.57 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 14.74 93.05 -1.00 14.30 94.22 0.73 31.69 27.40 -1.31 32.10 27.37 -3.38 coo 33.16 106.80 7.72 33.34 104.87 6.92 51.97 11.04 -6.64 50.39 11.62 -7.94 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 10 3 # 10 193 ASP B 171 ASP^? 16.92 MG MG B 301 231 ASP B 142 ASP^? 23.97 MG MG B 301 294 ASP B 177 ASP^? 9.03 MG MG B 301 coo 27.89 102.52 14.98 29.35 101.92 13.57 45.30 8.50 -0.71 46.30 6.81 0.12 coo 14.74 93.05 -1.00 14.30 94.22 0.73 31.69 27.40 -1.31 32.10 27.37 -3.38 coo 33.16 106.80 7.72 33.34 104.87 6.92 51.97 11.04 -6.64 50.39 11.62 -7.94 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 11 3 # 11 193 ASP B 177 ASP^? 9.03 MG MG B 301 231 ASP B 23 ASP^? 15.67 MG MG C 301 294 ASP B 148 ASP^? 2.58 MG MG B 302s coo 27.89 102.52 14.98 29.35 101.92 13.57 51.97 11.04 -6.64 50.39 11.62 -7.94 coo 14.74 93.05 -1.00 14.30 94.22 0.73 74.31 7.55 -1.09 75.08 9.17 -2.23 coo 33.16 106.80 7.72 33.34 104.87 6.92 52.73 19.23 -3.77 53.81 20.99 -4.31 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 12 3 # 12 193 ASP C 148 ASP^? 2.75 MG MG C 302s 231 ASP C 23 ASP^? 15.39 MG MG B 301 294 ASP C 177 ASP^? 8.84 MG MG C 301 coo 27.89 102.52 14.98 29.35 101.92 13.57 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 14.74 93.05 -1.00 14.30 94.22 0.73 65.24 6.82 -5.11 63.43 7.54 -4.15 coo 33.16 106.80 7.72 33.34 104.87 6.92 85.60 16.42 -0.31 86.51 17.71 1.09 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 13 3 # 13 193 ASP C 148 ASP^? 2.75 MG MG C 302s 231 ASP C 142 ASP^? 23.76 MG MG C 301 294 ASP C 177 ASP^? 8.84 MG MG C 301 coo 27.89 102.52 14.98 29.35 101.92 13.57 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 14.74 93.05 -1.00 14.30 94.22 0.73 97.94 39.27 -5.03 98.08 38.70 -2.97 coo 33.16 106.80 7.72 33.34 104.87 6.92 85.60 16.42 -0.31 86.51 17.71 1.09 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 14 3 # 14 193 ASP C 171 ASP^? 17.08 MG MG C 301 231 ASP C 142 ASP^? 23.76 MG MG C 301 294 ASP C 177 ASP^? 8.84 MG MG C 301 coo 27.89 102.52 14.98 29.35 101.92 13.57 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 14.74 93.05 -1.00 14.30 94.22 0.73 97.94 39.27 -5.03 98.08 38.70 -2.97 coo 33.16 106.80 7.72 33.34 104.87 6.92 85.60 16.42 -0.31 86.51 17.71 1.09 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 15 3 # 15 193 ASP C 177 ASP^? 8.84 MG MG C 301 231 ASP C 23 ASP^? 15.39 MG MG B 301 294 ASP C 148 ASP^? 2.75 MG MG C 302s coo 27.89 102.52 14.98 29.35 101.92 13.57 85.60 16.42 -0.31 86.51 17.71 1.09 coo 14.74 93.05 -1.00 14.30 94.22 0.73 65.24 6.82 -5.11 63.43 7.54 -4.15 coo 33.16 106.80 7.72 33.34 104.87 6.92 81.96 23.83 -2.68 80.24 25.11 -2.27 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 16 3 # 16 193 ASP C 187 ASP^? -3.72 MG MG C 301s 231 ASP C 142 ASP^? 23.76 MG MG C 301 294 ASP C 177 ASP^? 8.84 MG MG C 301 coo 27.89 102.52 14.98 29.35 101.92 13.57 84.01 23.73 3.39 83.47 22.54 1.59 coo 14.74 93.05 -1.00 14.30 94.22 0.73 97.94 39.27 -5.03 98.08 38.70 -2.97 coo 33.16 106.80 7.72 33.34 104.87 6.92 85.60 16.42 -0.31 86.51 17.71 1.09 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 17 3 # 17 193 ASP D 138 ASP^? 33.64 MG MG D 302 231 ASP D 100 ASP^? 19.59 MG MG D 302 294 ASP D 160 ASP^? 31.45 MG MG C 302 coo 27.89 102.52 14.98 29.35 101.92 13.57 93.00 7.50 -35.79 93.88 8.48 -37.45 coo 14.74 93.05 -1.00 14.30 94.22 0.73 76.41 19.73 -43.25 75.56 21.48 -44.12 coo 33.16 106.80 7.72 33.34 104.87 6.92 94.15 13.98 -26.57 92.71 12.42 -26.99 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 18 3 # 18 193 ASP D 148 ASP^? 2.35 MG MG D 302s 231 ASP D 23 ASP^? 15.37 MG MG E 301 294 ASP D 177 ASP^? 8.43 MG MG D 301 coo 27.89 102.52 14.98 29.35 101.92 13.57 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 14.74 93.05 -1.00 14.30 94.22 0.73 85.70 62.10 -45.60 84.07 62.13 -46.93 coo 33.16 106.80 7.72 33.34 104.87 6.92 95.74 41.01 -49.76 94.81 39.90 -51.24 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 19 3 # 19 193 ASP D 148 ASP^? 2.35 MG MG D 302s 231 ASP D 142 ASP^? 23.49 MG MG D 301 294 ASP D 177 ASP^? 8.43 MG MG D 301 coo 27.89 102.52 14.98 29.35 101.92 13.57 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 14.74 93.05 -1.00 14.30 94.22 0.73 90.90 15.58 -44.76 91.35 16.09 -46.79 coo 33.16 106.80 7.72 33.34 104.87 6.92 95.74 41.01 -49.76 94.81 39.90 -51.24 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 20 3 # 20 193 ASP D 171 ASP^? 16.95 MG MG D 301 231 ASP D 142 ASP^? 23.49 MG MG D 301 294 ASP D 177 ASP^? 8.43 MG MG D 301 coo 27.89 102.52 14.98 29.35 101.92 13.57 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 14.74 93.05 -1.00 14.30 94.22 0.73 90.90 15.58 -44.76 91.35 16.09 -46.79 coo 33.16 106.80 7.72 33.34 104.87 6.92 95.74 41.01 -49.76 94.81 39.90 -51.24 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 21 3 # 21 193 ASP D 177 ASP^? 8.43 MG MG D 301 231 ASP D 23 ASP^? 15.37 MG MG E 301 294 ASP D 148 ASP^? 2.35 MG MG D 302s coo 27.89 102.52 14.98 29.35 101.92 13.57 95.74 41.01 -49.76 94.81 39.90 -51.24 coo 14.74 93.05 -1.00 14.30 94.22 0.73 85.70 62.10 -45.60 84.07 62.13 -46.93 coo 33.16 106.80 7.72 33.34 104.87 6.92 87.78 37.50 -47.56 85.79 37.49 -48.28 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 22 3 # 22 193 ASP E 138 ASP^? 33.31 MG MG E 302 231 ASP E 100 ASP^? 19.27 MG MG E 302 294 ASP E 160 ASP^? 31.54 MG MG F 301 coo 27.89 102.52 14.98 29.35 101.92 13.57 39.58 70.77 -58.63 40.74 70.78 -56.80 coo 14.74 93.05 -1.00 14.30 94.22 0.73 49.30 52.58 -51.44 50.47 51.29 -50.20 coo 33.16 106.80 7.72 33.34 104.87 6.92 45.81 70.00 -68.45 44.10 68.87 -67.77 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 23 3 # 23 193 ASP E 148 ASP^? 2.62 MG MG E 302s 231 ASP E 23 ASP^? 15.43 MG MG D 301 294 ASP E 177 ASP^? 8.55 MG MG E 301 coo 27.89 102.52 14.98 29.35 101.92 13.57 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 14.74 93.05 -1.00 14.30 94.22 0.73 91.98 54.64 -49.37 91.93 52.78 -48.33 coo 33.16 106.80 7.72 33.34 104.87 6.92 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 24 3 # 24 193 ASP E 148 ASP^? 2.62 MG MG E 302s 231 ASP E 142 ASP^? 23.66 MG MG E 301 294 ASP E 177 ASP^? 8.55 MG MG E 301 coo 27.89 102.52 14.98 29.35 101.92 13.57 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 14.74 93.05 -1.00 14.30 94.22 0.73 47.19 67.15 -50.37 47.44 67.18 -48.23 coo 33.16 106.80 7.72 33.34 104.87 6.92 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 25 3 # 25 193 ASP E 171 ASP^? 16.73 MG MG E 301 231 ASP E 142 ASP^? 23.66 MG MG E 301 294 ASP E 177 ASP^? 8.55 MG MG E 301 coo 27.89 102.52 14.98 29.35 101.92 13.57 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 14.74 93.05 -1.00 14.30 94.22 0.73 47.19 67.15 -50.37 47.44 67.18 -48.23 coo 33.16 106.80 7.72 33.34 104.87 6.92 72.81 67.32 -45.03 71.14 67.96 -43.95 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 26 3 # 26 193 ASP E 177 ASP^? 8.55 MG MG E 301 231 ASP E 23 ASP^? 15.43 MG MG D 301 294 ASP E 148 ASP^? 2.62 MG MG E 302s coo 27.89 102.52 14.98 29.35 101.92 13.57 72.81 67.32 -45.03 71.14 67.96 -43.95 coo 14.74 93.05 -1.00 14.30 94.22 0.73 91.98 54.64 -49.37 91.93 52.78 -48.33 coo 33.16 106.80 7.72 33.34 104.87 6.92 68.29 60.44 -47.29 68.03 58.42 -46.50 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 27 3 # 27 193 ASP F 138 ASP^? 33.51 MG MG F 302 231 ASP F 100 ASP^? 19.36 MG MG F 301 294 ASP F 160 ASP^? 31.59 MG MG E 302 coo 27.89 102.52 14.98 29.35 101.92 13.57 77.17 76.66 -81.48 76.14 76.33 -83.32 coo 14.74 93.05 -1.00 14.30 94.22 0.73 74.18 55.53 -87.58 73.63 53.79 -88.67 coo 33.16 106.80 7.72 33.34 104.87 6.92 71.27 74.59 -71.77 73.23 74.02 -72.37 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 28 3 # 28 193 ASP F 148 ASP^? 2.72 MG MG F 301s 231 ASP F 142 ASP^? 23.43 MG MG F 302 294 ASP F 177 ASP^? 8.15 MG MG F 302 coo 27.89 102.52 14.98 29.35 101.92 13.57 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 14.74 93.05 -1.00 14.30 94.22 0.73 71.46 69.88 -89.76 71.03 69.93 -91.81 coo 33.16 106.80 7.72 33.34 104.87 6.92 47.18 61.22 -94.50 48.48 62.32 -95.73 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 29 3 # 29 193 ASP F 171 ASP^? 16.35 MG MG F 302 231 ASP F 142 ASP^? 23.43 MG MG F 302 294 ASP F 177 ASP^? 8.15 MG MG F 302 coo 27.89 102.52 14.98 29.35 101.92 13.57 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 14.74 93.05 -1.00 14.30 94.22 0.73 71.46 69.88 -89.76 71.03 69.93 -91.81 coo 33.16 106.80 7.72 33.34 104.87 6.92 47.18 61.22 -94.50 48.48 62.32 -95.73 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 30 3 # 30 193 ASP F 177 ASP^? 8.15 MG MG F 302 231 ASP F 23 ASP^? 23.03 MG MG F 301 294 ASP F 148 ASP^? 2.72 MG MG F 301s coo 27.89 102.52 14.98 29.35 101.92 13.57 47.18 61.22 -94.50 48.48 62.32 -95.73 coo 14.74 93.05 -1.00 14.30 94.22 0.73 31.30 43.61 -89.40 33.44 43.69 -89.02 coo 33.16 106.80 7.72 33.34 104.87 6.92 53.64 56.47 -91.98 54.61 54.68 -92.64 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 31 3 # 31 193 ASP F 187 ASP^? -3.27 MG MG F 302s 231 ASP F 142 ASP^? 23.43 MG MG F 302 294 ASP F 177 ASP^? 8.15 MG MG F 302 coo 27.89 102.52 14.98 29.35 101.92 13.57 53.93 58.87 -98.14 52.45 58.62 -96.61 coo 14.74 93.05 -1.00 14.30 94.22 0.73 71.46 69.88 -89.76 71.03 69.93 -91.81 coo 33.16 106.80 7.72 33.34 104.87 6.92 47.18 61.22 -94.50 48.48 62.32 -95.73 2amg_c06 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 31 hits 2amg_c06 naa= 3 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 1 3 # 1 A 14 ARG A 50 ARG^? 15.98 MG MG A 301 A 161 ASP A 128 ASP^? -3.32 MG MG A 301s A 174 TYR A 129 TYR^? 10.90 MG MG A 301 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 38.44 33.02 29.31 39.55 34.58 26.90 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 46.50 28.23 39.77 47.49 30.10 39.82 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 44.80 23.54 35.75 45.57 23.36 33.08 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 2 3 # 2 A 14 ARG A 50 ARG^? 15.98 MG MG A 301 A 161 ASP B 58 ASP^? 26.73 MG MG A 301 A 174 TYR B 60 TYR^? 27.11 MG MG A 301 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 38.44 33.02 29.31 39.55 34.58 26.90 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 34.42 33.56 15.74 33.50 33.49 17.59 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 28.84 35.27 19.49 28.03 36.56 21.83 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 3 3 # 3 A 14 ARG A 173 ARG^? 19.27 MG MG A 302 A 161 ASP A 148 ASP^? 2.72 MG MG A 301s A 174 TYR A 188 TYR^? 8.73 MG MG A 302 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 27.76 29.24 35.14 27.46 27.11 32.86 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 41.50 28.88 41.13 43.33 29.67 41.93 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 37.17 23.04 44.09 34.69 24.12 44.73 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 4 3 # 4 A 14 ARG B 50 ARG^? 16.38 MG MG B 302 A 161 ASP A 58 ASP^? 26.75 MG MG B 302 A 174 TYR A 60 TYR^? 27.11 MG MG B 302 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 55.38 14.91 7.80 56.60 14.73 10.62 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 53.93 9.80 21.09 53.83 8.90 19.15 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 55.01 4.24 16.98 56.13 3.24 14.65 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 5 3 # 5 A 14 ARG B 50 ARG^? 16.38 MG MG B 302 A 161 ASP B 128 ASP^? -3.57 MG MG B 302s A 174 TYR B 129 TYR^? 10.63 MG MG B 302 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 55.38 14.91 7.80 56.60 14.73 10.62 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 52.92 24.09 -2.19 54.73 25.14 -1.90 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 47.85 23.00 1.51 47.62 23.50 4.24 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 6 3 # 6 A 14 ARG B 173 ARG^? 18.75 MG MG B 301 A 161 ASP B 148 ASP^? 2.58 MG MG B 302s A 174 TYR B 188 TYR^? 8.84 MG MG B 301 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 49.83 5.55 0.39 48.19 5.30 3.03 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 46.41 16.35 -7.52 47.38 13.88 -8.38 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 7 3 # 7 A 14 ARG C 50 ARG^? 16.05 MG MG C 302 A 161 ASP C 128 ASP^? -3.22 MG MG C 302s A 174 TYR C 129 TYR^? 10.65 MG MG C 302 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 80.61 19.03 -14.42 79.16 18.55 -17.10 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 84.95 29.43 -7.96 85.04 30.16 -10.69 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 8 3 # 8 A 14 ARG C 50 ARG^? 16.05 MG MG C 302 A 161 ASP D 58 ASP^? 26.59 MG MG C 302 A 174 TYR D 60 TYR^? 26.93 MG MG C 302 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 80.61 19.03 -14.42 79.16 18.55 -17.10 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 83.38 14.85 -27.71 84.09 14.12 -25.85 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 84.40 9.28 -23.74 83.45 7.90 -21.49 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 9 3 # 9 A 14 ARG C 173 ARG^? 18.96 MG MG C 301 A 161 ASP C 148 ASP^? 2.75 MG MG C 302s A 174 TYR C 188 TYR^? 8.98 MG MG C 301 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 89.11 11.40 -7.73 91.21 12.63 -9.73 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 88.74 23.30 0.93 88.91 20.61 1.57 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 10 3 # 10 A 14 ARG D 50 ARG^? 16.15 MG MG D 302 A 161 ASP C 58 ASP^? 26.67 MG MG D 302 A 174 TYR C 60 TYR^? 26.95 MG MG D 302 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 88.00 43.26 -36.30 88.86 43.23 -33.34 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 93.40 43.81 -22.27 94.18 44.45 -24.11 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 97.75 47.69 -25.92 97.82 49.25 -28.26 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 11 3 # 11 A 14 ARG D 50 ARG^? 16.15 MG MG D 302 A 161 ASP D 128 ASP^? -3.70 MG MG D 302s A 174 TYR D 129 TYR^? 10.79 MG MG D 302 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 88.00 43.26 -36.30 88.86 43.23 -33.34 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 83.33 35.45 -46.13 81.57 36.63 -46.10 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 86.45 31.36 -42.20 86.02 30.90 -39.46 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 12 3 # 12 A 14 ARG D 173 ARG^? 18.88 MG MG D 301 A 161 ASP D 148 ASP^? 2.35 MG MG D 302s A 174 TYR D 188 TYR^? 8.87 MG MG D 301 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 100.48 42.57 -42.43 101.55 40.79 -40.06 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 93.72 33.91 -50.86 95.36 36.03 -51.61 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 13 3 # 13 A 14 ARG E 50 ARG^? 15.97 MG MG E 302 A 161 ASP E 128 ASP^? -3.53 MG MG E 302s A 174 TYR E 129 TYR^? 10.89 MG MG E 302 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 73.62 60.83 -58.23 74.10 60.41 -61.24 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 65.38 56.57 -48.58 66.15 54.57 -48.61 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 62.09 60.15 -52.83 61.47 59.53 -55.45 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 14 3 # 14 A 14 ARG E 50 ARG^? 15.97 MG MG E 302 A 161 ASP F 58 ASP^? 26.87 MG MG E 302 A 174 TYR F 60 TYR^? 27.07 MG MG E 302 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 73.62 60.83 -58.23 74.10 60.41 -61.24 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 75.55 64.68 -72.56 76.21 65.63 -70.79 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 79.79 68.64 -68.89 81.11 68.86 -66.46 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 15 3 # 15 A 14 ARG E 173 ARG^? 18.66 MG MG E 301 A 161 ASP E 148 ASP^? 2.62 MG MG E 302s A 174 TYR E 188 TYR^? 8.62 MG MG E 301 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 75.16 72.26 -52.56 73.67 73.54 -55.01 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 65.58 67.09 -44.08 67.82 68.57 -43.41 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 16 3 # 16 A 14 ARG F 50 ARG^? 16.24 MG MG F 301 A 161 ASP E 58 ASP^? 26.76 MG MG F 301 A 174 TYR E 60 TYR^? 27.19 MG MG F 301 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 48.85 56.05 -80.24 48.26 54.66 -77.55 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 39.82 61.07 -70.68 38.29 60.72 -72.98 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 17 3 # 17 A 14 ARG F 50 ARG^? 16.24 MG MG F 301 A 161 ASP F 128 ASP^? -3.41 MG MG F 301s A 174 TYR F 129 TYR^? 10.92 MG MG F 301 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 48.85 56.05 -80.24 48.26 54.66 -77.55 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 57.76 53.73 -90.50 57.46 51.64 -90.28 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 59.69 58.61 -86.67 60.36 58.48 -83.96 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 18 3 # 18 A 14 ARG F 173 ARG^? 18.61 MG MG F 302 A 161 ASP F 148 ASP^? 2.72 MG MG F 301s A 174 TYR F 188 TYR^? 8.06 MG MG F 302 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 43.18 65.58 -86.96 44.06 67.55 -84.65 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 54.23 63.50 -95.64 51.58 63.66 -96.35 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 19 3 # 19 A 14 ARG F 173 ARG^? 18.61 MG MG F 302 A 161 ASP F 187 ASP^? -3.27 MG MG F 302s A 174 TYR F 188 TYR^? 8.06 MG MG F 302 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 43.18 65.58 -86.96 44.06 67.55 -84.65 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 53.93 58.87 -98.14 52.45 58.62 -96.61 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 54.23 63.50 -95.64 51.58 63.66 -96.35 2c7v_c08 source 2c7v PTERIDINE REDUCTASE : 19 hits 2c7v_c08 naa= 3 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 1 3 # 1 B 14 ARG A 50 ARG^? 15.98 MG MG A 301 B 161 ASP A 128 ASP^? -3.32 MG MG A 301s B 174 TYR A 129 TYR^? 10.90 MG MG A 301 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 38.44 33.02 29.31 39.55 34.58 26.90 coo -14.86 10.19 8.14 -14.82 12.31 8.42 46.50 28.23 39.77 47.49 30.10 39.82 coo -21.46 12.70 8.53 -19.04 12.30 7.24 44.80 23.54 35.75 45.57 23.36 33.08 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 2 3 # 2 B 14 ARG A 50 ARG^? 15.98 MG MG A 301 B 161 ASP B 58 ASP^? 26.73 MG MG A 301 B 174 TYR B 60 TYR^? 27.11 MG MG A 301 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 38.44 33.02 29.31 39.55 34.58 26.90 coo -14.86 10.19 8.14 -14.82 12.31 8.42 34.42 33.56 15.74 33.50 33.49 17.59 coo -21.46 12.70 8.53 -19.04 12.30 7.24 28.84 35.27 19.49 28.03 36.56 21.83 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 3 3 # 3 B 14 ARG A 173 ARG^? 19.27 MG MG A 302 B 161 ASP A 148 ASP^? 2.72 MG MG A 301s B 174 TYR A 188 TYR^? 8.73 MG MG A 302 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 27.76 29.24 35.14 27.46 27.11 32.86 coo -14.86 10.19 8.14 -14.82 12.31 8.42 41.50 28.88 41.13 43.33 29.67 41.93 coo -21.46 12.70 8.53 -19.04 12.30 7.24 37.17 23.04 44.09 34.69 24.12 44.73 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 4 3 # 4 B 14 ARG B 50 ARG^? 16.38 MG MG B 302 B 161 ASP A 58 ASP^? 26.75 MG MG B 302 B 174 TYR A 60 TYR^? 27.11 MG MG B 302 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 55.38 14.91 7.80 56.60 14.73 10.62 coo -14.86 10.19 8.14 -14.82 12.31 8.42 53.93 9.80 21.09 53.83 8.90 19.15 coo -21.46 12.70 8.53 -19.04 12.30 7.24 55.01 4.24 16.98 56.13 3.24 14.65 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 5 3 # 5 B 14 ARG B 50 ARG^? 16.38 MG MG B 302 B 161 ASP B 128 ASP^? -3.57 MG MG B 302s B 174 TYR B 129 TYR^? 10.63 MG MG B 302 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 55.38 14.91 7.80 56.60 14.73 10.62 coo -14.86 10.19 8.14 -14.82 12.31 8.42 52.92 24.09 -2.19 54.73 25.14 -1.90 coo -21.46 12.70 8.53 -19.04 12.30 7.24 47.85 23.00 1.51 47.62 23.50 4.24 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 6 3 # 6 B 14 ARG B 173 ARG^? 18.75 MG MG B 301 B 161 ASP B 148 ASP^? 2.58 MG MG B 302s B 174 TYR B 188 TYR^? 8.84 MG MG B 301 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 49.83 5.55 0.39 48.19 5.30 3.03 coo -14.86 10.19 8.14 -14.82 12.31 8.42 52.73 19.23 -3.77 53.81 20.99 -4.31 coo -21.46 12.70 8.53 -19.04 12.30 7.24 46.41 16.35 -7.52 47.38 13.88 -8.38 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 7 3 # 7 B 14 ARG C 50 ARG^? 16.05 MG MG C 302 B 161 ASP C 128 ASP^? -3.22 MG MG C 302s B 174 TYR C 129 TYR^? 10.65 MG MG C 302 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 80.61 19.03 -14.42 79.16 18.55 -17.10 coo -14.86 10.19 8.14 -14.82 12.31 8.42 80.05 28.39 -4.25 77.97 28.60 -4.21 coo -21.46 12.70 8.53 -19.04 12.30 7.24 84.95 29.43 -7.96 85.04 30.16 -10.69 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 8 3 # 8 B 14 ARG C 50 ARG^? 16.05 MG MG C 302 B 161 ASP D 58 ASP^? 26.59 MG MG C 302 B 174 TYR D 60 TYR^? 26.93 MG MG C 302 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 80.61 19.03 -14.42 79.16 18.55 -17.10 coo -14.86 10.19 8.14 -14.82 12.31 8.42 83.38 14.85 -27.71 84.09 14.12 -25.85 coo -21.46 12.70 8.53 -19.04 12.30 7.24 84.40 9.28 -23.74 83.45 7.90 -21.49 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 9 3 # 9 B 14 ARG C 173 ARG^? 18.96 MG MG C 301 B 161 ASP C 148 ASP^? 2.75 MG MG C 302s B 174 TYR C 188 TYR^? 8.98 MG MG C 301 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 89.11 11.40 -7.73 91.21 12.63 -9.73 coo -14.86 10.19 8.14 -14.82 12.31 8.42 81.96 23.83 -2.68 80.24 25.11 -2.27 coo -21.46 12.70 8.53 -19.04 12.30 7.24 88.74 23.30 0.93 88.91 20.61 1.57 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 10 3 # 10 B 14 ARG D 50 ARG^? 16.15 MG MG D 302 B 161 ASP C 58 ASP^? 26.67 MG MG D 302 B 174 TYR C 60 TYR^? 26.95 MG MG D 302 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 88.00 43.26 -36.30 88.86 43.23 -33.34 coo -14.86 10.19 8.14 -14.82 12.31 8.42 93.40 43.81 -22.27 94.18 44.45 -24.11 coo -21.46 12.70 8.53 -19.04 12.30 7.24 97.75 47.69 -25.92 97.82 49.25 -28.26 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 11 3 # 11 B 14 ARG D 50 ARG^? 16.15 MG MG D 302 B 161 ASP D 128 ASP^? -3.70 MG MG D 302s B 174 TYR D 129 TYR^? 10.79 MG MG D 302 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 88.00 43.26 -36.30 88.86 43.23 -33.34 coo -14.86 10.19 8.14 -14.82 12.31 8.42 83.33 35.45 -46.13 81.57 36.63 -46.10 coo -21.46 12.70 8.53 -19.04 12.30 7.24 86.45 31.36 -42.20 86.02 30.90 -39.46 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 12 3 # 12 B 14 ARG D 173 ARG^? 18.88 MG MG D 301 B 161 ASP D 148 ASP^? 2.35 MG MG D 302s B 174 TYR D 188 TYR^? 8.87 MG MG D 301 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 100.48 42.57 -42.43 101.55 40.79 -40.06 coo -14.86 10.19 8.14 -14.82 12.31 8.42 87.78 37.50 -47.56 85.79 37.49 -48.28 coo -21.46 12.70 8.53 -19.04 12.30 7.24 93.72 33.91 -50.86 95.36 36.03 -51.61 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 13 3 # 13 B 14 ARG E 50 ARG^? 15.97 MG MG E 302 B 161 ASP E 128 ASP^? -3.53 MG MG E 302s B 174 TYR E 129 TYR^? 10.89 MG MG E 302 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 73.62 60.83 -58.23 74.10 60.41 -61.24 coo -14.86 10.19 8.14 -14.82 12.31 8.42 65.38 56.57 -48.58 66.15 54.57 -48.61 coo -21.46 12.70 8.53 -19.04 12.30 7.24 62.09 60.15 -52.83 61.47 59.53 -55.45 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 14 3 # 14 B 14 ARG E 50 ARG^? 15.97 MG MG E 302 B 161 ASP F 58 ASP^? 26.87 MG MG E 302 B 174 TYR F 60 TYR^? 27.07 MG MG E 302 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 73.62 60.83 -58.23 74.10 60.41 -61.24 coo -14.86 10.19 8.14 -14.82 12.31 8.42 75.55 64.68 -72.56 76.21 65.63 -70.79 coo -21.46 12.70 8.53 -19.04 12.30 7.24 79.79 68.64 -68.89 81.11 68.86 -66.46 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 15 3 # 15 B 14 ARG E 173 ARG^? 18.66 MG MG E 301 B 161 ASP E 148 ASP^? 2.62 MG MG E 302s B 174 TYR E 188 TYR^? 8.62 MG MG E 301 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 75.16 72.26 -52.56 73.67 73.54 -55.01 coo -14.86 10.19 8.14 -14.82 12.31 8.42 68.29 60.44 -47.29 68.03 58.42 -46.50 coo -21.46 12.70 8.53 -19.04 12.30 7.24 65.58 67.09 -44.08 67.82 68.57 -43.41 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 16 3 # 16 B 14 ARG F 50 ARG^? 16.24 MG MG F 301 B 161 ASP E 58 ASP^? 26.76 MG MG F 301 B 174 TYR E 60 TYR^? 27.19 MG MG F 301 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 48.85 56.05 -80.24 48.26 54.66 -77.55 coo -14.86 10.19 8.14 -14.82 12.31 8.42 45.39 59.31 -66.83 44.62 59.88 -68.72 coo -21.46 12.70 8.53 -19.04 12.30 7.24 39.82 61.07 -70.68 38.29 60.72 -72.98 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 17 3 # 17 B 14 ARG F 50 ARG^? 16.24 MG MG F 301 B 161 ASP F 128 ASP^? -3.41 MG MG F 301s B 174 TYR F 129 TYR^? 10.92 MG MG F 301 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 48.85 56.05 -80.24 48.26 54.66 -77.55 coo -14.86 10.19 8.14 -14.82 12.31 8.42 57.76 53.73 -90.50 57.46 51.64 -90.28 coo -21.46 12.70 8.53 -19.04 12.30 7.24 59.69 58.61 -86.67 60.36 58.48 -83.96 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 18 3 # 18 B 14 ARG F 173 ARG^? 18.61 MG MG F 302 B 161 ASP F 148 ASP^? 2.72 MG MG F 301s B 174 TYR F 188 TYR^? 8.06 MG MG F 302 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 43.18 65.58 -86.96 44.06 67.55 -84.65 coo -14.86 10.19 8.14 -14.82 12.31 8.42 53.64 56.47 -91.98 54.61 54.68 -92.64 coo -21.46 12.70 8.53 -19.04 12.30 7.24 54.23 63.50 -95.64 51.58 63.66 -96.35 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 19 3 # 19 B 14 ARG F 173 ARG^? 18.61 MG MG F 302 B 161 ASP F 187 ASP^? -3.27 MG MG F 302s B 174 TYR F 188 TYR^? 8.06 MG MG F 302 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 43.18 65.58 -86.96 44.06 67.55 -84.65 coo -14.86 10.19 8.14 -14.82 12.31 8.42 53.93 58.87 -98.14 52.45 58.62 -96.61 coo -21.46 12.70 8.53 -19.04 12.30 7.24 54.23 63.50 -95.64 51.58 63.66 -96.35 2c7v_c09 source 2c7v PTERIDINE REDUCTASE : 19 hits 2c7v_c09 naa= 3 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 1 3 # 1 C 14 ARG A 50 ARG^? 15.98 MG MG A 301 C 161 ASP A 128 ASP^? -3.32 MG MG A 301s C 174 TYR A 129 TYR^? 10.90 MG MG A 301 coo 2.84 19.43 40.34 1.59 20.35 37.65 38.44 33.02 29.31 39.55 34.58 26.90 coo -0.62 11.10 28.05 -0.65 13.15 27.46 46.50 28.23 39.77 47.49 30.10 39.82 coo 5.94 13.28 27.17 3.53 13.05 28.58 44.80 23.54 35.75 45.57 23.36 33.08 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 2 3 # 2 C 14 ARG A 50 ARG^? 15.98 MG MG A 301 C 161 ASP B 58 ASP^? 26.73 MG MG A 301 C 174 TYR B 60 TYR^? 27.11 MG MG A 301 coo 2.84 19.43 40.34 1.59 20.35 37.65 38.44 33.02 29.31 39.55 34.58 26.90 coo -0.62 11.10 28.05 -0.65 13.15 27.46 34.42 33.56 15.74 33.50 33.49 17.59 coo 5.94 13.28 27.17 3.53 13.05 28.58 28.84 35.27 19.49 28.03 36.56 21.83 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 3 3 # 3 C 14 ARG A 173 ARG^? 19.27 MG MG A 302 C 161 ASP A 148 ASP^? 2.72 MG MG A 301s C 174 TYR A 188 TYR^? 8.73 MG MG A 302 coo 2.84 19.43 40.34 1.59 20.35 37.65 27.76 29.24 35.14 27.46 27.11 32.86 coo -0.62 11.10 28.05 -0.65 13.15 27.46 41.50 28.88 41.13 43.33 29.67 41.93 coo 5.94 13.28 27.17 3.53 13.05 28.58 37.17 23.04 44.09 34.69 24.12 44.73 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 4 3 # 4 C 14 ARG B 50 ARG^? 16.38 MG MG B 302 C 161 ASP A 58 ASP^? 26.75 MG MG B 302 C 174 TYR A 60 TYR^? 27.11 MG MG B 302 coo 2.84 19.43 40.34 1.59 20.35 37.65 55.38 14.91 7.80 56.60 14.73 10.62 coo -0.62 11.10 28.05 -0.65 13.15 27.46 53.93 9.80 21.09 53.83 8.90 19.15 coo 5.94 13.28 27.17 3.53 13.05 28.58 55.01 4.24 16.98 56.13 3.24 14.65 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 5 3 # 5 C 14 ARG B 173 ARG^? 18.75 MG MG B 301 C 161 ASP B 148 ASP^? 2.58 MG MG B 302s C 174 TYR B 188 TYR^? 8.84 MG MG B 301 coo 2.84 19.43 40.34 1.59 20.35 37.65 49.83 5.55 0.39 48.19 5.30 3.03 coo -0.62 11.10 28.05 -0.65 13.15 27.46 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 5.94 13.28 27.17 3.53 13.05 28.58 46.41 16.35 -7.52 47.38 13.88 -8.38 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 6 3 # 6 C 14 ARG B 173 ARG^? 18.75 MG MG B 301 C 161 ASP B 187 ASP^? -3.44 MG MG B 301s C 174 TYR B 188 TYR^? 8.84 MG MG B 301 coo 2.84 19.43 40.34 1.59 20.35 37.65 49.83 5.55 0.39 48.19 5.30 3.03 coo -0.62 11.10 28.05 -0.65 13.15 27.46 50.64 18.14 -9.69 51.74 17.63 -7.86 coo 5.94 13.28 27.17 3.53 13.05 28.58 46.41 16.35 -7.52 47.38 13.88 -8.38 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 7 3 # 7 C 14 ARG C 50 ARG^? 16.05 MG MG C 302 C 161 ASP C 128 ASP^? -3.22 MG MG C 302s C 174 TYR C 129 TYR^? 10.65 MG MG C 302 coo 2.84 19.43 40.34 1.59 20.35 37.65 80.61 19.03 -14.42 79.16 18.55 -17.10 coo -0.62 11.10 28.05 -0.65 13.15 27.46 80.05 28.39 -4.25 77.97 28.60 -4.21 coo 5.94 13.28 27.17 3.53 13.05 28.58 84.95 29.43 -7.96 85.04 30.16 -10.69 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 8 3 # 8 C 14 ARG C 50 ARG^? 16.05 MG MG C 302 C 161 ASP D 58 ASP^? 26.59 MG MG C 302 C 174 TYR D 60 TYR^? 26.93 MG MG C 302 coo 2.84 19.43 40.34 1.59 20.35 37.65 80.61 19.03 -14.42 79.16 18.55 -17.10 coo -0.62 11.10 28.05 -0.65 13.15 27.46 83.38 14.85 -27.71 84.09 14.12 -25.85 coo 5.94 13.28 27.17 3.53 13.05 28.58 84.40 9.28 -23.74 83.45 7.90 -21.49 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 9 3 # 9 C 14 ARG C 173 ARG^? 18.96 MG MG C 301 C 161 ASP C 148 ASP^? 2.75 MG MG C 302s C 174 TYR C 188 TYR^? 8.98 MG MG C 301 coo 2.84 19.43 40.34 1.59 20.35 37.65 89.11 11.40 -7.73 91.21 12.63 -9.73 coo -0.62 11.10 28.05 -0.65 13.15 27.46 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 5.94 13.28 27.17 3.53 13.05 28.58 88.74 23.30 0.93 88.91 20.61 1.57 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 10 3 # 10 C 14 ARG D 50 ARG^? 16.15 MG MG D 302 C 161 ASP C 58 ASP^? 26.67 MG MG D 302 C 174 TYR C 60 TYR^? 26.95 MG MG D 302 coo 2.84 19.43 40.34 1.59 20.35 37.65 88.00 43.26 -36.30 88.86 43.23 -33.34 coo -0.62 11.10 28.05 -0.65 13.15 27.46 93.40 43.81 -22.27 94.18 44.45 -24.11 coo 5.94 13.28 27.17 3.53 13.05 28.58 97.75 47.69 -25.92 97.82 49.25 -28.26 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 11 3 # 11 C 14 ARG D 50 ARG^? 16.15 MG MG D 302 C 161 ASP D 128 ASP^? -3.70 MG MG D 302s C 174 TYR D 129 TYR^? 10.79 MG MG D 302 coo 2.84 19.43 40.34 1.59 20.35 37.65 88.00 43.26 -36.30 88.86 43.23 -33.34 coo -0.62 11.10 28.05 -0.65 13.15 27.46 83.33 35.45 -46.13 81.57 36.63 -46.10 coo 5.94 13.28 27.17 3.53 13.05 28.58 86.45 31.36 -42.20 86.02 30.90 -39.46 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 12 3 # 12 C 14 ARG D 173 ARG^? 18.88 MG MG D 301 C 161 ASP D 148 ASP^? 2.35 MG MG D 302s C 174 TYR D 188 TYR^? 8.87 MG MG D 301 coo 2.84 19.43 40.34 1.59 20.35 37.65 100.48 42.57 -42.43 101.55 40.79 -40.06 coo -0.62 11.10 28.05 -0.65 13.15 27.46 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 5.94 13.28 27.17 3.53 13.05 28.58 93.72 33.91 -50.86 95.36 36.03 -51.61 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 13 3 # 13 C 14 ARG E 50 ARG^? 15.97 MG MG E 302 C 161 ASP F 58 ASP^? 26.87 MG MG E 302 C 174 TYR F 60 TYR^? 27.07 MG MG E 302 coo 2.84 19.43 40.34 1.59 20.35 37.65 73.62 60.83 -58.23 74.10 60.41 -61.24 coo -0.62 11.10 28.05 -0.65 13.15 27.46 75.55 64.68 -72.56 76.21 65.63 -70.79 coo 5.94 13.28 27.17 3.53 13.05 28.58 79.79 68.64 -68.89 81.11 68.86 -66.46 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 14 3 # 14 C 14 ARG E 173 ARG^? 18.66 MG MG E 301 C 161 ASP E 148 ASP^? 2.62 MG MG E 302s C 174 TYR E 188 TYR^? 8.62 MG MG E 301 coo 2.84 19.43 40.34 1.59 20.35 37.65 75.16 72.26 -52.56 73.67 73.54 -55.01 coo -0.62 11.10 28.05 -0.65 13.15 27.46 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 5.94 13.28 27.17 3.53 13.05 28.58 65.58 67.09 -44.08 67.82 68.57 -43.41 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 15 3 # 15 C 14 ARG F 50 ARG^? 16.24 MG MG F 301 C 161 ASP E 58 ASP^? 26.76 MG MG F 301 C 174 TYR E 60 TYR^? 27.19 MG MG F 301 coo 2.84 19.43 40.34 1.59 20.35 37.65 48.85 56.05 -80.24 48.26 54.66 -77.55 coo -0.62 11.10 28.05 -0.65 13.15 27.46 45.39 59.31 -66.83 44.62 59.88 -68.72 coo 5.94 13.28 27.17 3.53 13.05 28.58 39.82 61.07 -70.68 38.29 60.72 -72.98 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 16 3 # 16 C 14 ARG F 173 ARG^? 18.61 MG MG F 302 C 161 ASP F 148 ASP^? 2.72 MG MG F 301s C 174 TYR F 188 TYR^? 8.06 MG MG F 302 coo 2.84 19.43 40.34 1.59 20.35 37.65 43.18 65.58 -86.96 44.06 67.55 -84.65 coo -0.62 11.10 28.05 -0.65 13.15 27.46 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 5.94 13.28 27.17 3.53 13.05 28.58 54.23 63.50 -95.64 51.58 63.66 -96.35 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 17 3 # 17 C 14 ARG F 173 ARG^? 18.61 MG MG F 302 C 161 ASP F 187 ASP^? -3.27 MG MG F 302s C 174 TYR F 188 TYR^? 8.06 MG MG F 302 coo 2.84 19.43 40.34 1.59 20.35 37.65 43.18 65.58 -86.96 44.06 67.55 -84.65 coo -0.62 11.10 28.05 -0.65 13.15 27.46 53.93 58.87 -98.14 52.45 58.62 -96.61 coo 5.94 13.28 27.17 3.53 13.05 28.58 54.23 63.50 -95.64 51.58 63.66 -96.35 2c7v_c10 source 2c7v PTERIDINE REDUCTASE : 17 hits 2c7v_c10 naa= 3 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 1 3 # 1 D 14 ARG A 50 ARG^? 15.98 MG MG A 301 D 161 ASP A 128 ASP^? -3.32 MG MG A 301s D 174 TYR A 129 TYR^? 10.90 MG MG A 301 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 38.44 33.02 29.31 39.55 34.58 26.90 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 46.50 28.23 39.77 47.49 30.10 39.82 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 44.80 23.54 35.75 45.57 23.36 33.08 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 2 3 # 2 D 14 ARG A 50 ARG^? 15.98 MG MG A 301 D 161 ASP B 58 ASP^? 26.73 MG MG A 301 D 174 TYR B 60 TYR^? 27.11 MG MG A 301 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 38.44 33.02 29.31 39.55 34.58 26.90 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 34.42 33.56 15.74 33.50 33.49 17.59 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 28.84 35.27 19.49 28.03 36.56 21.83 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 3 3 # 3 D 14 ARG A 173 ARG^? 19.27 MG MG A 302 D 161 ASP A 148 ASP^? 2.72 MG MG A 301s D 174 TYR A 188 TYR^? 8.73 MG MG A 302 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 27.76 29.24 35.14 27.46 27.11 32.86 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 41.50 28.88 41.13 43.33 29.67 41.93 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 37.17 23.04 44.09 34.69 24.12 44.73 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 4 3 # 4 D 14 ARG B 50 ARG^? 16.38 MG MG B 302 D 161 ASP A 58 ASP^? 26.75 MG MG B 302 D 174 TYR A 60 TYR^? 27.11 MG MG B 302 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 55.38 14.91 7.80 56.60 14.73 10.62 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 53.93 9.80 21.09 53.83 8.90 19.15 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 55.01 4.24 16.98 56.13 3.24 14.65 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 5 3 # 5 D 14 ARG B 50 ARG^? 16.38 MG MG B 302 D 161 ASP B 128 ASP^? -3.57 MG MG B 302s D 174 TYR B 129 TYR^? 10.63 MG MG B 302 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 55.38 14.91 7.80 56.60 14.73 10.62 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 52.92 24.09 -2.19 54.73 25.14 -1.90 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 47.85 23.00 1.51 47.62 23.50 4.24 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 6 3 # 6 D 14 ARG B 173 ARG^? 18.75 MG MG B 301 D 161 ASP B 148 ASP^? 2.58 MG MG B 302s D 174 TYR B 188 TYR^? 8.84 MG MG B 301 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 49.83 5.55 0.39 48.19 5.30 3.03 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 52.73 19.23 -3.77 53.81 20.99 -4.31 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 46.41 16.35 -7.52 47.38 13.88 -8.38 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 7 3 # 7 D 14 ARG C 50 ARG^? 16.05 MG MG C 302 D 161 ASP C 128 ASP^? -3.22 MG MG C 302s D 174 TYR C 129 TYR^? 10.65 MG MG C 302 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 80.61 19.03 -14.42 79.16 18.55 -17.10 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 80.05 28.39 -4.25 77.97 28.60 -4.21 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 84.95 29.43 -7.96 85.04 30.16 -10.69 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 8 3 # 8 D 14 ARG C 50 ARG^? 16.05 MG MG C 302 D 161 ASP D 58 ASP^? 26.59 MG MG C 302 D 174 TYR D 60 TYR^? 26.93 MG MG C 302 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 80.61 19.03 -14.42 79.16 18.55 -17.10 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 83.38 14.85 -27.71 84.09 14.12 -25.85 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 84.40 9.28 -23.74 83.45 7.90 -21.49 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 9 3 # 9 D 14 ARG C 173 ARG^? 18.96 MG MG C 301 D 161 ASP C 148 ASP^? 2.75 MG MG C 302s D 174 TYR C 188 TYR^? 8.98 MG MG C 301 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 89.11 11.40 -7.73 91.21 12.63 -9.73 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 81.96 23.83 -2.68 80.24 25.11 -2.27 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 88.74 23.30 0.93 88.91 20.61 1.57 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 10 3 # 10 D 14 ARG D 50 ARG^? 16.15 MG MG D 302 D 161 ASP C 58 ASP^? 26.67 MG MG D 302 D 174 TYR C 60 TYR^? 26.95 MG MG D 302 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 88.00 43.26 -36.30 88.86 43.23 -33.34 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 93.40 43.81 -22.27 94.18 44.45 -24.11 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 97.75 47.69 -25.92 97.82 49.25 -28.26 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 11 3 # 11 D 14 ARG D 50 ARG^? 16.15 MG MG D 302 D 161 ASP D 128 ASP^? -3.70 MG MG D 302s D 174 TYR D 129 TYR^? 10.79 MG MG D 302 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 88.00 43.26 -36.30 88.86 43.23 -33.34 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 83.33 35.45 -46.13 81.57 36.63 -46.10 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 86.45 31.36 -42.20 86.02 30.90 -39.46 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 12 3 # 12 D 14 ARG D 173 ARG^? 18.88 MG MG D 301 D 161 ASP D 148 ASP^? 2.35 MG MG D 302s D 174 TYR D 188 TYR^? 8.87 MG MG D 301 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 100.48 42.57 -42.43 101.55 40.79 -40.06 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 87.78 37.50 -47.56 85.79 37.49 -48.28 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 93.72 33.91 -50.86 95.36 36.03 -51.61 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 13 3 # 13 D 14 ARG E 50 ARG^? 15.97 MG MG E 302 D 161 ASP E 128 ASP^? -3.53 MG MG E 302s D 174 TYR E 129 TYR^? 10.89 MG MG E 302 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 73.62 60.83 -58.23 74.10 60.41 -61.24 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 65.38 56.57 -48.58 66.15 54.57 -48.61 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 62.09 60.15 -52.83 61.47 59.53 -55.45 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 14 3 # 14 D 14 ARG E 50 ARG^? 15.97 MG MG E 302 D 161 ASP F 58 ASP^? 26.87 MG MG E 302 D 174 TYR F 60 TYR^? 27.07 MG MG E 302 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 73.62 60.83 -58.23 74.10 60.41 -61.24 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 75.55 64.68 -72.56 76.21 65.63 -70.79 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 79.79 68.64 -68.89 81.11 68.86 -66.46 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 15 3 # 15 D 14 ARG E 173 ARG^? 18.66 MG MG E 301 D 161 ASP E 148 ASP^? 2.62 MG MG E 302s D 174 TYR E 188 TYR^? 8.62 MG MG E 301 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 75.16 72.26 -52.56 73.67 73.54 -55.01 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 68.29 60.44 -47.29 68.03 58.42 -46.50 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 65.58 67.09 -44.08 67.82 68.57 -43.41 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 16 3 # 16 D 14 ARG F 50 ARG^? 16.24 MG MG F 301 D 161 ASP E 58 ASP^? 26.76 MG MG F 301 D 174 TYR E 60 TYR^? 27.19 MG MG F 301 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 48.85 56.05 -80.24 48.26 54.66 -77.55 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 45.39 59.31 -66.83 44.62 59.88 -68.72 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 39.82 61.07 -70.68 38.29 60.72 -72.98 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 17 3 # 17 D 14 ARG F 50 ARG^? 16.24 MG MG F 301 D 161 ASP F 128 ASP^? -3.41 MG MG F 301s D 174 TYR F 129 TYR^? 10.92 MG MG F 301 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 48.85 56.05 -80.24 48.26 54.66 -77.55 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 57.76 53.73 -90.50 57.46 51.64 -90.28 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 59.69 58.61 -86.67 60.36 58.48 -83.96 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 18 3 # 18 D 14 ARG F 173 ARG^? 18.61 MG MG F 302 D 161 ASP F 148 ASP^? 2.72 MG MG F 301s D 174 TYR F 188 TYR^? 8.06 MG MG F 302 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 43.18 65.58 -86.96 44.06 67.55 -84.65 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 53.64 56.47 -91.98 54.61 54.68 -92.64 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 54.23 63.50 -95.64 51.58 63.66 -96.35 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 19 3 # 19 D 14 ARG F 173 ARG^? 18.61 MG MG F 302 D 161 ASP F 187 ASP^? -3.27 MG MG F 302s D 174 TYR F 188 TYR^? 8.06 MG MG F 302 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 43.18 65.58 -86.96 44.06 67.55 -84.65 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 53.93 58.87 -98.14 52.45 58.62 -96.61 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 54.23 63.50 -95.64 51.58 63.66 -96.35 2c7v_c11 source 2c7v PTERIDINE REDUCTASE : 19 hits 2c7v_c11 naa= 3 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 1 3 # 1 65 THR A 18 THR.? 15.77 MG MG A 301 242 CYH A 152 CYH^? 15.18 MG MG A 302 270 PHE A 150 PHE^? 10.47 MG MG A 302 coo 12.97 28.35 3.84 11.81 28.07 2.09 32.02 38.89 33.13 34.18 39.03 32.98 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 34.81 26.51 34.70 32.10 26.95 34.06 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 35.63 32.10 38.88 34.73 33.93 37.00 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 2 3 # 2 65 THR A 18 THR.? 15.77 MG MG A 301 242 CYH A 152 CYH^? 15.18 MG MG A 302 270 PHE A 172 PHE^? 13.28 MG MG A 302 coo 12.97 28.35 3.84 11.81 28.07 2.09 32.02 38.89 33.13 34.18 39.03 32.98 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 34.81 26.51 34.70 32.10 26.95 34.06 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 31.82 29.57 38.19 30.91 31.55 36.40 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 3 3 # 3 65 THR A 40 THR^? 24.69 MG MG A 301 242 CYH A 152 CYH^? 15.18 MG MG A 302 270 PHE A 12 PHE^? 17.15 MG MG A 301 coo 12.97 28.35 3.84 11.81 28.07 2.09 32.64 20.47 25.22 32.40 21.22 23.20 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 34.81 26.51 34.70 32.10 26.95 34.06 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 34.93 27.27 29.42 32.88 25.47 30.10 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 4 3 # 4 65 THR A 175 THR^? 12.07 MG MG A 302 242 CYH A 152 CYH^? 15.18 MG MG A 302 270 PHE A 150 PHE^? 10.47 MG MG A 302 coo 12.97 28.35 3.84 11.81 28.07 2.09 29.08 25.19 42.91 31.22 24.90 42.83 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 34.81 26.51 34.70 32.10 26.95 34.06 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 35.63 32.10 38.88 34.73 33.93 37.00 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 5 3 # 5 65 THR B 18 THR^? 16.08 MG MG B 302 242 CYH B 152 CYH^? 14.66 MG MG B 301 270 PHE B 150 PHE^? 9.88 MG MG B 301 coo 12.97 28.35 3.84 11.81 28.07 2.09 60.02 7.32 3.97 60.86 9.29 4.05 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 48.74 12.82 1.93 48.51 10.17 2.19 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 54.70 12.86 -1.84 56.31 11.50 0.05 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 6 3 # 6 65 THR B 18 THR^? 16.08 MG MG B 302 242 CYH B 152 CYH^? 14.66 MG MG B 301 270 PHE B 172 PHE^? 12.81 MG MG B 301 coo 12.97 28.35 3.84 11.81 28.07 2.09 60.02 7.32 3.97 60.86 9.29 4.05 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 48.74 12.82 1.93 48.51 10.17 2.19 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 51.51 9.59 -1.64 53.03 8.15 0.22 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 7 3 # 7 65 THR B 40 THR^? 24.25 MG MG B 302 242 CYH B 152 CYH^? 14.66 MG MG B 301 270 PHE B 12 PHE^? 17.13 MG MG B 302 coo 12.97 28.35 3.84 11.81 28.07 2.09 41.77 11.06 10.77 42.63 10.70 12.73 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 48.74 12.82 1.93 48.51 10.17 2.19 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 49.02 12.29 7.19 47.01 10.60 6.19 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 8 3 # 8 65 THR B 175 THR^? 12.15 MG MG B 301 242 CYH B 152 CYH^? 14.66 MG MG B 301 270 PHE B 150 PHE^? 9.88 MG MG B 301 coo 12.97 28.35 3.84 11.81 28.07 2.09 46.88 7.94 -7.07 47.05 10.06 -6.52 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 48.74 12.82 1.93 48.51 10.17 2.19 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 54.70 12.86 -1.84 56.31 11.50 0.05 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 9 3 # 9 65 THR B 175 THR^? 12.15 MG MG B 301 242 CYH B 152 CYH^? 14.66 MG MG B 301 270 PHE B 172 PHE^? 12.81 MG MG B 301 coo 12.97 28.35 3.84 11.81 28.07 2.09 46.88 7.94 -7.07 47.05 10.06 -6.52 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 48.74 12.82 1.93 48.51 10.17 2.19 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 51.51 9.59 -1.64 53.03 8.15 0.22 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 10 3 # 10 65 THR C 18 THR^? 15.72 MG MG C 302 242 CYH C 152 CYH^? 14.61 MG MG C 301 270 PHE C 150 PHE^? 10.02 MG MG C 301 coo 12.97 28.35 3.84 11.81 28.07 2.09 79.00 10.43 -10.53 77.64 12.10 -10.65 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 87.66 19.43 -8.58 88.77 17.04 -8.78 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 82.11 17.28 -4.80 81.16 15.47 -6.75 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 11 3 # 11 65 THR C 18 THR^? 15.72 MG MG C 302 242 CYH C 152 CYH^? 14.61 MG MG C 301 270 PHE C 172 PHE^? 13.00 MG MG C 301 coo 12.97 28.35 3.84 11.81 28.07 2.09 79.00 10.43 -10.53 77.64 12.10 -10.65 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 87.66 19.43 -8.58 88.77 17.04 -8.78 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 86.45 15.28 -5.05 85.50 13.59 -7.08 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 12 3 # 12 65 THR C 40 THR^? 24.02 MG MG C 302 242 CYH C 152 CYH^? 14.61 MG MG C 301 270 PHE C 12 PHE^? 16.92 MG MG C 302 coo 12.97 28.35 3.84 11.81 28.07 2.09 94.40 20.37 -17.61 93.73 19.75 -19.59 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 87.66 19.43 -8.58 88.77 17.04 -8.78 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 87.42 18.93 -13.86 90.00 18.25 -12.97 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 13 3 # 13 65 THR C 175 THR^? 12.73 MG MG C 301 242 CYH C 152 CYH^? 14.61 MG MG C 301 270 PHE C 150 PHE^? 10.02 MG MG C 301 coo 12.97 28.35 3.84 11.81 28.07 2.09 91.24 15.45 0.47 90.99 17.39 -0.47 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 87.66 19.43 -8.58 88.77 17.04 -8.78 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 82.11 17.28 -4.80 81.16 15.47 -6.75 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 14 3 # 14 65 THR C 175 THR^? 12.73 MG MG C 301 242 CYH C 152 CYH^? 14.61 MG MG C 301 270 PHE C 172 PHE^? 13.00 MG MG C 301 coo 12.97 28.35 3.84 11.81 28.07 2.09 91.24 15.45 0.47 90.99 17.39 -0.47 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 87.66 19.43 -8.58 88.77 17.04 -8.78 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 86.45 15.28 -5.05 85.50 13.59 -7.08 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 15 3 # 15 65 THR D 18 THR^? 15.54 MG MG D 302 242 CYH D 152 CYH^? 14.66 MG MG D 301 270 PHE D 150 PHE^? 10.21 MG MG D 301 coo 12.97 28.35 3.84 11.81 28.07 2.09 93.52 49.91 -39.68 91.41 49.57 -39.76 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 94.69 37.43 -41.36 96.92 38.83 -40.94 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 91.92 42.74 -45.34 92.24 44.79 -43.44 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 16 3 # 16 65 THR D 18 THR^? 15.54 MG MG D 302 242 CYH D 152 CYH^? 14.66 MG MG D 301 270 PHE D 172 PHE^? 13.02 MG MG D 301 coo 12.97 28.35 3.84 11.81 28.07 2.09 93.52 49.91 -39.68 91.41 49.57 -39.76 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 94.69 37.43 -41.36 96.92 38.83 -40.94 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 96.36 41.50 -44.84 96.77 43.66 -43.13 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 17 3 # 17 65 THR D 40 THR^? 24.02 MG MG D 302 242 CYH D 152 CYH^? 14.66 MG MG D 301 270 PHE D 12 PHE^? 16.78 MG MG D 302 coo 12.97 28.35 3.84 11.81 28.07 2.09 99.14 32.63 -32.12 99.04 33.58 -30.18 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 94.69 37.43 -41.36 96.92 38.83 -40.94 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 94.68 38.11 -36.05 97.16 37.10 -36.83 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 18 3 # 18 65 THR D 175 THR^? 12.60 MG MG D 301 242 CYH D 152 CYH^? 14.66 MG MG D 301 270 PHE D 150 PHE^? 10.21 MG MG D 301 coo 12.97 28.35 3.84 11.81 28.07 2.09 100.33 38.24 -50.15 98.81 36.95 -49.29 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 94.69 37.43 -41.36 96.92 38.83 -40.94 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 91.92 42.74 -45.34 92.24 44.79 -43.44 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 19 3 # 19 65 THR D 175 THR^? 12.60 MG MG D 301 242 CYH D 152 CYH^? 14.66 MG MG D 301 270 PHE D 172 PHE^? 13.02 MG MG D 301 coo 12.97 28.35 3.84 11.81 28.07 2.09 100.33 38.24 -50.15 98.81 36.95 -49.29 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 94.69 37.43 -41.36 96.92 38.83 -40.94 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 96.36 41.50 -44.84 96.77 43.66 -43.13 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 20 3 # 20 65 THR E 18 THR^? 15.84 MG MG E 302 242 CYH E 152 CYH^? 14.64 MG MG E 301 270 PHE E 150 PHE^? 10.10 MG MG E 301 coo 12.97 28.35 3.84 11.81 28.07 2.09 81.45 64.25 -55.27 80.73 62.21 -55.24 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 69.49 67.27 -53.54 71.02 69.50 -54.03 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 74.01 63.99 -49.53 76.06 63.87 -51.45 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 21 3 # 21 65 THR E 18 THR^? 15.84 MG MG E 302 242 CYH E 152 CYH^? 14.64 MG MG E 301 270 PHE E 172 PHE^? 12.71 MG MG E 301 coo 12.97 28.35 3.84 11.81 28.07 2.09 81.45 64.25 -55.27 80.73 62.21 -55.24 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 69.49 67.27 -53.54 71.02 69.50 -54.03 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 73.54 68.41 -50.00 75.58 68.36 -51.87 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 22 3 # 22 65 THR E 40 THR^? 24.66 MG MG E 302 242 CYH E 152 CYH^? 14.64 MG MG E 301 270 PHE E 12 PHE^? 17.09 MG MG E 302 coo 12.97 28.35 3.84 11.81 28.07 2.09 65.26 72.42 -63.00 65.97 72.32 -65.06 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 69.49 67.27 -53.54 71.02 69.50 -54.03 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 70.06 67.18 -58.76 69.33 69.81 -58.07 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 23 3 # 23 65 THR E 175 THR^? 12.38 MG MG E 301 242 CYH E 152 CYH^? 14.64 MG MG E 301 270 PHE E 150 PHE^? 10.10 MG MG E 301 coo 12.97 28.35 3.84 11.81 28.07 2.09 71.20 72.92 -44.89 69.57 71.76 -45.77 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 69.49 67.27 -53.54 71.02 69.50 -54.03 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 74.01 63.99 -49.53 76.06 63.87 -51.45 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 24 3 # 24 65 THR E 175 THR^? 12.38 MG MG E 301 242 CYH E 152 CYH^? 14.64 MG MG E 301 270 PHE E 172 PHE^? 12.71 MG MG E 301 coo 12.97 28.35 3.84 11.81 28.07 2.09 71.20 72.92 -44.89 69.57 71.76 -45.77 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 69.49 67.27 -53.54 71.02 69.50 -54.03 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 73.54 68.41 -50.00 75.58 68.36 -51.87 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 25 3 # 25 65 THR F 18 THR^? 15.93 MG MG F 301 242 CYH F 152 CYH^? 14.14 MG MG F 302 270 PHE F 150 PHE^? 9.82 MG MG F 302 coo 12.97 28.35 3.84 11.81 28.07 2.09 39.95 55.99 -83.96 41.26 54.27 -83.96 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 50.28 62.76 -86.08 48.12 64.34 -85.77 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 47.10 57.70 -89.94 45.06 57.27 -88.04 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 26 3 # 26 65 THR F 18 THR^? 15.93 MG MG F 301 242 CYH F 152 CYH^? 14.14 MG MG F 302 270 PHE F 172 PHE^? 12.43 MG MG F 302 coo 12.97 28.35 3.84 11.81 28.07 2.09 39.95 55.99 -83.96 41.26 54.27 -83.96 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 50.28 62.76 -86.08 48.12 64.34 -85.77 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 45.85 62.23 -89.68 43.95 61.55 -87.75 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 27 3 # 27 65 THR F 40 THR^? 24.18 MG MG F 301 242 CYH F 152 CYH^? 14.14 MG MG F 302 270 PHE F 12 PHE^? 17.12 MG MG F 301 coo 12.97 28.35 3.84 11.81 28.07 2.09 52.32 69.62 -77.21 51.38 69.00 -75.36 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 50.28 62.76 -86.08 48.12 64.34 -85.77 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 49.70 62.79 -80.90 49.37 65.44 -81.67 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 28 3 # 28 65 THR F 175 THR^? 11.83 MG MG F 302 242 CYH F 152 CYH^? 14.14 MG MG F 302 270 PHE F 150 PHE^? 9.82 MG MG F 302 coo 12.97 28.35 3.84 11.81 28.07 2.09 46.82 66.80 -95.29 48.97 66.65 -95.25 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 50.28 62.76 -86.08 48.12 64.34 -85.77 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 47.10 57.70 -89.94 45.06 57.27 -88.04 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 29 3 # 29 65 THR F 175 THR^? 11.83 MG MG F 302 242 CYH F 152 CYH^? 14.14 MG MG F 302 270 PHE F 172 PHE^? 12.43 MG MG F 302 coo 12.97 28.35 3.84 11.81 28.07 2.09 46.82 66.80 -95.29 48.97 66.65 -95.25 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 50.28 62.76 -86.08 48.12 64.34 -85.77 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 45.85 62.23 -89.68 43.95 61.55 -87.75 2cnd_c01 source 2cnd NADH-DEPENDENT NITRATE REDUCTASE (CYTOCHROME B: 29 hits 2cnd_c01 naa= 3 ULMN 3 2dbt_c00 CHITINASE C user 1 3 # 1 A 147 GLU A 63 GLU^? 28.10 MG MG B 302 A 156 GLU B 33 GLU^? 22.65 MG MG B 302 A 194 ASN A 3 ASN.? 30.14 MG MG B 302 coo 74.14 15.91 8.55 72.08 15.36 8.63 59.13 11.55 21.47 60.51 12.96 22.22 coo 67.47 20.07 1.34 65.99 20.06 2.88 59.88 9.09 12.22 59.91 9.49 14.33 coo 67.44 25.26 13.91 67.54 23.65 15.28 50.04 4.36 19.09 51.05 2.61 18.36 ULMN 3 2dbt_c00 CHITINASE C user 2 3 # 2 A 147 GLU B 33 GLU^? 22.65 MG MG B 302 A 156 GLU A 63 GLU^? 28.10 MG MG B 302 A 194 ASN A 3 ASN.? 30.14 MG MG B 302 coo 74.14 15.91 8.55 72.08 15.36 8.63 59.88 9.09 12.22 59.91 9.49 14.33 coo 67.47 20.07 1.34 65.99 20.06 2.88 59.13 11.55 21.47 60.51 12.96 22.22 coo 67.44 25.26 13.91 67.54 23.65 15.28 50.04 4.36 19.09 51.05 2.61 18.36 ULMN 3 2dbt_c00 CHITINASE C user 3 3 # 3 A 147 GLU B 63 GLU^? 27.83 MG MG A 301 A 156 GLU A 33 GLU^? 22.87 MG MG A 301 A 194 ASN B 3 ASN^? 29.91 MG MG A 301 coo 74.14 15.91 8.55 72.08 15.36 8.63 36.89 38.35 16.01 38.64 39.45 15.67 coo 67.47 20.07 1.34 65.99 20.06 2.88 33.74 38.67 24.96 34.13 38.85 22.87 coo 67.44 25.26 13.91 67.54 23.65 15.28 28.49 30.55 17.19 26.69 31.26 18.05 ULMN 3 2dbt_c00 CHITINASE C user 4 3 # 4 A 147 GLU C 33 GLU^? 22.71 MG MG C 302 A 156 GLU D 63 GLU^? 27.62 MG MG C 302 A 194 ASN D 3 ASN^? 28.85 MG MG C 302 coo 74.14 15.91 8.55 72.08 15.36 8.63 78.39 11.67 -18.82 78.34 12.01 -20.91 coo 67.47 20.07 1.34 65.99 20.06 2.88 77.46 14.75 -28.07 75.93 16.12 -28.66 coo 67.44 25.26 13.91 67.54 23.65 15.28 89.53 11.43 -25.56 88.66 9.94 -24.30 ULMN 3 2dbt_c00 CHITINASE C user 5 3 # 5 A 147 GLU C 63 GLU^? 27.26 MG MG D 302 A 156 GLU D 33 GLU^? 22.23 MG MG D 302 A 194 ASN C 3 ASN^? 29.15 MG MG D 302 coo 74.14 15.91 8.55 72.08 15.36 8.63 89.51 47.54 -22.35 87.55 48.20 -22.72 coo 67.47 20.07 1.34 65.99 20.06 2.88 91.55 48.87 -31.66 91.12 48.92 -29.63 coo 67.44 25.26 13.91 67.54 23.65 15.28 100.26 42.79 -23.94 100.99 44.40 -25.14 ULMN 3 2dbt_c00 CHITINASE C user 6 3 # 6 A 147 GLU D 33 GLU^? 22.23 MG MG D 302 A 156 GLU C 63 GLU^? 27.26 MG MG D 302 A 194 ASN C 3 ASN^? 29.15 MG MG D 302 coo 74.14 15.91 8.55 72.08 15.36 8.63 91.55 48.87 -31.66 91.12 48.92 -29.63 coo 67.47 20.07 1.34 65.99 20.06 2.88 89.51 47.54 -22.35 87.55 48.20 -22.72 coo 67.44 25.26 13.91 67.54 23.65 15.28 100.26 42.79 -23.94 100.99 44.40 -25.14 ULMN 3 2dbt_c00 CHITINASE C user 7 3 # 7 A 147 GLU D 63 GLU^? 27.62 MG MG C 302 A 156 GLU C 33 GLU^? 22.71 MG MG C 302 A 194 ASN D 3 ASN^? 28.85 MG MG C 302 coo 74.14 15.91 8.55 72.08 15.36 8.63 77.46 14.75 -28.07 75.93 16.12 -28.66 coo 67.47 20.07 1.34 65.99 20.06 2.88 78.39 11.67 -18.82 78.34 12.01 -20.91 coo 67.44 25.26 13.91 67.54 23.65 15.28 89.53 11.43 -25.56 88.66 9.94 -24.30 ULMN 3 2dbt_c00 CHITINASE C user 8 3 # 8 A 147 GLU E 33 GLU^? 22.81 MG MG E 302 A 156 GLU F 63 GLU^? 27.81 MG MG E 302 A 194 ASN F 3 ASN^? 30.46 MG MG E 302 coo 74.14 15.91 8.55 72.08 15.36 8.63 80.16 62.57 -63.35 80.54 62.13 -65.43 coo 67.47 20.07 1.34 65.99 20.06 2.88 78.38 60.07 -72.34 78.48 58.04 -72.84 coo 67.44 25.26 13.91 67.54 23.65 15.28 76.18 71.56 -71.39 78.06 72.28 -70.84 ULMN 3 2dbt_c00 CHITINASE C user 9 3 # 9 A 147 GLU E 63 GLU^? 28.08 MG MG F 301 A 156 GLU F 33 GLU^? 22.46 MG MG F 301 A 194 ASN E 3 ASN^? 30.27 MG MG F 301 coo 74.14 15.91 8.55 72.08 15.36 8.63 44.04 53.99 -66.79 43.77 51.93 -66.35 coo 67.47 20.07 1.34 65.99 20.06 2.88 41.88 55.13 -75.91 42.06 54.64 -73.84 coo 67.44 25.26 13.91 67.54 23.65 15.28 42.47 65.36 -68.69 40.59 66.02 -69.39 ULMN 3 2dbt_c00 CHITINASE C user 10 3 # 10 A 147 GLU F 33 GLU^? 22.46 MG MG F 301 A 156 GLU E 63 GLU^? 28.08 MG MG F 301 A 194 ASN E 3 ASN^? 30.27 MG MG F 301 coo 74.14 15.91 8.55 72.08 15.36 8.63 41.88 55.13 -75.91 42.06 54.64 -73.84 coo 67.47 20.07 1.34 65.99 20.06 2.88 44.04 53.99 -66.79 43.77 51.93 -66.35 coo 67.44 25.26 13.91 67.54 23.65 15.28 42.47 65.36 -68.69 40.59 66.02 -69.39 ULMN 3 2dbt_c00 CHITINASE C user 11 3 # 11 A 147 GLU F 63 GLU^? 27.81 MG MG E 302 A 156 GLU E 33 GLU^? 22.81 MG MG E 302 A 194 ASN F 3 ASN^? 30.46 MG MG E 302 coo 74.14 15.91 8.55 72.08 15.36 8.63 78.38 60.07 -72.34 78.48 58.04 -72.84 coo 67.47 20.07 1.34 65.99 20.06 2.88 80.16 62.57 -63.35 80.54 62.13 -65.43 coo 67.44 25.26 13.91 67.54 23.65 15.28 76.18 71.56 -71.39 78.06 72.28 -70.84 2dbt_c00 source 2dbt CHITINASE C : 11 hits 2dbt_c00 naa= 3 ULMN 3 2dbt_c01 CHITINASE C user 1 3 # 1 B 147 GLU A 33 GLU^? 22.87 MG MG A 301 B 156 GLU B 63 GLU^? 27.83 MG MG A 301 B 194 ASN B 3 ASN^? 29.91 MG MG A 301 coo 45.64 63.11 17.20 47.48 62.43 16.45 33.74 38.67 24.96 34.13 38.85 22.87 coo 54.43 67.89 19.82 55.62 67.90 18.07 36.89 38.35 16.01 38.64 39.45 15.67 coo 49.79 70.75 7.78 50.10 68.90 6.86 28.49 30.55 17.19 26.69 31.26 18.05 ULMN 3 2dbt_c01 CHITINASE C user 2 3 # 2 B 147 GLU A 63 GLU^? 28.10 MG MG B 302 B 156 GLU B 33 GLU^? 22.65 MG MG B 302 B 194 ASN A 3 ASN.? 30.14 MG MG B 302 coo 45.64 63.11 17.20 47.48 62.43 16.45 59.13 11.55 21.47 60.51 12.96 22.22 coo 54.43 67.89 19.82 55.62 67.90 18.07 59.88 9.09 12.22 59.91 9.49 14.33 coo 49.79 70.75 7.78 50.10 68.90 6.86 50.04 4.36 19.09 51.05 2.61 18.36 ULMN 3 2dbt_c01 CHITINASE C user 3 3 # 3 B 147 GLU B 33 GLU^? 22.65 MG MG B 302 B 156 GLU A 63 GLU^? 28.10 MG MG B 302 B 194 ASN A 3 ASN.? 30.14 MG MG B 302 coo 45.64 63.11 17.20 47.48 62.43 16.45 59.88 9.09 12.22 59.91 9.49 14.33 coo 54.43 67.89 19.82 55.62 67.90 18.07 59.13 11.55 21.47 60.51 12.96 22.22 coo 49.79 70.75 7.78 50.10 68.90 6.86 50.04 4.36 19.09 51.05 2.61 18.36 ULMN 3 2dbt_c01 CHITINASE C user 4 3 # 4 B 147 GLU B 63 GLU^? 27.83 MG MG A 301 B 156 GLU A 33 GLU^? 22.87 MG MG A 301 B 194 ASN B 3 ASN^? 29.91 MG MG A 301 coo 45.64 63.11 17.20 47.48 62.43 16.45 36.89 38.35 16.01 38.64 39.45 15.67 coo 54.43 67.89 19.82 55.62 67.90 18.07 33.74 38.67 24.96 34.13 38.85 22.87 coo 49.79 70.75 7.78 50.10 68.90 6.86 28.49 30.55 17.19 26.69 31.26 18.05 ULMN 3 2dbt_c01 CHITINASE C user 5 3 # 5 B 147 GLU C 33 GLU^? 22.71 MG MG C 302 B 156 GLU D 63 GLU^? 27.62 MG MG C 302 B 194 ASN D 3 ASN^? 28.85 MG MG C 302 coo 45.64 63.11 17.20 47.48 62.43 16.45 78.39 11.67 -18.82 78.34 12.01 -20.91 coo 54.43 67.89 19.82 55.62 67.90 18.07 77.46 14.75 -28.07 75.93 16.12 -28.66 coo 49.79 70.75 7.78 50.10 68.90 6.86 89.53 11.43 -25.56 88.66 9.94 -24.30 ULMN 3 2dbt_c01 CHITINASE C user 6 3 # 6 B 147 GLU C 63 GLU^? 27.26 MG MG D 302 B 156 GLU D 33 GLU^? 22.23 MG MG D 302 B 194 ASN C 3 ASN^? 29.15 MG MG D 302 coo 45.64 63.11 17.20 47.48 62.43 16.45 89.51 47.54 -22.35 87.55 48.20 -22.72 coo 54.43 67.89 19.82 55.62 67.90 18.07 91.55 48.87 -31.66 91.12 48.92 -29.63 coo 49.79 70.75 7.78 50.10 68.90 6.86 100.26 42.79 -23.94 100.99 44.40 -25.14 ULMN 3 2dbt_c01 CHITINASE C user 7 3 # 7 B 147 GLU D 33 GLU^? 22.23 MG MG D 302 B 156 GLU C 63 GLU^? 27.26 MG MG D 302 B 194 ASN C 3 ASN^? 29.15 MG MG D 302 coo 45.64 63.11 17.20 47.48 62.43 16.45 91.55 48.87 -31.66 91.12 48.92 -29.63 coo 54.43 67.89 19.82 55.62 67.90 18.07 89.51 47.54 -22.35 87.55 48.20 -22.72 coo 49.79 70.75 7.78 50.10 68.90 6.86 100.26 42.79 -23.94 100.99 44.40 -25.14 ULMN 3 2dbt_c01 CHITINASE C user 8 3 # 8 B 147 GLU D 63 GLU^? 27.62 MG MG C 302 B 156 GLU C 33 GLU^? 22.71 MG MG C 302 B 194 ASN D 3 ASN^? 28.85 MG MG C 302 coo 45.64 63.11 17.20 47.48 62.43 16.45 77.46 14.75 -28.07 75.93 16.12 -28.66 coo 54.43 67.89 19.82 55.62 67.90 18.07 78.39 11.67 -18.82 78.34 12.01 -20.91 coo 49.79 70.75 7.78 50.10 68.90 6.86 89.53 11.43 -25.56 88.66 9.94 -24.30 ULMN 3 2dbt_c01 CHITINASE C user 9 3 # 9 B 147 GLU E 33 GLU^? 22.81 MG MG E 302 B 156 GLU F 63 GLU^? 27.81 MG MG E 302 B 194 ASN F 3 ASN^? 30.46 MG MG E 302 coo 45.64 63.11 17.20 47.48 62.43 16.45 80.16 62.57 -63.35 80.54 62.13 -65.43 coo 54.43 67.89 19.82 55.62 67.90 18.07 78.38 60.07 -72.34 78.48 58.04 -72.84 coo 49.79 70.75 7.78 50.10 68.90 6.86 76.18 71.56 -71.39 78.06 72.28 -70.84 ULMN 3 2dbt_c01 CHITINASE C user 10 3 # 10 B 147 GLU E 63 GLU^? 28.08 MG MG F 301 B 156 GLU F 33 GLU^? 22.46 MG MG F 301 B 194 ASN E 3 ASN^? 30.27 MG MG F 301 coo 45.64 63.11 17.20 47.48 62.43 16.45 44.04 53.99 -66.79 43.77 51.93 -66.35 coo 54.43 67.89 19.82 55.62 67.90 18.07 41.88 55.13 -75.91 42.06 54.64 -73.84 coo 49.79 70.75 7.78 50.10 68.90 6.86 42.47 65.36 -68.69 40.59 66.02 -69.39 ULMN 3 2dbt_c01 CHITINASE C user 11 3 # 11 B 147 GLU F 33 GLU^? 22.46 MG MG F 301 B 156 GLU E 63 GLU^? 28.08 MG MG F 301 B 194 ASN E 3 ASN^? 30.27 MG MG F 301 coo 45.64 63.11 17.20 47.48 62.43 16.45 41.88 55.13 -75.91 42.06 54.64 -73.84 coo 54.43 67.89 19.82 55.62 67.90 18.07 44.04 53.99 -66.79 43.77 51.93 -66.35 coo 49.79 70.75 7.78 50.10 68.90 6.86 42.47 65.36 -68.69 40.59 66.02 -69.39 ULMN 3 2dbt_c01 CHITINASE C user 12 3 # 12 B 147 GLU F 63 GLU^? 27.81 MG MG E 302 B 156 GLU E 33 GLU^? 22.81 MG MG E 302 B 194 ASN F 3 ASN^? 30.46 MG MG E 302 coo 45.64 63.11 17.20 47.48 62.43 16.45 78.38 60.07 -72.34 78.48 58.04 -72.84 coo 54.43 67.89 19.82 55.62 67.90 18.07 80.16 62.57 -63.35 80.54 62.13 -65.43 coo 49.79 70.75 7.78 50.10 68.90 6.86 76.18 71.56 -71.39 78.06 72.28 -70.84 2dbt_c01 source 2dbt CHITINASE C : 12 hits 2dbt_c01 naa= 3 ULMN 3 2dbt_c02 CHITINASE C user 1 3 # 1 C 147 GLU A 63 GLU^? 28.10 MG MG B 302 C 156 GLU B 33 GLU^? 22.65 MG MG B 302 C 194 ASN A 3 ASN.? 30.14 MG MG B 302 coo 41.23 29.31 13.28 43.03 29.85 12.29 59.13 11.55 21.47 60.51 12.96 22.22 coo 44.75 23.09 5.51 46.77 22.91 6.12 59.88 9.09 12.22 59.91 9.49 14.33 coo 49.75 21.00 18.12 50.45 23.02 18.26 50.04 4.36 19.09 51.05 2.61 18.36 ULMN 3 2dbt_c02 CHITINASE C user 2 3 # 2 C 147 GLU B 33 GLU^? 22.65 MG MG B 302 C 156 GLU A 63 GLU^? 28.10 MG MG B 302 C 194 ASN A 3 ASN.? 30.14 MG MG B 302 coo 41.23 29.31 13.28 43.03 29.85 12.29 59.88 9.09 12.22 59.91 9.49 14.33 coo 44.75 23.09 5.51 46.77 22.91 6.12 59.13 11.55 21.47 60.51 12.96 22.22 coo 49.75 21.00 18.12 50.45 23.02 18.26 50.04 4.36 19.09 51.05 2.61 18.36 ULMN 3 2dbt_c02 CHITINASE C user 3 3 # 3 C 147 GLU B 63 GLU^? 27.83 MG MG A 301 C 156 GLU A 33 GLU^? 22.87 MG MG A 301 C 194 ASN B 3 ASN^? 29.91 MG MG A 301 coo 41.23 29.31 13.28 43.03 29.85 12.29 36.89 38.35 16.01 38.64 39.45 15.67 coo 44.75 23.09 5.51 46.77 22.91 6.12 33.74 38.67 24.96 34.13 38.85 22.87 coo 49.75 21.00 18.12 50.45 23.02 18.26 28.49 30.55 17.19 26.69 31.26 18.05 ULMN 3 2dbt_c02 CHITINASE C user 4 3 # 4 C 147 GLU C 33 GLU^? 22.71 MG MG C 302 C 156 GLU D 63 GLU^? 27.62 MG MG C 302 C 194 ASN D 3 ASN^? 28.85 MG MG C 302 coo 41.23 29.31 13.28 43.03 29.85 12.29 78.39 11.67 -18.82 78.34 12.01 -20.91 coo 44.75 23.09 5.51 46.77 22.91 6.12 77.46 14.75 -28.07 75.93 16.12 -28.66 coo 49.75 21.00 18.12 50.45 23.02 18.26 89.53 11.43 -25.56 88.66 9.94 -24.30 ULMN 3 2dbt_c02 CHITINASE C user 5 3 # 5 C 147 GLU C 63 GLU^? 27.26 MG MG D 302 C 156 GLU D 33 GLU^? 22.23 MG MG D 302 C 194 ASN C 3 ASN^? 29.15 MG MG D 302 coo 41.23 29.31 13.28 43.03 29.85 12.29 89.51 47.54 -22.35 87.55 48.20 -22.72 coo 44.75 23.09 5.51 46.77 22.91 6.12 91.55 48.87 -31.66 91.12 48.92 -29.63 coo 49.75 21.00 18.12 50.45 23.02 18.26 100.26 42.79 -23.94 100.99 44.40 -25.14 ULMN 3 2dbt_c02 CHITINASE C user 6 3 # 6 C 147 GLU D 33 GLU^? 22.23 MG MG D 302 C 156 GLU C 63 GLU^? 27.26 MG MG D 302 C 194 ASN C 3 ASN^? 29.15 MG MG D 302 coo 41.23 29.31 13.28 43.03 29.85 12.29 91.55 48.87 -31.66 91.12 48.92 -29.63 coo 44.75 23.09 5.51 46.77 22.91 6.12 89.51 47.54 -22.35 87.55 48.20 -22.72 coo 49.75 21.00 18.12 50.45 23.02 18.26 100.26 42.79 -23.94 100.99 44.40 -25.14 ULMN 3 2dbt_c02 CHITINASE C user 7 3 # 7 C 147 GLU D 63 GLU^? 27.62 MG MG C 302 C 156 GLU C 33 GLU^? 22.71 MG MG C 302 C 194 ASN D 3 ASN^? 28.85 MG MG C 302 coo 41.23 29.31 13.28 43.03 29.85 12.29 77.46 14.75 -28.07 75.93 16.12 -28.66 coo 44.75 23.09 5.51 46.77 22.91 6.12 78.39 11.67 -18.82 78.34 12.01 -20.91 coo 49.75 21.00 18.12 50.45 23.02 18.26 89.53 11.43 -25.56 88.66 9.94 -24.30 ULMN 3 2dbt_c02 CHITINASE C user 8 3 # 8 C 147 GLU E 33 GLU^? 22.81 MG MG E 302 C 156 GLU F 63 GLU^? 27.81 MG MG E 302 C 194 ASN F 3 ASN^? 30.46 MG MG E 302 coo 41.23 29.31 13.28 43.03 29.85 12.29 80.16 62.57 -63.35 80.54 62.13 -65.43 coo 44.75 23.09 5.51 46.77 22.91 6.12 78.38 60.07 -72.34 78.48 58.04 -72.84 coo 49.75 21.00 18.12 50.45 23.02 18.26 76.18 71.56 -71.39 78.06 72.28 -70.84 ULMN 3 2dbt_c02 CHITINASE C user 9 3 # 9 C 147 GLU E 63 GLU^? 28.08 MG MG F 301 C 156 GLU F 33 GLU^? 22.46 MG MG F 301 C 194 ASN E 3 ASN^? 30.27 MG MG F 301 coo 41.23 29.31 13.28 43.03 29.85 12.29 44.04 53.99 -66.79 43.77 51.93 -66.35 coo 44.75 23.09 5.51 46.77 22.91 6.12 41.88 55.13 -75.91 42.06 54.64 -73.84 coo 49.75 21.00 18.12 50.45 23.02 18.26 42.47 65.36 -68.69 40.59 66.02 -69.39 ULMN 3 2dbt_c02 CHITINASE C user 10 3 # 10 C 147 GLU F 63 GLU^? 27.81 MG MG E 302 C 156 GLU E 33 GLU^? 22.81 MG MG E 302 C 194 ASN F 3 ASN^? 30.46 MG MG E 302 coo 41.23 29.31 13.28 43.03 29.85 12.29 78.38 60.07 -72.34 78.48 58.04 -72.84 coo 44.75 23.09 5.51 46.77 22.91 6.12 80.16 62.57 -63.35 80.54 62.13 -65.43 coo 49.75 21.00 18.12 50.45 23.02 18.26 76.18 71.56 -71.39 78.06 72.28 -70.84 2dbt_c02 source 2dbt CHITINASE C : 10 hits 2dbt_c02 naa= 3 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 1 3 # 1 A 182 LYS A 6 LYS^? 25.88 MG MG A 301 A 184 LYS A 157 LYS^? 28.65 MG MG A 302 A 345 ASP A 138 ASP^? 33.08 MG MG A 302 coo 5.98 42.76 7.73 10.19 38.62 9.02 46.20 12.82 24.71 44.50 16.64 20.52 coo 2.77 37.17 4.99 6.33 34.76 8.06 41.42 12.06 27.58 41.46 5.93 29.41 coo 0.07 40.30 18.65 -0.21 42.34 18.18 47.10 -0.97 29.63 45.89 0.22 30.96 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 2 3 # 2 A 182 LYS A 157 LYS^? 28.65 MG MG A 302 A 184 LYS A 6 LYS^? 25.88 MG MG A 301 A 345 ASP A 138 ASP^? 33.08 MG MG A 302 coo 5.98 42.76 7.73 10.19 38.62 9.02 41.42 12.06 27.58 41.46 5.93 29.41 coo 2.77 37.17 4.99 6.33 34.76 8.06 46.20 12.82 24.71 44.50 16.64 20.52 coo 0.07 40.30 18.65 -0.21 42.34 18.18 47.10 -0.97 29.63 45.89 0.22 30.96 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 3 3 # 3 A 182 LYS A 157 LYS^? 28.65 MG MG A 302 A 184 LYS A 6 LYS^? 25.88 MG MG A 301 A 345 ASP A 142 ASP^? 23.70 MG MG A 302 coo 5.98 42.76 7.73 10.19 38.62 9.02 41.42 12.06 27.58 41.46 5.93 29.41 coo 2.77 37.17 4.99 6.33 34.76 8.06 46.20 12.82 24.71 44.50 16.64 20.52 coo 0.07 40.30 18.65 -0.21 42.34 18.18 46.39 7.18 37.53 46.28 7.18 39.63 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 4 3 # 4 A 182 LYS A 157 LYS^? 28.65 MG MG A 302 A 184 LYS A 166 LYS^? 20.93 MG MG A 302 A 345 ASP A 142 ASP^? 23.70 MG MG A 302 coo 5.98 42.76 7.73 10.19 38.62 9.02 41.42 12.06 27.58 41.46 5.93 29.41 coo 2.77 37.17 4.99 6.33 34.76 8.06 35.34 13.14 30.41 31.67 15.04 34.58 coo 0.07 40.30 18.65 -0.21 42.34 18.18 46.39 7.18 37.53 46.28 7.18 39.63 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 5 3 # 5 A 182 LYS A 157 LYS^? 28.65 MG MG A 302 A 184 LYS A 166 LYS^? 20.93 MG MG A 302 A 345 ASP A 160 ASP^? 31.61 MG MG B 302 coo 5.98 42.76 7.73 10.19 38.62 9.02 41.42 12.06 27.58 41.46 5.93 29.41 coo 2.77 37.17 4.99 6.33 34.76 8.06 35.34 13.14 30.41 31.67 15.04 34.58 coo 0.07 40.30 18.65 -0.21 42.34 18.18 44.21 5.00 19.54 46.02 3.84 19.76 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 6 3 # 6 A 182 LYS B 6 LYS^? 25.90 MG MG B 302 A 184 LYS B 157 LYS^? 28.85 MG MG B 302 A 345 ASP B 138 ASP^? 33.32 MG MG B 302 coo 5.98 42.76 7.73 10.19 38.62 9.02 36.26 25.44 11.74 39.65 23.12 16.29 coo 2.77 37.17 4.99 6.33 34.76 8.06 34.97 21.28 8.44 29.03 22.82 6.58 coo 0.07 40.30 18.65 -0.21 42.34 18.18 23.42 29.01 6.78 24.36 28.48 4.94 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 7 3 # 7 A 182 LYS B 157 LYS^? 28.85 MG MG B 302 A 184 LYS B 6 LYS^? 25.90 MG MG B 302 A 345 ASP B 138 ASP^? 33.32 MG MG B 302 coo 5.98 42.76 7.73 10.19 38.62 9.02 34.97 21.28 8.44 29.03 22.82 6.58 coo 2.77 37.17 4.99 6.33 34.76 8.06 36.26 25.44 11.74 39.65 23.12 16.29 coo 0.07 40.30 18.65 -0.21 42.34 18.18 23.42 29.01 6.78 24.36 28.48 4.94 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 8 3 # 8 A 182 LYS B 157 LYS^? 28.85 MG MG B 302 A 184 LYS B 6 LYS^? 25.90 MG MG B 302 A 345 ASP B 142 ASP^? 23.97 MG MG B 301 coo 5.98 42.76 7.73 10.19 38.62 9.02 34.97 21.28 8.44 29.03 22.82 6.58 coo 2.77 37.17 4.99 6.33 34.76 8.06 36.26 25.44 11.74 39.65 23.12 16.29 coo 0.07 40.30 18.65 -0.21 42.34 18.18 31.69 27.40 -1.31 32.10 27.37 -3.38 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 9 3 # 9 A 182 LYS B 157 LYS^? 28.85 MG MG B 302 A 184 LYS B 166 LYS^? 22.75 MG MG B 301 A 345 ASP B 142 ASP^? 23.97 MG MG B 301 coo 5.98 42.76 7.73 10.19 38.62 9.02 34.97 21.28 8.44 29.03 22.82 6.58 coo 2.77 37.17 4.99 6.33 34.76 8.06 35.27 15.38 5.31 37.27 9.81 3.93 coo 0.07 40.30 18.65 -0.21 42.34 18.18 31.69 27.40 -1.31 32.10 27.37 -3.38 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 10 3 # 10 A 182 LYS B 157 LYS^? 28.85 MG MG B 302 A 184 LYS B 166 LYS^? 22.75 MG MG B 301 A 345 ASP B 160 ASP^? 31.65 MG MG A 301 coo 5.98 42.76 7.73 10.19 38.62 9.02 34.97 21.28 8.44 29.03 22.82 6.58 coo 2.77 37.17 4.99 6.33 34.76 8.06 35.27 15.38 5.31 37.27 9.81 3.93 coo 0.07 40.30 18.65 -0.21 42.34 18.18 28.01 24.83 16.38 27.44 26.81 15.80 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 11 3 # 11 A 182 LYS C 6 LYS^? 25.73 MG MG C 302 A 184 LYS C 157 LYS^? 28.15 MG MG C 302 A 345 ASP C 142 ASP^? 23.76 MG MG C 301 coo 5.98 42.76 7.73 10.19 38.62 9.02 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 2.77 37.17 4.99 6.33 34.76 8.06 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 0.07 40.30 18.65 -0.21 42.34 18.18 97.94 39.27 -5.03 98.08 38.70 -2.97 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 12 3 # 12 A 182 LYS C 157 LYS^? 28.15 MG MG C 302 A 184 LYS C 6 LYS^? 25.73 MG MG C 302 A 345 ASP C 138 ASP^? 33.43 MG MG C 302 coo 5.98 42.76 7.73 10.19 38.62 9.02 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 2.77 37.17 4.99 6.33 34.76 8.06 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 0.07 40.30 18.65 -0.21 42.34 18.18 105.43 43.97 -13.30 104.85 43.08 -11.43 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 13 3 # 13 A 182 LYS C 157 LYS^? 28.15 MG MG C 302 A 184 LYS C 6 LYS^? 25.73 MG MG C 302 A 345 ASP C 142 ASP^? 23.76 MG MG C 301 coo 5.98 42.76 7.73 10.19 38.62 9.02 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 2.77 37.17 4.99 6.33 34.76 8.06 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 0.07 40.30 18.65 -0.21 42.34 18.18 97.94 39.27 -5.03 98.08 38.70 -2.97 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 14 3 # 14 A 182 LYS C 157 LYS^? 28.15 MG MG C 302 A 184 LYS C 166 LYS^? 22.53 MG MG C 301 A 345 ASP C 142 ASP^? 23.76 MG MG C 301 coo 5.98 42.76 7.73 10.19 38.62 9.02 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 2.77 37.17 4.99 6.33 34.76 8.06 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 0.07 40.30 18.65 -0.21 42.34 18.18 97.94 39.27 -5.03 98.08 38.70 -2.97 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 15 3 # 15 A 182 LYS C 157 LYS^? 28.15 MG MG C 302 A 184 LYS C 166 LYS^? 22.53 MG MG C 301 A 345 ASP C 160 ASP^? 31.63 MG MG D 302 coo 5.98 42.76 7.73 10.19 38.62 9.02 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 2.77 37.17 4.99 6.33 34.76 8.06 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 0.07 40.30 18.65 -0.21 42.34 18.18 102.50 38.00 -23.28 102.43 39.97 -22.46 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 16 3 # 16 A 182 LYS C 166 LYS^? 22.53 MG MG C 301 A 184 LYS C 157 LYS^? 28.15 MG MG C 302 A 345 ASP C 142 ASP^? 23.76 MG MG C 301 coo 5.98 42.76 7.73 10.19 38.62 9.02 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 2.77 37.17 4.99 6.33 34.76 8.06 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 0.07 40.30 18.65 -0.21 42.34 18.18 97.94 39.27 -5.03 98.08 38.70 -2.97 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 17 3 # 17 A 182 LYS D 6 LYS^? 25.98 MG MG D 302 A 184 LYS D 157 LYS^? 28.67 MG MG D 302 A 345 ASP D 138 ASP^? 33.64 MG MG D 302 coo 5.98 42.76 7.73 10.19 38.62 9.02 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 2.77 37.17 4.99 6.33 34.76 8.06 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 0.07 40.30 18.65 -0.21 42.34 18.18 93.00 7.50 -35.79 93.88 8.48 -37.45 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 18 3 # 18 A 182 LYS D 6 LYS^? 25.98 MG MG D 302 A 184 LYS D 157 LYS^? 28.67 MG MG D 302 A 345 ASP D 142 ASP^? 23.49 MG MG D 301 coo 5.98 42.76 7.73 10.19 38.62 9.02 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 2.77 37.17 4.99 6.33 34.76 8.06 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 0.07 40.30 18.65 -0.21 42.34 18.18 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 19 3 # 19 A 182 LYS D 157 LYS^? 28.67 MG MG D 302 A 184 LYS D 6 LYS^? 25.98 MG MG D 302 A 345 ASP D 138 ASP^? 33.64 MG MG D 302 coo 5.98 42.76 7.73 10.19 38.62 9.02 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 2.77 37.17 4.99 6.33 34.76 8.06 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 0.07 40.30 18.65 -0.21 42.34 18.18 93.00 7.50 -35.79 93.88 8.48 -37.45 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 20 3 # 20 A 182 LYS D 157 LYS^? 28.67 MG MG D 302 A 184 LYS D 6 LYS^? 25.98 MG MG D 302 A 345 ASP D 142 ASP^? 23.49 MG MG D 301 coo 5.98 42.76 7.73 10.19 38.62 9.02 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 2.77 37.17 4.99 6.33 34.76 8.06 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 0.07 40.30 18.65 -0.21 42.34 18.18 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 21 3 # 21 A 182 LYS D 157 LYS^? 28.67 MG MG D 302 A 184 LYS D 166 LYS^? 21.08 MG MG D 301 A 345 ASP D 142 ASP^? 23.49 MG MG D 301 coo 5.98 42.76 7.73 10.19 38.62 9.02 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 2.77 37.17 4.99 6.33 34.76 8.06 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 0.07 40.30 18.65 -0.21 42.34 18.18 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 22 3 # 22 A 182 LYS D 157 LYS^? 28.67 MG MG D 302 A 184 LYS D 166 LYS^? 21.08 MG MG D 301 A 345 ASP D 160 ASP^? 31.45 MG MG C 302 coo 5.98 42.76 7.73 10.19 38.62 9.02 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 2.77 37.17 4.99 6.33 34.76 8.06 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 0.07 40.30 18.65 -0.21 42.34 18.18 94.15 13.98 -26.57 92.71 12.42 -26.99 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 23 3 # 23 A 182 LYS D 166 LYS^? 21.08 MG MG D 301 A 184 LYS D 157 LYS^? 28.67 MG MG D 302 A 345 ASP D 142 ASP^? 23.49 MG MG D 301 coo 5.98 42.76 7.73 10.19 38.62 9.02 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 2.77 37.17 4.99 6.33 34.76 8.06 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 0.07 40.30 18.65 -0.21 42.34 18.18 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 24 3 # 24 A 182 LYS E 6 LYS^? 25.59 MG MG E 302 A 184 LYS E 157 LYS^? 28.40 MG MG E 302 A 345 ASP E 138 ASP^? 33.31 MG MG E 302 coo 5.98 42.76 7.73 10.19 38.62 9.02 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 2.77 37.17 4.99 6.33 34.76 8.06 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 0.07 40.30 18.65 -0.21 42.34 18.18 39.58 70.77 -58.63 40.74 70.78 -56.80 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 25 3 # 25 A 182 LYS E 157 LYS^? 28.40 MG MG E 302 A 184 LYS E 6 LYS^? 25.59 MG MG E 302 A 345 ASP E 138 ASP^? 33.31 MG MG E 302 coo 5.98 42.76 7.73 10.19 38.62 9.02 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 2.77 37.17 4.99 6.33 34.76 8.06 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 0.07 40.30 18.65 -0.21 42.34 18.18 39.58 70.77 -58.63 40.74 70.78 -56.80 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 26 3 # 26 A 182 LYS E 157 LYS^? 28.40 MG MG E 302 A 184 LYS E 6 LYS^? 25.59 MG MG E 302 A 345 ASP E 142 ASP^? 23.66 MG MG E 301 coo 5.98 42.76 7.73 10.19 38.62 9.02 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 2.77 37.17 4.99 6.33 34.76 8.06 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 0.07 40.30 18.65 -0.21 42.34 18.18 47.19 67.15 -50.37 47.44 67.18 -48.23 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 27 3 # 27 A 182 LYS E 157 LYS^? 28.40 MG MG E 302 A 184 LYS E 166 LYS^? 21.46 MG MG E 301 A 345 ASP E 142 ASP^? 23.66 MG MG E 301 coo 5.98 42.76 7.73 10.19 38.62 9.02 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 2.77 37.17 4.99 6.33 34.76 8.06 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 0.07 40.30 18.65 -0.21 42.34 18.18 47.19 67.15 -50.37 47.44 67.18 -48.23 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 28 3 # 28 A 182 LYS F 6 LYS^? 26.09 MG MG F 301 A 184 LYS F 157 LYS^? 28.36 MG MG F 302 A 345 ASP F 138 ASP^? 33.51 MG MG F 302 coo 5.98 42.76 7.73 10.19 38.62 9.02 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 2.77 37.17 4.99 6.33 34.76 8.06 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 0.07 40.30 18.65 -0.21 42.34 18.18 77.17 76.66 -81.48 76.14 76.33 -83.32 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 29 3 # 29 A 182 LYS F 6 LYS^? 26.09 MG MG F 301 A 184 LYS F 157 LYS^? 28.36 MG MG F 302 A 345 ASP F 142 ASP^? 23.43 MG MG F 302 coo 5.98 42.76 7.73 10.19 38.62 9.02 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 2.77 37.17 4.99 6.33 34.76 8.06 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 0.07 40.30 18.65 -0.21 42.34 18.18 71.46 69.88 -89.76 71.03 69.93 -91.81 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 30 3 # 30 A 182 LYS F 157 LYS^? 28.36 MG MG F 302 A 184 LYS F 6 LYS^? 26.09 MG MG F 301 A 345 ASP F 138 ASP^? 33.51 MG MG F 302 coo 5.98 42.76 7.73 10.19 38.62 9.02 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 2.77 37.17 4.99 6.33 34.76 8.06 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 0.07 40.30 18.65 -0.21 42.34 18.18 77.17 76.66 -81.48 76.14 76.33 -83.32 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 31 3 # 31 A 182 LYS F 157 LYS^? 28.36 MG MG F 302 A 184 LYS F 6 LYS^? 26.09 MG MG F 301 A 345 ASP F 142 ASP^? 23.43 MG MG F 302 coo 5.98 42.76 7.73 10.19 38.62 9.02 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 2.77 37.17 4.99 6.33 34.76 8.06 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 0.07 40.30 18.65 -0.21 42.34 18.18 71.46 69.88 -89.76 71.03 69.93 -91.81 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 32 3 # 32 A 182 LYS F 157 LYS^? 28.36 MG MG F 302 A 184 LYS F 166 LYS^? 20.76 MG MG F 302 A 345 ASP F 142 ASP^? 23.43 MG MG F 302 coo 5.98 42.76 7.73 10.19 38.62 9.02 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 2.77 37.17 4.99 6.33 34.76 8.06 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 0.07 40.30 18.65 -0.21 42.34 18.18 71.46 69.88 -89.76 71.03 69.93 -91.81 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 33 3 # 33 A 182 LYS F 157 LYS^? 28.36 MG MG F 302 A 184 LYS F 166 LYS^? 20.76 MG MG F 302 A 345 ASP F 160 ASP^? 31.59 MG MG E 302 coo 5.98 42.76 7.73 10.19 38.62 9.02 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 2.77 37.17 4.99 6.33 34.76 8.06 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 0.07 40.30 18.65 -0.21 42.34 18.18 71.27 74.59 -71.77 73.23 74.02 -72.37 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 34 3 # 34 A 182 LYS F 166 LYS^? 20.76 MG MG F 302 A 184 LYS F 157 LYS^? 28.36 MG MG F 302 A 345 ASP F 142 ASP^? 23.43 MG MG F 302 coo 5.98 42.76 7.73 10.19 38.62 9.02 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 2.77 37.17 4.99 6.33 34.76 8.06 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 0.07 40.30 18.65 -0.21 42.34 18.18 71.46 69.88 -89.76 71.03 69.93 -91.81 2dw7_c32 source 2dw7 BLL6730 PROTEIN : 34 hits 2dw7_c32 naa= 3 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 1 3 # 1 B 182 LYS A 6 LYS^? 25.88 MG MG A 301 B 184 LYS A 157 LYS^? 28.65 MG MG A 302 B 345 ASP A 138 ASP^? 33.08 MG MG A 302 coo 38.76 2.27 4.00 34.00 5.99 4.37 46.20 12.82 24.71 44.50 16.64 20.52 coo 40.63 7.13 9.06 35.85 7.36 8.95 41.42 12.06 27.58 41.46 5.93 29.41 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 47.10 -0.97 29.63 45.89 0.22 30.96 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 2 3 # 2 B 182 LYS A 157 LYS^? 28.65 MG MG A 302 B 184 LYS A 6 LYS^? 25.88 MG MG A 301 B 345 ASP A 138 ASP^? 33.08 MG MG A 302 coo 38.76 2.27 4.00 34.00 5.99 4.37 41.42 12.06 27.58 41.46 5.93 29.41 coo 40.63 7.13 9.06 35.85 7.36 8.95 46.20 12.82 24.71 44.50 16.64 20.52 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 47.10 -0.97 29.63 45.89 0.22 30.96 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 3 3 # 3 B 182 LYS A 157 LYS^? 28.65 MG MG A 302 B 184 LYS A 6 LYS^? 25.88 MG MG A 301 B 345 ASP A 142 ASP^? 23.70 MG MG A 302 coo 38.76 2.27 4.00 34.00 5.99 4.37 41.42 12.06 27.58 41.46 5.93 29.41 coo 40.63 7.13 9.06 35.85 7.36 8.95 46.20 12.82 24.71 44.50 16.64 20.52 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 46.39 7.18 37.53 46.28 7.18 39.63 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 4 3 # 4 B 182 LYS A 157 LYS^? 28.65 MG MG A 302 B 184 LYS A 166 LYS^? 20.93 MG MG A 302 B 345 ASP A 142 ASP^? 23.70 MG MG A 302 coo 38.76 2.27 4.00 34.00 5.99 4.37 41.42 12.06 27.58 41.46 5.93 29.41 coo 40.63 7.13 9.06 35.85 7.36 8.95 35.34 13.14 30.41 31.67 15.04 34.58 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 46.39 7.18 37.53 46.28 7.18 39.63 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 5 3 # 5 B 182 LYS B 6 LYS^? 25.90 MG MG B 302 B 184 LYS B 157 LYS^? 28.85 MG MG B 302 B 345 ASP B 138 ASP^? 33.32 MG MG B 302 coo 38.76 2.27 4.00 34.00 5.99 4.37 36.26 25.44 11.74 39.65 23.12 16.29 coo 40.63 7.13 9.06 35.85 7.36 8.95 34.97 21.28 8.44 29.03 22.82 6.58 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 23.42 29.01 6.78 24.36 28.48 4.94 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 6 3 # 6 B 182 LYS B 157 LYS^? 28.85 MG MG B 302 B 184 LYS B 6 LYS^? 25.90 MG MG B 302 B 345 ASP B 138 ASP^? 33.32 MG MG B 302 coo 38.76 2.27 4.00 34.00 5.99 4.37 34.97 21.28 8.44 29.03 22.82 6.58 coo 40.63 7.13 9.06 35.85 7.36 8.95 36.26 25.44 11.74 39.65 23.12 16.29 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 23.42 29.01 6.78 24.36 28.48 4.94 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 7 3 # 7 B 182 LYS B 157 LYS^? 28.85 MG MG B 302 B 184 LYS B 6 LYS^? 25.90 MG MG B 302 B 345 ASP B 142 ASP^? 23.97 MG MG B 301 coo 38.76 2.27 4.00 34.00 5.99 4.37 34.97 21.28 8.44 29.03 22.82 6.58 coo 40.63 7.13 9.06 35.85 7.36 8.95 36.26 25.44 11.74 39.65 23.12 16.29 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 31.69 27.40 -1.31 32.10 27.37 -3.38 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 8 3 # 8 B 182 LYS B 157 LYS^? 28.85 MG MG B 302 B 184 LYS B 166 LYS^? 22.75 MG MG B 301 B 345 ASP B 142 ASP^? 23.97 MG MG B 301 coo 38.76 2.27 4.00 34.00 5.99 4.37 34.97 21.28 8.44 29.03 22.82 6.58 coo 40.63 7.13 9.06 35.85 7.36 8.95 35.27 15.38 5.31 37.27 9.81 3.93 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 31.69 27.40 -1.31 32.10 27.37 -3.38 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 9 3 # 9 B 182 LYS C 6 LYS^? 25.73 MG MG C 302 B 184 LYS C 157 LYS^? 28.15 MG MG C 302 B 345 ASP C 138 ASP^? 33.43 MG MG C 302 coo 38.76 2.27 4.00 34.00 5.99 4.37 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 40.63 7.13 9.06 35.85 7.36 8.95 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 105.43 43.97 -13.30 104.85 43.08 -11.43 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 10 3 # 10 B 182 LYS C 157 LYS^? 28.15 MG MG C 302 B 184 LYS C 6 LYS^? 25.73 MG MG C 302 B 345 ASP C 138 ASP^? 33.43 MG MG C 302 coo 38.76 2.27 4.00 34.00 5.99 4.37 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 40.63 7.13 9.06 35.85 7.36 8.95 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 105.43 43.97 -13.30 104.85 43.08 -11.43 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 11 3 # 11 B 182 LYS C 157 LYS^? 28.15 MG MG C 302 B 184 LYS C 6 LYS^? 25.73 MG MG C 302 B 345 ASP C 142 ASP^? 23.76 MG MG C 301 coo 38.76 2.27 4.00 34.00 5.99 4.37 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 40.63 7.13 9.06 35.85 7.36 8.95 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 97.94 39.27 -5.03 98.08 38.70 -2.97 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 12 3 # 12 B 182 LYS C 157 LYS^? 28.15 MG MG C 302 B 184 LYS C 166 LYS^? 22.53 MG MG C 301 B 345 ASP C 142 ASP^? 23.76 MG MG C 301 coo 38.76 2.27 4.00 34.00 5.99 4.37 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 40.63 7.13 9.06 35.85 7.36 8.95 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 97.94 39.27 -5.03 98.08 38.70 -2.97 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 13 3 # 13 B 182 LYS D 157 LYS^? 28.67 MG MG D 302 B 184 LYS D 166 LYS^? 21.08 MG MG D 301 B 345 ASP D 142 ASP^? 23.49 MG MG D 301 coo 38.76 2.27 4.00 34.00 5.99 4.37 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 40.63 7.13 9.06 35.85 7.36 8.95 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 14 3 # 14 B 182 LYS E 6 LYS^? 25.59 MG MG E 302 B 184 LYS E 157 LYS^? 28.40 MG MG E 302 B 345 ASP E 138 ASP^? 33.31 MG MG E 302 coo 38.76 2.27 4.00 34.00 5.99 4.37 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 40.63 7.13 9.06 35.85 7.36 8.95 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 39.58 70.77 -58.63 40.74 70.78 -56.80 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 15 3 # 15 B 182 LYS E 157 LYS^? 28.40 MG MG E 302 B 184 LYS E 6 LYS^? 25.59 MG MG E 302 B 345 ASP E 138 ASP^? 33.31 MG MG E 302 coo 38.76 2.27 4.00 34.00 5.99 4.37 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 40.63 7.13 9.06 35.85 7.36 8.95 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 39.58 70.77 -58.63 40.74 70.78 -56.80 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 16 3 # 16 B 182 LYS E 157 LYS^? 28.40 MG MG E 302 B 184 LYS E 6 LYS^? 25.59 MG MG E 302 B 345 ASP E 142 ASP^? 23.66 MG MG E 301 coo 38.76 2.27 4.00 34.00 5.99 4.37 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 40.63 7.13 9.06 35.85 7.36 8.95 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 47.19 67.15 -50.37 47.44 67.18 -48.23 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 17 3 # 17 B 182 LYS E 157 LYS^? 28.40 MG MG E 302 B 184 LYS E 166 LYS^? 21.46 MG MG E 301 B 345 ASP E 142 ASP^? 23.66 MG MG E 301 coo 38.76 2.27 4.00 34.00 5.99 4.37 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 40.63 7.13 9.06 35.85 7.36 8.95 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 47.19 67.15 -50.37 47.44 67.18 -48.23 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 18 3 # 18 B 182 LYS F 6 LYS^? 26.09 MG MG F 301 B 184 LYS F 157 LYS^? 28.36 MG MG F 302 B 345 ASP F 138 ASP^? 33.51 MG MG F 302 coo 38.76 2.27 4.00 34.00 5.99 4.37 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 40.63 7.13 9.06 35.85 7.36 8.95 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 77.17 76.66 -81.48 76.14 76.33 -83.32 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 19 3 # 19 B 182 LYS F 157 LYS^? 28.36 MG MG F 302 B 184 LYS F 6 LYS^? 26.09 MG MG F 301 B 345 ASP F 138 ASP^? 33.51 MG MG F 302 coo 38.76 2.27 4.00 34.00 5.99 4.37 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 40.63 7.13 9.06 35.85 7.36 8.95 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 77.17 76.66 -81.48 76.14 76.33 -83.32 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 20 3 # 20 B 182 LYS F 157 LYS^? 28.36 MG MG F 302 B 184 LYS F 6 LYS^? 26.09 MG MG F 301 B 345 ASP F 142 ASP^? 23.43 MG MG F 302 coo 38.76 2.27 4.00 34.00 5.99 4.37 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 40.63 7.13 9.06 35.85 7.36 8.95 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 71.46 69.88 -89.76 71.03 69.93 -91.81 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 21 3 # 21 B 182 LYS F 157 LYS^? 28.36 MG MG F 302 B 184 LYS F 166 LYS^? 20.76 MG MG F 302 B 345 ASP F 142 ASP^? 23.43 MG MG F 302 coo 38.76 2.27 4.00 34.00 5.99 4.37 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 40.63 7.13 9.06 35.85 7.36 8.95 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 71.46 69.88 -89.76 71.03 69.93 -91.81 2dw7_c33 source 2dw7 BLL6730 PROTEIN : 21 hits 2dw7_c33 naa= 3 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 1 3 # 1 C 182 LYS A 6 LYS^? 25.88 MG MG A 301 C 184 LYS A 157 LYS^? 28.65 MG MG A 302 C 345 ASP A 138 ASP^? 33.08 MG MG A 302 coo -5.66 12.40 71.13 -2.66 9.98 66.50 46.20 12.82 24.71 44.50 16.64 20.52 coo 0.95 12.72 73.51 1.58 12.72 68.31 41.42 12.06 27.58 41.46 5.93 29.41 coo -4.59 24.28 66.67 -6.26 24.34 67.99 47.10 -0.97 29.63 45.89 0.22 30.96 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 2 3 # 2 C 182 LYS A 157 LYS^? 28.65 MG MG A 302 C 184 LYS A 6 LYS^? 25.88 MG MG A 301 C 345 ASP A 138 ASP^? 33.08 MG MG A 302 coo -5.66 12.40 71.13 -2.66 9.98 66.50 41.42 12.06 27.58 41.46 5.93 29.41 coo 0.95 12.72 73.51 1.58 12.72 68.31 46.20 12.82 24.71 44.50 16.64 20.52 coo -4.59 24.28 66.67 -6.26 24.34 67.99 47.10 -0.97 29.63 45.89 0.22 30.96 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 3 3 # 3 C 182 LYS A 157 LYS^? 28.65 MG MG A 302 C 184 LYS A 6 LYS^? 25.88 MG MG A 301 C 345 ASP A 142 ASP^? 23.70 MG MG A 302 coo -5.66 12.40 71.13 -2.66 9.98 66.50 41.42 12.06 27.58 41.46 5.93 29.41 coo 0.95 12.72 73.51 1.58 12.72 68.31 46.20 12.82 24.71 44.50 16.64 20.52 coo -4.59 24.28 66.67 -6.26 24.34 67.99 46.39 7.18 37.53 46.28 7.18 39.63 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 4 3 # 4 C 182 LYS A 157 LYS^? 28.65 MG MG A 302 C 184 LYS A 166 LYS^? 20.93 MG MG A 302 C 345 ASP A 142 ASP^? 23.70 MG MG A 302 coo -5.66 12.40 71.13 -2.66 9.98 66.50 41.42 12.06 27.58 41.46 5.93 29.41 coo 0.95 12.72 73.51 1.58 12.72 68.31 35.34 13.14 30.41 31.67 15.04 34.58 coo -4.59 24.28 66.67 -6.26 24.34 67.99 46.39 7.18 37.53 46.28 7.18 39.63 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 5 3 # 5 C 182 LYS A 157 LYS^? 28.65 MG MG A 302 C 184 LYS A 166 LYS^? 20.93 MG MG A 302 C 345 ASP A 160 ASP^? 31.61 MG MG B 302 coo -5.66 12.40 71.13 -2.66 9.98 66.50 41.42 12.06 27.58 41.46 5.93 29.41 coo 0.95 12.72 73.51 1.58 12.72 68.31 35.34 13.14 30.41 31.67 15.04 34.58 coo -4.59 24.28 66.67 -6.26 24.34 67.99 44.21 5.00 19.54 46.02 3.84 19.76 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 6 3 # 6 C 182 LYS B 6 LYS^? 25.90 MG MG B 302 C 184 LYS B 157 LYS^? 28.85 MG MG B 302 C 345 ASP B 138 ASP^? 33.32 MG MG B 302 coo -5.66 12.40 71.13 -2.66 9.98 66.50 36.26 25.44 11.74 39.65 23.12 16.29 coo 0.95 12.72 73.51 1.58 12.72 68.31 34.97 21.28 8.44 29.03 22.82 6.58 coo -4.59 24.28 66.67 -6.26 24.34 67.99 23.42 29.01 6.78 24.36 28.48 4.94 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 7 3 # 7 C 182 LYS B 157 LYS^? 28.85 MG MG B 302 C 184 LYS B 6 LYS^? 25.90 MG MG B 302 C 345 ASP B 138 ASP^? 33.32 MG MG B 302 coo -5.66 12.40 71.13 -2.66 9.98 66.50 34.97 21.28 8.44 29.03 22.82 6.58 coo 0.95 12.72 73.51 1.58 12.72 68.31 36.26 25.44 11.74 39.65 23.12 16.29 coo -4.59 24.28 66.67 -6.26 24.34 67.99 23.42 29.01 6.78 24.36 28.48 4.94 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 8 3 # 8 C 182 LYS B 157 LYS^? 28.85 MG MG B 302 C 184 LYS B 6 LYS^? 25.90 MG MG B 302 C 345 ASP B 142 ASP^? 23.97 MG MG B 301 coo -5.66 12.40 71.13 -2.66 9.98 66.50 34.97 21.28 8.44 29.03 22.82 6.58 coo 0.95 12.72 73.51 1.58 12.72 68.31 36.26 25.44 11.74 39.65 23.12 16.29 coo -4.59 24.28 66.67 -6.26 24.34 67.99 31.69 27.40 -1.31 32.10 27.37 -3.38 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 9 3 # 9 C 182 LYS B 157 LYS^? 28.85 MG MG B 302 C 184 LYS B 166 LYS^? 22.75 MG MG B 301 C 345 ASP B 142 ASP^? 23.97 MG MG B 301 coo -5.66 12.40 71.13 -2.66 9.98 66.50 34.97 21.28 8.44 29.03 22.82 6.58 coo 0.95 12.72 73.51 1.58 12.72 68.31 35.27 15.38 5.31 37.27 9.81 3.93 coo -4.59 24.28 66.67 -6.26 24.34 67.99 31.69 27.40 -1.31 32.10 27.37 -3.38 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 10 3 # 10 C 182 LYS B 157 LYS^? 28.85 MG MG B 302 C 184 LYS B 166 LYS^? 22.75 MG MG B 301 C 345 ASP B 160 ASP^? 31.65 MG MG A 301 coo -5.66 12.40 71.13 -2.66 9.98 66.50 34.97 21.28 8.44 29.03 22.82 6.58 coo 0.95 12.72 73.51 1.58 12.72 68.31 35.27 15.38 5.31 37.27 9.81 3.93 coo -4.59 24.28 66.67 -6.26 24.34 67.99 28.01 24.83 16.38 27.44 26.81 15.80 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 11 3 # 11 C 182 LYS C 157 LYS^? 28.15 MG MG C 302 C 184 LYS C 6 LYS^? 25.73 MG MG C 302 C 345 ASP C 138 ASP^? 33.43 MG MG C 302 coo -5.66 12.40 71.13 -2.66 9.98 66.50 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 0.95 12.72 73.51 1.58 12.72 68.31 94.42 35.68 -18.56 92.21 32.03 -23.05 coo -4.59 24.28 66.67 -6.26 24.34 67.99 105.43 43.97 -13.30 104.85 43.08 -11.43 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 12 3 # 12 C 182 LYS C 157 LYS^? 28.15 MG MG C 302 C 184 LYS C 6 LYS^? 25.73 MG MG C 302 C 345 ASP C 142 ASP^? 23.76 MG MG C 301 coo -5.66 12.40 71.13 -2.66 9.98 66.50 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 0.95 12.72 73.51 1.58 12.72 68.31 94.42 35.68 -18.56 92.21 32.03 -23.05 coo -4.59 24.28 66.67 -6.26 24.34 67.99 97.94 39.27 -5.03 98.08 38.70 -2.97 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 13 3 # 13 C 182 LYS C 157 LYS^? 28.15 MG MG C 302 C 184 LYS C 166 LYS^? 22.53 MG MG C 301 C 345 ASP C 142 ASP^? 23.76 MG MG C 301 coo -5.66 12.40 71.13 -2.66 9.98 66.50 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 0.95 12.72 73.51 1.58 12.72 68.31 99.24 26.71 -12.25 100.23 21.90 -8.99 coo -4.59 24.28 66.67 -6.26 24.34 67.99 97.94 39.27 -5.03 98.08 38.70 -2.97 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 14 3 # 14 C 182 LYS C 157 LYS^? 28.15 MG MG C 302 C 184 LYS C 166 LYS^? 22.53 MG MG C 301 C 345 ASP C 160 ASP^? 31.63 MG MG D 302 coo -5.66 12.40 71.13 -2.66 9.98 66.50 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 0.95 12.72 73.51 1.58 12.72 68.31 99.24 26.71 -12.25 100.23 21.90 -8.99 coo -4.59 24.28 66.67 -6.26 24.34 67.99 102.50 38.00 -23.28 102.43 39.97 -22.46 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 15 3 # 15 C 182 LYS D 6 LYS^? 25.98 MG MG D 302 C 184 LYS D 157 LYS^? 28.67 MG MG D 302 C 345 ASP D 138 ASP^? 33.64 MG MG D 302 coo -5.66 12.40 71.13 -2.66 9.98 66.50 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 0.95 12.72 73.51 1.58 12.72 68.31 94.17 21.71 -34.34 96.11 15.89 -35.92 coo -4.59 24.28 66.67 -6.26 24.34 67.99 93.00 7.50 -35.79 93.88 8.48 -37.45 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 16 3 # 16 C 182 LYS D 6 LYS^? 25.98 MG MG D 302 C 184 LYS D 157 LYS^? 28.67 MG MG D 302 C 345 ASP D 142 ASP^? 23.49 MG MG D 301 coo -5.66 12.40 71.13 -2.66 9.98 66.50 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 0.95 12.72 73.51 1.58 12.72 68.31 94.17 21.71 -34.34 96.11 15.89 -35.92 coo -4.59 24.28 66.67 -6.26 24.34 67.99 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 17 3 # 17 C 182 LYS D 157 LYS^? 28.67 MG MG D 302 C 184 LYS D 6 LYS^? 25.98 MG MG D 302 C 345 ASP D 138 ASP^? 33.64 MG MG D 302 coo -5.66 12.40 71.13 -2.66 9.98 66.50 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 0.95 12.72 73.51 1.58 12.72 68.31 89.78 20.68 -31.57 90.15 24.89 -27.02 coo -4.59 24.28 66.67 -6.26 24.34 67.99 93.00 7.50 -35.79 93.88 8.48 -37.45 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 18 3 # 18 C 182 LYS D 157 LYS^? 28.67 MG MG D 302 C 184 LYS D 6 LYS^? 25.98 MG MG D 302 C 345 ASP D 142 ASP^? 23.49 MG MG D 301 coo -5.66 12.40 71.13 -2.66 9.98 66.50 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 0.95 12.72 73.51 1.58 12.72 68.31 89.78 20.68 -31.57 90.15 24.89 -27.02 coo -4.59 24.28 66.67 -6.26 24.34 67.99 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 19 3 # 19 C 182 LYS D 157 LYS^? 28.67 MG MG D 302 C 184 LYS D 166 LYS^? 21.08 MG MG D 301 C 345 ASP D 142 ASP^? 23.49 MG MG D 301 coo -5.66 12.40 71.13 -2.66 9.98 66.50 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 0.95 12.72 73.51 1.58 12.72 68.31 99.23 24.85 -37.31 101.73 27.34 -42.07 coo -4.59 24.28 66.67 -6.26 24.34 67.99 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 20 3 # 20 C 182 LYS D 157 LYS^? 28.67 MG MG D 302 C 184 LYS D 166 LYS^? 21.08 MG MG D 301 C 345 ASP D 160 ASP^? 31.45 MG MG C 302 coo -5.66 12.40 71.13 -2.66 9.98 66.50 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 0.95 12.72 73.51 1.58 12.72 68.31 99.23 24.85 -37.31 101.73 27.34 -42.07 coo -4.59 24.28 66.67 -6.26 24.34 67.99 94.15 13.98 -26.57 92.71 12.42 -26.99 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 21 3 # 21 C 182 LYS D 166 LYS^? 21.08 MG MG D 301 C 184 LYS D 157 LYS^? 28.67 MG MG D 302 C 345 ASP D 142 ASP^? 23.49 MG MG D 301 coo -5.66 12.40 71.13 -2.66 9.98 66.50 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 0.95 12.72 73.51 1.58 12.72 68.31 94.17 21.71 -34.34 96.11 15.89 -35.92 coo -4.59 24.28 66.67 -6.26 24.34 67.99 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 22 3 # 22 C 182 LYS E 6 LYS^? 25.59 MG MG E 302 C 184 LYS E 157 LYS^? 28.40 MG MG E 302 C 345 ASP E 138 ASP^? 33.31 MG MG E 302 coo -5.66 12.40 71.13 -2.66 9.98 66.50 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 0.95 12.72 73.51 1.58 12.72 68.31 53.63 69.16 -60.42 48.34 71.81 -58.40 coo -4.59 24.28 66.67 -6.26 24.34 67.99 39.58 70.77 -58.63 40.74 70.78 -56.80 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 23 3 # 23 C 182 LYS E 157 LYS^? 28.40 MG MG E 302 C 184 LYS E 6 LYS^? 25.59 MG MG E 302 C 345 ASP E 138 ASP^? 33.31 MG MG E 302 coo -5.66 12.40 71.13 -2.66 9.98 66.50 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 0.95 12.72 73.51 1.58 12.72 68.31 51.95 64.70 -63.33 56.16 64.03 -67.52 coo -4.59 24.28 66.67 -6.26 24.34 67.99 39.58 70.77 -58.63 40.74 70.78 -56.80 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 24 3 # 24 C 182 LYS E 157 LYS^? 28.40 MG MG E 302 C 184 LYS E 6 LYS^? 25.59 MG MG E 302 C 345 ASP E 142 ASP^? 23.66 MG MG E 301 coo -5.66 12.40 71.13 -2.66 9.98 66.50 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 0.95 12.72 73.51 1.58 12.72 68.31 51.95 64.70 -63.33 56.16 64.03 -67.52 coo -4.59 24.28 66.67 -6.26 24.34 67.99 47.19 67.15 -50.37 47.44 67.18 -48.23 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 25 3 # 25 C 182 LYS E 157 LYS^? 28.40 MG MG E 302 C 184 LYS E 166 LYS^? 21.46 MG MG E 301 C 345 ASP E 142 ASP^? 23.66 MG MG E 301 coo -5.66 12.40 71.13 -2.66 9.98 66.50 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 0.95 12.72 73.51 1.58 12.72 68.31 57.66 73.57 -57.60 60.27 76.17 -53.59 coo -4.59 24.28 66.67 -6.26 24.34 67.99 47.19 67.15 -50.37 47.44 67.18 -48.23 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 26 3 # 26 C 182 LYS E 157 LYS^? 28.40 MG MG E 302 C 184 LYS E 166 LYS^? 21.46 MG MG E 301 C 345 ASP E 160 ASP^? 31.54 MG MG F 301 coo -5.66 12.40 71.13 -2.66 9.98 66.50 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 0.95 12.72 73.51 1.58 12.72 68.31 57.66 73.57 -57.60 60.27 76.17 -53.59 coo -4.59 24.28 66.67 -6.26 24.34 67.99 45.81 70.00 -68.45 44.10 68.87 -67.77 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 27 3 # 27 C 182 LYS F 6 LYS^? 26.09 MG MG F 301 C 184 LYS F 157 LYS^? 28.36 MG MG F 302 C 345 ASP F 138 ASP^? 33.51 MG MG F 302 coo -5.66 12.40 71.13 -2.66 9.98 66.50 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 0.95 12.72 73.51 1.58 12.72 68.31 64.43 70.47 -79.54 68.32 74.80 -81.65 coo -4.59 24.28 66.67 -6.26 24.34 67.99 77.17 76.66 -81.48 76.14 76.33 -83.32 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 28 3 # 28 C 182 LYS F 157 LYS^? 28.36 MG MG F 302 C 184 LYS F 6 LYS^? 26.09 MG MG F 301 C 345 ASP F 138 ASP^? 33.51 MG MG F 302 coo -5.66 12.40 71.13 -2.66 9.98 66.50 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 0.95 12.72 73.51 1.58 12.72 68.31 67.53 67.03 -76.43 64.05 65.33 -71.86 coo -4.59 24.28 66.67 -6.26 24.34 67.99 77.17 76.66 -81.48 76.14 76.33 -83.32 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 29 3 # 29 C 182 LYS F 157 LYS^? 28.36 MG MG F 302 C 184 LYS F 6 LYS^? 26.09 MG MG F 301 C 345 ASP F 142 ASP^? 23.43 MG MG F 302 coo -5.66 12.40 71.13 -2.66 9.98 66.50 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 0.95 12.72 73.51 1.58 12.72 68.31 67.53 67.03 -76.43 64.05 65.33 -71.86 coo -4.59 24.28 66.67 -6.26 24.34 67.99 71.46 69.88 -89.76 71.03 69.93 -91.81 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 30 3 # 30 C 182 LYS F 157 LYS^? 28.36 MG MG F 302 C 184 LYS F 166 LYS^? 20.76 MG MG F 302 C 345 ASP F 142 ASP^? 23.43 MG MG F 302 coo -5.66 12.40 71.13 -2.66 9.98 66.50 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 0.95 12.72 73.51 1.58 12.72 68.31 59.28 73.05 -82.63 55.63 74.15 -86.94 coo -4.59 24.28 66.67 -6.26 24.34 67.99 71.46 69.88 -89.76 71.03 69.93 -91.81 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 31 3 # 31 C 182 LYS F 157 LYS^? 28.36 MG MG F 302 C 184 LYS F 166 LYS^? 20.76 MG MG F 302 C 345 ASP F 160 ASP^? 31.59 MG MG E 302 coo -5.66 12.40 71.13 -2.66 9.98 66.50 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 0.95 12.72 73.51 1.58 12.72 68.31 59.28 73.05 -82.63 55.63 74.15 -86.94 coo -4.59 24.28 66.67 -6.26 24.34 67.99 71.27 74.59 -71.77 73.23 74.02 -72.37 2dw7_c34 source 2dw7 BLL6730 PROTEIN : 31 hits 2dw7_c34 naa= 3 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 1 3 # 1 D 182 LYS A 157 LYS^? 28.65 MG MG A 302 D 184 LYS A 6 LYS^? 25.88 MG MG A 301 D 345 ASP A 138 ASP^? 33.08 MG MG A 302 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 41.42 12.06 27.58 41.46 5.93 29.41 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 46.20 12.82 24.71 44.50 16.64 20.52 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 47.10 -0.97 29.63 45.89 0.22 30.96 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 2 3 # 2 D 182 LYS A 157 LYS^? 28.65 MG MG A 302 D 184 LYS A 6 LYS^? 25.88 MG MG A 301 D 345 ASP A 142 ASP^? 23.70 MG MG A 302 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 41.42 12.06 27.58 41.46 5.93 29.41 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 46.20 12.82 24.71 44.50 16.64 20.52 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 46.39 7.18 37.53 46.28 7.18 39.63 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 3 3 # 3 D 182 LYS A 157 LYS^? 28.65 MG MG A 302 D 184 LYS A 166 LYS^? 20.93 MG MG A 302 D 345 ASP A 142 ASP^? 23.70 MG MG A 302 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 41.42 12.06 27.58 41.46 5.93 29.41 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 35.34 13.14 30.41 31.67 15.04 34.58 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 46.39 7.18 37.53 46.28 7.18 39.63 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 4 3 # 4 D 182 LYS A 157 LYS^? 28.65 MG MG A 302 D 184 LYS A 166 LYS^? 20.93 MG MG A 302 D 345 ASP A 160 ASP^? 31.61 MG MG B 302 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 41.42 12.06 27.58 41.46 5.93 29.41 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 35.34 13.14 30.41 31.67 15.04 34.58 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 44.21 5.00 19.54 46.02 3.84 19.76 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 5 3 # 5 D 182 LYS B 6 LYS^? 25.90 MG MG B 302 D 184 LYS B 157 LYS^? 28.85 MG MG B 302 D 345 ASP B 138 ASP^? 33.32 MG MG B 302 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 36.26 25.44 11.74 39.65 23.12 16.29 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 34.97 21.28 8.44 29.03 22.82 6.58 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 23.42 29.01 6.78 24.36 28.48 4.94 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 6 3 # 6 D 182 LYS B 157 LYS^? 28.85 MG MG B 302 D 184 LYS B 6 LYS^? 25.90 MG MG B 302 D 345 ASP B 138 ASP^? 33.32 MG MG B 302 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 34.97 21.28 8.44 29.03 22.82 6.58 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 36.26 25.44 11.74 39.65 23.12 16.29 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 23.42 29.01 6.78 24.36 28.48 4.94 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 7 3 # 7 D 182 LYS B 157 LYS^? 28.85 MG MG B 302 D 184 LYS B 6 LYS^? 25.90 MG MG B 302 D 345 ASP B 142 ASP^? 23.97 MG MG B 301 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 34.97 21.28 8.44 29.03 22.82 6.58 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 36.26 25.44 11.74 39.65 23.12 16.29 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 31.69 27.40 -1.31 32.10 27.37 -3.38 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 8 3 # 8 D 182 LYS B 157 LYS^? 28.85 MG MG B 302 D 184 LYS B 166 LYS^? 22.75 MG MG B 301 D 345 ASP B 142 ASP^? 23.97 MG MG B 301 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 34.97 21.28 8.44 29.03 22.82 6.58 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 35.27 15.38 5.31 37.27 9.81 3.93 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 31.69 27.40 -1.31 32.10 27.37 -3.38 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 9 3 # 9 D 182 LYS B 157 LYS^? 28.85 MG MG B 302 D 184 LYS B 166 LYS^? 22.75 MG MG B 301 D 345 ASP B 160 ASP^? 31.65 MG MG A 301 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 34.97 21.28 8.44 29.03 22.82 6.58 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 35.27 15.38 5.31 37.27 9.81 3.93 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 28.01 24.83 16.38 27.44 26.81 15.80 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 10 3 # 10 D 182 LYS C 157 LYS^? 28.15 MG MG C 302 D 184 LYS C 6 LYS^? 25.73 MG MG C 302 D 345 ASP C 138 ASP^? 33.43 MG MG C 302 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 105.43 43.97 -13.30 104.85 43.08 -11.43 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 11 3 # 11 D 182 LYS C 157 LYS^? 28.15 MG MG C 302 D 184 LYS C 6 LYS^? 25.73 MG MG C 302 D 345 ASP C 142 ASP^? 23.76 MG MG C 301 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 97.94 39.27 -5.03 98.08 38.70 -2.97 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 12 3 # 12 D 182 LYS C 157 LYS^? 28.15 MG MG C 302 D 184 LYS C 166 LYS^? 22.53 MG MG C 301 D 345 ASP C 142 ASP^? 23.76 MG MG C 301 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 97.94 39.27 -5.03 98.08 38.70 -2.97 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 13 3 # 13 D 182 LYS C 157 LYS^? 28.15 MG MG C 302 D 184 LYS C 166 LYS^? 22.53 MG MG C 301 D 345 ASP C 160 ASP^? 31.63 MG MG D 302 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 102.50 38.00 -23.28 102.43 39.97 -22.46 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 14 3 # 14 D 182 LYS D 6 LYS^? 25.98 MG MG D 302 D 184 LYS D 157 LYS^? 28.67 MG MG D 302 D 345 ASP D 138 ASP^? 33.64 MG MG D 302 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 93.00 7.50 -35.79 93.88 8.48 -37.45 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 15 3 # 15 D 182 LYS D 6 LYS^? 25.98 MG MG D 302 D 184 LYS D 157 LYS^? 28.67 MG MG D 302 D 345 ASP D 142 ASP^? 23.49 MG MG D 301 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 16 3 # 16 D 182 LYS D 157 LYS^? 28.67 MG MG D 302 D 184 LYS D 6 LYS^? 25.98 MG MG D 302 D 345 ASP D 138 ASP^? 33.64 MG MG D 302 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 93.00 7.50 -35.79 93.88 8.48 -37.45 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 17 3 # 17 D 182 LYS D 157 LYS^? 28.67 MG MG D 302 D 184 LYS D 6 LYS^? 25.98 MG MG D 302 D 345 ASP D 142 ASP^? 23.49 MG MG D 301 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 18 3 # 18 D 182 LYS D 157 LYS^? 28.67 MG MG D 302 D 184 LYS D 166 LYS^? 21.08 MG MG D 301 D 345 ASP D 142 ASP^? 23.49 MG MG D 301 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 19 3 # 19 D 182 LYS D 157 LYS^? 28.67 MG MG D 302 D 184 LYS D 166 LYS^? 21.08 MG MG D 301 D 345 ASP D 160 ASP^? 31.45 MG MG C 302 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 94.15 13.98 -26.57 92.71 12.42 -26.99 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 20 3 # 20 D 182 LYS E 157 LYS^? 28.40 MG MG E 302 D 184 LYS E 6 LYS^? 25.59 MG MG E 302 D 345 ASP E 138 ASP^? 33.31 MG MG E 302 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 39.58 70.77 -58.63 40.74 70.78 -56.80 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 21 3 # 21 D 182 LYS E 157 LYS^? 28.40 MG MG E 302 D 184 LYS E 6 LYS^? 25.59 MG MG E 302 D 345 ASP E 142 ASP^? 23.66 MG MG E 301 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 47.19 67.15 -50.37 47.44 67.18 -48.23 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 22 3 # 22 D 182 LYS E 157 LYS^? 28.40 MG MG E 302 D 184 LYS E 166 LYS^? 21.46 MG MG E 301 D 345 ASP E 142 ASP^? 23.66 MG MG E 301 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 47.19 67.15 -50.37 47.44 67.18 -48.23 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 23 3 # 23 D 182 LYS E 157 LYS^? 28.40 MG MG E 302 D 184 LYS E 166 LYS^? 21.46 MG MG E 301 D 345 ASP E 160 ASP^? 31.54 MG MG F 301 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 45.81 70.00 -68.45 44.10 68.87 -67.77 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 24 3 # 24 D 182 LYS F 157 LYS^? 28.36 MG MG F 302 D 184 LYS F 6 LYS^? 26.09 MG MG F 301 D 345 ASP F 138 ASP^? 33.51 MG MG F 302 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 77.17 76.66 -81.48 76.14 76.33 -83.32 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 25 3 # 25 D 182 LYS F 157 LYS^? 28.36 MG MG F 302 D 184 LYS F 6 LYS^? 26.09 MG MG F 301 D 345 ASP F 142 ASP^? 23.43 MG MG F 302 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 71.46 69.88 -89.76 71.03 69.93 -91.81 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 26 3 # 26 D 182 LYS F 157 LYS^? 28.36 MG MG F 302 D 184 LYS F 166 LYS^? 20.76 MG MG F 302 D 345 ASP F 142 ASP^? 23.43 MG MG F 302 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 71.46 69.88 -89.76 71.03 69.93 -91.81 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 27 3 # 27 D 182 LYS F 157 LYS^? 28.36 MG MG F 302 D 184 LYS F 166 LYS^? 20.76 MG MG F 302 D 345 ASP F 160 ASP^? 31.59 MG MG E 302 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 71.27 74.59 -71.77 73.23 74.02 -72.37 2dw7_c35 source 2dw7 BLL6730 PROTEIN : 27 hits 2dw7_c35 naa= 3 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 1 3 # 1 E 182 LYS A 157 LYS^? 28.65 MG MG A 302 E 184 LYS A 6 LYS^? 25.88 MG MG A 301 E 345 ASP A 138 ASP^? 33.08 MG MG A 302 coo -21.16 62.58 121.86 -16.35 60.33 119.23 41.42 12.06 27.58 41.46 5.93 29.41 coo -23.22 55.98 120.74 -18.11 55.31 120.43 46.20 12.82 24.71 44.50 16.64 20.52 coo -17.15 59.71 133.33 -17.96 61.54 134.01 47.10 -0.97 29.63 45.89 0.22 30.96 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 2 3 # 2 E 182 LYS A 157 LYS^? 28.65 MG MG A 302 E 184 LYS A 6 LYS^? 25.88 MG MG A 301 E 345 ASP A 142 ASP^? 23.70 MG MG A 302 coo -21.16 62.58 121.86 -16.35 60.33 119.23 41.42 12.06 27.58 41.46 5.93 29.41 coo -23.22 55.98 120.74 -18.11 55.31 120.43 46.20 12.82 24.71 44.50 16.64 20.52 coo -17.15 59.71 133.33 -17.96 61.54 134.01 46.39 7.18 37.53 46.28 7.18 39.63 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 3 3 # 3 E 182 LYS A 157 LYS^? 28.65 MG MG A 302 E 184 LYS A 166 LYS^? 20.93 MG MG A 302 E 345 ASP A 142 ASP^? 23.70 MG MG A 302 coo -21.16 62.58 121.86 -16.35 60.33 119.23 41.42 12.06 27.58 41.46 5.93 29.41 coo -23.22 55.98 120.74 -18.11 55.31 120.43 35.34 13.14 30.41 31.67 15.04 34.58 coo -17.15 59.71 133.33 -17.96 61.54 134.01 46.39 7.18 37.53 46.28 7.18 39.63 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 4 3 # 4 E 182 LYS A 157 LYS^? 28.65 MG MG A 302 E 184 LYS A 166 LYS^? 20.93 MG MG A 302 E 345 ASP A 160 ASP^? 31.61 MG MG B 302 coo -21.16 62.58 121.86 -16.35 60.33 119.23 41.42 12.06 27.58 41.46 5.93 29.41 coo -23.22 55.98 120.74 -18.11 55.31 120.43 35.34 13.14 30.41 31.67 15.04 34.58 coo -17.15 59.71 133.33 -17.96 61.54 134.01 44.21 5.00 19.54 46.02 3.84 19.76 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 5 3 # 5 E 182 LYS B 6 LYS^? 25.90 MG MG B 302 E 184 LYS B 157 LYS^? 28.85 MG MG B 302 E 345 ASP B 138 ASP^? 33.32 MG MG B 302 coo -21.16 62.58 121.86 -16.35 60.33 119.23 36.26 25.44 11.74 39.65 23.12 16.29 coo -23.22 55.98 120.74 -18.11 55.31 120.43 34.97 21.28 8.44 29.03 22.82 6.58 coo -17.15 59.71 133.33 -17.96 61.54 134.01 23.42 29.01 6.78 24.36 28.48 4.94 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 6 3 # 6 E 182 LYS B 157 LYS^? 28.85 MG MG B 302 E 184 LYS B 6 LYS^? 25.90 MG MG B 302 E 345 ASP B 138 ASP^? 33.32 MG MG B 302 coo -21.16 62.58 121.86 -16.35 60.33 119.23 34.97 21.28 8.44 29.03 22.82 6.58 coo -23.22 55.98 120.74 -18.11 55.31 120.43 36.26 25.44 11.74 39.65 23.12 16.29 coo -17.15 59.71 133.33 -17.96 61.54 134.01 23.42 29.01 6.78 24.36 28.48 4.94 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 7 3 # 7 E 182 LYS B 157 LYS^? 28.85 MG MG B 302 E 184 LYS B 6 LYS^? 25.90 MG MG B 302 E 345 ASP B 142 ASP^? 23.97 MG MG B 301 coo -21.16 62.58 121.86 -16.35 60.33 119.23 34.97 21.28 8.44 29.03 22.82 6.58 coo -23.22 55.98 120.74 -18.11 55.31 120.43 36.26 25.44 11.74 39.65 23.12 16.29 coo -17.15 59.71 133.33 -17.96 61.54 134.01 31.69 27.40 -1.31 32.10 27.37 -3.38 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 8 3 # 8 E 182 LYS B 157 LYS^? 28.85 MG MG B 302 E 184 LYS B 166 LYS^? 22.75 MG MG B 301 E 345 ASP B 142 ASP^? 23.97 MG MG B 301 coo -21.16 62.58 121.86 -16.35 60.33 119.23 34.97 21.28 8.44 29.03 22.82 6.58 coo -23.22 55.98 120.74 -18.11 55.31 120.43 35.27 15.38 5.31 37.27 9.81 3.93 coo -17.15 59.71 133.33 -17.96 61.54 134.01 31.69 27.40 -1.31 32.10 27.37 -3.38 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 9 3 # 9 E 182 LYS B 157 LYS^? 28.85 MG MG B 302 E 184 LYS B 166 LYS^? 22.75 MG MG B 301 E 345 ASP B 160 ASP^? 31.65 MG MG A 301 coo -21.16 62.58 121.86 -16.35 60.33 119.23 34.97 21.28 8.44 29.03 22.82 6.58 coo -23.22 55.98 120.74 -18.11 55.31 120.43 35.27 15.38 5.31 37.27 9.81 3.93 coo -17.15 59.71 133.33 -17.96 61.54 134.01 28.01 24.83 16.38 27.44 26.81 15.80 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 10 3 # 10 E 182 LYS C 157 LYS^? 28.15 MG MG C 302 E 184 LYS C 6 LYS^? 25.73 MG MG C 302 E 345 ASP C 138 ASP^? 33.43 MG MG C 302 coo -21.16 62.58 121.86 -16.35 60.33 119.23 97.55 32.04 -15.10 101.49 36.24 -13.39 coo -23.22 55.98 120.74 -18.11 55.31 120.43 94.42 35.68 -18.56 92.21 32.03 -23.05 coo -17.15 59.71 133.33 -17.96 61.54 134.01 105.43 43.97 -13.30 104.85 43.08 -11.43 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 11 3 # 11 E 182 LYS C 157 LYS^? 28.15 MG MG C 302 E 184 LYS C 6 LYS^? 25.73 MG MG C 302 E 345 ASP C 142 ASP^? 23.76 MG MG C 301 coo -21.16 62.58 121.86 -16.35 60.33 119.23 97.55 32.04 -15.10 101.49 36.24 -13.39 coo -23.22 55.98 120.74 -18.11 55.31 120.43 94.42 35.68 -18.56 92.21 32.03 -23.05 coo -17.15 59.71 133.33 -17.96 61.54 134.01 97.94 39.27 -5.03 98.08 38.70 -2.97 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 12 3 # 12 E 182 LYS C 157 LYS^? 28.15 MG MG C 302 E 184 LYS C 166 LYS^? 22.53 MG MG C 301 E 345 ASP C 142 ASP^? 23.76 MG MG C 301 coo -21.16 62.58 121.86 -16.35 60.33 119.23 97.55 32.04 -15.10 101.49 36.24 -13.39 coo -23.22 55.98 120.74 -18.11 55.31 120.43 99.24 26.71 -12.25 100.23 21.90 -8.99 coo -17.15 59.71 133.33 -17.96 61.54 134.01 97.94 39.27 -5.03 98.08 38.70 -2.97 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 13 3 # 13 E 182 LYS C 157 LYS^? 28.15 MG MG C 302 E 184 LYS C 166 LYS^? 22.53 MG MG C 301 E 345 ASP C 160 ASP^? 31.63 MG MG D 302 coo -21.16 62.58 121.86 -16.35 60.33 119.23 97.55 32.04 -15.10 101.49 36.24 -13.39 coo -23.22 55.98 120.74 -18.11 55.31 120.43 99.24 26.71 -12.25 100.23 21.90 -8.99 coo -17.15 59.71 133.33 -17.96 61.54 134.01 102.50 38.00 -23.28 102.43 39.97 -22.46 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 14 3 # 14 E 182 LYS D 6 LYS^? 25.98 MG MG D 302 E 184 LYS D 157 LYS^? 28.67 MG MG D 302 E 345 ASP D 138 ASP^? 33.64 MG MG D 302 coo -21.16 62.58 121.86 -16.35 60.33 119.23 89.78 20.68 -31.57 90.15 24.89 -27.02 coo -23.22 55.98 120.74 -18.11 55.31 120.43 94.17 21.71 -34.34 96.11 15.89 -35.92 coo -17.15 59.71 133.33 -17.96 61.54 134.01 93.00 7.50 -35.79 93.88 8.48 -37.45 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 15 3 # 15 E 182 LYS D 6 LYS^? 25.98 MG MG D 302 E 184 LYS D 157 LYS^? 28.67 MG MG D 302 E 345 ASP D 142 ASP^? 23.49 MG MG D 301 coo -21.16 62.58 121.86 -16.35 60.33 119.23 89.78 20.68 -31.57 90.15 24.89 -27.02 coo -23.22 55.98 120.74 -18.11 55.31 120.43 94.17 21.71 -34.34 96.11 15.89 -35.92 coo -17.15 59.71 133.33 -17.96 61.54 134.01 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 16 3 # 16 E 182 LYS D 157 LYS^? 28.67 MG MG D 302 E 184 LYS D 6 LYS^? 25.98 MG MG D 302 E 345 ASP D 138 ASP^? 33.64 MG MG D 302 coo -21.16 62.58 121.86 -16.35 60.33 119.23 94.17 21.71 -34.34 96.11 15.89 -35.92 coo -23.22 55.98 120.74 -18.11 55.31 120.43 89.78 20.68 -31.57 90.15 24.89 -27.02 coo -17.15 59.71 133.33 -17.96 61.54 134.01 93.00 7.50 -35.79 93.88 8.48 -37.45 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 17 3 # 17 E 182 LYS D 157 LYS^? 28.67 MG MG D 302 E 184 LYS D 6 LYS^? 25.98 MG MG D 302 E 345 ASP D 142 ASP^? 23.49 MG MG D 301 coo -21.16 62.58 121.86 -16.35 60.33 119.23 94.17 21.71 -34.34 96.11 15.89 -35.92 coo -23.22 55.98 120.74 -18.11 55.31 120.43 89.78 20.68 -31.57 90.15 24.89 -27.02 coo -17.15 59.71 133.33 -17.96 61.54 134.01 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 18 3 # 18 E 182 LYS D 157 LYS^? 28.67 MG MG D 302 E 184 LYS D 166 LYS^? 21.08 MG MG D 301 E 345 ASP D 142 ASP^? 23.49 MG MG D 301 coo -21.16 62.58 121.86 -16.35 60.33 119.23 94.17 21.71 -34.34 96.11 15.89 -35.92 coo -23.22 55.98 120.74 -18.11 55.31 120.43 99.23 24.85 -37.31 101.73 27.34 -42.07 coo -17.15 59.71 133.33 -17.96 61.54 134.01 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 19 3 # 19 E 182 LYS D 157 LYS^? 28.67 MG MG D 302 E 184 LYS D 166 LYS^? 21.08 MG MG D 301 E 345 ASP D 160 ASP^? 31.45 MG MG C 302 coo -21.16 62.58 121.86 -16.35 60.33 119.23 94.17 21.71 -34.34 96.11 15.89 -35.92 coo -23.22 55.98 120.74 -18.11 55.31 120.43 99.23 24.85 -37.31 101.73 27.34 -42.07 coo -17.15 59.71 133.33 -17.96 61.54 134.01 94.15 13.98 -26.57 92.71 12.42 -26.99 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 20 3 # 20 E 182 LYS E 157 LYS^? 28.40 MG MG E 302 E 184 LYS E 6 LYS^? 25.59 MG MG E 302 E 345 ASP E 138 ASP^? 33.31 MG MG E 302 coo -21.16 62.58 121.86 -16.35 60.33 119.23 53.63 69.16 -60.42 48.34 71.81 -58.40 coo -23.22 55.98 120.74 -18.11 55.31 120.43 51.95 64.70 -63.33 56.16 64.03 -67.52 coo -17.15 59.71 133.33 -17.96 61.54 134.01 39.58 70.77 -58.63 40.74 70.78 -56.80 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 21 3 # 21 E 182 LYS E 157 LYS^? 28.40 MG MG E 302 E 184 LYS E 6 LYS^? 25.59 MG MG E 302 E 345 ASP E 142 ASP^? 23.66 MG MG E 301 coo -21.16 62.58 121.86 -16.35 60.33 119.23 53.63 69.16 -60.42 48.34 71.81 -58.40 coo -23.22 55.98 120.74 -18.11 55.31 120.43 51.95 64.70 -63.33 56.16 64.03 -67.52 coo -17.15 59.71 133.33 -17.96 61.54 134.01 47.19 67.15 -50.37 47.44 67.18 -48.23 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 22 3 # 22 E 182 LYS E 157 LYS^? 28.40 MG MG E 302 E 184 LYS E 166 LYS^? 21.46 MG MG E 301 E 345 ASP E 142 ASP^? 23.66 MG MG E 301 coo -21.16 62.58 121.86 -16.35 60.33 119.23 53.63 69.16 -60.42 48.34 71.81 -58.40 coo -23.22 55.98 120.74 -18.11 55.31 120.43 57.66 73.57 -57.60 60.27 76.17 -53.59 coo -17.15 59.71 133.33 -17.96 61.54 134.01 47.19 67.15 -50.37 47.44 67.18 -48.23 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 23 3 # 23 E 182 LYS E 157 LYS^? 28.40 MG MG E 302 E 184 LYS E 166 LYS^? 21.46 MG MG E 301 E 345 ASP E 160 ASP^? 31.54 MG MG F 301 coo -21.16 62.58 121.86 -16.35 60.33 119.23 53.63 69.16 -60.42 48.34 71.81 -58.40 coo -23.22 55.98 120.74 -18.11 55.31 120.43 57.66 73.57 -57.60 60.27 76.17 -53.59 coo -17.15 59.71 133.33 -17.96 61.54 134.01 45.81 70.00 -68.45 44.10 68.87 -67.77 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 24 3 # 24 E 182 LYS F 157 LYS^? 28.36 MG MG F 302 E 184 LYS F 6 LYS^? 26.09 MG MG F 301 E 345 ASP F 138 ASP^? 33.51 MG MG F 302 coo -21.16 62.58 121.86 -16.35 60.33 119.23 64.43 70.47 -79.54 68.32 74.80 -81.65 coo -23.22 55.98 120.74 -18.11 55.31 120.43 67.53 67.03 -76.43 64.05 65.33 -71.86 coo -17.15 59.71 133.33 -17.96 61.54 134.01 77.17 76.66 -81.48 76.14 76.33 -83.32 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 25 3 # 25 E 182 LYS F 157 LYS^? 28.36 MG MG F 302 E 184 LYS F 6 LYS^? 26.09 MG MG F 301 E 345 ASP F 142 ASP^? 23.43 MG MG F 302 coo -21.16 62.58 121.86 -16.35 60.33 119.23 64.43 70.47 -79.54 68.32 74.80 -81.65 coo -23.22 55.98 120.74 -18.11 55.31 120.43 67.53 67.03 -76.43 64.05 65.33 -71.86 coo -17.15 59.71 133.33 -17.96 61.54 134.01 71.46 69.88 -89.76 71.03 69.93 -91.81 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 26 3 # 26 E 182 LYS F 157 LYS^? 28.36 MG MG F 302 E 184 LYS F 166 LYS^? 20.76 MG MG F 302 E 345 ASP F 142 ASP^? 23.43 MG MG F 302 coo -21.16 62.58 121.86 -16.35 60.33 119.23 64.43 70.47 -79.54 68.32 74.80 -81.65 coo -23.22 55.98 120.74 -18.11 55.31 120.43 59.28 73.05 -82.63 55.63 74.15 -86.94 coo -17.15 59.71 133.33 -17.96 61.54 134.01 71.46 69.88 -89.76 71.03 69.93 -91.81 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 27 3 # 27 E 182 LYS F 157 LYS^? 28.36 MG MG F 302 E 184 LYS F 166 LYS^? 20.76 MG MG F 302 E 345 ASP F 160 ASP^? 31.59 MG MG E 302 coo -21.16 62.58 121.86 -16.35 60.33 119.23 64.43 70.47 -79.54 68.32 74.80 -81.65 coo -23.22 55.98 120.74 -18.11 55.31 120.43 59.28 73.05 -82.63 55.63 74.15 -86.94 coo -17.15 59.71 133.33 -17.96 61.54 134.01 71.27 74.59 -71.77 73.23 74.02 -72.37 2dw7_c36 source 2dw7 BLL6730 PROTEIN : 27 hits 2dw7_c36 naa= 3 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 1 3 # 1 F 182 LYS A 157 LYS^? 28.65 MG MG A 302 F 184 LYS A 6 LYS^? 25.88 MG MG A 301 F 345 ASP A 142 ASP^? 23.70 MG MG A 302 coo 10.64 34.02 91.30 6.30 35.60 95.11 41.42 12.06 27.58 41.46 5.93 29.41 coo 13.75 39.76 94.12 11.42 37.23 97.89 46.20 12.82 24.71 44.50 16.64 20.52 coo 16.35 26.90 99.56 16.81 25.90 97.75 46.39 7.18 37.53 46.28 7.18 39.63 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 2 3 # 2 F 182 LYS A 157 LYS^? 28.65 MG MG A 302 F 184 LYS A 166 LYS^? 20.93 MG MG A 302 F 345 ASP A 142 ASP^? 23.70 MG MG A 302 coo 10.64 34.02 91.30 6.30 35.60 95.11 41.42 12.06 27.58 41.46 5.93 29.41 coo 13.75 39.76 94.12 11.42 37.23 97.89 35.34 13.14 30.41 31.67 15.04 34.58 coo 16.35 26.90 99.56 16.81 25.90 97.75 46.39 7.18 37.53 46.28 7.18 39.63 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 3 3 # 3 F 182 LYS B 6 LYS^? 25.90 MG MG B 302 F 184 LYS B 157 LYS^? 28.85 MG MG B 302 F 345 ASP B 138 ASP^? 33.32 MG MG B 302 coo 10.64 34.02 91.30 6.30 35.60 95.11 36.26 25.44 11.74 39.65 23.12 16.29 coo 13.75 39.76 94.12 11.42 37.23 97.89 34.97 21.28 8.44 29.03 22.82 6.58 coo 16.35 26.90 99.56 16.81 25.90 97.75 23.42 29.01 6.78 24.36 28.48 4.94 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 4 3 # 4 F 182 LYS B 157 LYS^? 28.85 MG MG B 302 F 184 LYS B 6 LYS^? 25.90 MG MG B 302 F 345 ASP B 138 ASP^? 33.32 MG MG B 302 coo 10.64 34.02 91.30 6.30 35.60 95.11 34.97 21.28 8.44 29.03 22.82 6.58 coo 13.75 39.76 94.12 11.42 37.23 97.89 36.26 25.44 11.74 39.65 23.12 16.29 coo 16.35 26.90 99.56 16.81 25.90 97.75 23.42 29.01 6.78 24.36 28.48 4.94 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 5 3 # 5 F 182 LYS B 157 LYS^? 28.85 MG MG B 302 F 184 LYS B 6 LYS^? 25.90 MG MG B 302 F 345 ASP B 142 ASP^? 23.97 MG MG B 301 coo 10.64 34.02 91.30 6.30 35.60 95.11 34.97 21.28 8.44 29.03 22.82 6.58 coo 13.75 39.76 94.12 11.42 37.23 97.89 36.26 25.44 11.74 39.65 23.12 16.29 coo 16.35 26.90 99.56 16.81 25.90 97.75 31.69 27.40 -1.31 32.10 27.37 -3.38 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 6 3 # 6 F 182 LYS B 157 LYS^? 28.85 MG MG B 302 F 184 LYS B 166 LYS^? 22.75 MG MG B 301 F 345 ASP B 142 ASP^? 23.97 MG MG B 301 coo 10.64 34.02 91.30 6.30 35.60 95.11 34.97 21.28 8.44 29.03 22.82 6.58 coo 13.75 39.76 94.12 11.42 37.23 97.89 35.27 15.38 5.31 37.27 9.81 3.93 coo 16.35 26.90 99.56 16.81 25.90 97.75 31.69 27.40 -1.31 32.10 27.37 -3.38 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 7 3 # 7 F 182 LYS C 157 LYS^? 28.15 MG MG C 302 F 184 LYS C 6 LYS^? 25.73 MG MG C 302 F 345 ASP C 142 ASP^? 23.76 MG MG C 301 coo 10.64 34.02 91.30 6.30 35.60 95.11 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 13.75 39.76 94.12 11.42 37.23 97.89 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 16.35 26.90 99.56 16.81 25.90 97.75 97.94 39.27 -5.03 98.08 38.70 -2.97 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 8 3 # 8 F 182 LYS C 157 LYS^? 28.15 MG MG C 302 F 184 LYS C 166 LYS^? 22.53 MG MG C 301 F 345 ASP C 142 ASP^? 23.76 MG MG C 301 coo 10.64 34.02 91.30 6.30 35.60 95.11 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 13.75 39.76 94.12 11.42 37.23 97.89 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 16.35 26.90 99.56 16.81 25.90 97.75 97.94 39.27 -5.03 98.08 38.70 -2.97 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 9 3 # 9 F 182 LYS C 157 LYS^? 28.15 MG MG C 302 F 184 LYS C 166 LYS^? 22.53 MG MG C 301 F 345 ASP C 160 ASP^? 31.63 MG MG D 302 coo 10.64 34.02 91.30 6.30 35.60 95.11 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 13.75 39.76 94.12 11.42 37.23 97.89 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 16.35 26.90 99.56 16.81 25.90 97.75 102.50 38.00 -23.28 102.43 39.97 -22.46 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 10 3 # 10 F 182 LYS D 6 LYS^? 25.98 MG MG D 302 F 184 LYS D 157 LYS^? 28.67 MG MG D 302 F 345 ASP D 138 ASP^? 33.64 MG MG D 302 coo 10.64 34.02 91.30 6.30 35.60 95.11 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 13.75 39.76 94.12 11.42 37.23 97.89 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 16.35 26.90 99.56 16.81 25.90 97.75 93.00 7.50 -35.79 93.88 8.48 -37.45 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 11 3 # 11 F 182 LYS D 6 LYS^? 25.98 MG MG D 302 F 184 LYS D 157 LYS^? 28.67 MG MG D 302 F 345 ASP D 142 ASP^? 23.49 MG MG D 301 coo 10.64 34.02 91.30 6.30 35.60 95.11 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 13.75 39.76 94.12 11.42 37.23 97.89 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 16.35 26.90 99.56 16.81 25.90 97.75 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 12 3 # 12 F 182 LYS D 157 LYS^? 28.67 MG MG D 302 F 184 LYS D 6 LYS^? 25.98 MG MG D 302 F 345 ASP D 142 ASP^? 23.49 MG MG D 301 coo 10.64 34.02 91.30 6.30 35.60 95.11 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 13.75 39.76 94.12 11.42 37.23 97.89 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 16.35 26.90 99.56 16.81 25.90 97.75 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 13 3 # 13 F 182 LYS D 157 LYS^? 28.67 MG MG D 302 F 184 LYS D 166 LYS^? 21.08 MG MG D 301 F 345 ASP D 142 ASP^? 23.49 MG MG D 301 coo 10.64 34.02 91.30 6.30 35.60 95.11 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 13.75 39.76 94.12 11.42 37.23 97.89 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 16.35 26.90 99.56 16.81 25.90 97.75 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 14 3 # 14 F 182 LYS D 157 LYS^? 28.67 MG MG D 302 F 184 LYS D 166 LYS^? 21.08 MG MG D 301 F 345 ASP D 160 ASP^? 31.45 MG MG C 302 coo 10.64 34.02 91.30 6.30 35.60 95.11 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 13.75 39.76 94.12 11.42 37.23 97.89 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 16.35 26.90 99.56 16.81 25.90 97.75 94.15 13.98 -26.57 92.71 12.42 -26.99 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 15 3 # 15 F 182 LYS E 157 LYS^? 28.40 MG MG E 302 F 184 LYS E 6 LYS^? 25.59 MG MG E 302 F 345 ASP E 138 ASP^? 33.31 MG MG E 302 coo 10.64 34.02 91.30 6.30 35.60 95.11 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 13.75 39.76 94.12 11.42 37.23 97.89 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 16.35 26.90 99.56 16.81 25.90 97.75 39.58 70.77 -58.63 40.74 70.78 -56.80 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 16 3 # 16 F 182 LYS E 157 LYS^? 28.40 MG MG E 302 F 184 LYS E 6 LYS^? 25.59 MG MG E 302 F 345 ASP E 142 ASP^? 23.66 MG MG E 301 coo 10.64 34.02 91.30 6.30 35.60 95.11 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 13.75 39.76 94.12 11.42 37.23 97.89 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 16.35 26.90 99.56 16.81 25.90 97.75 47.19 67.15 -50.37 47.44 67.18 -48.23 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 17 3 # 17 F 182 LYS E 157 LYS^? 28.40 MG MG E 302 F 184 LYS E 166 LYS^? 21.46 MG MG E 301 F 345 ASP E 142 ASP^? 23.66 MG MG E 301 coo 10.64 34.02 91.30 6.30 35.60 95.11 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 13.75 39.76 94.12 11.42 37.23 97.89 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 16.35 26.90 99.56 16.81 25.90 97.75 47.19 67.15 -50.37 47.44 67.18 -48.23 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 18 3 # 18 F 182 LYS F 6 LYS^? 26.09 MG MG F 301 F 184 LYS F 157 LYS^? 28.36 MG MG F 302 F 345 ASP F 142 ASP^? 23.43 MG MG F 302 coo 10.64 34.02 91.30 6.30 35.60 95.11 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 13.75 39.76 94.12 11.42 37.23 97.89 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 16.35 26.90 99.56 16.81 25.90 97.75 71.46 69.88 -89.76 71.03 69.93 -91.81 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 19 3 # 19 F 182 LYS F 157 LYS^? 28.36 MG MG F 302 F 184 LYS F 6 LYS^? 26.09 MG MG F 301 F 345 ASP F 138 ASP^? 33.51 MG MG F 302 coo 10.64 34.02 91.30 6.30 35.60 95.11 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 13.75 39.76 94.12 11.42 37.23 97.89 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 16.35 26.90 99.56 16.81 25.90 97.75 77.17 76.66 -81.48 76.14 76.33 -83.32 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 20 3 # 20 F 182 LYS F 157 LYS^? 28.36 MG MG F 302 F 184 LYS F 6 LYS^? 26.09 MG MG F 301 F 345 ASP F 142 ASP^? 23.43 MG MG F 302 coo 10.64 34.02 91.30 6.30 35.60 95.11 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 13.75 39.76 94.12 11.42 37.23 97.89 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 16.35 26.90 99.56 16.81 25.90 97.75 71.46 69.88 -89.76 71.03 69.93 -91.81 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 21 3 # 21 F 182 LYS F 157 LYS^? 28.36 MG MG F 302 F 184 LYS F 166 LYS^? 20.76 MG MG F 302 F 345 ASP F 142 ASP^? 23.43 MG MG F 302 coo 10.64 34.02 91.30 6.30 35.60 95.11 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 13.75 39.76 94.12 11.42 37.23 97.89 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 16.35 26.90 99.56 16.81 25.90 97.75 71.46 69.88 -89.76 71.03 69.93 -91.81 2dw7_c37 source 2dw7 BLL6730 PROTEIN : 21 hits 2dw7_c37 naa= 3 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 1 3 # 1 G 182 LYS A 157 LYS^? 28.65 MG MG A 302 G 184 LYS A 6 LYS^? 25.88 MG MG A 301 G 345 ASP A 138 ASP^? 33.08 MG MG A 302 coo 39.68 42.04 76.11 43.42 46.43 74.96 41.42 12.06 27.58 41.46 5.93 29.41 coo 36.69 47.69 78.93 39.38 50.40 75.35 46.20 12.82 24.71 44.50 16.64 20.52 coo 33.43 44.37 65.47 33.10 42.30 65.37 47.10 -0.97 29.63 45.89 0.22 30.96 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 2 3 # 2 G 182 LYS A 157 LYS^? 28.65 MG MG A 302 G 184 LYS A 6 LYS^? 25.88 MG MG A 301 G 345 ASP A 142 ASP^? 23.70 MG MG A 302 coo 39.68 42.04 76.11 43.42 46.43 74.96 41.42 12.06 27.58 41.46 5.93 29.41 coo 36.69 47.69 78.93 39.38 50.40 75.35 46.20 12.82 24.71 44.50 16.64 20.52 coo 33.43 44.37 65.47 33.10 42.30 65.37 46.39 7.18 37.53 46.28 7.18 39.63 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 3 3 # 3 G 182 LYS A 157 LYS^? 28.65 MG MG A 302 G 184 LYS A 166 LYS^? 20.93 MG MG A 302 G 345 ASP A 142 ASP^? 23.70 MG MG A 302 coo 39.68 42.04 76.11 43.42 46.43 74.96 41.42 12.06 27.58 41.46 5.93 29.41 coo 36.69 47.69 78.93 39.38 50.40 75.35 35.34 13.14 30.41 31.67 15.04 34.58 coo 33.43 44.37 65.47 33.10 42.30 65.37 46.39 7.18 37.53 46.28 7.18 39.63 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 4 3 # 4 G 182 LYS B 6 LYS^? 25.90 MG MG B 302 G 184 LYS B 157 LYS^? 28.85 MG MG B 302 G 345 ASP B 138 ASP^? 33.32 MG MG B 302 coo 39.68 42.04 76.11 43.42 46.43 74.96 36.26 25.44 11.74 39.65 23.12 16.29 coo 36.69 47.69 78.93 39.38 50.40 75.35 34.97 21.28 8.44 29.03 22.82 6.58 coo 33.43 44.37 65.47 33.10 42.30 65.37 23.42 29.01 6.78 24.36 28.48 4.94 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 5 3 # 5 G 182 LYS B 157 LYS^? 28.85 MG MG B 302 G 184 LYS B 6 LYS^? 25.90 MG MG B 302 G 345 ASP B 138 ASP^? 33.32 MG MG B 302 coo 39.68 42.04 76.11 43.42 46.43 74.96 34.97 21.28 8.44 29.03 22.82 6.58 coo 36.69 47.69 78.93 39.38 50.40 75.35 36.26 25.44 11.74 39.65 23.12 16.29 coo 33.43 44.37 65.47 33.10 42.30 65.37 23.42 29.01 6.78 24.36 28.48 4.94 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 6 3 # 6 G 182 LYS B 157 LYS^? 28.85 MG MG B 302 G 184 LYS B 6 LYS^? 25.90 MG MG B 302 G 345 ASP B 142 ASP^? 23.97 MG MG B 301 coo 39.68 42.04 76.11 43.42 46.43 74.96 34.97 21.28 8.44 29.03 22.82 6.58 coo 36.69 47.69 78.93 39.38 50.40 75.35 36.26 25.44 11.74 39.65 23.12 16.29 coo 33.43 44.37 65.47 33.10 42.30 65.37 31.69 27.40 -1.31 32.10 27.37 -3.38 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 7 3 # 7 G 182 LYS B 157 LYS^? 28.85 MG MG B 302 G 184 LYS B 166 LYS^? 22.75 MG MG B 301 G 345 ASP B 142 ASP^? 23.97 MG MG B 301 coo 39.68 42.04 76.11 43.42 46.43 74.96 34.97 21.28 8.44 29.03 22.82 6.58 coo 36.69 47.69 78.93 39.38 50.40 75.35 35.27 15.38 5.31 37.27 9.81 3.93 coo 33.43 44.37 65.47 33.10 42.30 65.37 31.69 27.40 -1.31 32.10 27.37 -3.38 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 8 3 # 8 G 182 LYS C 6 LYS^? 25.73 MG MG C 302 G 184 LYS C 157 LYS^? 28.15 MG MG C 302 G 345 ASP C 142 ASP^? 23.76 MG MG C 301 coo 39.68 42.04 76.11 43.42 46.43 74.96 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 36.69 47.69 78.93 39.38 50.40 75.35 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 33.43 44.37 65.47 33.10 42.30 65.37 97.94 39.27 -5.03 98.08 38.70 -2.97 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 9 3 # 9 G 182 LYS C 157 LYS^? 28.15 MG MG C 302 G 184 LYS C 6 LYS^? 25.73 MG MG C 302 G 345 ASP C 138 ASP^? 33.43 MG MG C 302 coo 39.68 42.04 76.11 43.42 46.43 74.96 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 36.69 47.69 78.93 39.38 50.40 75.35 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 33.43 44.37 65.47 33.10 42.30 65.37 105.43 43.97 -13.30 104.85 43.08 -11.43 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 10 3 # 10 G 182 LYS C 157 LYS^? 28.15 MG MG C 302 G 184 LYS C 6 LYS^? 25.73 MG MG C 302 G 345 ASP C 142 ASP^? 23.76 MG MG C 301 coo 39.68 42.04 76.11 43.42 46.43 74.96 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 36.69 47.69 78.93 39.38 50.40 75.35 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 33.43 44.37 65.47 33.10 42.30 65.37 97.94 39.27 -5.03 98.08 38.70 -2.97 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 11 3 # 11 G 182 LYS C 157 LYS^? 28.15 MG MG C 302 G 184 LYS C 166 LYS^? 22.53 MG MG C 301 G 345 ASP C 142 ASP^? 23.76 MG MG C 301 coo 39.68 42.04 76.11 43.42 46.43 74.96 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 36.69 47.69 78.93 39.38 50.40 75.35 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 33.43 44.37 65.47 33.10 42.30 65.37 97.94 39.27 -5.03 98.08 38.70 -2.97 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 12 3 # 12 G 182 LYS C 157 LYS^? 28.15 MG MG C 302 G 184 LYS C 166 LYS^? 22.53 MG MG C 301 G 345 ASP C 160 ASP^? 31.63 MG MG D 302 coo 39.68 42.04 76.11 43.42 46.43 74.96 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 36.69 47.69 78.93 39.38 50.40 75.35 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 33.43 44.37 65.47 33.10 42.30 65.37 102.50 38.00 -23.28 102.43 39.97 -22.46 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 13 3 # 13 G 182 LYS C 166 LYS^? 22.53 MG MG C 301 G 184 LYS C 157 LYS^? 28.15 MG MG C 302 G 345 ASP C 142 ASP^? 23.76 MG MG C 301 coo 39.68 42.04 76.11 43.42 46.43 74.96 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 36.69 47.69 78.93 39.38 50.40 75.35 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 33.43 44.37 65.47 33.10 42.30 65.37 97.94 39.27 -5.03 98.08 38.70 -2.97 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 14 3 # 14 G 182 LYS D 6 LYS^? 25.98 MG MG D 302 G 184 LYS D 157 LYS^? 28.67 MG MG D 302 G 345 ASP D 138 ASP^? 33.64 MG MG D 302 coo 39.68 42.04 76.11 43.42 46.43 74.96 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 36.69 47.69 78.93 39.38 50.40 75.35 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 33.43 44.37 65.47 33.10 42.30 65.37 93.00 7.50 -35.79 93.88 8.48 -37.45 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 15 3 # 15 G 182 LYS D 6 LYS^? 25.98 MG MG D 302 G 184 LYS D 157 LYS^? 28.67 MG MG D 302 G 345 ASP D 142 ASP^? 23.49 MG MG D 301 coo 39.68 42.04 76.11 43.42 46.43 74.96 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 36.69 47.69 78.93 39.38 50.40 75.35 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 33.43 44.37 65.47 33.10 42.30 65.37 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 16 3 # 16 G 182 LYS D 157 LYS^? 28.67 MG MG D 302 G 184 LYS D 6 LYS^? 25.98 MG MG D 302 G 345 ASP D 138 ASP^? 33.64 MG MG D 302 coo 39.68 42.04 76.11 43.42 46.43 74.96 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 36.69 47.69 78.93 39.38 50.40 75.35 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 33.43 44.37 65.47 33.10 42.30 65.37 93.00 7.50 -35.79 93.88 8.48 -37.45 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 17 3 # 17 G 182 LYS D 157 LYS^? 28.67 MG MG D 302 G 184 LYS D 6 LYS^? 25.98 MG MG D 302 G 345 ASP D 142 ASP^? 23.49 MG MG D 301 coo 39.68 42.04 76.11 43.42 46.43 74.96 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 36.69 47.69 78.93 39.38 50.40 75.35 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 33.43 44.37 65.47 33.10 42.30 65.37 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 18 3 # 18 G 182 LYS D 157 LYS^? 28.67 MG MG D 302 G 184 LYS D 166 LYS^? 21.08 MG MG D 301 G 345 ASP D 142 ASP^? 23.49 MG MG D 301 coo 39.68 42.04 76.11 43.42 46.43 74.96 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 36.69 47.69 78.93 39.38 50.40 75.35 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 33.43 44.37 65.47 33.10 42.30 65.37 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 19 3 # 19 G 182 LYS D 157 LYS^? 28.67 MG MG D 302 G 184 LYS D 166 LYS^? 21.08 MG MG D 301 G 345 ASP D 160 ASP^? 31.45 MG MG C 302 coo 39.68 42.04 76.11 43.42 46.43 74.96 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 36.69 47.69 78.93 39.38 50.40 75.35 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 33.43 44.37 65.47 33.10 42.30 65.37 94.15 13.98 -26.57 92.71 12.42 -26.99 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 20 3 # 20 G 182 LYS D 166 LYS^? 21.08 MG MG D 301 G 184 LYS D 157 LYS^? 28.67 MG MG D 302 G 345 ASP D 142 ASP^? 23.49 MG MG D 301 coo 39.68 42.04 76.11 43.42 46.43 74.96 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 36.69 47.69 78.93 39.38 50.40 75.35 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 33.43 44.37 65.47 33.10 42.30 65.37 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 21 3 # 21 G 182 LYS E 6 LYS^? 25.59 MG MG E 302 G 184 LYS E 157 LYS^? 28.40 MG MG E 302 G 345 ASP E 138 ASP^? 33.31 MG MG E 302 coo 39.68 42.04 76.11 43.42 46.43 74.96 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 36.69 47.69 78.93 39.38 50.40 75.35 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 33.43 44.37 65.47 33.10 42.30 65.37 39.58 70.77 -58.63 40.74 70.78 -56.80 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 22 3 # 22 G 182 LYS E 157 LYS^? 28.40 MG MG E 302 G 184 LYS E 6 LYS^? 25.59 MG MG E 302 G 345 ASP E 138 ASP^? 33.31 MG MG E 302 coo 39.68 42.04 76.11 43.42 46.43 74.96 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 36.69 47.69 78.93 39.38 50.40 75.35 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 33.43 44.37 65.47 33.10 42.30 65.37 39.58 70.77 -58.63 40.74 70.78 -56.80 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 23 3 # 23 G 182 LYS E 157 LYS^? 28.40 MG MG E 302 G 184 LYS E 6 LYS^? 25.59 MG MG E 302 G 345 ASP E 142 ASP^? 23.66 MG MG E 301 coo 39.68 42.04 76.11 43.42 46.43 74.96 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 36.69 47.69 78.93 39.38 50.40 75.35 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 33.43 44.37 65.47 33.10 42.30 65.37 47.19 67.15 -50.37 47.44 67.18 -48.23 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 24 3 # 24 G 182 LYS E 157 LYS^? 28.40 MG MG E 302 G 184 LYS E 166 LYS^? 21.46 MG MG E 301 G 345 ASP E 142 ASP^? 23.66 MG MG E 301 coo 39.68 42.04 76.11 43.42 46.43 74.96 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 36.69 47.69 78.93 39.38 50.40 75.35 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 33.43 44.37 65.47 33.10 42.30 65.37 47.19 67.15 -50.37 47.44 67.18 -48.23 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 25 3 # 25 G 182 LYS F 6 LYS^? 26.09 MG MG F 301 G 184 LYS F 157 LYS^? 28.36 MG MG F 302 G 345 ASP F 138 ASP^? 33.51 MG MG F 302 coo 39.68 42.04 76.11 43.42 46.43 74.96 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 36.69 47.69 78.93 39.38 50.40 75.35 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 33.43 44.37 65.47 33.10 42.30 65.37 77.17 76.66 -81.48 76.14 76.33 -83.32 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 26 3 # 26 G 182 LYS F 6 LYS^? 26.09 MG MG F 301 G 184 LYS F 157 LYS^? 28.36 MG MG F 302 G 345 ASP F 142 ASP^? 23.43 MG MG F 302 coo 39.68 42.04 76.11 43.42 46.43 74.96 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 36.69 47.69 78.93 39.38 50.40 75.35 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 33.43 44.37 65.47 33.10 42.30 65.37 71.46 69.88 -89.76 71.03 69.93 -91.81 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 27 3 # 27 G 182 LYS F 157 LYS^? 28.36 MG MG F 302 G 184 LYS F 6 LYS^? 26.09 MG MG F 301 G 345 ASP F 138 ASP^? 33.51 MG MG F 302 coo 39.68 42.04 76.11 43.42 46.43 74.96 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 36.69 47.69 78.93 39.38 50.40 75.35 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 33.43 44.37 65.47 33.10 42.30 65.37 77.17 76.66 -81.48 76.14 76.33 -83.32 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 28 3 # 28 G 182 LYS F 157 LYS^? 28.36 MG MG F 302 G 184 LYS F 6 LYS^? 26.09 MG MG F 301 G 345 ASP F 142 ASP^? 23.43 MG MG F 302 coo 39.68 42.04 76.11 43.42 46.43 74.96 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 36.69 47.69 78.93 39.38 50.40 75.35 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 33.43 44.37 65.47 33.10 42.30 65.37 71.46 69.88 -89.76 71.03 69.93 -91.81 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 29 3 # 29 G 182 LYS F 157 LYS^? 28.36 MG MG F 302 G 184 LYS F 166 LYS^? 20.76 MG MG F 302 G 345 ASP F 142 ASP^? 23.43 MG MG F 302 coo 39.68 42.04 76.11 43.42 46.43 74.96 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 36.69 47.69 78.93 39.38 50.40 75.35 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 33.43 44.37 65.47 33.10 42.30 65.37 71.46 69.88 -89.76 71.03 69.93 -91.81 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 30 3 # 30 G 182 LYS F 166 LYS^? 20.76 MG MG F 302 G 184 LYS F 157 LYS^? 28.36 MG MG F 302 G 345 ASP F 142 ASP^? 23.43 MG MG F 302 coo 39.68 42.04 76.11 43.42 46.43 74.96 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 36.69 47.69 78.93 39.38 50.40 75.35 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 33.43 44.37 65.47 33.10 42.30 65.37 71.46 69.88 -89.76 71.03 69.93 -91.81 2dw7_c38 source 2dw7 BLL6730 PROTEIN : 30 hits 2dw7_c38 naa= 3 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 1 3 # 1 H 182 LYS A 157 LYS^? 28.65 MG MG A 302 H 184 LYS A 6 LYS^? 25.88 MG MG A 301 H 345 ASP A 138 ASP^? 33.08 MG MG A 302 coo 71.58 83.18 80.51 66.88 79.77 79.84 41.42 12.06 27.58 41.46 5.93 29.41 coo 73.65 78.64 75.66 68.14 79.07 75.04 46.20 12.82 24.71 44.50 16.64 20.52 coo 67.43 90.73 71.39 68.27 92.30 72.52 47.10 -0.97 29.63 45.89 0.22 30.96 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 2 3 # 2 H 182 LYS A 157 LYS^? 28.65 MG MG A 302 H 184 LYS A 6 LYS^? 25.88 MG MG A 301 H 345 ASP A 142 ASP^? 23.70 MG MG A 302 coo 71.58 83.18 80.51 66.88 79.77 79.84 41.42 12.06 27.58 41.46 5.93 29.41 coo 73.65 78.64 75.66 68.14 79.07 75.04 46.20 12.82 24.71 44.50 16.64 20.52 coo 67.43 90.73 71.39 68.27 92.30 72.52 46.39 7.18 37.53 46.28 7.18 39.63 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 3 3 # 3 H 182 LYS A 157 LYS^? 28.65 MG MG A 302 H 184 LYS A 166 LYS^? 20.93 MG MG A 302 H 345 ASP A 142 ASP^? 23.70 MG MG A 302 coo 71.58 83.18 80.51 66.88 79.77 79.84 41.42 12.06 27.58 41.46 5.93 29.41 coo 73.65 78.64 75.66 68.14 79.07 75.04 35.34 13.14 30.41 31.67 15.04 34.58 coo 67.43 90.73 71.39 68.27 92.30 72.52 46.39 7.18 37.53 46.28 7.18 39.63 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 4 3 # 4 H 182 LYS A 157 LYS^? 28.65 MG MG A 302 H 184 LYS A 166 LYS^? 20.93 MG MG A 302 H 345 ASP A 160 ASP^? 31.61 MG MG B 302 coo 71.58 83.18 80.51 66.88 79.77 79.84 41.42 12.06 27.58 41.46 5.93 29.41 coo 73.65 78.64 75.66 68.14 79.07 75.04 35.34 13.14 30.41 31.67 15.04 34.58 coo 67.43 90.73 71.39 68.27 92.30 72.52 44.21 5.00 19.54 46.02 3.84 19.76 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 5 3 # 5 H 182 LYS B 6 LYS^? 25.90 MG MG B 302 H 184 LYS B 157 LYS^? 28.85 MG MG B 302 H 345 ASP B 138 ASP^? 33.32 MG MG B 302 coo 71.58 83.18 80.51 66.88 79.77 79.84 36.26 25.44 11.74 39.65 23.12 16.29 coo 73.65 78.64 75.66 68.14 79.07 75.04 34.97 21.28 8.44 29.03 22.82 6.58 coo 67.43 90.73 71.39 68.27 92.30 72.52 23.42 29.01 6.78 24.36 28.48 4.94 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 6 3 # 6 H 182 LYS B 157 LYS^? 28.85 MG MG B 302 H 184 LYS B 6 LYS^? 25.90 MG MG B 302 H 345 ASP B 138 ASP^? 33.32 MG MG B 302 coo 71.58 83.18 80.51 66.88 79.77 79.84 34.97 21.28 8.44 29.03 22.82 6.58 coo 73.65 78.64 75.66 68.14 79.07 75.04 36.26 25.44 11.74 39.65 23.12 16.29 coo 67.43 90.73 71.39 68.27 92.30 72.52 23.42 29.01 6.78 24.36 28.48 4.94 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 7 3 # 7 H 182 LYS B 157 LYS^? 28.85 MG MG B 302 H 184 LYS B 6 LYS^? 25.90 MG MG B 302 H 345 ASP B 142 ASP^? 23.97 MG MG B 301 coo 71.58 83.18 80.51 66.88 79.77 79.84 34.97 21.28 8.44 29.03 22.82 6.58 coo 73.65 78.64 75.66 68.14 79.07 75.04 36.26 25.44 11.74 39.65 23.12 16.29 coo 67.43 90.73 71.39 68.27 92.30 72.52 31.69 27.40 -1.31 32.10 27.37 -3.38 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 8 3 # 8 H 182 LYS B 157 LYS^? 28.85 MG MG B 302 H 184 LYS B 166 LYS^? 22.75 MG MG B 301 H 345 ASP B 142 ASP^? 23.97 MG MG B 301 coo 71.58 83.18 80.51 66.88 79.77 79.84 34.97 21.28 8.44 29.03 22.82 6.58 coo 73.65 78.64 75.66 68.14 79.07 75.04 35.27 15.38 5.31 37.27 9.81 3.93 coo 67.43 90.73 71.39 68.27 92.30 72.52 31.69 27.40 -1.31 32.10 27.37 -3.38 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 9 3 # 9 H 182 LYS B 157 LYS^? 28.85 MG MG B 302 H 184 LYS B 166 LYS^? 22.75 MG MG B 301 H 345 ASP B 160 ASP^? 31.65 MG MG A 301 coo 71.58 83.18 80.51 66.88 79.77 79.84 34.97 21.28 8.44 29.03 22.82 6.58 coo 73.65 78.64 75.66 68.14 79.07 75.04 35.27 15.38 5.31 37.27 9.81 3.93 coo 67.43 90.73 71.39 68.27 92.30 72.52 28.01 24.83 16.38 27.44 26.81 15.80 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 10 3 # 10 H 182 LYS C 6 LYS^? 25.73 MG MG C 302 H 184 LYS C 157 LYS^? 28.15 MG MG C 302 H 345 ASP C 142 ASP^? 23.76 MG MG C 301 coo 71.58 83.18 80.51 66.88 79.77 79.84 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 73.65 78.64 75.66 68.14 79.07 75.04 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 67.43 90.73 71.39 68.27 92.30 72.52 97.94 39.27 -5.03 98.08 38.70 -2.97 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 11 3 # 11 H 182 LYS C 157 LYS^? 28.15 MG MG C 302 H 184 LYS C 6 LYS^? 25.73 MG MG C 302 H 345 ASP C 138 ASP^? 33.43 MG MG C 302 coo 71.58 83.18 80.51 66.88 79.77 79.84 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 73.65 78.64 75.66 68.14 79.07 75.04 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 67.43 90.73 71.39 68.27 92.30 72.52 105.43 43.97 -13.30 104.85 43.08 -11.43 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 12 3 # 12 H 182 LYS C 157 LYS^? 28.15 MG MG C 302 H 184 LYS C 6 LYS^? 25.73 MG MG C 302 H 345 ASP C 142 ASP^? 23.76 MG MG C 301 coo 71.58 83.18 80.51 66.88 79.77 79.84 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 73.65 78.64 75.66 68.14 79.07 75.04 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 67.43 90.73 71.39 68.27 92.30 72.52 97.94 39.27 -5.03 98.08 38.70 -2.97 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 13 3 # 13 H 182 LYS C 157 LYS^? 28.15 MG MG C 302 H 184 LYS C 166 LYS^? 22.53 MG MG C 301 H 345 ASP C 142 ASP^? 23.76 MG MG C 301 coo 71.58 83.18 80.51 66.88 79.77 79.84 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 73.65 78.64 75.66 68.14 79.07 75.04 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 67.43 90.73 71.39 68.27 92.30 72.52 97.94 39.27 -5.03 98.08 38.70 -2.97 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 14 3 # 14 H 182 LYS C 157 LYS^? 28.15 MG MG C 302 H 184 LYS C 166 LYS^? 22.53 MG MG C 301 H 345 ASP C 160 ASP^? 31.63 MG MG D 302 coo 71.58 83.18 80.51 66.88 79.77 79.84 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 73.65 78.64 75.66 68.14 79.07 75.04 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 67.43 90.73 71.39 68.27 92.30 72.52 102.50 38.00 -23.28 102.43 39.97 -22.46 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 15 3 # 15 H 182 LYS D 6 LYS^? 25.98 MG MG D 302 H 184 LYS D 157 LYS^? 28.67 MG MG D 302 H 345 ASP D 138 ASP^? 33.64 MG MG D 302 coo 71.58 83.18 80.51 66.88 79.77 79.84 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 73.65 78.64 75.66 68.14 79.07 75.04 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 67.43 90.73 71.39 68.27 92.30 72.52 93.00 7.50 -35.79 93.88 8.48 -37.45 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 16 3 # 16 H 182 LYS D 6 LYS^? 25.98 MG MG D 302 H 184 LYS D 157 LYS^? 28.67 MG MG D 302 H 345 ASP D 142 ASP^? 23.49 MG MG D 301 coo 71.58 83.18 80.51 66.88 79.77 79.84 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 73.65 78.64 75.66 68.14 79.07 75.04 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 67.43 90.73 71.39 68.27 92.30 72.52 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 17 3 # 17 H 182 LYS D 157 LYS^? 28.67 MG MG D 302 H 184 LYS D 6 LYS^? 25.98 MG MG D 302 H 345 ASP D 138 ASP^? 33.64 MG MG D 302 coo 71.58 83.18 80.51 66.88 79.77 79.84 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 73.65 78.64 75.66 68.14 79.07 75.04 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 67.43 90.73 71.39 68.27 92.30 72.52 93.00 7.50 -35.79 93.88 8.48 -37.45 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 18 3 # 18 H 182 LYS D 157 LYS^? 28.67 MG MG D 302 H 184 LYS D 6 LYS^? 25.98 MG MG D 302 H 345 ASP D 142 ASP^? 23.49 MG MG D 301 coo 71.58 83.18 80.51 66.88 79.77 79.84 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 73.65 78.64 75.66 68.14 79.07 75.04 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 67.43 90.73 71.39 68.27 92.30 72.52 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 19 3 # 19 H 182 LYS D 157 LYS^? 28.67 MG MG D 302 H 184 LYS D 166 LYS^? 21.08 MG MG D 301 H 345 ASP D 142 ASP^? 23.49 MG MG D 301 coo 71.58 83.18 80.51 66.88 79.77 79.84 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 73.65 78.64 75.66 68.14 79.07 75.04 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 67.43 90.73 71.39 68.27 92.30 72.52 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 20 3 # 20 H 182 LYS D 157 LYS^? 28.67 MG MG D 302 H 184 LYS D 166 LYS^? 21.08 MG MG D 301 H 345 ASP D 160 ASP^? 31.45 MG MG C 302 coo 71.58 83.18 80.51 66.88 79.77 79.84 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 73.65 78.64 75.66 68.14 79.07 75.04 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 67.43 90.73 71.39 68.27 92.30 72.52 94.15 13.98 -26.57 92.71 12.42 -26.99 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 21 3 # 21 H 182 LYS E 157 LYS^? 28.40 MG MG E 302 H 184 LYS E 6 LYS^? 25.59 MG MG E 302 H 345 ASP E 138 ASP^? 33.31 MG MG E 302 coo 71.58 83.18 80.51 66.88 79.77 79.84 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 73.65 78.64 75.66 68.14 79.07 75.04 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 67.43 90.73 71.39 68.27 92.30 72.52 39.58 70.77 -58.63 40.74 70.78 -56.80 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 22 3 # 22 H 182 LYS E 157 LYS^? 28.40 MG MG E 302 H 184 LYS E 6 LYS^? 25.59 MG MG E 302 H 345 ASP E 142 ASP^? 23.66 MG MG E 301 coo 71.58 83.18 80.51 66.88 79.77 79.84 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 73.65 78.64 75.66 68.14 79.07 75.04 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 67.43 90.73 71.39 68.27 92.30 72.52 47.19 67.15 -50.37 47.44 67.18 -48.23 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 23 3 # 23 H 182 LYS E 157 LYS^? 28.40 MG MG E 302 H 184 LYS E 166 LYS^? 21.46 MG MG E 301 H 345 ASP E 142 ASP^? 23.66 MG MG E 301 coo 71.58 83.18 80.51 66.88 79.77 79.84 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 73.65 78.64 75.66 68.14 79.07 75.04 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 67.43 90.73 71.39 68.27 92.30 72.52 47.19 67.15 -50.37 47.44 67.18 -48.23 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 24 3 # 24 H 182 LYS F 6 LYS^? 26.09 MG MG F 301 H 184 LYS F 157 LYS^? 28.36 MG MG F 302 H 345 ASP F 142 ASP^? 23.43 MG MG F 302 coo 71.58 83.18 80.51 66.88 79.77 79.84 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 73.65 78.64 75.66 68.14 79.07 75.04 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 67.43 90.73 71.39 68.27 92.30 72.52 71.46 69.88 -89.76 71.03 69.93 -91.81 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 25 3 # 25 H 182 LYS F 157 LYS^? 28.36 MG MG F 302 H 184 LYS F 6 LYS^? 26.09 MG MG F 301 H 345 ASP F 138 ASP^? 33.51 MG MG F 302 coo 71.58 83.18 80.51 66.88 79.77 79.84 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 73.65 78.64 75.66 68.14 79.07 75.04 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 67.43 90.73 71.39 68.27 92.30 72.52 77.17 76.66 -81.48 76.14 76.33 -83.32 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 26 3 # 26 H 182 LYS F 157 LYS^? 28.36 MG MG F 302 H 184 LYS F 6 LYS^? 26.09 MG MG F 301 H 345 ASP F 142 ASP^? 23.43 MG MG F 302 coo 71.58 83.18 80.51 66.88 79.77 79.84 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 73.65 78.64 75.66 68.14 79.07 75.04 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 67.43 90.73 71.39 68.27 92.30 72.52 71.46 69.88 -89.76 71.03 69.93 -91.81 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 27 3 # 27 H 182 LYS F 157 LYS^? 28.36 MG MG F 302 H 184 LYS F 166 LYS^? 20.76 MG MG F 302 H 345 ASP F 142 ASP^? 23.43 MG MG F 302 coo 71.58 83.18 80.51 66.88 79.77 79.84 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 73.65 78.64 75.66 68.14 79.07 75.04 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 67.43 90.73 71.39 68.27 92.30 72.52 71.46 69.88 -89.76 71.03 69.93 -91.81 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 28 3 # 28 H 182 LYS F 157 LYS^? 28.36 MG MG F 302 H 184 LYS F 166 LYS^? 20.76 MG MG F 302 H 345 ASP F 160 ASP^? 31.59 MG MG E 302 coo 71.58 83.18 80.51 66.88 79.77 79.84 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 73.65 78.64 75.66 68.14 79.07 75.04 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 67.43 90.73 71.39 68.27 92.30 72.52 71.27 74.59 -71.77 73.23 74.02 -72.37 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 29 3 # 29 H 182 LYS F 166 LYS^? 20.76 MG MG F 302 H 184 LYS F 157 LYS^? 28.36 MG MG F 302 H 345 ASP F 142 ASP^? 23.43 MG MG F 302 coo 71.58 83.18 80.51 66.88 79.77 79.84 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 73.65 78.64 75.66 68.14 79.07 75.04 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 67.43 90.73 71.39 68.27 92.30 72.52 71.46 69.88 -89.76 71.03 69.93 -91.81 2dw7_c39 source 2dw7 BLL6730 PROTEIN : 29 hits 2dw7_c39 naa= 3 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 1 3 # 1 I 182 LYS A 157 LYS^? 28.65 MG MG A 302 I 184 LYS A 6 LYS^? 25.88 MG MG A 301 I 345 ASP A 138 ASP^? 33.08 MG MG A 302 coo 60.20 96.92 42.53 57.60 93.13 38.67 41.42 12.06 27.58 41.46 5.93 29.41 coo 54.31 95.46 46.01 55.34 91.59 42.65 46.20 12.82 24.71 44.50 16.64 20.52 coo 66.35 87.81 48.53 68.10 89.01 48.77 47.10 -0.97 29.63 45.89 0.22 30.96 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 2 3 # 2 I 182 LYS A 157 LYS^? 28.65 MG MG A 302 I 184 LYS A 6 LYS^? 25.88 MG MG A 301 I 345 ASP A 142 ASP^? 23.70 MG MG A 302 coo 60.20 96.92 42.53 57.60 93.13 38.67 41.42 12.06 27.58 41.46 5.93 29.41 coo 54.31 95.46 46.01 55.34 91.59 42.65 46.20 12.82 24.71 44.50 16.64 20.52 coo 66.35 87.81 48.53 68.10 89.01 48.77 46.39 7.18 37.53 46.28 7.18 39.63 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 3 3 # 3 I 182 LYS A 157 LYS^? 28.65 MG MG A 302 I 184 LYS A 166 LYS^? 20.93 MG MG A 302 I 345 ASP A 142 ASP^? 23.70 MG MG A 302 coo 60.20 96.92 42.53 57.60 93.13 38.67 41.42 12.06 27.58 41.46 5.93 29.41 coo 54.31 95.46 46.01 55.34 91.59 42.65 35.34 13.14 30.41 31.67 15.04 34.58 coo 66.35 87.81 48.53 68.10 89.01 48.77 46.39 7.18 37.53 46.28 7.18 39.63 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 4 3 # 4 I 182 LYS A 157 LYS^? 28.65 MG MG A 302 I 184 LYS A 166 LYS^? 20.93 MG MG A 302 I 345 ASP A 160 ASP^? 31.61 MG MG B 302 coo 60.20 96.92 42.53 57.60 93.13 38.67 41.42 12.06 27.58 41.46 5.93 29.41 coo 54.31 95.46 46.01 55.34 91.59 42.65 35.34 13.14 30.41 31.67 15.04 34.58 coo 66.35 87.81 48.53 68.10 89.01 48.77 44.21 5.00 19.54 46.02 3.84 19.76 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 5 3 # 5 I 182 LYS B 6 LYS^? 25.90 MG MG B 302 I 184 LYS B 157 LYS^? 28.85 MG MG B 302 I 345 ASP B 138 ASP^? 33.32 MG MG B 302 coo 60.20 96.92 42.53 57.60 93.13 38.67 36.26 25.44 11.74 39.65 23.12 16.29 coo 54.31 95.46 46.01 55.34 91.59 42.65 34.97 21.28 8.44 29.03 22.82 6.58 coo 66.35 87.81 48.53 68.10 89.01 48.77 23.42 29.01 6.78 24.36 28.48 4.94 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 6 3 # 6 I 182 LYS B 157 LYS^? 28.85 MG MG B 302 I 184 LYS B 6 LYS^? 25.90 MG MG B 302 I 345 ASP B 138 ASP^? 33.32 MG MG B 302 coo 60.20 96.92 42.53 57.60 93.13 38.67 34.97 21.28 8.44 29.03 22.82 6.58 coo 54.31 95.46 46.01 55.34 91.59 42.65 36.26 25.44 11.74 39.65 23.12 16.29 coo 66.35 87.81 48.53 68.10 89.01 48.77 23.42 29.01 6.78 24.36 28.48 4.94 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 7 3 # 7 I 182 LYS B 157 LYS^? 28.85 MG MG B 302 I 184 LYS B 6 LYS^? 25.90 MG MG B 302 I 345 ASP B 142 ASP^? 23.97 MG MG B 301 coo 60.20 96.92 42.53 57.60 93.13 38.67 34.97 21.28 8.44 29.03 22.82 6.58 coo 54.31 95.46 46.01 55.34 91.59 42.65 36.26 25.44 11.74 39.65 23.12 16.29 coo 66.35 87.81 48.53 68.10 89.01 48.77 31.69 27.40 -1.31 32.10 27.37 -3.38 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 8 3 # 8 I 182 LYS B 157 LYS^? 28.85 MG MG B 302 I 184 LYS B 166 LYS^? 22.75 MG MG B 301 I 345 ASP B 142 ASP^? 23.97 MG MG B 301 coo 60.20 96.92 42.53 57.60 93.13 38.67 34.97 21.28 8.44 29.03 22.82 6.58 coo 54.31 95.46 46.01 55.34 91.59 42.65 35.27 15.38 5.31 37.27 9.81 3.93 coo 66.35 87.81 48.53 68.10 89.01 48.77 31.69 27.40 -1.31 32.10 27.37 -3.38 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 9 3 # 9 I 182 LYS B 157 LYS^? 28.85 MG MG B 302 I 184 LYS B 166 LYS^? 22.75 MG MG B 301 I 345 ASP B 160 ASP^? 31.65 MG MG A 301 coo 60.20 96.92 42.53 57.60 93.13 38.67 34.97 21.28 8.44 29.03 22.82 6.58 coo 54.31 95.46 46.01 55.34 91.59 42.65 35.27 15.38 5.31 37.27 9.81 3.93 coo 66.35 87.81 48.53 68.10 89.01 48.77 28.01 24.83 16.38 27.44 26.81 15.80 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 10 3 # 10 I 182 LYS C 157 LYS^? 28.15 MG MG C 302 I 184 LYS C 6 LYS^? 25.73 MG MG C 302 I 345 ASP C 138 ASP^? 33.43 MG MG C 302 coo 60.20 96.92 42.53 57.60 93.13 38.67 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 54.31 95.46 46.01 55.34 91.59 42.65 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 66.35 87.81 48.53 68.10 89.01 48.77 105.43 43.97 -13.30 104.85 43.08 -11.43 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 11 3 # 11 I 182 LYS C 157 LYS^? 28.15 MG MG C 302 I 184 LYS C 6 LYS^? 25.73 MG MG C 302 I 345 ASP C 142 ASP^? 23.76 MG MG C 301 coo 60.20 96.92 42.53 57.60 93.13 38.67 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 54.31 95.46 46.01 55.34 91.59 42.65 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 66.35 87.81 48.53 68.10 89.01 48.77 97.94 39.27 -5.03 98.08 38.70 -2.97 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 12 3 # 12 I 182 LYS C 157 LYS^? 28.15 MG MG C 302 I 184 LYS C 166 LYS^? 22.53 MG MG C 301 I 345 ASP C 142 ASP^? 23.76 MG MG C 301 coo 60.20 96.92 42.53 57.60 93.13 38.67 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 54.31 95.46 46.01 55.34 91.59 42.65 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 66.35 87.81 48.53 68.10 89.01 48.77 97.94 39.27 -5.03 98.08 38.70 -2.97 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 13 3 # 13 I 182 LYS C 157 LYS^? 28.15 MG MG C 302 I 184 LYS C 166 LYS^? 22.53 MG MG C 301 I 345 ASP C 160 ASP^? 31.63 MG MG D 302 coo 60.20 96.92 42.53 57.60 93.13 38.67 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 54.31 95.46 46.01 55.34 91.59 42.65 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 66.35 87.81 48.53 68.10 89.01 48.77 102.50 38.00 -23.28 102.43 39.97 -22.46 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 14 3 # 14 I 182 LYS D 6 LYS^? 25.98 MG MG D 302 I 184 LYS D 157 LYS^? 28.67 MG MG D 302 I 345 ASP D 138 ASP^? 33.64 MG MG D 302 coo 60.20 96.92 42.53 57.60 93.13 38.67 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 54.31 95.46 46.01 55.34 91.59 42.65 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 66.35 87.81 48.53 68.10 89.01 48.77 93.00 7.50 -35.79 93.88 8.48 -37.45 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 15 3 # 15 I 182 LYS D 6 LYS^? 25.98 MG MG D 302 I 184 LYS D 157 LYS^? 28.67 MG MG D 302 I 345 ASP D 142 ASP^? 23.49 MG MG D 301 coo 60.20 96.92 42.53 57.60 93.13 38.67 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 54.31 95.46 46.01 55.34 91.59 42.65 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 66.35 87.81 48.53 68.10 89.01 48.77 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 16 3 # 16 I 182 LYS D 157 LYS^? 28.67 MG MG D 302 I 184 LYS D 6 LYS^? 25.98 MG MG D 302 I 345 ASP D 138 ASP^? 33.64 MG MG D 302 coo 60.20 96.92 42.53 57.60 93.13 38.67 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 54.31 95.46 46.01 55.34 91.59 42.65 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 66.35 87.81 48.53 68.10 89.01 48.77 93.00 7.50 -35.79 93.88 8.48 -37.45 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 17 3 # 17 I 182 LYS D 157 LYS^? 28.67 MG MG D 302 I 184 LYS D 6 LYS^? 25.98 MG MG D 302 I 345 ASP D 142 ASP^? 23.49 MG MG D 301 coo 60.20 96.92 42.53 57.60 93.13 38.67 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 54.31 95.46 46.01 55.34 91.59 42.65 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 66.35 87.81 48.53 68.10 89.01 48.77 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 18 3 # 18 I 182 LYS D 157 LYS^? 28.67 MG MG D 302 I 184 LYS D 166 LYS^? 21.08 MG MG D 301 I 345 ASP D 142 ASP^? 23.49 MG MG D 301 coo 60.20 96.92 42.53 57.60 93.13 38.67 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 54.31 95.46 46.01 55.34 91.59 42.65 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 66.35 87.81 48.53 68.10 89.01 48.77 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 19 3 # 19 I 182 LYS D 157 LYS^? 28.67 MG MG D 302 I 184 LYS D 166 LYS^? 21.08 MG MG D 301 I 345 ASP D 160 ASP^? 31.45 MG MG C 302 coo 60.20 96.92 42.53 57.60 93.13 38.67 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 54.31 95.46 46.01 55.34 91.59 42.65 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 66.35 87.81 48.53 68.10 89.01 48.77 94.15 13.98 -26.57 92.71 12.42 -26.99 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 20 3 # 20 I 182 LYS E 157 LYS^? 28.40 MG MG E 302 I 184 LYS E 6 LYS^? 25.59 MG MG E 302 I 345 ASP E 138 ASP^? 33.31 MG MG E 302 coo 60.20 96.92 42.53 57.60 93.13 38.67 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 54.31 95.46 46.01 55.34 91.59 42.65 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 66.35 87.81 48.53 68.10 89.01 48.77 39.58 70.77 -58.63 40.74 70.78 -56.80 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 21 3 # 21 I 182 LYS E 157 LYS^? 28.40 MG MG E 302 I 184 LYS E 6 LYS^? 25.59 MG MG E 302 I 345 ASP E 142 ASP^? 23.66 MG MG E 301 coo 60.20 96.92 42.53 57.60 93.13 38.67 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 54.31 95.46 46.01 55.34 91.59 42.65 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 66.35 87.81 48.53 68.10 89.01 48.77 47.19 67.15 -50.37 47.44 67.18 -48.23 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 22 3 # 22 I 182 LYS E 157 LYS^? 28.40 MG MG E 302 I 184 LYS E 166 LYS^? 21.46 MG MG E 301 I 345 ASP E 142 ASP^? 23.66 MG MG E 301 coo 60.20 96.92 42.53 57.60 93.13 38.67 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 54.31 95.46 46.01 55.34 91.59 42.65 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 66.35 87.81 48.53 68.10 89.01 48.77 47.19 67.15 -50.37 47.44 67.18 -48.23 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 23 3 # 23 I 182 LYS E 157 LYS^? 28.40 MG MG E 302 I 184 LYS E 166 LYS^? 21.46 MG MG E 301 I 345 ASP E 160 ASP^? 31.54 MG MG F 301 coo 60.20 96.92 42.53 57.60 93.13 38.67 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 54.31 95.46 46.01 55.34 91.59 42.65 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 66.35 87.81 48.53 68.10 89.01 48.77 45.81 70.00 -68.45 44.10 68.87 -67.77 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 24 3 # 24 I 182 LYS F 157 LYS^? 28.36 MG MG F 302 I 184 LYS F 6 LYS^? 26.09 MG MG F 301 I 345 ASP F 138 ASP^? 33.51 MG MG F 302 coo 60.20 96.92 42.53 57.60 93.13 38.67 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 54.31 95.46 46.01 55.34 91.59 42.65 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 66.35 87.81 48.53 68.10 89.01 48.77 77.17 76.66 -81.48 76.14 76.33 -83.32 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 25 3 # 25 I 182 LYS F 157 LYS^? 28.36 MG MG F 302 I 184 LYS F 6 LYS^? 26.09 MG MG F 301 I 345 ASP F 142 ASP^? 23.43 MG MG F 302 coo 60.20 96.92 42.53 57.60 93.13 38.67 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 54.31 95.46 46.01 55.34 91.59 42.65 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 66.35 87.81 48.53 68.10 89.01 48.77 71.46 69.88 -89.76 71.03 69.93 -91.81 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 26 3 # 26 I 182 LYS F 157 LYS^? 28.36 MG MG F 302 I 184 LYS F 166 LYS^? 20.76 MG MG F 302 I 345 ASP F 142 ASP^? 23.43 MG MG F 302 coo 60.20 96.92 42.53 57.60 93.13 38.67 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 54.31 95.46 46.01 55.34 91.59 42.65 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 66.35 87.81 48.53 68.10 89.01 48.77 71.46 69.88 -89.76 71.03 69.93 -91.81 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 27 3 # 27 I 182 LYS F 157 LYS^? 28.36 MG MG F 302 I 184 LYS F 166 LYS^? 20.76 MG MG F 302 I 345 ASP F 160 ASP^? 31.59 MG MG E 302 coo 60.20 96.92 42.53 57.60 93.13 38.67 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 54.31 95.46 46.01 55.34 91.59 42.65 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 66.35 87.81 48.53 68.10 89.01 48.77 71.27 74.59 -71.77 73.23 74.02 -72.37 2dw7_c40 source 2dw7 BLL6730 PROTEIN : 27 hits 2dw7_c40 naa= 3 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 1 3 # 1 J 182 LYS A 6 LYS^? 25.88 MG MG A 301 J 184 LYS A 157 LYS^? 28.65 MG MG A 302 J 345 ASP A 138 ASP^? 33.08 MG MG A 302 coo 25.22 70.55 14.03 27.64 73.07 18.65 46.20 12.82 24.71 44.50 16.64 20.52 coo 31.73 69.87 11.50 32.73 70.19 16.40 41.42 12.06 27.58 41.46 5.93 29.41 coo 25.87 58.42 18.79 23.95 58.54 17.90 47.10 -0.97 29.63 45.89 0.22 30.96 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 2 3 # 2 J 182 LYS A 157 LYS^? 28.65 MG MG A 302 J 184 LYS A 6 LYS^? 25.88 MG MG A 301 J 345 ASP A 138 ASP^? 33.08 MG MG A 302 coo 25.22 70.55 14.03 27.64 73.07 18.65 41.42 12.06 27.58 41.46 5.93 29.41 coo 31.73 69.87 11.50 32.73 70.19 16.40 46.20 12.82 24.71 44.50 16.64 20.52 coo 25.87 58.42 18.79 23.95 58.54 17.90 47.10 -0.97 29.63 45.89 0.22 30.96 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 3 3 # 3 J 182 LYS A 157 LYS^? 28.65 MG MG A 302 J 184 LYS A 6 LYS^? 25.88 MG MG A 301 J 345 ASP A 142 ASP^? 23.70 MG MG A 302 coo 25.22 70.55 14.03 27.64 73.07 18.65 41.42 12.06 27.58 41.46 5.93 29.41 coo 31.73 69.87 11.50 32.73 70.19 16.40 46.20 12.82 24.71 44.50 16.64 20.52 coo 25.87 58.42 18.79 23.95 58.54 17.90 46.39 7.18 37.53 46.28 7.18 39.63 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 4 3 # 4 J 182 LYS A 157 LYS^? 28.65 MG MG A 302 J 184 LYS A 166 LYS^? 20.93 MG MG A 302 J 345 ASP A 142 ASP^? 23.70 MG MG A 302 coo 25.22 70.55 14.03 27.64 73.07 18.65 41.42 12.06 27.58 41.46 5.93 29.41 coo 31.73 69.87 11.50 32.73 70.19 16.40 35.34 13.14 30.41 31.67 15.04 34.58 coo 25.87 58.42 18.79 23.95 58.54 17.90 46.39 7.18 37.53 46.28 7.18 39.63 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 5 3 # 5 J 182 LYS A 157 LYS^? 28.65 MG MG A 302 J 184 LYS A 166 LYS^? 20.93 MG MG A 302 J 345 ASP A 160 ASP^? 31.61 MG MG B 302 coo 25.22 70.55 14.03 27.64 73.07 18.65 41.42 12.06 27.58 41.46 5.93 29.41 coo 31.73 69.87 11.50 32.73 70.19 16.40 35.34 13.14 30.41 31.67 15.04 34.58 coo 25.87 58.42 18.79 23.95 58.54 17.90 44.21 5.00 19.54 46.02 3.84 19.76 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 6 3 # 6 J 182 LYS B 6 LYS^? 25.90 MG MG B 302 J 184 LYS B 157 LYS^? 28.85 MG MG B 302 J 345 ASP B 138 ASP^? 33.32 MG MG B 302 coo 25.22 70.55 14.03 27.64 73.07 18.65 36.26 25.44 11.74 39.65 23.12 16.29 coo 31.73 69.87 11.50 32.73 70.19 16.40 34.97 21.28 8.44 29.03 22.82 6.58 coo 25.87 58.42 18.79 23.95 58.54 17.90 23.42 29.01 6.78 24.36 28.48 4.94 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 7 3 # 7 J 182 LYS B 157 LYS^? 28.85 MG MG B 302 J 184 LYS B 6 LYS^? 25.90 MG MG B 302 J 345 ASP B 138 ASP^? 33.32 MG MG B 302 coo 25.22 70.55 14.03 27.64 73.07 18.65 34.97 21.28 8.44 29.03 22.82 6.58 coo 31.73 69.87 11.50 32.73 70.19 16.40 36.26 25.44 11.74 39.65 23.12 16.29 coo 25.87 58.42 18.79 23.95 58.54 17.90 23.42 29.01 6.78 24.36 28.48 4.94 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 8 3 # 8 J 182 LYS B 157 LYS^? 28.85 MG MG B 302 J 184 LYS B 6 LYS^? 25.90 MG MG B 302 J 345 ASP B 142 ASP^? 23.97 MG MG B 301 coo 25.22 70.55 14.03 27.64 73.07 18.65 34.97 21.28 8.44 29.03 22.82 6.58 coo 31.73 69.87 11.50 32.73 70.19 16.40 36.26 25.44 11.74 39.65 23.12 16.29 coo 25.87 58.42 18.79 23.95 58.54 17.90 31.69 27.40 -1.31 32.10 27.37 -3.38 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 9 3 # 9 J 182 LYS B 157 LYS^? 28.85 MG MG B 302 J 184 LYS B 166 LYS^? 22.75 MG MG B 301 J 345 ASP B 142 ASP^? 23.97 MG MG B 301 coo 25.22 70.55 14.03 27.64 73.07 18.65 34.97 21.28 8.44 29.03 22.82 6.58 coo 31.73 69.87 11.50 32.73 70.19 16.40 35.27 15.38 5.31 37.27 9.81 3.93 coo 25.87 58.42 18.79 23.95 58.54 17.90 31.69 27.40 -1.31 32.10 27.37 -3.38 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 10 3 # 10 J 182 LYS B 157 LYS^? 28.85 MG MG B 302 J 184 LYS B 166 LYS^? 22.75 MG MG B 301 J 345 ASP B 160 ASP^? 31.65 MG MG A 301 coo 25.22 70.55 14.03 27.64 73.07 18.65 34.97 21.28 8.44 29.03 22.82 6.58 coo 31.73 69.87 11.50 32.73 70.19 16.40 35.27 15.38 5.31 37.27 9.81 3.93 coo 25.87 58.42 18.79 23.95 58.54 17.90 28.01 24.83 16.38 27.44 26.81 15.80 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 11 3 # 11 J 182 LYS C 6 LYS^? 25.73 MG MG C 302 J 184 LYS C 157 LYS^? 28.15 MG MG C 302 J 345 ASP C 138 ASP^? 33.43 MG MG C 302 coo 25.22 70.55 14.03 27.64 73.07 18.65 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 31.73 69.87 11.50 32.73 70.19 16.40 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 25.87 58.42 18.79 23.95 58.54 17.90 105.43 43.97 -13.30 104.85 43.08 -11.43 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 12 3 # 12 J 182 LYS C 157 LYS^? 28.15 MG MG C 302 J 184 LYS C 6 LYS^? 25.73 MG MG C 302 J 345 ASP C 138 ASP^? 33.43 MG MG C 302 coo 25.22 70.55 14.03 27.64 73.07 18.65 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 31.73 69.87 11.50 32.73 70.19 16.40 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 25.87 58.42 18.79 23.95 58.54 17.90 105.43 43.97 -13.30 104.85 43.08 -11.43 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 13 3 # 13 J 182 LYS C 157 LYS^? 28.15 MG MG C 302 J 184 LYS C 6 LYS^? 25.73 MG MG C 302 J 345 ASP C 142 ASP^? 23.76 MG MG C 301 coo 25.22 70.55 14.03 27.64 73.07 18.65 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 31.73 69.87 11.50 32.73 70.19 16.40 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 25.87 58.42 18.79 23.95 58.54 17.90 97.94 39.27 -5.03 98.08 38.70 -2.97 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 14 3 # 14 J 182 LYS C 157 LYS^? 28.15 MG MG C 302 J 184 LYS C 166 LYS^? 22.53 MG MG C 301 J 345 ASP C 142 ASP^? 23.76 MG MG C 301 coo 25.22 70.55 14.03 27.64 73.07 18.65 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 31.73 69.87 11.50 32.73 70.19 16.40 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 25.87 58.42 18.79 23.95 58.54 17.90 97.94 39.27 -5.03 98.08 38.70 -2.97 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 15 3 # 15 J 182 LYS C 157 LYS^? 28.15 MG MG C 302 J 184 LYS C 166 LYS^? 22.53 MG MG C 301 J 345 ASP C 160 ASP^? 31.63 MG MG D 302 coo 25.22 70.55 14.03 27.64 73.07 18.65 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 31.73 69.87 11.50 32.73 70.19 16.40 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 25.87 58.42 18.79 23.95 58.54 17.90 102.50 38.00 -23.28 102.43 39.97 -22.46 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 16 3 # 16 J 182 LYS D 6 LYS^? 25.98 MG MG D 302 J 184 LYS D 157 LYS^? 28.67 MG MG D 302 J 345 ASP D 138 ASP^? 33.64 MG MG D 302 coo 25.22 70.55 14.03 27.64 73.07 18.65 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 31.73 69.87 11.50 32.73 70.19 16.40 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 25.87 58.42 18.79 23.95 58.54 17.90 93.00 7.50 -35.79 93.88 8.48 -37.45 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 17 3 # 17 J 182 LYS D 157 LYS^? 28.67 MG MG D 302 J 184 LYS D 6 LYS^? 25.98 MG MG D 302 J 345 ASP D 138 ASP^? 33.64 MG MG D 302 coo 25.22 70.55 14.03 27.64 73.07 18.65 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 31.73 69.87 11.50 32.73 70.19 16.40 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 25.87 58.42 18.79 23.95 58.54 17.90 93.00 7.50 -35.79 93.88 8.48 -37.45 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 18 3 # 18 J 182 LYS D 157 LYS^? 28.67 MG MG D 302 J 184 LYS D 6 LYS^? 25.98 MG MG D 302 J 345 ASP D 142 ASP^? 23.49 MG MG D 301 coo 25.22 70.55 14.03 27.64 73.07 18.65 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 31.73 69.87 11.50 32.73 70.19 16.40 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 25.87 58.42 18.79 23.95 58.54 17.90 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 19 3 # 19 J 182 LYS D 157 LYS^? 28.67 MG MG D 302 J 184 LYS D 166 LYS^? 21.08 MG MG D 301 J 345 ASP D 142 ASP^? 23.49 MG MG D 301 coo 25.22 70.55 14.03 27.64 73.07 18.65 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 31.73 69.87 11.50 32.73 70.19 16.40 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 25.87 58.42 18.79 23.95 58.54 17.90 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 20 3 # 20 J 182 LYS E 6 LYS^? 25.59 MG MG E 302 J 184 LYS E 157 LYS^? 28.40 MG MG E 302 J 345 ASP E 138 ASP^? 33.31 MG MG E 302 coo 25.22 70.55 14.03 27.64 73.07 18.65 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 31.73 69.87 11.50 32.73 70.19 16.40 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 25.87 58.42 18.79 23.95 58.54 17.90 39.58 70.77 -58.63 40.74 70.78 -56.80 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 21 3 # 21 J 182 LYS E 157 LYS^? 28.40 MG MG E 302 J 184 LYS E 6 LYS^? 25.59 MG MG E 302 J 345 ASP E 138 ASP^? 33.31 MG MG E 302 coo 25.22 70.55 14.03 27.64 73.07 18.65 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 31.73 69.87 11.50 32.73 70.19 16.40 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 25.87 58.42 18.79 23.95 58.54 17.90 39.58 70.77 -58.63 40.74 70.78 -56.80 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 22 3 # 22 J 182 LYS E 157 LYS^? 28.40 MG MG E 302 J 184 LYS E 6 LYS^? 25.59 MG MG E 302 J 345 ASP E 142 ASP^? 23.66 MG MG E 301 coo 25.22 70.55 14.03 27.64 73.07 18.65 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 31.73 69.87 11.50 32.73 70.19 16.40 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 25.87 58.42 18.79 23.95 58.54 17.90 47.19 67.15 -50.37 47.44 67.18 -48.23 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 23 3 # 23 J 182 LYS E 157 LYS^? 28.40 MG MG E 302 J 184 LYS E 166 LYS^? 21.46 MG MG E 301 J 345 ASP E 142 ASP^? 23.66 MG MG E 301 coo 25.22 70.55 14.03 27.64 73.07 18.65 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 31.73 69.87 11.50 32.73 70.19 16.40 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 25.87 58.42 18.79 23.95 58.54 17.90 47.19 67.15 -50.37 47.44 67.18 -48.23 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 24 3 # 24 J 182 LYS E 157 LYS^? 28.40 MG MG E 302 J 184 LYS E 166 LYS^? 21.46 MG MG E 301 J 345 ASP E 160 ASP^? 31.54 MG MG F 301 coo 25.22 70.55 14.03 27.64 73.07 18.65 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 31.73 69.87 11.50 32.73 70.19 16.40 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 25.87 58.42 18.79 23.95 58.54 17.90 45.81 70.00 -68.45 44.10 68.87 -67.77 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 25 3 # 25 J 182 LYS F 6 LYS^? 26.09 MG MG F 301 J 184 LYS F 157 LYS^? 28.36 MG MG F 302 J 345 ASP F 138 ASP^? 33.51 MG MG F 302 coo 25.22 70.55 14.03 27.64 73.07 18.65 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 31.73 69.87 11.50 32.73 70.19 16.40 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 25.87 58.42 18.79 23.95 58.54 17.90 77.17 76.66 -81.48 76.14 76.33 -83.32 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 26 3 # 26 J 182 LYS F 157 LYS^? 28.36 MG MG F 302 J 184 LYS F 6 LYS^? 26.09 MG MG F 301 J 345 ASP F 138 ASP^? 33.51 MG MG F 302 coo 25.22 70.55 14.03 27.64 73.07 18.65 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 31.73 69.87 11.50 32.73 70.19 16.40 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 25.87 58.42 18.79 23.95 58.54 17.90 77.17 76.66 -81.48 76.14 76.33 -83.32 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 27 3 # 27 J 182 LYS F 157 LYS^? 28.36 MG MG F 302 J 184 LYS F 6 LYS^? 26.09 MG MG F 301 J 345 ASP F 142 ASP^? 23.43 MG MG F 302 coo 25.22 70.55 14.03 27.64 73.07 18.65 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 31.73 69.87 11.50 32.73 70.19 16.40 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 25.87 58.42 18.79 23.95 58.54 17.90 71.46 69.88 -89.76 71.03 69.93 -91.81 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 28 3 # 28 J 182 LYS F 157 LYS^? 28.36 MG MG F 302 J 184 LYS F 166 LYS^? 20.76 MG MG F 302 J 345 ASP F 142 ASP^? 23.43 MG MG F 302 coo 25.22 70.55 14.03 27.64 73.07 18.65 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 31.73 69.87 11.50 32.73 70.19 16.40 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 25.87 58.42 18.79 23.95 58.54 17.90 71.46 69.88 -89.76 71.03 69.93 -91.81 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 29 3 # 29 J 182 LYS F 157 LYS^? 28.36 MG MG F 302 J 184 LYS F 166 LYS^? 20.76 MG MG F 302 J 345 ASP F 160 ASP^? 31.59 MG MG E 302 coo 25.22 70.55 14.03 27.64 73.07 18.65 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 31.73 69.87 11.50 32.73 70.19 16.40 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 25.87 58.42 18.79 23.95 58.54 17.90 71.27 74.59 -71.77 73.23 74.02 -72.37 2dw7_c41 source 2dw7 BLL6730 PROTEIN : 29 hits 2dw7_c41 naa= 3 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 1 3 # 1 K 182 LYS A 6 LYS^? 25.88 MG MG A 301 K 184 LYS A 157 LYS^? 28.65 MG MG A 302 K 345 ASP A 138 ASP^? 33.08 MG MG A 302 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 46.20 12.82 24.71 44.50 16.64 20.52 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 41.42 12.06 27.58 41.46 5.93 29.41 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 47.10 -0.97 29.63 45.89 0.22 30.96 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 2 3 # 2 K 182 LYS A 157 LYS^? 28.65 MG MG A 302 K 184 LYS A 6 LYS^? 25.88 MG MG A 301 K 345 ASP A 138 ASP^? 33.08 MG MG A 302 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 41.42 12.06 27.58 41.46 5.93 29.41 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 46.20 12.82 24.71 44.50 16.64 20.52 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 47.10 -0.97 29.63 45.89 0.22 30.96 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 3 3 # 3 K 182 LYS A 157 LYS^? 28.65 MG MG A 302 K 184 LYS A 6 LYS^? 25.88 MG MG A 301 K 345 ASP A 142 ASP^? 23.70 MG MG A 302 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 41.42 12.06 27.58 41.46 5.93 29.41 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 46.20 12.82 24.71 44.50 16.64 20.52 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 46.39 7.18 37.53 46.28 7.18 39.63 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 4 3 # 4 K 182 LYS A 157 LYS^? 28.65 MG MG A 302 K 184 LYS A 166 LYS^? 20.93 MG MG A 302 K 345 ASP A 142 ASP^? 23.70 MG MG A 302 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 41.42 12.06 27.58 41.46 5.93 29.41 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 35.34 13.14 30.41 31.67 15.04 34.58 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 46.39 7.18 37.53 46.28 7.18 39.63 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 5 3 # 5 K 182 LYS A 157 LYS^? 28.65 MG MG A 302 K 184 LYS A 166 LYS^? 20.93 MG MG A 302 K 345 ASP A 160 ASP^? 31.61 MG MG B 302 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 41.42 12.06 27.58 41.46 5.93 29.41 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 35.34 13.14 30.41 31.67 15.04 34.58 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 44.21 5.00 19.54 46.02 3.84 19.76 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 6 3 # 6 K 182 LYS B 6 LYS^? 25.90 MG MG B 302 K 184 LYS B 157 LYS^? 28.85 MG MG B 302 K 345 ASP B 138 ASP^? 33.32 MG MG B 302 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 36.26 25.44 11.74 39.65 23.12 16.29 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 34.97 21.28 8.44 29.03 22.82 6.58 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 23.42 29.01 6.78 24.36 28.48 4.94 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 7 3 # 7 K 182 LYS B 157 LYS^? 28.85 MG MG B 302 K 184 LYS B 6 LYS^? 25.90 MG MG B 302 K 345 ASP B 138 ASP^? 33.32 MG MG B 302 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 34.97 21.28 8.44 29.03 22.82 6.58 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 36.26 25.44 11.74 39.65 23.12 16.29 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 23.42 29.01 6.78 24.36 28.48 4.94 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 8 3 # 8 K 182 LYS B 157 LYS^? 28.85 MG MG B 302 K 184 LYS B 6 LYS^? 25.90 MG MG B 302 K 345 ASP B 142 ASP^? 23.97 MG MG B 301 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 34.97 21.28 8.44 29.03 22.82 6.58 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 36.26 25.44 11.74 39.65 23.12 16.29 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 31.69 27.40 -1.31 32.10 27.37 -3.38 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 9 3 # 9 K 182 LYS B 157 LYS^? 28.85 MG MG B 302 K 184 LYS B 166 LYS^? 22.75 MG MG B 301 K 345 ASP B 142 ASP^? 23.97 MG MG B 301 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 34.97 21.28 8.44 29.03 22.82 6.58 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 35.27 15.38 5.31 37.27 9.81 3.93 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 31.69 27.40 -1.31 32.10 27.37 -3.38 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 10 3 # 10 K 182 LYS B 157 LYS^? 28.85 MG MG B 302 K 184 LYS B 166 LYS^? 22.75 MG MG B 301 K 345 ASP B 160 ASP^? 31.65 MG MG A 301 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 34.97 21.28 8.44 29.03 22.82 6.58 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 35.27 15.38 5.31 37.27 9.81 3.93 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 28.01 24.83 16.38 27.44 26.81 15.80 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 11 3 # 11 K 182 LYS C 157 LYS^? 28.15 MG MG C 302 K 184 LYS C 6 LYS^? 25.73 MG MG C 302 K 345 ASP C 138 ASP^? 33.43 MG MG C 302 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 105.43 43.97 -13.30 104.85 43.08 -11.43 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 12 3 # 12 K 182 LYS C 157 LYS^? 28.15 MG MG C 302 K 184 LYS C 6 LYS^? 25.73 MG MG C 302 K 345 ASP C 142 ASP^? 23.76 MG MG C 301 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 97.94 39.27 -5.03 98.08 38.70 -2.97 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 13 3 # 13 K 182 LYS C 157 LYS^? 28.15 MG MG C 302 K 184 LYS C 166 LYS^? 22.53 MG MG C 301 K 345 ASP C 142 ASP^? 23.76 MG MG C 301 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 97.94 39.27 -5.03 98.08 38.70 -2.97 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 14 3 # 14 K 182 LYS C 157 LYS^? 28.15 MG MG C 302 K 184 LYS C 166 LYS^? 22.53 MG MG C 301 K 345 ASP C 160 ASP^? 31.63 MG MG D 302 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 102.50 38.00 -23.28 102.43 39.97 -22.46 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 15 3 # 15 K 182 LYS D 6 LYS^? 25.98 MG MG D 302 K 184 LYS D 157 LYS^? 28.67 MG MG D 302 K 345 ASP D 138 ASP^? 33.64 MG MG D 302 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 93.00 7.50 -35.79 93.88 8.48 -37.45 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 16 3 # 16 K 182 LYS D 157 LYS^? 28.67 MG MG D 302 K 184 LYS D 6 LYS^? 25.98 MG MG D 302 K 345 ASP D 138 ASP^? 33.64 MG MG D 302 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 93.00 7.50 -35.79 93.88 8.48 -37.45 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 17 3 # 17 K 182 LYS D 157 LYS^? 28.67 MG MG D 302 K 184 LYS D 6 LYS^? 25.98 MG MG D 302 K 345 ASP D 142 ASP^? 23.49 MG MG D 301 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 18 3 # 18 K 182 LYS D 157 LYS^? 28.67 MG MG D 302 K 184 LYS D 166 LYS^? 21.08 MG MG D 301 K 345 ASP D 142 ASP^? 23.49 MG MG D 301 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 19 3 # 19 K 182 LYS D 157 LYS^? 28.67 MG MG D 302 K 184 LYS D 166 LYS^? 21.08 MG MG D 301 K 345 ASP D 160 ASP^? 31.45 MG MG C 302 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 94.15 13.98 -26.57 92.71 12.42 -26.99 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 20 3 # 20 K 182 LYS E 6 LYS^? 25.59 MG MG E 302 K 184 LYS E 157 LYS^? 28.40 MG MG E 302 K 345 ASP E 138 ASP^? 33.31 MG MG E 302 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 39.58 70.77 -58.63 40.74 70.78 -56.80 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 21 3 # 21 K 182 LYS E 157 LYS^? 28.40 MG MG E 302 K 184 LYS E 6 LYS^? 25.59 MG MG E 302 K 345 ASP E 138 ASP^? 33.31 MG MG E 302 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 39.58 70.77 -58.63 40.74 70.78 -56.80 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 22 3 # 22 K 182 LYS E 157 LYS^? 28.40 MG MG E 302 K 184 LYS E 6 LYS^? 25.59 MG MG E 302 K 345 ASP E 142 ASP^? 23.66 MG MG E 301 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 47.19 67.15 -50.37 47.44 67.18 -48.23 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 23 3 # 23 K 182 LYS E 157 LYS^? 28.40 MG MG E 302 K 184 LYS E 166 LYS^? 21.46 MG MG E 301 K 345 ASP E 142 ASP^? 23.66 MG MG E 301 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 47.19 67.15 -50.37 47.44 67.18 -48.23 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 24 3 # 24 K 182 LYS E 157 LYS^? 28.40 MG MG E 302 K 184 LYS E 166 LYS^? 21.46 MG MG E 301 K 345 ASP E 160 ASP^? 31.54 MG MG F 301 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 45.81 70.00 -68.45 44.10 68.87 -67.77 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 25 3 # 25 K 182 LYS F 6 LYS^? 26.09 MG MG F 301 K 184 LYS F 157 LYS^? 28.36 MG MG F 302 K 345 ASP F 138 ASP^? 33.51 MG MG F 302 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 77.17 76.66 -81.48 76.14 76.33 -83.32 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 26 3 # 26 K 182 LYS F 157 LYS^? 28.36 MG MG F 302 K 184 LYS F 6 LYS^? 26.09 MG MG F 301 K 345 ASP F 138 ASP^? 33.51 MG MG F 302 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 77.17 76.66 -81.48 76.14 76.33 -83.32 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 27 3 # 27 K 182 LYS F 157 LYS^? 28.36 MG MG F 302 K 184 LYS F 6 LYS^? 26.09 MG MG F 301 K 345 ASP F 142 ASP^? 23.43 MG MG F 302 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 71.46 69.88 -89.76 71.03 69.93 -91.81 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 28 3 # 28 K 182 LYS F 157 LYS^? 28.36 MG MG F 302 K 184 LYS F 166 LYS^? 20.76 MG MG F 302 K 345 ASP F 142 ASP^? 23.43 MG MG F 302 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 71.46 69.88 -89.76 71.03 69.93 -91.81 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 29 3 # 29 K 182 LYS F 157 LYS^? 28.36 MG MG F 302 K 184 LYS F 166 LYS^? 20.76 MG MG F 302 K 345 ASP F 160 ASP^? 31.59 MG MG E 302 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 71.27 74.59 -71.77 73.23 74.02 -72.37 2dw7_c42 source 2dw7 BLL6730 PROTEIN : 29 hits 2dw7_c42 naa= 3 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 1 3 # 1 L 182 LYS A 6 LYS^? 25.88 MG MG A 301 L 184 LYS A 157 LYS^? 28.65 MG MG A 302 L 345 ASP A 138 ASP^? 33.08 MG MG A 302 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 46.20 12.82 24.71 44.50 16.64 20.52 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 41.42 12.06 27.58 41.46 5.93 29.41 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 47.10 -0.97 29.63 45.89 0.22 30.96 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 2 3 # 2 L 182 LYS A 157 LYS^? 28.65 MG MG A 302 L 184 LYS A 6 LYS^? 25.88 MG MG A 301 L 345 ASP A 138 ASP^? 33.08 MG MG A 302 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 41.42 12.06 27.58 41.46 5.93 29.41 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 46.20 12.82 24.71 44.50 16.64 20.52 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 47.10 -0.97 29.63 45.89 0.22 30.96 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 3 3 # 3 L 182 LYS A 157 LYS^? 28.65 MG MG A 302 L 184 LYS A 6 LYS^? 25.88 MG MG A 301 L 345 ASP A 142 ASP^? 23.70 MG MG A 302 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 41.42 12.06 27.58 41.46 5.93 29.41 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 46.20 12.82 24.71 44.50 16.64 20.52 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 46.39 7.18 37.53 46.28 7.18 39.63 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 4 3 # 4 L 182 LYS A 157 LYS^? 28.65 MG MG A 302 L 184 LYS A 166 LYS^? 20.93 MG MG A 302 L 345 ASP A 142 ASP^? 23.70 MG MG A 302 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 41.42 12.06 27.58 41.46 5.93 29.41 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 35.34 13.14 30.41 31.67 15.04 34.58 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 46.39 7.18 37.53 46.28 7.18 39.63 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 5 3 # 5 L 182 LYS B 6 LYS^? 25.90 MG MG B 302 L 184 LYS B 157 LYS^? 28.85 MG MG B 302 L 345 ASP B 138 ASP^? 33.32 MG MG B 302 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 36.26 25.44 11.74 39.65 23.12 16.29 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 34.97 21.28 8.44 29.03 22.82 6.58 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 23.42 29.01 6.78 24.36 28.48 4.94 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 6 3 # 6 L 182 LYS B 157 LYS^? 28.85 MG MG B 302 L 184 LYS B 6 LYS^? 25.90 MG MG B 302 L 345 ASP B 138 ASP^? 33.32 MG MG B 302 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 34.97 21.28 8.44 29.03 22.82 6.58 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 36.26 25.44 11.74 39.65 23.12 16.29 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 23.42 29.01 6.78 24.36 28.48 4.94 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 7 3 # 7 L 182 LYS B 157 LYS^? 28.85 MG MG B 302 L 184 LYS B 6 LYS^? 25.90 MG MG B 302 L 345 ASP B 142 ASP^? 23.97 MG MG B 301 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 34.97 21.28 8.44 29.03 22.82 6.58 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 36.26 25.44 11.74 39.65 23.12 16.29 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 31.69 27.40 -1.31 32.10 27.37 -3.38 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 8 3 # 8 L 182 LYS B 157 LYS^? 28.85 MG MG B 302 L 184 LYS B 166 LYS^? 22.75 MG MG B 301 L 345 ASP B 142 ASP^? 23.97 MG MG B 301 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 34.97 21.28 8.44 29.03 22.82 6.58 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 35.27 15.38 5.31 37.27 9.81 3.93 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 31.69 27.40 -1.31 32.10 27.37 -3.38 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 9 3 # 9 L 182 LYS C 6 LYS^? 25.73 MG MG C 302 L 184 LYS C 157 LYS^? 28.15 MG MG C 302 L 345 ASP C 138 ASP^? 33.43 MG MG C 302 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 105.43 43.97 -13.30 104.85 43.08 -11.43 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 10 3 # 10 L 182 LYS C 157 LYS^? 28.15 MG MG C 302 L 184 LYS C 6 LYS^? 25.73 MG MG C 302 L 345 ASP C 138 ASP^? 33.43 MG MG C 302 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 105.43 43.97 -13.30 104.85 43.08 -11.43 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 11 3 # 11 L 182 LYS C 157 LYS^? 28.15 MG MG C 302 L 184 LYS C 6 LYS^? 25.73 MG MG C 302 L 345 ASP C 142 ASP^? 23.76 MG MG C 301 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 97.94 39.27 -5.03 98.08 38.70 -2.97 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 12 3 # 12 L 182 LYS C 157 LYS^? 28.15 MG MG C 302 L 184 LYS C 166 LYS^? 22.53 MG MG C 301 L 345 ASP C 142 ASP^? 23.76 MG MG C 301 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 97.94 39.27 -5.03 98.08 38.70 -2.97 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 13 3 # 13 L 182 LYS D 6 LYS^? 25.98 MG MG D 302 L 184 LYS D 157 LYS^? 28.67 MG MG D 302 L 345 ASP D 138 ASP^? 33.64 MG MG D 302 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 93.00 7.50 -35.79 93.88 8.48 -37.45 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 14 3 # 14 L 182 LYS D 157 LYS^? 28.67 MG MG D 302 L 184 LYS D 6 LYS^? 25.98 MG MG D 302 L 345 ASP D 138 ASP^? 33.64 MG MG D 302 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 93.00 7.50 -35.79 93.88 8.48 -37.45 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 15 3 # 15 L 182 LYS D 157 LYS^? 28.67 MG MG D 302 L 184 LYS D 6 LYS^? 25.98 MG MG D 302 L 345 ASP D 142 ASP^? 23.49 MG MG D 301 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 16 3 # 16 L 182 LYS D 157 LYS^? 28.67 MG MG D 302 L 184 LYS D 166 LYS^? 21.08 MG MG D 301 L 345 ASP D 142 ASP^? 23.49 MG MG D 301 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 17 3 # 17 L 182 LYS E 6 LYS^? 25.59 MG MG E 302 L 184 LYS E 157 LYS^? 28.40 MG MG E 302 L 345 ASP E 138 ASP^? 33.31 MG MG E 302 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 39.58 70.77 -58.63 40.74 70.78 -56.80 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 18 3 # 18 L 182 LYS E 157 LYS^? 28.40 MG MG E 302 L 184 LYS E 6 LYS^? 25.59 MG MG E 302 L 345 ASP E 138 ASP^? 33.31 MG MG E 302 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 39.58 70.77 -58.63 40.74 70.78 -56.80 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 19 3 # 19 L 182 LYS E 157 LYS^? 28.40 MG MG E 302 L 184 LYS E 6 LYS^? 25.59 MG MG E 302 L 345 ASP E 142 ASP^? 23.66 MG MG E 301 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 47.19 67.15 -50.37 47.44 67.18 -48.23 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 20 3 # 20 L 182 LYS E 157 LYS^? 28.40 MG MG E 302 L 184 LYS E 166 LYS^? 21.46 MG MG E 301 L 345 ASP E 142 ASP^? 23.66 MG MG E 301 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 47.19 67.15 -50.37 47.44 67.18 -48.23 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 21 3 # 21 L 182 LYS F 6 LYS^? 26.09 MG MG F 301 L 184 LYS F 157 LYS^? 28.36 MG MG F 302 L 345 ASP F 138 ASP^? 33.51 MG MG F 302 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 77.17 76.66 -81.48 76.14 76.33 -83.32 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 22 3 # 22 L 182 LYS F 157 LYS^? 28.36 MG MG F 302 L 184 LYS F 6 LYS^? 26.09 MG MG F 301 L 345 ASP F 138 ASP^? 33.51 MG MG F 302 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 77.17 76.66 -81.48 76.14 76.33 -83.32 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 23 3 # 23 L 182 LYS F 157 LYS^? 28.36 MG MG F 302 L 184 LYS F 6 LYS^? 26.09 MG MG F 301 L 345 ASP F 142 ASP^? 23.43 MG MG F 302 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 71.46 69.88 -89.76 71.03 69.93 -91.81 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 24 3 # 24 L 182 LYS F 157 LYS^? 28.36 MG MG F 302 L 184 LYS F 166 LYS^? 20.76 MG MG F 302 L 345 ASP F 142 ASP^? 23.43 MG MG F 302 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 71.46 69.88 -89.76 71.03 69.93 -91.81 2dw7_c43 source 2dw7 BLL6730 PROTEIN : 24 hits 2dw7_c43 naa= 3 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 1 3 # 1 M 182 LYS A 6 LYS^? 25.88 MG MG A 301 M 184 LYS A 157 LYS^? 28.65 MG MG A 302 M 345 ASP A 138 ASP^? 33.08 MG MG A 302 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 46.20 12.82 24.71 44.50 16.64 20.52 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 41.42 12.06 27.58 41.46 5.93 29.41 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 47.10 -0.97 29.63 45.89 0.22 30.96 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 2 3 # 2 M 182 LYS A 157 LYS^? 28.65 MG MG A 302 M 184 LYS A 6 LYS^? 25.88 MG MG A 301 M 345 ASP A 138 ASP^? 33.08 MG MG A 302 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 41.42 12.06 27.58 41.46 5.93 29.41 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 46.20 12.82 24.71 44.50 16.64 20.52 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 47.10 -0.97 29.63 45.89 0.22 30.96 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 3 3 # 3 M 182 LYS A 157 LYS^? 28.65 MG MG A 302 M 184 LYS A 6 LYS^? 25.88 MG MG A 301 M 345 ASP A 142 ASP^? 23.70 MG MG A 302 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 41.42 12.06 27.58 41.46 5.93 29.41 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 46.20 12.82 24.71 44.50 16.64 20.52 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 46.39 7.18 37.53 46.28 7.18 39.63 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 4 3 # 4 M 182 LYS A 157 LYS^? 28.65 MG MG A 302 M 184 LYS A 166 LYS^? 20.93 MG MG A 302 M 345 ASP A 142 ASP^? 23.70 MG MG A 302 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 41.42 12.06 27.58 41.46 5.93 29.41 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 35.34 13.14 30.41 31.67 15.04 34.58 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 46.39 7.18 37.53 46.28 7.18 39.63 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 5 3 # 5 M 182 LYS B 157 LYS^? 28.85 MG MG B 302 M 184 LYS B 6 LYS^? 25.90 MG MG B 302 M 345 ASP B 138 ASP^? 33.32 MG MG B 302 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 34.97 21.28 8.44 29.03 22.82 6.58 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 36.26 25.44 11.74 39.65 23.12 16.29 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 23.42 29.01 6.78 24.36 28.48 4.94 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 6 3 # 6 M 182 LYS B 157 LYS^? 28.85 MG MG B 302 M 184 LYS B 166 LYS^? 22.75 MG MG B 301 M 345 ASP B 142 ASP^? 23.97 MG MG B 301 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 34.97 21.28 8.44 29.03 22.82 6.58 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 35.27 15.38 5.31 37.27 9.81 3.93 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 31.69 27.40 -1.31 32.10 27.37 -3.38 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 7 3 # 7 M 182 LYS C 6 LYS^? 25.73 MG MG C 302 M 184 LYS C 157 LYS^? 28.15 MG MG C 302 M 345 ASP C 138 ASP^? 33.43 MG MG C 302 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 94.42 35.68 -18.56 92.21 32.03 -23.05 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 97.55 32.04 -15.10 101.49 36.24 -13.39 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 105.43 43.97 -13.30 104.85 43.08 -11.43 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 8 3 # 8 M 182 LYS C 157 LYS^? 28.15 MG MG C 302 M 184 LYS C 6 LYS^? 25.73 MG MG C 302 M 345 ASP C 138 ASP^? 33.43 MG MG C 302 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 97.55 32.04 -15.10 101.49 36.24 -13.39 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 94.42 35.68 -18.56 92.21 32.03 -23.05 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 105.43 43.97 -13.30 104.85 43.08 -11.43 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 9 3 # 9 M 182 LYS C 157 LYS^? 28.15 MG MG C 302 M 184 LYS C 6 LYS^? 25.73 MG MG C 302 M 345 ASP C 142 ASP^? 23.76 MG MG C 301 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 97.55 32.04 -15.10 101.49 36.24 -13.39 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 94.42 35.68 -18.56 92.21 32.03 -23.05 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 97.94 39.27 -5.03 98.08 38.70 -2.97 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 10 3 # 10 M 182 LYS C 157 LYS^? 28.15 MG MG C 302 M 184 LYS C 166 LYS^? 22.53 MG MG C 301 M 345 ASP C 142 ASP^? 23.76 MG MG C 301 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 97.55 32.04 -15.10 101.49 36.24 -13.39 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 99.24 26.71 -12.25 100.23 21.90 -8.99 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 97.94 39.27 -5.03 98.08 38.70 -2.97 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 11 3 # 11 M 182 LYS D 6 LYS^? 25.98 MG MG D 302 M 184 LYS D 157 LYS^? 28.67 MG MG D 302 M 345 ASP D 138 ASP^? 33.64 MG MG D 302 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 89.78 20.68 -31.57 90.15 24.89 -27.02 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 94.17 21.71 -34.34 96.11 15.89 -35.92 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 93.00 7.50 -35.79 93.88 8.48 -37.45 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 12 3 # 12 M 182 LYS D 157 LYS^? 28.67 MG MG D 302 M 184 LYS D 6 LYS^? 25.98 MG MG D 302 M 345 ASP D 138 ASP^? 33.64 MG MG D 302 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 94.17 21.71 -34.34 96.11 15.89 -35.92 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 89.78 20.68 -31.57 90.15 24.89 -27.02 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 93.00 7.50 -35.79 93.88 8.48 -37.45 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 13 3 # 13 M 182 LYS D 157 LYS^? 28.67 MG MG D 302 M 184 LYS D 6 LYS^? 25.98 MG MG D 302 M 345 ASP D 142 ASP^? 23.49 MG MG D 301 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 94.17 21.71 -34.34 96.11 15.89 -35.92 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 89.78 20.68 -31.57 90.15 24.89 -27.02 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 14 3 # 14 M 182 LYS D 157 LYS^? 28.67 MG MG D 302 M 184 LYS D 166 LYS^? 21.08 MG MG D 301 M 345 ASP D 142 ASP^? 23.49 MG MG D 301 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 94.17 21.71 -34.34 96.11 15.89 -35.92 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 99.23 24.85 -37.31 101.73 27.34 -42.07 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 15 3 # 15 M 182 LYS E 6 LYS^? 25.59 MG MG E 302 M 184 LYS E 157 LYS^? 28.40 MG MG E 302 M 345 ASP E 138 ASP^? 33.31 MG MG E 302 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 51.95 64.70 -63.33 56.16 64.03 -67.52 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 53.63 69.16 -60.42 48.34 71.81 -58.40 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 39.58 70.77 -58.63 40.74 70.78 -56.80 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 16 3 # 16 M 182 LYS E 157 LYS^? 28.40 MG MG E 302 M 184 LYS E 6 LYS^? 25.59 MG MG E 302 M 345 ASP E 138 ASP^? 33.31 MG MG E 302 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 53.63 69.16 -60.42 48.34 71.81 -58.40 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 51.95 64.70 -63.33 56.16 64.03 -67.52 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 39.58 70.77 -58.63 40.74 70.78 -56.80 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 17 3 # 17 M 182 LYS E 157 LYS^? 28.40 MG MG E 302 M 184 LYS E 6 LYS^? 25.59 MG MG E 302 M 345 ASP E 142 ASP^? 23.66 MG MG E 301 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 53.63 69.16 -60.42 48.34 71.81 -58.40 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 51.95 64.70 -63.33 56.16 64.03 -67.52 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 47.19 67.15 -50.37 47.44 67.18 -48.23 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 18 3 # 18 M 182 LYS E 157 LYS^? 28.40 MG MG E 302 M 184 LYS E 166 LYS^? 21.46 MG MG E 301 M 345 ASP E 142 ASP^? 23.66 MG MG E 301 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 53.63 69.16 -60.42 48.34 71.81 -58.40 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 57.66 73.57 -57.60 60.27 76.17 -53.59 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 47.19 67.15 -50.37 47.44 67.18 -48.23 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 19 3 # 19 M 182 LYS F 6 LYS^? 26.09 MG MG F 301 M 184 LYS F 157 LYS^? 28.36 MG MG F 302 M 345 ASP F 138 ASP^? 33.51 MG MG F 302 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 67.53 67.03 -76.43 64.05 65.33 -71.86 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 64.43 70.47 -79.54 68.32 74.80 -81.65 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 77.17 76.66 -81.48 76.14 76.33 -83.32 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 20 3 # 20 M 182 LYS F 157 LYS^? 28.36 MG MG F 302 M 184 LYS F 6 LYS^? 26.09 MG MG F 301 M 345 ASP F 138 ASP^? 33.51 MG MG F 302 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 64.43 70.47 -79.54 68.32 74.80 -81.65 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 67.53 67.03 -76.43 64.05 65.33 -71.86 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 77.17 76.66 -81.48 76.14 76.33 -83.32 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 21 3 # 21 M 182 LYS F 157 LYS^? 28.36 MG MG F 302 M 184 LYS F 6 LYS^? 26.09 MG MG F 301 M 345 ASP F 142 ASP^? 23.43 MG MG F 302 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 64.43 70.47 -79.54 68.32 74.80 -81.65 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 67.53 67.03 -76.43 64.05 65.33 -71.86 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 71.46 69.88 -89.76 71.03 69.93 -91.81 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 22 3 # 22 M 182 LYS F 157 LYS^? 28.36 MG MG F 302 M 184 LYS F 166 LYS^? 20.76 MG MG F 302 M 345 ASP F 142 ASP^? 23.43 MG MG F 302 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 64.43 70.47 -79.54 68.32 74.80 -81.65 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 59.28 73.05 -82.63 55.63 74.15 -86.94 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 71.46 69.88 -89.76 71.03 69.93 -91.81 2dw7_c44 source 2dw7 BLL6730 PROTEIN : 22 hits 2dw7_c44 naa= 3 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 1 3 # 1 N 182 LYS A 6 LYS^? 25.88 MG MG A 301 N 184 LYS A 157 LYS^? 28.65 MG MG A 302 N 345 ASP A 142 ASP^? 23.70 MG MG A 302 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 46.20 12.82 24.71 44.50 16.64 20.52 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 41.42 12.06 27.58 41.46 5.93 29.41 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 46.39 7.18 37.53 46.28 7.18 39.63 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 2 3 # 2 N 182 LYS A 157 LYS^? 28.65 MG MG A 302 N 184 LYS A 6 LYS^? 25.88 MG MG A 301 N 345 ASP A 142 ASP^? 23.70 MG MG A 302 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 41.42 12.06 27.58 41.46 5.93 29.41 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 46.20 12.82 24.71 44.50 16.64 20.52 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 46.39 7.18 37.53 46.28 7.18 39.63 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 3 3 # 3 N 182 LYS A 157 LYS^? 28.65 MG MG A 302 N 184 LYS A 166 LYS^? 20.93 MG MG A 302 N 345 ASP A 142 ASP^? 23.70 MG MG A 302 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 41.42 12.06 27.58 41.46 5.93 29.41 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 35.34 13.14 30.41 31.67 15.04 34.58 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 46.39 7.18 37.53 46.28 7.18 39.63 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 4 3 # 4 N 182 LYS B 6 LYS^? 25.90 MG MG B 302 N 184 LYS B 157 LYS^? 28.85 MG MG B 302 N 345 ASP B 138 ASP^? 33.32 MG MG B 302 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 36.26 25.44 11.74 39.65 23.12 16.29 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 34.97 21.28 8.44 29.03 22.82 6.58 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 23.42 29.01 6.78 24.36 28.48 4.94 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 5 3 # 5 N 182 LYS B 157 LYS^? 28.85 MG MG B 302 N 184 LYS B 6 LYS^? 25.90 MG MG B 302 N 345 ASP B 138 ASP^? 33.32 MG MG B 302 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 34.97 21.28 8.44 29.03 22.82 6.58 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 36.26 25.44 11.74 39.65 23.12 16.29 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 23.42 29.01 6.78 24.36 28.48 4.94 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 6 3 # 6 N 182 LYS B 157 LYS^? 28.85 MG MG B 302 N 184 LYS B 6 LYS^? 25.90 MG MG B 302 N 345 ASP B 142 ASP^? 23.97 MG MG B 301 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 34.97 21.28 8.44 29.03 22.82 6.58 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 36.26 25.44 11.74 39.65 23.12 16.29 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 31.69 27.40 -1.31 32.10 27.37 -3.38 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 7 3 # 7 N 182 LYS B 157 LYS^? 28.85 MG MG B 302 N 184 LYS B 166 LYS^? 22.75 MG MG B 301 N 345 ASP B 142 ASP^? 23.97 MG MG B 301 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 34.97 21.28 8.44 29.03 22.82 6.58 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 35.27 15.38 5.31 37.27 9.81 3.93 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 31.69 27.40 -1.31 32.10 27.37 -3.38 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 8 3 # 8 N 182 LYS C 157 LYS^? 28.15 MG MG C 302 N 184 LYS C 6 LYS^? 25.73 MG MG C 302 N 345 ASP C 142 ASP^? 23.76 MG MG C 301 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 97.94 39.27 -5.03 98.08 38.70 -2.97 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 9 3 # 9 N 182 LYS C 157 LYS^? 28.15 MG MG C 302 N 184 LYS C 166 LYS^? 22.53 MG MG C 301 N 345 ASP C 142 ASP^? 23.76 MG MG C 301 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 97.94 39.27 -5.03 98.08 38.70 -2.97 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 10 3 # 10 N 182 LYS D 6 LYS^? 25.98 MG MG D 302 N 184 LYS D 157 LYS^? 28.67 MG MG D 302 N 345 ASP D 138 ASP^? 33.64 MG MG D 302 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 93.00 7.50 -35.79 93.88 8.48 -37.45 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 11 3 # 11 N 182 LYS D 6 LYS^? 25.98 MG MG D 302 N 184 LYS D 157 LYS^? 28.67 MG MG D 302 N 345 ASP D 142 ASP^? 23.49 MG MG D 301 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 12 3 # 12 N 182 LYS D 157 LYS^? 28.67 MG MG D 302 N 184 LYS D 6 LYS^? 25.98 MG MG D 302 N 345 ASP D 142 ASP^? 23.49 MG MG D 301 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 13 3 # 13 N 182 LYS D 157 LYS^? 28.67 MG MG D 302 N 184 LYS D 166 LYS^? 21.08 MG MG D 301 N 345 ASP D 142 ASP^? 23.49 MG MG D 301 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 14 3 # 14 N 182 LYS E 6 LYS^? 25.59 MG MG E 302 N 184 LYS E 157 LYS^? 28.40 MG MG E 302 N 345 ASP E 142 ASP^? 23.66 MG MG E 301 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 47.19 67.15 -50.37 47.44 67.18 -48.23 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 15 3 # 15 N 182 LYS E 157 LYS^? 28.40 MG MG E 302 N 184 LYS E 6 LYS^? 25.59 MG MG E 302 N 345 ASP E 138 ASP^? 33.31 MG MG E 302 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 39.58 70.77 -58.63 40.74 70.78 -56.80 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 16 3 # 16 N 182 LYS E 157 LYS^? 28.40 MG MG E 302 N 184 LYS E 6 LYS^? 25.59 MG MG E 302 N 345 ASP E 142 ASP^? 23.66 MG MG E 301 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 47.19 67.15 -50.37 47.44 67.18 -48.23 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 17 3 # 17 N 182 LYS E 157 LYS^? 28.40 MG MG E 302 N 184 LYS E 166 LYS^? 21.46 MG MG E 301 N 345 ASP E 142 ASP^? 23.66 MG MG E 301 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 47.19 67.15 -50.37 47.44 67.18 -48.23 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 18 3 # 18 N 182 LYS E 166 LYS^? 21.46 MG MG E 301 N 184 LYS E 157 LYS^? 28.40 MG MG E 302 N 345 ASP E 142 ASP^? 23.66 MG MG E 301 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 47.19 67.15 -50.37 47.44 67.18 -48.23 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 19 3 # 19 N 182 LYS F 6 LYS^? 26.09 MG MG F 301 N 184 LYS F 157 LYS^? 28.36 MG MG F 302 N 345 ASP F 142 ASP^? 23.43 MG MG F 302 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 71.46 69.88 -89.76 71.03 69.93 -91.81 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 20 3 # 20 N 182 LYS F 157 LYS^? 28.36 MG MG F 302 N 184 LYS F 6 LYS^? 26.09 MG MG F 301 N 345 ASP F 138 ASP^? 33.51 MG MG F 302 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 77.17 76.66 -81.48 76.14 76.33 -83.32 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 21 3 # 21 N 182 LYS F 157 LYS^? 28.36 MG MG F 302 N 184 LYS F 6 LYS^? 26.09 MG MG F 301 N 345 ASP F 142 ASP^? 23.43 MG MG F 302 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 71.46 69.88 -89.76 71.03 69.93 -91.81 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 22 3 # 22 N 182 LYS F 157 LYS^? 28.36 MG MG F 302 N 184 LYS F 166 LYS^? 20.76 MG MG F 302 N 345 ASP F 142 ASP^? 23.43 MG MG F 302 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 71.46 69.88 -89.76 71.03 69.93 -91.81 2dw7_c45 source 2dw7 BLL6730 PROTEIN : 22 hits 2dw7_c45 naa= 3 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 1 3 # 1 O 182 LYS A 157 LYS^? 28.65 MG MG A 302 O 184 LYS A 6 LYS^? 25.88 MG MG A 301 O 345 ASP A 138 ASP^? 33.08 MG MG A 302 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 41.42 12.06 27.58 41.46 5.93 29.41 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 46.20 12.82 24.71 44.50 16.64 20.52 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 47.10 -0.97 29.63 45.89 0.22 30.96 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 2 3 # 2 O 182 LYS A 157 LYS^? 28.65 MG MG A 302 O 184 LYS A 6 LYS^? 25.88 MG MG A 301 O 345 ASP A 142 ASP^? 23.70 MG MG A 302 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 41.42 12.06 27.58 41.46 5.93 29.41 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 46.20 12.82 24.71 44.50 16.64 20.52 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 46.39 7.18 37.53 46.28 7.18 39.63 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 3 3 # 3 O 182 LYS A 157 LYS^? 28.65 MG MG A 302 O 184 LYS A 166 LYS^? 20.93 MG MG A 302 O 345 ASP A 142 ASP^? 23.70 MG MG A 302 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 41.42 12.06 27.58 41.46 5.93 29.41 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 35.34 13.14 30.41 31.67 15.04 34.58 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 46.39 7.18 37.53 46.28 7.18 39.63 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 4 3 # 4 O 182 LYS A 157 LYS^? 28.65 MG MG A 302 O 184 LYS A 166 LYS^? 20.93 MG MG A 302 O 345 ASP A 160 ASP^? 31.61 MG MG B 302 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 41.42 12.06 27.58 41.46 5.93 29.41 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 35.34 13.14 30.41 31.67 15.04 34.58 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 44.21 5.00 19.54 46.02 3.84 19.76 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 5 3 # 5 O 182 LYS B 6 LYS^? 25.90 MG MG B 302 O 184 LYS B 157 LYS^? 28.85 MG MG B 302 O 345 ASP B 138 ASP^? 33.32 MG MG B 302 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 36.26 25.44 11.74 39.65 23.12 16.29 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 34.97 21.28 8.44 29.03 22.82 6.58 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 23.42 29.01 6.78 24.36 28.48 4.94 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 6 3 # 6 O 182 LYS B 157 LYS^? 28.85 MG MG B 302 O 184 LYS B 6 LYS^? 25.90 MG MG B 302 O 345 ASP B 138 ASP^? 33.32 MG MG B 302 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 34.97 21.28 8.44 29.03 22.82 6.58 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 36.26 25.44 11.74 39.65 23.12 16.29 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 23.42 29.01 6.78 24.36 28.48 4.94 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 7 3 # 7 O 182 LYS B 157 LYS^? 28.85 MG MG B 302 O 184 LYS B 6 LYS^? 25.90 MG MG B 302 O 345 ASP B 142 ASP^? 23.97 MG MG B 301 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 34.97 21.28 8.44 29.03 22.82 6.58 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 36.26 25.44 11.74 39.65 23.12 16.29 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 31.69 27.40 -1.31 32.10 27.37 -3.38 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 8 3 # 8 O 182 LYS B 157 LYS^? 28.85 MG MG B 302 O 184 LYS B 166 LYS^? 22.75 MG MG B 301 O 345 ASP B 142 ASP^? 23.97 MG MG B 301 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 34.97 21.28 8.44 29.03 22.82 6.58 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 35.27 15.38 5.31 37.27 9.81 3.93 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 31.69 27.40 -1.31 32.10 27.37 -3.38 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 9 3 # 9 O 182 LYS B 157 LYS^? 28.85 MG MG B 302 O 184 LYS B 166 LYS^? 22.75 MG MG B 301 O 345 ASP B 160 ASP^? 31.65 MG MG A 301 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 34.97 21.28 8.44 29.03 22.82 6.58 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 35.27 15.38 5.31 37.27 9.81 3.93 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 28.01 24.83 16.38 27.44 26.81 15.80 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 10 3 # 10 O 182 LYS C 157 LYS^? 28.15 MG MG C 302 O 184 LYS C 6 LYS^? 25.73 MG MG C 302 O 345 ASP C 138 ASP^? 33.43 MG MG C 302 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 105.43 43.97 -13.30 104.85 43.08 -11.43 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 11 3 # 11 O 182 LYS C 157 LYS^? 28.15 MG MG C 302 O 184 LYS C 6 LYS^? 25.73 MG MG C 302 O 345 ASP C 142 ASP^? 23.76 MG MG C 301 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 97.94 39.27 -5.03 98.08 38.70 -2.97 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 12 3 # 12 O 182 LYS C 157 LYS^? 28.15 MG MG C 302 O 184 LYS C 166 LYS^? 22.53 MG MG C 301 O 345 ASP C 142 ASP^? 23.76 MG MG C 301 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 97.94 39.27 -5.03 98.08 38.70 -2.97 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 13 3 # 13 O 182 LYS C 157 LYS^? 28.15 MG MG C 302 O 184 LYS C 166 LYS^? 22.53 MG MG C 301 O 345 ASP C 160 ASP^? 31.63 MG MG D 302 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 102.50 38.00 -23.28 102.43 39.97 -22.46 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 14 3 # 14 O 182 LYS D 6 LYS^? 25.98 MG MG D 302 O 184 LYS D 157 LYS^? 28.67 MG MG D 302 O 345 ASP D 138 ASP^? 33.64 MG MG D 302 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 93.00 7.50 -35.79 93.88 8.48 -37.45 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 15 3 # 15 O 182 LYS D 157 LYS^? 28.67 MG MG D 302 O 184 LYS D 6 LYS^? 25.98 MG MG D 302 O 345 ASP D 138 ASP^? 33.64 MG MG D 302 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 93.00 7.50 -35.79 93.88 8.48 -37.45 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 16 3 # 16 O 182 LYS D 157 LYS^? 28.67 MG MG D 302 O 184 LYS D 6 LYS^? 25.98 MG MG D 302 O 345 ASP D 142 ASP^? 23.49 MG MG D 301 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 17 3 # 17 O 182 LYS D 157 LYS^? 28.67 MG MG D 302 O 184 LYS D 166 LYS^? 21.08 MG MG D 301 O 345 ASP D 142 ASP^? 23.49 MG MG D 301 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 18 3 # 18 O 182 LYS D 157 LYS^? 28.67 MG MG D 302 O 184 LYS D 166 LYS^? 21.08 MG MG D 301 O 345 ASP D 160 ASP^? 31.45 MG MG C 302 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 94.15 13.98 -26.57 92.71 12.42 -26.99 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 19 3 # 19 O 182 LYS E 6 LYS^? 25.59 MG MG E 302 O 184 LYS E 157 LYS^? 28.40 MG MG E 302 O 345 ASP E 138 ASP^? 33.31 MG MG E 302 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 39.58 70.77 -58.63 40.74 70.78 -56.80 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 20 3 # 20 O 182 LYS E 157 LYS^? 28.40 MG MG E 302 O 184 LYS E 6 LYS^? 25.59 MG MG E 302 O 345 ASP E 138 ASP^? 33.31 MG MG E 302 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 39.58 70.77 -58.63 40.74 70.78 -56.80 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 21 3 # 21 O 182 LYS E 157 LYS^? 28.40 MG MG E 302 O 184 LYS E 6 LYS^? 25.59 MG MG E 302 O 345 ASP E 142 ASP^? 23.66 MG MG E 301 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 47.19 67.15 -50.37 47.44 67.18 -48.23 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 22 3 # 22 O 182 LYS E 157 LYS^? 28.40 MG MG E 302 O 184 LYS E 166 LYS^? 21.46 MG MG E 301 O 345 ASP E 142 ASP^? 23.66 MG MG E 301 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 47.19 67.15 -50.37 47.44 67.18 -48.23 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 23 3 # 23 O 182 LYS E 157 LYS^? 28.40 MG MG E 302 O 184 LYS E 166 LYS^? 21.46 MG MG E 301 O 345 ASP E 160 ASP^? 31.54 MG MG F 301 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 45.81 70.00 -68.45 44.10 68.87 -67.77 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 24 3 # 24 O 182 LYS F 6 LYS^? 26.09 MG MG F 301 O 184 LYS F 157 LYS^? 28.36 MG MG F 302 O 345 ASP F 138 ASP^? 33.51 MG MG F 302 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 77.17 76.66 -81.48 76.14 76.33 -83.32 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 25 3 # 25 O 182 LYS F 157 LYS^? 28.36 MG MG F 302 O 184 LYS F 6 LYS^? 26.09 MG MG F 301 O 345 ASP F 138 ASP^? 33.51 MG MG F 302 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 77.17 76.66 -81.48 76.14 76.33 -83.32 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 26 3 # 26 O 182 LYS F 157 LYS^? 28.36 MG MG F 302 O 184 LYS F 6 LYS^? 26.09 MG MG F 301 O 345 ASP F 142 ASP^? 23.43 MG MG F 302 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 71.46 69.88 -89.76 71.03 69.93 -91.81 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 27 3 # 27 O 182 LYS F 157 LYS^? 28.36 MG MG F 302 O 184 LYS F 166 LYS^? 20.76 MG MG F 302 O 345 ASP F 142 ASP^? 23.43 MG MG F 302 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 71.46 69.88 -89.76 71.03 69.93 -91.81 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 28 3 # 28 O 182 LYS F 157 LYS^? 28.36 MG MG F 302 O 184 LYS F 166 LYS^? 20.76 MG MG F 302 O 345 ASP F 160 ASP^? 31.59 MG MG E 302 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 71.27 74.59 -71.77 73.23 74.02 -72.37 2dw7_c46 source 2dw7 BLL6730 PROTEIN : 28 hits 2dw7_c46 naa= 3 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 1 3 # 1 P 182 LYS A 6 LYS^? 25.88 MG MG A 301 P 184 LYS A 157 LYS^? 28.65 MG MG A 302 P 345 ASP A 138 ASP^? 33.08 MG MG A 302 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 46.20 12.82 24.71 44.50 16.64 20.52 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 41.42 12.06 27.58 41.46 5.93 29.41 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 47.10 -0.97 29.63 45.89 0.22 30.96 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 2 3 # 2 P 182 LYS A 157 LYS^? 28.65 MG MG A 302 P 184 LYS A 6 LYS^? 25.88 MG MG A 301 P 345 ASP A 138 ASP^? 33.08 MG MG A 302 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 41.42 12.06 27.58 41.46 5.93 29.41 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 46.20 12.82 24.71 44.50 16.64 20.52 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 47.10 -0.97 29.63 45.89 0.22 30.96 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 3 3 # 3 P 182 LYS A 157 LYS^? 28.65 MG MG A 302 P 184 LYS A 6 LYS^? 25.88 MG MG A 301 P 345 ASP A 142 ASP^? 23.70 MG MG A 302 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 41.42 12.06 27.58 41.46 5.93 29.41 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 46.20 12.82 24.71 44.50 16.64 20.52 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 46.39 7.18 37.53 46.28 7.18 39.63 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 4 3 # 4 P 182 LYS A 157 LYS^? 28.65 MG MG A 302 P 184 LYS A 166 LYS^? 20.93 MG MG A 302 P 345 ASP A 142 ASP^? 23.70 MG MG A 302 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 41.42 12.06 27.58 41.46 5.93 29.41 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 35.34 13.14 30.41 31.67 15.04 34.58 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 46.39 7.18 37.53 46.28 7.18 39.63 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 5 3 # 5 P 182 LYS B 6 LYS^? 25.90 MG MG B 302 P 184 LYS B 157 LYS^? 28.85 MG MG B 302 P 345 ASP B 138 ASP^? 33.32 MG MG B 302 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 36.26 25.44 11.74 39.65 23.12 16.29 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 34.97 21.28 8.44 29.03 22.82 6.58 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 23.42 29.01 6.78 24.36 28.48 4.94 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 6 3 # 6 P 182 LYS B 157 LYS^? 28.85 MG MG B 302 P 184 LYS B 6 LYS^? 25.90 MG MG B 302 P 345 ASP B 138 ASP^? 33.32 MG MG B 302 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 34.97 21.28 8.44 29.03 22.82 6.58 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 36.26 25.44 11.74 39.65 23.12 16.29 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 23.42 29.01 6.78 24.36 28.48 4.94 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 7 3 # 7 P 182 LYS B 157 LYS^? 28.85 MG MG B 302 P 184 LYS B 6 LYS^? 25.90 MG MG B 302 P 345 ASP B 142 ASP^? 23.97 MG MG B 301 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 34.97 21.28 8.44 29.03 22.82 6.58 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 36.26 25.44 11.74 39.65 23.12 16.29 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 31.69 27.40 -1.31 32.10 27.37 -3.38 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 8 3 # 8 P 182 LYS B 157 LYS^? 28.85 MG MG B 302 P 184 LYS B 166 LYS^? 22.75 MG MG B 301 P 345 ASP B 142 ASP^? 23.97 MG MG B 301 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 34.97 21.28 8.44 29.03 22.82 6.58 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 35.27 15.38 5.31 37.27 9.81 3.93 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 31.69 27.40 -1.31 32.10 27.37 -3.38 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 9 3 # 9 P 182 LYS C 6 LYS^? 25.73 MG MG C 302 P 184 LYS C 157 LYS^? 28.15 MG MG C 302 P 345 ASP C 138 ASP^? 33.43 MG MG C 302 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 105.43 43.97 -13.30 104.85 43.08 -11.43 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 10 3 # 10 P 182 LYS C 157 LYS^? 28.15 MG MG C 302 P 184 LYS C 6 LYS^? 25.73 MG MG C 302 P 345 ASP C 138 ASP^? 33.43 MG MG C 302 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 105.43 43.97 -13.30 104.85 43.08 -11.43 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 11 3 # 11 P 182 LYS C 157 LYS^? 28.15 MG MG C 302 P 184 LYS C 6 LYS^? 25.73 MG MG C 302 P 345 ASP C 142 ASP^? 23.76 MG MG C 301 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 97.94 39.27 -5.03 98.08 38.70 -2.97 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 12 3 # 12 P 182 LYS C 157 LYS^? 28.15 MG MG C 302 P 184 LYS C 166 LYS^? 22.53 MG MG C 301 P 345 ASP C 142 ASP^? 23.76 MG MG C 301 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 97.94 39.27 -5.03 98.08 38.70 -2.97 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 13 3 # 13 P 182 LYS D 6 LYS^? 25.98 MG MG D 302 P 184 LYS D 157 LYS^? 28.67 MG MG D 302 P 345 ASP D 138 ASP^? 33.64 MG MG D 302 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 93.00 7.50 -35.79 93.88 8.48 -37.45 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 14 3 # 14 P 182 LYS D 157 LYS^? 28.67 MG MG D 302 P 184 LYS D 6 LYS^? 25.98 MG MG D 302 P 345 ASP D 138 ASP^? 33.64 MG MG D 302 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 93.00 7.50 -35.79 93.88 8.48 -37.45 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 15 3 # 15 P 182 LYS D 157 LYS^? 28.67 MG MG D 302 P 184 LYS D 6 LYS^? 25.98 MG MG D 302 P 345 ASP D 142 ASP^? 23.49 MG MG D 301 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 16 3 # 16 P 182 LYS D 157 LYS^? 28.67 MG MG D 302 P 184 LYS D 166 LYS^? 21.08 MG MG D 301 P 345 ASP D 142 ASP^? 23.49 MG MG D 301 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 90.90 15.58 -44.76 91.35 16.09 -46.79 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 17 3 # 17 P 182 LYS E 6 LYS^? 25.59 MG MG E 302 P 184 LYS E 157 LYS^? 28.40 MG MG E 302 P 345 ASP E 138 ASP^? 33.31 MG MG E 302 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 39.58 70.77 -58.63 40.74 70.78 -56.80 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 18 3 # 18 P 182 LYS E 157 LYS^? 28.40 MG MG E 302 P 184 LYS E 6 LYS^? 25.59 MG MG E 302 P 345 ASP E 138 ASP^? 33.31 MG MG E 302 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 39.58 70.77 -58.63 40.74 70.78 -56.80 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 19 3 # 19 P 182 LYS E 157 LYS^? 28.40 MG MG E 302 P 184 LYS E 6 LYS^? 25.59 MG MG E 302 P 345 ASP E 142 ASP^? 23.66 MG MG E 301 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 47.19 67.15 -50.37 47.44 67.18 -48.23 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 20 3 # 20 P 182 LYS E 157 LYS^? 28.40 MG MG E 302 P 184 LYS E 166 LYS^? 21.46 MG MG E 301 P 345 ASP E 142 ASP^? 23.66 MG MG E 301 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 47.19 67.15 -50.37 47.44 67.18 -48.23 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 21 3 # 21 P 182 LYS F 6 LYS^? 26.09 MG MG F 301 P 184 LYS F 157 LYS^? 28.36 MG MG F 302 P 345 ASP F 138 ASP^? 33.51 MG MG F 302 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 77.17 76.66 -81.48 76.14 76.33 -83.32 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 22 3 # 22 P 182 LYS F 157 LYS^? 28.36 MG MG F 302 P 184 LYS F 6 LYS^? 26.09 MG MG F 301 P 345 ASP F 138 ASP^? 33.51 MG MG F 302 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 77.17 76.66 -81.48 76.14 76.33 -83.32 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 23 3 # 23 P 182 LYS F 157 LYS^? 28.36 MG MG F 302 P 184 LYS F 6 LYS^? 26.09 MG MG F 301 P 345 ASP F 142 ASP^? 23.43 MG MG F 302 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 71.46 69.88 -89.76 71.03 69.93 -91.81 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 24 3 # 24 P 182 LYS F 157 LYS^? 28.36 MG MG F 302 P 184 LYS F 166 LYS^? 20.76 MG MG F 302 P 345 ASP F 142 ASP^? 23.43 MG MG F 302 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 71.46 69.88 -89.76 71.03 69.93 -91.81 2dw7_c47 source 2dw7 BLL6730 PROTEIN : 24 hits 2dw7_c47 naa= 3 ULMN 3 2f61_c00 ACID BETA-GLUCOSIDASE user 1 3 # 1 A 235 GLU A 52 GLU^? 19.89 MG MG A 301 A 340 GLU A 154 GLU^? 19.22 MG MG A 301 A 342 CYH A 152 CYH^? 15.18 MG MG A 302 coo 13.45 37.14 -1.68 12.32 37.89 -3.28 42.67 25.16 24.80 42.61 25.77 22.75 coo 14.96 43.86 -2.28 14.91 42.15 -3.51 36.54 21.95 29.78 35.14 22.21 28.17 coo 11.37 47.97 -4.08 11.06 45.43 -5.26 34.81 26.51 34.70 32.10 26.95 34.06 ULMN 3 2f61_c00 ACID BETA-GLUCOSIDASE user 2 3 # 2 A 235 GLU B 52 GLU^? 20.06 MG MG B 302 A 340 GLU B 154 GLU^? 19.05 MG MG B 302 A 342 CYH B 152 CYH^? 14.66 MG MG B 301 coo 13.45 37.14 -1.68 12.32 37.89 -3.28 47.87 20.25 12.36 48.11 19.69 14.43 coo 14.96 43.86 -2.28 14.91 42.15 -3.51 44.04 15.11 6.74 44.19 13.59 8.30 coo 11.37 47.97 -4.08 11.06 45.43 -5.26 48.74 12.82 1.93 48.51 10.17 2.19 ULMN 3 2f61_c00 ACID BETA-GLUCOSIDASE user 3 3 # 3 A 235 GLU F 52 GLU^? 20.13 MG MG F 301 A 340 GLU F 154 GLU^? 18.97 MG MG F 301 A 342 CYH F 152 CYH^? 14.14 MG MG F 302 coo 13.45 37.14 -1.68 12.32 37.89 -3.28 57.09 59.62 -75.76 56.76 59.40 -73.62 coo 14.96 43.86 -2.28 14.91 42.15 -3.51 54.57 65.67 -81.55 53.36 66.51 -80.09 coo 11.37 47.97 -4.08 11.06 45.43 -5.26 50.28 62.76 -86.08 48.12 64.34 -85.77 2f61_c00 source 2f61 ACID BETA-GLUCOSIDASE : 3 hits 2f61_c00 naa= 3 ULMN 3 2f61_c01 ACID BETA-GLUCOSIDASE user 1 3 # 1 B 235 GLU A 52 GLU^? 19.89 MG MG A 301 B 340 GLU A 154 GLU^? 19.22 MG MG A 301 B 342 CYH A 152 CYH^? 15.18 MG MG A 302 coo 41.63 98.81 4.74 43.45 99.80 5.19 42.67 25.16 24.80 42.61 25.77 22.75 coo 40.49 105.59 6.14 40.82 103.64 6.89 36.54 21.95 29.78 35.14 22.21 28.17 coo 45.58 109.64 7.60 45.90 106.93 8.23 34.81 26.51 34.70 32.10 26.95 34.06 ULMN 3 2f61_c01 ACID BETA-GLUCOSIDASE user 2 3 # 2 B 235 GLU B 52 GLU^? 20.06 MG MG B 302 B 340 GLU B 154 GLU^? 19.05 MG MG B 302 B 342 CYH B 152 CYH^? 14.66 MG MG B 301 coo 41.63 98.81 4.74 43.45 99.80 5.19 47.87 20.25 12.36 48.11 19.69 14.43 coo 40.49 105.59 6.14 40.82 103.64 6.89 44.04 15.11 6.74 44.19 13.59 8.30 coo 45.58 109.64 7.60 45.90 106.93 8.23 48.74 12.82 1.93 48.51 10.17 2.19 ULMN 3 2f61_c01 ACID BETA-GLUCOSIDASE user 3 3 # 3 B 235 GLU F 52 GLU^? 20.13 MG MG F 301 B 340 GLU F 154 GLU^? 18.97 MG MG F 301 B 342 CYH F 152 CYH^? 14.14 MG MG F 302 coo 41.63 98.81 4.74 43.45 99.80 5.19 57.09 59.62 -75.76 56.76 59.40 -73.62 coo 40.49 105.59 6.14 40.82 103.64 6.89 54.57 65.67 -81.55 53.36 66.51 -80.09 coo 45.58 109.64 7.60 45.90 106.93 8.23 50.28 62.76 -86.08 48.12 64.34 -85.77 2f61_c01 source 2f61 ACID BETA-GLUCOSIDASE : 3 hits 2f61_c01 naa= 3 ULMN 3 2f9z_c00 PROTEIN (CHEMOTAXIS METHYLATION PROTuser 1 3 # 1 C 21 THR A 175 THR^? 12.07 MG MG A 302 C 27 CYH A 152 CYH^? 15.18 MG MG A 302 C 44 HIS A 170 HIS^? 10.56 MG MG A 302 coo 31.18 22.40 -15.93 30.94 20.86 -14.44 29.08 25.19 42.91 31.22 24.90 42.83 coo 33.52 13.02 -11.58 35.31 14.81 -10.35 34.81 26.51 34.70 32.10 26.95 34.06 coo 32.65 18.86 -10.97 34.16 18.23 -12.28 34.91 23.57 39.32 34.35 24.95 40.81 ULMN 3 2f9z_c00 PROTEIN (CHEMOTAXIS METHYLATION PROTuser 2 3 # 2 C 21 THR B 175 THR^? 12.15 MG MG B 301 C 27 CYH B 152 CYH^? 14.66 MG MG B 301 C 44 HIS B 170 HIS^? 10.51 MG MG B 301 coo 31.18 22.40 -15.93 30.94 20.86 -14.44 46.88 7.94 -7.07 47.05 10.06 -6.52 coo 33.52 13.02 -11.58 35.31 14.81 -10.35 48.74 12.82 1.93 48.51 10.17 2.19 coo 32.65 18.86 -10.97 34.16 18.23 -12.28 46.22 13.75 -2.72 47.53 13.11 -4.24 ULMN 3 2f9z_c00 PROTEIN (CHEMOTAXIS METHYLATION PROTuser 3 3 # 3 C 21 THR C 175 THR^? 12.73 MG MG C 301 C 27 CYH C 152 CYH^? 14.61 MG MG C 301 C 44 HIS C 170 HIS^? 10.68 MG MG C 301 coo 31.18 22.40 -15.93 30.94 20.86 -14.44 91.24 15.45 0.47 90.99 17.39 -0.47 coo 33.52 13.02 -11.58 35.31 14.81 -10.35 87.66 19.43 -8.58 88.77 17.04 -8.78 coo 32.65 18.86 -10.97 34.16 18.23 -12.28 89.96 21.05 -3.85 88.74 19.88 -2.61 ULMN 3 2f9z_c00 PROTEIN (CHEMOTAXIS METHYLATION PROTuser 4 3 # 4 C 21 THR D 175 THR^? 12.60 MG MG D 301 C 27 CYH D 152 CYH^? 14.66 MG MG D 301 C 44 HIS D 170 HIS^? 10.59 MG MG D 301 coo 31.18 22.40 -15.93 30.94 20.86 -14.44 100.33 38.24 -50.15 98.81 36.95 -49.29 coo 33.52 13.02 -11.58 35.31 14.81 -10.35 94.69 37.43 -41.36 96.92 38.83 -40.94 coo 32.65 18.86 -10.97 34.16 18.23 -12.28 95.57 34.81 -46.05 95.59 36.24 -47.59 ULMN 3 2f9z_c00 PROTEIN (CHEMOTAXIS METHYLATION PROTuser 5 3 # 5 C 21 THR E 175 THR^? 12.38 MG MG E 301 C 27 CYH E 152 CYH^? 14.64 MG MG E 301 C 44 HIS E 170 HIS^? 10.33 MG MG E 301 coo 31.18 22.40 -15.93 30.94 20.86 -14.44 71.20 72.92 -44.89 69.57 71.76 -45.77 coo 33.52 13.02 -11.58 35.31 14.81 -10.35 69.49 67.27 -53.54 71.02 69.50 -54.03 coo 32.65 18.86 -10.97 34.16 18.23 -12.28 66.96 68.76 -48.87 68.36 68.54 -47.33 ULMN 3 2f9z_c00 PROTEIN (CHEMOTAXIS METHYLATION PROTuser 6 3 # 6 C 21 THR F 175 THR^? 11.83 MG MG F 302 C 27 CYH F 152 CYH^? 14.14 MG MG F 302 C 44 HIS F 170 HIS^? 9.84 MG MG F 302 coo 31.18 22.40 -15.93 30.94 20.86 -14.44 46.82 66.80 -95.29 48.97 66.65 -95.25 coo 33.52 13.02 -11.58 35.31 14.81 -10.35 50.28 62.76 -86.08 48.12 64.34 -85.77 coo 32.65 18.86 -10.97 34.16 18.23 -12.28 52.25 64.82 -90.91 50.95 63.88 -92.26 2f9z_c00 source 2f9z PROTEIN (CHEMOTAXIS METHYLATION PROTEIN) : 6 hits 2f9z_c00 naa= 3 ULMN 3 2f9z_c01 PROTEIN (CHEMOTAXIS METHYLATION PROTuser 1 3 # 1 D 21 THR A 175 THR^? 12.07 MG MG A 302 D 27 CYH A 152 CYH^? 15.18 MG MG A 302 D 44 HIS A 170 HIS^? 10.56 MG MG A 302 coo 8.10 8.69 -37.60 9.58 7.79 -38.92 29.08 25.19 42.91 31.22 24.90 42.83 coo 15.06 1.75 -41.51 12.66 0.75 -42.59 34.81 26.51 34.70 32.10 26.95 34.06 coo 10.53 5.51 -42.28 10.30 3.78 -41.11 34.91 23.57 39.32 34.35 24.95 40.81 ULMN 3 2f9z_c01 PROTEIN (CHEMOTAXIS METHYLATION PROTuser 2 3 # 2 D 21 THR B 175 THR^? 12.15 MG MG B 301 D 27 CYH B 152 CYH^? 14.66 MG MG B 301 D 44 HIS B 170 HIS^? 10.51 MG MG B 301 coo 8.10 8.69 -37.60 9.58 7.79 -38.92 46.88 7.94 -7.07 47.05 10.06 -6.52 coo 15.06 1.75 -41.51 12.66 0.75 -42.59 48.74 12.82 1.93 48.51 10.17 2.19 coo 10.53 5.51 -42.28 10.30 3.78 -41.11 46.22 13.75 -2.72 47.53 13.11 -4.24 ULMN 3 2f9z_c01 PROTEIN (CHEMOTAXIS METHYLATION PROTuser 3 3 # 3 D 21 THR C 175 THR^? 12.73 MG MG C 301 D 27 CYH C 152 CYH^? 14.61 MG MG C 301 D 44 HIS C 170 HIS^? 10.68 MG MG C 301 coo 8.10 8.69 -37.60 9.58 7.79 -38.92 91.24 15.45 0.47 90.99 17.39 -0.47 coo 15.06 1.75 -41.51 12.66 0.75 -42.59 87.66 19.43 -8.58 88.77 17.04 -8.78 coo 10.53 5.51 -42.28 10.30 3.78 -41.11 89.96 21.05 -3.85 88.74 19.88 -2.61 ULMN 3 2f9z_c01 PROTEIN (CHEMOTAXIS METHYLATION PROTuser 4 3 # 4 D 21 THR D 175 THR^? 12.60 MG MG D 301 D 27 CYH D 152 CYH^? 14.66 MG MG D 301 D 44 HIS D 170 HIS^? 10.59 MG MG D 301 coo 8.10 8.69 -37.60 9.58 7.79 -38.92 100.33 38.24 -50.15 98.81 36.95 -49.29 coo 15.06 1.75 -41.51 12.66 0.75 -42.59 94.69 37.43 -41.36 96.92 38.83 -40.94 coo 10.53 5.51 -42.28 10.30 3.78 -41.11 95.57 34.81 -46.05 95.59 36.24 -47.59 ULMN 3 2f9z_c01 PROTEIN (CHEMOTAXIS METHYLATION PROTuser 5 3 # 5 D 21 THR E 175 THR^? 12.38 MG MG E 301 D 27 CYH E 152 CYH^? 14.64 MG MG E 301 D 44 HIS E 170 HIS^? 10.33 MG MG E 301 coo 8.10 8.69 -37.60 9.58 7.79 -38.92 71.20 72.92 -44.89 69.57 71.76 -45.77 coo 15.06 1.75 -41.51 12.66 0.75 -42.59 69.49 67.27 -53.54 71.02 69.50 -54.03 coo 10.53 5.51 -42.28 10.30 3.78 -41.11 66.96 68.76 -48.87 68.36 68.54 -47.33 ULMN 3 2f9z_c01 PROTEIN (CHEMOTAXIS METHYLATION PROTuser 6 3 # 6 D 21 THR F 175 THR^? 11.83 MG MG F 302 D 27 CYH F 152 CYH^? 14.14 MG MG F 302 D 44 HIS F 170 HIS^? 9.84 MG MG F 302 coo 8.10 8.69 -37.60 9.58 7.79 -38.92 46.82 66.80 -95.29 48.97 66.65 -95.25 coo 15.06 1.75 -41.51 12.66 0.75 -42.59 50.28 62.76 -86.08 48.12 64.34 -85.77 coo 10.53 5.51 -42.28 10.30 3.78 -41.11 52.25 64.82 -90.91 50.95 63.88 -92.26 2f9z_c01 source 2f9z PROTEIN (CHEMOTAXIS METHYLATION PROTEIN) : 6 hits 2f9z_c01 naa= 3 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 3 # 1 A 150 TYR A 60 TYR^? 27.11 MG MG B 302 A 245 ASP A 58 ASP^? 26.75 MG MG B 302 A 273 LYS A 137 LYS^? 34.85 MG MG A 301 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 55.01 4.24 16.98 56.13 3.24 14.65 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 53.93 9.80 21.09 53.83 8.90 19.15 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 50.97 1.58 28.14 56.13 1.49 28.03 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 3 # 2 A 150 TYR B 60 TYR^? 27.11 MG MG A 301 A 245 ASP B 58 ASP^? 26.73 MG MG A 301 A 273 LYS B 137 LYS^? 34.56 MG MG B 302 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 28.84 35.27 19.49 28.03 36.56 21.83 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 34.42 33.56 15.74 33.50 33.49 17.59 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 26.56 32.46 7.93 27.87 37.71 9.31 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 3 3 # 3 A 150 TYR D 60 TYR^? 26.93 MG MG C 302 A 245 ASP D 58 ASP^? 26.59 MG MG C 302 A 273 LYS D 137 LYS^? 37.57 MG MG D 302 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 84.40 9.28 -23.74 83.45 7.90 -21.49 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 83.38 14.85 -27.71 84.09 14.12 -25.85 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 88.48 8.58 -35.33 84.88 3.98 -33.96 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 4 3 # 4 A 150 TYR E 60 TYR^? 27.19 MG MG F 301 A 245 ASP E 58 ASP^? 26.76 MG MG F 301 A 273 LYS E 136 LYS^? 31.27 MG MG E 302 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 39.82 61.07 -70.68 38.29 60.72 -72.98 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 45.39 59.31 -66.83 44.62 59.88 -68.72 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 42.12 65.93 -56.52 39.36 65.07 -51.83 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 5 3 # 5 A 150 TYR E 60 TYR^? 27.19 MG MG F 301 A 245 ASP E 58 ASP^? 26.76 MG MG F 301 A 273 LYS E 137 LYS^? 35.26 MG MG E 302 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 39.82 61.07 -70.68 38.29 60.72 -72.98 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 45.39 59.31 -66.83 44.62 59.88 -68.72 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 40.01 66.05 -59.66 36.65 60.99 -60.28 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 6 3 # 6 A 150 TYR F 60 TYR^? 27.07 MG MG E 302 A 245 ASP F 160 ASP^? 31.59 MG MG E 302 A 273 LYS F 136 LYS^? 30.53 MG MG F 301 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 79.79 68.64 -68.89 81.11 68.86 -66.46 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 71.27 74.59 -71.77 73.23 74.02 -72.37 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 76.49 71.19 -83.39 78.38 70.88 -88.47 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 7 3 # 7 A 150 TYR F 60 TYR^? 27.07 MG MG E 302 A 245 ASP F 160 ASP^? 31.59 MG MG E 302 A 273 LYS F 137 LYS^? 35.13 MG MG F 301 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 79.79 68.64 -68.89 81.11 68.86 -66.46 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 71.27 74.59 -71.77 73.23 74.02 -72.37 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 78.53 72.20 -80.30 83.01 68.64 -79.79 2gsa_c02 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 7 hits 2gsa_c02 naa= 3 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 3 # 1 A 157 PHE A 153 PHE^? 9.64 MG MG A 301 A 245 ASP A 128 ASP^? -3.32 MG MG A 301s A 273 LYS A 111 LYS^? 15.16 MG MG A 301 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 38.89 24.49 36.07 40.14 26.70 37.23 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 46.50 28.23 39.77 47.49 30.10 39.82 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 52.67 17.19 35.90 54.65 19.90 40.50 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 3 # 2 A 157 PHE B 153 PHE^? 9.59 MG MG B 302 A 245 ASP B 128 ASP^? -3.57 MG MG B 302s A 273 LYS B 111 LYS^? 13.75 MG MG B 302 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 47.54 17.09 0.77 50.03 17.91 -0.19 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 52.92 24.09 -2.19 54.73 25.14 -1.90 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 42.84 32.14 1.80 46.84 32.68 -2.87 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 3 3 # 3 A 157 PHE C 153 PHE^? 9.34 MG MG C 302 A 245 ASP C 128 ASP^? -3.22 MG MG C 302s A 273 LYS C 111 LYS^? 16.56 MG MG C 302 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 87.15 23.83 -7.29 84.55 23.79 -6.26 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 80.05 28.39 -4.25 77.97 28.60 -4.21 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 86.36 39.56 -8.06 84.36 40.84 -3.15 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 4 3 # 4 A 157 PHE D 153 PHE^? 9.11 MG MG D 302 A 245 ASP D 128 ASP^? -3.70 MG MG D 302s A 273 LYS D 111 LYS^? 15.85 MG MG D 302 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 91.67 34.35 -42.71 89.76 36.10 -43.73 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 83.33 35.45 -46.13 81.57 36.63 -46.10 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 81.21 22.69 -42.10 78.68 23.89 -46.57 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 5 3 # 5 A 157 PHE E 153 PHE^? 9.50 MG MG E 302 A 245 ASP E 128 ASP^? -3.53 MG MG E 302s A 273 LYS E 111 LYS^? 14.52 MG MG E 302 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 65.86 64.95 -52.12 67.22 62.73 -51.09 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 65.38 56.57 -48.58 66.15 54.57 -48.61 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 52.49 56.44 -52.43 54.52 53.78 -47.52 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 6 3 # 6 A 157 PHE F 153 PHE^? 9.26 MG MG F 302 A 245 ASP F 128 ASP^? -3.41 MG MG F 301s A 273 LYS F 111 LYS^? 15.21 MG MG F 301 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 54.49 61.65 -87.43 53.89 59.08 -88.37 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 57.76 53.73 -90.50 57.46 51.64 -90.28 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 69.70 58.57 -86.86 69.67 53.74 -90.29 2gsa_c04 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 6 hits 2gsa_c04 naa= 3 ULMN 3 2hsa_c00 12-OXOPHYTODIENOATE REDUCTASE 3 user 1 3 # 1 B 185 HIS A 147 HIS^? 9.20 MG MG A 302 B 188 HIS A 170 HIS^? 10.56 MG MG A 302 B 190 TYR A 168 TYR^? 14.52 MG MG A 302 coo -2.40 8.56 71.48 -2.16 8.28 69.42 40.24 23.10 39.83 38.32 22.34 40.22 coo -0.71 6.39 65.98 -1.92 4.69 66.21 34.91 23.57 39.32 34.35 24.95 40.81 coo 0.03 12.24 67.96 -1.63 12.38 65.68 37.31 16.98 37.59 36.65 18.86 39.55 ULMN 3 2hsa_c00 12-OXOPHYTODIENOATE REDUCTASE 3 user 2 3 # 2 B 185 HIS A 147 HIS^? 9.20 MG MG A 302 B 188 HIS A 170 HIS^? 10.56 MG MG A 302 B 190 TYR A 188 TYR^? 8.73 MG MG A 302 coo -2.40 8.56 71.48 -2.16 8.28 69.42 40.24 23.10 39.83 38.32 22.34 40.22 coo -0.71 6.39 65.98 -1.92 4.69 66.21 34.91 23.57 39.32 34.35 24.95 40.81 coo 0.03 12.24 67.96 -1.63 12.38 65.68 37.17 23.04 44.09 34.69 24.12 44.73 ULMN 3 2hsa_c00 12-OXOPHYTODIENOATE REDUCTASE 3 user 3 3 # 3 B 185 HIS A 170 HIS^? 10.56 MG MG A 302 B 188 HIS A 147 HIS^? 9.20 MG MG A 302 B 190 TYR A 168 TYR^? 14.52 MG MG A 302 coo -2.40 8.56 71.48 -2.16 8.28 69.42 34.91 23.57 39.32 34.35 24.95 40.81 coo -0.71 6.39 65.98 -1.92 4.69 66.21 40.24 23.10 39.83 38.32 22.34 40.22 coo 0.03 12.24 67.96 -1.63 12.38 65.68 37.31 16.98 37.59 36.65 18.86 39.55 ULMN 3 2hsa_c00 12-OXOPHYTODIENOATE REDUCTASE 3 user 4 3 # 4 B 185 HIS A 170 HIS^? 10.56 MG MG A 302 B 188 HIS A 147 HIS^? 9.20 MG MG A 302 B 190 TYR A 188 TYR^? 8.73 MG MG A 302 coo -2.40 8.56 71.48 -2.16 8.28 69.42 34.91 23.57 39.32 34.35 24.95 40.81 coo -0.71 6.39 65.98 -1.92 4.69 66.21 40.24 23.10 39.83 38.32 22.34 40.22 coo 0.03 12.24 67.96 -1.63 12.38 65.68 37.17 23.04 44.09 34.69 24.12 44.73 ULMN 3 2hsa_c00 12-OXOPHYTODIENOATE REDUCTASE 3 user 5 3 # 5 B 185 HIS B 147 HIS^? 9.27 MG MG B 301 B 188 HIS B 170 HIS^? 10.51 MG MG B 301 B 190 TYR B 168 TYR^? 14.66 MG MG B 301 coo -2.40 8.56 71.48 -2.16 8.28 69.42 46.73 18.97 -3.05 45.63 17.32 -3.73 coo -0.71 6.39 65.98 -1.92 4.69 66.21 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 0.03 12.24 67.96 -1.63 12.38 65.68 40.03 17.20 -1.34 41.92 16.43 -3.19 ULMN 3 2hsa_c00 12-OXOPHYTODIENOATE REDUCTASE 3 user 6 3 # 6 B 185 HIS B 147 HIS^? 9.27 MG MG B 301 B 188 HIS B 170 HIS^? 10.51 MG MG B 301 B 190 TYR B 188 TYR^? 8.84 MG MG B 301 coo -2.40 8.56 71.48 -2.16 8.28 69.42 46.73 18.97 -3.05 45.63 17.32 -3.73 coo -0.71 6.39 65.98 -1.92 4.69 66.21 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 0.03 12.24 67.96 -1.63 12.38 65.68 46.41 16.35 -7.52 47.38 13.88 -8.38 ULMN 3 2hsa_c00 12-OXOPHYTODIENOATE REDUCTASE 3 user 7 3 # 7 B 185 HIS B 170 HIS^? 10.51 MG MG B 301 B 188 HIS B 147 HIS^? 9.27 MG MG B 301 B 190 TYR B 168 TYR^? 14.66 MG MG B 301 coo -2.40 8.56 71.48 -2.16 8.28 69.42 46.22 13.75 -2.72 47.53 13.11 -4.24 coo -0.71 6.39 65.98 -1.92 4.69 66.21 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 0.03 12.24 67.96 -1.63 12.38 65.68 40.03 17.20 -1.34 41.92 16.43 -3.19 ULMN 3 2hsa_c00 12-OXOPHYTODIENOATE REDUCTASE 3 user 8 3 # 8 B 185 HIS B 170 HIS^? 10.51 MG MG B 301 B 188 HIS B 147 HIS^? 9.27 MG MG B 301 B 190 TYR B 188 TYR^? 8.84 MG MG B 301 coo -2.40 8.56 71.48 -2.16 8.28 69.42 46.22 13.75 -2.72 47.53 13.11 -4.24 coo -0.71 6.39 65.98 -1.92 4.69 66.21 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 0.03 12.24 67.96 -1.63 12.38 65.68 46.41 16.35 -7.52 47.38 13.88 -8.38 ULMN 3 2hsa_c00 12-OXOPHYTODIENOATE REDUCTASE 3 user 9 3 # 9 B 185 HIS C 147 HIS^? 9.44 MG MG C 301 B 188 HIS C 170 HIS^? 10.68 MG MG C 301 B 190 TYR C 168 TYR^? 14.82 MG MG C 301 coo -2.40 8.56 71.48 -2.16 8.28 69.42 87.61 25.71 -3.59 89.22 24.50 -2.99 coo -0.71 6.39 65.98 -1.92 4.69 66.21 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 0.03 12.24 67.96 -1.63 12.38 65.68 94.44 26.43 -5.44 92.97 25.09 -3.55 ULMN 3 2hsa_c00 12-OXOPHYTODIENOATE REDUCTASE 3 user 10 3 # 10 B 185 HIS C 147 HIS^? 9.44 MG MG C 301 B 188 HIS C 170 HIS^? 10.68 MG MG C 301 B 190 TYR C 188 TYR^? 8.98 MG MG C 301 coo -2.40 8.56 71.48 -2.16 8.28 69.42 87.61 25.71 -3.59 89.22 24.50 -2.99 coo -0.71 6.39 65.98 -1.92 4.69 66.21 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 0.03 12.24 67.96 -1.63 12.38 65.68 88.74 23.30 0.93 88.91 20.61 1.57 ULMN 3 2hsa_c00 12-OXOPHYTODIENOATE REDUCTASE 3 user 11 3 # 11 B 185 HIS C 170 HIS^? 10.68 MG MG C 301 B 188 HIS C 147 HIS^? 9.44 MG MG C 301 B 190 TYR C 168 TYR^? 14.82 MG MG C 301 coo -2.40 8.56 71.48 -2.16 8.28 69.42 89.96 21.05 -3.85 88.74 19.88 -2.61 coo -0.71 6.39 65.98 -1.92 4.69 66.21 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 0.03 12.24 67.96 -1.63 12.38 65.68 94.44 26.43 -5.44 92.97 25.09 -3.55 ULMN 3 2hsa_c00 12-OXOPHYTODIENOATE REDUCTASE 3 user 12 3 # 12 B 185 HIS C 170 HIS^? 10.68 MG MG C 301 B 188 HIS C 147 HIS^? 9.44 MG MG C 301 B 190 TYR C 188 TYR^? 8.98 MG MG C 301 coo -2.40 8.56 71.48 -2.16 8.28 69.42 89.96 21.05 -3.85 88.74 19.88 -2.61 coo -0.71 6.39 65.98 -1.92 4.69 66.21 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 0.03 12.24 67.96 -1.63 12.38 65.68 88.74 23.30 0.93 88.91 20.61 1.57 ULMN 3 2hsa_c00 12-OXOPHYTODIENOATE REDUCTASE 3 user 13 3 # 13 B 185 HIS D 147 HIS^? 9.43 MG MG D 301 B 188 HIS D 170 HIS^? 10.59 MG MG D 301 B 190 TYR D 168 TYR^? 14.75 MG MG D 301 coo -2.40 8.56 71.48 -2.16 8.28 69.42 90.95 32.51 -46.42 92.98 32.42 -46.93 coo -0.71 6.39 65.98 -1.92 4.69 66.21 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 0.03 12.24 67.96 -1.63 12.38 65.68 95.79 27.80 -44.35 95.71 29.78 -46.32 ULMN 3 2hsa_c00 12-OXOPHYTODIENOATE REDUCTASE 3 user 14 3 # 14 B 185 HIS D 147 HIS^? 9.43 MG MG D 301 B 188 HIS D 170 HIS^? 10.59 MG MG D 301 B 190 TYR D 188 TYR^? 8.87 MG MG D 301 coo -2.40 8.56 71.48 -2.16 8.28 69.42 90.95 32.51 -46.42 92.98 32.42 -46.93 coo -0.71 6.39 65.98 -1.92 4.69 66.21 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 0.03 12.24 67.96 -1.63 12.38 65.68 93.72 33.91 -50.86 95.36 36.03 -51.61 ULMN 3 2hsa_c00 12-OXOPHYTODIENOATE REDUCTASE 3 user 15 3 # 15 B 185 HIS D 170 HIS^? 10.59 MG MG D 301 B 188 HIS D 147 HIS^? 9.43 MG MG D 301 B 190 TYR D 168 TYR^? 14.75 MG MG D 301 coo -2.40 8.56 71.48 -2.16 8.28 69.42 95.57 34.81 -46.05 95.59 36.24 -47.59 coo -0.71 6.39 65.98 -1.92 4.69 66.21 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 0.03 12.24 67.96 -1.63 12.38 65.68 95.79 27.80 -44.35 95.71 29.78 -46.32 ULMN 3 2hsa_c00 12-OXOPHYTODIENOATE REDUCTASE 3 user 16 3 # 16 B 185 HIS D 170 HIS^? 10.59 MG MG D 301 B 188 HIS D 147 HIS^? 9.43 MG MG D 301 B 190 TYR D 188 TYR^? 8.87 MG MG D 301 coo -2.40 8.56 71.48 -2.16 8.28 69.42 95.57 34.81 -46.05 95.59 36.24 -47.59 coo -0.71 6.39 65.98 -1.92 4.69 66.21 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 0.03 12.24 67.96 -1.63 12.38 65.68 93.72 33.91 -50.86 95.36 36.03 -51.61 ULMN 3 2hsa_c00 12-OXOPHYTODIENOATE REDUCTASE 3 user 17 3 # 17 B 185 HIS E 147 HIS^? 9.22 MG MG E 301 B 188 HIS E 170 HIS^? 10.33 MG MG E 301 B 190 TYR E 168 TYR^? 14.43 MG MG E 301 coo -2.40 8.56 71.48 -2.16 8.28 69.42 63.87 64.43 -48.39 64.18 66.45 -47.92 coo -0.71 6.39 65.98 -1.92 4.69 66.21 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 0.03 12.24 67.96 -1.63 12.38 65.68 60.07 69.95 -50.54 61.99 69.37 -48.59 ULMN 3 2hsa_c00 12-OXOPHYTODIENOATE REDUCTASE 3 user 18 3 # 18 B 185 HIS E 147 HIS^? 9.22 MG MG E 301 B 188 HIS E 170 HIS^? 10.33 MG MG E 301 B 190 TYR E 188 TYR^? 8.62 MG MG E 301 coo -2.40 8.56 71.48 -2.16 8.28 69.42 63.87 64.43 -48.39 64.18 66.45 -47.92 coo -0.71 6.39 65.98 -1.92 4.69 66.21 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 0.03 12.24 67.96 -1.63 12.38 65.68 65.58 67.09 -44.08 67.82 68.57 -43.41 ULMN 3 2hsa_c00 12-OXOPHYTODIENOATE REDUCTASE 3 user 19 3 # 19 B 185 HIS E 170 HIS^? 10.33 MG MG E 301 B 188 HIS E 147 HIS^? 9.22 MG MG E 301 B 190 TYR E 168 TYR^? 14.43 MG MG E 301 coo -2.40 8.56 71.48 -2.16 8.28 69.42 66.96 68.76 -48.87 68.36 68.54 -47.33 coo -0.71 6.39 65.98 -1.92 4.69 66.21 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 0.03 12.24 67.96 -1.63 12.38 65.68 60.07 69.95 -50.54 61.99 69.37 -48.59 ULMN 3 2hsa_c00 12-OXOPHYTODIENOATE REDUCTASE 3 user 20 3 # 20 B 185 HIS E 170 HIS^? 10.33 MG MG E 301 B 188 HIS E 147 HIS^? 9.22 MG MG E 301 B 190 TYR E 188 TYR^? 8.62 MG MG E 301 coo -2.40 8.56 71.48 -2.16 8.28 69.42 66.96 68.76 -48.87 68.36 68.54 -47.33 coo -0.71 6.39 65.98 -1.92 4.69 66.21 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 0.03 12.24 67.96 -1.63 12.38 65.68 65.58 67.09 -44.08 67.82 68.57 -43.41 ULMN 3 2hsa_c00 12-OXOPHYTODIENOATE REDUCTASE 3 user 21 3 # 21 B 185 HIS F 147 HIS^? 8.79 MG MG F 302 B 188 HIS F 170 HIS^? 9.84 MG MG F 302 B 190 TYR F 168 TYR^? 14.10 MG MG F 302 coo -2.40 8.56 71.48 -2.16 8.28 69.42 56.63 61.66 -91.16 55.69 63.43 -91.80 coo -0.71 6.39 65.98 -1.92 4.69 66.21 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 0.03 12.24 67.96 -1.63 12.38 65.68 58.29 68.32 -89.29 56.67 67.12 -91.21 ULMN 3 2hsa_c00 12-OXOPHYTODIENOATE REDUCTASE 3 user 22 3 # 22 B 185 HIS F 147 HIS^? 8.79 MG MG F 302 B 188 HIS F 170 HIS^? 9.84 MG MG F 302 B 190 TYR F 188 TYR^? 8.06 MG MG F 302 coo -2.40 8.56 71.48 -2.16 8.28 69.42 56.63 61.66 -91.16 55.69 63.43 -91.80 coo -0.71 6.39 65.98 -1.92 4.69 66.21 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 0.03 12.24 67.96 -1.63 12.38 65.68 54.23 63.50 -95.64 51.58 63.66 -96.35 ULMN 3 2hsa_c00 12-OXOPHYTODIENOATE REDUCTASE 3 user 23 3 # 23 B 185 HIS F 170 HIS^? 9.84 MG MG F 302 B 188 HIS F 147 HIS^? 8.79 MG MG F 302 B 190 TYR F 168 TYR^? 14.10 MG MG F 302 coo -2.40 8.56 71.48 -2.16 8.28 69.42 52.25 64.82 -90.91 50.95 63.88 -92.26 coo -0.71 6.39 65.98 -1.92 4.69 66.21 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 0.03 12.24 67.96 -1.63 12.38 65.68 58.29 68.32 -89.29 56.67 67.12 -91.21 ULMN 3 2hsa_c00 12-OXOPHYTODIENOATE REDUCTASE 3 user 24 3 # 24 B 185 HIS F 170 HIS^? 9.84 MG MG F 302 B 188 HIS F 147 HIS^? 8.79 MG MG F 302 B 190 TYR F 188 TYR^? 8.06 MG MG F 302 coo -2.40 8.56 71.48 -2.16 8.28 69.42 52.25 64.82 -90.91 50.95 63.88 -92.26 coo -0.71 6.39 65.98 -1.92 4.69 66.21 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 0.03 12.24 67.96 -1.63 12.38 65.68 54.23 63.50 -95.64 51.58 63.66 -96.35 2hsa_c00 source 2hsa 12-OXOPHYTODIENOATE REDUCTASE 3 : 24 hits 2hsa_c00 naa= 3 ULMN 3 2hsa_c01 12-OXOPHYTODIENOATE REDUCTASE 3 user 1 3 # 1 A 185 HIS A 147 HIS^? 9.20 MG MG A 302 A 188 HIS A 170 HIS^? 10.56 MG MG A 302 A 190 TYR A 168 TYR^? 14.52 MG MG A 302 coo 17.28 -0.40 35.65 16.37 -0.39 37.54 40.24 23.10 39.83 38.32 22.34 40.22 coo 14.39 1.55 40.83 12.71 2.07 39.67 34.91 23.57 39.32 34.35 24.95 40.81 coo 19.52 -1.97 40.54 17.56 -3.47 41.92 37.31 16.98 37.59 36.65 18.86 39.55 ULMN 3 2hsa_c01 12-OXOPHYTODIENOATE REDUCTASE 3 user 2 3 # 2 A 185 HIS A 147 HIS^? 9.20 MG MG A 302 A 188 HIS A 170 HIS^? 10.56 MG MG A 302 A 190 TYR A 188 TYR^? 8.73 MG MG A 302 coo 17.28 -0.40 35.65 16.37 -0.39 37.54 40.24 23.10 39.83 38.32 22.34 40.22 coo 14.39 1.55 40.83 12.71 2.07 39.67 34.91 23.57 39.32 34.35 24.95 40.81 coo 19.52 -1.97 40.54 17.56 -3.47 41.92 37.17 23.04 44.09 34.69 24.12 44.73 ULMN 3 2hsa_c01 12-OXOPHYTODIENOATE REDUCTASE 3 user 3 3 # 3 A 185 HIS A 170 HIS^? 10.56 MG MG A 302 A 188 HIS A 147 HIS^? 9.20 MG MG A 302 A 190 TYR A 168 TYR^? 14.52 MG MG A 302 coo 17.28 -0.40 35.65 16.37 -0.39 37.54 34.91 23.57 39.32 34.35 24.95 40.81 coo 14.39 1.55 40.83 12.71 2.07 39.67 40.24 23.10 39.83 38.32 22.34 40.22 coo 19.52 -1.97 40.54 17.56 -3.47 41.92 37.31 16.98 37.59 36.65 18.86 39.55 ULMN 3 2hsa_c01 12-OXOPHYTODIENOATE REDUCTASE 3 user 4 3 # 4 A 185 HIS A 170 HIS^? 10.56 MG MG A 302 A 188 HIS A 147 HIS^? 9.20 MG MG A 302 A 190 TYR A 188 TYR^? 8.73 MG MG A 302 coo 17.28 -0.40 35.65 16.37 -0.39 37.54 34.91 23.57 39.32 34.35 24.95 40.81 coo 14.39 1.55 40.83 12.71 2.07 39.67 40.24 23.10 39.83 38.32 22.34 40.22 coo 19.52 -1.97 40.54 17.56 -3.47 41.92 37.17 23.04 44.09 34.69 24.12 44.73 ULMN 3 2hsa_c01 12-OXOPHYTODIENOATE REDUCTASE 3 user 5 3 # 5 A 185 HIS B 147 HIS^? 9.27 MG MG B 301 A 188 HIS B 170 HIS^? 10.51 MG MG B 301 A 190 TYR B 168 TYR^? 14.66 MG MG B 301 coo 17.28 -0.40 35.65 16.37 -0.39 37.54 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 14.39 1.55 40.83 12.71 2.07 39.67 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 19.52 -1.97 40.54 17.56 -3.47 41.92 40.03 17.20 -1.34 41.92 16.43 -3.19 ULMN 3 2hsa_c01 12-OXOPHYTODIENOATE REDUCTASE 3 user 6 3 # 6 A 185 HIS B 147 HIS^? 9.27 MG MG B 301 A 188 HIS B 170 HIS^? 10.51 MG MG B 301 A 190 TYR B 188 TYR^? 8.84 MG MG B 301 coo 17.28 -0.40 35.65 16.37 -0.39 37.54 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 14.39 1.55 40.83 12.71 2.07 39.67 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 19.52 -1.97 40.54 17.56 -3.47 41.92 46.41 16.35 -7.52 47.38 13.88 -8.38 ULMN 3 2hsa_c01 12-OXOPHYTODIENOATE REDUCTASE 3 user 7 3 # 7 A 185 HIS B 170 HIS^? 10.51 MG MG B 301 A 188 HIS B 147 HIS^? 9.27 MG MG B 301 A 190 TYR B 168 TYR^? 14.66 MG MG B 301 coo 17.28 -0.40 35.65 16.37 -0.39 37.54 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 14.39 1.55 40.83 12.71 2.07 39.67 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 19.52 -1.97 40.54 17.56 -3.47 41.92 40.03 17.20 -1.34 41.92 16.43 -3.19 ULMN 3 2hsa_c01 12-OXOPHYTODIENOATE REDUCTASE 3 user 8 3 # 8 A 185 HIS B 170 HIS^? 10.51 MG MG B 301 A 188 HIS B 147 HIS^? 9.27 MG MG B 301 A 190 TYR B 188 TYR^? 8.84 MG MG B 301 coo 17.28 -0.40 35.65 16.37 -0.39 37.54 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 14.39 1.55 40.83 12.71 2.07 39.67 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 19.52 -1.97 40.54 17.56 -3.47 41.92 46.41 16.35 -7.52 47.38 13.88 -8.38 ULMN 3 2hsa_c01 12-OXOPHYTODIENOATE REDUCTASE 3 user 9 3 # 9 A 185 HIS C 147 HIS^? 9.44 MG MG C 301 A 188 HIS C 170 HIS^? 10.68 MG MG C 301 A 190 TYR C 168 TYR^? 14.82 MG MG C 301 coo 17.28 -0.40 35.65 16.37 -0.39 37.54 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 14.39 1.55 40.83 12.71 2.07 39.67 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 19.52 -1.97 40.54 17.56 -3.47 41.92 94.44 26.43 -5.44 92.97 25.09 -3.55 ULMN 3 2hsa_c01 12-OXOPHYTODIENOATE REDUCTASE 3 user 10 3 # 10 A 185 HIS C 147 HIS^? 9.44 MG MG C 301 A 188 HIS C 170 HIS^? 10.68 MG MG C 301 A 190 TYR C 188 TYR^? 8.98 MG MG C 301 coo 17.28 -0.40 35.65 16.37 -0.39 37.54 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 14.39 1.55 40.83 12.71 2.07 39.67 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 19.52 -1.97 40.54 17.56 -3.47 41.92 88.74 23.30 0.93 88.91 20.61 1.57 ULMN 3 2hsa_c01 12-OXOPHYTODIENOATE REDUCTASE 3 user 11 3 # 11 A 185 HIS C 170 HIS^? 10.68 MG MG C 301 A 188 HIS C 147 HIS^? 9.44 MG MG C 301 A 190 TYR C 168 TYR^? 14.82 MG MG C 301 coo 17.28 -0.40 35.65 16.37 -0.39 37.54 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 14.39 1.55 40.83 12.71 2.07 39.67 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 19.52 -1.97 40.54 17.56 -3.47 41.92 94.44 26.43 -5.44 92.97 25.09 -3.55 ULMN 3 2hsa_c01 12-OXOPHYTODIENOATE REDUCTASE 3 user 12 3 # 12 A 185 HIS C 170 HIS^? 10.68 MG MG C 301 A 188 HIS C 147 HIS^? 9.44 MG MG C 301 A 190 TYR C 188 TYR^? 8.98 MG MG C 301 coo 17.28 -0.40 35.65 16.37 -0.39 37.54 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 14.39 1.55 40.83 12.71 2.07 39.67 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 19.52 -1.97 40.54 17.56 -3.47 41.92 88.74 23.30 0.93 88.91 20.61 1.57 ULMN 3 2hsa_c01 12-OXOPHYTODIENOATE REDUCTASE 3 user 13 3 # 13 A 185 HIS D 147 HIS^? 9.43 MG MG D 301 A 188 HIS D 170 HIS^? 10.59 MG MG D 301 A 190 TYR D 168 TYR^? 14.75 MG MG D 301 coo 17.28 -0.40 35.65 16.37 -0.39 37.54 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 14.39 1.55 40.83 12.71 2.07 39.67 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 19.52 -1.97 40.54 17.56 -3.47 41.92 95.79 27.80 -44.35 95.71 29.78 -46.32 ULMN 3 2hsa_c01 12-OXOPHYTODIENOATE REDUCTASE 3 user 14 3 # 14 A 185 HIS D 147 HIS^? 9.43 MG MG D 301 A 188 HIS D 170 HIS^? 10.59 MG MG D 301 A 190 TYR D 188 TYR^? 8.87 MG MG D 301 coo 17.28 -0.40 35.65 16.37 -0.39 37.54 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 14.39 1.55 40.83 12.71 2.07 39.67 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 19.52 -1.97 40.54 17.56 -3.47 41.92 93.72 33.91 -50.86 95.36 36.03 -51.61 ULMN 3 2hsa_c01 12-OXOPHYTODIENOATE REDUCTASE 3 user 15 3 # 15 A 185 HIS D 170 HIS^? 10.59 MG MG D 301 A 188 HIS D 147 HIS^? 9.43 MG MG D 301 A 190 TYR D 168 TYR^? 14.75 MG MG D 301 coo 17.28 -0.40 35.65 16.37 -0.39 37.54 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 14.39 1.55 40.83 12.71 2.07 39.67 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 19.52 -1.97 40.54 17.56 -3.47 41.92 95.79 27.80 -44.35 95.71 29.78 -46.32 ULMN 3 2hsa_c01 12-OXOPHYTODIENOATE REDUCTASE 3 user 16 3 # 16 A 185 HIS D 170 HIS^? 10.59 MG MG D 301 A 188 HIS D 147 HIS^? 9.43 MG MG D 301 A 190 TYR D 188 TYR^? 8.87 MG MG D 301 coo 17.28 -0.40 35.65 16.37 -0.39 37.54 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 14.39 1.55 40.83 12.71 2.07 39.67 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 19.52 -1.97 40.54 17.56 -3.47 41.92 93.72 33.91 -50.86 95.36 36.03 -51.61 ULMN 3 2hsa_c01 12-OXOPHYTODIENOATE REDUCTASE 3 user 17 3 # 17 A 185 HIS E 147 HIS^? 9.22 MG MG E 301 A 188 HIS E 170 HIS^? 10.33 MG MG E 301 A 190 TYR E 168 TYR^? 14.43 MG MG E 301 coo 17.28 -0.40 35.65 16.37 -0.39 37.54 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 14.39 1.55 40.83 12.71 2.07 39.67 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 19.52 -1.97 40.54 17.56 -3.47 41.92 60.07 69.95 -50.54 61.99 69.37 -48.59 ULMN 3 2hsa_c01 12-OXOPHYTODIENOATE REDUCTASE 3 user 18 3 # 18 A 185 HIS E 147 HIS^? 9.22 MG MG E 301 A 188 HIS E 170 HIS^? 10.33 MG MG E 301 A 190 TYR E 188 TYR^? 8.62 MG MG E 301 coo 17.28 -0.40 35.65 16.37 -0.39 37.54 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 14.39 1.55 40.83 12.71 2.07 39.67 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 19.52 -1.97 40.54 17.56 -3.47 41.92 65.58 67.09 -44.08 67.82 68.57 -43.41 ULMN 3 2hsa_c01 12-OXOPHYTODIENOATE REDUCTASE 3 user 19 3 # 19 A 185 HIS E 170 HIS^? 10.33 MG MG E 301 A 188 HIS E 147 HIS^? 9.22 MG MG E 301 A 190 TYR E 168 TYR^? 14.43 MG MG E 301 coo 17.28 -0.40 35.65 16.37 -0.39 37.54 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 14.39 1.55 40.83 12.71 2.07 39.67 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 19.52 -1.97 40.54 17.56 -3.47 41.92 60.07 69.95 -50.54 61.99 69.37 -48.59 ULMN 3 2hsa_c01 12-OXOPHYTODIENOATE REDUCTASE 3 user 20 3 # 20 A 185 HIS E 170 HIS^? 10.33 MG MG E 301 A 188 HIS E 147 HIS^? 9.22 MG MG E 301 A 190 TYR E 188 TYR^? 8.62 MG MG E 301 coo 17.28 -0.40 35.65 16.37 -0.39 37.54 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 14.39 1.55 40.83 12.71 2.07 39.67 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 19.52 -1.97 40.54 17.56 -3.47 41.92 65.58 67.09 -44.08 67.82 68.57 -43.41 ULMN 3 2hsa_c01 12-OXOPHYTODIENOATE REDUCTASE 3 user 21 3 # 21 A 185 HIS F 147 HIS^? 8.79 MG MG F 302 A 188 HIS F 170 HIS^? 9.84 MG MG F 302 A 190 TYR F 168 TYR^? 14.10 MG MG F 302 coo 17.28 -0.40 35.65 16.37 -0.39 37.54 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 14.39 1.55 40.83 12.71 2.07 39.67 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 19.52 -1.97 40.54 17.56 -3.47 41.92 58.29 68.32 -89.29 56.67 67.12 -91.21 ULMN 3 2hsa_c01 12-OXOPHYTODIENOATE REDUCTASE 3 user 22 3 # 22 A 185 HIS F 147 HIS^? 8.79 MG MG F 302 A 188 HIS F 170 HIS^? 9.84 MG MG F 302 A 190 TYR F 188 TYR^? 8.06 MG MG F 302 coo 17.28 -0.40 35.65 16.37 -0.39 37.54 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 14.39 1.55 40.83 12.71 2.07 39.67 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 19.52 -1.97 40.54 17.56 -3.47 41.92 54.23 63.50 -95.64 51.58 63.66 -96.35 ULMN 3 2hsa_c01 12-OXOPHYTODIENOATE REDUCTASE 3 user 23 3 # 23 A 185 HIS F 170 HIS^? 9.84 MG MG F 302 A 188 HIS F 147 HIS^? 8.79 MG MG F 302 A 190 TYR F 168 TYR^? 14.10 MG MG F 302 coo 17.28 -0.40 35.65 16.37 -0.39 37.54 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 14.39 1.55 40.83 12.71 2.07 39.67 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 19.52 -1.97 40.54 17.56 -3.47 41.92 58.29 68.32 -89.29 56.67 67.12 -91.21 ULMN 3 2hsa_c01 12-OXOPHYTODIENOATE REDUCTASE 3 user 24 3 # 24 A 185 HIS F 170 HIS^? 9.84 MG MG F 302 A 188 HIS F 147 HIS^? 8.79 MG MG F 302 A 190 TYR F 188 TYR^? 8.06 MG MG F 302 coo 17.28 -0.40 35.65 16.37 -0.39 37.54 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 14.39 1.55 40.83 12.71 2.07 39.67 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 19.52 -1.97 40.54 17.56 -3.47 41.92 54.23 63.50 -95.64 51.58 63.66 -96.35 2hsa_c01 source 2hsa 12-OXOPHYTODIENOATE REDUCTASE 3 : 24 hits 2hsa_c01 naa= 3 ULMN 3 2lip_c00 LIPASE user 1 3 # 1 87 SER A 189 SER^? 11.75 MG MG A 302 264 ASP A 148 ASP^? 2.72 MG MG A 301s 286 HIS A 147 HIS^? 9.20 MG MG A 302 coo 10.47 25.91 18.67 10.67 27.13 20.84 40.99 19.00 44.32 41.51 18.14 46.48 coo 2.34 22.49 22.56 3.80 23.95 22.00 41.50 28.88 41.13 43.33 29.67 41.93 coo 7.10 24.11 23.40 8.18 25.09 21.87 40.24 23.10 39.83 38.32 22.34 40.22 ULMN 3 2lip_c00 LIPASE user 2 3 # 2 87 SER B 189 SER^? 12.11 MG MG B 301 264 ASP B 148 ASP^? 2.58 MG MG B 302s 286 HIS B 147 HIS^? 9.27 MG MG B 301 coo 10.47 25.91 18.67 10.67 27.13 20.84 43.10 20.95 -7.74 42.82 21.56 -10.02 coo 2.34 22.49 22.56 3.80 23.95 22.00 52.73 19.23 -3.77 53.81 20.99 -4.31 coo 7.10 24.11 23.40 8.18 25.09 21.87 46.73 18.97 -3.05 45.63 17.32 -3.73 ULMN 3 2lip_c00 LIPASE user 3 3 # 3 87 SER C 189 SER^? 12.09 MG MG C 301 264 ASP C 148 ASP^? 2.75 MG MG C 302s 286 HIS C 147 HIS^? 9.44 MG MG C 301 coo 10.47 25.91 18.67 10.67 27.13 20.84 90.33 28.79 1.19 90.26 29.61 3.45 coo 2.34 22.49 22.56 3.80 23.95 22.00 81.96 23.83 -2.68 80.24 25.11 -2.27 coo 7.10 24.11 23.40 8.18 25.09 21.87 87.61 25.71 -3.59 89.22 24.50 -2.99 ULMN 3 2lip_c00 LIPASE user 4 3 # 4 87 SER D 189 SER^? 12.12 MG MG D 301 264 ASP D 148 ASP^? 2.35 MG MG D 302s 286 HIS D 147 HIS^? 9.43 MG MG D 301 coo 10.47 25.91 18.67 10.67 27.13 20.84 91.62 28.58 -50.95 91.45 27.78 -53.25 coo 2.34 22.49 22.56 3.80 23.95 22.00 87.78 37.50 -47.56 85.79 37.49 -48.28 coo 7.10 24.11 23.40 8.18 25.09 21.87 90.95 32.51 -46.42 92.98 32.42 -46.93 ULMN 3 2lip_c00 LIPASE user 5 3 # 5 87 SER E 189 SER^? 11.91 MG MG E 301 264 ASP E 148 ASP^? 2.62 MG MG E 302s 286 HIS E 147 HIS^? 9.22 MG MG E 301 coo 10.47 25.91 18.67 10.67 27.13 20.84 60.13 65.61 -43.87 59.01 65.34 -41.74 coo 2.34 22.49 22.56 3.80 23.95 22.00 68.29 60.44 -47.29 68.03 58.42 -46.50 coo 7.10 24.11 23.40 8.18 25.09 21.87 63.87 64.43 -48.39 64.18 66.45 -47.92 ULMN 3 2lip_c00 LIPASE user 6 3 # 6 87 SER F 189 SER^? 11.88 MG MG F 302 264 ASP F 148 ASP^? 2.72 MG MG F 301s 286 HIS F 147 HIS^? 8.79 MG MG F 302 coo 10.47 25.91 18.67 10.67 27.13 20.84 59.91 63.90 -95.91 60.70 64.22 -98.13 coo 2.34 22.49 22.56 3.80 23.95 22.00 53.64 56.47 -91.98 54.61 54.68 -92.64 coo 7.10 24.11 23.40 8.18 25.09 21.87 56.63 61.66 -91.16 55.69 63.43 -91.80 2lip_c00 source 2lip LIPASE : 6 hits 2lip_c00 naa= 3 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 A 177 PHE A 12 PHE^? 17.15 MG MG A 301 A 263 ASP A 171 ASP^? 17.17 MG MG A 302 A 292 LYS A 166 LYS^? 20.93 MG MG A 302 coo 51.51 50.32 16.39 52.13 49.68 13.75 34.93 27.27 29.42 32.88 25.47 30.10 coo 54.43 44.82 23.74 55.21 45.06 21.80 29.78 23.67 36.63 28.48 25.11 35.71 coo 63.95 45.30 16.71 59.11 49.15 16.05 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 A 177 PHE A 59 PHE^? 31.59 MG MG A 301 A 263 ASP A 160 ASP^? 31.61 MG MG B 302 A 292 LYS A 157 LYS^? 28.65 MG MG A 302 coo 51.51 50.32 16.39 52.13 49.68 13.75 52.93 4.70 25.02 52.08 5.30 27.62 coo 54.43 44.82 23.74 55.21 45.06 21.80 44.21 5.00 19.54 46.02 3.84 19.76 coo 63.95 45.30 16.71 59.11 49.15 16.05 41.42 12.06 27.58 41.46 5.93 29.41 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 A 177 PHE A 110 PHE^? 21.60 MG MG A 301 A 263 ASP A 142 ASP^? 23.70 MG MG A 302 A 292 LYS A 137 LYS^? 34.85 MG MG A 301 coo 51.51 50.32 16.39 52.13 49.68 13.75 53.06 14.15 32.16 50.69 13.44 30.81 coo 54.43 44.82 23.74 55.21 45.06 21.80 46.39 7.18 37.53 46.28 7.18 39.63 coo 63.95 45.30 16.71 59.11 49.15 16.05 50.97 1.58 28.14 56.13 1.49 28.03 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 A 177 PHE A 110 PHE^? 21.60 MG MG A 301 A 263 ASP A 142 ASP^? 23.70 MG MG A 302 A 292 LYS A 157 LYS^? 28.65 MG MG A 302 coo 51.51 50.32 16.39 52.13 49.68 13.75 53.06 14.15 32.16 50.69 13.44 30.81 coo 54.43 44.82 23.74 55.21 45.06 21.80 46.39 7.18 37.53 46.28 7.18 39.63 coo 63.95 45.30 16.71 59.11 49.15 16.05 41.42 12.06 27.58 41.46 5.93 29.41 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 A 177 PHE A 153 PHE^? 9.64 MG MG A 301 A 263 ASP A 171 ASP^? 17.17 MG MG A 302 A 292 LYS A 166 LYS^? 20.93 MG MG A 302 coo 51.51 50.32 16.39 52.13 49.68 13.75 38.89 24.49 36.07 40.14 26.70 37.23 coo 54.43 44.82 23.74 55.21 45.06 21.80 29.78 23.67 36.63 28.48 25.11 35.71 coo 63.95 45.30 16.71 59.11 49.15 16.05 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 A 177 PHE A 161 PHE^? 25.62 MG MG B 302 A 263 ASP B 35 ASP^? 16.92 MG MG B 302 A 292 LYS A 61 LYS^? 21.99 MG MG B 302 coo 51.51 50.32 16.39 52.13 49.68 13.75 44.24 9.29 16.03 46.90 9.95 15.56 coo 54.43 44.82 23.74 55.21 45.06 21.80 52.63 11.07 10.18 53.68 12.85 9.94 coo 63.95 45.30 16.71 59.11 49.15 16.05 57.78 7.35 19.60 56.77 12.20 15.61 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 A 177 PHE B 12 PHE^? 17.13 MG MG B 302 A 263 ASP B 171 ASP^? 16.92 MG MG B 301 A 292 LYS B 166 LYS^? 22.75 MG MG B 301 coo 51.51 50.32 16.39 52.13 49.68 13.75 49.02 12.29 7.19 47.01 10.60 6.19 coo 54.43 44.82 23.74 55.21 45.06 21.80 45.30 8.50 -0.71 46.30 6.81 0.12 coo 63.95 45.30 16.71 59.11 49.15 16.05 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 8 3 # 8 A 177 PHE B 59 PHE^? 31.31 MG MG B 302 A 263 ASP B 160 ASP^? 31.65 MG MG A 301 A 292 LYS B 157 LYS^? 28.85 MG MG B 302 coo 51.51 50.32 16.39 52.13 49.68 13.75 29.63 33.55 11.36 30.42 32.81 8.75 coo 54.43 44.82 23.74 55.21 45.06 21.80 28.01 24.83 16.38 27.44 26.81 15.80 coo 63.95 45.30 16.71 59.11 49.15 16.05 34.97 21.28 8.44 29.03 22.82 6.58 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 9 3 # 9 A 177 PHE B 110 PHE^? 21.49 MG MG B 302 A 263 ASP B 142 ASP^? 23.97 MG MG B 301 A 292 LYS B 137 LYS^? 34.56 MG MG B 302 coo 51.51 50.32 16.39 52.13 49.68 13.75 39.39 32.59 5.17 38.42 30.20 6.23 coo 54.43 44.82 23.74 55.21 45.06 21.80 31.69 27.40 -1.31 32.10 27.37 -3.38 coo 63.95 45.30 16.71 59.11 49.15 16.05 26.56 32.46 7.93 27.87 37.71 9.31 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 10 3 # 10 A 177 PHE B 110 PHE^? 21.49 MG MG B 302 A 263 ASP B 142 ASP^? 23.97 MG MG B 301 A 292 LYS B 157 LYS^? 28.85 MG MG B 302 coo 51.51 50.32 16.39 52.13 49.68 13.75 39.39 32.59 5.17 38.42 30.20 6.23 coo 54.43 44.82 23.74 55.21 45.06 21.80 31.69 27.40 -1.31 32.10 27.37 -3.38 coo 63.95 45.30 16.71 59.11 49.15 16.05 34.97 21.28 8.44 29.03 22.82 6.58 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 11 3 # 11 A 177 PHE B 153 PHE^? 9.59 MG MG B 302 A 263 ASP B 171 ASP^? 16.92 MG MG B 301 A 292 LYS B 166 LYS^? 22.75 MG MG B 301 coo 51.51 50.32 16.39 52.13 49.68 13.75 47.54 17.09 0.77 50.03 17.91 -0.19 coo 54.43 44.82 23.74 55.21 45.06 21.80 45.30 8.50 -0.71 46.30 6.81 0.12 coo 63.95 45.30 16.71 59.11 49.15 16.05 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 12 3 # 12 A 177 PHE B 161 PHE^? 25.78 MG MG A 301 A 263 ASP A 35 ASP^? 16.92 MG MG A 301 A 292 LYS B 61 LYS^? 22.03 MG MG A 301 coo 51.51 50.32 16.39 52.13 49.68 13.75 31.87 23.58 19.99 32.61 26.21 20.65 coo 54.43 44.82 23.74 55.21 45.06 21.80 34.49 31.10 26.54 36.41 31.82 27.10 coo 63.95 45.30 16.71 59.11 49.15 16.05 32.50 37.62 17.61 36.68 34.92 21.51 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 13 3 # 13 A 177 PHE B 190 PHE^? 14.80 MG MG B 301 A 263 ASP B 142 ASP^? 23.97 MG MG B 301 A 292 LYS B 111 LYS^? 13.75 MG MG B 302 coo 51.51 50.32 16.39 52.13 49.68 13.75 40.06 19.97 -3.89 40.77 21.13 -1.45 coo 54.43 44.82 23.74 55.21 45.06 21.80 31.69 27.40 -1.31 32.10 27.37 -3.38 coo 63.95 45.30 16.71 59.11 49.15 16.05 42.84 32.14 1.80 46.84 32.68 -2.87 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 14 3 # 14 A 177 PHE B 190 PHE^? 14.80 MG MG B 301 A 263 ASP B 142 ASP^? 23.97 MG MG B 301 A 292 LYS B 157 LYS^? 28.85 MG MG B 302 coo 51.51 50.32 16.39 52.13 49.68 13.75 40.06 19.97 -3.89 40.77 21.13 -1.45 coo 54.43 44.82 23.74 55.21 45.06 21.80 31.69 27.40 -1.31 32.10 27.37 -3.38 coo 63.95 45.30 16.71 59.11 49.15 16.05 34.97 21.28 8.44 29.03 22.82 6.58 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 15 3 # 15 A 177 PHE C 12 PHE^? 16.92 MG MG C 302 A 263 ASP C 171 ASP^? 17.08 MG MG C 301 A 292 LYS C 166 LYS^? 22.53 MG MG C 301 coo 51.51 50.32 16.39 52.13 49.68 13.75 87.42 18.93 -13.86 90.00 18.25 -12.97 coo 54.43 44.82 23.74 55.21 45.06 21.80 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 63.95 45.30 16.71 59.11 49.15 16.05 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 16 3 # 16 A 177 PHE C 59 PHE^? 31.23 MG MG C 302 A 263 ASP C 160 ASP^? 31.63 MG MG D 302 A 292 LYS C 157 LYS^? 28.15 MG MG C 302 coo 51.51 50.32 16.39 52.13 49.68 13.75 98.06 45.52 -18.00 97.73 44.36 -15.53 coo 54.43 44.82 23.74 55.21 45.06 21.80 102.50 38.00 -23.28 102.43 39.97 -22.46 coo 63.95 45.30 16.71 59.11 49.15 16.05 97.55 32.04 -15.10 101.49 36.24 -13.39 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 17 3 # 17 A 177 PHE C 110 PHE^? 21.25 MG MG C 302 A 263 ASP C 142 ASP^? 23.76 MG MG C 301 A 292 LYS C 137 LYS^? 35.41 MG MG C 302 coo 51.51 50.32 16.39 52.13 49.68 13.75 89.08 41.33 -11.45 90.83 39.43 -12.52 coo 54.43 44.82 23.74 55.21 45.06 21.80 97.94 39.27 -5.03 98.08 38.70 -2.97 coo 63.95 45.30 16.71 59.11 49.15 16.05 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 18 3 # 18 A 177 PHE C 110 PHE^? 21.25 MG MG C 302 A 263 ASP C 142 ASP^? 23.76 MG MG C 301 A 292 LYS C 157 LYS^? 28.15 MG MG C 302 coo 51.51 50.32 16.39 52.13 49.68 13.75 89.08 41.33 -11.45 90.83 39.43 -12.52 coo 54.43 44.82 23.74 55.21 45.06 21.80 97.94 39.27 -5.03 98.08 38.70 -2.97 coo 63.95 45.30 16.71 59.11 49.15 16.05 97.55 32.04 -15.10 101.49 36.24 -13.39 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 19 3 # 19 A 177 PHE C 153 PHE^? 9.34 MG MG C 302 A 263 ASP C 171 ASP^? 17.08 MG MG C 301 A 292 LYS C 166 LYS^? 22.53 MG MG C 301 coo 51.51 50.32 16.39 52.13 49.68 13.75 87.15 23.83 -7.29 84.55 23.79 -6.26 coo 54.43 44.82 23.74 55.21 45.06 21.80 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 63.95 45.30 16.71 59.11 49.15 16.05 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 20 3 # 20 A 177 PHE C 161 PHE^? 25.47 MG MG D 302 A 263 ASP D 35 ASP^? 16.80 MG MG D 302 A 292 LYS C 61 LYS^? 21.91 MG MG D 302 coo 51.51 50.32 16.39 52.13 49.68 13.75 98.98 35.62 -26.76 97.40 37.84 -27.44 coo 54.43 44.82 23.74 55.21 45.06 21.80 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 63.95 45.30 16.71 59.11 49.15 16.05 93.60 48.56 -24.05 90.39 44.71 -27.98 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 21 3 # 21 A 177 PHE C 190 PHE^? 14.91 MG MG C 301 A 263 ASP C 142 ASP^? 23.76 MG MG C 301 A 292 LYS C 111 LYS^? 16.56 MG MG C 302 coo 51.51 50.32 16.39 52.13 49.68 13.75 93.44 29.01 -2.85 92.36 29.94 -5.20 coo 54.43 44.82 23.74 55.21 45.06 21.80 97.94 39.27 -5.03 98.08 38.70 -2.97 coo 63.95 45.30 16.71 59.11 49.15 16.05 86.36 39.56 -8.06 84.36 40.84 -3.15 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 22 3 # 22 A 177 PHE C 190 PHE^? 14.91 MG MG C 301 A 263 ASP C 142 ASP^? 23.76 MG MG C 301 A 292 LYS C 157 LYS^? 28.15 MG MG C 302 coo 51.51 50.32 16.39 52.13 49.68 13.75 93.44 29.01 -2.85 92.36 29.94 -5.20 coo 54.43 44.82 23.74 55.21 45.06 21.80 97.94 39.27 -5.03 98.08 38.70 -2.97 coo 63.95 45.30 16.71 59.11 49.15 16.05 97.55 32.04 -15.10 101.49 36.24 -13.39 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 23 3 # 23 A 177 PHE D 12 PHE^? 16.78 MG MG D 302 A 263 ASP D 171 ASP^? 16.95 MG MG D 301 A 292 LYS D 166 LYS^? 21.08 MG MG D 301 coo 51.51 50.32 16.39 52.13 49.68 13.75 94.68 38.11 -36.05 97.16 37.10 -36.83 coo 54.43 44.82 23.74 55.21 45.06 21.80 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 63.95 45.30 16.71 59.11 49.15 16.05 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 24 3 # 24 A 177 PHE D 59 PHE^? 31.49 MG MG D 302 A 263 ASP D 160 ASP^? 31.45 MG MG C 302 A 292 LYS D 157 LYS^? 28.67 MG MG D 302 coo 51.51 50.32 16.39 52.13 49.68 13.75 86.17 10.70 -31.86 86.41 11.56 -34.53 coo 54.43 44.82 23.74 55.21 45.06 21.80 94.15 13.98 -26.57 92.71 12.42 -26.99 coo 63.95 45.30 16.71 59.11 49.15 16.05 94.17 21.71 -34.34 96.11 15.89 -35.92 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 25 3 # 25 A 177 PHE D 110 PHE^? 21.56 MG MG D 302 A 263 ASP D 142 ASP^? 23.49 MG MG D 301 A 292 LYS D 137 LYS^? 37.57 MG MG D 302 coo 51.51 50.32 16.39 52.13 49.68 13.75 82.28 19.60 -38.58 84.73 19.89 -37.32 coo 54.43 44.82 23.74 55.21 45.06 21.80 90.90 15.58 -44.76 91.35 16.09 -46.79 coo 63.95 45.30 16.71 59.11 49.15 16.05 88.48 8.58 -35.33 84.88 3.98 -33.96 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 26 3 # 26 A 177 PHE D 110 PHE^? 21.56 MG MG D 302 A 263 ASP D 142 ASP^? 23.49 MG MG D 301 A 292 LYS D 157 LYS^? 28.67 MG MG D 302 coo 51.51 50.32 16.39 52.13 49.68 13.75 82.28 19.60 -38.58 84.73 19.89 -37.32 coo 54.43 44.82 23.74 55.21 45.06 21.80 90.90 15.58 -44.76 91.35 16.09 -46.79 coo 63.95 45.30 16.71 59.11 49.15 16.05 94.17 21.71 -34.34 96.11 15.89 -35.92 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 27 3 # 27 A 177 PHE D 153 PHE^? 9.11 MG MG D 302 A 263 ASP D 171 ASP^? 16.95 MG MG D 301 A 292 LYS D 166 LYS^? 21.08 MG MG D 301 coo 51.51 50.32 16.39 52.13 49.68 13.75 91.67 34.35 -42.71 89.76 36.10 -43.73 coo 54.43 44.82 23.74 55.21 45.06 21.80 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 63.95 45.30 16.71 59.11 49.15 16.05 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 28 3 # 28 A 177 PHE D 161 PHE^? 25.58 MG MG C 302 A 263 ASP C 35 ASP^? 16.42 MG MG C 302 A 292 LYS D 61 LYS^? 21.93 MG MG C 302 coo 51.51 50.32 16.39 52.13 49.68 13.75 92.97 17.97 -22.91 90.24 17.44 -22.45 coo 54.43 44.82 23.74 55.21 45.06 21.80 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 63.95 45.30 16.71 59.11 49.15 16.05 80.64 11.23 -26.16 80.65 16.24 -22.36 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 29 3 # 29 A 177 PHE D 190 PHE^? 14.83 MG MG D 301 A 263 ASP D 142 ASP^? 23.49 MG MG D 301 A 292 LYS D 111 LYS^? 15.85 MG MG D 302 coo 51.51 50.32 16.39 52.13 49.68 13.75 93.52 26.32 -46.94 92.08 26.47 -44.56 coo 54.43 44.82 23.74 55.21 45.06 21.80 90.90 15.58 -44.76 91.35 16.09 -46.79 coo 63.95 45.30 16.71 59.11 49.15 16.05 81.21 22.69 -42.10 78.68 23.89 -46.57 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 30 3 # 30 A 177 PHE D 190 PHE^? 14.83 MG MG D 301 A 263 ASP D 142 ASP^? 23.49 MG MG D 301 A 292 LYS D 157 LYS^? 28.67 MG MG D 302 coo 51.51 50.32 16.39 52.13 49.68 13.75 93.52 26.32 -46.94 92.08 26.47 -44.56 coo 54.43 44.82 23.74 55.21 45.06 21.80 90.90 15.58 -44.76 91.35 16.09 -46.79 coo 63.95 45.30 16.71 59.11 49.15 16.05 94.17 21.71 -34.34 96.11 15.89 -35.92 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 31 3 # 31 A 177 PHE E 12 PHE^? 17.09 MG MG E 302 A 263 ASP E 171 ASP^? 16.73 MG MG E 301 A 292 LYS E 166 LYS^? 21.46 MG MG E 301 coo 51.51 50.32 16.39 52.13 49.68 13.75 70.06 67.18 -58.76 69.33 69.81 -58.07 coo 54.43 44.82 23.74 55.21 45.06 21.80 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 63.95 45.30 16.71 59.11 49.15 16.05 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 32 3 # 32 A 177 PHE E 59 PHE^? 31.36 MG MG E 302 A 263 ASP E 160 ASP^? 31.54 MG MG F 301 A 292 LYS E 157 LYS^? 28.40 MG MG E 302 coo 51.51 50.32 16.39 52.13 49.68 13.75 41.55 62.67 -62.73 42.33 62.92 -60.06 coo 54.43 44.82 23.74 55.21 45.06 21.80 45.81 70.00 -68.45 44.10 68.87 -67.77 coo 63.95 45.30 16.71 59.11 49.15 16.05 53.63 69.16 -60.42 48.34 71.81 -58.40 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 33 3 # 33 A 177 PHE E 110 PHE^? 21.45 MG MG E 302 A 263 ASP E 142 ASP^? 23.66 MG MG E 301 A 292 LYS E 137 LYS^? 35.26 MG MG E 302 coo 51.51 50.32 16.39 52.13 49.68 13.75 49.73 57.83 -56.11 50.46 60.21 -57.41 coo 54.43 44.82 23.74 55.21 45.06 21.80 47.19 67.15 -50.37 47.44 67.18 -48.23 coo 63.95 45.30 16.71 59.11 49.15 16.05 40.01 66.05 -59.66 36.65 60.99 -60.28 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 34 3 # 34 A 177 PHE E 110 PHE^? 21.45 MG MG E 302 A 263 ASP E 142 ASP^? 23.66 MG MG E 301 A 292 LYS E 157 LYS^? 28.40 MG MG E 302 coo 51.51 50.32 16.39 52.13 49.68 13.75 49.73 57.83 -56.11 50.46 60.21 -57.41 coo 54.43 44.82 23.74 55.21 45.06 21.80 47.19 67.15 -50.37 47.44 67.18 -48.23 coo 63.95 45.30 16.71 59.11 49.15 16.05 53.63 69.16 -60.42 48.34 71.81 -58.40 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 35 3 # 35 A 177 PHE E 153 PHE^? 9.50 MG MG E 302 A 263 ASP E 171 ASP^? 16.73 MG MG E 301 A 292 LYS E 166 LYS^? 21.46 MG MG E 301 coo 51.51 50.32 16.39 52.13 49.68 13.75 65.86 64.95 -52.12 67.22 62.73 -51.09 coo 54.43 44.82 23.74 55.21 45.06 21.80 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 63.95 45.30 16.71 59.11 49.15 16.05 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 36 3 # 36 A 177 PHE E 161 PHE^? 25.51 MG MG F 301 A 263 ASP F 35 ASP^? 16.93 MG MG F 301 A 292 LYS E 61 LYS^? 22.16 MG MG F 301 coo 51.51 50.32 16.39 52.13 49.68 13.75 49.74 68.03 -71.94 48.60 65.47 -72.38 coo 54.43 44.82 23.74 55.21 45.06 21.80 46.82 60.47 -77.63 48.00 58.79 -78.23 coo 63.95 45.30 16.71 59.11 49.15 16.05 40.99 56.84 -68.48 45.99 56.72 -72.39 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 37 3 # 37 A 177 PHE E 190 PHE^? 14.70 MG MG E 301 A 263 ASP E 142 ASP^? 23.66 MG MG E 301 A 292 LYS E 111 LYS^? 14.52 MG MG E 302 coo 51.51 50.32 16.39 52.13 49.68 13.75 58.27 67.97 -47.86 58.03 66.58 -50.23 coo 54.43 44.82 23.74 55.21 45.06 21.80 47.19 67.15 -50.37 47.44 67.18 -48.23 coo 63.95 45.30 16.71 59.11 49.15 16.05 52.49 56.44 -52.43 54.52 53.78 -47.52 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 38 3 # 38 A 177 PHE E 190 PHE^? 14.70 MG MG E 301 A 263 ASP E 142 ASP^? 23.66 MG MG E 301 A 292 LYS E 157 LYS^? 28.40 MG MG E 302 coo 51.51 50.32 16.39 52.13 49.68 13.75 58.27 67.97 -47.86 58.03 66.58 -50.23 coo 54.43 44.82 23.74 55.21 45.06 21.80 47.19 67.15 -50.37 47.44 67.18 -48.23 coo 63.95 45.30 16.71 59.11 49.15 16.05 53.63 69.16 -60.42 48.34 71.81 -58.40 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 39 3 # 39 A 177 PHE F 12 PHE^? 17.12 MG MG F 301 A 263 ASP F 171 ASP^? 16.35 MG MG F 302 A 292 LYS F 166 LYS^? 20.76 MG MG F 302 coo 51.51 50.32 16.39 52.13 49.68 13.75 49.70 62.79 -80.90 49.37 65.44 -81.67 coo 54.43 44.82 23.74 55.21 45.06 21.80 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 63.95 45.30 16.71 59.11 49.15 16.05 59.28 73.05 -82.63 55.63 74.15 -86.94 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 40 3 # 40 A 177 PHE F 59 PHE^? 31.53 MG MG F 301 A 263 ASP F 160 ASP^? 31.59 MG MG E 302 A 292 LYS F 157 LYS^? 28.36 MG MG F 302 coo 51.51 50.32 16.39 52.13 49.68 13.75 77.96 68.89 -76.99 76.86 68.73 -79.55 coo 54.43 44.82 23.74 55.21 45.06 21.80 71.27 74.59 -71.77 73.23 74.02 -72.37 coo 63.95 45.30 16.71 59.11 49.15 16.05 64.43 70.47 -79.54 68.32 74.80 -81.65 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 41 3 # 41 A 177 PHE F 110 PHE^? 21.65 MG MG F 301 A 263 ASP F 142 ASP^? 23.43 MG MG F 302 A 292 LYS F 137 LYS^? 35.13 MG MG F 301 coo 51.51 50.32 16.39 52.13 49.68 13.75 72.02 60.99 -83.27 70.61 63.10 -82.08 coo 54.43 44.82 23.74 55.21 45.06 21.80 71.46 69.88 -89.76 71.03 69.93 -91.81 coo 63.95 45.30 16.71 59.11 49.15 16.05 78.53 72.20 -80.30 83.01 68.64 -79.79 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 42 3 # 42 A 177 PHE F 110 PHE^? 21.65 MG MG F 301 A 263 ASP F 142 ASP^? 23.43 MG MG F 302 A 292 LYS F 157 LYS^? 28.36 MG MG F 302 coo 51.51 50.32 16.39 52.13 49.68 13.75 72.02 60.99 -83.27 70.61 63.10 -82.08 coo 54.43 44.82 23.74 55.21 45.06 21.80 71.46 69.88 -89.76 71.03 69.93 -91.81 coo 63.95 45.30 16.71 59.11 49.15 16.05 64.43 70.47 -79.54 68.32 74.80 -81.65 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 43 3 # 43 A 177 PHE F 153 PHE^? 9.26 MG MG F 302 A 263 ASP F 171 ASP^? 16.35 MG MG F 302 A 292 LYS F 166 LYS^? 20.76 MG MG F 302 coo 51.51 50.32 16.39 52.13 49.68 13.75 54.49 61.65 -87.43 53.89 59.08 -88.37 coo 54.43 44.82 23.74 55.21 45.06 21.80 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 63.95 45.30 16.71 59.11 49.15 16.05 59.28 73.05 -82.63 55.63 74.15 -86.94 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 44 3 # 44 A 177 PHE F 161 PHE^? 25.66 MG MG E 302 A 263 ASP E 35 ASP^? 16.91 MG MG E 302 A 292 LYS F 61 LYS^? 21.75 MG MG E 302 coo 51.51 50.32 16.39 52.13 49.68 13.75 68.33 71.65 -68.19 70.12 69.57 -67.59 coo 54.43 44.82 23.74 55.21 45.06 21.80 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 63.95 45.30 16.71 59.11 49.15 16.05 80.24 64.12 -71.01 76.23 61.95 -66.39 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 45 3 # 45 A 177 PHE F 190 PHE^? 14.21 MG MG F 302 A 263 ASP F 142 ASP^? 23.43 MG MG F 302 A 292 LYS F 111 LYS^? 15.21 MG MG F 301 coo 51.51 50.32 16.39 52.13 49.68 13.75 60.66 66.91 -91.97 61.14 65.56 -89.57 coo 54.43 44.82 23.74 55.21 45.06 21.80 71.46 69.88 -89.76 71.03 69.93 -91.81 coo 63.95 45.30 16.71 59.11 49.15 16.05 69.70 58.57 -86.86 69.67 53.74 -90.29 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 46 3 # 46 A 177 PHE F 190 PHE^? 14.21 MG MG F 302 A 263 ASP F 142 ASP^? 23.43 MG MG F 302 A 292 LYS F 157 LYS^? 28.36 MG MG F 302 coo 51.51 50.32 16.39 52.13 49.68 13.75 60.66 66.91 -91.97 61.14 65.56 -89.57 coo 54.43 44.82 23.74 55.21 45.06 21.80 71.46 69.88 -89.76 71.03 69.93 -91.81 coo 63.95 45.30 16.71 59.11 49.15 16.05 64.43 70.47 -79.54 68.32 74.80 -81.65 2oat_c03 source 2oat ORNITHINE AMINOTRANSFERASE : 46 hits 2oat_c03 naa= 3 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 B 177 PHE A 12 PHE^? 17.15 MG MG A 301 B 263 ASP A 171 ASP^? 17.17 MG MG A 302 B 292 LYS A 166 LYS^? 20.93 MG MG A 302 coo 49.99 26.05 6.28 51.46 26.87 8.49 34.93 27.27 29.42 32.88 25.47 30.10 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 29.78 23.67 36.63 28.48 25.11 35.71 coo 60.53 31.67 0.97 57.79 27.51 3.63 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 B 177 PHE A 59 PHE^? 31.59 MG MG A 301 B 263 ASP A 160 ASP^? 31.61 MG MG B 302 B 292 LYS A 157 LYS^? 28.65 MG MG A 302 coo 49.99 26.05 6.28 51.46 26.87 8.49 52.93 4.70 25.02 52.08 5.30 27.62 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 44.21 5.00 19.54 46.02 3.84 19.76 coo 60.53 31.67 0.97 57.79 27.51 3.63 41.42 12.06 27.58 41.46 5.93 29.41 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 B 177 PHE A 110 PHE^? 21.60 MG MG A 301 B 263 ASP A 142 ASP^? 23.70 MG MG A 302 B 292 LYS A 137 LYS^? 34.85 MG MG A 301 coo 49.99 26.05 6.28 51.46 26.87 8.49 53.06 14.15 32.16 50.69 13.44 30.81 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 46.39 7.18 37.53 46.28 7.18 39.63 coo 60.53 31.67 0.97 57.79 27.51 3.63 50.97 1.58 28.14 56.13 1.49 28.03 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 B 177 PHE A 110 PHE^? 21.60 MG MG A 301 B 263 ASP A 142 ASP^? 23.70 MG MG A 302 B 292 LYS A 157 LYS^? 28.65 MG MG A 302 coo 49.99 26.05 6.28 51.46 26.87 8.49 53.06 14.15 32.16 50.69 13.44 30.81 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 46.39 7.18 37.53 46.28 7.18 39.63 coo 60.53 31.67 0.97 57.79 27.51 3.63 41.42 12.06 27.58 41.46 5.93 29.41 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 B 177 PHE A 153 PHE^? 9.64 MG MG A 301 B 263 ASP A 171 ASP^? 17.17 MG MG A 302 B 292 LYS A 166 LYS^? 20.93 MG MG A 302 coo 49.99 26.05 6.28 51.46 26.87 8.49 38.89 24.49 36.07 40.14 26.70 37.23 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 29.78 23.67 36.63 28.48 25.11 35.71 coo 60.53 31.67 0.97 57.79 27.51 3.63 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 B 177 PHE A 161 PHE^? 25.62 MG MG B 302 B 263 ASP B 35 ASP^? 16.92 MG MG B 302 B 292 LYS A 61 LYS^? 21.99 MG MG B 302 coo 49.99 26.05 6.28 51.46 26.87 8.49 44.24 9.29 16.03 46.90 9.95 15.56 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 52.63 11.07 10.18 53.68 12.85 9.94 coo 60.53 31.67 0.97 57.79 27.51 3.63 57.78 7.35 19.60 56.77 12.20 15.61 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 B 177 PHE B 12 PHE^? 17.13 MG MG B 302 B 263 ASP B 171 ASP^? 16.92 MG MG B 301 B 292 LYS B 166 LYS^? 22.75 MG MG B 301 coo 49.99 26.05 6.28 51.46 26.87 8.49 49.02 12.29 7.19 47.01 10.60 6.19 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 45.30 8.50 -0.71 46.30 6.81 0.12 coo 60.53 31.67 0.97 57.79 27.51 3.63 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 8 3 # 8 B 177 PHE B 59 PHE^? 31.31 MG MG B 302 B 263 ASP B 160 ASP^? 31.65 MG MG A 301 B 292 LYS B 157 LYS^? 28.85 MG MG B 302 coo 49.99 26.05 6.28 51.46 26.87 8.49 29.63 33.55 11.36 30.42 32.81 8.75 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 28.01 24.83 16.38 27.44 26.81 15.80 coo 60.53 31.67 0.97 57.79 27.51 3.63 34.97 21.28 8.44 29.03 22.82 6.58 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 9 3 # 9 B 177 PHE B 110 PHE^? 21.49 MG MG B 302 B 263 ASP B 142 ASP^? 23.97 MG MG B 301 B 292 LYS B 137 LYS^? 34.56 MG MG B 302 coo 49.99 26.05 6.28 51.46 26.87 8.49 39.39 32.59 5.17 38.42 30.20 6.23 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 31.69 27.40 -1.31 32.10 27.37 -3.38 coo 60.53 31.67 0.97 57.79 27.51 3.63 26.56 32.46 7.93 27.87 37.71 9.31 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 10 3 # 10 B 177 PHE B 110 PHE^? 21.49 MG MG B 302 B 263 ASP B 142 ASP^? 23.97 MG MG B 301 B 292 LYS B 157 LYS^? 28.85 MG MG B 302 coo 49.99 26.05 6.28 51.46 26.87 8.49 39.39 32.59 5.17 38.42 30.20 6.23 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 31.69 27.40 -1.31 32.10 27.37 -3.38 coo 60.53 31.67 0.97 57.79 27.51 3.63 34.97 21.28 8.44 29.03 22.82 6.58 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 11 3 # 11 B 177 PHE B 153 PHE^? 9.59 MG MG B 302 B 263 ASP B 171 ASP^? 16.92 MG MG B 301 B 292 LYS B 166 LYS^? 22.75 MG MG B 301 coo 49.99 26.05 6.28 51.46 26.87 8.49 47.54 17.09 0.77 50.03 17.91 -0.19 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 45.30 8.50 -0.71 46.30 6.81 0.12 coo 60.53 31.67 0.97 57.79 27.51 3.63 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 12 3 # 12 B 177 PHE B 161 PHE^? 25.78 MG MG A 301 B 263 ASP A 35 ASP^? 16.92 MG MG A 301 B 292 LYS B 61 LYS^? 22.03 MG MG A 301 coo 49.99 26.05 6.28 51.46 26.87 8.49 31.87 23.58 19.99 32.61 26.21 20.65 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 34.49 31.10 26.54 36.41 31.82 27.10 coo 60.53 31.67 0.97 57.79 27.51 3.63 32.50 37.62 17.61 36.68 34.92 21.51 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 13 3 # 13 B 177 PHE C 12 PHE^? 16.92 MG MG C 302 B 263 ASP C 171 ASP^? 17.08 MG MG C 301 B 292 LYS C 166 LYS^? 22.53 MG MG C 301 coo 49.99 26.05 6.28 51.46 26.87 8.49 87.42 18.93 -13.86 90.00 18.25 -12.97 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 60.53 31.67 0.97 57.79 27.51 3.63 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 14 3 # 14 B 177 PHE C 59 PHE^? 31.23 MG MG C 302 B 263 ASP C 160 ASP^? 31.63 MG MG D 302 B 292 LYS C 157 LYS^? 28.15 MG MG C 302 coo 49.99 26.05 6.28 51.46 26.87 8.49 98.06 45.52 -18.00 97.73 44.36 -15.53 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 102.50 38.00 -23.28 102.43 39.97 -22.46 coo 60.53 31.67 0.97 57.79 27.51 3.63 97.55 32.04 -15.10 101.49 36.24 -13.39 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 15 3 # 15 B 177 PHE C 110 PHE^? 21.25 MG MG C 302 B 263 ASP C 142 ASP^? 23.76 MG MG C 301 B 292 LYS C 137 LYS^? 35.41 MG MG C 302 coo 49.99 26.05 6.28 51.46 26.87 8.49 89.08 41.33 -11.45 90.83 39.43 -12.52 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 97.94 39.27 -5.03 98.08 38.70 -2.97 coo 60.53 31.67 0.97 57.79 27.51 3.63 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 16 3 # 16 B 177 PHE C 110 PHE^? 21.25 MG MG C 302 B 263 ASP C 142 ASP^? 23.76 MG MG C 301 B 292 LYS C 157 LYS^? 28.15 MG MG C 302 coo 49.99 26.05 6.28 51.46 26.87 8.49 89.08 41.33 -11.45 90.83 39.43 -12.52 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 97.94 39.27 -5.03 98.08 38.70 -2.97 coo 60.53 31.67 0.97 57.79 27.51 3.63 97.55 32.04 -15.10 101.49 36.24 -13.39 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 17 3 # 17 B 177 PHE C 153 PHE^? 9.34 MG MG C 302 B 263 ASP C 171 ASP^? 17.08 MG MG C 301 B 292 LYS C 166 LYS^? 22.53 MG MG C 301 coo 49.99 26.05 6.28 51.46 26.87 8.49 87.15 23.83 -7.29 84.55 23.79 -6.26 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 60.53 31.67 0.97 57.79 27.51 3.63 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 18 3 # 18 B 177 PHE C 161 PHE^? 25.47 MG MG D 302 B 263 ASP D 35 ASP^? 16.80 MG MG D 302 B 292 LYS C 61 LYS^? 21.91 MG MG D 302 coo 49.99 26.05 6.28 51.46 26.87 8.49 98.98 35.62 -26.76 97.40 37.84 -27.44 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 60.53 31.67 0.97 57.79 27.51 3.63 93.60 48.56 -24.05 90.39 44.71 -27.98 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 19 3 # 19 B 177 PHE D 12 PHE^? 16.78 MG MG D 302 B 263 ASP D 171 ASP^? 16.95 MG MG D 301 B 292 LYS D 166 LYS^? 21.08 MG MG D 301 coo 49.99 26.05 6.28 51.46 26.87 8.49 94.68 38.11 -36.05 97.16 37.10 -36.83 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 60.53 31.67 0.97 57.79 27.51 3.63 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 20 3 # 20 B 177 PHE D 59 PHE^? 31.49 MG MG D 302 B 263 ASP D 160 ASP^? 31.45 MG MG C 302 B 292 LYS D 157 LYS^? 28.67 MG MG D 302 coo 49.99 26.05 6.28 51.46 26.87 8.49 86.17 10.70 -31.86 86.41 11.56 -34.53 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 94.15 13.98 -26.57 92.71 12.42 -26.99 coo 60.53 31.67 0.97 57.79 27.51 3.63 94.17 21.71 -34.34 96.11 15.89 -35.92 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 21 3 # 21 B 177 PHE D 110 PHE^? 21.56 MG MG D 302 B 263 ASP D 142 ASP^? 23.49 MG MG D 301 B 292 LYS D 137 LYS^? 37.57 MG MG D 302 coo 49.99 26.05 6.28 51.46 26.87 8.49 82.28 19.60 -38.58 84.73 19.89 -37.32 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 90.90 15.58 -44.76 91.35 16.09 -46.79 coo 60.53 31.67 0.97 57.79 27.51 3.63 88.48 8.58 -35.33 84.88 3.98 -33.96 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 22 3 # 22 B 177 PHE D 110 PHE^? 21.56 MG MG D 302 B 263 ASP D 142 ASP^? 23.49 MG MG D 301 B 292 LYS D 157 LYS^? 28.67 MG MG D 302 coo 49.99 26.05 6.28 51.46 26.87 8.49 82.28 19.60 -38.58 84.73 19.89 -37.32 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 90.90 15.58 -44.76 91.35 16.09 -46.79 coo 60.53 31.67 0.97 57.79 27.51 3.63 94.17 21.71 -34.34 96.11 15.89 -35.92 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 23 3 # 23 B 177 PHE D 153 PHE^? 9.11 MG MG D 302 B 263 ASP D 171 ASP^? 16.95 MG MG D 301 B 292 LYS D 166 LYS^? 21.08 MG MG D 301 coo 49.99 26.05 6.28 51.46 26.87 8.49 91.67 34.35 -42.71 89.76 36.10 -43.73 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 60.53 31.67 0.97 57.79 27.51 3.63 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 24 3 # 24 B 177 PHE D 161 PHE^? 25.58 MG MG C 302 B 263 ASP C 35 ASP^? 16.42 MG MG C 302 B 292 LYS D 61 LYS^? 21.93 MG MG C 302 coo 49.99 26.05 6.28 51.46 26.87 8.49 92.97 17.97 -22.91 90.24 17.44 -22.45 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 60.53 31.67 0.97 57.79 27.51 3.63 80.64 11.23 -26.16 80.65 16.24 -22.36 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 25 3 # 25 B 177 PHE D 190 PHE^? 14.83 MG MG D 301 B 263 ASP D 142 ASP^? 23.49 MG MG D 301 B 292 LYS D 111 LYS^? 15.85 MG MG D 302 coo 49.99 26.05 6.28 51.46 26.87 8.49 93.52 26.32 -46.94 92.08 26.47 -44.56 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 90.90 15.58 -44.76 91.35 16.09 -46.79 coo 60.53 31.67 0.97 57.79 27.51 3.63 81.21 22.69 -42.10 78.68 23.89 -46.57 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 26 3 # 26 B 177 PHE D 190 PHE^? 14.83 MG MG D 301 B 263 ASP D 142 ASP^? 23.49 MG MG D 301 B 292 LYS D 157 LYS^? 28.67 MG MG D 302 coo 49.99 26.05 6.28 51.46 26.87 8.49 93.52 26.32 -46.94 92.08 26.47 -44.56 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 90.90 15.58 -44.76 91.35 16.09 -46.79 coo 60.53 31.67 0.97 57.79 27.51 3.63 94.17 21.71 -34.34 96.11 15.89 -35.92 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 27 3 # 27 B 177 PHE E 12 PHE^? 17.09 MG MG E 302 B 263 ASP E 171 ASP^? 16.73 MG MG E 301 B 292 LYS E 166 LYS^? 21.46 MG MG E 301 coo 49.99 26.05 6.28 51.46 26.87 8.49 70.06 67.18 -58.76 69.33 69.81 -58.07 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 60.53 31.67 0.97 57.79 27.51 3.63 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 28 3 # 28 B 177 PHE E 59 PHE^? 31.36 MG MG E 302 B 263 ASP E 160 ASP^? 31.54 MG MG F 301 B 292 LYS E 157 LYS^? 28.40 MG MG E 302 coo 49.99 26.05 6.28 51.46 26.87 8.49 41.55 62.67 -62.73 42.33 62.92 -60.06 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 45.81 70.00 -68.45 44.10 68.87 -67.77 coo 60.53 31.67 0.97 57.79 27.51 3.63 53.63 69.16 -60.42 48.34 71.81 -58.40 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 29 3 # 29 B 177 PHE E 110 PHE^? 21.45 MG MG E 302 B 263 ASP E 142 ASP^? 23.66 MG MG E 301 B 292 LYS E 137 LYS^? 35.26 MG MG E 302 coo 49.99 26.05 6.28 51.46 26.87 8.49 49.73 57.83 -56.11 50.46 60.21 -57.41 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 47.19 67.15 -50.37 47.44 67.18 -48.23 coo 60.53 31.67 0.97 57.79 27.51 3.63 40.01 66.05 -59.66 36.65 60.99 -60.28 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 30 3 # 30 B 177 PHE E 110 PHE^? 21.45 MG MG E 302 B 263 ASP E 142 ASP^? 23.66 MG MG E 301 B 292 LYS E 157 LYS^? 28.40 MG MG E 302 coo 49.99 26.05 6.28 51.46 26.87 8.49 49.73 57.83 -56.11 50.46 60.21 -57.41 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 47.19 67.15 -50.37 47.44 67.18 -48.23 coo 60.53 31.67 0.97 57.79 27.51 3.63 53.63 69.16 -60.42 48.34 71.81 -58.40 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 31 3 # 31 B 177 PHE E 153 PHE^? 9.50 MG MG E 302 B 263 ASP E 171 ASP^? 16.73 MG MG E 301 B 292 LYS E 166 LYS^? 21.46 MG MG E 301 coo 49.99 26.05 6.28 51.46 26.87 8.49 65.86 64.95 -52.12 67.22 62.73 -51.09 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 60.53 31.67 0.97 57.79 27.51 3.63 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 32 3 # 32 B 177 PHE E 161 PHE^? 25.51 MG MG F 301 B 263 ASP F 35 ASP^? 16.93 MG MG F 301 B 292 LYS E 61 LYS^? 22.16 MG MG F 301 coo 49.99 26.05 6.28 51.46 26.87 8.49 49.74 68.03 -71.94 48.60 65.47 -72.38 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 46.82 60.47 -77.63 48.00 58.79 -78.23 coo 60.53 31.67 0.97 57.79 27.51 3.63 40.99 56.84 -68.48 45.99 56.72 -72.39 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 33 3 # 33 B 177 PHE E 190 PHE^? 14.70 MG MG E 301 B 263 ASP E 142 ASP^? 23.66 MG MG E 301 B 292 LYS E 111 LYS^? 14.52 MG MG E 302 coo 49.99 26.05 6.28 51.46 26.87 8.49 58.27 67.97 -47.86 58.03 66.58 -50.23 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 47.19 67.15 -50.37 47.44 67.18 -48.23 coo 60.53 31.67 0.97 57.79 27.51 3.63 52.49 56.44 -52.43 54.52 53.78 -47.52 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 34 3 # 34 B 177 PHE E 190 PHE^? 14.70 MG MG E 301 B 263 ASP E 142 ASP^? 23.66 MG MG E 301 B 292 LYS E 157 LYS^? 28.40 MG MG E 302 coo 49.99 26.05 6.28 51.46 26.87 8.49 58.27 67.97 -47.86 58.03 66.58 -50.23 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 47.19 67.15 -50.37 47.44 67.18 -48.23 coo 60.53 31.67 0.97 57.79 27.51 3.63 53.63 69.16 -60.42 48.34 71.81 -58.40 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 35 3 # 35 B 177 PHE F 12 PHE^? 17.12 MG MG F 301 B 263 ASP F 171 ASP^? 16.35 MG MG F 302 B 292 LYS F 166 LYS^? 20.76 MG MG F 302 coo 49.99 26.05 6.28 51.46 26.87 8.49 49.70 62.79 -80.90 49.37 65.44 -81.67 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 60.53 31.67 0.97 57.79 27.51 3.63 59.28 73.05 -82.63 55.63 74.15 -86.94 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 36 3 # 36 B 177 PHE F 59 PHE^? 31.53 MG MG F 301 B 263 ASP F 160 ASP^? 31.59 MG MG E 302 B 292 LYS F 157 LYS^? 28.36 MG MG F 302 coo 49.99 26.05 6.28 51.46 26.87 8.49 77.96 68.89 -76.99 76.86 68.73 -79.55 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 71.27 74.59 -71.77 73.23 74.02 -72.37 coo 60.53 31.67 0.97 57.79 27.51 3.63 64.43 70.47 -79.54 68.32 74.80 -81.65 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 37 3 # 37 B 177 PHE F 110 PHE^? 21.65 MG MG F 301 B 263 ASP F 142 ASP^? 23.43 MG MG F 302 B 292 LYS F 137 LYS^? 35.13 MG MG F 301 coo 49.99 26.05 6.28 51.46 26.87 8.49 72.02 60.99 -83.27 70.61 63.10 -82.08 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 71.46 69.88 -89.76 71.03 69.93 -91.81 coo 60.53 31.67 0.97 57.79 27.51 3.63 78.53 72.20 -80.30 83.01 68.64 -79.79 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 38 3 # 38 B 177 PHE F 110 PHE^? 21.65 MG MG F 301 B 263 ASP F 142 ASP^? 23.43 MG MG F 302 B 292 LYS F 157 LYS^? 28.36 MG MG F 302 coo 49.99 26.05 6.28 51.46 26.87 8.49 72.02 60.99 -83.27 70.61 63.10 -82.08 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 71.46 69.88 -89.76 71.03 69.93 -91.81 coo 60.53 31.67 0.97 57.79 27.51 3.63 64.43 70.47 -79.54 68.32 74.80 -81.65 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 39 3 # 39 B 177 PHE F 153 PHE^? 9.26 MG MG F 302 B 263 ASP F 171 ASP^? 16.35 MG MG F 302 B 292 LYS F 166 LYS^? 20.76 MG MG F 302 coo 49.99 26.05 6.28 51.46 26.87 8.49 54.49 61.65 -87.43 53.89 59.08 -88.37 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 60.53 31.67 0.97 57.79 27.51 3.63 59.28 73.05 -82.63 55.63 74.15 -86.94 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 40 3 # 40 B 177 PHE F 161 PHE^? 25.66 MG MG E 302 B 263 ASP E 35 ASP^? 16.91 MG MG E 302 B 292 LYS F 61 LYS^? 21.75 MG MG E 302 coo 49.99 26.05 6.28 51.46 26.87 8.49 68.33 71.65 -68.19 70.12 69.57 -67.59 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 60.53 31.67 0.97 57.79 27.51 3.63 80.24 64.12 -71.01 76.23 61.95 -66.39 2oat_c04 source 2oat ORNITHINE AMINOTRANSFERASE : 40 hits 2oat_c04 naa= 3 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 C 177 PHE A 12 PHE^? 17.15 MG MG A 301 C 263 ASP A 171 ASP^? 17.17 MG MG A 302 C 292 LYS A 166 LYS^? 20.93 MG MG A 302 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 34.93 27.27 29.42 32.88 25.47 30.10 coo 19.84 12.02 9.33 18.68 11.23 7.75 29.78 23.67 36.63 28.48 25.11 35.71 coo 12.82 3.49 4.98 17.80 5.59 1.90 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 C 177 PHE A 59 PHE^? 31.59 MG MG A 301 C 263 ASP A 160 ASP^? 31.61 MG MG B 302 C 292 LYS A 157 LYS^? 28.65 MG MG A 302 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 52.93 4.70 25.02 52.08 5.30 27.62 coo 19.84 12.02 9.33 18.68 11.23 7.75 44.21 5.00 19.54 46.02 3.84 19.76 coo 12.82 3.49 4.98 17.80 5.59 1.90 41.42 12.06 27.58 41.46 5.93 29.41 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 C 177 PHE A 110 PHE^? 21.60 MG MG A 301 C 263 ASP A 142 ASP^? 23.70 MG MG A 302 C 292 LYS A 137 LYS^? 34.85 MG MG A 301 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 53.06 14.15 32.16 50.69 13.44 30.81 coo 19.84 12.02 9.33 18.68 11.23 7.75 46.39 7.18 37.53 46.28 7.18 39.63 coo 12.82 3.49 4.98 17.80 5.59 1.90 50.97 1.58 28.14 56.13 1.49 28.03 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 C 177 PHE A 110 PHE^? 21.60 MG MG A 301 C 263 ASP A 142 ASP^? 23.70 MG MG A 302 C 292 LYS A 157 LYS^? 28.65 MG MG A 302 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 53.06 14.15 32.16 50.69 13.44 30.81 coo 19.84 12.02 9.33 18.68 11.23 7.75 46.39 7.18 37.53 46.28 7.18 39.63 coo 12.82 3.49 4.98 17.80 5.59 1.90 41.42 12.06 27.58 41.46 5.93 29.41 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 C 177 PHE A 153 PHE^? 9.64 MG MG A 301 C 263 ASP A 171 ASP^? 17.17 MG MG A 302 C 292 LYS A 166 LYS^? 20.93 MG MG A 302 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 38.89 24.49 36.07 40.14 26.70 37.23 coo 19.84 12.02 9.33 18.68 11.23 7.75 29.78 23.67 36.63 28.48 25.11 35.71 coo 12.82 3.49 4.98 17.80 5.59 1.90 35.34 13.14 30.41 31.67 15.04 34.58 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 C 177 PHE A 161 PHE^? 25.62 MG MG B 302 C 263 ASP B 35 ASP^? 16.92 MG MG B 302 C 292 LYS A 61 LYS^? 21.99 MG MG B 302 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 44.24 9.29 16.03 46.90 9.95 15.56 coo 19.84 12.02 9.33 18.68 11.23 7.75 52.63 11.07 10.18 53.68 12.85 9.94 coo 12.82 3.49 4.98 17.80 5.59 1.90 57.78 7.35 19.60 56.77 12.20 15.61 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 C 177 PHE B 12 PHE^? 17.13 MG MG B 302 C 263 ASP B 171 ASP^? 16.92 MG MG B 301 C 292 LYS B 166 LYS^? 22.75 MG MG B 301 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 49.02 12.29 7.19 47.01 10.60 6.19 coo 19.84 12.02 9.33 18.68 11.23 7.75 45.30 8.50 -0.71 46.30 6.81 0.12 coo 12.82 3.49 4.98 17.80 5.59 1.90 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 8 3 # 8 C 177 PHE B 59 PHE^? 31.31 MG MG B 302 C 263 ASP B 160 ASP^? 31.65 MG MG A 301 C 292 LYS B 157 LYS^? 28.85 MG MG B 302 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 29.63 33.55 11.36 30.42 32.81 8.75 coo 19.84 12.02 9.33 18.68 11.23 7.75 28.01 24.83 16.38 27.44 26.81 15.80 coo 12.82 3.49 4.98 17.80 5.59 1.90 34.97 21.28 8.44 29.03 22.82 6.58 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 9 3 # 9 C 177 PHE B 110 PHE^? 21.49 MG MG B 302 C 263 ASP B 142 ASP^? 23.97 MG MG B 301 C 292 LYS B 137 LYS^? 34.56 MG MG B 302 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 39.39 32.59 5.17 38.42 30.20 6.23 coo 19.84 12.02 9.33 18.68 11.23 7.75 31.69 27.40 -1.31 32.10 27.37 -3.38 coo 12.82 3.49 4.98 17.80 5.59 1.90 26.56 32.46 7.93 27.87 37.71 9.31 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 10 3 # 10 C 177 PHE B 110 PHE^? 21.49 MG MG B 302 C 263 ASP B 142 ASP^? 23.97 MG MG B 301 C 292 LYS B 157 LYS^? 28.85 MG MG B 302 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 39.39 32.59 5.17 38.42 30.20 6.23 coo 19.84 12.02 9.33 18.68 11.23 7.75 31.69 27.40 -1.31 32.10 27.37 -3.38 coo 12.82 3.49 4.98 17.80 5.59 1.90 34.97 21.28 8.44 29.03 22.82 6.58 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 11 3 # 11 C 177 PHE B 153 PHE^? 9.59 MG MG B 302 C 263 ASP B 171 ASP^? 16.92 MG MG B 301 C 292 LYS B 166 LYS^? 22.75 MG MG B 301 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 47.54 17.09 0.77 50.03 17.91 -0.19 coo 19.84 12.02 9.33 18.68 11.23 7.75 45.30 8.50 -0.71 46.30 6.81 0.12 coo 12.82 3.49 4.98 17.80 5.59 1.90 35.27 15.38 5.31 37.27 9.81 3.93 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 12 3 # 12 C 177 PHE B 161 PHE^? 25.78 MG MG A 301 C 263 ASP A 35 ASP^? 16.92 MG MG A 301 C 292 LYS B 61 LYS^? 22.03 MG MG A 301 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 31.87 23.58 19.99 32.61 26.21 20.65 coo 19.84 12.02 9.33 18.68 11.23 7.75 34.49 31.10 26.54 36.41 31.82 27.10 coo 12.82 3.49 4.98 17.80 5.59 1.90 32.50 37.62 17.61 36.68 34.92 21.51 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 13 3 # 13 C 177 PHE B 190 PHE^? 14.80 MG MG B 301 C 263 ASP B 142 ASP^? 23.97 MG MG B 301 C 292 LYS B 111 LYS^? 13.75 MG MG B 302 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 40.06 19.97 -3.89 40.77 21.13 -1.45 coo 19.84 12.02 9.33 18.68 11.23 7.75 31.69 27.40 -1.31 32.10 27.37 -3.38 coo 12.82 3.49 4.98 17.80 5.59 1.90 42.84 32.14 1.80 46.84 32.68 -2.87 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 14 3 # 14 C 177 PHE B 190 PHE^? 14.80 MG MG B 301 C 263 ASP B 142 ASP^? 23.97 MG MG B 301 C 292 LYS B 157 LYS^? 28.85 MG MG B 302 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 40.06 19.97 -3.89 40.77 21.13 -1.45 coo 19.84 12.02 9.33 18.68 11.23 7.75 31.69 27.40 -1.31 32.10 27.37 -3.38 coo 12.82 3.49 4.98 17.80 5.59 1.90 34.97 21.28 8.44 29.03 22.82 6.58 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 15 3 # 15 C 177 PHE C 12 PHE^? 16.92 MG MG C 302 C 263 ASP C 171 ASP^? 17.08 MG MG C 301 C 292 LYS C 166 LYS^? 22.53 MG MG C 301 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 87.42 18.93 -13.86 90.00 18.25 -12.97 coo 19.84 12.02 9.33 18.68 11.23 7.75 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 12.82 3.49 4.98 17.80 5.59 1.90 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 16 3 # 16 C 177 PHE C 59 PHE^? 31.23 MG MG C 302 C 263 ASP C 160 ASP^? 31.63 MG MG D 302 C 292 LYS C 157 LYS^? 28.15 MG MG C 302 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 98.06 45.52 -18.00 97.73 44.36 -15.53 coo 19.84 12.02 9.33 18.68 11.23 7.75 102.50 38.00 -23.28 102.43 39.97 -22.46 coo 12.82 3.49 4.98 17.80 5.59 1.90 97.55 32.04 -15.10 101.49 36.24 -13.39 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 17 3 # 17 C 177 PHE C 110 PHE^? 21.25 MG MG C 302 C 263 ASP C 142 ASP^? 23.76 MG MG C 301 C 292 LYS C 137 LYS^? 35.41 MG MG C 302 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 89.08 41.33 -11.45 90.83 39.43 -12.52 coo 19.84 12.02 9.33 18.68 11.23 7.75 97.94 39.27 -5.03 98.08 38.70 -2.97 coo 12.82 3.49 4.98 17.80 5.59 1.90 101.12 45.96 -14.37 98.71 51.44 -14.96 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 18 3 # 18 C 177 PHE C 110 PHE^? 21.25 MG MG C 302 C 263 ASP C 142 ASP^? 23.76 MG MG C 301 C 292 LYS C 157 LYS^? 28.15 MG MG C 302 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 89.08 41.33 -11.45 90.83 39.43 -12.52 coo 19.84 12.02 9.33 18.68 11.23 7.75 97.94 39.27 -5.03 98.08 38.70 -2.97 coo 12.82 3.49 4.98 17.80 5.59 1.90 97.55 32.04 -15.10 101.49 36.24 -13.39 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 19 3 # 19 C 177 PHE C 153 PHE^? 9.34 MG MG C 302 C 263 ASP C 171 ASP^? 17.08 MG MG C 301 C 292 LYS C 166 LYS^? 22.53 MG MG C 301 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 87.15 23.83 -7.29 84.55 23.79 -6.26 coo 19.84 12.02 9.33 18.68 11.23 7.75 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 12.82 3.49 4.98 17.80 5.59 1.90 99.24 26.71 -12.25 100.23 21.90 -8.99 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 20 3 # 20 C 177 PHE C 161 PHE^? 25.47 MG MG D 302 C 263 ASP D 35 ASP^? 16.80 MG MG D 302 C 292 LYS C 61 LYS^? 21.91 MG MG D 302 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 98.98 35.62 -26.76 97.40 37.84 -27.44 coo 19.84 12.02 9.33 18.68 11.23 7.75 93.83 42.00 -33.14 91.74 41.83 -33.51 coo 12.82 3.49 4.98 17.80 5.59 1.90 93.60 48.56 -24.05 90.39 44.71 -27.98 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 21 3 # 21 C 177 PHE C 190 PHE^? 14.91 MG MG C 301 C 263 ASP C 142 ASP^? 23.76 MG MG C 301 C 292 LYS C 111 LYS^? 16.56 MG MG C 302 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 93.44 29.01 -2.85 92.36 29.94 -5.20 coo 19.84 12.02 9.33 18.68 11.23 7.75 97.94 39.27 -5.03 98.08 38.70 -2.97 coo 12.82 3.49 4.98 17.80 5.59 1.90 86.36 39.56 -8.06 84.36 40.84 -3.15 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 22 3 # 22 C 177 PHE C 190 PHE^? 14.91 MG MG C 301 C 263 ASP C 142 ASP^? 23.76 MG MG C 301 C 292 LYS C 157 LYS^? 28.15 MG MG C 302 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 93.44 29.01 -2.85 92.36 29.94 -5.20 coo 19.84 12.02 9.33 18.68 11.23 7.75 97.94 39.27 -5.03 98.08 38.70 -2.97 coo 12.82 3.49 4.98 17.80 5.59 1.90 97.55 32.04 -15.10 101.49 36.24 -13.39 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 23 3 # 23 C 177 PHE D 12 PHE^? 16.78 MG MG D 302 C 263 ASP D 171 ASP^? 16.95 MG MG D 301 C 292 LYS D 166 LYS^? 21.08 MG MG D 301 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 94.68 38.11 -36.05 97.16 37.10 -36.83 coo 19.84 12.02 9.33 18.68 11.23 7.75 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 12.82 3.49 4.98 17.80 5.59 1.90 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 24 3 # 24 C 177 PHE D 59 PHE^? 31.49 MG MG D 302 C 263 ASP D 160 ASP^? 31.45 MG MG C 302 C 292 LYS D 157 LYS^? 28.67 MG MG D 302 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 86.17 10.70 -31.86 86.41 11.56 -34.53 coo 19.84 12.02 9.33 18.68 11.23 7.75 94.15 13.98 -26.57 92.71 12.42 -26.99 coo 12.82 3.49 4.98 17.80 5.59 1.90 94.17 21.71 -34.34 96.11 15.89 -35.92 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 25 3 # 25 C 177 PHE D 110 PHE^? 21.56 MG MG D 302 C 263 ASP D 142 ASP^? 23.49 MG MG D 301 C 292 LYS D 137 LYS^? 37.57 MG MG D 302 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 82.28 19.60 -38.58 84.73 19.89 -37.32 coo 19.84 12.02 9.33 18.68 11.23 7.75 90.90 15.58 -44.76 91.35 16.09 -46.79 coo 12.82 3.49 4.98 17.80 5.59 1.90 88.48 8.58 -35.33 84.88 3.98 -33.96 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 26 3 # 26 C 177 PHE D 110 PHE^? 21.56 MG MG D 302 C 263 ASP D 142 ASP^? 23.49 MG MG D 301 C 292 LYS D 157 LYS^? 28.67 MG MG D 302 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 82.28 19.60 -38.58 84.73 19.89 -37.32 coo 19.84 12.02 9.33 18.68 11.23 7.75 90.90 15.58 -44.76 91.35 16.09 -46.79 coo 12.82 3.49 4.98 17.80 5.59 1.90 94.17 21.71 -34.34 96.11 15.89 -35.92 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 27 3 # 27 C 177 PHE D 153 PHE^? 9.11 MG MG D 302 C 263 ASP D 171 ASP^? 16.95 MG MG D 301 C 292 LYS D 166 LYS^? 21.08 MG MG D 301 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 91.67 34.35 -42.71 89.76 36.10 -43.73 coo 19.84 12.02 9.33 18.68 11.23 7.75 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 12.82 3.49 4.98 17.80 5.59 1.90 99.23 24.85 -37.31 101.73 27.34 -42.07 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 28 3 # 28 C 177 PHE D 161 PHE^? 25.58 MG MG C 302 C 263 ASP C 35 ASP^? 16.42 MG MG C 302 C 292 LYS D 61 LYS^? 21.93 MG MG C 302 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 92.97 17.97 -22.91 90.24 17.44 -22.45 coo 19.84 12.02 9.33 18.68 11.23 7.75 84.40 16.53 -16.68 82.83 17.91 -16.28 coo 12.82 3.49 4.98 17.80 5.59 1.90 80.64 11.23 -26.16 80.65 16.24 -22.36 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 29 3 # 29 C 177 PHE D 190 PHE^? 14.83 MG MG D 301 C 263 ASP D 142 ASP^? 23.49 MG MG D 301 C 292 LYS D 111 LYS^? 15.85 MG MG D 302 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 93.52 26.32 -46.94 92.08 26.47 -44.56 coo 19.84 12.02 9.33 18.68 11.23 7.75 90.90 15.58 -44.76 91.35 16.09 -46.79 coo 12.82 3.49 4.98 17.80 5.59 1.90 81.21 22.69 -42.10 78.68 23.89 -46.57 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 30 3 # 30 C 177 PHE D 190 PHE^? 14.83 MG MG D 301 C 263 ASP D 142 ASP^? 23.49 MG MG D 301 C 292 LYS D 157 LYS^? 28.67 MG MG D 302 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 93.52 26.32 -46.94 92.08 26.47 -44.56 coo 19.84 12.02 9.33 18.68 11.23 7.75 90.90 15.58 -44.76 91.35 16.09 -46.79 coo 12.82 3.49 4.98 17.80 5.59 1.90 94.17 21.71 -34.34 96.11 15.89 -35.92 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 31 3 # 31 C 177 PHE E 12 PHE^? 17.09 MG MG E 302 C 263 ASP E 171 ASP^? 16.73 MG MG E 301 C 292 LYS E 166 LYS^? 21.46 MG MG E 301 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 70.06 67.18 -58.76 69.33 69.81 -58.07 coo 19.84 12.02 9.33 18.68 11.23 7.75 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 12.82 3.49 4.98 17.80 5.59 1.90 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 32 3 # 32 C 177 PHE E 59 PHE^? 31.36 MG MG E 302 C 263 ASP E 160 ASP^? 31.54 MG MG F 301 C 292 LYS E 157 LYS^? 28.40 MG MG E 302 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 41.55 62.67 -62.73 42.33 62.92 -60.06 coo 19.84 12.02 9.33 18.68 11.23 7.75 45.81 70.00 -68.45 44.10 68.87 -67.77 coo 12.82 3.49 4.98 17.80 5.59 1.90 53.63 69.16 -60.42 48.34 71.81 -58.40 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 33 3 # 33 C 177 PHE E 110 PHE^? 21.45 MG MG E 302 C 263 ASP E 142 ASP^? 23.66 MG MG E 301 C 292 LYS E 137 LYS^? 35.26 MG MG E 302 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 49.73 57.83 -56.11 50.46 60.21 -57.41 coo 19.84 12.02 9.33 18.68 11.23 7.75 47.19 67.15 -50.37 47.44 67.18 -48.23 coo 12.82 3.49 4.98 17.80 5.59 1.90 40.01 66.05 -59.66 36.65 60.99 -60.28 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 34 3 # 34 C 177 PHE E 110 PHE^? 21.45 MG MG E 302 C 263 ASP E 142 ASP^? 23.66 MG MG E 301 C 292 LYS E 157 LYS^? 28.40 MG MG E 302 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 49.73 57.83 -56.11 50.46 60.21 -57.41 coo 19.84 12.02 9.33 18.68 11.23 7.75 47.19 67.15 -50.37 47.44 67.18 -48.23 coo 12.82 3.49 4.98 17.80 5.59 1.90 53.63 69.16 -60.42 48.34 71.81 -58.40 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 35 3 # 35 C 177 PHE E 153 PHE^? 9.50 MG MG E 302 C 263 ASP E 171 ASP^? 16.73 MG MG E 301 C 292 LYS E 166 LYS^? 21.46 MG MG E 301 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 65.86 64.95 -52.12 67.22 62.73 -51.09 coo 19.84 12.02 9.33 18.68 11.23 7.75 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 12.82 3.49 4.98 17.80 5.59 1.90 57.66 73.57 -57.60 60.27 76.17 -53.59 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 36 3 # 36 C 177 PHE E 161 PHE^? 25.51 MG MG F 301 C 263 ASP F 35 ASP^? 16.93 MG MG F 301 C 292 LYS E 61 LYS^? 22.16 MG MG F 301 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 49.74 68.03 -71.94 48.60 65.47 -72.38 coo 19.84 12.02 9.33 18.68 11.23 7.75 46.82 60.47 -77.63 48.00 58.79 -78.23 coo 12.82 3.49 4.98 17.80 5.59 1.90 40.99 56.84 -68.48 45.99 56.72 -72.39 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 37 3 # 37 C 177 PHE E 190 PHE^? 14.70 MG MG E 301 C 263 ASP E 142 ASP^? 23.66 MG MG E 301 C 292 LYS E 111 LYS^? 14.52 MG MG E 302 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 58.27 67.97 -47.86 58.03 66.58 -50.23 coo 19.84 12.02 9.33 18.68 11.23 7.75 47.19 67.15 -50.37 47.44 67.18 -48.23 coo 12.82 3.49 4.98 17.80 5.59 1.90 52.49 56.44 -52.43 54.52 53.78 -47.52 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 38 3 # 38 C 177 PHE E 190 PHE^? 14.70 MG MG E 301 C 263 ASP E 142 ASP^? 23.66 MG MG E 301 C 292 LYS E 157 LYS^? 28.40 MG MG E 302 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 58.27 67.97 -47.86 58.03 66.58 -50.23 coo 19.84 12.02 9.33 18.68 11.23 7.75 47.19 67.15 -50.37 47.44 67.18 -48.23 coo 12.82 3.49 4.98 17.80 5.59 1.90 53.63 69.16 -60.42 48.34 71.81 -58.40 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 39 3 # 39 C 177 PHE F 12 PHE^? 17.12 MG MG F 301 C 263 ASP F 171 ASP^? 16.35 MG MG F 302 C 292 LYS F 166 LYS^? 20.76 MG MG F 302 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 49.70 62.79 -80.90 49.37 65.44 -81.67 coo 19.84 12.02 9.33 18.68 11.23 7.75 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 12.82 3.49 4.98 17.80 5.59 1.90 59.28 73.05 -82.63 55.63 74.15 -86.94 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 40 3 # 40 C 177 PHE F 59 PHE^? 31.53 MG MG F 301 C 263 ASP F 160 ASP^? 31.59 MG MG E 302 C 292 LYS F 157 LYS^? 28.36 MG MG F 302 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 77.96 68.89 -76.99 76.86 68.73 -79.55 coo 19.84 12.02 9.33 18.68 11.23 7.75 71.27 74.59 -71.77 73.23 74.02 -72.37 coo 12.82 3.49 4.98 17.80 5.59 1.90 64.43 70.47 -79.54 68.32 74.80 -81.65 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 41 3 # 41 C 177 PHE F 110 PHE^? 21.65 MG MG F 301 C 263 ASP F 142 ASP^? 23.43 MG MG F 302 C 292 LYS F 137 LYS^? 35.13 MG MG F 301 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 72.02 60.99 -83.27 70.61 63.10 -82.08 coo 19.84 12.02 9.33 18.68 11.23 7.75 71.46 69.88 -89.76 71.03 69.93 -91.81 coo 12.82 3.49 4.98 17.80 5.59 1.90 78.53 72.20 -80.30 83.01 68.64 -79.79 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 42 3 # 42 C 177 PHE F 110 PHE^? 21.65 MG MG F 301 C 263 ASP F 142 ASP^? 23.43 MG MG F 302 C 292 LYS F 157 LYS^? 28.36 MG MG F 302 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 72.02 60.99 -83.27 70.61 63.10 -82.08 coo 19.84 12.02 9.33 18.68 11.23 7.75 71.46 69.88 -89.76 71.03 69.93 -91.81 coo 12.82 3.49 4.98 17.80 5.59 1.90 64.43 70.47 -79.54 68.32 74.80 -81.65 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 43 3 # 43 C 177 PHE F 153 PHE^? 9.26 MG MG F 302 C 263 ASP F 171 ASP^? 16.35 MG MG F 302 C 292 LYS F 166 LYS^? 20.76 MG MG F 302 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 54.49 61.65 -87.43 53.89 59.08 -88.37 coo 19.84 12.02 9.33 18.68 11.23 7.75 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 12.82 3.49 4.98 17.80 5.59 1.90 59.28 73.05 -82.63 55.63 74.15 -86.94 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 44 3 # 44 C 177 PHE F 161 PHE^? 25.66 MG MG E 302 C 263 ASP E 35 ASP^? 16.91 MG MG E 302 C 292 LYS F 61 LYS^? 21.75 MG MG E 302 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 68.33 71.65 -68.19 70.12 69.57 -67.59 coo 19.84 12.02 9.33 18.68 11.23 7.75 73.60 65.64 -62.00 73.13 63.73 -61.22 coo 12.82 3.49 4.98 17.80 5.59 1.90 80.24 64.12 -71.01 76.23 61.95 -66.39 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 45 3 # 45 C 177 PHE F 190 PHE^? 14.21 MG MG F 302 C 263 ASP F 142 ASP^? 23.43 MG MG F 302 C 292 LYS F 111 LYS^? 15.21 MG MG F 301 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 60.66 66.91 -91.97 61.14 65.56 -89.57 coo 19.84 12.02 9.33 18.68 11.23 7.75 71.46 69.88 -89.76 71.03 69.93 -91.81 coo 12.82 3.49 4.98 17.80 5.59 1.90 69.70 58.57 -86.86 69.67 53.74 -90.29 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 46 3 # 46 C 177 PHE F 190 PHE^? 14.21 MG MG F 302 C 263 ASP F 142 ASP^? 23.43 MG MG F 302 C 292 LYS F 157 LYS^? 28.36 MG MG F 302 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 60.66 66.91 -91.97 61.14 65.56 -89.57 coo 19.84 12.02 9.33 18.68 11.23 7.75 71.46 69.88 -89.76 71.03 69.93 -91.81 coo 12.82 3.49 4.98 17.80 5.59 1.90 64.43 70.47 -79.54 68.32 74.80 -81.65 2oat_c05 source 2oat ORNITHINE AMINOTRANSFERASE : 46 hits 2oat_c05 naa= 3 ULMN 3 2phk_c02 MC-PEPTIDE user 1 3 # 1 A 149 ASP A 138 ASP^? 33.08 MG MG A 302 A 151 LYS A 136 LYS^? 30.58 MG MG A 302 A 186 THR A 2 THR.? 34.64 MG MG A 301 coo 41.42 17.90 44.98 43.39 18.36 45.61 47.10 -0.97 29.63 45.89 0.22 30.96 coo 45.75 16.58 39.61 47.43 18.26 45.54 50.14 3.36 31.42 51.28 2.21 35.89 coo 45.88 23.02 44.72 46.99 21.16 44.68 47.80 1.72 22.09 46.70 1.88 23.97 ULMN 3 2phk_c02 MC-PEPTIDE user 2 3 # 2 A 149 ASP B 23 ASP^? 15.67 MG MG C 301 A 151 LYS C 21 LYS^? 14.49 MG MG C 302 A 186 THR B 26 THR^? 15.26 MG MG C 301 coo 41.42 17.90 44.98 43.39 18.36 45.61 74.31 7.55 -1.09 75.08 9.17 -2.23 coo 45.75 16.58 39.61 47.43 18.26 45.54 72.10 6.87 -6.14 72.84 12.21 -4.93 coo 45.88 23.02 44.72 46.99 21.16 44.68 78.84 6.55 0.66 78.10 8.59 1.24 ULMN 3 2phk_c02 MC-PEPTIDE user 3 3 # 3 A 149 ASP B 138 ASP^? 33.32 MG MG B 302 A 151 LYS B 136 LYS^? 33.75 MG MG B 302 A 186 THR B 2 THR^? 34.11 MG MG B 302 coo 41.42 17.90 44.98 43.39 18.36 45.61 23.42 29.01 6.78 24.36 28.48 4.94 coo 45.75 16.58 39.61 47.43 18.26 45.54 28.47 31.35 4.78 24.04 31.81 1.99 coo 45.88 23.02 44.72 46.99 21.16 44.68 25.51 29.18 13.74 26.24 28.19 11.93 ULMN 3 2phk_c02 MC-PEPTIDE user 4 3 # 4 A 149 ASP C 23 ASP^? 15.39 MG MG B 301 A 151 LYS B 21 LYS^? 13.97 MG MG B 301 A 186 THR C 26 THR^? 15.45 MG MG B 301 coo 41.42 17.90 44.98 43.39 18.36 45.61 65.24 6.82 -5.11 63.43 7.54 -4.15 coo 45.75 16.58 39.61 47.43 18.26 45.54 67.50 6.37 -0.39 64.53 11.03 -2.88 coo 45.88 23.02 44.72 46.99 21.16 44.68 60.72 4.69 -7.37 61.99 6.20 -8.33 ULMN 3 2phk_c02 MC-PEPTIDE user 5 3 # 5 A 149 ASP C 58 ASP^? 26.67 MG MG D 302 A 151 LYS C 6 LYS^? 25.73 MG MG C 302 A 186 THR D 46 THR^? 23.86 MG MG D 302 coo 41.42 17.90 44.98 43.39 18.36 45.61 93.40 43.81 -22.27 94.18 44.45 -24.11 coo 45.75 16.58 39.61 47.43 18.26 45.54 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 45.88 23.02 44.72 46.99 21.16 44.68 91.28 37.63 -25.27 93.05 36.72 -26.12 ULMN 3 2phk_c02 MC-PEPTIDE user 6 3 # 6 A 149 ASP C 138 ASP^? 33.43 MG MG C 302 A 151 LYS C 136 LYS^? 30.63 MG MG C 302 A 186 THR C 2 THR^? 33.69 MG MG C 302 coo 41.42 17.90 44.98 43.39 18.36 45.61 105.43 43.97 -13.30 104.85 43.08 -11.43 coo 45.75 16.58 39.61 47.43 18.26 45.54 99.75 44.04 -11.38 100.98 45.13 -6.77 coo 45.88 23.02 44.72 46.99 21.16 44.68 103.03 43.13 -20.15 102.74 41.72 -18.56 ULMN 3 2phk_c02 MC-PEPTIDE user 7 3 # 7 A 149 ASP D 23 ASP^? 15.37 MG MG E 301 A 151 LYS E 21 LYS^? 14.42 MG MG E 301 A 186 THR D 26 THR^? 14.34 MG MG E 301 coo 41.42 17.90 44.98 43.39 18.36 45.61 85.70 62.10 -45.60 84.07 62.13 -46.93 coo 45.75 16.58 39.61 47.43 18.26 45.54 87.88 60.38 -50.25 83.05 58.57 -47.65 coo 45.88 23.02 44.72 46.99 21.16 44.68 83.76 66.31 -43.53 82.86 64.39 -43.13 ULMN 3 2phk_c02 MC-PEPTIDE user 8 3 # 8 A 149 ASP D 138 ASP^? 33.64 MG MG D 302 A 151 LYS D 136 LYS^? 34.99 MG MG D 302 A 186 THR D 2 THR^? 33.99 MG MG D 302 coo 41.42 17.90 44.98 43.39 18.36 45.61 93.00 7.50 -35.79 93.88 8.48 -37.45 coo 45.75 16.58 39.61 47.43 18.26 45.54 88.96 10.62 -38.53 90.77 6.00 -38.00 coo 45.88 23.02 44.72 46.99 21.16 44.68 91.82 9.34 -29.18 91.80 10.46 -31.03 ULMN 3 2phk_c02 MC-PEPTIDE user 9 3 # 9 A 149 ASP E 23 ASP^? 15.43 MG MG D 301 A 151 LYS D 21 LYS^? 14.47 MG MG D 302 A 186 THR E 26 THR^? 15.11 MG MG D 301 coo 41.42 17.90 44.98 43.39 18.36 45.61 91.98 54.64 -49.37 91.93 52.78 -48.33 coo 45.75 16.58 39.61 47.43 18.26 45.54 90.57 56.85 -44.52 87.39 52.68 -46.00 coo 45.88 23.02 44.72 46.99 21.16 44.68 96.37 52.25 -51.33 94.44 51.47 -51.78 ULMN 3 2phk_c02 MC-PEPTIDE user 10 3 # 10 A 149 ASP E 138 ASP^? 33.31 MG MG E 302 A 151 LYS E 136 LYS^? 31.27 MG MG E 302 A 186 THR E 2 THR^? 33.84 MG MG E 302 coo 41.42 17.90 44.98 43.39 18.36 45.61 39.58 70.77 -58.63 40.74 70.78 -56.80 coo 45.75 16.58 39.61 47.43 18.26 45.54 42.12 65.93 -56.52 39.36 65.07 -51.83 coo 45.88 23.02 44.72 46.99 21.16 44.68 41.32 68.37 -65.29 42.66 69.03 -63.78 ULMN 3 2phk_c02 MC-PEPTIDE user 11 3 # 11 A 149 ASP F 138 ASP^? 33.51 MG MG F 302 A 151 LYS F 136 LYS^? 30.53 MG MG F 301 A 186 THR F 2 THR^? 34.54 MG MG F 301 coo 41.42 17.90 44.98 43.39 18.36 45.61 77.17 76.66 -81.48 76.14 76.33 -83.32 coo 45.75 16.58 39.61 47.43 18.26 45.54 76.49 71.19 -83.39 78.38 70.88 -88.47 coo 45.88 23.02 44.72 46.99 21.16 44.68 76.07 74.83 -74.70 74.98 75.15 -76.59 2phk_c02 source 2phk MC-PEPTIDE : 11 hits 2phk_c02 naa= 3 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 1 3 # 1 A 12 HIS A 42 HIS^? 28.45 MG MG A 301 A 40 LYS A 166 LYS^? 20.93 MG MG A 302 A 116 HIS B 42 HIS^? 28.37 MG MG B 302 coo 12.34 -0.45 10.80 13.53 1.19 11.34 34.62 18.32 19.57 34.29 16.25 19.41 coo 18.50 3.53 20.10 16.17 2.61 14.41 35.34 13.14 30.41 31.67 15.04 34.58 coo 14.70 6.01 5.61 14.27 7.69 6.78 39.34 12.99 16.30 37.26 13.24 16.40 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 2 3 # 2 A 12 HIS A 42 HIS^? 28.45 MG MG A 301 A 40 LYS B 6 LYS^? 25.90 MG MG B 302 A 116 HIS B 42 HIS^? 28.37 MG MG B 302 coo 12.34 -0.45 10.80 13.53 1.19 11.34 34.62 18.32 19.57 34.29 16.25 19.41 coo 18.50 3.53 20.10 16.17 2.61 14.41 36.26 25.44 11.74 39.65 23.12 16.29 coo 14.70 6.01 5.61 14.27 7.69 6.78 39.34 12.99 16.30 37.26 13.24 16.40 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 3 3 # 3 A 12 HIS B 42 HIS^? 28.37 MG MG B 302 A 40 LYS A 6 LYS^? 25.88 MG MG A 301 A 116 HIS A 42 HIS^? 28.45 MG MG A 301 coo 12.34 -0.45 10.80 13.53 1.19 11.34 39.34 12.99 16.30 37.26 13.24 16.40 coo 18.50 3.53 20.10 16.17 2.61 14.41 46.20 12.82 24.71 44.50 16.64 20.52 coo 14.70 6.01 5.61 14.27 7.69 6.78 34.62 18.32 19.57 34.29 16.25 19.41 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 4 3 # 4 A 12 HIS B 42 HIS^? 28.37 MG MG B 302 A 40 LYS B 166 LYS^? 22.75 MG MG B 301 A 116 HIS A 42 HIS^? 28.45 MG MG A 301 coo 12.34 -0.45 10.80 13.53 1.19 11.34 39.34 12.99 16.30 37.26 13.24 16.40 coo 18.50 3.53 20.10 16.17 2.61 14.41 35.27 15.38 5.31 37.27 9.81 3.93 coo 14.70 6.01 5.61 14.27 7.69 6.78 34.62 18.32 19.57 34.29 16.25 19.41 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 5 3 # 5 A 12 HIS C 42 HIS^? 28.09 MG MG C 302 A 40 LYS C 166 LYS^? 22.53 MG MG C 301 A 116 HIS D 42 HIS^? 28.21 MG MG D 302 coo 12.34 -0.45 10.80 13.53 1.19 11.34 95.93 22.96 -23.11 97.92 23.62 -23.02 coo 18.50 3.53 20.10 16.17 2.61 14.41 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 14.70 6.01 5.61 14.27 7.69 6.78 98.45 29.90 -26.44 99.32 28.02 -26.13 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 6 3 # 6 A 12 HIS C 42 HIS^? 28.09 MG MG C 302 A 40 LYS D 6 LYS^? 25.98 MG MG D 302 A 116 HIS D 42 HIS^? 28.21 MG MG D 302 coo 12.34 -0.45 10.80 13.53 1.19 11.34 95.93 22.96 -23.11 97.92 23.62 -23.02 coo 18.50 3.53 20.10 16.17 2.61 14.41 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 14.70 6.01 5.61 14.27 7.69 6.78 98.45 29.90 -26.44 99.32 28.02 -26.13 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 7 3 # 7 A 12 HIS D 42 HIS^? 28.21 MG MG D 302 A 40 LYS C 6 LYS^? 25.73 MG MG C 302 A 116 HIS C 42 HIS^? 28.09 MG MG C 302 coo 12.34 -0.45 10.80 13.53 1.19 11.34 98.45 29.90 -26.44 99.32 28.02 -26.13 coo 18.50 3.53 20.10 16.17 2.61 14.41 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 14.70 6.01 5.61 14.27 7.69 6.78 95.93 22.96 -23.11 97.92 23.62 -23.02 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 8 3 # 8 A 12 HIS D 42 HIS^? 28.21 MG MG D 302 A 40 LYS D 166 LYS^? 21.08 MG MG D 301 A 116 HIS C 42 HIS^? 28.09 MG MG C 302 coo 12.34 -0.45 10.80 13.53 1.19 11.34 98.45 29.90 -26.44 99.32 28.02 -26.13 coo 18.50 3.53 20.10 16.17 2.61 14.41 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 14.70 6.01 5.61 14.27 7.69 6.78 95.93 22.96 -23.11 97.92 23.62 -23.02 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 9 3 # 9 A 12 HIS E 42 HIS^? 28.20 MG MG E 302 A 40 LYS E 166 LYS^? 21.46 MG MG E 301 A 116 HIS F 42 HIS^? 28.34 MG MG F 301 coo 12.34 -0.45 10.80 13.53 1.19 11.34 62.33 71.93 -68.30 60.54 72.96 -68.64 coo 18.50 3.53 20.10 16.17 2.61 14.41 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 14.70 6.01 5.61 14.27 7.69 6.78 55.11 70.50 -71.64 56.29 72.22 -71.48 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 10 3 # 10 A 12 HIS E 42 HIS^? 28.20 MG MG E 302 A 40 LYS F 6 LYS^? 26.09 MG MG F 301 A 116 HIS F 42 HIS^? 28.34 MG MG F 301 coo 12.34 -0.45 10.80 13.53 1.19 11.34 62.33 71.93 -68.30 60.54 72.96 -68.64 coo 18.50 3.53 20.10 16.17 2.61 14.41 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 14.70 6.01 5.61 14.27 7.69 6.78 55.11 70.50 -71.64 56.29 72.22 -71.48 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 11 3 # 11 A 12 HIS F 42 HIS^? 28.34 MG MG F 301 A 40 LYS E 6 LYS^? 25.59 MG MG E 302 A 116 HIS E 42 HIS^? 28.20 MG MG E 302 coo 12.34 -0.45 10.80 13.53 1.19 11.34 55.11 70.50 -71.64 56.29 72.22 -71.48 coo 18.50 3.53 20.10 16.17 2.61 14.41 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 14.70 6.01 5.61 14.27 7.69 6.78 62.33 71.93 -68.30 60.54 72.96 -68.64 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 12 3 # 12 A 12 HIS F 42 HIS^? 28.34 MG MG F 301 A 40 LYS F 166 LYS^? 20.76 MG MG F 302 A 116 HIS E 42 HIS^? 28.20 MG MG E 302 coo 12.34 -0.45 10.80 13.53 1.19 11.34 55.11 70.50 -71.64 56.29 72.22 -71.48 coo 18.50 3.53 20.10 16.17 2.61 14.41 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 14.70 6.01 5.61 14.27 7.69 6.78 62.33 71.93 -68.30 60.54 72.96 -68.64 2rnf_c02 source 2rnf RIBONUCLEASE 4 : 12 hits 2rnf_c02 naa= 3 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 1 3 # 1 B 12 HIS A 42 HIS^? 28.45 MG MG A 301 B 40 LYS A 166 LYS^? 20.93 MG MG A 302 B 116 HIS B 42 HIS^? 28.37 MG MG B 302 coo -6.35 21.42 14.69 -6.06 23.46 15.04 34.62 18.32 19.57 34.29 16.25 19.41 coo -10.61 31.45 9.72 -8.75 26.69 13.45 35.34 13.14 30.41 31.67 15.04 34.58 coo -0.95 25.22 19.68 -0.68 26.73 18.24 39.34 12.99 16.30 37.26 13.24 16.40 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 2 3 # 2 B 12 HIS A 42 HIS^? 28.45 MG MG A 301 B 40 LYS B 6 LYS^? 25.90 MG MG B 302 B 116 HIS B 42 HIS^? 28.37 MG MG B 302 coo -6.35 21.42 14.69 -6.06 23.46 15.04 34.62 18.32 19.57 34.29 16.25 19.41 coo -10.61 31.45 9.72 -8.75 26.69 13.45 36.26 25.44 11.74 39.65 23.12 16.29 coo -0.95 25.22 19.68 -0.68 26.73 18.24 39.34 12.99 16.30 37.26 13.24 16.40 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 3 3 # 3 B 12 HIS B 42 HIS^? 28.37 MG MG B 302 B 40 LYS A 6 LYS^? 25.88 MG MG A 301 B 116 HIS A 42 HIS^? 28.45 MG MG A 301 coo -6.35 21.42 14.69 -6.06 23.46 15.04 39.34 12.99 16.30 37.26 13.24 16.40 coo -10.61 31.45 9.72 -8.75 26.69 13.45 46.20 12.82 24.71 44.50 16.64 20.52 coo -0.95 25.22 19.68 -0.68 26.73 18.24 34.62 18.32 19.57 34.29 16.25 19.41 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 4 3 # 4 B 12 HIS B 42 HIS^? 28.37 MG MG B 302 B 40 LYS B 166 LYS^? 22.75 MG MG B 301 B 116 HIS A 42 HIS^? 28.45 MG MG A 301 coo -6.35 21.42 14.69 -6.06 23.46 15.04 39.34 12.99 16.30 37.26 13.24 16.40 coo -10.61 31.45 9.72 -8.75 26.69 13.45 35.27 15.38 5.31 37.27 9.81 3.93 coo -0.95 25.22 19.68 -0.68 26.73 18.24 34.62 18.32 19.57 34.29 16.25 19.41 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 5 3 # 5 B 12 HIS C 42 HIS^? 28.09 MG MG C 302 B 40 LYS C 166 LYS^? 22.53 MG MG C 301 B 116 HIS D 42 HIS^? 28.21 MG MG D 302 coo -6.35 21.42 14.69 -6.06 23.46 15.04 95.93 22.96 -23.11 97.92 23.62 -23.02 coo -10.61 31.45 9.72 -8.75 26.69 13.45 99.24 26.71 -12.25 100.23 21.90 -8.99 coo -0.95 25.22 19.68 -0.68 26.73 18.24 98.45 29.90 -26.44 99.32 28.02 -26.13 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 6 3 # 6 B 12 HIS C 42 HIS^? 28.09 MG MG C 302 B 40 LYS D 6 LYS^? 25.98 MG MG D 302 B 116 HIS D 42 HIS^? 28.21 MG MG D 302 coo -6.35 21.42 14.69 -6.06 23.46 15.04 95.93 22.96 -23.11 97.92 23.62 -23.02 coo -10.61 31.45 9.72 -8.75 26.69 13.45 89.78 20.68 -31.57 90.15 24.89 -27.02 coo -0.95 25.22 19.68 -0.68 26.73 18.24 98.45 29.90 -26.44 99.32 28.02 -26.13 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 7 3 # 7 B 12 HIS D 42 HIS^? 28.21 MG MG D 302 B 40 LYS C 6 LYS^? 25.73 MG MG C 302 B 116 HIS C 42 HIS^? 28.09 MG MG C 302 coo -6.35 21.42 14.69 -6.06 23.46 15.04 98.45 29.90 -26.44 99.32 28.02 -26.13 coo -10.61 31.45 9.72 -8.75 26.69 13.45 94.42 35.68 -18.56 92.21 32.03 -23.05 coo -0.95 25.22 19.68 -0.68 26.73 18.24 95.93 22.96 -23.11 97.92 23.62 -23.02 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 8 3 # 8 B 12 HIS D 42 HIS^? 28.21 MG MG D 302 B 40 LYS D 166 LYS^? 21.08 MG MG D 301 B 116 HIS C 42 HIS^? 28.09 MG MG C 302 coo -6.35 21.42 14.69 -6.06 23.46 15.04 98.45 29.90 -26.44 99.32 28.02 -26.13 coo -10.61 31.45 9.72 -8.75 26.69 13.45 99.23 24.85 -37.31 101.73 27.34 -42.07 coo -0.95 25.22 19.68 -0.68 26.73 18.24 95.93 22.96 -23.11 97.92 23.62 -23.02 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 9 3 # 9 B 12 HIS E 42 HIS^? 28.20 MG MG E 302 B 40 LYS E 166 LYS^? 21.46 MG MG E 301 B 116 HIS F 42 HIS^? 28.34 MG MG F 301 coo -6.35 21.42 14.69 -6.06 23.46 15.04 62.33 71.93 -68.30 60.54 72.96 -68.64 coo -10.61 31.45 9.72 -8.75 26.69 13.45 57.66 73.57 -57.60 60.27 76.17 -53.59 coo -0.95 25.22 19.68 -0.68 26.73 18.24 55.11 70.50 -71.64 56.29 72.22 -71.48 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 10 3 # 10 B 12 HIS E 42 HIS^? 28.20 MG MG E 302 B 40 LYS F 6 LYS^? 26.09 MG MG F 301 B 116 HIS F 42 HIS^? 28.34 MG MG F 301 coo -6.35 21.42 14.69 -6.06 23.46 15.04 62.33 71.93 -68.30 60.54 72.96 -68.64 coo -10.61 31.45 9.72 -8.75 26.69 13.45 67.53 67.03 -76.43 64.05 65.33 -71.86 coo -0.95 25.22 19.68 -0.68 26.73 18.24 55.11 70.50 -71.64 56.29 72.22 -71.48 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 11 3 # 11 B 12 HIS F 42 HIS^? 28.34 MG MG F 301 B 40 LYS E 6 LYS^? 25.59 MG MG E 302 B 116 HIS E 42 HIS^? 28.20 MG MG E 302 coo -6.35 21.42 14.69 -6.06 23.46 15.04 55.11 70.50 -71.64 56.29 72.22 -71.48 coo -10.61 31.45 9.72 -8.75 26.69 13.45 51.95 64.70 -63.33 56.16 64.03 -67.52 coo -0.95 25.22 19.68 -0.68 26.73 18.24 62.33 71.93 -68.30 60.54 72.96 -68.64 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 12 3 # 12 B 12 HIS F 42 HIS^? 28.34 MG MG F 301 B 40 LYS F 166 LYS^? 20.76 MG MG F 302 B 116 HIS E 42 HIS^? 28.20 MG MG E 302 coo -6.35 21.42 14.69 -6.06 23.46 15.04 55.11 70.50 -71.64 56.29 72.22 -71.48 coo -10.61 31.45 9.72 -8.75 26.69 13.45 59.28 73.05 -82.63 55.63 74.15 -86.94 coo -0.95 25.22 19.68 -0.68 26.73 18.24 62.33 71.93 -68.30 60.54 72.96 -68.64 2rnf_c03 source 2rnf RIBONUCLEASE 4 : 12 hits 2rnf_c03 naa= 3 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 1 3 # 1 141 ASP A 35 ASP^? 16.92 MG MG A 301 166 GLY A 149 GLY^? 6.01 MG MG A 302 169 GLU A 146 GLU^? 9.80 MG MG A 302 coo 8.28 6.87 1.62 10.08 5.77 1.34 34.49 31.10 26.54 36.41 31.82 27.10 coo -8.58 13.22 3.21 -8.90 13.15 4.05 37.26 27.53 42.29 37.61 28.00 41.76 coo -16.67 7.89 2.78 -17.65 6.56 1.49 45.17 20.35 44.20 46.68 21.21 45.40 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 2 3 # 2 141 ASP A 35 ASP^? 16.92 MG MG A 301 166 GLY B 162 GLY^? 32.25 MG MG A 301 169 GLU B 165 GLU^? 29.66 MG MG B 302 coo 8.28 6.87 1.62 10.08 5.77 1.34 34.49 31.10 26.54 36.41 31.82 27.10 coo -8.58 13.22 3.21 -8.90 13.15 4.05 29.56 19.21 16.24 30.37 19.33 16.25 coo -16.67 7.89 2.78 -17.65 6.56 1.49 30.38 16.84 8.28 28.95 18.37 7.83 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 3 3 # 3 141 ASP A 100 ASP^? 19.37 MG MG A 301 166 GLY A 139 GLY^? 31.58 MG MG A 301 169 GLU A 165 GLU^? 29.56 MG MG A 302 coo 8.28 6.87 1.62 10.08 5.77 1.34 57.94 16.31 36.90 58.41 17.97 38.14 coo -8.58 13.22 3.21 -8.90 13.15 4.05 45.86 3.19 27.93 45.99 3.01 28.71 coo -16.67 7.89 2.78 -17.65 6.56 1.49 36.12 8.31 27.27 37.25 6.55 27.60 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 4 3 # 4 141 ASP A 160 ASP^? 31.61 MG MG B 302 166 GLY B 34 GLY^? 18.20 MG MG B 302 169 GLU B 19 GLU^? 18.96 MG MG B 301 coo 8.28 6.87 1.62 10.08 5.77 1.34 44.21 5.00 19.54 46.02 3.84 19.76 coo -8.58 13.22 3.21 -8.90 13.15 4.05 56.73 9.38 8.85 56.97 9.44 9.63 coo -16.67 7.89 2.78 -17.65 6.56 1.49 59.29 4.54 -0.16 58.81 2.51 -0.44 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 5 3 # 5 141 ASP A 171 ASP^? 17.17 MG MG A 302 166 GLY A 71 GLY^? 17.05 MG MG A 301 169 GLU B 63 GLU^? 27.83 MG MG A 301 coo 8.28 6.87 1.62 10.08 5.77 1.34 29.78 23.67 36.63 28.48 25.11 35.71 coo -8.58 13.22 3.21 -8.90 13.15 4.05 42.53 33.15 24.80 43.14 33.53 25.16 coo -16.67 7.89 2.78 -17.65 6.56 1.49 36.89 38.35 16.01 38.64 39.45 15.67 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 6 3 # 6 141 ASP B 35 ASP^? 16.92 MG MG B 302 166 GLY A 162 GLY^? 31.98 MG MG B 302 169 GLU A 165 GLU^? 29.56 MG MG A 302 coo 8.28 6.87 1.62 10.08 5.77 1.34 52.63 11.07 10.18 53.68 12.85 9.94 coo -8.58 13.22 3.21 -8.90 13.15 4.05 39.06 7.86 19.11 39.37 8.59 19.31 coo -16.67 7.89 2.78 -17.65 6.56 1.49 36.12 8.31 27.27 37.25 6.55 27.60 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 7 3 # 7 141 ASP B 35 ASP^? 16.92 MG MG B 302 166 GLY B 149 GLY^? 5.93 MG MG B 301 169 GLU B 146 GLU^? 10.54 MG MG B 301 coo 8.28 6.87 1.62 10.08 5.77 1.34 52.63 11.07 10.18 53.68 12.85 9.94 coo -8.58 13.22 3.21 -8.90 13.15 4.05 50.72 15.48 -5.33 51.24 15.67 -4.78 coo -16.67 7.89 2.78 -17.65 6.56 1.49 45.13 24.51 -7.01 46.08 25.99 -8.13 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 8 3 # 8 141 ASP B 81 ASP^? 24.85 MG MG C 301 166 GLY C 176 GLY^? 13.69 MG MG C 301 169 GLU C 174 GLU^? 19.72 MG MG C 301 coo 8.28 6.87 1.62 10.08 5.77 1.34 79.93 -0.44 10.01 79.44 1.19 11.29 coo -8.58 13.22 3.21 -8.90 13.15 4.05 88.42 12.91 1.06 88.29 13.68 0.87 coo -16.67 7.89 2.78 -17.65 6.56 1.49 95.09 14.29 -3.63 95.25 12.23 -4.17 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 9 3 # 9 141 ASP B 100 ASP^? 19.41 MG MG B 302 166 GLY B 139 GLY^? 31.17 MG MG B 302 169 GLU B 165 GLU^? 29.66 MG MG B 302 coo 8.28 6.87 1.62 10.08 5.77 1.34 42.99 37.37 0.88 44.84 37.85 0.06 coo -8.58 13.22 3.21 -8.90 13.15 4.05 27.46 26.88 8.05 27.27 27.18 7.33 coo -16.67 7.89 2.78 -17.65 6.56 1.49 30.38 16.84 8.28 28.95 18.37 7.83 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 10 3 # 10 141 ASP B 171 ASP^? 16.92 MG MG B 301 166 GLY B 71 GLY^? 17.03 MG MG B 302 169 GLU A 63 GLU^? 28.10 MG MG B 302 coo 8.28 6.87 1.62 10.08 5.77 1.34 45.30 8.50 -0.71 46.30 6.81 0.12 coo -8.58 13.22 3.21 -8.90 13.15 4.05 56.04 18.34 12.69 56.53 18.94 12.41 coo -16.67 7.89 2.78 -17.65 6.56 1.49 59.13 11.55 21.47 60.51 12.96 22.22 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 11 3 # 11 141 ASP C 23 ASP^? 15.39 MG MG B 301 166 GLY B 149 GLY^? 5.93 MG MG B 301 169 GLU B 146 GLU^? 10.54 MG MG B 301 coo 8.28 6.87 1.62 10.08 5.77 1.34 65.24 6.82 -5.11 63.43 7.54 -4.15 coo -8.58 13.22 3.21 -8.90 13.15 4.05 50.72 15.48 -5.33 51.24 15.67 -4.78 coo -16.67 7.89 2.78 -17.65 6.56 1.49 45.13 24.51 -7.01 46.08 25.99 -8.13 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 12 3 # 12 141 ASP C 35 ASP^? 16.42 MG MG C 302 166 GLY C 149 GLY^? 6.13 MG MG C 301 169 GLU C 146 GLU^? 10.46 MG MG C 301 coo 8.28 6.87 1.62 10.08 5.77 1.34 84.40 16.53 -16.68 82.83 17.91 -16.28 coo -8.58 13.22 3.21 -8.90 13.15 4.05 85.09 20.92 -1.20 84.51 20.95 -1.73 coo -16.67 7.89 2.78 -17.65 6.56 1.49 87.01 31.93 0.25 85.57 32.56 1.72 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 13 3 # 13 141 ASP C 35 ASP^? 16.42 MG MG C 302 166 GLY D 162 GLY^? 32.15 MG MG C 302 169 GLU D 165 GLU^? 29.85 MG MG D 302 coo 8.28 6.87 1.62 10.08 5.77 1.34 84.40 16.53 -16.68 82.83 17.91 -16.28 coo -8.58 13.22 3.21 -8.90 13.15 4.05 98.12 18.21 -26.42 97.63 18.90 -26.49 coo -16.67 7.89 2.78 -17.65 6.56 1.49 100.60 20.11 -34.27 100.38 17.96 -34.49 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 14 3 # 14 141 ASP C 100 ASP^? 19.40 MG MG C 302 166 GLY C 139 GLY^? 31.33 MG MG C 302 169 GLU C 165 GLU^? 29.32 MG MG C 302 coo 8.28 6.87 1.62 10.08 5.77 1.34 84.40 44.48 -7.24 82.54 44.18 -6.18 coo -8.58 13.22 3.21 -8.90 13.15 4.05 102.42 40.63 -14.81 102.41 40.87 -14.05 coo -16.67 7.89 2.78 -17.65 6.56 1.49 103.18 29.99 -15.18 103.57 32.09 -14.86 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 15 3 # 15 141 ASP C 160 ASP^? 31.63 MG MG D 302 166 GLY D 34 GLY^? 17.73 MG MG D 302 169 GLU D 19 GLU^? 18.95 MG MG D 301 coo 8.28 6.87 1.62 10.08 5.77 1.34 102.50 38.00 -23.28 102.43 39.97 -22.46 coo -8.58 13.22 3.21 -8.90 13.15 4.05 93.02 46.29 -34.84 92.89 46.52 -34.02 coo -16.67 7.89 2.78 -17.65 6.56 1.49 96.86 51.08 -43.04 98.60 51.44 -44.26 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 16 3 # 16 141 ASP D 35 ASP^? 16.80 MG MG D 302 166 GLY C 162 GLY^? 31.91 MG MG D 302 169 GLU C 165 GLU^? 29.32 MG MG C 302 coo 8.28 6.87 1.62 10.08 5.77 1.34 93.83 42.00 -33.14 91.74 41.83 -33.51 coo -8.58 13.22 3.21 -8.90 13.15 4.05 102.73 32.19 -23.18 101.94 32.02 -23.12 coo -16.67 7.89 2.78 -17.65 6.56 1.49 103.18 29.99 -15.18 103.57 32.09 -14.86 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 17 3 # 17 141 ASP D 35 ASP^? 16.80 MG MG D 302 166 GLY D 149 GLY^? 6.12 MG MG D 301 169 GLU D 146 GLU^? 10.62 MG MG D 301 coo 8.28 6.87 1.62 10.08 5.77 1.34 93.83 42.00 -33.14 91.74 41.83 -33.51 coo -8.58 13.22 3.21 -8.90 13.15 4.05 92.07 37.87 -48.88 91.62 38.12 -48.34 coo -16.67 7.89 2.78 -17.65 6.56 1.49 87.24 28.82 -50.92 85.47 28.08 -51.67 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 18 3 # 18 141 ASP D 81 ASP^? 23.25 MG MG E 301 166 GLY E 176 GLY^? 13.22 MG MG E 301 169 GLU E 174 GLU^? 19.83 MG MG E 301 coo 8.28 6.87 1.62 10.08 5.77 1.34 89.25 71.36 -34.47 87.72 70.06 -33.67 coo -8.58 13.22 3.21 -8.90 13.15 4.05 74.69 71.68 -44.17 74.06 71.19 -44.32 coo -16.67 7.89 2.78 -17.65 6.56 1.49 70.48 76.62 -49.45 71.76 78.34 -49.45 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 19 3 # 19 141 ASP D 100 ASP^? 19.59 MG MG D 302 166 GLY D 139 GLY^? 31.09 MG MG D 302 169 GLU D 165 GLU^? 29.85 MG MG D 302 coo 8.28 6.87 1.62 10.08 5.77 1.34 76.41 19.73 -43.25 75.56 21.48 -44.12 coo -8.58 13.22 3.21 -8.90 13.15 4.05 93.01 12.21 -34.78 93.02 11.88 -35.52 coo -16.67 7.89 2.78 -17.65 6.56 1.49 100.60 20.11 -34.27 100.38 17.96 -34.49 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 20 3 # 20 141 ASP D 160 ASP^? 31.45 MG MG C 302 166 GLY C 34 GLY^? 18.00 MG MG C 302 169 GLU C 19 GLU^? 19.08 MG MG C 301 coo 8.28 6.87 1.62 10.08 5.77 1.34 94.15 13.98 -26.57 92.71 12.42 -26.99 coo -8.58 13.22 3.21 -8.90 13.15 4.05 81.22 13.31 -15.34 80.98 13.29 -16.15 coo -16.67 7.89 2.78 -17.65 6.56 1.49 80.46 7.67 -6.81 81.43 5.97 -5.99 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 21 3 # 21 141 ASP D 171 ASP^? 16.95 MG MG D 301 166 GLY D 71 GLY^? 17.24 MG MG D 302 169 GLU C 63 GLU^? 27.26 MG MG D 302 coo 8.28 6.87 1.62 10.08 5.77 1.34 100.39 36.69 -43.49 101.13 38.51 -42.69 coo -8.58 13.22 3.21 -8.90 13.15 4.05 85.63 41.02 -31.04 84.94 41.10 -31.48 coo -16.67 7.89 2.78 -17.65 6.56 1.49 89.51 47.54 -22.35 87.55 48.20 -22.72 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 22 3 # 22 141 ASP E 23 ASP^? 15.43 MG MG D 301 166 GLY D 149 GLY^? 6.12 MG MG D 301 169 GLU D 146 GLU^? 10.62 MG MG D 301 coo 8.28 6.87 1.62 10.08 5.77 1.34 91.98 54.64 -49.37 91.93 52.78 -48.33 coo -8.58 13.22 3.21 -8.90 13.15 4.05 92.07 37.87 -48.88 91.62 38.12 -48.34 coo -16.67 7.89 2.78 -17.65 6.56 1.49 87.24 28.82 -50.92 85.47 28.08 -51.67 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 23 3 # 23 141 ASP E 35 ASP^? 16.91 MG MG E 302 166 GLY E 149 GLY^? 5.75 MG MG E 301 169 GLU E 146 GLU^? 10.15 MG MG E 301 coo 8.28 6.87 1.62 10.08 5.77 1.34 73.60 65.64 -62.00 73.13 63.73 -61.22 coo -8.58 13.22 3.21 -8.90 13.15 4.05 69.31 64.70 -46.05 69.60 64.17 -46.61 coo -16.67 7.89 2.78 -17.65 6.56 1.49 58.72 60.89 -44.51 59.23 60.24 -42.54 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 24 3 # 24 141 ASP E 35 ASP^? 16.91 MG MG E 302 166 GLY F 162 GLY^? 32.07 MG MG E 302 169 GLU F 165 GLU^? 29.11 MG MG F 302 coo 8.28 6.87 1.62 10.08 5.77 1.34 73.60 65.64 -62.00 73.13 63.73 -61.22 coo -8.58 13.22 3.21 -8.90 13.15 4.05 65.47 75.75 -71.83 65.14 74.99 -71.88 coo -16.67 7.89 2.78 -17.65 6.56 1.49 63.01 76.49 -79.50 64.84 77.22 -80.35 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 25 3 # 25 141 ASP E 81 ASP^? 24.19 MG MG D 301 166 GLY D 176 GLY^? 13.91 MG MG D 301 169 GLU D 174 GLU^? 19.76 MG MG D 301 coo 8.28 6.87 1.62 10.08 5.77 1.34 101.61 56.30 -60.24 100.25 55.53 -61.72 coo -8.58 13.22 3.21 -8.90 13.15 4.05 99.98 41.95 -51.04 99.39 41.45 -50.84 coo -16.67 7.89 2.78 -17.65 6.56 1.49 104.29 37.18 -46.00 105.30 38.94 -45.21 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 26 3 # 26 141 ASP E 100 ASP^? 19.27 MG MG E 302 166 GLY E 139 GLY^? 31.29 MG MG E 302 169 GLU E 165 GLU^? 29.48 MG MG E 301 coo 8.28 6.87 1.62 10.08 5.77 1.34 49.30 52.58 -51.44 50.47 51.29 -50.20 coo -8.58 13.22 3.21 -8.90 13.15 4.05 43.96 69.53 -60.06 43.71 69.52 -59.31 coo -16.67 7.89 2.78 -17.65 6.56 1.49 52.92 74.97 -61.04 50.84 74.87 -60.51 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 27 3 # 27 141 ASP E 160 ASP^? 31.54 MG MG F 301 166 GLY F 34 GLY^? 17.95 MG MG F 301 169 GLU F 19 GLU^? 17.88 MG MG F 302 coo 8.28 6.87 1.62 10.08 5.77 1.34 45.81 70.00 -68.45 44.10 68.87 -67.77 coo -8.58 13.22 3.21 -8.90 13.15 4.05 43.60 57.46 -79.20 43.37 57.32 -78.41 coo -16.67 7.89 2.78 -17.65 6.56 1.49 36.39 58.51 -87.58 37.20 60.13 -88.66 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 28 3 # 28 141 ASP E 171 ASP^? 16.73 MG MG E 301 166 GLY E 71 GLY^? 16.95 MG MG E 302 169 GLU F 63 GLU^? 27.81 MG MG E 302 coo 8.28 6.87 1.62 10.08 5.77 1.34 69.61 73.12 -51.56 71.50 73.53 -52.39 coo -8.58 13.22 3.21 -8.90 13.15 4.05 71.48 57.52 -63.50 71.50 56.77 -63.11 coo -16.67 7.89 2.78 -17.65 6.56 1.49 78.38 60.07 -72.34 78.48 58.04 -72.84 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 29 3 # 29 141 ASP F 35 ASP^? 16.93 MG MG F 301 166 GLY F 149 GLY^? 5.34 MG MG F 302 169 GLU F 146 GLU^? 10.36 MG MG F 302 coo 8.28 6.87 1.62 10.08 5.77 1.34 46.82 60.47 -77.63 48.00 58.79 -78.23 coo -8.58 13.22 3.21 -8.90 13.15 4.05 51.31 60.07 -93.46 51.26 59.51 -92.90 coo -16.67 7.89 2.78 -17.65 6.56 1.49 61.95 60.17 -95.28 62.87 58.56 -96.19 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 30 3 # 30 141 ASP F 100 ASP^? 19.36 MG MG F 301 166 GLY F 139 GLY^? 31.26 MG MG F 301 169 GLU F 165 GLU^? 29.11 MG MG F 302 coo 8.28 6.87 1.62 10.08 5.77 1.34 74.18 55.53 -87.58 73.63 53.79 -88.67 coo -8.58 13.22 3.21 -8.90 13.15 4.05 73.42 74.00 -80.33 73.70 74.23 -81.03 coo -16.67 7.89 2.78 -17.65 6.56 1.49 63.01 76.49 -79.50 64.84 77.22 -80.35 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 31 3 # 31 141 ASP F 160 ASP^? 31.59 MG MG E 302 166 GLY E 34 GLY^? 17.96 MG MG E 302 169 GLU E 19 GLU^? 18.42 MG MG E 301 coo 8.28 6.87 1.62 10.08 5.77 1.34 71.27 74.59 -71.77 73.23 74.02 -72.37 coo -8.58 13.22 3.21 -8.90 13.15 4.05 77.63 64.22 -60.15 77.94 64.12 -60.90 coo -16.67 7.89 2.78 -17.65 6.56 1.49 82.78 67.13 -51.44 83.71 68.75 -50.40 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 32 3 # 32 141 ASP F 171 ASP^? 16.35 MG MG F 302 166 GLY F 71 GLY^? 16.93 MG MG F 301 169 GLU E 63 GLU^? 28.08 MG MG F 301 coo 8.28 6.87 1.62 10.08 5.77 1.34 48.23 68.08 -88.47 46.26 68.02 -87.56 coo -8.58 13.22 3.21 -8.90 13.15 4.05 51.61 53.62 -75.65 51.89 52.91 -76.00 coo -16.67 7.89 2.78 -17.65 6.56 1.49 44.04 53.99 -66.79 43.77 51.93 -66.35 2tdt_c00 source 2tdt TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE : 32 hits 2tdt_c00 naa= 3 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 1 3 # 1 A 169 TYR A 129 TYR^? 10.90 MG MG A 301 A 172 HIS A 147 HIS^? 9.20 MG MG A 302 A 267 ASP A 187 ASP^? -3.29 MG MG A 302s coo 26.78 20.44 0.03 28.51 18.26 0.09 44.80 23.54 35.75 45.57 23.36 33.08 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 40.24 23.10 39.83 38.32 22.34 40.22 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 39.43 26.57 46.78 39.37 27.83 45.03 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 2 3 # 2 A 169 TYR A 168 TYR^? 14.52 MG MG A 302 A 172 HIS A 147 HIS^? 9.20 MG MG A 302 A 267 ASP A 148 ASP^? 2.72 MG MG A 301s coo 26.78 20.44 0.03 28.51 18.26 0.09 37.31 16.98 37.59 36.65 18.86 39.55 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 40.24 23.10 39.83 38.32 22.34 40.22 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 41.50 28.88 41.13 43.33 29.67 41.93 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 3 3 # 3 A 169 TYR A 168 TYR^? 14.52 MG MG A 302 A 172 HIS A 147 HIS^? 9.20 MG MG A 302 A 267 ASP A 187 ASP^? -3.29 MG MG A 302s coo 26.78 20.44 0.03 28.51 18.26 0.09 37.31 16.98 37.59 36.65 18.86 39.55 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 40.24 23.10 39.83 38.32 22.34 40.22 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 39.43 26.57 46.78 39.37 27.83 45.03 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 4 3 # 4 A 169 TYR A 168 TYR^? 14.52 MG MG A 302 A 172 HIS A 170 HIS^? 10.56 MG MG A 302 A 267 ASP A 171 ASP^? 17.17 MG MG A 302 coo 26.78 20.44 0.03 28.51 18.26 0.09 37.31 16.98 37.59 36.65 18.86 39.55 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 34.91 23.57 39.32 34.35 24.95 40.81 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 29.78 23.67 36.63 28.48 25.11 35.71 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 5 3 # 5 A 169 TYR A 188 TYR^? 8.73 MG MG A 302 A 172 HIS A 170 HIS^? 10.56 MG MG A 302 A 267 ASP A 171 ASP^? 17.17 MG MG A 302 coo 26.78 20.44 0.03 28.51 18.26 0.09 37.17 23.04 44.09 34.69 24.12 44.73 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 34.91 23.57 39.32 34.35 24.95 40.81 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 29.78 23.67 36.63 28.48 25.11 35.71 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 6 3 # 6 A 169 TYR B 129 TYR^? 10.63 MG MG B 302 A 172 HIS B 147 HIS^? 9.27 MG MG B 301 A 267 ASP B 187 ASP^? -3.44 MG MG B 301s coo 26.78 20.44 0.03 28.51 18.26 0.09 47.85 23.00 1.51 47.62 23.50 4.24 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 50.64 18.14 -9.69 51.74 17.63 -7.86 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 7 3 # 7 A 169 TYR B 168 TYR^? 14.66 MG MG B 301 A 172 HIS B 147 HIS^? 9.27 MG MG B 301 A 267 ASP B 148 ASP^? 2.58 MG MG B 302s coo 26.78 20.44 0.03 28.51 18.26 0.09 40.03 17.20 -1.34 41.92 16.43 -3.19 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 52.73 19.23 -3.77 53.81 20.99 -4.31 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 8 3 # 8 A 169 TYR B 168 TYR^? 14.66 MG MG B 301 A 172 HIS B 147 HIS^? 9.27 MG MG B 301 A 267 ASP B 187 ASP^? -3.44 MG MG B 301s coo 26.78 20.44 0.03 28.51 18.26 0.09 40.03 17.20 -1.34 41.92 16.43 -3.19 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 50.64 18.14 -9.69 51.74 17.63 -7.86 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 9 3 # 9 A 169 TYR B 168 TYR^? 14.66 MG MG B 301 A 172 HIS B 170 HIS^? 10.51 MG MG B 301 A 267 ASP B 171 ASP^? 16.92 MG MG B 301 coo 26.78 20.44 0.03 28.51 18.26 0.09 40.03 17.20 -1.34 41.92 16.43 -3.19 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 45.30 8.50 -0.71 46.30 6.81 0.12 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 10 3 # 10 A 169 TYR B 188 TYR^? 8.84 MG MG B 301 A 172 HIS B 170 HIS^? 10.51 MG MG B 301 A 267 ASP B 171 ASP^? 16.92 MG MG B 301 coo 26.78 20.44 0.03 28.51 18.26 0.09 46.41 16.35 -7.52 47.38 13.88 -8.38 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 45.30 8.50 -0.71 46.30 6.81 0.12 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 11 3 # 11 A 169 TYR C 168 TYR^? 14.82 MG MG C 301 A 172 HIS C 147 HIS^? 9.44 MG MG C 301 A 267 ASP C 148 ASP^? 2.75 MG MG C 302s coo 26.78 20.44 0.03 28.51 18.26 0.09 94.44 26.43 -5.44 92.97 25.09 -3.55 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 81.96 23.83 -2.68 80.24 25.11 -2.27 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 12 3 # 12 A 169 TYR C 168 TYR^? 14.82 MG MG C 301 A 172 HIS C 170 HIS^? 10.68 MG MG C 301 A 267 ASP C 171 ASP^? 17.08 MG MG C 301 coo 26.78 20.44 0.03 28.51 18.26 0.09 94.44 26.43 -5.44 92.97 25.09 -3.55 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 92.57 16.68 -6.24 92.24 14.74 -7.03 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 13 3 # 13 A 169 TYR C 188 TYR^? 8.98 MG MG C 301 A 172 HIS C 170 HIS^? 10.68 MG MG C 301 A 267 ASP C 171 ASP^? 17.08 MG MG C 301 coo 26.78 20.44 0.03 28.51 18.26 0.09 88.74 23.30 0.93 88.91 20.61 1.57 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 92.57 16.68 -6.24 92.24 14.74 -7.03 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 14 3 # 14 A 169 TYR D 129 TYR^? 10.79 MG MG D 302 A 172 HIS D 147 HIS^? 9.43 MG MG D 301 A 267 ASP D 187 ASP^? -2.95 MG MG D 301s coo 26.78 20.44 0.03 28.51 18.26 0.09 86.45 31.36 -42.20 86.02 30.90 -39.46 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 90.40 36.34 -52.69 89.24 37.98 -51.99 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 15 3 # 15 A 169 TYR D 168 TYR^? 14.75 MG MG D 301 A 172 HIS D 147 HIS^? 9.43 MG MG D 301 A 267 ASP D 148 ASP^? 2.35 MG MG D 302s coo 26.78 20.44 0.03 28.51 18.26 0.09 95.79 27.80 -44.35 95.71 29.78 -46.32 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 87.78 37.50 -47.56 85.79 37.49 -48.28 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 16 3 # 16 A 169 TYR D 168 TYR^? 14.75 MG MG D 301 A 172 HIS D 147 HIS^? 9.43 MG MG D 301 A 267 ASP D 187 ASP^? -2.95 MG MG D 301s coo 26.78 20.44 0.03 28.51 18.26 0.09 95.79 27.80 -44.35 95.71 29.78 -46.32 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 90.40 36.34 -52.69 89.24 37.98 -51.99 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 17 3 # 17 A 169 TYR D 168 TYR^? 14.75 MG MG D 301 A 172 HIS D 170 HIS^? 10.59 MG MG D 301 A 267 ASP D 171 ASP^? 16.95 MG MG D 301 coo 26.78 20.44 0.03 28.51 18.26 0.09 95.79 27.80 -44.35 95.71 29.78 -46.32 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 100.39 36.69 -43.49 101.13 38.51 -42.69 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 18 3 # 18 A 169 TYR D 188 TYR^? 8.87 MG MG D 301 A 172 HIS D 170 HIS^? 10.59 MG MG D 301 A 267 ASP D 171 ASP^? 16.95 MG MG D 301 coo 26.78 20.44 0.03 28.51 18.26 0.09 93.72 33.91 -50.86 95.36 36.03 -51.61 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 100.39 36.69 -43.49 101.13 38.51 -42.69 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 19 3 # 19 A 169 TYR E 129 TYR^? 10.89 MG MG E 302 A 172 HIS E 147 HIS^? 9.22 MG MG E 301 A 267 ASP E 187 ASP^? -2.71 MG MG E 301s coo 26.78 20.44 0.03 28.51 18.26 0.09 62.09 60.15 -52.83 61.47 59.53 -55.45 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 67.50 63.43 -41.69 68.97 62.26 -42.81 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 20 3 # 20 A 169 TYR E 168 TYR^? 14.43 MG MG E 301 A 172 HIS E 147 HIS^? 9.22 MG MG E 301 A 267 ASP E 148 ASP^? 2.62 MG MG E 302s coo 26.78 20.44 0.03 28.51 18.26 0.09 60.07 69.95 -50.54 61.99 69.37 -48.59 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 68.29 60.44 -47.29 68.03 58.42 -46.50 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 21 3 # 21 A 169 TYR E 168 TYR^? 14.43 MG MG E 301 A 172 HIS E 147 HIS^? 9.22 MG MG E 301 A 267 ASP E 187 ASP^? -2.71 MG MG E 301s coo 26.78 20.44 0.03 28.51 18.26 0.09 60.07 69.95 -50.54 61.99 69.37 -48.59 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 67.50 63.43 -41.69 68.97 62.26 -42.81 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 22 3 # 22 A 169 TYR E 168 TYR^? 14.43 MG MG E 301 A 172 HIS E 170 HIS^? 10.33 MG MG E 301 A 267 ASP E 171 ASP^? 16.73 MG MG E 301 coo 26.78 20.44 0.03 28.51 18.26 0.09 60.07 69.95 -50.54 61.99 69.37 -48.59 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 69.61 73.12 -51.56 71.50 73.53 -52.39 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 23 3 # 23 A 169 TYR E 188 TYR^? 8.62 MG MG E 301 A 172 HIS E 170 HIS^? 10.33 MG MG E 301 A 267 ASP E 171 ASP^? 16.73 MG MG E 301 coo 26.78 20.44 0.03 28.51 18.26 0.09 65.58 67.09 -44.08 67.82 68.57 -43.41 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 69.61 73.12 -51.56 71.50 73.53 -52.39 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 24 3 # 24 A 169 TYR F 168 TYR^? 14.10 MG MG F 302 A 172 HIS F 147 HIS^? 8.79 MG MG F 302 A 267 ASP F 148 ASP^? 2.72 MG MG F 301s coo 26.78 20.44 0.03 28.51 18.26 0.09 58.29 68.32 -89.29 56.67 67.12 -91.21 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 53.64 56.47 -91.98 54.61 54.68 -92.64 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 25 3 # 25 A 169 TYR F 168 TYR^? 14.10 MG MG F 302 A 172 HIS F 170 HIS^? 9.84 MG MG F 302 A 267 ASP F 171 ASP^? 16.35 MG MG F 302 coo 26.78 20.44 0.03 28.51 18.26 0.09 58.29 68.32 -89.29 56.67 67.12 -91.21 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 48.23 68.08 -88.47 46.26 68.02 -87.56 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 26 3 # 26 A 169 TYR F 188 TYR^? 8.06 MG MG F 302 A 172 HIS F 170 HIS^? 9.84 MG MG F 302 A 267 ASP F 171 ASP^? 16.35 MG MG F 302 coo 26.78 20.44 0.03 28.51 18.26 0.09 54.23 63.50 -95.64 51.58 63.66 -96.35 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 48.23 68.08 -88.47 46.26 68.02 -87.56 2tmd_c00 source 2tmd TRIMETHYLAMINE DEHYDROGENASE : 26 hits 2tmd_c00 naa= 3 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 1 3 # 1 B 169 TYR A 168 TYR^? 14.52 MG MG A 302 B 172 HIS A 147 HIS^? 9.20 MG MG A 302 B 267 ASP A 148 ASP^? 2.72 MG MG A 301s coo 44.86 1.98 33.27 42.75 1.12 31.67 37.31 16.98 37.59 36.65 18.86 39.55 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 40.24 23.10 39.83 38.32 22.34 40.22 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 41.50 28.88 41.13 43.33 29.67 41.93 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 2 3 # 2 B 169 TYR A 168 TYR^? 14.52 MG MG A 302 B 172 HIS A 170 HIS^? 10.56 MG MG A 302 B 267 ASP A 171 ASP^? 17.17 MG MG A 302 coo 44.86 1.98 33.27 42.75 1.12 31.67 37.31 16.98 37.59 36.65 18.86 39.55 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 34.91 23.57 39.32 34.35 24.95 40.81 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 29.78 23.67 36.63 28.48 25.11 35.71 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 3 3 # 3 B 169 TYR A 188 TYR^? 8.73 MG MG A 302 B 172 HIS A 170 HIS^? 10.56 MG MG A 302 B 267 ASP A 171 ASP^? 17.17 MG MG A 302 coo 44.86 1.98 33.27 42.75 1.12 31.67 37.17 23.04 44.09 34.69 24.12 44.73 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 34.91 23.57 39.32 34.35 24.95 40.81 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 29.78 23.67 36.63 28.48 25.11 35.71 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 4 3 # 4 B 169 TYR B 129 TYR^? 10.63 MG MG B 302 B 172 HIS B 147 HIS^? 9.27 MG MG B 301 B 267 ASP B 187 ASP^? -3.44 MG MG B 301s coo 44.86 1.98 33.27 42.75 1.12 31.67 47.85 23.00 1.51 47.62 23.50 4.24 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 50.64 18.14 -9.69 51.74 17.63 -7.86 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 5 3 # 5 B 169 TYR B 168 TYR^? 14.66 MG MG B 301 B 172 HIS B 147 HIS^? 9.27 MG MG B 301 B 267 ASP B 148 ASP^? 2.58 MG MG B 302s coo 44.86 1.98 33.27 42.75 1.12 31.67 40.03 17.20 -1.34 41.92 16.43 -3.19 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 52.73 19.23 -3.77 53.81 20.99 -4.31 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 6 3 # 6 B 169 TYR B 168 TYR^? 14.66 MG MG B 301 B 172 HIS B 147 HIS^? 9.27 MG MG B 301 B 267 ASP B 187 ASP^? -3.44 MG MG B 301s coo 44.86 1.98 33.27 42.75 1.12 31.67 40.03 17.20 -1.34 41.92 16.43 -3.19 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 50.64 18.14 -9.69 51.74 17.63 -7.86 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 7 3 # 7 B 169 TYR B 168 TYR^? 14.66 MG MG B 301 B 172 HIS B 170 HIS^? 10.51 MG MG B 301 B 267 ASP B 171 ASP^? 16.92 MG MG B 301 coo 44.86 1.98 33.27 42.75 1.12 31.67 40.03 17.20 -1.34 41.92 16.43 -3.19 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 45.30 8.50 -0.71 46.30 6.81 0.12 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 8 3 # 8 B 169 TYR B 188 TYR^? 8.84 MG MG B 301 B 172 HIS B 170 HIS^? 10.51 MG MG B 301 B 267 ASP B 171 ASP^? 16.92 MG MG B 301 coo 44.86 1.98 33.27 42.75 1.12 31.67 46.41 16.35 -7.52 47.38 13.88 -8.38 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 45.30 8.50 -0.71 46.30 6.81 0.12 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 9 3 # 9 B 169 TYR C 168 TYR^? 14.82 MG MG C 301 B 172 HIS C 147 HIS^? 9.44 MG MG C 301 B 267 ASP C 148 ASP^? 2.75 MG MG C 302s coo 44.86 1.98 33.27 42.75 1.12 31.67 94.44 26.43 -5.44 92.97 25.09 -3.55 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 87.61 25.71 -3.59 89.22 24.50 -2.99 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 81.96 23.83 -2.68 80.24 25.11 -2.27 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 10 3 # 10 B 169 TYR C 168 TYR^? 14.82 MG MG C 301 B 172 HIS C 170 HIS^? 10.68 MG MG C 301 B 267 ASP C 171 ASP^? 17.08 MG MG C 301 coo 44.86 1.98 33.27 42.75 1.12 31.67 94.44 26.43 -5.44 92.97 25.09 -3.55 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 92.57 16.68 -6.24 92.24 14.74 -7.03 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 11 3 # 11 B 169 TYR C 188 TYR^? 8.98 MG MG C 301 B 172 HIS C 170 HIS^? 10.68 MG MG C 301 B 267 ASP C 171 ASP^? 17.08 MG MG C 301 coo 44.86 1.98 33.27 42.75 1.12 31.67 88.74 23.30 0.93 88.91 20.61 1.57 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 92.57 16.68 -6.24 92.24 14.74 -7.03 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 12 3 # 12 B 169 TYR D 129 TYR^? 10.79 MG MG D 302 B 172 HIS D 147 HIS^? 9.43 MG MG D 301 B 267 ASP D 187 ASP^? -2.95 MG MG D 301s coo 44.86 1.98 33.27 42.75 1.12 31.67 86.45 31.36 -42.20 86.02 30.90 -39.46 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 90.40 36.34 -52.69 89.24 37.98 -51.99 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 13 3 # 13 B 169 TYR D 168 TYR^? 14.75 MG MG D 301 B 172 HIS D 147 HIS^? 9.43 MG MG D 301 B 267 ASP D 148 ASP^? 2.35 MG MG D 302s coo 44.86 1.98 33.27 42.75 1.12 31.67 95.79 27.80 -44.35 95.71 29.78 -46.32 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 87.78 37.50 -47.56 85.79 37.49 -48.28 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 14 3 # 14 B 169 TYR D 168 TYR^? 14.75 MG MG D 301 B 172 HIS D 147 HIS^? 9.43 MG MG D 301 B 267 ASP D 187 ASP^? -2.95 MG MG D 301s coo 44.86 1.98 33.27 42.75 1.12 31.67 95.79 27.80 -44.35 95.71 29.78 -46.32 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 90.95 32.51 -46.42 92.98 32.42 -46.93 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 90.40 36.34 -52.69 89.24 37.98 -51.99 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 15 3 # 15 B 169 TYR D 168 TYR^? 14.75 MG MG D 301 B 172 HIS D 170 HIS^? 10.59 MG MG D 301 B 267 ASP D 171 ASP^? 16.95 MG MG D 301 coo 44.86 1.98 33.27 42.75 1.12 31.67 95.79 27.80 -44.35 95.71 29.78 -46.32 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 100.39 36.69 -43.49 101.13 38.51 -42.69 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 16 3 # 16 B 169 TYR D 188 TYR^? 8.87 MG MG D 301 B 172 HIS D 170 HIS^? 10.59 MG MG D 301 B 267 ASP D 171 ASP^? 16.95 MG MG D 301 coo 44.86 1.98 33.27 42.75 1.12 31.67 93.72 33.91 -50.86 95.36 36.03 -51.61 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 100.39 36.69 -43.49 101.13 38.51 -42.69 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 17 3 # 17 B 169 TYR E 129 TYR^? 10.89 MG MG E 302 B 172 HIS E 147 HIS^? 9.22 MG MG E 301 B 267 ASP E 187 ASP^? -2.71 MG MG E 301s coo 44.86 1.98 33.27 42.75 1.12 31.67 62.09 60.15 -52.83 61.47 59.53 -55.45 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 67.50 63.43 -41.69 68.97 62.26 -42.81 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 18 3 # 18 B 169 TYR E 168 TYR^? 14.43 MG MG E 301 B 172 HIS E 147 HIS^? 9.22 MG MG E 301 B 267 ASP E 148 ASP^? 2.62 MG MG E 302s coo 44.86 1.98 33.27 42.75 1.12 31.67 60.07 69.95 -50.54 61.99 69.37 -48.59 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 68.29 60.44 -47.29 68.03 58.42 -46.50 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 19 3 # 19 B 169 TYR E 168 TYR^? 14.43 MG MG E 301 B 172 HIS E 147 HIS^? 9.22 MG MG E 301 B 267 ASP E 187 ASP^? -2.71 MG MG E 301s coo 44.86 1.98 33.27 42.75 1.12 31.67 60.07 69.95 -50.54 61.99 69.37 -48.59 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 63.87 64.43 -48.39 64.18 66.45 -47.92 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 67.50 63.43 -41.69 68.97 62.26 -42.81 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 20 3 # 20 B 169 TYR E 168 TYR^? 14.43 MG MG E 301 B 172 HIS E 170 HIS^? 10.33 MG MG E 301 B 267 ASP E 171 ASP^? 16.73 MG MG E 301 coo 44.86 1.98 33.27 42.75 1.12 31.67 60.07 69.95 -50.54 61.99 69.37 -48.59 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 69.61 73.12 -51.56 71.50 73.53 -52.39 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 21 3 # 21 B 169 TYR E 188 TYR^? 8.62 MG MG E 301 B 172 HIS E 170 HIS^? 10.33 MG MG E 301 B 267 ASP E 171 ASP^? 16.73 MG MG E 301 coo 44.86 1.98 33.27 42.75 1.12 31.67 65.58 67.09 -44.08 67.82 68.57 -43.41 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 69.61 73.12 -51.56 71.50 73.53 -52.39 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 22 3 # 22 B 169 TYR F 168 TYR^? 14.10 MG MG F 302 B 172 HIS F 147 HIS^? 8.79 MG MG F 302 B 267 ASP F 148 ASP^? 2.72 MG MG F 301s coo 44.86 1.98 33.27 42.75 1.12 31.67 58.29 68.32 -89.29 56.67 67.12 -91.21 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 53.64 56.47 -91.98 54.61 54.68 -92.64 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 23 3 # 23 B 169 TYR F 168 TYR^? 14.10 MG MG F 302 B 172 HIS F 170 HIS^? 9.84 MG MG F 302 B 267 ASP F 171 ASP^? 16.35 MG MG F 302 coo 44.86 1.98 33.27 42.75 1.12 31.67 58.29 68.32 -89.29 56.67 67.12 -91.21 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 48.23 68.08 -88.47 46.26 68.02 -87.56 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 24 3 # 24 B 169 TYR F 188 TYR^? 8.06 MG MG F 302 B 172 HIS F 170 HIS^? 9.84 MG MG F 302 B 267 ASP F 171 ASP^? 16.35 MG MG F 302 coo 44.86 1.98 33.27 42.75 1.12 31.67 54.23 63.50 -95.64 51.58 63.66 -96.35 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 48.23 68.08 -88.47 46.26 68.02 -87.56 2tmd_c01 source 2tmd TRIMETHYLAMINE DEHYDROGENASE : 24 hits 2tmd_c01 naa= 3 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 1 3 # 1 A 122 TYR A 60 TYR^? 27.11 MG MG B 302 A 214 ASP B 35 ASP^? 16.92 MG MG B 302 A 256 LYS B 90 LYS^? 18.68 MG MG B 302 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 55.01 4.24 16.98 56.13 3.24 14.65 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 52.63 11.07 10.18 53.68 12.85 9.94 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 61.66 21.61 12.88 56.74 22.88 14.81 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 2 3 # 2 A 122 TYR A 188 TYR^? 8.73 MG MG A 302 A 214 ASP A 128 ASP^? -3.32 MG MG A 301s A 256 LYS A 111 LYS^? 15.16 MG MG A 301 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 37.17 23.04 44.09 34.69 24.12 44.73 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 46.50 28.23 39.77 47.49 30.10 39.82 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 52.67 17.19 35.90 54.65 19.90 40.50 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 3 3 # 3 A 122 TYR B 60 TYR^? 27.11 MG MG A 301 A 214 ASP A 35 ASP^? 16.92 MG MG A 301 A 256 LYS A 90 LYS^? 18.58 MG MG A 301 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 28.84 35.27 19.49 28.03 36.56 21.83 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 34.49 31.10 26.54 36.41 31.82 27.10 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 46.62 38.29 25.46 47.51 33.29 23.22 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 4 3 # 4 A 122 TYR B 188 TYR^? 8.84 MG MG B 301 A 214 ASP B 128 ASP^? -3.57 MG MG B 302s A 256 LYS B 111 LYS^? 13.75 MG MG B 302 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 46.41 16.35 -7.52 47.38 13.88 -8.38 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 52.92 24.09 -2.19 54.73 25.14 -1.90 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 42.84 32.14 1.80 46.84 32.68 -2.87 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 5 3 # 5 A 122 TYR C 60 TYR^? 26.95 MG MG D 302 A 214 ASP D 35 ASP^? 16.80 MG MG D 302 A 256 LYS D 90 LYS^? 18.98 MG MG D 302 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 97.75 47.69 -25.92 97.82 49.25 -28.26 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 93.83 42.00 -33.14 91.74 41.83 -33.51 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 79.83 44.38 -31.44 80.32 39.55 -29.40 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 6 3 # 6 A 122 TYR C 188 TYR^? 8.98 MG MG C 301 A 214 ASP C 128 ASP^? -3.22 MG MG C 302s A 256 LYS C 111 LYS^? 16.56 MG MG C 302 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 88.74 23.30 0.93 88.91 20.61 1.57 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 80.05 28.39 -4.25 77.97 28.60 -4.21 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 86.36 39.56 -8.06 84.36 40.84 -3.15 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 7 3 # 7 A 122 TYR D 60 TYR^? 26.93 MG MG C 302 A 214 ASP C 35 ASP^? 16.42 MG MG C 302 A 256 LYS C 90 LYS^? 18.24 MG MG C 302 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 84.40 9.28 -23.74 83.45 7.90 -21.49 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 84.40 16.53 -16.68 82.83 17.91 -16.28 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 72.37 23.25 -18.94 76.11 26.52 -20.97 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 8 3 # 8 A 122 TYR D 188 TYR^? 8.87 MG MG D 301 A 214 ASP D 128 ASP^? -3.70 MG MG D 302s A 256 LYS D 111 LYS^? 15.85 MG MG D 302 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 93.72 33.91 -50.86 95.36 36.03 -51.61 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 83.33 35.45 -46.13 81.57 36.63 -46.10 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 81.21 22.69 -42.10 78.68 23.89 -46.57 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 9 3 # 9 A 122 TYR E 60 TYR^? 27.19 MG MG F 301 A 214 ASP F 35 ASP^? 16.93 MG MG F 301 A 256 LYS F 90 LYS^? 18.57 MG MG F 301 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 39.82 61.07 -70.68 38.29 60.72 -72.98 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 46.82 60.47 -77.63 48.00 58.79 -78.23 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 51.54 47.01 -75.58 55.05 50.31 -73.74 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 10 3 # 10 A 122 TYR E 188 TYR^? 8.62 MG MG E 301 A 214 ASP E 128 ASP^? -3.53 MG MG E 302s A 256 LYS E 111 LYS^? 14.52 MG MG E 302 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 65.58 67.09 -44.08 67.82 68.57 -43.41 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 65.38 56.57 -48.58 66.15 54.57 -48.61 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 52.49 56.44 -52.43 54.52 53.78 -47.52 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 11 3 # 11 A 122 TYR F 60 TYR^? 27.07 MG MG E 302 A 214 ASP E 35 ASP^? 16.91 MG MG E 302 A 256 LYS E 90 LYS^? 19.16 MG MG E 302 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 79.79 68.64 -68.89 81.11 68.86 -66.46 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 73.60 65.64 -62.00 73.13 63.73 -61.22 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 73.81 51.50 -63.18 69.15 52.39 -65.65 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 12 3 # 12 A 122 TYR F 188 TYR^? 8.06 MG MG F 302 A 214 ASP F 128 ASP^? -3.41 MG MG F 301s A 256 LYS F 111 LYS^? 15.21 MG MG F 301 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 54.23 63.50 -95.64 51.58 63.66 -96.35 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 57.76 53.73 -90.50 57.46 51.64 -90.28 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 69.70 58.57 -86.86 69.67 53.74 -90.29 2tpl_c04 source 2tpl TYROSINE PHENOL-LYASE : 12 hits 2tpl_c04 naa= 3 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 1 3 # 1 B 122 TYR A 60 TYR^? 27.11 MG MG B 302 B 214 ASP B 35 ASP^? 16.92 MG MG B 302 B 256 LYS B 90 LYS^? 18.68 MG MG B 302 coo -32.67 22.74 10.17 -32.85 23.98 7.70 55.01 4.24 16.98 56.13 3.24 14.65 coo -26.88 17.61 16.89 -26.08 17.11 15.00 52.63 11.07 10.18 53.68 12.85 9.94 coo -16.04 12.06 11.09 -17.97 10.54 5.71 61.66 21.61 12.88 56.74 22.88 14.81 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 2 3 # 2 B 122 TYR A 188 TYR^? 8.73 MG MG A 302 B 214 ASP A 128 ASP^? -3.32 MG MG A 301s B 256 LYS A 111 LYS^? 15.16 MG MG A 301 coo -32.67 22.74 10.17 -32.85 23.98 7.70 37.17 23.04 44.09 34.69 24.12 44.73 coo -26.88 17.61 16.89 -26.08 17.11 15.00 46.50 28.23 39.77 47.49 30.10 39.82 coo -16.04 12.06 11.09 -17.97 10.54 5.71 52.67 17.19 35.90 54.65 19.90 40.50 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 3 3 # 3 B 122 TYR B 60 TYR^? 27.11 MG MG A 301 B 214 ASP A 35 ASP^? 16.92 MG MG A 301 B 256 LYS A 90 LYS^? 18.58 MG MG A 301 coo -32.67 22.74 10.17 -32.85 23.98 7.70 28.84 35.27 19.49 28.03 36.56 21.83 coo -26.88 17.61 16.89 -26.08 17.11 15.00 34.49 31.10 26.54 36.41 31.82 27.10 coo -16.04 12.06 11.09 -17.97 10.54 5.71 46.62 38.29 25.46 47.51 33.29 23.22 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 4 3 # 4 B 122 TYR B 188 TYR^? 8.84 MG MG B 301 B 214 ASP B 128 ASP^? -3.57 MG MG B 302s B 256 LYS B 111 LYS^? 13.75 MG MG B 302 coo -32.67 22.74 10.17 -32.85 23.98 7.70 46.41 16.35 -7.52 47.38 13.88 -8.38 coo -26.88 17.61 16.89 -26.08 17.11 15.00 52.92 24.09 -2.19 54.73 25.14 -1.90 coo -16.04 12.06 11.09 -17.97 10.54 5.71 42.84 32.14 1.80 46.84 32.68 -2.87 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 5 3 # 5 B 122 TYR C 60 TYR^? 26.95 MG MG D 302 B 214 ASP D 35 ASP^? 16.80 MG MG D 302 B 256 LYS D 90 LYS^? 18.98 MG MG D 302 coo -32.67 22.74 10.17 -32.85 23.98 7.70 97.75 47.69 -25.92 97.82 49.25 -28.26 coo -26.88 17.61 16.89 -26.08 17.11 15.00 93.83 42.00 -33.14 91.74 41.83 -33.51 coo -16.04 12.06 11.09 -17.97 10.54 5.71 79.83 44.38 -31.44 80.32 39.55 -29.40 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 6 3 # 6 B 122 TYR C 188 TYR^? 8.98 MG MG C 301 B 214 ASP C 128 ASP^? -3.22 MG MG C 302s B 256 LYS C 111 LYS^? 16.56 MG MG C 302 coo -32.67 22.74 10.17 -32.85 23.98 7.70 88.74 23.30 0.93 88.91 20.61 1.57 coo -26.88 17.61 16.89 -26.08 17.11 15.00 80.05 28.39 -4.25 77.97 28.60 -4.21 coo -16.04 12.06 11.09 -17.97 10.54 5.71 86.36 39.56 -8.06 84.36 40.84 -3.15 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 7 3 # 7 B 122 TYR D 60 TYR^? 26.93 MG MG C 302 B 214 ASP C 35 ASP^? 16.42 MG MG C 302 B 256 LYS C 90 LYS^? 18.24 MG MG C 302 coo -32.67 22.74 10.17 -32.85 23.98 7.70 84.40 9.28 -23.74 83.45 7.90 -21.49 coo -26.88 17.61 16.89 -26.08 17.11 15.00 84.40 16.53 -16.68 82.83 17.91 -16.28 coo -16.04 12.06 11.09 -17.97 10.54 5.71 72.37 23.25 -18.94 76.11 26.52 -20.97 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 8 3 # 8 B 122 TYR D 188 TYR^? 8.87 MG MG D 301 B 214 ASP D 128 ASP^? -3.70 MG MG D 302s B 256 LYS D 111 LYS^? 15.85 MG MG D 302 coo -32.67 22.74 10.17 -32.85 23.98 7.70 93.72 33.91 -50.86 95.36 36.03 -51.61 coo -26.88 17.61 16.89 -26.08 17.11 15.00 83.33 35.45 -46.13 81.57 36.63 -46.10 coo -16.04 12.06 11.09 -17.97 10.54 5.71 81.21 22.69 -42.10 78.68 23.89 -46.57 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 9 3 # 9 B 122 TYR E 60 TYR^? 27.19 MG MG F 301 B 214 ASP F 35 ASP^? 16.93 MG MG F 301 B 256 LYS F 90 LYS^? 18.57 MG MG F 301 coo -32.67 22.74 10.17 -32.85 23.98 7.70 39.82 61.07 -70.68 38.29 60.72 -72.98 coo -26.88 17.61 16.89 -26.08 17.11 15.00 46.82 60.47 -77.63 48.00 58.79 -78.23 coo -16.04 12.06 11.09 -17.97 10.54 5.71 51.54 47.01 -75.58 55.05 50.31 -73.74 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 10 3 # 10 B 122 TYR E 188 TYR^? 8.62 MG MG E 301 B 214 ASP E 128 ASP^? -3.53 MG MG E 302s B 256 LYS E 111 LYS^? 14.52 MG MG E 302 coo -32.67 22.74 10.17 -32.85 23.98 7.70 65.58 67.09 -44.08 67.82 68.57 -43.41 coo -26.88 17.61 16.89 -26.08 17.11 15.00 65.38 56.57 -48.58 66.15 54.57 -48.61 coo -16.04 12.06 11.09 -17.97 10.54 5.71 52.49 56.44 -52.43 54.52 53.78 -47.52 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 11 3 # 11 B 122 TYR F 60 TYR^? 27.07 MG MG E 302 B 214 ASP E 35 ASP^? 16.91 MG MG E 302 B 256 LYS E 90 LYS^? 19.16 MG MG E 302 coo -32.67 22.74 10.17 -32.85 23.98 7.70 79.79 68.64 -68.89 81.11 68.86 -66.46 coo -26.88 17.61 16.89 -26.08 17.11 15.00 73.60 65.64 -62.00 73.13 63.73 -61.22 coo -16.04 12.06 11.09 -17.97 10.54 5.71 73.81 51.50 -63.18 69.15 52.39 -65.65 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 12 3 # 12 B 122 TYR F 188 TYR^? 8.06 MG MG F 302 B 214 ASP F 128 ASP^? -3.41 MG MG F 301s B 256 LYS F 111 LYS^? 15.21 MG MG F 301 coo -32.67 22.74 10.17 -32.85 23.98 7.70 54.23 63.50 -95.64 51.58 63.66 -96.35 coo -26.88 17.61 16.89 -26.08 17.11 15.00 57.76 53.73 -90.50 57.46 51.64 -90.28 coo -16.04 12.06 11.09 -17.97 10.54 5.71 69.70 58.57 -86.86 69.67 53.74 -90.29 2tpl_c05 source 2tpl TYROSINE PHENOL-LYASE : 12 hits 2tpl_c05 naa= 3 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 A 59 ARG A 8 ARG^? 20.36 MG MG A 301 A 130 SER A 66 SER^? 21.38 MG MG A 301 A 159 LYS A 157 LYS^? 28.65 MG MG A 302 coo 18.35 45.84 20.99 16.20 47.83 21.89 40.62 19.52 24.63 40.98 22.51 23.88 coo 15.14 43.67 10.77 15.61 44.43 13.04 52.67 19.58 24.88 54.49 20.94 25.63 coo 11.57 48.49 22.18 13.51 49.99 17.21 41.42 12.06 27.58 41.46 5.93 29.41 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 2 3 # 2 A 59 ARG B 8 ARG^? 20.39 MG MG B 302 A 130 SER B 66 SER^? 21.21 MG MG B 302 A 159 LYS B 157 LYS^? 28.85 MG MG B 302 coo 18.35 45.84 20.99 16.20 47.83 21.89 41.99 18.82 11.83 44.91 18.76 12.93 coo 15.14 43.67 10.77 15.61 44.43 13.04 44.21 30.46 12.82 45.29 32.17 11.68 coo 11.57 48.49 22.18 13.51 49.99 17.21 34.97 21.28 8.44 29.03 22.82 6.58 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 3 3 # 3 A 59 ARG C 8 ARG^? 20.00 MG MG C 302 A 130 SER C 66 SER^? 20.91 MG MG C 302 A 159 LYS C 157 LYS^? 28.15 MG MG C 302 coo 18.35 45.84 20.99 16.20 47.83 21.89 91.42 27.61 -18.53 88.82 26.28 -19.38 coo 15.14 43.67 10.77 15.61 44.43 13.04 85.39 37.79 -19.17 83.53 38.71 -18.09 coo 11.57 48.49 22.18 13.51 49.99 17.21 97.55 32.04 -15.10 101.49 36.24 -13.39 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 4 3 # 4 A 59 ARG C 87 ARG^? 14.11 MG MG B 301 A 130 SER C 79 SER^? 19.92 MG MG B 301 A 159 LYS C 86 LYS^? 27.34 MG MG C 302 coo 18.35 45.84 20.99 16.20 47.83 21.89 64.80 14.21 -18.13 65.25 15.52 -15.36 coo 15.14 43.67 10.77 15.61 44.43 13.04 64.38 1.95 -14.66 62.69 3.45 -15.45 coo 11.57 48.49 22.18 13.51 49.99 17.21 69.22 9.88 -20.56 74.70 7.02 -22.55 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 5 3 # 5 A 59 ARG D 8 ARG^? 20.22 MG MG D 302 A 130 SER D 66 SER^? 21.51 MG MG D 302 A 159 LYS D 157 LYS^? 28.67 MG MG D 302 coo 18.35 45.84 20.99 16.20 47.83 21.89 92.22 28.83 -31.23 90.93 31.55 -30.54 coo 15.14 43.67 10.77 15.61 44.43 13.04 81.04 24.82 -31.14 78.93 25.00 -32.28 coo 11.57 48.49 22.18 13.51 49.99 17.21 94.17 21.71 -34.34 96.11 15.89 -35.92 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 6 3 # 6 A 59 ARG E 8 ARG^? 20.19 MG MG E 302 A 130 SER E 66 SER^? 21.23 MG MG E 302 A 159 LYS E 157 LYS^? 28.40 MG MG E 302 coo 18.35 45.84 20.99 16.20 47.83 21.89 60.42 66.09 -63.48 62.84 64.38 -64.17 coo 15.14 43.67 10.77 15.61 44.43 13.04 54.72 55.62 -63.56 54.90 53.49 -62.62 coo 11.57 48.49 22.18 13.51 49.99 17.21 53.63 69.16 -60.42 48.34 71.81 -58.40 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 7 3 # 7 A 59 ARG F 8 ARG^? 20.20 MG MG F 301 A 130 SER F 66 SER^? 21.35 MG MG F 301 A 159 LYS F 157 LYS^? 28.36 MG MG F 302 coo 18.35 45.84 20.99 16.20 47.83 21.89 58.98 65.22 -76.31 57.29 62.84 -75.38 coo 15.14 43.67 10.77 15.61 44.43 13.04 68.12 57.69 -75.42 68.70 55.68 -76.54 coo 11.57 48.49 22.18 13.51 49.99 17.21 64.43 70.47 -79.54 68.32 74.80 -81.65 2tps_c00 source 2tps THIAMIN PHOSPHATE SYNTHASE : 7 hits 2tps_c00 naa= 3 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 B 59 ARG A 8 ARG^? 20.36 MG MG A 301 B 130 SER A 66 SER^? 21.38 MG MG A 301 B 159 LYS A 157 LYS^? 28.65 MG MG A 302 coo 58.72 31.58 20.45 60.80 29.39 20.94 40.62 19.52 24.63 40.98 22.51 23.88 coo 61.66 35.17 10.39 61.29 34.14 12.56 52.67 19.58 24.88 54.49 20.94 25.63 coo 65.38 28.77 21.17 63.49 28.03 16.12 41.42 12.06 27.58 41.46 5.93 29.41 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 2 3 # 2 B 59 ARG B 8 ARG^? 20.39 MG MG B 302 B 130 SER B 66 SER^? 21.21 MG MG B 302 B 159 LYS B 157 LYS^? 28.85 MG MG B 302 coo 58.72 31.58 20.45 60.80 29.39 20.94 41.99 18.82 11.83 44.91 18.76 12.93 coo 61.66 35.17 10.39 61.29 34.14 12.56 44.21 30.46 12.82 45.29 32.17 11.68 coo 65.38 28.77 21.17 63.49 28.03 16.12 34.97 21.28 8.44 29.03 22.82 6.58 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 3 3 # 3 B 59 ARG C 8 ARG^? 20.00 MG MG C 302 B 130 SER C 66 SER^? 20.91 MG MG C 302 B 159 LYS C 157 LYS^? 28.15 MG MG C 302 coo 58.72 31.58 20.45 60.80 29.39 20.94 91.42 27.61 -18.53 88.82 26.28 -19.38 coo 61.66 35.17 10.39 61.29 34.14 12.56 85.39 37.79 -19.17 83.53 38.71 -18.09 coo 65.38 28.77 21.17 63.49 28.03 16.12 97.55 32.04 -15.10 101.49 36.24 -13.39 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 4 3 # 4 B 59 ARG D 8 ARG^? 20.22 MG MG D 302 B 130 SER D 66 SER^? 21.51 MG MG D 302 B 159 LYS D 157 LYS^? 28.67 MG MG D 302 coo 58.72 31.58 20.45 60.80 29.39 20.94 92.22 28.83 -31.23 90.93 31.55 -30.54 coo 61.66 35.17 10.39 61.29 34.14 12.56 81.04 24.82 -31.14 78.93 25.00 -32.28 coo 65.38 28.77 21.17 63.49 28.03 16.12 94.17 21.71 -34.34 96.11 15.89 -35.92 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 5 3 # 5 B 59 ARG E 8 ARG^? 20.19 MG MG E 302 B 130 SER E 66 SER^? 21.23 MG MG E 302 B 159 LYS E 157 LYS^? 28.40 MG MG E 302 coo 58.72 31.58 20.45 60.80 29.39 20.94 60.42 66.09 -63.48 62.84 64.38 -64.17 coo 61.66 35.17 10.39 61.29 34.14 12.56 54.72 55.62 -63.56 54.90 53.49 -62.62 coo 65.38 28.77 21.17 63.49 28.03 16.12 53.63 69.16 -60.42 48.34 71.81 -58.40 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 6 3 # 6 B 59 ARG F 8 ARG^? 20.20 MG MG F 301 B 130 SER F 66 SER^? 21.35 MG MG F 301 B 159 LYS F 157 LYS^? 28.36 MG MG F 302 coo 58.72 31.58 20.45 60.80 29.39 20.94 58.98 65.22 -76.31 57.29 62.84 -75.38 coo 61.66 35.17 10.39 61.29 34.14 12.56 68.12 57.69 -75.42 68.70 55.68 -76.54 coo 65.38 28.77 21.17 63.49 28.03 16.12 64.43 70.47 -79.54 68.32 74.80 -81.65 2tps_c01 source 2tps THIAMIN PHOSPHATE SYNTHASE : 6 hits 2tps_c01 naa= 3 ULMN 3 3cla_c00 TYPE III CHLORAMPHENICOL ACETYLTRANSuser 1 3 # 1 18 ARG A 173 ARG^? 19.27 MG MG A 302 195 HIS A 170 HIS^? 10.56 MG MG A 302 199 ASP A 171 ASP^? 17.17 MG MG A 302 coo 21.96 2.03 15.24 19.33 1.86 13.55 27.76 29.24 35.14 27.46 27.11 32.86 coo 13.48 -0.87 14.56 14.47 -2.14 15.92 34.91 23.57 39.32 34.35 24.95 40.81 coo 17.92 -0.05 18.55 18.90 -0.38 16.73 29.78 23.67 36.63 28.48 25.11 35.71 ULMN 3 3cla_c00 TYPE III CHLORAMPHENICOL ACETYLTRANSuser 2 3 # 2 18 ARG B 173 ARG^? 18.75 MG MG B 301 195 HIS B 170 HIS^? 10.51 MG MG B 301 199 ASP B 171 ASP^? 16.92 MG MG B 301 coo 21.96 2.03 15.24 19.33 1.86 13.55 49.83 5.55 0.39 48.19 5.30 3.03 coo 13.48 -0.87 14.56 14.47 -2.14 15.92 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 17.92 -0.05 18.55 18.90 -0.38 16.73 45.30 8.50 -0.71 46.30 6.81 0.12 ULMN 3 3cla_c00 TYPE III CHLORAMPHENICOL ACETYLTRANSuser 3 3 # 3 18 ARG C 173 ARG^? 18.96 MG MG C 301 195 HIS C 170 HIS^? 10.68 MG MG C 301 199 ASP C 171 ASP^? 17.08 MG MG C 301 coo 21.96 2.03 15.24 19.33 1.86 13.55 89.11 11.40 -7.73 91.21 12.63 -9.73 coo 13.48 -0.87 14.56 14.47 -2.14 15.92 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 17.92 -0.05 18.55 18.90 -0.38 16.73 92.57 16.68 -6.24 92.24 14.74 -7.03 ULMN 3 3cla_c00 TYPE III CHLORAMPHENICOL ACETYLTRANSuser 4 3 # 4 18 ARG D 173 ARG^? 18.88 MG MG D 301 195 HIS D 170 HIS^? 10.59 MG MG D 301 199 ASP D 171 ASP^? 16.95 MG MG D 301 coo 21.96 2.03 15.24 19.33 1.86 13.55 100.48 42.57 -42.43 101.55 40.79 -40.06 coo 13.48 -0.87 14.56 14.47 -2.14 15.92 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 17.92 -0.05 18.55 18.90 -0.38 16.73 100.39 36.69 -43.49 101.13 38.51 -42.69 ULMN 3 3cla_c00 TYPE III CHLORAMPHENICOL ACETYLTRANSuser 5 3 # 5 18 ARG E 173 ARG^? 18.66 MG MG E 301 195 HIS E 170 HIS^? 10.33 MG MG E 301 199 ASP E 171 ASP^? 16.73 MG MG E 301 coo 21.96 2.03 15.24 19.33 1.86 13.55 75.16 72.26 -52.56 73.67 73.54 -55.01 coo 13.48 -0.87 14.56 14.47 -2.14 15.92 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 17.92 -0.05 18.55 18.90 -0.38 16.73 69.61 73.12 -51.56 71.50 73.53 -52.39 ULMN 3 3cla_c00 TYPE III CHLORAMPHENICOL ACETYLTRANSuser 6 3 # 6 18 ARG F 173 ARG^? 18.61 MG MG F 302 195 HIS F 170 HIS^? 9.84 MG MG F 302 199 ASP F 171 ASP^? 16.35 MG MG F 302 coo 21.96 2.03 15.24 19.33 1.86 13.55 43.18 65.58 -86.96 44.06 67.55 -84.65 coo 13.48 -0.87 14.56 14.47 -2.14 15.92 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 17.92 -0.05 18.55 18.90 -0.38 16.73 48.23 68.08 -88.47 46.26 68.02 -87.56 3cla_c00 source 3cla TYPE III CHLORAMPHENICOL ACETYLTRANSFERASE ( C: 6 hits 3cla_c00 naa= 3 ULMN 3 4mdh_c02 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 1 3 # 1 A 158 ASP A 171 ASP^? 17.17 MG MG A 302 A 161 ARG A 173 ARG^? 19.27 MG MG A 302 A 186 HIS A 170 HIS^? 10.56 MG MG A 302 coo 18.62 26.83 58.17 18.48 28.64 57.08 29.78 23.67 36.63 28.48 25.11 35.71 coo 23.76 27.69 57.88 24.05 29.81 55.69 27.76 29.24 35.14 27.46 27.11 32.86 coo 16.67 31.22 54.64 18.74 31.15 54.14 34.91 23.57 39.32 34.35 24.95 40.81 ULMN 3 4mdh_c02 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 2 3 # 2 A 158 ASP B 171 ASP^? 16.92 MG MG B 301 A 161 ARG B 173 ARG^? 18.75 MG MG B 301 A 186 HIS B 170 HIS^? 10.51 MG MG B 301 coo 18.62 26.83 58.17 18.48 28.64 57.08 45.30 8.50 -0.71 46.30 6.81 0.12 coo 23.76 27.69 57.88 24.05 29.81 55.69 49.83 5.55 0.39 48.19 5.30 3.03 coo 16.67 31.22 54.64 18.74 31.15 54.14 46.22 13.75 -2.72 47.53 13.11 -4.24 ULMN 3 4mdh_c02 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 3 3 # 3 A 158 ASP C 171 ASP^? 17.08 MG MG C 301 A 161 ARG C 173 ARG^? 18.96 MG MG C 301 A 186 HIS C 170 HIS^? 10.68 MG MG C 301 coo 18.62 26.83 58.17 18.48 28.64 57.08 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 23.76 27.69 57.88 24.05 29.81 55.69 89.11 11.40 -7.73 91.21 12.63 -9.73 coo 16.67 31.22 54.64 18.74 31.15 54.14 89.96 21.05 -3.85 88.74 19.88 -2.61 ULMN 3 4mdh_c02 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 4 3 # 4 A 158 ASP D 171 ASP^? 16.95 MG MG D 301 A 161 ARG D 173 ARG^? 18.88 MG MG D 301 A 186 HIS D 170 HIS^? 10.59 MG MG D 301 coo 18.62 26.83 58.17 18.48 28.64 57.08 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 23.76 27.69 57.88 24.05 29.81 55.69 100.48 42.57 -42.43 101.55 40.79 -40.06 coo 16.67 31.22 54.64 18.74 31.15 54.14 95.57 34.81 -46.05 95.59 36.24 -47.59 ULMN 3 4mdh_c02 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 5 3 # 5 A 158 ASP E 171 ASP^? 16.73 MG MG E 301 A 161 ARG E 173 ARG^? 18.66 MG MG E 301 A 186 HIS E 170 HIS^? 10.33 MG MG E 301 coo 18.62 26.83 58.17 18.48 28.64 57.08 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 23.76 27.69 57.88 24.05 29.81 55.69 75.16 72.26 -52.56 73.67 73.54 -55.01 coo 16.67 31.22 54.64 18.74 31.15 54.14 66.96 68.76 -48.87 68.36 68.54 -47.33 ULMN 3 4mdh_c02 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 6 3 # 6 A 158 ASP F 171 ASP^? 16.35 MG MG F 302 A 161 ARG F 173 ARG^? 18.61 MG MG F 302 A 186 HIS F 170 HIS^? 9.84 MG MG F 302 coo 18.62 26.83 58.17 18.48 28.64 57.08 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 23.76 27.69 57.88 24.05 29.81 55.69 43.18 65.58 -86.96 44.06 67.55 -84.65 coo 16.67 31.22 54.64 18.74 31.15 54.14 52.25 64.82 -90.91 50.95 63.88 -92.26 4mdh_c02 source 4mdh CYTOPLASMIC MALATE DEHYDROGENASE (E.C.1.1.1.37: 6 hits 4mdh_c02 naa= 3 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 1 3 # 1 B 158 ASP A 171 ASP^? 17.17 MG MG A 302 B 161 ARG A 173 ARG^? 19.27 MG MG A 302 B 186 HIS A 170 HIS^? 10.56 MG MG A 302 coo 44.53 16.44 28.54 44.89 18.45 28.77 29.78 23.67 36.63 28.48 25.11 35.71 coo 39.64 19.27 28.15 40.19 21.74 29.94 27.76 29.24 35.14 27.46 27.11 32.86 coo 48.32 20.00 31.44 46.45 20.91 31.50 34.91 23.57 39.32 34.35 24.95 40.81 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 2 3 # 2 B 158 ASP B 171 ASP^? 16.92 MG MG B 301 B 161 ARG B 173 ARG^? 18.75 MG MG B 301 B 186 HIS B 170 HIS^? 10.51 MG MG B 301 coo 44.53 16.44 28.54 44.89 18.45 28.77 45.30 8.50 -0.71 46.30 6.81 0.12 coo 39.64 19.27 28.15 40.19 21.74 29.94 49.83 5.55 0.39 48.19 5.30 3.03 coo 48.32 20.00 31.44 46.45 20.91 31.50 46.22 13.75 -2.72 47.53 13.11 -4.24 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 3 3 # 3 B 158 ASP C 171 ASP^? 17.08 MG MG C 301 B 161 ARG C 173 ARG^? 18.96 MG MG C 301 B 186 HIS C 170 HIS^? 10.68 MG MG C 301 coo 44.53 16.44 28.54 44.89 18.45 28.77 92.57 16.68 -6.24 92.24 14.74 -7.03 coo 39.64 19.27 28.15 40.19 21.74 29.94 89.11 11.40 -7.73 91.21 12.63 -9.73 coo 48.32 20.00 31.44 46.45 20.91 31.50 89.96 21.05 -3.85 88.74 19.88 -2.61 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 4 3 # 4 B 158 ASP D 171 ASP^? 16.95 MG MG D 301 B 161 ARG D 173 ARG^? 18.88 MG MG D 301 B 186 HIS D 170 HIS^? 10.59 MG MG D 301 coo 44.53 16.44 28.54 44.89 18.45 28.77 100.39 36.69 -43.49 101.13 38.51 -42.69 coo 39.64 19.27 28.15 40.19 21.74 29.94 100.48 42.57 -42.43 101.55 40.79 -40.06 coo 48.32 20.00 31.44 46.45 20.91 31.50 95.57 34.81 -46.05 95.59 36.24 -47.59 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 5 3 # 5 B 158 ASP E 171 ASP^? 16.73 MG MG E 301 B 161 ARG E 173 ARG^? 18.66 MG MG E 301 B 186 HIS E 170 HIS^? 10.33 MG MG E 301 coo 44.53 16.44 28.54 44.89 18.45 28.77 69.61 73.12 -51.56 71.50 73.53 -52.39 coo 39.64 19.27 28.15 40.19 21.74 29.94 75.16 72.26 -52.56 73.67 73.54 -55.01 coo 48.32 20.00 31.44 46.45 20.91 31.50 66.96 68.76 -48.87 68.36 68.54 -47.33 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 6 3 # 6 B 158 ASP F 171 ASP^? 16.35 MG MG F 302 B 161 ARG F 173 ARG^? 18.61 MG MG F 302 B 186 HIS F 170 HIS^? 9.84 MG MG F 302 coo 44.53 16.44 28.54 44.89 18.45 28.77 48.23 68.08 -88.47 46.26 68.02 -87.56 coo 39.64 19.27 28.15 40.19 21.74 29.94 43.18 65.58 -86.96 44.06 67.55 -84.65 coo 48.32 20.00 31.44 46.45 20.91 31.50 52.25 64.82 -90.91 50.95 63.88 -92.26 4mdh_c03 source 4mdh CYTOPLASMIC MALATE DEHYDROGENASE (E.C.1.1.1.37: 6 hits 4mdh_c03 naa= 3 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 1 3 # 1 71 ARG C 37 ARG^? 19.01 MG MG C 302 127 ARG C 48 ARG^? 25.02 MG MG C 302 270 GLU C 52 GLU^? 19.67 MG MG C 302 coo -1.14 25.72 1.64 0.76 28.10 1.50 89.36 17.23 -17.57 89.29 20.20 -16.76 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 84.94 16.06 -21.53 85.81 13.55 -23.08 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 84.27 26.98 -19.19 85.21 26.16 -20.96 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 2 3 # 2 71 ARG C 48 ARG^? 25.02 MG MG C 302 127 ARG C 37 ARG^? 19.01 MG MG C 302 270 GLU C 52 GLU^? 19.67 MG MG C 302 coo -1.14 25.72 1.64 0.76 28.10 1.50 84.94 16.06 -21.53 85.81 13.55 -23.08 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 89.36 17.23 -17.57 89.29 20.20 -16.76 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 84.27 26.98 -19.19 85.21 26.16 -20.96 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 3 3 # 3 71 ARG D 37 ARG^? 18.81 MG MG D 302 127 ARG D 48 ARG^? 24.87 MG MG D 302 270 GLU D 52 GLU^? 19.94 MG MG D 302 coo -1.14 25.72 1.64 0.76 28.10 1.50 96.81 38.21 -31.63 94.97 36.32 -33.06 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 94.06 41.76 -28.37 96.24 43.38 -26.96 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 87.13 33.17 -30.97 88.40 33.70 -29.31 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 4 3 # 4 71 ARG D 48 ARG^? 24.87 MG MG D 302 127 ARG D 37 ARG^? 18.81 MG MG D 302 270 GLU D 52 GLU^? 19.94 MG MG D 302 coo -1.14 25.72 1.64 0.76 28.10 1.50 94.06 41.76 -28.37 96.24 43.38 -26.96 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 96.81 38.21 -31.63 94.97 36.32 -33.06 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 87.13 33.17 -30.97 88.40 33.70 -29.31 5cpa_c01 source 5cpa CARBOXYPEPTIDASE A=ALPHA= (COX) (E.C.3.4.17.1): 4 hits 5cpa_c01 naa= 3 ULMN 3 5rsa_c01 RIBONUCLEASE A user 1 3 # 1 12 HIS A 42 HIS^? 28.45 MG MG A 301 41 LYS A 166 LYS^? 20.93 MG MG A 302 119 HIS B 42 HIS^? 28.37 MG MG B 302 coo 28.18 18.67 11.43 28.83 17.39 9.89 34.62 18.32 19.57 34.29 16.25 19.41 coo 25.33 8.32 6.30 27.86 13.90 7.82 35.34 13.14 30.41 31.67 15.04 34.58 coo 33.68 19.99 5.35 34.98 18.36 5.19 39.34 12.99 16.30 37.26 13.24 16.40 ULMN 3 5rsa_c01 RIBONUCLEASE A user 2 3 # 2 12 HIS A 42 HIS^? 28.45 MG MG A 301 41 LYS B 6 LYS^? 25.90 MG MG B 302 119 HIS B 42 HIS^? 28.37 MG MG B 302 coo 28.18 18.67 11.43 28.83 17.39 9.89 34.62 18.32 19.57 34.29 16.25 19.41 coo 25.33 8.32 6.30 27.86 13.90 7.82 36.26 25.44 11.74 39.65 23.12 16.29 coo 33.68 19.99 5.35 34.98 18.36 5.19 39.34 12.99 16.30 37.26 13.24 16.40 ULMN 3 5rsa_c01 RIBONUCLEASE A user 3 3 # 3 12 HIS B 42 HIS^? 28.37 MG MG B 302 41 LYS A 6 LYS^? 25.88 MG MG A 301 119 HIS A 42 HIS^? 28.45 MG MG A 301 coo 28.18 18.67 11.43 28.83 17.39 9.89 39.34 12.99 16.30 37.26 13.24 16.40 coo 25.33 8.32 6.30 27.86 13.90 7.82 46.20 12.82 24.71 44.50 16.64 20.52 coo 33.68 19.99 5.35 34.98 18.36 5.19 34.62 18.32 19.57 34.29 16.25 19.41 ULMN 3 5rsa_c01 RIBONUCLEASE A user 4 3 # 4 12 HIS B 42 HIS^? 28.37 MG MG B 302 41 LYS B 166 LYS^? 22.75 MG MG B 301 119 HIS A 42 HIS^? 28.45 MG MG A 301 coo 28.18 18.67 11.43 28.83 17.39 9.89 39.34 12.99 16.30 37.26 13.24 16.40 coo 25.33 8.32 6.30 27.86 13.90 7.82 35.27 15.38 5.31 37.27 9.81 3.93 coo 33.68 19.99 5.35 34.98 18.36 5.19 34.62 18.32 19.57 34.29 16.25 19.41 ULMN 3 5rsa_c01 RIBONUCLEASE A user 5 3 # 5 12 HIS C 42 HIS^? 28.09 MG MG C 302 41 LYS C 166 LYS^? 22.53 MG MG C 301 119 HIS D 42 HIS^? 28.21 MG MG D 302 coo 28.18 18.67 11.43 28.83 17.39 9.89 95.93 22.96 -23.11 97.92 23.62 -23.02 coo 25.33 8.32 6.30 27.86 13.90 7.82 99.24 26.71 -12.25 100.23 21.90 -8.99 coo 33.68 19.99 5.35 34.98 18.36 5.19 98.45 29.90 -26.44 99.32 28.02 -26.13 ULMN 3 5rsa_c01 RIBONUCLEASE A user 6 3 # 6 12 HIS C 42 HIS^? 28.09 MG MG C 302 41 LYS D 6 LYS^? 25.98 MG MG D 302 119 HIS D 42 HIS^? 28.21 MG MG D 302 coo 28.18 18.67 11.43 28.83 17.39 9.89 95.93 22.96 -23.11 97.92 23.62 -23.02 coo 25.33 8.32 6.30 27.86 13.90 7.82 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 33.68 19.99 5.35 34.98 18.36 5.19 98.45 29.90 -26.44 99.32 28.02 -26.13 ULMN 3 5rsa_c01 RIBONUCLEASE A user 7 3 # 7 12 HIS D 42 HIS^? 28.21 MG MG D 302 41 LYS C 6 LYS^? 25.73 MG MG C 302 119 HIS C 42 HIS^? 28.09 MG MG C 302 coo 28.18 18.67 11.43 28.83 17.39 9.89 98.45 29.90 -26.44 99.32 28.02 -26.13 coo 25.33 8.32 6.30 27.86 13.90 7.82 94.42 35.68 -18.56 92.21 32.03 -23.05 coo 33.68 19.99 5.35 34.98 18.36 5.19 95.93 22.96 -23.11 97.92 23.62 -23.02 ULMN 3 5rsa_c01 RIBONUCLEASE A user 8 3 # 8 12 HIS D 42 HIS^? 28.21 MG MG D 302 41 LYS D 166 LYS^? 21.08 MG MG D 301 119 HIS C 42 HIS^? 28.09 MG MG C 302 coo 28.18 18.67 11.43 28.83 17.39 9.89 98.45 29.90 -26.44 99.32 28.02 -26.13 coo 25.33 8.32 6.30 27.86 13.90 7.82 99.23 24.85 -37.31 101.73 27.34 -42.07 coo 33.68 19.99 5.35 34.98 18.36 5.19 95.93 22.96 -23.11 97.92 23.62 -23.02 ULMN 3 5rsa_c01 RIBONUCLEASE A user 9 3 # 9 12 HIS E 42 HIS^? 28.20 MG MG E 302 41 LYS E 166 LYS^? 21.46 MG MG E 301 119 HIS F 42 HIS^? 28.34 MG MG F 301 coo 28.18 18.67 11.43 28.83 17.39 9.89 62.33 71.93 -68.30 60.54 72.96 -68.64 coo 25.33 8.32 6.30 27.86 13.90 7.82 57.66 73.57 -57.60 60.27 76.17 -53.59 coo 33.68 19.99 5.35 34.98 18.36 5.19 55.11 70.50 -71.64 56.29 72.22 -71.48 ULMN 3 5rsa_c01 RIBONUCLEASE A user 10 3 # 10 12 HIS E 42 HIS^? 28.20 MG MG E 302 41 LYS F 6 LYS^? 26.09 MG MG F 301 119 HIS F 42 HIS^? 28.34 MG MG F 301 coo 28.18 18.67 11.43 28.83 17.39 9.89 62.33 71.93 -68.30 60.54 72.96 -68.64 coo 25.33 8.32 6.30 27.86 13.90 7.82 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 33.68 19.99 5.35 34.98 18.36 5.19 55.11 70.50 -71.64 56.29 72.22 -71.48 ULMN 3 5rsa_c01 RIBONUCLEASE A user 11 3 # 11 12 HIS F 42 HIS^? 28.34 MG MG F 301 41 LYS E 6 LYS^? 25.59 MG MG E 302 119 HIS E 42 HIS^? 28.20 MG MG E 302 coo 28.18 18.67 11.43 28.83 17.39 9.89 55.11 70.50 -71.64 56.29 72.22 -71.48 coo 25.33 8.32 6.30 27.86 13.90 7.82 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 33.68 19.99 5.35 34.98 18.36 5.19 62.33 71.93 -68.30 60.54 72.96 -68.64 ULMN 3 5rsa_c01 RIBONUCLEASE A user 12 3 # 12 12 HIS F 42 HIS^? 28.34 MG MG F 301 41 LYS F 166 LYS^? 20.76 MG MG F 302 119 HIS E 42 HIS^? 28.20 MG MG E 302 coo 28.18 18.67 11.43 28.83 17.39 9.89 55.11 70.50 -71.64 56.29 72.22 -71.48 coo 25.33 8.32 6.30 27.86 13.90 7.82 59.28 73.05 -82.63 55.63 74.15 -86.94 coo 33.68 19.99 5.35 34.98 18.36 5.19 62.33 71.93 -68.30 60.54 72.96 -68.64 5rsa_c01 source 5rsa RIBONUCLEASE A : 12 hits 5rsa_c01 naa= 3 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 1 1 # 1 A 461 ASN A 3 ASN.? 30.14 MG MG B 302 coo 5.80 63.03 55.85 5.52 65.03 56.45 50.04 4.36 19.09 51.05 2.61 18.36 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 2 1 # 2 A 461 ASN A 45 ASN^? 24.62 MG MG B 302 coo 5.80 63.03 55.85 5.52 65.03 56.45 42.72 26.12 17.32 44.44 25.00 17.78 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 3 1 # 3 A 461 ASN A 69 ASN^? 19.68 MG MG A 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 46.77 28.40 23.46 47.19 29.97 22.08 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 4 1 # 4 A 461 ASN A 85 ASN^? 29.83 MG MG A 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 36.44 52.20 24.38 35.62 54.19 24.50 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 5 1 # 5 A 461 ASN A 95 ASN^? 11.82 MG MG A 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 53.15 30.26 34.15 54.71 31.63 34.63 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 6 1 # 6 A 461 ASN A 104 ASN^? 31.44 MG MG A 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 58.56 3.32 34.63 56.45 3.24 34.31 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 7 1 # 7 A 461 ASN A 118 ASN^? 13.27 MG MG A 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 43.06 39.25 33.60 42.05 40.75 32.42 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 8 1 # 8 A 461 ASN A 121 ASN^? 13.12 MG MG A 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 42.17 43.63 35.13 41.78 43.56 37.19 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 9 1 # 9 A 461 ASN A 132 ASN^? 16.38 MG MG A 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 50.16 14.55 39.76 50.61 16.24 40.93 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 10 1 # 10 A 461 ASN A 185 ASN^? -6.30 MG MG A 302s coo 5.80 63.03 55.85 5.52 65.03 56.45 46.32 28.07 47.82 46.06 28.58 49.86 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 11 1 # 11 A 461 ASN B 3 ASN^? 29.91 MG MG A 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 28.49 30.55 17.19 26.69 31.26 18.05 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 12 1 # 12 A 461 ASN B 45 ASN^? 24.27 MG MG A 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 47.87 19.20 19.75 47.40 21.26 19.77 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 13 1 # 13 A 461 ASN B 69 ASN^? 19.69 MG MG B 302 coo 5.80 63.03 55.85 5.52 65.03 56.45 51.67 23.38 14.25 53.20 23.05 15.64 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 14 1 # 14 A 461 ASN B 85 ASN^? 20.68 MG MG C 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 73.33 8.76 12.96 74.70 9.19 14.54 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 15 1 # 15 A 461 ASN B 95 ASN^? 11.72 MG MG B 302 coo 5.80 63.03 55.85 5.52 65.03 56.45 55.48 29.92 4.32 57.36 30.88 4.11 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 16 1 # 16 A 461 ASN B 104 ASN^? 29.09 MG MG B 302 coo 5.80 63.03 55.85 5.52 65.03 56.45 30.21 38.92 1.75 31.47 37.16 1.65 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 17 1 # 17 A 461 ASN B 118 ASN^? 13.44 MG MG B 302 coo 5.80 63.03 55.85 5.52 65.03 56.45 63.19 18.87 4.27 64.22 17.47 5.51 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 18 1 # 18 A 461 ASN B 121 ASN^? 13.37 MG MG B 302 coo 5.80 63.03 55.85 5.52 65.03 56.45 67.88 18.90 2.12 66.44 17.41 2.72 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 19 1 # 19 A 461 ASN B 132 ASN^? 16.42 MG MG B 302 coo 5.80 63.03 55.85 5.52 65.03 56.45 40.27 30.00 -2.76 41.98 31.07 -3.41 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 20 1 # 20 A 461 ASN B 185 ASN^? -7.05 MG MG B 301s coo 5.80 63.03 55.85 5.52 65.03 56.45 52.96 23.67 -10.63 54.00 24.89 -11.96 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 21 1 # 21 A 461 ASN C 3 ASN^? 29.15 MG MG D 302 coo 5.80 63.03 55.85 5.52 65.03 56.45 100.26 42.79 -23.94 100.99 44.40 -25.14 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 22 1 # 22 A 461 ASN C 45 ASN^? 24.54 MG MG C 302 coo 5.80 63.03 55.85 5.52 65.03 56.45 85.43 25.82 -26.31 85.43 27.91 -25.97 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 23 1 # 23 A 461 ASN C 69 ASN^? 19.30 MG MG C 302 coo 5.80 63.03 55.85 5.52 65.03 56.45 80.86 28.32 -20.51 79.46 27.66 -21.93 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 24 1 # 24 A 461 ASN C 85 ASN^? 21.44 MG MG B 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 65.37 7.26 -19.82 63.94 6.11 -20.94 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 25 1 # 25 A 461 ASN C 95 ASN^? 11.50 MG MG C 302 coo 5.80 63.03 55.85 5.52 65.03 56.45 75.34 33.15 -10.39 73.27 33.38 -10.21 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 26 1 # 26 A 461 ASN C 104 ASN^? 31.05 MG MG C 302 coo 5.80 63.03 55.85 5.52 65.03 56.45 95.09 52.36 -8.91 95.46 50.61 -7.90 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 27 1 # 27 A 461 ASN C 118 ASN^? 13.08 MG MG C 302 coo 5.80 63.03 55.85 5.52 65.03 56.45 72.64 19.83 -10.69 72.07 18.17 -11.94 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 28 1 # 28 A 461 ASN C 121 ASN^? 13.53 MG MG C 302 coo 5.80 63.03 55.85 5.52 65.03 56.45 69.55 17.44 -9.40 69.18 16.30 -7.63 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 29 1 # 29 A 461 ASN C 132 ASN^? 16.52 MG MG C 302 coo 5.80 63.03 55.85 5.52 65.03 56.45 89.66 38.54 -3.77 87.74 38.77 -2.97 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 30 1 # 30 A 461 ASN C 185 ASN^? -7.11 MG MG C 301s coo 5.80 63.03 55.85 5.52 65.03 56.45 80.06 27.66 4.46 78.78 28.93 5.51 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 31 1 # 31 A 461 ASN D 3 ASN^? 28.85 MG MG C 302 coo 5.80 63.03 55.85 5.52 65.03 56.45 89.53 11.43 -25.56 88.66 9.94 -24.30 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 32 1 # 32 A 461 ASN D 45 ASN^? 24.33 MG MG C 302 coo 5.80 63.03 55.85 5.52 65.03 56.45 88.35 34.04 -23.87 86.82 32.62 -24.25 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 33 1 # 33 A 461 ASN D 69 ASN^? 19.77 MG MG D 302 coo 5.80 63.03 55.85 5.52 65.03 56.45 83.26 34.94 -29.76 82.66 36.44 -28.44 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 34 1 # 34 A 461 ASN D 85 ASN^? 20.22 MG MG E 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 84.79 61.03 -31.29 84.23 62.62 -30.02 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 35 1 # 35 A 461 ASN D 95 ASN^? 12.56 MG MG D 302 coo 5.80 63.03 55.85 5.52 65.03 56.45 76.36 34.77 -40.14 74.34 35.29 -40.63 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 36 1 # 36 A 461 ASN D 104 ASN^? 31.04 MG MG D 302 coo 5.80 63.03 55.85 5.52 65.03 56.45 80.93 7.65 -41.49 82.88 8.50 -41.33 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 37 1 # 37 A 461 ASN D 118 ASN^? 13.31 MG MG D 302 coo 5.80 63.03 55.85 5.52 65.03 56.45 82.29 46.70 -39.94 83.03 48.22 -38.68 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 38 1 # 38 A 461 ASN D 121 ASN^? 14.25 MG MG E 302 coo 5.80 63.03 55.85 5.52 65.03 56.45 80.38 49.72 -41.99 81.55 51.54 -42.09 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 39 1 # 39 A 461 ASN D 132 ASN^? 16.46 MG MG D 302 coo 5.80 63.03 55.85 5.52 65.03 56.45 84.64 21.31 -46.24 83.02 22.38 -47.10 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 40 1 # 40 A 461 ASN D 185 ASN^? -7.02 MG MG D 301s coo 5.80 63.03 55.85 5.52 65.03 56.45 83.84 35.36 -54.61 82.18 35.66 -55.90 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 41 1 # 41 A 461 ASN E 3 ASN^? 30.27 MG MG F 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 42.47 65.36 -68.69 40.59 66.02 -69.39 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 42 1 # 42 A 461 ASN E 45 ASN^? 24.46 MG MG F 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 64.97 61.33 -71.05 63.29 60.06 -70.79 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 43 1 # 43 A 461 ASN E 69 ASN^? 19.64 MG MG E 302 coo 5.80 63.03 55.85 5.52 65.03 56.45 65.28 56.38 -64.89 66.38 55.27 -66.29 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 44 1 # 44 A 461 ASN E 85 ASN^? 18.39 MG MG D 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 90.97 53.37 -63.23 89.62 51.76 -63.71 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 45 1 # 45 A 461 ASN E 95 ASN^? 11.73 MG MG E 302 coo 5.80 63.03 55.85 5.52 65.03 56.45 63.77 49.77 -54.50 64.30 47.82 -53.94 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 46 1 # 46 A 461 ASN E 104 ASN^? 31.37 MG MG E 302 coo 5.80 63.03 55.85 5.52 65.03 56.45 37.10 58.10 -53.77 38.39 59.70 -53.28 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 47 1 # 47 A 461 ASN E 118 ASN^? 13.13 MG MG E 302 coo 5.80 63.03 55.85 5.52 65.03 56.45 76.50 53.47 -54.63 78.11 53.97 -55.93 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 48 1 # 48 A 461 ASN E 121 ASN^? 13.28 MG MG E 302 coo 5.80 63.03 55.85 5.52 65.03 56.45 80.31 53.55 -53.29 81.18 54.02 -51.40 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 49 1 # 49 A 461 ASN E 132 ASN^? 16.39 MG MG E 302 coo 5.80 63.03 55.85 5.52 65.03 56.45 51.80 60.19 -48.38 52.68 58.51 -47.42 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 50 1 # 50 A 461 ASN E 185 ASN^? -7.20 MG MG E 301s coo 5.80 63.03 55.85 5.52 65.03 56.45 65.70 57.16 -40.06 65.41 55.24 -39.19 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 51 1 # 51 A 461 ASN F 3 ASN^? 30.46 MG MG E 302 coo 5.80 63.03 55.85 5.52 65.03 56.45 76.18 71.56 -71.39 78.06 72.28 -70.84 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 52 1 # 52 A 461 ASN F 45 ASN^? 24.43 MG MG E 302 coo 5.80 63.03 55.85 5.52 65.03 56.45 56.42 59.79 -68.43 58.48 59.32 -68.69 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 53 1 # 53 A 461 ASN F 69 ASN^? 19.72 MG MG F 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 58.04 54.70 -74.12 56.99 53.50 -72.70 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 54 1 # 54 A 461 ASN F 85 ASN^? 27.49 MG MG F 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 34.36 43.15 -75.19 36.11 42.05 -74.56 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 55 1 # 55 A 461 ASN F 95 ASN^? 12.10 MG MG F 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 61.81 48.42 -84.18 62.16 46.40 -84.52 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 56 1 # 56 A 461 ASN F 104 ASN^? 31.05 MG MG F 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 83.41 64.36 -86.23 81.96 65.80 -86.83 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 57 1 # 57 A 461 ASN F 118 ASN^? 13.34 MG MG F 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 48.40 47.22 -84.16 46.70 46.61 -82.99 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 58 1 # 58 A 461 ASN F 121 ASN^? 13.88 MG MG F 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 46.01 43.34 -85.92 45.76 42.32 -87.80 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 59 1 # 59 A 461 ASN F 132 ASN^? 16.48 MG MG F 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 69.23 61.88 -90.93 69.10 59.95 -91.77 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 60 1 # 60 A 461 ASN F 185 ASN^? -7.32 MG MG F 302s coo 5.80 63.03 55.85 5.52 65.03 56.45 57.56 53.83 -98.77 57.78 52.28-100.18 1kbk_p00 source 1kbk ALPHA-AMYLASE, PANCREATIC : 60 hits 1kbk_p00 naa= 1 ULMN 4 1kqr_p00 VP4 user 1 4 # 1 A 101 ARG A 37 ARG^? 18.99 MG MG A 301 A 187 LYS B 61 LYS^? 22.03 MG MG A 301 A 188 TYR B 60 TYR^? 27.11 MG MG A 301 A 190 SER A 36 SER^? 23.25 MG MG A 301 coo 10.93 40.49 13.39 9.72 39.25 15.90 32.99 26.50 25.19 35.50 25.33 26.51 coo 2.71 31.72 11.75 7.91 29.74 9.11 32.50 37.62 17.61 36.68 34.92 21.51 coo 1.39 36.04 13.60 -0.23 35.82 15.85 28.84 35.27 19.49 28.03 36.56 21.83 coo 4.80 41.21 15.27 3.05 40.92 16.89 29.88 32.10 25.40 29.53 34.39 24.57 ULMN 4 1kqr_p00 VP4 user 2 4 # 2 A 101 ARG B 37 ARG^? 19.17 MG MG B 302 A 187 LYS A 61 LYS^? 21.99 MG MG B 302 A 188 TYR A 60 TYR^? 27.11 MG MG B 302 A 190 SER B 36 SER^? 24.04 MG MG B 302 coo 10.93 40.49 13.39 9.72 39.25 15.90 47.41 10.20 11.40 46.99 12.91 10.22 coo 2.71 31.72 11.75 7.91 29.74 9.11 57.78 7.35 19.60 56.77 12.20 15.61 coo 1.39 36.04 13.60 -0.23 35.82 15.85 55.01 4.24 16.98 56.13 3.24 14.65 coo 4.80 41.21 15.27 3.05 40.92 16.89 52.58 6.45 11.01 53.61 4.84 12.41 ULMN 4 1kqr_p00 VP4 user 3 4 # 3 A 101 ARG C 37 ARG^? 19.01 MG MG C 302 A 187 LYS D 61 LYS^? 21.93 MG MG C 302 A 188 TYR D 60 TYR^? 26.93 MG MG C 302 A 190 SER C 36 SER^? 23.69 MG MG C 302 coo 10.93 40.49 13.39 9.72 39.25 15.90 89.36 17.23 -17.57 89.29 20.20 -16.76 coo 2.71 31.72 11.75 7.91 29.74 9.11 80.64 11.23 -26.16 80.65 16.24 -22.36 coo 1.39 36.04 13.60 -0.23 35.82 15.85 84.40 9.28 -23.74 83.45 7.90 -21.49 coo 4.80 41.21 15.27 3.05 40.92 16.89 86.07 12.19 -17.80 85.34 10.22 -18.98 ULMN 4 1kqr_p00 VP4 user 4 4 # 4 A 101 ARG D 37 ARG^? 18.81 MG MG D 302 A 187 LYS C 61 LYS^? 21.91 MG MG D 302 A 188 TYR C 60 TYR^? 26.95 MG MG D 302 A 190 SER D 36 SER^? 22.42 MG MG D 302 coo 10.93 40.49 13.39 9.72 39.25 15.90 96.81 38.21 -31.63 94.97 36.32 -33.06 coo 2.71 31.72 11.75 7.91 29.74 9.11 93.60 48.56 -24.05 90.39 44.71 -27.98 coo 1.39 36.04 13.60 -0.23 35.82 15.85 97.75 47.69 -25.92 97.82 49.25 -28.26 coo 4.80 41.21 15.27 3.05 40.92 16.89 97.85 44.42 -32.20 96.60 46.20 -31.15 ULMN 4 1kqr_p00 VP4 user 5 4 # 5 A 101 ARG E 37 ARG^? 19.17 MG MG E 302 A 187 LYS F 61 LYS^? 21.75 MG MG E 302 A 188 TYR F 60 TYR^? 27.07 MG MG E 302 A 190 SER E 36 SER^? 22.92 MG MG E 302 coo 10.93 40.49 13.39 9.72 39.25 15.90 70.82 68.02 -63.63 68.17 67.46 -62.14 coo 2.71 31.72 11.75 7.91 29.74 9.11 80.24 64.12 -71.01 76.23 61.95 -66.39 coo 1.39 36.04 13.60 -0.23 35.82 15.85 79.79 68.64 -68.89 81.11 68.86 -66.46 coo 4.80 41.21 15.27 3.05 40.92 16.89 76.63 69.18 -62.93 78.20 67.77 -64.11 ULMN 4 1kqr_p00 VP4 user 6 4 # 6 A 101 ARG F 37 ARG^? 19.14 MG MG F 301 A 187 LYS E 61 LYS^? 22.16 MG MG F 301 A 188 TYR E 60 TYR^? 27.19 MG MG F 301 A 190 SER F 36 SER^? 23.07 MG MG F 301 coo 10.93 40.49 13.39 9.72 39.25 15.90 48.80 64.46 -76.37 51.50 64.15 -77.79 coo 2.71 31.72 11.75 7.91 29.74 9.11 40.99 56.84 -68.48 45.99 56.72 -72.39 coo 1.39 36.04 13.60 -0.23 35.82 15.85 39.82 61.07 -70.68 38.29 60.72 -72.98 coo 4.80 41.21 15.27 3.05 40.92 16.89 42.79 62.77 -76.96 42.19 61.23 -75.17 1kqr_p00 source 1kqr VP4 : 6 hits 1kqr_p00 naa= 4 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 1 3 # 1 A 56 TYR C 123 TYR^? 10.31 MG MG B 302 A 112 PHE B 32 PHE^? 15.77 MG MG B 302 A 140 ASN B 118 ASN^? 13.44 MG MG B 302 coo -6.29 44.15 17.65 -9.00 44.92 17.68 65.55 16.66 -3.72 62.85 15.86 -3.85 coo -7.38 52.77 16.75 -5.54 52.71 18.82 63.68 12.44 5.83 65.90 13.72 4.72 coo -4.46 50.64 12.29 -5.69 49.89 13.85 63.19 18.87 4.27 64.22 17.47 5.51 1o8s_p00 source 1o8s PUTATIVE ENDO-XYLANASE : 1 hits 1o8s_p00 naa= 3 ULMN 4 1qfw_p00 GONADOTROPIN ALPHA SUBUNIT user 1 4 # 1 A 25 ILE A 4 ILE^? 27.80 MG MG B 302 A 52 ASN C 85 ASN^? 21.44 MG MG B 301 A 53 VAL C 77 VAL^? 19.30 MG MG B 301 A 78 ASN A 3 ASN.? 30.14 MG MG B 302 coo 71.59 -7.22 17.04 71.86 -6.51 15.90 48.54 8.78 19.99 48.80 9.70 19.10 coo 81.20 29.47 37.49 79.47 28.44 38.24 65.37 7.26 -19.82 63.94 6.11 -20.94 coo 82.17 24.86 36.27 81.03 23.67 37.80 68.24 6.87 -15.11 66.49 7.98 -14.47 coo 75.27 -4.71 13.39 75.98 -6.45 14.35 50.04 4.36 19.09 51.05 2.61 18.36 ULMN 4 1qfw_p00 GONADOTROPIN ALPHA SUBUNIT user 2 4 # 2 A 25 ILE C 4 ILE^? 27.97 MG MG D 302 A 52 ASN E 85 ASN^? 18.39 MG MG D 301 A 53 VAL E 77 VAL^? 18.80 MG MG D 301 A 78 ASN C 3 ASN^? 29.15 MG MG D 302 coo 71.59 -7.22 17.04 71.86 -6.51 15.90 97.33 39.55 -22.94 95.80 39.66 -23.34 coo 81.20 29.47 37.49 79.47 28.44 38.24 90.97 53.37 -63.23 89.62 51.76 -63.71 coo 82.17 24.86 36.27 81.03 23.67 37.80 90.04 56.55 -59.07 89.97 54.63 -58.04 coo 75.27 -4.71 13.39 75.98 -6.45 14.35 100.26 42.79 -23.94 100.99 44.40 -25.14 ULMN 4 1qfw_p00 GONADOTROPIN ALPHA SUBUNIT user 3 4 # 3 A 25 ILE D 4 ILE^? 27.61 MG MG C 302 A 52 ASN B 85 ASN^? 20.68 MG MG C 301 A 53 VAL B 77 VAL^? 19.17 MG MG C 301 A 78 ASN D 3 ASN^? 28.85 MG MG C 302 coo 71.59 -7.22 17.04 71.86 -6.51 15.90 88.19 15.57 -26.88 88.32 16.65 -25.93 coo 81.20 29.47 37.49 79.47 28.44 38.24 73.33 8.76 12.96 74.70 9.19 14.54 coo 82.17 24.86 36.27 81.03 23.67 37.80 71.13 7.26 8.54 72.49 8.75 7.68 coo 75.27 -4.71 13.39 75.98 -6.45 14.35 89.53 11.43 -25.56 88.66 9.94 -24.30 ULMN 4 1qfw_p00 GONADOTROPIN ALPHA SUBUNIT user 4 4 # 4 A 25 ILE F 4 ILE^? 27.98 MG MG E 302 A 52 ASN D 85 ASN^? 20.22 MG MG E 301 A 53 VAL D 77 VAL^? 18.56 MG MG E 301 A 78 ASN F 3 ASN^? 30.46 MG MG E 302 coo 71.59 -7.22 17.04 71.86 -6.51 15.90 72.14 69.20 -71.98 71.56 68.16 -71.16 coo 81.20 29.47 37.49 79.47 28.44 38.24 84.79 61.03 -31.29 84.23 62.62 -30.02 coo 82.17 24.86 36.27 81.03 23.67 37.80 87.45 59.70 -35.75 85.53 60.01 -36.78 coo 75.27 -4.71 13.39 75.98 -6.45 14.35 76.18 71.56 -71.39 78.06 72.28 -70.84 1qfw_p00 source 1qfw GONADOTROPIN ALPHA SUBUNIT : 4 hits 1qfw_p00 naa= 4 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 1 3 # 1 A 44 ASN A 118 ASN^? 13.27 MG MG A 301 A 213 PRO A 119 PRO^? 14.31 MG MG A 301 A 219 ASN A 95 ASN^? 11.82 MG MG A 301 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 43.06 39.25 33.60 42.05 40.75 32.42 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 45.83 39.92 29.07 46.23 40.45 31.16 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 53.15 30.26 34.15 54.71 31.63 34.63 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 2 3 # 2 A 44 ASN B 118 ASN^? 13.44 MG MG B 302 A 213 PRO B 119 PRO^? 14.64 MG MG B 302 A 219 ASN B 95 ASN^? 11.72 MG MG B 302 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 63.19 18.87 4.27 64.22 17.47 5.51 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 63.65 20.51 9.24 64.36 21.39 7.30 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 55.48 29.92 4.32 57.36 30.88 4.11 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 3 3 # 3 A 44 ASN C 118 ASN^? 13.08 MG MG C 302 A 213 PRO C 119 PRO^? 14.18 MG MG C 302 A 219 ASN C 95 ASN^? 11.50 MG MG C 302 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 72.64 19.83 -10.69 72.07 18.17 -11.94 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 70.85 21.90 -15.48 70.06 21.91 -13.40 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 75.34 33.15 -10.39 73.27 33.38 -10.21 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 4 3 # 4 A 44 ASN D 118 ASN^? 13.31 MG MG D 302 A 213 PRO D 119 PRO^? 14.74 MG MG D 302 A 219 ASN D 95 ASN^? 12.56 MG MG D 302 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 82.29 46.70 -39.94 83.03 48.22 -38.68 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 79.79 46.26 -35.22 79.03 46.66 -37.29 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 76.36 34.77 -40.14 74.34 35.29 -40.63 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 5 3 # 5 A 44 ASN E 118 ASN^? 13.13 MG MG E 302 A 213 PRO E 119 PRO^? 14.53 MG MG E 302 A 219 ASN E 95 ASN^? 11.73 MG MG E 302 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 76.50 53.47 -54.63 78.11 53.97 -55.93 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 75.96 51.35 -59.42 76.19 50.48 -57.34 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 63.77 49.77 -54.50 64.30 47.82 -53.94 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 6 3 # 6 A 44 ASN F 118 ASN^? 13.34 MG MG F 301 A 213 PRO F 119 PRO^? 14.46 MG MG F 301 A 219 ASN F 95 ASN^? 12.10 MG MG F 301 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 48.40 47.22 -84.16 46.70 46.61 -82.99 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 49.63 46.31 -79.28 50.07 45.00 -81.03 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 61.81 48.42 -84.18 62.16 46.40 -84.52 1wbf_p00 source 1wbf PROTEIN (AGGLUTININ) : 6 hits 1wbf_p00 naa= 3 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 1 3 # 1 A 26 HIS B 147 HIS^? 9.27 MG MG B 301 A 76 ASN B 185 ASN^? -7.05 MG MG B 301s A 81 ASP B 187 ASP^? -3.44 MG MG B 301s coo 4.09 43.69 67.89 2.45 42.40 68.10 46.73 18.97 -3.05 45.63 17.32 -3.73 coo 4.75 48.17 75.81 4.99 47.30 77.74 52.96 23.67 -10.63 54.00 24.89 -11.96 coo 0.57 50.41 73.18 0.46 48.28 73.56 50.64 18.14 -9.69 51.74 17.63 -7.86 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 2 3 # 2 A 26 HIS F 147 HIS^? 8.79 MG MG F 302 A 76 ASN F 185 ASN^? -7.32 MG MG F 302s A 81 ASP F 187 ASP^? -3.27 MG MG F 302s coo 4.09 43.69 67.89 2.45 42.40 68.10 56.63 61.66 -91.16 55.69 63.43 -91.80 coo 4.75 48.17 75.81 4.99 47.30 77.74 57.56 53.83 -98.77 57.78 52.28-100.18 coo 0.57 50.41 73.18 0.46 48.28 73.56 53.93 58.87 -98.14 52.45 58.62 -96.61 2c3x_p00 source 2c3x ALPHA-AMYLASE G-6 : 2 hits 2c3x_p00 naa= 3 ULMN 3 2p3i_p00 VP4 user 1 3 # 1 A 101 ARG A 37 ARG^? 18.99 MG MG A 301 A 188 TYR B 60 TYR^? 27.11 MG MG A 301 A 190 SER A 36 SER^? 23.25 MG MG A 301 coo 37.69 7.64 13.51 38.82 8.84 16.11 32.99 26.50 25.19 35.50 25.33 26.51 coo 47.14 12.10 13.73 48.75 12.33 16.01 28.84 35.27 19.49 28.03 36.56 21.83 coo 43.77 6.93 15.46 45.49 7.21 17.11 29.88 32.10 25.40 29.53 34.39 24.57 ULMN 3 2p3i_p00 VP4 user 2 3 # 2 A 101 ARG B 37 ARG^? 19.17 MG MG B 302 A 188 TYR A 60 TYR^? 27.11 MG MG B 302 A 190 SER B 36 SER^? 24.04 MG MG B 302 coo 37.69 7.64 13.51 38.82 8.84 16.11 47.41 10.20 11.40 46.99 12.91 10.22 coo 47.14 12.10 13.73 48.75 12.33 16.01 55.01 4.24 16.98 56.13 3.24 14.65 coo 43.77 6.93 15.46 45.49 7.21 17.11 52.58 6.45 11.01 53.61 4.84 12.41 ULMN 3 2p3i_p00 VP4 user 3 3 # 3 A 101 ARG C 37 ARG^? 19.01 MG MG C 302 A 188 TYR D 60 TYR^? 26.93 MG MG C 302 A 190 SER C 36 SER^? 23.69 MG MG C 302 coo 37.69 7.64 13.51 38.82 8.84 16.11 89.36 17.23 -17.57 89.29 20.20 -16.76 coo 47.14 12.10 13.73 48.75 12.33 16.01 84.40 9.28 -23.74 83.45 7.90 -21.49 coo 43.77 6.93 15.46 45.49 7.21 17.11 86.07 12.19 -17.80 85.34 10.22 -18.98 ULMN 3 2p3i_p00 VP4 user 4 3 # 4 A 101 ARG D 37 ARG^? 18.81 MG MG D 302 A 188 TYR C 60 TYR^? 26.95 MG MG D 302 A 190 SER D 36 SER^? 22.42 MG MG D 302 coo 37.69 7.64 13.51 38.82 8.84 16.11 96.81 38.21 -31.63 94.97 36.32 -33.06 coo 47.14 12.10 13.73 48.75 12.33 16.01 97.75 47.69 -25.92 97.82 49.25 -28.26 coo 43.77 6.93 15.46 45.49 7.21 17.11 97.85 44.42 -32.20 96.60 46.20 -31.15 ULMN 3 2p3i_p00 VP4 user 5 3 # 5 A 101 ARG E 8 ARG^? 20.19 MG MG E 302 A 188 TYR E 129 TYR^? 10.89 MG MG E 302 A 190 SER E 10 SER^? 16.92 MG MG E 302 coo 37.69 7.64 13.51 38.82 8.84 16.11 60.42 66.09 -63.48 62.84 64.38 -64.17 coo 47.14 12.10 13.73 48.75 12.33 16.01 62.09 60.15 -52.83 61.47 59.53 -55.45 coo 43.77 6.93 15.46 45.49 7.21 17.11 64.47 64.04 -59.12 65.96 65.01 -60.83 ULMN 3 2p3i_p00 VP4 user 6 3 # 6 A 101 ARG E 37 ARG^? 19.17 MG MG E 302 A 188 TYR F 60 TYR^? 27.07 MG MG E 302 A 190 SER E 36 SER^? 22.92 MG MG E 302 coo 37.69 7.64 13.51 38.82 8.84 16.11 70.82 68.02 -63.63 68.17 67.46 -62.14 coo 47.14 12.10 13.73 48.75 12.33 16.01 79.79 68.64 -68.89 81.11 68.86 -66.46 coo 43.77 6.93 15.46 45.49 7.21 17.11 76.63 69.18 -62.93 78.20 67.77 -64.11 ULMN 3 2p3i_p00 VP4 user 7 3 # 7 A 101 ARG F 8 ARG^? 20.20 MG MG F 301 A 188 TYR F 129 TYR^? 10.92 MG MG F 301 A 190 SER F 10 SER^? 16.76 MG MG F 301 coo 37.69 7.64 13.51 38.82 8.84 16.11 58.98 65.22 -76.31 57.29 62.84 -75.38 coo 47.14 12.10 13.73 48.75 12.33 16.01 59.69 58.61 -86.67 60.36 58.48 -83.96 coo 43.77 6.93 15.46 45.49 7.21 17.11 56.13 61.85 -80.66 54.44 62.39 -79.08 ULMN 3 2p3i_p00 VP4 user 8 3 # 8 A 101 ARG F 37 ARG^? 19.14 MG MG F 301 A 188 TYR E 60 TYR^? 27.19 MG MG F 301 A 190 SER F 36 SER^? 23.07 MG MG F 301 coo 37.69 7.64 13.51 38.82 8.84 16.11 48.80 64.46 -76.37 51.50 64.15 -77.79 coo 47.14 12.10 13.73 48.75 12.33 16.01 39.82 61.07 -70.68 38.29 60.72 -72.98 coo 43.77 6.93 15.46 45.49 7.21 17.11 42.79 62.77 -76.96 42.19 61.23 -75.17 2p3i_p00 source 2p3i VP4 : 8 hits 2p3i_p00 naa= 3 ULMN 4 2p3k_p00 VP4 user 1 4 # 1 A 101 ARG A 37 ARG^? 18.99 MG MG A 301 A 187 LYS B 61 LYS^? 22.03 MG MG A 301 A 188 TYR B 60 TYR^? 27.11 MG MG A 301 A 190 SER A 36 SER^? 23.25 MG MG A 301 coo 37.00 7.53 13.18 38.22 8.80 15.70 32.99 26.50 25.19 35.50 25.33 26.51 coo 45.42 16.25 11.76 45.82 18.39 15.98 32.50 37.62 17.61 36.68 34.92 21.51 coo 46.58 11.94 13.55 48.24 12.22 15.76 28.84 35.27 19.49 28.03 36.56 21.83 coo 43.09 6.80 15.14 44.84 7.11 16.79 29.88 32.10 25.40 29.53 34.39 24.57 ULMN 4 2p3k_p00 VP4 user 2 4 # 2 A 101 ARG B 37 ARG^? 19.17 MG MG B 302 A 187 LYS A 61 LYS^? 21.99 MG MG B 302 A 188 TYR A 60 TYR^? 27.11 MG MG B 302 A 190 SER B 36 SER^? 24.04 MG MG B 302 coo 37.00 7.53 13.18 38.22 8.80 15.70 47.41 10.20 11.40 46.99 12.91 10.22 coo 45.42 16.25 11.76 45.82 18.39 15.98 57.78 7.35 19.60 56.77 12.20 15.61 coo 46.58 11.94 13.55 48.24 12.22 15.76 55.01 4.24 16.98 56.13 3.24 14.65 coo 43.09 6.80 15.14 44.84 7.11 16.79 52.58 6.45 11.01 53.61 4.84 12.41 ULMN 4 2p3k_p00 VP4 user 3 4 # 3 A 101 ARG C 37 ARG^? 19.01 MG MG C 302 A 187 LYS D 61 LYS^? 21.93 MG MG C 302 A 188 TYR D 60 TYR^? 26.93 MG MG C 302 A 190 SER C 36 SER^? 23.69 MG MG C 302 coo 37.00 7.53 13.18 38.22 8.80 15.70 89.36 17.23 -17.57 89.29 20.20 -16.76 coo 45.42 16.25 11.76 45.82 18.39 15.98 80.64 11.23 -26.16 80.65 16.24 -22.36 coo 46.58 11.94 13.55 48.24 12.22 15.76 84.40 9.28 -23.74 83.45 7.90 -21.49 coo 43.09 6.80 15.14 44.84 7.11 16.79 86.07 12.19 -17.80 85.34 10.22 -18.98 ULMN 4 2p3k_p00 VP4 user 4 4 # 4 A 101 ARG D 37 ARG^? 18.81 MG MG D 302 A 187 LYS C 61 LYS^? 21.91 MG MG D 302 A 188 TYR C 60 TYR^? 26.95 MG MG D 302 A 190 SER D 36 SER^? 22.42 MG MG D 302 coo 37.00 7.53 13.18 38.22 8.80 15.70 96.81 38.21 -31.63 94.97 36.32 -33.06 coo 45.42 16.25 11.76 45.82 18.39 15.98 93.60 48.56 -24.05 90.39 44.71 -27.98 coo 46.58 11.94 13.55 48.24 12.22 15.76 97.75 47.69 -25.92 97.82 49.25 -28.26 coo 43.09 6.80 15.14 44.84 7.11 16.79 97.85 44.42 -32.20 96.60 46.20 -31.15 ULMN 4 2p3k_p00 VP4 user 5 4 # 5 A 101 ARG E 37 ARG^? 19.17 MG MG E 302 A 187 LYS F 61 LYS^? 21.75 MG MG E 302 A 188 TYR F 60 TYR^? 27.07 MG MG E 302 A 190 SER E 36 SER^? 22.92 MG MG E 302 coo 37.00 7.53 13.18 38.22 8.80 15.70 70.82 68.02 -63.63 68.17 67.46 -62.14 coo 45.42 16.25 11.76 45.82 18.39 15.98 80.24 64.12 -71.01 76.23 61.95 -66.39 coo 46.58 11.94 13.55 48.24 12.22 15.76 79.79 68.64 -68.89 81.11 68.86 -66.46 coo 43.09 6.80 15.14 44.84 7.11 16.79 76.63 69.18 -62.93 78.20 67.77 -64.11 ULMN 4 2p3k_p00 VP4 user 6 4 # 6 A 101 ARG F 37 ARG^? 19.14 MG MG F 301 A 187 LYS E 61 LYS^? 22.16 MG MG F 301 A 188 TYR E 60 TYR^? 27.19 MG MG F 301 A 190 SER F 36 SER^? 23.07 MG MG F 301 coo 37.00 7.53 13.18 38.22 8.80 15.70 48.80 64.46 -76.37 51.50 64.15 -77.79 coo 45.42 16.25 11.76 45.82 18.39 15.98 40.99 56.84 -68.48 45.99 56.72 -72.39 coo 46.58 11.94 13.55 48.24 12.22 15.76 39.82 61.07 -70.68 38.29 60.72 -72.98 coo 43.09 6.80 15.14 44.84 7.11 16.79 42.79 62.77 -76.96 42.19 61.23 -75.17 2p3k_p00 source 2p3k VP4 : 6 hits 2p3k_p00 naa= 4 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 1 3 # 1 A 270 ASN A 3 ASN.? 30.14 MG MG B 302 A 384 ASN A 45 ASN^? 24.62 MG MG B 302 A 385 GLU B 54 GLU^? 22.94 MG MG B 302 coo 22.28 63.17 110.61 22.47 65.06 111.53 50.04 4.36 19.09 51.05 2.61 18.36 coo 7.06 50.07 96.17 8.50 48.54 96.31 42.72 26.12 17.32 44.44 25.00 17.78 coo 11.59 49.83 99.41 10.92 47.97 100.16 43.18 23.27 12.99 42.40 22.23 14.68 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 2 3 # 2 A 270 ASN A 69 ASN^? 19.68 MG MG A 301 A 384 ASN A 85 ASN^? 29.83 MG MG A 301 A 385 GLU A 75 GLU^? 20.23 MG MG A 301 coo 22.28 63.17 110.61 22.47 65.06 111.53 46.77 28.40 23.46 47.19 29.97 22.08 coo 7.06 50.07 96.17 8.50 48.54 96.31 36.44 52.20 24.38 35.62 54.19 24.50 coo 11.59 49.83 99.41 10.92 47.97 100.16 38.99 46.65 28.68 39.94 47.65 30.33 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 3 3 # 3 A 270 ASN A 118 ASN^? 13.27 MG MG A 301 A 384 ASN B 45 ASN^? 24.27 MG MG A 301 A 385 GLU A 54 GLU^? 22.98 MG MG A 301 coo 22.28 63.17 110.61 22.47 65.06 111.53 43.06 39.25 33.60 42.05 40.75 32.42 coo 7.06 50.07 96.17 8.50 48.54 96.31 47.87 19.20 19.75 47.40 21.26 19.77 coo 11.59 49.83 99.41 10.92 47.97 100.16 45.06 19.97 24.02 44.05 19.39 22.19 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 4 3 # 4 A 270 ASN A 121 ASN^? 13.12 MG MG A 301 A 384 ASN A 45 ASN^? 24.62 MG MG B 302 A 385 GLU A 52 GLU^? 19.89 MG MG A 301 coo 22.28 63.17 110.61 22.47 65.06 111.53 42.17 43.63 35.13 41.78 43.56 37.19 coo 7.06 50.07 96.17 8.50 48.54 96.31 42.72 26.12 17.32 44.44 25.00 17.78 coo 11.59 49.83 99.41 10.92 47.97 100.16 42.67 25.16 24.80 42.61 25.77 22.75 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 5 3 # 5 A 270 ASN A 132 ASN^? 16.38 MG MG A 301 A 384 ASN A 45 ASN^? 24.62 MG MG B 302 A 385 GLU A 52 GLU^? 19.89 MG MG A 301 coo 22.28 63.17 110.61 22.47 65.06 111.53 50.16 14.55 39.76 50.61 16.24 40.93 coo 7.06 50.07 96.17 8.50 48.54 96.31 42.72 26.12 17.32 44.44 25.00 17.78 coo 11.59 49.83 99.41 10.92 47.97 100.16 42.67 25.16 24.80 42.61 25.77 22.75 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 6 3 # 6 A 270 ASN B 3 ASN^? 29.91 MG MG A 301 A 384 ASN A 85 ASN^? 29.83 MG MG A 301 A 385 GLU A 75 GLU^? 20.23 MG MG A 301 coo 22.28 63.17 110.61 22.47 65.06 111.53 28.49 30.55 17.19 26.69 31.26 18.05 coo 7.06 50.07 96.17 8.50 48.54 96.31 36.44 52.20 24.38 35.62 54.19 24.50 coo 11.59 49.83 99.41 10.92 47.97 100.16 38.99 46.65 28.68 39.94 47.65 30.33 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 7 3 # 7 A 270 ASN B 69 ASN^? 19.69 MG MG B 302 A 384 ASN B 85 ASN^? 20.68 MG MG C 301 A 385 GLU B 75 GLU^? 15.82 MG MG C 301 coo 22.28 63.17 110.61 22.47 65.06 111.53 51.67 23.38 14.25 53.20 23.05 15.64 coo 7.06 50.07 96.17 8.50 48.54 96.31 73.33 8.76 12.96 74.70 9.19 14.54 coo 11.59 49.83 99.41 10.92 47.97 100.16 68.81 12.14 8.61 69.95 13.49 7.45 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 8 3 # 8 A 270 ASN B 118 ASN^? 13.44 MG MG B 302 A 384 ASN A 45 ASN^? 24.62 MG MG B 302 A 385 GLU B 54 GLU^? 22.94 MG MG B 302 coo 22.28 63.17 110.61 22.47 65.06 111.53 63.19 18.87 4.27 64.22 17.47 5.51 coo 7.06 50.07 96.17 8.50 48.54 96.31 42.72 26.12 17.32 44.44 25.00 17.78 coo 11.59 49.83 99.41 10.92 47.97 100.16 43.18 23.27 12.99 42.40 22.23 14.68 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 9 3 # 9 A 270 ASN B 132 ASN^? 16.42 MG MG B 302 A 384 ASN B 45 ASN^? 24.27 MG MG A 301 A 385 GLU B 52 GLU^? 20.06 MG MG B 302 coo 22.28 63.17 110.61 22.47 65.06 111.53 40.27 30.00 -2.76 41.98 31.07 -3.41 coo 7.06 50.07 96.17 8.50 48.54 96.31 47.87 19.20 19.75 47.40 21.26 19.77 coo 11.59 49.83 99.41 10.92 47.97 100.16 47.87 20.25 12.36 48.11 19.69 14.43 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 10 3 # 10 A 270 ASN C 118 ASN^? 13.08 MG MG C 302 A 384 ASN B 85 ASN^? 20.68 MG MG C 301 A 385 GLU B 75 GLU^? 15.82 MG MG C 301 coo 22.28 63.17 110.61 22.47 65.06 111.53 72.64 19.83 -10.69 72.07 18.17 -11.94 coo 7.06 50.07 96.17 8.50 48.54 96.31 73.33 8.76 12.96 74.70 9.19 14.54 coo 11.59 49.83 99.41 10.92 47.97 100.16 68.81 12.14 8.61 69.95 13.49 7.45 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 11 3 # 11 A 270 ASN C 118 ASN^? 13.08 MG MG C 302 A 384 ASN D 45 ASN^? 24.33 MG MG C 302 A 385 GLU C 54 GLU^? 22.77 MG MG C 302 coo 22.28 63.17 110.61 22.47 65.06 111.53 72.64 19.83 -10.69 72.07 18.17 -11.94 coo 7.06 50.07 96.17 8.50 48.54 96.31 88.35 34.04 -23.87 86.82 32.62 -24.25 coo 11.59 49.83 99.41 10.92 47.97 100.16 88.91 31.25 -19.52 89.97 30.69 -21.29 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 12 3 # 12 A 270 ASN C 121 ASN^? 13.53 MG MG C 302 A 384 ASN B 85 ASN^? 20.68 MG MG C 301 A 385 GLU B 75 GLU^? 15.82 MG MG C 301 coo 22.28 63.17 110.61 22.47 65.06 111.53 69.55 17.44 -9.40 69.18 16.30 -7.63 coo 7.06 50.07 96.17 8.50 48.54 96.31 73.33 8.76 12.96 74.70 9.19 14.54 coo 11.59 49.83 99.41 10.92 47.97 100.16 68.81 12.14 8.61 69.95 13.49 7.45 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 13 3 # 13 A 270 ASN C 121 ASN^? 13.53 MG MG C 302 A 384 ASN C 45 ASN^? 24.54 MG MG C 302 A 385 GLU C 52 GLU^? 19.67 MG MG C 302 coo 22.28 63.17 110.61 22.47 65.06 111.53 69.55 17.44 -9.40 69.18 16.30 -7.63 coo 7.06 50.07 96.17 8.50 48.54 96.31 85.43 25.82 -26.31 85.43 27.91 -25.97 coo 11.59 49.83 99.41 10.92 47.97 100.16 84.27 26.98 -19.19 85.21 26.16 -20.96 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 14 3 # 14 A 270 ASN C 132 ASN^? 16.52 MG MG C 302 A 384 ASN C 45 ASN^? 24.54 MG MG C 302 A 385 GLU C 52 GLU^? 19.67 MG MG C 302 coo 22.28 63.17 110.61 22.47 65.06 111.53 89.66 38.54 -3.77 87.74 38.77 -2.97 coo 7.06 50.07 96.17 8.50 48.54 96.31 85.43 25.82 -26.31 85.43 27.91 -25.97 coo 11.59 49.83 99.41 10.92 47.97 100.16 84.27 26.98 -19.19 85.21 26.16 -20.96 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 15 3 # 15 A 270 ASN C 185 ASN^? -7.11 MG MG C 301s A 384 ASN B 95 ASN^? 11.72 MG MG B 302 A 385 GLU B 94 GLU^? 15.34 MG MG B 302 coo 22.28 63.17 110.61 22.47 65.06 111.53 80.06 27.66 4.46 78.78 28.93 5.51 coo 7.06 50.07 96.17 8.50 48.54 96.31 55.48 29.92 4.32 57.36 30.88 4.11 coo 11.59 49.83 99.41 10.92 47.97 100.16 58.44 31.30 7.43 60.35 32.14 7.14 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 16 3 # 16 A 270 ASN D 3 ASN^? 28.85 MG MG C 302 A 384 ASN D 45 ASN^? 24.33 MG MG C 302 A 385 GLU C 54 GLU^? 22.77 MG MG C 302 coo 22.28 63.17 110.61 22.47 65.06 111.53 89.53 11.43 -25.56 88.66 9.94 -24.30 coo 7.06 50.07 96.17 8.50 48.54 96.31 88.35 34.04 -23.87 86.82 32.62 -24.25 coo 11.59 49.83 99.41 10.92 47.97 100.16 88.91 31.25 -19.52 89.97 30.69 -21.29 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 17 3 # 17 A 270 ASN D 118 ASN^? 13.31 MG MG D 302 A 384 ASN C 45 ASN^? 24.54 MG MG C 302 A 385 GLU D 54 GLU^? 22.96 MG MG D 302 coo 22.28 63.17 110.61 22.47 65.06 111.53 82.29 46.70 -39.94 83.03 48.22 -38.68 coo 7.06 50.07 96.17 8.50 48.54 96.31 85.43 25.82 -26.31 85.43 27.91 -25.97 coo 11.59 49.83 99.41 10.92 47.97 100.16 87.96 27.60 -30.52 89.07 27.55 -28.72 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 18 3 # 18 A 270 ASN D 118 ASN^? 13.31 MG MG D 302 A 384 ASN E 85 ASN^? 18.39 MG MG D 301 A 385 GLU E 75 GLU^? 15.76 MG MG D 301 coo 22.28 63.17 110.61 22.47 65.06 111.53 82.29 46.70 -39.94 83.03 48.22 -38.68 coo 7.06 50.07 96.17 8.50 48.54 96.31 90.97 53.37 -63.23 89.62 51.76 -63.71 coo 11.59 49.83 99.41 10.92 47.97 100.16 84.65 53.96 -59.58 85.64 52.81 -58.05 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 19 3 # 19 A 270 ASN D 121 ASN^? 14.25 MG MG E 302 A 384 ASN D 45 ASN^? 24.33 MG MG C 302 A 385 GLU D 52 GLU^? 19.94 MG MG D 302 coo 22.28 63.17 110.61 22.47 65.06 111.53 80.38 49.72 -41.99 81.55 51.54 -42.09 coo 7.06 50.07 96.17 8.50 48.54 96.31 88.35 34.04 -23.87 86.82 32.62 -24.25 coo 11.59 49.83 99.41 10.92 47.97 100.16 87.13 33.17 -30.97 88.40 33.70 -29.31 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 20 3 # 20 A 270 ASN D 121 ASN^? 14.25 MG MG E 302 A 384 ASN E 85 ASN^? 18.39 MG MG D 301 A 385 GLU E 75 GLU^? 15.76 MG MG D 301 coo 22.28 63.17 110.61 22.47 65.06 111.53 80.38 49.72 -41.99 81.55 51.54 -42.09 coo 7.06 50.07 96.17 8.50 48.54 96.31 90.97 53.37 -63.23 89.62 51.76 -63.71 coo 11.59 49.83 99.41 10.92 47.97 100.16 84.65 53.96 -59.58 85.64 52.81 -58.05 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 21 3 # 21 A 270 ASN D 132 ASN^? 16.46 MG MG D 302 A 384 ASN D 45 ASN^? 24.33 MG MG C 302 A 385 GLU D 52 GLU^? 19.94 MG MG D 302 coo 22.28 63.17 110.61 22.47 65.06 111.53 84.64 21.31 -46.24 83.02 22.38 -47.10 coo 7.06 50.07 96.17 8.50 48.54 96.31 88.35 34.04 -23.87 86.82 32.62 -24.25 coo 11.59 49.83 99.41 10.92 47.97 100.16 87.13 33.17 -30.97 88.40 33.70 -29.31 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 22 3 # 22 A 270 ASN E 3 ASN^? 30.27 MG MG F 301 A 384 ASN E 45 ASN^? 24.46 MG MG F 301 A 385 GLU F 54 GLU^? 22.98 MG MG F 301 coo 22.28 63.17 110.61 22.47 65.06 111.53 42.47 65.36 -68.69 40.59 66.02 -69.39 coo 7.06 50.07 96.17 8.50 48.54 96.31 64.97 61.33 -71.05 63.29 60.06 -70.79 coo 11.59 49.83 99.41 10.92 47.97 100.16 62.26 62.27 -75.30 61.72 63.47 -73.60 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 23 3 # 23 A 270 ASN E 69 ASN^? 19.64 MG MG E 302 A 384 ASN E 85 ASN^? 18.39 MG MG D 301 A 385 GLU E 75 GLU^? 15.76 MG MG D 301 coo 22.28 63.17 110.61 22.47 65.06 111.53 65.28 56.38 -64.89 66.38 55.27 -66.29 coo 7.06 50.07 96.17 8.50 48.54 96.31 90.97 53.37 -63.23 89.62 51.76 -63.71 coo 11.59 49.83 99.41 10.92 47.97 100.16 84.65 53.96 -59.58 85.64 52.81 -58.05 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 24 3 # 24 A 270 ASN E 118 ASN^? 13.13 MG MG E 302 A 384 ASN F 45 ASN^? 24.43 MG MG E 302 A 385 GLU E 54 GLU^? 22.83 MG MG E 302 coo 22.28 63.17 110.61 22.47 65.06 111.53 76.50 53.47 -54.63 78.11 53.97 -55.93 coo 7.06 50.07 96.17 8.50 48.54 96.31 56.42 59.79 -68.43 58.48 59.32 -68.69 coo 11.59 49.83 99.41 10.92 47.97 100.16 58.39 62.16 -64.12 58.73 62.98 -66.04 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 25 3 # 25 A 270 ASN E 121 ASN^? 13.28 MG MG E 302 A 384 ASN E 45 ASN^? 24.46 MG MG F 301 A 385 GLU E 52 GLU^? 19.96 MG MG E 302 coo 22.28 63.17 110.61 22.47 65.06 111.53 80.31 53.55 -53.29 81.18 54.02 -51.40 coo 7.06 50.07 96.17 8.50 48.54 96.31 64.97 61.33 -71.05 63.29 60.06 -70.79 coo 11.59 49.83 99.41 10.92 47.97 100.16 64.71 60.06 -63.78 64.69 61.36 -65.58 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 26 3 # 26 A 270 ASN E 132 ASN^? 16.39 MG MG E 302 A 384 ASN E 45 ASN^? 24.46 MG MG F 301 A 385 GLU E 52 GLU^? 19.96 MG MG E 302 coo 22.28 63.17 110.61 22.47 65.06 111.53 51.80 60.19 -48.38 52.68 58.51 -47.42 coo 7.06 50.07 96.17 8.50 48.54 96.31 64.97 61.33 -71.05 63.29 60.06 -70.79 coo 11.59 49.83 99.41 10.92 47.97 100.16 64.71 60.06 -63.78 64.69 61.36 -65.58 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 27 3 # 27 A 270 ASN E 185 ASN^? -7.20 MG MG E 301s A 384 ASN D 95 ASN^? 12.56 MG MG D 302 A 385 GLU D 94 GLU^? 16.28 MG MG D 302 coo 22.28 63.17 110.61 22.47 65.06 111.53 65.70 57.16 -40.06 65.41 55.24 -39.19 coo 7.06 50.07 96.17 8.50 48.54 96.31 76.36 34.77 -40.14 74.34 35.29 -40.63 coo 11.59 49.83 99.41 10.92 47.97 100.16 72.85 36.59 -35.79 71.78 37.87 -37.16 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 28 3 # 28 A 270 ASN F 3 ASN^? 30.46 MG MG E 302 A 384 ASN F 45 ASN^? 24.43 MG MG E 302 A 385 GLU E 54 GLU^? 22.83 MG MG E 302 coo 22.28 63.17 110.61 22.47 65.06 111.53 76.18 71.56 -71.39 78.06 72.28 -70.84 coo 7.06 50.07 96.17 8.50 48.54 96.31 56.42 59.79 -68.43 58.48 59.32 -68.69 coo 11.59 49.83 99.41 10.92 47.97 100.16 58.39 62.16 -64.12 58.73 62.98 -66.04 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 29 3 # 29 A 270 ASN F 118 ASN^? 13.34 MG MG F 301 A 384 ASN E 45 ASN^? 24.46 MG MG F 301 A 385 GLU F 54 GLU^? 22.98 MG MG F 301 coo 22.28 63.17 110.61 22.47 65.06 111.53 48.40 47.22 -84.16 46.70 46.61 -82.99 coo 7.06 50.07 96.17 8.50 48.54 96.31 64.97 61.33 -71.05 63.29 60.06 -70.79 coo 11.59 49.83 99.41 10.92 47.97 100.16 62.26 62.27 -75.30 61.72 63.47 -73.60 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 30 3 # 30 A 270 ASN F 121 ASN^? 13.88 MG MG F 301 A 384 ASN F 45 ASN^? 24.43 MG MG E 302 A 385 GLU F 52 GLU^? 20.13 MG MG F 301 coo 22.28 63.17 110.61 22.47 65.06 111.53 46.01 43.34 -85.92 45.76 42.32 -87.80 coo 7.06 50.07 96.17 8.50 48.54 96.31 56.42 59.79 -68.43 58.48 59.32 -68.69 coo 11.59 49.83 99.41 10.92 47.97 100.16 57.09 59.62 -75.76 56.76 59.40 -73.62 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 31 3 # 31 A 270 ASN F 132 ASN^? 16.48 MG MG F 301 A 384 ASN F 45 ASN^? 24.43 MG MG E 302 A 385 GLU F 52 GLU^? 20.13 MG MG F 301 coo 22.28 63.17 110.61 22.47 65.06 111.53 69.23 61.88 -90.93 69.10 59.95 -91.77 coo 7.06 50.07 96.17 8.50 48.54 96.31 56.42 59.79 -68.43 58.48 59.32 -68.69 coo 11.59 49.83 99.41 10.92 47.97 100.16 57.09 59.62 -75.76 56.76 59.40 -73.62 2v3r_p00 source 2v3r EXOGLUCANASE 1 : 31 hits 2v3r_p00 naa= 3 ULMN 3 1b01_d00 GENE REGULATION/DNA user 1 3 # 1 B 4 ARG A 50 ARG^? 15.98 MG MG A 301 B 6 THR A 70 THR^? 14.66 MG MG A 301 B 8 THR A 93 THR^? 16.79 MG MG A 301 coo 40.52 16.08 100.90 37.97 16.41 102.60 38.44 33.02 29.31 39.55 34.58 26.90 coo 36.11 13.64 95.03 34.54 14.86 95.91 45.68 31.52 26.25 47.33 32.60 27.12 coo 32.72 8.05 92.39 31.25 9.11 91.35 51.84 31.38 28.05 51.33 31.03 25.98 ULMN 3 1b01_d00 GENE REGULATION/DNA user 2 3 # 2 B 4 ARG A 50 ARG^? 15.98 MG MG A 301 B 6 THR A 73 THR^? 15.13 MG MG A 301 B 8 THR A 88 THR^? 23.22 MG MG A 301 coo 40.52 16.08 100.90 37.97 16.41 102.60 38.44 33.02 29.31 39.55 34.58 26.90 coo 36.11 13.64 95.03 34.54 14.86 95.91 40.93 39.17 26.72 41.99 38.78 28.61 coo 32.72 8.05 92.39 31.25 9.11 91.35 42.44 43.75 23.46 42.54 42.92 21.44 ULMN 3 1b01_d00 GENE REGULATION/DNA user 3 3 # 3 B 4 ARG B 50 ARG^? 16.38 MG MG B 302 B 6 THR B 70 THR^? 14.69 MG MG B 302 B 8 THR B 93 THR^? 16.72 MG MG B 302 coo 40.52 16.08 100.90 37.97 16.41 102.60 55.38 14.91 7.80 56.60 14.73 10.62 coo 36.11 13.64 95.03 34.54 14.86 95.91 54.82 21.76 11.59 56.34 23.17 10.82 coo 32.72 8.05 92.39 31.25 9.11 91.35 55.83 27.92 10.11 55.23 27.31 12.11 ULMN 3 1b01_d00 GENE REGULATION/DNA user 4 3 # 4 B 4 ARG B 50 ARG^? 16.38 MG MG B 302 B 6 THR B 73 THR^? 15.28 MG MG B 302 B 8 THR B 88 THR^? 22.44 MG MG C 301 coo 40.52 16.08 100.90 37.97 16.41 102.60 55.38 14.91 7.80 56.60 14.73 10.62 coo 36.11 13.64 95.03 34.54 14.86 95.91 61.79 16.15 11.00 62.15 17.08 9.05 coo 32.72 8.05 92.39 31.25 9.11 91.35 66.42 16.42 14.22 65.45 16.28 16.18 ULMN 3 1b01_d00 GENE REGULATION/DNA user 5 3 # 5 B 4 ARG C 50 ARG^? 16.05 MG MG C 302 B 6 THR C 70 THR^? 14.45 MG MG C 302 B 8 THR C 93 THR^? 16.71 MG MG C 302 coo 40.52 16.08 100.90 37.97 16.41 102.60 80.61 19.03 -14.42 79.16 18.55 -17.10 coo 36.11 13.64 95.03 34.54 14.86 95.91 78.63 25.77 -17.76 76.70 26.55 -17.21 coo 32.72 8.05 92.39 31.25 9.11 91.35 75.66 31.10 -16.50 76.28 30.99 -18.61 ULMN 3 1b01_d00 GENE REGULATION/DNA user 6 3 # 6 B 4 ARG C 50 ARG^? 16.05 MG MG C 302 B 6 THR C 73 THR^? 14.95 MG MG C 302 B 8 THR C 88 THR^? 22.58 MG MG B 301 coo 40.52 16.08 100.90 37.97 16.41 102.60 80.61 19.03 -14.42 79.16 18.55 -17.10 coo 36.11 13.64 95.03 34.54 14.86 95.91 74.44 18.04 -17.45 73.99 18.64 -15.48 coo 32.72 8.05 92.39 31.25 9.11 91.35 69.96 16.71 -20.56 70.75 16.33 -22.54 ULMN 3 1b01_d00 GENE REGULATION/DNA user 7 3 # 7 B 4 ARG D 50 ARG^? 16.15 MG MG D 302 B 6 THR D 70 THR^? 14.99 MG MG D 302 B 8 THR D 93 THR^? 17.20 MG MG D 302 coo 40.52 16.08 100.90 37.97 16.41 102.60 88.00 43.26 -36.30 88.86 43.23 -33.34 coo 36.11 13.64 95.03 34.54 14.86 95.91 83.38 38.35 -32.45 81.51 39.04 -33.23 coo 32.72 8.05 92.39 31.25 9.11 91.35 77.48 36.07 -34.09 78.19 35.86 -32.06 ULMN 3 1b01_d00 GENE REGULATION/DNA user 8 3 # 8 B 4 ARG E 50 ARG^? 15.97 MG MG E 302 B 6 THR E 70 THR^? 14.75 MG MG E 302 B 8 THR E 93 THR^? 16.89 MG MG E 302 coo 40.52 16.08 100.90 37.97 16.41 102.60 73.62 60.83 -58.23 74.10 60.41 -61.24 coo 36.11 13.64 95.03 34.54 14.86 95.91 68.45 55.77 -62.07 68.75 53.75 -61.41 coo 32.72 8.05 92.39 31.25 9.11 91.35 65.27 50.61 -60.45 64.92 51.11 -62.51 ULMN 3 1b01_d00 GENE REGULATION/DNA user 9 3 # 9 B 4 ARG E 50 ARG^? 15.97 MG MG E 302 B 6 THR E 73 THR^? 15.13 MG MG E 302 B 8 THR E 88 THR^? 21.98 MG MG D 301 coo 40.52 16.08 100.90 37.97 16.41 102.60 73.62 60.83 -58.23 74.10 60.41 -61.24 coo 36.11 13.64 95.03 34.54 14.86 95.91 77.31 55.78 -61.57 77.11 55.21 -59.48 coo 32.72 8.05 92.39 31.25 9.11 91.35 80.56 52.52 -64.50 80.70 53.32 -66.53 ULMN 3 1b01_d00 GENE REGULATION/DNA user 10 3 # 10 B 4 ARG F 50 ARG^? 16.24 MG MG F 301 B 6 THR F 70 THR^? 14.73 MG MG F 301 B 8 THR F 93 THR^? 16.99 MG MG F 301 coo 40.52 16.08 100.90 37.97 16.41 102.60 48.85 56.05 -80.24 48.26 54.66 -77.55 coo 36.11 13.64 95.03 34.54 14.86 95.91 55.11 52.83 -76.85 55.53 50.86 -77.56 coo 32.72 8.05 92.39 31.25 9.11 91.35 59.88 48.90 -78.21 59.85 49.68 -76.20 ULMN 3 1b01_d00 GENE REGULATION/DNA user 11 3 # 11 B 4 ARG F 50 ARG^? 16.24 MG MG F 301 B 6 THR F 73 THR^? 15.13 MG MG F 301 B 8 THR F 88 THR^? 23.06 MG MG F 301 coo 40.52 16.08 100.90 37.97 16.41 102.60 48.85 56.05 -80.24 48.26 54.66 -77.55 coo 36.11 13.64 95.03 34.54 14.86 95.91 46.81 49.68 -77.46 47.14 48.99 -79.45 coo 32.72 8.05 92.39 31.25 9.11 91.35 44.71 45.78 -74.10 45.06 46.44 -72.02 1b01_d00 source 1b01 GENE REGULATION/DNA : 11 hits 1b01_d00 naa= 3 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 1 3 # 1 A 9 GLN A 28 GLN^? 24.98 MG MG A 301 A 11 ASN A 85 ASN^? 29.83 MG MG A 301 A 13 ARG A 87 ARG^? 20.70 MG MG A 301 coo 33.45 2.10 7.21 34.51 1.09 5.67 35.69 54.32 33.07 37.56 53.64 32.43 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 36.44 52.20 24.38 35.62 54.19 24.50 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 43.15 49.03 26.22 43.83 48.14 29.12 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 2 3 # 2 A 9 GLN B 28 GLN^? 16.31 MG MG C 301 A 11 ASN B 85 ASN^? 20.68 MG MG C 301 A 13 ARG B 87 ARG^? 13.84 MG MG C 301 coo 33.45 2.10 7.21 34.51 1.09 5.67 76.08 6.47 4.44 76.37 8.43 5.15 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 73.33 8.76 12.96 74.70 9.19 14.54 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 72.30 15.49 11.27 71.00 17.29 9.11 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 3 3 # 3 A 9 GLN D 28 GLN^? 15.42 MG MG E 301 A 11 ASN D 85 ASN^? 20.22 MG MG E 301 A 13 ARG D 87 ARG^? 13.34 MG MG E 301 coo 33.45 2.10 7.21 34.51 1.09 5.67 85.51 64.12 -40.17 83.84 63.05 -39.41 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 84.79 61.03 -31.29 84.23 62.62 -30.02 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 79.72 56.28 -33.10 79.15 54.81 -35.72 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 4 3 # 4 A 9 GLN E 28 GLN^? 16.27 MG MG D 301 A 11 ASN E 85 ASN^? 18.39 MG MG D 301 A 13 ARG E 87 ARG^? 13.25 MG MG D 301 coo 33.45 2.10 7.21 34.51 1.09 5.67 93.86 53.90 -54.34 93.32 52.63 -55.94 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 90.97 53.37 -63.23 89.62 51.76 -63.71 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 85.24 49.22 -61.34 83.59 49.18 -58.71 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 5 3 # 5 A 9 GLN F 28 GLN^? 26.45 MG MG F 301 A 11 ASN F 85 ASN^? 27.49 MG MG F 301 A 13 ARG F 87 ARG^? 20.27 MG MG F 301 coo 33.45 2.10 7.21 34.51 1.09 5.67 31.58 43.72 -83.84 32.04 41.78 -83.12 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 34.36 43.15 -75.19 36.11 42.05 -74.56 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 41.14 41.21 -77.31 42.93 41.07 -79.84 1bdv_d00 source 1bdv GENE REGULATION/DNA : 5 hits 1bdv_d00 naa= 3 ULMN 4 1ckt_d00 GENE REGULATION/DNA user 1 4 # 1 A 15 TYR A 67 TYR^? 21.33 MG MG A 301 A 19 VAL A 44 VAL^? 23.47 MG MG A 301 A 37 PHE A 12 PHE^? 17.15 MG MG A 301 A 41 SER A 10 SER^? 16.72 MG MG A 301 coo 30.31 -14.95 20.82 28.24 -14.29 22.55 48.62 23.20 22.09 46.84 25.23 21.44 coo 24.83 -14.85 17.78 25.17 -13.31 19.32 40.71 23.59 20.27 42.01 21.87 20.17 coo 20.60 -4.04 22.72 21.46 -2.67 20.51 34.93 27.27 29.42 32.88 25.47 30.10 coo 23.13 -11.27 24.75 25.16 -10.10 25.52 40.39 23.85 29.26 38.85 24.86 27.67 ULMN 4 1ckt_d00 GENE REGULATION/DNA user 2 4 # 2 A 15 TYR A 67 TYR^? 21.33 MG MG A 301 A 19 VAL A 44 VAL^? 23.47 MG MG A 301 A 37 PHE A 155 PHE^? 14.59 MG MG A 301 A 41 SER A 10 SER^? 16.72 MG MG A 301 coo 30.31 -14.95 20.82 28.24 -14.29 22.55 48.62 23.20 22.09 46.84 25.23 21.44 coo 24.83 -14.85 17.78 25.17 -13.31 19.32 40.71 23.59 20.27 42.01 21.87 20.17 coo 20.60 -4.04 22.72 21.46 -2.67 20.51 40.89 18.60 33.43 41.76 20.84 34.84 coo 23.13 -11.27 24.75 25.16 -10.10 25.52 40.39 23.85 29.26 38.85 24.86 27.67 ULMN 4 1ckt_d00 GENE REGULATION/DNA user 3 4 # 3 A 15 TYR C 67 TYR^? 21.03 MG MG C 302 A 19 VAL C 44 VAL^? 22.99 MG MG C 302 A 37 PHE C 12 PHE^? 16.92 MG MG C 302 A 41 SER C 10 SER^? 16.50 MG MG C 302 coo 30.31 -14.95 20.82 28.24 -14.29 22.55 84.52 32.45 -21.76 83.69 29.84 -22.37 coo 24.83 -14.85 17.78 25.17 -13.31 19.32 88.23 25.46 -22.96 89.26 27.37 -22.88 coo 20.60 -4.04 22.72 21.46 -2.67 20.51 87.42 18.93 -13.86 90.00 18.25 -12.97 coo 23.13 -11.27 24.75 25.16 -10.10 25.52 87.65 25.37 -14.15 87.84 23.42 -15.55 ULMN 4 1ckt_d00 GENE REGULATION/DNA user 4 4 # 4 A 15 TYR C 67 TYR^? 21.03 MG MG C 302 A 19 VAL C 44 VAL^? 22.99 MG MG C 302 A 37 PHE C 155 PHE^? 14.45 MG MG C 302 A 41 SER C 10 SER^? 16.50 MG MG C 302 coo 30.31 -14.95 20.82 28.24 -14.29 22.55 84.52 32.45 -21.76 83.69 29.84 -22.37 coo 24.83 -14.85 17.78 25.17 -13.31 19.32 88.23 25.46 -22.96 89.26 27.37 -22.88 coo 20.60 -4.04 22.72 21.46 -2.67 20.51 91.63 28.51 -9.66 89.28 28.13 -8.17 coo 23.13 -11.27 24.75 25.16 -10.10 25.52 87.65 25.37 -14.15 87.84 23.42 -15.55 ULMN 4 1ckt_d00 GENE REGULATION/DNA user 5 4 # 5 A 15 TYR D 67 TYR^? 21.42 MG MG D 302 A 19 VAL D 44 VAL^? 23.17 MG MG D 302 A 37 PHE D 12 PHE^? 16.78 MG MG D 302 A 41 SER D 10 SER^? 16.71 MG MG D 302 coo 30.31 -14.95 20.82 28.24 -14.29 22.55 83.62 29.64 -28.35 84.67 32.17 -27.90 coo 24.83 -14.85 17.78 25.17 -13.31 19.32 90.88 32.60 -27.10 90.06 30.62 -26.95 coo 20.60 -4.04 22.72 21.46 -2.67 20.51 94.68 38.11 -36.05 97.16 37.10 -36.83 coo 23.13 -11.27 24.75 25.16 -10.10 25.52 90.76 33.07 -35.81 92.04 34.36 -34.16 ULMN 4 1ckt_d00 GENE REGULATION/DNA user 6 4 # 6 A 15 TYR D 67 TYR^? 21.42 MG MG D 302 A 19 VAL D 44 VAL^? 23.17 MG MG D 302 A 37 PHE D 155 PHE^? 14.27 MG MG D 302 A 41 SER D 10 SER^? 16.71 MG MG D 302 coo 30.31 -14.95 20.82 28.24 -14.29 22.55 83.62 29.64 -28.35 84.67 32.17 -27.90 coo 24.83 -14.85 17.78 25.17 -13.31 19.32 90.88 32.60 -27.10 90.06 30.62 -26.95 coo 20.60 -4.04 22.72 21.46 -2.67 20.51 92.10 28.06 -40.17 90.44 29.86 -41.52 coo 23.13 -11.27 24.75 25.16 -10.10 25.52 90.76 33.07 -35.81 92.04 34.36 -34.16 ULMN 4 1ckt_d00 GENE REGULATION/DNA user 7 4 # 7 A 15 TYR E 67 TYR^? 21.41 MG MG E 302 A 19 VAL E 44 VAL^? 23.25 MG MG E 302 A 37 PHE E 12 PHE^? 17.09 MG MG E 302 A 41 SER E 10 SER^? 16.92 MG MG E 302 coo 30.31 -14.95 20.82 28.24 -14.29 22.55 59.76 57.41 -66.37 62.46 58.08 -67.03 coo 24.83 -14.85 17.78 25.17 -13.31 19.32 63.87 63.92 -67.77 61.69 63.98 -67.81 coo 20.60 -4.04 22.72 21.46 -2.67 20.51 70.06 67.18 -58.76 69.33 69.81 -58.07 coo 23.13 -11.27 24.75 25.16 -10.10 25.52 64.47 64.04 -59.12 65.96 65.01 -60.83 ULMN 4 1ckt_d00 GENE REGULATION/DNA user 8 4 # 8 A 15 TYR E 67 TYR^? 21.41 MG MG E 302 A 19 VAL E 44 VAL^? 23.25 MG MG E 302 A 37 PHE E 155 PHE^? 14.42 MG MG E 302 A 41 SER E 10 SER^? 16.92 MG MG E 302 coo 30.31 -14.95 20.82 28.24 -14.29 22.55 59.76 57.41 -66.37 62.46 58.08 -67.03 coo 24.83 -14.85 17.78 25.17 -13.31 19.32 63.87 63.92 -67.77 61.69 63.98 -67.81 coo 20.60 -4.04 22.72 21.46 -2.67 20.51 59.64 66.20 -54.61 61.24 64.46 -53.08 coo 23.13 -11.27 24.75 25.16 -10.10 25.52 64.47 64.04 -59.12 65.96 65.01 -60.83 ULMN 4 1ckt_d00 GENE REGULATION/DNA user 9 4 # 9 A 15 TYR F 67 TYR^? 21.41 MG MG F 301 A 19 VAL F 44 VAL^? 23.29 MG MG F 301 A 37 PHE F 12 PHE^? 17.12 MG MG F 301 A 41 SER F 10 SER^? 16.76 MG MG F 301 coo 30.31 -14.95 20.82 28.24 -14.29 22.55 62.63 57.65 -72.90 59.95 57.21 -72.29 coo 24.83 -14.85 17.78 25.17 -13.31 19.32 56.46 62.56 -71.76 58.56 63.03 -71.80 coo 20.60 -4.04 22.72 21.46 -2.67 20.51 49.70 62.79 -80.90 49.37 65.44 -81.67 coo 23.13 -11.27 24.75 25.16 -10.10 25.52 56.13 61.85 -80.66 54.44 62.39 -79.08 ULMN 4 1ckt_d00 GENE REGULATION/DNA user 10 4 # 10 A 15 TYR F 67 TYR^? 21.41 MG MG F 301 A 19 VAL F 44 VAL^? 23.29 MG MG F 301 A 37 PHE F 155 PHE^? 14.54 MG MG F 301 A 41 SER F 10 SER^? 16.76 MG MG F 301 coo 30.31 -14.95 20.82 28.24 -14.29 22.55 62.63 57.65 -72.90 59.95 57.21 -72.29 coo 24.83 -14.85 17.78 25.17 -13.31 19.32 56.46 62.56 -71.76 58.56 63.03 -71.80 coo 20.60 -4.04 22.72 21.46 -2.67 20.51 59.83 65.32 -85.14 59.10 62.92 -86.45 coo 23.13 -11.27 24.75 25.16 -10.10 25.52 56.13 61.85 -80.66 54.44 62.39 -79.08 1ckt_d00 source 1ckt GENE REGULATION/DNA : 10 hits 1ckt_d00 naa= 4 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 1 3 # 1 I 303 TYR A 67 TYR^? 21.33 MG MG A 301 I 306 VAL A 55 VAL^? 21.25 MG MG A 301 I 308 VAL A 57 VAL^? 27.19 MG MG A 301 coo 26.18 35.24 6.87 24.33 35.18 8.97 48.62 23.20 22.09 46.84 25.23 21.44 coo 23.55 29.53 9.81 23.15 27.39 10.24 49.65 16.90 26.44 50.84 16.66 28.18 coo 16.43 30.18 9.35 15.05 30.67 11.01 51.92 10.88 25.16 52.00 9.88 27.05 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 2 3 # 2 I 303 TYR A 67 TYR^? 21.33 MG MG A 301 I 306 VAL A 55 VAL^? 21.25 MG MG A 301 I 308 VAL A 64 VAL^? 25.64 MG MG A 301 coo 26.18 35.24 6.87 24.33 35.18 8.97 48.62 23.20 22.09 46.84 25.23 21.44 coo 23.55 29.53 9.81 23.15 27.39 10.24 49.65 16.90 26.44 50.84 16.66 28.18 coo 16.43 30.18 9.35 15.05 30.67 11.01 55.68 13.62 25.40 55.07 13.75 27.48 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 3 3 # 3 I 303 TYR B 67 TYR^? 21.41 MG MG B 302 I 306 VAL B 55 VAL^? 21.03 MG MG B 302 I 308 VAL B 64 VAL^? 25.70 MG MG B 302 coo 26.18 35.24 6.87 24.33 35.18 8.97 46.94 25.86 15.48 48.70 23.84 16.15 coo 23.55 29.53 9.81 23.15 27.39 10.24 41.16 28.33 10.56 41.44 29.73 8.92 coo 16.43 30.18 9.35 15.05 30.67 11.01 38.92 34.89 12.06 38.92 34.47 9.96 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 4 3 # 4 I 303 TYR C 67 TYR^? 21.03 MG MG C 302 I 306 VAL C 55 VAL^? 20.86 MG MG C 302 I 308 VAL C 57 VAL^? 26.99 MG MG C 302 coo 26.18 35.24 6.87 24.33 35.18 8.97 84.52 32.45 -21.76 83.69 29.84 -22.37 coo 23.55 29.53 9.81 23.15 27.39 10.24 88.86 36.78 -17.07 88.40 37.87 -15.33 coo 16.43 30.18 9.35 15.05 30.67 11.01 93.03 41.79 -18.34 94.13 41.98 -16.42 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 5 3 # 5 I 303 TYR C 67 TYR^? 21.03 MG MG C 302 I 306 VAL C 55 VAL^? 20.86 MG MG C 302 I 308 VAL C 64 VAL^? 25.41 MG MG C 302 coo 26.18 35.24 6.87 24.33 35.18 8.97 84.52 32.45 -21.76 83.69 29.84 -22.37 coo 23.55 29.53 9.81 23.15 27.39 10.24 88.86 36.78 -17.07 88.40 37.87 -15.33 coo 16.43 30.18 9.35 15.05 30.67 11.01 88.94 43.55 -18.33 88.89 43.01 -16.24 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 6 3 # 6 I 303 TYR C 67 TYR^? 21.03 MG MG C 302 I 306 VAL C 55 VAL^? 20.86 MG MG C 302 I 308 VAL C 97 VAL^? 15.12 MG MG C 302 coo 26.18 35.24 6.87 24.33 35.18 8.97 84.52 32.45 -21.76 83.69 29.84 -22.37 coo 23.55 29.53 9.81 23.15 27.39 10.24 88.86 36.78 -17.07 88.40 37.87 -15.33 coo 16.43 30.18 9.35 15.05 30.67 11.01 80.64 36.81 -13.09 78.89 37.47 -11.89 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 7 3 # 7 I 303 TYR D 67 TYR^? 21.42 MG MG D 302 I 306 VAL D 55 VAL^? 21.11 MG MG D 302 I 308 VAL D 64 VAL^? 26.01 MG MG D 302 coo 26.18 35.24 6.87 24.33 35.18 8.97 83.62 29.64 -28.35 84.67 32.17 -27.90 coo 23.55 29.53 9.81 23.15 27.39 10.24 84.67 23.33 -33.08 83.47 22.86 -34.79 coo 16.43 30.18 9.35 15.05 30.67 11.01 80.20 18.02 -31.67 80.73 18.10 -33.74 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 8 3 # 8 I 303 TYR E 67 TYR^? 21.41 MG MG E 302 I 306 VAL E 55 VAL^? 21.05 MG MG E 302 I 308 VAL E 57 VAL^? 27.05 MG MG E 302 coo 26.18 35.24 6.87 24.33 35.18 8.97 59.76 57.41 -66.37 62.46 58.08 -67.03 coo 23.55 29.53 9.81 23.15 27.39 10.24 53.75 59.42 -61.74 53.12 58.39 -59.94 coo 16.43 30.18 9.35 15.05 30.67 11.01 47.41 60.37 -62.88 46.53 61.21 -61.05 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 9 3 # 9 I 303 TYR E 67 TYR^? 21.41 MG MG E 302 I 306 VAL E 55 VAL^? 21.05 MG MG E 302 I 308 VAL E 64 VAL^? 25.56 MG MG E 302 coo 26.18 35.24 6.87 24.33 35.18 8.97 59.76 57.41 -66.37 62.46 58.08 -67.03 coo 23.55 29.53 9.81 23.15 27.39 10.24 53.75 59.42 -61.74 53.12 58.39 -59.94 coo 16.43 30.18 9.35 15.05 30.67 11.01 47.99 55.95 -62.87 48.37 56.45 -60.81 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 10 3 # 10 I 303 TYR F 67 TYR^? 21.41 MG MG F 301 I 306 VAL F 55 VAL^? 21.23 MG MG F 301 I 308 VAL F 64 VAL^? 25.95 MG MG F 301 coo 26.18 35.24 6.87 24.33 35.18 8.97 62.63 57.65 -72.90 59.95 57.21 -72.29 coo 23.55 29.53 9.81 23.15 27.39 10.24 67.66 61.48 -77.69 68.65 60.68 -79.44 coo 16.43 30.18 9.35 15.05 30.67 11.01 74.42 60.22 -76.24 73.90 60.55 -78.32 1cqt_d00 source 1cqt GENE REGULATION/DNA : 10 hits 1cqt_d00 naa= 3 ULMN 5 1dsz_d01 TRANSCRIPTION/DNA user 1 5 # 1 B1253 GLU D 165 GLU^? 29.85 MG MG D 302 B1256 LYS D 157 LYS^? 28.67 MG MG D 302 B1260 LYS D 6 LYS^? 25.98 MG MG D 302 B1261 ARG D 8 ARG^? 20.22 MG MG D 302 B1309 ARG C 37 ARG^? 19.01 MG MG C 302 coo 25.03 -5.46 27.50 23.96 -4.30 26.11 100.60 20.11 -34.27 100.38 17.96 -34.49 coo 29.37 0.59 27.76 24.30 0.08 23.85 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 28.12 6.66 28.49 22.65 4.86 27.19 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 24.19 5.45 33.62 25.28 2.56 33.94 92.22 28.83 -31.23 90.93 31.55 -30.54 coo 19.12 9.52 18.44 21.11 7.74 16.84 89.36 17.23 -17.57 89.29 20.20 -16.76 ULMN 5 1dsz_d01 TRANSCRIPTION/DNA user 2 5 # 2 B1253 GLU E 165 GLU^? 29.48 MG MG E 301 B1256 LYS E 157 LYS^? 28.40 MG MG E 302 B1260 LYS E 6 LYS^? 25.59 MG MG E 302 B1261 ARG E 8 ARG^? 20.19 MG MG E 302 B1309 ARG F 37 ARG^? 19.14 MG MG F 301 coo 25.03 -5.46 27.50 23.96 -4.30 26.11 52.92 74.97 -61.04 50.84 74.87 -60.51 coo 29.37 0.59 27.76 24.30 0.08 23.85 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 28.12 6.66 28.49 22.65 4.86 27.19 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 24.19 5.45 33.62 25.28 2.56 33.94 60.42 66.09 -63.48 62.84 64.38 -64.17 coo 19.12 9.52 18.44 21.11 7.74 16.84 48.80 64.46 -76.37 51.50 64.15 -77.79 1dsz_d01 source 1dsz TRANSCRIPTION/DNA : 2 hits 1dsz_d01 naa= 5 ULMN 3 1emh_d00 HYDROLASE/DNA user 1 3 # 1 A 271 PRO B 119 PRO^? 14.64 MG MG B 302 A 272 LEU B 120 LEU^? 16.04 MG MG C 301 A 276 ARG B 87 ARG^? 13.84 MG MG C 301 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 63.65 20.51 9.24 64.36 21.39 7.30 coo 10.97 0.43 16.73 11.31 2.11 18.06 67.42 17.84 7.44 67.26 17.40 9.56 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 72.30 15.49 11.27 71.00 17.29 9.11 ULMN 3 1emh_d00 HYDROLASE/DNA user 2 3 # 2 A 271 PRO D 119 PRO^? 14.74 MG MG D 302 A 272 LEU D 120 LEU^? 15.56 MG MG E 301 A 276 ARG D 87 ARG^? 13.34 MG MG E 301 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 79.79 46.26 -35.22 79.03 46.66 -37.29 coo 10.97 0.43 16.73 11.31 2.11 18.06 79.91 51.38 -37.00 80.73 51.53 -34.95 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 79.72 56.28 -33.10 79.15 54.81 -35.72 1emh_d00 source 1emh HYDROLASE/DNA : 2 hits 1emh_d00 naa= 3 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 1 3 # 1 C 70 ARG A 193 ARG^? 28.88 MG MG A 302 C 71 LYS A 192 LYS^? 22.83 MG MG A 302 C 72 VAL A 143 VAL^? 19.34 MG MG A 302 coo 23.89 33.54 29.21 26.59 34.86 28.68 43.09 4.06 39.01 41.78 1.42 39.93 coo 25.82 26.89 29.68 23.33 22.98 25.84 40.19 10.20 38.86 35.42 9.85 36.29 coo 28.86 29.08 30.37 28.04 31.02 29.93 45.10 11.92 37.77 44.64 13.24 36.06 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 2 3 # 2 C 70 ARG B 87 ARG^? 13.84 MG MG C 301 C 71 LYS B 76 LYS^? 25.77 MG MG B 302 C 72 VAL B 77 VAL^? 19.17 MG MG C 301 coo 23.89 33.54 29.21 26.59 34.86 28.68 72.30 15.49 11.27 71.00 17.29 9.11 coo 25.82 26.89 29.68 23.33 22.98 25.84 67.82 8.19 10.14 64.96 3.09 10.62 coo 28.86 29.08 30.37 28.04 31.02 29.93 71.13 7.26 8.54 72.49 8.75 7.68 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 3 3 # 3 C 70 ARG B 193 ARG^? 28.40 MG MG B 301 C 71 LYS B 192 LYS^? 23.73 MG MG B 301 C 72 VAL B 143 VAL^? 19.78 MG MG B 302 coo 23.89 33.54 29.21 26.59 34.86 28.68 29.25 23.93 -4.74 26.96 25.70 -3.52 coo 25.82 26.89 29.68 23.33 22.98 25.84 33.83 21.17 -2.93 31.87 16.45 -0.74 coo 28.86 29.08 30.37 28.04 31.02 29.93 36.18 25.53 -1.17 37.09 24.47 0.52 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 4 3 # 4 C 70 ARG C 87 ARG^? 14.11 MG MG B 301 C 71 LYS C 76 LYS^? 24.95 MG MG C 302 C 72 VAL C 77 VAL^? 19.30 MG MG B 301 coo 23.89 33.54 29.21 26.59 34.86 28.68 64.80 14.21 -18.13 65.25 15.52 -15.36 coo 25.82 26.89 29.68 23.33 22.98 25.84 71.11 8.63 -16.76 75.44 5.17 -16.80 coo 28.86 29.08 30.37 28.04 31.02 29.93 68.24 6.87 -15.11 66.49 7.98 -14.47 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 5 3 # 5 C 70 ARG C 193 ARG^? 28.20 MG MG C 301 C 71 LYS C 192 LYS^? 24.43 MG MG C 301 C 72 VAL C 143 VAL^? 19.61 MG MG C 302 coo 23.89 33.54 29.21 26.59 34.86 28.68 102.52 36.87 -2.60 102.78 39.94 -3.05 coo 25.82 26.89 29.68 23.33 22.98 25.84 98.71 32.33 -3.93 102.89 29.25 -5.78 coo 28.86 29.08 30.37 28.04 31.02 29.93 94.76 35.65 -5.55 94.30 34.33 -7.20 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 6 3 # 6 C 70 ARG D 193 ARG^? 27.92 MG MG D 301 C 71 LYS D 192 LYS^? 24.09 MG MG D 301 C 72 VAL D 143 VAL^? 19.60 MG MG D 302 coo 23.89 33.54 29.21 26.59 34.86 28.68 95.76 15.06 -47.43 94.58 12.31 -46.69 coo 25.82 26.89 29.68 23.33 22.98 25.84 95.35 20.28 -45.75 100.42 20.77 -43.05 coo 28.86 29.08 30.37 28.04 31.02 29.93 90.42 20.32 -44.16 90.59 21.63 -42.45 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 7 3 # 7 C 70 ARG E 193 ARG^? 28.25 MG MG E 301 C 71 LYS E 192 LYS^? 23.62 MG MG E 301 C 72 VAL E 143 VAL^? 19.53 MG MG E 301 coo 23.89 33.54 29.21 26.59 34.86 28.68 47.02 71.25 -47.53 44.19 71.23 -48.93 coo 25.82 26.89 29.68 23.33 22.98 25.84 52.64 70.58 -49.14 53.48 75.40 -50.95 coo 28.86 29.08 30.37 28.04 31.02 29.93 51.84 65.79 -50.38 53.29 65.87 -52.03 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 8 3 # 8 C 70 ARG F 193 ARG^? 27.27 MG MG F 302 C 71 LYS F 192 LYS^? 23.61 MG MG F 302 C 72 VAL F 143 VAL^? 19.37 MG MG F 302 coo 23.89 33.54 29.21 26.59 34.86 28.68 70.24 75.04 -91.81 72.97 73.73 -92.20 coo 25.82 26.89 29.68 23.33 22.98 25.84 64.82 71.59 -91.06 62.22 76.11 -88.75 coo 28.86 29.08 30.37 28.04 31.02 29.93 67.37 67.46 -89.48 66.03 67.03 -87.89 1hwt_d00 source 1hwt GENE REGULATION/DNA : 8 hits 1hwt_d00 naa= 3 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 1 3 # 1 E 40 ARG B 8 ARG^? 20.39 MG MG B 302 E 41 TYR B 67 TYR^? 21.41 MG MG B 302 E 83 ARG C 173 ARG^? 18.96 MG MG C 301 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 41.99 18.82 11.83 44.91 18.76 12.93 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 46.94 25.86 15.48 48.70 23.84 16.15 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 89.11 11.40 -7.73 91.21 12.63 -9.73 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 2 3 # 2 E 40 ARG B 48 ARG^? 25.20 MG MG B 302 E 41 TYR A 60 TYR^? 27.11 MG MG B 302 E 83 ARG C 37 ARG^? 19.01 MG MG C 302 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 52.22 10.51 15.00 52.46 7.79 16.39 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 55.01 4.24 16.98 56.13 3.24 14.65 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 89.36 17.23 -17.57 89.29 20.20 -16.76 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 3 3 # 3 E 40 ARG C 8 ARG^? 20.00 MG MG C 302 E 41 TYR C 67 TYR^? 21.03 MG MG C 302 E 83 ARG B 173 ARG^? 18.75 MG MG B 301 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 91.42 27.61 -18.53 88.82 26.28 -19.38 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 84.52 32.45 -21.76 83.69 29.84 -22.37 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 49.83 5.55 0.39 48.19 5.30 3.03 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 4 3 # 4 E 40 ARG C 48 ARG^? 25.02 MG MG C 302 E 41 TYR D 60 TYR^? 26.93 MG MG C 302 E 83 ARG B 37 ARG^? 19.17 MG MG B 302 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 84.94 16.06 -21.53 85.81 13.55 -23.08 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 84.40 9.28 -23.74 83.45 7.90 -21.49 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 47.41 10.20 11.40 46.99 12.91 10.22 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 5 3 # 5 E 40 ARG D 8 ARG^? 20.22 MG MG D 302 E 41 TYR D 67 TYR^? 21.42 MG MG D 302 E 83 ARG E 173 ARG^? 18.66 MG MG E 301 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 92.22 28.83 -31.23 90.93 31.55 -30.54 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 83.62 29.64 -28.35 84.67 32.17 -27.90 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 75.16 72.26 -52.56 73.67 73.54 -55.01 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 6 3 # 6 E 40 ARG D 48 ARG^? 24.87 MG MG D 302 E 41 TYR C 60 TYR^? 26.95 MG MG D 302 E 83 ARG E 37 ARG^? 19.17 MG MG E 302 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 94.06 41.76 -28.37 96.24 43.38 -26.96 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 97.75 47.69 -25.92 97.82 49.25 -28.26 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 70.82 68.02 -63.63 68.17 67.46 -62.14 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 7 3 # 7 E 40 ARG D 48 ARG^? 24.87 MG MG D 302 E 41 TYR C 60 TYR^? 26.95 MG MG D 302 E 83 ARG E 48 ARG^? 25.02 MG MG E 302 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 94.06 41.76 -28.37 96.24 43.38 -26.96 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 97.75 47.69 -25.92 97.82 49.25 -28.26 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 73.60 65.75 -66.57 75.51 67.67 -67.91 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 8 3 # 8 E 40 ARG E 8 ARG^? 20.19 MG MG E 302 E 41 TYR E 67 TYR^? 21.41 MG MG E 302 E 83 ARG D 173 ARG^? 18.88 MG MG D 301 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 60.42 66.09 -63.48 62.84 64.38 -64.17 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 59.76 57.41 -66.37 62.46 58.08 -67.03 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 100.48 42.57 -42.43 101.55 40.79 -40.06 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 9 3 # 9 E 40 ARG E 48 ARG^? 25.02 MG MG E 302 E 41 TYR F 60 TYR^? 27.07 MG MG E 302 E 83 ARG D 37 ARG^? 18.81 MG MG D 302 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 73.60 65.75 -66.57 75.51 67.67 -67.91 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 79.79 68.64 -68.89 81.11 68.86 -66.46 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 96.81 38.21 -31.63 94.97 36.32 -33.06 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 10 3 # 10 E 40 ARG E 48 ARG^? 25.02 MG MG E 302 E 41 TYR F 60 TYR^? 27.07 MG MG E 302 E 83 ARG D 48 ARG^? 24.87 MG MG D 302 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 73.60 65.75 -66.57 75.51 67.67 -67.91 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 79.79 68.64 -68.89 81.11 68.86 -66.46 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 94.06 41.76 -28.37 96.24 43.38 -26.96 1id3_d00 source 1id3 STRUCTURAL PROTEIN/DNA : 10 hits 1id3_d00 naa= 3 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 1 3 # 1 D 23 LYS A 21 LYS^? 14.51 MG MG A 301 D 25 THR A 18 THR.? 15.77 MG MG A 301 D 27 SER A 16 SER.? 24.16 MG MG A 301 coo 86.60 33.38 44.00 87.05 39.52 42.71 32.50 46.40 37.91 34.61 41.52 40.01 coo 81.20 31.58 48.03 79.23 32.24 47.54 32.02 38.89 33.13 34.18 39.03 32.98 coo 79.09 29.82 54.20 77.17 28.90 53.05 29.26 36.32 27.22 27.38 35.99 25.78 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 2 3 # 2 D 23 LYS A 90 LYS^? 18.58 MG MG A 301 D 25 THR A 70 THR^? 14.66 MG MG A 301 D 27 SER A 49 SER^? 17.63 MG MG A 301 coo 86.60 33.38 44.00 87.05 39.52 42.71 46.62 38.29 25.46 47.51 33.29 23.22 coo 81.20 31.58 48.03 79.23 32.24 47.54 45.68 31.52 26.25 47.33 32.60 27.12 coo 79.09 29.82 54.20 77.17 28.90 53.05 38.68 29.52 26.48 39.52 27.49 25.41 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 3 3 # 3 D 23 LYS B 21 LYS^? 13.97 MG MG B 301 D 25 THR B 18 THR^? 16.08 MG MG B 302 D 27 SER B 16 SER^? 23.97 MG MG B 302 coo 86.60 33.38 44.00 87.05 39.52 42.71 67.50 6.37 -0.39 64.53 11.03 -2.88 coo 81.20 31.58 48.03 79.23 32.24 47.54 60.02 7.32 3.97 60.86 9.29 4.05 coo 79.09 29.82 54.20 77.17 28.90 53.05 56.70 5.18 9.63 55.76 3.58 11.01 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 4 3 # 4 D 23 LYS B 90 LYS^? 18.68 MG MG B 302 D 25 THR B 70 THR^? 14.69 MG MG B 302 D 27 SER B 49 SER^? 17.51 MG MG B 302 coo 86.60 33.38 44.00 87.05 39.52 42.71 61.66 21.61 12.88 56.74 22.88 14.81 coo 81.20 31.58 48.03 79.23 32.24 47.54 54.82 21.76 11.59 56.34 23.17 10.82 coo 79.09 29.82 54.20 77.17 28.90 53.05 51.67 15.70 10.57 49.37 16.19 11.15 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 5 3 # 5 D 23 LYS C 21 LYS^? 14.49 MG MG C 302 D 25 THR C 18 THR^? 15.72 MG MG C 302 D 27 SER C 16 SER^? 24.15 MG MG C 302 coo 86.60 33.38 44.00 87.05 39.52 42.71 72.10 6.87 -6.14 72.84 12.21 -4.93 coo 81.20 31.58 48.03 79.23 32.24 47.54 79.00 10.43 -10.53 77.64 12.10 -10.65 coo 79.09 29.82 54.20 77.17 28.90 53.05 82.88 9.31 -16.30 84.27 7.80 -17.58 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 6 3 # 6 D 23 LYS C 90 LYS^? 18.24 MG MG C 302 D 25 THR C 70 THR^? 14.45 MG MG C 302 D 27 SER C 49 SER^? 17.53 MG MG C 302 coo 86.60 33.38 44.00 87.05 39.52 42.71 72.37 23.25 -18.94 76.11 26.52 -20.97 coo 81.20 31.58 48.03 79.23 32.24 47.54 78.63 25.77 -17.76 76.70 26.55 -17.21 coo 79.09 29.82 54.20 77.17 28.90 53.05 83.83 21.24 -17.13 85.75 22.50 -18.00 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 7 3 # 7 D 23 LYS C 90 LYS^? 18.24 MG MG C 302 D 25 THR C 93 THR^? 16.71 MG MG C 302 D 27 SER C 115 SER^? 5.99 MG MG C 302 coo 86.60 33.38 44.00 87.05 39.52 42.71 72.37 23.25 -18.94 76.11 26.52 -20.97 coo 81.20 31.58 48.03 79.23 32.24 47.54 75.66 31.10 -16.50 76.28 30.99 -18.61 coo 79.09 29.82 54.20 77.17 28.90 53.05 77.67 29.66 -8.53 76.02 29.92 -6.77 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 8 3 # 8 D 23 LYS D 21 LYS^? 14.47 MG MG D 302 D 25 THR D 18 THR^? 15.54 MG MG D 302 D 27 SER D 16 SER^? 23.71 MG MG D 302 coo 86.60 33.38 44.00 87.05 39.52 42.71 90.57 56.85 -44.52 87.39 52.68 -46.00 coo 81.20 31.58 48.03 79.23 32.24 47.54 93.52 49.91 -39.68 91.41 49.57 -39.76 coo 79.09 29.82 54.20 77.17 28.90 53.05 96.73 48.43 -33.75 98.58 48.68 -32.31 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 9 3 # 9 D 23 LYS D 90 LYS^? 18.98 MG MG D 302 D 25 THR D 70 THR^? 14.99 MG MG D 302 D 27 SER D 49 SER^? 17.22 MG MG D 302 coo 86.60 33.38 44.00 87.05 39.52 42.71 79.83 44.38 -31.44 80.32 39.55 -29.40 coo 81.20 31.58 48.03 79.23 32.24 47.54 83.38 38.35 -32.45 81.51 39.04 -33.23 coo 79.09 29.82 54.20 77.17 28.90 53.05 90.26 38.73 -32.99 91.21 36.48 -32.65 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 10 3 # 10 D 23 LYS E 90 LYS^? 19.16 MG MG E 302 D 25 THR E 70 THR^? 14.75 MG MG E 302 D 27 SER E 49 SER^? 17.46 MG MG E 302 coo 86.60 33.38 44.00 87.05 39.52 42.71 73.81 51.50 -63.18 69.15 52.39 -65.65 coo 81.20 31.58 48.03 79.23 32.24 47.54 68.45 55.77 -62.07 68.75 53.75 -61.41 coo 79.09 29.82 54.20 77.17 28.90 53.05 69.86 62.56 -61.93 67.83 63.87 -62.36 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 11 3 # 11 D 23 LYS F 21 LYS^? 14.14 MG MG F 301 D 25 THR F 18 THR^? 15.93 MG MG F 301 D 27 SER F 16 SER^? 24.10 MG MG F 301 coo 86.60 33.38 44.00 87.05 39.52 42.71 35.01 50.26 -88.61 40.89 49.42 -90.41 coo 81.20 31.58 48.03 79.23 32.24 47.54 39.95 55.99 -83.96 41.26 54.27 -83.96 coo 79.09 29.82 54.20 77.17 28.90 53.05 39.77 59.81 -78.14 38.80 61.26 -76.65 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 12 3 # 12 D 23 LYS F 90 LYS^? 18.57 MG MG F 301 D 25 THR F 70 THR^? 14.73 MG MG F 301 D 27 SER F 49 SER^? 17.41 MG MG F 301 coo 86.60 33.38 44.00 87.05 39.52 42.71 51.54 47.01 -75.58 55.05 50.31 -73.74 coo 81.20 31.58 48.03 79.23 32.24 47.54 55.11 52.83 -76.85 55.53 50.86 -77.56 coo 79.09 29.82 54.20 77.17 28.90 53.05 51.43 58.69 -77.53 52.81 60.66 -77.24 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 13 3 # 13 D 23 LYS F 90 LYS^? 18.57 MG MG F 301 D 25 THR F 93 THR^? 16.99 MG MG F 301 D 27 SER F 115 SER^? 6.67 MG MG F 301 coo 86.60 33.38 44.00 87.05 39.52 42.71 51.54 47.01 -75.58 55.05 50.31 -73.74 coo 81.20 31.58 48.03 79.23 32.24 47.54 59.88 48.90 -78.21 59.85 49.68 -76.20 coo 79.09 29.82 54.20 77.17 28.90 53.05 58.74 51.50 -86.07 58.73 49.57 -87.50 1mjo_d00 source 1mjo TRANSCRIPTION/DNA : 13 hits 1mjo_d00 naa= 3 ULMN 4 1orn_d00 HYDROLASE/DNA user 1 4 # 1 A 42 GLN B 53 GLN^? 14.94 MG MG B 302 A 43 CYH B 98 CYH^? 20.05 MG MG B 302 A 44 THR B 99 THR^? 17.59 MG MG B 302 A 82 LEU B 131 LEU^? 14.77 MG MG B 302 coo 39.64 32.76 11.40 39.88 34.83 10.93 46.20 26.35 8.70 46.62 27.22 6.80 coo 44.93 31.14 14.36 45.88 28.73 15.51 45.60 32.73 6.62 42.99 32.75 7.44 coo 48.44 32.33 15.28 48.46 32.64 17.43 45.21 35.64 4.32 46.88 35.89 2.90 coo 38.12 26.67 13.75 37.39 28.72 13.67 42.21 26.02 0.98 42.26 23.91 1.14 ULMN 4 1orn_d00 HYDROLASE/DNA user 2 4 # 2 A 42 GLN F 53 GLN^? 15.06 MG MG F 301 A 43 CYH F 98 CYH^? 20.19 MG MG F 301 A 44 THR F 99 THR^? 17.65 MG MG F 301 A 82 LEU F 131 LEU^? 14.81 MG MG F 301 coo 39.64 32.76 11.40 39.88 34.83 10.93 63.34 58.26 -79.73 63.90 57.42 -81.62 coo 44.93 31.14 14.36 45.88 28.73 15.51 69.09 55.56 -81.88 70.41 57.83 -80.99 coo 48.44 32.33 15.28 48.46 32.64 17.43 71.75 54.31 -84.19 71.11 53.07 -85.87 coo 38.12 26.67 13.75 37.39 28.72 13.67 64.89 61.59 -87.10 63.34 63.04 -87.61 1orn_d00 source 1orn HYDROLASE/DNA : 2 hits 1orn_d00 naa= 4 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 1 3 # 1 A 40 LYS A 6 LYS^? 25.88 MG MG A 301 A 41 LYS A 157 LYS^? 28.65 MG MG A 302 A 42 ILE A 7 ILE^? 21.07 MG MG A 301 coo 36.07 63.73 124.22 32.72 60.75 122.39 46.20 12.82 24.71 44.50 16.64 20.52 coo 38.49 66.12 125.64 35.69 66.71 131.25 41.42 12.06 27.58 41.46 5.93 29.41 coo 41.08 63.27 123.17 40.13 62.43 122.44 45.81 14.75 29.06 45.10 13.95 30.11 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 2 3 # 2 A 40 LYS A 157 LYS^? 28.65 MG MG A 302 A 41 LYS A 6 LYS^? 25.88 MG MG A 301 A 42 ILE A 7 ILE^? 21.07 MG MG A 301 coo 36.07 63.73 124.22 32.72 60.75 122.39 41.42 12.06 27.58 41.46 5.93 29.41 coo 38.49 66.12 125.64 35.69 66.71 131.25 46.20 12.82 24.71 44.50 16.64 20.52 coo 41.08 63.27 123.17 40.13 62.43 122.44 45.81 14.75 29.06 45.10 13.95 30.11 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 3 3 # 3 A 40 LYS B 6 LYS^? 25.90 MG MG B 302 A 41 LYS B 157 LYS^? 28.85 MG MG B 302 A 42 ILE B 7 ILE^? 21.00 MG MG B 302 coo 36.07 63.73 124.22 32.72 60.75 122.39 36.26 25.44 11.74 39.65 23.12 16.29 coo 38.49 66.12 125.64 35.69 66.71 131.25 34.97 21.28 8.44 29.03 22.82 6.58 coo 41.08 63.27 123.17 40.13 62.43 122.44 38.55 25.14 7.56 37.66 24.77 6.38 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 4 3 # 4 A 40 LYS B 157 LYS^? 28.85 MG MG B 302 A 41 LYS B 6 LYS^? 25.90 MG MG B 302 A 42 ILE B 5 ILE^? 28.18 MG MG B 302 coo 36.07 63.73 124.22 32.72 60.75 122.39 34.97 21.28 8.44 29.03 22.82 6.58 coo 38.49 66.12 125.64 35.69 66.71 131.25 36.26 25.44 11.74 39.65 23.12 16.29 coo 41.08 63.27 123.17 40.13 62.43 122.44 31.93 27.22 10.78 32.19 27.23 9.93 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 5 3 # 5 A 40 LYS B 157 LYS^? 28.85 MG MG B 302 A 41 LYS B 6 LYS^? 25.90 MG MG B 302 A 42 ILE B 7 ILE^? 21.00 MG MG B 302 coo 36.07 63.73 124.22 32.72 60.75 122.39 34.97 21.28 8.44 29.03 22.82 6.58 coo 38.49 66.12 125.64 35.69 66.71 131.25 36.26 25.44 11.74 39.65 23.12 16.29 coo 41.08 63.27 123.17 40.13 62.43 122.44 38.55 25.14 7.56 37.66 24.77 6.38 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 6 3 # 6 A 40 LYS D 6 LYS^? 25.98 MG MG D 302 A 41 LYS D 157 LYS^? 28.67 MG MG D 302 A 42 ILE D 7 ILE^? 20.93 MG MG D 302 coo 36.07 63.73 124.22 32.72 60.75 122.39 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 38.49 66.12 125.64 35.69 66.71 131.25 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 41.08 63.27 123.17 40.13 62.43 122.44 89.03 22.73 -35.87 89.94 22.01 -36.86 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 7 3 # 7 A 40 LYS D 157 LYS^? 28.67 MG MG D 302 A 41 LYS D 6 LYS^? 25.98 MG MG D 302 A 42 ILE D 7 ILE^? 20.93 MG MG D 302 coo 36.07 63.73 124.22 32.72 60.75 122.39 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 38.49 66.12 125.64 35.69 66.71 131.25 89.78 20.68 -31.57 90.15 24.89 -27.02 coo 41.08 63.27 123.17 40.13 62.43 122.44 89.03 22.73 -35.87 89.94 22.01 -36.86 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 8 3 # 8 A 40 LYS E 6 LYS^? 25.59 MG MG E 302 A 41 LYS E 157 LYS^? 28.40 MG MG E 302 A 42 ILE E 7 ILE^? 20.91 MG MG E 302 coo 36.07 63.73 124.22 32.72 60.75 122.39 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 38.49 66.12 125.64 35.69 66.71 131.25 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 41.08 63.27 123.17 40.13 62.43 122.44 53.75 63.88 -58.98 53.36 64.78 -57.73 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 9 3 # 9 A 40 LYS E 157 LYS^? 28.40 MG MG E 302 A 41 LYS E 6 LYS^? 25.59 MG MG E 302 A 42 ILE E 7 ILE^? 20.91 MG MG E 302 coo 36.07 63.73 124.22 32.72 60.75 122.39 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 38.49 66.12 125.64 35.69 66.71 131.25 51.95 64.70 -63.33 56.16 64.03 -67.52 coo 41.08 63.27 123.17 40.13 62.43 122.44 53.75 63.88 -58.98 53.36 64.78 -57.73 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 10 3 # 10 A 40 LYS F 6 LYS^? 26.09 MG MG F 301 A 41 LYS F 157 LYS^? 28.36 MG MG F 302 A 42 ILE F 7 ILE^? 21.04 MG MG F 301 coo 36.07 63.73 124.22 32.72 60.75 122.39 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 38.49 66.12 125.64 35.69 66.71 131.25 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 41.08 63.27 123.17 40.13 62.43 122.44 66.12 65.31 -80.72 66.15 66.34 -81.81 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 11 3 # 11 A 40 LYS F 157 LYS^? 28.36 MG MG F 302 A 41 LYS F 6 LYS^? 26.09 MG MG F 301 A 42 ILE F 5 ILE^? 28.12 MG MG F 301 coo 36.07 63.73 124.22 32.72 60.75 122.39 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 38.49 66.12 125.64 35.69 66.71 131.25 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 41.08 63.27 123.17 40.13 62.43 122.44 70.87 70.15 -77.59 70.92 69.96 -78.47 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 12 3 # 12 A 40 LYS F 157 LYS^? 28.36 MG MG F 302 A 41 LYS F 6 LYS^? 26.09 MG MG F 301 A 42 ILE F 7 ILE^? 21.04 MG MG F 301 coo 36.07 63.73 124.22 32.72 60.75 122.39 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 38.49 66.12 125.64 35.69 66.71 131.25 67.53 67.03 -76.43 64.05 65.33 -71.86 coo 41.08 63.27 123.17 40.13 62.43 122.44 66.12 65.31 -80.72 66.15 66.34 -81.81 1pyi_d00 source 1pyi PROTEIN (PYRIMIDINE PATHWAY REGULATOR 1) : 12 hits 1pyi_d00 naa= 3 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 1 3 # 1 A1290 LYS A 111 LYS^? 15.16 MG MG A 301 A1294 ASN A 132 ASN^? 16.38 MG MG A 301 A1297 GLU A 146 GLU^? 9.80 MG MG A 302 coo 39.24 18.84-161.99 36.62 21.47-165.99 52.67 17.19 35.90 54.65 19.90 40.50 coo 33.53 17.37-161.81 34.31 17.81-163.76 50.16 14.55 39.76 50.61 16.24 40.93 coo 29.78 23.31-161.30 31.23 23.66-162.84 45.17 20.35 44.20 46.68 21.21 45.40 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 2 3 # 2 A1290 LYS B 111 LYS^? 13.75 MG MG B 302 A1294 ASN B 132 ASN^? 16.42 MG MG B 302 A1297 GLU B 146 GLU^? 10.54 MG MG B 301 coo 39.24 18.84-161.99 36.62 21.47-165.99 42.84 32.14 1.80 46.84 32.68 -2.87 coo 33.53 17.37-161.81 34.31 17.81-163.76 40.27 30.00 -2.76 41.98 31.07 -3.41 coo 29.78 23.31-161.30 31.23 23.66-162.84 45.13 24.51 -7.01 46.08 25.99 -8.13 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 3 3 # 3 A1290 LYS C 111 LYS^? 16.56 MG MG C 302 A1294 ASN C 132 ASN^? 16.52 MG MG C 302 A1297 GLU C 146 GLU^? 10.46 MG MG C 301 coo 39.24 18.84-161.99 36.62 21.47-165.99 86.36 39.56 -8.06 84.36 40.84 -3.15 coo 33.53 17.37-161.81 34.31 17.81-163.76 89.66 38.54 -3.77 87.74 38.77 -2.97 coo 29.78 23.31-161.30 31.23 23.66-162.84 87.01 31.93 0.25 85.57 32.56 1.72 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 4 3 # 4 A1290 LYS E 111 LYS^? 14.52 MG MG E 302 A1294 ASN E 132 ASN^? 16.39 MG MG E 302 A1297 GLU E 146 GLU^? 10.15 MG MG E 301 coo 39.24 18.84-161.99 36.62 21.47-165.99 52.49 56.44 -52.43 54.52 53.78 -47.52 coo 33.53 17.37-161.81 34.31 17.81-163.76 51.80 60.19 -48.38 52.68 58.51 -47.42 coo 29.78 23.31-161.30 31.23 23.66-162.84 58.72 60.89 -44.51 59.23 60.24 -42.54 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 5 3 # 5 A1290 LYS F 111 LYS^? 15.21 MG MG F 301 A1294 ASN F 132 ASN^? 16.48 MG MG F 301 A1297 GLU F 146 GLU^? 10.36 MG MG F 302 coo 39.24 18.84-161.99 36.62 21.47-165.99 69.70 58.57 -86.86 69.67 53.74 -90.29 coo 33.53 17.37-161.81 34.31 17.81-163.76 69.23 61.88 -90.93 69.10 59.95 -91.77 coo 29.78 23.31-161.30 31.23 23.66-162.84 61.95 60.17 -95.28 62.87 58.56 -96.19 1xpx_d00 source 1xpx TRANSCRIPTION REGULATION/DNA : 5 hits 1xpx_d00 naa= 3 ULMN 4 1zme_d00 TRANSCRIPTION/DNA user 1 4 # 1 D 41 HIS A 170 HIS^? 10.56 MG MG A 302 D 67 LYS A 157 LYS^? 28.65 MG MG A 302 D 69 ILE A 5 ILE^? 28.35 MG MG A 301 D 70 VAL A 57 VAL^? 27.19 MG MG A 301 coo 33.21 28.24 12.68 34.93 27.24 13.36 34.91 23.57 39.32 34.35 24.95 40.81 coo 43.60 24.24 -2.92 40.98 22.76 -1.01 41.42 12.06 27.58 41.46 5.93 29.41 coo 45.09 17.16 -5.36 44.78 17.47 -6.67 46.97 8.09 25.49 46.80 8.12 26.34 coo 48.05 14.52 -3.67 47.42 13.00 -2.17 51.92 10.88 25.16 52.00 9.88 27.05 ULMN 4 1zme_d00 TRANSCRIPTION/DNA user 2 4 # 2 D 41 HIS B 170 HIS^? 10.51 MG MG B 301 D 67 LYS B 157 LYS^? 28.85 MG MG B 302 D 69 ILE B 5 ILE^? 28.18 MG MG B 302 D 70 VAL B 57 VAL^? 27.23 MG MG B 302 coo 33.21 28.24 12.68 34.93 27.24 13.36 46.22 13.75 -2.72 47.53 13.11 -4.24 coo 43.60 24.24 -2.92 40.98 22.76 -1.01 34.97 21.28 8.44 29.03 22.82 6.58 coo 45.09 17.16 -5.36 44.78 17.47 -6.67 31.93 27.22 10.78 32.19 27.23 9.93 coo 48.05 14.52 -3.67 47.42 13.00 -2.17 35.51 31.68 11.79 34.41 31.67 9.89 ULMN 4 1zme_d00 TRANSCRIPTION/DNA user 3 4 # 3 D 41 HIS C 170 HIS^? 10.68 MG MG C 301 D 67 LYS C 157 LYS^? 28.15 MG MG C 302 D 69 ILE C 5 ILE^? 27.99 MG MG C 302 D 70 VAL C 57 VAL^? 26.99 MG MG C 302 coo 33.21 28.24 12.68 34.93 27.24 13.36 89.96 21.05 -3.85 88.74 19.88 -2.61 coo 43.60 24.24 -2.92 40.98 22.76 -1.01 97.55 32.04 -15.10 101.49 36.24 -13.39 coo 45.09 17.16 -5.36 44.78 17.47 -6.67 97.43 38.97 -17.17 98.71 38.70 -16.25 coo 48.05 14.52 -3.67 47.42 13.00 -2.17 93.03 41.79 -18.34 94.13 41.98 -16.42 ULMN 4 1zme_d00 TRANSCRIPTION/DNA user 4 4 # 4 D 41 HIS D 170 HIS^? 10.59 MG MG D 301 D 67 LYS D 157 LYS^? 28.67 MG MG D 302 D 69 ILE D 5 ILE^? 28.18 MG MG D 302 D 70 VAL D 57 VAL^? 27.17 MG MG D 302 coo 33.21 28.24 12.68 34.93 27.24 13.36 95.57 34.81 -46.05 95.59 36.24 -47.59 coo 43.60 24.24 -2.92 40.98 22.76 -1.01 94.17 21.71 -34.34 96.11 15.89 -35.92 coo 45.09 17.16 -5.36 44.78 17.47 -6.67 90.32 16.10 -32.21 90.23 15.98 -33.22 coo 48.05 14.52 -3.67 47.42 13.00 -2.17 84.62 16.81 -31.71 85.26 16.00 -33.66 ULMN 4 1zme_d00 TRANSCRIPTION/DNA user 5 4 # 5 D 41 HIS E 170 HIS^? 10.33 MG MG E 301 D 67 LYS E 157 LYS^? 28.40 MG MG E 302 D 69 ILE E 5 ILE^? 28.19 MG MG E 302 D 70 VAL E 57 VAL^? 27.05 MG MG E 302 coo 33.21 28.24 12.68 34.93 27.24 13.36 66.96 68.76 -48.87 68.36 68.54 -47.33 coo 43.60 24.24 -2.92 40.98 22.76 -1.01 53.63 69.16 -60.42 48.34 71.81 -58.40 coo 45.09 17.16 -5.36 44.78 17.47 -6.67 47.35 66.12 -62.41 47.45 66.08 -61.64 coo 48.05 14.52 -3.67 47.42 13.00 -2.17 47.41 60.37 -62.88 46.53 61.21 -61.05 ULMN 4 1zme_d00 TRANSCRIPTION/DNA user 6 4 # 6 D 41 HIS F 170 HIS^? 9.84 MG MG F 302 D 67 LYS F 157 LYS^? 28.36 MG MG F 302 D 69 ILE F 5 ILE^? 28.12 MG MG F 301 D 70 VAL F 57 VAL^? 27.33 MG MG F 301 coo 33.21 28.24 12.68 34.93 27.24 13.36 52.25 64.82 -90.91 50.95 63.88 -92.26 coo 43.60 24.24 -2.92 40.98 22.76 -1.01 64.43 70.47 -79.54 68.32 74.80 -81.65 coo 45.09 17.16 -5.36 44.78 17.47 -6.67 70.87 70.15 -77.59 70.92 69.96 -78.47 coo 48.05 14.52 -3.67 47.42 13.00 -2.17 73.34 64.65 -76.61 73.69 65.86 -78.43 1zme_d00 source 1zme TRANSCRIPTION/DNA : 6 hits 1zme_d00 naa= 4 ULMN 4 2bgw_d00 HYDROLASE user 1 4 # 1 A 86 ALA A 9 ALA^? 15.22 MG MG A 301 A 87 GLU A 52 GLU^? 19.89 MG MG A 301 A 123 TYR A 129 TYR^? 10.90 MG MG A 301 A 182 ARG A 8 ARG^? 20.36 MG MG A 301 coo 33.66 63.14 16.62 34.95 63.46 15.91 42.54 20.81 29.78 43.62 21.07 30.77 coo 28.97 64.99 12.92 27.92 64.06 11.28 42.67 25.16 24.80 42.61 25.77 22.75 coo 38.40 63.73 13.00 38.79 62.53 10.47 44.80 23.54 35.75 45.57 23.36 33.08 coo 29.35 67.59 19.60 30.93 68.47 17.09 40.62 19.52 24.63 40.98 22.51 23.88 ULMN 4 2bgw_d00 HYDROLASE user 2 4 # 2 A 86 ALA A 9 ALA^? 15.22 MG MG A 301 A 87 GLU A 154 GLU^? 19.22 MG MG A 301 A 123 TYR A 129 TYR^? 10.90 MG MG A 301 A 182 ARG A 8 ARG^? 20.36 MG MG A 301 coo 33.66 63.14 16.62 34.95 63.46 15.91 42.54 20.81 29.78 43.62 21.07 30.77 coo 28.97 64.99 12.92 27.92 64.06 11.28 36.54 21.95 29.78 35.14 22.21 28.17 coo 38.40 63.73 13.00 38.79 62.53 10.47 44.80 23.54 35.75 45.57 23.36 33.08 coo 29.35 67.59 19.60 30.93 68.47 17.09 40.62 19.52 24.63 40.98 22.51 23.88 ULMN 4 2bgw_d00 HYDROLASE user 3 4 # 3 A 86 ALA B 9 ALA^? 15.20 MG MG B 302 A 87 GLU B 52 GLU^? 20.06 MG MG B 302 A 123 TYR B 129 TYR^? 10.63 MG MG B 302 A 182 ARG B 8 ARG^? 20.39 MG MG B 302 coo 33.66 63.14 16.62 34.95 63.46 15.91 44.07 20.95 7.16 44.62 22.08 6.31 coo 28.97 64.99 12.92 27.92 64.06 11.28 47.87 20.25 12.36 48.11 19.69 14.43 coo 38.40 63.73 13.00 38.79 62.53 10.47 47.85 23.00 1.51 47.62 23.50 4.24 coo 29.35 67.59 19.60 30.93 68.47 17.09 41.99 18.82 11.83 44.91 18.76 12.93 ULMN 4 2bgw_d00 HYDROLASE user 4 4 # 4 A 86 ALA B 9 ALA^? 15.20 MG MG B 302 A 87 GLU B 154 GLU^? 19.05 MG MG B 302 A 123 TYR B 129 TYR^? 10.63 MG MG B 302 A 182 ARG B 8 ARG^? 20.39 MG MG B 302 coo 33.66 63.14 16.62 34.95 63.46 15.91 44.07 20.95 7.16 44.62 22.08 6.31 coo 28.97 64.99 12.92 27.92 64.06 11.28 44.04 15.11 6.74 44.19 13.59 8.30 coo 38.40 63.73 13.00 38.79 62.53 10.47 47.85 23.00 1.51 47.62 23.50 4.24 coo 29.35 67.59 19.60 30.93 68.47 17.09 41.99 18.82 11.83 44.91 18.76 12.93 ULMN 4 2bgw_d00 HYDROLASE user 5 4 # 5 A 86 ALA C 9 ALA^? 15.00 MG MG C 302 A 87 GLU C 154 GLU^? 18.91 MG MG C 302 A 123 TYR C 129 TYR^? 10.65 MG MG C 302 A 182 ARG C 8 ARG^? 20.00 MG MG C 302 coo 33.66 63.14 16.62 34.95 63.46 15.91 89.05 28.81 -13.58 88.16 29.64 -12.74 coo 28.97 64.99 12.92 27.92 64.06 11.28 91.15 23.27 -13.33 91.61 21.91 -14.95 coo 38.40 63.73 13.00 38.79 62.53 10.47 84.95 29.43 -7.96 85.04 30.16 -10.69 coo 29.35 67.59 19.60 30.93 68.47 17.09 91.42 27.61 -18.53 88.82 26.28 -19.38 ULMN 4 2bgw_d00 HYDROLASE user 6 4 # 6 A 86 ALA D 9 ALA^? 15.02 MG MG D 302 A 87 GLU D 52 GLU^? 19.94 MG MG D 302 A 123 TYR D 129 TYR^? 10.79 MG MG D 302 A 182 ARG D 8 ARG^? 20.22 MG MG D 302 coo 33.66 63.14 16.62 34.95 63.46 15.91 89.67 29.50 -36.34 88.55 29.40 -37.31 coo 28.97 64.99 12.92 27.92 64.06 11.28 87.13 33.17 -30.97 88.40 33.70 -29.31 coo 38.40 63.73 13.00 38.79 62.53 10.47 86.45 31.36 -42.20 86.02 30.90 -39.46 coo 29.35 67.59 19.60 30.93 68.47 17.09 92.22 28.83 -31.23 90.93 31.55 -30.54 ULMN 4 2bgw_d00 HYDROLASE user 7 4 # 7 A 86 ALA D 9 ALA^? 15.02 MG MG D 302 A 87 GLU D 154 GLU^? 18.75 MG MG D 302 A 123 TYR D 129 TYR^? 10.79 MG MG D 302 A 182 ARG D 8 ARG^? 20.22 MG MG D 302 coo 33.66 63.14 16.62 34.95 63.46 15.91 89.67 29.50 -36.34 88.55 29.40 -37.31 coo 28.97 64.99 12.92 27.92 64.06 11.28 94.87 32.52 -36.42 96.07 33.39 -34.88 coo 38.40 63.73 13.00 38.79 62.53 10.47 86.45 31.36 -42.20 86.02 30.90 -39.46 coo 29.35 67.59 19.60 30.93 68.47 17.09 92.22 28.83 -31.23 90.93 31.55 -30.54 ULMN 4 2bgw_d00 HYDROLASE user 8 4 # 8 A 86 ALA E 9 ALA^? 15.19 MG MG E 302 A 87 GLU E 52 GLU^? 19.96 MG MG E 302 A 123 TYR E 129 TYR^? 10.89 MG MG E 302 A 182 ARG E 8 ARG^? 20.19 MG MG E 302 coo 33.66 63.14 16.62 34.95 63.46 15.91 60.74 63.76 -58.54 60.44 62.76 -57.48 coo 28.97 64.99 12.92 27.92 64.06 11.28 64.71 60.06 -63.78 64.69 61.36 -65.58 coo 38.40 63.73 13.00 38.79 62.53 10.47 62.09 60.15 -52.83 61.47 59.53 -55.45 coo 29.35 67.59 19.60 30.93 68.47 17.09 60.42 66.09 -63.48 62.84 64.38 -64.17 ULMN 4 2bgw_d00 HYDROLASE user 9 4 # 9 A 86 ALA E 9 ALA^? 15.19 MG MG E 302 A 87 GLU E 154 GLU^? 19.05 MG MG E 302 A 123 TYR E 129 TYR^? 10.89 MG MG E 302 A 182 ARG E 8 ARG^? 20.19 MG MG E 302 coo 33.66 63.14 16.62 34.95 63.46 15.91 60.74 63.76 -58.54 60.44 62.76 -57.48 coo 28.97 64.99 12.92 27.92 64.06 11.28 64.41 68.21 -58.47 65.40 69.20 -60.08 coo 38.40 63.73 13.00 38.79 62.53 10.47 62.09 60.15 -52.83 61.47 59.53 -55.45 coo 29.35 67.59 19.60 30.93 68.47 17.09 60.42 66.09 -63.48 62.84 64.38 -64.17 ULMN 4 2bgw_d00 HYDROLASE user 10 4 # 10 A 86 ALA F 9 ALA^? 15.22 MG MG F 301 A 87 GLU F 52 GLU^? 20.13 MG MG F 301 A 123 TYR F 129 TYR^? 10.92 MG MG F 301 A 182 ARG F 8 ARG^? 20.20 MG MG F 301 coo 33.66 63.14 16.62 34.95 63.46 15.91 59.78 62.63 -81.12 60.54 61.63 -82.00 coo 28.97 64.99 12.92 27.92 64.06 11.28 57.09 59.62 -75.76 56.76 59.40 -73.62 coo 38.40 63.73 13.00 38.79 62.53 10.47 59.69 58.61 -86.67 60.36 58.48 -83.96 coo 29.35 67.59 19.60 30.93 68.47 17.09 58.98 65.22 -76.31 57.29 62.84 -75.38 ULMN 4 2bgw_d00 HYDROLASE user 11 4 # 11 A 86 ALA F 9 ALA^? 15.22 MG MG F 301 A 87 GLU F 154 GLU^? 18.97 MG MG F 301 A 123 TYR F 129 TYR^? 10.92 MG MG F 301 A 182 ARG F 8 ARG^? 20.20 MG MG F 301 coo 33.66 63.14 16.62 34.95 63.46 15.91 59.78 62.63 -81.12 60.54 61.63 -82.00 coo 28.97 64.99 12.92 27.92 64.06 11.28 54.57 65.67 -81.55 53.36 66.51 -80.09 coo 38.40 63.73 13.00 38.79 62.53 10.47 59.69 58.61 -86.67 60.36 58.48 -83.96 coo 29.35 67.59 19.60 30.93 68.47 17.09 58.98 65.22 -76.31 57.29 62.84 -75.38 2bgw_d00 source 2bgw HYDROLASE : 11 hits 2bgw_d00 naa= 4 ULMN 3 2bsq_d00 TRANSCRIPTION user 1 3 # 1 E 3 SER A 49 SER^? 17.63 MG MG A 301 E 5 VAL A 44 VAL^? 23.47 MG MG A 301 E 7 ARG A 8 ARG^? 20.36 MG MG A 301 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 38.68 29.52 26.48 39.52 27.49 25.41 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 40.71 23.59 20.27 42.01 21.87 20.17 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 40.62 19.52 24.63 40.98 22.51 23.88 ULMN 3 2bsq_d00 TRANSCRIPTION user 2 3 # 2 E 3 SER A 115 SER^? 6.34 MG MG A 301 E 5 VAL A 51 VAL^? 12.03 MG MG A 301 E 7 ARG A 50 ARG^? 15.98 MG MG A 301 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 48.89 29.76 35.69 49.85 31.26 37.35 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 43.52 28.75 29.06 44.81 28.70 30.86 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 38.44 33.02 29.31 39.55 34.58 26.90 ULMN 3 2bsq_d00 TRANSCRIPTION user 3 3 # 3 E 3 SER B 49 SER^? 17.51 MG MG B 302 E 5 VAL B 44 VAL^? 23.27 MG MG B 302 E 7 ARG B 8 ARG^? 20.39 MG MG B 302 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 51.67 15.70 10.57 49.37 16.19 11.15 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 45.60 17.91 16.34 44.07 19.42 16.19 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 41.99 18.82 11.83 44.91 18.76 12.93 ULMN 3 2bsq_d00 TRANSCRIPTION user 4 3 # 4 E 3 SER B 115 SER^? 6.48 MG MG B 302 E 5 VAL B 51 VAL^? 12.05 MG MG B 302 E 7 ARG B 50 ARG^? 16.38 MG MG B 302 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 54.36 25.96 2.48 56.06 26.75 0.95 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 51.95 20.40 8.31 52.20 21.83 6.69 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 55.38 14.91 7.80 56.60 14.73 10.62 ULMN 3 2bsq_d00 TRANSCRIPTION user 5 3 # 5 E 3 SER C 115 SER^? 5.99 MG MG C 302 E 5 VAL C 51 VAL^? 11.91 MG MG C 302 E 7 ARG C 50 ARG^? 16.05 MG MG C 302 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 77.67 29.66 -8.53 76.02 29.92 -6.77 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 81.87 25.44 -14.84 81.15 26.76 -13.28 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 80.61 19.03 -14.42 79.16 18.55 -17.10 ULMN 3 2bsq_d00 TRANSCRIPTION user 6 3 # 6 E 3 SER D 10 SER^? 16.71 MG MG D 302 E 5 VAL D 51 VAL^? 12.02 MG MG D 302 E 7 ARG D 50 ARG^? 16.15 MG MG D 302 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 90.76 33.07 -35.81 92.04 34.36 -34.16 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 86.07 36.61 -35.50 84.81 36.17 -37.23 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 88.00 43.26 -36.30 88.86 43.23 -33.34 ULMN 3 2bsq_d00 TRANSCRIPTION user 7 3 # 7 E 3 SER D 49 SER^? 17.22 MG MG D 302 E 5 VAL D 44 VAL^? 23.17 MG MG D 302 E 7 ARG D 8 ARG^? 20.22 MG MG D 302 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 90.26 38.73 -32.99 91.21 36.48 -32.65 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 90.88 32.60 -27.10 90.06 30.62 -26.95 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 92.22 28.83 -31.23 90.93 31.55 -30.54 ULMN 3 2bsq_d00 TRANSCRIPTION user 8 3 # 8 E 3 SER D 115 SER^? 7.08 MG MG D 302 E 5 VAL D 51 VAL^? 12.02 MG MG D 302 E 7 ARG D 50 ARG^? 16.15 MG MG D 302 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 80.50 35.70 -41.83 78.94 36.81 -43.34 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 86.07 36.61 -35.50 84.81 36.17 -37.23 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 88.00 43.26 -36.30 88.86 43.23 -33.34 ULMN 3 2bsq_d00 TRANSCRIPTION user 9 3 # 9 E 3 SER E 49 SER^? 17.46 MG MG E 302 E 5 VAL E 44 VAL^? 23.25 MG MG E 302 E 7 ARG E 8 ARG^? 20.19 MG MG E 302 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 69.86 62.56 -61.93 67.83 63.87 -62.36 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 63.87 63.92 -67.77 61.69 63.98 -67.81 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 60.42 66.09 -63.48 62.84 64.38 -64.17 ULMN 3 2bsq_d00 TRANSCRIPTION user 10 3 # 10 E 3 SER E 115 SER^? 6.17 MG MG E 302 E 5 VAL E 51 VAL^? 11.96 MG MG E 302 E 7 ARG E 50 ARG^? 15.97 MG MG E 302 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 65.46 53.67 -52.76 66.19 52.26 -50.99 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 67.08 58.90 -59.21 66.40 57.78 -57.49 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 73.62 60.83 -58.23 74.10 60.41 -61.24 ULMN 3 2bsq_d00 TRANSCRIPTION user 11 3 # 11 E 3 SER F 115 SER^? 6.67 MG MG F 301 E 5 VAL F 51 VAL^? 12.06 MG MG F 301 E 7 ARG F 50 ARG^? 16.24 MG MG F 301 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 58.74 51.50 -86.07 58.73 49.57 -87.50 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 55.39 56.14 -80.00 56.48 55.14 -81.60 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 48.85 56.05 -80.24 48.26 54.66 -77.55 2bsq_d00 source 2bsq TRANSCRIPTION : 11 hits 2bsq_d00 naa= 3 ULMN 3 2er8_d00 TRANSCRIPTION ACTIVATOR/DNA user 1 3 # 1 C 43 GLN B 144 GLN^? 20.13 MG MG B 301 C 44 LYS B 192 LYS^? 23.73 MG MG B 301 C 75 ARG B 193 ARG^? 28.40 MG MG B 301 coo 34.33 34.01 1.06 32.24 34.35 1.22 37.08 26.58 -5.56 36.43 28.52 -6.04 coo 36.27 30.15 5.40 32.93 24.83 5.96 33.83 21.17 -2.93 31.87 16.45 -0.74 coo 30.88 29.31 6.12 29.39 29.02 3.47 29.25 23.93 -4.74 26.96 25.70 -3.52 ULMN 3 2er8_d00 TRANSCRIPTION ACTIVATOR/DNA user 2 3 # 2 C 43 GLN D 144 GLN^? 19.85 MG MG D 301 C 44 LYS D 192 LYS^? 24.09 MG MG D 301 C 75 ARG D 193 ARG^? 27.92 MG MG D 301 coo 34.33 34.01 1.06 32.24 34.35 1.22 89.60 20.24 -48.38 88.70 18.97 -49.74 coo 36.27 30.15 5.40 32.93 24.83 5.96 95.35 20.28 -45.75 100.42 20.77 -43.05 coo 30.88 29.31 6.12 29.39 29.02 3.47 95.76 15.06 -47.43 94.58 12.31 -46.69 ULMN 3 2er8_d00 TRANSCRIPTION ACTIVATOR/DNA user 3 3 # 3 C 43 GLN E 144 GLN^? 20.26 MG MG E 301 C 44 LYS E 192 LYS^? 23.62 MG MG E 301 C 75 ARG E 193 ARG^? 28.25 MG MG E 301 coo 34.33 34.01 1.06 32.24 34.35 1.22 51.74 64.42 -45.34 50.01 64.85 -46.49 coo 36.27 30.15 5.40 32.93 24.83 5.96 52.64 70.58 -49.14 53.48 75.40 -50.95 coo 30.88 29.31 6.12 29.39 29.02 3.47 47.02 71.25 -47.53 44.19 71.23 -48.93 ULMN 3 2er8_d00 TRANSCRIPTION ACTIVATOR/DNA user 4 3 # 4 C 43 GLN F 144 GLN^? 20.16 MG MG F 302 C 44 LYS F 192 LYS^? 23.61 MG MG F 302 C 75 ARG F 193 ARG^? 27.27 MG MG F 302 coo 34.33 34.01 1.06 32.24 34.35 1.22 68.06 66.27 -93.88 70.14 65.97 -94.00 coo 36.27 30.15 5.40 32.93 24.83 5.96 64.82 71.59 -91.06 62.22 76.11 -88.75 coo 30.88 29.31 6.12 29.39 29.02 3.47 70.24 75.04 -91.81 72.97 73.73 -92.20 2er8_d00 source 2er8 TRANSCRIPTION ACTIVATOR/DNA : 4 hits 2er8_d00 naa= 3 ULMN 5 2han_d00 TRANSCRIPTION/DNA user 1 5 # 1 A 25 GLU C 165 GLU^? 29.32 MG MG C 302 A 28 LYS C 157 LYS^? 28.15 MG MG C 302 A 32 LYS C 6 LYS^? 25.73 MG MG C 302 A 33 ARG C 8 ARG^? 20.00 MG MG C 302 A 81 ARG D 37 ARG^? 18.81 MG MG D 302 coo 10.24 25.49 10.40 8.96 25.32 8.75 103.18 29.99 -15.18 103.57 32.09 -14.86 coo 4.58 29.63 10.22 6.70 24.77 6.53 97.55 32.04 -15.10 101.49 36.24 -13.39 coo -1.33 28.24 9.83 -0.35 22.69 10.41 94.42 35.68 -18.56 92.21 32.03 -23.05 coo -1.24 24.36 15.23 1.58 25.45 15.90 91.42 27.61 -18.53 88.82 26.28 -19.38 coo -2.79 20.37 -0.06 0.13 20.84 -1.00 96.81 38.21 -31.63 94.97 36.32 -33.06 ULMN 5 2han_d00 TRANSCRIPTION/DNA user 2 5 # 2 A 25 GLU E 165 GLU^? 29.48 MG MG E 301 A 28 LYS E 157 LYS^? 28.40 MG MG E 302 A 32 LYS E 6 LYS^? 25.59 MG MG E 302 A 33 ARG E 8 ARG^? 20.19 MG MG E 302 A 81 ARG F 37 ARG^? 19.14 MG MG F 301 coo 10.24 25.49 10.40 8.96 25.32 8.75 52.92 74.97 -61.04 50.84 74.87 -60.51 coo 4.58 29.63 10.22 6.70 24.77 6.53 53.63 69.16 -60.42 48.34 71.81 -58.40 coo -1.33 28.24 9.83 -0.35 22.69 10.41 51.95 64.70 -63.33 56.16 64.03 -67.52 coo -1.24 24.36 15.23 1.58 25.45 15.90 60.42 66.09 -63.48 62.84 64.38 -64.17 coo -2.79 20.37 -0.06 0.13 20.84 -1.00 48.80 64.46 -76.37 51.50 64.15 -77.79 ULMN 5 2han_d00 TRANSCRIPTION/DNA user 3 5 # 3 A 25 GLU E 165 GLU^? 29.48 MG MG E 301 A 28 LYS E 157 LYS^? 28.40 MG MG E 302 A 32 LYS E 6 LYS^? 25.59 MG MG E 302 A 33 ARG E 8 ARG^? 20.19 MG MG E 302 A 81 ARG F 48 ARG^? 25.18 MG MG F 301 coo 10.24 25.49 10.40 8.96 25.32 8.75 52.92 74.97 -61.04 50.84 74.87 -60.51 coo 4.58 29.63 10.22 6.70 24.77 6.53 53.63 69.16 -60.42 48.34 71.81 -58.40 coo -1.33 28.24 9.83 -0.35 22.69 10.41 51.95 64.70 -63.33 56.16 64.03 -67.52 coo -1.24 24.36 15.23 1.58 25.45 15.90 60.42 66.09 -63.48 62.84 64.38 -64.17 coo -2.79 20.37 -0.06 0.13 20.84 -1.00 46.82 60.90 -73.07 44.43 61.88 -71.46 2han_d00 source 2han TRANSCRIPTION/DNA : 3 hits 2han_d00 naa= 5 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 5 ARG A 193 ARG^? 28.88 MG MG A 302 A 50 LYS A 111 LYS^? 15.16 MG MG A 301 A 51 ASN A 132 ASN^? 16.38 MG MG A 301 coo 28.68 23.77 42.74 27.76 26.72 42.93 43.09 4.06 39.01 41.78 1.42 39.93 coo 14.40 30.33 40.28 14.25 28.31 45.36 52.67 17.19 35.90 54.65 19.90 40.50 coo 19.09 30.55 41.51 19.09 28.89 42.82 50.16 14.55 39.76 50.61 16.24 40.93 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 2 3 # 2 A 5 ARG B 193 ARG^? 28.40 MG MG B 301 A 50 LYS B 111 LYS^? 13.75 MG MG B 302 A 51 ASN B 132 ASN^? 16.42 MG MG B 302 coo 28.68 23.77 42.74 27.76 26.72 42.93 29.25 23.93 -4.74 26.96 25.70 -3.52 coo 14.40 30.33 40.28 14.25 28.31 45.36 42.84 32.14 1.80 46.84 32.68 -2.87 coo 19.09 30.55 41.51 19.09 28.89 42.82 40.27 30.00 -2.76 41.98 31.07 -3.41 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 3 3 # 3 A 5 ARG C 193 ARG^? 28.20 MG MG C 301 A 50 LYS C 111 LYS^? 16.56 MG MG C 302 A 51 ASN C 132 ASN^? 16.52 MG MG C 302 coo 28.68 23.77 42.74 27.76 26.72 42.93 102.52 36.87 -2.60 102.78 39.94 -3.05 coo 14.40 30.33 40.28 14.25 28.31 45.36 86.36 39.56 -8.06 84.36 40.84 -3.15 coo 19.09 30.55 41.51 19.09 28.89 42.82 89.66 38.54 -3.77 87.74 38.77 -2.97 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 4 3 # 4 A 5 ARG D 193 ARG^? 27.92 MG MG D 301 A 50 LYS D 111 LYS^? 15.85 MG MG D 302 A 51 ASN D 132 ASN^? 16.46 MG MG D 302 coo 28.68 23.77 42.74 27.76 26.72 42.93 95.76 15.06 -47.43 94.58 12.31 -46.69 coo 14.40 30.33 40.28 14.25 28.31 45.36 81.21 22.69 -42.10 78.68 23.89 -46.57 coo 19.09 30.55 41.51 19.09 28.89 42.82 84.64 21.31 -46.24 83.02 22.38 -47.10 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 5 3 # 5 A 5 ARG E 193 ARG^? 28.25 MG MG E 301 A 50 LYS E 111 LYS^? 14.52 MG MG E 302 A 51 ASN E 132 ASN^? 16.39 MG MG E 302 coo 28.68 23.77 42.74 27.76 26.72 42.93 47.02 71.25 -47.53 44.19 71.23 -48.93 coo 14.40 30.33 40.28 14.25 28.31 45.36 52.49 56.44 -52.43 54.52 53.78 -47.52 coo 19.09 30.55 41.51 19.09 28.89 42.82 51.80 60.19 -48.38 52.68 58.51 -47.42 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 6 3 # 6 A 5 ARG F 193 ARG^? 27.27 MG MG F 302 A 50 LYS F 111 LYS^? 15.21 MG MG F 301 A 51 ASN F 132 ASN^? 16.48 MG MG F 301 coo 28.68 23.77 42.74 27.76 26.72 42.93 70.24 75.04 -91.81 72.97 73.73 -92.20 coo 14.40 30.33 40.28 14.25 28.31 45.36 69.70 58.57 -86.86 69.67 53.74 -90.29 coo 19.09 30.55 41.51 19.09 28.89 42.82 69.23 61.88 -90.93 69.10 59.95 -91.77 2hos_d00 source 2hos TRANSCRIPTION/DNA : 6 hits 2hos_d00 naa= 3 ULMN 4 2ve9_d00 TRANSPORT PROTEIN user 1 4 # 1 C 766 SER A 66 SER^? 21.38 MG MG A 301 C 769 GLN A 53 GLN^? 15.00 MG MG A 301 C 776 TYR A 67 TYR^? 21.33 MG MG A 301 C 777 ASN A 69 ASN^? 19.68 MG MG A 301 coo 23.61 29.92 45.10 24.50 29.24 47.28 52.67 19.58 24.88 54.49 20.94 25.63 coo 23.11 26.56 42.17 23.52 25.54 43.99 48.51 22.34 28.72 49.24 22.16 30.72 coo 27.75 23.53 43.88 30.40 24.12 44.60 48.62 23.20 22.09 46.84 25.23 21.44 coo 29.40 21.48 39.64 30.54 20.83 41.35 46.77 28.40 23.46 47.19 29.97 22.08 ULMN 4 2ve9_d00 TRANSPORT PROTEIN user 2 4 # 2 C 766 SER B 66 SER^? 21.21 MG MG B 302 C 769 GLN B 53 GLN^? 14.94 MG MG B 302 C 776 TYR B 67 TYR^? 21.41 MG MG B 302 C 777 ASN B 69 ASN^? 19.69 MG MG B 302 coo 23.61 29.92 45.10 24.50 29.24 47.28 44.21 30.46 12.82 45.29 32.17 11.68 coo 23.11 26.56 42.17 23.52 25.54 43.99 46.20 26.35 8.70 46.62 27.22 6.80 coo 27.75 23.53 43.88 30.40 24.12 44.60 46.94 25.86 15.48 48.70 23.84 16.15 coo 29.40 21.48 39.64 30.54 20.83 41.35 51.67 23.38 14.25 53.20 23.05 15.64 ULMN 4 2ve9_d00 TRANSPORT PROTEIN user 3 4 # 3 C 766 SER C 66 SER^? 20.91 MG MG C 302 C 769 GLN C 53 GLN^? 14.81 MG MG C 302 C 776 TYR C 67 TYR^? 21.03 MG MG C 302 C 777 ASN C 69 ASN^? 19.30 MG MG C 302 coo 23.61 29.92 45.10 24.50 29.24 47.28 85.39 37.79 -19.17 83.53 38.71 -18.09 coo 23.11 26.56 42.17 23.52 25.54 43.99 85.10 33.09 -15.04 84.28 33.88 -13.22 coo 27.75 23.53 43.88 30.40 24.12 44.60 84.52 32.45 -21.76 83.69 29.84 -22.37 coo 29.40 21.48 39.64 30.54 20.83 41.35 80.86 28.32 -20.51 79.46 27.66 -21.93 ULMN 4 2ve9_d00 TRANSPORT PROTEIN user 4 4 # 4 C 766 SER D 66 SER^? 21.51 MG MG D 302 C 769 GLN D 53 GLN^? 15.01 MG MG D 302 C 776 TYR D 67 TYR^? 21.42 MG MG D 302 C 777 ASN D 69 ASN^? 19.77 MG MG D 302 coo 23.61 29.92 45.10 24.50 29.24 47.28 81.04 24.82 -31.14 78.93 25.00 -32.28 coo 23.11 26.56 42.17 23.52 25.54 43.99 83.68 28.79 -35.08 83.11 28.49 -37.14 coo 27.75 23.53 43.88 30.40 24.12 44.60 83.62 29.64 -28.35 84.67 32.17 -27.90 coo 29.40 21.48 39.64 30.54 20.83 41.35 83.26 34.94 -29.76 82.66 36.44 -28.44 ULMN 4 2ve9_d00 TRANSPORT PROTEIN user 5 4 # 5 C 766 SER E 66 SER^? 21.23 MG MG E 302 C 769 GLN E 53 GLN^? 15.16 MG MG E 302 C 776 TYR E 67 TYR^? 21.41 MG MG E 302 C 777 ASN E 69 ASN^? 19.64 MG MG E 302 coo 23.61 29.92 45.10 24.50 29.24 47.28 54.72 55.62 -63.56 54.90 53.49 -62.62 coo 23.11 26.56 42.17 23.52 25.54 43.99 58.99 57.94 -59.66 58.42 57.10 -57.76 coo 27.75 23.53 43.88 30.40 24.12 44.60 59.76 57.41 -66.37 62.46 58.08 -67.03 coo 29.40 21.48 39.64 30.54 20.83 41.35 65.28 56.38 -64.89 66.38 55.27 -66.29 ULMN 4 2ve9_d00 TRANSPORT PROTEIN user 6 4 # 6 C 766 SER F 66 SER^? 21.35 MG MG F 301 C 769 GLN F 53 GLN^? 15.06 MG MG F 301 C 776 TYR F 67 TYR^? 21.41 MG MG F 301 C 777 ASN F 69 ASN^? 19.72 MG MG F 301 coo 23.61 29.92 45.10 24.50 29.24 47.28 68.12 57.69 -75.42 68.70 55.68 -76.54 coo 23.11 26.56 42.17 23.52 25.54 43.99 63.34 58.26 -79.73 63.90 57.42 -81.62 coo 27.75 23.53 43.88 30.40 24.12 44.60 62.63 57.65 -72.90 59.95 57.21 -72.29 coo 29.40 21.48 39.64 30.54 20.83 41.35 58.04 54.70 -74.12 56.99 53.50 -72.70 2ve9_d00 source 2ve9 TRANSPORT PROTEIN : 6 hits 2ve9_d00 naa= 4 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 B 34 SER A 117 SER^? 9.60 MG MG A 301 B 37 ASN A 118 ASN^? 13.27 MG MG A 301 B 45 THR A 178 THR^? 11.01 MG MG A 302 coo -19.49 41.97 71.08 -17.37 40.80 71.17 46.51 36.12 34.76 48.66 37.10 34.49 coo -23.05 39.62 69.74 -22.86 39.59 67.61 43.06 39.25 33.60 42.05 40.75 32.42 coo -30.87 34.84 80.57 -28.94 34.51 81.49 32.90 33.33 42.26 32.53 35.14 43.38 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 B 34 SER B 66 SER^? 21.21 MG MG B 302 B 37 ASN A 45 ASN^? 24.62 MG MG B 302 B 45 THR A 73 THR^? 15.13 MG MG A 301 coo -19.49 41.97 71.08 -17.37 40.80 71.17 44.21 30.46 12.82 45.29 32.17 11.68 coo -23.05 39.62 69.74 -22.86 39.59 67.61 42.72 26.12 17.32 44.44 25.00 17.78 coo -30.87 34.84 80.57 -28.94 34.51 81.49 40.93 39.17 26.72 41.99 38.78 28.61 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 B 34 SER B 66 SER^? 21.21 MG MG B 302 B 37 ASN A 45 ASN^? 24.62 MG MG B 302 B 45 THR A 93 THR^? 16.79 MG MG A 301 coo -19.49 41.97 71.08 -17.37 40.80 71.17 44.21 30.46 12.82 45.29 32.17 11.68 coo -23.05 39.62 69.74 -22.86 39.59 67.61 42.72 26.12 17.32 44.44 25.00 17.78 coo -30.87 34.84 80.57 -28.94 34.51 81.49 51.84 31.38 28.05 51.33 31.03 25.98 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 4 3 # 4 B 34 SER B 66 SER^? 21.21 MG MG B 302 B 37 ASN A 45 ASN^? 24.62 MG MG B 302 B 45 THR B 46 THR^? 23.88 MG MG B 302 coo -19.49 41.97 71.08 -17.37 40.80 71.17 44.21 30.46 12.82 45.29 32.17 11.68 coo -23.05 39.62 69.74 -22.86 39.59 67.61 42.72 26.12 17.32 44.44 25.00 17.78 coo -30.87 34.84 80.57 -28.94 34.51 81.49 49.71 15.16 18.13 48.80 13.51 17.14 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 5 3 # 5 B 34 SER B 105 SER^? 35.94 MG MG B 302 B 37 ASN B 104 ASN^? 29.09 MG MG B 302 B 45 THR B 2 THR^? 34.11 MG MG B 302 coo -19.49 41.97 71.08 -17.37 40.80 71.17 27.02 40.56 4.17 25.36 40.23 2.44 coo -23.05 39.62 69.74 -22.86 39.59 67.61 30.21 38.92 1.75 31.47 37.16 1.65 coo -30.87 34.84 80.57 -28.94 34.51 81.49 25.51 29.18 13.74 26.24 28.19 11.93 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 6 3 # 6 B 34 SER B 117 SER^? 9.14 MG MG B 302 B 37 ASN B 118 ASN^? 13.44 MG MG B 302 B 45 THR B 178 THR^? 10.48 MG MG B 301 coo -19.49 41.97 71.08 -17.37 40.80 71.17 60.50 22.87 3.68 61.23 25.10 3.08 coo -23.05 39.62 69.74 -22.86 39.59 67.61 63.19 18.87 4.27 64.22 17.47 5.51 coo -30.87 34.84 80.57 -28.94 34.51 81.49 56.23 10.27 -5.85 58.11 9.83 -6.86 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 7 3 # 7 B 34 SER C 117 SER^?